INTEDE - Interactome of Drug-Metabolizing Enzyme Database Title - Xenobiotics factors (health or environmental toxicant / natural product / extract or medicine, etc) altering DME activity Version 1.8.1 (2020.08.15) Provided by IDRB Lab of Innovative Drug Reasearch and Bioinformatics College of Pharmaceutical Sciences Zhejiang University https://idrblab.org/ Any question about data provided here, please contact with: Dr. Yin (yinjiayi@zju.edu.cn) and Dr. Li (lifengcheng@zju.edu.cn) -------------------------------------------------------------------------------------------------------- Abbreviations: DME___ID INTEDE Drug-Metabolizing Enzyme (DME) ID DME_NAME DME Name SPESNAME DME Species Name XEOTICID Xenobiotics ID XEO_NAME Xenobiotics Name XEO_TYPE Xenobiotics Type XEO_CLAS Xenobiotics Classification DESCRIPT Xenobiotics-DME Interaction Description GENEFORM Xenobiotics-DME Interaction Gene Form MOACRIVE Modulation Type (Induction, Inhibition, etc.) -------------------------------------------------------------------------------------------------------- DME0001 DME___ID DME0001 DME0001 DME_NAME Cytochrome P450 3A4 (CYP3A4) DME0001 SPESNAME Homo sapiens DME0001 XEOTICID XEO00001 XEO_NAME Dimethyl sulfoxide DME0001 XEOTICID XEO00001 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00001 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00001 DESCRIPT Dimethyl sulfoxide up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00001 GENEFORM mRNA DME0001 XEOTICID XEO00001 MOACRIVE Induction DME0001 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0001 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00011 DESCRIPT Carbamazepine induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00011 GENEFORM Protein DME0001 XEOTICID XEO00011 MOACRIVE Induction DME0001 XEOTICID XEO00015 XEO_NAME Cimetidine DME0001 XEOTICID XEO00015 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00015 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00015 DESCRIPT Cimetidine inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 15 microM) DME0001 XEOTICID XEO00015 GENEFORM Protein DME0001 XEOTICID XEO00015 MOACRIVE Inhibition DME0001 XEOTICID XEO00017 XEO_NAME Clotrimazole DME0001 XEOTICID XEO00017 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00017 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00017 DESCRIPT Clotrimazole inhibits the drug-metabolizing activity of DME CYP3A4 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.016 microM) DME0001 XEOTICID XEO00017 GENEFORM Protein DME0001 XEOTICID XEO00017 MOACRIVE Inhibition DME0001 XEOTICID XEO00018 XEO_NAME Cyclophosphamide DME0001 XEOTICID XEO00018 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00018 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00018 DESCRIPT Cyclophosphamide up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00018 GENEFORM mRNA DME0001 XEOTICID XEO00018 MOACRIVE Induction DME0001 XEOTICID XEO00022 XEO_NAME Desipramine DME0001 XEOTICID XEO00022 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00022 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00022 DESCRIPT Desipramine inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00022 GENEFORM Protein DME0001 XEOTICID XEO00022 MOACRIVE Inhibition DME0001 XEOTICID XEO00029 XEO_NAME Valproic acid DME0001 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00029 GENEFORM mRNA DME0001 XEOTICID XEO00029 MOACRIVE Inhibition DME0001 XEOTICID XEO00036 XEO_NAME Fluconazole DME0001 XEOTICID XEO00036 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00036 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00036 DESCRIPT Fluconazole inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 8 microM) DME0001 XEOTICID XEO00036 GENEFORM Protein DME0001 XEOTICID XEO00036 MOACRIVE Inhibition DME0001 XEOTICID XEO00038 XEO_NAME Flutamide DME0001 XEOTICID XEO00038 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00038 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00038 DESCRIPT Flutamide induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00038 GENEFORM Protein DME0001 XEOTICID XEO00038 MOACRIVE Induction DME0001 XEOTICID XEO00042 XEO_NAME Gemfibrozil DME0001 XEOTICID XEO00042 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00042 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00042 DESCRIPT Gemfibrozil induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00042 GENEFORM Protein DME0001 XEOTICID XEO00042 MOACRIVE Induction DME0001 XEOTICID XEO00046 XEO_NAME Ifosfamide DME0001 XEOTICID XEO00046 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00046 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00046 DESCRIPT Ifosfamide up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00046 GENEFORM mRNA DME0001 XEOTICID XEO00046 MOACRIVE Induction DME0001 XEOTICID XEO00049 XEO_NAME Isradipine DME0001 XEOTICID XEO00049 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00049 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00049 DESCRIPT Isradipine up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00049 GENEFORM mRNA DME0001 XEOTICID XEO00049 MOACRIVE Induction DME0001 XEOTICID XEO00052 XEO_NAME Lansoprazole DME0001 XEOTICID XEO00052 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00052 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00052 DESCRIPT Lansoprazole induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00052 GENEFORM Protein DME0001 XEOTICID XEO00052 MOACRIVE Induction DME0001 XEOTICID XEO00055 XEO_NAME Loratadine DME0001 XEOTICID XEO00055 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00055 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00055 DESCRIPT Loratadine inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 > 30 microM) DME0001 XEOTICID XEO00055 GENEFORM Protein DME0001 XEOTICID XEO00055 MOACRIVE Inhibition DME0001 XEOTICID XEO00056 XEO_NAME Malathion DME0001 XEOTICID XEO00056 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00056 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00056 DESCRIPT Malathion induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00056 GENEFORM Protein DME0001 XEOTICID XEO00056 MOACRIVE Induction DME0001 XEOTICID XEO00058 XEO_NAME Meclizine DME0001 XEOTICID XEO00058 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00058 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00058 DESCRIPT Meclizine inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00058 GENEFORM Protein DME0001 XEOTICID XEO00058 MOACRIVE Inhibition DME0001 XEOTICID XEO00062 XEO_NAME Methoxsalen DME0001 XEOTICID XEO00062 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00062 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00062 DESCRIPT Methoxsalen inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00062 GENEFORM mRNA DME0001 XEOTICID XEO00062 MOACRIVE Inhibition DME0001 XEOTICID XEO00064 XEO_NAME Mitotane DME0001 XEOTICID XEO00064 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00064 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00064 DESCRIPT Mitotane up-regulates the expression of DME CYP3A4 and leads to increasing the drug-metabolizing activity of this enzyme DME0001 XEOTICID XEO00064 GENEFORM Protein DME0001 XEOTICID XEO00064 MOACRIVE Induction DME0001 XEOTICID XEO00066 XEO_NAME Nifedipine DME0001 XEOTICID XEO00066 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00066 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00066 DESCRIPT Nifedipine up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00066 GENEFORM mRNA DME0001 XEOTICID XEO00066 MOACRIVE Induction DME0001 XEOTICID XEO00069 XEO_NAME Omeprazole DME0001 XEOTICID XEO00069 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00069 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00069 DESCRIPT Omeprazole up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00069 GENEFORM mRNA DME0001 XEOTICID XEO00069 MOACRIVE Induction DME0001 XEOTICID XEO00071 XEO_NAME Phenylbutazone DME0001 XEOTICID XEO00071 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00071 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00071 DESCRIPT Phenylbutazone induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00071 GENEFORM Protein DME0001 XEOTICID XEO00071 MOACRIVE Induction DME0001 XEOTICID XEO00072 XEO_NAME Probenecid DME0001 XEOTICID XEO00072 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00072 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00072 DESCRIPT Probenecid inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00072 GENEFORM mRNA DME0001 XEOTICID XEO00072 MOACRIVE Inhibition DME0001 XEOTICID XEO00083 XEO_NAME Thalidomide DME0001 XEOTICID XEO00083 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00083 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00083 DESCRIPT Thalidomide up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00083 GENEFORM mRNA DME0001 XEOTICID XEO00083 MOACRIVE Induction DME0001 XEOTICID XEO00084 XEO_NAME Thiabendazole DME0001 XEOTICID XEO00084 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00084 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00084 DESCRIPT Thiabendazole up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00084 GENEFORM mRNA DME0001 XEOTICID XEO00084 MOACRIVE Induction DME0001 XEOTICID XEO00086 XEO_NAME Troglitazone DME0001 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00086 GENEFORM mRNA DME0001 XEOTICID XEO00086 MOACRIVE Induction DME0001 XEOTICID XEO00087 XEO_NAME Zafirlukast DME0001 XEOTICID XEO00087 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00087 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00087 DESCRIPT Zafirlukast inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00087 GENEFORM mRNA DME0001 XEOTICID XEO00087 MOACRIVE Inhibition DME0001 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0001 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00088 DESCRIPT Dexamethasone induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00088 GENEFORM Protein DME0001 XEOTICID XEO00088 MOACRIVE Induction DME0001 XEOTICID XEO00090 XEO_NAME Estradiol DME0001 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00090 DESCRIPT Estradiol induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00090 GENEFORM Protein DME0001 XEOTICID XEO00090 MOACRIVE Induction DME0001 XEOTICID XEO00094 XEO_NAME Progesterone DME0001 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00094 DESCRIPT Progesterone up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00094 GENEFORM mRNA DME0001 XEOTICID XEO00094 MOACRIVE Induction DME0001 XEOTICID XEO00099 XEO_NAME Penicillin V DME0001 XEOTICID XEO00099 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00099 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00099 DESCRIPT Penicillin V up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00099 GENEFORM mRNA DME0001 XEOTICID XEO00099 MOACRIVE Induction DME0001 XEOTICID XEO00101 XEO_NAME Nafcillin DME0001 XEOTICID XEO00101 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00101 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00101 DESCRIPT Nafcillin induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00101 GENEFORM Protein DME0001 XEOTICID XEO00101 MOACRIVE Induction DME0001 XEOTICID XEO00102 XEO_NAME Azacitidine DME0001 XEOTICID XEO00102 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00102 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00102 DESCRIPT Azacitidine up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00102 GENEFORM mRNA DME0001 XEOTICID XEO00102 MOACRIVE Induction DME0001 XEOTICID XEO00105 XEO_NAME Dihydroergotamine DME0001 XEOTICID XEO00105 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00105 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00105 DESCRIPT Dihydroergotamine inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 2.99916 microM) DME0001 XEOTICID XEO00105 GENEFORM Protein DME0001 XEOTICID XEO00105 MOACRIVE Inhibition DME0001 XEOTICID XEO00111 XEO_NAME Erythromycin DME0001 XEOTICID XEO00111 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00111 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00111 DESCRIPT Erythromycin inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 0.19 microM) DME0001 XEOTICID XEO00111 GENEFORM Protein DME0001 XEOTICID XEO00111 MOACRIVE Inhibition DME0001 XEOTICID XEO00116 XEO_NAME Dicloxacillin DME0001 XEOTICID XEO00116 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00116 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00116 DESCRIPT Dicloxacillin up-regulates the expression of DME CYP3A4 and leads to increasing the drug-metabolizing activity of this enzyme DME0001 XEOTICID XEO00116 GENEFORM Protein DME0001 XEOTICID XEO00116 MOACRIVE Induction DME0001 XEOTICID XEO00123 XEO_NAME Permethrin DME0001 XEOTICID XEO00123 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00123 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00123 DESCRIPT Permethrin up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00123 GENEFORM mRNA DME0001 XEOTICID XEO00123 MOACRIVE Induction DME0001 XEOTICID XEO00124 XEO_NAME Cefaclor DME0001 XEOTICID XEO00124 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00124 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00124 DESCRIPT Cefaclor induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00124 GENEFORM Protein DME0001 XEOTICID XEO00124 MOACRIVE Induction DME0001 XEOTICID XEO00125 XEO_NAME Simvastatin DME0001 XEOTICID XEO00125 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00125 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00125 DESCRIPT Simvastatin up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00125 GENEFORM mRNA DME0001 XEOTICID XEO00125 MOACRIVE Induction DME0001 XEOTICID XEO00127 XEO_NAME Mifepristone DME0001 XEOTICID XEO00127 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00127 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00127 DESCRIPT Mifepristone inhibits the drug-metabolizing activity of DME CYP3A4 (Ki = 4.7 microM) DME0001 XEOTICID XEO00127 GENEFORM Protein DME0001 XEOTICID XEO00127 MOACRIVE Inhibition DME0001 XEOTICID XEO00135 XEO_NAME Ferric citrate DME0001 XEOTICID XEO00135 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00135 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00135 DESCRIPT Ferric citrate induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00135 GENEFORM Protein DME0001 XEOTICID XEO00135 MOACRIVE Induction DME0001 XEOTICID XEO00138 XEO_NAME Fenofibric acid DME0001 XEOTICID XEO00138 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00138 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00138 DESCRIPT Fenofibric acid induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00138 GENEFORM Protein DME0001 XEOTICID XEO00138 MOACRIVE Induction DME0001 XEOTICID XEO00139 XEO_NAME Amprenavir DME0001 XEOTICID XEO00139 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00139 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00139 DESCRIPT Amprenavir inhibits the drug-metabolizing activity of DME CYP3A4 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 1 microM) DME0001 XEOTICID XEO00139 GENEFORM Protein DME0001 XEOTICID XEO00139 MOACRIVE Inhibition DME0001 XEOTICID XEO00142 XEO_NAME Voriconazole DME0001 XEOTICID XEO00142 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00142 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00142 DESCRIPT Voriconazole inhibits the drug-metabolizing activity of DME CYP3A4 in Human hepatocyte (IC50 = 13 microM) DME0001 XEOTICID XEO00142 GENEFORM Protein DME0001 XEOTICID XEO00142 MOACRIVE Inhibition DME0001 XEOTICID XEO00146 XEO_NAME Clarithromycin DME0001 XEOTICID XEO00146 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00146 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00146 DESCRIPT Clarithromycin inhibits the drug-metabolizing activity of DME CYP3A4 (Ki = 5.49 microM) DME0001 XEOTICID XEO00146 GENEFORM Protein DME0001 XEOTICID XEO00146 MOACRIVE Inhibition DME0001 XEOTICID XEO00148 XEO_NAME Bosentan DME0001 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00148 DESCRIPT Bosentan up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00148 GENEFORM mRNA DME0001 XEOTICID XEO00148 MOACRIVE Induction DME0001 XEOTICID XEO00153 XEO_NAME Docetaxel DME0001 XEOTICID XEO00153 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00153 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00153 DESCRIPT Docetaxel up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00153 GENEFORM mRNA DME0001 XEOTICID XEO00153 MOACRIVE Induction DME0001 XEOTICID XEO00157 XEO_NAME Erlotinib hydrochloride DME0001 XEOTICID XEO00157 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00157 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00157 DESCRIPT Erlotinib hydrochloride inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00157 GENEFORM Protein DME0001 XEOTICID XEO00157 MOACRIVE Inhibition DME0001 XEOTICID XEO00158 XEO_NAME Cholic acid DME0001 XEOTICID XEO00158 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00158 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00158 DESCRIPT Cholic acid inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00158 GENEFORM Protein DME0001 XEOTICID XEO00158 MOACRIVE Inhibition DME0001 XEOTICID XEO00160 XEO_NAME Ritonavir DME0001 XEOTICID XEO00160 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00160 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00160 DESCRIPT Ritonavir inhibits the drug-metabolizing activity of DME CYP3A4 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.016 microM) DME0001 XEOTICID XEO00160 GENEFORM Protein DME0001 XEOTICID XEO00160 MOACRIVE Inhibition DME0001 XEOTICID XEO00161 XEO_NAME Griseofulvin DME0001 XEOTICID XEO00161 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00161 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00161 DESCRIPT Griseofulvin induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00161 GENEFORM Protein DME0001 XEOTICID XEO00161 MOACRIVE Induction DME0001 XEOTICID XEO00164 XEO_NAME Azithromycin DME0001 XEOTICID XEO00164 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00164 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00164 DESCRIPT Azithromycin inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 > 10 microM) DME0001 XEOTICID XEO00164 GENEFORM Protein DME0001 XEOTICID XEO00164 MOACRIVE Inhibition DME0001 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0001 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00166 GENEFORM Protein DME0001 XEOTICID XEO00166 MOACRIVE Induction DME0001 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0001 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00167 DESCRIPT Alitretinoin induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00167 GENEFORM Protein DME0001 XEOTICID XEO00167 MOACRIVE Induction DME0001 XEOTICID XEO00170 XEO_NAME Posaconazole DME0001 XEOTICID XEO00170 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00170 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00170 DESCRIPT Posaconazole inhibits the drug-metabolizing activity of DME CYP3A4 in Human hepatocyte (IC50 = 0.05 microM) DME0001 XEOTICID XEO00170 GENEFORM Protein DME0001 XEOTICID XEO00170 MOACRIVE Inhibition DME0001 XEOTICID XEO00173 XEO_NAME Cannabidiol DME0001 XEOTICID XEO00173 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00173 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00173 DESCRIPT Cannabidiol inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00173 GENEFORM Protein DME0001 XEOTICID XEO00173 MOACRIVE Inhibition DME0001 XEOTICID XEO00178 XEO_NAME Capsaicin DME0001 XEOTICID XEO00178 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00178 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00178 DESCRIPT Capsaicin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00178 GENEFORM Protein DME0001 XEOTICID XEO00178 MOACRIVE Inhibition DME0001 XEOTICID XEO00179 XEO_NAME Orlistat DME0001 XEOTICID XEO00179 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00179 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00179 DESCRIPT Orlistat up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00179 GENEFORM mRNA DME0001 XEOTICID XEO00179 MOACRIVE Induction DME0001 XEOTICID XEO00180 XEO_NAME Quinine DME0001 XEOTICID XEO00180 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00180 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00180 DESCRIPT Quinine inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00180 GENEFORM mRNA DME0001 XEOTICID XEO00180 MOACRIVE Inhibition DME0001 XEOTICID XEO00184 XEO_NAME Calcitriol DME0001 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME CYP3A4 and leads to increasing the drug-metabolizing activity of this enzyme DME0001 XEOTICID XEO00184 GENEFORM Protein DME0001 XEOTICID XEO00184 MOACRIVE Induction DME0001 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0001 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00186 DESCRIPT Isotretinoin induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00186 GENEFORM Protein DME0001 XEOTICID XEO00186 MOACRIVE Induction DME0001 XEOTICID XEO00189 XEO_NAME Topiramate DME0001 XEOTICID XEO00189 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00189 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00189 DESCRIPT Topiramate up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00189 GENEFORM mRNA DME0001 XEOTICID XEO00189 MOACRIVE Induction DME0001 XEOTICID XEO00195 XEO_NAME Crizotinib DME0001 XEOTICID XEO00195 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00195 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00195 DESCRIPT Crizotinib up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00195 GENEFORM mRNA DME0001 XEOTICID XEO00195 MOACRIVE Induction DME0001 XEOTICID XEO00216 XEO_NAME Efavirenz DME0001 XEOTICID XEO00216 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00216 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00216 DESCRIPT Efavirenz inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00216 GENEFORM Protein DME0001 XEOTICID XEO00216 MOACRIVE Inhibition DME0001 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0001 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00217 GENEFORM Protein DME0001 XEOTICID XEO00217 MOACRIVE Inhibition DME0001 XEOTICID XEO00218 XEO_NAME Caffeine DME0001 XEOTICID XEO00218 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00218 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00218 DESCRIPT Caffeine inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00218 GENEFORM Protein DME0001 XEOTICID XEO00218 MOACRIVE Inhibition DME0001 XEOTICID XEO00219 XEO_NAME Prednisolone DME0001 XEOTICID XEO00219 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00219 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00219 DESCRIPT Prednisolone up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00219 GENEFORM mRNA DME0001 XEOTICID XEO00219 MOACRIVE Induction DME0001 XEOTICID XEO00223 XEO_NAME Rifampin DME0001 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00223 DESCRIPT Rifampin induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00223 GENEFORM Protein DME0001 XEOTICID XEO00223 MOACRIVE Induction DME0001 XEOTICID XEO00224 XEO_NAME Isoniazid DME0001 XEOTICID XEO00224 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00224 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00224 DESCRIPT Isoniazid inhibits the drug-metabolizing activity of DME CYP3A4 (Ki = 36 microM) DME0001 XEOTICID XEO00224 GENEFORM Protein DME0001 XEOTICID XEO00224 MOACRIVE Inhibition DME0001 XEOTICID XEO00227 XEO_NAME Rifapentine DME0001 XEOTICID XEO00227 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00227 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00227 DESCRIPT Rifapentine up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00227 GENEFORM mRNA DME0001 XEOTICID XEO00227 MOACRIVE Induction DME0001 XEOTICID XEO00231 XEO_NAME Troleandomycin DME0001 XEOTICID XEO00231 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00231 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00231 DESCRIPT Troleandomycin up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00231 GENEFORM mRNA DME0001 XEOTICID XEO00231 MOACRIVE Induction DME0001 XEOTICID XEO00232 XEO_NAME Phenytoin DME0001 XEOTICID XEO00232 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00232 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00232 DESCRIPT Phenytoin up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00232 GENEFORM mRNA DME0001 XEOTICID XEO00232 MOACRIVE Induction DME0001 XEOTICID XEO00235 XEO_NAME Budesonide DME0001 XEOTICID XEO00235 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00235 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00235 DESCRIPT Budesonide up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00235 GENEFORM mRNA DME0001 XEOTICID XEO00235 MOACRIVE Induction DME0001 XEOTICID XEO00238 XEO_NAME Chloroquine DME0001 XEOTICID XEO00238 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00238 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00238 DESCRIPT Chloroquine inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 349.94517 microM) DME0001 XEOTICID XEO00238 GENEFORM Protein DME0001 XEOTICID XEO00238 MOACRIVE Inhibition DME0001 XEOTICID XEO00240 XEO_NAME Clindamycin DME0001 XEOTICID XEO00240 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00240 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00240 DESCRIPT Clindamycin up-regulates the expression of DME CYP3A4 and leads to increasing the drug-metabolizing activity of this enzyme DME0001 XEOTICID XEO00240 GENEFORM Protein DME0001 XEOTICID XEO00240 MOACRIVE Induction DME0001 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0001 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 > 10 microM) DME0001 XEOTICID XEO00241 GENEFORM Protein DME0001 XEOTICID XEO00241 MOACRIVE Inhibition DME0001 XEOTICID XEO00243 XEO_NAME Pimecrolimus DME0001 XEOTICID XEO00243 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00243 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00243 DESCRIPT Pimecrolimus up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00243 GENEFORM mRNA DME0001 XEOTICID XEO00243 MOACRIVE Induction DME0001 XEOTICID XEO00244 XEO_NAME Ivermectin DME0001 XEOTICID XEO00244 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00244 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00244 DESCRIPT Ivermectin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00244 GENEFORM Protein DME0001 XEOTICID XEO00244 MOACRIVE Inhibition DME0001 XEOTICID XEO00245 XEO_NAME Felodipine DME0001 XEOTICID XEO00245 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00245 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00245 DESCRIPT Felodipine up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00245 GENEFORM mRNA DME0001 XEOTICID XEO00245 MOACRIVE Induction DME0001 XEOTICID XEO00250 XEO_NAME Itraconazole DME0001 XEOTICID XEO00250 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00250 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00250 DESCRIPT Itraconazole inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 0.004 microM) DME0001 XEOTICID XEO00250 GENEFORM Protein DME0001 XEOTICID XEO00250 MOACRIVE Inhibition DME0001 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0001 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 < 0.062 microM) DME0001 XEOTICID XEO00251 GENEFORM Protein DME0001 XEOTICID XEO00251 MOACRIVE Inhibition DME0001 XEOTICID XEO00253 XEO_NAME Tretinoin DME0001 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00253 GENEFORM mRNA DME0001 XEOTICID XEO00253 MOACRIVE Inhibition DME0001 XEOTICID XEO00256 XEO_NAME Paclitaxel DME0001 XEOTICID XEO00256 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00256 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00256 DESCRIPT Paclitaxel inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00256 GENEFORM Protein DME0001 XEOTICID XEO00256 MOACRIVE Inhibition DME0001 XEOTICID XEO00262 XEO_NAME Lovastatin DME0001 XEOTICID XEO00262 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00262 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00262 DESCRIPT Lovastatin up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00262 GENEFORM mRNA DME0001 XEOTICID XEO00262 MOACRIVE Induction DME0001 XEOTICID XEO00264 XEO_NAME Hydrocortisone DME0001 XEOTICID XEO00264 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00264 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00264 DESCRIPT Hydrocortisone up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00264 GENEFORM mRNA DME0001 XEOTICID XEO00264 MOACRIVE Induction DME0001 XEOTICID XEO00267 XEO_NAME Ethinyl estradiol DME0001 XEOTICID XEO00267 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00267 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00267 DESCRIPT Ethinyl estradiol inhibits the drug-metabolizing activity of DME CYP3A4 (Ki = 18 microM) DME0001 XEOTICID XEO00267 GENEFORM Protein DME0001 XEOTICID XEO00267 MOACRIVE Inhibition DME0001 XEOTICID XEO00272 XEO_NAME Rifaximin DME0001 XEOTICID XEO00272 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00272 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00272 DESCRIPT Rifaximin induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00272 GENEFORM Protein DME0001 XEOTICID XEO00272 MOACRIVE Induction DME0001 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0001 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00277 GENEFORM Protein DME0001 XEOTICID XEO00277 MOACRIVE Inhibition DME0001 XEOTICID XEO00280 XEO_NAME Chlorpromazine hydrochloride DME0001 XEOTICID XEO00280 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00280 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00280 DESCRIPT Chlorpromazine hydrochloride inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 23.3 microM) DME0001 XEOTICID XEO00280 GENEFORM Protein DME0001 XEOTICID XEO00280 MOACRIVE Inhibition DME0001 XEOTICID XEO00286 XEO_NAME Deferoxamine mesylate DME0001 XEOTICID XEO00286 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00286 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00286 DESCRIPT Deferoxamine mesylate inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00286 GENEFORM Protein DME0001 XEOTICID XEO00286 MOACRIVE Inhibition DME0001 XEOTICID XEO00288 XEO_NAME Diltiazem hydrochloride DME0001 XEOTICID XEO00288 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00288 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00288 DESCRIPT Diltiazem hydrochloride inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 0.1 microM) DME0001 XEOTICID XEO00288 GENEFORM Protein DME0001 XEOTICID XEO00288 MOACRIVE Inhibition DME0001 XEOTICID XEO00290 XEO_NAME Dopamine hydrochloride DME0001 XEOTICID XEO00290 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00290 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00290 DESCRIPT Dopamine hydrochloride inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00290 GENEFORM Protein DME0001 XEOTICID XEO00290 MOACRIVE Inhibition DME0001 XEOTICID XEO00293 XEO_NAME Econazole nitrate DME0001 XEOTICID XEO00293 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00293 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00293 DESCRIPT Econazole nitrate inhibits the drug-metabolizing activity of DME CYP3A4 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.05 microM) DME0001 XEOTICID XEO00293 GENEFORM Protein DME0001 XEOTICID XEO00293 MOACRIVE Inhibition DME0001 XEOTICID XEO00295 XEO_NAME Fluphenazine hydrochloride DME0001 XEOTICID XEO00295 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00295 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00295 DESCRIPT Fluphenazine hydrochloride inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00295 GENEFORM Protein DME0001 XEOTICID XEO00295 MOACRIVE Inhibition DME0001 XEOTICID XEO00297 XEO_NAME Fluticasone furoate DME0001 XEOTICID XEO00297 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00297 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00297 DESCRIPT Fluticasone furoate inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00297 GENEFORM Protein DME0001 XEOTICID XEO00297 MOACRIVE Inhibition DME0001 XEOTICID XEO00301 XEO_NAME Irinotecan hydrochloride DME0001 XEOTICID XEO00301 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00301 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00301 DESCRIPT Irinotecan hydrochloride inhibits the drug-metabolizing activity of DME CYP3A4 (Ki = 24 microM) DME0001 XEOTICID XEO00301 GENEFORM Protein DME0001 XEOTICID XEO00301 MOACRIVE Inhibition DME0001 XEOTICID XEO00302 XEO_NAME Ketamine hydrochloride DME0001 XEOTICID XEO00302 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00302 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00302 DESCRIPT Ketamine hydrochloride inhibits the expression of DME CYP3A4 and leads to decreasing the drug-metabolizing activity of this enzyme DME0001 XEOTICID XEO00302 GENEFORM Protein DME0001 XEOTICID XEO00302 MOACRIVE Inhibition DME0001 XEOTICID XEO00308 XEO_NAME Miconazole nitrate DME0001 XEOTICID XEO00308 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00308 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00308 DESCRIPT Miconazole nitrate inhibits the drug-metabolizing activity of DME CYP3A4 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.1 microM) DME0001 XEOTICID XEO00308 GENEFORM Protein DME0001 XEOTICID XEO00308 MOACRIVE Inhibition DME0001 XEOTICID XEO00309 XEO_NAME Moricizine hydrochloride DME0001 XEOTICID XEO00309 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00309 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00309 DESCRIPT Moricizine hydrochloride up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00309 GENEFORM mRNA DME0001 XEOTICID XEO00309 MOACRIVE Induction DME0001 XEOTICID XEO00310 XEO_NAME Nelfinavir mesylate DME0001 XEOTICID XEO00310 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00310 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00310 DESCRIPT Nelfinavir mesylate inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 0.55 microM) DME0001 XEOTICID XEO00310 GENEFORM Protein DME0001 XEOTICID XEO00310 MOACRIVE Inhibition DME0001 XEOTICID XEO00311 XEO_NAME Nicardipine hydrochloride DME0001 XEOTICID XEO00311 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00311 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00311 DESCRIPT Nicardipine hydrochloride inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 0.38 microM) DME0001 XEOTICID XEO00311 GENEFORM Protein DME0001 XEOTICID XEO00311 MOACRIVE Inhibition DME0001 XEOTICID XEO00315 XEO_NAME Oxiconazole nitrate DME0001 XEOTICID XEO00315 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00315 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00315 DESCRIPT Oxiconazole nitrate up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00315 GENEFORM mRNA DME0001 XEOTICID XEO00315 MOACRIVE Induction DME0001 XEOTICID XEO00317 XEO_NAME Pentamidine isethionate DME0001 XEOTICID XEO00317 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00317 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00317 DESCRIPT Pentamidine isethionate inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 > 100 microM) DME0001 XEOTICID XEO00317 GENEFORM Protein DME0001 XEOTICID XEO00317 MOACRIVE Inhibition DME0001 XEOTICID XEO00318 XEO_NAME Phenelzine sulfate DME0001 XEOTICID XEO00318 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00318 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00318 DESCRIPT Phenelzine sulfate inhibits the drug-metabolizing activity of DME CYP3A4 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 2 microM) DME0001 XEOTICID XEO00318 GENEFORM Protein DME0001 XEOTICID XEO00318 MOACRIVE Inhibition DME0001 XEOTICID XEO00319 XEO_NAME Pioglitazone hydrochloride DME0001 XEOTICID XEO00319 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00319 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00319 DESCRIPT Pioglitazone hydrochloride up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00319 GENEFORM mRNA DME0001 XEOTICID XEO00319 MOACRIVE Induction DME0001 XEOTICID XEO00322 XEO_NAME Saquinavir mesylate DME0001 XEOTICID XEO00322 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00322 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00322 DESCRIPT Saquinavir mesylate inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 1.5 microM) DME0001 XEOTICID XEO00322 GENEFORM Protein DME0001 XEOTICID XEO00322 MOACRIVE Inhibition DME0001 XEOTICID XEO00327 XEO_NAME Sulfisoxazole acetyl DME0001 XEOTICID XEO00327 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00327 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00327 DESCRIPT Sulfisoxazole acetyl up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00327 GENEFORM mRNA DME0001 XEOTICID XEO00327 MOACRIVE Induction DME0001 XEOTICID XEO00330 XEO_NAME Thioridazine hydrochloride DME0001 XEOTICID XEO00330 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00330 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00330 DESCRIPT Thioridazine hydrochloride inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00330 GENEFORM Protein DME0001 XEOTICID XEO00330 MOACRIVE Inhibition DME0001 XEOTICID XEO00334 XEO_NAME Cisplatin DME0001 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00334 GENEFORM Protein DME0001 XEOTICID XEO00334 MOACRIVE Inhibition DME0001 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0001 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00339 GENEFORM mRNA DME0001 XEOTICID XEO00339 MOACRIVE Induction DME0001 XEOTICID XEO00340 XEO_NAME Atorvastatin DME0001 XEOTICID XEO00340 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00340 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00340 DESCRIPT Atorvastatin inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 5.1 microM) DME0001 XEOTICID XEO00340 GENEFORM Protein DME0001 XEOTICID XEO00340 MOACRIVE Inhibition DME0001 XEOTICID XEO00343 XEO_NAME Buprenorphine DME0001 XEOTICID XEO00343 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00343 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00343 DESCRIPT Buprenorphine inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00343 GENEFORM Protein DME0001 XEOTICID XEO00343 MOACRIVE Inhibition DME0001 XEOTICID XEO00348 XEO_NAME Cetirizine DME0001 XEOTICID XEO00348 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00348 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00348 DESCRIPT Cetirizine inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00348 GENEFORM Protein DME0001 XEOTICID XEO00348 MOACRIVE Inhibition DME0001 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME0001 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00349 DESCRIPT Ciprof DMEloxacin inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 > 10 microM) DME0001 XEOTICID XEO00349 GENEFORM Protein DME0001 XEOTICID XEO00349 MOACRIVE Inhibition DME0001 XEOTICID XEO00350 XEO_NAME Cisapride DME0001 XEOTICID XEO00350 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00350 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00350 DESCRIPT Cisapride inhibits the drug-metabolizing activity of DME CYP3A4 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.3 microM) DME0001 XEOTICID XEO00350 GENEFORM Protein DME0001 XEOTICID XEO00350 MOACRIVE Inhibition DME0001 XEOTICID XEO00352 XEO_NAME Diclofenac DME0001 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00352 DESCRIPT Diclof DMEenac inhibits the drug-metabolizing activity of DME CYP3A4 (Ki = 1640 microM) DME0001 XEOTICID XEO00352 GENEFORM Protein DME0001 XEOTICID XEO00352 MOACRIVE Inhibition DME0001 XEOTICID XEO00359 XEO_NAME Fluvastatin DME0001 XEOTICID XEO00359 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00359 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00359 DESCRIPT Fluvastatin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00359 GENEFORM Protein DME0001 XEOTICID XEO00359 MOACRIVE Inhibition DME0001 XEOTICID XEO00366 XEO_NAME Methotrexate DME0001 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00366 DESCRIPT Methotrexate inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00366 GENEFORM Protein DME0001 XEOTICID XEO00366 MOACRIVE Inhibition DME0001 XEOTICID XEO00373 XEO_NAME Pantoprazole DME0001 XEOTICID XEO00373 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00373 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00373 DESCRIPT Pantoprazole up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00373 GENEFORM mRNA DME0001 XEOTICID XEO00373 MOACRIVE Induction DME0001 XEOTICID XEO00374 XEO_NAME Pazopanib DME0001 XEOTICID XEO00374 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00374 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00374 DESCRIPT Pazopanib up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00374 GENEFORM mRNA DME0001 XEOTICID XEO00374 MOACRIVE Induction DME0001 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0001 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00380 DESCRIPT Rosiglitazone inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00380 GENEFORM Protein DME0001 XEOTICID XEO00380 MOACRIVE Inhibition DME0001 XEOTICID XEO00383 XEO_NAME Tamoxifen DME0001 XEOTICID XEO00383 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00383 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00383 DESCRIPT Tamoxifen inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 > 30 microM) DME0001 XEOTICID XEO00383 GENEFORM Protein DME0001 XEOTICID XEO00383 MOACRIVE Inhibition DME0001 XEOTICID XEO00387 XEO_NAME Verapamil DME0001 XEOTICID XEO00387 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00387 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00387 DESCRIPT Verapamil inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 12 microM) DME0001 XEOTICID XEO00387 GENEFORM Protein DME0001 XEOTICID XEO00387 MOACRIVE Inhibition DME0001 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0001 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00388 GENEFORM Protein DME0001 XEOTICID XEO00388 MOACRIVE Induction DME0001 XEOTICID XEO00405 XEO_NAME Niclosamide DME0001 XEOTICID XEO00405 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00405 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00405 DESCRIPT Niclosamide inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00405 GENEFORM mRNA DME0001 XEOTICID XEO00405 MOACRIVE Inhibition DME0001 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0001 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00410 GENEFORM Protein DME0001 XEOTICID XEO00410 MOACRIVE Inhibition DME0001 XEOTICID XEO00412 XEO_NAME Cefadroxil DME0001 XEOTICID XEO00412 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00412 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00412 DESCRIPT Cefadroxil induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00412 GENEFORM Protein DME0001 XEOTICID XEO00412 MOACRIVE Induction DME0001 XEOTICID XEO00416 XEO_NAME Menthol DME0001 XEOTICID XEO00416 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00416 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00416 DESCRIPT Menthol induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00416 GENEFORM Protein DME0001 XEOTICID XEO00416 MOACRIVE Induction DME0001 XEOTICID XEO00423 XEO_NAME Sulfamethazine DME0001 XEOTICID XEO00423 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00423 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00423 DESCRIPT Sulfamethazine up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00423 GENEFORM mRNA DME0001 XEOTICID XEO00423 MOACRIVE Induction DME0001 XEOTICID XEO00429 XEO_NAME Pyrantel DME0001 XEOTICID XEO00429 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00429 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00429 DESCRIPT Pyrantel inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00429 GENEFORM Protein DME0001 XEOTICID XEO00429 MOACRIVE Inhibition DME0001 XEOTICID XEO00431 XEO_NAME Proguanil DME0001 XEOTICID XEO00431 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00431 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00431 DESCRIPT Proguanil inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00431 GENEFORM mRNA DME0001 XEOTICID XEO00431 MOACRIVE Inhibition DME0001 XEOTICID XEO00436 XEO_NAME Mibefradil DME0001 XEOTICID XEO00436 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00436 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00436 DESCRIPT Mibefradil inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 0.13 microM) DME0001 XEOTICID XEO00436 GENEFORM Protein DME0001 XEOTICID XEO00436 MOACRIVE Inhibition DME0001 XEOTICID XEO00438 XEO_NAME Benidipine DME0001 XEOTICID XEO00438 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00438 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00438 DESCRIPT Benidipine inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00438 GENEFORM Protein DME0001 XEOTICID XEO00438 MOACRIVE Inhibition DME0001 XEOTICID XEO00439 XEO_NAME Daidzein DME0001 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00439 GENEFORM Protein DME0001 XEOTICID XEO00439 MOACRIVE Inhibition DME0001 XEOTICID XEO00440 XEO_NAME Roxithromycin DME0001 XEOTICID XEO00440 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00440 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00440 DESCRIPT Roxithromycin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00440 GENEFORM Protein DME0001 XEOTICID XEO00440 MOACRIVE Inhibition DME0001 XEOTICID XEO00446 XEO_NAME Methoxychlor DME0001 XEOTICID XEO00446 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00446 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00446 DESCRIPT Methoxychlor inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00446 GENEFORM mRNA DME0001 XEOTICID XEO00446 MOACRIVE Inhibition DME0001 XEOTICID XEO00448 XEO_NAME Stevioside DME0001 XEOTICID XEO00448 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00448 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00448 DESCRIPT Stevioside up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00448 GENEFORM mRNA DME0001 XEOTICID XEO00448 MOACRIVE Induction DME0001 XEOTICID XEO00452 XEO_NAME Apatinib DME0001 XEOTICID XEO00452 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00452 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00452 DESCRIPT Apatinib inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00452 GENEFORM Protein DME0001 XEOTICID XEO00452 MOACRIVE Inhibition DME0001 XEOTICID XEO00453 XEO_NAME Asiaticoside DME0001 XEOTICID XEO00453 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00453 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00453 DESCRIPT Asiaticoside inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00453 GENEFORM Protein DME0001 XEOTICID XEO00453 MOACRIVE Inhibition DME0001 XEOTICID XEO00454 XEO_NAME Dihydroartemisinin DME0001 XEOTICID XEO00454 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00454 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00454 DESCRIPT Dihydroartemisinin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00454 GENEFORM Protein DME0001 XEOTICID XEO00454 MOACRIVE Inhibition DME0001 XEOTICID XEO00456 XEO_NAME Tocotrienol delta DME0001 XEOTICID XEO00456 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00456 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00456 DESCRIPT Tocotrienol delta up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00456 GENEFORM mRNA DME0001 XEOTICID XEO00456 MOACRIVE Induction DME0001 XEOTICID XEO00464 XEO_NAME Bifonazole DME0001 XEOTICID XEO00464 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00464 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00464 DESCRIPT Bifonazole inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 0.8 microM) DME0001 XEOTICID XEO00464 GENEFORM Protein DME0001 XEOTICID XEO00464 MOACRIVE Inhibition DME0001 XEOTICID XEO00475 XEO_NAME Melarsoprol DME0001 XEOTICID XEO00475 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00475 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00475 DESCRIPT Melarsoprol inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00475 GENEFORM Protein DME0001 XEOTICID XEO00475 MOACRIVE Inhibition DME0001 XEOTICID XEO00486 XEO_NAME Tanshinone DME0001 XEOTICID XEO00486 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00486 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00486 DESCRIPT Tanshinone induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00486 GENEFORM Protein DME0001 XEOTICID XEO00486 MOACRIVE Induction DME0001 XEOTICID XEO00495 XEO_NAME Cyproterone acetate DME0001 XEOTICID XEO00495 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00495 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00495 DESCRIPT Cyproterone acetate up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00495 GENEFORM mRNA DME0001 XEOTICID XEO00495 MOACRIVE Induction DME0001 XEOTICID XEO00499 XEO_NAME Gestodene DME0001 XEOTICID XEO00499 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00499 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00499 DESCRIPT Gestodene inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00499 GENEFORM Protein DME0001 XEOTICID XEO00499 MOACRIVE Inhibition DME0001 XEOTICID XEO00522 XEO_NAME Sitaxsentan DME0001 XEOTICID XEO00522 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00522 XEO_CLAS Drug Marketed but Withdrawn from Market DME0001 XEOTICID XEO00522 DESCRIPT Sitaxsentan inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00522 GENEFORM mRNA DME0001 XEOTICID XEO00522 MOACRIVE Inhibition DME0001 XEOTICID XEO00538 XEO_NAME Quercetin DME0001 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0001 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 2.11 microM) DME0001 XEOTICID XEO00538 GENEFORM Protein DME0001 XEOTICID XEO00538 MOACRIVE Inhibition DME0001 XEOTICID XEO00539 XEO_NAME Ethanol DME0001 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0001 XEOTICID XEO00539 DESCRIPT Ethanol induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00539 GENEFORM Protein DME0001 XEOTICID XEO00539 MOACRIVE Induction DME0001 XEOTICID XEO00543 XEO_NAME Andrographolide DME0001 XEOTICID XEO00543 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00543 XEO_CLAS Drug in Phase 2 Clinical Trial DME0001 XEOTICID XEO00543 DESCRIPT Andrographolide inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00543 GENEFORM mRNA DME0001 XEOTICID XEO00543 MOACRIVE Inhibition DME0001 XEOTICID XEO00547 XEO_NAME Vitamin E DME0001 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0001 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00547 GENEFORM mRNA DME0001 XEOTICID XEO00547 MOACRIVE Inhibition DME0001 XEOTICID XEO00557 XEO_NAME Genistein DME0001 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0001 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00557 GENEFORM Protein DME0001 XEOTICID XEO00557 MOACRIVE Inhibition DME0001 XEOTICID XEO00559 XEO_NAME Glycyrrhizic acid DME0001 XEOTICID XEO00559 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00559 XEO_CLAS Drug in Phase 3 Clinical Trial DME0001 XEOTICID XEO00559 DESCRIPT Glycyrrhizic acid induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00559 GENEFORM Protein DME0001 XEOTICID XEO00559 MOACRIVE Induction DME0001 XEOTICID XEO00568 XEO_NAME Resveratrol DME0001 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0001 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of DME CYP3A4 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.6 microM) DME0001 XEOTICID XEO00568 GENEFORM Protein DME0001 XEOTICID XEO00568 MOACRIVE Inhibition DME0001 XEOTICID XEO00569 XEO_NAME Corticosterone DME0001 XEOTICID XEO00569 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00569 XEO_CLAS Drug in Phase 3 Clinical Trial DME0001 XEOTICID XEO00569 DESCRIPT Corticosterone up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00569 GENEFORM mRNA DME0001 XEOTICID XEO00569 MOACRIVE Induction DME0001 XEOTICID XEO00573 XEO_NAME Naringenin DME0001 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME0001 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00573 GENEFORM Protein DME0001 XEOTICID XEO00573 MOACRIVE Inhibition DME0001 XEOTICID XEO00579 XEO_NAME SGX301 DME0001 XEOTICID XEO00579 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00579 XEO_CLAS Drug in Phase 3 Clinical Trial DME0001 XEOTICID XEO00579 DESCRIPT SGX301 inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00579 GENEFORM Protein DME0001 XEOTICID XEO00579 MOACRIVE Inhibition DME0001 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0001 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0001 XEOTICID XEO00582 DESCRIPT Diethyltoluamide up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00582 GENEFORM mRNA DME0001 XEOTICID XEO00582 MOACRIVE Induction DME0001 XEOTICID XEO00588 XEO_NAME Bisphenol B DME0001 XEOTICID XEO00588 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00588 XEO_CLAS Drug in Phase 2 Clinical Trial DME0001 XEOTICID XEO00588 DESCRIPT Bisphenol B up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00588 GENEFORM mRNA DME0001 XEOTICID XEO00588 MOACRIVE Induction DME0001 XEOTICID XEO00596 XEO_NAME Phenethyl isothiocyanate DME0001 XEOTICID XEO00596 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00596 XEO_CLAS Drug in Phase 2 Clinical Trial DME0001 XEOTICID XEO00596 DESCRIPT Phenethyl isothiocyanate inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00596 GENEFORM mRNA DME0001 XEOTICID XEO00596 MOACRIVE Inhibition DME0001 XEOTICID XEO00598 XEO_NAME Carbendazim DME0001 XEOTICID XEO00598 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00598 XEO_CLAS Drug in Phase 1 Clinical Trial DME0001 XEOTICID XEO00598 DESCRIPT Carbendazim up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00598 GENEFORM mRNA DME0001 XEOTICID XEO00598 MOACRIVE Induction DME0001 XEOTICID XEO00601 XEO_NAME Butylated hydroxytoluene DME0001 XEOTICID XEO00601 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00601 XEO_CLAS Drug in Phase 1 Clinical Trial DME0001 XEOTICID XEO00601 DESCRIPT Butylated hydroxytoluene up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00601 GENEFORM mRNA DME0001 XEOTICID XEO00601 MOACRIVE Induction DME0001 XEOTICID XEO00610 XEO_NAME Afimoxifene DME0001 XEOTICID XEO00610 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00610 XEO_CLAS Drug in Phase 3 Clinical Trial DME0001 XEOTICID XEO00610 DESCRIPT Afimoxifene inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00610 GENEFORM Protein DME0001 XEOTICID XEO00610 MOACRIVE Inhibition DME0001 XEOTICID XEO00621 XEO_NAME Chitosan DME0001 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME0001 XEOTICID XEO00621 DESCRIPT Chitosan induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00621 GENEFORM Protein DME0001 XEOTICID XEO00621 MOACRIVE Induction DME0001 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0001 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0001 XEOTICID XEO00632 DESCRIPT Sodium arsenite induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00632 GENEFORM Protein DME0001 XEOTICID XEO00632 MOACRIVE Induction DME0001 XEOTICID XEO00633 XEO_NAME SR-12813 DME0001 XEOTICID XEO00633 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00633 XEO_CLAS Drug in Phase 1 Clinical Trial DME0001 XEOTICID XEO00633 DESCRIPT SR-12813 induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00633 GENEFORM Protein DME0001 XEOTICID XEO00633 MOACRIVE Induction DME0001 XEOTICID XEO00635 XEO_NAME Piperine DME0001 XEOTICID XEO00635 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00635 XEO_CLAS Drug in Phase 1 Clinical Trial DME0001 XEOTICID XEO00635 DESCRIPT Piperine induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00635 GENEFORM Protein DME0001 XEOTICID XEO00635 MOACRIVE Induction DME0001 XEOTICID XEO00640 XEO_NAME FK-435 DME0001 XEOTICID XEO00640 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00640 XEO_CLAS Drug in Phase 3 Clinical Trial DME0001 XEOTICID XEO00640 DESCRIPT FK-435 inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00640 GENEFORM Protein DME0001 XEOTICID XEO00640 MOACRIVE Inhibition DME0001 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME0001 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME0001 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00646 GENEFORM Protein DME0001 XEOTICID XEO00646 MOACRIVE Inhibition DME0001 XEOTICID XEO00664 XEO_NAME CI-1040 DME0001 XEOTICID XEO00664 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00664 XEO_CLAS Drug in Phase 2 Clinical Trial DME0001 XEOTICID XEO00664 DESCRIPT CI-1040 up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00664 GENEFORM mRNA DME0001 XEOTICID XEO00664 MOACRIVE Induction DME0001 XEOTICID XEO00665 XEO_NAME Bufalin DME0001 XEOTICID XEO00665 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00665 XEO_CLAS Drug in Phase 2 Clinical Trial DME0001 XEOTICID XEO00665 DESCRIPT Bufalin up-regulates the expression of DME CYP3A4 and leads to increasing the drug-metabolizing activity of this enzyme DME0001 XEOTICID XEO00665 GENEFORM Protein DME0001 XEOTICID XEO00665 MOACRIVE Induction DME0001 XEOTICID XEO00667 XEO_NAME PD-0325901 DME0001 XEOTICID XEO00667 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00667 XEO_CLAS Drug in Phase 2 Clinical Trial DME0001 XEOTICID XEO00667 DESCRIPT PD-0325901 up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00667 GENEFORM mRNA DME0001 XEOTICID XEO00667 MOACRIVE Induction DME0001 XEOTICID XEO00683 XEO_NAME Curcumin DME0001 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0001 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00683 GENEFORM mRNA DME0001 XEOTICID XEO00683 MOACRIVE Inhibition DME0001 XEOTICID XEO00700 XEO_NAME Mevastatin DME0001 XEOTICID XEO00700 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00700 XEO_CLAS Preclinical/Patented Drug DME0001 XEOTICID XEO00700 DESCRIPT Mevastatin up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00700 GENEFORM mRNA DME0001 XEOTICID XEO00700 MOACRIVE Induction DME0001 XEOTICID XEO00710 XEO_NAME Isoliquiritigenin DME0001 XEOTICID XEO00710 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00710 XEO_CLAS Preclinical/Patented Drug DME0001 XEOTICID XEO00710 DESCRIPT Isoliquiritigenin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00710 GENEFORM Protein DME0001 XEOTICID XEO00710 MOACRIVE Inhibition DME0001 XEOTICID XEO00719 XEO_NAME YM-758 DME0001 XEOTICID XEO00719 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00719 XEO_CLAS Preclinical/Patented Drug DME0001 XEOTICID XEO00719 DESCRIPT YM-758 up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00719 GENEFORM mRNA DME0001 XEOTICID XEO00719 MOACRIVE Induction DME0001 XEOTICID XEO00736 XEO_NAME Chir-99021 DME0001 XEOTICID XEO00736 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00736 XEO_CLAS Preclinical/Patented Drug DME0001 XEOTICID XEO00736 DESCRIPT Chir-99021 up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00736 GENEFORM mRNA DME0001 XEOTICID XEO00736 MOACRIVE Induction DME0001 XEOTICID XEO00738 XEO_NAME Flavanone DME0001 XEOTICID XEO00738 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00738 XEO_CLAS Drug in Phase 1 Clinical Trial DME0001 XEOTICID XEO00738 DESCRIPT Flavanone inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00738 GENEFORM Protein DME0001 XEOTICID XEO00738 MOACRIVE Inhibition DME0001 XEOTICID XEO00740 XEO_NAME Lindane DME0001 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00740 DESCRIPT Lindane induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00740 GENEFORM Protein DME0001 XEOTICID XEO00740 MOACRIVE Induction DME0001 XEOTICID XEO00743 XEO_NAME Medroxyprogesterone acetate DME0001 XEOTICID XEO00743 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00743 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00743 DESCRIPT Medroxyprogesterone acetate up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00743 GENEFORM mRNA DME0001 XEOTICID XEO00743 MOACRIVE Induction DME0001 XEOTICID XEO00745 XEO_NAME Adefovir dipivoxil DME0001 XEOTICID XEO00745 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00745 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00745 DESCRIPT Adefovir dipivoxil inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00745 GENEFORM Protein DME0001 XEOTICID XEO00745 MOACRIVE Inhibition DME0001 XEOTICID XEO00747 XEO_NAME Cholecalciferol DME0001 XEOTICID XEO00747 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00747 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00747 DESCRIPT Cholecalciferol inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00747 GENEFORM Protein DME0001 XEOTICID XEO00747 MOACRIVE Inhibition DME0001 XEOTICID XEO00749 XEO_NAME Teriflunomide DME0001 XEOTICID XEO00749 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00749 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00749 DESCRIPT Teriflunomide up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00749 GENEFORM mRNA DME0001 XEOTICID XEO00749 MOACRIVE Induction DME0001 XEOTICID XEO00759 XEO_NAME Caraway oil DME0001 XEOTICID XEO00759 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO00759 XEO_CLAS Plant Extract DME0001 XEOTICID XEO00759 DESCRIPT Caraway oil up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00759 GENEFORM mRNA DME0001 XEOTICID XEO00759 MOACRIVE Induction DME0001 XEOTICID XEO00764 XEO_NAME Naphthalene DME0001 XEOTICID XEO00764 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0001 XEOTICID XEO00764 XEO_CLAS Chemical Compound DME0001 XEOTICID XEO00764 DESCRIPT Naphthalene up-regulates the expression of DME CYP3A4 and leads to increasing the drug-metabolizing activity of this enzyme DME0001 XEOTICID XEO00764 GENEFORM Protein DME0001 XEOTICID XEO00764 MOACRIVE Induction DME0001 XEOTICID XEO00768 XEO_NAME Dichlorodiphenyl dichloroethylene DME0001 XEOTICID XEO00768 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00768 XEO_CLAS Environmental Pollutant DME0001 XEOTICID XEO00768 DESCRIPT Dichlorodiphenyl dichloroethylene up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00768 GENEFORM mRNA DME0001 XEOTICID XEO00768 MOACRIVE Induction DME0001 XEOTICID XEO00777 XEO_NAME Skatole DME0001 XEOTICID XEO00777 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO00777 XEO_CLAS Natural Product DME0001 XEOTICID XEO00777 DESCRIPT Skatole inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00777 GENEFORM mRNA DME0001 XEOTICID XEO00777 MOACRIVE Inhibition DME0001 XEOTICID XEO00780 XEO_NAME 2-aminopyrimidine DME0001 XEOTICID XEO00780 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00780 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO00780 DESCRIPT 2-aminopyrimidine inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00780 GENEFORM Protein DME0001 XEOTICID XEO00780 MOACRIVE Inhibition DME0001 XEOTICID XEO00786 XEO_NAME Isoxazole DME0001 XEOTICID XEO00786 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO00786 XEO_CLAS Natural Product DME0001 XEOTICID XEO00786 DESCRIPT Isoxazole inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00786 GENEFORM Protein DME0001 XEOTICID XEO00786 MOACRIVE Inhibition DME0001 XEOTICID XEO00787 XEO_NAME Lithocholic acid DME0001 XEOTICID XEO00787 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00787 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO00787 DESCRIPT Lithocholic acid up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00787 GENEFORM mRNA DME0001 XEOTICID XEO00787 MOACRIVE Induction DME0001 XEOTICID XEO00788 XEO_NAME Bufogenin DME0001 XEOTICID XEO00788 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00788 XEO_CLAS Biotoxin DME0001 XEOTICID XEO00788 DESCRIPT Bufogenin induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00788 GENEFORM Protein DME0001 XEOTICID XEO00788 MOACRIVE Induction DME0001 XEOTICID XEO00790 XEO_NAME Muscone DME0001 XEOTICID XEO00790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO00790 XEO_CLAS Natural Product DME0001 XEOTICID XEO00790 DESCRIPT Muscone up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00790 GENEFORM mRNA DME0001 XEOTICID XEO00790 MOACRIVE Induction DME0001 XEOTICID XEO00792 XEO_NAME Phloxine DME0001 XEOTICID XEO00792 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00792 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO00792 DESCRIPT Phloxine inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00792 GENEFORM Protein DME0001 XEOTICID XEO00792 MOACRIVE Inhibition DME0001 XEOTICID XEO00795 XEO_NAME Galactosamine DME0001 XEOTICID XEO00795 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00795 XEO_CLAS Health Hazard/Toxicant DME0001 XEOTICID XEO00795 DESCRIPT Galactosamine inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00795 GENEFORM mRNA DME0001 XEOTICID XEO00795 MOACRIVE Inhibition DME0001 XEOTICID XEO00804 XEO_NAME Avasimibe DME0001 XEOTICID XEO00804 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00804 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO00804 DESCRIPT Avasimibe up-regulates the expression of DME CYP3A4 and leads to increasing the drug-metabolizing activity of this enzyme DME0001 XEOTICID XEO00804 GENEFORM Protein DME0001 XEOTICID XEO00804 MOACRIVE Induction DME0001 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0001 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0001 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00806 GENEFORM Protein DME0001 XEOTICID XEO00806 MOACRIVE Inhibition DME0001 XEOTICID XEO00810 XEO_NAME Steviol DME0001 XEOTICID XEO00810 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO00810 XEO_CLAS Natural Product DME0001 XEOTICID XEO00810 DESCRIPT Steviol inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00810 GENEFORM mRNA DME0001 XEOTICID XEO00810 MOACRIVE Inhibition DME0001 XEOTICID XEO00816 XEO_NAME Aflatoxin M1 DME0001 XEOTICID XEO00816 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00816 XEO_CLAS Carcinogen DME0001 XEOTICID XEO00816 DESCRIPT Aflatoxin M1 up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00816 GENEFORM mRNA DME0001 XEOTICID XEO00816 MOACRIVE Induction DME0001 XEOTICID XEO00826 XEO_NAME Mangifera indica extract DME0001 XEOTICID XEO00826 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO00826 XEO_CLAS Plant Extract DME0001 XEOTICID XEO00826 DESCRIPT Mangifera indica extract inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00826 GENEFORM Protein DME0001 XEOTICID XEO00826 MOACRIVE Inhibition DME0001 XEOTICID XEO00838 XEO_NAME Lopinavir DME0001 XEOTICID XEO00838 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00838 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00838 DESCRIPT Lopinavir inhibits the drug-metabolizing activity of DME CYP3A4 (Ki = 0.41 microM) DME0001 XEOTICID XEO00838 GENEFORM Protein DME0001 XEOTICID XEO00838 MOACRIVE Inhibition DME0001 XEOTICID XEO00849 XEO_NAME Lycopene DME0001 XEOTICID XEO00849 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00849 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO00849 DESCRIPT Lycopene up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00849 GENEFORM mRNA DME0001 XEOTICID XEO00849 MOACRIVE Induction DME0001 XEOTICID XEO00852 XEO_NAME Allyl isothiocyanate DME0001 XEOTICID XEO00852 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00852 XEO_CLAS Acute Toxic Substance DME0001 XEOTICID XEO00852 DESCRIPT Allyl isothiocyanate inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00852 GENEFORM Protein DME0001 XEOTICID XEO00852 MOACRIVE Inhibition DME0001 XEOTICID XEO00857 XEO_NAME Cyclodextrins DME0001 XEOTICID XEO00857 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO00857 XEO_CLAS Natural Mixture DME0001 XEOTICID XEO00857 DESCRIPT Cyclodextrins inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00857 GENEFORM Protein DME0001 XEOTICID XEO00857 MOACRIVE Inhibition DME0001 XEOTICID XEO00859 XEO_NAME Ginkgolide B DME0001 XEOTICID XEO00859 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO00859 XEO_CLAS Natural Product DME0001 XEOTICID XEO00859 DESCRIPT Ginkgolide B up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00859 GENEFORM mRNA DME0001 XEOTICID XEO00859 MOACRIVE Induction DME0001 XEOTICID XEO00862 XEO_NAME Shexiang baoxin DME0001 XEOTICID XEO00862 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO00862 XEO_CLAS Traditional Medicine DME0001 XEOTICID XEO00862 DESCRIPT Shexiang baoxin up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00862 GENEFORM mRNA DME0001 XEOTICID XEO00862 MOACRIVE Induction DME0001 XEOTICID XEO00864 XEO_NAME Cinobufagin DME0001 XEOTICID XEO00864 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO00864 XEO_CLAS Natural Product DME0001 XEOTICID XEO00864 DESCRIPT Cinobufagin up-regulates the expression of DME CYP3A4 and leads to increasing the drug-metabolizing activity of this enzyme DME0001 XEOTICID XEO00864 GENEFORM Protein DME0001 XEOTICID XEO00864 MOACRIVE Induction DME0001 XEOTICID XEO00873 XEO_NAME Alpha-linolenic acid DME0001 XEOTICID XEO00873 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00873 XEO_CLAS Health Hazard/Toxicant DME0001 XEOTICID XEO00873 DESCRIPT Alpha-linolenic acid inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00873 GENEFORM Protein DME0001 XEOTICID XEO00873 MOACRIVE Inhibition DME0001 XEOTICID XEO00876 XEO_NAME Arachidonic acid DME0001 XEOTICID XEO00876 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00876 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO00876 DESCRIPT Arachidonic acid inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00876 GENEFORM Protein DME0001 XEOTICID XEO00876 MOACRIVE Inhibition DME0001 XEOTICID XEO00877 XEO_NAME Bilirubin DME0001 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO00877 XEO_CLAS Natural Product DME0001 XEOTICID XEO00877 DESCRIPT Bilirubin up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00877 GENEFORM mRNA DME0001 XEOTICID XEO00877 MOACRIVE Induction DME0001 XEOTICID XEO00878 XEO_NAME Chrysin DME0001 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO00878 XEO_CLAS Natural Product DME0001 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 > 50 microM) DME0001 XEOTICID XEO00878 GENEFORM Protein DME0001 XEOTICID XEO00878 MOACRIVE Inhibition DME0001 XEOTICID XEO00881 XEO_NAME Medazepam DME0001 XEOTICID XEO00881 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00881 XEO_CLAS Health Hazard/Toxicant DME0001 XEOTICID XEO00881 DESCRIPT Medazepam up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00881 GENEFORM mRNA DME0001 XEOTICID XEO00881 MOACRIVE Induction DME0001 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0001 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0001 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00898 GENEFORM mRNA DME0001 XEOTICID XEO00898 MOACRIVE Induction DME0001 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0001 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0001 XEOTICID XEO00899 DESCRIPT Methylcholanthrene inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 > 10 microM) DME0001 XEOTICID XEO00899 GENEFORM Protein DME0001 XEOTICID XEO00899 MOACRIVE Inhibition DME0001 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0001 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0001 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00905 GENEFORM Protein DME0001 XEOTICID XEO00905 MOACRIVE Inhibition DME0001 XEOTICID XEO00906 XEO_NAME Leptomycin B DME0001 XEOTICID XEO00906 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00906 XEO_CLAS Biotoxin DME0001 XEOTICID XEO00906 DESCRIPT Leptomycin B up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00906 GENEFORM mRNA DME0001 XEOTICID XEO00906 MOACRIVE Induction DME0001 XEOTICID XEO00910 XEO_NAME Bioallethrin DME0001 XEOTICID XEO00910 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00910 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO00910 DESCRIPT Bioallethrin up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00910 GENEFORM mRNA DME0001 XEOTICID XEO00910 MOACRIVE Induction DME0001 XEOTICID XEO00917 XEO_NAME Polychlorinated dibenzodioxin DME0001 XEOTICID XEO00917 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00917 XEO_CLAS Environmental Pollutant DME0001 XEOTICID XEO00917 DESCRIPT Polychlorinated dibenzodioxin induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00917 GENEFORM Protein DME0001 XEOTICID XEO00917 MOACRIVE Induction DME0001 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0001 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0001 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00921 GENEFORM mRNA DME0001 XEOTICID XEO00921 MOACRIVE Induction DME0001 XEOTICID XEO00925 XEO_NAME BDE-99 DME0001 XEOTICID XEO00925 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO00925 XEO_CLAS Natural Product DME0001 XEOTICID XEO00925 DESCRIPT BDE-99 up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00925 GENEFORM mRNA DME0001 XEOTICID XEO00925 MOACRIVE Induction DME0001 XEOTICID XEO00927 XEO_NAME Perfluorododecanoic acid DME0001 XEOTICID XEO00927 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO00927 XEO_CLAS Preclinical/Patented Drug DME0001 XEOTICID XEO00927 DESCRIPT Perfluorododecanoic acid inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO00927 GENEFORM mRNA DME0001 XEOTICID XEO00927 MOACRIVE Inhibition DME0001 XEOTICID XEO00938 XEO_NAME Azoxystrobin DME0001 XEOTICID XEO00938 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00938 XEO_CLAS Fungicide DME0001 XEOTICID XEO00938 DESCRIPT Azoxystrobin up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00938 GENEFORM mRNA DME0001 XEOTICID XEO00938 MOACRIVE Induction DME0001 XEOTICID XEO00942 XEO_NAME Cyproconazole DME0001 XEOTICID XEO00942 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00942 XEO_CLAS Fungicide DME0001 XEOTICID XEO00942 DESCRIPT Cyproconazole induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00942 GENEFORM Protein DME0001 XEOTICID XEO00942 MOACRIVE Induction DME0001 XEOTICID XEO00944 XEO_NAME Enilconazole DME0001 XEOTICID XEO00944 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00944 XEO_CLAS Fungicide DME0001 XEOTICID XEO00944 DESCRIPT Enilconazole inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00944 GENEFORM Protein DME0001 XEOTICID XEO00944 MOACRIVE Inhibition DME0001 XEOTICID XEO00945 XEO_NAME Epoxiconazole DME0001 XEOTICID XEO00945 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00945 XEO_CLAS Fungicide DME0001 XEOTICID XEO00945 DESCRIPT Epoxiconazole induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00945 GENEFORM Protein DME0001 XEOTICID XEO00945 MOACRIVE Induction DME0001 XEOTICID XEO00949 XEO_NAME Flutolanil DME0001 XEOTICID XEO00949 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00949 XEO_CLAS Fungicide DME0001 XEOTICID XEO00949 DESCRIPT Flutolanil up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00949 GENEFORM mRNA DME0001 XEOTICID XEO00949 MOACRIVE Induction DME0001 XEOTICID XEO00950 XEO_NAME Fluxapyroxad DME0001 XEOTICID XEO00950 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00950 XEO_CLAS Fungicide DME0001 XEOTICID XEO00950 DESCRIPT Fluxapyroxad up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00950 GENEFORM mRNA DME0001 XEOTICID XEO00950 MOACRIVE Induction DME0001 XEOTICID XEO00956 XEO_NAME Propiconazole DME0001 XEOTICID XEO00956 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00956 XEO_CLAS Fungicide DME0001 XEOTICID XEO00956 DESCRIPT Propiconazole inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 1.03992 microM) DME0001 XEOTICID XEO00956 GENEFORM Protein DME0001 XEOTICID XEO00956 MOACRIVE Inhibition DME0001 XEOTICID XEO00957 XEO_NAME Tebuconazole DME0001 XEOTICID XEO00957 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00957 XEO_CLAS Fungicide DME0001 XEOTICID XEO00957 DESCRIPT Tebuconazole up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00957 GENEFORM mRNA DME0001 XEOTICID XEO00957 MOACRIVE Induction DME0001 XEOTICID XEO00967 XEO_NAME Alachlor DME0001 XEOTICID XEO00967 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00967 XEO_CLAS Herbicide DME0001 XEOTICID XEO00967 DESCRIPT Alachlor up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00967 GENEFORM mRNA DME0001 XEOTICID XEO00967 MOACRIVE Induction DME0001 XEOTICID XEO00969 XEO_NAME Atrazine DME0001 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00969 XEO_CLAS Herbicide DME0001 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00969 GENEFORM Protein DME0001 XEOTICID XEO00969 MOACRIVE Inhibition DME0001 XEOTICID XEO00972 XEO_NAME Dithiopyr DME0001 XEOTICID XEO00972 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00972 XEO_CLAS Herbicide DME0001 XEOTICID XEO00972 DESCRIPT Dithiopyr up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00972 GENEFORM mRNA DME0001 XEOTICID XEO00972 MOACRIVE Induction DME0001 XEOTICID XEO00973 XEO_NAME Diuron DME0001 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00973 XEO_CLAS Herbicide DME0001 XEOTICID XEO00973 DESCRIPT Diuron up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00973 GENEFORM mRNA DME0001 XEOTICID XEO00973 MOACRIVE Induction DME0001 XEOTICID XEO00975 XEO_NAME Isoproturon DME0001 XEOTICID XEO00975 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00975 XEO_CLAS Herbicide DME0001 XEOTICID XEO00975 DESCRIPT Isoproturon inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00975 GENEFORM Protein DME0001 XEOTICID XEO00975 MOACRIVE Inhibition DME0001 XEOTICID XEO00978 XEO_NAME Pretilachlor DME0001 XEOTICID XEO00978 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO00978 XEO_CLAS Herbicide DME0001 XEOTICID XEO00978 DESCRIPT Pretilachlor up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO00978 GENEFORM mRNA DME0001 XEOTICID XEO00978 MOACRIVE Induction DME0001 XEOTICID XEO00986 XEO_NAME Isosafrole DME0001 XEOTICID XEO00986 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO00986 XEO_CLAS Health Hazard/Toxicant DME0001 XEOTICID XEO00986 DESCRIPT Isosafrole induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO00986 GENEFORM Protein DME0001 XEOTICID XEO00986 MOACRIVE Induction DME0001 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0001 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0001 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01004 GENEFORM Protein DME0001 XEOTICID XEO01004 MOACRIVE Induction DME0001 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0001 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0001 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01031 GENEFORM mRNA DME0001 XEOTICID XEO01031 MOACRIVE Induction DME0001 XEOTICID XEO01039 XEO_NAME Benfuracarb DME0001 XEOTICID XEO01039 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01039 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01039 DESCRIPT Benfuracarb induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01039 GENEFORM Protein DME0001 XEOTICID XEO01039 MOACRIVE Induction DME0001 XEOTICID XEO01040 XEO_NAME Bifenthrin DME0001 XEOTICID XEO01040 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01040 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01040 DESCRIPT Bifenthrin up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01040 GENEFORM mRNA DME0001 XEOTICID XEO01040 MOACRIVE Induction DME0001 XEOTICID XEO01041 XEO_NAME Bioresmethrin DME0001 XEOTICID XEO01041 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01041 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01041 DESCRIPT Bioresmethrin up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01041 GENEFORM mRNA DME0001 XEOTICID XEO01041 MOACRIVE Induction DME0001 XEOTICID XEO01043 XEO_NAME Chlorfluazuron DME0001 XEOTICID XEO01043 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01043 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01043 DESCRIPT Chlorfluazuron up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01043 GENEFORM mRNA DME0001 XEOTICID XEO01043 MOACRIVE Induction DME0001 XEOTICID XEO01045 XEO_NAME Cyfluthrin DME0001 XEOTICID XEO01045 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01045 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01045 DESCRIPT Cyfluthrin up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01045 GENEFORM mRNA DME0001 XEOTICID XEO01045 MOACRIVE Induction DME0001 XEOTICID XEO01046 XEO_NAME Cypermethrin DME0001 XEOTICID XEO01046 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01046 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01046 DESCRIPT Cypermethrin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01046 GENEFORM Protein DME0001 XEOTICID XEO01046 MOACRIVE Inhibition DME0001 XEOTICID XEO01047 XEO_NAME Decamethrin DME0001 XEOTICID XEO01047 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01047 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01047 DESCRIPT Decamethrin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01047 GENEFORM Protein DME0001 XEOTICID XEO01047 MOACRIVE Inhibition DME0001 XEOTICID XEO01048 XEO_NAME Dichlorodiphenyl dichloroethane DME0001 XEOTICID XEO01048 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01048 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01048 DESCRIPT Dichlorodiphenyl dichloroethane up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01048 GENEFORM mRNA DME0001 XEOTICID XEO01048 MOACRIVE Induction DME0001 XEOTICID XEO01051 XEO_NAME Dieldrin DME0001 XEOTICID XEO01051 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01051 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01051 DESCRIPT Dieldrin induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01051 GENEFORM Protein DME0001 XEOTICID XEO01051 MOACRIVE Induction DME0001 XEOTICID XEO01052 XEO_NAME Fenitrothion DME0001 XEOTICID XEO01052 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01052 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01052 DESCRIPT Fenitrothion inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01052 GENEFORM Protein DME0001 XEOTICID XEO01052 MOACRIVE Inhibition DME0001 XEOTICID XEO01053 XEO_NAME Fenvalerate DME0001 XEOTICID XEO01053 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01053 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01053 DESCRIPT Fenvalerate inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01053 GENEFORM Protein DME0001 XEOTICID XEO01053 MOACRIVE Inhibition DME0001 XEOTICID XEO01054 XEO_NAME Fonofos DME0001 XEOTICID XEO01054 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01054 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01054 DESCRIPT Fonof DMEos inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01054 GENEFORM Protein DME0001 XEOTICID XEO01054 MOACRIVE Inhibition DME0001 XEOTICID XEO01062 XEO_NAME Monocrotophos DME0001 XEOTICID XEO01062 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01062 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01062 DESCRIPT Monocrotophos up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01062 GENEFORM mRNA DME0001 XEOTICID XEO01062 MOACRIVE Induction DME0001 XEOTICID XEO01064 XEO_NAME Parathion DME0001 XEOTICID XEO01064 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01064 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01064 DESCRIPT Parathion up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01064 GENEFORM mRNA DME0001 XEOTICID XEO01064 MOACRIVE Induction DME0001 XEOTICID XEO01065 XEO_NAME Phenthoate DME0001 XEOTICID XEO01065 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01065 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01065 DESCRIPT Phenthoate inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01065 GENEFORM Protein DME0001 XEOTICID XEO01065 MOACRIVE Inhibition DME0001 XEOTICID XEO01068 XEO_NAME Profenofos DME0001 XEOTICID XEO01068 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01068 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01068 DESCRIPT Profenofos induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01068 GENEFORM Protein DME0001 XEOTICID XEO01068 MOACRIVE Induction DME0001 XEOTICID XEO01069 XEO_NAME Pyrethrins DME0001 XEOTICID XEO01069 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01069 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01069 DESCRIPT Pyrethrins up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01069 GENEFORM mRNA DME0001 XEOTICID XEO01069 MOACRIVE Induction DME0001 XEOTICID XEO01070 XEO_NAME Tebufenozide DME0001 XEOTICID XEO01070 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01070 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01070 DESCRIPT Tebufenozide up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01070 GENEFORM mRNA DME0001 XEOTICID XEO01070 MOACRIVE Induction DME0001 XEOTICID XEO01074 XEO_NAME Endosulfan DME0001 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01074 DESCRIPT Endosulfan inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01074 GENEFORM Protein DME0001 XEOTICID XEO01074 MOACRIVE Inhibition DME0001 XEOTICID XEO01089 XEO_NAME 1,4-naphthoquinone DME0001 XEOTICID XEO01089 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01089 XEO_CLAS Acute Toxic Substance DME0001 XEOTICID XEO01089 DESCRIPT 1,4-naphthoquinone up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01089 GENEFORM mRNA DME0001 XEOTICID XEO01089 MOACRIVE Induction DME0001 XEOTICID XEO01090 XEO_NAME 1,5-benzothiazepine DME0001 XEOTICID XEO01090 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01090 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01090 DESCRIPT 1,5-benzothiazepine up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01090 GENEFORM mRNA DME0001 XEOTICID XEO01090 MOACRIVE Induction DME0001 XEOTICID XEO01094 XEO_NAME 13-cis-retinal DME0001 XEOTICID XEO01094 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01094 XEO_CLAS Preclinical/Patented Drug DME0001 XEOTICID XEO01094 DESCRIPT 13-cis-retinal induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01094 GENEFORM Protein DME0001 XEOTICID XEO01094 MOACRIVE Induction DME0001 XEOTICID XEO01099 XEO_NAME 1-aminobenzotriazole DME0001 XEOTICID XEO01099 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01099 XEO_CLAS Preclinical/Patented Drug DME0001 XEOTICID XEO01099 DESCRIPT 1-aminobenzotriazole inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 0.45 microM) DME0001 XEOTICID XEO01099 GENEFORM Protein DME0001 XEOTICID XEO01099 MOACRIVE Inhibition DME0001 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0001 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0001 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01119 GENEFORM mRNA DME0001 XEOTICID XEO01119 MOACRIVE Induction DME0001 XEOTICID XEO01130 XEO_NAME DY-9760e DME0001 XEOTICID XEO01130 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01130 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01130 DESCRIPT DY-9760e inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01130 GENEFORM Protein DME0001 XEOTICID XEO01130 MOACRIVE Inhibition DME0001 XEOTICID XEO01133 XEO_NAME 3,3',4,5'-tetrahydroxystilbene DME0001 XEOTICID XEO01133 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01133 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01133 DESCRIPT 3,3',4,5'-tetrahydroxystilbene up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01133 GENEFORM mRNA DME0001 XEOTICID XEO01133 MOACRIVE Induction DME0001 XEOTICID XEO01138 XEO_NAME 3-ketolithocholic acid DME0001 XEOTICID XEO01138 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01138 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01138 DESCRIPT 3-ketolithocholic acid up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01138 GENEFORM mRNA DME0001 XEOTICID XEO01138 MOACRIVE Induction DME0001 XEOTICID XEO01141 XEO_NAME 3-methylquercetin DME0001 XEOTICID XEO01141 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01141 XEO_CLAS Health Hazard/Toxicant DME0001 XEOTICID XEO01141 DESCRIPT 3-methylquercetin up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01141 GENEFORM mRNA DME0001 XEOTICID XEO01141 MOACRIVE Induction DME0001 XEOTICID XEO01152 XEO_NAME 4-chlorophenylbiguanide DME0001 XEOTICID XEO01152 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01152 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01152 DESCRIPT 4-chlorophenylbiguanide inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01152 GENEFORM Protein DME0001 XEOTICID XEO01152 MOACRIVE Inhibition DME0001 XEOTICID XEO01161 XEO_NAME 5-hydroxyflavone DME0001 XEOTICID XEO01161 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01161 XEO_CLAS Natural Product DME0001 XEOTICID XEO01161 DESCRIPT 5-hydroxyflavone inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01161 GENEFORM Protein DME0001 XEOTICID XEO01161 MOACRIVE Inhibition DME0001 XEOTICID XEO01163 XEO_NAME 5-methoxyindole DME0001 XEOTICID XEO01163 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01163 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01163 DESCRIPT 5-methoxyindole inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01163 GENEFORM Protein DME0001 XEOTICID XEO01163 MOACRIVE Inhibition DME0001 XEOTICID XEO01165 XEO_NAME CITCO DME0001 XEOTICID XEO01165 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01165 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01165 DESCRIPT CITCO induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01165 GENEFORM Protein DME0001 XEOTICID XEO01165 MOACRIVE Induction DME0001 XEOTICID XEO01166 XEO_NAME 6',7'-dihydroxybergamottin DME0001 XEOTICID XEO01166 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01166 XEO_CLAS Natural Product DME0001 XEOTICID XEO01166 DESCRIPT 6',7'-dihydroxybergamottin inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 0.81 microM) DME0001 XEOTICID XEO01166 GENEFORM Protein DME0001 XEOTICID XEO01166 MOACRIVE Inhibition DME0001 XEOTICID XEO01167 XEO_NAME 6,7-dihydroxyflavone DME0001 XEOTICID XEO01167 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01167 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01167 DESCRIPT 6,7-dihydroxyflavone inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01167 GENEFORM Protein DME0001 XEOTICID XEO01167 MOACRIVE Inhibition DME0001 XEOTICID XEO01176 XEO_NAME 7-hydroxyflavone DME0001 XEOTICID XEO01176 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01176 XEO_CLAS Natural Product DME0001 XEOTICID XEO01176 DESCRIPT 7-hydroxyflavone inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01176 GENEFORM Protein DME0001 XEOTICID XEO01176 MOACRIVE Inhibition DME0001 XEOTICID XEO01179 XEO_NAME 8-prenylnaringenin DME0001 XEOTICID XEO01179 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01179 XEO_CLAS Biotoxin DME0001 XEOTICID XEO01179 DESCRIPT 8-prenylnaringenin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01179 GENEFORM Protein DME0001 XEOTICID XEO01179 MOACRIVE Inhibition DME0001 XEOTICID XEO01181 XEO_NAME 9-cis-retinal DME0001 XEOTICID XEO01181 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01181 XEO_CLAS Natural Product DME0001 XEOTICID XEO01181 DESCRIPT 9-cis-retinal induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01181 GENEFORM Protein DME0001 XEOTICID XEO01181 MOACRIVE Induction DME0001 XEOTICID XEO01184 XEO_NAME Acacetin DME0001 XEOTICID XEO01184 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01184 XEO_CLAS Natural Product DME0001 XEOTICID XEO01184 DESCRIPT Acacetin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01184 GENEFORM Protein DME0001 XEOTICID XEO01184 MOACRIVE Inhibition DME0001 XEOTICID XEO01192 XEO_NAME Alpha-naphthoflavone DME0001 XEOTICID XEO01192 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01192 XEO_CLAS Natural Product DME0001 XEOTICID XEO01192 DESCRIPT Alpha-naphthoflavone inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 > 10 microM) DME0001 XEOTICID XEO01192 GENEFORM Protein DME0001 XEOTICID XEO01192 MOACRIVE Inhibition DME0001 XEOTICID XEO01200 XEO_NAME NSC-305787 DME0001 XEOTICID XEO01200 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01200 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01200 DESCRIPT NSC-305787 induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01200 GENEFORM Protein DME0001 XEOTICID XEO01200 MOACRIVE Induction DME0001 XEOTICID XEO01203 XEO_NAME Apigenin DME0001 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01203 XEO_CLAS Natural Product DME0001 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01203 GENEFORM Protein DME0001 XEOTICID XEO01203 MOACRIVE Inhibition DME0001 XEOTICID XEO01211 XEO_NAME Azamulin DME0001 XEOTICID XEO01211 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01211 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01211 DESCRIPT Azamulin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01211 GENEFORM Protein DME0001 XEOTICID XEO01211 MOACRIVE Inhibition DME0001 XEOTICID XEO01212 XEO_NAME Baicalein DME0001 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01212 XEO_CLAS Natural Product DME0001 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 9.2 microM) DME0001 XEOTICID XEO01212 GENEFORM Protein DME0001 XEOTICID XEO01212 MOACRIVE Inhibition DME0001 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0001 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO01220 GENEFORM mRNA DME0001 XEOTICID XEO01220 MOACRIVE Inhibition DME0001 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0001 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0001 XEOTICID XEO01226 DESCRIPT Bisphenol A induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01226 GENEFORM Protein DME0001 XEOTICID XEO01226 MOACRIVE Induction DME0001 XEOTICID XEO01245 XEO_NAME Chlordan DME0001 XEOTICID XEO01245 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01245 XEO_CLAS Health Hazard/Toxicant DME0001 XEOTICID XEO01245 DESCRIPT Chlordan induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01245 GENEFORM Protein DME0001 XEOTICID XEO01245 MOACRIVE Induction DME0001 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0001 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0001 XEOTICID XEO01248 DESCRIPT Chlorpyrifos inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01248 GENEFORM Protein DME0001 XEOTICID XEO01248 MOACRIVE Inhibition DME0001 XEOTICID XEO01252 XEO_NAME Cinnamic acid DME0001 XEOTICID XEO01252 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01252 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO01252 DESCRIPT Cinnamic acid inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01252 GENEFORM Protein DME0001 XEOTICID XEO01252 MOACRIVE Inhibition DME0001 XEOTICID XEO01257 XEO_NAME Clofibric acid DME0001 XEOTICID XEO01257 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01257 XEO_CLAS Herbicide DME0001 XEOTICID XEO01257 DESCRIPT Clofibric acid induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01257 GENEFORM Protein DME0001 XEOTICID XEO01257 MOACRIVE Induction DME0001 XEOTICID XEO01268 XEO_NAME Cycloheximide DME0001 XEOTICID XEO01268 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01268 XEO_CLAS Acute Toxic Substance DME0001 XEOTICID XEO01268 DESCRIPT Cycloheximide inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO01268 GENEFORM mRNA DME0001 XEOTICID XEO01268 MOACRIVE Inhibition DME0001 XEOTICID XEO01272 XEO_NAME Deoxyelephantopin DME0001 XEOTICID XEO01272 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01272 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01272 DESCRIPT Deoxyelephantopin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01272 GENEFORM Protein DME0001 XEOTICID XEO01272 MOACRIVE Inhibition DME0001 XEOTICID XEO01274 XEO_NAME Diazinon DME0001 XEOTICID XEO01274 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01274 XEO_CLAS Environmental Pollutant DME0001 XEOTICID XEO01274 DESCRIPT Diazinon up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01274 GENEFORM mRNA DME0001 XEOTICID XEO01274 MOACRIVE Induction DME0001 XEOTICID XEO01292 XEO_NAME CINPA1 DME0001 XEOTICID XEO01292 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01292 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01292 DESCRIPT CINPA1 up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01292 GENEFORM mRNA DME0001 XEOTICID XEO01292 MOACRIVE Induction DME0001 XEOTICID XEO01295 XEO_NAME Etoxazole DME0001 XEOTICID XEO01295 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01295 XEO_CLAS Environmental Pollutant DME0001 XEOTICID XEO01295 DESCRIPT Etoxazole up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01295 GENEFORM mRNA DME0001 XEOTICID XEO01295 MOACRIVE Induction DME0001 XEOTICID XEO01298 XEO_NAME Farnesol DME0001 XEOTICID XEO01298 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01298 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01298 DESCRIPT Farnesol up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01298 GENEFORM mRNA DME0001 XEOTICID XEO01298 MOACRIVE Induction DME0001 XEOTICID XEO01302 XEO_NAME Fipronil DME0001 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0001 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME CYP3A4 and leads to increasing the drug-metabolizing activity of this enzyme DME0001 XEOTICID XEO01302 GENEFORM Protein DME0001 XEOTICID XEO01302 MOACRIVE Induction DME0001 XEOTICID XEO01304 XEO_NAME Flavone DME0001 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01304 XEO_CLAS Natural Product DME0001 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01304 GENEFORM Protein DME0001 XEOTICID XEO01304 MOACRIVE Inhibition DME0001 XEOTICID XEO01308 XEO_NAME Galangin DME0001 XEOTICID XEO01308 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01308 XEO_CLAS Natural Product DME0001 XEOTICID XEO01308 DESCRIPT Galangin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01308 GENEFORM Protein DME0001 XEOTICID XEO01308 MOACRIVE Inhibition DME0001 XEOTICID XEO01313 XEO_NAME Germacrone DME0001 XEOTICID XEO01313 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01313 XEO_CLAS Natural Product DME0001 XEOTICID XEO01313 DESCRIPT Germacrone inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01313 GENEFORM Protein DME0001 XEOTICID XEO01313 MOACRIVE Inhibition DME0001 XEOTICID XEO01314 XEO_NAME Ginkgo biloba extract DME0001 XEOTICID XEO01314 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01314 XEO_CLAS Plant Extract DME0001 XEOTICID XEO01314 DESCRIPT Ginkgo biloba extract inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01314 GENEFORM Protein DME0001 XEOTICID XEO01314 MOACRIVE Inhibition DME0001 XEOTICID XEO01315 XEO_NAME Ginkgolide A DME0001 XEOTICID XEO01315 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01315 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO01315 DESCRIPT Ginkgolide A up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01315 GENEFORM mRNA DME0001 XEOTICID XEO01315 MOACRIVE Induction DME0001 XEOTICID XEO01325 XEO_NAME GW-3965 DME0001 XEOTICID XEO01325 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01325 XEO_CLAS Preclinical/Patented Drug DME0001 XEOTICID XEO01325 DESCRIPT GW-3965 up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01325 GENEFORM mRNA DME0001 XEOTICID XEO01325 MOACRIVE Induction DME0001 XEOTICID XEO01335 XEO_NAME Hyperforin DME0001 XEOTICID XEO01335 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01335 XEO_CLAS Natural Product DME0001 XEOTICID XEO01335 DESCRIPT Hyperforin inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 2.3 microM) DME0001 XEOTICID XEO01335 GENEFORM Protein DME0001 XEOTICID XEO01335 MOACRIVE Inhibition DME0001 XEOTICID XEO01345 XEO_NAME Inermin DME0001 XEOTICID XEO01345 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01345 XEO_CLAS Natural Product DME0001 XEOTICID XEO01345 DESCRIPT Inermin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01345 GENEFORM Protein DME0001 XEOTICID XEO01345 MOACRIVE Inhibition DME0001 XEOTICID XEO01353 XEO_NAME Kaempferol DME0001 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME0001 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01353 GENEFORM Protein DME0001 XEOTICID XEO01353 MOACRIVE Inhibition DME0001 XEOTICID XEO01361 XEO_NAME L-754394 DME0001 XEOTICID XEO01361 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01361 XEO_CLAS Preclinical/Patented Drug DME0001 XEOTICID XEO01361 DESCRIPT L-754394 inhibits the drug-metabolizing activity of DME CYP3A4 (Ki = 7.5 microM) DME0001 XEOTICID XEO01361 GENEFORM Protein DME0001 XEOTICID XEO01361 MOACRIVE Inhibition DME0001 XEOTICID XEO01365 XEO_NAME Licochalcone A DME0001 XEOTICID XEO01365 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01365 XEO_CLAS Drug in Phase 1 Clinical Trial DME0001 XEOTICID XEO01365 DESCRIPT Licochalcone A inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01365 GENEFORM Protein DME0001 XEOTICID XEO01365 MOACRIVE Inhibition DME0001 XEOTICID XEO01367 XEO_NAME Linoleic acid DME0001 XEOTICID XEO01367 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01367 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO01367 DESCRIPT Linoleic acid inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01367 GENEFORM Protein DME0001 XEOTICID XEO01367 MOACRIVE Inhibition DME0001 XEOTICID XEO01391 XEO_NAME Naringin DME0001 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01391 XEO_CLAS Natural Product DME0001 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01391 GENEFORM Protein DME0001 XEOTICID XEO01391 MOACRIVE Inhibition DME0001 XEOTICID XEO01396 XEO_NAME HET-0016 DME0001 XEOTICID XEO01396 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01396 XEO_CLAS Preclinical/Patented Drug DME0001 XEOTICID XEO01396 DESCRIPT HET-0016 inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 65.4 microM) DME0001 XEOTICID XEO01396 GENEFORM Protein DME0001 XEOTICID XEO01396 MOACRIVE Inhibition DME0001 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0001 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0001 XEOTICID XEO01407 DESCRIPT Ochratoxin A inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01407 GENEFORM Protein DME0001 XEOTICID XEO01407 MOACRIVE Inhibition DME0001 XEOTICID XEO01411 XEO_NAME Oleanolic acid DME0001 XEOTICID XEO01411 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01411 XEO_CLAS Approved/Marketed Drug DME0001 XEOTICID XEO01411 DESCRIPT Oleanolic acid inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO01411 GENEFORM mRNA DME0001 XEOTICID XEO01411 MOACRIVE Inhibition DME0001 XEOTICID XEO01412 XEO_NAME Oleic acid DME0001 XEOTICID XEO01412 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01412 XEO_CLAS Preclinical/Patented Drug DME0001 XEOTICID XEO01412 DESCRIPT Oleic acid inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO01412 GENEFORM mRNA DME0001 XEOTICID XEO01412 MOACRIVE Inhibition DME0001 XEOTICID XEO01416 XEO_NAME Oxadiazon DME0001 XEOTICID XEO01416 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01416 XEO_CLAS Environmental Pollutant DME0001 XEOTICID XEO01416 DESCRIPT Oxadiazon induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01416 GENEFORM Protein DME0001 XEOTICID XEO01416 MOACRIVE Induction DME0001 XEOTICID XEO01430 XEO_NAME Phthalic acid DME0001 XEOTICID XEO01430 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0001 XEOTICID XEO01430 XEO_CLAS Chemical Compound DME0001 XEOTICID XEO01430 DESCRIPT Phthalic acid up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01430 GENEFORM mRNA DME0001 XEOTICID XEO01430 MOACRIVE Induction DME0001 XEOTICID XEO01433 XEO_NAME Pirinixic acid DME0001 XEOTICID XEO01433 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01433 XEO_CLAS Health Hazard/Toxicant DME0001 XEOTICID XEO01433 DESCRIPT Pirinixic acid up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01433 GENEFORM mRNA DME0001 XEOTICID XEO01433 MOACRIVE Induction DME0001 XEOTICID XEO01437 XEO_NAME Pregnenolone carbonitrile DME0001 XEOTICID XEO01437 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01437 XEO_CLAS Investigative Agent DME0001 XEOTICID XEO01437 DESCRIPT Pregnenolone carbonitrile up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01437 GENEFORM mRNA DME0001 XEOTICID XEO01437 MOACRIVE Induction DME0001 XEOTICID XEO01438 XEO_NAME Proadifen DME0001 XEOTICID XEO01438 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01438 XEO_CLAS Preclinical/Patented Drug DME0001 XEOTICID XEO01438 DESCRIPT Proadifen inhibits the expression of DME CYP3A4 DME0001 XEOTICID XEO01438 GENEFORM mRNA DME0001 XEOTICID XEO01438 MOACRIVE Inhibition DME0001 XEOTICID XEO01452 XEO_NAME R-116010 DME0001 XEOTICID XEO01452 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01452 XEO_CLAS Preclinical/Patented Drug DME0001 XEOTICID XEO01452 DESCRIPT R-116010 inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 0.35 microM) DME0001 XEOTICID XEO01452 GENEFORM Protein DME0001 XEOTICID XEO01452 MOACRIVE Inhibition DME0001 XEOTICID XEO01456 XEO_NAME Ro-21-5104 DME0001 XEOTICID XEO01456 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01456 XEO_CLAS Preclinical/Patented Drug DME0001 XEOTICID XEO01456 DESCRIPT Ro-21-5104 induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01456 GENEFORM Protein DME0001 XEOTICID XEO01456 MOACRIVE Induction DME0001 XEOTICID XEO01467 XEO_NAME Salinomycin DME0001 XEOTICID XEO01467 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01467 XEO_CLAS Acute Toxic Substance DME0001 XEOTICID XEO01467 DESCRIPT Salinomycin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01467 GENEFORM Protein DME0001 XEOTICID XEO01467 MOACRIVE Inhibition DME0001 XEOTICID XEO01469 XEO_NAME Schizandrol B DME0001 XEOTICID XEO01469 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01469 XEO_CLAS Natural Product DME0001 XEOTICID XEO01469 DESCRIPT Schizandrol B up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01469 GENEFORM mRNA DME0001 XEOTICID XEO01469 MOACRIVE Induction DME0001 XEOTICID XEO01478 XEO_NAME Sulforafan DME0001 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0001 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0001 XEOTICID XEO01478 DESCRIPT Sulforafan inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01478 GENEFORM Protein DME0001 XEOTICID XEO01478 MOACRIVE Inhibition DME0001 XEOTICID XEO01479 XEO_NAME Tamarixetin DME0001 XEOTICID XEO01479 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01479 XEO_CLAS Natural Product DME0001 XEOTICID XEO01479 DESCRIPT Tamarixetin up-regulates the expression of DME CYP3A4 and leads to increasing the drug-metabolizing activity of this enzyme DME0001 XEOTICID XEO01479 GENEFORM Protein DME0001 XEOTICID XEO01479 MOACRIVE Induction DME0001 XEOTICID XEO01498 XEO_NAME Walrycin A DME0001 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01498 XEO_CLAS Natural Product DME0001 XEOTICID XEO01498 DESCRIPT Walrycin A up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01498 GENEFORM mRNA DME0001 XEOTICID XEO01498 MOACRIVE Induction DME0001 XEOTICID XEO01505 XEO_NAME Lead DME0001 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0001 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0001 XEOTICID XEO01505 DESCRIPT Lead up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01505 GENEFORM mRNA DME0001 XEOTICID XEO01505 MOACRIVE Induction DME0001 XEOTICID XEO01526 XEO_NAME Basil oil DME0001 XEOTICID XEO01526 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01526 XEO_CLAS Plant Extract DME0001 XEOTICID XEO01526 DESCRIPT Basil oil up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01526 GENEFORM mRNA DME0001 XEOTICID XEO01526 MOACRIVE Induction DME0001 XEOTICID XEO01527 XEO_NAME Bergamottin DME0001 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01527 XEO_CLAS Natural Product DME0001 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of DME CYP3A4 (IC50 = 2.42 microM) DME0001 XEOTICID XEO01527 GENEFORM Protein DME0001 XEOTICID XEO01527 MOACRIVE Inhibition DME0001 XEOTICID XEO01530 XEO_NAME Cinnamon oil, bark DME0001 XEOTICID XEO01530 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01530 XEO_CLAS Plant Extract DME0001 XEOTICID XEO01530 DESCRIPT Cinnamon oil, bark up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01530 GENEFORM mRNA DME0001 XEOTICID XEO01530 MOACRIVE Induction DME0001 XEOTICID XEO01531 XEO_NAME Clove oil DME0001 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01531 XEO_CLAS Natural Product DME0001 XEOTICID XEO01531 DESCRIPT Clove oil up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01531 GENEFORM mRNA DME0001 XEOTICID XEO01531 MOACRIVE Induction DME0001 XEOTICID XEO01533 XEO_NAME Coriander oil DME0001 XEOTICID XEO01533 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01533 XEO_CLAS Plant Extract DME0001 XEOTICID XEO01533 DESCRIPT Coriander oil up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01533 GENEFORM mRNA DME0001 XEOTICID XEO01533 MOACRIVE Induction DME0001 XEOTICID XEO01534 XEO_NAME Cryptotanshinone DME0001 XEOTICID XEO01534 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01534 XEO_CLAS Natural Product DME0001 XEOTICID XEO01534 DESCRIPT Cryptotanshinone induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01534 GENEFORM Protein DME0001 XEOTICID XEO01534 MOACRIVE Induction DME0001 XEOTICID XEO01541 XEO_NAME Eupatorin DME0001 XEOTICID XEO01541 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01541 XEO_CLAS Natural Product DME0001 XEOTICID XEO01541 DESCRIPT Eupatorin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01541 GENEFORM Protein DME0001 XEOTICID XEO01541 MOACRIVE Inhibition DME0001 XEOTICID XEO01550 XEO_NAME Guggulu extract DME0001 XEOTICID XEO01550 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01550 XEO_CLAS Plant Extract DME0001 XEOTICID XEO01550 DESCRIPT Guggulu extract up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01550 GENEFORM mRNA DME0001 XEOTICID XEO01550 MOACRIVE Induction DME0001 XEOTICID XEO01556 XEO_NAME Juniperus communis oil DME0001 XEOTICID XEO01556 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01556 XEO_CLAS Plant Extract DME0001 XEOTICID XEO01556 DESCRIPT Juniperus communis oil up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01556 GENEFORM mRNA DME0001 XEOTICID XEO01556 MOACRIVE Induction DME0001 XEOTICID XEO01557 XEO_NAME Lemongrass oil DME0001 XEOTICID XEO01557 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01557 XEO_CLAS Natural Product DME0001 XEOTICID XEO01557 DESCRIPT Lemongrass oil up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01557 GENEFORM mRNA DME0001 XEOTICID XEO01557 MOACRIVE Induction DME0001 XEOTICID XEO01560 XEO_NAME Limonin DME0001 XEOTICID XEO01560 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01560 XEO_CLAS Natural Product DME0001 XEOTICID XEO01560 DESCRIPT Limonin inhibits the drug-metabolizing activity of DME CYP3A4 (Ki = 23.2 microM) DME0001 XEOTICID XEO01560 GENEFORM Protein DME0001 XEOTICID XEO01560 MOACRIVE Inhibition DME0001 XEOTICID XEO01569 XEO_NAME Volatile oil DME0001 XEOTICID XEO01569 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01569 XEO_CLAS Plant Extract DME0001 XEOTICID XEO01569 DESCRIPT Volatile oil up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01569 GENEFORM mRNA DME0001 XEOTICID XEO01569 MOACRIVE Induction DME0001 XEOTICID XEO01571 XEO_NAME Peppermint oil DME0001 XEOTICID XEO01571 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01571 XEO_CLAS Natural Product DME0001 XEOTICID XEO01571 DESCRIPT Peppermint oil up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01571 GENEFORM mRNA DME0001 XEOTICID XEO01571 MOACRIVE Induction DME0001 XEOTICID XEO01583 XEO_NAME Safrole DME0001 XEOTICID XEO01583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0001 XEOTICID XEO01583 XEO_CLAS Natural Product DME0001 XEOTICID XEO01583 DESCRIPT Safrole inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01583 GENEFORM Protein DME0001 XEOTICID XEO01583 MOACRIVE Inhibition DME0001 XEOTICID XEO01597 XEO_NAME Carbofuran DME0001 XEOTICID XEO01597 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01597 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01597 DESCRIPT Carbofuran induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01597 GENEFORM Protein DME0001 XEOTICID XEO01597 MOACRIVE Induction DME0001 XEOTICID XEO01598 XEO_NAME Chlordecone DME0001 XEOTICID XEO01598 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01598 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01598 DESCRIPT Chlordecone induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01598 GENEFORM Protein DME0001 XEOTICID XEO01598 MOACRIVE Induction DME0001 XEOTICID XEO01600 XEO_NAME Cyhalothrin DME0001 XEOTICID XEO01600 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01600 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01600 DESCRIPT Cyhalothrin inhibits the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01600 GENEFORM Protein DME0001 XEOTICID XEO01600 MOACRIVE Inhibition DME0001 XEOTICID XEO01604 XEO_NAME Nonachlor DME0001 XEOTICID XEO01604 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01604 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01604 DESCRIPT Nonachlor induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01604 GENEFORM Protein DME0001 XEOTICID XEO01604 MOACRIVE Induction DME0001 XEOTICID XEO01605 XEO_NAME Pentachlorophenol DME0001 XEOTICID XEO01605 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0001 XEOTICID XEO01605 XEO_CLAS Pesticide/Insecticide DME0001 XEOTICID XEO01605 DESCRIPT Pentachlorophenol up-regulates the expression of DME CYP3A4 DME0001 XEOTICID XEO01605 GENEFORM mRNA DME0001 XEOTICID XEO01605 MOACRIVE Induction DME0001 XEOTICID XEO01612 XEO_NAME 2-acetyltributylcitrate DME0001 XEOTICID XEO01612 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0001 XEOTICID XEO01612 XEO_CLAS Cosmetic Additive DME0001 XEOTICID XEO01612 DESCRIPT 2-acetyltributylcitrate induces the drug-metabolizing activity of DME CYP3A4 DME0001 XEOTICID XEO01612 GENEFORM Protein DME0001 XEOTICID XEO01612 MOACRIVE Induction DME0002 DME___ID DME0002 DME0002 DME_NAME Aromatase (CYP19A1) DME0002 SPESNAME Homo sapiens DME0002 XEOTICID XEO00006 XEO_NAME Anastrozole DME0002 XEOTICID XEO00006 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00006 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00006 DESCRIPT Anastrozole inhibits the drug-metabolizing activity of DME CYP19A1 in Human choriocarcinoma cell line (JEG-3) (IC50 = 0.0015 microM) DME0002 XEOTICID XEO00006 GENEFORM Protein DME0002 XEOTICID XEO00006 MOACRIVE Inhibition DME0002 XEOTICID XEO00012 XEO_NAME Carmustine DME0002 XEOTICID XEO00012 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00012 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00012 DESCRIPT Carmustine inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00012 GENEFORM mRNA DME0002 XEOTICID XEO00012 MOACRIVE Inhibition DME0002 XEOTICID XEO00013 XEO_NAME Celecoxib DME0002 XEOTICID XEO00013 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00013 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00013 DESCRIPT Celecoxib inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00013 GENEFORM Protein DME0002 XEOTICID XEO00013 MOACRIVE Inhibition DME0002 XEOTICID XEO00017 XEO_NAME Clotrimazole DME0002 XEOTICID XEO00017 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00017 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00017 DESCRIPT Clotrimazole inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 0.0018 microM) DME0002 XEOTICID XEO00017 GENEFORM Protein DME0002 XEOTICID XEO00017 MOACRIVE Inhibition DME0002 XEOTICID XEO00029 XEO_NAME Valproic acid DME0002 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00029 GENEFORM mRNA DME0002 XEOTICID XEO00029 MOACRIVE Inhibition DME0002 XEOTICID XEO00033 XEO_NAME Ethosuximide DME0002 XEOTICID XEO00033 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00033 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00033 DESCRIPT Ethosuximide inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00033 GENEFORM Protein DME0002 XEOTICID XEO00033 MOACRIVE Inhibition DME0002 XEOTICID XEO00047 XEO_NAME Indomethacin DME0002 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00047 DESCRIPT Indomethacin inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00047 GENEFORM Protein DME0002 XEOTICID XEO00047 MOACRIVE Inhibition DME0002 XEOTICID XEO00051 XEO_NAME Lamotrigine DME0002 XEOTICID XEO00051 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00051 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00051 DESCRIPT Lamotrigine inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00051 GENEFORM Protein DME0002 XEOTICID XEO00051 MOACRIVE Inhibition DME0002 XEOTICID XEO00053 XEO_NAME Leflunomide DME0002 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00053 GENEFORM mRNA DME0002 XEOTICID XEO00053 MOACRIVE Induction DME0002 XEOTICID XEO00054 XEO_NAME Letrozole DME0002 XEOTICID XEO00054 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00054 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00054 DESCRIPT Letrozole inhibits the drug-metabolizing activity of DME CYP19A1 in Human choriocarcinoma cell line (JEG-3) (IC50 = 0.00089 microM) DME0002 XEOTICID XEO00054 GENEFORM Protein DME0002 XEOTICID XEO00054 MOACRIVE Inhibition DME0002 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0002 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00088 DESCRIPT Dexamethasone induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00088 GENEFORM Protein DME0002 XEOTICID XEO00088 MOACRIVE Induction DME0002 XEOTICID XEO00090 XEO_NAME Estradiol DME0002 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00090 DESCRIPT Estradiol induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00090 GENEFORM Protein DME0002 XEOTICID XEO00090 MOACRIVE Induction DME0002 XEOTICID XEO00091 XEO_NAME Estrone DME0002 XEOTICID XEO00091 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00091 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00091 DESCRIPT Estrone inhibits the drug-metabolizing activity of DME CYP19A1 (Ki = 2.5 microM) DME0002 XEOTICID XEO00091 GENEFORM Protein DME0002 XEOTICID XEO00091 MOACRIVE Inhibition DME0002 XEOTICID XEO00094 XEO_NAME Progesterone DME0002 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00094 DESCRIPT Progesterone inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00094 GENEFORM mRNA DME0002 XEOTICID XEO00094 MOACRIVE Inhibition DME0002 XEOTICID XEO00095 XEO_NAME Testosterone DME0002 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00095 GENEFORM mRNA DME0002 XEOTICID XEO00095 MOACRIVE Induction DME0002 XEOTICID XEO00104 XEO_NAME Perflubron DME0002 XEOTICID XEO00104 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00104 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00104 DESCRIPT Perflubron up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00104 GENEFORM mRNA DME0002 XEOTICID XEO00104 MOACRIVE Induction DME0002 XEOTICID XEO00114 XEO_NAME Testolactone DME0002 XEOTICID XEO00114 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00114 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00114 DESCRIPT Testolactone inhibits the drug-metabolizing activity of DME CYP19A1 (Ki = 35 microM) DME0002 XEOTICID XEO00114 GENEFORM Protein DME0002 XEOTICID XEO00114 MOACRIVE Inhibition DME0002 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0002 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00117 GENEFORM mRNA DME0002 XEOTICID XEO00117 MOACRIVE Inhibition DME0002 XEOTICID XEO00130 XEO_NAME Exemestane DME0002 XEOTICID XEO00130 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00130 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00130 DESCRIPT Exemestane inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 0.0425 microM) DME0002 XEOTICID XEO00130 GENEFORM Protein DME0002 XEOTICID XEO00130 MOACRIVE Inhibition DME0002 XEOTICID XEO00147 XEO_NAME Fulvestrant DME0002 XEOTICID XEO00147 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00147 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00147 DESCRIPT Fulvestrant inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00147 GENEFORM Protein DME0002 XEOTICID XEO00147 MOACRIVE Inhibition DME0002 XEOTICID XEO00153 XEO_NAME Docetaxel DME0002 XEOTICID XEO00153 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00153 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00153 DESCRIPT Docetaxel inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00153 GENEFORM mRNA DME0002 XEOTICID XEO00153 MOACRIVE Inhibition DME0002 XEOTICID XEO00157 XEO_NAME Erlotinib hydrochloride DME0002 XEOTICID XEO00157 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00157 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00157 DESCRIPT Erlotinib hydrochloride inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00157 GENEFORM Protein DME0002 XEOTICID XEO00157 MOACRIVE Inhibition DME0002 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0002 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00166 GENEFORM Protein DME0002 XEOTICID XEO00166 MOACRIVE Inhibition DME0002 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0002 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00167 DESCRIPT Alitretinoin up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00167 GENEFORM mRNA DME0002 XEOTICID XEO00167 MOACRIVE Induction DME0002 XEOTICID XEO00184 XEO_NAME Calcitriol DME0002 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00184 DESCRIPT Calcitriol induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00184 GENEFORM Protein DME0002 XEOTICID XEO00184 MOACRIVE Induction DME0002 XEOTICID XEO00187 XEO_NAME Levetiracetam DME0002 XEOTICID XEO00187 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00187 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00187 DESCRIPT Levetiracetam inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00187 GENEFORM mRNA DME0002 XEOTICID XEO00187 MOACRIVE Inhibition DME0002 XEOTICID XEO00204 XEO_NAME Piroxicam DME0002 XEOTICID XEO00204 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00204 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00204 DESCRIPT Piroxicam inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00204 GENEFORM Protein DME0002 XEOTICID XEO00204 MOACRIVE Inhibition DME0002 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0002 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00217 GENEFORM mRNA DME0002 XEOTICID XEO00217 MOACRIVE Induction DME0002 XEOTICID XEO00233 XEO_NAME Aminoglutethimide DME0002 XEOTICID XEO00233 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00233 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00233 DESCRIPT Aminoglutethimide inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 0.0052 microM) DME0002 XEOTICID XEO00233 GENEFORM Protein DME0002 XEOTICID XEO00233 MOACRIVE Inhibition DME0002 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0002 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00241 GENEFORM mRNA DME0002 XEOTICID XEO00241 MOACRIVE Inhibition DME0002 XEOTICID XEO00246 XEO_NAME Amoxicillin DME0002 XEOTICID XEO00246 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00246 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00246 DESCRIPT Amoxicillin induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00246 GENEFORM Protein DME0002 XEOTICID XEO00246 MOACRIVE Induction DME0002 XEOTICID XEO00248 XEO_NAME Ibuprofen DME0002 XEOTICID XEO00248 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00248 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00248 DESCRIPT Ibuprof DMEen inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00248 GENEFORM Protein DME0002 XEOTICID XEO00248 MOACRIVE Inhibition DME0002 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0002 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 0.04 microM) DME0002 XEOTICID XEO00251 GENEFORM Protein DME0002 XEOTICID XEO00251 MOACRIVE Inhibition DME0002 XEOTICID XEO00253 XEO_NAME Tretinoin DME0002 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00253 GENEFORM mRNA DME0002 XEOTICID XEO00253 MOACRIVE Induction DME0002 XEOTICID XEO00260 XEO_NAME Dinoprostone DME0002 XEOTICID XEO00260 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00260 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00260 DESCRIPT Dinoprostone induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00260 GENEFORM Protein DME0002 XEOTICID XEO00260 MOACRIVE Induction DME0002 XEOTICID XEO00283 XEO_NAME Citalopram hydrobromide DME0002 XEOTICID XEO00283 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00283 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00283 DESCRIPT Citalopram hydrobromide inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00283 GENEFORM Protein DME0002 XEOTICID XEO00283 MOACRIVE Inhibition DME0002 XEOTICID XEO00308 XEO_NAME Miconazole nitrate DME0002 XEOTICID XEO00308 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00308 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00308 DESCRIPT Miconazole nitrate inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 0.6 microM) DME0002 XEOTICID XEO00308 GENEFORM Protein DME0002 XEOTICID XEO00308 MOACRIVE Inhibition DME0002 XEOTICID XEO00333 XEO_NAME Trovafloxacin mesylate DME0002 XEOTICID XEO00333 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00333 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00333 DESCRIPT Trovafloxacin mesylate inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00333 GENEFORM mRNA DME0002 XEOTICID XEO00333 MOACRIVE Inhibition DME0002 XEOTICID XEO00338 XEO_NAME Amlodipine DME0002 XEOTICID XEO00338 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00338 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00338 DESCRIPT Amlodipine inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00338 GENEFORM Protein DME0002 XEOTICID XEO00338 MOACRIVE Inhibition DME0002 XEOTICID XEO00358 XEO_NAME Fluoxetine DME0002 XEOTICID XEO00358 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00358 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00358 DESCRIPT Fluoxetine inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00358 GENEFORM Protein DME0002 XEOTICID XEO00358 MOACRIVE Inhibition DME0002 XEOTICID XEO00360 XEO_NAME Fluvoxamine DME0002 XEOTICID XEO00360 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00360 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00360 DESCRIPT Fluvoxamine inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00360 GENEFORM Protein DME0002 XEOTICID XEO00360 MOACRIVE Inhibition DME0002 XEOTICID XEO00366 XEO_NAME Methotrexate DME0002 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00366 DESCRIPT Methotrexate up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00366 GENEFORM mRNA DME0002 XEOTICID XEO00366 MOACRIVE Induction DME0002 XEOTICID XEO00383 XEO_NAME Tamoxifen DME0002 XEOTICID XEO00383 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00383 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00383 DESCRIPT Tamoxifen up-regulates the expression of DME CYP19A1 and leads to increasing the drug-metabolizing activity of this enzyme DME0002 XEOTICID XEO00383 GENEFORM Protein DME0002 XEOTICID XEO00383 MOACRIVE Induction DME0002 XEOTICID XEO00393 XEO_NAME Dehydroepiandrosterone DME0002 XEOTICID XEO00393 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00393 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00393 DESCRIPT Dehydroepiandrosterone inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00393 GENEFORM Protein DME0002 XEOTICID XEO00393 MOACRIVE Inhibition DME0002 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0002 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00410 GENEFORM mRNA DME0002 XEOTICID XEO00410 MOACRIVE Inhibition DME0002 XEOTICID XEO00433 XEO_NAME Dienogest DME0002 XEOTICID XEO00433 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00433 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00433 DESCRIPT Dienogest inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00433 GENEFORM Protein DME0002 XEOTICID XEO00433 MOACRIVE Inhibition DME0002 XEOTICID XEO00439 XEO_NAME Daidzein DME0002 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of DME CYP19A1 in Chinese hamster ovary (CHO) cell (Ki = 100 microM) DME0002 XEOTICID XEO00439 GENEFORM Protein DME0002 XEOTICID XEO00439 MOACRIVE Inhibition DME0002 XEOTICID XEO00446 XEO_NAME Methoxychlor DME0002 XEOTICID XEO00446 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00446 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00446 DESCRIPT Methoxychlor up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00446 GENEFORM mRNA DME0002 XEOTICID XEO00446 MOACRIVE Induction DME0002 XEOTICID XEO00457 XEO_NAME Estriol DME0002 XEOTICID XEO00457 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00457 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00457 DESCRIPT Estriol inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00457 GENEFORM mRNA DME0002 XEOTICID XEO00457 MOACRIVE Inhibition DME0002 XEOTICID XEO00464 XEO_NAME Bifonazole DME0002 XEOTICID XEO00464 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00464 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00464 DESCRIPT Bifonazole inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00464 GENEFORM Protein DME0002 XEOTICID XEO00464 MOACRIVE Inhibition DME0002 XEOTICID XEO00468 XEO_NAME Fadrozole DME0002 XEOTICID XEO00468 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00468 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00468 DESCRIPT Fadrozole inhibits the drug-metabolizing activity of DME CYP19A1 in Human breast adenocarcinoma cell line (MCF-7) (IC50 = 0.000004 microM) DME0002 XEOTICID XEO00468 GENEFORM Protein DME0002 XEOTICID XEO00468 MOACRIVE Inhibition DME0002 XEOTICID XEO00493 XEO_NAME Bezafibrate DME0002 XEOTICID XEO00493 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00493 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00493 DESCRIPT Bezafibrate inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00493 GENEFORM Protein DME0002 XEOTICID XEO00493 MOACRIVE Inhibition DME0002 XEOTICID XEO00505 XEO_NAME Melatonin DME0002 XEOTICID XEO00505 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00505 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00505 DESCRIPT Melatonin inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00505 GENEFORM Protein DME0002 XEOTICID XEO00505 MOACRIVE Inhibition DME0002 XEOTICID XEO00518 XEO_NAME Formestane DME0002 XEOTICID XEO00518 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00518 XEO_CLAS Drug Marketed but Withdrawn from Market DME0002 XEOTICID XEO00518 DESCRIPT Formestane inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00518 GENEFORM Protein DME0002 XEOTICID XEO00518 MOACRIVE Inhibition DME0002 XEOTICID XEO00519 XEO_NAME Nimesulide DME0002 XEOTICID XEO00519 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00519 XEO_CLAS Drug Marketed but Withdrawn from Market DME0002 XEOTICID XEO00519 DESCRIPT Nimesulide inhibits the drug-metabolizing activity of DME CYP19A1 in Human breast cancer cell line (SkBr3) (IC50 = 27 microM) DME0002 XEOTICID XEO00519 GENEFORM Protein DME0002 XEOTICID XEO00519 MOACRIVE Inhibition DME0002 XEOTICID XEO00538 XEO_NAME Quercetin DME0002 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0002 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 0.012 microM) DME0002 XEOTICID XEO00538 GENEFORM Protein DME0002 XEOTICID XEO00538 MOACRIVE Inhibition DME0002 XEOTICID XEO00554 XEO_NAME Fingolimod hydrochloride DME0002 XEOTICID XEO00554 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00554 XEO_CLAS Drug in Phase 1 Clinical Trial DME0002 XEOTICID XEO00554 DESCRIPT Fingolimod hydrochloride inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00554 GENEFORM mRNA DME0002 XEOTICID XEO00554 MOACRIVE Inhibition DME0002 XEOTICID XEO00557 XEO_NAME Genistein DME0002 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0002 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME CYP19A1 in Chinese hamster ovary (CHO) cell (Ki = 100 microM) DME0002 XEOTICID XEO00557 GENEFORM Protein DME0002 XEOTICID XEO00557 MOACRIVE Inhibition DME0002 XEOTICID XEO00568 XEO_NAME Resveratrol DME0002 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0002 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 25 microM) DME0002 XEOTICID XEO00568 GENEFORM Protein DME0002 XEOTICID XEO00568 MOACRIVE Inhibition DME0002 XEOTICID XEO00573 XEO_NAME Naringenin DME0002 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME0002 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 0.0029 microM) DME0002 XEOTICID XEO00573 GENEFORM Protein DME0002 XEOTICID XEO00573 MOACRIVE Inhibition DME0002 XEOTICID XEO00574 XEO_NAME Phenanthrene DME0002 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME0002 XEOTICID XEO00574 DESCRIPT Phenanthrene up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00574 GENEFORM mRNA DME0002 XEOTICID XEO00574 MOACRIVE Induction DME0002 XEOTICID XEO00583 XEO_NAME NS-398 DME0002 XEOTICID XEO00583 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00583 XEO_CLAS Drug in Phase 1 Clinical Trial DME0002 XEOTICID XEO00583 DESCRIPT NS-398 inhibits the drug-metabolizing activity of DME CYP19A1 in Human breast cancer cell line (SkBr3) (IC50 = 0.68 microM) DME0002 XEOTICID XEO00583 GENEFORM Protein DME0002 XEOTICID XEO00583 MOACRIVE Inhibition DME0002 XEOTICID XEO00598 XEO_NAME Carbendazim DME0002 XEOTICID XEO00598 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00598 XEO_CLAS Drug in Phase 1 Clinical Trial DME0002 XEOTICID XEO00598 DESCRIPT Carbendazim induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00598 GENEFORM Protein DME0002 XEOTICID XEO00598 MOACRIVE Induction DME0002 XEOTICID XEO00599 XEO_NAME Tetradecanoylphorbol acetate DME0002 XEOTICID XEO00599 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00599 XEO_CLAS Drug in Phase 1 Clinical Trial DME0002 XEOTICID XEO00599 DESCRIPT Tetradecanoylphorbol acetate inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00599 GENEFORM mRNA DME0002 XEOTICID XEO00599 MOACRIVE Inhibition DME0002 XEOTICID XEO00606 XEO_NAME Colforsin DME0002 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0002 XEOTICID XEO00606 DESCRIPT Colforsin induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00606 GENEFORM Protein DME0002 XEOTICID XEO00606 MOACRIVE Induction DME0002 XEOTICID XEO00610 XEO_NAME Afimoxifene DME0002 XEOTICID XEO00610 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00610 XEO_CLAS Drug in Phase 3 Clinical Trial DME0002 XEOTICID XEO00610 DESCRIPT Afimoxifene up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00610 GENEFORM mRNA DME0002 XEOTICID XEO00610 MOACRIVE Induction DME0002 XEOTICID XEO00623 XEO_NAME SC-58125 DME0002 XEOTICID XEO00623 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00623 XEO_CLAS Drug in Phase 1 Clinical Trial DME0002 XEOTICID XEO00623 DESCRIPT SC-58125 inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00623 GENEFORM Protein DME0002 XEOTICID XEO00623 MOACRIVE Inhibition DME0002 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0002 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0002 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00632 GENEFORM mRNA DME0002 XEOTICID XEO00632 MOACRIVE Induction DME0002 XEOTICID XEO00658 XEO_NAME Bakuchiol DME0002 XEOTICID XEO00658 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00658 XEO_CLAS Drug in Phase 1 Clinical Trial DME0002 XEOTICID XEO00658 DESCRIPT Bakuchiol inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00658 GENEFORM Protein DME0002 XEOTICID XEO00658 MOACRIVE Inhibition DME0002 XEOTICID XEO00694 XEO_NAME LG-100268 DME0002 XEOTICID XEO00694 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00694 XEO_CLAS Preclinical/Patented Drug DME0002 XEOTICID XEO00694 DESCRIPT LG-100268 inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00694 GENEFORM Protein DME0002 XEOTICID XEO00694 MOACRIVE Inhibition DME0002 XEOTICID XEO00711 XEO_NAME Rottlerin DME0002 XEOTICID XEO00711 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00711 XEO_CLAS Preclinical/Patented Drug DME0002 XEOTICID XEO00711 DESCRIPT Rottlerin inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00711 GENEFORM Protein DME0002 XEOTICID XEO00711 MOACRIVE Inhibition DME0002 XEOTICID XEO00728 XEO_NAME AM-580 DME0002 XEOTICID XEO00728 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00728 XEO_CLAS Preclinical/Patented Drug DME0002 XEOTICID XEO00728 DESCRIPT AM-580 up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00728 GENEFORM mRNA DME0002 XEOTICID XEO00728 MOACRIVE Induction DME0002 XEOTICID XEO00738 XEO_NAME Flavanone DME0002 XEOTICID XEO00738 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00738 XEO_CLAS Drug in Phase 1 Clinical Trial DME0002 XEOTICID XEO00738 DESCRIPT Flavanone inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00738 GENEFORM Protein DME0002 XEOTICID XEO00738 MOACRIVE Inhibition DME0002 XEOTICID XEO00740 XEO_NAME Lindane DME0002 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00740 DESCRIPT Lindane inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00740 GENEFORM Protein DME0002 XEOTICID XEO00740 MOACRIVE Inhibition DME0002 XEOTICID XEO00764 XEO_NAME Naphthalene DME0002 XEOTICID XEO00764 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0002 XEOTICID XEO00764 XEO_CLAS Chemical Compound DME0002 XEOTICID XEO00764 DESCRIPT Naphthalene induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00764 GENEFORM Protein DME0002 XEOTICID XEO00764 MOACRIVE Induction DME0002 XEOTICID XEO00768 XEO_NAME Dichlorodiphenyl dichloroethylene DME0002 XEOTICID XEO00768 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO00768 XEO_CLAS Environmental Pollutant DME0002 XEOTICID XEO00768 DESCRIPT Dichlorodiphenyl dichloroethylene inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00768 GENEFORM Protein DME0002 XEOTICID XEO00768 MOACRIVE Inhibition DME0002 XEOTICID XEO00805 XEO_NAME YM-511 DME0002 XEOTICID XEO00805 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00805 XEO_CLAS Investigative Agent DME0002 XEOTICID XEO00805 DESCRIPT YM-511 inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 0.00012 microM) DME0002 XEOTICID XEO00805 GENEFORM Protein DME0002 XEOTICID XEO00805 MOACRIVE Inhibition DME0002 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0002 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0002 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00806 GENEFORM Protein DME0002 XEOTICID XEO00806 MOACRIVE Induction DME0002 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0002 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0002 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0002 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00821 GENEFORM mRNA DME0002 XEOTICID XEO00821 MOACRIVE Inhibition DME0002 XEOTICID XEO00834 XEO_NAME Copper DME0002 XEOTICID XEO00834 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00834 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO00834 DESCRIPT Copper up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00834 GENEFORM mRNA DME0002 XEOTICID XEO00834 MOACRIVE Induction DME0002 XEOTICID XEO00851 XEO_NAME Iprodione DME0002 XEOTICID XEO00851 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO00851 XEO_CLAS Health Hazard/Toxicant DME0002 XEOTICID XEO00851 DESCRIPT Iprodione induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00851 GENEFORM Protein DME0002 XEOTICID XEO00851 MOACRIVE Induction DME0002 XEOTICID XEO00856 XEO_NAME Hesperetin DME0002 XEOTICID XEO00856 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0002 XEOTICID XEO00856 XEO_CLAS Natural Product DME0002 XEOTICID XEO00856 DESCRIPT Hesperetin inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00856 GENEFORM Protein DME0002 XEOTICID XEO00856 MOACRIVE Inhibition DME0002 XEOTICID XEO00858 XEO_NAME Flavonoids DME0002 XEOTICID XEO00858 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0002 XEOTICID XEO00858 XEO_CLAS Natural Mixture DME0002 XEOTICID XEO00858 DESCRIPT Flavonoids inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00858 GENEFORM Protein DME0002 XEOTICID XEO00858 MOACRIVE Inhibition DME0002 XEOTICID XEO00878 XEO_NAME Chrysin DME0002 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0002 XEOTICID XEO00878 XEO_CLAS Natural Product DME0002 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 0.001 microM) DME0002 XEOTICID XEO00878 GENEFORM Protein DME0002 XEOTICID XEO00878 MOACRIVE Inhibition DME0002 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0002 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0002 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00898 GENEFORM mRNA DME0002 XEOTICID XEO00898 MOACRIVE Induction DME0002 XEOTICID XEO00926 XEO_NAME Tetrabromobisphenol A DME0002 XEOTICID XEO00926 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO00926 XEO_CLAS Environmental Pollutant DME0002 XEOTICID XEO00926 DESCRIPT Tetrabromobisphenol A inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00926 GENEFORM mRNA DME0002 XEOTICID XEO00926 MOACRIVE Inhibition DME0002 XEOTICID XEO00930 XEO_NAME Butylparaben DME0002 XEOTICID XEO00930 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO00930 XEO_CLAS Investigative Agent DME0002 XEOTICID XEO00930 DESCRIPT Butylparaben inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00930 GENEFORM Protein DME0002 XEOTICID XEO00930 MOACRIVE Inhibition DME0002 XEOTICID XEO00939 XEO_NAME Benomyl DME0002 XEOTICID XEO00939 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO00939 XEO_CLAS Fungicide DME0002 XEOTICID XEO00939 DESCRIPT Benomyl induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00939 GENEFORM Protein DME0002 XEOTICID XEO00939 MOACRIVE Induction DME0002 XEOTICID XEO00944 XEO_NAME Enilconazole DME0002 XEOTICID XEO00944 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO00944 XEO_CLAS Fungicide DME0002 XEOTICID XEO00944 DESCRIPT Enilconazole inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00944 GENEFORM Protein DME0002 XEOTICID XEO00944 MOACRIVE Inhibition DME0002 XEOTICID XEO00946 XEO_NAME Fenarimol DME0002 XEOTICID XEO00946 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO00946 XEO_CLAS Fungicide DME0002 XEOTICID XEO00946 DESCRIPT Fenarimol inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00946 GENEFORM Protein DME0002 XEOTICID XEO00946 MOACRIVE Inhibition DME0002 XEOTICID XEO00948 XEO_NAME Flusilazole DME0002 XEOTICID XEO00948 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO00948 XEO_CLAS Fungicide DME0002 XEOTICID XEO00948 DESCRIPT Flusilazole inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00948 GENEFORM Protein DME0002 XEOTICID XEO00948 MOACRIVE Inhibition DME0002 XEOTICID XEO00952 XEO_NAME Hexaconazole DME0002 XEOTICID XEO00952 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO00952 XEO_CLAS Fungicide DME0002 XEOTICID XEO00952 DESCRIPT Hexaconazole inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00952 GENEFORM Protein DME0002 XEOTICID XEO00952 MOACRIVE Inhibition DME0002 XEOTICID XEO00955 XEO_NAME Prochloraz DME0002 XEOTICID XEO00955 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO00955 XEO_CLAS Fungicide DME0002 XEOTICID XEO00955 DESCRIPT Prochloraz inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00955 GENEFORM mRNA DME0002 XEOTICID XEO00955 MOACRIVE Inhibition DME0002 XEOTICID XEO00957 XEO_NAME Tebuconazole DME0002 XEOTICID XEO00957 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO00957 XEO_CLAS Fungicide DME0002 XEOTICID XEO00957 DESCRIPT Tebuconazole inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00957 GENEFORM Protein DME0002 XEOTICID XEO00957 MOACRIVE Inhibition DME0002 XEOTICID XEO00958 XEO_NAME Triadimefon DME0002 XEOTICID XEO00958 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO00958 XEO_CLAS Fungicide DME0002 XEOTICID XEO00958 DESCRIPT Triadimefon inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00958 GENEFORM mRNA DME0002 XEOTICID XEO00958 MOACRIVE Inhibition DME0002 XEOTICID XEO00960 XEO_NAME Vinclozolin DME0002 XEOTICID XEO00960 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO00960 XEO_CLAS Fungicide DME0002 XEOTICID XEO00960 DESCRIPT Vinclozolin up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00960 GENEFORM mRNA DME0002 XEOTICID XEO00960 MOACRIVE Induction DME0002 XEOTICID XEO00961 XEO_NAME Triphenyltin chloride DME0002 XEOTICID XEO00961 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO00961 XEO_CLAS Fungicide DME0002 XEOTICID XEO00961 DESCRIPT Triphenyltin chloride up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00961 GENEFORM mRNA DME0002 XEOTICID XEO00961 MOACRIVE Induction DME0002 XEOTICID XEO00962 XEO_NAME 2,4,6-trichlorophenol DME0002 XEOTICID XEO00962 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO00962 XEO_CLAS Fungicide DME0002 XEOTICID XEO00962 DESCRIPT 2,4,6-trichlorophenol inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO00962 GENEFORM mRNA DME0002 XEOTICID XEO00962 MOACRIVE Inhibition DME0002 XEOTICID XEO00969 XEO_NAME Atrazine DME0002 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO00969 XEO_CLAS Herbicide DME0002 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00969 GENEFORM Protein DME0002 XEOTICID XEO00969 MOACRIVE Inhibition DME0002 XEOTICID XEO00976 XEO_NAME Metolachlor DME0002 XEOTICID XEO00976 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO00976 XEO_CLAS Herbicide DME0002 XEOTICID XEO00976 DESCRIPT Metolachlor up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO00976 GENEFORM mRNA DME0002 XEOTICID XEO00976 MOACRIVE Induction DME0002 XEOTICID XEO00998 XEO_NAME Butylbenzyl phthalate DME0002 XEOTICID XEO00998 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO00998 XEO_CLAS Health Hazard/Toxicant DME0002 XEOTICID XEO00998 DESCRIPT Butylbenzyl phthalate inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO00998 GENEFORM Protein DME0002 XEOTICID XEO00998 MOACRIVE Inhibition DME0002 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0002 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0002 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO01004 GENEFORM mRNA DME0002 XEOTICID XEO01004 MOACRIVE Induction DME0002 XEOTICID XEO01033 XEO_NAME Diethyl phthalate DME0002 XEOTICID XEO01033 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO01033 XEO_CLAS Approved/Marketed Drug DME0002 XEOTICID XEO01033 DESCRIPT Diethyl phthalate induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01033 GENEFORM Protein DME0002 XEOTICID XEO01033 MOACRIVE Induction DME0002 XEOTICID XEO01040 XEO_NAME Bifenthrin DME0002 XEOTICID XEO01040 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO01040 XEO_CLAS Pesticide/Insecticide DME0002 XEOTICID XEO01040 DESCRIPT Bifenthrin up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO01040 GENEFORM mRNA DME0002 XEOTICID XEO01040 MOACRIVE Induction DME0002 XEOTICID XEO01046 XEO_NAME Cypermethrin DME0002 XEOTICID XEO01046 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO01046 XEO_CLAS Pesticide/Insecticide DME0002 XEOTICID XEO01046 DESCRIPT Cypermethrin induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01046 GENEFORM Protein DME0002 XEOTICID XEO01046 MOACRIVE Induction DME0002 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0002 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0002 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO01050 GENEFORM mRNA DME0002 XEOTICID XEO01050 MOACRIVE Inhibition DME0002 XEOTICID XEO01055 XEO_NAME Heptachlor DME0002 XEOTICID XEO01055 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO01055 XEO_CLAS Pesticide/Insecticide DME0002 XEOTICID XEO01055 DESCRIPT Heptachlor inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01055 GENEFORM Protein DME0002 XEOTICID XEO01055 MOACRIVE Inhibition DME0002 XEOTICID XEO01067 XEO_NAME Pirimicarb DME0002 XEOTICID XEO01067 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO01067 XEO_CLAS Pesticide/Insecticide DME0002 XEOTICID XEO01067 DESCRIPT Pirimicarb up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO01067 GENEFORM mRNA DME0002 XEOTICID XEO01067 MOACRIVE Induction DME0002 XEOTICID XEO01074 XEO_NAME Endosulfan DME0002 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0002 XEOTICID XEO01074 DESCRIPT Endosulfan induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01074 GENEFORM Protein DME0002 XEOTICID XEO01074 MOACRIVE Induction DME0002 XEOTICID XEO01110 XEO_NAME p,p'-Hydroxy-DDT DME0002 XEOTICID XEO01110 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO01110 XEO_CLAS Environmental Pollutant DME0002 XEOTICID XEO01110 DESCRIPT p,p'-Hydroxy-DDT inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01110 GENEFORM Protein DME0002 XEOTICID XEO01110 MOACRIVE Inhibition DME0002 XEOTICID XEO01121 XEO_NAME 2-bromophenol DME0002 XEOTICID XEO01121 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO01121 XEO_CLAS Environmental Pollutant DME0002 XEOTICID XEO01121 DESCRIPT 2-bromophenol up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO01121 GENEFORM mRNA DME0002 XEOTICID XEO01121 MOACRIVE Induction DME0002 XEOTICID XEO01145 XEO_NAME 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid DME0002 XEOTICID XEO01145 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO01145 XEO_CLAS Health Hazard/Toxicant DME0002 XEOTICID XEO01145 DESCRIPT 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01145 GENEFORM Protein DME0002 XEOTICID XEO01145 MOACRIVE Induction DME0002 XEOTICID XEO01175 XEO_NAME 7-hydroxyflavanone DME0002 XEOTICID XEO01175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0002 XEOTICID XEO01175 XEO_CLAS Natural Product DME0002 XEOTICID XEO01175 DESCRIPT 7-hydroxyflavanone inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 3.8 microM) DME0002 XEOTICID XEO01175 GENEFORM Protein DME0002 XEOTICID XEO01175 MOACRIVE Inhibition DME0002 XEOTICID XEO01176 XEO_NAME 7-hydroxyflavone DME0002 XEOTICID XEO01176 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0002 XEOTICID XEO01176 XEO_CLAS Natural Product DME0002 XEOTICID XEO01176 DESCRIPT 7-hydroxyflavone inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 0.0305 microM) DME0002 XEOTICID XEO01176 GENEFORM Protein DME0002 XEOTICID XEO01176 MOACRIVE Inhibition DME0002 XEOTICID XEO01192 XEO_NAME Alpha-naphthoflavone DME0002 XEOTICID XEO01192 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0002 XEOTICID XEO01192 XEO_CLAS Natural Product DME0002 XEOTICID XEO01192 DESCRIPT Alpha-naphthof DMElavone inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 0.07 microM) DME0002 XEOTICID XEO01192 GENEFORM Protein DME0002 XEOTICID XEO01192 MOACRIVE Inhibition DME0002 XEOTICID XEO01203 XEO_NAME Apigenin DME0002 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0002 XEOTICID XEO01203 XEO_CLAS Natural Product DME0002 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 0.9 microM) DME0002 XEOTICID XEO01203 GENEFORM Protein DME0002 XEOTICID XEO01203 MOACRIVE Inhibition DME0002 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0002 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0002 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO01220 GENEFORM mRNA DME0002 XEOTICID XEO01220 MOACRIVE Induction DME0002 XEOTICID XEO01222 XEO_NAME Biochanin A DME0002 XEOTICID XEO01222 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0002 XEOTICID XEO01222 XEO_CLAS Natural Product DME0002 XEOTICID XEO01222 DESCRIPT Biochanin A inhibits the drug-metabolizing activity of DME CYP19A1 (IC50 = 0.0102 microM) DME0002 XEOTICID XEO01222 GENEFORM Protein DME0002 XEOTICID XEO01222 MOACRIVE Inhibition DME0002 XEOTICID XEO01225 XEO_NAME Bisindolylmaleimide DME0002 XEOTICID XEO01225 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO01225 XEO_CLAS Investigative Agent DME0002 XEOTICID XEO01225 DESCRIPT Bisindolylmaleimide inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01225 GENEFORM Protein DME0002 XEOTICID XEO01225 MOACRIVE Inhibition DME0002 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0002 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0002 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01226 GENEFORM Protein DME0002 XEOTICID XEO01226 MOACRIVE Inhibition DME0002 XEOTICID XEO01245 XEO_NAME Chlordan DME0002 XEOTICID XEO01245 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO01245 XEO_CLAS Health Hazard/Toxicant DME0002 XEOTICID XEO01245 DESCRIPT Chlordan induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01245 GENEFORM Protein DME0002 XEOTICID XEO01245 MOACRIVE Induction DME0002 XEOTICID XEO01267 XEO_NAME Cyclic AMP DME0002 XEOTICID XEO01267 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO01267 XEO_CLAS Drug in Phase 1 Clinical Trial DME0002 XEOTICID XEO01267 DESCRIPT Cyclic AMP induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01267 GENEFORM Protein DME0002 XEOTICID XEO01267 MOACRIVE Induction DME0002 XEOTICID XEO01268 XEO_NAME Cycloheximide DME0002 XEOTICID XEO01268 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO01268 XEO_CLAS Acute Toxic Substance DME0002 XEOTICID XEO01268 DESCRIPT Cycloheximide inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01268 GENEFORM Protein DME0002 XEOTICID XEO01268 MOACRIVE Inhibition DME0002 XEOTICID XEO01275 XEO_NAME Dibutyl phthalate DME0002 XEOTICID XEO01275 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO01275 XEO_CLAS Health Hazard/Toxicant DME0002 XEOTICID XEO01275 DESCRIPT Dibutyl phthalate inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01275 GENEFORM Protein DME0002 XEOTICID XEO01275 MOACRIVE Inhibition DME0002 XEOTICID XEO01289 XEO_NAME Enniatins DME0002 XEOTICID XEO01289 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO01289 XEO_CLAS Acute Toxic Substance DME0002 XEOTICID XEO01289 DESCRIPT Enniatins up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO01289 GENEFORM mRNA DME0002 XEOTICID XEO01289 MOACRIVE Induction DME0002 XEOTICID XEO01304 XEO_NAME Flavone DME0002 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0002 XEOTICID XEO01304 XEO_CLAS Natural Product DME0002 XEOTICID XEO01304 DESCRIPT Flavone induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01304 GENEFORM Protein DME0002 XEOTICID XEO01304 MOACRIVE Induction DME0002 XEOTICID XEO01314 XEO_NAME Ginkgo biloba extract DME0002 XEOTICID XEO01314 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0002 XEOTICID XEO01314 XEO_CLAS Plant Extract DME0002 XEOTICID XEO01314 DESCRIPT Ginkgo biloba extract inhibits the expression of DME CYP19A1 and leads to decreasing the drug-metabolizing activity of this enzyme DME0002 XEOTICID XEO01314 GENEFORM Protein DME0002 XEOTICID XEO01314 MOACRIVE Inhibition DME0002 XEOTICID XEO01320 XEO_NAME Glyphosate DME0002 XEOTICID XEO01320 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO01320 XEO_CLAS Environmental Pollutant DME0002 XEOTICID XEO01320 DESCRIPT Glyphosate inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01320 GENEFORM Protein DME0002 XEOTICID XEO01320 MOACRIVE Inhibition DME0002 XEOTICID XEO01380 XEO_NAME Mono-(2-ethylhexyl)phthalate DME0002 XEOTICID XEO01380 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO01380 XEO_CLAS Investigative Agent DME0002 XEOTICID XEO01380 DESCRIPT Mono-(2-ethylhexyl)phthalate inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01380 GENEFORM Protein DME0002 XEOTICID XEO01380 MOACRIVE Inhibition DME0002 XEOTICID XEO01414 XEO_NAME Oleuropein DME0002 XEOTICID XEO01414 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0002 XEOTICID XEO01414 XEO_CLAS Natural Product DME0002 XEOTICID XEO01414 DESCRIPT Oleuropein inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO01414 GENEFORM mRNA DME0002 XEOTICID XEO01414 MOACRIVE Inhibition DME0002 XEOTICID XEO01416 XEO_NAME Oxadiazon DME0002 XEOTICID XEO01416 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO01416 XEO_CLAS Environmental Pollutant DME0002 XEOTICID XEO01416 DESCRIPT Oxadiazon up-regulates the expression of DME CYP19A1 DME0002 XEOTICID XEO01416 GENEFORM mRNA DME0002 XEOTICID XEO01416 MOACRIVE Induction DME0002 XEOTICID XEO01468 XEO_NAME SC-560 DME0002 XEOTICID XEO01468 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO01468 XEO_CLAS Preclinical/Patented Drug DME0002 XEOTICID XEO01468 DESCRIPT SC-560 inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01468 GENEFORM Protein DME0002 XEOTICID XEO01468 MOACRIVE Inhibition DME0002 XEOTICID XEO01491 XEO_NAME Tributyltin DME0002 XEOTICID XEO01491 XEO_TYPE Pharmaceutical Agent(s) DME0002 XEOTICID XEO01491 XEO_CLAS Investigative Agent DME0002 XEOTICID XEO01491 DESCRIPT Tributyltin induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01491 GENEFORM Protein DME0002 XEOTICID XEO01491 MOACRIVE Induction DME0002 XEOTICID XEO01503 XEO_NAME Cadmium DME0002 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0002 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO01503 GENEFORM mRNA DME0002 XEOTICID XEO01503 MOACRIVE Inhibition DME0002 XEOTICID XEO01514 XEO_NAME Deoxynivalenol DME0002 XEOTICID XEO01514 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO01514 XEO_CLAS Mycotoxin DME0002 XEOTICID XEO01514 DESCRIPT Deoxynivalenol inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO01514 GENEFORM mRNA DME0002 XEOTICID XEO01514 MOACRIVE Inhibition DME0002 XEOTICID XEO01515 XEO_NAME HT-2 toxin DME0002 XEOTICID XEO01515 XEO_TYPE Health or Environmental Toxicant(s) DME0002 XEOTICID XEO01515 XEO_CLAS Mycotoxin DME0002 XEOTICID XEO01515 DESCRIPT HT-2 toxin inhibits the expression of DME CYP19A1 DME0002 XEOTICID XEO01515 GENEFORM mRNA DME0002 XEOTICID XEO01515 MOACRIVE Inhibition DME0002 XEOTICID XEO01598 XEO_NAME Chlordecone DME0002 XEOTICID XEO01598 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO01598 XEO_CLAS Pesticide/Insecticide DME0002 XEOTICID XEO01598 DESCRIPT Chlordecone inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01598 GENEFORM Protein DME0002 XEOTICID XEO01598 MOACRIVE Inhibition DME0002 XEOTICID XEO01601 XEO_NAME Dicofol DME0002 XEOTICID XEO01601 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO01601 XEO_CLAS Pesticide/Insecticide DME0002 XEOTICID XEO01601 DESCRIPT Dicof DMEol inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01601 GENEFORM Protein DME0002 XEOTICID XEO01601 MOACRIVE Inhibition DME0002 XEOTICID XEO01602 XEO_NAME Imidacloprid DME0002 XEOTICID XEO01602 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0002 XEOTICID XEO01602 XEO_CLAS Pesticide/Insecticide DME0002 XEOTICID XEO01602 DESCRIPT Imidacloprid induces the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO01602 GENEFORM Protein DME0002 XEOTICID XEO01602 MOACRIVE Induction DME0002 XEOTICID XEO02228 XEO_NAME Aniline DME0002 XEOTICID XEO02228 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0002 XEOTICID XEO02228 XEO_CLAS Chemical Compound DME0002 XEOTICID XEO02228 DESCRIPT Aniline inhibits the drug-metabolizing activity of DME CYP19A1 DME0002 XEOTICID XEO02228 GENEFORM Protein DME0002 XEOTICID XEO02228 MOACRIVE Inhibition DME0003 DME___ID DME0003 DME0003 DME_NAME Cytochrome P450 1A2 (CYP1A2) DME0003 SPESNAME Homo sapiens DME0003 XEOTICID XEO00001 XEO_NAME Dimethyl sulfoxide DME0003 XEOTICID XEO00001 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00001 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00001 DESCRIPT Dimethyl sulfoxide up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00001 GENEFORM mRNA DME0003 XEOTICID XEO00001 MOACRIVE Induction DME0003 XEOTICID XEO00003 XEO_NAME Albendazole DME0003 XEOTICID XEO00003 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00003 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00003 DESCRIPT Albendazole up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00003 GENEFORM mRNA DME0003 XEOTICID XEO00003 MOACRIVE Induction DME0003 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0003 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00011 GENEFORM mRNA DME0003 XEOTICID XEO00011 MOACRIVE Induction DME0003 XEOTICID XEO00013 XEO_NAME Celecoxib DME0003 XEOTICID XEO00013 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00013 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00013 DESCRIPT Celecoxib inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00013 GENEFORM Protein DME0003 XEOTICID XEO00013 MOACRIVE Inhibition DME0003 XEOTICID XEO00015 XEO_NAME Cimetidine DME0003 XEOTICID XEO00015 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00015 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00015 DESCRIPT Cimetidine inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00015 GENEFORM Protein DME0003 XEOTICID XEO00015 MOACRIVE Inhibition DME0003 XEOTICID XEO00030 XEO_NAME Enoxacin DME0003 XEOTICID XEO00030 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00030 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00030 DESCRIPT Enoxacin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00030 GENEFORM Protein DME0003 XEOTICID XEO00030 MOACRIVE Inhibition DME0003 XEOTICID XEO00034 XEO_NAME Etodolac DME0003 XEOTICID XEO00034 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00034 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00034 DESCRIPT Etodolac inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00034 GENEFORM Protein DME0003 XEOTICID XEO00034 MOACRIVE Inhibition DME0003 XEOTICID XEO00042 XEO_NAME Gemfibrozil DME0003 XEOTICID XEO00042 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00042 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00042 DESCRIPT Gemfibrozil inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00042 GENEFORM Protein DME0003 XEOTICID XEO00042 MOACRIVE Inhibition DME0003 XEOTICID XEO00046 XEO_NAME Ifosfamide DME0003 XEOTICID XEO00046 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00046 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00046 DESCRIPT Ifosfamide up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00046 GENEFORM mRNA DME0003 XEOTICID XEO00046 MOACRIVE Induction DME0003 XEOTICID XEO00049 XEO_NAME Isradipine DME0003 XEOTICID XEO00049 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00049 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00049 DESCRIPT Isradipine up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00049 GENEFORM mRNA DME0003 XEOTICID XEO00049 MOACRIVE Induction DME0003 XEOTICID XEO00052 XEO_NAME Lansoprazole DME0003 XEOTICID XEO00052 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00052 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00052 DESCRIPT Lansoprazole induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00052 GENEFORM Protein DME0003 XEOTICID XEO00052 MOACRIVE Induction DME0003 XEOTICID XEO00053 XEO_NAME Leflunomide DME0003 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00053 GENEFORM mRNA DME0003 XEOTICID XEO00053 MOACRIVE Induction DME0003 XEOTICID XEO00056 XEO_NAME Malathion DME0003 XEOTICID XEO00056 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00056 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00056 DESCRIPT Malathion induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00056 GENEFORM Protein DME0003 XEOTICID XEO00056 MOACRIVE Induction DME0003 XEOTICID XEO00059 XEO_NAME Mefenamic acid DME0003 XEOTICID XEO00059 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00059 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00059 DESCRIPT Mefenamic acid inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00059 GENEFORM Protein DME0003 XEOTICID XEO00059 MOACRIVE Inhibition DME0003 XEOTICID XEO00062 XEO_NAME Methoxsalen DME0003 XEOTICID XEO00062 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00062 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00062 DESCRIPT Methoxsalen inhibits the drug-metabolizing activity of DME CYP1A2 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.04 microM) DME0003 XEOTICID XEO00062 GENEFORM Protein DME0003 XEOTICID XEO00062 MOACRIVE Inhibition DME0003 XEOTICID XEO00066 XEO_NAME Nifedipine DME0003 XEOTICID XEO00066 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00066 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00066 DESCRIPT Nifedipine inhibits the drug-metabolizing activity of DME CYP1A2 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.3 microM) DME0003 XEOTICID XEO00066 GENEFORM Protein DME0003 XEOTICID XEO00066 MOACRIVE Inhibition DME0003 XEOTICID XEO00067 XEO_NAME Nisoldipine DME0003 XEOTICID XEO00067 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00067 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00067 DESCRIPT Nisoldipine inhibits the drug-metabolizing activity of DME CYP1A2 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 1 microM) DME0003 XEOTICID XEO00067 GENEFORM Protein DME0003 XEOTICID XEO00067 MOACRIVE Inhibition DME0003 XEOTICID XEO00069 XEO_NAME Omeprazole DME0003 XEOTICID XEO00069 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00069 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00069 DESCRIPT Omeprazole inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO00069 GENEFORM mRNA DME0003 XEOTICID XEO00069 MOACRIVE Inhibition DME0003 XEOTICID XEO00084 XEO_NAME Thiabendazole DME0003 XEOTICID XEO00084 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00084 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00084 DESCRIPT Thiabendazole inhibits the drug-metabolizing activity of DME CYP1A2 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.8 microM) DME0003 XEOTICID XEO00084 GENEFORM Protein DME0003 XEOTICID XEO00084 MOACRIVE Inhibition DME0003 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0003 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00088 DESCRIPT Dexamethasone inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00088 GENEFORM Protein DME0003 XEOTICID XEO00088 MOACRIVE Inhibition DME0003 XEOTICID XEO00090 XEO_NAME Estradiol DME0003 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO00090 GENEFORM mRNA DME0003 XEOTICID XEO00090 MOACRIVE Inhibition DME0003 XEOTICID XEO00102 XEO_NAME Azacitidine DME0003 XEOTICID XEO00102 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00102 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00102 DESCRIPT Azacitidine up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00102 GENEFORM mRNA DME0003 XEOTICID XEO00102 MOACRIVE Induction DME0003 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0003 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO00117 GENEFORM mRNA DME0003 XEOTICID XEO00117 MOACRIVE Inhibition DME0003 XEOTICID XEO00123 XEO_NAME Permethrin DME0003 XEOTICID XEO00123 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00123 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00123 DESCRIPT Permethrin up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00123 GENEFORM mRNA DME0003 XEOTICID XEO00123 MOACRIVE Induction DME0003 XEOTICID XEO00131 XEO_NAME Zileuton DME0003 XEOTICID XEO00131 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00131 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00131 DESCRIPT Zileuton inhibits the drug-metabolizing activity of DME CYP1A2 (Ki = 117 microM) DME0003 XEOTICID XEO00131 GENEFORM Protein DME0003 XEOTICID XEO00131 MOACRIVE Inhibition DME0003 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0003 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00140 DESCRIPT Zoledronic acid induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00140 GENEFORM Protein DME0003 XEOTICID XEO00140 MOACRIVE Induction DME0003 XEOTICID XEO00143 XEO_NAME Atovaquone DME0003 XEOTICID XEO00143 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00143 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00143 DESCRIPT Atovaquone induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00143 GENEFORM Protein DME0003 XEOTICID XEO00143 MOACRIVE Induction DME0003 XEOTICID XEO00160 XEO_NAME Ritonavir DME0003 XEOTICID XEO00160 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00160 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00160 DESCRIPT Ritonavir induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00160 GENEFORM Protein DME0003 XEOTICID XEO00160 MOACRIVE Induction DME0003 XEOTICID XEO00168 XEO_NAME Decitabine DME0003 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00168 DESCRIPT Decitabine up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00168 GENEFORM mRNA DME0003 XEOTICID XEO00168 MOACRIVE Induction DME0003 XEOTICID XEO00173 XEO_NAME Cannabidiol DME0003 XEOTICID XEO00173 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00173 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00173 DESCRIPT Cannabidiol inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00173 GENEFORM Protein DME0003 XEOTICID XEO00173 MOACRIVE Inhibition DME0003 XEOTICID XEO00177 XEO_NAME Sulindac DME0003 XEOTICID XEO00177 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00177 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00177 DESCRIPT Sulindac induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00177 GENEFORM Protein DME0003 XEOTICID XEO00177 MOACRIVE Induction DME0003 XEOTICID XEO00178 XEO_NAME Capsaicin DME0003 XEOTICID XEO00178 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00178 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00178 DESCRIPT Capsaicin inhibits the drug-metabolizing activity of DME CYP1A2 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 3 microM) DME0003 XEOTICID XEO00178 GENEFORM Protein DME0003 XEOTICID XEO00178 MOACRIVE Inhibition DME0003 XEOTICID XEO00180 XEO_NAME Quinine DME0003 XEOTICID XEO00180 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00180 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00180 DESCRIPT Quinine induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00180 GENEFORM Protein DME0003 XEOTICID XEO00180 MOACRIVE Induction DME0003 XEOTICID XEO00218 XEO_NAME Caffeine DME0003 XEOTICID XEO00218 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00218 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00218 DESCRIPT Caffeine inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00218 GENEFORM Protein DME0003 XEOTICID XEO00218 MOACRIVE Inhibition DME0003 XEOTICID XEO00223 XEO_NAME Rifampin DME0003 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00223 DESCRIPT Rifampin induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00223 GENEFORM Protein DME0003 XEOTICID XEO00223 MOACRIVE Induction DME0003 XEOTICID XEO00225 XEO_NAME Quinidine DME0003 XEOTICID XEO00225 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00225 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00225 DESCRIPT Quinidine inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00225 GENEFORM Protein DME0003 XEOTICID XEO00225 MOACRIVE Inhibition DME0003 XEOTICID XEO00245 XEO_NAME Felodipine DME0003 XEOTICID XEO00245 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00245 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00245 DESCRIPT Felodipine up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00245 GENEFORM mRNA DME0003 XEOTICID XEO00245 MOACRIVE Induction DME0003 XEOTICID XEO00248 XEO_NAME Ibuprofen DME0003 XEOTICID XEO00248 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00248 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00248 DESCRIPT Ibuprofen inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO00248 GENEFORM mRNA DME0003 XEOTICID XEO00248 MOACRIVE Inhibition DME0003 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0003 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 26 microM) DME0003 XEOTICID XEO00251 GENEFORM Protein DME0003 XEOTICID XEO00251 MOACRIVE Inhibition DME0003 XEOTICID XEO00253 XEO_NAME Tretinoin DME0003 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO00253 GENEFORM mRNA DME0003 XEOTICID XEO00253 MOACRIVE Inhibition DME0003 XEOTICID XEO00258 XEO_NAME Primaquine DME0003 XEOTICID XEO00258 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00258 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00258 DESCRIPT Primaquine up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00258 GENEFORM mRNA DME0003 XEOTICID XEO00258 MOACRIVE Induction DME0003 XEOTICID XEO00263 XEO_NAME Trimethoprim DME0003 XEOTICID XEO00263 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00263 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00263 DESCRIPT Trimethoprim inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO00263 GENEFORM mRNA DME0003 XEOTICID XEO00263 MOACRIVE Inhibition DME0003 XEOTICID XEO00267 XEO_NAME Ethinyl estradiol DME0003 XEOTICID XEO00267 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00267 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00267 DESCRIPT Ethinyl estradiol inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00267 GENEFORM Protein DME0003 XEOTICID XEO00267 MOACRIVE Inhibition DME0003 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0003 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00277 GENEFORM Protein DME0003 XEOTICID XEO00277 MOACRIVE Inhibition DME0003 XEOTICID XEO00311 XEO_NAME Nicardipine hydrochloride DME0003 XEOTICID XEO00311 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00311 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00311 DESCRIPT Nicardipine hydrochloride inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 13.3 microM) DME0003 XEOTICID XEO00311 GENEFORM Protein DME0003 XEOTICID XEO00311 MOACRIVE Inhibition DME0003 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0003 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 4100 microM) DME0003 XEOTICID XEO00312 GENEFORM Protein DME0003 XEOTICID XEO00312 MOACRIVE Inhibition DME0003 XEOTICID XEO00314 XEO_NAME Orphenadrine hydrochloride DME0003 XEOTICID XEO00314 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00314 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00314 DESCRIPT Orphenadrine hydrochloride inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 > 30 microM) DME0003 XEOTICID XEO00314 GENEFORM Protein DME0003 XEOTICID XEO00314 MOACRIVE Inhibition DME0003 XEOTICID XEO00331 XEO_NAME Ticlopidine hydrochloride DME0003 XEOTICID XEO00331 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00331 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00331 DESCRIPT Ticlopidine hydrochloride inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 8.59 microM) DME0003 XEOTICID XEO00331 GENEFORM Protein DME0003 XEOTICID XEO00331 MOACRIVE Inhibition DME0003 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME0003 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00349 DESCRIPT Ciprof DMEloxacin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00349 GENEFORM Protein DME0003 XEOTICID XEO00349 MOACRIVE Inhibition DME0003 XEOTICID XEO00352 XEO_NAME Diclofenac DME0003 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00352 DESCRIPT Diclof DMEenac inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00352 GENEFORM Protein DME0003 XEOTICID XEO00352 MOACRIVE Inhibition DME0003 XEOTICID XEO00357 XEO_NAME Ethambutol DME0003 XEOTICID XEO00357 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00357 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00357 DESCRIPT Ethambutol inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00357 GENEFORM Protein DME0003 XEOTICID XEO00357 MOACRIVE Inhibition DME0003 XEOTICID XEO00360 XEO_NAME Fluvoxamine DME0003 XEOTICID XEO00360 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00360 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00360 DESCRIPT Fluvoxamine inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00360 GENEFORM Protein DME0003 XEOTICID XEO00360 MOACRIVE Inhibition DME0003 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0003 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00380 DESCRIPT Rosiglitazone induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00380 GENEFORM Protein DME0003 XEOTICID XEO00380 MOACRIVE Induction DME0003 XEOTICID XEO00383 XEO_NAME Tamoxifen DME0003 XEOTICID XEO00383 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00383 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00383 DESCRIPT Tamoxifen up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00383 GENEFORM mRNA DME0003 XEOTICID XEO00383 MOACRIVE Induction DME0003 XEOTICID XEO00393 XEO_NAME Dehydroepiandrosterone DME0003 XEOTICID XEO00393 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00393 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00393 DESCRIPT Dehydroepiandrosterone inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO00393 GENEFORM mRNA DME0003 XEOTICID XEO00393 MOACRIVE Inhibition DME0003 XEOTICID XEO00405 XEO_NAME Niclosamide DME0003 XEOTICID XEO00405 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00405 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00405 DESCRIPT Niclosamide inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO00405 GENEFORM mRNA DME0003 XEOTICID XEO00405 MOACRIVE Inhibition DME0003 XEOTICID XEO00409 XEO_NAME Semaxanib DME0003 XEOTICID XEO00409 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00409 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00409 DESCRIPT Semaxanib up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00409 GENEFORM mRNA DME0003 XEOTICID XEO00409 MOACRIVE Induction DME0003 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0003 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00410 GENEFORM Protein DME0003 XEOTICID XEO00410 MOACRIVE Inhibition DME0003 XEOTICID XEO00432 XEO_NAME Desogestrel DME0003 XEOTICID XEO00432 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00432 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00432 DESCRIPT Desogestrel inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00432 GENEFORM Protein DME0003 XEOTICID XEO00432 MOACRIVE Inhibition DME0003 XEOTICID XEO00438 XEO_NAME Benidipine DME0003 XEOTICID XEO00438 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00438 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00438 DESCRIPT Benidipine up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00438 GENEFORM mRNA DME0003 XEOTICID XEO00438 MOACRIVE Induction DME0003 XEOTICID XEO00446 XEO_NAME Methoxychlor DME0003 XEOTICID XEO00446 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00446 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00446 DESCRIPT Methoxychlor up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00446 GENEFORM mRNA DME0003 XEOTICID XEO00446 MOACRIVE Induction DME0003 XEOTICID XEO00448 XEO_NAME Stevioside DME0003 XEOTICID XEO00448 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00448 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00448 DESCRIPT Stevioside induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00448 GENEFORM Protein DME0003 XEOTICID XEO00448 MOACRIVE Induction DME0003 XEOTICID XEO00449 XEO_NAME Artemisinine DME0003 XEOTICID XEO00449 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00449 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00449 DESCRIPT Artemisinine inhibits the drug-metabolizing activity of DME CYP1A2 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 2 microM) DME0003 XEOTICID XEO00449 GENEFORM Protein DME0003 XEOTICID XEO00449 MOACRIVE Inhibition DME0003 XEOTICID XEO00454 XEO_NAME Dihydroartemisinin DME0003 XEOTICID XEO00454 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00454 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00454 DESCRIPT Dihydroartemisinin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00454 GENEFORM Protein DME0003 XEOTICID XEO00454 MOACRIVE Inhibition DME0003 XEOTICID XEO00465 XEO_NAME Clodronic acid DME0003 XEOTICID XEO00465 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00465 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00465 DESCRIPT Clodronic acid up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00465 GENEFORM mRNA DME0003 XEOTICID XEO00465 MOACRIVE Induction DME0003 XEOTICID XEO00485 XEO_NAME Suramin DME0003 XEOTICID XEO00485 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00485 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00485 DESCRIPT Suramin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00485 GENEFORM Protein DME0003 XEOTICID XEO00485 MOACRIVE Inhibition DME0003 XEOTICID XEO00486 XEO_NAME Tanshinone DME0003 XEOTICID XEO00486 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00486 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00486 DESCRIPT Tanshinone up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00486 GENEFORM mRNA DME0003 XEOTICID XEO00486 MOACRIVE Induction DME0003 XEOTICID XEO00489 XEO_NAME Amodiaquine DME0003 XEOTICID XEO00489 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00489 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00489 DESCRIPT Amodiaquine inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 41 microM) DME0003 XEOTICID XEO00489 GENEFORM Protein DME0003 XEOTICID XEO00489 MOACRIVE Inhibition DME0003 XEOTICID XEO00497 XEO_NAME Etoricoxib DME0003 XEOTICID XEO00497 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00497 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00497 DESCRIPT Etoricoxib inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00497 GENEFORM Protein DME0003 XEOTICID XEO00497 MOACRIVE Inhibition DME0003 XEOTICID XEO00505 XEO_NAME Melatonin DME0003 XEOTICID XEO00505 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00505 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO00505 DESCRIPT Melatonin inhibits the drug-metabolizing activity of DME CYP1A2 (Ki = 12 microM) DME0003 XEOTICID XEO00505 GENEFORM Protein DME0003 XEOTICID XEO00505 MOACRIVE Inhibition DME0003 XEOTICID XEO00532 XEO_NAME Cotinine DME0003 XEOTICID XEO00532 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00532 XEO_CLAS Drug Marketed but Withdrawn from Market DME0003 XEOTICID XEO00532 DESCRIPT Cotinine inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 5400 microM) DME0003 XEOTICID XEO00532 GENEFORM Protein DME0003 XEOTICID XEO00532 MOACRIVE Inhibition DME0003 XEOTICID XEO00537 XEO_NAME Luteolin DME0003 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME0003 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 3.37 microM) DME0003 XEOTICID XEO00537 GENEFORM Protein DME0003 XEOTICID XEO00537 MOACRIVE Inhibition DME0003 XEOTICID XEO00538 XEO_NAME Quercetin DME0003 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0003 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 1.55 microM) DME0003 XEOTICID XEO00538 GENEFORM Protein DME0003 XEOTICID XEO00538 MOACRIVE Inhibition DME0003 XEOTICID XEO00543 XEO_NAME Andrographolide DME0003 XEOTICID XEO00543 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00543 XEO_CLAS Drug in Phase 2 Clinical Trial DME0003 XEOTICID XEO00543 DESCRIPT Andrographolide inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO00543 GENEFORM mRNA DME0003 XEOTICID XEO00543 MOACRIVE Inhibition DME0003 XEOTICID XEO00556 XEO_NAME Tolfenamic acid DME0003 XEOTICID XEO00556 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00556 XEO_CLAS Drug in Phase 1 Clinical Trial DME0003 XEOTICID XEO00556 DESCRIPT Tolfenamic acid inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO00556 GENEFORM mRNA DME0003 XEOTICID XEO00556 MOACRIVE Inhibition DME0003 XEOTICID XEO00557 XEO_NAME Genistein DME0003 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0003 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00557 GENEFORM Protein DME0003 XEOTICID XEO00557 MOACRIVE Inhibition DME0003 XEOTICID XEO00568 XEO_NAME Resveratrol DME0003 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0003 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of DME CYP1A2 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 3 microM) DME0003 XEOTICID XEO00568 GENEFORM Protein DME0003 XEOTICID XEO00568 MOACRIVE Inhibition DME0003 XEOTICID XEO00573 XEO_NAME Naringenin DME0003 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME0003 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 26.339 microM) DME0003 XEOTICID XEO00573 GENEFORM Protein DME0003 XEOTICID XEO00573 MOACRIVE Inhibition DME0003 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0003 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0003 XEOTICID XEO00582 DESCRIPT Diethyltoluamide up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00582 GENEFORM mRNA DME0003 XEOTICID XEO00582 MOACRIVE Induction DME0003 XEOTICID XEO00595 XEO_NAME Butylcyclohexane DME0003 XEOTICID XEO00595 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00595 XEO_CLAS Drug in Phase 2 Clinical Trial DME0003 XEOTICID XEO00595 DESCRIPT Butylcyclohexane inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 55 microM) DME0003 XEOTICID XEO00595 GENEFORM Protein DME0003 XEOTICID XEO00595 MOACRIVE Inhibition DME0003 XEOTICID XEO00596 XEO_NAME Phenethyl isothiocyanate DME0003 XEOTICID XEO00596 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00596 XEO_CLAS Drug in Phase 2 Clinical Trial DME0003 XEOTICID XEO00596 DESCRIPT Phenethyl isothiocyanate induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00596 GENEFORM Protein DME0003 XEOTICID XEO00596 MOACRIVE Induction DME0003 XEOTICID XEO00598 XEO_NAME Carbendazim DME0003 XEOTICID XEO00598 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00598 XEO_CLAS Drug in Phase 1 Clinical Trial DME0003 XEOTICID XEO00598 DESCRIPT Carbendazim induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00598 GENEFORM Protein DME0003 XEOTICID XEO00598 MOACRIVE Induction DME0003 XEOTICID XEO00605 XEO_NAME Oltipraz DME0003 XEOTICID XEO00605 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00605 XEO_CLAS Drug in Phase 3 Clinical Trial DME0003 XEOTICID XEO00605 DESCRIPT Oltipraz inhibits the drug-metabolizing activity of DME CYP1A2 (Ki = 9 microM) DME0003 XEOTICID XEO00605 GENEFORM Protein DME0003 XEOTICID XEO00605 MOACRIVE Inhibition DME0003 XEOTICID XEO00609 XEO_NAME MeIQx DME0003 XEOTICID XEO00609 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00609 XEO_CLAS Drug in Phase 2 Clinical Trial DME0003 XEOTICID XEO00609 DESCRIPT MeIQx induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00609 GENEFORM Protein DME0003 XEOTICID XEO00609 MOACRIVE Induction DME0003 XEOTICID XEO00618 XEO_NAME Pinocembrin DME0003 XEOTICID XEO00618 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00618 XEO_CLAS Drug in Phase 2 Clinical Trial DME0003 XEOTICID XEO00618 DESCRIPT Pinocembrin inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 1.491 microM) DME0003 XEOTICID XEO00618 GENEFORM Protein DME0003 XEOTICID XEO00618 MOACRIVE Inhibition DME0003 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0003 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0003 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00632 GENEFORM Protein DME0003 XEOTICID XEO00632 MOACRIVE Inhibition DME0003 XEOTICID XEO00636 XEO_NAME Xanthohumol DME0003 XEOTICID XEO00636 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00636 XEO_CLAS Drug in Phase 1 Clinical Trial DME0003 XEOTICID XEO00636 DESCRIPT Xanthohumol induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00636 GENEFORM Protein DME0003 XEOTICID XEO00636 MOACRIVE Induction DME0003 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME0003 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME0003 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00646 GENEFORM Protein DME0003 XEOTICID XEO00646 MOACRIVE Inhibition DME0003 XEOTICID XEO00653 XEO_NAME Icaritin DME0003 XEOTICID XEO00653 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00653 XEO_CLAS Drug in Phase 2 Clinical Trial DME0003 XEOTICID XEO00653 DESCRIPT Icaritin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00653 GENEFORM Protein DME0003 XEOTICID XEO00653 MOACRIVE Inhibition DME0003 XEOTICID XEO00656 XEO_NAME Sulindac sulfide DME0003 XEOTICID XEO00656 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00656 XEO_CLAS Drug in Phase 2 Clinical Trial DME0003 XEOTICID XEO00656 DESCRIPT Sulindac sulfide up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00656 GENEFORM mRNA DME0003 XEOTICID XEO00656 MOACRIVE Induction DME0003 XEOTICID XEO00668 XEO_NAME SR-13668 DME0003 XEOTICID XEO00668 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00668 XEO_CLAS Drug in Phase 1 Clinical Trial DME0003 XEOTICID XEO00668 DESCRIPT SR-13668 up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00668 GENEFORM mRNA DME0003 XEOTICID XEO00668 MOACRIVE Induction DME0003 XEOTICID XEO00683 XEO_NAME Curcumin DME0003 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0003 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00683 GENEFORM Protein DME0003 XEOTICID XEO00683 MOACRIVE Inhibition DME0003 XEOTICID XEO00692 XEO_NAME Emodin DME0003 XEOTICID XEO00692 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00692 XEO_CLAS Preclinical/Patented Drug DME0003 XEOTICID XEO00692 DESCRIPT Emodin inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 3.73 microM) DME0003 XEOTICID XEO00692 GENEFORM Protein DME0003 XEOTICID XEO00692 MOACRIVE Inhibition DME0003 XEOTICID XEO00702 XEO_NAME Baicalin DME0003 XEOTICID XEO00702 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00702 XEO_CLAS Preclinical/Patented Drug DME0003 XEOTICID XEO00702 DESCRIPT Baicalin induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00702 GENEFORM Protein DME0003 XEOTICID XEO00702 MOACRIVE Induction DME0003 XEOTICID XEO00710 XEO_NAME Isoliquiritigenin DME0003 XEOTICID XEO00710 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00710 XEO_CLAS Preclinical/Patented Drug DME0003 XEOTICID XEO00710 DESCRIPT Isoliquiritigenin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00710 GENEFORM Protein DME0003 XEOTICID XEO00710 MOACRIVE Inhibition DME0003 XEOTICID XEO00714 XEO_NAME LS-131849 DME0003 XEOTICID XEO00714 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00714 XEO_CLAS Preclinical/Patented Drug DME0003 XEOTICID XEO00714 DESCRIPT LS-131849 inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00714 GENEFORM Protein DME0003 XEOTICID XEO00714 MOACRIVE Inhibition DME0003 XEOTICID XEO00730 XEO_NAME Ferulic acid DME0003 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME0003 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00730 GENEFORM Protein DME0003 XEOTICID XEO00730 MOACRIVE Inhibition DME0003 XEOTICID XEO00733 XEO_NAME Okanin DME0003 XEOTICID XEO00733 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00733 XEO_CLAS Preclinical/Patented Drug DME0003 XEOTICID XEO00733 DESCRIPT Okanin inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO00733 GENEFORM mRNA DME0003 XEOTICID XEO00733 MOACRIVE Inhibition DME0003 XEOTICID XEO00736 XEO_NAME Chir-99021 DME0003 XEOTICID XEO00736 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00736 XEO_CLAS Preclinical/Patented Drug DME0003 XEOTICID XEO00736 DESCRIPT Chir-99021 up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00736 GENEFORM mRNA DME0003 XEOTICID XEO00736 MOACRIVE Induction DME0003 XEOTICID XEO00738 XEO_NAME Flavanone DME0003 XEOTICID XEO00738 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00738 XEO_CLAS Drug in Phase 1 Clinical Trial DME0003 XEOTICID XEO00738 DESCRIPT Flavanone inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00738 GENEFORM Protein DME0003 XEOTICID XEO00738 MOACRIVE Inhibition DME0003 XEOTICID XEO00755 XEO_NAME Coal tar DME0003 XEOTICID XEO00755 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO00755 XEO_CLAS Natural Mixture DME0003 XEOTICID XEO00755 DESCRIPT Coal tar up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00755 GENEFORM mRNA DME0003 XEOTICID XEO00755 MOACRIVE Induction DME0003 XEOTICID XEO00764 XEO_NAME Naphthalene DME0003 XEOTICID XEO00764 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0003 XEOTICID XEO00764 XEO_CLAS Chemical Compound DME0003 XEOTICID XEO00764 DESCRIPT Naphthalene inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 700 microM) DME0003 XEOTICID XEO00764 GENEFORM Protein DME0003 XEOTICID XEO00764 MOACRIVE Inhibition DME0003 XEOTICID XEO00776 XEO_NAME Polychlorinated biphenyls DME0003 XEOTICID XEO00776 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO00776 XEO_CLAS Carcinogen DME0003 XEOTICID XEO00776 DESCRIPT Polychlorinated biphenyls induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00776 GENEFORM Protein DME0003 XEOTICID XEO00776 MOACRIVE Induction DME0003 XEOTICID XEO00785 XEO_NAME Acridine DME0003 XEOTICID XEO00785 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0003 XEOTICID XEO00785 XEO_CLAS Chemical Compound DME0003 XEOTICID XEO00785 DESCRIPT Acridine inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00785 GENEFORM Protein DME0003 XEOTICID XEO00785 MOACRIVE Inhibition DME0003 XEOTICID XEO00794 XEO_NAME 6-nitrochrysene DME0003 XEOTICID XEO00794 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO00794 XEO_CLAS Environmental Pollutant DME0003 XEOTICID XEO00794 DESCRIPT 6-nitrochrysene up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00794 GENEFORM mRNA DME0003 XEOTICID XEO00794 MOACRIVE Induction DME0003 XEOTICID XEO00802 XEO_NAME Dihydrocapsaicin DME0003 XEOTICID XEO00802 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO00802 XEO_CLAS Natural Product DME0003 XEOTICID XEO00802 DESCRIPT Dihydrocapsaicin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00802 GENEFORM Protein DME0003 XEOTICID XEO00802 MOACRIVE Inhibition DME0003 XEOTICID XEO00804 XEO_NAME Avasimibe DME0003 XEOTICID XEO00804 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00804 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO00804 DESCRIPT Avasimibe inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00804 GENEFORM Protein DME0003 XEOTICID XEO00804 MOACRIVE Inhibition DME0003 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0003 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0003 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO00806 GENEFORM mRNA DME0003 XEOTICID XEO00806 MOACRIVE Inhibition DME0003 XEOTICID XEO00810 XEO_NAME Steviol DME0003 XEOTICID XEO00810 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO00810 XEO_CLAS Natural Product DME0003 XEOTICID XEO00810 DESCRIPT Steviol up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00810 GENEFORM mRNA DME0003 XEOTICID XEO00810 MOACRIVE Induction DME0003 XEOTICID XEO00811 XEO_NAME Isoxanthohumol DME0003 XEOTICID XEO00811 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO00811 XEO_CLAS Natural Product DME0003 XEOTICID XEO00811 DESCRIPT Isoxanthohumol up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00811 GENEFORM mRNA DME0003 XEOTICID XEO00811 MOACRIVE Induction DME0003 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0003 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0003 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME CYP1A2 and leads to increasing the drug-metabolizing activity of this enzyme DME0003 XEOTICID XEO00821 GENEFORM Protein DME0003 XEOTICID XEO00821 MOACRIVE Induction DME0003 XEOTICID XEO00827 XEO_NAME Polycyclic aromatic hydrocarbon DME0003 XEOTICID XEO00827 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO00827 XEO_CLAS Natural Product DME0003 XEOTICID XEO00827 DESCRIPT Polycyclic aromatic hydrocarbon up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00827 GENEFORM mRNA DME0003 XEOTICID XEO00827 MOACRIVE Induction DME0003 XEOTICID XEO00856 XEO_NAME Hesperetin DME0003 XEOTICID XEO00856 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO00856 XEO_CLAS Natural Product DME0003 XEOTICID XEO00856 DESCRIPT Hesperetin inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 34.647 microM) DME0003 XEOTICID XEO00856 GENEFORM Protein DME0003 XEOTICID XEO00856 MOACRIVE Inhibition DME0003 XEOTICID XEO00857 XEO_NAME Cyclodextrins DME0003 XEOTICID XEO00857 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO00857 XEO_CLAS Natural Mixture DME0003 XEOTICID XEO00857 DESCRIPT Cyclodextrins inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00857 GENEFORM Protein DME0003 XEOTICID XEO00857 MOACRIVE Inhibition DME0003 XEOTICID XEO00863 XEO_NAME Artemisin DME0003 XEOTICID XEO00863 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO00863 XEO_CLAS Natural Product DME0003 XEOTICID XEO00863 DESCRIPT Artemisin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00863 GENEFORM Protein DME0003 XEOTICID XEO00863 MOACRIVE Inhibition DME0003 XEOTICID XEO00873 XEO_NAME Alpha-linolenic acid DME0003 XEOTICID XEO00873 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO00873 XEO_CLAS Health Hazard/Toxicant DME0003 XEOTICID XEO00873 DESCRIPT Alpha-linolenic acid inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00873 GENEFORM Protein DME0003 XEOTICID XEO00873 MOACRIVE Inhibition DME0003 XEOTICID XEO00876 XEO_NAME Arachidonic acid DME0003 XEOTICID XEO00876 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00876 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO00876 DESCRIPT Arachidonic acid inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00876 GENEFORM Protein DME0003 XEOTICID XEO00876 MOACRIVE Inhibition DME0003 XEOTICID XEO00878 XEO_NAME Chrysin DME0003 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO00878 XEO_CLAS Natural Product DME0003 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 0.054 microM) DME0003 XEOTICID XEO00878 GENEFORM Protein DME0003 XEOTICID XEO00878 MOACRIVE Inhibition DME0003 XEOTICID XEO00889 XEO_NAME Piperonyl butoxide DME0003 XEOTICID XEO00889 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO00889 XEO_CLAS Pesticide/Insecticide DME0003 XEOTICID XEO00889 DESCRIPT Piperonyl butoxide induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00889 GENEFORM Protein DME0003 XEOTICID XEO00889 MOACRIVE Induction DME0003 XEOTICID XEO00895 XEO_NAME 2-amino-3-methylimidazo(4,5-f)quinoline DME0003 XEOTICID XEO00895 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO00895 XEO_CLAS Carcinogen DME0003 XEOTICID XEO00895 DESCRIPT 2-amino-3-methylimidazo(4,5-f)quinoline up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00895 GENEFORM mRNA DME0003 XEOTICID XEO00895 MOACRIVE Induction DME0003 XEOTICID XEO00897 XEO_NAME Benz(a)anthracenes DME0003 XEOTICID XEO00897 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO00897 XEO_CLAS Carcinogen DME0003 XEOTICID XEO00897 DESCRIPT Benz(a)anthracenes up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00897 GENEFORM mRNA DME0003 XEOTICID XEO00897 MOACRIVE Induction DME0003 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0003 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0003 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the drug-metabolizing activity of DME CYP1A2 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.04 microM) DME0003 XEOTICID XEO00898 GENEFORM Protein DME0003 XEOTICID XEO00898 MOACRIVE Inhibition DME0003 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0003 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0003 XEOTICID XEO00899 DESCRIPT Methylcholanthrene induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00899 GENEFORM Protein DME0003 XEOTICID XEO00899 MOACRIVE Induction DME0003 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0003 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0003 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00905 GENEFORM mRNA DME0003 XEOTICID XEO00905 MOACRIVE Induction DME0003 XEOTICID XEO00909 XEO_NAME Cloflucarban DME0003 XEOTICID XEO00909 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO00909 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO00909 DESCRIPT Cloflucarban induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00909 GENEFORM Protein DME0003 XEOTICID XEO00909 MOACRIVE Induction DME0003 XEOTICID XEO00913 XEO_NAME 6-nitrobenzo(a)pyrene DME0003 XEOTICID XEO00913 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO00913 XEO_CLAS Health Hazard/Toxicant DME0003 XEOTICID XEO00913 DESCRIPT 6-nitrobenzo(a)pyrene up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00913 GENEFORM mRNA DME0003 XEOTICID XEO00913 MOACRIVE Induction DME0003 XEOTICID XEO00917 XEO_NAME Polychlorinated dibenzodioxin DME0003 XEOTICID XEO00917 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO00917 XEO_CLAS Environmental Pollutant DME0003 XEOTICID XEO00917 DESCRIPT Polychlorinated dibenzodioxin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00917 GENEFORM Protein DME0003 XEOTICID XEO00917 MOACRIVE Inhibition DME0003 XEOTICID XEO00925 XEO_NAME BDE-99 DME0003 XEOTICID XEO00925 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO00925 XEO_CLAS Natural Product DME0003 XEOTICID XEO00925 DESCRIPT BDE-99 up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00925 GENEFORM mRNA DME0003 XEOTICID XEO00925 MOACRIVE Induction DME0003 XEOTICID XEO00938 XEO_NAME Azoxystrobin DME0003 XEOTICID XEO00938 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO00938 XEO_CLAS Fungicide DME0003 XEOTICID XEO00938 DESCRIPT Azoxystrobin induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00938 GENEFORM Protein DME0003 XEOTICID XEO00938 MOACRIVE Induction DME0003 XEOTICID XEO00942 XEO_NAME Cyproconazole DME0003 XEOTICID XEO00942 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO00942 XEO_CLAS Fungicide DME0003 XEOTICID XEO00942 DESCRIPT Cyproconazole up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00942 GENEFORM mRNA DME0003 XEOTICID XEO00942 MOACRIVE Induction DME0003 XEOTICID XEO00955 XEO_NAME Prochloraz DME0003 XEOTICID XEO00955 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO00955 XEO_CLAS Fungicide DME0003 XEOTICID XEO00955 DESCRIPT Prochloraz up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00955 GENEFORM mRNA DME0003 XEOTICID XEO00955 MOACRIVE Induction DME0003 XEOTICID XEO00956 XEO_NAME Propiconazole DME0003 XEOTICID XEO00956 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO00956 XEO_CLAS Fungicide DME0003 XEOTICID XEO00956 DESCRIPT Propiconazole up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00956 GENEFORM mRNA DME0003 XEOTICID XEO00956 MOACRIVE Induction DME0003 XEOTICID XEO00957 XEO_NAME Tebuconazole DME0003 XEOTICID XEO00957 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO00957 XEO_CLAS Fungicide DME0003 XEOTICID XEO00957 DESCRIPT Tebuconazole induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00957 GENEFORM Protein DME0003 XEOTICID XEO00957 MOACRIVE Induction DME0003 XEOTICID XEO00969 XEO_NAME Atrazine DME0003 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO00969 XEO_CLAS Herbicide DME0003 XEOTICID XEO00969 DESCRIPT Atrazine induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00969 GENEFORM Protein DME0003 XEOTICID XEO00969 MOACRIVE Induction DME0003 XEOTICID XEO00973 XEO_NAME Diuron DME0003 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO00973 XEO_CLAS Herbicide DME0003 XEOTICID XEO00973 DESCRIPT Diuron induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00973 GENEFORM Protein DME0003 XEOTICID XEO00973 MOACRIVE Induction DME0003 XEOTICID XEO00975 XEO_NAME Isoproturon DME0003 XEOTICID XEO00975 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO00975 XEO_CLAS Herbicide DME0003 XEOTICID XEO00975 DESCRIPT Isoproturon induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00975 GENEFORM Protein DME0003 XEOTICID XEO00975 MOACRIVE Induction DME0003 XEOTICID XEO00976 XEO_NAME Metolachlor DME0003 XEOTICID XEO00976 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO00976 XEO_CLAS Herbicide DME0003 XEOTICID XEO00976 DESCRIPT Metolachlor up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO00976 GENEFORM mRNA DME0003 XEOTICID XEO00976 MOACRIVE Induction DME0003 XEOTICID XEO00988 XEO_NAME 2,6-dimethylnaphthalene DME0003 XEOTICID XEO00988 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO00988 XEO_CLAS Environmental Pollutant DME0003 XEOTICID XEO00988 DESCRIPT 2,6-dimethylnaphthalene inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 52 microM) DME0003 XEOTICID XEO00988 GENEFORM Protein DME0003 XEOTICID XEO00988 MOACRIVE Inhibition DME0003 XEOTICID XEO00989 XEO_NAME 2-methylindole DME0003 XEOTICID XEO00989 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO00989 XEO_CLAS Health Hazard/Toxicant DME0003 XEOTICID XEO00989 DESCRIPT 2-methylindole induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00989 GENEFORM Protein DME0003 XEOTICID XEO00989 MOACRIVE Induction DME0003 XEOTICID XEO00990 XEO_NAME 2-naphthol DME0003 XEOTICID XEO00990 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO00990 XEO_CLAS Environmental Pollutant DME0003 XEOTICID XEO00990 DESCRIPT 2-naphthol inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 17 microM) DME0003 XEOTICID XEO00990 GENEFORM Protein DME0003 XEOTICID XEO00990 MOACRIVE Inhibition DME0003 XEOTICID XEO00993 XEO_NAME Alizarin DME0003 XEOTICID XEO00993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO00993 XEO_CLAS Natural Product DME0003 XEOTICID XEO00993 DESCRIPT Alizarin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO00993 GENEFORM Protein DME0003 XEOTICID XEO00993 MOACRIVE Inhibition DME0003 XEOTICID XEO01012 XEO_NAME Indan DME0003 XEOTICID XEO01012 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO01012 XEO_CLAS Health Hazard/Toxicant DME0003 XEOTICID XEO01012 DESCRIPT Indan inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 550 microM) DME0003 XEOTICID XEO01012 GENEFORM Protein DME0003 XEOTICID XEO01012 MOACRIVE Inhibition DME0003 XEOTICID XEO01035 XEO_NAME 1-chloronaphthalene DME0003 XEOTICID XEO01035 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO01035 XEO_CLAS Pesticide/Insecticide DME0003 XEOTICID XEO01035 DESCRIPT 1-chloronaphthalene inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 50 microM) DME0003 XEOTICID XEO01035 GENEFORM Protein DME0003 XEOTICID XEO01035 MOACRIVE Inhibition DME0003 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0003 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0003 XEOTICID XEO01050 DESCRIPT Dicrotophos up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO01050 GENEFORM mRNA DME0003 XEOTICID XEO01050 MOACRIVE Induction DME0003 XEOTICID XEO01052 XEO_NAME Fenitrothion DME0003 XEOTICID XEO01052 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO01052 XEO_CLAS Pesticide/Insecticide DME0003 XEOTICID XEO01052 DESCRIPT Fenitrothion inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01052 GENEFORM Protein DME0003 XEOTICID XEO01052 MOACRIVE Inhibition DME0003 XEOTICID XEO01053 XEO_NAME Fenvalerate DME0003 XEOTICID XEO01053 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO01053 XEO_CLAS Pesticide/Insecticide DME0003 XEOTICID XEO01053 DESCRIPT Fenvalerate induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01053 GENEFORM Protein DME0003 XEOTICID XEO01053 MOACRIVE Induction DME0003 XEOTICID XEO01054 XEO_NAME Fonofos DME0003 XEOTICID XEO01054 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO01054 XEO_CLAS Pesticide/Insecticide DME0003 XEOTICID XEO01054 DESCRIPT Fonof DMEos inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01054 GENEFORM Protein DME0003 XEOTICID XEO01054 MOACRIVE Inhibition DME0003 XEOTICID XEO01058 XEO_NAME Isomalathion DME0003 XEOTICID XEO01058 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO01058 XEO_CLAS Pesticide/Insecticide DME0003 XEOTICID XEO01058 DESCRIPT Isomalathion inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO01058 GENEFORM mRNA DME0003 XEOTICID XEO01058 MOACRIVE Inhibition DME0003 XEOTICID XEO01064 XEO_NAME Parathion DME0003 XEOTICID XEO01064 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO01064 XEO_CLAS Pesticide/Insecticide DME0003 XEOTICID XEO01064 DESCRIPT Parathion up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO01064 GENEFORM mRNA DME0003 XEOTICID XEO01064 MOACRIVE Induction DME0003 XEOTICID XEO01068 XEO_NAME Profenofos DME0003 XEOTICID XEO01068 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO01068 XEO_CLAS Pesticide/Insecticide DME0003 XEOTICID XEO01068 DESCRIPT Profenofos inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO01068 GENEFORM mRNA DME0003 XEOTICID XEO01068 MOACRIVE Inhibition DME0003 XEOTICID XEO01075 XEO_NAME Myristicin DME0003 XEOTICID XEO01075 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO01075 XEO_CLAS Pesticide/Insecticide DME0003 XEOTICID XEO01075 DESCRIPT Myristicin inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO01075 GENEFORM mRNA DME0003 XEOTICID XEO01075 MOACRIVE Inhibition DME0003 XEOTICID XEO01088 XEO_NAME Tcpobop DME0003 XEOTICID XEO01088 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01088 XEO_CLAS Preclinical/Patented Drug DME0003 XEOTICID XEO01088 DESCRIPT Tcpobop up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO01088 GENEFORM mRNA DME0003 XEOTICID XEO01088 MOACRIVE Induction DME0003 XEOTICID XEO01089 XEO_NAME 1,4-naphthoquinone DME0003 XEOTICID XEO01089 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO01089 XEO_CLAS Acute Toxic Substance DME0003 XEOTICID XEO01089 DESCRIPT 1,4-naphthoquinone up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO01089 GENEFORM mRNA DME0003 XEOTICID XEO01089 MOACRIVE Induction DME0003 XEOTICID XEO01099 XEO_NAME 1-aminobenzotriazole DME0003 XEOTICID XEO01099 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01099 XEO_CLAS Preclinical/Patented Drug DME0003 XEOTICID XEO01099 DESCRIPT 1-aminobenzotriazole inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01099 GENEFORM Protein DME0003 XEOTICID XEO01099 MOACRIVE Inhibition DME0003 XEOTICID XEO01102 XEO_NAME 1-methyl-3-isobutylxanthine DME0003 XEOTICID XEO01102 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01102 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01102 DESCRIPT 1-methyl-3-isobutylxanthine inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01102 GENEFORM Protein DME0003 XEOTICID XEO01102 MOACRIVE Inhibition DME0003 XEOTICID XEO01104 XEO_NAME 1-methylxanthine DME0003 XEOTICID XEO01104 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01104 XEO_CLAS Natural Product DME0003 XEOTICID XEO01104 DESCRIPT 1-methylxanthine inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01104 GENEFORM Protein DME0003 XEOTICID XEO01104 MOACRIVE Inhibition DME0003 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0003 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0003 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO01119 GENEFORM mRNA DME0003 XEOTICID XEO01119 MOACRIVE Induction DME0003 XEOTICID XEO01130 XEO_NAME DY-9760e DME0003 XEOTICID XEO01130 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01130 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01130 DESCRIPT DY-9760e inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01130 GENEFORM Protein DME0003 XEOTICID XEO01130 MOACRIVE Inhibition DME0003 XEOTICID XEO01135 XEO_NAME 3,4',5-trimethoxystilbene DME0003 XEOTICID XEO01135 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO01135 XEO_CLAS Environmental Pollutant DME0003 XEOTICID XEO01135 DESCRIPT 3,4',5-trimethoxystilbene induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01135 GENEFORM Protein DME0003 XEOTICID XEO01135 MOACRIVE Induction DME0003 XEOTICID XEO01159 XEO_NAME 5-fluorotryptamine DME0003 XEOTICID XEO01159 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01159 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01159 DESCRIPT 5-fluorotryptamine inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01159 GENEFORM Protein DME0003 XEOTICID XEO01159 MOACRIVE Inhibition DME0003 XEOTICID XEO01161 XEO_NAME 5-hydroxyflavone DME0003 XEOTICID XEO01161 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01161 XEO_CLAS Natural Product DME0003 XEOTICID XEO01161 DESCRIPT 5-hydroxyflavone inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 0.31 microM) DME0003 XEOTICID XEO01161 GENEFORM Protein DME0003 XEOTICID XEO01161 MOACRIVE Inhibition DME0003 XEOTICID XEO01167 XEO_NAME 6,7-dihydroxyflavone DME0003 XEOTICID XEO01167 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01167 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01167 DESCRIPT 6,7-dihydroxyflavone inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01167 GENEFORM Protein DME0003 XEOTICID XEO01167 MOACRIVE Inhibition DME0003 XEOTICID XEO01168 XEO_NAME 6-bromoindirubin-3'-oxime DME0003 XEOTICID XEO01168 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01168 XEO_CLAS Natural Product DME0003 XEOTICID XEO01168 DESCRIPT 6-bromoindirubin-3'-oxime up-regulates the expression of DME CYP1A2 and leads to increasing the drug-metabolizing activity of this enzyme DME0003 XEOTICID XEO01168 GENEFORM Protein DME0003 XEOTICID XEO01168 MOACRIVE Induction DME0003 XEOTICID XEO01169 XEO_NAME 6-methyl-2-(phenylethynyl)pyridine DME0003 XEOTICID XEO01169 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01169 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01169 DESCRIPT 6-methyl-2-(phenylethynyl)pyridine inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01169 GENEFORM Protein DME0003 XEOTICID XEO01169 MOACRIVE Inhibition DME0003 XEOTICID XEO01176 XEO_NAME 7-hydroxyflavone DME0003 XEOTICID XEO01176 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01176 XEO_CLAS Natural Product DME0003 XEOTICID XEO01176 DESCRIPT 7-hydroxyflavone inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 0.24 microM) DME0003 XEOTICID XEO01176 GENEFORM Protein DME0003 XEOTICID XEO01176 MOACRIVE Inhibition DME0003 XEOTICID XEO01177 XEO_NAME 7-methyltryptamine DME0003 XEOTICID XEO01177 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01177 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01177 DESCRIPT 7-methyltryptamine inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01177 GENEFORM Protein DME0003 XEOTICID XEO01177 MOACRIVE Inhibition DME0003 XEOTICID XEO01178 XEO_NAME 8-phenyltheophylline DME0003 XEOTICID XEO01178 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01178 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01178 DESCRIPT 8-phenyltheophylline inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01178 GENEFORM Protein DME0003 XEOTICID XEO01178 MOACRIVE Inhibition DME0003 XEOTICID XEO01179 XEO_NAME 8-prenylnaringenin DME0003 XEOTICID XEO01179 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO01179 XEO_CLAS Biotoxin DME0003 XEOTICID XEO01179 DESCRIPT 8-prenylnaringenin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01179 GENEFORM Protein DME0003 XEOTICID XEO01179 MOACRIVE Inhibition DME0003 XEOTICID XEO01184 XEO_NAME Acacetin DME0003 XEOTICID XEO01184 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01184 XEO_CLAS Natural Product DME0003 XEOTICID XEO01184 DESCRIPT Acacetin inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 0.08 microM) DME0003 XEOTICID XEO01184 GENEFORM Protein DME0003 XEOTICID XEO01184 MOACRIVE Inhibition DME0003 XEOTICID XEO01191 XEO_NAME Aloe-emodin DME0003 XEOTICID XEO01191 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01191 XEO_CLAS Natural Product DME0003 XEOTICID XEO01191 DESCRIPT Aloe-emodin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01191 GENEFORM Protein DME0003 XEOTICID XEO01191 MOACRIVE Inhibition DME0003 XEOTICID XEO01192 XEO_NAME Alpha-naphthoflavone DME0003 XEOTICID XEO01192 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01192 XEO_CLAS Natural Product DME0003 XEOTICID XEO01192 DESCRIPT Alpha-naphthof DMElavone inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 0.0038 microM) DME0003 XEOTICID XEO01192 GENEFORM Protein DME0003 XEOTICID XEO01192 MOACRIVE Inhibition DME0003 XEOTICID XEO01203 XEO_NAME Apigenin DME0003 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01203 XEO_CLAS Natural Product DME0003 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 0.795 microM) DME0003 XEOTICID XEO01203 GENEFORM Protein DME0003 XEOTICID XEO01203 MOACRIVE Inhibition DME0003 XEOTICID XEO01204 XEO_NAME MPC1304 DME0003 XEOTICID XEO01204 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01204 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01204 DESCRIPT MPC1304 inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01204 GENEFORM Protein DME0003 XEOTICID XEO01204 MOACRIVE Inhibition DME0003 XEOTICID XEO01212 XEO_NAME Baicalein DME0003 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01212 XEO_CLAS Natural Product DME0003 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01212 GENEFORM Protein DME0003 XEOTICID XEO01212 MOACRIVE Inhibition DME0003 XEOTICID XEO01218 XEO_NAME Benzyl selenocyanate DME0003 XEOTICID XEO01218 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01218 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01218 DESCRIPT Benzyl selenocyanate inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 0.2 microM) DME0003 XEOTICID XEO01218 GENEFORM Protein DME0003 XEOTICID XEO01218 MOACRIVE Inhibition DME0003 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0003 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01220 DESCRIPT Beta-naphthof DMElavone inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 0.47 microM) DME0003 XEOTICID XEO01220 GENEFORM Protein DME0003 XEOTICID XEO01220 MOACRIVE Inhibition DME0003 XEOTICID XEO01222 XEO_NAME Biochanin A DME0003 XEOTICID XEO01222 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01222 XEO_CLAS Natural Product DME0003 XEOTICID XEO01222 DESCRIPT Biochanin A inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01222 GENEFORM Protein DME0003 XEOTICID XEO01222 MOACRIVE Inhibition DME0003 XEOTICID XEO01230 XEO_NAME Butyric acid DME0003 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0003 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO01230 GENEFORM mRNA DME0003 XEOTICID XEO01230 MOACRIVE Induction DME0003 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0003 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0003 XEOTICID XEO01248 DESCRIPT Chlorpyrifos inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01248 GENEFORM Protein DME0003 XEOTICID XEO01248 MOACRIVE Inhibition DME0003 XEOTICID XEO01274 XEO_NAME Diazinon DME0003 XEOTICID XEO01274 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO01274 XEO_CLAS Environmental Pollutant DME0003 XEOTICID XEO01274 DESCRIPT Diazinon induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01274 GENEFORM Protein DME0003 XEOTICID XEO01274 MOACRIVE Induction DME0003 XEOTICID XEO01281 XEO_NAME Diosmetin DME0003 XEOTICID XEO01281 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01281 XEO_CLAS Natural Product DME0003 XEOTICID XEO01281 DESCRIPT Diosmetin inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 2.437 microM) DME0003 XEOTICID XEO01281 GENEFORM Protein DME0003 XEOTICID XEO01281 MOACRIVE Inhibition DME0003 XEOTICID XEO01284 XEO_NAME Dust DME0003 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0003 XEOTICID XEO01284 DESCRIPT Dust up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO01284 GENEFORM mRNA DME0003 XEOTICID XEO01284 MOACRIVE Induction DME0003 XEOTICID XEO01293 XEO_NAME Ethyl isopropylamiloride DME0003 XEOTICID XEO01293 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01293 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01293 DESCRIPT Ethyl isopropylamiloride inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01293 GENEFORM Protein DME0003 XEOTICID XEO01293 MOACRIVE Inhibition DME0003 XEOTICID XEO01304 XEO_NAME Flavone DME0003 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01304 XEO_CLAS Natural Product DME0003 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01304 GENEFORM Protein DME0003 XEOTICID XEO01304 MOACRIVE Inhibition DME0003 XEOTICID XEO01306 XEO_NAME Formononetin DME0003 XEOTICID XEO01306 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01306 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO01306 DESCRIPT Formononetin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01306 GENEFORM Protein DME0003 XEOTICID XEO01306 MOACRIVE Inhibition DME0003 XEOTICID XEO01307 XEO_NAME Furafylline DME0003 XEOTICID XEO01307 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01307 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01307 DESCRIPT Furafylline inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 0.3 microM) DME0003 XEOTICID XEO01307 GENEFORM Protein DME0003 XEOTICID XEO01307 MOACRIVE Inhibition DME0003 XEOTICID XEO01308 XEO_NAME Galangin DME0003 XEOTICID XEO01308 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01308 XEO_CLAS Natural Product DME0003 XEOTICID XEO01308 DESCRIPT Galangin inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 0.04 microM) DME0003 XEOTICID XEO01308 GENEFORM Protein DME0003 XEOTICID XEO01308 MOACRIVE Inhibition DME0003 XEOTICID XEO01313 XEO_NAME Germacrone DME0003 XEOTICID XEO01313 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01313 XEO_CLAS Natural Product DME0003 XEOTICID XEO01313 DESCRIPT Germacrone inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01313 GENEFORM Protein DME0003 XEOTICID XEO01313 MOACRIVE Inhibition DME0003 XEOTICID XEO01314 XEO_NAME Ginkgo biloba extract DME0003 XEOTICID XEO01314 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01314 XEO_CLAS Plant Extract DME0003 XEOTICID XEO01314 DESCRIPT Ginkgo biloba extract inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01314 GENEFORM Protein DME0003 XEOTICID XEO01314 MOACRIVE Inhibition DME0003 XEOTICID XEO01325 XEO_NAME GW-3965 DME0003 XEOTICID XEO01325 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01325 XEO_CLAS Preclinical/Patented Drug DME0003 XEOTICID XEO01325 DESCRIPT GW-3965 up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO01325 GENEFORM mRNA DME0003 XEOTICID XEO01325 MOACRIVE Induction DME0003 XEOTICID XEO01341 XEO_NAME Indacrinone DME0003 XEOTICID XEO01341 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01341 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01341 DESCRIPT Indacrinone inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01341 GENEFORM Protein DME0003 XEOTICID XEO01341 MOACRIVE Inhibition DME0003 XEOTICID XEO01345 XEO_NAME Inermin DME0003 XEOTICID XEO01345 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01345 XEO_CLAS Natural Product DME0003 XEOTICID XEO01345 DESCRIPT Inermin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01345 GENEFORM Protein DME0003 XEOTICID XEO01345 MOACRIVE Inhibition DME0003 XEOTICID XEO01353 XEO_NAME Kaempferol DME0003 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME0003 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 0.716 microM) DME0003 XEOTICID XEO01353 GENEFORM Protein DME0003 XEOTICID XEO01353 MOACRIVE Inhibition DME0003 XEOTICID XEO01365 XEO_NAME Licochalcone A DME0003 XEOTICID XEO01365 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01365 XEO_CLAS Drug in Phase 1 Clinical Trial DME0003 XEOTICID XEO01365 DESCRIPT Licochalcone A inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01365 GENEFORM Protein DME0003 XEOTICID XEO01365 MOACRIVE Inhibition DME0003 XEOTICID XEO01367 XEO_NAME Linoleic acid DME0003 XEOTICID XEO01367 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01367 XEO_CLAS Approved/Marketed Drug DME0003 XEOTICID XEO01367 DESCRIPT Linoleic acid inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01367 GENEFORM Protein DME0003 XEOTICID XEO01367 MOACRIVE Inhibition DME0003 XEOTICID XEO01370 XEO_NAME Mangiferin DME0003 XEOTICID XEO01370 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01370 XEO_CLAS Natural Product DME0003 XEOTICID XEO01370 DESCRIPT Mangiferin up-regulates the expression of DME CYP1A2 and leads to increasing the drug-metabolizing activity of this enzyme DME0003 XEOTICID XEO01370 GENEFORM Protein DME0003 XEOTICID XEO01370 MOACRIVE Induction DME0003 XEOTICID XEO01384 XEO_NAME Myricetin DME0003 XEOTICID XEO01384 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01384 XEO_CLAS Preclinical/Patented Drug DME0003 XEOTICID XEO01384 DESCRIPT Myricetin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01384 GENEFORM Protein DME0003 XEOTICID XEO01384 MOACRIVE Inhibition DME0003 XEOTICID XEO01391 XEO_NAME Naringin DME0003 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01391 XEO_CLAS Natural Product DME0003 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01391 GENEFORM Protein DME0003 XEOTICID XEO01391 MOACRIVE Inhibition DME0003 XEOTICID XEO01394 XEO_NAME NCX-4040 DME0003 XEOTICID XEO01394 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO01394 XEO_CLAS Environmental Pollutant DME0003 XEOTICID XEO01394 DESCRIPT NCX-4040 inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01394 GENEFORM Protein DME0003 XEOTICID XEO01394 MOACRIVE Inhibition DME0003 XEOTICID XEO01397 XEO_NAME Nickel chloride DME0003 XEOTICID XEO01397 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO01397 XEO_CLAS Acute Toxic Substance DME0003 XEOTICID XEO01397 DESCRIPT Nickel chloride inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO01397 GENEFORM mRNA DME0003 XEOTICID XEO01397 MOACRIVE Inhibition DME0003 XEOTICID XEO01405 XEO_NAME O(6)-benzylguanine DME0003 XEOTICID XEO01405 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01405 XEO_CLAS Drug in Phase 1 Clinical Trial DME0003 XEOTICID XEO01405 DESCRIPT O(6)-benzylguanine inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01405 GENEFORM Protein DME0003 XEOTICID XEO01405 MOACRIVE Inhibition DME0003 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0003 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0003 XEOTICID XEO01407 DESCRIPT Ochratoxin A induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01407 GENEFORM Protein DME0003 XEOTICID XEO01407 MOACRIVE Induction DME0003 XEOTICID XEO01412 XEO_NAME Oleic acid DME0003 XEOTICID XEO01412 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01412 XEO_CLAS Preclinical/Patented Drug DME0003 XEOTICID XEO01412 DESCRIPT Oleic acid inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO01412 GENEFORM mRNA DME0003 XEOTICID XEO01412 MOACRIVE Inhibition DME0003 XEOTICID XEO01415 XEO_NAME Olivacine DME0003 XEOTICID XEO01415 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01415 XEO_CLAS Natural Product DME0003 XEOTICID XEO01415 DESCRIPT Olivacine induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01415 GENEFORM Protein DME0003 XEOTICID XEO01415 MOACRIVE Induction DME0003 XEOTICID XEO01424 XEO_NAME Pelargonidin DME0003 XEOTICID XEO01424 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01424 XEO_CLAS Natural Product DME0003 XEOTICID XEO01424 DESCRIPT Pelargonidin up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO01424 GENEFORM mRNA DME0003 XEOTICID XEO01424 MOACRIVE Induction DME0003 XEOTICID XEO01431 XEO_NAME Pifithrin DME0003 XEOTICID XEO01431 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01431 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01431 DESCRIPT Pifithrin inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO01431 GENEFORM mRNA DME0003 XEOTICID XEO01431 MOACRIVE Inhibition DME0003 XEOTICID XEO01438 XEO_NAME Proadifen DME0003 XEOTICID XEO01438 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01438 XEO_CLAS Preclinical/Patented Drug DME0003 XEOTICID XEO01438 DESCRIPT Proadifen inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO01438 GENEFORM mRNA DME0003 XEOTICID XEO01438 MOACRIVE Inhibition DME0003 XEOTICID XEO01442 XEO_NAME Puag-haad DME0003 XEOTICID XEO01442 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01442 XEO_CLAS Natural Product DME0003 XEOTICID XEO01442 DESCRIPT Puag-haad inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 150 microM) DME0003 XEOTICID XEO01442 GENEFORM Protein DME0003 XEOTICID XEO01442 MOACRIVE Inhibition DME0003 XEOTICID XEO01443 XEO_NAME Purpurin DME0003 XEOTICID XEO01443 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01443 XEO_CLAS Natural Product DME0003 XEOTICID XEO01443 DESCRIPT Purpurin inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01443 GENEFORM Protein DME0003 XEOTICID XEO01443 MOACRIVE Inhibition DME0003 XEOTICID XEO01445 XEO_NAME Pyrazolanthrone DME0003 XEOTICID XEO01445 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01445 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01445 DESCRIPT Pyrazolanthrone induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01445 GENEFORM Protein DME0003 XEOTICID XEO01445 MOACRIVE Induction DME0003 XEOTICID XEO01455 XEO_NAME Rhein DME0003 XEOTICID XEO01455 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01455 XEO_CLAS Investigative Agent DME0003 XEOTICID XEO01455 DESCRIPT Rhein inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01455 GENEFORM Protein DME0003 XEOTICID XEO01455 MOACRIVE Inhibition DME0003 XEOTICID XEO01462 XEO_NAME Rutecarpine DME0003 XEOTICID XEO01462 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01462 XEO_CLAS Natural Product DME0003 XEOTICID XEO01462 DESCRIPT Rutecarpine inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 0.022 microM) DME0003 XEOTICID XEO01462 GENEFORM Protein DME0003 XEOTICID XEO01462 MOACRIVE Inhibition DME0003 XEOTICID XEO01478 XEO_NAME Sulforafan DME0003 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0003 XEOTICID XEO01478 DESCRIPT Sulforafan inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01478 GENEFORM Protein DME0003 XEOTICID XEO01478 MOACRIVE Inhibition DME0003 XEOTICID XEO01479 XEO_NAME Tamarixetin DME0003 XEOTICID XEO01479 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01479 XEO_CLAS Natural Product DME0003 XEOTICID XEO01479 DESCRIPT Tamarixetin up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO01479 GENEFORM mRNA DME0003 XEOTICID XEO01479 MOACRIVE Induction DME0003 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0003 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0003 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0003 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO01492 GENEFORM mRNA DME0003 XEOTICID XEO01492 MOACRIVE Induction DME0003 XEOTICID XEO01507 XEO_NAME Lead nitrate DME0003 XEOTICID XEO01507 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO01507 XEO_CLAS Health Hazard/Toxicant DME0003 XEOTICID XEO01507 DESCRIPT Lead nitrate inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01507 GENEFORM Protein DME0003 XEOTICID XEO01507 MOACRIVE Inhibition DME0003 XEOTICID XEO01508 XEO_NAME Mercuric chloride DME0003 XEOTICID XEO01508 XEO_TYPE Health or Environmental Toxicant(s) DME0003 XEOTICID XEO01508 XEO_CLAS Acute Toxic Substance DME0003 XEOTICID XEO01508 DESCRIPT Mercuric chloride inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO01508 GENEFORM mRNA DME0003 XEOTICID XEO01508 MOACRIVE Inhibition DME0003 XEOTICID XEO01517 XEO_NAME 15,16-dihydrotanshinone I DME0003 XEOTICID XEO01517 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01517 XEO_CLAS Natural Product DME0003 XEOTICID XEO01517 DESCRIPT 15,16-dihydrotanshinone I induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01517 GENEFORM Protein DME0003 XEOTICID XEO01517 MOACRIVE Induction DME0003 XEOTICID XEO01518 XEO_NAME 5-methyltryptamine DME0003 XEOTICID XEO01518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01518 XEO_CLAS Natural Product DME0003 XEOTICID XEO01518 DESCRIPT 5-methyltryptamine inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01518 GENEFORM Protein DME0003 XEOTICID XEO01518 MOACRIVE Inhibition DME0003 XEOTICID XEO01519 XEO_NAME Allocryptopine DME0003 XEOTICID XEO01519 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01519 XEO_CLAS Natural Product DME0003 XEOTICID XEO01519 DESCRIPT Allocryptopine up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO01519 GENEFORM mRNA DME0003 XEOTICID XEO01519 MOACRIVE Induction DME0003 XEOTICID XEO01528 XEO_NAME Chrysophanic acid DME0003 XEOTICID XEO01528 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01528 XEO_CLAS Natural Product DME0003 XEOTICID XEO01528 DESCRIPT Chrysophanic acid inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01528 GENEFORM Protein DME0003 XEOTICID XEO01528 MOACRIVE Inhibition DME0003 XEOTICID XEO01534 XEO_NAME Cryptotanshinone DME0003 XEOTICID XEO01534 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01534 XEO_CLAS Natural Product DME0003 XEOTICID XEO01534 DESCRIPT Cryptotanshinone induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01534 GENEFORM Protein DME0003 XEOTICID XEO01534 MOACRIVE Induction DME0003 XEOTICID XEO01544 XEO_NAME Gamma-valerolactone DME0003 XEOTICID XEO01544 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01544 XEO_CLAS Natural Product DME0003 XEOTICID XEO01544 DESCRIPT Gamma-valerolactone inhibits the drug-metabolizing activity of DME CYP1A2 (IC50 = 15000 microM) DME0003 XEOTICID XEO01544 GENEFORM Protein DME0003 XEOTICID XEO01544 MOACRIVE Inhibition DME0003 XEOTICID XEO01564 XEO_NAME Mitragynine DME0003 XEOTICID XEO01564 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01564 XEO_CLAS Natural Product DME0003 XEOTICID XEO01564 DESCRIPT Mitragynine induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01564 GENEFORM Protein DME0003 XEOTICID XEO01564 MOACRIVE Induction DME0003 XEOTICID XEO01572 XEO_NAME Physcione DME0003 XEOTICID XEO01572 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01572 XEO_CLAS Natural Product DME0003 XEOTICID XEO01572 DESCRIPT Physcione inhibits the expression of DME CYP1A2 DME0003 XEOTICID XEO01572 GENEFORM mRNA DME0003 XEOTICID XEO01572 MOACRIVE Inhibition DME0003 XEOTICID XEO01574 XEO_NAME Plant extracts DME0003 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0003 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01574 GENEFORM Protein DME0003 XEOTICID XEO01574 MOACRIVE Inhibition DME0003 XEOTICID XEO01581 XEO_NAME Protopine DME0003 XEOTICID XEO01581 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01581 XEO_CLAS Natural Product DME0003 XEOTICID XEO01581 DESCRIPT Protopine up-regulates the expression of DME CYP1A2 DME0003 XEOTICID XEO01581 GENEFORM mRNA DME0003 XEOTICID XEO01581 MOACRIVE Induction DME0003 XEOTICID XEO01583 XEO_NAME Safrole DME0003 XEOTICID XEO01583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0003 XEOTICID XEO01583 XEO_CLAS Natural Product DME0003 XEOTICID XEO01583 DESCRIPT Safrole inhibits the drug-metabolizing activity of DME CYP1A2 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 10 microM) DME0003 XEOTICID XEO01583 GENEFORM Protein DME0003 XEOTICID XEO01583 MOACRIVE Inhibition DME0003 XEOTICID XEO01600 XEO_NAME Cyhalothrin DME0003 XEOTICID XEO01600 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0003 XEOTICID XEO01600 XEO_CLAS Pesticide/Insecticide DME0003 XEOTICID XEO01600 DESCRIPT Cyhalothrin induces the drug-metabolizing activity of DME CYP1A2 DME0003 XEOTICID XEO01600 GENEFORM Protein DME0003 XEOTICID XEO01600 MOACRIVE Induction DME0004 DME___ID DME0004 DME0004 DME_NAME UDP-glucuronosyltransferase 1A1 (UGT1A1) DME0004 SPESNAME Homo sapiens DME0004 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0004 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00011 DESCRIPT Carbamazepine induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00011 GENEFORM Protein DME0004 XEOTICID XEO00011 MOACRIVE Induction DME0004 XEOTICID XEO00026 XEO_NAME Diflunisal DME0004 XEOTICID XEO00026 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00026 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00026 DESCRIPT Diflunisal inhibits the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00026 GENEFORM Protein DME0004 XEOTICID XEO00026 MOACRIVE Inhibition DME0004 XEOTICID XEO00029 XEO_NAME Valproic acid DME0004 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00029 GENEFORM mRNA DME0004 XEOTICID XEO00029 MOACRIVE Induction DME0004 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0004 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00035 GENEFORM mRNA DME0004 XEOTICID XEO00035 MOACRIVE Induction DME0004 XEOTICID XEO00040 XEO_NAME Furosemide DME0004 XEOTICID XEO00040 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00040 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00040 DESCRIPT Furosemide up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00040 GENEFORM mRNA DME0004 XEOTICID XEO00040 MOACRIVE Induction DME0004 XEOTICID XEO00042 XEO_NAME Gemfibrozil DME0004 XEOTICID XEO00042 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00042 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00042 DESCRIPT Gemfibrozil up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00042 GENEFORM mRNA DME0004 XEOTICID XEO00042 MOACRIVE Induction DME0004 XEOTICID XEO00047 XEO_NAME Indomethacin DME0004 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00047 DESCRIPT Indomethacin inhibits the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00047 GENEFORM Protein DME0004 XEOTICID XEO00047 MOACRIVE Inhibition DME0004 XEOTICID XEO00050 XEO_NAME Ketoprofen DME0004 XEOTICID XEO00050 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00050 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00050 DESCRIPT Ketoprof DMEen inhibits the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00050 GENEFORM Protein DME0004 XEOTICID XEO00050 MOACRIVE Inhibition DME0004 XEOTICID XEO00053 XEO_NAME Leflunomide DME0004 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00053 GENEFORM mRNA DME0004 XEOTICID XEO00053 MOACRIVE Induction DME0004 XEOTICID XEO00069 XEO_NAME Omeprazole DME0004 XEOTICID XEO00069 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00069 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00069 DESCRIPT Omeprazole up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00069 GENEFORM mRNA DME0004 XEOTICID XEO00069 MOACRIVE Induction DME0004 XEOTICID XEO00086 XEO_NAME Troglitazone DME0004 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00086 GENEFORM mRNA DME0004 XEOTICID XEO00086 MOACRIVE Induction DME0004 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0004 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00088 DESCRIPT Dexamethasone induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00088 GENEFORM Protein DME0004 XEOTICID XEO00088 MOACRIVE Induction DME0004 XEOTICID XEO00090 XEO_NAME Estradiol DME0004 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00090 GENEFORM Protein DME0004 XEOTICID XEO00090 MOACRIVE Inhibition DME0004 XEOTICID XEO00095 XEO_NAME Testosterone DME0004 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00095 DESCRIPT Testosterone induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00095 GENEFORM Protein DME0004 XEOTICID XEO00095 MOACRIVE Induction DME0004 XEOTICID XEO00138 XEO_NAME Fenofibric acid DME0004 XEOTICID XEO00138 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00138 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00138 DESCRIPT Fenofibric acid up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00138 GENEFORM mRNA DME0004 XEOTICID XEO00138 MOACRIVE Induction DME0004 XEOTICID XEO00147 XEO_NAME Fulvestrant DME0004 XEOTICID XEO00147 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00147 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00147 DESCRIPT Fulvestrant up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00147 GENEFORM mRNA DME0004 XEOTICID XEO00147 MOACRIVE Induction DME0004 XEOTICID XEO00156 XEO_NAME Naproxen DME0004 XEOTICID XEO00156 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00156 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00156 DESCRIPT Naproxen inhibits the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00156 GENEFORM Protein DME0004 XEOTICID XEO00156 MOACRIVE Inhibition DME0004 XEOTICID XEO00168 XEO_NAME Decitabine DME0004 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00168 DESCRIPT Decitabine up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00168 GENEFORM mRNA DME0004 XEOTICID XEO00168 MOACRIVE Induction DME0004 XEOTICID XEO00177 XEO_NAME Sulindac DME0004 XEOTICID XEO00177 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00177 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00177 DESCRIPT Sulindac induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00177 GENEFORM Protein DME0004 XEOTICID XEO00177 MOACRIVE Induction DME0004 XEOTICID XEO00184 XEO_NAME Calcitriol DME0004 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00184 GENEFORM mRNA DME0004 XEOTICID XEO00184 MOACRIVE Induction DME0004 XEOTICID XEO00209 XEO_NAME Clozapine DME0004 XEOTICID XEO00209 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00209 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00209 DESCRIPT Clozapine up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00209 GENEFORM mRNA DME0004 XEOTICID XEO00209 MOACRIVE Induction DME0004 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0004 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00217 GENEFORM Protein DME0004 XEOTICID XEO00217 MOACRIVE Inhibition DME0004 XEOTICID XEO00218 XEO_NAME Caffeine DME0004 XEOTICID XEO00218 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00218 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00218 DESCRIPT Caffeine up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00218 GENEFORM mRNA DME0004 XEOTICID XEO00218 MOACRIVE Induction DME0004 XEOTICID XEO00223 XEO_NAME Rifampin DME0004 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00223 DESCRIPT Rifampin up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00223 GENEFORM mRNA DME0004 XEOTICID XEO00223 MOACRIVE Induction DME0004 XEOTICID XEO00232 XEO_NAME Phenytoin DME0004 XEOTICID XEO00232 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00232 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00232 DESCRIPT Phenytoin up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00232 GENEFORM mRNA DME0004 XEOTICID XEO00232 MOACRIVE Induction DME0004 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0004 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME UGT1A1 in Human embryonic kidney 293 cell (HEK293) (IC50 = 13 microM) DME0004 XEOTICID XEO00251 GENEFORM Protein DME0004 XEOTICID XEO00251 MOACRIVE Inhibition DME0004 XEOTICID XEO00274 XEO_NAME Nilotinib hydrochloride DME0004 XEOTICID XEO00274 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00274 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00274 DESCRIPT Nilotinib hydrochloride inhibits the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00274 GENEFORM Protein DME0004 XEOTICID XEO00274 MOACRIVE Inhibition DME0004 XEOTICID XEO00319 XEO_NAME Pioglitazone hydrochloride DME0004 XEOTICID XEO00319 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00319 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00319 DESCRIPT Pioglitazone hydrochloride up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00319 GENEFORM mRNA DME0004 XEOTICID XEO00319 MOACRIVE Induction DME0004 XEOTICID XEO00331 XEO_NAME Ticlopidine hydrochloride DME0004 XEOTICID XEO00331 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00331 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00331 DESCRIPT Ticlopidine hydrochloride up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00331 GENEFORM mRNA DME0004 XEOTICID XEO00331 MOACRIVE Induction DME0004 XEOTICID XEO00352 XEO_NAME Diclofenac DME0004 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00352 DESCRIPT Diclof DMEenac inhibits the drug-metabolizing activity of DME UGT1A1 (Ki = 52 microM) DME0004 XEOTICID XEO00352 GENEFORM Protein DME0004 XEOTICID XEO00352 MOACRIVE Inhibition DME0004 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0004 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00380 DESCRIPT Rosiglitazone up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00380 GENEFORM mRNA DME0004 XEOTICID XEO00380 MOACRIVE Induction DME0004 XEOTICID XEO00439 XEO_NAME Daidzein DME0004 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00439 DESCRIPT Daidzein induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00439 GENEFORM Protein DME0004 XEOTICID XEO00439 MOACRIVE Induction DME0004 XEOTICID XEO00455 XEO_NAME Tocotrienol beta DME0004 XEOTICID XEO00455 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00455 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00455 DESCRIPT Tocotrienol beta induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00455 GENEFORM Protein DME0004 XEOTICID XEO00455 MOACRIVE Induction DME0004 XEOTICID XEO00456 XEO_NAME Tocotrienol delta DME0004 XEOTICID XEO00456 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00456 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00456 DESCRIPT Tocotrienol delta up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00456 GENEFORM mRNA DME0004 XEOTICID XEO00456 MOACRIVE Induction DME0004 XEOTICID XEO00498 XEO_NAME Flunitrazepam DME0004 XEOTICID XEO00498 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00498 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO00498 DESCRIPT Flunitrazepam inhibits the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00498 GENEFORM Protein DME0004 XEOTICID XEO00498 MOACRIVE Inhibition DME0004 XEOTICID XEO00538 XEO_NAME Quercetin DME0004 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0004 XEOTICID XEO00538 DESCRIPT Quercetin up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00538 GENEFORM mRNA DME0004 XEOTICID XEO00538 MOACRIVE Induction DME0004 XEOTICID XEO00555 XEO_NAME Hymecromone DME0004 XEOTICID XEO00555 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00555 XEO_CLAS Drug in Phase 1 Clinical Trial DME0004 XEOTICID XEO00555 DESCRIPT Hymecromone induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00555 GENEFORM Protein DME0004 XEOTICID XEO00555 MOACRIVE Induction DME0004 XEOTICID XEO00557 XEO_NAME Genistein DME0004 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0004 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00557 GENEFORM Protein DME0004 XEOTICID XEO00557 MOACRIVE Inhibition DME0004 XEOTICID XEO00560 XEO_NAME Triclosan DME0004 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0004 XEOTICID XEO00560 DESCRIPT Triclosan up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00560 GENEFORM mRNA DME0004 XEOTICID XEO00560 MOACRIVE Induction DME0004 XEOTICID XEO00588 XEO_NAME Bisphenol B DME0004 XEOTICID XEO00588 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00588 XEO_CLAS Drug in Phase 2 Clinical Trial DME0004 XEOTICID XEO00588 DESCRIPT Bisphenol B up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00588 GENEFORM mRNA DME0004 XEOTICID XEO00588 MOACRIVE Induction DME0004 XEOTICID XEO00609 XEO_NAME MeIQx DME0004 XEOTICID XEO00609 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00609 XEO_CLAS Drug in Phase 2 Clinical Trial DME0004 XEOTICID XEO00609 DESCRIPT MeIQx up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00609 GENEFORM mRNA DME0004 XEOTICID XEO00609 MOACRIVE Induction DME0004 XEOTICID XEO00634 XEO_NAME Hydroxytamoxifen DME0004 XEOTICID XEO00634 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00634 XEO_CLAS Drug in Phase 2 Clinical Trial DME0004 XEOTICID XEO00634 DESCRIPT Hydroxytamoxifen inhibits the expression of DME UGT1A1 DME0004 XEOTICID XEO00634 GENEFORM mRNA DME0004 XEOTICID XEO00634 MOACRIVE Inhibition DME0004 XEOTICID XEO00636 XEO_NAME Xanthohumol DME0004 XEOTICID XEO00636 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00636 XEO_CLAS Drug in Phase 1 Clinical Trial DME0004 XEOTICID XEO00636 DESCRIPT Xanthohumol up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00636 GENEFORM mRNA DME0004 XEOTICID XEO00636 MOACRIVE Induction DME0004 XEOTICID XEO00656 XEO_NAME Sulindac sulfide DME0004 XEOTICID XEO00656 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00656 XEO_CLAS Drug in Phase 2 Clinical Trial DME0004 XEOTICID XEO00656 DESCRIPT Sulindac sulfide induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00656 GENEFORM Protein DME0004 XEOTICID XEO00656 MOACRIVE Induction DME0004 XEOTICID XEO00659 XEO_NAME Exisulind DME0004 XEOTICID XEO00659 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00659 XEO_CLAS Drug in Phase 3 Clinical Trial DME0004 XEOTICID XEO00659 DESCRIPT Exisulind up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00659 GENEFORM mRNA DME0004 XEOTICID XEO00659 MOACRIVE Induction DME0004 XEOTICID XEO00683 XEO_NAME Curcumin DME0004 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0004 XEOTICID XEO00683 DESCRIPT Curcumin up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00683 GENEFORM mRNA DME0004 XEOTICID XEO00683 MOACRIVE Induction DME0004 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0004 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0004 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME UGT1A1 DME0004 XEOTICID XEO00723 GENEFORM mRNA DME0004 XEOTICID XEO00723 MOACRIVE Inhibition DME0004 XEOTICID XEO00756 XEO_NAME Turmeric extract DME0004 XEOTICID XEO00756 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0004 XEOTICID XEO00756 XEO_CLAS Plant Extract DME0004 XEOTICID XEO00756 DESCRIPT Turmeric extract up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00756 GENEFORM mRNA DME0004 XEOTICID XEO00756 MOACRIVE Induction DME0004 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0004 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0004 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0004 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00806 GENEFORM mRNA DME0004 XEOTICID XEO00806 MOACRIVE Induction DME0004 XEOTICID XEO00829 XEO_NAME Niflumic acid DME0004 XEOTICID XEO00829 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO00829 XEO_CLAS Investigative Agent DME0004 XEOTICID XEO00829 DESCRIPT Niflumic acid inhibits the drug-metabolizing activity of DME UGT1A1 in Human embryonic kidney 293 cell (HEK293) (IC50 = 13 microM) DME0004 XEOTICID XEO00829 GENEFORM Protein DME0004 XEOTICID XEO00829 MOACRIVE Inhibition DME0004 XEOTICID XEO00858 XEO_NAME Flavonoids DME0004 XEOTICID XEO00858 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0004 XEOTICID XEO00858 XEO_CLAS Natural Mixture DME0004 XEOTICID XEO00858 DESCRIPT Flavonoids induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00858 GENEFORM Protein DME0004 XEOTICID XEO00858 MOACRIVE Induction DME0004 XEOTICID XEO00859 XEO_NAME Ginkgolide B DME0004 XEOTICID XEO00859 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0004 XEOTICID XEO00859 XEO_CLAS Natural Product DME0004 XEOTICID XEO00859 DESCRIPT Ginkgolide B up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00859 GENEFORM mRNA DME0004 XEOTICID XEO00859 MOACRIVE Induction DME0004 XEOTICID XEO00877 XEO_NAME Bilirubin DME0004 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0004 XEOTICID XEO00877 XEO_CLAS Natural Product DME0004 XEOTICID XEO00877 DESCRIPT Bilirubin inhibits the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00877 GENEFORM Protein DME0004 XEOTICID XEO00877 MOACRIVE Inhibition DME0004 XEOTICID XEO00878 XEO_NAME Chrysin DME0004 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0004 XEOTICID XEO00878 XEO_CLAS Natural Product DME0004 XEOTICID XEO00878 DESCRIPT Chrysin induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00878 GENEFORM Protein DME0004 XEOTICID XEO00878 MOACRIVE Induction DME0004 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0004 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0004 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0004 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME UGT1A1 and leads to increasing the drug-metabolizing activity of this enzyme DME0004 XEOTICID XEO00898 GENEFORM Protein DME0004 XEOTICID XEO00898 MOACRIVE Induction DME0004 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0004 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0004 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0004 XEOTICID XEO00899 DESCRIPT Methylcholanthrene induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00899 GENEFORM Protein DME0004 XEOTICID XEO00899 MOACRIVE Induction DME0004 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0004 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0004 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0004 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00905 GENEFORM mRNA DME0004 XEOTICID XEO00905 MOACRIVE Induction DME0004 XEOTICID XEO00957 XEO_NAME Tebuconazole DME0004 XEOTICID XEO00957 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0004 XEOTICID XEO00957 XEO_CLAS Fungicide DME0004 XEOTICID XEO00957 DESCRIPT Tebuconazole up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO00957 GENEFORM mRNA DME0004 XEOTICID XEO00957 MOACRIVE Induction DME0004 XEOTICID XEO00997 XEO_NAME Bisphenol F DME0004 XEOTICID XEO00997 XEO_TYPE Health or Environmental Toxicant(s) DME0004 XEOTICID XEO00997 XEO_CLAS Environmental Pollutant DME0004 XEOTICID XEO00997 DESCRIPT Bisphenol F induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO00997 GENEFORM Protein DME0004 XEOTICID XEO00997 MOACRIVE Induction DME0004 XEOTICID XEO01064 XEO_NAME Parathion DME0004 XEOTICID XEO01064 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0004 XEOTICID XEO01064 XEO_CLAS Pesticide/Insecticide DME0004 XEOTICID XEO01064 DESCRIPT Parathion induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO01064 GENEFORM Protein DME0004 XEOTICID XEO01064 MOACRIVE Induction DME0004 XEOTICID XEO01074 XEO_NAME Endosulfan DME0004 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0004 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0004 XEOTICID XEO01074 DESCRIPT Endosulfan up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO01074 GENEFORM mRNA DME0004 XEOTICID XEO01074 MOACRIVE Induction DME0004 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0004 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0004 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0004 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO01119 GENEFORM mRNA DME0004 XEOTICID XEO01119 MOACRIVE Induction DME0004 XEOTICID XEO01195 XEO_NAME Amentoflavone DME0004 XEOTICID XEO01195 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0004 XEOTICID XEO01195 XEO_CLAS Natural Product DME0004 XEOTICID XEO01195 DESCRIPT Amentof DMElavone inhibits the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO01195 GENEFORM Protein DME0004 XEOTICID XEO01195 MOACRIVE Inhibition DME0004 XEOTICID XEO01203 XEO_NAME Apigenin DME0004 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0004 XEOTICID XEO01203 XEO_CLAS Natural Product DME0004 XEOTICID XEO01203 DESCRIPT Apigenin up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO01203 GENEFORM mRNA DME0004 XEOTICID XEO01203 MOACRIVE Induction DME0004 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0004 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0004 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME UGT1A1 and leads to increasing the drug-metabolizing activity of this enzyme DME0004 XEOTICID XEO01220 GENEFORM Protein DME0004 XEOTICID XEO01220 MOACRIVE Induction DME0004 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0004 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0004 XEOTICID XEO01226 DESCRIPT Bisphenol A induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO01226 GENEFORM Protein DME0004 XEOTICID XEO01226 MOACRIVE Induction DME0004 XEOTICID XEO01230 XEO_NAME Butyric acid DME0004 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0004 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO01230 GENEFORM mRNA DME0004 XEOTICID XEO01230 MOACRIVE Induction DME0004 XEOTICID XEO01257 XEO_NAME Clofibric acid DME0004 XEOTICID XEO01257 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0004 XEOTICID XEO01257 XEO_CLAS Herbicide DME0004 XEOTICID XEO01257 DESCRIPT Clofibric acid up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO01257 GENEFORM mRNA DME0004 XEOTICID XEO01257 MOACRIVE Induction DME0004 XEOTICID XEO01268 XEO_NAME Cycloheximide DME0004 XEOTICID XEO01268 XEO_TYPE Health or Environmental Toxicant(s) DME0004 XEOTICID XEO01268 XEO_CLAS Acute Toxic Substance DME0004 XEOTICID XEO01268 DESCRIPT Cycloheximide inhibits the expression of DME UGT1A1 DME0004 XEOTICID XEO01268 GENEFORM mRNA DME0004 XEOTICID XEO01268 MOACRIVE Inhibition DME0004 XEOTICID XEO01314 XEO_NAME Ginkgo biloba extract DME0004 XEOTICID XEO01314 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0004 XEOTICID XEO01314 XEO_CLAS Plant Extract DME0004 XEOTICID XEO01314 DESCRIPT Ginkgo biloba extract up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO01314 GENEFORM mRNA DME0004 XEOTICID XEO01314 MOACRIVE Induction DME0004 XEOTICID XEO01315 XEO_NAME Ginkgolide A DME0004 XEOTICID XEO01315 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO01315 XEO_CLAS Approved/Marketed Drug DME0004 XEOTICID XEO01315 DESCRIPT Ginkgolide A up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO01315 GENEFORM mRNA DME0004 XEOTICID XEO01315 MOACRIVE Induction DME0004 XEOTICID XEO01335 XEO_NAME Hyperforin DME0004 XEOTICID XEO01335 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0004 XEOTICID XEO01335 XEO_CLAS Natural Product DME0004 XEOTICID XEO01335 DESCRIPT Hyperforin up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO01335 GENEFORM mRNA DME0004 XEOTICID XEO01335 MOACRIVE Induction DME0004 XEOTICID XEO01370 XEO_NAME Mangiferin DME0004 XEOTICID XEO01370 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0004 XEOTICID XEO01370 XEO_CLAS Natural Product DME0004 XEOTICID XEO01370 DESCRIPT Mangiferin up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO01370 GENEFORM mRNA DME0004 XEOTICID XEO01370 MOACRIVE Induction DME0004 XEOTICID XEO01433 XEO_NAME Pirinixic acid DME0004 XEOTICID XEO01433 XEO_TYPE Health or Environmental Toxicant(s) DME0004 XEOTICID XEO01433 XEO_CLAS Health Hazard/Toxicant DME0004 XEOTICID XEO01433 DESCRIPT Pirinixic acid up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO01433 GENEFORM mRNA DME0004 XEOTICID XEO01433 MOACRIVE Induction DME0004 XEOTICID XEO01437 XEO_NAME Pregnenolone carbonitrile DME0004 XEOTICID XEO01437 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO01437 XEO_CLAS Investigative Agent DME0004 XEOTICID XEO01437 DESCRIPT Pregnenolone carbonitrile up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO01437 GENEFORM mRNA DME0004 XEOTICID XEO01437 MOACRIVE Induction DME0004 XEOTICID XEO01478 XEO_NAME Sulforafan DME0004 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0004 XEOTICID XEO01478 DESCRIPT Sulforafan up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO01478 GENEFORM mRNA DME0004 XEOTICID XEO01478 MOACRIVE Induction DME0004 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0004 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0004 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0004 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO01492 GENEFORM mRNA DME0004 XEOTICID XEO01492 MOACRIVE Induction DME0004 XEOTICID XEO01558 XEO_NAME Ligustilide DME0004 XEOTICID XEO01558 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0004 XEOTICID XEO01558 XEO_CLAS Natural Product DME0004 XEOTICID XEO01558 DESCRIPT Ligustilide up-regulates the expression of DME UGT1A1 DME0004 XEOTICID XEO01558 GENEFORM mRNA DME0004 XEOTICID XEO01558 MOACRIVE Induction DME0004 XEOTICID XEO01567 XEO_NAME Notoginsenoside R1 DME0004 XEOTICID XEO01567 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0004 XEOTICID XEO01567 XEO_CLAS Natural Product DME0004 XEOTICID XEO01567 DESCRIPT Notoginsenoside R1 induces the drug-metabolizing activity of DME UGT1A1 DME0004 XEOTICID XEO01567 GENEFORM Protein DME0004 XEOTICID XEO01567 MOACRIVE Induction DME0005 DME___ID DME0005 DME0005 DME_NAME Cytochrome P450 2A6 (CYP2A6) DME0005 SPESNAME Homo sapiens DME0005 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0005 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00011 GENEFORM mRNA DME0005 XEOTICID XEO00011 MOACRIVE Induction DME0005 XEOTICID XEO00022 XEO_NAME Desipramine DME0005 XEOTICID XEO00022 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00022 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00022 DESCRIPT Desipramine inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00022 GENEFORM Protein DME0005 XEOTICID XEO00022 MOACRIVE Inhibition DME0005 XEOTICID XEO00029 XEO_NAME Valproic acid DME0005 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00029 GENEFORM mRNA DME0005 XEOTICID XEO00029 MOACRIVE Induction DME0005 XEOTICID XEO00049 XEO_NAME Isradipine DME0005 XEOTICID XEO00049 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00049 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00049 DESCRIPT Isradipine induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00049 GENEFORM Protein DME0005 XEOTICID XEO00049 MOACRIVE Induction DME0005 XEOTICID XEO00062 XEO_NAME Methoxsalen DME0005 XEOTICID XEO00062 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00062 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00062 DESCRIPT Methoxsalen inhibits the drug-metabolizing activity of DME CYP2A6 (Ki = 0.25 microM) DME0005 XEOTICID XEO00062 GENEFORM Protein DME0005 XEOTICID XEO00062 MOACRIVE Inhibition DME0005 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0005 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00088 DESCRIPT Dexamethasone induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00088 GENEFORM Protein DME0005 XEOTICID XEO00088 MOACRIVE Induction DME0005 XEOTICID XEO00090 XEO_NAME Estradiol DME0005 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00090 GENEFORM mRNA DME0005 XEOTICID XEO00090 MOACRIVE Induction DME0005 XEOTICID XEO00092 XEO_NAME Pilocarpine DME0005 XEOTICID XEO00092 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00092 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00092 DESCRIPT Pilocarpine inhibits the drug-metabolizing activity of DME CYP2A6 (Ki = 3 microM) DME0005 XEOTICID XEO00092 GENEFORM Protein DME0005 XEOTICID XEO00092 MOACRIVE Inhibition DME0005 XEOTICID XEO00095 XEO_NAME Testosterone DME0005 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00095 GENEFORM mRNA DME0005 XEOTICID XEO00095 MOACRIVE Induction DME0005 XEOTICID XEO00123 XEO_NAME Permethrin DME0005 XEOTICID XEO00123 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00123 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00123 DESCRIPT Permethrin up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00123 GENEFORM mRNA DME0005 XEOTICID XEO00123 MOACRIVE Induction DME0005 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0005 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00165 DESCRIPT Obeticholic acid up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00165 GENEFORM mRNA DME0005 XEOTICID XEO00165 MOACRIVE Induction DME0005 XEOTICID XEO00184 XEO_NAME Calcitriol DME0005 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00184 GENEFORM mRNA DME0005 XEOTICID XEO00184 MOACRIVE Induction DME0005 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0005 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP2A6 DME0005 XEOTICID XEO00217 GENEFORM mRNA DME0005 XEOTICID XEO00217 MOACRIVE Inhibition DME0005 XEOTICID XEO00223 XEO_NAME Rifampin DME0005 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00223 DESCRIPT Rifampin up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00223 GENEFORM mRNA DME0005 XEOTICID XEO00223 MOACRIVE Induction DME0005 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0005 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP2A6 DME0005 XEOTICID XEO00241 GENEFORM mRNA DME0005 XEOTICID XEO00241 MOACRIVE Inhibition DME0005 XEOTICID XEO00245 XEO_NAME Felodipine DME0005 XEOTICID XEO00245 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00245 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00245 DESCRIPT Felodipine induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00245 GENEFORM Protein DME0005 XEOTICID XEO00245 MOACRIVE Induction DME0005 XEOTICID XEO00280 XEO_NAME Chlorpromazine hydrochloride DME0005 XEOTICID XEO00280 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00280 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00280 DESCRIPT Chlorpromazine hydrochloride inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00280 GENEFORM Protein DME0005 XEOTICID XEO00280 MOACRIVE Inhibition DME0005 XEOTICID XEO00295 XEO_NAME Fluphenazine hydrochloride DME0005 XEOTICID XEO00295 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00295 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00295 DESCRIPT Fluphenazine hydrochloride inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00295 GENEFORM Protein DME0005 XEOTICID XEO00295 MOACRIVE Inhibition DME0005 XEOTICID XEO00301 XEO_NAME Irinotecan hydrochloride DME0005 XEOTICID XEO00301 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00301 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00301 DESCRIPT Irinotecan hydrochloride inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00301 GENEFORM Protein DME0005 XEOTICID XEO00301 MOACRIVE Inhibition DME0005 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0005 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00312 GENEFORM mRNA DME0005 XEOTICID XEO00312 MOACRIVE Induction DME0005 XEOTICID XEO00330 XEO_NAME Thioridazine hydrochloride DME0005 XEOTICID XEO00330 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00330 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00330 DESCRIPT Thioridazine hydrochloride inhibits the expression of DME CYP2A6 DME0005 XEOTICID XEO00330 GENEFORM mRNA DME0005 XEOTICID XEO00330 MOACRIVE Inhibition DME0005 XEOTICID XEO00385 XEO_NAME Tranylcypromine DME0005 XEOTICID XEO00385 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00385 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00385 DESCRIPT Tranylcypromine inhibits the drug-metabolizing activity of DME CYP2A6 (Ki = 0.13 microM) DME0005 XEOTICID XEO00385 GENEFORM Protein DME0005 XEOTICID XEO00385 MOACRIVE Inhibition DME0005 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0005 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00410 DESCRIPT Phenobarbital induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00410 GENEFORM Protein DME0005 XEOTICID XEO00410 MOACRIVE Induction DME0005 XEOTICID XEO00438 XEO_NAME Benidipine DME0005 XEOTICID XEO00438 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00438 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO00438 DESCRIPT Benidipine induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00438 GENEFORM Protein DME0005 XEOTICID XEO00438 MOACRIVE Induction DME0005 XEOTICID XEO00538 XEO_NAME Quercetin DME0005 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0005 XEOTICID XEO00538 DESCRIPT Quercetin induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00538 GENEFORM Protein DME0005 XEOTICID XEO00538 MOACRIVE Induction DME0005 XEOTICID XEO00539 XEO_NAME Ethanol DME0005 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0005 XEOTICID XEO00539 DESCRIPT Ethanol induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00539 GENEFORM Protein DME0005 XEOTICID XEO00539 MOACRIVE Induction DME0005 XEOTICID XEO00576 XEO_NAME Tryptamine DME0005 XEOTICID XEO00576 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00576 XEO_CLAS Drug in Phase 2 Clinical Trial DME0005 XEOTICID XEO00576 DESCRIPT Tryptamine inhibits the drug-metabolizing activity of DME CYP2A6 (Ki = 1.7 microM) DME0005 XEOTICID XEO00576 GENEFORM Protein DME0005 XEOTICID XEO00576 MOACRIVE Inhibition DME0005 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0005 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0005 XEOTICID XEO00582 DESCRIPT Diethyltoluamide up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00582 GENEFORM mRNA DME0005 XEOTICID XEO00582 MOACRIVE Induction DME0005 XEOTICID XEO00591 XEO_NAME Ditiocarb DME0005 XEOTICID XEO00591 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00591 XEO_CLAS Drug in Phase 2 Clinical Trial DME0005 XEOTICID XEO00591 DESCRIPT Ditiocarb inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00591 GENEFORM Protein DME0005 XEOTICID XEO00591 MOACRIVE Inhibition DME0005 XEOTICID XEO00596 XEO_NAME Phenethyl isothiocyanate DME0005 XEOTICID XEO00596 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00596 XEO_CLAS Drug in Phase 2 Clinical Trial DME0005 XEOTICID XEO00596 DESCRIPT Phenethyl isothiocyanate inhibits the drug-metabolizing activity of DME CYP2A6 (Ki = 1.7 microM) DME0005 XEOTICID XEO00596 GENEFORM Protein DME0005 XEOTICID XEO00596 MOACRIVE Inhibition DME0005 XEOTICID XEO00598 XEO_NAME Carbendazim DME0005 XEOTICID XEO00598 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00598 XEO_CLAS Drug in Phase 1 Clinical Trial DME0005 XEOTICID XEO00598 DESCRIPT Carbendazim up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00598 GENEFORM mRNA DME0005 XEOTICID XEO00598 MOACRIVE Induction DME0005 XEOTICID XEO00610 XEO_NAME Afimoxifene DME0005 XEOTICID XEO00610 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00610 XEO_CLAS Drug in Phase 3 Clinical Trial DME0005 XEOTICID XEO00610 DESCRIPT Afimoxifene inhibits the expression of DME CYP2A6 DME0005 XEOTICID XEO00610 GENEFORM mRNA DME0005 XEOTICID XEO00610 MOACRIVE Inhibition DME0005 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME0005 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME0005 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00646 GENEFORM Protein DME0005 XEOTICID XEO00646 MOACRIVE Inhibition DME0005 XEOTICID XEO00777 XEO_NAME Skatole DME0005 XEOTICID XEO00777 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0005 XEOTICID XEO00777 XEO_CLAS Natural Product DME0005 XEOTICID XEO00777 DESCRIPT Skatole inhibits the expression of DME CYP2A6 DME0005 XEOTICID XEO00777 GENEFORM mRNA DME0005 XEOTICID XEO00777 MOACRIVE Inhibition DME0005 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0005 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0005 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0005 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYP2A6 DME0005 XEOTICID XEO00806 GENEFORM mRNA DME0005 XEOTICID XEO00806 MOACRIVE Inhibition DME0005 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0005 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0005 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0005 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00821 GENEFORM Protein DME0005 XEOTICID XEO00821 MOACRIVE Induction DME0005 XEOTICID XEO00873 XEO_NAME Alpha-linolenic acid DME0005 XEOTICID XEO00873 XEO_TYPE Health or Environmental Toxicant(s) DME0005 XEOTICID XEO00873 XEO_CLAS Health Hazard/Toxicant DME0005 XEOTICID XEO00873 DESCRIPT Alpha-linolenic acid induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00873 GENEFORM Protein DME0005 XEOTICID XEO00873 MOACRIVE Induction DME0005 XEOTICID XEO00877 XEO_NAME Bilirubin DME0005 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0005 XEOTICID XEO00877 XEO_CLAS Natural Product DME0005 XEOTICID XEO00877 DESCRIPT Bilirubin inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00877 GENEFORM Protein DME0005 XEOTICID XEO00877 MOACRIVE Inhibition DME0005 XEOTICID XEO00879 XEO_NAME Coumarin DME0005 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME0005 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME0005 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00879 GENEFORM Protein DME0005 XEOTICID XEO00879 MOACRIVE Inhibition DME0005 XEOTICID XEO00880 XEO_NAME Isatin DME0005 XEOTICID XEO00880 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0005 XEOTICID XEO00880 XEO_CLAS Natural Product DME0005 XEOTICID XEO00880 DESCRIPT Isatin up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00880 GENEFORM mRNA DME0005 XEOTICID XEO00880 MOACRIVE Induction DME0005 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0005 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0005 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0005 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00898 GENEFORM Protein DME0005 XEOTICID XEO00898 MOACRIVE Induction DME0005 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0005 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0005 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0005 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME CYP2A6 DME0005 XEOTICID XEO00905 GENEFORM mRNA DME0005 XEOTICID XEO00905 MOACRIVE Inhibition DME0005 XEOTICID XEO00942 XEO_NAME Cyproconazole DME0005 XEOTICID XEO00942 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO00942 XEO_CLAS Fungicide DME0005 XEOTICID XEO00942 DESCRIPT Cyproconazole inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00942 GENEFORM Protein DME0005 XEOTICID XEO00942 MOACRIVE Inhibition DME0005 XEOTICID XEO00969 XEO_NAME Atrazine DME0005 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO00969 XEO_CLAS Herbicide DME0005 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00969 GENEFORM mRNA DME0005 XEOTICID XEO00969 MOACRIVE Induction DME0005 XEOTICID XEO00973 XEO_NAME Diuron DME0005 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO00973 XEO_CLAS Herbicide DME0005 XEOTICID XEO00973 DESCRIPT Diuron up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00973 GENEFORM mRNA DME0005 XEOTICID XEO00973 MOACRIVE Induction DME0005 XEOTICID XEO00975 XEO_NAME Isoproturon DME0005 XEOTICID XEO00975 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO00975 XEO_CLAS Herbicide DME0005 XEOTICID XEO00975 DESCRIPT Isoproturon up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO00975 GENEFORM mRNA DME0005 XEOTICID XEO00975 MOACRIVE Induction DME0005 XEOTICID XEO00993 XEO_NAME Alizarin DME0005 XEOTICID XEO00993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0005 XEOTICID XEO00993 XEO_CLAS Natural Product DME0005 XEOTICID XEO00993 DESCRIPT Alizarin inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO00993 GENEFORM Protein DME0005 XEOTICID XEO00993 MOACRIVE Inhibition DME0005 XEOTICID XEO01043 XEO_NAME Chlorfluazuron DME0005 XEOTICID XEO01043 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO01043 XEO_CLAS Pesticide/Insecticide DME0005 XEOTICID XEO01043 DESCRIPT Chlorfluazuron up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO01043 GENEFORM mRNA DME0005 XEOTICID XEO01043 MOACRIVE Induction DME0005 XEOTICID XEO01046 XEO_NAME Cypermethrin DME0005 XEOTICID XEO01046 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO01046 XEO_CLAS Pesticide/Insecticide DME0005 XEOTICID XEO01046 DESCRIPT Cypermethrin up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO01046 GENEFORM mRNA DME0005 XEOTICID XEO01046 MOACRIVE Induction DME0005 XEOTICID XEO01047 XEO_NAME Decamethrin DME0005 XEOTICID XEO01047 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO01047 XEO_CLAS Pesticide/Insecticide DME0005 XEOTICID XEO01047 DESCRIPT Decamethrin up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO01047 GENEFORM mRNA DME0005 XEOTICID XEO01047 MOACRIVE Induction DME0005 XEOTICID XEO01052 XEO_NAME Fenitrothion DME0005 XEOTICID XEO01052 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO01052 XEO_CLAS Pesticide/Insecticide DME0005 XEOTICID XEO01052 DESCRIPT Fenitrothion up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO01052 GENEFORM mRNA DME0005 XEOTICID XEO01052 MOACRIVE Induction DME0005 XEOTICID XEO01053 XEO_NAME Fenvalerate DME0005 XEOTICID XEO01053 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO01053 XEO_CLAS Pesticide/Insecticide DME0005 XEOTICID XEO01053 DESCRIPT Fenvalerate up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO01053 GENEFORM mRNA DME0005 XEOTICID XEO01053 MOACRIVE Induction DME0005 XEOTICID XEO01064 XEO_NAME Parathion DME0005 XEOTICID XEO01064 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO01064 XEO_CLAS Pesticide/Insecticide DME0005 XEOTICID XEO01064 DESCRIPT Parathion induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO01064 GENEFORM Protein DME0005 XEOTICID XEO01064 MOACRIVE Induction DME0005 XEOTICID XEO01065 XEO_NAME Phenthoate DME0005 XEOTICID XEO01065 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO01065 XEO_CLAS Pesticide/Insecticide DME0005 XEOTICID XEO01065 DESCRIPT Phenthoate induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO01065 GENEFORM Protein DME0005 XEOTICID XEO01065 MOACRIVE Induction DME0005 XEOTICID XEO01068 XEO_NAME Profenofos DME0005 XEOTICID XEO01068 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO01068 XEO_CLAS Pesticide/Insecticide DME0005 XEOTICID XEO01068 DESCRIPT Profenofos induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO01068 GENEFORM Protein DME0005 XEOTICID XEO01068 MOACRIVE Induction DME0005 XEOTICID XEO01070 XEO_NAME Tebufenozide DME0005 XEOTICID XEO01070 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO01070 XEO_CLAS Pesticide/Insecticide DME0005 XEOTICID XEO01070 DESCRIPT Tebufenozide up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO01070 GENEFORM mRNA DME0005 XEOTICID XEO01070 MOACRIVE Induction DME0005 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0005 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0005 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0005 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO01129 GENEFORM mRNA DME0005 XEOTICID XEO01129 MOACRIVE Induction DME0005 XEOTICID XEO01165 XEO_NAME CITCO DME0005 XEOTICID XEO01165 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO01165 XEO_CLAS Investigative Agent DME0005 XEOTICID XEO01165 DESCRIPT CITCO up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO01165 GENEFORM mRNA DME0005 XEOTICID XEO01165 MOACRIVE Induction DME0005 XEOTICID XEO01177 XEO_NAME 7-methyltryptamine DME0005 XEOTICID XEO01177 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO01177 XEO_CLAS Investigative Agent DME0005 XEOTICID XEO01177 DESCRIPT 7-methyltryptamine inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO01177 GENEFORM Protein DME0005 XEOTICID XEO01177 MOACRIVE Inhibition DME0005 XEOTICID XEO01218 XEO_NAME Benzyl selenocyanate DME0005 XEOTICID XEO01218 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO01218 XEO_CLAS Investigative Agent DME0005 XEOTICID XEO01218 DESCRIPT Benzyl selenocyanate inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO01218 GENEFORM Protein DME0005 XEOTICID XEO01218 MOACRIVE Inhibition DME0005 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0005 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0005 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO01220 GENEFORM mRNA DME0005 XEOTICID XEO01220 MOACRIVE Induction DME0005 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0005 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0005 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO01226 GENEFORM mRNA DME0005 XEOTICID XEO01226 MOACRIVE Induction DME0005 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0005 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0005 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0005 XEOTICID XEO01248 DESCRIPT Chlorpyrifos up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO01248 GENEFORM mRNA DME0005 XEOTICID XEO01248 MOACRIVE Induction DME0005 XEOTICID XEO01252 XEO_NAME Cinnamic acid DME0005 XEOTICID XEO01252 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO01252 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO01252 DESCRIPT Cinnamic acid inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO01252 GENEFORM Protein DME0005 XEOTICID XEO01252 MOACRIVE Inhibition DME0005 XEOTICID XEO01257 XEO_NAME Clofibric acid DME0005 XEOTICID XEO01257 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO01257 XEO_CLAS Herbicide DME0005 XEOTICID XEO01257 DESCRIPT Clof DMEibric acid inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO01257 GENEFORM Protein DME0005 XEOTICID XEO01257 MOACRIVE Inhibition DME0005 XEOTICID XEO01268 XEO_NAME Cycloheximide DME0005 XEOTICID XEO01268 XEO_TYPE Health or Environmental Toxicant(s) DME0005 XEOTICID XEO01268 XEO_CLAS Acute Toxic Substance DME0005 XEOTICID XEO01268 DESCRIPT Cycloheximide inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO01268 GENEFORM Protein DME0005 XEOTICID XEO01268 MOACRIVE Inhibition DME0005 XEOTICID XEO01302 XEO_NAME Fipronil DME0005 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0005 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0005 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO01302 GENEFORM mRNA DME0005 XEOTICID XEO01302 MOACRIVE Induction DME0005 XEOTICID XEO01367 XEO_NAME Linoleic acid DME0005 XEOTICID XEO01367 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO01367 XEO_CLAS Approved/Marketed Drug DME0005 XEOTICID XEO01367 DESCRIPT Linoleic acid induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO01367 GENEFORM Protein DME0005 XEOTICID XEO01367 MOACRIVE Induction DME0005 XEOTICID XEO01412 XEO_NAME Oleic acid DME0005 XEOTICID XEO01412 XEO_TYPE Pharmaceutical Agent(s) DME0005 XEOTICID XEO01412 XEO_CLAS Preclinical/Patented Drug DME0005 XEOTICID XEO01412 DESCRIPT Oleic acid up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO01412 GENEFORM mRNA DME0005 XEOTICID XEO01412 MOACRIVE Induction DME0005 XEOTICID XEO01443 XEO_NAME Purpurin DME0005 XEOTICID XEO01443 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0005 XEOTICID XEO01443 XEO_CLAS Natural Product DME0005 XEOTICID XEO01443 DESCRIPT Purpurin inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO01443 GENEFORM Protein DME0005 XEOTICID XEO01443 MOACRIVE Inhibition DME0005 XEOTICID XEO01475 XEO_NAME Stearic acid DME0005 XEOTICID XEO01475 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0005 XEOTICID XEO01475 XEO_CLAS Food Additive DME0005 XEOTICID XEO01475 DESCRIPT Stearic acid induces the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO01475 GENEFORM Protein DME0005 XEOTICID XEO01475 MOACRIVE Induction DME0005 XEOTICID XEO01518 XEO_NAME 5-methyltryptamine DME0005 XEOTICID XEO01518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0005 XEOTICID XEO01518 XEO_CLAS Natural Product DME0005 XEOTICID XEO01518 DESCRIPT 5-methyltryptamine inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO01518 GENEFORM Protein DME0005 XEOTICID XEO01518 MOACRIVE Inhibition DME0005 XEOTICID XEO01583 XEO_NAME Safrole DME0005 XEOTICID XEO01583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0005 XEOTICID XEO01583 XEO_CLAS Natural Product DME0005 XEOTICID XEO01583 DESCRIPT Safrole inhibits the drug-metabolizing activity of DME CYP2A6 DME0005 XEOTICID XEO01583 GENEFORM Protein DME0005 XEOTICID XEO01583 MOACRIVE Inhibition DME0005 XEOTICID XEO01600 XEO_NAME Cyhalothrin DME0005 XEOTICID XEO01600 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0005 XEOTICID XEO01600 XEO_CLAS Pesticide/Insecticide DME0005 XEOTICID XEO01600 DESCRIPT Cyhalothrin up-regulates the expression of DME CYP2A6 DME0005 XEOTICID XEO01600 GENEFORM mRNA DME0005 XEOTICID XEO01600 MOACRIVE Induction DME0006 DME___ID DME0006 DME0006 DME_NAME Cytochrome P450 1A1 (CYP1A1) DME0006 SPESNAME Homo sapiens DME0006 XEOTICID XEO00003 XEO_NAME Albendazole DME0006 XEOTICID XEO00003 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00003 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00003 DESCRIPT Albendazole induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00003 GENEFORM Protein DME0006 XEOTICID XEO00003 MOACRIVE Induction DME0006 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0006 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00011 DESCRIPT Carbamazepine inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00011 GENEFORM Protein DME0006 XEOTICID XEO00011 MOACRIVE Inhibition DME0006 XEOTICID XEO00015 XEO_NAME Cimetidine DME0006 XEOTICID XEO00015 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00015 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00015 DESCRIPT Cimetidine inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00015 GENEFORM Protein DME0006 XEOTICID XEO00015 MOACRIVE Inhibition DME0006 XEOTICID XEO00016 XEO_NAME Clofibrate DME0006 XEOTICID XEO00016 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00016 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00016 DESCRIPT Clofibrate up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00016 GENEFORM mRNA DME0006 XEOTICID XEO00016 MOACRIVE Induction DME0006 XEOTICID XEO00019 XEO_NAME Dapsone DME0006 XEOTICID XEO00019 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00019 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00019 DESCRIPT Dapsone induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00019 GENEFORM Protein DME0006 XEOTICID XEO00019 MOACRIVE Induction DME0006 XEOTICID XEO00029 XEO_NAME Valproic acid DME0006 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00029 GENEFORM mRNA DME0006 XEOTICID XEO00029 MOACRIVE Induction DME0006 XEOTICID XEO00032 XEO_NAME Ethacrynic acid DME0006 XEOTICID XEO00032 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00032 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00032 DESCRIPT Ethacrynic acid up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00032 GENEFORM mRNA DME0006 XEOTICID XEO00032 MOACRIVE Induction DME0006 XEOTICID XEO00046 XEO_NAME Ifosfamide DME0006 XEOTICID XEO00046 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00046 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00046 DESCRIPT Ifosfamide inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00046 GENEFORM mRNA DME0006 XEOTICID XEO00046 MOACRIVE Inhibition DME0006 XEOTICID XEO00048 XEO_NAME Isoproterenol DME0006 XEOTICID XEO00048 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00048 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00048 DESCRIPT Isoproterenol inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00048 GENEFORM mRNA DME0006 XEOTICID XEO00048 MOACRIVE Inhibition DME0006 XEOTICID XEO00049 XEO_NAME Isradipine DME0006 XEOTICID XEO00049 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00049 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00049 DESCRIPT Isradipine up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00049 GENEFORM mRNA DME0006 XEOTICID XEO00049 MOACRIVE Induction DME0006 XEOTICID XEO00052 XEO_NAME Lansoprazole DME0006 XEOTICID XEO00052 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00052 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00052 DESCRIPT Lansoprazole induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00052 GENEFORM Protein DME0006 XEOTICID XEO00052 MOACRIVE Induction DME0006 XEOTICID XEO00053 XEO_NAME Leflunomide DME0006 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00053 GENEFORM mRNA DME0006 XEOTICID XEO00053 MOACRIVE Induction DME0006 XEOTICID XEO00057 XEO_NAME Mebendazole DME0006 XEOTICID XEO00057 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00057 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00057 DESCRIPT Mebendazole induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00057 GENEFORM Protein DME0006 XEOTICID XEO00057 MOACRIVE Induction DME0006 XEOTICID XEO00069 XEO_NAME Omeprazole DME0006 XEOTICID XEO00069 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00069 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00069 DESCRIPT Omeprazole up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00069 GENEFORM mRNA DME0006 XEOTICID XEO00069 MOACRIVE Induction DME0006 XEOTICID XEO00070 XEO_NAME Esomeprazole DME0006 XEOTICID XEO00070 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00070 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00070 DESCRIPT Esomeprazole up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00070 GENEFORM mRNA DME0006 XEOTICID XEO00070 MOACRIVE Induction DME0006 XEOTICID XEO00086 XEO_NAME Troglitazone DME0006 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00086 GENEFORM mRNA DME0006 XEOTICID XEO00086 MOACRIVE Induction DME0006 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0006 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00088 DESCRIPT Dexamethasone inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00088 GENEFORM Protein DME0006 XEOTICID XEO00088 MOACRIVE Inhibition DME0006 XEOTICID XEO00090 XEO_NAME Estradiol DME0006 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00090 GENEFORM Protein DME0006 XEOTICID XEO00090 MOACRIVE Inhibition DME0006 XEOTICID XEO00096 XEO_NAME Ampicillin DME0006 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00096 GENEFORM mRNA DME0006 XEOTICID XEO00096 MOACRIVE Inhibition DME0006 XEOTICID XEO00102 XEO_NAME Azacitidine DME0006 XEOTICID XEO00102 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00102 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00102 DESCRIPT Azacitidine up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00102 GENEFORM mRNA DME0006 XEOTICID XEO00102 MOACRIVE Induction DME0006 XEOTICID XEO00105 XEO_NAME Dihydroergotamine DME0006 XEOTICID XEO00105 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00105 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00105 DESCRIPT Dihydroergotamine induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00105 GENEFORM Protein DME0006 XEOTICID XEO00105 MOACRIVE Induction DME0006 XEOTICID XEO00115 XEO_NAME Dronabinol DME0006 XEOTICID XEO00115 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00115 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00115 DESCRIPT Dronabinol inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00115 GENEFORM mRNA DME0006 XEOTICID XEO00115 MOACRIVE Inhibition DME0006 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0006 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00117 GENEFORM mRNA DME0006 XEOTICID XEO00117 MOACRIVE Induction DME0006 XEOTICID XEO00121 XEO_NAME Etoposide DME0006 XEOTICID XEO00121 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00121 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00121 DESCRIPT Etoposide induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00121 GENEFORM Protein DME0006 XEOTICID XEO00121 MOACRIVE Induction DME0006 XEOTICID XEO00123 XEO_NAME Permethrin DME0006 XEOTICID XEO00123 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00123 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00123 DESCRIPT Permethrin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00123 GENEFORM mRNA DME0006 XEOTICID XEO00123 MOACRIVE Induction DME0006 XEOTICID XEO00132 XEO_NAME Cidofovir DME0006 XEOTICID XEO00132 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00132 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00132 DESCRIPT Cidofovir inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00132 GENEFORM mRNA DME0006 XEOTICID XEO00132 MOACRIVE Inhibition DME0006 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0006 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00140 DESCRIPT Zoledronic acid up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00140 GENEFORM mRNA DME0006 XEOTICID XEO00140 MOACRIVE Induction DME0006 XEOTICID XEO00147 XEO_NAME Fulvestrant DME0006 XEOTICID XEO00147 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00147 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00147 DESCRIPT Fulvestrant up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00147 GENEFORM mRNA DME0006 XEOTICID XEO00147 MOACRIVE Induction DME0006 XEOTICID XEO00160 XEO_NAME Ritonavir DME0006 XEOTICID XEO00160 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00160 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00160 DESCRIPT Ritonavir up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00160 GENEFORM mRNA DME0006 XEOTICID XEO00160 MOACRIVE Induction DME0006 XEOTICID XEO00163 XEO_NAME Mycophenolic acid DME0006 XEOTICID XEO00163 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00163 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00163 DESCRIPT Mycophenolic acid induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00163 GENEFORM Protein DME0006 XEOTICID XEO00163 MOACRIVE Induction DME0006 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0006 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00166 GENEFORM mRNA DME0006 XEOTICID XEO00166 MOACRIVE Inhibition DME0006 XEOTICID XEO00168 XEO_NAME Decitabine DME0006 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00168 DESCRIPT Decitabine up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00168 GENEFORM mRNA DME0006 XEOTICID XEO00168 MOACRIVE Induction DME0006 XEOTICID XEO00173 XEO_NAME Cannabidiol DME0006 XEOTICID XEO00173 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00173 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00173 DESCRIPT Cannabidiol inhibits the drug-metabolizing activity of DME CYP1A1 (Ki = 0.15 microM) DME0006 XEOTICID XEO00173 GENEFORM Protein DME0006 XEOTICID XEO00173 MOACRIVE Inhibition DME0006 XEOTICID XEO00177 XEO_NAME Sulindac DME0006 XEOTICID XEO00177 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00177 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00177 DESCRIPT Sulindac induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00177 GENEFORM Protein DME0006 XEOTICID XEO00177 MOACRIVE Induction DME0006 XEOTICID XEO00184 XEO_NAME Calcitriol DME0006 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00184 GENEFORM mRNA DME0006 XEOTICID XEO00184 MOACRIVE Induction DME0006 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0006 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00217 GENEFORM mRNA DME0006 XEOTICID XEO00217 MOACRIVE Inhibition DME0006 XEOTICID XEO00223 XEO_NAME Rifampin DME0006 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00223 DESCRIPT Rifampin induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00223 GENEFORM Protein DME0006 XEOTICID XEO00223 MOACRIVE Induction DME0006 XEOTICID XEO00232 XEO_NAME Phenytoin DME0006 XEOTICID XEO00232 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00232 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00232 DESCRIPT Phenytoin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00232 GENEFORM mRNA DME0006 XEOTICID XEO00232 MOACRIVE Induction DME0006 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0006 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00241 GENEFORM mRNA DME0006 XEOTICID XEO00241 MOACRIVE Inhibition DME0006 XEOTICID XEO00245 XEO_NAME Felodipine DME0006 XEOTICID XEO00245 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00245 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00245 DESCRIPT Felodipine up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00245 GENEFORM mRNA DME0006 XEOTICID XEO00245 MOACRIVE Induction DME0006 XEOTICID XEO00250 XEO_NAME Itraconazole DME0006 XEOTICID XEO00250 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00250 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00250 DESCRIPT Itraconazole inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00250 GENEFORM Protein DME0006 XEOTICID XEO00250 MOACRIVE Inhibition DME0006 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0006 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00251 GENEFORM Protein DME0006 XEOTICID XEO00251 MOACRIVE Inhibition DME0006 XEOTICID XEO00253 XEO_NAME Tretinoin DME0006 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00253 GENEFORM mRNA DME0006 XEOTICID XEO00253 MOACRIVE Inhibition DME0006 XEOTICID XEO00258 XEO_NAME Primaquine DME0006 XEOTICID XEO00258 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00258 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00258 DESCRIPT Primaquine up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00258 GENEFORM mRNA DME0006 XEOTICID XEO00258 MOACRIVE Induction DME0006 XEOTICID XEO00267 XEO_NAME Ethinyl estradiol DME0006 XEOTICID XEO00267 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00267 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00267 DESCRIPT Ethinyl estradiol inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00267 GENEFORM mRNA DME0006 XEOTICID XEO00267 MOACRIVE Inhibition DME0006 XEOTICID XEO00284 XEO_NAME Clobetasol propionate DME0006 XEOTICID XEO00284 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00284 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00284 DESCRIPT Clobetasol propionate up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00284 GENEFORM mRNA DME0006 XEOTICID XEO00284 MOACRIVE Induction DME0006 XEOTICID XEO00310 XEO_NAME Nelfinavir mesylate DME0006 XEOTICID XEO00310 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00310 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00310 DESCRIPT Nelfinavir mesylate up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00310 GENEFORM mRNA DME0006 XEOTICID XEO00310 MOACRIVE Induction DME0006 XEOTICID XEO00311 XEO_NAME Nicardipine hydrochloride DME0006 XEOTICID XEO00311 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00311 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00311 DESCRIPT Nicardipine hydrochloride up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00311 GENEFORM mRNA DME0006 XEOTICID XEO00311 MOACRIVE Induction DME0006 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0006 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00312 GENEFORM Protein DME0006 XEOTICID XEO00312 MOACRIVE Induction DME0006 XEOTICID XEO00334 XEO_NAME Cisplatin DME0006 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00334 GENEFORM mRNA DME0006 XEOTICID XEO00334 MOACRIVE Inhibition DME0006 XEOTICID XEO00338 XEO_NAME Amlodipine DME0006 XEOTICID XEO00338 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00338 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00338 DESCRIPT Amlodipine inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00338 GENEFORM Protein DME0006 XEOTICID XEO00338 MOACRIVE Inhibition DME0006 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0006 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00339 GENEFORM mRNA DME0006 XEOTICID XEO00339 MOACRIVE Induction DME0006 XEOTICID XEO00352 XEO_NAME Diclofenac DME0006 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00352 DESCRIPT Diclofenac induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00352 GENEFORM Protein DME0006 XEOTICID XEO00352 MOACRIVE Induction DME0006 XEOTICID XEO00364 XEO_NAME Losartan DME0006 XEOTICID XEO00364 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00364 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00364 DESCRIPT Losartan up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00364 GENEFORM mRNA DME0006 XEOTICID XEO00364 MOACRIVE Induction DME0006 XEOTICID XEO00378 XEO_NAME Rabeprazole DME0006 XEOTICID XEO00378 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00378 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00378 DESCRIPT Rabeprazole induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00378 GENEFORM Protein DME0006 XEOTICID XEO00378 MOACRIVE Induction DME0006 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0006 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00380 DESCRIPT Rosiglitazone induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00380 GENEFORM Protein DME0006 XEOTICID XEO00380 MOACRIVE Induction DME0006 XEOTICID XEO00382 XEO_NAME Sunitinib DME0006 XEOTICID XEO00382 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00382 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00382 DESCRIPT Sunitinib induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00382 GENEFORM Protein DME0006 XEOTICID XEO00382 MOACRIVE Induction DME0006 XEOTICID XEO00383 XEO_NAME Tamoxifen DME0006 XEOTICID XEO00383 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00383 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00383 DESCRIPT Tamoxifen up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00383 GENEFORM mRNA DME0006 XEOTICID XEO00383 MOACRIVE Induction DME0006 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0006 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00388 GENEFORM mRNA DME0006 XEOTICID XEO00388 MOACRIVE Induction DME0006 XEOTICID XEO00405 XEO_NAME Niclosamide DME0006 XEOTICID XEO00405 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00405 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00405 DESCRIPT Niclosamide up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00405 GENEFORM mRNA DME0006 XEOTICID XEO00405 MOACRIVE Induction DME0006 XEOTICID XEO00409 XEO_NAME Semaxanib DME0006 XEOTICID XEO00409 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00409 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00409 DESCRIPT Semaxanib up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00409 GENEFORM mRNA DME0006 XEOTICID XEO00409 MOACRIVE Induction DME0006 XEOTICID XEO00411 XEO_NAME Avobenzone DME0006 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00411 GENEFORM mRNA DME0006 XEOTICID XEO00411 MOACRIVE Induction DME0006 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0006 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00430 DESCRIPT Hydroquinone up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00430 GENEFORM mRNA DME0006 XEOTICID XEO00430 MOACRIVE Induction DME0006 XEOTICID XEO00435 XEO_NAME Urethane DME0006 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00435 GENEFORM mRNA DME0006 XEOTICID XEO00435 MOACRIVE Inhibition DME0006 XEOTICID XEO00438 XEO_NAME Benidipine DME0006 XEOTICID XEO00438 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00438 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00438 DESCRIPT Benidipine inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00438 GENEFORM Protein DME0006 XEOTICID XEO00438 MOACRIVE Inhibition DME0006 XEOTICID XEO00439 XEO_NAME Daidzein DME0006 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00439 GENEFORM Protein DME0006 XEOTICID XEO00439 MOACRIVE Inhibition DME0006 XEOTICID XEO00448 XEO_NAME Stevioside DME0006 XEOTICID XEO00448 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00448 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00448 DESCRIPT Stevioside induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00448 GENEFORM Protein DME0006 XEOTICID XEO00448 MOACRIVE Induction DME0006 XEOTICID XEO00463 XEO_NAME Berberine DME0006 XEOTICID XEO00463 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00463 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00463 DESCRIPT Berberine inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00463 GENEFORM Protein DME0006 XEOTICID XEO00463 MOACRIVE Inhibition DME0006 XEOTICID XEO00486 XEO_NAME Tanshinone DME0006 XEOTICID XEO00486 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00486 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00486 DESCRIPT Tanshinone up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00486 GENEFORM mRNA DME0006 XEOTICID XEO00486 MOACRIVE Induction DME0006 XEOTICID XEO00487 XEO_NAME Thymol DME0006 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00487 DESCRIPT Thymol up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00487 GENEFORM mRNA DME0006 XEOTICID XEO00487 MOACRIVE Induction DME0006 XEOTICID XEO00489 XEO_NAME Amodiaquine DME0006 XEOTICID XEO00489 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00489 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00489 DESCRIPT Amodiaquine induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00489 GENEFORM Protein DME0006 XEOTICID XEO00489 MOACRIVE Induction DME0006 XEOTICID XEO00493 XEO_NAME Bezafibrate DME0006 XEOTICID XEO00493 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00493 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00493 DESCRIPT Bezafibrate up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00493 GENEFORM mRNA DME0006 XEOTICID XEO00493 MOACRIVE Induction DME0006 XEOTICID XEO00505 XEO_NAME Melatonin DME0006 XEOTICID XEO00505 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00505 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00505 DESCRIPT Melatonin inhibits the drug-metabolizing activity of DME CYP1A1 (Ki = 59 microM) DME0006 XEOTICID XEO00505 GENEFORM Protein DME0006 XEOTICID XEO00505 MOACRIVE Inhibition DME0006 XEOTICID XEO00509 XEO_NAME Tranilast DME0006 XEOTICID XEO00509 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00509 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00509 DESCRIPT Tranilast up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00509 GENEFORM mRNA DME0006 XEOTICID XEO00509 MOACRIVE Induction DME0006 XEOTICID XEO00531 XEO_NAME Cantharidin DME0006 XEOTICID XEO00531 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00531 XEO_CLAS Drug Marketed but Withdrawn from Market DME0006 XEOTICID XEO00531 DESCRIPT Cantharidin induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00531 GENEFORM Protein DME0006 XEOTICID XEO00531 MOACRIVE Induction DME0006 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0006 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00536 GENEFORM mRNA DME0006 XEOTICID XEO00536 MOACRIVE Induction DME0006 XEOTICID XEO00537 XEO_NAME Luteolin DME0006 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 1.249 microM) DME0006 XEOTICID XEO00537 GENEFORM Protein DME0006 XEOTICID XEO00537 MOACRIVE Inhibition DME0006 XEOTICID XEO00538 XEO_NAME Quercetin DME0006 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 1.191 microM) DME0006 XEOTICID XEO00538 GENEFORM Protein DME0006 XEOTICID XEO00538 MOACRIVE Inhibition DME0006 XEOTICID XEO00545 XEO_NAME Lucanthone DME0006 XEOTICID XEO00545 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00545 XEO_CLAS Drug in Phase 2 Clinical Trial DME0006 XEOTICID XEO00545 DESCRIPT Lucanthone up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00545 GENEFORM mRNA DME0006 XEOTICID XEO00545 MOACRIVE Induction DME0006 XEOTICID XEO00548 XEO_NAME Domperidone DME0006 XEOTICID XEO00548 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00548 XEO_CLAS Drug in Phase 3 Clinical Trial DME0006 XEOTICID XEO00548 DESCRIPT Domperidone up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00548 GENEFORM mRNA DME0006 XEOTICID XEO00548 MOACRIVE Induction DME0006 XEOTICID XEO00554 XEO_NAME Fingolimod hydrochloride DME0006 XEOTICID XEO00554 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00554 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO00554 DESCRIPT Fingolimod hydrochloride inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00554 GENEFORM mRNA DME0006 XEOTICID XEO00554 MOACRIVE Inhibition DME0006 XEOTICID XEO00557 XEO_NAME Genistein DME0006 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0006 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00557 GENEFORM Protein DME0006 XEOTICID XEO00557 MOACRIVE Inhibition DME0006 XEOTICID XEO00568 XEO_NAME Resveratrol DME0006 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0006 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 34 microM) DME0006 XEOTICID XEO00568 GENEFORM Protein DME0006 XEOTICID XEO00568 MOACRIVE Inhibition DME0006 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0006 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00571 GENEFORM mRNA DME0006 XEOTICID XEO00571 MOACRIVE Induction DME0006 XEOTICID XEO00573 XEO_NAME Naringenin DME0006 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 15.167 microM) DME0006 XEOTICID XEO00573 GENEFORM Protein DME0006 XEOTICID XEO00573 MOACRIVE Inhibition DME0006 XEOTICID XEO00574 XEO_NAME Phenanthrene DME0006 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO00574 DESCRIPT Phenanthrene up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00574 GENEFORM mRNA DME0006 XEOTICID XEO00574 MOACRIVE Induction DME0006 XEOTICID XEO00579 XEO_NAME SGX301 DME0006 XEOTICID XEO00579 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00579 XEO_CLAS Drug in Phase 3 Clinical Trial DME0006 XEOTICID XEO00579 DESCRIPT SGX301 inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00579 GENEFORM Protein DME0006 XEOTICID XEO00579 MOACRIVE Inhibition DME0006 XEOTICID XEO00581 XEO_NAME MS-275 DME0006 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0006 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00581 GENEFORM mRNA DME0006 XEOTICID XEO00581 MOACRIVE Induction DME0006 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0006 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0006 XEOTICID XEO00582 DESCRIPT Diethyltoluamide up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00582 GENEFORM mRNA DME0006 XEOTICID XEO00582 MOACRIVE Induction DME0006 XEOTICID XEO00596 XEO_NAME Phenethyl isothiocyanate DME0006 XEOTICID XEO00596 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00596 XEO_CLAS Drug in Phase 2 Clinical Trial DME0006 XEOTICID XEO00596 DESCRIPT Phenethyl isothiocyanate induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00596 GENEFORM Protein DME0006 XEOTICID XEO00596 MOACRIVE Induction DME0006 XEOTICID XEO00598 XEO_NAME Carbendazim DME0006 XEOTICID XEO00598 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00598 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO00598 DESCRIPT Carbendazim induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00598 GENEFORM Protein DME0006 XEOTICID XEO00598 MOACRIVE Induction DME0006 XEOTICID XEO00605 XEO_NAME Oltipraz DME0006 XEOTICID XEO00605 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00605 XEO_CLAS Drug in Phase 3 Clinical Trial DME0006 XEOTICID XEO00605 DESCRIPT Oltipraz induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00605 GENEFORM Protein DME0006 XEOTICID XEO00605 MOACRIVE Induction DME0006 XEOTICID XEO00609 XEO_NAME MeIQx DME0006 XEOTICID XEO00609 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00609 XEO_CLAS Drug in Phase 2 Clinical Trial DME0006 XEOTICID XEO00609 DESCRIPT MeIQx up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00609 GENEFORM mRNA DME0006 XEOTICID XEO00609 MOACRIVE Induction DME0006 XEOTICID XEO00610 XEO_NAME Afimoxifene DME0006 XEOTICID XEO00610 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00610 XEO_CLAS Drug in Phase 3 Clinical Trial DME0006 XEOTICID XEO00610 DESCRIPT Afimoxifene up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00610 GENEFORM mRNA DME0006 XEOTICID XEO00610 MOACRIVE Induction DME0006 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME0006 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME0006 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00613 GENEFORM mRNA DME0006 XEOTICID XEO00613 MOACRIVE Inhibition DME0006 XEOTICID XEO00619 XEO_NAME Delphinidin DME0006 XEOTICID XEO00619 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00619 XEO_CLAS Drug in Phase 2 Clinical Trial DME0006 XEOTICID XEO00619 DESCRIPT Delphinidin inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00619 GENEFORM Protein DME0006 XEOTICID XEO00619 MOACRIVE Inhibition DME0006 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0006 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00632 GENEFORM Protein DME0006 XEOTICID XEO00632 MOACRIVE Inhibition DME0006 XEOTICID XEO00637 XEO_NAME HK-001 DME0006 XEOTICID XEO00637 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00637 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO00637 DESCRIPT HK-001 up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00637 GENEFORM mRNA DME0006 XEOTICID XEO00637 MOACRIVE Induction DME0006 XEOTICID XEO00644 XEO_NAME Isoquercitrin DME0006 XEOTICID XEO00644 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00644 XEO_CLAS Drug in Phase 2 Clinical Trial DME0006 XEOTICID XEO00644 DESCRIPT Isoquercitrin inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00644 GENEFORM Protein DME0006 XEOTICID XEO00644 MOACRIVE Inhibition DME0006 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME0006 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00646 GENEFORM Protein DME0006 XEOTICID XEO00646 MOACRIVE Inhibition DME0006 XEOTICID XEO00647 XEO_NAME Acteoside DME0006 XEOTICID XEO00647 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00647 XEO_CLAS Drug in Phase 2 Clinical Trial DME0006 XEOTICID XEO00647 DESCRIPT Acteoside up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00647 GENEFORM mRNA DME0006 XEOTICID XEO00647 MOACRIVE Induction DME0006 XEOTICID XEO00656 XEO_NAME Sulindac sulfide DME0006 XEOTICID XEO00656 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00656 XEO_CLAS Drug in Phase 2 Clinical Trial DME0006 XEOTICID XEO00656 DESCRIPT Sulindac sulfide up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00656 GENEFORM mRNA DME0006 XEOTICID XEO00656 MOACRIVE Induction DME0006 XEOTICID XEO00662 XEO_NAME R-76713 DME0006 XEOTICID XEO00662 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00662 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO00662 DESCRIPT R-76713 up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00662 GENEFORM mRNA DME0006 XEOTICID XEO00662 MOACRIVE Induction DME0006 XEOTICID XEO00671 XEO_NAME Endoxifen DME0006 XEOTICID XEO00671 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00671 XEO_CLAS Drug in Phase 3 Clinical Trial DME0006 XEOTICID XEO00671 DESCRIPT Endoxifen up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00671 GENEFORM mRNA DME0006 XEOTICID XEO00671 MOACRIVE Induction DME0006 XEOTICID XEO00683 XEO_NAME Curcumin DME0006 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0006 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00683 GENEFORM Protein DME0006 XEOTICID XEO00683 MOACRIVE Inhibition DME0006 XEOTICID XEO00685 XEO_NAME Aminoflavone DME0006 XEOTICID XEO00685 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00685 XEO_CLAS Drug in Phase 2 Clinical Trial DME0006 XEOTICID XEO00685 DESCRIPT Aminoflavone induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00685 GENEFORM Protein DME0006 XEOTICID XEO00685 MOACRIVE Induction DME0006 XEOTICID XEO00692 XEO_NAME Emodin DME0006 XEOTICID XEO00692 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00692 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO00692 DESCRIPT Emodin inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 12.25 microM) DME0006 XEOTICID XEO00692 GENEFORM Protein DME0006 XEOTICID XEO00692 MOACRIVE Inhibition DME0006 XEOTICID XEO00693 XEO_NAME Harmaline DME0006 XEOTICID XEO00693 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00693 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO00693 DESCRIPT Harmaline inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00693 GENEFORM Protein DME0006 XEOTICID XEO00693 MOACRIVE Inhibition DME0006 XEOTICID XEO00701 XEO_NAME Beta-carboline DME0006 XEOTICID XEO00701 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00701 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO00701 DESCRIPT Beta-carboline up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00701 GENEFORM mRNA DME0006 XEOTICID XEO00701 MOACRIVE Induction DME0006 XEOTICID XEO00702 XEO_NAME Baicalin DME0006 XEOTICID XEO00702 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00702 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO00702 DESCRIPT Baicalin induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00702 GENEFORM Protein DME0006 XEOTICID XEO00702 MOACRIVE Induction DME0006 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0006 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00723 GENEFORM mRNA DME0006 XEOTICID XEO00723 MOACRIVE Inhibition DME0006 XEOTICID XEO00730 XEO_NAME Ferulic acid DME0006 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00730 GENEFORM Protein DME0006 XEOTICID XEO00730 MOACRIVE Inhibition DME0006 XEOTICID XEO00732 XEO_NAME Harmine DME0006 XEOTICID XEO00732 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00732 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO00732 DESCRIPT Harmine inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00732 GENEFORM Protein DME0006 XEOTICID XEO00732 MOACRIVE Inhibition DME0006 XEOTICID XEO00738 XEO_NAME Flavanone DME0006 XEOTICID XEO00738 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00738 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO00738 DESCRIPT Flavanone inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00738 GENEFORM Protein DME0006 XEOTICID XEO00738 MOACRIVE Inhibition DME0006 XEOTICID XEO00743 XEO_NAME Medroxyprogesterone acetate DME0006 XEOTICID XEO00743 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00743 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00743 DESCRIPT Medroxyprogesterone acetate induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00743 GENEFORM Protein DME0006 XEOTICID XEO00743 MOACRIVE Induction DME0006 XEOTICID XEO00755 XEO_NAME Coal tar DME0006 XEOTICID XEO00755 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00755 XEO_CLAS Natural Mixture DME0006 XEOTICID XEO00755 DESCRIPT Coal tar induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00755 GENEFORM Protein DME0006 XEOTICID XEO00755 MOACRIVE Induction DME0006 XEOTICID XEO00758 XEO_NAME Grape seed proanthocyanidins DME0006 XEOTICID XEO00758 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00758 XEO_CLAS Plant Extract DME0006 XEOTICID XEO00758 DESCRIPT Grape seed proanthocyanidins inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00758 GENEFORM mRNA DME0006 XEOTICID XEO00758 MOACRIVE Inhibition DME0006 XEOTICID XEO00764 XEO_NAME Naphthalene DME0006 XEOTICID XEO00764 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0006 XEOTICID XEO00764 XEO_CLAS Chemical Compound DME0006 XEOTICID XEO00764 DESCRIPT Naphthalene induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00764 GENEFORM Protein DME0006 XEOTICID XEO00764 MOACRIVE Induction DME0006 XEOTICID XEO00770 XEO_NAME AG-1879 DME0006 XEOTICID XEO00770 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00770 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO00770 DESCRIPT AG-1879 induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00770 GENEFORM Protein DME0006 XEOTICID XEO00770 MOACRIVE Induction DME0006 XEOTICID XEO00776 XEO_NAME Polychlorinated biphenyls DME0006 XEOTICID XEO00776 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00776 XEO_CLAS Carcinogen DME0006 XEOTICID XEO00776 DESCRIPT Polychlorinated biphenyls up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00776 GENEFORM mRNA DME0006 XEOTICID XEO00776 MOACRIVE Induction DME0006 XEOTICID XEO00777 XEO_NAME Skatole DME0006 XEOTICID XEO00777 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00777 XEO_CLAS Natural Product DME0006 XEOTICID XEO00777 DESCRIPT Skatole up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00777 GENEFORM mRNA DME0006 XEOTICID XEO00777 MOACRIVE Induction DME0006 XEOTICID XEO00791 XEO_NAME Pyridine N-oxide DME0006 XEOTICID XEO00791 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0006 XEOTICID XEO00791 XEO_CLAS Chemical Compound DME0006 XEOTICID XEO00791 DESCRIPT Pyridine N-oxide up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00791 GENEFORM mRNA DME0006 XEOTICID XEO00791 MOACRIVE Induction DME0006 XEOTICID XEO00794 XEO_NAME 6-nitrochrysene DME0006 XEOTICID XEO00794 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00794 XEO_CLAS Environmental Pollutant DME0006 XEOTICID XEO00794 DESCRIPT 6-nitrochrysene up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00794 GENEFORM mRNA DME0006 XEOTICID XEO00794 MOACRIVE Induction DME0006 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0006 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0006 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00806 GENEFORM mRNA DME0006 XEOTICID XEO00806 MOACRIVE Induction DME0006 XEOTICID XEO00808 XEO_NAME Puromycin DME0006 XEOTICID XEO00808 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00808 XEO_CLAS Mycotoxin DME0006 XEOTICID XEO00808 DESCRIPT Puromycin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00808 GENEFORM mRNA DME0006 XEOTICID XEO00808 MOACRIVE Induction DME0006 XEOTICID XEO00810 XEO_NAME Steviol DME0006 XEOTICID XEO00810 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00810 XEO_CLAS Natural Product DME0006 XEOTICID XEO00810 DESCRIPT Steviol induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00810 GENEFORM Protein DME0006 XEOTICID XEO00810 MOACRIVE Induction DME0006 XEOTICID XEO00816 XEO_NAME Aflatoxin M1 DME0006 XEOTICID XEO00816 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00816 XEO_CLAS Carcinogen DME0006 XEOTICID XEO00816 DESCRIPT Aflatoxin M1 up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00816 GENEFORM mRNA DME0006 XEOTICID XEO00816 MOACRIVE Induction DME0006 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0006 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0006 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00821 GENEFORM mRNA DME0006 XEOTICID XEO00821 MOACRIVE Induction DME0006 XEOTICID XEO00826 XEO_NAME Mangifera indica extract DME0006 XEOTICID XEO00826 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00826 XEO_CLAS Plant Extract DME0006 XEOTICID XEO00826 DESCRIPT Mangifera indica extract up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00826 GENEFORM mRNA DME0006 XEOTICID XEO00826 MOACRIVE Induction DME0006 XEOTICID XEO00835 XEO_NAME Thiazolidinedione DME0006 XEOTICID XEO00835 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00835 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00835 DESCRIPT Thiazolidinedione inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00835 GENEFORM mRNA DME0006 XEOTICID XEO00835 MOACRIVE Inhibition DME0006 XEOTICID XEO00850 XEO_NAME Pyridine DME0006 XEOTICID XEO00850 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00850 XEO_CLAS Health Hazard/Toxicant DME0006 XEOTICID XEO00850 DESCRIPT Pyridine up-regulates the expression of DME CYP1A1 and leads to increasing the drug-metabolizing activity of this enzyme DME0006 XEOTICID XEO00850 GENEFORM Protein DME0006 XEOTICID XEO00850 MOACRIVE Induction DME0006 XEOTICID XEO00851 XEO_NAME Iprodione DME0006 XEOTICID XEO00851 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00851 XEO_CLAS Health Hazard/Toxicant DME0006 XEOTICID XEO00851 DESCRIPT Iprodione up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00851 GENEFORM mRNA DME0006 XEOTICID XEO00851 MOACRIVE Induction DME0006 XEOTICID XEO00858 XEO_NAME Flavonoids DME0006 XEOTICID XEO00858 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00858 XEO_CLAS Natural Mixture DME0006 XEOTICID XEO00858 DESCRIPT Flavonoids induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00858 GENEFORM Protein DME0006 XEOTICID XEO00858 MOACRIVE Induction DME0006 XEOTICID XEO00865 XEO_NAME Sanguinarine DME0006 XEOTICID XEO00865 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00865 XEO_CLAS Natural Product DME0006 XEOTICID XEO00865 DESCRIPT Sanguinarine inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO00865 GENEFORM mRNA DME0006 XEOTICID XEO00865 MOACRIVE Inhibition DME0006 XEOTICID XEO00868 XEO_NAME 1,2-naphthoquinone DME0006 XEOTICID XEO00868 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00868 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO00868 DESCRIPT 1,2-naphthoquinone up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00868 GENEFORM mRNA DME0006 XEOTICID XEO00868 MOACRIVE Induction DME0006 XEOTICID XEO00877 XEO_NAME Bilirubin DME0006 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00877 XEO_CLAS Natural Product DME0006 XEOTICID XEO00877 DESCRIPT Bilirubin induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00877 GENEFORM Protein DME0006 XEOTICID XEO00877 MOACRIVE Induction DME0006 XEOTICID XEO00878 XEO_NAME Chrysin DME0006 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00878 XEO_CLAS Natural Product DME0006 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 0.153 microM) DME0006 XEOTICID XEO00878 GENEFORM Protein DME0006 XEOTICID XEO00878 MOACRIVE Inhibition DME0006 XEOTICID XEO00885 XEO_NAME Eugenol DME0006 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00885 GENEFORM Protein DME0006 XEOTICID XEO00885 MOACRIVE Inhibition DME0006 XEOTICID XEO00889 XEO_NAME Piperonyl butoxide DME0006 XEOTICID XEO00889 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO00889 XEO_CLAS Pesticide/Insecticide DME0006 XEOTICID XEO00889 DESCRIPT Piperonyl butoxide induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00889 GENEFORM Protein DME0006 XEOTICID XEO00889 MOACRIVE Induction DME0006 XEOTICID XEO00890 XEO_NAME 2-methyl-4-isothiazolin-3-one DME0006 XEOTICID XEO00890 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00890 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO00890 DESCRIPT 2-methyl-4-isothiazolin-3-one up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00890 GENEFORM mRNA DME0006 XEOTICID XEO00890 MOACRIVE Induction DME0006 XEOTICID XEO00895 XEO_NAME 2-amino-3-methylimidazo(4,5-f)quinoline DME0006 XEOTICID XEO00895 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00895 XEO_CLAS Carcinogen DME0006 XEOTICID XEO00895 DESCRIPT 2-amino-3-methylimidazo(4,5-f)quinoline up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00895 GENEFORM mRNA DME0006 XEOTICID XEO00895 MOACRIVE Induction DME0006 XEOTICID XEO00896 XEO_NAME 2-naphthylamine DME0006 XEOTICID XEO00896 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00896 XEO_CLAS Carcinogen DME0006 XEOTICID XEO00896 DESCRIPT 2-naphthylamine up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00896 GENEFORM mRNA DME0006 XEOTICID XEO00896 MOACRIVE Induction DME0006 XEOTICID XEO00897 XEO_NAME Benz(a)anthracenes DME0006 XEOTICID XEO00897 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00897 XEO_CLAS Carcinogen DME0006 XEOTICID XEO00897 DESCRIPT Benz(a)anthracenes up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00897 GENEFORM mRNA DME0006 XEOTICID XEO00897 MOACRIVE Induction DME0006 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0006 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0006 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00898 GENEFORM Protein DME0006 XEOTICID XEO00898 MOACRIVE Inhibition DME0006 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0006 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0006 XEOTICID XEO00899 DESCRIPT Methylcholanthrene inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00899 GENEFORM Protein DME0006 XEOTICID XEO00899 MOACRIVE Inhibition DME0006 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0006 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0006 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00905 GENEFORM mRNA DME0006 XEOTICID XEO00905 MOACRIVE Induction DME0006 XEOTICID XEO00909 XEO_NAME Cloflucarban DME0006 XEOTICID XEO00909 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00909 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO00909 DESCRIPT Cloflucarban induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00909 GENEFORM Protein DME0006 XEOTICID XEO00909 MOACRIVE Induction DME0006 XEOTICID XEO00913 XEO_NAME 6-nitrobenzo(a)pyrene DME0006 XEOTICID XEO00913 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00913 XEO_CLAS Health Hazard/Toxicant DME0006 XEOTICID XEO00913 DESCRIPT 6-nitrobenzo(a)pyrene up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00913 GENEFORM mRNA DME0006 XEOTICID XEO00913 MOACRIVE Induction DME0006 XEOTICID XEO00916 XEO_NAME Coal ash DME0006 XEOTICID XEO00916 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00916 XEO_CLAS Natural Mixture DME0006 XEOTICID XEO00916 DESCRIPT Coal ash up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00916 GENEFORM mRNA DME0006 XEOTICID XEO00916 MOACRIVE Induction DME0006 XEOTICID XEO00917 XEO_NAME Polychlorinated dibenzodioxin DME0006 XEOTICID XEO00917 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00917 XEO_CLAS Environmental Pollutant DME0006 XEOTICID XEO00917 DESCRIPT Polychlorinated dibenzodioxin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00917 GENEFORM mRNA DME0006 XEOTICID XEO00917 MOACRIVE Induction DME0006 XEOTICID XEO00919 XEO_NAME Particulate matter DME0006 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0006 XEOTICID XEO00919 DESCRIPT Particulate matter up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00919 GENEFORM mRNA DME0006 XEOTICID XEO00919 MOACRIVE Induction DME0006 XEOTICID XEO00925 XEO_NAME BDE-99 DME0006 XEOTICID XEO00925 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00925 XEO_CLAS Natural Product DME0006 XEOTICID XEO00925 DESCRIPT BDE-99 up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00925 GENEFORM mRNA DME0006 XEOTICID XEO00925 MOACRIVE Induction DME0006 XEOTICID XEO00933 XEO_NAME Indigo carmine DME0006 XEOTICID XEO00933 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO00933 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO00933 DESCRIPT Indigo carmine induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00933 GENEFORM Protein DME0006 XEOTICID XEO00933 MOACRIVE Induction DME0006 XEOTICID XEO00935 XEO_NAME Aurofusarin DME0006 XEOTICID XEO00935 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00935 XEO_CLAS Mycotoxin DME0006 XEOTICID XEO00935 DESCRIPT Aurofusarin induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00935 GENEFORM Protein DME0006 XEOTICID XEO00935 MOACRIVE Induction DME0006 XEOTICID XEO00938 XEO_NAME Azoxystrobin DME0006 XEOTICID XEO00938 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO00938 XEO_CLAS Fungicide DME0006 XEOTICID XEO00938 DESCRIPT Azoxystrobin induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00938 GENEFORM Protein DME0006 XEOTICID XEO00938 MOACRIVE Induction DME0006 XEOTICID XEO00942 XEO_NAME Cyproconazole DME0006 XEOTICID XEO00942 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO00942 XEO_CLAS Fungicide DME0006 XEOTICID XEO00942 DESCRIPT Cyproconazole up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00942 GENEFORM mRNA DME0006 XEOTICID XEO00942 MOACRIVE Induction DME0006 XEOTICID XEO00943 XEO_NAME Cyprodinil DME0006 XEOTICID XEO00943 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO00943 XEO_CLAS Fungicide DME0006 XEOTICID XEO00943 DESCRIPT Cyprodinil induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00943 GENEFORM Protein DME0006 XEOTICID XEO00943 MOACRIVE Induction DME0006 XEOTICID XEO00944 XEO_NAME Enilconazole DME0006 XEOTICID XEO00944 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO00944 XEO_CLAS Fungicide DME0006 XEOTICID XEO00944 DESCRIPT Enilconazole induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00944 GENEFORM Protein DME0006 XEOTICID XEO00944 MOACRIVE Induction DME0006 XEOTICID XEO00945 XEO_NAME Epoxiconazole DME0006 XEOTICID XEO00945 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO00945 XEO_CLAS Fungicide DME0006 XEOTICID XEO00945 DESCRIPT Epoxiconazole induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00945 GENEFORM Protein DME0006 XEOTICID XEO00945 MOACRIVE Induction DME0006 XEOTICID XEO00948 XEO_NAME Flusilazole DME0006 XEOTICID XEO00948 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO00948 XEO_CLAS Fungicide DME0006 XEOTICID XEO00948 DESCRIPT Flusilazole up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00948 GENEFORM mRNA DME0006 XEOTICID XEO00948 MOACRIVE Induction DME0006 XEOTICID XEO00951 XEO_NAME Hexachlorobenzene DME0006 XEOTICID XEO00951 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO00951 XEO_CLAS Fungicide DME0006 XEOTICID XEO00951 DESCRIPT Hexachlorobenzene up-regulates the expression of DME CYP1A1 and leads to increasing the drug-metabolizing activity of this enzyme DME0006 XEOTICID XEO00951 GENEFORM Protein DME0006 XEOTICID XEO00951 MOACRIVE Induction DME0006 XEOTICID XEO00956 XEO_NAME Propiconazole DME0006 XEOTICID XEO00956 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO00956 XEO_CLAS Fungicide DME0006 XEOTICID XEO00956 DESCRIPT Propiconazole up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00956 GENEFORM mRNA DME0006 XEOTICID XEO00956 MOACRIVE Induction DME0006 XEOTICID XEO00957 XEO_NAME Tebuconazole DME0006 XEOTICID XEO00957 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO00957 XEO_CLAS Fungicide DME0006 XEOTICID XEO00957 DESCRIPT Tebuconazole up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00957 GENEFORM mRNA DME0006 XEOTICID XEO00957 MOACRIVE Induction DME0006 XEOTICID XEO00973 XEO_NAME Diuron DME0006 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO00973 XEO_CLAS Herbicide DME0006 XEOTICID XEO00973 DESCRIPT Diuron induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00973 GENEFORM Protein DME0006 XEOTICID XEO00973 MOACRIVE Induction DME0006 XEOTICID XEO00982 XEO_NAME Monomethylarsonic acid DME0006 XEOTICID XEO00982 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO00982 XEO_CLAS Herbicide DME0006 XEOTICID XEO00982 DESCRIPT Monomethylarsonic acid up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00982 GENEFORM mRNA DME0006 XEOTICID XEO00982 MOACRIVE Induction DME0006 XEOTICID XEO00989 XEO_NAME 2-methylindole DME0006 XEOTICID XEO00989 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00989 XEO_CLAS Health Hazard/Toxicant DME0006 XEOTICID XEO00989 DESCRIPT 2-methylindole induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00989 GENEFORM Protein DME0006 XEOTICID XEO00989 MOACRIVE Induction DME0006 XEOTICID XEO00993 XEO_NAME Alizarin DME0006 XEOTICID XEO00993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00993 XEO_CLAS Natural Product DME0006 XEOTICID XEO00993 DESCRIPT Alizarin inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00993 GENEFORM Protein DME0006 XEOTICID XEO00993 MOACRIVE Inhibition DME0006 XEOTICID XEO00995 XEO_NAME Amphibole asbestos DME0006 XEOTICID XEO00995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO00995 XEO_CLAS Natural Mixture DME0006 XEOTICID XEO00995 DESCRIPT Amphibole asbestos inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00995 GENEFORM Protein DME0006 XEOTICID XEO00995 MOACRIVE Inhibition DME0006 XEOTICID XEO00997 XEO_NAME Bisphenol F DME0006 XEOTICID XEO00997 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00997 XEO_CLAS Environmental Pollutant DME0006 XEOTICID XEO00997 DESCRIPT Bisphenol F induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00997 GENEFORM Protein DME0006 XEOTICID XEO00997 MOACRIVE Induction DME0006 XEOTICID XEO00998 XEO_NAME Butylbenzyl phthalate DME0006 XEOTICID XEO00998 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00998 XEO_CLAS Health Hazard/Toxicant DME0006 XEOTICID XEO00998 DESCRIPT Butylbenzyl phthalate induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO00998 GENEFORM Protein DME0006 XEOTICID XEO00998 MOACRIVE Induction DME0006 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0006 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0006 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO00999 GENEFORM mRNA DME0006 XEOTICID XEO00999 MOACRIVE Induction DME0006 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0006 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0006 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01004 GENEFORM Protein DME0006 XEOTICID XEO01004 MOACRIVE Induction DME0006 XEOTICID XEO01009 XEO_NAME Glycidamide DME0006 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0006 XEOTICID XEO01009 DESCRIPT Glycidamide inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO01009 GENEFORM mRNA DME0006 XEOTICID XEO01009 MOACRIVE Inhibition DME0006 XEOTICID XEO01011 XEO_NAME Heptanal DME0006 XEOTICID XEO01011 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01011 XEO_CLAS Natural Product DME0006 XEOTICID XEO01011 DESCRIPT Heptanal up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01011 GENEFORM mRNA DME0006 XEOTICID XEO01011 MOACRIVE Induction DME0006 XEOTICID XEO01015 XEO_NAME Naphthenic acid DME0006 XEOTICID XEO01015 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01015 XEO_CLAS Environmental Pollutant DME0006 XEOTICID XEO01015 DESCRIPT Naphthenic acid up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01015 GENEFORM mRNA DME0006 XEOTICID XEO01015 MOACRIVE Induction DME0006 XEOTICID XEO01029 XEO_NAME Trinitrotoluene DME0006 XEOTICID XEO01029 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01029 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01029 DESCRIPT Trinitrotoluene up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01029 GENEFORM mRNA DME0006 XEOTICID XEO01029 MOACRIVE Induction DME0006 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0006 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0006 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01031 GENEFORM mRNA DME0006 XEOTICID XEO01031 MOACRIVE Induction DME0006 XEOTICID XEO01047 XEO_NAME Decamethrin DME0006 XEOTICID XEO01047 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO01047 XEO_CLAS Pesticide/Insecticide DME0006 XEOTICID XEO01047 DESCRIPT Decamethrin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01047 GENEFORM mRNA DME0006 XEOTICID XEO01047 MOACRIVE Induction DME0006 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0006 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0006 XEOTICID XEO01050 DESCRIPT Dicrotophos up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01050 GENEFORM mRNA DME0006 XEOTICID XEO01050 MOACRIVE Induction DME0006 XEOTICID XEO01052 XEO_NAME Fenitrothion DME0006 XEOTICID XEO01052 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO01052 XEO_CLAS Pesticide/Insecticide DME0006 XEOTICID XEO01052 DESCRIPT Fenitrothion inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01052 GENEFORM Protein DME0006 XEOTICID XEO01052 MOACRIVE Inhibition DME0006 XEOTICID XEO01062 XEO_NAME Monocrotophos DME0006 XEOTICID XEO01062 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO01062 XEO_CLAS Pesticide/Insecticide DME0006 XEOTICID XEO01062 DESCRIPT Monocrotophos induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01062 GENEFORM Protein DME0006 XEOTICID XEO01062 MOACRIVE Induction DME0006 XEOTICID XEO01064 XEO_NAME Parathion DME0006 XEOTICID XEO01064 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO01064 XEO_CLAS Pesticide/Insecticide DME0006 XEOTICID XEO01064 DESCRIPT Parathion up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01064 GENEFORM mRNA DME0006 XEOTICID XEO01064 MOACRIVE Induction DME0006 XEOTICID XEO01068 XEO_NAME Profenofos DME0006 XEOTICID XEO01068 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO01068 XEO_CLAS Pesticide/Insecticide DME0006 XEOTICID XEO01068 DESCRIPT Prof DMEenof DMEos inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01068 GENEFORM Protein DME0006 XEOTICID XEO01068 MOACRIVE Inhibition DME0006 XEOTICID XEO01074 XEO_NAME Endosulfan DME0006 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0006 XEOTICID XEO01074 DESCRIPT Endosulfan inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01074 GENEFORM Protein DME0006 XEOTICID XEO01074 MOACRIVE Inhibition DME0006 XEOTICID XEO01086 XEO_NAME G-1 DME0006 XEOTICID XEO01086 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01086 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01086 DESCRIPT G-1 up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01086 GENEFORM mRNA DME0006 XEOTICID XEO01086 MOACRIVE Induction DME0006 XEOTICID XEO01089 XEO_NAME 1,4-naphthoquinone DME0006 XEOTICID XEO01089 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01089 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01089 DESCRIPT 1,4-naphthoquinone up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01089 GENEFORM mRNA DME0006 XEOTICID XEO01089 MOACRIVE Induction DME0006 XEOTICID XEO01105 XEO_NAME 1-phenyl-1,2-propanedione DME0006 XEOTICID XEO01105 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01105 XEO_CLAS Health Hazard/Toxicant DME0006 XEOTICID XEO01105 DESCRIPT 1-phenyl-1,2-propanedione up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01105 GENEFORM mRNA DME0006 XEOTICID XEO01105 MOACRIVE Induction DME0006 XEOTICID XEO01107 XEO_NAME NSC 703786 DME0006 XEOTICID XEO01107 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01107 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO01107 DESCRIPT NSC 703786 induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01107 GENEFORM Protein DME0006 XEOTICID XEO01107 MOACRIVE Induction DME0006 XEOTICID XEO01108 XEO_NAME 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole DME0006 XEOTICID XEO01108 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01108 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01108 DESCRIPT 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01108 GENEFORM Protein DME0006 XEOTICID XEO01108 MOACRIVE Induction DME0006 XEOTICID XEO01111 XEO_NAME 2,3,4,4'5-pentachlorobiphenyl DME0006 XEOTICID XEO01111 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01111 XEO_CLAS Health Hazard/Toxicant DME0006 XEOTICID XEO01111 DESCRIPT 2,3,4,4'5-pentachlorobiphenyl up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01111 GENEFORM mRNA DME0006 XEOTICID XEO01111 MOACRIVE Induction DME0006 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0006 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01119 GENEFORM Protein DME0006 XEOTICID XEO01119 MOACRIVE Induction DME0006 XEOTICID XEO01126 XEO_NAME 2'-hydroxychalcone DME0006 XEOTICID XEO01126 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01126 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01126 DESCRIPT 2'-hydroxychalcone inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01126 GENEFORM Protein DME0006 XEOTICID XEO01126 MOACRIVE Inhibition DME0006 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0006 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0006 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01129 GENEFORM Protein DME0006 XEOTICID XEO01129 MOACRIVE Induction DME0006 XEOTICID XEO01133 XEO_NAME 3,3',4,5'-tetrahydroxystilbene DME0006 XEOTICID XEO01133 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01133 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01133 DESCRIPT 3,3',4,5'-tetrahydroxystilbene induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01133 GENEFORM Protein DME0006 XEOTICID XEO01133 MOACRIVE Induction DME0006 XEOTICID XEO01135 XEO_NAME 3,4',5-trimethoxystilbene DME0006 XEOTICID XEO01135 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01135 XEO_CLAS Environmental Pollutant DME0006 XEOTICID XEO01135 DESCRIPT 3,4',5-trimethoxystilbene induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01135 GENEFORM Protein DME0006 XEOTICID XEO01135 MOACRIVE Induction DME0006 XEOTICID XEO01139 XEO_NAME 3'-methoxy-4'-nitroflavone DME0006 XEOTICID XEO01139 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01139 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01139 DESCRIPT 3'-methoxy-4'-nitroflavone induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01139 GENEFORM Protein DME0006 XEOTICID XEO01139 MOACRIVE Induction DME0006 XEOTICID XEO01146 XEO_NAME SB-202190 DME0006 XEOTICID XEO01146 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01146 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01146 DESCRIPT SB-202190 induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01146 GENEFORM Protein DME0006 XEOTICID XEO01146 MOACRIVE Induction DME0006 XEOTICID XEO01150 XEO_NAME 4'-bromoflavone DME0006 XEOTICID XEO01150 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01150 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01150 DESCRIPT 4'-bromoflavone up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01150 GENEFORM mRNA DME0006 XEOTICID XEO01150 MOACRIVE Induction DME0006 XEOTICID XEO01152 XEO_NAME 4-chlorophenylbiguanide DME0006 XEOTICID XEO01152 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01152 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01152 DESCRIPT 4-chlorophenylbiguanide induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01152 GENEFORM Protein DME0006 XEOTICID XEO01152 MOACRIVE Induction DME0006 XEOTICID XEO01161 XEO_NAME 5-hydroxyflavone DME0006 XEOTICID XEO01161 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01161 XEO_CLAS Natural Product DME0006 XEOTICID XEO01161 DESCRIPT 5-hydroxyflavone inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 4.03 microM) DME0006 XEOTICID XEO01161 GENEFORM Protein DME0006 XEOTICID XEO01161 MOACRIVE Inhibition DME0006 XEOTICID XEO01166 XEO_NAME 6',7'-dihydroxybergamottin DME0006 XEOTICID XEO01166 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01166 XEO_CLAS Natural Product DME0006 XEOTICID XEO01166 DESCRIPT 6',7'-dihydroxybergamottin inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01166 GENEFORM Protein DME0006 XEOTICID XEO01166 MOACRIVE Inhibition DME0006 XEOTICID XEO01167 XEO_NAME 6,7-dihydroxyflavone DME0006 XEOTICID XEO01167 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01167 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01167 DESCRIPT 6,7-dihydroxyflavone inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01167 GENEFORM Protein DME0006 XEOTICID XEO01167 MOACRIVE Inhibition DME0006 XEOTICID XEO01176 XEO_NAME 7-hydroxyflavone DME0006 XEOTICID XEO01176 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01176 XEO_CLAS Natural Product DME0006 XEOTICID XEO01176 DESCRIPT 7-hydroxyflavone inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01176 GENEFORM Protein DME0006 XEOTICID XEO01176 MOACRIVE Inhibition DME0006 XEOTICID XEO01179 XEO_NAME 8-prenylnaringenin DME0006 XEOTICID XEO01179 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01179 XEO_CLAS Biotoxin DME0006 XEOTICID XEO01179 DESCRIPT 8-prenylnaringenin inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01179 GENEFORM Protein DME0006 XEOTICID XEO01179 MOACRIVE Inhibition DME0006 XEOTICID XEO01184 XEO_NAME Acacetin DME0006 XEOTICID XEO01184 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01184 XEO_CLAS Natural Product DME0006 XEOTICID XEO01184 DESCRIPT Acacetin inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 0.08 microM) DME0006 XEOTICID XEO01184 GENEFORM Protein DME0006 XEOTICID XEO01184 MOACRIVE Inhibition DME0006 XEOTICID XEO01191 XEO_NAME Aloe-emodin DME0006 XEOTICID XEO01191 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01191 XEO_CLAS Natural Product DME0006 XEOTICID XEO01191 DESCRIPT Aloe-emodin inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01191 GENEFORM Protein DME0006 XEOTICID XEO01191 MOACRIVE Inhibition DME0006 XEOTICID XEO01192 XEO_NAME Alpha-naphthoflavone DME0006 XEOTICID XEO01192 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01192 XEO_CLAS Natural Product DME0006 XEOTICID XEO01192 DESCRIPT Alpha-naphthoflavone inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 0.01 microM) DME0006 XEOTICID XEO01192 GENEFORM Protein DME0006 XEOTICID XEO01192 MOACRIVE Inhibition DME0006 XEOTICID XEO01199 XEO_NAME Anisomycin DME0006 XEOTICID XEO01199 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01199 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01199 DESCRIPT Anisomycin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01199 GENEFORM mRNA DME0006 XEOTICID XEO01199 MOACRIVE Induction DME0006 XEOTICID XEO01203 XEO_NAME Apigenin DME0006 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01203 XEO_CLAS Natural Product DME0006 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 0.427 microM) DME0006 XEOTICID XEO01203 GENEFORM Protein DME0006 XEOTICID XEO01203 MOACRIVE Inhibition DME0006 XEOTICID XEO01212 XEO_NAME Baicalein DME0006 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01212 XEO_CLAS Natural Product DME0006 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of DME CYP1A1 (Ki = 1.22 microM) DME0006 XEOTICID XEO01212 GENEFORM Protein DME0006 XEOTICID XEO01212 MOACRIVE Inhibition DME0006 XEOTICID XEO01218 XEO_NAME Benzyl selenocyanate DME0006 XEOTICID XEO01218 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01218 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01218 DESCRIPT Benzyl selenocyanate inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 0.1 microM) DME0006 XEOTICID XEO01218 GENEFORM Protein DME0006 XEOTICID XEO01218 MOACRIVE Inhibition DME0006 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0006 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01220 DESCRIPT Beta-naphthof DMElavone inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 0.054 microM) DME0006 XEOTICID XEO01220 GENEFORM Protein DME0006 XEOTICID XEO01220 MOACRIVE Inhibition DME0006 XEOTICID XEO01222 XEO_NAME Biochanin A DME0006 XEOTICID XEO01222 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01222 XEO_CLAS Natural Product DME0006 XEOTICID XEO01222 DESCRIPT Biochanin A induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01222 GENEFORM Protein DME0006 XEOTICID XEO01222 MOACRIVE Induction DME0006 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0006 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0006 XEOTICID XEO01226 DESCRIPT Bisphenol A induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01226 GENEFORM Protein DME0006 XEOTICID XEO01226 MOACRIVE Induction DME0006 XEOTICID XEO01230 XEO_NAME Butyric acid DME0006 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0006 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01230 GENEFORM mRNA DME0006 XEOTICID XEO01230 MOACRIVE Induction DME0006 XEOTICID XEO01231 XEO_NAME Cacodylic acid DME0006 XEOTICID XEO01231 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01231 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01231 DESCRIPT Cacodylic acid up-regulates the expression of DME CYP1A1 and leads to increasing the drug-metabolizing activity of this enzyme DME0006 XEOTICID XEO01231 GENEFORM Protein DME0006 XEOTICID XEO01231 MOACRIVE Induction DME0006 XEOTICID XEO01234 XEO_NAME Cannabidiol dimethyl ether DME0006 XEOTICID XEO01234 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01234 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO01234 DESCRIPT Cannabidiol dimethyl ether inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01234 GENEFORM Protein DME0006 XEOTICID XEO01234 MOACRIVE Inhibition DME0006 XEOTICID XEO01237 XEO_NAME Carvacrol DME0006 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO01237 DESCRIPT Carvacrol up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01237 GENEFORM mRNA DME0006 XEOTICID XEO01237 MOACRIVE Induction DME0006 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0006 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01248 DESCRIPT Chlorpyrifos inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01248 GENEFORM Protein DME0006 XEOTICID XEO01248 MOACRIVE Inhibition DME0006 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME0006 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01253 XEO_CLAS Natural Product DME0006 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01253 GENEFORM mRNA DME0006 XEOTICID XEO01253 MOACRIVE Induction DME0006 XEOTICID XEO01268 XEO_NAME Cycloheximide DME0006 XEOTICID XEO01268 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01268 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01268 DESCRIPT Cycloheximide up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01268 GENEFORM mRNA DME0006 XEOTICID XEO01268 MOACRIVE Induction DME0006 XEOTICID XEO01269 XEO_NAME Cynaropicrin DME0006 XEOTICID XEO01269 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01269 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01269 DESCRIPT Cynaropicrin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01269 GENEFORM mRNA DME0006 XEOTICID XEO01269 MOACRIVE Induction DME0006 XEOTICID XEO01273 XEO_NAME Diarylpropionitrile DME0006 XEOTICID XEO01273 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01273 XEO_CLAS Environmental Pollutant DME0006 XEOTICID XEO01273 DESCRIPT Diarylpropionitrile up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01273 GENEFORM mRNA DME0006 XEOTICID XEO01273 MOACRIVE Induction DME0006 XEOTICID XEO01274 XEO_NAME Diazinon DME0006 XEOTICID XEO01274 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01274 XEO_CLAS Environmental Pollutant DME0006 XEOTICID XEO01274 DESCRIPT Diazinon induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01274 GENEFORM Protein DME0006 XEOTICID XEO01274 MOACRIVE Induction DME0006 XEOTICID XEO01281 XEO_NAME Diosmetin DME0006 XEOTICID XEO01281 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01281 XEO_CLAS Natural Product DME0006 XEOTICID XEO01281 DESCRIPT Diosmetin inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 0.14 microM) DME0006 XEOTICID XEO01281 GENEFORM Protein DME0006 XEOTICID XEO01281 MOACRIVE Inhibition DME0006 XEOTICID XEO01283 XEO_NAME DMU-212 DME0006 XEOTICID XEO01283 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01283 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO01283 DESCRIPT DMU-212 inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01283 GENEFORM Protein DME0006 XEOTICID XEO01283 MOACRIVE Inhibition DME0006 XEOTICID XEO01284 XEO_NAME Dust DME0006 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0006 XEOTICID XEO01284 DESCRIPT Dust inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01284 GENEFORM Protein DME0006 XEOTICID XEO01284 MOACRIVE Inhibition DME0006 XEOTICID XEO01287 XEO_NAME Ellagic acid DME0006 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO01287 GENEFORM mRNA DME0006 XEOTICID XEO01287 MOACRIVE Inhibition DME0006 XEOTICID XEO01288 XEO_NAME Ellipticine DME0006 XEOTICID XEO01288 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01288 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01288 DESCRIPT Ellipticine induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01288 GENEFORM Protein DME0006 XEOTICID XEO01288 MOACRIVE Induction DME0006 XEOTICID XEO01289 XEO_NAME Enniatins DME0006 XEOTICID XEO01289 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01289 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01289 DESCRIPT Enniatins up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01289 GENEFORM mRNA DME0006 XEOTICID XEO01289 MOACRIVE Induction DME0006 XEOTICID XEO01293 XEO_NAME Ethyl isopropylamiloride DME0006 XEOTICID XEO01293 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01293 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01293 DESCRIPT Ethyl isopropylamiloride inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01293 GENEFORM Protein DME0006 XEOTICID XEO01293 MOACRIVE Inhibition DME0006 XEOTICID XEO01298 XEO_NAME Farnesol DME0006 XEOTICID XEO01298 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01298 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01298 DESCRIPT Farnesol up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01298 GENEFORM mRNA DME0006 XEOTICID XEO01298 MOACRIVE Induction DME0006 XEOTICID XEO01302 XEO_NAME Fipronil DME0006 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01302 GENEFORM mRNA DME0006 XEOTICID XEO01302 MOACRIVE Induction DME0006 XEOTICID XEO01303 XEO_NAME Fisetin DME0006 XEOTICID XEO01303 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01303 XEO_CLAS Drug in Phase 2 Clinical Trial DME0006 XEOTICID XEO01303 DESCRIPT Fisetin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01303 GENEFORM mRNA DME0006 XEOTICID XEO01303 MOACRIVE Induction DME0006 XEOTICID XEO01304 XEO_NAME Flavone DME0006 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01304 XEO_CLAS Natural Product DME0006 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01304 GENEFORM Protein DME0006 XEOTICID XEO01304 MOACRIVE Inhibition DME0006 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0006 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01305 GENEFORM mRNA DME0006 XEOTICID XEO01305 MOACRIVE Induction DME0006 XEOTICID XEO01306 XEO_NAME Formononetin DME0006 XEOTICID XEO01306 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01306 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO01306 DESCRIPT Formononetin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01306 GENEFORM mRNA DME0006 XEOTICID XEO01306 MOACRIVE Induction DME0006 XEOTICID XEO01307 XEO_NAME Furafylline DME0006 XEOTICID XEO01307 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01307 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01307 DESCRIPT Furafylline inhibits the drug-metabolizing activity of DME CYP1A1 (Ki > 200 microM) DME0006 XEOTICID XEO01307 GENEFORM Protein DME0006 XEOTICID XEO01307 MOACRIVE Inhibition DME0006 XEOTICID XEO01308 XEO_NAME Galangin DME0006 XEOTICID XEO01308 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01308 XEO_CLAS Natural Product DME0006 XEOTICID XEO01308 DESCRIPT Galangin inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 0.077 microM) DME0006 XEOTICID XEO01308 GENEFORM Protein DME0006 XEOTICID XEO01308 MOACRIVE Inhibition DME0006 XEOTICID XEO01311 XEO_NAME Gedunin DME0006 XEOTICID XEO01311 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01311 XEO_CLAS Natural Product DME0006 XEOTICID XEO01311 DESCRIPT Gedunin inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO01311 GENEFORM mRNA DME0006 XEOTICID XEO01311 MOACRIVE Inhibition DME0006 XEOTICID XEO01322 XEO_NAME Gossypetin DME0006 XEOTICID XEO01322 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01322 XEO_CLAS Natural Product DME0006 XEOTICID XEO01322 DESCRIPT Gossypetin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01322 GENEFORM mRNA DME0006 XEOTICID XEO01322 MOACRIVE Induction DME0006 XEOTICID XEO01325 XEO_NAME GW-3965 DME0006 XEOTICID XEO01325 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01325 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO01325 DESCRIPT GW-3965 up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01325 GENEFORM mRNA DME0006 XEOTICID XEO01325 MOACRIVE Induction DME0006 XEOTICID XEO01335 XEO_NAME Hyperforin DME0006 XEOTICID XEO01335 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01335 XEO_CLAS Natural Product DME0006 XEOTICID XEO01335 DESCRIPT Hyperforin inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01335 GENEFORM Protein DME0006 XEOTICID XEO01335 MOACRIVE Inhibition DME0006 XEOTICID XEO01342 XEO_NAME Indirubin-3'-monoxime DME0006 XEOTICID XEO01342 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01342 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01342 DESCRIPT Indirubin-3'-monoxime up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01342 GENEFORM mRNA DME0006 XEOTICID XEO01342 MOACRIVE Induction DME0006 XEOTICID XEO01343 XEO_NAME Indolo(3,2-B)carbazole DME0006 XEOTICID XEO01343 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01343 XEO_CLAS Natural Product DME0006 XEOTICID XEO01343 DESCRIPT Indolo(3,2-B)carbazole up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01343 GENEFORM mRNA DME0006 XEOTICID XEO01343 MOACRIVE Induction DME0006 XEOTICID XEO01353 XEO_NAME Kaempferol DME0006 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 0.632 microM) DME0006 XEOTICID XEO01353 GENEFORM Protein DME0006 XEOTICID XEO01353 MOACRIVE Inhibition DME0006 XEOTICID XEO01359 XEO_NAME Kynurenic acid DME0006 XEOTICID XEO01359 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01359 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO01359 DESCRIPT Kynurenic acid induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01359 GENEFORM Protein DME0006 XEOTICID XEO01359 MOACRIVE Induction DME0006 XEOTICID XEO01366 XEO_NAME Linalool DME0006 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01366 XEO_CLAS Natural Product DME0006 XEOTICID XEO01366 DESCRIPT Linalool up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01366 GENEFORM mRNA DME0006 XEOTICID XEO01366 MOACRIVE Induction DME0006 XEOTICID XEO01380 XEO_NAME Mono-(2-ethylhexyl)phthalate DME0006 XEOTICID XEO01380 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01380 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01380 DESCRIPT Mono-(2-ethylhexyl)phthalate induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01380 GENEFORM Protein DME0006 XEOTICID XEO01380 MOACRIVE Induction DME0006 XEOTICID XEO01381 XEO_NAME Morin DME0006 XEOTICID XEO01381 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01381 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01381 DESCRIPT Morin induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01381 GENEFORM Protein DME0006 XEOTICID XEO01381 MOACRIVE Induction DME0006 XEOTICID XEO01384 XEO_NAME Myricetin DME0006 XEOTICID XEO01384 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01384 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO01384 DESCRIPT Myricetin inhibits the drug-metabolizing activity of DME CYP1A1 (Ki = 0.37 microM) DME0006 XEOTICID XEO01384 GENEFORM Protein DME0006 XEOTICID XEO01384 MOACRIVE Inhibition DME0006 XEOTICID XEO01391 XEO_NAME Naringin DME0006 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01391 XEO_CLAS Natural Product DME0006 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01391 GENEFORM Protein DME0006 XEOTICID XEO01391 MOACRIVE Inhibition DME0006 XEOTICID XEO01394 XEO_NAME NCX-4040 DME0006 XEOTICID XEO01394 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01394 XEO_CLAS Environmental Pollutant DME0006 XEOTICID XEO01394 DESCRIPT NCX-4040 inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01394 GENEFORM Protein DME0006 XEOTICID XEO01394 MOACRIVE Inhibition DME0006 XEOTICID XEO01397 XEO_NAME Nickel chloride DME0006 XEOTICID XEO01397 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01397 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01397 DESCRIPT Nickel chloride inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO01397 GENEFORM mRNA DME0006 XEOTICID XEO01397 MOACRIVE Inhibition DME0006 XEOTICID XEO01400 XEO_NAME NSC-674495 DME0006 XEOTICID XEO01400 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01400 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO01400 DESCRIPT NSC-674495 induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01400 GENEFORM Protein DME0006 XEOTICID XEO01400 MOACRIVE Induction DME0006 XEOTICID XEO01405 XEO_NAME O(6)-benzylguanine DME0006 XEOTICID XEO01405 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01405 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO01405 DESCRIPT O(6)-benzylguanine inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01405 GENEFORM Protein DME0006 XEOTICID XEO01405 MOACRIVE Inhibition DME0006 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0006 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01407 DESCRIPT Ochratoxin A up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01407 GENEFORM mRNA DME0006 XEOTICID XEO01407 MOACRIVE Induction DME0006 XEOTICID XEO01424 XEO_NAME Pelargonidin DME0006 XEOTICID XEO01424 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01424 XEO_CLAS Natural Product DME0006 XEOTICID XEO01424 DESCRIPT Pelargonidin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01424 GENEFORM mRNA DME0006 XEOTICID XEO01424 MOACRIVE Induction DME0006 XEOTICID XEO01431 XEO_NAME Pifithrin DME0006 XEOTICID XEO01431 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01431 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01431 DESCRIPT Pifithrin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01431 GENEFORM mRNA DME0006 XEOTICID XEO01431 MOACRIVE Induction DME0006 XEOTICID XEO01433 XEO_NAME Pirinixic acid DME0006 XEOTICID XEO01433 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01433 XEO_CLAS Health Hazard/Toxicant DME0006 XEOTICID XEO01433 DESCRIPT Pirinixic acid induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01433 GENEFORM Protein DME0006 XEOTICID XEO01433 MOACRIVE Induction DME0006 XEOTICID XEO01441 XEO_NAME Pterostilbene DME0006 XEOTICID XEO01441 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01441 XEO_CLAS Environmental Pollutant DME0006 XEOTICID XEO01441 DESCRIPT Pterostilbene up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01441 GENEFORM mRNA DME0006 XEOTICID XEO01441 MOACRIVE Induction DME0006 XEOTICID XEO01442 XEO_NAME Puag-haad DME0006 XEOTICID XEO01442 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01442 XEO_CLAS Natural Product DME0006 XEOTICID XEO01442 DESCRIPT Puag-haad up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01442 GENEFORM mRNA DME0006 XEOTICID XEO01442 MOACRIVE Induction DME0006 XEOTICID XEO01443 XEO_NAME Purpurin DME0006 XEOTICID XEO01443 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01443 XEO_CLAS Natural Product DME0006 XEOTICID XEO01443 DESCRIPT Purpurin inhibits the drug-metabolizing activity of DME CYP1A1 (IC50 = 5.5 microM) DME0006 XEOTICID XEO01443 GENEFORM Protein DME0006 XEOTICID XEO01443 MOACRIVE Inhibition DME0006 XEOTICID XEO01445 XEO_NAME Pyrazolanthrone DME0006 XEOTICID XEO01445 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01445 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01445 DESCRIPT Pyrazolanthrone induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01445 GENEFORM Protein DME0006 XEOTICID XEO01445 MOACRIVE Induction DME0006 XEOTICID XEO01450 XEO_NAME Quinone DME0006 XEOTICID XEO01450 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01450 XEO_CLAS Natural Product DME0006 XEOTICID XEO01450 DESCRIPT Quinone up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01450 GENEFORM mRNA DME0006 XEOTICID XEO01450 MOACRIVE Induction DME0006 XEOTICID XEO01455 XEO_NAME Rhein DME0006 XEOTICID XEO01455 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01455 XEO_CLAS Investigative Agent DME0006 XEOTICID XEO01455 DESCRIPT Rhein inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01455 GENEFORM Protein DME0006 XEOTICID XEO01455 MOACRIVE Inhibition DME0006 XEOTICID XEO01458 XEO_NAME Robinetin DME0006 XEOTICID XEO01458 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01458 XEO_CLAS Natural Product DME0006 XEOTICID XEO01458 DESCRIPT Robinetin induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01458 GENEFORM Protein DME0006 XEOTICID XEO01458 MOACRIVE Induction DME0006 XEOTICID XEO01462 XEO_NAME Rutecarpine DME0006 XEOTICID XEO01462 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01462 XEO_CLAS Natural Product DME0006 XEOTICID XEO01462 DESCRIPT Rutecarpine induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01462 GENEFORM Protein DME0006 XEOTICID XEO01462 MOACRIVE Induction DME0006 XEOTICID XEO01463 XEO_NAME Rutin DME0006 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01463 XEO_CLAS Natural Product DME0006 XEOTICID XEO01463 DESCRIPT Rutin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01463 GENEFORM mRNA DME0006 XEOTICID XEO01463 MOACRIVE Induction DME0006 XEOTICID XEO01470 XEO_NAME Scutellarein DME0006 XEOTICID XEO01470 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01470 XEO_CLAS Natural Product DME0006 XEOTICID XEO01470 DESCRIPT Scutellarein inhibits the drug-metabolizing activity of DME CYP1A1 (Ki = 1.64 microM) DME0006 XEOTICID XEO01470 GENEFORM Protein DME0006 XEOTICID XEO01470 MOACRIVE Inhibition DME0006 XEOTICID XEO01476 XEO_NAME STO-609 DME0006 XEOTICID XEO01476 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01476 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO01476 DESCRIPT STO-609 up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01476 GENEFORM mRNA DME0006 XEOTICID XEO01476 MOACRIVE Induction DME0006 XEOTICID XEO01485 XEO_NAME Thiostrepton DME0006 XEOTICID XEO01485 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01485 XEO_CLAS Approved/Marketed Drug DME0006 XEOTICID XEO01485 DESCRIPT Thiostrepton inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01485 GENEFORM Protein DME0006 XEOTICID XEO01485 MOACRIVE Inhibition DME0006 XEOTICID XEO01487 XEO_NAME TO-901317 DME0006 XEOTICID XEO01487 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01487 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO01487 DESCRIPT TO-901317 up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01487 GENEFORM mRNA DME0006 XEOTICID XEO01487 MOACRIVE Induction DME0006 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0006 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0006 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01492 GENEFORM mRNA DME0006 XEOTICID XEO01492 MOACRIVE Induction DME0006 XEOTICID XEO01498 XEO_NAME Walrycin A DME0006 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01498 XEO_CLAS Natural Product DME0006 XEOTICID XEO01498 DESCRIPT Walrycin A up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01498 GENEFORM mRNA DME0006 XEOTICID XEO01498 MOACRIVE Induction DME0006 XEOTICID XEO01499 XEO_NAME WAY-169916 DME0006 XEOTICID XEO01499 XEO_TYPE Pharmaceutical Agent(s) DME0006 XEOTICID XEO01499 XEO_CLAS Preclinical/Patented Drug DME0006 XEOTICID XEO01499 DESCRIPT WAY-169916 inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO01499 GENEFORM mRNA DME0006 XEOTICID XEO01499 MOACRIVE Inhibition DME0006 XEOTICID XEO01503 XEO_NAME Cadmium DME0006 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01503 GENEFORM mRNA DME0006 XEOTICID XEO01503 MOACRIVE Induction DME0006 XEOTICID XEO01505 XEO_NAME Lead DME0006 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0006 XEOTICID XEO01505 DESCRIPT Lead up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01505 GENEFORM mRNA DME0006 XEOTICID XEO01505 MOACRIVE Induction DME0006 XEOTICID XEO01508 XEO_NAME Mercuric chloride DME0006 XEOTICID XEO01508 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01508 XEO_CLAS Acute Toxic Substance DME0006 XEOTICID XEO01508 DESCRIPT Mercuric chloride inhibits the expression of DME CYP1A1 DME0006 XEOTICID XEO01508 GENEFORM mRNA DME0006 XEOTICID XEO01508 MOACRIVE Inhibition DME0006 XEOTICID XEO01514 XEO_NAME Deoxynivalenol DME0006 XEOTICID XEO01514 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01514 XEO_CLAS Mycotoxin DME0006 XEOTICID XEO01514 DESCRIPT Deoxynivalenol up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01514 GENEFORM mRNA DME0006 XEOTICID XEO01514 MOACRIVE Induction DME0006 XEOTICID XEO01515 XEO_NAME HT-2 toxin DME0006 XEOTICID XEO01515 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01515 XEO_CLAS Mycotoxin DME0006 XEOTICID XEO01515 DESCRIPT HT-2 toxin up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01515 GENEFORM mRNA DME0006 XEOTICID XEO01515 MOACRIVE Induction DME0006 XEOTICID XEO01517 XEO_NAME 15,16-dihydrotanshinone I DME0006 XEOTICID XEO01517 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01517 XEO_CLAS Natural Product DME0006 XEOTICID XEO01517 DESCRIPT 15,16-dihydrotanshinone I induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01517 GENEFORM Protein DME0006 XEOTICID XEO01517 MOACRIVE Induction DME0006 XEOTICID XEO01519 XEO_NAME Allocryptopine DME0006 XEOTICID XEO01519 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01519 XEO_CLAS Natural Product DME0006 XEOTICID XEO01519 DESCRIPT Allocryptopine up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01519 GENEFORM mRNA DME0006 XEOTICID XEO01519 MOACRIVE Induction DME0006 XEOTICID XEO01521 XEO_NAME Annomontine DME0006 XEOTICID XEO01521 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01521 XEO_CLAS Natural Product DME0006 XEOTICID XEO01521 DESCRIPT Annomontine up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01521 GENEFORM mRNA DME0006 XEOTICID XEO01521 MOACRIVE Induction DME0006 XEOTICID XEO01528 XEO_NAME Chrysophanic acid DME0006 XEOTICID XEO01528 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01528 XEO_CLAS Natural Product DME0006 XEOTICID XEO01528 DESCRIPT Chrysophanic acid inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01528 GENEFORM Protein DME0006 XEOTICID XEO01528 MOACRIVE Inhibition DME0006 XEOTICID XEO01534 XEO_NAME Cryptotanshinone DME0006 XEOTICID XEO01534 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01534 XEO_CLAS Natural Product DME0006 XEOTICID XEO01534 DESCRIPT Cryptotanshinone induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01534 GENEFORM Protein DME0006 XEOTICID XEO01534 MOACRIVE Induction DME0006 XEOTICID XEO01535 XEO_NAME Cyanidin 3-O-glucoside DME0006 XEOTICID XEO01535 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01535 XEO_CLAS Natural Product DME0006 XEOTICID XEO01535 DESCRIPT Cyanidin 3-O-glucoside inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01535 GENEFORM Protein DME0006 XEOTICID XEO01535 MOACRIVE Inhibition DME0006 XEOTICID XEO01541 XEO_NAME Eupatorin DME0006 XEOTICID XEO01541 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01541 XEO_CLAS Natural Product DME0006 XEOTICID XEO01541 DESCRIPT Eupatorin inhibits the drug-metabolizing activity of DME CYP1A1 (Ki = 0.21 microM) DME0006 XEOTICID XEO01541 GENEFORM Protein DME0006 XEOTICID XEO01541 MOACRIVE Inhibition DME0006 XEOTICID XEO01546 XEO_NAME Genkwanin DME0006 XEOTICID XEO01546 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01546 XEO_CLAS Natural Product DME0006 XEOTICID XEO01546 DESCRIPT Genkwanin inhibits the drug-metabolizing activity of DME CYP1A1 (Ki > 2.34 microM) DME0006 XEOTICID XEO01546 GENEFORM Protein DME0006 XEOTICID XEO01546 MOACRIVE Inhibition DME0006 XEOTICID XEO01549 XEO_NAME Green tea extract AR25 DME0006 XEOTICID XEO01549 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01549 XEO_CLAS Plant Extract DME0006 XEOTICID XEO01549 DESCRIPT Green tea extract AR25 inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01549 GENEFORM Protein DME0006 XEOTICID XEO01549 MOACRIVE Inhibition DME0006 XEOTICID XEO01553 XEO_NAME Isoflavone DME0006 XEOTICID XEO01553 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01553 XEO_CLAS Natural Product DME0006 XEOTICID XEO01553 DESCRIPT Isof DMElavone inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01553 GENEFORM Protein DME0006 XEOTICID XEO01553 MOACRIVE Inhibition DME0006 XEOTICID XEO01558 XEO_NAME Ligustilide DME0006 XEOTICID XEO01558 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01558 XEO_CLAS Natural Product DME0006 XEOTICID XEO01558 DESCRIPT Ligustilide up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01558 GENEFORM mRNA DME0006 XEOTICID XEO01558 MOACRIVE Induction DME0006 XEOTICID XEO01559 XEO_NAME Limonene DME0006 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01559 XEO_CLAS Natural Product DME0006 XEOTICID XEO01559 DESCRIPT Limonene up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01559 GENEFORM mRNA DME0006 XEOTICID XEO01559 MOACRIVE Induction DME0006 XEOTICID XEO01566 XEO_NAME Nobiletin DME0006 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01566 XEO_CLAS Natural Product DME0006 XEOTICID XEO01566 DESCRIPT Nobiletin induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01566 GENEFORM Protein DME0006 XEOTICID XEO01566 MOACRIVE Induction DME0006 XEOTICID XEO01574 XEO_NAME Plant extracts DME0006 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0006 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01574 GENEFORM Protein DME0006 XEOTICID XEO01574 MOACRIVE Inhibition DME0006 XEOTICID XEO01578 XEO_NAME Polyphenols DME0006 XEOTICID XEO01578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01578 XEO_CLAS Natural Mixture DME0006 XEOTICID XEO01578 DESCRIPT Polyphenols up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01578 GENEFORM mRNA DME0006 XEOTICID XEO01578 MOACRIVE Induction DME0006 XEOTICID XEO01581 XEO_NAME Protopine DME0006 XEOTICID XEO01581 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01581 XEO_CLAS Natural Product DME0006 XEOTICID XEO01581 DESCRIPT Protopine up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01581 GENEFORM mRNA DME0006 XEOTICID XEO01581 MOACRIVE Induction DME0006 XEOTICID XEO01585 XEO_NAME Senecionine DME0006 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01585 XEO_CLAS Natural Product DME0006 XEOTICID XEO01585 DESCRIPT Senecionine induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01585 GENEFORM Protein DME0006 XEOTICID XEO01585 MOACRIVE Induction DME0006 XEOTICID XEO01591 XEO_NAME Taxifolin DME0006 XEOTICID XEO01591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0006 XEOTICID XEO01591 XEO_CLAS Natural Product DME0006 XEOTICID XEO01591 DESCRIPT Taxifolin induces the drug-metabolizing activity of DME CYP1A1 DME0006 XEOTICID XEO01591 GENEFORM Protein DME0006 XEOTICID XEO01591 MOACRIVE Induction DME0006 XEOTICID XEO01605 XEO_NAME Pentachlorophenol DME0006 XEOTICID XEO01605 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0006 XEOTICID XEO01605 XEO_CLAS Pesticide/Insecticide DME0006 XEOTICID XEO01605 DESCRIPT Pentachlorophenol up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01605 GENEFORM mRNA DME0006 XEOTICID XEO01605 MOACRIVE Induction DME0006 XEOTICID XEO01614 XEO_NAME Phthalic anhydride DME0006 XEOTICID XEO01614 XEO_TYPE Health or Environmental Toxicant(s) DME0006 XEOTICID XEO01614 XEO_CLAS Environmental Pollutant DME0006 XEOTICID XEO01614 DESCRIPT Phthalic anhydride up-regulates the expression of DME CYP1A1 DME0006 XEOTICID XEO01614 GENEFORM mRNA DME0006 XEOTICID XEO01614 MOACRIVE Induction DME0007 DME___ID DME0007 DME0007 DME_NAME RNA cytidine acetyltransferase (hALP) DME0007 SPESNAME Homo sapiens DME0007 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0007 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0007 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0007 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME NAT10 DME0007 XEOTICID XEO00772 GENEFORM mRNA DME0007 XEOTICID XEO00772 MOACRIVE Inhibition DME0007 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0007 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0007 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0007 XEOTICID XEO01050 DESCRIPT Dicrotophos up-regulates the expression of DME NAT10 DME0007 XEOTICID XEO01050 GENEFORM mRNA DME0007 XEOTICID XEO01050 MOACRIVE Induction DME0007 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0007 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0007 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0007 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME NAT10 DME0007 XEOTICID XEO01305 GENEFORM mRNA DME0007 XEOTICID XEO01305 MOACRIVE Inhibition DME0007 XEOTICID XEO01348 XEO_NAME K-7174 DME0007 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0007 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0007 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME NAT10 DME0007 XEOTICID XEO01348 GENEFORM mRNA DME0007 XEOTICID XEO01348 MOACRIVE Inhibition DME0007 XEOTICID XEO01467 XEO_NAME Salinomycin DME0007 XEOTICID XEO01467 XEO_TYPE Health or Environmental Toxicant(s) DME0007 XEOTICID XEO01467 XEO_CLAS Acute Toxic Substance DME0007 XEOTICID XEO01467 DESCRIPT Salinomycin inhibits the expression of DME NAT10 DME0007 XEOTICID XEO01467 GENEFORM mRNA DME0007 XEOTICID XEO01467 MOACRIVE Inhibition DME0007 XEOTICID XEO01505 XEO_NAME Lead DME0007 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0007 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0007 XEOTICID XEO01505 DESCRIPT Lead inhibits the expression of DME NAT10 DME0007 XEOTICID XEO01505 GENEFORM mRNA DME0007 XEOTICID XEO01505 MOACRIVE Inhibition DME0008 DME___ID DME0008 DME0008 DME_NAME Sulfotransferase 1A1 (SULT1A1) DME0008 SPESNAME Homo sapiens DME0008 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0008 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0008 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0008 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the drug-metabolizing activity of DME SULT1A1 DME0008 XEOTICID XEO00217 GENEFORM Protein DME0008 XEOTICID XEO00217 MOACRIVE Inhibition DME0008 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0008 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0008 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0008 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME SULT1A1 DME0008 XEOTICID XEO00241 GENEFORM mRNA DME0008 XEOTICID XEO00241 MOACRIVE Inhibition DME0008 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0008 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0008 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0008 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME SULT1A1 DME0008 XEOTICID XEO00292 GENEFORM mRNA DME0008 XEOTICID XEO00292 MOACRIVE Inhibition DME0008 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0008 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0008 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0008 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME SULT1A1 DME0008 XEOTICID XEO00339 GENEFORM mRNA DME0008 XEOTICID XEO00339 MOACRIVE Induction DME0008 XEOTICID XEO00366 XEO_NAME Methotrexate DME0008 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0008 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0008 XEOTICID XEO00366 DESCRIPT Methotrexate induces the drug-metabolizing activity of DME SULT1A1 DME0008 XEOTICID XEO00366 GENEFORM Protein DME0008 XEOTICID XEO00366 MOACRIVE Induction DME0008 XEOTICID XEO00539 XEO_NAME Ethanol DME0008 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0008 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0008 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the drug-metabolizing activity of DME SULT1A1 DME0008 XEOTICID XEO00539 GENEFORM Protein DME0008 XEOTICID XEO00539 MOACRIVE Inhibition DME0008 XEOTICID XEO00581 XEO_NAME MS-275 DME0008 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0008 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0008 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME SULT1A1 DME0008 XEOTICID XEO00581 GENEFORM mRNA DME0008 XEOTICID XEO00581 MOACRIVE Induction DME0008 XEOTICID XEO00636 XEO_NAME Xanthohumol DME0008 XEOTICID XEO00636 XEO_TYPE Pharmaceutical Agent(s) DME0008 XEOTICID XEO00636 XEO_CLAS Drug in Phase 1 Clinical Trial DME0008 XEOTICID XEO00636 DESCRIPT Xanthohumol inhibits the drug-metabolizing activity of DME SULT1A1 DME0008 XEOTICID XEO00636 GENEFORM Protein DME0008 XEOTICID XEO00636 MOACRIVE Inhibition DME0008 XEOTICID XEO00692 XEO_NAME Emodin DME0008 XEOTICID XEO00692 XEO_TYPE Pharmaceutical Agent(s) DME0008 XEOTICID XEO00692 XEO_CLAS Preclinical/Patented Drug DME0008 XEOTICID XEO00692 DESCRIPT Emodin inhibits the drug-metabolizing activity of DME SULT1A1 DME0008 XEOTICID XEO00692 GENEFORM Protein DME0008 XEOTICID XEO00692 MOACRIVE Inhibition DME0008 XEOTICID XEO00760 XEO_NAME Jinfukang DME0008 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0008 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0008 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME SULT1A1 DME0008 XEOTICID XEO00760 GENEFORM mRNA DME0008 XEOTICID XEO00760 MOACRIVE Induction DME0008 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0008 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0008 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0008 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME SULT1A1 DME0008 XEOTICID XEO00772 GENEFORM mRNA DME0008 XEOTICID XEO00772 MOACRIVE Induction DME0008 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0008 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0008 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0008 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME SULT1A1 DME0008 XEOTICID XEO00806 GENEFORM mRNA DME0008 XEOTICID XEO00806 MOACRIVE Inhibition DME0008 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0008 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0008 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0008 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME SULT1A1 DME0008 XEOTICID XEO00818 GENEFORM mRNA DME0008 XEOTICID XEO00818 MOACRIVE Induction DME0008 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0008 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0008 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0008 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME SULT1A1 DME0008 XEOTICID XEO00898 GENEFORM mRNA DME0008 XEOTICID XEO00898 MOACRIVE Inhibition DME0008 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0008 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0008 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0008 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME SULT1A1 DME0008 XEOTICID XEO00905 GENEFORM mRNA DME0008 XEOTICID XEO00905 MOACRIVE Inhibition DME0008 XEOTICID XEO01009 XEO_NAME Glycidamide DME0008 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0008 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0008 XEOTICID XEO01009 DESCRIPT Glycidamide up-regulates the expression of DME SULT1A1 DME0008 XEOTICID XEO01009 GENEFORM mRNA DME0008 XEOTICID XEO01009 MOACRIVE Induction DME0008 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0008 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0008 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0008 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the expression of DME SULT1A1 DME0008 XEOTICID XEO01119 GENEFORM mRNA DME0008 XEOTICID XEO01119 MOACRIVE Inhibition DME0008 XEOTICID XEO01191 XEO_NAME Aloe-emodin DME0008 XEOTICID XEO01191 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0008 XEOTICID XEO01191 XEO_CLAS Natural Product DME0008 XEOTICID XEO01191 DESCRIPT Aloe-emodin inhibits the drug-metabolizing activity of DME SULT1A1 DME0008 XEOTICID XEO01191 GENEFORM Protein DME0008 XEOTICID XEO01191 MOACRIVE Inhibition DME0008 XEOTICID XEO01230 XEO_NAME Butyric acid DME0008 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0008 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0008 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME SULT1A1 DME0008 XEOTICID XEO01230 GENEFORM mRNA DME0008 XEOTICID XEO01230 MOACRIVE Induction DME0008 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0008 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0008 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0008 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME SULT1A1 DME0008 XEOTICID XEO01305 GENEFORM mRNA DME0008 XEOTICID XEO01305 MOACRIVE Induction DME0008 XEOTICID XEO01309 XEO_NAME Gallic acid DME0008 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0008 XEOTICID XEO01309 XEO_CLAS Natural Product DME0008 XEOTICID XEO01309 DESCRIPT Gallic acid induces the drug-metabolizing activity of DME SULT1A1 DME0008 XEOTICID XEO01309 GENEFORM Protein DME0008 XEOTICID XEO01309 MOACRIVE Induction DME0008 XEOTICID XEO01336 XEO_NAME ICG-001 DME0008 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0008 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0008 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME SULT1A1 DME0008 XEOTICID XEO01336 GENEFORM mRNA DME0008 XEOTICID XEO01336 MOACRIVE Induction DME0008 XEOTICID XEO01455 XEO_NAME Rhein DME0008 XEOTICID XEO01455 XEO_TYPE Pharmaceutical Agent(s) DME0008 XEOTICID XEO01455 XEO_CLAS Investigative Agent DME0008 XEOTICID XEO01455 DESCRIPT Rhein inhibits the drug-metabolizing activity of DME SULT1A1 DME0008 XEOTICID XEO01455 GENEFORM Protein DME0008 XEOTICID XEO01455 MOACRIVE Inhibition DME0008 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0008 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0008 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0008 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME SULT1A1 DME0008 XEOTICID XEO01492 GENEFORM mRNA DME0008 XEOTICID XEO01492 MOACRIVE Induction DME0008 XEOTICID XEO01528 XEO_NAME Chrysophanic acid DME0008 XEOTICID XEO01528 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0008 XEOTICID XEO01528 XEO_CLAS Natural Product DME0008 XEOTICID XEO01528 DESCRIPT Chrysophanic acid inhibits the drug-metabolizing activity of DME SULT1A1 DME0008 XEOTICID XEO01528 GENEFORM Protein DME0008 XEOTICID XEO01528 MOACRIVE Inhibition DME0009 DME___ID DME0009 DME0009 DME_NAME Cytochrome P450 2D6 (CYP2D6) DME0009 SPESNAME Homo sapiens DME0009 XEOTICID XEO00015 XEO_NAME Cimetidine DME0009 XEOTICID XEO00015 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00015 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00015 DESCRIPT Cimetidine inhibits the drug-metabolizing activity of DME CYP2D6 (Ki = 77 microM) DME0009 XEOTICID XEO00015 GENEFORM Protein DME0009 XEOTICID XEO00015 MOACRIVE Inhibition DME0009 XEOTICID XEO00029 XEO_NAME Valproic acid DME0009 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME CYP2D6 DME0009 XEOTICID XEO00029 GENEFORM mRNA DME0009 XEOTICID XEO00029 MOACRIVE Inhibition DME0009 XEOTICID XEO00105 XEO_NAME Dihydroergotamine DME0009 XEOTICID XEO00105 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00105 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00105 DESCRIPT Dihydroergotamine inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00105 GENEFORM Protein DME0009 XEOTICID XEO00105 MOACRIVE Inhibition DME0009 XEOTICID XEO00173 XEO_NAME Cannabidiol DME0009 XEOTICID XEO00173 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00173 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00173 DESCRIPT Cannabidiol inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00173 GENEFORM Protein DME0009 XEOTICID XEO00173 MOACRIVE Inhibition DME0009 XEOTICID XEO00178 XEO_NAME Capsaicin DME0009 XEOTICID XEO00178 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00178 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00178 DESCRIPT Capsaicin inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00178 GENEFORM Protein DME0009 XEOTICID XEO00178 MOACRIVE Inhibition DME0009 XEOTICID XEO00225 XEO_NAME Quinidine DME0009 XEOTICID XEO00225 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00225 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00225 DESCRIPT Quinidine inhibits the drug-metabolizing activity of DME CYP2D6 (IC50 < 0.006 microM) DME0009 XEOTICID XEO00225 GENEFORM Protein DME0009 XEOTICID XEO00225 MOACRIVE Inhibition DME0009 XEOTICID XEO00244 XEO_NAME Ivermectin DME0009 XEOTICID XEO00244 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00244 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00244 DESCRIPT Ivermectin inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00244 GENEFORM Protein DME0009 XEOTICID XEO00244 MOACRIVE Inhibition DME0009 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0009 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP2D6 (IC50 = 16.3 microM) DME0009 XEOTICID XEO00251 GENEFORM Protein DME0009 XEOTICID XEO00251 MOACRIVE Inhibition DME0009 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0009 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00277 GENEFORM Protein DME0009 XEOTICID XEO00277 MOACRIVE Inhibition DME0009 XEOTICID XEO00282 XEO_NAME Cinacalcet hydrochloride DME0009 XEOTICID XEO00282 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00282 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00282 DESCRIPT Cinacalcet hydrochloride inhibits the drug-metabolizing activity of DME CYP2D6 (IC50 = 0.05 microM) DME0009 XEOTICID XEO00282 GENEFORM Protein DME0009 XEOTICID XEO00282 MOACRIVE Inhibition DME0009 XEOTICID XEO00290 XEO_NAME Dopamine hydrochloride DME0009 XEOTICID XEO00290 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00290 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00290 DESCRIPT Dopamine hydrochloride inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00290 GENEFORM Protein DME0009 XEOTICID XEO00290 MOACRIVE Inhibition DME0009 XEOTICID XEO00311 XEO_NAME Nicardipine hydrochloride DME0009 XEOTICID XEO00311 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00311 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00311 DESCRIPT Nicardipine hydrochloride inhibits the drug-metabolizing activity of DME CYP2D6 (IC50 = 1.59 microM) DME0009 XEOTICID XEO00311 GENEFORM Protein DME0009 XEOTICID XEO00311 MOACRIVE Inhibition DME0009 XEOTICID XEO00316 XEO_NAME Paroxetine hydrochloride DME0009 XEOTICID XEO00316 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00316 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00316 DESCRIPT Paroxetine hydrochloride inhibits the drug-metabolizing activity of DME CYP2D6 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 1 microM) DME0009 XEOTICID XEO00316 GENEFORM Protein DME0009 XEOTICID XEO00316 MOACRIVE Inhibition DME0009 XEOTICID XEO00317 XEO_NAME Pentamidine isethionate DME0009 XEOTICID XEO00317 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00317 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00317 DESCRIPT Pentamidine isethionate inhibits the drug-metabolizing activity of DME CYP2D6 (IC50 = 24.8 microM) DME0009 XEOTICID XEO00317 GENEFORM Protein DME0009 XEOTICID XEO00317 MOACRIVE Inhibition DME0009 XEOTICID XEO00329 XEO_NAME Terbinafine hydrochloride DME0009 XEOTICID XEO00329 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00329 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00329 DESCRIPT Terbinafine hydrochloride inhibits the drug-metabolizing activity of DME CYP2D6 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.2 microM) DME0009 XEOTICID XEO00329 GENEFORM Protein DME0009 XEOTICID XEO00329 MOACRIVE Inhibition DME0009 XEOTICID XEO00331 XEO_NAME Ticlopidine hydrochloride DME0009 XEOTICID XEO00331 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00331 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00331 DESCRIPT Ticlopidine hydrochloride inhibits the drug-metabolizing activity of DME CYP2D6 (IC50 = 4.8 microM) DME0009 XEOTICID XEO00331 GENEFORM Protein DME0009 XEOTICID XEO00331 MOACRIVE Inhibition DME0009 XEOTICID XEO00337 XEO_NAME Amitriptyline DME0009 XEOTICID XEO00337 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00337 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00337 DESCRIPT Amitriptyline inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00337 GENEFORM Protein DME0009 XEOTICID XEO00337 MOACRIVE Inhibition DME0009 XEOTICID XEO00343 XEO_NAME Buprenorphine DME0009 XEOTICID XEO00343 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00343 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00343 DESCRIPT Buprenorphine inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00343 GENEFORM Protein DME0009 XEOTICID XEO00343 MOACRIVE Inhibition DME0009 XEOTICID XEO00357 XEO_NAME Ethambutol DME0009 XEOTICID XEO00357 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00357 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00357 DESCRIPT Ethambutol inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00357 GENEFORM Protein DME0009 XEOTICID XEO00357 MOACRIVE Inhibition DME0009 XEOTICID XEO00358 XEO_NAME Fluoxetine DME0009 XEOTICID XEO00358 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00358 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00358 DESCRIPT Fluoxetine inhibits the drug-metabolizing activity of DME CYP2D6 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.7 microM) DME0009 XEOTICID XEO00358 GENEFORM Protein DME0009 XEOTICID XEO00358 MOACRIVE Inhibition DME0009 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0009 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00380 DESCRIPT Rosiglitazone inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00380 GENEFORM Protein DME0009 XEOTICID XEO00380 MOACRIVE Inhibition DME0009 XEOTICID XEO00405 XEO_NAME Niclosamide DME0009 XEOTICID XEO00405 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00405 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00405 DESCRIPT Niclosamide inhibits the expression of DME CYP2D6 DME0009 XEOTICID XEO00405 GENEFORM mRNA DME0009 XEOTICID XEO00405 MOACRIVE Inhibition DME0009 XEOTICID XEO00431 XEO_NAME Proguanil DME0009 XEOTICID XEO00431 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00431 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00431 DESCRIPT Proguanil inhibits the expression of DME CYP2D6 DME0009 XEOTICID XEO00431 GENEFORM mRNA DME0009 XEOTICID XEO00431 MOACRIVE Inhibition DME0009 XEOTICID XEO00438 XEO_NAME Benidipine DME0009 XEOTICID XEO00438 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00438 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00438 DESCRIPT Benidipine inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00438 GENEFORM Protein DME0009 XEOTICID XEO00438 MOACRIVE Inhibition DME0009 XEOTICID XEO00439 XEO_NAME Daidzein DME0009 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00439 GENEFORM Protein DME0009 XEOTICID XEO00439 MOACRIVE Inhibition DME0009 XEOTICID XEO00452 XEO_NAME Apatinib DME0009 XEOTICID XEO00452 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00452 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00452 DESCRIPT Apatinib inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00452 GENEFORM Protein DME0009 XEOTICID XEO00452 MOACRIVE Inhibition DME0009 XEOTICID XEO00475 XEO_NAME Melarsoprol DME0009 XEOTICID XEO00475 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00475 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00475 DESCRIPT Melarsoprol inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00475 GENEFORM Protein DME0009 XEOTICID XEO00475 MOACRIVE Inhibition DME0009 XEOTICID XEO00480 XEO_NAME Raubasine DME0009 XEOTICID XEO00480 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00480 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00480 DESCRIPT Raubasine inhibits the drug-metabolizing activity of DME CYP2D6 (Ki = 0.0033 microM) DME0009 XEOTICID XEO00480 GENEFORM Protein DME0009 XEOTICID XEO00480 MOACRIVE Inhibition DME0009 XEOTICID XEO00482 XEO_NAME Sarpogrelate DME0009 XEOTICID XEO00482 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00482 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00482 DESCRIPT Sarpogrelate inhibits the expression of DME CYP2D6 DME0009 XEOTICID XEO00482 GENEFORM mRNA DME0009 XEOTICID XEO00482 MOACRIVE Inhibition DME0009 XEOTICID XEO00538 XEO_NAME Quercetin DME0009 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0009 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME CYP2D6 (IC50 = 18.8 microM) DME0009 XEOTICID XEO00538 GENEFORM Protein DME0009 XEOTICID XEO00538 MOACRIVE Inhibition DME0009 XEOTICID XEO00539 XEO_NAME Ethanol DME0009 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0009 XEOTICID XEO00539 DESCRIPT Ethanol induces the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00539 GENEFORM Protein DME0009 XEOTICID XEO00539 MOACRIVE Induction DME0009 XEOTICID XEO00560 XEO_NAME Triclosan DME0009 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0009 XEOTICID XEO00560 DESCRIPT Triclosan up-regulates the expression of DME CYP2D6 DME0009 XEOTICID XEO00560 GENEFORM mRNA DME0009 XEOTICID XEO00560 MOACRIVE Induction DME0009 XEOTICID XEO00567 XEO_NAME Manidipine DME0009 XEOTICID XEO00567 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00567 XEO_CLAS Drug in Phase 3 Clinical Trial DME0009 XEOTICID XEO00567 DESCRIPT Manidipine inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00567 GENEFORM Protein DME0009 XEOTICID XEO00567 MOACRIVE Inhibition DME0009 XEOTICID XEO00568 XEO_NAME Resveratrol DME0009 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0009 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00568 GENEFORM Protein DME0009 XEOTICID XEO00568 MOACRIVE Inhibition DME0009 XEOTICID XEO00598 XEO_NAME Carbendazim DME0009 XEOTICID XEO00598 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00598 XEO_CLAS Drug in Phase 1 Clinical Trial DME0009 XEOTICID XEO00598 DESCRIPT Carbendazim inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00598 GENEFORM Protein DME0009 XEOTICID XEO00598 MOACRIVE Inhibition DME0009 XEOTICID XEO00679 XEO_NAME GSK-369796 DME0009 XEOTICID XEO00679 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00679 XEO_CLAS Drug in Phase 1 Clinical Trial DME0009 XEOTICID XEO00679 DESCRIPT GSK-369796 inhibits the drug-metabolizing activity of DME CYP2D6 (IC50 = 3 microM) DME0009 XEOTICID XEO00679 GENEFORM Protein DME0009 XEOTICID XEO00679 MOACRIVE Inhibition DME0009 XEOTICID XEO00740 XEO_NAME Lindane DME0009 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00740 DESCRIPT Lindane inhibits the expression of DME CYP2D6 DME0009 XEOTICID XEO00740 GENEFORM mRNA DME0009 XEOTICID XEO00740 MOACRIVE Inhibition DME0009 XEOTICID XEO00747 XEO_NAME Cholecalciferol DME0009 XEOTICID XEO00747 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO00747 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO00747 DESCRIPT Cholecalciferol inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00747 GENEFORM Protein DME0009 XEOTICID XEO00747 MOACRIVE Inhibition DME0009 XEOTICID XEO00764 XEO_NAME Naphthalene DME0009 XEOTICID XEO00764 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0009 XEOTICID XEO00764 XEO_CLAS Chemical Compound DME0009 XEOTICID XEO00764 DESCRIPT Naphthalene induces the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00764 GENEFORM Protein DME0009 XEOTICID XEO00764 MOACRIVE Induction DME0009 XEOTICID XEO00802 XEO_NAME Dihydrocapsaicin DME0009 XEOTICID XEO00802 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0009 XEOTICID XEO00802 XEO_CLAS Natural Product DME0009 XEOTICID XEO00802 DESCRIPT Dihydrocapsaicin inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00802 GENEFORM Protein DME0009 XEOTICID XEO00802 MOACRIVE Inhibition DME0009 XEOTICID XEO00857 XEO_NAME Cyclodextrins DME0009 XEOTICID XEO00857 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0009 XEOTICID XEO00857 XEO_CLAS Natural Mixture DME0009 XEOTICID XEO00857 DESCRIPT Cyclodextrins inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00857 GENEFORM Protein DME0009 XEOTICID XEO00857 MOACRIVE Inhibition DME0009 XEOTICID XEO00880 XEO_NAME Isatin DME0009 XEOTICID XEO00880 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0009 XEOTICID XEO00880 XEO_CLAS Natural Product DME0009 XEOTICID XEO00880 DESCRIPT Isatin up-regulates the expression of DME CYP2D6 DME0009 XEOTICID XEO00880 GENEFORM mRNA DME0009 XEOTICID XEO00880 MOACRIVE Induction DME0009 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0009 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0009 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0009 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CYP2D6 DME0009 XEOTICID XEO00898 GENEFORM mRNA DME0009 XEOTICID XEO00898 MOACRIVE Induction DME0009 XEOTICID XEO00955 XEO_NAME Prochloraz DME0009 XEOTICID XEO00955 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0009 XEOTICID XEO00955 XEO_CLAS Fungicide DME0009 XEOTICID XEO00955 DESCRIPT Prochloraz inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00955 GENEFORM Protein DME0009 XEOTICID XEO00955 MOACRIVE Inhibition DME0009 XEOTICID XEO00975 XEO_NAME Isoproturon DME0009 XEOTICID XEO00975 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0009 XEOTICID XEO00975 XEO_CLAS Herbicide DME0009 XEOTICID XEO00975 DESCRIPT Isoproturon inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO00975 GENEFORM Protein DME0009 XEOTICID XEO00975 MOACRIVE Inhibition DME0009 XEOTICID XEO01046 XEO_NAME Cypermethrin DME0009 XEOTICID XEO01046 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0009 XEOTICID XEO01046 XEO_CLAS Pesticide/Insecticide DME0009 XEOTICID XEO01046 DESCRIPT Cypermethrin inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01046 GENEFORM Protein DME0009 XEOTICID XEO01046 MOACRIVE Inhibition DME0009 XEOTICID XEO01047 XEO_NAME Decamethrin DME0009 XEOTICID XEO01047 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0009 XEOTICID XEO01047 XEO_CLAS Pesticide/Insecticide DME0009 XEOTICID XEO01047 DESCRIPT Decamethrin inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01047 GENEFORM Protein DME0009 XEOTICID XEO01047 MOACRIVE Inhibition DME0009 XEOTICID XEO01053 XEO_NAME Fenvalerate DME0009 XEOTICID XEO01053 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0009 XEOTICID XEO01053 XEO_CLAS Pesticide/Insecticide DME0009 XEOTICID XEO01053 DESCRIPT Fenvalerate inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01053 GENEFORM Protein DME0009 XEOTICID XEO01053 MOACRIVE Inhibition DME0009 XEOTICID XEO01099 XEO_NAME 1-aminobenzotriazole DME0009 XEOTICID XEO01099 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO01099 XEO_CLAS Preclinical/Patented Drug DME0009 XEOTICID XEO01099 DESCRIPT 1-aminobenzotriazole inhibits the drug-metabolizing activity of DME CYP2D6 (IC50 = 10.5 microM) DME0009 XEOTICID XEO01099 GENEFORM Protein DME0009 XEOTICID XEO01099 MOACRIVE Inhibition DME0009 XEOTICID XEO01130 XEO_NAME DY-9760e DME0009 XEOTICID XEO01130 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO01130 XEO_CLAS Investigative Agent DME0009 XEOTICID XEO01130 DESCRIPT DY-9760e inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01130 GENEFORM Protein DME0009 XEOTICID XEO01130 MOACRIVE Inhibition DME0009 XEOTICID XEO01159 XEO_NAME 5-fluorotryptamine DME0009 XEOTICID XEO01159 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO01159 XEO_CLAS Investigative Agent DME0009 XEOTICID XEO01159 DESCRIPT 5-fluorotryptamine inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01159 GENEFORM Protein DME0009 XEOTICID XEO01159 MOACRIVE Inhibition DME0009 XEOTICID XEO01163 XEO_NAME 5-methoxyindole DME0009 XEOTICID XEO01163 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO01163 XEO_CLAS Investigative Agent DME0009 XEOTICID XEO01163 DESCRIPT 5-methoxyindole inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01163 GENEFORM Protein DME0009 XEOTICID XEO01163 MOACRIVE Inhibition DME0009 XEOTICID XEO01177 XEO_NAME 7-methyltryptamine DME0009 XEOTICID XEO01177 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO01177 XEO_CLAS Investigative Agent DME0009 XEOTICID XEO01177 DESCRIPT 7-methyltryptamine inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01177 GENEFORM Protein DME0009 XEOTICID XEO01177 MOACRIVE Inhibition DME0009 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0009 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0009 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME CYP2D6 DME0009 XEOTICID XEO01220 GENEFORM mRNA DME0009 XEOTICID XEO01220 MOACRIVE Inhibition DME0009 XEOTICID XEO01230 XEO_NAME Butyric acid DME0009 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0009 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME CYP2D6 DME0009 XEOTICID XEO01230 GENEFORM mRNA DME0009 XEOTICID XEO01230 MOACRIVE Induction DME0009 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0009 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0009 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0009 XEOTICID XEO01248 DESCRIPT Chlorpyrifos inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01248 GENEFORM Protein DME0009 XEOTICID XEO01248 MOACRIVE Inhibition DME0009 XEOTICID XEO01252 XEO_NAME Cinnamic acid DME0009 XEOTICID XEO01252 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO01252 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO01252 DESCRIPT Cinnamic acid inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01252 GENEFORM Protein DME0009 XEOTICID XEO01252 MOACRIVE Inhibition DME0009 XEOTICID XEO01274 XEO_NAME Diazinon DME0009 XEOTICID XEO01274 XEO_TYPE Health or Environmental Toxicant(s) DME0009 XEOTICID XEO01274 XEO_CLAS Environmental Pollutant DME0009 XEOTICID XEO01274 DESCRIPT Diazinon up-regulates the expression of DME CYP2D6 DME0009 XEOTICID XEO01274 GENEFORM mRNA DME0009 XEOTICID XEO01274 MOACRIVE Induction DME0009 XEOTICID XEO01302 XEO_NAME Fipronil DME0009 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0009 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0009 XEOTICID XEO01302 DESCRIPT Fipronil inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01302 GENEFORM Protein DME0009 XEOTICID XEO01302 MOACRIVE Inhibition DME0009 XEOTICID XEO01306 XEO_NAME Formononetin DME0009 XEOTICID XEO01306 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO01306 XEO_CLAS Approved/Marketed Drug DME0009 XEOTICID XEO01306 DESCRIPT Formononetin inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01306 GENEFORM Protein DME0009 XEOTICID XEO01306 MOACRIVE Inhibition DME0009 XEOTICID XEO01313 XEO_NAME Germacrone DME0009 XEOTICID XEO01313 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0009 XEOTICID XEO01313 XEO_CLAS Natural Product DME0009 XEOTICID XEO01313 DESCRIPT Germacrone inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01313 GENEFORM Protein DME0009 XEOTICID XEO01313 MOACRIVE Inhibition DME0009 XEOTICID XEO01337 XEO_NAME ICI-199441 DME0009 XEOTICID XEO01337 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO01337 XEO_CLAS Preclinical/Patented Drug DME0009 XEOTICID XEO01337 DESCRIPT ICI-199441 inhibits the drug-metabolizing activity of DME CYP2D6 (IC50 = 0.026 microM) DME0009 XEOTICID XEO01337 GENEFORM Protein DME0009 XEOTICID XEO01337 MOACRIVE Inhibition DME0009 XEOTICID XEO01345 XEO_NAME Inermin DME0009 XEOTICID XEO01345 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0009 XEOTICID XEO01345 XEO_CLAS Natural Product DME0009 XEOTICID XEO01345 DESCRIPT Inermin inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01345 GENEFORM Protein DME0009 XEOTICID XEO01345 MOACRIVE Inhibition DME0009 XEOTICID XEO01384 XEO_NAME Myricetin DME0009 XEOTICID XEO01384 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO01384 XEO_CLAS Preclinical/Patented Drug DME0009 XEOTICID XEO01384 DESCRIPT Myricetin inhibits the expression of DME CYP2D6 DME0009 XEOTICID XEO01384 GENEFORM mRNA DME0009 XEOTICID XEO01384 MOACRIVE Inhibition DME0009 XEOTICID XEO01396 XEO_NAME HET-0016 DME0009 XEOTICID XEO01396 XEO_TYPE Pharmaceutical Agent(s) DME0009 XEOTICID XEO01396 XEO_CLAS Preclinical/Patented Drug DME0009 XEOTICID XEO01396 DESCRIPT HET-0016 inhibits the drug-metabolizing activity of DME CYP2D6 (IC50 = 83.9 microM) DME0009 XEOTICID XEO01396 GENEFORM Protein DME0009 XEOTICID XEO01396 MOACRIVE Inhibition DME0009 XEOTICID XEO01467 XEO_NAME Salinomycin DME0009 XEOTICID XEO01467 XEO_TYPE Health or Environmental Toxicant(s) DME0009 XEOTICID XEO01467 XEO_CLAS Acute Toxic Substance DME0009 XEOTICID XEO01467 DESCRIPT Salinomycin inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01467 GENEFORM Protein DME0009 XEOTICID XEO01467 MOACRIVE Inhibition DME0009 XEOTICID XEO01472 XEO_NAME Sophoranone DME0009 XEOTICID XEO01472 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0009 XEOTICID XEO01472 XEO_CLAS Natural Product DME0009 XEOTICID XEO01472 DESCRIPT Sophoranone inhibits the expression of DME CYP2D6 DME0009 XEOTICID XEO01472 GENEFORM mRNA DME0009 XEOTICID XEO01472 MOACRIVE Inhibition DME0009 XEOTICID XEO01512 XEO_NAME Zinc DME0009 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME0009 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME0009 XEOTICID XEO01512 DESCRIPT Zinc up-regulates the expression of DME CYP2D6 DME0009 XEOTICID XEO01512 GENEFORM mRNA DME0009 XEOTICID XEO01512 MOACRIVE Induction DME0009 XEOTICID XEO01518 XEO_NAME 5-methyltryptamine DME0009 XEOTICID XEO01518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0009 XEOTICID XEO01518 XEO_CLAS Natural Product DME0009 XEOTICID XEO01518 DESCRIPT 5-methyltryptamine inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01518 GENEFORM Protein DME0009 XEOTICID XEO01518 MOACRIVE Inhibition DME0009 XEOTICID XEO01541 XEO_NAME Eupatorin DME0009 XEOTICID XEO01541 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0009 XEOTICID XEO01541 XEO_CLAS Natural Product DME0009 XEOTICID XEO01541 DESCRIPT Eupatorin inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01541 GENEFORM Protein DME0009 XEOTICID XEO01541 MOACRIVE Inhibition DME0009 XEOTICID XEO01564 XEO_NAME Mitragynine DME0009 XEOTICID XEO01564 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0009 XEOTICID XEO01564 XEO_CLAS Natural Product DME0009 XEOTICID XEO01564 DESCRIPT Mitragynine up-regulates the expression of DME CYP2D6 DME0009 XEOTICID XEO01564 GENEFORM mRNA DME0009 XEOTICID XEO01564 MOACRIVE Induction DME0009 XEOTICID XEO01574 XEO_NAME Plant extracts DME0009 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0009 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0009 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01574 GENEFORM Protein DME0009 XEOTICID XEO01574 MOACRIVE Inhibition DME0009 XEOTICID XEO01586 XEO_NAME Serpentine hydroxide DME0009 XEOTICID XEO01586 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0009 XEOTICID XEO01586 XEO_CLAS Natural Product DME0009 XEOTICID XEO01586 DESCRIPT Serpentine hydroxide inhibits the expression of DME CYP2D6 DME0009 XEOTICID XEO01586 GENEFORM mRNA DME0009 XEOTICID XEO01586 MOACRIVE Inhibition DME0009 XEOTICID XEO01587 XEO_NAME Shikonin DME0009 XEOTICID XEO01587 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0009 XEOTICID XEO01587 XEO_CLAS Natural Product DME0009 XEOTICID XEO01587 DESCRIPT Shikonin inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01587 GENEFORM Protein DME0009 XEOTICID XEO01587 MOACRIVE Inhibition DME0009 XEOTICID XEO01600 XEO_NAME Cyhalothrin DME0009 XEOTICID XEO01600 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0009 XEOTICID XEO01600 XEO_CLAS Pesticide/Insecticide DME0009 XEOTICID XEO01600 DESCRIPT Cyhalothrin inhibits the drug-metabolizing activity of DME CYP2D6 DME0009 XEOTICID XEO01600 GENEFORM Protein DME0009 XEOTICID XEO01600 MOACRIVE Inhibition DME0010 DME___ID DME0010 DME0010 DME_NAME Cytochrome P450 4B1 (CYP4B1) DME0010 SPESNAME Homo sapiens DME0010 XEOTICID XEO00184 XEO_NAME Calcitriol DME0010 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0010 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0010 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME CYP4B1 DME0010 XEOTICID XEO00184 GENEFORM mRNA DME0010 XEOTICID XEO00184 MOACRIVE Inhibition DME0010 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0010 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0010 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0010 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP4B1 DME0010 XEOTICID XEO00217 GENEFORM mRNA DME0010 XEOTICID XEO00217 MOACRIVE Inhibition DME0010 XEOTICID XEO00218 XEO_NAME Caffeine DME0010 XEOTICID XEO00218 XEO_TYPE Pharmaceutical Agent(s) DME0010 XEOTICID XEO00218 XEO_CLAS Approved/Marketed Drug DME0010 XEOTICID XEO00218 DESCRIPT Caffeine up-regulates the expression of DME CYP4B1 DME0010 XEOTICID XEO00218 GENEFORM mRNA DME0010 XEOTICID XEO00218 MOACRIVE Induction DME0010 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0010 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0010 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0010 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP4B1 DME0010 XEOTICID XEO00241 GENEFORM mRNA DME0010 XEOTICID XEO00241 MOACRIVE Inhibition DME0010 XEOTICID XEO00253 XEO_NAME Tretinoin DME0010 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0010 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0010 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME CYP4B1 DME0010 XEOTICID XEO00253 GENEFORM mRNA DME0010 XEOTICID XEO00253 MOACRIVE Inhibition DME0010 XEOTICID XEO00557 XEO_NAME Genistein DME0010 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0010 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0010 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME CYP4B1 DME0010 XEOTICID XEO00557 GENEFORM mRNA DME0010 XEOTICID XEO00557 MOACRIVE Inhibition DME0010 XEOTICID XEO00560 XEO_NAME Triclosan DME0010 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0010 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0010 XEOTICID XEO00560 DESCRIPT Triclosan up-regulates the expression of DME CYP4B1 DME0010 XEOTICID XEO00560 GENEFORM mRNA DME0010 XEOTICID XEO00560 MOACRIVE Induction DME0010 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0010 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0010 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0010 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME CYP4B1 DME0010 XEOTICID XEO00772 GENEFORM mRNA DME0010 XEOTICID XEO00772 MOACRIVE Induction DME0010 XEOTICID XEO00793 XEO_NAME Tungsten DME0010 XEOTICID XEO00793 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0010 XEOTICID XEO00793 XEO_CLAS Chemical Compound DME0010 XEOTICID XEO00793 DESCRIPT Tungsten up-regulates the expression of DME CYP4B1 DME0010 XEOTICID XEO00793 GENEFORM mRNA DME0010 XEOTICID XEO00793 MOACRIVE Induction DME0010 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0010 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0010 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0010 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME CYP4B1 DME0010 XEOTICID XEO00821 GENEFORM mRNA DME0010 XEOTICID XEO00821 MOACRIVE Inhibition DME0010 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0010 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0010 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0010 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME CYP4B1 DME0010 XEOTICID XEO00898 GENEFORM mRNA DME0010 XEOTICID XEO00898 MOACRIVE Inhibition DME0010 XEOTICID XEO01009 XEO_NAME Glycidamide DME0010 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0010 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0010 XEOTICID XEO01009 DESCRIPT Glycidamide inhibits the expression of DME CYP4B1 DME0010 XEOTICID XEO01009 GENEFORM mRNA DME0010 XEOTICID XEO01009 MOACRIVE Inhibition DME0010 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0010 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0010 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0010 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME CYP4B1 DME0010 XEOTICID XEO01220 GENEFORM mRNA DME0010 XEOTICID XEO01220 MOACRIVE Inhibition DME0010 XEOTICID XEO01574 XEO_NAME Plant extracts DME0010 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0010 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0010 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME CYP4B1 DME0010 XEOTICID XEO01574 GENEFORM Protein DME0010 XEOTICID XEO01574 MOACRIVE Inhibition DME0011 DME___ID DME0011 DME0011 DME_NAME Glutathione S-transferase alpha-1 (GSTA1) DME0011 SPESNAME Homo sapiens DME0011 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0011 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME GSTA1 DME0011 XEOTICID XEO00011 GENEFORM mRNA DME0011 XEOTICID XEO00011 MOACRIVE Induction DME0011 XEOTICID XEO00014 XEO_NAME Chlorambucil DME0011 XEOTICID XEO00014 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00014 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00014 DESCRIPT Chlorambucil inhibits the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00014 GENEFORM Protein DME0011 XEOTICID XEO00014 MOACRIVE Inhibition DME0011 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0011 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00088 DESCRIPT Dexamethasone induces the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00088 GENEFORM Protein DME0011 XEOTICID XEO00088 MOACRIVE Induction DME0011 XEOTICID XEO00090 XEO_NAME Estradiol DME0011 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO00090 GENEFORM mRNA DME0011 XEOTICID XEO00090 MOACRIVE Inhibition DME0011 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0011 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO00117 GENEFORM mRNA DME0011 XEOTICID XEO00117 MOACRIVE Inhibition DME0011 XEOTICID XEO00127 XEO_NAME Mifepristone DME0011 XEOTICID XEO00127 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00127 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00127 DESCRIPT Mifepristone induces the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00127 GENEFORM Protein DME0011 XEOTICID XEO00127 MOACRIVE Induction DME0011 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0011 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME GSTA1 DME0011 XEOTICID XEO00217 GENEFORM mRNA DME0011 XEOTICID XEO00217 MOACRIVE Induction DME0011 XEOTICID XEO00223 XEO_NAME Rifampin DME0011 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00223 DESCRIPT Rifampin induces the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00223 GENEFORM Protein DME0011 XEOTICID XEO00223 MOACRIVE Induction DME0011 XEOTICID XEO00232 XEO_NAME Phenytoin DME0011 XEOTICID XEO00232 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00232 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00232 DESCRIPT Phenytoin up-regulates the expression of DME GSTA1 DME0011 XEOTICID XEO00232 GENEFORM mRNA DME0011 XEOTICID XEO00232 MOACRIVE Induction DME0011 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0011 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO00241 GENEFORM mRNA DME0011 XEOTICID XEO00241 MOACRIVE Inhibition DME0011 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0011 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO00251 GENEFORM mRNA DME0011 XEOTICID XEO00251 MOACRIVE Inhibition DME0011 XEOTICID XEO00264 XEO_NAME Hydrocortisone DME0011 XEOTICID XEO00264 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00264 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00264 DESCRIPT Hydrocortisone up-regulates the expression of DME GSTA1 and leads to increasing the drug-metabolizing activity of this enzyme DME0011 XEOTICID XEO00264 GENEFORM Protein DME0011 XEOTICID XEO00264 MOACRIVE Induction DME0011 XEOTICID XEO00290 XEO_NAME Dopamine hydrochloride DME0011 XEOTICID XEO00290 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00290 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00290 DESCRIPT Dopamine hydrochloride inhibits the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00290 GENEFORM Protein DME0011 XEOTICID XEO00290 MOACRIVE Inhibition DME0011 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0011 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME GSTA1 DME0011 XEOTICID XEO00339 GENEFORM mRNA DME0011 XEOTICID XEO00339 MOACRIVE Induction DME0011 XEOTICID XEO00352 XEO_NAME Diclofenac DME0011 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00352 DESCRIPT Diclof DMEenac inhibits the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00352 GENEFORM Protein DME0011 XEOTICID XEO00352 MOACRIVE Inhibition DME0011 XEOTICID XEO00366 XEO_NAME Methotrexate DME0011 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00366 DESCRIPT Methotrexate up-regulates the expression of DME GSTA1 DME0011 XEOTICID XEO00366 GENEFORM mRNA DME0011 XEOTICID XEO00366 MOACRIVE Induction DME0011 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0011 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00410 GENEFORM Protein DME0011 XEOTICID XEO00410 MOACRIVE Inhibition DME0011 XEOTICID XEO00421 XEO_NAME Aemcolo DME0011 XEOTICID XEO00421 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00421 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00421 DESCRIPT Aemcolo up-regulates the expression of DME GSTA1 DME0011 XEOTICID XEO00421 GENEFORM mRNA DME0011 XEOTICID XEO00421 MOACRIVE Induction DME0011 XEOTICID XEO00435 XEO_NAME Urethane DME0011 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO00435 GENEFORM mRNA DME0011 XEOTICID XEO00435 MOACRIVE Inhibition DME0011 XEOTICID XEO00447 XEO_NAME Benzoic acid DME0011 XEOTICID XEO00447 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00447 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00447 DESCRIPT Benzoic acid induces the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00447 GENEFORM Protein DME0011 XEOTICID XEO00447 MOACRIVE Induction DME0011 XEOTICID XEO00449 XEO_NAME Artemisinine DME0011 XEOTICID XEO00449 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00449 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO00449 DESCRIPT Artemisinine inhibits the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00449 GENEFORM Protein DME0011 XEOTICID XEO00449 MOACRIVE Inhibition DME0011 XEOTICID XEO00538 XEO_NAME Quercetin DME0011 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0011 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00538 GENEFORM Protein DME0011 XEOTICID XEO00538 MOACRIVE Inhibition DME0011 XEOTICID XEO00579 XEO_NAME SGX301 DME0011 XEOTICID XEO00579 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00579 XEO_CLAS Drug in Phase 3 Clinical Trial DME0011 XEOTICID XEO00579 DESCRIPT SGX301 inhibits the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00579 GENEFORM Protein DME0011 XEOTICID XEO00579 MOACRIVE Inhibition DME0011 XEOTICID XEO00609 XEO_NAME MeIQx DME0011 XEOTICID XEO00609 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00609 XEO_CLAS Drug in Phase 2 Clinical Trial DME0011 XEOTICID XEO00609 DESCRIPT MeIQx inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO00609 GENEFORM mRNA DME0011 XEOTICID XEO00609 MOACRIVE Inhibition DME0011 XEOTICID XEO00636 XEO_NAME Xanthohumol DME0011 XEOTICID XEO00636 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00636 XEO_CLAS Drug in Phase 1 Clinical Trial DME0011 XEOTICID XEO00636 DESCRIPT Xanthohumol inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO00636 GENEFORM mRNA DME0011 XEOTICID XEO00636 MOACRIVE Inhibition DME0011 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0011 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0011 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0011 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME GSTA1 DME0011 XEOTICID XEO00772 GENEFORM mRNA DME0011 XEOTICID XEO00772 MOACRIVE Induction DME0011 XEOTICID XEO00793 XEO_NAME Tungsten DME0011 XEOTICID XEO00793 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0011 XEOTICID XEO00793 XEO_CLAS Chemical Compound DME0011 XEOTICID XEO00793 DESCRIPT Tungsten up-regulates the expression of DME GSTA1 DME0011 XEOTICID XEO00793 GENEFORM mRNA DME0011 XEOTICID XEO00793 MOACRIVE Induction DME0011 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0011 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0011 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0011 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO00806 GENEFORM mRNA DME0011 XEOTICID XEO00806 MOACRIVE Inhibition DME0011 XEOTICID XEO00813 XEO_NAME Dinophysistoxin 1 DME0011 XEOTICID XEO00813 XEO_TYPE Health or Environmental Toxicant(s) DME0011 XEOTICID XEO00813 XEO_CLAS Biotoxin DME0011 XEOTICID XEO00813 DESCRIPT Dinophysistoxin 1 inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO00813 GENEFORM mRNA DME0011 XEOTICID XEO00813 MOACRIVE Inhibition DME0011 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0011 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0011 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0011 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO00821 GENEFORM mRNA DME0011 XEOTICID XEO00821 MOACRIVE Inhibition DME0011 XEOTICID XEO00873 XEO_NAME Alpha-linolenic acid DME0011 XEOTICID XEO00873 XEO_TYPE Health or Environmental Toxicant(s) DME0011 XEOTICID XEO00873 XEO_CLAS Health Hazard/Toxicant DME0011 XEOTICID XEO00873 DESCRIPT Alpha-linolenic acid up-regulates the expression of DME GSTA1 DME0011 XEOTICID XEO00873 GENEFORM mRNA DME0011 XEOTICID XEO00873 MOACRIVE Induction DME0011 XEOTICID XEO00877 XEO_NAME Bilirubin DME0011 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0011 XEOTICID XEO00877 XEO_CLAS Natural Product DME0011 XEOTICID XEO00877 DESCRIPT Bilirubin up-regulates the expression of DME GSTA1 DME0011 XEOTICID XEO00877 GENEFORM mRNA DME0011 XEOTICID XEO00877 MOACRIVE Induction DME0011 XEOTICID XEO00885 XEO_NAME Eugenol DME0011 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0011 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00885 GENEFORM Protein DME0011 XEOTICID XEO00885 MOACRIVE Inhibition DME0011 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0011 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0011 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0011 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO00898 GENEFORM mRNA DME0011 XEOTICID XEO00898 MOACRIVE Inhibition DME0011 XEOTICID XEO00901 XEO_NAME Arachidoyl-coenzyme A DME0011 XEOTICID XEO00901 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0011 XEOTICID XEO00901 XEO_CLAS Natural Product DME0011 XEOTICID XEO00901 DESCRIPT Arachidoyl-coenzyme A inhibits the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00901 GENEFORM Protein DME0011 XEOTICID XEO00901 MOACRIVE Inhibition DME0011 XEOTICID XEO00902 XEO_NAME Lauroyl-coenzyme A DME0011 XEOTICID XEO00902 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0011 XEOTICID XEO00902 XEO_CLAS Natural Product DME0011 XEOTICID XEO00902 DESCRIPT Lauroyl-coenzyme A inhibits the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00902 GENEFORM Protein DME0011 XEOTICID XEO00902 MOACRIVE Inhibition DME0011 XEOTICID XEO00912 XEO_NAME Estradiol 3,17-disulfate DME0011 XEOTICID XEO00912 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0011 XEOTICID XEO00912 XEO_CLAS Natural Product DME0011 XEOTICID XEO00912 DESCRIPT Estradiol 3,17-disulfate inhibits the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00912 GENEFORM Protein DME0011 XEOTICID XEO00912 MOACRIVE Inhibition DME0011 XEOTICID XEO00917 XEO_NAME Polychlorinated dibenzodioxin DME0011 XEOTICID XEO00917 XEO_TYPE Health or Environmental Toxicant(s) DME0011 XEOTICID XEO00917 XEO_CLAS Environmental Pollutant DME0011 XEOTICID XEO00917 DESCRIPT Polychlorinated dibenzodioxin up-regulates the expression of DME GSTA1 DME0011 XEOTICID XEO00917 GENEFORM mRNA DME0011 XEOTICID XEO00917 MOACRIVE Induction DME0011 XEOTICID XEO00929 XEO_NAME 4-propylphenol DME0011 XEOTICID XEO00929 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0011 XEOTICID XEO00929 XEO_CLAS Food Additive DME0011 XEOTICID XEO00929 DESCRIPT 4-propylphenol inhibits the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO00929 GENEFORM Protein DME0011 XEOTICID XEO00929 MOACRIVE Inhibition DME0011 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0011 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0011 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0011 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME GSTA1 DME0011 XEOTICID XEO01004 GENEFORM mRNA DME0011 XEOTICID XEO01004 MOACRIVE Induction DME0011 XEOTICID XEO01020 XEO_NAME Picolines DME0011 XEOTICID XEO01020 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0011 XEOTICID XEO01020 XEO_CLAS Chemical Compound DME0011 XEOTICID XEO01020 DESCRIPT Picolines inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO01020 GENEFORM mRNA DME0011 XEOTICID XEO01020 MOACRIVE Inhibition DME0011 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0011 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0011 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0011 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO01050 GENEFORM mRNA DME0011 XEOTICID XEO01050 MOACRIVE Inhibition DME0011 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0011 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0011 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0011 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO01119 GENEFORM mRNA DME0011 XEOTICID XEO01119 MOACRIVE Inhibition DME0011 XEOTICID XEO01140 XEO_NAME 3-methylpyridine DME0011 XEOTICID XEO01140 XEO_TYPE Health or Environmental Toxicant(s) DME0011 XEOTICID XEO01140 XEO_CLAS Acute Toxic Substance DME0011 XEOTICID XEO01140 DESCRIPT 3-methylpyridine inhibits the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO01140 GENEFORM Protein DME0011 XEOTICID XEO01140 MOACRIVE Inhibition DME0011 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0011 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0011 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO01220 GENEFORM mRNA DME0011 XEOTICID XEO01220 MOACRIVE Inhibition DME0011 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0011 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0011 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0011 XEOTICID XEO01248 DESCRIPT Chlorpyrifos induces the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO01248 GENEFORM Protein DME0011 XEOTICID XEO01248 MOACRIVE Induction DME0011 XEOTICID XEO01348 XEO_NAME K-7174 DME0011 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0011 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO01348 GENEFORM mRNA DME0011 XEOTICID XEO01348 MOACRIVE Inhibition DME0011 XEOTICID XEO01353 XEO_NAME Kaempferol DME0011 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME0011 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME0011 XEOTICID XEO01353 DESCRIPT Kaempferol up-regulates the expression of DME GSTA1 DME0011 XEOTICID XEO01353 GENEFORM mRNA DME0011 XEOTICID XEO01353 MOACRIVE Induction DME0011 XEOTICID XEO01367 XEO_NAME Linoleic acid DME0011 XEOTICID XEO01367 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO01367 XEO_CLAS Approved/Marketed Drug DME0011 XEOTICID XEO01367 DESCRIPT Linoleic acid up-regulates the expression of DME GSTA1 DME0011 XEOTICID XEO01367 GENEFORM mRNA DME0011 XEOTICID XEO01367 MOACRIVE Induction DME0011 XEOTICID XEO01409 XEO_NAME Okadaic acid DME0011 XEOTICID XEO01409 XEO_TYPE Health or Environmental Toxicant(s) DME0011 XEOTICID XEO01409 XEO_CLAS Acute Toxic Substance DME0011 XEOTICID XEO01409 DESCRIPT Okadaic acid inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO01409 GENEFORM mRNA DME0011 XEOTICID XEO01409 MOACRIVE Inhibition DME0011 XEOTICID XEO01413 XEO_NAME Oleoyl-coenzyme A DME0011 XEOTICID XEO01413 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO01413 XEO_CLAS Preclinical/Patented Drug DME0011 XEOTICID XEO01413 DESCRIPT Oleoyl-coenzyme A inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO01413 GENEFORM mRNA DME0011 XEOTICID XEO01413 MOACRIVE Inhibition DME0011 XEOTICID XEO01478 XEO_NAME Sulforafan DME0011 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0011 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0011 XEOTICID XEO01478 DESCRIPT Sulforafan induces the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO01478 GENEFORM Protein DME0011 XEOTICID XEO01478 MOACRIVE Induction DME0011 XEOTICID XEO01497 XEO_NAME Usnic acid DME0011 XEOTICID XEO01497 XEO_TYPE Health or Environmental Toxicant(s) DME0011 XEOTICID XEO01497 XEO_CLAS Acute Toxic Substance DME0011 XEOTICID XEO01497 DESCRIPT Usnic acid induces the drug-metabolizing activity of DME GSTA1 DME0011 XEOTICID XEO01497 GENEFORM Protein DME0011 XEOTICID XEO01497 MOACRIVE Induction DME0011 XEOTICID XEO01502 XEO_NAME Azaspiracid DME0011 XEOTICID XEO01502 XEO_TYPE Health or Environmental Toxicant(s) DME0011 XEOTICID XEO01502 XEO_CLAS Biotoxin DME0011 XEOTICID XEO01502 DESCRIPT Azaspiracid inhibits the expression of DME GSTA1 DME0011 XEOTICID XEO01502 GENEFORM mRNA DME0011 XEOTICID XEO01502 MOACRIVE Inhibition DME0012 DME___ID DME0012 DME0012 DME_NAME Cytochrome P450 3A5 (CYP3A5) DME0012 SPESNAME Homo sapiens DME0012 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0012 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00011 GENEFORM mRNA DME0012 XEOTICID XEO00011 MOACRIVE Induction DME0012 XEOTICID XEO00017 XEO_NAME Clotrimazole DME0012 XEOTICID XEO00017 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00017 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00017 DESCRIPT Clotrimazole induces the drug-metabolizing activity of DME CYP3A5 DME0012 XEOTICID XEO00017 GENEFORM Protein DME0012 XEOTICID XEO00017 MOACRIVE Induction DME0012 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0012 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00088 GENEFORM mRNA DME0012 XEOTICID XEO00088 MOACRIVE Induction DME0012 XEOTICID XEO00094 XEO_NAME Progesterone DME0012 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00094 DESCRIPT Progesterone induces the drug-metabolizing activity of DME CYP3A5 DME0012 XEOTICID XEO00094 GENEFORM Protein DME0012 XEOTICID XEO00094 MOACRIVE Induction DME0012 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0012 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00117 GENEFORM mRNA DME0012 XEOTICID XEO00117 MOACRIVE Induction DME0012 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0012 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00140 DESCRIPT Zoledronic acid up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00140 GENEFORM mRNA DME0012 XEOTICID XEO00140 MOACRIVE Induction DME0012 XEOTICID XEO00145 XEO_NAME Flunisolide DME0012 XEOTICID XEO00145 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00145 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00145 DESCRIPT Flunisolide up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00145 GENEFORM mRNA DME0012 XEOTICID XEO00145 MOACRIVE Induction DME0012 XEOTICID XEO00160 XEO_NAME Ritonavir DME0012 XEOTICID XEO00160 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00160 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00160 DESCRIPT Ritonavir inhibits the drug-metabolizing activity of DME CYP3A5 (Ki = 0.12 microM) DME0012 XEOTICID XEO00160 GENEFORM Protein DME0012 XEOTICID XEO00160 MOACRIVE Inhibition DME0012 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0012 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00165 DESCRIPT Obeticholic acid inhibits the drug-metabolizing activity of DME CYP3A5 DME0012 XEOTICID XEO00165 GENEFORM Protein DME0012 XEOTICID XEO00165 MOACRIVE Inhibition DME0012 XEOTICID XEO00173 XEO_NAME Cannabidiol DME0012 XEOTICID XEO00173 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00173 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00173 DESCRIPT Cannabidiol inhibits the drug-metabolizing activity of DME CYP3A5 DME0012 XEOTICID XEO00173 GENEFORM Protein DME0012 XEOTICID XEO00173 MOACRIVE Inhibition DME0012 XEOTICID XEO00184 XEO_NAME Calcitriol DME0012 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00184 GENEFORM mRNA DME0012 XEOTICID XEO00184 MOACRIVE Induction DME0012 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0012 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP3A5 DME0012 XEOTICID XEO00217 GENEFORM mRNA DME0012 XEOTICID XEO00217 MOACRIVE Inhibition DME0012 XEOTICID XEO00222 XEO_NAME Reserpine DME0012 XEOTICID XEO00222 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00222 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00222 DESCRIPT Reserpine up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00222 GENEFORM mRNA DME0012 XEOTICID XEO00222 MOACRIVE Induction DME0012 XEOTICID XEO00223 XEO_NAME Rifampin DME0012 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00223 DESCRIPT Rifampin up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00223 GENEFORM mRNA DME0012 XEOTICID XEO00223 MOACRIVE Induction DME0012 XEOTICID XEO00231 XEO_NAME Troleandomycin DME0012 XEOTICID XEO00231 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00231 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00231 DESCRIPT Troleandomycin inhibits the expression of DME CYP3A5 DME0012 XEOTICID XEO00231 GENEFORM mRNA DME0012 XEOTICID XEO00231 MOACRIVE Inhibition DME0012 XEOTICID XEO00232 XEO_NAME Phenytoin DME0012 XEOTICID XEO00232 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00232 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00232 DESCRIPT Phenytoin up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00232 GENEFORM mRNA DME0012 XEOTICID XEO00232 MOACRIVE Induction DME0012 XEOTICID XEO00235 XEO_NAME Budesonide DME0012 XEOTICID XEO00235 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00235 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00235 DESCRIPT Budesonide up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00235 GENEFORM mRNA DME0012 XEOTICID XEO00235 MOACRIVE Induction DME0012 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0012 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP3A5 DME0012 XEOTICID XEO00241 GENEFORM mRNA DME0012 XEOTICID XEO00241 MOACRIVE Inhibition DME0012 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0012 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP3A5 (IC50 = 0.12 microM) DME0012 XEOTICID XEO00251 GENEFORM Protein DME0012 XEOTICID XEO00251 MOACRIVE Inhibition DME0012 XEOTICID XEO00264 XEO_NAME Hydrocortisone DME0012 XEOTICID XEO00264 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00264 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00264 DESCRIPT Hydrocortisone up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00264 GENEFORM mRNA DME0012 XEOTICID XEO00264 MOACRIVE Induction DME0012 XEOTICID XEO00278 XEO_NAME Beclomethasone dipropionate DME0012 XEOTICID XEO00278 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00278 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00278 DESCRIPT Beclomethasone dipropionate up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00278 GENEFORM mRNA DME0012 XEOTICID XEO00278 MOACRIVE Induction DME0012 XEOTICID XEO00284 XEO_NAME Clobetasol propionate DME0012 XEOTICID XEO00284 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00284 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00284 DESCRIPT Clobetasol propionate up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00284 GENEFORM mRNA DME0012 XEOTICID XEO00284 MOACRIVE Induction DME0012 XEOTICID XEO00297 XEO_NAME Fluticasone furoate DME0012 XEOTICID XEO00297 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00297 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00297 DESCRIPT Fluticasone furoate inhibits the drug-metabolizing activity of DME CYP3A5 DME0012 XEOTICID XEO00297 GENEFORM Protein DME0012 XEOTICID XEO00297 MOACRIVE Inhibition DME0012 XEOTICID XEO00310 XEO_NAME Nelfinavir mesylate DME0012 XEOTICID XEO00310 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00310 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00310 DESCRIPT Nelfinavir mesylate inhibits the drug-metabolizing activity of DME CYP3A5 (Ki = 0.57 microM) DME0012 XEOTICID XEO00310 GENEFORM Protein DME0012 XEOTICID XEO00310 MOACRIVE Inhibition DME0012 XEOTICID XEO00387 XEO_NAME Verapamil DME0012 XEOTICID XEO00387 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00387 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00387 DESCRIPT Verapamil inhibits the expression of DME CYP3A5 DME0012 XEOTICID XEO00387 GENEFORM mRNA DME0012 XEOTICID XEO00387 MOACRIVE Inhibition DME0012 XEOTICID XEO00390 XEO_NAME Triamcinolone acetonide DME0012 XEOTICID XEO00390 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00390 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00390 DESCRIPT Triamcinolone acetonide up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00390 GENEFORM mRNA DME0012 XEOTICID XEO00390 MOACRIVE Induction DME0012 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0012 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0012 XEOTICID XEO00410 DESCRIPT Phenobarbital up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00410 GENEFORM mRNA DME0012 XEOTICID XEO00410 MOACRIVE Induction DME0012 XEOTICID XEO00560 XEO_NAME Triclosan DME0012 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0012 XEOTICID XEO00560 DESCRIPT Triclosan up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00560 GENEFORM mRNA DME0012 XEOTICID XEO00560 MOACRIVE Induction DME0012 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0012 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0012 XEOTICID XEO00582 DESCRIPT Diethyltoluamide up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00582 GENEFORM mRNA DME0012 XEOTICID XEO00582 MOACRIVE Induction DME0012 XEOTICID XEO00610 XEO_NAME Afimoxifene DME0012 XEOTICID XEO00610 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00610 XEO_CLAS Drug in Phase 3 Clinical Trial DME0012 XEOTICID XEO00610 DESCRIPT Afimoxifene inhibits the drug-metabolizing activity of DME CYP3A5 DME0012 XEOTICID XEO00610 GENEFORM Protein DME0012 XEOTICID XEO00610 MOACRIVE Inhibition DME0012 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0012 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0012 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the drug-metabolizing activity of DME CYP3A5 DME0012 XEOTICID XEO00632 GENEFORM Protein DME0012 XEOTICID XEO00632 MOACRIVE Inhibition DME0012 XEOTICID XEO00640 XEO_NAME FK-435 DME0012 XEOTICID XEO00640 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00640 XEO_CLAS Drug in Phase 3 Clinical Trial DME0012 XEOTICID XEO00640 DESCRIPT FK-435 inhibits the drug-metabolizing activity of DME CYP3A5 DME0012 XEOTICID XEO00640 GENEFORM Protein DME0012 XEOTICID XEO00640 MOACRIVE Inhibition DME0012 XEOTICID XEO00664 XEO_NAME CI-1040 DME0012 XEOTICID XEO00664 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00664 XEO_CLAS Drug in Phase 2 Clinical Trial DME0012 XEOTICID XEO00664 DESCRIPT CI-1040 up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00664 GENEFORM mRNA DME0012 XEOTICID XEO00664 MOACRIVE Induction DME0012 XEOTICID XEO00705 XEO_NAME Norverapamil DME0012 XEOTICID XEO00705 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO00705 XEO_CLAS Preclinical/Patented Drug DME0012 XEOTICID XEO00705 DESCRIPT Norverapamil inhibits the drug-metabolizing activity of DME CYP3A5 (Ki = 4.53 microM) DME0012 XEOTICID XEO00705 GENEFORM Protein DME0012 XEOTICID XEO00705 MOACRIVE Inhibition DME0012 XEOTICID XEO00764 XEO_NAME Naphthalene DME0012 XEOTICID XEO00764 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0012 XEOTICID XEO00764 XEO_CLAS Chemical Compound DME0012 XEOTICID XEO00764 DESCRIPT Naphthalene up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00764 GENEFORM mRNA DME0012 XEOTICID XEO00764 MOACRIVE Induction DME0012 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0012 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0012 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0012 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYP3A5 DME0012 XEOTICID XEO00806 GENEFORM mRNA DME0012 XEOTICID XEO00806 MOACRIVE Inhibition DME0012 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0012 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0012 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0012 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME CYP3A5 DME0012 XEOTICID XEO00821 GENEFORM mRNA DME0012 XEOTICID XEO00821 MOACRIVE Inhibition DME0012 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0012 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0012 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0012 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO00898 GENEFORM mRNA DME0012 XEOTICID XEO00898 MOACRIVE Induction DME0012 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0012 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0012 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0012 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME CYP3A5 DME0012 XEOTICID XEO01004 GENEFORM mRNA DME0012 XEOTICID XEO01004 MOACRIVE Inhibition DME0012 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0012 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0012 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0012 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME CYP3A5 DME0012 XEOTICID XEO01050 GENEFORM mRNA DME0012 XEOTICID XEO01050 MOACRIVE Inhibition DME0012 XEOTICID XEO01230 XEO_NAME Butyric acid DME0012 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0012 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0012 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO01230 GENEFORM mRNA DME0012 XEOTICID XEO01230 MOACRIVE Induction DME0012 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0012 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0012 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0012 XEOTICID XEO01248 DESCRIPT Chlorpyrifos up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO01248 GENEFORM mRNA DME0012 XEOTICID XEO01248 MOACRIVE Induction DME0012 XEOTICID XEO01274 XEO_NAME Diazinon DME0012 XEOTICID XEO01274 XEO_TYPE Health or Environmental Toxicant(s) DME0012 XEOTICID XEO01274 XEO_CLAS Environmental Pollutant DME0012 XEOTICID XEO01274 DESCRIPT Diazinon up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO01274 GENEFORM mRNA DME0012 XEOTICID XEO01274 MOACRIVE Induction DME0012 XEOTICID XEO01302 XEO_NAME Fipronil DME0012 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0012 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0012 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO01302 GENEFORM mRNA DME0012 XEOTICID XEO01302 MOACRIVE Induction DME0012 XEOTICID XEO01335 XEO_NAME Hyperforin DME0012 XEOTICID XEO01335 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0012 XEOTICID XEO01335 XEO_CLAS Natural Product DME0012 XEOTICID XEO01335 DESCRIPT Hyperforin up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO01335 GENEFORM mRNA DME0012 XEOTICID XEO01335 MOACRIVE Induction DME0012 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0012 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0012 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0012 XEOTICID XEO01407 DESCRIPT Ochratoxin A up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO01407 GENEFORM mRNA DME0012 XEOTICID XEO01407 MOACRIVE Induction DME0012 XEOTICID XEO01479 XEO_NAME Tamarixetin DME0012 XEOTICID XEO01479 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0012 XEOTICID XEO01479 XEO_CLAS Natural Product DME0012 XEOTICID XEO01479 DESCRIPT Tamarixetin up-regulates the expression of DME CYP3A5 DME0012 XEOTICID XEO01479 GENEFORM mRNA DME0012 XEOTICID XEO01479 MOACRIVE Induction DME0012 XEOTICID XEO01551 XEO_NAME Heliotrine DME0012 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0012 XEOTICID XEO01551 XEO_CLAS Natural Product DME0012 XEOTICID XEO01551 DESCRIPT Heliotrine inhibits the expression of DME CYP3A5 DME0012 XEOTICID XEO01551 GENEFORM mRNA DME0012 XEOTICID XEO01551 MOACRIVE Inhibition DME0012 XEOTICID XEO01574 XEO_NAME Plant extracts DME0012 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0012 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0012 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME CYP3A5 DME0012 XEOTICID XEO01574 GENEFORM Protein DME0012 XEOTICID XEO01574 MOACRIVE Inhibition DME0013 DME___ID DME0013 DME0013 DME_NAME Cytochrome P450 2E1 (CYP2E1) DME0013 SPESNAME Homo sapiens DME0013 XEOTICID XEO00001 XEO_NAME Dimethyl sulfoxide DME0013 XEOTICID XEO00001 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00001 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00001 DESCRIPT Dimethyl sulfoxide induces the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00001 GENEFORM Protein DME0013 XEOTICID XEO00001 MOACRIVE Induction DME0013 XEOTICID XEO00015 XEO_NAME Cimetidine DME0013 XEOTICID XEO00015 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00015 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00015 DESCRIPT Cimetidine inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00015 GENEFORM Protein DME0013 XEOTICID XEO00015 MOACRIVE Inhibition DME0013 XEOTICID XEO00022 XEO_NAME Desipramine DME0013 XEOTICID XEO00022 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00022 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00022 DESCRIPT Desipramine inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00022 GENEFORM Protein DME0013 XEOTICID XEO00022 MOACRIVE Inhibition DME0013 XEOTICID XEO00028 XEO_NAME Disulfiram DME0013 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00028 DESCRIPT Disulfiram inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00028 GENEFORM Protein DME0013 XEOTICID XEO00028 MOACRIVE Inhibition DME0013 XEOTICID XEO00039 XEO_NAME Fomepizole DME0013 XEOTICID XEO00039 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00039 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00039 DESCRIPT Fomepizole inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00039 GENEFORM Protein DME0013 XEOTICID XEO00039 MOACRIVE Inhibition DME0013 XEOTICID XEO00056 XEO_NAME Malathion DME0013 XEOTICID XEO00056 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00056 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00056 DESCRIPT Malathion inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00056 GENEFORM Protein DME0013 XEOTICID XEO00056 MOACRIVE Inhibition DME0013 XEOTICID XEO00090 XEO_NAME Estradiol DME0013 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00090 DESCRIPT Estradiol induces the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00090 GENEFORM Protein DME0013 XEOTICID XEO00090 MOACRIVE Induction DME0013 XEOTICID XEO00135 XEO_NAME Ferric citrate DME0013 XEOTICID XEO00135 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00135 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00135 DESCRIPT Ferric citrate up-regulates the expression of DME CYP2E1 DME0013 XEOTICID XEO00135 GENEFORM mRNA DME0013 XEOTICID XEO00135 MOACRIVE Induction DME0013 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0013 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00165 DESCRIPT Obeticholic acid inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO00165 GENEFORM mRNA DME0013 XEOTICID XEO00165 MOACRIVE Inhibition DME0013 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0013 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00217 GENEFORM Protein DME0013 XEOTICID XEO00217 MOACRIVE Inhibition DME0013 XEOTICID XEO00223 XEO_NAME Rifampin DME0013 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00223 DESCRIPT Rifampin induces the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00223 GENEFORM Protein DME0013 XEOTICID XEO00223 MOACRIVE Induction DME0013 XEOTICID XEO00224 XEO_NAME Isoniazid DME0013 XEOTICID XEO00224 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00224 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00224 DESCRIPT Isoniazid induces the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00224 GENEFORM Protein DME0013 XEOTICID XEO00224 MOACRIVE Induction DME0013 XEOTICID XEO00232 XEO_NAME Phenytoin DME0013 XEOTICID XEO00232 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00232 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00232 DESCRIPT Phenytoin induces the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00232 GENEFORM Protein DME0013 XEOTICID XEO00232 MOACRIVE Induction DME0013 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0013 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO00241 GENEFORM mRNA DME0013 XEOTICID XEO00241 MOACRIVE Inhibition DME0013 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0013 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00251 GENEFORM Protein DME0013 XEOTICID XEO00251 MOACRIVE Inhibition DME0013 XEOTICID XEO00280 XEO_NAME Chlorpromazine hydrochloride DME0013 XEOTICID XEO00280 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00280 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00280 DESCRIPT Chlorpromazine hydrochloride inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00280 GENEFORM Protein DME0013 XEOTICID XEO00280 MOACRIVE Inhibition DME0013 XEOTICID XEO00295 XEO_NAME Fluphenazine hydrochloride DME0013 XEOTICID XEO00295 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00295 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00295 DESCRIPT Fluphenazine hydrochloride inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00295 GENEFORM Protein DME0013 XEOTICID XEO00295 MOACRIVE Inhibition DME0013 XEOTICID XEO00330 XEO_NAME Thioridazine hydrochloride DME0013 XEOTICID XEO00330 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00330 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00330 DESCRIPT Thioridazine hydrochloride inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00330 GENEFORM Protein DME0013 XEOTICID XEO00330 MOACRIVE Inhibition DME0013 XEOTICID XEO00352 XEO_NAME Diclofenac DME0013 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00352 DESCRIPT Diclof DMEenac inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00352 GENEFORM Protein DME0013 XEOTICID XEO00352 MOACRIVE Inhibition DME0013 XEOTICID XEO00357 XEO_NAME Ethambutol DME0013 XEOTICID XEO00357 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00357 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00357 DESCRIPT Ethambutol inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00357 GENEFORM Protein DME0013 XEOTICID XEO00357 MOACRIVE Inhibition DME0013 XEOTICID XEO00384 XEO_NAME Tenofovir DME0013 XEOTICID XEO00384 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00384 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00384 DESCRIPT Tenof DMEovir inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00384 GENEFORM Protein DME0013 XEOTICID XEO00384 MOACRIVE Inhibition DME0013 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0013 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00430 DESCRIPT Hydroquinone induces the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00430 GENEFORM Protein DME0013 XEOTICID XEO00430 MOACRIVE Induction DME0013 XEOTICID XEO00539 XEO_NAME Ethanol DME0013 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0013 XEOTICID XEO00539 DESCRIPT Ethanol up-regulates the expression of DME CYP2E1 and leads to increasing the drug-metabolizing activity of this enzyme DME0013 XEOTICID XEO00539 GENEFORM Protein DME0013 XEOTICID XEO00539 MOACRIVE Induction DME0013 XEOTICID XEO00572 XEO_NAME Carbon monoxide DME0013 XEOTICID XEO00572 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00572 XEO_CLAS Drug in Phase 2 Clinical Trial DME0013 XEOTICID XEO00572 DESCRIPT Carbon monoxide inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00572 GENEFORM Protein DME0013 XEOTICID XEO00572 MOACRIVE Inhibition DME0013 XEOTICID XEO00587 XEO_NAME Trichloroethylene DME0013 XEOTICID XEO00587 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00587 XEO_CLAS Drug in Phase 2 Clinical Trial DME0013 XEOTICID XEO00587 DESCRIPT Trichloroethylene up-regulates the expression of DME CYP2E1 DME0013 XEOTICID XEO00587 GENEFORM mRNA DME0013 XEOTICID XEO00587 MOACRIVE Induction DME0013 XEOTICID XEO00591 XEO_NAME Ditiocarb DME0013 XEOTICID XEO00591 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00591 XEO_CLAS Drug in Phase 2 Clinical Trial DME0013 XEOTICID XEO00591 DESCRIPT Ditiocarb inhibits the drug-metabolizing activity of DME CYP2E1 (IC50 = 0.85 microM) DME0013 XEOTICID XEO00591 GENEFORM Protein DME0013 XEOTICID XEO00591 MOACRIVE Inhibition DME0013 XEOTICID XEO00593 XEO_NAME Chlormethiazole DME0013 XEOTICID XEO00593 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00593 XEO_CLAS Drug in Phase 3 Clinical Trial DME0013 XEOTICID XEO00593 DESCRIPT Chlormethiazole inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00593 GENEFORM Protein DME0013 XEOTICID XEO00593 MOACRIVE Inhibition DME0013 XEOTICID XEO00596 XEO_NAME Phenethyl isothiocyanate DME0013 XEOTICID XEO00596 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00596 XEO_CLAS Drug in Phase 2 Clinical Trial DME0013 XEOTICID XEO00596 DESCRIPT Phenethyl isothiocyanate inhibits the drug-metabolizing activity of DME CYP2E1 (Ki = 11 microM) DME0013 XEOTICID XEO00596 GENEFORM Protein DME0013 XEOTICID XEO00596 MOACRIVE Inhibition DME0013 XEOTICID XEO00599 XEO_NAME Tetradecanoylphorbol acetate DME0013 XEOTICID XEO00599 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00599 XEO_CLAS Drug in Phase 1 Clinical Trial DME0013 XEOTICID XEO00599 DESCRIPT Tetradecanoylphorbol acetate up-regulates the expression of DME CYP2E1 DME0013 XEOTICID XEO00599 GENEFORM mRNA DME0013 XEOTICID XEO00599 MOACRIVE Induction DME0013 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME0013 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME0013 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00646 GENEFORM Protein DME0013 XEOTICID XEO00646 MOACRIVE Inhibition DME0013 XEOTICID XEO00663 XEO_NAME Satraplatin DME0013 XEOTICID XEO00663 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00663 XEO_CLAS Drug in Phase 3 Clinical Trial DME0013 XEOTICID XEO00663 DESCRIPT Satraplatin inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO00663 GENEFORM mRNA DME0013 XEOTICID XEO00663 MOACRIVE Inhibition DME0013 XEOTICID XEO00735 XEO_NAME GW-4064 DME0013 XEOTICID XEO00735 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00735 XEO_CLAS Preclinical/Patented Drug DME0013 XEOTICID XEO00735 DESCRIPT GW-4064 inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO00735 GENEFORM mRNA DME0013 XEOTICID XEO00735 MOACRIVE Inhibition DME0013 XEOTICID XEO00736 XEO_NAME Chir-99021 DME0013 XEOTICID XEO00736 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00736 XEO_CLAS Preclinical/Patented Drug DME0013 XEOTICID XEO00736 DESCRIPT Chir-99021 up-regulates the expression of DME CYP2E1 and leads to increasing the drug-metabolizing activity of this enzyme DME0013 XEOTICID XEO00736 GENEFORM Protein DME0013 XEOTICID XEO00736 MOACRIVE Induction DME0013 XEOTICID XEO00740 XEO_NAME Lindane DME0013 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO00740 DESCRIPT Lindane inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO00740 GENEFORM mRNA DME0013 XEOTICID XEO00740 MOACRIVE Inhibition DME0013 XEOTICID XEO00758 XEO_NAME Grape seed proanthocyanidins DME0013 XEOTICID XEO00758 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO00758 XEO_CLAS Plant Extract DME0013 XEOTICID XEO00758 DESCRIPT Grape seed proanthocyanidins inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00758 GENEFORM Protein DME0013 XEOTICID XEO00758 MOACRIVE Inhibition DME0013 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0013 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0013 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0013 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO00772 GENEFORM mRNA DME0013 XEOTICID XEO00772 MOACRIVE Inhibition DME0013 XEOTICID XEO00777 XEO_NAME Skatole DME0013 XEOTICID XEO00777 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO00777 XEO_CLAS Natural Product DME0013 XEOTICID XEO00777 DESCRIPT Skatole inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO00777 GENEFORM mRNA DME0013 XEOTICID XEO00777 MOACRIVE Inhibition DME0013 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0013 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0013 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0013 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO00806 GENEFORM mRNA DME0013 XEOTICID XEO00806 MOACRIVE Inhibition DME0013 XEOTICID XEO00850 XEO_NAME Pyridine DME0013 XEOTICID XEO00850 XEO_TYPE Health or Environmental Toxicant(s) DME0013 XEOTICID XEO00850 XEO_CLAS Health Hazard/Toxicant DME0013 XEOTICID XEO00850 DESCRIPT Pyridine up-regulates the expression of DME CYP2E1 DME0013 XEOTICID XEO00850 GENEFORM mRNA DME0013 XEOTICID XEO00850 MOACRIVE Induction DME0013 XEOTICID XEO00873 XEO_NAME Alpha-linolenic acid DME0013 XEOTICID XEO00873 XEO_TYPE Health or Environmental Toxicant(s) DME0013 XEOTICID XEO00873 XEO_CLAS Health Hazard/Toxicant DME0013 XEOTICID XEO00873 DESCRIPT Alpha-linolenic acid inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00873 GENEFORM Protein DME0013 XEOTICID XEO00873 MOACRIVE Inhibition DME0013 XEOTICID XEO00876 XEO_NAME Arachidonic acid DME0013 XEOTICID XEO00876 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO00876 XEO_CLAS Investigative Agent DME0013 XEOTICID XEO00876 DESCRIPT Arachidonic acid inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00876 GENEFORM Protein DME0013 XEOTICID XEO00876 MOACRIVE Inhibition DME0013 XEOTICID XEO00880 XEO_NAME Isatin DME0013 XEOTICID XEO00880 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO00880 XEO_CLAS Natural Product DME0013 XEOTICID XEO00880 DESCRIPT Isatin up-regulates the expression of DME CYP2E1 DME0013 XEOTICID XEO00880 GENEFORM mRNA DME0013 XEOTICID XEO00880 MOACRIVE Induction DME0013 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0013 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0013 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0013 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CYP2E1 DME0013 XEOTICID XEO00898 GENEFORM mRNA DME0013 XEOTICID XEO00898 MOACRIVE Induction DME0013 XEOTICID XEO00942 XEO_NAME Cyproconazole DME0013 XEOTICID XEO00942 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0013 XEOTICID XEO00942 XEO_CLAS Fungicide DME0013 XEOTICID XEO00942 DESCRIPT Cyproconazole inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO00942 GENEFORM mRNA DME0013 XEOTICID XEO00942 MOACRIVE Inhibition DME0013 XEOTICID XEO00968 XEO_NAME Amitrole DME0013 XEOTICID XEO00968 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0013 XEOTICID XEO00968 XEO_CLAS Herbicide DME0013 XEOTICID XEO00968 DESCRIPT Amitrole inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00968 GENEFORM Protein DME0013 XEOTICID XEO00968 MOACRIVE Inhibition DME0013 XEOTICID XEO00975 XEO_NAME Isoproturon DME0013 XEOTICID XEO00975 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0013 XEOTICID XEO00975 XEO_CLAS Herbicide DME0013 XEOTICID XEO00975 DESCRIPT Isoproturon inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00975 GENEFORM Protein DME0013 XEOTICID XEO00975 MOACRIVE Inhibition DME0013 XEOTICID XEO00993 XEO_NAME Alizarin DME0013 XEOTICID XEO00993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO00993 XEO_CLAS Natural Product DME0013 XEOTICID XEO00993 DESCRIPT Alizarin inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO00993 GENEFORM Protein DME0013 XEOTICID XEO00993 MOACRIVE Inhibition DME0013 XEOTICID XEO01000 XEO_NAME Carbon tetrachloride DME0013 XEOTICID XEO01000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME0013 XEOTICID XEO01000 XEO_CLAS Peptide DME0013 XEOTICID XEO01000 DESCRIPT Carbon tetrachloride inhibits the drug-metabolizing activity of DME CYP2E1 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 11 microM) DME0013 XEOTICID XEO01000 GENEFORM Protein DME0013 XEOTICID XEO01000 MOACRIVE Inhibition DME0013 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0013 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0013 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0013 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO01004 GENEFORM mRNA DME0013 XEOTICID XEO01004 MOACRIVE Inhibition DME0013 XEOTICID XEO01006 XEO_NAME Dimethyl nitrosamine DME0013 XEOTICID XEO01006 XEO_TYPE Health or Environmental Toxicant(s) DME0013 XEOTICID XEO01006 XEO_CLAS Carcinogen DME0013 XEOTICID XEO01006 DESCRIPT Dimethyl nitrosamine inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01006 GENEFORM Protein DME0013 XEOTICID XEO01006 MOACRIVE Inhibition DME0013 XEOTICID XEO01043 XEO_NAME Chlorfluazuron DME0013 XEOTICID XEO01043 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0013 XEOTICID XEO01043 XEO_CLAS Pesticide/Insecticide DME0013 XEOTICID XEO01043 DESCRIPT Chlorfluazuron inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01043 GENEFORM Protein DME0013 XEOTICID XEO01043 MOACRIVE Inhibition DME0013 XEOTICID XEO01046 XEO_NAME Cypermethrin DME0013 XEOTICID XEO01046 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0013 XEOTICID XEO01046 XEO_CLAS Pesticide/Insecticide DME0013 XEOTICID XEO01046 DESCRIPT Cypermethrin inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01046 GENEFORM Protein DME0013 XEOTICID XEO01046 MOACRIVE Inhibition DME0013 XEOTICID XEO01052 XEO_NAME Fenitrothion DME0013 XEOTICID XEO01052 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0013 XEOTICID XEO01052 XEO_CLAS Pesticide/Insecticide DME0013 XEOTICID XEO01052 DESCRIPT Fenitrothion inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01052 GENEFORM Protein DME0013 XEOTICID XEO01052 MOACRIVE Inhibition DME0013 XEOTICID XEO01053 XEO_NAME Fenvalerate DME0013 XEOTICID XEO01053 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0013 XEOTICID XEO01053 XEO_CLAS Pesticide/Insecticide DME0013 XEOTICID XEO01053 DESCRIPT Fenvalerate inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01053 GENEFORM Protein DME0013 XEOTICID XEO01053 MOACRIVE Inhibition DME0013 XEOTICID XEO01062 XEO_NAME Monocrotophos DME0013 XEOTICID XEO01062 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0013 XEOTICID XEO01062 XEO_CLAS Pesticide/Insecticide DME0013 XEOTICID XEO01062 DESCRIPT Monocrotophos up-regulates the expression of DME CYP2E1 DME0013 XEOTICID XEO01062 GENEFORM mRNA DME0013 XEOTICID XEO01062 MOACRIVE Induction DME0013 XEOTICID XEO01074 XEO_NAME Endosulfan DME0013 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0013 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0013 XEOTICID XEO01074 DESCRIPT Endosulfan inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01074 GENEFORM Protein DME0013 XEOTICID XEO01074 MOACRIVE Inhibition DME0013 XEOTICID XEO01099 XEO_NAME 1-aminobenzotriazole DME0013 XEOTICID XEO01099 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO01099 XEO_CLAS Preclinical/Patented Drug DME0013 XEOTICID XEO01099 DESCRIPT 1-aminobenzotriazole inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01099 GENEFORM Protein DME0013 XEOTICID XEO01099 MOACRIVE Inhibition DME0013 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0013 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0013 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0013 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine up-regulates the expression of DME CYP2E1 DME0013 XEOTICID XEO01119 GENEFORM mRNA DME0013 XEOTICID XEO01119 MOACRIVE Induction DME0013 XEOTICID XEO01159 XEO_NAME 5-fluorotryptamine DME0013 XEOTICID XEO01159 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO01159 XEO_CLAS Investigative Agent DME0013 XEOTICID XEO01159 DESCRIPT 5-fluorotryptamine inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01159 GENEFORM Protein DME0013 XEOTICID XEO01159 MOACRIVE Inhibition DME0013 XEOTICID XEO01177 XEO_NAME 7-methyltryptamine DME0013 XEOTICID XEO01177 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO01177 XEO_CLAS Investigative Agent DME0013 XEOTICID XEO01177 DESCRIPT 7-methyltryptamine inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01177 GENEFORM Protein DME0013 XEOTICID XEO01177 MOACRIVE Inhibition DME0013 XEOTICID XEO01187 XEO_NAME Acrylamide DME0013 XEOTICID XEO01187 XEO_TYPE Health or Environmental Toxicant(s) DME0013 XEOTICID XEO01187 XEO_CLAS Acute Toxic Substance DME0013 XEOTICID XEO01187 DESCRIPT Acrylamide induces the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01187 GENEFORM Protein DME0013 XEOTICID XEO01187 MOACRIVE Induction DME0013 XEOTICID XEO01203 XEO_NAME Apigenin DME0013 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO01203 XEO_CLAS Natural Product DME0013 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01203 GENEFORM Protein DME0013 XEOTICID XEO01203 MOACRIVE Inhibition DME0013 XEOTICID XEO01208 XEO_NAME HI-6 DME0013 XEOTICID XEO01208 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO01208 XEO_CLAS Preclinical/Patented Drug DME0013 XEOTICID XEO01208 DESCRIPT HI-6 inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01208 GENEFORM Protein DME0013 XEOTICID XEO01208 MOACRIVE Inhibition DME0013 XEOTICID XEO01212 XEO_NAME Baicalein DME0013 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO01212 XEO_CLAS Natural Product DME0013 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01212 GENEFORM Protein DME0013 XEOTICID XEO01212 MOACRIVE Inhibition DME0013 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0013 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0013 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone induces the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01220 GENEFORM Protein DME0013 XEOTICID XEO01220 MOACRIVE Induction DME0013 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0013 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0013 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0013 XEOTICID XEO01248 DESCRIPT Chlorpyrifos inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01248 GENEFORM Protein DME0013 XEOTICID XEO01248 MOACRIVE Inhibition DME0013 XEOTICID XEO01252 XEO_NAME Cinnamic acid DME0013 XEOTICID XEO01252 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO01252 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO01252 DESCRIPT Cinnamic acid inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01252 GENEFORM Protein DME0013 XEOTICID XEO01252 MOACRIVE Inhibition DME0013 XEOTICID XEO01279 XEO_NAME Dimethyl formamide DME0013 XEOTICID XEO01279 XEO_TYPE Health or Environmental Toxicant(s) DME0013 XEOTICID XEO01279 XEO_CLAS Health Hazard/Toxicant DME0013 XEOTICID XEO01279 DESCRIPT Dimethyl formamide induces the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01279 GENEFORM Protein DME0013 XEOTICID XEO01279 MOACRIVE Induction DME0013 XEOTICID XEO01281 XEO_NAME Diosmetin DME0013 XEOTICID XEO01281 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO01281 XEO_CLAS Natural Product DME0013 XEOTICID XEO01281 DESCRIPT Diosmetin inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01281 GENEFORM Protein DME0013 XEOTICID XEO01281 MOACRIVE Inhibition DME0013 XEOTICID XEO01298 XEO_NAME Farnesol DME0013 XEOTICID XEO01298 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO01298 XEO_CLAS Investigative Agent DME0013 XEOTICID XEO01298 DESCRIPT Farnesol inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO01298 GENEFORM mRNA DME0013 XEOTICID XEO01298 MOACRIVE Inhibition DME0013 XEOTICID XEO01302 XEO_NAME Fipronil DME0013 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0013 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0013 XEOTICID XEO01302 DESCRIPT Fipronil inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO01302 GENEFORM mRNA DME0013 XEOTICID XEO01302 MOACRIVE Inhibition DME0013 XEOTICID XEO01314 XEO_NAME Ginkgo biloba extract DME0013 XEOTICID XEO01314 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO01314 XEO_CLAS Plant Extract DME0013 XEOTICID XEO01314 DESCRIPT Ginkgo biloba extract inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01314 GENEFORM Protein DME0013 XEOTICID XEO01314 MOACRIVE Inhibition DME0013 XEOTICID XEO01367 XEO_NAME Linoleic acid DME0013 XEOTICID XEO01367 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO01367 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO01367 DESCRIPT Linoleic acid inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01367 GENEFORM Protein DME0013 XEOTICID XEO01367 MOACRIVE Inhibition DME0013 XEOTICID XEO01412 XEO_NAME Oleic acid DME0013 XEOTICID XEO01412 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO01412 XEO_CLAS Preclinical/Patented Drug DME0013 XEOTICID XEO01412 DESCRIPT Oleic acid up-regulates the expression of DME CYP2E1 DME0013 XEOTICID XEO01412 GENEFORM mRNA DME0013 XEOTICID XEO01412 MOACRIVE Induction DME0013 XEOTICID XEO01438 XEO_NAME Proadifen DME0013 XEOTICID XEO01438 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO01438 XEO_CLAS Preclinical/Patented Drug DME0013 XEOTICID XEO01438 DESCRIPT Proadifen inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO01438 GENEFORM mRNA DME0013 XEOTICID XEO01438 MOACRIVE Inhibition DME0013 XEOTICID XEO01443 XEO_NAME Purpurin DME0013 XEOTICID XEO01443 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO01443 XEO_CLAS Natural Product DME0013 XEOTICID XEO01443 DESCRIPT Purpurin inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01443 GENEFORM Protein DME0013 XEOTICID XEO01443 MOACRIVE Inhibition DME0013 XEOTICID XEO01466 XEO_NAME S-adenosylmethionine DME0013 XEOTICID XEO01466 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO01466 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO01466 DESCRIPT S-adenosylmethionine inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO01466 GENEFORM mRNA DME0013 XEOTICID XEO01466 MOACRIVE Inhibition DME0013 XEOTICID XEO01475 XEO_NAME Stearic acid DME0013 XEOTICID XEO01475 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0013 XEOTICID XEO01475 XEO_CLAS Food Additive DME0013 XEOTICID XEO01475 DESCRIPT Stearic acid induces the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01475 GENEFORM Protein DME0013 XEOTICID XEO01475 MOACRIVE Induction DME0013 XEOTICID XEO01485 XEO_NAME Thiostrepton DME0013 XEOTICID XEO01485 XEO_TYPE Pharmaceutical Agent(s) DME0013 XEOTICID XEO01485 XEO_CLAS Approved/Marketed Drug DME0013 XEOTICID XEO01485 DESCRIPT Thiostrepton inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01485 GENEFORM Protein DME0013 XEOTICID XEO01485 MOACRIVE Inhibition DME0013 XEOTICID XEO01489 XEO_NAME Toluene DME0013 XEOTICID XEO01489 XEO_TYPE Health or Environmental Toxicant(s) DME0013 XEOTICID XEO01489 XEO_CLAS Health Hazard/Toxicant DME0013 XEOTICID XEO01489 DESCRIPT Toluene up-regulates the expression of DME CYP2E1 DME0013 XEOTICID XEO01489 GENEFORM mRNA DME0013 XEOTICID XEO01489 MOACRIVE Induction DME0013 XEOTICID XEO01498 XEO_NAME Walrycin A DME0013 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO01498 XEO_CLAS Natural Product DME0013 XEOTICID XEO01498 DESCRIPT Walrycin A up-regulates the expression of DME CYP2E1 DME0013 XEOTICID XEO01498 GENEFORM mRNA DME0013 XEOTICID XEO01498 MOACRIVE Induction DME0013 XEOTICID XEO01503 XEO_NAME Cadmium DME0013 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0013 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0013 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME CYP2E1 DME0013 XEOTICID XEO01503 GENEFORM mRNA DME0013 XEOTICID XEO01503 MOACRIVE Induction DME0013 XEOTICID XEO01511 XEO_NAME Vitallium DME0013 XEOTICID XEO01511 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO01511 XEO_CLAS Natural Mixture DME0013 XEOTICID XEO01511 DESCRIPT Vitallium inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO01511 GENEFORM mRNA DME0013 XEOTICID XEO01511 MOACRIVE Inhibition DME0013 XEOTICID XEO01518 XEO_NAME 5-methyltryptamine DME0013 XEOTICID XEO01518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO01518 XEO_CLAS Natural Product DME0013 XEOTICID XEO01518 DESCRIPT 5-methyltryptamine inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01518 GENEFORM Protein DME0013 XEOTICID XEO01518 MOACRIVE Inhibition DME0013 XEOTICID XEO01574 XEO_NAME Plant extracts DME0013 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0013 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01574 GENEFORM Protein DME0013 XEOTICID XEO01574 MOACRIVE Inhibition DME0013 XEOTICID XEO01585 XEO_NAME Senecionine DME0013 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO01585 XEO_CLAS Natural Product DME0013 XEOTICID XEO01585 DESCRIPT Senecionine induces the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO01585 GENEFORM Protein DME0013 XEOTICID XEO01585 MOACRIVE Induction DME0013 XEOTICID XEO01591 XEO_NAME Taxifolin DME0013 XEOTICID XEO01591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0013 XEOTICID XEO01591 XEO_CLAS Natural Product DME0013 XEOTICID XEO01591 DESCRIPT Taxifolin inhibits the expression of DME CYP2E1 DME0013 XEOTICID XEO01591 GENEFORM mRNA DME0013 XEOTICID XEO01591 MOACRIVE Inhibition DME0013 XEOTICID XEO02228 XEO_NAME Aniline DME0013 XEOTICID XEO02228 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0013 XEOTICID XEO02228 XEO_CLAS Chemical Compound DME0013 XEOTICID XEO02228 DESCRIPT Aniline inhibits the drug-metabolizing activity of DME CYP2E1 DME0013 XEOTICID XEO02228 GENEFORM Protein DME0013 XEOTICID XEO02228 MOACRIVE Inhibition DME0014 DME___ID DME0014 DME0014 DME_NAME Thiopurine methyltransferase (TPMT) DME0014 SPESNAME Homo sapiens DME0014 XEOTICID XEO00005 XEO_NAME Theophylline DME0014 XEOTICID XEO00005 XEO_TYPE Pharmaceutical Agent(s) DME0014 XEOTICID XEO00005 XEO_CLAS Approved/Marketed Drug DME0014 XEOTICID XEO00005 DESCRIPT Theophylline up-regulates the expression of DME TPMT DME0014 XEOTICID XEO00005 GENEFORM mRNA DME0014 XEOTICID XEO00005 MOACRIVE Induction DME0014 XEOTICID XEO00040 XEO_NAME Furosemide DME0014 XEOTICID XEO00040 XEO_TYPE Pharmaceutical Agent(s) DME0014 XEOTICID XEO00040 XEO_CLAS Approved/Marketed Drug DME0014 XEOTICID XEO00040 DESCRIPT Furosemide inhibits the drug-metabolizing activity of DME TPMT DME0014 XEOTICID XEO00040 GENEFORM Protein DME0014 XEOTICID XEO00040 MOACRIVE Inhibition DME0014 XEOTICID XEO00079 XEO_NAME Vorinostat DME0014 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0014 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0014 XEOTICID XEO00079 DESCRIPT Vorinostat induces the drug-metabolizing activity of DME TPMT DME0014 XEOTICID XEO00079 GENEFORM Protein DME0014 XEOTICID XEO00079 MOACRIVE Induction DME0014 XEOTICID XEO00090 XEO_NAME Estradiol DME0014 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0014 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0014 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME TPMT DME0014 XEOTICID XEO00090 GENEFORM mRNA DME0014 XEOTICID XEO00090 MOACRIVE Inhibition DME0014 XEOTICID XEO00221 XEO_NAME Trichlormethiazide DME0014 XEOTICID XEO00221 XEO_TYPE Pharmaceutical Agent(s) DME0014 XEOTICID XEO00221 XEO_CLAS Approved/Marketed Drug DME0014 XEOTICID XEO00221 DESCRIPT Trichlormethiazide inhibits the expression of DME TPMT DME0014 XEOTICID XEO00221 GENEFORM mRNA DME0014 XEOTICID XEO00221 MOACRIVE Inhibition DME0014 XEOTICID XEO00234 XEO_NAME Bendroflumethiazide DME0014 XEOTICID XEO00234 XEO_TYPE Pharmaceutical Agent(s) DME0014 XEOTICID XEO00234 XEO_CLAS Approved/Marketed Drug DME0014 XEOTICID XEO00234 DESCRIPT Bendrof DMElumethiazide inhibits the drug-metabolizing activity of DME TPMT DME0014 XEOTICID XEO00234 GENEFORM Protein DME0014 XEOTICID XEO00234 MOACRIVE Inhibition DME0014 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0014 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0014 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0014 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME TPMT DME0014 XEOTICID XEO00241 GENEFORM mRNA DME0014 XEOTICID XEO00241 MOACRIVE Inhibition DME0014 XEOTICID XEO00301 XEO_NAME Irinotecan hydrochloride DME0014 XEOTICID XEO00301 XEO_TYPE Pharmaceutical Agent(s) DME0014 XEOTICID XEO00301 XEO_CLAS Approved/Marketed Drug DME0014 XEOTICID XEO00301 DESCRIPT Irinotecan hydrochloride up-regulates the expression of DME TPMT DME0014 XEOTICID XEO00301 GENEFORM mRNA DME0014 XEOTICID XEO00301 MOACRIVE Induction DME0014 XEOTICID XEO00334 XEO_NAME Cisplatin DME0014 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0014 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0014 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME TPMT DME0014 XEOTICID XEO00334 GENEFORM mRNA DME0014 XEOTICID XEO00334 MOACRIVE Induction DME0014 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0014 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0014 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0014 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME TPMT DME0014 XEOTICID XEO01050 GENEFORM mRNA DME0014 XEOTICID XEO01050 MOACRIVE Inhibition DME0014 XEOTICID XEO01064 XEO_NAME Parathion DME0014 XEOTICID XEO01064 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0014 XEOTICID XEO01064 XEO_CLAS Pesticide/Insecticide DME0014 XEOTICID XEO01064 DESCRIPT Parathion induces the drug-metabolizing activity of DME TPMT DME0014 XEOTICID XEO01064 GENEFORM Protein DME0014 XEOTICID XEO01064 MOACRIVE Induction DME0014 XEOTICID XEO01585 XEO_NAME Senecionine DME0014 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0014 XEOTICID XEO01585 XEO_CLAS Natural Product DME0014 XEOTICID XEO01585 DESCRIPT Senecionine induces the drug-metabolizing activity of DME TPMT DME0014 XEOTICID XEO01585 GENEFORM Protein DME0014 XEOTICID XEO01585 MOACRIVE Induction DME0015 DME___ID DME0015 DME0015 DME_NAME Cytochrome P450 3A7 (CYP3A7) DME0015 SPESNAME Homo sapiens DME0015 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0015 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00011 GENEFORM mRNA DME0015 XEOTICID XEO00011 MOACRIVE Induction DME0015 XEOTICID XEO00017 XEO_NAME Clotrimazole DME0015 XEOTICID XEO00017 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00017 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00017 DESCRIPT Clotrimazole up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00017 GENEFORM mRNA DME0015 XEOTICID XEO00017 MOACRIVE Induction DME0015 XEOTICID XEO00029 XEO_NAME Valproic acid DME0015 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the drug-metabolizing activity of DME CYP3A7 DME0015 XEOTICID XEO00029 GENEFORM Protein DME0015 XEOTICID XEO00029 MOACRIVE Inhibition DME0015 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0015 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00035 GENEFORM mRNA DME0015 XEOTICID XEO00035 MOACRIVE Induction DME0015 XEOTICID XEO00086 XEO_NAME Troglitazone DME0015 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00086 DESCRIPT Troglitazone inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO00086 GENEFORM mRNA DME0015 XEOTICID XEO00086 MOACRIVE Inhibition DME0015 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0015 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00088 GENEFORM mRNA DME0015 XEOTICID XEO00088 MOACRIVE Induction DME0015 XEOTICID XEO00090 XEO_NAME Estradiol DME0015 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO00090 GENEFORM mRNA DME0015 XEOTICID XEO00090 MOACRIVE Inhibition DME0015 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0015 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00117 GENEFORM mRNA DME0015 XEOTICID XEO00117 MOACRIVE Induction DME0015 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0015 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00140 DESCRIPT Zoledronic acid up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00140 GENEFORM mRNA DME0015 XEOTICID XEO00140 MOACRIVE Induction DME0015 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0015 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00167 DESCRIPT Alitretinoin inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO00167 GENEFORM mRNA DME0015 XEOTICID XEO00167 MOACRIVE Inhibition DME0015 XEOTICID XEO00184 XEO_NAME Calcitriol DME0015 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00184 GENEFORM mRNA DME0015 XEOTICID XEO00184 MOACRIVE Induction DME0015 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0015 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO00186 GENEFORM mRNA DME0015 XEOTICID XEO00186 MOACRIVE Inhibition DME0015 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0015 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO00217 GENEFORM mRNA DME0015 XEOTICID XEO00217 MOACRIVE Inhibition DME0015 XEOTICID XEO00223 XEO_NAME Rifampin DME0015 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00223 DESCRIPT Rifampin induces the drug-metabolizing activity of DME CYP3A7 DME0015 XEOTICID XEO00223 GENEFORM Protein DME0015 XEOTICID XEO00223 MOACRIVE Induction DME0015 XEOTICID XEO00232 XEO_NAME Phenytoin DME0015 XEOTICID XEO00232 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00232 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00232 DESCRIPT Phenytoin up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00232 GENEFORM mRNA DME0015 XEOTICID XEO00232 MOACRIVE Induction DME0015 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0015 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO00241 GENEFORM mRNA DME0015 XEOTICID XEO00241 MOACRIVE Inhibition DME0015 XEOTICID XEO00253 XEO_NAME Tretinoin DME0015 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO00253 GENEFORM mRNA DME0015 XEOTICID XEO00253 MOACRIVE Inhibition DME0015 XEOTICID XEO00435 XEO_NAME Urethane DME0015 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO00435 GENEFORM mRNA DME0015 XEOTICID XEO00435 MOACRIVE Inhibition DME0015 XEOTICID XEO00539 XEO_NAME Ethanol DME0015 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0015 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO00539 GENEFORM mRNA DME0015 XEOTICID XEO00539 MOACRIVE Inhibition DME0015 XEOTICID XEO00547 XEO_NAME Vitamin E DME0015 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0015 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO00547 GENEFORM mRNA DME0015 XEOTICID XEO00547 MOACRIVE Inhibition DME0015 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0015 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0015 XEOTICID XEO00582 DESCRIPT Diethyltoluamide up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00582 GENEFORM mRNA DME0015 XEOTICID XEO00582 MOACRIVE Induction DME0015 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0015 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0015 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO00632 GENEFORM mRNA DME0015 XEOTICID XEO00632 MOACRIVE Inhibition DME0015 XEOTICID XEO00652 XEO_NAME Seocalcitol DME0015 XEOTICID XEO00652 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00652 XEO_CLAS Drug in Phase 3 Clinical Trial DME0015 XEOTICID XEO00652 DESCRIPT Seocalcitol up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00652 GENEFORM mRNA DME0015 XEOTICID XEO00652 MOACRIVE Induction DME0015 XEOTICID XEO00664 XEO_NAME CI-1040 DME0015 XEOTICID XEO00664 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00664 XEO_CLAS Drug in Phase 2 Clinical Trial DME0015 XEOTICID XEO00664 DESCRIPT CI-1040 up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00664 GENEFORM mRNA DME0015 XEOTICID XEO00664 MOACRIVE Induction DME0015 XEOTICID XEO00667 XEO_NAME PD-0325901 DME0015 XEOTICID XEO00667 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00667 XEO_CLAS Drug in Phase 2 Clinical Trial DME0015 XEOTICID XEO00667 DESCRIPT PD-0325901 up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00667 GENEFORM mRNA DME0015 XEOTICID XEO00667 MOACRIVE Induction DME0015 XEOTICID XEO00740 XEO_NAME Lindane DME0015 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0015 XEOTICID XEO00740 DESCRIPT Lindane induces the drug-metabolizing activity of DME CYP3A7 DME0015 XEOTICID XEO00740 GENEFORM Protein DME0015 XEOTICID XEO00740 MOACRIVE Induction DME0015 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0015 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0015 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0015 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO00806 GENEFORM mRNA DME0015 XEOTICID XEO00806 MOACRIVE Inhibition DME0015 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0015 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0015 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0015 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00898 GENEFORM mRNA DME0015 XEOTICID XEO00898 MOACRIVE Induction DME0015 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0015 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0015 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0015 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO00905 GENEFORM mRNA DME0015 XEOTICID XEO00905 MOACRIVE Inhibition DME0015 XEOTICID XEO00942 XEO_NAME Cyproconazole DME0015 XEOTICID XEO00942 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0015 XEOTICID XEO00942 XEO_CLAS Fungicide DME0015 XEOTICID XEO00942 DESCRIPT Cyproconazole up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00942 GENEFORM mRNA DME0015 XEOTICID XEO00942 MOACRIVE Induction DME0015 XEOTICID XEO00957 XEO_NAME Tebuconazole DME0015 XEOTICID XEO00957 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0015 XEOTICID XEO00957 XEO_CLAS Fungicide DME0015 XEOTICID XEO00957 DESCRIPT Tebuconazole up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO00957 GENEFORM mRNA DME0015 XEOTICID XEO00957 MOACRIVE Induction DME0015 XEOTICID XEO00966 XEO_NAME 2,4,5-trichlorophenoxyacetic acid DME0015 XEOTICID XEO00966 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0015 XEOTICID XEO00966 XEO_CLAS Herbicide DME0015 XEOTICID XEO00966 DESCRIPT 2,4,5-trichlorophenoxyacetic acid induces the drug-metabolizing activity of DME CYP3A7 DME0015 XEOTICID XEO00966 GENEFORM Protein DME0015 XEOTICID XEO00966 MOACRIVE Induction DME0015 XEOTICID XEO00973 XEO_NAME Diuron DME0015 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0015 XEOTICID XEO00973 XEO_CLAS Herbicide DME0015 XEOTICID XEO00973 DESCRIPT Diuron induces the drug-metabolizing activity of DME CYP3A7 DME0015 XEOTICID XEO00973 GENEFORM Protein DME0015 XEOTICID XEO00973 MOACRIVE Induction DME0015 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0015 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0015 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0015 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO01031 GENEFORM mRNA DME0015 XEOTICID XEO01031 MOACRIVE Induction DME0015 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0015 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0015 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0015 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO01050 GENEFORM mRNA DME0015 XEOTICID XEO01050 MOACRIVE Inhibition DME0015 XEOTICID XEO01071 XEO_NAME Thiamethoxam DME0015 XEOTICID XEO01071 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0015 XEOTICID XEO01071 XEO_CLAS Pesticide/Insecticide DME0015 XEOTICID XEO01071 DESCRIPT Thiamethoxam up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO01071 GENEFORM mRNA DME0015 XEOTICID XEO01071 MOACRIVE Induction DME0015 XEOTICID XEO01154 XEO_NAME 4-oxoretinoic acid DME0015 XEOTICID XEO01154 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0015 XEOTICID XEO01154 XEO_CLAS Natural Product DME0015 XEOTICID XEO01154 DESCRIPT 4-oxoretinoic acid inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO01154 GENEFORM mRNA DME0015 XEOTICID XEO01154 MOACRIVE Inhibition DME0015 XEOTICID XEO01165 XEO_NAME CITCO DME0015 XEOTICID XEO01165 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO01165 XEO_CLAS Investigative Agent DME0015 XEOTICID XEO01165 DESCRIPT CITCO induces the drug-metabolizing activity of DME CYP3A7 DME0015 XEOTICID XEO01165 GENEFORM Protein DME0015 XEOTICID XEO01165 MOACRIVE Induction DME0015 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0015 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0015 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0015 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO01220 GENEFORM mRNA DME0015 XEOTICID XEO01220 MOACRIVE Inhibition DME0015 XEOTICID XEO01302 XEO_NAME Fipronil DME0015 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0015 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0015 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO01302 GENEFORM mRNA DME0015 XEOTICID XEO01302 MOACRIVE Induction DME0015 XEOTICID XEO01551 XEO_NAME Heliotrine DME0015 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0015 XEOTICID XEO01551 XEO_CLAS Natural Product DME0015 XEOTICID XEO01551 DESCRIPT Heliotrine inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO01551 GENEFORM mRNA DME0015 XEOTICID XEO01551 MOACRIVE Inhibition DME0015 XEOTICID XEO01574 XEO_NAME Plant extracts DME0015 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0015 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0015 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the expression of DME CYP3A7 DME0015 XEOTICID XEO01574 GENEFORM mRNA DME0015 XEOTICID XEO01574 MOACRIVE Inhibition DME0015 XEOTICID XEO01585 XEO_NAME Senecionine DME0015 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0015 XEOTICID XEO01585 XEO_CLAS Natural Product DME0015 XEOTICID XEO01585 DESCRIPT Senecionine induces the drug-metabolizing activity of DME CYP3A7 DME0015 XEOTICID XEO01585 GENEFORM Protein DME0015 XEOTICID XEO01585 MOACRIVE Induction DME0015 XEOTICID XEO01602 XEO_NAME Imidacloprid DME0015 XEOTICID XEO01602 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0015 XEOTICID XEO01602 XEO_CLAS Pesticide/Insecticide DME0015 XEOTICID XEO01602 DESCRIPT Imidacloprid induces the drug-metabolizing activity of DME CYP3A7 DME0015 XEOTICID XEO01602 GENEFORM Protein DME0015 XEOTICID XEO01602 MOACRIVE Induction DME0015 XEOTICID XEO01605 XEO_NAME Pentachlorophenol DME0015 XEOTICID XEO01605 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0015 XEOTICID XEO01605 XEO_CLAS Pesticide/Insecticide DME0015 XEOTICID XEO01605 DESCRIPT Pentachlorophenol up-regulates the expression of DME CYP3A7 DME0015 XEOTICID XEO01605 GENEFORM mRNA DME0015 XEOTICID XEO01605 MOACRIVE Induction DME0015 XEOTICID XEO01609 XEO_NAME 2,4-dichlorophenoxyacetic acid DME0015 XEOTICID XEO01609 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0015 XEOTICID XEO01609 XEO_CLAS Pesticide/Insecticide DME0015 XEOTICID XEO01609 DESCRIPT 2,4-dichlorophenoxyacetic acid induces the drug-metabolizing activity of DME CYP3A7 DME0015 XEOTICID XEO01609 GENEFORM Protein DME0015 XEOTICID XEO01609 MOACRIVE Induction DME0016 DME___ID DME0016 DME0016 DME_NAME Cytochrome P450 2F1 (CYP2F1) DME0016 SPESNAME Homo sapiens DME0016 XEOTICID XEO00090 XEO_NAME Estradiol DME0016 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0016 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0016 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME CYP2F1 DME0016 XEOTICID XEO00090 GENEFORM mRNA DME0016 XEOTICID XEO00090 MOACRIVE Inhibition DME0016 XEOTICID XEO00152 XEO_NAME Gefitinib DME0016 XEOTICID XEO00152 XEO_TYPE Pharmaceutical Agent(s) DME0016 XEOTICID XEO00152 XEO_CLAS Approved/Marketed Drug DME0016 XEOTICID XEO00152 DESCRIPT Gefitinib inhibits the expression of DME CYP2F1 DME0016 XEOTICID XEO00152 GENEFORM mRNA DME0016 XEOTICID XEO00152 MOACRIVE Inhibition DME0016 XEOTICID XEO00223 XEO_NAME Rifampin DME0016 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0016 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0016 XEOTICID XEO00223 DESCRIPT Rifampin inhibits the expression of DME CYP2F1 DME0016 XEOTICID XEO00223 GENEFORM mRNA DME0016 XEOTICID XEO00223 MOACRIVE Inhibition DME0016 XEOTICID XEO00777 XEO_NAME Skatole DME0016 XEOTICID XEO00777 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0016 XEOTICID XEO00777 XEO_CLAS Natural Product DME0016 XEOTICID XEO00777 DESCRIPT Skatole up-regulates the expression of DME CYP2F1 DME0016 XEOTICID XEO00777 GENEFORM mRNA DME0016 XEOTICID XEO00777 MOACRIVE Induction DME0016 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0016 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0016 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0016 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME CYP2F1 DME0016 XEOTICID XEO00905 GENEFORM mRNA DME0016 XEOTICID XEO00905 MOACRIVE Inhibition DME0016 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0016 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0016 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0016 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME CYP2F1 DME0016 XEOTICID XEO01004 GENEFORM mRNA DME0016 XEOTICID XEO01004 MOACRIVE Inhibition DME0016 XEOTICID XEO01512 XEO_NAME Zinc DME0016 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME0016 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME0016 XEOTICID XEO01512 DESCRIPT Zinc up-regulates the expression of DME CYP2F1 DME0016 XEOTICID XEO01512 GENEFORM mRNA DME0016 XEOTICID XEO01512 MOACRIVE Induction DME0017 DME___ID DME0017 DME0017 DME_NAME Cytochrome P450 2C18 (CYP2C18) DME0017 SPESNAME Homo sapiens DME0017 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0017 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0017 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0017 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP2C18 DME0017 XEOTICID XEO00217 GENEFORM mRNA DME0017 XEOTICID XEO00217 MOACRIVE Inhibition DME0017 XEOTICID XEO00223 XEO_NAME Rifampin DME0017 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0017 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0017 XEOTICID XEO00223 DESCRIPT Rifampin inhibits the expression of DME CYP2C18 DME0017 XEOTICID XEO00223 GENEFORM mRNA DME0017 XEOTICID XEO00223 MOACRIVE Inhibition DME0017 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0017 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0017 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0017 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP2C18 DME0017 XEOTICID XEO00241 GENEFORM mRNA DME0017 XEOTICID XEO00241 MOACRIVE Inhibition DME0017 XEOTICID XEO00253 XEO_NAME Tretinoin DME0017 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0017 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0017 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME CYP2C18 DME0017 XEOTICID XEO00253 GENEFORM mRNA DME0017 XEOTICID XEO00253 MOACRIVE Inhibition DME0017 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0017 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0017 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0017 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME CYP2C18 DME0017 XEOTICID XEO00723 GENEFORM mRNA DME0017 XEOTICID XEO00723 MOACRIVE Inhibition DME0017 XEOTICID XEO00755 XEO_NAME Coal tar DME0017 XEOTICID XEO00755 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0017 XEOTICID XEO00755 XEO_CLAS Natural Mixture DME0017 XEOTICID XEO00755 DESCRIPT Coal tar up-regulates the expression of DME CYP2C18 DME0017 XEOTICID XEO00755 GENEFORM mRNA DME0017 XEOTICID XEO00755 MOACRIVE Induction DME0017 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0017 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0017 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0017 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYP2C18 DME0017 XEOTICID XEO00806 GENEFORM mRNA DME0017 XEOTICID XEO00806 MOACRIVE Inhibition DME0017 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0017 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0017 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0017 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME CYP2C18 DME0017 XEOTICID XEO00821 GENEFORM Protein DME0017 XEOTICID XEO00821 MOACRIVE Inhibition DME0017 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0017 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0017 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0017 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME CYP2C18 DME0017 XEOTICID XEO00999 GENEFORM mRNA DME0017 XEOTICID XEO00999 MOACRIVE Induction DME0017 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0017 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0017 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0017 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME CYP2C18 DME0017 XEOTICID XEO01220 GENEFORM mRNA DME0017 XEOTICID XEO01220 MOACRIVE Inhibition DME0017 XEOTICID XEO01498 XEO_NAME Walrycin A DME0017 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0017 XEOTICID XEO01498 XEO_CLAS Natural Product DME0017 XEOTICID XEO01498 DESCRIPT Walrycin A up-regulates the expression of DME CYP2C18 DME0017 XEOTICID XEO01498 GENEFORM mRNA DME0017 XEOTICID XEO01498 MOACRIVE Induction DME0017 XEOTICID XEO01574 XEO_NAME Plant extracts DME0017 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0017 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0017 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME CYP2C18 DME0017 XEOTICID XEO01574 GENEFORM Protein DME0017 XEOTICID XEO01574 MOACRIVE Inhibition DME0017 XEOTICID XEO01585 XEO_NAME Senecionine DME0017 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0017 XEOTICID XEO01585 XEO_CLAS Natural Product DME0017 XEOTICID XEO01585 DESCRIPT Senecionine inhibits the drug-metabolizing activity of DME CYP2C18 DME0017 XEOTICID XEO01585 GENEFORM Protein DME0017 XEOTICID XEO01585 MOACRIVE Inhibition DME0018 DME___ID DME0018 DME0018 DME_NAME Cytochrome P450 2C8 (CYP2C8) DME0018 SPESNAME Homo sapiens DME0018 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0018 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME CYP2C8 DME0018 XEOTICID XEO00011 GENEFORM mRNA DME0018 XEOTICID XEO00011 MOACRIVE Induction DME0018 XEOTICID XEO00017 XEO_NAME Clotrimazole DME0018 XEOTICID XEO00017 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00017 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00017 DESCRIPT Clotrimazole inhibits the drug-metabolizing activity of DME CYP2C8 (IC50 = 0.803 microM) DME0018 XEOTICID XEO00017 GENEFORM Protein DME0018 XEOTICID XEO00017 MOACRIVE Inhibition DME0018 XEOTICID XEO00029 XEO_NAME Valproic acid DME0018 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME CYP2C8 DME0018 XEOTICID XEO00029 GENEFORM mRNA DME0018 XEOTICID XEO00029 MOACRIVE Inhibition DME0018 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0018 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00035 DESCRIPT Fenof DMEibrate inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00035 GENEFORM Protein DME0018 XEOTICID XEO00035 MOACRIVE Inhibition DME0018 XEOTICID XEO00042 XEO_NAME Gemfibrozil DME0018 XEOTICID XEO00042 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00042 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00042 DESCRIPT Gemfibrozil inhibits the drug-metabolizing activity of DME CYP2C8 (IC50 = 4.1 microM) DME0018 XEOTICID XEO00042 GENEFORM Protein DME0018 XEOTICID XEO00042 MOACRIVE Inhibition DME0018 XEOTICID XEO00055 XEO_NAME Loratadine DME0018 XEOTICID XEO00055 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00055 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00055 DESCRIPT Loratadine inhibits the drug-metabolizing activity of DME CYP2C8 (IC50 = 2.95 microM) DME0018 XEOTICID XEO00055 GENEFORM Protein DME0018 XEOTICID XEO00055 MOACRIVE Inhibition DME0018 XEOTICID XEO00081 XEO_NAME Sulfinpyrazone DME0018 XEOTICID XEO00081 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00081 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00081 DESCRIPT Sulfinpyrazone inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00081 GENEFORM Protein DME0018 XEOTICID XEO00081 MOACRIVE Inhibition DME0018 XEOTICID XEO00086 XEO_NAME Troglitazone DME0018 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME CYP2C8 DME0018 XEOTICID XEO00086 GENEFORM mRNA DME0018 XEOTICID XEO00086 MOACRIVE Induction DME0018 XEOTICID XEO00087 XEO_NAME Zafirlukast DME0018 XEOTICID XEO00087 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00087 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00087 DESCRIPT Zafirlukast inhibits the expression of DME CYP2C8 DME0018 XEOTICID XEO00087 GENEFORM mRNA DME0018 XEOTICID XEO00087 MOACRIVE Inhibition DME0018 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0018 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME CYP2C8 DME0018 XEOTICID XEO00088 GENEFORM mRNA DME0018 XEOTICID XEO00088 MOACRIVE Induction DME0018 XEOTICID XEO00090 XEO_NAME Estradiol DME0018 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME CYP2C8 DME0018 XEOTICID XEO00090 GENEFORM mRNA DME0018 XEOTICID XEO00090 MOACRIVE Inhibition DME0018 XEOTICID XEO00125 XEO_NAME Simvastatin DME0018 XEOTICID XEO00125 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00125 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00125 DESCRIPT Simvastatin inhibits the drug-metabolizing activity of DME CYP2C8 (IC50 = 3.7 microM) DME0018 XEOTICID XEO00125 GENEFORM Protein DME0018 XEOTICID XEO00125 MOACRIVE Inhibition DME0018 XEOTICID XEO00126 XEO_NAME Raloxifene hydrochloride DME0018 XEOTICID XEO00126 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00126 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00126 DESCRIPT Raloxifene hydrochloride inhibits the expression of DME CYP2C8 DME0018 XEOTICID XEO00126 GENEFORM mRNA DME0018 XEOTICID XEO00126 MOACRIVE Inhibition DME0018 XEOTICID XEO00128 XEO_NAME Salmeterol xinafoate DME0018 XEOTICID XEO00128 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00128 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00128 DESCRIPT Salmeterol xinafoate inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00128 GENEFORM Protein DME0018 XEOTICID XEO00128 MOACRIVE Inhibition DME0018 XEOTICID XEO00138 XEO_NAME Fenofibric acid DME0018 XEOTICID XEO00138 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00138 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00138 DESCRIPT Fenofibric acid induces the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00138 GENEFORM Protein DME0018 XEOTICID XEO00138 MOACRIVE Induction DME0018 XEOTICID XEO00162 XEO_NAME Mometasone furoate DME0018 XEOTICID XEO00162 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00162 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00162 DESCRIPT Mometasone furoate inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00162 GENEFORM Protein DME0018 XEOTICID XEO00162 MOACRIVE Inhibition DME0018 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0018 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP2C8 DME0018 XEOTICID XEO00217 GENEFORM mRNA DME0018 XEOTICID XEO00217 MOACRIVE Inhibition DME0018 XEOTICID XEO00223 XEO_NAME Rifampin DME0018 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00223 DESCRIPT Rifampin up-regulates the expression of DME CYP2C8 and leads to increasing the drug-metabolizing activity of this enzyme DME0018 XEOTICID XEO00223 GENEFORM Protein DME0018 XEOTICID XEO00223 MOACRIVE Induction DME0018 XEOTICID XEO00224 XEO_NAME Isoniazid DME0018 XEOTICID XEO00224 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00224 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00224 DESCRIPT Isoniazid inhibits the drug-metabolizing activity of DME CYP2C8 (Ki = 170 microM) DME0018 XEOTICID XEO00224 GENEFORM Protein DME0018 XEOTICID XEO00224 MOACRIVE Inhibition DME0018 XEOTICID XEO00236 XEO_NAME Candesartan cilexetil DME0018 XEOTICID XEO00236 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00236 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00236 DESCRIPT Candesartan cilexetil inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00236 GENEFORM Protein DME0018 XEOTICID XEO00236 MOACRIVE Inhibition DME0018 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0018 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP2C8 DME0018 XEOTICID XEO00241 GENEFORM mRNA DME0018 XEOTICID XEO00241 MOACRIVE Inhibition DME0018 XEOTICID XEO00245 XEO_NAME Felodipine DME0018 XEOTICID XEO00245 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00245 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00245 DESCRIPT Felodipine inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00245 GENEFORM Protein DME0018 XEOTICID XEO00245 MOACRIVE Inhibition DME0018 XEOTICID XEO00246 XEO_NAME Amoxicillin DME0018 XEOTICID XEO00246 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00246 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00246 DESCRIPT Amoxicillin inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00246 GENEFORM Protein DME0018 XEOTICID XEO00246 MOACRIVE Inhibition DME0018 XEOTICID XEO00249 XEO_NAME Irbesartan DME0018 XEOTICID XEO00249 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00249 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00249 DESCRIPT Irbesartan inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00249 GENEFORM Protein DME0018 XEOTICID XEO00249 MOACRIVE Inhibition DME0018 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0018 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP2C8 (IC50 = 2.45 microM) DME0018 XEOTICID XEO00251 GENEFORM Protein DME0018 XEOTICID XEO00251 MOACRIVE Inhibition DME0018 XEOTICID XEO00262 XEO_NAME Lovastatin DME0018 XEOTICID XEO00262 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00262 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00262 DESCRIPT Lovastatin inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00262 GENEFORM Protein DME0018 XEOTICID XEO00262 MOACRIVE Inhibition DME0018 XEOTICID XEO00263 XEO_NAME Trimethoprim DME0018 XEOTICID XEO00263 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00263 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00263 DESCRIPT Trimethoprim inhibits the expression of DME CYP2C8 DME0018 XEOTICID XEO00263 GENEFORM mRNA DME0018 XEOTICID XEO00263 MOACRIVE Inhibition DME0018 XEOTICID XEO00266 XEO_NAME Spironolactone DME0018 XEOTICID XEO00266 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00266 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00266 DESCRIPT Spironolactone inhibits the expression of DME CYP2C8 DME0018 XEOTICID XEO00266 GENEFORM mRNA DME0018 XEOTICID XEO00266 MOACRIVE Inhibition DME0018 XEOTICID XEO00267 XEO_NAME Ethinyl estradiol DME0018 XEOTICID XEO00267 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00267 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00267 DESCRIPT Ethinyl estradiol inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00267 GENEFORM Protein DME0018 XEOTICID XEO00267 MOACRIVE Inhibition DME0018 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0018 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride inhibits the drug-metabolizing activity of DME CYP2C8 (Ki = 1.5 microM) DME0018 XEOTICID XEO00277 GENEFORM Protein DME0018 XEOTICID XEO00277 MOACRIVE Inhibition DME0018 XEOTICID XEO00311 XEO_NAME Nicardipine hydrochloride DME0018 XEOTICID XEO00311 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00311 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00311 DESCRIPT Nicardipine hydrochloride inhibits the drug-metabolizing activity of DME CYP2C8 (IC50 = 1.56 microM) DME0018 XEOTICID XEO00311 GENEFORM Protein DME0018 XEOTICID XEO00311 MOACRIVE Inhibition DME0018 XEOTICID XEO00313 XEO_NAME Nortriptyline hydrochloride DME0018 XEOTICID XEO00313 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00313 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00313 DESCRIPT Nortriptyline hydrochloride inhibits the drug-metabolizing activity of DME CYP2C8 (Ki = 49.9 microM) DME0018 XEOTICID XEO00313 GENEFORM Protein DME0018 XEOTICID XEO00313 MOACRIVE Inhibition DME0018 XEOTICID XEO00318 XEO_NAME Phenelzine sulfate DME0018 XEOTICID XEO00318 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00318 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00318 DESCRIPT Phenelzine sulfate inhibits the drug-metabolizing activity of DME CYP2C8 (Ki = 1.2 microM) DME0018 XEOTICID XEO00318 GENEFORM Protein DME0018 XEOTICID XEO00318 MOACRIVE Inhibition DME0018 XEOTICID XEO00319 XEO_NAME Pioglitazone hydrochloride DME0018 XEOTICID XEO00319 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00319 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00319 DESCRIPT Pioglitazone hydrochloride inhibits the expression of DME CYP2C8 DME0018 XEOTICID XEO00319 GENEFORM mRNA DME0018 XEOTICID XEO00319 MOACRIVE Inhibition DME0018 XEOTICID XEO00358 XEO_NAME Fluoxetine DME0018 XEOTICID XEO00358 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00358 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00358 DESCRIPT Fluoxetine inhibits the drug-metabolizing activity of DME CYP2C8 (Ki = 294 microM) DME0018 XEOTICID XEO00358 GENEFORM Protein DME0018 XEOTICID XEO00358 MOACRIVE Inhibition DME0018 XEOTICID XEO00368 XEO_NAME Montelukast DME0018 XEOTICID XEO00368 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00368 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00368 DESCRIPT Montelukast inhibits the drug-metabolizing activity of DME CYP2C8 (IC50 = 1 microM) DME0018 XEOTICID XEO00368 GENEFORM Protein DME0018 XEOTICID XEO00368 MOACRIVE Inhibition DME0018 XEOTICID XEO00374 XEO_NAME Pazopanib DME0018 XEOTICID XEO00374 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00374 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00374 DESCRIPT Pazopanib up-regulates the expression of DME CYP2C8 DME0018 XEOTICID XEO00374 GENEFORM mRNA DME0018 XEOTICID XEO00374 MOACRIVE Induction DME0018 XEOTICID XEO00375 XEO_NAME Piperacillin DME0018 XEOTICID XEO00375 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00375 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00375 DESCRIPT Piperacillin inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00375 GENEFORM Protein DME0018 XEOTICID XEO00375 MOACRIVE Inhibition DME0018 XEOTICID XEO00383 XEO_NAME Tamoxifen DME0018 XEOTICID XEO00383 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00383 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00383 DESCRIPT Tamoxifen inhibits the drug-metabolizing activity of DME CYP2C8 (IC50 = 14.3 microM) DME0018 XEOTICID XEO00383 GENEFORM Protein DME0018 XEOTICID XEO00383 MOACRIVE Inhibition DME0018 XEOTICID XEO00387 XEO_NAME Verapamil DME0018 XEOTICID XEO00387 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00387 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00387 DESCRIPT Verapamil inhibits the drug-metabolizing activity of DME CYP2C8 (IC50 > 30 microM) DME0018 XEOTICID XEO00387 GENEFORM Protein DME0018 XEOTICID XEO00387 MOACRIVE Inhibition DME0018 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0018 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00410 DESCRIPT Phenobarbital induces the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00410 GENEFORM Protein DME0018 XEOTICID XEO00410 MOACRIVE Induction DME0018 XEOTICID XEO00493 XEO_NAME Bezafibrate DME0018 XEOTICID XEO00493 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00493 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00493 DESCRIPT Bezafibrate inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00493 GENEFORM Protein DME0018 XEOTICID XEO00493 MOACRIVE Inhibition DME0018 XEOTICID XEO00538 XEO_NAME Quercetin DME0018 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0018 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME CYP2C8 (IC50 = 1.2 microM) DME0018 XEOTICID XEO00538 GENEFORM Protein DME0018 XEOTICID XEO00538 MOACRIVE Inhibition DME0018 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0018 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0018 XEOTICID XEO00582 DESCRIPT Diethyltoluamide up-regulates the expression of DME CYP2C8 DME0018 XEOTICID XEO00582 GENEFORM mRNA DME0018 XEOTICID XEO00582 MOACRIVE Induction DME0018 XEOTICID XEO00597 XEO_NAME Camptothecin DME0018 XEOTICID XEO00597 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00597 XEO_CLAS Drug in Phase 2 Clinical Trial DME0018 XEOTICID XEO00597 DESCRIPT Camptothecin inhibits the expression of DME CYP2C8 DME0018 XEOTICID XEO00597 GENEFORM mRNA DME0018 XEOTICID XEO00597 MOACRIVE Inhibition DME0018 XEOTICID XEO00609 XEO_NAME MeIQx DME0018 XEOTICID XEO00609 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00609 XEO_CLAS Drug in Phase 2 Clinical Trial DME0018 XEOTICID XEO00609 DESCRIPT MeIQx inhibits the expression of DME CYP2C8 DME0018 XEOTICID XEO00609 GENEFORM mRNA DME0018 XEOTICID XEO00609 MOACRIVE Inhibition DME0018 XEOTICID XEO00610 XEO_NAME Afimoxifene DME0018 XEOTICID XEO00610 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00610 XEO_CLAS Drug in Phase 3 Clinical Trial DME0018 XEOTICID XEO00610 DESCRIPT Afimoxifene inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00610 GENEFORM Protein DME0018 XEOTICID XEO00610 MOACRIVE Inhibition DME0018 XEOTICID XEO00663 XEO_NAME Satraplatin DME0018 XEOTICID XEO00663 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00663 XEO_CLAS Drug in Phase 3 Clinical Trial DME0018 XEOTICID XEO00663 DESCRIPT Satraplatin inhibits the expression of DME CYP2C8 DME0018 XEOTICID XEO00663 GENEFORM mRNA DME0018 XEOTICID XEO00663 MOACRIVE Inhibition DME0018 XEOTICID XEO00671 XEO_NAME Endoxifen DME0018 XEOTICID XEO00671 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00671 XEO_CLAS Drug in Phase 3 Clinical Trial DME0018 XEOTICID XEO00671 DESCRIPT Endoxifen inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00671 GENEFORM Protein DME0018 XEOTICID XEO00671 MOACRIVE Inhibition DME0018 XEOTICID XEO00686 XEO_NAME Silibinin B DME0018 XEOTICID XEO00686 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00686 XEO_CLAS Drug in Phase 2 Clinical Trial DME0018 XEOTICID XEO00686 DESCRIPT Silibinin B inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00686 GENEFORM Protein DME0018 XEOTICID XEO00686 MOACRIVE Inhibition DME0018 XEOTICID XEO00743 XEO_NAME Medroxyprogesterone acetate DME0018 XEOTICID XEO00743 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00743 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00743 DESCRIPT Medroxyprogesterone acetate inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00743 GENEFORM Protein DME0018 XEOTICID XEO00743 MOACRIVE Inhibition DME0018 XEOTICID XEO00751 XEO_NAME Cocaine hydrochloride DME0018 XEOTICID XEO00751 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO00751 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO00751 DESCRIPT Cocaine hydrochloride inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00751 GENEFORM Protein DME0018 XEOTICID XEO00751 MOACRIVE Inhibition DME0018 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0018 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0018 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0018 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYP2C8 DME0018 XEOTICID XEO00806 GENEFORM mRNA DME0018 XEOTICID XEO00806 MOACRIVE Inhibition DME0018 XEOTICID XEO00861 XEO_NAME Salvianolic acid C DME0018 XEOTICID XEO00861 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0018 XEOTICID XEO00861 XEO_CLAS Natural Product DME0018 XEOTICID XEO00861 DESCRIPT Salvianolic acid C inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO00861 GENEFORM Protein DME0018 XEOTICID XEO00861 MOACRIVE Inhibition DME0018 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0018 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0018 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0018 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME CYP2C8 DME0018 XEOTICID XEO00905 GENEFORM mRNA DME0018 XEOTICID XEO00905 MOACRIVE Inhibition DME0018 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0018 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0018 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0018 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid up-regulates the expression of DME CYP2C8 DME0018 XEOTICID XEO00921 GENEFORM mRNA DME0018 XEOTICID XEO00921 MOACRIVE Induction DME0018 XEOTICID XEO01046 XEO_NAME Cypermethrin DME0018 XEOTICID XEO01046 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0018 XEOTICID XEO01046 XEO_CLAS Pesticide/Insecticide DME0018 XEOTICID XEO01046 DESCRIPT Cypermethrin up-regulates the expression of DME CYP2C8 DME0018 XEOTICID XEO01046 GENEFORM mRNA DME0018 XEOTICID XEO01046 MOACRIVE Induction DME0018 XEOTICID XEO01047 XEO_NAME Decamethrin DME0018 XEOTICID XEO01047 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0018 XEOTICID XEO01047 XEO_CLAS Pesticide/Insecticide DME0018 XEOTICID XEO01047 DESCRIPT Decamethrin up-regulates the expression of DME CYP2C8 DME0018 XEOTICID XEO01047 GENEFORM mRNA DME0018 XEOTICID XEO01047 MOACRIVE Induction DME0018 XEOTICID XEO01052 XEO_NAME Fenitrothion DME0018 XEOTICID XEO01052 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0018 XEOTICID XEO01052 XEO_CLAS Pesticide/Insecticide DME0018 XEOTICID XEO01052 DESCRIPT Fenitrothion inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO01052 GENEFORM Protein DME0018 XEOTICID XEO01052 MOACRIVE Inhibition DME0018 XEOTICID XEO01053 XEO_NAME Fenvalerate DME0018 XEOTICID XEO01053 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0018 XEOTICID XEO01053 XEO_CLAS Pesticide/Insecticide DME0018 XEOTICID XEO01053 DESCRIPT Fenvalerate up-regulates the expression of DME CYP2C8 DME0018 XEOTICID XEO01053 GENEFORM mRNA DME0018 XEOTICID XEO01053 MOACRIVE Induction DME0018 XEOTICID XEO01130 XEO_NAME DY-9760e DME0018 XEOTICID XEO01130 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO01130 XEO_CLAS Investigative Agent DME0018 XEOTICID XEO01130 DESCRIPT DY-9760e inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO01130 GENEFORM Protein DME0018 XEOTICID XEO01130 MOACRIVE Inhibition DME0018 XEOTICID XEO01156 XEO_NAME CP-778875 DME0018 XEOTICID XEO01156 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO01156 XEO_CLAS Preclinical/Patented Drug DME0018 XEOTICID XEO01156 DESCRIPT CP-778875 inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO01156 GENEFORM Protein DME0018 XEOTICID XEO01156 MOACRIVE Inhibition DME0018 XEOTICID XEO01159 XEO_NAME 5-fluorotryptamine DME0018 XEOTICID XEO01159 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO01159 XEO_CLAS Investigative Agent DME0018 XEOTICID XEO01159 DESCRIPT 5-fluorotryptamine inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO01159 GENEFORM Protein DME0018 XEOTICID XEO01159 MOACRIVE Inhibition DME0018 XEOTICID XEO01165 XEO_NAME CITCO DME0018 XEOTICID XEO01165 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO01165 XEO_CLAS Investigative Agent DME0018 XEOTICID XEO01165 DESCRIPT CITCO up-regulates the expression of DME CYP2C8 DME0018 XEOTICID XEO01165 GENEFORM mRNA DME0018 XEOTICID XEO01165 MOACRIVE Induction DME0018 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0018 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0018 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO01226 GENEFORM Protein DME0018 XEOTICID XEO01226 MOACRIVE Inhibition DME0018 XEOTICID XEO01230 XEO_NAME Butyric acid DME0018 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0018 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME CYP2C8 DME0018 XEOTICID XEO01230 GENEFORM mRNA DME0018 XEOTICID XEO01230 MOACRIVE Induction DME0018 XEOTICID XEO01252 XEO_NAME Cinnamic acid DME0018 XEOTICID XEO01252 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO01252 XEO_CLAS Approved/Marketed Drug DME0018 XEOTICID XEO01252 DESCRIPT Cinnamic acid inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO01252 GENEFORM Protein DME0018 XEOTICID XEO01252 MOACRIVE Inhibition DME0018 XEOTICID XEO01257 XEO_NAME Clofibric acid DME0018 XEOTICID XEO01257 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0018 XEOTICID XEO01257 XEO_CLAS Herbicide DME0018 XEOTICID XEO01257 DESCRIPT Clofibric acid induces the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO01257 GENEFORM Protein DME0018 XEOTICID XEO01257 MOACRIVE Induction DME0018 XEOTICID XEO01281 XEO_NAME Diosmetin DME0018 XEOTICID XEO01281 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0018 XEOTICID XEO01281 XEO_CLAS Natural Product DME0018 XEOTICID XEO01281 DESCRIPT Diosmetin inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO01281 GENEFORM Protein DME0018 XEOTICID XEO01281 MOACRIVE Inhibition DME0018 XEOTICID XEO01302 XEO_NAME Fipronil DME0018 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0018 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0018 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME CYP2C8 DME0018 XEOTICID XEO01302 GENEFORM mRNA DME0018 XEOTICID XEO01302 MOACRIVE Induction DME0018 XEOTICID XEO01365 XEO_NAME Licochalcone A DME0018 XEOTICID XEO01365 XEO_TYPE Pharmaceutical Agent(s) DME0018 XEOTICID XEO01365 XEO_CLAS Drug in Phase 1 Clinical Trial DME0018 XEOTICID XEO01365 DESCRIPT Licochalcone A inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO01365 GENEFORM Protein DME0018 XEOTICID XEO01365 MOACRIVE Inhibition DME0018 XEOTICID XEO01442 XEO_NAME Puag-haad DME0018 XEOTICID XEO01442 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0018 XEOTICID XEO01442 XEO_CLAS Natural Product DME0018 XEOTICID XEO01442 DESCRIPT Puag-haad inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO01442 GENEFORM Protein DME0018 XEOTICID XEO01442 MOACRIVE Inhibition DME0018 XEOTICID XEO01498 XEO_NAME Walrycin A DME0018 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0018 XEOTICID XEO01498 XEO_CLAS Natural Product DME0018 XEOTICID XEO01498 DESCRIPT Walrycin A up-regulates the expression of DME CYP2C8 DME0018 XEOTICID XEO01498 GENEFORM mRNA DME0018 XEOTICID XEO01498 MOACRIVE Induction DME0018 XEOTICID XEO01517 XEO_NAME 15,16-dihydrotanshinone I DME0018 XEOTICID XEO01517 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0018 XEOTICID XEO01517 XEO_CLAS Natural Product DME0018 XEOTICID XEO01517 DESCRIPT 15,16-dihydrotanshinone I inhibits the drug-metabolizing activity of DME CYP2C8 DME0018 XEOTICID XEO01517 GENEFORM Protein DME0018 XEOTICID XEO01517 MOACRIVE Inhibition DME0019 DME___ID DME0019 DME0019 DME_NAME Cytochrome P450 2C9 (CYP2C9) DME0019 SPESNAME Homo sapiens DME0019 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0019 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00011 DESCRIPT Carbamazepine induces the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00011 GENEFORM Protein DME0019 XEOTICID XEO00011 MOACRIVE Induction DME0019 XEOTICID XEO00015 XEO_NAME Cimetidine DME0019 XEOTICID XEO00015 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00015 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00015 DESCRIPT Cimetidine inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00015 GENEFORM Protein DME0019 XEOTICID XEO00015 MOACRIVE Inhibition DME0019 XEOTICID XEO00017 XEO_NAME Clotrimazole DME0019 XEOTICID XEO00017 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00017 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00017 DESCRIPT Clotrimazole up-regulates the expression of DME CYP2C9 and leads to increasing the drug-metabolizing activity of this enzyme DME0019 XEOTICID XEO00017 GENEFORM Protein DME0019 XEOTICID XEO00017 MOACRIVE Induction DME0019 XEOTICID XEO00019 XEO_NAME Dapsone DME0019 XEOTICID XEO00019 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00019 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00019 DESCRIPT Dapsone inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00019 GENEFORM Protein DME0019 XEOTICID XEO00019 MOACRIVE Inhibition DME0019 XEOTICID XEO00022 XEO_NAME Desipramine DME0019 XEOTICID XEO00022 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00022 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00022 DESCRIPT Desipramine inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00022 GENEFORM Protein DME0019 XEOTICID XEO00022 MOACRIVE Inhibition DME0019 XEOTICID XEO00029 XEO_NAME Valproic acid DME0019 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO00029 GENEFORM mRNA DME0019 XEOTICID XEO00029 MOACRIVE Induction DME0019 XEOTICID XEO00036 XEO_NAME Fluconazole DME0019 XEOTICID XEO00036 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00036 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00036 DESCRIPT Fluconazole inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 = 13 microM) DME0019 XEOTICID XEO00036 GENEFORM Protein DME0019 XEOTICID XEO00036 MOACRIVE Inhibition DME0019 XEOTICID XEO00049 XEO_NAME Isradipine DME0019 XEOTICID XEO00049 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00049 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00049 DESCRIPT Isradipine inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 = 3.66 microM) DME0019 XEOTICID XEO00049 GENEFORM Protein DME0019 XEOTICID XEO00049 MOACRIVE Inhibition DME0019 XEOTICID XEO00053 XEO_NAME Leflunomide DME0019 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO00053 GENEFORM mRNA DME0019 XEOTICID XEO00053 MOACRIVE Induction DME0019 XEOTICID XEO00056 XEO_NAME Malathion DME0019 XEOTICID XEO00056 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00056 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00056 DESCRIPT Malathion inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00056 GENEFORM Protein DME0019 XEOTICID XEO00056 MOACRIVE Inhibition DME0019 XEOTICID XEO00076 XEO_NAME Pyrimethamine DME0019 XEOTICID XEO00076 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00076 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00076 DESCRIPT Pyrimethamine inhibits the drug-metabolizing activity of DME CYP2C9 (Ki = 51.5 microM) DME0019 XEOTICID XEO00076 GENEFORM Protein DME0019 XEOTICID XEO00076 MOACRIVE Inhibition DME0019 XEOTICID XEO00080 XEO_NAME Sulfaphenazole DME0019 XEOTICID XEO00080 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00080 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00080 DESCRIPT Sulfaphenazole inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 = 0.08 microM) DME0019 XEOTICID XEO00080 GENEFORM Protein DME0019 XEOTICID XEO00080 MOACRIVE Inhibition DME0019 XEOTICID XEO00084 XEO_NAME Thiabendazole DME0019 XEOTICID XEO00084 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00084 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00084 DESCRIPT Thiabendazole inhibits the drug-metabolizing activity of DME CYP2C9 (Ki = 245 microM) DME0019 XEOTICID XEO00084 GENEFORM Protein DME0019 XEOTICID XEO00084 MOACRIVE Inhibition DME0019 XEOTICID XEO00087 XEO_NAME Zafirlukast DME0019 XEOTICID XEO00087 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00087 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00087 DESCRIPT Zafirlukast inhibits the drug-metabolizing activity of DME CYP2C9 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 2.2575 microM) DME0019 XEOTICID XEO00087 GENEFORM Protein DME0019 XEOTICID XEO00087 MOACRIVE Inhibition DME0019 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0019 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME CYP2C9 and leads to increasing the drug-metabolizing activity of this enzyme DME0019 XEOTICID XEO00088 GENEFORM Protein DME0019 XEOTICID XEO00088 MOACRIVE Induction DME0019 XEOTICID XEO00090 XEO_NAME Estradiol DME0019 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00090 DESCRIPT Estradiol induces the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00090 GENEFORM Protein DME0019 XEOTICID XEO00090 MOACRIVE Induction DME0019 XEOTICID XEO00105 XEO_NAME Dihydroergotamine DME0019 XEOTICID XEO00105 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00105 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00105 DESCRIPT Dihydroergotamine inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00105 GENEFORM Protein DME0019 XEOTICID XEO00105 MOACRIVE Inhibition DME0019 XEOTICID XEO00142 XEO_NAME Voriconazole DME0019 XEOTICID XEO00142 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00142 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00142 DESCRIPT Voriconazole inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 = 14 microM) DME0019 XEOTICID XEO00142 GENEFORM Protein DME0019 XEOTICID XEO00142 MOACRIVE Inhibition DME0019 XEOTICID XEO00160 XEO_NAME Ritonavir DME0019 XEOTICID XEO00160 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00160 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00160 DESCRIPT Ritonavir up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO00160 GENEFORM mRNA DME0019 XEOTICID XEO00160 MOACRIVE Induction DME0019 XEOTICID XEO00173 XEO_NAME Cannabidiol DME0019 XEOTICID XEO00173 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00173 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00173 DESCRIPT Cannabidiol inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00173 GENEFORM Protein DME0019 XEOTICID XEO00173 MOACRIVE Inhibition DME0019 XEOTICID XEO00178 XEO_NAME Capsaicin DME0019 XEOTICID XEO00178 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00178 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00178 DESCRIPT Capsaicin inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00178 GENEFORM Protein DME0019 XEOTICID XEO00178 MOACRIVE Inhibition DME0019 XEOTICID XEO00188 XEO_NAME Sirolimus DME0019 XEOTICID XEO00188 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00188 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00188 DESCRIPT Sirolimus inhibits the expression of DME CYP2C9 DME0019 XEOTICID XEO00188 GENEFORM mRNA DME0019 XEOTICID XEO00188 MOACRIVE Inhibition DME0019 XEOTICID XEO00216 XEO_NAME Efavirenz DME0019 XEOTICID XEO00216 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00216 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00216 DESCRIPT Efavirenz inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00216 GENEFORM Protein DME0019 XEOTICID XEO00216 MOACRIVE Inhibition DME0019 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0019 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP2C9 DME0019 XEOTICID XEO00217 GENEFORM mRNA DME0019 XEOTICID XEO00217 MOACRIVE Inhibition DME0019 XEOTICID XEO00223 XEO_NAME Rifampin DME0019 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00223 DESCRIPT Rifampin induces the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00223 GENEFORM Protein DME0019 XEOTICID XEO00223 MOACRIVE Induction DME0019 XEOTICID XEO00232 XEO_NAME Phenytoin DME0019 XEOTICID XEO00232 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00232 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00232 DESCRIPT Phenytoin induces the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00232 GENEFORM Protein DME0019 XEOTICID XEO00232 MOACRIVE Induction DME0019 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0019 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 = 38.8 microM) DME0019 XEOTICID XEO00241 GENEFORM Protein DME0019 XEOTICID XEO00241 MOACRIVE Inhibition DME0019 XEOTICID XEO00244 XEO_NAME Ivermectin DME0019 XEOTICID XEO00244 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00244 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00244 DESCRIPT Ivermectin inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00244 GENEFORM Protein DME0019 XEOTICID XEO00244 MOACRIVE Inhibition DME0019 XEOTICID XEO00245 XEO_NAME Felodipine DME0019 XEOTICID XEO00245 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00245 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00245 DESCRIPT Felodipine inhibits the drug-metabolizing activity of DME CYP2C9 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 4.5795 microM) DME0019 XEOTICID XEO00245 GENEFORM Protein DME0019 XEOTICID XEO00245 MOACRIVE Inhibition DME0019 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0019 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 = 40 microM) DME0019 XEOTICID XEO00251 GENEFORM Protein DME0019 XEOTICID XEO00251 MOACRIVE Inhibition DME0019 XEOTICID XEO00253 XEO_NAME Tretinoin DME0019 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME CYP2C9 DME0019 XEOTICID XEO00253 GENEFORM mRNA DME0019 XEOTICID XEO00253 MOACRIVE Inhibition DME0019 XEOTICID XEO00256 XEO_NAME Paclitaxel DME0019 XEOTICID XEO00256 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00256 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00256 DESCRIPT Paclitaxel induces the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00256 GENEFORM Protein DME0019 XEOTICID XEO00256 MOACRIVE Induction DME0019 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0019 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00277 GENEFORM Protein DME0019 XEOTICID XEO00277 MOACRIVE Inhibition DME0019 XEOTICID XEO00280 XEO_NAME Chlorpromazine hydrochloride DME0019 XEOTICID XEO00280 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00280 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00280 DESCRIPT Chlorpromazine hydrochloride inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 > 50 microM) DME0019 XEOTICID XEO00280 GENEFORM Protein DME0019 XEOTICID XEO00280 MOACRIVE Inhibition DME0019 XEOTICID XEO00287 XEO_NAME Delavirdine mesylate DME0019 XEOTICID XEO00287 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00287 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00287 DESCRIPT Delavirdine mesylate inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00287 GENEFORM Protein DME0019 XEOTICID XEO00287 MOACRIVE Inhibition DME0019 XEOTICID XEO00293 XEO_NAME Econazole nitrate DME0019 XEOTICID XEO00293 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00293 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00293 DESCRIPT Econazole nitrate inhibits the drug-metabolizing activity of DME CYP2C9 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.2 microM) DME0019 XEOTICID XEO00293 GENEFORM Protein DME0019 XEOTICID XEO00293 MOACRIVE Inhibition DME0019 XEOTICID XEO00295 XEO_NAME Fluphenazine hydrochloride DME0019 XEOTICID XEO00295 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00295 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00295 DESCRIPT Fluphenazine hydrochloride inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00295 GENEFORM Protein DME0019 XEOTICID XEO00295 MOACRIVE Inhibition DME0019 XEOTICID XEO00301 XEO_NAME Irinotecan hydrochloride DME0019 XEOTICID XEO00301 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00301 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00301 DESCRIPT Irinotecan hydrochloride inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00301 GENEFORM Protein DME0019 XEOTICID XEO00301 MOACRIVE Inhibition DME0019 XEOTICID XEO00308 XEO_NAME Miconazole nitrate DME0019 XEOTICID XEO00308 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00308 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00308 DESCRIPT Miconazole nitrate inhibits the drug-metabolizing activity of DME CYP2C9 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.2 microM) DME0019 XEOTICID XEO00308 GENEFORM Protein DME0019 XEOTICID XEO00308 MOACRIVE Inhibition DME0019 XEOTICID XEO00311 XEO_NAME Nicardipine hydrochloride DME0019 XEOTICID XEO00311 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00311 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00311 DESCRIPT Nicardipine hydrochloride inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 = 0.378 microM) DME0019 XEOTICID XEO00311 GENEFORM Protein DME0019 XEOTICID XEO00311 MOACRIVE Inhibition DME0019 XEOTICID XEO00317 XEO_NAME Pentamidine isethionate DME0019 XEOTICID XEO00317 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00317 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00317 DESCRIPT Pentamidine isethionate inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 > 100 microM) DME0019 XEOTICID XEO00317 GENEFORM Protein DME0019 XEOTICID XEO00317 MOACRIVE Inhibition DME0019 XEOTICID XEO00331 XEO_NAME Ticlopidine hydrochloride DME0019 XEOTICID XEO00331 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00331 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00331 DESCRIPT Ticlopidine hydrochloride inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 = 31.1 microM) DME0019 XEOTICID XEO00331 GENEFORM Protein DME0019 XEOTICID XEO00331 MOACRIVE Inhibition DME0019 XEOTICID XEO00350 XEO_NAME Cisapride DME0019 XEOTICID XEO00350 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00350 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00350 DESCRIPT Cisapride inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00350 GENEFORM Protein DME0019 XEOTICID XEO00350 MOACRIVE Inhibition DME0019 XEOTICID XEO00352 XEO_NAME Diclofenac DME0019 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00352 DESCRIPT Diclof DMEenac inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00352 GENEFORM Protein DME0019 XEOTICID XEO00352 MOACRIVE Inhibition DME0019 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0019 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00380 DESCRIPT Rosiglitazone up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO00380 GENEFORM mRNA DME0019 XEOTICID XEO00380 MOACRIVE Induction DME0019 XEOTICID XEO00384 XEO_NAME Tenofovir DME0019 XEOTICID XEO00384 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00384 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00384 DESCRIPT Tenof DMEovir inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00384 GENEFORM Protein DME0019 XEOTICID XEO00384 MOACRIVE Inhibition DME0019 XEOTICID XEO00400 XEO_NAME Warfarin DME0019 XEOTICID XEO00400 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00400 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00400 DESCRIPT Warfarin inhibits the drug-metabolizing activity of DME CYP2C9 (Ki = 20 microM) DME0019 XEOTICID XEO00400 GENEFORM Protein DME0019 XEOTICID XEO00400 MOACRIVE Inhibition DME0019 XEOTICID XEO00401 XEO_NAME Beta carotene DME0019 XEOTICID XEO00401 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00401 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00401 DESCRIPT Beta carotene up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO00401 GENEFORM mRNA DME0019 XEOTICID XEO00401 MOACRIVE Induction DME0019 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0019 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00410 DESCRIPT Phenobarbital induces the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00410 GENEFORM Protein DME0019 XEOTICID XEO00410 MOACRIVE Induction DME0019 XEOTICID XEO00438 XEO_NAME Benidipine DME0019 XEOTICID XEO00438 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00438 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00438 DESCRIPT Benidipine inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00438 GENEFORM Protein DME0019 XEOTICID XEO00438 MOACRIVE Inhibition DME0019 XEOTICID XEO00439 XEO_NAME Daidzein DME0019 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00439 GENEFORM Protein DME0019 XEOTICID XEO00439 MOACRIVE Inhibition DME0019 XEOTICID XEO00441 XEO_NAME Silybin DME0019 XEOTICID XEO00441 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00441 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00441 DESCRIPT Silybin inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 = 18 microM) DME0019 XEOTICID XEO00441 GENEFORM Protein DME0019 XEOTICID XEO00441 MOACRIVE Inhibition DME0019 XEOTICID XEO00446 XEO_NAME Methoxychlor DME0019 XEOTICID XEO00446 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00446 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00446 DESCRIPT Methoxychlor inhibits the expression of DME CYP2C9 DME0019 XEOTICID XEO00446 GENEFORM mRNA DME0019 XEOTICID XEO00446 MOACRIVE Inhibition DME0019 XEOTICID XEO00452 XEO_NAME Apatinib DME0019 XEOTICID XEO00452 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00452 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00452 DESCRIPT Apatinib inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00452 GENEFORM Protein DME0019 XEOTICID XEO00452 MOACRIVE Inhibition DME0019 XEOTICID XEO00475 XEO_NAME Melarsoprol DME0019 XEOTICID XEO00475 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00475 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00475 DESCRIPT Melarsoprol inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00475 GENEFORM Protein DME0019 XEOTICID XEO00475 MOACRIVE Inhibition DME0019 XEOTICID XEO00489 XEO_NAME Amodiaquine DME0019 XEOTICID XEO00489 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00489 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00489 DESCRIPT Amodiaquine inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 > 50 microM) DME0019 XEOTICID XEO00489 GENEFORM Protein DME0019 XEOTICID XEO00489 MOACRIVE Inhibition DME0019 XEOTICID XEO00492 XEO_NAME Benzbromarone DME0019 XEOTICID XEO00492 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00492 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00492 DESCRIPT Benzbromarone inhibits the drug-metabolizing activity of DME CYP2C9 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.016 microM) DME0019 XEOTICID XEO00492 GENEFORM Protein DME0019 XEOTICID XEO00492 MOACRIVE Inhibition DME0019 XEOTICID XEO00507 XEO_NAME Pranlukast DME0019 XEOTICID XEO00507 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00507 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00507 DESCRIPT Pranlukast inhibits the expression of DME CYP2C9 DME0019 XEOTICID XEO00507 GENEFORM mRNA DME0019 XEOTICID XEO00507 MOACRIVE Inhibition DME0019 XEOTICID XEO00524 XEO_NAME Ticrynafen DME0019 XEOTICID XEO00524 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00524 XEO_CLAS Drug Marketed but Withdrawn from Market DME0019 XEOTICID XEO00524 DESCRIPT Ticrynafen inhibits the drug-metabolizing activity of DME CYP2C9 (Ki = 11 microM) DME0019 XEOTICID XEO00524 GENEFORM Protein DME0019 XEOTICID XEO00524 MOACRIVE Inhibition DME0019 XEOTICID XEO00537 XEO_NAME Luteolin DME0019 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME0019 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00537 GENEFORM Protein DME0019 XEOTICID XEO00537 MOACRIVE Inhibition DME0019 XEOTICID XEO00538 XEO_NAME Quercetin DME0019 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0019 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 = 10.2 microM) DME0019 XEOTICID XEO00538 GENEFORM Protein DME0019 XEOTICID XEO00538 MOACRIVE Inhibition DME0019 XEOTICID XEO00539 XEO_NAME Ethanol DME0019 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0019 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the expression of DME CYP2C9 DME0019 XEOTICID XEO00539 GENEFORM mRNA DME0019 XEOTICID XEO00539 MOACRIVE Inhibition DME0019 XEOTICID XEO00543 XEO_NAME Andrographolide DME0019 XEOTICID XEO00543 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00543 XEO_CLAS Drug in Phase 2 Clinical Trial DME0019 XEOTICID XEO00543 DESCRIPT Andrographolide inhibits the expression of DME CYP2C9 DME0019 XEOTICID XEO00543 GENEFORM mRNA DME0019 XEOTICID XEO00543 MOACRIVE Inhibition DME0019 XEOTICID XEO00557 XEO_NAME Genistein DME0019 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0019 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00557 GENEFORM Protein DME0019 XEOTICID XEO00557 MOACRIVE Inhibition DME0019 XEOTICID XEO00560 XEO_NAME Triclosan DME0019 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0019 XEOTICID XEO00560 DESCRIPT Triclosan up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO00560 GENEFORM mRNA DME0019 XEOTICID XEO00560 MOACRIVE Induction DME0019 XEOTICID XEO00568 XEO_NAME Resveratrol DME0019 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0019 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of DME CYP2C9 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 7 microM) DME0019 XEOTICID XEO00568 GENEFORM Protein DME0019 XEOTICID XEO00568 MOACRIVE Inhibition DME0019 XEOTICID XEO00573 XEO_NAME Naringenin DME0019 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME0019 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00573 GENEFORM Protein DME0019 XEOTICID XEO00573 MOACRIVE Inhibition DME0019 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0019 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0019 XEOTICID XEO00582 DESCRIPT Diethyltoluamide up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO00582 GENEFORM mRNA DME0019 XEOTICID XEO00582 MOACRIVE Induction DME0019 XEOTICID XEO00653 XEO_NAME Icaritin DME0019 XEOTICID XEO00653 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00653 XEO_CLAS Drug in Phase 2 Clinical Trial DME0019 XEOTICID XEO00653 DESCRIPT Icaritin inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00653 GENEFORM Protein DME0019 XEOTICID XEO00653 MOACRIVE Inhibition DME0019 XEOTICID XEO00671 XEO_NAME Endoxifen DME0019 XEOTICID XEO00671 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00671 XEO_CLAS Drug in Phase 3 Clinical Trial DME0019 XEOTICID XEO00671 DESCRIPT Endoxifen inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00671 GENEFORM Protein DME0019 XEOTICID XEO00671 MOACRIVE Inhibition DME0019 XEOTICID XEO00692 XEO_NAME Emodin DME0019 XEOTICID XEO00692 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00692 XEO_CLAS Preclinical/Patented Drug DME0019 XEOTICID XEO00692 DESCRIPT Emodin inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00692 GENEFORM Protein DME0019 XEOTICID XEO00692 MOACRIVE Inhibition DME0019 XEOTICID XEO00710 XEO_NAME Isoliquiritigenin DME0019 XEOTICID XEO00710 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00710 XEO_CLAS Preclinical/Patented Drug DME0019 XEOTICID XEO00710 DESCRIPT Isoliquiritigenin inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00710 GENEFORM Protein DME0019 XEOTICID XEO00710 MOACRIVE Inhibition DME0019 XEOTICID XEO00733 XEO_NAME Okanin DME0019 XEOTICID XEO00733 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00733 XEO_CLAS Preclinical/Patented Drug DME0019 XEOTICID XEO00733 DESCRIPT Okanin inhibits the expression of DME CYP2C9 DME0019 XEOTICID XEO00733 GENEFORM mRNA DME0019 XEOTICID XEO00733 MOACRIVE Inhibition DME0019 XEOTICID XEO00745 XEO_NAME Adefovir dipivoxil DME0019 XEOTICID XEO00745 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00745 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00745 DESCRIPT Adefovir dipivoxil inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00745 GENEFORM Protein DME0019 XEOTICID XEO00745 MOACRIVE Inhibition DME0019 XEOTICID XEO00747 XEO_NAME Cholecalciferol DME0019 XEOTICID XEO00747 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00747 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00747 DESCRIPT Cholecalciferol inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00747 GENEFORM Protein DME0019 XEOTICID XEO00747 MOACRIVE Inhibition DME0019 XEOTICID XEO00749 XEO_NAME Teriflunomide DME0019 XEOTICID XEO00749 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00749 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00749 DESCRIPT Teriflunomide up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO00749 GENEFORM mRNA DME0019 XEOTICID XEO00749 MOACRIVE Induction DME0019 XEOTICID XEO00751 XEO_NAME Cocaine hydrochloride DME0019 XEOTICID XEO00751 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00751 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO00751 DESCRIPT Cocaine hydrochloride inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00751 GENEFORM Protein DME0019 XEOTICID XEO00751 MOACRIVE Inhibition DME0019 XEOTICID XEO00802 XEO_NAME Dihydrocapsaicin DME0019 XEOTICID XEO00802 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO00802 XEO_CLAS Natural Product DME0019 XEOTICID XEO00802 DESCRIPT Dihydrocapsaicin inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00802 GENEFORM Protein DME0019 XEOTICID XEO00802 MOACRIVE Inhibition DME0019 XEOTICID XEO00804 XEO_NAME Avasimibe DME0019 XEOTICID XEO00804 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00804 XEO_CLAS Investigative Agent DME0019 XEOTICID XEO00804 DESCRIPT Avasimibe inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00804 GENEFORM Protein DME0019 XEOTICID XEO00804 MOACRIVE Inhibition DME0019 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0019 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0019 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0019 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYP2C9 DME0019 XEOTICID XEO00806 GENEFORM mRNA DME0019 XEOTICID XEO00806 MOACRIVE Inhibition DME0019 XEOTICID XEO00856 XEO_NAME Hesperetin DME0019 XEOTICID XEO00856 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO00856 XEO_CLAS Natural Product DME0019 XEOTICID XEO00856 DESCRIPT Hesperetin inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00856 GENEFORM Protein DME0019 XEOTICID XEO00856 MOACRIVE Inhibition DME0019 XEOTICID XEO00857 XEO_NAME Cyclodextrins DME0019 XEOTICID XEO00857 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO00857 XEO_CLAS Natural Mixture DME0019 XEOTICID XEO00857 DESCRIPT Cyclodextrins induces the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00857 GENEFORM Protein DME0019 XEOTICID XEO00857 MOACRIVE Induction DME0019 XEOTICID XEO00873 XEO_NAME Alpha-linolenic acid DME0019 XEOTICID XEO00873 XEO_TYPE Health or Environmental Toxicant(s) DME0019 XEOTICID XEO00873 XEO_CLAS Health Hazard/Toxicant DME0019 XEOTICID XEO00873 DESCRIPT Alpha-linolenic acid inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00873 GENEFORM Protein DME0019 XEOTICID XEO00873 MOACRIVE Inhibition DME0019 XEOTICID XEO00876 XEO_NAME Arachidonic acid DME0019 XEOTICID XEO00876 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO00876 XEO_CLAS Investigative Agent DME0019 XEOTICID XEO00876 DESCRIPT Arachidonic acid inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00876 GENEFORM Protein DME0019 XEOTICID XEO00876 MOACRIVE Inhibition DME0019 XEOTICID XEO00877 XEO_NAME Bilirubin DME0019 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO00877 XEO_CLAS Natural Product DME0019 XEOTICID XEO00877 DESCRIPT Bilirubin up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO00877 GENEFORM mRNA DME0019 XEOTICID XEO00877 MOACRIVE Induction DME0019 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0019 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0019 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0019 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00905 GENEFORM Protein DME0019 XEOTICID XEO00905 MOACRIVE Inhibition DME0019 XEOTICID XEO00936 XEO_NAME Sporidesmin DME0019 XEOTICID XEO00936 XEO_TYPE Health or Environmental Toxicant(s) DME0019 XEOTICID XEO00936 XEO_CLAS Mycotoxin DME0019 XEOTICID XEO00936 DESCRIPT Sporidesmin up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO00936 GENEFORM mRNA DME0019 XEOTICID XEO00936 MOACRIVE Induction DME0019 XEOTICID XEO00942 XEO_NAME Cyproconazole DME0019 XEOTICID XEO00942 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0019 XEOTICID XEO00942 XEO_CLAS Fungicide DME0019 XEOTICID XEO00942 DESCRIPT Cyproconazole inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00942 GENEFORM Protein DME0019 XEOTICID XEO00942 MOACRIVE Inhibition DME0019 XEOTICID XEO00975 XEO_NAME Isoproturon DME0019 XEOTICID XEO00975 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0019 XEOTICID XEO00975 XEO_CLAS Herbicide DME0019 XEOTICID XEO00975 DESCRIPT Isoproturon inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO00975 GENEFORM Protein DME0019 XEOTICID XEO00975 MOACRIVE Inhibition DME0019 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0019 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0019 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0019 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO00999 GENEFORM mRNA DME0019 XEOTICID XEO00999 MOACRIVE Induction DME0019 XEOTICID XEO01046 XEO_NAME Cypermethrin DME0019 XEOTICID XEO01046 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0019 XEOTICID XEO01046 XEO_CLAS Pesticide/Insecticide DME0019 XEOTICID XEO01046 DESCRIPT Cypermethrin inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01046 GENEFORM Protein DME0019 XEOTICID XEO01046 MOACRIVE Inhibition DME0019 XEOTICID XEO01047 XEO_NAME Decamethrin DME0019 XEOTICID XEO01047 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0019 XEOTICID XEO01047 XEO_CLAS Pesticide/Insecticide DME0019 XEOTICID XEO01047 DESCRIPT Decamethrin up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO01047 GENEFORM mRNA DME0019 XEOTICID XEO01047 MOACRIVE Induction DME0019 XEOTICID XEO01052 XEO_NAME Fenitrothion DME0019 XEOTICID XEO01052 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0019 XEOTICID XEO01052 XEO_CLAS Pesticide/Insecticide DME0019 XEOTICID XEO01052 DESCRIPT Fenitrothion inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01052 GENEFORM Protein DME0019 XEOTICID XEO01052 MOACRIVE Inhibition DME0019 XEOTICID XEO01053 XEO_NAME Fenvalerate DME0019 XEOTICID XEO01053 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0019 XEOTICID XEO01053 XEO_CLAS Pesticide/Insecticide DME0019 XEOTICID XEO01053 DESCRIPT Fenvalerate up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO01053 GENEFORM mRNA DME0019 XEOTICID XEO01053 MOACRIVE Induction DME0019 XEOTICID XEO01064 XEO_NAME Parathion DME0019 XEOTICID XEO01064 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0019 XEOTICID XEO01064 XEO_CLAS Pesticide/Insecticide DME0019 XEOTICID XEO01064 DESCRIPT Parathion induces the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01064 GENEFORM Protein DME0019 XEOTICID XEO01064 MOACRIVE Induction DME0019 XEOTICID XEO01099 XEO_NAME 1-aminobenzotriazole DME0019 XEOTICID XEO01099 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01099 XEO_CLAS Preclinical/Patented Drug DME0019 XEOTICID XEO01099 DESCRIPT 1-aminobenzotriazole inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 = 42.9 microM) DME0019 XEOTICID XEO01099 GENEFORM Protein DME0019 XEOTICID XEO01099 MOACRIVE Inhibition DME0019 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0019 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0019 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0019 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone induces the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01129 GENEFORM Protein DME0019 XEOTICID XEO01129 MOACRIVE Induction DME0019 XEOTICID XEO01130 XEO_NAME DY-9760e DME0019 XEOTICID XEO01130 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01130 XEO_CLAS Investigative Agent DME0019 XEOTICID XEO01130 DESCRIPT DY-9760e inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01130 GENEFORM Protein DME0019 XEOTICID XEO01130 MOACRIVE Inhibition DME0019 XEOTICID XEO01156 XEO_NAME CP-778875 DME0019 XEOTICID XEO01156 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01156 XEO_CLAS Preclinical/Patented Drug DME0019 XEOTICID XEO01156 DESCRIPT CP-778875 inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01156 GENEFORM Protein DME0019 XEOTICID XEO01156 MOACRIVE Inhibition DME0019 XEOTICID XEO01159 XEO_NAME 5-fluorotryptamine DME0019 XEOTICID XEO01159 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01159 XEO_CLAS Investigative Agent DME0019 XEOTICID XEO01159 DESCRIPT 5-fluorotryptamine inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01159 GENEFORM Protein DME0019 XEOTICID XEO01159 MOACRIVE Inhibition DME0019 XEOTICID XEO01163 XEO_NAME 5-methoxyindole DME0019 XEOTICID XEO01163 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01163 XEO_CLAS Investigative Agent DME0019 XEOTICID XEO01163 DESCRIPT 5-methoxyindole inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01163 GENEFORM Protein DME0019 XEOTICID XEO01163 MOACRIVE Inhibition DME0019 XEOTICID XEO01165 XEO_NAME CITCO DME0019 XEOTICID XEO01165 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01165 XEO_CLAS Investigative Agent DME0019 XEOTICID XEO01165 DESCRIPT CITCO up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO01165 GENEFORM mRNA DME0019 XEOTICID XEO01165 MOACRIVE Induction DME0019 XEOTICID XEO01176 XEO_NAME 7-hydroxyflavone DME0019 XEOTICID XEO01176 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO01176 XEO_CLAS Natural Product DME0019 XEOTICID XEO01176 DESCRIPT 7-hydroxyflavone inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01176 GENEFORM Protein DME0019 XEOTICID XEO01176 MOACRIVE Inhibition DME0019 XEOTICID XEO01177 XEO_NAME 7-methyltryptamine DME0019 XEOTICID XEO01177 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01177 XEO_CLAS Investigative Agent DME0019 XEOTICID XEO01177 DESCRIPT 7-methyltryptamine inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01177 GENEFORM Protein DME0019 XEOTICID XEO01177 MOACRIVE Inhibition DME0019 XEOTICID XEO01203 XEO_NAME Apigenin DME0019 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO01203 XEO_CLAS Natural Product DME0019 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01203 GENEFORM Protein DME0019 XEOTICID XEO01203 MOACRIVE Inhibition DME0019 XEOTICID XEO01212 XEO_NAME Baicalein DME0019 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO01212 XEO_CLAS Natural Product DME0019 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01212 GENEFORM Protein DME0019 XEOTICID XEO01212 MOACRIVE Inhibition DME0019 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0019 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0019 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME CYP2C9 DME0019 XEOTICID XEO01220 GENEFORM mRNA DME0019 XEOTICID XEO01220 MOACRIVE Inhibition DME0019 XEOTICID XEO01222 XEO_NAME Biochanin A DME0019 XEOTICID XEO01222 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO01222 XEO_CLAS Natural Product DME0019 XEOTICID XEO01222 DESCRIPT Biochanin A inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01222 GENEFORM Protein DME0019 XEOTICID XEO01222 MOACRIVE Inhibition DME0019 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0019 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0019 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO01226 GENEFORM mRNA DME0019 XEOTICID XEO01226 MOACRIVE Induction DME0019 XEOTICID XEO01252 XEO_NAME Cinnamic acid DME0019 XEOTICID XEO01252 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01252 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO01252 DESCRIPT Cinnamic acid inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01252 GENEFORM Protein DME0019 XEOTICID XEO01252 MOACRIVE Inhibition DME0019 XEOTICID XEO01257 XEO_NAME Clofibric acid DME0019 XEOTICID XEO01257 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0019 XEOTICID XEO01257 XEO_CLAS Herbicide DME0019 XEOTICID XEO01257 DESCRIPT Clofibric acid up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO01257 GENEFORM mRNA DME0019 XEOTICID XEO01257 MOACRIVE Induction DME0019 XEOTICID XEO01280 XEO_NAME Dioscin DME0019 XEOTICID XEO01280 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01280 XEO_CLAS Preclinical/Patented Drug DME0019 XEOTICID XEO01280 DESCRIPT Dioscin up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO01280 GENEFORM mRNA DME0019 XEOTICID XEO01280 MOACRIVE Induction DME0019 XEOTICID XEO01281 XEO_NAME Diosmetin DME0019 XEOTICID XEO01281 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO01281 XEO_CLAS Natural Product DME0019 XEOTICID XEO01281 DESCRIPT Diosmetin inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01281 GENEFORM Protein DME0019 XEOTICID XEO01281 MOACRIVE Inhibition DME0019 XEOTICID XEO01302 XEO_NAME Fipronil DME0019 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0019 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0019 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO01302 GENEFORM mRNA DME0019 XEOTICID XEO01302 MOACRIVE Induction DME0019 XEOTICID XEO01313 XEO_NAME Germacrone DME0019 XEOTICID XEO01313 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO01313 XEO_CLAS Natural Product DME0019 XEOTICID XEO01313 DESCRIPT Germacrone inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01313 GENEFORM Protein DME0019 XEOTICID XEO01313 MOACRIVE Inhibition DME0019 XEOTICID XEO01314 XEO_NAME Ginkgo biloba extract DME0019 XEOTICID XEO01314 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO01314 XEO_CLAS Plant Extract DME0019 XEOTICID XEO01314 DESCRIPT Ginkgo biloba extract inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01314 GENEFORM Protein DME0019 XEOTICID XEO01314 MOACRIVE Inhibition DME0019 XEOTICID XEO01320 XEO_NAME Glyphosate DME0019 XEOTICID XEO01320 XEO_TYPE Health or Environmental Toxicant(s) DME0019 XEOTICID XEO01320 XEO_CLAS Environmental Pollutant DME0019 XEOTICID XEO01320 DESCRIPT Glyphosate inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01320 GENEFORM Protein DME0019 XEOTICID XEO01320 MOACRIVE Inhibition DME0019 XEOTICID XEO01335 XEO_NAME Hyperforin DME0019 XEOTICID XEO01335 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO01335 XEO_CLAS Natural Product DME0019 XEOTICID XEO01335 DESCRIPT Hyperforin up-regulates the expression of DME CYP2C9 and leads to increasing the drug-metabolizing activity of this enzyme DME0019 XEOTICID XEO01335 GENEFORM Protein DME0019 XEOTICID XEO01335 MOACRIVE Induction DME0019 XEOTICID XEO01345 XEO_NAME Inermin DME0019 XEOTICID XEO01345 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO01345 XEO_CLAS Natural Product DME0019 XEOTICID XEO01345 DESCRIPT Inermin inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01345 GENEFORM Protein DME0019 XEOTICID XEO01345 MOACRIVE Inhibition DME0019 XEOTICID XEO01353 XEO_NAME Kaempferol DME0019 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME0019 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME0019 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of DME CYP2C9 (Ki = 6 microM) DME0019 XEOTICID XEO01353 GENEFORM Protein DME0019 XEOTICID XEO01353 MOACRIVE Inhibition DME0019 XEOTICID XEO01365 XEO_NAME Licochalcone A DME0019 XEOTICID XEO01365 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01365 XEO_CLAS Drug in Phase 1 Clinical Trial DME0019 XEOTICID XEO01365 DESCRIPT Licochalcone A inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01365 GENEFORM Protein DME0019 XEOTICID XEO01365 MOACRIVE Inhibition DME0019 XEOTICID XEO01367 XEO_NAME Linoleic acid DME0019 XEOTICID XEO01367 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01367 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO01367 DESCRIPT Linoleic acid inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01367 GENEFORM Protein DME0019 XEOTICID XEO01367 MOACRIVE Inhibition DME0019 XEOTICID XEO01370 XEO_NAME Mangiferin DME0019 XEOTICID XEO01370 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO01370 XEO_CLAS Natural Product DME0019 XEOTICID XEO01370 DESCRIPT Mangiferin inhibits the expression of DME CYP2C9 DME0019 XEOTICID XEO01370 GENEFORM mRNA DME0019 XEOTICID XEO01370 MOACRIVE Inhibition DME0019 XEOTICID XEO01372 XEO_NAME Mepirodipine DME0019 XEOTICID XEO01372 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01372 XEO_CLAS Approved/Marketed Drug DME0019 XEOTICID XEO01372 DESCRIPT Mepirodipine inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01372 GENEFORM Protein DME0019 XEOTICID XEO01372 MOACRIVE Inhibition DME0019 XEOTICID XEO01384 XEO_NAME Myricetin DME0019 XEOTICID XEO01384 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01384 XEO_CLAS Preclinical/Patented Drug DME0019 XEOTICID XEO01384 DESCRIPT Myricetin inhibits the expression of DME CYP2C9 DME0019 XEOTICID XEO01384 GENEFORM mRNA DME0019 XEOTICID XEO01384 MOACRIVE Inhibition DME0019 XEOTICID XEO01396 XEO_NAME HET-0016 DME0019 XEOTICID XEO01396 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01396 XEO_CLAS Preclinical/Patented Drug DME0019 XEOTICID XEO01396 DESCRIPT HET-0016 inhibits the drug-metabolizing activity of DME CYP2C9 (IC50 = 3.3 microM) DME0019 XEOTICID XEO01396 GENEFORM Protein DME0019 XEOTICID XEO01396 MOACRIVE Inhibition DME0019 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0019 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0019 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0019 XEOTICID XEO01407 DESCRIPT Ochratoxin A up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO01407 GENEFORM mRNA DME0019 XEOTICID XEO01407 MOACRIVE Induction DME0019 XEOTICID XEO01455 XEO_NAME Rhein DME0019 XEOTICID XEO01455 XEO_TYPE Pharmaceutical Agent(s) DME0019 XEOTICID XEO01455 XEO_CLAS Investigative Agent DME0019 XEOTICID XEO01455 DESCRIPT Rhein inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01455 GENEFORM Protein DME0019 XEOTICID XEO01455 MOACRIVE Inhibition DME0019 XEOTICID XEO01472 XEO_NAME Sophoranone DME0019 XEOTICID XEO01472 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO01472 XEO_CLAS Natural Product DME0019 XEOTICID XEO01472 DESCRIPT Sophoranone inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01472 GENEFORM Protein DME0019 XEOTICID XEO01472 MOACRIVE Inhibition DME0019 XEOTICID XEO01503 XEO_NAME Cadmium DME0019 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0019 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0019 XEOTICID XEO01503 DESCRIPT Cadmium induces the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01503 GENEFORM Protein DME0019 XEOTICID XEO01503 MOACRIVE Induction DME0019 XEOTICID XEO01505 XEO_NAME Lead DME0019 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0019 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0019 XEOTICID XEO01505 DESCRIPT Lead inhibits the expression of DME CYP2C9 DME0019 XEOTICID XEO01505 GENEFORM mRNA DME0019 XEOTICID XEO01505 MOACRIVE Inhibition DME0019 XEOTICID XEO01518 XEO_NAME 5-methyltryptamine DME0019 XEOTICID XEO01518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO01518 XEO_CLAS Natural Product DME0019 XEOTICID XEO01518 DESCRIPT 5-methyltryptamine inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01518 GENEFORM Protein DME0019 XEOTICID XEO01518 MOACRIVE Inhibition DME0019 XEOTICID XEO01523 XEO_NAME Apocarotenal DME0019 XEOTICID XEO01523 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO01523 XEO_CLAS Natural Product DME0019 XEOTICID XEO01523 DESCRIPT Apocarotenal up-regulates the expression of DME CYP2C9 DME0019 XEOTICID XEO01523 GENEFORM mRNA DME0019 XEOTICID XEO01523 MOACRIVE Induction DME0019 XEOTICID XEO01528 XEO_NAME Chrysophanic acid DME0019 XEOTICID XEO01528 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0019 XEOTICID XEO01528 XEO_CLAS Natural Product DME0019 XEOTICID XEO01528 DESCRIPT Chrysophanic acid inhibits the drug-metabolizing activity of DME CYP2C9 DME0019 XEOTICID XEO01528 GENEFORM Protein DME0019 XEOTICID XEO01528 MOACRIVE Inhibition DME0020 DME___ID DME0020 DME0020 DME_NAME Cytochrome P450 2B6 (CYP2B6) DME0020 SPESNAME Homo sapiens DME0020 XEOTICID XEO00001 XEO_NAME Dimethyl sulfoxide DME0020 XEOTICID XEO00001 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00001 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00001 DESCRIPT Dimethyl sulfoxide up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00001 GENEFORM mRNA DME0020 XEOTICID XEO00001 MOACRIVE Induction DME0020 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0020 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00011 DESCRIPT Carbamazepine induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00011 GENEFORM Protein DME0020 XEOTICID XEO00011 MOACRIVE Induction DME0020 XEOTICID XEO00015 XEO_NAME Cimetidine DME0020 XEOTICID XEO00015 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00015 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00015 DESCRIPT Cimetidine inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00015 GENEFORM Protein DME0020 XEOTICID XEO00015 MOACRIVE Inhibition DME0020 XEOTICID XEO00017 XEO_NAME Clotrimazole DME0020 XEOTICID XEO00017 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00017 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00017 DESCRIPT Clotrimazole up-regulates the expression of DME CYP2B6 and leads to increasing the drug-metabolizing activity of this enzyme DME0020 XEOTICID XEO00017 GENEFORM Protein DME0020 XEOTICID XEO00017 MOACRIVE Induction DME0020 XEOTICID XEO00018 XEO_NAME Cyclophosphamide DME0020 XEOTICID XEO00018 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00018 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00018 DESCRIPT Cyclophosphamide inhibits the expression of DME CYP2B6 and leads to decreasing the drug-metabolizing activity of this enzyme DME0020 XEOTICID XEO00018 GENEFORM Protein DME0020 XEOTICID XEO00018 MOACRIVE Inhibition DME0020 XEOTICID XEO00049 XEO_NAME Isradipine DME0020 XEOTICID XEO00049 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00049 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00049 DESCRIPT Isradipine induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00049 GENEFORM Protein DME0020 XEOTICID XEO00049 MOACRIVE Induction DME0020 XEOTICID XEO00053 XEO_NAME Leflunomide DME0020 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00053 GENEFORM mRNA DME0020 XEOTICID XEO00053 MOACRIVE Induction DME0020 XEOTICID XEO00056 XEO_NAME Malathion DME0020 XEOTICID XEO00056 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00056 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00056 DESCRIPT Malathion up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00056 GENEFORM mRNA DME0020 XEOTICID XEO00056 MOACRIVE Induction DME0020 XEOTICID XEO00069 XEO_NAME Omeprazole DME0020 XEOTICID XEO00069 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00069 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00069 DESCRIPT Omeprazole induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00069 GENEFORM Protein DME0020 XEOTICID XEO00069 MOACRIVE Induction DME0020 XEOTICID XEO00084 XEO_NAME Thiabendazole DME0020 XEOTICID XEO00084 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00084 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00084 DESCRIPT Thiabendazole up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00084 GENEFORM mRNA DME0020 XEOTICID XEO00084 MOACRIVE Induction DME0020 XEOTICID XEO00085 XEO_NAME Thiotepa DME0020 XEOTICID XEO00085 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00085 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00085 DESCRIPT Thiotepa inhibits the drug-metabolizing activity of DME CYP2B6 (Ki = 2.2 microM) DME0020 XEOTICID XEO00085 GENEFORM Protein DME0020 XEOTICID XEO00085 MOACRIVE Inhibition DME0020 XEOTICID XEO00086 XEO_NAME Troglitazone DME0020 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00086 GENEFORM mRNA DME0020 XEOTICID XEO00086 MOACRIVE Induction DME0020 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0020 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME CYP2B6 and leads to increasing the drug-metabolizing activity of this enzyme DME0020 XEOTICID XEO00088 GENEFORM Protein DME0020 XEOTICID XEO00088 MOACRIVE Induction DME0020 XEOTICID XEO00090 XEO_NAME Estradiol DME0020 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00090 GENEFORM mRNA DME0020 XEOTICID XEO00090 MOACRIVE Induction DME0020 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0020 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00117 GENEFORM mRNA DME0020 XEOTICID XEO00117 MOACRIVE Induction DME0020 XEOTICID XEO00148 XEO_NAME Bosentan DME0020 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00148 DESCRIPT Bosentan up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00148 GENEFORM mRNA DME0020 XEOTICID XEO00148 MOACRIVE Induction DME0020 XEOTICID XEO00157 XEO_NAME Erlotinib hydrochloride DME0020 XEOTICID XEO00157 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00157 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00157 DESCRIPT Erlotinib hydrochloride up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00157 GENEFORM mRNA DME0020 XEOTICID XEO00157 MOACRIVE Induction DME0020 XEOTICID XEO00160 XEO_NAME Ritonavir DME0020 XEOTICID XEO00160 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00160 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00160 DESCRIPT Ritonavir induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00160 GENEFORM Protein DME0020 XEOTICID XEO00160 MOACRIVE Induction DME0020 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0020 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00166 GENEFORM mRNA DME0020 XEOTICID XEO00166 MOACRIVE Induction DME0020 XEOTICID XEO00173 XEO_NAME Cannabidiol DME0020 XEOTICID XEO00173 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00173 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00173 DESCRIPT Cannabidiol inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00173 GENEFORM Protein DME0020 XEOTICID XEO00173 MOACRIVE Inhibition DME0020 XEOTICID XEO00216 XEO_NAME Efavirenz DME0020 XEOTICID XEO00216 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00216 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00216 DESCRIPT Efavirenz inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00216 GENEFORM Protein DME0020 XEOTICID XEO00216 MOACRIVE Inhibition DME0020 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0020 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP2B6 DME0020 XEOTICID XEO00217 GENEFORM mRNA DME0020 XEOTICID XEO00217 MOACRIVE Inhibition DME0020 XEOTICID XEO00223 XEO_NAME Rifampin DME0020 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00223 DESCRIPT Rifampin induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00223 GENEFORM Protein DME0020 XEOTICID XEO00223 MOACRIVE Induction DME0020 XEOTICID XEO00232 XEO_NAME Phenytoin DME0020 XEOTICID XEO00232 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00232 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00232 DESCRIPT Phenytoin up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00232 GENEFORM mRNA DME0020 XEOTICID XEO00232 MOACRIVE Induction DME0020 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0020 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP2B6 DME0020 XEOTICID XEO00241 GENEFORM mRNA DME0020 XEOTICID XEO00241 MOACRIVE Inhibition DME0020 XEOTICID XEO00243 XEO_NAME Pimecrolimus DME0020 XEOTICID XEO00243 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00243 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00243 DESCRIPT Pimecrolimus up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00243 GENEFORM mRNA DME0020 XEOTICID XEO00243 MOACRIVE Induction DME0020 XEOTICID XEO00245 XEO_NAME Felodipine DME0020 XEOTICID XEO00245 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00245 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00245 DESCRIPT Felodipine induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00245 GENEFORM Protein DME0020 XEOTICID XEO00245 MOACRIVE Induction DME0020 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0020 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00251 GENEFORM Protein DME0020 XEOTICID XEO00251 MOACRIVE Inhibition DME0020 XEOTICID XEO00279 XEO_NAME Cerivastatin sodium DME0020 XEOTICID XEO00279 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00279 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00279 DESCRIPT Cerivastatin sodium up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00279 GENEFORM mRNA DME0020 XEOTICID XEO00279 MOACRIVE Induction DME0020 XEOTICID XEO00314 XEO_NAME Orphenadrine hydrochloride DME0020 XEOTICID XEO00314 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00314 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00314 DESCRIPT Orphenadrine hydrochloride inhibits the expression of DME CYP2B6 DME0020 XEOTICID XEO00314 GENEFORM mRNA DME0020 XEOTICID XEO00314 MOACRIVE Inhibition DME0020 XEOTICID XEO00316 XEO_NAME Paroxetine hydrochloride DME0020 XEOTICID XEO00316 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00316 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00316 DESCRIPT Paroxetine hydrochloride inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00316 GENEFORM Protein DME0020 XEOTICID XEO00316 MOACRIVE Inhibition DME0020 XEOTICID XEO00323 XEO_NAME Selegiline hydrochloride DME0020 XEOTICID XEO00323 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00323 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00323 DESCRIPT Selegiline hydrochloride inhibits the expression of DME CYP2B6 DME0020 XEOTICID XEO00323 GENEFORM mRNA DME0020 XEOTICID XEO00323 MOACRIVE Inhibition DME0020 XEOTICID XEO00331 XEO_NAME Ticlopidine hydrochloride DME0020 XEOTICID XEO00331 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00331 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00331 DESCRIPT Ticlopidine hydrochloride inhibits the drug-metabolizing activity of DME CYP2B6 (IC50 = 0.6 microM) DME0020 XEOTICID XEO00331 GENEFORM Protein DME0020 XEOTICID XEO00331 MOACRIVE Inhibition DME0020 XEOTICID XEO00338 XEO_NAME Amlodipine DME0020 XEOTICID XEO00338 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00338 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00338 DESCRIPT Amlodipine inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00338 GENEFORM Protein DME0020 XEOTICID XEO00338 MOACRIVE Inhibition DME0020 XEOTICID XEO00340 XEO_NAME Atorvastatin DME0020 XEOTICID XEO00340 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00340 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00340 DESCRIPT Atorvastatin up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00340 GENEFORM mRNA DME0020 XEOTICID XEO00340 MOACRIVE Induction DME0020 XEOTICID XEO00359 XEO_NAME Fluvastatin DME0020 XEOTICID XEO00359 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00359 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00359 DESCRIPT Fluvastatin up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00359 GENEFORM mRNA DME0020 XEOTICID XEO00359 MOACRIVE Induction DME0020 XEOTICID XEO00374 XEO_NAME Pazopanib DME0020 XEOTICID XEO00374 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00374 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00374 DESCRIPT Pazopanib up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00374 GENEFORM mRNA DME0020 XEOTICID XEO00374 MOACRIVE Induction DME0020 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0020 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00380 DESCRIPT Rosiglitazone induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00380 GENEFORM Protein DME0020 XEOTICID XEO00380 MOACRIVE Induction DME0020 XEOTICID XEO00383 XEO_NAME Tamoxifen DME0020 XEOTICID XEO00383 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00383 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00383 DESCRIPT Tamoxifen induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00383 GENEFORM Protein DME0020 XEOTICID XEO00383 MOACRIVE Induction DME0020 XEOTICID XEO00385 XEO_NAME Tranylcypromine DME0020 XEOTICID XEO00385 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00385 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00385 DESCRIPT Tranylcypromine inhibits the drug-metabolizing activity of DME CYP2B6 (IC50 = 6.96 microM) DME0020 XEOTICID XEO00385 GENEFORM Protein DME0020 XEOTICID XEO00385 MOACRIVE Inhibition DME0020 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0020 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00410 DESCRIPT Phenobarbital induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00410 GENEFORM Protein DME0020 XEOTICID XEO00410 MOACRIVE Induction DME0020 XEOTICID XEO00438 XEO_NAME Benidipine DME0020 XEOTICID XEO00438 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00438 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00438 DESCRIPT Benidipine induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00438 GENEFORM Protein DME0020 XEOTICID XEO00438 MOACRIVE Induction DME0020 XEOTICID XEO00446 XEO_NAME Methoxychlor DME0020 XEOTICID XEO00446 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00446 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00446 DESCRIPT Methoxychlor inhibits the expression of DME CYP2B6 DME0020 XEOTICID XEO00446 GENEFORM mRNA DME0020 XEOTICID XEO00446 MOACRIVE Inhibition DME0020 XEOTICID XEO00452 XEO_NAME Apatinib DME0020 XEOTICID XEO00452 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00452 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00452 DESCRIPT Apatinib inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00452 GENEFORM Protein DME0020 XEOTICID XEO00452 MOACRIVE Inhibition DME0020 XEOTICID XEO00476 XEO_NAME Perfluorobutane DME0020 XEOTICID XEO00476 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00476 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00476 DESCRIPT Perfluorobutane up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00476 GENEFORM mRNA DME0020 XEOTICID XEO00476 MOACRIVE Induction DME0020 XEOTICID XEO00560 XEO_NAME Triclosan DME0020 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0020 XEOTICID XEO00560 DESCRIPT Triclosan up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00560 GENEFORM mRNA DME0020 XEOTICID XEO00560 MOACRIVE Induction DME0020 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0020 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0020 XEOTICID XEO00582 DESCRIPT Diethyltoluamide up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00582 GENEFORM mRNA DME0020 XEOTICID XEO00582 MOACRIVE Induction DME0020 XEOTICID XEO00597 XEO_NAME Camptothecin DME0020 XEOTICID XEO00597 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00597 XEO_CLAS Drug in Phase 2 Clinical Trial DME0020 XEOTICID XEO00597 DESCRIPT Camptothecin inhibits the expression of DME CYP2B6 DME0020 XEOTICID XEO00597 GENEFORM mRNA DME0020 XEOTICID XEO00597 MOACRIVE Inhibition DME0020 XEOTICID XEO00598 XEO_NAME Carbendazim DME0020 XEOTICID XEO00598 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00598 XEO_CLAS Drug in Phase 1 Clinical Trial DME0020 XEOTICID XEO00598 DESCRIPT Carbendazim up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00598 GENEFORM mRNA DME0020 XEOTICID XEO00598 MOACRIVE Induction DME0020 XEOTICID XEO00601 XEO_NAME Butylated hydroxytoluene DME0020 XEOTICID XEO00601 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00601 XEO_CLAS Drug in Phase 1 Clinical Trial DME0020 XEOTICID XEO00601 DESCRIPT Butylated hydroxytoluene up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00601 GENEFORM mRNA DME0020 XEOTICID XEO00601 MOACRIVE Induction DME0020 XEOTICID XEO00605 XEO_NAME Oltipraz DME0020 XEOTICID XEO00605 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00605 XEO_CLAS Drug in Phase 3 Clinical Trial DME0020 XEOTICID XEO00605 DESCRIPT Oltipraz up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00605 GENEFORM mRNA DME0020 XEOTICID XEO00605 MOACRIVE Induction DME0020 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME0020 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME0020 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00646 GENEFORM Protein DME0020 XEOTICID XEO00646 MOACRIVE Inhibition DME0020 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0020 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0020 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME CYP2B6 DME0020 XEOTICID XEO00723 GENEFORM mRNA DME0020 XEOTICID XEO00723 MOACRIVE Inhibition DME0020 XEOTICID XEO00735 XEO_NAME GW-4064 DME0020 XEOTICID XEO00735 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00735 XEO_CLAS Preclinical/Patented Drug DME0020 XEOTICID XEO00735 DESCRIPT GW-4064 inhibits the expression of DME CYP2B6 DME0020 XEOTICID XEO00735 GENEFORM mRNA DME0020 XEOTICID XEO00735 MOACRIVE Inhibition DME0020 XEOTICID XEO00740 XEO_NAME Lindane DME0020 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00740 DESCRIPT Lindane induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00740 GENEFORM Protein DME0020 XEOTICID XEO00740 MOACRIVE Induction DME0020 XEOTICID XEO00747 XEO_NAME Cholecalciferol DME0020 XEOTICID XEO00747 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00747 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00747 DESCRIPT Cholecalciferol induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00747 GENEFORM Protein DME0020 XEOTICID XEO00747 MOACRIVE Induction DME0020 XEOTICID XEO00749 XEO_NAME Teriflunomide DME0020 XEOTICID XEO00749 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00749 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO00749 DESCRIPT Teriflunomide up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00749 GENEFORM mRNA DME0020 XEOTICID XEO00749 MOACRIVE Induction DME0020 XEOTICID XEO00759 XEO_NAME Caraway oil DME0020 XEOTICID XEO00759 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO00759 XEO_CLAS Plant Extract DME0020 XEOTICID XEO00759 DESCRIPT Caraway oil up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00759 GENEFORM mRNA DME0020 XEOTICID XEO00759 MOACRIVE Induction DME0020 XEOTICID XEO00768 XEO_NAME Dichlorodiphenyl dichloroethylene DME0020 XEOTICID XEO00768 XEO_TYPE Health or Environmental Toxicant(s) DME0020 XEOTICID XEO00768 XEO_CLAS Environmental Pollutant DME0020 XEOTICID XEO00768 DESCRIPT Dichlorodiphenyl dichloroethylene up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00768 GENEFORM mRNA DME0020 XEOTICID XEO00768 MOACRIVE Induction DME0020 XEOTICID XEO00786 XEO_NAME Isoxazole DME0020 XEOTICID XEO00786 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO00786 XEO_CLAS Natural Product DME0020 XEOTICID XEO00786 DESCRIPT Isoxazole up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00786 GENEFORM mRNA DME0020 XEOTICID XEO00786 MOACRIVE Induction DME0020 XEOTICID XEO00804 XEO_NAME Avasimibe DME0020 XEOTICID XEO00804 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00804 XEO_CLAS Investigative Agent DME0020 XEOTICID XEO00804 DESCRIPT Avasimibe up-regulates the expression of DME CYP2B6 and leads to increasing the drug-metabolizing activity of this enzyme DME0020 XEOTICID XEO00804 GENEFORM Protein DME0020 XEOTICID XEO00804 MOACRIVE Induction DME0020 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0020 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0020 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0020 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYP2B6 DME0020 XEOTICID XEO00806 GENEFORM mRNA DME0020 XEOTICID XEO00806 MOACRIVE Inhibition DME0020 XEOTICID XEO00810 XEO_NAME Steviol DME0020 XEOTICID XEO00810 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO00810 XEO_CLAS Natural Product DME0020 XEOTICID XEO00810 DESCRIPT Steviol up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00810 GENEFORM mRNA DME0020 XEOTICID XEO00810 MOACRIVE Induction DME0020 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0020 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0020 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00821 GENEFORM Protein DME0020 XEOTICID XEO00821 MOACRIVE Inhibition DME0020 XEOTICID XEO00853 XEO_NAME Clorgyline DME0020 XEOTICID XEO00853 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO00853 XEO_CLAS Investigative Agent DME0020 XEOTICID XEO00853 DESCRIPT Clorgyline inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00853 GENEFORM Protein DME0020 XEOTICID XEO00853 MOACRIVE Inhibition DME0020 XEOTICID XEO00859 XEO_NAME Ginkgolide B DME0020 XEOTICID XEO00859 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO00859 XEO_CLAS Natural Product DME0020 XEOTICID XEO00859 DESCRIPT Ginkgolide B up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00859 GENEFORM mRNA DME0020 XEOTICID XEO00859 MOACRIVE Induction DME0020 XEOTICID XEO00877 XEO_NAME Bilirubin DME0020 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO00877 XEO_CLAS Natural Product DME0020 XEOTICID XEO00877 DESCRIPT Bilirubin up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00877 GENEFORM mRNA DME0020 XEOTICID XEO00877 MOACRIVE Induction DME0020 XEOTICID XEO00878 XEO_NAME Chrysin DME0020 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO00878 XEO_CLAS Natural Product DME0020 XEOTICID XEO00878 DESCRIPT Chrysin up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00878 GENEFORM mRNA DME0020 XEOTICID XEO00878 MOACRIVE Induction DME0020 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0020 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0020 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0020 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00898 GENEFORM mRNA DME0020 XEOTICID XEO00898 MOACRIVE Induction DME0020 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0020 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0020 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0020 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00905 GENEFORM Protein DME0020 XEOTICID XEO00905 MOACRIVE Inhibition DME0020 XEOTICID XEO00920 XEO_NAME Perfluorohexanoic acid DME0020 XEOTICID XEO00920 XEO_TYPE Health or Environmental Toxicant(s) DME0020 XEOTICID XEO00920 XEO_CLAS Environmental Pollutant DME0020 XEOTICID XEO00920 DESCRIPT Perfluorohexanoic acid up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00920 GENEFORM mRNA DME0020 XEOTICID XEO00920 MOACRIVE Induction DME0020 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0020 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0020 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0020 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00921 GENEFORM mRNA DME0020 XEOTICID XEO00921 MOACRIVE Induction DME0020 XEOTICID XEO00938 XEO_NAME Azoxystrobin DME0020 XEOTICID XEO00938 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO00938 XEO_CLAS Fungicide DME0020 XEOTICID XEO00938 DESCRIPT Azoxystrobin induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00938 GENEFORM Protein DME0020 XEOTICID XEO00938 MOACRIVE Induction DME0020 XEOTICID XEO00942 XEO_NAME Cyproconazole DME0020 XEOTICID XEO00942 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO00942 XEO_CLAS Fungicide DME0020 XEOTICID XEO00942 DESCRIPT Cyproconazole induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00942 GENEFORM Protein DME0020 XEOTICID XEO00942 MOACRIVE Induction DME0020 XEOTICID XEO00950 XEO_NAME Fluxapyroxad DME0020 XEOTICID XEO00950 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO00950 XEO_CLAS Fungicide DME0020 XEOTICID XEO00950 DESCRIPT Fluxapyroxad induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00950 GENEFORM Protein DME0020 XEOTICID XEO00950 MOACRIVE Induction DME0020 XEOTICID XEO00955 XEO_NAME Prochloraz DME0020 XEOTICID XEO00955 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO00955 XEO_CLAS Fungicide DME0020 XEOTICID XEO00955 DESCRIPT Prochloraz up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00955 GENEFORM mRNA DME0020 XEOTICID XEO00955 MOACRIVE Induction DME0020 XEOTICID XEO00969 XEO_NAME Atrazine DME0020 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO00969 XEO_CLAS Herbicide DME0020 XEOTICID XEO00969 DESCRIPT Atrazine induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00969 GENEFORM Protein DME0020 XEOTICID XEO00969 MOACRIVE Induction DME0020 XEOTICID XEO00973 XEO_NAME Diuron DME0020 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO00973 XEO_CLAS Herbicide DME0020 XEOTICID XEO00973 DESCRIPT Diuron up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO00973 GENEFORM mRNA DME0020 XEOTICID XEO00973 MOACRIVE Induction DME0020 XEOTICID XEO00975 XEO_NAME Isoproturon DME0020 XEOTICID XEO00975 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO00975 XEO_CLAS Herbicide DME0020 XEOTICID XEO00975 DESCRIPT Isoproturon induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO00975 GENEFORM Protein DME0020 XEOTICID XEO00975 MOACRIVE Induction DME0020 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0020 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0020 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0020 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME CYP2B6 DME0020 XEOTICID XEO01004 GENEFORM mRNA DME0020 XEOTICID XEO01004 MOACRIVE Inhibition DME0020 XEOTICID XEO01018 XEO_NAME Perfluorodecanoic acid DME0020 XEOTICID XEO01018 XEO_TYPE Health or Environmental Toxicant(s) DME0020 XEOTICID XEO01018 XEO_CLAS Acute Toxic Substance DME0020 XEOTICID XEO01018 DESCRIPT Perfluorodecanoic acid up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01018 GENEFORM mRNA DME0020 XEOTICID XEO01018 MOACRIVE Induction DME0020 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0020 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0020 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0020 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME CYP2B6 DME0020 XEOTICID XEO01031 GENEFORM mRNA DME0020 XEOTICID XEO01031 MOACRIVE Inhibition DME0020 XEOTICID XEO01039 XEO_NAME Benfuracarb DME0020 XEOTICID XEO01039 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01039 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01039 DESCRIPT Benfuracarb induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01039 GENEFORM Protein DME0020 XEOTICID XEO01039 MOACRIVE Induction DME0020 XEOTICID XEO01043 XEO_NAME Chlorfluazuron DME0020 XEOTICID XEO01043 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01043 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01043 DESCRIPT Chlorfluazuron induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01043 GENEFORM Protein DME0020 XEOTICID XEO01043 MOACRIVE Induction DME0020 XEOTICID XEO01046 XEO_NAME Cypermethrin DME0020 XEOTICID XEO01046 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01046 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01046 DESCRIPT Cypermethrin induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01046 GENEFORM Protein DME0020 XEOTICID XEO01046 MOACRIVE Induction DME0020 XEOTICID XEO01047 XEO_NAME Decamethrin DME0020 XEOTICID XEO01047 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01047 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01047 DESCRIPT Decamethrin inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01047 GENEFORM Protein DME0020 XEOTICID XEO01047 MOACRIVE Inhibition DME0020 XEOTICID XEO01048 XEO_NAME Dichlorodiphenyl dichloroethane DME0020 XEOTICID XEO01048 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01048 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01048 DESCRIPT Dichlorodiphenyl dichloroethane up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01048 GENEFORM mRNA DME0020 XEOTICID XEO01048 MOACRIVE Induction DME0020 XEOTICID XEO01051 XEO_NAME Dieldrin DME0020 XEOTICID XEO01051 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01051 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01051 DESCRIPT Dieldrin induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01051 GENEFORM Protein DME0020 XEOTICID XEO01051 MOACRIVE Induction DME0020 XEOTICID XEO01052 XEO_NAME Fenitrothion DME0020 XEOTICID XEO01052 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01052 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01052 DESCRIPT Fenitrothion inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01052 GENEFORM Protein DME0020 XEOTICID XEO01052 MOACRIVE Inhibition DME0020 XEOTICID XEO01053 XEO_NAME Fenvalerate DME0020 XEOTICID XEO01053 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01053 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01053 DESCRIPT Fenvalerate inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01053 GENEFORM Protein DME0020 XEOTICID XEO01053 MOACRIVE Inhibition DME0020 XEOTICID XEO01058 XEO_NAME Isomalathion DME0020 XEOTICID XEO01058 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01058 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01058 DESCRIPT Isomalathion up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01058 GENEFORM mRNA DME0020 XEOTICID XEO01058 MOACRIVE Induction DME0020 XEOTICID XEO01062 XEO_NAME Monocrotophos DME0020 XEOTICID XEO01062 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01062 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01062 DESCRIPT Monocrotophos up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01062 GENEFORM mRNA DME0020 XEOTICID XEO01062 MOACRIVE Induction DME0020 XEOTICID XEO01068 XEO_NAME Profenofos DME0020 XEOTICID XEO01068 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01068 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01068 DESCRIPT Prof DMEenof DMEos inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01068 GENEFORM Protein DME0020 XEOTICID XEO01068 MOACRIVE Inhibition DME0020 XEOTICID XEO01069 XEO_NAME Pyrethrins DME0020 XEOTICID XEO01069 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01069 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01069 DESCRIPT Pyrethrins up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01069 GENEFORM mRNA DME0020 XEOTICID XEO01069 MOACRIVE Induction DME0020 XEOTICID XEO01074 XEO_NAME Endosulfan DME0020 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01074 DESCRIPT Endosulfan induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01074 GENEFORM Protein DME0020 XEOTICID XEO01074 MOACRIVE Induction DME0020 XEOTICID XEO01090 XEO_NAME 1,5-benzothiazepine DME0020 XEOTICID XEO01090 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO01090 XEO_CLAS Investigative Agent DME0020 XEOTICID XEO01090 DESCRIPT 1,5-benzothiazepine up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01090 GENEFORM mRNA DME0020 XEOTICID XEO01090 MOACRIVE Induction DME0020 XEOTICID XEO01156 XEO_NAME CP-778875 DME0020 XEOTICID XEO01156 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO01156 XEO_CLAS Preclinical/Patented Drug DME0020 XEOTICID XEO01156 DESCRIPT CP-778875 inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01156 GENEFORM Protein DME0020 XEOTICID XEO01156 MOACRIVE Inhibition DME0020 XEOTICID XEO01159 XEO_NAME 5-fluorotryptamine DME0020 XEOTICID XEO01159 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO01159 XEO_CLAS Investigative Agent DME0020 XEOTICID XEO01159 DESCRIPT 5-fluorotryptamine inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01159 GENEFORM Protein DME0020 XEOTICID XEO01159 MOACRIVE Inhibition DME0020 XEOTICID XEO01165 XEO_NAME CITCO DME0020 XEOTICID XEO01165 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO01165 XEO_CLAS Investigative Agent DME0020 XEOTICID XEO01165 DESCRIPT CITCO induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01165 GENEFORM Protein DME0020 XEOTICID XEO01165 MOACRIVE Induction DME0020 XEOTICID XEO01177 XEO_NAME 7-methyltryptamine DME0020 XEOTICID XEO01177 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO01177 XEO_CLAS Investigative Agent DME0020 XEOTICID XEO01177 DESCRIPT 7-methyltryptamine inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01177 GENEFORM Protein DME0020 XEOTICID XEO01177 MOACRIVE Inhibition DME0020 XEOTICID XEO01212 XEO_NAME Baicalein DME0020 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01212 XEO_CLAS Natural Product DME0020 XEOTICID XEO01212 DESCRIPT Baicalein up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01212 GENEFORM mRNA DME0020 XEOTICID XEO01212 MOACRIVE Induction DME0020 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0020 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0020 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01220 GENEFORM Protein DME0020 XEOTICID XEO01220 MOACRIVE Induction DME0020 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0020 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0020 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01226 GENEFORM mRNA DME0020 XEOTICID XEO01226 MOACRIVE Induction DME0020 XEOTICID XEO01230 XEO_NAME Butyric acid DME0020 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0020 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01230 GENEFORM mRNA DME0020 XEOTICID XEO01230 MOACRIVE Induction DME0020 XEOTICID XEO01245 XEO_NAME Chlordan DME0020 XEOTICID XEO01245 XEO_TYPE Health or Environmental Toxicant(s) DME0020 XEOTICID XEO01245 XEO_CLAS Health Hazard/Toxicant DME0020 XEOTICID XEO01245 DESCRIPT Chlordan induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01245 GENEFORM Protein DME0020 XEOTICID XEO01245 MOACRIVE Induction DME0020 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0020 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0020 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0020 XEOTICID XEO01248 DESCRIPT Chlorpyrifos inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01248 GENEFORM Protein DME0020 XEOTICID XEO01248 MOACRIVE Inhibition DME0020 XEOTICID XEO01292 XEO_NAME CINPA1 DME0020 XEOTICID XEO01292 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO01292 XEO_CLAS Investigative Agent DME0020 XEOTICID XEO01292 DESCRIPT CINPA1 up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01292 GENEFORM mRNA DME0020 XEOTICID XEO01292 MOACRIVE Induction DME0020 XEOTICID XEO01298 XEO_NAME Farnesol DME0020 XEOTICID XEO01298 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO01298 XEO_CLAS Investigative Agent DME0020 XEOTICID XEO01298 DESCRIPT Farnesol up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01298 GENEFORM mRNA DME0020 XEOTICID XEO01298 MOACRIVE Induction DME0020 XEOTICID XEO01301 XEO_NAME FG-7142 DME0020 XEOTICID XEO01301 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO01301 XEO_CLAS Investigative Agent DME0020 XEOTICID XEO01301 DESCRIPT FG-7142 up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01301 GENEFORM mRNA DME0020 XEOTICID XEO01301 MOACRIVE Induction DME0020 XEOTICID XEO01302 XEO_NAME Fipronil DME0020 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0020 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0020 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01302 GENEFORM mRNA DME0020 XEOTICID XEO01302 MOACRIVE Induction DME0020 XEOTICID XEO01308 XEO_NAME Galangin DME0020 XEOTICID XEO01308 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01308 XEO_CLAS Natural Product DME0020 XEOTICID XEO01308 DESCRIPT Galangin up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01308 GENEFORM mRNA DME0020 XEOTICID XEO01308 MOACRIVE Induction DME0020 XEOTICID XEO01313 XEO_NAME Germacrone DME0020 XEOTICID XEO01313 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01313 XEO_CLAS Natural Product DME0020 XEOTICID XEO01313 DESCRIPT Germacrone inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01313 GENEFORM Protein DME0020 XEOTICID XEO01313 MOACRIVE Inhibition DME0020 XEOTICID XEO01314 XEO_NAME Ginkgo biloba extract DME0020 XEOTICID XEO01314 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01314 XEO_CLAS Plant Extract DME0020 XEOTICID XEO01314 DESCRIPT Ginkgo biloba extract up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01314 GENEFORM mRNA DME0020 XEOTICID XEO01314 MOACRIVE Induction DME0020 XEOTICID XEO01315 XEO_NAME Ginkgolide A DME0020 XEOTICID XEO01315 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO01315 XEO_CLAS Approved/Marketed Drug DME0020 XEOTICID XEO01315 DESCRIPT Ginkgolide A up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01315 GENEFORM mRNA DME0020 XEOTICID XEO01315 MOACRIVE Induction DME0020 XEOTICID XEO01335 XEO_NAME Hyperforin DME0020 XEOTICID XEO01335 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01335 XEO_CLAS Natural Product DME0020 XEOTICID XEO01335 DESCRIPT Hyperforin up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01335 GENEFORM mRNA DME0020 XEOTICID XEO01335 MOACRIVE Induction DME0020 XEOTICID XEO01375 XEO_NAME Methoxydimethyltryptamines DME0020 XEOTICID XEO01375 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01375 XEO_CLAS Natural Product DME0020 XEOTICID XEO01375 DESCRIPT Methoxydimethyltryptamines inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01375 GENEFORM Protein DME0020 XEOTICID XEO01375 MOACRIVE Inhibition DME0020 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0020 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0020 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0020 XEOTICID XEO01407 DESCRIPT Ochratoxin A up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01407 GENEFORM mRNA DME0020 XEOTICID XEO01407 MOACRIVE Induction DME0020 XEOTICID XEO01412 XEO_NAME Oleic acid DME0020 XEOTICID XEO01412 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO01412 XEO_CLAS Preclinical/Patented Drug DME0020 XEOTICID XEO01412 DESCRIPT Oleic acid inhibits the expression of DME CYP2B6 DME0020 XEOTICID XEO01412 GENEFORM mRNA DME0020 XEOTICID XEO01412 MOACRIVE Inhibition DME0020 XEOTICID XEO01426 XEO_NAME Phencyclidine DME0020 XEOTICID XEO01426 XEO_TYPE Pharmaceutical Agent(s) DME0020 XEOTICID XEO01426 XEO_CLAS Drug Marketed but Withdrawn from Market DME0020 XEOTICID XEO01426 DESCRIPT Phencyclidine inhibits the drug-metabolizing activity of DME CYP2B6 (Ki = 10 microM) DME0020 XEOTICID XEO01426 GENEFORM Protein DME0020 XEOTICID XEO01426 MOACRIVE Inhibition DME0020 XEOTICID XEO01433 XEO_NAME Pirinixic acid DME0020 XEOTICID XEO01433 XEO_TYPE Health or Environmental Toxicant(s) DME0020 XEOTICID XEO01433 XEO_CLAS Health Hazard/Toxicant DME0020 XEOTICID XEO01433 DESCRIPT Pirinixic acid induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01433 GENEFORM Protein DME0020 XEOTICID XEO01433 MOACRIVE Induction DME0020 XEOTICID XEO01498 XEO_NAME Walrycin A DME0020 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01498 XEO_CLAS Natural Product DME0020 XEOTICID XEO01498 DESCRIPT Walrycin A up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01498 GENEFORM mRNA DME0020 XEOTICID XEO01498 MOACRIVE Induction DME0020 XEOTICID XEO01518 XEO_NAME 5-methyltryptamine DME0020 XEOTICID XEO01518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01518 XEO_CLAS Natural Product DME0020 XEOTICID XEO01518 DESCRIPT 5-methyltryptamine inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01518 GENEFORM Protein DME0020 XEOTICID XEO01518 MOACRIVE Inhibition DME0020 XEOTICID XEO01526 XEO_NAME Basil oil DME0020 XEOTICID XEO01526 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01526 XEO_CLAS Plant Extract DME0020 XEOTICID XEO01526 DESCRIPT Basil oil up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01526 GENEFORM mRNA DME0020 XEOTICID XEO01526 MOACRIVE Induction DME0020 XEOTICID XEO01527 XEO_NAME Bergamottin DME0020 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01527 XEO_CLAS Natural Product DME0020 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of DME CYP2B6 (Ki = 5.2 microM) DME0020 XEOTICID XEO01527 GENEFORM Protein DME0020 XEOTICID XEO01527 MOACRIVE Inhibition DME0020 XEOTICID XEO01530 XEO_NAME Cinnamon oil, bark DME0020 XEOTICID XEO01530 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01530 XEO_CLAS Plant Extract DME0020 XEOTICID XEO01530 DESCRIPT Cinnamon oil, bark up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01530 GENEFORM mRNA DME0020 XEOTICID XEO01530 MOACRIVE Induction DME0020 XEOTICID XEO01531 XEO_NAME Clove oil DME0020 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01531 XEO_CLAS Natural Product DME0020 XEOTICID XEO01531 DESCRIPT Clove oil up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01531 GENEFORM mRNA DME0020 XEOTICID XEO01531 MOACRIVE Induction DME0020 XEOTICID XEO01533 XEO_NAME Coriander oil DME0020 XEOTICID XEO01533 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01533 XEO_CLAS Plant Extract DME0020 XEOTICID XEO01533 DESCRIPT Coriander oil up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01533 GENEFORM mRNA DME0020 XEOTICID XEO01533 MOACRIVE Induction DME0020 XEOTICID XEO01556 XEO_NAME Juniperus communis oil DME0020 XEOTICID XEO01556 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01556 XEO_CLAS Plant Extract DME0020 XEOTICID XEO01556 DESCRIPT Juniperus communis oil up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01556 GENEFORM mRNA DME0020 XEOTICID XEO01556 MOACRIVE Induction DME0020 XEOTICID XEO01557 XEO_NAME Lemongrass oil DME0020 XEOTICID XEO01557 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01557 XEO_CLAS Natural Product DME0020 XEOTICID XEO01557 DESCRIPT Lemongrass oil up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01557 GENEFORM mRNA DME0020 XEOTICID XEO01557 MOACRIVE Induction DME0020 XEOTICID XEO01574 XEO_NAME Plant extracts DME0020 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0020 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01574 GENEFORM Protein DME0020 XEOTICID XEO01574 MOACRIVE Inhibition DME0020 XEOTICID XEO01585 XEO_NAME Senecionine DME0020 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0020 XEOTICID XEO01585 XEO_CLAS Natural Product DME0020 XEOTICID XEO01585 DESCRIPT Senecionine up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01585 GENEFORM mRNA DME0020 XEOTICID XEO01585 MOACRIVE Induction DME0020 XEOTICID XEO01597 XEO_NAME Carbofuran DME0020 XEOTICID XEO01597 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01597 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01597 DESCRIPT Carbofuran induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01597 GENEFORM Protein DME0020 XEOTICID XEO01597 MOACRIVE Induction DME0020 XEOTICID XEO01598 XEO_NAME Chlordecone DME0020 XEOTICID XEO01598 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01598 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01598 DESCRIPT Chlordecone induces the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01598 GENEFORM Protein DME0020 XEOTICID XEO01598 MOACRIVE Induction DME0020 XEOTICID XEO01600 XEO_NAME Cyhalothrin DME0020 XEOTICID XEO01600 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01600 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01600 DESCRIPT Cyhalothrin inhibits the drug-metabolizing activity of DME CYP2B6 DME0020 XEOTICID XEO01600 GENEFORM Protein DME0020 XEOTICID XEO01600 MOACRIVE Inhibition DME0020 XEOTICID XEO01604 XEO_NAME Nonachlor DME0020 XEOTICID XEO01604 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01604 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01604 DESCRIPT Nonachlor up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01604 GENEFORM mRNA DME0020 XEOTICID XEO01604 MOACRIVE Induction DME0020 XEOTICID XEO01605 XEO_NAME Pentachlorophenol DME0020 XEOTICID XEO01605 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0020 XEOTICID XEO01605 XEO_CLAS Pesticide/Insecticide DME0020 XEOTICID XEO01605 DESCRIPT Pentachlorophenol up-regulates the expression of DME CYP2B6 DME0020 XEOTICID XEO01605 GENEFORM mRNA DME0020 XEOTICID XEO01605 MOACRIVE Induction DME0021 DME___ID DME0021 DME0021 DME_NAME Mephenytoin 4-hydroxylase (CYP2C19) DME0021 SPESNAME Homo sapiens DME0021 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0021 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME CYP2C19 DME0021 XEOTICID XEO00011 GENEFORM mRNA DME0021 XEOTICID XEO00011 MOACRIVE Induction DME0021 XEOTICID XEO00022 XEO_NAME Desipramine DME0021 XEOTICID XEO00022 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00022 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00022 DESCRIPT Desipramine inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00022 GENEFORM Protein DME0021 XEOTICID XEO00022 MOACRIVE Inhibition DME0021 XEOTICID XEO00029 XEO_NAME Valproic acid DME0021 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME CYP2C19 DME0021 XEOTICID XEO00029 GENEFORM mRNA DME0021 XEOTICID XEO00029 MOACRIVE Induction DME0021 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0021 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME CYP2C19 DME0021 XEOTICID XEO00035 GENEFORM mRNA DME0021 XEOTICID XEO00035 MOACRIVE Induction DME0021 XEOTICID XEO00036 XEO_NAME Fluconazole DME0021 XEOTICID XEO00036 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00036 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00036 DESCRIPT Fluconazole inhibits the drug-metabolizing activity of DME CYP2C19 (IC50 = 8.2 microM) DME0021 XEOTICID XEO00036 GENEFORM Protein DME0021 XEOTICID XEO00036 MOACRIVE Inhibition DME0021 XEOTICID XEO00052 XEO_NAME Lansoprazole DME0021 XEOTICID XEO00052 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00052 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00052 DESCRIPT Lansoprazole inhibits the drug-metabolizing activity of DME CYP2C19 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.3367 microM) DME0021 XEOTICID XEO00052 GENEFORM Protein DME0021 XEOTICID XEO00052 MOACRIVE Inhibition DME0021 XEOTICID XEO00060 XEO_NAME Mephenytoin DME0021 XEOTICID XEO00060 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00060 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00060 DESCRIPT Mephenytoin inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00060 GENEFORM Protein DME0021 XEOTICID XEO00060 MOACRIVE Inhibition DME0021 XEOTICID XEO00069 XEO_NAME Omeprazole DME0021 XEOTICID XEO00069 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00069 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00069 DESCRIPT Omeprazole inhibits the drug-metabolizing activity of DME CYP2C19 (IC50 = 35 microM) DME0021 XEOTICID XEO00069 GENEFORM Protein DME0021 XEOTICID XEO00069 MOACRIVE Inhibition DME0021 XEOTICID XEO00086 XEO_NAME Troglitazone DME0021 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME CYP2C19 DME0021 XEOTICID XEO00086 GENEFORM mRNA DME0021 XEOTICID XEO00086 MOACRIVE Induction DME0021 XEOTICID XEO00087 XEO_NAME Zafirlukast DME0021 XEOTICID XEO00087 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00087 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00087 DESCRIPT Zafirlukast inhibits the expression of DME CYP2C19 DME0021 XEOTICID XEO00087 GENEFORM mRNA DME0021 XEOTICID XEO00087 MOACRIVE Inhibition DME0021 XEOTICID XEO00142 XEO_NAME Voriconazole DME0021 XEOTICID XEO00142 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00142 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00142 DESCRIPT Voriconazole inhibits the drug-metabolizing activity of DME CYP2C19 (IC50 = 15 microM) DME0021 XEOTICID XEO00142 GENEFORM Protein DME0021 XEOTICID XEO00142 MOACRIVE Inhibition DME0021 XEOTICID XEO00160 XEO_NAME Ritonavir DME0021 XEOTICID XEO00160 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00160 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00160 DESCRIPT Ritonavir up-regulates the expression of DME CYP2C19 DME0021 XEOTICID XEO00160 GENEFORM mRNA DME0021 XEOTICID XEO00160 MOACRIVE Induction DME0021 XEOTICID XEO00173 XEO_NAME Cannabidiol DME0021 XEOTICID XEO00173 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00173 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00173 DESCRIPT Cannabidiol inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00173 GENEFORM Protein DME0021 XEOTICID XEO00173 MOACRIVE Inhibition DME0021 XEOTICID XEO00178 XEO_NAME Capsaicin DME0021 XEOTICID XEO00178 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00178 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00178 DESCRIPT Capsaicin inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00178 GENEFORM Protein DME0021 XEOTICID XEO00178 MOACRIVE Inhibition DME0021 XEOTICID XEO00180 XEO_NAME Quinine DME0021 XEOTICID XEO00180 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00180 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00180 DESCRIPT Quinine inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00180 GENEFORM Protein DME0021 XEOTICID XEO00180 MOACRIVE Inhibition DME0021 XEOTICID XEO00184 XEO_NAME Calcitriol DME0021 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME CYP2C19 DME0021 XEOTICID XEO00184 GENEFORM mRNA DME0021 XEOTICID XEO00184 MOACRIVE Induction DME0021 XEOTICID XEO00216 XEO_NAME Efavirenz DME0021 XEOTICID XEO00216 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00216 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00216 DESCRIPT Efavirenz inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00216 GENEFORM Protein DME0021 XEOTICID XEO00216 MOACRIVE Inhibition DME0021 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0021 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP2C19 DME0021 XEOTICID XEO00217 GENEFORM mRNA DME0021 XEOTICID XEO00217 MOACRIVE Inhibition DME0021 XEOTICID XEO00220 XEO_NAME Chloramphenicol DME0021 XEOTICID XEO00220 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00220 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00220 DESCRIPT Chloramphenicol inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00220 GENEFORM Protein DME0021 XEOTICID XEO00220 MOACRIVE Inhibition DME0021 XEOTICID XEO00223 XEO_NAME Rifampin DME0021 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00223 DESCRIPT Rifampin induces the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00223 GENEFORM Protein DME0021 XEOTICID XEO00223 MOACRIVE Induction DME0021 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0021 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the drug-metabolizing activity of DME CYP2C19 (IC50 = 7 microM) DME0021 XEOTICID XEO00241 GENEFORM Protein DME0021 XEOTICID XEO00241 MOACRIVE Inhibition DME0021 XEOTICID XEO00242 XEO_NAME Diethylcarbamazine DME0021 XEOTICID XEO00242 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00242 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00242 DESCRIPT Diethylcarbamazine induces the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00242 GENEFORM Protein DME0021 XEOTICID XEO00242 MOACRIVE Induction DME0021 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0021 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP2C19 (IC50 = 10.1 microM) DME0021 XEOTICID XEO00251 GENEFORM Protein DME0021 XEOTICID XEO00251 MOACRIVE Inhibition DME0021 XEOTICID XEO00280 XEO_NAME Chlorpromazine hydrochloride DME0021 XEOTICID XEO00280 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00280 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00280 DESCRIPT Chlorpromazine hydrochloride inhibits the drug-metabolizing activity of DME CYP2C19 (IC50 = 34.1 microM) DME0021 XEOTICID XEO00280 GENEFORM Protein DME0021 XEOTICID XEO00280 MOACRIVE Inhibition DME0021 XEOTICID XEO00287 XEO_NAME Delavirdine mesylate DME0021 XEOTICID XEO00287 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00287 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00287 DESCRIPT Delavirdine mesylate inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00287 GENEFORM Protein DME0021 XEOTICID XEO00287 MOACRIVE Inhibition DME0021 XEOTICID XEO00295 XEO_NAME Fluphenazine hydrochloride DME0021 XEOTICID XEO00295 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00295 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00295 DESCRIPT Fluphenazine hydrochloride inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00295 GENEFORM Protein DME0021 XEOTICID XEO00295 MOACRIVE Inhibition DME0021 XEOTICID XEO00308 XEO_NAME Miconazole nitrate DME0021 XEOTICID XEO00308 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00308 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00308 DESCRIPT Miconazole nitrate inhibits the drug-metabolizing activity of DME CYP2C19 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.016 microM) DME0021 XEOTICID XEO00308 GENEFORM Protein DME0021 XEOTICID XEO00308 MOACRIVE Inhibition DME0021 XEOTICID XEO00311 XEO_NAME Nicardipine hydrochloride DME0021 XEOTICID XEO00311 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00311 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00311 DESCRIPT Nicardipine hydrochloride inhibits the drug-metabolizing activity of DME CYP2C19 (IC50 = 0.56 microM) DME0021 XEOTICID XEO00311 GENEFORM Protein DME0021 XEOTICID XEO00311 MOACRIVE Inhibition DME0021 XEOTICID XEO00317 XEO_NAME Pentamidine isethionate DME0021 XEOTICID XEO00317 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00317 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00317 DESCRIPT Pentamidine isethionate inhibits the drug-metabolizing activity of DME CYP2C19 (IC50 > 100 microM) DME0021 XEOTICID XEO00317 GENEFORM Protein DME0021 XEOTICID XEO00317 MOACRIVE Inhibition DME0021 XEOTICID XEO00330 XEO_NAME Thioridazine hydrochloride DME0021 XEOTICID XEO00330 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00330 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00330 DESCRIPT Thioridazine hydrochloride inhibits the drug-metabolizing activity of DME CYP2C19 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 6.3778 microM) DME0021 XEOTICID XEO00330 GENEFORM Protein DME0021 XEOTICID XEO00330 MOACRIVE Inhibition DME0021 XEOTICID XEO00331 XEO_NAME Ticlopidine hydrochloride DME0021 XEOTICID XEO00331 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00331 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00331 DESCRIPT Ticlopidine hydrochloride inhibits the drug-metabolizing activity of DME CYP2C19 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.6678 microM) DME0021 XEOTICID XEO00331 GENEFORM Protein DME0021 XEOTICID XEO00331 MOACRIVE Inhibition DME0021 XEOTICID XEO00357 XEO_NAME Ethambutol DME0021 XEOTICID XEO00357 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00357 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00357 DESCRIPT Ethambutol inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00357 GENEFORM Protein DME0021 XEOTICID XEO00357 MOACRIVE Inhibition DME0021 XEOTICID XEO00358 XEO_NAME Fluoxetine DME0021 XEOTICID XEO00358 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00358 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00358 DESCRIPT Fluoxetine inhibits the drug-metabolizing activity of DME CYP2C19 (IC50 = 0.04 microM) DME0021 XEOTICID XEO00358 GENEFORM Protein DME0021 XEOTICID XEO00358 MOACRIVE Inhibition DME0021 XEOTICID XEO00383 XEO_NAME Tamoxifen DME0021 XEOTICID XEO00383 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00383 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00383 DESCRIPT Tamoxifen up-regulates the expression of DME CYP2C19 DME0021 XEOTICID XEO00383 GENEFORM mRNA DME0021 XEOTICID XEO00383 MOACRIVE Induction DME0021 XEOTICID XEO00385 XEO_NAME Tranylcypromine DME0021 XEOTICID XEO00385 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00385 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00385 DESCRIPT Tranylcypromine inhibits the drug-metabolizing activity of DME CYP2C19 (IC50 = 3.04 microM) DME0021 XEOTICID XEO00385 GENEFORM Protein DME0021 XEOTICID XEO00385 MOACRIVE Inhibition DME0021 XEOTICID XEO00438 XEO_NAME Benidipine DME0021 XEOTICID XEO00438 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00438 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00438 DESCRIPT Benidipine inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00438 GENEFORM Protein DME0021 XEOTICID XEO00438 MOACRIVE Inhibition DME0021 XEOTICID XEO00449 XEO_NAME Artemisinine DME0021 XEOTICID XEO00449 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00449 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00449 DESCRIPT Artemisinine inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00449 GENEFORM Protein DME0021 XEOTICID XEO00449 MOACRIVE Inhibition DME0021 XEOTICID XEO00453 XEO_NAME Asiaticoside DME0021 XEOTICID XEO00453 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00453 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00453 DESCRIPT Asiaticoside inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00453 GENEFORM Protein DME0021 XEOTICID XEO00453 MOACRIVE Inhibition DME0021 XEOTICID XEO00454 XEO_NAME Dihydroartemisinin DME0021 XEOTICID XEO00454 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00454 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00454 DESCRIPT Dihydroartemisinin inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00454 GENEFORM Protein DME0021 XEOTICID XEO00454 MOACRIVE Inhibition DME0021 XEOTICID XEO00475 XEO_NAME Melarsoprol DME0021 XEOTICID XEO00475 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00475 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00475 DESCRIPT Melarsoprol inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00475 GENEFORM Protein DME0021 XEOTICID XEO00475 MOACRIVE Inhibition DME0021 XEOTICID XEO00489 XEO_NAME Amodiaquine DME0021 XEOTICID XEO00489 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00489 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00489 DESCRIPT Amodiaquine inhibits the drug-metabolizing activity of DME CYP2C19 (IC50 > 50 microM) DME0021 XEOTICID XEO00489 GENEFORM Protein DME0021 XEOTICID XEO00489 MOACRIVE Inhibition DME0021 XEOTICID XEO00492 XEO_NAME Benzbromarone DME0021 XEOTICID XEO00492 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00492 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO00492 DESCRIPT Benzbromarone inhibits the drug-metabolizing activity of DME CYP2C19 (IC50 = 18.2 microM) DME0021 XEOTICID XEO00492 GENEFORM Protein DME0021 XEOTICID XEO00492 MOACRIVE Inhibition DME0021 XEOTICID XEO00537 XEO_NAME Luteolin DME0021 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME0021 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00537 GENEFORM Protein DME0021 XEOTICID XEO00537 MOACRIVE Inhibition DME0021 XEOTICID XEO00538 XEO_NAME Quercetin DME0021 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0021 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME CYP2C19 (IC50 = 10.5 microM) DME0021 XEOTICID XEO00538 GENEFORM Protein DME0021 XEOTICID XEO00538 MOACRIVE Inhibition DME0021 XEOTICID XEO00557 XEO_NAME Genistein DME0021 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0021 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00557 GENEFORM Protein DME0021 XEOTICID XEO00557 MOACRIVE Inhibition DME0021 XEOTICID XEO00560 XEO_NAME Triclosan DME0021 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0021 XEOTICID XEO00560 DESCRIPT Triclosan up-regulates the expression of DME CYP2C19 DME0021 XEOTICID XEO00560 GENEFORM mRNA DME0021 XEOTICID XEO00560 MOACRIVE Induction DME0021 XEOTICID XEO00568 XEO_NAME Resveratrol DME0021 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0021 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of DME CYP2C19 in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 3 microM) DME0021 XEOTICID XEO00568 GENEFORM Protein DME0021 XEOTICID XEO00568 MOACRIVE Inhibition DME0021 XEOTICID XEO00573 XEO_NAME Naringenin DME0021 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME0021 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00573 GENEFORM Protein DME0021 XEOTICID XEO00573 MOACRIVE Inhibition DME0021 XEOTICID XEO00591 XEO_NAME Ditiocarb DME0021 XEOTICID XEO00591 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00591 XEO_CLAS Drug in Phase 2 Clinical Trial DME0021 XEOTICID XEO00591 DESCRIPT Ditiocarb inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00591 GENEFORM Protein DME0021 XEOTICID XEO00591 MOACRIVE Inhibition DME0021 XEOTICID XEO00653 XEO_NAME Icaritin DME0021 XEOTICID XEO00653 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00653 XEO_CLAS Drug in Phase 2 Clinical Trial DME0021 XEOTICID XEO00653 DESCRIPT Icaritin inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00653 GENEFORM Protein DME0021 XEOTICID XEO00653 MOACRIVE Inhibition DME0021 XEOTICID XEO00708 XEO_NAME Miltirone DME0021 XEOTICID XEO00708 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00708 XEO_CLAS Preclinical/Patented Drug DME0021 XEOTICID XEO00708 DESCRIPT Miltirone inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00708 GENEFORM Protein DME0021 XEOTICID XEO00708 MOACRIVE Inhibition DME0021 XEOTICID XEO00710 XEO_NAME Isoliquiritigenin DME0021 XEOTICID XEO00710 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00710 XEO_CLAS Preclinical/Patented Drug DME0021 XEOTICID XEO00710 DESCRIPT Isoliquiritigenin inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00710 GENEFORM Protein DME0021 XEOTICID XEO00710 MOACRIVE Inhibition DME0021 XEOTICID XEO00733 XEO_NAME Okanin DME0021 XEOTICID XEO00733 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00733 XEO_CLAS Preclinical/Patented Drug DME0021 XEOTICID XEO00733 DESCRIPT Okanin inhibits the expression of DME CYP2C19 DME0021 XEOTICID XEO00733 GENEFORM mRNA DME0021 XEOTICID XEO00733 MOACRIVE Inhibition DME0021 XEOTICID XEO00802 XEO_NAME Dihydrocapsaicin DME0021 XEOTICID XEO00802 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0021 XEOTICID XEO00802 XEO_CLAS Natural Product DME0021 XEOTICID XEO00802 DESCRIPT Dihydrocapsaicin inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00802 GENEFORM Protein DME0021 XEOTICID XEO00802 MOACRIVE Inhibition DME0021 XEOTICID XEO00804 XEO_NAME Avasimibe DME0021 XEOTICID XEO00804 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00804 XEO_CLAS Investigative Agent DME0021 XEOTICID XEO00804 DESCRIPT Avasimibe inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00804 GENEFORM Protein DME0021 XEOTICID XEO00804 MOACRIVE Inhibition DME0021 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0021 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0021 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0021 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYP2C19 DME0021 XEOTICID XEO00806 GENEFORM mRNA DME0021 XEOTICID XEO00806 MOACRIVE Inhibition DME0021 XEOTICID XEO00856 XEO_NAME Hesperetin DME0021 XEOTICID XEO00856 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0021 XEOTICID XEO00856 XEO_CLAS Natural Product DME0021 XEOTICID XEO00856 DESCRIPT Hesperetin inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00856 GENEFORM Protein DME0021 XEOTICID XEO00856 MOACRIVE Inhibition DME0021 XEOTICID XEO00857 XEO_NAME Cyclodextrins DME0021 XEOTICID XEO00857 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0021 XEOTICID XEO00857 XEO_CLAS Natural Mixture DME0021 XEOTICID XEO00857 DESCRIPT Cyclodextrins inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00857 GENEFORM Protein DME0021 XEOTICID XEO00857 MOACRIVE Inhibition DME0021 XEOTICID XEO00873 XEO_NAME Alpha-linolenic acid DME0021 XEOTICID XEO00873 XEO_TYPE Health or Environmental Toxicant(s) DME0021 XEOTICID XEO00873 XEO_CLAS Health Hazard/Toxicant DME0021 XEOTICID XEO00873 DESCRIPT Alpha-linolenic acid inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00873 GENEFORM Protein DME0021 XEOTICID XEO00873 MOACRIVE Inhibition DME0021 XEOTICID XEO00876 XEO_NAME Arachidonic acid DME0021 XEOTICID XEO00876 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO00876 XEO_CLAS Investigative Agent DME0021 XEOTICID XEO00876 DESCRIPT Arachidonic acid inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO00876 GENEFORM Protein DME0021 XEOTICID XEO00876 MOACRIVE Inhibition DME0021 XEOTICID XEO01046 XEO_NAME Cypermethrin DME0021 XEOTICID XEO01046 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0021 XEOTICID XEO01046 XEO_CLAS Pesticide/Insecticide DME0021 XEOTICID XEO01046 DESCRIPT Cypermethrin up-regulates the expression of DME CYP2C19 DME0021 XEOTICID XEO01046 GENEFORM mRNA DME0021 XEOTICID XEO01046 MOACRIVE Induction DME0021 XEOTICID XEO01047 XEO_NAME Decamethrin DME0021 XEOTICID XEO01047 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0021 XEOTICID XEO01047 XEO_CLAS Pesticide/Insecticide DME0021 XEOTICID XEO01047 DESCRIPT Decamethrin up-regulates the expression of DME CYP2C19 DME0021 XEOTICID XEO01047 GENEFORM mRNA DME0021 XEOTICID XEO01047 MOACRIVE Induction DME0021 XEOTICID XEO01053 XEO_NAME Fenvalerate DME0021 XEOTICID XEO01053 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0021 XEOTICID XEO01053 XEO_CLAS Pesticide/Insecticide DME0021 XEOTICID XEO01053 DESCRIPT Fenvalerate up-regulates the expression of DME CYP2C19 DME0021 XEOTICID XEO01053 GENEFORM mRNA DME0021 XEOTICID XEO01053 MOACRIVE Induction DME0021 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0021 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0021 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0021 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone induces the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01129 GENEFORM Protein DME0021 XEOTICID XEO01129 MOACRIVE Induction DME0021 XEOTICID XEO01130 XEO_NAME DY-9760e DME0021 XEOTICID XEO01130 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO01130 XEO_CLAS Investigative Agent DME0021 XEOTICID XEO01130 DESCRIPT DY-9760e inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01130 GENEFORM Protein DME0021 XEOTICID XEO01130 MOACRIVE Inhibition DME0021 XEOTICID XEO01156 XEO_NAME CP-778875 DME0021 XEOTICID XEO01156 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO01156 XEO_CLAS Preclinical/Patented Drug DME0021 XEOTICID XEO01156 DESCRIPT CP-778875 inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01156 GENEFORM Protein DME0021 XEOTICID XEO01156 MOACRIVE Inhibition DME0021 XEOTICID XEO01159 XEO_NAME 5-fluorotryptamine DME0021 XEOTICID XEO01159 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO01159 XEO_CLAS Investigative Agent DME0021 XEOTICID XEO01159 DESCRIPT 5-fluorotryptamine inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01159 GENEFORM Protein DME0021 XEOTICID XEO01159 MOACRIVE Inhibition DME0021 XEOTICID XEO01176 XEO_NAME 7-hydroxyflavone DME0021 XEOTICID XEO01176 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0021 XEOTICID XEO01176 XEO_CLAS Natural Product DME0021 XEOTICID XEO01176 DESCRIPT 7-hydroxyflavone inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01176 GENEFORM Protein DME0021 XEOTICID XEO01176 MOACRIVE Inhibition DME0021 XEOTICID XEO01177 XEO_NAME 7-methyltryptamine DME0021 XEOTICID XEO01177 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO01177 XEO_CLAS Investigative Agent DME0021 XEOTICID XEO01177 DESCRIPT 7-methyltryptamine inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01177 GENEFORM Protein DME0021 XEOTICID XEO01177 MOACRIVE Inhibition DME0021 XEOTICID XEO01212 XEO_NAME Baicalein DME0021 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0021 XEOTICID XEO01212 XEO_CLAS Natural Product DME0021 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01212 GENEFORM Protein DME0021 XEOTICID XEO01212 MOACRIVE Inhibition DME0021 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0021 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0021 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME CYP2C19 DME0021 XEOTICID XEO01220 GENEFORM mRNA DME0021 XEOTICID XEO01220 MOACRIVE Inhibition DME0021 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0021 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0021 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01226 GENEFORM Protein DME0021 XEOTICID XEO01226 MOACRIVE Inhibition DME0021 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0021 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0021 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0021 XEOTICID XEO01248 DESCRIPT Chlorpyrifos up-regulates the expression of DME CYP2C19 DME0021 XEOTICID XEO01248 GENEFORM mRNA DME0021 XEOTICID XEO01248 MOACRIVE Induction DME0021 XEOTICID XEO01252 XEO_NAME Cinnamic acid DME0021 XEOTICID XEO01252 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO01252 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO01252 DESCRIPT Cinnamic acid inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01252 GENEFORM Protein DME0021 XEOTICID XEO01252 MOACRIVE Inhibition DME0021 XEOTICID XEO01274 XEO_NAME Diazinon DME0021 XEOTICID XEO01274 XEO_TYPE Health or Environmental Toxicant(s) DME0021 XEOTICID XEO01274 XEO_CLAS Environmental Pollutant DME0021 XEOTICID XEO01274 DESCRIPT Diazinon up-regulates the expression of DME CYP2C19 DME0021 XEOTICID XEO01274 GENEFORM mRNA DME0021 XEOTICID XEO01274 MOACRIVE Induction DME0021 XEOTICID XEO01281 XEO_NAME Diosmetin DME0021 XEOTICID XEO01281 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0021 XEOTICID XEO01281 XEO_CLAS Natural Product DME0021 XEOTICID XEO01281 DESCRIPT Diosmetin inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01281 GENEFORM Protein DME0021 XEOTICID XEO01281 MOACRIVE Inhibition DME0021 XEOTICID XEO01313 XEO_NAME Germacrone DME0021 XEOTICID XEO01313 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0021 XEOTICID XEO01313 XEO_CLAS Natural Product DME0021 XEOTICID XEO01313 DESCRIPT Germacrone inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01313 GENEFORM Protein DME0021 XEOTICID XEO01313 MOACRIVE Inhibition DME0021 XEOTICID XEO01345 XEO_NAME Inermin DME0021 XEOTICID XEO01345 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0021 XEOTICID XEO01345 XEO_CLAS Natural Product DME0021 XEOTICID XEO01345 DESCRIPT Inermin inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01345 GENEFORM Protein DME0021 XEOTICID XEO01345 MOACRIVE Inhibition DME0021 XEOTICID XEO01365 XEO_NAME Licochalcone A DME0021 XEOTICID XEO01365 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO01365 XEO_CLAS Drug in Phase 1 Clinical Trial DME0021 XEOTICID XEO01365 DESCRIPT Licochalcone A inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01365 GENEFORM Protein DME0021 XEOTICID XEO01365 MOACRIVE Inhibition DME0021 XEOTICID XEO01367 XEO_NAME Linoleic acid DME0021 XEOTICID XEO01367 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO01367 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO01367 DESCRIPT Linoleic acid inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01367 GENEFORM Protein DME0021 XEOTICID XEO01367 MOACRIVE Inhibition DME0021 XEOTICID XEO01372 XEO_NAME Mepirodipine DME0021 XEOTICID XEO01372 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO01372 XEO_CLAS Approved/Marketed Drug DME0021 XEOTICID XEO01372 DESCRIPT Mepirodipine inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01372 GENEFORM Protein DME0021 XEOTICID XEO01372 MOACRIVE Inhibition DME0021 XEOTICID XEO01388 XEO_NAME N-3-benzylnirvanol DME0021 XEOTICID XEO01388 XEO_TYPE Health or Environmental Toxicant(s) DME0021 XEOTICID XEO01388 XEO_CLAS Environmental Pollutant DME0021 XEOTICID XEO01388 DESCRIPT N-3-benzylnirvanol inhibits the drug-metabolizing activity of DME CYP2C19 (IC50 = 0.138 microM) DME0021 XEOTICID XEO01388 GENEFORM Protein DME0021 XEOTICID XEO01388 MOACRIVE Inhibition DME0021 XEOTICID XEO01389 XEO_NAME N-3-benzylphenobarbital DME0021 XEOTICID XEO01389 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO01389 XEO_CLAS Investigative Agent DME0021 XEOTICID XEO01389 DESCRIPT N-3-benzylphenobarbital inhibits the drug-metabolizing activity of DME CYP2C19 (Ki = 79 microM) DME0021 XEOTICID XEO01389 GENEFORM Protein DME0021 XEOTICID XEO01389 MOACRIVE Inhibition DME0021 XEOTICID XEO01426 XEO_NAME Phencyclidine DME0021 XEOTICID XEO01426 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO01426 XEO_CLAS Drug Marketed but Withdrawn from Market DME0021 XEOTICID XEO01426 DESCRIPT Phencyclidine inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01426 GENEFORM Protein DME0021 XEOTICID XEO01426 MOACRIVE Inhibition DME0021 XEOTICID XEO01472 XEO_NAME Sophoranone DME0021 XEOTICID XEO01472 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0021 XEOTICID XEO01472 XEO_CLAS Natural Product DME0021 XEOTICID XEO01472 DESCRIPT Sophoranone inhibits the expression of DME CYP2C19 DME0021 XEOTICID XEO01472 GENEFORM mRNA DME0021 XEOTICID XEO01472 MOACRIVE Inhibition DME0021 XEOTICID XEO01496 XEO_NAME Ursolic acid DME0021 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME0021 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME0021 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the expression of DME CYP2C19 DME0021 XEOTICID XEO01496 GENEFORM mRNA DME0021 XEOTICID XEO01496 MOACRIVE Inhibition DME0021 XEOTICID XEO01518 XEO_NAME 5-methyltryptamine DME0021 XEOTICID XEO01518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0021 XEOTICID XEO01518 XEO_CLAS Natural Product DME0021 XEOTICID XEO01518 DESCRIPT 5-methyltryptamine inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01518 GENEFORM Protein DME0021 XEOTICID XEO01518 MOACRIVE Inhibition DME0021 XEOTICID XEO01529 XEO_NAME Chrysosplenetin DME0021 XEOTICID XEO01529 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0021 XEOTICID XEO01529 XEO_CLAS Natural Product DME0021 XEOTICID XEO01529 DESCRIPT Chrysosplenetin inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01529 GENEFORM Protein DME0021 XEOTICID XEO01529 MOACRIVE Inhibition DME0021 XEOTICID XEO01541 XEO_NAME Eupatorin DME0021 XEOTICID XEO01541 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0021 XEOTICID XEO01541 XEO_CLAS Natural Product DME0021 XEOTICID XEO01541 DESCRIPT Eupatorin inhibits the drug-metabolizing activity of DME CYP2C19 DME0021 XEOTICID XEO01541 GENEFORM Protein DME0021 XEOTICID XEO01541 MOACRIVE Inhibition DME0021 XEOTICID XEO01573 XEO_NAME Pinostilbene DME0021 XEOTICID XEO01573 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0021 XEOTICID XEO01573 XEO_CLAS Natural Product DME0021 XEOTICID XEO01573 DESCRIPT Pinostilbene inhibits the expression of DME CYP2C19 DME0021 XEOTICID XEO01573 GENEFORM mRNA DME0021 XEOTICID XEO01573 MOACRIVE Inhibition DME0021 XEOTICID XEO01584 XEO_NAME Salvia extract DME0021 XEOTICID XEO01584 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0021 XEOTICID XEO01584 XEO_CLAS Plant Extract DME0021 XEOTICID XEO01584 DESCRIPT Salvia extract inhibits the expression of DME CYP2C19 DME0021 XEOTICID XEO01584 GENEFORM mRNA DME0021 XEOTICID XEO01584 MOACRIVE Inhibition DME0022 DME___ID DME0022 DME0022 DME_NAME Cytochrome P450 3A43 (CYP3A43) DME0022 SPESNAME Homo sapiens DME0022 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0022 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0022 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0022 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME CYP3A43 DME0022 XEOTICID XEO00011 GENEFORM mRNA DME0022 XEOTICID XEO00011 MOACRIVE Induction DME0022 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0022 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0022 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0022 XEOTICID XEO00165 DESCRIPT Obeticholic acid inhibits the drug-metabolizing activity of DME CYP3A43 DME0022 XEOTICID XEO00165 GENEFORM Protein DME0022 XEOTICID XEO00165 MOACRIVE Inhibition DME0022 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0022 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0022 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0022 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME CYP3A43 DME0022 XEOTICID XEO00217 GENEFORM mRNA DME0022 XEOTICID XEO00217 MOACRIVE Induction DME0022 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0022 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0022 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0022 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP3A43 DME0022 XEOTICID XEO00241 GENEFORM mRNA DME0022 XEOTICID XEO00241 MOACRIVE Inhibition DME0022 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0022 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0022 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0022 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME CYP3A43 DME0022 XEOTICID XEO00339 GENEFORM mRNA DME0022 XEOTICID XEO00339 MOACRIVE Induction DME0022 XEOTICID XEO00401 XEO_NAME Beta carotene DME0022 XEOTICID XEO00401 XEO_TYPE Pharmaceutical Agent(s) DME0022 XEOTICID XEO00401 XEO_CLAS Approved/Marketed Drug DME0022 XEOTICID XEO00401 DESCRIPT Beta carotene up-regulates the expression of DME CYP3A43 DME0022 XEOTICID XEO00401 GENEFORM mRNA DME0022 XEOTICID XEO00401 MOACRIVE Induction DME0022 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0022 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0022 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0022 XEOTICID XEO00582 DESCRIPT Diethyltoluamide up-regulates the expression of DME CYP3A43 DME0022 XEOTICID XEO00582 GENEFORM mRNA DME0022 XEOTICID XEO00582 MOACRIVE Induction DME0022 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0022 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0022 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0022 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME CYP3A43 DME0022 XEOTICID XEO00806 GENEFORM mRNA DME0022 XEOTICID XEO00806 MOACRIVE Induction DME0022 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0022 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0022 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0022 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME CYP3A43 DME0022 XEOTICID XEO00905 GENEFORM mRNA DME0022 XEOTICID XEO00905 MOACRIVE Inhibition DME0022 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0022 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0022 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0022 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME CYP3A43 DME0022 XEOTICID XEO01004 GENEFORM mRNA DME0022 XEOTICID XEO01004 MOACRIVE Inhibition DME0022 XEOTICID XEO01302 XEO_NAME Fipronil DME0022 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0022 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0022 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME CYP3A43 DME0022 XEOTICID XEO01302 GENEFORM mRNA DME0022 XEOTICID XEO01302 MOACRIVE Induction DME0022 XEOTICID XEO01585 XEO_NAME Senecionine DME0022 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0022 XEOTICID XEO01585 XEO_CLAS Natural Product DME0022 XEOTICID XEO01585 DESCRIPT Senecionine induces the drug-metabolizing activity of DME CYP3A43 DME0022 XEOTICID XEO01585 GENEFORM Protein DME0022 XEOTICID XEO01585 MOACRIVE Induction DME0023 DME___ID DME0023 DME0023 DME_NAME Cytochrome P450 1B1 (CYP1B1) DME0023 SPESNAME Homo sapiens DME0023 XEOTICID XEO00018 XEO_NAME Cyclophosphamide DME0023 XEOTICID XEO00018 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00018 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00018 DESCRIPT Cyclophosphamide inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO00018 GENEFORM mRNA DME0023 XEOTICID XEO00018 MOACRIVE Inhibition DME0023 XEOTICID XEO00046 XEO_NAME Ifosfamide DME0023 XEOTICID XEO00046 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00046 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00046 DESCRIPT Ifosfamide inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO00046 GENEFORM mRNA DME0023 XEOTICID XEO00046 MOACRIVE Inhibition DME0023 XEOTICID XEO00052 XEO_NAME Lansoprazole DME0023 XEOTICID XEO00052 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00052 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00052 DESCRIPT Lansoprazole up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00052 GENEFORM mRNA DME0023 XEOTICID XEO00052 MOACRIVE Induction DME0023 XEOTICID XEO00053 XEO_NAME Leflunomide DME0023 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00053 GENEFORM mRNA DME0023 XEOTICID XEO00053 MOACRIVE Induction DME0023 XEOTICID XEO00069 XEO_NAME Omeprazole DME0023 XEOTICID XEO00069 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00069 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00069 DESCRIPT Omeprazole up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00069 GENEFORM mRNA DME0023 XEOTICID XEO00069 MOACRIVE Induction DME0023 XEOTICID XEO00079 XEO_NAME Vorinostat DME0023 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00079 DESCRIPT Vorinostat inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO00079 GENEFORM mRNA DME0023 XEOTICID XEO00079 MOACRIVE Inhibition DME0023 XEOTICID XEO00086 XEO_NAME Troglitazone DME0023 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00086 GENEFORM mRNA DME0023 XEOTICID XEO00086 MOACRIVE Induction DME0023 XEOTICID XEO00090 XEO_NAME Estradiol DME0023 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 > 50 microM) DME0023 XEOTICID XEO00090 GENEFORM Protein DME0023 XEOTICID XEO00090 MOACRIVE Inhibition DME0023 XEOTICID XEO00091 XEO_NAME Estrone DME0023 XEOTICID XEO00091 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00091 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00091 DESCRIPT Estrone inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 > 50 microM) DME0023 XEOTICID XEO00091 GENEFORM Protein DME0023 XEOTICID XEO00091 MOACRIVE Inhibition DME0023 XEOTICID XEO00094 XEO_NAME Progesterone DME0023 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00094 DESCRIPT Progesterone inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO00094 GENEFORM mRNA DME0023 XEOTICID XEO00094 MOACRIVE Inhibition DME0023 XEOTICID XEO00102 XEO_NAME Azacitidine DME0023 XEOTICID XEO00102 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00102 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00102 DESCRIPT Azacitidine up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00102 GENEFORM mRNA DME0023 XEOTICID XEO00102 MOACRIVE Induction DME0023 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0023 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00117 GENEFORM mRNA DME0023 XEOTICID XEO00117 MOACRIVE Induction DME0023 XEOTICID XEO00132 XEO_NAME Cidofovir DME0023 XEOTICID XEO00132 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00132 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00132 DESCRIPT Cidofovir up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00132 GENEFORM mRNA DME0023 XEOTICID XEO00132 MOACRIVE Induction DME0023 XEOTICID XEO00147 XEO_NAME Fulvestrant DME0023 XEOTICID XEO00147 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00147 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00147 DESCRIPT Fulvestrant up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00147 GENEFORM mRNA DME0023 XEOTICID XEO00147 MOACRIVE Induction DME0023 XEOTICID XEO00177 XEO_NAME Sulindac DME0023 XEOTICID XEO00177 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00177 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00177 DESCRIPT Sulindac up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00177 GENEFORM mRNA DME0023 XEOTICID XEO00177 MOACRIVE Induction DME0023 XEOTICID XEO00181 XEO_NAME Dasatinib DME0023 XEOTICID XEO00181 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00181 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00181 DESCRIPT Dasatinib up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00181 GENEFORM mRNA DME0023 XEOTICID XEO00181 MOACRIVE Induction DME0023 XEOTICID XEO00193 XEO_NAME Belinostat DME0023 XEOTICID XEO00193 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00193 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00193 DESCRIPT Belinostat up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00193 GENEFORM mRNA DME0023 XEOTICID XEO00193 MOACRIVE Induction DME0023 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0023 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO00217 GENEFORM mRNA DME0023 XEOTICID XEO00217 MOACRIVE Inhibition DME0023 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0023 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO00241 GENEFORM mRNA DME0023 XEOTICID XEO00241 MOACRIVE Inhibition DME0023 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0023 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00251 GENEFORM Protein DME0023 XEOTICID XEO00251 MOACRIVE Inhibition DME0023 XEOTICID XEO00253 XEO_NAME Tretinoin DME0023 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00253 DESCRIPT Tretinoin induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00253 GENEFORM Protein DME0023 XEOTICID XEO00253 MOACRIVE Induction DME0023 XEOTICID XEO00258 XEO_NAME Primaquine DME0023 XEOTICID XEO00258 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00258 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00258 DESCRIPT Primaquine up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00258 GENEFORM mRNA DME0023 XEOTICID XEO00258 MOACRIVE Induction DME0023 XEOTICID XEO00260 XEO_NAME Dinoprostone DME0023 XEOTICID XEO00260 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00260 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00260 DESCRIPT Dinoprostone induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00260 GENEFORM Protein DME0023 XEOTICID XEO00260 MOACRIVE Induction DME0023 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0023 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO00292 GENEFORM mRNA DME0023 XEOTICID XEO00292 MOACRIVE Inhibition DME0023 XEOTICID XEO00334 XEO_NAME Cisplatin DME0023 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00334 GENEFORM mRNA DME0023 XEOTICID XEO00334 MOACRIVE Induction DME0023 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0023 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00339 GENEFORM Protein DME0023 XEOTICID XEO00339 MOACRIVE Inhibition DME0023 XEOTICID XEO00365 XEO_NAME Metformin DME0023 XEOTICID XEO00365 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00365 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00365 DESCRIPT Metformin inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00365 GENEFORM Protein DME0023 XEOTICID XEO00365 MOACRIVE Inhibition DME0023 XEOTICID XEO00372 XEO_NAME Panobinostat DME0023 XEOTICID XEO00372 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00372 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00372 DESCRIPT Panobinostat induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00372 GENEFORM Protein DME0023 XEOTICID XEO00372 MOACRIVE Induction DME0023 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0023 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00380 DESCRIPT Rosiglitazone up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00380 GENEFORM mRNA DME0023 XEOTICID XEO00380 MOACRIVE Induction DME0023 XEOTICID XEO00383 XEO_NAME Tamoxifen DME0023 XEOTICID XEO00383 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00383 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00383 DESCRIPT Tamoxifen up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00383 GENEFORM mRNA DME0023 XEOTICID XEO00383 MOACRIVE Induction DME0023 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0023 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00388 GENEFORM mRNA DME0023 XEOTICID XEO00388 MOACRIVE Induction DME0023 XEOTICID XEO00411 XEO_NAME Avobenzone DME0023 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00411 DESCRIPT Avobenzone inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO00411 GENEFORM mRNA DME0023 XEOTICID XEO00411 MOACRIVE Inhibition DME0023 XEOTICID XEO00428 XEO_NAME Menadione DME0023 XEOTICID XEO00428 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00428 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00428 DESCRIPT Menadione up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00428 GENEFORM mRNA DME0023 XEOTICID XEO00428 MOACRIVE Induction DME0023 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0023 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00430 DESCRIPT Hydroquinone up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00430 GENEFORM mRNA DME0023 XEOTICID XEO00430 MOACRIVE Induction DME0023 XEOTICID XEO00439 XEO_NAME Daidzein DME0023 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00439 GENEFORM Protein DME0023 XEOTICID XEO00439 MOACRIVE Inhibition DME0023 XEOTICID XEO00448 XEO_NAME Stevioside DME0023 XEOTICID XEO00448 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00448 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00448 DESCRIPT Stevioside induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00448 GENEFORM Protein DME0023 XEOTICID XEO00448 MOACRIVE Induction DME0023 XEOTICID XEO00465 XEO_NAME Clodronic acid DME0023 XEOTICID XEO00465 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00465 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00465 DESCRIPT Clodronic acid up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00465 GENEFORM mRNA DME0023 XEOTICID XEO00465 MOACRIVE Induction DME0023 XEOTICID XEO00505 XEO_NAME Melatonin DME0023 XEOTICID XEO00505 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00505 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00505 DESCRIPT Melatonin inhibits the drug-metabolizing activity of DME CYP1B1 (Ki = 14 microM) DME0023 XEOTICID XEO00505 GENEFORM Protein DME0023 XEOTICID XEO00505 MOACRIVE Inhibition DME0023 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0023 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0023 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00536 GENEFORM mRNA DME0023 XEOTICID XEO00536 MOACRIVE Induction DME0023 XEOTICID XEO00537 XEO_NAME Luteolin DME0023 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME0023 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 0.079 microM) DME0023 XEOTICID XEO00537 GENEFORM Protein DME0023 XEOTICID XEO00537 MOACRIVE Inhibition DME0023 XEOTICID XEO00538 XEO_NAME Quercetin DME0023 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0023 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 0.077 microM) DME0023 XEOTICID XEO00538 GENEFORM Protein DME0023 XEOTICID XEO00538 MOACRIVE Inhibition DME0023 XEOTICID XEO00554 XEO_NAME Fingolimod hydrochloride DME0023 XEOTICID XEO00554 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00554 XEO_CLAS Drug in Phase 1 Clinical Trial DME0023 XEOTICID XEO00554 DESCRIPT Fingolimod hydrochloride inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO00554 GENEFORM mRNA DME0023 XEOTICID XEO00554 MOACRIVE Inhibition DME0023 XEOTICID XEO00557 XEO_NAME Genistein DME0023 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0023 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00557 GENEFORM Protein DME0023 XEOTICID XEO00557 MOACRIVE Inhibition DME0023 XEOTICID XEO00560 XEO_NAME Triclosan DME0023 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0023 XEOTICID XEO00560 DESCRIPT Triclosan induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00560 GENEFORM Protein DME0023 XEOTICID XEO00560 MOACRIVE Induction DME0023 XEOTICID XEO00568 XEO_NAME Resveratrol DME0023 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0023 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 55 microM) DME0023 XEOTICID XEO00568 GENEFORM Protein DME0023 XEOTICID XEO00568 MOACRIVE Inhibition DME0023 XEOTICID XEO00573 XEO_NAME Naringenin DME0023 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME0023 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 3.656 microM) DME0023 XEOTICID XEO00573 GENEFORM Protein DME0023 XEOTICID XEO00573 MOACRIVE Inhibition DME0023 XEOTICID XEO00609 XEO_NAME MeIQx DME0023 XEOTICID XEO00609 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00609 XEO_CLAS Drug in Phase 2 Clinical Trial DME0023 XEOTICID XEO00609 DESCRIPT MeIQx up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00609 GENEFORM mRNA DME0023 XEOTICID XEO00609 MOACRIVE Induction DME0023 XEOTICID XEO00610 XEO_NAME Afimoxifene DME0023 XEOTICID XEO00610 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00610 XEO_CLAS Drug in Phase 3 Clinical Trial DME0023 XEOTICID XEO00610 DESCRIPT Afimoxifene inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00610 GENEFORM Protein DME0023 XEOTICID XEO00610 MOACRIVE Inhibition DME0023 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0023 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0023 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00632 GENEFORM Protein DME0023 XEOTICID XEO00632 MOACRIVE Inhibition DME0023 XEOTICID XEO00640 XEO_NAME FK-435 DME0023 XEOTICID XEO00640 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00640 XEO_CLAS Drug in Phase 3 Clinical Trial DME0023 XEOTICID XEO00640 DESCRIPT FK-435 inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00640 GENEFORM Protein DME0023 XEOTICID XEO00640 MOACRIVE Inhibition DME0023 XEOTICID XEO00644 XEO_NAME Isoquercitrin DME0023 XEOTICID XEO00644 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00644 XEO_CLAS Drug in Phase 2 Clinical Trial DME0023 XEOTICID XEO00644 DESCRIPT Isoquercitrin inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00644 GENEFORM Protein DME0023 XEOTICID XEO00644 MOACRIVE Inhibition DME0023 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME0023 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME0023 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00646 GENEFORM Protein DME0023 XEOTICID XEO00646 MOACRIVE Inhibition DME0023 XEOTICID XEO00677 XEO_NAME Stemregenin 1 DME0023 XEOTICID XEO00677 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00677 XEO_CLAS Drug in Phase 2 Clinical Trial DME0023 XEOTICID XEO00677 DESCRIPT Stemregenin 1 inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00677 GENEFORM Protein DME0023 XEOTICID XEO00677 MOACRIVE Inhibition DME0023 XEOTICID XEO00683 XEO_NAME Curcumin DME0023 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0023 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO00683 GENEFORM mRNA DME0023 XEOTICID XEO00683 MOACRIVE Inhibition DME0023 XEOTICID XEO00685 XEO_NAME Aminoflavone DME0023 XEOTICID XEO00685 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00685 XEO_CLAS Drug in Phase 2 Clinical Trial DME0023 XEOTICID XEO00685 DESCRIPT Aminoflavone induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00685 GENEFORM Protein DME0023 XEOTICID XEO00685 MOACRIVE Induction DME0023 XEOTICID XEO00692 XEO_NAME Emodin DME0023 XEOTICID XEO00692 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00692 XEO_CLAS Preclinical/Patented Drug DME0023 XEOTICID XEO00692 DESCRIPT Emodin inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00692 GENEFORM Protein DME0023 XEOTICID XEO00692 MOACRIVE Inhibition DME0023 XEOTICID XEO00710 XEO_NAME Isoliquiritigenin DME0023 XEOTICID XEO00710 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00710 XEO_CLAS Preclinical/Patented Drug DME0023 XEOTICID XEO00710 DESCRIPT Isoliquiritigenin up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00710 GENEFORM mRNA DME0023 XEOTICID XEO00710 MOACRIVE Induction DME0023 XEOTICID XEO00722 XEO_NAME Gardiquimod DME0023 XEOTICID XEO00722 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00722 XEO_CLAS Preclinical/Patented Drug DME0023 XEOTICID XEO00722 DESCRIPT Gardiquimod inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO00722 GENEFORM mRNA DME0023 XEOTICID XEO00722 MOACRIVE Inhibition DME0023 XEOTICID XEO00738 XEO_NAME Flavanone DME0023 XEOTICID XEO00738 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00738 XEO_CLAS Drug in Phase 1 Clinical Trial DME0023 XEOTICID XEO00738 DESCRIPT Flavanone inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00738 GENEFORM Protein DME0023 XEOTICID XEO00738 MOACRIVE Inhibition DME0023 XEOTICID XEO00745 XEO_NAME Adefovir dipivoxil DME0023 XEOTICID XEO00745 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00745 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO00745 DESCRIPT Adefovir dipivoxil up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00745 GENEFORM mRNA DME0023 XEOTICID XEO00745 MOACRIVE Induction DME0023 XEOTICID XEO00755 XEO_NAME Coal tar DME0023 XEOTICID XEO00755 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO00755 XEO_CLAS Natural Mixture DME0023 XEOTICID XEO00755 DESCRIPT Coal tar induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00755 GENEFORM Protein DME0023 XEOTICID XEO00755 MOACRIVE Induction DME0023 XEOTICID XEO00758 XEO_NAME Grape seed proanthocyanidins DME0023 XEOTICID XEO00758 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO00758 XEO_CLAS Plant Extract DME0023 XEOTICID XEO00758 DESCRIPT Grape seed proanthocyanidins inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO00758 GENEFORM mRNA DME0023 XEOTICID XEO00758 MOACRIVE Inhibition DME0023 XEOTICID XEO00760 XEO_NAME Jinfukang DME0023 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0023 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00760 GENEFORM mRNA DME0023 XEOTICID XEO00760 MOACRIVE Induction DME0023 XEOTICID XEO00764 XEO_NAME Naphthalene DME0023 XEOTICID XEO00764 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0023 XEOTICID XEO00764 XEO_CLAS Chemical Compound DME0023 XEOTICID XEO00764 DESCRIPT Naphthalene inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00764 GENEFORM Protein DME0023 XEOTICID XEO00764 MOACRIVE Inhibition DME0023 XEOTICID XEO00768 XEO_NAME Dichlorodiphenyl dichloroethylene DME0023 XEOTICID XEO00768 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO00768 XEO_CLAS Environmental Pollutant DME0023 XEOTICID XEO00768 DESCRIPT Dichlorodiphenyl dichloroethylene up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00768 GENEFORM mRNA DME0023 XEOTICID XEO00768 MOACRIVE Induction DME0023 XEOTICID XEO00784 XEO_NAME Benzo(c)phenanthrene DME0023 XEOTICID XEO00784 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO00784 XEO_CLAS Carcinogen DME0023 XEOTICID XEO00784 DESCRIPT Benzo(c)phenanthrene induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00784 GENEFORM Protein DME0023 XEOTICID XEO00784 MOACRIVE Induction DME0023 XEOTICID XEO00794 XEO_NAME 6-nitrochrysene DME0023 XEOTICID XEO00794 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO00794 XEO_CLAS Environmental Pollutant DME0023 XEOTICID XEO00794 DESCRIPT 6-nitrochrysene up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00794 GENEFORM mRNA DME0023 XEOTICID XEO00794 MOACRIVE Induction DME0023 XEOTICID XEO00797 XEO_NAME Pyrene DME0023 XEOTICID XEO00797 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0023 XEOTICID XEO00797 XEO_CLAS Chemical Compound DME0023 XEOTICID XEO00797 DESCRIPT Pyrene inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 0.002 microM) DME0023 XEOTICID XEO00797 GENEFORM Protein DME0023 XEOTICID XEO00797 MOACRIVE Inhibition DME0023 XEOTICID XEO00809 XEO_NAME Thapsigargin DME0023 XEOTICID XEO00809 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO00809 XEO_CLAS Natural Product DME0023 XEOTICID XEO00809 DESCRIPT Thapsigargin up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00809 GENEFORM mRNA DME0023 XEOTICID XEO00809 MOACRIVE Induction DME0023 XEOTICID XEO00810 XEO_NAME Steviol DME0023 XEOTICID XEO00810 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO00810 XEO_CLAS Natural Product DME0023 XEOTICID XEO00810 DESCRIPT Steviol up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00810 GENEFORM mRNA DME0023 XEOTICID XEO00810 MOACRIVE Induction DME0023 XEOTICID XEO00812 XEO_NAME Fumonisin B1 DME0023 XEOTICID XEO00812 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO00812 XEO_CLAS Mycotoxin DME0023 XEOTICID XEO00812 DESCRIPT Fumonisin B1 induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00812 GENEFORM Protein DME0023 XEOTICID XEO00812 MOACRIVE Induction DME0023 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0023 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0023 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00818 GENEFORM mRNA DME0023 XEOTICID XEO00818 MOACRIVE Induction DME0023 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0023 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0023 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00821 GENEFORM mRNA DME0023 XEOTICID XEO00821 MOACRIVE Induction DME0023 XEOTICID XEO00827 XEO_NAME Polycyclic aromatic hydrocarbon DME0023 XEOTICID XEO00827 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO00827 XEO_CLAS Natural Product DME0023 XEOTICID XEO00827 DESCRIPT Polycyclic aromatic hydrocarbon induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00827 GENEFORM Protein DME0023 XEOTICID XEO00827 MOACRIVE Induction DME0023 XEOTICID XEO00865 XEO_NAME Sanguinarine DME0023 XEOTICID XEO00865 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO00865 XEO_CLAS Natural Product DME0023 XEOTICID XEO00865 DESCRIPT Sanguinarine induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00865 GENEFORM Protein DME0023 XEOTICID XEO00865 MOACRIVE Induction DME0023 XEOTICID XEO00869 XEO_NAME 4-hydroxy-2-nonenal DME0023 XEOTICID XEO00869 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00869 XEO_CLAS Investigative Agent DME0023 XEOTICID XEO00869 DESCRIPT 4-hydroxy-2-nonenal inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO00869 GENEFORM mRNA DME0023 XEOTICID XEO00869 MOACRIVE Inhibition DME0023 XEOTICID XEO00878 XEO_NAME Chrysin DME0023 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO00878 XEO_CLAS Natural Product DME0023 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 0.024 microM) DME0023 XEOTICID XEO00878 GENEFORM Protein DME0023 XEOTICID XEO00878 MOACRIVE Inhibition DME0023 XEOTICID XEO00885 XEO_NAME Eugenol DME0023 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0023 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00885 GENEFORM Protein DME0023 XEOTICID XEO00885 MOACRIVE Inhibition DME0023 XEOTICID XEO00893 XEO_NAME 1-nitropyrene DME0023 XEOTICID XEO00893 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO00893 XEO_CLAS Carcinogen DME0023 XEOTICID XEO00893 DESCRIPT 1-nitropyrene up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00893 GENEFORM mRNA DME0023 XEOTICID XEO00893 MOACRIVE Induction DME0023 XEOTICID XEO00897 XEO_NAME Benz(a)anthracenes DME0023 XEOTICID XEO00897 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO00897 XEO_CLAS Carcinogen DME0023 XEOTICID XEO00897 DESCRIPT Benz(a)anthracenes up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00897 GENEFORM mRNA DME0023 XEOTICID XEO00897 MOACRIVE Induction DME0023 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0023 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0023 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00898 GENEFORM Protein DME0023 XEOTICID XEO00898 MOACRIVE Induction DME0023 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0023 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0023 XEOTICID XEO00899 DESCRIPT Methylcholanthrene up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00899 GENEFORM mRNA DME0023 XEOTICID XEO00899 MOACRIVE Induction DME0023 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0023 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0023 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00905 GENEFORM mRNA DME0023 XEOTICID XEO00905 MOACRIVE Induction DME0023 XEOTICID XEO00907 XEO_NAME Dietary carbohydrates DME0023 XEOTICID XEO00907 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO00907 XEO_CLAS Natural Mixture DME0023 XEOTICID XEO00907 DESCRIPT Dietary carbohydrates up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00907 GENEFORM mRNA DME0023 XEOTICID XEO00907 MOACRIVE Induction DME0023 XEOTICID XEO00913 XEO_NAME 6-nitrobenzo(a)pyrene DME0023 XEOTICID XEO00913 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO00913 XEO_CLAS Health Hazard/Toxicant DME0023 XEOTICID XEO00913 DESCRIPT 6-nitrobenzo(a)pyrene up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00913 GENEFORM mRNA DME0023 XEOTICID XEO00913 MOACRIVE Induction DME0023 XEOTICID XEO00917 XEO_NAME Polychlorinated dibenzodioxin DME0023 XEOTICID XEO00917 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO00917 XEO_CLAS Environmental Pollutant DME0023 XEOTICID XEO00917 DESCRIPT Polychlorinated dibenzodioxin up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00917 GENEFORM mRNA DME0023 XEOTICID XEO00917 MOACRIVE Induction DME0023 XEOTICID XEO00919 XEO_NAME Particulate matter DME0023 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0023 XEOTICID XEO00919 DESCRIPT Particulate matter inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00919 GENEFORM Protein DME0023 XEOTICID XEO00919 MOACRIVE Inhibition DME0023 XEOTICID XEO00925 XEO_NAME BDE-99 DME0023 XEOTICID XEO00925 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO00925 XEO_CLAS Natural Product DME0023 XEOTICID XEO00925 DESCRIPT BDE-99 up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00925 GENEFORM mRNA DME0023 XEOTICID XEO00925 MOACRIVE Induction DME0023 XEOTICID XEO00930 XEO_NAME Butylparaben DME0023 XEOTICID XEO00930 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO00930 XEO_CLAS Investigative Agent DME0023 XEOTICID XEO00930 DESCRIPT Butylparaben up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00930 GENEFORM mRNA DME0023 XEOTICID XEO00930 MOACRIVE Induction DME0023 XEOTICID XEO00955 XEO_NAME Prochloraz DME0023 XEOTICID XEO00955 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0023 XEOTICID XEO00955 XEO_CLAS Fungicide DME0023 XEOTICID XEO00955 DESCRIPT Prochloraz induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00955 GENEFORM Protein DME0023 XEOTICID XEO00955 MOACRIVE Induction DME0023 XEOTICID XEO00958 XEO_NAME Triadimefon DME0023 XEOTICID XEO00958 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0023 XEOTICID XEO00958 XEO_CLAS Fungicide DME0023 XEOTICID XEO00958 DESCRIPT Triadimefon up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00958 GENEFORM mRNA DME0023 XEOTICID XEO00958 MOACRIVE Induction DME0023 XEOTICID XEO00973 XEO_NAME Diuron DME0023 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0023 XEOTICID XEO00973 XEO_CLAS Herbicide DME0023 XEOTICID XEO00973 DESCRIPT Diuron up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO00973 GENEFORM mRNA DME0023 XEOTICID XEO00973 MOACRIVE Induction DME0023 XEOTICID XEO00993 XEO_NAME Alizarin DME0023 XEOTICID XEO00993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO00993 XEO_CLAS Natural Product DME0023 XEOTICID XEO00993 DESCRIPT Alizarin inhibits the drug-metabolizing activity of DME CYP1B1 (Ki = 0.5 microM) DME0023 XEOTICID XEO00993 GENEFORM Protein DME0023 XEOTICID XEO00993 MOACRIVE Inhibition DME0023 XEOTICID XEO00998 XEO_NAME Butylbenzyl phthalate DME0023 XEOTICID XEO00998 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO00998 XEO_CLAS Health Hazard/Toxicant DME0023 XEOTICID XEO00998 DESCRIPT Butylbenzyl phthalate induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO00998 GENEFORM Protein DME0023 XEOTICID XEO00998 MOACRIVE Induction DME0023 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0023 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0023 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME CYP1B1 and leads to increasing the drug-metabolizing activity of this enzyme DME0023 XEOTICID XEO01004 GENEFORM Protein DME0023 XEOTICID XEO01004 MOACRIVE Induction DME0023 XEOTICID XEO01007 XEO_NAME Ethyl benzene DME0023 XEOTICID XEO01007 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO01007 XEO_CLAS Health Hazard/Toxicant DME0023 XEOTICID XEO01007 DESCRIPT Ethyl benzene inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO01007 GENEFORM mRNA DME0023 XEOTICID XEO01007 MOACRIVE Inhibition DME0023 XEOTICID XEO01009 XEO_NAME Glycidamide DME0023 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0023 XEOTICID XEO01009 DESCRIPT Glycidamide inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO01009 GENEFORM mRNA DME0023 XEOTICID XEO01009 MOACRIVE Inhibition DME0023 XEOTICID XEO01033 XEO_NAME Diethyl phthalate DME0023 XEOTICID XEO01033 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01033 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO01033 DESCRIPT Diethyl phthalate up-regulates the expression of DME CYP1B1 and leads to increasing the drug-metabolizing activity of this enzyme DME0023 XEOTICID XEO01033 GENEFORM Protein DME0023 XEOTICID XEO01033 MOACRIVE Induction DME0023 XEOTICID XEO01086 XEO_NAME G-1 DME0023 XEOTICID XEO01086 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01086 XEO_CLAS Investigative Agent DME0023 XEOTICID XEO01086 DESCRIPT G-1 up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01086 GENEFORM mRNA DME0023 XEOTICID XEO01086 MOACRIVE Induction DME0023 XEOTICID XEO01107 XEO_NAME NSC 703786 DME0023 XEOTICID XEO01107 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01107 XEO_CLAS Drug in Phase 1 Clinical Trial DME0023 XEOTICID XEO01107 DESCRIPT NSC 703786 up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01107 GENEFORM mRNA DME0023 XEOTICID XEO01107 MOACRIVE Induction DME0023 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0023 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0023 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01119 GENEFORM Protein DME0023 XEOTICID XEO01119 MOACRIVE Induction DME0023 XEOTICID XEO01125 XEO_NAME 2-ethynylnaphthalene DME0023 XEOTICID XEO01125 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01125 XEO_CLAS Investigative Agent DME0023 XEOTICID XEO01125 DESCRIPT 2-ethynylnaphthalene inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01125 GENEFORM Protein DME0023 XEOTICID XEO01125 MOACRIVE Inhibition DME0023 XEOTICID XEO01126 XEO_NAME 2'-hydroxychalcone DME0023 XEOTICID XEO01126 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01126 XEO_CLAS Investigative Agent DME0023 XEOTICID XEO01126 DESCRIPT 2'-hydroxychalcone inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01126 GENEFORM Protein DME0023 XEOTICID XEO01126 MOACRIVE Inhibition DME0023 XEOTICID XEO01161 XEO_NAME 5-hydroxyflavone DME0023 XEOTICID XEO01161 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01161 XEO_CLAS Natural Product DME0023 XEOTICID XEO01161 DESCRIPT 5-hydroxyflavone inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 0.21 microM) DME0023 XEOTICID XEO01161 GENEFORM Protein DME0023 XEOTICID XEO01161 MOACRIVE Inhibition DME0023 XEOTICID XEO01167 XEO_NAME 6,7-dihydroxyflavone DME0023 XEOTICID XEO01167 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01167 XEO_CLAS Investigative Agent DME0023 XEOTICID XEO01167 DESCRIPT 6,7-dihydroxyflavone inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01167 GENEFORM Protein DME0023 XEOTICID XEO01167 MOACRIVE Inhibition DME0023 XEOTICID XEO01176 XEO_NAME 7-hydroxyflavone DME0023 XEOTICID XEO01176 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01176 XEO_CLAS Natural Product DME0023 XEOTICID XEO01176 DESCRIPT 7-hydroxyflavone inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 0.25 microM) DME0023 XEOTICID XEO01176 GENEFORM Protein DME0023 XEOTICID XEO01176 MOACRIVE Inhibition DME0023 XEOTICID XEO01184 XEO_NAME Acacetin DME0023 XEOTICID XEO01184 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01184 XEO_CLAS Natural Product DME0023 XEOTICID XEO01184 DESCRIPT Acacetin inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 0.007 microM) DME0023 XEOTICID XEO01184 GENEFORM Protein DME0023 XEOTICID XEO01184 MOACRIVE Inhibition DME0023 XEOTICID XEO01191 XEO_NAME Aloe-emodin DME0023 XEOTICID XEO01191 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01191 XEO_CLAS Natural Product DME0023 XEOTICID XEO01191 DESCRIPT Aloe-emodin inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01191 GENEFORM Protein DME0023 XEOTICID XEO01191 MOACRIVE Inhibition DME0023 XEOTICID XEO01192 XEO_NAME Alpha-naphthoflavone DME0023 XEOTICID XEO01192 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01192 XEO_CLAS Natural Product DME0023 XEOTICID XEO01192 DESCRIPT Alpha-naphthof DMElavone inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 0.0013 microM) DME0023 XEOTICID XEO01192 GENEFORM Protein DME0023 XEOTICID XEO01192 MOACRIVE Inhibition DME0023 XEOTICID XEO01195 XEO_NAME Amentoflavone DME0023 XEOTICID XEO01195 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01195 XEO_CLAS Natural Product DME0023 XEOTICID XEO01195 DESCRIPT Amentof DMElavone inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01195 GENEFORM Protein DME0023 XEOTICID XEO01195 MOACRIVE Inhibition DME0023 XEOTICID XEO01203 XEO_NAME Apigenin DME0023 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01203 XEO_CLAS Natural Product DME0023 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 0.025 microM) DME0023 XEOTICID XEO01203 GENEFORM Protein DME0023 XEOTICID XEO01203 MOACRIVE Inhibition DME0023 XEOTICID XEO01212 XEO_NAME Baicalein DME0023 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01212 XEO_CLAS Natural Product DME0023 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of DME CYP1B1 (Ki = 0.26 microM) DME0023 XEOTICID XEO01212 GENEFORM Protein DME0023 XEOTICID XEO01212 MOACRIVE Inhibition DME0023 XEOTICID XEO01218 XEO_NAME Benzyl selenocyanate DME0023 XEOTICID XEO01218 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01218 XEO_CLAS Investigative Agent DME0023 XEOTICID XEO01218 DESCRIPT Benzyl selenocyanate inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 0.13 microM) DME0023 XEOTICID XEO01218 GENEFORM Protein DME0023 XEOTICID XEO01218 MOACRIVE Inhibition DME0023 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0023 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0023 XEOTICID XEO01220 DESCRIPT Beta-naphthof DMElavone inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01220 GENEFORM Protein DME0023 XEOTICID XEO01220 MOACRIVE Inhibition DME0023 XEOTICID XEO01222 XEO_NAME Biochanin A DME0023 XEOTICID XEO01222 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01222 XEO_CLAS Natural Product DME0023 XEOTICID XEO01222 DESCRIPT Biochanin A up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01222 GENEFORM mRNA DME0023 XEOTICID XEO01222 MOACRIVE Induction DME0023 XEOTICID XEO01223 XEO_NAME Biotin DME0023 XEOTICID XEO01223 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01223 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO01223 DESCRIPT Biotin up-regulates the expression of DME CYP1B1 and leads to increasing the drug-metabolizing activity of this enzyme DME0023 XEOTICID XEO01223 GENEFORM Protein DME0023 XEOTICID XEO01223 MOACRIVE Induction DME0023 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0023 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0023 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO01226 GENEFORM mRNA DME0023 XEOTICID XEO01226 MOACRIVE Inhibition DME0023 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0023 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0023 XEOTICID XEO01247 DESCRIPT Chloropicrin up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01247 GENEFORM mRNA DME0023 XEOTICID XEO01247 MOACRIVE Induction DME0023 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0023 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0023 XEOTICID XEO01248 DESCRIPT Chlorpyrifos up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01248 GENEFORM mRNA DME0023 XEOTICID XEO01248 MOACRIVE Induction DME0023 XEOTICID XEO01256 XEO_NAME CL075 DME0023 XEOTICID XEO01256 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01256 XEO_CLAS Investigative Agent DME0023 XEOTICID XEO01256 DESCRIPT CL075 up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01256 GENEFORM mRNA DME0023 XEOTICID XEO01256 MOACRIVE Induction DME0023 XEOTICID XEO01261 XEO_NAME Coumestrol DME0023 XEOTICID XEO01261 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01261 XEO_CLAS Investigative Agent DME0023 XEOTICID XEO01261 DESCRIPT Coumestrol up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01261 GENEFORM mRNA DME0023 XEOTICID XEO01261 MOACRIVE Induction DME0023 XEOTICID XEO01268 XEO_NAME Cycloheximide DME0023 XEOTICID XEO01268 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO01268 XEO_CLAS Acute Toxic Substance DME0023 XEOTICID XEO01268 DESCRIPT Cycloheximide up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01268 GENEFORM mRNA DME0023 XEOTICID XEO01268 MOACRIVE Induction DME0023 XEOTICID XEO01275 XEO_NAME Dibutyl phthalate DME0023 XEOTICID XEO01275 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO01275 XEO_CLAS Health Hazard/Toxicant DME0023 XEOTICID XEO01275 DESCRIPT Dibutyl phthalate up-regulates the expression of DME CYP1B1 and leads to increasing the drug-metabolizing activity of this enzyme DME0023 XEOTICID XEO01275 GENEFORM Protein DME0023 XEOTICID XEO01275 MOACRIVE Induction DME0023 XEOTICID XEO01281 XEO_NAME Diosmetin DME0023 XEOTICID XEO01281 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01281 XEO_CLAS Natural Product DME0023 XEOTICID XEO01281 DESCRIPT Diosmetin inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 0.029 microM) DME0023 XEOTICID XEO01281 GENEFORM Protein DME0023 XEOTICID XEO01281 MOACRIVE Inhibition DME0023 XEOTICID XEO01283 XEO_NAME DMU-212 DME0023 XEOTICID XEO01283 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01283 XEO_CLAS Preclinical/Patented Drug DME0023 XEOTICID XEO01283 DESCRIPT DMU-212 inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01283 GENEFORM Protein DME0023 XEOTICID XEO01283 MOACRIVE Inhibition DME0023 XEOTICID XEO01284 XEO_NAME Dust DME0023 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0023 XEOTICID XEO01284 DESCRIPT Dust inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01284 GENEFORM Protein DME0023 XEOTICID XEO01284 MOACRIVE Inhibition DME0023 XEOTICID XEO01293 XEO_NAME Ethyl isopropylamiloride DME0023 XEOTICID XEO01293 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01293 XEO_CLAS Investigative Agent DME0023 XEOTICID XEO01293 DESCRIPT Ethyl isopropylamiloride inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01293 GENEFORM Protein DME0023 XEOTICID XEO01293 MOACRIVE Inhibition DME0023 XEOTICID XEO01299 XEO_NAME Fatostatin DME0023 XEOTICID XEO01299 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO01299 XEO_CLAS Acute Toxic Substance DME0023 XEOTICID XEO01299 DESCRIPT Fatostatin inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO01299 GENEFORM mRNA DME0023 XEOTICID XEO01299 MOACRIVE Inhibition DME0023 XEOTICID XEO01304 XEO_NAME Flavone DME0023 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01304 XEO_CLAS Natural Product DME0023 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 0.6 microM) DME0023 XEOTICID XEO01304 GENEFORM Protein DME0023 XEOTICID XEO01304 MOACRIVE Inhibition DME0023 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0023 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0023 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO01305 GENEFORM mRNA DME0023 XEOTICID XEO01305 MOACRIVE Inhibition DME0023 XEOTICID XEO01306 XEO_NAME Formononetin DME0023 XEOTICID XEO01306 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01306 XEO_CLAS Approved/Marketed Drug DME0023 XEOTICID XEO01306 DESCRIPT Formononetin up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01306 GENEFORM mRNA DME0023 XEOTICID XEO01306 MOACRIVE Induction DME0023 XEOTICID XEO01308 XEO_NAME Galangin DME0023 XEOTICID XEO01308 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01308 XEO_CLAS Natural Product DME0023 XEOTICID XEO01308 DESCRIPT Galangin inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 0.003 microM) DME0023 XEOTICID XEO01308 GENEFORM Protein DME0023 XEOTICID XEO01308 MOACRIVE Inhibition DME0023 XEOTICID XEO01340 XEO_NAME Imperatorin DME0023 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01340 XEO_CLAS Natural Product DME0023 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of DME CYP1B1 (Ki = 1 microM) DME0023 XEOTICID XEO01340 GENEFORM Protein DME0023 XEOTICID XEO01340 MOACRIVE Inhibition DME0023 XEOTICID XEO01343 XEO_NAME Indolo(3,2-B)carbazole DME0023 XEOTICID XEO01343 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01343 XEO_CLAS Natural Product DME0023 XEOTICID XEO01343 DESCRIPT Indolo(3,2-B)carbazole up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01343 GENEFORM mRNA DME0023 XEOTICID XEO01343 MOACRIVE Induction DME0023 XEOTICID XEO01353 XEO_NAME Kaempferol DME0023 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME0023 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of DME CYP1B1 (IC50 = 0.047 microM) DME0023 XEOTICID XEO01353 GENEFORM Protein DME0023 XEOTICID XEO01353 MOACRIVE Inhibition DME0023 XEOTICID XEO01365 XEO_NAME Licochalcone A DME0023 XEOTICID XEO01365 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01365 XEO_CLAS Drug in Phase 1 Clinical Trial DME0023 XEOTICID XEO01365 DESCRIPT Licochalcone A inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO01365 GENEFORM mRNA DME0023 XEOTICID XEO01365 MOACRIVE Inhibition DME0023 XEOTICID XEO01384 XEO_NAME Myricetin DME0023 XEOTICID XEO01384 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01384 XEO_CLAS Preclinical/Patented Drug DME0023 XEOTICID XEO01384 DESCRIPT Myricetin inhibits the drug-metabolizing activity of DME CYP1B1 (Ki = 0.027 microM) DME0023 XEOTICID XEO01384 GENEFORM Protein DME0023 XEOTICID XEO01384 MOACRIVE Inhibition DME0023 XEOTICID XEO01391 XEO_NAME Naringin DME0023 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01391 XEO_CLAS Natural Product DME0023 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01391 GENEFORM Protein DME0023 XEOTICID XEO01391 MOACRIVE Inhibition DME0023 XEOTICID XEO01394 XEO_NAME NCX-4040 DME0023 XEOTICID XEO01394 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO01394 XEO_CLAS Environmental Pollutant DME0023 XEOTICID XEO01394 DESCRIPT NCX-4040 inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01394 GENEFORM Protein DME0023 XEOTICID XEO01394 MOACRIVE Inhibition DME0023 XEOTICID XEO01400 XEO_NAME NSC-674495 DME0023 XEOTICID XEO01400 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01400 XEO_CLAS Preclinical/Patented Drug DME0023 XEOTICID XEO01400 DESCRIPT NSC-674495 up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01400 GENEFORM mRNA DME0023 XEOTICID XEO01400 MOACRIVE Induction DME0023 XEOTICID XEO01431 XEO_NAME Pifithrin DME0023 XEOTICID XEO01431 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01431 XEO_CLAS Investigative Agent DME0023 XEOTICID XEO01431 DESCRIPT Pifithrin up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01431 GENEFORM mRNA DME0023 XEOTICID XEO01431 MOACRIVE Induction DME0023 XEOTICID XEO01449 XEO_NAME Quercitrin DME0023 XEOTICID XEO01449 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01449 XEO_CLAS Natural Product DME0023 XEOTICID XEO01449 DESCRIPT Quercitrin inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO01449 GENEFORM mRNA DME0023 XEOTICID XEO01449 MOACRIVE Inhibition DME0023 XEOTICID XEO01470 XEO_NAME Scutellarein DME0023 XEOTICID XEO01470 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01470 XEO_CLAS Natural Product DME0023 XEOTICID XEO01470 DESCRIPT Scutellarein inhibits the drug-metabolizing activity of DME CYP1B1 (Ki = 0.22 microM) DME0023 XEOTICID XEO01470 GENEFORM Protein DME0023 XEOTICID XEO01470 MOACRIVE Inhibition DME0023 XEOTICID XEO01476 XEO_NAME STO-609 DME0023 XEOTICID XEO01476 XEO_TYPE Pharmaceutical Agent(s) DME0023 XEOTICID XEO01476 XEO_CLAS Preclinical/Patented Drug DME0023 XEOTICID XEO01476 DESCRIPT STO-609 up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01476 GENEFORM mRNA DME0023 XEOTICID XEO01476 MOACRIVE Induction DME0023 XEOTICID XEO01511 XEO_NAME Vitallium DME0023 XEOTICID XEO01511 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01511 XEO_CLAS Natural Mixture DME0023 XEOTICID XEO01511 DESCRIPT Vitallium up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01511 GENEFORM mRNA DME0023 XEOTICID XEO01511 MOACRIVE Induction DME0023 XEOTICID XEO01514 XEO_NAME Deoxynivalenol DME0023 XEOTICID XEO01514 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO01514 XEO_CLAS Mycotoxin DME0023 XEOTICID XEO01514 DESCRIPT Deoxynivalenol inhibits the expression of DME CYP1B1 DME0023 XEOTICID XEO01514 GENEFORM mRNA DME0023 XEOTICID XEO01514 MOACRIVE Inhibition DME0023 XEOTICID XEO01527 XEO_NAME Bergamottin DME0023 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01527 XEO_CLAS Natural Product DME0023 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of DME CYP1B1 (Ki = 587 microM) DME0023 XEOTICID XEO01527 GENEFORM Protein DME0023 XEOTICID XEO01527 MOACRIVE Inhibition DME0023 XEOTICID XEO01528 XEO_NAME Chrysophanic acid DME0023 XEOTICID XEO01528 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01528 XEO_CLAS Natural Product DME0023 XEOTICID XEO01528 DESCRIPT Chrysophanic acid inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01528 GENEFORM Protein DME0023 XEOTICID XEO01528 MOACRIVE Inhibition DME0023 XEOTICID XEO01541 XEO_NAME Eupatorin DME0023 XEOTICID XEO01541 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01541 XEO_CLAS Natural Product DME0023 XEOTICID XEO01541 DESCRIPT Eupatorin inhibits the drug-metabolizing activity of DME CYP1B1 (Ki = 0.035 microM) DME0023 XEOTICID XEO01541 GENEFORM Protein DME0023 XEOTICID XEO01541 MOACRIVE Inhibition DME0023 XEOTICID XEO01554 XEO_NAME Isoimperatorin DME0023 XEOTICID XEO01554 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01554 XEO_CLAS Natural Product DME0023 XEOTICID XEO01554 DESCRIPT Isoimperatorin inhibits the drug-metabolizing activity of DME CYP1B1 (Ki = 6 microM) DME0023 XEOTICID XEO01554 GENEFORM Protein DME0023 XEOTICID XEO01554 MOACRIVE Inhibition DME0023 XEOTICID XEO01555 XEO_NAME Isopimpinellin DME0023 XEOTICID XEO01555 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01555 XEO_CLAS Natural Product DME0023 XEOTICID XEO01555 DESCRIPT Isopimpinellin inhibits the drug-metabolizing activity of DME CYP1B1 (Ki = 11 microM) DME0023 XEOTICID XEO01555 GENEFORM Protein DME0023 XEOTICID XEO01555 MOACRIVE Inhibition DME0023 XEOTICID XEO01566 XEO_NAME Nobiletin DME0023 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01566 XEO_CLAS Natural Product DME0023 XEOTICID XEO01566 DESCRIPT Nobiletin induces the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01566 GENEFORM Protein DME0023 XEOTICID XEO01566 MOACRIVE Induction DME0023 XEOTICID XEO01574 XEO_NAME Plant extracts DME0023 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0023 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO01574 GENEFORM Protein DME0023 XEOTICID XEO01574 MOACRIVE Inhibition DME0023 XEOTICID XEO01582 XEO_NAME Pyrrolizidine alkaloid DME0023 XEOTICID XEO01582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01582 XEO_CLAS Natural Product DME0023 XEOTICID XEO01582 DESCRIPT Pyrrolizidine alkaloid up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01582 GENEFORM mRNA DME0023 XEOTICID XEO01582 MOACRIVE Induction DME0023 XEOTICID XEO01585 XEO_NAME Senecionine DME0023 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0023 XEOTICID XEO01585 XEO_CLAS Natural Product DME0023 XEOTICID XEO01585 DESCRIPT Senecionine up-regulates the expression of DME CYP1B1 DME0023 XEOTICID XEO01585 GENEFORM mRNA DME0023 XEOTICID XEO01585 MOACRIVE Induction DME0023 XEOTICID XEO03181 XEO_NAME Dichloromethane DME0023 XEOTICID XEO03181 XEO_TYPE Health or Environmental Toxicant(s) DME0023 XEOTICID XEO03181 XEO_CLAS Health Hazard/Toxicant DME0023 XEOTICID XEO03181 DESCRIPT Dichloromethane inhibits the drug-metabolizing activity of DME CYP1B1 DME0023 XEOTICID XEO03181 GENEFORM Protein DME0023 XEOTICID XEO03181 MOACRIVE Inhibition DME0024 DME___ID DME0024 DME0024 DME_NAME Steroid 17-alpha-monooxygenase (CYP17A1) DME0024 SPESNAME Homo sapiens DME0024 XEOTICID XEO00004 XEO_NAME Albuterol DME0024 XEOTICID XEO00004 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00004 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00004 DESCRIPT Albuterol induces the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO00004 GENEFORM Protein DME0024 XEOTICID XEO00004 MOACRIVE Induction DME0024 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0024 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00011 DESCRIPT Carbamazepine inhibits the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO00011 GENEFORM Protein DME0024 XEOTICID XEO00011 MOACRIVE Inhibition DME0024 XEOTICID XEO00029 XEO_NAME Valproic acid DME0024 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME CYP17A1 and leads to increasing the drug-metabolizing activity of this enzyme DME0024 XEOTICID XEO00029 GENEFORM Protein DME0024 XEOTICID XEO00029 MOACRIVE Induction DME0024 XEOTICID XEO00051 XEO_NAME Lamotrigine DME0024 XEOTICID XEO00051 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00051 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00051 DESCRIPT Lamotrigine inhibits the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO00051 GENEFORM Protein DME0024 XEOTICID XEO00051 MOACRIVE Inhibition DME0024 XEOTICID XEO00064 XEO_NAME Mitotane DME0024 XEOTICID XEO00064 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00064 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00064 DESCRIPT Mitotane inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO00064 GENEFORM mRNA DME0024 XEOTICID XEO00064 MOACRIVE Inhibition DME0024 XEOTICID XEO00086 XEO_NAME Troglitazone DME0024 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00086 DESCRIPT Troglitazone inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO00086 GENEFORM mRNA DME0024 XEOTICID XEO00086 MOACRIVE Inhibition DME0024 XEOTICID XEO00095 XEO_NAME Testosterone DME0024 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00095 DESCRIPT Testosterone inhibits the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO00095 GENEFORM Protein DME0024 XEOTICID XEO00095 MOACRIVE Inhibition DME0024 XEOTICID XEO00137 XEO_NAME Venlafaxine hydrochloride DME0024 XEOTICID XEO00137 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00137 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00137 DESCRIPT Venlafaxine hydrochloride inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO00137 GENEFORM mRNA DME0024 XEOTICID XEO00137 MOACRIVE Inhibition DME0024 XEOTICID XEO00187 XEO_NAME Levetiracetam DME0024 XEOTICID XEO00187 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00187 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00187 DESCRIPT Levetiracetam inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO00187 GENEFORM mRNA DME0024 XEOTICID XEO00187 MOACRIVE Inhibition DME0024 XEOTICID XEO00233 XEO_NAME Aminoglutethimide DME0024 XEOTICID XEO00233 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00233 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00233 DESCRIPT Aminoglutethimide inhibits the drug-metabolizing activity of DME CYP17A1 (IC50 = 60 microM) DME0024 XEOTICID XEO00233 GENEFORM Protein DME0024 XEOTICID XEO00233 MOACRIVE Inhibition DME0024 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0024 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO00241 GENEFORM mRNA DME0024 XEOTICID XEO00241 MOACRIVE Inhibition DME0024 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0024 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP17A1 (IC50 = 0.026 microM) DME0024 XEOTICID XEO00251 GENEFORM Protein DME0024 XEOTICID XEO00251 MOACRIVE Inhibition DME0024 XEOTICID XEO00253 XEO_NAME Tretinoin DME0024 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME CYP17A1 DME0024 XEOTICID XEO00253 GENEFORM mRNA DME0024 XEOTICID XEO00253 MOACRIVE Induction DME0024 XEOTICID XEO00260 XEO_NAME Dinoprostone DME0024 XEOTICID XEO00260 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00260 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00260 DESCRIPT Dinoprostone up-regulates the expression of DME CYP17A1 DME0024 XEOTICID XEO00260 GENEFORM mRNA DME0024 XEOTICID XEO00260 MOACRIVE Induction DME0024 XEOTICID XEO00269 XEO_NAME Duloxetine hydrochloride DME0024 XEOTICID XEO00269 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00269 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00269 DESCRIPT Duloxetine hydrochloride inhibits the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO00269 GENEFORM Protein DME0024 XEOTICID XEO00269 MOACRIVE Inhibition DME0024 XEOTICID XEO00275 XEO_NAME Abiraterone acetate DME0024 XEOTICID XEO00275 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00275 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00275 DESCRIPT Abiraterone acetate inhibits the drug-metabolizing activity of DME CYP17A1 (IC50 <= 0.011 microM) DME0024 XEOTICID XEO00275 GENEFORM Protein DME0024 XEOTICID XEO00275 MOACRIVE Inhibition DME0024 XEOTICID XEO00296 XEO_NAME Flurbiprofen sodium DME0024 XEOTICID XEO00296 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00296 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00296 DESCRIPT Flurbiprof DMEen sodium inhibits the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO00296 GENEFORM Protein DME0024 XEOTICID XEO00296 MOACRIVE Inhibition DME0024 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0024 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO00312 GENEFORM mRNA DME0024 XEOTICID XEO00312 MOACRIVE Inhibition DME0024 XEOTICID XEO00319 XEO_NAME Pioglitazone hydrochloride DME0024 XEOTICID XEO00319 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00319 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00319 DESCRIPT Pioglitazone hydrochloride inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO00319 GENEFORM mRNA DME0024 XEOTICID XEO00319 MOACRIVE Inhibition DME0024 XEOTICID XEO00393 XEO_NAME Dehydroepiandrosterone DME0024 XEOTICID XEO00393 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00393 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00393 DESCRIPT Dehydroepiandrosterone inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO00393 GENEFORM mRNA DME0024 XEOTICID XEO00393 MOACRIVE Inhibition DME0024 XEOTICID XEO00406 XEO_NAME Testosterone undecanoate DME0024 XEOTICID XEO00406 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00406 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00406 DESCRIPT Testosterone undecanoate inhibits the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO00406 GENEFORM Protein DME0024 XEOTICID XEO00406 MOACRIVE Inhibition DME0024 XEOTICID XEO00468 XEO_NAME Fadrozole DME0024 XEOTICID XEO00468 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00468 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00468 DESCRIPT Fadrozole inhibits the drug-metabolizing activity of DME CYP17A1 (IC50 > 5 microM) DME0024 XEOTICID XEO00468 GENEFORM Protein DME0024 XEOTICID XEO00468 MOACRIVE Inhibition DME0024 XEOTICID XEO00478 XEO_NAME Pyruvic acid DME0024 XEOTICID XEO00478 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00478 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO00478 DESCRIPT Pyruvic acid up-regulates the expression of DME CYP17A1 DME0024 XEOTICID XEO00478 GENEFORM mRNA DME0024 XEOTICID XEO00478 MOACRIVE Induction DME0024 XEOTICID XEO00568 XEO_NAME Resveratrol DME0024 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0024 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO00568 GENEFORM Protein DME0024 XEOTICID XEO00568 MOACRIVE Inhibition DME0024 XEOTICID XEO00606 XEO_NAME Colforsin DME0024 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0024 XEOTICID XEO00606 DESCRIPT Colforsin up-regulates the expression of DME CYP17A1 DME0024 XEOTICID XEO00606 GENEFORM mRNA DME0024 XEOTICID XEO00606 MOACRIVE Induction DME0024 XEOTICID XEO00672 XEO_NAME TOK-001 DME0024 XEOTICID XEO00672 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00672 XEO_CLAS Drug in Phase 2 Clinical Trial DME0024 XEOTICID XEO00672 DESCRIPT TOK-001 inhibits the drug-metabolizing activity of DME CYP17A1 (IC50 = 0.3 microM) DME0024 XEOTICID XEO00672 GENEFORM Protein DME0024 XEOTICID XEO00672 MOACRIVE Inhibition DME0024 XEOTICID XEO00709 XEO_NAME Antalarmin DME0024 XEOTICID XEO00709 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO00709 XEO_CLAS Preclinical/Patented Drug DME0024 XEOTICID XEO00709 DESCRIPT Antalarmin inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO00709 GENEFORM mRNA DME0024 XEOTICID XEO00709 MOACRIVE Inhibition DME0024 XEOTICID XEO00874 XEO_NAME Androstenedione DME0024 XEOTICID XEO00874 XEO_TYPE Health or Environmental Toxicant(s) DME0024 XEOTICID XEO00874 XEO_CLAS Health Hazard/Toxicant DME0024 XEOTICID XEO00874 DESCRIPT Androstenedione inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO00874 GENEFORM mRNA DME0024 XEOTICID XEO00874 MOACRIVE Inhibition DME0024 XEOTICID XEO00904 XEO_NAME Pentabromophenol DME0024 XEOTICID XEO00904 XEO_TYPE Health or Environmental Toxicant(s) DME0024 XEOTICID XEO00904 XEO_CLAS Acute Toxic Substance DME0024 XEOTICID XEO00904 DESCRIPT Pentabromophenol up-regulates the expression of DME CYP17A1 DME0024 XEOTICID XEO00904 GENEFORM mRNA DME0024 XEOTICID XEO00904 MOACRIVE Induction DME0024 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0024 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0024 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0024 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO00921 GENEFORM mRNA DME0024 XEOTICID XEO00921 MOACRIVE Inhibition DME0024 XEOTICID XEO00924 XEO_NAME Water pollutants chemical DME0024 XEOTICID XEO00924 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0024 XEOTICID XEO00924 XEO_CLAS Natural Mixture DME0024 XEOTICID XEO00924 DESCRIPT Water pollutants chemical up-regulates the expression of DME CYP17A1 DME0024 XEOTICID XEO00924 GENEFORM mRNA DME0024 XEOTICID XEO00924 MOACRIVE Induction DME0024 XEOTICID XEO00939 XEO_NAME Benomyl DME0024 XEOTICID XEO00939 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0024 XEOTICID XEO00939 XEO_CLAS Fungicide DME0024 XEOTICID XEO00939 DESCRIPT Benomyl inhibits the expression of DME CYP17A1 and leads to decreasing the drug-metabolizing activity of this enzyme DME0024 XEOTICID XEO00939 GENEFORM Protein DME0024 XEOTICID XEO00939 MOACRIVE Inhibition DME0024 XEOTICID XEO00955 XEO_NAME Prochloraz DME0024 XEOTICID XEO00955 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0024 XEOTICID XEO00955 XEO_CLAS Fungicide DME0024 XEOTICID XEO00955 DESCRIPT Prochloraz inhibits the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO00955 GENEFORM Protein DME0024 XEOTICID XEO00955 MOACRIVE Inhibition DME0024 XEOTICID XEO00984 XEO_NAME Galaxolide DME0024 XEOTICID XEO00984 XEO_TYPE Health or Environmental Toxicant(s) DME0024 XEOTICID XEO00984 XEO_CLAS Environmental Pollutant DME0024 XEOTICID XEO00984 DESCRIPT Galaxolide inhibits the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO00984 GENEFORM Protein DME0024 XEOTICID XEO00984 MOACRIVE Inhibition DME0024 XEOTICID XEO01040 XEO_NAME Bifenthrin DME0024 XEOTICID XEO01040 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0024 XEOTICID XEO01040 XEO_CLAS Pesticide/Insecticide DME0024 XEOTICID XEO01040 DESCRIPT Bifenthrin up-regulates the expression of DME CYP17A1 DME0024 XEOTICID XEO01040 GENEFORM mRNA DME0024 XEOTICID XEO01040 MOACRIVE Induction DME0024 XEOTICID XEO01110 XEO_NAME p,p'-Hydroxy-DDT DME0024 XEOTICID XEO01110 XEO_TYPE Health or Environmental Toxicant(s) DME0024 XEOTICID XEO01110 XEO_CLAS Environmental Pollutant DME0024 XEOTICID XEO01110 DESCRIPT p,p'-Hydroxy-DDT inhibits the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO01110 GENEFORM Protein DME0024 XEOTICID XEO01110 MOACRIVE Inhibition DME0024 XEOTICID XEO01121 XEO_NAME 2-bromophenol DME0024 XEOTICID XEO01121 XEO_TYPE Health or Environmental Toxicant(s) DME0024 XEOTICID XEO01121 XEO_CLAS Environmental Pollutant DME0024 XEOTICID XEO01121 DESCRIPT 2-bromophenol up-regulates the expression of DME CYP17A1 DME0024 XEOTICID XEO01121 GENEFORM mRNA DME0024 XEOTICID XEO01121 MOACRIVE Induction DME0024 XEOTICID XEO01133 XEO_NAME 3,3',4,5'-tetrahydroxystilbene DME0024 XEOTICID XEO01133 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO01133 XEO_CLAS Investigative Agent DME0024 XEOTICID XEO01133 DESCRIPT 3,3',4,5'-tetrahydroxystilbene inhibits the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO01133 GENEFORM Protein DME0024 XEOTICID XEO01133 MOACRIVE Inhibition DME0024 XEOTICID XEO01192 XEO_NAME Alpha-naphthoflavone DME0024 XEOTICID XEO01192 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0024 XEOTICID XEO01192 XEO_CLAS Natural Product DME0024 XEOTICID XEO01192 DESCRIPT Alpha-naphthoflavone inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO01192 GENEFORM mRNA DME0024 XEOTICID XEO01192 MOACRIVE Inhibition DME0024 XEOTICID XEO01210 XEO_NAME Astressin DME0024 XEOTICID XEO01210 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO01210 XEO_CLAS Investigative Agent DME0024 XEOTICID XEO01210 DESCRIPT Astressin inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO01210 GENEFORM mRNA DME0024 XEOTICID XEO01210 MOACRIVE Inhibition DME0024 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0024 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0024 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO01226 GENEFORM Protein DME0024 XEOTICID XEO01226 MOACRIVE Inhibition DME0024 XEOTICID XEO01252 XEO_NAME Cinnamic acid DME0024 XEOTICID XEO01252 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO01252 XEO_CLAS Approved/Marketed Drug DME0024 XEOTICID XEO01252 DESCRIPT Cinnamic acid inhibits the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO01252 GENEFORM Protein DME0024 XEOTICID XEO01252 MOACRIVE Inhibition DME0024 XEOTICID XEO01289 XEO_NAME Enniatins DME0024 XEOTICID XEO01289 XEO_TYPE Health or Environmental Toxicant(s) DME0024 XEOTICID XEO01289 XEO_CLAS Acute Toxic Substance DME0024 XEOTICID XEO01289 DESCRIPT Enniatins inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO01289 GENEFORM mRNA DME0024 XEOTICID XEO01289 MOACRIVE Inhibition DME0024 XEOTICID XEO01445 XEO_NAME Pyrazolanthrone DME0024 XEOTICID XEO01445 XEO_TYPE Pharmaceutical Agent(s) DME0024 XEOTICID XEO01445 XEO_CLAS Investigative Agent DME0024 XEOTICID XEO01445 DESCRIPT Pyrazolanthrone induces the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO01445 GENEFORM Protein DME0024 XEOTICID XEO01445 MOACRIVE Induction DME0024 XEOTICID XEO01514 XEO_NAME Deoxynivalenol DME0024 XEOTICID XEO01514 XEO_TYPE Health or Environmental Toxicant(s) DME0024 XEOTICID XEO01514 XEO_CLAS Mycotoxin DME0024 XEOTICID XEO01514 DESCRIPT Deoxynivalenol up-regulates the expression of DME CYP17A1 DME0024 XEOTICID XEO01514 GENEFORM mRNA DME0024 XEOTICID XEO01514 MOACRIVE Induction DME0024 XEOTICID XEO01515 XEO_NAME HT-2 toxin DME0024 XEOTICID XEO01515 XEO_TYPE Health or Environmental Toxicant(s) DME0024 XEOTICID XEO01515 XEO_CLAS Mycotoxin DME0024 XEOTICID XEO01515 DESCRIPT HT-2 toxin inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO01515 GENEFORM mRNA DME0024 XEOTICID XEO01515 MOACRIVE Inhibition DME0024 XEOTICID XEO01574 XEO_NAME Plant extracts DME0024 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0024 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0024 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME CYP17A1 DME0024 XEOTICID XEO01574 GENEFORM Protein DME0024 XEOTICID XEO01574 MOACRIVE Inhibition DME0024 XEOTICID XEO01612 XEO_NAME 2-acetyltributylcitrate DME0024 XEOTICID XEO01612 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0024 XEOTICID XEO01612 XEO_CLAS Cosmetic Additive DME0024 XEOTICID XEO01612 DESCRIPT 2-acetyltributylcitrate inhibits the expression of DME CYP17A1 DME0024 XEOTICID XEO01612 GENEFORM mRNA DME0024 XEOTICID XEO01612 MOACRIVE Inhibition DME0025 DME___ID DME0025 DME0025 DME_NAME Cytochrome P450 4F2 (CYP4F2) DME0025 SPESNAME Homo sapiens DME0025 XEOTICID XEO00090 XEO_NAME Estradiol DME0025 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0025 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0025 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME CYP4F2 DME0025 XEOTICID XEO00090 GENEFORM mRNA DME0025 XEOTICID XEO00090 MOACRIVE Inhibition DME0025 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0025 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0025 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0025 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME CYP4F2 DME0025 XEOTICID XEO00186 GENEFORM mRNA DME0025 XEOTICID XEO00186 MOACRIVE Inhibition DME0025 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0025 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0025 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0025 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP4F2 DME0025 XEOTICID XEO00217 GENEFORM mRNA DME0025 XEOTICID XEO00217 MOACRIVE Inhibition DME0025 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0025 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0025 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0025 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP4F2 DME0025 XEOTICID XEO00241 GENEFORM mRNA DME0025 XEOTICID XEO00241 MOACRIVE Inhibition DME0025 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0025 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0025 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0025 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP4F2 (IC50 = 1.6 microM) DME0025 XEOTICID XEO00251 GENEFORM Protein DME0025 XEOTICID XEO00251 MOACRIVE Inhibition DME0025 XEOTICID XEO00392 XEO_NAME Vincristine DME0025 XEOTICID XEO00392 XEO_TYPE Pharmaceutical Agent(s) DME0025 XEOTICID XEO00392 XEO_CLAS Approved/Marketed Drug DME0025 XEOTICID XEO00392 DESCRIPT Vincristine up-regulates the expression of DME CYP4F2 DME0025 XEOTICID XEO00392 GENEFORM mRNA DME0025 XEOTICID XEO00392 MOACRIVE Induction DME0025 XEOTICID XEO00466 XEO_NAME Demecolcine DME0025 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0025 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0025 XEOTICID XEO00466 DESCRIPT Demecolcine up-regulates the expression of DME CYP4F2 DME0025 XEOTICID XEO00466 GENEFORM mRNA DME0025 XEOTICID XEO00466 MOACRIVE Induction DME0025 XEOTICID XEO00539 XEO_NAME Ethanol DME0025 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0025 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0025 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the drug-metabolizing activity of DME CYP4F2 DME0025 XEOTICID XEO00539 GENEFORM Protein DME0025 XEOTICID XEO00539 MOACRIVE Inhibition DME0025 XEOTICID XEO00557 XEO_NAME Genistein DME0025 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0025 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0025 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME CYP4F2 DME0025 XEOTICID XEO00557 GENEFORM mRNA DME0025 XEOTICID XEO00557 MOACRIVE Induction DME0025 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0025 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0025 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0025 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME CYP4F2 DME0025 XEOTICID XEO00772 GENEFORM mRNA DME0025 XEOTICID XEO00772 MOACRIVE Induction DME0025 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0025 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0025 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0025 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYP4F2 DME0025 XEOTICID XEO00806 GENEFORM mRNA DME0025 XEOTICID XEO00806 MOACRIVE Inhibition DME0025 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0025 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0025 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0025 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME CYP4F2 DME0025 XEOTICID XEO00898 GENEFORM mRNA DME0025 XEOTICID XEO00898 MOACRIVE Inhibition DME0025 XEOTICID XEO01123 XEO_NAME GW9662 DME0025 XEOTICID XEO01123 XEO_TYPE Pharmaceutical Agent(s) DME0025 XEOTICID XEO01123 XEO_CLAS Investigative Agent DME0025 XEOTICID XEO01123 DESCRIPT GW9662 inhibits the drug-metabolizing activity of DME CYP4F2 DME0025 XEOTICID XEO01123 GENEFORM Protein DME0025 XEOTICID XEO01123 MOACRIVE Inhibition DME0025 XEOTICID XEO01183 XEO_NAME A-769662 DME0025 XEOTICID XEO01183 XEO_TYPE Pharmaceutical Agent(s) DME0025 XEOTICID XEO01183 XEO_CLAS Preclinical/Patented Drug DME0025 XEOTICID XEO01183 DESCRIPT A-769662 up-regulates the expression of DME CYP4F2 DME0025 XEOTICID XEO01183 GENEFORM mRNA DME0025 XEOTICID XEO01183 MOACRIVE Induction DME0025 XEOTICID XEO01190 XEO_NAME Aica ribonucleotide DME0025 XEOTICID XEO01190 XEO_TYPE Pharmaceutical Agent(s) DME0025 XEOTICID XEO01190 XEO_CLAS Drug in Phase 1 Clinical Trial DME0025 XEOTICID XEO01190 DESCRIPT Aica ribonucleotide up-regulates the expression of DME CYP4F2 DME0025 XEOTICID XEO01190 GENEFORM mRNA DME0025 XEOTICID XEO01190 MOACRIVE Induction DME0025 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0025 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0025 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0025 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME CYP4F2 DME0025 XEOTICID XEO01305 GENEFORM mRNA DME0025 XEOTICID XEO01305 MOACRIVE Induction DME0025 XEOTICID XEO01386 XEO_NAME TS-011 DME0025 XEOTICID XEO01386 XEO_TYPE Pharmaceutical Agent(s) DME0025 XEOTICID XEO01386 XEO_CLAS Preclinical/Patented Drug DME0025 XEOTICID XEO01386 DESCRIPT TS-011 inhibits the drug-metabolizing activity of DME CYP4F2 DME0025 XEOTICID XEO01386 GENEFORM Protein DME0025 XEOTICID XEO01386 MOACRIVE Inhibition DME0025 XEOTICID XEO01478 XEO_NAME Sulforafan DME0025 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0025 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0025 XEOTICID XEO01478 DESCRIPT Sulforafan induces the drug-metabolizing activity of DME CYP4F2 DME0025 XEOTICID XEO01478 GENEFORM Protein DME0025 XEOTICID XEO01478 MOACRIVE Induction DME0026 DME___ID DME0026 DME0026 DME_NAME Vitamin D(3) 25-hydroxylase (CYP27A1) DME0026 SPESNAME Homo sapiens DME0026 XEOTICID XEO00029 XEO_NAME Valproic acid DME0026 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0026 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the drug-metabolizing activity of DME CYP27A1 DME0026 XEOTICID XEO00029 GENEFORM Protein DME0026 XEOTICID XEO00029 MOACRIVE Inhibition DME0026 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0026 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0026 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME CYP27A1 DME0026 XEOTICID XEO00088 GENEFORM mRNA DME0026 XEOTICID XEO00088 MOACRIVE Induction DME0026 XEOTICID XEO00097 XEO_NAME Cytarabine DME0026 XEOTICID XEO00097 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO00097 XEO_CLAS Approved/Marketed Drug DME0026 XEOTICID XEO00097 DESCRIPT Cytarabine inhibits the expression of DME CYP27A1 DME0026 XEOTICID XEO00097 GENEFORM mRNA DME0026 XEOTICID XEO00097 MOACRIVE Inhibition DME0026 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0026 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0026 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME CYP27A1 DME0026 XEOTICID XEO00117 GENEFORM mRNA DME0026 XEOTICID XEO00117 MOACRIVE Inhibition DME0026 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0026 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0026 XEOTICID XEO00167 DESCRIPT Alitretinoin inhibits the expression of DME CYP27A1 DME0026 XEOTICID XEO00167 GENEFORM mRNA DME0026 XEOTICID XEO00167 MOACRIVE Inhibition DME0026 XEOTICID XEO00184 XEO_NAME Calcitriol DME0026 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0026 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME CYP27A1 DME0026 XEOTICID XEO00184 GENEFORM mRNA DME0026 XEOTICID XEO00184 MOACRIVE Inhibition DME0026 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0026 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0026 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME CYP27A1 DME0026 XEOTICID XEO00186 GENEFORM mRNA DME0026 XEOTICID XEO00186 MOACRIVE Inhibition DME0026 XEOTICID XEO00188 XEO_NAME Sirolimus DME0026 XEOTICID XEO00188 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO00188 XEO_CLAS Approved/Marketed Drug DME0026 XEOTICID XEO00188 DESCRIPT Sirolimus inhibits the expression of DME CYP27A1 DME0026 XEOTICID XEO00188 GENEFORM mRNA DME0026 XEOTICID XEO00188 MOACRIVE Inhibition DME0026 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0026 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0026 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP27A1 DME0026 XEOTICID XEO00217 GENEFORM mRNA DME0026 XEOTICID XEO00217 MOACRIVE Inhibition DME0026 XEOTICID XEO00223 XEO_NAME Rifampin DME0026 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0026 XEOTICID XEO00223 DESCRIPT Rifampin induces the drug-metabolizing activity of DME CYP27A1 DME0026 XEOTICID XEO00223 GENEFORM Protein DME0026 XEOTICID XEO00223 MOACRIVE Induction DME0026 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0026 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0026 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the drug-metabolizing activity of DME CYP27A1 DME0026 XEOTICID XEO00241 GENEFORM Protein DME0026 XEOTICID XEO00241 MOACRIVE Inhibition DME0026 XEOTICID XEO00340 XEO_NAME Atorvastatin DME0026 XEOTICID XEO00340 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO00340 XEO_CLAS Approved/Marketed Drug DME0026 XEOTICID XEO00340 DESCRIPT Atorvastatin inhibits the drug-metabolizing activity of DME CYP27A1 DME0026 XEOTICID XEO00340 GENEFORM Protein DME0026 XEOTICID XEO00340 MOACRIVE Inhibition DME0026 XEOTICID XEO00740 XEO_NAME Lindane DME0026 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0026 XEOTICID XEO00740 DESCRIPT Lindane up-regulates the expression of DME CYP27A1 DME0026 XEOTICID XEO00740 GENEFORM mRNA DME0026 XEOTICID XEO00740 MOACRIVE Induction DME0026 XEOTICID XEO00768 XEO_NAME Dichlorodiphenyl dichloroethylene DME0026 XEOTICID XEO00768 XEO_TYPE Health or Environmental Toxicant(s) DME0026 XEOTICID XEO00768 XEO_CLAS Environmental Pollutant DME0026 XEOTICID XEO00768 DESCRIPT Dichlorodiphenyl dichloroethylene up-regulates the expression of DME CYP27A1 DME0026 XEOTICID XEO00768 GENEFORM mRNA DME0026 XEOTICID XEO00768 MOACRIVE Induction DME0026 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0026 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0026 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0026 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYP27A1 DME0026 XEOTICID XEO00806 GENEFORM mRNA DME0026 XEOTICID XEO00806 MOACRIVE Inhibition DME0026 XEOTICID XEO00885 XEO_NAME Eugenol DME0026 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0026 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the expression of DME CYP27A1 DME0026 XEOTICID XEO00885 GENEFORM mRNA DME0026 XEOTICID XEO00885 MOACRIVE Inhibition DME0026 XEOTICID XEO00969 XEO_NAME Atrazine DME0026 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0026 XEOTICID XEO00969 XEO_CLAS Herbicide DME0026 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME CYP27A1 DME0026 XEOTICID XEO00969 GENEFORM mRNA DME0026 XEOTICID XEO00969 MOACRIVE Induction DME0026 XEOTICID XEO01123 XEO_NAME GW9662 DME0026 XEOTICID XEO01123 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO01123 XEO_CLAS Investigative Agent DME0026 XEOTICID XEO01123 DESCRIPT GW9662 inhibits the drug-metabolizing activity of DME CYP27A1 DME0026 XEOTICID XEO01123 GENEFORM Protein DME0026 XEOTICID XEO01123 MOACRIVE Inhibition DME0026 XEOTICID XEO01154 XEO_NAME 4-oxoretinoic acid DME0026 XEOTICID XEO01154 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0026 XEOTICID XEO01154 XEO_CLAS Natural Product DME0026 XEOTICID XEO01154 DESCRIPT 4-oxoretinoic acid inhibits the expression of DME CYP27A1 DME0026 XEOTICID XEO01154 GENEFORM mRNA DME0026 XEOTICID XEO01154 MOACRIVE Inhibition DME0026 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0026 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0026 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0026 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME CYP27A1 DME0026 XEOTICID XEO01226 GENEFORM mRNA DME0026 XEOTICID XEO01226 MOACRIVE Induction DME0026 XEOTICID XEO01317 XEO_NAME Glyceryl 2-arachidonate DME0026 XEOTICID XEO01317 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0026 XEOTICID XEO01317 XEO_CLAS Natural Product DME0026 XEOTICID XEO01317 DESCRIPT Glyceryl 2-arachidonate up-regulates the expression of DME CYP27A1 DME0026 XEOTICID XEO01317 GENEFORM mRNA DME0026 XEOTICID XEO01317 MOACRIVE Induction DME0026 XEOTICID XEO01366 XEO_NAME Linalool DME0026 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0026 XEOTICID XEO01366 XEO_CLAS Natural Product DME0026 XEOTICID XEO01366 DESCRIPT Linalool up-regulates the expression of DME CYP27A1 DME0026 XEOTICID XEO01366 GENEFORM mRNA DME0026 XEOTICID XEO01366 MOACRIVE Induction DME0026 XEOTICID XEO01511 XEO_NAME Vitallium DME0026 XEOTICID XEO01511 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0026 XEOTICID XEO01511 XEO_CLAS Natural Mixture DME0026 XEOTICID XEO01511 DESCRIPT Vitallium up-regulates the expression of DME CYP27A1 DME0026 XEOTICID XEO01511 GENEFORM mRNA DME0026 XEOTICID XEO01511 MOACRIVE Induction DME0026 XEOTICID XEO01582 XEO_NAME Pyrrolizidine alkaloid DME0026 XEOTICID XEO01582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0026 XEOTICID XEO01582 XEO_CLAS Natural Product DME0026 XEOTICID XEO01582 DESCRIPT Pyrrolizidine alkaloid inhibits the expression of DME CYP27A1 DME0026 XEOTICID XEO01582 GENEFORM mRNA DME0026 XEOTICID XEO01582 MOACRIVE Inhibition DME0027 DME___ID DME0027 DME0027 DME_NAME Steroid 11-beta-hydroxylase (CYP11B1) DME0027 SPESNAME Homo sapiens DME0027 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0027 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0027 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0027 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP11B1 (IC50 = 0.116 microM) DME0027 XEOTICID XEO00251 GENEFORM Protein DME0027 XEOTICID XEO00251 MOACRIVE Inhibition DME0027 XEOTICID XEO00468 XEO_NAME Fadrozole DME0027 XEOTICID XEO00468 XEO_TYPE Pharmaceutical Agent(s) DME0027 XEOTICID XEO00468 XEO_CLAS Approved/Marketed Drug DME0027 XEOTICID XEO00468 DESCRIPT Fadrozole inhibits the drug-metabolizing activity of DME CYP11B1 (IC50 = 0.0063 microM) DME0027 XEOTICID XEO00468 GENEFORM Protein DME0027 XEOTICID XEO00468 MOACRIVE Inhibition DME0027 XEOTICID XEO00539 XEO_NAME Ethanol DME0027 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0027 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0027 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the expression of DME CYP11B1 DME0027 XEOTICID XEO00539 GENEFORM mRNA DME0027 XEOTICID XEO00539 MOACRIVE Inhibition DME0027 XEOTICID XEO00561 XEO_NAME Anacetrapib DME0027 XEOTICID XEO00561 XEO_TYPE Pharmaceutical Agent(s) DME0027 XEOTICID XEO00561 XEO_CLAS Drug in Phase 3 Clinical Trial DME0027 XEOTICID XEO00561 DESCRIPT Anacetrapib up-regulates the expression of DME CYP11B1 DME0027 XEOTICID XEO00561 GENEFORM mRNA DME0027 XEOTICID XEO00561 MOACRIVE Induction DME0027 XEOTICID XEO00564 XEO_NAME Dalcetrapib DME0027 XEOTICID XEO00564 XEO_TYPE Pharmaceutical Agent(s) DME0027 XEOTICID XEO00564 XEO_CLAS Drug in Phase 3 Clinical Trial DME0027 XEOTICID XEO00564 DESCRIPT Dalcetrapib up-regulates the expression of DME CYP11B1 DME0027 XEOTICID XEO00564 GENEFORM mRNA DME0027 XEOTICID XEO00564 MOACRIVE Induction DME0027 XEOTICID XEO00606 XEO_NAME Colforsin DME0027 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0027 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0027 XEOTICID XEO00606 DESCRIPT Colforsin induces the drug-metabolizing activity of DME CYP11B1 DME0027 XEOTICID XEO00606 GENEFORM Protein DME0027 XEOTICID XEO00606 MOACRIVE Induction DME0027 XEOTICID XEO00697 XEO_NAME Tetramethylpyrazine DME0027 XEOTICID XEO00697 XEO_TYPE Pharmaceutical Agent(s) DME0027 XEOTICID XEO00697 XEO_CLAS Preclinical/Patented Drug DME0027 XEOTICID XEO00697 DESCRIPT Tetramethylpyrazine up-regulates the expression of DME CYP11B1 DME0027 XEOTICID XEO00697 GENEFORM mRNA DME0027 XEOTICID XEO00697 MOACRIVE Induction DME0027 XEOTICID XEO00955 XEO_NAME Prochloraz DME0027 XEOTICID XEO00955 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0027 XEOTICID XEO00955 XEO_CLAS Fungicide DME0027 XEOTICID XEO00955 DESCRIPT Prochloraz inhibits the drug-metabolizing activity of DME CYP11B1 DME0027 XEOTICID XEO00955 GENEFORM Protein DME0027 XEOTICID XEO00955 MOACRIVE Inhibition DME0027 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0027 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0027 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0027 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME CYP11B1 DME0027 XEOTICID XEO01004 GENEFORM mRNA DME0027 XEOTICID XEO01004 MOACRIVE Inhibition DME0027 XEOTICID XEO01100 XEO_NAME 3-Methylsulfonyl-dde DME0027 XEOTICID XEO01100 XEO_TYPE Health or Environmental Toxicant(s) DME0027 XEOTICID XEO01100 XEO_CLAS Environmental Pollutant DME0027 XEOTICID XEO01100 DESCRIPT 3-Methylsulfonyl-dde up-regulates the expression of DME CYP11B1 DME0027 XEOTICID XEO01100 GENEFORM mRNA DME0027 XEOTICID XEO01100 MOACRIVE Induction DME0027 XEOTICID XEO01192 XEO_NAME Alpha-naphthoflavone DME0027 XEOTICID XEO01192 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0027 XEOTICID XEO01192 XEO_CLAS Natural Product DME0027 XEOTICID XEO01192 DESCRIPT Alpha-naphthoflavone up-regulates the expression of DME CYP11B1 DME0027 XEOTICID XEO01192 GENEFORM mRNA DME0027 XEOTICID XEO01192 MOACRIVE Induction DME0027 XEOTICID XEO01203 XEO_NAME Apigenin DME0027 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0027 XEOTICID XEO01203 XEO_CLAS Natural Product DME0027 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the expression of DME CYP11B1 DME0027 XEOTICID XEO01203 GENEFORM mRNA DME0027 XEOTICID XEO01203 MOACRIVE Inhibition DME0027 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0027 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0027 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0027 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME CYP11B1 DME0027 XEOTICID XEO01220 GENEFORM mRNA DME0027 XEOTICID XEO01220 MOACRIVE Induction DME0027 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0027 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0027 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0027 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME CYP11B1 DME0027 XEOTICID XEO01226 GENEFORM mRNA DME0027 XEOTICID XEO01226 MOACRIVE Induction DME0027 XEOTICID XEO01264 XEO_NAME Cyadox DME0027 XEOTICID XEO01264 XEO_TYPE Pharmaceutical Agent(s) DME0027 XEOTICID XEO01264 XEO_CLAS Investigative Agent DME0027 XEOTICID XEO01264 DESCRIPT Cyadox inhibits the expression of DME CYP11B1 DME0027 XEOTICID XEO01264 GENEFORM mRNA DME0027 XEOTICID XEO01264 MOACRIVE Inhibition DME0027 XEOTICID XEO01267 XEO_NAME Cyclic AMP DME0027 XEOTICID XEO01267 XEO_TYPE Pharmaceutical Agent(s) DME0027 XEOTICID XEO01267 XEO_CLAS Drug in Phase 1 Clinical Trial DME0027 XEOTICID XEO01267 DESCRIPT Cyclic AMP up-regulates the expression of DME CYP11B1 DME0027 XEOTICID XEO01267 GENEFORM mRNA DME0027 XEOTICID XEO01267 MOACRIVE Induction DME0027 XEOTICID XEO01289 XEO_NAME Enniatins DME0027 XEOTICID XEO01289 XEO_TYPE Health or Environmental Toxicant(s) DME0027 XEOTICID XEO01289 XEO_CLAS Acute Toxic Substance DME0027 XEOTICID XEO01289 DESCRIPT Enniatins up-regulates the expression of DME CYP11B1 DME0027 XEOTICID XEO01289 GENEFORM mRNA DME0027 XEOTICID XEO01289 MOACRIVE Induction DME0027 XEOTICID XEO01373 XEO_NAME Mequindox DME0027 XEOTICID XEO01373 XEO_TYPE Pharmaceutical Agent(s) DME0027 XEOTICID XEO01373 XEO_CLAS Investigative Agent DME0027 XEOTICID XEO01373 DESCRIPT Mequindox inhibits the drug-metabolizing activity of DME CYP11B1 DME0027 XEOTICID XEO01373 GENEFORM Protein DME0027 XEOTICID XEO01373 MOACRIVE Inhibition DME0027 XEOTICID XEO01491 XEO_NAME Tributyltin DME0027 XEOTICID XEO01491 XEO_TYPE Pharmaceutical Agent(s) DME0027 XEOTICID XEO01491 XEO_CLAS Investigative Agent DME0027 XEOTICID XEO01491 DESCRIPT Tributyltin inhibits the expression of DME CYP11B1 DME0027 XEOTICID XEO01491 GENEFORM mRNA DME0027 XEOTICID XEO01491 MOACRIVE Inhibition DME0027 XEOTICID XEO01514 XEO_NAME Deoxynivalenol DME0027 XEOTICID XEO01514 XEO_TYPE Health or Environmental Toxicant(s) DME0027 XEOTICID XEO01514 XEO_CLAS Mycotoxin DME0027 XEOTICID XEO01514 DESCRIPT Deoxynivalenol up-regulates the expression of DME CYP11B1 DME0027 XEOTICID XEO01514 GENEFORM mRNA DME0027 XEOTICID XEO01514 MOACRIVE Induction DME0028 DME___ID DME0028 DME0028 DME_NAME Cholesterol 24-hydroxylase (CYP46A1) DME0028 SPESNAME Homo sapiens DME0028 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0028 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0028 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0028 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP46A1 DME0028 XEOTICID XEO00241 GENEFORM mRNA DME0028 XEOTICID XEO00241 MOACRIVE Inhibition DME0028 XEOTICID XEO00557 XEO_NAME Genistein DME0028 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0028 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0028 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME CYP46A1 DME0028 XEOTICID XEO00557 GENEFORM mRNA DME0028 XEOTICID XEO00557 MOACRIVE Induction DME0028 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0028 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0028 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0028 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME CYP46A1 DME0028 XEOTICID XEO01004 GENEFORM mRNA DME0028 XEOTICID XEO01004 MOACRIVE Inhibition DME0029 DME___ID DME0029 DME0029 DME_NAME Lauric acid omega-hydroxylase (CYP4A11) DME0029 SPESNAME Homo sapiens DME0029 XEOTICID XEO00016 XEO_NAME Clofibrate DME0029 XEOTICID XEO00016 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO00016 XEO_CLAS Approved/Marketed Drug DME0029 XEOTICID XEO00016 DESCRIPT Clofibrate induces the drug-metabolizing activity of DME CYP4A11 DME0029 XEOTICID XEO00016 GENEFORM Protein DME0029 XEOTICID XEO00016 MOACRIVE Induction DME0029 XEOTICID XEO00029 XEO_NAME Valproic acid DME0029 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0029 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the drug-metabolizing activity of DME CYP4A11 DME0029 XEOTICID XEO00029 GENEFORM Protein DME0029 XEOTICID XEO00029 MOACRIVE Inhibition DME0029 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0029 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0029 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME CYP4A11 DME0029 XEOTICID XEO00035 GENEFORM mRNA DME0029 XEOTICID XEO00035 MOACRIVE Induction DME0029 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0029 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0029 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME CYP4A11 DME0029 XEOTICID XEO00186 GENEFORM mRNA DME0029 XEOTICID XEO00186 MOACRIVE Inhibition DME0029 XEOTICID XEO00253 XEO_NAME Tretinoin DME0029 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0029 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME CYP4A11 DME0029 XEOTICID XEO00253 GENEFORM mRNA DME0029 XEOTICID XEO00253 MOACRIVE Inhibition DME0029 XEOTICID XEO00334 XEO_NAME Cisplatin DME0029 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0029 XEOTICID XEO00334 DESCRIPT Cisplatin induces the drug-metabolizing activity of DME CYP4A11 DME0029 XEOTICID XEO00334 GENEFORM Protein DME0029 XEOTICID XEO00334 MOACRIVE Induction DME0029 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0029 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0029 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME CYP4A11 DME0029 XEOTICID XEO00410 GENEFORM Protein DME0029 XEOTICID XEO00410 MOACRIVE Inhibition DME0029 XEOTICID XEO00493 XEO_NAME Bezafibrate DME0029 XEOTICID XEO00493 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO00493 XEO_CLAS Approved/Marketed Drug DME0029 XEOTICID XEO00493 DESCRIPT Bezafibrate up-regulates the expression of DME CYP4A11 DME0029 XEOTICID XEO00493 GENEFORM mRNA DME0029 XEOTICID XEO00493 MOACRIVE Induction DME0029 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0029 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0029 XEOTICID XEO00582 DESCRIPT Diethyltoluamide inhibits the expression of DME CYP4A11 DME0029 XEOTICID XEO00582 GENEFORM mRNA DME0029 XEOTICID XEO00582 MOACRIVE Inhibition DME0029 XEOTICID XEO00710 XEO_NAME Isoliquiritigenin DME0029 XEOTICID XEO00710 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO00710 XEO_CLAS Preclinical/Patented Drug DME0029 XEOTICID XEO00710 DESCRIPT Isoliquiritigenin inhibits the expression of DME CYP4A11 DME0029 XEOTICID XEO00710 GENEFORM mRNA DME0029 XEOTICID XEO00710 MOACRIVE Inhibition DME0029 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0029 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0029 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME CYP4A11 DME0029 XEOTICID XEO00723 GENEFORM mRNA DME0029 XEOTICID XEO00723 MOACRIVE Inhibition DME0029 XEOTICID XEO00735 XEO_NAME GW-4064 DME0029 XEOTICID XEO00735 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO00735 XEO_CLAS Preclinical/Patented Drug DME0029 XEOTICID XEO00735 DESCRIPT GW-4064 inhibits the expression of DME CYP4A11 DME0029 XEOTICID XEO00735 GENEFORM mRNA DME0029 XEOTICID XEO00735 MOACRIVE Inhibition DME0029 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0029 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0029 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0029 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYP4A11 DME0029 XEOTICID XEO00806 GENEFORM mRNA DME0029 XEOTICID XEO00806 MOACRIVE Inhibition DME0029 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0029 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0029 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0029 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid up-regulates the expression of DME CYP4A11 DME0029 XEOTICID XEO00921 GENEFORM mRNA DME0029 XEOTICID XEO00921 MOACRIVE Induction DME0029 XEOTICID XEO00969 XEO_NAME Atrazine DME0029 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0029 XEOTICID XEO00969 XEO_CLAS Herbicide DME0029 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME CYP4A11 DME0029 XEOTICID XEO00969 GENEFORM mRNA DME0029 XEOTICID XEO00969 MOACRIVE Induction DME0029 XEOTICID XEO01096 XEO_NAME 15d-PGJ2 DME0029 XEOTICID XEO01096 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO01096 XEO_CLAS Investigative Agent DME0029 XEOTICID XEO01096 DESCRIPT 15d-PGJ2 inhibits the expression of DME CYP4A11 DME0029 XEOTICID XEO01096 GENEFORM mRNA DME0029 XEOTICID XEO01096 MOACRIVE Inhibition DME0029 XEOTICID XEO01120 XEO_NAME 2-bromopalmitate DME0029 XEOTICID XEO01120 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO01120 XEO_CLAS Investigative Agent DME0029 XEOTICID XEO01120 DESCRIPT 2-bromopalmitate up-regulates the expression of DME CYP4A11 DME0029 XEOTICID XEO01120 GENEFORM mRNA DME0029 XEOTICID XEO01120 MOACRIVE Induction DME0029 XEOTICID XEO01154 XEO_NAME 4-oxoretinoic acid DME0029 XEOTICID XEO01154 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0029 XEOTICID XEO01154 XEO_CLAS Natural Product DME0029 XEOTICID XEO01154 DESCRIPT 4-oxoretinoic acid inhibits the expression of DME CYP4A11 DME0029 XEOTICID XEO01154 GENEFORM mRNA DME0029 XEOTICID XEO01154 MOACRIVE Inhibition DME0029 XEOTICID XEO01302 XEO_NAME Fipronil DME0029 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0029 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0029 XEOTICID XEO01302 DESCRIPT Fipronil inhibits the expression of DME CYP4A11 DME0029 XEOTICID XEO01302 GENEFORM mRNA DME0029 XEOTICID XEO01302 MOACRIVE Inhibition DME0029 XEOTICID XEO01327 XEO_NAME GW-7647 DME0029 XEOTICID XEO01327 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO01327 XEO_CLAS Preclinical/Patented Drug DME0029 XEOTICID XEO01327 DESCRIPT GW-7647 up-regulates the expression of DME CYP4A11 DME0029 XEOTICID XEO01327 GENEFORM mRNA DME0029 XEOTICID XEO01327 MOACRIVE Induction DME0029 XEOTICID XEO01386 XEO_NAME TS-011 DME0029 XEOTICID XEO01386 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO01386 XEO_CLAS Preclinical/Patented Drug DME0029 XEOTICID XEO01386 DESCRIPT TS-011 inhibits the drug-metabolizing activity of DME CYP4A11 DME0029 XEOTICID XEO01386 GENEFORM Protein DME0029 XEOTICID XEO01386 MOACRIVE Inhibition DME0029 XEOTICID XEO01396 XEO_NAME HET-0016 DME0029 XEOTICID XEO01396 XEO_TYPE Pharmaceutical Agent(s) DME0029 XEOTICID XEO01396 XEO_CLAS Preclinical/Patented Drug DME0029 XEOTICID XEO01396 DESCRIPT HET-0016 inhibits the drug-metabolizing activity of DME CYP4A11 DME0029 XEOTICID XEO01396 GENEFORM Protein DME0029 XEOTICID XEO01396 MOACRIVE Inhibition DME0029 XEOTICID XEO01433 XEO_NAME Pirinixic acid DME0029 XEOTICID XEO01433 XEO_TYPE Health or Environmental Toxicant(s) DME0029 XEOTICID XEO01433 XEO_CLAS Health Hazard/Toxicant DME0029 XEOTICID XEO01433 DESCRIPT Pirinixic acid induces the drug-metabolizing activity of DME CYP4A11 DME0029 XEOTICID XEO01433 GENEFORM Protein DME0029 XEOTICID XEO01433 MOACRIVE Induction DME0029 XEOTICID XEO01498 XEO_NAME Walrycin A DME0029 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0029 XEOTICID XEO01498 XEO_CLAS Natural Product DME0029 XEOTICID XEO01498 DESCRIPT Walrycin A up-regulates the expression of DME CYP4A11 DME0029 XEOTICID XEO01498 GENEFORM mRNA DME0029 XEOTICID XEO01498 MOACRIVE Induction DME0029 XEOTICID XEO01551 XEO_NAME Heliotrine DME0029 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0029 XEOTICID XEO01551 XEO_CLAS Natural Product DME0029 XEOTICID XEO01551 DESCRIPT Heliotrine inhibits the expression of DME CYP4A11 DME0029 XEOTICID XEO01551 GENEFORM mRNA DME0029 XEOTICID XEO01551 MOACRIVE Inhibition DME0029 XEOTICID XEO01585 XEO_NAME Senecionine DME0029 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0029 XEOTICID XEO01585 XEO_CLAS Natural Product DME0029 XEOTICID XEO01585 DESCRIPT Senecionine inhibits the drug-metabolizing activity of DME CYP4A11 DME0029 XEOTICID XEO01585 GENEFORM Protein DME0029 XEOTICID XEO01585 MOACRIVE Inhibition DME0030 DME___ID DME0030 DME0030 DME_NAME Cytochrome P450 2A13 (CYP2A13) DME0030 SPESNAME Homo sapiens DME0030 XEOTICID XEO00223 XEO_NAME Rifampin DME0030 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0030 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0030 XEOTICID XEO00223 DESCRIPT Rifampin inhibits the expression of DME CYP2A13 DME0030 XEOTICID XEO00223 GENEFORM mRNA DME0030 XEOTICID XEO00223 MOACRIVE Inhibition DME0030 XEOTICID XEO00253 XEO_NAME Tretinoin DME0030 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0030 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0030 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME CYP2A13 DME0030 XEOTICID XEO00253 GENEFORM mRNA DME0030 XEOTICID XEO00253 MOACRIVE Induction DME0030 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0030 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0030 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0030 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex inhibits the drug-metabolizing activity of DME CYP2A13 (Ki = 72 microM) DME0030 XEOTICID XEO00312 GENEFORM Protein DME0030 XEOTICID XEO00312 MOACRIVE Inhibition DME0030 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0030 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0030 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0030 XEOTICID XEO00410 DESCRIPT Phenobarbital up-regulates the expression of DME CYP2A13 DME0030 XEOTICID XEO00410 GENEFORM mRNA DME0030 XEOTICID XEO00410 MOACRIVE Induction DME0030 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0030 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0030 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0030 XEOTICID XEO00582 DESCRIPT Diethyltoluamide up-regulates the expression of DME CYP2A13 DME0030 XEOTICID XEO00582 GENEFORM mRNA DME0030 XEOTICID XEO00582 MOACRIVE Induction DME0030 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0030 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0030 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0030 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME CYP2A13 DME0030 XEOTICID XEO00821 GENEFORM mRNA DME0030 XEOTICID XEO00821 MOACRIVE Induction DME0030 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0030 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0030 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0030 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME CYP2A13 DME0030 XEOTICID XEO00905 GENEFORM mRNA DME0030 XEOTICID XEO00905 MOACRIVE Inhibition DME0030 XEOTICID XEO01218 XEO_NAME Benzyl selenocyanate DME0030 XEOTICID XEO01218 XEO_TYPE Pharmaceutical Agent(s) DME0030 XEOTICID XEO01218 XEO_CLAS Investigative Agent DME0030 XEOTICID XEO01218 DESCRIPT Benzyl selenocyanate inhibits the drug-metabolizing activity of DME CYP2A13 DME0030 XEOTICID XEO01218 GENEFORM Protein DME0030 XEOTICID XEO01218 MOACRIVE Inhibition DME0030 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0030 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0030 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0030 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME CYP2A13 DME0030 XEOTICID XEO01220 GENEFORM mRNA DME0030 XEOTICID XEO01220 MOACRIVE Induction DME0031 DME___ID DME0031 DME0031 DME_NAME Cytochrome P450 2J2 (CYP2J2) DME0031 SPESNAME Homo sapiens DME0031 XEOTICID XEO00066 XEO_NAME Nifedipine DME0031 XEOTICID XEO00066 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00066 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00066 DESCRIPT Nifedipine inhibits the drug-metabolizing activity of DME CYP2J2 (IC50 = 3.06 microM) DME0031 XEOTICID XEO00066 GENEFORM Protein DME0031 XEOTICID XEO00066 MOACRIVE Inhibition DME0031 XEOTICID XEO00086 XEO_NAME Troglitazone DME0031 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00086 DESCRIPT Troglitazone inhibits the expression of DME CYP2J2 DME0031 XEOTICID XEO00086 GENEFORM mRNA DME0031 XEOTICID XEO00086 MOACRIVE Inhibition DME0031 XEOTICID XEO00090 XEO_NAME Estradiol DME0031 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME CYP2J2 DME0031 XEOTICID XEO00090 GENEFORM mRNA DME0031 XEOTICID XEO00090 MOACRIVE Induction DME0031 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0031 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME CYP2J2 DME0031 XEOTICID XEO00117 GENEFORM mRNA DME0031 XEOTICID XEO00117 MOACRIVE Inhibition DME0031 XEOTICID XEO00118 XEO_NAME Danazol DME0031 XEOTICID XEO00118 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00118 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00118 DESCRIPT Danazol inhibits the drug-metabolizing activity of DME CYP2J2 (IC50 < 0.1 microM) DME0031 XEOTICID XEO00118 GENEFORM Protein DME0031 XEOTICID XEO00118 MOACRIVE Inhibition DME0031 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0031 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the drug-metabolizing activity of DME CYP2J2 (IC50 > 50 microM) DME0031 XEOTICID XEO00217 GENEFORM Protein DME0031 XEOTICID XEO00217 MOACRIVE Inhibition DME0031 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0031 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP2J2 DME0031 XEOTICID XEO00241 GENEFORM mRNA DME0031 XEOTICID XEO00241 MOACRIVE Inhibition DME0031 XEOTICID XEO00245 XEO_NAME Felodipine DME0031 XEOTICID XEO00245 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00245 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00245 DESCRIPT Felodipine inhibits the drug-metabolizing activity of DME CYP2J2 DME0031 XEOTICID XEO00245 GENEFORM Protein DME0031 XEOTICID XEO00245 MOACRIVE Inhibition DME0031 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0031 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP2J2 DME0031 XEOTICID XEO00251 GENEFORM Protein DME0031 XEOTICID XEO00251 MOACRIVE Inhibition DME0031 XEOTICID XEO00253 XEO_NAME Tretinoin DME0031 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME CYP2J2 DME0031 XEOTICID XEO00253 GENEFORM mRNA DME0031 XEOTICID XEO00253 MOACRIVE Inhibition DME0031 XEOTICID XEO00271 XEO_NAME Telmisartan DME0031 XEOTICID XEO00271 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00271 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00271 DESCRIPT Telmisartan inhibits the drug-metabolizing activity of DME CYP2J2 (IC50 = 0.42 microM) DME0031 XEOTICID XEO00271 GENEFORM Protein DME0031 XEOTICID XEO00271 MOACRIVE Inhibition DME0031 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0031 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride up-regulates the expression of DME CYP2J2 DME0031 XEOTICID XEO00277 GENEFORM mRNA DME0031 XEOTICID XEO00277 MOACRIVE Induction DME0031 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0031 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME CYP2J2 DME0031 XEOTICID XEO00292 GENEFORM mRNA DME0031 XEOTICID XEO00292 MOACRIVE Inhibition DME0031 XEOTICID XEO00311 XEO_NAME Nicardipine hydrochloride DME0031 XEOTICID XEO00311 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00311 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00311 DESCRIPT Nicardipine hydrochloride inhibits the drug-metabolizing activity of DME CYP2J2 (IC50 = 1.69 microM) DME0031 XEOTICID XEO00311 GENEFORM Protein DME0031 XEOTICID XEO00311 MOACRIVE Inhibition DME0031 XEOTICID XEO00338 XEO_NAME Amlodipine DME0031 XEOTICID XEO00338 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00338 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00338 DESCRIPT Amlodipine inhibits the drug-metabolizing activity of DME CYP2J2 DME0031 XEOTICID XEO00338 GENEFORM Protein DME0031 XEOTICID XEO00338 MOACRIVE Inhibition DME0031 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0031 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00380 DESCRIPT Rosiglitazone up-regulates the expression of DME CYP2J2 DME0031 XEOTICID XEO00380 GENEFORM mRNA DME0031 XEOTICID XEO00380 MOACRIVE Induction DME0031 XEOTICID XEO00435 XEO_NAME Urethane DME0031 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00435 DESCRIPT Urethane up-regulates the expression of DME CYP2J2 DME0031 XEOTICID XEO00435 GENEFORM mRNA DME0031 XEOTICID XEO00435 MOACRIVE Induction DME0031 XEOTICID XEO00438 XEO_NAME Benidipine DME0031 XEOTICID XEO00438 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00438 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00438 DESCRIPT Benidipine inhibits the drug-metabolizing activity of DME CYP2J2 DME0031 XEOTICID XEO00438 GENEFORM Protein DME0031 XEOTICID XEO00438 MOACRIVE Inhibition DME0031 XEOTICID XEO00467 XEO_NAME Efonidipine DME0031 XEOTICID XEO00467 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00467 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00467 DESCRIPT Efonidipine inhibits the drug-metabolizing activity of DME CYP2J2 DME0031 XEOTICID XEO00467 GENEFORM Protein DME0031 XEOTICID XEO00467 MOACRIVE Inhibition DME0031 XEOTICID XEO00491 XEO_NAME Azelnidipine DME0031 XEOTICID XEO00491 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00491 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00491 DESCRIPT Azelnidipine inhibits the drug-metabolizing activity of DME CYP2J2 DME0031 XEOTICID XEO00491 GENEFORM Protein DME0031 XEOTICID XEO00491 MOACRIVE Inhibition DME0031 XEOTICID XEO00496 XEO_NAME Ebastine DME0031 XEOTICID XEO00496 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00496 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00496 DESCRIPT Ebastine inhibits the drug-metabolizing activity of DME CYP2J2 DME0031 XEOTICID XEO00496 GENEFORM Protein DME0031 XEOTICID XEO00496 MOACRIVE Inhibition DME0031 XEOTICID XEO00514 XEO_NAME Nitrendipine DME0031 XEOTICID XEO00514 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00514 XEO_CLAS Approved/Marketed Drug DME0031 XEOTICID XEO00514 DESCRIPT Nitrendipine inhibits the drug-metabolizing activity of DME CYP2J2 DME0031 XEOTICID XEO00514 GENEFORM Protein DME0031 XEOTICID XEO00514 MOACRIVE Inhibition DME0031 XEOTICID XEO00523 XEO_NAME Terfenadine DME0031 XEOTICID XEO00523 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00523 XEO_CLAS Drug Marketed but Withdrawn from Market DME0031 XEOTICID XEO00523 DESCRIPT Terfenadine inhibits the drug-metabolizing activity of DME CYP2J2 (IC50 = 1.13 microM) DME0031 XEOTICID XEO00523 GENEFORM Protein DME0031 XEOTICID XEO00523 MOACRIVE Inhibition DME0031 XEOTICID XEO00552 XEO_NAME Delapril DME0031 XEOTICID XEO00552 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00552 XEO_CLAS Drug in Phase 3 Clinical Trial DME0031 XEOTICID XEO00552 DESCRIPT Delapril inhibits the drug-metabolizing activity of DME CYP2J2 DME0031 XEOTICID XEO00552 GENEFORM Protein DME0031 XEOTICID XEO00552 MOACRIVE Inhibition DME0031 XEOTICID XEO00563 XEO_NAME Cilnidipine DME0031 XEOTICID XEO00563 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00563 XEO_CLAS Drug in Phase 3 Clinical Trial DME0031 XEOTICID XEO00563 DESCRIPT Cilnidipine inhibits the drug-metabolizing activity of DME CYP2J2 DME0031 XEOTICID XEO00563 GENEFORM Protein DME0031 XEOTICID XEO00563 MOACRIVE Inhibition DME0031 XEOTICID XEO00567 XEO_NAME Manidipine DME0031 XEOTICID XEO00567 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00567 XEO_CLAS Drug in Phase 3 Clinical Trial DME0031 XEOTICID XEO00567 DESCRIPT Manidipine inhibits the drug-metabolizing activity of DME CYP2J2 DME0031 XEOTICID XEO00567 GENEFORM Protein DME0031 XEOTICID XEO00567 MOACRIVE Inhibition DME0031 XEOTICID XEO00601 XEO_NAME Butylated hydroxytoluene DME0031 XEOTICID XEO00601 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00601 XEO_CLAS Drug in Phase 1 Clinical Trial DME0031 XEOTICID XEO00601 DESCRIPT Butylated hydroxytoluene up-regulates the expression of DME CYP2J2 DME0031 XEOTICID XEO00601 GENEFORM mRNA DME0031 XEOTICID XEO00601 MOACRIVE Induction DME0031 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0031 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0031 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME CYP2J2 DME0031 XEOTICID XEO00632 GENEFORM mRNA DME0031 XEOTICID XEO00632 MOACRIVE Induction DME0031 XEOTICID XEO00721 XEO_NAME MRK-003 DME0031 XEOTICID XEO00721 XEO_TYPE Pharmaceutical Agent(s) DME0031 XEOTICID XEO00721 XEO_CLAS Preclinical/Patented Drug DME0031 XEOTICID XEO00721 DESCRIPT MRK-003 inhibits the drug-metabolizing activity of DME CYP2J2 DME0031 XEOTICID XEO00721 GENEFORM Protein DME0031 XEOTICID XEO00721 MOACRIVE Inhibition DME0031 XEOTICID XEO00861 XEO_NAME Salvianolic acid C DME0031 XEOTICID XEO00861 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0031 XEOTICID XEO00861 XEO_CLAS Natural Product DME0031 XEOTICID XEO00861 DESCRIPT Salvianolic acid C inhibits the drug-metabolizing activity of DME CYP2J2 DME0031 XEOTICID XEO00861 GENEFORM Protein DME0031 XEOTICID XEO00861 MOACRIVE Inhibition DME0031 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0031 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0031 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0031 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CYP2J2 DME0031 XEOTICID XEO00898 GENEFORM mRNA DME0031 XEOTICID XEO00898 MOACRIVE Induction DME0031 XEOTICID XEO00969 XEO_NAME Atrazine DME0031 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0031 XEOTICID XEO00969 XEO_CLAS Herbicide DME0031 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME CYP2J2 DME0031 XEOTICID XEO00969 GENEFORM mRNA DME0031 XEOTICID XEO00969 MOACRIVE Induction DME0031 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0031 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0031 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0031 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME CYP2J2 DME0031 XEOTICID XEO00999 GENEFORM mRNA DME0031 XEOTICID XEO00999 MOACRIVE Induction DME0031 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0031 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0031 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0031 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME CYP2J2 DME0031 XEOTICID XEO01004 GENEFORM mRNA DME0031 XEOTICID XEO01004 MOACRIVE Inhibition DME0031 XEOTICID XEO01009 XEO_NAME Glycidamide DME0031 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0031 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0031 XEOTICID XEO01009 DESCRIPT Glycidamide inhibits the expression of DME CYP2J2 DME0031 XEOTICID XEO01009 GENEFORM mRNA DME0031 XEOTICID XEO01009 MOACRIVE Inhibition DME0031 XEOTICID XEO01034 XEO_NAME Pentanal DME0031 XEOTICID XEO01034 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0031 XEOTICID XEO01034 XEO_CLAS Chemical Compound DME0031 XEOTICID XEO01034 DESCRIPT Pentanal up-regulates the expression of DME CYP2J2 DME0031 XEOTICID XEO01034 GENEFORM mRNA DME0031 XEOTICID XEO01034 MOACRIVE Induction DME0031 XEOTICID XEO01192 XEO_NAME Alpha-naphthoflavone DME0031 XEOTICID XEO01192 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0031 XEOTICID XEO01192 XEO_CLAS Natural Product DME0031 XEOTICID XEO01192 DESCRIPT Alpha-naphthof DMElavone inhibits the drug-metabolizing activity of DME CYP2J2 DME0031 XEOTICID XEO01192 GENEFORM Protein DME0031 XEOTICID XEO01192 MOACRIVE Inhibition DME0032 DME___ID DME0032 DME0032 DME_NAME Retinoic acid 4-hydroxylase 26B1 (CYP26B1) DME0032 SPESNAME Homo sapiens DME0032 XEOTICID XEO00090 XEO_NAME Estradiol DME0032 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0032 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0032 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME CYP26B1 DME0032 XEOTICID XEO00090 GENEFORM mRNA DME0032 XEOTICID XEO00090 MOACRIVE Inhibition DME0032 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0032 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0032 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0032 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME CYP26B1 DME0032 XEOTICID XEO00117 GENEFORM mRNA DME0032 XEOTICID XEO00117 MOACRIVE Induction DME0032 XEOTICID XEO00184 XEO_NAME Calcitriol DME0032 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0032 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0032 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME CYP26B1 DME0032 XEOTICID XEO00184 GENEFORM mRNA DME0032 XEOTICID XEO00184 MOACRIVE Induction DME0032 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0032 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0032 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0032 XEOTICID XEO00186 DESCRIPT Isotretinoin up-regulates the expression of DME CYP26B1 DME0032 XEOTICID XEO00186 GENEFORM mRNA DME0032 XEOTICID XEO00186 MOACRIVE Induction DME0032 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0032 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0032 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0032 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP26B1 DME0032 XEOTICID XEO00251 GENEFORM Protein DME0032 XEOTICID XEO00251 MOACRIVE Inhibition DME0032 XEOTICID XEO00253 XEO_NAME Tretinoin DME0032 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0032 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0032 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME CYP26B1 DME0032 XEOTICID XEO00253 GENEFORM mRNA DME0032 XEOTICID XEO00253 MOACRIVE Induction DME0032 XEOTICID XEO00267 XEO_NAME Ethinyl estradiol DME0032 XEOTICID XEO00267 XEO_TYPE Pharmaceutical Agent(s) DME0032 XEOTICID XEO00267 XEO_CLAS Approved/Marketed Drug DME0032 XEOTICID XEO00267 DESCRIPT Ethinyl estradiol inhibits the expression of DME CYP26B1 DME0032 XEOTICID XEO00267 GENEFORM mRNA DME0032 XEOTICID XEO00267 MOACRIVE Inhibition DME0032 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0032 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0032 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0032 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME CYP26B1 DME0032 XEOTICID XEO00292 GENEFORM mRNA DME0032 XEOTICID XEO00292 MOACRIVE Inhibition DME0032 XEOTICID XEO00334 XEO_NAME Cisplatin DME0032 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0032 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0032 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME CYP26B1 DME0032 XEOTICID XEO00334 GENEFORM mRNA DME0032 XEOTICID XEO00334 MOACRIVE Inhibition DME0032 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0032 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0032 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0032 XEOTICID XEO00410 DESCRIPT Phenobarbital up-regulates the expression of DME CYP26B1 DME0032 XEOTICID XEO00410 GENEFORM mRNA DME0032 XEOTICID XEO00410 MOACRIVE Induction DME0032 XEOTICID XEO00578 XEO_NAME Arecoline DME0032 XEOTICID XEO00578 XEO_TYPE Pharmaceutical Agent(s) DME0032 XEOTICID XEO00578 XEO_CLAS Drug in Phase 2 Clinical Trial DME0032 XEOTICID XEO00578 DESCRIPT Arecoline inhibits the expression of DME CYP26B1 DME0032 XEOTICID XEO00578 GENEFORM mRNA DME0032 XEOTICID XEO00578 MOACRIVE Inhibition DME0032 XEOTICID XEO01302 XEO_NAME Fipronil DME0032 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0032 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0032 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME CYP26B1 DME0032 XEOTICID XEO01302 GENEFORM mRNA DME0032 XEOTICID XEO01302 MOACRIVE Induction DME0032 XEOTICID XEO01357 XEO_NAME Kojic acid DME0032 XEOTICID XEO01357 XEO_TYPE Health or Environmental Toxicant(s) DME0032 XEOTICID XEO01357 XEO_CLAS Health Hazard/Toxicant DME0032 XEOTICID XEO01357 DESCRIPT Kojic acid up-regulates the expression of DME CYP26B1 DME0032 XEOTICID XEO01357 GENEFORM mRNA DME0032 XEOTICID XEO01357 MOACRIVE Induction DME0032 XEOTICID XEO01449 XEO_NAME Quercitrin DME0032 XEOTICID XEO01449 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0032 XEOTICID XEO01449 XEO_CLAS Natural Product DME0032 XEOTICID XEO01449 DESCRIPT Quercitrin up-regulates the expression of DME CYP26B1 DME0032 XEOTICID XEO01449 GENEFORM mRNA DME0032 XEOTICID XEO01449 MOACRIVE Induction DME0032 XEOTICID XEO01498 XEO_NAME Walrycin A DME0032 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0032 XEOTICID XEO01498 XEO_CLAS Natural Product DME0032 XEOTICID XEO01498 DESCRIPT Walrycin A up-regulates the expression of DME CYP26B1 DME0032 XEOTICID XEO01498 GENEFORM mRNA DME0032 XEOTICID XEO01498 MOACRIVE Induction DME0033 DME___ID DME0033 DME0033 DME_NAME Cytochrome P450 2S1 (CYP2S1) DME0033 SPESNAME Homo sapiens DME0033 XEOTICID XEO00007 XEO_NAME Azathioprine DME0033 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0033 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0033 XEOTICID XEO00007 DESCRIPT Azathioprine up-regulates the expression of DME CYP2S1 DME0033 XEOTICID XEO00007 GENEFORM mRNA DME0033 XEOTICID XEO00007 MOACRIVE Induction DME0033 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0033 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0033 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0033 XEOTICID XEO00088 DESCRIPT Dexamethasone inhibits the drug-metabolizing activity of DME CYP2S1 DME0033 XEOTICID XEO00088 GENEFORM Protein DME0033 XEOTICID XEO00088 MOACRIVE Inhibition DME0033 XEOTICID XEO00090 XEO_NAME Estradiol DME0033 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0033 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0033 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME CYP2S1 DME0033 XEOTICID XEO00090 GENEFORM mRNA DME0033 XEOTICID XEO00090 MOACRIVE Induction DME0033 XEOTICID XEO00095 XEO_NAME Testosterone DME0033 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0033 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0033 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME CYP2S1 DME0033 XEOTICID XEO00095 GENEFORM mRNA DME0033 XEOTICID XEO00095 MOACRIVE Induction DME0033 XEOTICID XEO00145 XEO_NAME Flunisolide DME0033 XEOTICID XEO00145 XEO_TYPE Pharmaceutical Agent(s) DME0033 XEOTICID XEO00145 XEO_CLAS Approved/Marketed Drug DME0033 XEOTICID XEO00145 DESCRIPT Flunisolide inhibits the expression of DME CYP2S1 DME0033 XEOTICID XEO00145 GENEFORM mRNA DME0033 XEOTICID XEO00145 MOACRIVE Inhibition DME0033 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0033 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0033 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0033 XEOTICID XEO00165 DESCRIPT Obeticholic acid inhibits the drug-metabolizing activity of DME CYP2S1 DME0033 XEOTICID XEO00165 GENEFORM Protein DME0033 XEOTICID XEO00165 MOACRIVE Inhibition DME0033 XEOTICID XEO00184 XEO_NAME Calcitriol DME0033 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0033 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0033 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME CYP2S1 DME0033 XEOTICID XEO00184 GENEFORM mRNA DME0033 XEOTICID XEO00184 MOACRIVE Inhibition DME0033 XEOTICID XEO00219 XEO_NAME Prednisolone DME0033 XEOTICID XEO00219 XEO_TYPE Pharmaceutical Agent(s) DME0033 XEOTICID XEO00219 XEO_CLAS Approved/Marketed Drug DME0033 XEOTICID XEO00219 DESCRIPT Prednisolone inhibits the expression of DME CYP2S1 DME0033 XEOTICID XEO00219 GENEFORM mRNA DME0033 XEOTICID XEO00219 MOACRIVE Inhibition DME0033 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0033 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0033 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0033 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME CYP2S1 DME0033 XEOTICID XEO00241 GENEFORM mRNA DME0033 XEOTICID XEO00241 MOACRIVE Induction DME0033 XEOTICID XEO00264 XEO_NAME Hydrocortisone DME0033 XEOTICID XEO00264 XEO_TYPE Pharmaceutical Agent(s) DME0033 XEOTICID XEO00264 XEO_CLAS Approved/Marketed Drug DME0033 XEOTICID XEO00264 DESCRIPT Hydrocortisone inhibits the expression of DME CYP2S1 DME0033 XEOTICID XEO00264 GENEFORM mRNA DME0033 XEOTICID XEO00264 MOACRIVE Inhibition DME0033 XEOTICID XEO00278 XEO_NAME Beclomethasone dipropionate DME0033 XEOTICID XEO00278 XEO_TYPE Pharmaceutical Agent(s) DME0033 XEOTICID XEO00278 XEO_CLAS Approved/Marketed Drug DME0033 XEOTICID XEO00278 DESCRIPT Beclomethasone dipropionate inhibits the expression of DME CYP2S1 DME0033 XEOTICID XEO00278 GENEFORM mRNA DME0033 XEOTICID XEO00278 MOACRIVE Inhibition DME0033 XEOTICID XEO00334 XEO_NAME Cisplatin DME0033 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0033 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0033 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME CYP2S1 DME0033 XEOTICID XEO00334 GENEFORM mRNA DME0033 XEOTICID XEO00334 MOACRIVE Induction DME0033 XEOTICID XEO00581 XEO_NAME MS-275 DME0033 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0033 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0033 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME CYP2S1 DME0033 XEOTICID XEO00581 GENEFORM mRNA DME0033 XEOTICID XEO00581 MOACRIVE Induction DME0033 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0033 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0033 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0033 XEOTICID XEO00632 DESCRIPT Sodium arsenite induces the drug-metabolizing activity of DME CYP2S1 DME0033 XEOTICID XEO00632 GENEFORM Protein DME0033 XEOTICID XEO00632 MOACRIVE Induction DME0033 XEOTICID XEO00755 XEO_NAME Coal tar DME0033 XEOTICID XEO00755 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0033 XEOTICID XEO00755 XEO_CLAS Natural Mixture DME0033 XEOTICID XEO00755 DESCRIPT Coal tar up-regulates the expression of DME CYP2S1 DME0033 XEOTICID XEO00755 GENEFORM mRNA DME0033 XEOTICID XEO00755 MOACRIVE Induction DME0033 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0033 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0033 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0033 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME CYP2S1 DME0033 XEOTICID XEO00806 GENEFORM mRNA DME0033 XEOTICID XEO00806 MOACRIVE Induction DME0033 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0033 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0033 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0033 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME CYP2S1 DME0033 XEOTICID XEO00821 GENEFORM mRNA DME0033 XEOTICID XEO00821 MOACRIVE Induction DME0033 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0033 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0033 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0033 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CYP2S1 DME0033 XEOTICID XEO00898 GENEFORM mRNA DME0033 XEOTICID XEO00898 MOACRIVE Induction DME0033 XEOTICID XEO00917 XEO_NAME Polychlorinated dibenzodioxin DME0033 XEOTICID XEO00917 XEO_TYPE Health or Environmental Toxicant(s) DME0033 XEOTICID XEO00917 XEO_CLAS Environmental Pollutant DME0033 XEOTICID XEO00917 DESCRIPT Polychlorinated dibenzodioxin induces the drug-metabolizing activity of DME CYP2S1 DME0033 XEOTICID XEO00917 GENEFORM Protein DME0033 XEOTICID XEO00917 MOACRIVE Induction DME0033 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0033 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0033 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0033 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME CYP2S1 DME0033 XEOTICID XEO00999 GENEFORM mRNA DME0033 XEOTICID XEO00999 MOACRIVE Inhibition DME0034 DME___ID DME0034 DME0034 DME_NAME Leukotriene B4 omega-hydroxylase (CYP4F3) DME0034 SPESNAME Homo sapiens DME0034 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0034 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0034 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0034 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME CYP4F3 DME0034 XEOTICID XEO00011 GENEFORM mRNA DME0034 XEOTICID XEO00011 MOACRIVE Induction DME0034 XEOTICID XEO00029 XEO_NAME Valproic acid DME0034 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0034 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0034 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the drug-metabolizing activity of DME CYP4F3 DME0034 XEOTICID XEO00029 GENEFORM Protein DME0034 XEOTICID XEO00029 MOACRIVE Inhibition DME0034 XEOTICID XEO00090 XEO_NAME Estradiol DME0034 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0034 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0034 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME CYP4F3 DME0034 XEOTICID XEO00090 GENEFORM mRNA DME0034 XEOTICID XEO00090 MOACRIVE Inhibition DME0034 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0034 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0034 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0034 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME CYP4F3 DME0034 XEOTICID XEO00117 GENEFORM mRNA DME0034 XEOTICID XEO00117 MOACRIVE Inhibition DME0034 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0034 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0034 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0034 XEOTICID XEO00165 DESCRIPT Obeticholic acid inhibits the drug-metabolizing activity of DME CYP4F3 DME0034 XEOTICID XEO00165 GENEFORM Protein DME0034 XEOTICID XEO00165 MOACRIVE Inhibition DME0034 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0034 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0034 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0034 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME CYP4F3 DME0034 XEOTICID XEO00186 GENEFORM mRNA DME0034 XEOTICID XEO00186 MOACRIVE Inhibition DME0034 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0034 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0034 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0034 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME CYP4F3 DME0034 XEOTICID XEO00217 GENEFORM mRNA DME0034 XEOTICID XEO00217 MOACRIVE Induction DME0034 XEOTICID XEO00253 XEO_NAME Tretinoin DME0034 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0034 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0034 XEOTICID XEO00253 DESCRIPT Tretinoin induces the drug-metabolizing activity of DME CYP4F3 DME0034 XEOTICID XEO00253 GENEFORM Protein DME0034 XEOTICID XEO00253 MOACRIVE Induction DME0034 XEOTICID XEO00334 XEO_NAME Cisplatin DME0034 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0034 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0034 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME CYP4F3 DME0034 XEOTICID XEO00334 GENEFORM mRNA DME0034 XEOTICID XEO00334 MOACRIVE Induction DME0034 XEOTICID XEO00466 XEO_NAME Demecolcine DME0034 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0034 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0034 XEOTICID XEO00466 DESCRIPT Demecolcine up-regulates the expression of DME CYP4F3 DME0034 XEOTICID XEO00466 GENEFORM mRNA DME0034 XEOTICID XEO00466 MOACRIVE Induction DME0034 XEOTICID XEO00757 XEO_NAME Apple polyphenol extract DME0034 XEOTICID XEO00757 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0034 XEOTICID XEO00757 XEO_CLAS Plant Extract DME0034 XEOTICID XEO00757 DESCRIPT Apple polyphenol extract up-regulates the expression of DME CYP4F3 DME0034 XEOTICID XEO00757 GENEFORM mRNA DME0034 XEOTICID XEO00757 MOACRIVE Induction DME0034 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0034 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0034 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0034 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME CYP4F3 DME0034 XEOTICID XEO00772 GENEFORM mRNA DME0034 XEOTICID XEO00772 MOACRIVE Induction DME0034 XEOTICID XEO00809 XEO_NAME Thapsigargin DME0034 XEOTICID XEO00809 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0034 XEOTICID XEO00809 XEO_CLAS Natural Product DME0034 XEOTICID XEO00809 DESCRIPT Thapsigargin inhibits the expression of DME CYP4F3 DME0034 XEOTICID XEO00809 GENEFORM mRNA DME0034 XEOTICID XEO00809 MOACRIVE Inhibition DME0034 XEOTICID XEO00973 XEO_NAME Diuron DME0034 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0034 XEOTICID XEO00973 XEO_CLAS Herbicide DME0034 XEOTICID XEO00973 DESCRIPT Diuron up-regulates the expression of DME CYP4F3 DME0034 XEOTICID XEO00973 GENEFORM mRNA DME0034 XEOTICID XEO00973 MOACRIVE Induction DME0034 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0034 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0034 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0034 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME CYP4F3 DME0034 XEOTICID XEO00999 GENEFORM mRNA DME0034 XEOTICID XEO00999 MOACRIVE Inhibition DME0034 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0034 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0034 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0034 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME CYP4F3 DME0034 XEOTICID XEO01220 GENEFORM mRNA DME0034 XEOTICID XEO01220 MOACRIVE Induction DME0034 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0034 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0034 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0034 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME CYP4F3 DME0034 XEOTICID XEO01305 GENEFORM mRNA DME0034 XEOTICID XEO01305 MOACRIVE Inhibition DME0034 XEOTICID XEO01503 XEO_NAME Cadmium DME0034 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0034 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0034 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME CYP4F3 DME0034 XEOTICID XEO01503 GENEFORM mRNA DME0034 XEOTICID XEO01503 MOACRIVE Induction DME0034 XEOTICID XEO01551 XEO_NAME Heliotrine DME0034 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0034 XEOTICID XEO01551 XEO_CLAS Natural Product DME0034 XEOTICID XEO01551 DESCRIPT Heliotrine inhibits the expression of DME CYP4F3 DME0034 XEOTICID XEO01551 GENEFORM mRNA DME0034 XEOTICID XEO01551 MOACRIVE Inhibition DME0036 DME___ID DME0036 DME0036 DME_NAME Aldosterone synthase (CYP11B2) DME0036 SPESNAME Homo sapiens DME0036 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0036 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0036 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0036 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME CYP11B2 DME0036 XEOTICID XEO00011 GENEFORM mRNA DME0036 XEOTICID XEO00011 MOACRIVE Induction DME0036 XEOTICID XEO00111 XEO_NAME Erythromycin DME0036 XEOTICID XEO00111 XEO_TYPE Pharmaceutical Agent(s) DME0036 XEOTICID XEO00111 XEO_CLAS Approved/Marketed Drug DME0036 XEOTICID XEO00111 DESCRIPT Erythromycin induces the drug-metabolizing activity of DME CYP11B2 DME0036 XEOTICID XEO00111 GENEFORM Protein DME0036 XEOTICID XEO00111 MOACRIVE Induction DME0036 XEOTICID XEO00192 XEO_NAME Dutasteride DME0036 XEOTICID XEO00192 XEO_TYPE Pharmaceutical Agent(s) DME0036 XEOTICID XEO00192 XEO_CLAS Approved/Marketed Drug DME0036 XEOTICID XEO00192 DESCRIPT Dutasteride up-regulates the expression of DME CYP11B2 DME0036 XEOTICID XEO00192 GENEFORM mRNA DME0036 XEOTICID XEO00192 MOACRIVE Induction DME0036 XEOTICID XEO00246 XEO_NAME Amoxicillin DME0036 XEOTICID XEO00246 XEO_TYPE Pharmaceutical Agent(s) DME0036 XEOTICID XEO00246 XEO_CLAS Approved/Marketed Drug DME0036 XEOTICID XEO00246 DESCRIPT Amoxicillin induces the drug-metabolizing activity of DME CYP11B2 DME0036 XEOTICID XEO00246 GENEFORM Protein DME0036 XEOTICID XEO00246 MOACRIVE Induction DME0036 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0036 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0036 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0036 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP11B2 (IC50 = 0.067 microM) DME0036 XEOTICID XEO00251 GENEFORM Protein DME0036 XEOTICID XEO00251 MOACRIVE Inhibition DME0036 XEOTICID XEO00395 XEO_NAME Potassium chloride DME0036 XEOTICID XEO00395 XEO_TYPE Pharmaceutical Agent(s) DME0036 XEOTICID XEO00395 XEO_CLAS Approved/Marketed Drug DME0036 XEOTICID XEO00395 DESCRIPT Potassium chloride induces the drug-metabolizing activity of DME CYP11B2 DME0036 XEOTICID XEO00395 GENEFORM Protein DME0036 XEOTICID XEO00395 MOACRIVE Induction DME0036 XEOTICID XEO00468 XEO_NAME Fadrozole DME0036 XEOTICID XEO00468 XEO_TYPE Pharmaceutical Agent(s) DME0036 XEOTICID XEO00468 XEO_CLAS Approved/Marketed Drug DME0036 XEOTICID XEO00468 DESCRIPT Fadrozole inhibits the drug-metabolizing activity of DME CYP11B2 (IC50 = 0.0008 microM) DME0036 XEOTICID XEO00468 GENEFORM Protein DME0036 XEOTICID XEO00468 MOACRIVE Inhibition DME0036 XEOTICID XEO00561 XEO_NAME Anacetrapib DME0036 XEOTICID XEO00561 XEO_TYPE Pharmaceutical Agent(s) DME0036 XEOTICID XEO00561 XEO_CLAS Drug in Phase 3 Clinical Trial DME0036 XEOTICID XEO00561 DESCRIPT Anacetrapib up-regulates the expression of DME CYP11B2 DME0036 XEOTICID XEO00561 GENEFORM mRNA DME0036 XEOTICID XEO00561 MOACRIVE Induction DME0036 XEOTICID XEO00564 XEO_NAME Dalcetrapib DME0036 XEOTICID XEO00564 XEO_TYPE Pharmaceutical Agent(s) DME0036 XEOTICID XEO00564 XEO_CLAS Drug in Phase 3 Clinical Trial DME0036 XEOTICID XEO00564 DESCRIPT Dalcetrapib induces the drug-metabolizing activity of DME CYP11B2 DME0036 XEOTICID XEO00564 GENEFORM Protein DME0036 XEOTICID XEO00564 MOACRIVE Induction DME0036 XEOTICID XEO00606 XEO_NAME Colforsin DME0036 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0036 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0036 XEOTICID XEO00606 DESCRIPT Colforsin up-regulates the expression of DME CYP11B2 DME0036 XEOTICID XEO00606 GENEFORM mRNA DME0036 XEOTICID XEO00606 MOACRIVE Induction DME0036 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0036 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0036 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0036 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CYP11B2 DME0036 XEOTICID XEO00898 GENEFORM mRNA DME0036 XEOTICID XEO00898 MOACRIVE Induction DME0036 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0036 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0036 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0036 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid up-regulates the expression of DME CYP11B2 DME0036 XEOTICID XEO00921 GENEFORM mRNA DME0036 XEOTICID XEO00921 MOACRIVE Induction DME0036 XEOTICID XEO00991 XEO_NAME Acenaphthenes DME0036 XEOTICID XEO00991 XEO_TYPE Health or Environmental Toxicant(s) DME0036 XEOTICID XEO00991 XEO_CLAS Environmental Pollutant DME0036 XEOTICID XEO00991 DESCRIPT Acenaphthenes inhibits the drug-metabolizing activity of DME CYP11B2 DME0036 XEOTICID XEO00991 GENEFORM Protein DME0036 XEOTICID XEO00991 MOACRIVE Inhibition DME0036 XEOTICID XEO01100 XEO_NAME 3-Methylsulfonyl-dde DME0036 XEOTICID XEO01100 XEO_TYPE Health or Environmental Toxicant(s) DME0036 XEOTICID XEO01100 XEO_CLAS Environmental Pollutant DME0036 XEOTICID XEO01100 DESCRIPT 3-Methylsulfonyl-dde up-regulates the expression of DME CYP11B2 DME0036 XEOTICID XEO01100 GENEFORM mRNA DME0036 XEOTICID XEO01100 MOACRIVE Induction DME0036 XEOTICID XEO01143 XEO_NAME Bay K 8644 DME0036 XEOTICID XEO01143 XEO_TYPE Pharmaceutical Agent(s) DME0036 XEOTICID XEO01143 XEO_CLAS Investigative Agent DME0036 XEOTICID XEO01143 DESCRIPT Bay K 8644 up-regulates the expression of DME CYP11B2 DME0036 XEOTICID XEO01143 GENEFORM mRNA DME0036 XEOTICID XEO01143 MOACRIVE Induction DME0036 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0036 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0036 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0036 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME CYP11B2 DME0036 XEOTICID XEO01226 GENEFORM mRNA DME0036 XEOTICID XEO01226 MOACRIVE Inhibition DME0036 XEOTICID XEO01289 XEO_NAME Enniatins DME0036 XEOTICID XEO01289 XEO_TYPE Health or Environmental Toxicant(s) DME0036 XEOTICID XEO01289 XEO_CLAS Acute Toxic Substance DME0036 XEOTICID XEO01289 DESCRIPT Enniatins up-regulates the expression of DME CYP11B2 DME0036 XEOTICID XEO01289 GENEFORM mRNA DME0036 XEOTICID XEO01289 MOACRIVE Induction DME0036 XEOTICID XEO01373 XEO_NAME Mequindox DME0036 XEOTICID XEO01373 XEO_TYPE Pharmaceutical Agent(s) DME0036 XEOTICID XEO01373 XEO_CLAS Investigative Agent DME0036 XEOTICID XEO01373 DESCRIPT Mequindox inhibits the drug-metabolizing activity of DME CYP11B2 DME0036 XEOTICID XEO01373 GENEFORM Protein DME0036 XEOTICID XEO01373 MOACRIVE Inhibition DME0036 XEOTICID XEO01491 XEO_NAME Tributyltin DME0036 XEOTICID XEO01491 XEO_TYPE Pharmaceutical Agent(s) DME0036 XEOTICID XEO01491 XEO_CLAS Investigative Agent DME0036 XEOTICID XEO01491 DESCRIPT Tributyltin up-regulates the expression of DME CYP11B2 DME0036 XEOTICID XEO01491 GENEFORM mRNA DME0036 XEOTICID XEO01491 MOACRIVE Induction DME0036 XEOTICID XEO01514 XEO_NAME Deoxynivalenol DME0036 XEOTICID XEO01514 XEO_TYPE Health or Environmental Toxicant(s) DME0036 XEOTICID XEO01514 XEO_CLAS Mycotoxin DME0036 XEOTICID XEO01514 DESCRIPT Deoxynivalenol up-regulates the expression of DME CYP11B2 DME0036 XEOTICID XEO01514 GENEFORM mRNA DME0036 XEOTICID XEO01514 MOACRIVE Induction DME0036 XEOTICID XEO01612 XEO_NAME 2-acetyltributylcitrate DME0036 XEOTICID XEO01612 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0036 XEOTICID XEO01612 XEO_CLAS Cosmetic Additive DME0036 XEOTICID XEO01612 DESCRIPT 2-acetyltributylcitrate up-regulates the expression of DME CYP11B2 DME0036 XEOTICID XEO01612 GENEFORM mRNA DME0036 XEOTICID XEO01612 MOACRIVE Induction DME0037 DME___ID DME0037 DME0037 DME_NAME Steroid 21-hydroxylase (CYP21A2) DME0037 SPESNAME Homo sapiens DME0037 XEOTICID XEO00029 XEO_NAME Valproic acid DME0037 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0037 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0037 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the drug-metabolizing activity of DME CYP21A2 DME0037 XEOTICID XEO00029 GENEFORM Protein DME0037 XEOTICID XEO00029 MOACRIVE Inhibition DME0037 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0037 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0037 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0037 XEOTICID XEO00165 DESCRIPT Obeticholic acid inhibits the drug-metabolizing activity of DME CYP21A2 DME0037 XEOTICID XEO00165 GENEFORM Protein DME0037 XEOTICID XEO00165 MOACRIVE Inhibition DME0037 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0037 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0037 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0037 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP21A2 DME0037 XEOTICID XEO00217 GENEFORM mRNA DME0037 XEOTICID XEO00217 MOACRIVE Inhibition DME0037 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0037 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0037 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0037 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP21A2 DME0037 XEOTICID XEO00241 GENEFORM mRNA DME0037 XEOTICID XEO00241 MOACRIVE Inhibition DME0037 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0037 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0037 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0037 XEOTICID XEO00251 DESCRIPT Ketoconazole induces the drug-metabolizing activity of DME CYP21A2 DME0037 XEOTICID XEO00251 GENEFORM Protein DME0037 XEOTICID XEO00251 MOACRIVE Induction DME0037 XEOTICID XEO00435 XEO_NAME Urethane DME0037 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0037 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0037 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME CYP21A2 DME0037 XEOTICID XEO00435 GENEFORM mRNA DME0037 XEOTICID XEO00435 MOACRIVE Inhibition DME0037 XEOTICID XEO00568 XEO_NAME Resveratrol DME0037 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0037 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0037 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the expression of DME CYP21A2 DME0037 XEOTICID XEO00568 GENEFORM mRNA DME0037 XEOTICID XEO00568 MOACRIVE Inhibition DME0037 XEOTICID XEO00606 XEO_NAME Colforsin DME0037 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0037 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0037 XEOTICID XEO00606 DESCRIPT Colforsin up-regulates the expression of DME CYP21A2 DME0037 XEOTICID XEO00606 GENEFORM mRNA DME0037 XEOTICID XEO00606 MOACRIVE Induction DME0037 XEOTICID XEO00627 XEO_NAME Torcetrapib DME0037 XEOTICID XEO00627 XEO_TYPE Pharmaceutical Agent(s) DME0037 XEOTICID XEO00627 XEO_CLAS Drug in Phase 3 Clinical Trial DME0037 XEOTICID XEO00627 DESCRIPT Torcetrapib up-regulates the expression of DME CYP21A2 DME0037 XEOTICID XEO00627 GENEFORM mRNA DME0037 XEOTICID XEO00627 MOACRIVE Induction DME0037 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0037 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0037 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0037 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME CYP21A2 DME0037 XEOTICID XEO00806 GENEFORM mRNA DME0037 XEOTICID XEO00806 MOACRIVE Induction DME0037 XEOTICID XEO00893 XEO_NAME 1-nitropyrene DME0037 XEOTICID XEO00893 XEO_TYPE Health or Environmental Toxicant(s) DME0037 XEOTICID XEO00893 XEO_CLAS Carcinogen DME0037 XEOTICID XEO00893 DESCRIPT 1-nitropyrene inhibits the expression of DME CYP21A2 DME0037 XEOTICID XEO00893 GENEFORM mRNA DME0037 XEOTICID XEO00893 MOACRIVE Inhibition DME0037 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0037 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0037 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0037 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CYP21A2 DME0037 XEOTICID XEO00898 GENEFORM mRNA DME0037 XEOTICID XEO00898 MOACRIVE Induction DME0037 XEOTICID XEO00904 XEO_NAME Pentabromophenol DME0037 XEOTICID XEO00904 XEO_TYPE Health or Environmental Toxicant(s) DME0037 XEOTICID XEO00904 XEO_CLAS Acute Toxic Substance DME0037 XEOTICID XEO00904 DESCRIPT Pentabromophenol up-regulates the expression of DME CYP21A2 DME0037 XEOTICID XEO00904 GENEFORM mRNA DME0037 XEOTICID XEO00904 MOACRIVE Induction DME0037 XEOTICID XEO00984 XEO_NAME Galaxolide DME0037 XEOTICID XEO00984 XEO_TYPE Health or Environmental Toxicant(s) DME0037 XEOTICID XEO00984 XEO_CLAS Environmental Pollutant DME0037 XEOTICID XEO00984 DESCRIPT Galaxolide inhibits the drug-metabolizing activity of DME CYP21A2 DME0037 XEOTICID XEO00984 GENEFORM Protein DME0037 XEOTICID XEO00984 MOACRIVE Inhibition DME0037 XEOTICID XEO01100 XEO_NAME 3-Methylsulfonyl-dde DME0037 XEOTICID XEO01100 XEO_TYPE Health or Environmental Toxicant(s) DME0037 XEOTICID XEO01100 XEO_CLAS Environmental Pollutant DME0037 XEOTICID XEO01100 DESCRIPT 3-Methylsulfonyl-dde inhibits the expression of DME CYP21A2 DME0037 XEOTICID XEO01100 GENEFORM mRNA DME0037 XEOTICID XEO01100 MOACRIVE Inhibition DME0037 XEOTICID XEO01133 XEO_NAME 3,3',4,5'-tetrahydroxystilbene DME0037 XEOTICID XEO01133 XEO_TYPE Pharmaceutical Agent(s) DME0037 XEOTICID XEO01133 XEO_CLAS Investigative Agent DME0037 XEOTICID XEO01133 DESCRIPT 3,3',4,5'-tetrahydroxystilbene inhibits the expression of DME CYP21A2 DME0037 XEOTICID XEO01133 GENEFORM mRNA DME0037 XEOTICID XEO01133 MOACRIVE Inhibition DME0037 XEOTICID XEO01289 XEO_NAME Enniatins DME0037 XEOTICID XEO01289 XEO_TYPE Health or Environmental Toxicant(s) DME0037 XEOTICID XEO01289 XEO_CLAS Acute Toxic Substance DME0037 XEOTICID XEO01289 DESCRIPT Enniatins up-regulates the expression of DME CYP21A2 DME0037 XEOTICID XEO01289 GENEFORM mRNA DME0037 XEOTICID XEO01289 MOACRIVE Induction DME0037 XEOTICID XEO01302 XEO_NAME Fipronil DME0037 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0037 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0037 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME CYP21A2 DME0037 XEOTICID XEO01302 GENEFORM mRNA DME0037 XEOTICID XEO01302 MOACRIVE Induction DME0037 XEOTICID XEO01491 XEO_NAME Tributyltin DME0037 XEOTICID XEO01491 XEO_TYPE Pharmaceutical Agent(s) DME0037 XEOTICID XEO01491 XEO_CLAS Investigative Agent DME0037 XEOTICID XEO01491 DESCRIPT Tributyltin inhibits the expression of DME CYP21A2 DME0037 XEOTICID XEO01491 GENEFORM mRNA DME0037 XEOTICID XEO01491 MOACRIVE Inhibition DME0037 XEOTICID XEO01514 XEO_NAME Deoxynivalenol DME0037 XEOTICID XEO01514 XEO_TYPE Health or Environmental Toxicant(s) DME0037 XEOTICID XEO01514 XEO_CLAS Mycotoxin DME0037 XEOTICID XEO01514 DESCRIPT Deoxynivalenol up-regulates the expression of DME CYP21A2 DME0037 XEOTICID XEO01514 GENEFORM mRNA DME0037 XEOTICID XEO01514 MOACRIVE Induction DME0037 XEOTICID XEO01515 XEO_NAME HT-2 toxin DME0037 XEOTICID XEO01515 XEO_TYPE Health or Environmental Toxicant(s) DME0037 XEOTICID XEO01515 XEO_CLAS Mycotoxin DME0037 XEOTICID XEO01515 DESCRIPT HT-2 toxin up-regulates the expression of DME CYP21A2 DME0037 XEOTICID XEO01515 GENEFORM mRNA DME0037 XEOTICID XEO01515 MOACRIVE Induction DME0037 XEOTICID XEO01612 XEO_NAME 2-acetyltributylcitrate DME0037 XEOTICID XEO01612 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0037 XEOTICID XEO01612 XEO_CLAS Cosmetic Additive DME0037 XEOTICID XEO01612 DESCRIPT 2-acetyltributylcitrate up-regulates the expression of DME CYP21A2 DME0037 XEOTICID XEO01612 GENEFORM mRNA DME0037 XEOTICID XEO01612 MOACRIVE Induction DME0038 DME___ID DME0038 DME0038 DME_NAME Vitamin D(3) 24-hydroxylase (CYP24A1) DME0038 SPESNAME Homo sapiens DME0038 XEOTICID XEO00053 XEO_NAME Leflunomide DME0038 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00053 GENEFORM mRNA DME0038 XEOTICID XEO00053 MOACRIVE Induction DME0038 XEOTICID XEO00090 XEO_NAME Estradiol DME0038 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00090 GENEFORM mRNA DME0038 XEOTICID XEO00090 MOACRIVE Induction DME0038 XEOTICID XEO00096 XEO_NAME Ampicillin DME0038 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the expression of DME CYP24A1 DME0038 XEOTICID XEO00096 GENEFORM mRNA DME0038 XEOTICID XEO00096 MOACRIVE Inhibition DME0038 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0038 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00117 GENEFORM mRNA DME0038 XEOTICID XEO00117 MOACRIVE Induction DME0038 XEOTICID XEO00184 XEO_NAME Calcitriol DME0038 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00184 DESCRIPT Calcitriol induces the drug-metabolizing activity of DME CYP24A1 DME0038 XEOTICID XEO00184 GENEFORM Protein DME0038 XEOTICID XEO00184 MOACRIVE Induction DME0038 XEOTICID XEO00223 XEO_NAME Rifampin DME0038 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00223 DESCRIPT Rifampin up-regulates the expression of DME CYP24A1 and leads to increasing the drug-metabolizing activity of this enzyme DME0038 XEOTICID XEO00223 GENEFORM Protein DME0038 XEOTICID XEO00223 MOACRIVE Induction DME0038 XEOTICID XEO00230 XEO_NAME Calcifediol DME0038 XEOTICID XEO00230 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00230 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00230 DESCRIPT Calcifediol up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00230 GENEFORM mRNA DME0038 XEOTICID XEO00230 MOACRIVE Induction DME0038 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0038 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00241 GENEFORM mRNA DME0038 XEOTICID XEO00241 MOACRIVE Induction DME0038 XEOTICID XEO00250 XEO_NAME Itraconazole DME0038 XEOTICID XEO00250 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00250 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00250 DESCRIPT Itraconazole inhibits the drug-metabolizing activity of DME CYP24A1 DME0038 XEOTICID XEO00250 GENEFORM Protein DME0038 XEOTICID XEO00250 MOACRIVE Inhibition DME0038 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0038 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP24A1 (IC50 = 0.126 microM) DME0038 XEOTICID XEO00251 GENEFORM Protein DME0038 XEOTICID XEO00251 MOACRIVE Inhibition DME0038 XEOTICID XEO00261 XEO_NAME Calcipotriene DME0038 XEOTICID XEO00261 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00261 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00261 DESCRIPT Calcipotriene up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00261 GENEFORM mRNA DME0038 XEOTICID XEO00261 MOACRIVE Induction DME0038 XEOTICID XEO00334 XEO_NAME Cisplatin DME0038 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME CYP24A1 DME0038 XEOTICID XEO00334 GENEFORM mRNA DME0038 XEOTICID XEO00334 MOACRIVE Inhibition DME0038 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0038 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the drug-metabolizing activity of DME CYP24A1 DME0038 XEOTICID XEO00339 GENEFORM Protein DME0038 XEOTICID XEO00339 MOACRIVE Inhibition DME0038 XEOTICID XEO00361 XEO_NAME Gemcitabine DME0038 XEOTICID XEO00361 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00361 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00361 DESCRIPT Gemcitabine inhibits the expression of DME CYP24A1 DME0038 XEOTICID XEO00361 GENEFORM mRNA DME0038 XEOTICID XEO00361 MOACRIVE Inhibition DME0038 XEOTICID XEO00474 XEO_NAME Maxacalcitol DME0038 XEOTICID XEO00474 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00474 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00474 DESCRIPT Maxacalcitol up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00474 GENEFORM mRNA DME0038 XEOTICID XEO00474 MOACRIVE Induction DME0038 XEOTICID XEO00490 XEO_NAME Alfacalcidol DME0038 XEOTICID XEO00490 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00490 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00490 DESCRIPT Alfacalcidol up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00490 GENEFORM mRNA DME0038 XEOTICID XEO00490 MOACRIVE Induction DME0038 XEOTICID XEO00538 XEO_NAME Quercetin DME0038 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0038 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME CYP24A1 DME0038 XEOTICID XEO00538 GENEFORM Protein DME0038 XEOTICID XEO00538 MOACRIVE Inhibition DME0038 XEOTICID XEO00557 XEO_NAME Genistein DME0038 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0038 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME CYP24A1 DME0038 XEOTICID XEO00557 GENEFORM Protein DME0038 XEOTICID XEO00557 MOACRIVE Inhibition DME0038 XEOTICID XEO00581 XEO_NAME MS-275 DME0038 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0038 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00581 GENEFORM mRNA DME0038 XEOTICID XEO00581 MOACRIVE Induction DME0038 XEOTICID XEO00652 XEO_NAME Seocalcitol DME0038 XEOTICID XEO00652 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00652 XEO_CLAS Drug in Phase 3 Clinical Trial DME0038 XEOTICID XEO00652 DESCRIPT Seocalcitol up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00652 GENEFORM mRNA DME0038 XEOTICID XEO00652 MOACRIVE Induction DME0038 XEOTICID XEO00683 XEO_NAME Curcumin DME0038 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0038 XEOTICID XEO00683 DESCRIPT Curcumin induces the drug-metabolizing activity of DME CYP24A1 DME0038 XEOTICID XEO00683 GENEFORM Protein DME0038 XEOTICID XEO00683 MOACRIVE Induction DME0038 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0038 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0038 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME CYP24A1 DME0038 XEOTICID XEO00723 GENEFORM mRNA DME0038 XEOTICID XEO00723 MOACRIVE Inhibition DME0038 XEOTICID XEO00747 XEO_NAME Cholecalciferol DME0038 XEOTICID XEO00747 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00747 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00747 DESCRIPT Cholecalciferol up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00747 GENEFORM mRNA DME0038 XEOTICID XEO00747 MOACRIVE Induction DME0038 XEOTICID XEO00749 XEO_NAME Teriflunomide DME0038 XEOTICID XEO00749 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00749 XEO_CLAS Approved/Marketed Drug DME0038 XEOTICID XEO00749 DESCRIPT Teriflunomide inhibits the expression of DME CYP24A1 DME0038 XEOTICID XEO00749 GENEFORM mRNA DME0038 XEOTICID XEO00749 MOACRIVE Inhibition DME0038 XEOTICID XEO00757 XEO_NAME Apple polyphenol extract DME0038 XEOTICID XEO00757 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0038 XEOTICID XEO00757 XEO_CLAS Plant Extract DME0038 XEOTICID XEO00757 DESCRIPT Apple polyphenol extract up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00757 GENEFORM mRNA DME0038 XEOTICID XEO00757 MOACRIVE Induction DME0038 XEOTICID XEO00760 XEO_NAME Jinfukang DME0038 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0038 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0038 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00760 GENEFORM mRNA DME0038 XEOTICID XEO00760 MOACRIVE Induction DME0038 XEOTICID XEO00787 XEO_NAME Lithocholic acid DME0038 XEOTICID XEO00787 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO00787 XEO_CLAS Investigative Agent DME0038 XEOTICID XEO00787 DESCRIPT Lithocholic acid up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00787 GENEFORM mRNA DME0038 XEOTICID XEO00787 MOACRIVE Induction DME0038 XEOTICID XEO00831 XEO_NAME Nano-sized iron particle DME0038 XEOTICID XEO00831 XEO_TYPE Health or Environmental Toxicant(s) DME0038 XEOTICID XEO00831 XEO_CLAS Health Hazard/Toxicant DME0038 XEOTICID XEO00831 DESCRIPT Nano-sized iron particle inhibits the expression of DME CYP24A1 DME0038 XEOTICID XEO00831 GENEFORM mRNA DME0038 XEOTICID XEO00831 MOACRIVE Inhibition DME0038 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0038 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0038 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0038 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00898 GENEFORM mRNA DME0038 XEOTICID XEO00898 MOACRIVE Induction DME0038 XEOTICID XEO00919 XEO_NAME Particulate matter DME0038 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0038 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0038 XEOTICID XEO00919 DESCRIPT Particulate matter up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO00919 GENEFORM mRNA DME0038 XEOTICID XEO00919 MOACRIVE Induction DME0038 XEOTICID XEO00995 XEO_NAME Amphibole asbestos DME0038 XEOTICID XEO00995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0038 XEOTICID XEO00995 XEO_CLAS Natural Mixture DME0038 XEOTICID XEO00995 DESCRIPT Amphibole asbestos inhibits the expression of DME CYP24A1 DME0038 XEOTICID XEO00995 GENEFORM mRNA DME0038 XEOTICID XEO00995 MOACRIVE Inhibition DME0038 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0038 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0038 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0038 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate induces the drug-metabolizing activity of DME CYP24A1 DME0038 XEOTICID XEO01031 GENEFORM Protein DME0038 XEOTICID XEO01031 MOACRIVE Induction DME0038 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0038 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0038 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0038 XEOTICID XEO01050 DESCRIPT Dicrotophos up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO01050 GENEFORM mRNA DME0038 XEOTICID XEO01050 MOACRIVE Induction DME0038 XEOTICID XEO01335 XEO_NAME Hyperforin DME0038 XEOTICID XEO01335 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0038 XEOTICID XEO01335 XEO_CLAS Natural Product DME0038 XEOTICID XEO01335 DESCRIPT Hyperforin up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO01335 GENEFORM mRNA DME0038 XEOTICID XEO01335 MOACRIVE Induction DME0038 XEOTICID XEO01336 XEO_NAME ICG-001 DME0038 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0038 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0038 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME CYP24A1 DME0038 XEOTICID XEO01336 GENEFORM mRNA DME0038 XEOTICID XEO01336 MOACRIVE Inhibition DME0038 XEOTICID XEO01503 XEO_NAME Cadmium DME0038 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0038 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0038 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the expression of DME CYP24A1 DME0038 XEOTICID XEO01503 GENEFORM mRNA DME0038 XEOTICID XEO01503 MOACRIVE Inhibition DME0038 XEOTICID XEO01504 XEO_NAME Gold DME0038 XEOTICID XEO01504 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0038 XEOTICID XEO01504 XEO_CLAS Chemical Compound DME0038 XEOTICID XEO01504 DESCRIPT Gold up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO01504 GENEFORM mRNA DME0038 XEOTICID XEO01504 MOACRIVE Induction DME0038 XEOTICID XEO01512 XEO_NAME Zinc DME0038 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME0038 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME0038 XEOTICID XEO01512 DESCRIPT Zinc up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO01512 GENEFORM mRNA DME0038 XEOTICID XEO01512 MOACRIVE Induction DME0038 XEOTICID XEO01574 XEO_NAME Plant extracts DME0038 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0038 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0038 XEOTICID XEO01574 DESCRIPT Plant extracts up-regulates the expression of DME CYP24A1 DME0038 XEOTICID XEO01574 GENEFORM mRNA DME0038 XEOTICID XEO01574 MOACRIVE Induction DME0039 DME___ID DME0039 DME0039 DME_NAME Dimethylaniline oxidase 3 (FMO3) DME0039 SPESNAME Homo sapiens DME0039 XEOTICID XEO00171 XEO_NAME Potassium perchlorate DME0039 XEOTICID XEO00171 XEO_TYPE Pharmaceutical Agent(s) DME0039 XEOTICID XEO00171 XEO_CLAS Approved/Marketed Drug DME0039 XEOTICID XEO00171 DESCRIPT Potassium perchlorate inhibits the drug-metabolizing activity of DME FMO3 DME0039 XEOTICID XEO00171 GENEFORM Protein DME0039 XEOTICID XEO00171 MOACRIVE Inhibition DME0039 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0039 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0039 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0039 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME FMO3 DME0039 XEOTICID XEO00217 GENEFORM mRNA DME0039 XEOTICID XEO00217 MOACRIVE Inhibition DME0039 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0039 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0039 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0039 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME FMO3 DME0039 XEOTICID XEO00241 GENEFORM mRNA DME0039 XEOTICID XEO00241 MOACRIVE Inhibition DME0039 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0039 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0039 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0039 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME FMO3 DME0039 XEOTICID XEO00723 GENEFORM mRNA DME0039 XEOTICID XEO00723 MOACRIVE Inhibition DME0039 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0039 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0039 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0039 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME FMO3 DME0039 XEOTICID XEO00806 GENEFORM mRNA DME0039 XEOTICID XEO00806 MOACRIVE Inhibition DME0039 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0039 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0039 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0039 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution induces the drug-metabolizing activity of DME FMO3 DME0039 XEOTICID XEO00821 GENEFORM Protein DME0039 XEOTICID XEO00821 MOACRIVE Induction DME0039 XEOTICID XEO01551 XEO_NAME Heliotrine DME0039 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0039 XEOTICID XEO01551 XEO_CLAS Natural Product DME0039 XEOTICID XEO01551 DESCRIPT Heliotrine inhibits the expression of DME FMO3 DME0039 XEOTICID XEO01551 GENEFORM mRNA DME0039 XEOTICID XEO01551 MOACRIVE Inhibition DME0039 XEOTICID XEO01582 XEO_NAME Pyrrolizidine alkaloid DME0039 XEOTICID XEO01582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0039 XEOTICID XEO01582 XEO_CLAS Natural Product DME0039 XEOTICID XEO01582 DESCRIPT Pyrrolizidine alkaloid inhibits the expression of DME FMO3 DME0039 XEOTICID XEO01582 GENEFORM mRNA DME0039 XEOTICID XEO01582 MOACRIVE Inhibition DME0040 DME___ID DME0040 DME0040 DME_NAME UDP-glucuronosyltransferase 2B7 (UGT2B7) DME0040 SPESNAME Homo sapiens DME0040 XEOTICID XEO00029 XEO_NAME Valproic acid DME0040 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0040 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0040 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the drug-metabolizing activity of DME UGT2B7 (Ki = 1600 microM) DME0040 XEOTICID XEO00029 GENEFORM Protein DME0040 XEOTICID XEO00029 MOACRIVE Inhibition DME0040 XEOTICID XEO00095 XEO_NAME Testosterone DME0040 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0040 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0040 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME UGT2B7 DME0040 XEOTICID XEO00095 GENEFORM mRNA DME0040 XEOTICID XEO00095 MOACRIVE Induction DME0040 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0040 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0040 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0040 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME UGT2B7 DME0040 XEOTICID XEO00117 GENEFORM mRNA DME0040 XEOTICID XEO00117 MOACRIVE Inhibition DME0040 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0040 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0040 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0040 XEOTICID XEO00165 DESCRIPT Obeticholic acid inhibits the drug-metabolizing activity of DME UGT2B7 DME0040 XEOTICID XEO00165 GENEFORM Protein DME0040 XEOTICID XEO00165 MOACRIVE Inhibition DME0040 XEOTICID XEO00215 XEO_NAME Zidovudine DME0040 XEOTICID XEO00215 XEO_TYPE Pharmaceutical Agent(s) DME0040 XEOTICID XEO00215 XEO_CLAS Approved/Marketed Drug DME0040 XEOTICID XEO00215 DESCRIPT Zidovudine inhibits the drug-metabolizing activity of DME UGT2B7 (Ki = 150 microM) DME0040 XEOTICID XEO00215 GENEFORM Protein DME0040 XEOTICID XEO00215 MOACRIVE Inhibition DME0040 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0040 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0040 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0040 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME UGT2B7 DME0040 XEOTICID XEO00217 GENEFORM mRNA DME0040 XEOTICID XEO00217 MOACRIVE Inhibition DME0040 XEOTICID XEO00435 XEO_NAME Urethane DME0040 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0040 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0040 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME UGT2B7 DME0040 XEOTICID XEO00435 GENEFORM mRNA DME0040 XEOTICID XEO00435 MOACRIVE Inhibition DME0040 XEOTICID XEO00555 XEO_NAME Hymecromone DME0040 XEOTICID XEO00555 XEO_TYPE Pharmaceutical Agent(s) DME0040 XEOTICID XEO00555 XEO_CLAS Drug in Phase 1 Clinical Trial DME0040 XEOTICID XEO00555 DESCRIPT Hymecromone induces the drug-metabolizing activity of DME UGT2B7 DME0040 XEOTICID XEO00555 GENEFORM Protein DME0040 XEOTICID XEO00555 MOACRIVE Induction DME0040 XEOTICID XEO00560 XEO_NAME Triclosan DME0040 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0040 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0040 XEOTICID XEO00560 DESCRIPT Triclosan induces the drug-metabolizing activity of DME UGT2B7 DME0040 XEOTICID XEO00560 GENEFORM Protein DME0040 XEOTICID XEO00560 MOACRIVE Induction DME0040 XEOTICID XEO00562 XEO_NAME Androsterone DME0040 XEOTICID XEO00562 XEO_TYPE Pharmaceutical Agent(s) DME0040 XEOTICID XEO00562 XEO_CLAS Drug in Phase 3 Clinical Trial DME0040 XEOTICID XEO00562 DESCRIPT Androsterone inhibits the drug-metabolizing activity of DME UGT2B7 DME0040 XEOTICID XEO00562 GENEFORM Protein DME0040 XEOTICID XEO00562 MOACRIVE Inhibition DME0040 XEOTICID XEO00568 XEO_NAME Resveratrol DME0040 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0040 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0040 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME UGT2B7 DME0040 XEOTICID XEO00568 GENEFORM mRNA DME0040 XEOTICID XEO00568 MOACRIVE Induction DME0040 XEOTICID XEO00757 XEO_NAME Apple polyphenol extract DME0040 XEOTICID XEO00757 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0040 XEOTICID XEO00757 XEO_CLAS Plant Extract DME0040 XEOTICID XEO00757 DESCRIPT Apple polyphenol extract up-regulates the expression of DME UGT2B7 DME0040 XEOTICID XEO00757 GENEFORM mRNA DME0040 XEOTICID XEO00757 MOACRIVE Induction DME0040 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0040 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0040 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0040 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME UGT2B7 DME0040 XEOTICID XEO00806 GENEFORM mRNA DME0040 XEOTICID XEO00806 MOACRIVE Induction DME0040 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0040 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0040 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0040 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME UGT2B7 DME0040 XEOTICID XEO00898 GENEFORM mRNA DME0040 XEOTICID XEO00898 MOACRIVE Induction DME0040 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0040 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0040 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0040 XEOTICID XEO00899 DESCRIPT Methylcholanthrene up-regulates the expression of DME UGT2B7 DME0040 XEOTICID XEO00899 GENEFORM mRNA DME0040 XEOTICID XEO00899 MOACRIVE Induction DME0040 XEOTICID XEO00942 XEO_NAME Cyproconazole DME0040 XEOTICID XEO00942 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0040 XEOTICID XEO00942 XEO_CLAS Fungicide DME0040 XEOTICID XEO00942 DESCRIPT Cyproconazole inhibits the drug-metabolizing activity of DME UGT2B7 DME0040 XEOTICID XEO00942 GENEFORM Protein DME0040 XEOTICID XEO00942 MOACRIVE Inhibition DME0040 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0040 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0040 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0040 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME UGT2B7 DME0040 XEOTICID XEO01050 GENEFORM mRNA DME0040 XEOTICID XEO01050 MOACRIVE Inhibition DME0040 XEOTICID XEO01088 XEO_NAME Tcpobop DME0040 XEOTICID XEO01088 XEO_TYPE Pharmaceutical Agent(s) DME0040 XEOTICID XEO01088 XEO_CLAS Preclinical/Patented Drug DME0040 XEOTICID XEO01088 DESCRIPT Tcpobop inhibits the expression of DME UGT2B7 DME0040 XEOTICID XEO01088 GENEFORM mRNA DME0040 XEOTICID XEO01088 MOACRIVE Inhibition DME0040 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0040 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0040 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0040 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone up-regulates the expression of DME UGT2B7 DME0040 XEOTICID XEO01129 GENEFORM mRNA DME0040 XEOTICID XEO01129 MOACRIVE Induction DME0040 XEOTICID XEO01370 XEO_NAME Mangiferin DME0040 XEOTICID XEO01370 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0040 XEOTICID XEO01370 XEO_CLAS Natural Product DME0040 XEOTICID XEO01370 DESCRIPT Mangiferin inhibits the drug-metabolizing activity of DME UGT2B7 DME0040 XEOTICID XEO01370 GENEFORM Protein DME0040 XEOTICID XEO01370 MOACRIVE Inhibition DME0041 DME___ID DME0041 DME0041 DME_NAME UDP-glucuronosyltransferase 1A3 (UGT1A3) DME0041 SPESNAME Homo sapiens DME0041 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0041 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0041 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0041 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME UGT1A3 DME0041 XEOTICID XEO00035 GENEFORM mRNA DME0041 XEOTICID XEO00035 MOACRIVE Induction DME0041 XEOTICID XEO00090 XEO_NAME Estradiol DME0041 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0041 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0041 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME UGT1A3 DME0041 XEOTICID XEO00090 GENEFORM mRNA DME0041 XEOTICID XEO00090 MOACRIVE Inhibition DME0041 XEOTICID XEO00223 XEO_NAME Rifampin DME0041 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0041 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0041 XEOTICID XEO00223 DESCRIPT Rifampin induces the drug-metabolizing activity of DME UGT1A3 DME0041 XEOTICID XEO00223 GENEFORM Protein DME0041 XEOTICID XEO00223 MOACRIVE Induction DME0041 XEOTICID XEO00352 XEO_NAME Diclofenac DME0041 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0041 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0041 XEOTICID XEO00352 DESCRIPT Diclof DMEenac inhibits the drug-metabolizing activity of DME UGT1A3 DME0041 XEOTICID XEO00352 GENEFORM Protein DME0041 XEOTICID XEO00352 MOACRIVE Inhibition DME0041 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0041 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0041 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0041 XEOTICID XEO00380 DESCRIPT Rosiglitazone up-regulates the expression of DME UGT1A3 DME0041 XEOTICID XEO00380 GENEFORM mRNA DME0041 XEOTICID XEO00380 MOACRIVE Induction DME0041 XEOTICID XEO00400 XEO_NAME Warfarin DME0041 XEOTICID XEO00400 XEO_TYPE Pharmaceutical Agent(s) DME0041 XEOTICID XEO00400 XEO_CLAS Approved/Marketed Drug DME0041 XEOTICID XEO00400 DESCRIPT Warfarin up-regulates the expression of DME UGT1A3 DME0041 XEOTICID XEO00400 GENEFORM mRNA DME0041 XEOTICID XEO00400 MOACRIVE Induction DME0041 XEOTICID XEO00498 XEO_NAME Flunitrazepam DME0041 XEOTICID XEO00498 XEO_TYPE Pharmaceutical Agent(s) DME0041 XEOTICID XEO00498 XEO_CLAS Approved/Marketed Drug DME0041 XEOTICID XEO00498 DESCRIPT Flunitrazepam inhibits the drug-metabolizing activity of DME UGT1A3 DME0041 XEOTICID XEO00498 GENEFORM Protein DME0041 XEOTICID XEO00498 MOACRIVE Inhibition DME0041 XEOTICID XEO00555 XEO_NAME Hymecromone DME0041 XEOTICID XEO00555 XEO_TYPE Pharmaceutical Agent(s) DME0041 XEOTICID XEO00555 XEO_CLAS Drug in Phase 1 Clinical Trial DME0041 XEOTICID XEO00555 DESCRIPT Hymecromone induces the drug-metabolizing activity of DME UGT1A3 DME0041 XEOTICID XEO00555 GENEFORM Protein DME0041 XEOTICID XEO00555 MOACRIVE Induction DME0041 XEOTICID XEO00557 XEO_NAME Genistein DME0041 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0041 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0041 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME UGT1A3 DME0041 XEOTICID XEO00557 GENEFORM mRNA DME0041 XEOTICID XEO00557 MOACRIVE Inhibition DME0041 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0041 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0041 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0041 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME UGT1A3 DME0041 XEOTICID XEO00723 GENEFORM mRNA DME0041 XEOTICID XEO00723 MOACRIVE Inhibition DME0041 XEOTICID XEO00787 XEO_NAME Lithocholic acid DME0041 XEOTICID XEO00787 XEO_TYPE Pharmaceutical Agent(s) DME0041 XEOTICID XEO00787 XEO_CLAS Investigative Agent DME0041 XEOTICID XEO00787 DESCRIPT Lithocholic acid up-regulates the expression of DME UGT1A3 DME0041 XEOTICID XEO00787 GENEFORM mRNA DME0041 XEOTICID XEO00787 MOACRIVE Induction DME0041 XEOTICID XEO00877 XEO_NAME Bilirubin DME0041 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0041 XEOTICID XEO00877 XEO_CLAS Natural Product DME0041 XEOTICID XEO00877 DESCRIPT Bilirubin inhibits the drug-metabolizing activity of DME UGT1A3 DME0041 XEOTICID XEO00877 GENEFORM Protein DME0041 XEOTICID XEO00877 MOACRIVE Inhibition DME0041 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0041 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0041 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0041 XEOTICID XEO00899 DESCRIPT Methylcholanthrene up-regulates the expression of DME UGT1A3 DME0041 XEOTICID XEO00899 GENEFORM mRNA DME0041 XEOTICID XEO00899 MOACRIVE Induction DME0041 XEOTICID XEO01195 XEO_NAME Amentoflavone DME0041 XEOTICID XEO01195 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0041 XEOTICID XEO01195 XEO_CLAS Natural Product DME0041 XEOTICID XEO01195 DESCRIPT Amentof DMElavone inhibits the drug-metabolizing activity of DME UGT1A3 DME0041 XEOTICID XEO01195 GENEFORM Protein DME0041 XEOTICID XEO01195 MOACRIVE Inhibition DME0041 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0041 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0041 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0041 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME UGT1A3 DME0041 XEOTICID XEO01220 GENEFORM mRNA DME0041 XEOTICID XEO01220 MOACRIVE Induction DME0041 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0041 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0041 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0041 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME UGT1A3 DME0041 XEOTICID XEO01226 GENEFORM mRNA DME0041 XEOTICID XEO01226 MOACRIVE Inhibition DME0041 XEOTICID XEO01433 XEO_NAME Pirinixic acid DME0041 XEOTICID XEO01433 XEO_TYPE Health or Environmental Toxicant(s) DME0041 XEOTICID XEO01433 XEO_CLAS Health Hazard/Toxicant DME0041 XEOTICID XEO01433 DESCRIPT Pirinixic acid induces the drug-metabolizing activity of DME UGT1A3 DME0041 XEOTICID XEO01433 GENEFORM Protein DME0041 XEOTICID XEO01433 MOACRIVE Induction DME0041 XEOTICID XEO01512 XEO_NAME Zinc DME0041 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME0041 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME0041 XEOTICID XEO01512 DESCRIPT Zinc induces the drug-metabolizing activity of DME UGT1A3 DME0041 XEOTICID XEO01512 GENEFORM Protein DME0041 XEOTICID XEO01512 MOACRIVE Induction DME0042 DME___ID DME0042 DME0042 DME_NAME UDP-glucuronosyltransferase 1A9 (UGT1A9) DME0042 SPESNAME Homo sapiens DME0042 XEOTICID XEO00029 XEO_NAME Valproic acid DME0042 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0042 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0042 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME UGT1A9 DME0042 XEOTICID XEO00029 GENEFORM mRNA DME0042 XEOTICID XEO00029 MOACRIVE Inhibition DME0042 XEOTICID XEO00069 XEO_NAME Omeprazole DME0042 XEOTICID XEO00069 XEO_TYPE Pharmaceutical Agent(s) DME0042 XEOTICID XEO00069 XEO_CLAS Approved/Marketed Drug DME0042 XEOTICID XEO00069 DESCRIPT Omeprazole up-regulates the expression of DME UGT1A9 DME0042 XEOTICID XEO00069 GENEFORM mRNA DME0042 XEOTICID XEO00069 MOACRIVE Induction DME0042 XEOTICID XEO00090 XEO_NAME Estradiol DME0042 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0042 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0042 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the drug-metabolizing activity of DME UGT1A9 DME0042 XEOTICID XEO00090 GENEFORM Protein DME0042 XEOTICID XEO00090 MOACRIVE Inhibition DME0042 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0042 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0042 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0042 XEOTICID XEO00165 DESCRIPT Obeticholic acid inhibits the drug-metabolizing activity of DME UGT1A9 DME0042 XEOTICID XEO00165 GENEFORM Protein DME0042 XEOTICID XEO00165 MOACRIVE Inhibition DME0042 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0042 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0042 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0042 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME UGT1A9 DME0042 XEOTICID XEO00217 GENEFORM mRNA DME0042 XEOTICID XEO00217 MOACRIVE Inhibition DME0042 XEOTICID XEO00223 XEO_NAME Rifampin DME0042 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0042 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0042 XEOTICID XEO00223 DESCRIPT Rifampin up-regulates the expression of DME UGT1A9 DME0042 XEOTICID XEO00223 GENEFORM mRNA DME0042 XEOTICID XEO00223 MOACRIVE Induction DME0042 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0042 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0042 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0042 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME UGT1A9 DME0042 XEOTICID XEO00339 GENEFORM mRNA DME0042 XEOTICID XEO00339 MOACRIVE Inhibition DME0042 XEOTICID XEO00366 XEO_NAME Methotrexate DME0042 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0042 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0042 XEOTICID XEO00366 DESCRIPT Methotrexate inhibits the expression of DME UGT1A9 DME0042 XEOTICID XEO00366 GENEFORM mRNA DME0042 XEOTICID XEO00366 MOACRIVE Inhibition DME0042 XEOTICID XEO00555 XEO_NAME Hymecromone DME0042 XEOTICID XEO00555 XEO_TYPE Pharmaceutical Agent(s) DME0042 XEOTICID XEO00555 XEO_CLAS Drug in Phase 1 Clinical Trial DME0042 XEOTICID XEO00555 DESCRIPT Hymecromone induces the drug-metabolizing activity of DME UGT1A9 DME0042 XEOTICID XEO00555 GENEFORM Protein DME0042 XEOTICID XEO00555 MOACRIVE Induction DME0042 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0042 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0042 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0042 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME UGT1A9 DME0042 XEOTICID XEO00723 GENEFORM mRNA DME0042 XEOTICID XEO00723 MOACRIVE Inhibition DME0042 XEOTICID XEO00760 XEO_NAME Jinfukang DME0042 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0042 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0042 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME UGT1A9 DME0042 XEOTICID XEO00760 GENEFORM mRNA DME0042 XEOTICID XEO00760 MOACRIVE Induction DME0042 XEOTICID XEO00826 XEO_NAME Mangifera indica extract DME0042 XEOTICID XEO00826 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0042 XEOTICID XEO00826 XEO_CLAS Plant Extract DME0042 XEOTICID XEO00826 DESCRIPT Mangifera indica extract induces the drug-metabolizing activity of DME UGT1A9 DME0042 XEOTICID XEO00826 GENEFORM Protein DME0042 XEOTICID XEO00826 MOACRIVE Induction DME0042 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0042 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0042 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0042 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene induces the drug-metabolizing activity of DME UGT1A9 DME0042 XEOTICID XEO00898 GENEFORM Protein DME0042 XEOTICID XEO00898 MOACRIVE Induction DME0042 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0042 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0042 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0042 XEOTICID XEO00899 DESCRIPT Methylcholanthrene up-regulates the expression of DME UGT1A9 DME0042 XEOTICID XEO00899 GENEFORM mRNA DME0042 XEOTICID XEO00899 MOACRIVE Induction DME0042 XEOTICID XEO00987 XEO_NAME 1-naphthylamine DME0042 XEOTICID XEO00987 XEO_TYPE Health or Environmental Toxicant(s) DME0042 XEOTICID XEO00987 XEO_CLAS Environmental Pollutant DME0042 XEOTICID XEO00987 DESCRIPT 1-naphthylamine inhibits the drug-metabolizing activity of DME UGT1A9 DME0042 XEOTICID XEO00987 GENEFORM Protein DME0042 XEOTICID XEO00987 MOACRIVE Inhibition DME0042 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0042 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0042 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0042 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone up-regulates the expression of DME UGT1A9 DME0042 XEOTICID XEO01129 GENEFORM mRNA DME0042 XEOTICID XEO01129 MOACRIVE Induction DME0042 XEOTICID XEO01195 XEO_NAME Amentoflavone DME0042 XEOTICID XEO01195 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0042 XEOTICID XEO01195 XEO_CLAS Natural Product DME0042 XEOTICID XEO01195 DESCRIPT Amentof DMElavone inhibits the drug-metabolizing activity of DME UGT1A9 DME0042 XEOTICID XEO01195 GENEFORM Protein DME0042 XEOTICID XEO01195 MOACRIVE Inhibition DME0042 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0042 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0042 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0042 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME UGT1A9 DME0042 XEOTICID XEO01220 GENEFORM mRNA DME0042 XEOTICID XEO01220 MOACRIVE Induction DME0042 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0042 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0042 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0042 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME UGT1A9 DME0042 XEOTICID XEO01226 GENEFORM mRNA DME0042 XEOTICID XEO01226 MOACRIVE Inhibition DME0043 DME___ID DME0043 DME0043 DME_NAME Catechol O-methyltransferase (COMT) DME0043 SPESNAME Homo sapiens DME0043 XEOTICID XEO00029 XEO_NAME Valproic acid DME0043 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0043 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the drug-metabolizing activity of DME COMT DME0043 XEOTICID XEO00029 GENEFORM Protein DME0043 XEOTICID XEO00029 MOACRIVE Inhibition DME0043 XEOTICID XEO00090 XEO_NAME Estradiol DME0043 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0043 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the drug-metabolizing activity of DME COMT DME0043 XEOTICID XEO00090 GENEFORM Protein DME0043 XEOTICID XEO00090 MOACRIVE Inhibition DME0043 XEOTICID XEO00094 XEO_NAME Progesterone DME0043 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0043 XEOTICID XEO00094 DESCRIPT Progesterone inhibits the expression of DME COMT DME0043 XEOTICID XEO00094 GENEFORM mRNA DME0043 XEOTICID XEO00094 MOACRIVE Inhibition DME0043 XEOTICID XEO00109 XEO_NAME Megestrol acetate DME0043 XEOTICID XEO00109 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO00109 XEO_CLAS Approved/Marketed Drug DME0043 XEOTICID XEO00109 DESCRIPT Megestrol acetate up-regulates the expression of DME COMT DME0043 XEOTICID XEO00109 GENEFORM mRNA DME0043 XEOTICID XEO00109 MOACRIVE Induction DME0043 XEOTICID XEO00182 XEO_NAME Tolcapone DME0043 XEOTICID XEO00182 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO00182 XEO_CLAS Approved/Marketed Drug DME0043 XEOTICID XEO00182 DESCRIPT Tolcapone inhibits the drug-metabolizing activity of DME COMT (IC50 = 0.127 microM) DME0043 XEOTICID XEO00182 GENEFORM Protein DME0043 XEOTICID XEO00182 MOACRIVE Inhibition DME0043 XEOTICID XEO00185 XEO_NAME Entacapone DME0043 XEOTICID XEO00185 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO00185 XEO_CLAS Approved/Marketed Drug DME0043 XEOTICID XEO00185 DESCRIPT Entacapone inhibits the drug-metabolizing activity of DME COMT (IC50 = 0.386 microM) DME0043 XEOTICID XEO00185 GENEFORM Protein DME0043 XEOTICID XEO00185 MOACRIVE Inhibition DME0043 XEOTICID XEO00233 XEO_NAME Aminoglutethimide DME0043 XEOTICID XEO00233 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO00233 XEO_CLAS Approved/Marketed Drug DME0043 XEOTICID XEO00233 DESCRIPT Aminoglutethimide induces the drug-metabolizing activity of DME COMT DME0043 XEOTICID XEO00233 GENEFORM Protein DME0043 XEOTICID XEO00233 MOACRIVE Induction DME0043 XEOTICID XEO00253 XEO_NAME Tretinoin DME0043 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0043 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME COMT DME0043 XEOTICID XEO00253 GENEFORM mRNA DME0043 XEOTICID XEO00253 MOACRIVE Induction DME0043 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0043 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0043 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the expression of DME COMT DME0043 XEOTICID XEO00388 GENEFORM mRNA DME0043 XEOTICID XEO00388 MOACRIVE Inhibition DME0043 XEOTICID XEO00439 XEO_NAME Daidzein DME0043 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME0043 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of DME COMT DME0043 XEOTICID XEO00439 GENEFORM Protein DME0043 XEOTICID XEO00439 MOACRIVE Inhibition DME0043 XEOTICID XEO00554 XEO_NAME Fingolimod hydrochloride DME0043 XEOTICID XEO00554 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO00554 XEO_CLAS Drug in Phase 1 Clinical Trial DME0043 XEOTICID XEO00554 DESCRIPT Fingolimod hydrochloride up-regulates the expression of DME COMT DME0043 XEOTICID XEO00554 GENEFORM mRNA DME0043 XEOTICID XEO00554 MOACRIVE Induction DME0043 XEOTICID XEO00557 XEO_NAME Genistein DME0043 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0043 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME COMT DME0043 XEOTICID XEO00557 GENEFORM Protein DME0043 XEOTICID XEO00557 MOACRIVE Inhibition DME0043 XEOTICID XEO00869 XEO_NAME 4-hydroxy-2-nonenal DME0043 XEOTICID XEO00869 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO00869 XEO_CLAS Investigative Agent DME0043 XEOTICID XEO00869 DESCRIPT 4-hydroxy-2-nonenal inhibits the expression of DME COMT DME0043 XEOTICID XEO00869 GENEFORM mRNA DME0043 XEOTICID XEO00869 MOACRIVE Inhibition DME0043 XEOTICID XEO00951 XEO_NAME Hexachlorobenzene DME0043 XEOTICID XEO00951 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0043 XEOTICID XEO00951 XEO_CLAS Fungicide DME0043 XEOTICID XEO00951 DESCRIPT Hexachlorobenzene induces the drug-metabolizing activity of DME COMT DME0043 XEOTICID XEO00951 GENEFORM Protein DME0043 XEOTICID XEO00951 MOACRIVE Induction DME0043 XEOTICID XEO00998 XEO_NAME Butylbenzyl phthalate DME0043 XEOTICID XEO00998 XEO_TYPE Health or Environmental Toxicant(s) DME0043 XEOTICID XEO00998 XEO_CLAS Health Hazard/Toxicant DME0043 XEOTICID XEO00998 DESCRIPT Butylbenzyl phthalate inhibits the expression of DME COMT DME0043 XEOTICID XEO00998 GENEFORM mRNA DME0043 XEOTICID XEO00998 MOACRIVE Inhibition DME0043 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0043 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0043 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0043 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME COMT DME0043 XEOTICID XEO01004 GENEFORM mRNA DME0043 XEOTICID XEO01004 MOACRIVE Induction DME0043 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0043 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0043 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME COMT DME0043 XEOTICID XEO01226 GENEFORM mRNA DME0043 XEOTICID XEO01226 MOACRIVE Inhibition DME0043 XEOTICID XEO01230 XEO_NAME Butyric acid DME0043 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0043 XEOTICID XEO01230 DESCRIPT Butyric acid inhibits the expression of DME COMT DME0043 XEOTICID XEO01230 GENEFORM mRNA DME0043 XEOTICID XEO01230 MOACRIVE Inhibition DME0043 XEOTICID XEO01261 XEO_NAME Coumestrol DME0043 XEOTICID XEO01261 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO01261 XEO_CLAS Investigative Agent DME0043 XEOTICID XEO01261 DESCRIPT Coumestrol inhibits the expression of DME COMT DME0043 XEOTICID XEO01261 GENEFORM mRNA DME0043 XEOTICID XEO01261 MOACRIVE Inhibition DME0043 XEOTICID XEO01275 XEO_NAME Dibutyl phthalate DME0043 XEOTICID XEO01275 XEO_TYPE Health or Environmental Toxicant(s) DME0043 XEOTICID XEO01275 XEO_CLAS Health Hazard/Toxicant DME0043 XEOTICID XEO01275 DESCRIPT Dibutyl phthalate inhibits the expression of DME COMT DME0043 XEOTICID XEO01275 GENEFORM mRNA DME0043 XEOTICID XEO01275 MOACRIVE Inhibition DME0043 XEOTICID XEO01284 XEO_NAME Dust DME0043 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0043 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0043 XEOTICID XEO01284 DESCRIPT Dust inhibits the expression of DME COMT DME0043 XEOTICID XEO01284 GENEFORM mRNA DME0043 XEOTICID XEO01284 MOACRIVE Inhibition DME0043 XEOTICID XEO01336 XEO_NAME ICG-001 DME0043 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0043 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME COMT DME0043 XEOTICID XEO01336 GENEFORM mRNA DME0043 XEOTICID XEO01336 MOACRIVE Induction DME0043 XEOTICID XEO01348 XEO_NAME K-7174 DME0043 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0043 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0043 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME COMT DME0043 XEOTICID XEO01348 GENEFORM mRNA DME0043 XEOTICID XEO01348 MOACRIVE Inhibition DME0043 XEOTICID XEO01409 XEO_NAME Okadaic acid DME0043 XEOTICID XEO01409 XEO_TYPE Health or Environmental Toxicant(s) DME0043 XEOTICID XEO01409 XEO_CLAS Acute Toxic Substance DME0043 XEOTICID XEO01409 DESCRIPT Okadaic acid inhibits the expression of DME COMT DME0043 XEOTICID XEO01409 GENEFORM mRNA DME0043 XEOTICID XEO01409 MOACRIVE Inhibition DME0043 XEOTICID XEO01410 XEO_NAME Oleacein DME0043 XEOTICID XEO01410 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0043 XEOTICID XEO01410 XEO_CLAS Natural Product DME0043 XEOTICID XEO01410 DESCRIPT Oleacein inhibits the expression of DME COMT DME0043 XEOTICID XEO01410 GENEFORM mRNA DME0043 XEOTICID XEO01410 MOACRIVE Inhibition DME0044 DME___ID DME0044 DME0044 DME_NAME Monoamine oxidase type A (MAO-A) DME0044 SPESNAME Homo sapiens DME0044 XEOTICID XEO00008 XEO_NAME Benzyl benzoate DME0044 XEOTICID XEO00008 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00008 XEO_CLAS Approved/Marketed Drug DME0044 XEOTICID XEO00008 DESCRIPT Benzyl benzoate inhibits the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO00008 GENEFORM Protein DME0044 XEOTICID XEO00008 MOACRIVE Inhibition DME0044 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0044 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0044 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME MAOA DME0044 XEOTICID XEO00011 GENEFORM mRNA DME0044 XEOTICID XEO00011 MOACRIVE Induction DME0044 XEOTICID XEO00018 XEO_NAME Cyclophosphamide DME0044 XEOTICID XEO00018 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00018 XEO_CLAS Approved/Marketed Drug DME0044 XEOTICID XEO00018 DESCRIPT Cyclophosphamide up-regulates the expression of DME MAOA DME0044 XEOTICID XEO00018 GENEFORM mRNA DME0044 XEOTICID XEO00018 MOACRIVE Induction DME0044 XEOTICID XEO00029 XEO_NAME Valproic acid DME0044 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0044 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME MAOA DME0044 XEOTICID XEO00029 GENEFORM mRNA DME0044 XEOTICID XEO00029 MOACRIVE Induction DME0044 XEOTICID XEO00086 XEO_NAME Troglitazone DME0044 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0044 XEOTICID XEO00086 DESCRIPT Troglitazone inhibits the expression of DME MAOA DME0044 XEOTICID XEO00086 GENEFORM mRNA DME0044 XEOTICID XEO00086 MOACRIVE Inhibition DME0044 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0044 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0044 XEOTICID XEO00088 DESCRIPT Dexamethasone induces the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO00088 GENEFORM Protein DME0044 XEOTICID XEO00088 MOACRIVE Induction DME0044 XEOTICID XEO00090 XEO_NAME Estradiol DME0044 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0044 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME MAOA DME0044 XEOTICID XEO00090 GENEFORM mRNA DME0044 XEOTICID XEO00090 MOACRIVE Inhibition DME0044 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0044 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0044 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME MAOA DME0044 XEOTICID XEO00117 GENEFORM mRNA DME0044 XEOTICID XEO00117 MOACRIVE Inhibition DME0044 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0044 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0044 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol up-regulates the expression of DME MAOA DME0044 XEOTICID XEO00166 GENEFORM mRNA DME0044 XEOTICID XEO00166 MOACRIVE Induction DME0044 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0044 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0044 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME MAOA DME0044 XEOTICID XEO00217 GENEFORM mRNA DME0044 XEOTICID XEO00217 MOACRIVE Inhibition DME0044 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0044 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0044 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME MAOA DME0044 XEOTICID XEO00241 GENEFORM mRNA DME0044 XEOTICID XEO00241 MOACRIVE Inhibition DME0044 XEOTICID XEO00264 XEO_NAME Hydrocortisone DME0044 XEOTICID XEO00264 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00264 XEO_CLAS Approved/Marketed Drug DME0044 XEOTICID XEO00264 DESCRIPT Hydrocortisone up-regulates the expression of DME MAOA DME0044 XEOTICID XEO00264 GENEFORM mRNA DME0044 XEOTICID XEO00264 MOACRIVE Induction DME0044 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0044 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0044 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME MAOA DME0044 XEOTICID XEO00292 GENEFORM mRNA DME0044 XEOTICID XEO00292 MOACRIVE Inhibition DME0044 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0044 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0044 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME MAOA DME0044 XEOTICID XEO00339 GENEFORM mRNA DME0044 XEOTICID XEO00339 MOACRIVE Induction DME0044 XEOTICID XEO00529 XEO_NAME Phenylpropanolamine DME0044 XEOTICID XEO00529 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00529 XEO_CLAS Drug Marketed but Withdrawn from Market DME0044 XEOTICID XEO00529 DESCRIPT Phenylpropanolamine inhibits the expression of DME MAOA DME0044 XEOTICID XEO00529 GENEFORM mRNA DME0044 XEOTICID XEO00529 MOACRIVE Inhibition DME0044 XEOTICID XEO00537 XEO_NAME Luteolin DME0044 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME0044 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of DME MAOA (IC50 = 4.9 microM) DME0044 XEOTICID XEO00537 GENEFORM Protein DME0044 XEOTICID XEO00537 MOACRIVE Inhibition DME0044 XEOTICID XEO00539 XEO_NAME Ethanol DME0044 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0044 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO00539 GENEFORM Protein DME0044 XEOTICID XEO00539 MOACRIVE Inhibition DME0044 XEOTICID XEO00549 XEO_NAME Moclobemide DME0044 XEOTICID XEO00549 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00549 XEO_CLAS Drug in Phase 3 Clinical Trial DME0044 XEOTICID XEO00549 DESCRIPT Moclobemide inhibits the drug-metabolizing activity of DME MAOA in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 0.36138 microM) DME0044 XEOTICID XEO00549 GENEFORM Protein DME0044 XEOTICID XEO00549 MOACRIVE Inhibition DME0044 XEOTICID XEO00557 XEO_NAME Genistein DME0044 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0044 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME MAOA DME0044 XEOTICID XEO00557 GENEFORM mRNA DME0044 XEOTICID XEO00557 MOACRIVE Induction DME0044 XEOTICID XEO00578 XEO_NAME Arecoline DME0044 XEOTICID XEO00578 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00578 XEO_CLAS Drug in Phase 2 Clinical Trial DME0044 XEOTICID XEO00578 DESCRIPT Arecoline inhibits the expression of DME MAOA DME0044 XEOTICID XEO00578 GENEFORM mRNA DME0044 XEOTICID XEO00578 MOACRIVE Inhibition DME0044 XEOTICID XEO00581 XEO_NAME MS-275 DME0044 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0044 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME MAOA DME0044 XEOTICID XEO00581 GENEFORM mRNA DME0044 XEOTICID XEO00581 MOACRIVE Induction DME0044 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0044 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0044 XEOTICID XEO00632 DESCRIPT Sodium arsenite induces the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO00632 GENEFORM Protein DME0044 XEOTICID XEO00632 MOACRIVE Induction DME0044 XEOTICID XEO00676 XEO_NAME CX157 DME0044 XEOTICID XEO00676 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00676 XEO_CLAS Drug in Phase 2 Clinical Trial DME0044 XEOTICID XEO00676 DESCRIPT CX157 inhibits the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO00676 GENEFORM Protein DME0044 XEOTICID XEO00676 MOACRIVE Inhibition DME0044 XEOTICID XEO00693 XEO_NAME Harmaline DME0044 XEOTICID XEO00693 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00693 XEO_CLAS Preclinical/Patented Drug DME0044 XEOTICID XEO00693 DESCRIPT Harmaline inhibits the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO00693 GENEFORM Protein DME0044 XEOTICID XEO00693 MOACRIVE Inhibition DME0044 XEOTICID XEO00701 XEO_NAME Beta-carboline DME0044 XEOTICID XEO00701 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00701 XEO_CLAS Preclinical/Patented Drug DME0044 XEOTICID XEO00701 DESCRIPT Beta-carboline inhibits the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO00701 GENEFORM Protein DME0044 XEOTICID XEO00701 MOACRIVE Inhibition DME0044 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0044 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0044 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME MAOA DME0044 XEOTICID XEO00723 GENEFORM mRNA DME0044 XEOTICID XEO00723 MOACRIVE Inhibition DME0044 XEOTICID XEO00732 XEO_NAME Harmine DME0044 XEOTICID XEO00732 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00732 XEO_CLAS Preclinical/Patented Drug DME0044 XEOTICID XEO00732 DESCRIPT Harmine inhibits the drug-metabolizing activity of DME MAOA (Ki = 0.005 microM) DME0044 XEOTICID XEO00732 GENEFORM Protein DME0044 XEOTICID XEO00732 MOACRIVE Inhibition DME0044 XEOTICID XEO00738 XEO_NAME Flavanone DME0044 XEOTICID XEO00738 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00738 XEO_CLAS Drug in Phase 1 Clinical Trial DME0044 XEOTICID XEO00738 DESCRIPT Flavanone inhibits the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO00738 GENEFORM Protein DME0044 XEOTICID XEO00738 MOACRIVE Inhibition DME0044 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0044 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0044 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate inhibits the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO00818 GENEFORM Protein DME0044 XEOTICID XEO00818 MOACRIVE Inhibition DME0044 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0044 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0044 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0044 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO00821 GENEFORM Protein DME0044 XEOTICID XEO00821 MOACRIVE Inhibition DME0044 XEOTICID XEO00853 XEO_NAME Clorgyline DME0044 XEOTICID XEO00853 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO00853 XEO_CLAS Investigative Agent DME0044 XEOTICID XEO00853 DESCRIPT Clorgyline inhibits the drug-metabolizing activity of DME MAOA (IC50 = 0.0000049 microM) DME0044 XEOTICID XEO00853 GENEFORM Protein DME0044 XEOTICID XEO00853 MOACRIVE Inhibition DME0044 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0044 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0044 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0044 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the drug-metabolizing activity of DME MAOA in Cellosaurus cell line BTI-Tn-5B1-4 (IC50 = 5.972 microM) DME0044 XEOTICID XEO00898 GENEFORM Protein DME0044 XEOTICID XEO00898 MOACRIVE Inhibition DME0044 XEOTICID XEO00963 XEO_NAME Zeranol DME0044 XEOTICID XEO00963 XEO_TYPE Health or Environmental Toxicant(s) DME0044 XEOTICID XEO00963 XEO_CLAS Health Hazard/Toxicant DME0044 XEOTICID XEO00963 DESCRIPT Zeranol up-regulates the expression of DME MAOA DME0044 XEOTICID XEO00963 GENEFORM mRNA DME0044 XEOTICID XEO00963 MOACRIVE Induction DME0044 XEOTICID XEO00969 XEO_NAME Atrazine DME0044 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0044 XEOTICID XEO00969 XEO_CLAS Herbicide DME0044 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME MAOA DME0044 XEOTICID XEO00969 GENEFORM mRNA DME0044 XEOTICID XEO00969 MOACRIVE Induction DME0044 XEOTICID XEO01074 XEO_NAME Endosulfan DME0044 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0044 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0044 XEOTICID XEO01074 DESCRIPT Endosulfan inhibits the expression of DME MAOA DME0044 XEOTICID XEO01074 GENEFORM mRNA DME0044 XEOTICID XEO01074 MOACRIVE Inhibition DME0044 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0044 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0044 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0044 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium inhibits the expression of DME MAOA DME0044 XEOTICID XEO01103 GENEFORM mRNA DME0044 XEOTICID XEO01103 MOACRIVE Inhibition DME0044 XEOTICID XEO01177 XEO_NAME 7-methyltryptamine DME0044 XEOTICID XEO01177 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO01177 XEO_CLAS Investigative Agent DME0044 XEOTICID XEO01177 DESCRIPT 7-methyltryptamine inhibits the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO01177 GENEFORM Protein DME0044 XEOTICID XEO01177 MOACRIVE Inhibition DME0044 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0044 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0044 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME MAOA DME0044 XEOTICID XEO01226 GENEFORM mRNA DME0044 XEOTICID XEO01226 MOACRIVE Induction DME0044 XEOTICID XEO01232 XEO_NAME Caffeic acid DME0044 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME0044 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME0044 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO01232 GENEFORM Protein DME0044 XEOTICID XEO01232 MOACRIVE Inhibition DME0044 XEOTICID XEO01246 XEO_NAME Chlorogenic acid DME0044 XEOTICID XEO01246 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO01246 XEO_CLAS Drug in Phase 2 Clinical Trial DME0044 XEOTICID XEO01246 DESCRIPT Chlorogenic acid inhibits the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO01246 GENEFORM Protein DME0044 XEOTICID XEO01246 MOACRIVE Inhibition DME0044 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0044 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0044 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0044 XEOTICID XEO01247 DESCRIPT Chloropicrin up-regulates the expression of DME MAOA DME0044 XEOTICID XEO01247 GENEFORM mRNA DME0044 XEOTICID XEO01247 MOACRIVE Induction DME0044 XEOTICID XEO01304 XEO_NAME Flavone DME0044 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0044 XEOTICID XEO01304 XEO_CLAS Natural Product DME0044 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO01304 GENEFORM Protein DME0044 XEOTICID XEO01304 MOACRIVE Inhibition DME0044 XEOTICID XEO01460 XEO_NAME Rosmarinic acid DME0044 XEOTICID XEO01460 XEO_TYPE Health or Environmental Toxicant(s) DME0044 XEOTICID XEO01460 XEO_CLAS Acute Toxic Substance DME0044 XEOTICID XEO01460 DESCRIPT Rosmarinic acid inhibits the expression of DME MAOA DME0044 XEOTICID XEO01460 GENEFORM mRNA DME0044 XEOTICID XEO01460 MOACRIVE Inhibition DME0044 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0044 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0044 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0044 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME MAOA DME0044 XEOTICID XEO01492 GENEFORM mRNA DME0044 XEOTICID XEO01492 MOACRIVE Induction DME0044 XEOTICID XEO01518 XEO_NAME 5-methyltryptamine DME0044 XEOTICID XEO01518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0044 XEOTICID XEO01518 XEO_CLAS Natural Product DME0044 XEOTICID XEO01518 DESCRIPT 5-methyltryptamine inhibits the drug-metabolizing activity of DME MAOA DME0044 XEOTICID XEO01518 GENEFORM Protein DME0044 XEOTICID XEO01518 MOACRIVE Inhibition DME0044 XEOTICID XEO01551 XEO_NAME Heliotrine DME0044 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0044 XEOTICID XEO01551 XEO_CLAS Natural Product DME0044 XEOTICID XEO01551 DESCRIPT Heliotrine inhibits the expression of DME MAOA DME0044 XEOTICID XEO01551 GENEFORM mRNA DME0044 XEOTICID XEO01551 MOACRIVE Inhibition DME0044 XEOTICID XEO01553 XEO_NAME Isoflavone DME0044 XEOTICID XEO01553 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0044 XEOTICID XEO01553 XEO_CLAS Natural Product DME0044 XEOTICID XEO01553 DESCRIPT Isoflavone inhibits the expression of DME MAOA DME0044 XEOTICID XEO01553 GENEFORM mRNA DME0044 XEOTICID XEO01553 MOACRIVE Inhibition DME0045 DME___ID DME0045 DME0045 DME_NAME Monoamine oxidase type B (MAO-B) DME0045 SPESNAME Homo sapiens DME0045 XEOTICID XEO00008 XEO_NAME Benzyl benzoate DME0045 XEOTICID XEO00008 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00008 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00008 DESCRIPT Benzyl benzoate inhibits the drug-metabolizing activity of DME MAOB DME0045 XEOTICID XEO00008 GENEFORM Protein DME0045 XEOTICID XEO00008 MOACRIVE Inhibition DME0045 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0045 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME MAOB DME0045 XEOTICID XEO00011 GENEFORM mRNA DME0045 XEOTICID XEO00011 MOACRIVE Induction DME0045 XEOTICID XEO00029 XEO_NAME Valproic acid DME0045 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME MAOB DME0045 XEOTICID XEO00029 GENEFORM mRNA DME0045 XEOTICID XEO00029 MOACRIVE Induction DME0045 XEOTICID XEO00184 XEO_NAME Calcitriol DME0045 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME MAOB DME0045 XEOTICID XEO00184 GENEFORM mRNA DME0045 XEOTICID XEO00184 MOACRIVE Induction DME0045 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0045 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME MAOB DME0045 XEOTICID XEO00217 GENEFORM mRNA DME0045 XEOTICID XEO00217 MOACRIVE Inhibition DME0045 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0045 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME MAOB DME0045 XEOTICID XEO00241 GENEFORM mRNA DME0045 XEOTICID XEO00241 MOACRIVE Inhibition DME0045 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0045 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME MAOB DME0045 XEOTICID XEO00292 GENEFORM mRNA DME0045 XEOTICID XEO00292 MOACRIVE Inhibition DME0045 XEOTICID XEO00320 XEO_NAME Rasagiline mesylate DME0045 XEOTICID XEO00320 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00320 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00320 DESCRIPT Rasagiline mesylate inhibits the drug-metabolizing activity of DME MAOB (IC50 = 0.004 microM) DME0045 XEOTICID XEO00320 GENEFORM Protein DME0045 XEOTICID XEO00320 MOACRIVE Inhibition DME0045 XEOTICID XEO00323 XEO_NAME Selegiline hydrochloride DME0045 XEOTICID XEO00323 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00323 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00323 DESCRIPT Selegiline hydrochloride inhibits the drug-metabolizing activity of DME MAOB (IC50 = 0.000017 microM) DME0045 XEOTICID XEO00323 GENEFORM Protein DME0045 XEOTICID XEO00323 MOACRIVE Inhibition DME0045 XEOTICID XEO00366 XEO_NAME Methotrexate DME0045 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00366 DESCRIPT Methotrexate induces the drug-metabolizing activity of DME MAOB DME0045 XEOTICID XEO00366 GENEFORM Protein DME0045 XEOTICID XEO00366 MOACRIVE Induction DME0045 XEOTICID XEO00417 XEO_NAME Methylene blue DME0045 XEOTICID XEO00417 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00417 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00417 DESCRIPT Methylene blue inhibits the drug-metabolizing activity of DME MAOB DME0045 XEOTICID XEO00417 GENEFORM Protein DME0045 XEOTICID XEO00417 MOACRIVE Inhibition DME0045 XEOTICID XEO00420 XEO_NAME Pargyline DME0045 XEOTICID XEO00420 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00420 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00420 DESCRIPT Pargyline inhibits the drug-metabolizing activity of DME MAOB (IC50 = 0.13 microM) DME0045 XEOTICID XEO00420 GENEFORM Protein DME0045 XEOTICID XEO00420 MOACRIVE Inhibition DME0045 XEOTICID XEO00428 XEO_NAME Menadione DME0045 XEOTICID XEO00428 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00428 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00428 DESCRIPT Menadione inhibits the drug-metabolizing activity of DME MAOB (Ki = 0.4 microM) DME0045 XEOTICID XEO00428 GENEFORM Protein DME0045 XEOTICID XEO00428 MOACRIVE Inhibition DME0045 XEOTICID XEO00435 XEO_NAME Urethane DME0045 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME MAOB DME0045 XEOTICID XEO00435 GENEFORM mRNA DME0045 XEOTICID XEO00435 MOACRIVE Inhibition DME0045 XEOTICID XEO00486 XEO_NAME Tanshinone DME0045 XEOTICID XEO00486 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00486 XEO_CLAS Approved/Marketed Drug DME0045 XEOTICID XEO00486 DESCRIPT Tanshinone induces the drug-metabolizing activity of DME MAOB DME0045 XEOTICID XEO00486 GENEFORM Protein DME0045 XEOTICID XEO00486 MOACRIVE Induction DME0045 XEOTICID XEO00560 XEO_NAME Triclosan DME0045 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0045 XEOTICID XEO00560 DESCRIPT Triclosan inhibits the expression of DME MAOB DME0045 XEOTICID XEO00560 GENEFORM mRNA DME0045 XEOTICID XEO00560 MOACRIVE Inhibition DME0045 XEOTICID XEO00620 XEO_NAME Lazabemide DME0045 XEOTICID XEO00620 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00620 XEO_CLAS Drug in Phase 2 Clinical Trial DME0045 XEOTICID XEO00620 DESCRIPT Lazabemide inhibits the drug-metabolizing activity of DME MAOB (IC50 = 0.091 microM) DME0045 XEOTICID XEO00620 GENEFORM Protein DME0045 XEOTICID XEO00620 MOACRIVE Inhibition DME0045 XEOTICID XEO00701 XEO_NAME Beta-carboline DME0045 XEOTICID XEO00701 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO00701 XEO_CLAS Preclinical/Patented Drug DME0045 XEOTICID XEO00701 DESCRIPT Beta-carboline inhibits the drug-metabolizing activity of DME MAOB (Ki = 1.2 microM) DME0045 XEOTICID XEO00701 GENEFORM Protein DME0045 XEOTICID XEO00701 MOACRIVE Inhibition DME0045 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0045 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0045 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0045 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME MAOB DME0045 XEOTICID XEO00898 GENEFORM mRNA DME0045 XEOTICID XEO00898 MOACRIVE Inhibition DME0045 XEOTICID XEO00919 XEO_NAME Particulate matter DME0045 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0045 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0045 XEOTICID XEO00919 DESCRIPT Particulate matter induces the drug-metabolizing activity of DME MAOB DME0045 XEOTICID XEO00919 GENEFORM Protein DME0045 XEOTICID XEO00919 MOACRIVE Induction DME0045 XEOTICID XEO00964 XEO_NAME Uranium DME0045 XEOTICID XEO00964 XEO_TYPE Health or Environmental Toxicant(s) DME0045 XEOTICID XEO00964 XEO_CLAS Acute Toxic Substance DME0045 XEOTICID XEO00964 DESCRIPT Uranium inhibits the expression of DME MAOB DME0045 XEOTICID XEO00964 GENEFORM mRNA DME0045 XEOTICID XEO00964 MOACRIVE Inhibition DME0045 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0045 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0045 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0045 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME MAOB DME0045 XEOTICID XEO00999 GENEFORM mRNA DME0045 XEOTICID XEO00999 MOACRIVE Inhibition DME0045 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0045 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0045 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0045 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME MAOB DME0045 XEOTICID XEO01004 GENEFORM mRNA DME0045 XEOTICID XEO01004 MOACRIVE Inhibition DME0045 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0045 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0045 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0045 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME MAOB DME0045 XEOTICID XEO01031 GENEFORM mRNA DME0045 XEOTICID XEO01031 MOACRIVE Inhibition DME0045 XEOTICID XEO01164 XEO_NAME 5-nitroindazole DME0045 XEOTICID XEO01164 XEO_TYPE Health or Environmental Toxicant(s) DME0045 XEOTICID XEO01164 XEO_CLAS Health Hazard/Toxicant DME0045 XEOTICID XEO01164 DESCRIPT 5-nitroindazole inhibits the drug-metabolizing activity of DME MAOB (IC50 = 2.5 microM) DME0045 XEOTICID XEO01164 GENEFORM Protein DME0045 XEOTICID XEO01164 MOACRIVE Inhibition DME0045 XEOTICID XEO01232 XEO_NAME Caffeic acid DME0045 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME0045 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME0045 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of DME MAOB DME0045 XEOTICID XEO01232 GENEFORM Protein DME0045 XEOTICID XEO01232 MOACRIVE Inhibition DME0045 XEOTICID XEO01246 XEO_NAME Chlorogenic acid DME0045 XEOTICID XEO01246 XEO_TYPE Pharmaceutical Agent(s) DME0045 XEOTICID XEO01246 XEO_CLAS Drug in Phase 2 Clinical Trial DME0045 XEOTICID XEO01246 DESCRIPT Chlorogenic acid inhibits the drug-metabolizing activity of DME MAOB DME0045 XEOTICID XEO01246 GENEFORM Protein DME0045 XEOTICID XEO01246 MOACRIVE Inhibition DME0045 XEOTICID XEO01503 XEO_NAME Cadmium DME0045 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0045 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0045 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME MAOB DME0045 XEOTICID XEO01503 GENEFORM mRNA DME0045 XEOTICID XEO01503 MOACRIVE Induction DME0045 XEOTICID XEO01551 XEO_NAME Heliotrine DME0045 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0045 XEOTICID XEO01551 XEO_CLAS Natural Product DME0045 XEOTICID XEO01551 DESCRIPT Heliotrine inhibits the expression of DME MAOB DME0045 XEOTICID XEO01551 GENEFORM mRNA DME0045 XEOTICID XEO01551 MOACRIVE Inhibition DME0045 XEOTICID XEO01582 XEO_NAME Pyrrolizidine alkaloid DME0045 XEOTICID XEO01582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0045 XEOTICID XEO01582 XEO_CLAS Natural Product DME0045 XEOTICID XEO01582 DESCRIPT Pyrrolizidine alkaloid inhibits the expression of DME MAOB DME0045 XEOTICID XEO01582 GENEFORM mRNA DME0045 XEOTICID XEO01582 MOACRIVE Inhibition DME0046 DME___ID DME0046 DME0046 DME_NAME Calcidiol 1-monooxygenase (CYP27B1) DME0046 SPESNAME Homo sapiens DME0046 XEOTICID XEO00090 XEO_NAME Estradiol DME0046 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0046 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0046 XEOTICID XEO00090 DESCRIPT Estradiol induces the drug-metabolizing activity of DME CYP27B1 DME0046 XEOTICID XEO00090 GENEFORM Protein DME0046 XEOTICID XEO00090 MOACRIVE Induction DME0046 XEOTICID XEO00094 XEO_NAME Progesterone DME0046 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0046 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0046 XEOTICID XEO00094 DESCRIPT Progesterone inhibits the expression of DME CYP27B1 DME0046 XEOTICID XEO00094 GENEFORM mRNA DME0046 XEOTICID XEO00094 MOACRIVE Inhibition DME0046 XEOTICID XEO00121 XEO_NAME Etoposide DME0046 XEOTICID XEO00121 XEO_TYPE Pharmaceutical Agent(s) DME0046 XEOTICID XEO00121 XEO_CLAS Approved/Marketed Drug DME0046 XEOTICID XEO00121 DESCRIPT Etoposide up-regulates the expression of DME CYP27B1 DME0046 XEOTICID XEO00121 GENEFORM mRNA DME0046 XEOTICID XEO00121 MOACRIVE Induction DME0046 XEOTICID XEO00184 XEO_NAME Calcitriol DME0046 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0046 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0046 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME CYP27B1 DME0046 XEOTICID XEO00184 GENEFORM mRNA DME0046 XEOTICID XEO00184 MOACRIVE Induction DME0046 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0046 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0046 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0046 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP27B1 DME0046 XEOTICID XEO00217 GENEFORM mRNA DME0046 XEOTICID XEO00217 MOACRIVE Inhibition DME0046 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0046 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0046 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0046 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME CYP27B1 DME0046 XEOTICID XEO00241 GENEFORM mRNA DME0046 XEOTICID XEO00241 MOACRIVE Induction DME0046 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0046 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0046 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0046 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME CYP27B1 DME0046 XEOTICID XEO00292 GENEFORM mRNA DME0046 XEOTICID XEO00292 MOACRIVE Induction DME0046 XEOTICID XEO00383 XEO_NAME Tamoxifen DME0046 XEOTICID XEO00383 XEO_TYPE Pharmaceutical Agent(s) DME0046 XEOTICID XEO00383 XEO_CLAS Approved/Marketed Drug DME0046 XEOTICID XEO00383 DESCRIPT Tamoxifen inhibits the expression of DME CYP27B1 DME0046 XEOTICID XEO00383 GENEFORM mRNA DME0046 XEOTICID XEO00383 MOACRIVE Inhibition DME0046 XEOTICID XEO00435 XEO_NAME Urethane DME0046 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0046 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0046 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME CYP27B1 DME0046 XEOTICID XEO00435 GENEFORM mRNA DME0046 XEOTICID XEO00435 MOACRIVE Inhibition DME0046 XEOTICID XEO00538 XEO_NAME Quercetin DME0046 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0046 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0046 XEOTICID XEO00538 DESCRIPT Quercetin up-regulates the expression of DME CYP27B1 DME0046 XEOTICID XEO00538 GENEFORM mRNA DME0046 XEOTICID XEO00538 MOACRIVE Induction DME0046 XEOTICID XEO00557 XEO_NAME Genistein DME0046 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0046 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0046 XEOTICID XEO00557 DESCRIPT Genistein induces the drug-metabolizing activity of DME CYP27B1 DME0046 XEOTICID XEO00557 GENEFORM Protein DME0046 XEOTICID XEO00557 MOACRIVE Induction DME0046 XEOTICID XEO00760 XEO_NAME Jinfukang DME0046 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0046 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0046 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME CYP27B1 DME0046 XEOTICID XEO00760 GENEFORM mRNA DME0046 XEOTICID XEO00760 MOACRIVE Inhibition DME0046 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0046 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0046 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0046 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution induces the drug-metabolizing activity of DME CYP27B1 DME0046 XEOTICID XEO00821 GENEFORM Protein DME0046 XEOTICID XEO00821 MOACRIVE Induction DME0046 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0046 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0046 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0046 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the expression of DME CYP27B1 DME0046 XEOTICID XEO01119 GENEFORM mRNA DME0046 XEOTICID XEO01119 MOACRIVE Inhibition DME0046 XEOTICID XEO01222 XEO_NAME Biochanin A DME0046 XEOTICID XEO01222 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0046 XEOTICID XEO01222 XEO_CLAS Natural Product DME0046 XEOTICID XEO01222 DESCRIPT Biochanin A induces the drug-metabolizing activity of DME CYP27B1 DME0046 XEOTICID XEO01222 GENEFORM Protein DME0046 XEOTICID XEO01222 MOACRIVE Induction DME0046 XEOTICID XEO01336 XEO_NAME ICG-001 DME0046 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0046 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0046 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME CYP27B1 DME0046 XEOTICID XEO01336 GENEFORM mRNA DME0046 XEOTICID XEO01336 MOACRIVE Inhibition DME0046 XEOTICID XEO01582 XEO_NAME Pyrrolizidine alkaloid DME0046 XEOTICID XEO01582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0046 XEOTICID XEO01582 XEO_CLAS Natural Product DME0046 XEOTICID XEO01582 DESCRIPT Pyrrolizidine alkaloid up-regulates the expression of DME CYP27B1 DME0046 XEOTICID XEO01582 GENEFORM mRNA DME0046 XEOTICID XEO01582 MOACRIVE Induction DME0047 DME___ID DME0047 DME0047 DME_NAME UDP-glucuronosyltransferase 2B4 (UGT2B4) DME0047 SPESNAME Homo sapiens DME0047 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0047 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0047 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0047 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME UGT2B4 DME0047 XEOTICID XEO00035 GENEFORM mRNA DME0047 XEOTICID XEO00035 MOACRIVE Induction DME0047 XEOTICID XEO00090 XEO_NAME Estradiol DME0047 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0047 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0047 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME UGT2B4 DME0047 XEOTICID XEO00090 GENEFORM mRNA DME0047 XEOTICID XEO00090 MOACRIVE Inhibition DME0047 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0047 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0047 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0047 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME UGT2B4 DME0047 XEOTICID XEO00117 GENEFORM mRNA DME0047 XEOTICID XEO00117 MOACRIVE Inhibition DME0047 XEOTICID XEO00148 XEO_NAME Bosentan DME0047 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0047 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0047 XEOTICID XEO00148 DESCRIPT Bosentan inhibits the expression of DME UGT2B4 DME0047 XEOTICID XEO00148 GENEFORM mRNA DME0047 XEOTICID XEO00148 MOACRIVE Inhibition DME0047 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0047 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0047 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0047 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME UGT2B4 DME0047 XEOTICID XEO00217 GENEFORM mRNA DME0047 XEOTICID XEO00217 MOACRIVE Inhibition DME0047 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0047 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0047 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0047 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME UGT2B4 DME0047 XEOTICID XEO00241 GENEFORM mRNA DME0047 XEOTICID XEO00241 MOACRIVE Inhibition DME0047 XEOTICID XEO00278 XEO_NAME Beclomethasone dipropionate DME0047 XEOTICID XEO00278 XEO_TYPE Pharmaceutical Agent(s) DME0047 XEOTICID XEO00278 XEO_CLAS Approved/Marketed Drug DME0047 XEOTICID XEO00278 DESCRIPT Beclomethasone dipropionate up-regulates the expression of DME UGT2B4 DME0047 XEOTICID XEO00278 GENEFORM mRNA DME0047 XEOTICID XEO00278 MOACRIVE Induction DME0047 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0047 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0047 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0047 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME UGT2B4 DME0047 XEOTICID XEO00292 GENEFORM mRNA DME0047 XEOTICID XEO00292 MOACRIVE Inhibition DME0047 XEOTICID XEO00435 XEO_NAME Urethane DME0047 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0047 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0047 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME UGT2B4 DME0047 XEOTICID XEO00435 GENEFORM mRNA DME0047 XEOTICID XEO00435 MOACRIVE Inhibition DME0047 XEOTICID XEO00555 XEO_NAME Hymecromone DME0047 XEOTICID XEO00555 XEO_TYPE Pharmaceutical Agent(s) DME0047 XEOTICID XEO00555 XEO_CLAS Drug in Phase 1 Clinical Trial DME0047 XEOTICID XEO00555 DESCRIPT Hymecromone induces the drug-metabolizing activity of DME UGT2B4 DME0047 XEOTICID XEO00555 GENEFORM Protein DME0047 XEOTICID XEO00555 MOACRIVE Induction DME0047 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0047 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0047 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0047 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME UGT2B4 DME0047 XEOTICID XEO00723 GENEFORM mRNA DME0047 XEOTICID XEO00723 MOACRIVE Inhibition DME0047 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0047 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0047 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0047 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME UGT2B4 DME0047 XEOTICID XEO00898 GENEFORM mRNA DME0047 XEOTICID XEO00898 MOACRIVE Inhibition DME0047 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0047 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0047 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0047 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME UGT2B4 DME0047 XEOTICID XEO00905 GENEFORM mRNA DME0047 XEOTICID XEO00905 MOACRIVE Inhibition DME0047 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0047 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0047 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0047 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME UGT2B4 DME0047 XEOTICID XEO01050 GENEFORM mRNA DME0047 XEOTICID XEO01050 MOACRIVE Inhibition DME0047 XEOTICID XEO01195 XEO_NAME Amentoflavone DME0047 XEOTICID XEO01195 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0047 XEOTICID XEO01195 XEO_CLAS Natural Product DME0047 XEOTICID XEO01195 DESCRIPT Amentof DMElavone inhibits the drug-metabolizing activity of DME UGT2B4 DME0047 XEOTICID XEO01195 GENEFORM Protein DME0047 XEOTICID XEO01195 MOACRIVE Inhibition DME0047 XEOTICID XEO01284 XEO_NAME Dust DME0047 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0047 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0047 XEOTICID XEO01284 DESCRIPT Dust up-regulates the expression of DME UGT2B4 DME0047 XEOTICID XEO01284 GENEFORM mRNA DME0047 XEOTICID XEO01284 MOACRIVE Induction DME0048 DME___ID DME0048 DME0048 DME_NAME UDP-glucuronosyltransferase 1A4 (UGT1A4) DME0048 SPESNAME Homo sapiens DME0048 XEOTICID XEO00069 XEO_NAME Omeprazole DME0048 XEOTICID XEO00069 XEO_TYPE Pharmaceutical Agent(s) DME0048 XEOTICID XEO00069 XEO_CLAS Approved/Marketed Drug DME0048 XEOTICID XEO00069 DESCRIPT Omeprazole up-regulates the expression of DME UGT1A4 DME0048 XEOTICID XEO00069 GENEFORM mRNA DME0048 XEOTICID XEO00069 MOACRIVE Induction DME0048 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0048 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0048 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0048 XEOTICID XEO00165 DESCRIPT Obeticholic acid inhibits the drug-metabolizing activity of DME UGT1A4 DME0048 XEOTICID XEO00165 GENEFORM Protein DME0048 XEOTICID XEO00165 MOACRIVE Inhibition DME0048 XEOTICID XEO00386 XEO_NAME Trifluoperazine DME0048 XEOTICID XEO00386 XEO_TYPE Pharmaceutical Agent(s) DME0048 XEOTICID XEO00386 XEO_CLAS Approved/Marketed Drug DME0048 XEOTICID XEO00386 DESCRIPT Trifluoperazine up-regulates the expression of DME UGT1A4 DME0048 XEOTICID XEO00386 GENEFORM mRNA DME0048 XEOTICID XEO00386 MOACRIVE Induction DME0048 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0048 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0048 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0048 XEOTICID XEO00410 DESCRIPT Phenobarbital up-regulates the expression of DME UGT1A4 DME0048 XEOTICID XEO00410 GENEFORM mRNA DME0048 XEOTICID XEO00410 MOACRIVE Induction DME0048 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0048 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0048 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0048 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME UGT1A4 DME0048 XEOTICID XEO00723 GENEFORM mRNA DME0048 XEOTICID XEO00723 MOACRIVE Inhibition DME0048 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0048 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0048 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0048 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene induces the drug-metabolizing activity of DME UGT1A4 DME0048 XEOTICID XEO00898 GENEFORM Protein DME0048 XEOTICID XEO00898 MOACRIVE Induction DME0048 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0048 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0048 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0048 XEOTICID XEO00899 DESCRIPT Methylcholanthrene up-regulates the expression of DME UGT1A4 DME0048 XEOTICID XEO00899 GENEFORM mRNA DME0048 XEOTICID XEO00899 MOACRIVE Induction DME0048 XEOTICID XEO00995 XEO_NAME Amphibole asbestos DME0048 XEOTICID XEO00995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0048 XEOTICID XEO00995 XEO_CLAS Natural Mixture DME0048 XEOTICID XEO00995 DESCRIPT Amphibole asbestos inhibits the drug-metabolizing activity of DME UGT1A4 DME0048 XEOTICID XEO00995 GENEFORM Protein DME0048 XEOTICID XEO00995 MOACRIVE Inhibition DME0048 XEOTICID XEO01195 XEO_NAME Amentoflavone DME0048 XEOTICID XEO01195 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0048 XEOTICID XEO01195 XEO_CLAS Natural Product DME0048 XEOTICID XEO01195 DESCRIPT Amentof DMElavone inhibits the drug-metabolizing activity of DME UGT1A4 DME0048 XEOTICID XEO01195 GENEFORM Protein DME0048 XEOTICID XEO01195 MOACRIVE Inhibition DME0048 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0048 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0048 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0048 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME UGT1A4 DME0048 XEOTICID XEO01220 GENEFORM mRNA DME0048 XEOTICID XEO01220 MOACRIVE Induction DME0048 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0048 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0048 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0048 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME UGT1A4 DME0048 XEOTICID XEO01226 GENEFORM mRNA DME0048 XEOTICID XEO01226 MOACRIVE Inhibition DME0048 XEOTICID XEO01230 XEO_NAME Butyric acid DME0048 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0048 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0048 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME UGT1A4 DME0048 XEOTICID XEO01230 GENEFORM mRNA DME0048 XEOTICID XEO01230 MOACRIVE Induction DME0048 XEOTICID XEO01433 XEO_NAME Pirinixic acid DME0048 XEOTICID XEO01433 XEO_TYPE Health or Environmental Toxicant(s) DME0048 XEOTICID XEO01433 XEO_CLAS Health Hazard/Toxicant DME0048 XEOTICID XEO01433 DESCRIPT Pirinixic acid up-regulates the expression of DME UGT1A4 and leads to increasing the drug-metabolizing activity of this enzyme DME0048 XEOTICID XEO01433 GENEFORM Protein DME0048 XEOTICID XEO01433 MOACRIVE Induction DME0048 XEOTICID XEO01497 XEO_NAME Usnic acid DME0048 XEOTICID XEO01497 XEO_TYPE Health or Environmental Toxicant(s) DME0048 XEOTICID XEO01497 XEO_CLAS Acute Toxic Substance DME0048 XEOTICID XEO01497 DESCRIPT Usnic acid up-regulates the expression of DME UGT1A4 DME0048 XEOTICID XEO01497 GENEFORM mRNA DME0048 XEOTICID XEO01497 MOACRIVE Induction DME0049 DME___ID DME0049 DME0049 DME_NAME UDP-glucuronosyltransferase 2B15 (UGT2B15) DME0049 SPESNAME Homo sapiens DME0049 XEOTICID XEO00005 XEO_NAME Theophylline DME0049 XEOTICID XEO00005 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00005 XEO_CLAS Approved/Marketed Drug DME0049 XEOTICID XEO00005 DESCRIPT Theophylline inhibits the expression of DME UGT2B15 DME0049 XEOTICID XEO00005 GENEFORM mRNA DME0049 XEOTICID XEO00005 MOACRIVE Inhibition DME0049 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0049 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0049 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME UGT2B15 DME0049 XEOTICID XEO00011 GENEFORM mRNA DME0049 XEOTICID XEO00011 MOACRIVE Induction DME0049 XEOTICID XEO00090 XEO_NAME Estradiol DME0049 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0049 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME UGT2B15 and leads to increasing the drug-metabolizing activity of this enzyme DME0049 XEOTICID XEO00090 GENEFORM Protein DME0049 XEOTICID XEO00090 MOACRIVE Induction DME0049 XEOTICID XEO00095 XEO_NAME Testosterone DME0049 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0049 XEOTICID XEO00095 DESCRIPT Testosterone inhibits the expression of DME UGT2B15 DME0049 XEOTICID XEO00095 GENEFORM mRNA DME0049 XEOTICID XEO00095 MOACRIVE Inhibition DME0049 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0049 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0049 XEOTICID XEO00165 DESCRIPT Obeticholic acid up-regulates the expression of DME UGT2B15 DME0049 XEOTICID XEO00165 GENEFORM mRNA DME0049 XEOTICID XEO00165 MOACRIVE Induction DME0049 XEOTICID XEO00184 XEO_NAME Calcitriol DME0049 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0049 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME UGT2B15 DME0049 XEOTICID XEO00184 GENEFORM mRNA DME0049 XEOTICID XEO00184 MOACRIVE Inhibition DME0049 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0049 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0049 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the drug-metabolizing activity of DME UGT2B15 DME0049 XEOTICID XEO00217 GENEFORM Protein DME0049 XEOTICID XEO00217 MOACRIVE Inhibition DME0049 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0049 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0049 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME UGT2B15 DME0049 XEOTICID XEO00241 GENEFORM mRNA DME0049 XEOTICID XEO00241 MOACRIVE Inhibition DME0049 XEOTICID XEO00352 XEO_NAME Diclofenac DME0049 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0049 XEOTICID XEO00352 DESCRIPT Diclof DMEenac inhibits the drug-metabolizing activity of DME UGT2B15 DME0049 XEOTICID XEO00352 GENEFORM Protein DME0049 XEOTICID XEO00352 MOACRIVE Inhibition DME0049 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0049 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0049 XEOTICID XEO00410 DESCRIPT Phenobarbital up-regulates the expression of DME UGT2B15 DME0049 XEOTICID XEO00410 GENEFORM mRNA DME0049 XEOTICID XEO00410 MOACRIVE Induction DME0049 XEOTICID XEO00498 XEO_NAME Flunitrazepam DME0049 XEOTICID XEO00498 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00498 XEO_CLAS Approved/Marketed Drug DME0049 XEOTICID XEO00498 DESCRIPT Flunitrazepam inhibits the drug-metabolizing activity of DME UGT2B15 DME0049 XEOTICID XEO00498 GENEFORM Protein DME0049 XEOTICID XEO00498 MOACRIVE Inhibition DME0049 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0049 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0049 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME UGT2B15 DME0049 XEOTICID XEO00536 GENEFORM mRNA DME0049 XEOTICID XEO00536 MOACRIVE Induction DME0049 XEOTICID XEO00555 XEO_NAME Hymecromone DME0049 XEOTICID XEO00555 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00555 XEO_CLAS Drug in Phase 1 Clinical Trial DME0049 XEOTICID XEO00555 DESCRIPT Hymecromone induces the drug-metabolizing activity of DME UGT2B15 DME0049 XEOTICID XEO00555 GENEFORM Protein DME0049 XEOTICID XEO00555 MOACRIVE Induction DME0049 XEOTICID XEO00557 XEO_NAME Genistein DME0049 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0049 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME UGT2B15 DME0049 XEOTICID XEO00557 GENEFORM mRNA DME0049 XEOTICID XEO00557 MOACRIVE Induction DME0049 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0049 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0049 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME UGT2B15 DME0049 XEOTICID XEO00723 GENEFORM mRNA DME0049 XEOTICID XEO00723 MOACRIVE Inhibition DME0049 XEOTICID XEO00816 XEO_NAME Aflatoxin M1 DME0049 XEOTICID XEO00816 XEO_TYPE Health or Environmental Toxicant(s) DME0049 XEOTICID XEO00816 XEO_CLAS Carcinogen DME0049 XEOTICID XEO00816 DESCRIPT Aflatoxin M1 inhibits the expression of DME UGT2B15 DME0049 XEOTICID XEO00816 GENEFORM mRNA DME0049 XEOTICID XEO00816 MOACRIVE Inhibition DME0049 XEOTICID XEO00877 XEO_NAME Bilirubin DME0049 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0049 XEOTICID XEO00877 XEO_CLAS Natural Product DME0049 XEOTICID XEO00877 DESCRIPT Bilirubin inhibits the drug-metabolizing activity of DME UGT2B15 DME0049 XEOTICID XEO00877 GENEFORM Protein DME0049 XEOTICID XEO00877 MOACRIVE Inhibition DME0049 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0049 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0049 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0049 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME UGT2B15 DME0049 XEOTICID XEO00905 GENEFORM mRNA DME0049 XEOTICID XEO00905 MOACRIVE Inhibition DME0049 XEOTICID XEO00930 XEO_NAME Butylparaben DME0049 XEOTICID XEO00930 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO00930 XEO_CLAS Investigative Agent DME0049 XEOTICID XEO00930 DESCRIPT Butylparaben up-regulates the expression of DME UGT2B15 DME0049 XEOTICID XEO00930 GENEFORM mRNA DME0049 XEOTICID XEO00930 MOACRIVE Induction DME0049 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0049 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0049 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0049 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME UGT2B15 DME0049 XEOTICID XEO00999 GENEFORM mRNA DME0049 XEOTICID XEO00999 MOACRIVE Inhibition DME0049 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0049 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0049 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME UGT2B15 DME0049 XEOTICID XEO01220 GENEFORM mRNA DME0049 XEOTICID XEO01220 MOACRIVE Inhibition DME0049 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0049 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0049 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0049 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME UGT2B15 DME0049 XEOTICID XEO01226 GENEFORM mRNA DME0049 XEOTICID XEO01226 MOACRIVE Induction DME0049 XEOTICID XEO01268 XEO_NAME Cycloheximide DME0049 XEOTICID XEO01268 XEO_TYPE Health or Environmental Toxicant(s) DME0049 XEOTICID XEO01268 XEO_CLAS Acute Toxic Substance DME0049 XEOTICID XEO01268 DESCRIPT Cycloheximide up-regulates the expression of DME UGT2B15 DME0049 XEOTICID XEO01268 GENEFORM mRNA DME0049 XEOTICID XEO01268 MOACRIVE Induction DME0049 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0049 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0049 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0049 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME UGT2B15 DME0049 XEOTICID XEO01305 GENEFORM mRNA DME0049 XEOTICID XEO01305 MOACRIVE Induction DME0050 DME___ID DME0050 DME0050 DME_NAME N-acetyltransferase 1 (NAT1) DME0050 SPESNAME Homo sapiens DME0050 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0050 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0050 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0050 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME NAT1 DME0050 XEOTICID XEO00011 GENEFORM mRNA DME0050 XEOTICID XEO00011 MOACRIVE Induction DME0050 XEOTICID XEO00090 XEO_NAME Estradiol DME0050 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0050 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0050 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME NAT1 DME0050 XEOTICID XEO00090 GENEFORM mRNA DME0050 XEOTICID XEO00090 MOACRIVE Inhibition DME0050 XEOTICID XEO00095 XEO_NAME Testosterone DME0050 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0050 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0050 XEOTICID XEO00095 DESCRIPT Testosterone induces the drug-metabolizing activity of DME NAT1 DME0050 XEOTICID XEO00095 GENEFORM Protein DME0050 XEOTICID XEO00095 MOACRIVE Induction DME0050 XEOTICID XEO00177 XEO_NAME Sulindac DME0050 XEOTICID XEO00177 XEO_TYPE Pharmaceutical Agent(s) DME0050 XEOTICID XEO00177 XEO_CLAS Approved/Marketed Drug DME0050 XEOTICID XEO00177 DESCRIPT Sulindac inhibits the drug-metabolizing activity of DME NAT1 DME0050 XEOTICID XEO00177 GENEFORM Protein DME0050 XEOTICID XEO00177 MOACRIVE Inhibition DME0050 XEOTICID XEO00184 XEO_NAME Calcitriol DME0050 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0050 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0050 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME NAT1 DME0050 XEOTICID XEO00184 GENEFORM mRNA DME0050 XEOTICID XEO00184 MOACRIVE Induction DME0050 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0050 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0050 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0050 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME NAT1 DME0050 XEOTICID XEO00241 GENEFORM mRNA DME0050 XEOTICID XEO00241 MOACRIVE Inhibition DME0050 XEOTICID XEO00256 XEO_NAME Paclitaxel DME0050 XEOTICID XEO00256 XEO_TYPE Pharmaceutical Agent(s) DME0050 XEOTICID XEO00256 XEO_CLAS Approved/Marketed Drug DME0050 XEOTICID XEO00256 DESCRIPT Paclitaxel inhibits the drug-metabolizing activity of DME NAT1 DME0050 XEOTICID XEO00256 GENEFORM Protein DME0050 XEOTICID XEO00256 MOACRIVE Inhibition DME0050 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0050 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0050 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0050 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the drug-metabolizing activity of DME NAT1 DME0050 XEOTICID XEO00388 GENEFORM Protein DME0050 XEOTICID XEO00388 MOACRIVE Inhibition DME0050 XEOTICID XEO00404 XEO_NAME Folic acid DME0050 XEOTICID XEO00404 XEO_TYPE Pharmaceutical Agent(s) DME0050 XEOTICID XEO00404 XEO_CLAS Approved/Marketed Drug DME0050 XEOTICID XEO00404 DESCRIPT Folic acid inhibits the drug-metabolizing activity of DME NAT1 DME0050 XEOTICID XEO00404 GENEFORM Protein DME0050 XEOTICID XEO00404 MOACRIVE Inhibition DME0050 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0050 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0050 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0050 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME NAT1 DME0050 XEOTICID XEO00536 GENEFORM mRNA DME0050 XEOTICID XEO00536 MOACRIVE Induction DME0050 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0050 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0050 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0050 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME NAT1 DME0050 XEOTICID XEO00772 GENEFORM mRNA DME0050 XEOTICID XEO00772 MOACRIVE Induction DME0050 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0050 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0050 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0050 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution induces the drug-metabolizing activity of DME NAT1 DME0050 XEOTICID XEO00821 GENEFORM Protein DME0050 XEOTICID XEO00821 MOACRIVE Induction DME0050 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0050 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0050 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0050 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin up-regulates the expression of DME NAT1 DME0050 XEOTICID XEO00905 GENEFORM mRNA DME0050 XEOTICID XEO00905 MOACRIVE Induction DME0050 XEOTICID XEO00925 XEO_NAME BDE-99 DME0050 XEOTICID XEO00925 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0050 XEOTICID XEO00925 XEO_CLAS Natural Product DME0050 XEOTICID XEO00925 DESCRIPT BDE-99 inhibits the expression of DME NAT1 DME0050 XEOTICID XEO00925 GENEFORM mRNA DME0050 XEOTICID XEO00925 MOACRIVE Inhibition DME0050 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0050 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0050 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0050 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME NAT1 DME0050 XEOTICID XEO01050 GENEFORM mRNA DME0050 XEOTICID XEO01050 MOACRIVE Inhibition DME0050 XEOTICID XEO01191 XEO_NAME Aloe-emodin DME0050 XEOTICID XEO01191 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0050 XEOTICID XEO01191 XEO_CLAS Natural Product DME0050 XEOTICID XEO01191 DESCRIPT Aloe-emodin inhibits the expression of DME NAT1 and leads to decreasing the drug-metabolizing activity of this enzyme DME0050 XEOTICID XEO01191 GENEFORM Protein DME0050 XEOTICID XEO01191 MOACRIVE Inhibition DME0050 XEOTICID XEO01212 XEO_NAME Baicalein DME0050 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0050 XEOTICID XEO01212 XEO_CLAS Natural Product DME0050 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of DME NAT1 DME0050 XEOTICID XEO01212 GENEFORM Protein DME0050 XEOTICID XEO01212 MOACRIVE Inhibition DME0050 XEOTICID XEO01230 XEO_NAME Butyric acid DME0050 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0050 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0050 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME NAT1 DME0050 XEOTICID XEO01230 GENEFORM mRNA DME0050 XEOTICID XEO01230 MOACRIVE Induction DME0050 XEOTICID XEO01265 XEO_NAME Cyanamide DME0050 XEOTICID XEO01265 XEO_TYPE Health or Environmental Toxicant(s) DME0050 XEOTICID XEO01265 XEO_CLAS Acute Toxic Substance DME0050 XEOTICID XEO01265 DESCRIPT Cyanamide inhibits the drug-metabolizing activity of DME NAT1 DME0050 XEOTICID XEO01265 GENEFORM Protein DME0050 XEOTICID XEO01265 MOACRIVE Inhibition DME0050 XEOTICID XEO01282 XEO_NAME Dithiothreitol DME0050 XEOTICID XEO01282 XEO_TYPE Pharmaceutical Agent(s) DME0050 XEOTICID XEO01282 XEO_CLAS Preclinical/Patented Drug DME0050 XEOTICID XEO01282 DESCRIPT Dithiothreitol induces the drug-metabolizing activity of DME NAT1 DME0050 XEOTICID XEO01282 GENEFORM Protein DME0050 XEOTICID XEO01282 MOACRIVE Induction DME0050 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0050 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0050 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0050 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME NAT1 DME0050 XEOTICID XEO01305 GENEFORM mRNA DME0050 XEOTICID XEO01305 MOACRIVE Induction DME0050 XEOTICID XEO01346 XEO_NAME Iodoacetamide DME0050 XEOTICID XEO01346 XEO_TYPE Health or Environmental Toxicant(s) DME0050 XEOTICID XEO01346 XEO_CLAS Acute Toxic Substance DME0050 XEOTICID XEO01346 DESCRIPT Iodoacetamide inhibits the drug-metabolizing activity of DME NAT1 DME0050 XEOTICID XEO01346 GENEFORM Protein DME0050 XEOTICID XEO01346 MOACRIVE Inhibition DME0051 DME___ID DME0051 DME0051 DME_NAME N-acetyltransferase 2 (NAT2) DME0051 SPESNAME Homo sapiens DME0051 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0051 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0051 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0051 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME NAT2 DME0051 XEOTICID XEO00011 GENEFORM mRNA DME0051 XEOTICID XEO00011 MOACRIVE Induction DME0051 XEOTICID XEO00029 XEO_NAME Valproic acid DME0051 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0051 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0051 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME NAT2 DME0051 XEOTICID XEO00029 GENEFORM mRNA DME0051 XEOTICID XEO00029 MOACRIVE Induction DME0051 XEOTICID XEO00090 XEO_NAME Estradiol DME0051 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0051 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0051 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME NAT2 DME0051 XEOTICID XEO00090 GENEFORM mRNA DME0051 XEOTICID XEO00090 MOACRIVE Inhibition DME0051 XEOTICID XEO00095 XEO_NAME Testosterone DME0051 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0051 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0051 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME NAT2 DME0051 XEOTICID XEO00095 GENEFORM mRNA DME0051 XEOTICID XEO00095 MOACRIVE Induction DME0051 XEOTICID XEO00184 XEO_NAME Calcitriol DME0051 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0051 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0051 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME NAT2 DME0051 XEOTICID XEO00184 GENEFORM mRNA DME0051 XEOTICID XEO00184 MOACRIVE Inhibition DME0051 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0051 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0051 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0051 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME NAT2 DME0051 XEOTICID XEO00217 GENEFORM mRNA DME0051 XEOTICID XEO00217 MOACRIVE Inhibition DME0051 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0051 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0051 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0051 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME NAT2 DME0051 XEOTICID XEO00241 GENEFORM mRNA DME0051 XEOTICID XEO00241 MOACRIVE Inhibition DME0051 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0051 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0051 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0051 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the drug-metabolizing activity of DME NAT2 DME0051 XEOTICID XEO00388 GENEFORM Protein DME0051 XEOTICID XEO00388 MOACRIVE Inhibition DME0051 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0051 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0051 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0051 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME NAT2 DME0051 XEOTICID XEO00806 GENEFORM mRNA DME0051 XEOTICID XEO00806 MOACRIVE Inhibition DME0051 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0051 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0051 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0051 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the expression of DME NAT2 DME0051 XEOTICID XEO01119 GENEFORM mRNA DME0051 XEOTICID XEO01119 MOACRIVE Inhibition DME0051 XEOTICID XEO01230 XEO_NAME Butyric acid DME0051 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0051 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0051 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME NAT2 DME0051 XEOTICID XEO01230 GENEFORM mRNA DME0051 XEOTICID XEO01230 MOACRIVE Induction DME0051 XEOTICID XEO01346 XEO_NAME Iodoacetamide DME0051 XEOTICID XEO01346 XEO_TYPE Health or Environmental Toxicant(s) DME0051 XEOTICID XEO01346 XEO_CLAS Acute Toxic Substance DME0051 XEOTICID XEO01346 DESCRIPT Iodoacetamide inhibits the drug-metabolizing activity of DME NAT2 DME0051 XEOTICID XEO01346 GENEFORM Protein DME0051 XEOTICID XEO01346 MOACRIVE Inhibition DME0051 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0051 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0051 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0051 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME NAT2 DME0051 XEOTICID XEO01492 GENEFORM mRNA DME0051 XEOTICID XEO01492 MOACRIVE Induction DME0052 DME___ID DME0052 DME0052 DME_NAME Aldehyde oxidase (AOX1) DME0052 SPESNAME Homo sapiens DME0052 XEOTICID XEO00007 XEO_NAME Azathioprine DME0052 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0052 XEOTICID XEO00007 DESCRIPT Azathioprine up-regulates the expression of DME AOX1 DME0052 XEOTICID XEO00007 GENEFORM mRNA DME0052 XEOTICID XEO00007 MOACRIVE Induction DME0052 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0052 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0052 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME AOX1 DME0052 XEOTICID XEO00088 GENEFORM mRNA DME0052 XEOTICID XEO00088 MOACRIVE Induction DME0052 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0052 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0052 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME AOX1 DME0052 XEOTICID XEO00117 GENEFORM mRNA DME0052 XEOTICID XEO00117 MOACRIVE Induction DME0052 XEOTICID XEO00181 XEO_NAME Dasatinib DME0052 XEOTICID XEO00181 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO00181 XEO_CLAS Approved/Marketed Drug DME0052 XEOTICID XEO00181 DESCRIPT Dasatinib inhibits the expression of DME AOX1 DME0052 XEOTICID XEO00181 GENEFORM mRNA DME0052 XEOTICID XEO00181 MOACRIVE Inhibition DME0052 XEOTICID XEO00193 XEO_NAME Belinostat DME0052 XEOTICID XEO00193 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO00193 XEO_CLAS Approved/Marketed Drug DME0052 XEOTICID XEO00193 DESCRIPT Belinostat inhibits the expression of DME AOX1 DME0052 XEOTICID XEO00193 GENEFORM mRNA DME0052 XEOTICID XEO00193 MOACRIVE Inhibition DME0052 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0052 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0052 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME AOX1 DME0052 XEOTICID XEO00217 GENEFORM mRNA DME0052 XEOTICID XEO00217 MOACRIVE Inhibition DME0052 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0052 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0052 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME AOX1 DME0052 XEOTICID XEO00241 GENEFORM mRNA DME0052 XEOTICID XEO00241 MOACRIVE Inhibition DME0052 XEOTICID XEO00428 XEO_NAME Menadione DME0052 XEOTICID XEO00428 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO00428 XEO_CLAS Approved/Marketed Drug DME0052 XEOTICID XEO00428 DESCRIPT Menadione inhibits the drug-metabolizing activity of DME AOX1 (IC50 = 0.2 microM) DME0052 XEOTICID XEO00428 GENEFORM Protein DME0052 XEOTICID XEO00428 MOACRIVE Inhibition DME0052 XEOTICID XEO00435 XEO_NAME Urethane DME0052 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0052 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME AOX1 DME0052 XEOTICID XEO00435 GENEFORM mRNA DME0052 XEOTICID XEO00435 MOACRIVE Inhibition DME0052 XEOTICID XEO00533 XEO_NAME Gold sodium thiomalate DME0052 XEOTICID XEO00533 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO00533 XEO_CLAS Drug in Phase 1 Clinical Trial DME0052 XEOTICID XEO00533 DESCRIPT Gold sodium thiomalate up-regulates the expression of DME AOX1 DME0052 XEOTICID XEO00533 GENEFORM mRNA DME0052 XEOTICID XEO00533 MOACRIVE Induction DME0052 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0052 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0052 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME AOX1 DME0052 XEOTICID XEO00723 GENEFORM mRNA DME0052 XEOTICID XEO00723 MOACRIVE Inhibition DME0052 XEOTICID XEO00760 XEO_NAME Jinfukang DME0052 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0052 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0052 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME AOX1 DME0052 XEOTICID XEO00760 GENEFORM mRNA DME0052 XEOTICID XEO00760 MOACRIVE Inhibition DME0052 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0052 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0052 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate inhibits the expression of DME AOX1 DME0052 XEOTICID XEO00818 GENEFORM mRNA DME0052 XEOTICID XEO00818 MOACRIVE Inhibition DME0052 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0052 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0052 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0052 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME AOX1 DME0052 XEOTICID XEO00821 GENEFORM Protein DME0052 XEOTICID XEO00821 MOACRIVE Inhibition DME0052 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0052 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0052 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0052 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME AOX1 DME0052 XEOTICID XEO00898 GENEFORM mRNA DME0052 XEOTICID XEO00898 MOACRIVE Induction DME0052 XEOTICID XEO00973 XEO_NAME Diuron DME0052 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0052 XEOTICID XEO00973 XEO_CLAS Herbicide DME0052 XEOTICID XEO00973 DESCRIPT Diuron inhibits the expression of DME AOX1 DME0052 XEOTICID XEO00973 GENEFORM mRNA DME0052 XEOTICID XEO00973 MOACRIVE Inhibition DME0052 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0052 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0052 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0052 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME AOX1 DME0052 XEOTICID XEO00999 GENEFORM mRNA DME0052 XEOTICID XEO00999 MOACRIVE Induction DME0052 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0052 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0052 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0052 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME AOX1 DME0052 XEOTICID XEO01004 GENEFORM mRNA DME0052 XEOTICID XEO01004 MOACRIVE Inhibition DME0052 XEOTICID XEO01034 XEO_NAME Pentanal DME0052 XEOTICID XEO01034 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0052 XEOTICID XEO01034 XEO_CLAS Chemical Compound DME0052 XEOTICID XEO01034 DESCRIPT Pentanal up-regulates the expression of DME AOX1 DME0052 XEOTICID XEO01034 GENEFORM mRNA DME0052 XEOTICID XEO01034 MOACRIVE Induction DME0052 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0052 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0052 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0052 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME AOX1 DME0052 XEOTICID XEO01050 GENEFORM mRNA DME0052 XEOTICID XEO01050 MOACRIVE Inhibition DME0052 XEOTICID XEO01107 XEO_NAME NSC 703786 DME0052 XEOTICID XEO01107 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO01107 XEO_CLAS Drug in Phase 1 Clinical Trial DME0052 XEOTICID XEO01107 DESCRIPT NSC 703786 inhibits the expression of DME AOX1 DME0052 XEOTICID XEO01107 GENEFORM mRNA DME0052 XEOTICID XEO01107 MOACRIVE Inhibition DME0052 XEOTICID XEO01401 XEO_NAME NSC-689534 DME0052 XEOTICID XEO01401 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO01401 XEO_CLAS Preclinical/Patented Drug DME0052 XEOTICID XEO01401 DESCRIPT NSC-689534 induces the drug-metabolizing activity of DME AOX1 DME0052 XEOTICID XEO01401 GENEFORM Protein DME0052 XEOTICID XEO01401 MOACRIVE Induction DME0052 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0052 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0052 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0052 XEOTICID XEO01492 DESCRIPT Trichostatin A inhibits the expression of DME AOX1 DME0052 XEOTICID XEO01492 GENEFORM mRNA DME0052 XEOTICID XEO01492 MOACRIVE Inhibition DME0053 DME___ID DME0053 DME0053 DME_NAME Dihydrothymine dehydrogenase (DPYD) DME0053 SPESNAME Homo sapiens DME0053 XEOTICID XEO00007 XEO_NAME Azathioprine DME0053 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0053 XEOTICID XEO00007 DESCRIPT Azathioprine inhibits the expression of DME DPYD DME0053 XEOTICID XEO00007 GENEFORM mRNA DME0053 XEOTICID XEO00007 MOACRIVE Inhibition DME0053 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0053 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0053 XEOTICID XEO00037 DESCRIPT Fluorouracil induces the drug-metabolizing activity of DME DPYD DME0053 XEOTICID XEO00037 GENEFORM Protein DME0053 XEOTICID XEO00037 MOACRIVE Induction DME0053 XEOTICID XEO00133 XEO_NAME Capecitabine DME0053 XEOTICID XEO00133 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00133 XEO_CLAS Approved/Marketed Drug DME0053 XEOTICID XEO00133 DESCRIPT Capecitabine up-regulates the expression of DME DPYD DME0053 XEOTICID XEO00133 GENEFORM mRNA DME0053 XEOTICID XEO00133 MOACRIVE Induction DME0053 XEOTICID XEO00153 XEO_NAME Docetaxel DME0053 XEOTICID XEO00153 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00153 XEO_CLAS Approved/Marketed Drug DME0053 XEOTICID XEO00153 DESCRIPT Docetaxel inhibits the drug-metabolizing activity of DME DPYD DME0053 XEOTICID XEO00153 GENEFORM Protein DME0053 XEOTICID XEO00153 MOACRIVE Inhibition DME0053 XEOTICID XEO00168 XEO_NAME Decitabine DME0053 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0053 XEOTICID XEO00168 DESCRIPT Decitabine up-regulates the expression of DME DPYD DME0053 XEOTICID XEO00168 GENEFORM mRNA DME0053 XEOTICID XEO00168 MOACRIVE Induction DME0053 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0053 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0053 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME DPYD DME0053 XEOTICID XEO00217 GENEFORM mRNA DME0053 XEOTICID XEO00217 MOACRIVE Inhibition DME0053 XEOTICID XEO00229 XEO_NAME Temsirolimus DME0053 XEOTICID XEO00229 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00229 XEO_CLAS Approved/Marketed Drug DME0053 XEOTICID XEO00229 DESCRIPT Temsirolimus inhibits the drug-metabolizing activity of DME DPYD DME0053 XEOTICID XEO00229 GENEFORM Protein DME0053 XEOTICID XEO00229 MOACRIVE Inhibition DME0053 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0053 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0053 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME DPYD DME0053 XEOTICID XEO00241 GENEFORM mRNA DME0053 XEOTICID XEO00241 MOACRIVE Inhibition DME0053 XEOTICID XEO00256 XEO_NAME Paclitaxel DME0053 XEOTICID XEO00256 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00256 XEO_CLAS Approved/Marketed Drug DME0053 XEOTICID XEO00256 DESCRIPT Paclitaxel inhibits the drug-metabolizing activity of DME DPYD DME0053 XEOTICID XEO00256 GENEFORM Protein DME0053 XEOTICID XEO00256 MOACRIVE Inhibition DME0053 XEOTICID XEO00301 XEO_NAME Irinotecan hydrochloride DME0053 XEOTICID XEO00301 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00301 XEO_CLAS Approved/Marketed Drug DME0053 XEOTICID XEO00301 DESCRIPT Irinotecan hydrochloride inhibits the expression of DME DPYD DME0053 XEOTICID XEO00301 GENEFORM mRNA DME0053 XEOTICID XEO00301 MOACRIVE Inhibition DME0053 XEOTICID XEO00334 XEO_NAME Cisplatin DME0053 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0053 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the drug-metabolizing activity of DME DPYD DME0053 XEOTICID XEO00334 GENEFORM Protein DME0053 XEOTICID XEO00334 MOACRIVE Inhibition DME0053 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0053 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0053 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME DPYD DME0053 XEOTICID XEO00339 GENEFORM mRNA DME0053 XEOTICID XEO00339 MOACRIVE Induction DME0053 XEOTICID XEO00472 XEO_NAME Gimeracil DME0053 XEOTICID XEO00472 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00472 XEO_CLAS Approved/Marketed Drug DME0053 XEOTICID XEO00472 DESCRIPT Gimeracil inhibits the drug-metabolizing activity of DME DPYD DME0053 XEOTICID XEO00472 GENEFORM Protein DME0053 XEOTICID XEO00472 MOACRIVE Inhibition DME0053 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0053 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0053 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene inhibits the expression of DME DPYD DME0053 XEOTICID XEO00571 GENEFORM mRNA DME0053 XEOTICID XEO00571 MOACRIVE Inhibition DME0053 XEOTICID XEO00597 XEO_NAME Camptothecin DME0053 XEOTICID XEO00597 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00597 XEO_CLAS Drug in Phase 2 Clinical Trial DME0053 XEOTICID XEO00597 DESCRIPT Camptothecin inhibits the drug-metabolizing activity of DME DPYD DME0053 XEOTICID XEO00597 GENEFORM Protein DME0053 XEOTICID XEO00597 MOACRIVE Inhibition DME0053 XEOTICID XEO00760 XEO_NAME Jinfukang DME0053 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0053 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0053 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME DPYD DME0053 XEOTICID XEO00760 GENEFORM mRNA DME0053 XEOTICID XEO00760 MOACRIVE Inhibition DME0053 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0053 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0053 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0053 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME DPYD DME0053 XEOTICID XEO00772 GENEFORM mRNA DME0053 XEOTICID XEO00772 MOACRIVE Inhibition DME0053 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0053 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0053 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0053 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME DPYD DME0053 XEOTICID XEO00806 GENEFORM mRNA DME0053 XEOTICID XEO00806 MOACRIVE Inhibition DME0053 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0053 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0053 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME DPYD DME0053 XEOTICID XEO00818 GENEFORM mRNA DME0053 XEOTICID XEO00818 MOACRIVE Induction DME0053 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0053 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0053 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0053 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME DPYD DME0053 XEOTICID XEO00821 GENEFORM Protein DME0053 XEOTICID XEO00821 MOACRIVE Inhibition DME0053 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0053 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0053 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0053 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME DPYD DME0053 XEOTICID XEO00898 GENEFORM mRNA DME0053 XEOTICID XEO00898 MOACRIVE Inhibition DME0053 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0053 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0053 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0053 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME DPYD DME0053 XEOTICID XEO00999 GENEFORM mRNA DME0053 XEOTICID XEO00999 MOACRIVE Inhibition DME0053 XEOTICID XEO01024 XEO_NAME Sodium bichromate DME0053 XEOTICID XEO01024 XEO_TYPE Health or Environmental Toxicant(s) DME0053 XEOTICID XEO01024 XEO_CLAS Carcinogen DME0053 XEOTICID XEO01024 DESCRIPT Sodium bichromate inhibits the expression of DME DPYD DME0053 XEOTICID XEO01024 GENEFORM mRNA DME0053 XEOTICID XEO01024 MOACRIVE Inhibition DME0053 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0053 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0053 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0053 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME DPYD DME0053 XEOTICID XEO01305 GENEFORM mRNA DME0053 XEOTICID XEO01305 MOACRIVE Inhibition DME0053 XEOTICID XEO01478 XEO_NAME Sulforafan DME0053 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0053 XEOTICID XEO01478 DESCRIPT Sulforafan up-regulates the expression of DME DPYD DME0053 XEOTICID XEO01478 GENEFORM mRNA DME0053 XEOTICID XEO01478 MOACRIVE Induction DME0053 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0053 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0053 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0053 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME DPYD DME0053 XEOTICID XEO01492 GENEFORM mRNA DME0053 XEOTICID XEO01492 MOACRIVE Induction DME0053 XEOTICID XEO01551 XEO_NAME Heliotrine DME0053 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0053 XEOTICID XEO01551 XEO_CLAS Natural Product DME0053 XEOTICID XEO01551 DESCRIPT Heliotrine inhibits the expression of DME DPYD DME0053 XEOTICID XEO01551 GENEFORM mRNA DME0053 XEOTICID XEO01551 MOACRIVE Inhibition DME0053 XEOTICID XEO01574 XEO_NAME Plant extracts DME0053 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0053 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0053 XEOTICID XEO01574 DESCRIPT Plant extracts up-regulates the expression of DME DPYD DME0053 XEOTICID XEO01574 GENEFORM mRNA DME0053 XEOTICID XEO01574 MOACRIVE Induction DME0053 XEOTICID XEO01582 XEO_NAME Pyrrolizidine alkaloid DME0053 XEOTICID XEO01582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0053 XEOTICID XEO01582 XEO_CLAS Natural Product DME0053 XEOTICID XEO01582 DESCRIPT Pyrrolizidine alkaloid inhibits the drug-metabolizing activity of DME DPYD DME0053 XEOTICID XEO01582 GENEFORM Protein DME0053 XEOTICID XEO01582 MOACRIVE Inhibition DME0054 DME___ID DME0054 DME0054 DME_NAME Carboxylesterase 1 (CES1) DME0054 SPESNAME Homo sapiens DME0054 XEOTICID XEO00029 XEO_NAME Valproic acid DME0054 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00029 GENEFORM mRNA DME0054 XEOTICID XEO00029 MOACRIVE Induction DME0054 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0054 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00088 DESCRIPT Dexamethasone induces the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO00088 GENEFORM Protein DME0054 XEOTICID XEO00088 MOACRIVE Induction DME0054 XEOTICID XEO00096 XEO_NAME Ampicillin DME0054 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00096 DESCRIPT Ampicillin up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00096 GENEFORM mRNA DME0054 XEOTICID XEO00096 MOACRIVE Induction DME0054 XEOTICID XEO00099 XEO_NAME Penicillin V DME0054 XEOTICID XEO00099 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00099 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00099 DESCRIPT Penicillin V up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00099 GENEFORM mRNA DME0054 XEOTICID XEO00099 MOACRIVE Induction DME0054 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0054 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00117 GENEFORM mRNA DME0054 XEOTICID XEO00117 MOACRIVE Induction DME0054 XEOTICID XEO00181 XEO_NAME Dasatinib DME0054 XEOTICID XEO00181 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00181 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00181 DESCRIPT Dasatinib up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00181 GENEFORM mRNA DME0054 XEOTICID XEO00181 MOACRIVE Induction DME0054 XEOTICID XEO00191 XEO_NAME Everolimus DME0054 XEOTICID XEO00191 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00191 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00191 DESCRIPT Everolimus inhibits the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO00191 GENEFORM Protein DME0054 XEOTICID XEO00191 MOACRIVE Inhibition DME0054 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0054 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CES1 DME0054 XEOTICID XEO00217 GENEFORM mRNA DME0054 XEOTICID XEO00217 MOACRIVE Inhibition DME0054 XEOTICID XEO00223 XEO_NAME Rifampin DME0054 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00223 DESCRIPT Rifampin induces the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO00223 GENEFORM Protein DME0054 XEOTICID XEO00223 MOACRIVE Induction DME0054 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0054 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00241 GENEFORM mRNA DME0054 XEOTICID XEO00241 MOACRIVE Induction DME0054 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0054 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00277 GENEFORM mRNA DME0054 XEOTICID XEO00277 MOACRIVE Induction DME0054 XEOTICID XEO00319 XEO_NAME Pioglitazone hydrochloride DME0054 XEOTICID XEO00319 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00319 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00319 DESCRIPT Pioglitazone hydrochloride up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00319 GENEFORM mRNA DME0054 XEOTICID XEO00319 MOACRIVE Induction DME0054 XEOTICID XEO00328 XEO_NAME Tacrine hydrochloride DME0054 XEOTICID XEO00328 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00328 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00328 DESCRIPT Tacrine hydrochloride inhibits the drug-metabolizing activity of DME CES1 (IC50 > 100 microM) DME0054 XEOTICID XEO00328 GENEFORM Protein DME0054 XEOTICID XEO00328 MOACRIVE Inhibition DME0054 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0054 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00380 DESCRIPT Rosiglitazone induces the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO00380 GENEFORM Protein DME0054 XEOTICID XEO00380 MOACRIVE Induction DME0054 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0054 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00410 DESCRIPT Phenobarbital up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00410 GENEFORM mRNA DME0054 XEOTICID XEO00410 MOACRIVE Induction DME0054 XEOTICID XEO00411 XEO_NAME Avobenzone DME0054 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00411 GENEFORM mRNA DME0054 XEOTICID XEO00411 MOACRIVE Induction DME0054 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0054 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0054 XEOTICID XEO00430 DESCRIPT Hydroquinone up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00430 GENEFORM mRNA DME0054 XEOTICID XEO00430 MOACRIVE Induction DME0054 XEOTICID XEO00547 XEO_NAME Vitamin E DME0054 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0054 XEOTICID XEO00547 DESCRIPT Vitamin E up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00547 GENEFORM mRNA DME0054 XEOTICID XEO00547 MOACRIVE Induction DME0054 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0054 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0054 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00571 GENEFORM mRNA DME0054 XEOTICID XEO00571 MOACRIVE Induction DME0054 XEOTICID XEO00581 XEO_NAME MS-275 DME0054 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0054 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00581 GENEFORM mRNA DME0054 XEOTICID XEO00581 MOACRIVE Induction DME0054 XEOTICID XEO00639 XEO_NAME URB-597 DME0054 XEOTICID XEO00639 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00639 XEO_CLAS Drug in Phase 1 Clinical Trial DME0054 XEOTICID XEO00639 DESCRIPT URB-597 inhibits the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO00639 GENEFORM Protein DME0054 XEOTICID XEO00639 MOACRIVE Inhibition DME0054 XEOTICID XEO00722 XEO_NAME Gardiquimod DME0054 XEOTICID XEO00722 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00722 XEO_CLAS Preclinical/Patented Drug DME0054 XEOTICID XEO00722 DESCRIPT Gardiquimod up-regulates the expression of DME CES1 DME0054 XEOTICID XEO00722 GENEFORM mRNA DME0054 XEOTICID XEO00722 MOACRIVE Induction DME0054 XEOTICID XEO00767 XEO_NAME Ciglitazone DME0054 XEOTICID XEO00767 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00767 XEO_CLAS Investigative Agent DME0054 XEOTICID XEO00767 DESCRIPT Ciglitazone inhibits the expression of DME CES1 DME0054 XEOTICID XEO00767 GENEFORM mRNA DME0054 XEOTICID XEO00767 MOACRIVE Inhibition DME0054 XEOTICID XEO00785 XEO_NAME Acridine DME0054 XEOTICID XEO00785 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0054 XEOTICID XEO00785 XEO_CLAS Chemical Compound DME0054 XEOTICID XEO00785 DESCRIPT Acridine inhibits the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO00785 GENEFORM Protein DME0054 XEOTICID XEO00785 MOACRIVE Inhibition DME0054 XEOTICID XEO00869 XEO_NAME 4-hydroxy-2-nonenal DME0054 XEOTICID XEO00869 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00869 XEO_CLAS Investigative Agent DME0054 XEOTICID XEO00869 DESCRIPT 4-hydroxy-2-nonenal inhibits the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO00869 GENEFORM Protein DME0054 XEOTICID XEO00869 MOACRIVE Inhibition DME0054 XEOTICID XEO00876 XEO_NAME Arachidonic acid DME0054 XEOTICID XEO00876 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO00876 XEO_CLAS Investigative Agent DME0054 XEOTICID XEO00876 DESCRIPT Arachidonic acid inhibits the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO00876 GENEFORM Protein DME0054 XEOTICID XEO00876 MOACRIVE Inhibition DME0054 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0054 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0054 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0054 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME CES1 DME0054 XEOTICID XEO00905 GENEFORM mRNA DME0054 XEOTICID XEO00905 MOACRIVE Inhibition DME0054 XEOTICID XEO00984 XEO_NAME Galaxolide DME0054 XEOTICID XEO00984 XEO_TYPE Health or Environmental Toxicant(s) DME0054 XEOTICID XEO00984 XEO_CLAS Environmental Pollutant DME0054 XEOTICID XEO00984 DESCRIPT Galaxolide inhibits the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO00984 GENEFORM Protein DME0054 XEOTICID XEO00984 MOACRIVE Inhibition DME0054 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0054 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0054 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0054 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME CES1 DME0054 XEOTICID XEO00999 GENEFORM mRNA DME0054 XEOTICID XEO00999 MOACRIVE Inhibition DME0054 XEOTICID XEO01006 XEO_NAME Dimethyl nitrosamine DME0054 XEOTICID XEO01006 XEO_TYPE Health or Environmental Toxicant(s) DME0054 XEOTICID XEO01006 XEO_CLAS Carcinogen DME0054 XEOTICID XEO01006 DESCRIPT Dimethyl nitrosamine up-regulates the expression of DME CES1 DME0054 XEOTICID XEO01006 GENEFORM mRNA DME0054 XEOTICID XEO01006 MOACRIVE Induction DME0054 XEOTICID XEO01038 XEO_NAME Azinphosmethyl DME0054 XEOTICID XEO01038 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0054 XEOTICID XEO01038 XEO_CLAS Pesticide/Insecticide DME0054 XEOTICID XEO01038 DESCRIPT Azinphosmethyl inhibits the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO01038 GENEFORM Protein DME0054 XEOTICID XEO01038 MOACRIVE Inhibition DME0054 XEOTICID XEO01117 XEO_NAME 27-hydroxycholesterol DME0054 XEOTICID XEO01117 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO01117 XEO_CLAS Investigative Agent DME0054 XEOTICID XEO01117 DESCRIPT 27-hydroxycholesterol inhibits the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO01117 GENEFORM Protein DME0054 XEOTICID XEO01117 MOACRIVE Inhibition DME0054 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0054 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0054 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0054 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone up-regulates the expression of DME CES1 and leads to increasing the drug-metabolizing activity of this enzyme DME0054 XEOTICID XEO01129 GENEFORM Protein DME0054 XEOTICID XEO01129 MOACRIVE Induction DME0054 XEOTICID XEO01158 XEO_NAME 5,8,11,14-eicosatetraynoic Acid DME0054 XEOTICID XEO01158 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO01158 XEO_CLAS Investigative Agent DME0054 XEOTICID XEO01158 DESCRIPT 5,8,11,14-eicosatetraynoic Acid inhibits the expression of DME CES1 DME0054 XEOTICID XEO01158 GENEFORM mRNA DME0054 XEOTICID XEO01158 MOACRIVE Inhibition DME0054 XEOTICID XEO01182 XEO_NAME Prostaglandin J2 DME0054 XEOTICID XEO01182 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO01182 XEO_CLAS Investigative Agent DME0054 XEOTICID XEO01182 DESCRIPT Prostaglandin J2 inhibits the expression of DME CES1 DME0054 XEOTICID XEO01182 GENEFORM mRNA DME0054 XEOTICID XEO01182 MOACRIVE Inhibition DME0054 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0054 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0054 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME CES1 DME0054 XEOTICID XEO01226 GENEFORM mRNA DME0054 XEOTICID XEO01226 MOACRIVE Induction DME0054 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0054 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0054 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0054 XEOTICID XEO01248 DESCRIPT Chlorpyrifos inhibits the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO01248 GENEFORM Protein DME0054 XEOTICID XEO01248 MOACRIVE Inhibition DME0054 XEOTICID XEO01250 XEO_NAME Cholesterol DME0054 XEOTICID XEO01250 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0054 XEOTICID XEO01250 XEO_CLAS Natural Product DME0054 XEOTICID XEO01250 DESCRIPT Cholesterol up-regulates the expression of DME CES1 DME0054 XEOTICID XEO01250 GENEFORM mRNA DME0054 XEOTICID XEO01250 MOACRIVE Induction DME0054 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME0054 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0054 XEOTICID XEO01253 XEO_CLAS Natural Product DME0054 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde up-regulates the expression of DME CES1 DME0054 XEOTICID XEO01253 GENEFORM mRNA DME0054 XEOTICID XEO01253 MOACRIVE Induction DME0054 XEOTICID XEO01348 XEO_NAME K-7174 DME0054 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0054 XEOTICID XEO01348 DESCRIPT K-7174 up-regulates the expression of DME CES1 DME0054 XEOTICID XEO01348 GENEFORM mRNA DME0054 XEOTICID XEO01348 MOACRIVE Induction DME0054 XEOTICID XEO01427 XEO_NAME Phenylmethylsulfonyl fluoride DME0054 XEOTICID XEO01427 XEO_TYPE Health or Environmental Toxicant(s) DME0054 XEOTICID XEO01427 XEO_CLAS Acute Toxic Substance DME0054 XEOTICID XEO01427 DESCRIPT Phenylmethylsulfonyl fluoride inhibits the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO01427 GENEFORM Protein DME0054 XEOTICID XEO01427 MOACRIVE Inhibition DME0054 XEOTICID XEO01433 XEO_NAME Pirinixic acid DME0054 XEOTICID XEO01433 XEO_TYPE Health or Environmental Toxicant(s) DME0054 XEOTICID XEO01433 XEO_CLAS Health Hazard/Toxicant DME0054 XEOTICID XEO01433 DESCRIPT Pirinixic acid inhibits the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO01433 GENEFORM Protein DME0054 XEOTICID XEO01433 MOACRIVE Inhibition DME0054 XEOTICID XEO01478 XEO_NAME Sulforafan DME0054 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0054 XEOTICID XEO01478 DESCRIPT Sulforafan induces the drug-metabolizing activity of DME CES1 DME0054 XEOTICID XEO01478 GENEFORM Protein DME0054 XEOTICID XEO01478 MOACRIVE Induction DME0054 XEOTICID XEO01488 XEO_NAME Tolserine DME0054 XEOTICID XEO01488 XEO_TYPE Pharmaceutical Agent(s) DME0054 XEOTICID XEO01488 XEO_CLAS Investigative Agent DME0054 XEOTICID XEO01488 DESCRIPT Tolserine inhibits the expression of DME CES1 DME0054 XEOTICID XEO01488 GENEFORM mRNA DME0054 XEOTICID XEO01488 MOACRIVE Inhibition DME0056 DME___ID DME0056 DME0056 DME_NAME Carboxylesterase 3 (CES3) DME0056 SPESNAME Homo sapiens DME0056 XEOTICID XEO01427 XEO_NAME Phenylmethylsulfonyl fluoride DME0056 XEOTICID XEO01427 XEO_TYPE Health or Environmental Toxicant(s) DME0056 XEOTICID XEO01427 XEO_CLAS Acute Toxic Substance DME0056 XEOTICID XEO01427 DESCRIPT Phenylmethylsulfonyl fluoride inhibits the expression of DME CES3 DME0056 XEOTICID XEO01427 GENEFORM mRNA DME0056 XEOTICID XEO01427 MOACRIVE Inhibition DME0056 XEOTICID XEO01574 XEO_NAME Plant extracts DME0056 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0056 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0056 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME CES3 DME0056 XEOTICID XEO01574 GENEFORM Protein DME0056 XEOTICID XEO01574 MOACRIVE Inhibition DME0057 DME___ID DME0057 DME0057 DME_NAME Carboxylesterase 2 (CES2) DME0057 SPESNAME Homo sapiens DME0057 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0057 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00037 DESCRIPT Fluorouracil up-regulates the expression of DME CES2 DME0057 XEOTICID XEO00037 GENEFORM mRNA DME0057 XEOTICID XEO00037 MOACRIVE Induction DME0057 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0057 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00088 DESCRIPT Dexamethasone induces the drug-metabolizing activity of DME CES2 DME0057 XEOTICID XEO00088 GENEFORM Protein DME0057 XEOTICID XEO00088 MOACRIVE Induction DME0057 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0057 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME CES2 DME0057 XEOTICID XEO00117 GENEFORM mRNA DME0057 XEOTICID XEO00117 MOACRIVE Inhibition DME0057 XEOTICID XEO00191 XEO_NAME Everolimus DME0057 XEOTICID XEO00191 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00191 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00191 DESCRIPT Everolimus inhibits the drug-metabolizing activity of DME CES2 DME0057 XEOTICID XEO00191 GENEFORM Protein DME0057 XEOTICID XEO00191 MOACRIVE Inhibition DME0057 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0057 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CES2 DME0057 XEOTICID XEO00217 GENEFORM mRNA DME0057 XEOTICID XEO00217 MOACRIVE Inhibition DME0057 XEOTICID XEO00223 XEO_NAME Rifampin DME0057 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00223 DESCRIPT Rifampin up-regulates the expression of DME CES2 DME0057 XEOTICID XEO00223 GENEFORM mRNA DME0057 XEOTICID XEO00223 MOACRIVE Induction DME0057 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0057 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CES2 DME0057 XEOTICID XEO00241 GENEFORM mRNA DME0057 XEOTICID XEO00241 MOACRIVE Inhibition DME0057 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0057 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME CES2 DME0057 XEOTICID XEO00292 GENEFORM mRNA DME0057 XEOTICID XEO00292 MOACRIVE Induction DME0057 XEOTICID XEO00298 XEO_NAME Galantamine hydrobromide DME0057 XEOTICID XEO00298 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00298 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00298 DESCRIPT Galantamine hydrobromide inhibits the drug-metabolizing activity of DME CES2 DME0057 XEOTICID XEO00298 GENEFORM Protein DME0057 XEOTICID XEO00298 MOACRIVE Inhibition DME0057 XEOTICID XEO00301 XEO_NAME Irinotecan hydrochloride DME0057 XEOTICID XEO00301 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00301 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00301 DESCRIPT Irinotecan hydrochloride up-regulates the expression of DME CES2 DME0057 XEOTICID XEO00301 GENEFORM mRNA DME0057 XEOTICID XEO00301 MOACRIVE Induction DME0057 XEOTICID XEO00321 XEO_NAME Rivastigmine tartrate DME0057 XEOTICID XEO00321 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00321 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00321 DESCRIPT Rivastigmine tartrate inhibits the drug-metabolizing activity of DME CES2 DME0057 XEOTICID XEO00321 GENEFORM Protein DME0057 XEOTICID XEO00321 MOACRIVE Inhibition DME0057 XEOTICID XEO00334 XEO_NAME Cisplatin DME0057 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME CES2 DME0057 XEOTICID XEO00334 GENEFORM mRNA DME0057 XEOTICID XEO00334 MOACRIVE Induction DME0057 XEOTICID XEO00366 XEO_NAME Methotrexate DME0057 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00366 DESCRIPT Methotrexate inhibits the expression of DME CES2 DME0057 XEOTICID XEO00366 GENEFORM mRNA DME0057 XEOTICID XEO00366 MOACRIVE Inhibition DME0057 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0057 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00410 DESCRIPT Phenobarbital up-regulates the expression of DME CES2 DME0057 XEOTICID XEO00410 GENEFORM mRNA DME0057 XEOTICID XEO00410 MOACRIVE Induction DME0057 XEOTICID XEO00538 XEO_NAME Quercetin DME0057 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0057 XEOTICID XEO00538 DESCRIPT Quercetin induces the drug-metabolizing activity of DME CES2 DME0057 XEOTICID XEO00538 GENEFORM Protein DME0057 XEOTICID XEO00538 MOACRIVE Induction DME0057 XEOTICID XEO00586 XEO_NAME Physostigmine DME0057 XEOTICID XEO00586 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00586 XEO_CLAS Drug in Phase 3 Clinical Trial DME0057 XEOTICID XEO00586 DESCRIPT Physostigmine inhibits the expression of DME CES2 DME0057 XEOTICID XEO00586 GENEFORM mRNA DME0057 XEOTICID XEO00586 MOACRIVE Inhibition DME0057 XEOTICID XEO00639 XEO_NAME URB-597 DME0057 XEOTICID XEO00639 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00639 XEO_CLAS Drug in Phase 1 Clinical Trial DME0057 XEOTICID XEO00639 DESCRIPT URB-597 inhibits the drug-metabolizing activity of DME CES2 DME0057 XEOTICID XEO00639 GENEFORM Protein DME0057 XEOTICID XEO00639 MOACRIVE Inhibition DME0057 XEOTICID XEO00751 XEO_NAME Cocaine hydrochloride DME0057 XEOTICID XEO00751 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00751 XEO_CLAS Approved/Marketed Drug DME0057 XEOTICID XEO00751 DESCRIPT Cocaine hydrochloride inhibits the expression of DME CES2 DME0057 XEOTICID XEO00751 GENEFORM mRNA DME0057 XEOTICID XEO00751 MOACRIVE Inhibition DME0057 XEOTICID XEO00785 XEO_NAME Acridine DME0057 XEOTICID XEO00785 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0057 XEOTICID XEO00785 XEO_CLAS Chemical Compound DME0057 XEOTICID XEO00785 DESCRIPT Acridine inhibits the drug-metabolizing activity of DME CES2 DME0057 XEOTICID XEO00785 GENEFORM Protein DME0057 XEOTICID XEO00785 MOACRIVE Inhibition DME0057 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0057 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0057 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0057 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CES2 DME0057 XEOTICID XEO00806 GENEFORM mRNA DME0057 XEOTICID XEO00806 MOACRIVE Inhibition DME0057 XEOTICID XEO00869 XEO_NAME 4-hydroxy-2-nonenal DME0057 XEOTICID XEO00869 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO00869 XEO_CLAS Investigative Agent DME0057 XEOTICID XEO00869 DESCRIPT 4-hydroxy-2-nonenal induces the drug-metabolizing activity of DME CES2 DME0057 XEOTICID XEO00869 GENEFORM Protein DME0057 XEOTICID XEO00869 MOACRIVE Induction DME0057 XEOTICID XEO00882 XEO_NAME Ethyl paraoxon DME0057 XEOTICID XEO00882 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0057 XEOTICID XEO00882 XEO_CLAS Pesticide/Insecticide DME0057 XEOTICID XEO00882 DESCRIPT Ethyl paraoxon inhibits the expression of DME CES2 DME0057 XEOTICID XEO00882 GENEFORM mRNA DME0057 XEOTICID XEO00882 MOACRIVE Inhibition DME0057 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0057 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0057 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0057 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CES2 DME0057 XEOTICID XEO00898 GENEFORM mRNA DME0057 XEOTICID XEO00898 MOACRIVE Induction DME0057 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0057 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0057 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0057 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin up-regulates the expression of DME CES2 DME0057 XEOTICID XEO00905 GENEFORM mRNA DME0057 XEOTICID XEO00905 MOACRIVE Induction DME0057 XEOTICID XEO00942 XEO_NAME Cyproconazole DME0057 XEOTICID XEO00942 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0057 XEOTICID XEO00942 XEO_CLAS Fungicide DME0057 XEOTICID XEO00942 DESCRIPT Cyproconazole induces the drug-metabolizing activity of DME CES2 DME0057 XEOTICID XEO00942 GENEFORM Protein DME0057 XEOTICID XEO00942 MOACRIVE Induction DME0057 XEOTICID XEO01038 XEO_NAME Azinphosmethyl DME0057 XEOTICID XEO01038 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0057 XEOTICID XEO01038 XEO_CLAS Pesticide/Insecticide DME0057 XEOTICID XEO01038 DESCRIPT Azinphosmethyl inhibits the drug-metabolizing activity of DME CES2 DME0057 XEOTICID XEO01038 GENEFORM Protein DME0057 XEOTICID XEO01038 MOACRIVE Inhibition DME0057 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0057 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0057 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME CES2 DME0057 XEOTICID XEO01226 GENEFORM mRNA DME0057 XEOTICID XEO01226 MOACRIVE Inhibition DME0057 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0057 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0057 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0057 XEOTICID XEO01248 DESCRIPT Chlorpyrifos inhibits the drug-metabolizing activity of DME CES2 DME0057 XEOTICID XEO01248 GENEFORM Protein DME0057 XEOTICID XEO01248 MOACRIVE Inhibition DME0057 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0057 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0057 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0057 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME CES2 DME0057 XEOTICID XEO01324 GENEFORM mRNA DME0057 XEOTICID XEO01324 MOACRIVE Inhibition DME0057 XEOTICID XEO01427 XEO_NAME Phenylmethylsulfonyl fluoride DME0057 XEOTICID XEO01427 XEO_TYPE Health or Environmental Toxicant(s) DME0057 XEOTICID XEO01427 XEO_CLAS Acute Toxic Substance DME0057 XEOTICID XEO01427 DESCRIPT Phenylmethylsulfonyl fluoride inhibits the expression of DME CES2 DME0057 XEOTICID XEO01427 GENEFORM mRNA DME0057 XEOTICID XEO01427 MOACRIVE Inhibition DME0057 XEOTICID XEO01505 XEO_NAME Lead DME0057 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0057 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0057 XEOTICID XEO01505 DESCRIPT Lead inhibits the expression of DME CES2 DME0057 XEOTICID XEO01505 GENEFORM mRNA DME0057 XEOTICID XEO01505 MOACRIVE Inhibition DME0058 DME___ID DME0058 DME0058 DME_NAME Acetylcholinesterase (ACHE) DME0058 SPESNAME Homo sapiens DME0058 XEOTICID XEO00056 XEO_NAME Malathion DME0058 XEOTICID XEO00056 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00056 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00056 DESCRIPT Malathion inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00056 GENEFORM Protein DME0058 XEOTICID XEO00056 MOACRIVE Inhibition DME0058 XEOTICID XEO00065 XEO_NAME Neostigmine DME0058 XEOTICID XEO00065 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00065 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00065 DESCRIPT Neostigmine inhibits the drug-metabolizing activity of DME ACHE (IC50 = 2.4 microM) DME0058 XEOTICID XEO00065 GENEFORM Protein DME0058 XEOTICID XEO00065 MOACRIVE Inhibition DME0058 XEOTICID XEO00090 XEO_NAME Estradiol DME0058 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME ACHE DME0058 XEOTICID XEO00090 GENEFORM mRNA DME0058 XEOTICID XEO00090 MOACRIVE Induction DME0058 XEOTICID XEO00093 XEO_NAME Isoflurophate DME0058 XEOTICID XEO00093 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00093 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00093 DESCRIPT Isof DMElurophate inhibits the drug-metabolizing activity of DME ACHE (IC50 = 0.12 microM) DME0058 XEOTICID XEO00093 GENEFORM Protein DME0058 XEOTICID XEO00093 MOACRIVE Inhibition DME0058 XEOTICID XEO00100 XEO_NAME Pyridostigmine bromide DME0058 XEOTICID XEO00100 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00100 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00100 DESCRIPT Pyridostigmine bromide inhibits the drug-metabolizing activity of DME ACHE (IC50 = 0.35 microM) DME0058 XEOTICID XEO00100 GENEFORM Protein DME0058 XEOTICID XEO00100 MOACRIVE Inhibition DME0058 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0058 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME ACHE DME0058 XEOTICID XEO00117 GENEFORM mRNA DME0058 XEOTICID XEO00117 MOACRIVE Induction DME0058 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0058 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME ACHE DME0058 XEOTICID XEO00241 GENEFORM mRNA DME0058 XEOTICID XEO00241 MOACRIVE Induction DME0058 XEOTICID XEO00259 XEO_NAME Scopolamine DME0058 XEOTICID XEO00259 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00259 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00259 DESCRIPT Scopolamine induces the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00259 GENEFORM Protein DME0058 XEOTICID XEO00259 MOACRIVE Induction DME0058 XEOTICID XEO00280 XEO_NAME Chlorpromazine hydrochloride DME0058 XEOTICID XEO00280 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00280 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00280 DESCRIPT Chlorpromazine hydrochloride inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00280 GENEFORM Protein DME0058 XEOTICID XEO00280 MOACRIVE Inhibition DME0058 XEOTICID XEO00281 XEO_NAME Choline C-11 DME0058 XEOTICID XEO00281 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00281 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00281 DESCRIPT Choline C-11 inhibits the drug-metabolizing activity of DME ACHE (IC50 = 3013.00602 microM) DME0058 XEOTICID XEO00281 GENEFORM Protein DME0058 XEOTICID XEO00281 MOACRIVE Inhibition DME0058 XEOTICID XEO00289 XEO_NAME Donepezil hydrochloride DME0058 XEOTICID XEO00289 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00289 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00289 DESCRIPT Donepezil hydrochloride inhibits the drug-metabolizing activity of DME ACHE (IC50 = 0.002 microM) DME0058 XEOTICID XEO00289 GENEFORM Protein DME0058 XEOTICID XEO00289 MOACRIVE Inhibition DME0058 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0058 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME ACHE DME0058 XEOTICID XEO00292 GENEFORM mRNA DME0058 XEOTICID XEO00292 MOACRIVE Induction DME0058 XEOTICID XEO00298 XEO_NAME Galantamine hydrobromide DME0058 XEOTICID XEO00298 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00298 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00298 DESCRIPT Galantamine hydrobromide inhibits the drug-metabolizing activity of DME ACHE (IC50 = 0.1 microM) DME0058 XEOTICID XEO00298 GENEFORM Protein DME0058 XEOTICID XEO00298 MOACRIVE Inhibition DME0058 XEOTICID XEO00300 XEO_NAME Imipramine hydrochloride DME0058 XEOTICID XEO00300 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00300 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00300 DESCRIPT Imipramine hydrochloride inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00300 GENEFORM Protein DME0058 XEOTICID XEO00300 MOACRIVE Inhibition DME0058 XEOTICID XEO00307 XEO_NAME Metoclopramide hydrochloride DME0058 XEOTICID XEO00307 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00307 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00307 DESCRIPT Metoclopramide hydrochloride inhibits the drug-metabolizing activity of DME ACHE (IC50 > 20 microM) DME0058 XEOTICID XEO00307 GENEFORM Protein DME0058 XEOTICID XEO00307 MOACRIVE Inhibition DME0058 XEOTICID XEO00328 XEO_NAME Tacrine hydrochloride DME0058 XEOTICID XEO00328 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00328 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00328 DESCRIPT Tacrine hydrochloride inhibits the drug-metabolizing activity of DME ACHE (IC50 = 0.00316 microM) DME0058 XEOTICID XEO00328 GENEFORM Protein DME0058 XEOTICID XEO00328 MOACRIVE Inhibition DME0058 XEOTICID XEO00334 XEO_NAME Cisplatin DME0058 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME ACHE DME0058 XEOTICID XEO00334 GENEFORM mRNA DME0058 XEOTICID XEO00334 MOACRIVE Induction DME0058 XEOTICID XEO00355 XEO_NAME Edrophonium DME0058 XEOTICID XEO00355 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00355 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00355 DESCRIPT Edrophonium inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00355 GENEFORM Protein DME0058 XEOTICID XEO00355 MOACRIVE Inhibition DME0058 XEOTICID XEO00366 XEO_NAME Methotrexate DME0058 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00366 DESCRIPT Methotrexate up-regulates the expression of DME ACHE DME0058 XEOTICID XEO00366 GENEFORM mRNA DME0058 XEOTICID XEO00366 MOACRIVE Induction DME0058 XEOTICID XEO00379 XEO_NAME Ranitidine DME0058 XEOTICID XEO00379 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00379 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00379 DESCRIPT Ranitidine inhibits the expression of DME ACHE DME0058 XEOTICID XEO00379 GENEFORM mRNA DME0058 XEOTICID XEO00379 MOACRIVE Inhibition DME0058 XEOTICID XEO00424 XEO_NAME Sulfonamide DME0058 XEOTICID XEO00424 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00424 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00424 DESCRIPT Sulfonamide inhibits the expression of DME ACHE DME0058 XEOTICID XEO00424 GENEFORM mRNA DME0058 XEOTICID XEO00424 MOACRIVE Inhibition DME0058 XEOTICID XEO00451 XEO_NAME Huperzine A DME0058 XEOTICID XEO00451 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00451 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00451 DESCRIPT Huperzine A inhibits the drug-metabolizing activity of DME ACHE (IC50 = 0.00054 microM) DME0058 XEOTICID XEO00451 GENEFORM Protein DME0058 XEOTICID XEO00451 MOACRIVE Inhibition DME0058 XEOTICID XEO00462 XEO_NAME Bambuterol DME0058 XEOTICID XEO00462 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00462 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO00462 DESCRIPT Bambuterol inhibits the drug-metabolizing activity of DME ACHE (IC50 = 30 microM) DME0058 XEOTICID XEO00462 GENEFORM Protein DME0058 XEOTICID XEO00462 MOACRIVE Inhibition DME0058 XEOTICID XEO00539 XEO_NAME Ethanol DME0058 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0058 XEOTICID XEO00539 DESCRIPT Ethanol induces the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00539 GENEFORM Protein DME0058 XEOTICID XEO00539 MOACRIVE Induction DME0058 XEOTICID XEO00570 XEO_NAME Itopride DME0058 XEOTICID XEO00570 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00570 XEO_CLAS Drug in Phase 3 Clinical Trial DME0058 XEOTICID XEO00570 DESCRIPT Itopride inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00570 GENEFORM Protein DME0058 XEOTICID XEO00570 MOACRIVE Inhibition DME0058 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0058 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0058 XEOTICID XEO00582 DESCRIPT Diethyltoluamide inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00582 GENEFORM Protein DME0058 XEOTICID XEO00582 MOACRIVE Inhibition DME0058 XEOTICID XEO00586 XEO_NAME Physostigmine DME0058 XEOTICID XEO00586 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00586 XEO_CLAS Drug in Phase 3 Clinical Trial DME0058 XEOTICID XEO00586 DESCRIPT Physostigmine inhibits the drug-metabolizing activity of DME ACHE (IC50 = 0.00043 microM) DME0058 XEOTICID XEO00586 GENEFORM Protein DME0058 XEOTICID XEO00586 MOACRIVE Inhibition DME0058 XEOTICID XEO00616 XEO_NAME Physostigmine heptyl DME0058 XEOTICID XEO00616 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00616 XEO_CLAS Drug in Phase 3 Clinical Trial DME0058 XEOTICID XEO00616 DESCRIPT Physostigmine heptyl inhibits the drug-metabolizing activity of DME ACHE (IC50 = 0.005 microM) DME0058 XEOTICID XEO00616 GENEFORM Protein DME0058 XEOTICID XEO00616 MOACRIVE Inhibition DME0058 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0058 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0058 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00632 GENEFORM Protein DME0058 XEOTICID XEO00632 MOACRIVE Inhibition DME0058 XEOTICID XEO00698 XEO_NAME AM-2282 DME0058 XEOTICID XEO00698 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00698 XEO_CLAS Preclinical/Patented Drug DME0058 XEOTICID XEO00698 DESCRIPT AM-2282 up-regulates the expression of DME ACHE DME0058 XEOTICID XEO00698 GENEFORM mRNA DME0058 XEOTICID XEO00698 MOACRIVE Induction DME0058 XEOTICID XEO00760 XEO_NAME Jinfukang DME0058 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0058 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0058 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME ACHE DME0058 XEOTICID XEO00760 GENEFORM mRNA DME0058 XEOTICID XEO00760 MOACRIVE Inhibition DME0058 XEOTICID XEO00778 XEO_NAME Soman DME0058 XEOTICID XEO00778 XEO_TYPE Health or Environmental Toxicant(s) DME0058 XEOTICID XEO00778 XEO_CLAS Acute Toxic Substance DME0058 XEOTICID XEO00778 DESCRIPT Soman inhibits the expression of DME ACHE DME0058 XEOTICID XEO00778 GENEFORM mRNA DME0058 XEOTICID XEO00778 MOACRIVE Inhibition DME0058 XEOTICID XEO00779 XEO_NAME Sarin DME0058 XEOTICID XEO00779 XEO_TYPE Health or Environmental Toxicant(s) DME0058 XEOTICID XEO00779 XEO_CLAS Acute Toxic Substance DME0058 XEOTICID XEO00779 DESCRIPT Sarin inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00779 GENEFORM Protein DME0058 XEOTICID XEO00779 MOACRIVE Inhibition DME0058 XEOTICID XEO00799 XEO_NAME Azamethiphos DME0058 XEOTICID XEO00799 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO00799 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO00799 DESCRIPT Azamethiphos inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00799 GENEFORM Protein DME0058 XEOTICID XEO00799 MOACRIVE Inhibition DME0058 XEOTICID XEO00807 XEO_NAME Chlorite DME0058 XEOTICID XEO00807 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO00807 XEO_CLAS Investigative Agent DME0058 XEOTICID XEO00807 DESCRIPT Chlorite induces the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00807 GENEFORM Protein DME0058 XEOTICID XEO00807 MOACRIVE Induction DME0058 XEOTICID XEO00823 XEO_NAME Carbamate DME0058 XEOTICID XEO00823 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO00823 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO00823 DESCRIPT Carbamate inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00823 GENEFORM Protein DME0058 XEOTICID XEO00823 MOACRIVE Inhibition DME0058 XEOTICID XEO00867 XEO_NAME Fenthion DME0058 XEOTICID XEO00867 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO00867 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO00867 DESCRIPT Fenthion inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00867 GENEFORM Protein DME0058 XEOTICID XEO00867 MOACRIVE Inhibition DME0058 XEOTICID XEO00872 XEO_NAME Acetaldehyde DME0058 XEOTICID XEO00872 XEO_TYPE Health or Environmental Toxicant(s) DME0058 XEOTICID XEO00872 XEO_CLAS Health Hazard/Toxicant DME0058 XEOTICID XEO00872 DESCRIPT Acetaldehyde inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00872 GENEFORM Protein DME0058 XEOTICID XEO00872 MOACRIVE Inhibition DME0058 XEOTICID XEO00882 XEO_NAME Ethyl paraoxon DME0058 XEOTICID XEO00882 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO00882 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO00882 DESCRIPT Ethyl paraoxon inhibits the drug-metabolizing activity of DME ACHE (IC50 = 0.01 microM) DME0058 XEOTICID XEO00882 GENEFORM Protein DME0058 XEOTICID XEO00882 MOACRIVE Inhibition DME0058 XEOTICID XEO00887 XEO_NAME Demeton-S-methyl DME0058 XEOTICID XEO00887 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO00887 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO00887 DESCRIPT Demeton-S-methyl inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00887 GENEFORM Protein DME0058 XEOTICID XEO00887 MOACRIVE Inhibition DME0058 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0058 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0058 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0058 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene induces the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00898 GENEFORM Protein DME0058 XEOTICID XEO00898 MOACRIVE Induction DME0058 XEOTICID XEO00900 XEO_NAME Methylphosphonic difluoride DME0058 XEOTICID XEO00900 XEO_TYPE Health or Environmental Toxicant(s) DME0058 XEOTICID XEO00900 XEO_CLAS Health Hazard/Toxicant DME0058 XEOTICID XEO00900 DESCRIPT Methylphosphonic difluoride inhibits the expression of DME ACHE DME0058 XEOTICID XEO00900 GENEFORM mRNA DME0058 XEOTICID XEO00900 MOACRIVE Inhibition DME0058 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0058 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0058 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0058 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00921 GENEFORM Protein DME0058 XEOTICID XEO00921 MOACRIVE Inhibition DME0058 XEOTICID XEO00967 XEO_NAME Alachlor DME0058 XEOTICID XEO00967 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO00967 XEO_CLAS Herbicide DME0058 XEOTICID XEO00967 DESCRIPT Alachlor induces the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00967 GENEFORM Protein DME0058 XEOTICID XEO00967 MOACRIVE Induction DME0058 XEOTICID XEO00970 XEO_NAME Bensulide DME0058 XEOTICID XEO00970 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO00970 XEO_CLAS Herbicide DME0058 XEOTICID XEO00970 DESCRIPT Bensulide inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00970 GENEFORM Protein DME0058 XEOTICID XEO00970 MOACRIVE Inhibition DME0058 XEOTICID XEO00997 XEO_NAME Bisphenol F DME0058 XEOTICID XEO00997 XEO_TYPE Health or Environmental Toxicant(s) DME0058 XEOTICID XEO00997 XEO_CLAS Environmental Pollutant DME0058 XEOTICID XEO00997 DESCRIPT Bisphenol F induces the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO00997 GENEFORM Protein DME0058 XEOTICID XEO00997 MOACRIVE Induction DME0058 XEOTICID XEO01019 XEO_NAME Phosphorous acids DME0058 XEOTICID XEO01019 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0058 XEOTICID XEO01019 XEO_CLAS Chemical Compound DME0058 XEOTICID XEO01019 DESCRIPT Phosphorous acids inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01019 GENEFORM Protein DME0058 XEOTICID XEO01019 MOACRIVE Inhibition DME0058 XEOTICID XEO01027 XEO_NAME Thioflavin T DME0058 XEOTICID XEO01027 XEO_TYPE Health or Environmental Toxicant(s) DME0058 XEOTICID XEO01027 XEO_CLAS Acute Toxic Substance DME0058 XEOTICID XEO01027 DESCRIPT Thiof DMElavin T inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01027 GENEFORM Protein DME0058 XEOTICID XEO01027 MOACRIVE Inhibition DME0058 XEOTICID XEO01037 XEO_NAME Aldicarb DME0058 XEOTICID XEO01037 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01037 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01037 DESCRIPT Aldicarb inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01037 GENEFORM Protein DME0058 XEOTICID XEO01037 MOACRIVE Inhibition DME0058 XEOTICID XEO01038 XEO_NAME Azinphosmethyl DME0058 XEOTICID XEO01038 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01038 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01038 DESCRIPT Azinphosmethyl inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01038 GENEFORM Protein DME0058 XEOTICID XEO01038 MOACRIVE Inhibition DME0058 XEOTICID XEO01042 XEO_NAME Chlorfenvinphos DME0058 XEOTICID XEO01042 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01042 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01042 DESCRIPT Chlorfenvinphos inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01042 GENEFORM Protein DME0058 XEOTICID XEO01042 MOACRIVE Inhibition DME0058 XEOTICID XEO01049 XEO_NAME Dichlorvos DME0058 XEOTICID XEO01049 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01049 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01049 DESCRIPT Dichlorvos inhibits the drug-metabolizing activity of DME ACHE (IC50 = 0.627 microM) DME0058 XEOTICID XEO01049 GENEFORM Protein DME0058 XEOTICID XEO01049 MOACRIVE Inhibition DME0058 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0058 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01050 GENEFORM Protein DME0058 XEOTICID XEO01050 MOACRIVE Inhibition DME0058 XEOTICID XEO01056 XEO_NAME Heptenophos DME0058 XEOTICID XEO01056 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01056 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01056 DESCRIPT Heptenophos inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01056 GENEFORM Protein DME0058 XEOTICID XEO01056 MOACRIVE Inhibition DME0058 XEOTICID XEO01057 XEO_NAME Isocarbophos DME0058 XEOTICID XEO01057 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01057 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01057 DESCRIPT Isocarbophos inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01057 GENEFORM Protein DME0058 XEOTICID XEO01057 MOACRIVE Inhibition DME0058 XEOTICID XEO01059 XEO_NAME Methamidophos DME0058 XEOTICID XEO01059 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01059 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01059 DESCRIPT Methamidophos inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01059 GENEFORM Protein DME0058 XEOTICID XEO01059 MOACRIVE Inhibition DME0058 XEOTICID XEO01060 XEO_NAME Methomyl DME0058 XEOTICID XEO01060 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01060 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01060 DESCRIPT Methomyl inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01060 GENEFORM Protein DME0058 XEOTICID XEO01060 MOACRIVE Inhibition DME0058 XEOTICID XEO01061 XEO_NAME Mipafox DME0058 XEOTICID XEO01061 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01061 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01061 DESCRIPT Mipafox inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01061 GENEFORM Protein DME0058 XEOTICID XEO01061 MOACRIVE Inhibition DME0058 XEOTICID XEO01063 XEO_NAME Arthodibrom DME0058 XEOTICID XEO01063 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01063 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01063 DESCRIPT Arthodibrom inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01063 GENEFORM Protein DME0058 XEOTICID XEO01063 MOACRIVE Inhibition DME0058 XEOTICID XEO01064 XEO_NAME Parathion DME0058 XEOTICID XEO01064 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01064 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01064 DESCRIPT Parathion inhibits the expression of DME ACHE DME0058 XEOTICID XEO01064 GENEFORM mRNA DME0058 XEOTICID XEO01064 MOACRIVE Inhibition DME0058 XEOTICID XEO01066 XEO_NAME Phosphamidon DME0058 XEOTICID XEO01066 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01066 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01066 DESCRIPT Phosphamidon inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01066 GENEFORM Protein DME0058 XEOTICID XEO01066 MOACRIVE Inhibition DME0058 XEOTICID XEO01068 XEO_NAME Profenofos DME0058 XEOTICID XEO01068 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01068 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01068 DESCRIPT Prof DMEenof DMEos inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01068 GENEFORM Protein DME0058 XEOTICID XEO01068 MOACRIVE Inhibition DME0058 XEOTICID XEO01072 XEO_NAME Trichlorfon DME0058 XEOTICID XEO01072 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01072 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01072 DESCRIPT Trichlorfon inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01072 GENEFORM Protein DME0058 XEOTICID XEO01072 MOACRIVE Inhibition DME0058 XEOTICID XEO01073 XEO_NAME Dimethoate DME0058 XEOTICID XEO01073 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01073 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01073 DESCRIPT Dimethoate inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01073 GENEFORM Protein DME0058 XEOTICID XEO01073 MOACRIVE Inhibition DME0058 XEOTICID XEO01076 XEO_NAME Phorate DME0058 XEOTICID XEO01076 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01076 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01076 DESCRIPT Phorate inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01076 GENEFORM Protein DME0058 XEOTICID XEO01076 MOACRIVE Inhibition DME0058 XEOTICID XEO01077 XEO_NAME Ethoprop DME0058 XEOTICID XEO01077 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01077 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01077 DESCRIPT Ethoprop inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01077 GENEFORM Protein DME0058 XEOTICID XEO01077 MOACRIVE Inhibition DME0058 XEOTICID XEO01078 XEO_NAME Fenamiphos DME0058 XEOTICID XEO01078 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01078 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01078 DESCRIPT Fenamiphos inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01078 GENEFORM Protein DME0058 XEOTICID XEO01078 MOACRIVE Inhibition DME0058 XEOTICID XEO01079 XEO_NAME Terbufos DME0058 XEOTICID XEO01079 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01079 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01079 DESCRIPT Terbufos inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01079 GENEFORM Protein DME0058 XEOTICID XEO01079 MOACRIVE Inhibition DME0058 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0058 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0058 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0058 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01103 GENEFORM Protein DME0058 XEOTICID XEO01103 MOACRIVE Inhibition DME0058 XEOTICID XEO01196 XEO_NAME Amiridine DME0058 XEOTICID XEO01196 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO01196 XEO_CLAS Investigative Agent DME0058 XEOTICID XEO01196 DESCRIPT Amiridine inhibits the drug-metabolizing activity of DME ACHE (IC50 = 0.658 microM) DME0058 XEOTICID XEO01196 GENEFORM Protein DME0058 XEOTICID XEO01196 MOACRIVE Inhibition DME0058 XEOTICID XEO01208 XEO_NAME HI-6 DME0058 XEOTICID XEO01208 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO01208 XEO_CLAS Preclinical/Patented Drug DME0058 XEOTICID XEO01208 DESCRIPT HI-6 inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01208 GENEFORM Protein DME0058 XEOTICID XEO01208 MOACRIVE Inhibition DME0058 XEOTICID XEO01209 XEO_NAME Aspartame DME0058 XEOTICID XEO01209 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO01209 XEO_CLAS Drug in Phase 1 Clinical Trial DME0058 XEOTICID XEO01209 DESCRIPT Aspartame inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01209 GENEFORM Protein DME0058 XEOTICID XEO01209 MOACRIVE Inhibition DME0058 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0058 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0058 XEOTICID XEO01226 DESCRIPT Bisphenol A induces the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01226 GENEFORM Protein DME0058 XEOTICID XEO01226 MOACRIVE Induction DME0058 XEOTICID XEO01244 XEO_NAME Chebulinic acid DME0058 XEOTICID XEO01244 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0058 XEOTICID XEO01244 XEO_CLAS Natural Product DME0058 XEOTICID XEO01244 DESCRIPT Chebulinic acid inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01244 GENEFORM Protein DME0058 XEOTICID XEO01244 MOACRIVE Inhibition DME0058 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0058 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0058 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0058 XEOTICID XEO01248 DESCRIPT Chlorpyrifos inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01248 GENEFORM Protein DME0058 XEOTICID XEO01248 MOACRIVE Inhibition DME0058 XEOTICID XEO01274 XEO_NAME Diazinon DME0058 XEOTICID XEO01274 XEO_TYPE Health or Environmental Toxicant(s) DME0058 XEOTICID XEO01274 XEO_CLAS Environmental Pollutant DME0058 XEOTICID XEO01274 DESCRIPT Diazinon inhibits the drug-metabolizing activity of DME ACHE (IC50 = 1.9 microM) DME0058 XEOTICID XEO01274 GENEFORM Protein DME0058 XEOTICID XEO01274 MOACRIVE Inhibition DME0058 XEOTICID XEO01331 XEO_NAME Homocysteine DME0058 XEOTICID XEO01331 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO01331 XEO_CLAS Drug in Phase 1 Clinical Trial DME0058 XEOTICID XEO01331 DESCRIPT Homocysteine induces the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01331 GENEFORM Protein DME0058 XEOTICID XEO01331 MOACRIVE Induction DME0058 XEOTICID XEO01333 XEO_NAME Hopeahainol A DME0058 XEOTICID XEO01333 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0058 XEOTICID XEO01333 XEO_CLAS Natural Product DME0058 XEOTICID XEO01333 DESCRIPT Hopeahainol A inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01333 GENEFORM Protein DME0058 XEOTICID XEO01333 MOACRIVE Inhibition DME0058 XEOTICID XEO01349 XEO_NAME K075 compound DME0058 XEOTICID XEO01349 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO01349 XEO_CLAS Investigative Agent DME0058 XEOTICID XEO01349 DESCRIPT K075 compound inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01349 GENEFORM Protein DME0058 XEOTICID XEO01349 MOACRIVE Inhibition DME0058 XEOTICID XEO01371 XEO_NAME Memoquin DME0058 XEOTICID XEO01371 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO01371 XEO_CLAS Investigative Agent DME0058 XEOTICID XEO01371 DESCRIPT Memoquin inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01371 GENEFORM Protein DME0058 XEOTICID XEO01371 MOACRIVE Inhibition DME0058 XEOTICID XEO01374 XEO_NAME Methanethiosulfonate DME0058 XEOTICID XEO01374 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO01374 XEO_CLAS Investigative Agent DME0058 XEOTICID XEO01374 DESCRIPT Methanethiosulfonate inhibits the expression of DME ACHE DME0058 XEOTICID XEO01374 GENEFORM mRNA DME0058 XEOTICID XEO01374 MOACRIVE Inhibition DME0058 XEOTICID XEO01406 XEO_NAME Obidoxime chloride DME0058 XEOTICID XEO01406 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO01406 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO01406 DESCRIPT Obidoxime chloride inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01406 GENEFORM Protein DME0058 XEOTICID XEO01406 MOACRIVE Inhibition DME0058 XEOTICID XEO01464 XEO_NAME Russian VX DME0058 XEOTICID XEO01464 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO01464 XEO_CLAS Investigative Agent DME0058 XEOTICID XEO01464 DESCRIPT Russian VX inhibits the expression of DME ACHE DME0058 XEOTICID XEO01464 GENEFORM mRNA DME0058 XEOTICID XEO01464 MOACRIVE Inhibition DME0058 XEOTICID XEO01493 XEO_NAME Trimedoxime DME0058 XEOTICID XEO01493 XEO_TYPE Pharmaceutical Agent(s) DME0058 XEOTICID XEO01493 XEO_CLAS Approved/Marketed Drug DME0058 XEOTICID XEO01493 DESCRIPT Trimedoxime inhibits the drug-metabolizing activity of DME ACHE (IC50 = 167 microM) DME0058 XEOTICID XEO01493 GENEFORM Protein DME0058 XEOTICID XEO01493 MOACRIVE Inhibition DME0058 XEOTICID XEO01509 XEO_NAME Mercury DME0058 XEOTICID XEO01509 XEO_TYPE Health or Environmental Toxicant(s) DME0058 XEOTICID XEO01509 XEO_CLAS Acute Toxic Substance DME0058 XEOTICID XEO01509 DESCRIPT Mercury up-regulates the expression of DME ACHE DME0058 XEOTICID XEO01509 GENEFORM mRNA DME0058 XEOTICID XEO01509 MOACRIVE Induction DME0058 XEOTICID XEO01534 XEO_NAME Cryptotanshinone DME0058 XEOTICID XEO01534 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0058 XEOTICID XEO01534 XEO_CLAS Natural Product DME0058 XEOTICID XEO01534 DESCRIPT Cryptotanshinone inhibits the drug-metabolizing activity of DME ACHE (Ki = 6.41 microM) DME0058 XEOTICID XEO01534 GENEFORM Protein DME0058 XEOTICID XEO01534 MOACRIVE Inhibition DME0058 XEOTICID XEO01574 XEO_NAME Plant extracts DME0058 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0058 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0058 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01574 GENEFORM Protein DME0058 XEOTICID XEO01574 MOACRIVE Inhibition DME0058 XEOTICID XEO01593 XEO_NAME Tellimagrandin I DME0058 XEOTICID XEO01593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0058 XEOTICID XEO01593 XEO_CLAS Natural Product DME0058 XEOTICID XEO01593 DESCRIPT Tellimagrandin I inhibits the expression of DME ACHE DME0058 XEOTICID XEO01593 GENEFORM mRNA DME0058 XEOTICID XEO01593 MOACRIVE Inhibition DME0058 XEOTICID XEO01596 XEO_NAME Tabun DME0058 XEOTICID XEO01596 XEO_TYPE Health or Environmental Toxicant(s) DME0058 XEOTICID XEO01596 XEO_CLAS Neurotoxin DME0058 XEOTICID XEO01596 DESCRIPT Tabun inhibits the expression of DME ACHE DME0058 XEOTICID XEO01596 GENEFORM mRNA DME0058 XEOTICID XEO01596 MOACRIVE Inhibition DME0058 XEOTICID XEO01597 XEO_NAME Carbofuran DME0058 XEOTICID XEO01597 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01597 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01597 DESCRIPT Carbof DMEuran inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01597 GENEFORM Protein DME0058 XEOTICID XEO01597 MOACRIVE Inhibition DME0058 XEOTICID XEO01599 XEO_NAME Coumaphos DME0058 XEOTICID XEO01599 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01599 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01599 DESCRIPT Coumaphos inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01599 GENEFORM Protein DME0058 XEOTICID XEO01599 MOACRIVE Inhibition DME0058 XEOTICID XEO01607 XEO_NAME Propoxur DME0058 XEOTICID XEO01607 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0058 XEOTICID XEO01607 XEO_CLAS Pesticide/Insecticide DME0058 XEOTICID XEO01607 DESCRIPT Propoxur inhibits the drug-metabolizing activity of DME ACHE (IC50 = 0.59 microM) DME0058 XEOTICID XEO01607 GENEFORM Protein DME0058 XEOTICID XEO01607 MOACRIVE Inhibition DME0058 XEOTICID XEO01615 XEO_NAME Dimethoxon DME0058 XEOTICID XEO01615 XEO_TYPE Health or Environmental Toxicant(s) DME0058 XEOTICID XEO01615 XEO_CLAS Acute Toxic Substance DME0058 XEOTICID XEO01615 DESCRIPT Dimethoxon inhibits the drug-metabolizing activity of DME ACHE DME0058 XEOTICID XEO01615 GENEFORM Protein DME0058 XEOTICID XEO01615 MOACRIVE Inhibition DME0059 DME___ID DME0059 DME0059 DME_NAME Dimethylaniline oxidase 1 (FMO1) DME0059 SPESNAME Homo sapiens DME0059 XEOTICID XEO00029 XEO_NAME Valproic acid DME0059 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0059 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0059 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME FMO1 DME0059 XEOTICID XEO00029 GENEFORM mRNA DME0059 XEOTICID XEO00029 MOACRIVE Inhibition DME0059 XEOTICID XEO00097 XEO_NAME Cytarabine DME0059 XEOTICID XEO00097 XEO_TYPE Pharmaceutical Agent(s) DME0059 XEOTICID XEO00097 XEO_CLAS Approved/Marketed Drug DME0059 XEOTICID XEO00097 DESCRIPT Cytarabine inhibits the expression of DME FMO1 DME0059 XEOTICID XEO00097 GENEFORM mRNA DME0059 XEOTICID XEO00097 MOACRIVE Inhibition DME0059 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0059 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0059 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0059 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME FMO1 DME0059 XEOTICID XEO00241 GENEFORM mRNA DME0059 XEOTICID XEO00241 MOACRIVE Inhibition DME0059 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0059 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0059 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0059 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the expression of DME FMO1 DME0059 XEOTICID XEO00388 GENEFORM mRNA DME0059 XEOTICID XEO00388 MOACRIVE Inhibition DME0059 XEOTICID XEO00399 XEO_NAME Pyrithione zinc DME0059 XEOTICID XEO00399 XEO_TYPE Pharmaceutical Agent(s) DME0059 XEOTICID XEO00399 XEO_CLAS Approved/Marketed Drug DME0059 XEOTICID XEO00399 DESCRIPT Pyrithione zinc up-regulates the expression of DME FMO1 DME0059 XEOTICID XEO00399 GENEFORM mRNA DME0059 XEOTICID XEO00399 MOACRIVE Induction DME0059 XEOTICID XEO00560 XEO_NAME Triclosan DME0059 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0059 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0059 XEOTICID XEO00560 DESCRIPT Triclosan up-regulates the expression of DME FMO1 DME0059 XEOTICID XEO00560 GENEFORM mRNA DME0059 XEOTICID XEO00560 MOACRIVE Induction DME0059 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0059 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0059 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0059 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME FMO1 DME0059 XEOTICID XEO00898 GENEFORM mRNA DME0059 XEOTICID XEO00898 MOACRIVE Induction DME0059 XEOTICID XEO00995 XEO_NAME Amphibole asbestos DME0059 XEOTICID XEO00995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0059 XEOTICID XEO00995 XEO_CLAS Natural Mixture DME0059 XEOTICID XEO00995 DESCRIPT Amphibole asbestos inhibits the drug-metabolizing activity of DME FMO1 DME0059 XEOTICID XEO00995 GENEFORM Protein DME0059 XEOTICID XEO00995 MOACRIVE Inhibition DME0059 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0059 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0059 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0059 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME FMO1 DME0059 XEOTICID XEO01220 GENEFORM mRNA DME0059 XEOTICID XEO01220 MOACRIVE Inhibition DME0059 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0059 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0059 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0059 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME FMO1 DME0059 XEOTICID XEO01226 GENEFORM mRNA DME0059 XEOTICID XEO01226 MOACRIVE Induction DME0059 XEOTICID XEO01394 XEO_NAME NCX-4040 DME0059 XEOTICID XEO01394 XEO_TYPE Health or Environmental Toxicant(s) DME0059 XEOTICID XEO01394 XEO_CLAS Environmental Pollutant DME0059 XEOTICID XEO01394 DESCRIPT NCX-4040 induces the drug-metabolizing activity of DME FMO1 DME0059 XEOTICID XEO01394 GENEFORM Protein DME0059 XEOTICID XEO01394 MOACRIVE Induction DME0060 DME___ID DME0060 DME0060 DME_NAME Adenosine aminohydrolase (ADA) DME0060 SPESNAME Homo sapiens DME0060 XEOTICID XEO00029 XEO_NAME Valproic acid DME0060 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0060 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME ADA DME0060 XEOTICID XEO00029 GENEFORM mRNA DME0060 XEOTICID XEO00029 MOACRIVE Inhibition DME0060 XEOTICID XEO00193 XEO_NAME Belinostat DME0060 XEOTICID XEO00193 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00193 XEO_CLAS Approved/Marketed Drug DME0060 XEOTICID XEO00193 DESCRIPT Belinostat inhibits the expression of DME ADA DME0060 XEOTICID XEO00193 GENEFORM mRNA DME0060 XEOTICID XEO00193 MOACRIVE Inhibition DME0060 XEOTICID XEO00198 XEO_NAME Adrenocorticotropic hormone DME0060 XEOTICID XEO00198 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00198 XEO_CLAS Approved/Marketed Drug DME0060 XEOTICID XEO00198 DESCRIPT Adrenocorticotropic hormone induces the drug-metabolizing activity of DME ADA DME0060 XEOTICID XEO00198 GENEFORM Protein DME0060 XEOTICID XEO00198 MOACRIVE Induction DME0060 XEOTICID XEO00207 XEO_NAME Oxaliplatin DME0060 XEOTICID XEO00207 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00207 XEO_CLAS Approved/Marketed Drug DME0060 XEOTICID XEO00207 DESCRIPT Oxaliplatin inhibits the expression of DME ADA DME0060 XEOTICID XEO00207 GENEFORM mRNA DME0060 XEOTICID XEO00207 MOACRIVE Inhibition DME0060 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0060 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0060 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ADA DME0060 XEOTICID XEO00217 GENEFORM mRNA DME0060 XEOTICID XEO00217 MOACRIVE Inhibition DME0060 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0060 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0060 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME ADA DME0060 XEOTICID XEO00241 GENEFORM mRNA DME0060 XEOTICID XEO00241 MOACRIVE Induction DME0060 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0060 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0060 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME ADA DME0060 XEOTICID XEO00292 GENEFORM mRNA DME0060 XEOTICID XEO00292 MOACRIVE Inhibition DME0060 XEOTICID XEO00334 XEO_NAME Cisplatin DME0060 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0060 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME ADA DME0060 XEOTICID XEO00334 GENEFORM mRNA DME0060 XEOTICID XEO00334 MOACRIVE Induction DME0060 XEOTICID XEO00372 XEO_NAME Panobinostat DME0060 XEOTICID XEO00372 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00372 XEO_CLAS Approved/Marketed Drug DME0060 XEOTICID XEO00372 DESCRIPT Panobinostat inhibits the expression of DME ADA DME0060 XEOTICID XEO00372 GENEFORM mRNA DME0060 XEOTICID XEO00372 MOACRIVE Inhibition DME0060 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0060 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0060 XEOTICID XEO00380 DESCRIPT Rosiglitazone induces the drug-metabolizing activity of DME ADA DME0060 XEOTICID XEO00380 GENEFORM Protein DME0060 XEOTICID XEO00380 MOACRIVE Induction DME0060 XEOTICID XEO00481 XEO_NAME Rotenone DME0060 XEOTICID XEO00481 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00481 XEO_CLAS Approved/Marketed Drug DME0060 XEOTICID XEO00481 DESCRIPT Rotenone up-regulates the expression of DME ADA DME0060 XEOTICID XEO00481 GENEFORM mRNA DME0060 XEOTICID XEO00481 MOACRIVE Induction DME0060 XEOTICID XEO00538 XEO_NAME Quercetin DME0060 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0060 XEOTICID XEO00538 DESCRIPT Quercetin up-regulates the expression of DME ADA DME0060 XEOTICID XEO00538 GENEFORM mRNA DME0060 XEOTICID XEO00538 MOACRIVE Induction DME0060 XEOTICID XEO00581 XEO_NAME MS-275 DME0060 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0060 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME ADA DME0060 XEOTICID XEO00581 GENEFORM mRNA DME0060 XEOTICID XEO00581 MOACRIVE Induction DME0060 XEOTICID XEO00610 XEO_NAME Afimoxifene DME0060 XEOTICID XEO00610 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00610 XEO_CLAS Drug in Phase 3 Clinical Trial DME0060 XEOTICID XEO00610 DESCRIPT Afimoxifene inhibits the expression of DME ADA DME0060 XEOTICID XEO00610 GENEFORM mRNA DME0060 XEOTICID XEO00610 MOACRIVE Inhibition DME0060 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0060 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0060 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME ADA DME0060 XEOTICID XEO00723 GENEFORM mRNA DME0060 XEOTICID XEO00723 MOACRIVE Inhibition DME0060 XEOTICID XEO00728 XEO_NAME AM-580 DME0060 XEOTICID XEO00728 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO00728 XEO_CLAS Preclinical/Patented Drug DME0060 XEOTICID XEO00728 DESCRIPT AM-580 up-regulates the expression of DME ADA DME0060 XEOTICID XEO00728 GENEFORM mRNA DME0060 XEOTICID XEO00728 MOACRIVE Induction DME0060 XEOTICID XEO00760 XEO_NAME Jinfukang DME0060 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0060 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0060 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME ADA DME0060 XEOTICID XEO00760 GENEFORM mRNA DME0060 XEOTICID XEO00760 MOACRIVE Induction DME0060 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0060 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0060 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0060 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME ADA DME0060 XEOTICID XEO00772 GENEFORM mRNA DME0060 XEOTICID XEO00772 MOACRIVE Induction DME0060 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0060 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0060 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0060 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME ADA DME0060 XEOTICID XEO00898 GENEFORM mRNA DME0060 XEOTICID XEO00898 MOACRIVE Induction DME0060 XEOTICID XEO00969 XEO_NAME Atrazine DME0060 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0060 XEOTICID XEO00969 XEO_CLAS Herbicide DME0060 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME ADA DME0060 XEOTICID XEO00969 GENEFORM mRNA DME0060 XEOTICID XEO00969 MOACRIVE Induction DME0060 XEOTICID XEO01336 XEO_NAME ICG-001 DME0060 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0060 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0060 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME ADA DME0060 XEOTICID XEO01336 GENEFORM mRNA DME0060 XEOTICID XEO01336 MOACRIVE Inhibition DME0061 DME___ID DME0061 DME0061 DME_NAME Sulfotransferase 1E1 (SULT1E1) DME0061 SPESNAME Homo sapiens DME0061 XEOTICID XEO00090 XEO_NAME Estradiol DME0061 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0061 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00090 GENEFORM Protein DME0061 XEOTICID XEO00090 MOACRIVE Inhibition DME0061 XEOTICID XEO00091 XEO_NAME Estrone DME0061 XEOTICID XEO00091 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00091 XEO_CLAS Approved/Marketed Drug DME0061 XEOTICID XEO00091 DESCRIPT Estrone inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00091 GENEFORM Protein DME0061 XEOTICID XEO00091 MOACRIVE Inhibition DME0061 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0061 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0061 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00166 GENEFORM Protein DME0061 XEOTICID XEO00166 MOACRIVE Inhibition DME0061 XEOTICID XEO00175 XEO_NAME Dienestrol DME0061 XEOTICID XEO00175 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00175 XEO_CLAS Approved/Marketed Drug DME0061 XEOTICID XEO00175 DESCRIPT Dienestrol inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00175 GENEFORM Protein DME0061 XEOTICID XEO00175 MOACRIVE Inhibition DME0061 XEOTICID XEO00177 XEO_NAME Sulindac DME0061 XEOTICID XEO00177 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00177 XEO_CLAS Approved/Marketed Drug DME0061 XEOTICID XEO00177 DESCRIPT Sulindac inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00177 GENEFORM Protein DME0061 XEOTICID XEO00177 MOACRIVE Inhibition DME0061 XEOTICID XEO00248 XEO_NAME Ibuprofen DME0061 XEOTICID XEO00248 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00248 XEO_CLAS Approved/Marketed Drug DME0061 XEOTICID XEO00248 DESCRIPT Ibuprof DMEen inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00248 GENEFORM Protein DME0061 XEOTICID XEO00248 MOACRIVE Inhibition DME0061 XEOTICID XEO00267 XEO_NAME Ethinyl estradiol DME0061 XEOTICID XEO00267 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00267 XEO_CLAS Approved/Marketed Drug DME0061 XEOTICID XEO00267 DESCRIPT Ethinyl estradiol inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00267 GENEFORM Protein DME0061 XEOTICID XEO00267 MOACRIVE Inhibition DME0061 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0061 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0061 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME SULT1E1 DME0061 XEOTICID XEO00292 GENEFORM mRNA DME0061 XEOTICID XEO00292 MOACRIVE Inhibition DME0061 XEOTICID XEO00366 XEO_NAME Methotrexate DME0061 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0061 XEOTICID XEO00366 DESCRIPT Methotrexate up-regulates the expression of DME SULT1E1 DME0061 XEOTICID XEO00366 GENEFORM mRNA DME0061 XEOTICID XEO00366 MOACRIVE Induction DME0061 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0061 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0061 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00410 GENEFORM Protein DME0061 XEOTICID XEO00410 MOACRIVE Inhibition DME0061 XEOTICID XEO00411 XEO_NAME Avobenzone DME0061 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0061 XEOTICID XEO00411 DESCRIPT Avobenzone inhibits the expression of DME SULT1E1 DME0061 XEOTICID XEO00411 GENEFORM mRNA DME0061 XEOTICID XEO00411 MOACRIVE Inhibition DME0061 XEOTICID XEO00415 XEO_NAME Meclofenamic acid DME0061 XEOTICID XEO00415 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00415 XEO_CLAS Approved/Marketed Drug DME0061 XEOTICID XEO00415 DESCRIPT Meclof DMEenamic acid inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00415 GENEFORM Protein DME0061 XEOTICID XEO00415 MOACRIVE Inhibition DME0061 XEOTICID XEO00457 XEO_NAME Estriol DME0061 XEOTICID XEO00457 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00457 XEO_CLAS Approved/Marketed Drug DME0061 XEOTICID XEO00457 DESCRIPT Estriol inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00457 GENEFORM Protein DME0061 XEOTICID XEO00457 MOACRIVE Inhibition DME0061 XEOTICID XEO00539 XEO_NAME Ethanol DME0061 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0061 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00539 GENEFORM Protein DME0061 XEOTICID XEO00539 MOACRIVE Inhibition DME0061 XEOTICID XEO00557 XEO_NAME Genistein DME0061 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0061 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00557 GENEFORM Protein DME0061 XEOTICID XEO00557 MOACRIVE Inhibition DME0061 XEOTICID XEO00568 XEO_NAME Resveratrol DME0061 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0061 XEOTICID XEO00568 DESCRIPT Resveratrol induces the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00568 GENEFORM Protein DME0061 XEOTICID XEO00568 MOACRIVE Induction DME0061 XEOTICID XEO00606 XEO_NAME Colforsin DME0061 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0061 XEOTICID XEO00606 DESCRIPT Colforsin inhibits the expression of DME SULT1E1 DME0061 XEOTICID XEO00606 GENEFORM mRNA DME0061 XEOTICID XEO00606 MOACRIVE Inhibition DME0061 XEOTICID XEO00769 XEO_NAME Hexestrol DME0061 XEOTICID XEO00769 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO00769 XEO_CLAS Approved/Marketed Drug DME0061 XEOTICID XEO00769 DESCRIPT Hexestrol inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00769 GENEFORM Protein DME0061 XEOTICID XEO00769 MOACRIVE Inhibition DME0061 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0061 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0061 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0061 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME SULT1E1 DME0061 XEOTICID XEO00821 GENEFORM mRNA DME0061 XEOTICID XEO00821 MOACRIVE Inhibition DME0061 XEOTICID XEO00926 XEO_NAME Tetrabromobisphenol A DME0061 XEOTICID XEO00926 XEO_TYPE Health or Environmental Toxicant(s) DME0061 XEOTICID XEO00926 XEO_CLAS Environmental Pollutant DME0061 XEOTICID XEO00926 DESCRIPT Tetrabromobisphenol A inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO00926 GENEFORM Protein DME0061 XEOTICID XEO00926 MOACRIVE Inhibition DME0061 XEOTICID XEO00958 XEO_NAME Triadimefon DME0061 XEOTICID XEO00958 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0061 XEOTICID XEO00958 XEO_CLAS Fungicide DME0061 XEOTICID XEO00958 DESCRIPT Triadimefon inhibits the expression of DME SULT1E1 DME0061 XEOTICID XEO00958 GENEFORM mRNA DME0061 XEOTICID XEO00958 MOACRIVE Inhibition DME0061 XEOTICID XEO01133 XEO_NAME 3,3',4,5'-tetrahydroxystilbene DME0061 XEOTICID XEO01133 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO01133 XEO_CLAS Investigative Agent DME0061 XEOTICID XEO01133 DESCRIPT 3,3',4,5'-tetrahydroxystilbene inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO01133 GENEFORM Protein DME0061 XEOTICID XEO01133 MOACRIVE Inhibition DME0061 XEOTICID XEO01191 XEO_NAME Aloe-emodin DME0061 XEOTICID XEO01191 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0061 XEOTICID XEO01191 XEO_CLAS Natural Product DME0061 XEOTICID XEO01191 DESCRIPT Aloe-emodin inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO01191 GENEFORM Protein DME0061 XEOTICID XEO01191 MOACRIVE Inhibition DME0061 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0061 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0061 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME SULT1E1 DME0061 XEOTICID XEO01220 GENEFORM mRNA DME0061 XEOTICID XEO01220 MOACRIVE Induction DME0061 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0061 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0061 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0061 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO01226 GENEFORM Protein DME0061 XEOTICID XEO01226 MOACRIVE Inhibition DME0061 XEOTICID XEO01302 XEO_NAME Fipronil DME0061 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0061 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0061 XEOTICID XEO01302 DESCRIPT Fipronil inhibits the expression of DME SULT1E1 DME0061 XEOTICID XEO01302 GENEFORM mRNA DME0061 XEOTICID XEO01302 MOACRIVE Inhibition DME0061 XEOTICID XEO01551 XEO_NAME Heliotrine DME0061 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0061 XEOTICID XEO01551 XEO_CLAS Natural Product DME0061 XEOTICID XEO01551 DESCRIPT Heliotrine inhibits the expression of DME SULT1E1 DME0061 XEOTICID XEO01551 GENEFORM mRNA DME0061 XEOTICID XEO01551 MOACRIVE Inhibition DME0061 XEOTICID XEO01582 XEO_NAME Pyrrolizidine alkaloid DME0061 XEOTICID XEO01582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0061 XEOTICID XEO01582 XEO_CLAS Natural Product DME0061 XEOTICID XEO01582 DESCRIPT Pyrrolizidine alkaloid inhibits the drug-metabolizing activity of DME SULT1E1 DME0061 XEOTICID XEO01582 GENEFORM Protein DME0061 XEOTICID XEO01582 MOACRIVE Inhibition DME0062 DME___ID DME0062 DME0062 DME_NAME Sulfotransferase 1A2 (SULT1A2) DME0062 SPESNAME Homo sapiens DME0062 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0062 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0062 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0062 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME SULT1A2 DME0062 XEOTICID XEO00117 GENEFORM mRNA DME0062 XEOTICID XEO00117 MOACRIVE Inhibition DME0062 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0062 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0062 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0062 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME SULT1A2 DME0062 XEOTICID XEO00217 GENEFORM mRNA DME0062 XEOTICID XEO00217 MOACRIVE Inhibition DME0062 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0062 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0062 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0062 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME SULT1A2 DME0062 XEOTICID XEO00241 GENEFORM mRNA DME0062 XEOTICID XEO00241 MOACRIVE Inhibition DME0062 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0062 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0062 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0062 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME SULT1A2 DME0062 XEOTICID XEO00292 GENEFORM mRNA DME0062 XEOTICID XEO00292 MOACRIVE Inhibition DME0062 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0062 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0062 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0062 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME SULT1A2 DME0062 XEOTICID XEO00339 GENEFORM mRNA DME0062 XEOTICID XEO00339 MOACRIVE Induction DME0062 XEOTICID XEO00372 XEO_NAME Panobinostat DME0062 XEOTICID XEO00372 XEO_TYPE Pharmaceutical Agent(s) DME0062 XEOTICID XEO00372 XEO_CLAS Approved/Marketed Drug DME0062 XEOTICID XEO00372 DESCRIPT Panobinostat up-regulates the expression of DME SULT1A2 DME0062 XEOTICID XEO00372 GENEFORM mRNA DME0062 XEOTICID XEO00372 MOACRIVE Induction DME0062 XEOTICID XEO00581 XEO_NAME MS-275 DME0062 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0062 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0062 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME SULT1A2 DME0062 XEOTICID XEO00581 GENEFORM mRNA DME0062 XEOTICID XEO00581 MOACRIVE Induction DME0062 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0062 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0062 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0062 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME SULT1A2 DME0062 XEOTICID XEO00818 GENEFORM mRNA DME0062 XEOTICID XEO00818 MOACRIVE Induction DME0062 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0062 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0062 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0062 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME SULT1A2 DME0062 XEOTICID XEO01031 GENEFORM mRNA DME0062 XEOTICID XEO01031 MOACRIVE Inhibition DME0063 DME___ID DME0063 DME0063 DME_NAME Sulfotransferase 1A3 (SULT1A3) DME0063 SPESNAME Homo sapiens DME0063 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0063 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0063 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0063 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride up-regulates the expression of DME SULT1A3 DME0063 XEOTICID XEO00277 GENEFORM mRNA DME0063 XEOTICID XEO00277 MOACRIVE Induction DME0063 XEOTICID XEO00539 XEO_NAME Ethanol DME0063 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0063 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0063 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the drug-metabolizing activity of DME SULT1A3 DME0063 XEOTICID XEO00539 GENEFORM Protein DME0063 XEOTICID XEO00539 MOACRIVE Inhibition DME0063 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0063 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0063 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0063 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME SULT1A3 DME0063 XEOTICID XEO00898 GENEFORM mRNA DME0063 XEOTICID XEO00898 MOACRIVE Induction DME0063 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0063 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0063 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0063 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME SULT1A3 DME0063 XEOTICID XEO01004 GENEFORM mRNA DME0063 XEOTICID XEO01004 MOACRIVE Induction DME0063 XEOTICID XEO01009 XEO_NAME Glycidamide DME0063 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0063 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0063 XEOTICID XEO01009 DESCRIPT Glycidamide up-regulates the expression of DME SULT1A3 DME0063 XEOTICID XEO01009 GENEFORM mRNA DME0063 XEOTICID XEO01009 MOACRIVE Induction DME0064 DME___ID DME0064 DME0064 DME_NAME UDP-glucuronosyltransferase 1A8 (UGT1A8) DME0064 SPESNAME Homo sapiens DME0064 XEOTICID XEO00079 XEO_NAME Vorinostat DME0064 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0064 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0064 XEOTICID XEO00079 DESCRIPT Vorinostat inhibits the expression of DME UGT1A8 DME0064 XEOTICID XEO00079 GENEFORM mRNA DME0064 XEOTICID XEO00079 MOACRIVE Inhibition DME0064 XEOTICID XEO00199 XEO_NAME Doxycycline DME0064 XEOTICID XEO00199 XEO_TYPE Pharmaceutical Agent(s) DME0064 XEOTICID XEO00199 XEO_CLAS Approved/Marketed Drug DME0064 XEOTICID XEO00199 DESCRIPT Doxycycline up-regulates the expression of DME UGT1A8 DME0064 XEOTICID XEO00199 GENEFORM mRNA DME0064 XEOTICID XEO00199 MOACRIVE Induction DME0064 XEOTICID XEO00555 XEO_NAME Hymecromone DME0064 XEOTICID XEO00555 XEO_TYPE Pharmaceutical Agent(s) DME0064 XEOTICID XEO00555 XEO_CLAS Drug in Phase 1 Clinical Trial DME0064 XEOTICID XEO00555 DESCRIPT Hymecromone induces the drug-metabolizing activity of DME UGT1A8 DME0064 XEOTICID XEO00555 GENEFORM Protein DME0064 XEOTICID XEO00555 MOACRIVE Induction DME0064 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0064 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0064 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0064 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME UGT1A8 DME0064 XEOTICID XEO00723 GENEFORM mRNA DME0064 XEOTICID XEO00723 MOACRIVE Inhibition DME0064 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0064 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0064 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0064 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME UGT1A8 DME0064 XEOTICID XEO00821 GENEFORM mRNA DME0064 XEOTICID XEO00821 MOACRIVE Induction DME0064 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0064 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0064 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0064 XEOTICID XEO00899 DESCRIPT Methylcholanthrene up-regulates the expression of DME UGT1A8 DME0064 XEOTICID XEO00899 GENEFORM mRNA DME0064 XEOTICID XEO00899 MOACRIVE Induction DME0064 XEOTICID XEO01195 XEO_NAME Amentoflavone DME0064 XEOTICID XEO01195 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0064 XEOTICID XEO01195 XEO_CLAS Natural Product DME0064 XEOTICID XEO01195 DESCRIPT Amentof DMElavone inhibits the drug-metabolizing activity of DME UGT1A8 DME0064 XEOTICID XEO01195 GENEFORM Protein DME0064 XEOTICID XEO01195 MOACRIVE Inhibition DME0064 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0064 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0064 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0064 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME UGT1A8 DME0064 XEOTICID XEO01220 GENEFORM mRNA DME0064 XEOTICID XEO01220 MOACRIVE Induction DME0064 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0064 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0064 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0064 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME UGT1A8 DME0064 XEOTICID XEO01226 GENEFORM mRNA DME0064 XEOTICID XEO01226 MOACRIVE Inhibition DME0064 XEOTICID XEO01437 XEO_NAME Pregnenolone carbonitrile DME0064 XEOTICID XEO01437 XEO_TYPE Pharmaceutical Agent(s) DME0064 XEOTICID XEO01437 XEO_CLAS Investigative Agent DME0064 XEOTICID XEO01437 DESCRIPT Pregnenolone carbonitrile up-regulates the expression of DME UGT1A8 DME0064 XEOTICID XEO01437 GENEFORM mRNA DME0064 XEOTICID XEO01437 MOACRIVE Induction DME0065 DME___ID DME0065 DME0065 DME_NAME UDP-glucuronosyltransferase 1A7 (UGT1A7) DME0065 SPESNAME Homo sapiens DME0065 XEOTICID XEO00555 XEO_NAME Hymecromone DME0065 XEOTICID XEO00555 XEO_TYPE Pharmaceutical Agent(s) DME0065 XEOTICID XEO00555 XEO_CLAS Drug in Phase 1 Clinical Trial DME0065 XEOTICID XEO00555 DESCRIPT Hymecromone induces the drug-metabolizing activity of DME UGT1A7 DME0065 XEOTICID XEO00555 GENEFORM Protein DME0065 XEOTICID XEO00555 MOACRIVE Induction DME0065 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0065 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0065 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0065 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME UGT1A7 DME0065 XEOTICID XEO00723 GENEFORM mRNA DME0065 XEOTICID XEO00723 MOACRIVE Inhibition DME0065 XEOTICID XEO00760 XEO_NAME Jinfukang DME0065 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0065 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0065 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME UGT1A7 DME0065 XEOTICID XEO00760 GENEFORM mRNA DME0065 XEOTICID XEO00760 MOACRIVE Induction DME0065 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0065 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0065 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0065 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME UGT1A7 DME0065 XEOTICID XEO00898 GENEFORM mRNA DME0065 XEOTICID XEO00898 MOACRIVE Induction DME0065 XEOTICID XEO00919 XEO_NAME Particulate matter DME0065 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0065 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0065 XEOTICID XEO00919 DESCRIPT Particulate matter induces the drug-metabolizing activity of DME UGT1A7 DME0065 XEOTICID XEO00919 GENEFORM Protein DME0065 XEOTICID XEO00919 MOACRIVE Induction DME0065 XEOTICID XEO01195 XEO_NAME Amentoflavone DME0065 XEOTICID XEO01195 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0065 XEOTICID XEO01195 XEO_CLAS Natural Product DME0065 XEOTICID XEO01195 DESCRIPT Amentof DMElavone inhibits the drug-metabolizing activity of DME UGT1A7 DME0065 XEOTICID XEO01195 GENEFORM Protein DME0065 XEOTICID XEO01195 MOACRIVE Inhibition DME0065 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0065 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0065 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0065 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME UGT1A7 DME0065 XEOTICID XEO01220 GENEFORM mRNA DME0065 XEOTICID XEO01220 MOACRIVE Induction DME0066 DME___ID DME0066 DME0066 DME_NAME UDP-glucuronosyltransferase 2B17 (UGT2B17) DME0066 SPESNAME Homo sapiens DME0066 XEOTICID XEO00009 XEO_NAME Bicalutamide DME0066 XEOTICID XEO00009 XEO_TYPE Pharmaceutical Agent(s) DME0066 XEOTICID XEO00009 XEO_CLAS Approved/Marketed Drug DME0066 XEOTICID XEO00009 DESCRIPT Bicalutamide inhibits the expression of DME UGT2B17 DME0066 XEOTICID XEO00009 GENEFORM mRNA DME0066 XEOTICID XEO00009 MOACRIVE Inhibition DME0066 XEOTICID XEO00090 XEO_NAME Estradiol DME0066 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0066 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0066 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME UGT2B17 DME0066 XEOTICID XEO00090 GENEFORM mRNA DME0066 XEOTICID XEO00090 MOACRIVE Induction DME0066 XEOTICID XEO00095 XEO_NAME Testosterone DME0066 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0066 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0066 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME UGT2B17 DME0066 XEOTICID XEO00095 GENEFORM mRNA DME0066 XEOTICID XEO00095 MOACRIVE Induction DME0066 XEOTICID XEO00184 XEO_NAME Calcitriol DME0066 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0066 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0066 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME UGT2B17 DME0066 XEOTICID XEO00184 GENEFORM mRNA DME0066 XEOTICID XEO00184 MOACRIVE Inhibition DME0066 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0066 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0066 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0066 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME UGT2B17 DME0066 XEOTICID XEO00241 GENEFORM mRNA DME0066 XEOTICID XEO00241 MOACRIVE Inhibition DME0066 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0066 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0066 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0066 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME UGT2B17 DME0066 XEOTICID XEO00410 GENEFORM Protein DME0066 XEOTICID XEO00410 MOACRIVE Inhibition DME0066 XEOTICID XEO00439 XEO_NAME Daidzein DME0066 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME0066 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME0066 XEOTICID XEO00439 DESCRIPT Daidzein up-regulates the expression of DME UGT2B17 DME0066 XEOTICID XEO00439 GENEFORM mRNA DME0066 XEOTICID XEO00439 MOACRIVE Induction DME0066 XEOTICID XEO00555 XEO_NAME Hymecromone DME0066 XEOTICID XEO00555 XEO_TYPE Pharmaceutical Agent(s) DME0066 XEOTICID XEO00555 XEO_CLAS Drug in Phase 1 Clinical Trial DME0066 XEOTICID XEO00555 DESCRIPT Hymecromone induces the drug-metabolizing activity of DME UGT2B17 DME0066 XEOTICID XEO00555 GENEFORM Protein DME0066 XEOTICID XEO00555 MOACRIVE Induction DME0066 XEOTICID XEO00557 XEO_NAME Genistein DME0066 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0066 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0066 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME UGT2B17 DME0066 XEOTICID XEO00557 GENEFORM mRNA DME0066 XEOTICID XEO00557 MOACRIVE Induction DME0066 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0066 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0066 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0066 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME UGT2B17 DME0066 XEOTICID XEO00772 GENEFORM mRNA DME0066 XEOTICID XEO00772 MOACRIVE Induction DME0066 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0066 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0066 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0066 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME UGT2B17 DME0066 XEOTICID XEO00806 GENEFORM mRNA DME0066 XEOTICID XEO00806 MOACRIVE Induction DME0066 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0066 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0066 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0066 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME UGT2B17 DME0066 XEOTICID XEO00905 GENEFORM mRNA DME0066 XEOTICID XEO00905 MOACRIVE Inhibition DME0066 XEOTICID XEO01195 XEO_NAME Amentoflavone DME0066 XEOTICID XEO01195 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0066 XEOTICID XEO01195 XEO_CLAS Natural Product DME0066 XEOTICID XEO01195 DESCRIPT Amentof DMElavone inhibits the drug-metabolizing activity of DME UGT2B17 DME0066 XEOTICID XEO01195 GENEFORM Protein DME0066 XEOTICID XEO01195 MOACRIVE Inhibition DME0066 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0066 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0066 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0066 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME UGT2B17 DME0066 XEOTICID XEO01305 GENEFORM mRNA DME0066 XEOTICID XEO01305 MOACRIVE Induction DME0066 XEOTICID XEO01582 XEO_NAME Pyrrolizidine alkaloid DME0066 XEOTICID XEO01582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0066 XEOTICID XEO01582 XEO_CLAS Natural Product DME0066 XEOTICID XEO01582 DESCRIPT Pyrrolizidine alkaloid inhibits the drug-metabolizing activity of DME UGT2B17 DME0066 XEOTICID XEO01582 GENEFORM Protein DME0066 XEOTICID XEO01582 MOACRIVE Inhibition DME0067 DME___ID DME0067 DME0067 DME_NAME NADPH-dependent carbonyl reductase 1 (CBR1) DME0067 SPESNAME Homo sapiens DME0067 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0067 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0067 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0067 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CBR1 DME0067 XEOTICID XEO00217 GENEFORM mRNA DME0067 XEOTICID XEO00217 MOACRIVE Inhibition DME0067 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0067 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0067 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0067 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CBR1 DME0067 XEOTICID XEO00241 GENEFORM mRNA DME0067 XEOTICID XEO00241 MOACRIVE Inhibition DME0067 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0067 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0067 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0067 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride induces the drug-metabolizing activity of DME CBR1 DME0067 XEOTICID XEO00292 GENEFORM Protein DME0067 XEOTICID XEO00292 MOACRIVE Induction DME0067 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0067 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0067 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0067 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME CBR1 DME0067 XEOTICID XEO00339 GENEFORM mRNA DME0067 XEOTICID XEO00339 MOACRIVE Induction DME0067 XEOTICID XEO00557 XEO_NAME Genistein DME0067 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0067 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0067 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME CBR1 DME0067 XEOTICID XEO00557 GENEFORM mRNA DME0067 XEOTICID XEO00557 MOACRIVE Induction DME0067 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0067 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0067 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0067 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME CBR1 DME0067 XEOTICID XEO00632 GENEFORM mRNA DME0067 XEOTICID XEO00632 MOACRIVE Induction DME0067 XEOTICID XEO00683 XEO_NAME Curcumin DME0067 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0067 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0067 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of DME CBR1 DME0067 XEOTICID XEO00683 GENEFORM Protein DME0067 XEOTICID XEO00683 MOACRIVE Inhibition DME0067 XEOTICID XEO00760 XEO_NAME Jinfukang DME0067 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0067 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0067 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME CBR1 DME0067 XEOTICID XEO00760 GENEFORM mRNA DME0067 XEOTICID XEO00760 MOACRIVE Induction DME0067 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0067 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0067 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0067 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene induces the drug-metabolizing activity of DME CBR1 DME0067 XEOTICID XEO00898 GENEFORM Protein DME0067 XEOTICID XEO00898 MOACRIVE Induction DME0067 XEOTICID XEO00969 XEO_NAME Atrazine DME0067 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0067 XEOTICID XEO00969 XEO_CLAS Herbicide DME0067 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME CBR1 DME0067 XEOTICID XEO00969 GENEFORM mRNA DME0067 XEOTICID XEO00969 MOACRIVE Inhibition DME0067 XEOTICID XEO01009 XEO_NAME Glycidamide DME0067 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0067 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0067 XEOTICID XEO01009 DESCRIPT Glycidamide up-regulates the expression of DME CBR1 DME0067 XEOTICID XEO01009 GENEFORM mRNA DME0067 XEOTICID XEO01009 MOACRIVE Induction DME0067 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0067 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0067 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0067 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME CBR1 DME0067 XEOTICID XEO01220 GENEFORM mRNA DME0067 XEOTICID XEO01220 MOACRIVE Induction DME0067 XEOTICID XEO01261 XEO_NAME Coumestrol DME0067 XEOTICID XEO01261 XEO_TYPE Pharmaceutical Agent(s) DME0067 XEOTICID XEO01261 XEO_CLAS Investigative Agent DME0067 XEOTICID XEO01261 DESCRIPT Coumestrol up-regulates the expression of DME CBR1 DME0067 XEOTICID XEO01261 GENEFORM mRNA DME0067 XEOTICID XEO01261 MOACRIVE Induction DME0067 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0067 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0067 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0067 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME CBR1 DME0067 XEOTICID XEO01324 GENEFORM mRNA DME0067 XEOTICID XEO01324 MOACRIVE Inhibition DME0068 DME___ID DME0068 DME0068 DME_NAME NADPH-dependent carbonyl reductase 3 (CBR3) DME0068 SPESNAME Homo sapiens DME0068 XEOTICID XEO00029 XEO_NAME Valproic acid DME0068 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0068 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0068 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME CBR3 DME0068 XEOTICID XEO00029 GENEFORM mRNA DME0068 XEOTICID XEO00029 MOACRIVE Induction DME0068 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0068 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0068 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0068 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME CBR3 DME0068 XEOTICID XEO00117 GENEFORM mRNA DME0068 XEOTICID XEO00117 MOACRIVE Induction DME0068 XEOTICID XEO00159 XEO_NAME Bortezomib DME0068 XEOTICID XEO00159 XEO_TYPE Pharmaceutical Agent(s) DME0068 XEOTICID XEO00159 XEO_CLAS Approved/Marketed Drug DME0068 XEOTICID XEO00159 DESCRIPT Bortezomib up-regulates the expression of DME CBR3 DME0068 XEOTICID XEO00159 GENEFORM mRNA DME0068 XEOTICID XEO00159 MOACRIVE Induction DME0068 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0068 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0068 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0068 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME CBR3 DME0068 XEOTICID XEO00217 GENEFORM mRNA DME0068 XEOTICID XEO00217 MOACRIVE Induction DME0068 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0068 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0068 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0068 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME CBR3 DME0068 XEOTICID XEO00241 GENEFORM mRNA DME0068 XEOTICID XEO00241 MOACRIVE Induction DME0068 XEOTICID XEO00581 XEO_NAME MS-275 DME0068 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0068 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0068 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME CBR3 DME0068 XEOTICID XEO00581 GENEFORM mRNA DME0068 XEOTICID XEO00581 MOACRIVE Induction DME0068 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0068 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0068 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0068 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CBR3 DME0068 XEOTICID XEO00898 GENEFORM mRNA DME0068 XEOTICID XEO00898 MOACRIVE Induction DME0068 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0068 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0068 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0068 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME CBR3 DME0068 XEOTICID XEO01004 GENEFORM mRNA DME0068 XEOTICID XEO01004 MOACRIVE Induction DME0068 XEOTICID XEO01009 XEO_NAME Glycidamide DME0068 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0068 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0068 XEOTICID XEO01009 DESCRIPT Glycidamide up-regulates the expression of DME CBR3 DME0068 XEOTICID XEO01009 GENEFORM mRNA DME0068 XEOTICID XEO01009 MOACRIVE Induction DME0068 XEOTICID XEO01081 XEO_NAME Thioxotriazole copper(II) DME0068 XEOTICID XEO01081 XEO_TYPE Pharmaceutical Agent(s) DME0068 XEOTICID XEO01081 XEO_CLAS Investigative Agent DME0068 XEOTICID XEO01081 DESCRIPT Thioxotriazole copper(II) inhibits the expression of DME CBR3 DME0068 XEOTICID XEO01081 GENEFORM mRNA DME0068 XEOTICID XEO01081 MOACRIVE Inhibition DME0068 XEOTICID XEO01311 XEO_NAME Gedunin DME0068 XEOTICID XEO01311 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0068 XEOTICID XEO01311 XEO_CLAS Natural Product DME0068 XEOTICID XEO01311 DESCRIPT Gedunin up-regulates the expression of DME CBR3 DME0068 XEOTICID XEO01311 GENEFORM mRNA DME0068 XEOTICID XEO01311 MOACRIVE Induction DME0068 XEOTICID XEO01478 XEO_NAME Sulforafan DME0068 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0068 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0068 XEOTICID XEO01478 DESCRIPT Sulforafan up-regulates the expression of DME CBR3 DME0068 XEOTICID XEO01478 GENEFORM mRNA DME0068 XEOTICID XEO01478 MOACRIVE Induction DME0068 XEOTICID XEO01579 XEO_NAME Guggulsterone DME0068 XEOTICID XEO01579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0068 XEOTICID XEO01579 XEO_CLAS Natural Product DME0068 XEOTICID XEO01579 DESCRIPT Guggulsterone up-regulates the expression of DME CBR3 DME0068 XEOTICID XEO01579 GENEFORM mRNA DME0068 XEOTICID XEO01579 MOACRIVE Induction DME0069 DME___ID DME0069 DME0069 DME_NAME Butyrylcholine esterase (BCHE) DME0069 SPESNAME Homo sapiens DME0069 XEOTICID XEO00009 XEO_NAME Bicalutamide DME0069 XEOTICID XEO00009 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00009 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00009 DESCRIPT Bicalutamide inhibits the expression of DME BCHE DME0069 XEOTICID XEO00009 GENEFORM mRNA DME0069 XEOTICID XEO00009 MOACRIVE Inhibition DME0069 XEOTICID XEO00018 XEO_NAME Cyclophosphamide DME0069 XEOTICID XEO00018 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00018 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00018 DESCRIPT Cyclophosphamide inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00018 GENEFORM Protein DME0069 XEOTICID XEO00018 MOACRIVE Inhibition DME0069 XEOTICID XEO00020 XEO_NAME Decamethonium DME0069 XEOTICID XEO00020 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00020 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00020 DESCRIPT Decamethonium inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00020 GENEFORM Protein DME0069 XEOTICID XEO00020 MOACRIVE Inhibition DME0069 XEOTICID XEO00029 XEO_NAME Valproic acid DME0069 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME BCHE DME0069 XEOTICID XEO00029 GENEFORM mRNA DME0069 XEOTICID XEO00029 MOACRIVE Inhibition DME0069 XEOTICID XEO00056 XEO_NAME Malathion DME0069 XEOTICID XEO00056 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00056 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00056 DESCRIPT Malathion inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00056 GENEFORM Protein DME0069 XEOTICID XEO00056 MOACRIVE Inhibition DME0069 XEOTICID XEO00074 XEO_NAME Promethazine DME0069 XEOTICID XEO00074 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00074 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00074 DESCRIPT Promethazine inhibits the expression of DME BCHE DME0069 XEOTICID XEO00074 GENEFORM mRNA DME0069 XEOTICID XEO00074 MOACRIVE Inhibition DME0069 XEOTICID XEO00079 XEO_NAME Vorinostat DME0069 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00079 DESCRIPT Vorinostat up-regulates the expression of DME BCHE DME0069 XEOTICID XEO00079 GENEFORM mRNA DME0069 XEOTICID XEO00079 MOACRIVE Induction DME0069 XEOTICID XEO00093 XEO_NAME Isoflurophate DME0069 XEOTICID XEO00093 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00093 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00093 DESCRIPT Isof DMElurophate inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00093 GENEFORM Protein DME0069 XEOTICID XEO00093 MOACRIVE Inhibition DME0069 XEOTICID XEO00095 XEO_NAME Testosterone DME0069 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00095 DESCRIPT Testosterone inhibits the expression of DME BCHE DME0069 XEOTICID XEO00095 GENEFORM mRNA DME0069 XEOTICID XEO00095 MOACRIVE Inhibition DME0069 XEOTICID XEO00106 XEO_NAME Echothiophate iodide DME0069 XEOTICID XEO00106 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00106 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00106 DESCRIPT Echothiophate iodide inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00106 GENEFORM Protein DME0069 XEOTICID XEO00106 MOACRIVE Inhibition DME0069 XEOTICID XEO00107 XEO_NAME Dimenhydrinate DME0069 XEOTICID XEO00107 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00107 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00107 DESCRIPT Dimenhydrinate inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00107 GENEFORM Protein DME0069 XEOTICID XEO00107 MOACRIVE Inhibition DME0069 XEOTICID XEO00112 XEO_NAME Isosorbide DME0069 XEOTICID XEO00112 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00112 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00112 DESCRIPT Isosorbide inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00112 GENEFORM Protein DME0069 XEOTICID XEO00112 MOACRIVE Inhibition DME0069 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0069 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00140 DESCRIPT Zoledronic acid inhibits the expression of DME BCHE DME0069 XEOTICID XEO00140 GENEFORM mRNA DME0069 XEOTICID XEO00140 MOACRIVE Inhibition DME0069 XEOTICID XEO00184 XEO_NAME Calcitriol DME0069 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME BCHE DME0069 XEOTICID XEO00184 GENEFORM mRNA DME0069 XEOTICID XEO00184 MOACRIVE Inhibition DME0069 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0069 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME BCHE DME0069 XEOTICID XEO00217 GENEFORM mRNA DME0069 XEOTICID XEO00217 MOACRIVE Inhibition DME0069 XEOTICID XEO00239 XEO_NAME Chlorpheniramine DME0069 XEOTICID XEO00239 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00239 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00239 DESCRIPT Chlorpheniramine inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00239 GENEFORM Protein DME0069 XEOTICID XEO00239 MOACRIVE Inhibition DME0069 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0069 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME BCHE DME0069 XEOTICID XEO00241 GENEFORM mRNA DME0069 XEOTICID XEO00241 MOACRIVE Inhibition DME0069 XEOTICID XEO00281 XEO_NAME Choline C-11 DME0069 XEOTICID XEO00281 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00281 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00281 DESCRIPT Choline C-11 inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00281 GENEFORM Protein DME0069 XEOTICID XEO00281 MOACRIVE Inhibition DME0069 XEOTICID XEO00298 XEO_NAME Galantamine hydrobromide DME0069 XEOTICID XEO00298 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00298 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00298 DESCRIPT Galantamine hydrobromide inhibits the drug-metabolizing activity of DME BCHE (IC50 = 0.17 microM) DME0069 XEOTICID XEO00298 GENEFORM Protein DME0069 XEOTICID XEO00298 MOACRIVE Inhibition DME0069 XEOTICID XEO00321 XEO_NAME Rivastigmine tartrate DME0069 XEOTICID XEO00321 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00321 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00321 DESCRIPT Rivastigmine tartrate inhibits the drug-metabolizing activity of DME BCHE (IC50 = 0.03 microM) DME0069 XEOTICID XEO00321 GENEFORM Protein DME0069 XEOTICID XEO00321 MOACRIVE Inhibition DME0069 XEOTICID XEO00328 XEO_NAME Tacrine hydrochloride DME0069 XEOTICID XEO00328 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00328 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00328 DESCRIPT Tacrine hydrochloride inhibits the drug-metabolizing activity of DME BCHE (IC50 = 0.0000267 microM) DME0069 XEOTICID XEO00328 GENEFORM Protein DME0069 XEOTICID XEO00328 MOACRIVE Inhibition DME0069 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0069 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME BCHE DME0069 XEOTICID XEO00339 GENEFORM mRNA DME0069 XEOTICID XEO00339 MOACRIVE Induction DME0069 XEOTICID XEO00353 XEO_NAME Diphenhydramine DME0069 XEOTICID XEO00353 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00353 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00353 DESCRIPT Diphenhydramine inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00353 GENEFORM Protein DME0069 XEOTICID XEO00353 MOACRIVE Inhibition DME0069 XEOTICID XEO00355 XEO_NAME Edrophonium DME0069 XEOTICID XEO00355 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00355 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00355 DESCRIPT Edrophonium inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00355 GENEFORM Protein DME0069 XEOTICID XEO00355 MOACRIVE Inhibition DME0069 XEOTICID XEO00379 XEO_NAME Ranitidine DME0069 XEOTICID XEO00379 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00379 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00379 DESCRIPT Ranitidine inhibits the expression of DME BCHE DME0069 XEOTICID XEO00379 GENEFORM mRNA DME0069 XEOTICID XEO00379 MOACRIVE Inhibition DME0069 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0069 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00380 DESCRIPT Rosiglitazone inhibits the expression of DME BCHE DME0069 XEOTICID XEO00380 GENEFORM mRNA DME0069 XEOTICID XEO00380 MOACRIVE Inhibition DME0069 XEOTICID XEO00462 XEO_NAME Bambuterol DME0069 XEOTICID XEO00462 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00462 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00462 DESCRIPT Bambuterol inhibits the drug-metabolizing activity of DME BCHE (IC50 = 0.003 microM) DME0069 XEOTICID XEO00462 GENEFORM Protein DME0069 XEOTICID XEO00462 MOACRIVE Inhibition DME0069 XEOTICID XEO00477 XEO_NAME Profenamine DME0069 XEOTICID XEO00477 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00477 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO00477 DESCRIPT Prof DMEenamine inhibits the drug-metabolizing activity of DME BCHE (IC50 = 0.3 microM) DME0069 XEOTICID XEO00477 GENEFORM Protein DME0069 XEOTICID XEO00477 MOACRIVE Inhibition DME0069 XEOTICID XEO00557 XEO_NAME Genistein DME0069 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0069 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME BCHE DME0069 XEOTICID XEO00557 GENEFORM mRNA DME0069 XEOTICID XEO00557 MOACRIVE Induction DME0069 XEOTICID XEO00581 XEO_NAME MS-275 DME0069 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0069 XEOTICID XEO00581 DESCRIPT MS-275 inhibits the expression of DME BCHE DME0069 XEOTICID XEO00581 GENEFORM mRNA DME0069 XEOTICID XEO00581 MOACRIVE Inhibition DME0069 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0069 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0069 XEOTICID XEO00582 DESCRIPT Diethyltoluamide inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00582 GENEFORM Protein DME0069 XEOTICID XEO00582 MOACRIVE Inhibition DME0069 XEOTICID XEO00594 XEO_NAME SNX-001 DME0069 XEOTICID XEO00594 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO00594 XEO_CLAS Drug in Phase 2 Clinical Trial DME0069 XEOTICID XEO00594 DESCRIPT SNX-001 inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00594 GENEFORM Protein DME0069 XEOTICID XEO00594 MOACRIVE Inhibition DME0069 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0069 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0069 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME BCHE DME0069 XEOTICID XEO00772 GENEFORM mRNA DME0069 XEOTICID XEO00772 MOACRIVE Inhibition DME0069 XEOTICID XEO00779 XEO_NAME Sarin DME0069 XEOTICID XEO00779 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO00779 XEO_CLAS Acute Toxic Substance DME0069 XEOTICID XEO00779 DESCRIPT Sarin inhibits the expression of DME BCHE DME0069 XEOTICID XEO00779 GENEFORM mRNA DME0069 XEOTICID XEO00779 MOACRIVE Inhibition DME0069 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0069 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0069 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME BCHE DME0069 XEOTICID XEO00806 GENEFORM mRNA DME0069 XEOTICID XEO00806 MOACRIVE Inhibition DME0069 XEOTICID XEO00867 XEO_NAME Fenthion DME0069 XEOTICID XEO00867 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0069 XEOTICID XEO00867 XEO_CLAS Pesticide/Insecticide DME0069 XEOTICID XEO00867 DESCRIPT Fenthion inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00867 GENEFORM Protein DME0069 XEOTICID XEO00867 MOACRIVE Inhibition DME0069 XEOTICID XEO00873 XEO_NAME Alpha-linolenic acid DME0069 XEOTICID XEO00873 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO00873 XEO_CLAS Health Hazard/Toxicant DME0069 XEOTICID XEO00873 DESCRIPT Alpha-linolenic acid up-regulates the expression of DME BCHE DME0069 XEOTICID XEO00873 GENEFORM mRNA DME0069 XEOTICID XEO00873 MOACRIVE Induction DME0069 XEOTICID XEO00882 XEO_NAME Ethyl paraoxon DME0069 XEOTICID XEO00882 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0069 XEOTICID XEO00882 XEO_CLAS Pesticide/Insecticide DME0069 XEOTICID XEO00882 DESCRIPT Ethyl paraoxon inhibits the drug-metabolizing activity of DME BCHE (IC50 = 0.007 microM) DME0069 XEOTICID XEO00882 GENEFORM Protein DME0069 XEOTICID XEO00882 MOACRIVE Inhibition DME0069 XEOTICID XEO00887 XEO_NAME Demeton-S-methyl DME0069 XEOTICID XEO00887 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0069 XEOTICID XEO00887 XEO_CLAS Pesticide/Insecticide DME0069 XEOTICID XEO00887 DESCRIPT Demeton-S-methyl inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO00887 GENEFORM Protein DME0069 XEOTICID XEO00887 MOACRIVE Inhibition DME0069 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0069 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0069 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME BCHE DME0069 XEOTICID XEO01004 GENEFORM mRNA DME0069 XEOTICID XEO01004 MOACRIVE Inhibition DME0069 XEOTICID XEO01013 XEO_NAME Malachite green DME0069 XEOTICID XEO01013 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO01013 XEO_CLAS Investigative Agent DME0069 XEOTICID XEO01013 DESCRIPT Malachite green inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01013 GENEFORM Protein DME0069 XEOTICID XEO01013 MOACRIVE Inhibition DME0069 XEOTICID XEO01049 XEO_NAME Dichlorvos DME0069 XEOTICID XEO01049 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0069 XEOTICID XEO01049 XEO_CLAS Pesticide/Insecticide DME0069 XEOTICID XEO01049 DESCRIPT Dichlorvos inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01049 GENEFORM Protein DME0069 XEOTICID XEO01049 MOACRIVE Inhibition DME0069 XEOTICID XEO01058 XEO_NAME Isomalathion DME0069 XEOTICID XEO01058 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0069 XEOTICID XEO01058 XEO_CLAS Pesticide/Insecticide DME0069 XEOTICID XEO01058 DESCRIPT Isomalathion inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01058 GENEFORM Protein DME0069 XEOTICID XEO01058 MOACRIVE Inhibition DME0069 XEOTICID XEO01059 XEO_NAME Methamidophos DME0069 XEOTICID XEO01059 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0069 XEOTICID XEO01059 XEO_CLAS Pesticide/Insecticide DME0069 XEOTICID XEO01059 DESCRIPT Methamidophos inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01059 GENEFORM Protein DME0069 XEOTICID XEO01059 MOACRIVE Inhibition DME0069 XEOTICID XEO01061 XEO_NAME Mipafox DME0069 XEOTICID XEO01061 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0069 XEOTICID XEO01061 XEO_CLAS Pesticide/Insecticide DME0069 XEOTICID XEO01061 DESCRIPT Mipafox inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01061 GENEFORM Protein DME0069 XEOTICID XEO01061 MOACRIVE Inhibition DME0069 XEOTICID XEO01064 XEO_NAME Parathion DME0069 XEOTICID XEO01064 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0069 XEOTICID XEO01064 XEO_CLAS Pesticide/Insecticide DME0069 XEOTICID XEO01064 DESCRIPT Parathion inhibits the expression of DME BCHE DME0069 XEOTICID XEO01064 GENEFORM mRNA DME0069 XEOTICID XEO01064 MOACRIVE Inhibition DME0069 XEOTICID XEO01072 XEO_NAME Trichlorfon DME0069 XEOTICID XEO01072 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0069 XEOTICID XEO01072 XEO_CLAS Pesticide/Insecticide DME0069 XEOTICID XEO01072 DESCRIPT Trichlorfon inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01072 GENEFORM Protein DME0069 XEOTICID XEO01072 MOACRIVE Inhibition DME0069 XEOTICID XEO01073 XEO_NAME Dimethoate DME0069 XEOTICID XEO01073 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0069 XEOTICID XEO01073 XEO_CLAS Pesticide/Insecticide DME0069 XEOTICID XEO01073 DESCRIPT Dimethoate inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01073 GENEFORM Protein DME0069 XEOTICID XEO01073 MOACRIVE Inhibition DME0069 XEOTICID XEO01196 XEO_NAME Amiridine DME0069 XEOTICID XEO01196 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO01196 XEO_CLAS Investigative Agent DME0069 XEOTICID XEO01196 DESCRIPT Amiridine inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01196 GENEFORM Protein DME0069 XEOTICID XEO01196 MOACRIVE Inhibition DME0069 XEOTICID XEO01208 XEO_NAME HI-6 DME0069 XEOTICID XEO01208 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO01208 XEO_CLAS Preclinical/Patented Drug DME0069 XEOTICID XEO01208 DESCRIPT HI-6 inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01208 GENEFORM Protein DME0069 XEOTICID XEO01208 MOACRIVE Inhibition DME0069 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0069 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0069 XEOTICID XEO01248 DESCRIPT Chlorpyrifos inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01248 GENEFORM Protein DME0069 XEOTICID XEO01248 MOACRIVE Inhibition DME0069 XEOTICID XEO01274 XEO_NAME Diazinon DME0069 XEOTICID XEO01274 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO01274 XEO_CLAS Environmental Pollutant DME0069 XEOTICID XEO01274 DESCRIPT Diazinon inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01274 GENEFORM Protein DME0069 XEOTICID XEO01274 MOACRIVE Inhibition DME0069 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0069 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0069 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME BCHE DME0069 XEOTICID XEO01305 GENEFORM mRNA DME0069 XEOTICID XEO01305 MOACRIVE Inhibition DME0069 XEOTICID XEO01367 XEO_NAME Linoleic acid DME0069 XEOTICID XEO01367 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO01367 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO01367 DESCRIPT Linoleic acid up-regulates the expression of DME BCHE DME0069 XEOTICID XEO01367 GENEFORM mRNA DME0069 XEOTICID XEO01367 MOACRIVE Induction DME0069 XEOTICID XEO01406 XEO_NAME Obidoxime chloride DME0069 XEOTICID XEO01406 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO01406 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO01406 DESCRIPT Obidoxime chloride up-regulates the expression of DME BCHE DME0069 XEOTICID XEO01406 GENEFORM mRNA DME0069 XEOTICID XEO01406 MOACRIVE Induction DME0069 XEOTICID XEO01422 XEO_NAME Paraquat DME0069 XEOTICID XEO01422 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO01422 XEO_CLAS Acute Toxic Substance DME0069 XEOTICID XEO01422 DESCRIPT Paraquat inhibits the expression of DME BCHE DME0069 XEOTICID XEO01422 GENEFORM mRNA DME0069 XEOTICID XEO01422 MOACRIVE Inhibition DME0069 XEOTICID XEO01427 XEO_NAME Phenylmethylsulfonyl fluoride DME0069 XEOTICID XEO01427 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO01427 XEO_CLAS Acute Toxic Substance DME0069 XEOTICID XEO01427 DESCRIPT Phenylmethylsulfonyl fluoride inhibits the expression of DME BCHE DME0069 XEOTICID XEO01427 GENEFORM mRNA DME0069 XEOTICID XEO01427 MOACRIVE Inhibition DME0069 XEOTICID XEO01428 XEO_NAME Phenylsaligenin cyclic phosphate DME0069 XEOTICID XEO01428 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO01428 XEO_CLAS Preclinical/Patented Drug DME0069 XEOTICID XEO01428 DESCRIPT Phenylsaligenin cyclic phosphate inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01428 GENEFORM Protein DME0069 XEOTICID XEO01428 MOACRIVE Inhibition DME0069 XEOTICID XEO01481 XEO_NAME Tetraethylammonium DME0069 XEOTICID XEO01481 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO01481 XEO_CLAS Drug in Phase 2 Clinical Trial DME0069 XEOTICID XEO01481 DESCRIPT Tetraethylammonium inhibits the expression of DME BCHE DME0069 XEOTICID XEO01481 GENEFORM mRNA DME0069 XEOTICID XEO01481 MOACRIVE Inhibition DME0069 XEOTICID XEO01482 XEO_NAME Tetraisopropylpyrophosphamide DME0069 XEOTICID XEO01482 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO01482 XEO_CLAS Acute Toxic Substance DME0069 XEOTICID XEO01482 DESCRIPT Tetraisopropylpyrophosphamide inhibits the drug-metabolizing activity of DME BCHE (IC50 = 0.733 microM) DME0069 XEOTICID XEO01482 GENEFORM Protein DME0069 XEOTICID XEO01482 MOACRIVE Inhibition DME0069 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0069 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0069 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME BCHE DME0069 XEOTICID XEO01492 GENEFORM mRNA DME0069 XEOTICID XEO01492 MOACRIVE Induction DME0069 XEOTICID XEO01493 XEO_NAME Trimedoxime DME0069 XEOTICID XEO01493 XEO_TYPE Pharmaceutical Agent(s) DME0069 XEOTICID XEO01493 XEO_CLAS Approved/Marketed Drug DME0069 XEOTICID XEO01493 DESCRIPT Trimedoxime inhibits the expression of DME BCHE DME0069 XEOTICID XEO01493 GENEFORM mRNA DME0069 XEOTICID XEO01493 MOACRIVE Inhibition DME0069 XEOTICID XEO01503 XEO_NAME Cadmium DME0069 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0069 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME BCHE DME0069 XEOTICID XEO01503 GENEFORM mRNA DME0069 XEOTICID XEO01503 MOACRIVE Induction DME0069 XEOTICID XEO01534 XEO_NAME Cryptotanshinone DME0069 XEOTICID XEO01534 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0069 XEOTICID XEO01534 XEO_CLAS Natural Product DME0069 XEOTICID XEO01534 DESCRIPT Cryptotanshinone inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01534 GENEFORM Protein DME0069 XEOTICID XEO01534 MOACRIVE Inhibition DME0069 XEOTICID XEO01589 XEO_NAME Solanidine DME0069 XEOTICID XEO01589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0069 XEOTICID XEO01589 XEO_CLAS Natural Product DME0069 XEOTICID XEO01589 DESCRIPT Solanidine inhibits the expression of DME BCHE DME0069 XEOTICID XEO01589 GENEFORM mRNA DME0069 XEOTICID XEO01589 MOACRIVE Inhibition DME0069 XEOTICID XEO01596 XEO_NAME Tabun DME0069 XEOTICID XEO01596 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO01596 XEO_CLAS Neurotoxin DME0069 XEOTICID XEO01596 DESCRIPT Tabun inhibits the expression of DME BCHE DME0069 XEOTICID XEO01596 GENEFORM mRNA DME0069 XEOTICID XEO01596 MOACRIVE Inhibition DME0069 XEOTICID XEO01597 XEO_NAME Carbofuran DME0069 XEOTICID XEO01597 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0069 XEOTICID XEO01597 XEO_CLAS Pesticide/Insecticide DME0069 XEOTICID XEO01597 DESCRIPT Carbof DMEuran inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01597 GENEFORM Protein DME0069 XEOTICID XEO01597 MOACRIVE Inhibition DME0069 XEOTICID XEO01610 XEO_NAME Ethephon DME0069 XEOTICID XEO01610 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO01610 XEO_CLAS Acute Toxic Substance DME0069 XEOTICID XEO01610 DESCRIPT Ethephon inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01610 GENEFORM Protein DME0069 XEOTICID XEO01610 MOACRIVE Inhibition DME0069 XEOTICID XEO01615 XEO_NAME Dimethoxon DME0069 XEOTICID XEO01615 XEO_TYPE Health or Environmental Toxicant(s) DME0069 XEOTICID XEO01615 XEO_CLAS Acute Toxic Substance DME0069 XEOTICID XEO01615 DESCRIPT Dimethoxon inhibits the drug-metabolizing activity of DME BCHE DME0069 XEOTICID XEO01615 GENEFORM Protein DME0069 XEOTICID XEO01615 MOACRIVE Inhibition DME0070 DME___ID DME0070 DME0070 DME_NAME Xanthine dehydrogenase/oxidase (XDH) DME0070 SPESNAME Homo sapiens DME0070 XEOTICID XEO00029 XEO_NAME Valproic acid DME0070 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0070 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0070 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME XDH DME0070 XEOTICID XEO00029 GENEFORM mRNA DME0070 XEOTICID XEO00029 MOACRIVE Induction DME0070 XEOTICID XEO00047 XEO_NAME Indomethacin DME0070 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0070 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0070 XEOTICID XEO00047 DESCRIPT Indomethacin induces the drug-metabolizing activity of DME XDH DME0070 XEOTICID XEO00047 GENEFORM Protein DME0070 XEOTICID XEO00047 MOACRIVE Induction DME0070 XEOTICID XEO00089 XEO_NAME Mitomycin DME0070 XEOTICID XEO00089 XEO_TYPE Pharmaceutical Agent(s) DME0070 XEOTICID XEO00089 XEO_CLAS Approved/Marketed Drug DME0070 XEOTICID XEO00089 DESCRIPT Mitomycin inhibits the drug-metabolizing activity of DME XDH DME0070 XEOTICID XEO00089 GENEFORM Protein DME0070 XEOTICID XEO00089 MOACRIVE Inhibition DME0070 XEOTICID XEO00148 XEO_NAME Bosentan DME0070 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0070 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0070 XEOTICID XEO00148 DESCRIPT Bosentan inhibits the expression of DME XDH DME0070 XEOTICID XEO00148 GENEFORM mRNA DME0070 XEOTICID XEO00148 MOACRIVE Inhibition DME0070 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0070 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0070 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0070 XEOTICID XEO00165 DESCRIPT Obeticholic acid up-regulates the expression of DME XDH DME0070 XEOTICID XEO00165 GENEFORM mRNA DME0070 XEOTICID XEO00165 MOACRIVE Induction DME0070 XEOTICID XEO00210 XEO_NAME Allopurinol DME0070 XEOTICID XEO00210 XEO_TYPE Pharmaceutical Agent(s) DME0070 XEOTICID XEO00210 XEO_CLAS Approved/Marketed Drug DME0070 XEOTICID XEO00210 DESCRIPT Allopurinol inhibits the drug-metabolizing activity of DME XDH (IC50 = 0.0036 microM) DME0070 XEOTICID XEO00210 GENEFORM Protein DME0070 XEOTICID XEO00210 MOACRIVE Inhibition DME0070 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0070 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0070 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0070 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME XDH DME0070 XEOTICID XEO00217 GENEFORM mRNA DME0070 XEOTICID XEO00217 MOACRIVE Inhibition DME0070 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0070 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0070 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0070 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME XDH DME0070 XEOTICID XEO00241 GENEFORM mRNA DME0070 XEOTICID XEO00241 MOACRIVE Induction DME0070 XEOTICID XEO00334 XEO_NAME Cisplatin DME0070 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0070 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0070 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME XDH DME0070 XEOTICID XEO00334 GENEFORM mRNA DME0070 XEOTICID XEO00334 MOACRIVE Induction DME0070 XEOTICID XEO00411 XEO_NAME Avobenzone DME0070 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0070 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0070 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME XDH DME0070 XEOTICID XEO00411 GENEFORM mRNA DME0070 XEOTICID XEO00411 MOACRIVE Induction DME0070 XEOTICID XEO00538 XEO_NAME Quercetin DME0070 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0070 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0070 XEOTICID XEO00538 DESCRIPT Quercetin up-regulates the expression of DME XDH DME0070 XEOTICID XEO00538 GENEFORM mRNA DME0070 XEOTICID XEO00538 MOACRIVE Induction DME0070 XEOTICID XEO00539 XEO_NAME Ethanol DME0070 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0070 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0070 XEOTICID XEO00539 DESCRIPT Ethanol induces the drug-metabolizing activity of DME XDH DME0070 XEOTICID XEO00539 GENEFORM Protein DME0070 XEOTICID XEO00539 MOACRIVE Induction DME0070 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0070 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0070 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0070 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME XDH DME0070 XEOTICID XEO00632 GENEFORM mRNA DME0070 XEOTICID XEO00632 MOACRIVE Inhibition DME0070 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0070 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0070 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0070 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME XDH DME0070 XEOTICID XEO00723 GENEFORM mRNA DME0070 XEOTICID XEO00723 MOACRIVE Inhibition DME0070 XEOTICID XEO00760 XEO_NAME Jinfukang DME0070 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0070 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0070 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME XDH DME0070 XEOTICID XEO00760 GENEFORM mRNA DME0070 XEOTICID XEO00760 MOACRIVE Inhibition DME0070 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0070 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0070 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0070 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME XDH DME0070 XEOTICID XEO00806 GENEFORM mRNA DME0070 XEOTICID XEO00806 MOACRIVE Inhibition DME0070 XEOTICID XEO00872 XEO_NAME Acetaldehyde DME0070 XEOTICID XEO00872 XEO_TYPE Health or Environmental Toxicant(s) DME0070 XEOTICID XEO00872 XEO_CLAS Health Hazard/Toxicant DME0070 XEOTICID XEO00872 DESCRIPT Acetaldehyde induces the drug-metabolizing activity of DME XDH DME0070 XEOTICID XEO00872 GENEFORM Protein DME0070 XEOTICID XEO00872 MOACRIVE Induction DME0070 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0070 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0070 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0070 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME XDH DME0070 XEOTICID XEO00999 GENEFORM mRNA DME0070 XEOTICID XEO00999 MOACRIVE Induction DME0070 XEOTICID XEO01034 XEO_NAME Pentanal DME0070 XEOTICID XEO01034 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0070 XEOTICID XEO01034 XEO_CLAS Chemical Compound DME0070 XEOTICID XEO01034 DESCRIPT Pentanal up-regulates the expression of DME XDH DME0070 XEOTICID XEO01034 GENEFORM mRNA DME0070 XEOTICID XEO01034 MOACRIVE Induction DME0070 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0070 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0070 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0070 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME XDH DME0070 XEOTICID XEO01305 GENEFORM mRNA DME0070 XEOTICID XEO01305 MOACRIVE Induction DME0070 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0070 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0070 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0070 XEOTICID XEO01407 DESCRIPT Ochratoxin A up-regulates the expression of DME XDH DME0070 XEOTICID XEO01407 GENEFORM mRNA DME0070 XEOTICID XEO01407 MOACRIVE Induction DME0070 XEOTICID XEO01505 XEO_NAME Lead DME0070 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0070 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0070 XEOTICID XEO01505 DESCRIPT Lead inhibits the expression of DME XDH DME0070 XEOTICID XEO01505 GENEFORM mRNA DME0070 XEOTICID XEO01505 MOACRIVE Inhibition DME0070 XEOTICID XEO01574 XEO_NAME Plant extracts DME0070 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0070 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0070 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME XDH DME0070 XEOTICID XEO01574 GENEFORM Protein DME0070 XEOTICID XEO01574 MOACRIVE Inhibition DME0071 DME___ID DME0071 DME0071 DME_NAME Cathepsin A (CTSA) DME0071 SPESNAME Homo sapiens DME0071 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0071 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0071 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0071 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME CTSA DME0071 XEOTICID XEO00217 GENEFORM mRNA DME0071 XEOTICID XEO00217 MOACRIVE Induction DME0071 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0071 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0071 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0071 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CTSA DME0071 XEOTICID XEO00241 GENEFORM mRNA DME0071 XEOTICID XEO00241 MOACRIVE Inhibition DME0071 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0071 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0071 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0071 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME CTSA DME0071 XEOTICID XEO00339 GENEFORM mRNA DME0071 XEOTICID XEO00339 MOACRIVE Induction DME0071 XEOTICID XEO00622 XEO_NAME AM-80 DME0071 XEOTICID XEO00622 XEO_TYPE Pharmaceutical Agent(s) DME0071 XEOTICID XEO00622 XEO_CLAS Drug in Phase 2 Clinical Trial DME0071 XEOTICID XEO00622 DESCRIPT AM-80 induces the drug-metabolizing activity of DME CTSA DME0071 XEOTICID XEO00622 GENEFORM Protein DME0071 XEOTICID XEO00622 MOACRIVE Induction DME0071 XEOTICID XEO00760 XEO_NAME Jinfukang DME0071 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0071 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0071 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME CTSA DME0071 XEOTICID XEO00760 GENEFORM mRNA DME0071 XEOTICID XEO00760 MOACRIVE Induction DME0071 XEOTICID XEO00969 XEO_NAME Atrazine DME0071 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0071 XEOTICID XEO00969 XEO_CLAS Herbicide DME0071 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME CTSA DME0071 XEOTICID XEO00969 GENEFORM mRNA DME0071 XEOTICID XEO00969 MOACRIVE Inhibition DME0071 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0071 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0071 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0071 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME CTSA DME0071 XEOTICID XEO00999 GENEFORM mRNA DME0071 XEOTICID XEO00999 MOACRIVE Inhibition DME0071 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0071 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0071 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0071 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME CTSA DME0071 XEOTICID XEO01226 GENEFORM mRNA DME0071 XEOTICID XEO01226 MOACRIVE Induction DME0072 DME___ID DME0072 DME0072 DME_NAME UDP-glucuronosyltransferase 1A6 (UGT1A6) DME0072 SPESNAME Homo sapiens DME0072 XEOTICID XEO00028 XEO_NAME Disulfiram DME0072 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0072 XEOTICID XEO00028 DESCRIPT Disulfiram up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO00028 GENEFORM mRNA DME0072 XEOTICID XEO00028 MOACRIVE Induction DME0072 XEOTICID XEO00029 XEO_NAME Valproic acid DME0072 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0072 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME UGT1A6 DME0072 XEOTICID XEO00029 GENEFORM mRNA DME0072 XEOTICID XEO00029 MOACRIVE Inhibition DME0072 XEOTICID XEO00069 XEO_NAME Omeprazole DME0072 XEOTICID XEO00069 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00069 XEO_CLAS Approved/Marketed Drug DME0072 XEOTICID XEO00069 DESCRIPT Omeprazole up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO00069 GENEFORM mRNA DME0072 XEOTICID XEO00069 MOACRIVE Induction DME0072 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0072 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0072 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME UGT1A6 DME0072 XEOTICID XEO00117 GENEFORM mRNA DME0072 XEOTICID XEO00117 MOACRIVE Inhibition DME0072 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0072 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0072 XEOTICID XEO00140 DESCRIPT Zoledronic acid inhibits the drug-metabolizing activity of DME UGT1A6 DME0072 XEOTICID XEO00140 GENEFORM Protein DME0072 XEOTICID XEO00140 MOACRIVE Inhibition DME0072 XEOTICID XEO00148 XEO_NAME Bosentan DME0072 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0072 XEOTICID XEO00148 DESCRIPT Bosentan inhibits the expression of DME UGT1A6 DME0072 XEOTICID XEO00148 GENEFORM mRNA DME0072 XEOTICID XEO00148 MOACRIVE Inhibition DME0072 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0072 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0072 XEOTICID XEO00165 DESCRIPT Obeticholic acid inhibits the drug-metabolizing activity of DME UGT1A6 DME0072 XEOTICID XEO00165 GENEFORM Protein DME0072 XEOTICID XEO00165 MOACRIVE Inhibition DME0072 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0072 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0072 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME UGT1A6 DME0072 XEOTICID XEO00217 GENEFORM mRNA DME0072 XEOTICID XEO00217 MOACRIVE Inhibition DME0072 XEOTICID XEO00223 XEO_NAME Rifampin DME0072 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0072 XEOTICID XEO00223 DESCRIPT Rifampin up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO00223 GENEFORM mRNA DME0072 XEOTICID XEO00223 MOACRIVE Induction DME0072 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0072 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0072 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME UGT1A6 DME0072 XEOTICID XEO00241 GENEFORM mRNA DME0072 XEOTICID XEO00241 MOACRIVE Inhibition DME0072 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0072 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0072 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO00339 GENEFORM mRNA DME0072 XEOTICID XEO00339 MOACRIVE Induction DME0072 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0072 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0072 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME UGT1A6 DME0072 XEOTICID XEO00410 GENEFORM Protein DME0072 XEOTICID XEO00410 MOACRIVE Inhibition DME0072 XEOTICID XEO00538 XEO_NAME Quercetin DME0072 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0072 XEOTICID XEO00538 DESCRIPT Quercetin induces the drug-metabolizing activity of DME UGT1A6 DME0072 XEOTICID XEO00538 GENEFORM Protein DME0072 XEOTICID XEO00538 MOACRIVE Induction DME0072 XEOTICID XEO00555 XEO_NAME Hymecromone DME0072 XEOTICID XEO00555 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00555 XEO_CLAS Drug in Phase 1 Clinical Trial DME0072 XEOTICID XEO00555 DESCRIPT Hymecromone induces the drug-metabolizing activity of DME UGT1A6 DME0072 XEOTICID XEO00555 GENEFORM Protein DME0072 XEOTICID XEO00555 MOACRIVE Induction DME0072 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0072 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0072 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO00571 GENEFORM mRNA DME0072 XEOTICID XEO00571 MOACRIVE Induction DME0072 XEOTICID XEO00683 XEO_NAME Curcumin DME0072 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0072 XEOTICID XEO00683 DESCRIPT Curcumin up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO00683 GENEFORM mRNA DME0072 XEOTICID XEO00683 MOACRIVE Induction DME0072 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0072 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0072 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME UGT1A6 DME0072 XEOTICID XEO00723 GENEFORM mRNA DME0072 XEOTICID XEO00723 MOACRIVE Inhibition DME0072 XEOTICID XEO00756 XEO_NAME Turmeric extract DME0072 XEOTICID XEO00756 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0072 XEOTICID XEO00756 XEO_CLAS Plant Extract DME0072 XEOTICID XEO00756 DESCRIPT Turmeric extract up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO00756 GENEFORM mRNA DME0072 XEOTICID XEO00756 MOACRIVE Induction DME0072 XEOTICID XEO00792 XEO_NAME Phloxine DME0072 XEOTICID XEO00792 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00792 XEO_CLAS Investigative Agent DME0072 XEOTICID XEO00792 DESCRIPT Phloxine inhibits the drug-metabolizing activity of DME UGT1A6 DME0072 XEOTICID XEO00792 GENEFORM Protein DME0072 XEOTICID XEO00792 MOACRIVE Inhibition DME0072 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0072 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0072 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0072 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO00806 GENEFORM mRNA DME0072 XEOTICID XEO00806 MOACRIVE Induction DME0072 XEOTICID XEO00885 XEO_NAME Eugenol DME0072 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0072 XEOTICID XEO00885 DESCRIPT Eugenol up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO00885 GENEFORM mRNA DME0072 XEOTICID XEO00885 MOACRIVE Induction DME0072 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0072 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0072 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0072 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene induces the drug-metabolizing activity of DME UGT1A6 DME0072 XEOTICID XEO00898 GENEFORM Protein DME0072 XEOTICID XEO00898 MOACRIVE Induction DME0072 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0072 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0072 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0072 XEOTICID XEO00899 DESCRIPT Methylcholanthrene induces the drug-metabolizing activity of DME UGT1A6 DME0072 XEOTICID XEO00899 GENEFORM Protein DME0072 XEOTICID XEO00899 MOACRIVE Induction DME0072 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0072 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0072 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0072 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO00905 GENEFORM mRNA DME0072 XEOTICID XEO00905 MOACRIVE Induction DME0072 XEOTICID XEO00985 XEO_NAME Hexyl cinnamic aldehyde DME0072 XEOTICID XEO00985 XEO_TYPE Health or Environmental Toxicant(s) DME0072 XEOTICID XEO00985 XEO_CLAS Environmental Pollutant DME0072 XEOTICID XEO00985 DESCRIPT Hexyl cinnamic aldehyde up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO00985 GENEFORM mRNA DME0072 XEOTICID XEO00985 MOACRIVE Induction DME0072 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0072 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0072 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0072 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone induces the drug-metabolizing activity of DME UGT1A6 DME0072 XEOTICID XEO01129 GENEFORM Protein DME0072 XEOTICID XEO01129 MOACRIVE Induction DME0072 XEOTICID XEO01195 XEO_NAME Amentoflavone DME0072 XEOTICID XEO01195 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0072 XEOTICID XEO01195 XEO_CLAS Natural Product DME0072 XEOTICID XEO01195 DESCRIPT Amentof DMElavone inhibits the drug-metabolizing activity of DME UGT1A6 DME0072 XEOTICID XEO01195 GENEFORM Protein DME0072 XEOTICID XEO01195 MOACRIVE Inhibition DME0072 XEOTICID XEO01201 XEO_NAME Antimony potassium tartrate DME0072 XEOTICID XEO01201 XEO_TYPE Health or Environmental Toxicant(s) DME0072 XEOTICID XEO01201 XEO_CLAS Environmental Pollutant DME0072 XEOTICID XEO01201 DESCRIPT Antimony potassium tartrate up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO01201 GENEFORM mRNA DME0072 XEOTICID XEO01201 MOACRIVE Induction DME0072 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0072 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0072 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO01220 GENEFORM mRNA DME0072 XEOTICID XEO01220 MOACRIVE Induction DME0072 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0072 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0072 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME UGT1A6 DME0072 XEOTICID XEO01226 GENEFORM mRNA DME0072 XEOTICID XEO01226 MOACRIVE Inhibition DME0072 XEOTICID XEO01230 XEO_NAME Butyric acid DME0072 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0072 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0072 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO01230 GENEFORM mRNA DME0072 XEOTICID XEO01230 MOACRIVE Induction DME0072 XEOTICID XEO01343 XEO_NAME Indolo(3,2-B)carbazole DME0072 XEOTICID XEO01343 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0072 XEOTICID XEO01343 XEO_CLAS Natural Product DME0072 XEOTICID XEO01343 DESCRIPT Indolo(3,2-B)carbazole up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO01343 GENEFORM mRNA DME0072 XEOTICID XEO01343 MOACRIVE Induction DME0072 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0072 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0072 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0072 XEOTICID XEO01407 DESCRIPT Ochratoxin A up-regulates the expression of DME UGT1A6 DME0072 XEOTICID XEO01407 GENEFORM mRNA DME0072 XEOTICID XEO01407 MOACRIVE Induction DME0073 DME___ID DME0073 DME0073 DME_NAME Alcohol dehydrogenase class-V (ADH6) DME0073 SPESNAME Homo sapiens DME0073 XEOTICID XEO00029 XEO_NAME Valproic acid DME0073 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0073 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0073 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME ADH6 DME0073 XEOTICID XEO00029 GENEFORM mRNA DME0073 XEOTICID XEO00029 MOACRIVE Inhibition DME0073 XEOTICID XEO00053 XEO_NAME Leflunomide DME0073 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0073 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0073 XEOTICID XEO00053 DESCRIPT Leflunomide inhibits the expression of DME ADH6 DME0073 XEOTICID XEO00053 GENEFORM mRNA DME0073 XEOTICID XEO00053 MOACRIVE Inhibition DME0073 XEOTICID XEO00090 XEO_NAME Estradiol DME0073 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0073 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0073 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME ADH6 DME0073 XEOTICID XEO00090 GENEFORM mRNA DME0073 XEOTICID XEO00090 MOACRIVE Inhibition DME0073 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0073 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0073 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0073 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME ADH6 DME0073 XEOTICID XEO00117 GENEFORM mRNA DME0073 XEOTICID XEO00117 MOACRIVE Inhibition DME0073 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0073 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0073 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0073 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ADH6 DME0073 XEOTICID XEO00217 GENEFORM mRNA DME0073 XEOTICID XEO00217 MOACRIVE Inhibition DME0073 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0073 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0073 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0073 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME ADH6 DME0073 XEOTICID XEO00241 GENEFORM mRNA DME0073 XEOTICID XEO00241 MOACRIVE Inhibition DME0073 XEOTICID XEO00435 XEO_NAME Urethane DME0073 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0073 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0073 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME ADH6 DME0073 XEOTICID XEO00435 GENEFORM mRNA DME0073 XEOTICID XEO00435 MOACRIVE Inhibition DME0073 XEOTICID XEO00538 XEO_NAME Quercetin DME0073 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0073 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0073 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME ADH6 DME0073 XEOTICID XEO00538 GENEFORM Protein DME0073 XEOTICID XEO00538 MOACRIVE Inhibition DME0073 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0073 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0073 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0073 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the drug-metabolizing activity of DME ADH6 DME0073 XEOTICID XEO00632 GENEFORM Protein DME0073 XEOTICID XEO00632 MOACRIVE Inhibition DME0073 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0073 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0073 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0073 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME ADH6 DME0073 XEOTICID XEO00806 GENEFORM mRNA DME0073 XEOTICID XEO00806 MOACRIVE Inhibition DME0073 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0073 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0073 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0073 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME ADH6 DME0073 XEOTICID XEO00898 GENEFORM mRNA DME0073 XEOTICID XEO00898 MOACRIVE Inhibition DME0073 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0073 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0073 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0073 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME ADH6 DME0073 XEOTICID XEO00999 GENEFORM mRNA DME0073 XEOTICID XEO00999 MOACRIVE Inhibition DME0073 XEOTICID XEO01006 XEO_NAME Dimethyl nitrosamine DME0073 XEOTICID XEO01006 XEO_TYPE Health or Environmental Toxicant(s) DME0073 XEOTICID XEO01006 XEO_CLAS Carcinogen DME0073 XEOTICID XEO01006 DESCRIPT Dimethyl nitrosamine inhibits the expression of DME ADH6 DME0073 XEOTICID XEO01006 GENEFORM mRNA DME0073 XEOTICID XEO01006 MOACRIVE Inhibition DME0073 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0073 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0073 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0073 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME ADH6 DME0073 XEOTICID XEO01031 GENEFORM mRNA DME0073 XEOTICID XEO01031 MOACRIVE Inhibition DME0073 XEOTICID XEO01498 XEO_NAME Walrycin A DME0073 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0073 XEOTICID XEO01498 XEO_CLAS Natural Product DME0073 XEOTICID XEO01498 DESCRIPT Walrycin A inhibits the expression of DME ADH6 DME0073 XEOTICID XEO01498 GENEFORM mRNA DME0073 XEOTICID XEO01498 MOACRIVE Inhibition DME0073 XEOTICID XEO01503 XEO_NAME Cadmium DME0073 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0073 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0073 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the expression of DME ADH6 DME0073 XEOTICID XEO01503 GENEFORM mRNA DME0073 XEOTICID XEO01503 MOACRIVE Inhibition DME0073 XEOTICID XEO01512 XEO_NAME Zinc DME0073 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME0073 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME0073 XEOTICID XEO01512 DESCRIPT Zinc up-regulates the expression of DME ADH6 DME0073 XEOTICID XEO01512 GENEFORM mRNA DME0073 XEOTICID XEO01512 MOACRIVE Induction DME0074 DME___ID DME0074 DME0074 DME_NAME Sulfotransferase 2A1 (SULT2A1) DME0074 SPESNAME Homo sapiens DME0074 XEOTICID XEO00029 XEO_NAME Valproic acid DME0074 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0074 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO00029 GENEFORM mRNA DME0074 XEOTICID XEO00029 MOACRIVE Inhibition DME0074 XEOTICID XEO00053 XEO_NAME Leflunomide DME0074 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0074 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME SULT2A1 DME0074 XEOTICID XEO00053 GENEFORM mRNA DME0074 XEOTICID XEO00053 MOACRIVE Induction DME0074 XEOTICID XEO00090 XEO_NAME Estradiol DME0074 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0074 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO00090 GENEFORM mRNA DME0074 XEOTICID XEO00090 MOACRIVE Inhibition DME0074 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0074 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0074 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO00117 GENEFORM mRNA DME0074 XEOTICID XEO00117 MOACRIVE Inhibition DME0074 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0074 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0074 XEOTICID XEO00167 DESCRIPT Alitretinoin inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO00167 GENEFORM mRNA DME0074 XEOTICID XEO00167 MOACRIVE Inhibition DME0074 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0074 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0074 XEOTICID XEO00186 DESCRIPT Isotretinoin up-regulates the expression of DME SULT2A1 DME0074 XEOTICID XEO00186 GENEFORM mRNA DME0074 XEOTICID XEO00186 MOACRIVE Induction DME0074 XEOTICID XEO00193 XEO_NAME Belinostat DME0074 XEOTICID XEO00193 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00193 XEO_CLAS Approved/Marketed Drug DME0074 XEOTICID XEO00193 DESCRIPT Belinostat inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO00193 GENEFORM mRNA DME0074 XEOTICID XEO00193 MOACRIVE Inhibition DME0074 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0074 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0074 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the drug-metabolizing activity of DME SULT2A1 DME0074 XEOTICID XEO00217 GENEFORM Protein DME0074 XEOTICID XEO00217 MOACRIVE Inhibition DME0074 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0074 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0074 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the drug-metabolizing activity of DME SULT2A1 DME0074 XEOTICID XEO00241 GENEFORM Protein DME0074 XEOTICID XEO00241 MOACRIVE Inhibition DME0074 XEOTICID XEO00253 XEO_NAME Tretinoin DME0074 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0074 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO00253 GENEFORM mRNA DME0074 XEOTICID XEO00253 MOACRIVE Inhibition DME0074 XEOTICID XEO00366 XEO_NAME Methotrexate DME0074 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0074 XEOTICID XEO00366 DESCRIPT Methotrexate inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO00366 GENEFORM mRNA DME0074 XEOTICID XEO00366 MOACRIVE Inhibition DME0074 XEOTICID XEO00435 XEO_NAME Urethane DME0074 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0074 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO00435 GENEFORM mRNA DME0074 XEOTICID XEO00435 MOACRIVE Inhibition DME0074 XEOTICID XEO00494 XEO_NAME Ciprofibrate DME0074 XEOTICID XEO00494 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00494 XEO_CLAS Approved/Marketed Drug DME0074 XEOTICID XEO00494 DESCRIPT Ciprofibrate up-regulates the expression of DME SULT2A1 and leads to increasing the drug-metabolizing activity of this enzyme DME0074 XEOTICID XEO00494 GENEFORM Protein DME0074 XEOTICID XEO00494 MOACRIVE Induction DME0074 XEOTICID XEO00539 XEO_NAME Ethanol DME0074 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0074 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the drug-metabolizing activity of DME SULT2A1 DME0074 XEOTICID XEO00539 GENEFORM Protein DME0074 XEOTICID XEO00539 MOACRIVE Inhibition DME0074 XEOTICID XEO00557 XEO_NAME Genistein DME0074 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0074 XEOTICID XEO00557 DESCRIPT Genistein induces the drug-metabolizing activity of DME SULT2A1 DME0074 XEOTICID XEO00557 GENEFORM Protein DME0074 XEOTICID XEO00557 MOACRIVE Induction DME0074 XEOTICID XEO00606 XEO_NAME Colforsin DME0074 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0074 XEOTICID XEO00606 DESCRIPT Colforsin inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO00606 GENEFORM mRNA DME0074 XEOTICID XEO00606 MOACRIVE Inhibition DME0074 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0074 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0074 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO00632 GENEFORM mRNA DME0074 XEOTICID XEO00632 MOACRIVE Inhibition DME0074 XEOTICID XEO00709 XEO_NAME Antalarmin DME0074 XEOTICID XEO00709 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00709 XEO_CLAS Preclinical/Patented Drug DME0074 XEOTICID XEO00709 DESCRIPT Antalarmin inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO00709 GENEFORM mRNA DME0074 XEOTICID XEO00709 MOACRIVE Inhibition DME0074 XEOTICID XEO00735 XEO_NAME GW-4064 DME0074 XEOTICID XEO00735 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00735 XEO_CLAS Preclinical/Patented Drug DME0074 XEOTICID XEO00735 DESCRIPT GW-4064 inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO00735 GENEFORM mRNA DME0074 XEOTICID XEO00735 MOACRIVE Inhibition DME0074 XEOTICID XEO00740 XEO_NAME Lindane DME0074 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0074 XEOTICID XEO00740 DESCRIPT Lindane inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO00740 GENEFORM mRNA DME0074 XEOTICID XEO00740 MOACRIVE Inhibition DME0074 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0074 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0074 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0074 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO00806 GENEFORM mRNA DME0074 XEOTICID XEO00806 MOACRIVE Inhibition DME0074 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0074 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0074 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0074 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME SULT2A1 DME0074 XEOTICID XEO00898 GENEFORM mRNA DME0074 XEOTICID XEO00898 MOACRIVE Induction DME0074 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0074 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0074 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0074 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO01050 GENEFORM mRNA DME0074 XEOTICID XEO01050 MOACRIVE Inhibition DME0074 XEOTICID XEO01133 XEO_NAME 3,3',4,5'-tetrahydroxystilbene DME0074 XEOTICID XEO01133 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO01133 XEO_CLAS Investigative Agent DME0074 XEOTICID XEO01133 DESCRIPT 3,3',4,5'-tetrahydroxystilbene inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO01133 GENEFORM mRNA DME0074 XEOTICID XEO01133 MOACRIVE Inhibition DME0074 XEOTICID XEO01154 XEO_NAME 4-oxoretinoic acid DME0074 XEOTICID XEO01154 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0074 XEOTICID XEO01154 XEO_CLAS Natural Product DME0074 XEOTICID XEO01154 DESCRIPT 4-oxoretinoic acid inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO01154 GENEFORM mRNA DME0074 XEOTICID XEO01154 MOACRIVE Inhibition DME0074 XEOTICID XEO01210 XEO_NAME Astressin DME0074 XEOTICID XEO01210 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO01210 XEO_CLAS Investigative Agent DME0074 XEOTICID XEO01210 DESCRIPT Astressin inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO01210 GENEFORM mRNA DME0074 XEOTICID XEO01210 MOACRIVE Inhibition DME0074 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0074 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0074 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO01226 GENEFORM mRNA DME0074 XEOTICID XEO01226 MOACRIVE Inhibition DME0074 XEOTICID XEO01348 XEO_NAME K-7174 DME0074 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0074 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0074 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO01348 GENEFORM mRNA DME0074 XEOTICID XEO01348 MOACRIVE Inhibition DME0074 XEOTICID XEO01551 XEO_NAME Heliotrine DME0074 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0074 XEOTICID XEO01551 XEO_CLAS Natural Product DME0074 XEOTICID XEO01551 DESCRIPT Heliotrine inhibits the expression of DME SULT2A1 DME0074 XEOTICID XEO01551 GENEFORM mRNA DME0074 XEOTICID XEO01551 MOACRIVE Inhibition DME0075 DME___ID DME0075 DME0075 DME_NAME UDP-glucuronosyltransferase 1A10 (UGT1A10) DME0075 SPESNAME Homo sapiens DME0075 XEOTICID XEO00079 XEO_NAME Vorinostat DME0075 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0075 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0075 XEOTICID XEO00079 DESCRIPT Vorinostat inhibits the expression of DME UGT1A10 DME0075 XEOTICID XEO00079 GENEFORM mRNA DME0075 XEOTICID XEO00079 MOACRIVE Inhibition DME0075 XEOTICID XEO00199 XEO_NAME Doxycycline DME0075 XEOTICID XEO00199 XEO_TYPE Pharmaceutical Agent(s) DME0075 XEOTICID XEO00199 XEO_CLAS Approved/Marketed Drug DME0075 XEOTICID XEO00199 DESCRIPT Doxycycline up-regulates the expression of DME UGT1A10 DME0075 XEOTICID XEO00199 GENEFORM mRNA DME0075 XEOTICID XEO00199 MOACRIVE Induction DME0075 XEOTICID XEO00555 XEO_NAME Hymecromone DME0075 XEOTICID XEO00555 XEO_TYPE Pharmaceutical Agent(s) DME0075 XEOTICID XEO00555 XEO_CLAS Drug in Phase 1 Clinical Trial DME0075 XEOTICID XEO00555 DESCRIPT Hymecromone induces the drug-metabolizing activity of DME UGT1A10 DME0075 XEOTICID XEO00555 GENEFORM Protein DME0075 XEOTICID XEO00555 MOACRIVE Induction DME0075 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0075 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0075 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0075 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME UGT1A10 DME0075 XEOTICID XEO00723 GENEFORM mRNA DME0075 XEOTICID XEO00723 MOACRIVE Inhibition DME0075 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0075 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0075 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0075 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME UGT1A10 DME0075 XEOTICID XEO00898 GENEFORM mRNA DME0075 XEOTICID XEO00898 MOACRIVE Induction DME0075 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0075 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0075 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0075 XEOTICID XEO00899 DESCRIPT Methylcholanthrene up-regulates the expression of DME UGT1A10 DME0075 XEOTICID XEO00899 GENEFORM mRNA DME0075 XEOTICID XEO00899 MOACRIVE Induction DME0075 XEOTICID XEO01195 XEO_NAME Amentoflavone DME0075 XEOTICID XEO01195 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0075 XEOTICID XEO01195 XEO_CLAS Natural Product DME0075 XEOTICID XEO01195 DESCRIPT Amentof DMElavone inhibits the drug-metabolizing activity of DME UGT1A10 DME0075 XEOTICID XEO01195 GENEFORM Protein DME0075 XEOTICID XEO01195 MOACRIVE Inhibition DME0075 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0075 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0075 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0075 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME UGT1A10 DME0075 XEOTICID XEO01220 GENEFORM mRNA DME0075 XEOTICID XEO01220 MOACRIVE Induction DME0075 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0075 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0075 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0075 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME UGT1A10 DME0075 XEOTICID XEO01226 GENEFORM mRNA DME0075 XEOTICID XEO01226 MOACRIVE Inhibition DME0075 XEOTICID XEO01437 XEO_NAME Pregnenolone carbonitrile DME0075 XEOTICID XEO01437 XEO_TYPE Pharmaceutical Agent(s) DME0075 XEOTICID XEO01437 XEO_CLAS Investigative Agent DME0075 XEOTICID XEO01437 DESCRIPT Pregnenolone carbonitrile up-regulates the expression of DME UGT1A10 DME0075 XEOTICID XEO01437 GENEFORM mRNA DME0075 XEOTICID XEO01437 MOACRIVE Induction DME0075 XEOTICID XEO01605 XEO_NAME Pentachlorophenol DME0075 XEOTICID XEO01605 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0075 XEOTICID XEO01605 XEO_CLAS Pesticide/Insecticide DME0075 XEOTICID XEO01605 DESCRIPT Pentachlorophenol up-regulates the expression of DME UGT1A10 DME0075 XEOTICID XEO01605 GENEFORM mRNA DME0075 XEOTICID XEO01605 MOACRIVE Induction DME0076 DME___ID DME0076 DME0076 DME_NAME NADPH-cytochrome P450 reductase (CPR) DME0076 SPESNAME Homo sapiens DME0076 XEOTICID XEO00001 XEO_NAME Dimethyl sulfoxide DME0076 XEOTICID XEO00001 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00001 XEO_CLAS Approved/Marketed Drug DME0076 XEOTICID XEO00001 DESCRIPT Dimethyl sulfoxide inhibits the drug-metabolizing activity of DME POR DME0076 XEOTICID XEO00001 GENEFORM Protein DME0076 XEOTICID XEO00001 MOACRIVE Inhibition DME0076 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0076 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0076 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME POR DME0076 XEOTICID XEO00011 GENEFORM mRNA DME0076 XEOTICID XEO00011 MOACRIVE Induction DME0076 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0076 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0076 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME POR DME0076 XEOTICID XEO00035 GENEFORM mRNA DME0076 XEOTICID XEO00035 MOACRIVE Induction DME0076 XEOTICID XEO00053 XEO_NAME Leflunomide DME0076 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0076 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME POR DME0076 XEOTICID XEO00053 GENEFORM mRNA DME0076 XEOTICID XEO00053 MOACRIVE Induction DME0076 XEOTICID XEO00086 XEO_NAME Troglitazone DME0076 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0076 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME POR DME0076 XEOTICID XEO00086 GENEFORM mRNA DME0076 XEOTICID XEO00086 MOACRIVE Induction DME0076 XEOTICID XEO00213 XEO_NAME Aspirin DME0076 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0076 XEOTICID XEO00213 DESCRIPT Aspirin inhibits the expression of DME POR DME0076 XEOTICID XEO00213 GENEFORM mRNA DME0076 XEOTICID XEO00213 MOACRIVE Inhibition DME0076 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0076 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0076 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME POR DME0076 XEOTICID XEO00217 GENEFORM mRNA DME0076 XEOTICID XEO00217 MOACRIVE Induction DME0076 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0076 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0076 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME POR DME0076 XEOTICID XEO00241 GENEFORM mRNA DME0076 XEOTICID XEO00241 MOACRIVE Inhibition DME0076 XEOTICID XEO00253 XEO_NAME Tretinoin DME0076 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0076 XEOTICID XEO00253 DESCRIPT Tretinoin induces the drug-metabolizing activity of DME POR DME0076 XEOTICID XEO00253 GENEFORM Protein DME0076 XEOTICID XEO00253 MOACRIVE Induction DME0076 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0076 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0076 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME POR DME0076 XEOTICID XEO00292 GENEFORM mRNA DME0076 XEOTICID XEO00292 MOACRIVE Inhibition DME0076 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0076 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0076 XEOTICID XEO00380 DESCRIPT Rosiglitazone up-regulates the expression of DME POR DME0076 XEOTICID XEO00380 GENEFORM mRNA DME0076 XEOTICID XEO00380 MOACRIVE Induction DME0076 XEOTICID XEO00399 XEO_NAME Pyrithione zinc DME0076 XEOTICID XEO00399 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00399 XEO_CLAS Approved/Marketed Drug DME0076 XEOTICID XEO00399 DESCRIPT Pyrithione zinc inhibits the expression of DME POR DME0076 XEOTICID XEO00399 GENEFORM mRNA DME0076 XEOTICID XEO00399 MOACRIVE Inhibition DME0076 XEOTICID XEO00538 XEO_NAME Quercetin DME0076 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0076 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME POR DME0076 XEOTICID XEO00538 GENEFORM Protein DME0076 XEOTICID XEO00538 MOACRIVE Inhibition DME0076 XEOTICID XEO00547 XEO_NAME Vitamin E DME0076 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0076 XEOTICID XEO00547 DESCRIPT Vitamin E up-regulates the expression of DME POR DME0076 XEOTICID XEO00547 GENEFORM mRNA DME0076 XEOTICID XEO00547 MOACRIVE Induction DME0076 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0076 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0076 XEOTICID XEO00582 DESCRIPT Diethyltoluamide up-regulates the expression of DME POR DME0076 XEOTICID XEO00582 GENEFORM mRNA DME0076 XEOTICID XEO00582 MOACRIVE Induction DME0076 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME0076 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME0076 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate induces the drug-metabolizing activity of DME POR DME0076 XEOTICID XEO00613 GENEFORM Protein DME0076 XEOTICID XEO00613 MOACRIVE Induction DME0076 XEOTICID XEO00622 XEO_NAME AM-80 DME0076 XEOTICID XEO00622 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00622 XEO_CLAS Drug in Phase 2 Clinical Trial DME0076 XEOTICID XEO00622 DESCRIPT AM-80 induces the drug-metabolizing activity of DME POR DME0076 XEOTICID XEO00622 GENEFORM Protein DME0076 XEOTICID XEO00622 MOACRIVE Induction DME0076 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0076 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0076 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME POR DME0076 XEOTICID XEO00632 GENEFORM mRNA DME0076 XEOTICID XEO00632 MOACRIVE Induction DME0076 XEOTICID XEO00760 XEO_NAME Jinfukang DME0076 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0076 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0076 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME POR DME0076 XEOTICID XEO00760 GENEFORM mRNA DME0076 XEOTICID XEO00760 MOACRIVE Induction DME0076 XEOTICID XEO00779 XEO_NAME Sarin DME0076 XEOTICID XEO00779 XEO_TYPE Health or Environmental Toxicant(s) DME0076 XEOTICID XEO00779 XEO_CLAS Acute Toxic Substance DME0076 XEOTICID XEO00779 DESCRIPT Sarin inhibits the drug-metabolizing activity of DME POR DME0076 XEOTICID XEO00779 GENEFORM Protein DME0076 XEOTICID XEO00779 MOACRIVE Inhibition DME0076 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0076 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0076 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0076 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME POR DME0076 XEOTICID XEO00806 GENEFORM mRNA DME0076 XEOTICID XEO00806 MOACRIVE Inhibition DME0076 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0076 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0076 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0076 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME POR DME0076 XEOTICID XEO00821 GENEFORM mRNA DME0076 XEOTICID XEO00821 MOACRIVE Inhibition DME0076 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0076 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0076 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0076 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME POR DME0076 XEOTICID XEO00898 GENEFORM mRNA DME0076 XEOTICID XEO00898 MOACRIVE Inhibition DME0076 XEOTICID XEO00920 XEO_NAME Perfluorohexanoic acid DME0076 XEOTICID XEO00920 XEO_TYPE Health or Environmental Toxicant(s) DME0076 XEOTICID XEO00920 XEO_CLAS Environmental Pollutant DME0076 XEOTICID XEO00920 DESCRIPT Perfluorohexanoic acid up-regulates the expression of DME POR DME0076 XEOTICID XEO00920 GENEFORM mRNA DME0076 XEOTICID XEO00920 MOACRIVE Induction DME0076 XEOTICID XEO00969 XEO_NAME Atrazine DME0076 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0076 XEOTICID XEO00969 XEO_CLAS Herbicide DME0076 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME POR DME0076 XEOTICID XEO00969 GENEFORM mRNA DME0076 XEOTICID XEO00969 MOACRIVE Induction DME0076 XEOTICID XEO01018 XEO_NAME Perfluorodecanoic acid DME0076 XEOTICID XEO01018 XEO_TYPE Health or Environmental Toxicant(s) DME0076 XEOTICID XEO01018 XEO_CLAS Acute Toxic Substance DME0076 XEOTICID XEO01018 DESCRIPT Perfluorodecanoic acid up-regulates the expression of DME POR DME0076 XEOTICID XEO01018 GENEFORM mRNA DME0076 XEOTICID XEO01018 MOACRIVE Induction DME0076 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0076 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0076 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0076 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME POR DME0076 XEOTICID XEO01031 GENEFORM mRNA DME0076 XEOTICID XEO01031 MOACRIVE Induction DME0076 XEOTICID XEO01166 XEO_NAME 6',7'-dihydroxybergamottin DME0076 XEOTICID XEO01166 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0076 XEOTICID XEO01166 XEO_CLAS Natural Product DME0076 XEOTICID XEO01166 DESCRIPT 6',7'-dihydroxybergamottin inhibits the drug-metabolizing activity of DME POR DME0076 XEOTICID XEO01166 GENEFORM Protein DME0076 XEOTICID XEO01166 MOACRIVE Inhibition DME0076 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0076 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0076 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME POR DME0076 XEOTICID XEO01226 GENEFORM mRNA DME0076 XEOTICID XEO01226 MOACRIVE Induction DME0076 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME0076 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0076 XEOTICID XEO01253 XEO_CLAS Natural Product DME0076 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde up-regulates the expression of DME POR DME0076 XEOTICID XEO01253 GENEFORM mRNA DME0076 XEOTICID XEO01253 MOACRIVE Induction DME0076 XEOTICID XEO01268 XEO_NAME Cycloheximide DME0076 XEOTICID XEO01268 XEO_TYPE Health or Environmental Toxicant(s) DME0076 XEOTICID XEO01268 XEO_CLAS Acute Toxic Substance DME0076 XEOTICID XEO01268 DESCRIPT Cycloheximide inhibits the drug-metabolizing activity of DME POR DME0076 XEOTICID XEO01268 GENEFORM Protein DME0076 XEOTICID XEO01268 MOACRIVE Inhibition DME0076 XEOTICID XEO01284 XEO_NAME Dust DME0076 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0076 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0076 XEOTICID XEO01284 DESCRIPT Dust up-regulates the expression of DME POR DME0076 XEOTICID XEO01284 GENEFORM mRNA DME0076 XEOTICID XEO01284 MOACRIVE Induction DME0076 XEOTICID XEO01302 XEO_NAME Fipronil DME0076 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0076 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0076 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME POR DME0076 XEOTICID XEO01302 GENEFORM mRNA DME0076 XEOTICID XEO01302 MOACRIVE Induction DME0076 XEOTICID XEO01328 XEO_NAME Hemin DME0076 XEOTICID XEO01328 XEO_TYPE Pharmaceutical Agent(s) DME0076 XEOTICID XEO01328 XEO_CLAS Approved/Marketed Drug DME0076 XEOTICID XEO01328 DESCRIPT Hemin inhibits the drug-metabolizing activity of DME POR DME0076 XEOTICID XEO01328 GENEFORM Protein DME0076 XEOTICID XEO01328 MOACRIVE Inhibition DME0076 XEOTICID XEO01335 XEO_NAME Hyperforin DME0076 XEOTICID XEO01335 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0076 XEOTICID XEO01335 XEO_CLAS Natural Product DME0076 XEOTICID XEO01335 DESCRIPT Hyperforin up-regulates the expression of DME POR DME0076 XEOTICID XEO01335 GENEFORM mRNA DME0076 XEOTICID XEO01335 MOACRIVE Induction DME0076 XEOTICID XEO01511 XEO_NAME Vitallium DME0076 XEOTICID XEO01511 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0076 XEOTICID XEO01511 XEO_CLAS Natural Mixture DME0076 XEOTICID XEO01511 DESCRIPT Vitallium up-regulates the expression of DME POR DME0076 XEOTICID XEO01511 GENEFORM mRNA DME0076 XEOTICID XEO01511 MOACRIVE Induction DME0076 XEOTICID XEO01605 XEO_NAME Pentachlorophenol DME0076 XEOTICID XEO01605 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0076 XEOTICID XEO01605 XEO_CLAS Pesticide/Insecticide DME0076 XEOTICID XEO01605 DESCRIPT Pentachlorophenol up-regulates the expression of DME POR DME0076 XEOTICID XEO01605 GENEFORM mRNA DME0076 XEOTICID XEO01605 MOACRIVE Induction DME0077 DME___ID DME0077 DME0077 DME_NAME Aldehyde dehydrogenase 2 (ALDH2) DME0077 SPESNAME Homo sapiens DME0077 XEOTICID XEO00018 XEO_NAME Cyclophosphamide DME0077 XEOTICID XEO00018 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00018 XEO_CLAS Approved/Marketed Drug DME0077 XEOTICID XEO00018 DESCRIPT Cyclophosphamide up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO00018 GENEFORM mRNA DME0077 XEOTICID XEO00018 MOACRIVE Induction DME0077 XEOTICID XEO00028 XEO_NAME Disulfiram DME0077 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0077 XEOTICID XEO00028 DESCRIPT Disulfiram inhibits the drug-metabolizing activity of DME ALDH2 DME0077 XEOTICID XEO00028 GENEFORM Protein DME0077 XEOTICID XEO00028 MOACRIVE Inhibition DME0077 XEOTICID XEO00029 XEO_NAME Valproic acid DME0077 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0077 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO00029 GENEFORM mRNA DME0077 XEOTICID XEO00029 MOACRIVE Induction DME0077 XEOTICID XEO00151 XEO_NAME Imatinib mesylate DME0077 XEOTICID XEO00151 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00151 XEO_CLAS Approved/Marketed Drug DME0077 XEOTICID XEO00151 DESCRIPT Imatinib mesylate inhibits the expression of DME ALDH2 DME0077 XEOTICID XEO00151 GENEFORM mRNA DME0077 XEOTICID XEO00151 MOACRIVE Inhibition DME0077 XEOTICID XEO00168 XEO_NAME Decitabine DME0077 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0077 XEOTICID XEO00168 DESCRIPT Decitabine up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO00168 GENEFORM mRNA DME0077 XEOTICID XEO00168 MOACRIVE Induction DME0077 XEOTICID XEO00181 XEO_NAME Dasatinib DME0077 XEOTICID XEO00181 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00181 XEO_CLAS Approved/Marketed Drug DME0077 XEOTICID XEO00181 DESCRIPT Dasatinib up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO00181 GENEFORM mRNA DME0077 XEOTICID XEO00181 MOACRIVE Induction DME0077 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0077 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0077 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ALDH2 DME0077 XEOTICID XEO00217 GENEFORM mRNA DME0077 XEOTICID XEO00217 MOACRIVE Inhibition DME0077 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0077 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0077 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO00241 GENEFORM mRNA DME0077 XEOTICID XEO00241 MOACRIVE Induction DME0077 XEOTICID XEO00253 XEO_NAME Tretinoin DME0077 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0077 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO00253 GENEFORM mRNA DME0077 XEOTICID XEO00253 MOACRIVE Induction DME0077 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0077 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0077 XEOTICID XEO00430 DESCRIPT Hydroquinone up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO00430 GENEFORM mRNA DME0077 XEOTICID XEO00430 MOACRIVE Induction DME0077 XEOTICID XEO00538 XEO_NAME Quercetin DME0077 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0077 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME ALDH2 DME0077 XEOTICID XEO00538 GENEFORM Protein DME0077 XEOTICID XEO00538 MOACRIVE Inhibition DME0077 XEOTICID XEO00539 XEO_NAME Ethanol DME0077 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0077 XEOTICID XEO00539 DESCRIPT Ethanol up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO00539 GENEFORM mRNA DME0077 XEOTICID XEO00539 MOACRIVE Induction DME0077 XEOTICID XEO00568 XEO_NAME Resveratrol DME0077 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0077 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO00568 GENEFORM mRNA DME0077 XEOTICID XEO00568 MOACRIVE Induction DME0077 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0077 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0077 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO00632 GENEFORM mRNA DME0077 XEOTICID XEO00632 MOACRIVE Induction DME0077 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0077 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0077 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0077 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME ALDH2 DME0077 XEOTICID XEO00806 GENEFORM mRNA DME0077 XEOTICID XEO00806 MOACRIVE Inhibition DME0077 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0077 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0077 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0077 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME ALDH2 DME0077 XEOTICID XEO00821 GENEFORM mRNA DME0077 XEOTICID XEO00821 MOACRIVE Inhibition DME0077 XEOTICID XEO00869 XEO_NAME 4-hydroxy-2-nonenal DME0077 XEOTICID XEO00869 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO00869 XEO_CLAS Investigative Agent DME0077 XEOTICID XEO00869 DESCRIPT 4-hydroxy-2-nonenal inhibits the drug-metabolizing activity of DME ALDH2 DME0077 XEOTICID XEO00869 GENEFORM Protein DME0077 XEOTICID XEO00869 MOACRIVE Inhibition DME0077 XEOTICID XEO00919 XEO_NAME Particulate matter DME0077 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0077 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0077 XEOTICID XEO00919 DESCRIPT Particulate matter up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO00919 GENEFORM mRNA DME0077 XEOTICID XEO00919 MOACRIVE Induction DME0077 XEOTICID XEO00969 XEO_NAME Atrazine DME0077 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0077 XEOTICID XEO00969 XEO_CLAS Herbicide DME0077 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO00969 GENEFORM mRNA DME0077 XEOTICID XEO00969 MOACRIVE Induction DME0077 XEOTICID XEO00996 XEO_NAME Benzaldehydes DME0077 XEOTICID XEO00996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0077 XEOTICID XEO00996 XEO_CLAS Natural Product DME0077 XEOTICID XEO00996 DESCRIPT Benzaldehydes inhibits the drug-metabolizing activity of DME ALDH2 DME0077 XEOTICID XEO00996 GENEFORM Protein DME0077 XEOTICID XEO00996 MOACRIVE Inhibition DME0077 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0077 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0077 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0077 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME ALDH2 DME0077 XEOTICID XEO00999 GENEFORM mRNA DME0077 XEOTICID XEO00999 MOACRIVE Inhibition DME0077 XEOTICID XEO01186 XEO_NAME Acrolein DME0077 XEOTICID XEO01186 XEO_TYPE Health or Environmental Toxicant(s) DME0077 XEOTICID XEO01186 XEO_CLAS Acute Toxic Substance DME0077 XEOTICID XEO01186 DESCRIPT Acrolein inhibits the drug-metabolizing activity of DME ALDH2 DME0077 XEOTICID XEO01186 GENEFORM Protein DME0077 XEOTICID XEO01186 MOACRIVE Inhibition DME0077 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0077 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0077 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO01226 GENEFORM mRNA DME0077 XEOTICID XEO01226 MOACRIVE Induction DME0077 XEOTICID XEO01284 XEO_NAME Dust DME0077 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0077 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0077 XEOTICID XEO01284 DESCRIPT Dust inhibits the expression of DME ALDH2 DME0077 XEOTICID XEO01284 GENEFORM mRNA DME0077 XEOTICID XEO01284 MOACRIVE Inhibition DME0077 XEOTICID XEO01336 XEO_NAME ICG-001 DME0077 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0077 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO01336 GENEFORM mRNA DME0077 XEOTICID XEO01336 MOACRIVE Induction DME0077 XEOTICID XEO01385 XEO_NAME N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide DME0077 XEOTICID XEO01385 XEO_TYPE Health or Environmental Toxicant(s) DME0077 XEOTICID XEO01385 XEO_CLAS Acute Toxic Substance DME0077 XEOTICID XEO01385 DESCRIPT N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide induces the drug-metabolizing activity of DME ALDH2 DME0077 XEOTICID XEO01385 GENEFORM Protein DME0077 XEOTICID XEO01385 MOACRIVE Induction DME0077 XEOTICID XEO01393 XEO_NAME NCS-382 DME0077 XEOTICID XEO01393 XEO_TYPE Pharmaceutical Agent(s) DME0077 XEOTICID XEO01393 XEO_CLAS Preclinical/Patented Drug DME0077 XEOTICID XEO01393 DESCRIPT NCS-382 up-regulates the expression of DME ALDH2 DME0077 XEOTICID XEO01393 GENEFORM mRNA DME0077 XEOTICID XEO01393 MOACRIVE Induction DME0077 XEOTICID XEO01416 XEO_NAME Oxadiazon DME0077 XEOTICID XEO01416 XEO_TYPE Health or Environmental Toxicant(s) DME0077 XEOTICID XEO01416 XEO_CLAS Environmental Pollutant DME0077 XEOTICID XEO01416 DESCRIPT Oxadiazon inhibits the expression of DME ALDH2 DME0077 XEOTICID XEO01416 GENEFORM mRNA DME0077 XEOTICID XEO01416 MOACRIVE Inhibition DME0077 XEOTICID XEO01574 XEO_NAME Plant extracts DME0077 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0077 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0077 XEOTICID XEO01574 DESCRIPT Plant extracts induces the drug-metabolizing activity of DME ALDH2 DME0077 XEOTICID XEO01574 GENEFORM Protein DME0077 XEOTICID XEO01574 MOACRIVE Induction DME0078 DME___ID DME0078 DME0078 DME_NAME Adenine phosphoribosyltransferase (APRT) DME0078 SPESNAME Homo sapiens DME0078 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0078 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0078 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0078 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME APRT DME0078 XEOTICID XEO00117 GENEFORM mRNA DME0078 XEOTICID XEO00117 MOACRIVE Inhibition DME0078 XEOTICID XEO00213 XEO_NAME Aspirin DME0078 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0078 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0078 XEOTICID XEO00213 DESCRIPT Aspirin inhibits the expression of DME APRT DME0078 XEOTICID XEO00213 GENEFORM mRNA DME0078 XEOTICID XEO00213 MOACRIVE Inhibition DME0078 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0078 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0078 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0078 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME APRT DME0078 XEOTICID XEO00292 GENEFORM mRNA DME0078 XEOTICID XEO00292 MOACRIVE Induction DME0078 XEOTICID XEO00435 XEO_NAME Urethane DME0078 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0078 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0078 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME APRT DME0078 XEOTICID XEO00435 GENEFORM mRNA DME0078 XEOTICID XEO00435 MOACRIVE Inhibition DME0078 XEOTICID XEO00557 XEO_NAME Genistein DME0078 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0078 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0078 XEOTICID XEO00557 DESCRIPT Genistein induces the drug-metabolizing activity of DME APRT DME0078 XEOTICID XEO00557 GENEFORM Protein DME0078 XEOTICID XEO00557 MOACRIVE Induction DME0078 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0078 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0078 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0078 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the drug-metabolizing activity of DME APRT DME0078 XEOTICID XEO00632 GENEFORM Protein DME0078 XEOTICID XEO00632 MOACRIVE Inhibition DME0078 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0078 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0078 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0078 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME APRT DME0078 XEOTICID XEO00723 GENEFORM mRNA DME0078 XEOTICID XEO00723 MOACRIVE Inhibition DME0078 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0078 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0078 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0078 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME APRT DME0078 XEOTICID XEO00772 GENEFORM mRNA DME0078 XEOTICID XEO00772 MOACRIVE Inhibition DME0078 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0078 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0078 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0078 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME APRT DME0078 XEOTICID XEO00821 GENEFORM mRNA DME0078 XEOTICID XEO00821 MOACRIVE Inhibition DME0078 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0078 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0078 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0078 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid up-regulates the expression of DME APRT DME0078 XEOTICID XEO00921 GENEFORM mRNA DME0078 XEOTICID XEO00921 MOACRIVE Induction DME0078 XEOTICID XEO00969 XEO_NAME Atrazine DME0078 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0078 XEOTICID XEO00969 XEO_CLAS Herbicide DME0078 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME APRT DME0078 XEOTICID XEO00969 GENEFORM mRNA DME0078 XEOTICID XEO00969 MOACRIVE Induction DME0078 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0078 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0078 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0078 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME APRT DME0078 XEOTICID XEO01324 GENEFORM mRNA DME0078 XEOTICID XEO01324 MOACRIVE Inhibition DME0078 XEOTICID XEO01336 XEO_NAME ICG-001 DME0078 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0078 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0078 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME APRT DME0078 XEOTICID XEO01336 GENEFORM mRNA DME0078 XEOTICID XEO01336 MOACRIVE Inhibition DME0078 XEOTICID XEO01513 XEO_NAME Beauvericin DME0078 XEOTICID XEO01513 XEO_TYPE Health or Environmental Toxicant(s) DME0078 XEOTICID XEO01513 XEO_CLAS Mycotoxin DME0078 XEOTICID XEO01513 DESCRIPT Beauvericin inhibits the expression of DME APRT DME0078 XEOTICID XEO01513 GENEFORM mRNA DME0078 XEOTICID XEO01513 MOACRIVE Inhibition DME0079 DME___ID DME0079 DME0079 DME_NAME Alkaline phosphatase (ALPL) DME0079 SPESNAME Homo sapiens DME0079 XEOTICID XEO00029 XEO_NAME Valproic acid DME0079 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00029 DESCRIPT Valproic acid induces the drug-metabolizing activity of DME ALPL DME0079 XEOTICID XEO00029 GENEFORM Protein DME0079 XEOTICID XEO00029 MOACRIVE Induction DME0079 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0079 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00035 DESCRIPT Fenofibrate inhibits the expression of DME ALPL DME0079 XEOTICID XEO00035 GENEFORM mRNA DME0079 XEOTICID XEO00035 MOACRIVE Inhibition DME0079 XEOTICID XEO00073 XEO_NAME Procaine DME0079 XEOTICID XEO00073 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00073 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00073 DESCRIPT Procaine up-regulates the expression of DME ALPL DME0079 XEOTICID XEO00073 GENEFORM mRNA DME0079 XEOTICID XEO00073 MOACRIVE Induction DME0079 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0079 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME ALPL DME0079 XEOTICID XEO00088 GENEFORM mRNA DME0079 XEOTICID XEO00088 MOACRIVE Induction DME0079 XEOTICID XEO00094 XEO_NAME Progesterone DME0079 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00094 DESCRIPT Progesterone inhibits the drug-metabolizing activity of DME ALPL DME0079 XEOTICID XEO00094 GENEFORM Protein DME0079 XEOTICID XEO00094 MOACRIVE Inhibition DME0079 XEOTICID XEO00184 XEO_NAME Calcitriol DME0079 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00184 DESCRIPT Calcitriol induces the drug-metabolizing activity of DME ALPL DME0079 XEOTICID XEO00184 GENEFORM Protein DME0079 XEOTICID XEO00184 MOACRIVE Induction DME0079 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0079 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ALPL DME0079 XEOTICID XEO00217 GENEFORM mRNA DME0079 XEOTICID XEO00217 MOACRIVE Inhibition DME0079 XEOTICID XEO00220 XEO_NAME Chloramphenicol DME0079 XEOTICID XEO00220 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00220 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00220 DESCRIPT Chloramphenicol up-regulates the expression of DME ALPL DME0079 XEOTICID XEO00220 GENEFORM mRNA DME0079 XEOTICID XEO00220 MOACRIVE Induction DME0079 XEOTICID XEO00230 XEO_NAME Calcifediol DME0079 XEOTICID XEO00230 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00230 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00230 DESCRIPT Calcifediol induces the drug-metabolizing activity of DME ALPL DME0079 XEOTICID XEO00230 GENEFORM Protein DME0079 XEOTICID XEO00230 MOACRIVE Induction DME0079 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0079 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00241 DESCRIPT Cyclosporine induces the drug-metabolizing activity of DME ALPL DME0079 XEOTICID XEO00241 GENEFORM Protein DME0079 XEOTICID XEO00241 MOACRIVE Induction DME0079 XEOTICID XEO00253 XEO_NAME Tretinoin DME0079 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME ALPL DME0079 XEOTICID XEO00253 GENEFORM mRNA DME0079 XEOTICID XEO00253 MOACRIVE Induction DME0079 XEOTICID XEO00286 XEO_NAME Deferoxamine mesylate DME0079 XEOTICID XEO00286 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00286 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00286 DESCRIPT Deferoxamine mesylate inhibits the drug-metabolizing activity of DME ALPL DME0079 XEOTICID XEO00286 GENEFORM Protein DME0079 XEOTICID XEO00286 MOACRIVE Inhibition DME0079 XEOTICID XEO00371 XEO_NAME Pamidronate DME0079 XEOTICID XEO00371 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00371 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00371 DESCRIPT Pamidronate up-regulates the expression of DME ALPL DME0079 XEOTICID XEO00371 GENEFORM mRNA DME0079 XEOTICID XEO00371 MOACRIVE Induction DME0079 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0079 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00380 DESCRIPT Rosiglitazone inhibits the expression of DME ALPL DME0079 XEOTICID XEO00380 GENEFORM mRNA DME0079 XEOTICID XEO00380 MOACRIVE Inhibition DME0079 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0079 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the expression of DME ALPL DME0079 XEOTICID XEO00388 GENEFORM mRNA DME0079 XEOTICID XEO00388 MOACRIVE Inhibition DME0079 XEOTICID XEO00422 XEO_NAME Sodium fluoride F-18 DME0079 XEOTICID XEO00422 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00422 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00422 DESCRIPT Sodium fluoride F-18 up-regulates the expression of DME ALPL DME0079 XEOTICID XEO00422 GENEFORM mRNA DME0079 XEOTICID XEO00422 MOACRIVE Induction DME0079 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME0079 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00425 DESCRIPT Titanium dioxide up-regulates the expression of DME ALPL DME0079 XEOTICID XEO00425 GENEFORM mRNA DME0079 XEOTICID XEO00425 MOACRIVE Induction DME0079 XEOTICID XEO00459 XEO_NAME Falecalcitriol DME0079 XEOTICID XEO00459 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00459 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00459 DESCRIPT Falecalcitriol up-regulates the expression of DME ALPL DME0079 XEOTICID XEO00459 GENEFORM mRNA DME0079 XEOTICID XEO00459 MOACRIVE Induction DME0079 XEOTICID XEO00493 XEO_NAME Bezafibrate DME0079 XEOTICID XEO00493 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00493 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00493 DESCRIPT Bezafibrate inhibits the drug-metabolizing activity of DME ALPL DME0079 XEOTICID XEO00493 GENEFORM Protein DME0079 XEOTICID XEO00493 MOACRIVE Inhibition DME0079 XEOTICID XEO00502 XEO_NAME Glucosamine DME0079 XEOTICID XEO00502 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00502 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00502 DESCRIPT Glucosamine induces the drug-metabolizing activity of DME ALPL DME0079 XEOTICID XEO00502 GENEFORM Protein DME0079 XEOTICID XEO00502 MOACRIVE Induction DME0079 XEOTICID XEO00505 XEO_NAME Melatonin DME0079 XEOTICID XEO00505 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00505 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00505 DESCRIPT Melatonin induces the drug-metabolizing activity of DME ALPL DME0079 XEOTICID XEO00505 GENEFORM Protein DME0079 XEOTICID XEO00505 MOACRIVE Induction DME0079 XEOTICID XEO00534 XEO_NAME Aldosterone DME0079 XEOTICID XEO00534 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00534 XEO_CLAS Drug in Phase 1 Clinical Trial DME0079 XEOTICID XEO00534 DESCRIPT Aldosterone up-regulates the expression of DME ALPL DME0079 XEOTICID XEO00534 GENEFORM mRNA DME0079 XEOTICID XEO00534 MOACRIVE Induction DME0079 XEOTICID XEO00539 XEO_NAME Ethanol DME0079 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0079 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the expression of DME ALPL DME0079 XEOTICID XEO00539 GENEFORM mRNA DME0079 XEOTICID XEO00539 MOACRIVE Inhibition DME0079 XEOTICID XEO00621 XEO_NAME Chitosan DME0079 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME0079 XEOTICID XEO00621 DESCRIPT Chitosan induces the drug-metabolizing activity of DME ALPL DME0079 XEOTICID XEO00621 GENEFORM Protein DME0079 XEOTICID XEO00621 MOACRIVE Induction DME0079 XEOTICID XEO00636 XEO_NAME Xanthohumol DME0079 XEOTICID XEO00636 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00636 XEO_CLAS Drug in Phase 1 Clinical Trial DME0079 XEOTICID XEO00636 DESCRIPT Xanthohumol induces the drug-metabolizing activity of DME ALPL DME0079 XEOTICID XEO00636 GENEFORM Protein DME0079 XEOTICID XEO00636 MOACRIVE Induction DME0079 XEOTICID XEO00836 XEO_NAME Aluminum oxide DME0079 XEOTICID XEO00836 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00836 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00836 DESCRIPT Aluminum oxide up-regulates the expression of DME ALPL DME0079 XEOTICID XEO00836 GENEFORM mRNA DME0079 XEOTICID XEO00836 MOACRIVE Induction DME0079 XEOTICID XEO00837 XEO_NAME Calcium chloride DME0079 XEOTICID XEO00837 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00837 XEO_CLAS Approved/Marketed Drug DME0079 XEOTICID XEO00837 DESCRIPT Calcium chloride up-regulates the expression of DME ALPL DME0079 XEOTICID XEO00837 GENEFORM mRNA DME0079 XEOTICID XEO00837 MOACRIVE Induction DME0079 XEOTICID XEO00860 XEO_NAME Phytoestrogen DME0079 XEOTICID XEO00860 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0079 XEOTICID XEO00860 XEO_CLAS Natural Product DME0079 XEOTICID XEO00860 DESCRIPT Phytoestrogen up-regulates the expression of DME ALPL DME0079 XEOTICID XEO00860 GENEFORM mRNA DME0079 XEOTICID XEO00860 MOACRIVE Induction DME0079 XEOTICID XEO00885 XEO_NAME Eugenol DME0079 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0079 XEOTICID XEO00885 DESCRIPT Eugenol up-regulates the expression of DME ALPL DME0079 XEOTICID XEO00885 GENEFORM mRNA DME0079 XEOTICID XEO00885 MOACRIVE Induction DME0079 XEOTICID XEO00983 XEO_NAME Sodium hypochlorite DME0079 XEOTICID XEO00983 XEO_TYPE Health or Environmental Toxicant(s) DME0079 XEOTICID XEO00983 XEO_CLAS Environmental Pollutant DME0079 XEOTICID XEO00983 DESCRIPT Sodium hypochlorite up-regulates the expression of DME ALPL DME0079 XEOTICID XEO00983 GENEFORM mRNA DME0079 XEOTICID XEO00983 MOACRIVE Induction DME0079 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0079 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0079 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0079 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate induces the drug-metabolizing activity of DME ALPL DME0079 XEOTICID XEO01004 GENEFORM Protein DME0079 XEOTICID XEO01004 MOACRIVE Induction DME0079 XEOTICID XEO01179 XEO_NAME 8-prenylnaringenin DME0079 XEOTICID XEO01179 XEO_TYPE Health or Environmental Toxicant(s) DME0079 XEOTICID XEO01179 XEO_CLAS Biotoxin DME0079 XEOTICID XEO01179 DESCRIPT 8-prenylnaringenin induces the drug-metabolizing activity of DME ALPL DME0079 XEOTICID XEO01179 GENEFORM Protein DME0079 XEOTICID XEO01179 MOACRIVE Induction DME0079 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0079 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0079 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME ALPL DME0079 XEOTICID XEO01226 GENEFORM mRNA DME0079 XEOTICID XEO01226 MOACRIVE Inhibition DME0079 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0079 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0079 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0079 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME ALPL DME0079 XEOTICID XEO01305 GENEFORM mRNA DME0079 XEOTICID XEO01305 MOACRIVE Induction DME0079 XEOTICID XEO01323 XEO_NAME GSK-126 DME0079 XEOTICID XEO01323 XEO_TYPE Pharmaceutical Agent(s) DME0079 XEOTICID XEO01323 XEO_CLAS Preclinical/Patented Drug DME0079 XEOTICID XEO01323 DESCRIPT GSK-126 induces the drug-metabolizing activity of DME ALPL DME0079 XEOTICID XEO01323 GENEFORM Protein DME0079 XEOTICID XEO01323 MOACRIVE Induction DME0079 XEOTICID XEO01355 XEO_NAME Ketoglutaric acid DME0079 XEOTICID XEO01355 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0079 XEOTICID XEO01355 XEO_CLAS Natural Product DME0079 XEOTICID XEO01355 DESCRIPT Ketoglutaric acid up-regulates the expression of DME ALPL DME0079 XEOTICID XEO01355 GENEFORM mRNA DME0079 XEOTICID XEO01355 MOACRIVE Induction DME0079 XEOTICID XEO01503 XEO_NAME Cadmium DME0079 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0079 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0079 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the expression of DME ALPL DME0079 XEOTICID XEO01503 GENEFORM mRNA DME0079 XEOTICID XEO01503 MOACRIVE Inhibition DME0080 DME___ID DME0080 DME0080 DME_NAME Cytidine aminohydrolase (CDA) DME0080 SPESNAME Homo sapiens DME0080 XEOTICID XEO00029 XEO_NAME Valproic acid DME0080 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0080 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0080 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME CDA DME0080 XEOTICID XEO00029 GENEFORM mRNA DME0080 XEOTICID XEO00029 MOACRIVE Induction DME0080 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0080 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0080 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0080 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME CDA DME0080 XEOTICID XEO00117 GENEFORM mRNA DME0080 XEOTICID XEO00117 MOACRIVE Induction DME0080 XEOTICID XEO00184 XEO_NAME Calcitriol DME0080 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0080 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0080 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME CDA DME0080 XEOTICID XEO00184 GENEFORM mRNA DME0080 XEOTICID XEO00184 MOACRIVE Induction DME0080 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0080 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0080 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0080 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME CDA DME0080 XEOTICID XEO00186 GENEFORM mRNA DME0080 XEOTICID XEO00186 MOACRIVE Inhibition DME0080 XEOTICID XEO00195 XEO_NAME Crizotinib DME0080 XEOTICID XEO00195 XEO_TYPE Pharmaceutical Agent(s) DME0080 XEOTICID XEO00195 XEO_CLAS Approved/Marketed Drug DME0080 XEOTICID XEO00195 DESCRIPT Crizotinib inhibits the drug-metabolizing activity of DME CDA DME0080 XEOTICID XEO00195 GENEFORM Protein DME0080 XEOTICID XEO00195 MOACRIVE Inhibition DME0080 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0080 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0080 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0080 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME CDA DME0080 XEOTICID XEO00241 GENEFORM mRNA DME0080 XEOTICID XEO00241 MOACRIVE Induction DME0080 XEOTICID XEO00538 XEO_NAME Quercetin DME0080 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0080 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0080 XEOTICID XEO00538 DESCRIPT Quercetin induces the drug-metabolizing activity of DME CDA DME0080 XEOTICID XEO00538 GENEFORM Protein DME0080 XEOTICID XEO00538 MOACRIVE Induction DME0080 XEOTICID XEO00581 XEO_NAME MS-275 DME0080 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0080 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0080 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME CDA DME0080 XEOTICID XEO00581 GENEFORM mRNA DME0080 XEOTICID XEO00581 MOACRIVE Induction DME0080 XEOTICID XEO00600 XEO_NAME EP-101 DME0080 XEOTICID XEO00600 XEO_TYPE Pharmaceutical Agent(s) DME0080 XEOTICID XEO00600 XEO_CLAS Drug in Phase 1 Clinical Trial DME0080 XEOTICID XEO00600 DESCRIPT EP-101 inhibits the drug-metabolizing activity of DME CDA (IC50 = 0.113 microM) DME0080 XEOTICID XEO00600 GENEFORM Protein DME0080 XEOTICID XEO00600 MOACRIVE Inhibition DME0080 XEOTICID XEO00706 XEO_NAME Tripterine DME0080 XEOTICID XEO00706 XEO_TYPE Pharmaceutical Agent(s) DME0080 XEOTICID XEO00706 XEO_CLAS Preclinical/Patented Drug DME0080 XEOTICID XEO00706 DESCRIPT Tripterine up-regulates the expression of DME CDA DME0080 XEOTICID XEO00706 GENEFORM mRNA DME0080 XEOTICID XEO00706 MOACRIVE Induction DME0080 XEOTICID XEO00722 XEO_NAME Gardiquimod DME0080 XEOTICID XEO00722 XEO_TYPE Pharmaceutical Agent(s) DME0080 XEOTICID XEO00722 XEO_CLAS Preclinical/Patented Drug DME0080 XEOTICID XEO00722 DESCRIPT Gardiquimod inhibits the expression of DME CDA DME0080 XEOTICID XEO00722 GENEFORM mRNA DME0080 XEOTICID XEO00722 MOACRIVE Inhibition DME0080 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0080 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0080 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0080 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME CDA DME0080 XEOTICID XEO00723 GENEFORM mRNA DME0080 XEOTICID XEO00723 MOACRIVE Inhibition DME0080 XEOTICID XEO00747 XEO_NAME Cholecalciferol DME0080 XEOTICID XEO00747 XEO_TYPE Pharmaceutical Agent(s) DME0080 XEOTICID XEO00747 XEO_CLAS Approved/Marketed Drug DME0080 XEOTICID XEO00747 DESCRIPT Cholecalciferol up-regulates the expression of DME CDA DME0080 XEOTICID XEO00747 GENEFORM mRNA DME0080 XEOTICID XEO00747 MOACRIVE Induction DME0080 XEOTICID XEO00760 XEO_NAME Jinfukang DME0080 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0080 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0080 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME CDA DME0080 XEOTICID XEO00760 GENEFORM mRNA DME0080 XEOTICID XEO00760 MOACRIVE Induction DME0080 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0080 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0080 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0080 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME CDA DME0080 XEOTICID XEO00806 GENEFORM mRNA DME0080 XEOTICID XEO00806 MOACRIVE Induction DME0080 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0080 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0080 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0080 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate induces the drug-metabolizing activity of DME CDA DME0080 XEOTICID XEO01031 GENEFORM Protein DME0080 XEOTICID XEO01031 MOACRIVE Induction DME0080 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0080 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0080 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0080 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME CDA DME0080 XEOTICID XEO01305 GENEFORM mRNA DME0080 XEOTICID XEO01305 MOACRIVE Induction DME0080 XEOTICID XEO01503 XEO_NAME Cadmium DME0080 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0080 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0080 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME CDA DME0080 XEOTICID XEO01503 GENEFORM mRNA DME0080 XEOTICID XEO01503 MOACRIVE Induction DME0081 DME___ID DME0081 DME0081 DME_NAME Glutathione S-transferase alpha-2 (GSTA2) DME0081 SPESNAME Homo sapiens DME0081 XEOTICID XEO00053 XEO_NAME Leflunomide DME0081 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0081 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0081 XEOTICID XEO00053 DESCRIPT Leflunomide inhibits the expression of DME GSTA2 DME0081 XEOTICID XEO00053 GENEFORM mRNA DME0081 XEOTICID XEO00053 MOACRIVE Inhibition DME0081 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0081 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0081 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0081 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME GSTA2 DME0081 XEOTICID XEO00117 GENEFORM mRNA DME0081 XEOTICID XEO00117 MOACRIVE Inhibition DME0081 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0081 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0081 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0081 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the expression of DME GSTA2 DME0081 XEOTICID XEO00251 GENEFORM mRNA DME0081 XEOTICID XEO00251 MOACRIVE Inhibition DME0081 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0081 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0081 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0081 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME GSTA2 DME0081 XEOTICID XEO00410 GENEFORM Protein DME0081 XEOTICID XEO00410 MOACRIVE Inhibition DME0081 XEOTICID XEO00435 XEO_NAME Urethane DME0081 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0081 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0081 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME GSTA2 DME0081 XEOTICID XEO00435 GENEFORM mRNA DME0081 XEOTICID XEO00435 MOACRIVE Inhibition DME0081 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0081 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0081 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0081 XEOTICID XEO00582 DESCRIPT Diethyltoluamide up-regulates the expression of DME GSTA2 DME0081 XEOTICID XEO00582 GENEFORM mRNA DME0081 XEOTICID XEO00582 MOACRIVE Induction DME0081 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0081 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0081 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0081 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME GSTA2 DME0081 XEOTICID XEO00806 GENEFORM mRNA DME0081 XEOTICID XEO00806 MOACRIVE Inhibition DME0081 XEOTICID XEO00851 XEO_NAME Iprodione DME0081 XEOTICID XEO00851 XEO_TYPE Health or Environmental Toxicant(s) DME0081 XEOTICID XEO00851 XEO_CLAS Health Hazard/Toxicant DME0081 XEOTICID XEO00851 DESCRIPT Iprodione up-regulates the expression of DME GSTA2 DME0081 XEOTICID XEO00851 GENEFORM mRNA DME0081 XEOTICID XEO00851 MOACRIVE Induction DME0081 XEOTICID XEO00877 XEO_NAME Bilirubin DME0081 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0081 XEOTICID XEO00877 XEO_CLAS Natural Product DME0081 XEOTICID XEO00877 DESCRIPT Bilirubin up-regulates the expression of DME GSTA2 DME0081 XEOTICID XEO00877 GENEFORM mRNA DME0081 XEOTICID XEO00877 MOACRIVE Induction DME0081 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0081 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0081 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0081 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME GSTA2 DME0081 XEOTICID XEO00898 GENEFORM mRNA DME0081 XEOTICID XEO00898 MOACRIVE Inhibition DME0081 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0081 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0081 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0081 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME GSTA2 DME0081 XEOTICID XEO00905 GENEFORM mRNA DME0081 XEOTICID XEO00905 MOACRIVE Inhibition DME0081 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0081 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0081 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0081 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME GSTA2 DME0081 XEOTICID XEO00999 GENEFORM mRNA DME0081 XEOTICID XEO00999 MOACRIVE Inhibition DME0081 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0081 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0081 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0081 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME GSTA2 DME0081 XEOTICID XEO01004 GENEFORM mRNA DME0081 XEOTICID XEO01004 MOACRIVE Induction DME0081 XEOTICID XEO01219 XEO_NAME MG-132 DME0081 XEOTICID XEO01219 XEO_TYPE Pharmaceutical Agent(s) DME0081 XEOTICID XEO01219 XEO_CLAS Investigative Agent DME0081 XEOTICID XEO01219 DESCRIPT MG-132 up-regulates the expression of DME GSTA2 DME0081 XEOTICID XEO01219 GENEFORM mRNA DME0081 XEOTICID XEO01219 MOACRIVE Induction DME0081 XEOTICID XEO01343 XEO_NAME Indolo(3,2-B)carbazole DME0081 XEOTICID XEO01343 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0081 XEOTICID XEO01343 XEO_CLAS Natural Product DME0081 XEOTICID XEO01343 DESCRIPT Indolo(3,2-B)carbazole inhibits the expression of DME GSTA2 DME0081 XEOTICID XEO01343 GENEFORM mRNA DME0081 XEOTICID XEO01343 MOACRIVE Inhibition DME0081 XEOTICID XEO01348 XEO_NAME K-7174 DME0081 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0081 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0081 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME GSTA2 DME0081 XEOTICID XEO01348 GENEFORM mRNA DME0081 XEOTICID XEO01348 MOACRIVE Inhibition DME0081 XEOTICID XEO01362 XEO_NAME Lactacystin DME0081 XEOTICID XEO01362 XEO_TYPE Pharmaceutical Agent(s) DME0081 XEOTICID XEO01362 XEO_CLAS Drug in Phase 2 Clinical Trial DME0081 XEOTICID XEO01362 DESCRIPT Lactacystin up-regulates the expression of DME GSTA2 DME0081 XEOTICID XEO01362 GENEFORM mRNA DME0081 XEOTICID XEO01362 MOACRIVE Induction DME0081 XEOTICID XEO01502 XEO_NAME Azaspiracid DME0081 XEOTICID XEO01502 XEO_TYPE Health or Environmental Toxicant(s) DME0081 XEOTICID XEO01502 XEO_CLAS Biotoxin DME0081 XEOTICID XEO01502 DESCRIPT Azaspiracid inhibits the expression of DME GSTA2 DME0081 XEOTICID XEO01502 GENEFORM mRNA DME0081 XEOTICID XEO01502 MOACRIVE Inhibition DME0081 XEOTICID XEO01554 XEO_NAME Isoimperatorin DME0081 XEOTICID XEO01554 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0081 XEOTICID XEO01554 XEO_CLAS Natural Product DME0081 XEOTICID XEO01554 DESCRIPT Isoimperatorin up-regulates the expression of DME GSTA2 DME0081 XEOTICID XEO01554 GENEFORM mRNA DME0081 XEOTICID XEO01554 MOACRIVE Induction DME0083 DME___ID DME0083 DME0083 DME_NAME Methylenetetrahydrofolate reductase (MTHFR) DME0083 SPESNAME Homo sapiens DME0083 XEOTICID XEO00029 XEO_NAME Valproic acid DME0083 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0083 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0083 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME MTHFR DME0083 XEOTICID XEO00029 GENEFORM mRNA DME0083 XEOTICID XEO00029 MOACRIVE Induction DME0083 XEOTICID XEO00095 XEO_NAME Testosterone DME0083 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0083 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0083 XEOTICID XEO00095 DESCRIPT Testosterone induces the drug-metabolizing activity of DME MTHFR DME0083 XEOTICID XEO00095 GENEFORM Protein DME0083 XEOTICID XEO00095 MOACRIVE Induction DME0083 XEOTICID XEO00126 XEO_NAME Raloxifene hydrochloride DME0083 XEOTICID XEO00126 XEO_TYPE Pharmaceutical Agent(s) DME0083 XEOTICID XEO00126 XEO_CLAS Approved/Marketed Drug DME0083 XEOTICID XEO00126 DESCRIPT Raloxifene hydrochloride inhibits the expression of DME MTHFR DME0083 XEOTICID XEO00126 GENEFORM mRNA DME0083 XEOTICID XEO00126 MOACRIVE Inhibition DME0083 XEOTICID XEO00184 XEO_NAME Calcitriol DME0083 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0083 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0083 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME MTHFR DME0083 XEOTICID XEO00184 GENEFORM mRNA DME0083 XEOTICID XEO00184 MOACRIVE Induction DME0083 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0083 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0083 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0083 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME MTHFR DME0083 XEOTICID XEO00217 GENEFORM mRNA DME0083 XEOTICID XEO00217 MOACRIVE Inhibition DME0083 XEOTICID XEO00253 XEO_NAME Tretinoin DME0083 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0083 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0083 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME MTHFR DME0083 XEOTICID XEO00253 GENEFORM mRNA DME0083 XEOTICID XEO00253 MOACRIVE Inhibition DME0083 XEOTICID XEO00366 XEO_NAME Methotrexate DME0083 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0083 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0083 XEOTICID XEO00366 DESCRIPT Methotrexate up-regulates the expression of DME MTHFR DME0083 XEOTICID XEO00366 GENEFORM mRNA DME0083 XEOTICID XEO00366 MOACRIVE Induction DME0083 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0083 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0083 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0083 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME MTHFR DME0083 XEOTICID XEO00723 GENEFORM mRNA DME0083 XEOTICID XEO00723 MOACRIVE Inhibition DME0083 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0083 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0083 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0083 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME MTHFR DME0083 XEOTICID XEO00999 GENEFORM mRNA DME0083 XEOTICID XEO00999 MOACRIVE Inhibition DME0083 XEOTICID XEO01034 XEO_NAME Pentanal DME0083 XEOTICID XEO01034 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0083 XEOTICID XEO01034 XEO_CLAS Chemical Compound DME0083 XEOTICID XEO01034 DESCRIPT Pentanal inhibits the expression of DME MTHFR DME0083 XEOTICID XEO01034 GENEFORM mRNA DME0083 XEOTICID XEO01034 MOACRIVE Inhibition DME0083 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0083 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0083 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0083 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME MTHFR DME0083 XEOTICID XEO01226 GENEFORM mRNA DME0083 XEOTICID XEO01226 MOACRIVE Induction DME0083 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0083 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0083 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0083 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME MTHFR DME0083 XEOTICID XEO01324 GENEFORM mRNA DME0083 XEOTICID XEO01324 MOACRIVE Inhibition DME0083 XEOTICID XEO01331 XEO_NAME Homocysteine DME0083 XEOTICID XEO01331 XEO_TYPE Pharmaceutical Agent(s) DME0083 XEOTICID XEO01331 XEO_CLAS Drug in Phase 1 Clinical Trial DME0083 XEOTICID XEO01331 DESCRIPT Homocysteine induces the drug-metabolizing activity of DME MTHFR DME0083 XEOTICID XEO01331 GENEFORM Protein DME0083 XEOTICID XEO01331 MOACRIVE Induction DME0084 DME___ID DME0084 DME0084 DME_NAME Beta,beta-carotene 15,15'-dioxygenase (BCO1) DME0084 SPESNAME Homo sapiens DME0084 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0084 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0084 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0084 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME BCO1 DME0084 XEOTICID XEO00217 GENEFORM mRNA DME0084 XEOTICID XEO00217 MOACRIVE Inhibition DME0084 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0084 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0084 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0084 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME BCO1 DME0084 XEOTICID XEO00339 GENEFORM mRNA DME0084 XEOTICID XEO00339 MOACRIVE Inhibition DME0084 XEOTICID XEO00401 XEO_NAME Beta carotene DME0084 XEOTICID XEO00401 XEO_TYPE Pharmaceutical Agent(s) DME0084 XEOTICID XEO00401 XEO_CLAS Approved/Marketed Drug DME0084 XEOTICID XEO00401 DESCRIPT Beta carotene up-regulates the expression of DME BCO1 and leads to increasing the drug-metabolizing activity of this enzyme DME0084 XEOTICID XEO00401 GENEFORM Protein DME0084 XEOTICID XEO00401 MOACRIVE Induction DME0084 XEOTICID XEO00581 XEO_NAME MS-275 DME0084 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0084 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0084 XEOTICID XEO00581 DESCRIPT MS-275 inhibits the expression of DME BCO1 DME0084 XEOTICID XEO00581 GENEFORM mRNA DME0084 XEOTICID XEO00581 MOACRIVE Inhibition DME0084 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0084 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0084 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0084 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME BCO1 DME0084 XEOTICID XEO00999 GENEFORM mRNA DME0084 XEOTICID XEO00999 MOACRIVE Inhibition DME0084 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0084 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0084 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0084 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME BCO1 DME0084 XEOTICID XEO01004 GENEFORM mRNA DME0084 XEOTICID XEO01004 MOACRIVE Inhibition DME0084 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0084 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0084 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0084 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME BCO1 DME0084 XEOTICID XEO01226 GENEFORM mRNA DME0084 XEOTICID XEO01226 MOACRIVE Induction DME0084 XEOTICID XEO01457 XEO_NAME Ro-41-5253 DME0084 XEOTICID XEO01457 XEO_TYPE Pharmaceutical Agent(s) DME0084 XEOTICID XEO01457 XEO_CLAS Preclinical/Patented Drug DME0084 XEOTICID XEO01457 DESCRIPT Ro-41-5253 up-regulates the expression of DME BCO1 DME0084 XEOTICID XEO01457 GENEFORM mRNA DME0084 XEOTICID XEO01457 MOACRIVE Induction DME0086 DME___ID DME0086 DME0086 DME_NAME Bleomycin hydrolase (BLMH) DME0086 SPESNAME Homo sapiens DME0086 XEOTICID XEO00029 XEO_NAME Valproic acid DME0086 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0086 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0086 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME BLMH DME0086 XEOTICID XEO00029 GENEFORM mRNA DME0086 XEOTICID XEO00029 MOACRIVE Induction DME0086 XEOTICID XEO00213 XEO_NAME Aspirin DME0086 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0086 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0086 XEOTICID XEO00213 DESCRIPT Aspirin inhibits the expression of DME BLMH DME0086 XEOTICID XEO00213 GENEFORM mRNA DME0086 XEOTICID XEO00213 MOACRIVE Inhibition DME0086 XEOTICID XEO00253 XEO_NAME Tretinoin DME0086 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0086 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0086 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME BLMH DME0086 XEOTICID XEO00253 GENEFORM mRNA DME0086 XEOTICID XEO00253 MOACRIVE Inhibition DME0086 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0086 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0086 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0086 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME BLMH DME0086 XEOTICID XEO00292 GENEFORM mRNA DME0086 XEOTICID XEO00292 MOACRIVE Inhibition DME0086 XEOTICID XEO00334 XEO_NAME Cisplatin DME0086 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0086 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0086 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME BLMH DME0086 XEOTICID XEO00334 GENEFORM mRNA DME0086 XEOTICID XEO00334 MOACRIVE Induction DME0086 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0086 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0086 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0086 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME BLMH DME0086 XEOTICID XEO00410 GENEFORM Protein DME0086 XEOTICID XEO00410 MOACRIVE Inhibition DME0086 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0086 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0086 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0086 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME BLMH DME0086 XEOTICID XEO01226 GENEFORM mRNA DME0086 XEOTICID XEO01226 MOACRIVE Inhibition DME0087 DME___ID DME0087 DME0087 DME_NAME Aldo-keto reductase 1B1 (AKR1B1) DME0087 SPESNAME Homo sapiens DME0087 XEOTICID XEO00028 XEO_NAME Disulfiram DME0087 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0087 XEOTICID XEO00028 DESCRIPT Disulfiram up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO00028 GENEFORM mRNA DME0087 XEOTICID XEO00028 MOACRIVE Induction DME0087 XEOTICID XEO00159 XEO_NAME Bortezomib DME0087 XEOTICID XEO00159 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00159 XEO_CLAS Approved/Marketed Drug DME0087 XEOTICID XEO00159 DESCRIPT Bortezomib induces the drug-metabolizing activity of DME AKR1B1 DME0087 XEOTICID XEO00159 GENEFORM Protein DME0087 XEOTICID XEO00159 MOACRIVE Induction DME0087 XEOTICID XEO00177 XEO_NAME Sulindac DME0087 XEOTICID XEO00177 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00177 XEO_CLAS Approved/Marketed Drug DME0087 XEOTICID XEO00177 DESCRIPT Sulindac inhibits the drug-metabolizing activity of DME AKR1B1 (IC50 = 0.374 microM) DME0087 XEOTICID XEO00177 GENEFORM Protein DME0087 XEOTICID XEO00177 MOACRIVE Inhibition DME0087 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0087 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0087 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO00217 GENEFORM mRNA DME0087 XEOTICID XEO00217 MOACRIVE Induction DME0087 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0087 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0087 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO00241 GENEFORM mRNA DME0087 XEOTICID XEO00241 MOACRIVE Induction DME0087 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0087 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0087 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO00292 GENEFORM mRNA DME0087 XEOTICID XEO00292 MOACRIVE Induction DME0087 XEOTICID XEO00334 XEO_NAME Cisplatin DME0087 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0087 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the drug-metabolizing activity of DME AKR1B1 DME0087 XEOTICID XEO00334 GENEFORM Protein DME0087 XEOTICID XEO00334 MOACRIVE Inhibition DME0087 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0087 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0087 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME AKR1B1 DME0087 XEOTICID XEO00339 GENEFORM mRNA DME0087 XEOTICID XEO00339 MOACRIVE Inhibition DME0087 XEOTICID XEO00447 XEO_NAME Benzoic acid DME0087 XEOTICID XEO00447 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00447 XEO_CLAS Approved/Marketed Drug DME0087 XEOTICID XEO00447 DESCRIPT Benzoic acid up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO00447 GENEFORM mRNA DME0087 XEOTICID XEO00447 MOACRIVE Induction DME0087 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0087 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0087 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO00571 GENEFORM mRNA DME0087 XEOTICID XEO00571 MOACRIVE Induction DME0087 XEOTICID XEO00628 XEO_NAME SNK-860 DME0087 XEOTICID XEO00628 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00628 XEO_CLAS Drug in Phase 1 Clinical Trial DME0087 XEOTICID XEO00628 DESCRIPT SNK-860 inhibits the drug-metabolizing activity of DME AKR1B1 (IC50 = 0.009 microM) DME0087 XEOTICID XEO00628 GENEFORM Protein DME0087 XEOTICID XEO00628 MOACRIVE Inhibition DME0087 XEOTICID XEO00630 XEO_NAME Sorbinil DME0087 XEOTICID XEO00630 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00630 XEO_CLAS Drug in Phase 3 Clinical Trial DME0087 XEOTICID XEO00630 DESCRIPT Sorbinil inhibits the drug-metabolizing activity of DME AKR1B1 (IC50 = 0.067 microM) DME0087 XEOTICID XEO00630 GENEFORM Protein DME0087 XEOTICID XEO00630 MOACRIVE Inhibition DME0087 XEOTICID XEO00657 XEO_NAME Antimony DME0087 XEOTICID XEO00657 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00657 XEO_CLAS Drug in Phase 2 Clinical Trial DME0087 XEOTICID XEO00657 DESCRIPT Antimony inhibits the expression of DME AKR1B1 DME0087 XEOTICID XEO00657 GENEFORM mRNA DME0087 XEOTICID XEO00657 MOACRIVE Inhibition DME0087 XEOTICID XEO00659 XEO_NAME Exisulind DME0087 XEOTICID XEO00659 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00659 XEO_CLAS Drug in Phase 3 Clinical Trial DME0087 XEOTICID XEO00659 DESCRIPT Exisulind inhibits the drug-metabolizing activity of DME AKR1B1 DME0087 XEOTICID XEO00659 GENEFORM Protein DME0087 XEOTICID XEO00659 MOACRIVE Inhibition DME0087 XEOTICID XEO00688 XEO_NAME Zopolrestat DME0087 XEOTICID XEO00688 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00688 XEO_CLAS Preclinical/Patented Drug DME0087 XEOTICID XEO00688 DESCRIPT Zopolrestat inhibits the drug-metabolizing activity of DME AKR1B1 (IC50 = 0.0019 microM) DME0087 XEOTICID XEO00688 GENEFORM Protein DME0087 XEOTICID XEO00688 MOACRIVE Inhibition DME0087 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0087 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0087 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME AKR1B1 DME0087 XEOTICID XEO00723 GENEFORM mRNA DME0087 XEOTICID XEO00723 MOACRIVE Inhibition DME0087 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0087 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0087 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0087 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO00806 GENEFORM mRNA DME0087 XEOTICID XEO00806 MOACRIVE Induction DME0087 XEOTICID XEO00885 XEO_NAME Eugenol DME0087 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0087 XEOTICID XEO00885 DESCRIPT Eugenol up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO00885 GENEFORM mRNA DME0087 XEOTICID XEO00885 MOACRIVE Induction DME0087 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0087 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0087 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0087 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO00898 GENEFORM mRNA DME0087 XEOTICID XEO00898 MOACRIVE Induction DME0087 XEOTICID XEO00985 XEO_NAME Hexyl cinnamic aldehyde DME0087 XEOTICID XEO00985 XEO_TYPE Health or Environmental Toxicant(s) DME0087 XEOTICID XEO00985 XEO_CLAS Environmental Pollutant DME0087 XEOTICID XEO00985 DESCRIPT Hexyl cinnamic aldehyde up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO00985 GENEFORM mRNA DME0087 XEOTICID XEO00985 MOACRIVE Induction DME0087 XEOTICID XEO01006 XEO_NAME Dimethyl nitrosamine DME0087 XEOTICID XEO01006 XEO_TYPE Health or Environmental Toxicant(s) DME0087 XEOTICID XEO01006 XEO_CLAS Carcinogen DME0087 XEOTICID XEO01006 DESCRIPT Dimethyl nitrosamine inhibits the expression of DME AKR1B1 DME0087 XEOTICID XEO01006 GENEFORM mRNA DME0087 XEOTICID XEO01006 MOACRIVE Inhibition DME0087 XEOTICID XEO01016 XEO_NAME N-hexane DME0087 XEOTICID XEO01016 XEO_TYPE Health or Environmental Toxicant(s) DME0087 XEOTICID XEO01016 XEO_CLAS Health Hazard/Toxicant DME0087 XEOTICID XEO01016 DESCRIPT N-hexane up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO01016 GENEFORM mRNA DME0087 XEOTICID XEO01016 MOACRIVE Induction DME0087 XEOTICID XEO01023 XEO_NAME Sodium arsenate DME0087 XEOTICID XEO01023 XEO_TYPE Health or Environmental Toxicant(s) DME0087 XEOTICID XEO01023 XEO_CLAS Environmental Pollutant DME0087 XEOTICID XEO01023 DESCRIPT Sodium arsenate up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO01023 GENEFORM mRNA DME0087 XEOTICID XEO01023 MOACRIVE Induction DME0087 XEOTICID XEO01128 XEO_NAME Isopropanol DME0087 XEOTICID XEO01128 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO01128 XEO_CLAS Investigative Agent DME0087 XEOTICID XEO01128 DESCRIPT Isopropanol up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO01128 GENEFORM mRNA DME0087 XEOTICID XEO01128 MOACRIVE Induction DME0087 XEOTICID XEO01201 XEO_NAME Antimony potassium tartrate DME0087 XEOTICID XEO01201 XEO_TYPE Health or Environmental Toxicant(s) DME0087 XEOTICID XEO01201 XEO_CLAS Environmental Pollutant DME0087 XEOTICID XEO01201 DESCRIPT Antimony potassium tartrate up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO01201 GENEFORM mRNA DME0087 XEOTICID XEO01201 MOACRIVE Induction DME0087 XEOTICID XEO01219 XEO_NAME MG-132 DME0087 XEOTICID XEO01219 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO01219 XEO_CLAS Investigative Agent DME0087 XEOTICID XEO01219 DESCRIPT MG-132 up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO01219 GENEFORM mRNA DME0087 XEOTICID XEO01219 MOACRIVE Induction DME0087 XEOTICID XEO01233 XEO_NAME Phenethyl caffeate DME0087 XEOTICID XEO01233 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO01233 XEO_CLAS Drug in Phase 1 Clinical Trial DME0087 XEOTICID XEO01233 DESCRIPT Phenethyl caffeate inhibits the drug-metabolizing activity of DME AKR1B1 (IC50 = 0.57 microM) DME0087 XEOTICID XEO01233 GENEFORM Protein DME0087 XEOTICID XEO01233 MOACRIVE Inhibition DME0087 XEOTICID XEO01241 XEO_NAME CD-437 DME0087 XEOTICID XEO01241 XEO_TYPE Health or Environmental Toxicant(s) DME0087 XEOTICID XEO01241 XEO_CLAS Health Hazard/Toxicant DME0087 XEOTICID XEO01241 DESCRIPT CD-437 inhibits the expression of DME AKR1B1 DME0087 XEOTICID XEO01241 GENEFORM mRNA DME0087 XEOTICID XEO01241 MOACRIVE Inhibition DME0087 XEOTICID XEO01376 XEO_NAME Methyl salicylate DME0087 XEOTICID XEO01376 XEO_TYPE Pharmaceutical Agent(s) DME0087 XEOTICID XEO01376 XEO_CLAS Drug in Phase 1 Clinical Trial DME0087 XEOTICID XEO01376 DESCRIPT Methyl salicylate up-regulates the expression of DME AKR1B1 DME0087 XEOTICID XEO01376 GENEFORM mRNA DME0087 XEOTICID XEO01376 MOACRIVE Induction DME0087 XEOTICID XEO01397 XEO_NAME Nickel chloride DME0087 XEOTICID XEO01397 XEO_TYPE Health or Environmental Toxicant(s) DME0087 XEOTICID XEO01397 XEO_CLAS Acute Toxic Substance DME0087 XEOTICID XEO01397 DESCRIPT Nickel chloride inhibits the expression of DME AKR1B1 DME0087 XEOTICID XEO01397 GENEFORM mRNA DME0087 XEOTICID XEO01397 MOACRIVE Inhibition DME0087 XEOTICID XEO01433 XEO_NAME Pirinixic acid DME0087 XEOTICID XEO01433 XEO_TYPE Health or Environmental Toxicant(s) DME0087 XEOTICID XEO01433 XEO_CLAS Health Hazard/Toxicant DME0087 XEOTICID XEO01433 DESCRIPT Pirinixic acid inhibits the drug-metabolizing activity of DME AKR1B1 DME0087 XEOTICID XEO01433 GENEFORM Protein DME0087 XEOTICID XEO01433 MOACRIVE Inhibition DME0087 XEOTICID XEO01503 XEO_NAME Cadmium DME0087 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0087 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0087 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the expression of DME AKR1B1 DME0087 XEOTICID XEO01503 GENEFORM mRNA DME0087 XEOTICID XEO01503 MOACRIVE Inhibition DME0088 DME___ID DME0088 DME0088 DME_NAME Glutathione S-transferase pi (GSTP1) DME0088 SPESNAME Homo sapiens DME0088 XEOTICID XEO00013 XEO_NAME Celecoxib DME0088 XEOTICID XEO00013 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00013 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00013 DESCRIPT Celecoxib up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO00013 GENEFORM mRNA DME0088 XEOTICID XEO00013 MOACRIVE Induction DME0088 XEOTICID XEO00032 XEO_NAME Ethacrynic acid DME0088 XEOTICID XEO00032 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00032 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00032 DESCRIPT Ethacrynic acid inhibits the drug-metabolizing activity of DME GSTP1 in Human leukemia cell line (HL-60) (IC50 = 3.4 microM) DME0088 XEOTICID XEO00032 GENEFORM Protein DME0088 XEOTICID XEO00032 MOACRIVE Inhibition DME0088 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0088 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00037 DESCRIPT Fluorouracil up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO00037 GENEFORM mRNA DME0088 XEOTICID XEO00037 MOACRIVE Induction DME0088 XEOTICID XEO00045 XEO_NAME Haloperidol DME0088 XEOTICID XEO00045 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00045 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00045 DESCRIPT Haloperidol inhibits the expression of DME GSTP1 DME0088 XEOTICID XEO00045 GENEFORM mRNA DME0088 XEOTICID XEO00045 MOACRIVE Inhibition DME0088 XEOTICID XEO00053 XEO_NAME Leflunomide DME0088 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO00053 GENEFORM mRNA DME0088 XEOTICID XEO00053 MOACRIVE Induction DME0088 XEOTICID XEO00090 XEO_NAME Estradiol DME0088 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME GSTP1 DME0088 XEOTICID XEO00090 GENEFORM mRNA DME0088 XEOTICID XEO00090 MOACRIVE Inhibition DME0088 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0088 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00165 DESCRIPT Obeticholic acid inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00165 GENEFORM Protein DME0088 XEOTICID XEO00165 MOACRIVE Inhibition DME0088 XEOTICID XEO00168 XEO_NAME Decitabine DME0088 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00168 DESCRIPT Decitabine induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00168 GENEFORM Protein DME0088 XEOTICID XEO00168 MOACRIVE Induction DME0088 XEOTICID XEO00200 XEO_NAME Tetracycline DME0088 XEOTICID XEO00200 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00200 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00200 DESCRIPT Tetracycline inhibits the expression of DME GSTP1 DME0088 XEOTICID XEO00200 GENEFORM mRNA DME0088 XEOTICID XEO00200 MOACRIVE Inhibition DME0088 XEOTICID XEO00207 XEO_NAME Oxaliplatin DME0088 XEOTICID XEO00207 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00207 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00207 DESCRIPT Oxaliplatin up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO00207 GENEFORM mRNA DME0088 XEOTICID XEO00207 MOACRIVE Induction DME0088 XEOTICID XEO00209 XEO_NAME Clozapine DME0088 XEOTICID XEO00209 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00209 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00209 DESCRIPT Clozapine inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00209 GENEFORM Protein DME0088 XEOTICID XEO00209 MOACRIVE Inhibition DME0088 XEOTICID XEO00223 XEO_NAME Rifampin DME0088 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00223 DESCRIPT Rifampin induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00223 GENEFORM Protein DME0088 XEOTICID XEO00223 MOACRIVE Induction DME0088 XEOTICID XEO00285 XEO_NAME Clomipramine hydrochloride DME0088 XEOTICID XEO00285 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00285 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00285 DESCRIPT Clomipramine hydrochloride inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00285 GENEFORM Protein DME0088 XEOTICID XEO00285 MOACRIVE Inhibition DME0088 XEOTICID XEO00290 XEO_NAME Dopamine hydrochloride DME0088 XEOTICID XEO00290 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00290 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00290 DESCRIPT Dopamine hydrochloride inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00290 GENEFORM Protein DME0088 XEOTICID XEO00290 MOACRIVE Inhibition DME0088 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0088 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00292 GENEFORM Protein DME0088 XEOTICID XEO00292 MOACRIVE Induction DME0088 XEOTICID XEO00300 XEO_NAME Imipramine hydrochloride DME0088 XEOTICID XEO00300 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00300 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00300 DESCRIPT Imipramine hydrochloride inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00300 GENEFORM Protein DME0088 XEOTICID XEO00300 MOACRIVE Inhibition DME0088 XEOTICID XEO00324 XEO_NAME Selenomethionine Se-75 DME0088 XEOTICID XEO00324 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00324 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00324 DESCRIPT Selenomethionine Se-75 induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00324 GENEFORM Protein DME0088 XEOTICID XEO00324 MOACRIVE Induction DME0088 XEOTICID XEO00334 XEO_NAME Cisplatin DME0088 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO00334 GENEFORM mRNA DME0088 XEOTICID XEO00334 MOACRIVE Induction DME0088 XEOTICID XEO00337 XEO_NAME Amitriptyline DME0088 XEOTICID XEO00337 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00337 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00337 DESCRIPT Amitriptyline inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00337 GENEFORM Protein DME0088 XEOTICID XEO00337 MOACRIVE Inhibition DME0088 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0088 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO00339 GENEFORM mRNA DME0088 XEOTICID XEO00339 MOACRIVE Induction DME0088 XEOTICID XEO00354 XEO_NAME Doxepin DME0088 XEOTICID XEO00354 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00354 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00354 DESCRIPT Doxepin inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00354 GENEFORM Protein DME0088 XEOTICID XEO00354 MOACRIVE Inhibition DME0088 XEOTICID XEO00362 XEO_NAME Hydralazine DME0088 XEOTICID XEO00362 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00362 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00362 DESCRIPT Hydralazine up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO00362 GENEFORM mRNA DME0088 XEOTICID XEO00362 MOACRIVE Induction DME0088 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0088 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00388 GENEFORM Protein DME0088 XEOTICID XEO00388 MOACRIVE Inhibition DME0088 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0088 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00410 GENEFORM Protein DME0088 XEOTICID XEO00410 MOACRIVE Inhibition DME0088 XEOTICID XEO00442 XEO_NAME Chlorobenzene DME0088 XEOTICID XEO00442 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00442 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00442 DESCRIPT Chlorobenzene induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00442 GENEFORM Protein DME0088 XEOTICID XEO00442 MOACRIVE Induction DME0088 XEOTICID XEO00449 XEO_NAME Artemisinine DME0088 XEOTICID XEO00449 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00449 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00449 DESCRIPT Artemisinine inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00449 GENEFORM Protein DME0088 XEOTICID XEO00449 MOACRIVE Inhibition DME0088 XEOTICID XEO00450 XEO_NAME Aclarubicin DME0088 XEOTICID XEO00450 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00450 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO00450 DESCRIPT Aclarubicin induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00450 GENEFORM Protein DME0088 XEOTICID XEO00450 MOACRIVE Induction DME0088 XEOTICID XEO00538 XEO_NAME Quercetin DME0088 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0088 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME GSTP1 DME0088 XEOTICID XEO00538 GENEFORM mRNA DME0088 XEOTICID XEO00538 MOACRIVE Inhibition DME0088 XEOTICID XEO00540 XEO_NAME Artesunate DME0088 XEOTICID XEO00540 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00540 XEO_CLAS Drug in Phase 2 Clinical Trial DME0088 XEOTICID XEO00540 DESCRIPT Artesunate inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00540 GENEFORM Protein DME0088 XEOTICID XEO00540 MOACRIVE Inhibition DME0088 XEOTICID XEO00542 XEO_NAME Glutathione DME0088 XEOTICID XEO00542 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00542 XEO_CLAS Drug in Phase 2 Clinical Trial DME0088 XEOTICID XEO00542 DESCRIPT Glutathione inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00542 GENEFORM Protein DME0088 XEOTICID XEO00542 MOACRIVE Inhibition DME0088 XEOTICID XEO00547 XEO_NAME Vitamin E DME0088 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0088 XEOTICID XEO00547 DESCRIPT Vitamin E up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO00547 GENEFORM mRNA DME0088 XEOTICID XEO00547 MOACRIVE Induction DME0088 XEOTICID XEO00579 XEO_NAME SGX301 DME0088 XEOTICID XEO00579 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00579 XEO_CLAS Drug in Phase 3 Clinical Trial DME0088 XEOTICID XEO00579 DESCRIPT SGX301 inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00579 GENEFORM Protein DME0088 XEOTICID XEO00579 MOACRIVE Inhibition DME0088 XEOTICID XEO00597 XEO_NAME Camptothecin DME0088 XEOTICID XEO00597 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00597 XEO_CLAS Drug in Phase 2 Clinical Trial DME0088 XEOTICID XEO00597 DESCRIPT Camptothecin induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00597 GENEFORM Protein DME0088 XEOTICID XEO00597 MOACRIVE Induction DME0088 XEOTICID XEO00599 XEO_NAME Tetradecanoylphorbol acetate DME0088 XEOTICID XEO00599 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00599 XEO_CLAS Drug in Phase 1 Clinical Trial DME0088 XEOTICID XEO00599 DESCRIPT Tetradecanoylphorbol acetate up-regulates the expression of DME GSTP1 and leads to increasing the drug-metabolizing activity of this enzyme DME0088 XEOTICID XEO00599 GENEFORM Protein DME0088 XEOTICID XEO00599 MOACRIVE Induction DME0088 XEOTICID XEO00605 XEO_NAME Oltipraz DME0088 XEOTICID XEO00605 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00605 XEO_CLAS Drug in Phase 3 Clinical Trial DME0088 XEOTICID XEO00605 DESCRIPT Oltipraz up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO00605 GENEFORM mRNA DME0088 XEOTICID XEO00605 MOACRIVE Induction DME0088 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME0088 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME0088 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the expression of DME GSTP1 DME0088 XEOTICID XEO00613 GENEFORM mRNA DME0088 XEOTICID XEO00613 MOACRIVE Inhibition DME0088 XEOTICID XEO00614 XEO_NAME Salvin DME0088 XEOTICID XEO00614 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00614 XEO_CLAS Drug in Phase 2 Clinical Trial DME0088 XEOTICID XEO00614 DESCRIPT Salvin up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO00614 GENEFORM mRNA DME0088 XEOTICID XEO00614 MOACRIVE Induction DME0088 XEOTICID XEO00615 XEO_NAME Procysteine DME0088 XEOTICID XEO00615 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00615 XEO_CLAS Drug in Phase 2 Clinical Trial DME0088 XEOTICID XEO00615 DESCRIPT Procysteine up-regulates the expression of DME GSTP1 and leads to increasing the drug-metabolizing activity of this enzyme DME0088 XEOTICID XEO00615 GENEFORM Protein DME0088 XEOTICID XEO00615 MOACRIVE Induction DME0088 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0088 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0088 XEOTICID XEO00632 DESCRIPT Sodium arsenite induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00632 GENEFORM Protein DME0088 XEOTICID XEO00632 MOACRIVE Induction DME0088 XEOTICID XEO00636 XEO_NAME Xanthohumol DME0088 XEOTICID XEO00636 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00636 XEO_CLAS Drug in Phase 1 Clinical Trial DME0088 XEOTICID XEO00636 DESCRIPT Xanthohumol up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO00636 GENEFORM mRNA DME0088 XEOTICID XEO00636 MOACRIVE Induction DME0088 XEOTICID XEO00665 XEO_NAME Bufalin DME0088 XEOTICID XEO00665 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00665 XEO_CLAS Drug in Phase 2 Clinical Trial DME0088 XEOTICID XEO00665 DESCRIPT Bufalin inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00665 GENEFORM Protein DME0088 XEOTICID XEO00665 MOACRIVE Inhibition DME0088 XEOTICID XEO00683 XEO_NAME Curcumin DME0088 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0088 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00683 GENEFORM Protein DME0088 XEOTICID XEO00683 MOACRIVE Inhibition DME0088 XEOTICID XEO00755 XEO_NAME Coal tar DME0088 XEOTICID XEO00755 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0088 XEOTICID XEO00755 XEO_CLAS Natural Mixture DME0088 XEOTICID XEO00755 DESCRIPT Coal tar up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO00755 GENEFORM mRNA DME0088 XEOTICID XEO00755 MOACRIVE Induction DME0088 XEOTICID XEO00757 XEO_NAME Apple polyphenol extract DME0088 XEOTICID XEO00757 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0088 XEOTICID XEO00757 XEO_CLAS Plant Extract DME0088 XEOTICID XEO00757 DESCRIPT Apple polyphenol extract up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO00757 GENEFORM mRNA DME0088 XEOTICID XEO00757 MOACRIVE Induction DME0088 XEOTICID XEO00801 XEO_NAME WR-1065 DME0088 XEOTICID XEO00801 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00801 XEO_CLAS Investigative Agent DME0088 XEOTICID XEO00801 DESCRIPT WR-1065 inhibits the expression of DME GSTP1 DME0088 XEOTICID XEO00801 GENEFORM mRNA DME0088 XEOTICID XEO00801 MOACRIVE Inhibition DME0088 XEOTICID XEO00813 XEO_NAME Dinophysistoxin 1 DME0088 XEOTICID XEO00813 XEO_TYPE Health or Environmental Toxicant(s) DME0088 XEOTICID XEO00813 XEO_CLAS Biotoxin DME0088 XEOTICID XEO00813 DESCRIPT Dinophysistoxin 1 up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO00813 GENEFORM mRNA DME0088 XEOTICID XEO00813 MOACRIVE Induction DME0088 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0088 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0088 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00818 GENEFORM Protein DME0088 XEOTICID XEO00818 MOACRIVE Induction DME0088 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0088 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0088 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0088 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME GSTP1 DME0088 XEOTICID XEO00821 GENEFORM mRNA DME0088 XEOTICID XEO00821 MOACRIVE Inhibition DME0088 XEOTICID XEO00858 XEO_NAME Flavonoids DME0088 XEOTICID XEO00858 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0088 XEOTICID XEO00858 XEO_CLAS Natural Mixture DME0088 XEOTICID XEO00858 DESCRIPT Flavonoids inhibits the expression of DME GSTP1 DME0088 XEOTICID XEO00858 GENEFORM mRNA DME0088 XEOTICID XEO00858 MOACRIVE Inhibition DME0088 XEOTICID XEO00869 XEO_NAME 4-hydroxy-2-nonenal DME0088 XEOTICID XEO00869 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00869 XEO_CLAS Investigative Agent DME0088 XEOTICID XEO00869 DESCRIPT 4-hydroxy-2-nonenal inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00869 GENEFORM Protein DME0088 XEOTICID XEO00869 MOACRIVE Inhibition DME0088 XEOTICID XEO00877 XEO_NAME Bilirubin DME0088 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0088 XEOTICID XEO00877 XEO_CLAS Natural Product DME0088 XEOTICID XEO00877 DESCRIPT Bilirubin inhibits the expression of DME GSTP1 DME0088 XEOTICID XEO00877 GENEFORM mRNA DME0088 XEOTICID XEO00877 MOACRIVE Inhibition DME0088 XEOTICID XEO00885 XEO_NAME Eugenol DME0088 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0088 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00885 GENEFORM Protein DME0088 XEOTICID XEO00885 MOACRIVE Inhibition DME0088 XEOTICID XEO00886 XEO_NAME 2-dichlorobenzene DME0088 XEOTICID XEO00886 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0088 XEOTICID XEO00886 XEO_CLAS Pesticide/Insecticide DME0088 XEOTICID XEO00886 DESCRIPT 2-dichlorobenzene inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00886 GENEFORM Protein DME0088 XEOTICID XEO00886 MOACRIVE Inhibition DME0088 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0088 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0088 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0088 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00898 GENEFORM Protein DME0088 XEOTICID XEO00898 MOACRIVE Induction DME0088 XEOTICID XEO00928 XEO_NAME 2-heptanone DME0088 XEOTICID XEO00928 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0088 XEOTICID XEO00928 XEO_CLAS Food Additive DME0088 XEOTICID XEO00928 DESCRIPT 2-heptanone inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00928 GENEFORM Protein DME0088 XEOTICID XEO00928 MOACRIVE Inhibition DME0088 XEOTICID XEO00929 XEO_NAME 4-propylphenol DME0088 XEOTICID XEO00929 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0088 XEOTICID XEO00929 XEO_CLAS Food Additive DME0088 XEOTICID XEO00929 DESCRIPT 4-propylphenol inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00929 GENEFORM Protein DME0088 XEOTICID XEO00929 MOACRIVE Inhibition DME0088 XEOTICID XEO00940 XEO_NAME Captafol DME0088 XEOTICID XEO00940 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0088 XEOTICID XEO00940 XEO_CLAS Fungicide DME0088 XEOTICID XEO00940 DESCRIPT Captafol inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00940 GENEFORM Protein DME0088 XEOTICID XEO00940 MOACRIVE Inhibition DME0088 XEOTICID XEO00941 XEO_NAME Captan DME0088 XEOTICID XEO00941 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0088 XEOTICID XEO00941 XEO_CLAS Fungicide DME0088 XEOTICID XEO00941 DESCRIPT Captan inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO00941 GENEFORM Protein DME0088 XEOTICID XEO00941 MOACRIVE Inhibition DME0088 XEOTICID XEO01003 XEO_NAME Cumene DME0088 XEOTICID XEO01003 XEO_TYPE Health or Environmental Toxicant(s) DME0088 XEOTICID XEO01003 XEO_CLAS Health Hazard/Toxicant DME0088 XEOTICID XEO01003 DESCRIPT Cumene inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01003 GENEFORM Protein DME0088 XEOTICID XEO01003 MOACRIVE Inhibition DME0088 XEOTICID XEO01007 XEO_NAME Ethyl benzene DME0088 XEOTICID XEO01007 XEO_TYPE Health or Environmental Toxicant(s) DME0088 XEOTICID XEO01007 XEO_CLAS Health Hazard/Toxicant DME0088 XEOTICID XEO01007 DESCRIPT Ethyl benzene inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01007 GENEFORM Protein DME0088 XEOTICID XEO01007 MOACRIVE Inhibition DME0088 XEOTICID XEO01062 XEO_NAME Monocrotophos DME0088 XEOTICID XEO01062 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0088 XEOTICID XEO01062 XEO_CLAS Pesticide/Insecticide DME0088 XEOTICID XEO01062 DESCRIPT Monocrotophos up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO01062 GENEFORM mRNA DME0088 XEOTICID XEO01062 MOACRIVE Induction DME0088 XEOTICID XEO01064 XEO_NAME Parathion DME0088 XEOTICID XEO01064 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0088 XEOTICID XEO01064 XEO_CLAS Pesticide/Insecticide DME0088 XEOTICID XEO01064 DESCRIPT Parathion induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01064 GENEFORM Protein DME0088 XEOTICID XEO01064 MOACRIVE Induction DME0088 XEOTICID XEO01122 XEO_NAME 2-butenal DME0088 XEOTICID XEO01122 XEO_TYPE Health or Environmental Toxicant(s) DME0088 XEOTICID XEO01122 XEO_CLAS Acute Toxic Substance DME0088 XEOTICID XEO01122 DESCRIPT 2-butenal inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01122 GENEFORM Protein DME0088 XEOTICID XEO01122 MOACRIVE Inhibition DME0088 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0088 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0088 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0088 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO01129 GENEFORM mRNA DME0088 XEOTICID XEO01129 MOACRIVE Induction DME0088 XEOTICID XEO01142 XEO_NAME 3-morpholinopropyl isothiocyanate DME0088 XEOTICID XEO01142 XEO_TYPE Health or Environmental Toxicant(s) DME0088 XEOTICID XEO01142 XEO_CLAS Health Hazard/Toxicant DME0088 XEOTICID XEO01142 DESCRIPT 3-morpholinopropyl isothiocyanate induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01142 GENEFORM Protein DME0088 XEOTICID XEO01142 MOACRIVE Induction DME0088 XEOTICID XEO01186 XEO_NAME Acrolein DME0088 XEOTICID XEO01186 XEO_TYPE Health or Environmental Toxicant(s) DME0088 XEOTICID XEO01186 XEO_CLAS Acute Toxic Substance DME0088 XEOTICID XEO01186 DESCRIPT Acrolein inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01186 GENEFORM Protein DME0088 XEOTICID XEO01186 MOACRIVE Inhibition DME0088 XEOTICID XEO01192 XEO_NAME Alpha-naphthoflavone DME0088 XEOTICID XEO01192 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0088 XEOTICID XEO01192 XEO_CLAS Natural Product DME0088 XEOTICID XEO01192 DESCRIPT Alpha-naphthoflavone inhibits the expression of DME GSTP1 DME0088 XEOTICID XEO01192 GENEFORM mRNA DME0088 XEOTICID XEO01192 MOACRIVE Inhibition DME0088 XEOTICID XEO01217 XEO_NAME Benzyl isothiocyanate DME0088 XEOTICID XEO01217 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0088 XEOTICID XEO01217 XEO_CLAS Natural Product DME0088 XEOTICID XEO01217 DESCRIPT Benzyl isothiocyanate inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01217 GENEFORM Protein DME0088 XEOTICID XEO01217 MOACRIVE Inhibition DME0088 XEOTICID XEO01219 XEO_NAME MG-132 DME0088 XEOTICID XEO01219 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO01219 XEO_CLAS Investigative Agent DME0088 XEOTICID XEO01219 DESCRIPT MG-132 induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01219 GENEFORM Protein DME0088 XEOTICID XEO01219 MOACRIVE Induction DME0088 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0088 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0088 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01220 GENEFORM Protein DME0088 XEOTICID XEO01220 MOACRIVE Induction DME0088 XEOTICID XEO01230 XEO_NAME Butyric acid DME0088 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0088 XEOTICID XEO01230 DESCRIPT Butyric acid inhibits the expression of DME GSTP1 DME0088 XEOTICID XEO01230 GENEFORM mRNA DME0088 XEOTICID XEO01230 MOACRIVE Inhibition DME0088 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0088 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0088 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0088 XEOTICID XEO01247 DESCRIPT Chloropicrin inhibits the expression of DME GSTP1 DME0088 XEOTICID XEO01247 GENEFORM mRNA DME0088 XEOTICID XEO01247 MOACRIVE Inhibition DME0088 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME0088 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0088 XEOTICID XEO01253 XEO_CLAS Natural Product DME0088 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01253 GENEFORM Protein DME0088 XEOTICID XEO01253 MOACRIVE Inhibition DME0088 XEOTICID XEO01290 XEO_NAME Eriodictyol DME0088 XEOTICID XEO01290 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO01290 XEO_CLAS Drug in Phase 1 Clinical Trial DME0088 XEOTICID XEO01290 DESCRIPT Eriodictyol inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01290 GENEFORM Protein DME0088 XEOTICID XEO01290 MOACRIVE Inhibition DME0088 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0088 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0088 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0088 XEOTICID XEO01305 DESCRIPT Formaldehyde induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01305 GENEFORM Protein DME0088 XEOTICID XEO01305 MOACRIVE Induction DME0088 XEOTICID XEO01308 XEO_NAME Galangin DME0088 XEOTICID XEO01308 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0088 XEOTICID XEO01308 XEO_CLAS Natural Product DME0088 XEOTICID XEO01308 DESCRIPT Galangin inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01308 GENEFORM Protein DME0088 XEOTICID XEO01308 MOACRIVE Inhibition DME0088 XEOTICID XEO01328 XEO_NAME Hemin DME0088 XEOTICID XEO01328 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO01328 XEO_CLAS Approved/Marketed Drug DME0088 XEOTICID XEO01328 DESCRIPT Hemin up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO01328 GENEFORM mRNA DME0088 XEOTICID XEO01328 MOACRIVE Induction DME0088 XEOTICID XEO01336 XEO_NAME ICG-001 DME0088 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0088 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO01336 GENEFORM mRNA DME0088 XEOTICID XEO01336 MOACRIVE Induction DME0088 XEOTICID XEO01353 XEO_NAME Kaempferol DME0088 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME0088 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME0088 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01353 GENEFORM Protein DME0088 XEOTICID XEO01353 MOACRIVE Inhibition DME0088 XEOTICID XEO01418 XEO_NAME Oxidopamine DME0088 XEOTICID XEO01418 XEO_TYPE Pharmaceutical Agent(s) DME0088 XEOTICID XEO01418 XEO_CLAS Investigative Agent DME0088 XEOTICID XEO01418 DESCRIPT Oxidopamine inhibits the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01418 GENEFORM Protein DME0088 XEOTICID XEO01418 MOACRIVE Inhibition DME0088 XEOTICID XEO01503 XEO_NAME Cadmium DME0088 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0088 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0088 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME GSTP1 DME0088 XEOTICID XEO01503 GENEFORM mRNA DME0088 XEOTICID XEO01503 MOACRIVE Induction DME0088 XEOTICID XEO01552 XEO_NAME Indioside D DME0088 XEOTICID XEO01552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0088 XEOTICID XEO01552 XEO_CLAS Natural Product DME0088 XEOTICID XEO01552 DESCRIPT Indioside D induces the drug-metabolizing activity of DME GSTP1 DME0088 XEOTICID XEO01552 GENEFORM Protein DME0088 XEOTICID XEO01552 MOACRIVE Induction DME0088 XEOTICID XEO01578 XEO_NAME Polyphenols DME0088 XEOTICID XEO01578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0088 XEOTICID XEO01578 XEO_CLAS Natural Mixture DME0088 XEOTICID XEO01578 DESCRIPT Polyphenols inhibits the expression of DME GSTP1 DME0088 XEOTICID XEO01578 GENEFORM mRNA DME0088 XEOTICID XEO01578 MOACRIVE Inhibition DME0088 XEOTICID XEO01608 XEO_NAME Sulfotepp DME0088 XEOTICID XEO01608 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0088 XEOTICID XEO01608 XEO_CLAS Pesticide/Insecticide DME0088 XEOTICID XEO01608 DESCRIPT Sulfotepp inhibits the expression of DME GSTP1 DME0088 XEOTICID XEO01608 GENEFORM mRNA DME0088 XEOTICID XEO01608 MOACRIVE Inhibition DME0089 DME___ID DME0089 DME0089 DME_NAME Microsomal glutathione S-transferase 2 (MGST2) DME0089 SPESNAME Homo sapiens DME0089 XEOTICID XEO00029 XEO_NAME Valproic acid DME0089 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0089 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0089 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME MGST2 DME0089 XEOTICID XEO00029 GENEFORM mRNA DME0089 XEOTICID XEO00029 MOACRIVE Induction DME0089 XEOTICID XEO00090 XEO_NAME Estradiol DME0089 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0089 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0089 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME MGST2 DME0089 XEOTICID XEO00090 GENEFORM mRNA DME0089 XEOTICID XEO00090 MOACRIVE Induction DME0089 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0089 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0089 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0089 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME MGST2 DME0089 XEOTICID XEO00117 GENEFORM mRNA DME0089 XEOTICID XEO00117 MOACRIVE Inhibition DME0089 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0089 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0089 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0089 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME MGST2 DME0089 XEOTICID XEO00217 GENEFORM mRNA DME0089 XEOTICID XEO00217 MOACRIVE Inhibition DME0089 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0089 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0089 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0089 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME MGST2 DME0089 XEOTICID XEO00241 GENEFORM mRNA DME0089 XEOTICID XEO00241 MOACRIVE Inhibition DME0089 XEOTICID XEO00334 XEO_NAME Cisplatin DME0089 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0089 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0089 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME MGST2 DME0089 XEOTICID XEO00334 GENEFORM mRNA DME0089 XEOTICID XEO00334 MOACRIVE Induction DME0089 XEOTICID XEO00538 XEO_NAME Quercetin DME0089 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0089 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0089 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME MGST2 DME0089 XEOTICID XEO00538 GENEFORM Protein DME0089 XEOTICID XEO00538 MOACRIVE Inhibition DME0089 XEOTICID XEO00581 XEO_NAME MS-275 DME0089 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0089 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0089 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME MGST2 DME0089 XEOTICID XEO00581 GENEFORM mRNA DME0089 XEOTICID XEO00581 MOACRIVE Induction DME0089 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0089 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0089 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0089 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME MGST2 DME0089 XEOTICID XEO00723 GENEFORM mRNA DME0089 XEOTICID XEO00723 MOACRIVE Inhibition DME0089 XEOTICID XEO00757 XEO_NAME Apple polyphenol extract DME0089 XEOTICID XEO00757 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0089 XEOTICID XEO00757 XEO_CLAS Plant Extract DME0089 XEOTICID XEO00757 DESCRIPT Apple polyphenol extract up-regulates the expression of DME MGST2 DME0089 XEOTICID XEO00757 GENEFORM mRNA DME0089 XEOTICID XEO00757 MOACRIVE Induction DME0089 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0089 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0089 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0089 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME MGST2 DME0089 XEOTICID XEO00821 GENEFORM mRNA DME0089 XEOTICID XEO00821 MOACRIVE Inhibition DME0089 XEOTICID XEO00877 XEO_NAME Bilirubin DME0089 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0089 XEOTICID XEO00877 XEO_CLAS Natural Product DME0089 XEOTICID XEO00877 DESCRIPT Bilirubin inhibits the expression of DME MGST2 DME0089 XEOTICID XEO00877 GENEFORM mRNA DME0089 XEOTICID XEO00877 MOACRIVE Inhibition DME0089 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0089 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0089 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0089 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME MGST2 DME0089 XEOTICID XEO00898 GENEFORM mRNA DME0089 XEOTICID XEO00898 MOACRIVE Inhibition DME0089 XEOTICID XEO00919 XEO_NAME Particulate matter DME0089 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0089 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0089 XEOTICID XEO00919 DESCRIPT Particulate matter inhibits the expression of DME MGST2 DME0089 XEOTICID XEO00919 GENEFORM mRNA DME0089 XEOTICID XEO00919 MOACRIVE Inhibition DME0089 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0089 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0089 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0089 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME MGST2 DME0089 XEOTICID XEO01004 GENEFORM mRNA DME0089 XEOTICID XEO01004 MOACRIVE Induction DME0089 XEOTICID XEO01284 XEO_NAME Dust DME0089 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0089 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0089 XEOTICID XEO01284 DESCRIPT Dust inhibits the expression of DME MGST2 DME0089 XEOTICID XEO01284 GENEFORM mRNA DME0089 XEOTICID XEO01284 MOACRIVE Inhibition DME0089 XEOTICID XEO01348 XEO_NAME K-7174 DME0089 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0089 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0089 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME MGST2 DME0089 XEOTICID XEO01348 GENEFORM mRNA DME0089 XEOTICID XEO01348 MOACRIVE Inhibition DME0089 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0089 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0089 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0089 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME MGST2 and leads to increasing the drug-metabolizing activity of this enzyme DME0089 XEOTICID XEO01492 GENEFORM Protein DME0089 XEOTICID XEO01492 MOACRIVE Induction DME0089 XEOTICID XEO01502 XEO_NAME Azaspiracid DME0089 XEOTICID XEO01502 XEO_TYPE Health or Environmental Toxicant(s) DME0089 XEOTICID XEO01502 XEO_CLAS Biotoxin DME0089 XEOTICID XEO01502 DESCRIPT Azaspiracid up-regulates the expression of DME MGST2 DME0089 XEOTICID XEO01502 GENEFORM mRNA DME0089 XEOTICID XEO01502 MOACRIVE Induction DME0089 XEOTICID XEO01582 XEO_NAME Pyrrolizidine alkaloid DME0089 XEOTICID XEO01582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0089 XEOTICID XEO01582 XEO_CLAS Natural Product DME0089 XEOTICID XEO01582 DESCRIPT Pyrrolizidine alkaloid inhibits the expression of DME MGST2 DME0089 XEOTICID XEO01582 GENEFORM mRNA DME0089 XEOTICID XEO01582 MOACRIVE Inhibition DME0090 DME___ID DME0090 DME0090 DME_NAME Catalase (CAT) DME0090 SPESNAME Homo sapiens DME0090 XEOTICID XEO00013 XEO_NAME Celecoxib DME0090 XEOTICID XEO00013 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00013 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00013 DESCRIPT Celecoxib inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00013 GENEFORM Protein DME0090 XEOTICID XEO00013 MOACRIVE Inhibition DME0090 XEOTICID XEO00023 XEO_NAME Amphetamine DME0090 XEOTICID XEO00023 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00023 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00023 DESCRIPT Amphetamine inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00023 GENEFORM Protein DME0090 XEOTICID XEO00023 MOACRIVE Inhibition DME0090 XEOTICID XEO00028 XEO_NAME Disulfiram DME0090 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00028 DESCRIPT Disulfiram up-regulates the expression of DME CAT DME0090 XEOTICID XEO00028 GENEFORM mRNA DME0090 XEOTICID XEO00028 MOACRIVE Induction DME0090 XEOTICID XEO00053 XEO_NAME Leflunomide DME0090 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00053 DESCRIPT Leflunomide inhibits the expression of DME CAT DME0090 XEOTICID XEO00053 GENEFORM mRNA DME0090 XEOTICID XEO00053 MOACRIVE Inhibition DME0090 XEOTICID XEO00056 XEO_NAME Malathion DME0090 XEOTICID XEO00056 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00056 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00056 DESCRIPT Malathion up-regulates the expression of DME CAT DME0090 XEOTICID XEO00056 GENEFORM mRNA DME0090 XEOTICID XEO00056 MOACRIVE Induction DME0090 XEOTICID XEO00075 XEO_NAME Propofol DME0090 XEOTICID XEO00075 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00075 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00075 DESCRIPT Propofol inhibits the expression of DME CAT DME0090 XEOTICID XEO00075 GENEFORM mRNA DME0090 XEOTICID XEO00075 MOACRIVE Inhibition DME0090 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0090 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME CAT DME0090 XEOTICID XEO00088 GENEFORM mRNA DME0090 XEOTICID XEO00088 MOACRIVE Induction DME0090 XEOTICID XEO00100 XEO_NAME Pyridostigmine bromide DME0090 XEOTICID XEO00100 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00100 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00100 DESCRIPT Pyridostigmine bromide up-regulates the expression of DME CAT DME0090 XEOTICID XEO00100 GENEFORM mRNA DME0090 XEOTICID XEO00100 MOACRIVE Induction DME0090 XEOTICID XEO00110 XEO_NAME Acetylcysteine DME0090 XEOTICID XEO00110 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00110 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00110 DESCRIPT Acetylcysteine inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00110 GENEFORM Protein DME0090 XEOTICID XEO00110 MOACRIVE Inhibition DME0090 XEOTICID XEO00115 XEO_NAME Dronabinol DME0090 XEOTICID XEO00115 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00115 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00115 DESCRIPT Dronabinol inhibits the expression of DME CAT DME0090 XEOTICID XEO00115 GENEFORM mRNA DME0090 XEOTICID XEO00115 MOACRIVE Inhibition DME0090 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0090 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME CAT DME0090 XEOTICID XEO00117 GENEFORM mRNA DME0090 XEOTICID XEO00117 MOACRIVE Inhibition DME0090 XEOTICID XEO00121 XEO_NAME Etoposide DME0090 XEOTICID XEO00121 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00121 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00121 DESCRIPT Etoposide induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00121 GENEFORM Protein DME0090 XEOTICID XEO00121 MOACRIVE Induction DME0090 XEOTICID XEO00122 XEO_NAME Amikacin DME0090 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00122 GENEFORM Protein DME0090 XEOTICID XEO00122 MOACRIVE Inhibition DME0090 XEOTICID XEO00126 XEO_NAME Raloxifene hydrochloride DME0090 XEOTICID XEO00126 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00126 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00126 DESCRIPT Raloxifene hydrochloride up-regulates the expression of DME CAT DME0090 XEOTICID XEO00126 GENEFORM mRNA DME0090 XEOTICID XEO00126 MOACRIVE Induction DME0090 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME0090 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the expression of DME CAT DME0090 XEOTICID XEO00136 GENEFORM mRNA DME0090 XEOTICID XEO00136 MOACRIVE Inhibition DME0090 XEOTICID XEO00148 XEO_NAME Bosentan DME0090 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00148 DESCRIPT Bosentan inhibits the expression of DME CAT DME0090 XEOTICID XEO00148 GENEFORM mRNA DME0090 XEOTICID XEO00148 MOACRIVE Inhibition DME0090 XEOTICID XEO00176 XEO_NAME Methimazole DME0090 XEOTICID XEO00176 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00176 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00176 DESCRIPT Methimazole inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00176 GENEFORM Protein DME0090 XEOTICID XEO00176 MOACRIVE Inhibition DME0090 XEOTICID XEO00201 XEO_NAME Chlortetracycline DME0090 XEOTICID XEO00201 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00201 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00201 DESCRIPT Chlortetracycline inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00201 GENEFORM Protein DME0090 XEOTICID XEO00201 MOACRIVE Inhibition DME0090 XEOTICID XEO00202 XEO_NAME Oxytetracycline DME0090 XEOTICID XEO00202 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00202 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00202 DESCRIPT Oxytetracycline inhibits the expression of DME CAT DME0090 XEOTICID XEO00202 GENEFORM mRNA DME0090 XEOTICID XEO00202 MOACRIVE Inhibition DME0090 XEOTICID XEO00207 XEO_NAME Oxaliplatin DME0090 XEOTICID XEO00207 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00207 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00207 DESCRIPT Oxaliplatin inhibits the expression of DME CAT DME0090 XEOTICID XEO00207 GENEFORM mRNA DME0090 XEOTICID XEO00207 MOACRIVE Inhibition DME0090 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0090 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CAT DME0090 XEOTICID XEO00217 GENEFORM mRNA DME0090 XEOTICID XEO00217 MOACRIVE Inhibition DME0090 XEOTICID XEO00220 XEO_NAME Chloramphenicol DME0090 XEOTICID XEO00220 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00220 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00220 DESCRIPT Chloramphenicol induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00220 GENEFORM Protein DME0090 XEOTICID XEO00220 MOACRIVE Induction DME0090 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0090 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CAT DME0090 XEOTICID XEO00241 GENEFORM mRNA DME0090 XEOTICID XEO00241 MOACRIVE Inhibition DME0090 XEOTICID XEO00278 XEO_NAME Beclomethasone dipropionate DME0090 XEOTICID XEO00278 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00278 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00278 DESCRIPT Beclomethasone dipropionate induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00278 GENEFORM Protein DME0090 XEOTICID XEO00278 MOACRIVE Induction DME0090 XEOTICID XEO00280 XEO_NAME Chlorpromazine hydrochloride DME0090 XEOTICID XEO00280 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00280 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00280 DESCRIPT Chlorpromazine hydrochloride inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00280 GENEFORM Protein DME0090 XEOTICID XEO00280 MOACRIVE Inhibition DME0090 XEOTICID XEO00283 XEO_NAME Citalopram hydrobromide DME0090 XEOTICID XEO00283 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00283 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00283 DESCRIPT Citalopram hydrobromide inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00283 GENEFORM Protein DME0090 XEOTICID XEO00283 MOACRIVE Inhibition DME0090 XEOTICID XEO00285 XEO_NAME Clomipramine hydrochloride DME0090 XEOTICID XEO00285 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00285 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00285 DESCRIPT Clomipramine hydrochloride inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00285 GENEFORM Protein DME0090 XEOTICID XEO00285 MOACRIVE Inhibition DME0090 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0090 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00292 GENEFORM Protein DME0090 XEOTICID XEO00292 MOACRIVE Induction DME0090 XEOTICID XEO00299 XEO_NAME Heparin sodium DME0090 XEOTICID XEO00299 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00299 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00299 DESCRIPT Heparin sodium induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00299 GENEFORM Protein DME0090 XEOTICID XEO00299 MOACRIVE Induction DME0090 XEOTICID XEO00334 XEO_NAME Cisplatin DME0090 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00334 GENEFORM Protein DME0090 XEOTICID XEO00334 MOACRIVE Inhibition DME0090 XEOTICID XEO00337 XEO_NAME Amitriptyline DME0090 XEOTICID XEO00337 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00337 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00337 DESCRIPT Amitriptyline inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00337 GENEFORM Protein DME0090 XEOTICID XEO00337 MOACRIVE Inhibition DME0090 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0090 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00339 GENEFORM Protein DME0090 XEOTICID XEO00339 MOACRIVE Inhibition DME0090 XEOTICID XEO00340 XEO_NAME Atorvastatin DME0090 XEOTICID XEO00340 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00340 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00340 DESCRIPT Atorvastatin induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00340 GENEFORM Protein DME0090 XEOTICID XEO00340 MOACRIVE Induction DME0090 XEOTICID XEO00341 XEO_NAME Bleomycin DME0090 XEOTICID XEO00341 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00341 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00341 DESCRIPT Bleomycin induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00341 GENEFORM Protein DME0090 XEOTICID XEO00341 MOACRIVE Induction DME0090 XEOTICID XEO00359 XEO_NAME Fluvastatin DME0090 XEOTICID XEO00359 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00359 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00359 DESCRIPT Fluvastatin induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00359 GENEFORM Protein DME0090 XEOTICID XEO00359 MOACRIVE Induction DME0090 XEOTICID XEO00365 XEO_NAME Metformin DME0090 XEOTICID XEO00365 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00365 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00365 DESCRIPT Metformin inhibits the expression of DME CAT DME0090 XEOTICID XEO00365 GENEFORM mRNA DME0090 XEOTICID XEO00365 MOACRIVE Inhibition DME0090 XEOTICID XEO00366 XEO_NAME Methotrexate DME0090 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00366 DESCRIPT Methotrexate up-regulates the expression of DME CAT DME0090 XEOTICID XEO00366 GENEFORM mRNA DME0090 XEOTICID XEO00366 MOACRIVE Induction DME0090 XEOTICID XEO00377 XEO_NAME Pravastatin DME0090 XEOTICID XEO00377 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00377 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00377 DESCRIPT Pravastatin up-regulates the expression of DME CAT DME0090 XEOTICID XEO00377 GENEFORM mRNA DME0090 XEOTICID XEO00377 MOACRIVE Induction DME0090 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0090 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00388 GENEFORM Protein DME0090 XEOTICID XEO00388 MOACRIVE Inhibition DME0090 XEOTICID XEO00389 XEO_NAME Benzoyl peroxide DME0090 XEOTICID XEO00389 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00389 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00389 DESCRIPT Benzoyl peroxide induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00389 GENEFORM Protein DME0090 XEOTICID XEO00389 MOACRIVE Induction DME0090 XEOTICID XEO00397 XEO_NAME Sodium nitrite DME0090 XEOTICID XEO00397 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00397 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00397 DESCRIPT Sodium nitrite inhibits the expression of DME CAT DME0090 XEOTICID XEO00397 GENEFORM mRNA DME0090 XEOTICID XEO00397 MOACRIVE Inhibition DME0090 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0090 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00410 GENEFORM Protein DME0090 XEOTICID XEO00410 MOACRIVE Inhibition DME0090 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME0090 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the expression of DME CAT DME0090 XEOTICID XEO00425 GENEFORM mRNA DME0090 XEOTICID XEO00425 MOACRIVE Inhibition DME0090 XEOTICID XEO00444 XEO_NAME Zinc chloride DME0090 XEOTICID XEO00444 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00444 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00444 DESCRIPT Zinc chloride up-regulates the expression of DME CAT DME0090 XEOTICID XEO00444 GENEFORM mRNA DME0090 XEOTICID XEO00444 MOACRIVE Induction DME0090 XEOTICID XEO00447 XEO_NAME Benzoic acid DME0090 XEOTICID XEO00447 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00447 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00447 DESCRIPT Benzoic acid inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00447 GENEFORM Protein DME0090 XEOTICID XEO00447 MOACRIVE Inhibition DME0090 XEOTICID XEO00454 XEO_NAME Dihydroartemisinin DME0090 XEOTICID XEO00454 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00454 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00454 DESCRIPT Dihydroartemisinin induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00454 GENEFORM Protein DME0090 XEOTICID XEO00454 MOACRIVE Induction DME0090 XEOTICID XEO00481 XEO_NAME Rotenone DME0090 XEOTICID XEO00481 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00481 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00481 DESCRIPT Rotenone induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00481 GENEFORM Protein DME0090 XEOTICID XEO00481 MOACRIVE Induction DME0090 XEOTICID XEO00535 XEO_NAME Adenosine triphosphate DME0090 XEOTICID XEO00535 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00535 XEO_CLAS Drug in Phase 1 Clinical Trial DME0090 XEOTICID XEO00535 DESCRIPT Adenosine triphosphate up-regulates the expression of DME CAT DME0090 XEOTICID XEO00535 GENEFORM mRNA DME0090 XEOTICID XEO00535 MOACRIVE Induction DME0090 XEOTICID XEO00538 XEO_NAME Quercetin DME0090 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0090 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00538 GENEFORM Protein DME0090 XEOTICID XEO00538 MOACRIVE Inhibition DME0090 XEOTICID XEO00539 XEO_NAME Ethanol DME0090 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0090 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00539 GENEFORM Protein DME0090 XEOTICID XEO00539 MOACRIVE Inhibition DME0090 XEOTICID XEO00540 XEO_NAME Artesunate DME0090 XEOTICID XEO00540 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00540 XEO_CLAS Drug in Phase 2 Clinical Trial DME0090 XEOTICID XEO00540 DESCRIPT Artesunate induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00540 GENEFORM Protein DME0090 XEOTICID XEO00540 MOACRIVE Induction DME0090 XEOTICID XEO00557 XEO_NAME Genistein DME0090 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0090 XEOTICID XEO00557 DESCRIPT Genistein induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00557 GENEFORM Protein DME0090 XEOTICID XEO00557 MOACRIVE Induction DME0090 XEOTICID XEO00568 XEO_NAME Resveratrol DME0090 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0090 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME CAT DME0090 XEOTICID XEO00568 GENEFORM mRNA DME0090 XEOTICID XEO00568 MOACRIVE Induction DME0090 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0090 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0090 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME CAT DME0090 XEOTICID XEO00571 GENEFORM mRNA DME0090 XEOTICID XEO00571 MOACRIVE Induction DME0090 XEOTICID XEO00574 XEO_NAME Phenanthrene DME0090 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME0090 XEOTICID XEO00574 DESCRIPT Phenanthrene up-regulates the expression of DME CAT DME0090 XEOTICID XEO00574 GENEFORM mRNA DME0090 XEOTICID XEO00574 MOACRIVE Induction DME0090 XEOTICID XEO00577 XEO_NAME Pimagedine DME0090 XEOTICID XEO00577 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00577 XEO_CLAS Drug in Phase 2 Clinical Trial DME0090 XEOTICID XEO00577 DESCRIPT Pimagedine inhibits the expression of DME CAT DME0090 XEOTICID XEO00577 GENEFORM mRNA DME0090 XEOTICID XEO00577 MOACRIVE Inhibition DME0090 XEOTICID XEO00591 XEO_NAME Ditiocarb DME0090 XEOTICID XEO00591 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00591 XEO_CLAS Drug in Phase 2 Clinical Trial DME0090 XEOTICID XEO00591 DESCRIPT Ditiocarb inhibits the expression of DME CAT DME0090 XEOTICID XEO00591 GENEFORM mRNA DME0090 XEOTICID XEO00591 MOACRIVE Inhibition DME0090 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME0090 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME0090 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00613 GENEFORM Protein DME0090 XEOTICID XEO00613 MOACRIVE Induction DME0090 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0090 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0090 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00632 GENEFORM Protein DME0090 XEOTICID XEO00632 MOACRIVE Inhibition DME0090 XEOTICID XEO00635 XEO_NAME Piperine DME0090 XEOTICID XEO00635 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00635 XEO_CLAS Drug in Phase 1 Clinical Trial DME0090 XEOTICID XEO00635 DESCRIPT Piperine inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00635 GENEFORM Protein DME0090 XEOTICID XEO00635 MOACRIVE Inhibition DME0090 XEOTICID XEO00697 XEO_NAME Tetramethylpyrazine DME0090 XEOTICID XEO00697 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00697 XEO_CLAS Preclinical/Patented Drug DME0090 XEOTICID XEO00697 DESCRIPT Tetramethylpyrazine up-regulates the expression of DME CAT DME0090 XEOTICID XEO00697 GENEFORM mRNA DME0090 XEOTICID XEO00697 MOACRIVE Induction DME0090 XEOTICID XEO00724 XEO_NAME Trimidox DME0090 XEOTICID XEO00724 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00724 XEO_CLAS Preclinical/Patented Drug DME0090 XEOTICID XEO00724 DESCRIPT Trimidox induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00724 GENEFORM Protein DME0090 XEOTICID XEO00724 MOACRIVE Induction DME0090 XEOTICID XEO00729 XEO_NAME Anethole trithione DME0090 XEOTICID XEO00729 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00729 XEO_CLAS Preclinical/Patented Drug DME0090 XEOTICID XEO00729 DESCRIPT Anethole trithione induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00729 GENEFORM Protein DME0090 XEOTICID XEO00729 MOACRIVE Induction DME0090 XEOTICID XEO00740 XEO_NAME Lindane DME0090 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00740 DESCRIPT Lindane induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00740 GENEFORM Protein DME0090 XEOTICID XEO00740 MOACRIVE Induction DME0090 XEOTICID XEO00758 XEO_NAME Grape seed proanthocyanidins DME0090 XEOTICID XEO00758 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO00758 XEO_CLAS Plant Extract DME0090 XEOTICID XEO00758 DESCRIPT Grape seed proanthocyanidins inhibits the expression of DME CAT DME0090 XEOTICID XEO00758 GENEFORM mRNA DME0090 XEOTICID XEO00758 MOACRIVE Inhibition DME0090 XEOTICID XEO00766 XEO_NAME 1,10-phenanthroline DME0090 XEOTICID XEO00766 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0090 XEOTICID XEO00766 XEO_CLAS Chemical Compound DME0090 XEOTICID XEO00766 DESCRIPT 1,10-phenanthroline inhibits the expression of DME CAT DME0090 XEOTICID XEO00766 GENEFORM mRNA DME0090 XEOTICID XEO00766 MOACRIVE Inhibition DME0090 XEOTICID XEO00768 XEO_NAME Dichlorodiphenyl dichloroethylene DME0090 XEOTICID XEO00768 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO00768 XEO_CLAS Environmental Pollutant DME0090 XEOTICID XEO00768 DESCRIPT Dichlorodiphenyl dichloroethylene inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00768 GENEFORM Protein DME0090 XEOTICID XEO00768 MOACRIVE Inhibition DME0090 XEOTICID XEO00802 XEO_NAME Dihydrocapsaicin DME0090 XEOTICID XEO00802 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO00802 XEO_CLAS Natural Product DME0090 XEOTICID XEO00802 DESCRIPT Dihydrocapsaicin induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00802 GENEFORM Protein DME0090 XEOTICID XEO00802 MOACRIVE Induction DME0090 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0090 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0090 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CAT DME0090 XEOTICID XEO00806 GENEFORM mRNA DME0090 XEOTICID XEO00806 MOACRIVE Inhibition DME0090 XEOTICID XEO00807 XEO_NAME Chlorite DME0090 XEOTICID XEO00807 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00807 XEO_CLAS Investigative Agent DME0090 XEOTICID XEO00807 DESCRIPT Chlorite inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00807 GENEFORM Protein DME0090 XEOTICID XEO00807 MOACRIVE Inhibition DME0090 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0090 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0090 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME CAT DME0090 XEOTICID XEO00821 GENEFORM mRNA DME0090 XEOTICID XEO00821 MOACRIVE Inhibition DME0090 XEOTICID XEO00828 XEO_NAME Aprindine DME0090 XEOTICID XEO00828 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00828 XEO_CLAS Investigative Agent DME0090 XEOTICID XEO00828 DESCRIPT Aprindine inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00828 GENEFORM Protein DME0090 XEOTICID XEO00828 MOACRIVE Inhibition DME0090 XEOTICID XEO00834 XEO_NAME Copper DME0090 XEOTICID XEO00834 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00834 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO00834 DESCRIPT Copper induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00834 GENEFORM Protein DME0090 XEOTICID XEO00834 MOACRIVE Induction DME0090 XEOTICID XEO00839 XEO_NAME Aluminum DME0090 XEOTICID XEO00839 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0090 XEOTICID XEO00839 XEO_CLAS Chemical Compound DME0090 XEOTICID XEO00839 DESCRIPT Aluminum inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00839 GENEFORM Protein DME0090 XEOTICID XEO00839 MOACRIVE Inhibition DME0090 XEOTICID XEO00840 XEO_NAME Cupric oxide DME0090 XEOTICID XEO00840 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0090 XEOTICID XEO00840 XEO_CLAS Chemical Compound DME0090 XEOTICID XEO00840 DESCRIPT Cupric oxide inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00840 GENEFORM Protein DME0090 XEOTICID XEO00840 MOACRIVE Inhibition DME0090 XEOTICID XEO00856 XEO_NAME Hesperetin DME0090 XEOTICID XEO00856 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO00856 XEO_CLAS Natural Product DME0090 XEOTICID XEO00856 DESCRIPT Hesperetin inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00856 GENEFORM Protein DME0090 XEOTICID XEO00856 MOACRIVE Inhibition DME0090 XEOTICID XEO00872 XEO_NAME Acetaldehyde DME0090 XEOTICID XEO00872 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO00872 XEO_CLAS Health Hazard/Toxicant DME0090 XEOTICID XEO00872 DESCRIPT Acetaldehyde inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00872 GENEFORM Protein DME0090 XEOTICID XEO00872 MOACRIVE Inhibition DME0090 XEOTICID XEO00877 XEO_NAME Bilirubin DME0090 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO00877 XEO_CLAS Natural Product DME0090 XEOTICID XEO00877 DESCRIPT Bilirubin inhibits the expression of DME CAT DME0090 XEOTICID XEO00877 GENEFORM mRNA DME0090 XEOTICID XEO00877 MOACRIVE Inhibition DME0090 XEOTICID XEO00885 XEO_NAME Eugenol DME0090 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0090 XEOTICID XEO00885 DESCRIPT Eugenol up-regulates the expression of DME CAT DME0090 XEOTICID XEO00885 GENEFORM mRNA DME0090 XEOTICID XEO00885 MOACRIVE Induction DME0090 XEOTICID XEO00888 XEO_NAME Agrochemicals DME0090 XEOTICID XEO00888 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO00888 XEO_CLAS Natural Mixture DME0090 XEOTICID XEO00888 DESCRIPT Agrochemicals induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00888 GENEFORM Protein DME0090 XEOTICID XEO00888 MOACRIVE Induction DME0090 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0090 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0090 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00898 GENEFORM Protein DME0090 XEOTICID XEO00898 MOACRIVE Inhibition DME0090 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0090 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0090 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00905 GENEFORM Protein DME0090 XEOTICID XEO00905 MOACRIVE Inhibition DME0090 XEOTICID XEO00919 XEO_NAME Particulate matter DME0090 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0090 XEOTICID XEO00919 DESCRIPT Particulate matter inhibits the expression of DME CAT DME0090 XEOTICID XEO00919 GENEFORM mRNA DME0090 XEOTICID XEO00919 MOACRIVE Inhibition DME0090 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0090 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0090 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid up-regulates the expression of DME CAT DME0090 XEOTICID XEO00921 GENEFORM mRNA DME0090 XEOTICID XEO00921 MOACRIVE Induction DME0090 XEOTICID XEO00924 XEO_NAME Water pollutants chemical DME0090 XEOTICID XEO00924 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO00924 XEO_CLAS Natural Mixture DME0090 XEOTICID XEO00924 DESCRIPT Water pollutants chemical induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00924 GENEFORM Protein DME0090 XEOTICID XEO00924 MOACRIVE Induction DME0090 XEOTICID XEO00937 XEO_NAME 2,4,5-trichlorophenol DME0090 XEOTICID XEO00937 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0090 XEOTICID XEO00937 XEO_CLAS Fungicide DME0090 XEOTICID XEO00937 DESCRIPT 2,4,5-trichlorophenol inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00937 GENEFORM Protein DME0090 XEOTICID XEO00937 MOACRIVE Inhibition DME0090 XEOTICID XEO00953 XEO_NAME Mancozeb DME0090 XEOTICID XEO00953 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0090 XEOTICID XEO00953 XEO_CLAS Fungicide DME0090 XEOTICID XEO00953 DESCRIPT Mancozeb inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00953 GENEFORM Protein DME0090 XEOTICID XEO00953 MOACRIVE Inhibition DME0090 XEOTICID XEO00965 XEO_NAME Cyanoginosin LR DME0090 XEOTICID XEO00965 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO00965 XEO_CLAS Acute Toxic Substance DME0090 XEOTICID XEO00965 DESCRIPT Cyanoginosin LR inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00965 GENEFORM Protein DME0090 XEOTICID XEO00965 MOACRIVE Inhibition DME0090 XEOTICID XEO00968 XEO_NAME Amitrole DME0090 XEOTICID XEO00968 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0090 XEOTICID XEO00968 XEO_CLAS Herbicide DME0090 XEOTICID XEO00968 DESCRIPT Amitrole inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00968 GENEFORM Protein DME0090 XEOTICID XEO00968 MOACRIVE Inhibition DME0090 XEOTICID XEO00969 XEO_NAME Atrazine DME0090 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0090 XEOTICID XEO00969 XEO_CLAS Herbicide DME0090 XEOTICID XEO00969 DESCRIPT Atrazine induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00969 GENEFORM Protein DME0090 XEOTICID XEO00969 MOACRIVE Induction DME0090 XEOTICID XEO00985 XEO_NAME Hexyl cinnamic aldehyde DME0090 XEOTICID XEO00985 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO00985 XEO_CLAS Environmental Pollutant DME0090 XEOTICID XEO00985 DESCRIPT Hexyl cinnamic aldehyde up-regulates the expression of DME CAT DME0090 XEOTICID XEO00985 GENEFORM mRNA DME0090 XEOTICID XEO00985 MOACRIVE Induction DME0090 XEOTICID XEO00994 XEO_NAME Arsenic disulfide DME0090 XEOTICID XEO00994 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO00994 XEO_CLAS Drug in Phase 3 Clinical Trial DME0090 XEOTICID XEO00994 DESCRIPT Arsenic disulfide induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00994 GENEFORM Protein DME0090 XEOTICID XEO00994 MOACRIVE Induction DME0090 XEOTICID XEO00995 XEO_NAME Amphibole asbestos DME0090 XEOTICID XEO00995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO00995 XEO_CLAS Natural Mixture DME0090 XEOTICID XEO00995 DESCRIPT Amphibole asbestos inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00995 GENEFORM Protein DME0090 XEOTICID XEO00995 MOACRIVE Inhibition DME0090 XEOTICID XEO00997 XEO_NAME Bisphenol F DME0090 XEOTICID XEO00997 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO00997 XEO_CLAS Environmental Pollutant DME0090 XEOTICID XEO00997 DESCRIPT Bisphenol F inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO00997 GENEFORM Protein DME0090 XEOTICID XEO00997 MOACRIVE Inhibition DME0090 XEOTICID XEO01001 XEO_NAME Chloric acid DME0090 XEOTICID XEO01001 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01001 XEO_CLAS Health Hazard/Toxicant DME0090 XEOTICID XEO01001 DESCRIPT Chloric acid inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01001 GENEFORM Protein DME0090 XEOTICID XEO01001 MOACRIVE Inhibition DME0090 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0090 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0090 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01004 GENEFORM Protein DME0090 XEOTICID XEO01004 MOACRIVE Induction DME0090 XEOTICID XEO01008 XEO_NAME Ferric oxide DME0090 XEOTICID XEO01008 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01008 XEO_CLAS Drug in Phase 1 Clinical Trial DME0090 XEOTICID XEO01008 DESCRIPT Ferric oxide inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01008 GENEFORM Protein DME0090 XEOTICID XEO01008 MOACRIVE Inhibition DME0090 XEOTICID XEO01014 XEO_NAME Molybdenum trioxide DME0090 XEOTICID XEO01014 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01014 XEO_CLAS Health Hazard/Toxicant DME0090 XEOTICID XEO01014 DESCRIPT Molybdenum trioxide inhibits the expression of DME CAT DME0090 XEOTICID XEO01014 GENEFORM mRNA DME0090 XEOTICID XEO01014 MOACRIVE Inhibition DME0090 XEOTICID XEO01025 XEO_NAME Styrene DME0090 XEOTICID XEO01025 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01025 XEO_CLAS Health Hazard/Toxicant DME0090 XEOTICID XEO01025 DESCRIPT Styrene inhibits the expression of DME CAT DME0090 XEOTICID XEO01025 GENEFORM mRNA DME0090 XEOTICID XEO01025 MOACRIVE Inhibition DME0090 XEOTICID XEO01026 XEO_NAME Tetrachloroethylene DME0090 XEOTICID XEO01026 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01026 XEO_CLAS Health Hazard/Toxicant DME0090 XEOTICID XEO01026 DESCRIPT Tetrachloroethylene inhibits the expression of DME CAT DME0090 XEOTICID XEO01026 GENEFORM mRNA DME0090 XEOTICID XEO01026 MOACRIVE Inhibition DME0090 XEOTICID XEO01029 XEO_NAME Trinitrotoluene DME0090 XEOTICID XEO01029 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01029 XEO_CLAS Acute Toxic Substance DME0090 XEOTICID XEO01029 DESCRIPT Trinitrotoluene up-regulates the expression of DME CAT DME0090 XEOTICID XEO01029 GENEFORM mRNA DME0090 XEOTICID XEO01029 MOACRIVE Induction DME0090 XEOTICID XEO01040 XEO_NAME Bifenthrin DME0090 XEOTICID XEO01040 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0090 XEOTICID XEO01040 XEO_CLAS Pesticide/Insecticide DME0090 XEOTICID XEO01040 DESCRIPT Bifenthrin inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01040 GENEFORM Protein DME0090 XEOTICID XEO01040 MOACRIVE Inhibition DME0090 XEOTICID XEO01045 XEO_NAME Cyfluthrin DME0090 XEOTICID XEO01045 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0090 XEOTICID XEO01045 XEO_CLAS Pesticide/Insecticide DME0090 XEOTICID XEO01045 DESCRIPT Cyfluthrin inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01045 GENEFORM Protein DME0090 XEOTICID XEO01045 MOACRIVE Inhibition DME0090 XEOTICID XEO01046 XEO_NAME Cypermethrin DME0090 XEOTICID XEO01046 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0090 XEOTICID XEO01046 XEO_CLAS Pesticide/Insecticide DME0090 XEOTICID XEO01046 DESCRIPT Cypermethrin inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01046 GENEFORM Protein DME0090 XEOTICID XEO01046 MOACRIVE Inhibition DME0090 XEOTICID XEO01072 XEO_NAME Trichlorfon DME0090 XEOTICID XEO01072 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0090 XEOTICID XEO01072 XEO_CLAS Pesticide/Insecticide DME0090 XEOTICID XEO01072 DESCRIPT Trichlorfon up-regulates the expression of DME CAT DME0090 XEOTICID XEO01072 GENEFORM mRNA DME0090 XEOTICID XEO01072 MOACRIVE Induction DME0090 XEOTICID XEO01073 XEO_NAME Dimethoate DME0090 XEOTICID XEO01073 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0090 XEOTICID XEO01073 XEO_CLAS Pesticide/Insecticide DME0090 XEOTICID XEO01073 DESCRIPT Dimethoate induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01073 GENEFORM Protein DME0090 XEOTICID XEO01073 MOACRIVE Induction DME0090 XEOTICID XEO01187 XEO_NAME Acrylamide DME0090 XEOTICID XEO01187 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01187 XEO_CLAS Acute Toxic Substance DME0090 XEOTICID XEO01187 DESCRIPT Acrylamide inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01187 GENEFORM Protein DME0090 XEOTICID XEO01187 MOACRIVE Inhibition DME0090 XEOTICID XEO01190 XEO_NAME Aica ribonucleotide DME0090 XEOTICID XEO01190 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01190 XEO_CLAS Drug in Phase 1 Clinical Trial DME0090 XEOTICID XEO01190 DESCRIPT Aica ribonucleotide induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01190 GENEFORM Protein DME0090 XEOTICID XEO01190 MOACRIVE Induction DME0090 XEOTICID XEO01203 XEO_NAME Apigenin DME0090 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO01203 XEO_CLAS Natural Product DME0090 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the expression of DME CAT DME0090 XEOTICID XEO01203 GENEFORM mRNA DME0090 XEOTICID XEO01203 MOACRIVE Inhibition DME0090 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0090 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0090 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01226 GENEFORM Protein DME0090 XEOTICID XEO01226 MOACRIVE Inhibition DME0090 XEOTICID XEO01239 XEO_NAME Catechin DME0090 XEOTICID XEO01239 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01239 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO01239 DESCRIPT Catechin induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01239 GENEFORM Protein DME0090 XEOTICID XEO01239 MOACRIVE Induction DME0090 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0090 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0090 XEOTICID XEO01248 DESCRIPT Chlorpyrifos induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01248 GENEFORM Protein DME0090 XEOTICID XEO01248 MOACRIVE Induction DME0090 XEOTICID XEO01255 XEO_NAME Citric acid DME0090 XEOTICID XEO01255 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01255 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO01255 DESCRIPT Citric acid inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01255 GENEFORM Protein DME0090 XEOTICID XEO01255 MOACRIVE Inhibition DME0090 XEOTICID XEO01259 XEO_NAME Cordycepin DME0090 XEOTICID XEO01259 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01259 XEO_CLAS Acute Toxic Substance DME0090 XEOTICID XEO01259 DESCRIPT Cordycepin inhibits the expression of DME CAT DME0090 XEOTICID XEO01259 GENEFORM mRNA DME0090 XEOTICID XEO01259 MOACRIVE Inhibition DME0090 XEOTICID XEO01270 XEO_NAME Dehydroascorbic acid DME0090 XEOTICID XEO01270 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01270 XEO_CLAS Drug in Phase 2 Clinical Trial DME0090 XEOTICID XEO01270 DESCRIPT Dehydroascorbic acid induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01270 GENEFORM Protein DME0090 XEOTICID XEO01270 MOACRIVE Induction DME0090 XEOTICID XEO01284 XEO_NAME Dust DME0090 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0090 XEOTICID XEO01284 DESCRIPT Dust inhibits the expression of DME CAT DME0090 XEOTICID XEO01284 GENEFORM mRNA DME0090 XEOTICID XEO01284 MOACRIVE Inhibition DME0090 XEOTICID XEO01297 XEO_NAME Excavatolide B DME0090 XEOTICID XEO01297 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO01297 XEO_CLAS Natural Product DME0090 XEOTICID XEO01297 DESCRIPT Excavatolide B inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01297 GENEFORM Protein DME0090 XEOTICID XEO01297 MOACRIVE Inhibition DME0090 XEOTICID XEO01320 XEO_NAME Glyphosate DME0090 XEOTICID XEO01320 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01320 XEO_CLAS Environmental Pollutant DME0090 XEOTICID XEO01320 DESCRIPT Glyphosate induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01320 GENEFORM Protein DME0090 XEOTICID XEO01320 MOACRIVE Induction DME0090 XEOTICID XEO01329 XEO_NAME Hexylresorcinol DME0090 XEOTICID XEO01329 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01329 XEO_CLAS Drug in Phase 1 Clinical Trial DME0090 XEOTICID XEO01329 DESCRIPT Hexylresorcinol inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01329 GENEFORM Protein DME0090 XEOTICID XEO01329 MOACRIVE Inhibition DME0090 XEOTICID XEO01331 XEO_NAME Homocysteine DME0090 XEOTICID XEO01331 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01331 XEO_CLAS Drug in Phase 1 Clinical Trial DME0090 XEOTICID XEO01331 DESCRIPT Homocysteine inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01331 GENEFORM Protein DME0090 XEOTICID XEO01331 MOACRIVE Inhibition DME0090 XEOTICID XEO01336 XEO_NAME ICG-001 DME0090 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0090 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME CAT DME0090 XEOTICID XEO01336 GENEFORM mRNA DME0090 XEOTICID XEO01336 MOACRIVE Inhibition DME0090 XEOTICID XEO01348 XEO_NAME K-7174 DME0090 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0090 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME CAT DME0090 XEOTICID XEO01348 GENEFORM mRNA DME0090 XEOTICID XEO01348 MOACRIVE Inhibition DME0090 XEOTICID XEO01358 XEO_NAME Kolaviron DME0090 XEOTICID XEO01358 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01358 XEO_CLAS Preclinical/Patented Drug DME0090 XEOTICID XEO01358 DESCRIPT Kolaviron induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01358 GENEFORM Protein DME0090 XEOTICID XEO01358 MOACRIVE Induction DME0090 XEOTICID XEO01367 XEO_NAME Linoleic acid DME0090 XEOTICID XEO01367 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01367 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO01367 DESCRIPT Linoleic acid induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01367 GENEFORM Protein DME0090 XEOTICID XEO01367 MOACRIVE Induction DME0090 XEOTICID XEO01368 XEO_NAME Linsidomine DME0090 XEOTICID XEO01368 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01368 XEO_CLAS Approved/Marketed Drug DME0090 XEOTICID XEO01368 DESCRIPT Linsidomine inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01368 GENEFORM Protein DME0090 XEOTICID XEO01368 MOACRIVE Inhibition DME0090 XEOTICID XEO01370 XEO_NAME Mangiferin DME0090 XEOTICID XEO01370 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO01370 XEO_CLAS Natural Product DME0090 XEOTICID XEO01370 DESCRIPT Mangiferin up-regulates the expression of DME CAT DME0090 XEOTICID XEO01370 GENEFORM mRNA DME0090 XEOTICID XEO01370 MOACRIVE Induction DME0090 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0090 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0090 XEOTICID XEO01407 DESCRIPT Ochratoxin A up-regulates the expression of DME CAT DME0090 XEOTICID XEO01407 GENEFORM mRNA DME0090 XEOTICID XEO01407 MOACRIVE Induction DME0090 XEOTICID XEO01412 XEO_NAME Oleic acid DME0090 XEOTICID XEO01412 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01412 XEO_CLAS Preclinical/Patented Drug DME0090 XEOTICID XEO01412 DESCRIPT Oleic acid inhibits the expression of DME CAT DME0090 XEOTICID XEO01412 GENEFORM mRNA DME0090 XEOTICID XEO01412 MOACRIVE Inhibition DME0090 XEOTICID XEO01417 XEO_NAME Oxalic acid DME0090 XEOTICID XEO01417 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01417 XEO_CLAS Drug Marketed but Withdrawn from Market DME0090 XEOTICID XEO01417 DESCRIPT Oxalic acid inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01417 GENEFORM Protein DME0090 XEOTICID XEO01417 MOACRIVE Inhibition DME0090 XEOTICID XEO01422 XEO_NAME Paraquat DME0090 XEOTICID XEO01422 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01422 XEO_CLAS Acute Toxic Substance DME0090 XEOTICID XEO01422 DESCRIPT Paraquat inhibits the expression of DME CAT DME0090 XEOTICID XEO01422 GENEFORM mRNA DME0090 XEOTICID XEO01422 MOACRIVE Inhibition DME0090 XEOTICID XEO01433 XEO_NAME Pirinixic acid DME0090 XEOTICID XEO01433 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01433 XEO_CLAS Health Hazard/Toxicant DME0090 XEOTICID XEO01433 DESCRIPT Pirinixic acid inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01433 GENEFORM Protein DME0090 XEOTICID XEO01433 MOACRIVE Inhibition DME0090 XEOTICID XEO01441 XEO_NAME Pterostilbene DME0090 XEOTICID XEO01441 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01441 XEO_CLAS Environmental Pollutant DME0090 XEOTICID XEO01441 DESCRIPT Pterostilbene up-regulates the expression of DME CAT DME0090 XEOTICID XEO01441 GENEFORM mRNA DME0090 XEOTICID XEO01441 MOACRIVE Induction DME0090 XEOTICID XEO01446 XEO_NAME Pyrogallol DME0090 XEOTICID XEO01446 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01446 XEO_CLAS Health Hazard/Toxicant DME0090 XEOTICID XEO01446 DESCRIPT Pyrogallol inhibits the expression of DME CAT DME0090 XEOTICID XEO01446 GENEFORM mRNA DME0090 XEOTICID XEO01446 MOACRIVE Inhibition DME0090 XEOTICID XEO01483 XEO_NAME Thioctic acid DME0090 XEOTICID XEO01483 XEO_TYPE Pharmaceutical Agent(s) DME0090 XEOTICID XEO01483 XEO_CLAS Drug in Phase 1 Clinical Trial DME0090 XEOTICID XEO01483 DESCRIPT Thioctic acid up-regulates the expression of DME CAT and leads to increasing the drug-metabolizing activity of this enzyme DME0090 XEOTICID XEO01483 GENEFORM Protein DME0090 XEOTICID XEO01483 MOACRIVE Induction DME0090 XEOTICID XEO01489 XEO_NAME Toluene DME0090 XEOTICID XEO01489 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01489 XEO_CLAS Health Hazard/Toxicant DME0090 XEOTICID XEO01489 DESCRIPT Toluene inhibits the expression of DME CAT DME0090 XEOTICID XEO01489 GENEFORM mRNA DME0090 XEOTICID XEO01489 MOACRIVE Inhibition DME0090 XEOTICID XEO01501 XEO_NAME Zymosan DME0090 XEOTICID XEO01501 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01501 XEO_CLAS Health Hazard/Toxicant DME0090 XEOTICID XEO01501 DESCRIPT Zymosan up-regulates the expression of DME CAT DME0090 XEOTICID XEO01501 GENEFORM mRNA DME0090 XEOTICID XEO01501 MOACRIVE Induction DME0090 XEOTICID XEO01503 XEO_NAME Cadmium DME0090 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0090 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01503 GENEFORM Protein DME0090 XEOTICID XEO01503 MOACRIVE Inhibition DME0090 XEOTICID XEO01508 XEO_NAME Mercuric chloride DME0090 XEOTICID XEO01508 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01508 XEO_CLAS Acute Toxic Substance DME0090 XEOTICID XEO01508 DESCRIPT Mercuric chloride inhibits the expression of DME CAT DME0090 XEOTICID XEO01508 GENEFORM mRNA DME0090 XEOTICID XEO01508 MOACRIVE Inhibition DME0090 XEOTICID XEO01512 XEO_NAME Zinc DME0090 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME0090 XEOTICID XEO01512 DESCRIPT Zinc inhibits the expression of DME CAT DME0090 XEOTICID XEO01512 GENEFORM mRNA DME0090 XEOTICID XEO01512 MOACRIVE Inhibition DME0090 XEOTICID XEO01514 XEO_NAME Deoxynivalenol DME0090 XEOTICID XEO01514 XEO_TYPE Health or Environmental Toxicant(s) DME0090 XEOTICID XEO01514 XEO_CLAS Mycotoxin DME0090 XEOTICID XEO01514 DESCRIPT Deoxynivalenol induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01514 GENEFORM Protein DME0090 XEOTICID XEO01514 MOACRIVE Induction DME0090 XEOTICID XEO01547 XEO_NAME Ginsenoside DME0090 XEOTICID XEO01547 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO01547 XEO_CLAS Natural Product DME0090 XEOTICID XEO01547 DESCRIPT Ginsenoside inhibits the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01547 GENEFORM Protein DME0090 XEOTICID XEO01547 MOACRIVE Inhibition DME0090 XEOTICID XEO01574 XEO_NAME Plant extracts DME0090 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0090 XEOTICID XEO01574 DESCRIPT Plant extracts up-regulates the expression of DME CAT DME0090 XEOTICID XEO01574 GENEFORM mRNA DME0090 XEOTICID XEO01574 MOACRIVE Induction DME0090 XEOTICID XEO01592 XEO_NAME Tea extracts DME0090 XEOTICID XEO01592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0090 XEOTICID XEO01592 XEO_CLAS Plant Extract DME0090 XEOTICID XEO01592 DESCRIPT Tea extracts induces the drug-metabolizing activity of DME CAT DME0090 XEOTICID XEO01592 GENEFORM Protein DME0090 XEOTICID XEO01592 MOACRIVE Induction DME0091 DME___ID DME0091 DME0091 DME_NAME Prostaglandin G/H synthase 1 (COX-1) DME0091 SPESNAME Homo sapiens DME0091 XEOTICID XEO00001 XEO_NAME Dimethyl sulfoxide DME0091 XEOTICID XEO00001 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00001 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00001 DESCRIPT Dimethyl sulfoxide inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00001 GENEFORM mRNA DME0091 XEOTICID XEO00001 MOACRIVE Inhibition DME0091 XEOTICID XEO00013 XEO_NAME Celecoxib DME0091 XEOTICID XEO00013 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00013 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00013 DESCRIPT Celecoxib inhibits the drug-metabolizing activity of DME PTGS1 (IC50 < 100 microM) DME0091 XEOTICID XEO00013 GENEFORM Protein DME0091 XEOTICID XEO00013 MOACRIVE Inhibition DME0091 XEOTICID XEO00029 XEO_NAME Valproic acid DME0091 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME PTGS1 and leads to increasing the drug-metabolizing activity of this enzyme DME0091 XEOTICID XEO00029 GENEFORM Protein DME0091 XEOTICID XEO00029 MOACRIVE Induction DME0091 XEOTICID XEO00034 XEO_NAME Etodolac DME0091 XEOTICID XEO00034 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00034 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00034 DESCRIPT Etodolac inhibits the drug-metabolizing activity of DME PTGS1 (IC50 = 10.3 microM) DME0091 XEOTICID XEO00034 GENEFORM Protein DME0091 XEOTICID XEO00034 MOACRIVE Inhibition DME0091 XEOTICID XEO00047 XEO_NAME Indomethacin DME0091 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00047 DESCRIPT Indomethacin inhibits the drug-metabolizing activity of DME PTGS1 in U937 cell lines (IC50 = 0.002 microM) DME0091 XEOTICID XEO00047 GENEFORM Protein DME0091 XEOTICID XEO00047 MOACRIVE Inhibition DME0091 XEOTICID XEO00078 XEO_NAME Rofecoxib DME0091 XEOTICID XEO00078 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00078 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00078 DESCRIPT Rof DMEecoxib inhibits the drug-metabolizing activity of DME PTGS1 (IC50 = 1.7 microM) DME0091 XEOTICID XEO00078 GENEFORM Protein DME0091 XEOTICID XEO00078 MOACRIVE Inhibition DME0091 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0091 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME PTGS1 DME0091 XEOTICID XEO00088 GENEFORM mRNA DME0091 XEOTICID XEO00088 MOACRIVE Induction DME0091 XEOTICID XEO00094 XEO_NAME Progesterone DME0091 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00094 DESCRIPT Progesterone up-regulates the expression of DME PTGS1 DME0091 XEOTICID XEO00094 GENEFORM mRNA DME0091 XEOTICID XEO00094 MOACRIVE Induction DME0091 XEOTICID XEO00156 XEO_NAME Naproxen DME0091 XEOTICID XEO00156 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00156 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00156 DESCRIPT Naproxen inhibits the drug-metabolizing activity of DME PTGS1 in Platelet (IC50 = 0.211 microM) DME0091 XEOTICID XEO00156 GENEFORM Protein DME0091 XEOTICID XEO00156 MOACRIVE Inhibition DME0091 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0091 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00167 DESCRIPT Alitretinoin inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00167 GENEFORM mRNA DME0091 XEOTICID XEO00167 MOACRIVE Inhibition DME0091 XEOTICID XEO00184 XEO_NAME Calcitriol DME0091 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME PTGS1 DME0091 XEOTICID XEO00184 GENEFORM mRNA DME0091 XEOTICID XEO00184 MOACRIVE Induction DME0091 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0091 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00186 GENEFORM mRNA DME0091 XEOTICID XEO00186 MOACRIVE Inhibition DME0091 XEOTICID XEO00213 XEO_NAME Aspirin DME0091 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00213 DESCRIPT Aspirin inhibits the drug-metabolizing activity of DME PTGS1 (IC50 = 100 microM) DME0091 XEOTICID XEO00213 GENEFORM Protein DME0091 XEOTICID XEO00213 MOACRIVE Inhibition DME0091 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0091 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the drug-metabolizing activity of DME PTGS1 in Spodoptera frugiperda (Sf9) cell (IC50 = 200 microM) DME0091 XEOTICID XEO00217 GENEFORM Protein DME0091 XEOTICID XEO00217 MOACRIVE Inhibition DME0091 XEOTICID XEO00248 XEO_NAME Ibuprofen DME0091 XEOTICID XEO00248 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00248 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00248 DESCRIPT Ibuprof DMEen inhibits the drug-metabolizing activity of DME PTGS1 in Human erythroleukemia cell line (HEL) (IC50 = 0.09865 microM) DME0091 XEOTICID XEO00248 GENEFORM Protein DME0091 XEOTICID XEO00248 MOACRIVE Inhibition DME0091 XEOTICID XEO00253 XEO_NAME Tretinoin DME0091 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00253 GENEFORM mRNA DME0091 XEOTICID XEO00253 MOACRIVE Inhibition DME0091 XEOTICID XEO00267 XEO_NAME Ethinyl estradiol DME0091 XEOTICID XEO00267 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00267 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00267 DESCRIPT Ethinyl estradiol inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00267 GENEFORM mRNA DME0091 XEOTICID XEO00267 MOACRIVE Inhibition DME0091 XEOTICID XEO00289 XEO_NAME Donepezil hydrochloride DME0091 XEOTICID XEO00289 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00289 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00289 DESCRIPT Donepezil hydrochloride inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00289 GENEFORM mRNA DME0091 XEOTICID XEO00289 MOACRIVE Inhibition DME0091 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0091 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00292 GENEFORM mRNA DME0091 XEOTICID XEO00292 MOACRIVE Inhibition DME0091 XEOTICID XEO00296 XEO_NAME Flurbiprofen sodium DME0091 XEOTICID XEO00296 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00296 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00296 DESCRIPT Flurbiprof DMEen sodium inhibits the drug-metabolizing activity of DME PTGS1 (IC50 = 0.01 microM) DME0091 XEOTICID XEO00296 GENEFORM Protein DME0091 XEOTICID XEO00296 MOACRIVE Inhibition DME0091 XEOTICID XEO00303 XEO_NAME Ketorolac tromethamine DME0091 XEOTICID XEO00303 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00303 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00303 DESCRIPT Ketorolac tromethamine inhibits the drug-metabolizing activity of DME PTGS1 in Platelet (IC50 = 0.013 microM) DME0091 XEOTICID XEO00303 GENEFORM Protein DME0091 XEOTICID XEO00303 MOACRIVE Inhibition DME0091 XEOTICID XEO00334 XEO_NAME Cisplatin DME0091 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME PTGS1 DME0091 XEOTICID XEO00334 GENEFORM mRNA DME0091 XEOTICID XEO00334 MOACRIVE Induction DME0091 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0091 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00339 GENEFORM mRNA DME0091 XEOTICID XEO00339 MOACRIVE Inhibition DME0091 XEOTICID XEO00342 XEO_NAME Bupivacaine DME0091 XEOTICID XEO00342 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00342 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00342 DESCRIPT Bupivacaine up-regulates the expression of DME PTGS1 DME0091 XEOTICID XEO00342 GENEFORM mRNA DME0091 XEOTICID XEO00342 MOACRIVE Induction DME0091 XEOTICID XEO00352 XEO_NAME Diclofenac DME0091 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00352 DESCRIPT Diclof DMEenac inhibits the drug-metabolizing activity of DME PTGS1 (IC50 = 0.003 microM) DME0091 XEOTICID XEO00352 GENEFORM Protein DME0091 XEOTICID XEO00352 MOACRIVE Inhibition DME0091 XEOTICID XEO00361 XEO_NAME Gemcitabine DME0091 XEOTICID XEO00361 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00361 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00361 DESCRIPT Gemcitabine inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00361 GENEFORM mRNA DME0091 XEOTICID XEO00361 MOACRIVE Inhibition DME0091 XEOTICID XEO00372 XEO_NAME Panobinostat DME0091 XEOTICID XEO00372 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00372 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00372 DESCRIPT Panobinostat inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00372 GENEFORM mRNA DME0091 XEOTICID XEO00372 MOACRIVE Inhibition DME0091 XEOTICID XEO00503 XEO_NAME Lornoxicam DME0091 XEOTICID XEO00503 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00503 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO00503 DESCRIPT Lornoxicam inhibits the drug-metabolizing activity of DME PTGS1 DME0091 XEOTICID XEO00503 GENEFORM Protein DME0091 XEOTICID XEO00503 MOACRIVE Inhibition DME0091 XEOTICID XEO00517 XEO_NAME Dipyrone DME0091 XEOTICID XEO00517 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00517 XEO_CLAS Drug Marketed but Withdrawn from Market DME0091 XEOTICID XEO00517 DESCRIPT Dipyrone inhibits the drug-metabolizing activity of DME PTGS1 DME0091 XEOTICID XEO00517 GENEFORM Protein DME0091 XEOTICID XEO00517 MOACRIVE Inhibition DME0091 XEOTICID XEO00519 XEO_NAME Nimesulide DME0091 XEOTICID XEO00519 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00519 XEO_CLAS Drug Marketed but Withdrawn from Market DME0091 XEOTICID XEO00519 DESCRIPT Nimesulide up-regulates the expression of DME PTGS1 DME0091 XEOTICID XEO00519 GENEFORM mRNA DME0091 XEOTICID XEO00519 MOACRIVE Induction DME0091 XEOTICID XEO00520 XEO_NAME Phenacetin DME0091 XEOTICID XEO00520 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00520 XEO_CLAS Drug Marketed but Withdrawn from Market DME0091 XEOTICID XEO00520 DESCRIPT Phenacetin inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00520 GENEFORM mRNA DME0091 XEOTICID XEO00520 MOACRIVE Inhibition DME0091 XEOTICID XEO00528 XEO_NAME Flupenthixol DME0091 XEOTICID XEO00528 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00528 XEO_CLAS Drug Marketed but Withdrawn from Market DME0091 XEOTICID XEO00528 DESCRIPT Flupenthixol inhibits the drug-metabolizing activity of DME PTGS1 DME0091 XEOTICID XEO00528 GENEFORM Protein DME0091 XEOTICID XEO00528 MOACRIVE Inhibition DME0091 XEOTICID XEO00538 XEO_NAME Quercetin DME0091 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0091 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME PTGS1 DME0091 XEOTICID XEO00538 GENEFORM Protein DME0091 XEOTICID XEO00538 MOACRIVE Inhibition DME0091 XEOTICID XEO00557 XEO_NAME Genistein DME0091 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0091 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME PTGS1 (IC50 = 80 microM) DME0091 XEOTICID XEO00557 GENEFORM Protein DME0091 XEOTICID XEO00557 MOACRIVE Inhibition DME0091 XEOTICID XEO00568 XEO_NAME Resveratrol DME0091 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0091 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of DME PTGS1 in Platelet (IC50 = 0.625 microM) DME0091 XEOTICID XEO00568 GENEFORM Protein DME0091 XEOTICID XEO00568 MOACRIVE Inhibition DME0091 XEOTICID XEO00581 XEO_NAME MS-275 DME0091 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0091 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME PTGS1 DME0091 XEOTICID XEO00581 GENEFORM mRNA DME0091 XEOTICID XEO00581 MOACRIVE Induction DME0091 XEOTICID XEO00583 XEO_NAME NS-398 DME0091 XEOTICID XEO00583 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00583 XEO_CLAS Drug in Phase 1 Clinical Trial DME0091 XEOTICID XEO00583 DESCRIPT NS-398 inhibits the drug-metabolizing activity of DME PTGS1 (IC50 = 220 microM) DME0091 XEOTICID XEO00583 GENEFORM Protein DME0091 XEOTICID XEO00583 MOACRIVE Inhibition DME0091 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME0091 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME0091 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00613 GENEFORM mRNA DME0091 XEOTICID XEO00613 MOACRIVE Inhibition DME0091 XEOTICID XEO00623 XEO_NAME SC-58125 DME0091 XEOTICID XEO00623 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00623 XEO_CLAS Drug in Phase 1 Clinical Trial DME0091 XEOTICID XEO00623 DESCRIPT SC-58125 inhibits the drug-metabolizing activity of DME PTGS1 (IC50 = 32 microM) DME0091 XEOTICID XEO00623 GENEFORM Protein DME0091 XEOTICID XEO00623 MOACRIVE Inhibition DME0091 XEOTICID XEO00649 XEO_NAME Geldanamycin DME0091 XEOTICID XEO00649 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00649 XEO_CLAS Drug in Phase 1 Clinical Trial DME0091 XEOTICID XEO00649 DESCRIPT Geldanamycin inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00649 GENEFORM mRNA DME0091 XEOTICID XEO00649 MOACRIVE Inhibition DME0091 XEOTICID XEO00656 XEO_NAME Sulindac sulfide DME0091 XEOTICID XEO00656 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00656 XEO_CLAS Drug in Phase 2 Clinical Trial DME0091 XEOTICID XEO00656 DESCRIPT Sulindac sulfide inhibits the drug-metabolizing activity of DME PTGS1 (IC50 = 0.115 microM) DME0091 XEOTICID XEO00656 GENEFORM Protein DME0091 XEOTICID XEO00656 MOACRIVE Inhibition DME0091 XEOTICID XEO00670 XEO_NAME CHF-5074 DME0091 XEOTICID XEO00670 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00670 XEO_CLAS Drug in Phase 2 Clinical Trial DME0091 XEOTICID XEO00670 DESCRIPT CHF-5074 inhibits the drug-metabolizing activity of DME PTGS1 DME0091 XEOTICID XEO00670 GENEFORM Protein DME0091 XEOTICID XEO00670 MOACRIVE Inhibition DME0091 XEOTICID XEO00683 XEO_NAME Curcumin DME0091 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0091 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00683 GENEFORM mRNA DME0091 XEOTICID XEO00683 MOACRIVE Inhibition DME0091 XEOTICID XEO00703 XEO_NAME Flosulide DME0091 XEOTICID XEO00703 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00703 XEO_CLAS Preclinical/Patented Drug DME0091 XEOTICID XEO00703 DESCRIPT Flosulide inhibits the drug-metabolizing activity of DME PTGS1 in U937 cell lines (IC50 > 50 microM) DME0091 XEOTICID XEO00703 GENEFORM Protein DME0091 XEOTICID XEO00703 MOACRIVE Inhibition DME0091 XEOTICID XEO00706 XEO_NAME Tripterine DME0091 XEOTICID XEO00706 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00706 XEO_CLAS Preclinical/Patented Drug DME0091 XEOTICID XEO00706 DESCRIPT Tripterine up-regulates the expression of DME PTGS1 DME0091 XEOTICID XEO00706 GENEFORM mRNA DME0091 XEOTICID XEO00706 MOACRIVE Induction DME0091 XEOTICID XEO00710 XEO_NAME Isoliquiritigenin DME0091 XEOTICID XEO00710 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00710 XEO_CLAS Preclinical/Patented Drug DME0091 XEOTICID XEO00710 DESCRIPT Isoliquiritigenin inhibits the drug-metabolizing activity of DME PTGS1 (IC50 = 130 microM) DME0091 XEOTICID XEO00710 GENEFORM Protein DME0091 XEOTICID XEO00710 MOACRIVE Inhibition DME0091 XEOTICID XEO00730 XEO_NAME Ferulic acid DME0091 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME0091 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO00730 GENEFORM mRNA DME0091 XEOTICID XEO00730 MOACRIVE Inhibition DME0091 XEOTICID XEO00872 XEO_NAME Acetaldehyde DME0091 XEOTICID XEO00872 XEO_TYPE Health or Environmental Toxicant(s) DME0091 XEOTICID XEO00872 XEO_CLAS Health Hazard/Toxicant DME0091 XEOTICID XEO00872 DESCRIPT Acetaldehyde up-regulates the expression of DME PTGS1 DME0091 XEOTICID XEO00872 GENEFORM mRNA DME0091 XEOTICID XEO00872 MOACRIVE Induction DME0091 XEOTICID XEO00875 XEO_NAME Antipyrine DME0091 XEOTICID XEO00875 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00875 XEO_CLAS Drug in Phase 2 Clinical Trial DME0091 XEOTICID XEO00875 DESCRIPT Antipyrine inhibits the drug-metabolizing activity of DME PTGS1 DME0091 XEOTICID XEO00875 GENEFORM Protein DME0091 XEOTICID XEO00875 MOACRIVE Inhibition DME0091 XEOTICID XEO00876 XEO_NAME Arachidonic acid DME0091 XEOTICID XEO00876 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO00876 XEO_CLAS Investigative Agent DME0091 XEOTICID XEO00876 DESCRIPT Arachidonic acid induces the drug-metabolizing activity of DME PTGS1 DME0091 XEOTICID XEO00876 GENEFORM Protein DME0091 XEOTICID XEO00876 MOACRIVE Induction DME0091 XEOTICID XEO00969 XEO_NAME Atrazine DME0091 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0091 XEOTICID XEO00969 XEO_CLAS Herbicide DME0091 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME PTGS1 DME0091 XEOTICID XEO00969 GENEFORM mRNA DME0091 XEOTICID XEO00969 MOACRIVE Induction DME0091 XEOTICID XEO00995 XEO_NAME Amphibole asbestos DME0091 XEOTICID XEO00995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0091 XEOTICID XEO00995 XEO_CLAS Natural Mixture DME0091 XEOTICID XEO00995 DESCRIPT Amphibole asbestos inhibits the drug-metabolizing activity of DME PTGS1 DME0091 XEOTICID XEO00995 GENEFORM Protein DME0091 XEOTICID XEO00995 MOACRIVE Inhibition DME0091 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0091 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0091 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0091 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO01004 GENEFORM mRNA DME0091 XEOTICID XEO01004 MOACRIVE Inhibition DME0091 XEOTICID XEO01024 XEO_NAME Sodium bichromate DME0091 XEOTICID XEO01024 XEO_TYPE Health or Environmental Toxicant(s) DME0091 XEOTICID XEO01024 XEO_CLAS Carcinogen DME0091 XEOTICID XEO01024 DESCRIPT Sodium bichromate inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO01024 GENEFORM mRNA DME0091 XEOTICID XEO01024 MOACRIVE Inhibition DME0091 XEOTICID XEO01154 XEO_NAME 4-oxoretinoic acid DME0091 XEOTICID XEO01154 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0091 XEOTICID XEO01154 XEO_CLAS Natural Product DME0091 XEOTICID XEO01154 DESCRIPT 4-oxoretinoic acid inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO01154 GENEFORM mRNA DME0091 XEOTICID XEO01154 MOACRIVE Inhibition DME0091 XEOTICID XEO01207 XEO_NAME Arzanol DME0091 XEOTICID XEO01207 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0091 XEOTICID XEO01207 XEO_CLAS Natural Product DME0091 XEOTICID XEO01207 DESCRIPT Arzanol inhibits the drug-metabolizing activity of DME PTGS1 DME0091 XEOTICID XEO01207 GENEFORM Protein DME0091 XEOTICID XEO01207 MOACRIVE Inhibition DME0091 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0091 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0091 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO01226 GENEFORM mRNA DME0091 XEOTICID XEO01226 MOACRIVE Inhibition DME0091 XEOTICID XEO01230 XEO_NAME Butyric acid DME0091 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0091 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME PTGS1 DME0091 XEOTICID XEO01230 GENEFORM mRNA DME0091 XEOTICID XEO01230 MOACRIVE Induction DME0091 XEOTICID XEO01260 XEO_NAME Cotylenin A DME0091 XEOTICID XEO01260 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO01260 XEO_CLAS Investigative Agent DME0091 XEOTICID XEO01260 DESCRIPT Cotylenin A up-regulates the expression of DME PTGS1 DME0091 XEOTICID XEO01260 GENEFORM mRNA DME0091 XEOTICID XEO01260 MOACRIVE Induction DME0091 XEOTICID XEO01289 XEO_NAME Enniatins DME0091 XEOTICID XEO01289 XEO_TYPE Health or Environmental Toxicant(s) DME0091 XEOTICID XEO01289 XEO_CLAS Acute Toxic Substance DME0091 XEOTICID XEO01289 DESCRIPT Enniatins inhibits the expression of DME PTGS1 DME0091 XEOTICID XEO01289 GENEFORM mRNA DME0091 XEOTICID XEO01289 MOACRIVE Inhibition DME0091 XEOTICID XEO01434 XEO_NAME Platelet activating factor DME0091 XEOTICID XEO01434 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0091 XEOTICID XEO01434 XEO_CLAS Natural Product DME0091 XEOTICID XEO01434 DESCRIPT Platelet activating factor up-regulates the expression of DME PTGS1 DME0091 XEOTICID XEO01434 GENEFORM mRNA DME0091 XEOTICID XEO01434 MOACRIVE Induction DME0091 XEOTICID XEO01468 XEO_NAME SC-560 DME0091 XEOTICID XEO01468 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO01468 XEO_CLAS Preclinical/Patented Drug DME0091 XEOTICID XEO01468 DESCRIPT SC-560 inhibits the drug-metabolizing activity of DME PTGS1 (IC50 = 0.007 microM) DME0091 XEOTICID XEO01468 GENEFORM Protein DME0091 XEOTICID XEO01468 MOACRIVE Inhibition DME0091 XEOTICID XEO01485 XEO_NAME Thiostrepton DME0091 XEOTICID XEO01485 XEO_TYPE Pharmaceutical Agent(s) DME0091 XEOTICID XEO01485 XEO_CLAS Approved/Marketed Drug DME0091 XEOTICID XEO01485 DESCRIPT Thiostrepton induces the drug-metabolizing activity of DME PTGS1 DME0091 XEOTICID XEO01485 GENEFORM Protein DME0091 XEOTICID XEO01485 MOACRIVE Induction DME0092 DME___ID DME0092 DME0092 DME_NAME Thymidine phosphorylase (TYMP) DME0092 SPESNAME Homo sapiens DME0092 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0092 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0092 XEOTICID XEO00037 DESCRIPT Fluorouracil inhibits the expression of DME TYMP DME0092 XEOTICID XEO00037 GENEFORM mRNA DME0092 XEOTICID XEO00037 MOACRIVE Inhibition DME0092 XEOTICID XEO00089 XEO_NAME Mitomycin DME0092 XEOTICID XEO00089 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO00089 XEO_CLAS Approved/Marketed Drug DME0092 XEOTICID XEO00089 DESCRIPT Mitomycin inhibits the drug-metabolizing activity of DME TYMP DME0092 XEOTICID XEO00089 GENEFORM Protein DME0092 XEOTICID XEO00089 MOACRIVE Inhibition DME0092 XEOTICID XEO00095 XEO_NAME Testosterone DME0092 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0092 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME TYMP DME0092 XEOTICID XEO00095 GENEFORM mRNA DME0092 XEOTICID XEO00095 MOACRIVE Induction DME0092 XEOTICID XEO00184 XEO_NAME Calcitriol DME0092 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0092 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME TYMP DME0092 XEOTICID XEO00184 GENEFORM mRNA DME0092 XEOTICID XEO00184 MOACRIVE Induction DME0092 XEOTICID XEO00213 XEO_NAME Aspirin DME0092 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0092 XEOTICID XEO00213 DESCRIPT Aspirin inhibits the expression of DME TYMP DME0092 XEOTICID XEO00213 GENEFORM mRNA DME0092 XEOTICID XEO00213 MOACRIVE Inhibition DME0092 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0092 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0092 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME TYMP DME0092 XEOTICID XEO00217 GENEFORM mRNA DME0092 XEOTICID XEO00217 MOACRIVE Inhibition DME0092 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0092 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0092 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME TYMP DME0092 XEOTICID XEO00241 GENEFORM mRNA DME0092 XEOTICID XEO00241 MOACRIVE Induction DME0092 XEOTICID XEO00334 XEO_NAME Cisplatin DME0092 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0092 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME TYMP DME0092 XEOTICID XEO00334 GENEFORM mRNA DME0092 XEOTICID XEO00334 MOACRIVE Inhibition DME0092 XEOTICID XEO00547 XEO_NAME Vitamin E DME0092 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0092 XEOTICID XEO00547 DESCRIPT Vitamin E up-regulates the expression of DME TYMP DME0092 XEOTICID XEO00547 GENEFORM mRNA DME0092 XEOTICID XEO00547 MOACRIVE Induction DME0092 XEOTICID XEO00560 XEO_NAME Triclosan DME0092 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0092 XEOTICID XEO00560 DESCRIPT Triclosan up-regulates the expression of DME TYMP DME0092 XEOTICID XEO00560 GENEFORM mRNA DME0092 XEOTICID XEO00560 MOACRIVE Induction DME0092 XEOTICID XEO00599 XEO_NAME Tetradecanoylphorbol acetate DME0092 XEOTICID XEO00599 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO00599 XEO_CLAS Drug in Phase 1 Clinical Trial DME0092 XEOTICID XEO00599 DESCRIPT Tetradecanoylphorbol acetate induces the drug-metabolizing activity of DME TYMP DME0092 XEOTICID XEO00599 GENEFORM Protein DME0092 XEOTICID XEO00599 MOACRIVE Induction DME0092 XEOTICID XEO00661 XEO_NAME IPI-504 DME0092 XEOTICID XEO00661 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO00661 XEO_CLAS Drug in Phase 2 Clinical Trial DME0092 XEOTICID XEO00661 DESCRIPT IPI-504 inhibits the drug-metabolizing activity of DME TYMP DME0092 XEOTICID XEO00661 GENEFORM Protein DME0092 XEOTICID XEO00661 MOACRIVE Inhibition DME0092 XEOTICID XEO00683 XEO_NAME Curcumin DME0092 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0092 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of DME TYMP DME0092 XEOTICID XEO00683 GENEFORM Protein DME0092 XEOTICID XEO00683 MOACRIVE Inhibition DME0092 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0092 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0092 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME TYMP DME0092 XEOTICID XEO01226 GENEFORM mRNA DME0092 XEOTICID XEO01226 MOACRIVE Inhibition DME0092 XEOTICID XEO01268 XEO_NAME Cycloheximide DME0092 XEOTICID XEO01268 XEO_TYPE Health or Environmental Toxicant(s) DME0092 XEOTICID XEO01268 XEO_CLAS Acute Toxic Substance DME0092 XEOTICID XEO01268 DESCRIPT Cycloheximide inhibits the drug-metabolizing activity of DME TYMP DME0092 XEOTICID XEO01268 GENEFORM Protein DME0092 XEOTICID XEO01268 MOACRIVE Inhibition DME0092 XEOTICID XEO01284 XEO_NAME Dust DME0092 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0092 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0092 XEOTICID XEO01284 DESCRIPT Dust inhibits the expression of DME TYMP DME0092 XEOTICID XEO01284 GENEFORM mRNA DME0092 XEOTICID XEO01284 MOACRIVE Inhibition DME0092 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0092 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0092 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0092 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME TYMP DME0092 XEOTICID XEO01305 GENEFORM mRNA DME0092 XEOTICID XEO01305 MOACRIVE Induction DME0092 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0092 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0092 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0092 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME TYMP DME0092 XEOTICID XEO01324 GENEFORM mRNA DME0092 XEOTICID XEO01324 MOACRIVE Inhibition DME0092 XEOTICID XEO01467 XEO_NAME Salinomycin DME0092 XEOTICID XEO01467 XEO_TYPE Health or Environmental Toxicant(s) DME0092 XEOTICID XEO01467 XEO_CLAS Acute Toxic Substance DME0092 XEOTICID XEO01467 DESCRIPT Salinomycin up-regulates the expression of DME TYMP DME0092 XEOTICID XEO01467 GENEFORM mRNA DME0092 XEOTICID XEO01467 MOACRIVE Induction DME0093 DME___ID DME0093 DME0093 DME_NAME Glutathione S-transferase theta-1 (GSTT1) DME0093 SPESNAME Homo sapiens DME0093 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0093 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0093 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0093 XEOTICID XEO00037 DESCRIPT Fluorouracil induces the drug-metabolizing activity of DME GSTT1 DME0093 XEOTICID XEO00037 GENEFORM Protein DME0093 XEOTICID XEO00037 MOACRIVE Induction DME0093 XEOTICID XEO00090 XEO_NAME Estradiol DME0093 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0093 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0093 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME GSTT1 DME0093 XEOTICID XEO00090 GENEFORM mRNA DME0093 XEOTICID XEO00090 MOACRIVE Inhibition DME0093 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0093 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0093 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0093 XEOTICID XEO00165 DESCRIPT Obeticholic acid up-regulates the expression of DME GSTT1 DME0093 XEOTICID XEO00165 GENEFORM mRNA DME0093 XEOTICID XEO00165 MOACRIVE Induction DME0093 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0093 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0093 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0093 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME GSTT1 DME0093 XEOTICID XEO00217 GENEFORM mRNA DME0093 XEOTICID XEO00217 MOACRIVE Induction DME0093 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0093 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0093 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0093 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME GSTT1 DME0093 XEOTICID XEO00241 GENEFORM mRNA DME0093 XEOTICID XEO00241 MOACRIVE Inhibition DME0093 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0093 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0093 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0093 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME GSTT1 DME0093 XEOTICID XEO00339 GENEFORM mRNA DME0093 XEOTICID XEO00339 MOACRIVE Inhibition DME0093 XEOTICID XEO00636 XEO_NAME Xanthohumol DME0093 XEOTICID XEO00636 XEO_TYPE Pharmaceutical Agent(s) DME0093 XEOTICID XEO00636 XEO_CLAS Drug in Phase 1 Clinical Trial DME0093 XEOTICID XEO00636 DESCRIPT Xanthohumol up-regulates the expression of DME GSTT1 DME0093 XEOTICID XEO00636 GENEFORM mRNA DME0093 XEOTICID XEO00636 MOACRIVE Induction DME0093 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0093 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0093 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0093 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME GSTT1 DME0093 XEOTICID XEO00806 GENEFORM mRNA DME0093 XEOTICID XEO00806 MOACRIVE Inhibition DME0093 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0093 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0093 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0093 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME GSTT1 DME0093 XEOTICID XEO01031 GENEFORM mRNA DME0093 XEOTICID XEO01031 MOACRIVE Inhibition DME0093 XEOTICID XEO01348 XEO_NAME K-7174 DME0093 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0093 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0093 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME GSTT1 DME0093 XEOTICID XEO01348 GENEFORM mRNA DME0093 XEOTICID XEO01348 MOACRIVE Inhibition DME0093 XEOTICID XEO01505 XEO_NAME Lead DME0093 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0093 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0093 XEOTICID XEO01505 DESCRIPT Lead inhibits the expression of DME GSTT1 DME0093 XEOTICID XEO01505 GENEFORM mRNA DME0093 XEOTICID XEO01505 MOACRIVE Inhibition DME0093 XEOTICID XEO01585 XEO_NAME Senecionine DME0093 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0093 XEOTICID XEO01585 XEO_CLAS Natural Product DME0093 XEOTICID XEO01585 DESCRIPT Senecionine inhibits the drug-metabolizing activity of DME GSTT1 DME0093 XEOTICID XEO01585 GENEFORM Protein DME0093 XEOTICID XEO01585 MOACRIVE Inhibition DME0094 DME___ID DME0094 DME0094 DME_NAME Metallothionein-1A (MT1A) DME0094 SPESNAME Homo sapiens DME0094 XEOTICID XEO00029 XEO_NAME Valproic acid DME0094 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0094 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00029 GENEFORM mRNA DME0094 XEOTICID XEO00029 MOACRIVE Induction DME0094 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0094 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0094 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00088 GENEFORM mRNA DME0094 XEOTICID XEO00088 MOACRIVE Induction DME0094 XEOTICID XEO00090 XEO_NAME Estradiol DME0094 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0094 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME MT1A DME0094 XEOTICID XEO00090 GENEFORM mRNA DME0094 XEOTICID XEO00090 MOACRIVE Inhibition DME0094 XEOTICID XEO00094 XEO_NAME Progesterone DME0094 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0094 XEOTICID XEO00094 DESCRIPT Progesterone up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00094 GENEFORM mRNA DME0094 XEOTICID XEO00094 MOACRIVE Induction DME0094 XEOTICID XEO00097 XEO_NAME Cytarabine DME0094 XEOTICID XEO00097 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00097 XEO_CLAS Approved/Marketed Drug DME0094 XEOTICID XEO00097 DESCRIPT Cytarabine inhibits the expression of DME MT1A DME0094 XEOTICID XEO00097 GENEFORM mRNA DME0094 XEOTICID XEO00097 MOACRIVE Inhibition DME0094 XEOTICID XEO00115 XEO_NAME Dronabinol DME0094 XEOTICID XEO00115 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00115 XEO_CLAS Approved/Marketed Drug DME0094 XEOTICID XEO00115 DESCRIPT Dronabinol up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00115 GENEFORM mRNA DME0094 XEOTICID XEO00115 MOACRIVE Induction DME0094 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0094 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0094 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00117 GENEFORM mRNA DME0094 XEOTICID XEO00117 MOACRIVE Induction DME0094 XEOTICID XEO00334 XEO_NAME Cisplatin DME0094 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0094 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00334 GENEFORM mRNA DME0094 XEOTICID XEO00334 MOACRIVE Induction DME0094 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0094 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0094 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME MT1A DME0094 XEOTICID XEO00339 GENEFORM mRNA DME0094 XEOTICID XEO00339 MOACRIVE Inhibition DME0094 XEOTICID XEO00398 XEO_NAME Nitroprusside DME0094 XEOTICID XEO00398 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00398 XEO_CLAS Approved/Marketed Drug DME0094 XEOTICID XEO00398 DESCRIPT Nitroprusside up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00398 GENEFORM mRNA DME0094 XEOTICID XEO00398 MOACRIVE Induction DME0094 XEOTICID XEO00407 XEO_NAME Cupric chloride DME0094 XEOTICID XEO00407 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00407 XEO_CLAS Approved/Marketed Drug DME0094 XEOTICID XEO00407 DESCRIPT Cupric chloride up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00407 GENEFORM mRNA DME0094 XEOTICID XEO00407 MOACRIVE Induction DME0094 XEOTICID XEO00447 XEO_NAME Benzoic acid DME0094 XEOTICID XEO00447 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00447 XEO_CLAS Approved/Marketed Drug DME0094 XEOTICID XEO00447 DESCRIPT Benzoic acid up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00447 GENEFORM mRNA DME0094 XEOTICID XEO00447 MOACRIVE Induction DME0094 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME0094 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME0094 XEOTICID XEO00460 DESCRIPT Zinc sulfate up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00460 GENEFORM mRNA DME0094 XEOTICID XEO00460 MOACRIVE Induction DME0094 XEOTICID XEO00511 XEO_NAME Silver nitrate DME0094 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME0094 XEOTICID XEO00511 DESCRIPT Silver nitrate up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00511 GENEFORM mRNA DME0094 XEOTICID XEO00511 MOACRIVE Induction DME0094 XEOTICID XEO00546 XEO_NAME Salicylic acid DME0094 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME0094 XEOTICID XEO00546 DESCRIPT Salicylic acid up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00546 GENEFORM mRNA DME0094 XEOTICID XEO00546 MOACRIVE Induction DME0094 XEOTICID XEO00578 XEO_NAME Arecoline DME0094 XEOTICID XEO00578 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00578 XEO_CLAS Drug in Phase 2 Clinical Trial DME0094 XEOTICID XEO00578 DESCRIPT Arecoline up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00578 GENEFORM mRNA DME0094 XEOTICID XEO00578 MOACRIVE Induction DME0094 XEOTICID XEO00612 XEO_NAME Diphenylcyclopropenone DME0094 XEOTICID XEO00612 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00612 XEO_CLAS Drug in Phase 3 Clinical Trial DME0094 XEOTICID XEO00612 DESCRIPT Diphenylcyclopropenone up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00612 GENEFORM mRNA DME0094 XEOTICID XEO00612 MOACRIVE Induction DME0094 XEOTICID XEO00622 XEO_NAME AM-80 DME0094 XEOTICID XEO00622 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00622 XEO_CLAS Drug in Phase 2 Clinical Trial DME0094 XEOTICID XEO00622 DESCRIPT AM-80 up-regulates the expression of DME MT1A and leads to increasing the drug-metabolizing activity of this enzyme DME0094 XEOTICID XEO00622 GENEFORM Protein DME0094 XEOTICID XEO00622 MOACRIVE Induction DME0094 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0094 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0094 XEOTICID XEO00632 DESCRIPT Sodium arsenite induces the drug-metabolizing activity of DME MT1A DME0094 XEOTICID XEO00632 GENEFORM Protein DME0094 XEOTICID XEO00632 MOACRIVE Induction DME0094 XEOTICID XEO00634 XEO_NAME Hydroxytamoxifen DME0094 XEOTICID XEO00634 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00634 XEO_CLAS Drug in Phase 2 Clinical Trial DME0094 XEOTICID XEO00634 DESCRIPT Hydroxytamoxifen up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00634 GENEFORM mRNA DME0094 XEOTICID XEO00634 MOACRIVE Induction DME0094 XEOTICID XEO00645 XEO_NAME Genistin DME0094 XEOTICID XEO00645 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00645 XEO_CLAS Drug in Phase 2 Clinical Trial DME0094 XEOTICID XEO00645 DESCRIPT Genistin up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00645 GENEFORM mRNA DME0094 XEOTICID XEO00645 MOACRIVE Induction DME0094 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0094 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0094 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME MT1A DME0094 XEOTICID XEO00723 GENEFORM mRNA DME0094 XEOTICID XEO00723 MOACRIVE Inhibition DME0094 XEOTICID XEO00758 XEO_NAME Grape seed proanthocyanidins DME0094 XEOTICID XEO00758 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0094 XEOTICID XEO00758 XEO_CLAS Plant Extract DME0094 XEOTICID XEO00758 DESCRIPT Grape seed proanthocyanidins inhibits the expression of DME MT1A DME0094 XEOTICID XEO00758 GENEFORM mRNA DME0094 XEOTICID XEO00758 MOACRIVE Inhibition DME0094 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0094 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0094 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0094 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00806 GENEFORM mRNA DME0094 XEOTICID XEO00806 MOACRIVE Induction DME0094 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0094 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0094 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0094 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME MT1A DME0094 XEOTICID XEO00821 GENEFORM Protein DME0094 XEOTICID XEO00821 MOACRIVE Inhibition DME0094 XEOTICID XEO00840 XEO_NAME Cupric oxide DME0094 XEOTICID XEO00840 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0094 XEOTICID XEO00840 XEO_CLAS Chemical Compound DME0094 XEOTICID XEO00840 DESCRIPT Cupric oxide up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00840 GENEFORM mRNA DME0094 XEOTICID XEO00840 MOACRIVE Induction DME0094 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0094 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0094 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0094 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME MT1A DME0094 XEOTICID XEO00898 GENEFORM mRNA DME0094 XEOTICID XEO00898 MOACRIVE Inhibition DME0094 XEOTICID XEO00919 XEO_NAME Particulate matter DME0094 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0094 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0094 XEOTICID XEO00919 DESCRIPT Particulate matter up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00919 GENEFORM mRNA DME0094 XEOTICID XEO00919 MOACRIVE Induction DME0094 XEOTICID XEO00969 XEO_NAME Atrazine DME0094 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0094 XEOTICID XEO00969 XEO_CLAS Herbicide DME0094 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME MT1A DME0094 XEOTICID XEO00969 GENEFORM mRNA DME0094 XEOTICID XEO00969 MOACRIVE Induction DME0094 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0094 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0094 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0094 XEOTICID XEO01247 DESCRIPT Chloropicrin up-regulates the expression of DME MT1A DME0094 XEOTICID XEO01247 GENEFORM mRNA DME0094 XEOTICID XEO01247 MOACRIVE Induction DME0094 XEOTICID XEO01284 XEO_NAME Dust DME0094 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0094 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0094 XEOTICID XEO01284 DESCRIPT Dust up-regulates the expression of DME MT1A DME0094 XEOTICID XEO01284 GENEFORM mRNA DME0094 XEOTICID XEO01284 MOACRIVE Induction DME0094 XEOTICID XEO01334 XEO_NAME Hydroxycitronellal DME0094 XEOTICID XEO01334 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0094 XEOTICID XEO01334 XEO_CLAS Cosmetic Additive DME0094 XEOTICID XEO01334 DESCRIPT Hydroxycitronellal up-regulates the expression of DME MT1A DME0094 XEOTICID XEO01334 GENEFORM mRNA DME0094 XEOTICID XEO01334 MOACRIVE Induction DME0094 XEOTICID XEO01348 XEO_NAME K-7174 DME0094 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0094 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0094 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME MT1A DME0094 XEOTICID XEO01348 GENEFORM mRNA DME0094 XEOTICID XEO01348 MOACRIVE Inhibition DME0094 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0094 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0094 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0094 XEOTICID XEO01407 DESCRIPT Ochratoxin A up-regulates the expression of DME MT1A DME0094 XEOTICID XEO01407 GENEFORM mRNA DME0094 XEOTICID XEO01407 MOACRIVE Induction DME0094 XEOTICID XEO01502 XEO_NAME Azaspiracid DME0094 XEOTICID XEO01502 XEO_TYPE Health or Environmental Toxicant(s) DME0094 XEOTICID XEO01502 XEO_CLAS Biotoxin DME0094 XEOTICID XEO01502 DESCRIPT Azaspiracid up-regulates the expression of DME MT1A DME0094 XEOTICID XEO01502 GENEFORM mRNA DME0094 XEOTICID XEO01502 MOACRIVE Induction DME0094 XEOTICID XEO01503 XEO_NAME Cadmium DME0094 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0094 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0094 XEOTICID XEO01503 DESCRIPT Cadmium induces the drug-metabolizing activity of DME MT1A DME0094 XEOTICID XEO01503 GENEFORM Protein DME0094 XEOTICID XEO01503 MOACRIVE Induction DME0095 DME___ID DME0095 DME0095 DME_NAME Metallothionein-2A (MT2A) DME0095 SPESNAME Homo sapiens DME0095 XEOTICID XEO00028 XEO_NAME Disulfiram DME0095 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00028 DESCRIPT Disulfiram up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00028 GENEFORM mRNA DME0095 XEOTICID XEO00028 MOACRIVE Induction DME0095 XEOTICID XEO00029 XEO_NAME Valproic acid DME0095 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00029 DESCRIPT Valproic acid induces the drug-metabolizing activity of DME MT2A DME0095 XEOTICID XEO00029 GENEFORM Protein DME0095 XEOTICID XEO00029 MOACRIVE Induction DME0095 XEOTICID XEO00046 XEO_NAME Ifosfamide DME0095 XEOTICID XEO00046 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00046 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00046 DESCRIPT Ifosfamide up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00046 GENEFORM mRNA DME0095 XEOTICID XEO00046 MOACRIVE Induction DME0095 XEOTICID XEO00086 XEO_NAME Troglitazone DME0095 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00086 GENEFORM mRNA DME0095 XEOTICID XEO00086 MOACRIVE Induction DME0095 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0095 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00088 GENEFORM mRNA DME0095 XEOTICID XEO00088 MOACRIVE Induction DME0095 XEOTICID XEO00090 XEO_NAME Estradiol DME0095 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME MT2A DME0095 XEOTICID XEO00090 GENEFORM mRNA DME0095 XEOTICID XEO00090 MOACRIVE Inhibition DME0095 XEOTICID XEO00097 XEO_NAME Cytarabine DME0095 XEOTICID XEO00097 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00097 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00097 DESCRIPT Cytarabine inhibits the expression of DME MT2A DME0095 XEOTICID XEO00097 GENEFORM mRNA DME0095 XEOTICID XEO00097 MOACRIVE Inhibition DME0095 XEOTICID XEO00115 XEO_NAME Dronabinol DME0095 XEOTICID XEO00115 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00115 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00115 DESCRIPT Dronabinol inhibits the expression of DME MT2A DME0095 XEOTICID XEO00115 GENEFORM mRNA DME0095 XEOTICID XEO00115 MOACRIVE Inhibition DME0095 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0095 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00117 GENEFORM mRNA DME0095 XEOTICID XEO00117 MOACRIVE Induction DME0095 XEOTICID XEO00126 XEO_NAME Raloxifene hydrochloride DME0095 XEOTICID XEO00126 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00126 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00126 DESCRIPT Raloxifene hydrochloride up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00126 GENEFORM mRNA DME0095 XEOTICID XEO00126 MOACRIVE Induction DME0095 XEOTICID XEO00132 XEO_NAME Cidofovir DME0095 XEOTICID XEO00132 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00132 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00132 DESCRIPT Cidofovir up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00132 GENEFORM mRNA DME0095 XEOTICID XEO00132 MOACRIVE Induction DME0095 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME0095 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00136 DESCRIPT Gallium nitrate induces the drug-metabolizing activity of DME MT2A DME0095 XEOTICID XEO00136 GENEFORM Protein DME0095 XEOTICID XEO00136 MOACRIVE Induction DME0095 XEOTICID XEO00168 XEO_NAME Decitabine DME0095 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00168 DESCRIPT Decitabine up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00168 GENEFORM mRNA DME0095 XEOTICID XEO00168 MOACRIVE Induction DME0095 XEOTICID XEO00207 XEO_NAME Oxaliplatin DME0095 XEOTICID XEO00207 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00207 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00207 DESCRIPT Oxaliplatin inhibits the drug-metabolizing activity of DME MT2A DME0095 XEOTICID XEO00207 GENEFORM Protein DME0095 XEOTICID XEO00207 MOACRIVE Inhibition DME0095 XEOTICID XEO00235 XEO_NAME Budesonide DME0095 XEOTICID XEO00235 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00235 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00235 DESCRIPT Budesonide up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00235 GENEFORM mRNA DME0095 XEOTICID XEO00235 MOACRIVE Induction DME0095 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0095 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00241 GENEFORM mRNA DME0095 XEOTICID XEO00241 MOACRIVE Induction DME0095 XEOTICID XEO00267 XEO_NAME Ethinyl estradiol DME0095 XEOTICID XEO00267 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00267 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00267 DESCRIPT Ethinyl estradiol up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00267 GENEFORM mRNA DME0095 XEOTICID XEO00267 MOACRIVE Induction DME0095 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0095 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME MT2A DME0095 XEOTICID XEO00292 GENEFORM mRNA DME0095 XEOTICID XEO00292 MOACRIVE Inhibition DME0095 XEOTICID XEO00334 XEO_NAME Cisplatin DME0095 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00334 GENEFORM mRNA DME0095 XEOTICID XEO00334 MOACRIVE Induction DME0095 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0095 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00339 DESCRIPT Arsenic trioxide induces the drug-metabolizing activity of DME MT2A DME0095 XEOTICID XEO00339 GENEFORM Protein DME0095 XEOTICID XEO00339 MOACRIVE Induction DME0095 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0095 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00388 GENEFORM mRNA DME0095 XEOTICID XEO00388 MOACRIVE Induction DME0095 XEOTICID XEO00392 XEO_NAME Vincristine DME0095 XEOTICID XEO00392 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00392 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00392 DESCRIPT Vincristine up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00392 GENEFORM mRNA DME0095 XEOTICID XEO00392 MOACRIVE Induction DME0095 XEOTICID XEO00398 XEO_NAME Nitroprusside DME0095 XEOTICID XEO00398 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00398 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00398 DESCRIPT Nitroprusside induces the drug-metabolizing activity of DME MT2A DME0095 XEOTICID XEO00398 GENEFORM Protein DME0095 XEOTICID XEO00398 MOACRIVE Induction DME0095 XEOTICID XEO00399 XEO_NAME Pyrithione zinc DME0095 XEOTICID XEO00399 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00399 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00399 DESCRIPT Pyrithione zinc up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00399 GENEFORM mRNA DME0095 XEOTICID XEO00399 MOACRIVE Induction DME0095 XEOTICID XEO00407 XEO_NAME Cupric chloride DME0095 XEOTICID XEO00407 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00407 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00407 DESCRIPT Cupric chloride up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00407 GENEFORM mRNA DME0095 XEOTICID XEO00407 MOACRIVE Induction DME0095 XEOTICID XEO00411 XEO_NAME Avobenzone DME0095 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00411 GENEFORM mRNA DME0095 XEOTICID XEO00411 MOACRIVE Induction DME0095 XEOTICID XEO00428 XEO_NAME Menadione DME0095 XEOTICID XEO00428 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00428 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00428 DESCRIPT Menadione up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00428 GENEFORM mRNA DME0095 XEOTICID XEO00428 MOACRIVE Induction DME0095 XEOTICID XEO00435 XEO_NAME Urethane DME0095 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00435 DESCRIPT Urethane up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00435 GENEFORM mRNA DME0095 XEOTICID XEO00435 MOACRIVE Induction DME0095 XEOTICID XEO00439 XEO_NAME Daidzein DME0095 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00439 DESCRIPT Daidzein up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00439 GENEFORM mRNA DME0095 XEOTICID XEO00439 MOACRIVE Induction DME0095 XEOTICID XEO00447 XEO_NAME Benzoic acid DME0095 XEOTICID XEO00447 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00447 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00447 DESCRIPT Benzoic acid up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00447 GENEFORM mRNA DME0095 XEOTICID XEO00447 MOACRIVE Induction DME0095 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME0095 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00460 DESCRIPT Zinc sulfate up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00460 GENEFORM mRNA DME0095 XEOTICID XEO00460 MOACRIVE Induction DME0095 XEOTICID XEO00466 XEO_NAME Demecolcine DME0095 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00466 DESCRIPT Demecolcine up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00466 GENEFORM mRNA DME0095 XEOTICID XEO00466 MOACRIVE Induction DME0095 XEOTICID XEO00481 XEO_NAME Rotenone DME0095 XEOTICID XEO00481 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00481 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00481 DESCRIPT Rotenone up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00481 GENEFORM mRNA DME0095 XEOTICID XEO00481 MOACRIVE Induction DME0095 XEOTICID XEO00508 XEO_NAME Promegestone DME0095 XEOTICID XEO00508 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00508 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00508 DESCRIPT Promegestone up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00508 GENEFORM mRNA DME0095 XEOTICID XEO00508 MOACRIVE Induction DME0095 XEOTICID XEO00526 XEO_NAME Zomepirac glucuronide DME0095 XEOTICID XEO00526 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00526 XEO_CLAS Drug Marketed but Withdrawn from Market DME0095 XEOTICID XEO00526 DESCRIPT Zomepirac glucuronide up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00526 GENEFORM mRNA DME0095 XEOTICID XEO00526 MOACRIVE Induction DME0095 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0095 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0095 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone inhibits the expression of DME MT2A DME0095 XEOTICID XEO00536 GENEFORM mRNA DME0095 XEOTICID XEO00536 MOACRIVE Inhibition DME0095 XEOTICID XEO00538 XEO_NAME Quercetin DME0095 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0095 XEOTICID XEO00538 DESCRIPT Quercetin up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00538 GENEFORM mRNA DME0095 XEOTICID XEO00538 MOACRIVE Induction DME0095 XEOTICID XEO00541 XEO_NAME Motexafin gadolinium DME0095 XEOTICID XEO00541 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00541 XEO_CLAS Drug in Phase 2 Clinical Trial DME0095 XEOTICID XEO00541 DESCRIPT Motexafin gadolinium up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00541 GENEFORM mRNA DME0095 XEOTICID XEO00541 MOACRIVE Induction DME0095 XEOTICID XEO00557 XEO_NAME Genistein DME0095 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0095 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00557 GENEFORM mRNA DME0095 XEOTICID XEO00557 MOACRIVE Induction DME0095 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0095 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0095 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00571 GENEFORM mRNA DME0095 XEOTICID XEO00571 MOACRIVE Induction DME0095 XEOTICID XEO00581 XEO_NAME MS-275 DME0095 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0095 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00581 GENEFORM mRNA DME0095 XEOTICID XEO00581 MOACRIVE Induction DME0095 XEOTICID XEO00599 XEO_NAME Tetradecanoylphorbol acetate DME0095 XEOTICID XEO00599 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00599 XEO_CLAS Drug in Phase 1 Clinical Trial DME0095 XEOTICID XEO00599 DESCRIPT Tetradecanoylphorbol acetate up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00599 GENEFORM mRNA DME0095 XEOTICID XEO00599 MOACRIVE Induction DME0095 XEOTICID XEO00612 XEO_NAME Diphenylcyclopropenone DME0095 XEOTICID XEO00612 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00612 XEO_CLAS Drug in Phase 3 Clinical Trial DME0095 XEOTICID XEO00612 DESCRIPT Diphenylcyclopropenone up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00612 GENEFORM mRNA DME0095 XEOTICID XEO00612 MOACRIVE Induction DME0095 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME0095 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME0095 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the expression of DME MT2A DME0095 XEOTICID XEO00613 GENEFORM mRNA DME0095 XEOTICID XEO00613 MOACRIVE Inhibition DME0095 XEOTICID XEO00626 XEO_NAME Copper histidine DME0095 XEOTICID XEO00626 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00626 XEO_CLAS Drug in Phase 3 Clinical Trial DME0095 XEOTICID XEO00626 DESCRIPT Copper histidine up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00626 GENEFORM mRNA DME0095 XEOTICID XEO00626 MOACRIVE Induction DME0095 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0095 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0095 XEOTICID XEO00632 DESCRIPT Sodium arsenite induces the drug-metabolizing activity of DME MT2A DME0095 XEOTICID XEO00632 GENEFORM Protein DME0095 XEOTICID XEO00632 MOACRIVE Induction DME0095 XEOTICID XEO00634 XEO_NAME Hydroxytamoxifen DME0095 XEOTICID XEO00634 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00634 XEO_CLAS Drug in Phase 2 Clinical Trial DME0095 XEOTICID XEO00634 DESCRIPT Hydroxytamoxifen up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00634 GENEFORM mRNA DME0095 XEOTICID XEO00634 MOACRIVE Induction DME0095 XEOTICID XEO00645 XEO_NAME Genistin DME0095 XEOTICID XEO00645 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00645 XEO_CLAS Drug in Phase 2 Clinical Trial DME0095 XEOTICID XEO00645 DESCRIPT Genistin up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00645 GENEFORM mRNA DME0095 XEOTICID XEO00645 MOACRIVE Induction DME0095 XEOTICID XEO00674 XEO_NAME Acyline DME0095 XEOTICID XEO00674 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00674 XEO_CLAS Drug in Phase 2 Clinical Trial DME0095 XEOTICID XEO00674 DESCRIPT Acyline inhibits the expression of DME MT2A DME0095 XEOTICID XEO00674 GENEFORM mRNA DME0095 XEOTICID XEO00674 MOACRIVE Inhibition DME0095 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0095 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0095 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00723 GENEFORM mRNA DME0095 XEOTICID XEO00723 MOACRIVE Induction DME0095 XEOTICID XEO00727 XEO_NAME Vanillin DME0095 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME0095 XEOTICID XEO00727 DESCRIPT Vanillin up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00727 GENEFORM mRNA DME0095 XEOTICID XEO00727 MOACRIVE Induction DME0095 XEOTICID XEO00758 XEO_NAME Grape seed proanthocyanidins DME0095 XEOTICID XEO00758 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0095 XEOTICID XEO00758 XEO_CLAS Plant Extract DME0095 XEOTICID XEO00758 DESCRIPT Grape seed proanthocyanidins inhibits the expression of DME MT2A DME0095 XEOTICID XEO00758 GENEFORM mRNA DME0095 XEOTICID XEO00758 MOACRIVE Inhibition DME0095 XEOTICID XEO00793 XEO_NAME Tungsten DME0095 XEOTICID XEO00793 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0095 XEOTICID XEO00793 XEO_CLAS Chemical Compound DME0095 XEOTICID XEO00793 DESCRIPT Tungsten up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00793 GENEFORM mRNA DME0095 XEOTICID XEO00793 MOACRIVE Induction DME0095 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0095 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0095 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00806 GENEFORM mRNA DME0095 XEOTICID XEO00806 MOACRIVE Induction DME0095 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0095 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0095 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00818 GENEFORM mRNA DME0095 XEOTICID XEO00818 MOACRIVE Induction DME0095 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0095 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0095 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0095 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution induces the drug-metabolizing activity of DME MT2A DME0095 XEOTICID XEO00821 GENEFORM Protein DME0095 XEOTICID XEO00821 MOACRIVE Induction DME0095 XEOTICID XEO00834 XEO_NAME Copper DME0095 XEOTICID XEO00834 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO00834 XEO_CLAS Approved/Marketed Drug DME0095 XEOTICID XEO00834 DESCRIPT Copper up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00834 GENEFORM mRNA DME0095 XEOTICID XEO00834 MOACRIVE Induction DME0095 XEOTICID XEO00840 XEO_NAME Cupric oxide DME0095 XEOTICID XEO00840 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0095 XEOTICID XEO00840 XEO_CLAS Chemical Compound DME0095 XEOTICID XEO00840 DESCRIPT Cupric oxide up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00840 GENEFORM mRNA DME0095 XEOTICID XEO00840 MOACRIVE Induction DME0095 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0095 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0095 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME MT2A DME0095 XEOTICID XEO00898 GENEFORM mRNA DME0095 XEOTICID XEO00898 MOACRIVE Inhibition DME0095 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0095 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0095 XEOTICID XEO00899 DESCRIPT Methylcholanthrene up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00899 GENEFORM mRNA DME0095 XEOTICID XEO00899 MOACRIVE Induction DME0095 XEOTICID XEO00919 XEO_NAME Particulate matter DME0095 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0095 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0095 XEOTICID XEO00919 DESCRIPT Particulate matter up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00919 GENEFORM mRNA DME0095 XEOTICID XEO00919 MOACRIVE Induction DME0095 XEOTICID XEO00964 XEO_NAME Uranium DME0095 XEOTICID XEO00964 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO00964 XEO_CLAS Acute Toxic Substance DME0095 XEOTICID XEO00964 DESCRIPT Uranium up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00964 GENEFORM mRNA DME0095 XEOTICID XEO00964 MOACRIVE Induction DME0095 XEOTICID XEO00969 XEO_NAME Atrazine DME0095 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0095 XEOTICID XEO00969 XEO_CLAS Herbicide DME0095 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME MT2A DME0095 XEOTICID XEO00969 GENEFORM mRNA DME0095 XEOTICID XEO00969 MOACRIVE Induction DME0095 XEOTICID XEO00995 XEO_NAME Amphibole asbestos DME0095 XEOTICID XEO00995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0095 XEOTICID XEO00995 XEO_CLAS Natural Mixture DME0095 XEOTICID XEO00995 DESCRIPT Amphibole asbestos induces the drug-metabolizing activity of DME MT2A DME0095 XEOTICID XEO00995 GENEFORM Protein DME0095 XEOTICID XEO00995 MOACRIVE Induction DME0095 XEOTICID XEO01002 XEO_NAME Chromium nitrate DME0095 XEOTICID XEO01002 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO01002 XEO_CLAS Environmental Pollutant DME0095 XEOTICID XEO01002 DESCRIPT Chromium nitrate up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01002 GENEFORM mRNA DME0095 XEOTICID XEO01002 MOACRIVE Induction DME0095 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0095 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0095 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01004 GENEFORM mRNA DME0095 XEOTICID XEO01004 MOACRIVE Induction DME0095 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0095 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0095 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01031 GENEFORM mRNA DME0095 XEOTICID XEO01031 MOACRIVE Induction DME0095 XEOTICID XEO01081 XEO_NAME Thioxotriazole copper(II) DME0095 XEOTICID XEO01081 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO01081 XEO_CLAS Investigative Agent DME0095 XEOTICID XEO01081 DESCRIPT Thioxotriazole copper(II) up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01081 GENEFORM mRNA DME0095 XEOTICID XEO01081 MOACRIVE Induction DME0095 XEOTICID XEO01201 XEO_NAME Antimony potassium tartrate DME0095 XEOTICID XEO01201 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO01201 XEO_CLAS Environmental Pollutant DME0095 XEOTICID XEO01201 DESCRIPT Antimony potassium tartrate up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01201 GENEFORM mRNA DME0095 XEOTICID XEO01201 MOACRIVE Induction DME0095 XEOTICID XEO01222 XEO_NAME Biochanin A DME0095 XEOTICID XEO01222 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0095 XEOTICID XEO01222 XEO_CLAS Natural Product DME0095 XEOTICID XEO01222 DESCRIPT Biochanin A up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01222 GENEFORM mRNA DME0095 XEOTICID XEO01222 MOACRIVE Induction DME0095 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0095 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0095 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME MT2A DME0095 XEOTICID XEO01226 GENEFORM mRNA DME0095 XEOTICID XEO01226 MOACRIVE Inhibition DME0095 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0095 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0095 XEOTICID XEO01247 DESCRIPT Chloropicrin inhibits the expression of DME MT2A DME0095 XEOTICID XEO01247 GENEFORM mRNA DME0095 XEOTICID XEO01247 MOACRIVE Inhibition DME0095 XEOTICID XEO01284 XEO_NAME Dust DME0095 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0095 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0095 XEOTICID XEO01284 DESCRIPT Dust inhibits the expression of DME MT2A DME0095 XEOTICID XEO01284 GENEFORM mRNA DME0095 XEOTICID XEO01284 MOACRIVE Inhibition DME0095 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0095 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0095 XEOTICID XEO01324 DESCRIPT GSK-J4 up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01324 GENEFORM mRNA DME0095 XEOTICID XEO01324 MOACRIVE Induction DME0095 XEOTICID XEO01334 XEO_NAME Hydroxycitronellal DME0095 XEOTICID XEO01334 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0095 XEOTICID XEO01334 XEO_CLAS Cosmetic Additive DME0095 XEOTICID XEO01334 DESCRIPT Hydroxycitronellal up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01334 GENEFORM mRNA DME0095 XEOTICID XEO01334 MOACRIVE Induction DME0095 XEOTICID XEO01348 XEO_NAME K-7174 DME0095 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0095 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME MT2A DME0095 XEOTICID XEO01348 GENEFORM mRNA DME0095 XEOTICID XEO01348 MOACRIVE Inhibition DME0095 XEOTICID XEO01353 XEO_NAME Kaempferol DME0095 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME0095 XEOTICID XEO01353 DESCRIPT Kaempferol up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01353 GENEFORM mRNA DME0095 XEOTICID XEO01353 MOACRIVE Induction DME0095 XEOTICID XEO01397 XEO_NAME Nickel chloride DME0095 XEOTICID XEO01397 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO01397 XEO_CLAS Acute Toxic Substance DME0095 XEOTICID XEO01397 DESCRIPT Nickel chloride up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01397 GENEFORM mRNA DME0095 XEOTICID XEO01397 MOACRIVE Induction DME0095 XEOTICID XEO01420 XEO_NAME Palmitic acid DME0095 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME0095 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the expression of DME MT2A DME0095 XEOTICID XEO01420 GENEFORM mRNA DME0095 XEOTICID XEO01420 MOACRIVE Inhibition DME0095 XEOTICID XEO01423 XEO_NAME PCI-5002 DME0095 XEOTICID XEO01423 XEO_TYPE Pharmaceutical Agent(s) DME0095 XEOTICID XEO01423 XEO_CLAS Investigative Agent DME0095 XEOTICID XEO01423 DESCRIPT PCI-5002 up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01423 GENEFORM mRNA DME0095 XEOTICID XEO01423 MOACRIVE Induction DME0095 XEOTICID XEO01502 XEO_NAME Azaspiracid DME0095 XEOTICID XEO01502 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO01502 XEO_CLAS Biotoxin DME0095 XEOTICID XEO01502 DESCRIPT Azaspiracid up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01502 GENEFORM mRNA DME0095 XEOTICID XEO01502 MOACRIVE Induction DME0095 XEOTICID XEO01503 XEO_NAME Cadmium DME0095 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0095 XEOTICID XEO01503 DESCRIPT Cadmium induces the drug-metabolizing activity of DME MT2A DME0095 XEOTICID XEO01503 GENEFORM Protein DME0095 XEOTICID XEO01503 MOACRIVE Induction DME0095 XEOTICID XEO01504 XEO_NAME Gold DME0095 XEOTICID XEO01504 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0095 XEOTICID XEO01504 XEO_CLAS Chemical Compound DME0095 XEOTICID XEO01504 DESCRIPT Gold up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01504 GENEFORM mRNA DME0095 XEOTICID XEO01504 MOACRIVE Induction DME0095 XEOTICID XEO01505 XEO_NAME Lead DME0095 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0095 XEOTICID XEO01505 DESCRIPT Lead up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01505 GENEFORM mRNA DME0095 XEOTICID XEO01505 MOACRIVE Induction DME0095 XEOTICID XEO01508 XEO_NAME Mercuric chloride DME0095 XEOTICID XEO01508 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO01508 XEO_CLAS Acute Toxic Substance DME0095 XEOTICID XEO01508 DESCRIPT Mercuric chloride up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01508 GENEFORM mRNA DME0095 XEOTICID XEO01508 MOACRIVE Induction DME0095 XEOTICID XEO01512 XEO_NAME Zinc DME0095 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME0095 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME0095 XEOTICID XEO01512 DESCRIPT Zinc up-regulates the expression of DME MT2A DME0095 XEOTICID XEO01512 GENEFORM mRNA DME0095 XEOTICID XEO01512 MOACRIVE Induction DME0096 DME___ID DME0096 DME0096 DME_NAME Myeloperoxidase (MPO) DME0096 SPESNAME Homo sapiens DME0096 XEOTICID XEO00125 XEO_NAME Simvastatin DME0096 XEOTICID XEO00125 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00125 XEO_CLAS Approved/Marketed Drug DME0096 XEOTICID XEO00125 DESCRIPT Simvastatin inhibits the expression of DME MPO DME0096 XEOTICID XEO00125 GENEFORM mRNA DME0096 XEOTICID XEO00125 MOACRIVE Inhibition DME0096 XEOTICID XEO00174 XEO_NAME Propylthiouracil DME0096 XEOTICID XEO00174 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00174 XEO_CLAS Approved/Marketed Drug DME0096 XEOTICID XEO00174 DESCRIPT Propylthiouracil inhibits the drug-metabolizing activity of DME MPO (IC50 = 2.81 microM) DME0096 XEOTICID XEO00174 GENEFORM Protein DME0096 XEOTICID XEO00174 MOACRIVE Inhibition DME0096 XEOTICID XEO00197 XEO_NAME Bivalirudin DME0096 XEOTICID XEO00197 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00197 XEO_CLAS Approved/Marketed Drug DME0096 XEOTICID XEO00197 DESCRIPT Bivalirudin inhibits the drug-metabolizing activity of DME MPO DME0096 XEOTICID XEO00197 GENEFORM Protein DME0096 XEOTICID XEO00197 MOACRIVE Inhibition DME0096 XEOTICID XEO00253 XEO_NAME Tretinoin DME0096 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0096 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the drug-metabolizing activity of DME MPO DME0096 XEOTICID XEO00253 GENEFORM Protein DME0096 XEOTICID XEO00253 MOACRIVE Inhibition DME0096 XEOTICID XEO00301 XEO_NAME Irinotecan hydrochloride DME0096 XEOTICID XEO00301 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00301 XEO_CLAS Approved/Marketed Drug DME0096 XEOTICID XEO00301 DESCRIPT Irinotecan hydrochloride inhibits the expression of DME MPO DME0096 XEOTICID XEO00301 GENEFORM mRNA DME0096 XEOTICID XEO00301 MOACRIVE Inhibition DME0096 XEOTICID XEO00334 XEO_NAME Cisplatin DME0096 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0096 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME MPO DME0096 XEOTICID XEO00334 GENEFORM mRNA DME0096 XEOTICID XEO00334 MOACRIVE Inhibition DME0096 XEOTICID XEO00336 XEO_NAME Abacavir DME0096 XEOTICID XEO00336 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00336 XEO_CLAS Approved/Marketed Drug DME0096 XEOTICID XEO00336 DESCRIPT Abacavir induces the drug-metabolizing activity of DME MPO DME0096 XEOTICID XEO00336 GENEFORM Protein DME0096 XEOTICID XEO00336 MOACRIVE Induction DME0096 XEOTICID XEO00361 XEO_NAME Gemcitabine DME0096 XEOTICID XEO00361 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00361 XEO_CLAS Approved/Marketed Drug DME0096 XEOTICID XEO00361 DESCRIPT Gemcitabine induces the drug-metabolizing activity of DME MPO DME0096 XEOTICID XEO00361 GENEFORM Protein DME0096 XEOTICID XEO00361 MOACRIVE Induction DME0096 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0096 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0096 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide induces the drug-metabolizing activity of DME MPO DME0096 XEOTICID XEO00388 GENEFORM Protein DME0096 XEOTICID XEO00388 MOACRIVE Induction DME0096 XEOTICID XEO00447 XEO_NAME Benzoic acid DME0096 XEOTICID XEO00447 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00447 XEO_CLAS Approved/Marketed Drug DME0096 XEOTICID XEO00447 DESCRIPT Benzoic acid induces the drug-metabolizing activity of DME MPO DME0096 XEOTICID XEO00447 GENEFORM Protein DME0096 XEOTICID XEO00447 MOACRIVE Induction DME0096 XEOTICID XEO00546 XEO_NAME Salicylic acid DME0096 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME0096 XEOTICID XEO00546 DESCRIPT Salicylic acid up-regulates the expression of DME MPO and leads to increasing the drug-metabolizing activity of this enzyme DME0096 XEOTICID XEO00546 GENEFORM Protein DME0096 XEOTICID XEO00546 MOACRIVE Induction DME0096 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0096 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0096 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene inhibits the expression of DME MPO DME0096 XEOTICID XEO00571 GENEFORM mRNA DME0096 XEOTICID XEO00571 MOACRIVE Inhibition DME0096 XEOTICID XEO00683 XEO_NAME Curcumin DME0096 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0096 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of DME MPO DME0096 XEOTICID XEO00683 GENEFORM Protein DME0096 XEOTICID XEO00683 MOACRIVE Inhibition DME0096 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0096 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0096 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME MPO DME0096 XEOTICID XEO00723 GENEFORM mRNA DME0096 XEOTICID XEO00723 MOACRIVE Inhibition DME0096 XEOTICID XEO00834 XEO_NAME Copper DME0096 XEOTICID XEO00834 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO00834 XEO_CLAS Approved/Marketed Drug DME0096 XEOTICID XEO00834 DESCRIPT Copper inhibits the drug-metabolizing activity of DME MPO DME0096 XEOTICID XEO00834 GENEFORM Protein DME0096 XEOTICID XEO00834 MOACRIVE Inhibition DME0096 XEOTICID XEO00839 XEO_NAME Aluminum DME0096 XEOTICID XEO00839 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0096 XEOTICID XEO00839 XEO_CLAS Chemical Compound DME0096 XEOTICID XEO00839 DESCRIPT Aluminum induces the drug-metabolizing activity of DME MPO DME0096 XEOTICID XEO00839 GENEFORM Protein DME0096 XEOTICID XEO00839 MOACRIVE Induction DME0096 XEOTICID XEO00924 XEO_NAME Water pollutants chemical DME0096 XEOTICID XEO00924 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0096 XEOTICID XEO00924 XEO_CLAS Natural Mixture DME0096 XEOTICID XEO00924 DESCRIPT Water pollutants chemical up-regulates the expression of DME MPO DME0096 XEOTICID XEO00924 GENEFORM mRNA DME0096 XEOTICID XEO00924 MOACRIVE Induction DME0096 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0096 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0096 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0096 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium up-regulates the expression of DME MPO DME0096 XEOTICID XEO01103 GENEFORM mRNA DME0096 XEOTICID XEO01103 MOACRIVE Induction DME0096 XEOTICID XEO01149 XEO_NAME 4-aminobenzhydrazide DME0096 XEOTICID XEO01149 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO01149 XEO_CLAS Investigative Agent DME0096 XEOTICID XEO01149 DESCRIPT 4-aminobenzhydrazide inhibits the drug-metabolizing activity of DME MPO (IC50 = 0.3 microM) DME0096 XEOTICID XEO01149 GENEFORM Protein DME0096 XEOTICID XEO01149 MOACRIVE Inhibition DME0096 XEOTICID XEO01232 XEO_NAME Caffeic acid DME0096 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME0096 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME0096 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of DME MPO DME0096 XEOTICID XEO01232 GENEFORM Protein DME0096 XEOTICID XEO01232 MOACRIVE Inhibition DME0096 XEOTICID XEO01279 XEO_NAME Dimethyl formamide DME0096 XEOTICID XEO01279 XEO_TYPE Health or Environmental Toxicant(s) DME0096 XEOTICID XEO01279 XEO_CLAS Health Hazard/Toxicant DME0096 XEOTICID XEO01279 DESCRIPT Dimethyl formamide up-regulates the expression of DME MPO DME0096 XEOTICID XEO01279 GENEFORM mRNA DME0096 XEOTICID XEO01279 MOACRIVE Induction DME0096 XEOTICID XEO01309 XEO_NAME Gallic acid DME0096 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0096 XEOTICID XEO01309 XEO_CLAS Natural Product DME0096 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of DME MPO DME0096 XEOTICID XEO01309 GENEFORM Protein DME0096 XEOTICID XEO01309 MOACRIVE Inhibition DME0096 XEOTICID XEO01330 XEO_NAME Hirudin DME0096 XEOTICID XEO01330 XEO_TYPE Health or Environmental Toxicant(s) DME0096 XEOTICID XEO01330 XEO_CLAS Health Hazard/Toxicant DME0096 XEOTICID XEO01330 DESCRIPT Hirudin inhibits the drug-metabolizing activity of DME MPO DME0096 XEOTICID XEO01330 GENEFORM Protein DME0096 XEOTICID XEO01330 MOACRIVE Inhibition DME0096 XEOTICID XEO01395 XEO_NAME N-formylmethionine leucyl-phenylalanine DME0096 XEOTICID XEO01395 XEO_TYPE Pharmaceutical Agent(s) DME0096 XEOTICID XEO01395 XEO_CLAS Investigative Agent DME0096 XEOTICID XEO01395 DESCRIPT N-formylmethionine leucyl-phenylalanine up-regulates the expression of DME MPO DME0096 XEOTICID XEO01395 GENEFORM mRNA DME0096 XEOTICID XEO01395 MOACRIVE Induction DME0097 DME___ID DME0097 DME0097 DME_NAME Quinone reductase 1 (NQO1) DME0097 SPESNAME Homo sapiens DME0097 XEOTICID XEO00028 XEO_NAME Disulfiram DME0097 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00028 DESCRIPT Disulfiram up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00028 GENEFORM mRNA DME0097 XEOTICID XEO00028 MOACRIVE Induction DME0097 XEOTICID XEO00046 XEO_NAME Ifosfamide DME0097 XEOTICID XEO00046 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00046 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00046 DESCRIPT Ifosfamide inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00046 GENEFORM mRNA DME0097 XEOTICID XEO00046 MOACRIVE Inhibition DME0097 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0097 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00088 GENEFORM mRNA DME0097 XEOTICID XEO00088 MOACRIVE Induction DME0097 XEOTICID XEO00090 XEO_NAME Estradiol DME0097 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00090 GENEFORM Protein DME0097 XEOTICID XEO00090 MOACRIVE Inhibition DME0097 XEOTICID XEO00096 XEO_NAME Ampicillin DME0097 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00096 DESCRIPT Ampicillin up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00096 GENEFORM mRNA DME0097 XEOTICID XEO00096 MOACRIVE Induction DME0097 XEOTICID XEO00099 XEO_NAME Penicillin V DME0097 XEOTICID XEO00099 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00099 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00099 DESCRIPT Penicillin V up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00099 GENEFORM mRNA DME0097 XEOTICID XEO00099 MOACRIVE Induction DME0097 XEOTICID XEO00121 XEO_NAME Etoposide DME0097 XEOTICID XEO00121 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00121 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00121 DESCRIPT Etoposide up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00121 GENEFORM mRNA DME0097 XEOTICID XEO00121 MOACRIVE Induction DME0097 XEOTICID XEO00125 XEO_NAME Simvastatin DME0097 XEOTICID XEO00125 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00125 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00125 DESCRIPT Simvastatin up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00125 GENEFORM mRNA DME0097 XEOTICID XEO00125 MOACRIVE Induction DME0097 XEOTICID XEO00127 XEO_NAME Mifepristone DME0097 XEOTICID XEO00127 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00127 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00127 DESCRIPT Mifepristone inhibits the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00127 GENEFORM Protein DME0097 XEOTICID XEO00127 MOACRIVE Inhibition DME0097 XEOTICID XEO00132 XEO_NAME Cidofovir DME0097 XEOTICID XEO00132 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00132 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00132 DESCRIPT Cidofovir inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00132 GENEFORM mRNA DME0097 XEOTICID XEO00132 MOACRIVE Inhibition DME0097 XEOTICID XEO00135 XEO_NAME Ferric citrate DME0097 XEOTICID XEO00135 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00135 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00135 DESCRIPT Ferric citrate induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00135 GENEFORM Protein DME0097 XEOTICID XEO00135 MOACRIVE Induction DME0097 XEOTICID XEO00148 XEO_NAME Bosentan DME0097 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00148 DESCRIPT Bosentan up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00148 GENEFORM mRNA DME0097 XEOTICID XEO00148 MOACRIVE Induction DME0097 XEOTICID XEO00159 XEO_NAME Bortezomib DME0097 XEOTICID XEO00159 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00159 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00159 DESCRIPT Bortezomib up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00159 GENEFORM mRNA DME0097 XEOTICID XEO00159 MOACRIVE Induction DME0097 XEOTICID XEO00168 XEO_NAME Decitabine DME0097 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00168 DESCRIPT Decitabine up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00168 GENEFORM mRNA DME0097 XEOTICID XEO00168 MOACRIVE Induction DME0097 XEOTICID XEO00172 XEO_NAME Dimethyl fumarate DME0097 XEOTICID XEO00172 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00172 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00172 DESCRIPT Dimethyl fumarate induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00172 GENEFORM Protein DME0097 XEOTICID XEO00172 MOACRIVE Induction DME0097 XEOTICID XEO00177 XEO_NAME Sulindac DME0097 XEOTICID XEO00177 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00177 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00177 DESCRIPT Sulindac induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00177 GENEFORM Protein DME0097 XEOTICID XEO00177 MOACRIVE Induction DME0097 XEOTICID XEO00178 XEO_NAME Capsaicin DME0097 XEOTICID XEO00178 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00178 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00178 DESCRIPT Capsaicin inhibits the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00178 GENEFORM Protein DME0097 XEOTICID XEO00178 MOACRIVE Inhibition DME0097 XEOTICID XEO00193 XEO_NAME Belinostat DME0097 XEOTICID XEO00193 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00193 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00193 DESCRIPT Belinostat up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00193 GENEFORM mRNA DME0097 XEOTICID XEO00193 MOACRIVE Induction DME0097 XEOTICID XEO00203 XEO_NAME Dicumarol DME0097 XEOTICID XEO00203 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00203 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00203 DESCRIPT Dicumarol inhibits the drug-metabolizing activity of DME NQO1 (IC50 = 0.0026 microM) DME0097 XEOTICID XEO00203 GENEFORM Protein DME0097 XEOTICID XEO00203 MOACRIVE Inhibition DME0097 XEOTICID XEO00213 XEO_NAME Aspirin DME0097 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00213 DESCRIPT Aspirin induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00213 GENEFORM Protein DME0097 XEOTICID XEO00213 MOACRIVE Induction DME0097 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0097 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00217 GENEFORM Protein DME0097 XEOTICID XEO00217 MOACRIVE Inhibition DME0097 XEOTICID XEO00224 XEO_NAME Isoniazid DME0097 XEOTICID XEO00224 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00224 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00224 DESCRIPT Isoniazid up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00224 GENEFORM mRNA DME0097 XEOTICID XEO00224 MOACRIVE Induction DME0097 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0097 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00241 GENEFORM mRNA DME0097 XEOTICID XEO00241 MOACRIVE Inhibition DME0097 XEOTICID XEO00244 XEO_NAME Ivermectin DME0097 XEOTICID XEO00244 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00244 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00244 DESCRIPT Ivermectin inhibits the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00244 GENEFORM Protein DME0097 XEOTICID XEO00244 MOACRIVE Inhibition DME0097 XEOTICID XEO00246 XEO_NAME Amoxicillin DME0097 XEOTICID XEO00246 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00246 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00246 DESCRIPT Amoxicillin up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00246 GENEFORM mRNA DME0097 XEOTICID XEO00246 MOACRIVE Induction DME0097 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0097 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00251 DESCRIPT Ketoconazole induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00251 GENEFORM Protein DME0097 XEOTICID XEO00251 MOACRIVE Induction DME0097 XEOTICID XEO00253 XEO_NAME Tretinoin DME0097 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00253 GENEFORM mRNA DME0097 XEOTICID XEO00253 MOACRIVE Induction DME0097 XEOTICID XEO00286 XEO_NAME Deferoxamine mesylate DME0097 XEOTICID XEO00286 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00286 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00286 DESCRIPT Deferoxamine mesylate inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00286 GENEFORM mRNA DME0097 XEOTICID XEO00286 MOACRIVE Inhibition DME0097 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0097 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00292 GENEFORM mRNA DME0097 XEOTICID XEO00292 MOACRIVE Induction DME0097 XEOTICID XEO00296 XEO_NAME Flurbiprofen sodium DME0097 XEOTICID XEO00296 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00296 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00296 DESCRIPT Flurbiprofen sodium induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00296 GENEFORM Protein DME0097 XEOTICID XEO00296 MOACRIVE Induction DME0097 XEOTICID XEO00301 XEO_NAME Irinotecan hydrochloride DME0097 XEOTICID XEO00301 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00301 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00301 DESCRIPT Irinotecan hydrochloride inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00301 GENEFORM mRNA DME0097 XEOTICID XEO00301 MOACRIVE Inhibition DME0097 XEOTICID XEO00304 XEO_NAME Lapatinib ditosylate DME0097 XEOTICID XEO00304 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00304 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00304 DESCRIPT Lapatinib ditosylate up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00304 GENEFORM mRNA DME0097 XEOTICID XEO00304 MOACRIVE Induction DME0097 XEOTICID XEO00334 XEO_NAME Cisplatin DME0097 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00334 DESCRIPT Cisplatin induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00334 GENEFORM Protein DME0097 XEOTICID XEO00334 MOACRIVE Induction DME0097 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0097 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00339 GENEFORM Protein DME0097 XEOTICID XEO00339 MOACRIVE Inhibition DME0097 XEOTICID XEO00351 XEO_NAME Daunorubicin DME0097 XEOTICID XEO00351 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00351 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00351 DESCRIPT Daunorubicin inhibits the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00351 GENEFORM Protein DME0097 XEOTICID XEO00351 MOACRIVE Inhibition DME0097 XEOTICID XEO00352 XEO_NAME Diclofenac DME0097 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00352 DESCRIPT Diclofenac induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00352 GENEFORM Protein DME0097 XEOTICID XEO00352 MOACRIVE Induction DME0097 XEOTICID XEO00365 XEO_NAME Metformin DME0097 XEOTICID XEO00365 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00365 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00365 DESCRIPT Metformin inhibits the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00365 GENEFORM Protein DME0097 XEOTICID XEO00365 MOACRIVE Inhibition DME0097 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0097 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00380 DESCRIPT Rosiglitazone induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00380 GENEFORM Protein DME0097 XEOTICID XEO00380 MOACRIVE Induction DME0097 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0097 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00388 GENEFORM Protein DME0097 XEOTICID XEO00388 MOACRIVE Inhibition DME0097 XEOTICID XEO00411 XEO_NAME Avobenzone DME0097 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00411 GENEFORM mRNA DME0097 XEOTICID XEO00411 MOACRIVE Induction DME0097 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0097 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00430 DESCRIPT Hydroquinone up-regulates the expression of DME NQO1 and leads to increasing the drug-metabolizing activity of this enzyme DME0097 XEOTICID XEO00430 GENEFORM Protein DME0097 XEOTICID XEO00430 MOACRIVE Induction DME0097 XEOTICID XEO00435 XEO_NAME Urethane DME0097 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00435 GENEFORM mRNA DME0097 XEOTICID XEO00435 MOACRIVE Inhibition DME0097 XEOTICID XEO00437 XEO_NAME Penicillin G DME0097 XEOTICID XEO00437 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00437 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00437 DESCRIPT Penicillin G up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00437 GENEFORM mRNA DME0097 XEOTICID XEO00437 MOACRIVE Induction DME0097 XEOTICID XEO00439 XEO_NAME Daidzein DME0097 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00439 GENEFORM mRNA DME0097 XEOTICID XEO00439 MOACRIVE Inhibition DME0097 XEOTICID XEO00447 XEO_NAME Benzoic acid DME0097 XEOTICID XEO00447 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00447 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00447 DESCRIPT Benzoic acid up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00447 GENEFORM mRNA DME0097 XEOTICID XEO00447 MOACRIVE Induction DME0097 XEOTICID XEO00465 XEO_NAME Clodronic acid DME0097 XEOTICID XEO00465 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00465 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00465 DESCRIPT Clodronic acid inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00465 GENEFORM mRNA DME0097 XEOTICID XEO00465 MOACRIVE Inhibition DME0097 XEOTICID XEO00538 XEO_NAME Quercetin DME0097 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0097 XEOTICID XEO00538 DESCRIPT Quercetin induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00538 GENEFORM Protein DME0097 XEOTICID XEO00538 MOACRIVE Induction DME0097 XEOTICID XEO00539 XEO_NAME Ethanol DME0097 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0097 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00539 GENEFORM mRNA DME0097 XEOTICID XEO00539 MOACRIVE Inhibition DME0097 XEOTICID XEO00543 XEO_NAME Andrographolide DME0097 XEOTICID XEO00543 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00543 XEO_CLAS Drug in Phase 2 Clinical Trial DME0097 XEOTICID XEO00543 DESCRIPT Andrographolide induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00543 GENEFORM Protein DME0097 XEOTICID XEO00543 MOACRIVE Induction DME0097 XEOTICID XEO00547 XEO_NAME Vitamin E DME0097 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0097 XEOTICID XEO00547 DESCRIPT Vitamin E up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00547 GENEFORM mRNA DME0097 XEOTICID XEO00547 MOACRIVE Induction DME0097 XEOTICID XEO00557 XEO_NAME Genistein DME0097 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0097 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00557 GENEFORM mRNA DME0097 XEOTICID XEO00557 MOACRIVE Inhibition DME0097 XEOTICID XEO00558 XEO_NAME Phenol DME0097 XEOTICID XEO00558 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00558 XEO_CLAS Drug in Phase 2 Clinical Trial DME0097 XEOTICID XEO00558 DESCRIPT Phenol up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00558 GENEFORM mRNA DME0097 XEOTICID XEO00558 MOACRIVE Induction DME0097 XEOTICID XEO00568 XEO_NAME Resveratrol DME0097 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0097 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00568 GENEFORM mRNA DME0097 XEOTICID XEO00568 MOACRIVE Inhibition DME0097 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0097 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0097 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00571 GENEFORM mRNA DME0097 XEOTICID XEO00571 MOACRIVE Induction DME0097 XEOTICID XEO00573 XEO_NAME Naringenin DME0097 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME0097 XEOTICID XEO00573 DESCRIPT Naringenin induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00573 GENEFORM Protein DME0097 XEOTICID XEO00573 MOACRIVE Induction DME0097 XEOTICID XEO00581 XEO_NAME MS-275 DME0097 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0097 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00581 GENEFORM mRNA DME0097 XEOTICID XEO00581 MOACRIVE Induction DME0097 XEOTICID XEO00596 XEO_NAME Phenethyl isothiocyanate DME0097 XEOTICID XEO00596 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00596 XEO_CLAS Drug in Phase 2 Clinical Trial DME0097 XEOTICID XEO00596 DESCRIPT Phenethyl isothiocyanate up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00596 GENEFORM mRNA DME0097 XEOTICID XEO00596 MOACRIVE Induction DME0097 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0097 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0097 XEOTICID XEO00632 DESCRIPT Sodium arsenite induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00632 GENEFORM Protein DME0097 XEOTICID XEO00632 MOACRIVE Induction DME0097 XEOTICID XEO00636 XEO_NAME Xanthohumol DME0097 XEOTICID XEO00636 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00636 XEO_CLAS Drug in Phase 1 Clinical Trial DME0097 XEOTICID XEO00636 DESCRIPT Xanthohumol induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00636 GENEFORM Protein DME0097 XEOTICID XEO00636 MOACRIVE Induction DME0097 XEOTICID XEO00656 XEO_NAME Sulindac sulfide DME0097 XEOTICID XEO00656 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00656 XEO_CLAS Drug in Phase 2 Clinical Trial DME0097 XEOTICID XEO00656 DESCRIPT Sulindac sulfide up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00656 GENEFORM mRNA DME0097 XEOTICID XEO00656 MOACRIVE Induction DME0097 XEOTICID XEO00673 XEO_NAME ZIO-101 DME0097 XEOTICID XEO00673 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00673 XEO_CLAS Drug in Phase 2 Clinical Trial DME0097 XEOTICID XEO00673 DESCRIPT ZIO-101 induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00673 GENEFORM Protein DME0097 XEOTICID XEO00673 MOACRIVE Induction DME0097 XEOTICID XEO00683 XEO_NAME Curcumin DME0097 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0097 XEOTICID XEO00683 DESCRIPT Curcumin induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00683 GENEFORM Protein DME0097 XEOTICID XEO00683 MOACRIVE Induction DME0097 XEOTICID XEO00710 XEO_NAME Isoliquiritigenin DME0097 XEOTICID XEO00710 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00710 XEO_CLAS Preclinical/Patented Drug DME0097 XEOTICID XEO00710 DESCRIPT Isoliquiritigenin induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00710 GENEFORM Protein DME0097 XEOTICID XEO00710 MOACRIVE Induction DME0097 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0097 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0097 XEOTICID XEO00723 DESCRIPT (+)-JQ1 induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00723 GENEFORM Protein DME0097 XEOTICID XEO00723 MOACRIVE Induction DME0097 XEOTICID XEO00745 XEO_NAME Adefovir dipivoxil DME0097 XEOTICID XEO00745 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00745 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO00745 DESCRIPT Adefovir dipivoxil inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00745 GENEFORM mRNA DME0097 XEOTICID XEO00745 MOACRIVE Inhibition DME0097 XEOTICID XEO00755 XEO_NAME Coal tar DME0097 XEOTICID XEO00755 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO00755 XEO_CLAS Natural Mixture DME0097 XEOTICID XEO00755 DESCRIPT Coal tar up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00755 GENEFORM mRNA DME0097 XEOTICID XEO00755 MOACRIVE Induction DME0097 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0097 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0097 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00772 GENEFORM mRNA DME0097 XEOTICID XEO00772 MOACRIVE Induction DME0097 XEOTICID XEO00776 XEO_NAME Polychlorinated biphenyls DME0097 XEOTICID XEO00776 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO00776 XEO_CLAS Carcinogen DME0097 XEOTICID XEO00776 DESCRIPT Polychlorinated biphenyls up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00776 GENEFORM mRNA DME0097 XEOTICID XEO00776 MOACRIVE Induction DME0097 XEOTICID XEO00779 XEO_NAME Sarin DME0097 XEOTICID XEO00779 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO00779 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO00779 DESCRIPT Sarin inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00779 GENEFORM mRNA DME0097 XEOTICID XEO00779 MOACRIVE Inhibition DME0097 XEOTICID XEO00814 XEO_NAME Sesquiterpene DME0097 XEOTICID XEO00814 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO00814 XEO_CLAS Natural Product DME0097 XEOTICID XEO00814 DESCRIPT Sesquiterpene up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00814 GENEFORM mRNA DME0097 XEOTICID XEO00814 MOACRIVE Induction DME0097 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0097 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0097 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME NQO1 and leads to increasing the drug-metabolizing activity of this enzyme DME0097 XEOTICID XEO00818 GENEFORM Protein DME0097 XEOTICID XEO00818 MOACRIVE Induction DME0097 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0097 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0097 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00821 GENEFORM mRNA DME0097 XEOTICID XEO00821 MOACRIVE Induction DME0097 XEOTICID XEO00825 XEO_NAME Angelicae sinensis extract DME0097 XEOTICID XEO00825 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO00825 XEO_CLAS Plant Extract DME0097 XEOTICID XEO00825 DESCRIPT Angelicae sinensis extract up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00825 GENEFORM mRNA DME0097 XEOTICID XEO00825 MOACRIVE Induction DME0097 XEOTICID XEO00847 XEO_NAME LY-353381 DME0097 XEOTICID XEO00847 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00847 XEO_CLAS Drug in Phase 3 Clinical Trial DME0097 XEOTICID XEO00847 DESCRIPT LY-353381 up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00847 GENEFORM mRNA DME0097 XEOTICID XEO00847 MOACRIVE Induction DME0097 XEOTICID XEO00856 XEO_NAME Hesperetin DME0097 XEOTICID XEO00856 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO00856 XEO_CLAS Natural Product DME0097 XEOTICID XEO00856 DESCRIPT Hesperetin induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00856 GENEFORM Protein DME0097 XEOTICID XEO00856 MOACRIVE Induction DME0097 XEOTICID XEO00865 XEO_NAME Sanguinarine DME0097 XEOTICID XEO00865 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO00865 XEO_CLAS Natural Product DME0097 XEOTICID XEO00865 DESCRIPT Sanguinarine inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00865 GENEFORM mRNA DME0097 XEOTICID XEO00865 MOACRIVE Inhibition DME0097 XEOTICID XEO00869 XEO_NAME 4-hydroxy-2-nonenal DME0097 XEOTICID XEO00869 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00869 XEO_CLAS Investigative Agent DME0097 XEOTICID XEO00869 DESCRIPT 4-hydroxy-2-nonenal induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00869 GENEFORM Protein DME0097 XEOTICID XEO00869 MOACRIVE Induction DME0097 XEOTICID XEO00871 XEO_NAME 9,10-phenanthrenequinone DME0097 XEOTICID XEO00871 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00871 XEO_CLAS Investigative Agent DME0097 XEOTICID XEO00871 DESCRIPT 9,10-phenanthrenequinone induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00871 GENEFORM Protein DME0097 XEOTICID XEO00871 MOACRIVE Induction DME0097 XEOTICID XEO00884 XEO_NAME Thiram DME0097 XEOTICID XEO00884 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO00884 XEO_CLAS Health Hazard/Toxicant DME0097 XEOTICID XEO00884 DESCRIPT Thiram up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00884 GENEFORM mRNA DME0097 XEOTICID XEO00884 MOACRIVE Induction DME0097 XEOTICID XEO00885 XEO_NAME Eugenol DME0097 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0097 XEOTICID XEO00885 DESCRIPT Eugenol induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00885 GENEFORM Protein DME0097 XEOTICID XEO00885 MOACRIVE Induction DME0097 XEOTICID XEO00890 XEO_NAME 2-methyl-4-isothiazolin-3-one DME0097 XEOTICID XEO00890 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO00890 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO00890 DESCRIPT 2-methyl-4-isothiazolin-3-one up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00890 GENEFORM mRNA DME0097 XEOTICID XEO00890 MOACRIVE Induction DME0097 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0097 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0097 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00898 GENEFORM Protein DME0097 XEOTICID XEO00898 MOACRIVE Induction DME0097 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0097 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0097 XEOTICID XEO00899 DESCRIPT Methylcholanthrene induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00899 GENEFORM Protein DME0097 XEOTICID XEO00899 MOACRIVE Induction DME0097 XEOTICID XEO00919 XEO_NAME Particulate matter DME0097 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0097 XEOTICID XEO00919 DESCRIPT Particulate matter up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00919 GENEFORM mRNA DME0097 XEOTICID XEO00919 MOACRIVE Induction DME0097 XEOTICID XEO00954 XEO_NAME Polyhexamethyleneguanidine DME0097 XEOTICID XEO00954 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0097 XEOTICID XEO00954 XEO_CLAS Fungicide DME0097 XEOTICID XEO00954 DESCRIPT Polyhexamethyleneguanidine inhibits the expression of DME NQO1 DME0097 XEOTICID XEO00954 GENEFORM mRNA DME0097 XEOTICID XEO00954 MOACRIVE Inhibition DME0097 XEOTICID XEO00965 XEO_NAME Cyanoginosin LR DME0097 XEOTICID XEO00965 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO00965 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO00965 DESCRIPT Cyanoginosin LR induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00965 GENEFORM Protein DME0097 XEOTICID XEO00965 MOACRIVE Induction DME0097 XEOTICID XEO00971 XEO_NAME Diquat DME0097 XEOTICID XEO00971 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0097 XEOTICID XEO00971 XEO_CLAS Herbicide DME0097 XEOTICID XEO00971 DESCRIPT Diquat induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00971 GENEFORM Protein DME0097 XEOTICID XEO00971 MOACRIVE Induction DME0097 XEOTICID XEO00982 XEO_NAME Monomethylarsonic acid DME0097 XEOTICID XEO00982 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0097 XEOTICID XEO00982 XEO_CLAS Herbicide DME0097 XEOTICID XEO00982 DESCRIPT Monomethylarsonic acid induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00982 GENEFORM Protein DME0097 XEOTICID XEO00982 MOACRIVE Induction DME0097 XEOTICID XEO00985 XEO_NAME Hexyl cinnamic aldehyde DME0097 XEOTICID XEO00985 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO00985 XEO_CLAS Environmental Pollutant DME0097 XEOTICID XEO00985 DESCRIPT Hexyl cinnamic aldehyde up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO00985 GENEFORM mRNA DME0097 XEOTICID XEO00985 MOACRIVE Induction DME0097 XEOTICID XEO00992 XEO_NAME Acrylonitrile DME0097 XEOTICID XEO00992 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO00992 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO00992 DESCRIPT Acrylonitrile induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO00992 GENEFORM Protein DME0097 XEOTICID XEO00992 MOACRIVE Induction DME0097 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0097 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0097 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01004 GENEFORM mRNA DME0097 XEOTICID XEO01004 MOACRIVE Induction DME0097 XEOTICID XEO01009 XEO_NAME Glycidamide DME0097 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0097 XEOTICID XEO01009 DESCRIPT Glycidamide up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01009 GENEFORM mRNA DME0097 XEOTICID XEO01009 MOACRIVE Induction DME0097 XEOTICID XEO01014 XEO_NAME Molybdenum trioxide DME0097 XEOTICID XEO01014 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01014 XEO_CLAS Health Hazard/Toxicant DME0097 XEOTICID XEO01014 DESCRIPT Molybdenum trioxide up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01014 GENEFORM mRNA DME0097 XEOTICID XEO01014 MOACRIVE Induction DME0097 XEOTICID XEO01016 XEO_NAME N-hexane DME0097 XEOTICID XEO01016 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01016 XEO_CLAS Health Hazard/Toxicant DME0097 XEOTICID XEO01016 DESCRIPT N-hexane induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01016 GENEFORM Protein DME0097 XEOTICID XEO01016 MOACRIVE Induction DME0097 XEOTICID XEO01023 XEO_NAME Sodium arsenate DME0097 XEOTICID XEO01023 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01023 XEO_CLAS Environmental Pollutant DME0097 XEOTICID XEO01023 DESCRIPT Sodium arsenate up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01023 GENEFORM mRNA DME0097 XEOTICID XEO01023 MOACRIVE Induction DME0097 XEOTICID XEO01093 XEO_NAME 1,6-hexamethylene diisocyanate DME0097 XEOTICID XEO01093 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01093 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO01093 DESCRIPT 1,6-hexamethylene diisocyanate up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01093 GENEFORM mRNA DME0097 XEOTICID XEO01093 MOACRIVE Induction DME0097 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0097 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0097 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01103 GENEFORM Protein DME0097 XEOTICID XEO01103 MOACRIVE Induction DME0097 XEOTICID XEO01123 XEO_NAME GW9662 DME0097 XEOTICID XEO01123 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01123 XEO_CLAS Investigative Agent DME0097 XEOTICID XEO01123 DESCRIPT GW9662 up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01123 GENEFORM mRNA DME0097 XEOTICID XEO01123 MOACRIVE Induction DME0097 XEOTICID XEO01128 XEO_NAME Isopropanol DME0097 XEOTICID XEO01128 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01128 XEO_CLAS Investigative Agent DME0097 XEOTICID XEO01128 DESCRIPT Isopropanol up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01128 GENEFORM mRNA DME0097 XEOTICID XEO01128 MOACRIVE Induction DME0097 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0097 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0097 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01129 GENEFORM Protein DME0097 XEOTICID XEO01129 MOACRIVE Induction DME0097 XEOTICID XEO01142 XEO_NAME 3-morpholinopropyl isothiocyanate DME0097 XEOTICID XEO01142 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01142 XEO_CLAS Health Hazard/Toxicant DME0097 XEOTICID XEO01142 DESCRIPT 3-morpholinopropyl isothiocyanate up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01142 GENEFORM mRNA DME0097 XEOTICID XEO01142 MOACRIVE Induction DME0097 XEOTICID XEO01148 XEO_NAME TIMBD DME0097 XEOTICID XEO01148 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01148 XEO_CLAS Investigative Agent DME0097 XEOTICID XEO01148 DESCRIPT TIMBD induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01148 GENEFORM Protein DME0097 XEOTICID XEO01148 MOACRIVE Induction DME0097 XEOTICID XEO01150 XEO_NAME 4'-bromoflavone DME0097 XEOTICID XEO01150 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01150 XEO_CLAS Investigative Agent DME0097 XEOTICID XEO01150 DESCRIPT 4'-bromoflavone induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01150 GENEFORM Protein DME0097 XEOTICID XEO01150 MOACRIVE Induction DME0097 XEOTICID XEO01162 XEO_NAME ES-936 DME0097 XEOTICID XEO01162 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01162 XEO_CLAS Investigative Agent DME0097 XEOTICID XEO01162 DESCRIPT ES-936 inhibits the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01162 GENEFORM Protein DME0097 XEOTICID XEO01162 MOACRIVE Inhibition DME0097 XEOTICID XEO01173 XEO_NAME 7-aminocephalosporanic acid DME0097 XEOTICID XEO01173 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01173 XEO_CLAS Health Hazard/Toxicant DME0097 XEOTICID XEO01173 DESCRIPT 7-aminocephalosporanic acid up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01173 GENEFORM mRNA DME0097 XEOTICID XEO01173 MOACRIVE Induction DME0097 XEOTICID XEO01186 XEO_NAME Acrolein DME0097 XEOTICID XEO01186 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01186 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO01186 DESCRIPT Acrolein induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01186 GENEFORM Protein DME0097 XEOTICID XEO01186 MOACRIVE Induction DME0097 XEOTICID XEO01187 XEO_NAME Acrylamide DME0097 XEOTICID XEO01187 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01187 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO01187 DESCRIPT Acrylamide inhibits the expression of DME NQO1 DME0097 XEOTICID XEO01187 GENEFORM mRNA DME0097 XEOTICID XEO01187 MOACRIVE Inhibition DME0097 XEOTICID XEO01193 XEO_NAME Aluminum maltolate DME0097 XEOTICID XEO01193 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01193 XEO_CLAS Investigative Agent DME0097 XEOTICID XEO01193 DESCRIPT Aluminum maltolate inhibits the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01193 GENEFORM Protein DME0097 XEOTICID XEO01193 MOACRIVE Inhibition DME0097 XEOTICID XEO01201 XEO_NAME Antimony potassium tartrate DME0097 XEOTICID XEO01201 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01201 XEO_CLAS Environmental Pollutant DME0097 XEOTICID XEO01201 DESCRIPT Antimony potassium tartrate induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01201 GENEFORM Protein DME0097 XEOTICID XEO01201 MOACRIVE Induction DME0097 XEOTICID XEO01214 XEO_NAME Bay 11-7085 DME0097 XEOTICID XEO01214 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01214 XEO_CLAS Preclinical/Patented Drug DME0097 XEOTICID XEO01214 DESCRIPT Bay 11-7085 up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01214 GENEFORM mRNA DME0097 XEOTICID XEO01214 MOACRIVE Induction DME0097 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0097 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0097 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01220 GENEFORM Protein DME0097 XEOTICID XEO01220 MOACRIVE Induction DME0097 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0097 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0097 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01226 GENEFORM mRNA DME0097 XEOTICID XEO01226 MOACRIVE Induction DME0097 XEOTICID XEO01230 XEO_NAME Butyric acid DME0097 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0097 XEOTICID XEO01230 DESCRIPT Butyric acid induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01230 GENEFORM Protein DME0097 XEOTICID XEO01230 MOACRIVE Induction DME0097 XEOTICID XEO01231 XEO_NAME Cacodylic acid DME0097 XEOTICID XEO01231 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01231 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO01231 DESCRIPT Cacodylic acid up-regulates the expression of DME NQO1 and leads to increasing the drug-metabolizing activity of this enzyme DME0097 XEOTICID XEO01231 GENEFORM Protein DME0097 XEOTICID XEO01231 MOACRIVE Induction DME0097 XEOTICID XEO01240 XEO_NAME Catechol DME0097 XEOTICID XEO01240 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01240 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO01240 DESCRIPT Catechol up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01240 GENEFORM mRNA DME0097 XEOTICID XEO01240 MOACRIVE Induction DME0097 XEOTICID XEO01246 XEO_NAME Chlorogenic acid DME0097 XEOTICID XEO01246 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01246 XEO_CLAS Drug in Phase 2 Clinical Trial DME0097 XEOTICID XEO01246 DESCRIPT Chlorogenic acid up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01246 GENEFORM mRNA DME0097 XEOTICID XEO01246 MOACRIVE Induction DME0097 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0097 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO01247 DESCRIPT Chloropicrin up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01247 GENEFORM mRNA DME0097 XEOTICID XEO01247 MOACRIVE Induction DME0097 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME0097 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO01253 XEO_CLAS Natural Product DME0097 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01253 GENEFORM Protein DME0097 XEOTICID XEO01253 MOACRIVE Induction DME0097 XEOTICID XEO01262 XEO_NAME CP-673,451 DME0097 XEOTICID XEO01262 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01262 XEO_CLAS Preclinical/Patented Drug DME0097 XEOTICID XEO01262 DESCRIPT CP-673,451 inhibits the expression of DME NQO1 DME0097 XEOTICID XEO01262 GENEFORM mRNA DME0097 XEOTICID XEO01262 MOACRIVE Inhibition DME0097 XEOTICID XEO01269 XEO_NAME Cynaropicrin DME0097 XEOTICID XEO01269 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01269 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO01269 DESCRIPT Cynaropicrin up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01269 GENEFORM mRNA DME0097 XEOTICID XEO01269 MOACRIVE Induction DME0097 XEOTICID XEO01271 XEO_NAME Demethoxycurcumin DME0097 XEOTICID XEO01271 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01271 XEO_CLAS Environmental Pollutant DME0097 XEOTICID XEO01271 DESCRIPT Demethoxycurcumin induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01271 GENEFORM Protein DME0097 XEOTICID XEO01271 MOACRIVE Induction DME0097 XEOTICID XEO01274 XEO_NAME Diazinon DME0097 XEOTICID XEO01274 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01274 XEO_CLAS Environmental Pollutant DME0097 XEOTICID XEO01274 DESCRIPT Diazinon up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01274 GENEFORM mRNA DME0097 XEOTICID XEO01274 MOACRIVE Induction DME0097 XEOTICID XEO01284 XEO_NAME Dust DME0097 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0097 XEOTICID XEO01284 DESCRIPT Dust up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01284 GENEFORM mRNA DME0097 XEOTICID XEO01284 MOACRIVE Induction DME0097 XEOTICID XEO01287 XEO_NAME Ellagic acid DME0097 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME0097 XEOTICID XEO01287 DESCRIPT Ellagic acid induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01287 GENEFORM Protein DME0097 XEOTICID XEO01287 MOACRIVE Induction DME0097 XEOTICID XEO01291 XEO_NAME Esculetin DME0097 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME0097 XEOTICID XEO01291 DESCRIPT Esculetin up-regulates the expression of DME NQO1 and leads to increasing the drug-metabolizing activity of this enzyme DME0097 XEOTICID XEO01291 GENEFORM Protein DME0097 XEOTICID XEO01291 MOACRIVE Induction DME0097 XEOTICID XEO01328 XEO_NAME Hemin DME0097 XEOTICID XEO01328 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01328 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO01328 DESCRIPT Hemin induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01328 GENEFORM Protein DME0097 XEOTICID XEO01328 MOACRIVE Induction DME0097 XEOTICID XEO01366 XEO_NAME Linalool DME0097 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO01366 XEO_CLAS Natural Product DME0097 XEOTICID XEO01366 DESCRIPT Linalool up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01366 GENEFORM mRNA DME0097 XEOTICID XEO01366 MOACRIVE Induction DME0097 XEOTICID XEO01367 XEO_NAME Linoleic acid DME0097 XEOTICID XEO01367 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01367 XEO_CLAS Approved/Marketed Drug DME0097 XEOTICID XEO01367 DESCRIPT Linoleic acid up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01367 GENEFORM mRNA DME0097 XEOTICID XEO01367 MOACRIVE Induction DME0097 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0097 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO01407 DESCRIPT Ochratoxin A inhibits the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01407 GENEFORM Protein DME0097 XEOTICID XEO01407 MOACRIVE Inhibition DME0097 XEOTICID XEO01422 XEO_NAME Paraquat DME0097 XEOTICID XEO01422 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01422 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO01422 DESCRIPT Paraquat inhibits the expression of DME NQO1 DME0097 XEOTICID XEO01422 GENEFORM mRNA DME0097 XEOTICID XEO01422 MOACRIVE Inhibition DME0097 XEOTICID XEO01435 XEO_NAME Plumbagin DME0097 XEOTICID XEO01435 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01435 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO01435 DESCRIPT Plumbagin up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01435 GENEFORM mRNA DME0097 XEOTICID XEO01435 MOACRIVE Induction DME0097 XEOTICID XEO01441 XEO_NAME Pterostilbene DME0097 XEOTICID XEO01441 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01441 XEO_CLAS Environmental Pollutant DME0097 XEOTICID XEO01441 DESCRIPT Pterostilbene up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01441 GENEFORM mRNA DME0097 XEOTICID XEO01441 MOACRIVE Induction DME0097 XEOTICID XEO01448 XEO_NAME Pyruvaldehyde DME0097 XEOTICID XEO01448 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01448 XEO_CLAS Health Hazard/Toxicant DME0097 XEOTICID XEO01448 DESCRIPT Pyruvaldehyde up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01448 GENEFORM mRNA DME0097 XEOTICID XEO01448 MOACRIVE Induction DME0097 XEOTICID XEO01450 XEO_NAME Quinone DME0097 XEOTICID XEO01450 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO01450 XEO_CLAS Natural Product DME0097 XEOTICID XEO01450 DESCRIPT Quinone up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01450 GENEFORM mRNA DME0097 XEOTICID XEO01450 MOACRIVE Induction DME0097 XEOTICID XEO01471 XEO_NAME Sirtinol DME0097 XEOTICID XEO01471 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01471 XEO_CLAS Investigative Agent DME0097 XEOTICID XEO01471 DESCRIPT Sirtinol up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01471 GENEFORM mRNA DME0097 XEOTICID XEO01471 MOACRIVE Induction DME0097 XEOTICID XEO01478 XEO_NAME Sulforafan DME0097 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0097 XEOTICID XEO01478 DESCRIPT Sulforafan induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01478 GENEFORM Protein DME0097 XEOTICID XEO01478 MOACRIVE Induction DME0097 XEOTICID XEO01483 XEO_NAME Thioctic acid DME0097 XEOTICID XEO01483 XEO_TYPE Pharmaceutical Agent(s) DME0097 XEOTICID XEO01483 XEO_CLAS Drug in Phase 1 Clinical Trial DME0097 XEOTICID XEO01483 DESCRIPT Thioctic acid induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01483 GENEFORM Protein DME0097 XEOTICID XEO01483 MOACRIVE Induction DME0097 XEOTICID XEO01489 XEO_NAME Toluene DME0097 XEOTICID XEO01489 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01489 XEO_CLAS Health Hazard/Toxicant DME0097 XEOTICID XEO01489 DESCRIPT Toluene up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01489 GENEFORM mRNA DME0097 XEOTICID XEO01489 MOACRIVE Induction DME0097 XEOTICID XEO01497 XEO_NAME Usnic acid DME0097 XEOTICID XEO01497 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01497 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO01497 DESCRIPT Usnic acid up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01497 GENEFORM mRNA DME0097 XEOTICID XEO01497 MOACRIVE Induction DME0097 XEOTICID XEO01503 XEO_NAME Cadmium DME0097 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO01503 DESCRIPT Cadmium induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01503 GENEFORM Protein DME0097 XEOTICID XEO01503 MOACRIVE Induction DME0097 XEOTICID XEO01504 XEO_NAME Gold DME0097 XEOTICID XEO01504 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0097 XEOTICID XEO01504 XEO_CLAS Chemical Compound DME0097 XEOTICID XEO01504 DESCRIPT Gold up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01504 GENEFORM mRNA DME0097 XEOTICID XEO01504 MOACRIVE Induction DME0097 XEOTICID XEO01505 XEO_NAME Lead DME0097 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0097 XEOTICID XEO01505 DESCRIPT Lead up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01505 GENEFORM mRNA DME0097 XEOTICID XEO01505 MOACRIVE Induction DME0097 XEOTICID XEO01508 XEO_NAME Mercuric chloride DME0097 XEOTICID XEO01508 XEO_TYPE Health or Environmental Toxicant(s) DME0097 XEOTICID XEO01508 XEO_CLAS Acute Toxic Substance DME0097 XEOTICID XEO01508 DESCRIPT Mercuric chloride up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01508 GENEFORM mRNA DME0097 XEOTICID XEO01508 MOACRIVE Induction DME0097 XEOTICID XEO01535 XEO_NAME Cyanidin 3-O-glucoside DME0097 XEOTICID XEO01535 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO01535 XEO_CLAS Natural Product DME0097 XEOTICID XEO01535 DESCRIPT Cyanidin 3-O-glucoside up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01535 GENEFORM mRNA DME0097 XEOTICID XEO01535 MOACRIVE Induction DME0097 XEOTICID XEO01536 XEO_NAME Daphnetin DME0097 XEOTICID XEO01536 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO01536 XEO_CLAS Natural Product DME0097 XEOTICID XEO01536 DESCRIPT Daphnetin induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01536 GENEFORM Protein DME0097 XEOTICID XEO01536 MOACRIVE Induction DME0097 XEOTICID XEO01545 XEO_NAME Genipin DME0097 XEOTICID XEO01545 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO01545 XEO_CLAS Natural Product DME0097 XEOTICID XEO01545 DESCRIPT Genipin induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01545 GENEFORM Protein DME0097 XEOTICID XEO01545 MOACRIVE Induction DME0097 XEOTICID XEO01548 XEO_NAME Glucobrassicin DME0097 XEOTICID XEO01548 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO01548 XEO_CLAS Natural Product DME0097 XEOTICID XEO01548 DESCRIPT Glucobrassicin inhibits the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01548 GENEFORM Protein DME0097 XEOTICID XEO01548 MOACRIVE Inhibition DME0097 XEOTICID XEO01553 XEO_NAME Isoflavone DME0097 XEOTICID XEO01553 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO01553 XEO_CLAS Natural Product DME0097 XEOTICID XEO01553 DESCRIPT Isoflavone up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01553 GENEFORM mRNA DME0097 XEOTICID XEO01553 MOACRIVE Induction DME0097 XEOTICID XEO01558 XEO_NAME Ligustilide DME0097 XEOTICID XEO01558 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO01558 XEO_CLAS Natural Product DME0097 XEOTICID XEO01558 DESCRIPT Ligustilide up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01558 GENEFORM mRNA DME0097 XEOTICID XEO01558 MOACRIVE Induction DME0097 XEOTICID XEO01574 XEO_NAME Plant extracts DME0097 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0097 XEOTICID XEO01574 DESCRIPT Plant extracts induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01574 GENEFORM Protein DME0097 XEOTICID XEO01574 MOACRIVE Induction DME0097 XEOTICID XEO01578 XEO_NAME Polyphenols DME0097 XEOTICID XEO01578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO01578 XEO_CLAS Natural Mixture DME0097 XEOTICID XEO01578 DESCRIPT Polyphenols up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01578 GENEFORM mRNA DME0097 XEOTICID XEO01578 MOACRIVE Induction DME0097 XEOTICID XEO01579 XEO_NAME Guggulsterone DME0097 XEOTICID XEO01579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO01579 XEO_CLAS Natural Product DME0097 XEOTICID XEO01579 DESCRIPT Guggulsterone up-regulates the expression of DME NQO1 DME0097 XEOTICID XEO01579 GENEFORM mRNA DME0097 XEOTICID XEO01579 MOACRIVE Induction DME0097 XEOTICID XEO01591 XEO_NAME Taxifolin DME0097 XEOTICID XEO01591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0097 XEOTICID XEO01591 XEO_CLAS Natural Product DME0097 XEOTICID XEO01591 DESCRIPT Taxifolin induces the drug-metabolizing activity of DME NQO1 DME0097 XEOTICID XEO01591 GENEFORM Protein DME0097 XEOTICID XEO01591 MOACRIVE Induction DME0098 DME___ID DME0098 DME0098 DME_NAME Aldo-keto reductase 1A1 (AKR1A1) DME0098 SPESNAME Homo sapiens DME0098 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0098 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0098 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0098 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME AKR1A1 DME0098 XEOTICID XEO00117 GENEFORM mRNA DME0098 XEOTICID XEO00117 MOACRIVE Inhibition DME0098 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0098 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0098 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0098 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME AKR1A1 DME0098 XEOTICID XEO00186 GENEFORM mRNA DME0098 XEOTICID XEO00186 MOACRIVE Inhibition DME0098 XEOTICID XEO00578 XEO_NAME Arecoline DME0098 XEOTICID XEO00578 XEO_TYPE Pharmaceutical Agent(s) DME0098 XEOTICID XEO00578 XEO_CLAS Drug in Phase 2 Clinical Trial DME0098 XEOTICID XEO00578 DESCRIPT Arecoline inhibits the expression of DME AKR1A1 DME0098 XEOTICID XEO00578 GENEFORM mRNA DME0098 XEOTICID XEO00578 MOACRIVE Inhibition DME0098 XEOTICID XEO00760 XEO_NAME Jinfukang DME0098 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0098 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0098 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME AKR1A1 DME0098 XEOTICID XEO00760 GENEFORM mRNA DME0098 XEOTICID XEO00760 MOACRIVE Induction DME0098 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0098 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0098 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0098 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME AKR1A1 DME0098 XEOTICID XEO00806 GENEFORM mRNA DME0098 XEOTICID XEO00806 MOACRIVE Inhibition DME0098 XEOTICID XEO00907 XEO_NAME Dietary carbohydrates DME0098 XEOTICID XEO00907 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0098 XEOTICID XEO00907 XEO_CLAS Natural Mixture DME0098 XEOTICID XEO00907 DESCRIPT Dietary carbohydrates inhibits the expression of DME AKR1A1 DME0098 XEOTICID XEO00907 GENEFORM mRNA DME0098 XEOTICID XEO00907 MOACRIVE Inhibition DME0098 XEOTICID XEO00969 XEO_NAME Atrazine DME0098 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0098 XEOTICID XEO00969 XEO_CLAS Herbicide DME0098 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME AKR1A1 DME0098 XEOTICID XEO00969 GENEFORM mRNA DME0098 XEOTICID XEO00969 MOACRIVE Induction DME0098 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0098 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0098 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0098 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME AKR1A1 DME0098 XEOTICID XEO01220 GENEFORM mRNA DME0098 XEOTICID XEO01220 MOACRIVE Induction DME0098 XEOTICID XEO01378 XEO_NAME Metribolone DME0098 XEOTICID XEO01378 XEO_TYPE Pharmaceutical Agent(s) DME0098 XEOTICID XEO01378 XEO_CLAS Investigative Agent DME0098 XEOTICID XEO01378 DESCRIPT Metribolone up-regulates the expression of DME AKR1A1 DME0098 XEOTICID XEO01378 GENEFORM mRNA DME0098 XEOTICID XEO01378 MOACRIVE Induction DME0098 XEOTICID XEO01436 XEO_NAME PP242 DME0098 XEOTICID XEO01436 XEO_TYPE Pharmaceutical Agent(s) DME0098 XEOTICID XEO01436 XEO_CLAS Investigative Agent DME0098 XEOTICID XEO01436 DESCRIPT PP242 inhibits the expression of DME AKR1A1 DME0098 XEOTICID XEO01436 GENEFORM mRNA DME0098 XEOTICID XEO01436 MOACRIVE Inhibition DME0099 DME___ID DME0099 DME0099 DME_NAME Cholesterol desmolase (CYP11A1) DME0099 SPESNAME Homo sapiens DME0099 XEOTICID XEO00029 XEO_NAME Valproic acid DME0099 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0099 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the drug-metabolizing activity of DME CYP11A1 DME0099 XEOTICID XEO00029 GENEFORM Protein DME0099 XEOTICID XEO00029 MOACRIVE Inhibition DME0099 XEOTICID XEO00064 XEO_NAME Mitotane DME0099 XEOTICID XEO00064 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00064 XEO_CLAS Approved/Marketed Drug DME0099 XEOTICID XEO00064 DESCRIPT Mitotane inhibits the drug-metabolizing activity of DME CYP11A1 DME0099 XEOTICID XEO00064 GENEFORM Protein DME0099 XEOTICID XEO00064 MOACRIVE Inhibition DME0099 XEOTICID XEO00090 XEO_NAME Estradiol DME0099 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0099 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO00090 GENEFORM mRNA DME0099 XEOTICID XEO00090 MOACRIVE Induction DME0099 XEOTICID XEO00095 XEO_NAME Testosterone DME0099 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0099 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO00095 GENEFORM mRNA DME0099 XEOTICID XEO00095 MOACRIVE Induction DME0099 XEOTICID XEO00104 XEO_NAME Perflubron DME0099 XEOTICID XEO00104 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00104 XEO_CLAS Approved/Marketed Drug DME0099 XEOTICID XEO00104 DESCRIPT Perflubron up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO00104 GENEFORM mRNA DME0099 XEOTICID XEO00104 MOACRIVE Induction DME0099 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0099 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0099 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol inhibits the expression of DME CYP11A1 DME0099 XEOTICID XEO00166 GENEFORM mRNA DME0099 XEOTICID XEO00166 MOACRIVE Inhibition DME0099 XEOTICID XEO00184 XEO_NAME Calcitriol DME0099 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0099 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO00184 GENEFORM mRNA DME0099 XEOTICID XEO00184 MOACRIVE Induction DME0099 XEOTICID XEO00260 XEO_NAME Dinoprostone DME0099 XEOTICID XEO00260 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00260 XEO_CLAS Approved/Marketed Drug DME0099 XEOTICID XEO00260 DESCRIPT Dinoprostone up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO00260 GENEFORM mRNA DME0099 XEOTICID XEO00260 MOACRIVE Induction DME0099 XEOTICID XEO00264 XEO_NAME Hydrocortisone DME0099 XEOTICID XEO00264 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00264 XEO_CLAS Approved/Marketed Drug DME0099 XEOTICID XEO00264 DESCRIPT Hydrocortisone inhibits the drug-metabolizing activity of DME CYP11A1 DME0099 XEOTICID XEO00264 GENEFORM Protein DME0099 XEOTICID XEO00264 MOACRIVE Inhibition DME0099 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0099 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0099 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex inhibits the expression of DME CYP11A1 DME0099 XEOTICID XEO00312 GENEFORM mRNA DME0099 XEOTICID XEO00312 MOACRIVE Inhibition DME0099 XEOTICID XEO00446 XEO_NAME Methoxychlor DME0099 XEOTICID XEO00446 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00446 XEO_CLAS Approved/Marketed Drug DME0099 XEOTICID XEO00446 DESCRIPT Methoxychlor induces the drug-metabolizing activity of DME CYP11A1 DME0099 XEOTICID XEO00446 GENEFORM Protein DME0099 XEOTICID XEO00446 MOACRIVE Induction DME0099 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0099 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0099 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO00536 GENEFORM mRNA DME0099 XEOTICID XEO00536 MOACRIVE Induction DME0099 XEOTICID XEO00539 XEO_NAME Ethanol DME0099 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0099 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the expression of DME CYP11A1 DME0099 XEOTICID XEO00539 GENEFORM mRNA DME0099 XEOTICID XEO00539 MOACRIVE Inhibition DME0099 XEOTICID XEO00568 XEO_NAME Resveratrol DME0099 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0099 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO00568 GENEFORM mRNA DME0099 XEOTICID XEO00568 MOACRIVE Induction DME0099 XEOTICID XEO00602 XEO_NAME Vanadyl sulfate DME0099 XEOTICID XEO00602 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00602 XEO_CLAS Drug in Phase 3 Clinical Trial DME0099 XEOTICID XEO00602 DESCRIPT Vanadyl sulfate up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO00602 GENEFORM mRNA DME0099 XEOTICID XEO00602 MOACRIVE Induction DME0099 XEOTICID XEO00606 XEO_NAME Colforsin DME0099 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0099 XEOTICID XEO00606 DESCRIPT Colforsin up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO00606 GENEFORM mRNA DME0099 XEOTICID XEO00606 MOACRIVE Induction DME0099 XEOTICID XEO00709 XEO_NAME Antalarmin DME0099 XEOTICID XEO00709 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00709 XEO_CLAS Preclinical/Patented Drug DME0099 XEOTICID XEO00709 DESCRIPT Antalarmin inhibits the expression of DME CYP11A1 DME0099 XEOTICID XEO00709 GENEFORM mRNA DME0099 XEOTICID XEO00709 MOACRIVE Inhibition DME0099 XEOTICID XEO00740 XEO_NAME Lindane DME0099 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0099 XEOTICID XEO00740 DESCRIPT Lindane inhibits the expression of DME CYP11A1 DME0099 XEOTICID XEO00740 GENEFORM mRNA DME0099 XEOTICID XEO00740 MOACRIVE Inhibition DME0099 XEOTICID XEO00904 XEO_NAME Pentabromophenol DME0099 XEOTICID XEO00904 XEO_TYPE Health or Environmental Toxicant(s) DME0099 XEOTICID XEO00904 XEO_CLAS Acute Toxic Substance DME0099 XEOTICID XEO00904 DESCRIPT Pentabromophenol up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO00904 GENEFORM mRNA DME0099 XEOTICID XEO00904 MOACRIVE Induction DME0099 XEOTICID XEO00911 XEO_NAME Cholesteryl sulfate DME0099 XEOTICID XEO00911 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0099 XEOTICID XEO00911 XEO_CLAS Natural Product DME0099 XEOTICID XEO00911 DESCRIPT Cholesteryl sulfate inhibits the expression of DME CYP11A1 DME0099 XEOTICID XEO00911 GENEFORM mRNA DME0099 XEOTICID XEO00911 MOACRIVE Inhibition DME0099 XEOTICID XEO00924 XEO_NAME Water pollutants chemical DME0099 XEOTICID XEO00924 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0099 XEOTICID XEO00924 XEO_CLAS Natural Mixture DME0099 XEOTICID XEO00924 DESCRIPT Water pollutants chemical induces the drug-metabolizing activity of DME CYP11A1 DME0099 XEOTICID XEO00924 GENEFORM Protein DME0099 XEOTICID XEO00924 MOACRIVE Induction DME0099 XEOTICID XEO00951 XEO_NAME Hexachlorobenzene DME0099 XEOTICID XEO00951 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0099 XEOTICID XEO00951 XEO_CLAS Fungicide DME0099 XEOTICID XEO00951 DESCRIPT Hexachlorobenzene induces the drug-metabolizing activity of DME CYP11A1 DME0099 XEOTICID XEO00951 GENEFORM Protein DME0099 XEOTICID XEO00951 MOACRIVE Induction DME0099 XEOTICID XEO00962 XEO_NAME 2,4,6-trichlorophenol DME0099 XEOTICID XEO00962 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0099 XEOTICID XEO00962 XEO_CLAS Fungicide DME0099 XEOTICID XEO00962 DESCRIPT 2,4,6-trichlorophenol inhibits the expression of DME CYP11A1 DME0099 XEOTICID XEO00962 GENEFORM mRNA DME0099 XEOTICID XEO00962 MOACRIVE Inhibition DME0099 XEOTICID XEO00969 XEO_NAME Atrazine DME0099 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0099 XEOTICID XEO00969 XEO_CLAS Herbicide DME0099 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO00969 GENEFORM mRNA DME0099 XEOTICID XEO00969 MOACRIVE Induction DME0099 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0099 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0099 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0099 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO01004 GENEFORM mRNA DME0099 XEOTICID XEO01004 MOACRIVE Induction DME0099 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0099 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0099 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0099 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO01031 GENEFORM mRNA DME0099 XEOTICID XEO01031 MOACRIVE Induction DME0099 XEOTICID XEO01121 XEO_NAME 2-bromophenol DME0099 XEOTICID XEO01121 XEO_TYPE Health or Environmental Toxicant(s) DME0099 XEOTICID XEO01121 XEO_CLAS Environmental Pollutant DME0099 XEOTICID XEO01121 DESCRIPT 2-bromophenol up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO01121 GENEFORM mRNA DME0099 XEOTICID XEO01121 MOACRIVE Induction DME0099 XEOTICID XEO01133 XEO_NAME 3,3',4,5'-tetrahydroxystilbene DME0099 XEOTICID XEO01133 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO01133 XEO_CLAS Investigative Agent DME0099 XEOTICID XEO01133 DESCRIPT 3,3',4,5'-tetrahydroxystilbene inhibits the expression of DME CYP11A1 DME0099 XEOTICID XEO01133 GENEFORM mRNA DME0099 XEOTICID XEO01133 MOACRIVE Inhibition DME0099 XEOTICID XEO01210 XEO_NAME Astressin DME0099 XEOTICID XEO01210 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO01210 XEO_CLAS Investigative Agent DME0099 XEOTICID XEO01210 DESCRIPT Astressin inhibits the expression of DME CYP11A1 DME0099 XEOTICID XEO01210 GENEFORM mRNA DME0099 XEOTICID XEO01210 MOACRIVE Inhibition DME0099 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0099 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0099 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the drug-metabolizing activity of DME CYP11A1 DME0099 XEOTICID XEO01226 GENEFORM Protein DME0099 XEOTICID XEO01226 MOACRIVE Inhibition DME0099 XEOTICID XEO01267 XEO_NAME Cyclic AMP DME0099 XEOTICID XEO01267 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO01267 XEO_CLAS Drug in Phase 1 Clinical Trial DME0099 XEOTICID XEO01267 DESCRIPT Cyclic AMP induces the drug-metabolizing activity of DME CYP11A1 DME0099 XEOTICID XEO01267 GENEFORM Protein DME0099 XEOTICID XEO01267 MOACRIVE Induction DME0099 XEOTICID XEO01275 XEO_NAME Dibutyl phthalate DME0099 XEOTICID XEO01275 XEO_TYPE Health or Environmental Toxicant(s) DME0099 XEOTICID XEO01275 XEO_CLAS Health Hazard/Toxicant DME0099 XEOTICID XEO01275 DESCRIPT Dibutyl phthalate inhibits the expression of DME CYP11A1 DME0099 XEOTICID XEO01275 GENEFORM mRNA DME0099 XEOTICID XEO01275 MOACRIVE Inhibition DME0099 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0099 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0099 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0099 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME CYP11A1 DME0099 XEOTICID XEO01305 GENEFORM mRNA DME0099 XEOTICID XEO01305 MOACRIVE Inhibition DME0099 XEOTICID XEO01321 XEO_NAME Go-6976 DME0099 XEOTICID XEO01321 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO01321 XEO_CLAS Investigative Agent DME0099 XEOTICID XEO01321 DESCRIPT Go-6976 up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO01321 GENEFORM mRNA DME0099 XEOTICID XEO01321 MOACRIVE Induction DME0099 XEOTICID XEO01325 XEO_NAME GW-3965 DME0099 XEOTICID XEO01325 XEO_TYPE Pharmaceutical Agent(s) DME0099 XEOTICID XEO01325 XEO_CLAS Preclinical/Patented Drug DME0099 XEOTICID XEO01325 DESCRIPT GW-3965 inhibits the expression of DME CYP11A1 DME0099 XEOTICID XEO01325 GENEFORM mRNA DME0099 XEOTICID XEO01325 MOACRIVE Inhibition DME0099 XEOTICID XEO01498 XEO_NAME Walrycin A DME0099 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0099 XEOTICID XEO01498 XEO_CLAS Natural Product DME0099 XEOTICID XEO01498 DESCRIPT Walrycin A up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO01498 GENEFORM mRNA DME0099 XEOTICID XEO01498 MOACRIVE Induction DME0099 XEOTICID XEO01612 XEO_NAME 2-acetyltributylcitrate DME0099 XEOTICID XEO01612 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0099 XEOTICID XEO01612 XEO_CLAS Cosmetic Additive DME0099 XEOTICID XEO01612 DESCRIPT 2-acetyltributylcitrate up-regulates the expression of DME CYP11A1 DME0099 XEOTICID XEO01612 GENEFORM mRNA DME0099 XEOTICID XEO01612 MOACRIVE Induction DME0100 DME___ID DME0100 DME0100 DME_NAME Vitamin D 25-hydroxylase (CYP2R1) DME0100 SPESNAME Homo sapiens DME0100 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0100 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0100 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0100 XEOTICID XEO00165 DESCRIPT Obeticholic acid induces the drug-metabolizing activity of DME CYP2R1 DME0100 XEOTICID XEO00165 GENEFORM Protein DME0100 XEOTICID XEO00165 MOACRIVE Induction DME0100 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0100 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0100 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0100 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME CYP2R1 DME0100 XEOTICID XEO00241 GENEFORM mRNA DME0100 XEOTICID XEO00241 MOACRIVE Induction DME0100 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0100 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0100 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0100 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride up-regulates the expression of DME CYP2R1 DME0100 XEOTICID XEO00277 GENEFORM mRNA DME0100 XEOTICID XEO00277 MOACRIVE Induction DME0100 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0100 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0100 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0100 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME CYP2R1 DME0100 XEOTICID XEO00632 GENEFORM mRNA DME0100 XEOTICID XEO00632 MOACRIVE Inhibition DME0100 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0100 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0100 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0100 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME CYP2R1 DME0100 XEOTICID XEO00723 GENEFORM mRNA DME0100 XEOTICID XEO00723 MOACRIVE Induction DME0100 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0100 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0100 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0100 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME CYP2R1 DME0100 XEOTICID XEO00806 GENEFORM mRNA DME0100 XEOTICID XEO00806 MOACRIVE Induction DME0100 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0100 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0100 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0100 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME CYP2R1 DME0100 XEOTICID XEO00821 GENEFORM Protein DME0100 XEOTICID XEO00821 MOACRIVE Inhibition DME0100 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0100 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0100 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0100 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium up-regulates the expression of DME CYP2R1 DME0100 XEOTICID XEO01103 GENEFORM mRNA DME0100 XEOTICID XEO01103 MOACRIVE Induction DME0100 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0100 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0100 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0100 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME CYP2R1 DME0100 XEOTICID XEO01324 GENEFORM mRNA DME0100 XEOTICID XEO01324 MOACRIVE Inhibition DME0100 XEOTICID XEO01574 XEO_NAME Plant extracts DME0100 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0100 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0100 XEOTICID XEO01574 DESCRIPT Plant extracts induces the drug-metabolizing activity of DME CYP2R1 DME0100 XEOTICID XEO01574 GENEFORM Protein DME0100 XEOTICID XEO01574 MOACRIVE Induction DME0101 DME___ID DME0101 DME0101 DME_NAME Choline dehydrogenase (CHDH) DME0101 SPESNAME Homo sapiens DME0101 XEOTICID XEO00029 XEO_NAME Valproic acid DME0101 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0101 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0101 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME CHDH DME0101 XEOTICID XEO00029 GENEFORM mRNA DME0101 XEOTICID XEO00029 MOACRIVE Inhibition DME0101 XEOTICID XEO00053 XEO_NAME Leflunomide DME0101 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0101 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0101 XEOTICID XEO00053 DESCRIPT Leflunomide inhibits the expression of DME CHDH DME0101 XEOTICID XEO00053 GENEFORM mRNA DME0101 XEOTICID XEO00053 MOACRIVE Inhibition DME0101 XEOTICID XEO00090 XEO_NAME Estradiol DME0101 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0101 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0101 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME CHDH DME0101 XEOTICID XEO00090 GENEFORM mRNA DME0101 XEOTICID XEO00090 MOACRIVE Induction DME0101 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0101 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0101 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0101 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME CHDH DME0101 XEOTICID XEO00117 GENEFORM mRNA DME0101 XEOTICID XEO00117 MOACRIVE Inhibition DME0101 XEOTICID XEO00184 XEO_NAME Calcitriol DME0101 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0101 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0101 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME CHDH DME0101 XEOTICID XEO00184 GENEFORM mRNA DME0101 XEOTICID XEO00184 MOACRIVE Induction DME0101 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0101 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0101 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0101 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CHDH DME0101 XEOTICID XEO00217 GENEFORM mRNA DME0101 XEOTICID XEO00217 MOACRIVE Inhibition DME0101 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0101 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0101 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0101 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CHDH DME0101 XEOTICID XEO00241 GENEFORM mRNA DME0101 XEOTICID XEO00241 MOACRIVE Inhibition DME0101 XEOTICID XEO00334 XEO_NAME Cisplatin DME0101 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0101 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0101 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME CHDH DME0101 XEOTICID XEO00334 GENEFORM mRNA DME0101 XEOTICID XEO00334 MOACRIVE Inhibition DME0101 XEOTICID XEO00435 XEO_NAME Urethane DME0101 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0101 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0101 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME CHDH DME0101 XEOTICID XEO00435 GENEFORM mRNA DME0101 XEOTICID XEO00435 MOACRIVE Inhibition DME0101 XEOTICID XEO00749 XEO_NAME Teriflunomide DME0101 XEOTICID XEO00749 XEO_TYPE Pharmaceutical Agent(s) DME0101 XEOTICID XEO00749 XEO_CLAS Approved/Marketed Drug DME0101 XEOTICID XEO00749 DESCRIPT Teriflunomide inhibits the expression of DME CHDH DME0101 XEOTICID XEO00749 GENEFORM mRNA DME0101 XEOTICID XEO00749 MOACRIVE Inhibition DME0101 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0101 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0101 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0101 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CHDH DME0101 XEOTICID XEO00806 GENEFORM mRNA DME0101 XEOTICID XEO00806 MOACRIVE Inhibition DME0101 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0101 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0101 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0101 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME CHDH DME0101 XEOTICID XEO01305 GENEFORM mRNA DME0101 XEOTICID XEO01305 MOACRIVE Inhibition DME0101 XEOTICID XEO01348 XEO_NAME K-7174 DME0101 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0101 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0101 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME CHDH DME0101 XEOTICID XEO01348 GENEFORM mRNA DME0101 XEOTICID XEO01348 MOACRIVE Inhibition DME0102 DME___ID DME0102 DME0102 DME_NAME Choline O-acetyltransferase (CHAT) DME0102 SPESNAME Homo sapiens DME0102 XEOTICID XEO00108 XEO_NAME Methamphetamine DME0102 XEOTICID XEO00108 XEO_TYPE Pharmaceutical Agent(s) DME0102 XEOTICID XEO00108 XEO_CLAS Approved/Marketed Drug DME0102 XEOTICID XEO00108 DESCRIPT Methamphetamine inhibits the expression of DME CHAT DME0102 XEOTICID XEO00108 GENEFORM mRNA DME0102 XEOTICID XEO00108 MOACRIVE Inhibition DME0102 XEOTICID XEO00439 XEO_NAME Daidzein DME0102 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME0102 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME0102 XEOTICID XEO00439 DESCRIPT Daidzein induces the drug-metabolizing activity of DME CHAT DME0102 XEOTICID XEO00439 GENEFORM Protein DME0102 XEOTICID XEO00439 MOACRIVE Induction DME0102 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0102 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0102 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0102 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME CHAT DME0102 XEOTICID XEO00999 GENEFORM mRNA DME0102 XEOTICID XEO00999 MOACRIVE Induction DME0102 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0102 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0102 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0102 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine up-regulates the expression of DME CHAT DME0102 XEOTICID XEO01119 GENEFORM mRNA DME0102 XEOTICID XEO01119 MOACRIVE Induction DME0102 XEOTICID XEO01503 XEO_NAME Cadmium DME0102 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0102 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0102 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the expression of DME CHAT DME0102 XEOTICID XEO01503 GENEFORM mRNA DME0102 XEOTICID XEO01503 MOACRIVE Inhibition DME0103 DME___ID DME0103 DME0103 DME_NAME Choline/ethanolaminephosphotransferase 1 (CEPT1) DME0103 SPESNAME Homo sapiens DME0103 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0103 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0103 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0103 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME CEPT1 DME0103 XEOTICID XEO00117 GENEFORM mRNA DME0103 XEOTICID XEO00117 MOACRIVE Inhibition DME0103 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0103 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0103 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0103 XEOTICID XEO00140 DESCRIPT Zoledronic acid up-regulates the expression of DME CEPT1 DME0103 XEOTICID XEO00140 GENEFORM mRNA DME0103 XEOTICID XEO00140 MOACRIVE Induction DME0103 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0103 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0103 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0103 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME CEPT1 DME0103 XEOTICID XEO01050 GENEFORM mRNA DME0103 XEOTICID XEO01050 MOACRIVE Inhibition DME0104 DME___ID DME0104 DME0104 DME_NAME Alpha-L-iduronidase (IDUA) DME0104 SPESNAME Homo sapiens DME0104 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0104 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0104 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0104 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME IDUA DME0104 XEOTICID XEO00241 GENEFORM mRNA DME0104 XEOTICID XEO00241 MOACRIVE Inhibition DME0104 XEOTICID XEO00334 XEO_NAME Cisplatin DME0104 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0104 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0104 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME IDUA DME0104 XEOTICID XEO00334 GENEFORM mRNA DME0104 XEOTICID XEO00334 MOACRIVE Induction DME0104 XEOTICID XEO00396 XEO_NAME Gentamicin DME0104 XEOTICID XEO00396 XEO_TYPE Pharmaceutical Agent(s) DME0104 XEOTICID XEO00396 XEO_CLAS Approved/Marketed Drug DME0104 XEOTICID XEO00396 DESCRIPT Gentamicin up-regulates the expression of DME IDUA and leads to increasing the drug-metabolizing activity of this enzyme DME0104 XEOTICID XEO00396 GENEFORM Protein DME0104 XEOTICID XEO00396 MOACRIVE Induction DME0104 XEOTICID XEO00435 XEO_NAME Urethane DME0104 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0104 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0104 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME IDUA DME0104 XEOTICID XEO00435 GENEFORM mRNA DME0104 XEOTICID XEO00435 MOACRIVE Inhibition DME0104 XEOTICID XEO00760 XEO_NAME Jinfukang DME0104 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0104 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0104 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME IDUA DME0104 XEOTICID XEO00760 GENEFORM mRNA DME0104 XEOTICID XEO00760 MOACRIVE Induction DME0105 DME___ID DME0105 DME0105 DME_NAME Arylsulfatase B (ARSB) DME0105 SPESNAME Homo sapiens DME0105 XEOTICID XEO00029 XEO_NAME Valproic acid DME0105 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0105 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0105 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME ARSB DME0105 XEOTICID XEO00029 GENEFORM mRNA DME0105 XEOTICID XEO00029 MOACRIVE Inhibition DME0105 XEOTICID XEO00079 XEO_NAME Vorinostat DME0105 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0105 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0105 XEOTICID XEO00079 DESCRIPT Vorinostat inhibits the expression of DME ARSB DME0105 XEOTICID XEO00079 GENEFORM mRNA DME0105 XEOTICID XEO00079 MOACRIVE Inhibition DME0105 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0105 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0105 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0105 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ARSB DME0105 XEOTICID XEO00217 GENEFORM mRNA DME0105 XEOTICID XEO00217 MOACRIVE Inhibition DME0105 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0105 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0105 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0105 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME ARSB DME0105 XEOTICID XEO00292 GENEFORM mRNA DME0105 XEOTICID XEO00292 MOACRIVE Inhibition DME0105 XEOTICID XEO00301 XEO_NAME Irinotecan hydrochloride DME0105 XEOTICID XEO00301 XEO_TYPE Pharmaceutical Agent(s) DME0105 XEOTICID XEO00301 XEO_CLAS Approved/Marketed Drug DME0105 XEOTICID XEO00301 DESCRIPT Irinotecan hydrochloride inhibits the expression of DME ARSB DME0105 XEOTICID XEO00301 GENEFORM mRNA DME0105 XEOTICID XEO00301 MOACRIVE Inhibition DME0105 XEOTICID XEO00334 XEO_NAME Cisplatin DME0105 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0105 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0105 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME ARSB DME0105 XEOTICID XEO00334 GENEFORM mRNA DME0105 XEOTICID XEO00334 MOACRIVE Inhibition DME0105 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0105 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0105 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0105 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME ARSB DME0105 XEOTICID XEO00772 GENEFORM mRNA DME0105 XEOTICID XEO00772 MOACRIVE Inhibition DME0105 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0105 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0105 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0105 XEOTICID XEO01050 DESCRIPT Dicrotophos up-regulates the expression of DME ARSB DME0105 XEOTICID XEO01050 GENEFORM mRNA DME0105 XEOTICID XEO01050 MOACRIVE Induction DME0105 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0105 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0105 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0105 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME ARSB DME0105 XEOTICID XEO01305 GENEFORM mRNA DME0105 XEOTICID XEO01305 MOACRIVE Inhibition DME0106 DME___ID DME0106 DME0106 DME_NAME Beta-glucuronidase (GUSB) DME0106 SPESNAME Homo sapiens DME0106 XEOTICID XEO00029 XEO_NAME Valproic acid DME0106 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0106 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0106 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME GUSB DME0106 XEOTICID XEO00029 GENEFORM mRNA DME0106 XEOTICID XEO00029 MOACRIVE Induction DME0106 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0106 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0106 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0106 XEOTICID XEO00217 DESCRIPT Acetaminophen induces the drug-metabolizing activity of DME GUSB DME0106 XEOTICID XEO00217 GENEFORM Protein DME0106 XEOTICID XEO00217 MOACRIVE Induction DME0106 XEOTICID XEO00273 XEO_NAME Histamine DME0106 XEOTICID XEO00273 XEO_TYPE Pharmaceutical Agent(s) DME0106 XEOTICID XEO00273 XEO_CLAS Approved/Marketed Drug DME0106 XEOTICID XEO00273 DESCRIPT Histamine induces the drug-metabolizing activity of DME GUSB DME0106 XEOTICID XEO00273 GENEFORM Protein DME0106 XEOTICID XEO00273 MOACRIVE Induction DME0106 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0106 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0106 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0106 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME GUSB DME0106 XEOTICID XEO00292 GENEFORM mRNA DME0106 XEOTICID XEO00292 MOACRIVE Inhibition DME0106 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0106 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0106 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0106 XEOTICID XEO00380 DESCRIPT Rosiglitazone induces the drug-metabolizing activity of DME GUSB DME0106 XEOTICID XEO00380 GENEFORM Protein DME0106 XEOTICID XEO00380 MOACRIVE Induction DME0106 XEOTICID XEO00728 XEO_NAME AM-580 DME0106 XEOTICID XEO00728 XEO_TYPE Pharmaceutical Agent(s) DME0106 XEOTICID XEO00728 XEO_CLAS Preclinical/Patented Drug DME0106 XEOTICID XEO00728 DESCRIPT AM-580 up-regulates the expression of DME GUSB DME0106 XEOTICID XEO00728 GENEFORM mRNA DME0106 XEOTICID XEO00728 MOACRIVE Induction DME0106 XEOTICID XEO00760 XEO_NAME Jinfukang DME0106 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0106 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0106 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME GUSB DME0106 XEOTICID XEO00760 GENEFORM mRNA DME0106 XEOTICID XEO00760 MOACRIVE Induction DME0106 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0106 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0106 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0106 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME GUSB DME0106 XEOTICID XEO00772 GENEFORM mRNA DME0106 XEOTICID XEO00772 MOACRIVE Induction DME0106 XEOTICID XEO01336 XEO_NAME ICG-001 DME0106 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0106 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0106 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME GUSB DME0106 XEOTICID XEO01336 GENEFORM mRNA DME0106 XEOTICID XEO01336 MOACRIVE Induction DME0107 DME___ID DME0107 DME0107 DME_NAME N-acetyl-beta-glucosaminidase beta (HEXB) DME0107 SPESNAME Homo sapiens DME0107 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0107 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0107 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0107 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME HEXB DME0107 XEOTICID XEO00217 GENEFORM mRNA DME0107 XEOTICID XEO00217 MOACRIVE Induction DME0107 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0107 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0107 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0107 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME HEXB DME0107 XEOTICID XEO00241 GENEFORM mRNA DME0107 XEOTICID XEO00241 MOACRIVE Induction DME0107 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0107 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0107 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0107 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME HEXB DME0107 XEOTICID XEO00292 GENEFORM mRNA DME0107 XEOTICID XEO00292 MOACRIVE Inhibition DME0107 XEOTICID XEO00334 XEO_NAME Cisplatin DME0107 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0107 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0107 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME HEXB DME0107 XEOTICID XEO00334 GENEFORM mRNA DME0107 XEOTICID XEO00334 MOACRIVE Induction DME0107 XEOTICID XEO00481 XEO_NAME Rotenone DME0107 XEOTICID XEO00481 XEO_TYPE Pharmaceutical Agent(s) DME0107 XEOTICID XEO00481 XEO_CLAS Approved/Marketed Drug DME0107 XEOTICID XEO00481 DESCRIPT Rotenone up-regulates the expression of DME HEXB DME0107 XEOTICID XEO00481 GENEFORM mRNA DME0107 XEOTICID XEO00481 MOACRIVE Induction DME0107 XEOTICID XEO00510 XEO_NAME Gamolenic acid DME0107 XEOTICID XEO00510 XEO_TYPE Pharmaceutical Agent(s) DME0107 XEOTICID XEO00510 XEO_CLAS Approved/Marketed Drug DME0107 XEOTICID XEO00510 DESCRIPT Gamolenic acid up-regulates the expression of DME HEXB DME0107 XEOTICID XEO00510 GENEFORM mRNA DME0107 XEOTICID XEO00510 MOACRIVE Induction DME0107 XEOTICID XEO00538 XEO_NAME Quercetin DME0107 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0107 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0107 XEOTICID XEO00538 DESCRIPT Quercetin up-regulates the expression of DME HEXB DME0107 XEOTICID XEO00538 GENEFORM mRNA DME0107 XEOTICID XEO00538 MOACRIVE Induction DME0107 XEOTICID XEO00581 XEO_NAME MS-275 DME0107 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0107 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0107 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME HEXB DME0107 XEOTICID XEO00581 GENEFORM mRNA DME0107 XEOTICID XEO00581 MOACRIVE Induction DME0107 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0107 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0107 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0107 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME HEXB DME0107 XEOTICID XEO00898 GENEFORM mRNA DME0107 XEOTICID XEO00898 MOACRIVE Induction DME0107 XEOTICID XEO00969 XEO_NAME Atrazine DME0107 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0107 XEOTICID XEO00969 XEO_CLAS Herbicide DME0107 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME HEXB DME0107 XEOTICID XEO00969 GENEFORM mRNA DME0107 XEOTICID XEO00969 MOACRIVE Induction DME0107 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0107 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0107 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0107 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME HEXB DME0107 XEOTICID XEO01050 GENEFORM mRNA DME0107 XEOTICID XEO01050 MOACRIVE Inhibition DME0107 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0107 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0107 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0107 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium up-regulates the expression of DME HEXB DME0107 XEOTICID XEO01103 GENEFORM mRNA DME0107 XEOTICID XEO01103 MOACRIVE Induction DME0107 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0107 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0107 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0107 XEOTICID XEO01226 DESCRIPT Bisphenol A induces the drug-metabolizing activity of DME HEXB DME0107 XEOTICID XEO01226 GENEFORM Protein DME0107 XEOTICID XEO01226 MOACRIVE Induction DME0107 XEOTICID XEO01348 XEO_NAME K-7174 DME0107 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0107 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0107 XEOTICID XEO01348 DESCRIPT K-7174 up-regulates the expression of DME HEXB DME0107 XEOTICID XEO01348 GENEFORM mRNA DME0107 XEOTICID XEO01348 MOACRIVE Induction DME0107 XEOTICID XEO01503 XEO_NAME Cadmium DME0107 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0107 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0107 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME HEXB DME0107 XEOTICID XEO01503 GENEFORM mRNA DME0107 XEOTICID XEO01503 MOACRIVE Induction DME0108 DME___ID DME0108 DME0108 DME_NAME Iduronate 2-sulfatase (IDS) DME0108 SPESNAME Homo sapiens DME0108 XEOTICID XEO00012 XEO_NAME Carmustine DME0108 XEOTICID XEO00012 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00012 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00012 DESCRIPT Carmustine inhibits the expression of DME IDS DME0108 XEOTICID XEO00012 GENEFORM mRNA DME0108 XEOTICID XEO00012 MOACRIVE Inhibition DME0108 XEOTICID XEO00029 XEO_NAME Valproic acid DME0108 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME IDS DME0108 XEOTICID XEO00029 GENEFORM mRNA DME0108 XEOTICID XEO00029 MOACRIVE Induction DME0108 XEOTICID XEO00046 XEO_NAME Ifosfamide DME0108 XEOTICID XEO00046 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00046 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00046 DESCRIPT Ifosfamide inhibits the expression of DME IDS DME0108 XEOTICID XEO00046 GENEFORM mRNA DME0108 XEOTICID XEO00046 MOACRIVE Inhibition DME0108 XEOTICID XEO00079 XEO_NAME Vorinostat DME0108 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00079 DESCRIPT Vorinostat inhibits the expression of DME IDS DME0108 XEOTICID XEO00079 GENEFORM mRNA DME0108 XEOTICID XEO00079 MOACRIVE Inhibition DME0108 XEOTICID XEO00090 XEO_NAME Estradiol DME0108 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME IDS DME0108 XEOTICID XEO00090 GENEFORM mRNA DME0108 XEOTICID XEO00090 MOACRIVE Inhibition DME0108 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0108 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME IDS DME0108 XEOTICID XEO00117 GENEFORM mRNA DME0108 XEOTICID XEO00117 MOACRIVE Induction DME0108 XEOTICID XEO00132 XEO_NAME Cidofovir DME0108 XEOTICID XEO00132 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00132 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00132 DESCRIPT Cidofovir inhibits the expression of DME IDS DME0108 XEOTICID XEO00132 GENEFORM mRNA DME0108 XEOTICID XEO00132 MOACRIVE Inhibition DME0108 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0108 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME IDS DME0108 XEOTICID XEO00241 GENEFORM mRNA DME0108 XEOTICID XEO00241 MOACRIVE Induction DME0108 XEOTICID XEO00248 XEO_NAME Ibuprofen DME0108 XEOTICID XEO00248 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00248 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00248 DESCRIPT Ibuprofen up-regulates the expression of DME IDS DME0108 XEOTICID XEO00248 GENEFORM mRNA DME0108 XEOTICID XEO00248 MOACRIVE Induction DME0108 XEOTICID XEO00253 XEO_NAME Tretinoin DME0108 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME IDS DME0108 XEOTICID XEO00253 GENEFORM mRNA DME0108 XEOTICID XEO00253 MOACRIVE Inhibition DME0108 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0108 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME IDS DME0108 XEOTICID XEO00292 GENEFORM mRNA DME0108 XEOTICID XEO00292 MOACRIVE Induction DME0108 XEOTICID XEO00334 XEO_NAME Cisplatin DME0108 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME IDS DME0108 XEOTICID XEO00334 GENEFORM mRNA DME0108 XEOTICID XEO00334 MOACRIVE Inhibition DME0108 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0108 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME IDS DME0108 XEOTICID XEO00339 GENEFORM mRNA DME0108 XEOTICID XEO00339 MOACRIVE Induction DME0108 XEOTICID XEO00435 XEO_NAME Urethane DME0108 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00435 DESCRIPT Urethane up-regulates the expression of DME IDS DME0108 XEOTICID XEO00435 GENEFORM mRNA DME0108 XEOTICID XEO00435 MOACRIVE Induction DME0108 XEOTICID XEO00465 XEO_NAME Clodronic acid DME0108 XEOTICID XEO00465 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00465 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00465 DESCRIPT Clodronic acid inhibits the expression of DME IDS DME0108 XEOTICID XEO00465 GENEFORM mRNA DME0108 XEOTICID XEO00465 MOACRIVE Inhibition DME0108 XEOTICID XEO00466 XEO_NAME Demecolcine DME0108 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0108 XEOTICID XEO00466 DESCRIPT Demecolcine up-regulates the expression of DME IDS DME0108 XEOTICID XEO00466 GENEFORM mRNA DME0108 XEOTICID XEO00466 MOACRIVE Induction DME0108 XEOTICID XEO00779 XEO_NAME Sarin DME0108 XEOTICID XEO00779 XEO_TYPE Health or Environmental Toxicant(s) DME0108 XEOTICID XEO00779 XEO_CLAS Acute Toxic Substance DME0108 XEOTICID XEO00779 DESCRIPT Sarin inhibits the expression of DME IDS DME0108 XEOTICID XEO00779 GENEFORM mRNA DME0108 XEOTICID XEO00779 MOACRIVE Inhibition DME0108 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0108 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0108 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0108 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME IDS DME0108 XEOTICID XEO00806 GENEFORM mRNA DME0108 XEOTICID XEO00806 MOACRIVE Induction DME0108 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0108 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0108 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME IDS and leads to increasing the drug-metabolizing activity of this enzyme DME0108 XEOTICID XEO00818 GENEFORM Protein DME0108 XEOTICID XEO00818 MOACRIVE Induction DME0108 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0108 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0108 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0108 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME IDS DME0108 XEOTICID XEO01305 GENEFORM mRNA DME0108 XEOTICID XEO01305 MOACRIVE Inhibition DME0108 XEOTICID XEO01369 XEO_NAME Lithium chloride DME0108 XEOTICID XEO01369 XEO_TYPE Health or Environmental Toxicant(s) DME0108 XEOTICID XEO01369 XEO_CLAS Health Hazard/Toxicant DME0108 XEOTICID XEO01369 DESCRIPT Lithium chloride induces the drug-metabolizing activity of DME IDS DME0108 XEOTICID XEO01369 GENEFORM Protein DME0108 XEOTICID XEO01369 MOACRIVE Induction DME0108 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0108 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0108 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0108 XEOTICID XEO01492 DESCRIPT Trichostatin A induces the drug-metabolizing activity of DME IDS DME0108 XEOTICID XEO01492 GENEFORM Protein DME0108 XEOTICID XEO01492 MOACRIVE Induction DME0108 XEOTICID XEO01503 XEO_NAME Cadmium DME0108 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0108 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0108 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME IDS DME0108 XEOTICID XEO01503 GENEFORM mRNA DME0108 XEOTICID XEO01503 MOACRIVE Induction DME0109 DME___ID DME0109 DME0109 DME_NAME Superoxide dismutase 1 (SOD1) DME0109 SPESNAME Homo sapiens DME0109 XEOTICID XEO00012 XEO_NAME Carmustine DME0109 XEOTICID XEO00012 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00012 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00012 DESCRIPT Carmustine inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00012 GENEFORM Protein DME0109 XEOTICID XEO00012 MOACRIVE Inhibition DME0109 XEOTICID XEO00016 XEO_NAME Clofibrate DME0109 XEOTICID XEO00016 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00016 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00016 DESCRIPT Clofibrate inhibits the expression of DME SOD1 DME0109 XEOTICID XEO00016 GENEFORM mRNA DME0109 XEOTICID XEO00016 MOACRIVE Inhibition DME0109 XEOTICID XEO00028 XEO_NAME Disulfiram DME0109 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00028 DESCRIPT Disulfiram up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO00028 GENEFORM mRNA DME0109 XEOTICID XEO00028 MOACRIVE Induction DME0109 XEOTICID XEO00086 XEO_NAME Troglitazone DME0109 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00086 DESCRIPT Troglitazone inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00086 GENEFORM Protein DME0109 XEOTICID XEO00086 MOACRIVE Inhibition DME0109 XEOTICID XEO00089 XEO_NAME Mitomycin DME0109 XEOTICID XEO00089 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00089 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00089 DESCRIPT Mitomycin up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO00089 GENEFORM mRNA DME0109 XEOTICID XEO00089 MOACRIVE Induction DME0109 XEOTICID XEO00126 XEO_NAME Raloxifene hydrochloride DME0109 XEOTICID XEO00126 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00126 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00126 DESCRIPT Raloxifene hydrochloride up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO00126 GENEFORM mRNA DME0109 XEOTICID XEO00126 MOACRIVE Induction DME0109 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME0109 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the expression of DME SOD1 DME0109 XEOTICID XEO00136 GENEFORM mRNA DME0109 XEOTICID XEO00136 MOACRIVE Inhibition DME0109 XEOTICID XEO00147 XEO_NAME Fulvestrant DME0109 XEOTICID XEO00147 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00147 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00147 DESCRIPT Fulvestrant up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO00147 GENEFORM mRNA DME0109 XEOTICID XEO00147 MOACRIVE Induction DME0109 XEOTICID XEO00148 XEO_NAME Bosentan DME0109 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00148 DESCRIPT Bosentan inhibits the expression of DME SOD1 DME0109 XEOTICID XEO00148 GENEFORM mRNA DME0109 XEOTICID XEO00148 MOACRIVE Inhibition DME0109 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0109 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00217 GENEFORM Protein DME0109 XEOTICID XEO00217 MOACRIVE Inhibition DME0109 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0109 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME SOD1 DME0109 XEOTICID XEO00241 GENEFORM mRNA DME0109 XEOTICID XEO00241 MOACRIVE Inhibition DME0109 XEOTICID XEO00257 XEO_NAME Penicillamine DME0109 XEOTICID XEO00257 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00257 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00257 DESCRIPT Penicillamine inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00257 GENEFORM Protein DME0109 XEOTICID XEO00257 MOACRIVE Inhibition DME0109 XEOTICID XEO00265 XEO_NAME Epinephrine DME0109 XEOTICID XEO00265 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00265 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00265 DESCRIPT Epinephrine induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00265 GENEFORM Protein DME0109 XEOTICID XEO00265 MOACRIVE Induction DME0109 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0109 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00292 GENEFORM Protein DME0109 XEOTICID XEO00292 MOACRIVE Induction DME0109 XEOTICID XEO00319 XEO_NAME Pioglitazone hydrochloride DME0109 XEOTICID XEO00319 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00319 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00319 DESCRIPT Pioglitazone hydrochloride up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO00319 GENEFORM mRNA DME0109 XEOTICID XEO00319 MOACRIVE Induction DME0109 XEOTICID XEO00332 XEO_NAME Trientine hydrochloride DME0109 XEOTICID XEO00332 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00332 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00332 DESCRIPT Trientine hydrochloride inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00332 GENEFORM Protein DME0109 XEOTICID XEO00332 MOACRIVE Inhibition DME0109 XEOTICID XEO00334 XEO_NAME Cisplatin DME0109 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00334 DESCRIPT Cisplatin induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00334 GENEFORM Protein DME0109 XEOTICID XEO00334 MOACRIVE Induction DME0109 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0109 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00339 GENEFORM Protein DME0109 XEOTICID XEO00339 MOACRIVE Inhibition DME0109 XEOTICID XEO00341 XEO_NAME Bleomycin DME0109 XEOTICID XEO00341 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00341 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00341 DESCRIPT Bleomycin induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00341 GENEFORM Protein DME0109 XEOTICID XEO00341 MOACRIVE Induction DME0109 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0109 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00380 DESCRIPT Rosiglitazone up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO00380 GENEFORM mRNA DME0109 XEOTICID XEO00380 MOACRIVE Induction DME0109 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0109 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00388 GENEFORM Protein DME0109 XEOTICID XEO00388 MOACRIVE Inhibition DME0109 XEOTICID XEO00389 XEO_NAME Benzoyl peroxide DME0109 XEOTICID XEO00389 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00389 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00389 DESCRIPT Benzoyl peroxide induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00389 GENEFORM Protein DME0109 XEOTICID XEO00389 MOACRIVE Induction DME0109 XEOTICID XEO00401 XEO_NAME Beta carotene DME0109 XEOTICID XEO00401 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00401 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00401 DESCRIPT Beta carotene inhibits the expression of DME SOD1 DME0109 XEOTICID XEO00401 GENEFORM mRNA DME0109 XEOTICID XEO00401 MOACRIVE Inhibition DME0109 XEOTICID XEO00426 XEO_NAME Undecylenic acid DME0109 XEOTICID XEO00426 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00426 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00426 DESCRIPT Undecylenic acid inhibits the expression of DME SOD1 DME0109 XEOTICID XEO00426 GENEFORM mRNA DME0109 XEOTICID XEO00426 MOACRIVE Inhibition DME0109 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0109 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00430 DESCRIPT Hydroquinone inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00430 GENEFORM Protein DME0109 XEOTICID XEO00430 MOACRIVE Inhibition DME0109 XEOTICID XEO00442 XEO_NAME Chlorobenzene DME0109 XEOTICID XEO00442 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00442 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00442 DESCRIPT Chlorobenzene induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00442 GENEFORM Protein DME0109 XEOTICID XEO00442 MOACRIVE Induction DME0109 XEOTICID XEO00450 XEO_NAME Aclarubicin DME0109 XEOTICID XEO00450 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00450 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00450 DESCRIPT Aclarubicin inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00450 GENEFORM Protein DME0109 XEOTICID XEO00450 MOACRIVE Inhibition DME0109 XEOTICID XEO00454 XEO_NAME Dihydroartemisinin DME0109 XEOTICID XEO00454 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00454 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00454 DESCRIPT Dihydroartemisinin induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00454 GENEFORM Protein DME0109 XEOTICID XEO00454 MOACRIVE Induction DME0109 XEOTICID XEO00493 XEO_NAME Bezafibrate DME0109 XEOTICID XEO00493 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00493 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00493 DESCRIPT Bezafibrate induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00493 GENEFORM Protein DME0109 XEOTICID XEO00493 MOACRIVE Induction DME0109 XEOTICID XEO00516 XEO_NAME Danthron DME0109 XEOTICID XEO00516 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00516 XEO_CLAS Drug Marketed but Withdrawn from Market DME0109 XEOTICID XEO00516 DESCRIPT Danthron inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00516 GENEFORM Protein DME0109 XEOTICID XEO00516 MOACRIVE Inhibition DME0109 XEOTICID XEO00535 XEO_NAME Adenosine triphosphate DME0109 XEOTICID XEO00535 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00535 XEO_CLAS Drug in Phase 1 Clinical Trial DME0109 XEOTICID XEO00535 DESCRIPT Adenosine triphosphate induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00535 GENEFORM Protein DME0109 XEOTICID XEO00535 MOACRIVE Induction DME0109 XEOTICID XEO00538 XEO_NAME Quercetin DME0109 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0109 XEOTICID XEO00538 DESCRIPT Quercetin up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO00538 GENEFORM mRNA DME0109 XEOTICID XEO00538 MOACRIVE Induction DME0109 XEOTICID XEO00557 XEO_NAME Genistein DME0109 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0109 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO00557 GENEFORM mRNA DME0109 XEOTICID XEO00557 MOACRIVE Induction DME0109 XEOTICID XEO00565 XEO_NAME Fenretinide DME0109 XEOTICID XEO00565 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00565 XEO_CLAS Drug in Phase 3 Clinical Trial DME0109 XEOTICID XEO00565 DESCRIPT Fenretinide induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00565 GENEFORM Protein DME0109 XEOTICID XEO00565 MOACRIVE Induction DME0109 XEOTICID XEO00568 XEO_NAME Resveratrol DME0109 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0109 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO00568 GENEFORM mRNA DME0109 XEOTICID XEO00568 MOACRIVE Induction DME0109 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0109 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0109 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO00571 GENEFORM mRNA DME0109 XEOTICID XEO00571 MOACRIVE Induction DME0109 XEOTICID XEO00572 XEO_NAME Carbon monoxide DME0109 XEOTICID XEO00572 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00572 XEO_CLAS Drug in Phase 2 Clinical Trial DME0109 XEOTICID XEO00572 DESCRIPT Carbon monoxide inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00572 GENEFORM Protein DME0109 XEOTICID XEO00572 MOACRIVE Inhibition DME0109 XEOTICID XEO00591 XEO_NAME Ditiocarb DME0109 XEOTICID XEO00591 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00591 XEO_CLAS Drug in Phase 2 Clinical Trial DME0109 XEOTICID XEO00591 DESCRIPT Ditiocarb inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00591 GENEFORM Protein DME0109 XEOTICID XEO00591 MOACRIVE Inhibition DME0109 XEOTICID XEO00597 XEO_NAME Camptothecin DME0109 XEOTICID XEO00597 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00597 XEO_CLAS Drug in Phase 2 Clinical Trial DME0109 XEOTICID XEO00597 DESCRIPT Camptothecin induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00597 GENEFORM Protein DME0109 XEOTICID XEO00597 MOACRIVE Induction DME0109 XEOTICID XEO00599 XEO_NAME Tetradecanoylphorbol acetate DME0109 XEOTICID XEO00599 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00599 XEO_CLAS Drug in Phase 1 Clinical Trial DME0109 XEOTICID XEO00599 DESCRIPT Tetradecanoylphorbol acetate induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00599 GENEFORM Protein DME0109 XEOTICID XEO00599 MOACRIVE Induction DME0109 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0109 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0109 XEOTICID XEO00632 DESCRIPT Sodium arsenite induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00632 GENEFORM Protein DME0109 XEOTICID XEO00632 MOACRIVE Induction DME0109 XEOTICID XEO00713 XEO_NAME Manumycin DME0109 XEOTICID XEO00713 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00713 XEO_CLAS Preclinical/Patented Drug DME0109 XEOTICID XEO00713 DESCRIPT Manumycin inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00713 GENEFORM Protein DME0109 XEOTICID XEO00713 MOACRIVE Inhibition DME0109 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0109 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0109 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME SOD1 DME0109 XEOTICID XEO00723 GENEFORM mRNA DME0109 XEOTICID XEO00723 MOACRIVE Inhibition DME0109 XEOTICID XEO00743 XEO_NAME Medroxyprogesterone acetate DME0109 XEOTICID XEO00743 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00743 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00743 DESCRIPT Medroxyprogesterone acetate up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO00743 GENEFORM mRNA DME0109 XEOTICID XEO00743 MOACRIVE Induction DME0109 XEOTICID XEO00751 XEO_NAME Cocaine hydrochloride DME0109 XEOTICID XEO00751 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00751 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00751 DESCRIPT Cocaine hydrochloride inhibits the expression of DME SOD1 DME0109 XEOTICID XEO00751 GENEFORM mRNA DME0109 XEOTICID XEO00751 MOACRIVE Inhibition DME0109 XEOTICID XEO00758 XEO_NAME Grape seed proanthocyanidins DME0109 XEOTICID XEO00758 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0109 XEOTICID XEO00758 XEO_CLAS Plant Extract DME0109 XEOTICID XEO00758 DESCRIPT Grape seed proanthocyanidins inhibits the expression of DME SOD1 DME0109 XEOTICID XEO00758 GENEFORM mRNA DME0109 XEOTICID XEO00758 MOACRIVE Inhibition DME0109 XEOTICID XEO00768 XEO_NAME Dichlorodiphenyl dichloroethylene DME0109 XEOTICID XEO00768 XEO_TYPE Health or Environmental Toxicant(s) DME0109 XEOTICID XEO00768 XEO_CLAS Environmental Pollutant DME0109 XEOTICID XEO00768 DESCRIPT Dichlorodiphenyl dichloroethylene induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00768 GENEFORM Protein DME0109 XEOTICID XEO00768 MOACRIVE Induction DME0109 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0109 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0109 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0109 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO00806 GENEFORM mRNA DME0109 XEOTICID XEO00806 MOACRIVE Induction DME0109 XEOTICID XEO00807 XEO_NAME Chlorite DME0109 XEOTICID XEO00807 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00807 XEO_CLAS Investigative Agent DME0109 XEOTICID XEO00807 DESCRIPT Chlorite induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00807 GENEFORM Protein DME0109 XEOTICID XEO00807 MOACRIVE Induction DME0109 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0109 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0109 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0109 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00821 GENEFORM Protein DME0109 XEOTICID XEO00821 MOACRIVE Inhibition DME0109 XEOTICID XEO00834 XEO_NAME Copper DME0109 XEOTICID XEO00834 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00834 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO00834 DESCRIPT Copper inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00834 GENEFORM Protein DME0109 XEOTICID XEO00834 MOACRIVE Inhibition DME0109 XEOTICID XEO00871 XEO_NAME 9,10-phenanthrenequinone DME0109 XEOTICID XEO00871 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00871 XEO_CLAS Investigative Agent DME0109 XEOTICID XEO00871 DESCRIPT 9,10-phenanthrenequinone inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00871 GENEFORM Protein DME0109 XEOTICID XEO00871 MOACRIVE Inhibition DME0109 XEOTICID XEO00885 XEO_NAME Eugenol DME0109 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0109 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00885 GENEFORM Protein DME0109 XEOTICID XEO00885 MOACRIVE Inhibition DME0109 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0109 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0109 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0109 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00898 GENEFORM Protein DME0109 XEOTICID XEO00898 MOACRIVE Inhibition DME0109 XEOTICID XEO00919 XEO_NAME Particulate matter DME0109 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0109 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0109 XEOTICID XEO00919 DESCRIPT Particulate matter inhibits the expression of DME SOD1 DME0109 XEOTICID XEO00919 GENEFORM mRNA DME0109 XEOTICID XEO00919 MOACRIVE Inhibition DME0109 XEOTICID XEO00969 XEO_NAME Atrazine DME0109 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0109 XEOTICID XEO00969 XEO_CLAS Herbicide DME0109 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME SOD1 DME0109 XEOTICID XEO00969 GENEFORM mRNA DME0109 XEOTICID XEO00969 MOACRIVE Inhibition DME0109 XEOTICID XEO00982 XEO_NAME Monomethylarsonic acid DME0109 XEOTICID XEO00982 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0109 XEOTICID XEO00982 XEO_CLAS Herbicide DME0109 XEOTICID XEO00982 DESCRIPT Monomethylarsonic acid induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00982 GENEFORM Protein DME0109 XEOTICID XEO00982 MOACRIVE Induction DME0109 XEOTICID XEO00985 XEO_NAME Hexyl cinnamic aldehyde DME0109 XEOTICID XEO00985 XEO_TYPE Health or Environmental Toxicant(s) DME0109 XEOTICID XEO00985 XEO_CLAS Environmental Pollutant DME0109 XEOTICID XEO00985 DESCRIPT Hexyl cinnamic aldehyde up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO00985 GENEFORM mRNA DME0109 XEOTICID XEO00985 MOACRIVE Induction DME0109 XEOTICID XEO00995 XEO_NAME Amphibole asbestos DME0109 XEOTICID XEO00995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0109 XEOTICID XEO00995 XEO_CLAS Natural Mixture DME0109 XEOTICID XEO00995 DESCRIPT Amphibole asbestos inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO00995 GENEFORM Protein DME0109 XEOTICID XEO00995 MOACRIVE Inhibition DME0109 XEOTICID XEO01047 XEO_NAME Decamethrin DME0109 XEOTICID XEO01047 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0109 XEOTICID XEO01047 XEO_CLAS Pesticide/Insecticide DME0109 XEOTICID XEO01047 DESCRIPT Decamethrin inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO01047 GENEFORM Protein DME0109 XEOTICID XEO01047 MOACRIVE Inhibition DME0109 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0109 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0109 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0109 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME SOD1 DME0109 XEOTICID XEO01050 GENEFORM mRNA DME0109 XEOTICID XEO01050 MOACRIVE Inhibition DME0109 XEOTICID XEO01081 XEO_NAME Thioxotriazole copper(II) DME0109 XEOTICID XEO01081 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO01081 XEO_CLAS Investigative Agent DME0109 XEOTICID XEO01081 DESCRIPT Thioxotriazole copper(II) up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO01081 GENEFORM mRNA DME0109 XEOTICID XEO01081 MOACRIVE Induction DME0109 XEOTICID XEO01187 XEO_NAME Acrylamide DME0109 XEOTICID XEO01187 XEO_TYPE Health or Environmental Toxicant(s) DME0109 XEOTICID XEO01187 XEO_CLAS Acute Toxic Substance DME0109 XEOTICID XEO01187 DESCRIPT Acrylamide inhibits the expression of DME SOD1 DME0109 XEOTICID XEO01187 GENEFORM mRNA DME0109 XEOTICID XEO01187 MOACRIVE Inhibition DME0109 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0109 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0109 XEOTICID XEO01226 DESCRIPT Bisphenol A induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO01226 GENEFORM Protein DME0109 XEOTICID XEO01226 MOACRIVE Induction DME0109 XEOTICID XEO01241 XEO_NAME CD-437 DME0109 XEOTICID XEO01241 XEO_TYPE Health or Environmental Toxicant(s) DME0109 XEOTICID XEO01241 XEO_CLAS Health Hazard/Toxicant DME0109 XEOTICID XEO01241 DESCRIPT CD-437 inhibits the expression of DME SOD1 DME0109 XEOTICID XEO01241 GENEFORM mRNA DME0109 XEOTICID XEO01241 MOACRIVE Inhibition DME0109 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0109 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0109 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0109 XEOTICID XEO01247 DESCRIPT Chloropicrin up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO01247 GENEFORM mRNA DME0109 XEOTICID XEO01247 MOACRIVE Induction DME0109 XEOTICID XEO01259 XEO_NAME Cordycepin DME0109 XEOTICID XEO01259 XEO_TYPE Health or Environmental Toxicant(s) DME0109 XEOTICID XEO01259 XEO_CLAS Acute Toxic Substance DME0109 XEOTICID XEO01259 DESCRIPT Cordycepin inhibits the expression of DME SOD1 DME0109 XEOTICID XEO01259 GENEFORM mRNA DME0109 XEOTICID XEO01259 MOACRIVE Inhibition DME0109 XEOTICID XEO01320 XEO_NAME Glyphosate DME0109 XEOTICID XEO01320 XEO_TYPE Health or Environmental Toxicant(s) DME0109 XEOTICID XEO01320 XEO_CLAS Environmental Pollutant DME0109 XEOTICID XEO01320 DESCRIPT Glyphosate inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO01320 GENEFORM Protein DME0109 XEOTICID XEO01320 MOACRIVE Inhibition DME0109 XEOTICID XEO01326 XEO_NAME GW-7604 DME0109 XEOTICID XEO01326 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO01326 XEO_CLAS Preclinical/Patented Drug DME0109 XEOTICID XEO01326 DESCRIPT GW-7604 up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO01326 GENEFORM mRNA DME0109 XEOTICID XEO01326 MOACRIVE Induction DME0109 XEOTICID XEO01336 XEO_NAME ICG-001 DME0109 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0109 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME SOD1 DME0109 XEOTICID XEO01336 GENEFORM mRNA DME0109 XEOTICID XEO01336 MOACRIVE Inhibition DME0109 XEOTICID XEO01348 XEO_NAME K-7174 DME0109 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0109 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME SOD1 DME0109 XEOTICID XEO01348 GENEFORM mRNA DME0109 XEOTICID XEO01348 MOACRIVE Inhibition DME0109 XEOTICID XEO01353 XEO_NAME Kaempferol DME0109 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME0109 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME0109 XEOTICID XEO01353 DESCRIPT Kaempferol induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO01353 GENEFORM Protein DME0109 XEOTICID XEO01353 MOACRIVE Induction DME0109 XEOTICID XEO01368 XEO_NAME Linsidomine DME0109 XEOTICID XEO01368 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO01368 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO01368 DESCRIPT Linsidomine inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO01368 GENEFORM Protein DME0109 XEOTICID XEO01368 MOACRIVE Inhibition DME0109 XEOTICID XEO01397 XEO_NAME Nickel chloride DME0109 XEOTICID XEO01397 XEO_TYPE Health or Environmental Toxicant(s) DME0109 XEOTICID XEO01397 XEO_CLAS Acute Toxic Substance DME0109 XEOTICID XEO01397 DESCRIPT Nickel chloride up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO01397 GENEFORM mRNA DME0109 XEOTICID XEO01397 MOACRIVE Induction DME0109 XEOTICID XEO01409 XEO_NAME Okadaic acid DME0109 XEOTICID XEO01409 XEO_TYPE Health or Environmental Toxicant(s) DME0109 XEOTICID XEO01409 XEO_CLAS Acute Toxic Substance DME0109 XEOTICID XEO01409 DESCRIPT Okadaic acid inhibits the expression of DME SOD1 DME0109 XEOTICID XEO01409 GENEFORM mRNA DME0109 XEOTICID XEO01409 MOACRIVE Inhibition DME0109 XEOTICID XEO01422 XEO_NAME Paraquat DME0109 XEOTICID XEO01422 XEO_TYPE Health or Environmental Toxicant(s) DME0109 XEOTICID XEO01422 XEO_CLAS Acute Toxic Substance DME0109 XEOTICID XEO01422 DESCRIPT Paraquat inhibits the expression of DME SOD1 DME0109 XEOTICID XEO01422 GENEFORM mRNA DME0109 XEOTICID XEO01422 MOACRIVE Inhibition DME0109 XEOTICID XEO01478 XEO_NAME Sulforafan DME0109 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0109 XEOTICID XEO01478 DESCRIPT Sulforafan up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO01478 GENEFORM mRNA DME0109 XEOTICID XEO01478 MOACRIVE Induction DME0109 XEOTICID XEO01485 XEO_NAME Thiostrepton DME0109 XEOTICID XEO01485 XEO_TYPE Pharmaceutical Agent(s) DME0109 XEOTICID XEO01485 XEO_CLAS Approved/Marketed Drug DME0109 XEOTICID XEO01485 DESCRIPT Thiostrepton induces the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO01485 GENEFORM Protein DME0109 XEOTICID XEO01485 MOACRIVE Induction DME0109 XEOTICID XEO01503 XEO_NAME Cadmium DME0109 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0109 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0109 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the drug-metabolizing activity of DME SOD1 DME0109 XEOTICID XEO01503 GENEFORM Protein DME0109 XEOTICID XEO01503 MOACRIVE Inhibition DME0109 XEOTICID XEO01523 XEO_NAME Apocarotenal DME0109 XEOTICID XEO01523 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0109 XEOTICID XEO01523 XEO_CLAS Natural Product DME0109 XEOTICID XEO01523 DESCRIPT Apocarotenal inhibits the expression of DME SOD1 DME0109 XEOTICID XEO01523 GENEFORM mRNA DME0109 XEOTICID XEO01523 MOACRIVE Inhibition DME0109 XEOTICID XEO01574 XEO_NAME Plant extracts DME0109 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0109 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0109 XEOTICID XEO01574 DESCRIPT Plant extracts up-regulates the expression of DME SOD1 DME0109 XEOTICID XEO01574 GENEFORM mRNA DME0109 XEOTICID XEO01574 MOACRIVE Induction DME0110 DME___ID DME0110 DME0110 DME_NAME Glutathione reductase (GSR) DME0110 SPESNAME Homo sapiens DME0110 XEOTICID XEO00007 XEO_NAME Azathioprine DME0110 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00007 DESCRIPT Azathioprine up-regulates the expression of DME GSR DME0110 XEOTICID XEO00007 GENEFORM mRNA DME0110 XEOTICID XEO00007 MOACRIVE Induction DME0110 XEOTICID XEO00012 XEO_NAME Carmustine DME0110 XEOTICID XEO00012 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00012 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00012 DESCRIPT Carmustine inhibits the drug-metabolizing activity of DME GSR (IC50 = 8.1 microM) DME0110 XEOTICID XEO00012 GENEFORM Protein DME0110 XEOTICID XEO00012 MOACRIVE Inhibition DME0110 XEOTICID XEO00028 XEO_NAME Disulfiram DME0110 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00028 DESCRIPT Disulfiram up-regulates the expression of DME GSR DME0110 XEOTICID XEO00028 GENEFORM mRNA DME0110 XEOTICID XEO00028 MOACRIVE Induction DME0110 XEOTICID XEO00046 XEO_NAME Ifosfamide DME0110 XEOTICID XEO00046 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00046 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00046 DESCRIPT Ifosfamide up-regulates the expression of DME GSR DME0110 XEOTICID XEO00046 GENEFORM mRNA DME0110 XEOTICID XEO00046 MOACRIVE Induction DME0110 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0110 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME GSR DME0110 XEOTICID XEO00088 GENEFORM mRNA DME0110 XEOTICID XEO00088 MOACRIVE Induction DME0110 XEOTICID XEO00095 XEO_NAME Testosterone DME0110 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00095 DESCRIPT Testosterone induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00095 GENEFORM Protein DME0110 XEOTICID XEO00095 MOACRIVE Induction DME0110 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0110 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME GSR DME0110 XEOTICID XEO00117 GENEFORM mRNA DME0110 XEOTICID XEO00117 MOACRIVE Induction DME0110 XEOTICID XEO00132 XEO_NAME Cidofovir DME0110 XEOTICID XEO00132 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00132 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00132 DESCRIPT Cidofovir up-regulates the expression of DME GSR DME0110 XEOTICID XEO00132 GENEFORM mRNA DME0110 XEOTICID XEO00132 MOACRIVE Induction DME0110 XEOTICID XEO00159 XEO_NAME Bortezomib DME0110 XEOTICID XEO00159 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00159 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00159 DESCRIPT Bortezomib up-regulates the expression of DME GSR DME0110 XEOTICID XEO00159 GENEFORM mRNA DME0110 XEOTICID XEO00159 MOACRIVE Induction DME0110 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0110 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00165 DESCRIPT Obeticholic acid up-regulates the expression of DME GSR DME0110 XEOTICID XEO00165 GENEFORM mRNA DME0110 XEOTICID XEO00165 MOACRIVE Induction DME0110 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0110 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME GSR DME0110 XEOTICID XEO00217 GENEFORM mRNA DME0110 XEOTICID XEO00217 MOACRIVE Induction DME0110 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0110 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME GSR DME0110 XEOTICID XEO00241 GENEFORM mRNA DME0110 XEOTICID XEO00241 MOACRIVE Induction DME0110 XEOTICID XEO00253 XEO_NAME Tretinoin DME0110 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00253 DESCRIPT Tretinoin induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00253 GENEFORM Protein DME0110 XEOTICID XEO00253 MOACRIVE Induction DME0110 XEOTICID XEO00334 XEO_NAME Cisplatin DME0110 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00334 GENEFORM Protein DME0110 XEOTICID XEO00334 MOACRIVE Inhibition DME0110 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0110 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME GSR DME0110 XEOTICID XEO00339 GENEFORM mRNA DME0110 XEOTICID XEO00339 MOACRIVE Induction DME0110 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0110 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00388 GENEFORM Protein DME0110 XEOTICID XEO00388 MOACRIVE Induction DME0110 XEOTICID XEO00399 XEO_NAME Pyrithione zinc DME0110 XEOTICID XEO00399 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00399 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00399 DESCRIPT Pyrithione zinc up-regulates the expression of DME GSR DME0110 XEOTICID XEO00399 GENEFORM mRNA DME0110 XEOTICID XEO00399 MOACRIVE Induction DME0110 XEOTICID XEO00447 XEO_NAME Benzoic acid DME0110 XEOTICID XEO00447 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00447 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00447 DESCRIPT Benzoic acid up-regulates the expression of DME GSR DME0110 XEOTICID XEO00447 GENEFORM mRNA DME0110 XEOTICID XEO00447 MOACRIVE Induction DME0110 XEOTICID XEO00465 XEO_NAME Clodronic acid DME0110 XEOTICID XEO00465 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00465 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00465 DESCRIPT Clodronic acid up-regulates the expression of DME GSR DME0110 XEOTICID XEO00465 GENEFORM mRNA DME0110 XEOTICID XEO00465 MOACRIVE Induction DME0110 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0110 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0110 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME GSR DME0110 XEOTICID XEO00536 GENEFORM mRNA DME0110 XEOTICID XEO00536 MOACRIVE Induction DME0110 XEOTICID XEO00539 XEO_NAME Ethanol DME0110 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0110 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00539 GENEFORM Protein DME0110 XEOTICID XEO00539 MOACRIVE Inhibition DME0110 XEOTICID XEO00541 XEO_NAME Motexafin gadolinium DME0110 XEOTICID XEO00541 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00541 XEO_CLAS Drug in Phase 2 Clinical Trial DME0110 XEOTICID XEO00541 DESCRIPT Motexafin gadolinium induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00541 GENEFORM Protein DME0110 XEOTICID XEO00541 MOACRIVE Induction DME0110 XEOTICID XEO00542 XEO_NAME Glutathione DME0110 XEOTICID XEO00542 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00542 XEO_CLAS Drug in Phase 2 Clinical Trial DME0110 XEOTICID XEO00542 DESCRIPT Glutathione inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00542 GENEFORM Protein DME0110 XEOTICID XEO00542 MOACRIVE Inhibition DME0110 XEOTICID XEO00557 XEO_NAME Genistein DME0110 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0110 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME GSR DME0110 XEOTICID XEO00557 GENEFORM mRNA DME0110 XEOTICID XEO00557 MOACRIVE Inhibition DME0110 XEOTICID XEO00568 XEO_NAME Resveratrol DME0110 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0110 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME GSR DME0110 XEOTICID XEO00568 GENEFORM mRNA DME0110 XEOTICID XEO00568 MOACRIVE Induction DME0110 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0110 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0110 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME GSR DME0110 XEOTICID XEO00571 GENEFORM mRNA DME0110 XEOTICID XEO00571 MOACRIVE Induction DME0110 XEOTICID XEO00575 XEO_NAME Selenic acid DME0110 XEOTICID XEO00575 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00575 XEO_CLAS Drug in Phase 2 Clinical Trial DME0110 XEOTICID XEO00575 DESCRIPT Selenic acid up-regulates the expression of DME GSR DME0110 XEOTICID XEO00575 GENEFORM mRNA DME0110 XEOTICID XEO00575 MOACRIVE Induction DME0110 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME0110 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME0110 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00613 GENEFORM Protein DME0110 XEOTICID XEO00613 MOACRIVE Induction DME0110 XEOTICID XEO00625 XEO_NAME MGI-114 DME0110 XEOTICID XEO00625 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00625 XEO_CLAS Drug in Phase 2 Clinical Trial DME0110 XEOTICID XEO00625 DESCRIPT MGI-114 inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00625 GENEFORM Protein DME0110 XEOTICID XEO00625 MOACRIVE Inhibition DME0110 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0110 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0110 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME GSR DME0110 XEOTICID XEO00632 GENEFORM mRNA DME0110 XEOTICID XEO00632 MOACRIVE Induction DME0110 XEOTICID XEO00729 XEO_NAME Anethole trithione DME0110 XEOTICID XEO00729 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00729 XEO_CLAS Preclinical/Patented Drug DME0110 XEOTICID XEO00729 DESCRIPT Anethole trithione induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00729 GENEFORM Protein DME0110 XEOTICID XEO00729 MOACRIVE Induction DME0110 XEOTICID XEO00740 XEO_NAME Lindane DME0110 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO00740 DESCRIPT Lindane up-regulates the expression of DME GSR DME0110 XEOTICID XEO00740 GENEFORM mRNA DME0110 XEOTICID XEO00740 MOACRIVE Induction DME0110 XEOTICID XEO00807 XEO_NAME Chlorite DME0110 XEOTICID XEO00807 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00807 XEO_CLAS Investigative Agent DME0110 XEOTICID XEO00807 DESCRIPT Chlorite inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00807 GENEFORM Protein DME0110 XEOTICID XEO00807 MOACRIVE Inhibition DME0110 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0110 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0110 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00818 GENEFORM Protein DME0110 XEOTICID XEO00818 MOACRIVE Induction DME0110 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0110 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0110 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0110 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00821 GENEFORM Protein DME0110 XEOTICID XEO00821 MOACRIVE Inhibition DME0110 XEOTICID XEO00823 XEO_NAME Carbamate DME0110 XEOTICID XEO00823 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0110 XEOTICID XEO00823 XEO_CLAS Pesticide/Insecticide DME0110 XEOTICID XEO00823 DESCRIPT Carbamate inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00823 GENEFORM Protein DME0110 XEOTICID XEO00823 MOACRIVE Inhibition DME0110 XEOTICID XEO00840 XEO_NAME Cupric oxide DME0110 XEOTICID XEO00840 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0110 XEOTICID XEO00840 XEO_CLAS Chemical Compound DME0110 XEOTICID XEO00840 DESCRIPT Cupric oxide inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00840 GENEFORM Protein DME0110 XEOTICID XEO00840 MOACRIVE Inhibition DME0110 XEOTICID XEO00852 XEO_NAME Allyl isothiocyanate DME0110 XEOTICID XEO00852 XEO_TYPE Health or Environmental Toxicant(s) DME0110 XEOTICID XEO00852 XEO_CLAS Acute Toxic Substance DME0110 XEOTICID XEO00852 DESCRIPT Allyl isothiocyanate inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00852 GENEFORM Protein DME0110 XEOTICID XEO00852 MOACRIVE Inhibition DME0110 XEOTICID XEO00885 XEO_NAME Eugenol DME0110 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0110 XEOTICID XEO00885 DESCRIPT Eugenol up-regulates the expression of DME GSR DME0110 XEOTICID XEO00885 GENEFORM mRNA DME0110 XEOTICID XEO00885 MOACRIVE Induction DME0110 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0110 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0110 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0110 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00898 GENEFORM Protein DME0110 XEOTICID XEO00898 MOACRIVE Inhibition DME0110 XEOTICID XEO00969 XEO_NAME Atrazine DME0110 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0110 XEOTICID XEO00969 XEO_CLAS Herbicide DME0110 XEOTICID XEO00969 DESCRIPT Atrazine induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO00969 GENEFORM Protein DME0110 XEOTICID XEO00969 MOACRIVE Induction DME0110 XEOTICID XEO00985 XEO_NAME Hexyl cinnamic aldehyde DME0110 XEOTICID XEO00985 XEO_TYPE Health or Environmental Toxicant(s) DME0110 XEOTICID XEO00985 XEO_CLAS Environmental Pollutant DME0110 XEOTICID XEO00985 DESCRIPT Hexyl cinnamic aldehyde up-regulates the expression of DME GSR DME0110 XEOTICID XEO00985 GENEFORM mRNA DME0110 XEOTICID XEO00985 MOACRIVE Induction DME0110 XEOTICID XEO01001 XEO_NAME Chloric acid DME0110 XEOTICID XEO01001 XEO_TYPE Health or Environmental Toxicant(s) DME0110 XEOTICID XEO01001 XEO_CLAS Health Hazard/Toxicant DME0110 XEOTICID XEO01001 DESCRIPT Chloric acid inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO01001 GENEFORM Protein DME0110 XEOTICID XEO01001 MOACRIVE Inhibition DME0110 XEOTICID XEO01016 XEO_NAME N-hexane DME0110 XEOTICID XEO01016 XEO_TYPE Health or Environmental Toxicant(s) DME0110 XEOTICID XEO01016 XEO_CLAS Health Hazard/Toxicant DME0110 XEOTICID XEO01016 DESCRIPT N-hexane up-regulates the expression of DME GSR DME0110 XEOTICID XEO01016 GENEFORM mRNA DME0110 XEOTICID XEO01016 MOACRIVE Induction DME0110 XEOTICID XEO01128 XEO_NAME Isopropanol DME0110 XEOTICID XEO01128 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO01128 XEO_CLAS Investigative Agent DME0110 XEOTICID XEO01128 DESCRIPT Isopropanol up-regulates the expression of DME GSR DME0110 XEOTICID XEO01128 GENEFORM mRNA DME0110 XEOTICID XEO01128 MOACRIVE Induction DME0110 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0110 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0110 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0110 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO01129 GENEFORM Protein DME0110 XEOTICID XEO01129 MOACRIVE Induction DME0110 XEOTICID XEO01187 XEO_NAME Acrylamide DME0110 XEOTICID XEO01187 XEO_TYPE Health or Environmental Toxicant(s) DME0110 XEOTICID XEO01187 XEO_CLAS Acute Toxic Substance DME0110 XEOTICID XEO01187 DESCRIPT Acrylamide induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO01187 GENEFORM Protein DME0110 XEOTICID XEO01187 MOACRIVE Induction DME0110 XEOTICID XEO01188 XEO_NAME Acylfulvene DME0110 XEOTICID XEO01188 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0110 XEOTICID XEO01188 XEO_CLAS Natural Product DME0110 XEOTICID XEO01188 DESCRIPT Acylfulvene inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO01188 GENEFORM Protein DME0110 XEOTICID XEO01188 MOACRIVE Inhibition DME0110 XEOTICID XEO01217 XEO_NAME Benzyl isothiocyanate DME0110 XEOTICID XEO01217 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0110 XEOTICID XEO01217 XEO_CLAS Natural Product DME0110 XEOTICID XEO01217 DESCRIPT Benzyl isothiocyanate inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO01217 GENEFORM Protein DME0110 XEOTICID XEO01217 MOACRIVE Inhibition DME0110 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0110 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0110 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME GSR DME0110 XEOTICID XEO01226 GENEFORM mRNA DME0110 XEOTICID XEO01226 MOACRIVE Induction DME0110 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0110 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0110 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0110 XEOTICID XEO01248 DESCRIPT Chlorpyrifos up-regulates the expression of DME GSR DME0110 XEOTICID XEO01248 GENEFORM mRNA DME0110 XEOTICID XEO01248 MOACRIVE Induction DME0110 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME0110 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0110 XEOTICID XEO01253 XEO_CLAS Natural Product DME0110 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde up-regulates the expression of DME GSR DME0110 XEOTICID XEO01253 GENEFORM mRNA DME0110 XEOTICID XEO01253 MOACRIVE Induction DME0110 XEOTICID XEO01316 XEO_NAME Glutaral DME0110 XEOTICID XEO01316 XEO_TYPE Health or Environmental Toxicant(s) DME0110 XEOTICID XEO01316 XEO_CLAS Acute Toxic Substance DME0110 XEOTICID XEO01316 DESCRIPT Glutaral inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO01316 GENEFORM Protein DME0110 XEOTICID XEO01316 MOACRIVE Inhibition DME0110 XEOTICID XEO01329 XEO_NAME Hexylresorcinol DME0110 XEOTICID XEO01329 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO01329 XEO_CLAS Drug in Phase 1 Clinical Trial DME0110 XEOTICID XEO01329 DESCRIPT Hexylresorcinol induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO01329 GENEFORM Protein DME0110 XEOTICID XEO01329 MOACRIVE Induction DME0110 XEOTICID XEO01331 XEO_NAME Homocysteine DME0110 XEOTICID XEO01331 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO01331 XEO_CLAS Drug in Phase 1 Clinical Trial DME0110 XEOTICID XEO01331 DESCRIPT Homocysteine inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO01331 GENEFORM Protein DME0110 XEOTICID XEO01331 MOACRIVE Inhibition DME0110 XEOTICID XEO01336 XEO_NAME ICG-001 DME0110 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0110 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME GSR DME0110 XEOTICID XEO01336 GENEFORM mRNA DME0110 XEOTICID XEO01336 MOACRIVE Inhibition DME0110 XEOTICID XEO01339 XEO_NAME Illudin S DME0110 XEOTICID XEO01339 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0110 XEOTICID XEO01339 XEO_CLAS Natural Product DME0110 XEOTICID XEO01339 DESCRIPT Illudin S inhibits the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO01339 GENEFORM Protein DME0110 XEOTICID XEO01339 MOACRIVE Inhibition DME0110 XEOTICID XEO01342 XEO_NAME Indirubin-3'-monoxime DME0110 XEOTICID XEO01342 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO01342 XEO_CLAS Investigative Agent DME0110 XEOTICID XEO01342 DESCRIPT Indirubin-3'-monoxime up-regulates the expression of DME GSR DME0110 XEOTICID XEO01342 GENEFORM mRNA DME0110 XEOTICID XEO01342 MOACRIVE Induction DME0110 XEOTICID XEO01348 XEO_NAME K-7174 DME0110 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0110 XEOTICID XEO01348 DESCRIPT K-7174 up-regulates the expression of DME GSR DME0110 XEOTICID XEO01348 GENEFORM mRNA DME0110 XEOTICID XEO01348 MOACRIVE Induction DME0110 XEOTICID XEO01358 XEO_NAME Kolaviron DME0110 XEOTICID XEO01358 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO01358 XEO_CLAS Preclinical/Patented Drug DME0110 XEOTICID XEO01358 DESCRIPT Kolaviron induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO01358 GENEFORM Protein DME0110 XEOTICID XEO01358 MOACRIVE Induction DME0110 XEOTICID XEO01422 XEO_NAME Paraquat DME0110 XEOTICID XEO01422 XEO_TYPE Health or Environmental Toxicant(s) DME0110 XEOTICID XEO01422 XEO_CLAS Acute Toxic Substance DME0110 XEOTICID XEO01422 DESCRIPT Paraquat inhibits the expression of DME GSR DME0110 XEOTICID XEO01422 GENEFORM mRNA DME0110 XEOTICID XEO01422 MOACRIVE Inhibition DME0110 XEOTICID XEO01441 XEO_NAME Pterostilbene DME0110 XEOTICID XEO01441 XEO_TYPE Health or Environmental Toxicant(s) DME0110 XEOTICID XEO01441 XEO_CLAS Environmental Pollutant DME0110 XEOTICID XEO01441 DESCRIPT Pterostilbene inhibits the expression of DME GSR DME0110 XEOTICID XEO01441 GENEFORM mRNA DME0110 XEOTICID XEO01441 MOACRIVE Inhibition DME0110 XEOTICID XEO01478 XEO_NAME Sulforafan DME0110 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0110 XEOTICID XEO01478 DESCRIPT Sulforafan up-regulates the expression of DME GSR DME0110 XEOTICID XEO01478 GENEFORM mRNA DME0110 XEOTICID XEO01478 MOACRIVE Induction DME0110 XEOTICID XEO01483 XEO_NAME Thioctic acid DME0110 XEOTICID XEO01483 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO01483 XEO_CLAS Drug in Phase 1 Clinical Trial DME0110 XEOTICID XEO01483 DESCRIPT Thioctic acid up-regulates the expression of DME GSR DME0110 XEOTICID XEO01483 GENEFORM mRNA DME0110 XEOTICID XEO01483 MOACRIVE Induction DME0110 XEOTICID XEO01485 XEO_NAME Thiostrepton DME0110 XEOTICID XEO01485 XEO_TYPE Pharmaceutical Agent(s) DME0110 XEOTICID XEO01485 XEO_CLAS Approved/Marketed Drug DME0110 XEOTICID XEO01485 DESCRIPT Thiostrepton induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO01485 GENEFORM Protein DME0110 XEOTICID XEO01485 MOACRIVE Induction DME0110 XEOTICID XEO01503 XEO_NAME Cadmium DME0110 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0110 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0110 XEOTICID XEO01503 DESCRIPT Cadmium induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO01503 GENEFORM Protein DME0110 XEOTICID XEO01503 MOACRIVE Induction DME0110 XEOTICID XEO01542 XEO_NAME Gallocatechol DME0110 XEOTICID XEO01542 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0110 XEOTICID XEO01542 XEO_CLAS Natural Product DME0110 XEOTICID XEO01542 DESCRIPT Gallocatechol induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO01542 GENEFORM Protein DME0110 XEOTICID XEO01542 MOACRIVE Induction DME0110 XEOTICID XEO01574 XEO_NAME Plant extracts DME0110 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0110 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0110 XEOTICID XEO01574 DESCRIPT Plant extracts induces the drug-metabolizing activity of DME GSR DME0110 XEOTICID XEO01574 GENEFORM Protein DME0110 XEOTICID XEO01574 MOACRIVE Induction DME0111 DME___ID DME0111 DME0111 DME_NAME Ecto-5'-nucleotidase (NT5E) DME0111 SPESNAME Homo sapiens DME0111 XEOTICID XEO00029 XEO_NAME Valproic acid DME0111 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0111 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME NT5E DME0111 XEOTICID XEO00029 GENEFORM mRNA DME0111 XEOTICID XEO00029 MOACRIVE Inhibition DME0111 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0111 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0111 XEOTICID XEO00037 DESCRIPT Fluorouracil up-regulates the expression of DME NT5E DME0111 XEOTICID XEO00037 GENEFORM mRNA DME0111 XEOTICID XEO00037 MOACRIVE Induction DME0111 XEOTICID XEO00047 XEO_NAME Indomethacin DME0111 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0111 XEOTICID XEO00047 DESCRIPT Indomethacin up-regulates the expression of DME NT5E and leads to increasing the drug-metabolizing activity of this enzyme DME0111 XEOTICID XEO00047 GENEFORM Protein DME0111 XEOTICID XEO00047 MOACRIVE Induction DME0111 XEOTICID XEO00090 XEO_NAME Estradiol DME0111 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0111 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME NT5E DME0111 XEOTICID XEO00090 GENEFORM mRNA DME0111 XEOTICID XEO00090 MOACRIVE Inhibition DME0111 XEOTICID XEO00102 XEO_NAME Azacitidine DME0111 XEOTICID XEO00102 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00102 XEO_CLAS Approved/Marketed Drug DME0111 XEOTICID XEO00102 DESCRIPT Azacitidine up-regulates the expression of DME NT5E DME0111 XEOTICID XEO00102 GENEFORM mRNA DME0111 XEOTICID XEO00102 MOACRIVE Induction DME0111 XEOTICID XEO00159 XEO_NAME Bortezomib DME0111 XEOTICID XEO00159 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00159 XEO_CLAS Approved/Marketed Drug DME0111 XEOTICID XEO00159 DESCRIPT Bortezomib inhibits the expression of DME NT5E DME0111 XEOTICID XEO00159 GENEFORM mRNA DME0111 XEOTICID XEO00159 MOACRIVE Inhibition DME0111 XEOTICID XEO00168 XEO_NAME Decitabine DME0111 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0111 XEOTICID XEO00168 DESCRIPT Decitabine up-regulates the expression of DME NT5E DME0111 XEOTICID XEO00168 GENEFORM mRNA DME0111 XEOTICID XEO00168 MOACRIVE Induction DME0111 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0111 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0111 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME NT5E DME0111 XEOTICID XEO00217 GENEFORM mRNA DME0111 XEOTICID XEO00217 MOACRIVE Inhibition DME0111 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0111 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0111 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME NT5E DME0111 XEOTICID XEO00241 GENEFORM mRNA DME0111 XEOTICID XEO00241 MOACRIVE Induction DME0111 XEOTICID XEO00253 XEO_NAME Tretinoin DME0111 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0111 XEOTICID XEO00253 DESCRIPT Tretinoin induces the drug-metabolizing activity of DME NT5E DME0111 XEOTICID XEO00253 GENEFORM Protein DME0111 XEOTICID XEO00253 MOACRIVE Induction DME0111 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0111 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0111 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME NT5E DME0111 XEOTICID XEO00292 GENEFORM mRNA DME0111 XEOTICID XEO00292 MOACRIVE Inhibition DME0111 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0111 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0111 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME NT5E DME0111 XEOTICID XEO00339 GENEFORM mRNA DME0111 XEOTICID XEO00339 MOACRIVE Inhibition DME0111 XEOTICID XEO00466 XEO_NAME Demecolcine DME0111 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0111 XEOTICID XEO00466 DESCRIPT Demecolcine up-regulates the expression of DME NT5E DME0111 XEOTICID XEO00466 GENEFORM mRNA DME0111 XEOTICID XEO00466 MOACRIVE Induction DME0111 XEOTICID XEO00538 XEO_NAME Quercetin DME0111 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0111 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME NT5E DME0111 XEOTICID XEO00538 GENEFORM Protein DME0111 XEOTICID XEO00538 MOACRIVE Inhibition DME0111 XEOTICID XEO00557 XEO_NAME Genistein DME0111 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0111 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME NT5E DME0111 XEOTICID XEO00557 GENEFORM mRNA DME0111 XEOTICID XEO00557 MOACRIVE Inhibition DME0111 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0111 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0111 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0111 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME NT5E DME0111 XEOTICID XEO00772 GENEFORM mRNA DME0111 XEOTICID XEO00772 MOACRIVE Induction DME0111 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0111 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0111 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate induces the drug-metabolizing activity of DME NT5E DME0111 XEOTICID XEO00818 GENEFORM Protein DME0111 XEOTICID XEO00818 MOACRIVE Induction DME0111 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0111 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0111 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0111 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME NT5E DME0111 XEOTICID XEO00821 GENEFORM Protein DME0111 XEOTICID XEO00821 MOACRIVE Inhibition DME0111 XEOTICID XEO00893 XEO_NAME 1-nitropyrene DME0111 XEOTICID XEO00893 XEO_TYPE Health or Environmental Toxicant(s) DME0111 XEOTICID XEO00893 XEO_CLAS Carcinogen DME0111 XEOTICID XEO00893 DESCRIPT 1-nitropyrene up-regulates the expression of DME NT5E DME0111 XEOTICID XEO00893 GENEFORM mRNA DME0111 XEOTICID XEO00893 MOACRIVE Induction DME0111 XEOTICID XEO00919 XEO_NAME Particulate matter DME0111 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0111 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0111 XEOTICID XEO00919 DESCRIPT Particulate matter induces the drug-metabolizing activity of DME NT5E DME0111 XEOTICID XEO00919 GENEFORM Protein DME0111 XEOTICID XEO00919 MOACRIVE Induction DME0111 XEOTICID XEO00973 XEO_NAME Diuron DME0111 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0111 XEOTICID XEO00973 XEO_CLAS Herbicide DME0111 XEOTICID XEO00973 DESCRIPT Diuron up-regulates the expression of DME NT5E DME0111 XEOTICID XEO00973 GENEFORM mRNA DME0111 XEOTICID XEO00973 MOACRIVE Induction DME0111 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0111 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0111 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0111 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME NT5E DME0111 XEOTICID XEO01004 GENEFORM mRNA DME0111 XEOTICID XEO01004 MOACRIVE Induction DME0111 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0111 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0111 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0111 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME NT5E DME0111 XEOTICID XEO01031 GENEFORM mRNA DME0111 XEOTICID XEO01031 MOACRIVE Inhibition DME0111 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0111 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0111 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0111 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME NT5E DME0111 XEOTICID XEO01050 GENEFORM mRNA DME0111 XEOTICID XEO01050 MOACRIVE Inhibition DME0111 XEOTICID XEO01189 XEO_NAME Adenosine diphosphate DME0111 XEOTICID XEO01189 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0111 XEOTICID XEO01189 XEO_CLAS Natural Product DME0111 XEOTICID XEO01189 DESCRIPT Adenosine diphosphate inhibits the drug-metabolizing activity of DME NT5E DME0111 XEOTICID XEO01189 GENEFORM Protein DME0111 XEOTICID XEO01189 MOACRIVE Inhibition DME0111 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0111 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0111 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME NT5E DME0111 XEOTICID XEO01226 GENEFORM mRNA DME0111 XEOTICID XEO01226 MOACRIVE Induction DME0111 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0111 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0111 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0111 XEOTICID XEO01247 DESCRIPT Chloropicrin inhibits the expression of DME NT5E DME0111 XEOTICID XEO01247 GENEFORM mRNA DME0111 XEOTICID XEO01247 MOACRIVE Inhibition DME0111 XEOTICID XEO01261 XEO_NAME Coumestrol DME0111 XEOTICID XEO01261 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO01261 XEO_CLAS Investigative Agent DME0111 XEOTICID XEO01261 DESCRIPT Coumestrol inhibits the expression of DME NT5E DME0111 XEOTICID XEO01261 GENEFORM mRNA DME0111 XEOTICID XEO01261 MOACRIVE Inhibition DME0111 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0111 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0111 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0111 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME NT5E DME0111 XEOTICID XEO01305 GENEFORM mRNA DME0111 XEOTICID XEO01305 MOACRIVE Inhibition DME0111 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0111 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0111 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0111 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME NT5E DME0111 XEOTICID XEO01492 GENEFORM mRNA DME0111 XEOTICID XEO01492 MOACRIVE Induction DME0112 DME___ID DME0112 DME0112 DME_NAME Deoxycytidylate deaminase (DCTD) DME0112 SPESNAME Homo sapiens DME0112 XEOTICID XEO00029 XEO_NAME Valproic acid DME0112 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0112 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0112 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME DCTD DME0112 XEOTICID XEO00029 GENEFORM mRNA DME0112 XEOTICID XEO00029 MOACRIVE Inhibition DME0112 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0112 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0112 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0112 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME DCTD DME0112 XEOTICID XEO00241 GENEFORM mRNA DME0112 XEOTICID XEO00241 MOACRIVE Induction DME0112 XEOTICID XEO01336 XEO_NAME ICG-001 DME0112 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0112 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0112 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME DCTD DME0112 XEOTICID XEO01336 GENEFORM mRNA DME0112 XEOTICID XEO01336 MOACRIVE Induction DME0113 DME___ID DME0113 DME0113 DME_NAME Heparanase (HPSE) DME0113 SPESNAME Homo sapiens DME0113 XEOTICID XEO00090 XEO_NAME Estradiol DME0113 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0113 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0113 XEOTICID XEO00090 DESCRIPT Estradiol induces the drug-metabolizing activity of DME HPSE DME0113 XEOTICID XEO00090 GENEFORM Protein DME0113 XEOTICID XEO00090 MOACRIVE Induction DME0113 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0113 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0113 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0113 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME HPSE DME0113 XEOTICID XEO00217 GENEFORM mRNA DME0113 XEOTICID XEO00217 MOACRIVE Induction DME0113 XEOTICID XEO00253 XEO_NAME Tretinoin DME0113 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0113 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0113 XEOTICID XEO00253 DESCRIPT Tretinoin induces the drug-metabolizing activity of DME HPSE DME0113 XEOTICID XEO00253 GENEFORM Protein DME0113 XEOTICID XEO00253 MOACRIVE Induction DME0113 XEOTICID XEO00334 XEO_NAME Cisplatin DME0113 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0113 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0113 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME HPSE DME0113 XEOTICID XEO00334 GENEFORM mRNA DME0113 XEOTICID XEO00334 MOACRIVE Induction DME0113 XEOTICID XEO00538 XEO_NAME Quercetin DME0113 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0113 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0113 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME HPSE DME0113 XEOTICID XEO00538 GENEFORM Protein DME0113 XEOTICID XEO00538 MOACRIVE Inhibition DME0113 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0113 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0113 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0113 XEOTICID XEO00632 DESCRIPT Sodium arsenite induces the drug-metabolizing activity of DME HPSE DME0113 XEOTICID XEO00632 GENEFORM Protein DME0113 XEOTICID XEO00632 MOACRIVE Induction DME0113 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0113 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0113 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0113 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME HPSE DME0113 XEOTICID XEO00818 GENEFORM mRNA DME0113 XEOTICID XEO00818 MOACRIVE Induction DME0113 XEOTICID XEO00919 XEO_NAME Particulate matter DME0113 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0113 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0113 XEOTICID XEO00919 DESCRIPT Particulate matter inhibits the drug-metabolizing activity of DME HPSE DME0113 XEOTICID XEO00919 GENEFORM Protein DME0113 XEOTICID XEO00919 MOACRIVE Inhibition DME0113 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0113 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0113 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0113 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME HPSE DME0113 XEOTICID XEO00999 GENEFORM mRNA DME0113 XEOTICID XEO00999 MOACRIVE Induction DME0113 XEOTICID XEO01034 XEO_NAME Pentanal DME0113 XEOTICID XEO01034 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0113 XEOTICID XEO01034 XEO_CLAS Chemical Compound DME0113 XEOTICID XEO01034 DESCRIPT Pentanal up-regulates the expression of DME HPSE DME0113 XEOTICID XEO01034 GENEFORM mRNA DME0113 XEOTICID XEO01034 MOACRIVE Induction DME0113 XEOTICID XEO01574 XEO_NAME Plant extracts DME0113 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0113 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0113 XEOTICID XEO01574 DESCRIPT Plant extracts up-regulates the expression of DME HPSE DME0113 XEOTICID XEO01574 GENEFORM mRNA DME0113 XEOTICID XEO01574 MOACRIVE Induction DME0114 DME___ID DME0114 DME0114 DME_NAME Prostaglandin G/H synthase 2 (COX-2) DME0114 SPESNAME Homo sapiens DME0114 XEOTICID XEO00007 XEO_NAME Azathioprine DME0114 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00007 DESCRIPT Azathioprine inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00007 GENEFORM mRNA DME0114 XEOTICID XEO00007 MOACRIVE Inhibition DME0114 XEOTICID XEO00010 XEO_NAME Busulfan DME0114 XEOTICID XEO00010 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00010 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00010 DESCRIPT Busulfan up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00010 GENEFORM mRNA DME0114 XEOTICID XEO00010 MOACRIVE Induction DME0114 XEOTICID XEO00013 XEO_NAME Celecoxib DME0114 XEOTICID XEO00013 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00013 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00013 DESCRIPT Celecoxib inhibits the drug-metabolizing activity of DME PTGS2 (IC50 < 0.3 microM) DME0114 XEOTICID XEO00013 GENEFORM Protein DME0114 XEOTICID XEO00013 MOACRIVE Inhibition DME0114 XEOTICID XEO00029 XEO_NAME Valproic acid DME0114 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00029 GENEFORM mRNA DME0114 XEOTICID XEO00029 MOACRIVE Induction DME0114 XEOTICID XEO00034 XEO_NAME Etodolac DME0114 XEOTICID XEO00034 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00034 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00034 DESCRIPT Etodolac inhibits the drug-metabolizing activity of DME PTGS2 in Spodoptera frugiperda (Sf21) cell (IC50 = 0.561 microM) DME0114 XEOTICID XEO00034 GENEFORM Protein DME0114 XEOTICID XEO00034 MOACRIVE Inhibition DME0114 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0114 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00037 DESCRIPT Fluorouracil inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00037 GENEFORM Protein DME0114 XEOTICID XEO00037 MOACRIVE Inhibition DME0114 XEOTICID XEO00047 XEO_NAME Indomethacin DME0114 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00047 DESCRIPT Indomethacin inhibits the drug-metabolizing activity of DME PTGS2 (IC50 < 0.2 microM) DME0114 XEOTICID XEO00047 GENEFORM Protein DME0114 XEOTICID XEO00047 MOACRIVE Inhibition DME0114 XEOTICID XEO00078 XEO_NAME Rofecoxib DME0114 XEOTICID XEO00078 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00078 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00078 DESCRIPT Rof DMEecoxib inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.001 microM) DME0114 XEOTICID XEO00078 GENEFORM Protein DME0114 XEOTICID XEO00078 MOACRIVE Inhibition DME0114 XEOTICID XEO00082 XEO_NAME Temozolomide DME0114 XEOTICID XEO00082 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00082 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00082 DESCRIPT Temozolomide inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00082 GENEFORM Protein DME0114 XEOTICID XEO00082 MOACRIVE Inhibition DME0114 XEOTICID XEO00083 XEO_NAME Thalidomide DME0114 XEOTICID XEO00083 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00083 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00083 DESCRIPT Thalidomide inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00083 GENEFORM mRNA DME0114 XEOTICID XEO00083 MOACRIVE Inhibition DME0114 XEOTICID XEO00086 XEO_NAME Troglitazone DME0114 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00086 DESCRIPT Troglitazone inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00086 GENEFORM Protein DME0114 XEOTICID XEO00086 MOACRIVE Inhibition DME0114 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0114 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00088 DESCRIPT Dexamethasone inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00088 GENEFORM Protein DME0114 XEOTICID XEO00088 MOACRIVE Inhibition DME0114 XEOTICID XEO00090 XEO_NAME Estradiol DME0114 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00090 DESCRIPT Estradiol induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00090 GENEFORM Protein DME0114 XEOTICID XEO00090 MOACRIVE Induction DME0114 XEOTICID XEO00094 XEO_NAME Progesterone DME0114 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00094 DESCRIPT Progesterone inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00094 GENEFORM mRNA DME0114 XEOTICID XEO00094 MOACRIVE Inhibition DME0114 XEOTICID XEO00108 XEO_NAME Methamphetamine DME0114 XEOTICID XEO00108 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00108 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00108 DESCRIPT Methamphetamine up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00108 GENEFORM mRNA DME0114 XEOTICID XEO00108 MOACRIVE Induction DME0114 XEOTICID XEO00110 XEO_NAME Acetylcysteine DME0114 XEOTICID XEO00110 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00110 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00110 DESCRIPT Acetylcysteine inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00110 GENEFORM mRNA DME0114 XEOTICID XEO00110 MOACRIVE Inhibition DME0114 XEOTICID XEO00115 XEO_NAME Dronabinol DME0114 XEOTICID XEO00115 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00115 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00115 DESCRIPT Dronabinol induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00115 GENEFORM Protein DME0114 XEOTICID XEO00115 MOACRIVE Induction DME0114 XEOTICID XEO00121 XEO_NAME Etoposide DME0114 XEOTICID XEO00121 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00121 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00121 DESCRIPT Etoposide induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00121 GENEFORM Protein DME0114 XEOTICID XEO00121 MOACRIVE Induction DME0114 XEOTICID XEO00125 XEO_NAME Simvastatin DME0114 XEOTICID XEO00125 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00125 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00125 DESCRIPT Simvastatin inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00125 GENEFORM mRNA DME0114 XEOTICID XEO00125 MOACRIVE Inhibition DME0114 XEOTICID XEO00126 XEO_NAME Raloxifene hydrochloride DME0114 XEOTICID XEO00126 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00126 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00126 DESCRIPT Raloxifene hydrochloride inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00126 GENEFORM mRNA DME0114 XEOTICID XEO00126 MOACRIVE Inhibition DME0114 XEOTICID XEO00133 XEO_NAME Capecitabine DME0114 XEOTICID XEO00133 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00133 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00133 DESCRIPT Capecitabine inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00133 GENEFORM Protein DME0114 XEOTICID XEO00133 MOACRIVE Inhibition DME0114 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0114 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00140 DESCRIPT Zoledronic acid inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00140 GENEFORM mRNA DME0114 XEOTICID XEO00140 MOACRIVE Inhibition DME0114 XEOTICID XEO00150 XEO_NAME Valdecoxib DME0114 XEOTICID XEO00150 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00150 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00150 DESCRIPT Valdecoxib inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.005 microM) DME0114 XEOTICID XEO00150 GENEFORM Protein DME0114 XEOTICID XEO00150 MOACRIVE Inhibition DME0114 XEOTICID XEO00151 XEO_NAME Imatinib mesylate DME0114 XEOTICID XEO00151 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00151 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00151 DESCRIPT Imatinib mesylate inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00151 GENEFORM Protein DME0114 XEOTICID XEO00151 MOACRIVE Inhibition DME0114 XEOTICID XEO00153 XEO_NAME Docetaxel DME0114 XEOTICID XEO00153 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00153 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00153 DESCRIPT Docetaxel up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00153 GENEFORM mRNA DME0114 XEOTICID XEO00153 MOACRIVE Induction DME0114 XEOTICID XEO00156 XEO_NAME Naproxen DME0114 XEOTICID XEO00156 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00156 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00156 DESCRIPT Naproxen inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 1010 microM) DME0114 XEOTICID XEO00156 GENEFORM Protein DME0114 XEOTICID XEO00156 MOACRIVE Inhibition DME0114 XEOTICID XEO00159 XEO_NAME Bortezomib DME0114 XEOTICID XEO00159 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00159 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00159 DESCRIPT Bortezomib up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00159 GENEFORM mRNA DME0114 XEOTICID XEO00159 MOACRIVE Induction DME0114 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0114 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00167 DESCRIPT Alitretinoin inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00167 GENEFORM mRNA DME0114 XEOTICID XEO00167 MOACRIVE Inhibition DME0114 XEOTICID XEO00173 XEO_NAME Cannabidiol DME0114 XEOTICID XEO00173 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00173 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00173 DESCRIPT Cannabidiol induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00173 GENEFORM Protein DME0114 XEOTICID XEO00173 MOACRIVE Induction DME0114 XEOTICID XEO00177 XEO_NAME Sulindac DME0114 XEOTICID XEO00177 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00177 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00177 DESCRIPT Sulindac inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 8.8 microM) DME0114 XEOTICID XEO00177 GENEFORM Protein DME0114 XEOTICID XEO00177 MOACRIVE Inhibition DME0114 XEOTICID XEO00184 XEO_NAME Calcitriol DME0114 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00184 GENEFORM mRNA DME0114 XEOTICID XEO00184 MOACRIVE Induction DME0114 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0114 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00186 GENEFORM mRNA DME0114 XEOTICID XEO00186 MOACRIVE Inhibition DME0114 XEOTICID XEO00205 XEO_NAME Meloxicam DME0114 XEOTICID XEO00205 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00205 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00205 DESCRIPT Meloxicam inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.16 microM) DME0114 XEOTICID XEO00205 GENEFORM Protein DME0114 XEOTICID XEO00205 MOACRIVE Inhibition DME0114 XEOTICID XEO00213 XEO_NAME Aspirin DME0114 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00213 DESCRIPT Aspirin inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 100 microM) DME0114 XEOTICID XEO00213 GENEFORM Protein DME0114 XEOTICID XEO00213 MOACRIVE Inhibition DME0114 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0114 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 141 microM) DME0114 XEOTICID XEO00217 GENEFORM Protein DME0114 XEOTICID XEO00217 MOACRIVE Inhibition DME0114 XEOTICID XEO00218 XEO_NAME Caffeine DME0114 XEOTICID XEO00218 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00218 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00218 DESCRIPT Caffeine inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00218 GENEFORM Protein DME0114 XEOTICID XEO00218 MOACRIVE Inhibition DME0114 XEOTICID XEO00248 XEO_NAME Ibuprofen DME0114 XEOTICID XEO00248 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00248 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00248 DESCRIPT Ibuprof DMEen inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.1 microM) DME0114 XEOTICID XEO00248 GENEFORM Protein DME0114 XEOTICID XEO00248 MOACRIVE Inhibition DME0114 XEOTICID XEO00253 XEO_NAME Tretinoin DME0114 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00253 DESCRIPT Tretinoin induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00253 GENEFORM Protein DME0114 XEOTICID XEO00253 MOACRIVE Induction DME0114 XEOTICID XEO00256 XEO_NAME Paclitaxel DME0114 XEOTICID XEO00256 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00256 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00256 DESCRIPT Paclitaxel inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00256 GENEFORM mRNA DME0114 XEOTICID XEO00256 MOACRIVE Inhibition DME0114 XEOTICID XEO00260 XEO_NAME Dinoprostone DME0114 XEOTICID XEO00260 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00260 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00260 DESCRIPT Dinoprostone induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00260 GENEFORM Protein DME0114 XEOTICID XEO00260 MOACRIVE Induction DME0114 XEOTICID XEO00262 XEO_NAME Lovastatin DME0114 XEOTICID XEO00262 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00262 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00262 DESCRIPT Lovastatin inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00262 GENEFORM Protein DME0114 XEOTICID XEO00262 MOACRIVE Inhibition DME0114 XEOTICID XEO00267 XEO_NAME Ethinyl estradiol DME0114 XEOTICID XEO00267 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00267 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00267 DESCRIPT Ethinyl estradiol up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00267 GENEFORM mRNA DME0114 XEOTICID XEO00267 MOACRIVE Induction DME0114 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0114 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00277 GENEFORM mRNA DME0114 XEOTICID XEO00277 MOACRIVE Induction DME0114 XEOTICID XEO00286 XEO_NAME Deferoxamine mesylate DME0114 XEOTICID XEO00286 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00286 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00286 DESCRIPT Deferoxamine mesylate induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00286 GENEFORM Protein DME0114 XEOTICID XEO00286 MOACRIVE Induction DME0114 XEOTICID XEO00289 XEO_NAME Donepezil hydrochloride DME0114 XEOTICID XEO00289 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00289 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00289 DESCRIPT Donepezil hydrochloride inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00289 GENEFORM Protein DME0114 XEOTICID XEO00289 MOACRIVE Inhibition DME0114 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0114 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00292 GENEFORM Protein DME0114 XEOTICID XEO00292 MOACRIVE Inhibition DME0114 XEOTICID XEO00296 XEO_NAME Flurbiprofen sodium DME0114 XEOTICID XEO00296 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00296 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00296 DESCRIPT Flurbiprof DMEen sodium inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.01 microM) DME0114 XEOTICID XEO00296 GENEFORM Protein DME0114 XEOTICID XEO00296 MOACRIVE Inhibition DME0114 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0114 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00312 GENEFORM mRNA DME0114 XEOTICID XEO00312 MOACRIVE Induction DME0114 XEOTICID XEO00316 XEO_NAME Paroxetine hydrochloride DME0114 XEOTICID XEO00316 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00316 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00316 DESCRIPT Paroxetine hydrochloride inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00316 GENEFORM mRNA DME0114 XEOTICID XEO00316 MOACRIVE Inhibition DME0114 XEOTICID XEO00321 XEO_NAME Rivastigmine tartrate DME0114 XEOTICID XEO00321 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00321 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00321 DESCRIPT Rivastigmine tartrate inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00321 GENEFORM Protein DME0114 XEOTICID XEO00321 MOACRIVE Inhibition DME0114 XEOTICID XEO00334 XEO_NAME Cisplatin DME0114 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00334 GENEFORM Protein DME0114 XEOTICID XEO00334 MOACRIVE Inhibition DME0114 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0114 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00339 GENEFORM Protein DME0114 XEOTICID XEO00339 MOACRIVE Inhibition DME0114 XEOTICID XEO00342 XEO_NAME Bupivacaine DME0114 XEOTICID XEO00342 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00342 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00342 DESCRIPT Bupivacaine up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00342 GENEFORM mRNA DME0114 XEOTICID XEO00342 MOACRIVE Induction DME0114 XEOTICID XEO00352 XEO_NAME Diclofenac DME0114 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00352 DESCRIPT Diclof DMEenac inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.005 microM) DME0114 XEOTICID XEO00352 GENEFORM Protein DME0114 XEOTICID XEO00352 MOACRIVE Inhibition DME0114 XEOTICID XEO00366 XEO_NAME Methotrexate DME0114 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00366 DESCRIPT Methotrexate inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00366 GENEFORM Protein DME0114 XEOTICID XEO00366 MOACRIVE Inhibition DME0114 XEOTICID XEO00367 XEO_NAME Metoprolol DME0114 XEOTICID XEO00367 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00367 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00367 DESCRIPT Metoprolol inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00367 GENEFORM Protein DME0114 XEOTICID XEO00367 MOACRIVE Inhibition DME0114 XEOTICID XEO00370 XEO_NAME Nebivolol DME0114 XEOTICID XEO00370 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00370 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00370 DESCRIPT Nebivolol inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00370 GENEFORM Protein DME0114 XEOTICID XEO00370 MOACRIVE Inhibition DME0114 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0114 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00388 GENEFORM Protein DME0114 XEOTICID XEO00388 MOACRIVE Induction DME0114 XEOTICID XEO00391 XEO_NAME Boniva DME0114 XEOTICID XEO00391 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00391 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00391 DESCRIPT Boniva inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00391 GENEFORM Protein DME0114 XEOTICID XEO00391 MOACRIVE Inhibition DME0114 XEOTICID XEO00394 XEO_NAME Vinorelbine DME0114 XEOTICID XEO00394 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00394 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00394 DESCRIPT Vinorelbine inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00394 GENEFORM mRNA DME0114 XEOTICID XEO00394 MOACRIVE Inhibition DME0114 XEOTICID XEO00398 XEO_NAME Nitroprusside DME0114 XEOTICID XEO00398 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00398 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00398 DESCRIPT Nitroprusside induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00398 GENEFORM Protein DME0114 XEOTICID XEO00398 MOACRIVE Induction DME0114 XEOTICID XEO00419 XEO_NAME Niacinamide DME0114 XEOTICID XEO00419 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00419 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00419 DESCRIPT Niacinamide up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00419 GENEFORM mRNA DME0114 XEOTICID XEO00419 MOACRIVE Induction DME0114 XEOTICID XEO00422 XEO_NAME Sodium fluoride F-18 DME0114 XEOTICID XEO00422 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00422 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00422 DESCRIPT Sodium fluoride F-18 up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00422 GENEFORM mRNA DME0114 XEOTICID XEO00422 MOACRIVE Induction DME0114 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME0114 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00425 DESCRIPT Titanium dioxide up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00425 GENEFORM mRNA DME0114 XEOTICID XEO00425 MOACRIVE Induction DME0114 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0114 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00430 DESCRIPT Hydroquinone up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00430 GENEFORM mRNA DME0114 XEOTICID XEO00430 MOACRIVE Induction DME0114 XEOTICID XEO00433 XEO_NAME Dienogest DME0114 XEOTICID XEO00433 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00433 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00433 DESCRIPT Dienogest inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00433 GENEFORM Protein DME0114 XEOTICID XEO00433 MOACRIVE Inhibition DME0114 XEOTICID XEO00434 XEO_NAME Manganese chloride DME0114 XEOTICID XEO00434 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00434 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00434 DESCRIPT Manganese chloride up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00434 GENEFORM mRNA DME0114 XEOTICID XEO00434 MOACRIVE Induction DME0114 XEOTICID XEO00442 XEO_NAME Chlorobenzene DME0114 XEOTICID XEO00442 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00442 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00442 DESCRIPT Chlorobenzene induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00442 GENEFORM Protein DME0114 XEOTICID XEO00442 MOACRIVE Induction DME0114 XEOTICID XEO00470 XEO_NAME Flufenamic acid DME0114 XEOTICID XEO00470 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00470 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00470 DESCRIPT Flufenamic acid induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00470 GENEFORM Protein DME0114 XEOTICID XEO00470 MOACRIVE Induction DME0114 XEOTICID XEO00483 XEO_NAME Sodium salicylate DME0114 XEOTICID XEO00483 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00483 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00483 DESCRIPT Sodium salicylate up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00483 GENEFORM mRNA DME0114 XEOTICID XEO00483 MOACRIVE Induction DME0114 XEOTICID XEO00497 XEO_NAME Etoricoxib DME0114 XEOTICID XEO00497 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00497 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00497 DESCRIPT Etoricoxib inhibits the drug-metabolizing activity of DME PTGS2 in Chinese hamster ovary (CHO) cell (IC50 = 0.081 microM) DME0114 XEOTICID XEO00497 GENEFORM Protein DME0114 XEOTICID XEO00497 MOACRIVE Inhibition DME0114 XEOTICID XEO00502 XEO_NAME Glucosamine DME0114 XEOTICID XEO00502 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00502 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00502 DESCRIPT Glucosamine induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00502 GENEFORM Protein DME0114 XEOTICID XEO00502 MOACRIVE Induction DME0114 XEOTICID XEO00504 XEO_NAME Lumiracoxib DME0114 XEOTICID XEO00504 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00504 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00504 DESCRIPT Lumiracoxib inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.007 microM) DME0114 XEOTICID XEO00504 GENEFORM Protein DME0114 XEOTICID XEO00504 MOACRIVE Inhibition DME0114 XEOTICID XEO00510 XEO_NAME Gamolenic acid DME0114 XEOTICID XEO00510 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00510 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00510 DESCRIPT Gamolenic acid up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00510 GENEFORM mRNA DME0114 XEOTICID XEO00510 MOACRIVE Induction DME0114 XEOTICID XEO00519 XEO_NAME Nimesulide DME0114 XEOTICID XEO00519 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00519 XEO_CLAS Drug Marketed but Withdrawn from Market DME0114 XEOTICID XEO00519 DESCRIPT Nimesulide inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.015 microM) DME0114 XEOTICID XEO00519 GENEFORM Protein DME0114 XEOTICID XEO00519 MOACRIVE Inhibition DME0114 XEOTICID XEO00528 XEO_NAME Flupenthixol DME0114 XEOTICID XEO00528 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00528 XEO_CLAS Drug Marketed but Withdrawn from Market DME0114 XEOTICID XEO00528 DESCRIPT Flupenthixol inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00528 GENEFORM Protein DME0114 XEOTICID XEO00528 MOACRIVE Inhibition DME0114 XEOTICID XEO00533 XEO_NAME Gold sodium thiomalate DME0114 XEOTICID XEO00533 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00533 XEO_CLAS Drug in Phase 1 Clinical Trial DME0114 XEOTICID XEO00533 DESCRIPT Gold sodium thiomalate inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00533 GENEFORM mRNA DME0114 XEOTICID XEO00533 MOACRIVE Inhibition DME0114 XEOTICID XEO00538 XEO_NAME Quercetin DME0114 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0114 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME PTGS2 in Spodoptera frugiperda (Sf21) cell (IC50 = 28.6 microM) DME0114 XEOTICID XEO00538 GENEFORM Protein DME0114 XEOTICID XEO00538 MOACRIVE Inhibition DME0114 XEOTICID XEO00539 XEO_NAME Ethanol DME0114 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0114 XEOTICID XEO00539 DESCRIPT Ethanol induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00539 GENEFORM Protein DME0114 XEOTICID XEO00539 MOACRIVE Induction DME0114 XEOTICID XEO00557 XEO_NAME Genistein DME0114 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0114 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00557 GENEFORM Protein DME0114 XEOTICID XEO00557 MOACRIVE Inhibition DME0114 XEOTICID XEO00565 XEO_NAME Fenretinide DME0114 XEOTICID XEO00565 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00565 XEO_CLAS Drug in Phase 3 Clinical Trial DME0114 XEOTICID XEO00565 DESCRIPT Fenretinide up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00565 GENEFORM mRNA DME0114 XEOTICID XEO00565 MOACRIVE Induction DME0114 XEOTICID XEO00568 XEO_NAME Resveratrol DME0114 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0114 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.75 microM) DME0114 XEOTICID XEO00568 GENEFORM Protein DME0114 XEOTICID XEO00568 MOACRIVE Inhibition DME0114 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0114 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0114 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00571 GENEFORM mRNA DME0114 XEOTICID XEO00571 MOACRIVE Induction DME0114 XEOTICID XEO00578 XEO_NAME Arecoline DME0114 XEOTICID XEO00578 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00578 XEO_CLAS Drug in Phase 2 Clinical Trial DME0114 XEOTICID XEO00578 DESCRIPT Arecoline induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00578 GENEFORM Protein DME0114 XEOTICID XEO00578 MOACRIVE Induction DME0114 XEOTICID XEO00580 XEO_NAME LY-294002 DME0114 XEOTICID XEO00580 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00580 XEO_CLAS Drug in Phase 1 Clinical Trial DME0114 XEOTICID XEO00580 DESCRIPT LY-294002 inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00580 GENEFORM Protein DME0114 XEOTICID XEO00580 MOACRIVE Inhibition DME0114 XEOTICID XEO00583 XEO_NAME NS-398 DME0114 XEOTICID XEO00583 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00583 XEO_CLAS Drug in Phase 1 Clinical Trial DME0114 XEOTICID XEO00583 DESCRIPT NS-398 inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.001 microM) DME0114 XEOTICID XEO00583 GENEFORM Protein DME0114 XEOTICID XEO00583 MOACRIVE Inhibition DME0114 XEOTICID XEO00589 XEO_NAME Taurocholic acid DME0114 XEOTICID XEO00589 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00589 XEO_CLAS Drug in Phase 2 Clinical Trial DME0114 XEOTICID XEO00589 DESCRIPT Taurocholic acid up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00589 GENEFORM mRNA DME0114 XEOTICID XEO00589 MOACRIVE Induction DME0114 XEOTICID XEO00599 XEO_NAME Tetradecanoylphorbol acetate DME0114 XEOTICID XEO00599 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00599 XEO_CLAS Drug in Phase 1 Clinical Trial DME0114 XEOTICID XEO00599 DESCRIPT Tetradecanoylphorbol acetate up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00599 GENEFORM mRNA DME0114 XEOTICID XEO00599 MOACRIVE Induction DME0114 XEOTICID XEO00606 XEO_NAME Colforsin DME0114 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0114 XEOTICID XEO00606 DESCRIPT Colforsin up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00606 GENEFORM mRNA DME0114 XEOTICID XEO00606 MOACRIVE Induction DME0114 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME0114 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME0114 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00613 GENEFORM Protein DME0114 XEOTICID XEO00613 MOACRIVE Induction DME0114 XEOTICID XEO00623 XEO_NAME SC-58125 DME0114 XEOTICID XEO00623 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00623 XEO_CLAS Drug in Phase 1 Clinical Trial DME0114 XEOTICID XEO00623 DESCRIPT SC-58125 inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.05 microM) DME0114 XEOTICID XEO00623 GENEFORM Protein DME0114 XEOTICID XEO00623 MOACRIVE Inhibition DME0114 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0114 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0114 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00632 GENEFORM Protein DME0114 XEOTICID XEO00632 MOACRIVE Inhibition DME0114 XEOTICID XEO00641 XEO_NAME JBT-101 DME0114 XEOTICID XEO00641 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00641 XEO_CLAS Drug in Phase 2 Clinical Trial DME0114 XEOTICID XEO00641 DESCRIPT JBT-101 up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00641 GENEFORM mRNA DME0114 XEOTICID XEO00641 MOACRIVE Induction DME0114 XEOTICID XEO00642 XEO_NAME Tetrathiomolybdate DME0114 XEOTICID XEO00642 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00642 XEO_CLAS Drug in Phase 3 Clinical Trial DME0114 XEOTICID XEO00642 DESCRIPT Tetrathiomolybdate up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00642 GENEFORM mRNA DME0114 XEOTICID XEO00642 MOACRIVE Induction DME0114 XEOTICID XEO00650 XEO_NAME Sphingosine 1-phosphate DME0114 XEOTICID XEO00650 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00650 XEO_CLAS Drug in Phase 2 Clinical Trial DME0114 XEOTICID XEO00650 DESCRIPT Sphingosine 1-phosphate induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00650 GENEFORM Protein DME0114 XEOTICID XEO00650 MOACRIVE Induction DME0114 XEOTICID XEO00652 XEO_NAME Seocalcitol DME0114 XEOTICID XEO00652 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00652 XEO_CLAS Drug in Phase 3 Clinical Trial DME0114 XEOTICID XEO00652 DESCRIPT Seocalcitol up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00652 GENEFORM mRNA DME0114 XEOTICID XEO00652 MOACRIVE Induction DME0114 XEOTICID XEO00656 XEO_NAME Sulindac sulfide DME0114 XEOTICID XEO00656 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00656 XEO_CLAS Drug in Phase 2 Clinical Trial DME0114 XEOTICID XEO00656 DESCRIPT Sulindac sulfide inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.1 microM) DME0114 XEOTICID XEO00656 GENEFORM Protein DME0114 XEOTICID XEO00656 MOACRIVE Inhibition DME0114 XEOTICID XEO00665 XEO_NAME Bufalin DME0114 XEOTICID XEO00665 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00665 XEO_CLAS Drug in Phase 2 Clinical Trial DME0114 XEOTICID XEO00665 DESCRIPT Bufalin inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00665 GENEFORM Protein DME0114 XEOTICID XEO00665 MOACRIVE Inhibition DME0114 XEOTICID XEO00683 XEO_NAME Curcumin DME0114 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0114 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00683 GENEFORM Protein DME0114 XEOTICID XEO00683 MOACRIVE Inhibition DME0114 XEOTICID XEO00687 XEO_NAME Edelfosine DME0114 XEOTICID XEO00687 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00687 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO00687 DESCRIPT Edelfosine induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00687 GENEFORM Protein DME0114 XEOTICID XEO00687 MOACRIVE Induction DME0114 XEOTICID XEO00690 XEO_NAME DuP-697 DME0114 XEOTICID XEO00690 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00690 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO00690 DESCRIPT DuP-697 inhibits the drug-metabolizing activity of DME PTGS2 (IC50 < 0.2 microM) DME0114 XEOTICID XEO00690 GENEFORM Protein DME0114 XEOTICID XEO00690 MOACRIVE Inhibition DME0114 XEOTICID XEO00691 XEO_NAME Embelin DME0114 XEOTICID XEO00691 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00691 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO00691 DESCRIPT Embelin inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00691 GENEFORM Protein DME0114 XEOTICID XEO00691 MOACRIVE Inhibition DME0114 XEOTICID XEO00704 XEO_NAME ICI-118551 DME0114 XEOTICID XEO00704 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00704 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO00704 DESCRIPT ICI-118551 inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00704 GENEFORM Protein DME0114 XEOTICID XEO00704 MOACRIVE Inhibition DME0114 XEOTICID XEO00707 XEO_NAME JTE-522 DME0114 XEOTICID XEO00707 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00707 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO00707 DESCRIPT JTE-522 inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.085 microM) DME0114 XEOTICID XEO00707 GENEFORM Protein DME0114 XEOTICID XEO00707 MOACRIVE Inhibition DME0114 XEOTICID XEO00710 XEO_NAME Isoliquiritigenin DME0114 XEOTICID XEO00710 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00710 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO00710 DESCRIPT Isoliquiritigenin inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 130 microM) DME0114 XEOTICID XEO00710 GENEFORM Protein DME0114 XEOTICID XEO00710 MOACRIVE Inhibition DME0114 XEOTICID XEO00712 XEO_NAME FT-1050 DME0114 XEOTICID XEO00712 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00712 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO00712 DESCRIPT FT-1050 up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00712 GENEFORM mRNA DME0114 XEOTICID XEO00712 MOACRIVE Induction DME0114 XEOTICID XEO00715 XEO_NAME L-745337 DME0114 XEOTICID XEO00715 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00715 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO00715 DESCRIPT L-745337 inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.02 microM) DME0114 XEOTICID XEO00715 GENEFORM Protein DME0114 XEOTICID XEO00715 MOACRIVE Inhibition DME0114 XEOTICID XEO00718 XEO_NAME SC-58236 DME0114 XEOTICID XEO00718 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00718 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO00718 DESCRIPT SC-58236 inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 0.00045 microM) DME0114 XEOTICID XEO00718 GENEFORM Protein DME0114 XEOTICID XEO00718 MOACRIVE Inhibition DME0114 XEOTICID XEO00722 XEO_NAME Gardiquimod DME0114 XEOTICID XEO00722 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00722 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO00722 DESCRIPT Gardiquimod up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00722 GENEFORM mRNA DME0114 XEOTICID XEO00722 MOACRIVE Induction DME0114 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0114 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00723 GENEFORM mRNA DME0114 XEOTICID XEO00723 MOACRIVE Inhibition DME0114 XEOTICID XEO00730 XEO_NAME Ferulic acid DME0114 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00730 GENEFORM Protein DME0114 XEOTICID XEO00730 MOACRIVE Inhibition DME0114 XEOTICID XEO00737 XEO_NAME Erastin DME0114 XEOTICID XEO00737 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00737 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO00737 DESCRIPT Erastin up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00737 GENEFORM mRNA DME0114 XEOTICID XEO00737 MOACRIVE Induction DME0114 XEOTICID XEO00743 XEO_NAME Medroxyprogesterone acetate DME0114 XEOTICID XEO00743 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00743 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00743 DESCRIPT Medroxyprogesterone acetate inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00743 GENEFORM Protein DME0114 XEOTICID XEO00743 MOACRIVE Inhibition DME0114 XEOTICID XEO00755 XEO_NAME Coal tar DME0114 XEOTICID XEO00755 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO00755 XEO_CLAS Natural Mixture DME0114 XEOTICID XEO00755 DESCRIPT Coal tar up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00755 GENEFORM mRNA DME0114 XEOTICID XEO00755 MOACRIVE Induction DME0114 XEOTICID XEO00760 XEO_NAME Jinfukang DME0114 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0114 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00760 GENEFORM mRNA DME0114 XEOTICID XEO00760 MOACRIVE Inhibition DME0114 XEOTICID XEO00767 XEO_NAME Ciglitazone DME0114 XEOTICID XEO00767 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00767 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO00767 DESCRIPT Ciglitazone up-regulates the expression of DME PTGS2 and leads to increasing the drug-metabolizing activity of this enzyme DME0114 XEOTICID XEO00767 GENEFORM Protein DME0114 XEOTICID XEO00767 MOACRIVE Induction DME0114 XEOTICID XEO00768 XEO_NAME Dichlorodiphenyl dichloroethylene DME0114 XEOTICID XEO00768 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO00768 XEO_CLAS Environmental Pollutant DME0114 XEOTICID XEO00768 DESCRIPT Dichlorodiphenyl dichloroethylene induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00768 GENEFORM Protein DME0114 XEOTICID XEO00768 MOACRIVE Induction DME0114 XEOTICID XEO00770 XEO_NAME AG-1879 DME0114 XEOTICID XEO00770 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00770 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO00770 DESCRIPT AG-1879 inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00770 GENEFORM Protein DME0114 XEOTICID XEO00770 MOACRIVE Inhibition DME0114 XEOTICID XEO00774 XEO_NAME Dinitrofluorobenzene DME0114 XEOTICID XEO00774 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0114 XEOTICID XEO00774 XEO_CLAS Chemical Compound DME0114 XEOTICID XEO00774 DESCRIPT Dinitrofluorobenzene induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00774 GENEFORM Protein DME0114 XEOTICID XEO00774 MOACRIVE Induction DME0114 XEOTICID XEO00787 XEO_NAME Lithocholic acid DME0114 XEOTICID XEO00787 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00787 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO00787 DESCRIPT Lithocholic acid induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00787 GENEFORM Protein DME0114 XEOTICID XEO00787 MOACRIVE Induction DME0114 XEOTICID XEO00796 XEO_NAME Nickel sulfide DME0114 XEOTICID XEO00796 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0114 XEOTICID XEO00796 XEO_CLAS Chemical Compound DME0114 XEOTICID XEO00796 DESCRIPT Nickel sulfide up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00796 GENEFORM mRNA DME0114 XEOTICID XEO00796 MOACRIVE Induction DME0114 XEOTICID XEO00803 XEO_NAME Cannabidiolic acid DME0114 XEOTICID XEO00803 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO00803 XEO_CLAS Natural Product DME0114 XEOTICID XEO00803 DESCRIPT Cannabidiolic acid inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00803 GENEFORM mRNA DME0114 XEOTICID XEO00803 MOACRIVE Inhibition DME0114 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0114 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0114 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00806 GENEFORM Protein DME0114 XEOTICID XEO00806 MOACRIVE Induction DME0114 XEOTICID XEO00817 XEO_NAME Melitten DME0114 XEOTICID XEO00817 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO00817 XEO_CLAS Biotoxin DME0114 XEOTICID XEO00817 DESCRIPT Melitten up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00817 GENEFORM mRNA DME0114 XEOTICID XEO00817 MOACRIVE Induction DME0114 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0114 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0114 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00821 GENEFORM mRNA DME0114 XEOTICID XEO00821 MOACRIVE Induction DME0114 XEOTICID XEO00824 XEO_NAME Boron compound DME0114 XEOTICID XEO00824 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0114 XEOTICID XEO00824 XEO_CLAS Pesticide/Insecticide DME0114 XEOTICID XEO00824 DESCRIPT Boron compound inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00824 GENEFORM mRNA DME0114 XEOTICID XEO00824 MOACRIVE Inhibition DME0114 XEOTICID XEO00829 XEO_NAME Niflumic acid DME0114 XEOTICID XEO00829 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00829 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO00829 DESCRIPT Niflumic acid up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00829 GENEFORM mRNA DME0114 XEOTICID XEO00829 MOACRIVE Induction DME0114 XEOTICID XEO00834 XEO_NAME Copper DME0114 XEOTICID XEO00834 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00834 XEO_CLAS Approved/Marketed Drug DME0114 XEOTICID XEO00834 DESCRIPT Copper induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00834 GENEFORM Protein DME0114 XEOTICID XEO00834 MOACRIVE Induction DME0114 XEOTICID XEO00844 XEO_NAME Folfox DME0114 XEOTICID XEO00844 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00844 XEO_CLAS Drug in Phase 3 Clinical Trial DME0114 XEOTICID XEO00844 DESCRIPT Folfox inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00844 GENEFORM Protein DME0114 XEOTICID XEO00844 MOACRIVE Inhibition DME0114 XEOTICID XEO00868 XEO_NAME 1,2-naphthoquinone DME0114 XEOTICID XEO00868 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00868 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO00868 DESCRIPT 1,2-naphthoquinone up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00868 GENEFORM mRNA DME0114 XEOTICID XEO00868 MOACRIVE Induction DME0114 XEOTICID XEO00872 XEO_NAME Acetaldehyde DME0114 XEOTICID XEO00872 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO00872 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO00872 DESCRIPT Acetaldehyde up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00872 GENEFORM mRNA DME0114 XEOTICID XEO00872 MOACRIVE Induction DME0114 XEOTICID XEO00873 XEO_NAME Alpha-linolenic acid DME0114 XEOTICID XEO00873 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO00873 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO00873 DESCRIPT Alpha-linolenic acid up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00873 GENEFORM mRNA DME0114 XEOTICID XEO00873 MOACRIVE Induction DME0114 XEOTICID XEO00876 XEO_NAME Arachidonic acid DME0114 XEOTICID XEO00876 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO00876 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO00876 DESCRIPT Arachidonic acid induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00876 GENEFORM Protein DME0114 XEOTICID XEO00876 MOACRIVE Induction DME0114 XEOTICID XEO00878 XEO_NAME Chrysin DME0114 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO00878 XEO_CLAS Natural Product DME0114 XEOTICID XEO00878 DESCRIPT Chrysin up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00878 GENEFORM mRNA DME0114 XEOTICID XEO00878 MOACRIVE Induction DME0114 XEOTICID XEO00884 XEO_NAME Thiram DME0114 XEOTICID XEO00884 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO00884 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO00884 DESCRIPT Thiram induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00884 GENEFORM Protein DME0114 XEOTICID XEO00884 MOACRIVE Induction DME0114 XEOTICID XEO00890 XEO_NAME 2-methyl-4-isothiazolin-3-one DME0114 XEOTICID XEO00890 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO00890 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO00890 DESCRIPT 2-methyl-4-isothiazolin-3-one up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00890 GENEFORM mRNA DME0114 XEOTICID XEO00890 MOACRIVE Induction DME0114 XEOTICID XEO00892 XEO_NAME Viper venoms DME0114 XEOTICID XEO00892 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO00892 XEO_CLAS Natural Mixture DME0114 XEOTICID XEO00892 DESCRIPT Viper venoms up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00892 GENEFORM mRNA DME0114 XEOTICID XEO00892 MOACRIVE Induction DME0114 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0114 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0114 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00898 GENEFORM Protein DME0114 XEOTICID XEO00898 MOACRIVE Induction DME0114 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0114 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0114 XEOTICID XEO00899 DESCRIPT Methylcholanthrene induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00899 GENEFORM Protein DME0114 XEOTICID XEO00899 MOACRIVE Induction DME0114 XEOTICID XEO00919 XEO_NAME Particulate matter DME0114 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0114 XEOTICID XEO00919 DESCRIPT Particulate matter inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00919 GENEFORM Protein DME0114 XEOTICID XEO00919 MOACRIVE Inhibition DME0114 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0114 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00921 GENEFORM Protein DME0114 XEOTICID XEO00921 MOACRIVE Induction DME0114 XEOTICID XEO00925 XEO_NAME BDE-99 DME0114 XEOTICID XEO00925 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO00925 XEO_CLAS Natural Product DME0114 XEOTICID XEO00925 DESCRIPT BDE-99 up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00925 GENEFORM mRNA DME0114 XEOTICID XEO00925 MOACRIVE Induction DME0114 XEOTICID XEO00926 XEO_NAME Tetrabromobisphenol A DME0114 XEOTICID XEO00926 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO00926 XEO_CLAS Environmental Pollutant DME0114 XEOTICID XEO00926 DESCRIPT Tetrabromobisphenol A up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00926 GENEFORM mRNA DME0114 XEOTICID XEO00926 MOACRIVE Induction DME0114 XEOTICID XEO00931 XEO_NAME Diacetyl DME0114 XEOTICID XEO00931 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO00931 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO00931 DESCRIPT Diacetyl inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO00931 GENEFORM mRNA DME0114 XEOTICID XEO00931 MOACRIVE Inhibition DME0114 XEOTICID XEO00951 XEO_NAME Hexachlorobenzene DME0114 XEOTICID XEO00951 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0114 XEOTICID XEO00951 XEO_CLAS Fungicide DME0114 XEOTICID XEO00951 DESCRIPT Hexachlorobenzene induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO00951 GENEFORM Protein DME0114 XEOTICID XEO00951 MOACRIVE Induction DME0114 XEOTICID XEO00954 XEO_NAME Polyhexamethyleneguanidine DME0114 XEOTICID XEO00954 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0114 XEOTICID XEO00954 XEO_CLAS Fungicide DME0114 XEOTICID XEO00954 DESCRIPT Polyhexamethyleneguanidine up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00954 GENEFORM mRNA DME0114 XEOTICID XEO00954 MOACRIVE Induction DME0114 XEOTICID XEO00963 XEO_NAME Zeranol DME0114 XEOTICID XEO00963 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO00963 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO00963 DESCRIPT Zeranol up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00963 GENEFORM mRNA DME0114 XEOTICID XEO00963 MOACRIVE Induction DME0114 XEOTICID XEO00973 XEO_NAME Diuron DME0114 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0114 XEOTICID XEO00973 XEO_CLAS Herbicide DME0114 XEOTICID XEO00973 DESCRIPT Diuron up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00973 GENEFORM mRNA DME0114 XEOTICID XEO00973 MOACRIVE Induction DME0114 XEOTICID XEO00995 XEO_NAME Amphibole asbestos DME0114 XEOTICID XEO00995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO00995 XEO_CLAS Natural Mixture DME0114 XEOTICID XEO00995 DESCRIPT Amphibole asbestos up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00995 GENEFORM mRNA DME0114 XEOTICID XEO00995 MOACRIVE Induction DME0114 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0114 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO00999 GENEFORM mRNA DME0114 XEOTICID XEO00999 MOACRIVE Induction DME0114 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0114 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO01004 GENEFORM mRNA DME0114 XEOTICID XEO01004 MOACRIVE Inhibition DME0114 XEOTICID XEO01025 XEO_NAME Styrene DME0114 XEOTICID XEO01025 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01025 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO01025 DESCRIPT Styrene induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01025 GENEFORM Protein DME0114 XEOTICID XEO01025 MOACRIVE Induction DME0114 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0114 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01031 GENEFORM mRNA DME0114 XEOTICID XEO01031 MOACRIVE Induction DME0114 XEOTICID XEO01048 XEO_NAME Dichlorodiphenyl dichloroethane DME0114 XEOTICID XEO01048 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0114 XEOTICID XEO01048 XEO_CLAS Pesticide/Insecticide DME0114 XEOTICID XEO01048 DESCRIPT Dichlorodiphenyl dichloroethane induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01048 GENEFORM Protein DME0114 XEOTICID XEO01048 MOACRIVE Induction DME0114 XEOTICID XEO01084 XEO_NAME 1-(1-naphthyl)piperazine DME0114 XEOTICID XEO01084 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01084 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO01084 DESCRIPT 1-(1-naphthyl)piperazine up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01084 GENEFORM mRNA DME0114 XEOTICID XEO01084 MOACRIVE Induction DME0114 XEOTICID XEO01085 XEO_NAME 7-Phloroeckol DME0114 XEOTICID XEO01085 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01085 XEO_CLAS Natural Product DME0114 XEOTICID XEO01085 DESCRIPT 7-Phloroeckol inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01085 GENEFORM Protein DME0114 XEOTICID XEO01085 MOACRIVE Inhibition DME0114 XEOTICID XEO01089 XEO_NAME 1,4-naphthoquinone DME0114 XEOTICID XEO01089 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01089 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01089 DESCRIPT 1,4-naphthoquinone up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01089 GENEFORM mRNA DME0114 XEOTICID XEO01089 MOACRIVE Induction DME0114 XEOTICID XEO01096 XEO_NAME 15d-PGJ2 DME0114 XEOTICID XEO01096 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01096 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01096 DESCRIPT 15d-PGJ2 induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01096 GENEFORM Protein DME0114 XEOTICID XEO01096 MOACRIVE Induction DME0114 XEOTICID XEO01107 XEO_NAME NSC 703786 DME0114 XEOTICID XEO01107 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01107 XEO_CLAS Drug in Phase 1 Clinical Trial DME0114 XEOTICID XEO01107 DESCRIPT NSC 703786 up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01107 GENEFORM mRNA DME0114 XEOTICID XEO01107 MOACRIVE Induction DME0114 XEOTICID XEO01117 XEO_NAME 27-hydroxycholesterol DME0114 XEOTICID XEO01117 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01117 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01117 DESCRIPT 27-hydroxycholesterol induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01117 GENEFORM Protein DME0114 XEOTICID XEO01117 MOACRIVE Induction DME0114 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0114 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01119 GENEFORM Protein DME0114 XEOTICID XEO01119 MOACRIVE Induction DME0114 XEOTICID XEO01132 XEO_NAME 3,3',4,4',5,5'-hexahydroxystilbene DME0114 XEOTICID XEO01132 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01132 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO01132 DESCRIPT 3,3',4,4',5,5'-hexahydroxystilbene inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01132 GENEFORM Protein DME0114 XEOTICID XEO01132 MOACRIVE Inhibition DME0114 XEOTICID XEO01134 XEO_NAME 3,4,5,4'-tetrahydroxystilbene DME0114 XEOTICID XEO01134 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01134 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01134 DESCRIPT 3,4,5,4'-tetrahydroxystilbene inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO01134 GENEFORM mRNA DME0114 XEOTICID XEO01134 MOACRIVE Inhibition DME0114 XEOTICID XEO01141 XEO_NAME 3-methylquercetin DME0114 XEOTICID XEO01141 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01141 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO01141 DESCRIPT 3-methylquercetin inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01141 GENEFORM Protein DME0114 XEOTICID XEO01141 MOACRIVE Inhibition DME0114 XEOTICID XEO01154 XEO_NAME 4-oxoretinoic acid DME0114 XEOTICID XEO01154 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01154 XEO_CLAS Natural Product DME0114 XEOTICID XEO01154 DESCRIPT 4-oxoretinoic acid inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO01154 GENEFORM mRNA DME0114 XEOTICID XEO01154 MOACRIVE Inhibition DME0114 XEOTICID XEO01157 XEO_NAME 5-(N,N-hexamethylene)amiloride DME0114 XEOTICID XEO01157 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01157 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01157 DESCRIPT 5-(N,N-hexamethylene)amiloride up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01157 GENEFORM mRNA DME0114 XEOTICID XEO01157 MOACRIVE Induction DME0114 XEOTICID XEO01171 XEO_NAME 7,8-diacetoxy-4-methylcoumarin DME0114 XEOTICID XEO01171 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01171 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01171 DESCRIPT 7,8-diacetoxy-4-methylcoumarin inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01171 GENEFORM Protein DME0114 XEOTICID XEO01171 MOACRIVE Inhibition DME0114 XEOTICID XEO01172 XEO_NAME 7,8-diacetoxy-4-methylthiocoumarin DME0114 XEOTICID XEO01172 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01172 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01172 DESCRIPT 7,8-diacetoxy-4-methylthiocoumarin inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01172 GENEFORM Protein DME0114 XEOTICID XEO01172 MOACRIVE Inhibition DME0114 XEOTICID XEO01180 XEO_NAME 9,10-anthraquinone DME0114 XEOTICID XEO01180 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01180 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO01180 DESCRIPT 9,10-anthraquinone inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01180 GENEFORM Protein DME0114 XEOTICID XEO01180 MOACRIVE Inhibition DME0114 XEOTICID XEO01185 XEO_NAME Acenaphthenequinone DME0114 XEOTICID XEO01185 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01185 XEO_CLAS Environmental Pollutant DME0114 XEOTICID XEO01185 DESCRIPT Acenaphthenequinone induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01185 GENEFORM Protein DME0114 XEOTICID XEO01185 MOACRIVE Induction DME0114 XEOTICID XEO01186 XEO_NAME Acrolein DME0114 XEOTICID XEO01186 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01186 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01186 DESCRIPT Acrolein induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01186 GENEFORM Protein DME0114 XEOTICID XEO01186 MOACRIVE Induction DME0114 XEOTICID XEO01192 XEO_NAME Alpha-naphthoflavone DME0114 XEOTICID XEO01192 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01192 XEO_CLAS Natural Product DME0114 XEOTICID XEO01192 DESCRIPT Alpha-naphthoflavone inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO01192 GENEFORM mRNA DME0114 XEOTICID XEO01192 MOACRIVE Inhibition DME0114 XEOTICID XEO01195 XEO_NAME Amentoflavone DME0114 XEOTICID XEO01195 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01195 XEO_CLAS Natural Product DME0114 XEOTICID XEO01195 DESCRIPT Amentof DMElavone inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01195 GENEFORM Protein DME0114 XEOTICID XEO01195 MOACRIVE Inhibition DME0114 XEOTICID XEO01198 XEO_NAME Anandamide DME0114 XEOTICID XEO01198 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01198 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO01198 DESCRIPT Anandamide induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01198 GENEFORM Protein DME0114 XEOTICID XEO01198 MOACRIVE Induction DME0114 XEOTICID XEO01202 XEO_NAME Antimycin A DME0114 XEOTICID XEO01202 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01202 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01202 DESCRIPT Antimycin A induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01202 GENEFORM Protein DME0114 XEOTICID XEO01202 MOACRIVE Induction DME0114 XEOTICID XEO01205 XEO_NAME Archazolid B DME0114 XEOTICID XEO01205 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01205 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01205 DESCRIPT Archazolid B up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01205 GENEFORM mRNA DME0114 XEOTICID XEO01205 MOACRIVE Induction DME0114 XEOTICID XEO01213 XEO_NAME Baohuoside I DME0114 XEOTICID XEO01213 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01213 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01213 DESCRIPT Baohuoside I inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01213 GENEFORM Protein DME0114 XEOTICID XEO01213 MOACRIVE Inhibition DME0114 XEOTICID XEO01219 XEO_NAME MG-132 DME0114 XEOTICID XEO01219 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01219 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01219 DESCRIPT MG-132 up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01219 GENEFORM mRNA DME0114 XEOTICID XEO01219 MOACRIVE Induction DME0114 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0114 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0114 XEOTICID XEO01226 DESCRIPT Bisphenol A induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01226 GENEFORM Protein DME0114 XEOTICID XEO01226 MOACRIVE Induction DME0114 XEOTICID XEO01228 XEO_NAME Brucine DME0114 XEOTICID XEO01228 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01228 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01228 DESCRIPT Brucine inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01228 GENEFORM Protein DME0114 XEOTICID XEO01228 MOACRIVE Inhibition DME0114 XEOTICID XEO01230 XEO_NAME Butyric acid DME0114 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0114 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01230 GENEFORM mRNA DME0114 XEOTICID XEO01230 MOACRIVE Induction DME0114 XEOTICID XEO01243 XEO_NAME Chan su DME0114 XEOTICID XEO01243 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01243 XEO_CLAS Traditional Medicine DME0114 XEOTICID XEO01243 DESCRIPT Chan su inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01243 GENEFORM Protein DME0114 XEOTICID XEO01243 MOACRIVE Inhibition DME0114 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0114 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01247 DESCRIPT Chloropicrin inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO01247 GENEFORM mRNA DME0114 XEOTICID XEO01247 MOACRIVE Inhibition DME0114 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0114 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01248 DESCRIPT Chlorpyrifos induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01248 GENEFORM Protein DME0114 XEOTICID XEO01248 MOACRIVE Induction DME0114 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME0114 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01253 XEO_CLAS Natural Product DME0114 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01253 GENEFORM mRNA DME0114 XEOTICID XEO01253 MOACRIVE Induction DME0114 XEOTICID XEO01263 XEO_NAME CR-3294 DME0114 XEOTICID XEO01263 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01263 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO01263 DESCRIPT CR-3294 inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO01263 GENEFORM mRNA DME0114 XEOTICID XEO01263 MOACRIVE Inhibition DME0114 XEOTICID XEO01276 XEO_NAME Dieckol DME0114 XEOTICID XEO01276 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01276 XEO_CLAS Drug in Phase 1 Clinical Trial DME0114 XEOTICID XEO01276 DESCRIPT Dieckol inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01276 GENEFORM Protein DME0114 XEOTICID XEO01276 MOACRIVE Inhibition DME0114 XEOTICID XEO01277 XEO_NAME Dihydrosphingosine 1-phosphate DME0114 XEOTICID XEO01277 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01277 XEO_CLAS Drug in Phase 1 Clinical Trial DME0114 XEOTICID XEO01277 DESCRIPT Dihydrosphingosine 1-phosphate induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01277 GENEFORM Protein DME0114 XEOTICID XEO01277 MOACRIVE Induction DME0114 XEOTICID XEO01284 XEO_NAME Dust DME0114 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0114 XEOTICID XEO01284 DESCRIPT Dust up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01284 GENEFORM mRNA DME0114 XEOTICID XEO01284 MOACRIVE Induction DME0114 XEOTICID XEO01289 XEO_NAME Enniatins DME0114 XEOTICID XEO01289 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01289 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01289 DESCRIPT Enniatins inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO01289 GENEFORM mRNA DME0114 XEOTICID XEO01289 MOACRIVE Inhibition DME0114 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0114 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01305 GENEFORM mRNA DME0114 XEOTICID XEO01305 MOACRIVE Induction DME0114 XEOTICID XEO01309 XEO_NAME Gallic acid DME0114 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01309 XEO_CLAS Natural Product DME0114 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01309 GENEFORM Protein DME0114 XEOTICID XEO01309 MOACRIVE Inhibition DME0114 XEOTICID XEO01331 XEO_NAME Homocysteine DME0114 XEOTICID XEO01331 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01331 XEO_CLAS Drug in Phase 1 Clinical Trial DME0114 XEOTICID XEO01331 DESCRIPT Homocysteine up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01331 GENEFORM mRNA DME0114 XEOTICID XEO01331 MOACRIVE Induction DME0114 XEOTICID XEO01332 XEO_NAME Honokiol DME0114 XEOTICID XEO01332 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01332 XEO_CLAS Natural Product DME0114 XEOTICID XEO01332 DESCRIPT Honokiol inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01332 GENEFORM Protein DME0114 XEOTICID XEO01332 MOACRIVE Inhibition DME0114 XEOTICID XEO01344 XEO_NAME Indomethacin phenethylamide DME0114 XEOTICID XEO01344 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01344 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01344 DESCRIPT Indomethacin phenethylamide inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01344 GENEFORM Protein DME0114 XEOTICID XEO01344 MOACRIVE Inhibition DME0114 XEOTICID XEO01353 XEO_NAME Kaempferol DME0114 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of DME PTGS2 in Spodoptera frugiperda (Sf21) cell (IC50 > 100 microM) DME0114 XEOTICID XEO01353 GENEFORM Protein DME0114 XEOTICID XEO01353 MOACRIVE Inhibition DME0114 XEOTICID XEO01369 XEO_NAME Lithium chloride DME0114 XEOTICID XEO01369 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01369 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO01369 DESCRIPT Lithium chloride induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01369 GENEFORM Protein DME0114 XEOTICID XEO01369 MOACRIVE Induction DME0114 XEOTICID XEO01380 XEO_NAME Mono-(2-ethylhexyl)phthalate DME0114 XEOTICID XEO01380 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01380 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01380 DESCRIPT Mono-(2-ethylhexyl)phthalate induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01380 GENEFORM Protein DME0114 XEOTICID XEO01380 MOACRIVE Induction DME0114 XEOTICID XEO01395 XEO_NAME N-formylmethionine leucyl-phenylalanine DME0114 XEOTICID XEO01395 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01395 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01395 DESCRIPT N-formylmethionine leucyl-phenylalanine up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01395 GENEFORM mRNA DME0114 XEOTICID XEO01395 MOACRIVE Induction DME0114 XEOTICID XEO01397 XEO_NAME Nickel chloride DME0114 XEOTICID XEO01397 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01397 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01397 DESCRIPT Nickel chloride induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01397 GENEFORM Protein DME0114 XEOTICID XEO01397 MOACRIVE Induction DME0114 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0114 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01407 DESCRIPT Ochratoxin A inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01407 GENEFORM Protein DME0114 XEOTICID XEO01407 MOACRIVE Inhibition DME0114 XEOTICID XEO01409 XEO_NAME Okadaic acid DME0114 XEOTICID XEO01409 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01409 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01409 DESCRIPT Okadaic acid up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01409 GENEFORM mRNA DME0114 XEOTICID XEO01409 MOACRIVE Induction DME0114 XEOTICID XEO01412 XEO_NAME Oleic acid DME0114 XEOTICID XEO01412 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01412 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO01412 DESCRIPT Oleic acid up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01412 GENEFORM mRNA DME0114 XEOTICID XEO01412 MOACRIVE Induction DME0114 XEOTICID XEO01418 XEO_NAME Oxidopamine DME0114 XEOTICID XEO01418 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01418 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01418 DESCRIPT Oxidopamine up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01418 GENEFORM mRNA DME0114 XEOTICID XEO01418 MOACRIVE Induction DME0114 XEOTICID XEO01422 XEO_NAME Paraquat DME0114 XEOTICID XEO01422 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01422 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01422 DESCRIPT Paraquat induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01422 GENEFORM Protein DME0114 XEOTICID XEO01422 MOACRIVE Induction DME0114 XEOTICID XEO01433 XEO_NAME Pirinixic acid DME0114 XEOTICID XEO01433 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01433 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO01433 DESCRIPT Pirinixic acid induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01433 GENEFORM Protein DME0114 XEOTICID XEO01433 MOACRIVE Induction DME0114 XEOTICID XEO01444 XEO_NAME Pyranoprofen DME0114 XEOTICID XEO01444 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01444 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01444 DESCRIPT Pyranoprofen up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01444 GENEFORM mRNA DME0114 XEOTICID XEO01444 MOACRIVE Induction DME0114 XEOTICID XEO01453 XEO_NAME Resorcinol DME0114 XEOTICID XEO01453 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01453 XEO_CLAS Environmental Pollutant DME0114 XEOTICID XEO01453 DESCRIPT Resorcinol inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01453 GENEFORM Protein DME0114 XEOTICID XEO01453 MOACRIVE Inhibition DME0114 XEOTICID XEO01455 XEO_NAME Rhein DME0114 XEOTICID XEO01455 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01455 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01455 DESCRIPT Rhein inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO01455 GENEFORM mRNA DME0114 XEOTICID XEO01455 MOACRIVE Inhibition DME0114 XEOTICID XEO01461 XEO_NAME RSL3 compound DME0114 XEOTICID XEO01461 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01461 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01461 DESCRIPT RSL3 compound up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01461 GENEFORM mRNA DME0114 XEOTICID XEO01461 MOACRIVE Induction DME0114 XEOTICID XEO01468 XEO_NAME SC-560 DME0114 XEOTICID XEO01468 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01468 XEO_CLAS Preclinical/Patented Drug DME0114 XEOTICID XEO01468 DESCRIPT SC-560 inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 6.3 microM) DME0114 XEOTICID XEO01468 GENEFORM Protein DME0114 XEOTICID XEO01468 MOACRIVE Inhibition DME0114 XEOTICID XEO01475 XEO_NAME Stearic acid DME0114 XEOTICID XEO01475 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0114 XEOTICID XEO01475 XEO_CLAS Food Additive DME0114 XEOTICID XEO01475 DESCRIPT Stearic acid up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01475 GENEFORM mRNA DME0114 XEOTICID XEO01475 MOACRIVE Induction DME0114 XEOTICID XEO01479 XEO_NAME Tamarixetin DME0114 XEOTICID XEO01479 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01479 XEO_CLAS Natural Product DME0114 XEOTICID XEO01479 DESCRIPT Tamarixetin inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01479 GENEFORM Protein DME0114 XEOTICID XEO01479 MOACRIVE Inhibition DME0114 XEOTICID XEO01491 XEO_NAME Tributyltin DME0114 XEOTICID XEO01491 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01491 XEO_CLAS Investigative Agent DME0114 XEOTICID XEO01491 DESCRIPT Tributyltin up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01491 GENEFORM mRNA DME0114 XEOTICID XEO01491 MOACRIVE Induction DME0114 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0114 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0114 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0114 XEOTICID XEO01492 DESCRIPT Trichostatin A inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO01492 GENEFORM mRNA DME0114 XEOTICID XEO01492 MOACRIVE Inhibition DME0114 XEOTICID XEO01501 XEO_NAME Zymosan DME0114 XEOTICID XEO01501 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01501 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO01501 DESCRIPT Zymosan up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01501 GENEFORM mRNA DME0114 XEOTICID XEO01501 MOACRIVE Induction DME0114 XEOTICID XEO01503 XEO_NAME Cadmium DME0114 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0114 XEOTICID XEO01503 DESCRIPT Cadmium induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01503 GENEFORM Protein DME0114 XEOTICID XEO01503 MOACRIVE Induction DME0114 XEOTICID XEO01505 XEO_NAME Lead DME0114 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO01505 DESCRIPT Lead induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01505 GENEFORM Protein DME0114 XEOTICID XEO01505 MOACRIVE Induction DME0114 XEOTICID XEO01507 XEO_NAME Lead nitrate DME0114 XEOTICID XEO01507 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01507 XEO_CLAS Health Hazard/Toxicant DME0114 XEOTICID XEO01507 DESCRIPT Lead nitrate induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01507 GENEFORM Protein DME0114 XEOTICID XEO01507 MOACRIVE Induction DME0114 XEOTICID XEO01511 XEO_NAME Vitallium DME0114 XEOTICID XEO01511 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01511 XEO_CLAS Natural Mixture DME0114 XEOTICID XEO01511 DESCRIPT Vitallium up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01511 GENEFORM mRNA DME0114 XEOTICID XEO01511 MOACRIVE Induction DME0114 XEOTICID XEO01512 XEO_NAME Zinc DME0114 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME0114 XEOTICID XEO01512 DESCRIPT Zinc up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01512 GENEFORM mRNA DME0114 XEOTICID XEO01512 MOACRIVE Induction DME0114 XEOTICID XEO01514 XEO_NAME Deoxynivalenol DME0114 XEOTICID XEO01514 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01514 XEO_CLAS Mycotoxin DME0114 XEOTICID XEO01514 DESCRIPT Deoxynivalenol induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01514 GENEFORM Protein DME0114 XEOTICID XEO01514 MOACRIVE Induction DME0114 XEOTICID XEO01516 XEO_NAME Oligomycins DME0114 XEOTICID XEO01516 XEO_TYPE Health or Environmental Toxicant(s) DME0114 XEOTICID XEO01516 XEO_CLAS Mycotoxin DME0114 XEOTICID XEO01516 DESCRIPT Oligomycins induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01516 GENEFORM Protein DME0114 XEOTICID XEO01516 MOACRIVE Induction DME0114 XEOTICID XEO01525 XEO_NAME Avarol DME0114 XEOTICID XEO01525 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01525 XEO_CLAS Natural Product DME0114 XEOTICID XEO01525 DESCRIPT Avarol inhibits the drug-metabolizing activity of DME PTGS2 (IC50 = 2.3 microM) DME0114 XEOTICID XEO01525 GENEFORM Protein DME0114 XEOTICID XEO01525 MOACRIVE Inhibition DME0114 XEOTICID XEO01537 XEO_NAME Deguelin DME0114 XEOTICID XEO01537 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01537 XEO_CLAS Natural Product DME0114 XEOTICID XEO01537 DESCRIPT Deguelin inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01537 GENEFORM Protein DME0114 XEOTICID XEO01537 MOACRIVE Inhibition DME0114 XEOTICID XEO01568 XEO_NAME Obacunone DME0114 XEOTICID XEO01568 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01568 XEO_CLAS Natural Product DME0114 XEOTICID XEO01568 DESCRIPT Obacunone inhibits the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01568 GENEFORM Protein DME0114 XEOTICID XEO01568 MOACRIVE Inhibition DME0114 XEOTICID XEO01574 XEO_NAME Plant extracts DME0114 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0114 XEOTICID XEO01574 DESCRIPT Plant extracts induces the drug-metabolizing activity of DME PTGS2 DME0114 XEOTICID XEO01574 GENEFORM Protein DME0114 XEOTICID XEO01574 MOACRIVE Induction DME0114 XEOTICID XEO01585 XEO_NAME Senecionine DME0114 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01585 XEO_CLAS Natural Product DME0114 XEOTICID XEO01585 DESCRIPT Senecionine up-regulates the expression of DME PTGS2 DME0114 XEOTICID XEO01585 GENEFORM mRNA DME0114 XEOTICID XEO01585 MOACRIVE Induction DME0114 XEOTICID XEO01590 XEO_NAME Sulphoraphene DME0114 XEOTICID XEO01590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0114 XEOTICID XEO01590 XEO_CLAS Natural Product DME0114 XEOTICID XEO01590 DESCRIPT Sulphoraphene inhibits the expression of DME PTGS2 DME0114 XEOTICID XEO01590 GENEFORM mRNA DME0114 XEOTICID XEO01590 MOACRIVE Inhibition DME0117 DME___ID DME0117 DME0117 DME_NAME Dehydropeptidase-I (DPEP1) DME0117 SPESNAME Homo sapiens DME0117 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0117 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0117 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0117 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME DPEP1 DME0117 XEOTICID XEO00117 GENEFORM mRNA DME0117 XEOTICID XEO00117 MOACRIVE Inhibition DME0117 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0117 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0117 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0117 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME DPEP1 DME0117 XEOTICID XEO00241 GENEFORM mRNA DME0117 XEOTICID XEO00241 MOACRIVE Inhibition DME0117 XEOTICID XEO00413 XEO_NAME Cilastatin DME0117 XEOTICID XEO00413 XEO_TYPE Pharmaceutical Agent(s) DME0117 XEOTICID XEO00413 XEO_CLAS Approved/Marketed Drug DME0117 XEOTICID XEO00413 DESCRIPT Cilastatin inhibits the drug-metabolizing activity of DME DPEP1 DME0117 XEOTICID XEO00413 GENEFORM Protein DME0117 XEOTICID XEO00413 MOACRIVE Inhibition DME0117 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0117 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0117 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0117 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME DPEP1 DME0117 XEOTICID XEO00898 GENEFORM mRNA DME0117 XEOTICID XEO00898 MOACRIVE Inhibition DME0117 XEOTICID XEO01348 XEO_NAME K-7174 DME0117 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0117 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0117 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME DPEP1 DME0117 XEOTICID XEO01348 GENEFORM mRNA DME0117 XEOTICID XEO01348 MOACRIVE Inhibition DME0118 DME___ID DME0118 DME0118 DME_NAME Aldo-keto reductase 1C3 (AKR1C3) DME0118 SPESNAME Homo sapiens DME0118 XEOTICID XEO00024 XEO_NAME Diazepam DME0118 XEOTICID XEO00024 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00024 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00024 DESCRIPT Diazepam inhibits the drug-metabolizing activity of DME AKR1C3 (IC50 = 84 microM) DME0118 XEOTICID XEO00024 GENEFORM Protein DME0118 XEOTICID XEO00024 MOACRIVE Inhibition DME0118 XEOTICID XEO00028 XEO_NAME Disulfiram DME0118 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00028 DESCRIPT Disulfiram up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00028 GENEFORM mRNA DME0118 XEOTICID XEO00028 MOACRIVE Induction DME0118 XEOTICID XEO00031 XEO_NAME Estazolam DME0118 XEOTICID XEO00031 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00031 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00031 DESCRIPT Estazolam inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00031 GENEFORM Protein DME0118 XEOTICID XEO00031 MOACRIVE Inhibition DME0118 XEOTICID XEO00043 XEO_NAME Glimepiride DME0118 XEOTICID XEO00043 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00043 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00043 DESCRIPT Glimepiride inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00043 GENEFORM Protein DME0118 XEOTICID XEO00043 MOACRIVE Inhibition DME0118 XEOTICID XEO00044 XEO_NAME Glipizide DME0118 XEOTICID XEO00044 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00044 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00044 DESCRIPT Glipizide inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00044 GENEFORM Protein DME0118 XEOTICID XEO00044 MOACRIVE Inhibition DME0118 XEOTICID XEO00047 XEO_NAME Indomethacin DME0118 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00047 DESCRIPT Indomethacin inhibits the drug-metabolizing activity of DME AKR1C3 (IC50 = 0.1 microM) DME0118 XEOTICID XEO00047 GENEFORM Protein DME0118 XEOTICID XEO00047 MOACRIVE Inhibition DME0118 XEOTICID XEO00079 XEO_NAME Vorinostat DME0118 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00079 DESCRIPT Vorinostat inhibits the expression of DME AKR1C3 DME0118 XEOTICID XEO00079 GENEFORM mRNA DME0118 XEOTICID XEO00079 MOACRIVE Inhibition DME0118 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0118 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00088 GENEFORM mRNA DME0118 XEOTICID XEO00088 MOACRIVE Induction DME0118 XEOTICID XEO00090 XEO_NAME Estradiol DME0118 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME AKR1C3 DME0118 XEOTICID XEO00090 GENEFORM mRNA DME0118 XEOTICID XEO00090 MOACRIVE Inhibition DME0118 XEOTICID XEO00094 XEO_NAME Progesterone DME0118 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00094 DESCRIPT Progesterone inhibits the expression of DME AKR1C3 DME0118 XEOTICID XEO00094 GENEFORM mRNA DME0118 XEOTICID XEO00094 MOACRIVE Inhibition DME0118 XEOTICID XEO00113 XEO_NAME Levonorgestrel DME0118 XEOTICID XEO00113 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00113 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00113 DESCRIPT Levonorgestrel inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00113 GENEFORM Protein DME0118 XEOTICID XEO00113 MOACRIVE Inhibition DME0118 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0118 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00117 GENEFORM mRNA DME0118 XEOTICID XEO00117 MOACRIVE Induction DME0118 XEOTICID XEO00125 XEO_NAME Simvastatin DME0118 XEOTICID XEO00125 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00125 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00125 DESCRIPT Simvastatin inhibits the expression of DME AKR1C3 DME0118 XEOTICID XEO00125 GENEFORM mRNA DME0118 XEOTICID XEO00125 MOACRIVE Inhibition DME0118 XEOTICID XEO00144 XEO_NAME Bexarotene DME0118 XEOTICID XEO00144 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00144 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00144 DESCRIPT Bexarotene up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00144 GENEFORM mRNA DME0118 XEOTICID XEO00144 MOACRIVE Induction DME0118 XEOTICID XEO00156 XEO_NAME Naproxen DME0118 XEOTICID XEO00156 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00156 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00156 DESCRIPT Naproxen inhibits the drug-metabolizing activity of DME AKR1C3 (IC50 = 0.48 microM) DME0118 XEOTICID XEO00156 GENEFORM Protein DME0118 XEOTICID XEO00156 MOACRIVE Inhibition DME0118 XEOTICID XEO00159 XEO_NAME Bortezomib DME0118 XEOTICID XEO00159 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00159 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00159 DESCRIPT Bortezomib up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00159 GENEFORM mRNA DME0118 XEOTICID XEO00159 MOACRIVE Induction DME0118 XEOTICID XEO00177 XEO_NAME Sulindac DME0118 XEOTICID XEO00177 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00177 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00177 DESCRIPT Sulindac inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00177 GENEFORM Protein DME0118 XEOTICID XEO00177 MOACRIVE Inhibition DME0118 XEOTICID XEO00181 XEO_NAME Dasatinib DME0118 XEOTICID XEO00181 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00181 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00181 DESCRIPT Dasatinib up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00181 GENEFORM mRNA DME0118 XEOTICID XEO00181 MOACRIVE Induction DME0118 XEOTICID XEO00192 XEO_NAME Dutasteride DME0118 XEOTICID XEO00192 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00192 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00192 DESCRIPT Dutasteride up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00192 GENEFORM mRNA DME0118 XEOTICID XEO00192 MOACRIVE Induction DME0118 XEOTICID XEO00213 XEO_NAME Aspirin DME0118 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00213 DESCRIPT Aspirin inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00213 GENEFORM Protein DME0118 XEOTICID XEO00213 MOACRIVE Inhibition DME0118 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0118 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME AKR1C3 DME0118 XEOTICID XEO00217 GENEFORM mRNA DME0118 XEOTICID XEO00217 MOACRIVE Inhibition DME0118 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0118 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME AKR1C3 DME0118 XEOTICID XEO00241 GENEFORM mRNA DME0118 XEOTICID XEO00241 MOACRIVE Inhibition DME0118 XEOTICID XEO00247 XEO_NAME Glyburide DME0118 XEOTICID XEO00247 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00247 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00247 DESCRIPT Glyburide inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00247 GENEFORM Protein DME0118 XEOTICID XEO00247 MOACRIVE Inhibition DME0118 XEOTICID XEO00248 XEO_NAME Ibuprofen DME0118 XEOTICID XEO00248 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00248 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00248 DESCRIPT Ibuprofen inhibits the drug-metabolizing activity of DME AKR1C3 (IC50 = 32.7 microM) DME0118 XEOTICID XEO00248 GENEFORM Protein DME0118 XEOTICID XEO00248 MOACRIVE Inhibition DME0118 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0118 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME AKR1C3 DME0118 XEOTICID XEO00292 GENEFORM mRNA DME0118 XEOTICID XEO00292 MOACRIVE Inhibition DME0118 XEOTICID XEO00296 XEO_NAME Flurbiprofen sodium DME0118 XEOTICID XEO00296 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00296 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00296 DESCRIPT Flurbiprofen sodium inhibits the drug-metabolizing activity of DME AKR1C3 (IC50 = 1.56 microM) DME0118 XEOTICID XEO00296 GENEFORM Protein DME0118 XEOTICID XEO00296 MOACRIVE Inhibition DME0118 XEOTICID XEO00334 XEO_NAME Cisplatin DME0118 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00334 DESCRIPT Cisplatin induces the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00334 GENEFORM Protein DME0118 XEOTICID XEO00334 MOACRIVE Induction DME0118 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0118 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00339 GENEFORM mRNA DME0118 XEOTICID XEO00339 MOACRIVE Induction DME0118 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0118 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide induces the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00388 GENEFORM Protein DME0118 XEOTICID XEO00388 MOACRIVE Induction DME0118 XEOTICID XEO00403 XEO_NAME Dydrogesterone DME0118 XEOTICID XEO00403 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00403 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00403 DESCRIPT Dydrogesterone inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00403 GENEFORM Protein DME0118 XEOTICID XEO00403 MOACRIVE Inhibition DME0118 XEOTICID XEO00411 XEO_NAME Avobenzone DME0118 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00411 GENEFORM mRNA DME0118 XEOTICID XEO00411 MOACRIVE Induction DME0118 XEOTICID XEO00415 XEO_NAME Meclofenamic acid DME0118 XEOTICID XEO00415 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00415 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00415 DESCRIPT Meclofenamic acid inhibits the drug-metabolizing activity of DME AKR1C3 (IC50 = 0.54 microM) DME0118 XEOTICID XEO00415 GENEFORM Protein DME0118 XEOTICID XEO00415 MOACRIVE Inhibition DME0118 XEOTICID XEO00432 XEO_NAME Desogestrel DME0118 XEOTICID XEO00432 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00432 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00432 DESCRIPT Desogestrel inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00432 GENEFORM Protein DME0118 XEOTICID XEO00432 MOACRIVE Inhibition DME0118 XEOTICID XEO00435 XEO_NAME Urethane DME0118 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME AKR1C3 DME0118 XEOTICID XEO00435 GENEFORM mRNA DME0118 XEOTICID XEO00435 MOACRIVE Inhibition DME0118 XEOTICID XEO00447 XEO_NAME Benzoic acid DME0118 XEOTICID XEO00447 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00447 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00447 DESCRIPT Benzoic acid up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00447 GENEFORM mRNA DME0118 XEOTICID XEO00447 MOACRIVE Induction DME0118 XEOTICID XEO00458 XEO_NAME Bromazepam DME0118 XEOTICID XEO00458 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00458 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00458 DESCRIPT Bromazepam inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00458 GENEFORM Protein DME0118 XEOTICID XEO00458 MOACRIVE Inhibition DME0118 XEOTICID XEO00470 XEO_NAME Flufenamic acid DME0118 XEOTICID XEO00470 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00470 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00470 DESCRIPT Flufenamic acid inhibits the drug-metabolizing activity of DME AKR1C3 (IC50 = 0.05 microM) DME0118 XEOTICID XEO00470 GENEFORM Protein DME0118 XEOTICID XEO00470 MOACRIVE Inhibition DME0118 XEOTICID XEO00492 XEO_NAME Benzbromarone DME0118 XEOTICID XEO00492 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00492 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00492 DESCRIPT Benzbromarone inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00492 GENEFORM Protein DME0118 XEOTICID XEO00492 MOACRIVE Inhibition DME0118 XEOTICID XEO00498 XEO_NAME Flunitrazepam DME0118 XEOTICID XEO00498 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00498 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00498 DESCRIPT Flunitrazepam inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00498 GENEFORM Protein DME0118 XEOTICID XEO00498 MOACRIVE Inhibition DME0118 XEOTICID XEO00500 XEO_NAME Gliclazide DME0118 XEOTICID XEO00500 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00500 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00500 DESCRIPT Gliclazide inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00500 GENEFORM Protein DME0118 XEOTICID XEO00500 MOACRIVE Inhibition DME0118 XEOTICID XEO00501 XEO_NAME Gliquidone DME0118 XEOTICID XEO00501 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00501 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00501 DESCRIPT Gliquidone inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00501 GENEFORM Protein DME0118 XEOTICID XEO00501 MOACRIVE Inhibition DME0118 XEOTICID XEO00556 XEO_NAME Tolfenamic acid DME0118 XEOTICID XEO00556 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00556 XEO_CLAS Drug in Phase 1 Clinical Trial DME0118 XEOTICID XEO00556 DESCRIPT Tolfenamic acid inhibits the drug-metabolizing activity of DME AKR1C3 (Ki = 0.008 microM) DME0118 XEOTICID XEO00556 GENEFORM Protein DME0118 XEOTICID XEO00556 MOACRIVE Inhibition DME0118 XEOTICID XEO00560 XEO_NAME Triclosan DME0118 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0118 XEOTICID XEO00560 DESCRIPT Triclosan inhibits the expression of DME AKR1C3 DME0118 XEOTICID XEO00560 GENEFORM mRNA DME0118 XEOTICID XEO00560 MOACRIVE Inhibition DME0118 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0118 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0118 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00571 GENEFORM mRNA DME0118 XEOTICID XEO00571 MOACRIVE Induction DME0118 XEOTICID XEO00573 XEO_NAME Naringenin DME0118 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME0118 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00573 GENEFORM Protein DME0118 XEOTICID XEO00573 MOACRIVE Inhibition DME0118 XEOTICID XEO00606 XEO_NAME Colforsin DME0118 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0118 XEOTICID XEO00606 DESCRIPT Colforsin inhibits the expression of DME AKR1C3 DME0118 XEOTICID XEO00606 GENEFORM mRNA DME0118 XEOTICID XEO00606 MOACRIVE Inhibition DME0118 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0118 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0118 XEOTICID XEO00632 DESCRIPT Sodium arsenite induces the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00632 GENEFORM Protein DME0118 XEOTICID XEO00632 MOACRIVE Induction DME0118 XEOTICID XEO00652 XEO_NAME Seocalcitol DME0118 XEOTICID XEO00652 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00652 XEO_CLAS Drug in Phase 3 Clinical Trial DME0118 XEOTICID XEO00652 DESCRIPT Seocalcitol induces the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00652 GENEFORM Protein DME0118 XEOTICID XEO00652 MOACRIVE Induction DME0118 XEOTICID XEO00675 XEO_NAME NVP-BKM120 DME0118 XEOTICID XEO00675 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00675 XEO_CLAS Drug in Phase 3 Clinical Trial DME0118 XEOTICID XEO00675 DESCRIPT NVP-BKM120 inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00675 GENEFORM Protein DME0118 XEOTICID XEO00675 MOACRIVE Inhibition DME0118 XEOTICID XEO00678 XEO_NAME Dinaciclib DME0118 XEOTICID XEO00678 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00678 XEO_CLAS Drug in Phase 3 Clinical Trial DME0118 XEOTICID XEO00678 DESCRIPT Dinaciclib inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00678 GENEFORM Protein DME0118 XEOTICID XEO00678 MOACRIVE Inhibition DME0118 XEOTICID XEO00743 XEO_NAME Medroxyprogesterone acetate DME0118 XEOTICID XEO00743 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00743 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00743 DESCRIPT Medroxyprogesterone acetate inhibits the drug-metabolizing activity of DME AKR1C3 (IC50 = 0.28 microM) DME0118 XEOTICID XEO00743 GENEFORM Protein DME0118 XEOTICID XEO00743 MOACRIVE Inhibition DME0118 XEOTICID XEO00760 XEO_NAME Jinfukang DME0118 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0118 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0118 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00760 GENEFORM mRNA DME0118 XEOTICID XEO00760 MOACRIVE Induction DME0118 XEOTICID XEO00766 XEO_NAME 1,10-phenanthroline DME0118 XEOTICID XEO00766 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0118 XEOTICID XEO00766 XEO_CLAS Chemical Compound DME0118 XEOTICID XEO00766 DESCRIPT 1,10-phenanthroline inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00766 GENEFORM Protein DME0118 XEOTICID XEO00766 MOACRIVE Inhibition DME0118 XEOTICID XEO00769 XEO_NAME Hexestrol DME0118 XEOTICID XEO00769 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00769 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO00769 DESCRIPT Hexestrol inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00769 GENEFORM Protein DME0118 XEOTICID XEO00769 MOACRIVE Inhibition DME0118 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0118 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0118 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME AKR1C3 and leads to increasing the drug-metabolizing activity of this enzyme DME0118 XEOTICID XEO00818 GENEFORM Protein DME0118 XEOTICID XEO00818 MOACRIVE Induction DME0118 XEOTICID XEO00869 XEO_NAME 4-hydroxy-2-nonenal DME0118 XEOTICID XEO00869 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00869 XEO_CLAS Investigative Agent DME0118 XEOTICID XEO00869 DESCRIPT 4-hydroxy-2-nonenal induces the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00869 GENEFORM Protein DME0118 XEOTICID XEO00869 MOACRIVE Induction DME0118 XEOTICID XEO00871 XEO_NAME 9,10-phenanthrenequinone DME0118 XEOTICID XEO00871 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00871 XEO_CLAS Investigative Agent DME0118 XEOTICID XEO00871 DESCRIPT 9,10-phenanthrenequinone induces the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00871 GENEFORM Protein DME0118 XEOTICID XEO00871 MOACRIVE Induction DME0118 XEOTICID XEO00885 XEO_NAME Eugenol DME0118 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0118 XEOTICID XEO00885 DESCRIPT Eugenol up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00885 GENEFORM mRNA DME0118 XEOTICID XEO00885 MOACRIVE Induction DME0118 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0118 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0118 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0118 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00898 GENEFORM mRNA DME0118 XEOTICID XEO00898 MOACRIVE Induction DME0118 XEOTICID XEO00919 XEO_NAME Particulate matter DME0118 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0118 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0118 XEOTICID XEO00919 DESCRIPT Particulate matter induces the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO00919 GENEFORM Protein DME0118 XEOTICID XEO00919 MOACRIVE Induction DME0118 XEOTICID XEO00973 XEO_NAME Diuron DME0118 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0118 XEOTICID XEO00973 XEO_CLAS Herbicide DME0118 XEOTICID XEO00973 DESCRIPT Diuron up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00973 GENEFORM mRNA DME0118 XEOTICID XEO00973 MOACRIVE Induction DME0118 XEOTICID XEO00985 XEO_NAME Hexyl cinnamic aldehyde DME0118 XEOTICID XEO00985 XEO_TYPE Health or Environmental Toxicant(s) DME0118 XEOTICID XEO00985 XEO_CLAS Environmental Pollutant DME0118 XEOTICID XEO00985 DESCRIPT Hexyl cinnamic aldehyde up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO00985 GENEFORM mRNA DME0118 XEOTICID XEO00985 MOACRIVE Induction DME0118 XEOTICID XEO01009 XEO_NAME Glycidamide DME0118 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0118 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0118 XEOTICID XEO01009 DESCRIPT Glycidamide up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO01009 GENEFORM mRNA DME0118 XEOTICID XEO01009 MOACRIVE Induction DME0118 XEOTICID XEO01016 XEO_NAME N-hexane DME0118 XEOTICID XEO01016 XEO_TYPE Health or Environmental Toxicant(s) DME0118 XEOTICID XEO01016 XEO_CLAS Health Hazard/Toxicant DME0118 XEOTICID XEO01016 DESCRIPT N-hexane up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO01016 GENEFORM mRNA DME0118 XEOTICID XEO01016 MOACRIVE Induction DME0118 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0118 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0118 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0118 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME AKR1C3 DME0118 XEOTICID XEO01050 GENEFORM mRNA DME0118 XEOTICID XEO01050 MOACRIVE Inhibition DME0118 XEOTICID XEO01122 XEO_NAME 2-butenal DME0118 XEOTICID XEO01122 XEO_TYPE Health or Environmental Toxicant(s) DME0118 XEOTICID XEO01122 XEO_CLAS Acute Toxic Substance DME0118 XEOTICID XEO01122 DESCRIPT 2-butenal up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO01122 GENEFORM mRNA DME0118 XEOTICID XEO01122 MOACRIVE Induction DME0118 XEOTICID XEO01127 XEO_NAME 2'-hydroxyflavanone DME0118 XEOTICID XEO01127 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0118 XEOTICID XEO01127 XEO_CLAS Natural Product DME0118 XEOTICID XEO01127 DESCRIPT 2'-hydroxyflavanone inhibits the drug-metabolizing activity of DME AKR1C3 (IC50 = 0.1 microM) DME0118 XEOTICID XEO01127 GENEFORM Protein DME0118 XEOTICID XEO01127 MOACRIVE Inhibition DME0118 XEOTICID XEO01128 XEO_NAME Isopropanol DME0118 XEOTICID XEO01128 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO01128 XEO_CLAS Investigative Agent DME0118 XEOTICID XEO01128 DESCRIPT Isopropanol up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO01128 GENEFORM mRNA DME0118 XEOTICID XEO01128 MOACRIVE Induction DME0118 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME0118 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0118 XEOTICID XEO01174 XEO_CLAS Natural Product DME0118 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin induces the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO01174 GENEFORM Protein DME0118 XEOTICID XEO01174 MOACRIVE Induction DME0118 XEOTICID XEO01176 XEO_NAME 7-hydroxyflavone DME0118 XEOTICID XEO01176 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0118 XEOTICID XEO01176 XEO_CLAS Natural Product DME0118 XEOTICID XEO01176 DESCRIPT 7-hydroxyflavone inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO01176 GENEFORM Protein DME0118 XEOTICID XEO01176 MOACRIVE Inhibition DME0118 XEOTICID XEO01201 XEO_NAME Antimony potassium tartrate DME0118 XEOTICID XEO01201 XEO_TYPE Health or Environmental Toxicant(s) DME0118 XEOTICID XEO01201 XEO_CLAS Environmental Pollutant DME0118 XEOTICID XEO01201 DESCRIPT Antimony potassium tartrate induces the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO01201 GENEFORM Protein DME0118 XEOTICID XEO01201 MOACRIVE Induction DME0118 XEOTICID XEO01219 XEO_NAME MG-132 DME0118 XEOTICID XEO01219 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO01219 XEO_CLAS Investigative Agent DME0118 XEOTICID XEO01219 DESCRIPT MG-132 up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO01219 GENEFORM mRNA DME0118 XEOTICID XEO01219 MOACRIVE Induction DME0118 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0118 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0118 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO01220 GENEFORM mRNA DME0118 XEOTICID XEO01220 MOACRIVE Induction DME0118 XEOTICID XEO01230 XEO_NAME Butyric acid DME0118 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0118 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO01230 GENEFORM mRNA DME0118 XEOTICID XEO01230 MOACRIVE Induction DME0118 XEOTICID XEO01233 XEO_NAME Phenethyl caffeate DME0118 XEOTICID XEO01233 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO01233 XEO_CLAS Drug in Phase 1 Clinical Trial DME0118 XEOTICID XEO01233 DESCRIPT Phenethyl caffeate inhibits the drug-metabolizing activity of DME AKR1C3 (IC50 = 1.7 microM) DME0118 XEOTICID XEO01233 GENEFORM Protein DME0118 XEOTICID XEO01233 MOACRIVE Inhibition DME0118 XEOTICID XEO01258 XEO_NAME Cloxazolam DME0118 XEOTICID XEO01258 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO01258 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO01258 DESCRIPT Cloxazolam inhibits the drug-metabolizing activity of DME AKR1C3 (Ki = 1.5 microM) DME0118 XEOTICID XEO01258 GENEFORM Protein DME0118 XEOTICID XEO01258 MOACRIVE Inhibition DME0118 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0118 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0118 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0118 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO01305 GENEFORM mRNA DME0118 XEOTICID XEO01305 MOACRIVE Induction DME0118 XEOTICID XEO01319 XEO_NAME Glycyrrhetinic acid DME0118 XEOTICID XEO01319 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO01319 XEO_CLAS Approved/Marketed Drug DME0118 XEOTICID XEO01319 DESCRIPT Glycyrrhetinic acid inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO01319 GENEFORM Protein DME0118 XEOTICID XEO01319 MOACRIVE Inhibition DME0118 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0118 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0118 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME AKR1C3 DME0118 XEOTICID XEO01324 GENEFORM mRNA DME0118 XEOTICID XEO01324 MOACRIVE Inhibition DME0118 XEOTICID XEO01336 XEO_NAME ICG-001 DME0118 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0118 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME AKR1C3 DME0118 XEOTICID XEO01336 GENEFORM mRNA DME0118 XEOTICID XEO01336 MOACRIVE Inhibition DME0118 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0118 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0118 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0118 XEOTICID XEO01407 DESCRIPT Ochratoxin A inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO01407 GENEFORM Protein DME0118 XEOTICID XEO01407 MOACRIVE Inhibition DME0118 XEOTICID XEO01408 XEO_NAME Octyl gallate DME0118 XEOTICID XEO01408 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0118 XEOTICID XEO01408 XEO_CLAS Natural Product DME0118 XEOTICID XEO01408 DESCRIPT Octyl gallate inhibits the drug-metabolizing activity of DME AKR1C3 DME0118 XEOTICID XEO01408 GENEFORM Protein DME0118 XEOTICID XEO01408 MOACRIVE Inhibition DME0118 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0118 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0118 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0118 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO01492 GENEFORM mRNA DME0118 XEOTICID XEO01492 MOACRIVE Induction DME0118 XEOTICID XEO01503 XEO_NAME Cadmium DME0118 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0118 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0118 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO01503 GENEFORM mRNA DME0118 XEOTICID XEO01503 MOACRIVE Induction DME0118 XEOTICID XEO01504 XEO_NAME Gold DME0118 XEOTICID XEO01504 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0118 XEOTICID XEO01504 XEO_CLAS Chemical Compound DME0118 XEOTICID XEO01504 DESCRIPT Gold up-regulates the expression of DME AKR1C3 DME0118 XEOTICID XEO01504 GENEFORM mRNA DME0118 XEOTICID XEO01504 MOACRIVE Induction DME0119 DME___ID DME0119 DME0119 DME_NAME NADH-ubiquinone oxidoreductase 49 kDa (NDUFS2) DME0119 SPESNAME Homo sapiens DME0119 XEOTICID XEO00029 XEO_NAME Valproic acid DME0119 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0119 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0119 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME NDUFS2 DME0119 XEOTICID XEO00029 GENEFORM mRNA DME0119 XEOTICID XEO00029 MOACRIVE Induction DME0119 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0119 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0119 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0119 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME NDUFS2 DME0119 XEOTICID XEO00117 GENEFORM mRNA DME0119 XEOTICID XEO00117 MOACRIVE Inhibition DME0119 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0119 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0119 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0119 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME NDUFS2 DME0119 XEOTICID XEO00217 GENEFORM mRNA DME0119 XEOTICID XEO00217 MOACRIVE Inhibition DME0119 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0119 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0119 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0119 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME NDUFS2 DME0119 XEOTICID XEO00241 GENEFORM mRNA DME0119 XEOTICID XEO00241 MOACRIVE Inhibition DME0119 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0119 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0119 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0119 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME NDUFS2 DME0119 XEOTICID XEO00292 GENEFORM mRNA DME0119 XEOTICID XEO00292 MOACRIVE Induction DME0119 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0119 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0119 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0119 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME NDUFS2 DME0119 XEOTICID XEO00339 GENEFORM mRNA DME0119 XEOTICID XEO00339 MOACRIVE Induction DME0119 XEOTICID XEO00405 XEO_NAME Niclosamide DME0119 XEOTICID XEO00405 XEO_TYPE Pharmaceutical Agent(s) DME0119 XEOTICID XEO00405 XEO_CLAS Approved/Marketed Drug DME0119 XEOTICID XEO00405 DESCRIPT Niclosamide inhibits the drug-metabolizing activity of DME NDUFS2 DME0119 XEOTICID XEO00405 GENEFORM Protein DME0119 XEOTICID XEO00405 MOACRIVE Inhibition DME0119 XEOTICID XEO00435 XEO_NAME Urethane DME0119 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0119 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0119 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME NDUFS2 DME0119 XEOTICID XEO00435 GENEFORM mRNA DME0119 XEOTICID XEO00435 MOACRIVE Inhibition DME0119 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0119 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0119 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0119 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME NDUFS2 DME0119 XEOTICID XEO00723 GENEFORM mRNA DME0119 XEOTICID XEO00723 MOACRIVE Inhibition DME0119 XEOTICID XEO00760 XEO_NAME Jinfukang DME0119 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0119 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0119 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME NDUFS2 DME0119 XEOTICID XEO00760 GENEFORM mRNA DME0119 XEOTICID XEO00760 MOACRIVE Induction DME0119 XEOTICID XEO00969 XEO_NAME Atrazine DME0119 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0119 XEOTICID XEO00969 XEO_CLAS Herbicide DME0119 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME NDUFS2 DME0119 XEOTICID XEO00969 GENEFORM mRNA DME0119 XEOTICID XEO00969 MOACRIVE Inhibition DME0119 XEOTICID XEO01505 XEO_NAME Lead DME0119 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0119 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0119 XEOTICID XEO01505 DESCRIPT Lead inhibits the expression of DME NDUFS2 DME0119 XEOTICID XEO01505 GENEFORM mRNA DME0119 XEOTICID XEO01505 MOACRIVE Inhibition DME0119 XEOTICID XEO01574 XEO_NAME Plant extracts DME0119 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0119 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0119 XEOTICID XEO01574 DESCRIPT Plant extracts up-regulates the expression of DME NDUFS2 DME0119 XEOTICID XEO01574 GENEFORM mRNA DME0119 XEOTICID XEO01574 MOACRIVE Induction DME0120 DME___ID DME0120 DME0120 DME_NAME NADH-ubiquinone oxidoreductase 30 kDa (NDUFS3) DME0120 SPESNAME Homo sapiens DME0120 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0120 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0120 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0120 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME NDUFS3 DME0120 XEOTICID XEO00117 GENEFORM mRNA DME0120 XEOTICID XEO00117 MOACRIVE Inhibition DME0120 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0120 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0120 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0120 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME NDUFS3 DME0120 XEOTICID XEO00186 GENEFORM mRNA DME0120 XEOTICID XEO00186 MOACRIVE Inhibition DME0120 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0120 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0120 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0120 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME NDUFS3 DME0120 XEOTICID XEO00217 GENEFORM mRNA DME0120 XEOTICID XEO00217 MOACRIVE Inhibition DME0120 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0120 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0120 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0120 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME NDUFS3 DME0120 XEOTICID XEO00241 GENEFORM mRNA DME0120 XEOTICID XEO00241 MOACRIVE Inhibition DME0120 XEOTICID XEO00334 XEO_NAME Cisplatin DME0120 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0120 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0120 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME NDUFS3 DME0120 XEOTICID XEO00334 GENEFORM mRNA DME0120 XEOTICID XEO00334 MOACRIVE Induction DME0120 XEOTICID XEO00405 XEO_NAME Niclosamide DME0120 XEOTICID XEO00405 XEO_TYPE Pharmaceutical Agent(s) DME0120 XEOTICID XEO00405 XEO_CLAS Approved/Marketed Drug DME0120 XEOTICID XEO00405 DESCRIPT Niclosamide inhibits the expression of DME NDUFS3 DME0120 XEOTICID XEO00405 GENEFORM mRNA DME0120 XEOTICID XEO00405 MOACRIVE Inhibition DME0120 XEOTICID XEO00547 XEO_NAME Vitamin E DME0120 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0120 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0120 XEOTICID XEO00547 DESCRIPT Vitamin E up-regulates the expression of DME NDUFS3 DME0120 XEOTICID XEO00547 GENEFORM mRNA DME0120 XEOTICID XEO00547 MOACRIVE Induction DME0120 XEOTICID XEO00568 XEO_NAME Resveratrol DME0120 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0120 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0120 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME NDUFS3 DME0120 XEOTICID XEO00568 GENEFORM mRNA DME0120 XEOTICID XEO00568 MOACRIVE Induction DME0120 XEOTICID XEO00969 XEO_NAME Atrazine DME0120 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0120 XEOTICID XEO00969 XEO_CLAS Herbicide DME0120 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME NDUFS3 DME0120 XEOTICID XEO00969 GENEFORM mRNA DME0120 XEOTICID XEO00969 MOACRIVE Inhibition DME0120 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0120 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0120 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0120 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium inhibits the drug-metabolizing activity of DME NDUFS3 DME0120 XEOTICID XEO01103 GENEFORM Protein DME0120 XEOTICID XEO01103 MOACRIVE Inhibition DME0120 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0120 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0120 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0120 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME NDUFS3 DME0120 XEOTICID XEO01226 GENEFORM mRNA DME0120 XEOTICID XEO01226 MOACRIVE Induction DME0120 XEOTICID XEO01227 XEO_NAME Bromovanin DME0120 XEOTICID XEO01227 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0120 XEOTICID XEO01227 XEO_CLAS Natural Product DME0120 XEOTICID XEO01227 DESCRIPT Bromovanin induces the drug-metabolizing activity of DME NDUFS3 DME0120 XEOTICID XEO01227 GENEFORM Protein DME0120 XEOTICID XEO01227 MOACRIVE Induction DME0120 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0120 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0120 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0120 XEOTICID XEO01247 DESCRIPT Chloropicrin up-regulates the expression of DME NDUFS3 DME0120 XEOTICID XEO01247 GENEFORM mRNA DME0120 XEOTICID XEO01247 MOACRIVE Induction DME0120 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0120 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0120 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0120 XEOTICID XEO01248 DESCRIPT Chlorpyrifos inhibits the drug-metabolizing activity of DME NDUFS3 DME0120 XEOTICID XEO01248 GENEFORM Protein DME0120 XEOTICID XEO01248 MOACRIVE Inhibition DME0120 XEOTICID XEO01348 XEO_NAME K-7174 DME0120 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0120 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0120 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME NDUFS3 DME0120 XEOTICID XEO01348 GENEFORM mRNA DME0120 XEOTICID XEO01348 MOACRIVE Inhibition DME0120 XEOTICID XEO01574 XEO_NAME Plant extracts DME0120 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0120 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0120 XEOTICID XEO01574 DESCRIPT Plant extracts up-regulates the expression of DME NDUFS3 and leads to increasing the drug-metabolizing activity of this enzyme DME0120 XEOTICID XEO01574 GENEFORM Protein DME0120 XEOTICID XEO01574 MOACRIVE Induction DME0121 DME___ID DME0121 DME0121 DME_NAME NADH-ubiquinone oxidoreductase 20 kDa (NDUFS7) DME0121 SPESNAME Homo sapiens DME0121 XEOTICID XEO00110 XEO_NAME Acetylcysteine DME0121 XEOTICID XEO00110 XEO_TYPE Pharmaceutical Agent(s) DME0121 XEOTICID XEO00110 XEO_CLAS Approved/Marketed Drug DME0121 XEOTICID XEO00110 DESCRIPT Acetylcysteine induces the drug-metabolizing activity of DME NDUFS7 DME0121 XEOTICID XEO00110 GENEFORM Protein DME0121 XEOTICID XEO00110 MOACRIVE Induction DME0121 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0121 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0121 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0121 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME NDUFS7 DME0121 XEOTICID XEO00186 GENEFORM mRNA DME0121 XEOTICID XEO00186 MOACRIVE Inhibition DME0121 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0121 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0121 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0121 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME NDUFS7 DME0121 XEOTICID XEO00241 GENEFORM mRNA DME0121 XEOTICID XEO00241 MOACRIVE Inhibition DME0121 XEOTICID XEO00405 XEO_NAME Niclosamide DME0121 XEOTICID XEO00405 XEO_TYPE Pharmaceutical Agent(s) DME0121 XEOTICID XEO00405 XEO_CLAS Approved/Marketed Drug DME0121 XEOTICID XEO00405 DESCRIPT Niclosamide inhibits the drug-metabolizing activity of DME NDUFS7 DME0121 XEOTICID XEO00405 GENEFORM Protein DME0121 XEOTICID XEO00405 MOACRIVE Inhibition DME0121 XEOTICID XEO00846 XEO_NAME Coenzyme Q10 DME0121 XEOTICID XEO00846 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0121 XEOTICID XEO00846 XEO_CLAS Natural Product DME0121 XEOTICID XEO00846 DESCRIPT Coenzyme Q10 induces the drug-metabolizing activity of DME NDUFS7 DME0121 XEOTICID XEO00846 GENEFORM Protein DME0121 XEOTICID XEO00846 MOACRIVE Induction DME0121 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0121 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0121 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0121 XEOTICID XEO01407 DESCRIPT Ochratoxin A induces the drug-metabolizing activity of DME NDUFS7 DME0121 XEOTICID XEO01407 GENEFORM Protein DME0121 XEOTICID XEO01407 MOACRIVE Induction DME0121 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0121 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0121 XEOTICID XEO01494 XEO_CLAS Natural Product DME0121 XEOTICID XEO01494 DESCRIPT Tunicamycin A up-regulates the expression of DME NDUFS7 DME0121 XEOTICID XEO01494 GENEFORM mRNA DME0121 XEOTICID XEO01494 MOACRIVE Induction DME0121 XEOTICID XEO01503 XEO_NAME Cadmium DME0121 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0121 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0121 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the expression of DME NDUFS7 DME0121 XEOTICID XEO01503 GENEFORM mRNA DME0121 XEOTICID XEO01503 MOACRIVE Inhibition DME0122 DME___ID DME0122 DME0122 DME_NAME Nitric oxide synthase brain (NOS1) DME0122 SPESNAME Homo sapiens DME0122 XEOTICID XEO00095 XEO_NAME Testosterone DME0122 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0122 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0122 XEOTICID XEO00095 DESCRIPT Testosterone induces the drug-metabolizing activity of DME NOS1 DME0122 XEOTICID XEO00095 GENEFORM Protein DME0122 XEOTICID XEO00095 MOACRIVE Induction DME0122 XEOTICID XEO00178 XEO_NAME Capsaicin DME0122 XEOTICID XEO00178 XEO_TYPE Pharmaceutical Agent(s) DME0122 XEOTICID XEO00178 XEO_CLAS Approved/Marketed Drug DME0122 XEOTICID XEO00178 DESCRIPT Capsaicin induces the drug-metabolizing activity of DME NOS1 DME0122 XEOTICID XEO00178 GENEFORM Protein DME0122 XEOTICID XEO00178 MOACRIVE Induction DME0122 XEOTICID XEO00324 XEO_NAME Selenomethionine Se-75 DME0122 XEOTICID XEO00324 XEO_TYPE Pharmaceutical Agent(s) DME0122 XEOTICID XEO00324 XEO_CLAS Approved/Marketed Drug DME0122 XEOTICID XEO00324 DESCRIPT Selenomethionine Se-75 up-regulates the expression of DME NOS1 DME0122 XEOTICID XEO00324 GENEFORM mRNA DME0122 XEOTICID XEO00324 MOACRIVE Induction DME0122 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0122 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0122 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0122 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide induces the drug-metabolizing activity of DME NOS1 DME0122 XEOTICID XEO00388 GENEFORM Protein DME0122 XEOTICID XEO00388 MOACRIVE Induction DME0122 XEOTICID XEO00401 XEO_NAME Beta carotene DME0122 XEOTICID XEO00401 XEO_TYPE Pharmaceutical Agent(s) DME0122 XEOTICID XEO00401 XEO_CLAS Approved/Marketed Drug DME0122 XEOTICID XEO00401 DESCRIPT Beta carotene up-regulates the expression of DME NOS1 DME0122 XEOTICID XEO00401 GENEFORM mRNA DME0122 XEOTICID XEO00401 MOACRIVE Induction DME0122 XEOTICID XEO00568 XEO_NAME Resveratrol DME0122 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0122 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0122 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME NOS1 DME0122 XEOTICID XEO00568 GENEFORM mRNA DME0122 XEOTICID XEO00568 MOACRIVE Induction DME0122 XEOTICID XEO00581 XEO_NAME MS-275 DME0122 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0122 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0122 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME NOS1 DME0122 XEOTICID XEO00581 GENEFORM mRNA DME0122 XEOTICID XEO00581 MOACRIVE Induction DME0122 XEOTICID XEO00834 XEO_NAME Copper DME0122 XEOTICID XEO00834 XEO_TYPE Pharmaceutical Agent(s) DME0122 XEOTICID XEO00834 XEO_CLAS Approved/Marketed Drug DME0122 XEOTICID XEO00834 DESCRIPT Copper induces the drug-metabolizing activity of DME NOS1 DME0122 XEOTICID XEO00834 GENEFORM Protein DME0122 XEOTICID XEO00834 MOACRIVE Induction DME0122 XEOTICID XEO00849 XEO_NAME Lycopene DME0122 XEOTICID XEO00849 XEO_TYPE Pharmaceutical Agent(s) DME0122 XEOTICID XEO00849 XEO_CLAS Approved/Marketed Drug DME0122 XEOTICID XEO00849 DESCRIPT Lycopene inhibits the drug-metabolizing activity of DME NOS1 DME0122 XEOTICID XEO00849 GENEFORM Protein DME0122 XEOTICID XEO00849 MOACRIVE Inhibition DME0122 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0122 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0122 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0122 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME NOS1 DME0122 XEOTICID XEO01004 GENEFORM mRNA DME0122 XEOTICID XEO01004 MOACRIVE Inhibition DME0122 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0122 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0122 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0122 XEOTICID XEO01226 DESCRIPT Bisphenol A induces the drug-metabolizing activity of DME NOS1 DME0122 XEOTICID XEO01226 GENEFORM Protein DME0122 XEOTICID XEO01226 MOACRIVE Induction DME0122 XEOTICID XEO01286 XEO_NAME Egtazic acid DME0122 XEOTICID XEO01286 XEO_TYPE Pharmaceutical Agent(s) DME0122 XEOTICID XEO01286 XEO_CLAS Investigative Agent DME0122 XEOTICID XEO01286 DESCRIPT Egtazic acid inhibits the drug-metabolizing activity of DME NOS1 DME0122 XEOTICID XEO01286 GENEFORM Protein DME0122 XEOTICID XEO01286 MOACRIVE Inhibition DME0122 XEOTICID XEO01356 XEO_NAME KMUP 1 DME0122 XEOTICID XEO01356 XEO_TYPE Health or Environmental Toxicant(s) DME0122 XEOTICID XEO01356 XEO_CLAS Acute Toxic Substance DME0122 XEOTICID XEO01356 DESCRIPT KMUP 1 induces the drug-metabolizing activity of DME NOS1 DME0122 XEOTICID XEO01356 GENEFORM Protein DME0122 XEOTICID XEO01356 MOACRIVE Induction DME0122 XEOTICID XEO01418 XEO_NAME Oxidopamine DME0122 XEOTICID XEO01418 XEO_TYPE Pharmaceutical Agent(s) DME0122 XEOTICID XEO01418 XEO_CLAS Investigative Agent DME0122 XEOTICID XEO01418 DESCRIPT Oxidopamine up-regulates the expression of DME NOS1 and leads to increasing the drug-metabolizing activity of this enzyme DME0122 XEOTICID XEO01418 GENEFORM Protein DME0122 XEOTICID XEO01418 MOACRIVE Induction DME0122 XEOTICID XEO01506 XEO_NAME Lead chloride DME0122 XEOTICID XEO01506 XEO_TYPE Health or Environmental Toxicant(s) DME0122 XEOTICID XEO01506 XEO_CLAS Health Hazard/Toxicant DME0122 XEOTICID XEO01506 DESCRIPT Lead chloride inhibits the drug-metabolizing activity of DME NOS1 DME0122 XEOTICID XEO01506 GENEFORM Protein DME0122 XEOTICID XEO01506 MOACRIVE Inhibition DME0122 XEOTICID XEO01523 XEO_NAME Apocarotenal DME0122 XEOTICID XEO01523 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0122 XEOTICID XEO01523 XEO_CLAS Natural Product DME0122 XEOTICID XEO01523 DESCRIPT Apocarotenal up-regulates the expression of DME NOS1 DME0122 XEOTICID XEO01523 GENEFORM mRNA DME0122 XEOTICID XEO01523 MOACRIVE Induction DME0122 XEOTICID XEO01574 XEO_NAME Plant extracts DME0122 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0122 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0122 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME NOS1 DME0122 XEOTICID XEO01574 GENEFORM Protein DME0122 XEOTICID XEO01574 MOACRIVE Inhibition DME0123 DME___ID DME0123 DME0123 DME_NAME Nitric oxide synthase endothelial (NOS3) DME0123 SPESNAME Homo sapiens DME0123 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0123 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00035 DESCRIPT Fenofibrate induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00035 GENEFORM Protein DME0123 XEOTICID XEO00035 MOACRIVE Induction DME0123 XEOTICID XEO00086 XEO_NAME Troglitazone DME0123 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00086 DESCRIPT Troglitazone induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00086 GENEFORM Protein DME0123 XEOTICID XEO00086 MOACRIVE Induction DME0123 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0123 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00088 DESCRIPT Dexamethasone inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00088 GENEFORM Protein DME0123 XEOTICID XEO00088 MOACRIVE Inhibition DME0123 XEOTICID XEO00090 XEO_NAME Estradiol DME0123 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00090 DESCRIPT Estradiol induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00090 GENEFORM Protein DME0123 XEOTICID XEO00090 MOACRIVE Induction DME0123 XEOTICID XEO00094 XEO_NAME Progesterone DME0123 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00094 DESCRIPT Progesterone up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00094 GENEFORM mRNA DME0123 XEOTICID XEO00094 MOACRIVE Induction DME0123 XEOTICID XEO00125 XEO_NAME Simvastatin DME0123 XEOTICID XEO00125 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00125 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00125 DESCRIPT Simvastatin up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00125 GENEFORM mRNA DME0123 XEOTICID XEO00125 MOACRIVE Induction DME0123 XEOTICID XEO00168 XEO_NAME Decitabine DME0123 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00168 DESCRIPT Decitabine up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00168 GENEFORM mRNA DME0123 XEOTICID XEO00168 MOACRIVE Induction DME0123 XEOTICID XEO00178 XEO_NAME Capsaicin DME0123 XEOTICID XEO00178 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00178 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00178 DESCRIPT Capsaicin induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00178 GENEFORM Protein DME0123 XEOTICID XEO00178 MOACRIVE Induction DME0123 XEOTICID XEO00188 XEO_NAME Sirolimus DME0123 XEOTICID XEO00188 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00188 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00188 DESCRIPT Sirolimus inhibits the expression of DME NOS3 DME0123 XEOTICID XEO00188 GENEFORM mRNA DME0123 XEOTICID XEO00188 MOACRIVE Inhibition DME0123 XEOTICID XEO00191 XEO_NAME Everolimus DME0123 XEOTICID XEO00191 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00191 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00191 DESCRIPT Everolimus inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00191 GENEFORM Protein DME0123 XEOTICID XEO00191 MOACRIVE Inhibition DME0123 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0123 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00241 GENEFORM mRNA DME0123 XEOTICID XEO00241 MOACRIVE Induction DME0123 XEOTICID XEO00254 XEO_NAME Tacrolimus DME0123 XEOTICID XEO00254 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00254 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00254 DESCRIPT Tacrolimus up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00254 GENEFORM mRNA DME0123 XEOTICID XEO00254 MOACRIVE Induction DME0123 XEOTICID XEO00255 XEO_NAME Rosuvastatin calcium DME0123 XEOTICID XEO00255 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00255 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00255 DESCRIPT Rosuvastatin calcium induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00255 GENEFORM Protein DME0123 XEOTICID XEO00255 MOACRIVE Induction DME0123 XEOTICID XEO00256 XEO_NAME Paclitaxel DME0123 XEOTICID XEO00256 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00256 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00256 DESCRIPT Paclitaxel inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00256 GENEFORM Protein DME0123 XEOTICID XEO00256 MOACRIVE Inhibition DME0123 XEOTICID XEO00305 XEO_NAME Levamisole hydrochloride DME0123 XEOTICID XEO00305 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00305 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00305 DESCRIPT Levamisole hydrochloride inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00305 GENEFORM Protein DME0123 XEOTICID XEO00305 MOACRIVE Inhibition DME0123 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0123 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00312 GENEFORM mRNA DME0123 XEOTICID XEO00312 MOACRIVE Induction DME0123 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0123 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00339 GENEFORM Protein DME0123 XEOTICID XEO00339 MOACRIVE Inhibition DME0123 XEOTICID XEO00340 XEO_NAME Atorvastatin DME0123 XEOTICID XEO00340 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00340 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00340 DESCRIPT Atorvastatin induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00340 GENEFORM Protein DME0123 XEOTICID XEO00340 MOACRIVE Induction DME0123 XEOTICID XEO00366 XEO_NAME Methotrexate DME0123 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00366 DESCRIPT Methotrexate inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00366 GENEFORM Protein DME0123 XEOTICID XEO00366 MOACRIVE Inhibition DME0123 XEOTICID XEO00370 XEO_NAME Nebivolol DME0123 XEOTICID XEO00370 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00370 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00370 DESCRIPT Nebivolol up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00370 GENEFORM mRNA DME0123 XEOTICID XEO00370 MOACRIVE Induction DME0123 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0123 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00388 GENEFORM Protein DME0123 XEOTICID XEO00388 MOACRIVE Inhibition DME0123 XEOTICID XEO00402 XEO_NAME Digitoxin DME0123 XEOTICID XEO00402 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00402 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00402 DESCRIPT Digitoxin induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00402 GENEFORM Protein DME0123 XEOTICID XEO00402 MOACRIVE Induction DME0123 XEOTICID XEO00439 XEO_NAME Daidzein DME0123 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00439 DESCRIPT Daidzein induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00439 GENEFORM Protein DME0123 XEOTICID XEO00439 MOACRIVE Induction DME0123 XEOTICID XEO00447 XEO_NAME Benzoic acid DME0123 XEOTICID XEO00447 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00447 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00447 DESCRIPT Benzoic acid up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00447 GENEFORM mRNA DME0123 XEOTICID XEO00447 MOACRIVE Induction DME0123 XEOTICID XEO00457 XEO_NAME Estriol DME0123 XEOTICID XEO00457 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00457 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00457 DESCRIPT Estriol induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00457 GENEFORM Protein DME0123 XEOTICID XEO00457 MOACRIVE Induction DME0123 XEOTICID XEO00486 XEO_NAME Tanshinone DME0123 XEOTICID XEO00486 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00486 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00486 DESCRIPT Tanshinone up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00486 GENEFORM mRNA DME0123 XEOTICID XEO00486 MOACRIVE Induction DME0123 XEOTICID XEO00539 XEO_NAME Ethanol DME0123 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0123 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00539 GENEFORM Protein DME0123 XEOTICID XEO00539 MOACRIVE Inhibition DME0123 XEOTICID XEO00557 XEO_NAME Genistein DME0123 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0123 XEOTICID XEO00557 DESCRIPT Genistein induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00557 GENEFORM Protein DME0123 XEOTICID XEO00557 MOACRIVE Induction DME0123 XEOTICID XEO00568 XEO_NAME Resveratrol DME0123 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0123 XEOTICID XEO00568 DESCRIPT Resveratrol induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00568 GENEFORM Protein DME0123 XEOTICID XEO00568 MOACRIVE Induction DME0123 XEOTICID XEO00587 XEO_NAME Trichloroethylene DME0123 XEOTICID XEO00587 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00587 XEO_CLAS Drug in Phase 2 Clinical Trial DME0123 XEOTICID XEO00587 DESCRIPT Trichloroethylene induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00587 GENEFORM Protein DME0123 XEOTICID XEO00587 MOACRIVE Induction DME0123 XEOTICID XEO00604 XEO_NAME Calcimycin DME0123 XEOTICID XEO00604 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00604 XEO_CLAS Drug in Phase 2 Clinical Trial DME0123 XEOTICID XEO00604 DESCRIPT Calcimycin up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00604 GENEFORM mRNA DME0123 XEOTICID XEO00604 MOACRIVE Induction DME0123 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME0123 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME0123 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00613 GENEFORM mRNA DME0123 XEOTICID XEO00613 MOACRIVE Induction DME0123 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0123 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0123 XEOTICID XEO00632 DESCRIPT Sodium arsenite induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00632 GENEFORM Protein DME0123 XEOTICID XEO00632 MOACRIVE Induction DME0123 XEOTICID XEO00648 XEO_NAME Puerarin DME0123 XEOTICID XEO00648 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00648 XEO_CLAS Drug in Phase 2 Clinical Trial DME0123 XEOTICID XEO00648 DESCRIPT Puerarin up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00648 GENEFORM mRNA DME0123 XEOTICID XEO00648 MOACRIVE Induction DME0123 XEOTICID XEO00654 XEO_NAME Icariin DME0123 XEOTICID XEO00654 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00654 XEO_CLAS Drug in Phase 3 Clinical Trial DME0123 XEOTICID XEO00654 DESCRIPT Icariin up-regulates the expression of DME NOS3 and leads to increasing the drug-metabolizing activity of this enzyme DME0123 XEOTICID XEO00654 GENEFORM Protein DME0123 XEOTICID XEO00654 MOACRIVE Induction DME0123 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0123 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0123 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME NOS3 DME0123 XEOTICID XEO00723 GENEFORM mRNA DME0123 XEOTICID XEO00723 MOACRIVE Inhibition DME0123 XEOTICID XEO00740 XEO_NAME Lindane DME0123 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00740 DESCRIPT Lindane up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00740 GENEFORM mRNA DME0123 XEOTICID XEO00740 MOACRIVE Induction DME0123 XEOTICID XEO00751 XEO_NAME Cocaine hydrochloride DME0123 XEOTICID XEO00751 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00751 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00751 DESCRIPT Cocaine hydrochloride inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00751 GENEFORM Protein DME0123 XEOTICID XEO00751 MOACRIVE Inhibition DME0123 XEOTICID XEO00768 XEO_NAME Dichlorodiphenyl dichloroethylene DME0123 XEOTICID XEO00768 XEO_TYPE Health or Environmental Toxicant(s) DME0123 XEOTICID XEO00768 XEO_CLAS Environmental Pollutant DME0123 XEOTICID XEO00768 DESCRIPT Dichlorodiphenyl dichloroethylene up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00768 GENEFORM mRNA DME0123 XEOTICID XEO00768 MOACRIVE Induction DME0123 XEOTICID XEO00782 XEO_NAME Vanillic acid DME0123 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0123 XEOTICID XEO00782 XEO_CLAS Natural Product DME0123 XEOTICID XEO00782 DESCRIPT Vanillic acid up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00782 GENEFORM mRNA DME0123 XEOTICID XEO00782 MOACRIVE Induction DME0123 XEOTICID XEO00832 XEO_NAME Calcium DME0123 XEOTICID XEO00832 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO00832 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO00832 DESCRIPT Calcium induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00832 GENEFORM Protein DME0123 XEOTICID XEO00832 MOACRIVE Induction DME0123 XEOTICID XEO00843 XEO_NAME Sodium bisulfide DME0123 XEOTICID XEO00843 XEO_TYPE Health or Environmental Toxicant(s) DME0123 XEOTICID XEO00843 XEO_CLAS Acute Toxic Substance DME0123 XEOTICID XEO00843 DESCRIPT Sodium bisulfide up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO00843 GENEFORM mRNA DME0123 XEOTICID XEO00843 MOACRIVE Induction DME0123 XEOTICID XEO00855 XEO_NAME Fructose DME0123 XEOTICID XEO00855 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0123 XEOTICID XEO00855 XEO_CLAS Natural Product DME0123 XEOTICID XEO00855 DESCRIPT Fructose inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00855 GENEFORM Protein DME0123 XEOTICID XEO00855 MOACRIVE Inhibition DME0123 XEOTICID XEO00883 XEO_NAME Phloretin DME0123 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0123 XEOTICID XEO00883 XEO_CLAS Natural Product DME0123 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00883 GENEFORM Protein DME0123 XEOTICID XEO00883 MOACRIVE Inhibition DME0123 XEOTICID XEO00969 XEO_NAME Atrazine DME0123 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0123 XEOTICID XEO00969 XEO_CLAS Herbicide DME0123 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00969 GENEFORM Protein DME0123 XEOTICID XEO00969 MOACRIVE Inhibition DME0123 XEOTICID XEO00979 XEO_NAME Propazine DME0123 XEOTICID XEO00979 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0123 XEOTICID XEO00979 XEO_CLAS Herbicide DME0123 XEOTICID XEO00979 DESCRIPT Propazine inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00979 GENEFORM Protein DME0123 XEOTICID XEO00979 MOACRIVE Inhibition DME0123 XEOTICID XEO00980 XEO_NAME Simazine DME0123 XEOTICID XEO00980 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0123 XEOTICID XEO00980 XEO_CLAS Herbicide DME0123 XEOTICID XEO00980 DESCRIPT Simazine inhibits the expression of DME NOS3 DME0123 XEOTICID XEO00980 GENEFORM mRNA DME0123 XEOTICID XEO00980 MOACRIVE Inhibition DME0123 XEOTICID XEO00981 XEO_NAME Terbutylazine DME0123 XEOTICID XEO00981 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0123 XEOTICID XEO00981 XEO_CLAS Herbicide DME0123 XEOTICID XEO00981 DESCRIPT Terbutylazine inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO00981 GENEFORM Protein DME0123 XEOTICID XEO00981 MOACRIVE Inhibition DME0123 XEOTICID XEO01028 XEO_NAME Toluene 2,4-diisocyanate DME0123 XEOTICID XEO01028 XEO_TYPE Health or Environmental Toxicant(s) DME0123 XEOTICID XEO01028 XEO_CLAS Acute Toxic Substance DME0123 XEOTICID XEO01028 DESCRIPT Toluene 2,4-diisocyanate up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO01028 GENEFORM mRNA DME0123 XEOTICID XEO01028 MOACRIVE Induction DME0123 XEOTICID XEO01074 XEO_NAME Endosulfan DME0123 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0123 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0123 XEOTICID XEO01074 DESCRIPT Endosulfan up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO01074 GENEFORM mRNA DME0123 XEOTICID XEO01074 MOACRIVE Induction DME0123 XEOTICID XEO01116 XEO_NAME 25-hydroxycholesterol DME0123 XEOTICID XEO01116 XEO_TYPE Health or Environmental Toxicant(s) DME0123 XEOTICID XEO01116 XEO_CLAS Health Hazard/Toxicant DME0123 XEOTICID XEO01116 DESCRIPT 25-hydroxycholesterol inhibits the expression of DME NOS3 DME0123 XEOTICID XEO01116 GENEFORM mRNA DME0123 XEOTICID XEO01116 MOACRIVE Inhibition DME0123 XEOTICID XEO01171 XEO_NAME 7,8-diacetoxy-4-methylcoumarin DME0123 XEOTICID XEO01171 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO01171 XEO_CLAS Investigative Agent DME0123 XEOTICID XEO01171 DESCRIPT 7,8-diacetoxy-4-methylcoumarin induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO01171 GENEFORM Protein DME0123 XEOTICID XEO01171 MOACRIVE Induction DME0123 XEOTICID XEO01197 XEO_NAME Amurensin G DME0123 XEOTICID XEO01197 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0123 XEOTICID XEO01197 XEO_CLAS Natural Product DME0123 XEOTICID XEO01197 DESCRIPT Amurensin G up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO01197 GENEFORM mRNA DME0123 XEOTICID XEO01197 MOACRIVE Induction DME0123 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0123 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0123 XEOTICID XEO01226 DESCRIPT Bisphenol A induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO01226 GENEFORM Protein DME0123 XEOTICID XEO01226 MOACRIVE Induction DME0123 XEOTICID XEO01232 XEO_NAME Caffeic acid DME0123 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME0123 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME0123 XEOTICID XEO01232 DESCRIPT Caffeic acid up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO01232 GENEFORM mRNA DME0123 XEOTICID XEO01232 MOACRIVE Induction DME0123 XEOTICID XEO01246 XEO_NAME Chlorogenic acid DME0123 XEOTICID XEO01246 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO01246 XEO_CLAS Drug in Phase 2 Clinical Trial DME0123 XEOTICID XEO01246 DESCRIPT Chlorogenic acid up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO01246 GENEFORM mRNA DME0123 XEOTICID XEO01246 MOACRIVE Induction DME0123 XEOTICID XEO01252 XEO_NAME Cinnamic acid DME0123 XEOTICID XEO01252 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO01252 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO01252 DESCRIPT Cinnamic acid up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO01252 GENEFORM mRNA DME0123 XEOTICID XEO01252 MOACRIVE Induction DME0123 XEOTICID XEO01266 XEO_NAME Cyanidin DME0123 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME0123 XEOTICID XEO01266 DESCRIPT Cyanidin up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO01266 GENEFORM mRNA DME0123 XEOTICID XEO01266 MOACRIVE Induction DME0123 XEOTICID XEO01286 XEO_NAME Egtazic acid DME0123 XEOTICID XEO01286 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO01286 XEO_CLAS Investigative Agent DME0123 XEOTICID XEO01286 DESCRIPT Egtazic acid inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO01286 GENEFORM Protein DME0123 XEOTICID XEO01286 MOACRIVE Inhibition DME0123 XEOTICID XEO01318 XEO_NAME Glycochenodeoxycholic acid DME0123 XEOTICID XEO01318 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO01318 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO01318 DESCRIPT Glycochenodeoxycholic acid inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO01318 GENEFORM Protein DME0123 XEOTICID XEO01318 MOACRIVE Inhibition DME0123 XEOTICID XEO01331 XEO_NAME Homocysteine DME0123 XEOTICID XEO01331 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO01331 XEO_CLAS Drug in Phase 1 Clinical Trial DME0123 XEOTICID XEO01331 DESCRIPT Homocysteine inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO01331 GENEFORM Protein DME0123 XEOTICID XEO01331 MOACRIVE Inhibition DME0123 XEOTICID XEO01367 XEO_NAME Linoleic acid DME0123 XEOTICID XEO01367 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO01367 XEO_CLAS Approved/Marketed Drug DME0123 XEOTICID XEO01367 DESCRIPT Linoleic acid inhibits the expression of DME NOS3 DME0123 XEOTICID XEO01367 GENEFORM mRNA DME0123 XEOTICID XEO01367 MOACRIVE Inhibition DME0123 XEOTICID XEO01412 XEO_NAME Oleic acid DME0123 XEOTICID XEO01412 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO01412 XEO_CLAS Preclinical/Patented Drug DME0123 XEOTICID XEO01412 DESCRIPT Oleic acid inhibits the expression of DME NOS3 DME0123 XEOTICID XEO01412 GENEFORM mRNA DME0123 XEOTICID XEO01412 MOACRIVE Inhibition DME0123 XEOTICID XEO01429 XEO_NAME Phlorhizin DME0123 XEOTICID XEO01429 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0123 XEOTICID XEO01429 XEO_CLAS Natural Product DME0123 XEOTICID XEO01429 DESCRIPT Phlorhizin inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO01429 GENEFORM Protein DME0123 XEOTICID XEO01429 MOACRIVE Inhibition DME0123 XEOTICID XEO01440 XEO_NAME Protoporphyrin IX DME0123 XEOTICID XEO01440 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO01440 XEO_CLAS Investigative Agent DME0123 XEOTICID XEO01440 DESCRIPT Protoporphyrin IX inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO01440 GENEFORM Protein DME0123 XEOTICID XEO01440 MOACRIVE Inhibition DME0123 XEOTICID XEO01459 XEO_NAME Rosavin DME0123 XEOTICID XEO01459 XEO_TYPE Pharmaceutical Agent(s) DME0123 XEOTICID XEO01459 XEO_CLAS Preclinical/Patented Drug DME0123 XEOTICID XEO01459 DESCRIPT Rosavin up-regulates the expression of DME NOS3 DME0123 XEOTICID XEO01459 GENEFORM mRNA DME0123 XEOTICID XEO01459 MOACRIVE Induction DME0123 XEOTICID XEO01506 XEO_NAME Lead chloride DME0123 XEOTICID XEO01506 XEO_TYPE Health or Environmental Toxicant(s) DME0123 XEOTICID XEO01506 XEO_CLAS Health Hazard/Toxicant DME0123 XEOTICID XEO01506 DESCRIPT Lead chloride inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO01506 GENEFORM Protein DME0123 XEOTICID XEO01506 MOACRIVE Inhibition DME0123 XEOTICID XEO01537 XEO_NAME Deguelin DME0123 XEOTICID XEO01537 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0123 XEOTICID XEO01537 XEO_CLAS Natural Product DME0123 XEOTICID XEO01537 DESCRIPT Deguelin inhibits the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO01537 GENEFORM Protein DME0123 XEOTICID XEO01537 MOACRIVE Inhibition DME0123 XEOTICID XEO01574 XEO_NAME Plant extracts DME0123 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0123 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0123 XEOTICID XEO01574 DESCRIPT Plant extracts induces the drug-metabolizing activity of DME NOS3 DME0123 XEOTICID XEO01574 GENEFORM Protein DME0123 XEOTICID XEO01574 MOACRIVE Induction DME0124 DME___ID DME0124 DME0124 DME_NAME Nitric oxide synthase inducible (NOS2) DME0124 SPESNAME Homo sapiens DME0124 XEOTICID XEO00001 XEO_NAME Dimethyl sulfoxide DME0124 XEOTICID XEO00001 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00001 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00001 DESCRIPT Dimethyl sulfoxide inhibits the expression of DME NOS2 DME0124 XEOTICID XEO00001 GENEFORM mRNA DME0124 XEOTICID XEO00001 MOACRIVE Inhibition DME0124 XEOTICID XEO00029 XEO_NAME Valproic acid DME0124 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME NOS2 DME0124 XEOTICID XEO00029 GENEFORM mRNA DME0124 XEOTICID XEO00029 MOACRIVE Inhibition DME0124 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0124 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00037 DESCRIPT Fluorouracil induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00037 GENEFORM Protein DME0124 XEOTICID XEO00037 MOACRIVE Induction DME0124 XEOTICID XEO00048 XEO_NAME Isoproterenol DME0124 XEOTICID XEO00048 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00048 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00048 DESCRIPT Isoproterenol inhibits the expression of DME NOS2 DME0124 XEOTICID XEO00048 GENEFORM mRNA DME0124 XEOTICID XEO00048 MOACRIVE Inhibition DME0124 XEOTICID XEO00068 XEO_NAME Nitroglycerin DME0124 XEOTICID XEO00068 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00068 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00068 DESCRIPT Nitroglycerin inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00068 GENEFORM Protein DME0124 XEOTICID XEO00068 MOACRIVE Inhibition DME0124 XEOTICID XEO00086 XEO_NAME Troglitazone DME0124 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00086 GENEFORM mRNA DME0124 XEOTICID XEO00086 MOACRIVE Induction DME0124 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0124 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00088 DESCRIPT Dexamethasone inhibits the expression of DME NOS2 DME0124 XEOTICID XEO00088 GENEFORM mRNA DME0124 XEOTICID XEO00088 MOACRIVE Inhibition DME0124 XEOTICID XEO00090 XEO_NAME Estradiol DME0124 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00090 GENEFORM mRNA DME0124 XEOTICID XEO00090 MOACRIVE Induction DME0124 XEOTICID XEO00094 XEO_NAME Progesterone DME0124 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00094 DESCRIPT Progesterone induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00094 GENEFORM Protein DME0124 XEOTICID XEO00094 MOACRIVE Induction DME0124 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0124 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME NOS2 DME0124 XEOTICID XEO00117 GENEFORM mRNA DME0124 XEOTICID XEO00117 MOACRIVE Inhibition DME0124 XEOTICID XEO00121 XEO_NAME Etoposide DME0124 XEOTICID XEO00121 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00121 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00121 DESCRIPT Etoposide induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00121 GENEFORM Protein DME0124 XEOTICID XEO00121 MOACRIVE Induction DME0124 XEOTICID XEO00125 XEO_NAME Simvastatin DME0124 XEOTICID XEO00125 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00125 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00125 DESCRIPT Simvastatin up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00125 GENEFORM mRNA DME0124 XEOTICID XEO00125 MOACRIVE Induction DME0124 XEOTICID XEO00126 XEO_NAME Raloxifene hydrochloride DME0124 XEOTICID XEO00126 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00126 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00126 DESCRIPT Raloxifene hydrochloride inhibits the expression of DME NOS2 DME0124 XEOTICID XEO00126 GENEFORM mRNA DME0124 XEOTICID XEO00126 MOACRIVE Inhibition DME0124 XEOTICID XEO00178 XEO_NAME Capsaicin DME0124 XEOTICID XEO00178 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00178 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00178 DESCRIPT Capsaicin induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00178 GENEFORM Protein DME0124 XEOTICID XEO00178 MOACRIVE Induction DME0124 XEOTICID XEO00213 XEO_NAME Aspirin DME0124 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00213 DESCRIPT Aspirin induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00213 GENEFORM Protein DME0124 XEOTICID XEO00213 MOACRIVE Induction DME0124 XEOTICID XEO00223 XEO_NAME Rifampin DME0124 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00223 DESCRIPT Rifampin up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00223 GENEFORM mRNA DME0124 XEOTICID XEO00223 MOACRIVE Induction DME0124 XEOTICID XEO00228 XEO_NAME Nitric oxide DME0124 XEOTICID XEO00228 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00228 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00228 DESCRIPT Nitric oxide induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00228 GENEFORM Protein DME0124 XEOTICID XEO00228 MOACRIVE Induction DME0124 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0124 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00241 DESCRIPT Cyclosporine induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00241 GENEFORM Protein DME0124 XEOTICID XEO00241 MOACRIVE Induction DME0124 XEOTICID XEO00257 XEO_NAME Penicillamine DME0124 XEOTICID XEO00257 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00257 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00257 DESCRIPT Penicillamine induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00257 GENEFORM Protein DME0124 XEOTICID XEO00257 MOACRIVE Induction DME0124 XEOTICID XEO00268 XEO_NAME Gadodiamide DME0124 XEOTICID XEO00268 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00268 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00268 DESCRIPT Gadodiamide induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00268 GENEFORM Protein DME0124 XEOTICID XEO00268 MOACRIVE Induction DME0124 XEOTICID XEO00278 XEO_NAME Beclomethasone dipropionate DME0124 XEOTICID XEO00278 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00278 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00278 DESCRIPT Beclomethasone dipropionate inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00278 GENEFORM Protein DME0124 XEOTICID XEO00278 MOACRIVE Inhibition DME0124 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0124 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00292 GENEFORM Protein DME0124 XEOTICID XEO00292 MOACRIVE Induction DME0124 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0124 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00312 GENEFORM mRNA DME0124 XEOTICID XEO00312 MOACRIVE Induction DME0124 XEOTICID XEO00334 XEO_NAME Cisplatin DME0124 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00334 DESCRIPT Cisplatin induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00334 GENEFORM Protein DME0124 XEOTICID XEO00334 MOACRIVE Induction DME0124 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0124 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00339 DESCRIPT Arsenic trioxide induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00339 GENEFORM Protein DME0124 XEOTICID XEO00339 MOACRIVE Induction DME0124 XEOTICID XEO00359 XEO_NAME Fluvastatin DME0124 XEOTICID XEO00359 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00359 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00359 DESCRIPT Fluvastatin induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00359 GENEFORM Protein DME0124 XEOTICID XEO00359 MOACRIVE Induction DME0124 XEOTICID XEO00366 XEO_NAME Methotrexate DME0124 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00366 DESCRIPT Methotrexate up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00366 GENEFORM mRNA DME0124 XEOTICID XEO00366 MOACRIVE Induction DME0124 XEOTICID XEO00369 XEO_NAME Naltrexone DME0124 XEOTICID XEO00369 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00369 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00369 DESCRIPT Naltrexone inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00369 GENEFORM Protein DME0124 XEOTICID XEO00369 MOACRIVE Inhibition DME0124 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0124 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00388 GENEFORM mRNA DME0124 XEOTICID XEO00388 MOACRIVE Induction DME0124 XEOTICID XEO00398 XEO_NAME Nitroprusside DME0124 XEOTICID XEO00398 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00398 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00398 DESCRIPT Nitroprusside induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00398 GENEFORM Protein DME0124 XEOTICID XEO00398 MOACRIVE Induction DME0124 XEOTICID XEO00538 XEO_NAME Quercetin DME0124 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0124 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME NOS2 DME0124 XEOTICID XEO00538 GENEFORM mRNA DME0124 XEOTICID XEO00538 MOACRIVE Inhibition DME0124 XEOTICID XEO00539 XEO_NAME Ethanol DME0124 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0124 XEOTICID XEO00539 DESCRIPT Ethanol induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00539 GENEFORM Protein DME0124 XEOTICID XEO00539 MOACRIVE Induction DME0124 XEOTICID XEO00553 XEO_NAME Spermine DME0124 XEOTICID XEO00553 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00553 XEO_CLAS Drug in Phase 1 Clinical Trial DME0124 XEOTICID XEO00553 DESCRIPT Spermine up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00553 GENEFORM mRNA DME0124 XEOTICID XEO00553 MOACRIVE Induction DME0124 XEOTICID XEO00557 XEO_NAME Genistein DME0124 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0124 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME NOS2 DME0124 XEOTICID XEO00557 GENEFORM mRNA DME0124 XEOTICID XEO00557 MOACRIVE Inhibition DME0124 XEOTICID XEO00577 XEO_NAME Pimagedine DME0124 XEOTICID XEO00577 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00577 XEO_CLAS Drug in Phase 2 Clinical Trial DME0124 XEOTICID XEO00577 DESCRIPT Pimagedine inhibits the drug-metabolizing activity of DME NOS2 (IC50 = 101 microM) DME0124 XEOTICID XEO00577 GENEFORM Protein DME0124 XEOTICID XEO00577 MOACRIVE Inhibition DME0124 XEOTICID XEO00580 XEO_NAME LY-294002 DME0124 XEOTICID XEO00580 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00580 XEO_CLAS Drug in Phase 1 Clinical Trial DME0124 XEOTICID XEO00580 DESCRIPT LY-294002 induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00580 GENEFORM Protein DME0124 XEOTICID XEO00580 MOACRIVE Induction DME0124 XEOTICID XEO00587 XEO_NAME Trichloroethylene DME0124 XEOTICID XEO00587 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00587 XEO_CLAS Drug in Phase 2 Clinical Trial DME0124 XEOTICID XEO00587 DESCRIPT Trichloroethylene up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00587 GENEFORM mRNA DME0124 XEOTICID XEO00587 MOACRIVE Induction DME0124 XEOTICID XEO00599 XEO_NAME Tetradecanoylphorbol acetate DME0124 XEOTICID XEO00599 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00599 XEO_CLAS Drug in Phase 1 Clinical Trial DME0124 XEOTICID XEO00599 DESCRIPT Tetradecanoylphorbol acetate up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00599 GENEFORM mRNA DME0124 XEOTICID XEO00599 MOACRIVE Induction DME0124 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0124 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0124 XEOTICID XEO00632 DESCRIPT Sodium arsenite induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00632 GENEFORM Protein DME0124 XEOTICID XEO00632 MOACRIVE Induction DME0124 XEOTICID XEO00648 XEO_NAME Puerarin DME0124 XEOTICID XEO00648 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00648 XEO_CLAS Drug in Phase 2 Clinical Trial DME0124 XEOTICID XEO00648 DESCRIPT Puerarin inhibits the expression of DME NOS2 DME0124 XEOTICID XEO00648 GENEFORM mRNA DME0124 XEOTICID XEO00648 MOACRIVE Inhibition DME0124 XEOTICID XEO00665 XEO_NAME Bufalin DME0124 XEOTICID XEO00665 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00665 XEO_CLAS Drug in Phase 2 Clinical Trial DME0124 XEOTICID XEO00665 DESCRIPT Bufalin inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00665 GENEFORM Protein DME0124 XEOTICID XEO00665 MOACRIVE Inhibition DME0124 XEOTICID XEO00680 XEO_NAME Lanthanum Chloride Hydroxide DME0124 XEOTICID XEO00680 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00680 XEO_CLAS Drug in Phase 1 Clinical Trial DME0124 XEOTICID XEO00680 DESCRIPT Lanthanum Chloride Hydroxide up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00680 GENEFORM mRNA DME0124 XEOTICID XEO00680 MOACRIVE Induction DME0124 XEOTICID XEO00717 XEO_NAME GGTI-298 DME0124 XEOTICID XEO00717 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00717 XEO_CLAS Preclinical/Patented Drug DME0124 XEOTICID XEO00717 DESCRIPT GGTI-298 induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00717 GENEFORM Protein DME0124 XEOTICID XEO00717 MOACRIVE Induction DME0124 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0124 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0124 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME NOS2 DME0124 XEOTICID XEO00723 GENEFORM mRNA DME0124 XEOTICID XEO00723 MOACRIVE Inhibition DME0124 XEOTICID XEO00740 XEO_NAME Lindane DME0124 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00740 DESCRIPT Lindane induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00740 GENEFORM Protein DME0124 XEOTICID XEO00740 MOACRIVE Induction DME0124 XEOTICID XEO00747 XEO_NAME Cholecalciferol DME0124 XEOTICID XEO00747 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00747 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00747 DESCRIPT Cholecalciferol inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00747 GENEFORM Protein DME0124 XEOTICID XEO00747 MOACRIVE Inhibition DME0124 XEOTICID XEO00795 XEO_NAME Galactosamine DME0124 XEOTICID XEO00795 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO00795 XEO_CLAS Health Hazard/Toxicant DME0124 XEOTICID XEO00795 DESCRIPT Galactosamine up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00795 GENEFORM mRNA DME0124 XEOTICID XEO00795 MOACRIVE Induction DME0124 XEOTICID XEO00833 XEO_NAME Ammonia N-13 DME0124 XEOTICID XEO00833 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00833 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00833 DESCRIPT Ammonia N-13 up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00833 GENEFORM mRNA DME0124 XEOTICID XEO00833 MOACRIVE Induction DME0124 XEOTICID XEO00834 XEO_NAME Copper DME0124 XEOTICID XEO00834 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO00834 XEO_CLAS Approved/Marketed Drug DME0124 XEOTICID XEO00834 DESCRIPT Copper inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00834 GENEFORM Protein DME0124 XEOTICID XEO00834 MOACRIVE Inhibition DME0124 XEOTICID XEO00858 XEO_NAME Flavonoids DME0124 XEOTICID XEO00858 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0124 XEOTICID XEO00858 XEO_CLAS Natural Mixture DME0124 XEOTICID XEO00858 DESCRIPT Flavonoids induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00858 GENEFORM Protein DME0124 XEOTICID XEO00858 MOACRIVE Induction DME0124 XEOTICID XEO00872 XEO_NAME Acetaldehyde DME0124 XEOTICID XEO00872 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO00872 XEO_CLAS Health Hazard/Toxicant DME0124 XEOTICID XEO00872 DESCRIPT Acetaldehyde induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00872 GENEFORM Protein DME0124 XEOTICID XEO00872 MOACRIVE Induction DME0124 XEOTICID XEO00896 XEO_NAME 2-naphthylamine DME0124 XEOTICID XEO00896 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO00896 XEO_CLAS Carcinogen DME0124 XEOTICID XEO00896 DESCRIPT 2-naphthylamine up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00896 GENEFORM mRNA DME0124 XEOTICID XEO00896 MOACRIVE Induction DME0124 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0124 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0124 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00898 GENEFORM Protein DME0124 XEOTICID XEO00898 MOACRIVE Induction DME0124 XEOTICID XEO00954 XEO_NAME Polyhexamethyleneguanidine DME0124 XEOTICID XEO00954 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0124 XEOTICID XEO00954 XEO_CLAS Fungicide DME0124 XEOTICID XEO00954 DESCRIPT Polyhexamethyleneguanidine up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00954 GENEFORM mRNA DME0124 XEOTICID XEO00954 MOACRIVE Induction DME0124 XEOTICID XEO00969 XEO_NAME Atrazine DME0124 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0124 XEOTICID XEO00969 XEO_CLAS Herbicide DME0124 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00969 GENEFORM Protein DME0124 XEOTICID XEO00969 MOACRIVE Inhibition DME0124 XEOTICID XEO00979 XEO_NAME Propazine DME0124 XEOTICID XEO00979 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0124 XEOTICID XEO00979 XEO_CLAS Herbicide DME0124 XEOTICID XEO00979 DESCRIPT Propazine inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00979 GENEFORM Protein DME0124 XEOTICID XEO00979 MOACRIVE Inhibition DME0124 XEOTICID XEO00980 XEO_NAME Simazine DME0124 XEOTICID XEO00980 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0124 XEOTICID XEO00980 XEO_CLAS Herbicide DME0124 XEOTICID XEO00980 DESCRIPT Simazine inhibits the expression of DME NOS2 DME0124 XEOTICID XEO00980 GENEFORM mRNA DME0124 XEOTICID XEO00980 MOACRIVE Inhibition DME0124 XEOTICID XEO00995 XEO_NAME Amphibole asbestos DME0124 XEOTICID XEO00995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0124 XEOTICID XEO00995 XEO_CLAS Natural Mixture DME0124 XEOTICID XEO00995 DESCRIPT Amphibole asbestos inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO00995 GENEFORM Protein DME0124 XEOTICID XEO00995 MOACRIVE Inhibition DME0124 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0124 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0124 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO00999 GENEFORM mRNA DME0124 XEOTICID XEO00999 MOACRIVE Induction DME0124 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0124 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0124 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME NOS2 DME0124 XEOTICID XEO01004 GENEFORM mRNA DME0124 XEOTICID XEO01004 MOACRIVE Inhibition DME0124 XEOTICID XEO01028 XEO_NAME Toluene 2,4-diisocyanate DME0124 XEOTICID XEO01028 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO01028 XEO_CLAS Acute Toxic Substance DME0124 XEOTICID XEO01028 DESCRIPT Toluene 2,4-diisocyanate up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO01028 GENEFORM mRNA DME0124 XEOTICID XEO01028 MOACRIVE Induction DME0124 XEOTICID XEO01085 XEO_NAME 7-Phloroeckol DME0124 XEOTICID XEO01085 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0124 XEOTICID XEO01085 XEO_CLAS Natural Product DME0124 XEOTICID XEO01085 DESCRIPT 7-Phloroeckol inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01085 GENEFORM Protein DME0124 XEOTICID XEO01085 MOACRIVE Inhibition DME0124 XEOTICID XEO01101 XEO_NAME PB28 DME0124 XEOTICID XEO01101 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO01101 XEO_CLAS Investigative Agent DME0124 XEOTICID XEO01101 DESCRIPT PB28 induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01101 GENEFORM Protein DME0124 XEOTICID XEO01101 MOACRIVE Induction DME0124 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0124 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0124 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01103 GENEFORM Protein DME0124 XEOTICID XEO01103 MOACRIVE Induction DME0124 XEOTICID XEO01116 XEO_NAME 25-hydroxycholesterol DME0124 XEOTICID XEO01116 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO01116 XEO_CLAS Health Hazard/Toxicant DME0124 XEOTICID XEO01116 DESCRIPT 25-hydroxycholesterol up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO01116 GENEFORM mRNA DME0124 XEOTICID XEO01116 MOACRIVE Induction DME0124 XEOTICID XEO01171 XEO_NAME 7,8-diacetoxy-4-methylcoumarin DME0124 XEOTICID XEO01171 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO01171 XEO_CLAS Investigative Agent DME0124 XEOTICID XEO01171 DESCRIPT 7,8-diacetoxy-4-methylcoumarin induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01171 GENEFORM Protein DME0124 XEOTICID XEO01171 MOACRIVE Induction DME0124 XEOTICID XEO01195 XEO_NAME Amentoflavone DME0124 XEOTICID XEO01195 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0124 XEOTICID XEO01195 XEO_CLAS Natural Product DME0124 XEOTICID XEO01195 DESCRIPT Amentof DMElavone inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01195 GENEFORM Protein DME0124 XEOTICID XEO01195 MOACRIVE Inhibition DME0124 XEOTICID XEO01213 XEO_NAME Baohuoside I DME0124 XEOTICID XEO01213 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO01213 XEO_CLAS Investigative Agent DME0124 XEOTICID XEO01213 DESCRIPT Baohuoside I inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01213 GENEFORM Protein DME0124 XEOTICID XEO01213 MOACRIVE Inhibition DME0124 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0124 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0124 XEOTICID XEO01226 DESCRIPT Bisphenol A induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01226 GENEFORM Protein DME0124 XEOTICID XEO01226 MOACRIVE Induction DME0124 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0124 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0124 XEOTICID XEO01248 DESCRIPT Chlorpyrifos induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01248 GENEFORM Protein DME0124 XEOTICID XEO01248 MOACRIVE Induction DME0124 XEOTICID XEO01263 XEO_NAME CR-3294 DME0124 XEOTICID XEO01263 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO01263 XEO_CLAS Preclinical/Patented Drug DME0124 XEOTICID XEO01263 DESCRIPT CR-3294 inhibits the expression of DME NOS2 DME0124 XEOTICID XEO01263 GENEFORM mRNA DME0124 XEOTICID XEO01263 MOACRIVE Inhibition DME0124 XEOTICID XEO01276 XEO_NAME Dieckol DME0124 XEOTICID XEO01276 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO01276 XEO_CLAS Drug in Phase 1 Clinical Trial DME0124 XEOTICID XEO01276 DESCRIPT Dieckol inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01276 GENEFORM Protein DME0124 XEOTICID XEO01276 MOACRIVE Inhibition DME0124 XEOTICID XEO01353 XEO_NAME Kaempferol DME0124 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME0124 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01353 GENEFORM Protein DME0124 XEOTICID XEO01353 MOACRIVE Inhibition DME0124 XEOTICID XEO01369 XEO_NAME Lithium chloride DME0124 XEOTICID XEO01369 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO01369 XEO_CLAS Health Hazard/Toxicant DME0124 XEOTICID XEO01369 DESCRIPT Lithium chloride up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO01369 GENEFORM mRNA DME0124 XEOTICID XEO01369 MOACRIVE Induction DME0124 XEOTICID XEO01418 XEO_NAME Oxidopamine DME0124 XEOTICID XEO01418 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO01418 XEO_CLAS Investigative Agent DME0124 XEOTICID XEO01418 DESCRIPT Oxidopamine induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01418 GENEFORM Protein DME0124 XEOTICID XEO01418 MOACRIVE Induction DME0124 XEOTICID XEO01420 XEO_NAME Palmitic acid DME0124 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME0124 XEOTICID XEO01420 DESCRIPT Palmitic acid up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO01420 GENEFORM mRNA DME0124 XEOTICID XEO01420 MOACRIVE Induction DME0124 XEOTICID XEO01422 XEO_NAME Paraquat DME0124 XEOTICID XEO01422 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO01422 XEO_CLAS Acute Toxic Substance DME0124 XEOTICID XEO01422 DESCRIPT Paraquat induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01422 GENEFORM Protein DME0124 XEOTICID XEO01422 MOACRIVE Induction DME0124 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0124 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0124 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0124 XEOTICID XEO01492 DESCRIPT Trichostatin A inhibits the expression of DME NOS2 DME0124 XEOTICID XEO01492 GENEFORM mRNA DME0124 XEOTICID XEO01492 MOACRIVE Inhibition DME0124 XEOTICID XEO01503 XEO_NAME Cadmium DME0124 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0124 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO01503 GENEFORM mRNA DME0124 XEOTICID XEO01503 MOACRIVE Induction DME0124 XEOTICID XEO01504 XEO_NAME Gold DME0124 XEOTICID XEO01504 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0124 XEOTICID XEO01504 XEO_CLAS Chemical Compound DME0124 XEOTICID XEO01504 DESCRIPT Gold induces the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01504 GENEFORM Protein DME0124 XEOTICID XEO01504 MOACRIVE Induction DME0124 XEOTICID XEO01506 XEO_NAME Lead chloride DME0124 XEOTICID XEO01506 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO01506 XEO_CLAS Health Hazard/Toxicant DME0124 XEOTICID XEO01506 DESCRIPT Lead chloride inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01506 GENEFORM Protein DME0124 XEOTICID XEO01506 MOACRIVE Inhibition DME0124 XEOTICID XEO01514 XEO_NAME Deoxynivalenol DME0124 XEOTICID XEO01514 XEO_TYPE Health or Environmental Toxicant(s) DME0124 XEOTICID XEO01514 XEO_CLAS Mycotoxin DME0124 XEOTICID XEO01514 DESCRIPT Deoxynivalenol up-regulates the expression of DME NOS2 DME0124 XEOTICID XEO01514 GENEFORM mRNA DME0124 XEOTICID XEO01514 MOACRIVE Induction DME0124 XEOTICID XEO01537 XEO_NAME Deguelin DME0124 XEOTICID XEO01537 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0124 XEOTICID XEO01537 XEO_CLAS Natural Product DME0124 XEOTICID XEO01537 DESCRIPT Deguelin inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01537 GENEFORM Protein DME0124 XEOTICID XEO01537 MOACRIVE Inhibition DME0124 XEOTICID XEO01570 XEO_NAME Osajin DME0124 XEOTICID XEO01570 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0124 XEOTICID XEO01570 XEO_CLAS Natural Product DME0124 XEOTICID XEO01570 DESCRIPT Osajin inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01570 GENEFORM Protein DME0124 XEOTICID XEO01570 MOACRIVE Inhibition DME0124 XEOTICID XEO01574 XEO_NAME Plant extracts DME0124 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0124 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0124 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME NOS2 DME0124 XEOTICID XEO01574 GENEFORM Protein DME0124 XEOTICID XEO01574 MOACRIVE Inhibition DME0124 XEOTICID XEO01590 XEO_NAME Sulphoraphene DME0124 XEOTICID XEO01590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0124 XEOTICID XEO01590 XEO_CLAS Natural Product DME0124 XEOTICID XEO01590 DESCRIPT Sulphoraphene inhibits the expression of DME NOS2 and leads to decreasing the drug-metabolizing activity of this enzyme DME0124 XEOTICID XEO01590 GENEFORM Protein DME0124 XEOTICID XEO01590 MOACRIVE Inhibition DME0125 DME___ID DME0125 DME0125 DME_NAME DOPA decarboxylase (DDC) DME0125 SPESNAME Homo sapiens DME0125 XEOTICID XEO00007 XEO_NAME Azathioprine DME0125 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0125 XEOTICID XEO00007 DESCRIPT Azathioprine inhibits the expression of DME DDC DME0125 XEOTICID XEO00007 GENEFORM mRNA DME0125 XEOTICID XEO00007 MOACRIVE Inhibition DME0125 XEOTICID XEO00079 XEO_NAME Vorinostat DME0125 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0125 XEOTICID XEO00079 DESCRIPT Vorinostat inhibits the expression of DME DDC DME0125 XEOTICID XEO00079 GENEFORM mRNA DME0125 XEOTICID XEO00079 MOACRIVE Inhibition DME0125 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0125 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0125 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME DDC DME0125 XEOTICID XEO00117 GENEFORM mRNA DME0125 XEOTICID XEO00117 MOACRIVE Inhibition DME0125 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0125 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0125 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME DDC DME0125 XEOTICID XEO00186 GENEFORM mRNA DME0125 XEOTICID XEO00186 MOACRIVE Inhibition DME0125 XEOTICID XEO00193 XEO_NAME Belinostat DME0125 XEOTICID XEO00193 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00193 XEO_CLAS Approved/Marketed Drug DME0125 XEOTICID XEO00193 DESCRIPT Belinostat inhibits the expression of DME DDC DME0125 XEOTICID XEO00193 GENEFORM mRNA DME0125 XEOTICID XEO00193 MOACRIVE Inhibition DME0125 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0125 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0125 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME DDC DME0125 XEOTICID XEO00217 GENEFORM mRNA DME0125 XEOTICID XEO00217 MOACRIVE Inhibition DME0125 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0125 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0125 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME DDC DME0125 XEOTICID XEO00241 GENEFORM mRNA DME0125 XEOTICID XEO00241 MOACRIVE Inhibition DME0125 XEOTICID XEO00253 XEO_NAME Tretinoin DME0125 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0125 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the drug-metabolizing activity of DME DDC DME0125 XEOTICID XEO00253 GENEFORM Protein DME0125 XEOTICID XEO00253 MOACRIVE Inhibition DME0125 XEOTICID XEO00435 XEO_NAME Urethane DME0125 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0125 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME DDC DME0125 XEOTICID XEO00435 GENEFORM mRNA DME0125 XEOTICID XEO00435 MOACRIVE Inhibition DME0125 XEOTICID XEO00512 XEO_NAME Benserazide + levodopa DME0125 XEOTICID XEO00512 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00512 XEO_CLAS Approved/Marketed Drug DME0125 XEOTICID XEO00512 DESCRIPT Benserazide + levodopa inhibits the drug-metabolizing activity of DME DDC DME0125 XEOTICID XEO00512 GENEFORM Protein DME0125 XEOTICID XEO00512 MOACRIVE Inhibition DME0125 XEOTICID XEO00538 XEO_NAME Quercetin DME0125 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0125 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME DDC DME0125 XEOTICID XEO00538 GENEFORM mRNA DME0125 XEOTICID XEO00538 MOACRIVE Inhibition DME0125 XEOTICID XEO00557 XEO_NAME Genistein DME0125 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0125 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME DDC DME0125 XEOTICID XEO00557 GENEFORM mRNA DME0125 XEOTICID XEO00557 MOACRIVE Induction DME0125 XEOTICID XEO00581 XEO_NAME MS-275 DME0125 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0125 XEOTICID XEO00581 DESCRIPT MS-275 inhibits the expression of DME DDC DME0125 XEOTICID XEO00581 GENEFORM mRNA DME0125 XEOTICID XEO00581 MOACRIVE Inhibition DME0125 XEOTICID XEO00684 XEO_NAME Carbidopa + levodopa DME0125 XEOTICID XEO00684 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00684 XEO_CLAS Drug in Phase 2 Clinical Trial DME0125 XEOTICID XEO00684 DESCRIPT Carbidopa + levodopa inhibits the drug-metabolizing activity of DME DDC DME0125 XEOTICID XEO00684 GENEFORM Protein DME0125 XEOTICID XEO00684 MOACRIVE Inhibition DME0125 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0125 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0125 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME DDC DME0125 XEOTICID XEO00723 GENEFORM mRNA DME0125 XEOTICID XEO00723 MOACRIVE Inhibition DME0125 XEOTICID XEO00779 XEO_NAME Sarin DME0125 XEOTICID XEO00779 XEO_TYPE Health or Environmental Toxicant(s) DME0125 XEOTICID XEO00779 XEO_CLAS Acute Toxic Substance DME0125 XEOTICID XEO00779 DESCRIPT Sarin inhibits the drug-metabolizing activity of DME DDC DME0125 XEOTICID XEO00779 GENEFORM Protein DME0125 XEOTICID XEO00779 MOACRIVE Inhibition DME0125 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0125 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0125 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0125 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME DDC DME0125 XEOTICID XEO00806 GENEFORM mRNA DME0125 XEOTICID XEO00806 MOACRIVE Inhibition DME0125 XEOTICID XEO00809 XEO_NAME Thapsigargin DME0125 XEOTICID XEO00809 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0125 XEOTICID XEO00809 XEO_CLAS Natural Product DME0125 XEOTICID XEO00809 DESCRIPT Thapsigargin inhibits the expression of DME DDC DME0125 XEOTICID XEO00809 GENEFORM mRNA DME0125 XEOTICID XEO00809 MOACRIVE Inhibition DME0125 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0125 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0125 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0125 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME DDC DME0125 XEOTICID XEO00898 GENEFORM mRNA DME0125 XEOTICID XEO00898 MOACRIVE Inhibition DME0125 XEOTICID XEO00969 XEO_NAME Atrazine DME0125 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0125 XEOTICID XEO00969 XEO_CLAS Herbicide DME0125 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME DDC DME0125 XEOTICID XEO00969 GENEFORM mRNA DME0125 XEOTICID XEO00969 MOACRIVE Inhibition DME0125 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0125 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0125 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0125 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME DDC DME0125 XEOTICID XEO01031 GENEFORM mRNA DME0125 XEOTICID XEO01031 MOACRIVE Inhibition DME0125 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0125 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0125 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0125 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the drug-metabolizing activity of DME DDC DME0125 XEOTICID XEO01119 GENEFORM Protein DME0125 XEOTICID XEO01119 MOACRIVE Inhibition DME0125 XEOTICID XEO01348 XEO_NAME K-7174 DME0125 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0125 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0125 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME DDC DME0125 XEOTICID XEO01348 GENEFORM mRNA DME0125 XEOTICID XEO01348 MOACRIVE Inhibition DME0126 DME___ID DME0126 DME0126 DME_NAME L-glutamine amidohydrolase (GLS) DME0126 SPESNAME Homo sapiens DME0126 XEOTICID XEO00018 XEO_NAME Cyclophosphamide DME0126 XEOTICID XEO00018 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00018 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00018 DESCRIPT Cyclophosphamide up-regulates the expression of DME GLS DME0126 XEOTICID XEO00018 GENEFORM mRNA DME0126 XEOTICID XEO00018 MOACRIVE Induction DME0126 XEOTICID XEO00029 XEO_NAME Valproic acid DME0126 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME GLS DME0126 XEOTICID XEO00029 GENEFORM mRNA DME0126 XEOTICID XEO00029 MOACRIVE Inhibition DME0126 XEOTICID XEO00047 XEO_NAME Indomethacin DME0126 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00047 DESCRIPT Indomethacin inhibits the expression of DME GLS DME0126 XEOTICID XEO00047 GENEFORM mRNA DME0126 XEOTICID XEO00047 MOACRIVE Inhibition DME0126 XEOTICID XEO00079 XEO_NAME Vorinostat DME0126 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00079 DESCRIPT Vorinostat up-regulates the expression of DME GLS DME0126 XEOTICID XEO00079 GENEFORM mRNA DME0126 XEOTICID XEO00079 MOACRIVE Induction DME0126 XEOTICID XEO00086 XEO_NAME Troglitazone DME0126 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME GLS DME0126 XEOTICID XEO00086 GENEFORM mRNA DME0126 XEOTICID XEO00086 MOACRIVE Induction DME0126 XEOTICID XEO00090 XEO_NAME Estradiol DME0126 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00090 DESCRIPT Estradiol induces the drug-metabolizing activity of DME GLS DME0126 XEOTICID XEO00090 GENEFORM Protein DME0126 XEOTICID XEO00090 MOACRIVE Induction DME0126 XEOTICID XEO00097 XEO_NAME Cytarabine DME0126 XEOTICID XEO00097 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00097 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00097 DESCRIPT Cytarabine inhibits the expression of DME GLS DME0126 XEOTICID XEO00097 GENEFORM mRNA DME0126 XEOTICID XEO00097 MOACRIVE Inhibition DME0126 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0126 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME GLS DME0126 XEOTICID XEO00117 GENEFORM mRNA DME0126 XEOTICID XEO00117 MOACRIVE Induction DME0126 XEOTICID XEO00184 XEO_NAME Calcitriol DME0126 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME GLS DME0126 XEOTICID XEO00184 GENEFORM mRNA DME0126 XEOTICID XEO00184 MOACRIVE Inhibition DME0126 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0126 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME GLS DME0126 XEOTICID XEO00217 GENEFORM mRNA DME0126 XEOTICID XEO00217 MOACRIVE Induction DME0126 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0126 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME GLS DME0126 XEOTICID XEO00241 GENEFORM mRNA DME0126 XEOTICID XEO00241 MOACRIVE Inhibition DME0126 XEOTICID XEO00253 XEO_NAME Tretinoin DME0126 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME GLS DME0126 XEOTICID XEO00253 GENEFORM mRNA DME0126 XEOTICID XEO00253 MOACRIVE Induction DME0126 XEOTICID XEO00334 XEO_NAME Cisplatin DME0126 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME GLS DME0126 XEOTICID XEO00334 GENEFORM mRNA DME0126 XEOTICID XEO00334 MOACRIVE Inhibition DME0126 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0126 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME GLS DME0126 XEOTICID XEO00339 GENEFORM mRNA DME0126 XEOTICID XEO00339 MOACRIVE Induction DME0126 XEOTICID XEO00365 XEO_NAME Metformin DME0126 XEOTICID XEO00365 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00365 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00365 DESCRIPT Metformin inhibits the drug-metabolizing activity of DME GLS DME0126 XEOTICID XEO00365 GENEFORM Protein DME0126 XEOTICID XEO00365 MOACRIVE Inhibition DME0126 XEOTICID XEO00366 XEO_NAME Methotrexate DME0126 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00366 DESCRIPT Methotrexate inhibits the expression of DME GLS DME0126 XEOTICID XEO00366 GENEFORM mRNA DME0126 XEOTICID XEO00366 MOACRIVE Inhibition DME0126 XEOTICID XEO00408 XEO_NAME Zinc acetate DME0126 XEOTICID XEO00408 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00408 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00408 DESCRIPT Zinc acetate inhibits the expression of DME GLS DME0126 XEOTICID XEO00408 GENEFORM mRNA DME0126 XEOTICID XEO00408 MOACRIVE Inhibition DME0126 XEOTICID XEO00435 XEO_NAME Urethane DME0126 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00435 DESCRIPT Urethane up-regulates the expression of DME GLS DME0126 XEOTICID XEO00435 GENEFORM mRNA DME0126 XEOTICID XEO00435 MOACRIVE Induction DME0126 XEOTICID XEO00466 XEO_NAME Demecolcine DME0126 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0126 XEOTICID XEO00466 DESCRIPT Demecolcine up-regulates the expression of DME GLS DME0126 XEOTICID XEO00466 GENEFORM mRNA DME0126 XEOTICID XEO00466 MOACRIVE Induction DME0126 XEOTICID XEO00541 XEO_NAME Motexafin gadolinium DME0126 XEOTICID XEO00541 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00541 XEO_CLAS Drug in Phase 2 Clinical Trial DME0126 XEOTICID XEO00541 DESCRIPT Motexafin gadolinium inhibits the drug-metabolizing activity of DME GLS DME0126 XEOTICID XEO00541 GENEFORM Protein DME0126 XEOTICID XEO00541 MOACRIVE Inhibition DME0126 XEOTICID XEO00557 XEO_NAME Genistein DME0126 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0126 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME GLS DME0126 XEOTICID XEO00557 GENEFORM mRNA DME0126 XEOTICID XEO00557 MOACRIVE Inhibition DME0126 XEOTICID XEO00649 XEO_NAME Geldanamycin DME0126 XEOTICID XEO00649 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00649 XEO_CLAS Drug in Phase 1 Clinical Trial DME0126 XEOTICID XEO00649 DESCRIPT Geldanamycin up-regulates the expression of DME GLS DME0126 XEOTICID XEO00649 GENEFORM mRNA DME0126 XEOTICID XEO00649 MOACRIVE Induction DME0126 XEOTICID XEO00681 XEO_NAME CB-839 DME0126 XEOTICID XEO00681 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00681 XEO_CLAS Drug in Phase 1 Clinical Trial DME0126 XEOTICID XEO00681 DESCRIPT CB-839 inhibits the drug-metabolizing activity of DME GLS (IC50 = 0.005 microM) DME0126 XEOTICID XEO00681 GENEFORM Protein DME0126 XEOTICID XEO00681 MOACRIVE Inhibition DME0126 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0126 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0126 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME GLS DME0126 XEOTICID XEO00723 GENEFORM mRNA DME0126 XEOTICID XEO00723 MOACRIVE Induction DME0126 XEOTICID XEO00760 XEO_NAME Jinfukang DME0126 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0126 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0126 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME GLS DME0126 XEOTICID XEO00760 GENEFORM mRNA DME0126 XEOTICID XEO00760 MOACRIVE Inhibition DME0126 XEOTICID XEO00779 XEO_NAME Sarin DME0126 XEOTICID XEO00779 XEO_TYPE Health or Environmental Toxicant(s) DME0126 XEOTICID XEO00779 XEO_CLAS Acute Toxic Substance DME0126 XEOTICID XEO00779 DESCRIPT Sarin inhibits the drug-metabolizing activity of DME GLS DME0126 XEOTICID XEO00779 GENEFORM Protein DME0126 XEOTICID XEO00779 MOACRIVE Inhibition DME0126 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0126 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0126 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0126 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME GLS DME0126 XEOTICID XEO00806 GENEFORM mRNA DME0126 XEOTICID XEO00806 MOACRIVE Induction DME0126 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0126 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0126 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME GLS DME0126 XEOTICID XEO00818 GENEFORM mRNA DME0126 XEOTICID XEO00818 MOACRIVE Induction DME0126 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0126 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0126 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0126 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME GLS DME0126 XEOTICID XEO00898 GENEFORM mRNA DME0126 XEOTICID XEO00898 MOACRIVE Induction DME0126 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0126 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0126 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0126 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME GLS DME0126 XEOTICID XEO00999 GENEFORM mRNA DME0126 XEOTICID XEO00999 MOACRIVE Induction DME0126 XEOTICID XEO01215 XEO_NAME Benzenearsonic acid DME0126 XEOTICID XEO01215 XEO_TYPE Health or Environmental Toxicant(s) DME0126 XEOTICID XEO01215 XEO_CLAS Acute Toxic Substance DME0126 XEOTICID XEO01215 DESCRIPT Benzenearsonic acid inhibits the drug-metabolizing activity of DME GLS DME0126 XEOTICID XEO01215 GENEFORM Protein DME0126 XEOTICID XEO01215 MOACRIVE Inhibition DME0126 XEOTICID XEO01232 XEO_NAME Caffeic acid DME0126 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME0126 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME0126 XEOTICID XEO01232 DESCRIPT Caffeic acid induces the drug-metabolizing activity of DME GLS DME0126 XEOTICID XEO01232 GENEFORM Protein DME0126 XEOTICID XEO01232 MOACRIVE Induction DME0126 XEOTICID XEO01261 XEO_NAME Coumestrol DME0126 XEOTICID XEO01261 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO01261 XEO_CLAS Investigative Agent DME0126 XEOTICID XEO01261 DESCRIPT Coumestrol inhibits the expression of DME GLS DME0126 XEOTICID XEO01261 GENEFORM mRNA DME0126 XEOTICID XEO01261 MOACRIVE Inhibition DME0126 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0126 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0126 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0126 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME GLS DME0126 XEOTICID XEO01305 GENEFORM mRNA DME0126 XEOTICID XEO01305 MOACRIVE Induction DME0126 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0126 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0126 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0126 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME GLS DME0126 XEOTICID XEO01492 GENEFORM mRNA DME0126 XEOTICID XEO01492 MOACRIVE Induction DME0126 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0126 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0126 XEOTICID XEO01494 XEO_CLAS Natural Product DME0126 XEOTICID XEO01494 DESCRIPT Tunicamycin A up-regulates the expression of DME GLS DME0126 XEOTICID XEO01494 GENEFORM mRNA DME0126 XEOTICID XEO01494 MOACRIVE Induction DME0126 XEOTICID XEO01551 XEO_NAME Heliotrine DME0126 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0126 XEOTICID XEO01551 XEO_CLAS Natural Product DME0126 XEOTICID XEO01551 DESCRIPT Heliotrine up-regulates the expression of DME GLS DME0126 XEOTICID XEO01551 GENEFORM mRNA DME0126 XEOTICID XEO01551 MOACRIVE Induction DME0127 DME___ID DME0127 DME0127 DME_NAME Alcohol dehydrogenase class-I alpha (ADH1A) DME0127 SPESNAME Homo sapiens DME0127 XEOTICID XEO00029 XEO_NAME Valproic acid DME0127 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0127 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0127 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME ADH1A DME0127 XEOTICID XEO00029 GENEFORM mRNA DME0127 XEOTICID XEO00029 MOACRIVE Inhibition DME0127 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0127 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0127 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0127 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME ADH1A DME0127 XEOTICID XEO00088 GENEFORM mRNA DME0127 XEOTICID XEO00088 MOACRIVE Induction DME0127 XEOTICID XEO00090 XEO_NAME Estradiol DME0127 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0127 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0127 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME ADH1A DME0127 XEOTICID XEO00090 GENEFORM mRNA DME0127 XEOTICID XEO00090 MOACRIVE Inhibition DME0127 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0127 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0127 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0127 XEOTICID XEO00140 DESCRIPT Zoledronic acid inhibits the expression of DME ADH1A DME0127 XEOTICID XEO00140 GENEFORM mRNA DME0127 XEOTICID XEO00140 MOACRIVE Inhibition DME0127 XEOTICID XEO00148 XEO_NAME Bosentan DME0127 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0127 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0127 XEOTICID XEO00148 DESCRIPT Bosentan inhibits the drug-metabolizing activity of DME ADH1A DME0127 XEOTICID XEO00148 GENEFORM Protein DME0127 XEOTICID XEO00148 MOACRIVE Inhibition DME0127 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0127 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0127 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0127 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME ADH1A DME0127 XEOTICID XEO00217 GENEFORM mRNA DME0127 XEOTICID XEO00217 MOACRIVE Induction DME0127 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0127 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0127 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0127 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME ADH1A DME0127 XEOTICID XEO00241 GENEFORM mRNA DME0127 XEOTICID XEO00241 MOACRIVE Induction DME0127 XEOTICID XEO00253 XEO_NAME Tretinoin DME0127 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0127 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0127 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME ADH1A DME0127 XEOTICID XEO00253 GENEFORM mRNA DME0127 XEOTICID XEO00253 MOACRIVE Induction DME0127 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0127 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0127 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0127 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME ADH1A DME0127 XEOTICID XEO00339 GENEFORM mRNA DME0127 XEOTICID XEO00339 MOACRIVE Induction DME0127 XEOTICID XEO00401 XEO_NAME Beta carotene DME0127 XEOTICID XEO00401 XEO_TYPE Pharmaceutical Agent(s) DME0127 XEOTICID XEO00401 XEO_CLAS Approved/Marketed Drug DME0127 XEOTICID XEO00401 DESCRIPT Beta carotene up-regulates the expression of DME ADH1A DME0127 XEOTICID XEO00401 GENEFORM mRNA DME0127 XEOTICID XEO00401 MOACRIVE Induction DME0127 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0127 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0127 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0127 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME ADH1A DME0127 XEOTICID XEO00410 GENEFORM Protein DME0127 XEOTICID XEO00410 MOACRIVE Inhibition DME0127 XEOTICID XEO00539 XEO_NAME Ethanol DME0127 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0127 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0127 XEOTICID XEO00539 DESCRIPT Ethanol induces the drug-metabolizing activity of DME ADH1A DME0127 XEOTICID XEO00539 GENEFORM Protein DME0127 XEOTICID XEO00539 MOACRIVE Induction DME0127 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0127 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0127 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0127 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME ADH1A DME0127 XEOTICID XEO00806 GENEFORM mRNA DME0127 XEOTICID XEO00806 MOACRIVE Inhibition DME0127 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0127 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0127 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0127 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME ADH1A DME0127 XEOTICID XEO00905 GENEFORM mRNA DME0127 XEOTICID XEO00905 MOACRIVE Inhibition DME0127 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0127 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0127 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0127 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME ADH1A DME0127 XEOTICID XEO00999 GENEFORM mRNA DME0127 XEOTICID XEO00999 MOACRIVE Induction DME0127 XEOTICID XEO01074 XEO_NAME Endosulfan DME0127 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0127 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0127 XEOTICID XEO01074 DESCRIPT Endosulfan inhibits the expression of DME ADH1A DME0127 XEOTICID XEO01074 GENEFORM mRNA DME0127 XEOTICID XEO01074 MOACRIVE Inhibition DME0127 XEOTICID XEO01523 XEO_NAME Apocarotenal DME0127 XEOTICID XEO01523 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0127 XEOTICID XEO01523 XEO_CLAS Natural Product DME0127 XEOTICID XEO01523 DESCRIPT Apocarotenal up-regulates the expression of DME ADH1A DME0127 XEOTICID XEO01523 GENEFORM mRNA DME0127 XEOTICID XEO01523 MOACRIVE Induction DME0127 XEOTICID XEO01582 XEO_NAME Pyrrolizidine alkaloid DME0127 XEOTICID XEO01582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0127 XEOTICID XEO01582 XEO_CLAS Natural Product DME0127 XEOTICID XEO01582 DESCRIPT Pyrrolizidine alkaloid inhibits the drug-metabolizing activity of DME ADH1A DME0127 XEOTICID XEO01582 GENEFORM Protein DME0127 XEOTICID XEO01582 MOACRIVE Inhibition DME0128 DME___ID DME0128 DME0128 DME_NAME Alcohol dehydrogenase class-I beta (ADH1B) DME0128 SPESNAME Homo sapiens DME0128 XEOTICID XEO00029 XEO_NAME Valproic acid DME0128 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0128 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0128 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME ADH1B DME0128 XEOTICID XEO00029 GENEFORM mRNA DME0128 XEOTICID XEO00029 MOACRIVE Induction DME0128 XEOTICID XEO00053 XEO_NAME Leflunomide DME0128 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0128 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0128 XEOTICID XEO00053 DESCRIPT Leflunomide inhibits the expression of DME ADH1B DME0128 XEOTICID XEO00053 GENEFORM mRNA DME0128 XEOTICID XEO00053 MOACRIVE Inhibition DME0128 XEOTICID XEO00079 XEO_NAME Vorinostat DME0128 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0128 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0128 XEOTICID XEO00079 DESCRIPT Vorinostat inhibits the drug-metabolizing activity of DME ADH1B DME0128 XEOTICID XEO00079 GENEFORM Protein DME0128 XEOTICID XEO00079 MOACRIVE Inhibition DME0128 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0128 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0128 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0128 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME ADH1B DME0128 XEOTICID XEO00088 GENEFORM mRNA DME0128 XEOTICID XEO00088 MOACRIVE Induction DME0128 XEOTICID XEO00090 XEO_NAME Estradiol DME0128 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0128 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0128 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME ADH1B DME0128 XEOTICID XEO00090 GENEFORM mRNA DME0128 XEOTICID XEO00090 MOACRIVE Inhibition DME0128 XEOTICID XEO00094 XEO_NAME Progesterone DME0128 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0128 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0128 XEOTICID XEO00094 DESCRIPT Progesterone induces the drug-metabolizing activity of DME ADH1B DME0128 XEOTICID XEO00094 GENEFORM Protein DME0128 XEOTICID XEO00094 MOACRIVE Induction DME0128 XEOTICID XEO00148 XEO_NAME Bosentan DME0128 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0128 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0128 XEOTICID XEO00148 DESCRIPT Bosentan inhibits the drug-metabolizing activity of DME ADH1B DME0128 XEOTICID XEO00148 GENEFORM Protein DME0128 XEOTICID XEO00148 MOACRIVE Inhibition DME0128 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0128 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0128 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0128 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME ADH1B DME0128 XEOTICID XEO00241 GENEFORM mRNA DME0128 XEOTICID XEO00241 MOACRIVE Inhibition DME0128 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0128 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0128 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0128 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME ADH1B DME0128 XEOTICID XEO00410 GENEFORM Protein DME0128 XEOTICID XEO00410 MOACRIVE Inhibition DME0128 XEOTICID XEO00539 XEO_NAME Ethanol DME0128 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0128 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0128 XEOTICID XEO00539 DESCRIPT Ethanol up-regulates the expression of DME ADH1B DME0128 XEOTICID XEO00539 GENEFORM mRNA DME0128 XEOTICID XEO00539 MOACRIVE Induction DME0128 XEOTICID XEO00581 XEO_NAME MS-275 DME0128 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0128 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0128 XEOTICID XEO00581 DESCRIPT MS-275 inhibits the expression of DME ADH1B DME0128 XEOTICID XEO00581 GENEFORM mRNA DME0128 XEOTICID XEO00581 MOACRIVE Inhibition DME0128 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0128 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0128 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0128 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME ADH1B DME0128 XEOTICID XEO00632 GENEFORM mRNA DME0128 XEOTICID XEO00632 MOACRIVE Inhibition DME0128 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0128 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0128 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0128 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME ADH1B DME0128 XEOTICID XEO00806 GENEFORM mRNA DME0128 XEOTICID XEO00806 MOACRIVE Inhibition DME0128 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0128 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0128 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0128 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME ADH1B DME0128 XEOTICID XEO00821 GENEFORM mRNA DME0128 XEOTICID XEO00821 MOACRIVE Inhibition DME0128 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0128 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0128 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0128 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME ADH1B DME0128 XEOTICID XEO00905 GENEFORM mRNA DME0128 XEOTICID XEO00905 MOACRIVE Inhibition DME0128 XEOTICID XEO01074 XEO_NAME Endosulfan DME0128 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0128 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0128 XEOTICID XEO01074 DESCRIPT Endosulfan inhibits the expression of DME ADH1B DME0128 XEOTICID XEO01074 GENEFORM mRNA DME0128 XEOTICID XEO01074 MOACRIVE Inhibition DME0128 XEOTICID XEO01302 XEO_NAME Fipronil DME0128 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0128 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0128 XEOTICID XEO01302 DESCRIPT Fipronil inhibits the expression of DME ADH1B DME0128 XEOTICID XEO01302 GENEFORM mRNA DME0128 XEOTICID XEO01302 MOACRIVE Inhibition DME0128 XEOTICID XEO01498 XEO_NAME Walrycin A DME0128 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0128 XEOTICID XEO01498 XEO_CLAS Natural Product DME0128 XEOTICID XEO01498 DESCRIPT Walrycin A up-regulates the expression of DME ADH1B DME0128 XEOTICID XEO01498 GENEFORM mRNA DME0128 XEOTICID XEO01498 MOACRIVE Induction DME0128 XEOTICID XEO01505 XEO_NAME Lead DME0128 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0128 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0128 XEOTICID XEO01505 DESCRIPT Lead inhibits the expression of DME ADH1B DME0128 XEOTICID XEO01505 GENEFORM mRNA DME0128 XEOTICID XEO01505 MOACRIVE Inhibition DME0129 DME___ID DME0129 DME0129 DME_NAME Alcohol dehydrogenase class-I gamma (ADH1C) DME0129 SPESNAME Homo sapiens DME0129 XEOTICID XEO00029 XEO_NAME Valproic acid DME0129 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0129 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0129 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME ADH1C DME0129 XEOTICID XEO00029 GENEFORM mRNA DME0129 XEOTICID XEO00029 MOACRIVE Inhibition DME0129 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0129 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0129 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0129 XEOTICID XEO00035 DESCRIPT Fenofibrate inhibits the expression of DME ADH1C DME0129 XEOTICID XEO00035 GENEFORM mRNA DME0129 XEOTICID XEO00035 MOACRIVE Inhibition DME0129 XEOTICID XEO00086 XEO_NAME Troglitazone DME0129 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0129 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0129 XEOTICID XEO00086 DESCRIPT Troglitazone inhibits the expression of DME ADH1C DME0129 XEOTICID XEO00086 GENEFORM mRNA DME0129 XEOTICID XEO00086 MOACRIVE Inhibition DME0129 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0129 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0129 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0129 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME ADH1C DME0129 XEOTICID XEO00088 GENEFORM mRNA DME0129 XEOTICID XEO00088 MOACRIVE Induction DME0129 XEOTICID XEO00090 XEO_NAME Estradiol DME0129 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0129 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0129 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME ADH1C DME0129 XEOTICID XEO00090 GENEFORM mRNA DME0129 XEOTICID XEO00090 MOACRIVE Inhibition DME0129 XEOTICID XEO00094 XEO_NAME Progesterone DME0129 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0129 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0129 XEOTICID XEO00094 DESCRIPT Progesterone up-regulates the expression of DME ADH1C DME0129 XEOTICID XEO00094 GENEFORM mRNA DME0129 XEOTICID XEO00094 MOACRIVE Induction DME0129 XEOTICID XEO00148 XEO_NAME Bosentan DME0129 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0129 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0129 XEOTICID XEO00148 DESCRIPT Bosentan inhibits the drug-metabolizing activity of DME ADH1C DME0129 XEOTICID XEO00148 GENEFORM Protein DME0129 XEOTICID XEO00148 MOACRIVE Inhibition DME0129 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0129 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0129 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0129 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ADH1C DME0129 XEOTICID XEO00217 GENEFORM mRNA DME0129 XEOTICID XEO00217 MOACRIVE Inhibition DME0129 XEOTICID XEO00223 XEO_NAME Rifampin DME0129 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0129 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0129 XEOTICID XEO00223 DESCRIPT Rifampin induces the drug-metabolizing activity of DME ADH1C DME0129 XEOTICID XEO00223 GENEFORM Protein DME0129 XEOTICID XEO00223 MOACRIVE Induction DME0129 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0129 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0129 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0129 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME ADH1C DME0129 XEOTICID XEO00241 GENEFORM mRNA DME0129 XEOTICID XEO00241 MOACRIVE Inhibition DME0129 XEOTICID XEO00539 XEO_NAME Ethanol DME0129 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0129 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0129 XEOTICID XEO00539 DESCRIPT Ethanol up-regulates the expression of DME ADH1C DME0129 XEOTICID XEO00539 GENEFORM mRNA DME0129 XEOTICID XEO00539 MOACRIVE Induction DME0129 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0129 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0129 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0129 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the drug-metabolizing activity of DME ADH1C DME0129 XEOTICID XEO00632 GENEFORM Protein DME0129 XEOTICID XEO00632 MOACRIVE Inhibition DME0129 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0129 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0129 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0129 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME ADH1C DME0129 XEOTICID XEO00806 GENEFORM mRNA DME0129 XEOTICID XEO00806 MOACRIVE Inhibition DME0129 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0129 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0129 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0129 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME ADH1C DME0129 XEOTICID XEO01226 GENEFORM mRNA DME0129 XEOTICID XEO01226 MOACRIVE Induction DME0130 DME___ID DME0130 DME0130 DME_NAME Alcohol dehydrogenase class-II (ADH4) DME0130 SPESNAME Homo sapiens DME0130 XEOTICID XEO00029 XEO_NAME Valproic acid DME0130 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0130 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0130 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME ADH4 DME0130 XEOTICID XEO00029 GENEFORM mRNA DME0130 XEOTICID XEO00029 MOACRIVE Inhibition DME0130 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0130 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0130 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0130 XEOTICID XEO00035 DESCRIPT Fenofibrate inhibits the expression of DME ADH4 DME0130 XEOTICID XEO00035 GENEFORM mRNA DME0130 XEOTICID XEO00035 MOACRIVE Inhibition DME0130 XEOTICID XEO00090 XEO_NAME Estradiol DME0130 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0130 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0130 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME ADH4 DME0130 XEOTICID XEO00090 GENEFORM mRNA DME0130 XEOTICID XEO00090 MOACRIVE Inhibition DME0130 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0130 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0130 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0130 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME ADH4 DME0130 XEOTICID XEO00117 GENEFORM mRNA DME0130 XEOTICID XEO00117 MOACRIVE Inhibition DME0130 XEOTICID XEO00148 XEO_NAME Bosentan DME0130 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0130 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0130 XEOTICID XEO00148 DESCRIPT Bosentan inhibits the drug-metabolizing activity of DME ADH4 DME0130 XEOTICID XEO00148 GENEFORM Protein DME0130 XEOTICID XEO00148 MOACRIVE Inhibition DME0130 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0130 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0130 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0130 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ADH4 DME0130 XEOTICID XEO00217 GENEFORM mRNA DME0130 XEOTICID XEO00217 MOACRIVE Inhibition DME0130 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0130 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0130 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0130 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME ADH4 DME0130 XEOTICID XEO00241 GENEFORM mRNA DME0130 XEOTICID XEO00241 MOACRIVE Inhibition DME0130 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0130 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0130 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0130 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME ADH4 DME0130 XEOTICID XEO00632 GENEFORM mRNA DME0130 XEOTICID XEO00632 MOACRIVE Inhibition DME0130 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0130 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0130 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0130 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME ADH4 DME0130 XEOTICID XEO00806 GENEFORM mRNA DME0130 XEOTICID XEO00806 MOACRIVE Inhibition DME0130 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0130 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0130 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0130 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME ADH4 DME0130 XEOTICID XEO00898 GENEFORM mRNA DME0130 XEOTICID XEO00898 MOACRIVE Inhibition DME0130 XEOTICID XEO00957 XEO_NAME Tebuconazole DME0130 XEOTICID XEO00957 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0130 XEOTICID XEO00957 XEO_CLAS Fungicide DME0130 XEOTICID XEO00957 DESCRIPT Tebuconazole inhibits the drug-metabolizing activity of DME ADH4 DME0130 XEOTICID XEO00957 GENEFORM Protein DME0130 XEOTICID XEO00957 MOACRIVE Inhibition DME0130 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0130 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0130 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0130 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the drug-metabolizing activity of DME ADH4 DME0130 XEOTICID XEO01031 GENEFORM Protein DME0130 XEOTICID XEO01031 MOACRIVE Inhibition DME0130 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0130 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0130 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0130 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME ADH4 DME0130 XEOTICID XEO01050 GENEFORM mRNA DME0130 XEOTICID XEO01050 MOACRIVE Inhibition DME0130 XEOTICID XEO01074 XEO_NAME Endosulfan DME0130 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0130 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0130 XEOTICID XEO01074 DESCRIPT Endosulfan inhibits the drug-metabolizing activity of DME ADH4 DME0130 XEOTICID XEO01074 GENEFORM Protein DME0130 XEOTICID XEO01074 MOACRIVE Inhibition DME0130 XEOTICID XEO01089 XEO_NAME 1,4-naphthoquinone DME0130 XEOTICID XEO01089 XEO_TYPE Health or Environmental Toxicant(s) DME0130 XEOTICID XEO01089 XEO_CLAS Acute Toxic Substance DME0130 XEOTICID XEO01089 DESCRIPT 1,4-naphthoquinone up-regulates the expression of DME ADH4 DME0130 XEOTICID XEO01089 GENEFORM mRNA DME0130 XEOTICID XEO01089 MOACRIVE Induction DME0130 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0130 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0130 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0130 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME ADH4 DME0130 XEOTICID XEO01305 GENEFORM mRNA DME0130 XEOTICID XEO01305 MOACRIVE Induction DME0130 XEOTICID XEO01419 XEO_NAME Oxyquinoline DME0130 XEOTICID XEO01419 XEO_TYPE Health or Environmental Toxicant(s) DME0130 XEOTICID XEO01419 XEO_CLAS Acute Toxic Substance DME0130 XEOTICID XEO01419 DESCRIPT Oxyquinoline inhibits the expression of DME ADH4 and leads to decreasing the drug-metabolizing activity of this enzyme DME0130 XEOTICID XEO01419 GENEFORM Protein DME0130 XEOTICID XEO01419 MOACRIVE Inhibition DME0130 XEOTICID XEO01505 XEO_NAME Lead DME0130 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0130 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0130 XEOTICID XEO01505 DESCRIPT Lead up-regulates the expression of DME ADH4 DME0130 XEOTICID XEO01505 GENEFORM mRNA DME0130 XEOTICID XEO01505 MOACRIVE Induction DME0131 DME___ID DME0131 DME0131 DME_NAME Gastric alcohol dehydrogenase (ADH7) DME0131 SPESNAME Homo sapiens DME0131 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0131 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0131 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0131 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME ADH7 DME0131 XEOTICID XEO00217 GENEFORM mRNA DME0131 XEOTICID XEO00217 MOACRIVE Induction DME0131 XEOTICID XEO00547 XEO_NAME Vitamin E DME0131 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0131 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0131 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the expression of DME ADH7 DME0131 XEOTICID XEO00547 GENEFORM mRNA DME0131 XEOTICID XEO00547 MOACRIVE Inhibition DME0131 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0131 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0131 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0131 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME ADH7 DME0131 XEOTICID XEO00821 GENEFORM mRNA DME0131 XEOTICID XEO00821 MOACRIVE Inhibition DME0131 XEOTICID XEO01498 XEO_NAME Walrycin A DME0131 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0131 XEOTICID XEO01498 XEO_CLAS Natural Product DME0131 XEOTICID XEO01498 DESCRIPT Walrycin A up-regulates the expression of DME ADH7 DME0131 XEOTICID XEO01498 GENEFORM mRNA DME0131 XEOTICID XEO01498 MOACRIVE Induction DME0132 DME___ID DME0132 DME0132 DME_NAME Alcohol dehydrogenase class-III (ADH5) DME0132 SPESNAME Homo sapiens DME0132 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0132 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0132 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0132 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME ADH5 DME0132 XEOTICID XEO00117 GENEFORM mRNA DME0132 XEOTICID XEO00117 MOACRIVE Inhibition DME0132 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0132 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0132 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0132 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ADH5 DME0132 XEOTICID XEO00217 GENEFORM mRNA DME0132 XEOTICID XEO00217 MOACRIVE Inhibition DME0132 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0132 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0132 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0132 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME ADH5 DME0132 XEOTICID XEO00241 GENEFORM mRNA DME0132 XEOTICID XEO00241 MOACRIVE Inhibition DME0132 XEOTICID XEO00401 XEO_NAME Beta carotene DME0132 XEOTICID XEO00401 XEO_TYPE Pharmaceutical Agent(s) DME0132 XEOTICID XEO00401 XEO_CLAS Approved/Marketed Drug DME0132 XEOTICID XEO00401 DESCRIPT Beta carotene up-regulates the expression of DME ADH5 DME0132 XEOTICID XEO00401 GENEFORM mRNA DME0132 XEOTICID XEO00401 MOACRIVE Induction DME0132 XEOTICID XEO00435 XEO_NAME Urethane DME0132 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0132 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0132 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME ADH5 DME0132 XEOTICID XEO00435 GENEFORM mRNA DME0132 XEOTICID XEO00435 MOACRIVE Inhibition DME0132 XEOTICID XEO00538 XEO_NAME Quercetin DME0132 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0132 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0132 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME ADH5 DME0132 XEOTICID XEO00538 GENEFORM mRNA DME0132 XEOTICID XEO00538 MOACRIVE Inhibition DME0132 XEOTICID XEO00539 XEO_NAME Ethanol DME0132 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0132 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0132 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the drug-metabolizing activity of DME ADH5 DME0132 XEOTICID XEO00539 GENEFORM Protein DME0132 XEOTICID XEO00539 MOACRIVE Inhibition DME0132 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0132 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0132 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0132 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME ADH5 DME0132 XEOTICID XEO00898 GENEFORM mRNA DME0132 XEOTICID XEO00898 MOACRIVE Inhibition DME0132 XEOTICID XEO00969 XEO_NAME Atrazine DME0132 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0132 XEOTICID XEO00969 XEO_CLAS Herbicide DME0132 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME ADH5 DME0132 XEOTICID XEO00969 GENEFORM mRNA DME0132 XEOTICID XEO00969 MOACRIVE Inhibition DME0132 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0132 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0132 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0132 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME ADH5 DME0132 XEOTICID XEO01050 GENEFORM mRNA DME0132 XEOTICID XEO01050 MOACRIVE Inhibition DME0132 XEOTICID XEO01348 XEO_NAME K-7174 DME0132 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0132 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0132 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME ADH5 DME0132 XEOTICID XEO01348 GENEFORM mRNA DME0132 XEOTICID XEO01348 MOACRIVE Inhibition DME0132 XEOTICID XEO01503 XEO_NAME Cadmium DME0132 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0132 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0132 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the expression of DME ADH5 DME0132 XEOTICID XEO01503 GENEFORM mRNA DME0132 XEOTICID XEO01503 MOACRIVE Inhibition DME0132 XEOTICID XEO01504 XEO_NAME Gold DME0132 XEOTICID XEO01504 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0132 XEOTICID XEO01504 XEO_CLAS Chemical Compound DME0132 XEOTICID XEO01504 DESCRIPT Gold inhibits the expression of DME ADH5 DME0132 XEOTICID XEO01504 GENEFORM mRNA DME0132 XEOTICID XEO01504 MOACRIVE Inhibition DME0132 XEOTICID XEO01523 XEO_NAME Apocarotenal DME0132 XEOTICID XEO01523 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0132 XEOTICID XEO01523 XEO_CLAS Natural Product DME0132 XEOTICID XEO01523 DESCRIPT Apocarotenal up-regulates the expression of DME ADH5 DME0132 XEOTICID XEO01523 GENEFORM mRNA DME0132 XEOTICID XEO01523 MOACRIVE Induction DME0133 DME___ID DME0133 DME0133 DME_NAME Dipeptidyl peptidase IV (DPP4) DME0133 SPESNAME Homo sapiens DME0133 XEOTICID XEO00007 XEO_NAME Azathioprine DME0133 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00007 DESCRIPT Azathioprine inhibits the expression of DME DPP4 DME0133 XEOTICID XEO00007 GENEFORM mRNA DME0133 XEOTICID XEO00007 MOACRIVE Inhibition DME0133 XEOTICID XEO00094 XEO_NAME Progesterone DME0133 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00094 DESCRIPT Progesterone induces the drug-metabolizing activity of DME DPP4 DME0133 XEOTICID XEO00094 GENEFORM Protein DME0133 XEOTICID XEO00094 MOACRIVE Induction DME0133 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0133 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME DPP4 DME0133 XEOTICID XEO00117 GENEFORM mRNA DME0133 XEOTICID XEO00117 MOACRIVE Inhibition DME0133 XEOTICID XEO00134 XEO_NAME Adenosine DME0133 XEOTICID XEO00134 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00134 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00134 DESCRIPT Adenosine inhibits the drug-metabolizing activity of DME DPP4 DME0133 XEOTICID XEO00134 GENEFORM Protein DME0133 XEOTICID XEO00134 MOACRIVE Inhibition DME0133 XEOTICID XEO00181 XEO_NAME Dasatinib DME0133 XEOTICID XEO00181 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00181 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00181 DESCRIPT Dasatinib up-regulates the expression of DME DPP4 DME0133 XEOTICID XEO00181 GENEFORM mRNA DME0133 XEOTICID XEO00181 MOACRIVE Induction DME0133 XEOTICID XEO00184 XEO_NAME Calcitriol DME0133 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME DPP4 DME0133 XEOTICID XEO00184 GENEFORM mRNA DME0133 XEOTICID XEO00184 MOACRIVE Induction DME0133 XEOTICID XEO00196 XEO_NAME Mdv-3100 DME0133 XEOTICID XEO00196 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00196 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00196 DESCRIPT Mdv-3100 inhibits the drug-metabolizing activity of DME DPP4 DME0133 XEOTICID XEO00196 GENEFORM Protein DME0133 XEOTICID XEO00196 MOACRIVE Inhibition DME0133 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0133 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00217 DESCRIPT Acetaminophen induces the drug-metabolizing activity of DME DPP4 DME0133 XEOTICID XEO00217 GENEFORM Protein DME0133 XEOTICID XEO00217 MOACRIVE Induction DME0133 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0133 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME DPP4 DME0133 XEOTICID XEO00241 GENEFORM mRNA DME0133 XEOTICID XEO00241 MOACRIVE Inhibition DME0133 XEOTICID XEO00252 XEO_NAME Sitagliptin phosphate DME0133 XEOTICID XEO00252 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00252 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00252 DESCRIPT Sitagliptin phosphate inhibits the drug-metabolizing activity of DME DPP4 (IC50 = 0.0035 microM) DME0133 XEOTICID XEO00252 GENEFORM Protein DME0133 XEOTICID XEO00252 MOACRIVE Inhibition DME0133 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0133 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME DPP4 DME0133 XEOTICID XEO00292 GENEFORM mRNA DME0133 XEOTICID XEO00292 MOACRIVE Inhibition DME0133 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0133 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME DPP4 DME0133 XEOTICID XEO00339 GENEFORM mRNA DME0133 XEOTICID XEO00339 MOACRIVE Inhibition DME0133 XEOTICID XEO00381 XEO_NAME Saxagliptin DME0133 XEOTICID XEO00381 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00381 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00381 DESCRIPT Saxagliptin inhibits the drug-metabolizing activity of DME DPP4 (IC50 = 0.0006 microM) DME0133 XEOTICID XEO00381 GENEFORM Protein DME0133 XEOTICID XEO00381 MOACRIVE Inhibition DME0133 XEOTICID XEO00392 XEO_NAME Vincristine DME0133 XEOTICID XEO00392 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00392 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00392 DESCRIPT Vincristine inhibits the expression of DME DPP4 DME0133 XEOTICID XEO00392 GENEFORM mRNA DME0133 XEOTICID XEO00392 MOACRIVE Inhibition DME0133 XEOTICID XEO00445 XEO_NAME Vildagliptin DME0133 XEOTICID XEO00445 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00445 XEO_CLAS Approved/Marketed Drug DME0133 XEOTICID XEO00445 DESCRIPT Vildagliptin inhibits the drug-metabolizing activity of DME DPP4 (IC50 = 0.00058 microM) DME0133 XEOTICID XEO00445 GENEFORM Protein DME0133 XEOTICID XEO00445 MOACRIVE Inhibition DME0133 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0133 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0133 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME DPP4 DME0133 XEOTICID XEO00536 GENEFORM mRNA DME0133 XEOTICID XEO00536 MOACRIVE Induction DME0133 XEOTICID XEO00560 XEO_NAME Triclosan DME0133 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0133 XEOTICID XEO00560 DESCRIPT Triclosan up-regulates the expression of DME DPP4 DME0133 XEOTICID XEO00560 GENEFORM mRNA DME0133 XEOTICID XEO00560 MOACRIVE Induction DME0133 XEOTICID XEO00581 XEO_NAME MS-275 DME0133 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0133 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME DPP4 DME0133 XEOTICID XEO00581 GENEFORM mRNA DME0133 XEOTICID XEO00581 MOACRIVE Induction DME0133 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0133 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0133 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME DPP4 DME0133 XEOTICID XEO00723 GENEFORM mRNA DME0133 XEOTICID XEO00723 MOACRIVE Inhibition DME0133 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0133 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0133 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0133 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME DPP4 DME0133 XEOTICID XEO00772 GENEFORM mRNA DME0133 XEOTICID XEO00772 MOACRIVE Inhibition DME0133 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0133 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0133 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0133 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME DPP4 DME0133 XEOTICID XEO00898 GENEFORM mRNA DME0133 XEOTICID XEO00898 MOACRIVE Inhibition DME0133 XEOTICID XEO00973 XEO_NAME Diuron DME0133 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0133 XEOTICID XEO00973 XEO_CLAS Herbicide DME0133 XEOTICID XEO00973 DESCRIPT Diuron up-regulates the expression of DME DPP4 DME0133 XEOTICID XEO00973 GENEFORM mRNA DME0133 XEOTICID XEO00973 MOACRIVE Induction DME0133 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0133 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0133 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0133 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME DPP4 DME0133 XEOTICID XEO01050 GENEFORM mRNA DME0133 XEOTICID XEO01050 MOACRIVE Inhibition DME0133 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0133 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0133 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME DPP4 DME0133 XEOTICID XEO01226 GENEFORM mRNA DME0133 XEOTICID XEO01226 MOACRIVE Induction DME0133 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0133 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0133 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0133 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME DPP4 DME0133 XEOTICID XEO01305 GENEFORM mRNA DME0133 XEOTICID XEO01305 MOACRIVE Inhibition DME0133 XEOTICID XEO01348 XEO_NAME K-7174 DME0133 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0133 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME DPP4 DME0133 XEOTICID XEO01348 GENEFORM mRNA DME0133 XEOTICID XEO01348 MOACRIVE Inhibition DME0133 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0133 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0133 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0133 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME DPP4 DME0133 XEOTICID XEO01492 GENEFORM mRNA DME0133 XEOTICID XEO01492 MOACRIVE Induction DME0135 DME___ID DME0135 DME0135 DME_NAME Cytochrome P450 4F12 (CYP4F12) DME0135 SPESNAME Homo sapiens DME0135 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0135 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0135 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0135 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME CYP4F12 DME0135 XEOTICID XEO00117 GENEFORM mRNA DME0135 XEOTICID XEO00117 MOACRIVE Inhibition DME0135 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0135 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0135 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0135 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME CYP4F12 DME0135 XEOTICID XEO00217 GENEFORM mRNA DME0135 XEOTICID XEO00217 MOACRIVE Induction DME0135 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0135 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0135 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0135 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYP4F12 DME0135 XEOTICID XEO00241 GENEFORM mRNA DME0135 XEOTICID XEO00241 MOACRIVE Inhibition DME0135 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0135 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0135 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0135 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP4F12 DME0135 XEOTICID XEO00251 GENEFORM Protein DME0135 XEOTICID XEO00251 MOACRIVE Inhibition DME0135 XEOTICID XEO00411 XEO_NAME Avobenzone DME0135 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0135 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0135 XEOTICID XEO00411 DESCRIPT Avobenzone inhibits the expression of DME CYP4F12 DME0135 XEOTICID XEO00411 GENEFORM mRNA DME0135 XEOTICID XEO00411 MOACRIVE Inhibition DME0135 XEOTICID XEO00539 XEO_NAME Ethanol DME0135 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0135 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0135 XEOTICID XEO00539 DESCRIPT Ethanol up-regulates the expression of DME CYP4F12 DME0135 XEOTICID XEO00539 GENEFORM mRNA DME0135 XEOTICID XEO00539 MOACRIVE Induction DME0135 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0135 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0135 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0135 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME CYP4F12 DME0135 XEOTICID XEO00723 GENEFORM mRNA DME0135 XEOTICID XEO00723 MOACRIVE Induction DME0135 XEOTICID XEO00760 XEO_NAME Jinfukang DME0135 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0135 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0135 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME CYP4F12 DME0135 XEOTICID XEO00760 GENEFORM mRNA DME0135 XEOTICID XEO00760 MOACRIVE Induction DME0135 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0135 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0135 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0135 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYP4F12 DME0135 XEOTICID XEO00806 GENEFORM mRNA DME0135 XEOTICID XEO00806 MOACRIVE Inhibition DME0135 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0135 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0135 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0135 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME CYP4F12 DME0135 XEOTICID XEO00898 GENEFORM mRNA DME0135 XEOTICID XEO00898 MOACRIVE Inhibition DME0135 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0135 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0135 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0135 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME CYP4F12 DME0135 XEOTICID XEO01305 GENEFORM mRNA DME0135 XEOTICID XEO01305 MOACRIVE Induction DME0135 XEOTICID XEO01585 XEO_NAME Senecionine DME0135 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0135 XEOTICID XEO01585 XEO_CLAS Natural Product DME0135 XEOTICID XEO01585 DESCRIPT Senecionine inhibits the expression of DME CYP4F12 DME0135 XEOTICID XEO01585 GENEFORM mRNA DME0135 XEOTICID XEO01585 MOACRIVE Inhibition DME0136 DME___ID DME0136 DME0136 DME_NAME Amidophosphoribosyltransferase (GPAT) DME0136 SPESNAME Homo sapiens DME0136 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0136 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0136 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0136 XEOTICID XEO00088 DESCRIPT Dexamethasone inhibits the expression of DME PPAT DME0136 XEOTICID XEO00088 GENEFORM mRNA DME0136 XEOTICID XEO00088 MOACRIVE Inhibition DME0136 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0136 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0136 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0136 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME PPAT DME0136 XEOTICID XEO00217 GENEFORM mRNA DME0136 XEOTICID XEO00217 MOACRIVE Induction DME0136 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0136 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0136 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0136 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME PPAT DME0136 XEOTICID XEO00339 GENEFORM mRNA DME0136 XEOTICID XEO00339 MOACRIVE Induction DME0136 XEOTICID XEO00760 XEO_NAME Jinfukang DME0136 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0136 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0136 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME PPAT DME0136 XEOTICID XEO00760 GENEFORM mRNA DME0136 XEOTICID XEO00760 MOACRIVE Inhibition DME0136 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0136 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0136 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0136 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME PPAT DME0136 XEOTICID XEO00772 GENEFORM mRNA DME0136 XEOTICID XEO00772 MOACRIVE Inhibition DME0137 DME___ID DME0137 DME0137 DME_NAME Thymidylate synthase (TYMS) DME0137 SPESNAME Homo sapiens DME0137 XEOTICID XEO00007 XEO_NAME Azathioprine DME0137 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00007 DESCRIPT Azathioprine inhibits the expression of DME TYMS DME0137 XEOTICID XEO00007 GENEFORM mRNA DME0137 XEOTICID XEO00007 MOACRIVE Inhibition DME0137 XEOTICID XEO00009 XEO_NAME Bicalutamide DME0137 XEOTICID XEO00009 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00009 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00009 DESCRIPT Bicalutamide inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00009 GENEFORM Protein DME0137 XEOTICID XEO00009 MOACRIVE Inhibition DME0137 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0137 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00037 DESCRIPT Fluorouracil inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00037 GENEFORM Protein DME0137 XEOTICID XEO00037 MOACRIVE Inhibition DME0137 XEOTICID XEO00056 XEO_NAME Malathion DME0137 XEOTICID XEO00056 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00056 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00056 DESCRIPT Malathion inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00056 GENEFORM Protein DME0137 XEOTICID XEO00056 MOACRIVE Inhibition DME0137 XEOTICID XEO00079 XEO_NAME Vorinostat DME0137 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00079 DESCRIPT Vorinostat inhibits the expression of DME TYMS DME0137 XEOTICID XEO00079 GENEFORM mRNA DME0137 XEOTICID XEO00079 MOACRIVE Inhibition DME0137 XEOTICID XEO00086 XEO_NAME Troglitazone DME0137 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00086 DESCRIPT Troglitazone inhibits the expression of DME TYMS DME0137 XEOTICID XEO00086 GENEFORM mRNA DME0137 XEOTICID XEO00086 MOACRIVE Inhibition DME0137 XEOTICID XEO00089 XEO_NAME Mitomycin DME0137 XEOTICID XEO00089 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00089 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00089 DESCRIPT Mitomycin up-regulates the expression of DME TYMS DME0137 XEOTICID XEO00089 GENEFORM mRNA DME0137 XEOTICID XEO00089 MOACRIVE Induction DME0137 XEOTICID XEO00090 XEO_NAME Estradiol DME0137 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME TYMS DME0137 XEOTICID XEO00090 GENEFORM mRNA DME0137 XEOTICID XEO00090 MOACRIVE Induction DME0137 XEOTICID XEO00094 XEO_NAME Progesterone DME0137 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00094 DESCRIPT Progesterone up-regulates the expression of DME TYMS DME0137 XEOTICID XEO00094 GENEFORM mRNA DME0137 XEOTICID XEO00094 MOACRIVE Induction DME0137 XEOTICID XEO00095 XEO_NAME Testosterone DME0137 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00095 DESCRIPT Testosterone inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00095 GENEFORM Protein DME0137 XEOTICID XEO00095 MOACRIVE Inhibition DME0137 XEOTICID XEO00115 XEO_NAME Dronabinol DME0137 XEOTICID XEO00115 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00115 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00115 DESCRIPT Dronabinol inhibits the expression of DME TYMS DME0137 XEOTICID XEO00115 GENEFORM mRNA DME0137 XEOTICID XEO00115 MOACRIVE Inhibition DME0137 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0137 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME TYMS DME0137 XEOTICID XEO00117 GENEFORM mRNA DME0137 XEOTICID XEO00117 MOACRIVE Inhibition DME0137 XEOTICID XEO00125 XEO_NAME Simvastatin DME0137 XEOTICID XEO00125 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00125 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00125 DESCRIPT Simvastatin inhibits the expression of DME TYMS DME0137 XEOTICID XEO00125 GENEFORM mRNA DME0137 XEOTICID XEO00125 MOACRIVE Inhibition DME0137 XEOTICID XEO00152 XEO_NAME Gefitinib DME0137 XEOTICID XEO00152 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00152 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00152 DESCRIPT Gefitinib inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00152 GENEFORM Protein DME0137 XEOTICID XEO00152 MOACRIVE Inhibition DME0137 XEOTICID XEO00153 XEO_NAME Docetaxel DME0137 XEOTICID XEO00153 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00153 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00153 DESCRIPT Docetaxel inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00153 GENEFORM Protein DME0137 XEOTICID XEO00153 MOACRIVE Inhibition DME0137 XEOTICID XEO00157 XEO_NAME Erlotinib hydrochloride DME0137 XEOTICID XEO00157 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00157 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00157 DESCRIPT Erlotinib hydrochloride inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00157 GENEFORM Protein DME0137 XEOTICID XEO00157 MOACRIVE Inhibition DME0137 XEOTICID XEO00184 XEO_NAME Calcitriol DME0137 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME TYMS DME0137 XEOTICID XEO00184 GENEFORM mRNA DME0137 XEOTICID XEO00184 MOACRIVE Inhibition DME0137 XEOTICID XEO00188 XEO_NAME Sirolimus DME0137 XEOTICID XEO00188 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00188 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00188 DESCRIPT Sirolimus inhibits the expression of DME TYMS DME0137 XEOTICID XEO00188 GENEFORM mRNA DME0137 XEOTICID XEO00188 MOACRIVE Inhibition DME0137 XEOTICID XEO00190 XEO_NAME Palbociclib DME0137 XEOTICID XEO00190 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00190 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00190 DESCRIPT Palbociclib inhibits the expression of DME TYMS DME0137 XEOTICID XEO00190 GENEFORM mRNA DME0137 XEOTICID XEO00190 MOACRIVE Inhibition DME0137 XEOTICID XEO00193 XEO_NAME Belinostat DME0137 XEOTICID XEO00193 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00193 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00193 DESCRIPT Belinostat inhibits the expression of DME TYMS DME0137 XEOTICID XEO00193 GENEFORM mRNA DME0137 XEOTICID XEO00193 MOACRIVE Inhibition DME0137 XEOTICID XEO00207 XEO_NAME Oxaliplatin DME0137 XEOTICID XEO00207 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00207 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00207 DESCRIPT Oxaliplatin inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00207 GENEFORM Protein DME0137 XEOTICID XEO00207 MOACRIVE Inhibition DME0137 XEOTICID XEO00211 XEO_NAME Pemetrexed DME0137 XEOTICID XEO00211 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00211 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00211 DESCRIPT Pemetrexed inhibits the drug-metabolizing activity of DME TYMS (IC50 = 11 microM) DME0137 XEOTICID XEO00211 GENEFORM Protein DME0137 XEOTICID XEO00211 MOACRIVE Inhibition DME0137 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0137 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME TYMS DME0137 XEOTICID XEO00217 GENEFORM mRNA DME0137 XEOTICID XEO00217 MOACRIVE Inhibition DME0137 XEOTICID XEO00229 XEO_NAME Temsirolimus DME0137 XEOTICID XEO00229 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00229 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00229 DESCRIPT Temsirolimus inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00229 GENEFORM Protein DME0137 XEOTICID XEO00229 MOACRIVE Inhibition DME0137 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0137 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME TYMS DME0137 XEOTICID XEO00241 GENEFORM mRNA DME0137 XEOTICID XEO00241 MOACRIVE Inhibition DME0137 XEOTICID XEO00256 XEO_NAME Paclitaxel DME0137 XEOTICID XEO00256 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00256 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00256 DESCRIPT Paclitaxel up-regulates the expression of DME TYMS DME0137 XEOTICID XEO00256 GENEFORM mRNA DME0137 XEOTICID XEO00256 MOACRIVE Induction DME0137 XEOTICID XEO00334 XEO_NAME Cisplatin DME0137 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00334 DESCRIPT Cisplatin induces the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00334 GENEFORM Protein DME0137 XEOTICID XEO00334 MOACRIVE Induction DME0137 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0137 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00339 GENEFORM Protein DME0137 XEOTICID XEO00339 MOACRIVE Inhibition DME0137 XEOTICID XEO00366 XEO_NAME Methotrexate DME0137 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00366 DESCRIPT Methotrexate up-regulates the expression of DME TYMS DME0137 XEOTICID XEO00366 GENEFORM mRNA DME0137 XEOTICID XEO00366 MOACRIVE Induction DME0137 XEOTICID XEO00435 XEO_NAME Urethane DME0137 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME TYMS DME0137 XEOTICID XEO00435 GENEFORM mRNA DME0137 XEOTICID XEO00435 MOACRIVE Inhibition DME0137 XEOTICID XEO00479 XEO_NAME Raltitrexed DME0137 XEOTICID XEO00479 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00479 XEO_CLAS Approved/Marketed Drug DME0137 XEOTICID XEO00479 DESCRIPT Raltitrexed inhibits the drug-metabolizing activity of DME TYMS (IC50 = 0.26 microM) DME0137 XEOTICID XEO00479 GENEFORM Protein DME0137 XEOTICID XEO00479 MOACRIVE Inhibition DME0137 XEOTICID XEO00521 XEO_NAME Phenolphthalein DME0137 XEOTICID XEO00521 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00521 XEO_CLAS Drug Marketed but Withdrawn from Market DME0137 XEOTICID XEO00521 DESCRIPT Phenolphthalein inhibits the drug-metabolizing activity of DME TYMS (Ki = 1.2 microM) DME0137 XEOTICID XEO00521 GENEFORM Protein DME0137 XEOTICID XEO00521 MOACRIVE Inhibition DME0137 XEOTICID XEO00538 XEO_NAME Quercetin DME0137 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0137 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME TYMS DME0137 XEOTICID XEO00538 GENEFORM mRNA DME0137 XEOTICID XEO00538 MOACRIVE Inhibition DME0137 XEOTICID XEO00557 XEO_NAME Genistein DME0137 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0137 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME TYMS DME0137 XEOTICID XEO00557 GENEFORM mRNA DME0137 XEOTICID XEO00557 MOACRIVE Induction DME0137 XEOTICID XEO00560 XEO_NAME Triclosan DME0137 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0137 XEOTICID XEO00560 DESCRIPT Triclosan inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00560 GENEFORM Protein DME0137 XEOTICID XEO00560 MOACRIVE Inhibition DME0137 XEOTICID XEO00568 XEO_NAME Resveratrol DME0137 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0137 XEOTICID XEO00568 DESCRIPT Resveratrol induces the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00568 GENEFORM Protein DME0137 XEOTICID XEO00568 MOACRIVE Induction DME0137 XEOTICID XEO00590 XEO_NAME FdUMP(10) DME0137 XEOTICID XEO00590 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00590 XEO_CLAS Drug in Phase 2 Clinical Trial DME0137 XEOTICID XEO00590 DESCRIPT FdUMP(10) inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00590 GENEFORM Protein DME0137 XEOTICID XEO00590 MOACRIVE Inhibition DME0137 XEOTICID XEO00592 XEO_NAME PF-00299804 DME0137 XEOTICID XEO00592 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00592 XEO_CLAS Drug in Phase 2 Clinical Trial DME0137 XEOTICID XEO00592 DESCRIPT PF-00299804 inhibits the expression of DME TYMS DME0137 XEOTICID XEO00592 GENEFORM mRNA DME0137 XEOTICID XEO00592 MOACRIVE Inhibition DME0137 XEOTICID XEO00597 XEO_NAME Camptothecin DME0137 XEOTICID XEO00597 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00597 XEO_CLAS Drug in Phase 2 Clinical Trial DME0137 XEOTICID XEO00597 DESCRIPT Camptothecin up-regulates the expression of DME TYMS DME0137 XEOTICID XEO00597 GENEFORM mRNA DME0137 XEOTICID XEO00597 MOACRIVE Induction DME0137 XEOTICID XEO00599 XEO_NAME Tetradecanoylphorbol acetate DME0137 XEOTICID XEO00599 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00599 XEO_CLAS Drug in Phase 1 Clinical Trial DME0137 XEOTICID XEO00599 DESCRIPT Tetradecanoylphorbol acetate up-regulates the expression of DME TYMS DME0137 XEOTICID XEO00599 GENEFORM mRNA DME0137 XEOTICID XEO00599 MOACRIVE Induction DME0137 XEOTICID XEO00611 XEO_NAME Betulinic acid DME0137 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME0137 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00611 GENEFORM Protein DME0137 XEOTICID XEO00611 MOACRIVE Inhibition DME0137 XEOTICID XEO00657 XEO_NAME Antimony DME0137 XEOTICID XEO00657 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00657 XEO_CLAS Drug in Phase 2 Clinical Trial DME0137 XEOTICID XEO00657 DESCRIPT Antimony up-regulates the expression of DME TYMS DME0137 XEOTICID XEO00657 GENEFORM mRNA DME0137 XEOTICID XEO00657 MOACRIVE Induction DME0137 XEOTICID XEO00682 XEO_NAME Nolatrexed DME0137 XEOTICID XEO00682 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00682 XEO_CLAS Drug in Phase 3 Clinical Trial DME0137 XEOTICID XEO00682 DESCRIPT Nolatrexed inhibits the drug-metabolizing activity of DME TYMS (Ki = 0.015 microM) DME0137 XEOTICID XEO00682 GENEFORM Protein DME0137 XEOTICID XEO00682 MOACRIVE Inhibition DME0137 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0137 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0137 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME TYMS DME0137 XEOTICID XEO00723 GENEFORM mRNA DME0137 XEOTICID XEO00723 MOACRIVE Inhibition DME0137 XEOTICID XEO00770 XEO_NAME AG-1879 DME0137 XEOTICID XEO00770 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO00770 XEO_CLAS Investigative Agent DME0137 XEOTICID XEO00770 DESCRIPT AG-1879 inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO00770 GENEFORM Protein DME0137 XEOTICID XEO00770 MOACRIVE Inhibition DME0137 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0137 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0137 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0137 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME TYMS DME0137 XEOTICID XEO00772 GENEFORM mRNA DME0137 XEOTICID XEO00772 MOACRIVE Induction DME0137 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0137 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0137 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0137 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME TYMS DME0137 XEOTICID XEO00806 GENEFORM mRNA DME0137 XEOTICID XEO00806 MOACRIVE Induction DME0137 XEOTICID XEO00809 XEO_NAME Thapsigargin DME0137 XEOTICID XEO00809 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0137 XEOTICID XEO00809 XEO_CLAS Natural Product DME0137 XEOTICID XEO00809 DESCRIPT Thapsigargin inhibits the expression of DME TYMS DME0137 XEOTICID XEO00809 GENEFORM mRNA DME0137 XEOTICID XEO00809 MOACRIVE Inhibition DME0137 XEOTICID XEO00860 XEO_NAME Phytoestrogen DME0137 XEOTICID XEO00860 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0137 XEOTICID XEO00860 XEO_CLAS Natural Product DME0137 XEOTICID XEO00860 DESCRIPT Phytoestrogen up-regulates the expression of DME TYMS DME0137 XEOTICID XEO00860 GENEFORM mRNA DME0137 XEOTICID XEO00860 MOACRIVE Induction DME0137 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0137 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0137 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0137 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME TYMS DME0137 XEOTICID XEO00898 GENEFORM mRNA DME0137 XEOTICID XEO00898 MOACRIVE Inhibition DME0137 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0137 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0137 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0137 XEOTICID XEO00899 DESCRIPT Methylcholanthrene up-regulates the expression of DME TYMS and leads to increasing the drug-metabolizing activity of this enzyme DME0137 XEOTICID XEO00899 GENEFORM Protein DME0137 XEOTICID XEO00899 MOACRIVE Induction DME0137 XEOTICID XEO00969 XEO_NAME Atrazine DME0137 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0137 XEOTICID XEO00969 XEO_CLAS Herbicide DME0137 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME TYMS DME0137 XEOTICID XEO00969 GENEFORM mRNA DME0137 XEOTICID XEO00969 MOACRIVE Inhibition DME0137 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0137 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0137 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0137 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME TYMS DME0137 XEOTICID XEO01031 GENEFORM mRNA DME0137 XEOTICID XEO01031 MOACRIVE Inhibition DME0137 XEOTICID XEO01095 XEO_NAME 14-deoxy-11,12-didehydroandrographolide DME0137 XEOTICID XEO01095 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0137 XEOTICID XEO01095 XEO_CLAS Natural Product DME0137 XEOTICID XEO01095 DESCRIPT 14-deoxy-11,12-didehydroandrographolide inhibits the expression of DME TYMS DME0137 XEOTICID XEO01095 GENEFORM mRNA DME0137 XEOTICID XEO01095 MOACRIVE Inhibition DME0137 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0137 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0137 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0137 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium inhibits the expression of DME TYMS DME0137 XEOTICID XEO01103 GENEFORM mRNA DME0137 XEOTICID XEO01103 MOACRIVE Inhibition DME0137 XEOTICID XEO01201 XEO_NAME Antimony potassium tartrate DME0137 XEOTICID XEO01201 XEO_TYPE Health or Environmental Toxicant(s) DME0137 XEOTICID XEO01201 XEO_CLAS Environmental Pollutant DME0137 XEOTICID XEO01201 DESCRIPT Antimony potassium tartrate up-regulates the expression of DME TYMS DME0137 XEOTICID XEO01201 GENEFORM mRNA DME0137 XEOTICID XEO01201 MOACRIVE Induction DME0137 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0137 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0137 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME TYMS DME0137 XEOTICID XEO01226 GENEFORM mRNA DME0137 XEOTICID XEO01226 MOACRIVE Inhibition DME0137 XEOTICID XEO01261 XEO_NAME Coumestrol DME0137 XEOTICID XEO01261 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO01261 XEO_CLAS Investigative Agent DME0137 XEOTICID XEO01261 DESCRIPT Coumestrol up-regulates the expression of DME TYMS DME0137 XEOTICID XEO01261 GENEFORM mRNA DME0137 XEOTICID XEO01261 MOACRIVE Induction DME0137 XEOTICID XEO01312 XEO_NAME Geraniol DME0137 XEOTICID XEO01312 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0137 XEOTICID XEO01312 XEO_CLAS Natural Product DME0137 XEOTICID XEO01312 DESCRIPT Geraniol inhibits the expression of DME TYMS DME0137 XEOTICID XEO01312 GENEFORM mRNA DME0137 XEOTICID XEO01312 MOACRIVE Inhibition DME0137 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0137 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0137 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME TYMS DME0137 XEOTICID XEO01324 GENEFORM mRNA DME0137 XEOTICID XEO01324 MOACRIVE Inhibition DME0137 XEOTICID XEO01348 XEO_NAME K-7174 DME0137 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0137 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME TYMS DME0137 XEOTICID XEO01348 GENEFORM mRNA DME0137 XEOTICID XEO01348 MOACRIVE Inhibition DME0137 XEOTICID XEO01404 XEO_NAME NU2058 DME0137 XEOTICID XEO01404 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO01404 XEO_CLAS Investigative Agent DME0137 XEOTICID XEO01404 DESCRIPT NU2058 inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO01404 GENEFORM Protein DME0137 XEOTICID XEO01404 MOACRIVE Inhibition DME0137 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0137 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0137 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0137 XEOTICID XEO01492 DESCRIPT Trichostatin A inhibits the expression of DME TYMS DME0137 XEOTICID XEO01492 GENEFORM mRNA DME0137 XEOTICID XEO01492 MOACRIVE Inhibition DME0137 XEOTICID XEO01500 XEO_NAME Wogonin DME0137 XEOTICID XEO01500 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0137 XEOTICID XEO01500 XEO_CLAS Natural Product DME0137 XEOTICID XEO01500 DESCRIPT Wogonin up-regulates the expression of DME TYMS DME0137 XEOTICID XEO01500 GENEFORM mRNA DME0137 XEOTICID XEO01500 MOACRIVE Induction DME0137 XEOTICID XEO01503 XEO_NAME Cadmium DME0137 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0137 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0137 XEOTICID XEO01503 DESCRIPT Cadmium induces the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO01503 GENEFORM Protein DME0137 XEOTICID XEO01503 MOACRIVE Induction DME0137 XEOTICID XEO01509 XEO_NAME Mercury DME0137 XEOTICID XEO01509 XEO_TYPE Health or Environmental Toxicant(s) DME0137 XEOTICID XEO01509 XEO_CLAS Acute Toxic Substance DME0137 XEOTICID XEO01509 DESCRIPT Mercury up-regulates the expression of DME TYMS DME0137 XEOTICID XEO01509 GENEFORM mRNA DME0137 XEOTICID XEO01509 MOACRIVE Induction DME0137 XEOTICID XEO01512 XEO_NAME Zinc DME0137 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME0137 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME0137 XEOTICID XEO01512 DESCRIPT Zinc up-regulates the expression of DME TYMS DME0137 XEOTICID XEO01512 GENEFORM mRNA DME0137 XEOTICID XEO01512 MOACRIVE Induction DME0137 XEOTICID XEO01543 XEO_NAME Gambogic acid DME0137 XEOTICID XEO01543 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0137 XEOTICID XEO01543 XEO_CLAS Natural Product DME0137 XEOTICID XEO01543 DESCRIPT Gambogic acid inhibits the expression of DME TYMS DME0137 XEOTICID XEO01543 GENEFORM mRNA DME0137 XEOTICID XEO01543 MOACRIVE Inhibition DME0137 XEOTICID XEO01574 XEO_NAME Plant extracts DME0137 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0137 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0137 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME TYMS DME0137 XEOTICID XEO01574 GENEFORM Protein DME0137 XEOTICID XEO01574 MOACRIVE Inhibition DME0138 DME___ID DME0138 DME0138 DME_NAME Uridine 5'-monophosphate synthase (UMPS) DME0138 SPESNAME Homo sapiens DME0138 XEOTICID XEO00029 XEO_NAME Valproic acid DME0138 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0138 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0138 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME UMPS DME0138 XEOTICID XEO00029 GENEFORM mRNA DME0138 XEOTICID XEO00029 MOACRIVE Inhibition DME0138 XEOTICID XEO00089 XEO_NAME Mitomycin DME0138 XEOTICID XEO00089 XEO_TYPE Pharmaceutical Agent(s) DME0138 XEOTICID XEO00089 XEO_CLAS Approved/Marketed Drug DME0138 XEOTICID XEO00089 DESCRIPT Mitomycin inhibits the expression of DME UMPS DME0138 XEOTICID XEO00089 GENEFORM mRNA DME0138 XEOTICID XEO00089 MOACRIVE Inhibition DME0138 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0138 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0138 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0138 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME UMPS DME0138 XEOTICID XEO00117 GENEFORM mRNA DME0138 XEOTICID XEO00117 MOACRIVE Inhibition DME0138 XEOTICID XEO00153 XEO_NAME Docetaxel DME0138 XEOTICID XEO00153 XEO_TYPE Pharmaceutical Agent(s) DME0138 XEOTICID XEO00153 XEO_CLAS Approved/Marketed Drug DME0138 XEOTICID XEO00153 DESCRIPT Docetaxel induces the drug-metabolizing activity of DME UMPS DME0138 XEOTICID XEO00153 GENEFORM Protein DME0138 XEOTICID XEO00153 MOACRIVE Induction DME0138 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0138 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0138 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0138 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME UMPS DME0138 XEOTICID XEO00241 GENEFORM mRNA DME0138 XEOTICID XEO00241 MOACRIVE Inhibition DME0138 XEOTICID XEO00256 XEO_NAME Paclitaxel DME0138 XEOTICID XEO00256 XEO_TYPE Pharmaceutical Agent(s) DME0138 XEOTICID XEO00256 XEO_CLAS Approved/Marketed Drug DME0138 XEOTICID XEO00256 DESCRIPT Paclitaxel inhibits the expression of DME UMPS DME0138 XEOTICID XEO00256 GENEFORM mRNA DME0138 XEOTICID XEO00256 MOACRIVE Inhibition DME0138 XEOTICID XEO00334 XEO_NAME Cisplatin DME0138 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0138 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0138 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME UMPS DME0138 XEOTICID XEO00334 GENEFORM mRNA DME0138 XEOTICID XEO00334 MOACRIVE Inhibition DME0138 XEOTICID XEO00530 XEO_NAME Azaribine DME0138 XEOTICID XEO00530 XEO_TYPE Pharmaceutical Agent(s) DME0138 XEOTICID XEO00530 XEO_CLAS Drug Marketed but Withdrawn from Market DME0138 XEOTICID XEO00530 DESCRIPT Azaribine induces the drug-metabolizing activity of DME UMPS DME0138 XEOTICID XEO00530 GENEFORM Protein DME0138 XEOTICID XEO00530 MOACRIVE Induction DME0138 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0138 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0138 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0138 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin up-regulates the expression of DME UMPS DME0138 XEOTICID XEO00905 GENEFORM mRNA DME0138 XEOTICID XEO00905 MOACRIVE Induction DME0138 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0138 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0138 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0138 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME UMPS DME0138 XEOTICID XEO01050 GENEFORM mRNA DME0138 XEOTICID XEO01050 MOACRIVE Inhibition DME0138 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0138 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0138 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0138 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME UMPS DME0138 XEOTICID XEO01226 GENEFORM mRNA DME0138 XEOTICID XEO01226 MOACRIVE Inhibition DME0138 XEOTICID XEO01261 XEO_NAME Coumestrol DME0138 XEOTICID XEO01261 XEO_TYPE Pharmaceutical Agent(s) DME0138 XEOTICID XEO01261 XEO_CLAS Investigative Agent DME0138 XEOTICID XEO01261 DESCRIPT Coumestrol up-regulates the expression of DME UMPS DME0138 XEOTICID XEO01261 GENEFORM mRNA DME0138 XEOTICID XEO01261 MOACRIVE Induction DME0138 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0138 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0138 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0138 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME UMPS DME0138 XEOTICID XEO01324 GENEFORM mRNA DME0138 XEOTICID XEO01324 MOACRIVE Inhibition DME0138 XEOTICID XEO01348 XEO_NAME K-7174 DME0138 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0138 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0138 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME UMPS DME0138 XEOTICID XEO01348 GENEFORM mRNA DME0138 XEOTICID XEO01348 MOACRIVE Inhibition DME0138 XEOTICID XEO01397 XEO_NAME Nickel chloride DME0138 XEOTICID XEO01397 XEO_TYPE Health or Environmental Toxicant(s) DME0138 XEOTICID XEO01397 XEO_CLAS Acute Toxic Substance DME0138 XEOTICID XEO01397 DESCRIPT Nickel chloride inhibits the expression of DME UMPS DME0138 XEOTICID XEO01397 GENEFORM mRNA DME0138 XEOTICID XEO01397 MOACRIVE Inhibition DME0138 XEOTICID XEO01543 XEO_NAME Gambogic acid DME0138 XEOTICID XEO01543 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0138 XEOTICID XEO01543 XEO_CLAS Natural Product DME0138 XEOTICID XEO01543 DESCRIPT Gambogic acid up-regulates the expression of DME UMPS DME0138 XEOTICID XEO01543 GENEFORM mRNA DME0138 XEOTICID XEO01543 MOACRIVE Induction DME0138 XEOTICID XEO01574 XEO_NAME Plant extracts DME0138 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0138 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0138 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the expression of DME UMPS DME0138 XEOTICID XEO01574 GENEFORM mRNA DME0138 XEOTICID XEO01574 MOACRIVE Inhibition DME0139 DME___ID DME0139 DME0139 DME_NAME Uridine phosphorylase 1 (UPP1) DME0139 SPESNAME Homo sapiens DME0139 XEOTICID XEO00007 XEO_NAME Azathioprine DME0139 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00007 DESCRIPT Azathioprine up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00007 GENEFORM mRNA DME0139 XEOTICID XEO00007 MOACRIVE Induction DME0139 XEOTICID XEO00009 XEO_NAME Bicalutamide DME0139 XEOTICID XEO00009 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00009 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00009 DESCRIPT Bicalutamide up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00009 GENEFORM mRNA DME0139 XEOTICID XEO00009 MOACRIVE Induction DME0139 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0139 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00037 DESCRIPT Fluorouracil induces the drug-metabolizing activity of DME UPP1 DME0139 XEOTICID XEO00037 GENEFORM Protein DME0139 XEOTICID XEO00037 MOACRIVE Induction DME0139 XEOTICID XEO00047 XEO_NAME Indomethacin DME0139 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00047 DESCRIPT Indomethacin up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00047 GENEFORM mRNA DME0139 XEOTICID XEO00047 MOACRIVE Induction DME0139 XEOTICID XEO00090 XEO_NAME Estradiol DME0139 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00090 GENEFORM mRNA DME0139 XEOTICID XEO00090 MOACRIVE Induction DME0139 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0139 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00117 GENEFORM mRNA DME0139 XEOTICID XEO00117 MOACRIVE Induction DME0139 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0139 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00165 DESCRIPT Obeticholic acid up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00165 GENEFORM mRNA DME0139 XEOTICID XEO00165 MOACRIVE Induction DME0139 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0139 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00217 GENEFORM mRNA DME0139 XEOTICID XEO00217 MOACRIVE Induction DME0139 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0139 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00241 GENEFORM mRNA DME0139 XEOTICID XEO00241 MOACRIVE Induction DME0139 XEOTICID XEO00253 XEO_NAME Tretinoin DME0139 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00253 DESCRIPT Tretinoin induces the drug-metabolizing activity of DME UPP1 DME0139 XEOTICID XEO00253 GENEFORM Protein DME0139 XEOTICID XEO00253 MOACRIVE Induction DME0139 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0139 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME UPP1 DME0139 XEOTICID XEO00292 GENEFORM mRNA DME0139 XEOTICID XEO00292 MOACRIVE Inhibition DME0139 XEOTICID XEO00334 XEO_NAME Cisplatin DME0139 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME UPP1 DME0139 XEOTICID XEO00334 GENEFORM mRNA DME0139 XEOTICID XEO00334 MOACRIVE Inhibition DME0139 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0139 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00339 GENEFORM mRNA DME0139 XEOTICID XEO00339 MOACRIVE Induction DME0139 XEOTICID XEO00366 XEO_NAME Methotrexate DME0139 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00366 DESCRIPT Methotrexate up-regulates the expression of DME UPP1 and leads to increasing the drug-metabolizing activity of this enzyme DME0139 XEOTICID XEO00366 GENEFORM Protein DME0139 XEOTICID XEO00366 MOACRIVE Induction DME0139 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0139 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00430 DESCRIPT Hydroquinone up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00430 GENEFORM mRNA DME0139 XEOTICID XEO00430 MOACRIVE Induction DME0139 XEOTICID XEO00435 XEO_NAME Urethane DME0139 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0139 XEOTICID XEO00435 DESCRIPT Urethane up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00435 GENEFORM mRNA DME0139 XEOTICID XEO00435 MOACRIVE Induction DME0139 XEOTICID XEO00539 XEO_NAME Ethanol DME0139 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0139 XEOTICID XEO00539 DESCRIPT Ethanol up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00539 GENEFORM mRNA DME0139 XEOTICID XEO00539 MOACRIVE Induction DME0139 XEOTICID XEO00656 XEO_NAME Sulindac sulfide DME0139 XEOTICID XEO00656 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00656 XEO_CLAS Drug in Phase 2 Clinical Trial DME0139 XEOTICID XEO00656 DESCRIPT Sulindac sulfide up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00656 GENEFORM mRNA DME0139 XEOTICID XEO00656 MOACRIVE Induction DME0139 XEOTICID XEO00673 XEO_NAME ZIO-101 DME0139 XEOTICID XEO00673 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00673 XEO_CLAS Drug in Phase 2 Clinical Trial DME0139 XEOTICID XEO00673 DESCRIPT ZIO-101 up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00673 GENEFORM mRNA DME0139 XEOTICID XEO00673 MOACRIVE Induction DME0139 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0139 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0139 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME UPP1 DME0139 XEOTICID XEO00723 GENEFORM mRNA DME0139 XEOTICID XEO00723 MOACRIVE Inhibition DME0139 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0139 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0139 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0139 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00806 GENEFORM mRNA DME0139 XEOTICID XEO00806 MOACRIVE Induction DME0139 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0139 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0139 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0139 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00821 GENEFORM mRNA DME0139 XEOTICID XEO00821 MOACRIVE Induction DME0139 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0139 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0139 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0139 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00898 GENEFORM mRNA DME0139 XEOTICID XEO00898 MOACRIVE Induction DME0139 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0139 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0139 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0139 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00905 GENEFORM mRNA DME0139 XEOTICID XEO00905 MOACRIVE Induction DME0139 XEOTICID XEO00971 XEO_NAME Diquat DME0139 XEOTICID XEO00971 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0139 XEOTICID XEO00971 XEO_CLAS Herbicide DME0139 XEOTICID XEO00971 DESCRIPT Diquat up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00971 GENEFORM mRNA DME0139 XEOTICID XEO00971 MOACRIVE Induction DME0139 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0139 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0139 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0139 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO00999 GENEFORM mRNA DME0139 XEOTICID XEO00999 MOACRIVE Induction DME0139 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0139 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0139 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0139 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO01004 GENEFORM mRNA DME0139 XEOTICID XEO01004 MOACRIVE Induction DME0139 XEOTICID XEO01023 XEO_NAME Sodium arsenate DME0139 XEOTICID XEO01023 XEO_TYPE Health or Environmental Toxicant(s) DME0139 XEOTICID XEO01023 XEO_CLAS Environmental Pollutant DME0139 XEOTICID XEO01023 DESCRIPT Sodium arsenate up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO01023 GENEFORM mRNA DME0139 XEOTICID XEO01023 MOACRIVE Induction DME0139 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0139 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0139 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0139 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO01031 GENEFORM mRNA DME0139 XEOTICID XEO01031 MOACRIVE Induction DME0139 XEOTICID XEO01074 XEO_NAME Endosulfan DME0139 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0139 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0139 XEOTICID XEO01074 DESCRIPT Endosulfan up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO01074 GENEFORM mRNA DME0139 XEOTICID XEO01074 MOACRIVE Induction DME0139 XEOTICID XEO01081 XEO_NAME Thioxotriazole copper(II) DME0139 XEOTICID XEO01081 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO01081 XEO_CLAS Investigative Agent DME0139 XEOTICID XEO01081 DESCRIPT Thioxotriazole copper(II) up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO01081 GENEFORM mRNA DME0139 XEOTICID XEO01081 MOACRIVE Induction DME0139 XEOTICID XEO01122 XEO_NAME 2-butenal DME0139 XEOTICID XEO01122 XEO_TYPE Health or Environmental Toxicant(s) DME0139 XEOTICID XEO01122 XEO_CLAS Acute Toxic Substance DME0139 XEOTICID XEO01122 DESCRIPT 2-butenal up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO01122 GENEFORM mRNA DME0139 XEOTICID XEO01122 MOACRIVE Induction DME0139 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0139 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0139 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME UPP1 DME0139 XEOTICID XEO01226 GENEFORM mRNA DME0139 XEOTICID XEO01226 MOACRIVE Inhibition DME0139 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0139 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0139 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0139 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO01305 GENEFORM mRNA DME0139 XEOTICID XEO01305 MOACRIVE Induction DME0139 XEOTICID XEO01336 XEO_NAME ICG-001 DME0139 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0139 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0139 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO01336 GENEFORM mRNA DME0139 XEOTICID XEO01336 MOACRIVE Induction DME0139 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0139 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0139 XEOTICID XEO01494 XEO_CLAS Natural Product DME0139 XEOTICID XEO01494 DESCRIPT Tunicamycin A up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO01494 GENEFORM mRNA DME0139 XEOTICID XEO01494 MOACRIVE Induction DME0139 XEOTICID XEO01503 XEO_NAME Cadmium DME0139 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0139 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0139 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME UPP1 DME0139 XEOTICID XEO01503 GENEFORM mRNA DME0139 XEOTICID XEO01503 MOACRIVE Induction DME0140 DME___ID DME0140 DME0140 DME_NAME Uridine phosphorylase 2 (UPP2) DME0140 SPESNAME Homo sapiens DME0140 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0140 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0140 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0140 XEOTICID XEO00165 DESCRIPT Obeticholic acid up-regulates the expression of DME UPP2 DME0140 XEOTICID XEO00165 GENEFORM mRNA DME0140 XEOTICID XEO00165 MOACRIVE Induction DME0140 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0140 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0140 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0140 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME UPP2 DME0140 XEOTICID XEO00217 GENEFORM mRNA DME0140 XEOTICID XEO00217 MOACRIVE Inhibition DME0141 DME___ID DME0141 DME0141 DME_NAME Dihydrofolate reductase (DHFR) DME0141 SPESNAME Homo sapiens DME0141 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0141 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00037 DESCRIPT Fluorouracil up-regulates the expression of DME DHFR DME0141 XEOTICID XEO00037 GENEFORM mRNA DME0141 XEOTICID XEO00037 MOACRIVE Induction DME0141 XEOTICID XEO00090 XEO_NAME Estradiol DME0141 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME DHFR DME0141 XEOTICID XEO00090 GENEFORM mRNA DME0141 XEOTICID XEO00090 MOACRIVE Induction DME0141 XEOTICID XEO00097 XEO_NAME Cytarabine DME0141 XEOTICID XEO00097 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00097 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00097 DESCRIPT Cytarabine up-regulates the expression of DME DHFR DME0141 XEOTICID XEO00097 GENEFORM mRNA DME0141 XEOTICID XEO00097 MOACRIVE Induction DME0141 XEOTICID XEO00115 XEO_NAME Dronabinol DME0141 XEOTICID XEO00115 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00115 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00115 DESCRIPT Dronabinol inhibits the expression of DME DHFR DME0141 XEOTICID XEO00115 GENEFORM mRNA DME0141 XEOTICID XEO00115 MOACRIVE Inhibition DME0141 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0141 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME DHFR DME0141 XEOTICID XEO00117 GENEFORM mRNA DME0141 XEOTICID XEO00117 MOACRIVE Inhibition DME0141 XEOTICID XEO00120 XEO_NAME Cefazolin DME0141 XEOTICID XEO00120 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00120 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00120 DESCRIPT Cefazolin inhibits the drug-metabolizing activity of DME DHFR DME0141 XEOTICID XEO00120 GENEFORM Protein DME0141 XEOTICID XEO00120 MOACRIVE Inhibition DME0141 XEOTICID XEO00154 XEO_NAME Levofloxacin DME0141 XEOTICID XEO00154 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00154 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00154 DESCRIPT Levof DMEloxacin inhibits the drug-metabolizing activity of DME DHFR DME0141 XEOTICID XEO00154 GENEFORM Protein DME0141 XEOTICID XEO00154 MOACRIVE Inhibition DME0141 XEOTICID XEO00181 XEO_NAME Dasatinib DME0141 XEOTICID XEO00181 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00181 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00181 DESCRIPT Dasatinib inhibits the expression of DME DHFR DME0141 XEOTICID XEO00181 GENEFORM mRNA DME0141 XEOTICID XEO00181 MOACRIVE Inhibition DME0141 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0141 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME DHFR DME0141 XEOTICID XEO00186 GENEFORM mRNA DME0141 XEOTICID XEO00186 MOACRIVE Inhibition DME0141 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0141 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME DHFR DME0141 XEOTICID XEO00217 GENEFORM mRNA DME0141 XEOTICID XEO00217 MOACRIVE Induction DME0141 XEOTICID XEO00237 XEO_NAME Ceftazidime DME0141 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of DME DHFR DME0141 XEOTICID XEO00237 GENEFORM Protein DME0141 XEOTICID XEO00237 MOACRIVE Inhibition DME0141 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0141 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME DHFR DME0141 XEOTICID XEO00292 GENEFORM mRNA DME0141 XEOTICID XEO00292 MOACRIVE Inhibition DME0141 XEOTICID XEO00306 XEO_NAME Mecamylamine hydrochloride DME0141 XEOTICID XEO00306 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00306 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00306 DESCRIPT Mecamylamine hydrochloride inhibits the drug-metabolizing activity of DME DHFR DME0141 XEOTICID XEO00306 GENEFORM Protein DME0141 XEOTICID XEO00306 MOACRIVE Inhibition DME0141 XEOTICID XEO00334 XEO_NAME Cisplatin DME0141 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME DHFR DME0141 XEOTICID XEO00334 GENEFORM mRNA DME0141 XEOTICID XEO00334 MOACRIVE Induction DME0141 XEOTICID XEO00345 XEO_NAME Cefepime DME0141 XEOTICID XEO00345 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00345 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00345 DESCRIPT Cefepime inhibits the drug-metabolizing activity of DME DHFR DME0141 XEOTICID XEO00345 GENEFORM Protein DME0141 XEOTICID XEO00345 MOACRIVE Inhibition DME0141 XEOTICID XEO00346 XEO_NAME Ceftizoxime DME0141 XEOTICID XEO00346 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00346 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00346 DESCRIPT Ceftizoxime inhibits the drug-metabolizing activity of DME DHFR DME0141 XEOTICID XEO00346 GENEFORM Protein DME0141 XEOTICID XEO00346 MOACRIVE Inhibition DME0141 XEOTICID XEO00347 XEO_NAME Ceftriaxone DME0141 XEOTICID XEO00347 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00347 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00347 DESCRIPT Ceftriaxone inhibits the drug-metabolizing activity of DME DHFR DME0141 XEOTICID XEO00347 GENEFORM Protein DME0141 XEOTICID XEO00347 MOACRIVE Inhibition DME0141 XEOTICID XEO00363 XEO_NAME Leucovorin DME0141 XEOTICID XEO00363 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00363 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00363 DESCRIPT Leucovorin induces the drug-metabolizing activity of DME DHFR DME0141 XEOTICID XEO00363 GENEFORM Protein DME0141 XEOTICID XEO00363 MOACRIVE Induction DME0141 XEOTICID XEO00366 XEO_NAME Methotrexate DME0141 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00366 DESCRIPT Methotrexate inhibits the expression of DME DHFR DME0141 XEOTICID XEO00366 GENEFORM mRNA DME0141 XEOTICID XEO00366 MOACRIVE Inhibition DME0141 XEOTICID XEO00383 XEO_NAME Tamoxifen DME0141 XEOTICID XEO00383 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00383 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00383 DESCRIPT Tamoxifen up-regulates the expression of DME DHFR DME0141 XEOTICID XEO00383 GENEFORM mRNA DME0141 XEOTICID XEO00383 MOACRIVE Induction DME0141 XEOTICID XEO00435 XEO_NAME Urethane DME0141 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME DHFR DME0141 XEOTICID XEO00435 GENEFORM mRNA DME0141 XEOTICID XEO00435 MOACRIVE Inhibition DME0141 XEOTICID XEO00466 XEO_NAME Demecolcine DME0141 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0141 XEOTICID XEO00466 DESCRIPT Demecolcine inhibits the expression of DME DHFR DME0141 XEOTICID XEO00466 GENEFORM mRNA DME0141 XEOTICID XEO00466 MOACRIVE Inhibition DME0141 XEOTICID XEO00539 XEO_NAME Ethanol DME0141 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0141 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the expression of DME DHFR DME0141 XEOTICID XEO00539 GENEFORM mRNA DME0141 XEOTICID XEO00539 MOACRIVE Inhibition DME0141 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME0141 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME0141 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of DME DHFR DME0141 XEOTICID XEO00613 GENEFORM Protein DME0141 XEOTICID XEO00613 MOACRIVE Inhibition DME0141 XEOTICID XEO00692 XEO_NAME Emodin DME0141 XEOTICID XEO00692 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00692 XEO_CLAS Preclinical/Patented Drug DME0141 XEOTICID XEO00692 DESCRIPT Emodin inhibits the expression of DME DHFR DME0141 XEOTICID XEO00692 GENEFORM mRNA DME0141 XEOTICID XEO00692 MOACRIVE Inhibition DME0141 XEOTICID XEO00730 XEO_NAME Ferulic acid DME0141 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME0141 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of DME DHFR DME0141 XEOTICID XEO00730 GENEFORM Protein DME0141 XEOTICID XEO00730 MOACRIVE Inhibition DME0141 XEOTICID XEO00816 XEO_NAME Aflatoxin M1 DME0141 XEOTICID XEO00816 XEO_TYPE Health or Environmental Toxicant(s) DME0141 XEOTICID XEO00816 XEO_CLAS Carcinogen DME0141 XEOTICID XEO00816 DESCRIPT Aflatoxin M1 inhibits the expression of DME DHFR DME0141 XEOTICID XEO00816 GENEFORM mRNA DME0141 XEOTICID XEO00816 MOACRIVE Inhibition DME0141 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0141 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0141 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0141 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene induces the drug-metabolizing activity of DME DHFR DME0141 XEOTICID XEO00898 GENEFORM Protein DME0141 XEOTICID XEO00898 MOACRIVE Induction DME0141 XEOTICID XEO01095 XEO_NAME 14-deoxy-11,12-didehydroandrographolide DME0141 XEOTICID XEO01095 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0141 XEOTICID XEO01095 XEO_CLAS Natural Product DME0141 XEOTICID XEO01095 DESCRIPT 14-deoxy-11,12-didehydroandrographolide inhibits the expression of DME DHFR DME0141 XEOTICID XEO01095 GENEFORM mRNA DME0141 XEOTICID XEO01095 MOACRIVE Inhibition DME0141 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0141 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0141 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0141 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium inhibits the expression of DME DHFR DME0141 XEOTICID XEO01103 GENEFORM mRNA DME0141 XEOTICID XEO01103 MOACRIVE Inhibition DME0141 XEOTICID XEO01124 XEO_NAME 2-desamino-2-methylaminopterin DME0141 XEOTICID XEO01124 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO01124 XEO_CLAS Investigative Agent DME0141 XEOTICID XEO01124 DESCRIPT 2-desamino-2-methylaminopterin inhibits the drug-metabolizing activity of DME DHFR DME0141 XEOTICID XEO01124 GENEFORM Protein DME0141 XEOTICID XEO01124 MOACRIVE Inhibition DME0141 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0141 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0141 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME DHFR DME0141 XEOTICID XEO01226 GENEFORM mRNA DME0141 XEOTICID XEO01226 MOACRIVE Inhibition DME0141 XEOTICID XEO01261 XEO_NAME Coumestrol DME0141 XEOTICID XEO01261 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO01261 XEO_CLAS Investigative Agent DME0141 XEOTICID XEO01261 DESCRIPT Coumestrol up-regulates the expression of DME DHFR DME0141 XEOTICID XEO01261 GENEFORM mRNA DME0141 XEOTICID XEO01261 MOACRIVE Induction DME0141 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0141 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0141 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0141 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME DHFR DME0141 XEOTICID XEO01305 GENEFORM mRNA DME0141 XEOTICID XEO01305 MOACRIVE Inhibition DME0141 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0141 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0141 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME DHFR DME0141 XEOTICID XEO01324 GENEFORM mRNA DME0141 XEOTICID XEO01324 MOACRIVE Inhibition DME0141 XEOTICID XEO01348 XEO_NAME K-7174 DME0141 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0141 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0141 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME DHFR DME0141 XEOTICID XEO01348 GENEFORM mRNA DME0141 XEOTICID XEO01348 MOACRIVE Inhibition DME0141 XEOTICID XEO01391 XEO_NAME Naringin DME0141 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0141 XEOTICID XEO01391 XEO_CLAS Natural Product DME0141 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of DME DHFR DME0141 XEOTICID XEO01391 GENEFORM Protein DME0141 XEOTICID XEO01391 MOACRIVE Inhibition DME0141 XEOTICID XEO01540 XEO_NAME Epicatechin gallate DME0141 XEOTICID XEO01540 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0141 XEOTICID XEO01540 XEO_CLAS Natural Product DME0141 XEOTICID XEO01540 DESCRIPT Epicatechin gallate inhibits the drug-metabolizing activity of DME DHFR DME0141 XEOTICID XEO01540 GENEFORM Protein DME0141 XEOTICID XEO01540 MOACRIVE Inhibition DME0141 XEOTICID XEO01553 XEO_NAME Isoflavone DME0141 XEOTICID XEO01553 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0141 XEOTICID XEO01553 XEO_CLAS Natural Product DME0141 XEOTICID XEO01553 DESCRIPT Isoflavone inhibits the expression of DME DHFR DME0141 XEOTICID XEO01553 GENEFORM mRNA DME0141 XEOTICID XEO01553 MOACRIVE Inhibition DME0141 XEOTICID XEO01594 XEO_NAME Alpha-cobratoxin DME0141 XEOTICID XEO01594 XEO_TYPE Health or Environmental Toxicant(s) DME0141 XEOTICID XEO01594 XEO_CLAS Neurotoxin DME0141 XEOTICID XEO01594 DESCRIPT Alpha-cobratoxin inhibits the expression of DME DHFR DME0141 XEOTICID XEO01594 GENEFORM mRNA DME0141 XEOTICID XEO01594 MOACRIVE Inhibition DME0142 DME___ID DME0142 DME0142 DME_NAME Gamma-Glu-X carboxypeptidase (GGH) DME0142 SPESNAME Homo sapiens DME0142 XEOTICID XEO00007 XEO_NAME Azathioprine DME0142 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0142 XEOTICID XEO00007 DESCRIPT Azathioprine inhibits the expression of DME GGH DME0142 XEOTICID XEO00007 GENEFORM mRNA DME0142 XEOTICID XEO00007 MOACRIVE Inhibition DME0142 XEOTICID XEO00079 XEO_NAME Vorinostat DME0142 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0142 XEOTICID XEO00079 DESCRIPT Vorinostat up-regulates the expression of DME GGH DME0142 XEOTICID XEO00079 GENEFORM mRNA DME0142 XEOTICID XEO00079 MOACRIVE Induction DME0142 XEOTICID XEO00090 XEO_NAME Estradiol DME0142 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0142 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME GGH DME0142 XEOTICID XEO00090 GENEFORM mRNA DME0142 XEOTICID XEO00090 MOACRIVE Induction DME0142 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0142 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0142 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME GGH DME0142 XEOTICID XEO00117 GENEFORM mRNA DME0142 XEOTICID XEO00117 MOACRIVE Inhibition DME0142 XEOTICID XEO00184 XEO_NAME Calcitriol DME0142 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0142 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME GGH DME0142 XEOTICID XEO00184 GENEFORM mRNA DME0142 XEOTICID XEO00184 MOACRIVE Inhibition DME0142 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0142 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0142 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME GGH DME0142 XEOTICID XEO00217 GENEFORM mRNA DME0142 XEOTICID XEO00217 MOACRIVE Induction DME0142 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0142 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0142 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME GGH DME0142 XEOTICID XEO00241 GENEFORM mRNA DME0142 XEOTICID XEO00241 MOACRIVE Inhibition DME0142 XEOTICID XEO00334 XEO_NAME Cisplatin DME0142 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0142 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME GGH DME0142 XEOTICID XEO00334 GENEFORM mRNA DME0142 XEOTICID XEO00334 MOACRIVE Induction DME0142 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0142 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0142 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME GGH DME0142 XEOTICID XEO00339 GENEFORM mRNA DME0142 XEOTICID XEO00339 MOACRIVE Induction DME0142 XEOTICID XEO00366 XEO_NAME Methotrexate DME0142 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0142 XEOTICID XEO00366 DESCRIPT Methotrexate inhibits the expression of DME GGH DME0142 XEOTICID XEO00366 GENEFORM mRNA DME0142 XEOTICID XEO00366 MOACRIVE Inhibition DME0142 XEOTICID XEO00404 XEO_NAME Folic acid DME0142 XEOTICID XEO00404 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO00404 XEO_CLAS Approved/Marketed Drug DME0142 XEOTICID XEO00404 DESCRIPT Folic acid inhibits the drug-metabolizing activity of DME GGH DME0142 XEOTICID XEO00404 GENEFORM Protein DME0142 XEOTICID XEO00404 MOACRIVE Inhibition DME0142 XEOTICID XEO00557 XEO_NAME Genistein DME0142 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0142 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME GGH DME0142 XEOTICID XEO00557 GENEFORM mRNA DME0142 XEOTICID XEO00557 MOACRIVE Induction DME0142 XEOTICID XEO00585 XEO_NAME Tetrahydropalmatine DME0142 XEOTICID XEO00585 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO00585 XEO_CLAS Drug in Phase 2 Clinical Trial DME0142 XEOTICID XEO00585 DESCRIPT Tetrahydropalmatine up-regulates the expression of DME GGH DME0142 XEOTICID XEO00585 GENEFORM mRNA DME0142 XEOTICID XEO00585 MOACRIVE Induction DME0142 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0142 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0142 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0142 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME GGH DME0142 XEOTICID XEO00898 GENEFORM mRNA DME0142 XEOTICID XEO00898 MOACRIVE Induction DME0142 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0142 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0142 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0142 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME GGH DME0142 XEOTICID XEO01050 GENEFORM mRNA DME0142 XEOTICID XEO01050 MOACRIVE Inhibition DME0142 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0142 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0142 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME GGH DME0142 XEOTICID XEO01226 GENEFORM mRNA DME0142 XEOTICID XEO01226 MOACRIVE Inhibition DME0142 XEOTICID XEO01261 XEO_NAME Coumestrol DME0142 XEOTICID XEO01261 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO01261 XEO_CLAS Investigative Agent DME0142 XEOTICID XEO01261 DESCRIPT Coumestrol up-regulates the expression of DME GGH DME0142 XEOTICID XEO01261 GENEFORM mRNA DME0142 XEOTICID XEO01261 MOACRIVE Induction DME0142 XEOTICID XEO01348 XEO_NAME K-7174 DME0142 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0142 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0142 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME GGH DME0142 XEOTICID XEO01348 GENEFORM mRNA DME0142 XEOTICID XEO01348 MOACRIVE Inhibition DME0142 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0142 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0142 XEOTICID XEO01494 XEO_CLAS Natural Product DME0142 XEOTICID XEO01494 DESCRIPT Tunicamycin A inhibits the expression of DME GGH DME0142 XEOTICID XEO01494 GENEFORM mRNA DME0142 XEOTICID XEO01494 MOACRIVE Inhibition DME0143 DME___ID DME0143 DME0143 DME_NAME Histamine N-methyltransferase (HNMT) DME0143 SPESNAME Homo sapiens DME0143 XEOTICID XEO00029 XEO_NAME Valproic acid DME0143 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0143 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME HNMT DME0143 XEOTICID XEO00029 GENEFORM mRNA DME0143 XEOTICID XEO00029 MOACRIVE Inhibition DME0143 XEOTICID XEO00079 XEO_NAME Vorinostat DME0143 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0143 XEOTICID XEO00079 DESCRIPT Vorinostat up-regulates the expression of DME HNMT DME0143 XEOTICID XEO00079 GENEFORM mRNA DME0143 XEOTICID XEO00079 MOACRIVE Induction DME0143 XEOTICID XEO00090 XEO_NAME Estradiol DME0143 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0143 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME HNMT DME0143 XEOTICID XEO00090 GENEFORM mRNA DME0143 XEOTICID XEO00090 MOACRIVE Induction DME0143 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0143 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0143 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME HNMT DME0143 XEOTICID XEO00117 GENEFORM mRNA DME0143 XEOTICID XEO00117 MOACRIVE Inhibition DME0143 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0143 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0143 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME HNMT DME0143 XEOTICID XEO00217 GENEFORM mRNA DME0143 XEOTICID XEO00217 MOACRIVE Inhibition DME0143 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0143 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0143 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME HNMT DME0143 XEOTICID XEO00241 GENEFORM mRNA DME0143 XEOTICID XEO00241 MOACRIVE Inhibition DME0143 XEOTICID XEO00344 XEO_NAME Caspofungin DME0143 XEOTICID XEO00344 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO00344 XEO_CLAS Approved/Marketed Drug DME0143 XEOTICID XEO00344 DESCRIPT Caspof DMEungin inhibits the drug-metabolizing activity of DME HNMT DME0143 XEOTICID XEO00344 GENEFORM Protein DME0143 XEOTICID XEO00344 MOACRIVE Inhibition DME0143 XEOTICID XEO00372 XEO_NAME Panobinostat DME0143 XEOTICID XEO00372 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO00372 XEO_CLAS Approved/Marketed Drug DME0143 XEOTICID XEO00372 DESCRIPT Panobinostat up-regulates the expression of DME HNMT DME0143 XEOTICID XEO00372 GENEFORM mRNA DME0143 XEOTICID XEO00372 MOACRIVE Induction DME0143 XEOTICID XEO00435 XEO_NAME Urethane DME0143 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0143 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME HNMT DME0143 XEOTICID XEO00435 GENEFORM mRNA DME0143 XEOTICID XEO00435 MOACRIVE Inhibition DME0143 XEOTICID XEO00538 XEO_NAME Quercetin DME0143 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0143 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME HNMT DME0143 XEOTICID XEO00538 GENEFORM mRNA DME0143 XEOTICID XEO00538 MOACRIVE Inhibition DME0143 XEOTICID XEO00547 XEO_NAME Vitamin E DME0143 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0143 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the expression of DME HNMT DME0143 XEOTICID XEO00547 GENEFORM mRNA DME0143 XEOTICID XEO00547 MOACRIVE Inhibition DME0143 XEOTICID XEO00560 XEO_NAME Triclosan DME0143 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0143 XEOTICID XEO00560 DESCRIPT Triclosan induces the drug-metabolizing activity of DME HNMT DME0143 XEOTICID XEO00560 GENEFORM Protein DME0143 XEOTICID XEO00560 MOACRIVE Induction DME0143 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0143 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0143 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0143 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME HNMT DME0143 XEOTICID XEO00806 GENEFORM mRNA DME0143 XEOTICID XEO00806 MOACRIVE Inhibition DME0143 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0143 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0143 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0143 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME HNMT DME0143 XEOTICID XEO00821 GENEFORM Protein DME0143 XEOTICID XEO00821 MOACRIVE Inhibition DME0143 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0143 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0143 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0143 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene induces the drug-metabolizing activity of DME HNMT DME0143 XEOTICID XEO00898 GENEFORM Protein DME0143 XEOTICID XEO00898 MOACRIVE Induction DME0143 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0143 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0143 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0143 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME HNMT DME0143 XEOTICID XEO00999 GENEFORM mRNA DME0143 XEOTICID XEO00999 MOACRIVE Inhibition DME0143 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0143 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0143 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0143 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME HNMT DME0143 XEOTICID XEO01004 GENEFORM mRNA DME0143 XEOTICID XEO01004 MOACRIVE Induction DME0143 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0143 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0143 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0143 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME HNMT DME0143 XEOTICID XEO01050 GENEFORM mRNA DME0143 XEOTICID XEO01050 MOACRIVE Inhibition DME0143 XEOTICID XEO01194 XEO_NAME AM-251 DME0143 XEOTICID XEO01194 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO01194 XEO_CLAS Preclinical/Patented Drug DME0143 XEOTICID XEO01194 DESCRIPT AM-251 up-regulates the expression of DME HNMT DME0143 XEOTICID XEO01194 GENEFORM mRNA DME0143 XEOTICID XEO01194 MOACRIVE Induction DME0143 XEOTICID XEO01348 XEO_NAME K-7174 DME0143 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0143 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME HNMT DME0143 XEOTICID XEO01348 GENEFORM mRNA DME0143 XEOTICID XEO01348 MOACRIVE Inhibition DME0143 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0143 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0143 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0143 XEOTICID XEO01492 DESCRIPT Trichostatin A inhibits the expression of DME HNMT DME0143 XEOTICID XEO01492 GENEFORM mRNA DME0143 XEOTICID XEO01492 MOACRIVE Inhibition DME0143 XEOTICID XEO01551 XEO_NAME Heliotrine DME0143 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0143 XEOTICID XEO01551 XEO_CLAS Natural Product DME0143 XEOTICID XEO01551 DESCRIPT Heliotrine inhibits the expression of DME HNMT DME0143 XEOTICID XEO01551 GENEFORM mRNA DME0143 XEOTICID XEO01551 MOACRIVE Inhibition DME0143 XEOTICID XEO01582 XEO_NAME Pyrrolizidine alkaloid DME0143 XEOTICID XEO01582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0143 XEOTICID XEO01582 XEO_CLAS Natural Product DME0143 XEOTICID XEO01582 DESCRIPT Pyrrolizidine alkaloid inhibits the expression of DME HNMT DME0143 XEOTICID XEO01582 GENEFORM mRNA DME0143 XEOTICID XEO01582 MOACRIVE Inhibition DME0143 XEOTICID XEO01585 XEO_NAME Senecionine DME0143 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0143 XEOTICID XEO01585 XEO_CLAS Natural Product DME0143 XEOTICID XEO01585 DESCRIPT Senecionine inhibits the drug-metabolizing activity of DME HNMT DME0143 XEOTICID XEO01585 GENEFORM Protein DME0143 XEOTICID XEO01585 MOACRIVE Inhibition DME0144 DME___ID DME0144 DME0144 DME_NAME Alpha-N-acetylglucosaminidase (NAG) DME0144 SPESNAME Homo sapiens DME0144 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0144 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0144 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0144 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME NAGLU DME0144 XEOTICID XEO00117 GENEFORM mRNA DME0144 XEOTICID XEO00117 MOACRIVE Inhibition DME0144 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0144 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0144 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0144 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME NAGLU DME0144 XEOTICID XEO00241 GENEFORM mRNA DME0144 XEOTICID XEO00241 MOACRIVE Inhibition DME0144 XEOTICID XEO00253 XEO_NAME Tretinoin DME0144 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0144 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0144 XEOTICID XEO00253 DESCRIPT Tretinoin induces the drug-metabolizing activity of DME NAGLU DME0144 XEOTICID XEO00253 GENEFORM Protein DME0144 XEOTICID XEO00253 MOACRIVE Induction DME0144 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0144 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0144 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0144 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME NAGLU DME0144 XEOTICID XEO00292 GENEFORM mRNA DME0144 XEOTICID XEO00292 MOACRIVE Induction DME0144 XEOTICID XEO00581 XEO_NAME MS-275 DME0144 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0144 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0144 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME NAGLU DME0144 XEOTICID XEO00581 GENEFORM mRNA DME0144 XEOTICID XEO00581 MOACRIVE Induction DME0144 XEOTICID XEO00760 XEO_NAME Jinfukang DME0144 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0144 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0144 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME NAGLU DME0144 XEOTICID XEO00760 GENEFORM mRNA DME0144 XEOTICID XEO00760 MOACRIVE Induction DME0144 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0144 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0144 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0144 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME NAGLU DME0144 XEOTICID XEO01324 GENEFORM mRNA DME0144 XEOTICID XEO01324 MOACRIVE Inhibition DME0144 XEOTICID XEO01436 XEO_NAME PP242 DME0144 XEOTICID XEO01436 XEO_TYPE Pharmaceutical Agent(s) DME0144 XEOTICID XEO01436 XEO_CLAS Investigative Agent DME0144 XEOTICID XEO01436 DESCRIPT PP242 inhibits the expression of DME NAGLU DME0144 XEOTICID XEO01436 GENEFORM mRNA DME0144 XEOTICID XEO01436 MOACRIVE Inhibition DME0145 DME___ID DME0145 DME0145 DME_NAME Alanyl aminopeptidase (ANPEP) DME0145 SPESNAME Homo sapiens DME0145 XEOTICID XEO00086 XEO_NAME Troglitazone DME0145 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME ANPEP DME0145 XEOTICID XEO00086 GENEFORM mRNA DME0145 XEOTICID XEO00086 MOACRIVE Induction DME0145 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0145 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME ANPEP DME0145 XEOTICID XEO00117 GENEFORM mRNA DME0145 XEOTICID XEO00117 MOACRIVE Inhibition DME0145 XEOTICID XEO00127 XEO_NAME Mifepristone DME0145 XEOTICID XEO00127 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00127 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00127 DESCRIPT Mifepristone inhibits the drug-metabolizing activity of DME ANPEP DME0145 XEOTICID XEO00127 GENEFORM Protein DME0145 XEOTICID XEO00127 MOACRIVE Inhibition DME0145 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0145 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00140 DESCRIPT Zoledronic acid up-regulates the expression of DME ANPEP DME0145 XEOTICID XEO00140 GENEFORM mRNA DME0145 XEOTICID XEO00140 MOACRIVE Induction DME0145 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0145 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol up-regulates the expression of DME ANPEP DME0145 XEOTICID XEO00166 GENEFORM mRNA DME0145 XEOTICID XEO00166 MOACRIVE Induction DME0145 XEOTICID XEO00168 XEO_NAME Decitabine DME0145 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00168 DESCRIPT Decitabine up-regulates the expression of DME ANPEP DME0145 XEOTICID XEO00168 GENEFORM mRNA DME0145 XEOTICID XEO00168 MOACRIVE Induction DME0145 XEOTICID XEO00181 XEO_NAME Dasatinib DME0145 XEOTICID XEO00181 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00181 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00181 DESCRIPT Dasatinib inhibits the drug-metabolizing activity of DME ANPEP DME0145 XEOTICID XEO00181 GENEFORM Protein DME0145 XEOTICID XEO00181 MOACRIVE Inhibition DME0145 XEOTICID XEO00213 XEO_NAME Aspirin DME0145 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00213 DESCRIPT Aspirin induces the drug-metabolizing activity of DME ANPEP DME0145 XEOTICID XEO00213 GENEFORM Protein DME0145 XEOTICID XEO00213 MOACRIVE Induction DME0145 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0145 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ANPEP DME0145 XEOTICID XEO00217 GENEFORM mRNA DME0145 XEOTICID XEO00217 MOACRIVE Inhibition DME0145 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0145 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME ANPEP DME0145 XEOTICID XEO00241 GENEFORM mRNA DME0145 XEOTICID XEO00241 MOACRIVE Inhibition DME0145 XEOTICID XEO00334 XEO_NAME Cisplatin DME0145 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME ANPEP DME0145 XEOTICID XEO00334 GENEFORM mRNA DME0145 XEOTICID XEO00334 MOACRIVE Inhibition DME0145 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0145 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME ANPEP DME0145 XEOTICID XEO00339 GENEFORM mRNA DME0145 XEOTICID XEO00339 MOACRIVE Inhibition DME0145 XEOTICID XEO00366 XEO_NAME Methotrexate DME0145 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00366 DESCRIPT Methotrexate up-regulates the expression of DME ANPEP DME0145 XEOTICID XEO00366 GENEFORM mRNA DME0145 XEOTICID XEO00366 MOACRIVE Induction DME0145 XEOTICID XEO00407 XEO_NAME Cupric chloride DME0145 XEOTICID XEO00407 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00407 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00407 DESCRIPT Cupric chloride inhibits the expression of DME ANPEP DME0145 XEOTICID XEO00407 GENEFORM mRNA DME0145 XEOTICID XEO00407 MOACRIVE Inhibition DME0145 XEOTICID XEO00481 XEO_NAME Rotenone DME0145 XEOTICID XEO00481 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00481 XEO_CLAS Approved/Marketed Drug DME0145 XEOTICID XEO00481 DESCRIPT Rotenone up-regulates the expression of DME ANPEP DME0145 XEOTICID XEO00481 GENEFORM mRNA DME0145 XEOTICID XEO00481 MOACRIVE Induction DME0145 XEOTICID XEO00565 XEO_NAME Fenretinide DME0145 XEOTICID XEO00565 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO00565 XEO_CLAS Drug in Phase 3 Clinical Trial DME0145 XEOTICID XEO00565 DESCRIPT Fenretinide inhibits the drug-metabolizing activity of DME ANPEP DME0145 XEOTICID XEO00565 GENEFORM Protein DME0145 XEOTICID XEO00565 MOACRIVE Inhibition DME0145 XEOTICID XEO00766 XEO_NAME 1,10-phenanthroline DME0145 XEOTICID XEO00766 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0145 XEOTICID XEO00766 XEO_CLAS Chemical Compound DME0145 XEOTICID XEO00766 DESCRIPT 1,10-phenanthroline inhibits the drug-metabolizing activity of DME ANPEP DME0145 XEOTICID XEO00766 GENEFORM Protein DME0145 XEOTICID XEO00766 MOACRIVE Inhibition DME0145 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0145 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0145 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0145 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME ANPEP DME0145 XEOTICID XEO00806 GENEFORM mRNA DME0145 XEOTICID XEO00806 MOACRIVE Inhibition DME0145 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0145 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0145 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0145 XEOTICID XEO01050 DESCRIPT Dicrotophos up-regulates the expression of DME ANPEP DME0145 XEOTICID XEO01050 GENEFORM mRNA DME0145 XEOTICID XEO01050 MOACRIVE Induction DME0145 XEOTICID XEO01336 XEO_NAME ICG-001 DME0145 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0145 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME ANPEP DME0145 XEOTICID XEO01336 GENEFORM mRNA DME0145 XEOTICID XEO01336 MOACRIVE Inhibition DME0145 XEOTICID XEO01348 XEO_NAME K-7174 DME0145 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0145 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0145 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME ANPEP DME0145 XEOTICID XEO01348 GENEFORM mRNA DME0145 XEOTICID XEO01348 MOACRIVE Inhibition DME0146 DME___ID DME0146 DME0146 DME_NAME Phosphoglucomutase 1 (PGM1) DME0146 SPESNAME Homo sapiens DME0146 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0146 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0146 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME PGM1 DME0146 XEOTICID XEO00035 GENEFORM mRNA DME0146 XEOTICID XEO00035 MOACRIVE Induction DME0146 XEOTICID XEO00178 XEO_NAME Capsaicin DME0146 XEOTICID XEO00178 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO00178 XEO_CLAS Approved/Marketed Drug DME0146 XEOTICID XEO00178 DESCRIPT Capsaicin induces the drug-metabolizing activity of DME PGM1 DME0146 XEOTICID XEO00178 GENEFORM Protein DME0146 XEOTICID XEO00178 MOACRIVE Induction DME0146 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0146 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0146 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME PGM1 DME0146 XEOTICID XEO00186 GENEFORM mRNA DME0146 XEOTICID XEO00186 MOACRIVE Inhibition DME0146 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0146 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0146 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME PGM1 DME0146 XEOTICID XEO00217 GENEFORM mRNA DME0146 XEOTICID XEO00217 MOACRIVE Inhibition DME0146 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0146 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0146 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME PGM1 DME0146 XEOTICID XEO00241 GENEFORM mRNA DME0146 XEOTICID XEO00241 MOACRIVE Inhibition DME0146 XEOTICID XEO00253 XEO_NAME Tretinoin DME0146 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0146 XEOTICID XEO00253 DESCRIPT Tretinoin induces the drug-metabolizing activity of DME PGM1 DME0146 XEOTICID XEO00253 GENEFORM Protein DME0146 XEOTICID XEO00253 MOACRIVE Induction DME0146 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0146 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0146 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME PGM1 DME0146 XEOTICID XEO00292 GENEFORM mRNA DME0146 XEOTICID XEO00292 MOACRIVE Induction DME0146 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0146 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0146 XEOTICID XEO00339 DESCRIPT Arsenic trioxide induces the drug-metabolizing activity of DME PGM1 DME0146 XEOTICID XEO00339 GENEFORM Protein DME0146 XEOTICID XEO00339 MOACRIVE Induction DME0146 XEOTICID XEO00392 XEO_NAME Vincristine DME0146 XEOTICID XEO00392 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO00392 XEO_CLAS Approved/Marketed Drug DME0146 XEOTICID XEO00392 DESCRIPT Vincristine inhibits the drug-metabolizing activity of DME PGM1 DME0146 XEOTICID XEO00392 GENEFORM Protein DME0146 XEOTICID XEO00392 MOACRIVE Inhibition DME0146 XEOTICID XEO00435 XEO_NAME Urethane DME0146 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0146 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME PGM1 DME0146 XEOTICID XEO00435 GENEFORM mRNA DME0146 XEOTICID XEO00435 MOACRIVE Inhibition DME0146 XEOTICID XEO00466 XEO_NAME Demecolcine DME0146 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0146 XEOTICID XEO00466 DESCRIPT Demecolcine inhibits the expression of DME PGM1 DME0146 XEOTICID XEO00466 GENEFORM mRNA DME0146 XEOTICID XEO00466 MOACRIVE Inhibition DME0146 XEOTICID XEO00481 XEO_NAME Rotenone DME0146 XEOTICID XEO00481 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO00481 XEO_CLAS Approved/Marketed Drug DME0146 XEOTICID XEO00481 DESCRIPT Rotenone up-regulates the expression of DME PGM1 DME0146 XEOTICID XEO00481 GENEFORM mRNA DME0146 XEOTICID XEO00481 MOACRIVE Induction DME0146 XEOTICID XEO00538 XEO_NAME Quercetin DME0146 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0146 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME PGM1 DME0146 XEOTICID XEO00538 GENEFORM mRNA DME0146 XEOTICID XEO00538 MOACRIVE Inhibition DME0146 XEOTICID XEO00581 XEO_NAME MS-275 DME0146 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0146 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME PGM1 DME0146 XEOTICID XEO00581 GENEFORM mRNA DME0146 XEOTICID XEO00581 MOACRIVE Induction DME0146 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0146 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0146 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0146 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME PGM1 DME0146 XEOTICID XEO00772 GENEFORM mRNA DME0146 XEOTICID XEO00772 MOACRIVE Inhibition DME0146 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0146 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0146 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0146 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME PGM1 DME0146 XEOTICID XEO00806 GENEFORM mRNA DME0146 XEOTICID XEO00806 MOACRIVE Inhibition DME0146 XEOTICID XEO00813 XEO_NAME Dinophysistoxin 1 DME0146 XEOTICID XEO00813 XEO_TYPE Health or Environmental Toxicant(s) DME0146 XEOTICID XEO00813 XEO_CLAS Biotoxin DME0146 XEOTICID XEO00813 DESCRIPT Dinophysistoxin 1 inhibits the expression of DME PGM1 DME0146 XEOTICID XEO00813 GENEFORM mRNA DME0146 XEOTICID XEO00813 MOACRIVE Inhibition DME0146 XEOTICID XEO01192 XEO_NAME Alpha-naphthoflavone DME0146 XEOTICID XEO01192 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0146 XEOTICID XEO01192 XEO_CLAS Natural Product DME0146 XEOTICID XEO01192 DESCRIPT Alpha-naphthoflavone up-regulates the expression of DME PGM1 DME0146 XEOTICID XEO01192 GENEFORM mRNA DME0146 XEOTICID XEO01192 MOACRIVE Induction DME0146 XEOTICID XEO01201 XEO_NAME Antimony potassium tartrate DME0146 XEOTICID XEO01201 XEO_TYPE Health or Environmental Toxicant(s) DME0146 XEOTICID XEO01201 XEO_CLAS Environmental Pollutant DME0146 XEOTICID XEO01201 DESCRIPT Antimony potassium tartrate up-regulates the expression of DME PGM1 DME0146 XEOTICID XEO01201 GENEFORM mRNA DME0146 XEOTICID XEO01201 MOACRIVE Induction DME0146 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0146 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0146 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME PGM1 DME0146 XEOTICID XEO01226 GENEFORM mRNA DME0146 XEOTICID XEO01226 MOACRIVE Induction DME0146 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0146 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0146 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0146 XEOTICID XEO01247 DESCRIPT Chloropicrin inhibits the expression of DME PGM1 DME0146 XEOTICID XEO01247 GENEFORM mRNA DME0146 XEOTICID XEO01247 MOACRIVE Inhibition DME0146 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0146 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0146 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0146 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME PGM1 DME0146 XEOTICID XEO01305 GENEFORM mRNA DME0146 XEOTICID XEO01305 MOACRIVE Inhibition DME0146 XEOTICID XEO01348 XEO_NAME K-7174 DME0146 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0146 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0146 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME PGM1 DME0146 XEOTICID XEO01348 GENEFORM mRNA DME0146 XEOTICID XEO01348 MOACRIVE Inhibition DME0146 XEOTICID XEO01366 XEO_NAME Linalool DME0146 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0146 XEOTICID XEO01366 XEO_CLAS Natural Product DME0146 XEOTICID XEO01366 DESCRIPT Linalool up-regulates the expression of DME PGM1 DME0146 XEOTICID XEO01366 GENEFORM mRNA DME0146 XEOTICID XEO01366 MOACRIVE Induction DME0147 DME___ID DME0147 DME0147 DME_NAME Cellular glutathione peroxidase (GPX1) DME0147 SPESNAME Homo sapiens DME0147 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0147 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00037 DESCRIPT Fluorouracil up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00037 GENEFORM mRNA DME0147 XEOTICID XEO00037 MOACRIVE Induction DME0147 XEOTICID XEO00086 XEO_NAME Troglitazone DME0147 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00086 GENEFORM mRNA DME0147 XEOTICID XEO00086 MOACRIVE Induction DME0147 XEOTICID XEO00090 XEO_NAME Estradiol DME0147 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME GPX1 DME0147 XEOTICID XEO00090 GENEFORM mRNA DME0147 XEOTICID XEO00090 MOACRIVE Inhibition DME0147 XEOTICID XEO00100 XEO_NAME Pyridostigmine bromide DME0147 XEOTICID XEO00100 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00100 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00100 DESCRIPT Pyridostigmine bromide inhibits the expression of DME GPX1 DME0147 XEOTICID XEO00100 GENEFORM mRNA DME0147 XEOTICID XEO00100 MOACRIVE Inhibition DME0147 XEOTICID XEO00115 XEO_NAME Dronabinol DME0147 XEOTICID XEO00115 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00115 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00115 DESCRIPT Dronabinol induces the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO00115 GENEFORM Protein DME0147 XEOTICID XEO00115 MOACRIVE Induction DME0147 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0147 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME GPX1 DME0147 XEOTICID XEO00117 GENEFORM mRNA DME0147 XEOTICID XEO00117 MOACRIVE Inhibition DME0147 XEOTICID XEO00121 XEO_NAME Etoposide DME0147 XEOTICID XEO00121 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00121 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00121 DESCRIPT Etoposide up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00121 GENEFORM mRNA DME0147 XEOTICID XEO00121 MOACRIVE Induction DME0147 XEOTICID XEO00148 XEO_NAME Bosentan DME0147 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00148 DESCRIPT Bosentan inhibits the expression of DME GPX1 DME0147 XEOTICID XEO00148 GENEFORM mRNA DME0147 XEOTICID XEO00148 MOACRIVE Inhibition DME0147 XEOTICID XEO00194 XEO_NAME Omacor DME0147 XEOTICID XEO00194 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00194 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00194 DESCRIPT Omacor up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00194 GENEFORM mRNA DME0147 XEOTICID XEO00194 MOACRIVE Induction DME0147 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0147 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME GPX1 DME0147 XEOTICID XEO00217 GENEFORM mRNA DME0147 XEOTICID XEO00217 MOACRIVE Inhibition DME0147 XEOTICID XEO00233 XEO_NAME Aminoglutethimide DME0147 XEOTICID XEO00233 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00233 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00233 DESCRIPT Aminoglutethimide induces the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO00233 GENEFORM Protein DME0147 XEOTICID XEO00233 MOACRIVE Induction DME0147 XEOTICID XEO00253 XEO_NAME Tretinoin DME0147 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO00253 GENEFORM Protein DME0147 XEOTICID XEO00253 MOACRIVE Inhibition DME0147 XEOTICID XEO00270 XEO_NAME Auranofin DME0147 XEOTICID XEO00270 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00270 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00270 DESCRIPT Auranofin induces the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO00270 GENEFORM Protein DME0147 XEOTICID XEO00270 MOACRIVE Induction DME0147 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0147 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride induces the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO00292 GENEFORM Protein DME0147 XEOTICID XEO00292 MOACRIVE Induction DME0147 XEOTICID XEO00334 XEO_NAME Cisplatin DME0147 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00334 GENEFORM mRNA DME0147 XEOTICID XEO00334 MOACRIVE Induction DME0147 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0147 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO00339 GENEFORM Protein DME0147 XEOTICID XEO00339 MOACRIVE Inhibition DME0147 XEOTICID XEO00351 XEO_NAME Daunorubicin DME0147 XEOTICID XEO00351 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00351 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00351 DESCRIPT Daunorubicin up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00351 GENEFORM mRNA DME0147 XEOTICID XEO00351 MOACRIVE Induction DME0147 XEOTICID XEO00366 XEO_NAME Methotrexate DME0147 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00366 DESCRIPT Methotrexate up-regulates the expression of DME GPX1 and leads to increasing the drug-metabolizing activity of this enzyme DME0147 XEOTICID XEO00366 GENEFORM Protein DME0147 XEOTICID XEO00366 MOACRIVE Induction DME0147 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0147 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO00388 GENEFORM Protein DME0147 XEOTICID XEO00388 MOACRIVE Inhibition DME0147 XEOTICID XEO00481 XEO_NAME Rotenone DME0147 XEOTICID XEO00481 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00481 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00481 DESCRIPT Rotenone up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00481 GENEFORM mRNA DME0147 XEOTICID XEO00481 MOACRIVE Induction DME0147 XEOTICID XEO00511 XEO_NAME Silver nitrate DME0147 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME0147 XEOTICID XEO00511 DESCRIPT Silver nitrate up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00511 GENEFORM mRNA DME0147 XEOTICID XEO00511 MOACRIVE Induction DME0147 XEOTICID XEO00519 XEO_NAME Nimesulide DME0147 XEOTICID XEO00519 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00519 XEO_CLAS Drug Marketed but Withdrawn from Market DME0147 XEOTICID XEO00519 DESCRIPT Nimesulide inhibits the expression of DME GPX1 DME0147 XEOTICID XEO00519 GENEFORM mRNA DME0147 XEOTICID XEO00519 MOACRIVE Inhibition DME0147 XEOTICID XEO00557 XEO_NAME Genistein DME0147 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0147 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00557 GENEFORM mRNA DME0147 XEOTICID XEO00557 MOACRIVE Induction DME0147 XEOTICID XEO00565 XEO_NAME Fenretinide DME0147 XEOTICID XEO00565 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00565 XEO_CLAS Drug in Phase 3 Clinical Trial DME0147 XEOTICID XEO00565 DESCRIPT Fenretinide induces the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO00565 GENEFORM Protein DME0147 XEOTICID XEO00565 MOACRIVE Induction DME0147 XEOTICID XEO00568 XEO_NAME Resveratrol DME0147 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0147 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00568 GENEFORM mRNA DME0147 XEOTICID XEO00568 MOACRIVE Induction DME0147 XEOTICID XEO00583 XEO_NAME NS-398 DME0147 XEOTICID XEO00583 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00583 XEO_CLAS Drug in Phase 1 Clinical Trial DME0147 XEOTICID XEO00583 DESCRIPT NS-398 up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00583 GENEFORM mRNA DME0147 XEOTICID XEO00583 MOACRIVE Induction DME0147 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME0147 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME0147 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the expression of DME GPX1 DME0147 XEOTICID XEO00613 GENEFORM mRNA DME0147 XEOTICID XEO00613 MOACRIVE Inhibition DME0147 XEOTICID XEO00655 XEO_NAME Thiomalates DME0147 XEOTICID XEO00655 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00655 XEO_CLAS Drug in Phase 1 Clinical Trial DME0147 XEOTICID XEO00655 DESCRIPT Thiomalates up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00655 GENEFORM mRNA DME0147 XEOTICID XEO00655 MOACRIVE Induction DME0147 XEOTICID XEO00692 XEO_NAME Emodin DME0147 XEOTICID XEO00692 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00692 XEO_CLAS Preclinical/Patented Drug DME0147 XEOTICID XEO00692 DESCRIPT Emodin up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00692 GENEFORM mRNA DME0147 XEOTICID XEO00692 MOACRIVE Induction DME0147 XEOTICID XEO00696 XEO_NAME Iodoacetate DME0147 XEOTICID XEO00696 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO00696 XEO_CLAS Preclinical/Patented Drug DME0147 XEOTICID XEO00696 DESCRIPT Iodoacetate inhibits the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO00696 GENEFORM Protein DME0147 XEOTICID XEO00696 MOACRIVE Inhibition DME0147 XEOTICID XEO00755 XEO_NAME Coal tar DME0147 XEOTICID XEO00755 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0147 XEOTICID XEO00755 XEO_CLAS Natural Mixture DME0147 XEOTICID XEO00755 DESCRIPT Coal tar up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00755 GENEFORM mRNA DME0147 XEOTICID XEO00755 MOACRIVE Induction DME0147 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0147 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0147 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0147 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00772 GENEFORM mRNA DME0147 XEOTICID XEO00772 MOACRIVE Induction DME0147 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0147 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0147 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0147 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00806 GENEFORM mRNA DME0147 XEOTICID XEO00806 MOACRIVE Induction DME0147 XEOTICID XEO00839 XEO_NAME Aluminum DME0147 XEOTICID XEO00839 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0147 XEOTICID XEO00839 XEO_CLAS Chemical Compound DME0147 XEOTICID XEO00839 DESCRIPT Aluminum inhibits the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO00839 GENEFORM Protein DME0147 XEOTICID XEO00839 MOACRIVE Inhibition DME0147 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0147 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0147 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0147 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME GPX1 DME0147 XEOTICID XEO00898 GENEFORM mRNA DME0147 XEOTICID XEO00898 MOACRIVE Inhibition DME0147 XEOTICID XEO00906 XEO_NAME Leptomycin B DME0147 XEOTICID XEO00906 XEO_TYPE Health or Environmental Toxicant(s) DME0147 XEOTICID XEO00906 XEO_CLAS Biotoxin DME0147 XEOTICID XEO00906 DESCRIPT Leptomycin B up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00906 GENEFORM mRNA DME0147 XEOTICID XEO00906 MOACRIVE Induction DME0147 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0147 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0147 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0147 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid inhibits the expression of DME GPX1 DME0147 XEOTICID XEO00921 GENEFORM mRNA DME0147 XEOTICID XEO00921 MOACRIVE Inhibition DME0147 XEOTICID XEO00947 XEO_NAME Fludioxonil DME0147 XEOTICID XEO00947 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0147 XEOTICID XEO00947 XEO_CLAS Fungicide DME0147 XEOTICID XEO00947 DESCRIPT Fludioxonil up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO00947 GENEFORM mRNA DME0147 XEOTICID XEO00947 MOACRIVE Induction DME0147 XEOTICID XEO00995 XEO_NAME Amphibole asbestos DME0147 XEOTICID XEO00995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0147 XEOTICID XEO00995 XEO_CLAS Natural Mixture DME0147 XEOTICID XEO00995 DESCRIPT Amphibole asbestos inhibits the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO00995 GENEFORM Protein DME0147 XEOTICID XEO00995 MOACRIVE Inhibition DME0147 XEOTICID XEO01147 XEO_NAME SB-431542 DME0147 XEOTICID XEO01147 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO01147 XEO_CLAS Investigative Agent DME0147 XEOTICID XEO01147 DESCRIPT SB-431542 induces the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO01147 GENEFORM Protein DME0147 XEOTICID XEO01147 MOACRIVE Induction DME0147 XEOTICID XEO01187 XEO_NAME Acrylamide DME0147 XEOTICID XEO01187 XEO_TYPE Health or Environmental Toxicant(s) DME0147 XEOTICID XEO01187 XEO_CLAS Acute Toxic Substance DME0147 XEOTICID XEO01187 DESCRIPT Acrylamide inhibits the expression of DME GPX1 DME0147 XEOTICID XEO01187 GENEFORM mRNA DME0147 XEOTICID XEO01187 MOACRIVE Inhibition DME0147 XEOTICID XEO01194 XEO_NAME AM-251 DME0147 XEOTICID XEO01194 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO01194 XEO_CLAS Preclinical/Patented Drug DME0147 XEOTICID XEO01194 DESCRIPT AM-251 up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO01194 GENEFORM mRNA DME0147 XEOTICID XEO01194 MOACRIVE Induction DME0147 XEOTICID XEO01222 XEO_NAME Biochanin A DME0147 XEOTICID XEO01222 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0147 XEOTICID XEO01222 XEO_CLAS Natural Product DME0147 XEOTICID XEO01222 DESCRIPT Biochanin A inhibits the expression of DME GPX1 DME0147 XEOTICID XEO01222 GENEFORM mRNA DME0147 XEOTICID XEO01222 MOACRIVE Inhibition DME0147 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0147 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0147 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME GPX1 and leads to decreasing the drug-metabolizing activity of this enzyme DME0147 XEOTICID XEO01226 GENEFORM Protein DME0147 XEOTICID XEO01226 MOACRIVE Inhibition DME0147 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0147 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0147 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0147 XEOTICID XEO01247 DESCRIPT Chloropicrin inhibits the expression of DME GPX1 DME0147 XEOTICID XEO01247 GENEFORM mRNA DME0147 XEOTICID XEO01247 MOACRIVE Inhibition DME0147 XEOTICID XEO01259 XEO_NAME Cordycepin DME0147 XEOTICID XEO01259 XEO_TYPE Health or Environmental Toxicant(s) DME0147 XEOTICID XEO01259 XEO_CLAS Acute Toxic Substance DME0147 XEOTICID XEO01259 DESCRIPT Cordycepin inhibits the expression of DME GPX1 DME0147 XEOTICID XEO01259 GENEFORM mRNA DME0147 XEOTICID XEO01259 MOACRIVE Inhibition DME0147 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0147 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0147 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0147 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO01305 GENEFORM mRNA DME0147 XEOTICID XEO01305 MOACRIVE Induction DME0147 XEOTICID XEO01331 XEO_NAME Homocysteine DME0147 XEOTICID XEO01331 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO01331 XEO_CLAS Drug in Phase 1 Clinical Trial DME0147 XEOTICID XEO01331 DESCRIPT Homocysteine inhibits the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO01331 GENEFORM Protein DME0147 XEOTICID XEO01331 MOACRIVE Inhibition DME0147 XEOTICID XEO01342 XEO_NAME Indirubin-3'-monoxime DME0147 XEOTICID XEO01342 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO01342 XEO_CLAS Investigative Agent DME0147 XEOTICID XEO01342 DESCRIPT Indirubin-3'-monoxime inhibits the expression of DME GPX1 DME0147 XEOTICID XEO01342 GENEFORM mRNA DME0147 XEOTICID XEO01342 MOACRIVE Inhibition DME0147 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0147 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0147 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0147 XEOTICID XEO01407 DESCRIPT Ochratoxin A induces the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO01407 GENEFORM Protein DME0147 XEOTICID XEO01407 MOACRIVE Induction DME0147 XEOTICID XEO01422 XEO_NAME Paraquat DME0147 XEOTICID XEO01422 XEO_TYPE Health or Environmental Toxicant(s) DME0147 XEOTICID XEO01422 XEO_CLAS Acute Toxic Substance DME0147 XEOTICID XEO01422 DESCRIPT Paraquat induces the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO01422 GENEFORM Protein DME0147 XEOTICID XEO01422 MOACRIVE Induction DME0147 XEOTICID XEO01441 XEO_NAME Pterostilbene DME0147 XEOTICID XEO01441 XEO_TYPE Health or Environmental Toxicant(s) DME0147 XEOTICID XEO01441 XEO_CLAS Environmental Pollutant DME0147 XEOTICID XEO01441 DESCRIPT Pterostilbene up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO01441 GENEFORM mRNA DME0147 XEOTICID XEO01441 MOACRIVE Induction DME0147 XEOTICID XEO01483 XEO_NAME Thioctic acid DME0147 XEOTICID XEO01483 XEO_TYPE Pharmaceutical Agent(s) DME0147 XEOTICID XEO01483 XEO_CLAS Drug in Phase 1 Clinical Trial DME0147 XEOTICID XEO01483 DESCRIPT Thioctic acid induces the drug-metabolizing activity of DME GPX1 DME0147 XEOTICID XEO01483 GENEFORM Protein DME0147 XEOTICID XEO01483 MOACRIVE Induction DME0147 XEOTICID XEO01509 XEO_NAME Mercury DME0147 XEOTICID XEO01509 XEO_TYPE Health or Environmental Toxicant(s) DME0147 XEOTICID XEO01509 XEO_CLAS Acute Toxic Substance DME0147 XEOTICID XEO01509 DESCRIPT Mercury up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO01509 GENEFORM mRNA DME0147 XEOTICID XEO01509 MOACRIVE Induction DME0147 XEOTICID XEO01511 XEO_NAME Vitallium DME0147 XEOTICID XEO01511 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0147 XEOTICID XEO01511 XEO_CLAS Natural Mixture DME0147 XEOTICID XEO01511 DESCRIPT Vitallium inhibits the expression of DME GPX1 DME0147 XEOTICID XEO01511 GENEFORM mRNA DME0147 XEOTICID XEO01511 MOACRIVE Inhibition DME0147 XEOTICID XEO01592 XEO_NAME Tea extracts DME0147 XEOTICID XEO01592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0147 XEOTICID XEO01592 XEO_CLAS Plant Extract DME0147 XEOTICID XEO01592 DESCRIPT Tea extracts up-regulates the expression of DME GPX1 DME0147 XEOTICID XEO01592 GENEFORM mRNA DME0147 XEOTICID XEO01592 MOACRIVE Induction DME0148 DME___ID DME0148 DME0148 DME_NAME Pancreatic alpha-amylase (AMY2A) DME0148 SPESNAME Homo sapiens DME0148 XEOTICID XEO01503 XEO_NAME Cadmium DME0148 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0148 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0148 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the expression of DME AMY2A DME0148 XEOTICID XEO01503 GENEFORM mRNA DME0148 XEOTICID XEO01503 MOACRIVE Inhibition DME0148 XEOTICID XEO01574 XEO_NAME Plant extracts DME0148 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0148 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0148 XEOTICID XEO01574 DESCRIPT Plant extracts up-regulates the expression of DME AMY2A DME0148 XEOTICID XEO01574 GENEFORM mRNA DME0148 XEOTICID XEO01574 MOACRIVE Induction DME0149 DME___ID DME0149 DME0149 DME_NAME Vitamin K1 2,3-epoxide reductase 1 (VKOR) DME0149 SPESNAME Homo sapiens DME0149 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0149 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0149 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0149 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME VKORC1 DME0149 XEOTICID XEO00117 GENEFORM mRNA DME0149 XEOTICID XEO00117 MOACRIVE Inhibition DME0149 XEOTICID XEO00206 XEO_NAME Phenprocoumon DME0149 XEOTICID XEO00206 XEO_TYPE Pharmaceutical Agent(s) DME0149 XEOTICID XEO00206 XEO_CLAS Approved/Marketed Drug DME0149 XEOTICID XEO00206 DESCRIPT Phenprocoumon inhibits the expression of DME VKORC1 and leads to decreasing the drug-metabolizing activity of this enzyme DME0149 XEOTICID XEO00206 GENEFORM Protein DME0149 XEOTICID XEO00206 MOACRIVE Inhibition DME0149 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0149 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0149 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0149 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME VKORC1 DME0149 XEOTICID XEO00241 GENEFORM mRNA DME0149 XEOTICID XEO00241 MOACRIVE Inhibition DME0149 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0149 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0149 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0149 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME VKORC1 DME0149 XEOTICID XEO00292 GENEFORM mRNA DME0149 XEOTICID XEO00292 MOACRIVE Inhibition DME0149 XEOTICID XEO00471 XEO_NAME Fluindione DME0149 XEOTICID XEO00471 XEO_TYPE Pharmaceutical Agent(s) DME0149 XEOTICID XEO00471 XEO_CLAS Approved/Marketed Drug DME0149 XEOTICID XEO00471 DESCRIPT Fluindione inhibits the drug-metabolizing activity of DME VKORC1 DME0149 XEOTICID XEO00471 GENEFORM Protein DME0149 XEOTICID XEO00471 MOACRIVE Inhibition DME0149 XEOTICID XEO00513 XEO_NAME Acenocoumarol DME0149 XEOTICID XEO00513 XEO_TYPE Pharmaceutical Agent(s) DME0149 XEOTICID XEO00513 XEO_CLAS Approved/Marketed Drug DME0149 XEOTICID XEO00513 DESCRIPT Acenocoumarol inhibits the drug-metabolizing activity of DME VKORC1 DME0149 XEOTICID XEO00513 GENEFORM Protein DME0149 XEOTICID XEO00513 MOACRIVE Inhibition DME0149 XEOTICID XEO00547 XEO_NAME Vitamin E DME0149 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0149 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0149 XEOTICID XEO00547 DESCRIPT Vitamin E up-regulates the expression of DME VKORC1 DME0149 XEOTICID XEO00547 GENEFORM mRNA DME0149 XEOTICID XEO00547 MOACRIVE Induction DME0149 XEOTICID XEO00760 XEO_NAME Jinfukang DME0149 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0149 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0149 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME VKORC1 DME0149 XEOTICID XEO00760 GENEFORM mRNA DME0149 XEOTICID XEO00760 MOACRIVE Induction DME0149 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME0149 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME0149 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME0149 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of DME VKORC1 DME0149 XEOTICID XEO00866 GENEFORM Protein DME0149 XEOTICID XEO00866 MOACRIVE Inhibition DME0149 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0149 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0149 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0149 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME VKORC1 DME0149 XEOTICID XEO00898 GENEFORM mRNA DME0149 XEOTICID XEO00898 MOACRIVE Inhibition DME0149 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0149 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0149 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0149 XEOTICID XEO01247 DESCRIPT Chloropicrin up-regulates the expression of DME VKORC1 DME0149 XEOTICID XEO01247 GENEFORM mRNA DME0149 XEOTICID XEO01247 MOACRIVE Induction DME0149 XEOTICID XEO01336 XEO_NAME ICG-001 DME0149 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0149 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0149 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME VKORC1 DME0149 XEOTICID XEO01336 GENEFORM mRNA DME0149 XEOTICID XEO01336 MOACRIVE Induction DME0149 XEOTICID XEO01348 XEO_NAME K-7174 DME0149 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0149 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0149 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME VKORC1 DME0149 XEOTICID XEO01348 GENEFORM mRNA DME0149 XEOTICID XEO01348 MOACRIVE Inhibition DME0149 XEOTICID XEO01616 XEO_NAME Bromadiolone DME0149 XEOTICID XEO01616 XEO_TYPE Health or Environmental Toxicant(s) DME0149 XEOTICID XEO01616 XEO_CLAS Acute Toxic Substance DME0149 XEOTICID XEO01616 DESCRIPT Bromadiolone inhibits the drug-metabolizing activity of DME VKORC1 DME0149 XEOTICID XEO01616 GENEFORM Protein DME0149 XEOTICID XEO01616 MOACRIVE Inhibition DME0149 XEOTICID XEO01617 XEO_NAME Coumatetralyl DME0149 XEOTICID XEO01617 XEO_TYPE Health or Environmental Toxicant(s) DME0149 XEOTICID XEO01617 XEO_CLAS Acute Toxic Substance DME0149 XEOTICID XEO01617 DESCRIPT Coumatetralyl inhibits the drug-metabolizing activity of DME VKORC1 DME0149 XEOTICID XEO01617 GENEFORM Protein DME0149 XEOTICID XEO01617 MOACRIVE Inhibition DME0150 DME___ID DME0150 DME0150 DME_NAME Deoxy-5'-nucleotidase 1 (NT5C) DME0150 SPESNAME Homo sapiens DME0150 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0150 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0150 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0150 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME NT5C DME0150 XEOTICID XEO00117 GENEFORM mRNA DME0150 XEOTICID XEO00117 MOACRIVE Inhibition DME0150 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0150 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0150 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0150 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME NT5C DME0150 XEOTICID XEO00217 GENEFORM mRNA DME0150 XEOTICID XEO00217 MOACRIVE Inhibition DME0150 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0150 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0150 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0150 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME NT5C DME0150 XEOTICID XEO00241 GENEFORM mRNA DME0150 XEOTICID XEO00241 MOACRIVE Induction DME0150 XEOTICID XEO00334 XEO_NAME Cisplatin DME0150 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0150 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0150 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME NT5C DME0150 XEOTICID XEO00334 GENEFORM mRNA DME0150 XEOTICID XEO00334 MOACRIVE Inhibition DME0150 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0150 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0150 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0150 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME NT5C DME0150 XEOTICID XEO00339 GENEFORM mRNA DME0150 XEOTICID XEO00339 MOACRIVE Inhibition DME0150 XEOTICID XEO00557 XEO_NAME Genistein DME0150 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0150 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0150 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME NT5C DME0150 XEOTICID XEO00557 GENEFORM mRNA DME0150 XEOTICID XEO00557 MOACRIVE Inhibition DME0150 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0150 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0150 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0150 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME NT5C DME0150 XEOTICID XEO00723 GENEFORM mRNA DME0150 XEOTICID XEO00723 MOACRIVE Inhibition DME0150 XEOTICID XEO00760 XEO_NAME Jinfukang DME0150 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0150 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0150 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME NT5C DME0150 XEOTICID XEO00760 GENEFORM mRNA DME0150 XEOTICID XEO00760 MOACRIVE Induction DME0150 XEOTICID XEO00837 XEO_NAME Calcium chloride DME0150 XEOTICID XEO00837 XEO_TYPE Pharmaceutical Agent(s) DME0150 XEOTICID XEO00837 XEO_CLAS Approved/Marketed Drug DME0150 XEOTICID XEO00837 DESCRIPT Calcium chloride induces the drug-metabolizing activity of DME NT5C DME0150 XEOTICID XEO00837 GENEFORM Protein DME0150 XEOTICID XEO00837 MOACRIVE Induction DME0150 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0150 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0150 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0150 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME NT5C DME0150 XEOTICID XEO00898 GENEFORM mRNA DME0150 XEOTICID XEO00898 MOACRIVE Inhibition DME0150 XEOTICID XEO01336 XEO_NAME ICG-001 DME0150 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0150 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0150 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME NT5C DME0150 XEOTICID XEO01336 GENEFORM mRNA DME0150 XEOTICID XEO01336 MOACRIVE Induction DME0151 DME___ID DME0151 DME0151 DME_NAME Phosphorylcholine transferase A (PCYT1A) DME0151 SPESNAME Homo sapiens DME0151 XEOTICID XEO00012 XEO_NAME Carmustine DME0151 XEOTICID XEO00012 XEO_TYPE Pharmaceutical Agent(s) DME0151 XEOTICID XEO00012 XEO_CLAS Approved/Marketed Drug DME0151 XEOTICID XEO00012 DESCRIPT Carmustine inhibits the expression of DME PCYT1A DME0151 XEOTICID XEO00012 GENEFORM mRNA DME0151 XEOTICID XEO00012 MOACRIVE Inhibition DME0151 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0151 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0151 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0151 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME PCYT1A DME0151 XEOTICID XEO00117 GENEFORM mRNA DME0151 XEOTICID XEO00117 MOACRIVE Induction DME0151 XEOTICID XEO00159 XEO_NAME Bortezomib DME0151 XEOTICID XEO00159 XEO_TYPE Pharmaceutical Agent(s) DME0151 XEOTICID XEO00159 XEO_CLAS Approved/Marketed Drug DME0151 XEOTICID XEO00159 DESCRIPT Bortezomib up-regulates the expression of DME PCYT1A DME0151 XEOTICID XEO00159 GENEFORM mRNA DME0151 XEOTICID XEO00159 MOACRIVE Induction DME0151 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0151 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0151 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0151 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME PCYT1A DME0151 XEOTICID XEO00241 GENEFORM mRNA DME0151 XEOTICID XEO00241 MOACRIVE Induction DME0151 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0151 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0151 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0151 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME PCYT1A DME0151 XEOTICID XEO00292 GENEFORM mRNA DME0151 XEOTICID XEO00292 MOACRIVE Inhibition DME0151 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0151 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0151 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0151 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME PCYT1A DME0151 XEOTICID XEO00898 GENEFORM mRNA DME0151 XEOTICID XEO00898 MOACRIVE Induction DME0152 DME___ID DME0152 DME0152 DME_NAME Phosphorylethanolamine transferase (PCYT2) DME0152 SPESNAME Homo sapiens DME0152 XEOTICID XEO00079 XEO_NAME Vorinostat DME0152 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0152 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0152 XEOTICID XEO00079 DESCRIPT Vorinostat inhibits the expression of DME PCYT2 DME0152 XEOTICID XEO00079 GENEFORM mRNA DME0152 XEOTICID XEO00079 MOACRIVE Inhibition DME0152 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0152 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0152 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0152 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME PCYT2 DME0152 XEOTICID XEO00088 GENEFORM mRNA DME0152 XEOTICID XEO00088 MOACRIVE Induction DME0152 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0152 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0152 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0152 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME PCYT2 DME0152 XEOTICID XEO00117 GENEFORM mRNA DME0152 XEOTICID XEO00117 MOACRIVE Inhibition DME0152 XEOTICID XEO00168 XEO_NAME Decitabine DME0152 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0152 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0152 XEOTICID XEO00168 DESCRIPT Decitabine up-regulates the expression of DME PCYT2 DME0152 XEOTICID XEO00168 GENEFORM mRNA DME0152 XEOTICID XEO00168 MOACRIVE Induction DME0152 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0152 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0152 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0152 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME PCYT2 DME0152 XEOTICID XEO00217 GENEFORM mRNA DME0152 XEOTICID XEO00217 MOACRIVE Inhibition DME0152 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0152 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0152 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0152 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME PCYT2 DME0152 XEOTICID XEO00241 GENEFORM mRNA DME0152 XEOTICID XEO00241 MOACRIVE Inhibition DME0152 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0152 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0152 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0152 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME PCYT2 DME0152 XEOTICID XEO00292 GENEFORM mRNA DME0152 XEOTICID XEO00292 MOACRIVE Inhibition DME0152 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0152 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0152 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0152 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME PCYT2 DME0152 XEOTICID XEO00339 GENEFORM mRNA DME0152 XEOTICID XEO00339 MOACRIVE Inhibition DME0152 XEOTICID XEO00481 XEO_NAME Rotenone DME0152 XEOTICID XEO00481 XEO_TYPE Pharmaceutical Agent(s) DME0152 XEOTICID XEO00481 XEO_CLAS Approved/Marketed Drug DME0152 XEOTICID XEO00481 DESCRIPT Rotenone up-regulates the expression of DME PCYT2 DME0152 XEOTICID XEO00481 GENEFORM mRNA DME0152 XEOTICID XEO00481 MOACRIVE Induction DME0152 XEOTICID XEO00560 XEO_NAME Triclosan DME0152 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0152 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0152 XEOTICID XEO00560 DESCRIPT Triclosan inhibits the drug-metabolizing activity of DME PCYT2 DME0152 XEOTICID XEO00560 GENEFORM Protein DME0152 XEOTICID XEO00560 MOACRIVE Inhibition DME0152 XEOTICID XEO00760 XEO_NAME Jinfukang DME0152 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0152 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0152 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME PCYT2 DME0152 XEOTICID XEO00760 GENEFORM mRNA DME0152 XEOTICID XEO00760 MOACRIVE Induction DME0152 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0152 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0152 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0152 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME PCYT2 DME0152 XEOTICID XEO00772 GENEFORM mRNA DME0152 XEOTICID XEO00772 MOACRIVE Inhibition DME0152 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0152 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0152 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0152 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME PCYT2 DME0152 XEOTICID XEO00806 GENEFORM mRNA DME0152 XEOTICID XEO00806 MOACRIVE Inhibition DME0152 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0152 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0152 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0152 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME PCYT2 DME0152 XEOTICID XEO00821 GENEFORM Protein DME0152 XEOTICID XEO00821 MOACRIVE Inhibition DME0152 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0152 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0152 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0152 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME PCYT2 DME0152 XEOTICID XEO00898 GENEFORM mRNA DME0152 XEOTICID XEO00898 MOACRIVE Inhibition DME0152 XEOTICID XEO00969 XEO_NAME Atrazine DME0152 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0152 XEOTICID XEO00969 XEO_CLAS Herbicide DME0152 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME PCYT2 DME0152 XEOTICID XEO00969 GENEFORM mRNA DME0152 XEOTICID XEO00969 MOACRIVE Inhibition DME0152 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0152 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0152 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0152 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium up-regulates the expression of DME PCYT2 DME0152 XEOTICID XEO01103 GENEFORM mRNA DME0152 XEOTICID XEO01103 MOACRIVE Induction DME0152 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0152 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0152 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0152 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME PCYT2 DME0152 XEOTICID XEO01226 GENEFORM mRNA DME0152 XEOTICID XEO01226 MOACRIVE Induction DME0152 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0152 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0152 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0152 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME PCYT2 DME0152 XEOTICID XEO01305 GENEFORM mRNA DME0152 XEOTICID XEO01305 MOACRIVE Inhibition DME0152 XEOTICID XEO01348 XEO_NAME K-7174 DME0152 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0152 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0152 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME PCYT2 DME0152 XEOTICID XEO01348 GENEFORM mRNA DME0152 XEOTICID XEO01348 MOACRIVE Inhibition DME0153 DME___ID DME0153 DME0153 DME_NAME Vitamin B12 methionine synthase (MTR) DME0153 SPESNAME Homo sapiens DME0153 XEOTICID XEO00094 XEO_NAME Progesterone DME0153 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0153 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0153 XEOTICID XEO00094 DESCRIPT Progesterone up-regulates the expression of DME MTR DME0153 XEOTICID XEO00094 GENEFORM mRNA DME0153 XEOTICID XEO00094 MOACRIVE Induction DME0153 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0153 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0153 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0153 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME MTR DME0153 XEOTICID XEO00117 GENEFORM mRNA DME0153 XEOTICID XEO00117 MOACRIVE Inhibition DME0153 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0153 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0153 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0153 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME MTR DME0153 XEOTICID XEO00217 GENEFORM mRNA DME0153 XEOTICID XEO00217 MOACRIVE Inhibition DME0153 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0153 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0153 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0153 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME MTR DME0153 XEOTICID XEO00241 GENEFORM mRNA DME0153 XEOTICID XEO00241 MOACRIVE Inhibition DME0153 XEOTICID XEO00290 XEO_NAME Dopamine hydrochloride DME0153 XEOTICID XEO00290 XEO_TYPE Pharmaceutical Agent(s) DME0153 XEOTICID XEO00290 XEO_CLAS Approved/Marketed Drug DME0153 XEOTICID XEO00290 DESCRIPT Dopamine hydrochloride induces the drug-metabolizing activity of DME MTR DME0153 XEOTICID XEO00290 GENEFORM Protein DME0153 XEOTICID XEO00290 MOACRIVE Induction DME0153 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0153 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0153 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0153 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the drug-metabolizing activity of DME MTR DME0153 XEOTICID XEO00339 GENEFORM Protein DME0153 XEOTICID XEO00339 MOACRIVE Inhibition DME0153 XEOTICID XEO00366 XEO_NAME Methotrexate DME0153 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0153 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0153 XEOTICID XEO00366 DESCRIPT Methotrexate inhibits the expression of DME MTR DME0153 XEOTICID XEO00366 GENEFORM mRNA DME0153 XEOTICID XEO00366 MOACRIVE Inhibition DME0153 XEOTICID XEO00435 XEO_NAME Urethane DME0153 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0153 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0153 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME MTR DME0153 XEOTICID XEO00435 GENEFORM mRNA DME0153 XEOTICID XEO00435 MOACRIVE Inhibition DME0153 XEOTICID XEO00443 XEO_NAME Mecobalamin DME0153 XEOTICID XEO00443 XEO_TYPE Pharmaceutical Agent(s) DME0153 XEOTICID XEO00443 XEO_CLAS Approved/Marketed Drug DME0153 XEOTICID XEO00443 DESCRIPT Mecobalamin induces the drug-metabolizing activity of DME MTR DME0153 XEOTICID XEO00443 GENEFORM Protein DME0153 XEOTICID XEO00443 MOACRIVE Induction DME0153 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0153 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0153 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0153 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME MTR DME0153 XEOTICID XEO00898 GENEFORM mRNA DME0153 XEOTICID XEO00898 MOACRIVE Inhibition DME0153 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0153 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0153 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0153 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME MTR DME0153 XEOTICID XEO00999 GENEFORM mRNA DME0153 XEOTICID XEO00999 MOACRIVE Inhibition DME0153 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0153 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0153 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0153 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME MTR DME0153 XEOTICID XEO01305 GENEFORM mRNA DME0153 XEOTICID XEO01305 MOACRIVE Inhibition DME0154 DME___ID DME0154 DME0154 DME_NAME Asparagine synthetase (ASNS) DME0154 SPESNAME Homo sapiens DME0154 XEOTICID XEO00007 XEO_NAME Azathioprine DME0154 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00007 DESCRIPT Azathioprine inhibits the expression of DME ASNS DME0154 XEOTICID XEO00007 GENEFORM mRNA DME0154 XEOTICID XEO00007 MOACRIVE Inhibition DME0154 XEOTICID XEO00018 XEO_NAME Cyclophosphamide DME0154 XEOTICID XEO00018 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00018 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00018 DESCRIPT Cyclophosphamide inhibits the expression of DME ASNS DME0154 XEOTICID XEO00018 GENEFORM mRNA DME0154 XEOTICID XEO00018 MOACRIVE Inhibition DME0154 XEOTICID XEO00029 XEO_NAME Valproic acid DME0154 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME ASNS DME0154 XEOTICID XEO00029 GENEFORM mRNA DME0154 XEOTICID XEO00029 MOACRIVE Inhibition DME0154 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0154 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00035 GENEFORM mRNA DME0154 XEOTICID XEO00035 MOACRIVE Induction DME0154 XEOTICID XEO00045 XEO_NAME Haloperidol DME0154 XEOTICID XEO00045 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00045 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00045 DESCRIPT Haloperidol inhibits the expression of DME ASNS DME0154 XEOTICID XEO00045 GENEFORM mRNA DME0154 XEOTICID XEO00045 MOACRIVE Inhibition DME0154 XEOTICID XEO00046 XEO_NAME Ifosfamide DME0154 XEOTICID XEO00046 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00046 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00046 DESCRIPT Ifosfamide up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00046 GENEFORM mRNA DME0154 XEOTICID XEO00046 MOACRIVE Induction DME0154 XEOTICID XEO00047 XEO_NAME Indomethacin DME0154 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00047 DESCRIPT Indomethacin up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00047 GENEFORM mRNA DME0154 XEOTICID XEO00047 MOACRIVE Induction DME0154 XEOTICID XEO00053 XEO_NAME Leflunomide DME0154 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00053 GENEFORM mRNA DME0154 XEOTICID XEO00053 MOACRIVE Induction DME0154 XEOTICID XEO00055 XEO_NAME Loratadine DME0154 XEOTICID XEO00055 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00055 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00055 DESCRIPT Loratadine induces the drug-metabolizing activity of DME ASNS DME0154 XEOTICID XEO00055 GENEFORM Protein DME0154 XEOTICID XEO00055 MOACRIVE Induction DME0154 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0154 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00088 DESCRIPT Dexamethasone inhibits the expression of DME ASNS DME0154 XEOTICID XEO00088 GENEFORM mRNA DME0154 XEOTICID XEO00088 MOACRIVE Inhibition DME0154 XEOTICID XEO00090 XEO_NAME Estradiol DME0154 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00090 GENEFORM mRNA DME0154 XEOTICID XEO00090 MOACRIVE Induction DME0154 XEOTICID XEO00094 XEO_NAME Progesterone DME0154 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00094 DESCRIPT Progesterone induces the drug-metabolizing activity of DME ASNS DME0154 XEOTICID XEO00094 GENEFORM Protein DME0154 XEOTICID XEO00094 MOACRIVE Induction DME0154 XEOTICID XEO00096 XEO_NAME Ampicillin DME0154 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the expression of DME ASNS DME0154 XEOTICID XEO00096 GENEFORM mRNA DME0154 XEOTICID XEO00096 MOACRIVE Inhibition DME0154 XEOTICID XEO00111 XEO_NAME Erythromycin DME0154 XEOTICID XEO00111 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00111 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00111 DESCRIPT Erythromycin inhibits the expression of DME ASNS DME0154 XEOTICID XEO00111 GENEFORM mRNA DME0154 XEOTICID XEO00111 MOACRIVE Inhibition DME0154 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0154 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00117 GENEFORM mRNA DME0154 XEOTICID XEO00117 MOACRIVE Induction DME0154 XEOTICID XEO00126 XEO_NAME Raloxifene hydrochloride DME0154 XEOTICID XEO00126 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00126 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00126 DESCRIPT Raloxifene hydrochloride inhibits the expression of DME ASNS DME0154 XEOTICID XEO00126 GENEFORM mRNA DME0154 XEOTICID XEO00126 MOACRIVE Inhibition DME0154 XEOTICID XEO00132 XEO_NAME Cidofovir DME0154 XEOTICID XEO00132 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00132 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00132 DESCRIPT Cidofovir up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00132 GENEFORM mRNA DME0154 XEOTICID XEO00132 MOACRIVE Induction DME0154 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0154 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00140 DESCRIPT Zoledronic acid inhibits the expression of DME ASNS DME0154 XEOTICID XEO00140 GENEFORM mRNA DME0154 XEOTICID XEO00140 MOACRIVE Inhibition DME0154 XEOTICID XEO00144 XEO_NAME Bexarotene DME0154 XEOTICID XEO00144 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00144 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00144 DESCRIPT Bexarotene inhibits the expression of DME ASNS DME0154 XEOTICID XEO00144 GENEFORM mRNA DME0154 XEOTICID XEO00144 MOACRIVE Inhibition DME0154 XEOTICID XEO00147 XEO_NAME Fulvestrant DME0154 XEOTICID XEO00147 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00147 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00147 DESCRIPT Fulvestrant inhibits the expression of DME ASNS DME0154 XEOTICID XEO00147 GENEFORM mRNA DME0154 XEOTICID XEO00147 MOACRIVE Inhibition DME0154 XEOTICID XEO00177 XEO_NAME Sulindac DME0154 XEOTICID XEO00177 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00177 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00177 DESCRIPT Sulindac induces the drug-metabolizing activity of DME ASNS DME0154 XEOTICID XEO00177 GENEFORM Protein DME0154 XEOTICID XEO00177 MOACRIVE Induction DME0154 XEOTICID XEO00181 XEO_NAME Dasatinib DME0154 XEOTICID XEO00181 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00181 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00181 DESCRIPT Dasatinib up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00181 GENEFORM mRNA DME0154 XEOTICID XEO00181 MOACRIVE Induction DME0154 XEOTICID XEO00193 XEO_NAME Belinostat DME0154 XEOTICID XEO00193 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00193 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00193 DESCRIPT Belinostat inhibits the expression of DME ASNS DME0154 XEOTICID XEO00193 GENEFORM mRNA DME0154 XEOTICID XEO00193 MOACRIVE Inhibition DME0154 XEOTICID XEO00200 XEO_NAME Tetracycline DME0154 XEOTICID XEO00200 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00200 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00200 DESCRIPT Tetracycline up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00200 GENEFORM mRNA DME0154 XEOTICID XEO00200 MOACRIVE Induction DME0154 XEOTICID XEO00207 XEO_NAME Oxaliplatin DME0154 XEOTICID XEO00207 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00207 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00207 DESCRIPT Oxaliplatin inhibits the drug-metabolizing activity of DME ASNS DME0154 XEOTICID XEO00207 GENEFORM Protein DME0154 XEOTICID XEO00207 MOACRIVE Inhibition DME0154 XEOTICID XEO00209 XEO_NAME Clozapine DME0154 XEOTICID XEO00209 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00209 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00209 DESCRIPT Clozapine up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00209 GENEFORM mRNA DME0154 XEOTICID XEO00209 MOACRIVE Induction DME0154 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0154 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00217 GENEFORM mRNA DME0154 XEOTICID XEO00217 MOACRIVE Induction DME0154 XEOTICID XEO00218 XEO_NAME Caffeine DME0154 XEOTICID XEO00218 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00218 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00218 DESCRIPT Caffeine inhibits the expression of DME ASNS DME0154 XEOTICID XEO00218 GENEFORM mRNA DME0154 XEOTICID XEO00218 MOACRIVE Inhibition DME0154 XEOTICID XEO00219 XEO_NAME Prednisolone DME0154 XEOTICID XEO00219 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00219 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00219 DESCRIPT Prednisolone inhibits the expression of DME ASNS DME0154 XEOTICID XEO00219 GENEFORM mRNA DME0154 XEOTICID XEO00219 MOACRIVE Inhibition DME0154 XEOTICID XEO00225 XEO_NAME Quinidine DME0154 XEOTICID XEO00225 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00225 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00225 DESCRIPT Quinidine up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00225 GENEFORM mRNA DME0154 XEOTICID XEO00225 MOACRIVE Induction DME0154 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0154 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00241 GENEFORM mRNA DME0154 XEOTICID XEO00241 MOACRIVE Induction DME0154 XEOTICID XEO00248 XEO_NAME Ibuprofen DME0154 XEOTICID XEO00248 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00248 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00248 DESCRIPT Ibuprofen up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00248 GENEFORM mRNA DME0154 XEOTICID XEO00248 MOACRIVE Induction DME0154 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0154 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00251 DESCRIPT Ketoconazole up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00251 GENEFORM mRNA DME0154 XEOTICID XEO00251 MOACRIVE Induction DME0154 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0154 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00277 GENEFORM mRNA DME0154 XEOTICID XEO00277 MOACRIVE Induction DME0154 XEOTICID XEO00280 XEO_NAME Chlorpromazine hydrochloride DME0154 XEOTICID XEO00280 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00280 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00280 DESCRIPT Chlorpromazine hydrochloride up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00280 GENEFORM mRNA DME0154 XEOTICID XEO00280 MOACRIVE Induction DME0154 XEOTICID XEO00285 XEO_NAME Clomipramine hydrochloride DME0154 XEOTICID XEO00285 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00285 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00285 DESCRIPT Clomipramine hydrochloride up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00285 GENEFORM mRNA DME0154 XEOTICID XEO00285 MOACRIVE Induction DME0154 XEOTICID XEO00294 XEO_NAME Flecainide acetate DME0154 XEOTICID XEO00294 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00294 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00294 DESCRIPT Flecainide acetate up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00294 GENEFORM mRNA DME0154 XEOTICID XEO00294 MOACRIVE Induction DME0154 XEOTICID XEO00300 XEO_NAME Imipramine hydrochloride DME0154 XEOTICID XEO00300 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00300 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00300 DESCRIPT Imipramine hydrochloride up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00300 GENEFORM mRNA DME0154 XEOTICID XEO00300 MOACRIVE Induction DME0154 XEOTICID XEO00326 XEO_NAME Sotalol hydrochloride DME0154 XEOTICID XEO00326 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00326 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00326 DESCRIPT Sotalol hydrochloride inhibits the expression of DME ASNS DME0154 XEOTICID XEO00326 GENEFORM mRNA DME0154 XEOTICID XEO00326 MOACRIVE Inhibition DME0154 XEOTICID XEO00330 XEO_NAME Thioridazine hydrochloride DME0154 XEOTICID XEO00330 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00330 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00330 DESCRIPT Thioridazine hydrochloride up-regulates the expression of DME ASNS and leads to increasing the drug-metabolizing activity of this enzyme DME0154 XEOTICID XEO00330 GENEFORM Protein DME0154 XEOTICID XEO00330 MOACRIVE Induction DME0154 XEOTICID XEO00334 XEO_NAME Cisplatin DME0154 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00334 GENEFORM mRNA DME0154 XEOTICID XEO00334 MOACRIVE Induction DME0154 XEOTICID XEO00337 XEO_NAME Amitriptyline DME0154 XEOTICID XEO00337 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00337 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00337 DESCRIPT Amitriptyline up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00337 GENEFORM mRNA DME0154 XEOTICID XEO00337 MOACRIVE Induction DME0154 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0154 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the drug-metabolizing activity of DME ASNS DME0154 XEOTICID XEO00339 GENEFORM Protein DME0154 XEOTICID XEO00339 MOACRIVE Inhibition DME0154 XEOTICID XEO00352 XEO_NAME Diclofenac DME0154 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00352 DESCRIPT Diclofenac inhibits the expression of DME ASNS DME0154 XEOTICID XEO00352 GENEFORM mRNA DME0154 XEOTICID XEO00352 MOACRIVE Inhibition DME0154 XEOTICID XEO00354 XEO_NAME Doxepin DME0154 XEOTICID XEO00354 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00354 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00354 DESCRIPT Doxepin up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00354 GENEFORM mRNA DME0154 XEOTICID XEO00354 MOACRIVE Induction DME0154 XEOTICID XEO00358 XEO_NAME Fluoxetine DME0154 XEOTICID XEO00358 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00358 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00358 DESCRIPT Fluoxetine up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00358 GENEFORM mRNA DME0154 XEOTICID XEO00358 MOACRIVE Induction DME0154 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0154 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME ASNS DME0154 XEOTICID XEO00410 GENEFORM Protein DME0154 XEOTICID XEO00410 MOACRIVE Inhibition DME0154 XEOTICID XEO00411 XEO_NAME Avobenzone DME0154 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00411 DESCRIPT Avobenzone inhibits the expression of DME ASNS DME0154 XEOTICID XEO00411 GENEFORM mRNA DME0154 XEOTICID XEO00411 MOACRIVE Inhibition DME0154 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0154 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00430 DESCRIPT Hydroquinone up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00430 GENEFORM mRNA DME0154 XEOTICID XEO00430 MOACRIVE Induction DME0154 XEOTICID XEO00465 XEO_NAME Clodronic acid DME0154 XEOTICID XEO00465 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00465 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00465 DESCRIPT Clodronic acid inhibits the expression of DME ASNS DME0154 XEOTICID XEO00465 GENEFORM mRNA DME0154 XEOTICID XEO00465 MOACRIVE Inhibition DME0154 XEOTICID XEO00481 XEO_NAME Rotenone DME0154 XEOTICID XEO00481 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00481 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00481 DESCRIPT Rotenone up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00481 GENEFORM mRNA DME0154 XEOTICID XEO00481 MOACRIVE Induction DME0154 XEOTICID XEO00525 XEO_NAME Zimeldine DME0154 XEOTICID XEO00525 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00525 XEO_CLAS Drug Marketed but Withdrawn from Market DME0154 XEOTICID XEO00525 DESCRIPT Zimeldine induces the drug-metabolizing activity of DME ASNS DME0154 XEOTICID XEO00525 GENEFORM Protein DME0154 XEOTICID XEO00525 MOACRIVE Induction DME0154 XEOTICID XEO00545 XEO_NAME Lucanthone DME0154 XEOTICID XEO00545 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00545 XEO_CLAS Drug in Phase 2 Clinical Trial DME0154 XEOTICID XEO00545 DESCRIPT Lucanthone inhibits the drug-metabolizing activity of DME ASNS DME0154 XEOTICID XEO00545 GENEFORM Protein DME0154 XEOTICID XEO00545 MOACRIVE Inhibition DME0154 XEOTICID XEO00557 XEO_NAME Genistein DME0154 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0154 XEOTICID XEO00557 DESCRIPT Genistein induces the drug-metabolizing activity of DME ASNS DME0154 XEOTICID XEO00557 GENEFORM Protein DME0154 XEOTICID XEO00557 MOACRIVE Induction DME0154 XEOTICID XEO00568 XEO_NAME Resveratrol DME0154 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0154 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of DME ASNS DME0154 XEOTICID XEO00568 GENEFORM Protein DME0154 XEOTICID XEO00568 MOACRIVE Inhibition DME0154 XEOTICID XEO00581 XEO_NAME MS-275 DME0154 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0154 XEOTICID XEO00581 DESCRIPT MS-275 inhibits the expression of DME ASNS DME0154 XEOTICID XEO00581 GENEFORM mRNA DME0154 XEOTICID XEO00581 MOACRIVE Inhibition DME0154 XEOTICID XEO00610 XEO_NAME Afimoxifene DME0154 XEOTICID XEO00610 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00610 XEO_CLAS Drug in Phase 3 Clinical Trial DME0154 XEOTICID XEO00610 DESCRIPT Afimoxifene inhibits the expression of DME ASNS DME0154 XEOTICID XEO00610 GENEFORM mRNA DME0154 XEOTICID XEO00610 MOACRIVE Inhibition DME0154 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0154 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0154 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00632 GENEFORM mRNA DME0154 XEOTICID XEO00632 MOACRIVE Induction DME0154 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0154 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0154 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00723 GENEFORM mRNA DME0154 XEOTICID XEO00723 MOACRIVE Induction DME0154 XEOTICID XEO00740 XEO_NAME Lindane DME0154 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00740 DESCRIPT Lindane up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00740 GENEFORM mRNA DME0154 XEOTICID XEO00740 MOACRIVE Induction DME0154 XEOTICID XEO00745 XEO_NAME Adefovir dipivoxil DME0154 XEOTICID XEO00745 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00745 XEO_CLAS Approved/Marketed Drug DME0154 XEOTICID XEO00745 DESCRIPT Adefovir dipivoxil inhibits the expression of DME ASNS DME0154 XEOTICID XEO00745 GENEFORM mRNA DME0154 XEOTICID XEO00745 MOACRIVE Inhibition DME0154 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0154 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0154 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0154 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME ASNS DME0154 XEOTICID XEO00806 GENEFORM mRNA DME0154 XEOTICID XEO00806 MOACRIVE Inhibition DME0154 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0154 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0154 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00818 GENEFORM mRNA DME0154 XEOTICID XEO00818 MOACRIVE Induction DME0154 XEOTICID XEO00824 XEO_NAME Boron compound DME0154 XEOTICID XEO00824 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0154 XEOTICID XEO00824 XEO_CLAS Pesticide/Insecticide DME0154 XEOTICID XEO00824 DESCRIPT Boron compound up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00824 GENEFORM mRNA DME0154 XEOTICID XEO00824 MOACRIVE Induction DME0154 XEOTICID XEO00840 XEO_NAME Cupric oxide DME0154 XEOTICID XEO00840 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0154 XEOTICID XEO00840 XEO_CLAS Chemical Compound DME0154 XEOTICID XEO00840 DESCRIPT Cupric oxide up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00840 GENEFORM mRNA DME0154 XEOTICID XEO00840 MOACRIVE Induction DME0154 XEOTICID XEO00893 XEO_NAME 1-nitropyrene DME0154 XEOTICID XEO00893 XEO_TYPE Health or Environmental Toxicant(s) DME0154 XEOTICID XEO00893 XEO_CLAS Carcinogen DME0154 XEOTICID XEO00893 DESCRIPT 1-nitropyrene up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00893 GENEFORM mRNA DME0154 XEOTICID XEO00893 MOACRIVE Induction DME0154 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0154 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0154 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0154 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME ASNS DME0154 XEOTICID XEO00898 GENEFORM mRNA DME0154 XEOTICID XEO00898 MOACRIVE Inhibition DME0154 XEOTICID XEO00925 XEO_NAME BDE-99 DME0154 XEOTICID XEO00925 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0154 XEOTICID XEO00925 XEO_CLAS Natural Product DME0154 XEOTICID XEO00925 DESCRIPT BDE-99 up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00925 GENEFORM mRNA DME0154 XEOTICID XEO00925 MOACRIVE Induction DME0154 XEOTICID XEO00969 XEO_NAME Atrazine DME0154 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0154 XEOTICID XEO00969 XEO_CLAS Herbicide DME0154 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00969 GENEFORM mRNA DME0154 XEOTICID XEO00969 MOACRIVE Induction DME0154 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0154 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0154 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0154 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME ASNS DME0154 XEOTICID XEO00999 GENEFORM mRNA DME0154 XEOTICID XEO00999 MOACRIVE Induction DME0154 XEOTICID XEO01006 XEO_NAME Dimethyl nitrosamine DME0154 XEOTICID XEO01006 XEO_TYPE Health or Environmental Toxicant(s) DME0154 XEOTICID XEO01006 XEO_CLAS Carcinogen DME0154 XEOTICID XEO01006 DESCRIPT Dimethyl nitrosamine up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01006 GENEFORM mRNA DME0154 XEOTICID XEO01006 MOACRIVE Induction DME0154 XEOTICID XEO01023 XEO_NAME Sodium arsenate DME0154 XEOTICID XEO01023 XEO_TYPE Health or Environmental Toxicant(s) DME0154 XEOTICID XEO01023 XEO_CLAS Environmental Pollutant DME0154 XEOTICID XEO01023 DESCRIPT Sodium arsenate up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01023 GENEFORM mRNA DME0154 XEOTICID XEO01023 MOACRIVE Induction DME0154 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0154 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0154 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0154 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01031 GENEFORM mRNA DME0154 XEOTICID XEO01031 MOACRIVE Induction DME0154 XEOTICID XEO01034 XEO_NAME Pentanal DME0154 XEOTICID XEO01034 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0154 XEOTICID XEO01034 XEO_CLAS Chemical Compound DME0154 XEOTICID XEO01034 DESCRIPT Pentanal up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01034 GENEFORM mRNA DME0154 XEOTICID XEO01034 MOACRIVE Induction DME0154 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0154 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0154 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0154 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME ASNS DME0154 XEOTICID XEO01050 GENEFORM mRNA DME0154 XEOTICID XEO01050 MOACRIVE Inhibition DME0154 XEOTICID XEO01081 XEO_NAME Thioxotriazole copper(II) DME0154 XEOTICID XEO01081 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO01081 XEO_CLAS Investigative Agent DME0154 XEOTICID XEO01081 DESCRIPT Thioxotriazole copper(II) up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01081 GENEFORM mRNA DME0154 XEOTICID XEO01081 MOACRIVE Induction DME0154 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0154 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0154 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0154 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium induces the drug-metabolizing activity of DME ASNS DME0154 XEOTICID XEO01103 GENEFORM Protein DME0154 XEOTICID XEO01103 MOACRIVE Induction DME0154 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0154 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0154 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01220 GENEFORM mRNA DME0154 XEOTICID XEO01220 MOACRIVE Induction DME0154 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0154 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0154 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME ASNS DME0154 XEOTICID XEO01226 GENEFORM mRNA DME0154 XEOTICID XEO01226 MOACRIVE Inhibition DME0154 XEOTICID XEO01274 XEO_NAME Diazinon DME0154 XEOTICID XEO01274 XEO_TYPE Health or Environmental Toxicant(s) DME0154 XEOTICID XEO01274 XEO_CLAS Environmental Pollutant DME0154 XEOTICID XEO01274 DESCRIPT Diazinon up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01274 GENEFORM mRNA DME0154 XEOTICID XEO01274 MOACRIVE Induction DME0154 XEOTICID XEO01287 XEO_NAME Ellagic acid DME0154 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME0154 XEOTICID XEO01287 DESCRIPT Ellagic acid up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01287 GENEFORM mRNA DME0154 XEOTICID XEO01287 MOACRIVE Induction DME0154 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0154 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0154 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0154 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01305 GENEFORM mRNA DME0154 XEOTICID XEO01305 MOACRIVE Induction DME0154 XEOTICID XEO01336 XEO_NAME ICG-001 DME0154 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0154 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01336 GENEFORM mRNA DME0154 XEOTICID XEO01336 MOACRIVE Induction DME0154 XEOTICID XEO01348 XEO_NAME K-7174 DME0154 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0154 XEOTICID XEO01348 DESCRIPT K-7174 up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01348 GENEFORM mRNA DME0154 XEOTICID XEO01348 MOACRIVE Induction DME0154 XEOTICID XEO01378 XEO_NAME Metribolone DME0154 XEOTICID XEO01378 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO01378 XEO_CLAS Investigative Agent DME0154 XEOTICID XEO01378 DESCRIPT Metribolone inhibits the expression of DME ASNS DME0154 XEOTICID XEO01378 GENEFORM mRNA DME0154 XEOTICID XEO01378 MOACRIVE Inhibition DME0154 XEOTICID XEO01397 XEO_NAME Nickel chloride DME0154 XEOTICID XEO01397 XEO_TYPE Health or Environmental Toxicant(s) DME0154 XEOTICID XEO01397 XEO_CLAS Acute Toxic Substance DME0154 XEOTICID XEO01397 DESCRIPT Nickel chloride up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01397 GENEFORM mRNA DME0154 XEOTICID XEO01397 MOACRIVE Induction DME0154 XEOTICID XEO01403 XEO_NAME NSC-668394 DME0154 XEOTICID XEO01403 XEO_TYPE Pharmaceutical Agent(s) DME0154 XEOTICID XEO01403 XEO_CLAS Preclinical/Patented Drug DME0154 XEOTICID XEO01403 DESCRIPT NSC-668394 induces the drug-metabolizing activity of DME ASNS DME0154 XEOTICID XEO01403 GENEFORM Protein DME0154 XEOTICID XEO01403 MOACRIVE Induction DME0154 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0154 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0154 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0154 XEOTICID XEO01407 DESCRIPT Ochratoxin A inhibits the drug-metabolizing activity of DME ASNS DME0154 XEOTICID XEO01407 GENEFORM Protein DME0154 XEOTICID XEO01407 MOACRIVE Inhibition DME0154 XEOTICID XEO01490 XEO_NAME Trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride DME0154 XEOTICID XEO01490 XEO_TYPE Health or Environmental Toxicant(s) DME0154 XEOTICID XEO01490 XEO_CLAS Acute Toxic Substance DME0154 XEOTICID XEO01490 DESCRIPT Trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01490 GENEFORM mRNA DME0154 XEOTICID XEO01490 MOACRIVE Induction DME0154 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0154 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0154 XEOTICID XEO01494 XEO_CLAS Natural Product DME0154 XEOTICID XEO01494 DESCRIPT Tunicamycin A up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01494 GENEFORM mRNA DME0154 XEOTICID XEO01494 MOACRIVE Induction DME0154 XEOTICID XEO01566 XEO_NAME Nobiletin DME0154 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0154 XEOTICID XEO01566 XEO_CLAS Natural Product DME0154 XEOTICID XEO01566 DESCRIPT Nobiletin up-regulates the expression of DME ASNS DME0154 XEOTICID XEO01566 GENEFORM mRNA DME0154 XEOTICID XEO01566 MOACRIVE Induction DME0155 DME___ID DME0155 DME0155 DME_NAME Glutamine-dependent NAD(+) synthetase (NADSYN1) DME0155 SPESNAME Homo sapiens DME0155 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0155 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0155 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0155 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME NADSYN1 DME0155 XEOTICID XEO00241 GENEFORM mRNA DME0155 XEOTICID XEO00241 MOACRIVE Inhibition DME0155 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0155 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0155 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0155 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME NADSYN1 DME0155 XEOTICID XEO00292 GENEFORM mRNA DME0155 XEOTICID XEO00292 MOACRIVE Induction DME0155 XEOTICID XEO00334 XEO_NAME Cisplatin DME0155 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0155 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0155 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME NADSYN1 DME0155 XEOTICID XEO00334 GENEFORM mRNA DME0155 XEOTICID XEO00334 MOACRIVE Induction DME0155 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0155 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0155 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0155 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME NADSYN1 DME0155 XEOTICID XEO00772 GENEFORM mRNA DME0155 XEOTICID XEO00772 MOACRIVE Induction DME0155 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0155 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0155 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0155 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME NADSYN1 DME0155 XEOTICID XEO00818 GENEFORM mRNA DME0155 XEOTICID XEO00818 MOACRIVE Induction DME0155 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0155 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0155 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0155 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME NADSYN1 DME0155 XEOTICID XEO00898 GENEFORM mRNA DME0155 XEOTICID XEO00898 MOACRIVE Induction DME0155 XEOTICID XEO00969 XEO_NAME Atrazine DME0155 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0155 XEOTICID XEO00969 XEO_CLAS Herbicide DME0155 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME NADSYN1 DME0155 XEOTICID XEO00969 GENEFORM mRNA DME0155 XEOTICID XEO00969 MOACRIVE Inhibition DME0155 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0155 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0155 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0155 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME NADSYN1 DME0155 XEOTICID XEO01226 GENEFORM mRNA DME0155 XEOTICID XEO01226 MOACRIVE Induction DME0155 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0155 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0155 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0155 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME NADSYN1 DME0155 XEOTICID XEO01305 GENEFORM mRNA DME0155 XEOTICID XEO01305 MOACRIVE Induction DME0155 XEOTICID XEO01336 XEO_NAME ICG-001 DME0155 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0155 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0155 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME NADSYN1 DME0155 XEOTICID XEO01336 GENEFORM mRNA DME0155 XEOTICID XEO01336 MOACRIVE Induction DME0155 XEOTICID XEO01505 XEO_NAME Lead DME0155 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0155 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0155 XEOTICID XEO01505 DESCRIPT Lead inhibits the expression of DME NADSYN1 DME0155 XEOTICID XEO01505 GENEFORM mRNA DME0155 XEOTICID XEO01505 MOACRIVE Inhibition DME0156 DME___ID DME0156 DME0156 DME_NAME Hexosephosphate aminotransferase 2 (GFPT2) DME0156 SPESNAME Homo sapiens DME0156 XEOTICID XEO00094 XEO_NAME Progesterone DME0156 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0156 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0156 XEOTICID XEO00094 DESCRIPT Progesterone induces the drug-metabolizing activity of DME GFPT2 DME0156 XEOTICID XEO00094 GENEFORM Protein DME0156 XEOTICID XEO00094 MOACRIVE Induction DME0156 XEOTICID XEO00184 XEO_NAME Calcitriol DME0156 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0156 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0156 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME GFPT2 DME0156 XEOTICID XEO00184 GENEFORM mRNA DME0156 XEOTICID XEO00184 MOACRIVE Inhibition DME0156 XEOTICID XEO00253 XEO_NAME Tretinoin DME0156 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0156 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0156 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME GFPT2 DME0156 XEOTICID XEO00253 GENEFORM mRNA DME0156 XEOTICID XEO00253 MOACRIVE Induction DME0156 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0156 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0156 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0156 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME GFPT2 DME0156 XEOTICID XEO00292 GENEFORM mRNA DME0156 XEOTICID XEO00292 MOACRIVE Inhibition DME0156 XEOTICID XEO00334 XEO_NAME Cisplatin DME0156 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0156 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0156 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME GFPT2 DME0156 XEOTICID XEO00334 GENEFORM mRNA DME0156 XEOTICID XEO00334 MOACRIVE Inhibition DME0156 XEOTICID XEO00435 XEO_NAME Urethane DME0156 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0156 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0156 XEOTICID XEO00435 DESCRIPT Urethane up-regulates the expression of DME GFPT2 DME0156 XEOTICID XEO00435 GENEFORM mRNA DME0156 XEOTICID XEO00435 MOACRIVE Induction DME0156 XEOTICID XEO00581 XEO_NAME MS-275 DME0156 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0156 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0156 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME GFPT2 DME0156 XEOTICID XEO00581 GENEFORM mRNA DME0156 XEOTICID XEO00581 MOACRIVE Induction DME0156 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0156 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0156 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0156 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME GFPT2 DME0156 XEOTICID XEO00632 GENEFORM mRNA DME0156 XEOTICID XEO00632 MOACRIVE Induction DME0156 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0156 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0156 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0156 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME GFPT2 DME0156 XEOTICID XEO00806 GENEFORM mRNA DME0156 XEOTICID XEO00806 MOACRIVE Induction DME0156 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0156 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0156 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0156 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME GFPT2 DME0156 XEOTICID XEO00898 GENEFORM mRNA DME0156 XEOTICID XEO00898 MOACRIVE Induction DME0156 XEOTICID XEO00969 XEO_NAME Atrazine DME0156 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0156 XEOTICID XEO00969 XEO_CLAS Herbicide DME0156 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME GFPT2 DME0156 XEOTICID XEO00969 GENEFORM mRNA DME0156 XEOTICID XEO00969 MOACRIVE Induction DME0156 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0156 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0156 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0156 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME GFPT2 DME0156 XEOTICID XEO00999 GENEFORM mRNA DME0156 XEOTICID XEO00999 MOACRIVE Induction DME0156 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0156 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0156 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0156 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium up-regulates the expression of DME GFPT2 DME0156 XEOTICID XEO01103 GENEFORM mRNA DME0156 XEOTICID XEO01103 MOACRIVE Induction DME0156 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0156 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0156 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0156 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME GFPT2 DME0156 XEOTICID XEO01492 GENEFORM mRNA DME0156 XEOTICID XEO01492 MOACRIVE Induction DME0158 DME___ID DME0158 DME0158 DME_NAME Glutamyl-tRNA(Gln) amidotransferase B (GATB) DME0158 SPESNAME Homo sapiens DME0158 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0158 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0158 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0158 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME GATB DME0158 XEOTICID XEO00117 GENEFORM mRNA DME0158 XEOTICID XEO00117 MOACRIVE Inhibition DME0158 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0158 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0158 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0158 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME GATB DME0158 XEOTICID XEO00217 GENEFORM mRNA DME0158 XEOTICID XEO00217 MOACRIVE Inhibition DME0158 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0158 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0158 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0158 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME GATB DME0158 XEOTICID XEO00241 GENEFORM mRNA DME0158 XEOTICID XEO00241 MOACRIVE Inhibition DME0158 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0158 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0158 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0158 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME GATB DME0158 XEOTICID XEO00292 GENEFORM mRNA DME0158 XEOTICID XEO00292 MOACRIVE Inhibition DME0158 XEOTICID XEO00760 XEO_NAME Jinfukang DME0158 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0158 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0158 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME GATB DME0158 XEOTICID XEO00760 GENEFORM mRNA DME0158 XEOTICID XEO00760 MOACRIVE Induction DME0158 XEOTICID XEO00969 XEO_NAME Atrazine DME0158 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0158 XEOTICID XEO00969 XEO_CLAS Herbicide DME0158 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME GATB DME0158 XEOTICID XEO00969 GENEFORM mRNA DME0158 XEOTICID XEO00969 MOACRIVE Inhibition DME0158 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0158 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0158 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0158 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME GATB DME0158 XEOTICID XEO01031 GENEFORM mRNA DME0158 XEOTICID XEO01031 MOACRIVE Inhibition DME0158 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0158 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0158 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0158 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME GATB DME0158 XEOTICID XEO01226 GENEFORM mRNA DME0158 XEOTICID XEO01226 MOACRIVE Induction DME0158 XEOTICID XEO01348 XEO_NAME K-7174 DME0158 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0158 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0158 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME GATB DME0158 XEOTICID XEO01348 GENEFORM mRNA DME0158 XEOTICID XEO01348 MOACRIVE Inhibition DME0159 DME___ID DME0159 DME0159 DME_NAME Glutamine amidotransferase (GMPS) DME0159 SPESNAME Homo sapiens DME0159 XEOTICID XEO00029 XEO_NAME Valproic acid DME0159 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0159 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0159 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME GMPS DME0159 XEOTICID XEO00029 GENEFORM mRNA DME0159 XEOTICID XEO00029 MOACRIVE Inhibition DME0159 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0159 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0159 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0159 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the drug-metabolizing activity of DME GMPS DME0159 XEOTICID XEO00339 GENEFORM Protein DME0159 XEOTICID XEO00339 MOACRIVE Inhibition DME0159 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0159 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0159 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0159 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid induces the drug-metabolizing activity of DME GMPS DME0159 XEOTICID XEO00921 GENEFORM Protein DME0159 XEOTICID XEO00921 MOACRIVE Induction DME0159 XEOTICID XEO00969 XEO_NAME Atrazine DME0159 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0159 XEOTICID XEO00969 XEO_CLAS Herbicide DME0159 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME GMPS DME0159 XEOTICID XEO00969 GENEFORM mRNA DME0159 XEOTICID XEO00969 MOACRIVE Induction DME0159 XEOTICID XEO01227 XEO_NAME Bromovanin DME0159 XEOTICID XEO01227 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0159 XEOTICID XEO01227 XEO_CLAS Natural Product DME0159 XEOTICID XEO01227 DESCRIPT Bromovanin inhibits the drug-metabolizing activity of DME GMPS DME0159 XEOTICID XEO01227 GENEFORM Protein DME0159 XEOTICID XEO01227 MOACRIVE Inhibition DME0159 XEOTICID XEO01336 XEO_NAME ICG-001 DME0159 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0159 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0159 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME GMPS DME0159 XEOTICID XEO01336 GENEFORM mRNA DME0159 XEOTICID XEO01336 MOACRIVE Inhibition DME0160 DME___ID DME0160 DME0160 DME_NAME Kynurenine aminotransferase I (KYAT1) DME0160 SPESNAME Homo sapiens DME0160 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0160 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0160 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0160 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME KYAT1 DME0160 XEOTICID XEO00241 GENEFORM mRNA DME0160 XEOTICID XEO00241 MOACRIVE Inhibition DME0160 XEOTICID XEO00411 XEO_NAME Avobenzone DME0160 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0160 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0160 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME KYAT1 DME0160 XEOTICID XEO00411 GENEFORM mRNA DME0160 XEOTICID XEO00411 MOACRIVE Induction DME0160 XEOTICID XEO00760 XEO_NAME Jinfukang DME0160 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0160 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0160 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME KYAT1 DME0160 XEOTICID XEO00760 GENEFORM mRNA DME0160 XEOTICID XEO00760 MOACRIVE Induction DME0160 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0160 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0160 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0160 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME KYAT1 DME0160 XEOTICID XEO00806 GENEFORM mRNA DME0160 XEOTICID XEO00806 MOACRIVE Inhibition DME0160 XEOTICID XEO01348 XEO_NAME K-7174 DME0160 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0160 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0160 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME KYAT1 DME0160 XEOTICID XEO01348 GENEFORM mRNA DME0160 XEOTICID XEO01348 MOACRIVE Inhibition DME0160 XEOTICID XEO01585 XEO_NAME Senecionine DME0160 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0160 XEOTICID XEO01585 XEO_CLAS Natural Product DME0160 XEOTICID XEO01585 DESCRIPT Senecionine inhibits the expression of DME KYAT1 DME0160 XEOTICID XEO01585 GENEFORM mRNA DME0160 XEOTICID XEO01585 MOACRIVE Inhibition DME0160 XEOTICID XEO01595 XEO_NAME Methylmercury cysteine DME0160 XEOTICID XEO01595 XEO_TYPE Health or Environmental Toxicant(s) DME0160 XEOTICID XEO01595 XEO_CLAS Neurotoxin DME0160 XEOTICID XEO01595 DESCRIPT Methylmercury cysteine inhibits the expression of DME KYAT1 DME0160 XEOTICID XEO01595 GENEFORM mRNA DME0160 XEOTICID XEO01595 MOACRIVE Inhibition DME0161 DME___ID DME0161 DME0161 DME_NAME Phosphoribosylformylglycinamidine synthase (PFAS) DME0161 SPESNAME Homo sapiens DME0161 XEOTICID XEO00029 XEO_NAME Valproic acid DME0161 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0161 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0161 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME PFAS DME0161 XEOTICID XEO00029 GENEFORM mRNA DME0161 XEOTICID XEO00029 MOACRIVE Inhibition DME0161 XEOTICID XEO00090 XEO_NAME Estradiol DME0161 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0161 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0161 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME PFAS DME0161 XEOTICID XEO00090 GENEFORM mRNA DME0161 XEOTICID XEO00090 MOACRIVE Induction DME0161 XEOTICID XEO00184 XEO_NAME Calcitriol DME0161 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0161 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0161 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME PFAS DME0161 XEOTICID XEO00184 GENEFORM mRNA DME0161 XEOTICID XEO00184 MOACRIVE Inhibition DME0161 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0161 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0161 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0161 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME PFAS DME0161 XEOTICID XEO00217 GENEFORM mRNA DME0161 XEOTICID XEO00217 MOACRIVE Inhibition DME0161 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0161 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0161 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0161 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME PFAS DME0161 XEOTICID XEO00241 GENEFORM mRNA DME0161 XEOTICID XEO00241 MOACRIVE Inhibition DME0161 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0161 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0161 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0161 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME PFAS DME0161 XEOTICID XEO00292 GENEFORM mRNA DME0161 XEOTICID XEO00292 MOACRIVE Inhibition DME0161 XEOTICID XEO00334 XEO_NAME Cisplatin DME0161 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0161 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0161 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME PFAS DME0161 XEOTICID XEO00334 GENEFORM mRNA DME0161 XEOTICID XEO00334 MOACRIVE Inhibition DME0161 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0161 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0161 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0161 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME PFAS DME0161 XEOTICID XEO00339 GENEFORM mRNA DME0161 XEOTICID XEO00339 MOACRIVE Induction DME0161 XEOTICID XEO00392 XEO_NAME Vincristine DME0161 XEOTICID XEO00392 XEO_TYPE Pharmaceutical Agent(s) DME0161 XEOTICID XEO00392 XEO_CLAS Approved/Marketed Drug DME0161 XEOTICID XEO00392 DESCRIPT Vincristine inhibits the expression of DME PFAS DME0161 XEOTICID XEO00392 GENEFORM mRNA DME0161 XEOTICID XEO00392 MOACRIVE Inhibition DME0161 XEOTICID XEO00435 XEO_NAME Urethane DME0161 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0161 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0161 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME PFAS DME0161 XEOTICID XEO00435 GENEFORM mRNA DME0161 XEOTICID XEO00435 MOACRIVE Inhibition DME0161 XEOTICID XEO00466 XEO_NAME Demecolcine DME0161 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0161 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0161 XEOTICID XEO00466 DESCRIPT Demecolcine inhibits the expression of DME PFAS DME0161 XEOTICID XEO00466 GENEFORM mRNA DME0161 XEOTICID XEO00466 MOACRIVE Inhibition DME0161 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0161 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0161 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0161 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME PFAS DME0161 XEOTICID XEO00772 GENEFORM mRNA DME0161 XEOTICID XEO00772 MOACRIVE Inhibition DME0161 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0161 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0161 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0161 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME PFAS DME0161 XEOTICID XEO00898 GENEFORM mRNA DME0161 XEOTICID XEO00898 MOACRIVE Inhibition DME0161 XEOTICID XEO00969 XEO_NAME Atrazine DME0161 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0161 XEOTICID XEO00969 XEO_CLAS Herbicide DME0161 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME PFAS DME0161 XEOTICID XEO00969 GENEFORM mRNA DME0161 XEOTICID XEO00969 MOACRIVE Inhibition DME0161 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0161 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0161 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0161 XEOTICID XEO01050 DESCRIPT Dicrotophos up-regulates the expression of DME PFAS DME0161 XEOTICID XEO01050 GENEFORM mRNA DME0161 XEOTICID XEO01050 MOACRIVE Induction DME0161 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0161 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0161 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0161 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME PFAS DME0161 XEOTICID XEO01226 GENEFORM mRNA DME0161 XEOTICID XEO01226 MOACRIVE Inhibition DME0161 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0161 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0161 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0161 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME PFAS DME0161 XEOTICID XEO01305 GENEFORM mRNA DME0161 XEOTICID XEO01305 MOACRIVE Inhibition DME0161 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0161 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0161 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0161 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME PFAS DME0161 XEOTICID XEO01324 GENEFORM mRNA DME0161 XEOTICID XEO01324 MOACRIVE Inhibition DME0162 DME___ID DME0162 DME0162 DME_NAME Transglutaminase H (TGM2) DME0162 SPESNAME Homo sapiens DME0162 XEOTICID XEO00029 XEO_NAME Valproic acid DME0162 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0162 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME TGM2 DME0162 XEOTICID XEO00029 GENEFORM mRNA DME0162 XEOTICID XEO00029 MOACRIVE Induction DME0162 XEOTICID XEO00090 XEO_NAME Estradiol DME0162 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0162 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME TGM2 DME0162 XEOTICID XEO00090 GENEFORM mRNA DME0162 XEOTICID XEO00090 MOACRIVE Induction DME0162 XEOTICID XEO00094 XEO_NAME Progesterone DME0162 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0162 XEOTICID XEO00094 DESCRIPT Progesterone up-regulates the expression of DME TGM2 DME0162 XEOTICID XEO00094 GENEFORM mRNA DME0162 XEOTICID XEO00094 MOACRIVE Induction DME0162 XEOTICID XEO00095 XEO_NAME Testosterone DME0162 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0162 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME TGM2 DME0162 XEOTICID XEO00095 GENEFORM mRNA DME0162 XEOTICID XEO00095 MOACRIVE Induction DME0162 XEOTICID XEO00144 XEO_NAME Bexarotene DME0162 XEOTICID XEO00144 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00144 XEO_CLAS Approved/Marketed Drug DME0162 XEOTICID XEO00144 DESCRIPT Bexarotene up-regulates the expression of DME TGM2 DME0162 XEOTICID XEO00144 GENEFORM mRNA DME0162 XEOTICID XEO00144 MOACRIVE Induction DME0162 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0162 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0162 XEOTICID XEO00167 DESCRIPT Alitretinoin induces the drug-metabolizing activity of DME TGM2 DME0162 XEOTICID XEO00167 GENEFORM Protein DME0162 XEOTICID XEO00167 MOACRIVE Induction DME0162 XEOTICID XEO00184 XEO_NAME Calcitriol DME0162 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0162 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME TGM2 DME0162 XEOTICID XEO00184 GENEFORM mRNA DME0162 XEOTICID XEO00184 MOACRIVE Induction DME0162 XEOTICID XEO00204 XEO_NAME Piroxicam DME0162 XEOTICID XEO00204 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00204 XEO_CLAS Approved/Marketed Drug DME0162 XEOTICID XEO00204 DESCRIPT Piroxicam inhibits the drug-metabolizing activity of DME TGM2 DME0162 XEOTICID XEO00204 GENEFORM Protein DME0162 XEOTICID XEO00204 MOACRIVE Inhibition DME0162 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0162 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0162 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME TGM2 DME0162 XEOTICID XEO00217 GENEFORM mRNA DME0162 XEOTICID XEO00217 MOACRIVE Inhibition DME0162 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0162 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0162 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME TGM2 DME0162 XEOTICID XEO00241 GENEFORM mRNA DME0162 XEOTICID XEO00241 MOACRIVE Inhibition DME0162 XEOTICID XEO00253 XEO_NAME Tretinoin DME0162 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0162 XEOTICID XEO00253 DESCRIPT Tretinoin induces the drug-metabolizing activity of DME TGM2 DME0162 XEOTICID XEO00253 GENEFORM Protein DME0162 XEOTICID XEO00253 MOACRIVE Induction DME0162 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0162 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0162 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME TGM2 DME0162 XEOTICID XEO00292 GENEFORM mRNA DME0162 XEOTICID XEO00292 MOACRIVE Induction DME0162 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0162 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0162 XEOTICID XEO00380 DESCRIPT Rosiglitazone up-regulates the expression of DME TGM2 and leads to increasing the drug-metabolizing activity of this enzyme DME0162 XEOTICID XEO00380 GENEFORM Protein DME0162 XEOTICID XEO00380 MOACRIVE Induction DME0162 XEOTICID XEO00401 XEO_NAME Beta carotene DME0162 XEOTICID XEO00401 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00401 XEO_CLAS Approved/Marketed Drug DME0162 XEOTICID XEO00401 DESCRIPT Beta carotene up-regulates the expression of DME TGM2 DME0162 XEOTICID XEO00401 GENEFORM mRNA DME0162 XEOTICID XEO00401 MOACRIVE Induction DME0162 XEOTICID XEO00538 XEO_NAME Quercetin DME0162 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0162 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME TGM2 DME0162 XEOTICID XEO00538 GENEFORM mRNA DME0162 XEOTICID XEO00538 MOACRIVE Inhibition DME0162 XEOTICID XEO00539 XEO_NAME Ethanol DME0162 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0162 XEOTICID XEO00539 DESCRIPT Ethanol induces the drug-metabolizing activity of DME TGM2 DME0162 XEOTICID XEO00539 GENEFORM Protein DME0162 XEOTICID XEO00539 MOACRIVE Induction DME0162 XEOTICID XEO00551 XEO_NAME Vitamin A DME0162 XEOTICID XEO00551 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00551 XEO_CLAS Drug in Phase 3 Clinical Trial DME0162 XEOTICID XEO00551 DESCRIPT Vitamin A up-regulates the expression of DME TGM2 DME0162 XEOTICID XEO00551 GENEFORM mRNA DME0162 XEOTICID XEO00551 MOACRIVE Induction DME0162 XEOTICID XEO00560 XEO_NAME Triclosan DME0162 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0162 XEOTICID XEO00560 DESCRIPT Triclosan inhibits the drug-metabolizing activity of DME TGM2 DME0162 XEOTICID XEO00560 GENEFORM Protein DME0162 XEOTICID XEO00560 MOACRIVE Inhibition DME0162 XEOTICID XEO00581 XEO_NAME MS-275 DME0162 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0162 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME TGM2 DME0162 XEOTICID XEO00581 GENEFORM mRNA DME0162 XEOTICID XEO00581 MOACRIVE Induction DME0162 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0162 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0162 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME TGM2 DME0162 XEOTICID XEO00723 GENEFORM mRNA DME0162 XEOTICID XEO00723 MOACRIVE Inhibition DME0162 XEOTICID XEO00728 XEO_NAME AM-580 DME0162 XEOTICID XEO00728 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO00728 XEO_CLAS Preclinical/Patented Drug DME0162 XEOTICID XEO00728 DESCRIPT AM-580 induces the drug-metabolizing activity of DME TGM2 DME0162 XEOTICID XEO00728 GENEFORM Protein DME0162 XEOTICID XEO00728 MOACRIVE Induction DME0162 XEOTICID XEO00786 XEO_NAME Isoxazole DME0162 XEOTICID XEO00786 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0162 XEOTICID XEO00786 XEO_CLAS Natural Product DME0162 XEOTICID XEO00786 DESCRIPT Isoxazole inhibits the drug-metabolizing activity of DME TGM2 DME0162 XEOTICID XEO00786 GENEFORM Protein DME0162 XEOTICID XEO00786 MOACRIVE Inhibition DME0162 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0162 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0162 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0162 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME TGM2 DME0162 XEOTICID XEO00806 GENEFORM mRNA DME0162 XEOTICID XEO00806 MOACRIVE Induction DME0162 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0162 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0162 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0162 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME TGM2 DME0162 XEOTICID XEO00821 GENEFORM Protein DME0162 XEOTICID XEO00821 MOACRIVE Inhibition DME0162 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0162 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0162 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0162 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME TGM2 DME0162 XEOTICID XEO00898 GENEFORM mRNA DME0162 XEOTICID XEO00898 MOACRIVE Inhibition DME0162 XEOTICID XEO00903 XEO_NAME Enzacamene DME0162 XEOTICID XEO00903 XEO_TYPE Health or Environmental Toxicant(s) DME0162 XEOTICID XEO00903 XEO_CLAS Environmental Pollutant DME0162 XEOTICID XEO00903 DESCRIPT Enzacamene inhibits the expression of DME TGM2 DME0162 XEOTICID XEO00903 GENEFORM mRNA DME0162 XEOTICID XEO00903 MOACRIVE Inhibition DME0162 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0162 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0162 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0162 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the drug-metabolizing activity of DME TGM2 DME0162 XEOTICID XEO01004 GENEFORM Protein DME0162 XEOTICID XEO01004 MOACRIVE Inhibition DME0162 XEOTICID XEO01145 XEO_NAME 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid DME0162 XEOTICID XEO01145 XEO_TYPE Health or Environmental Toxicant(s) DME0162 XEOTICID XEO01145 XEO_CLAS Health Hazard/Toxicant DME0162 XEOTICID XEO01145 DESCRIPT 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid induces the drug-metabolizing activity of DME TGM2 DME0162 XEOTICID XEO01145 GENEFORM Protein DME0162 XEOTICID XEO01145 MOACRIVE Induction DME0162 XEOTICID XEO01154 XEO_NAME 4-oxoretinoic acid DME0162 XEOTICID XEO01154 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0162 XEOTICID XEO01154 XEO_CLAS Natural Product DME0162 XEOTICID XEO01154 DESCRIPT 4-oxoretinoic acid up-regulates the expression of DME TGM2 DME0162 XEOTICID XEO01154 GENEFORM mRNA DME0162 XEOTICID XEO01154 MOACRIVE Induction DME0162 XEOTICID XEO01155 XEO_NAME 4-oxoretinol DME0162 XEOTICID XEO01155 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0162 XEOTICID XEO01155 XEO_CLAS Natural Product DME0162 XEOTICID XEO01155 DESCRIPT 4-oxoretinol up-regulates the expression of DME TGM2 DME0162 XEOTICID XEO01155 GENEFORM mRNA DME0162 XEOTICID XEO01155 MOACRIVE Induction DME0162 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0162 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0162 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME TGM2 DME0162 XEOTICID XEO01226 GENEFORM mRNA DME0162 XEOTICID XEO01226 MOACRIVE Inhibition DME0162 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0162 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0162 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0162 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME TGM2 DME0162 XEOTICID XEO01305 GENEFORM mRNA DME0162 XEOTICID XEO01305 MOACRIVE Inhibition DME0162 XEOTICID XEO01329 XEO_NAME Hexylresorcinol DME0162 XEOTICID XEO01329 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO01329 XEO_CLAS Drug in Phase 1 Clinical Trial DME0162 XEOTICID XEO01329 DESCRIPT Hexylresorcinol inhibits the drug-metabolizing activity of DME TGM2 DME0162 XEOTICID XEO01329 GENEFORM Protein DME0162 XEOTICID XEO01329 MOACRIVE Inhibition DME0162 XEOTICID XEO01449 XEO_NAME Quercitrin DME0162 XEOTICID XEO01449 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0162 XEOTICID XEO01449 XEO_CLAS Natural Product DME0162 XEOTICID XEO01449 DESCRIPT Quercitrin inhibits the expression of DME TGM2 DME0162 XEOTICID XEO01449 GENEFORM mRNA DME0162 XEOTICID XEO01449 MOACRIVE Inhibition DME0162 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0162 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0162 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0162 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME TGM2 DME0162 XEOTICID XEO01492 GENEFORM mRNA DME0162 XEOTICID XEO01492 MOACRIVE Induction DME0163 DME___ID DME0163 DME0163 DME_NAME Transglutaminase X (TGM5) DME0163 SPESNAME Homo sapiens DME0163 XEOTICID XEO00253 XEO_NAME Tretinoin DME0163 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0163 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0163 XEOTICID XEO00253 DESCRIPT Tretinoin induces the drug-metabolizing activity of DME TGM5 DME0163 XEOTICID XEO00253 GENEFORM Protein DME0163 XEOTICID XEO00253 MOACRIVE Induction DME0163 XEOTICID XEO00334 XEO_NAME Cisplatin DME0163 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0163 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0163 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME TGM5 DME0163 XEOTICID XEO00334 GENEFORM mRNA DME0163 XEOTICID XEO00334 MOACRIVE Induction DME0163 XEOTICID XEO00622 XEO_NAME AM-80 DME0163 XEOTICID XEO00622 XEO_TYPE Pharmaceutical Agent(s) DME0163 XEOTICID XEO00622 XEO_CLAS Drug in Phase 2 Clinical Trial DME0163 XEOTICID XEO00622 DESCRIPT AM-80 up-regulates the expression of DME TGM5 DME0163 XEOTICID XEO00622 GENEFORM mRNA DME0163 XEOTICID XEO00622 MOACRIVE Induction DME0163 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0163 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0163 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0163 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME TGM5 DME0163 XEOTICID XEO00723 GENEFORM mRNA DME0163 XEOTICID XEO00723 MOACRIVE Inhibition DME0163 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0163 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0163 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0163 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME TGM5 DME0163 XEOTICID XEO00806 GENEFORM mRNA DME0163 XEOTICID XEO00806 MOACRIVE Induction DME0163 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0163 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0163 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0163 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME TGM5 DME0163 XEOTICID XEO00898 GENEFORM mRNA DME0163 XEOTICID XEO00898 MOACRIVE Induction DME0163 XEOTICID XEO01044 XEO_NAME Clothianidin DME0163 XEOTICID XEO01044 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0163 XEOTICID XEO01044 XEO_CLAS Pesticide/Insecticide DME0163 XEOTICID XEO01044 DESCRIPT Clothianidin inhibits the expression of DME TGM5 DME0163 XEOTICID XEO01044 GENEFORM mRNA DME0163 XEOTICID XEO01044 MOACRIVE Inhibition DME0164 DME___ID DME0164 DME0164 DME_NAME Transglutaminase Y (TGM6) DME0164 SPESNAME Homo sapiens DME0164 XEOTICID XEO00969 XEO_NAME Atrazine DME0164 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0164 XEOTICID XEO00969 XEO_CLAS Herbicide DME0164 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME TGM6 DME0164 XEOTICID XEO00969 GENEFORM mRNA DME0164 XEOTICID XEO00969 MOACRIVE Induction DME0165 DME___ID DME0165 DME0165 DME_NAME Transglutaminase E (TGM3) DME0165 SPESNAME Homo sapiens DME0165 XEOTICID XEO00184 XEO_NAME Calcitriol DME0165 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0165 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0165 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME TGM3 DME0165 XEOTICID XEO00184 GENEFORM mRNA DME0165 XEOTICID XEO00184 MOACRIVE Inhibition DME0165 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0165 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0165 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0165 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME TGM3 DME0165 XEOTICID XEO00723 GENEFORM mRNA DME0165 XEOTICID XEO00723 MOACRIVE Inhibition DME0165 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0165 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0165 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0165 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME TGM3 DME0165 XEOTICID XEO00821 GENEFORM Protein DME0165 XEOTICID XEO00821 MOACRIVE Inhibition DME0165 XEOTICID XEO00919 XEO_NAME Particulate matter DME0165 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0165 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0165 XEOTICID XEO00919 DESCRIPT Particulate matter up-regulates the expression of DME TGM3 DME0165 XEOTICID XEO00919 GENEFORM mRNA DME0165 XEOTICID XEO00919 MOACRIVE Induction DME0166 DME___ID DME0166 DME0166 DME_NAME Transglutaminase K (TGM1) DME0166 SPESNAME Homo sapiens DME0166 XEOTICID XEO00053 XEO_NAME Leflunomide DME0166 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0166 XEOTICID XEO00053 DESCRIPT Leflunomide inhibits the expression of DME TGM1 DME0166 XEOTICID XEO00053 GENEFORM mRNA DME0166 XEOTICID XEO00053 MOACRIVE Inhibition DME0166 XEOTICID XEO00090 XEO_NAME Estradiol DME0166 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0166 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME TGM1 DME0166 XEOTICID XEO00090 GENEFORM mRNA DME0166 XEOTICID XEO00090 MOACRIVE Inhibition DME0166 XEOTICID XEO00144 XEO_NAME Bexarotene DME0166 XEOTICID XEO00144 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO00144 XEO_CLAS Approved/Marketed Drug DME0166 XEOTICID XEO00144 DESCRIPT Bexarotene inhibits the expression of DME TGM1 DME0166 XEOTICID XEO00144 GENEFORM mRNA DME0166 XEOTICID XEO00144 MOACRIVE Inhibition DME0166 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0166 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0166 XEOTICID XEO00167 DESCRIPT Alitretinoin inhibits the expression of DME TGM1 DME0166 XEOTICID XEO00167 GENEFORM mRNA DME0166 XEOTICID XEO00167 MOACRIVE Inhibition DME0166 XEOTICID XEO00184 XEO_NAME Calcitriol DME0166 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0166 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME TGM1 DME0166 XEOTICID XEO00184 GENEFORM mRNA DME0166 XEOTICID XEO00184 MOACRIVE Inhibition DME0166 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0166 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0166 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME TGM1 DME0166 XEOTICID XEO00186 GENEFORM mRNA DME0166 XEOTICID XEO00186 MOACRIVE Inhibition DME0166 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0166 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0166 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME TGM1 DME0166 XEOTICID XEO00241 GENEFORM mRNA DME0166 XEOTICID XEO00241 MOACRIVE Inhibition DME0166 XEOTICID XEO00253 XEO_NAME Tretinoin DME0166 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0166 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the drug-metabolizing activity of DME TGM1 DME0166 XEOTICID XEO00253 GENEFORM Protein DME0166 XEOTICID XEO00253 MOACRIVE Inhibition DME0166 XEOTICID XEO00264 XEO_NAME Hydrocortisone DME0166 XEOTICID XEO00264 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO00264 XEO_CLAS Approved/Marketed Drug DME0166 XEOTICID XEO00264 DESCRIPT Hydrocortisone up-regulates the expression of DME TGM1 DME0166 XEOTICID XEO00264 GENEFORM mRNA DME0166 XEOTICID XEO00264 MOACRIVE Induction DME0166 XEOTICID XEO00334 XEO_NAME Cisplatin DME0166 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0166 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME TGM1 DME0166 XEOTICID XEO00334 GENEFORM mRNA DME0166 XEOTICID XEO00334 MOACRIVE Induction DME0166 XEOTICID XEO00411 XEO_NAME Avobenzone DME0166 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0166 XEOTICID XEO00411 DESCRIPT Avobenzone inhibits the expression of DME TGM1 DME0166 XEOTICID XEO00411 GENEFORM mRNA DME0166 XEOTICID XEO00411 MOACRIVE Inhibition DME0166 XEOTICID XEO00568 XEO_NAME Resveratrol DME0166 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0166 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME TGM1 DME0166 XEOTICID XEO00568 GENEFORM mRNA DME0166 XEOTICID XEO00568 MOACRIVE Induction DME0166 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0166 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0166 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME TGM1 DME0166 XEOTICID XEO00632 GENEFORM mRNA DME0166 XEOTICID XEO00632 MOACRIVE Inhibition DME0166 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0166 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0166 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0166 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME TGM1 DME0166 XEOTICID XEO00806 GENEFORM mRNA DME0166 XEOTICID XEO00806 MOACRIVE Induction DME0166 XEOTICID XEO00832 XEO_NAME Calcium DME0166 XEOTICID XEO00832 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO00832 XEO_CLAS Approved/Marketed Drug DME0166 XEOTICID XEO00832 DESCRIPT Calcium up-regulates the expression of DME TGM1 DME0166 XEOTICID XEO00832 GENEFORM mRNA DME0166 XEOTICID XEO00832 MOACRIVE Induction DME0166 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0166 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0166 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0166 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME TGM1 DME0166 XEOTICID XEO01004 GENEFORM mRNA DME0166 XEOTICID XEO01004 MOACRIVE Induction DME0166 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0166 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0166 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0166 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME TGM1 DME0166 XEOTICID XEO01050 GENEFORM mRNA DME0166 XEOTICID XEO01050 MOACRIVE Inhibition DME0166 XEOTICID XEO01145 XEO_NAME 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid DME0166 XEOTICID XEO01145 XEO_TYPE Health or Environmental Toxicant(s) DME0166 XEOTICID XEO01145 XEO_CLAS Health Hazard/Toxicant DME0166 XEOTICID XEO01145 DESCRIPT 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid inhibits the expression of DME TGM1 DME0166 XEOTICID XEO01145 GENEFORM mRNA DME0166 XEOTICID XEO01145 MOACRIVE Inhibition DME0166 XEOTICID XEO01154 XEO_NAME 4-oxoretinoic acid DME0166 XEOTICID XEO01154 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0166 XEOTICID XEO01154 XEO_CLAS Natural Product DME0166 XEOTICID XEO01154 DESCRIPT 4-oxoretinoic acid inhibits the expression of DME TGM1 DME0166 XEOTICID XEO01154 GENEFORM mRNA DME0166 XEOTICID XEO01154 MOACRIVE Inhibition DME0166 XEOTICID XEO01473 XEO_NAME SR-11238 DME0166 XEOTICID XEO01473 XEO_TYPE Pharmaceutical Agent(s) DME0166 XEOTICID XEO01473 XEO_CLAS Preclinical/Patented Drug DME0166 XEOTICID XEO01473 DESCRIPT SR-11238 inhibits the expression of DME TGM1 DME0166 XEOTICID XEO01473 GENEFORM mRNA DME0166 XEOTICID XEO01473 MOACRIVE Inhibition DME0167 DME___ID DME0167 DME0167 DME_NAME Transglutaminase Z (TGM7) DME0167 SPESNAME Homo sapiens DME0167 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0167 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0167 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0167 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME TGM7 DME0167 XEOTICID XEO00217 GENEFORM mRNA DME0167 XEOTICID XEO00217 MOACRIVE Inhibition DME0168 DME___ID DME0168 DME0168 DME_NAME Neprilysin (MME) DME0168 SPESNAME Homo sapiens DME0168 XEOTICID XEO00009 XEO_NAME Bicalutamide DME0168 XEOTICID XEO00009 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00009 XEO_CLAS Approved/Marketed Drug DME0168 XEOTICID XEO00009 DESCRIPT Bicalutamide up-regulates the expression of DME MME DME0168 XEOTICID XEO00009 GENEFORM mRNA DME0168 XEOTICID XEO00009 MOACRIVE Induction DME0168 XEOTICID XEO00029 XEO_NAME Valproic acid DME0168 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0168 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME MME DME0168 XEOTICID XEO00029 GENEFORM mRNA DME0168 XEOTICID XEO00029 MOACRIVE Induction DME0168 XEOTICID XEO00090 XEO_NAME Estradiol DME0168 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0168 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME MME DME0168 XEOTICID XEO00090 GENEFORM mRNA DME0168 XEOTICID XEO00090 MOACRIVE Inhibition DME0168 XEOTICID XEO00094 XEO_NAME Progesterone DME0168 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0168 XEOTICID XEO00094 DESCRIPT Progesterone up-regulates the expression of DME MME DME0168 XEOTICID XEO00094 GENEFORM mRNA DME0168 XEOTICID XEO00094 MOACRIVE Induction DME0168 XEOTICID XEO00147 XEO_NAME Fulvestrant DME0168 XEOTICID XEO00147 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00147 XEO_CLAS Approved/Marketed Drug DME0168 XEOTICID XEO00147 DESCRIPT Fulvestrant up-regulates the expression of DME MME DME0168 XEOTICID XEO00147 GENEFORM mRNA DME0168 XEOTICID XEO00147 MOACRIVE Induction DME0168 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0168 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0168 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME MME DME0168 XEOTICID XEO00217 GENEFORM mRNA DME0168 XEOTICID XEO00217 MOACRIVE Inhibition DME0168 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0168 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0168 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME MME DME0168 XEOTICID XEO00241 GENEFORM mRNA DME0168 XEOTICID XEO00241 MOACRIVE Inhibition DME0168 XEOTICID XEO00253 XEO_NAME Tretinoin DME0168 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0168 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME MME DME0168 XEOTICID XEO00253 GENEFORM mRNA DME0168 XEOTICID XEO00253 MOACRIVE Induction DME0168 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0168 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0168 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the drug-metabolizing activity of DME MME DME0168 XEOTICID XEO00292 GENEFORM Protein DME0168 XEOTICID XEO00292 MOACRIVE Inhibition DME0168 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0168 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0168 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex up-regulates the expression of DME MME DME0168 XEOTICID XEO00312 GENEFORM mRNA DME0168 XEOTICID XEO00312 MOACRIVE Induction DME0168 XEOTICID XEO00581 XEO_NAME MS-275 DME0168 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0168 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME MME DME0168 XEOTICID XEO00581 GENEFORM mRNA DME0168 XEOTICID XEO00581 MOACRIVE Induction DME0168 XEOTICID XEO00599 XEO_NAME Tetradecanoylphorbol acetate DME0168 XEOTICID XEO00599 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00599 XEO_CLAS Drug in Phase 1 Clinical Trial DME0168 XEOTICID XEO00599 DESCRIPT Tetradecanoylphorbol acetate inhibits the drug-metabolizing activity of DME MME DME0168 XEOTICID XEO00599 GENEFORM Protein DME0168 XEOTICID XEO00599 MOACRIVE Inhibition DME0168 XEOTICID XEO00631 XEO_NAME Candoxatrilat DME0168 XEOTICID XEO00631 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00631 XEO_CLAS Drug in Phase 2 Clinical Trial DME0168 XEOTICID XEO00631 DESCRIPT Candoxatrilat inhibits the drug-metabolizing activity of DME MME (IC50 = 0.0078 microM) DME0168 XEOTICID XEO00631 GENEFORM Protein DME0168 XEOTICID XEO00631 MOACRIVE Inhibition DME0168 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0168 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0168 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME MME DME0168 XEOTICID XEO00632 GENEFORM mRNA DME0168 XEOTICID XEO00632 MOACRIVE Induction DME0168 XEOTICID XEO00638 XEO_NAME Omapatrilat DME0168 XEOTICID XEO00638 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00638 XEO_CLAS Drug in Phase 2 Clinical Trial DME0168 XEOTICID XEO00638 DESCRIPT Omapatrilat inhibits the drug-metabolizing activity of DME MME (Ki = 0.009 microM) DME0168 XEOTICID XEO00638 GENEFORM Protein DME0168 XEOTICID XEO00638 MOACRIVE Inhibition DME0168 XEOTICID XEO00669 XEO_NAME ZD4054 DME0168 XEOTICID XEO00669 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00669 XEO_CLAS Drug in Phase 2 Clinical Trial DME0168 XEOTICID XEO00669 DESCRIPT ZD4054 inhibits the expression of DME MME DME0168 XEOTICID XEO00669 GENEFORM mRNA DME0168 XEOTICID XEO00669 MOACRIVE Inhibition DME0168 XEOTICID XEO00674 XEO_NAME Acyline DME0168 XEOTICID XEO00674 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00674 XEO_CLAS Drug in Phase 2 Clinical Trial DME0168 XEOTICID XEO00674 DESCRIPT Acyline inhibits the expression of DME MME DME0168 XEOTICID XEO00674 GENEFORM mRNA DME0168 XEOTICID XEO00674 MOACRIVE Inhibition DME0168 XEOTICID XEO00683 XEO_NAME Curcumin DME0168 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0168 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the expression of DME MME DME0168 XEOTICID XEO00683 GENEFORM mRNA DME0168 XEOTICID XEO00683 MOACRIVE Inhibition DME0168 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0168 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0168 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME MME DME0168 XEOTICID XEO00723 GENEFORM mRNA DME0168 XEOTICID XEO00723 MOACRIVE Inhibition DME0168 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0168 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0168 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0168 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME MME DME0168 XEOTICID XEO00806 GENEFORM mRNA DME0168 XEOTICID XEO00806 MOACRIVE Inhibition DME0168 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0168 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0168 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0168 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the drug-metabolizing activity of DME MME DME0168 XEOTICID XEO00821 GENEFORM Protein DME0168 XEOTICID XEO00821 MOACRIVE Inhibition DME0168 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0168 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0168 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0168 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME MME DME0168 XEOTICID XEO00898 GENEFORM mRNA DME0168 XEOTICID XEO00898 MOACRIVE Inhibition DME0168 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0168 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0168 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0168 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the drug-metabolizing activity of DME MME DME0168 XEOTICID XEO01004 GENEFORM Protein DME0168 XEOTICID XEO01004 MOACRIVE Inhibition DME0168 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0168 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0168 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME MME DME0168 XEOTICID XEO01226 GENEFORM mRNA DME0168 XEOTICID XEO01226 MOACRIVE Inhibition DME0168 XEOTICID XEO01484 XEO_NAME Thiorphan DME0168 XEOTICID XEO01484 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO01484 XEO_CLAS Investigative Agent DME0168 XEOTICID XEO01484 DESCRIPT Thiorphan inhibits the drug-metabolizing activity of DME MME (IC50 = 0.001 microM) DME0168 XEOTICID XEO01484 GENEFORM Protein DME0168 XEOTICID XEO01484 MOACRIVE Inhibition DME0168 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0168 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0168 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0168 XEOTICID XEO01492 DESCRIPT Trichostatin A induces the drug-metabolizing activity of DME MME DME0168 XEOTICID XEO01492 GENEFORM Protein DME0168 XEOTICID XEO01492 MOACRIVE Induction DME0168 XEOTICID XEO01505 XEO_NAME Lead DME0168 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0168 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0168 XEOTICID XEO01505 DESCRIPT Lead inhibits the expression of DME MME and leads to decreasing the drug-metabolizing activity of this enzyme DME0168 XEOTICID XEO01505 GENEFORM Protein DME0168 XEOTICID XEO01505 MOACRIVE Inhibition DME0168 XEOTICID XEO01509 XEO_NAME Mercury DME0168 XEOTICID XEO01509 XEO_TYPE Health or Environmental Toxicant(s) DME0168 XEOTICID XEO01509 XEO_CLAS Acute Toxic Substance DME0168 XEOTICID XEO01509 DESCRIPT Mercury inhibits the drug-metabolizing activity of DME MME DME0168 XEOTICID XEO01509 GENEFORM Protein DME0168 XEOTICID XEO01509 MOACRIVE Inhibition DME0169 DME___ID DME0169 DME0169 DME_NAME Serum paraoxonase/arylesterase 1 (PON1) DME0169 SPESNAME Homo sapiens DME0169 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0169 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00011 DESCRIPT Carbamazepine inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00011 GENEFORM Protein DME0169 XEOTICID XEO00011 MOACRIVE Inhibition DME0169 XEOTICID XEO00029 XEO_NAME Valproic acid DME0169 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME PON1 DME0169 XEOTICID XEO00029 GENEFORM mRNA DME0169 XEOTICID XEO00029 MOACRIVE Inhibition DME0169 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0169 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00035 DESCRIPT Fenofibrate induces the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00035 GENEFORM Protein DME0169 XEOTICID XEO00035 MOACRIVE Induction DME0169 XEOTICID XEO00041 XEO_NAME Gabapentin DME0169 XEOTICID XEO00041 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00041 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00041 DESCRIPT Gabapentin inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00041 GENEFORM Protein DME0169 XEOTICID XEO00041 MOACRIVE Inhibition DME0169 XEOTICID XEO00079 XEO_NAME Vorinostat DME0169 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00079 DESCRIPT Vorinostat inhibits the expression of DME PON1 DME0169 XEOTICID XEO00079 GENEFORM mRNA DME0169 XEOTICID XEO00079 MOACRIVE Inhibition DME0169 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0169 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00088 DESCRIPT Dexamethasone induces the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00088 GENEFORM Protein DME0169 XEOTICID XEO00088 MOACRIVE Induction DME0169 XEOTICID XEO00090 XEO_NAME Estradiol DME0169 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME PON1 DME0169 XEOTICID XEO00090 GENEFORM mRNA DME0169 XEOTICID XEO00090 MOACRIVE Inhibition DME0169 XEOTICID XEO00096 XEO_NAME Ampicillin DME0169 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00096 GENEFORM Protein DME0169 XEOTICID XEO00096 MOACRIVE Inhibition DME0169 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0169 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME PON1 DME0169 XEOTICID XEO00117 GENEFORM mRNA DME0169 XEOTICID XEO00117 MOACRIVE Inhibition DME0169 XEOTICID XEO00148 XEO_NAME Bosentan DME0169 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00148 DESCRIPT Bosentan inhibits the expression of DME PON1 DME0169 XEOTICID XEO00148 GENEFORM mRNA DME0169 XEOTICID XEO00148 MOACRIVE Inhibition DME0169 XEOTICID XEO00194 XEO_NAME Omacor DME0169 XEOTICID XEO00194 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00194 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00194 DESCRIPT Omacor up-regulates the expression of DME PON1 DME0169 XEOTICID XEO00194 GENEFORM mRNA DME0169 XEOTICID XEO00194 MOACRIVE Induction DME0169 XEOTICID XEO00213 XEO_NAME Aspirin DME0169 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00213 DESCRIPT Aspirin induces the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00213 GENEFORM Protein DME0169 XEOTICID XEO00213 MOACRIVE Induction DME0169 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0169 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME PON1 DME0169 XEOTICID XEO00217 GENEFORM mRNA DME0169 XEOTICID XEO00217 MOACRIVE Inhibition DME0169 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0169 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME PON1 DME0169 XEOTICID XEO00241 GENEFORM mRNA DME0169 XEOTICID XEO00241 MOACRIVE Inhibition DME0169 XEOTICID XEO00327 XEO_NAME Sulfisoxazole acetyl DME0169 XEOTICID XEO00327 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00327 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00327 DESCRIPT Sulfisoxazole acetyl inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00327 GENEFORM Protein DME0169 XEOTICID XEO00327 MOACRIVE Inhibition DME0169 XEOTICID XEO00340 XEO_NAME Atorvastatin DME0169 XEOTICID XEO00340 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00340 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00340 DESCRIPT Atorvastatin induces the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00340 GENEFORM Protein DME0169 XEOTICID XEO00340 MOACRIVE Induction DME0169 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME0169 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00349 DESCRIPT Ciprof DMEloxacin inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00349 GENEFORM Protein DME0169 XEOTICID XEO00349 MOACRIVE Inhibition DME0169 XEOTICID XEO00372 XEO_NAME Panobinostat DME0169 XEOTICID XEO00372 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00372 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00372 DESCRIPT Panobinostat inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00372 GENEFORM Protein DME0169 XEOTICID XEO00372 MOACRIVE Inhibition DME0169 XEOTICID XEO00376 XEO_NAME Pitavastatin DME0169 XEOTICID XEO00376 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00376 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00376 DESCRIPT Pitavastatin up-regulates the expression of DME PON1 DME0169 XEOTICID XEO00376 GENEFORM mRNA DME0169 XEOTICID XEO00376 MOACRIVE Induction DME0169 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0169 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00388 GENEFORM Protein DME0169 XEOTICID XEO00388 MOACRIVE Inhibition DME0169 XEOTICID XEO00418 XEO_NAME Nandrolone decanoate DME0169 XEOTICID XEO00418 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00418 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00418 DESCRIPT Nandrolone decanoate inhibits the expression of DME PON1 DME0169 XEOTICID XEO00418 GENEFORM mRNA DME0169 XEOTICID XEO00418 MOACRIVE Inhibition DME0169 XEOTICID XEO00568 XEO_NAME Resveratrol DME0169 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0169 XEOTICID XEO00568 DESCRIPT Resveratrol induces the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00568 GENEFORM Protein DME0169 XEOTICID XEO00568 MOACRIVE Induction DME0169 XEOTICID XEO00573 XEO_NAME Naringenin DME0169 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME0169 XEOTICID XEO00573 DESCRIPT Naringenin induces the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00573 GENEFORM Protein DME0169 XEOTICID XEO00573 MOACRIVE Induction DME0169 XEOTICID XEO00581 XEO_NAME MS-275 DME0169 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0169 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME PON1 DME0169 XEOTICID XEO00581 GENEFORM mRNA DME0169 XEOTICID XEO00581 MOACRIVE Induction DME0169 XEOTICID XEO00624 XEO_NAME NCX-4016 DME0169 XEOTICID XEO00624 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00624 XEO_CLAS Drug in Phase 2 Clinical Trial DME0169 XEOTICID XEO00624 DESCRIPT NCX-4016 induces the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00624 GENEFORM Protein DME0169 XEOTICID XEO00624 MOACRIVE Induction DME0169 XEOTICID XEO00735 XEO_NAME GW-4064 DME0169 XEOTICID XEO00735 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00735 XEO_CLAS Preclinical/Patented Drug DME0169 XEOTICID XEO00735 DESCRIPT GW-4064 inhibits the expression of DME PON1 DME0169 XEOTICID XEO00735 GENEFORM mRNA DME0169 XEOTICID XEO00735 MOACRIVE Inhibition DME0169 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0169 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0169 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0169 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME PON1 DME0169 XEOTICID XEO00806 GENEFORM mRNA DME0169 XEOTICID XEO00806 MOACRIVE Inhibition DME0169 XEOTICID XEO00832 XEO_NAME Calcium DME0169 XEOTICID XEO00832 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00832 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00832 DESCRIPT Calcium induces the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00832 GENEFORM Protein DME0169 XEOTICID XEO00832 MOACRIVE Induction DME0169 XEOTICID XEO00834 XEO_NAME Copper DME0169 XEOTICID XEO00834 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00834 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO00834 DESCRIPT Copper inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00834 GENEFORM Protein DME0169 XEOTICID XEO00834 MOACRIVE Inhibition DME0169 XEOTICID XEO00869 XEO_NAME 4-hydroxy-2-nonenal DME0169 XEOTICID XEO00869 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00869 XEO_CLAS Investigative Agent DME0169 XEOTICID XEO00869 DESCRIPT 4-hydroxy-2-nonenal inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00869 GENEFORM Protein DME0169 XEOTICID XEO00869 MOACRIVE Inhibition DME0169 XEOTICID XEO00876 XEO_NAME Arachidonic acid DME0169 XEOTICID XEO00876 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO00876 XEO_CLAS Investigative Agent DME0169 XEOTICID XEO00876 DESCRIPT Arachidonic acid inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00876 GENEFORM Protein DME0169 XEOTICID XEO00876 MOACRIVE Inhibition DME0169 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0169 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0169 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0169 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME PON1 DME0169 XEOTICID XEO00898 GENEFORM mRNA DME0169 XEOTICID XEO00898 MOACRIVE Inhibition DME0169 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0169 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0169 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0169 XEOTICID XEO00899 DESCRIPT Methylcholanthrene induces the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO00899 GENEFORM Protein DME0169 XEOTICID XEO00899 MOACRIVE Induction DME0169 XEOTICID XEO01141 XEO_NAME 3-methylquercetin DME0169 XEOTICID XEO01141 XEO_TYPE Health or Environmental Toxicant(s) DME0169 XEOTICID XEO01141 XEO_CLAS Health Hazard/Toxicant DME0169 XEOTICID XEO01141 DESCRIPT 3-methylquercetin up-regulates the expression of DME PON1 DME0169 XEOTICID XEO01141 GENEFORM mRNA DME0169 XEOTICID XEO01141 MOACRIVE Induction DME0169 XEOTICID XEO01286 XEO_NAME Egtazic acid DME0169 XEOTICID XEO01286 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO01286 XEO_CLAS Investigative Agent DME0169 XEOTICID XEO01286 DESCRIPT Egtazic acid inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO01286 GENEFORM Protein DME0169 XEOTICID XEO01286 MOACRIVE Inhibition DME0169 XEOTICID XEO01304 XEO_NAME Flavone DME0169 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0169 XEOTICID XEO01304 XEO_CLAS Natural Product DME0169 XEOTICID XEO01304 DESCRIPT Flavone up-regulates the expression of DME PON1 DME0169 XEOTICID XEO01304 GENEFORM mRNA DME0169 XEOTICID XEO01304 MOACRIVE Induction DME0169 XEOTICID XEO01367 XEO_NAME Linoleic acid DME0169 XEOTICID XEO01367 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO01367 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO01367 DESCRIPT Linoleic acid inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO01367 GENEFORM Protein DME0169 XEOTICID XEO01367 MOACRIVE Inhibition DME0169 XEOTICID XEO01421 XEO_NAME Palmitoleic acid DME0169 XEOTICID XEO01421 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO01421 XEO_CLAS Drug in Phase 1 Clinical Trial DME0169 XEOTICID XEO01421 DESCRIPT Palmitoleic acid inhibits the expression of DME PON1 DME0169 XEOTICID XEO01421 GENEFORM mRNA DME0169 XEOTICID XEO01421 MOACRIVE Inhibition DME0169 XEOTICID XEO01448 XEO_NAME Pyruvaldehyde DME0169 XEOTICID XEO01448 XEO_TYPE Health or Environmental Toxicant(s) DME0169 XEOTICID XEO01448 XEO_CLAS Health Hazard/Toxicant DME0169 XEOTICID XEO01448 DESCRIPT Pyruvaldehyde inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO01448 GENEFORM Protein DME0169 XEOTICID XEO01448 MOACRIVE Inhibition DME0169 XEOTICID XEO01477 XEO_NAME Sulfisomidine DME0169 XEOTICID XEO01477 XEO_TYPE Pharmaceutical Agent(s) DME0169 XEOTICID XEO01477 XEO_CLAS Approved/Marketed Drug DME0169 XEOTICID XEO01477 DESCRIPT Sulfisomidine inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO01477 GENEFORM Protein DME0169 XEOTICID XEO01477 MOACRIVE Inhibition DME0169 XEOTICID XEO01505 XEO_NAME Lead DME0169 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0169 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0169 XEOTICID XEO01505 DESCRIPT Lead inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO01505 GENEFORM Protein DME0169 XEOTICID XEO01505 MOACRIVE Inhibition DME0169 XEOTICID XEO01509 XEO_NAME Mercury DME0169 XEOTICID XEO01509 XEO_TYPE Health or Environmental Toxicant(s) DME0169 XEOTICID XEO01509 XEO_CLAS Acute Toxic Substance DME0169 XEOTICID XEO01509 DESCRIPT Mercury inhibits the drug-metabolizing activity of DME PON1 DME0169 XEOTICID XEO01509 GENEFORM Protein DME0169 XEOTICID XEO01509 MOACRIVE Inhibition DME0170 DME___ID DME0170 DME0170 DME_NAME Serum paraoxonase/lactonase 3 (PON3) DME0170 SPESNAME Homo sapiens DME0170 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0170 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0170 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0170 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME PON3 DME0170 XEOTICID XEO00186 GENEFORM mRNA DME0170 XEOTICID XEO00186 MOACRIVE Inhibition DME0170 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0170 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0170 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0170 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME PON3 DME0170 XEOTICID XEO00217 GENEFORM mRNA DME0170 XEOTICID XEO00217 MOACRIVE Inhibition DME0170 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0170 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0170 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0170 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME PON3 DME0170 XEOTICID XEO00241 GENEFORM mRNA DME0170 XEOTICID XEO00241 MOACRIVE Inhibition DME0170 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0170 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0170 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0170 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME PON3 DME0170 XEOTICID XEO01050 GENEFORM mRNA DME0170 XEOTICID XEO01050 MOACRIVE Inhibition DME0170 XEOTICID XEO01348 XEO_NAME K-7174 DME0170 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0170 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0170 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME PON3 DME0170 XEOTICID XEO01348 GENEFORM mRNA DME0170 XEOTICID XEO01348 MOACRIVE Inhibition DME0171 DME___ID DME0171 DME0171 DME_NAME Indoleamine 2,3-dioxygenase 1 (IDO1) DME0171 SPESNAME Homo sapiens DME0171 XEOTICID XEO00125 XEO_NAME Simvastatin DME0171 XEOTICID XEO00125 XEO_TYPE Pharmaceutical Agent(s) DME0171 XEOTICID XEO00125 XEO_CLAS Approved/Marketed Drug DME0171 XEOTICID XEO00125 DESCRIPT Simvastatin up-regulates the expression of DME IDO1 DME0171 XEOTICID XEO00125 GENEFORM mRNA DME0171 XEOTICID XEO00125 MOACRIVE Induction DME0171 XEOTICID XEO00208 XEO_NAME Acyclovir DME0171 XEOTICID XEO00208 XEO_TYPE Pharmaceutical Agent(s) DME0171 XEOTICID XEO00208 XEO_CLAS Approved/Marketed Drug DME0171 XEOTICID XEO00208 DESCRIPT Acyclovir inhibits the drug-metabolizing activity of DME IDO1 DME0171 XEOTICID XEO00208 GENEFORM Protein DME0171 XEOTICID XEO00208 MOACRIVE Inhibition DME0171 XEOTICID XEO00268 XEO_NAME Gadodiamide DME0171 XEOTICID XEO00268 XEO_TYPE Pharmaceutical Agent(s) DME0171 XEOTICID XEO00268 XEO_CLAS Approved/Marketed Drug DME0171 XEOTICID XEO00268 DESCRIPT Gadodiamide up-regulates the expression of DME IDO1 DME0171 XEOTICID XEO00268 GENEFORM mRNA DME0171 XEOTICID XEO00268 MOACRIVE Induction DME0171 XEOTICID XEO00334 XEO_NAME Cisplatin DME0171 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0171 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0171 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME IDO1 DME0171 XEOTICID XEO00334 GENEFORM mRNA DME0171 XEOTICID XEO00334 MOACRIVE Induction DME0171 XEOTICID XEO00581 XEO_NAME MS-275 DME0171 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0171 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0171 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME IDO1 DME0171 XEOTICID XEO00581 GENEFORM mRNA DME0171 XEOTICID XEO00581 MOACRIVE Induction DME0171 XEOTICID XEO00683 XEO_NAME Curcumin DME0171 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0171 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0171 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the expression of DME IDO1 DME0171 XEOTICID XEO00683 GENEFORM mRNA DME0171 XEOTICID XEO00683 MOACRIVE Inhibition DME0171 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0171 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0171 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0171 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME IDO1 DME0171 XEOTICID XEO00898 GENEFORM mRNA DME0171 XEOTICID XEO00898 MOACRIVE Induction DME0171 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0171 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0171 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0171 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME IDO1 DME0171 XEOTICID XEO00999 GENEFORM mRNA DME0171 XEOTICID XEO00999 MOACRIVE Induction DME0171 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0171 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0171 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0171 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME IDO1 DME0171 XEOTICID XEO01004 GENEFORM mRNA DME0171 XEOTICID XEO01004 MOACRIVE Inhibition DME0171 XEOTICID XEO01256 XEO_NAME CL075 DME0171 XEOTICID XEO01256 XEO_TYPE Pharmaceutical Agent(s) DME0171 XEOTICID XEO01256 XEO_CLAS Investigative Agent DME0171 XEOTICID XEO01256 DESCRIPT CL075 up-regulates the expression of DME IDO1 DME0171 XEOTICID XEO01256 GENEFORM mRNA DME0171 XEOTICID XEO01256 MOACRIVE Induction DME0171 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0171 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0171 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0171 XEOTICID XEO01492 DESCRIPT Trichostatin A inhibits the drug-metabolizing activity of DME IDO1 DME0171 XEOTICID XEO01492 GENEFORM Protein DME0171 XEOTICID XEO01492 MOACRIVE Inhibition DME0171 XEOTICID XEO01511 XEO_NAME Vitallium DME0171 XEOTICID XEO01511 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0171 XEOTICID XEO01511 XEO_CLAS Natural Mixture DME0171 XEOTICID XEO01511 DESCRIPT Vitallium inhibits the expression of DME IDO1 DME0171 XEOTICID XEO01511 GENEFORM mRNA DME0171 XEOTICID XEO01511 MOACRIVE Inhibition DME0172 DME___ID DME0172 DME0172 DME_NAME Tryptophan oxygenase (TRPO) DME0172 SPESNAME Homo sapiens DME0172 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0172 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0172 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0172 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME TDO2 DME0172 XEOTICID XEO00035 GENEFORM mRNA DME0172 XEOTICID XEO00035 MOACRIVE Induction DME0172 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0172 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0172 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0172 XEOTICID XEO00088 DESCRIPT Dexamethasone induces the drug-metabolizing activity of DME TDO2 DME0172 XEOTICID XEO00088 GENEFORM Protein DME0172 XEOTICID XEO00088 MOACRIVE Induction DME0172 XEOTICID XEO00090 XEO_NAME Estradiol DME0172 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0172 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0172 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME TDO2 DME0172 XEOTICID XEO00090 GENEFORM mRNA DME0172 XEOTICID XEO00090 MOACRIVE Inhibition DME0172 XEOTICID XEO00094 XEO_NAME Progesterone DME0172 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0172 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0172 XEOTICID XEO00094 DESCRIPT Progesterone induces the drug-metabolizing activity of DME TDO2 DME0172 XEOTICID XEO00094 GENEFORM Protein DME0172 XEOTICID XEO00094 MOACRIVE Induction DME0172 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0172 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0172 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0172 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME TDO2 DME0172 XEOTICID XEO00241 GENEFORM mRNA DME0172 XEOTICID XEO00241 MOACRIVE Inhibition DME0172 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0172 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0172 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0172 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride up-regulates the expression of DME TDO2 DME0172 XEOTICID XEO00277 GENEFORM mRNA DME0172 XEOTICID XEO00277 MOACRIVE Induction DME0172 XEOTICID XEO00365 XEO_NAME Metformin DME0172 XEOTICID XEO00365 XEO_TYPE Pharmaceutical Agent(s) DME0172 XEOTICID XEO00365 XEO_CLAS Approved/Marketed Drug DME0172 XEOTICID XEO00365 DESCRIPT Metformin inhibits the expression of DME TDO2 DME0172 XEOTICID XEO00365 GENEFORM mRNA DME0172 XEOTICID XEO00365 MOACRIVE Inhibition DME0172 XEOTICID XEO00466 XEO_NAME Demecolcine DME0172 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0172 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0172 XEOTICID XEO00466 DESCRIPT Demecolcine up-regulates the expression of DME TDO2 DME0172 XEOTICID XEO00466 GENEFORM mRNA DME0172 XEOTICID XEO00466 MOACRIVE Induction DME0172 XEOTICID XEO00560 XEO_NAME Triclosan DME0172 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0172 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0172 XEOTICID XEO00560 DESCRIPT Triclosan induces the drug-metabolizing activity of DME TDO2 DME0172 XEOTICID XEO00560 GENEFORM Protein DME0172 XEOTICID XEO00560 MOACRIVE Induction DME0172 XEOTICID XEO00568 XEO_NAME Resveratrol DME0172 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0172 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0172 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME TDO2 DME0172 XEOTICID XEO00568 GENEFORM mRNA DME0172 XEOTICID XEO00568 MOACRIVE Induction DME0172 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0172 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0172 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0172 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME TDO2 DME0172 XEOTICID XEO00632 GENEFORM mRNA DME0172 XEOTICID XEO00632 MOACRIVE Inhibition DME0172 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0172 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0172 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0172 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME TDO2 DME0172 XEOTICID XEO00723 GENEFORM mRNA DME0172 XEOTICID XEO00723 MOACRIVE Inhibition DME0172 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0172 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0172 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0172 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME TDO2 DME0172 XEOTICID XEO00806 GENEFORM mRNA DME0172 XEOTICID XEO00806 MOACRIVE Inhibition DME0172 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0172 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0172 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0172 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME TDO2 DME0172 XEOTICID XEO00898 GENEFORM mRNA DME0172 XEOTICID XEO00898 MOACRIVE Induction DME0172 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0172 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0172 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0172 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin up-regulates the expression of DME TDO2 DME0172 XEOTICID XEO00905 GENEFORM mRNA DME0172 XEOTICID XEO00905 MOACRIVE Induction DME0172 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0172 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0172 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0172 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid inhibits the expression of DME TDO2 DME0172 XEOTICID XEO00921 GENEFORM mRNA DME0172 XEOTICID XEO00921 MOACRIVE Inhibition DME0172 XEOTICID XEO01089 XEO_NAME 1,4-naphthoquinone DME0172 XEOTICID XEO01089 XEO_TYPE Health or Environmental Toxicant(s) DME0172 XEOTICID XEO01089 XEO_CLAS Acute Toxic Substance DME0172 XEOTICID XEO01089 DESCRIPT 1,4-naphthoquinone induces the drug-metabolizing activity of DME TDO2 DME0172 XEOTICID XEO01089 GENEFORM Protein DME0172 XEOTICID XEO01089 MOACRIVE Induction DME0172 XEOTICID XEO01504 XEO_NAME Gold DME0172 XEOTICID XEO01504 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0172 XEOTICID XEO01504 XEO_CLAS Chemical Compound DME0172 XEOTICID XEO01504 DESCRIPT Gold inhibits the expression of DME TDO2 DME0172 XEOTICID XEO01504 GENEFORM mRNA DME0172 XEOTICID XEO01504 MOACRIVE Inhibition DME0173 DME___ID DME0173 DME0173 DME_NAME Tryptophan 5-hydroxylase 1 (TPH1) DME0173 SPESNAME Homo sapiens DME0173 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0173 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0173 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0173 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME TPH1 DME0173 XEOTICID XEO00898 GENEFORM mRNA DME0173 XEOTICID XEO00898 MOACRIVE Induction DME0173 XEOTICID XEO01074 XEO_NAME Endosulfan DME0173 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0173 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0173 XEOTICID XEO01074 DESCRIPT Endosulfan inhibits the expression of DME TPH1 DME0173 XEOTICID XEO01074 GENEFORM mRNA DME0173 XEOTICID XEO01074 MOACRIVE Inhibition DME0176 DME___ID DME0176 DME0176 DME_NAME Tryptophanyl-tRNA synthetase mitochondrial (WARS2) DME0176 SPESNAME Homo sapiens DME0176 XEOTICID XEO00029 XEO_NAME Valproic acid DME0176 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0176 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0176 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME WARS2 DME0176 XEOTICID XEO00029 GENEFORM mRNA DME0176 XEOTICID XEO00029 MOACRIVE Inhibition DME0176 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0176 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0176 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0176 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME WARS2 DME0176 XEOTICID XEO00217 GENEFORM mRNA DME0176 XEOTICID XEO00217 MOACRIVE Inhibition DME0176 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0176 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0176 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0176 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME WARS2 DME0176 XEOTICID XEO00241 GENEFORM mRNA DME0176 XEOTICID XEO00241 MOACRIVE Induction DME0176 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0176 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0176 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0176 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME WARS2 DME0176 XEOTICID XEO00292 GENEFORM mRNA DME0176 XEOTICID XEO00292 MOACRIVE Inhibition DME0176 XEOTICID XEO00602 XEO_NAME Vanadyl sulfate DME0176 XEOTICID XEO00602 XEO_TYPE Pharmaceutical Agent(s) DME0176 XEOTICID XEO00602 XEO_CLAS Drug in Phase 3 Clinical Trial DME0176 XEOTICID XEO00602 DESCRIPT Vanadyl sulfate up-regulates the expression of DME WARS2 DME0176 XEOTICID XEO00602 GENEFORM mRNA DME0176 XEOTICID XEO00602 MOACRIVE Induction DME0176 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0176 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0176 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0176 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME WARS2 DME0176 XEOTICID XEO00806 GENEFORM mRNA DME0176 XEOTICID XEO00806 MOACRIVE Inhibition DME0176 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0176 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0176 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0176 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME WARS2 DME0176 XEOTICID XEO00898 GENEFORM mRNA DME0176 XEOTICID XEO00898 MOACRIVE Inhibition DME0176 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0176 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0176 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0176 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME WARS2 DME0176 XEOTICID XEO01305 GENEFORM mRNA DME0176 XEOTICID XEO01305 MOACRIVE Inhibition DME0177 DME___ID DME0177 DME0177 DME_NAME Cytosolic branched aminotransferase (BCAT1) DME0177 SPESNAME Homo sapiens DME0177 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0177 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0177 XEOTICID XEO00035 DESCRIPT Fenofibrate inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00035 GENEFORM mRNA DME0177 XEOTICID XEO00035 MOACRIVE Inhibition DME0177 XEOTICID XEO00046 XEO_NAME Ifosfamide DME0177 XEOTICID XEO00046 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO00046 XEO_CLAS Approved/Marketed Drug DME0177 XEOTICID XEO00046 DESCRIPT Ifosfamide inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00046 GENEFORM mRNA DME0177 XEOTICID XEO00046 MOACRIVE Inhibition DME0177 XEOTICID XEO00090 XEO_NAME Estradiol DME0177 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0177 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME BCAT1 DME0177 XEOTICID XEO00090 GENEFORM mRNA DME0177 XEOTICID XEO00090 MOACRIVE Induction DME0177 XEOTICID XEO00102 XEO_NAME Azacitidine DME0177 XEOTICID XEO00102 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO00102 XEO_CLAS Approved/Marketed Drug DME0177 XEOTICID XEO00102 DESCRIPT Azacitidine inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00102 GENEFORM mRNA DME0177 XEOTICID XEO00102 MOACRIVE Inhibition DME0177 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0177 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0177 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME BCAT1 DME0177 XEOTICID XEO00117 GENEFORM mRNA DME0177 XEOTICID XEO00117 MOACRIVE Induction DME0177 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0177 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0177 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00217 GENEFORM mRNA DME0177 XEOTICID XEO00217 MOACRIVE Inhibition DME0177 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0177 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0177 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME BCAT1 DME0177 XEOTICID XEO00241 GENEFORM mRNA DME0177 XEOTICID XEO00241 MOACRIVE Induction DME0177 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0177 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0177 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00292 GENEFORM mRNA DME0177 XEOTICID XEO00292 MOACRIVE Inhibition DME0177 XEOTICID XEO00334 XEO_NAME Cisplatin DME0177 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0177 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00334 GENEFORM mRNA DME0177 XEOTICID XEO00334 MOACRIVE Inhibition DME0177 XEOTICID XEO00435 XEO_NAME Urethane DME0177 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0177 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00435 GENEFORM mRNA DME0177 XEOTICID XEO00435 MOACRIVE Inhibition DME0177 XEOTICID XEO00465 XEO_NAME Clodronic acid DME0177 XEOTICID XEO00465 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO00465 XEO_CLAS Approved/Marketed Drug DME0177 XEOTICID XEO00465 DESCRIPT Clodronic acid up-regulates the expression of DME BCAT1 DME0177 XEOTICID XEO00465 GENEFORM mRNA DME0177 XEOTICID XEO00465 MOACRIVE Induction DME0177 XEOTICID XEO00466 XEO_NAME Demecolcine DME0177 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0177 XEOTICID XEO00466 DESCRIPT Demecolcine up-regulates the expression of DME BCAT1 DME0177 XEOTICID XEO00466 GENEFORM mRNA DME0177 XEOTICID XEO00466 MOACRIVE Induction DME0177 XEOTICID XEO00538 XEO_NAME Quercetin DME0177 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0177 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00538 GENEFORM mRNA DME0177 XEOTICID XEO00538 MOACRIVE Inhibition DME0177 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0177 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0177 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00723 GENEFORM mRNA DME0177 XEOTICID XEO00723 MOACRIVE Inhibition DME0177 XEOTICID XEO00760 XEO_NAME Jinfukang DME0177 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0177 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0177 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00760 GENEFORM mRNA DME0177 XEOTICID XEO00760 MOACRIVE Inhibition DME0177 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0177 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0177 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0177 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00772 GENEFORM mRNA DME0177 XEOTICID XEO00772 MOACRIVE Inhibition DME0177 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0177 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0177 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0177 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00806 GENEFORM mRNA DME0177 XEOTICID XEO00806 MOACRIVE Inhibition DME0177 XEOTICID XEO00809 XEO_NAME Thapsigargin DME0177 XEOTICID XEO00809 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0177 XEOTICID XEO00809 XEO_CLAS Natural Product DME0177 XEOTICID XEO00809 DESCRIPT Thapsigargin up-regulates the expression of DME BCAT1 DME0177 XEOTICID XEO00809 GENEFORM mRNA DME0177 XEOTICID XEO00809 MOACRIVE Induction DME0177 XEOTICID XEO00816 XEO_NAME Aflatoxin M1 DME0177 XEOTICID XEO00816 XEO_TYPE Health or Environmental Toxicant(s) DME0177 XEOTICID XEO00816 XEO_CLAS Carcinogen DME0177 XEOTICID XEO00816 DESCRIPT Aflatoxin M1 inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00816 GENEFORM mRNA DME0177 XEOTICID XEO00816 MOACRIVE Inhibition DME0177 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0177 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0177 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0177 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00898 GENEFORM mRNA DME0177 XEOTICID XEO00898 MOACRIVE Inhibition DME0177 XEOTICID XEO00969 XEO_NAME Atrazine DME0177 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0177 XEOTICID XEO00969 XEO_CLAS Herbicide DME0177 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME BCAT1 DME0177 XEOTICID XEO00969 GENEFORM mRNA DME0177 XEOTICID XEO00969 MOACRIVE Inhibition DME0177 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0177 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0177 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0177 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium up-regulates the expression of DME BCAT1 DME0177 XEOTICID XEO01103 GENEFORM mRNA DME0177 XEOTICID XEO01103 MOACRIVE Induction DME0177 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0177 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0177 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0177 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME BCAT1 DME0177 XEOTICID XEO01305 GENEFORM mRNA DME0177 XEOTICID XEO01305 MOACRIVE Induction DME0177 XEOTICID XEO01336 XEO_NAME ICG-001 DME0177 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0177 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME BCAT1 DME0177 XEOTICID XEO01336 GENEFORM mRNA DME0177 XEOTICID XEO01336 MOACRIVE Induction DME0177 XEOTICID XEO01348 XEO_NAME K-7174 DME0177 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0177 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0177 XEOTICID XEO01348 DESCRIPT K-7174 up-regulates the expression of DME BCAT1 DME0177 XEOTICID XEO01348 GENEFORM mRNA DME0177 XEOTICID XEO01348 MOACRIVE Induction DME0178 DME___ID DME0178 DME0178 DME_NAME Propionyl-CoA carboxylase beta (PCCB) DME0178 SPESNAME Homo sapiens DME0178 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0178 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0178 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0178 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME PCCB DME0178 XEOTICID XEO00117 GENEFORM mRNA DME0178 XEOTICID XEO00117 MOACRIVE Inhibition DME0178 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0178 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0178 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0178 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME PCCB DME0178 XEOTICID XEO00186 GENEFORM mRNA DME0178 XEOTICID XEO00186 MOACRIVE Inhibition DME0178 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0178 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0178 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0178 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME PCCB DME0178 XEOTICID XEO00217 GENEFORM mRNA DME0178 XEOTICID XEO00217 MOACRIVE Inhibition DME0178 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0178 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0178 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0178 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME PCCB DME0178 XEOTICID XEO00241 GENEFORM mRNA DME0178 XEOTICID XEO00241 MOACRIVE Inhibition DME0178 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0178 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0178 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0178 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME PCCB DME0178 XEOTICID XEO00292 GENEFORM mRNA DME0178 XEOTICID XEO00292 MOACRIVE Inhibition DME0178 XEOTICID XEO00435 XEO_NAME Urethane DME0178 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0178 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0178 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME PCCB DME0178 XEOTICID XEO00435 GENEFORM mRNA DME0178 XEOTICID XEO00435 MOACRIVE Inhibition DME0178 XEOTICID XEO00809 XEO_NAME Thapsigargin DME0178 XEOTICID XEO00809 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0178 XEOTICID XEO00809 XEO_CLAS Natural Product DME0178 XEOTICID XEO00809 DESCRIPT Thapsigargin inhibits the expression of DME PCCB DME0178 XEOTICID XEO00809 GENEFORM mRNA DME0178 XEOTICID XEO00809 MOACRIVE Inhibition DME0178 XEOTICID XEO00969 XEO_NAME Atrazine DME0178 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0178 XEOTICID XEO00969 XEO_CLAS Herbicide DME0178 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME PCCB DME0178 XEOTICID XEO00969 GENEFORM mRNA DME0178 XEOTICID XEO00969 MOACRIVE Induction DME0178 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0178 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0178 XEOTICID XEO01494 XEO_CLAS Natural Product DME0178 XEOTICID XEO01494 DESCRIPT Tunicamycin A inhibits the expression of DME PCCB DME0178 XEOTICID XEO01494 GENEFORM mRNA DME0178 XEOTICID XEO01494 MOACRIVE Inhibition DME0178 XEOTICID XEO01503 XEO_NAME Cadmium DME0178 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0178 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0178 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the expression of DME PCCB DME0178 XEOTICID XEO01503 GENEFORM mRNA DME0178 XEOTICID XEO01503 MOACRIVE Inhibition DME0182 DME___ID DME0182 DME0182 DME_NAME Hydroxyindole O-methyltransferase (ASMT) DME0182 SPESNAME Homo sapiens DME0182 XEOTICID XEO00435 XEO_NAME Urethane DME0182 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0182 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0182 XEOTICID XEO00435 DESCRIPT Urethane up-regulates the expression of DME ASMT DME0182 XEOTICID XEO00435 GENEFORM mRNA DME0182 XEOTICID XEO00435 MOACRIVE Induction DME0182 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0182 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0182 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0182 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME ASMT DME0182 XEOTICID XEO01031 GENEFORM mRNA DME0182 XEOTICID XEO01031 MOACRIVE Induction DME0183 DME___ID DME0183 DME0183 DME_NAME Methionine adenosyltransferase II beta (MAT2B) DME0183 SPESNAME Homo sapiens DME0183 XEOTICID XEO00029 XEO_NAME Valproic acid DME0183 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0183 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0183 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME MAT2B DME0183 XEOTICID XEO00029 GENEFORM mRNA DME0183 XEOTICID XEO00029 MOACRIVE Inhibition DME0183 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0183 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0183 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0183 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME MAT2B DME0183 XEOTICID XEO00117 GENEFORM mRNA DME0183 XEOTICID XEO00117 MOACRIVE Inhibition DME0183 XEOTICID XEO00334 XEO_NAME Cisplatin DME0183 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0183 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0183 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME MAT2B DME0183 XEOTICID XEO00334 GENEFORM mRNA DME0183 XEOTICID XEO00334 MOACRIVE Induction DME0183 XEOTICID XEO00568 XEO_NAME Resveratrol DME0183 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0183 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0183 XEOTICID XEO00568 DESCRIPT Resveratrol induces the drug-metabolizing activity of DME MAT2B DME0183 XEOTICID XEO00568 GENEFORM Protein DME0183 XEOTICID XEO00568 MOACRIVE Induction DME0183 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0183 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0183 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0183 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME MAT2B DME0183 XEOTICID XEO00999 GENEFORM mRNA DME0183 XEOTICID XEO00999 MOACRIVE Inhibition DME0183 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0183 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0183 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0183 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME MAT2B DME0183 XEOTICID XEO01050 GENEFORM mRNA DME0183 XEOTICID XEO01050 MOACRIVE Inhibition DME0183 XEOTICID XEO01336 XEO_NAME ICG-001 DME0183 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0183 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0183 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME MAT2B DME0183 XEOTICID XEO01336 GENEFORM mRNA DME0183 XEOTICID XEO01336 MOACRIVE Induction DME0184 DME___ID DME0184 DME0184 DME_NAME Methionine-R-sulfoxide reductase B1 (MSRB1) DME0184 SPESNAME Homo sapiens DME0184 XEOTICID XEO00053 XEO_NAME Leflunomide DME0184 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0184 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0184 XEOTICID XEO00053 DESCRIPT Leflunomide inhibits the expression of DME MSRB1 DME0184 XEOTICID XEO00053 GENEFORM mRNA DME0184 XEOTICID XEO00053 MOACRIVE Inhibition DME0184 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0184 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0184 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0184 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME MSRB1 DME0184 XEOTICID XEO00186 GENEFORM mRNA DME0184 XEOTICID XEO00186 MOACRIVE Inhibition DME0184 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0184 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0184 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0184 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME MSRB1 DME0184 XEOTICID XEO00217 GENEFORM mRNA DME0184 XEOTICID XEO00217 MOACRIVE Inhibition DME0184 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0184 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0184 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0184 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME MSRB1 DME0184 XEOTICID XEO00241 GENEFORM mRNA DME0184 XEOTICID XEO00241 MOACRIVE Inhibition DME0184 XEOTICID XEO00407 XEO_NAME Cupric chloride DME0184 XEOTICID XEO00407 XEO_TYPE Pharmaceutical Agent(s) DME0184 XEOTICID XEO00407 XEO_CLAS Approved/Marketed Drug DME0184 XEOTICID XEO00407 DESCRIPT Cupric chloride up-regulates the expression of DME MSRB1 DME0184 XEOTICID XEO00407 GENEFORM mRNA DME0184 XEOTICID XEO00407 MOACRIVE Induction DME0184 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0184 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0184 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0184 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME MSRB1 DME0184 XEOTICID XEO00772 GENEFORM mRNA DME0184 XEOTICID XEO00772 MOACRIVE Inhibition DME0184 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0184 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0184 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0184 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME MSRB1 DME0184 XEOTICID XEO00806 GENEFORM mRNA DME0184 XEOTICID XEO00806 MOACRIVE Inhibition DME0184 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0184 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0184 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0184 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME MSRB1 DME0184 XEOTICID XEO00821 GENEFORM mRNA DME0184 XEOTICID XEO00821 MOACRIVE Induction DME0184 XEOTICID XEO00969 XEO_NAME Atrazine DME0184 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0184 XEOTICID XEO00969 XEO_CLAS Herbicide DME0184 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME MSRB1 DME0184 XEOTICID XEO00969 GENEFORM mRNA DME0184 XEOTICID XEO00969 MOACRIVE Inhibition DME0184 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0184 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0184 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0184 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME MSRB1 DME0184 XEOTICID XEO01305 GENEFORM mRNA DME0184 XEOTICID XEO01305 MOACRIVE Inhibition DME0184 XEOTICID XEO01348 XEO_NAME K-7174 DME0184 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0184 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0184 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME MSRB1 DME0184 XEOTICID XEO01348 GENEFORM mRNA DME0184 XEOTICID XEO01348 MOACRIVE Inhibition DME0185 DME___ID DME0185 DME0185 DME_NAME Methionine-R-sulfoxide reductase B2 (MSRB2) DME0185 SPESNAME Homo sapiens DME0185 XEOTICID XEO00029 XEO_NAME Valproic acid DME0185 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0185 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0185 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME MSRB2 DME0185 XEOTICID XEO00029 GENEFORM mRNA DME0185 XEOTICID XEO00029 MOACRIVE Inhibition DME0185 XEOTICID XEO00102 XEO_NAME Azacitidine DME0185 XEOTICID XEO00102 XEO_TYPE Pharmaceutical Agent(s) DME0185 XEOTICID XEO00102 XEO_CLAS Approved/Marketed Drug DME0185 XEOTICID XEO00102 DESCRIPT Azacitidine up-regulates the expression of DME MSRB2 DME0185 XEOTICID XEO00102 GENEFORM mRNA DME0185 XEOTICID XEO00102 MOACRIVE Induction DME0185 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0185 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0185 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0185 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME MSRB2 DME0185 XEOTICID XEO00117 GENEFORM mRNA DME0185 XEOTICID XEO00117 MOACRIVE Inhibition DME0185 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0185 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0185 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0185 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME MSRB2 DME0185 XEOTICID XEO00217 GENEFORM mRNA DME0185 XEOTICID XEO00217 MOACRIVE Inhibition DME0185 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0185 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0185 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0185 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME MSRB2 DME0185 XEOTICID XEO00241 GENEFORM mRNA DME0185 XEOTICID XEO00241 MOACRIVE Inhibition DME0185 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0185 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0185 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0185 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME MSRB2 DME0185 XEOTICID XEO00292 GENEFORM mRNA DME0185 XEOTICID XEO00292 MOACRIVE Inhibition DME0185 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0185 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0185 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0185 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME MSRB2 DME0185 XEOTICID XEO00339 GENEFORM mRNA DME0185 XEOTICID XEO00339 MOACRIVE Inhibition DME0185 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0185 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0185 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0185 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME MSRB2 DME0185 XEOTICID XEO00772 GENEFORM mRNA DME0185 XEOTICID XEO00772 MOACRIVE Induction DME0185 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0185 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0185 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0185 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME MSRB2 DME0185 XEOTICID XEO00898 GENEFORM mRNA DME0185 XEOTICID XEO00898 MOACRIVE Induction DME0185 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0185 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0185 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0185 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME MSRB2 DME0185 XEOTICID XEO00999 GENEFORM mRNA DME0185 XEOTICID XEO00999 MOACRIVE Inhibition DME0185 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0185 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0185 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0185 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME MSRB2 DME0185 XEOTICID XEO01226 GENEFORM mRNA DME0185 XEOTICID XEO01226 MOACRIVE Inhibition DME0185 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0185 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0185 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0185 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME MSRB2 DME0185 XEOTICID XEO01324 GENEFORM mRNA DME0185 XEOTICID XEO01324 MOACRIVE Inhibition DME0185 XEOTICID XEO01336 XEO_NAME ICG-001 DME0185 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0185 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0185 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME MSRB2 DME0185 XEOTICID XEO01336 GENEFORM mRNA DME0185 XEOTICID XEO01336 MOACRIVE Induction DME0185 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0185 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0185 XEOTICID XEO01494 XEO_CLAS Natural Product DME0185 XEOTICID XEO01494 DESCRIPT Tunicamycin A inhibits the expression of DME MSRB2 DME0185 XEOTICID XEO01494 GENEFORM mRNA DME0185 XEOTICID XEO01494 MOACRIVE Inhibition DME0187 DME___ID DME0187 DME0187 DME_NAME Methionine-tRNA ligase mitochondrial (MARS2) DME0187 SPESNAME Homo sapiens DME0187 XEOTICID XEO00090 XEO_NAME Estradiol DME0187 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0187 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0187 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME MARS2 DME0187 XEOTICID XEO00090 GENEFORM mRNA DME0187 XEOTICID XEO00090 MOACRIVE Induction DME0187 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0187 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0187 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0187 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME MARS2 DME0187 XEOTICID XEO00117 GENEFORM mRNA DME0187 XEOTICID XEO00117 MOACRIVE Inhibition DME0187 XEOTICID XEO00334 XEO_NAME Cisplatin DME0187 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0187 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0187 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME MARS2 DME0187 XEOTICID XEO00334 GENEFORM mRNA DME0187 XEOTICID XEO00334 MOACRIVE Inhibition DME0187 XEOTICID XEO00392 XEO_NAME Vincristine DME0187 XEOTICID XEO00392 XEO_TYPE Pharmaceutical Agent(s) DME0187 XEOTICID XEO00392 XEO_CLAS Approved/Marketed Drug DME0187 XEOTICID XEO00392 DESCRIPT Vincristine inhibits the expression of DME MARS2 DME0187 XEOTICID XEO00392 GENEFORM mRNA DME0187 XEOTICID XEO00392 MOACRIVE Inhibition DME0187 XEOTICID XEO00435 XEO_NAME Urethane DME0187 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0187 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0187 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME MARS2 DME0187 XEOTICID XEO00435 GENEFORM mRNA DME0187 XEOTICID XEO00435 MOACRIVE Inhibition DME0187 XEOTICID XEO00466 XEO_NAME Demecolcine DME0187 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0187 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0187 XEOTICID XEO00466 DESCRIPT Demecolcine inhibits the expression of DME MARS2 DME0187 XEOTICID XEO00466 GENEFORM mRNA DME0187 XEOTICID XEO00466 MOACRIVE Inhibition DME0187 XEOTICID XEO00538 XEO_NAME Quercetin DME0187 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0187 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0187 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME MARS2 DME0187 XEOTICID XEO00538 GENEFORM mRNA DME0187 XEOTICID XEO00538 MOACRIVE Inhibition DME0187 XEOTICID XEO00656 XEO_NAME Sulindac sulfide DME0187 XEOTICID XEO00656 XEO_TYPE Pharmaceutical Agent(s) DME0187 XEOTICID XEO00656 XEO_CLAS Drug in Phase 2 Clinical Trial DME0187 XEOTICID XEO00656 DESCRIPT Sulindac sulfide up-regulates the expression of DME MARS2 DME0187 XEOTICID XEO00656 GENEFORM mRNA DME0187 XEOTICID XEO00656 MOACRIVE Induction DME0187 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0187 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0187 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0187 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME MARS2 DME0187 XEOTICID XEO00772 GENEFORM mRNA DME0187 XEOTICID XEO00772 MOACRIVE Inhibition DME0187 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0187 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0187 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0187 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME MARS2 DME0187 XEOTICID XEO00806 GENEFORM mRNA DME0187 XEOTICID XEO00806 MOACRIVE Induction DME0187 XEOTICID XEO00969 XEO_NAME Atrazine DME0187 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0187 XEOTICID XEO00969 XEO_CLAS Herbicide DME0187 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME MARS2 DME0187 XEOTICID XEO00969 GENEFORM mRNA DME0187 XEOTICID XEO00969 MOACRIVE Inhibition DME0187 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0187 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0187 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0187 XEOTICID XEO01050 DESCRIPT Dicrotophos up-regulates the expression of DME MARS2 DME0187 XEOTICID XEO01050 GENEFORM mRNA DME0187 XEOTICID XEO01050 MOACRIVE Induction DME0187 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0187 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0187 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0187 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME MARS2 DME0187 XEOTICID XEO01305 GENEFORM mRNA DME0187 XEOTICID XEO01305 MOACRIVE Inhibition DME0187 XEOTICID XEO01348 XEO_NAME K-7174 DME0187 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0187 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0187 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME MARS2 DME0187 XEOTICID XEO01348 GENEFORM mRNA DME0187 XEOTICID XEO01348 MOACRIVE Inhibition DME0187 XEOTICID XEO01503 XEO_NAME Cadmium DME0187 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0187 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0187 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME MARS2 DME0187 XEOTICID XEO01503 GENEFORM mRNA DME0187 XEOTICID XEO01503 MOACRIVE Induction DME0187 XEOTICID XEO01574 XEO_NAME Plant extracts DME0187 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0187 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0187 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the expression of DME MARS2 DME0187 XEOTICID XEO01574 GENEFORM mRNA DME0187 XEOTICID XEO01574 MOACRIVE Inhibition DME0188 DME___ID DME0188 DME0188 DME_NAME Peptide methionine sulfoxide reductase (MSRA) DME0188 SPESNAME Homo sapiens DME0188 XEOTICID XEO00029 XEO_NAME Valproic acid DME0188 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0188 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0188 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME MSRA DME0188 XEOTICID XEO00029 GENEFORM mRNA DME0188 XEOTICID XEO00029 MOACRIVE Inhibition DME0188 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0188 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0188 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0188 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME MSRA DME0188 XEOTICID XEO00117 GENEFORM mRNA DME0188 XEOTICID XEO00117 MOACRIVE Inhibition DME0188 XEOTICID XEO00334 XEO_NAME Cisplatin DME0188 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0188 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0188 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME MSRA DME0188 XEOTICID XEO00334 GENEFORM mRNA DME0188 XEOTICID XEO00334 MOACRIVE Inhibition DME0188 XEOTICID XEO00568 XEO_NAME Resveratrol DME0188 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0188 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0188 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME MSRA DME0188 XEOTICID XEO00568 GENEFORM mRNA DME0188 XEOTICID XEO00568 MOACRIVE Induction DME0188 XEOTICID XEO00721 XEO_NAME MRK-003 DME0188 XEOTICID XEO00721 XEO_TYPE Pharmaceutical Agent(s) DME0188 XEOTICID XEO00721 XEO_CLAS Preclinical/Patented Drug DME0188 XEOTICID XEO00721 DESCRIPT MRK-003 inhibits the expression of DME MSRA DME0188 XEOTICID XEO00721 GENEFORM mRNA DME0188 XEOTICID XEO00721 MOACRIVE Inhibition DME0188 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0188 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0188 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0188 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME MSRA DME0188 XEOTICID XEO00806 GENEFORM mRNA DME0188 XEOTICID XEO00806 MOACRIVE Inhibition DME0188 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0188 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0188 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0188 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME MSRA DME0188 XEOTICID XEO00898 GENEFORM mRNA DME0188 XEOTICID XEO00898 MOACRIVE Inhibition DME0188 XEOTICID XEO00969 XEO_NAME Atrazine DME0188 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0188 XEOTICID XEO00969 XEO_CLAS Herbicide DME0188 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME MSRA DME0188 XEOTICID XEO00969 GENEFORM mRNA DME0188 XEOTICID XEO00969 MOACRIVE Induction DME0188 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0188 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0188 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0188 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME MSRA DME0188 XEOTICID XEO00999 GENEFORM mRNA DME0188 XEOTICID XEO00999 MOACRIVE Inhibition DME0188 XEOTICID XEO01024 XEO_NAME Sodium bichromate DME0188 XEOTICID XEO01024 XEO_TYPE Health or Environmental Toxicant(s) DME0188 XEOTICID XEO01024 XEO_CLAS Carcinogen DME0188 XEOTICID XEO01024 DESCRIPT Sodium bichromate inhibits the drug-metabolizing activity of DME MSRA DME0188 XEOTICID XEO01024 GENEFORM Protein DME0188 XEOTICID XEO01024 MOACRIVE Inhibition DME0188 XEOTICID XEO01107 XEO_NAME NSC 703786 DME0188 XEOTICID XEO01107 XEO_TYPE Pharmaceutical Agent(s) DME0188 XEOTICID XEO01107 XEO_CLAS Drug in Phase 1 Clinical Trial DME0188 XEOTICID XEO01107 DESCRIPT NSC 703786 inhibits the expression of DME MSRA DME0188 XEOTICID XEO01107 GENEFORM mRNA DME0188 XEOTICID XEO01107 MOACRIVE Inhibition DME0188 XEOTICID XEO01348 XEO_NAME K-7174 DME0188 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0188 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0188 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME MSRA DME0188 XEOTICID XEO01348 GENEFORM mRNA DME0188 XEOTICID XEO01348 MOACRIVE Inhibition DME0188 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0188 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0188 XEOTICID XEO01494 XEO_CLAS Natural Product DME0188 XEOTICID XEO01494 DESCRIPT Tunicamycin A up-regulates the expression of DME MSRA DME0188 XEOTICID XEO01494 GENEFORM mRNA DME0188 XEOTICID XEO01494 MOACRIVE Induction DME0189 DME___ID DME0189 DME0189 DME_NAME S-adenosylmethionine synthase 1 (MAT1A) DME0189 SPESNAME Homo sapiens DME0189 XEOTICID XEO00012 XEO_NAME Carmustine DME0189 XEOTICID XEO00012 XEO_TYPE Pharmaceutical Agent(s) DME0189 XEOTICID XEO00012 XEO_CLAS Approved/Marketed Drug DME0189 XEOTICID XEO00012 DESCRIPT Carmustine inhibits the expression of DME MAT1A DME0189 XEOTICID XEO00012 GENEFORM mRNA DME0189 XEOTICID XEO00012 MOACRIVE Inhibition DME0189 XEOTICID XEO00090 XEO_NAME Estradiol DME0189 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0189 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0189 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME MAT1A DME0189 XEOTICID XEO00090 GENEFORM mRNA DME0189 XEOTICID XEO00090 MOACRIVE Inhibition DME0189 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0189 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0189 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0189 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME MAT1A DME0189 XEOTICID XEO00117 GENEFORM mRNA DME0189 XEOTICID XEO00117 MOACRIVE Inhibition DME0189 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0189 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0189 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0189 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME MAT1A DME0189 XEOTICID XEO00217 GENEFORM mRNA DME0189 XEOTICID XEO00217 MOACRIVE Inhibition DME0189 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0189 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0189 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0189 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME MAT1A DME0189 XEOTICID XEO00241 GENEFORM mRNA DME0189 XEOTICID XEO00241 MOACRIVE Inhibition DME0189 XEOTICID XEO00435 XEO_NAME Urethane DME0189 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0189 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0189 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME MAT1A DME0189 XEOTICID XEO00435 GENEFORM mRNA DME0189 XEOTICID XEO00435 MOACRIVE Inhibition DME0189 XEOTICID XEO00538 XEO_NAME Quercetin DME0189 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0189 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0189 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME MAT1A DME0189 XEOTICID XEO00538 GENEFORM mRNA DME0189 XEOTICID XEO00538 MOACRIVE Inhibition DME0189 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0189 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0189 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0189 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME MAT1A DME0189 XEOTICID XEO00632 GENEFORM mRNA DME0189 XEOTICID XEO00632 MOACRIVE Inhibition DME0189 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0189 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0189 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0189 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME MAT1A DME0189 XEOTICID XEO00772 GENEFORM mRNA DME0189 XEOTICID XEO00772 MOACRIVE Induction DME0189 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0189 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0189 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0189 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME MAT1A DME0189 XEOTICID XEO00806 GENEFORM mRNA DME0189 XEOTICID XEO00806 MOACRIVE Inhibition DME0189 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0189 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0189 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0189 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME MAT1A DME0189 XEOTICID XEO00999 GENEFORM mRNA DME0189 XEOTICID XEO00999 MOACRIVE Inhibition DME0189 XEOTICID XEO01348 XEO_NAME K-7174 DME0189 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0189 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0189 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME MAT1A DME0189 XEOTICID XEO01348 GENEFORM mRNA DME0189 XEOTICID XEO01348 MOACRIVE Inhibition DME0190 DME___ID DME0190 DME0190 DME_NAME S-adenosylmethionine synthase 2 (MAT2A) DME0190 SPESNAME Homo sapiens DME0190 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0190 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0190 XEOTICID XEO00035 DESCRIPT Fenofibrate inhibits the expression of DME MAT2A DME0190 XEOTICID XEO00035 GENEFORM mRNA DME0190 XEOTICID XEO00035 MOACRIVE Inhibition DME0190 XEOTICID XEO00053 XEO_NAME Leflunomide DME0190 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0190 XEOTICID XEO00053 DESCRIPT Leflunomide inhibits the expression of DME MAT2A DME0190 XEOTICID XEO00053 GENEFORM mRNA DME0190 XEOTICID XEO00053 MOACRIVE Inhibition DME0190 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0190 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0190 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME MAT2A DME0190 XEOTICID XEO00088 GENEFORM mRNA DME0190 XEOTICID XEO00088 MOACRIVE Induction DME0190 XEOTICID XEO00090 XEO_NAME Estradiol DME0190 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0190 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME MAT2A DME0190 XEOTICID XEO00090 GENEFORM mRNA DME0190 XEOTICID XEO00090 MOACRIVE Induction DME0190 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0190 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0190 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME MAT2A DME0190 XEOTICID XEO00117 GENEFORM mRNA DME0190 XEOTICID XEO00117 MOACRIVE Induction DME0190 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0190 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0190 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME MAT2A DME0190 XEOTICID XEO00241 GENEFORM mRNA DME0190 XEOTICID XEO00241 MOACRIVE Inhibition DME0190 XEOTICID XEO00253 XEO_NAME Tretinoin DME0190 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0190 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the drug-metabolizing activity of DME MAT2A DME0190 XEOTICID XEO00253 GENEFORM Protein DME0190 XEOTICID XEO00253 MOACRIVE Inhibition DME0190 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0190 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0190 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME MAT2A DME0190 XEOTICID XEO00292 GENEFORM mRNA DME0190 XEOTICID XEO00292 MOACRIVE Inhibition DME0190 XEOTICID XEO00334 XEO_NAME Cisplatin DME0190 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0190 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME MAT2A DME0190 XEOTICID XEO00334 GENEFORM mRNA DME0190 XEOTICID XEO00334 MOACRIVE Inhibition DME0190 XEOTICID XEO00366 XEO_NAME Methotrexate DME0190 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0190 XEOTICID XEO00366 DESCRIPT Methotrexate inhibits the expression of DME MAT2A DME0190 XEOTICID XEO00366 GENEFORM mRNA DME0190 XEOTICID XEO00366 MOACRIVE Inhibition DME0190 XEOTICID XEO00404 XEO_NAME Folic acid DME0190 XEOTICID XEO00404 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00404 XEO_CLAS Approved/Marketed Drug DME0190 XEOTICID XEO00404 DESCRIPT Folic acid up-regulates the expression of DME MAT2A DME0190 XEOTICID XEO00404 GENEFORM mRNA DME0190 XEOTICID XEO00404 MOACRIVE Induction DME0190 XEOTICID XEO00539 XEO_NAME Ethanol DME0190 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0190 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the expression of DME MAT2A DME0190 XEOTICID XEO00539 GENEFORM mRNA DME0190 XEOTICID XEO00539 MOACRIVE Inhibition DME0190 XEOTICID XEO00584 XEO_NAME 4-phenylbutyric acid DME0190 XEOTICID XEO00584 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00584 XEO_CLAS Drug in Phase 2 Clinical Trial DME0190 XEOTICID XEO00584 DESCRIPT 4-phenylbutyric acid inhibits the expression of DME MAT2A DME0190 XEOTICID XEO00584 GENEFORM mRNA DME0190 XEOTICID XEO00584 MOACRIVE Inhibition DME0190 XEOTICID XEO00609 XEO_NAME MeIQx DME0190 XEOTICID XEO00609 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00609 XEO_CLAS Drug in Phase 2 Clinical Trial DME0190 XEOTICID XEO00609 DESCRIPT MeIQx up-regulates the expression of DME MAT2A DME0190 XEOTICID XEO00609 GENEFORM mRNA DME0190 XEOTICID XEO00609 MOACRIVE Induction DME0190 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0190 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0190 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0190 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME MAT2A DME0190 XEOTICID XEO00723 GENEFORM mRNA DME0190 XEOTICID XEO00723 MOACRIVE Inhibition DME0190 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0190 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0190 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0190 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME MAT2A DME0190 XEOTICID XEO00772 GENEFORM mRNA DME0190 XEOTICID XEO00772 MOACRIVE Inhibition DME0190 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0190 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0190 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0190 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME MAT2A DME0190 XEOTICID XEO00806 GENEFORM mRNA DME0190 XEOTICID XEO00806 MOACRIVE Induction DME0190 XEOTICID XEO00872 XEO_NAME Acetaldehyde DME0190 XEOTICID XEO00872 XEO_TYPE Health or Environmental Toxicant(s) DME0190 XEOTICID XEO00872 XEO_CLAS Health Hazard/Toxicant DME0190 XEOTICID XEO00872 DESCRIPT Acetaldehyde inhibits the expression of DME MAT2A DME0190 XEOTICID XEO00872 GENEFORM mRNA DME0190 XEOTICID XEO00872 MOACRIVE Inhibition DME0190 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0190 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0190 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0190 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME MAT2A DME0190 XEOTICID XEO00898 GENEFORM mRNA DME0190 XEOTICID XEO00898 MOACRIVE Induction DME0190 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0190 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0190 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0190 XEOTICID XEO01050 DESCRIPT Dicrotophos up-regulates the expression of DME MAT2A DME0190 XEOTICID XEO01050 GENEFORM mRNA DME0190 XEOTICID XEO01050 MOACRIVE Induction DME0190 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0190 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0190 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0190 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the expression of DME MAT2A DME0190 XEOTICID XEO01119 GENEFORM mRNA DME0190 XEOTICID XEO01119 MOACRIVE Inhibition DME0190 XEOTICID XEO01122 XEO_NAME 2-butenal DME0190 XEOTICID XEO01122 XEO_TYPE Health or Environmental Toxicant(s) DME0190 XEOTICID XEO01122 XEO_CLAS Acute Toxic Substance DME0190 XEOTICID XEO01122 DESCRIPT 2-butenal inhibits the expression of DME MAT2A DME0190 XEOTICID XEO01122 GENEFORM mRNA DME0190 XEOTICID XEO01122 MOACRIVE Inhibition DME0190 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0190 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0190 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0190 XEOTICID XEO01247 DESCRIPT Chloropicrin inhibits the expression of DME MAT2A DME0190 XEOTICID XEO01247 GENEFORM mRNA DME0190 XEOTICID XEO01247 MOACRIVE Inhibition DME0190 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0190 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0190 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0190 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME MAT2A DME0190 XEOTICID XEO01305 GENEFORM mRNA DME0190 XEOTICID XEO01305 MOACRIVE Inhibition DME0190 XEOTICID XEO01397 XEO_NAME Nickel chloride DME0190 XEOTICID XEO01397 XEO_TYPE Health or Environmental Toxicant(s) DME0190 XEOTICID XEO01397 XEO_CLAS Acute Toxic Substance DME0190 XEOTICID XEO01397 DESCRIPT Nickel chloride inhibits the expression of DME MAT2A DME0190 XEOTICID XEO01397 GENEFORM mRNA DME0190 XEOTICID XEO01397 MOACRIVE Inhibition DME0190 XEOTICID XEO01449 XEO_NAME Quercitrin DME0190 XEOTICID XEO01449 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0190 XEOTICID XEO01449 XEO_CLAS Natural Product DME0190 XEOTICID XEO01449 DESCRIPT Quercitrin induces the drug-metabolizing activity of DME MAT2A DME0190 XEOTICID XEO01449 GENEFORM Protein DME0190 XEOTICID XEO01449 MOACRIVE Induction DME0191 DME___ID DME0191 DME0191 DME_NAME Folylpolyglutamate synthase (FPGS) DME0191 SPESNAME Homo sapiens DME0191 XEOTICID XEO00079 XEO_NAME Vorinostat DME0191 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0191 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0191 XEOTICID XEO00079 DESCRIPT Vorinostat up-regulates the expression of DME FPGS DME0191 XEOTICID XEO00079 GENEFORM mRNA DME0191 XEOTICID XEO00079 MOACRIVE Induction DME0191 XEOTICID XEO00168 XEO_NAME Decitabine DME0191 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0191 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0191 XEOTICID XEO00168 DESCRIPT Decitabine up-regulates the expression of DME FPGS DME0191 XEOTICID XEO00168 GENEFORM mRNA DME0191 XEOTICID XEO00168 MOACRIVE Induction DME0191 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0191 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0191 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0191 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME FPGS DME0191 XEOTICID XEO00217 GENEFORM mRNA DME0191 XEOTICID XEO00217 MOACRIVE Inhibition DME0191 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0191 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0191 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0191 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME FPGS DME0191 XEOTICID XEO00292 GENEFORM mRNA DME0191 XEOTICID XEO00292 MOACRIVE Inhibition DME0191 XEOTICID XEO00404 XEO_NAME Folic acid DME0191 XEOTICID XEO00404 XEO_TYPE Pharmaceutical Agent(s) DME0191 XEOTICID XEO00404 XEO_CLAS Approved/Marketed Drug DME0191 XEOTICID XEO00404 DESCRIPT Folic acid up-regulates the expression of DME FPGS DME0191 XEOTICID XEO00404 GENEFORM mRNA DME0191 XEOTICID XEO00404 MOACRIVE Induction DME0191 XEOTICID XEO00660 XEO_NAME 7-hydroxymethotrexate DME0191 XEOTICID XEO00660 XEO_TYPE Pharmaceutical Agent(s) DME0191 XEOTICID XEO00660 XEO_CLAS Drug in Phase 1 Clinical Trial DME0191 XEOTICID XEO00660 DESCRIPT 7-hydroxymethotrexate inhibits the drug-metabolizing activity of DME FPGS DME0191 XEOTICID XEO00660 GENEFORM Protein DME0191 XEOTICID XEO00660 MOACRIVE Inhibition DME0191 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0191 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0191 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0191 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME FPGS DME0191 XEOTICID XEO01324 GENEFORM mRNA DME0191 XEOTICID XEO01324 MOACRIVE Inhibition DME0191 XEOTICID XEO01574 XEO_NAME Plant extracts DME0191 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0191 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0191 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the expression of DME FPGS DME0191 XEOTICID XEO01574 GENEFORM mRNA DME0191 XEOTICID XEO01574 MOACRIVE Inhibition DME0193 DME___ID DME0193 DME0193 DME_NAME Arylsulfatase A (ARSA) DME0193 SPESNAME Homo sapiens DME0193 XEOTICID XEO00095 XEO_NAME Testosterone DME0193 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0193 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0193 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME ARSA DME0193 XEOTICID XEO00095 GENEFORM mRNA DME0193 XEOTICID XEO00095 MOACRIVE Induction DME0193 XEOTICID XEO00184 XEO_NAME Calcitriol DME0193 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0193 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0193 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME ARSA DME0193 XEOTICID XEO00184 GENEFORM mRNA DME0193 XEOTICID XEO00184 MOACRIVE Induction DME0193 XEOTICID XEO00334 XEO_NAME Cisplatin DME0193 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0193 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0193 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME ARSA DME0193 XEOTICID XEO00334 GENEFORM mRNA DME0193 XEOTICID XEO00334 MOACRIVE Induction DME0193 XEOTICID XEO00538 XEO_NAME Quercetin DME0193 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0193 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0193 XEOTICID XEO00538 DESCRIPT Quercetin up-regulates the expression of DME ARSA DME0193 XEOTICID XEO00538 GENEFORM mRNA DME0193 XEOTICID XEO00538 MOACRIVE Induction DME0193 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0193 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0193 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0193 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME ARSA DME0193 XEOTICID XEO00723 GENEFORM mRNA DME0193 XEOTICID XEO00723 MOACRIVE Induction DME0193 XEOTICID XEO00760 XEO_NAME Jinfukang DME0193 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0193 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0193 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME ARSA DME0193 XEOTICID XEO00760 GENEFORM mRNA DME0193 XEOTICID XEO00760 MOACRIVE Induction DME0193 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0193 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0193 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0193 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the drug-metabolizing activity of DME ARSA DME0193 XEOTICID XEO01004 GENEFORM Protein DME0193 XEOTICID XEO01004 MOACRIVE Inhibition DME0193 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0193 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0193 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0193 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME ARSA DME0193 XEOTICID XEO01226 GENEFORM mRNA DME0193 XEOTICID XEO01226 MOACRIVE Induction DME0193 XEOTICID XEO01241 XEO_NAME CD-437 DME0193 XEOTICID XEO01241 XEO_TYPE Health or Environmental Toxicant(s) DME0193 XEOTICID XEO01241 XEO_CLAS Health Hazard/Toxicant DME0193 XEOTICID XEO01241 DESCRIPT CD-437 inhibits the expression of DME ARSA DME0193 XEOTICID XEO01241 GENEFORM mRNA DME0193 XEOTICID XEO01241 MOACRIVE Inhibition DME0193 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0193 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0193 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0193 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME ARSA DME0193 XEOTICID XEO01324 GENEFORM mRNA DME0193 XEOTICID XEO01324 MOACRIVE Inhibition DME0194 DME___ID DME0194 DME0194 DME_NAME Choline phosphatase 1 (PLD1) DME0194 SPESNAME Homo sapiens DME0194 XEOTICID XEO00090 XEO_NAME Estradiol DME0194 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0194 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0194 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME PLD1 DME0194 XEOTICID XEO00090 GENEFORM mRNA DME0194 XEOTICID XEO00090 MOACRIVE Induction DME0194 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0194 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0194 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0194 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME PLD1 DME0194 XEOTICID XEO00117 GENEFORM mRNA DME0194 XEOTICID XEO00117 MOACRIVE Inhibition DME0194 XEOTICID XEO00127 XEO_NAME Mifepristone DME0194 XEOTICID XEO00127 XEO_TYPE Pharmaceutical Agent(s) DME0194 XEOTICID XEO00127 XEO_CLAS Approved/Marketed Drug DME0194 XEOTICID XEO00127 DESCRIPT Mifepristone induces the drug-metabolizing activity of DME PLD1 DME0194 XEOTICID XEO00127 GENEFORM Protein DME0194 XEOTICID XEO00127 MOACRIVE Induction DME0194 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0194 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0194 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0194 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME PLD1 DME0194 XEOTICID XEO00217 GENEFORM mRNA DME0194 XEOTICID XEO00217 MOACRIVE Inhibition DME0194 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0194 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0194 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0194 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME PLD1 DME0194 XEOTICID XEO00241 GENEFORM mRNA DME0194 XEOTICID XEO00241 MOACRIVE Inhibition DME0194 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0194 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0194 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0194 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME PLD1 DME0194 XEOTICID XEO00292 GENEFORM mRNA DME0194 XEOTICID XEO00292 MOACRIVE Inhibition DME0194 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0194 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0194 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0194 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex inhibits the expression of DME PLD1 DME0194 XEOTICID XEO00312 GENEFORM mRNA DME0194 XEOTICID XEO00312 MOACRIVE Inhibition DME0194 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0194 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0194 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0194 XEOTICID XEO00430 DESCRIPT Hydroquinone inhibits the expression of DME PLD1 DME0194 XEOTICID XEO00430 GENEFORM mRNA DME0194 XEOTICID XEO00430 MOACRIVE Inhibition DME0194 XEOTICID XEO00538 XEO_NAME Quercetin DME0194 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0194 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0194 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME PLD1 DME0194 XEOTICID XEO00538 GENEFORM mRNA DME0194 XEOTICID XEO00538 MOACRIVE Inhibition DME0194 XEOTICID XEO00581 XEO_NAME MS-275 DME0194 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0194 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0194 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME PLD1 DME0194 XEOTICID XEO00581 GENEFORM mRNA DME0194 XEOTICID XEO00581 MOACRIVE Induction DME0194 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME0194 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME0194 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME0194 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate up-regulates the expression of DME PLD1 DME0194 XEOTICID XEO00613 GENEFORM mRNA DME0194 XEOTICID XEO00613 MOACRIVE Induction DME0194 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0194 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0194 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0194 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME PLD1 DME0194 XEOTICID XEO00723 GENEFORM mRNA DME0194 XEOTICID XEO00723 MOACRIVE Induction DME0194 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0194 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0194 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0194 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME PLD1 DME0194 XEOTICID XEO00806 GENEFORM mRNA DME0194 XEOTICID XEO00806 MOACRIVE Induction DME0194 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0194 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0194 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0194 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME PLD1 DME0194 XEOTICID XEO00818 GENEFORM mRNA DME0194 XEOTICID XEO00818 MOACRIVE Induction DME0194 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0194 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0194 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0194 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME PLD1 DME0194 XEOTICID XEO00821 GENEFORM mRNA DME0194 XEOTICID XEO00821 MOACRIVE Induction DME0194 XEOTICID XEO00896 XEO_NAME 2-naphthylamine DME0194 XEOTICID XEO00896 XEO_TYPE Health or Environmental Toxicant(s) DME0194 XEOTICID XEO00896 XEO_CLAS Carcinogen DME0194 XEOTICID XEO00896 DESCRIPT 2-naphthylamine inhibits the expression of DME PLD1 DME0194 XEOTICID XEO00896 GENEFORM mRNA DME0194 XEOTICID XEO00896 MOACRIVE Inhibition DME0194 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0194 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0194 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0194 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME PLD1 DME0194 XEOTICID XEO00898 GENEFORM mRNA DME0194 XEOTICID XEO00898 MOACRIVE Inhibition DME0194 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0194 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0194 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0194 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the drug-metabolizing activity of DME PLD1 DME0194 XEOTICID XEO01004 GENEFORM Protein DME0194 XEOTICID XEO01004 MOACRIVE Inhibition DME0194 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0194 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0194 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0194 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME PLD1 DME0194 XEOTICID XEO01226 GENEFORM mRNA DME0194 XEOTICID XEO01226 MOACRIVE Inhibition DME0194 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0194 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0194 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0194 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME PLD1 DME0194 XEOTICID XEO01305 GENEFORM mRNA DME0194 XEOTICID XEO01305 MOACRIVE Induction DME0194 XEOTICID XEO01369 XEO_NAME Lithium chloride DME0194 XEOTICID XEO01369 XEO_TYPE Health or Environmental Toxicant(s) DME0194 XEOTICID XEO01369 XEO_CLAS Health Hazard/Toxicant DME0194 XEOTICID XEO01369 DESCRIPT Lithium chloride up-regulates the expression of DME PLD1 DME0194 XEOTICID XEO01369 GENEFORM mRNA DME0194 XEOTICID XEO01369 MOACRIVE Induction DME0195 DME___ID DME0195 DME0195 DME_NAME Phosphodiesterase 5A (PDE5A) DME0195 SPESNAME Homo sapiens DME0195 XEOTICID XEO00029 XEO_NAME Valproic acid DME0195 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0195 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME PDE5A DME0195 XEOTICID XEO00029 GENEFORM mRNA DME0195 XEOTICID XEO00029 MOACRIVE Inhibition DME0195 XEOTICID XEO00090 XEO_NAME Estradiol DME0195 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0195 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME PDE5A DME0195 XEOTICID XEO00090 GENEFORM mRNA DME0195 XEOTICID XEO00090 MOACRIVE Inhibition DME0195 XEOTICID XEO00126 XEO_NAME Raloxifene hydrochloride DME0195 XEOTICID XEO00126 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00126 XEO_CLAS Approved/Marketed Drug DME0195 XEOTICID XEO00126 DESCRIPT Raloxifene hydrochloride inhibits the expression of DME PDE5A DME0195 XEOTICID XEO00126 GENEFORM mRNA DME0195 XEOTICID XEO00126 MOACRIVE Inhibition DME0195 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0195 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0195 XEOTICID XEO00140 DESCRIPT Zoledronic acid inhibits the expression of DME PDE5A DME0195 XEOTICID XEO00140 GENEFORM mRNA DME0195 XEOTICID XEO00140 MOACRIVE Inhibition DME0195 XEOTICID XEO00149 XEO_NAME Tadalafil DME0195 XEOTICID XEO00149 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00149 XEO_CLAS Approved/Marketed Drug DME0195 XEOTICID XEO00149 DESCRIPT Tadalafil inhibits the drug-metabolizing activity of DME PDE5A (IC50 = 0.0012 microM) DME0195 XEOTICID XEO00149 GENEFORM Protein DME0195 XEOTICID XEO00149 MOACRIVE Inhibition DME0195 XEOTICID XEO00212 XEO_NAME Sildenafil citrate DME0195 XEOTICID XEO00212 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00212 XEO_CLAS Approved/Marketed Drug DME0195 XEOTICID XEO00212 DESCRIPT Sildenafil citrate inhibits the drug-metabolizing activity of DME PDE5A (IC50 = 0.0022 microM) DME0195 XEOTICID XEO00212 GENEFORM Protein DME0195 XEOTICID XEO00212 MOACRIVE Inhibition DME0195 XEOTICID XEO00214 XEO_NAME Dipyridamole DME0195 XEOTICID XEO00214 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00214 XEO_CLAS Approved/Marketed Drug DME0195 XEOTICID XEO00214 DESCRIPT Dipyridamole inhibits the drug-metabolizing activity of DME PDE5A (IC50 = 0.52 microM) DME0195 XEOTICID XEO00214 GENEFORM Protein DME0195 XEOTICID XEO00214 MOACRIVE Inhibition DME0195 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0195 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0195 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME PDE5A DME0195 XEOTICID XEO00217 GENEFORM mRNA DME0195 XEOTICID XEO00217 MOACRIVE Induction DME0195 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0195 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0195 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME PDE5A DME0195 XEOTICID XEO00241 GENEFORM mRNA DME0195 XEOTICID XEO00241 MOACRIVE Inhibition DME0195 XEOTICID XEO00253 XEO_NAME Tretinoin DME0195 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0195 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME PDE5A DME0195 XEOTICID XEO00253 GENEFORM mRNA DME0195 XEOTICID XEO00253 MOACRIVE Induction DME0195 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0195 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0195 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME PDE5A DME0195 XEOTICID XEO00292 GENEFORM mRNA DME0195 XEOTICID XEO00292 MOACRIVE Inhibition DME0195 XEOTICID XEO00334 XEO_NAME Cisplatin DME0195 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0195 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME PDE5A DME0195 XEOTICID XEO00334 GENEFORM mRNA DME0195 XEOTICID XEO00334 MOACRIVE Inhibition DME0195 XEOTICID XEO00411 XEO_NAME Avobenzone DME0195 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0195 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME PDE5A DME0195 XEOTICID XEO00411 GENEFORM mRNA DME0195 XEOTICID XEO00411 MOACRIVE Induction DME0195 XEOTICID XEO00427 XEO_NAME Vardenafil dihydrochloride DME0195 XEOTICID XEO00427 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00427 XEO_CLAS Approved/Marketed Drug DME0195 XEOTICID XEO00427 DESCRIPT Vardenafil dihydrochloride inhibits the expression of DME PDE5A DME0195 XEOTICID XEO00427 GENEFORM mRNA DME0195 XEOTICID XEO00427 MOACRIVE Inhibition DME0195 XEOTICID XEO00568 XEO_NAME Resveratrol DME0195 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0195 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the expression of DME PDE5A DME0195 XEOTICID XEO00568 GENEFORM mRNA DME0195 XEOTICID XEO00568 MOACRIVE Inhibition DME0195 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0195 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0195 XEOTICID XEO00632 DESCRIPT Sodium arsenite induces the drug-metabolizing activity of DME PDE5A DME0195 XEOTICID XEO00632 GENEFORM Protein DME0195 XEOTICID XEO00632 MOACRIVE Induction DME0195 XEOTICID XEO00654 XEO_NAME Icariin DME0195 XEOTICID XEO00654 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00654 XEO_CLAS Drug in Phase 3 Clinical Trial DME0195 XEOTICID XEO00654 DESCRIPT Icariin inhibits the drug-metabolizing activity of DME PDE5A in Monkey kidney tissue Fibroblast-like cell lines (COS)7 (IC50 = 5.9 microM) DME0195 XEOTICID XEO00654 GENEFORM Protein DME0195 XEOTICID XEO00654 MOACRIVE Inhibition DME0195 XEOTICID XEO00659 XEO_NAME Exisulind DME0195 XEOTICID XEO00659 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00659 XEO_CLAS Drug in Phase 3 Clinical Trial DME0195 XEOTICID XEO00659 DESCRIPT Exisulind inhibits the drug-metabolizing activity of DME PDE5A DME0195 XEOTICID XEO00659 GENEFORM Protein DME0195 XEOTICID XEO00659 MOACRIVE Inhibition DME0195 XEOTICID XEO00760 XEO_NAME Jinfukang DME0195 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0195 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0195 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME PDE5A DME0195 XEOTICID XEO00760 GENEFORM mRNA DME0195 XEOTICID XEO00760 MOACRIVE Inhibition DME0195 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0195 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0195 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate inhibits the expression of DME PDE5A DME0195 XEOTICID XEO00818 GENEFORM mRNA DME0195 XEOTICID XEO00818 MOACRIVE Inhibition DME0195 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0195 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0195 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0195 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME PDE5A DME0195 XEOTICID XEO00898 GENEFORM mRNA DME0195 XEOTICID XEO00898 MOACRIVE Induction DME0195 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0195 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0195 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0195 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME PDE5A DME0195 XEOTICID XEO00999 GENEFORM mRNA DME0195 XEOTICID XEO00999 MOACRIVE Induction DME0195 XEOTICID XEO01034 XEO_NAME Pentanal DME0195 XEOTICID XEO01034 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0195 XEOTICID XEO01034 XEO_CLAS Chemical Compound DME0195 XEOTICID XEO01034 DESCRIPT Pentanal up-regulates the expression of DME PDE5A DME0195 XEOTICID XEO01034 GENEFORM mRNA DME0195 XEOTICID XEO01034 MOACRIVE Induction DME0195 XEOTICID XEO01082 XEO_NAME CP-461 DME0195 XEOTICID XEO01082 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO01082 XEO_CLAS Drug in Phase 2 Clinical Trial DME0195 XEOTICID XEO01082 DESCRIPT CP-461 inhibits the drug-metabolizing activity of DME PDE5A DME0195 XEOTICID XEO01082 GENEFORM Protein DME0195 XEOTICID XEO01082 MOACRIVE Inhibition DME0195 XEOTICID XEO01136 XEO_NAME 3,7-bis(2-hydroxyethyl)icaritin DME0195 XEOTICID XEO01136 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO01136 XEO_CLAS Investigative Agent DME0195 XEOTICID XEO01136 DESCRIPT 3,7-bis(2-hydroxyethyl)icaritin inhibits the drug-metabolizing activity of DME PDE5A in Monkey kidney tissue Fibroblast-like cell lines (COS)7 (IC50 = 0.074 microM) DME0195 XEOTICID XEO01136 GENEFORM Protein DME0195 XEOTICID XEO01136 MOACRIVE Inhibition DME0195 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0195 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0195 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME PDE5A DME0195 XEOTICID XEO01226 GENEFORM mRNA DME0195 XEOTICID XEO01226 MOACRIVE Induction DME0195 XEOTICID XEO01356 XEO_NAME KMUP 1 DME0195 XEOTICID XEO01356 XEO_TYPE Health or Environmental Toxicant(s) DME0195 XEOTICID XEO01356 XEO_CLAS Acute Toxic Substance DME0195 XEOTICID XEO01356 DESCRIPT KMUP 1 inhibits the drug-metabolizing activity of DME PDE5A DME0195 XEOTICID XEO01356 GENEFORM Protein DME0195 XEOTICID XEO01356 MOACRIVE Inhibition DME0195 XEOTICID XEO01383 XEO_NAME MY-5445 DME0195 XEOTICID XEO01383 XEO_TYPE Pharmaceutical Agent(s) DME0195 XEOTICID XEO01383 XEO_CLAS Preclinical/Patented Drug DME0195 XEOTICID XEO01383 DESCRIPT MY-5445 inhibits the drug-metabolizing activity of DME PDE5A (IC50 = 0.5 microM) DME0195 XEOTICID XEO01383 GENEFORM Protein DME0195 XEOTICID XEO01383 MOACRIVE Inhibition DME0195 XEOTICID XEO01522 XEO_NAME Anthocyanins DME0195 XEOTICID XEO01522 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0195 XEOTICID XEO01522 XEO_CLAS Natural Product DME0195 XEOTICID XEO01522 DESCRIPT Anthocyanins inhibits the drug-metabolizing activity of DME PDE5A DME0195 XEOTICID XEO01522 GENEFORM Protein DME0195 XEOTICID XEO01522 MOACRIVE Inhibition DME0195 XEOTICID XEO01561 XEO_NAME Malvidin DME0195 XEOTICID XEO01561 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0195 XEOTICID XEO01561 XEO_CLAS Natural Product DME0195 XEOTICID XEO01561 DESCRIPT Malvidin inhibits the drug-metabolizing activity of DME PDE5A DME0195 XEOTICID XEO01561 GENEFORM Protein DME0195 XEOTICID XEO01561 MOACRIVE Inhibition DME0195 XEOTICID XEO01562 XEO_NAME Malvidin-3-glucoside DME0195 XEOTICID XEO01562 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0195 XEOTICID XEO01562 XEO_CLAS Natural Product DME0195 XEOTICID XEO01562 DESCRIPT Malvidin-3-glucoside inhibits the drug-metabolizing activity of DME PDE5A DME0195 XEOTICID XEO01562 GENEFORM Protein DME0195 XEOTICID XEO01562 MOACRIVE Inhibition DME0195 XEOTICID XEO01577 XEO_NAME Polydatin DME0195 XEOTICID XEO01577 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0195 XEOTICID XEO01577 XEO_CLAS Natural Product DME0195 XEOTICID XEO01577 DESCRIPT Polydatin inhibits the drug-metabolizing activity of DME PDE5A DME0195 XEOTICID XEO01577 GENEFORM Protein DME0195 XEOTICID XEO01577 MOACRIVE Inhibition DME0197 DME___ID DME0197 DME0197 DME_NAME Aldo-keto reductase 1C1 (AKR1C1) DME0197 SPESNAME Homo sapiens DME0197 XEOTICID XEO00007 XEO_NAME Azathioprine DME0197 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00007 DESCRIPT Azathioprine up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00007 GENEFORM mRNA DME0197 XEOTICID XEO00007 MOACRIVE Induction DME0197 XEOTICID XEO00024 XEO_NAME Diazepam DME0197 XEOTICID XEO00024 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00024 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00024 DESCRIPT Diazepam inhibits the drug-metabolizing activity of DME AKR1C1 (IC50 = 5.6 microM) DME0197 XEOTICID XEO00024 GENEFORM Protein DME0197 XEOTICID XEO00024 MOACRIVE Inhibition DME0197 XEOTICID XEO00028 XEO_NAME Disulfiram DME0197 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00028 DESCRIPT Disulfiram up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00028 GENEFORM mRNA DME0197 XEOTICID XEO00028 MOACRIVE Induction DME0197 XEOTICID XEO00031 XEO_NAME Estazolam DME0197 XEOTICID XEO00031 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00031 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00031 DESCRIPT Estazolam inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00031 GENEFORM Protein DME0197 XEOTICID XEO00031 MOACRIVE Inhibition DME0197 XEOTICID XEO00032 XEO_NAME Ethacrynic acid DME0197 XEOTICID XEO00032 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00032 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00032 DESCRIPT Ethacrynic acid up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00032 GENEFORM mRNA DME0197 XEOTICID XEO00032 MOACRIVE Induction DME0197 XEOTICID XEO00043 XEO_NAME Glimepiride DME0197 XEOTICID XEO00043 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00043 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00043 DESCRIPT Glimepiride inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00043 GENEFORM Protein DME0197 XEOTICID XEO00043 MOACRIVE Inhibition DME0197 XEOTICID XEO00044 XEO_NAME Glipizide DME0197 XEOTICID XEO00044 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00044 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00044 DESCRIPT Glipizide inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00044 GENEFORM Protein DME0197 XEOTICID XEO00044 MOACRIVE Inhibition DME0197 XEOTICID XEO00047 XEO_NAME Indomethacin DME0197 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00047 DESCRIPT Indomethacin inhibits the drug-metabolizing activity of DME AKR1C1 (IC50 = 130 microM) DME0197 XEOTICID XEO00047 GENEFORM Protein DME0197 XEOTICID XEO00047 MOACRIVE Inhibition DME0197 XEOTICID XEO00053 XEO_NAME Leflunomide DME0197 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00053 DESCRIPT Leflunomide inhibits the expression of DME AKR1C1 DME0197 XEOTICID XEO00053 GENEFORM mRNA DME0197 XEOTICID XEO00053 MOACRIVE Inhibition DME0197 XEOTICID XEO00079 XEO_NAME Vorinostat DME0197 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00079 DESCRIPT Vorinostat up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00079 GENEFORM mRNA DME0197 XEOTICID XEO00079 MOACRIVE Induction DME0197 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0197 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00088 GENEFORM mRNA DME0197 XEOTICID XEO00088 MOACRIVE Induction DME0197 XEOTICID XEO00090 XEO_NAME Estradiol DME0197 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00090 GENEFORM mRNA DME0197 XEOTICID XEO00090 MOACRIVE Induction DME0197 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0197 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00117 GENEFORM mRNA DME0197 XEOTICID XEO00117 MOACRIVE Induction DME0197 XEOTICID XEO00119 XEO_NAME Ursodeoxycholic acid DME0197 XEOTICID XEO00119 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00119 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00119 DESCRIPT Ursodeoxycholic acid inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00119 GENEFORM Protein DME0197 XEOTICID XEO00119 MOACRIVE Inhibition DME0197 XEOTICID XEO00125 XEO_NAME Simvastatin DME0197 XEOTICID XEO00125 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00125 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00125 DESCRIPT Simvastatin up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00125 GENEFORM mRNA DME0197 XEOTICID XEO00125 MOACRIVE Induction DME0197 XEOTICID XEO00144 XEO_NAME Bexarotene DME0197 XEOTICID XEO00144 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00144 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00144 DESCRIPT Bexarotene up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00144 GENEFORM mRNA DME0197 XEOTICID XEO00144 MOACRIVE Induction DME0197 XEOTICID XEO00156 XEO_NAME Naproxen DME0197 XEOTICID XEO00156 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00156 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00156 DESCRIPT Naproxen inhibits the drug-metabolizing activity of DME AKR1C1 (IC50 > 100 microM) DME0197 XEOTICID XEO00156 GENEFORM Protein DME0197 XEOTICID XEO00156 MOACRIVE Inhibition DME0197 XEOTICID XEO00159 XEO_NAME Bortezomib DME0197 XEOTICID XEO00159 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00159 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00159 DESCRIPT Bortezomib up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00159 GENEFORM mRNA DME0197 XEOTICID XEO00159 MOACRIVE Induction DME0197 XEOTICID XEO00184 XEO_NAME Calcitriol DME0197 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00184 GENEFORM mRNA DME0197 XEOTICID XEO00184 MOACRIVE Induction DME0197 XEOTICID XEO00192 XEO_NAME Dutasteride DME0197 XEOTICID XEO00192 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00192 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00192 DESCRIPT Dutasteride up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00192 GENEFORM mRNA DME0197 XEOTICID XEO00192 MOACRIVE Induction DME0197 XEOTICID XEO00213 XEO_NAME Aspirin DME0197 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00213 DESCRIPT Aspirin inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00213 GENEFORM Protein DME0197 XEOTICID XEO00213 MOACRIVE Inhibition DME0197 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0197 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00217 GENEFORM mRNA DME0197 XEOTICID XEO00217 MOACRIVE Induction DME0197 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0197 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00241 GENEFORM mRNA DME0197 XEOTICID XEO00241 MOACRIVE Induction DME0197 XEOTICID XEO00247 XEO_NAME Glyburide DME0197 XEOTICID XEO00247 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00247 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00247 DESCRIPT Glyburide inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00247 GENEFORM Protein DME0197 XEOTICID XEO00247 MOACRIVE Inhibition DME0197 XEOTICID XEO00248 XEO_NAME Ibuprofen DME0197 XEOTICID XEO00248 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00248 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00248 DESCRIPT Ibuprofen inhibits the drug-metabolizing activity of DME AKR1C1 (IC50 > 100 microM) DME0197 XEOTICID XEO00248 GENEFORM Protein DME0197 XEOTICID XEO00248 MOACRIVE Inhibition DME0197 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0197 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00277 GENEFORM mRNA DME0197 XEOTICID XEO00277 MOACRIVE Induction DME0197 XEOTICID XEO00296 XEO_NAME Flurbiprofen sodium DME0197 XEOTICID XEO00296 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00296 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00296 DESCRIPT Flurbiprofen sodium inhibits the drug-metabolizing activity of DME AKR1C1 (IC50 > 100 microM) DME0197 XEOTICID XEO00296 GENEFORM Protein DME0197 XEOTICID XEO00296 MOACRIVE Inhibition DME0197 XEOTICID XEO00334 XEO_NAME Cisplatin DME0197 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00334 GENEFORM mRNA DME0197 XEOTICID XEO00334 MOACRIVE Induction DME0197 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0197 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00388 GENEFORM mRNA DME0197 XEOTICID XEO00388 MOACRIVE Induction DME0197 XEOTICID XEO00403 XEO_NAME Dydrogesterone DME0197 XEOTICID XEO00403 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00403 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00403 DESCRIPT Dydrogesterone inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00403 GENEFORM Protein DME0197 XEOTICID XEO00403 MOACRIVE Inhibition DME0197 XEOTICID XEO00411 XEO_NAME Avobenzone DME0197 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00411 GENEFORM mRNA DME0197 XEOTICID XEO00411 MOACRIVE Induction DME0197 XEOTICID XEO00415 XEO_NAME Meclofenamic acid DME0197 XEOTICID XEO00415 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00415 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00415 DESCRIPT Meclofenamic acid inhibits the drug-metabolizing activity of DME AKR1C1 (IC50 = 3.16 microM) DME0197 XEOTICID XEO00415 GENEFORM Protein DME0197 XEOTICID XEO00415 MOACRIVE Inhibition DME0197 XEOTICID XEO00433 XEO_NAME Dienogest DME0197 XEOTICID XEO00433 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00433 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00433 DESCRIPT Dienogest inhibits the expression of DME AKR1C1 DME0197 XEOTICID XEO00433 GENEFORM mRNA DME0197 XEOTICID XEO00433 MOACRIVE Inhibition DME0197 XEOTICID XEO00435 XEO_NAME Urethane DME0197 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00435 DESCRIPT Urethane inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00435 GENEFORM Protein DME0197 XEOTICID XEO00435 MOACRIVE Inhibition DME0197 XEOTICID XEO00447 XEO_NAME Benzoic acid DME0197 XEOTICID XEO00447 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00447 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00447 DESCRIPT Benzoic acid up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00447 GENEFORM mRNA DME0197 XEOTICID XEO00447 MOACRIVE Induction DME0197 XEOTICID XEO00470 XEO_NAME Flufenamic acid DME0197 XEOTICID XEO00470 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00470 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00470 DESCRIPT Flufenamic acid inhibits the drug-metabolizing activity of DME AKR1C1 (IC50 = 0.98 microM) DME0197 XEOTICID XEO00470 GENEFORM Protein DME0197 XEOTICID XEO00470 MOACRIVE Inhibition DME0197 XEOTICID XEO00492 XEO_NAME Benzbromarone DME0197 XEOTICID XEO00492 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00492 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00492 DESCRIPT Benzbromarone inhibits the drug-metabolizing activity of DME AKR1C1 (IC50 = 0.048 microM) DME0197 XEOTICID XEO00492 GENEFORM Protein DME0197 XEOTICID XEO00492 MOACRIVE Inhibition DME0197 XEOTICID XEO00498 XEO_NAME Flunitrazepam DME0197 XEOTICID XEO00498 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00498 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00498 DESCRIPT Flunitrazepam inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00498 GENEFORM Protein DME0197 XEOTICID XEO00498 MOACRIVE Inhibition DME0197 XEOTICID XEO00501 XEO_NAME Gliquidone DME0197 XEOTICID XEO00501 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00501 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00501 DESCRIPT Gliquidone inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00501 GENEFORM Protein DME0197 XEOTICID XEO00501 MOACRIVE Inhibition DME0197 XEOTICID XEO00510 XEO_NAME Gamolenic acid DME0197 XEOTICID XEO00510 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00510 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00510 DESCRIPT Gamolenic acid up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00510 GENEFORM mRNA DME0197 XEOTICID XEO00510 MOACRIVE Induction DME0197 XEOTICID XEO00521 XEO_NAME Phenolphthalein DME0197 XEOTICID XEO00521 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00521 XEO_CLAS Drug Marketed but Withdrawn from Market DME0197 XEOTICID XEO00521 DESCRIPT Phenolphthalein inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00521 GENEFORM Protein DME0197 XEOTICID XEO00521 MOACRIVE Inhibition DME0197 XEOTICID XEO00560 XEO_NAME Triclosan DME0197 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0197 XEOTICID XEO00560 DESCRIPT Triclosan inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00560 GENEFORM Protein DME0197 XEOTICID XEO00560 MOACRIVE Inhibition DME0197 XEOTICID XEO00565 XEO_NAME Fenretinide DME0197 XEOTICID XEO00565 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00565 XEO_CLAS Drug in Phase 3 Clinical Trial DME0197 XEOTICID XEO00565 DESCRIPT Fenretinide up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00565 GENEFORM mRNA DME0197 XEOTICID XEO00565 MOACRIVE Induction DME0197 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0197 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0197 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00571 GENEFORM mRNA DME0197 XEOTICID XEO00571 MOACRIVE Induction DME0197 XEOTICID XEO00573 XEO_NAME Naringenin DME0197 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME0197 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00573 GENEFORM Protein DME0197 XEOTICID XEO00573 MOACRIVE Inhibition DME0197 XEOTICID XEO00581 XEO_NAME MS-275 DME0197 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0197 XEOTICID XEO00581 DESCRIPT MS-275 inhibits the expression of DME AKR1C1 DME0197 XEOTICID XEO00581 GENEFORM mRNA DME0197 XEOTICID XEO00581 MOACRIVE Inhibition DME0197 XEOTICID XEO00584 XEO_NAME 4-phenylbutyric acid DME0197 XEOTICID XEO00584 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00584 XEO_CLAS Drug in Phase 2 Clinical Trial DME0197 XEOTICID XEO00584 DESCRIPT 4-phenylbutyric acid up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00584 GENEFORM mRNA DME0197 XEOTICID XEO00584 MOACRIVE Induction DME0197 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0197 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0197 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00632 GENEFORM mRNA DME0197 XEOTICID XEO00632 MOACRIVE Induction DME0197 XEOTICID XEO00652 XEO_NAME Seocalcitol DME0197 XEOTICID XEO00652 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00652 XEO_CLAS Drug in Phase 3 Clinical Trial DME0197 XEOTICID XEO00652 DESCRIPT Seocalcitol induces the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00652 GENEFORM Protein DME0197 XEOTICID XEO00652 MOACRIVE Induction DME0197 XEOTICID XEO00743 XEO_NAME Medroxyprogesterone acetate DME0197 XEOTICID XEO00743 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00743 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00743 DESCRIPT Medroxyprogesterone acetate inhibits the drug-metabolizing activity of DME AKR1C1 (IC50 = 0.7 microM) DME0197 XEOTICID XEO00743 GENEFORM Protein DME0197 XEOTICID XEO00743 MOACRIVE Inhibition DME0197 XEOTICID XEO00747 XEO_NAME Cholecalciferol DME0197 XEOTICID XEO00747 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00747 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00747 DESCRIPT Cholecalciferol up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00747 GENEFORM mRNA DME0197 XEOTICID XEO00747 MOACRIVE Induction DME0197 XEOTICID XEO00760 XEO_NAME Jinfukang DME0197 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0197 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0197 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00760 GENEFORM mRNA DME0197 XEOTICID XEO00760 MOACRIVE Induction DME0197 XEOTICID XEO00763 XEO_NAME Anthranilic acid DME0197 XEOTICID XEO00763 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0197 XEOTICID XEO00763 XEO_CLAS Natural Product DME0197 XEOTICID XEO00763 DESCRIPT Anthranilic acid inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00763 GENEFORM Protein DME0197 XEOTICID XEO00763 MOACRIVE Inhibition DME0197 XEOTICID XEO00766 XEO_NAME 1,10-phenanthroline DME0197 XEOTICID XEO00766 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0197 XEOTICID XEO00766 XEO_CLAS Chemical Compound DME0197 XEOTICID XEO00766 DESCRIPT 1,10-phenanthroline inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00766 GENEFORM Protein DME0197 XEOTICID XEO00766 MOACRIVE Inhibition DME0197 XEOTICID XEO00769 XEO_NAME Hexestrol DME0197 XEOTICID XEO00769 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00769 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO00769 DESCRIPT Hexestrol inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00769 GENEFORM Protein DME0197 XEOTICID XEO00769 MOACRIVE Inhibition DME0197 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0197 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0197 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00772 GENEFORM mRNA DME0197 XEOTICID XEO00772 MOACRIVE Induction DME0197 XEOTICID XEO00787 XEO_NAME Lithocholic acid DME0197 XEOTICID XEO00787 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00787 XEO_CLAS Investigative Agent DME0197 XEOTICID XEO00787 DESCRIPT Lithocholic acid inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00787 GENEFORM Protein DME0197 XEOTICID XEO00787 MOACRIVE Inhibition DME0197 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0197 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0197 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0197 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00821 GENEFORM mRNA DME0197 XEOTICID XEO00821 MOACRIVE Induction DME0197 XEOTICID XEO00881 XEO_NAME Medazepam DME0197 XEOTICID XEO00881 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO00881 XEO_CLAS Health Hazard/Toxicant DME0197 XEOTICID XEO00881 DESCRIPT Medazepam inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO00881 GENEFORM Protein DME0197 XEOTICID XEO00881 MOACRIVE Inhibition DME0197 XEOTICID XEO00885 XEO_NAME Eugenol DME0197 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0197 XEOTICID XEO00885 DESCRIPT Eugenol up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00885 GENEFORM mRNA DME0197 XEOTICID XEO00885 MOACRIVE Induction DME0197 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0197 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0197 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00898 GENEFORM mRNA DME0197 XEOTICID XEO00898 MOACRIVE Induction DME0197 XEOTICID XEO00899 XEO_NAME Methylcholanthrene DME0197 XEOTICID XEO00899 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO00899 XEO_CLAS Carcinogen DME0197 XEOTICID XEO00899 DESCRIPT Methylcholanthrene up-regulates the expression of DME AKR1C1 and leads to increasing the drug-metabolizing activity of this enzyme DME0197 XEOTICID XEO00899 GENEFORM Protein DME0197 XEOTICID XEO00899 MOACRIVE Induction DME0197 XEOTICID XEO00971 XEO_NAME Diquat DME0197 XEOTICID XEO00971 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0197 XEOTICID XEO00971 XEO_CLAS Herbicide DME0197 XEOTICID XEO00971 DESCRIPT Diquat up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00971 GENEFORM mRNA DME0197 XEOTICID XEO00971 MOACRIVE Induction DME0197 XEOTICID XEO00973 XEO_NAME Diuron DME0197 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0197 XEOTICID XEO00973 XEO_CLAS Herbicide DME0197 XEOTICID XEO00973 DESCRIPT Diuron up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00973 GENEFORM mRNA DME0197 XEOTICID XEO00973 MOACRIVE Induction DME0197 XEOTICID XEO00985 XEO_NAME Hexyl cinnamic aldehyde DME0197 XEOTICID XEO00985 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO00985 XEO_CLAS Environmental Pollutant DME0197 XEOTICID XEO00985 DESCRIPT Hexyl cinnamic aldehyde up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO00985 GENEFORM mRNA DME0197 XEOTICID XEO00985 MOACRIVE Induction DME0197 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0197 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0197 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01004 GENEFORM mRNA DME0197 XEOTICID XEO01004 MOACRIVE Induction DME0197 XEOTICID XEO01009 XEO_NAME Glycidamide DME0197 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0197 XEOTICID XEO01009 DESCRIPT Glycidamide up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01009 GENEFORM mRNA DME0197 XEOTICID XEO01009 MOACRIVE Induction DME0197 XEOTICID XEO01016 XEO_NAME N-hexane DME0197 XEOTICID XEO01016 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO01016 XEO_CLAS Health Hazard/Toxicant DME0197 XEOTICID XEO01016 DESCRIPT N-hexane up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01016 GENEFORM mRNA DME0197 XEOTICID XEO01016 MOACRIVE Induction DME0197 XEOTICID XEO01023 XEO_NAME Sodium arsenate DME0197 XEOTICID XEO01023 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO01023 XEO_CLAS Environmental Pollutant DME0197 XEOTICID XEO01023 DESCRIPT Sodium arsenate up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01023 GENEFORM mRNA DME0197 XEOTICID XEO01023 MOACRIVE Induction DME0197 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0197 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0197 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01031 GENEFORM mRNA DME0197 XEOTICID XEO01031 MOACRIVE Induction DME0197 XEOTICID XEO01122 XEO_NAME 2-butenal DME0197 XEOTICID XEO01122 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO01122 XEO_CLAS Acute Toxic Substance DME0197 XEOTICID XEO01122 DESCRIPT 2-butenal up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01122 GENEFORM mRNA DME0197 XEOTICID XEO01122 MOACRIVE Induction DME0197 XEOTICID XEO01128 XEO_NAME Isopropanol DME0197 XEOTICID XEO01128 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO01128 XEO_CLAS Investigative Agent DME0197 XEOTICID XEO01128 DESCRIPT Isopropanol up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01128 GENEFORM mRNA DME0197 XEOTICID XEO01128 MOACRIVE Induction DME0197 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0197 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0197 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01129 GENEFORM mRNA DME0197 XEOTICID XEO01129 MOACRIVE Induction DME0197 XEOTICID XEO01137 XEO_NAME 3,7-dihydroxyflavone DME0197 XEOTICID XEO01137 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO01137 XEO_CLAS Investigative Agent DME0197 XEOTICID XEO01137 DESCRIPT 3,7-dihydroxyflavone inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO01137 GENEFORM Protein DME0197 XEOTICID XEO01137 MOACRIVE Inhibition DME0197 XEOTICID XEO01176 XEO_NAME 7-hydroxyflavone DME0197 XEOTICID XEO01176 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0197 XEOTICID XEO01176 XEO_CLAS Natural Product DME0197 XEOTICID XEO01176 DESCRIPT 7-hydroxyflavone inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO01176 GENEFORM Protein DME0197 XEOTICID XEO01176 MOACRIVE Inhibition DME0197 XEOTICID XEO01219 XEO_NAME MG-132 DME0197 XEOTICID XEO01219 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO01219 XEO_CLAS Investigative Agent DME0197 XEOTICID XEO01219 DESCRIPT MG-132 up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01219 GENEFORM mRNA DME0197 XEOTICID XEO01219 MOACRIVE Induction DME0197 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0197 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0197 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01220 GENEFORM mRNA DME0197 XEOTICID XEO01220 MOACRIVE Induction DME0197 XEOTICID XEO01233 XEO_NAME Phenethyl caffeate DME0197 XEOTICID XEO01233 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO01233 XEO_CLAS Drug in Phase 1 Clinical Trial DME0197 XEOTICID XEO01233 DESCRIPT Phenethyl caffeate inhibits the drug-metabolizing activity of DME AKR1C1 (IC50 = 13 microM) DME0197 XEOTICID XEO01233 GENEFORM Protein DME0197 XEOTICID XEO01233 MOACRIVE Inhibition DME0197 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME0197 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0197 XEOTICID XEO01253 XEO_CLAS Natural Product DME0197 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01253 GENEFORM mRNA DME0197 XEOTICID XEO01253 MOACRIVE Induction DME0197 XEOTICID XEO01258 XEO_NAME Cloxazolam DME0197 XEOTICID XEO01258 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO01258 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO01258 DESCRIPT Cloxazolam inhibits the drug-metabolizing activity of DME AKR1C1 (Ki > 10 microM) DME0197 XEOTICID XEO01258 GENEFORM Protein DME0197 XEOTICID XEO01258 MOACRIVE Inhibition DME0197 XEOTICID XEO01275 XEO_NAME Dibutyl phthalate DME0197 XEOTICID XEO01275 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO01275 XEO_CLAS Health Hazard/Toxicant DME0197 XEOTICID XEO01275 DESCRIPT Dibutyl phthalate up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01275 GENEFORM mRNA DME0197 XEOTICID XEO01275 MOACRIVE Induction DME0197 XEOTICID XEO01298 XEO_NAME Farnesol DME0197 XEOTICID XEO01298 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO01298 XEO_CLAS Investigative Agent DME0197 XEOTICID XEO01298 DESCRIPT Farnesol up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01298 GENEFORM mRNA DME0197 XEOTICID XEO01298 MOACRIVE Induction DME0197 XEOTICID XEO01300 XEO_NAME Fenamic acid DME0197 XEOTICID XEO01300 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO01300 XEO_CLAS Investigative Agent DME0197 XEOTICID XEO01300 DESCRIPT Fenamic acid inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO01300 GENEFORM Protein DME0197 XEOTICID XEO01300 MOACRIVE Inhibition DME0197 XEOTICID XEO01311 XEO_NAME Gedunin DME0197 XEOTICID XEO01311 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0197 XEOTICID XEO01311 XEO_CLAS Natural Product DME0197 XEOTICID XEO01311 DESCRIPT Gedunin up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01311 GENEFORM mRNA DME0197 XEOTICID XEO01311 MOACRIVE Induction DME0197 XEOTICID XEO01312 XEO_NAME Geraniol DME0197 XEOTICID XEO01312 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0197 XEOTICID XEO01312 XEO_CLAS Natural Product DME0197 XEOTICID XEO01312 DESCRIPT Geraniol up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01312 GENEFORM mRNA DME0197 XEOTICID XEO01312 MOACRIVE Induction DME0197 XEOTICID XEO01319 XEO_NAME Glycyrrhetinic acid DME0197 XEOTICID XEO01319 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO01319 XEO_CLAS Approved/Marketed Drug DME0197 XEOTICID XEO01319 DESCRIPT Glycyrrhetinic acid inhibits the drug-metabolizing activity of DME AKR1C1 DME0197 XEOTICID XEO01319 GENEFORM Protein DME0197 XEOTICID XEO01319 MOACRIVE Inhibition DME0197 XEOTICID XEO01376 XEO_NAME Methyl salicylate DME0197 XEOTICID XEO01376 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO01376 XEO_CLAS Drug in Phase 1 Clinical Trial DME0197 XEOTICID XEO01376 DESCRIPT Methyl salicylate up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01376 GENEFORM mRNA DME0197 XEOTICID XEO01376 MOACRIVE Induction DME0197 XEOTICID XEO01408 XEO_NAME Octyl gallate DME0197 XEOTICID XEO01408 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0197 XEOTICID XEO01408 XEO_CLAS Natural Product DME0197 XEOTICID XEO01408 DESCRIPT Octyl gallate inhibits the expression of DME AKR1C1 DME0197 XEOTICID XEO01408 GENEFORM mRNA DME0197 XEOTICID XEO01408 MOACRIVE Inhibition DME0197 XEOTICID XEO01478 XEO_NAME Sulforafan DME0197 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0197 XEOTICID XEO01478 DESCRIPT Sulforafan up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01478 GENEFORM mRNA DME0197 XEOTICID XEO01478 MOACRIVE Induction DME0197 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0197 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0197 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0197 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01492 GENEFORM mRNA DME0197 XEOTICID XEO01492 MOACRIVE Induction DME0197 XEOTICID XEO01503 XEO_NAME Cadmium DME0197 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0197 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01503 GENEFORM mRNA DME0197 XEOTICID XEO01503 MOACRIVE Induction DME0197 XEOTICID XEO01506 XEO_NAME Lead chloride DME0197 XEOTICID XEO01506 XEO_TYPE Health or Environmental Toxicant(s) DME0197 XEOTICID XEO01506 XEO_CLAS Health Hazard/Toxicant DME0197 XEOTICID XEO01506 DESCRIPT Lead chloride up-regulates the expression of DME AKR1C1 DME0197 XEOTICID XEO01506 GENEFORM mRNA DME0197 XEOTICID XEO01506 MOACRIVE Induction DME0198 DME___ID DME0198 DME0198 DME_NAME Aldo-keto reductase 1C4 (AKR1C4) DME0198 SPESNAME Homo sapiens DME0198 XEOTICID XEO00024 XEO_NAME Diazepam DME0198 XEOTICID XEO00024 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO00024 XEO_CLAS Approved/Marketed Drug DME0198 XEOTICID XEO00024 DESCRIPT Diazepam inhibits the drug-metabolizing activity of DME AKR1C4 DME0198 XEOTICID XEO00024 GENEFORM Protein DME0198 XEOTICID XEO00024 MOACRIVE Inhibition DME0198 XEOTICID XEO00047 XEO_NAME Indomethacin DME0198 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0198 XEOTICID XEO00047 DESCRIPT Indomethacin inhibits the drug-metabolizing activity of DME AKR1C4 (IC50 = 54 microM) DME0198 XEOTICID XEO00047 GENEFORM Protein DME0198 XEOTICID XEO00047 MOACRIVE Inhibition DME0198 XEOTICID XEO00090 XEO_NAME Estradiol DME0198 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0198 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME AKR1C4 DME0198 XEOTICID XEO00090 GENEFORM mRNA DME0198 XEOTICID XEO00090 MOACRIVE Inhibition DME0198 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0198 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0198 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME AKR1C4 DME0198 XEOTICID XEO00217 GENEFORM mRNA DME0198 XEOTICID XEO00217 MOACRIVE Inhibition DME0198 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0198 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0198 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME AKR1C4 DME0198 XEOTICID XEO00241 GENEFORM mRNA DME0198 XEOTICID XEO00241 MOACRIVE Inhibition DME0198 XEOTICID XEO00415 XEO_NAME Meclofenamic acid DME0198 XEOTICID XEO00415 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO00415 XEO_CLAS Approved/Marketed Drug DME0198 XEOTICID XEO00415 DESCRIPT Meclofenamic acid inhibits the drug-metabolizing activity of DME AKR1C4 (IC50 > 100 microM) DME0198 XEOTICID XEO00415 GENEFORM Protein DME0198 XEOTICID XEO00415 MOACRIVE Inhibition DME0198 XEOTICID XEO00470 XEO_NAME Flufenamic acid DME0198 XEOTICID XEO00470 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO00470 XEO_CLAS Approved/Marketed Drug DME0198 XEOTICID XEO00470 DESCRIPT Flufenamic acid inhibits the drug-metabolizing activity of DME AKR1C4 (IC50 > 100 microM) DME0198 XEOTICID XEO00470 GENEFORM Protein DME0198 XEOTICID XEO00470 MOACRIVE Inhibition DME0198 XEOTICID XEO00492 XEO_NAME Benzbromarone DME0198 XEOTICID XEO00492 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO00492 XEO_CLAS Approved/Marketed Drug DME0198 XEOTICID XEO00492 DESCRIPT Benzbromarone inhibits the drug-metabolizing activity of DME AKR1C4 DME0198 XEOTICID XEO00492 GENEFORM Protein DME0198 XEOTICID XEO00492 MOACRIVE Inhibition DME0198 XEOTICID XEO00498 XEO_NAME Flunitrazepam DME0198 XEOTICID XEO00498 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO00498 XEO_CLAS Approved/Marketed Drug DME0198 XEOTICID XEO00498 DESCRIPT Flunitrazepam inhibits the drug-metabolizing activity of DME AKR1C4 DME0198 XEOTICID XEO00498 GENEFORM Protein DME0198 XEOTICID XEO00498 MOACRIVE Inhibition DME0198 XEOTICID XEO00510 XEO_NAME Gamolenic acid DME0198 XEOTICID XEO00510 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO00510 XEO_CLAS Approved/Marketed Drug DME0198 XEOTICID XEO00510 DESCRIPT Gamolenic acid up-regulates the expression of DME AKR1C4 DME0198 XEOTICID XEO00510 GENEFORM mRNA DME0198 XEOTICID XEO00510 MOACRIVE Induction DME0198 XEOTICID XEO00521 XEO_NAME Phenolphthalein DME0198 XEOTICID XEO00521 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO00521 XEO_CLAS Drug Marketed but Withdrawn from Market DME0198 XEOTICID XEO00521 DESCRIPT Phenolphthalein inhibits the expression of DME AKR1C4 DME0198 XEOTICID XEO00521 GENEFORM mRNA DME0198 XEOTICID XEO00521 MOACRIVE Inhibition DME0198 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0198 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0198 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME AKR1C4 and leads to decreasing the drug-metabolizing activity of this enzyme DME0198 XEOTICID XEO00632 GENEFORM Protein DME0198 XEOTICID XEO00632 MOACRIVE Inhibition DME0198 XEOTICID XEO00760 XEO_NAME Jinfukang DME0198 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0198 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0198 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME AKR1C4 DME0198 XEOTICID XEO00760 GENEFORM mRNA DME0198 XEOTICID XEO00760 MOACRIVE Induction DME0198 XEOTICID XEO00766 XEO_NAME 1,10-phenanthroline DME0198 XEOTICID XEO00766 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0198 XEOTICID XEO00766 XEO_CLAS Chemical Compound DME0198 XEOTICID XEO00766 DESCRIPT 1,10-phenanthroline inhibits the drug-metabolizing activity of DME AKR1C4 DME0198 XEOTICID XEO00766 GENEFORM Protein DME0198 XEOTICID XEO00766 MOACRIVE Inhibition DME0198 XEOTICID XEO00769 XEO_NAME Hexestrol DME0198 XEOTICID XEO00769 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO00769 XEO_CLAS Approved/Marketed Drug DME0198 XEOTICID XEO00769 DESCRIPT Hexestrol inhibits the drug-metabolizing activity of DME AKR1C4 DME0198 XEOTICID XEO00769 GENEFORM Protein DME0198 XEOTICID XEO00769 MOACRIVE Inhibition DME0198 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0198 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0198 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0198 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME AKR1C4 DME0198 XEOTICID XEO00806 GENEFORM mRNA DME0198 XEOTICID XEO00806 MOACRIVE Inhibition DME0198 XEOTICID XEO00881 XEO_NAME Medazepam DME0198 XEOTICID XEO00881 XEO_TYPE Health or Environmental Toxicant(s) DME0198 XEOTICID XEO00881 XEO_CLAS Health Hazard/Toxicant DME0198 XEOTICID XEO00881 DESCRIPT Medazepam inhibits the drug-metabolizing activity of DME AKR1C4 DME0198 XEOTICID XEO00881 GENEFORM Protein DME0198 XEOTICID XEO00881 MOACRIVE Inhibition DME0198 XEOTICID XEO00919 XEO_NAME Particulate matter DME0198 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0198 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0198 XEOTICID XEO00919 DESCRIPT Particulate matter induces the drug-metabolizing activity of DME AKR1C4 DME0198 XEOTICID XEO00919 GENEFORM Protein DME0198 XEOTICID XEO00919 MOACRIVE Induction DME0198 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0198 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0198 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0198 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME AKR1C4 DME0198 XEOTICID XEO00999 GENEFORM mRNA DME0198 XEOTICID XEO00999 MOACRIVE Inhibition DME0198 XEOTICID XEO01233 XEO_NAME Phenethyl caffeate DME0198 XEOTICID XEO01233 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO01233 XEO_CLAS Drug in Phase 1 Clinical Trial DME0198 XEOTICID XEO01233 DESCRIPT Phenethyl caffeate inhibits the drug-metabolizing activity of DME AKR1C4 (IC50 = 2.3 microM) DME0198 XEOTICID XEO01233 GENEFORM Protein DME0198 XEOTICID XEO01233 MOACRIVE Inhibition DME0198 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0198 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0198 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0198 XEOTICID XEO01247 DESCRIPT Chloropicrin up-regulates the expression of DME AKR1C4 DME0198 XEOTICID XEO01247 GENEFORM mRNA DME0198 XEOTICID XEO01247 MOACRIVE Induction DME0198 XEOTICID XEO01258 XEO_NAME Cloxazolam DME0198 XEOTICID XEO01258 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO01258 XEO_CLAS Approved/Marketed Drug DME0198 XEOTICID XEO01258 DESCRIPT Cloxazolam inhibits the drug-metabolizing activity of DME AKR1C4 DME0198 XEOTICID XEO01258 GENEFORM Protein DME0198 XEOTICID XEO01258 MOACRIVE Inhibition DME0198 XEOTICID XEO01319 XEO_NAME Glycyrrhetinic acid DME0198 XEOTICID XEO01319 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO01319 XEO_CLAS Approved/Marketed Drug DME0198 XEOTICID XEO01319 DESCRIPT Glycyrrhetinic acid inhibits the drug-metabolizing activity of DME AKR1C4 DME0198 XEOTICID XEO01319 GENEFORM Protein DME0198 XEOTICID XEO01319 MOACRIVE Inhibition DME0198 XEOTICID XEO01403 XEO_NAME NSC-668394 DME0198 XEOTICID XEO01403 XEO_TYPE Pharmaceutical Agent(s) DME0198 XEOTICID XEO01403 XEO_CLAS Preclinical/Patented Drug DME0198 XEOTICID XEO01403 DESCRIPT NSC-668394 induces the drug-metabolizing activity of DME AKR1C4 DME0198 XEOTICID XEO01403 GENEFORM Protein DME0198 XEOTICID XEO01403 MOACRIVE Induction DME0198 XEOTICID XEO01408 XEO_NAME Octyl gallate DME0198 XEOTICID XEO01408 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0198 XEOTICID XEO01408 XEO_CLAS Natural Product DME0198 XEOTICID XEO01408 DESCRIPT Octyl gallate inhibits the expression of DME AKR1C4 DME0198 XEOTICID XEO01408 GENEFORM mRNA DME0198 XEOTICID XEO01408 MOACRIVE Inhibition DME0199 DME___ID DME0199 DME0199 DME_NAME Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1) DME0199 SPESNAME Homo sapiens DME0199 XEOTICID XEO00007 XEO_NAME Azathioprine DME0199 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00007 DESCRIPT Azathioprine inhibits the expression of DME HSD11B1 DME0199 XEOTICID XEO00007 GENEFORM mRNA DME0199 XEOTICID XEO00007 MOACRIVE Inhibition DME0199 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0199 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME HSD11B1 DME0199 XEOTICID XEO00035 GENEFORM mRNA DME0199 XEOTICID XEO00035 MOACRIVE Induction DME0199 XEOTICID XEO00063 XEO_NAME Metyrapone DME0199 XEOTICID XEO00063 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00063 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00063 DESCRIPT Metyrapone inhibits the expression of DME HSD11B1 DME0199 XEOTICID XEO00063 GENEFORM mRNA DME0199 XEOTICID XEO00063 MOACRIVE Inhibition DME0199 XEOTICID XEO00086 XEO_NAME Troglitazone DME0199 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME HSD11B1 DME0199 XEOTICID XEO00086 GENEFORM mRNA DME0199 XEOTICID XEO00086 MOACRIVE Induction DME0199 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0199 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME HSD11B1 and leads to increasing the drug-metabolizing activity of this enzyme DME0199 XEOTICID XEO00088 GENEFORM Protein DME0199 XEOTICID XEO00088 MOACRIVE Induction DME0199 XEOTICID XEO00094 XEO_NAME Progesterone DME0199 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00094 DESCRIPT Progesterone up-regulates the expression of DME HSD11B1 DME0199 XEOTICID XEO00094 GENEFORM mRNA DME0199 XEOTICID XEO00094 MOACRIVE Induction DME0199 XEOTICID XEO00095 XEO_NAME Testosterone DME0199 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME HSD11B1 DME0199 XEOTICID XEO00095 GENEFORM mRNA DME0199 XEOTICID XEO00095 MOACRIVE Induction DME0199 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0199 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00140 DESCRIPT Zoledronic acid up-regulates the expression of DME HSD11B1 DME0199 XEOTICID XEO00140 GENEFORM mRNA DME0199 XEOTICID XEO00140 MOACRIVE Induction DME0199 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0199 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00167 DESCRIPT Alitretinoin inhibits the expression of DME HSD11B1 DME0199 XEOTICID XEO00167 GENEFORM mRNA DME0199 XEOTICID XEO00167 MOACRIVE Inhibition DME0199 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0199 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME HSD11B1 DME0199 XEOTICID XEO00186 GENEFORM mRNA DME0199 XEOTICID XEO00186 MOACRIVE Inhibition DME0199 XEOTICID XEO00204 XEO_NAME Piroxicam DME0199 XEOTICID XEO00204 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00204 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00204 DESCRIPT Piroxicam inhibits the drug-metabolizing activity of DME HSD11B1 DME0199 XEOTICID XEO00204 GENEFORM Protein DME0199 XEOTICID XEO00204 MOACRIVE Inhibition DME0199 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0199 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME HSD11B1 DME0199 XEOTICID XEO00217 GENEFORM mRNA DME0199 XEOTICID XEO00217 MOACRIVE Inhibition DME0199 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0199 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME HSD11B1 DME0199 XEOTICID XEO00241 GENEFORM mRNA DME0199 XEOTICID XEO00241 MOACRIVE Inhibition DME0199 XEOTICID XEO00260 XEO_NAME Dinoprostone DME0199 XEOTICID XEO00260 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00260 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00260 DESCRIPT Dinoprostone induces the drug-metabolizing activity of DME HSD11B1 DME0199 XEOTICID XEO00260 GENEFORM Protein DME0199 XEOTICID XEO00260 MOACRIVE Induction DME0199 XEOTICID XEO00264 XEO_NAME Hydrocortisone DME0199 XEOTICID XEO00264 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00264 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00264 DESCRIPT Hydrocortisone induces the drug-metabolizing activity of DME HSD11B1 DME0199 XEOTICID XEO00264 GENEFORM Protein DME0199 XEOTICID XEO00264 MOACRIVE Induction DME0199 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0199 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME HSD11B1 DME0199 XEOTICID XEO00292 GENEFORM mRNA DME0199 XEOTICID XEO00292 MOACRIVE Inhibition DME0199 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0199 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00380 DESCRIPT Rosiglitazone induces the drug-metabolizing activity of DME HSD11B1 DME0199 XEOTICID XEO00380 GENEFORM Protein DME0199 XEOTICID XEO00380 MOACRIVE Induction DME0199 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME0199 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of DME HSD11B1 DME0199 XEOTICID XEO00460 GENEFORM Protein DME0199 XEOTICID XEO00460 MOACRIVE Inhibition DME0199 XEOTICID XEO00533 XEO_NAME Gold sodium thiomalate DME0199 XEOTICID XEO00533 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00533 XEO_CLAS Drug in Phase 1 Clinical Trial DME0199 XEOTICID XEO00533 DESCRIPT Gold sodium thiomalate inhibits the expression of DME HSD11B1 DME0199 XEOTICID XEO00533 GENEFORM mRNA DME0199 XEOTICID XEO00533 MOACRIVE Inhibition DME0199 XEOTICID XEO00725 XEO_NAME PF-915275 DME0199 XEOTICID XEO00725 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00725 XEO_CLAS Preclinical/Patented Drug DME0199 XEOTICID XEO00725 DESCRIPT PF-915275 inhibits the drug-metabolizing activity of DME HSD11B1 (Ki < 0.001 microM) DME0199 XEOTICID XEO00725 GENEFORM Protein DME0199 XEOTICID XEO00725 MOACRIVE Inhibition DME0199 XEOTICID XEO00734 XEO_NAME Butaprost DME0199 XEOTICID XEO00734 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO00734 XEO_CLAS Preclinical/Patented Drug DME0199 XEOTICID XEO00734 DESCRIPT Butaprost induces the drug-metabolizing activity of DME HSD11B1 DME0199 XEOTICID XEO00734 GENEFORM Protein DME0199 XEOTICID XEO00734 MOACRIVE Induction DME0199 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0199 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0199 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0199 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME HSD11B1 DME0199 XEOTICID XEO00806 GENEFORM mRNA DME0199 XEOTICID XEO00806 MOACRIVE Inhibition DME0199 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0199 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0199 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0199 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution induces the drug-metabolizing activity of DME HSD11B1 DME0199 XEOTICID XEO00821 GENEFORM Protein DME0199 XEOTICID XEO00821 MOACRIVE Induction DME0199 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0199 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0199 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0199 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME HSD11B1 DME0199 XEOTICID XEO00898 GENEFORM mRNA DME0199 XEOTICID XEO00898 MOACRIVE Inhibition DME0199 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0199 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0199 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0199 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid inhibits the drug-metabolizing activity of DME HSD11B1 DME0199 XEOTICID XEO00921 GENEFORM Protein DME0199 XEOTICID XEO00921 MOACRIVE Inhibition DME0199 XEOTICID XEO01098 XEO_NAME 18alpha-glycyrrhetinic acid DME0199 XEOTICID XEO01098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0199 XEOTICID XEO01098 XEO_CLAS Natural Product DME0199 XEOTICID XEO01098 DESCRIPT 18alpha-glycyrrhetinic acid inhibits the drug-metabolizing activity of DME HSD11B1 in Human embryonic kidney 293 cell (HEK293) (IC50 = 0.0086 microM) DME0199 XEOTICID XEO01098 GENEFORM Protein DME0199 XEOTICID XEO01098 MOACRIVE Inhibition DME0199 XEOTICID XEO01110 XEO_NAME p,p'-Hydroxy-DDT DME0199 XEOTICID XEO01110 XEO_TYPE Health or Environmental Toxicant(s) DME0199 XEOTICID XEO01110 XEO_CLAS Environmental Pollutant DME0199 XEOTICID XEO01110 DESCRIPT p,p'-Hydroxy-DDT inhibits the drug-metabolizing activity of DME HSD11B1 DME0199 XEOTICID XEO01110 GENEFORM Protein DME0199 XEOTICID XEO01110 MOACRIVE Inhibition DME0199 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0199 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0199 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the drug-metabolizing activity of DME HSD11B1 DME0199 XEOTICID XEO01226 GENEFORM Protein DME0199 XEOTICID XEO01226 MOACRIVE Inhibition DME0199 XEOTICID XEO01236 XEO_NAME Carbenoxolone DME0199 XEOTICID XEO01236 XEO_TYPE Pharmaceutical Agent(s) DME0199 XEOTICID XEO01236 XEO_CLAS Approved/Marketed Drug DME0199 XEOTICID XEO01236 DESCRIPT Carbenoxolone inhibits the drug-metabolizing activity of DME HSD11B1 (IC50 = 0.083 microM) DME0199 XEOTICID XEO01236 GENEFORM Protein DME0199 XEOTICID XEO01236 MOACRIVE Inhibition DME0199 XEOTICID XEO01613 XEO_NAME Dioctyl adipate DME0199 XEOTICID XEO01613 XEO_TYPE Health or Environmental Toxicant(s) DME0199 XEOTICID XEO01613 XEO_CLAS Health Hazard/Toxicant DME0199 XEOTICID XEO01613 DESCRIPT Dioctyl adipate inhibits the drug-metabolizing activity of DME HSD11B1 DME0199 XEOTICID XEO01613 GENEFORM Protein DME0199 XEOTICID XEO01613 MOACRIVE Inhibition DME0200 DME___ID DME0200 DME0200 DME_NAME Bile acid-CoA thioesterase (BAAT) DME0200 SPESNAME Homo sapiens DME0200 XEOTICID XEO00090 XEO_NAME Estradiol DME0200 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0200 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0200 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME BAAT DME0200 XEOTICID XEO00090 GENEFORM mRNA DME0200 XEOTICID XEO00090 MOACRIVE Inhibition DME0200 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0200 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0200 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0200 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME BAAT DME0200 XEOTICID XEO00117 GENEFORM mRNA DME0200 XEOTICID XEO00117 MOACRIVE Induction DME0200 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0200 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0200 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0200 XEOTICID XEO00140 DESCRIPT Zoledronic acid up-regulates the expression of DME BAAT DME0200 XEOTICID XEO00140 GENEFORM mRNA DME0200 XEOTICID XEO00140 MOACRIVE Induction DME0200 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0200 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0200 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0200 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME BAAT DME0200 XEOTICID XEO00217 GENEFORM mRNA DME0200 XEOTICID XEO00217 MOACRIVE Inhibition DME0200 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0200 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0200 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0200 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME BAAT DME0200 XEOTICID XEO00241 GENEFORM mRNA DME0200 XEOTICID XEO00241 MOACRIVE Inhibition DME0200 XEOTICID XEO00334 XEO_NAME Cisplatin DME0200 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0200 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0200 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME BAAT DME0200 XEOTICID XEO00334 GENEFORM mRNA DME0200 XEOTICID XEO00334 MOACRIVE Inhibition DME0200 XEOTICID XEO00481 XEO_NAME Rotenone DME0200 XEOTICID XEO00481 XEO_TYPE Pharmaceutical Agent(s) DME0200 XEOTICID XEO00481 XEO_CLAS Approved/Marketed Drug DME0200 XEOTICID XEO00481 DESCRIPT Rotenone inhibits the drug-metabolizing activity of DME BAAT DME0200 XEOTICID XEO00481 GENEFORM Protein DME0200 XEOTICID XEO00481 MOACRIVE Inhibition DME0200 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0200 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0200 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0200 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME BAAT DME0200 XEOTICID XEO00723 GENEFORM mRNA DME0200 XEOTICID XEO00723 MOACRIVE Inhibition DME0200 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0200 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0200 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0200 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME BAAT DME0200 XEOTICID XEO00806 GENEFORM mRNA DME0200 XEOTICID XEO00806 MOACRIVE Inhibition DME0200 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0200 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0200 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0200 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME BAAT DME0200 XEOTICID XEO00898 GENEFORM mRNA DME0200 XEOTICID XEO00898 MOACRIVE Inhibition DME0200 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0200 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0200 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0200 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME BAAT DME0200 XEOTICID XEO01050 GENEFORM mRNA DME0200 XEOTICID XEO01050 MOACRIVE Inhibition DME0200 XEOTICID XEO01585 XEO_NAME Senecionine DME0200 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0200 XEOTICID XEO01585 XEO_CLAS Natural Product DME0200 XEOTICID XEO01585 DESCRIPT Senecionine inhibits the expression of DME BAAT DME0200 XEOTICID XEO01585 GENEFORM mRNA DME0200 XEOTICID XEO01585 MOACRIVE Inhibition DME0201 DME___ID DME0201 DME0201 DME_NAME Arachidonate 5-lipoxygenase (ALOX5) DME0201 SPESNAME Homo sapiens DME0201 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0201 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0201 XEOTICID XEO00140 DESCRIPT Zoledronic acid up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO00140 GENEFORM mRNA DME0201 XEOTICID XEO00140 MOACRIVE Induction DME0201 XEOTICID XEO00184 XEO_NAME Calcitriol DME0201 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0201 XEOTICID XEO00184 DESCRIPT Calcitriol induces the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00184 GENEFORM Protein DME0201 XEOTICID XEO00184 MOACRIVE Induction DME0201 XEOTICID XEO00253 XEO_NAME Tretinoin DME0201 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0201 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO00253 GENEFORM mRNA DME0201 XEOTICID XEO00253 MOACRIVE Induction DME0201 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0201 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0201 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO00292 GENEFORM mRNA DME0201 XEOTICID XEO00292 MOACRIVE Induction DME0201 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0201 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0201 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO00312 GENEFORM mRNA DME0201 XEOTICID XEO00312 MOACRIVE Induction DME0201 XEOTICID XEO00334 XEO_NAME Cisplatin DME0201 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0201 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO00334 GENEFORM mRNA DME0201 XEOTICID XEO00334 MOACRIVE Induction DME0201 XEOTICID XEO00348 XEO_NAME Cetirizine DME0201 XEOTICID XEO00348 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00348 XEO_CLAS Approved/Marketed Drug DME0201 XEOTICID XEO00348 DESCRIPT Cetirizine inhibits the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00348 GENEFORM Protein DME0201 XEOTICID XEO00348 MOACRIVE Inhibition DME0201 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0201 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0201 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide induces the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00388 GENEFORM Protein DME0201 XEOTICID XEO00388 MOACRIVE Induction DME0201 XEOTICID XEO00405 XEO_NAME Niclosamide DME0201 XEOTICID XEO00405 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00405 XEO_CLAS Approved/Marketed Drug DME0201 XEOTICID XEO00405 DESCRIPT Niclosamide induces the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00405 GENEFORM Protein DME0201 XEOTICID XEO00405 MOACRIVE Induction DME0201 XEOTICID XEO00415 XEO_NAME Meclofenamic acid DME0201 XEOTICID XEO00415 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00415 XEO_CLAS Approved/Marketed Drug DME0201 XEOTICID XEO00415 DESCRIPT Meclof DMEenamic acid inhibits the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00415 GENEFORM Protein DME0201 XEOTICID XEO00415 MOACRIVE Inhibition DME0201 XEOTICID XEO00515 XEO_NAME Benoxaprofen DME0201 XEOTICID XEO00515 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00515 XEO_CLAS Drug Marketed but Withdrawn from Market DME0201 XEOTICID XEO00515 DESCRIPT Benoxaprof DMEen inhibits the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00515 GENEFORM Protein DME0201 XEOTICID XEO00515 MOACRIVE Inhibition DME0201 XEOTICID XEO00544 XEO_NAME Ebselen DME0201 XEOTICID XEO00544 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00544 XEO_CLAS Drug in Phase 2 Clinical Trial DME0201 XEOTICID XEO00544 DESCRIPT Ebselen inhibits the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00544 GENEFORM Protein DME0201 XEOTICID XEO00544 MOACRIVE Inhibition DME0201 XEOTICID XEO00547 XEO_NAME Vitamin E DME0201 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0201 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the expression of DME ALOX5 DME0201 XEOTICID XEO00547 GENEFORM mRNA DME0201 XEOTICID XEO00547 MOACRIVE Inhibition DME0201 XEOTICID XEO00581 XEO_NAME MS-275 DME0201 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0201 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO00581 GENEFORM mRNA DME0201 XEOTICID XEO00581 MOACRIVE Induction DME0201 XEOTICID XEO00604 XEO_NAME Calcimycin DME0201 XEOTICID XEO00604 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00604 XEO_CLAS Drug in Phase 2 Clinical Trial DME0201 XEOTICID XEO00604 DESCRIPT Calcimycin induces the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00604 GENEFORM Protein DME0201 XEOTICID XEO00604 MOACRIVE Induction DME0201 XEOTICID XEO00608 XEO_NAME Tenidap DME0201 XEOTICID XEO00608 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00608 XEO_CLAS Drug in Phase 2 Clinical Trial DME0201 XEOTICID XEO00608 DESCRIPT Tenidap inhibits the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00608 GENEFORM Protein DME0201 XEOTICID XEO00608 MOACRIVE Inhibition DME0201 XEOTICID XEO00617 XEO_NAME Efletirizine DME0201 XEOTICID XEO00617 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00617 XEO_CLAS Drug in Phase 2 Clinical Trial DME0201 XEOTICID XEO00617 DESCRIPT Efletirizine inhibits the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00617 GENEFORM Protein DME0201 XEOTICID XEO00617 MOACRIVE Inhibition DME0201 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0201 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0201 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO00632 GENEFORM mRNA DME0201 XEOTICID XEO00632 MOACRIVE Induction DME0201 XEOTICID XEO00652 XEO_NAME Seocalcitol DME0201 XEOTICID XEO00652 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00652 XEO_CLAS Drug in Phase 3 Clinical Trial DME0201 XEOTICID XEO00652 DESCRIPT Seocalcitol up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO00652 GENEFORM mRNA DME0201 XEOTICID XEO00652 MOACRIVE Induction DME0201 XEOTICID XEO00689 XEO_NAME AA-861 DME0201 XEOTICID XEO00689 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00689 XEO_CLAS Preclinical/Patented Drug DME0201 XEOTICID XEO00689 DESCRIPT AA-861 inhibits the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00689 GENEFORM Protein DME0201 XEOTICID XEO00689 MOACRIVE Inhibition DME0201 XEOTICID XEO00695 XEO_NAME REV-5901 DME0201 XEOTICID XEO00695 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00695 XEO_CLAS Preclinical/Patented Drug DME0201 XEOTICID XEO00695 DESCRIPT REV-5901 inhibits the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00695 GENEFORM Protein DME0201 XEOTICID XEO00695 MOACRIVE Inhibition DME0201 XEOTICID XEO00699 XEO_NAME BW-755C DME0201 XEOTICID XEO00699 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00699 XEO_CLAS Preclinical/Patented Drug DME0201 XEOTICID XEO00699 DESCRIPT BW-755C inhibits the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00699 GENEFORM Protein DME0201 XEOTICID XEO00699 MOACRIVE Inhibition DME0201 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0201 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0201 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME ALOX5 DME0201 XEOTICID XEO00723 GENEFORM mRNA DME0201 XEOTICID XEO00723 MOACRIVE Inhibition DME0201 XEOTICID XEO00726 XEO_NAME CJ-13610 DME0201 XEOTICID XEO00726 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00726 XEO_CLAS Preclinical/Patented Drug DME0201 XEOTICID XEO00726 DESCRIPT CJ-13610 inhibits the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00726 GENEFORM Protein DME0201 XEOTICID XEO00726 MOACRIVE Inhibition DME0201 XEOTICID XEO00731 XEO_NAME JHW-015 DME0201 XEOTICID XEO00731 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO00731 XEO_CLAS Preclinical/Patented Drug DME0201 XEOTICID XEO00731 DESCRIPT JHW-015 inhibits the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO00731 GENEFORM Protein DME0201 XEOTICID XEO00731 MOACRIVE Inhibition DME0201 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0201 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0201 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0201 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO00806 GENEFORM mRNA DME0201 XEOTICID XEO00806 MOACRIVE Induction DME0201 XEOTICID XEO00809 XEO_NAME Thapsigargin DME0201 XEOTICID XEO00809 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0201 XEOTICID XEO00809 XEO_CLAS Natural Product DME0201 XEOTICID XEO00809 DESCRIPT Thapsigargin up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO00809 GENEFORM mRNA DME0201 XEOTICID XEO00809 MOACRIVE Induction DME0201 XEOTICID XEO00817 XEO_NAME Melitten DME0201 XEOTICID XEO00817 XEO_TYPE Health or Environmental Toxicant(s) DME0201 XEOTICID XEO00817 XEO_CLAS Biotoxin DME0201 XEOTICID XEO00817 DESCRIPT Melitten up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO00817 GENEFORM mRNA DME0201 XEOTICID XEO00817 MOACRIVE Induction DME0201 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0201 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0201 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0201 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO00999 GENEFORM mRNA DME0201 XEOTICID XEO00999 MOACRIVE Induction DME0201 XEOTICID XEO01024 XEO_NAME Sodium bichromate DME0201 XEOTICID XEO01024 XEO_TYPE Health or Environmental Toxicant(s) DME0201 XEOTICID XEO01024 XEO_CLAS Carcinogen DME0201 XEOTICID XEO01024 DESCRIPT Sodium bichromate inhibits the expression of DME ALOX5 DME0201 XEOTICID XEO01024 GENEFORM mRNA DME0201 XEOTICID XEO01024 MOACRIVE Inhibition DME0201 XEOTICID XEO01034 XEO_NAME Pentanal DME0201 XEOTICID XEO01034 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0201 XEOTICID XEO01034 XEO_CLAS Chemical Compound DME0201 XEOTICID XEO01034 DESCRIPT Pentanal up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO01034 GENEFORM mRNA DME0201 XEOTICID XEO01034 MOACRIVE Induction DME0201 XEOTICID XEO01074 XEO_NAME Endosulfan DME0201 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0201 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0201 XEOTICID XEO01074 DESCRIPT Endosulfan up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO01074 GENEFORM mRNA DME0201 XEOTICID XEO01074 MOACRIVE Induction DME0201 XEOTICID XEO01119 XEO_NAME 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DME0201 XEOTICID XEO01119 XEO_TYPE Health or Environmental Toxicant(s) DME0201 XEOTICID XEO01119 XEO_CLAS Acute Toxic Substance DME0201 XEOTICID XEO01119 DESCRIPT 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the expression of DME ALOX5 DME0201 XEOTICID XEO01119 GENEFORM mRNA DME0201 XEOTICID XEO01119 MOACRIVE Inhibition DME0201 XEOTICID XEO01207 XEO_NAME Arzanol DME0201 XEOTICID XEO01207 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0201 XEOTICID XEO01207 XEO_CLAS Natural Product DME0201 XEOTICID XEO01207 DESCRIPT Arzanol inhibits the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO01207 GENEFORM Protein DME0201 XEOTICID XEO01207 MOACRIVE Inhibition DME0201 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0201 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0201 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO01220 GENEFORM mRNA DME0201 XEOTICID XEO01220 MOACRIVE Induction DME0201 XEOTICID XEO01260 XEO_NAME Cotylenin A DME0201 XEOTICID XEO01260 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO01260 XEO_CLAS Investigative Agent DME0201 XEOTICID XEO01260 DESCRIPT Cotylenin A up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO01260 GENEFORM mRNA DME0201 XEOTICID XEO01260 MOACRIVE Induction DME0201 XEOTICID XEO01338 XEO_NAME ICI-211965 DME0201 XEOTICID XEO01338 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO01338 XEO_CLAS Preclinical/Patented Drug DME0201 XEOTICID XEO01338 DESCRIPT ICI-211965 inhibits the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO01338 GENEFORM Protein DME0201 XEOTICID XEO01338 MOACRIVE Inhibition DME0201 XEOTICID XEO01360 XEO_NAME L-708714 DME0201 XEOTICID XEO01360 XEO_TYPE Pharmaceutical Agent(s) DME0201 XEOTICID XEO01360 XEO_CLAS Preclinical/Patented Drug DME0201 XEOTICID XEO01360 DESCRIPT L-708714 inhibits the drug-metabolizing activity of DME ALOX5 DME0201 XEOTICID XEO01360 GENEFORM Protein DME0201 XEOTICID XEO01360 MOACRIVE Inhibition DME0201 XEOTICID XEO01433 XEO_NAME Pirinixic acid DME0201 XEOTICID XEO01433 XEO_TYPE Health or Environmental Toxicant(s) DME0201 XEOTICID XEO01433 XEO_CLAS Health Hazard/Toxicant DME0201 XEOTICID XEO01433 DESCRIPT Pirinixic acid inhibits the expression of DME ALOX5 DME0201 XEOTICID XEO01433 GENEFORM mRNA DME0201 XEOTICID XEO01433 MOACRIVE Inhibition DME0201 XEOTICID XEO01512 XEO_NAME Zinc DME0201 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME0201 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME0201 XEOTICID XEO01512 DESCRIPT Zinc up-regulates the expression of DME ALOX5 DME0201 XEOTICID XEO01512 GENEFORM mRNA DME0201 XEOTICID XEO01512 MOACRIVE Induction DME0202 DME___ID DME0202 DME0202 DME_NAME Fatty acid desaturase 1 (FADS1) DME0202 SPESNAME Homo sapiens DME0202 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0202 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0202 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME FADS1 DME0202 XEOTICID XEO00035 GENEFORM mRNA DME0202 XEOTICID XEO00035 MOACRIVE Induction DME0202 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0202 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0202 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME FADS1 DME0202 XEOTICID XEO00088 GENEFORM mRNA DME0202 XEOTICID XEO00088 MOACRIVE Induction DME0202 XEOTICID XEO00090 XEO_NAME Estradiol DME0202 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0202 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME FADS1 DME0202 XEOTICID XEO00090 GENEFORM mRNA DME0202 XEOTICID XEO00090 MOACRIVE Induction DME0202 XEOTICID XEO00095 XEO_NAME Testosterone DME0202 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0202 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME FADS1 DME0202 XEOTICID XEO00095 GENEFORM mRNA DME0202 XEOTICID XEO00095 MOACRIVE Induction DME0202 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0202 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0202 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME FADS1 DME0202 XEOTICID XEO00117 GENEFORM mRNA DME0202 XEOTICID XEO00117 MOACRIVE Inhibition DME0202 XEOTICID XEO00168 XEO_NAME Decitabine DME0202 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0202 XEOTICID XEO00168 DESCRIPT Decitabine up-regulates the expression of DME FADS1 DME0202 XEOTICID XEO00168 GENEFORM mRNA DME0202 XEOTICID XEO00168 MOACRIVE Induction DME0202 XEOTICID XEO00184 XEO_NAME Calcitriol DME0202 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0202 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME FADS1 DME0202 XEOTICID XEO00184 GENEFORM mRNA DME0202 XEOTICID XEO00184 MOACRIVE Induction DME0202 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0202 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0202 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME FADS1 DME0202 XEOTICID XEO00186 GENEFORM mRNA DME0202 XEOTICID XEO00186 MOACRIVE Inhibition DME0202 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0202 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0202 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME FADS1 DME0202 XEOTICID XEO00217 GENEFORM mRNA DME0202 XEOTICID XEO00217 MOACRIVE Inhibition DME0202 XEOTICID XEO00334 XEO_NAME Cisplatin DME0202 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0202 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME FADS1 DME0202 XEOTICID XEO00334 GENEFORM mRNA DME0202 XEOTICID XEO00334 MOACRIVE Induction DME0202 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0202 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0202 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME FADS1 DME0202 XEOTICID XEO00536 GENEFORM mRNA DME0202 XEOTICID XEO00536 MOACRIVE Induction DME0202 XEOTICID XEO00606 XEO_NAME Colforsin DME0202 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0202 XEOTICID XEO00606 DESCRIPT Colforsin up-regulates the expression of DME FADS1 DME0202 XEOTICID XEO00606 GENEFORM mRNA DME0202 XEOTICID XEO00606 MOACRIVE Induction DME0202 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0202 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0202 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME FADS1 DME0202 XEOTICID XEO00723 GENEFORM mRNA DME0202 XEOTICID XEO00723 MOACRIVE Inhibition DME0202 XEOTICID XEO00760 XEO_NAME Jinfukang DME0202 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0202 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0202 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME FADS1 DME0202 XEOTICID XEO00760 GENEFORM mRNA DME0202 XEOTICID XEO00760 MOACRIVE Induction DME0202 XEOTICID XEO00767 XEO_NAME Ciglitazone DME0202 XEOTICID XEO00767 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO00767 XEO_CLAS Investigative Agent DME0202 XEOTICID XEO00767 DESCRIPT Ciglitazone up-regulates the expression of DME FADS1 DME0202 XEOTICID XEO00767 GENEFORM mRNA DME0202 XEOTICID XEO00767 MOACRIVE Induction DME0202 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0202 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0202 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0202 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME FADS1 DME0202 XEOTICID XEO00806 GENEFORM mRNA DME0202 XEOTICID XEO00806 MOACRIVE Inhibition DME0202 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0202 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0202 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0202 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME FADS1 DME0202 XEOTICID XEO00821 GENEFORM mRNA DME0202 XEOTICID XEO00821 MOACRIVE Induction DME0202 XEOTICID XEO01116 XEO_NAME 25-hydroxycholesterol DME0202 XEOTICID XEO01116 XEO_TYPE Health or Environmental Toxicant(s) DME0202 XEOTICID XEO01116 XEO_CLAS Health Hazard/Toxicant DME0202 XEOTICID XEO01116 DESCRIPT 25-hydroxycholesterol inhibits the expression of DME FADS1 DME0202 XEOTICID XEO01116 GENEFORM mRNA DME0202 XEOTICID XEO01116 MOACRIVE Inhibition DME0202 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0202 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0202 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME FADS1 DME0202 XEOTICID XEO01226 GENEFORM mRNA DME0202 XEOTICID XEO01226 MOACRIVE Induction DME0202 XEOTICID XEO01261 XEO_NAME Coumestrol DME0202 XEOTICID XEO01261 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO01261 XEO_CLAS Investigative Agent DME0202 XEOTICID XEO01261 DESCRIPT Coumestrol up-regulates the expression of DME FADS1 DME0202 XEOTICID XEO01261 GENEFORM mRNA DME0202 XEOTICID XEO01261 MOACRIVE Induction DME0202 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0202 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0202 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0202 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME FADS1 DME0202 XEOTICID XEO01305 GENEFORM mRNA DME0202 XEOTICID XEO01305 MOACRIVE Inhibition DME0202 XEOTICID XEO01312 XEO_NAME Geraniol DME0202 XEOTICID XEO01312 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0202 XEOTICID XEO01312 XEO_CLAS Natural Product DME0202 XEOTICID XEO01312 DESCRIPT Geraniol inhibits the drug-metabolizing activity of DME FADS1 DME0202 XEOTICID XEO01312 GENEFORM Protein DME0202 XEOTICID XEO01312 MOACRIVE Inhibition DME0202 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0202 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0202 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0202 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME FADS1 DME0202 XEOTICID XEO01324 GENEFORM mRNA DME0202 XEOTICID XEO01324 MOACRIVE Inhibition DME0203 DME___ID DME0203 DME0203 DME_NAME Fatty acid desaturase 2 (FADS2) DME0203 SPESNAME Homo sapiens DME0203 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0203 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0203 XEOTICID XEO00011 DESCRIPT Carbamazepine inhibits the expression of DME FADS2 DME0203 XEOTICID XEO00011 GENEFORM mRNA DME0203 XEOTICID XEO00011 MOACRIVE Inhibition DME0203 XEOTICID XEO00029 XEO_NAME Valproic acid DME0203 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0203 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME FADS2 DME0203 XEOTICID XEO00029 GENEFORM mRNA DME0203 XEOTICID XEO00029 MOACRIVE Inhibition DME0203 XEOTICID XEO00079 XEO_NAME Vorinostat DME0203 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0203 XEOTICID XEO00079 DESCRIPT Vorinostat inhibits the expression of DME FADS2 DME0203 XEOTICID XEO00079 GENEFORM mRNA DME0203 XEOTICID XEO00079 MOACRIVE Inhibition DME0203 XEOTICID XEO00094 XEO_NAME Progesterone DME0203 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0203 XEOTICID XEO00094 DESCRIPT Progesterone up-regulates the expression of DME FADS2 DME0203 XEOTICID XEO00094 GENEFORM mRNA DME0203 XEOTICID XEO00094 MOACRIVE Induction DME0203 XEOTICID XEO00102 XEO_NAME Azacitidine DME0203 XEOTICID XEO00102 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00102 XEO_CLAS Approved/Marketed Drug DME0203 XEOTICID XEO00102 DESCRIPT Azacitidine inhibits the expression of DME FADS2 DME0203 XEOTICID XEO00102 GENEFORM mRNA DME0203 XEOTICID XEO00102 MOACRIVE Inhibition DME0203 XEOTICID XEO00159 XEO_NAME Bortezomib DME0203 XEOTICID XEO00159 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00159 XEO_CLAS Approved/Marketed Drug DME0203 XEOTICID XEO00159 DESCRIPT Bortezomib inhibits the expression of DME FADS2 DME0203 XEOTICID XEO00159 GENEFORM mRNA DME0203 XEOTICID XEO00159 MOACRIVE Inhibition DME0203 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0203 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0203 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME FADS2 DME0203 XEOTICID XEO00186 GENEFORM mRNA DME0203 XEOTICID XEO00186 MOACRIVE Inhibition DME0203 XEOTICID XEO00195 XEO_NAME Crizotinib DME0203 XEOTICID XEO00195 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00195 XEO_CLAS Approved/Marketed Drug DME0203 XEOTICID XEO00195 DESCRIPT Crizotinib up-regulates the expression of DME FADS2 DME0203 XEOTICID XEO00195 GENEFORM mRNA DME0203 XEOTICID XEO00195 MOACRIVE Induction DME0203 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0203 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0203 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME FADS2 DME0203 XEOTICID XEO00217 GENEFORM mRNA DME0203 XEOTICID XEO00217 MOACRIVE Inhibition DME0203 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0203 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0203 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride up-regulates the expression of DME FADS2 DME0203 XEOTICID XEO00277 GENEFORM mRNA DME0203 XEOTICID XEO00277 MOACRIVE Induction DME0203 XEOTICID XEO00334 XEO_NAME Cisplatin DME0203 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0203 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME FADS2 DME0203 XEOTICID XEO00334 GENEFORM mRNA DME0203 XEOTICID XEO00334 MOACRIVE Induction DME0203 XEOTICID XEO00382 XEO_NAME Sunitinib DME0203 XEOTICID XEO00382 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00382 XEO_CLAS Approved/Marketed Drug DME0203 XEOTICID XEO00382 DESCRIPT Sunitinib up-regulates the expression of DME FADS2 DME0203 XEOTICID XEO00382 GENEFORM mRNA DME0203 XEOTICID XEO00382 MOACRIVE Induction DME0203 XEOTICID XEO00435 XEO_NAME Urethane DME0203 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0203 XEOTICID XEO00435 DESCRIPT Urethane inhibits the drug-metabolizing activity of DME FADS2 DME0203 XEOTICID XEO00435 GENEFORM Protein DME0203 XEOTICID XEO00435 MOACRIVE Inhibition DME0203 XEOTICID XEO00557 XEO_NAME Genistein DME0203 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0203 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME FADS2 DME0203 XEOTICID XEO00557 GENEFORM mRNA DME0203 XEOTICID XEO00557 MOACRIVE Inhibition DME0203 XEOTICID XEO00596 XEO_NAME Phenethyl isothiocyanate DME0203 XEOTICID XEO00596 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00596 XEO_CLAS Drug in Phase 2 Clinical Trial DME0203 XEOTICID XEO00596 DESCRIPT Phenethyl isothiocyanate inhibits the expression of DME FADS2 DME0203 XEOTICID XEO00596 GENEFORM mRNA DME0203 XEOTICID XEO00596 MOACRIVE Inhibition DME0203 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0203 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0203 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME FADS2 DME0203 XEOTICID XEO00723 GENEFORM mRNA DME0203 XEOTICID XEO00723 MOACRIVE Induction DME0203 XEOTICID XEO00760 XEO_NAME Jinfukang DME0203 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0203 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0203 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME FADS2 DME0203 XEOTICID XEO00760 GENEFORM mRNA DME0203 XEOTICID XEO00760 MOACRIVE Induction DME0203 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0203 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0203 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0203 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME FADS2 DME0203 XEOTICID XEO00806 GENEFORM mRNA DME0203 XEOTICID XEO00806 MOACRIVE Inhibition DME0203 XEOTICID XEO00876 XEO_NAME Arachidonic acid DME0203 XEOTICID XEO00876 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO00876 XEO_CLAS Investigative Agent DME0203 XEOTICID XEO00876 DESCRIPT Arachidonic acid inhibits the expression of DME FADS2 DME0203 XEOTICID XEO00876 GENEFORM mRNA DME0203 XEOTICID XEO00876 MOACRIVE Inhibition DME0203 XEOTICID XEO00878 XEO_NAME Chrysin DME0203 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0203 XEOTICID XEO00878 XEO_CLAS Natural Product DME0203 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the expression of DME FADS2 DME0203 XEOTICID XEO00878 GENEFORM mRNA DME0203 XEOTICID XEO00878 MOACRIVE Inhibition DME0203 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0203 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0203 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0203 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME FADS2 DME0203 XEOTICID XEO00898 GENEFORM mRNA DME0203 XEOTICID XEO00898 MOACRIVE Inhibition DME0203 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0203 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0203 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0203 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME FADS2 DME0203 XEOTICID XEO00999 GENEFORM mRNA DME0203 XEOTICID XEO00999 MOACRIVE Inhibition DME0203 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0203 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0203 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0203 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME FADS2 DME0203 XEOTICID XEO01031 GENEFORM mRNA DME0203 XEOTICID XEO01031 MOACRIVE Inhibition DME0203 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0203 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0203 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME FADS2 DME0203 XEOTICID XEO01226 GENEFORM mRNA DME0203 XEOTICID XEO01226 MOACRIVE Induction DME0203 XEOTICID XEO01310 XEO_NAME Ganoderic acid A DME0203 XEOTICID XEO01310 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0203 XEOTICID XEO01310 XEO_CLAS Natural Product DME0203 XEOTICID XEO01310 DESCRIPT Ganoderic acid A inhibits the expression of DME FADS2 DME0203 XEOTICID XEO01310 GENEFORM mRNA DME0203 XEOTICID XEO01310 MOACRIVE Inhibition DME0203 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0203 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0203 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME FADS2 DME0203 XEOTICID XEO01324 GENEFORM mRNA DME0203 XEOTICID XEO01324 MOACRIVE Inhibition DME0203 XEOTICID XEO01348 XEO_NAME K-7174 DME0203 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0203 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME FADS2 DME0203 XEOTICID XEO01348 GENEFORM mRNA DME0203 XEOTICID XEO01348 MOACRIVE Inhibition DME0203 XEOTICID XEO01367 XEO_NAME Linoleic acid DME0203 XEOTICID XEO01367 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO01367 XEO_CLAS Approved/Marketed Drug DME0203 XEOTICID XEO01367 DESCRIPT Linoleic acid induces the drug-metabolizing activity of DME FADS2 DME0203 XEOTICID XEO01367 GENEFORM Protein DME0203 XEOTICID XEO01367 MOACRIVE Induction DME0203 XEOTICID XEO01436 XEO_NAME PP242 DME0203 XEOTICID XEO01436 XEO_TYPE Pharmaceutical Agent(s) DME0203 XEOTICID XEO01436 XEO_CLAS Investigative Agent DME0203 XEOTICID XEO01436 DESCRIPT PP242 inhibits the drug-metabolizing activity of DME FADS2 DME0203 XEOTICID XEO01436 GENEFORM Protein DME0203 XEOTICID XEO01436 MOACRIVE Inhibition DME0203 XEOTICID XEO01553 XEO_NAME Isoflavone DME0203 XEOTICID XEO01553 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0203 XEOTICID XEO01553 XEO_CLAS Natural Product DME0203 XEOTICID XEO01553 DESCRIPT Isoflavone up-regulates the expression of DME FADS2 DME0203 XEOTICID XEO01553 GENEFORM mRNA DME0203 XEOTICID XEO01553 MOACRIVE Induction DME0204 DME___ID DME0204 DME0204 DME_NAME Steroid 5-alpha-reductase 1 (SRD5A1) DME0204 SPESNAME Homo sapiens DME0204 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0204 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0204 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0204 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME SRD5A1 DME0204 XEOTICID XEO00117 GENEFORM mRNA DME0204 XEOTICID XEO00117 MOACRIVE Inhibition DME0204 XEOTICID XEO00129 XEO_NAME Finasteride DME0204 XEOTICID XEO00129 XEO_TYPE Pharmaceutical Agent(s) DME0204 XEOTICID XEO00129 XEO_CLAS Approved/Marketed Drug DME0204 XEOTICID XEO00129 DESCRIPT Finasteride inhibits the drug-metabolizing activity of DME SRD5A1 in Human prostate cancer cell lines (LNCaP) (IC50 = 0.0198 microM) DME0204 XEOTICID XEO00129 GENEFORM Protein DME0204 XEOTICID XEO00129 MOACRIVE Inhibition DME0204 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0204 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0204 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0204 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME SRD5A1 DME0204 XEOTICID XEO00186 GENEFORM mRNA DME0204 XEOTICID XEO00186 MOACRIVE Inhibition DME0204 XEOTICID XEO00192 XEO_NAME Dutasteride DME0204 XEOTICID XEO00192 XEO_TYPE Pharmaceutical Agent(s) DME0204 XEOTICID XEO00192 XEO_CLAS Approved/Marketed Drug DME0204 XEOTICID XEO00192 DESCRIPT Dutasteride inhibits the drug-metabolizing activity of DME SRD5A1 DME0204 XEOTICID XEO00192 GENEFORM Protein DME0204 XEOTICID XEO00192 MOACRIVE Inhibition DME0204 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0204 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0204 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0204 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME SRD5A1 DME0204 XEOTICID XEO00292 GENEFORM mRNA DME0204 XEOTICID XEO00292 MOACRIVE Induction DME0204 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0204 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0204 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0204 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME SRD5A1 DME0204 XEOTICID XEO00339 GENEFORM mRNA DME0204 XEOTICID XEO00339 MOACRIVE Inhibition DME0204 XEOTICID XEO00403 XEO_NAME Dydrogesterone DME0204 XEOTICID XEO00403 XEO_TYPE Pharmaceutical Agent(s) DME0204 XEOTICID XEO00403 XEO_CLAS Approved/Marketed Drug DME0204 XEOTICID XEO00403 DESCRIPT Dydrogesterone inhibits the expression of DME SRD5A1 DME0204 XEOTICID XEO00403 GENEFORM mRNA DME0204 XEOTICID XEO00403 MOACRIVE Inhibition DME0204 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0204 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0204 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0204 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME SRD5A1 DME0204 XEOTICID XEO00536 GENEFORM mRNA DME0204 XEOTICID XEO00536 MOACRIVE Induction DME0204 XEOTICID XEO00634 XEO_NAME Hydroxytamoxifen DME0204 XEOTICID XEO00634 XEO_TYPE Pharmaceutical Agent(s) DME0204 XEOTICID XEO00634 XEO_CLAS Drug in Phase 2 Clinical Trial DME0204 XEOTICID XEO00634 DESCRIPT Hydroxytamoxifen up-regulates the expression of DME SRD5A1 DME0204 XEOTICID XEO00634 GENEFORM mRNA DME0204 XEOTICID XEO00634 MOACRIVE Induction DME0204 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0204 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0204 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0204 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME SRD5A1 DME0204 XEOTICID XEO00723 GENEFORM mRNA DME0204 XEOTICID XEO00723 MOACRIVE Induction DME0204 XEOTICID XEO01112 XEO_NAME 2,3-dibromopropyl-2,4,6-tribromophenyl ether DME0204 XEOTICID XEO01112 XEO_TYPE Health or Environmental Toxicant(s) DME0204 XEOTICID XEO01112 XEO_CLAS Environmental Pollutant DME0204 XEOTICID XEO01112 DESCRIPT 2,3-dibromopropyl-2,4,6-tribromophenyl ether inhibits the expression of DME SRD5A1 DME0204 XEOTICID XEO01112 GENEFORM mRNA DME0204 XEOTICID XEO01112 MOACRIVE Inhibition DME0204 XEOTICID XEO01503 XEO_NAME Cadmium DME0204 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0204 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0204 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME SRD5A1 DME0204 XEOTICID XEO01503 GENEFORM mRNA DME0204 XEOTICID XEO01503 MOACRIVE Induction DME0204 XEOTICID XEO01574 XEO_NAME Plant extracts DME0204 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0204 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0204 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the expression of DME SRD5A1 DME0204 XEOTICID XEO01574 GENEFORM mRNA DME0204 XEOTICID XEO01574 MOACRIVE Inhibition DME0205 DME___ID DME0205 DME0205 DME_NAME UDP-glucuronosyltransferase 2B10 (UGT2B10) DME0205 SPESNAME Homo sapiens DME0205 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0205 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0205 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0205 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME UGT2B10 DME0205 XEOTICID XEO00117 GENEFORM mRNA DME0205 XEOTICID XEO00117 MOACRIVE Inhibition DME0205 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0205 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0205 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0205 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME UGT2B10 DME0205 XEOTICID XEO00410 GENEFORM Protein DME0205 XEOTICID XEO00410 MOACRIVE Inhibition DME0205 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0205 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0205 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0205 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the drug-metabolizing activity of DME UGT2B10 DME0205 XEOTICID XEO00632 GENEFORM Protein DME0205 XEOTICID XEO00632 MOACRIVE Inhibition DME0205 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0205 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0205 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0205 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME UGT2B10 DME0205 XEOTICID XEO00806 GENEFORM mRNA DME0205 XEOTICID XEO00806 MOACRIVE Induction DME0205 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0205 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0205 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0205 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME UGT2B10 DME0205 XEOTICID XEO01050 GENEFORM mRNA DME0205 XEOTICID XEO01050 MOACRIVE Inhibition DME0205 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0205 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0205 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0205 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME UGT2B10 DME0205 XEOTICID XEO01220 GENEFORM mRNA DME0205 XEOTICID XEO01220 MOACRIVE Inhibition DME0205 XEOTICID XEO01284 XEO_NAME Dust DME0205 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0205 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0205 XEOTICID XEO01284 DESCRIPT Dust up-regulates the expression of DME UGT2B10 DME0205 XEOTICID XEO01284 GENEFORM mRNA DME0205 XEOTICID XEO01284 MOACRIVE Induction DME0206 DME___ID DME0206 DME0206 DME_NAME Sodium/potassium-transporting ATPase gamma (FXYD2) DME0206 SPESNAME Homo sapiens DME0206 XEOTICID XEO00053 XEO_NAME Leflunomide DME0206 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0206 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0206 XEOTICID XEO00053 DESCRIPT Leflunomide inhibits the expression of DME FXYD2 DME0206 XEOTICID XEO00053 GENEFORM mRNA DME0206 XEOTICID XEO00053 MOACRIVE Inhibition DME0206 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0206 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0206 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0206 XEOTICID XEO00140 DESCRIPT Zoledronic acid inhibits the expression of DME FXYD2 DME0206 XEOTICID XEO00140 GENEFORM mRNA DME0206 XEOTICID XEO00140 MOACRIVE Inhibition DME0206 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0206 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0206 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0206 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME FXYD2 DME0206 XEOTICID XEO00217 GENEFORM mRNA DME0206 XEOTICID XEO00217 MOACRIVE Induction DME0206 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0206 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0206 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0206 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME FXYD2 DME0206 XEOTICID XEO00241 GENEFORM mRNA DME0206 XEOTICID XEO00241 MOACRIVE Inhibition DME0206 XEOTICID XEO00334 XEO_NAME Cisplatin DME0206 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0206 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0206 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME FXYD2 DME0206 XEOTICID XEO00334 GENEFORM mRNA DME0206 XEOTICID XEO00334 MOACRIVE Induction DME0206 XEOTICID XEO00538 XEO_NAME Quercetin DME0206 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0206 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0206 XEOTICID XEO00538 DESCRIPT Quercetin induces the drug-metabolizing activity of DME FXYD2 DME0206 XEOTICID XEO00538 GENEFORM Protein DME0206 XEOTICID XEO00538 MOACRIVE Induction DME0206 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0206 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0206 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0206 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME FXYD2 DME0206 XEOTICID XEO00632 GENEFORM mRNA DME0206 XEOTICID XEO00632 MOACRIVE Inhibition DME0206 XEOTICID XEO00760 XEO_NAME Jinfukang DME0206 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0206 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0206 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME FXYD2 DME0206 XEOTICID XEO00760 GENEFORM mRNA DME0206 XEOTICID XEO00760 MOACRIVE Induction DME0206 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0206 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0206 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0206 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME FXYD2 DME0206 XEOTICID XEO00806 GENEFORM mRNA DME0206 XEOTICID XEO00806 MOACRIVE Induction DME0206 XEOTICID XEO00832 XEO_NAME Calcium DME0206 XEOTICID XEO00832 XEO_TYPE Pharmaceutical Agent(s) DME0206 XEOTICID XEO00832 XEO_CLAS Approved/Marketed Drug DME0206 XEOTICID XEO00832 DESCRIPT Calcium inhibits the drug-metabolizing activity of DME FXYD2 DME0206 XEOTICID XEO00832 GENEFORM Protein DME0206 XEOTICID XEO00832 MOACRIVE Inhibition DME0206 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0206 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0206 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0206 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME FXYD2 DME0206 XEOTICID XEO00898 GENEFORM mRNA DME0206 XEOTICID XEO00898 MOACRIVE Induction DME0206 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0206 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0206 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0206 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME FXYD2 DME0206 XEOTICID XEO01050 GENEFORM mRNA DME0206 XEOTICID XEO01050 MOACRIVE Inhibition DME0206 XEOTICID XEO01574 XEO_NAME Plant extracts DME0206 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0206 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0206 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the expression of DME FXYD2 DME0206 XEOTICID XEO01574 GENEFORM mRNA DME0206 XEOTICID XEO01574 MOACRIVE Inhibition DME0207 DME___ID DME0207 DME0207 DME_NAME Proline dehydrogenase 1 (PRODH) DME0207 SPESNAME Homo sapiens DME0207 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0207 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0207 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0207 XEOTICID XEO00035 DESCRIPT Fenofibrate inhibits the expression of DME PRODH DME0207 XEOTICID XEO00035 GENEFORM mRNA DME0207 XEOTICID XEO00035 MOACRIVE Inhibition DME0207 XEOTICID XEO00086 XEO_NAME Troglitazone DME0207 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0207 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0207 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME PRODH and leads to increasing the drug-metabolizing activity of this enzyme DME0207 XEOTICID XEO00086 GENEFORM Protein DME0207 XEOTICID XEO00086 MOACRIVE Induction DME0207 XEOTICID XEO00090 XEO_NAME Estradiol DME0207 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0207 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0207 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME PRODH DME0207 XEOTICID XEO00090 GENEFORM mRNA DME0207 XEOTICID XEO00090 MOACRIVE Inhibition DME0207 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0207 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0207 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0207 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME PRODH DME0207 XEOTICID XEO00117 GENEFORM mRNA DME0207 XEOTICID XEO00117 MOACRIVE Induction DME0207 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0207 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0207 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0207 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol inhibits the expression of DME PRODH DME0207 XEOTICID XEO00166 GENEFORM mRNA DME0207 XEOTICID XEO00166 MOACRIVE Inhibition DME0207 XEOTICID XEO00184 XEO_NAME Calcitriol DME0207 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0207 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0207 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME PRODH DME0207 XEOTICID XEO00184 GENEFORM mRNA DME0207 XEOTICID XEO00184 MOACRIVE Induction DME0207 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0207 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0207 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0207 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME PRODH DME0207 XEOTICID XEO00217 GENEFORM mRNA DME0207 XEOTICID XEO00217 MOACRIVE Inhibition DME0207 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0207 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0207 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0207 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME PRODH DME0207 XEOTICID XEO00241 GENEFORM mRNA DME0207 XEOTICID XEO00241 MOACRIVE Inhibition DME0207 XEOTICID XEO00334 XEO_NAME Cisplatin DME0207 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0207 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0207 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME PRODH DME0207 XEOTICID XEO00334 GENEFORM mRNA DME0207 XEOTICID XEO00334 MOACRIVE Induction DME0207 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0207 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0207 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0207 XEOTICID XEO00380 DESCRIPT Rosiglitazone up-regulates the expression of DME PRODH DME0207 XEOTICID XEO00380 GENEFORM mRNA DME0207 XEOTICID XEO00380 MOACRIVE Induction DME0207 XEOTICID XEO00560 XEO_NAME Triclosan DME0207 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0207 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0207 XEOTICID XEO00560 DESCRIPT Triclosan inhibits the drug-metabolizing activity of DME PRODH DME0207 XEOTICID XEO00560 GENEFORM Protein DME0207 XEOTICID XEO00560 MOACRIVE Inhibition DME0207 XEOTICID XEO00581 XEO_NAME MS-275 DME0207 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0207 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0207 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME PRODH DME0207 XEOTICID XEO00581 GENEFORM mRNA DME0207 XEOTICID XEO00581 MOACRIVE Induction DME0207 XEOTICID XEO00610 XEO_NAME Afimoxifene DME0207 XEOTICID XEO00610 XEO_TYPE Pharmaceutical Agent(s) DME0207 XEOTICID XEO00610 XEO_CLAS Drug in Phase 3 Clinical Trial DME0207 XEOTICID XEO00610 DESCRIPT Afimoxifene inhibits the expression of DME PRODH DME0207 XEOTICID XEO00610 GENEFORM mRNA DME0207 XEOTICID XEO00610 MOACRIVE Inhibition DME0207 XEOTICID XEO00760 XEO_NAME Jinfukang DME0207 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0207 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0207 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME PRODH DME0207 XEOTICID XEO00760 GENEFORM mRNA DME0207 XEOTICID XEO00760 MOACRIVE Induction DME0207 XEOTICID XEO00767 XEO_NAME Ciglitazone DME0207 XEOTICID XEO00767 XEO_TYPE Pharmaceutical Agent(s) DME0207 XEOTICID XEO00767 XEO_CLAS Investigative Agent DME0207 XEOTICID XEO00767 DESCRIPT Ciglitazone up-regulates the expression of DME PRODH DME0207 XEOTICID XEO00767 GENEFORM mRNA DME0207 XEOTICID XEO00767 MOACRIVE Induction DME0207 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0207 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0207 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0207 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME PRODH DME0207 XEOTICID XEO00772 GENEFORM mRNA DME0207 XEOTICID XEO00772 MOACRIVE Induction DME0207 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0207 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0207 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0207 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME PRODH DME0207 XEOTICID XEO00898 GENEFORM mRNA DME0207 XEOTICID XEO00898 MOACRIVE Inhibition DME0208 DME___ID DME0208 DME0208 DME_NAME Oleamide hydrolase 1 (FAAH) DME0208 SPESNAME Homo sapiens DME0208 XEOTICID XEO00029 XEO_NAME Valproic acid DME0208 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0208 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0208 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME FAAH DME0208 XEOTICID XEO00029 GENEFORM mRNA DME0208 XEOTICID XEO00029 MOACRIVE Inhibition DME0208 XEOTICID XEO00094 XEO_NAME Progesterone DME0208 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0208 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0208 XEOTICID XEO00094 DESCRIPT Progesterone induces the drug-metabolizing activity of DME FAAH DME0208 XEOTICID XEO00094 GENEFORM Protein DME0208 XEOTICID XEO00094 MOACRIVE Induction DME0208 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0208 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0208 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0208 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME FAAH DME0208 XEOTICID XEO00217 GENEFORM mRNA DME0208 XEOTICID XEO00217 MOACRIVE Induction DME0208 XEOTICID XEO00584 XEO_NAME 4-phenylbutyric acid DME0208 XEOTICID XEO00584 XEO_TYPE Pharmaceutical Agent(s) DME0208 XEOTICID XEO00584 XEO_CLAS Drug in Phase 2 Clinical Trial DME0208 XEOTICID XEO00584 DESCRIPT 4-phenylbutyric acid up-regulates the expression of DME FAAH DME0208 XEOTICID XEO00584 GENEFORM mRNA DME0208 XEOTICID XEO00584 MOACRIVE Induction DME0208 XEOTICID XEO00639 XEO_NAME URB-597 DME0208 XEOTICID XEO00639 XEO_TYPE Pharmaceutical Agent(s) DME0208 XEOTICID XEO00639 XEO_CLAS Drug in Phase 1 Clinical Trial DME0208 XEOTICID XEO00639 DESCRIPT URB-597 inhibits the drug-metabolizing activity of DME FAAH (IC50 = 0.00024 microM) DME0208 XEOTICID XEO00639 GENEFORM Protein DME0208 XEOTICID XEO00639 MOACRIVE Inhibition DME0208 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0208 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0208 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0208 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME FAAH DME0208 XEOTICID XEO00898 GENEFORM mRNA DME0208 XEOTICID XEO00898 MOACRIVE Induction DME0208 XEOTICID XEO00930 XEO_NAME Butylparaben DME0208 XEOTICID XEO00930 XEO_TYPE Pharmaceutical Agent(s) DME0208 XEOTICID XEO00930 XEO_CLAS Investigative Agent DME0208 XEOTICID XEO00930 DESCRIPT Butylparaben inhibits the drug-metabolizing activity of DME FAAH DME0208 XEOTICID XEO00930 GENEFORM Protein DME0208 XEOTICID XEO00930 MOACRIVE Inhibition DME0208 XEOTICID XEO00932 XEO_NAME Heptylparaben DME0208 XEOTICID XEO00932 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0208 XEOTICID XEO00932 XEO_CLAS Food Additive DME0208 XEOTICID XEO00932 DESCRIPT Heptylparaben inhibits the drug-metabolizing activity of DME FAAH DME0208 XEOTICID XEO00932 GENEFORM Protein DME0208 XEOTICID XEO00932 MOACRIVE Inhibition DME0208 XEOTICID XEO00969 XEO_NAME Atrazine DME0208 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0208 XEOTICID XEO00969 XEO_CLAS Herbicide DME0208 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME FAAH DME0208 XEOTICID XEO00969 GENEFORM mRNA DME0208 XEOTICID XEO00969 MOACRIVE Induction DME0208 XEOTICID XEO01092 XEO_NAME RHC-80267 DME0208 XEOTICID XEO01092 XEO_TYPE Pharmaceutical Agent(s) DME0208 XEOTICID XEO01092 XEO_CLAS Preclinical/Patented Drug DME0208 XEOTICID XEO01092 DESCRIPT RHC-80267 inhibits the drug-metabolizing activity of DME FAAH in Human embryonic kidney 293 cell (HEK293T) (IC50 = 70 microM) DME0208 XEOTICID XEO01092 GENEFORM Protein DME0208 XEOTICID XEO01092 MOACRIVE Inhibition DME0208 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0208 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0208 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0208 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the drug-metabolizing activity of DME FAAH DME0208 XEOTICID XEO01226 GENEFORM Protein DME0208 XEOTICID XEO01226 MOACRIVE Inhibition DME0209 DME___ID DME0209 DME0209 DME_NAME Pyridoxamine-phosphate oxidase (PNPO) DME0209 SPESNAME Homo sapiens DME0209 XEOTICID XEO00029 XEO_NAME Valproic acid DME0209 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0209 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0209 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME PNPO DME0209 XEOTICID XEO00029 GENEFORM mRNA DME0209 XEOTICID XEO00029 MOACRIVE Induction DME0209 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0209 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0209 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0209 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME PNPO DME0209 XEOTICID XEO00217 GENEFORM mRNA DME0209 XEOTICID XEO00217 MOACRIVE Inhibition DME0209 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0209 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0209 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0209 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME PNPO DME0209 XEOTICID XEO00241 GENEFORM mRNA DME0209 XEOTICID XEO00241 MOACRIVE Inhibition DME0209 XEOTICID XEO00334 XEO_NAME Cisplatin DME0209 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0209 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0209 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME PNPO DME0209 XEOTICID XEO00334 GENEFORM mRNA DME0209 XEOTICID XEO00334 MOACRIVE Induction DME0209 XEOTICID XEO00581 XEO_NAME MS-275 DME0209 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0209 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0209 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME PNPO DME0209 XEOTICID XEO00581 GENEFORM mRNA DME0209 XEOTICID XEO00581 MOACRIVE Induction DME0209 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0209 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0209 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0209 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME PNPO DME0209 XEOTICID XEO00898 GENEFORM mRNA DME0209 XEOTICID XEO00898 MOACRIVE Induction DME0209 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0209 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0209 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0209 XEOTICID XEO01050 DESCRIPT Dicrotophos up-regulates the expression of DME PNPO DME0209 XEOTICID XEO01050 GENEFORM mRNA DME0209 XEOTICID XEO01050 MOACRIVE Induction DME0210 DME___ID DME0210 DME0210 DME_NAME Thioredoxin reductase TR1 (TXNRD1) DME0210 SPESNAME Homo sapiens DME0210 XEOTICID XEO00007 XEO_NAME Azathioprine DME0210 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00007 DESCRIPT Azathioprine up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00007 GENEFORM mRNA DME0210 XEOTICID XEO00007 MOACRIVE Induction DME0210 XEOTICID XEO00028 XEO_NAME Disulfiram DME0210 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00028 DESCRIPT Disulfiram up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00028 GENEFORM mRNA DME0210 XEOTICID XEO00028 MOACRIVE Induction DME0210 XEOTICID XEO00029 XEO_NAME Valproic acid DME0210 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME TXNRD1 DME0210 XEOTICID XEO00029 GENEFORM mRNA DME0210 XEOTICID XEO00029 MOACRIVE Inhibition DME0210 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0210 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00035 GENEFORM mRNA DME0210 XEOTICID XEO00035 MOACRIVE Induction DME0210 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0210 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00037 DESCRIPT Fluorouracil inhibits the expression of DME TXNRD1 DME0210 XEOTICID XEO00037 GENEFORM mRNA DME0210 XEOTICID XEO00037 MOACRIVE Inhibition DME0210 XEOTICID XEO00046 XEO_NAME Ifosfamide DME0210 XEOTICID XEO00046 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00046 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00046 DESCRIPT Ifosfamide up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00046 GENEFORM mRNA DME0210 XEOTICID XEO00046 MOACRIVE Induction DME0210 XEOTICID XEO00053 XEO_NAME Leflunomide DME0210 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00053 GENEFORM mRNA DME0210 XEOTICID XEO00053 MOACRIVE Induction DME0210 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0210 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00088 GENEFORM mRNA DME0210 XEOTICID XEO00088 MOACRIVE Induction DME0210 XEOTICID XEO00090 XEO_NAME Estradiol DME0210 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00090 GENEFORM mRNA DME0210 XEOTICID XEO00090 MOACRIVE Induction DME0210 XEOTICID XEO00115 XEO_NAME Dronabinol DME0210 XEOTICID XEO00115 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00115 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00115 DESCRIPT Dronabinol up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00115 GENEFORM mRNA DME0210 XEOTICID XEO00115 MOACRIVE Induction DME0210 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0210 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00117 GENEFORM mRNA DME0210 XEOTICID XEO00117 MOACRIVE Induction DME0210 XEOTICID XEO00126 XEO_NAME Raloxifene hydrochloride DME0210 XEOTICID XEO00126 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00126 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00126 DESCRIPT Raloxifene hydrochloride inhibits the expression of DME TXNRD1 DME0210 XEOTICID XEO00126 GENEFORM mRNA DME0210 XEOTICID XEO00126 MOACRIVE Inhibition DME0210 XEOTICID XEO00132 XEO_NAME Cidofovir DME0210 XEOTICID XEO00132 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00132 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00132 DESCRIPT Cidofovir up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00132 GENEFORM mRNA DME0210 XEOTICID XEO00132 MOACRIVE Induction DME0210 XEOTICID XEO00135 XEO_NAME Ferric citrate DME0210 XEOTICID XEO00135 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00135 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00135 DESCRIPT Ferric citrate up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00135 GENEFORM mRNA DME0210 XEOTICID XEO00135 MOACRIVE Induction DME0210 XEOTICID XEO00147 XEO_NAME Fulvestrant DME0210 XEOTICID XEO00147 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00147 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00147 DESCRIPT Fulvestrant inhibits the expression of DME TXNRD1 DME0210 XEOTICID XEO00147 GENEFORM mRNA DME0210 XEOTICID XEO00147 MOACRIVE Inhibition DME0210 XEOTICID XEO00148 XEO_NAME Bosentan DME0210 XEOTICID XEO00148 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00148 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00148 DESCRIPT Bosentan up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00148 GENEFORM mRNA DME0210 XEOTICID XEO00148 MOACRIVE Induction DME0210 XEOTICID XEO00184 XEO_NAME Calcitriol DME0210 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00184 GENEFORM mRNA DME0210 XEOTICID XEO00184 MOACRIVE Induction DME0210 XEOTICID XEO00213 XEO_NAME Aspirin DME0210 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00213 DESCRIPT Aspirin inhibits the expression of DME TXNRD1 DME0210 XEOTICID XEO00213 GENEFORM mRNA DME0210 XEOTICID XEO00213 MOACRIVE Inhibition DME0210 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0210 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00217 DESCRIPT Acetaminophen induces the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO00217 GENEFORM Protein DME0210 XEOTICID XEO00217 MOACRIVE Induction DME0210 XEOTICID XEO00218 XEO_NAME Caffeine DME0210 XEOTICID XEO00218 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00218 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00218 DESCRIPT Caffeine inhibits the expression of DME TXNRD1 DME0210 XEOTICID XEO00218 GENEFORM mRNA DME0210 XEOTICID XEO00218 MOACRIVE Inhibition DME0210 XEOTICID XEO00224 XEO_NAME Isoniazid DME0210 XEOTICID XEO00224 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00224 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00224 DESCRIPT Isoniazid up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00224 GENEFORM mRNA DME0210 XEOTICID XEO00224 MOACRIVE Induction DME0210 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0210 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00241 GENEFORM mRNA DME0210 XEOTICID XEO00241 MOACRIVE Induction DME0210 XEOTICID XEO00270 XEO_NAME Auranofin DME0210 XEOTICID XEO00270 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00270 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00270 DESCRIPT Auranof DMEin inhibits the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO00270 GENEFORM Protein DME0210 XEOTICID XEO00270 MOACRIVE Inhibition DME0210 XEOTICID XEO00324 XEO_NAME Selenomethionine Se-75 DME0210 XEOTICID XEO00324 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00324 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00324 DESCRIPT Selenomethionine Se-75 induces the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO00324 GENEFORM Protein DME0210 XEOTICID XEO00324 MOACRIVE Induction DME0210 XEOTICID XEO00325 XEO_NAME Sorafenib tosylate DME0210 XEOTICID XEO00325 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00325 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00325 DESCRIPT Sorafenib tosylate up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00325 GENEFORM mRNA DME0210 XEOTICID XEO00325 MOACRIVE Induction DME0210 XEOTICID XEO00334 XEO_NAME Cisplatin DME0210 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO00334 GENEFORM Protein DME0210 XEOTICID XEO00334 MOACRIVE Inhibition DME0210 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0210 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO00339 GENEFORM Protein DME0210 XEOTICID XEO00339 MOACRIVE Inhibition DME0210 XEOTICID XEO00366 XEO_NAME Methotrexate DME0210 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00366 DESCRIPT Methotrexate up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00366 GENEFORM mRNA DME0210 XEOTICID XEO00366 MOACRIVE Induction DME0210 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0210 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the expression of DME TXNRD1 DME0210 XEOTICID XEO00388 GENEFORM mRNA DME0210 XEOTICID XEO00388 MOACRIVE Inhibition DME0210 XEOTICID XEO00407 XEO_NAME Cupric chloride DME0210 XEOTICID XEO00407 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00407 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00407 DESCRIPT Cupric chloride up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00407 GENEFORM mRNA DME0210 XEOTICID XEO00407 MOACRIVE Induction DME0210 XEOTICID XEO00408 XEO_NAME Zinc acetate DME0210 XEOTICID XEO00408 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00408 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00408 DESCRIPT Zinc acetate up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00408 GENEFORM mRNA DME0210 XEOTICID XEO00408 MOACRIVE Induction DME0210 XEOTICID XEO00411 XEO_NAME Avobenzone DME0210 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00411 GENEFORM mRNA DME0210 XEOTICID XEO00411 MOACRIVE Induction DME0210 XEOTICID XEO00428 XEO_NAME Menadione DME0210 XEOTICID XEO00428 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00428 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00428 DESCRIPT Menadione up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00428 GENEFORM mRNA DME0210 XEOTICID XEO00428 MOACRIVE Induction DME0210 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0210 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00430 DESCRIPT Hydroquinone up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00430 GENEFORM mRNA DME0210 XEOTICID XEO00430 MOACRIVE Induction DME0210 XEOTICID XEO00442 XEO_NAME Chlorobenzene DME0210 XEOTICID XEO00442 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00442 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00442 DESCRIPT Chlorobenzene up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00442 GENEFORM mRNA DME0210 XEOTICID XEO00442 MOACRIVE Induction DME0210 XEOTICID XEO00447 XEO_NAME Benzoic acid DME0210 XEOTICID XEO00447 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00447 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00447 DESCRIPT Benzoic acid up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00447 GENEFORM mRNA DME0210 XEOTICID XEO00447 MOACRIVE Induction DME0210 XEOTICID XEO00465 XEO_NAME Clodronic acid DME0210 XEOTICID XEO00465 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00465 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00465 DESCRIPT Clodronic acid up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00465 GENEFORM mRNA DME0210 XEOTICID XEO00465 MOACRIVE Induction DME0210 XEOTICID XEO00469 XEO_NAME Floxacillin DME0210 XEOTICID XEO00469 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00469 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00469 DESCRIPT Floxacillin up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00469 GENEFORM mRNA DME0210 XEOTICID XEO00469 MOACRIVE Induction DME0210 XEOTICID XEO00510 XEO_NAME Gamolenic acid DME0210 XEOTICID XEO00510 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00510 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00510 DESCRIPT Gamolenic acid up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00510 GENEFORM mRNA DME0210 XEOTICID XEO00510 MOACRIVE Induction DME0210 XEOTICID XEO00527 XEO_NAME Aurothioglucose DME0210 XEOTICID XEO00527 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00527 XEO_CLAS Drug Marketed but Withdrawn from Market DME0210 XEOTICID XEO00527 DESCRIPT Aurothioglucose inhibits the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO00527 GENEFORM Protein DME0210 XEOTICID XEO00527 MOACRIVE Inhibition DME0210 XEOTICID XEO00538 XEO_NAME Quercetin DME0210 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0210 XEOTICID XEO00538 DESCRIPT Quercetin up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00538 GENEFORM mRNA DME0210 XEOTICID XEO00538 MOACRIVE Induction DME0210 XEOTICID XEO00557 XEO_NAME Genistein DME0210 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0210 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00557 GENEFORM mRNA DME0210 XEOTICID XEO00557 MOACRIVE Induction DME0210 XEOTICID XEO00568 XEO_NAME Resveratrol DME0210 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0210 XEOTICID XEO00568 DESCRIPT Resveratrol induces the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO00568 GENEFORM Protein DME0210 XEOTICID XEO00568 MOACRIVE Induction DME0210 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0210 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0210 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00571 GENEFORM mRNA DME0210 XEOTICID XEO00571 MOACRIVE Induction DME0210 XEOTICID XEO00596 XEO_NAME Phenethyl isothiocyanate DME0210 XEOTICID XEO00596 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00596 XEO_CLAS Drug in Phase 2 Clinical Trial DME0210 XEOTICID XEO00596 DESCRIPT Phenethyl isothiocyanate induces the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO00596 GENEFORM Protein DME0210 XEOTICID XEO00596 MOACRIVE Induction DME0210 XEOTICID XEO00610 XEO_NAME Afimoxifene DME0210 XEOTICID XEO00610 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00610 XEO_CLAS Drug in Phase 3 Clinical Trial DME0210 XEOTICID XEO00610 DESCRIPT Afimoxifene inhibits the expression of DME TXNRD1 DME0210 XEOTICID XEO00610 GENEFORM mRNA DME0210 XEOTICID XEO00610 MOACRIVE Inhibition DME0210 XEOTICID XEO00629 XEO_NAME STA-4783 DME0210 XEOTICID XEO00629 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00629 XEO_CLAS Drug in Phase 2 Clinical Trial DME0210 XEOTICID XEO00629 DESCRIPT STA-4783 up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00629 GENEFORM mRNA DME0210 XEOTICID XEO00629 MOACRIVE Induction DME0210 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0210 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0210 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00632 GENEFORM mRNA DME0210 XEOTICID XEO00632 MOACRIVE Induction DME0210 XEOTICID XEO00652 XEO_NAME Seocalcitol DME0210 XEOTICID XEO00652 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00652 XEO_CLAS Drug in Phase 3 Clinical Trial DME0210 XEOTICID XEO00652 DESCRIPT Seocalcitol up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00652 GENEFORM mRNA DME0210 XEOTICID XEO00652 MOACRIVE Induction DME0210 XEOTICID XEO00657 XEO_NAME Antimony DME0210 XEOTICID XEO00657 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00657 XEO_CLAS Drug in Phase 2 Clinical Trial DME0210 XEOTICID XEO00657 DESCRIPT Antimony up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00657 GENEFORM mRNA DME0210 XEOTICID XEO00657 MOACRIVE Induction DME0210 XEOTICID XEO00673 XEO_NAME ZIO-101 DME0210 XEOTICID XEO00673 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00673 XEO_CLAS Drug in Phase 2 Clinical Trial DME0210 XEOTICID XEO00673 DESCRIPT ZIO-101 up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00673 GENEFORM mRNA DME0210 XEOTICID XEO00673 MOACRIVE Induction DME0210 XEOTICID XEO00683 XEO_NAME Curcumin DME0210 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0210 XEOTICID XEO00683 DESCRIPT Curcumin up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00683 GENEFORM mRNA DME0210 XEOTICID XEO00683 MOACRIVE Induction DME0210 XEOTICID XEO00692 XEO_NAME Emodin DME0210 XEOTICID XEO00692 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00692 XEO_CLAS Preclinical/Patented Drug DME0210 XEOTICID XEO00692 DESCRIPT Emodin inhibits the expression of DME TXNRD1 DME0210 XEOTICID XEO00692 GENEFORM mRNA DME0210 XEOTICID XEO00692 MOACRIVE Inhibition DME0210 XEOTICID XEO00706 XEO_NAME Tripterine DME0210 XEOTICID XEO00706 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00706 XEO_CLAS Preclinical/Patented Drug DME0210 XEOTICID XEO00706 DESCRIPT Tripterine up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00706 GENEFORM mRNA DME0210 XEOTICID XEO00706 MOACRIVE Induction DME0210 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0210 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0210 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00723 GENEFORM mRNA DME0210 XEOTICID XEO00723 MOACRIVE Induction DME0210 XEOTICID XEO00789 XEO_NAME Iberin DME0210 XEOTICID XEO00789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0210 XEOTICID XEO00789 XEO_CLAS Natural Product DME0210 XEOTICID XEO00789 DESCRIPT Iberin up-regulates the expression of DME TXNRD1 and leads to increasing the drug-metabolizing activity of this enzyme DME0210 XEOTICID XEO00789 GENEFORM Protein DME0210 XEOTICID XEO00789 MOACRIVE Induction DME0210 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0210 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0210 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00806 GENEFORM mRNA DME0210 XEOTICID XEO00806 MOACRIVE Induction DME0210 XEOTICID XEO00807 XEO_NAME Chlorite DME0210 XEOTICID XEO00807 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00807 XEO_CLAS Investigative Agent DME0210 XEOTICID XEO00807 DESCRIPT Chlorite inhibits the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO00807 GENEFORM Protein DME0210 XEOTICID XEO00807 MOACRIVE Inhibition DME0210 XEOTICID XEO00834 XEO_NAME Copper DME0210 XEOTICID XEO00834 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00834 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO00834 DESCRIPT Copper up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00834 GENEFORM mRNA DME0210 XEOTICID XEO00834 MOACRIVE Induction DME0210 XEOTICID XEO00852 XEO_NAME Allyl isothiocyanate DME0210 XEOTICID XEO00852 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO00852 XEO_CLAS Acute Toxic Substance DME0210 XEOTICID XEO00852 DESCRIPT Allyl isothiocyanate inhibits the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO00852 GENEFORM Protein DME0210 XEOTICID XEO00852 MOACRIVE Inhibition DME0210 XEOTICID XEO00885 XEO_NAME Eugenol DME0210 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0210 XEOTICID XEO00885 DESCRIPT Eugenol up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00885 GENEFORM mRNA DME0210 XEOTICID XEO00885 MOACRIVE Induction DME0210 XEOTICID XEO00890 XEO_NAME 2-methyl-4-isothiazolin-3-one DME0210 XEOTICID XEO00890 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO00890 XEO_CLAS Acute Toxic Substance DME0210 XEOTICID XEO00890 DESCRIPT 2-methyl-4-isothiazolin-3-one up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00890 GENEFORM mRNA DME0210 XEOTICID XEO00890 MOACRIVE Induction DME0210 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0210 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0210 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00898 GENEFORM mRNA DME0210 XEOTICID XEO00898 MOACRIVE Induction DME0210 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0210 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0210 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00905 GENEFORM mRNA DME0210 XEOTICID XEO00905 MOACRIVE Induction DME0210 XEOTICID XEO00919 XEO_NAME Particulate matter DME0210 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0210 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0210 XEOTICID XEO00919 DESCRIPT Particulate matter inhibits the expression of DME TXNRD1 DME0210 XEOTICID XEO00919 GENEFORM mRNA DME0210 XEOTICID XEO00919 MOACRIVE Inhibition DME0210 XEOTICID XEO00964 XEO_NAME Uranium DME0210 XEOTICID XEO00964 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO00964 XEO_CLAS Acute Toxic Substance DME0210 XEOTICID XEO00964 DESCRIPT Uranium up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00964 GENEFORM mRNA DME0210 XEOTICID XEO00964 MOACRIVE Induction DME0210 XEOTICID XEO00971 XEO_NAME Diquat DME0210 XEOTICID XEO00971 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0210 XEOTICID XEO00971 XEO_CLAS Herbicide DME0210 XEOTICID XEO00971 DESCRIPT Diquat up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00971 GENEFORM mRNA DME0210 XEOTICID XEO00971 MOACRIVE Induction DME0210 XEOTICID XEO00985 XEO_NAME Hexyl cinnamic aldehyde DME0210 XEOTICID XEO00985 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO00985 XEO_CLAS Environmental Pollutant DME0210 XEOTICID XEO00985 DESCRIPT Hexyl cinnamic aldehyde up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO00985 GENEFORM mRNA DME0210 XEOTICID XEO00985 MOACRIVE Induction DME0210 XEOTICID XEO01006 XEO_NAME Dimethyl nitrosamine DME0210 XEOTICID XEO01006 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01006 XEO_CLAS Carcinogen DME0210 XEOTICID XEO01006 DESCRIPT Dimethyl nitrosamine up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01006 GENEFORM mRNA DME0210 XEOTICID XEO01006 MOACRIVE Induction DME0210 XEOTICID XEO01009 XEO_NAME Glycidamide DME0210 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0210 XEOTICID XEO01009 DESCRIPT Glycidamide up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01009 GENEFORM mRNA DME0210 XEOTICID XEO01009 MOACRIVE Induction DME0210 XEOTICID XEO01016 XEO_NAME N-hexane DME0210 XEOTICID XEO01016 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01016 XEO_CLAS Health Hazard/Toxicant DME0210 XEOTICID XEO01016 DESCRIPT N-hexane up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01016 GENEFORM mRNA DME0210 XEOTICID XEO01016 MOACRIVE Induction DME0210 XEOTICID XEO01023 XEO_NAME Sodium arsenate DME0210 XEOTICID XEO01023 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01023 XEO_CLAS Environmental Pollutant DME0210 XEOTICID XEO01023 DESCRIPT Sodium arsenate up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01023 GENEFORM mRNA DME0210 XEOTICID XEO01023 MOACRIVE Induction DME0210 XEOTICID XEO01032 XEO_NAME Zinc oxide DME0210 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME0210 XEOTICID XEO01032 DESCRIPT Zinc oxide up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01032 GENEFORM mRNA DME0210 XEOTICID XEO01032 MOACRIVE Induction DME0210 XEOTICID XEO01080 XEO_NAME Ethaselen DME0210 XEOTICID XEO01080 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO01080 XEO_CLAS Drug in Phase 1 Clinical Trial DME0210 XEOTICID XEO01080 DESCRIPT Ethaselen inhibits the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO01080 GENEFORM Protein DME0210 XEOTICID XEO01080 MOACRIVE Inhibition DME0210 XEOTICID XEO01089 XEO_NAME 1,4-naphthoquinone DME0210 XEOTICID XEO01089 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01089 XEO_CLAS Acute Toxic Substance DME0210 XEOTICID XEO01089 DESCRIPT 1,4-naphthoquinone up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01089 GENEFORM mRNA DME0210 XEOTICID XEO01089 MOACRIVE Induction DME0210 XEOTICID XEO01093 XEO_NAME 1,6-hexamethylene diisocyanate DME0210 XEOTICID XEO01093 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01093 XEO_CLAS Acute Toxic Substance DME0210 XEOTICID XEO01093 DESCRIPT 1,6-hexamethylene diisocyanate up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01093 GENEFORM mRNA DME0210 XEOTICID XEO01093 MOACRIVE Induction DME0210 XEOTICID XEO01122 XEO_NAME 2-butenal DME0210 XEOTICID XEO01122 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01122 XEO_CLAS Acute Toxic Substance DME0210 XEOTICID XEO01122 DESCRIPT 2-butenal up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01122 GENEFORM mRNA DME0210 XEOTICID XEO01122 MOACRIVE Induction DME0210 XEOTICID XEO01128 XEO_NAME Isopropanol DME0210 XEOTICID XEO01128 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO01128 XEO_CLAS Investigative Agent DME0210 XEOTICID XEO01128 DESCRIPT Isopropanol up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01128 GENEFORM mRNA DME0210 XEOTICID XEO01128 MOACRIVE Induction DME0210 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0210 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0210 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01129 GENEFORM mRNA DME0210 XEOTICID XEO01129 MOACRIVE Induction DME0210 XEOTICID XEO01171 XEO_NAME 7,8-diacetoxy-4-methylcoumarin DME0210 XEOTICID XEO01171 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO01171 XEO_CLAS Investigative Agent DME0210 XEOTICID XEO01171 DESCRIPT 7,8-diacetoxy-4-methylcoumarin up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01171 GENEFORM mRNA DME0210 XEOTICID XEO01171 MOACRIVE Induction DME0210 XEOTICID XEO01173 XEO_NAME 7-aminocephalosporanic acid DME0210 XEOTICID XEO01173 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01173 XEO_CLAS Health Hazard/Toxicant DME0210 XEOTICID XEO01173 DESCRIPT 7-aminocephalosporanic acid up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01173 GENEFORM mRNA DME0210 XEOTICID XEO01173 MOACRIVE Induction DME0210 XEOTICID XEO01186 XEO_NAME Acrolein DME0210 XEOTICID XEO01186 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01186 XEO_CLAS Acute Toxic Substance DME0210 XEOTICID XEO01186 DESCRIPT Acrolein inhibits the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO01186 GENEFORM Protein DME0210 XEOTICID XEO01186 MOACRIVE Inhibition DME0210 XEOTICID XEO01201 XEO_NAME Antimony potassium tartrate DME0210 XEOTICID XEO01201 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01201 XEO_CLAS Environmental Pollutant DME0210 XEOTICID XEO01201 DESCRIPT Antimony potassium tartrate up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01201 GENEFORM mRNA DME0210 XEOTICID XEO01201 MOACRIVE Induction DME0210 XEOTICID XEO01217 XEO_NAME Benzyl isothiocyanate DME0210 XEOTICID XEO01217 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0210 XEOTICID XEO01217 XEO_CLAS Natural Product DME0210 XEOTICID XEO01217 DESCRIPT Benzyl isothiocyanate inhibits the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO01217 GENEFORM Protein DME0210 XEOTICID XEO01217 MOACRIVE Inhibition DME0210 XEOTICID XEO01219 XEO_NAME MG-132 DME0210 XEOTICID XEO01219 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO01219 XEO_CLAS Investigative Agent DME0210 XEOTICID XEO01219 DESCRIPT MG-132 up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01219 GENEFORM mRNA DME0210 XEOTICID XEO01219 MOACRIVE Induction DME0210 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0210 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0210 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01220 GENEFORM mRNA DME0210 XEOTICID XEO01220 MOACRIVE Induction DME0210 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0210 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0210 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01226 GENEFORM mRNA DME0210 XEOTICID XEO01226 MOACRIVE Induction DME0210 XEOTICID XEO01229 XEO_NAME Buthionine sulfoximine DME0210 XEOTICID XEO01229 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO01229 XEO_CLAS Drug in Phase 1 Clinical Trial DME0210 XEOTICID XEO01229 DESCRIPT Buthionine sulfoximine up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01229 GENEFORM mRNA DME0210 XEOTICID XEO01229 MOACRIVE Induction DME0210 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0210 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0210 XEOTICID XEO01247 DESCRIPT Chloropicrin up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01247 GENEFORM mRNA DME0210 XEOTICID XEO01247 MOACRIVE Induction DME0210 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME0210 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0210 XEOTICID XEO01253 XEO_CLAS Natural Product DME0210 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde induces the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO01253 GENEFORM Protein DME0210 XEOTICID XEO01253 MOACRIVE Induction DME0210 XEOTICID XEO01285 XEO_NAME Edetic acid DME0210 XEOTICID XEO01285 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO01285 XEO_CLAS Approved/Marketed Drug DME0210 XEOTICID XEO01285 DESCRIPT Edetic acid induces the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO01285 GENEFORM Protein DME0210 XEOTICID XEO01285 MOACRIVE Induction DME0210 XEOTICID XEO01311 XEO_NAME Gedunin DME0210 XEOTICID XEO01311 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0210 XEOTICID XEO01311 XEO_CLAS Natural Product DME0210 XEOTICID XEO01311 DESCRIPT Gedunin up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01311 GENEFORM mRNA DME0210 XEOTICID XEO01311 MOACRIVE Induction DME0210 XEOTICID XEO01336 XEO_NAME ICG-001 DME0210 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0210 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME TXNRD1 DME0210 XEOTICID XEO01336 GENEFORM mRNA DME0210 XEOTICID XEO01336 MOACRIVE Inhibition DME0210 XEOTICID XEO01348 XEO_NAME K-7174 DME0210 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0210 XEOTICID XEO01348 DESCRIPT K-7174 up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01348 GENEFORM mRNA DME0210 XEOTICID XEO01348 MOACRIVE Induction DME0210 XEOTICID XEO01376 XEO_NAME Methyl salicylate DME0210 XEOTICID XEO01376 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO01376 XEO_CLAS Drug in Phase 1 Clinical Trial DME0210 XEOTICID XEO01376 DESCRIPT Methyl salicylate up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01376 GENEFORM mRNA DME0210 XEOTICID XEO01376 MOACRIVE Induction DME0210 XEOTICID XEO01380 XEO_NAME Mono-(2-ethylhexyl)phthalate DME0210 XEOTICID XEO01380 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO01380 XEO_CLAS Investigative Agent DME0210 XEOTICID XEO01380 DESCRIPT Mono-(2-ethylhexyl)phthalate induces the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO01380 GENEFORM Protein DME0210 XEOTICID XEO01380 MOACRIVE Induction DME0210 XEOTICID XEO01397 XEO_NAME Nickel chloride DME0210 XEOTICID XEO01397 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01397 XEO_CLAS Acute Toxic Substance DME0210 XEOTICID XEO01397 DESCRIPT Nickel chloride up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01397 GENEFORM mRNA DME0210 XEOTICID XEO01397 MOACRIVE Induction DME0210 XEOTICID XEO01478 XEO_NAME Sulforafan DME0210 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0210 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0210 XEOTICID XEO01478 DESCRIPT Sulforafan inhibits the expression of DME TXNRD1 DME0210 XEOTICID XEO01478 GENEFORM mRNA DME0210 XEOTICID XEO01478 MOACRIVE Inhibition DME0210 XEOTICID XEO01503 XEO_NAME Cadmium DME0210 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0210 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01503 GENEFORM mRNA DME0210 XEOTICID XEO01503 MOACRIVE Induction DME0210 XEOTICID XEO01504 XEO_NAME Gold DME0210 XEOTICID XEO01504 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0210 XEOTICID XEO01504 XEO_CLAS Chemical Compound DME0210 XEOTICID XEO01504 DESCRIPT Gold inhibits the drug-metabolizing activity of DME TXNRD1 DME0210 XEOTICID XEO01504 GENEFORM Protein DME0210 XEOTICID XEO01504 MOACRIVE Inhibition DME0210 XEOTICID XEO01508 XEO_NAME Mercuric chloride DME0210 XEOTICID XEO01508 XEO_TYPE Health or Environmental Toxicant(s) DME0210 XEOTICID XEO01508 XEO_CLAS Acute Toxic Substance DME0210 XEOTICID XEO01508 DESCRIPT Mercuric chloride up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01508 GENEFORM mRNA DME0210 XEOTICID XEO01508 MOACRIVE Induction DME0210 XEOTICID XEO01553 XEO_NAME Isoflavone DME0210 XEOTICID XEO01553 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0210 XEOTICID XEO01553 XEO_CLAS Natural Product DME0210 XEOTICID XEO01553 DESCRIPT Isoflavone up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01553 GENEFORM mRNA DME0210 XEOTICID XEO01553 MOACRIVE Induction DME0210 XEOTICID XEO01574 XEO_NAME Plant extracts DME0210 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0210 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0210 XEOTICID XEO01574 DESCRIPT Plant extracts up-regulates the expression of DME TXNRD1 DME0210 XEOTICID XEO01574 GENEFORM mRNA DME0210 XEOTICID XEO01574 MOACRIVE Induction DME0211 DME___ID DME0211 DME0211 DME_NAME Selenocysteine lyase (SCLY) DME0211 SPESNAME Homo sapiens DME0211 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0211 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0211 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0211 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME SCLY DME0211 XEOTICID XEO00217 GENEFORM mRNA DME0211 XEOTICID XEO00217 MOACRIVE Inhibition DME0211 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0211 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0211 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0211 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME SCLY DME0211 XEOTICID XEO00241 GENEFORM mRNA DME0211 XEOTICID XEO00241 MOACRIVE Inhibition DME0211 XEOTICID XEO00253 XEO_NAME Tretinoin DME0211 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0211 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0211 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME SCLY DME0211 XEOTICID XEO00253 GENEFORM mRNA DME0211 XEOTICID XEO00253 MOACRIVE Inhibition DME0211 XEOTICID XEO00334 XEO_NAME Cisplatin DME0211 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0211 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0211 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME SCLY DME0211 XEOTICID XEO00334 GENEFORM mRNA DME0211 XEOTICID XEO00334 MOACRIVE Inhibition DME0211 XEOTICID XEO00392 XEO_NAME Vincristine DME0211 XEOTICID XEO00392 XEO_TYPE Pharmaceutical Agent(s) DME0211 XEOTICID XEO00392 XEO_CLAS Approved/Marketed Drug DME0211 XEOTICID XEO00392 DESCRIPT Vincristine inhibits the expression of DME SCLY DME0211 XEOTICID XEO00392 GENEFORM mRNA DME0211 XEOTICID XEO00392 MOACRIVE Inhibition DME0211 XEOTICID XEO00466 XEO_NAME Demecolcine DME0211 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0211 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0211 XEOTICID XEO00466 DESCRIPT Demecolcine inhibits the expression of DME SCLY DME0211 XEOTICID XEO00466 GENEFORM mRNA DME0211 XEOTICID XEO00466 MOACRIVE Inhibition DME0211 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0211 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0211 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0211 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME SCLY DME0211 XEOTICID XEO00772 GENEFORM mRNA DME0211 XEOTICID XEO00772 MOACRIVE Inhibition DME0211 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0211 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0211 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0211 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME SCLY DME0211 XEOTICID XEO01305 GENEFORM mRNA DME0211 XEOTICID XEO01305 MOACRIVE Inhibition DME0211 XEOTICID XEO01348 XEO_NAME K-7174 DME0211 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0211 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0211 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME SCLY DME0211 XEOTICID XEO01348 GENEFORM mRNA DME0211 XEOTICID XEO01348 MOACRIVE Inhibition DME0212 DME___ID DME0212 DME0212 DME_NAME Acetyl-CoA synthetase (ACSS2) DME0212 SPESNAME Homo sapiens DME0212 XEOTICID XEO00029 XEO_NAME Valproic acid DME0212 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0212 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0212 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME ACSS2 DME0212 XEOTICID XEO00029 GENEFORM mRNA DME0212 XEOTICID XEO00029 MOACRIVE Inhibition DME0212 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0212 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0212 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0212 XEOTICID XEO00035 DESCRIPT Fenofibrate inhibits the expression of DME ACSS2 DME0212 XEOTICID XEO00035 GENEFORM mRNA DME0212 XEOTICID XEO00035 MOACRIVE Inhibition DME0212 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0212 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0212 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0212 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME ACSS2 DME0212 XEOTICID XEO00088 GENEFORM mRNA DME0212 XEOTICID XEO00088 MOACRIVE Induction DME0212 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0212 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0212 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0212 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME ACSS2 DME0212 XEOTICID XEO00117 GENEFORM mRNA DME0212 XEOTICID XEO00117 MOACRIVE Inhibition DME0212 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0212 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0212 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0212 XEOTICID XEO00140 DESCRIPT Zoledronic acid up-regulates the expression of DME ACSS2 DME0212 XEOTICID XEO00140 GENEFORM mRNA DME0212 XEOTICID XEO00140 MOACRIVE Induction DME0212 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0212 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0212 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0212 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ACSS2 DME0212 XEOTICID XEO00217 GENEFORM mRNA DME0212 XEOTICID XEO00217 MOACRIVE Inhibition DME0212 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0212 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0212 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0212 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME ACSS2 DME0212 XEOTICID XEO00241 GENEFORM mRNA DME0212 XEOTICID XEO00241 MOACRIVE Induction DME0212 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0212 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0212 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0212 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME ACSS2 DME0212 XEOTICID XEO00292 GENEFORM mRNA DME0212 XEOTICID XEO00292 MOACRIVE Inhibition DME0212 XEOTICID XEO00334 XEO_NAME Cisplatin DME0212 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0212 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0212 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME ACSS2 DME0212 XEOTICID XEO00334 GENEFORM mRNA DME0212 XEOTICID XEO00334 MOACRIVE Induction DME0212 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0212 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0212 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0212 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME ACSS2 DME0212 XEOTICID XEO00339 GENEFORM mRNA DME0212 XEOTICID XEO00339 MOACRIVE Inhibition DME0212 XEOTICID XEO00366 XEO_NAME Methotrexate DME0212 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0212 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0212 XEOTICID XEO00366 DESCRIPT Methotrexate up-regulates the expression of DME ACSS2 DME0212 XEOTICID XEO00366 GENEFORM mRNA DME0212 XEOTICID XEO00366 MOACRIVE Induction DME0212 XEOTICID XEO00411 XEO_NAME Avobenzone DME0212 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0212 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0212 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME ACSS2 DME0212 XEOTICID XEO00411 GENEFORM mRNA DME0212 XEOTICID XEO00411 MOACRIVE Induction DME0212 XEOTICID XEO00435 XEO_NAME Urethane DME0212 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0212 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0212 XEOTICID XEO00435 DESCRIPT Urethane inhibits the drug-metabolizing activity of DME ACSS2 DME0212 XEOTICID XEO00435 GENEFORM Protein DME0212 XEOTICID XEO00435 MOACRIVE Inhibition DME0212 XEOTICID XEO00481 XEO_NAME Rotenone DME0212 XEOTICID XEO00481 XEO_TYPE Pharmaceutical Agent(s) DME0212 XEOTICID XEO00481 XEO_CLAS Approved/Marketed Drug DME0212 XEOTICID XEO00481 DESCRIPT Rotenone induces the drug-metabolizing activity of DME ACSS2 DME0212 XEOTICID XEO00481 GENEFORM Protein DME0212 XEOTICID XEO00481 MOACRIVE Induction DME0212 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0212 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0212 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0212 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME ACSS2 DME0212 XEOTICID XEO00806 GENEFORM mRNA DME0212 XEOTICID XEO00806 MOACRIVE Inhibition DME0212 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0212 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0212 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0212 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME ACSS2 DME0212 XEOTICID XEO00898 GENEFORM mRNA DME0212 XEOTICID XEO00898 MOACRIVE Inhibition DME0212 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0212 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0212 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0212 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the drug-metabolizing activity of DME ACSS2 DME0212 XEOTICID XEO01004 GENEFORM Protein DME0212 XEOTICID XEO01004 MOACRIVE Inhibition DME0213 DME___ID DME0213 DME0213 DME_NAME Hydroxyacid-oxoacid transhydrogenase (ADHFE1) DME0213 SPESNAME Homo sapiens DME0213 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0213 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0213 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0213 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME ADHFE1 DME0213 XEOTICID XEO00217 GENEFORM mRNA DME0213 XEOTICID XEO00217 MOACRIVE Induction DME0213 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0213 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0213 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0213 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME ADHFE1 DME0213 XEOTICID XEO00241 GENEFORM mRNA DME0213 XEOTICID XEO00241 MOACRIVE Induction DME0213 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0213 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0213 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0213 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME ADHFE1 DME0213 XEOTICID XEO00292 GENEFORM mRNA DME0213 XEOTICID XEO00292 MOACRIVE Inhibition DME0213 XEOTICID XEO00334 XEO_NAME Cisplatin DME0213 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0213 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0213 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME ADHFE1 DME0213 XEOTICID XEO00334 GENEFORM mRNA DME0213 XEOTICID XEO00334 MOACRIVE Induction DME0213 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0213 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0213 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0213 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME ADHFE1 DME0213 XEOTICID XEO00806 GENEFORM mRNA DME0213 XEOTICID XEO00806 MOACRIVE Inhibition DME0213 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0213 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0213 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0213 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME ADHFE1 DME0213 XEOTICID XEO00898 GENEFORM mRNA DME0213 XEOTICID XEO00898 MOACRIVE Inhibition DME0213 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0213 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0213 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0213 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME ADHFE1 DME0213 XEOTICID XEO01226 GENEFORM mRNA DME0213 XEOTICID XEO01226 MOACRIVE Induction DME0213 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0213 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0213 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0213 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME ADHFE1 DME0213 XEOTICID XEO01324 GENEFORM mRNA DME0213 XEOTICID XEO01324 MOACRIVE Inhibition DME0214 DME___ID DME0214 DME0214 DME_NAME Succinate-semialdehyde dehydrogenase (ALDH5A1) DME0214 SPESNAME Homo sapiens DME0214 XEOTICID XEO00029 XEO_NAME Valproic acid DME0214 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0214 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0214 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME ALDH5A1 DME0214 XEOTICID XEO00029 GENEFORM mRNA DME0214 XEOTICID XEO00029 MOACRIVE Inhibition DME0214 XEOTICID XEO00053 XEO_NAME Leflunomide DME0214 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0214 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0214 XEOTICID XEO00053 DESCRIPT Leflunomide inhibits the expression of DME ALDH5A1 DME0214 XEOTICID XEO00053 GENEFORM mRNA DME0214 XEOTICID XEO00053 MOACRIVE Inhibition DME0214 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0214 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0214 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0214 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME ALDH5A1 DME0214 XEOTICID XEO00117 GENEFORM mRNA DME0214 XEOTICID XEO00117 MOACRIVE Inhibition DME0214 XEOTICID XEO00159 XEO_NAME Bortezomib DME0214 XEOTICID XEO00159 XEO_TYPE Pharmaceutical Agent(s) DME0214 XEOTICID XEO00159 XEO_CLAS Approved/Marketed Drug DME0214 XEOTICID XEO00159 DESCRIPT Bortezomib inhibits the expression of DME ALDH5A1 DME0214 XEOTICID XEO00159 GENEFORM mRNA DME0214 XEOTICID XEO00159 MOACRIVE Inhibition DME0214 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0214 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0214 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0214 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ALDH5A1 DME0214 XEOTICID XEO00217 GENEFORM mRNA DME0214 XEOTICID XEO00217 MOACRIVE Inhibition DME0214 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0214 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0214 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0214 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME ALDH5A1 DME0214 XEOTICID XEO00241 GENEFORM mRNA DME0214 XEOTICID XEO00241 MOACRIVE Inhibition DME0214 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0214 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0214 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0214 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME ALDH5A1 DME0214 XEOTICID XEO00292 GENEFORM mRNA DME0214 XEOTICID XEO00292 MOACRIVE Inhibition DME0214 XEOTICID XEO00334 XEO_NAME Cisplatin DME0214 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0214 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0214 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME ALDH5A1 DME0214 XEOTICID XEO00334 GENEFORM mRNA DME0214 XEOTICID XEO00334 MOACRIVE Induction DME0214 XEOTICID XEO00408 XEO_NAME Zinc acetate DME0214 XEOTICID XEO00408 XEO_TYPE Pharmaceutical Agent(s) DME0214 XEOTICID XEO00408 XEO_CLAS Approved/Marketed Drug DME0214 XEOTICID XEO00408 DESCRIPT Zinc acetate up-regulates the expression of DME ALDH5A1 DME0214 XEOTICID XEO00408 GENEFORM mRNA DME0214 XEOTICID XEO00408 MOACRIVE Induction DME0214 XEOTICID XEO00541 XEO_NAME Motexafin gadolinium DME0214 XEOTICID XEO00541 XEO_TYPE Pharmaceutical Agent(s) DME0214 XEOTICID XEO00541 XEO_CLAS Drug in Phase 2 Clinical Trial DME0214 XEOTICID XEO00541 DESCRIPT Motexafin gadolinium up-regulates the expression of DME ALDH5A1 DME0214 XEOTICID XEO00541 GENEFORM mRNA DME0214 XEOTICID XEO00541 MOACRIVE Induction DME0214 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0214 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0214 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0214 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME ALDH5A1 DME0214 XEOTICID XEO00806 GENEFORM mRNA DME0214 XEOTICID XEO00806 MOACRIVE Inhibition DME0214 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0214 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0214 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0214 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME ALDH5A1 DME0214 XEOTICID XEO00898 GENEFORM mRNA DME0214 XEOTICID XEO00898 MOACRIVE Inhibition DME0214 XEOTICID XEO00969 XEO_NAME Atrazine DME0214 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0214 XEOTICID XEO00969 XEO_CLAS Herbicide DME0214 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME ALDH5A1 DME0214 XEOTICID XEO00969 GENEFORM mRNA DME0214 XEOTICID XEO00969 MOACRIVE Inhibition DME0214 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0214 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0214 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0214 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME ALDH5A1 DME0214 XEOTICID XEO00999 GENEFORM mRNA DME0214 XEOTICID XEO00999 MOACRIVE Inhibition DME0214 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0214 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0214 XEOTICID XEO01494 XEO_CLAS Natural Product DME0214 XEOTICID XEO01494 DESCRIPT Tunicamycin A inhibits the expression of DME ALDH5A1 DME0214 XEOTICID XEO01494 GENEFORM mRNA DME0214 XEOTICID XEO01494 MOACRIVE Inhibition DME0214 XEOTICID XEO01551 XEO_NAME Heliotrine DME0214 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0214 XEOTICID XEO01551 XEO_CLAS Natural Product DME0214 XEOTICID XEO01551 DESCRIPT Heliotrine inhibits the expression of DME ALDH5A1 DME0214 XEOTICID XEO01551 GENEFORM mRNA DME0214 XEOTICID XEO01551 MOACRIVE Inhibition DME0215 DME___ID DME0215 DME0215 DME_NAME Adenosine 5'-monophosphoramidase (HINT1) DME0215 SPESNAME Homo sapiens DME0215 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0215 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0215 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0215 XEOTICID XEO00037 DESCRIPT Fluorouracil induces the drug-metabolizing activity of DME HINT1 DME0215 XEOTICID XEO00037 GENEFORM Protein DME0215 XEOTICID XEO00037 MOACRIVE Induction DME0215 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0215 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0215 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0215 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol up-regulates the expression of DME HINT1 DME0215 XEOTICID XEO00166 GENEFORM mRNA DME0215 XEOTICID XEO00166 MOACRIVE Induction DME0215 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0215 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0215 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0215 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME HINT1 DME0215 XEOTICID XEO00217 GENEFORM mRNA DME0215 XEOTICID XEO00217 MOACRIVE Inhibition DME0215 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0215 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0215 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0215 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME HINT1 DME0215 XEOTICID XEO00292 GENEFORM mRNA DME0215 XEOTICID XEO00292 MOACRIVE Induction DME0215 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0215 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0215 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0215 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex up-regulates the expression of DME HINT1 DME0215 XEOTICID XEO00312 GENEFORM mRNA DME0215 XEOTICID XEO00312 MOACRIVE Induction DME0215 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0215 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0215 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0215 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the expression of DME HINT1 DME0215 XEOTICID XEO00388 GENEFORM mRNA DME0215 XEOTICID XEO00388 MOACRIVE Inhibition DME0215 XEOTICID XEO00466 XEO_NAME Demecolcine DME0215 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0215 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0215 XEOTICID XEO00466 DESCRIPT Demecolcine inhibits the expression of DME HINT1 DME0215 XEOTICID XEO00466 GENEFORM mRNA DME0215 XEOTICID XEO00466 MOACRIVE Inhibition DME0215 XEOTICID XEO00659 XEO_NAME Exisulind DME0215 XEOTICID XEO00659 XEO_TYPE Pharmaceutical Agent(s) DME0215 XEOTICID XEO00659 XEO_CLAS Drug in Phase 3 Clinical Trial DME0215 XEOTICID XEO00659 DESCRIPT Exisulind induces the drug-metabolizing activity of DME HINT1 DME0215 XEOTICID XEO00659 GENEFORM Protein DME0215 XEOTICID XEO00659 MOACRIVE Induction DME0215 XEOTICID XEO00869 XEO_NAME 4-hydroxy-2-nonenal DME0215 XEOTICID XEO00869 XEO_TYPE Pharmaceutical Agent(s) DME0215 XEOTICID XEO00869 XEO_CLAS Investigative Agent DME0215 XEOTICID XEO00869 DESCRIPT 4-hydroxy-2-nonenal inhibits the expression of DME HINT1 DME0215 XEOTICID XEO00869 GENEFORM mRNA DME0215 XEOTICID XEO00869 MOACRIVE Inhibition DME0215 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0215 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0215 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0215 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME HINT1 DME0215 XEOTICID XEO00898 GENEFORM mRNA DME0215 XEOTICID XEO00898 MOACRIVE Induction DME0215 XEOTICID XEO00919 XEO_NAME Particulate matter DME0215 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0215 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0215 XEOTICID XEO00919 DESCRIPT Particulate matter inhibits the drug-metabolizing activity of DME HINT1 DME0215 XEOTICID XEO00919 GENEFORM Protein DME0215 XEOTICID XEO00919 MOACRIVE Inhibition DME0215 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0215 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0215 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0215 XEOTICID XEO01247 DESCRIPT Chloropicrin inhibits the expression of DME HINT1 DME0215 XEOTICID XEO01247 GENEFORM mRNA DME0215 XEOTICID XEO01247 MOACRIVE Inhibition DME0215 XEOTICID XEO01336 XEO_NAME ICG-001 DME0215 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0215 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0215 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME HINT1 DME0215 XEOTICID XEO01336 GENEFORM mRNA DME0215 XEOTICID XEO01336 MOACRIVE Induction DME0216 DME___ID DME0216 DME0216 DME_NAME Putrescine acetyltransferase (SSAT1) DME0216 SPESNAME Homo sapiens DME0216 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0216 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00037 DESCRIPT Fluorouracil up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00037 GENEFORM mRNA DME0216 XEOTICID XEO00037 MOACRIVE Induction DME0216 XEOTICID XEO00047 XEO_NAME Indomethacin DME0216 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00047 DESCRIPT Indomethacin up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00047 GENEFORM mRNA DME0216 XEOTICID XEO00047 MOACRIVE Induction DME0216 XEOTICID XEO00053 XEO_NAME Leflunomide DME0216 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00053 GENEFORM mRNA DME0216 XEOTICID XEO00053 MOACRIVE Induction DME0216 XEOTICID XEO00079 XEO_NAME Vorinostat DME0216 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00079 DESCRIPT Vorinostat up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00079 GENEFORM mRNA DME0216 XEOTICID XEO00079 MOACRIVE Induction DME0216 XEOTICID XEO00090 XEO_NAME Estradiol DME0216 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME SAT1 DME0216 XEOTICID XEO00090 GENEFORM mRNA DME0216 XEOTICID XEO00090 MOACRIVE Inhibition DME0216 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0216 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00117 GENEFORM mRNA DME0216 XEOTICID XEO00117 MOACRIVE Induction DME0216 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0216 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol inhibits the expression of DME SAT1 DME0216 XEOTICID XEO00166 GENEFORM mRNA DME0216 XEOTICID XEO00166 MOACRIVE Inhibition DME0216 XEOTICID XEO00193 XEO_NAME Belinostat DME0216 XEOTICID XEO00193 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00193 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00193 DESCRIPT Belinostat up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00193 GENEFORM mRNA DME0216 XEOTICID XEO00193 MOACRIVE Induction DME0216 XEOTICID XEO00207 XEO_NAME Oxaliplatin DME0216 XEOTICID XEO00207 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00207 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00207 DESCRIPT Oxaliplatin induces the drug-metabolizing activity of DME SAT1 DME0216 XEOTICID XEO00207 GENEFORM Protein DME0216 XEOTICID XEO00207 MOACRIVE Induction DME0216 XEOTICID XEO00213 XEO_NAME Aspirin DME0216 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00213 DESCRIPT Aspirin up-regulates the expression of DME SAT1 and leads to increasing the drug-metabolizing activity of this enzyme DME0216 XEOTICID XEO00213 GENEFORM Protein DME0216 XEOTICID XEO00213 MOACRIVE Induction DME0216 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0216 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00217 GENEFORM mRNA DME0216 XEOTICID XEO00217 MOACRIVE Induction DME0216 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0216 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME SAT1 DME0216 XEOTICID XEO00241 GENEFORM mRNA DME0216 XEOTICID XEO00241 MOACRIVE Inhibition DME0216 XEOTICID XEO00248 XEO_NAME Ibuprofen DME0216 XEOTICID XEO00248 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00248 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00248 DESCRIPT Ibuprofen up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00248 GENEFORM mRNA DME0216 XEOTICID XEO00248 MOACRIVE Induction DME0216 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0216 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME SAT1 DME0216 XEOTICID XEO00292 GENEFORM mRNA DME0216 XEOTICID XEO00292 MOACRIVE Inhibition DME0216 XEOTICID XEO00301 XEO_NAME Irinotecan hydrochloride DME0216 XEOTICID XEO00301 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00301 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00301 DESCRIPT Irinotecan hydrochloride up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00301 GENEFORM mRNA DME0216 XEOTICID XEO00301 MOACRIVE Induction DME0216 XEOTICID XEO00334 XEO_NAME Cisplatin DME0216 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00334 GENEFORM mRNA DME0216 XEOTICID XEO00334 MOACRIVE Induction DME0216 XEOTICID XEO00361 XEO_NAME Gemcitabine DME0216 XEOTICID XEO00361 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00361 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00361 DESCRIPT Gemcitabine up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00361 GENEFORM mRNA DME0216 XEOTICID XEO00361 MOACRIVE Induction DME0216 XEOTICID XEO00372 XEO_NAME Panobinostat DME0216 XEOTICID XEO00372 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00372 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00372 DESCRIPT Panobinostat up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00372 GENEFORM mRNA DME0216 XEOTICID XEO00372 MOACRIVE Induction DME0216 XEOTICID XEO00392 XEO_NAME Vincristine DME0216 XEOTICID XEO00392 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00392 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00392 DESCRIPT Vincristine up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00392 GENEFORM mRNA DME0216 XEOTICID XEO00392 MOACRIVE Induction DME0216 XEOTICID XEO00404 XEO_NAME Folic acid DME0216 XEOTICID XEO00404 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00404 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00404 DESCRIPT Folic acid up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00404 GENEFORM mRNA DME0216 XEOTICID XEO00404 MOACRIVE Induction DME0216 XEOTICID XEO00466 XEO_NAME Demecolcine DME0216 XEOTICID XEO00466 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00466 XEO_CLAS Approved/Marketed Drug DME0216 XEOTICID XEO00466 DESCRIPT Demecolcine up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00466 GENEFORM mRNA DME0216 XEOTICID XEO00466 MOACRIVE Induction DME0216 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0216 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0216 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00536 GENEFORM mRNA DME0216 XEOTICID XEO00536 MOACRIVE Induction DME0216 XEOTICID XEO00557 XEO_NAME Genistein DME0216 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0216 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME SAT1 DME0216 XEOTICID XEO00557 GENEFORM mRNA DME0216 XEOTICID XEO00557 MOACRIVE Inhibition DME0216 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0216 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0216 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00571 GENEFORM mRNA DME0216 XEOTICID XEO00571 MOACRIVE Induction DME0216 XEOTICID XEO00622 XEO_NAME AM-80 DME0216 XEOTICID XEO00622 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00622 XEO_CLAS Drug in Phase 2 Clinical Trial DME0216 XEOTICID XEO00622 DESCRIPT AM-80 up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00622 GENEFORM mRNA DME0216 XEOTICID XEO00622 MOACRIVE Induction DME0216 XEOTICID XEO00629 XEO_NAME STA-4783 DME0216 XEOTICID XEO00629 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00629 XEO_CLAS Drug in Phase 2 Clinical Trial DME0216 XEOTICID XEO00629 DESCRIPT STA-4783 up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00629 GENEFORM mRNA DME0216 XEOTICID XEO00629 MOACRIVE Induction DME0216 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0216 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0216 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00723 GENEFORM mRNA DME0216 XEOTICID XEO00723 MOACRIVE Induction DME0216 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0216 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0216 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0216 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00772 GENEFORM mRNA DME0216 XEOTICID XEO00772 MOACRIVE Induction DME0216 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0216 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0216 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0216 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00806 GENEFORM mRNA DME0216 XEOTICID XEO00806 MOACRIVE Induction DME0216 XEOTICID XEO00809 XEO_NAME Thapsigargin DME0216 XEOTICID XEO00809 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0216 XEOTICID XEO00809 XEO_CLAS Natural Product DME0216 XEOTICID XEO00809 DESCRIPT Thapsigargin induces the drug-metabolizing activity of DME SAT1 DME0216 XEOTICID XEO00809 GENEFORM Protein DME0216 XEOTICID XEO00809 MOACRIVE Induction DME0216 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0216 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0216 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate induces the drug-metabolizing activity of DME SAT1 DME0216 XEOTICID XEO00818 GENEFORM Protein DME0216 XEOTICID XEO00818 MOACRIVE Induction DME0216 XEOTICID XEO00840 XEO_NAME Cupric oxide DME0216 XEOTICID XEO00840 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0216 XEOTICID XEO00840 XEO_CLAS Chemical Compound DME0216 XEOTICID XEO00840 DESCRIPT Cupric oxide up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00840 GENEFORM mRNA DME0216 XEOTICID XEO00840 MOACRIVE Induction DME0216 XEOTICID XEO00885 XEO_NAME Eugenol DME0216 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0216 XEOTICID XEO00885 DESCRIPT Eugenol up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00885 GENEFORM mRNA DME0216 XEOTICID XEO00885 MOACRIVE Induction DME0216 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0216 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0216 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0216 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME SAT1 DME0216 XEOTICID XEO00898 GENEFORM mRNA DME0216 XEOTICID XEO00898 MOACRIVE Inhibition DME0216 XEOTICID XEO00969 XEO_NAME Atrazine DME0216 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0216 XEOTICID XEO00969 XEO_CLAS Herbicide DME0216 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00969 GENEFORM mRNA DME0216 XEOTICID XEO00969 MOACRIVE Induction DME0216 XEOTICID XEO00971 XEO_NAME Diquat DME0216 XEOTICID XEO00971 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0216 XEOTICID XEO00971 XEO_CLAS Herbicide DME0216 XEOTICID XEO00971 DESCRIPT Diquat up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO00971 GENEFORM mRNA DME0216 XEOTICID XEO00971 MOACRIVE Induction DME0216 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0216 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0216 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0216 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO01004 GENEFORM mRNA DME0216 XEOTICID XEO01004 MOACRIVE Induction DME0216 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0216 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0216 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0216 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO01031 GENEFORM mRNA DME0216 XEOTICID XEO01031 MOACRIVE Induction DME0216 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0216 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0216 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0216 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME SAT1 DME0216 XEOTICID XEO01050 GENEFORM mRNA DME0216 XEOTICID XEO01050 MOACRIVE Inhibition DME0216 XEOTICID XEO01081 XEO_NAME Thioxotriazole copper(II) DME0216 XEOTICID XEO01081 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO01081 XEO_CLAS Investigative Agent DME0216 XEOTICID XEO01081 DESCRIPT Thioxotriazole copper(II) up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO01081 GENEFORM mRNA DME0216 XEOTICID XEO01081 MOACRIVE Induction DME0216 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0216 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0216 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO01226 GENEFORM mRNA DME0216 XEOTICID XEO01226 MOACRIVE Induction DME0216 XEOTICID XEO01261 XEO_NAME Coumestrol DME0216 XEOTICID XEO01261 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO01261 XEO_CLAS Investigative Agent DME0216 XEOTICID XEO01261 DESCRIPT Coumestrol inhibits the expression of DME SAT1 DME0216 XEOTICID XEO01261 GENEFORM mRNA DME0216 XEOTICID XEO01261 MOACRIVE Inhibition DME0216 XEOTICID XEO01284 XEO_NAME Dust DME0216 XEOTICID XEO01284 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0216 XEOTICID XEO01284 XEO_CLAS Natural Mixture DME0216 XEOTICID XEO01284 DESCRIPT Dust up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO01284 GENEFORM mRNA DME0216 XEOTICID XEO01284 MOACRIVE Induction DME0216 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0216 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0216 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0216 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO01305 GENEFORM mRNA DME0216 XEOTICID XEO01305 MOACRIVE Induction DME0216 XEOTICID XEO01348 XEO_NAME K-7174 DME0216 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0216 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0216 XEOTICID XEO01348 DESCRIPT K-7174 up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO01348 GENEFORM mRNA DME0216 XEOTICID XEO01348 MOACRIVE Induction DME0216 XEOTICID XEO01449 XEO_NAME Quercitrin DME0216 XEOTICID XEO01449 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0216 XEOTICID XEO01449 XEO_CLAS Natural Product DME0216 XEOTICID XEO01449 DESCRIPT Quercitrin inhibits the expression of DME SAT1 DME0216 XEOTICID XEO01449 GENEFORM mRNA DME0216 XEOTICID XEO01449 MOACRIVE Inhibition DME0216 XEOTICID XEO01474 XEO_NAME Stallimycin DME0216 XEOTICID XEO01474 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0216 XEOTICID XEO01474 XEO_CLAS Natural Product DME0216 XEOTICID XEO01474 DESCRIPT Stallimycin up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO01474 GENEFORM mRNA DME0216 XEOTICID XEO01474 MOACRIVE Induction DME0216 XEOTICID XEO01503 XEO_NAME Cadmium DME0216 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0216 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0216 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME SAT1 DME0216 XEOTICID XEO01503 GENEFORM mRNA DME0216 XEOTICID XEO01503 MOACRIVE Induction DME0218 DME___ID DME0218 DME0218 DME_NAME Steroid 5-alpha-reductase 2 (SRD5A2) DME0218 SPESNAME Homo sapiens DME0218 XEOTICID XEO00038 XEO_NAME Flutamide DME0218 XEOTICID XEO00038 XEO_TYPE Pharmaceutical Agent(s) DME0218 XEOTICID XEO00038 XEO_CLAS Approved/Marketed Drug DME0218 XEOTICID XEO00038 DESCRIPT Flutamide inhibits the drug-metabolizing activity of DME SRD5A2 DME0218 XEOTICID XEO00038 GENEFORM Protein DME0218 XEOTICID XEO00038 MOACRIVE Inhibition DME0218 XEOTICID XEO00090 XEO_NAME Estradiol DME0218 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0218 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0218 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME SRD5A2 DME0218 XEOTICID XEO00090 GENEFORM mRNA DME0218 XEOTICID XEO00090 MOACRIVE Inhibition DME0218 XEOTICID XEO00129 XEO_NAME Finasteride DME0218 XEOTICID XEO00129 XEO_TYPE Pharmaceutical Agent(s) DME0218 XEOTICID XEO00129 XEO_CLAS Approved/Marketed Drug DME0218 XEOTICID XEO00129 DESCRIPT Finasteride inhibits the drug-metabolizing activity of DME SRD5A2 (IC50 < 0.0001 microM) DME0218 XEOTICID XEO00129 GENEFORM Protein DME0218 XEOTICID XEO00129 MOACRIVE Inhibition DME0218 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0218 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0218 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0218 XEOTICID XEO00140 DESCRIPT Zoledronic acid up-regulates the expression of DME SRD5A2 DME0218 XEOTICID XEO00140 GENEFORM mRNA DME0218 XEOTICID XEO00140 MOACRIVE Induction DME0218 XEOTICID XEO00192 XEO_NAME Dutasteride DME0218 XEOTICID XEO00192 XEO_TYPE Pharmaceutical Agent(s) DME0218 XEOTICID XEO00192 XEO_CLAS Approved/Marketed Drug DME0218 XEOTICID XEO00192 DESCRIPT Dutasteride inhibits the expression of DME SRD5A2 DME0218 XEOTICID XEO00192 GENEFORM mRNA DME0218 XEOTICID XEO00192 MOACRIVE Inhibition DME0218 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0218 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0218 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0218 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME SRD5A2 DME0218 XEOTICID XEO00241 GENEFORM mRNA DME0218 XEOTICID XEO00241 MOACRIVE Inhibition DME0218 XEOTICID XEO00557 XEO_NAME Genistein DME0218 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0218 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0218 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME SRD5A2 DME0218 XEOTICID XEO00557 GENEFORM mRNA DME0218 XEOTICID XEO00557 MOACRIVE Inhibition DME0218 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME0218 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME0218 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME0218 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the expression of DME SRD5A2 DME0218 XEOTICID XEO00613 GENEFORM mRNA DME0218 XEOTICID XEO00613 MOACRIVE Inhibition DME0218 XEOTICID XEO00768 XEO_NAME Dichlorodiphenyl dichloroethylene DME0218 XEOTICID XEO00768 XEO_TYPE Health or Environmental Toxicant(s) DME0218 XEOTICID XEO00768 XEO_CLAS Environmental Pollutant DME0218 XEOTICID XEO00768 DESCRIPT Dichlorodiphenyl dichloroethylene inhibits the drug-metabolizing activity of DME SRD5A2 DME0218 XEOTICID XEO00768 GENEFORM Protein DME0218 XEOTICID XEO00768 MOACRIVE Inhibition DME0218 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0218 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0218 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0218 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME SRD5A2 DME0218 XEOTICID XEO00806 GENEFORM mRNA DME0218 XEOTICID XEO00806 MOACRIVE Inhibition DME0218 XEOTICID XEO00815 XEO_NAME Pregnadienes DME0218 XEOTICID XEO00815 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0218 XEOTICID XEO00815 XEO_CLAS Chemical Compound DME0218 XEOTICID XEO00815 DESCRIPT Pregnadienes inhibits the expression of DME SRD5A2 DME0218 XEOTICID XEO00815 GENEFORM mRNA DME0218 XEOTICID XEO00815 MOACRIVE Inhibition DME0218 XEOTICID XEO00946 XEO_NAME Fenarimol DME0218 XEOTICID XEO00946 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0218 XEOTICID XEO00946 XEO_CLAS Fungicide DME0218 XEOTICID XEO00946 DESCRIPT Fenarimol inhibits the drug-metabolizing activity of DME SRD5A2 DME0218 XEOTICID XEO00946 GENEFORM Protein DME0218 XEOTICID XEO00946 MOACRIVE Inhibition DME0218 XEOTICID XEO00955 XEO_NAME Prochloraz DME0218 XEOTICID XEO00955 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0218 XEOTICID XEO00955 XEO_CLAS Fungicide DME0218 XEOTICID XEO00955 DESCRIPT Prochloraz inhibits the drug-metabolizing activity of DME SRD5A2 DME0218 XEOTICID XEO00955 GENEFORM Protein DME0218 XEOTICID XEO00955 MOACRIVE Inhibition DME0218 XEOTICID XEO01246 XEO_NAME Chlorogenic acid DME0218 XEOTICID XEO01246 XEO_TYPE Pharmaceutical Agent(s) DME0218 XEOTICID XEO01246 XEO_CLAS Drug in Phase 2 Clinical Trial DME0218 XEOTICID XEO01246 DESCRIPT Chlorogenic acid inhibits the expression of DME SRD5A2 DME0218 XEOTICID XEO01246 GENEFORM mRNA DME0218 XEOTICID XEO01246 MOACRIVE Inhibition DME0218 XEOTICID XEO01432 XEO_NAME Piperidine DME0218 XEOTICID XEO01432 XEO_TYPE Health or Environmental Toxicant(s) DME0218 XEOTICID XEO01432 XEO_CLAS Acute Toxic Substance DME0218 XEOTICID XEO01432 DESCRIPT Piperidine inhibits the drug-metabolizing activity of DME SRD5A2 DME0218 XEOTICID XEO01432 GENEFORM Protein DME0218 XEOTICID XEO01432 MOACRIVE Inhibition DME0218 XEOTICID XEO01503 XEO_NAME Cadmium DME0218 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0218 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0218 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME SRD5A2 DME0218 XEOTICID XEO01503 GENEFORM mRNA DME0218 XEOTICID XEO01503 MOACRIVE Induction DME0218 XEOTICID XEO01570 XEO_NAME Osajin DME0218 XEOTICID XEO01570 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0218 XEOTICID XEO01570 XEO_CLAS Natural Product DME0218 XEOTICID XEO01570 DESCRIPT Osajin inhibits the drug-metabolizing activity of DME SRD5A2 DME0218 XEOTICID XEO01570 GENEFORM Protein DME0218 XEOTICID XEO01570 MOACRIVE Inhibition DME0219 DME___ID DME0219 DME0219 DME_NAME Steroid 5-alpha-reductase 3 (SRD5A3) DME0219 SPESNAME Homo sapiens DME0219 XEOTICID XEO00046 XEO_NAME Ifosfamide DME0219 XEOTICID XEO00046 XEO_TYPE Pharmaceutical Agent(s) DME0219 XEOTICID XEO00046 XEO_CLAS Approved/Marketed Drug DME0219 XEOTICID XEO00046 DESCRIPT Ifosfamide inhibits the expression of DME SRD5A3 DME0219 XEOTICID XEO00046 GENEFORM mRNA DME0219 XEOTICID XEO00046 MOACRIVE Inhibition DME0219 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0219 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0219 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0219 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME SRD5A3 DME0219 XEOTICID XEO00117 GENEFORM mRNA DME0219 XEOTICID XEO00117 MOACRIVE Inhibition DME0219 XEOTICID XEO00132 XEO_NAME Cidofovir DME0219 XEOTICID XEO00132 XEO_TYPE Pharmaceutical Agent(s) DME0219 XEOTICID XEO00132 XEO_CLAS Approved/Marketed Drug DME0219 XEOTICID XEO00132 DESCRIPT Cidofovir inhibits the expression of DME SRD5A3 DME0219 XEOTICID XEO00132 GENEFORM mRNA DME0219 XEOTICID XEO00132 MOACRIVE Inhibition DME0219 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0219 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0219 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0219 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME SRD5A3 DME0219 XEOTICID XEO00217 GENEFORM mRNA DME0219 XEOTICID XEO00217 MOACRIVE Inhibition DME0219 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0219 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0219 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0219 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME SRD5A3 DME0219 XEOTICID XEO00241 GENEFORM mRNA DME0219 XEOTICID XEO00241 MOACRIVE Inhibition DME0219 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0219 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0219 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0219 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME SRD5A3 DME0219 XEOTICID XEO00292 GENEFORM mRNA DME0219 XEOTICID XEO00292 MOACRIVE Inhibition DME0219 XEOTICID XEO00334 XEO_NAME Cisplatin DME0219 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0219 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0219 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME SRD5A3 DME0219 XEOTICID XEO00334 GENEFORM mRNA DME0219 XEOTICID XEO00334 MOACRIVE Inhibition DME0219 XEOTICID XEO00465 XEO_NAME Clodronic acid DME0219 XEOTICID XEO00465 XEO_TYPE Pharmaceutical Agent(s) DME0219 XEOTICID XEO00465 XEO_CLAS Approved/Marketed Drug DME0219 XEOTICID XEO00465 DESCRIPT Clodronic acid inhibits the expression of DME SRD5A3 DME0219 XEOTICID XEO00465 GENEFORM mRNA DME0219 XEOTICID XEO00465 MOACRIVE Inhibition DME0219 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0219 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0219 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0219 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME SRD5A3 DME0219 XEOTICID XEO00536 GENEFORM mRNA DME0219 XEOTICID XEO00536 MOACRIVE Induction DME0219 XEOTICID XEO00557 XEO_NAME Genistein DME0219 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0219 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0219 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME SRD5A3 DME0219 XEOTICID XEO00557 GENEFORM mRNA DME0219 XEOTICID XEO00557 MOACRIVE Induction DME0219 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0219 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0219 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0219 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME SRD5A3 DME0219 XEOTICID XEO00772 GENEFORM mRNA DME0219 XEOTICID XEO00772 MOACRIVE Inhibition DME0219 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0219 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0219 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0219 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME SRD5A3 DME0219 XEOTICID XEO01050 GENEFORM mRNA DME0219 XEOTICID XEO01050 MOACRIVE Inhibition DME0219 XEOTICID XEO01112 XEO_NAME 2,3-dibromopropyl-2,4,6-tribromophenyl ether DME0219 XEOTICID XEO01112 XEO_TYPE Health or Environmental Toxicant(s) DME0219 XEOTICID XEO01112 XEO_CLAS Environmental Pollutant DME0219 XEOTICID XEO01112 DESCRIPT 2,3-dibromopropyl-2,4,6-tribromophenyl ether inhibits the expression of DME SRD5A3 DME0219 XEOTICID XEO01112 GENEFORM mRNA DME0219 XEOTICID XEO01112 MOACRIVE Inhibition DME0219 XEOTICID XEO01348 XEO_NAME K-7174 DME0219 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0219 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0219 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME SRD5A3 DME0219 XEOTICID XEO01348 GENEFORM mRNA DME0219 XEOTICID XEO01348 MOACRIVE Inhibition DME0221 DME___ID DME0221 DME0221 DME_NAME Dihydrotestosterone oxidoreductase (HSD3B1) DME0221 SPESNAME Homo sapiens DME0221 XEOTICID XEO00064 XEO_NAME Mitotane DME0221 XEOTICID XEO00064 XEO_TYPE Pharmaceutical Agent(s) DME0221 XEOTICID XEO00064 XEO_CLAS Approved/Marketed Drug DME0221 XEOTICID XEO00064 DESCRIPT Mitotane inhibits the drug-metabolizing activity of DME HSD3B1 DME0221 XEOTICID XEO00064 GENEFORM Protein DME0221 XEOTICID XEO00064 MOACRIVE Inhibition DME0221 XEOTICID XEO00090 XEO_NAME Estradiol DME0221 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0221 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0221 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME HSD3B1 DME0221 XEOTICID XEO00090 GENEFORM mRNA DME0221 XEOTICID XEO00090 MOACRIVE Induction DME0221 XEOTICID XEO00095 XEO_NAME Testosterone DME0221 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0221 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0221 XEOTICID XEO00095 DESCRIPT Testosterone inhibits the expression of DME HSD3B1 DME0221 XEOTICID XEO00095 GENEFORM mRNA DME0221 XEOTICID XEO00095 MOACRIVE Inhibition DME0221 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0221 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0221 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0221 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol inhibits the expression of DME HSD3B1 DME0221 XEOTICID XEO00166 GENEFORM mRNA DME0221 XEOTICID XEO00166 MOACRIVE Inhibition DME0221 XEOTICID XEO00184 XEO_NAME Calcitriol DME0221 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0221 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0221 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME HSD3B1 DME0221 XEOTICID XEO00184 GENEFORM mRNA DME0221 XEOTICID XEO00184 MOACRIVE Induction DME0221 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0221 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0221 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0221 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME HSD3B1 DME0221 XEOTICID XEO00186 GENEFORM mRNA DME0221 XEOTICID XEO00186 MOACRIVE Inhibition DME0221 XEOTICID XEO00461 XEO_NAME Arbutin DME0221 XEOTICID XEO00461 XEO_TYPE Pharmaceutical Agent(s) DME0221 XEOTICID XEO00461 XEO_CLAS Approved/Marketed Drug DME0221 XEOTICID XEO00461 DESCRIPT Arbutin inhibits the expression of DME HSD3B1 DME0221 XEOTICID XEO00461 GENEFORM mRNA DME0221 XEOTICID XEO00461 MOACRIVE Inhibition DME0221 XEOTICID XEO00581 XEO_NAME MS-275 DME0221 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0221 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0221 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME HSD3B1 DME0221 XEOTICID XEO00581 GENEFORM mRNA DME0221 XEOTICID XEO00581 MOACRIVE Induction DME0221 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0221 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0221 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0221 XEOTICID XEO00582 DESCRIPT Diethyltoluamide inhibits the expression of DME HSD3B1 DME0221 XEOTICID XEO00582 GENEFORM mRNA DME0221 XEOTICID XEO00582 MOACRIVE Inhibition DME0221 XEOTICID XEO00656 XEO_NAME Sulindac sulfide DME0221 XEOTICID XEO00656 XEO_TYPE Pharmaceutical Agent(s) DME0221 XEOTICID XEO00656 XEO_CLAS Drug in Phase 2 Clinical Trial DME0221 XEOTICID XEO00656 DESCRIPT Sulindac sulfide inhibits the drug-metabolizing activity of DME HSD3B1 DME0221 XEOTICID XEO00656 GENEFORM Protein DME0221 XEOTICID XEO00656 MOACRIVE Inhibition DME0221 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0221 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0221 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0221 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME HSD3B1 DME0221 XEOTICID XEO00806 GENEFORM mRNA DME0221 XEOTICID XEO00806 MOACRIVE Inhibition DME0221 XEOTICID XEO00962 XEO_NAME 2,4,6-trichlorophenol DME0221 XEOTICID XEO00962 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0221 XEOTICID XEO00962 XEO_CLAS Fungicide DME0221 XEOTICID XEO00962 DESCRIPT 2,4,6-trichlorophenol inhibits the expression of DME HSD3B1 DME0221 XEOTICID XEO00962 GENEFORM mRNA DME0221 XEOTICID XEO00962 MOACRIVE Inhibition DME0221 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0221 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0221 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0221 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the drug-metabolizing activity of DME HSD3B1 DME0221 XEOTICID XEO01004 GENEFORM Protein DME0221 XEOTICID XEO01004 MOACRIVE Inhibition DME0221 XEOTICID XEO01147 XEO_NAME SB-431542 DME0221 XEOTICID XEO01147 XEO_TYPE Pharmaceutical Agent(s) DME0221 XEOTICID XEO01147 XEO_CLAS Investigative Agent DME0221 XEOTICID XEO01147 DESCRIPT SB-431542 up-regulates the expression of DME HSD3B1 DME0221 XEOTICID XEO01147 GENEFORM mRNA DME0221 XEOTICID XEO01147 MOACRIVE Induction DME0221 XEOTICID XEO01302 XEO_NAME Fipronil DME0221 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0221 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0221 XEOTICID XEO01302 DESCRIPT Fipronil inhibits the expression of DME HSD3B1 DME0221 XEOTICID XEO01302 GENEFORM mRNA DME0221 XEOTICID XEO01302 MOACRIVE Inhibition DME0221 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0221 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0221 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0221 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME HSD3B1 DME0221 XEOTICID XEO01305 GENEFORM mRNA DME0221 XEOTICID XEO01305 MOACRIVE Induction DME0221 XEOTICID XEO01321 XEO_NAME Go-6976 DME0221 XEOTICID XEO01321 XEO_TYPE Pharmaceutical Agent(s) DME0221 XEOTICID XEO01321 XEO_CLAS Investigative Agent DME0221 XEOTICID XEO01321 DESCRIPT Go-6976 up-regulates the expression of DME HSD3B1 DME0221 XEOTICID XEO01321 GENEFORM mRNA DME0221 XEOTICID XEO01321 MOACRIVE Induction DME0221 XEOTICID XEO01390 XEO_NAME Nadide DME0221 XEOTICID XEO01390 XEO_TYPE Pharmaceutical Agent(s) DME0221 XEOTICID XEO01390 XEO_CLAS Approved/Marketed Drug DME0221 XEOTICID XEO01390 DESCRIPT Nadide up-regulates the expression of DME HSD3B1 DME0221 XEOTICID XEO01390 GENEFORM mRNA DME0221 XEOTICID XEO01390 MOACRIVE Induction DME0221 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0221 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0221 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0221 XEOTICID XEO01407 DESCRIPT Ochratoxin A induces the drug-metabolizing activity of DME HSD3B1 DME0221 XEOTICID XEO01407 GENEFORM Protein DME0221 XEOTICID XEO01407 MOACRIVE Induction DME0221 XEOTICID XEO01605 XEO_NAME Pentachlorophenol DME0221 XEOTICID XEO01605 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0221 XEOTICID XEO01605 XEO_CLAS Pesticide/Insecticide DME0221 XEOTICID XEO01605 DESCRIPT Pentachlorophenol inhibits the expression of DME HSD3B1 DME0221 XEOTICID XEO01605 GENEFORM mRNA DME0221 XEOTICID XEO01605 MOACRIVE Inhibition DME0222 DME___ID DME0222 DME0222 DME_NAME Beta-HSD adrenal and gonadal type (HSD3B2) DME0222 SPESNAME Homo sapiens DME0222 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0222 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0222 XEOTICID XEO00011 DESCRIPT Carbamazepine inhibits the drug-metabolizing activity of DME HSD3B2 DME0222 XEOTICID XEO00011 GENEFORM Protein DME0222 XEOTICID XEO00011 MOACRIVE Inhibition DME0222 XEOTICID XEO00029 XEO_NAME Valproic acid DME0222 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0222 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME HSD3B2 DME0222 XEOTICID XEO00029 GENEFORM mRNA DME0222 XEOTICID XEO00029 MOACRIVE Inhibition DME0222 XEOTICID XEO00051 XEO_NAME Lamotrigine DME0222 XEOTICID XEO00051 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO00051 XEO_CLAS Approved/Marketed Drug DME0222 XEOTICID XEO00051 DESCRIPT Lamotrigine inhibits the drug-metabolizing activity of DME HSD3B2 DME0222 XEOTICID XEO00051 GENEFORM Protein DME0222 XEOTICID XEO00051 MOACRIVE Inhibition DME0222 XEOTICID XEO00064 XEO_NAME Mitotane DME0222 XEOTICID XEO00064 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO00064 XEO_CLAS Approved/Marketed Drug DME0222 XEOTICID XEO00064 DESCRIPT Mitotane inhibits the drug-metabolizing activity of DME HSD3B2 DME0222 XEOTICID XEO00064 GENEFORM Protein DME0222 XEOTICID XEO00064 MOACRIVE Inhibition DME0222 XEOTICID XEO00187 XEO_NAME Levetiracetam DME0222 XEOTICID XEO00187 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO00187 XEO_CLAS Approved/Marketed Drug DME0222 XEOTICID XEO00187 DESCRIPT Levetiracetam inhibits the expression of DME HSD3B2 DME0222 XEOTICID XEO00187 GENEFORM mRNA DME0222 XEOTICID XEO00187 MOACRIVE Inhibition DME0222 XEOTICID XEO00189 XEO_NAME Topiramate DME0222 XEOTICID XEO00189 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO00189 XEO_CLAS Approved/Marketed Drug DME0222 XEOTICID XEO00189 DESCRIPT Topiramate inhibits the expression of DME HSD3B2 DME0222 XEOTICID XEO00189 GENEFORM mRNA DME0222 XEOTICID XEO00189 MOACRIVE Inhibition DME0222 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0222 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0222 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the expression of DME HSD3B2 DME0222 XEOTICID XEO00251 GENEFORM mRNA DME0222 XEOTICID XEO00251 MOACRIVE Inhibition DME0222 XEOTICID XEO00260 XEO_NAME Dinoprostone DME0222 XEOTICID XEO00260 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO00260 XEO_CLAS Approved/Marketed Drug DME0222 XEOTICID XEO00260 DESCRIPT Dinoprostone up-regulates the expression of DME HSD3B2 DME0222 XEOTICID XEO00260 GENEFORM mRNA DME0222 XEOTICID XEO00260 MOACRIVE Induction DME0222 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0222 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0222 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME HSD3B2 DME0222 XEOTICID XEO00292 GENEFORM mRNA DME0222 XEOTICID XEO00292 MOACRIVE Inhibition DME0222 XEOTICID XEO00319 XEO_NAME Pioglitazone hydrochloride DME0222 XEOTICID XEO00319 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO00319 XEO_CLAS Approved/Marketed Drug DME0222 XEOTICID XEO00319 DESCRIPT Pioglitazone hydrochloride inhibits the drug-metabolizing activity of DME HSD3B2 DME0222 XEOTICID XEO00319 GENEFORM Protein DME0222 XEOTICID XEO00319 MOACRIVE Inhibition DME0222 XEOTICID XEO00606 XEO_NAME Colforsin DME0222 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0222 XEOTICID XEO00606 DESCRIPT Colforsin up-regulates the expression of DME HSD3B2 DME0222 XEOTICID XEO00606 GENEFORM mRNA DME0222 XEOTICID XEO00606 MOACRIVE Induction DME0222 XEOTICID XEO00627 XEO_NAME Torcetrapib DME0222 XEOTICID XEO00627 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO00627 XEO_CLAS Drug in Phase 3 Clinical Trial DME0222 XEOTICID XEO00627 DESCRIPT Torcetrapib up-regulates the expression of DME HSD3B2 DME0222 XEOTICID XEO00627 GENEFORM mRNA DME0222 XEOTICID XEO00627 MOACRIVE Induction DME0222 XEOTICID XEO00740 XEO_NAME Lindane DME0222 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0222 XEOTICID XEO00740 DESCRIPT Lindane inhibits the expression of DME HSD3B2 DME0222 XEOTICID XEO00740 GENEFORM mRNA DME0222 XEOTICID XEO00740 MOACRIVE Inhibition DME0222 XEOTICID XEO00834 XEO_NAME Copper DME0222 XEOTICID XEO00834 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO00834 XEO_CLAS Approved/Marketed Drug DME0222 XEOTICID XEO00834 DESCRIPT Copper up-regulates the expression of DME HSD3B2 DME0222 XEOTICID XEO00834 GENEFORM mRNA DME0222 XEOTICID XEO00834 MOACRIVE Induction DME0222 XEOTICID XEO00904 XEO_NAME Pentabromophenol DME0222 XEOTICID XEO00904 XEO_TYPE Health or Environmental Toxicant(s) DME0222 XEOTICID XEO00904 XEO_CLAS Acute Toxic Substance DME0222 XEOTICID XEO00904 DESCRIPT Pentabromophenol up-regulates the expression of DME HSD3B2 DME0222 XEOTICID XEO00904 GENEFORM mRNA DME0222 XEOTICID XEO00904 MOACRIVE Induction DME0222 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0222 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0222 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0222 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid up-regulates the expression of DME HSD3B2 DME0222 XEOTICID XEO00921 GENEFORM mRNA DME0222 XEOTICID XEO00921 MOACRIVE Induction DME0222 XEOTICID XEO00924 XEO_NAME Water pollutants chemical DME0222 XEOTICID XEO00924 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0222 XEOTICID XEO00924 XEO_CLAS Natural Mixture DME0222 XEOTICID XEO00924 DESCRIPT Water pollutants chemical induces the drug-metabolizing activity of DME HSD3B2 DME0222 XEOTICID XEO00924 GENEFORM Protein DME0222 XEOTICID XEO00924 MOACRIVE Induction DME0222 XEOTICID XEO00984 XEO_NAME Galaxolide DME0222 XEOTICID XEO00984 XEO_TYPE Health or Environmental Toxicant(s) DME0222 XEOTICID XEO00984 XEO_CLAS Environmental Pollutant DME0222 XEOTICID XEO00984 DESCRIPT Galaxolide inhibits the drug-metabolizing activity of DME HSD3B2 DME0222 XEOTICID XEO00984 GENEFORM Protein DME0222 XEOTICID XEO00984 MOACRIVE Inhibition DME0222 XEOTICID XEO01040 XEO_NAME Bifenthrin DME0222 XEOTICID XEO01040 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0222 XEOTICID XEO01040 XEO_CLAS Pesticide/Insecticide DME0222 XEOTICID XEO01040 DESCRIPT Bifenthrin up-regulates the expression of DME HSD3B2 DME0222 XEOTICID XEO01040 GENEFORM mRNA DME0222 XEOTICID XEO01040 MOACRIVE Induction DME0222 XEOTICID XEO01121 XEO_NAME 2-bromophenol DME0222 XEOTICID XEO01121 XEO_TYPE Health or Environmental Toxicant(s) DME0222 XEOTICID XEO01121 XEO_CLAS Environmental Pollutant DME0222 XEOTICID XEO01121 DESCRIPT 2-bromophenol up-regulates the expression of DME HSD3B2 DME0222 XEOTICID XEO01121 GENEFORM mRNA DME0222 XEOTICID XEO01121 MOACRIVE Induction DME0222 XEOTICID XEO01133 XEO_NAME 3,3',4,5'-tetrahydroxystilbene DME0222 XEOTICID XEO01133 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO01133 XEO_CLAS Investigative Agent DME0222 XEOTICID XEO01133 DESCRIPT 3,3',4,5'-tetrahydroxystilbene inhibits the expression of DME HSD3B2 DME0222 XEOTICID XEO01133 GENEFORM mRNA DME0222 XEOTICID XEO01133 MOACRIVE Inhibition DME0222 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0222 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0222 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the drug-metabolizing activity of DME HSD3B2 DME0222 XEOTICID XEO01226 GENEFORM Protein DME0222 XEOTICID XEO01226 MOACRIVE Inhibition DME0222 XEOTICID XEO01252 XEO_NAME Cinnamic acid DME0222 XEOTICID XEO01252 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO01252 XEO_CLAS Approved/Marketed Drug DME0222 XEOTICID XEO01252 DESCRIPT Cinnamic acid inhibits the drug-metabolizing activity of DME HSD3B2 DME0222 XEOTICID XEO01252 GENEFORM Protein DME0222 XEOTICID XEO01252 MOACRIVE Inhibition DME0222 XEOTICID XEO01267 XEO_NAME Cyclic AMP DME0222 XEOTICID XEO01267 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO01267 XEO_CLAS Drug in Phase 1 Clinical Trial DME0222 XEOTICID XEO01267 DESCRIPT Cyclic AMP up-regulates the expression of DME HSD3B2 DME0222 XEOTICID XEO01267 GENEFORM mRNA DME0222 XEOTICID XEO01267 MOACRIVE Induction DME0222 XEOTICID XEO01289 XEO_NAME Enniatins DME0222 XEOTICID XEO01289 XEO_TYPE Health or Environmental Toxicant(s) DME0222 XEOTICID XEO01289 XEO_CLAS Acute Toxic Substance DME0222 XEOTICID XEO01289 DESCRIPT Enniatins inhibits the expression of DME HSD3B2 DME0222 XEOTICID XEO01289 GENEFORM mRNA DME0222 XEOTICID XEO01289 MOACRIVE Inhibition DME0222 XEOTICID XEO01491 XEO_NAME Tributyltin DME0222 XEOTICID XEO01491 XEO_TYPE Pharmaceutical Agent(s) DME0222 XEOTICID XEO01491 XEO_CLAS Investigative Agent DME0222 XEOTICID XEO01491 DESCRIPT Tributyltin inhibits the expression of DME HSD3B2 DME0222 XEOTICID XEO01491 GENEFORM mRNA DME0222 XEOTICID XEO01491 MOACRIVE Inhibition DME0222 XEOTICID XEO01514 XEO_NAME Deoxynivalenol DME0222 XEOTICID XEO01514 XEO_TYPE Health or Environmental Toxicant(s) DME0222 XEOTICID XEO01514 XEO_CLAS Mycotoxin DME0222 XEOTICID XEO01514 DESCRIPT Deoxynivalenol up-regulates the expression of DME HSD3B2 DME0222 XEOTICID XEO01514 GENEFORM mRNA DME0222 XEOTICID XEO01514 MOACRIVE Induction DME0222 XEOTICID XEO01612 XEO_NAME 2-acetyltributylcitrate DME0222 XEOTICID XEO01612 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0222 XEOTICID XEO01612 XEO_CLAS Cosmetic Additive DME0222 XEOTICID XEO01612 DESCRIPT 2-acetyltributylcitrate up-regulates the expression of DME HSD3B2 DME0222 XEOTICID XEO01612 GENEFORM mRNA DME0222 XEOTICID XEO01612 MOACRIVE Induction DME0223 DME___ID DME0223 DME0223 DME_NAME Hypoxanthine phosphoribosyltransferase (HPRT1) DME0223 SPESNAME Homo sapiens DME0223 XEOTICID XEO00095 XEO_NAME Testosterone DME0223 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0223 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0223 XEOTICID XEO00095 DESCRIPT Testosterone inhibits the expression of DME HPRT1 DME0223 XEOTICID XEO00095 GENEFORM mRNA DME0223 XEOTICID XEO00095 MOACRIVE Inhibition DME0223 XEOTICID XEO00184 XEO_NAME Calcitriol DME0223 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0223 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0223 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME HPRT1 DME0223 XEOTICID XEO00184 GENEFORM mRNA DME0223 XEOTICID XEO00184 MOACRIVE Inhibition DME0223 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0223 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0223 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0223 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME HPRT1 DME0223 XEOTICID XEO00241 GENEFORM mRNA DME0223 XEOTICID XEO00241 MOACRIVE Induction DME0223 XEOTICID XEO00557 XEO_NAME Genistein DME0223 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0223 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0223 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME HPRT1 DME0223 XEOTICID XEO00557 GENEFORM mRNA DME0223 XEOTICID XEO00557 MOACRIVE Inhibition DME0223 XEOTICID XEO00683 XEO_NAME Curcumin DME0223 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0223 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0223 XEOTICID XEO00683 DESCRIPT Curcumin up-regulates the expression of DME HPRT1 DME0223 XEOTICID XEO00683 GENEFORM mRNA DME0223 XEOTICID XEO00683 MOACRIVE Induction DME0223 XEOTICID XEO00809 XEO_NAME Thapsigargin DME0223 XEOTICID XEO00809 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0223 XEOTICID XEO00809 XEO_CLAS Natural Product DME0223 XEOTICID XEO00809 DESCRIPT Thapsigargin inhibits the expression of DME HPRT1 DME0223 XEOTICID XEO00809 GENEFORM mRNA DME0223 XEOTICID XEO00809 MOACRIVE Inhibition DME0223 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0223 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0223 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0223 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME HPRT1 DME0223 XEOTICID XEO00898 GENEFORM mRNA DME0223 XEOTICID XEO00898 MOACRIVE Induction DME0223 XEOTICID XEO00969 XEO_NAME Atrazine DME0223 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0223 XEOTICID XEO00969 XEO_CLAS Herbicide DME0223 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME HPRT1 DME0223 XEOTICID XEO00969 GENEFORM mRNA DME0223 XEOTICID XEO00969 MOACRIVE Inhibition DME0223 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0223 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0223 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0223 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME HPRT1 DME0223 XEOTICID XEO01226 GENEFORM mRNA DME0223 XEOTICID XEO01226 MOACRIVE Inhibition DME0223 XEOTICID XEO01261 XEO_NAME Coumestrol DME0223 XEOTICID XEO01261 XEO_TYPE Pharmaceutical Agent(s) DME0223 XEOTICID XEO01261 XEO_CLAS Investigative Agent DME0223 XEOTICID XEO01261 DESCRIPT Coumestrol up-regulates the expression of DME HPRT1 DME0223 XEOTICID XEO01261 GENEFORM mRNA DME0223 XEOTICID XEO01261 MOACRIVE Induction DME0223 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0223 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0223 XEOTICID XEO01494 XEO_CLAS Natural Product DME0223 XEOTICID XEO01494 DESCRIPT Tunicamycin A inhibits the expression of DME HPRT1 DME0223 XEOTICID XEO01494 GENEFORM mRNA DME0223 XEOTICID XEO01494 MOACRIVE Inhibition DME0223 XEOTICID XEO01504 XEO_NAME Gold DME0223 XEOTICID XEO01504 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0223 XEOTICID XEO01504 XEO_CLAS Chemical Compound DME0223 XEOTICID XEO01504 DESCRIPT Gold inhibits the expression of DME HPRT1 DME0223 XEOTICID XEO01504 GENEFORM mRNA DME0223 XEOTICID XEO01504 MOACRIVE Inhibition DME0224 DME___ID DME0224 DME0224 DME_NAME HMG-CoA reductase (HMGCR) DME0224 SPESNAME Homo sapiens DME0224 XEOTICID XEO00007 XEO_NAME Azathioprine DME0224 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00007 DESCRIPT Azathioprine inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00007 GENEFORM mRNA DME0224 XEOTICID XEO00007 MOACRIVE Inhibition DME0224 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0224 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00011 DESCRIPT Carbamazepine inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00011 GENEFORM mRNA DME0224 XEOTICID XEO00011 MOACRIVE Inhibition DME0224 XEOTICID XEO00016 XEO_NAME Clofibrate DME0224 XEOTICID XEO00016 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00016 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00016 DESCRIPT Clof DMEibrate inhibits the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO00016 GENEFORM Protein DME0224 XEOTICID XEO00016 MOACRIVE Inhibition DME0224 XEOTICID XEO00029 XEO_NAME Valproic acid DME0224 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00029 GENEFORM mRNA DME0224 XEOTICID XEO00029 MOACRIVE Inhibition DME0224 XEOTICID XEO00045 XEO_NAME Haloperidol DME0224 XEOTICID XEO00045 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00045 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00045 DESCRIPT Haloperidol induces the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO00045 GENEFORM Protein DME0224 XEOTICID XEO00045 MOACRIVE Induction DME0224 XEOTICID XEO00077 XEO_NAME Risperidone DME0224 XEOTICID XEO00077 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00077 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00077 DESCRIPT Risperidone induces the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO00077 GENEFORM Protein DME0224 XEOTICID XEO00077 MOACRIVE Induction DME0224 XEOTICID XEO00086 XEO_NAME Troglitazone DME0224 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00086 DESCRIPT Troglitazone induces the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO00086 GENEFORM Protein DME0224 XEOTICID XEO00086 MOACRIVE Induction DME0224 XEOTICID XEO00094 XEO_NAME Progesterone DME0224 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00094 DESCRIPT Progesterone induces the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO00094 GENEFORM Protein DME0224 XEOTICID XEO00094 MOACRIVE Induction DME0224 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0224 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00117 GENEFORM mRNA DME0224 XEOTICID XEO00117 MOACRIVE Inhibition DME0224 XEOTICID XEO00125 XEO_NAME Simvastatin DME0224 XEOTICID XEO00125 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00125 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00125 DESCRIPT Simvastatin inhibits the drug-metabolizing activity of DME HMGCR (IC50 = 0.0009 microM) DME0224 XEOTICID XEO00125 GENEFORM Protein DME0224 XEOTICID XEO00125 MOACRIVE Inhibition DME0224 XEOTICID XEO00155 XEO_NAME Ezetimibe DME0224 XEOTICID XEO00155 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00155 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00155 DESCRIPT Ezetimibe induces the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO00155 GENEFORM Protein DME0224 XEOTICID XEO00155 MOACRIVE Induction DME0224 XEOTICID XEO00176 XEO_NAME Methimazole DME0224 XEOTICID XEO00176 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00176 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00176 DESCRIPT Methimazole inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00176 GENEFORM mRNA DME0224 XEOTICID XEO00176 MOACRIVE Inhibition DME0224 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0224 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00186 GENEFORM mRNA DME0224 XEOTICID XEO00186 MOACRIVE Inhibition DME0224 XEOTICID XEO00195 XEO_NAME Crizotinib DME0224 XEOTICID XEO00195 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00195 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00195 DESCRIPT Crizotinib up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO00195 GENEFORM mRNA DME0224 XEOTICID XEO00195 MOACRIVE Induction DME0224 XEOTICID XEO00204 XEO_NAME Piroxicam DME0224 XEOTICID XEO00204 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00204 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00204 DESCRIPT Piroxicam inhibits the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO00204 GENEFORM Protein DME0224 XEOTICID XEO00204 MOACRIVE Inhibition DME0224 XEOTICID XEO00209 XEO_NAME Clozapine DME0224 XEOTICID XEO00209 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00209 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00209 DESCRIPT Clozapine induces the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO00209 GENEFORM Protein DME0224 XEOTICID XEO00209 MOACRIVE Induction DME0224 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0224 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00217 GENEFORM mRNA DME0224 XEOTICID XEO00217 MOACRIVE Inhibition DME0224 XEOTICID XEO00218 XEO_NAME Caffeine DME0224 XEOTICID XEO00218 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00218 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00218 DESCRIPT Caffeine induces the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO00218 GENEFORM Protein DME0224 XEOTICID XEO00218 MOACRIVE Induction DME0224 XEOTICID XEO00226 XEO_NAME Olanzapine DME0224 XEOTICID XEO00226 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00226 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00226 DESCRIPT Olanzapine up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO00226 GENEFORM mRNA DME0224 XEOTICID XEO00226 MOACRIVE Induction DME0224 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0224 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00241 GENEFORM mRNA DME0224 XEOTICID XEO00241 MOACRIVE Inhibition DME0224 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0224 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00251 GENEFORM mRNA DME0224 XEOTICID XEO00251 MOACRIVE Inhibition DME0224 XEOTICID XEO00262 XEO_NAME Lovastatin DME0224 XEOTICID XEO00262 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00262 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00262 DESCRIPT Lovastatin up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO00262 GENEFORM mRNA DME0224 XEOTICID XEO00262 MOACRIVE Induction DME0224 XEOTICID XEO00264 XEO_NAME Hydrocortisone DME0224 XEOTICID XEO00264 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00264 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00264 DESCRIPT Hydrocortisone inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00264 GENEFORM mRNA DME0224 XEOTICID XEO00264 MOACRIVE Inhibition DME0224 XEOTICID XEO00280 XEO_NAME Chlorpromazine hydrochloride DME0224 XEOTICID XEO00280 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00280 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00280 DESCRIPT Chlorpromazine hydrochloride up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO00280 GENEFORM mRNA DME0224 XEOTICID XEO00280 MOACRIVE Induction DME0224 XEOTICID XEO00334 XEO_NAME Cisplatin DME0224 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00334 GENEFORM mRNA DME0224 XEOTICID XEO00334 MOACRIVE Inhibition DME0224 XEOTICID XEO00340 XEO_NAME Atorvastatin DME0224 XEOTICID XEO00340 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00340 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00340 DESCRIPT Atorvastatin up-regulates the expression of DME HMGCR and leads to increasing the drug-metabolizing activity of this enzyme DME0224 XEOTICID XEO00340 GENEFORM Protein DME0224 XEOTICID XEO00340 MOACRIVE Induction DME0224 XEOTICID XEO00359 XEO_NAME Fluvastatin DME0224 XEOTICID XEO00359 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00359 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00359 DESCRIPT Fluvastatin inhibits the drug-metabolizing activity of DME HMGCR (IC50 = 0.000353 microM) DME0224 XEOTICID XEO00359 GENEFORM Protein DME0224 XEOTICID XEO00359 MOACRIVE Inhibition DME0224 XEOTICID XEO00377 XEO_NAME Pravastatin DME0224 XEOTICID XEO00377 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00377 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00377 DESCRIPT Pravastatin inhibits the drug-metabolizing activity of DME HMGCR (IC50 = 0.005591 microM) DME0224 XEOTICID XEO00377 GENEFORM Protein DME0224 XEOTICID XEO00377 MOACRIVE Inhibition DME0224 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0224 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO00388 GENEFORM mRNA DME0224 XEOTICID XEO00388 MOACRIVE Induction DME0224 XEOTICID XEO00411 XEO_NAME Avobenzone DME0224 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO00411 GENEFORM mRNA DME0224 XEOTICID XEO00411 MOACRIVE Induction DME0224 XEOTICID XEO00428 XEO_NAME Menadione DME0224 XEOTICID XEO00428 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00428 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00428 DESCRIPT Menadione inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00428 GENEFORM mRNA DME0224 XEOTICID XEO00428 MOACRIVE Inhibition DME0224 XEOTICID XEO00493 XEO_NAME Bezafibrate DME0224 XEOTICID XEO00493 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00493 XEO_CLAS Approved/Marketed Drug DME0224 XEOTICID XEO00493 DESCRIPT Bezafibrate induces the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO00493 GENEFORM Protein DME0224 XEOTICID XEO00493 MOACRIVE Induction DME0224 XEOTICID XEO00529 XEO_NAME Phenylpropanolamine DME0224 XEOTICID XEO00529 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00529 XEO_CLAS Drug Marketed but Withdrawn from Market DME0224 XEOTICID XEO00529 DESCRIPT Phenylpropanolamine up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO00529 GENEFORM mRNA DME0224 XEOTICID XEO00529 MOACRIVE Induction DME0224 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0224 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0224 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO00536 GENEFORM mRNA DME0224 XEOTICID XEO00536 MOACRIVE Induction DME0224 XEOTICID XEO00538 XEO_NAME Quercetin DME0224 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0224 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00538 GENEFORM mRNA DME0224 XEOTICID XEO00538 MOACRIVE Inhibition DME0224 XEOTICID XEO00539 XEO_NAME Ethanol DME0224 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0224 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO00539 GENEFORM Protein DME0224 XEOTICID XEO00539 MOACRIVE Inhibition DME0224 XEOTICID XEO00554 XEO_NAME Fingolimod hydrochloride DME0224 XEOTICID XEO00554 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00554 XEO_CLAS Drug in Phase 1 Clinical Trial DME0224 XEOTICID XEO00554 DESCRIPT Fingolimod hydrochloride up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO00554 GENEFORM mRNA DME0224 XEOTICID XEO00554 MOACRIVE Induction DME0224 XEOTICID XEO00568 XEO_NAME Resveratrol DME0224 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0224 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00568 GENEFORM mRNA DME0224 XEOTICID XEO00568 MOACRIVE Inhibition DME0224 XEOTICID XEO00581 XEO_NAME MS-275 DME0224 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0224 XEOTICID XEO00581 DESCRIPT MS-275 inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00581 GENEFORM mRNA DME0224 XEOTICID XEO00581 MOACRIVE Inhibition DME0224 XEOTICID XEO00606 XEO_NAME Colforsin DME0224 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0224 XEOTICID XEO00606 DESCRIPT Colforsin up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO00606 GENEFORM mRNA DME0224 XEOTICID XEO00606 MOACRIVE Induction DME0224 XEOTICID XEO00626 XEO_NAME Copper histidine DME0224 XEOTICID XEO00626 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00626 XEO_CLAS Drug in Phase 3 Clinical Trial DME0224 XEOTICID XEO00626 DESCRIPT Copper histidine up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO00626 GENEFORM mRNA DME0224 XEOTICID XEO00626 MOACRIVE Induction DME0224 XEOTICID XEO00683 XEO_NAME Curcumin DME0224 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0224 XEOTICID XEO00683 DESCRIPT Curcumin up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO00683 GENEFORM mRNA DME0224 XEOTICID XEO00683 MOACRIVE Induction DME0224 XEOTICID XEO00735 XEO_NAME GW-4064 DME0224 XEOTICID XEO00735 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00735 XEO_CLAS Preclinical/Patented Drug DME0224 XEOTICID XEO00735 DESCRIPT GW-4064 up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO00735 GENEFORM mRNA DME0224 XEOTICID XEO00735 MOACRIVE Induction DME0224 XEOTICID XEO00760 XEO_NAME Jinfukang DME0224 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0224 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0224 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00760 GENEFORM mRNA DME0224 XEOTICID XEO00760 MOACRIVE Inhibition DME0224 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0224 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0224 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00772 GENEFORM mRNA DME0224 XEOTICID XEO00772 MOACRIVE Inhibition DME0224 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0224 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0224 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00806 GENEFORM mRNA DME0224 XEOTICID XEO00806 MOACRIVE Inhibition DME0224 XEOTICID XEO00809 XEO_NAME Thapsigargin DME0224 XEOTICID XEO00809 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0224 XEOTICID XEO00809 XEO_CLAS Natural Product DME0224 XEOTICID XEO00809 DESCRIPT Thapsigargin inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00809 GENEFORM mRNA DME0224 XEOTICID XEO00809 MOACRIVE Inhibition DME0224 XEOTICID XEO00813 XEO_NAME Dinophysistoxin 1 DME0224 XEOTICID XEO00813 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO00813 XEO_CLAS Biotoxin DME0224 XEOTICID XEO00813 DESCRIPT Dinophysistoxin 1 inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00813 GENEFORM mRNA DME0224 XEOTICID XEO00813 MOACRIVE Inhibition DME0224 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0224 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0224 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00818 GENEFORM mRNA DME0224 XEOTICID XEO00818 MOACRIVE Inhibition DME0224 XEOTICID XEO00876 XEO_NAME Arachidonic acid DME0224 XEOTICID XEO00876 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO00876 XEO_CLAS Investigative Agent DME0224 XEOTICID XEO00876 DESCRIPT Arachidonic acid inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00876 GENEFORM mRNA DME0224 XEOTICID XEO00876 MOACRIVE Inhibition DME0224 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0224 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0224 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00898 GENEFORM mRNA DME0224 XEOTICID XEO00898 MOACRIVE Inhibition DME0224 XEOTICID XEO00904 XEO_NAME Pentabromophenol DME0224 XEOTICID XEO00904 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO00904 XEO_CLAS Acute Toxic Substance DME0224 XEOTICID XEO00904 DESCRIPT Pentabromophenol inhibits the expression of DME HMGCR DME0224 XEOTICID XEO00904 GENEFORM mRNA DME0224 XEOTICID XEO00904 MOACRIVE Inhibition DME0224 XEOTICID XEO01006 XEO_NAME Dimethyl nitrosamine DME0224 XEOTICID XEO01006 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO01006 XEO_CLAS Carcinogen DME0224 XEOTICID XEO01006 DESCRIPT Dimethyl nitrosamine inhibits the expression of DME HMGCR DME0224 XEOTICID XEO01006 GENEFORM mRNA DME0224 XEOTICID XEO01006 MOACRIVE Inhibition DME0224 XEOTICID XEO01030 XEO_NAME Triparacresyl phosphate DME0224 XEOTICID XEO01030 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO01030 XEO_CLAS Health Hazard/Toxicant DME0224 XEOTICID XEO01030 DESCRIPT Triparacresyl phosphate up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO01030 GENEFORM mRNA DME0224 XEOTICID XEO01030 MOACRIVE Induction DME0224 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0224 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0224 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME HMGCR DME0224 XEOTICID XEO01031 GENEFORM mRNA DME0224 XEOTICID XEO01031 MOACRIVE Inhibition DME0224 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0224 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0224 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0224 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME HMGCR DME0224 XEOTICID XEO01050 GENEFORM mRNA DME0224 XEOTICID XEO01050 MOACRIVE Inhibition DME0224 XEOTICID XEO01116 XEO_NAME 25-hydroxycholesterol DME0224 XEOTICID XEO01116 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO01116 XEO_CLAS Health Hazard/Toxicant DME0224 XEOTICID XEO01116 DESCRIPT 25-hydroxycholesterol inhibits the drug-metabolizing activity of DME HMGCR in Human hepatocellular carcinoma cell line (HepG2) (IC50 = 0.3 microM) DME0224 XEOTICID XEO01116 GENEFORM Protein DME0224 XEOTICID XEO01116 MOACRIVE Inhibition DME0224 XEOTICID XEO01117 XEO_NAME 27-hydroxycholesterol DME0224 XEOTICID XEO01117 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO01117 XEO_CLAS Investigative Agent DME0224 XEOTICID XEO01117 DESCRIPT 27-hydroxycholesterol inhibits the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO01117 GENEFORM Protein DME0224 XEOTICID XEO01117 MOACRIVE Inhibition DME0224 XEOTICID XEO01200 XEO_NAME NSC-305787 DME0224 XEOTICID XEO01200 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO01200 XEO_CLAS Investigative Agent DME0224 XEOTICID XEO01200 DESCRIPT NSC-305787 induces the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO01200 GENEFORM Protein DME0224 XEOTICID XEO01200 MOACRIVE Induction DME0224 XEOTICID XEO01205 XEO_NAME Archazolid B DME0224 XEOTICID XEO01205 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO01205 XEO_CLAS Investigative Agent DME0224 XEOTICID XEO01205 DESCRIPT Archazolid B up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO01205 GENEFORM mRNA DME0224 XEOTICID XEO01205 MOACRIVE Induction DME0224 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0224 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0224 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME HMGCR DME0224 XEOTICID XEO01220 GENEFORM mRNA DME0224 XEOTICID XEO01220 MOACRIVE Inhibition DME0224 XEOTICID XEO01221 XEO_NAME Betulin DME0224 XEOTICID XEO01221 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0224 XEOTICID XEO01221 XEO_CLAS Natural Product DME0224 XEOTICID XEO01221 DESCRIPT Betulin inhibits the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO01221 GENEFORM Protein DME0224 XEOTICID XEO01221 MOACRIVE Inhibition DME0224 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0224 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0224 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME HMGCR and leads to increasing the drug-metabolizing activity of this enzyme DME0224 XEOTICID XEO01226 GENEFORM Protein DME0224 XEOTICID XEO01226 MOACRIVE Induction DME0224 XEOTICID XEO01250 XEO_NAME Cholesterol DME0224 XEOTICID XEO01250 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0224 XEOTICID XEO01250 XEO_CLAS Natural Product DME0224 XEOTICID XEO01250 DESCRIPT Cholesterol inhibits the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO01250 GENEFORM Protein DME0224 XEOTICID XEO01250 MOACRIVE Inhibition DME0224 XEOTICID XEO01289 XEO_NAME Enniatins DME0224 XEOTICID XEO01289 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO01289 XEO_CLAS Acute Toxic Substance DME0224 XEOTICID XEO01289 DESCRIPT Enniatins inhibits the expression of DME HMGCR DME0224 XEOTICID XEO01289 GENEFORM mRNA DME0224 XEOTICID XEO01289 MOACRIVE Inhibition DME0224 XEOTICID XEO01296 XEO_NAME Eucalyptol DME0224 XEOTICID XEO01296 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO01296 XEO_CLAS Health Hazard/Toxicant DME0224 XEOTICID XEO01296 DESCRIPT Eucalyptol inhibits the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO01296 GENEFORM Protein DME0224 XEOTICID XEO01296 MOACRIVE Inhibition DME0224 XEOTICID XEO01298 XEO_NAME Farnesol DME0224 XEOTICID XEO01298 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO01298 XEO_CLAS Investigative Agent DME0224 XEOTICID XEO01298 DESCRIPT Farnesol inhibits the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO01298 GENEFORM Protein DME0224 XEOTICID XEO01298 MOACRIVE Inhibition DME0224 XEOTICID XEO01299 XEO_NAME Fatostatin DME0224 XEOTICID XEO01299 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO01299 XEO_CLAS Acute Toxic Substance DME0224 XEOTICID XEO01299 DESCRIPT Fatostatin inhibits the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO01299 GENEFORM Protein DME0224 XEOTICID XEO01299 MOACRIVE Inhibition DME0224 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0224 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0224 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME HMGCR DME0224 XEOTICID XEO01305 GENEFORM mRNA DME0224 XEOTICID XEO01305 MOACRIVE Inhibition DME0224 XEOTICID XEO01310 XEO_NAME Ganoderic acid A DME0224 XEOTICID XEO01310 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0224 XEOTICID XEO01310 XEO_CLAS Natural Product DME0224 XEOTICID XEO01310 DESCRIPT Ganoderic acid A inhibits the expression of DME HMGCR DME0224 XEOTICID XEO01310 GENEFORM mRNA DME0224 XEOTICID XEO01310 MOACRIVE Inhibition DME0224 XEOTICID XEO01312 XEO_NAME Geraniol DME0224 XEOTICID XEO01312 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0224 XEOTICID XEO01312 XEO_CLAS Natural Product DME0224 XEOTICID XEO01312 DESCRIPT Geraniol inhibits the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO01312 GENEFORM Protein DME0224 XEOTICID XEO01312 MOACRIVE Inhibition DME0224 XEOTICID XEO01336 XEO_NAME ICG-001 DME0224 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0224 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME HMGCR DME0224 XEOTICID XEO01336 GENEFORM mRNA DME0224 XEOTICID XEO01336 MOACRIVE Inhibition DME0224 XEOTICID XEO01366 XEO_NAME Linalool DME0224 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0224 XEOTICID XEO01366 XEO_CLAS Natural Product DME0224 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO01366 GENEFORM Protein DME0224 XEOTICID XEO01366 MOACRIVE Inhibition DME0224 XEOTICID XEO01378 XEO_NAME Metribolone DME0224 XEOTICID XEO01378 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO01378 XEO_CLAS Investigative Agent DME0224 XEOTICID XEO01378 DESCRIPT Metribolone induces the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO01378 GENEFORM Protein DME0224 XEOTICID XEO01378 MOACRIVE Induction DME0224 XEOTICID XEO01379 XEO_NAME Mevalonic acid DME0224 XEOTICID XEO01379 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO01379 XEO_CLAS Investigative Agent DME0224 XEOTICID XEO01379 DESCRIPT Mevalonic acid inhibits the expression of DME HMGCR DME0224 XEOTICID XEO01379 GENEFORM mRNA DME0224 XEOTICID XEO01379 MOACRIVE Inhibition DME0224 XEOTICID XEO01380 XEO_NAME Mono-(2-ethylhexyl)phthalate DME0224 XEOTICID XEO01380 XEO_TYPE Pharmaceutical Agent(s) DME0224 XEOTICID XEO01380 XEO_CLAS Investigative Agent DME0224 XEOTICID XEO01380 DESCRIPT Mono-(2-ethylhexyl)phthalate up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO01380 GENEFORM mRNA DME0224 XEOTICID XEO01380 MOACRIVE Induction DME0224 XEOTICID XEO01409 XEO_NAME Okadaic acid DME0224 XEOTICID XEO01409 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO01409 XEO_CLAS Acute Toxic Substance DME0224 XEOTICID XEO01409 DESCRIPT Okadaic acid inhibits the expression of DME HMGCR DME0224 XEOTICID XEO01409 GENEFORM mRNA DME0224 XEOTICID XEO01409 MOACRIVE Inhibition DME0224 XEOTICID XEO01419 XEO_NAME Oxyquinoline DME0224 XEOTICID XEO01419 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO01419 XEO_CLAS Acute Toxic Substance DME0224 XEOTICID XEO01419 DESCRIPT Oxyquinoline inhibits the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO01419 GENEFORM Protein DME0224 XEOTICID XEO01419 MOACRIVE Inhibition DME0224 XEOTICID XEO01425 XEO_NAME PF-429242 DME0224 XEOTICID XEO01425 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO01425 XEO_CLAS Environmental Pollutant DME0224 XEOTICID XEO01425 DESCRIPT PF-429242 inhibits the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO01425 GENEFORM Protein DME0224 XEOTICID XEO01425 MOACRIVE Inhibition DME0224 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0224 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0224 XEOTICID XEO01494 XEO_CLAS Natural Product DME0224 XEOTICID XEO01494 DESCRIPT Tunicamycin A inhibits the expression of DME HMGCR DME0224 XEOTICID XEO01494 GENEFORM mRNA DME0224 XEOTICID XEO01494 MOACRIVE Inhibition DME0224 XEOTICID XEO01502 XEO_NAME Azaspiracid DME0224 XEOTICID XEO01502 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO01502 XEO_CLAS Biotoxin DME0224 XEOTICID XEO01502 DESCRIPT Azaspiracid up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO01502 GENEFORM mRNA DME0224 XEOTICID XEO01502 MOACRIVE Induction DME0224 XEOTICID XEO01514 XEO_NAME Deoxynivalenol DME0224 XEOTICID XEO01514 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO01514 XEO_CLAS Mycotoxin DME0224 XEOTICID XEO01514 DESCRIPT Deoxynivalenol inhibits the expression of DME HMGCR DME0224 XEOTICID XEO01514 GENEFORM mRNA DME0224 XEOTICID XEO01514 MOACRIVE Inhibition DME0224 XEOTICID XEO01515 XEO_NAME HT-2 toxin DME0224 XEOTICID XEO01515 XEO_TYPE Health or Environmental Toxicant(s) DME0224 XEOTICID XEO01515 XEO_CLAS Mycotoxin DME0224 XEOTICID XEO01515 DESCRIPT HT-2 toxin inhibits the expression of DME HMGCR DME0224 XEOTICID XEO01515 GENEFORM mRNA DME0224 XEOTICID XEO01515 MOACRIVE Inhibition DME0224 XEOTICID XEO01524 XEO_NAME Artemisic acid DME0224 XEOTICID XEO01524 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0224 XEOTICID XEO01524 XEO_CLAS Natural Product DME0224 XEOTICID XEO01524 DESCRIPT Artemisic acid inhibits the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO01524 GENEFORM Protein DME0224 XEOTICID XEO01524 MOACRIVE Inhibition DME0224 XEOTICID XEO01532 XEO_NAME Coconut oil DME0224 XEOTICID XEO01532 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0224 XEOTICID XEO01532 XEO_CLAS Plant Extract DME0224 XEOTICID XEO01532 DESCRIPT Coconut oil up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO01532 GENEFORM mRNA DME0224 XEOTICID XEO01532 MOACRIVE Induction DME0224 XEOTICID XEO01574 XEO_NAME Plant extracts DME0224 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0224 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0224 XEOTICID XEO01574 DESCRIPT Plant extracts induces the drug-metabolizing activity of DME HMGCR DME0224 XEOTICID XEO01574 GENEFORM Protein DME0224 XEOTICID XEO01574 MOACRIVE Induction DME0224 XEOTICID XEO01611 XEO_NAME Stigmasterol DME0224 XEOTICID XEO01611 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0224 XEOTICID XEO01611 XEO_CLAS Natural Product DME0224 XEOTICID XEO01611 DESCRIPT Stigmasterol up-regulates the expression of DME HMGCR DME0224 XEOTICID XEO01611 GENEFORM mRNA DME0224 XEOTICID XEO01611 MOACRIVE Induction DME0225 DME___ID DME0225 DME0225 DME_NAME Cytosolic phospholipase A2 (PLA2G4A) DME0225 SPESNAME Homo sapiens DME0225 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0225 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0225 XEOTICID XEO00011 DESCRIPT Carbamazepine inhibits the drug-metabolizing activity of DME PLA2G4A DME0225 XEOTICID XEO00011 GENEFORM Protein DME0225 XEOTICID XEO00011 MOACRIVE Inhibition DME0225 XEOTICID XEO00094 XEO_NAME Progesterone DME0225 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0225 XEOTICID XEO00094 DESCRIPT Progesterone up-regulates the expression of DME PLA2G4A DME0225 XEOTICID XEO00094 GENEFORM mRNA DME0225 XEOTICID XEO00094 MOACRIVE Induction DME0225 XEOTICID XEO00193 XEO_NAME Belinostat DME0225 XEOTICID XEO00193 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00193 XEO_CLAS Approved/Marketed Drug DME0225 XEOTICID XEO00193 DESCRIPT Belinostat up-regulates the expression of DME PLA2G4A DME0225 XEOTICID XEO00193 GENEFORM mRNA DME0225 XEOTICID XEO00193 MOACRIVE Induction DME0225 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0225 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0225 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME PLA2G4A DME0225 XEOTICID XEO00217 GENEFORM mRNA DME0225 XEOTICID XEO00217 MOACRIVE Inhibition DME0225 XEOTICID XEO00235 XEO_NAME Budesonide DME0225 XEOTICID XEO00235 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00235 XEO_CLAS Approved/Marketed Drug DME0225 XEOTICID XEO00235 DESCRIPT Budesonide inhibits the drug-metabolizing activity of DME PLA2G4A DME0225 XEOTICID XEO00235 GENEFORM Protein DME0225 XEOTICID XEO00235 MOACRIVE Inhibition DME0225 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0225 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0225 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME PLA2G4A DME0225 XEOTICID XEO00241 GENEFORM mRNA DME0225 XEOTICID XEO00241 MOACRIVE Inhibition DME0225 XEOTICID XEO00273 XEO_NAME Histamine DME0225 XEOTICID XEO00273 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00273 XEO_CLAS Approved/Marketed Drug DME0225 XEOTICID XEO00273 DESCRIPT Histamine up-regulates the expression of DME PLA2G4A DME0225 XEOTICID XEO00273 GENEFORM mRNA DME0225 XEOTICID XEO00273 MOACRIVE Induction DME0225 XEOTICID XEO00278 XEO_NAME Beclomethasone dipropionate DME0225 XEOTICID XEO00278 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00278 XEO_CLAS Approved/Marketed Drug DME0225 XEOTICID XEO00278 DESCRIPT Beclomethasone dipropionate inhibits the drug-metabolizing activity of DME PLA2G4A DME0225 XEOTICID XEO00278 GENEFORM Protein DME0225 XEOTICID XEO00278 MOACRIVE Inhibition DME0225 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0225 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0225 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME PLA2G4A DME0225 XEOTICID XEO00292 GENEFORM mRNA DME0225 XEOTICID XEO00292 MOACRIVE Inhibition DME0225 XEOTICID XEO00334 XEO_NAME Cisplatin DME0225 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0225 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME PLA2G4A DME0225 XEOTICID XEO00334 GENEFORM mRNA DME0225 XEOTICID XEO00334 MOACRIVE Inhibition DME0225 XEOTICID XEO00372 XEO_NAME Panobinostat DME0225 XEOTICID XEO00372 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00372 XEO_CLAS Approved/Marketed Drug DME0225 XEOTICID XEO00372 DESCRIPT Panobinostat induces the drug-metabolizing activity of DME PLA2G4A DME0225 XEOTICID XEO00372 GENEFORM Protein DME0225 XEOTICID XEO00372 MOACRIVE Induction DME0225 XEOTICID XEO00581 XEO_NAME MS-275 DME0225 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0225 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME PLA2G4A DME0225 XEOTICID XEO00581 GENEFORM mRNA DME0225 XEOTICID XEO00581 MOACRIVE Induction DME0225 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0225 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0225 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME PLA2G4A DME0225 XEOTICID XEO00632 GENEFORM mRNA DME0225 XEOTICID XEO00632 MOACRIVE Inhibition DME0225 XEOTICID XEO00760 XEO_NAME Jinfukang DME0225 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0225 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0225 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME PLA2G4A DME0225 XEOTICID XEO00760 GENEFORM mRNA DME0225 XEOTICID XEO00760 MOACRIVE Inhibition DME0225 XEOTICID XEO00817 XEO_NAME Melitten DME0225 XEOTICID XEO00817 XEO_TYPE Health or Environmental Toxicant(s) DME0225 XEOTICID XEO00817 XEO_CLAS Biotoxin DME0225 XEOTICID XEO00817 DESCRIPT Melitten inhibits the expression of DME PLA2G4A DME0225 XEOTICID XEO00817 GENEFORM mRNA DME0225 XEOTICID XEO00817 MOACRIVE Inhibition DME0225 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0225 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0225 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME PLA2G4A DME0225 XEOTICID XEO00818 GENEFORM mRNA DME0225 XEOTICID XEO00818 MOACRIVE Induction DME0225 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0225 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0225 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0225 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME PLA2G4A DME0225 XEOTICID XEO00821 GENEFORM mRNA DME0225 XEOTICID XEO00821 MOACRIVE Induction DME0225 XEOTICID XEO00876 XEO_NAME Arachidonic acid DME0225 XEOTICID XEO00876 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO00876 XEO_CLAS Investigative Agent DME0225 XEOTICID XEO00876 DESCRIPT Arachidonic acid induces the drug-metabolizing activity of DME PLA2G4A DME0225 XEOTICID XEO00876 GENEFORM Protein DME0225 XEOTICID XEO00876 MOACRIVE Induction DME0225 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0225 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0225 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0225 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME PLA2G4A DME0225 XEOTICID XEO00898 GENEFORM mRNA DME0225 XEOTICID XEO00898 MOACRIVE Inhibition DME0225 XEOTICID XEO00919 XEO_NAME Particulate matter DME0225 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0225 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0225 XEOTICID XEO00919 DESCRIPT Particulate matter up-regulates the expression of DME PLA2G4A DME0225 XEOTICID XEO00919 GENEFORM mRNA DME0225 XEOTICID XEO00919 MOACRIVE Induction DME0225 XEOTICID XEO01403 XEO_NAME NSC-668394 DME0225 XEOTICID XEO01403 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO01403 XEO_CLAS Preclinical/Patented Drug DME0225 XEOTICID XEO01403 DESCRIPT NSC-668394 induces the drug-metabolizing activity of DME PLA2G4A DME0225 XEOTICID XEO01403 GENEFORM Protein DME0225 XEOTICID XEO01403 MOACRIVE Induction DME0225 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0225 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0225 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0225 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME PLA2G4A DME0225 XEOTICID XEO01492 GENEFORM mRNA DME0225 XEOTICID XEO01492 MOACRIVE Induction DME0225 XEOTICID XEO01507 XEO_NAME Lead nitrate DME0225 XEOTICID XEO01507 XEO_TYPE Health or Environmental Toxicant(s) DME0225 XEOTICID XEO01507 XEO_CLAS Health Hazard/Toxicant DME0225 XEOTICID XEO01507 DESCRIPT Lead nitrate up-regulates the expression of DME PLA2G4A DME0225 XEOTICID XEO01507 GENEFORM mRNA DME0225 XEOTICID XEO01507 MOACRIVE Induction DME0227 DME___ID DME0227 DME0227 DME_NAME Retinoic acid 4-hydroxylase 26A1 (CYP26A1) DME0227 SPESNAME Homo sapiens DME0227 XEOTICID XEO00029 XEO_NAME Valproic acid DME0227 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0227 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME CYP26A1 DME0227 XEOTICID XEO00029 GENEFORM mRNA DME0227 XEOTICID XEO00029 MOACRIVE Inhibition DME0227 XEOTICID XEO00079 XEO_NAME Vorinostat DME0227 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0227 XEOTICID XEO00079 DESCRIPT Vorinostat inhibits the expression of DME CYP26A1 DME0227 XEOTICID XEO00079 GENEFORM mRNA DME0227 XEOTICID XEO00079 MOACRIVE Inhibition DME0227 XEOTICID XEO00144 XEO_NAME Bexarotene DME0227 XEOTICID XEO00144 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00144 XEO_CLAS Approved/Marketed Drug DME0227 XEOTICID XEO00144 DESCRIPT Bexarotene up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO00144 GENEFORM mRNA DME0227 XEOTICID XEO00144 MOACRIVE Induction DME0227 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0227 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0227 XEOTICID XEO00167 DESCRIPT Alitretinoin up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO00167 GENEFORM mRNA DME0227 XEOTICID XEO00167 MOACRIVE Induction DME0227 XEOTICID XEO00184 XEO_NAME Calcitriol DME0227 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0227 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO00184 GENEFORM mRNA DME0227 XEOTICID XEO00184 MOACRIVE Induction DME0227 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0227 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0227 XEOTICID XEO00186 DESCRIPT Isotretinoin up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO00186 GENEFORM mRNA DME0227 XEOTICID XEO00186 MOACRIVE Induction DME0227 XEOTICID XEO00193 XEO_NAME Belinostat DME0227 XEOTICID XEO00193 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00193 XEO_CLAS Approved/Marketed Drug DME0227 XEOTICID XEO00193 DESCRIPT Belinostat up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO00193 GENEFORM mRNA DME0227 XEOTICID XEO00193 MOACRIVE Induction DME0227 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0227 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0227 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYP26A1 DME0227 XEOTICID XEO00217 GENEFORM mRNA DME0227 XEOTICID XEO00217 MOACRIVE Inhibition DME0227 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0227 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0227 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME CYP26A1 DME0227 XEOTICID XEO00251 GENEFORM Protein DME0227 XEOTICID XEO00251 MOACRIVE Inhibition DME0227 XEOTICID XEO00253 XEO_NAME Tretinoin DME0227 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0227 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO00253 GENEFORM mRNA DME0227 XEOTICID XEO00253 MOACRIVE Induction DME0227 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0227 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0227 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO00277 GENEFORM mRNA DME0227 XEOTICID XEO00277 MOACRIVE Induction DME0227 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0227 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0227 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex inhibits the expression of DME CYP26A1 DME0227 XEOTICID XEO00312 GENEFORM mRNA DME0227 XEOTICID XEO00312 MOACRIVE Inhibition DME0227 XEOTICID XEO00401 XEO_NAME Beta carotene DME0227 XEOTICID XEO00401 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00401 XEO_CLAS Approved/Marketed Drug DME0227 XEOTICID XEO00401 DESCRIPT Beta carotene up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO00401 GENEFORM mRNA DME0227 XEOTICID XEO00401 MOACRIVE Induction DME0227 XEOTICID XEO00565 XEO_NAME Fenretinide DME0227 XEOTICID XEO00565 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00565 XEO_CLAS Drug in Phase 3 Clinical Trial DME0227 XEOTICID XEO00565 DESCRIPT Fenretinide up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO00565 GENEFORM mRNA DME0227 XEOTICID XEO00565 MOACRIVE Induction DME0227 XEOTICID XEO00581 XEO_NAME MS-275 DME0227 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0227 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO00581 GENEFORM mRNA DME0227 XEOTICID XEO00581 MOACRIVE Induction DME0227 XEOTICID XEO00607 XEO_NAME Liarozole DME0227 XEOTICID XEO00607 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00607 XEO_CLAS Drug in Phase 2 Clinical Trial DME0227 XEOTICID XEO00607 DESCRIPT Liarozole inhibits the drug-metabolizing activity of DME CYP26A1 (IC50 = 0.54 microM) DME0227 XEOTICID XEO00607 GENEFORM Protein DME0227 XEOTICID XEO00607 MOACRIVE Inhibition DME0227 XEOTICID XEO00666 XEO_NAME R-115866 DME0227 XEOTICID XEO00666 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00666 XEO_CLAS Drug in Phase 2 Clinical Trial DME0227 XEOTICID XEO00666 DESCRIPT R-115866 inhibits the drug-metabolizing activity of DME CYP26A1 in Spodoptera frugiperda (Sf9) cell (IC50 = 0.0051 microM) DME0227 XEOTICID XEO00666 GENEFORM Protein DME0227 XEOTICID XEO00666 MOACRIVE Inhibition DME0227 XEOTICID XEO00728 XEO_NAME AM-580 DME0227 XEOTICID XEO00728 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO00728 XEO_CLAS Preclinical/Patented Drug DME0227 XEOTICID XEO00728 DESCRIPT AM-580 up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO00728 GENEFORM mRNA DME0227 XEOTICID XEO00728 MOACRIVE Induction DME0227 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0227 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0227 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0227 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO00806 GENEFORM mRNA DME0227 XEOTICID XEO00806 MOACRIVE Induction DME0227 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0227 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0227 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0227 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO00999 GENEFORM mRNA DME0227 XEOTICID XEO00999 MOACRIVE Induction DME0227 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0227 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0227 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0227 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME CYP26A1 DME0227 XEOTICID XEO01004 GENEFORM mRNA DME0227 XEOTICID XEO01004 MOACRIVE Inhibition DME0227 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0227 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0227 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0227 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME CYP26A1 DME0227 XEOTICID XEO01031 GENEFORM mRNA DME0227 XEOTICID XEO01031 MOACRIVE Inhibition DME0227 XEOTICID XEO01034 XEO_NAME Pentanal DME0227 XEOTICID XEO01034 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0227 XEOTICID XEO01034 XEO_CLAS Chemical Compound DME0227 XEOTICID XEO01034 DESCRIPT Pentanal up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO01034 GENEFORM mRNA DME0227 XEOTICID XEO01034 MOACRIVE Induction DME0227 XEOTICID XEO01051 XEO_NAME Dieldrin DME0227 XEOTICID XEO01051 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0227 XEOTICID XEO01051 XEO_CLAS Pesticide/Insecticide DME0227 XEOTICID XEO01051 DESCRIPT Dieldrin up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO01051 GENEFORM mRNA DME0227 XEOTICID XEO01051 MOACRIVE Induction DME0227 XEOTICID XEO01074 XEO_NAME Endosulfan DME0227 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0227 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0227 XEOTICID XEO01074 DESCRIPT Endosulfan up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO01074 GENEFORM mRNA DME0227 XEOTICID XEO01074 MOACRIVE Induction DME0227 XEOTICID XEO01145 XEO_NAME 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid DME0227 XEOTICID XEO01145 XEO_TYPE Health or Environmental Toxicant(s) DME0227 XEOTICID XEO01145 XEO_CLAS Health Hazard/Toxicant DME0227 XEOTICID XEO01145 DESCRIPT 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO01145 GENEFORM mRNA DME0227 XEOTICID XEO01145 MOACRIVE Induction DME0227 XEOTICID XEO01154 XEO_NAME 4-oxoretinoic acid DME0227 XEOTICID XEO01154 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0227 XEOTICID XEO01154 XEO_CLAS Natural Product DME0227 XEOTICID XEO01154 DESCRIPT 4-oxoretinoic acid up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO01154 GENEFORM mRNA DME0227 XEOTICID XEO01154 MOACRIVE Induction DME0227 XEOTICID XEO01241 XEO_NAME CD-437 DME0227 XEOTICID XEO01241 XEO_TYPE Health or Environmental Toxicant(s) DME0227 XEOTICID XEO01241 XEO_CLAS Health Hazard/Toxicant DME0227 XEOTICID XEO01241 DESCRIPT CD-437 up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO01241 GENEFORM mRNA DME0227 XEOTICID XEO01241 MOACRIVE Induction DME0227 XEOTICID XEO01245 XEO_NAME Chlordan DME0227 XEOTICID XEO01245 XEO_TYPE Health or Environmental Toxicant(s) DME0227 XEOTICID XEO01245 XEO_CLAS Health Hazard/Toxicant DME0227 XEOTICID XEO01245 DESCRIPT Chlordan up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO01245 GENEFORM mRNA DME0227 XEOTICID XEO01245 MOACRIVE Induction DME0227 XEOTICID XEO01302 XEO_NAME Fipronil DME0227 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0227 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0227 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO01302 GENEFORM mRNA DME0227 XEOTICID XEO01302 MOACRIVE Induction DME0227 XEOTICID XEO01454 XEO_NAME Retinaldehyde DME0227 XEOTICID XEO01454 XEO_TYPE Health or Environmental Toxicant(s) DME0227 XEOTICID XEO01454 XEO_CLAS Health Hazard/Toxicant DME0227 XEOTICID XEO01454 DESCRIPT Retinaldehyde induces the drug-metabolizing activity of DME CYP26A1 DME0227 XEOTICID XEO01454 GENEFORM Protein DME0227 XEOTICID XEO01454 MOACRIVE Induction DME0227 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0227 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0227 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0227 XEOTICID XEO01492 DESCRIPT Trichostatin A induces the drug-metabolizing activity of DME CYP26A1 DME0227 XEOTICID XEO01492 GENEFORM Protein DME0227 XEOTICID XEO01492 MOACRIVE Induction DME0227 XEOTICID XEO01498 XEO_NAME Walrycin A DME0227 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0227 XEOTICID XEO01498 XEO_CLAS Natural Product DME0227 XEOTICID XEO01498 DESCRIPT Walrycin A up-regulates the expression of DME CYP26A1 DME0227 XEOTICID XEO01498 GENEFORM mRNA DME0227 XEOTICID XEO01498 MOACRIVE Induction DME0227 XEOTICID XEO01574 XEO_NAME Plant extracts DME0227 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0227 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0227 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME CYP26A1 DME0227 XEOTICID XEO01574 GENEFORM Protein DME0227 XEOTICID XEO01574 MOACRIVE Inhibition DME0230 DME___ID DME0230 DME0230 DME_NAME Tartrate-resistant acid ATPase (ACP5) DME0230 SPESNAME Homo sapiens DME0230 XEOTICID XEO00029 XEO_NAME Valproic acid DME0230 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0230 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0230 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME ACP5 DME0230 XEOTICID XEO00029 GENEFORM mRNA DME0230 XEOTICID XEO00029 MOACRIVE Inhibition DME0230 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0230 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0230 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0230 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME ACP5 DME0230 XEOTICID XEO00117 GENEFORM mRNA DME0230 XEOTICID XEO00117 MOACRIVE Inhibition DME0230 XEOTICID XEO00184 XEO_NAME Calcitriol DME0230 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0230 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0230 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the drug-metabolizing activity of DME ACP5 DME0230 XEOTICID XEO00184 GENEFORM Protein DME0230 XEOTICID XEO00184 MOACRIVE Inhibition DME0230 XEOTICID XEO00193 XEO_NAME Belinostat DME0230 XEOTICID XEO00193 XEO_TYPE Pharmaceutical Agent(s) DME0230 XEOTICID XEO00193 XEO_CLAS Approved/Marketed Drug DME0230 XEOTICID XEO00193 DESCRIPT Belinostat inhibits the expression of DME ACP5 DME0230 XEOTICID XEO00193 GENEFORM mRNA DME0230 XEOTICID XEO00193 MOACRIVE Inhibition DME0230 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0230 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0230 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0230 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME ACP5 DME0230 XEOTICID XEO00241 GENEFORM mRNA DME0230 XEOTICID XEO00241 MOACRIVE Inhibition DME0230 XEOTICID XEO00278 XEO_NAME Beclomethasone dipropionate DME0230 XEOTICID XEO00278 XEO_TYPE Pharmaceutical Agent(s) DME0230 XEOTICID XEO00278 XEO_CLAS Approved/Marketed Drug DME0230 XEOTICID XEO00278 DESCRIPT Beclomethasone dipropionate inhibits the drug-metabolizing activity of DME ACP5 DME0230 XEOTICID XEO00278 GENEFORM Protein DME0230 XEOTICID XEO00278 MOACRIVE Inhibition DME0230 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0230 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0230 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0230 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME ACP5 DME0230 XEOTICID XEO00292 GENEFORM mRNA DME0230 XEOTICID XEO00292 MOACRIVE Inhibition DME0230 XEOTICID XEO00334 XEO_NAME Cisplatin DME0230 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0230 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0230 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME ACP5 DME0230 XEOTICID XEO00334 GENEFORM mRNA DME0230 XEOTICID XEO00334 MOACRIVE Induction DME0230 XEOTICID XEO00474 XEO_NAME Maxacalcitol DME0230 XEOTICID XEO00474 XEO_TYPE Pharmaceutical Agent(s) DME0230 XEOTICID XEO00474 XEO_CLAS Approved/Marketed Drug DME0230 XEOTICID XEO00474 DESCRIPT Maxacalcitol inhibits the drug-metabolizing activity of DME ACP5 DME0230 XEOTICID XEO00474 GENEFORM Protein DME0230 XEOTICID XEO00474 MOACRIVE Inhibition DME0230 XEOTICID XEO00581 XEO_NAME MS-275 DME0230 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0230 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0230 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME ACP5 DME0230 XEOTICID XEO00581 GENEFORM mRNA DME0230 XEOTICID XEO00581 MOACRIVE Induction DME0230 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0230 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0230 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0230 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME ACP5 DME0230 XEOTICID XEO00723 GENEFORM mRNA DME0230 XEOTICID XEO00723 MOACRIVE Inhibition DME0230 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0230 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0230 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0230 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME ACP5 DME0230 XEOTICID XEO00806 GENEFORM mRNA DME0230 XEOTICID XEO00806 MOACRIVE Induction DME0230 XEOTICID XEO00836 XEO_NAME Aluminum oxide DME0230 XEOTICID XEO00836 XEO_TYPE Pharmaceutical Agent(s) DME0230 XEOTICID XEO00836 XEO_CLAS Approved/Marketed Drug DME0230 XEOTICID XEO00836 DESCRIPT Aluminum oxide inhibits the expression of DME ACP5 DME0230 XEOTICID XEO00836 GENEFORM mRNA DME0230 XEOTICID XEO00836 MOACRIVE Inhibition DME0230 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0230 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0230 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0230 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME ACP5 DME0230 XEOTICID XEO00898 GENEFORM mRNA DME0230 XEOTICID XEO00898 MOACRIVE Induction DME0230 XEOTICID XEO01022 XEO_NAME Polyethylene DME0230 XEOTICID XEO01022 XEO_TYPE Health or Environmental Toxicant(s) DME0230 XEOTICID XEO01022 XEO_CLAS Environmental Pollutant DME0230 XEOTICID XEO01022 DESCRIPT Polyethylene inhibits the expression of DME ACP5 DME0230 XEOTICID XEO01022 GENEFORM mRNA DME0230 XEOTICID XEO01022 MOACRIVE Inhibition DME0231 DME___ID DME0231 DME0231 DME_NAME Acid phosphatase-like protein 1 (ACP6) DME0231 SPESNAME Homo sapiens DME0231 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0231 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0231 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0231 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME ACP6 DME0231 XEOTICID XEO00117 GENEFORM mRNA DME0231 XEOTICID XEO00117 MOACRIVE Inhibition DME0231 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0231 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0231 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0231 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME ACP6 DME0231 XEOTICID XEO00186 GENEFORM mRNA DME0231 XEOTICID XEO00186 MOACRIVE Inhibition DME0231 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0231 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0231 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0231 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ACP6 DME0231 XEOTICID XEO00217 GENEFORM mRNA DME0231 XEOTICID XEO00217 MOACRIVE Inhibition DME0231 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0231 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0231 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0231 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME ACP6 DME0231 XEOTICID XEO00241 GENEFORM mRNA DME0231 XEOTICID XEO00241 MOACRIVE Inhibition DME0231 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0231 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0231 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0231 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME ACP6 DME0231 XEOTICID XEO00292 GENEFORM mRNA DME0231 XEOTICID XEO00292 MOACRIVE Inhibition DME0231 XEOTICID XEO00760 XEO_NAME Jinfukang DME0231 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0231 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0231 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME ACP6 DME0231 XEOTICID XEO00760 GENEFORM mRNA DME0231 XEOTICID XEO00760 MOACRIVE Induction DME0233 DME___ID DME0233 DME0233 DME_NAME Aldo-keto reductase 1C2 (AKR1C2) DME0233 SPESNAME Homo sapiens DME0233 XEOTICID XEO00007 XEO_NAME Azathioprine DME0233 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00007 DESCRIPT Azathioprine up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00007 GENEFORM mRNA DME0233 XEOTICID XEO00007 MOACRIVE Induction DME0233 XEOTICID XEO00014 XEO_NAME Chlorambucil DME0233 XEOTICID XEO00014 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00014 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00014 DESCRIPT Chlorambucil inhibits the expression of DME AKR1C2 DME0233 XEOTICID XEO00014 GENEFORM mRNA DME0233 XEOTICID XEO00014 MOACRIVE Inhibition DME0233 XEOTICID XEO00024 XEO_NAME Diazepam DME0233 XEOTICID XEO00024 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00024 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00024 DESCRIPT Diazepam inhibits the drug-metabolizing activity of DME AKR1C2 (IC50 = 2.4 microM) DME0233 XEOTICID XEO00024 GENEFORM Protein DME0233 XEOTICID XEO00024 MOACRIVE Inhibition DME0233 XEOTICID XEO00031 XEO_NAME Estazolam DME0233 XEOTICID XEO00031 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00031 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00031 DESCRIPT Estazolam inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00031 GENEFORM Protein DME0233 XEOTICID XEO00031 MOACRIVE Inhibition DME0233 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0233 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00035 GENEFORM mRNA DME0233 XEOTICID XEO00035 MOACRIVE Induction DME0233 XEOTICID XEO00044 XEO_NAME Glipizide DME0233 XEOTICID XEO00044 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00044 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00044 DESCRIPT Glipizide inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00044 GENEFORM Protein DME0233 XEOTICID XEO00044 MOACRIVE Inhibition DME0233 XEOTICID XEO00046 XEO_NAME Ifosfamide DME0233 XEOTICID XEO00046 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00046 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00046 DESCRIPT Ifosfamide up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00046 GENEFORM mRNA DME0233 XEOTICID XEO00046 MOACRIVE Induction DME0233 XEOTICID XEO00047 XEO_NAME Indomethacin DME0233 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00047 DESCRIPT Indomethacin inhibits the drug-metabolizing activity of DME AKR1C2 (IC50 = 36.53 microM) DME0233 XEOTICID XEO00047 GENEFORM Protein DME0233 XEOTICID XEO00047 MOACRIVE Inhibition DME0233 XEOTICID XEO00090 XEO_NAME Estradiol DME0233 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00090 GENEFORM mRNA DME0233 XEOTICID XEO00090 MOACRIVE Induction DME0233 XEOTICID XEO00096 XEO_NAME Ampicillin DME0233 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the expression of DME AKR1C2 DME0233 XEOTICID XEO00096 GENEFORM mRNA DME0233 XEOTICID XEO00096 MOACRIVE Inhibition DME0233 XEOTICID XEO00156 XEO_NAME Naproxen DME0233 XEOTICID XEO00156 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00156 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00156 DESCRIPT Naproxen inhibits the drug-metabolizing activity of DME AKR1C2 (IC50 = 31.3 microM) DME0233 XEOTICID XEO00156 GENEFORM Protein DME0233 XEOTICID XEO00156 MOACRIVE Inhibition DME0233 XEOTICID XEO00192 XEO_NAME Dutasteride DME0233 XEOTICID XEO00192 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00192 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00192 DESCRIPT Dutasteride up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00192 GENEFORM mRNA DME0233 XEOTICID XEO00192 MOACRIVE Induction DME0233 XEOTICID XEO00213 XEO_NAME Aspirin DME0233 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00213 DESCRIPT Aspirin inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00213 GENEFORM Protein DME0233 XEOTICID XEO00213 MOACRIVE Inhibition DME0233 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0233 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME AKR1C2 DME0233 XEOTICID XEO00217 GENEFORM mRNA DME0233 XEOTICID XEO00217 MOACRIVE Inhibition DME0233 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0233 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00241 GENEFORM mRNA DME0233 XEOTICID XEO00241 MOACRIVE Induction DME0233 XEOTICID XEO00247 XEO_NAME Glyburide DME0233 XEOTICID XEO00247 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00247 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00247 DESCRIPT Glyburide inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00247 GENEFORM Protein DME0233 XEOTICID XEO00247 MOACRIVE Inhibition DME0233 XEOTICID XEO00248 XEO_NAME Ibuprofen DME0233 XEOTICID XEO00248 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00248 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00248 DESCRIPT Ibuprofen inhibits the drug-metabolizing activity of DME AKR1C2 (IC50 = 42.4 microM) DME0233 XEOTICID XEO00248 GENEFORM Protein DME0233 XEOTICID XEO00248 MOACRIVE Inhibition DME0233 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0233 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME AKR1C2 DME0233 XEOTICID XEO00292 GENEFORM mRNA DME0233 XEOTICID XEO00292 MOACRIVE Inhibition DME0233 XEOTICID XEO00296 XEO_NAME Flurbiprofen sodium DME0233 XEOTICID XEO00296 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00296 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00296 DESCRIPT Flurbiprofen sodium inhibits the drug-metabolizing activity of DME AKR1C2 (IC50 = 32.5 microM) DME0233 XEOTICID XEO00296 GENEFORM Protein DME0233 XEOTICID XEO00296 MOACRIVE Inhibition DME0233 XEOTICID XEO00334 XEO_NAME Cisplatin DME0233 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME AKR1C2 DME0233 XEOTICID XEO00334 GENEFORM mRNA DME0233 XEOTICID XEO00334 MOACRIVE Inhibition DME0233 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0233 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00339 GENEFORM mRNA DME0233 XEOTICID XEO00339 MOACRIVE Induction DME0233 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0233 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00388 GENEFORM mRNA DME0233 XEOTICID XEO00388 MOACRIVE Induction DME0233 XEOTICID XEO00403 XEO_NAME Dydrogesterone DME0233 XEOTICID XEO00403 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00403 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00403 DESCRIPT Dydrogesterone inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00403 GENEFORM Protein DME0233 XEOTICID XEO00403 MOACRIVE Inhibition DME0233 XEOTICID XEO00411 XEO_NAME Avobenzone DME0233 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00411 GENEFORM mRNA DME0233 XEOTICID XEO00411 MOACRIVE Induction DME0233 XEOTICID XEO00415 XEO_NAME Meclofenamic acid DME0233 XEOTICID XEO00415 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00415 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00415 DESCRIPT Meclofenamic acid inhibits the drug-metabolizing activity of DME AKR1C2 (IC50 = 8.74 microM) DME0233 XEOTICID XEO00415 GENEFORM Protein DME0233 XEOTICID XEO00415 MOACRIVE Inhibition DME0233 XEOTICID XEO00428 XEO_NAME Menadione DME0233 XEOTICID XEO00428 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00428 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00428 DESCRIPT Menadione up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00428 GENEFORM mRNA DME0233 XEOTICID XEO00428 MOACRIVE Induction DME0233 XEOTICID XEO00433 XEO_NAME Dienogest DME0233 XEOTICID XEO00433 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00433 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00433 DESCRIPT Dienogest inhibits the expression of DME AKR1C2 DME0233 XEOTICID XEO00433 GENEFORM mRNA DME0233 XEOTICID XEO00433 MOACRIVE Inhibition DME0233 XEOTICID XEO00435 XEO_NAME Urethane DME0233 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00435 DESCRIPT Urethane inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00435 GENEFORM Protein DME0233 XEOTICID XEO00435 MOACRIVE Inhibition DME0233 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME0233 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00460 DESCRIPT Zinc sulfate up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00460 GENEFORM mRNA DME0233 XEOTICID XEO00460 MOACRIVE Induction DME0233 XEOTICID XEO00465 XEO_NAME Clodronic acid DME0233 XEOTICID XEO00465 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00465 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00465 DESCRIPT Clodronic acid up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00465 GENEFORM mRNA DME0233 XEOTICID XEO00465 MOACRIVE Induction DME0233 XEOTICID XEO00470 XEO_NAME Flufenamic acid DME0233 XEOTICID XEO00470 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00470 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00470 DESCRIPT Flufenamic acid inhibits the drug-metabolizing activity of DME AKR1C2 (IC50 = 0.37 microM) DME0233 XEOTICID XEO00470 GENEFORM Protein DME0233 XEOTICID XEO00470 MOACRIVE Inhibition DME0233 XEOTICID XEO00492 XEO_NAME Benzbromarone DME0233 XEOTICID XEO00492 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00492 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00492 DESCRIPT Benzbromarone inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00492 GENEFORM Protein DME0233 XEOTICID XEO00492 MOACRIVE Inhibition DME0233 XEOTICID XEO00498 XEO_NAME Flunitrazepam DME0233 XEOTICID XEO00498 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00498 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00498 DESCRIPT Flunitrazepam inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00498 GENEFORM Protein DME0233 XEOTICID XEO00498 MOACRIVE Inhibition DME0233 XEOTICID XEO00501 XEO_NAME Gliquidone DME0233 XEOTICID XEO00501 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00501 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00501 DESCRIPT Gliquidone inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00501 GENEFORM Protein DME0233 XEOTICID XEO00501 MOACRIVE Inhibition DME0233 XEOTICID XEO00521 XEO_NAME Phenolphthalein DME0233 XEOTICID XEO00521 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00521 XEO_CLAS Drug Marketed but Withdrawn from Market DME0233 XEOTICID XEO00521 DESCRIPT Phenolphthalein inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00521 GENEFORM Protein DME0233 XEOTICID XEO00521 MOACRIVE Inhibition DME0233 XEOTICID XEO00538 XEO_NAME Quercetin DME0233 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0233 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME AKR1C2 DME0233 XEOTICID XEO00538 GENEFORM mRNA DME0233 XEOTICID XEO00538 MOACRIVE Inhibition DME0233 XEOTICID XEO00546 XEO_NAME Salicylic acid DME0233 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME0233 XEOTICID XEO00546 DESCRIPT Salicylic acid up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00546 GENEFORM mRNA DME0233 XEOTICID XEO00546 MOACRIVE Induction DME0233 XEOTICID XEO00547 XEO_NAME Vitamin E DME0233 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0233 XEOTICID XEO00547 DESCRIPT Vitamin E up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00547 GENEFORM mRNA DME0233 XEOTICID XEO00547 MOACRIVE Induction DME0233 XEOTICID XEO00550 XEO_NAME Nitrazepam DME0233 XEOTICID XEO00550 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00550 XEO_CLAS Drug in Phase 3 Clinical Trial DME0233 XEOTICID XEO00550 DESCRIPT Nitrazepam inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00550 GENEFORM Protein DME0233 XEOTICID XEO00550 MOACRIVE Inhibition DME0233 XEOTICID XEO00581 XEO_NAME MS-275 DME0233 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0233 XEOTICID XEO00581 DESCRIPT MS-275 inhibits the expression of DME AKR1C2 DME0233 XEOTICID XEO00581 GENEFORM mRNA DME0233 XEOTICID XEO00581 MOACRIVE Inhibition DME0233 XEOTICID XEO00599 XEO_NAME Tetradecanoylphorbol acetate DME0233 XEOTICID XEO00599 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00599 XEO_CLAS Drug in Phase 1 Clinical Trial DME0233 XEOTICID XEO00599 DESCRIPT Tetradecanoylphorbol acetate inhibits the expression of DME AKR1C2 DME0233 XEOTICID XEO00599 GENEFORM mRNA DME0233 XEOTICID XEO00599 MOACRIVE Inhibition DME0233 XEOTICID XEO00706 XEO_NAME Tripterine DME0233 XEOTICID XEO00706 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00706 XEO_CLAS Preclinical/Patented Drug DME0233 XEOTICID XEO00706 DESCRIPT Tripterine up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00706 GENEFORM mRNA DME0233 XEOTICID XEO00706 MOACRIVE Induction DME0233 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0233 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0233 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME AKR1C2 DME0233 XEOTICID XEO00723 GENEFORM mRNA DME0233 XEOTICID XEO00723 MOACRIVE Inhibition DME0233 XEOTICID XEO00727 XEO_NAME Vanillin DME0233 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME0233 XEOTICID XEO00727 DESCRIPT Vanillin up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00727 GENEFORM mRNA DME0233 XEOTICID XEO00727 MOACRIVE Induction DME0233 XEOTICID XEO00743 XEO_NAME Medroxyprogesterone acetate DME0233 XEOTICID XEO00743 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00743 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00743 DESCRIPT Medroxyprogesterone acetate inhibits the drug-metabolizing activity of DME AKR1C2 (IC50 = 1.6 microM) DME0233 XEOTICID XEO00743 GENEFORM Protein DME0233 XEOTICID XEO00743 MOACRIVE Inhibition DME0233 XEOTICID XEO00745 XEO_NAME Adefovir dipivoxil DME0233 XEOTICID XEO00745 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00745 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00745 DESCRIPT Adefovir dipivoxil inhibits the expression of DME AKR1C2 DME0233 XEOTICID XEO00745 GENEFORM mRNA DME0233 XEOTICID XEO00745 MOACRIVE Inhibition DME0233 XEOTICID XEO00760 XEO_NAME Jinfukang DME0233 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0233 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0233 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00760 GENEFORM mRNA DME0233 XEOTICID XEO00760 MOACRIVE Induction DME0233 XEOTICID XEO00766 XEO_NAME 1,10-phenanthroline DME0233 XEOTICID XEO00766 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0233 XEOTICID XEO00766 XEO_CLAS Chemical Compound DME0233 XEOTICID XEO00766 DESCRIPT 1,10-phenanthroline inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00766 GENEFORM Protein DME0233 XEOTICID XEO00766 MOACRIVE Inhibition DME0233 XEOTICID XEO00769 XEO_NAME Hexestrol DME0233 XEOTICID XEO00769 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00769 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO00769 DESCRIPT Hexestrol inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00769 GENEFORM Protein DME0233 XEOTICID XEO00769 MOACRIVE Inhibition DME0233 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0233 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0233 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0233 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00772 GENEFORM mRNA DME0233 XEOTICID XEO00772 MOACRIVE Induction DME0233 XEOTICID XEO00783 XEO_NAME Ethyl acrylate DME0233 XEOTICID XEO00783 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0233 XEOTICID XEO00783 XEO_CLAS Chemical Compound DME0233 XEOTICID XEO00783 DESCRIPT Ethyl acrylate up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00783 GENEFORM mRNA DME0233 XEOTICID XEO00783 MOACRIVE Induction DME0233 XEOTICID XEO00787 XEO_NAME Lithocholic acid DME0233 XEOTICID XEO00787 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00787 XEO_CLAS Investigative Agent DME0233 XEOTICID XEO00787 DESCRIPT Lithocholic acid inhibits the expression of DME AKR1C2 DME0233 XEOTICID XEO00787 GENEFORM mRNA DME0233 XEOTICID XEO00787 MOACRIVE Inhibition DME0233 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0233 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0233 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate induces the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00818 GENEFORM Protein DME0233 XEOTICID XEO00818 MOACRIVE Induction DME0233 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0233 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0233 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0233 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00821 GENEFORM mRNA DME0233 XEOTICID XEO00821 MOACRIVE Induction DME0233 XEOTICID XEO00885 XEO_NAME Eugenol DME0233 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0233 XEOTICID XEO00885 DESCRIPT Eugenol up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00885 GENEFORM mRNA DME0233 XEOTICID XEO00885 MOACRIVE Induction DME0233 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0233 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0233 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0233 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00898 GENEFORM mRNA DME0233 XEOTICID XEO00898 MOACRIVE Induction DME0233 XEOTICID XEO00919 XEO_NAME Particulate matter DME0233 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0233 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0233 XEOTICID XEO00919 DESCRIPT Particulate matter induces the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO00919 GENEFORM Protein DME0233 XEOTICID XEO00919 MOACRIVE Induction DME0233 XEOTICID XEO00971 XEO_NAME Diquat DME0233 XEOTICID XEO00971 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0233 XEOTICID XEO00971 XEO_CLAS Herbicide DME0233 XEOTICID XEO00971 DESCRIPT Diquat up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00971 GENEFORM mRNA DME0233 XEOTICID XEO00971 MOACRIVE Induction DME0233 XEOTICID XEO00973 XEO_NAME Diuron DME0233 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0233 XEOTICID XEO00973 XEO_CLAS Herbicide DME0233 XEOTICID XEO00973 DESCRIPT Diuron up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO00973 GENEFORM mRNA DME0233 XEOTICID XEO00973 MOACRIVE Induction DME0233 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0233 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0233 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0233 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO01004 GENEFORM mRNA DME0233 XEOTICID XEO01004 MOACRIVE Induction DME0233 XEOTICID XEO01009 XEO_NAME Glycidamide DME0233 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0233 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0233 XEOTICID XEO01009 DESCRIPT Glycidamide up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO01009 GENEFORM mRNA DME0233 XEOTICID XEO01009 MOACRIVE Induction DME0233 XEOTICID XEO01105 XEO_NAME 1-phenyl-1,2-propanedione DME0233 XEOTICID XEO01105 XEO_TYPE Health or Environmental Toxicant(s) DME0233 XEOTICID XEO01105 XEO_CLAS Health Hazard/Toxicant DME0233 XEOTICID XEO01105 DESCRIPT 1-phenyl-1,2-propanedione up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO01105 GENEFORM mRNA DME0233 XEOTICID XEO01105 MOACRIVE Induction DME0233 XEOTICID XEO01201 XEO_NAME Antimony potassium tartrate DME0233 XEOTICID XEO01201 XEO_TYPE Health or Environmental Toxicant(s) DME0233 XEOTICID XEO01201 XEO_CLAS Environmental Pollutant DME0233 XEOTICID XEO01201 DESCRIPT Antimony potassium tartrate induces the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO01201 GENEFORM Protein DME0233 XEOTICID XEO01201 MOACRIVE Induction DME0233 XEOTICID XEO01233 XEO_NAME Phenethyl caffeate DME0233 XEOTICID XEO01233 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO01233 XEO_CLAS Drug in Phase 1 Clinical Trial DME0233 XEOTICID XEO01233 DESCRIPT Phenethyl caffeate inhibits the drug-metabolizing activity of DME AKR1C2 (IC50 = 6 microM) DME0233 XEOTICID XEO01233 GENEFORM Protein DME0233 XEOTICID XEO01233 MOACRIVE Inhibition DME0233 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0233 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0233 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0233 XEOTICID XEO01247 DESCRIPT Chloropicrin up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO01247 GENEFORM mRNA DME0233 XEOTICID XEO01247 MOACRIVE Induction DME0233 XEOTICID XEO01258 XEO_NAME Cloxazolam DME0233 XEOTICID XEO01258 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO01258 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO01258 DESCRIPT Cloxazolam inhibits the drug-metabolizing activity of DME AKR1C2 (Ki > 10 microM) DME0233 XEOTICID XEO01258 GENEFORM Protein DME0233 XEOTICID XEO01258 MOACRIVE Inhibition DME0233 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0233 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0233 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0233 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO01305 GENEFORM mRNA DME0233 XEOTICID XEO01305 MOACRIVE Induction DME0233 XEOTICID XEO01311 XEO_NAME Gedunin DME0233 XEOTICID XEO01311 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0233 XEOTICID XEO01311 XEO_CLAS Natural Product DME0233 XEOTICID XEO01311 DESCRIPT Gedunin up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO01311 GENEFORM mRNA DME0233 XEOTICID XEO01311 MOACRIVE Induction DME0233 XEOTICID XEO01319 XEO_NAME Glycyrrhetinic acid DME0233 XEOTICID XEO01319 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO01319 XEO_CLAS Approved/Marketed Drug DME0233 XEOTICID XEO01319 DESCRIPT Glycyrrhetinic acid inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO01319 GENEFORM Protein DME0233 XEOTICID XEO01319 MOACRIVE Inhibition DME0233 XEOTICID XEO01348 XEO_NAME K-7174 DME0233 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0233 XEOTICID XEO01348 DESCRIPT K-7174 up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO01348 GENEFORM mRNA DME0233 XEOTICID XEO01348 MOACRIVE Induction DME0233 XEOTICID XEO01366 XEO_NAME Linalool DME0233 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0233 XEOTICID XEO01366 XEO_CLAS Natural Product DME0233 XEOTICID XEO01366 DESCRIPT Linalool up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO01366 GENEFORM mRNA DME0233 XEOTICID XEO01366 MOACRIVE Induction DME0233 XEOTICID XEO01408 XEO_NAME Octyl gallate DME0233 XEOTICID XEO01408 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0233 XEOTICID XEO01408 XEO_CLAS Natural Product DME0233 XEOTICID XEO01408 DESCRIPT Octyl gallate inhibits the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO01408 GENEFORM Protein DME0233 XEOTICID XEO01408 MOACRIVE Inhibition DME0233 XEOTICID XEO01450 XEO_NAME Quinone DME0233 XEOTICID XEO01450 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0233 XEOTICID XEO01450 XEO_CLAS Natural Product DME0233 XEOTICID XEO01450 DESCRIPT Quinone up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO01450 GENEFORM mRNA DME0233 XEOTICID XEO01450 MOACRIVE Induction DME0233 XEOTICID XEO01478 XEO_NAME Sulforafan DME0233 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0233 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0233 XEOTICID XEO01478 DESCRIPT Sulforafan induces the drug-metabolizing activity of DME AKR1C2 DME0233 XEOTICID XEO01478 GENEFORM Protein DME0233 XEOTICID XEO01478 MOACRIVE Induction DME0233 XEOTICID XEO01503 XEO_NAME Cadmium DME0233 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0233 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0233 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO01503 GENEFORM mRNA DME0233 XEOTICID XEO01503 MOACRIVE Induction DME0233 XEOTICID XEO01504 XEO_NAME Gold DME0233 XEOTICID XEO01504 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0233 XEOTICID XEO01504 XEO_CLAS Chemical Compound DME0233 XEOTICID XEO01504 DESCRIPT Gold up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO01504 GENEFORM mRNA DME0233 XEOTICID XEO01504 MOACRIVE Induction DME0233 XEOTICID XEO01506 XEO_NAME Lead chloride DME0233 XEOTICID XEO01506 XEO_TYPE Health or Environmental Toxicant(s) DME0233 XEOTICID XEO01506 XEO_CLAS Health Hazard/Toxicant DME0233 XEOTICID XEO01506 DESCRIPT Lead chloride up-regulates the expression of DME AKR1C2 DME0233 XEOTICID XEO01506 GENEFORM mRNA DME0233 XEOTICID XEO01506 MOACRIVE Induction DME0234 DME___ID DME0234 DME0234 DME_NAME Succinic semialdehyde reductase (AKR7A2) DME0234 SPESNAME Homo sapiens DME0234 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0234 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0234 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0234 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME AKR7A2 DME0234 XEOTICID XEO00117 GENEFORM mRNA DME0234 XEOTICID XEO00117 MOACRIVE Inhibition DME0234 XEOTICID XEO00204 XEO_NAME Piroxicam DME0234 XEOTICID XEO00204 XEO_TYPE Pharmaceutical Agent(s) DME0234 XEOTICID XEO00204 XEO_CLAS Approved/Marketed Drug DME0234 XEOTICID XEO00204 DESCRIPT Piroxicam inhibits the drug-metabolizing activity of DME AKR7A2 DME0234 XEOTICID XEO00204 GENEFORM Protein DME0234 XEOTICID XEO00204 MOACRIVE Inhibition DME0234 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0234 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0234 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0234 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME AKR7A2 DME0234 XEOTICID XEO00217 GENEFORM mRNA DME0234 XEOTICID XEO00217 MOACRIVE Induction DME0234 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0234 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0234 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0234 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME AKR7A2 DME0234 XEOTICID XEO00241 GENEFORM mRNA DME0234 XEOTICID XEO00241 MOACRIVE Inhibition DME0234 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0234 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0234 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0234 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME AKR7A2 DME0234 XEOTICID XEO00292 GENEFORM mRNA DME0234 XEOTICID XEO00292 MOACRIVE Inhibition DME0234 XEOTICID XEO00334 XEO_NAME Cisplatin DME0234 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0234 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0234 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME AKR7A2 DME0234 XEOTICID XEO00334 GENEFORM mRNA DME0234 XEOTICID XEO00334 MOACRIVE Induction DME0234 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0234 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0234 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0234 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide induces the drug-metabolizing activity of DME AKR7A2 DME0234 XEOTICID XEO00388 GENEFORM Protein DME0234 XEOTICID XEO00388 MOACRIVE Induction DME0234 XEOTICID XEO00760 XEO_NAME Jinfukang DME0234 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0234 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0234 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME AKR7A2 DME0234 XEOTICID XEO00760 GENEFORM mRNA DME0234 XEOTICID XEO00760 MOACRIVE Induction DME0234 XEOTICID XEO00869 XEO_NAME 4-hydroxy-2-nonenal DME0234 XEOTICID XEO00869 XEO_TYPE Pharmaceutical Agent(s) DME0234 XEOTICID XEO00869 XEO_CLAS Investigative Agent DME0234 XEOTICID XEO00869 DESCRIPT 4-hydroxy-2-nonenal induces the drug-metabolizing activity of DME AKR7A2 DME0234 XEOTICID XEO00869 GENEFORM Protein DME0234 XEOTICID XEO00869 MOACRIVE Induction DME0234 XEOTICID XEO01095 XEO_NAME 14-deoxy-11,12-didehydroandrographolide DME0234 XEOTICID XEO01095 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0234 XEOTICID XEO01095 XEO_CLAS Natural Product DME0234 XEOTICID XEO01095 DESCRIPT 14-deoxy-11,12-didehydroandrographolide inhibits the expression of DME AKR7A2 DME0234 XEOTICID XEO01095 GENEFORM mRNA DME0234 XEOTICID XEO01095 MOACRIVE Inhibition DME0234 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME0234 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0234 XEOTICID XEO01174 XEO_CLAS Natural Product DME0234 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin induces the drug-metabolizing activity of DME AKR7A2 DME0234 XEOTICID XEO01174 GENEFORM Protein DME0234 XEOTICID XEO01174 MOACRIVE Induction DME0234 XEOTICID XEO01336 XEO_NAME ICG-001 DME0234 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0234 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0234 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME AKR7A2 DME0234 XEOTICID XEO01336 GENEFORM mRNA DME0234 XEOTICID XEO01336 MOACRIVE Induction DME0234 XEOTICID XEO01448 XEO_NAME Pyruvaldehyde DME0234 XEOTICID XEO01448 XEO_TYPE Health or Environmental Toxicant(s) DME0234 XEOTICID XEO01448 XEO_CLAS Health Hazard/Toxicant DME0234 XEOTICID XEO01448 DESCRIPT Pyruvaldehyde induces the drug-metabolizing activity of DME AKR7A2 DME0234 XEOTICID XEO01448 GENEFORM Protein DME0234 XEOTICID XEO01448 MOACRIVE Induction DME0244 DME___ID DME0244 DME0244 DME_NAME Eosinophil peroxidase (EPX) DME0244 SPESNAME Homo sapiens DME0244 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0244 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0244 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0244 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME EPX DME0244 XEOTICID XEO00217 GENEFORM mRNA DME0244 XEOTICID XEO00217 MOACRIVE Induction DME0244 XEOTICID XEO00253 XEO_NAME Tretinoin DME0244 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0244 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0244 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME EPX DME0244 XEOTICID XEO00253 GENEFORM mRNA DME0244 XEOTICID XEO00253 MOACRIVE Inhibition DME0244 XEOTICID XEO00334 XEO_NAME Cisplatin DME0244 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0244 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0244 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME EPX DME0244 XEOTICID XEO00334 GENEFORM mRNA DME0244 XEOTICID XEO00334 MOACRIVE Inhibition DME0244 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0244 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0244 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0244 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME EPX DME0244 XEOTICID XEO00339 GENEFORM mRNA DME0244 XEOTICID XEO00339 MOACRIVE Induction DME0244 XEOTICID XEO00461 XEO_NAME Arbutin DME0244 XEOTICID XEO00461 XEO_TYPE Pharmaceutical Agent(s) DME0244 XEOTICID XEO00461 XEO_CLAS Approved/Marketed Drug DME0244 XEOTICID XEO00461 DESCRIPT Arbutin up-regulates the expression of DME EPX DME0244 XEOTICID XEO00461 GENEFORM mRNA DME0244 XEOTICID XEO00461 MOACRIVE Induction DME0244 XEOTICID XEO00680 XEO_NAME Lanthanum Chloride Hydroxide DME0244 XEOTICID XEO00680 XEO_TYPE Pharmaceutical Agent(s) DME0244 XEOTICID XEO00680 XEO_CLAS Drug in Phase 1 Clinical Trial DME0244 XEOTICID XEO00680 DESCRIPT Lanthanum Chloride Hydroxide up-regulates the expression of DME EPX DME0244 XEOTICID XEO00680 GENEFORM mRNA DME0244 XEOTICID XEO00680 MOACRIVE Induction DME0244 XEOTICID XEO01230 XEO_NAME Butyric acid DME0244 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0244 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0244 XEOTICID XEO01230 DESCRIPT Butyric acid induces the drug-metabolizing activity of DME EPX DME0244 XEOTICID XEO01230 GENEFORM Protein DME0244 XEOTICID XEO01230 MOACRIVE Induction DME0246 DME___ID DME0246 DME0246 DME_NAME Lactoperoxidase (LPO) DME0246 SPESNAME Homo sapiens DME0246 XEOTICID XEO00334 XEO_NAME Cisplatin DME0246 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0246 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0246 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME LPO DME0246 XEOTICID XEO00334 GENEFORM mRNA DME0246 XEOTICID XEO00334 MOACRIVE Inhibition DME0246 XEOTICID XEO00573 XEO_NAME Naringenin DME0246 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME0246 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME0246 XEOTICID XEO00573 DESCRIPT Naringenin induces the drug-metabolizing activity of DME LPO DME0246 XEOTICID XEO00573 GENEFORM Protein DME0246 XEOTICID XEO00573 MOACRIVE Induction DME0246 XEOTICID XEO00680 XEO_NAME Lanthanum Chloride Hydroxide DME0246 XEOTICID XEO00680 XEO_TYPE Pharmaceutical Agent(s) DME0246 XEOTICID XEO00680 XEO_CLAS Drug in Phase 1 Clinical Trial DME0246 XEOTICID XEO00680 DESCRIPT Lanthanum Chloride Hydroxide up-regulates the expression of DME LPO DME0246 XEOTICID XEO00680 GENEFORM mRNA DME0246 XEOTICID XEO00680 MOACRIVE Induction DME0246 XEOTICID XEO01422 XEO_NAME Paraquat DME0246 XEOTICID XEO01422 XEO_TYPE Health or Environmental Toxicant(s) DME0246 XEOTICID XEO01422 XEO_CLAS Acute Toxic Substance DME0246 XEOTICID XEO01422 DESCRIPT Paraquat up-regulates the expression of DME LPO DME0246 XEOTICID XEO01422 GENEFORM mRNA DME0246 XEOTICID XEO01422 MOACRIVE Induction DME0250 DME___ID DME0250 DME0250 DME_NAME Xylosyl phosphatase (PXYLP1) DME0250 SPESNAME Homo sapiens DME0250 XEOTICID XEO00007 XEO_NAME Azathioprine DME0250 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0250 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0250 XEOTICID XEO00007 DESCRIPT Azathioprine inhibits the expression of DME PXYLP1 DME0250 XEOTICID XEO00007 GENEFORM mRNA DME0250 XEOTICID XEO00007 MOACRIVE Inhibition DME0250 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0250 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0250 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0250 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME PXYLP1 DME0250 XEOTICID XEO00117 GENEFORM mRNA DME0250 XEOTICID XEO00117 MOACRIVE Inhibition DME0250 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0250 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0250 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0250 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME PXYLP1 DME0250 XEOTICID XEO00217 GENEFORM mRNA DME0250 XEOTICID XEO00217 MOACRIVE Induction DME0250 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0250 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0250 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0250 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME PXYLP1 DME0250 XEOTICID XEO00241 GENEFORM mRNA DME0250 XEOTICID XEO00241 MOACRIVE Inhibition DME0250 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0250 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0250 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0250 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME PXYLP1 DME0250 XEOTICID XEO00292 GENEFORM mRNA DME0250 XEOTICID XEO00292 MOACRIVE Inhibition DME0250 XEOTICID XEO00538 XEO_NAME Quercetin DME0250 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0250 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0250 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME PXYLP1 DME0250 XEOTICID XEO00538 GENEFORM mRNA DME0250 XEOTICID XEO00538 MOACRIVE Inhibition DME0250 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0250 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0250 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0250 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME PXYLP1 DME0250 XEOTICID XEO00772 GENEFORM mRNA DME0250 XEOTICID XEO00772 MOACRIVE Inhibition DME0250 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0250 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0250 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0250 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME PXYLP1 DME0250 XEOTICID XEO00806 GENEFORM mRNA DME0250 XEOTICID XEO00806 MOACRIVE Inhibition DME0250 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0250 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0250 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0250 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME PXYLP1 DME0250 XEOTICID XEO00898 GENEFORM mRNA DME0250 XEOTICID XEO00898 MOACRIVE Inhibition DME0250 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0250 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0250 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0250 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME PXYLP1 DME0250 XEOTICID XEO01305 GENEFORM mRNA DME0250 XEOTICID XEO01305 MOACRIVE Inhibition DME0255 DME___ID DME0255 DME0255 DME_NAME Acyl-CoA thioesterase 2 (ACOT2) DME0255 SPESNAME Homo sapiens DME0255 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0255 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0255 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0255 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME ACOT2 DME0255 XEOTICID XEO00117 GENEFORM mRNA DME0255 XEOTICID XEO00117 MOACRIVE Inhibition DME0255 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0255 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0255 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0255 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME ACOT2 DME0255 XEOTICID XEO00186 GENEFORM mRNA DME0255 XEOTICID XEO00186 MOACRIVE Inhibition DME0255 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0255 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0255 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0255 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ACOT2 DME0255 XEOTICID XEO00217 GENEFORM mRNA DME0255 XEOTICID XEO00217 MOACRIVE Inhibition DME0255 XEOTICID XEO00435 XEO_NAME Urethane DME0255 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0255 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0255 XEOTICID XEO00435 DESCRIPT Urethane inhibits the drug-metabolizing activity of DME ACOT2 DME0255 XEOTICID XEO00435 GENEFORM Protein DME0255 XEOTICID XEO00435 MOACRIVE Inhibition DME0255 XEOTICID XEO00547 XEO_NAME Vitamin E DME0255 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0255 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0255 XEOTICID XEO00547 DESCRIPT Vitamin E up-regulates the expression of DME ACOT2 DME0255 XEOTICID XEO00547 GENEFORM mRNA DME0255 XEOTICID XEO00547 MOACRIVE Induction DME0255 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0255 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0255 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0255 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME ACOT2 DME0255 XEOTICID XEO00723 GENEFORM mRNA DME0255 XEOTICID XEO00723 MOACRIVE Inhibition DME0255 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0255 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0255 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0255 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME ACOT2 DME0255 XEOTICID XEO00806 GENEFORM mRNA DME0255 XEOTICID XEO00806 MOACRIVE Inhibition DME0255 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0255 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0255 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0255 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME ACOT2 DME0255 XEOTICID XEO00898 GENEFORM mRNA DME0255 XEOTICID XEO00898 MOACRIVE Inhibition DME0255 XEOTICID XEO00919 XEO_NAME Particulate matter DME0255 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0255 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0255 XEOTICID XEO00919 DESCRIPT Particulate matter up-regulates the expression of DME ACOT2 DME0255 XEOTICID XEO00919 GENEFORM mRNA DME0255 XEOTICID XEO00919 MOACRIVE Induction DME0263 DME___ID DME0263 DME0263 DME_NAME Peroxisomal multifunctional enzyme 2 (HSD17B4) DME0263 SPESNAME Homo sapiens DME0263 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0263 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0263 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0263 XEOTICID XEO00035 DESCRIPT Fenofibrate up-regulates the expression of DME HSD17B4 DME0263 XEOTICID XEO00035 GENEFORM mRNA DME0263 XEOTICID XEO00035 MOACRIVE Induction DME0263 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0263 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0263 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0263 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME HSD17B4 DME0263 XEOTICID XEO00117 GENEFORM mRNA DME0263 XEOTICID XEO00117 MOACRIVE Inhibition DME0263 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0263 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0263 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0263 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME HSD17B4 DME0263 XEOTICID XEO00217 GENEFORM mRNA DME0263 XEOTICID XEO00217 MOACRIVE Inhibition DME0263 XEOTICID XEO00233 XEO_NAME Aminoglutethimide DME0263 XEOTICID XEO00233 XEO_TYPE Pharmaceutical Agent(s) DME0263 XEOTICID XEO00233 XEO_CLAS Approved/Marketed Drug DME0263 XEOTICID XEO00233 DESCRIPT Aminoglutethimide inhibits the expression of DME HSD17B4 DME0263 XEOTICID XEO00233 GENEFORM mRNA DME0263 XEOTICID XEO00233 MOACRIVE Inhibition DME0263 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0263 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0263 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0263 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME HSD17B4 DME0263 XEOTICID XEO00241 GENEFORM mRNA DME0263 XEOTICID XEO00241 MOACRIVE Inhibition DME0263 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0263 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0263 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0263 XEOTICID XEO00251 DESCRIPT Ketoconazole up-regulates the expression of DME HSD17B4 DME0263 XEOTICID XEO00251 GENEFORM mRNA DME0263 XEOTICID XEO00251 MOACRIVE Induction DME0263 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0263 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0263 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0263 XEOTICID XEO00339 DESCRIPT Arsenic trioxide induces the drug-metabolizing activity of DME HSD17B4 DME0263 XEOTICID XEO00339 GENEFORM Protein DME0263 XEOTICID XEO00339 MOACRIVE Induction DME0263 XEOTICID XEO00538 XEO_NAME Quercetin DME0263 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0263 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0263 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME HSD17B4 DME0263 XEOTICID XEO00538 GENEFORM mRNA DME0263 XEOTICID XEO00538 MOACRIVE Inhibition DME0263 XEOTICID XEO00606 XEO_NAME Colforsin DME0263 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0263 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0263 XEOTICID XEO00606 DESCRIPT Colforsin up-regulates the expression of DME HSD17B4 DME0263 XEOTICID XEO00606 GENEFORM mRNA DME0263 XEOTICID XEO00606 MOACRIVE Induction DME0263 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0263 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0263 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0263 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid inhibits the expression of DME HSD17B4 DME0263 XEOTICID XEO00921 GENEFORM mRNA DME0263 XEOTICID XEO00921 MOACRIVE Inhibition DME0263 XEOTICID XEO00962 XEO_NAME 2,4,6-trichlorophenol DME0263 XEOTICID XEO00962 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0263 XEOTICID XEO00962 XEO_CLAS Fungicide DME0263 XEOTICID XEO00962 DESCRIPT 2,4,6-trichlorophenol inhibits the expression of DME HSD17B4 DME0263 XEOTICID XEO00962 GENEFORM mRNA DME0263 XEOTICID XEO00962 MOACRIVE Inhibition DME0263 XEOTICID XEO00969 XEO_NAME Atrazine DME0263 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0263 XEOTICID XEO00969 XEO_CLAS Herbicide DME0263 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME HSD17B4 DME0263 XEOTICID XEO00969 GENEFORM mRNA DME0263 XEOTICID XEO00969 MOACRIVE Induction DME0263 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0263 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0263 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0263 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME HSD17B4 DME0263 XEOTICID XEO01050 GENEFORM mRNA DME0263 XEOTICID XEO01050 MOACRIVE Inhibition DME0263 XEOTICID XEO01121 XEO_NAME 2-bromophenol DME0263 XEOTICID XEO01121 XEO_TYPE Health or Environmental Toxicant(s) DME0263 XEOTICID XEO01121 XEO_CLAS Environmental Pollutant DME0263 XEOTICID XEO01121 DESCRIPT 2-bromophenol up-regulates the expression of DME HSD17B4 DME0263 XEOTICID XEO01121 GENEFORM mRNA DME0263 XEOTICID XEO01121 MOACRIVE Induction DME0263 XEOTICID XEO01336 XEO_NAME ICG-001 DME0263 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0263 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0263 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME HSD17B4 DME0263 XEOTICID XEO01336 GENEFORM mRNA DME0263 XEOTICID XEO01336 MOACRIVE Inhibition DME0263 XEOTICID XEO01505 XEO_NAME Lead DME0263 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0263 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0263 XEOTICID XEO01505 DESCRIPT Lead inhibits the expression of DME HSD17B4 DME0263 XEOTICID XEO01505 GENEFORM mRNA DME0263 XEOTICID XEO01505 MOACRIVE Inhibition DME0283 DME___ID DME0283 DME0283 DME_NAME Dimethylaniline oxidase 2 (FMO2) DME0283 SPESNAME Homo sapiens DME0283 XEOTICID XEO00184 XEO_NAME Calcitriol DME0283 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0283 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0283 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME FMO2 DME0283 XEOTICID XEO00184 GENEFORM mRNA DME0283 XEOTICID XEO00184 MOACRIVE Inhibition DME0283 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0283 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0283 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0283 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME FMO2 DME0283 XEOTICID XEO00241 GENEFORM mRNA DME0283 XEOTICID XEO00241 MOACRIVE Inhibition DME0283 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0283 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0283 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0283 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME FMO2 DME0283 XEOTICID XEO00292 GENEFORM mRNA DME0283 XEOTICID XEO00292 MOACRIVE Inhibition DME0283 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0283 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0283 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0283 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME FMO2 DME0283 XEOTICID XEO00632 GENEFORM mRNA DME0283 XEOTICID XEO00632 MOACRIVE Inhibition DME0286 DME___ID DME0286 DME0286 DME_NAME Aldehyde dehydrogenase 1 (ALDH1) DME0286 SPESNAME Homo sapiens DME0286 XEOTICID XEO00018 XEO_NAME Cyclophosphamide DME0286 XEOTICID XEO00018 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00018 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00018 DESCRIPT Cyclophosphamide up-regulates the expression of DME ALDH1A1 DME0286 XEOTICID XEO00018 GENEFORM mRNA DME0286 XEOTICID XEO00018 MOACRIVE Induction DME0286 XEOTICID XEO00028 XEO_NAME Disulfiram DME0286 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00028 DESCRIPT Disulfiram inhibits the drug-metabolizing activity of DME ALDH1A1 DME0286 XEOTICID XEO00028 GENEFORM Protein DME0286 XEOTICID XEO00028 MOACRIVE Inhibition DME0286 XEOTICID XEO00029 XEO_NAME Valproic acid DME0286 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME ALDH1A1 DME0286 XEOTICID XEO00029 GENEFORM mRNA DME0286 XEOTICID XEO00029 MOACRIVE Induction DME0286 XEOTICID XEO00181 XEO_NAME Dasatinib DME0286 XEOTICID XEO00181 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00181 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00181 DESCRIPT Dasatinib up-regulates the expression of DME ALDH1A1 DME0286 XEOTICID XEO00181 GENEFORM mRNA DME0286 XEOTICID XEO00181 MOACRIVE Induction DME0286 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0286 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ALDH1A1 DME0286 XEOTICID XEO00217 GENEFORM mRNA DME0286 XEOTICID XEO00217 MOACRIVE Inhibition DME0286 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0286 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME ALDH1A1 DME0286 XEOTICID XEO00241 GENEFORM mRNA DME0286 XEOTICID XEO00241 MOACRIVE Inhibition DME0286 XEOTICID XEO00253 XEO_NAME Tretinoin DME0286 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the drug-metabolizing activity of DME ALDH1A1 DME0286 XEOTICID XEO00253 GENEFORM Protein DME0286 XEOTICID XEO00253 MOACRIVE Inhibition DME0286 XEOTICID XEO00267 XEO_NAME Ethinyl estradiol DME0286 XEOTICID XEO00267 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00267 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00267 DESCRIPT Ethinyl estradiol inhibits the expression of DME ALDH1A1 DME0286 XEOTICID XEO00267 GENEFORM mRNA DME0286 XEOTICID XEO00267 MOACRIVE Inhibition DME0286 XEOTICID XEO00268 XEO_NAME Gadodiamide DME0286 XEOTICID XEO00268 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00268 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00268 DESCRIPT Gadodiamide up-regulates the expression of DME ALDH1A1 DME0286 XEOTICID XEO00268 GENEFORM mRNA DME0286 XEOTICID XEO00268 MOACRIVE Induction DME0286 XEOTICID XEO00301 XEO_NAME Irinotecan hydrochloride DME0286 XEOTICID XEO00301 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00301 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00301 DESCRIPT Irinotecan hydrochloride inhibits the expression of DME ALDH1A1 DME0286 XEOTICID XEO00301 GENEFORM mRNA DME0286 XEOTICID XEO00301 MOACRIVE Inhibition DME0286 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0286 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex up-regulates the expression of DME ALDH1A1 DME0286 XEOTICID XEO00312 GENEFORM mRNA DME0286 XEOTICID XEO00312 MOACRIVE Induction DME0286 XEOTICID XEO00334 XEO_NAME Cisplatin DME0286 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME ALDH1A1 DME0286 XEOTICID XEO00334 GENEFORM mRNA DME0286 XEOTICID XEO00334 MOACRIVE Inhibition DME0286 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0286 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME ALDH1A1 DME0286 XEOTICID XEO00339 GENEFORM mRNA DME0286 XEOTICID XEO00339 MOACRIVE Inhibition DME0286 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME0286 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00349 DESCRIPT Ciprofloxacin induces the drug-metabolizing activity of DME ALDH1A1 DME0286 XEOTICID XEO00349 GENEFORM Protein DME0286 XEOTICID XEO00349 MOACRIVE Induction DME0286 XEOTICID XEO00361 XEO_NAME Gemcitabine DME0286 XEOTICID XEO00361 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00361 XEO_CLAS Approved/Marketed Drug DME0286 XEOTICID XEO00361 DESCRIPT Gemcitabine inhibits the drug-metabolizing activity of DME ALDH1A1 DME0286 XEOTICID XEO00361 GENEFORM Protein DME0286 XEOTICID XEO00361 MOACRIVE Inhibition DME0286 XEOTICID XEO00557 XEO_NAME Genistein DME0286 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0286 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME ALDH1A1 DME0286 XEOTICID XEO00557 GENEFORM mRNA DME0286 XEOTICID XEO00557 MOACRIVE Inhibition DME0286 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0286 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0286 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME ALDH1A1 DME0286 XEOTICID XEO00723 GENEFORM mRNA DME0286 XEOTICID XEO00723 MOACRIVE Inhibition DME0286 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0286 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0286 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0286 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME ALDH1A1 DME0286 XEOTICID XEO00772 GENEFORM mRNA DME0286 XEOTICID XEO00772 MOACRIVE Inhibition DME0286 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0286 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0286 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0286 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid up-regulates the expression of DME ALDH1A1 DME0286 XEOTICID XEO00921 GENEFORM mRNA DME0286 XEOTICID XEO00921 MOACRIVE Induction DME0286 XEOTICID XEO00942 XEO_NAME Cyproconazole DME0286 XEOTICID XEO00942 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0286 XEOTICID XEO00942 XEO_CLAS Fungicide DME0286 XEOTICID XEO00942 DESCRIPT Cyproconazole inhibits the drug-metabolizing activity of DME ALDH1A1 DME0286 XEOTICID XEO00942 GENEFORM Protein DME0286 XEOTICID XEO00942 MOACRIVE Inhibition DME0286 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0286 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0286 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0286 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate induces the drug-metabolizing activity of DME ALDH1A1 DME0286 XEOTICID XEO01004 GENEFORM Protein DME0286 XEOTICID XEO01004 MOACRIVE Induction DME0286 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0286 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0286 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0286 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME ALDH1A1 DME0286 XEOTICID XEO01050 GENEFORM mRNA DME0286 XEOTICID XEO01050 MOACRIVE Inhibition DME0286 XEOTICID XEO01186 XEO_NAME Acrolein DME0286 XEOTICID XEO01186 XEO_TYPE Health or Environmental Toxicant(s) DME0286 XEOTICID XEO01186 XEO_CLAS Acute Toxic Substance DME0286 XEOTICID XEO01186 DESCRIPT Acrolein inhibits the drug-metabolizing activity of DME ALDH1A1 DME0286 XEOTICID XEO01186 GENEFORM Protein DME0286 XEOTICID XEO01186 MOACRIVE Inhibition DME0286 XEOTICID XEO01230 XEO_NAME Butyric acid DME0286 XEOTICID XEO01230 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO01230 XEO_CLAS Drug in Phase 2 Clinical Trial DME0286 XEOTICID XEO01230 DESCRIPT Butyric acid up-regulates the expression of DME ALDH1A1 DME0286 XEOTICID XEO01230 GENEFORM mRNA DME0286 XEOTICID XEO01230 MOACRIVE Induction DME0286 XEOTICID XEO01238 XEO_NAME Casticin DME0286 XEOTICID XEO01238 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO01238 XEO_CLAS Investigative Agent DME0286 XEOTICID XEO01238 DESCRIPT Casticin up-regulates the expression of DME ALDH1A1 DME0286 XEOTICID XEO01238 GENEFORM mRNA DME0286 XEOTICID XEO01238 MOACRIVE Induction DME0286 XEOTICID XEO01348 XEO_NAME K-7174 DME0286 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0286 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME ALDH1A1 DME0286 XEOTICID XEO01348 GENEFORM mRNA DME0286 XEOTICID XEO01348 MOACRIVE Inhibition DME0286 XEOTICID XEO01377 XEO_NAME Methylparaben DME0286 XEOTICID XEO01377 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0286 XEOTICID XEO01377 XEO_CLAS Natural Product DME0286 XEOTICID XEO01377 DESCRIPT Methylparaben up-regulates the expression of DME ALDH1A1 DME0286 XEOTICID XEO01377 GENEFORM mRNA DME0286 XEOTICID XEO01377 MOACRIVE Induction DME0286 XEOTICID XEO01397 XEO_NAME Nickel chloride DME0286 XEOTICID XEO01397 XEO_TYPE Health or Environmental Toxicant(s) DME0286 XEOTICID XEO01397 XEO_CLAS Acute Toxic Substance DME0286 XEOTICID XEO01397 DESCRIPT Nickel chloride induces the drug-metabolizing activity of DME ALDH1A1 DME0286 XEOTICID XEO01397 GENEFORM Protein DME0286 XEOTICID XEO01397 MOACRIVE Induction DME0286 XEOTICID XEO01412 XEO_NAME Oleic acid DME0286 XEOTICID XEO01412 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO01412 XEO_CLAS Preclinical/Patented Drug DME0286 XEOTICID XEO01412 DESCRIPT Oleic acid inhibits the expression of DME ALDH1A1 DME0286 XEOTICID XEO01412 GENEFORM mRNA DME0286 XEOTICID XEO01412 MOACRIVE Inhibition DME0286 XEOTICID XEO01475 XEO_NAME Stearic acid DME0286 XEOTICID XEO01475 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0286 XEOTICID XEO01475 XEO_CLAS Food Additive DME0286 XEOTICID XEO01475 DESCRIPT Stearic acid inhibits the drug-metabolizing activity of DME ALDH1A1 DME0286 XEOTICID XEO01475 GENEFORM Protein DME0286 XEOTICID XEO01475 MOACRIVE Inhibition DME0286 XEOTICID XEO01480 XEO_NAME Teroxirone DME0286 XEOTICID XEO01480 XEO_TYPE Pharmaceutical Agent(s) DME0286 XEOTICID XEO01480 XEO_CLAS Investigative Agent DME0286 XEOTICID XEO01480 DESCRIPT Teroxirone up-regulates the expression of DME ALDH1A1 DME0286 XEOTICID XEO01480 GENEFORM mRNA DME0286 XEOTICID XEO01480 MOACRIVE Induction DME0286 XEOTICID XEO01498 XEO_NAME Walrycin A DME0286 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0286 XEOTICID XEO01498 XEO_CLAS Natural Product DME0286 XEOTICID XEO01498 DESCRIPT Walrycin A up-regulates the expression of DME ALDH1A1 DME0286 XEOTICID XEO01498 GENEFORM mRNA DME0286 XEOTICID XEO01498 MOACRIVE Induction DME0286 XEOTICID XEO01503 XEO_NAME Cadmium DME0286 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0286 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0286 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the expression of DME ALDH1A1 DME0286 XEOTICID XEO01503 GENEFORM mRNA DME0286 XEOTICID XEO01503 MOACRIVE Inhibition DME0287 DME___ID DME0287 DME0287 DME_NAME Retinal dehydrogenase 2 (ALDH1A2) DME0287 SPESNAME Homo sapiens DME0287 XEOTICID XEO00028 XEO_NAME Disulfiram DME0287 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0287 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0287 XEOTICID XEO00028 DESCRIPT Disulfiram inhibits the drug-metabolizing activity of DME ALDH1A2 DME0287 XEOTICID XEO00028 GENEFORM Protein DME0287 XEOTICID XEO00028 MOACRIVE Inhibition DME0287 XEOTICID XEO00029 XEO_NAME Valproic acid DME0287 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0287 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0287 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME ALDH1A2 DME0287 XEOTICID XEO00029 GENEFORM mRNA DME0287 XEOTICID XEO00029 MOACRIVE Induction DME0287 XEOTICID XEO00108 XEO_NAME Methamphetamine DME0287 XEOTICID XEO00108 XEO_TYPE Pharmaceutical Agent(s) DME0287 XEOTICID XEO00108 XEO_CLAS Approved/Marketed Drug DME0287 XEOTICID XEO00108 DESCRIPT Methamphetamine up-regulates the expression of DME ALDH1A2 DME0287 XEOTICID XEO00108 GENEFORM mRNA DME0287 XEOTICID XEO00108 MOACRIVE Induction DME0287 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0287 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0287 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0287 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME ALDH1A2 DME0287 XEOTICID XEO00292 GENEFORM mRNA DME0287 XEOTICID XEO00292 MOACRIVE Inhibition DME0287 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0287 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0287 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0287 XEOTICID XEO00380 DESCRIPT Rosiglitazone induces the drug-metabolizing activity of DME ALDH1A2 DME0287 XEOTICID XEO00380 GENEFORM Protein DME0287 XEOTICID XEO00380 MOACRIVE Induction DME0287 XEOTICID XEO00581 XEO_NAME MS-275 DME0287 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0287 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0287 XEOTICID XEO00581 DESCRIPT MS-275 inhibits the expression of DME ALDH1A2 DME0287 XEOTICID XEO00581 GENEFORM mRNA DME0287 XEOTICID XEO00581 MOACRIVE Inhibition DME0287 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0287 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0287 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0287 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME ALDH1A2 DME0287 XEOTICID XEO00632 GENEFORM mRNA DME0287 XEOTICID XEO00632 MOACRIVE Inhibition DME0287 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0287 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0287 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0287 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin up-regulates the expression of DME ALDH1A2 DME0287 XEOTICID XEO00905 GENEFORM mRNA DME0287 XEOTICID XEO00905 MOACRIVE Induction DME0287 XEOTICID XEO00996 XEO_NAME Benzaldehydes DME0287 XEOTICID XEO00996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0287 XEOTICID XEO00996 XEO_CLAS Natural Product DME0287 XEOTICID XEO00996 DESCRIPT Benzaldehydes inhibits the drug-metabolizing activity of DME ALDH1A2 DME0287 XEOTICID XEO00996 GENEFORM Protein DME0287 XEOTICID XEO00996 MOACRIVE Inhibition DME0287 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0287 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0287 XEOTICID XEO01494 XEO_CLAS Natural Product DME0287 XEOTICID XEO01494 DESCRIPT Tunicamycin A inhibits the expression of DME ALDH1A2 DME0287 XEOTICID XEO01494 GENEFORM mRNA DME0287 XEOTICID XEO01494 MOACRIVE Inhibition DME0289 DME___ID DME0289 DME0289 DME_NAME Aldehyde dehydrogenase 5 (ALDHX) DME0289 SPESNAME Homo sapiens DME0289 XEOTICID XEO00053 XEO_NAME Leflunomide DME0289 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0289 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0289 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME ALDH1B1 DME0289 XEOTICID XEO00053 GENEFORM mRNA DME0289 XEOTICID XEO00053 MOACRIVE Induction DME0289 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0289 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0289 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0289 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME ALDH1B1 DME0289 XEOTICID XEO00117 GENEFORM mRNA DME0289 XEOTICID XEO00117 MOACRIVE Inhibition DME0289 XEOTICID XEO00184 XEO_NAME Calcitriol DME0289 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0289 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0289 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME ALDH1B1 DME0289 XEOTICID XEO00184 GENEFORM mRNA DME0289 XEOTICID XEO00184 MOACRIVE Inhibition DME0289 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0289 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0289 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0289 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ALDH1B1 DME0289 XEOTICID XEO00217 GENEFORM mRNA DME0289 XEOTICID XEO00217 MOACRIVE Inhibition DME0289 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0289 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0289 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0289 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME ALDH1B1 DME0289 XEOTICID XEO00241 GENEFORM mRNA DME0289 XEOTICID XEO00241 MOACRIVE Inhibition DME0289 XEOTICID XEO00334 XEO_NAME Cisplatin DME0289 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0289 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0289 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME ALDH1B1 DME0289 XEOTICID XEO00334 GENEFORM mRNA DME0289 XEOTICID XEO00334 MOACRIVE Induction DME0289 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0289 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0289 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0289 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME ALDH1B1 DME0289 XEOTICID XEO00339 GENEFORM mRNA DME0289 XEOTICID XEO00339 MOACRIVE Induction DME0289 XEOTICID XEO00435 XEO_NAME Urethane DME0289 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0289 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0289 XEOTICID XEO00435 DESCRIPT Urethane inhibits the drug-metabolizing activity of DME ALDH1B1 DME0289 XEOTICID XEO00435 GENEFORM Protein DME0289 XEOTICID XEO00435 MOACRIVE Inhibition DME0289 XEOTICID XEO00538 XEO_NAME Quercetin DME0289 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0289 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0289 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME ALDH1B1 DME0289 XEOTICID XEO00538 GENEFORM mRNA DME0289 XEOTICID XEO00538 MOACRIVE Inhibition DME0289 XEOTICID XEO00581 XEO_NAME MS-275 DME0289 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0289 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0289 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME ALDH1B1 DME0289 XEOTICID XEO00581 GENEFORM mRNA DME0289 XEOTICID XEO00581 MOACRIVE Induction DME0289 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0289 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0289 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0289 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME ALDH1B1 DME0289 XEOTICID XEO00723 GENEFORM mRNA DME0289 XEOTICID XEO00723 MOACRIVE Inhibition DME0289 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0289 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0289 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0289 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME ALDH1B1 DME0289 XEOTICID XEO01031 GENEFORM mRNA DME0289 XEOTICID XEO01031 MOACRIVE Inhibition DME0289 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0289 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0289 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0289 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME ALDH1B1 DME0289 XEOTICID XEO01226 GENEFORM mRNA DME0289 XEOTICID XEO01226 MOACRIVE Inhibition DME0289 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0289 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0289 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0289 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME ALDH1B1 DME0289 XEOTICID XEO01305 GENEFORM mRNA DME0289 XEOTICID XEO01305 MOACRIVE Inhibition DME0289 XEOTICID XEO01348 XEO_NAME K-7174 DME0289 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0289 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0289 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME ALDH1B1 DME0289 XEOTICID XEO01348 GENEFORM mRNA DME0289 XEOTICID XEO01348 MOACRIVE Inhibition DME0289 XEOTICID XEO01498 XEO_NAME Walrycin A DME0289 XEOTICID XEO01498 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0289 XEOTICID XEO01498 XEO_CLAS Natural Product DME0289 XEOTICID XEO01498 DESCRIPT Walrycin A up-regulates the expression of DME ALDH1B1 DME0289 XEOTICID XEO01498 GENEFORM mRNA DME0289 XEOTICID XEO01498 MOACRIVE Induction DME0289 XEOTICID XEO01505 XEO_NAME Lead DME0289 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0289 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0289 XEOTICID XEO01505 DESCRIPT Lead inhibits the expression of DME ALDH1B1 DME0289 XEOTICID XEO01505 GENEFORM mRNA DME0289 XEOTICID XEO01505 MOACRIVE Inhibition DME0289 XEOTICID XEO01523 XEO_NAME Apocarotenal DME0289 XEOTICID XEO01523 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0289 XEOTICID XEO01523 XEO_CLAS Natural Product DME0289 XEOTICID XEO01523 DESCRIPT Apocarotenal inhibits the expression of DME ALDH1B1 DME0289 XEOTICID XEO01523 GENEFORM mRNA DME0289 XEOTICID XEO01523 MOACRIVE Inhibition DME0294 DME___ID DME0294 DME0294 DME_NAME Aldehyde dehydrogenase 7 (ALDH7) DME0294 SPESNAME Homo sapiens DME0294 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0294 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0294 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0294 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME ALDH3B1 DME0294 XEOTICID XEO00292 GENEFORM mRNA DME0294 XEOTICID XEO00292 MOACRIVE Inhibition DME0294 XEOTICID XEO00334 XEO_NAME Cisplatin DME0294 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0294 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0294 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME ALDH3B1 DME0294 XEOTICID XEO00334 GENEFORM mRNA DME0294 XEOTICID XEO00334 MOACRIVE Inhibition DME0294 XEOTICID XEO00401 XEO_NAME Beta carotene DME0294 XEOTICID XEO00401 XEO_TYPE Pharmaceutical Agent(s) DME0294 XEOTICID XEO00401 XEO_CLAS Approved/Marketed Drug DME0294 XEOTICID XEO00401 DESCRIPT Beta carotene inhibits the expression of DME ALDH3B1 DME0294 XEOTICID XEO00401 GENEFORM mRNA DME0294 XEOTICID XEO00401 MOACRIVE Inhibition DME0294 XEOTICID XEO00560 XEO_NAME Triclosan DME0294 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0294 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0294 XEOTICID XEO00560 DESCRIPT Triclosan induces the drug-metabolizing activity of DME ALDH3B1 DME0294 XEOTICID XEO00560 GENEFORM Protein DME0294 XEOTICID XEO00560 MOACRIVE Induction DME0294 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0294 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0294 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0294 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME ALDH3B1 DME0294 XEOTICID XEO00898 GENEFORM mRNA DME0294 XEOTICID XEO00898 MOACRIVE Inhibition DME0294 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0294 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0294 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0294 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME ALDH3B1 DME0294 XEOTICID XEO00999 GENEFORM mRNA DME0294 XEOTICID XEO00999 MOACRIVE Inhibition DME0294 XEOTICID XEO01034 XEO_NAME Pentanal DME0294 XEOTICID XEO01034 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0294 XEOTICID XEO01034 XEO_CLAS Chemical Compound DME0294 XEOTICID XEO01034 DESCRIPT Pentanal inhibits the expression of DME ALDH3B1 DME0294 XEOTICID XEO01034 GENEFORM mRNA DME0294 XEOTICID XEO01034 MOACRIVE Inhibition DME0294 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0294 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0294 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0294 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME ALDH3B1 DME0294 XEOTICID XEO01226 GENEFORM mRNA DME0294 XEOTICID XEO01226 MOACRIVE Induction DME0294 XEOTICID XEO01523 XEO_NAME Apocarotenal DME0294 XEOTICID XEO01523 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0294 XEOTICID XEO01523 XEO_CLAS Natural Product DME0294 XEOTICID XEO01523 DESCRIPT Apocarotenal inhibits the expression of DME ALDH3B1 DME0294 XEOTICID XEO01523 GENEFORM mRNA DME0294 XEOTICID XEO01523 MOACRIVE Inhibition DME0299 DME___ID DME0299 DME0299 DME_NAME Aminomuconic semialdehyde dehydrogenase (ALDH12) DME0299 SPESNAME Homo sapiens DME0299 XEOTICID XEO00007 XEO_NAME Azathioprine DME0299 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0299 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0299 XEOTICID XEO00007 DESCRIPT Azathioprine inhibits the expression of DME ALDH8A1 DME0299 XEOTICID XEO00007 GENEFORM mRNA DME0299 XEOTICID XEO00007 MOACRIVE Inhibition DME0299 XEOTICID XEO00029 XEO_NAME Valproic acid DME0299 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0299 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0299 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the drug-metabolizing activity of DME ALDH8A1 DME0299 XEOTICID XEO00029 GENEFORM Protein DME0299 XEOTICID XEO00029 MOACRIVE Inhibition DME0299 XEOTICID XEO00090 XEO_NAME Estradiol DME0299 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0299 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0299 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME ALDH8A1 DME0299 XEOTICID XEO00090 GENEFORM mRNA DME0299 XEOTICID XEO00090 MOACRIVE Inhibition DME0299 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0299 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0299 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0299 XEOTICID XEO00140 DESCRIPT Zoledronic acid induces the drug-metabolizing activity of DME ALDH8A1 DME0299 XEOTICID XEO00140 GENEFORM Protein DME0299 XEOTICID XEO00140 MOACRIVE Induction DME0299 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0299 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0299 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0299 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ALDH8A1 DME0299 XEOTICID XEO00217 GENEFORM mRNA DME0299 XEOTICID XEO00217 MOACRIVE Inhibition DME0299 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0299 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0299 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0299 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME ALDH8A1 DME0299 XEOTICID XEO00241 GENEFORM mRNA DME0299 XEOTICID XEO00241 MOACRIVE Inhibition DME0299 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0299 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0299 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0299 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME ALDH8A1 DME0299 XEOTICID XEO00339 GENEFORM mRNA DME0299 XEOTICID XEO00339 MOACRIVE Inhibition DME0299 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0299 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0299 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0299 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME ALDH8A1 DME0299 XEOTICID XEO00632 GENEFORM mRNA DME0299 XEOTICID XEO00632 MOACRIVE Inhibition DME0299 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0299 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0299 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0299 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME ALDH8A1 DME0299 XEOTICID XEO00723 GENEFORM mRNA DME0299 XEOTICID XEO00723 MOACRIVE Induction DME0299 XEOTICID XEO00740 XEO_NAME Lindane DME0299 XEOTICID XEO00740 XEO_TYPE Pharmaceutical Agent(s) DME0299 XEOTICID XEO00740 XEO_CLAS Approved/Marketed Drug DME0299 XEOTICID XEO00740 DESCRIPT Lindane up-regulates the expression of DME ALDH8A1 DME0299 XEOTICID XEO00740 GENEFORM mRNA DME0299 XEOTICID XEO00740 MOACRIVE Induction DME0299 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0299 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0299 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0299 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME ALDH8A1 DME0299 XEOTICID XEO00806 GENEFORM mRNA DME0299 XEOTICID XEO00806 MOACRIVE Inhibition DME0299 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0299 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0299 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0299 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME ALDH8A1 DME0299 XEOTICID XEO00898 GENEFORM mRNA DME0299 XEOTICID XEO00898 MOACRIVE Inhibition DME0299 XEOTICID XEO01046 XEO_NAME Cypermethrin DME0299 XEOTICID XEO01046 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0299 XEOTICID XEO01046 XEO_CLAS Pesticide/Insecticide DME0299 XEOTICID XEO01046 DESCRIPT Cypermethrin inhibits the expression of DME ALDH8A1 DME0299 XEOTICID XEO01046 GENEFORM mRNA DME0299 XEOTICID XEO01046 MOACRIVE Inhibition DME0299 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0299 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0299 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0299 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME ALDH8A1 DME0299 XEOTICID XEO01220 GENEFORM mRNA DME0299 XEOTICID XEO01220 MOACRIVE Inhibition DME0299 XEOTICID XEO01248 XEO_NAME Chlorpyrifos DME0299 XEOTICID XEO01248 XEO_TYPE Health or Environmental Toxicant(s) DME0299 XEOTICID XEO01248 XEO_CLAS Acute Toxic Substance DME0299 XEOTICID XEO01248 DESCRIPT Chlorpyrifos inhibits the expression of DME ALDH8A1 DME0299 XEOTICID XEO01248 GENEFORM mRNA DME0299 XEOTICID XEO01248 MOACRIVE Inhibition DME0299 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0299 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0299 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0299 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME ALDH8A1 DME0299 XEOTICID XEO01305 GENEFORM mRNA DME0299 XEOTICID XEO01305 MOACRIVE Induction DME0299 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0299 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0299 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0299 XEOTICID XEO01407 DESCRIPT Ochratoxin A up-regulates the expression of DME ALDH8A1 DME0299 XEOTICID XEO01407 GENEFORM mRNA DME0299 XEOTICID XEO01407 MOACRIVE Induction DME0299 XEOTICID XEO01551 XEO_NAME Heliotrine DME0299 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0299 XEOTICID XEO01551 XEO_CLAS Natural Product DME0299 XEOTICID XEO01551 DESCRIPT Heliotrine inhibits the expression of DME ALDH8A1 DME0299 XEOTICID XEO01551 GENEFORM mRNA DME0299 XEOTICID XEO01551 MOACRIVE Inhibition DME0299 XEOTICID XEO01582 XEO_NAME Pyrrolizidine alkaloid DME0299 XEOTICID XEO01582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0299 XEOTICID XEO01582 XEO_CLAS Natural Product DME0299 XEOTICID XEO01582 DESCRIPT Pyrrolizidine alkaloid inhibits the drug-metabolizing activity of DME ALDH8A1 DME0299 XEOTICID XEO01582 GENEFORM Protein DME0299 XEOTICID XEO01582 MOACRIVE Inhibition DME0308 DME___ID DME0308 DME0308 DME_NAME Glutathione S-transferase mu-1 (GSTM1) DME0308 SPESNAME Homo sapiens DME0308 XEOTICID XEO00095 XEO_NAME Testosterone DME0308 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0308 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME GSTM1 DME0308 XEOTICID XEO00095 GENEFORM mRNA DME0308 XEOTICID XEO00095 MOACRIVE Induction DME0308 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0308 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0308 XEOTICID XEO00167 DESCRIPT Alitretinoin inhibits the expression of DME GSTM1 DME0308 XEOTICID XEO00167 GENEFORM mRNA DME0308 XEOTICID XEO00167 MOACRIVE Inhibition DME0308 XEOTICID XEO00180 XEO_NAME Quinine DME0308 XEOTICID XEO00180 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00180 XEO_CLAS Approved/Marketed Drug DME0308 XEOTICID XEO00180 DESCRIPT Quinine inhibits the expression of DME GSTM1 DME0308 XEOTICID XEO00180 GENEFORM mRNA DME0308 XEOTICID XEO00180 MOACRIVE Inhibition DME0308 XEOTICID XEO00184 XEO_NAME Calcitriol DME0308 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0308 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME GSTM1 DME0308 XEOTICID XEO00184 GENEFORM mRNA DME0308 XEOTICID XEO00184 MOACRIVE Induction DME0308 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0308 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0308 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME GSTM1 DME0308 XEOTICID XEO00186 GENEFORM mRNA DME0308 XEOTICID XEO00186 MOACRIVE Inhibition DME0308 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0308 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0308 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME GSTM1 DME0308 XEOTICID XEO00217 GENEFORM mRNA DME0308 XEOTICID XEO00217 MOACRIVE Inhibition DME0308 XEOTICID XEO00225 XEO_NAME Quinidine DME0308 XEOTICID XEO00225 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00225 XEO_CLAS Approved/Marketed Drug DME0308 XEOTICID XEO00225 DESCRIPT Quinidine inhibits the expression of DME GSTM1 DME0308 XEOTICID XEO00225 GENEFORM mRNA DME0308 XEOTICID XEO00225 MOACRIVE Inhibition DME0308 XEOTICID XEO00253 XEO_NAME Tretinoin DME0308 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0308 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the drug-metabolizing activity of DME GSTM1 DME0308 XEOTICID XEO00253 GENEFORM Protein DME0308 XEOTICID XEO00253 MOACRIVE Inhibition DME0308 XEOTICID XEO00290 XEO_NAME Dopamine hydrochloride DME0308 XEOTICID XEO00290 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00290 XEO_CLAS Approved/Marketed Drug DME0308 XEOTICID XEO00290 DESCRIPT Dopamine hydrochloride inhibits the drug-metabolizing activity of DME GSTM1 DME0308 XEOTICID XEO00290 GENEFORM Protein DME0308 XEOTICID XEO00290 MOACRIVE Inhibition DME0308 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0308 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0308 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME GSTM1 DME0308 XEOTICID XEO00339 GENEFORM mRNA DME0308 XEOTICID XEO00339 MOACRIVE Induction DME0308 XEOTICID XEO00352 XEO_NAME Diclofenac DME0308 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0308 XEOTICID XEO00352 DESCRIPT Diclof DMEenac inhibits the drug-metabolizing activity of DME GSTM1 DME0308 XEOTICID XEO00352 GENEFORM Protein DME0308 XEOTICID XEO00352 MOACRIVE Inhibition DME0308 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0308 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0308 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME GSTM1 DME0308 XEOTICID XEO00410 GENEFORM Protein DME0308 XEOTICID XEO00410 MOACRIVE Inhibition DME0308 XEOTICID XEO00622 XEO_NAME AM-80 DME0308 XEOTICID XEO00622 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00622 XEO_CLAS Drug in Phase 2 Clinical Trial DME0308 XEOTICID XEO00622 DESCRIPT AM-80 up-regulates the expression of DME GSTM1 DME0308 XEOTICID XEO00622 GENEFORM mRNA DME0308 XEOTICID XEO00622 MOACRIVE Induction DME0308 XEOTICID XEO00674 XEO_NAME Acyline DME0308 XEOTICID XEO00674 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00674 XEO_CLAS Drug in Phase 2 Clinical Trial DME0308 XEOTICID XEO00674 DESCRIPT Acyline inhibits the expression of DME GSTM1 DME0308 XEOTICID XEO00674 GENEFORM mRNA DME0308 XEOTICID XEO00674 MOACRIVE Inhibition DME0308 XEOTICID XEO00813 XEO_NAME Dinophysistoxin 1 DME0308 XEOTICID XEO00813 XEO_TYPE Health or Environmental Toxicant(s) DME0308 XEOTICID XEO00813 XEO_CLAS Biotoxin DME0308 XEOTICID XEO00813 DESCRIPT Dinophysistoxin 1 up-regulates the expression of DME GSTM1 DME0308 XEOTICID XEO00813 GENEFORM mRNA DME0308 XEOTICID XEO00813 MOACRIVE Induction DME0308 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0308 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0308 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0308 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME GSTM1 DME0308 XEOTICID XEO00821 GENEFORM mRNA DME0308 XEOTICID XEO00821 MOACRIVE Inhibition DME0308 XEOTICID XEO00877 XEO_NAME Bilirubin DME0308 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0308 XEOTICID XEO00877 XEO_CLAS Natural Product DME0308 XEOTICID XEO00877 DESCRIPT Bilirubin inhibits the expression of DME GSTM1 DME0308 XEOTICID XEO00877 GENEFORM mRNA DME0308 XEOTICID XEO00877 MOACRIVE Inhibition DME0308 XEOTICID XEO00885 XEO_NAME Eugenol DME0308 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0308 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of DME GSTM1 DME0308 XEOTICID XEO00885 GENEFORM Protein DME0308 XEOTICID XEO00885 MOACRIVE Inhibition DME0308 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0308 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0308 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0308 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME GSTM1 DME0308 XEOTICID XEO00898 GENEFORM mRNA DME0308 XEOTICID XEO00898 MOACRIVE Inhibition DME0308 XEOTICID XEO00925 XEO_NAME BDE-99 DME0308 XEOTICID XEO00925 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0308 XEOTICID XEO00925 XEO_CLAS Natural Product DME0308 XEOTICID XEO00925 DESCRIPT BDE-99 up-regulates the expression of DME GSTM1 DME0308 XEOTICID XEO00925 GENEFORM mRNA DME0308 XEOTICID XEO00925 MOACRIVE Induction DME0308 XEOTICID XEO00929 XEO_NAME 4-propylphenol DME0308 XEOTICID XEO00929 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0308 XEOTICID XEO00929 XEO_CLAS Food Additive DME0308 XEOTICID XEO00929 DESCRIPT 4-propylphenol inhibits the drug-metabolizing activity of DME GSTM1 DME0308 XEOTICID XEO00929 GENEFORM Protein DME0308 XEOTICID XEO00929 MOACRIVE Inhibition DME0308 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0308 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0308 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0308 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME GSTM1 DME0308 XEOTICID XEO00999 GENEFORM mRNA DME0308 XEOTICID XEO00999 MOACRIVE Induction DME0308 XEOTICID XEO01020 XEO_NAME Picolines DME0308 XEOTICID XEO01020 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0308 XEOTICID XEO01020 XEO_CLAS Chemical Compound DME0308 XEOTICID XEO01020 DESCRIPT Picolines inhibits the expression of DME GSTM1 DME0308 XEOTICID XEO01020 GENEFORM mRNA DME0308 XEOTICID XEO01020 MOACRIVE Inhibition DME0308 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0308 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0308 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0308 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone induces the drug-metabolizing activity of DME GSTM1 DME0308 XEOTICID XEO01129 GENEFORM Protein DME0308 XEOTICID XEO01129 MOACRIVE Induction DME0308 XEOTICID XEO01140 XEO_NAME 3-methylpyridine DME0308 XEOTICID XEO01140 XEO_TYPE Health or Environmental Toxicant(s) DME0308 XEOTICID XEO01140 XEO_CLAS Acute Toxic Substance DME0308 XEOTICID XEO01140 DESCRIPT 3-methylpyridine inhibits the drug-metabolizing activity of DME GSTM1 DME0308 XEOTICID XEO01140 GENEFORM Protein DME0308 XEOTICID XEO01140 MOACRIVE Inhibition DME0308 XEOTICID XEO01154 XEO_NAME 4-oxoretinoic acid DME0308 XEOTICID XEO01154 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0308 XEOTICID XEO01154 XEO_CLAS Natural Product DME0308 XEOTICID XEO01154 DESCRIPT 4-oxoretinoic acid inhibits the expression of DME GSTM1 DME0308 XEOTICID XEO01154 GENEFORM mRNA DME0308 XEOTICID XEO01154 MOACRIVE Inhibition DME0308 XEOTICID XEO01478 XEO_NAME Sulforafan DME0308 XEOTICID XEO01478 XEO_TYPE Pharmaceutical Agent(s) DME0308 XEOTICID XEO01478 XEO_CLAS Drug in Phase 3 Clinical Trial DME0308 XEOTICID XEO01478 DESCRIPT Sulforafan induces the drug-metabolizing activity of DME GSTM1 DME0308 XEOTICID XEO01478 GENEFORM Protein DME0308 XEOTICID XEO01478 MOACRIVE Induction DME0308 XEOTICID XEO01506 XEO_NAME Lead chloride DME0308 XEOTICID XEO01506 XEO_TYPE Health or Environmental Toxicant(s) DME0308 XEOTICID XEO01506 XEO_CLAS Health Hazard/Toxicant DME0308 XEOTICID XEO01506 DESCRIPT Lead chloride inhibits the drug-metabolizing activity of DME GSTM1 DME0308 XEOTICID XEO01506 GENEFORM Protein DME0308 XEOTICID XEO01506 MOACRIVE Inhibition DME0308 XEOTICID XEO01563 XEO_NAME Methyleugenol DME0308 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0308 XEOTICID XEO01563 XEO_CLAS Natural Product DME0308 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the expression of DME GSTM1 DME0308 XEOTICID XEO01563 GENEFORM mRNA DME0308 XEOTICID XEO01563 MOACRIVE Inhibition DME0313 DME___ID DME0313 DME0313 DME_NAME Glutathione S-transferase omega-1 (GSTO1) DME0313 SPESNAME Homo sapiens DME0313 XEOTICID XEO00029 XEO_NAME Valproic acid DME0313 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0313 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the drug-metabolizing activity of DME GSTO1 DME0313 XEOTICID XEO00029 GENEFORM Protein DME0313 XEOTICID XEO00029 MOACRIVE Inhibition DME0313 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0313 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0313 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME GSTO1 DME0313 XEOTICID XEO00117 GENEFORM mRNA DME0313 XEOTICID XEO00117 MOACRIVE Inhibition DME0313 XEOTICID XEO00168 XEO_NAME Decitabine DME0313 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0313 XEOTICID XEO00168 DESCRIPT Decitabine induces the drug-metabolizing activity of DME GSTO1 DME0313 XEOTICID XEO00168 GENEFORM Protein DME0313 XEOTICID XEO00168 MOACRIVE Induction DME0313 XEOTICID XEO00213 XEO_NAME Aspirin DME0313 XEOTICID XEO00213 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO00213 XEO_CLAS Approved/Marketed Drug DME0313 XEOTICID XEO00213 DESCRIPT Aspirin inhibits the expression of DME GSTO1 DME0313 XEOTICID XEO00213 GENEFORM mRNA DME0313 XEOTICID XEO00213 MOACRIVE Inhibition DME0313 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0313 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0313 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME GSTO1 DME0313 XEOTICID XEO00217 GENEFORM mRNA DME0313 XEOTICID XEO00217 MOACRIVE Inhibition DME0313 XEOTICID XEO00218 XEO_NAME Caffeine DME0313 XEOTICID XEO00218 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO00218 XEO_CLAS Approved/Marketed Drug DME0313 XEOTICID XEO00218 DESCRIPT Caffeine inhibits the expression of DME GSTO1 DME0313 XEOTICID XEO00218 GENEFORM mRNA DME0313 XEOTICID XEO00218 MOACRIVE Inhibition DME0313 XEOTICID XEO00232 XEO_NAME Phenytoin DME0313 XEOTICID XEO00232 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO00232 XEO_CLAS Approved/Marketed Drug DME0313 XEOTICID XEO00232 DESCRIPT Phenytoin inhibits the drug-metabolizing activity of DME GSTO1 DME0313 XEOTICID XEO00232 GENEFORM Protein DME0313 XEOTICID XEO00232 MOACRIVE Inhibition DME0313 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0313 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0313 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME GSTO1 DME0313 XEOTICID XEO00241 GENEFORM mRNA DME0313 XEOTICID XEO00241 MOACRIVE Inhibition DME0313 XEOTICID XEO00253 XEO_NAME Tretinoin DME0313 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0313 XEOTICID XEO00253 DESCRIPT Tretinoin induces the drug-metabolizing activity of DME GSTO1 DME0313 XEOTICID XEO00253 GENEFORM Protein DME0313 XEOTICID XEO00253 MOACRIVE Induction DME0313 XEOTICID XEO00334 XEO_NAME Cisplatin DME0313 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0313 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME GSTO1 DME0313 XEOTICID XEO00334 GENEFORM mRNA DME0313 XEOTICID XEO00334 MOACRIVE Induction DME0313 XEOTICID XEO00587 XEO_NAME Trichloroethylene DME0313 XEOTICID XEO00587 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO00587 XEO_CLAS Drug in Phase 2 Clinical Trial DME0313 XEOTICID XEO00587 DESCRIPT Trichloroethylene up-regulates the expression of DME GSTO1 DME0313 XEOTICID XEO00587 GENEFORM mRNA DME0313 XEOTICID XEO00587 MOACRIVE Induction DME0313 XEOTICID XEO00622 XEO_NAME AM-80 DME0313 XEOTICID XEO00622 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO00622 XEO_CLAS Drug in Phase 2 Clinical Trial DME0313 XEOTICID XEO00622 DESCRIPT AM-80 induces the drug-metabolizing activity of DME GSTO1 DME0313 XEOTICID XEO00622 GENEFORM Protein DME0313 XEOTICID XEO00622 MOACRIVE Induction DME0313 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0313 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0313 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME GSTO1 DME0313 XEOTICID XEO00632 GENEFORM mRNA DME0313 XEOTICID XEO00632 MOACRIVE Inhibition DME0313 XEOTICID XEO00760 XEO_NAME Jinfukang DME0313 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0313 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0313 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME GSTO1 DME0313 XEOTICID XEO00760 GENEFORM mRNA DME0313 XEOTICID XEO00760 MOACRIVE Induction DME0313 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0313 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0313 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0313 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the drug-metabolizing activity of DME GSTO1 DME0313 XEOTICID XEO00898 GENEFORM Protein DME0313 XEOTICID XEO00898 MOACRIVE Inhibition DME0313 XEOTICID XEO00919 XEO_NAME Particulate matter DME0313 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0313 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0313 XEOTICID XEO00919 DESCRIPT Particulate matter up-regulates the expression of DME GSTO1 DME0313 XEOTICID XEO00919 GENEFORM mRNA DME0313 XEOTICID XEO00919 MOACRIVE Induction DME0313 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0313 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0313 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0313 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME GSTO1 DME0313 XEOTICID XEO01004 GENEFORM mRNA DME0313 XEOTICID XEO01004 MOACRIVE Induction DME0313 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0313 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0313 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME GSTO1 DME0313 XEOTICID XEO01226 GENEFORM mRNA DME0313 XEOTICID XEO01226 MOACRIVE Inhibition DME0313 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0313 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0313 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0313 XEOTICID XEO01247 DESCRIPT Chloropicrin up-regulates the expression of DME GSTO1 DME0313 XEOTICID XEO01247 GENEFORM mRNA DME0313 XEOTICID XEO01247 MOACRIVE Induction DME0313 XEOTICID XEO01336 XEO_NAME ICG-001 DME0313 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0313 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME GSTO1 DME0313 XEOTICID XEO01336 GENEFORM mRNA DME0313 XEOTICID XEO01336 MOACRIVE Inhibition DME0313 XEOTICID XEO01394 XEO_NAME NCX-4040 DME0313 XEOTICID XEO01394 XEO_TYPE Health or Environmental Toxicant(s) DME0313 XEOTICID XEO01394 XEO_CLAS Environmental Pollutant DME0313 XEOTICID XEO01394 DESCRIPT NCX-4040 up-regulates the expression of DME GSTO1 DME0313 XEOTICID XEO01394 GENEFORM mRNA DME0313 XEOTICID XEO01394 MOACRIVE Induction DME0313 XEOTICID XEO01407 XEO_NAME Ochratoxin A DME0313 XEOTICID XEO01407 XEO_TYPE Health or Environmental Toxicant(s) DME0313 XEOTICID XEO01407 XEO_CLAS Acute Toxic Substance DME0313 XEOTICID XEO01407 DESCRIPT Ochratoxin A inhibits the drug-metabolizing activity of DME GSTO1 DME0313 XEOTICID XEO01407 GENEFORM Protein DME0313 XEOTICID XEO01407 MOACRIVE Inhibition DME0313 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0313 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0313 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0313 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME GSTO1 DME0313 XEOTICID XEO01492 GENEFORM mRNA DME0313 XEOTICID XEO01492 MOACRIVE Induction DME0313 XEOTICID XEO01503 XEO_NAME Cadmium DME0313 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0313 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0313 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME GSTO1 DME0313 XEOTICID XEO01503 GENEFORM mRNA DME0313 XEOTICID XEO01503 MOACRIVE Induction DME0314 DME___ID DME0314 DME0314 DME_NAME Glutathione S-transferase omega-2 (GSTO2) DME0314 SPESNAME Homo sapiens DME0314 XEOTICID XEO00029 XEO_NAME Valproic acid DME0314 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0314 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0314 XEOTICID XEO00029 DESCRIPT Valproic acid induces the drug-metabolizing activity of DME GSTO2 DME0314 XEOTICID XEO00029 GENEFORM Protein DME0314 XEOTICID XEO00029 MOACRIVE Induction DME0314 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0314 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0314 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0314 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME GSTO2 DME0314 XEOTICID XEO00117 GENEFORM mRNA DME0314 XEOTICID XEO00117 MOACRIVE Inhibition DME0314 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0314 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0314 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0314 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride up-regulates the expression of DME GSTO2 DME0314 XEOTICID XEO00277 GENEFORM mRNA DME0314 XEOTICID XEO00277 MOACRIVE Induction DME0314 XEOTICID XEO00435 XEO_NAME Urethane DME0314 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0314 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0314 XEOTICID XEO00435 DESCRIPT Urethane inhibits the drug-metabolizing activity of DME GSTO2 DME0314 XEOTICID XEO00435 GENEFORM Protein DME0314 XEOTICID XEO00435 MOACRIVE Inhibition DME0314 XEOTICID XEO00581 XEO_NAME MS-275 DME0314 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0314 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0314 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME GSTO2 DME0314 XEOTICID XEO00581 GENEFORM mRNA DME0314 XEOTICID XEO00581 MOACRIVE Induction DME0314 XEOTICID XEO00760 XEO_NAME Jinfukang DME0314 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0314 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0314 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME GSTO2 DME0314 XEOTICID XEO00760 GENEFORM mRNA DME0314 XEOTICID XEO00760 MOACRIVE Induction DME0314 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0314 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0314 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0314 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME GSTO2 DME0314 XEOTICID XEO01004 GENEFORM mRNA DME0314 XEOTICID XEO01004 MOACRIVE Inhibition DME0314 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0314 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0314 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0314 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME GSTO2 DME0314 XEOTICID XEO01031 GENEFORM mRNA DME0314 XEOTICID XEO01031 MOACRIVE Induction DME0314 XEOTICID XEO01336 XEO_NAME ICG-001 DME0314 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0314 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0314 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME GSTO2 DME0314 XEOTICID XEO01336 GENEFORM mRNA DME0314 XEOTICID XEO01336 MOACRIVE Induction DME0314 XEOTICID XEO01348 XEO_NAME K-7174 DME0314 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0314 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0314 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME GSTO2 DME0314 XEOTICID XEO01348 GENEFORM mRNA DME0314 XEOTICID XEO01348 MOACRIVE Inhibition DME0326 DME___ID DME0326 DME0326 DME_NAME UDP-glucuronosyltransferase 2A3 (UGT2A3) DME0326 SPESNAME Homo sapiens DME0326 XEOTICID XEO00029 XEO_NAME Valproic acid DME0326 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0326 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0326 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME UGT2A3 DME0326 XEOTICID XEO00029 GENEFORM mRNA DME0326 XEOTICID XEO00029 MOACRIVE Inhibition DME0326 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0326 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0326 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0326 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME UGT2A3 DME0326 XEOTICID XEO00217 GENEFORM mRNA DME0326 XEOTICID XEO00217 MOACRIVE Inhibition DME0326 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0326 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0326 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0326 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME UGT2A3 DME0326 XEOTICID XEO00241 GENEFORM mRNA DME0326 XEOTICID XEO00241 MOACRIVE Inhibition DME0326 XEOTICID XEO00334 XEO_NAME Cisplatin DME0326 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0326 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0326 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME UGT2A3 DME0326 XEOTICID XEO00334 GENEFORM mRNA DME0326 XEOTICID XEO00334 MOACRIVE Inhibition DME0326 XEOTICID XEO00539 XEO_NAME Ethanol DME0326 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0326 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0326 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the expression of DME UGT2A3 DME0326 XEOTICID XEO00539 GENEFORM mRNA DME0326 XEOTICID XEO00539 MOACRIVE Inhibition DME0326 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0326 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0326 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0326 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME UGT2A3 DME0326 XEOTICID XEO00723 GENEFORM mRNA DME0326 XEOTICID XEO00723 MOACRIVE Inhibition DME0326 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0326 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0326 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0326 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME UGT2A3 DME0326 XEOTICID XEO00898 GENEFORM mRNA DME0326 XEOTICID XEO00898 MOACRIVE Inhibition DME0326 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0326 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0326 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0326 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME UGT2A3 DME0326 XEOTICID XEO01050 GENEFORM mRNA DME0326 XEOTICID XEO01050 MOACRIVE Inhibition DME0326 XEOTICID XEO01348 XEO_NAME K-7174 DME0326 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0326 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0326 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME UGT2A3 DME0326 XEOTICID XEO01348 GENEFORM mRNA DME0326 XEOTICID XEO01348 MOACRIVE Inhibition DME0326 XEOTICID XEO01585 XEO_NAME Senecionine DME0326 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0326 XEOTICID XEO01585 XEO_CLAS Natural Product DME0326 XEOTICID XEO01585 DESCRIPT Senecionine inhibits the drug-metabolizing activity of DME UGT2A3 DME0326 XEOTICID XEO01585 GENEFORM Protein DME0326 XEOTICID XEO01585 MOACRIVE Inhibition DME0336 DME___ID DME0336 DME0336 DME_NAME Cysteinyl-conjugate N-acetyltransferase (NAT8) DME0336 SPESNAME Homo sapiens DME0336 XEOTICID XEO00090 XEO_NAME Estradiol DME0336 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0336 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0336 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME NAT8 DME0336 XEOTICID XEO00090 GENEFORM mRNA DME0336 XEOTICID XEO00090 MOACRIVE Induction DME0336 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0336 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0336 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0336 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME NAT8 DME0336 XEOTICID XEO00117 GENEFORM mRNA DME0336 XEOTICID XEO00117 MOACRIVE Inhibition DME0336 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0336 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0336 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0336 XEOTICID XEO00140 DESCRIPT Zoledronic acid inhibits the expression of DME NAT8 DME0336 XEOTICID XEO00140 GENEFORM mRNA DME0336 XEOTICID XEO00140 MOACRIVE Inhibition DME0336 XEOTICID XEO00184 XEO_NAME Calcitriol DME0336 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0336 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0336 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME NAT8 DME0336 XEOTICID XEO00184 GENEFORM mRNA DME0336 XEOTICID XEO00184 MOACRIVE Induction DME0336 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0336 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0336 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0336 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME NAT8 DME0336 XEOTICID XEO00217 GENEFORM mRNA DME0336 XEOTICID XEO00217 MOACRIVE Inhibition DME0336 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0336 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0336 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0336 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME NAT8 DME0336 XEOTICID XEO00241 GENEFORM mRNA DME0336 XEOTICID XEO00241 MOACRIVE Inhibition DME0336 XEOTICID XEO00334 XEO_NAME Cisplatin DME0336 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0336 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0336 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME NAT8 DME0336 XEOTICID XEO00334 GENEFORM mRNA DME0336 XEOTICID XEO00334 MOACRIVE Inhibition DME0336 XEOTICID XEO00435 XEO_NAME Urethane DME0336 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0336 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0336 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME NAT8 DME0336 XEOTICID XEO00435 GENEFORM mRNA DME0336 XEOTICID XEO00435 MOACRIVE Inhibition DME0336 XEOTICID XEO00578 XEO_NAME Arecoline DME0336 XEOTICID XEO00578 XEO_TYPE Pharmaceutical Agent(s) DME0336 XEOTICID XEO00578 XEO_CLAS Drug in Phase 2 Clinical Trial DME0336 XEOTICID XEO00578 DESCRIPT Arecoline inhibits the expression of DME NAT8 DME0336 XEOTICID XEO00578 GENEFORM mRNA DME0336 XEOTICID XEO00578 MOACRIVE Inhibition DME0336 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0336 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0336 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0336 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME NAT8 DME0336 XEOTICID XEO00632 GENEFORM mRNA DME0336 XEOTICID XEO00632 MOACRIVE Inhibition DME0336 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0336 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0336 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0336 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME NAT8 DME0336 XEOTICID XEO00806 GENEFORM mRNA DME0336 XEOTICID XEO00806 MOACRIVE Induction DME0336 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0336 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0336 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0336 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME NAT8 DME0336 XEOTICID XEO00898 GENEFORM mRNA DME0336 XEOTICID XEO00898 MOACRIVE Induction DME0336 XEOTICID XEO01465 XEO_NAME DCVAC DME0336 XEOTICID XEO01465 XEO_TYPE Pharmaceutical Agent(s) DME0336 XEOTICID XEO01465 XEO_CLAS Drug in Phase 3 Clinical Trial DME0336 XEOTICID XEO01465 DESCRIPT DCVAC induces the drug-metabolizing activity of DME NAT8 DME0336 XEOTICID XEO01465 GENEFORM Protein DME0336 XEOTICID XEO01465 MOACRIVE Induction DME0380 DME___ID DME0380 DME0380 DME_NAME Sulfotransferase 1B1 (SULT1B1) DME0380 SPESNAME Homo sapiens DME0380 XEOTICID XEO00184 XEO_NAME Calcitriol DME0380 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0380 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0380 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME SULT1B1 DME0380 XEOTICID XEO00184 GENEFORM mRNA DME0380 XEOTICID XEO00184 MOACRIVE Inhibition DME0380 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0380 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0380 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0380 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME SULT1B1 DME0380 XEOTICID XEO00217 GENEFORM mRNA DME0380 XEOTICID XEO00217 MOACRIVE Inhibition DME0380 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0380 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0380 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0380 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME SULT1B1 DME0380 XEOTICID XEO00241 GENEFORM mRNA DME0380 XEOTICID XEO00241 MOACRIVE Inhibition DME0380 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0380 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0380 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0380 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME SULT1B1 DME0380 XEOTICID XEO00632 GENEFORM mRNA DME0380 XEOTICID XEO00632 MOACRIVE Inhibition DME0380 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0380 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0380 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0380 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME SULT1B1 DME0380 XEOTICID XEO00806 GENEFORM mRNA DME0380 XEOTICID XEO00806 MOACRIVE Inhibition DME0380 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0380 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0380 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0380 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME SULT1B1 DME0380 XEOTICID XEO00898 GENEFORM mRNA DME0380 XEOTICID XEO00898 MOACRIVE Induction DME0380 XEOTICID XEO00942 XEO_NAME Cyproconazole DME0380 XEOTICID XEO00942 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0380 XEOTICID XEO00942 XEO_CLAS Fungicide DME0380 XEOTICID XEO00942 DESCRIPT Cyproconazole inhibits the expression of DME SULT1B1 DME0380 XEOTICID XEO00942 GENEFORM mRNA DME0380 XEOTICID XEO00942 MOACRIVE Inhibition DME0380 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0380 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0380 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0380 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME SULT1B1 DME0380 XEOTICID XEO01226 GENEFORM mRNA DME0380 XEOTICID XEO01226 MOACRIVE Inhibition DME0380 XEOTICID XEO01302 XEO_NAME Fipronil DME0380 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0380 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0380 XEOTICID XEO01302 DESCRIPT Fipronil inhibits the expression of DME SULT1B1 DME0380 XEOTICID XEO01302 GENEFORM mRNA DME0380 XEOTICID XEO01302 MOACRIVE Inhibition DME0383 DME___ID DME0383 DME0383 DME_NAME Sulfotransferase 1C4 (SULT1C4) DME0383 SPESNAME Homo sapiens DME0383 XEOTICID XEO00029 XEO_NAME Valproic acid DME0383 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0383 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0383 XEOTICID XEO00029 DESCRIPT Valproic acid induces the drug-metabolizing activity of DME SULT1C4 DME0383 XEOTICID XEO00029 GENEFORM Protein DME0383 XEOTICID XEO00029 MOACRIVE Induction DME0383 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0383 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0383 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0383 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME SULT1C4 DME0383 XEOTICID XEO00217 GENEFORM mRNA DME0383 XEOTICID XEO00217 MOACRIVE Induction DME0383 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0383 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0383 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0383 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME SULT1C4 DME0383 XEOTICID XEO00339 GENEFORM mRNA DME0383 XEOTICID XEO00339 MOACRIVE Induction DME0383 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0383 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0383 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0383 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME SULT1C4 DME0383 XEOTICID XEO00806 GENEFORM mRNA DME0383 XEOTICID XEO00806 MOACRIVE Induction DME0383 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0383 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0383 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0383 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME SULT1C4 DME0383 XEOTICID XEO00898 GENEFORM mRNA DME0383 XEOTICID XEO00898 MOACRIVE Induction DME0384 DME___ID DME0384 DME0384 DME_NAME Sulfotransferase 2B1 (SULT2B1) DME0384 SPESNAME Homo sapiens DME0384 XEOTICID XEO00184 XEO_NAME Calcitriol DME0384 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0384 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0384 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME SULT2B1 DME0384 XEOTICID XEO00184 GENEFORM mRNA DME0384 XEOTICID XEO00184 MOACRIVE Induction DME0384 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0384 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0384 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0384 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME SULT2B1 DME0384 XEOTICID XEO00217 GENEFORM mRNA DME0384 XEOTICID XEO00217 MOACRIVE Inhibition DME0384 XEOTICID XEO00334 XEO_NAME Cisplatin DME0384 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0384 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0384 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME SULT2B1 DME0384 XEOTICID XEO00334 GENEFORM mRNA DME0384 XEOTICID XEO00334 MOACRIVE Inhibition DME0384 XEOTICID XEO00581 XEO_NAME MS-275 DME0384 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0384 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0384 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME SULT2B1 DME0384 XEOTICID XEO00581 GENEFORM mRNA DME0384 XEOTICID XEO00581 MOACRIVE Induction DME0384 XEOTICID XEO00606 XEO_NAME Colforsin DME0384 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0384 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0384 XEOTICID XEO00606 DESCRIPT Colforsin inhibits the expression of DME SULT2B1 DME0384 XEOTICID XEO00606 GENEFORM mRNA DME0384 XEOTICID XEO00606 MOACRIVE Inhibition DME0384 XEOTICID XEO00760 XEO_NAME Jinfukang DME0384 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0384 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0384 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME SULT2B1 DME0384 XEOTICID XEO00760 GENEFORM mRNA DME0384 XEOTICID XEO00760 MOACRIVE Inhibition DME0384 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0384 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0384 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0384 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME SULT2B1 DME0384 XEOTICID XEO01031 GENEFORM mRNA DME0384 XEOTICID XEO01031 MOACRIVE Inhibition DME0384 XEOTICID XEO01261 XEO_NAME Coumestrol DME0384 XEOTICID XEO01261 XEO_TYPE Pharmaceutical Agent(s) DME0384 XEOTICID XEO01261 XEO_CLAS Investigative Agent DME0384 XEOTICID XEO01261 DESCRIPT Coumestrol up-regulates the expression of DME SULT2B1 DME0384 XEOTICID XEO01261 GENEFORM mRNA DME0384 XEOTICID XEO01261 MOACRIVE Induction DME0384 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0384 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0384 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0384 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME SULT2B1 DME0384 XEOTICID XEO01305 GENEFORM mRNA DME0384 XEOTICID XEO01305 MOACRIVE Induction DME0384 XEOTICID XEO01503 XEO_NAME Cadmium DME0384 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0384 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0384 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME SULT2B1 DME0384 XEOTICID XEO01503 GENEFORM mRNA DME0384 XEOTICID XEO01503 MOACRIVE Induction DME0389 DME___ID DME0389 DME0389 DME_NAME Bifunctional epoxide hydrolase 2 (EPHX2) DME0389 SPESNAME Homo sapiens DME0389 XEOTICID XEO00029 XEO_NAME Valproic acid DME0389 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0389 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO00029 GENEFORM mRNA DME0389 XEOTICID XEO00029 MOACRIVE Inhibition DME0389 XEOTICID XEO00053 XEO_NAME Leflunomide DME0389 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0389 XEOTICID XEO00053 DESCRIPT Leflunomide inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO00053 GENEFORM mRNA DME0389 XEOTICID XEO00053 MOACRIVE Inhibition DME0389 XEOTICID XEO00086 XEO_NAME Troglitazone DME0389 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0389 XEOTICID XEO00086 DESCRIPT Troglitazone up-regulates the expression of DME EPHX2 DME0389 XEOTICID XEO00086 GENEFORM mRNA DME0389 XEOTICID XEO00086 MOACRIVE Induction DME0389 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0389 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0389 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO00117 GENEFORM mRNA DME0389 XEOTICID XEO00117 MOACRIVE Inhibition DME0389 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0389 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0389 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO00217 GENEFORM mRNA DME0389 XEOTICID XEO00217 MOACRIVE Inhibition DME0389 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0389 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0389 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO00241 GENEFORM mRNA DME0389 XEOTICID XEO00241 MOACRIVE Inhibition DME0389 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0389 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0389 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO00292 GENEFORM mRNA DME0389 XEOTICID XEO00292 MOACRIVE Inhibition DME0389 XEOTICID XEO00334 XEO_NAME Cisplatin DME0389 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0389 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME EPHX2 DME0389 XEOTICID XEO00334 GENEFORM mRNA DME0389 XEOTICID XEO00334 MOACRIVE Induction DME0389 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0389 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0389 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME EPHX2 DME0389 XEOTICID XEO00339 GENEFORM mRNA DME0389 XEOTICID XEO00339 MOACRIVE Induction DME0389 XEOTICID XEO00399 XEO_NAME Pyrithione zinc DME0389 XEOTICID XEO00399 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00399 XEO_CLAS Approved/Marketed Drug DME0389 XEOTICID XEO00399 DESCRIPT Pyrithione zinc up-regulates the expression of DME EPHX2 DME0389 XEOTICID XEO00399 GENEFORM mRNA DME0389 XEOTICID XEO00399 MOACRIVE Induction DME0389 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0389 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0389 XEOTICID XEO00410 DESCRIPT Phenobarbital inhibits the drug-metabolizing activity of DME EPHX2 DME0389 XEOTICID XEO00410 GENEFORM Protein DME0389 XEOTICID XEO00410 MOACRIVE Inhibition DME0389 XEOTICID XEO00435 XEO_NAME Urethane DME0389 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0389 XEOTICID XEO00435 DESCRIPT Urethane inhibits the drug-metabolizing activity of DME EPHX2 DME0389 XEOTICID XEO00435 GENEFORM Protein DME0389 XEOTICID XEO00435 MOACRIVE Inhibition DME0389 XEOTICID XEO00442 XEO_NAME Chlorobenzene DME0389 XEOTICID XEO00442 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00442 XEO_CLAS Approved/Marketed Drug DME0389 XEOTICID XEO00442 DESCRIPT Chlorobenzene inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO00442 GENEFORM mRNA DME0389 XEOTICID XEO00442 MOACRIVE Inhibition DME0389 XEOTICID XEO00544 XEO_NAME Ebselen DME0389 XEOTICID XEO00544 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00544 XEO_CLAS Drug in Phase 2 Clinical Trial DME0389 XEOTICID XEO00544 DESCRIPT Ebselen inhibits the drug-metabolizing activity of DME EPHX2 (IC50 = 2.2 microM) DME0389 XEOTICID XEO00544 GENEFORM Protein DME0389 XEOTICID XEO00544 MOACRIVE Inhibition DME0389 XEOTICID XEO00557 XEO_NAME Genistein DME0389 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0389 XEOTICID XEO00557 DESCRIPT Genistein induces the drug-metabolizing activity of DME EPHX2 DME0389 XEOTICID XEO00557 GENEFORM Protein DME0389 XEOTICID XEO00557 MOACRIVE Induction DME0389 XEOTICID XEO00568 XEO_NAME Resveratrol DME0389 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0389 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME EPHX2 DME0389 XEOTICID XEO00568 GENEFORM mRNA DME0389 XEOTICID XEO00568 MOACRIVE Induction DME0389 XEOTICID XEO00760 XEO_NAME Jinfukang DME0389 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0389 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0389 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME EPHX2 DME0389 XEOTICID XEO00760 GENEFORM mRNA DME0389 XEOTICID XEO00760 MOACRIVE Induction DME0389 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0389 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0389 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0389 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO00806 GENEFORM mRNA DME0389 XEOTICID XEO00806 MOACRIVE Inhibition DME0389 XEOTICID XEO00813 XEO_NAME Dinophysistoxin 1 DME0389 XEOTICID XEO00813 XEO_TYPE Health or Environmental Toxicant(s) DME0389 XEOTICID XEO00813 XEO_CLAS Biotoxin DME0389 XEOTICID XEO00813 DESCRIPT Dinophysistoxin 1 inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO00813 GENEFORM mRNA DME0389 XEOTICID XEO00813 MOACRIVE Inhibition DME0389 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0389 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0389 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO00818 GENEFORM mRNA DME0389 XEOTICID XEO00818 MOACRIVE Inhibition DME0389 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0389 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0389 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0389 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO00898 GENEFORM mRNA DME0389 XEOTICID XEO00898 MOACRIVE Inhibition DME0389 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0389 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0389 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0389 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO01004 GENEFORM mRNA DME0389 XEOTICID XEO01004 MOACRIVE Inhibition DME0389 XEOTICID XEO01083 XEO_NAME AR-9281 DME0389 XEOTICID XEO01083 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO01083 XEO_CLAS Drug in Phase 2 Clinical Trial DME0389 XEOTICID XEO01083 DESCRIPT AR-9281 inhibits the drug-metabolizing activity of DME EPHX2 DME0389 XEOTICID XEO01083 GENEFORM Protein DME0389 XEOTICID XEO01083 MOACRIVE Inhibition DME0389 XEOTICID XEO01107 XEO_NAME NSC 703786 DME0389 XEOTICID XEO01107 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO01107 XEO_CLAS Drug in Phase 1 Clinical Trial DME0389 XEOTICID XEO01107 DESCRIPT NSC 703786 inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO01107 GENEFORM mRNA DME0389 XEOTICID XEO01107 MOACRIVE Inhibition DME0389 XEOTICID XEO01160 XEO_NAME 5-Hydroxyeicosatetraenoic acid DME0389 XEOTICID XEO01160 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO01160 XEO_CLAS Investigative Agent DME0389 XEOTICID XEO01160 DESCRIPT 5-Hydroxyeicosatetraenoic acid induces the drug-metabolizing activity of DME EPHX2 DME0389 XEOTICID XEO01160 GENEFORM Protein DME0389 XEOTICID XEO01160 MOACRIVE Induction DME0389 XEOTICID XEO01342 XEO_NAME Indirubin-3'-monoxime DME0389 XEOTICID XEO01342 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO01342 XEO_CLAS Investigative Agent DME0389 XEOTICID XEO01342 DESCRIPT Indirubin-3'-monoxime inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO01342 GENEFORM mRNA DME0389 XEOTICID XEO01342 MOACRIVE Inhibition DME0389 XEOTICID XEO01348 XEO_NAME K-7174 DME0389 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0389 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO01348 GENEFORM mRNA DME0389 XEOTICID XEO01348 MOACRIVE Inhibition DME0389 XEOTICID XEO01378 XEO_NAME Metribolone DME0389 XEOTICID XEO01378 XEO_TYPE Pharmaceutical Agent(s) DME0389 XEOTICID XEO01378 XEO_CLAS Investigative Agent DME0389 XEOTICID XEO01378 DESCRIPT Metribolone up-regulates the expression of DME EPHX2 DME0389 XEOTICID XEO01378 GENEFORM mRNA DME0389 XEOTICID XEO01378 MOACRIVE Induction DME0389 XEOTICID XEO01551 XEO_NAME Heliotrine DME0389 XEOTICID XEO01551 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0389 XEOTICID XEO01551 XEO_CLAS Natural Product DME0389 XEOTICID XEO01551 DESCRIPT Heliotrine inhibits the expression of DME EPHX2 DME0389 XEOTICID XEO01551 GENEFORM mRNA DME0389 XEOTICID XEO01551 MOACRIVE Inhibition DME0389 XEOTICID XEO01585 XEO_NAME Senecionine DME0389 XEOTICID XEO01585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0389 XEOTICID XEO01585 XEO_CLAS Natural Product DME0389 XEOTICID XEO01585 DESCRIPT Senecionine inhibits the drug-metabolizing activity of DME EPHX2 DME0389 XEOTICID XEO01585 GENEFORM Protein DME0389 XEOTICID XEO01585 MOACRIVE Inhibition DME0398 DME___ID DME0398 DME0398 DME_NAME Small intestine reductase (AKR1B10) DME0398 SPESNAME Homo sapiens DME0398 XEOTICID XEO00007 XEO_NAME Azathioprine DME0398 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00007 DESCRIPT Azathioprine up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00007 GENEFORM mRNA DME0398 XEOTICID XEO00007 MOACRIVE Induction DME0398 XEOTICID XEO00014 XEO_NAME Chlorambucil DME0398 XEOTICID XEO00014 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00014 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00014 DESCRIPT Chlorambucil inhibits the expression of DME AKR1B10 DME0398 XEOTICID XEO00014 GENEFORM mRNA DME0398 XEOTICID XEO00014 MOACRIVE Inhibition DME0398 XEOTICID XEO00028 XEO_NAME Disulfiram DME0398 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00028 DESCRIPT Disulfiram up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00028 GENEFORM mRNA DME0398 XEOTICID XEO00028 MOACRIVE Induction DME0398 XEOTICID XEO00035 XEO_NAME Fenofibrate DME0398 XEOTICID XEO00035 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00035 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00035 DESCRIPT Fenof DMEibrate inhibits the drug-metabolizing activity of DME AKR1B10 DME0398 XEOTICID XEO00035 GENEFORM Protein DME0398 XEOTICID XEO00035 MOACRIVE Inhibition DME0398 XEOTICID XEO00042 XEO_NAME Gemfibrozil DME0398 XEOTICID XEO00042 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00042 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00042 DESCRIPT Gemfibrozil inhibits the drug-metabolizing activity of DME AKR1B10 DME0398 XEOTICID XEO00042 GENEFORM Protein DME0398 XEOTICID XEO00042 MOACRIVE Inhibition DME0398 XEOTICID XEO00090 XEO_NAME Estradiol DME0398 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME AKR1B10 DME0398 XEOTICID XEO00090 GENEFORM mRNA DME0398 XEOTICID XEO00090 MOACRIVE Inhibition DME0398 XEOTICID XEO00094 XEO_NAME Progesterone DME0398 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00094 DESCRIPT Progesterone inhibits the drug-metabolizing activity of DME AKR1B10 DME0398 XEOTICID XEO00094 GENEFORM Protein DME0398 XEOTICID XEO00094 MOACRIVE Inhibition DME0398 XEOTICID XEO00096 XEO_NAME Ampicillin DME0398 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the expression of DME AKR1B10 DME0398 XEOTICID XEO00096 GENEFORM mRNA DME0398 XEOTICID XEO00096 MOACRIVE Inhibition DME0398 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0398 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00117 GENEFORM mRNA DME0398 XEOTICID XEO00117 MOACRIVE Induction DME0398 XEOTICID XEO00138 XEO_NAME Fenofibric acid DME0398 XEOTICID XEO00138 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00138 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00138 DESCRIPT Fenof DMEibric acid inhibits the drug-metabolizing activity of DME AKR1B10 DME0398 XEOTICID XEO00138 GENEFORM Protein DME0398 XEOTICID XEO00138 MOACRIVE Inhibition DME0398 XEOTICID XEO00159 XEO_NAME Bortezomib DME0398 XEOTICID XEO00159 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00159 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00159 DESCRIPT Bortezomib induces the drug-metabolizing activity of DME AKR1B10 DME0398 XEOTICID XEO00159 GENEFORM Protein DME0398 XEOTICID XEO00159 MOACRIVE Induction DME0398 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0398 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00166 GENEFORM mRNA DME0398 XEOTICID XEO00166 MOACRIVE Induction DME0398 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0398 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME AKR1B10 DME0398 XEOTICID XEO00217 GENEFORM mRNA DME0398 XEOTICID XEO00217 MOACRIVE Inhibition DME0398 XEOTICID XEO00222 XEO_NAME Reserpine DME0398 XEOTICID XEO00222 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00222 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00222 DESCRIPT Reserpine up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00222 GENEFORM mRNA DME0398 XEOTICID XEO00222 MOACRIVE Induction DME0398 XEOTICID XEO00223 XEO_NAME Rifampin DME0398 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00223 DESCRIPT Rifampin up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00223 GENEFORM mRNA DME0398 XEOTICID XEO00223 MOACRIVE Induction DME0398 XEOTICID XEO00224 XEO_NAME Isoniazid DME0398 XEOTICID XEO00224 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00224 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00224 DESCRIPT Isoniazid up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00224 GENEFORM mRNA DME0398 XEOTICID XEO00224 MOACRIVE Induction DME0398 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0398 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00241 GENEFORM mRNA DME0398 XEOTICID XEO00241 MOACRIVE Induction DME0398 XEOTICID XEO00246 XEO_NAME Amoxicillin DME0398 XEOTICID XEO00246 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00246 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00246 DESCRIPT Amoxicillin up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00246 GENEFORM mRNA DME0398 XEOTICID XEO00246 MOACRIVE Induction DME0398 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0398 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00292 GENEFORM mRNA DME0398 XEOTICID XEO00292 MOACRIVE Induction DME0398 XEOTICID XEO00334 XEO_NAME Cisplatin DME0398 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00334 GENEFORM mRNA DME0398 XEOTICID XEO00334 MOACRIVE Induction DME0398 XEOTICID XEO00428 XEO_NAME Menadione DME0398 XEOTICID XEO00428 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00428 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00428 DESCRIPT Menadione up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00428 GENEFORM mRNA DME0398 XEOTICID XEO00428 MOACRIVE Induction DME0398 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0398 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00430 DESCRIPT Hydroquinone inhibits the expression of DME AKR1B10 DME0398 XEOTICID XEO00430 GENEFORM mRNA DME0398 XEOTICID XEO00430 MOACRIVE Inhibition DME0398 XEOTICID XEO00435 XEO_NAME Urethane DME0398 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00435 DESCRIPT Urethane inhibits the drug-metabolizing activity of DME AKR1B10 DME0398 XEOTICID XEO00435 GENEFORM Protein DME0398 XEOTICID XEO00435 MOACRIVE Inhibition DME0398 XEOTICID XEO00447 XEO_NAME Benzoic acid DME0398 XEOTICID XEO00447 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00447 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00447 DESCRIPT Benzoic acid up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00447 GENEFORM mRNA DME0398 XEOTICID XEO00447 MOACRIVE Induction DME0398 XEOTICID XEO00469 XEO_NAME Floxacillin DME0398 XEOTICID XEO00469 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00469 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00469 DESCRIPT Floxacillin up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00469 GENEFORM mRNA DME0398 XEOTICID XEO00469 MOACRIVE Induction DME0398 XEOTICID XEO00494 XEO_NAME Ciprofibrate DME0398 XEOTICID XEO00494 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00494 XEO_CLAS Approved/Marketed Drug DME0398 XEOTICID XEO00494 DESCRIPT Ciprof DMEibrate inhibits the drug-metabolizing activity of DME AKR1B10 DME0398 XEOTICID XEO00494 GENEFORM Protein DME0398 XEOTICID XEO00494 MOACRIVE Inhibition DME0398 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0398 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0398 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00571 GENEFORM mRNA DME0398 XEOTICID XEO00571 MOACRIVE Induction DME0398 XEOTICID XEO00580 XEO_NAME LY-294002 DME0398 XEOTICID XEO00580 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00580 XEO_CLAS Drug in Phase 1 Clinical Trial DME0398 XEOTICID XEO00580 DESCRIPT LY-294002 inhibits the drug-metabolizing activity of DME AKR1B10 DME0398 XEOTICID XEO00580 GENEFORM Protein DME0398 XEOTICID XEO00580 MOACRIVE Inhibition DME0398 XEOTICID XEO00599 XEO_NAME Tetradecanoylphorbol acetate DME0398 XEOTICID XEO00599 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00599 XEO_CLAS Drug in Phase 1 Clinical Trial DME0398 XEOTICID XEO00599 DESCRIPT Tetradecanoylphorbol acetate inhibits the expression of DME AKR1B10 DME0398 XEOTICID XEO00599 GENEFORM mRNA DME0398 XEOTICID XEO00599 MOACRIVE Inhibition DME0398 XEOTICID XEO00628 XEO_NAME SNK-860 DME0398 XEOTICID XEO00628 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00628 XEO_CLAS Drug in Phase 1 Clinical Trial DME0398 XEOTICID XEO00628 DESCRIPT SNK-860 inhibits the drug-metabolizing activity of DME AKR1B10 DME0398 XEOTICID XEO00628 GENEFORM Protein DME0398 XEOTICID XEO00628 MOACRIVE Inhibition DME0398 XEOTICID XEO00630 XEO_NAME Sorbinil DME0398 XEOTICID XEO00630 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00630 XEO_CLAS Drug in Phase 3 Clinical Trial DME0398 XEOTICID XEO00630 DESCRIPT Sorbinil inhibits the drug-metabolizing activity of DME AKR1B10 (IC50 = 9.6 microM) DME0398 XEOTICID XEO00630 GENEFORM Protein DME0398 XEOTICID XEO00630 MOACRIVE Inhibition DME0398 XEOTICID XEO00659 XEO_NAME Exisulind DME0398 XEOTICID XEO00659 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00659 XEO_CLAS Drug in Phase 3 Clinical Trial DME0398 XEOTICID XEO00659 DESCRIPT Exisulind inhibits the drug-metabolizing activity of DME AKR1B10 DME0398 XEOTICID XEO00659 GENEFORM Protein DME0398 XEOTICID XEO00659 MOACRIVE Inhibition DME0398 XEOTICID XEO00688 XEO_NAME Zopolrestat DME0398 XEOTICID XEO00688 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00688 XEO_CLAS Preclinical/Patented Drug DME0398 XEOTICID XEO00688 DESCRIPT Zopolrestat inhibits the drug-metabolizing activity of DME AKR1B10 (IC50 = 0.62 microM) DME0398 XEOTICID XEO00688 GENEFORM Protein DME0398 XEOTICID XEO00688 MOACRIVE Inhibition DME0398 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0398 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0398 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME AKR1B10 DME0398 XEOTICID XEO00723 GENEFORM mRNA DME0398 XEOTICID XEO00723 MOACRIVE Inhibition DME0398 XEOTICID XEO00760 XEO_NAME Jinfukang DME0398 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0398 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0398 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00760 GENEFORM mRNA DME0398 XEOTICID XEO00760 MOACRIVE Induction DME0398 XEOTICID XEO00763 XEO_NAME Anthranilic acid DME0398 XEOTICID XEO00763 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0398 XEOTICID XEO00763 XEO_CLAS Natural Product DME0398 XEOTICID XEO00763 DESCRIPT Anthranilic acid up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00763 GENEFORM mRNA DME0398 XEOTICID XEO00763 MOACRIVE Induction DME0398 XEOTICID XEO00783 XEO_NAME Ethyl acrylate DME0398 XEOTICID XEO00783 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0398 XEOTICID XEO00783 XEO_CLAS Chemical Compound DME0398 XEOTICID XEO00783 DESCRIPT Ethyl acrylate up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00783 GENEFORM mRNA DME0398 XEOTICID XEO00783 MOACRIVE Induction DME0398 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0398 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0398 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0398 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00821 GENEFORM mRNA DME0398 XEOTICID XEO00821 MOACRIVE Induction DME0398 XEOTICID XEO00870 XEO_NAME 4-oxo-2-nonenal DME0398 XEOTICID XEO00870 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00870 XEO_CLAS Investigative Agent DME0398 XEOTICID XEO00870 DESCRIPT 4-oxo-2-nonenal inhibits the drug-metabolizing activity of DME AKR1B10 DME0398 XEOTICID XEO00870 GENEFORM Protein DME0398 XEOTICID XEO00870 MOACRIVE Inhibition DME0398 XEOTICID XEO00871 XEO_NAME 9,10-phenanthrenequinone DME0398 XEOTICID XEO00871 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00871 XEO_CLAS Investigative Agent DME0398 XEOTICID XEO00871 DESCRIPT 9,10-phenanthrenequinone up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00871 GENEFORM mRNA DME0398 XEOTICID XEO00871 MOACRIVE Induction DME0398 XEOTICID XEO00878 XEO_NAME Chrysin DME0398 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0398 XEOTICID XEO00878 XEO_CLAS Natural Product DME0398 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of DME AKR1B10 DME0398 XEOTICID XEO00878 GENEFORM Protein DME0398 XEOTICID XEO00878 MOACRIVE Inhibition DME0398 XEOTICID XEO00885 XEO_NAME Eugenol DME0398 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0398 XEOTICID XEO00885 DESCRIPT Eugenol up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00885 GENEFORM mRNA DME0398 XEOTICID XEO00885 MOACRIVE Induction DME0398 XEOTICID XEO00890 XEO_NAME 2-methyl-4-isothiazolin-3-one DME0398 XEOTICID XEO00890 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO00890 XEO_CLAS Acute Toxic Substance DME0398 XEOTICID XEO00890 DESCRIPT 2-methyl-4-isothiazolin-3-one up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00890 GENEFORM mRNA DME0398 XEOTICID XEO00890 MOACRIVE Induction DME0398 XEOTICID XEO00894 XEO_NAME 2-acetylaminofluorene DME0398 XEOTICID XEO00894 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO00894 XEO_CLAS Carcinogen DME0398 XEOTICID XEO00894 DESCRIPT 2-acetylaminofluorene up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00894 GENEFORM mRNA DME0398 XEOTICID XEO00894 MOACRIVE Induction DME0398 XEOTICID XEO00895 XEO_NAME 2-amino-3-methylimidazo(4,5-f)quinoline DME0398 XEOTICID XEO00895 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO00895 XEO_CLAS Carcinogen DME0398 XEOTICID XEO00895 DESCRIPT 2-amino-3-methylimidazo(4,5-f)quinoline inhibits the expression of DME AKR1B10 DME0398 XEOTICID XEO00895 GENEFORM mRNA DME0398 XEOTICID XEO00895 MOACRIVE Inhibition DME0398 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0398 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0398 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00898 GENEFORM mRNA DME0398 XEOTICID XEO00898 MOACRIVE Induction DME0398 XEOTICID XEO00919 XEO_NAME Particulate matter DME0398 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0398 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0398 XEOTICID XEO00919 DESCRIPT Particulate matter inhibits the expression of DME AKR1B10 DME0398 XEOTICID XEO00919 GENEFORM mRNA DME0398 XEOTICID XEO00919 MOACRIVE Inhibition DME0398 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0398 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0398 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00921 GENEFORM mRNA DME0398 XEOTICID XEO00921 MOACRIVE Induction DME0398 XEOTICID XEO00934 XEO_NAME Ethoxyquin DME0398 XEOTICID XEO00934 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0398 XEOTICID XEO00934 XEO_CLAS Food Additive DME0398 XEOTICID XEO00934 DESCRIPT Ethoxyquin up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00934 GENEFORM mRNA DME0398 XEOTICID XEO00934 MOACRIVE Induction DME0398 XEOTICID XEO00971 XEO_NAME Diquat DME0398 XEOTICID XEO00971 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0398 XEOTICID XEO00971 XEO_CLAS Herbicide DME0398 XEOTICID XEO00971 DESCRIPT Diquat up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00971 GENEFORM mRNA DME0398 XEOTICID XEO00971 MOACRIVE Induction DME0398 XEOTICID XEO00985 XEO_NAME Hexyl cinnamic aldehyde DME0398 XEOTICID XEO00985 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO00985 XEO_CLAS Environmental Pollutant DME0398 XEOTICID XEO00985 DESCRIPT Hexyl cinnamic aldehyde up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO00985 GENEFORM mRNA DME0398 XEOTICID XEO00985 MOACRIVE Induction DME0398 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0398 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0398 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO01004 GENEFORM mRNA DME0398 XEOTICID XEO01004 MOACRIVE Induction DME0398 XEOTICID XEO01009 XEO_NAME Glycidamide DME0398 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0398 XEOTICID XEO01009 DESCRIPT Glycidamide up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO01009 GENEFORM mRNA DME0398 XEOTICID XEO01009 MOACRIVE Induction DME0398 XEOTICID XEO01016 XEO_NAME N-hexane DME0398 XEOTICID XEO01016 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO01016 XEO_CLAS Health Hazard/Toxicant DME0398 XEOTICID XEO01016 DESCRIPT N-hexane up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO01016 GENEFORM mRNA DME0398 XEOTICID XEO01016 MOACRIVE Induction DME0398 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0398 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0398 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME AKR1B10 DME0398 XEOTICID XEO01031 GENEFORM mRNA DME0398 XEOTICID XEO01031 MOACRIVE Inhibition DME0398 XEOTICID XEO01128 XEO_NAME Isopropanol DME0398 XEOTICID XEO01128 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO01128 XEO_CLAS Investigative Agent DME0398 XEOTICID XEO01128 DESCRIPT Isopropanol up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO01128 GENEFORM mRNA DME0398 XEOTICID XEO01128 MOACRIVE Induction DME0398 XEOTICID XEO01129 XEO_NAME 2-tert-butylhydroquinone DME0398 XEOTICID XEO01129 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO01129 XEO_CLAS Environmental Pollutant DME0398 XEOTICID XEO01129 DESCRIPT 2-tert-butylhydroquinone up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO01129 GENEFORM mRNA DME0398 XEOTICID XEO01129 MOACRIVE Induction DME0398 XEOTICID XEO01151 XEO_NAME 4-chloromercuribenzenesulfonate DME0398 XEOTICID XEO01151 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0398 XEOTICID XEO01151 XEO_CLAS Chemical Compound DME0398 XEOTICID XEO01151 DESCRIPT 4-chloromercuribenzenesulfonate inhibits the drug-metabolizing activity of DME AKR1B10 DME0398 XEOTICID XEO01151 GENEFORM Protein DME0398 XEOTICID XEO01151 MOACRIVE Inhibition DME0398 XEOTICID XEO01201 XEO_NAME Antimony potassium tartrate DME0398 XEOTICID XEO01201 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO01201 XEO_CLAS Environmental Pollutant DME0398 XEOTICID XEO01201 DESCRIPT Antimony potassium tartrate up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO01201 GENEFORM mRNA DME0398 XEOTICID XEO01201 MOACRIVE Induction DME0398 XEOTICID XEO01219 XEO_NAME MG-132 DME0398 XEOTICID XEO01219 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO01219 XEO_CLAS Investigative Agent DME0398 XEOTICID XEO01219 DESCRIPT MG-132 up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO01219 GENEFORM mRNA DME0398 XEOTICID XEO01219 MOACRIVE Induction DME0398 XEOTICID XEO01233 XEO_NAME Phenethyl caffeate DME0398 XEOTICID XEO01233 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO01233 XEO_CLAS Drug in Phase 1 Clinical Trial DME0398 XEOTICID XEO01233 DESCRIPT Phenethyl caffeate inhibits the drug-metabolizing activity of DME AKR1B10 (IC50 = 0.08 microM) DME0398 XEOTICID XEO01233 GENEFORM Protein DME0398 XEOTICID XEO01233 MOACRIVE Inhibition DME0398 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME0398 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0398 XEOTICID XEO01253 XEO_CLAS Natural Product DME0398 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO01253 GENEFORM mRNA DME0398 XEOTICID XEO01253 MOACRIVE Induction DME0398 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0398 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0398 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME AKR1B10 DME0398 XEOTICID XEO01305 GENEFORM mRNA DME0398 XEOTICID XEO01305 MOACRIVE Inhibition DME0398 XEOTICID XEO01348 XEO_NAME K-7174 DME0398 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0398 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0398 XEOTICID XEO01348 DESCRIPT K-7174 up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO01348 GENEFORM mRNA DME0398 XEOTICID XEO01348 MOACRIVE Induction DME0398 XEOTICID XEO01433 XEO_NAME Pirinixic acid DME0398 XEOTICID XEO01433 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO01433 XEO_CLAS Health Hazard/Toxicant DME0398 XEOTICID XEO01433 DESCRIPT Pirinixic acid up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO01433 GENEFORM mRNA DME0398 XEOTICID XEO01433 MOACRIVE Induction DME0398 XEOTICID XEO01453 XEO_NAME Resorcinol DME0398 XEOTICID XEO01453 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO01453 XEO_CLAS Environmental Pollutant DME0398 XEOTICID XEO01453 DESCRIPT Resorcinol up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO01453 GENEFORM mRNA DME0398 XEOTICID XEO01453 MOACRIVE Induction DME0398 XEOTICID XEO01503 XEO_NAME Cadmium DME0398 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0398 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO01503 GENEFORM mRNA DME0398 XEOTICID XEO01503 MOACRIVE Induction DME0398 XEOTICID XEO01504 XEO_NAME Gold DME0398 XEOTICID XEO01504 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0398 XEOTICID XEO01504 XEO_CLAS Chemical Compound DME0398 XEOTICID XEO01504 DESCRIPT Gold up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO01504 GENEFORM mRNA DME0398 XEOTICID XEO01504 MOACRIVE Induction DME0398 XEOTICID XEO01506 XEO_NAME Lead chloride DME0398 XEOTICID XEO01506 XEO_TYPE Health or Environmental Toxicant(s) DME0398 XEOTICID XEO01506 XEO_CLAS Health Hazard/Toxicant DME0398 XEOTICID XEO01506 DESCRIPT Lead chloride up-regulates the expression of DME AKR1B10 DME0398 XEOTICID XEO01506 GENEFORM mRNA DME0398 XEOTICID XEO01506 MOACRIVE Induction DME0398 XEOTICID XEO01588 XEO_NAME Shogaol DME0398 XEOTICID XEO01588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0398 XEOTICID XEO01588 XEO_CLAS Natural Product DME0398 XEOTICID XEO01588 DESCRIPT Shogaol induces the drug-metabolizing activity of DME AKR1B10 DME0398 XEOTICID XEO01588 GENEFORM Protein DME0398 XEOTICID XEO01588 MOACRIVE Induction DME0399 DME___ID DME0399 DME0399 DME_NAME Farnesol dehydrogenase (AKR1B15) DME0399 SPESNAME Homo sapiens DME0399 XEOTICID XEO00097 XEO_NAME Cytarabine DME0399 XEOTICID XEO00097 XEO_TYPE Pharmaceutical Agent(s) DME0399 XEOTICID XEO00097 XEO_CLAS Approved/Marketed Drug DME0399 XEOTICID XEO00097 DESCRIPT Cytarabine inhibits the expression of DME AKR1B15 DME0399 XEOTICID XEO00097 GENEFORM mRNA DME0399 XEOTICID XEO00097 MOACRIVE Inhibition DME0399 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0399 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0399 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0399 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME AKR1B15 DME0399 XEOTICID XEO00117 GENEFORM mRNA DME0399 XEOTICID XEO00117 MOACRIVE Induction DME0399 XEOTICID XEO00334 XEO_NAME Cisplatin DME0399 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0399 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0399 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME AKR1B15 DME0399 XEOTICID XEO00334 GENEFORM mRNA DME0399 XEOTICID XEO00334 MOACRIVE Induction DME0399 XEOTICID XEO00760 XEO_NAME Jinfukang DME0399 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0399 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0399 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME AKR1B15 DME0399 XEOTICID XEO00760 GENEFORM mRNA DME0399 XEOTICID XEO00760 MOACRIVE Induction DME0399 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0399 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0399 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0399 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME AKR1B15 DME0399 XEOTICID XEO00898 GENEFORM mRNA DME0399 XEOTICID XEO00898 MOACRIVE Induction DME0400 DME___ID DME0400 DME0400 DME_NAME Aldo-keto reductase 1D1 (AKR1D1) DME0400 SPESNAME Homo sapiens DME0400 XEOTICID XEO00007 XEO_NAME Azathioprine DME0400 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0400 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0400 XEOTICID XEO00007 DESCRIPT Azathioprine inhibits the expression of DME AKR1D1 DME0400 XEOTICID XEO00007 GENEFORM mRNA DME0400 XEOTICID XEO00007 MOACRIVE Inhibition DME0400 XEOTICID XEO00029 XEO_NAME Valproic acid DME0400 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0400 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0400 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the drug-metabolizing activity of DME AKR1D1 DME0400 XEOTICID XEO00029 GENEFORM Protein DME0400 XEOTICID XEO00029 MOACRIVE Inhibition DME0400 XEOTICID XEO00090 XEO_NAME Estradiol DME0400 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0400 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0400 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME AKR1D1 DME0400 XEOTICID XEO00090 GENEFORM mRNA DME0400 XEOTICID XEO00090 MOACRIVE Inhibition DME0400 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0400 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0400 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0400 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME AKR1D1 DME0400 XEOTICID XEO00117 GENEFORM mRNA DME0400 XEOTICID XEO00117 MOACRIVE Inhibition DME0400 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0400 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0400 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0400 XEOTICID XEO00165 DESCRIPT Obeticholic acid inhibits the drug-metabolizing activity of DME AKR1D1 DME0400 XEOTICID XEO00165 GENEFORM Protein DME0400 XEOTICID XEO00165 MOACRIVE Inhibition DME0400 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0400 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0400 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0400 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME AKR1D1 DME0400 XEOTICID XEO00217 GENEFORM mRNA DME0400 XEOTICID XEO00217 MOACRIVE Inhibition DME0400 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0400 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0400 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0400 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME AKR1D1 DME0400 XEOTICID XEO00241 GENEFORM mRNA DME0400 XEOTICID XEO00241 MOACRIVE Inhibition DME0400 XEOTICID XEO00334 XEO_NAME Cisplatin DME0400 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0400 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0400 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME AKR1D1 DME0400 XEOTICID XEO00334 GENEFORM mRNA DME0400 XEOTICID XEO00334 MOACRIVE Induction DME0400 XEOTICID XEO00410 XEO_NAME Phenobarbital DME0400 XEOTICID XEO00410 XEO_TYPE Pharmaceutical Agent(s) DME0400 XEOTICID XEO00410 XEO_CLAS Approved/Marketed Drug DME0400 XEOTICID XEO00410 DESCRIPT Phenobarbital induces the drug-metabolizing activity of DME AKR1D1 DME0400 XEOTICID XEO00410 GENEFORM Protein DME0400 XEOTICID XEO00410 MOACRIVE Induction DME0400 XEOTICID XEO00435 XEO_NAME Urethane DME0400 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0400 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0400 XEOTICID XEO00435 DESCRIPT Urethane inhibits the drug-metabolizing activity of DME AKR1D1 DME0400 XEOTICID XEO00435 GENEFORM Protein DME0400 XEOTICID XEO00435 MOACRIVE Inhibition DME0400 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0400 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0400 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0400 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME AKR1D1 DME0400 XEOTICID XEO00536 GENEFORM mRNA DME0400 XEOTICID XEO00536 MOACRIVE Induction DME0400 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0400 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0400 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0400 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME AKR1D1 DME0400 XEOTICID XEO00772 GENEFORM mRNA DME0400 XEOTICID XEO00772 MOACRIVE Induction DME0400 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0400 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0400 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0400 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME AKR1D1 DME0400 XEOTICID XEO00806 GENEFORM mRNA DME0400 XEOTICID XEO00806 MOACRIVE Inhibition DME0400 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0400 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0400 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0400 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME AKR1D1 DME0400 XEOTICID XEO00898 GENEFORM mRNA DME0400 XEOTICID XEO00898 MOACRIVE Inhibition DME0400 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0400 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0400 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0400 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME AKR1D1 DME0400 XEOTICID XEO01050 GENEFORM mRNA DME0400 XEOTICID XEO01050 MOACRIVE Inhibition DME0400 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0400 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0400 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0400 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME AKR1D1 DME0400 XEOTICID XEO01220 GENEFORM mRNA DME0400 XEOTICID XEO01220 MOACRIVE Inhibition DME0400 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0400 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0400 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0400 XEOTICID XEO01247 DESCRIPT Chloropicrin up-regulates the expression of DME AKR1D1 DME0400 XEOTICID XEO01247 GENEFORM mRNA DME0400 XEOTICID XEO01247 MOACRIVE Induction DME0400 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0400 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0400 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0400 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME AKR1D1 DME0400 XEOTICID XEO01305 GENEFORM mRNA DME0400 XEOTICID XEO01305 MOACRIVE Induction DME0400 XEOTICID XEO01503 XEO_NAME Cadmium DME0400 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0400 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0400 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME AKR1D1 DME0400 XEOTICID XEO01503 GENEFORM mRNA DME0400 XEOTICID XEO01503 MOACRIVE Induction DME0401 DME___ID DME0401 DME0401 DME_NAME Porphobilinogen synthase (ALAD) DME0401 SPESNAME Homo sapiens DME0401 XEOTICID XEO00012 XEO_NAME Carmustine DME0401 XEOTICID XEO00012 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00012 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00012 DESCRIPT Carmustine inhibits the expression of DME ALAD DME0401 XEOTICID XEO00012 GENEFORM mRNA DME0401 XEOTICID XEO00012 MOACRIVE Inhibition DME0401 XEOTICID XEO00027 XEO_NAME Dimercaprol DME0401 XEOTICID XEO00027 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00027 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00027 DESCRIPT Dimercaprol inhibits the drug-metabolizing activity of DME ALAD DME0401 XEOTICID XEO00027 GENEFORM Protein DME0401 XEOTICID XEO00027 MOACRIVE Inhibition DME0401 XEOTICID XEO00090 XEO_NAME Estradiol DME0401 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME ALAD DME0401 XEOTICID XEO00090 GENEFORM mRNA DME0401 XEOTICID XEO00090 MOACRIVE Inhibition DME0401 XEOTICID XEO00091 XEO_NAME Estrone DME0401 XEOTICID XEO00091 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00091 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00091 DESCRIPT Estrone inhibits the expression of DME ALAD DME0401 XEOTICID XEO00091 GENEFORM mRNA DME0401 XEOTICID XEO00091 MOACRIVE Inhibition DME0401 XEOTICID XEO00102 XEO_NAME Azacitidine DME0401 XEOTICID XEO00102 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00102 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00102 DESCRIPT Azacitidine inhibits the expression of DME ALAD DME0401 XEOTICID XEO00102 GENEFORM mRNA DME0401 XEOTICID XEO00102 MOACRIVE Inhibition DME0401 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0401 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME ALAD DME0401 XEOTICID XEO00117 GENEFORM mRNA DME0401 XEOTICID XEO00117 MOACRIVE Inhibition DME0401 XEOTICID XEO00147 XEO_NAME Fulvestrant DME0401 XEOTICID XEO00147 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00147 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00147 DESCRIPT Fulvestrant up-regulates the expression of DME ALAD DME0401 XEOTICID XEO00147 GENEFORM mRNA DME0401 XEOTICID XEO00147 MOACRIVE Induction DME0401 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0401 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol inhibits the expression of DME ALAD DME0401 XEOTICID XEO00166 GENEFORM mRNA DME0401 XEOTICID XEO00166 MOACRIVE Inhibition DME0401 XEOTICID XEO00169 XEO_NAME Melphalan DME0401 XEOTICID XEO00169 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00169 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00169 DESCRIPT Melphalan inhibits the drug-metabolizing activity of DME ALAD DME0401 XEOTICID XEO00169 GENEFORM Protein DME0401 XEOTICID XEO00169 MOACRIVE Inhibition DME0401 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0401 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ALAD DME0401 XEOTICID XEO00217 GENEFORM mRNA DME0401 XEOTICID XEO00217 MOACRIVE Inhibition DME0401 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0401 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME ALAD DME0401 XEOTICID XEO00241 GENEFORM mRNA DME0401 XEOTICID XEO00241 MOACRIVE Inhibition DME0401 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME0401 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide up-regulates the expression of DME ALAD DME0401 XEOTICID XEO00388 GENEFORM mRNA DME0401 XEOTICID XEO00388 MOACRIVE Induction DME0401 XEOTICID XEO00488 XEO_NAME Unithiol DME0401 XEOTICID XEO00488 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00488 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00488 DESCRIPT Unithiol up-regulates the expression of DME ALAD DME0401 XEOTICID XEO00488 GENEFORM mRNA DME0401 XEOTICID XEO00488 MOACRIVE Induction DME0401 XEOTICID XEO00557 XEO_NAME Genistein DME0401 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0401 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME ALAD DME0401 XEOTICID XEO00557 GENEFORM mRNA DME0401 XEOTICID XEO00557 MOACRIVE Inhibition DME0401 XEOTICID XEO00587 XEO_NAME Trichloroethylene DME0401 XEOTICID XEO00587 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00587 XEO_CLAS Drug in Phase 2 Clinical Trial DME0401 XEOTICID XEO00587 DESCRIPT Trichloroethylene inhibits the expression of DME ALAD DME0401 XEOTICID XEO00587 GENEFORM mRNA DME0401 XEOTICID XEO00587 MOACRIVE Inhibition DME0401 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0401 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0401 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME ALAD DME0401 XEOTICID XEO00723 GENEFORM mRNA DME0401 XEOTICID XEO00723 MOACRIVE Induction DME0401 XEOTICID XEO00760 XEO_NAME Jinfukang DME0401 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0401 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0401 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME ALAD DME0401 XEOTICID XEO00760 GENEFORM mRNA DME0401 XEOTICID XEO00760 MOACRIVE Induction DME0401 XEOTICID XEO00769 XEO_NAME Hexestrol DME0401 XEOTICID XEO00769 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00769 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00769 DESCRIPT Hexestrol inhibits the expression of DME ALAD DME0401 XEOTICID XEO00769 GENEFORM mRNA DME0401 XEOTICID XEO00769 MOACRIVE Inhibition DME0401 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0401 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0401 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0401 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME ALAD DME0401 XEOTICID XEO00806 GENEFORM mRNA DME0401 XEOTICID XEO00806 MOACRIVE Inhibition DME0401 XEOTICID XEO00834 XEO_NAME Copper DME0401 XEOTICID XEO00834 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO00834 XEO_CLAS Approved/Marketed Drug DME0401 XEOTICID XEO00834 DESCRIPT Copper inhibits the drug-metabolizing activity of DME ALAD DME0401 XEOTICID XEO00834 GENEFORM Protein DME0401 XEOTICID XEO00834 MOACRIVE Inhibition DME0401 XEOTICID XEO00877 XEO_NAME Bilirubin DME0401 XEOTICID XEO00877 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0401 XEOTICID XEO00877 XEO_CLAS Natural Product DME0401 XEOTICID XEO00877 DESCRIPT Bilirubin inhibits the expression of DME ALAD DME0401 XEOTICID XEO00877 GENEFORM mRNA DME0401 XEOTICID XEO00877 MOACRIVE Inhibition DME0401 XEOTICID XEO00921 XEO_NAME Perfluorooctane sulfonic acid DME0401 XEOTICID XEO00921 XEO_TYPE Health or Environmental Toxicant(s) DME0401 XEOTICID XEO00921 XEO_CLAS Health Hazard/Toxicant DME0401 XEOTICID XEO00921 DESCRIPT Perfluorooctane sulfonic acid inhibits the expression of DME ALAD DME0401 XEOTICID XEO00921 GENEFORM mRNA DME0401 XEOTICID XEO00921 MOACRIVE Inhibition DME0401 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0401 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0401 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0401 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME ALAD DME0401 XEOTICID XEO00999 GENEFORM mRNA DME0401 XEOTICID XEO00999 MOACRIVE Inhibition DME0401 XEOTICID XEO01025 XEO_NAME Styrene DME0401 XEOTICID XEO01025 XEO_TYPE Health or Environmental Toxicant(s) DME0401 XEOTICID XEO01025 XEO_CLAS Health Hazard/Toxicant DME0401 XEOTICID XEO01025 DESCRIPT Styrene inhibits the drug-metabolizing activity of DME ALAD DME0401 XEOTICID XEO01025 GENEFORM Protein DME0401 XEOTICID XEO01025 MOACRIVE Inhibition DME0401 XEOTICID XEO01036 XEO_NAME Acephate DME0401 XEOTICID XEO01036 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0401 XEOTICID XEO01036 XEO_CLAS Pesticide/Insecticide DME0401 XEOTICID XEO01036 DESCRIPT Acephate inhibits the drug-metabolizing activity of DME ALAD DME0401 XEOTICID XEO01036 GENEFORM Protein DME0401 XEOTICID XEO01036 MOACRIVE Inhibition DME0401 XEOTICID XEO01059 XEO_NAME Methamidophos DME0401 XEOTICID XEO01059 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0401 XEOTICID XEO01059 XEO_CLAS Pesticide/Insecticide DME0401 XEOTICID XEO01059 DESCRIPT Methamidophos inhibits the drug-metabolizing activity of DME ALAD DME0401 XEOTICID XEO01059 GENEFORM Protein DME0401 XEOTICID XEO01059 MOACRIVE Inhibition DME0401 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0401 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0401 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME ALAD DME0401 XEOTICID XEO01226 GENEFORM mRNA DME0401 XEOTICID XEO01226 MOACRIVE Inhibition DME0401 XEOTICID XEO01282 XEO_NAME Dithiothreitol DME0401 XEOTICID XEO01282 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO01282 XEO_CLAS Preclinical/Patented Drug DME0401 XEOTICID XEO01282 DESCRIPT Dithiothreitol induces the drug-metabolizing activity of DME ALAD DME0401 XEOTICID XEO01282 GENEFORM Protein DME0401 XEOTICID XEO01282 MOACRIVE Induction DME0401 XEOTICID XEO01348 XEO_NAME K-7174 DME0401 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0401 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME ALAD DME0401 XEOTICID XEO01348 GENEFORM mRNA DME0401 XEOTICID XEO01348 MOACRIVE Inhibition DME0401 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0401 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0401 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0401 XEOTICID XEO01492 DESCRIPT Trichostatin A inhibits the expression of DME ALAD DME0401 XEOTICID XEO01492 GENEFORM mRNA DME0401 XEOTICID XEO01492 MOACRIVE Inhibition DME0401 XEOTICID XEO01503 XEO_NAME Cadmium DME0401 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0401 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0401 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the drug-metabolizing activity of DME ALAD DME0401 XEOTICID XEO01503 GENEFORM Protein DME0401 XEOTICID XEO01503 MOACRIVE Inhibition DME0401 XEOTICID XEO01505 XEO_NAME Lead DME0401 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0401 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0401 XEOTICID XEO01505 DESCRIPT Lead inhibits the drug-metabolizing activity of DME ALAD DME0401 XEOTICID XEO01505 GENEFORM Protein DME0401 XEOTICID XEO01505 MOACRIVE Inhibition DME0401 XEOTICID XEO01507 XEO_NAME Lead nitrate DME0401 XEOTICID XEO01507 XEO_TYPE Health or Environmental Toxicant(s) DME0401 XEOTICID XEO01507 XEO_CLAS Health Hazard/Toxicant DME0401 XEOTICID XEO01507 DESCRIPT Lead nitrate inhibits the drug-metabolizing activity of DME ALAD DME0401 XEOTICID XEO01507 GENEFORM Protein DME0401 XEOTICID XEO01507 MOACRIVE Inhibition DME0402 DME___ID DME0402 DME0402 DME_NAME Arachidonate 12-lipoxygenase (ALOX12B) DME0402 SPESNAME Homo sapiens DME0402 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0402 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0402 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0402 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME ALOX12B DME0402 XEOTICID XEO00292 GENEFORM mRNA DME0402 XEOTICID XEO00292 MOACRIVE Induction DME0402 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0402 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0402 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0402 XEOTICID XEO00430 DESCRIPT Hydroquinone up-regulates the expression of DME ALOX12B DME0402 XEOTICID XEO00430 GENEFORM mRNA DME0402 XEOTICID XEO00430 MOACRIVE Induction DME0402 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0402 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0402 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0402 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME ALOX12B DME0402 XEOTICID XEO00772 GENEFORM mRNA DME0402 XEOTICID XEO00772 MOACRIVE Induction DME0402 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0402 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0402 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0402 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME ALOX12B DME0402 XEOTICID XEO00806 GENEFORM mRNA DME0402 XEOTICID XEO00806 MOACRIVE Induction DME0402 XEOTICID XEO00919 XEO_NAME Particulate matter DME0402 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0402 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0402 XEOTICID XEO00919 DESCRIPT Particulate matter induces the drug-metabolizing activity of DME ALOX12B DME0402 XEOTICID XEO00919 GENEFORM Protein DME0402 XEOTICID XEO00919 MOACRIVE Induction DME0402 XEOTICID XEO01074 XEO_NAME Endosulfan DME0402 XEOTICID XEO01074 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0402 XEOTICID XEO01074 XEO_CLAS Pesticide/Insecticide DME0402 XEOTICID XEO01074 DESCRIPT Endosulfan up-regulates the expression of DME ALOX12B DME0402 XEOTICID XEO01074 GENEFORM mRNA DME0402 XEOTICID XEO01074 MOACRIVE Induction DME0402 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0402 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0402 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0402 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME ALOX12B DME0402 XEOTICID XEO01305 GENEFORM mRNA DME0402 XEOTICID XEO01305 MOACRIVE Induction DME0403 DME___ID DME0403 DME0403 DME_NAME Arachidonate 15-lipoxygenase (ALOX15) DME0403 SPESNAME Homo sapiens DME0403 XEOTICID XEO00177 XEO_NAME Sulindac DME0403 XEOTICID XEO00177 XEO_TYPE Pharmaceutical Agent(s) DME0403 XEOTICID XEO00177 XEO_CLAS Approved/Marketed Drug DME0403 XEOTICID XEO00177 DESCRIPT Sulindac up-regulates the expression of DME ALOX15 DME0403 XEOTICID XEO00177 GENEFORM mRNA DME0403 XEOTICID XEO00177 MOACRIVE Induction DME0403 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0403 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0403 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0403 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME ALOX15 DME0403 XEOTICID XEO00217 GENEFORM mRNA DME0403 XEOTICID XEO00217 MOACRIVE Inhibition DME0403 XEOTICID XEO00422 XEO_NAME Sodium fluoride F-18 DME0403 XEOTICID XEO00422 XEO_TYPE Pharmaceutical Agent(s) DME0403 XEOTICID XEO00422 XEO_CLAS Approved/Marketed Drug DME0403 XEOTICID XEO00422 DESCRIPT Sodium fluoride F-18 induces the drug-metabolizing activity of DME ALOX15 DME0403 XEOTICID XEO00422 GENEFORM Protein DME0403 XEOTICID XEO00422 MOACRIVE Induction DME0403 XEOTICID XEO00560 XEO_NAME Triclosan DME0403 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0403 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0403 XEOTICID XEO00560 DESCRIPT Triclosan induces the drug-metabolizing activity of DME ALOX15 DME0403 XEOTICID XEO00560 GENEFORM Protein DME0403 XEOTICID XEO00560 MOACRIVE Induction DME0403 XEOTICID XEO00568 XEO_NAME Resveratrol DME0403 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0403 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0403 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the expression of DME ALOX15 DME0403 XEOTICID XEO00568 GENEFORM mRNA DME0403 XEOTICID XEO00568 MOACRIVE Inhibition DME0403 XEOTICID XEO00583 XEO_NAME NS-398 DME0403 XEOTICID XEO00583 XEO_TYPE Pharmaceutical Agent(s) DME0403 XEOTICID XEO00583 XEO_CLAS Drug in Phase 1 Clinical Trial DME0403 XEOTICID XEO00583 DESCRIPT NS-398 up-regulates the expression of DME ALOX15 DME0403 XEOTICID XEO00583 GENEFORM mRNA DME0403 XEOTICID XEO00583 MOACRIVE Induction DME0403 XEOTICID XEO00656 XEO_NAME Sulindac sulfide DME0403 XEOTICID XEO00656 XEO_TYPE Pharmaceutical Agent(s) DME0403 XEOTICID XEO00656 XEO_CLAS Drug in Phase 2 Clinical Trial DME0403 XEOTICID XEO00656 DESCRIPT Sulindac sulfide induces the drug-metabolizing activity of DME ALOX15 DME0403 XEOTICID XEO00656 GENEFORM Protein DME0403 XEOTICID XEO00656 MOACRIVE Induction DME0403 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0403 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0403 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0403 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME ALOX15 DME0403 XEOTICID XEO00723 GENEFORM mRNA DME0403 XEOTICID XEO00723 MOACRIVE Induction DME0403 XEOTICID XEO01082 XEO_NAME CP-461 DME0403 XEOTICID XEO01082 XEO_TYPE Pharmaceutical Agent(s) DME0403 XEOTICID XEO01082 XEO_CLAS Drug in Phase 2 Clinical Trial DME0403 XEOTICID XEO01082 DESCRIPT CP-461 induces the drug-metabolizing activity of DME ALOX15 DME0403 XEOTICID XEO01082 GENEFORM Protein DME0403 XEOTICID XEO01082 MOACRIVE Induction DME0403 XEOTICID XEO01131 XEO_NAME YC-1 DME0403 XEOTICID XEO01131 XEO_TYPE Pharmaceutical Agent(s) DME0403 XEOTICID XEO01131 XEO_CLAS Preclinical/Patented Drug DME0403 XEOTICID XEO01131 DESCRIPT YC-1 induces the drug-metabolizing activity of DME ALOX15 DME0403 XEOTICID XEO01131 GENEFORM Protein DME0403 XEOTICID XEO01131 MOACRIVE Induction DME0403 XEOTICID XEO01212 XEO_NAME Baicalein DME0403 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0403 XEOTICID XEO01212 XEO_CLAS Natural Product DME0403 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of DME ALOX15 DME0403 XEOTICID XEO01212 GENEFORM Protein DME0403 XEOTICID XEO01212 MOACRIVE Inhibition DME0403 XEOTICID XEO01232 XEO_NAME Caffeic acid DME0403 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME0403 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME0403 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of DME ALOX15 DME0403 XEOTICID XEO01232 GENEFORM Protein DME0403 XEOTICID XEO01232 MOACRIVE Inhibition DME0403 XEOTICID XEO01291 XEO_NAME Esculetin DME0403 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME0403 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME0403 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of DME ALOX15 DME0403 XEOTICID XEO01291 GENEFORM Protein DME0403 XEOTICID XEO01291 MOACRIVE Inhibition DME0403 XEOTICID XEO01332 XEO_NAME Honokiol DME0403 XEOTICID XEO01332 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0403 XEOTICID XEO01332 XEO_CLAS Natural Product DME0403 XEOTICID XEO01332 DESCRIPT Honokiol induces the drug-metabolizing activity of DME ALOX15 DME0403 XEOTICID XEO01332 GENEFORM Protein DME0403 XEOTICID XEO01332 MOACRIVE Induction DME0404 DME___ID DME0404 DME0404 DME_NAME Amiloride-sensitive amine oxidase (AOC1) DME0404 SPESNAME Homo sapiens DME0404 XEOTICID XEO00005 XEO_NAME Theophylline DME0404 XEOTICID XEO00005 XEO_TYPE Pharmaceutical Agent(s) DME0404 XEOTICID XEO00005 XEO_CLAS Approved/Marketed Drug DME0404 XEOTICID XEO00005 DESCRIPT Theophylline inhibits the expression of DME AOC1 DME0404 XEOTICID XEO00005 GENEFORM mRNA DME0404 XEOTICID XEO00005 MOACRIVE Inhibition DME0404 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0404 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0404 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0404 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME AOC1 DME0404 XEOTICID XEO00217 GENEFORM mRNA DME0404 XEOTICID XEO00217 MOACRIVE Inhibition DME0404 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0404 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0404 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0404 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME AOC1 DME0404 XEOTICID XEO00241 GENEFORM mRNA DME0404 XEOTICID XEO00241 MOACRIVE Inhibition DME0404 XEOTICID XEO00276 XEO_NAME Amiloride hydrochloride DME0404 XEOTICID XEO00276 XEO_TYPE Pharmaceutical Agent(s) DME0404 XEOTICID XEO00276 XEO_CLAS Approved/Marketed Drug DME0404 XEOTICID XEO00276 DESCRIPT Amiloride hydrochloride inhibits the drug-metabolizing activity of DME AOC1 DME0404 XEOTICID XEO00276 GENEFORM Protein DME0404 XEOTICID XEO00276 MOACRIVE Inhibition DME0404 XEOTICID XEO00577 XEO_NAME Pimagedine DME0404 XEOTICID XEO00577 XEO_TYPE Pharmaceutical Agent(s) DME0404 XEOTICID XEO00577 XEO_CLAS Drug in Phase 2 Clinical Trial DME0404 XEOTICID XEO00577 DESCRIPT Pimagedine inhibits the drug-metabolizing activity of DME AOC1 (Ki = 0.14 microM) DME0404 XEOTICID XEO00577 GENEFORM Protein DME0404 XEOTICID XEO00577 MOACRIVE Inhibition DME0404 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0404 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0404 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0404 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME AOC1 DME0404 XEOTICID XEO00632 GENEFORM mRNA DME0404 XEOTICID XEO00632 MOACRIVE Inhibition DME0404 XEOTICID XEO00834 XEO_NAME Copper DME0404 XEOTICID XEO00834 XEO_TYPE Pharmaceutical Agent(s) DME0404 XEOTICID XEO00834 XEO_CLAS Approved/Marketed Drug DME0404 XEOTICID XEO00834 DESCRIPT Copper induces the drug-metabolizing activity of DME AOC1 DME0404 XEOTICID XEO00834 GENEFORM Protein DME0404 XEOTICID XEO00834 MOACRIVE Induction DME0404 XEOTICID XEO01113 XEO_NAME Topaquinone DME0404 XEOTICID XEO01113 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0404 XEOTICID XEO01113 XEO_CLAS Natural Product DME0404 XEOTICID XEO01113 DESCRIPT Topaquinone induces the drug-metabolizing activity of DME AOC1 DME0404 XEOTICID XEO01113 GENEFORM Protein DME0404 XEOTICID XEO01113 MOACRIVE Induction DME0404 XEOTICID XEO01293 XEO_NAME Ethyl isopropylamiloride DME0404 XEOTICID XEO01293 XEO_TYPE Pharmaceutical Agent(s) DME0404 XEOTICID XEO01293 XEO_CLAS Investigative Agent DME0404 XEOTICID XEO01293 DESCRIPT Ethyl isopropylamiloride inhibits the drug-metabolizing activity of DME AOC1 DME0404 XEOTICID XEO01293 GENEFORM Protein DME0404 XEOTICID XEO01293 MOACRIVE Inhibition DME0405 DME___ID DME0405 DME0405 DME_NAME Copper amine oxidase (AOC3) DME0405 SPESNAME Homo sapiens DME0405 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0405 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0405 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0405 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME AOC3 DME0405 XEOTICID XEO00088 GENEFORM mRNA DME0405 XEOTICID XEO00088 MOACRIVE Induction DME0405 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0405 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0405 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0405 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME AOC3 DME0405 XEOTICID XEO00117 GENEFORM mRNA DME0405 XEOTICID XEO00117 MOACRIVE Inhibition DME0405 XEOTICID XEO00184 XEO_NAME Calcitriol DME0405 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0405 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0405 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME AOC3 DME0405 XEOTICID XEO00184 GENEFORM mRNA DME0405 XEOTICID XEO00184 MOACRIVE Induction DME0405 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0405 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0405 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0405 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME AOC3 DME0405 XEOTICID XEO00241 GENEFORM mRNA DME0405 XEOTICID XEO00241 MOACRIVE Inhibition DME0405 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0405 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0405 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0405 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME AOC3 DME0405 XEOTICID XEO00292 GENEFORM mRNA DME0405 XEOTICID XEO00292 MOACRIVE Inhibition DME0405 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0405 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0405 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0405 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME AOC3 DME0405 XEOTICID XEO00339 GENEFORM mRNA DME0405 XEOTICID XEO00339 MOACRIVE Induction DME0405 XEOTICID XEO00760 XEO_NAME Jinfukang DME0405 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0405 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0405 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME AOC3 DME0405 XEOTICID XEO00760 GENEFORM mRNA DME0405 XEOTICID XEO00760 MOACRIVE Inhibition DME0405 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0405 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0405 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0405 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution up-regulates the expression of DME AOC3 DME0405 XEOTICID XEO00821 GENEFORM mRNA DME0405 XEOTICID XEO00821 MOACRIVE Induction DME0405 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0405 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0405 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0405 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME AOC3 DME0405 XEOTICID XEO00898 GENEFORM mRNA DME0405 XEOTICID XEO00898 MOACRIVE Inhibition DME0405 XEOTICID XEO00916 XEO_NAME Coal ash DME0405 XEOTICID XEO00916 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0405 XEOTICID XEO00916 XEO_CLAS Natural Mixture DME0405 XEOTICID XEO00916 DESCRIPT Coal ash inhibits the expression of DME AOC3 DME0405 XEOTICID XEO00916 GENEFORM mRNA DME0405 XEOTICID XEO00916 MOACRIVE Inhibition DME0405 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0405 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0405 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0405 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME AOC3 DME0405 XEOTICID XEO01226 GENEFORM mRNA DME0405 XEOTICID XEO01226 MOACRIVE Inhibition DME0405 XEOTICID XEO01235 XEO_NAME Carbamylhydrazine DME0405 XEOTICID XEO01235 XEO_TYPE Health or Environmental Toxicant(s) DME0405 XEOTICID XEO01235 XEO_CLAS Acute Toxic Substance DME0405 XEOTICID XEO01235 DESCRIPT Carbamylhydrazine inhibits the drug-metabolizing activity of DME AOC3 DME0405 XEOTICID XEO01235 GENEFORM Protein DME0405 XEOTICID XEO01235 MOACRIVE Inhibition DME0405 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0405 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0405 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0405 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME AOC3 DME0405 XEOTICID XEO01305 GENEFORM mRNA DME0405 XEOTICID XEO01305 MOACRIVE Induction DME0407 DME___ID DME0407 DME0407 DME_NAME Aquaporin adipose (AQP7) DME0407 SPESNAME Homo sapiens DME0407 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0407 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0407 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0407 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME AQP7 DME0407 XEOTICID XEO00088 GENEFORM mRNA DME0407 XEOTICID XEO00088 MOACRIVE Induction DME0407 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0407 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0407 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0407 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME AQP7 DME0407 XEOTICID XEO00217 GENEFORM mRNA DME0407 XEOTICID XEO00217 MOACRIVE Inhibition DME0407 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0407 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0407 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0407 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME AQP7 DME0407 XEOTICID XEO00241 GENEFORM mRNA DME0407 XEOTICID XEO00241 MOACRIVE Induction DME0407 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0407 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0407 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0407 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME AQP7 DME0407 XEOTICID XEO00292 GENEFORM mRNA DME0407 XEOTICID XEO00292 MOACRIVE Inhibition DME0407 XEOTICID XEO00560 XEO_NAME Triclosan DME0407 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0407 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0407 XEOTICID XEO00560 DESCRIPT Triclosan up-regulates the expression of DME AQP7 DME0407 XEOTICID XEO00560 GENEFORM mRNA DME0407 XEOTICID XEO00560 MOACRIVE Induction DME0407 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0407 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0407 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0407 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME AQP7 DME0407 XEOTICID XEO00806 GENEFORM mRNA DME0407 XEOTICID XEO00806 MOACRIVE Inhibition DME0407 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0407 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0407 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0407 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME AQP7 DME0407 XEOTICID XEO00898 GENEFORM mRNA DME0407 XEOTICID XEO00898 MOACRIVE Induction DME0407 XEOTICID XEO00969 XEO_NAME Atrazine DME0407 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0407 XEOTICID XEO00969 XEO_CLAS Herbicide DME0407 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME AQP7 DME0407 XEOTICID XEO00969 GENEFORM mRNA DME0407 XEOTICID XEO00969 MOACRIVE Induction DME0407 XEOTICID XEO01574 XEO_NAME Plant extracts DME0407 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0407 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0407 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the drug-metabolizing activity of DME AQP7 DME0407 XEOTICID XEO01574 GENEFORM Protein DME0407 XEOTICID XEO01574 MOACRIVE Inhibition DME0408 DME___ID DME0408 DME0408 DME_NAME Arsenite methyltransferase (AS3MT) DME0408 SPESNAME Homo sapiens DME0408 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0408 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0408 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0408 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME AS3MT DME0408 XEOTICID XEO00117 GENEFORM mRNA DME0408 XEOTICID XEO00117 MOACRIVE Inhibition DME0408 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0408 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0408 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0408 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME AS3MT DME0408 XEOTICID XEO00217 GENEFORM mRNA DME0408 XEOTICID XEO00217 MOACRIVE Induction DME0408 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0408 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0408 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0408 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME AS3MT DME0408 XEOTICID XEO00241 GENEFORM mRNA DME0408 XEOTICID XEO00241 MOACRIVE Inhibition DME0408 XEOTICID XEO00435 XEO_NAME Urethane DME0408 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0408 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0408 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME AS3MT DME0408 XEOTICID XEO00435 GENEFORM mRNA DME0408 XEOTICID XEO00435 MOACRIVE Inhibition DME0408 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0408 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0408 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0408 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME AS3MT DME0408 XEOTICID XEO00723 GENEFORM mRNA DME0408 XEOTICID XEO00723 MOACRIVE Inhibition DME0408 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0408 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0408 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0408 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate inhibits the expression of DME AS3MT DME0408 XEOTICID XEO00818 GENEFORM mRNA DME0408 XEOTICID XEO00818 MOACRIVE Inhibition DME0408 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0408 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0408 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0408 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME AS3MT DME0408 XEOTICID XEO00999 GENEFORM mRNA DME0408 XEOTICID XEO00999 MOACRIVE Inhibition DME0408 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0408 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0408 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0408 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME AS3MT DME0408 XEOTICID XEO01226 GENEFORM mRNA DME0408 XEOTICID XEO01226 MOACRIVE Inhibition DME0408 XEOTICID XEO01348 XEO_NAME K-7174 DME0408 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0408 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0408 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME AS3MT DME0408 XEOTICID XEO01348 GENEFORM mRNA DME0408 XEOTICID XEO01348 MOACRIVE Inhibition DME0408 XEOTICID XEO01582 XEO_NAME Pyrrolizidine alkaloid DME0408 XEOTICID XEO01582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0408 XEOTICID XEO01582 XEO_CLAS Natural Product DME0408 XEOTICID XEO01582 DESCRIPT Pyrrolizidine alkaloid inhibits the drug-metabolizing activity of DME AS3MT DME0408 XEOTICID XEO01582 GENEFORM Protein DME0408 XEOTICID XEO01582 MOACRIVE Inhibition DME0409 DME___ID DME0409 DME0409 DME_NAME Carbonic anhydrase II (CA2) DME0409 SPESNAME Homo sapiens DME0409 XEOTICID XEO00002 XEO_NAME Acetazolamide DME0409 XEOTICID XEO00002 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00002 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00002 DESCRIPT Acetazolamide inhibits the drug-metabolizing activity of DME CA2 (IC50 < 0.01 microM) DME0409 XEOTICID XEO00002 GENEFORM Protein DME0409 XEOTICID XEO00002 MOACRIVE Inhibition DME0409 XEOTICID XEO00013 XEO_NAME Celecoxib DME0409 XEOTICID XEO00013 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00013 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00013 DESCRIPT Celecoxib inhibits the drug-metabolizing activity of DME CA2 (IC50 = 0.021 microM) DME0409 XEOTICID XEO00013 GENEFORM Protein DME0409 XEOTICID XEO00013 MOACRIVE Inhibition DME0409 XEOTICID XEO00018 XEO_NAME Cyclophosphamide DME0409 XEOTICID XEO00018 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00018 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00018 DESCRIPT Cyclophosphamide inhibits the expression of DME CA2 DME0409 XEOTICID XEO00018 GENEFORM mRNA DME0409 XEOTICID XEO00018 MOACRIVE Inhibition DME0409 XEOTICID XEO00025 XEO_NAME Dichlorphenamide DME0409 XEOTICID XEO00025 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00025 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00025 DESCRIPT Dichlorphenamide inhibits the drug-metabolizing activity of DME CA2 (IC50 = 0.038 microM) DME0409 XEOTICID XEO00025 GENEFORM Protein DME0409 XEOTICID XEO00025 MOACRIVE Inhibition DME0409 XEOTICID XEO00029 XEO_NAME Valproic acid DME0409 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME CA2 DME0409 XEOTICID XEO00029 GENEFORM mRNA DME0409 XEOTICID XEO00029 MOACRIVE Induction DME0409 XEOTICID XEO00040 XEO_NAME Furosemide DME0409 XEOTICID XEO00040 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00040 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00040 DESCRIPT Furosemide inhibits the drug-metabolizing activity of DME CA2 (Ki = 0.065 microM) DME0409 XEOTICID XEO00040 GENEFORM Protein DME0409 XEOTICID XEO00040 MOACRIVE Inhibition DME0409 XEOTICID XEO00047 XEO_NAME Indomethacin DME0409 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00047 DESCRIPT Indomethacin induces the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO00047 GENEFORM Protein DME0409 XEOTICID XEO00047 MOACRIVE Induction DME0409 XEOTICID XEO00061 XEO_NAME Methazolamide DME0409 XEOTICID XEO00061 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00061 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00061 DESCRIPT Methazolamide inhibits the drug-metabolizing activity of DME CA2 (IC50 = 0.0048 microM) DME0409 XEOTICID XEO00061 GENEFORM Protein DME0409 XEOTICID XEO00061 MOACRIVE Inhibition DME0409 XEOTICID XEO00075 XEO_NAME Propofol DME0409 XEOTICID XEO00075 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00075 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00075 DESCRIPT Propofol inhibits the drug-metabolizing activity of DME CA2 (Ki = 19.5 microM) DME0409 XEOTICID XEO00075 GENEFORM Protein DME0409 XEOTICID XEO00075 MOACRIVE Inhibition DME0409 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0409 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME CA2 DME0409 XEOTICID XEO00088 GENEFORM mRNA DME0409 XEOTICID XEO00088 MOACRIVE Induction DME0409 XEOTICID XEO00090 XEO_NAME Estradiol DME0409 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME CA2 DME0409 XEOTICID XEO00090 GENEFORM mRNA DME0409 XEOTICID XEO00090 MOACRIVE Induction DME0409 XEOTICID XEO00094 XEO_NAME Progesterone DME0409 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00094 DESCRIPT Progesterone inhibits the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO00094 GENEFORM Protein DME0409 XEOTICID XEO00094 MOACRIVE Inhibition DME0409 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0409 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME CA2 DME0409 XEOTICID XEO00117 GENEFORM mRNA DME0409 XEOTICID XEO00117 MOACRIVE Induction DME0409 XEOTICID XEO00141 XEO_NAME Brinzolamide DME0409 XEOTICID XEO00141 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00141 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00141 DESCRIPT Brinzolamide inhibits the drug-metabolizing activity of DME CA2 (IC50 = 0.0032 microM) DME0409 XEOTICID XEO00141 GENEFORM Protein DME0409 XEOTICID XEO00141 MOACRIVE Inhibition DME0409 XEOTICID XEO00150 XEO_NAME Valdecoxib DME0409 XEOTICID XEO00150 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00150 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00150 DESCRIPT Valdecoxib inhibits the drug-metabolizing activity of DME CA2 (IC50 = 0.043 microM) DME0409 XEOTICID XEO00150 GENEFORM Protein DME0409 XEOTICID XEO00150 MOACRIVE Inhibition DME0409 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0409 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol up-regulates the expression of DME CA2 DME0409 XEOTICID XEO00166 GENEFORM mRNA DME0409 XEOTICID XEO00166 MOACRIVE Induction DME0409 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0409 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00167 DESCRIPT Alitretinoin induces the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO00167 GENEFORM Protein DME0409 XEOTICID XEO00167 MOACRIVE Induction DME0409 XEOTICID XEO00184 XEO_NAME Calcitriol DME0409 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME CA2 DME0409 XEOTICID XEO00184 GENEFORM mRNA DME0409 XEOTICID XEO00184 MOACRIVE Induction DME0409 XEOTICID XEO00189 XEO_NAME Topiramate DME0409 XEOTICID XEO00189 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00189 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00189 DESCRIPT Topiramate inhibits the drug-metabolizing activity of DME CA2 (IC50 = 0.005 microM) DME0409 XEOTICID XEO00189 GENEFORM Protein DME0409 XEOTICID XEO00189 MOACRIVE Inhibition DME0409 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0409 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CA2 DME0409 XEOTICID XEO00241 GENEFORM mRNA DME0409 XEOTICID XEO00241 MOACRIVE Inhibition DME0409 XEOTICID XEO00265 XEO_NAME Epinephrine DME0409 XEOTICID XEO00265 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00265 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00265 DESCRIPT Epinephrine up-regulates the expression of DME CA2 DME0409 XEOTICID XEO00265 GENEFORM mRNA DME0409 XEOTICID XEO00265 MOACRIVE Induction DME0409 XEOTICID XEO00267 XEO_NAME Ethinyl estradiol DME0409 XEOTICID XEO00267 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00267 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00267 DESCRIPT Ethinyl estradiol up-regulates the expression of DME CA2 DME0409 XEOTICID XEO00267 GENEFORM mRNA DME0409 XEOTICID XEO00267 MOACRIVE Induction DME0409 XEOTICID XEO00291 XEO_NAME Dorzolamide hydrochloride DME0409 XEOTICID XEO00291 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00291 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00291 DESCRIPT Dorzolamide hydrochloride inhibits the drug-metabolizing activity of DME CA2 (IC50 < 0.002 microM) DME0409 XEOTICID XEO00291 GENEFORM Protein DME0409 XEOTICID XEO00291 MOACRIVE Inhibition DME0409 XEOTICID XEO00356 XEO_NAME Enalapril DME0409 XEOTICID XEO00356 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00356 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00356 DESCRIPT Enalapril inhibits the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO00356 GENEFORM Protein DME0409 XEOTICID XEO00356 MOACRIVE Inhibition DME0409 XEOTICID XEO00414 XEO_NAME Ethoxzolamide DME0409 XEOTICID XEO00414 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00414 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00414 DESCRIPT Ethoxzolamide inhibits the drug-metabolizing activity of DME CA2 (IC50 = 0.0003 microM) DME0409 XEOTICID XEO00414 GENEFORM Protein DME0409 XEOTICID XEO00414 MOACRIVE Inhibition DME0409 XEOTICID XEO00424 XEO_NAME Sulfonamide DME0409 XEOTICID XEO00424 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00424 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00424 DESCRIPT Sulfonamide inhibits the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO00424 GENEFORM Protein DME0409 XEOTICID XEO00424 MOACRIVE Inhibition DME0409 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME0409 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00425 DESCRIPT Titanium dioxide up-regulates the expression of DME CA2 DME0409 XEOTICID XEO00425 GENEFORM mRNA DME0409 XEOTICID XEO00425 MOACRIVE Induction DME0409 XEOTICID XEO00484 XEO_NAME Sulpiride DME0409 XEOTICID XEO00484 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00484 XEO_CLAS Approved/Marketed Drug DME0409 XEOTICID XEO00484 DESCRIPT Sulpiride inhibits the drug-metabolizing activity of DME CA2 (IC50 = 0.04 microM) DME0409 XEOTICID XEO00484 GENEFORM Protein DME0409 XEOTICID XEO00484 MOACRIVE Inhibition DME0409 XEOTICID XEO00538 XEO_NAME Quercetin DME0409 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0409 XEOTICID XEO00538 DESCRIPT Quercetin induces the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO00538 GENEFORM Protein DME0409 XEOTICID XEO00538 MOACRIVE Induction DME0409 XEOTICID XEO00557 XEO_NAME Genistein DME0409 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0409 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME CA2 DME0409 XEOTICID XEO00557 GENEFORM mRNA DME0409 XEOTICID XEO00557 MOACRIVE Induction DME0409 XEOTICID XEO00566 XEO_NAME Guaiacol DME0409 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME0409 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of DME CA2 (Ki = 2.94 microM) DME0409 XEOTICID XEO00566 GENEFORM Protein DME0409 XEOTICID XEO00566 MOACRIVE Inhibition DME0409 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0409 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0409 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene inhibits the expression of DME CA2 DME0409 XEOTICID XEO00571 GENEFORM mRNA DME0409 XEOTICID XEO00571 MOACRIVE Inhibition DME0409 XEOTICID XEO00601 XEO_NAME Butylated hydroxytoluene DME0409 XEOTICID XEO00601 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00601 XEO_CLAS Drug in Phase 1 Clinical Trial DME0409 XEOTICID XEO00601 DESCRIPT Butylated hydroxytoluene inhibits the drug-metabolizing activity of DME CA2 (Ki = 0.63 microM) DME0409 XEOTICID XEO00601 GENEFORM Protein DME0409 XEOTICID XEO00601 MOACRIVE Inhibition DME0409 XEOTICID XEO00610 XEO_NAME Afimoxifene DME0409 XEOTICID XEO00610 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00610 XEO_CLAS Drug in Phase 3 Clinical Trial DME0409 XEOTICID XEO00610 DESCRIPT Afimoxifene up-regulates the expression of DME CA2 DME0409 XEOTICID XEO00610 GENEFORM mRNA DME0409 XEOTICID XEO00610 MOACRIVE Induction DME0409 XEOTICID XEO00651 XEO_NAME Irosustat DME0409 XEOTICID XEO00651 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00651 XEO_CLAS Drug in Phase 2 Clinical Trial DME0409 XEOTICID XEO00651 DESCRIPT Irosustat inhibits the drug-metabolizing activity of DME CA2 (IC50 = 0.017 microM) DME0409 XEOTICID XEO00651 GENEFORM Protein DME0409 XEOTICID XEO00651 MOACRIVE Inhibition DME0409 XEOTICID XEO00652 XEO_NAME Seocalcitol DME0409 XEOTICID XEO00652 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00652 XEO_CLAS Drug in Phase 3 Clinical Trial DME0409 XEOTICID XEO00652 DESCRIPT Seocalcitol up-regulates the expression of DME CA2 DME0409 XEOTICID XEO00652 GENEFORM mRNA DME0409 XEOTICID XEO00652 MOACRIVE Induction DME0409 XEOTICID XEO00716 XEO_NAME STX140 DME0409 XEOTICID XEO00716 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO00716 XEO_CLAS Preclinical/Patented Drug DME0409 XEOTICID XEO00716 DESCRIPT STX140 inhibits the drug-metabolizing activity of DME CA2 (IC50 = 0.379 microM) DME0409 XEOTICID XEO00716 GENEFORM Protein DME0409 XEOTICID XEO00716 MOACRIVE Inhibition DME0409 XEOTICID XEO00771 XEO_NAME Sulfamic acid DME0409 XEOTICID XEO00771 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0409 XEOTICID XEO00771 XEO_CLAS Chemical Compound DME0409 XEOTICID XEO00771 DESCRIPT Sulfamic acid inhibits the drug-metabolizing activity of DME CA2 (Ki = 0.00039 microM) DME0409 XEOTICID XEO00771 GENEFORM Protein DME0409 XEOTICID XEO00771 MOACRIVE Inhibition DME0409 XEOTICID XEO00781 XEO_NAME Thiophenes DME0409 XEOTICID XEO00781 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0409 XEOTICID XEO00781 XEO_CLAS Chemical Compound DME0409 XEOTICID XEO00781 DESCRIPT Thiophenes inhibits the expression of DME CA2 DME0409 XEOTICID XEO00781 GENEFORM mRNA DME0409 XEOTICID XEO00781 MOACRIVE Inhibition DME0409 XEOTICID XEO00800 XEO_NAME Iodate DME0409 XEOTICID XEO00800 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0409 XEOTICID XEO00800 XEO_CLAS Chemical Compound DME0409 XEOTICID XEO00800 DESCRIPT Iodate inhibits the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO00800 GENEFORM Protein DME0409 XEOTICID XEO00800 MOACRIVE Inhibition DME0409 XEOTICID XEO00858 XEO_NAME Flavonoids DME0409 XEOTICID XEO00858 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0409 XEOTICID XEO00858 XEO_CLAS Natural Mixture DME0409 XEOTICID XEO00858 DESCRIPT Flavonoids inhibits the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO00858 GENEFORM Protein DME0409 XEOTICID XEO00858 MOACRIVE Inhibition DME0409 XEOTICID XEO00879 XEO_NAME Coumarin DME0409 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME0409 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME0409 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of DME CA2 (Ki = 9.2 microM) DME0409 XEOTICID XEO00879 GENEFORM Protein DME0409 XEOTICID XEO00879 MOACRIVE Inhibition DME0409 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0409 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0409 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0409 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME CA2 DME0409 XEOTICID XEO00898 GENEFORM mRNA DME0409 XEOTICID XEO00898 MOACRIVE Induction DME0409 XEOTICID XEO00908 XEO_NAME Synephrine DME0409 XEOTICID XEO00908 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0409 XEOTICID XEO00908 XEO_CLAS Natural Product DME0409 XEOTICID XEO00908 DESCRIPT Synephrine inhibits the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO00908 GENEFORM Protein DME0409 XEOTICID XEO00908 MOACRIVE Inhibition DME0409 XEOTICID XEO00977 XEO_NAME Oryzalin DME0409 XEOTICID XEO00977 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0409 XEOTICID XEO00977 XEO_CLAS Herbicide DME0409 XEOTICID XEO00977 DESCRIPT Oryzalin inhibits the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO00977 GENEFORM Protein DME0409 XEOTICID XEO00977 MOACRIVE Inhibition DME0409 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0409 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0409 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0409 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME CA2 DME0409 XEOTICID XEO00999 GENEFORM mRNA DME0409 XEOTICID XEO00999 MOACRIVE Induction DME0409 XEOTICID XEO01001 XEO_NAME Chloric acid DME0409 XEOTICID XEO01001 XEO_TYPE Health or Environmental Toxicant(s) DME0409 XEOTICID XEO01001 XEO_CLAS Health Hazard/Toxicant DME0409 XEOTICID XEO01001 DESCRIPT Chloric acid inhibits the drug-metabolizing activity of DME CA2 (Ki = 850 microM) DME0409 XEOTICID XEO01001 GENEFORM Protein DME0409 XEOTICID XEO01001 MOACRIVE Inhibition DME0409 XEOTICID XEO01005 XEO_NAME Dimethyl amines DME0409 XEOTICID XEO01005 XEO_TYPE Health or Environmental Toxicant(s) DME0409 XEOTICID XEO01005 XEO_CLAS Environmental Pollutant DME0409 XEOTICID XEO01005 DESCRIPT Dimethyl amines inhibits the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO01005 GENEFORM Protein DME0409 XEOTICID XEO01005 MOACRIVE Inhibition DME0409 XEOTICID XEO01017 XEO_NAME Nitric acid DME0409 XEOTICID XEO01017 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0409 XEOTICID XEO01017 XEO_CLAS Chemical Compound DME0409 XEOTICID XEO01017 DESCRIPT Nitric acid inhibits the drug-metabolizing activity of DME CA2 (Ki = 35000 microM) DME0409 XEOTICID XEO01017 GENEFORM Protein DME0409 XEOTICID XEO01017 MOACRIVE Inhibition DME0409 XEOTICID XEO01087 XEO_NAME 1,2,4-triazole DME0409 XEOTICID XEO01087 XEO_TYPE Health or Environmental Toxicant(s) DME0409 XEOTICID XEO01087 XEO_CLAS Health Hazard/Toxicant DME0409 XEOTICID XEO01087 DESCRIPT 1,2,4-triazole inhibits the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO01087 GENEFORM Protein DME0409 XEOTICID XEO01087 MOACRIVE Inhibition DME0409 XEOTICID XEO01115 XEO_NAME 2,6-di-tert-butylphenol DME0409 XEOTICID XEO01115 XEO_TYPE Health or Environmental Toxicant(s) DME0409 XEOTICID XEO01115 XEO_CLAS Environmental Pollutant DME0409 XEOTICID XEO01115 DESCRIPT 2,6-di-tert-butylphenol inhibits the drug-metabolizing activity of DME CA2 (Ki = 0.51 microM) DME0409 XEOTICID XEO01115 GENEFORM Protein DME0409 XEOTICID XEO01115 MOACRIVE Inhibition DME0409 XEOTICID XEO01216 XEO_NAME Benzolamide DME0409 XEOTICID XEO01216 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO01216 XEO_CLAS Investigative Agent DME0409 XEOTICID XEO01216 DESCRIPT Benzolamide inhibits the drug-metabolizing activity of DME CA2 (Ki = 0.009 microM) DME0409 XEOTICID XEO01216 GENEFORM Protein DME0409 XEOTICID XEO01216 MOACRIVE Inhibition DME0409 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0409 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0409 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME CA2 DME0409 XEOTICID XEO01226 GENEFORM mRNA DME0409 XEOTICID XEO01226 MOACRIVE Induction DME0409 XEOTICID XEO01242 XEO_NAME Chalcone DME0409 XEOTICID XEO01242 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO01242 XEO_CLAS Drug in Phase 2 Clinical Trial DME0409 XEOTICID XEO01242 DESCRIPT Chalcone inhibits the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO01242 GENEFORM Protein DME0409 XEOTICID XEO01242 MOACRIVE Inhibition DME0409 XEOTICID XEO01387 XEO_NAME Indisulam DME0409 XEOTICID XEO01387 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO01387 XEO_CLAS Drug in Phase 2 Clinical Trial DME0409 XEOTICID XEO01387 DESCRIPT Indisulam inhibits the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO01387 GENEFORM Protein DME0409 XEOTICID XEO01387 MOACRIVE Inhibition DME0409 XEOTICID XEO01486 XEO_NAME Thioxolone DME0409 XEOTICID XEO01486 XEO_TYPE Pharmaceutical Agent(s) DME0409 XEOTICID XEO01486 XEO_CLAS Investigative Agent DME0409 XEOTICID XEO01486 DESCRIPT Thioxolone inhibits the drug-metabolizing activity of DME CA2 (IC50 = 1.77 microM) DME0409 XEOTICID XEO01486 GENEFORM Protein DME0409 XEOTICID XEO01486 MOACRIVE Inhibition DME0409 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0409 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0409 XEOTICID XEO01494 XEO_CLAS Natural Product DME0409 XEOTICID XEO01494 DESCRIPT Tunicamycin A inhibits the expression of DME CA2 DME0409 XEOTICID XEO01494 GENEFORM mRNA DME0409 XEOTICID XEO01494 MOACRIVE Inhibition DME0409 XEOTICID XEO01505 XEO_NAME Lead DME0409 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0409 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0409 XEOTICID XEO01505 DESCRIPT Lead inhibits the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO01505 GENEFORM Protein DME0409 XEOTICID XEO01505 MOACRIVE Inhibition DME0409 XEOTICID XEO01522 XEO_NAME Anthocyanins DME0409 XEOTICID XEO01522 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0409 XEOTICID XEO01522 XEO_CLAS Natural Product DME0409 XEOTICID XEO01522 DESCRIPT Anthocyanins inhibits the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO01522 GENEFORM Protein DME0409 XEOTICID XEO01522 MOACRIVE Inhibition DME0409 XEOTICID XEO01562 XEO_NAME Malvidin-3-glucoside DME0409 XEOTICID XEO01562 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0409 XEOTICID XEO01562 XEO_CLAS Natural Product DME0409 XEOTICID XEO01562 DESCRIPT Malvidin-3-glucoside inhibits the drug-metabolizing activity of DME CA2 DME0409 XEOTICID XEO01562 GENEFORM Protein DME0409 XEOTICID XEO01562 MOACRIVE Inhibition DME0410 DME___ID DME0410 DME0410 DME_NAME Serine sulfhydrase (CBS) DME0410 SPESNAME Homo sapiens DME0410 XEOTICID XEO00029 XEO_NAME Valproic acid DME0410 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0410 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME CBS DME0410 XEOTICID XEO00029 GENEFORM mRNA DME0410 XEOTICID XEO00029 MOACRIVE Induction DME0410 XEOTICID XEO00047 XEO_NAME Indomethacin DME0410 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0410 XEOTICID XEO00047 DESCRIPT Indomethacin up-regulates the expression of DME CBS DME0410 XEOTICID XEO00047 GENEFORM mRNA DME0410 XEOTICID XEO00047 MOACRIVE Induction DME0410 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0410 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0410 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME CBS DME0410 XEOTICID XEO00117 GENEFORM mRNA DME0410 XEOTICID XEO00117 MOACRIVE Induction DME0410 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0410 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0410 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CBS DME0410 XEOTICID XEO00217 GENEFORM mRNA DME0410 XEOTICID XEO00217 MOACRIVE Inhibition DME0410 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0410 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0410 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME CBS DME0410 XEOTICID XEO00241 GENEFORM mRNA DME0410 XEOTICID XEO00241 MOACRIVE Induction DME0410 XEOTICID XEO00253 XEO_NAME Tretinoin DME0410 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0410 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME CBS DME0410 XEOTICID XEO00253 GENEFORM mRNA DME0410 XEOTICID XEO00253 MOACRIVE Inhibition DME0410 XEOTICID XEO00334 XEO_NAME Cisplatin DME0410 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0410 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME CBS DME0410 XEOTICID XEO00334 GENEFORM mRNA DME0410 XEOTICID XEO00334 MOACRIVE Induction DME0410 XEOTICID XEO00411 XEO_NAME Avobenzone DME0410 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0410 XEOTICID XEO00411 DESCRIPT Avobenzone inhibits the expression of DME CBS DME0410 XEOTICID XEO00411 GENEFORM mRNA DME0410 XEOTICID XEO00411 MOACRIVE Inhibition DME0410 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0410 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0410 XEOTICID XEO00430 DESCRIPT Hydroquinone up-regulates the expression of DME CBS DME0410 XEOTICID XEO00430 GENEFORM mRNA DME0410 XEOTICID XEO00430 MOACRIVE Induction DME0410 XEOTICID XEO00481 XEO_NAME Rotenone DME0410 XEOTICID XEO00481 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00481 XEO_CLAS Approved/Marketed Drug DME0410 XEOTICID XEO00481 DESCRIPT Rotenone up-regulates the expression of DME CBS DME0410 XEOTICID XEO00481 GENEFORM mRNA DME0410 XEOTICID XEO00481 MOACRIVE Induction DME0410 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0410 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0410 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone inhibits the drug-metabolizing activity of DME CBS DME0410 XEOTICID XEO00536 GENEFORM Protein DME0410 XEOTICID XEO00536 MOACRIVE Inhibition DME0410 XEOTICID XEO00539 XEO_NAME Ethanol DME0410 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0410 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the expression of DME CBS DME0410 XEOTICID XEO00539 GENEFORM mRNA DME0410 XEOTICID XEO00539 MOACRIVE Inhibition DME0410 XEOTICID XEO00581 XEO_NAME MS-275 DME0410 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0410 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME CBS DME0410 XEOTICID XEO00581 GENEFORM mRNA DME0410 XEOTICID XEO00581 MOACRIVE Induction DME0410 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0410 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0410 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME CBS DME0410 XEOTICID XEO00632 GENEFORM mRNA DME0410 XEOTICID XEO00632 MOACRIVE Inhibition DME0410 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0410 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0410 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME CBS DME0410 XEOTICID XEO00723 GENEFORM mRNA DME0410 XEOTICID XEO00723 MOACRIVE Inhibition DME0410 XEOTICID XEO00760 XEO_NAME Jinfukang DME0410 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0410 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0410 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME CBS DME0410 XEOTICID XEO00760 GENEFORM mRNA DME0410 XEOTICID XEO00760 MOACRIVE Induction DME0410 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0410 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0410 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0410 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME CBS DME0410 XEOTICID XEO00821 GENEFORM mRNA DME0410 XEOTICID XEO00821 MOACRIVE Inhibition DME0410 XEOTICID XEO00893 XEO_NAME 1-nitropyrene DME0410 XEOTICID XEO00893 XEO_TYPE Health or Environmental Toxicant(s) DME0410 XEOTICID XEO00893 XEO_CLAS Carcinogen DME0410 XEOTICID XEO00893 DESCRIPT 1-nitropyrene up-regulates the expression of DME CBS DME0410 XEOTICID XEO00893 GENEFORM mRNA DME0410 XEOTICID XEO00893 MOACRIVE Induction DME0410 XEOTICID XEO00925 XEO_NAME BDE-99 DME0410 XEOTICID XEO00925 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0410 XEOTICID XEO00925 XEO_CLAS Natural Product DME0410 XEOTICID XEO00925 DESCRIPT BDE-99 up-regulates the expression of DME CBS DME0410 XEOTICID XEO00925 GENEFORM mRNA DME0410 XEOTICID XEO00925 MOACRIVE Induction DME0410 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0410 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0410 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0410 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate induces the drug-metabolizing activity of DME CBS DME0410 XEOTICID XEO01031 GENEFORM Protein DME0410 XEOTICID XEO01031 MOACRIVE Induction DME0410 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0410 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0410 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0410 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium induces the drug-metabolizing activity of DME CBS DME0410 XEOTICID XEO01103 GENEFORM Protein DME0410 XEOTICID XEO01103 MOACRIVE Induction DME0410 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0410 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0410 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME CBS DME0410 XEOTICID XEO01226 GENEFORM mRNA DME0410 XEOTICID XEO01226 MOACRIVE Inhibition DME0410 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0410 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0410 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0410 XEOTICID XEO01305 DESCRIPT Formaldehyde induces the drug-metabolizing activity of DME CBS DME0410 XEOTICID XEO01305 GENEFORM Protein DME0410 XEOTICID XEO01305 MOACRIVE Induction DME0410 XEOTICID XEO01336 XEO_NAME ICG-001 DME0410 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0410 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME CBS DME0410 XEOTICID XEO01336 GENEFORM mRNA DME0410 XEOTICID XEO01336 MOACRIVE Induction DME0410 XEOTICID XEO01348 XEO_NAME K-7174 DME0410 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0410 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0410 XEOTICID XEO01348 DESCRIPT K-7174 up-regulates the expression of DME CBS DME0410 XEOTICID XEO01348 GENEFORM mRNA DME0410 XEOTICID XEO01348 MOACRIVE Induction DME0410 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0410 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0410 XEOTICID XEO01494 XEO_CLAS Natural Product DME0410 XEOTICID XEO01494 DESCRIPT Tunicamycin A up-regulates the expression of DME CBS DME0410 XEOTICID XEO01494 GENEFORM mRNA DME0410 XEOTICID XEO01494 MOACRIVE Induction DME0410 XEOTICID XEO01574 XEO_NAME Plant extracts DME0410 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0410 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0410 XEOTICID XEO01574 DESCRIPT Plant extracts inhibits the expression of DME CBS DME0410 XEOTICID XEO01574 GENEFORM mRNA DME0410 XEOTICID XEO01574 MOACRIVE Inhibition DME0411 DME___ID DME0411 DME0411 DME_NAME Microsomal cytochrome MCB5 (CYB5A) DME0411 SPESNAME Homo sapiens DME0411 XEOTICID XEO00011 XEO_NAME Carbamazepine DME0411 XEOTICID XEO00011 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO00011 XEO_CLAS Approved/Marketed Drug DME0411 XEOTICID XEO00011 DESCRIPT Carbamazepine up-regulates the expression of DME CYB5A DME0411 XEOTICID XEO00011 GENEFORM mRNA DME0411 XEOTICID XEO00011 MOACRIVE Induction DME0411 XEOTICID XEO00029 XEO_NAME Valproic acid DME0411 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0411 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME CYB5A DME0411 XEOTICID XEO00029 GENEFORM mRNA DME0411 XEOTICID XEO00029 MOACRIVE Induction DME0411 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0411 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0411 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME CYB5A DME0411 XEOTICID XEO00088 GENEFORM mRNA DME0411 XEOTICID XEO00088 MOACRIVE Induction DME0411 XEOTICID XEO00097 XEO_NAME Cytarabine DME0411 XEOTICID XEO00097 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO00097 XEO_CLAS Approved/Marketed Drug DME0411 XEOTICID XEO00097 DESCRIPT Cytarabine inhibits the expression of DME CYB5A DME0411 XEOTICID XEO00097 GENEFORM mRNA DME0411 XEOTICID XEO00097 MOACRIVE Inhibition DME0411 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0411 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0411 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME CYB5A DME0411 XEOTICID XEO00117 GENEFORM mRNA DME0411 XEOTICID XEO00117 MOACRIVE Inhibition DME0411 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0411 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0411 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME CYB5A DME0411 XEOTICID XEO00186 GENEFORM mRNA DME0411 XEOTICID XEO00186 MOACRIVE Inhibition DME0411 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0411 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0411 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME CYB5A DME0411 XEOTICID XEO00217 GENEFORM mRNA DME0411 XEOTICID XEO00217 MOACRIVE Inhibition DME0411 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0411 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0411 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME CYB5A DME0411 XEOTICID XEO00241 GENEFORM mRNA DME0411 XEOTICID XEO00241 MOACRIVE Inhibition DME0411 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0411 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0411 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME CYB5A DME0411 XEOTICID XEO00292 GENEFORM mRNA DME0411 XEOTICID XEO00292 MOACRIVE Induction DME0411 XEOTICID XEO00334 XEO_NAME Cisplatin DME0411 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0411 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME CYB5A DME0411 XEOTICID XEO00334 GENEFORM mRNA DME0411 XEOTICID XEO00334 MOACRIVE Induction DME0411 XEOTICID XEO00538 XEO_NAME Quercetin DME0411 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0411 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME CYB5A DME0411 XEOTICID XEO00538 GENEFORM mRNA DME0411 XEOTICID XEO00538 MOACRIVE Inhibition DME0411 XEOTICID XEO00557 XEO_NAME Genistein DME0411 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0411 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME CYB5A DME0411 XEOTICID XEO00557 GENEFORM Protein DME0411 XEOTICID XEO00557 MOACRIVE Inhibition DME0411 XEOTICID XEO00582 XEO_NAME Diethyltoluamide DME0411 XEOTICID XEO00582 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO00582 XEO_CLAS Drug in Phase 3 Clinical Trial DME0411 XEOTICID XEO00582 DESCRIPT Diethyltoluamide up-regulates the expression of DME CYB5A DME0411 XEOTICID XEO00582 GENEFORM mRNA DME0411 XEOTICID XEO00582 MOACRIVE Induction DME0411 XEOTICID XEO00760 XEO_NAME Jinfukang DME0411 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0411 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0411 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME CYB5A DME0411 XEOTICID XEO00760 GENEFORM mRNA DME0411 XEOTICID XEO00760 MOACRIVE Induction DME0411 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0411 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0411 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0411 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME CYB5A DME0411 XEOTICID XEO00806 GENEFORM mRNA DME0411 XEOTICID XEO00806 MOACRIVE Inhibition DME0411 XEOTICID XEO00818 XEO_NAME Phenylmercuric acetate DME0411 XEOTICID XEO00818 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO00818 XEO_CLAS Investigative Agent DME0411 XEOTICID XEO00818 DESCRIPT Phenylmercuric acetate up-regulates the expression of DME CYB5A DME0411 XEOTICID XEO00818 GENEFORM mRNA DME0411 XEOTICID XEO00818 MOACRIVE Induction DME0411 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0411 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0411 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0411 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME CYB5A DME0411 XEOTICID XEO01031 GENEFORM mRNA DME0411 XEOTICID XEO01031 MOACRIVE Inhibition DME0411 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0411 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0411 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME CYB5A DME0411 XEOTICID XEO01226 GENEFORM mRNA DME0411 XEOTICID XEO01226 MOACRIVE Induction DME0411 XEOTICID XEO01278 XEO_NAME Malotilate DME0411 XEOTICID XEO01278 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO01278 XEO_CLAS Approved/Marketed Drug DME0411 XEOTICID XEO01278 DESCRIPT Malotilate induces the drug-metabolizing activity of DME CYB5A DME0411 XEOTICID XEO01278 GENEFORM Protein DME0411 XEOTICID XEO01278 MOACRIVE Induction DME0411 XEOTICID XEO01302 XEO_NAME Fipronil DME0411 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0411 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0411 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME CYB5A DME0411 XEOTICID XEO01302 GENEFORM mRNA DME0411 XEOTICID XEO01302 MOACRIVE Induction DME0411 XEOTICID XEO01348 XEO_NAME K-7174 DME0411 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0411 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME CYB5A DME0411 XEOTICID XEO01348 GENEFORM mRNA DME0411 XEOTICID XEO01348 MOACRIVE Inhibition DME0411 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0411 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0411 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0411 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME CYB5A DME0411 XEOTICID XEO01492 GENEFORM mRNA DME0411 XEOTICID XEO01492 MOACRIVE Induction DME0412 DME___ID DME0412 DME0412 DME_NAME Dicarbonyl/L-xylulose reductase (DCXR) DME0412 SPESNAME Homo sapiens DME0412 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0412 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0412 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME DCXR DME0412 XEOTICID XEO00088 GENEFORM mRNA DME0412 XEOTICID XEO00088 MOACRIVE Induction DME0412 XEOTICID XEO00090 XEO_NAME Estradiol DME0412 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0412 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME DCXR DME0412 XEOTICID XEO00090 GENEFORM mRNA DME0412 XEOTICID XEO00090 MOACRIVE Induction DME0412 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0412 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0412 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME DCXR DME0412 XEOTICID XEO00117 GENEFORM mRNA DME0412 XEOTICID XEO00117 MOACRIVE Inhibition DME0412 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0412 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0412 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME DCXR DME0412 XEOTICID XEO00186 GENEFORM mRNA DME0412 XEOTICID XEO00186 MOACRIVE Inhibition DME0412 XEOTICID XEO00204 XEO_NAME Piroxicam DME0412 XEOTICID XEO00204 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO00204 XEO_CLAS Approved/Marketed Drug DME0412 XEOTICID XEO00204 DESCRIPT Piroxicam inhibits the drug-metabolizing activity of DME DCXR DME0412 XEOTICID XEO00204 GENEFORM Protein DME0412 XEOTICID XEO00204 MOACRIVE Inhibition DME0412 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0412 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0412 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME DCXR DME0412 XEOTICID XEO00217 GENEFORM mRNA DME0412 XEOTICID XEO00217 MOACRIVE Induction DME0412 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0412 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0412 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME DCXR DME0412 XEOTICID XEO00241 GENEFORM mRNA DME0412 XEOTICID XEO00241 MOACRIVE Inhibition DME0412 XEOTICID XEO00253 XEO_NAME Tretinoin DME0412 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0412 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME DCXR DME0412 XEOTICID XEO00253 GENEFORM mRNA DME0412 XEOTICID XEO00253 MOACRIVE Induction DME0412 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0412 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0412 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME DCXR DME0412 XEOTICID XEO00292 GENEFORM mRNA DME0412 XEOTICID XEO00292 MOACRIVE Inhibition DME0412 XEOTICID XEO00334 XEO_NAME Cisplatin DME0412 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0412 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME DCXR DME0412 XEOTICID XEO00334 GENEFORM mRNA DME0412 XEOTICID XEO00334 MOACRIVE Induction DME0412 XEOTICID XEO00539 XEO_NAME Ethanol DME0412 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0412 XEOTICID XEO00539 DESCRIPT Ethanol up-regulates the expression of DME DCXR DME0412 XEOTICID XEO00539 GENEFORM mRNA DME0412 XEOTICID XEO00539 MOACRIVE Induction DME0412 XEOTICID XEO00557 XEO_NAME Genistein DME0412 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0412 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME DCXR DME0412 XEOTICID XEO00557 GENEFORM mRNA DME0412 XEOTICID XEO00557 MOACRIVE Induction DME0412 XEOTICID XEO00581 XEO_NAME MS-275 DME0412 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0412 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME DCXR DME0412 XEOTICID XEO00581 GENEFORM mRNA DME0412 XEOTICID XEO00581 MOACRIVE Induction DME0412 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0412 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0412 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME DCXR DME0412 XEOTICID XEO00723 GENEFORM mRNA DME0412 XEOTICID XEO00723 MOACRIVE Induction DME0412 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0412 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0412 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0412 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME DCXR DME0412 XEOTICID XEO00806 GENEFORM mRNA DME0412 XEOTICID XEO00806 MOACRIVE Inhibition DME0412 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0412 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0412 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0412 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME DCXR DME0412 XEOTICID XEO00898 GENEFORM mRNA DME0412 XEOTICID XEO00898 MOACRIVE Inhibition DME0412 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0412 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0412 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0412 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium inhibits the drug-metabolizing activity of DME DCXR DME0412 XEOTICID XEO01103 GENEFORM Protein DME0412 XEOTICID XEO01103 MOACRIVE Inhibition DME0412 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0412 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0412 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0412 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME DCXR DME0412 XEOTICID XEO01305 GENEFORM mRNA DME0412 XEOTICID XEO01305 MOACRIVE Inhibition DME0412 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0412 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0412 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0412 XEOTICID XEO01324 DESCRIPT GSK-J4 up-regulates the expression of DME DCXR DME0412 XEOTICID XEO01324 GENEFORM mRNA DME0412 XEOTICID XEO01324 MOACRIVE Induction DME0413 DME___ID DME0413 DME0413 DME_NAME Delta(24)-sterol reductase (DHCR24) DME0413 SPESNAME Homo sapiens DME0413 XEOTICID XEO00029 XEO_NAME Valproic acid DME0413 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00029 GENEFORM mRNA DME0413 XEOTICID XEO00029 MOACRIVE Inhibition DME0413 XEOTICID XEO00079 XEO_NAME Vorinostat DME0413 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00079 DESCRIPT Vorinostat inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00079 GENEFORM mRNA DME0413 XEOTICID XEO00079 MOACRIVE Inhibition DME0413 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0413 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME DHCR24 DME0413 XEOTICID XEO00088 GENEFORM mRNA DME0413 XEOTICID XEO00088 MOACRIVE Induction DME0413 XEOTICID XEO00090 XEO_NAME Estradiol DME0413 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00090 GENEFORM mRNA DME0413 XEOTICID XEO00090 MOACRIVE Inhibition DME0413 XEOTICID XEO00097 XEO_NAME Cytarabine DME0413 XEOTICID XEO00097 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00097 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00097 DESCRIPT Cytarabine inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00097 GENEFORM mRNA DME0413 XEOTICID XEO00097 MOACRIVE Inhibition DME0413 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0413 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00117 GENEFORM mRNA DME0413 XEOTICID XEO00117 MOACRIVE Inhibition DME0413 XEOTICID XEO00125 XEO_NAME Simvastatin DME0413 XEOTICID XEO00125 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00125 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00125 DESCRIPT Simvastatin up-regulates the expression of DME DHCR24 DME0413 XEOTICID XEO00125 GENEFORM mRNA DME0413 XEOTICID XEO00125 MOACRIVE Induction DME0413 XEOTICID XEO00126 XEO_NAME Raloxifene hydrochloride DME0413 XEOTICID XEO00126 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00126 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00126 DESCRIPT Raloxifene hydrochloride inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00126 GENEFORM mRNA DME0413 XEOTICID XEO00126 MOACRIVE Inhibition DME0413 XEOTICID XEO00184 XEO_NAME Calcitriol DME0413 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME DHCR24 DME0413 XEOTICID XEO00184 GENEFORM mRNA DME0413 XEOTICID XEO00184 MOACRIVE Induction DME0413 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0413 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00186 GENEFORM mRNA DME0413 XEOTICID XEO00186 MOACRIVE Inhibition DME0413 XEOTICID XEO00192 XEO_NAME Dutasteride DME0413 XEOTICID XEO00192 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00192 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00192 DESCRIPT Dutasteride inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00192 GENEFORM mRNA DME0413 XEOTICID XEO00192 MOACRIVE Inhibition DME0413 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0413 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00217 GENEFORM mRNA DME0413 XEOTICID XEO00217 MOACRIVE Inhibition DME0413 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0413 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00241 GENEFORM mRNA DME0413 XEOTICID XEO00241 MOACRIVE Inhibition DME0413 XEOTICID XEO00334 XEO_NAME Cisplatin DME0413 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00334 GENEFORM mRNA DME0413 XEOTICID XEO00334 MOACRIVE Inhibition DME0413 XEOTICID XEO00370 XEO_NAME Nebivolol DME0413 XEOTICID XEO00370 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00370 XEO_CLAS Approved/Marketed Drug DME0413 XEOTICID XEO00370 DESCRIPT Nebivolol up-regulates the expression of DME DHCR24 DME0413 XEOTICID XEO00370 GENEFORM mRNA DME0413 XEOTICID XEO00370 MOACRIVE Induction DME0413 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0413 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0413 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME DHCR24 DME0413 XEOTICID XEO00536 GENEFORM mRNA DME0413 XEOTICID XEO00536 MOACRIVE Induction DME0413 XEOTICID XEO00538 XEO_NAME Quercetin DME0413 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0413 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00538 GENEFORM mRNA DME0413 XEOTICID XEO00538 MOACRIVE Inhibition DME0413 XEOTICID XEO00557 XEO_NAME Genistein DME0413 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0413 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00557 GENEFORM mRNA DME0413 XEOTICID XEO00557 MOACRIVE Inhibition DME0413 XEOTICID XEO00760 XEO_NAME Jinfukang DME0413 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0413 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0413 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME DHCR24 DME0413 XEOTICID XEO00760 GENEFORM mRNA DME0413 XEOTICID XEO00760 MOACRIVE Induction DME0413 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0413 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0413 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0413 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00772 GENEFORM mRNA DME0413 XEOTICID XEO00772 MOACRIVE Inhibition DME0413 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0413 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0413 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0413 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00806 GENEFORM mRNA DME0413 XEOTICID XEO00806 MOACRIVE Inhibition DME0413 XEOTICID XEO00813 XEO_NAME Dinophysistoxin 1 DME0413 XEOTICID XEO00813 XEO_TYPE Health or Environmental Toxicant(s) DME0413 XEOTICID XEO00813 XEO_CLAS Biotoxin DME0413 XEOTICID XEO00813 DESCRIPT Dinophysistoxin 1 inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00813 GENEFORM mRNA DME0413 XEOTICID XEO00813 MOACRIVE Inhibition DME0413 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0413 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0413 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0413 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00821 GENEFORM mRNA DME0413 XEOTICID XEO00821 MOACRIVE Inhibition DME0413 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0413 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0413 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0413 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00898 GENEFORM mRNA DME0413 XEOTICID XEO00898 MOACRIVE Inhibition DME0413 XEOTICID XEO00969 XEO_NAME Atrazine DME0413 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0413 XEOTICID XEO00969 XEO_CLAS Herbicide DME0413 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00969 GENEFORM mRNA DME0413 XEOTICID XEO00969 MOACRIVE Inhibition DME0413 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0413 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0413 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0413 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO00999 GENEFORM mRNA DME0413 XEOTICID XEO00999 MOACRIVE Inhibition DME0413 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0413 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0413 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0413 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO01031 GENEFORM mRNA DME0413 XEOTICID XEO01031 MOACRIVE Inhibition DME0413 XEOTICID XEO01205 XEO_NAME Archazolid B DME0413 XEOTICID XEO01205 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO01205 XEO_CLAS Investigative Agent DME0413 XEOTICID XEO01205 DESCRIPT Archazolid B up-regulates the expression of DME DHCR24 DME0413 XEOTICID XEO01205 GENEFORM mRNA DME0413 XEOTICID XEO01205 MOACRIVE Induction DME0413 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0413 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0413 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME DHCR24 DME0413 XEOTICID XEO01226 GENEFORM mRNA DME0413 XEOTICID XEO01226 MOACRIVE Induction DME0413 XEOTICID XEO01273 XEO_NAME Diarylpropionitrile DME0413 XEOTICID XEO01273 XEO_TYPE Health or Environmental Toxicant(s) DME0413 XEOTICID XEO01273 XEO_CLAS Environmental Pollutant DME0413 XEOTICID XEO01273 DESCRIPT Diarylpropionitrile up-regulates the expression of DME DHCR24 DME0413 XEOTICID XEO01273 GENEFORM mRNA DME0413 XEOTICID XEO01273 MOACRIVE Induction DME0413 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0413 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0413 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0413 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO01305 GENEFORM mRNA DME0413 XEOTICID XEO01305 MOACRIVE Inhibition DME0413 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0413 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0413 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO01324 GENEFORM mRNA DME0413 XEOTICID XEO01324 MOACRIVE Inhibition DME0413 XEOTICID XEO01336 XEO_NAME ICG-001 DME0413 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0413 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO01336 GENEFORM mRNA DME0413 XEOTICID XEO01336 MOACRIVE Inhibition DME0413 XEOTICID XEO01397 XEO_NAME Nickel chloride DME0413 XEOTICID XEO01397 XEO_TYPE Health or Environmental Toxicant(s) DME0413 XEOTICID XEO01397 XEO_CLAS Acute Toxic Substance DME0413 XEOTICID XEO01397 DESCRIPT Nickel chloride inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO01397 GENEFORM mRNA DME0413 XEOTICID XEO01397 MOACRIVE Inhibition DME0413 XEOTICID XEO01436 XEO_NAME PP242 DME0413 XEOTICID XEO01436 XEO_TYPE Pharmaceutical Agent(s) DME0413 XEOTICID XEO01436 XEO_CLAS Investigative Agent DME0413 XEOTICID XEO01436 DESCRIPT PP242 inhibits the drug-metabolizing activity of DME DHCR24 DME0413 XEOTICID XEO01436 GENEFORM Protein DME0413 XEOTICID XEO01436 MOACRIVE Inhibition DME0413 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0413 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0413 XEOTICID XEO01494 XEO_CLAS Natural Product DME0413 XEOTICID XEO01494 DESCRIPT Tunicamycin A inhibits the expression of DME DHCR24 DME0413 XEOTICID XEO01494 GENEFORM mRNA DME0413 XEOTICID XEO01494 MOACRIVE Inhibition DME0414 DME___ID DME0414 DME0414 DME_NAME Short-chain dehydrogenase/reductase retSDR1 (DHRS3) DME0414 SPESNAME Homo sapiens DME0414 XEOTICID XEO00029 XEO_NAME Valproic acid DME0414 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME DHRS3 DME0414 XEOTICID XEO00029 GENEFORM mRNA DME0414 XEOTICID XEO00029 MOACRIVE Inhibition DME0414 XEOTICID XEO00090 XEO_NAME Estradiol DME0414 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00090 GENEFORM mRNA DME0414 XEOTICID XEO00090 MOACRIVE Induction DME0414 XEOTICID XEO00094 XEO_NAME Progesterone DME0414 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00094 DESCRIPT Progesterone up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00094 GENEFORM mRNA DME0414 XEOTICID XEO00094 MOACRIVE Induction DME0414 XEOTICID XEO00095 XEO_NAME Testosterone DME0414 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00095 GENEFORM mRNA DME0414 XEOTICID XEO00095 MOACRIVE Induction DME0414 XEOTICID XEO00144 XEO_NAME Bexarotene DME0414 XEOTICID XEO00144 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00144 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00144 DESCRIPT Bexarotene up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00144 GENEFORM mRNA DME0414 XEOTICID XEO00144 MOACRIVE Induction DME0414 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0414 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00166 GENEFORM mRNA DME0414 XEOTICID XEO00166 MOACRIVE Induction DME0414 XEOTICID XEO00181 XEO_NAME Dasatinib DME0414 XEOTICID XEO00181 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00181 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00181 DESCRIPT Dasatinib up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00181 GENEFORM mRNA DME0414 XEOTICID XEO00181 MOACRIVE Induction DME0414 XEOTICID XEO00184 XEO_NAME Calcitriol DME0414 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME DHRS3 DME0414 XEOTICID XEO00184 GENEFORM mRNA DME0414 XEOTICID XEO00184 MOACRIVE Inhibition DME0414 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0414 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00186 DESCRIPT Isotretinoin up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00186 GENEFORM mRNA DME0414 XEOTICID XEO00186 MOACRIVE Induction DME0414 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0414 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME DHRS3 DME0414 XEOTICID XEO00217 GENEFORM mRNA DME0414 XEOTICID XEO00217 MOACRIVE Inhibition DME0414 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0414 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME DHRS3 DME0414 XEOTICID XEO00241 GENEFORM mRNA DME0414 XEOTICID XEO00241 MOACRIVE Inhibition DME0414 XEOTICID XEO00253 XEO_NAME Tretinoin DME0414 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00253 GENEFORM mRNA DME0414 XEOTICID XEO00253 MOACRIVE Induction DME0414 XEOTICID XEO00267 XEO_NAME Ethinyl estradiol DME0414 XEOTICID XEO00267 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00267 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00267 DESCRIPT Ethinyl estradiol up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00267 GENEFORM mRNA DME0414 XEOTICID XEO00267 MOACRIVE Induction DME0414 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0414 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00292 GENEFORM mRNA DME0414 XEOTICID XEO00292 MOACRIVE Induction DME0414 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0414 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00312 GENEFORM mRNA DME0414 XEOTICID XEO00312 MOACRIVE Induction DME0414 XEOTICID XEO00380 XEO_NAME Rosiglitazone DME0414 XEOTICID XEO00380 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00380 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00380 DESCRIPT Rosiglitazone up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00380 GENEFORM mRNA DME0414 XEOTICID XEO00380 MOACRIVE Induction DME0414 XEOTICID XEO00435 XEO_NAME Urethane DME0414 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0414 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME DHRS3 DME0414 XEOTICID XEO00435 GENEFORM mRNA DME0414 XEOTICID XEO00435 MOACRIVE Inhibition DME0414 XEOTICID XEO00557 XEO_NAME Genistein DME0414 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0414 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00557 GENEFORM mRNA DME0414 XEOTICID XEO00557 MOACRIVE Induction DME0414 XEOTICID XEO00565 XEO_NAME Fenretinide DME0414 XEOTICID XEO00565 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00565 XEO_CLAS Drug in Phase 3 Clinical Trial DME0414 XEOTICID XEO00565 DESCRIPT Fenretinide up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00565 GENEFORM mRNA DME0414 XEOTICID XEO00565 MOACRIVE Induction DME0414 XEOTICID XEO00568 XEO_NAME Resveratrol DME0414 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0414 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00568 GENEFORM mRNA DME0414 XEOTICID XEO00568 MOACRIVE Induction DME0414 XEOTICID XEO00581 XEO_NAME MS-275 DME0414 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0414 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00581 GENEFORM mRNA DME0414 XEOTICID XEO00581 MOACRIVE Induction DME0414 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0414 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0414 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME DHRS3 DME0414 XEOTICID XEO00632 GENEFORM mRNA DME0414 XEOTICID XEO00632 MOACRIVE Inhibition DME0414 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0414 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0414 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME DHRS3 DME0414 XEOTICID XEO00723 GENEFORM mRNA DME0414 XEOTICID XEO00723 MOACRIVE Inhibition DME0414 XEOTICID XEO00728 XEO_NAME AM-580 DME0414 XEOTICID XEO00728 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO00728 XEO_CLAS Preclinical/Patented Drug DME0414 XEOTICID XEO00728 DESCRIPT AM-580 up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00728 GENEFORM mRNA DME0414 XEOTICID XEO00728 MOACRIVE Induction DME0414 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0414 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0414 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0414 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME DHRS3 DME0414 XEOTICID XEO00806 GENEFORM mRNA DME0414 XEOTICID XEO00806 MOACRIVE Inhibition DME0414 XEOTICID XEO00809 XEO_NAME Thapsigargin DME0414 XEOTICID XEO00809 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0414 XEOTICID XEO00809 XEO_CLAS Natural Product DME0414 XEOTICID XEO00809 DESCRIPT Thapsigargin up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00809 GENEFORM mRNA DME0414 XEOTICID XEO00809 MOACRIVE Induction DME0414 XEOTICID XEO00831 XEO_NAME Nano-sized iron particle DME0414 XEOTICID XEO00831 XEO_TYPE Health or Environmental Toxicant(s) DME0414 XEOTICID XEO00831 XEO_CLAS Health Hazard/Toxicant DME0414 XEOTICID XEO00831 DESCRIPT Nano-sized iron particle inhibits the expression of DME DHRS3 DME0414 XEOTICID XEO00831 GENEFORM mRNA DME0414 XEOTICID XEO00831 MOACRIVE Inhibition DME0414 XEOTICID XEO00919 XEO_NAME Particulate matter DME0414 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0414 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0414 XEOTICID XEO00919 DESCRIPT Particulate matter up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO00919 GENEFORM mRNA DME0414 XEOTICID XEO00919 MOACRIVE Induction DME0414 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0414 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0414 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0414 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME DHRS3 DME0414 XEOTICID XEO00999 GENEFORM mRNA DME0414 XEOTICID XEO00999 MOACRIVE Inhibition DME0414 XEOTICID XEO01023 XEO_NAME Sodium arsenate DME0414 XEOTICID XEO01023 XEO_TYPE Health or Environmental Toxicant(s) DME0414 XEOTICID XEO01023 XEO_CLAS Environmental Pollutant DME0414 XEOTICID XEO01023 DESCRIPT Sodium arsenate inhibits the drug-metabolizing activity of DME DHRS3 DME0414 XEOTICID XEO01023 GENEFORM Protein DME0414 XEOTICID XEO01023 MOACRIVE Inhibition DME0414 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0414 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0414 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME DHRS3 DME0414 XEOTICID XEO01226 GENEFORM mRNA DME0414 XEOTICID XEO01226 MOACRIVE Inhibition DME0414 XEOTICID XEO01336 XEO_NAME ICG-001 DME0414 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0414 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO01336 GENEFORM mRNA DME0414 XEOTICID XEO01336 MOACRIVE Induction DME0414 XEOTICID XEO01348 XEO_NAME K-7174 DME0414 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0414 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0414 XEOTICID XEO01348 DESCRIPT K-7174 up-regulates the expression of DME DHRS3 DME0414 XEOTICID XEO01348 GENEFORM mRNA DME0414 XEOTICID XEO01348 MOACRIVE Induction DME0415 DME___ID DME0415 DME0415 DME_NAME Thymidylate kinase (DTYMK) DME0415 SPESNAME Homo sapiens DME0415 XEOTICID XEO00029 XEO_NAME Valproic acid DME0415 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0415 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME DTYMK DME0415 XEOTICID XEO00029 GENEFORM mRNA DME0415 XEOTICID XEO00029 MOACRIVE Inhibition DME0415 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0415 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0415 XEOTICID XEO00037 DESCRIPT Fluorouracil up-regulates the expression of DME DTYMK DME0415 XEOTICID XEO00037 GENEFORM mRNA DME0415 XEOTICID XEO00037 MOACRIVE Induction DME0415 XEOTICID XEO00053 XEO_NAME Leflunomide DME0415 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0415 XEOTICID XEO00053 DESCRIPT Leflunomide inhibits the expression of DME DTYMK DME0415 XEOTICID XEO00053 GENEFORM mRNA DME0415 XEOTICID XEO00053 MOACRIVE Inhibition DME0415 XEOTICID XEO00086 XEO_NAME Troglitazone DME0415 XEOTICID XEO00086 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO00086 XEO_CLAS Approved/Marketed Drug DME0415 XEOTICID XEO00086 DESCRIPT Troglitazone inhibits the expression of DME DTYMK DME0415 XEOTICID XEO00086 GENEFORM mRNA DME0415 XEOTICID XEO00086 MOACRIVE Inhibition DME0415 XEOTICID XEO00090 XEO_NAME Estradiol DME0415 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0415 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME DTYMK DME0415 XEOTICID XEO00090 GENEFORM mRNA DME0415 XEOTICID XEO00090 MOACRIVE Induction DME0415 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0415 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0415 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME DTYMK DME0415 XEOTICID XEO00117 GENEFORM mRNA DME0415 XEOTICID XEO00117 MOACRIVE Inhibition DME0415 XEOTICID XEO00184 XEO_NAME Calcitriol DME0415 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0415 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME DTYMK DME0415 XEOTICID XEO00184 GENEFORM mRNA DME0415 XEOTICID XEO00184 MOACRIVE Inhibition DME0415 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0415 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0415 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME DTYMK DME0415 XEOTICID XEO00217 GENEFORM mRNA DME0415 XEOTICID XEO00217 MOACRIVE Induction DME0415 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0415 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0415 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME DTYMK DME0415 XEOTICID XEO00241 GENEFORM mRNA DME0415 XEOTICID XEO00241 MOACRIVE Inhibition DME0415 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0415 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0415 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex inhibits the expression of DME DTYMK DME0415 XEOTICID XEO00312 GENEFORM mRNA DME0415 XEOTICID XEO00312 MOACRIVE Inhibition DME0415 XEOTICID XEO00334 XEO_NAME Cisplatin DME0415 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0415 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME DTYMK DME0415 XEOTICID XEO00334 GENEFORM mRNA DME0415 XEOTICID XEO00334 MOACRIVE Induction DME0415 XEOTICID XEO00557 XEO_NAME Genistein DME0415 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0415 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME DTYMK DME0415 XEOTICID XEO00557 GENEFORM mRNA DME0415 XEOTICID XEO00557 MOACRIVE Induction DME0415 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME0415 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME0415 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the expression of DME DTYMK DME0415 XEOTICID XEO00613 GENEFORM mRNA DME0415 XEOTICID XEO00613 MOACRIVE Inhibition DME0415 XEOTICID XEO00760 XEO_NAME Jinfukang DME0415 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0415 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0415 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME DTYMK DME0415 XEOTICID XEO00760 GENEFORM mRNA DME0415 XEOTICID XEO00760 MOACRIVE Induction DME0415 XEOTICID XEO00776 XEO_NAME Polychlorinated biphenyls DME0415 XEOTICID XEO00776 XEO_TYPE Health or Environmental Toxicant(s) DME0415 XEOTICID XEO00776 XEO_CLAS Carcinogen DME0415 XEOTICID XEO00776 DESCRIPT Polychlorinated biphenyls induces the drug-metabolizing activity of DME DTYMK DME0415 XEOTICID XEO00776 GENEFORM Protein DME0415 XEOTICID XEO00776 MOACRIVE Induction DME0415 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0415 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0415 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0415 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME DTYMK DME0415 XEOTICID XEO01031 GENEFORM mRNA DME0415 XEOTICID XEO01031 MOACRIVE Inhibition DME0415 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0415 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0415 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME DTYMK DME0415 XEOTICID XEO01226 GENEFORM mRNA DME0415 XEOTICID XEO01226 MOACRIVE Inhibition DME0415 XEOTICID XEO01312 XEO_NAME Geraniol DME0415 XEOTICID XEO01312 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0415 XEOTICID XEO01312 XEO_CLAS Natural Product DME0415 XEOTICID XEO01312 DESCRIPT Geraniol inhibits the expression of DME DTYMK DME0415 XEOTICID XEO01312 GENEFORM mRNA DME0415 XEOTICID XEO01312 MOACRIVE Inhibition DME0415 XEOTICID XEO01348 XEO_NAME K-7174 DME0415 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0415 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0415 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME DTYMK DME0415 XEOTICID XEO01348 GENEFORM mRNA DME0415 XEOTICID XEO01348 MOACRIVE Inhibition DME0415 XEOTICID XEO01503 XEO_NAME Cadmium DME0415 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0415 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0415 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the expression of DME DTYMK DME0415 XEOTICID XEO01503 GENEFORM mRNA DME0415 XEOTICID XEO01503 MOACRIVE Inhibition DME0416 DME___ID DME0416 DME0416 DME_NAME Friedreich ataxia protein (FXN) DME0416 SPESNAME Homo sapiens DME0416 XEOTICID XEO00021 XEO_NAME Deferiprone DME0416 XEOTICID XEO00021 XEO_TYPE Pharmaceutical Agent(s) DME0416 XEOTICID XEO00021 XEO_CLAS Approved/Marketed Drug DME0416 XEOTICID XEO00021 DESCRIPT Deferiprone induces the drug-metabolizing activity of DME FXN DME0416 XEOTICID XEO00021 GENEFORM Protein DME0416 XEOTICID XEO00021 MOACRIVE Induction DME0416 XEOTICID XEO00103 XEO_NAME Betamethasone DME0416 XEOTICID XEO00103 XEO_TYPE Pharmaceutical Agent(s) DME0416 XEOTICID XEO00103 XEO_CLAS Approved/Marketed Drug DME0416 XEOTICID XEO00103 DESCRIPT Betamethasone up-regulates the expression of DME FXN DME0416 XEOTICID XEO00103 GENEFORM mRNA DME0416 XEOTICID XEO00103 MOACRIVE Induction DME0416 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0416 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0416 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0416 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME FXN DME0416 XEOTICID XEO00217 GENEFORM mRNA DME0416 XEOTICID XEO00217 MOACRIVE Inhibition DME0416 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0416 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0416 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0416 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME FXN DME0416 XEOTICID XEO00241 GENEFORM mRNA DME0416 XEOTICID XEO00241 MOACRIVE Induction DME0416 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0416 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0416 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0416 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME FXN DME0416 XEOTICID XEO00292 GENEFORM mRNA DME0416 XEOTICID XEO00292 MOACRIVE Inhibition DME0416 XEOTICID XEO00334 XEO_NAME Cisplatin DME0416 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0416 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0416 XEOTICID XEO00334 DESCRIPT Cisplatin induces the drug-metabolizing activity of DME FXN DME0416 XEOTICID XEO00334 GENEFORM Protein DME0416 XEOTICID XEO00334 MOACRIVE Induction DME0416 XEOTICID XEO00506 XEO_NAME Molsidomine DME0416 XEOTICID XEO00506 XEO_TYPE Pharmaceutical Agent(s) DME0416 XEOTICID XEO00506 XEO_CLAS Approved/Marketed Drug DME0416 XEOTICID XEO00506 DESCRIPT Molsidomine induces the drug-metabolizing activity of DME FXN DME0416 XEOTICID XEO00506 GENEFORM Protein DME0416 XEOTICID XEO00506 MOACRIVE Induction DME0416 XEOTICID XEO00568 XEO_NAME Resveratrol DME0416 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0416 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0416 XEOTICID XEO00568 DESCRIPT Resveratrol induces the drug-metabolizing activity of DME FXN DME0416 XEOTICID XEO00568 GENEFORM Protein DME0416 XEOTICID XEO00568 MOACRIVE Induction DME0416 XEOTICID XEO00597 XEO_NAME Camptothecin DME0416 XEOTICID XEO00597 XEO_TYPE Pharmaceutical Agent(s) DME0416 XEOTICID XEO00597 XEO_CLAS Drug in Phase 2 Clinical Trial DME0416 XEOTICID XEO00597 DESCRIPT Camptothecin induces the drug-metabolizing activity of DME FXN DME0416 XEOTICID XEO00597 GENEFORM Protein DME0416 XEOTICID XEO00597 MOACRIVE Induction DME0416 XEOTICID XEO00603 XEO_NAME Nimustine DME0416 XEOTICID XEO00603 XEO_TYPE Pharmaceutical Agent(s) DME0416 XEOTICID XEO00603 XEO_CLAS Drug in Phase 2 Clinical Trial DME0416 XEOTICID XEO00603 DESCRIPT Nimustine up-regulates the expression of DME FXN DME0416 XEOTICID XEO00603 GENEFORM mRNA DME0416 XEOTICID XEO00603 MOACRIVE Induction DME0416 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0416 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0416 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0416 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME FXN DME0416 XEOTICID XEO00632 GENEFORM mRNA DME0416 XEOTICID XEO00632 MOACRIVE Induction DME0416 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0416 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0416 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0416 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME FXN DME0416 XEOTICID XEO01324 GENEFORM mRNA DME0416 XEOTICID XEO01324 MOACRIVE Inhibition DME0417 DME___ID DME0417 DME0417 DME_NAME Galactose kinase (GALK1) DME0417 SPESNAME Homo sapiens DME0417 XEOTICID XEO00029 XEO_NAME Valproic acid DME0417 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0417 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0417 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME GALK1 DME0417 XEOTICID XEO00029 GENEFORM mRNA DME0417 XEOTICID XEO00029 MOACRIVE Inhibition DME0417 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0417 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0417 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0417 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME GALK1 DME0417 XEOTICID XEO00117 GENEFORM mRNA DME0417 XEOTICID XEO00117 MOACRIVE Inhibition DME0417 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0417 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0417 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0417 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME GALK1 DME0417 XEOTICID XEO00241 GENEFORM mRNA DME0417 XEOTICID XEO00241 MOACRIVE Inhibition DME0417 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0417 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0417 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0417 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride up-regulates the expression of DME GALK1 DME0417 XEOTICID XEO00292 GENEFORM mRNA DME0417 XEOTICID XEO00292 MOACRIVE Induction DME0417 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0417 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0417 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0417 XEOTICID XEO00339 DESCRIPT Arsenic trioxide induces the drug-metabolizing activity of DME GALK1 DME0417 XEOTICID XEO00339 GENEFORM Protein DME0417 XEOTICID XEO00339 MOACRIVE Induction DME0417 XEOTICID XEO00581 XEO_NAME MS-275 DME0417 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0417 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0417 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME GALK1 DME0417 XEOTICID XEO00581 GENEFORM mRNA DME0417 XEOTICID XEO00581 MOACRIVE Induction DME0417 XEOTICID XEO00585 XEO_NAME Tetrahydropalmatine DME0417 XEOTICID XEO00585 XEO_TYPE Pharmaceutical Agent(s) DME0417 XEOTICID XEO00585 XEO_CLAS Drug in Phase 2 Clinical Trial DME0417 XEOTICID XEO00585 DESCRIPT Tetrahydropalmatine inhibits the expression of DME GALK1 DME0417 XEOTICID XEO00585 GENEFORM mRNA DME0417 XEOTICID XEO00585 MOACRIVE Inhibition DME0417 XEOTICID XEO00760 XEO_NAME Jinfukang DME0417 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0417 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0417 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME GALK1 DME0417 XEOTICID XEO00760 GENEFORM mRNA DME0417 XEOTICID XEO00760 MOACRIVE Induction DME0417 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0417 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0417 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0417 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME GALK1 DME0417 XEOTICID XEO00821 GENEFORM mRNA DME0417 XEOTICID XEO00821 MOACRIVE Inhibition DME0417 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0417 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0417 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0417 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME GALK1 DME0417 XEOTICID XEO00898 GENEFORM mRNA DME0417 XEOTICID XEO00898 MOACRIVE Inhibition DME0417 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0417 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0417 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0417 XEOTICID XEO00999 DESCRIPT Butyraldehyde up-regulates the expression of DME GALK1 DME0417 XEOTICID XEO00999 GENEFORM mRNA DME0417 XEOTICID XEO00999 MOACRIVE Induction DME0417 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0417 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0417 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0417 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME GALK1 DME0417 XEOTICID XEO01050 GENEFORM mRNA DME0417 XEOTICID XEO01050 MOACRIVE Inhibition DME0417 XEOTICID XEO01103 XEO_NAME 1-methyl-4-phenylpyridinium DME0417 XEOTICID XEO01103 XEO_TYPE Health or Environmental Toxicant(s) DME0417 XEOTICID XEO01103 XEO_CLAS Health Hazard/Toxicant DME0417 XEOTICID XEO01103 DESCRIPT 1-methyl-4-phenylpyridinium up-regulates the expression of DME GALK1 DME0417 XEOTICID XEO01103 GENEFORM mRNA DME0417 XEOTICID XEO01103 MOACRIVE Induction DME0417 XEOTICID XEO01348 XEO_NAME K-7174 DME0417 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0417 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0417 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME GALK1 DME0417 XEOTICID XEO01348 GENEFORM mRNA DME0417 XEOTICID XEO01348 MOACRIVE Inhibition DME0418 DME___ID DME0418 DME0418 DME_NAME Glutamine synthetase (GLUL) DME0418 SPESNAME Homo sapiens DME0418 XEOTICID XEO00029 XEO_NAME Valproic acid DME0418 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME GLUL DME0418 XEOTICID XEO00029 GENEFORM mRNA DME0418 XEOTICID XEO00029 MOACRIVE Induction DME0418 XEOTICID XEO00047 XEO_NAME Indomethacin DME0418 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00047 DESCRIPT Indomethacin inhibits the expression of DME GLUL DME0418 XEOTICID XEO00047 GENEFORM mRNA DME0418 XEOTICID XEO00047 MOACRIVE Inhibition DME0418 XEOTICID XEO00053 XEO_NAME Leflunomide DME0418 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME GLUL DME0418 XEOTICID XEO00053 GENEFORM mRNA DME0418 XEOTICID XEO00053 MOACRIVE Induction DME0418 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0418 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00088 DESCRIPT Dexamethasone up-regulates the expression of DME GLUL DME0418 XEOTICID XEO00088 GENEFORM mRNA DME0418 XEOTICID XEO00088 MOACRIVE Induction DME0418 XEOTICID XEO00090 XEO_NAME Estradiol DME0418 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME GLUL DME0418 XEOTICID XEO00090 GENEFORM mRNA DME0418 XEOTICID XEO00090 MOACRIVE Induction DME0418 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0418 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00167 DESCRIPT Alitretinoin up-regulates the expression of DME GLUL DME0418 XEOTICID XEO00167 GENEFORM mRNA DME0418 XEOTICID XEO00167 MOACRIVE Induction DME0418 XEOTICID XEO00184 XEO_NAME Calcitriol DME0418 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00184 DESCRIPT Calcitriol inhibits the expression of DME GLUL DME0418 XEOTICID XEO00184 GENEFORM mRNA DME0418 XEOTICID XEO00184 MOACRIVE Inhibition DME0418 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0418 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00186 DESCRIPT Isotretinoin up-regulates the expression of DME GLUL DME0418 XEOTICID XEO00186 GENEFORM mRNA DME0418 XEOTICID XEO00186 MOACRIVE Induction DME0418 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0418 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME GLUL DME0418 XEOTICID XEO00217 GENEFORM mRNA DME0418 XEOTICID XEO00217 MOACRIVE Inhibition DME0418 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0418 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME GLUL DME0418 XEOTICID XEO00241 GENEFORM mRNA DME0418 XEOTICID XEO00241 MOACRIVE Inhibition DME0418 XEOTICID XEO00253 XEO_NAME Tretinoin DME0418 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the drug-metabolizing activity of DME GLUL DME0418 XEOTICID XEO00253 GENEFORM Protein DME0418 XEOTICID XEO00253 MOACRIVE Inhibition DME0418 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0418 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME GLUL DME0418 XEOTICID XEO00292 GENEFORM mRNA DME0418 XEOTICID XEO00292 MOACRIVE Inhibition DME0418 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0418 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME GLUL DME0418 XEOTICID XEO00339 GENEFORM mRNA DME0418 XEOTICID XEO00339 MOACRIVE Induction DME0418 XEOTICID XEO00411 XEO_NAME Avobenzone DME0418 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME GLUL DME0418 XEOTICID XEO00411 GENEFORM mRNA DME0418 XEOTICID XEO00411 MOACRIVE Induction DME0418 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0418 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0418 XEOTICID XEO00430 DESCRIPT Hydroquinone inhibits the expression of DME GLUL DME0418 XEOTICID XEO00430 GENEFORM mRNA DME0418 XEOTICID XEO00430 MOACRIVE Inhibition DME0418 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0418 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0418 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME GLUL DME0418 XEOTICID XEO00536 GENEFORM mRNA DME0418 XEOTICID XEO00536 MOACRIVE Induction DME0418 XEOTICID XEO00557 XEO_NAME Genistein DME0418 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0418 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME GLUL DME0418 XEOTICID XEO00557 GENEFORM mRNA DME0418 XEOTICID XEO00557 MOACRIVE Inhibition DME0418 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0418 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0418 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0418 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME GLUL DME0418 XEOTICID XEO00821 GENEFORM mRNA DME0418 XEOTICID XEO00821 MOACRIVE Inhibition DME0418 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0418 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0418 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0418 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME GLUL DME0418 XEOTICID XEO00898 GENEFORM mRNA DME0418 XEOTICID XEO00898 MOACRIVE Inhibition DME0418 XEOTICID XEO00964 XEO_NAME Uranium DME0418 XEOTICID XEO00964 XEO_TYPE Health or Environmental Toxicant(s) DME0418 XEOTICID XEO00964 XEO_CLAS Acute Toxic Substance DME0418 XEOTICID XEO00964 DESCRIPT Uranium inhibits the expression of DME GLUL DME0418 XEOTICID XEO00964 GENEFORM mRNA DME0418 XEOTICID XEO00964 MOACRIVE Inhibition DME0418 XEOTICID XEO01023 XEO_NAME Sodium arsenate DME0418 XEOTICID XEO01023 XEO_TYPE Health or Environmental Toxicant(s) DME0418 XEOTICID XEO01023 XEO_CLAS Environmental Pollutant DME0418 XEOTICID XEO01023 DESCRIPT Sodium arsenate inhibits the drug-metabolizing activity of DME GLUL DME0418 XEOTICID XEO01023 GENEFORM Protein DME0418 XEOTICID XEO01023 MOACRIVE Inhibition DME0418 XEOTICID XEO01024 XEO_NAME Sodium bichromate DME0418 XEOTICID XEO01024 XEO_TYPE Health or Environmental Toxicant(s) DME0418 XEOTICID XEO01024 XEO_CLAS Carcinogen DME0418 XEOTICID XEO01024 DESCRIPT Sodium bichromate inhibits the expression of DME GLUL DME0418 XEOTICID XEO01024 GENEFORM mRNA DME0418 XEOTICID XEO01024 MOACRIVE Inhibition DME0418 XEOTICID XEO01154 XEO_NAME 4-oxoretinoic acid DME0418 XEOTICID XEO01154 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0418 XEOTICID XEO01154 XEO_CLAS Natural Product DME0418 XEOTICID XEO01154 DESCRIPT 4-oxoretinoic acid up-regulates the expression of DME GLUL DME0418 XEOTICID XEO01154 GENEFORM mRNA DME0418 XEOTICID XEO01154 MOACRIVE Induction DME0418 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0418 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0418 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0418 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME GLUL DME0418 XEOTICID XEO01305 GENEFORM mRNA DME0418 XEOTICID XEO01305 MOACRIVE Inhibition DME0418 XEOTICID XEO01392 XEO_NAME N-butyrylglucosamine DME0418 XEOTICID XEO01392 XEO_TYPE Pharmaceutical Agent(s) DME0418 XEOTICID XEO01392 XEO_CLAS Investigative Agent DME0418 XEOTICID XEO01392 DESCRIPT N-butyrylglucosamine induces the drug-metabolizing activity of DME GLUL DME0418 XEOTICID XEO01392 GENEFORM Protein DME0418 XEOTICID XEO01392 MOACRIVE Induction DME0418 XEOTICID XEO01422 XEO_NAME Paraquat DME0418 XEOTICID XEO01422 XEO_TYPE Health or Environmental Toxicant(s) DME0418 XEOTICID XEO01422 XEO_CLAS Acute Toxic Substance DME0418 XEOTICID XEO01422 DESCRIPT Paraquat inhibits the drug-metabolizing activity of DME GLUL DME0418 XEOTICID XEO01422 GENEFORM Protein DME0418 XEOTICID XEO01422 MOACRIVE Inhibition DME0418 XEOTICID XEO01503 XEO_NAME Cadmium DME0418 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0418 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0418 XEOTICID XEO01503 DESCRIPT Cadmium up-regulates the expression of DME GLUL DME0418 XEOTICID XEO01503 GENEFORM mRNA DME0418 XEOTICID XEO01503 MOACRIVE Induction DME0418 XEOTICID XEO01511 XEO_NAME Vitallium DME0418 XEOTICID XEO01511 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0418 XEOTICID XEO01511 XEO_CLAS Natural Mixture DME0418 XEOTICID XEO01511 DESCRIPT Vitallium up-regulates the expression of DME GLUL DME0418 XEOTICID XEO01511 GENEFORM mRNA DME0418 XEOTICID XEO01511 MOACRIVE Induction DME0419 DME___ID DME0419 DME0419 DME_NAME Corticosteroid 11-beta-dehydrogenase 2 (HSD11B2) DME0419 SPESNAME Homo sapiens DME0419 XEOTICID XEO00007 XEO_NAME Azathioprine DME0419 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00007 DESCRIPT Azathioprine inhibits the expression of DME HSD11B2 DME0419 XEOTICID XEO00007 GENEFORM mRNA DME0419 XEOTICID XEO00007 MOACRIVE Inhibition DME0419 XEOTICID XEO00028 XEO_NAME Disulfiram DME0419 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00028 DESCRIPT Disulfiram inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00028 GENEFORM Protein DME0419 XEOTICID XEO00028 MOACRIVE Inhibition DME0419 XEOTICID XEO00029 XEO_NAME Valproic acid DME0419 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME HSD11B2 DME0419 XEOTICID XEO00029 GENEFORM mRNA DME0419 XEOTICID XEO00029 MOACRIVE Induction DME0419 XEOTICID XEO00047 XEO_NAME Indomethacin DME0419 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00047 DESCRIPT Indomethacin inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00047 GENEFORM Protein DME0419 XEOTICID XEO00047 MOACRIVE Inhibition DME0419 XEOTICID XEO00088 XEO_NAME Dexamethasone DME0419 XEOTICID XEO00088 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00088 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00088 DESCRIPT Dexamethasone induces the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00088 GENEFORM Protein DME0419 XEOTICID XEO00088 MOACRIVE Induction DME0419 XEOTICID XEO00090 XEO_NAME Estradiol DME0419 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00090 GENEFORM Protein DME0419 XEOTICID XEO00090 MOACRIVE Inhibition DME0419 XEOTICID XEO00094 XEO_NAME Progesterone DME0419 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00094 DESCRIPT Progesterone inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00094 GENEFORM Protein DME0419 XEOTICID XEO00094 MOACRIVE Inhibition DME0419 XEOTICID XEO00095 XEO_NAME Testosterone DME0419 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME HSD11B2 DME0419 XEOTICID XEO00095 GENEFORM mRNA DME0419 XEOTICID XEO00095 MOACRIVE Induction DME0419 XEOTICID XEO00098 XEO_NAME Fluoxymesterone DME0419 XEOTICID XEO00098 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00098 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00098 DESCRIPT Fluoxymesterone inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00098 GENEFORM Protein DME0419 XEOTICID XEO00098 MOACRIVE Inhibition DME0419 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0419 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME HSD11B2 DME0419 XEOTICID XEO00117 GENEFORM mRNA DME0419 XEOTICID XEO00117 MOACRIVE Inhibition DME0419 XEOTICID XEO00118 XEO_NAME Danazol DME0419 XEOTICID XEO00118 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00118 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00118 DESCRIPT Danazol inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00118 GENEFORM Protein DME0419 XEOTICID XEO00118 MOACRIVE Inhibition DME0419 XEOTICID XEO00127 XEO_NAME Mifepristone DME0419 XEOTICID XEO00127 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00127 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00127 DESCRIPT Mifepristone induces the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00127 GENEFORM Protein DME0419 XEOTICID XEO00127 MOACRIVE Induction DME0419 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0419 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00140 DESCRIPT Zoledronic acid inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00140 GENEFORM Protein DME0419 XEOTICID XEO00140 MOACRIVE Inhibition DME0419 XEOTICID XEO00168 XEO_NAME Decitabine DME0419 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00168 DESCRIPT Decitabine up-regulates the expression of DME HSD11B2 DME0419 XEOTICID XEO00168 GENEFORM mRNA DME0419 XEOTICID XEO00168 MOACRIVE Induction DME0419 XEOTICID XEO00183 XEO_NAME Dinoprost DME0419 XEOTICID XEO00183 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00183 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00183 DESCRIPT Dinoprost inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00183 GENEFORM Protein DME0419 XEOTICID XEO00183 MOACRIVE Inhibition DME0419 XEOTICID XEO00184 XEO_NAME Calcitriol DME0419 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME HSD11B2 DME0419 XEOTICID XEO00184 GENEFORM mRNA DME0419 XEOTICID XEO00184 MOACRIVE Induction DME0419 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0419 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME HSD11B2 DME0419 XEOTICID XEO00217 GENEFORM mRNA DME0419 XEOTICID XEO00217 MOACRIVE Inhibition DME0419 XEOTICID XEO00218 XEO_NAME Caffeine DME0419 XEOTICID XEO00218 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00218 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00218 DESCRIPT Caffeine inhibits the expression of DME HSD11B2 and leads to decreasing the drug-metabolizing activity of this enzyme DME0419 XEOTICID XEO00218 GENEFORM Protein DME0419 XEOTICID XEO00218 MOACRIVE Inhibition DME0419 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0419 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME HSD11B2 DME0419 XEOTICID XEO00241 GENEFORM mRNA DME0419 XEOTICID XEO00241 MOACRIVE Inhibition DME0419 XEOTICID XEO00251 XEO_NAME Ketoconazole DME0419 XEOTICID XEO00251 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00251 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00251 DESCRIPT Ketoconazole inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00251 GENEFORM Protein DME0419 XEOTICID XEO00251 MOACRIVE Inhibition DME0419 XEOTICID XEO00260 XEO_NAME Dinoprostone DME0419 XEOTICID XEO00260 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00260 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00260 DESCRIPT Dinoprostone inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00260 GENEFORM Protein DME0419 XEOTICID XEO00260 MOACRIVE Inhibition DME0419 XEOTICID XEO00264 XEO_NAME Hydrocortisone DME0419 XEOTICID XEO00264 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00264 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00264 DESCRIPT Hydrocortisone inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00264 GENEFORM Protein DME0419 XEOTICID XEO00264 MOACRIVE Inhibition DME0419 XEOTICID XEO00312 XEO_NAME Nicotine polacrilex DME0419 XEOTICID XEO00312 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00312 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00312 DESCRIPT Nicotine polacrilex up-regulates the expression of DME HSD11B2 DME0419 XEOTICID XEO00312 GENEFORM mRNA DME0419 XEOTICID XEO00312 MOACRIVE Induction DME0419 XEOTICID XEO00335 XEO_NAME Cosyntropin DME0419 XEOTICID XEO00335 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00335 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO00335 DESCRIPT Cosyntropin inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00335 GENEFORM Protein DME0419 XEOTICID XEO00335 MOACRIVE Inhibition DME0419 XEOTICID XEO00539 XEO_NAME Ethanol DME0419 XEOTICID XEO00539 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00539 XEO_CLAS Drug in Phase 2 Clinical Trial DME0419 XEOTICID XEO00539 DESCRIPT Ethanol inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00539 GENEFORM Protein DME0419 XEOTICID XEO00539 MOACRIVE Inhibition DME0419 XEOTICID XEO00557 XEO_NAME Genistein DME0419 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0419 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME HSD11B2 DME0419 XEOTICID XEO00557 GENEFORM mRNA DME0419 XEOTICID XEO00557 MOACRIVE Induction DME0419 XEOTICID XEO00581 XEO_NAME MS-275 DME0419 XEOTICID XEO00581 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00581 XEO_CLAS Drug in Phase 2 Clinical Trial DME0419 XEOTICID XEO00581 DESCRIPT MS-275 up-regulates the expression of DME HSD11B2 DME0419 XEOTICID XEO00581 GENEFORM mRNA DME0419 XEOTICID XEO00581 MOACRIVE Induction DME0419 XEOTICID XEO00591 XEO_NAME Ditiocarb DME0419 XEOTICID XEO00591 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00591 XEO_CLAS Drug in Phase 2 Clinical Trial DME0419 XEOTICID XEO00591 DESCRIPT Ditiocarb inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00591 GENEFORM Protein DME0419 XEOTICID XEO00591 MOACRIVE Inhibition DME0419 XEOTICID XEO00606 XEO_NAME Colforsin DME0419 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0419 XEOTICID XEO00606 DESCRIPT Colforsin induces the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00606 GENEFORM Protein DME0419 XEOTICID XEO00606 MOACRIVE Induction DME0419 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0419 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0419 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00632 GENEFORM Protein DME0419 XEOTICID XEO00632 MOACRIVE Inhibition DME0419 XEOTICID XEO00643 XEO_NAME Leukotriene B4 DME0419 XEOTICID XEO00643 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00643 XEO_CLAS Drug in Phase 2 Clinical Trial DME0419 XEOTICID XEO00643 DESCRIPT Leukotriene B4 inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00643 GENEFORM Protein DME0419 XEOTICID XEO00643 MOACRIVE Inhibition DME0419 XEOTICID XEO00689 XEO_NAME AA-861 DME0419 XEOTICID XEO00689 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00689 XEO_CLAS Preclinical/Patented Drug DME0419 XEOTICID XEO00689 DESCRIPT AA-861 induces the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO00689 GENEFORM Protein DME0419 XEOTICID XEO00689 MOACRIVE Induction DME0419 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0419 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0419 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME HSD11B2 DME0419 XEOTICID XEO00723 GENEFORM mRNA DME0419 XEOTICID XEO00723 MOACRIVE Inhibition DME0419 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0419 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0419 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0419 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME HSD11B2 DME0419 XEOTICID XEO00898 GENEFORM mRNA DME0419 XEOTICID XEO00898 MOACRIVE Inhibition DME0419 XEOTICID XEO00969 XEO_NAME Atrazine DME0419 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0419 XEOTICID XEO00969 XEO_CLAS Herbicide DME0419 XEOTICID XEO00969 DESCRIPT Atrazine up-regulates the expression of DME HSD11B2 DME0419 XEOTICID XEO00969 GENEFORM mRNA DME0419 XEOTICID XEO00969 MOACRIVE Induction DME0419 XEOTICID XEO01023 XEO_NAME Sodium arsenate DME0419 XEOTICID XEO01023 XEO_TYPE Health or Environmental Toxicant(s) DME0419 XEOTICID XEO01023 XEO_CLAS Environmental Pollutant DME0419 XEOTICID XEO01023 DESCRIPT Sodium arsenate inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO01023 GENEFORM Protein DME0419 XEOTICID XEO01023 MOACRIVE Inhibition DME0419 XEOTICID XEO01031 XEO_NAME Tris(1,3-dichloro-2-propyl)phosphate DME0419 XEOTICID XEO01031 XEO_TYPE Health or Environmental Toxicant(s) DME0419 XEOTICID XEO01031 XEO_CLAS Health Hazard/Toxicant DME0419 XEOTICID XEO01031 DESCRIPT Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME HSD11B2 DME0419 XEOTICID XEO01031 GENEFORM mRNA DME0419 XEOTICID XEO01031 MOACRIVE Induction DME0419 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0419 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0419 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0419 XEOTICID XEO01050 DESCRIPT Dicrotophos up-regulates the expression of DME HSD11B2 DME0419 XEOTICID XEO01050 GENEFORM mRNA DME0419 XEOTICID XEO01050 MOACRIVE Induction DME0419 XEOTICID XEO01098 XEO_NAME 18alpha-glycyrrhetinic acid DME0419 XEOTICID XEO01098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0419 XEOTICID XEO01098 XEO_CLAS Natural Product DME0419 XEOTICID XEO01098 DESCRIPT 18alpha-glycyrrhetinic acid inhibits the drug-metabolizing activity of DME HSD11B2 in Human embryonic kidney 293 cell (HEK293) (IC50 = 0.0012 microM) DME0419 XEOTICID XEO01098 GENEFORM Protein DME0419 XEOTICID XEO01098 MOACRIVE Inhibition DME0419 XEOTICID XEO01110 XEO_NAME p,p'-Hydroxy-DDT DME0419 XEOTICID XEO01110 XEO_TYPE Health or Environmental Toxicant(s) DME0419 XEOTICID XEO01110 XEO_CLAS Environmental Pollutant DME0419 XEOTICID XEO01110 DESCRIPT p,p'-Hydroxy-DDT inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO01110 GENEFORM Protein DME0419 XEOTICID XEO01110 MOACRIVE Inhibition DME0419 XEOTICID XEO01212 XEO_NAME Baicalein DME0419 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0419 XEOTICID XEO01212 XEO_CLAS Natural Product DME0419 XEOTICID XEO01212 DESCRIPT Baicalein induces the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO01212 GENEFORM Protein DME0419 XEOTICID XEO01212 MOACRIVE Induction DME0419 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0419 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0419 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO01226 GENEFORM Protein DME0419 XEOTICID XEO01226 MOACRIVE Inhibition DME0419 XEOTICID XEO01236 XEO_NAME Carbenoxolone DME0419 XEOTICID XEO01236 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO01236 XEO_CLAS Approved/Marketed Drug DME0419 XEOTICID XEO01236 DESCRIPT Carbenoxolone inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO01236 GENEFORM Protein DME0419 XEOTICID XEO01236 MOACRIVE Inhibition DME0419 XEOTICID XEO01275 XEO_NAME Dibutyl phthalate DME0419 XEOTICID XEO01275 XEO_TYPE Health or Environmental Toxicant(s) DME0419 XEOTICID XEO01275 XEO_CLAS Health Hazard/Toxicant DME0419 XEOTICID XEO01275 DESCRIPT Dibutyl phthalate inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO01275 GENEFORM Protein DME0419 XEOTICID XEO01275 MOACRIVE Inhibition DME0419 XEOTICID XEO01447 XEO_NAME Pyrrolidine dithiocarbamic acid DME0419 XEOTICID XEO01447 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO01447 XEO_CLAS Investigative Agent DME0419 XEOTICID XEO01447 DESCRIPT Pyrrolidine dithiocarbamic acid inhibits the expression of DME HSD11B2 DME0419 XEOTICID XEO01447 GENEFORM mRNA DME0419 XEOTICID XEO01447 MOACRIVE Inhibition DME0419 XEOTICID XEO01491 XEO_NAME Tributyltin DME0419 XEOTICID XEO01491 XEO_TYPE Pharmaceutical Agent(s) DME0419 XEOTICID XEO01491 XEO_CLAS Investigative Agent DME0419 XEOTICID XEO01491 DESCRIPT Tributyltin inhibits the drug-metabolizing activity of DME HSD11B2 DME0419 XEOTICID XEO01491 GENEFORM Protein DME0419 XEOTICID XEO01491 MOACRIVE Inhibition DME0419 XEOTICID XEO01503 XEO_NAME Cadmium DME0419 XEOTICID XEO01503 XEO_TYPE Health or Environmental Toxicant(s) DME0419 XEOTICID XEO01503 XEO_CLAS Acute Toxic Substance DME0419 XEOTICID XEO01503 DESCRIPT Cadmium inhibits the expression of DME HSD11B2 and leads to decreasing the drug-metabolizing activity of this enzyme DME0419 XEOTICID XEO01503 GENEFORM Protein DME0419 XEOTICID XEO01503 MOACRIVE Inhibition DME0420 DME___ID DME0420 DME0420 DME_NAME Estradiol 17-beta-dehydrogenase 1 (HSD17B1) DME0420 SPESNAME Homo sapiens DME0420 XEOTICID XEO00029 XEO_NAME Valproic acid DME0420 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0420 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME HSD17B1 DME0420 XEOTICID XEO00029 GENEFORM mRNA DME0420 XEOTICID XEO00029 MOACRIVE Inhibition DME0420 XEOTICID XEO00063 XEO_NAME Metyrapone DME0420 XEOTICID XEO00063 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO00063 XEO_CLAS Approved/Marketed Drug DME0420 XEOTICID XEO00063 DESCRIPT Metyrapone inhibits the expression of DME HSD17B1 DME0420 XEOTICID XEO00063 GENEFORM mRNA DME0420 XEOTICID XEO00063 MOACRIVE Inhibition DME0420 XEOTICID XEO00090 XEO_NAME Estradiol DME0420 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0420 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME HSD17B1 DME0420 XEOTICID XEO00090 GENEFORM mRNA DME0420 XEOTICID XEO00090 MOACRIVE Induction DME0420 XEOTICID XEO00104 XEO_NAME Perflubron DME0420 XEOTICID XEO00104 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO00104 XEO_CLAS Approved/Marketed Drug DME0420 XEOTICID XEO00104 DESCRIPT Perflubron up-regulates the expression of DME HSD17B1 DME0420 XEOTICID XEO00104 GENEFORM mRNA DME0420 XEOTICID XEO00104 MOACRIVE Induction DME0420 XEOTICID XEO00166 XEO_NAME Diethylstilbestrol DME0420 XEOTICID XEO00166 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO00166 XEO_CLAS Approved/Marketed Drug DME0420 XEOTICID XEO00166 DESCRIPT Diethylstilbestrol inhibits the expression of DME HSD17B1 DME0420 XEOTICID XEO00166 GENEFORM mRNA DME0420 XEOTICID XEO00166 MOACRIVE Inhibition DME0420 XEOTICID XEO00167 XEO_NAME Alitretinoin DME0420 XEOTICID XEO00167 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO00167 XEO_CLAS Approved/Marketed Drug DME0420 XEOTICID XEO00167 DESCRIPT Alitretinoin induces the drug-metabolizing activity of DME HSD17B1 DME0420 XEOTICID XEO00167 GENEFORM Protein DME0420 XEOTICID XEO00167 MOACRIVE Induction DME0420 XEOTICID XEO00192 XEO_NAME Dutasteride DME0420 XEOTICID XEO00192 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO00192 XEO_CLAS Approved/Marketed Drug DME0420 XEOTICID XEO00192 DESCRIPT Dutasteride up-regulates the expression of DME HSD17B1 DME0420 XEOTICID XEO00192 GENEFORM mRNA DME0420 XEOTICID XEO00192 MOACRIVE Induction DME0420 XEOTICID XEO00253 XEO_NAME Tretinoin DME0420 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0420 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the drug-metabolizing activity of DME HSD17B1 DME0420 XEOTICID XEO00253 GENEFORM Protein DME0420 XEOTICID XEO00253 MOACRIVE Inhibition DME0420 XEOTICID XEO00435 XEO_NAME Urethane DME0420 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0420 XEOTICID XEO00435 DESCRIPT Urethane inhibits the expression of DME HSD17B1 DME0420 XEOTICID XEO00435 GENEFORM mRNA DME0420 XEOTICID XEO00435 MOACRIVE Inhibition DME0420 XEOTICID XEO00446 XEO_NAME Methoxychlor DME0420 XEOTICID XEO00446 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO00446 XEO_CLAS Approved/Marketed Drug DME0420 XEOTICID XEO00446 DESCRIPT Methoxychlor inhibits the drug-metabolizing activity of DME HSD17B1 DME0420 XEOTICID XEO00446 GENEFORM Protein DME0420 XEOTICID XEO00446 MOACRIVE Inhibition DME0420 XEOTICID XEO00518 XEO_NAME Formestane DME0420 XEOTICID XEO00518 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO00518 XEO_CLAS Drug Marketed but Withdrawn from Market DME0420 XEOTICID XEO00518 DESCRIPT Formestane inhibits the drug-metabolizing activity of DME HSD17B1 DME0420 XEOTICID XEO00518 GENEFORM Protein DME0420 XEOTICID XEO00518 MOACRIVE Inhibition DME0420 XEOTICID XEO00557 XEO_NAME Genistein DME0420 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0420 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of DME HSD17B1 in Human embryonic kidney 293 cell (HEK293) (IC50 = 2.21 microM) DME0420 XEOTICID XEO00557 GENEFORM Protein DME0420 XEOTICID XEO00557 MOACRIVE Inhibition DME0420 XEOTICID XEO00606 XEO_NAME Colforsin DME0420 XEOTICID XEO00606 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO00606 XEO_CLAS Drug in Phase 2 Clinical Trial DME0420 XEOTICID XEO00606 DESCRIPT Colforsin up-regulates the expression of DME HSD17B1 DME0420 XEOTICID XEO00606 GENEFORM mRNA DME0420 XEOTICID XEO00606 MOACRIVE Induction DME0420 XEOTICID XEO00694 XEO_NAME LG-100268 DME0420 XEOTICID XEO00694 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO00694 XEO_CLAS Preclinical/Patented Drug DME0420 XEOTICID XEO00694 DESCRIPT LG-100268 induces the drug-metabolizing activity of DME HSD17B1 DME0420 XEOTICID XEO00694 GENEFORM Protein DME0420 XEOTICID XEO00694 MOACRIVE Induction DME0420 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0420 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0420 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0420 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME HSD17B1 DME0420 XEOTICID XEO00806 GENEFORM mRNA DME0420 XEOTICID XEO00806 MOACRIVE Induction DME0420 XEOTICID XEO00904 XEO_NAME Pentabromophenol DME0420 XEOTICID XEO00904 XEO_TYPE Health or Environmental Toxicant(s) DME0420 XEOTICID XEO00904 XEO_CLAS Acute Toxic Substance DME0420 XEOTICID XEO00904 DESCRIPT Pentabromophenol up-regulates the expression of DME HSD17B1 DME0420 XEOTICID XEO00904 GENEFORM mRNA DME0420 XEOTICID XEO00904 MOACRIVE Induction DME0420 XEOTICID XEO00959 XEO_NAME Triphenyltin hydroxide DME0420 XEOTICID XEO00959 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0420 XEOTICID XEO00959 XEO_CLAS Fungicide DME0420 XEOTICID XEO00959 DESCRIPT Triphenyltin hydroxide up-regulates the expression of DME HSD17B1 DME0420 XEOTICID XEO00959 GENEFORM mRNA DME0420 XEOTICID XEO00959 MOACRIVE Induction DME0420 XEOTICID XEO00961 XEO_NAME Triphenyltin chloride DME0420 XEOTICID XEO00961 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0420 XEOTICID XEO00961 XEO_CLAS Fungicide DME0420 XEOTICID XEO00961 DESCRIPT Triphenyltin chloride up-regulates the expression of DME HSD17B1 DME0420 XEOTICID XEO00961 GENEFORM mRNA DME0420 XEOTICID XEO00961 MOACRIVE Induction DME0420 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0420 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0420 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0420 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME HSD17B1 DME0420 XEOTICID XEO01004 GENEFORM mRNA DME0420 XEOTICID XEO01004 MOACRIVE Induction DME0420 XEOTICID XEO01040 XEO_NAME Bifenthrin DME0420 XEOTICID XEO01040 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0420 XEOTICID XEO01040 XEO_CLAS Pesticide/Insecticide DME0420 XEOTICID XEO01040 DESCRIPT Bifenthrin inhibits the expression of DME HSD17B1 DME0420 XEOTICID XEO01040 GENEFORM mRNA DME0420 XEOTICID XEO01040 MOACRIVE Inhibition DME0420 XEOTICID XEO01121 XEO_NAME 2-bromophenol DME0420 XEOTICID XEO01121 XEO_TYPE Health or Environmental Toxicant(s) DME0420 XEOTICID XEO01121 XEO_CLAS Environmental Pollutant DME0420 XEOTICID XEO01121 DESCRIPT 2-bromophenol up-regulates the expression of DME HSD17B1 DME0420 XEOTICID XEO01121 GENEFORM mRNA DME0420 XEOTICID XEO01121 MOACRIVE Induction DME0420 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0420 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0420 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME HSD17B1 DME0420 XEOTICID XEO01226 GENEFORM mRNA DME0420 XEOTICID XEO01226 MOACRIVE Inhibition DME0420 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0420 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0420 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0420 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME HSD17B1 DME0420 XEOTICID XEO01305 GENEFORM mRNA DME0420 XEOTICID XEO01305 MOACRIVE Inhibition DME0420 XEOTICID XEO01491 XEO_NAME Tributyltin DME0420 XEOTICID XEO01491 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO01491 XEO_CLAS Investigative Agent DME0420 XEOTICID XEO01491 DESCRIPT Tributyltin up-regulates the expression of DME HSD17B1 DME0420 XEOTICID XEO01491 GENEFORM mRNA DME0420 XEOTICID XEO01491 MOACRIVE Induction DME0420 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0420 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0420 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0420 XEOTICID XEO01492 DESCRIPT Trichostatin A inhibits the expression of DME HSD17B1 DME0420 XEOTICID XEO01492 GENEFORM mRNA DME0420 XEOTICID XEO01492 MOACRIVE Inhibition DME0420 XEOTICID XEO01515 XEO_NAME HT-2 toxin DME0420 XEOTICID XEO01515 XEO_TYPE Health or Environmental Toxicant(s) DME0420 XEOTICID XEO01515 XEO_CLAS Mycotoxin DME0420 XEOTICID XEO01515 DESCRIPT HT-2 toxin up-regulates the expression of DME HSD17B1 DME0420 XEOTICID XEO01515 GENEFORM mRNA DME0420 XEOTICID XEO01515 MOACRIVE Induction DME0421 DME___ID DME0421 DME0421 DME_NAME Ketoacyl-CoA reductase (HSD17B12) DME0421 SPESNAME Homo sapiens DME0421 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0421 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0421 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0421 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME HSD17B12 DME0421 XEOTICID XEO00186 GENEFORM mRNA DME0421 XEOTICID XEO00186 MOACRIVE Inhibition DME0421 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0421 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0421 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0421 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME HSD17B12 DME0421 XEOTICID XEO00241 GENEFORM mRNA DME0421 XEOTICID XEO00241 MOACRIVE Inhibition DME0421 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0421 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0421 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0421 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME HSD17B12 DME0421 XEOTICID XEO00292 GENEFORM mRNA DME0421 XEOTICID XEO00292 MOACRIVE Inhibition DME0421 XEOTICID XEO00557 XEO_NAME Genistein DME0421 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0421 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0421 XEOTICID XEO00557 DESCRIPT Genistein up-regulates the expression of DME HSD17B12 DME0421 XEOTICID XEO00557 GENEFORM mRNA DME0421 XEOTICID XEO00557 MOACRIVE Induction DME0421 XEOTICID XEO00760 XEO_NAME Jinfukang DME0421 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0421 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0421 XEOTICID XEO00760 DESCRIPT Jinfukang inhibits the expression of DME HSD17B12 DME0421 XEOTICID XEO00760 GENEFORM mRNA DME0421 XEOTICID XEO00760 MOACRIVE Inhibition DME0421 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0421 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0421 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0421 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate up-regulates the expression of DME HSD17B12 DME0421 XEOTICID XEO00772 GENEFORM mRNA DME0421 XEOTICID XEO00772 MOACRIVE Induction DME0421 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0421 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0421 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0421 XEOTICID XEO01305 DESCRIPT Formaldehyde up-regulates the expression of DME HSD17B12 DME0421 XEOTICID XEO01305 GENEFORM mRNA DME0421 XEOTICID XEO01305 MOACRIVE Induction DME0422 DME___ID DME0422 DME0422 DME_NAME Estradiol 17-beta-dehydrogenase 2 (HSD17B2) DME0422 SPESNAME Homo sapiens DME0422 XEOTICID XEO00053 XEO_NAME Leflunomide DME0422 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0422 XEOTICID XEO00053 DESCRIPT Leflunomide up-regulates the expression of DME HSD17B2 DME0422 XEOTICID XEO00053 GENEFORM mRNA DME0422 XEOTICID XEO00053 MOACRIVE Induction DME0422 XEOTICID XEO00090 XEO_NAME Estradiol DME0422 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0422 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO00090 GENEFORM mRNA DME0422 XEOTICID XEO00090 MOACRIVE Inhibition DME0422 XEOTICID XEO00095 XEO_NAME Testosterone DME0422 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0422 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME HSD17B2 DME0422 XEOTICID XEO00095 GENEFORM mRNA DME0422 XEOTICID XEO00095 MOACRIVE Induction DME0422 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0422 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0422 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO00117 GENEFORM mRNA DME0422 XEOTICID XEO00117 MOACRIVE Inhibition DME0422 XEOTICID XEO00184 XEO_NAME Calcitriol DME0422 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0422 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME HSD17B2 DME0422 XEOTICID XEO00184 GENEFORM mRNA DME0422 XEOTICID XEO00184 MOACRIVE Induction DME0422 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0422 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0422 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO00217 GENEFORM mRNA DME0422 XEOTICID XEO00217 MOACRIVE Inhibition DME0422 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0422 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0422 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO00241 GENEFORM mRNA DME0422 XEOTICID XEO00241 MOACRIVE Inhibition DME0422 XEOTICID XEO00253 XEO_NAME Tretinoin DME0422 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0422 XEOTICID XEO00253 DESCRIPT Tretinoin up-regulates the expression of DME HSD17B2 DME0422 XEOTICID XEO00253 GENEFORM mRNA DME0422 XEOTICID XEO00253 MOACRIVE Induction DME0422 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0422 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0422 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO00339 GENEFORM mRNA DME0422 XEOTICID XEO00339 MOACRIVE Inhibition DME0422 XEOTICID XEO00403 XEO_NAME Dydrogesterone DME0422 XEOTICID XEO00403 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00403 XEO_CLAS Approved/Marketed Drug DME0422 XEOTICID XEO00403 DESCRIPT Dydrogesterone induces the drug-metabolizing activity of DME HSD17B2 DME0422 XEOTICID XEO00403 GENEFORM Protein DME0422 XEOTICID XEO00403 MOACRIVE Induction DME0422 XEOTICID XEO00430 XEO_NAME Hydroquinone DME0422 XEOTICID XEO00430 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00430 XEO_CLAS Approved/Marketed Drug DME0422 XEOTICID XEO00430 DESCRIPT Hydroquinone up-regulates the expression of DME HSD17B2 DME0422 XEOTICID XEO00430 GENEFORM mRNA DME0422 XEOTICID XEO00430 MOACRIVE Induction DME0422 XEOTICID XEO00433 XEO_NAME Dienogest DME0422 XEOTICID XEO00433 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00433 XEO_CLAS Approved/Marketed Drug DME0422 XEOTICID XEO00433 DESCRIPT Dienogest inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO00433 GENEFORM mRNA DME0422 XEOTICID XEO00433 MOACRIVE Inhibition DME0422 XEOTICID XEO00538 XEO_NAME Quercetin DME0422 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0422 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of DME HSD17B2 in Human embryonic kidney 293 cell (HEK293) (IC50 = 1.54 microM) DME0422 XEOTICID XEO00538 GENEFORM Protein DME0422 XEOTICID XEO00538 MOACRIVE Inhibition DME0422 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0422 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0422 XEOTICID XEO00632 DESCRIPT Sodium arsenite inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO00632 GENEFORM mRNA DME0422 XEOTICID XEO00632 MOACRIVE Inhibition DME0422 XEOTICID XEO00657 XEO_NAME Antimony DME0422 XEOTICID XEO00657 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00657 XEO_CLAS Drug in Phase 2 Clinical Trial DME0422 XEOTICID XEO00657 DESCRIPT Antimony inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO00657 GENEFORM mRNA DME0422 XEOTICID XEO00657 MOACRIVE Inhibition DME0422 XEOTICID XEO00667 XEO_NAME PD-0325901 DME0422 XEOTICID XEO00667 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00667 XEO_CLAS Drug in Phase 2 Clinical Trial DME0422 XEOTICID XEO00667 DESCRIPT PD-0325901 inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO00667 GENEFORM mRNA DME0422 XEOTICID XEO00667 MOACRIVE Inhibition DME0422 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0422 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0422 XEOTICID XEO00723 DESCRIPT (+)-JQ1 inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO00723 GENEFORM mRNA DME0422 XEOTICID XEO00723 MOACRIVE Inhibition DME0422 XEOTICID XEO00743 XEO_NAME Medroxyprogesterone acetate DME0422 XEOTICID XEO00743 XEO_TYPE Pharmaceutical Agent(s) DME0422 XEOTICID XEO00743 XEO_CLAS Approved/Marketed Drug DME0422 XEOTICID XEO00743 DESCRIPT Medroxyprogesterone acetate inhibits the drug-metabolizing activity of DME HSD17B2 DME0422 XEOTICID XEO00743 GENEFORM Protein DME0422 XEOTICID XEO00743 MOACRIVE Inhibition DME0422 XEOTICID XEO00821 XEO_NAME Tobacco smoke pollution DME0422 XEOTICID XEO00821 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0422 XEOTICID XEO00821 XEO_CLAS Natural Mixture DME0422 XEOTICID XEO00821 DESCRIPT Tobacco smoke pollution inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO00821 GENEFORM mRNA DME0422 XEOTICID XEO00821 MOACRIVE Inhibition DME0422 XEOTICID XEO00824 XEO_NAME Boron compound DME0422 XEOTICID XEO00824 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0422 XEOTICID XEO00824 XEO_CLAS Pesticide/Insecticide DME0422 XEOTICID XEO00824 DESCRIPT Boron compound inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO00824 GENEFORM mRNA DME0422 XEOTICID XEO00824 MOACRIVE Inhibition DME0422 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0422 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0422 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0422 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME HSD17B2 DME0422 XEOTICID XEO00898 GENEFORM mRNA DME0422 XEOTICID XEO00898 MOACRIVE Induction DME0422 XEOTICID XEO00919 XEO_NAME Particulate matter DME0422 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0422 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0422 XEOTICID XEO00919 DESCRIPT Particulate matter up-regulates the expression of DME HSD17B2 DME0422 XEOTICID XEO00919 GENEFORM mRNA DME0422 XEOTICID XEO00919 MOACRIVE Induction DME0422 XEOTICID XEO00973 XEO_NAME Diuron DME0422 XEOTICID XEO00973 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0422 XEOTICID XEO00973 XEO_CLAS Herbicide DME0422 XEOTICID XEO00973 DESCRIPT Diuron up-regulates the expression of DME HSD17B2 DME0422 XEOTICID XEO00973 GENEFORM mRNA DME0422 XEOTICID XEO00973 MOACRIVE Induction DME0422 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0422 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0422 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0422 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO01004 GENEFORM mRNA DME0422 XEOTICID XEO01004 MOACRIVE Inhibition DME0422 XEOTICID XEO01006 XEO_NAME Dimethyl nitrosamine DME0422 XEOTICID XEO01006 XEO_TYPE Health or Environmental Toxicant(s) DME0422 XEOTICID XEO01006 XEO_CLAS Carcinogen DME0422 XEOTICID XEO01006 DESCRIPT Dimethyl nitrosamine inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO01006 GENEFORM mRNA DME0422 XEOTICID XEO01006 MOACRIVE Inhibition DME0422 XEOTICID XEO01201 XEO_NAME Antimony potassium tartrate DME0422 XEOTICID XEO01201 XEO_TYPE Health or Environmental Toxicant(s) DME0422 XEOTICID XEO01201 XEO_CLAS Environmental Pollutant DME0422 XEOTICID XEO01201 DESCRIPT Antimony potassium tartrate inhibits the expression of DME HSD17B2 DME0422 XEOTICID XEO01201 GENEFORM mRNA DME0422 XEOTICID XEO01201 MOACRIVE Inhibition DME0423 DME___ID DME0423 DME0423 DME_NAME Testicular 17-beta-hydroxysteroid dehydrogenase (HSD17B3) DME0423 SPESNAME Homo sapiens DME0423 XEOTICID XEO00192 XEO_NAME Dutasteride DME0423 XEOTICID XEO00192 XEO_TYPE Pharmaceutical Agent(s) DME0423 XEOTICID XEO00192 XEO_CLAS Approved/Marketed Drug DME0423 XEOTICID XEO00192 DESCRIPT Dutasteride up-regulates the expression of DME HSD17B3 DME0423 XEOTICID XEO00192 GENEFORM mRNA DME0423 XEOTICID XEO00192 MOACRIVE Induction DME0423 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0423 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0423 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0423 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME HSD17B3 DME0423 XEOTICID XEO00217 GENEFORM mRNA DME0423 XEOTICID XEO00217 MOACRIVE Inhibition DME0423 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0423 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0423 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0423 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME HSD17B3 DME0423 XEOTICID XEO00241 GENEFORM mRNA DME0423 XEOTICID XEO00241 MOACRIVE Inhibition DME0423 XEOTICID XEO00820 XEO_NAME Tobacco tar DME0423 XEOTICID XEO00820 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0423 XEOTICID XEO00820 XEO_CLAS Natural Mixture DME0423 XEOTICID XEO00820 DESCRIPT Tobacco tar inhibits the expression of DME HSD17B3 DME0423 XEOTICID XEO00820 GENEFORM mRNA DME0423 XEOTICID XEO00820 MOACRIVE Inhibition DME0423 XEOTICID XEO01110 XEO_NAME p,p'-Hydroxy-DDT DME0423 XEOTICID XEO01110 XEO_TYPE Health or Environmental Toxicant(s) DME0423 XEOTICID XEO01110 XEO_CLAS Environmental Pollutant DME0423 XEOTICID XEO01110 DESCRIPT p,p'-Hydroxy-DDT inhibits the drug-metabolizing activity of DME HSD17B3 DME0423 XEOTICID XEO01110 GENEFORM Protein DME0423 XEOTICID XEO01110 MOACRIVE Inhibition DME0423 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0423 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0423 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0423 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the drug-metabolizing activity of DME HSD17B3 DME0423 XEOTICID XEO01226 GENEFORM Protein DME0423 XEOTICID XEO01226 MOACRIVE Inhibition DME0423 XEOTICID XEO01302 XEO_NAME Fipronil DME0423 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0423 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0423 XEOTICID XEO01302 DESCRIPT Fipronil inhibits the expression of DME HSD17B3 DME0423 XEOTICID XEO01302 GENEFORM mRNA DME0423 XEOTICID XEO01302 MOACRIVE Inhibition DME0424 DME___ID DME0424 DME0424 DME_NAME Keto-steroid reductase (HSD17B7) DME0424 SPESNAME Homo sapiens DME0424 XEOTICID XEO00090 XEO_NAME Estradiol DME0424 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0424 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0424 XEOTICID XEO00090 DESCRIPT Estradiol inhibits the expression of DME HSD17B7 DME0424 XEOTICID XEO00090 GENEFORM mRNA DME0424 XEOTICID XEO00090 MOACRIVE Inhibition DME0424 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0424 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0424 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0424 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME HSD17B7 DME0424 XEOTICID XEO00117 GENEFORM mRNA DME0424 XEOTICID XEO00117 MOACRIVE Inhibition DME0424 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0424 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0424 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0424 XEOTICID XEO00165 DESCRIPT Obeticholic acid inhibits the drug-metabolizing activity of DME HSD17B7 DME0424 XEOTICID XEO00165 GENEFORM Protein DME0424 XEOTICID XEO00165 MOACRIVE Inhibition DME0424 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0424 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0424 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0424 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME HSD17B7 DME0424 XEOTICID XEO00186 GENEFORM mRNA DME0424 XEOTICID XEO00186 MOACRIVE Inhibition DME0424 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0424 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0424 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0424 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME HSD17B7 DME0424 XEOTICID XEO00217 GENEFORM mRNA DME0424 XEOTICID XEO00217 MOACRIVE Inhibition DME0424 XEOTICID XEO00253 XEO_NAME Tretinoin DME0424 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0424 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0424 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME HSD17B7 DME0424 XEOTICID XEO00253 GENEFORM mRNA DME0424 XEOTICID XEO00253 MOACRIVE Inhibition DME0424 XEOTICID XEO00334 XEO_NAME Cisplatin DME0424 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0424 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0424 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME HSD17B7 DME0424 XEOTICID XEO00334 GENEFORM mRNA DME0424 XEOTICID XEO00334 MOACRIVE Induction DME0424 XEOTICID XEO00435 XEO_NAME Urethane DME0424 XEOTICID XEO00435 XEO_TYPE Pharmaceutical Agent(s) DME0424 XEOTICID XEO00435 XEO_CLAS Approved/Marketed Drug DME0424 XEOTICID XEO00435 DESCRIPT Urethane up-regulates the expression of DME HSD17B7 DME0424 XEOTICID XEO00435 GENEFORM mRNA DME0424 XEOTICID XEO00435 MOACRIVE Induction DME0424 XEOTICID XEO00657 XEO_NAME Antimony DME0424 XEOTICID XEO00657 XEO_TYPE Pharmaceutical Agent(s) DME0424 XEOTICID XEO00657 XEO_CLAS Drug in Phase 2 Clinical Trial DME0424 XEOTICID XEO00657 DESCRIPT Antimony inhibits the expression of DME HSD17B7 DME0424 XEOTICID XEO00657 GENEFORM mRNA DME0424 XEOTICID XEO00657 MOACRIVE Inhibition DME0424 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0424 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0424 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0424 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME HSD17B7 DME0424 XEOTICID XEO00898 GENEFORM mRNA DME0424 XEOTICID XEO00898 MOACRIVE Inhibition DME0424 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0424 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0424 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0424 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate up-regulates the expression of DME HSD17B7 DME0424 XEOTICID XEO01004 GENEFORM mRNA DME0424 XEOTICID XEO01004 MOACRIVE Induction DME0424 XEOTICID XEO01006 XEO_NAME Dimethyl nitrosamine DME0424 XEOTICID XEO01006 XEO_TYPE Health or Environmental Toxicant(s) DME0424 XEOTICID XEO01006 XEO_CLAS Carcinogen DME0424 XEOTICID XEO01006 DESCRIPT Dimethyl nitrosamine inhibits the expression of DME HSD17B7 DME0424 XEOTICID XEO01006 GENEFORM mRNA DME0424 XEOTICID XEO01006 MOACRIVE Inhibition DME0424 XEOTICID XEO01201 XEO_NAME Antimony potassium tartrate DME0424 XEOTICID XEO01201 XEO_TYPE Health or Environmental Toxicant(s) DME0424 XEOTICID XEO01201 XEO_CLAS Environmental Pollutant DME0424 XEOTICID XEO01201 DESCRIPT Antimony potassium tartrate inhibits the expression of DME HSD17B7 DME0424 XEOTICID XEO01201 GENEFORM mRNA DME0424 XEOTICID XEO01201 MOACRIVE Inhibition DME0424 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0424 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0424 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0424 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME HSD17B7 DME0424 XEOTICID XEO01220 GENEFORM mRNA DME0424 XEOTICID XEO01220 MOACRIVE Inhibition DME0424 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0424 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0424 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0424 XEOTICID XEO01247 DESCRIPT Chloropicrin up-regulates the expression of DME HSD17B7 DME0424 XEOTICID XEO01247 GENEFORM mRNA DME0424 XEOTICID XEO01247 MOACRIVE Induction DME0424 XEOTICID XEO01299 XEO_NAME Fatostatin DME0424 XEOTICID XEO01299 XEO_TYPE Health or Environmental Toxicant(s) DME0424 XEOTICID XEO01299 XEO_CLAS Acute Toxic Substance DME0424 XEOTICID XEO01299 DESCRIPT Fatostatin inhibits the expression of DME HSD17B7 DME0424 XEOTICID XEO01299 GENEFORM mRNA DME0424 XEOTICID XEO01299 MOACRIVE Inhibition DME0424 XEOTICID XEO01302 XEO_NAME Fipronil DME0424 XEOTICID XEO01302 XEO_TYPE Health or Environmental Toxicant(s) DME0424 XEOTICID XEO01302 XEO_CLAS Acute Toxic Substance DME0424 XEOTICID XEO01302 DESCRIPT Fipronil up-regulates the expression of DME HSD17B7 DME0424 XEOTICID XEO01302 GENEFORM mRNA DME0424 XEOTICID XEO01302 MOACRIVE Induction DME0424 XEOTICID XEO01336 XEO_NAME ICG-001 DME0424 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0424 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0424 XEOTICID XEO01336 DESCRIPT ICG-001 up-regulates the expression of DME HSD17B7 DME0424 XEOTICID XEO01336 GENEFORM mRNA DME0424 XEOTICID XEO01336 MOACRIVE Induction DME0424 XEOTICID XEO01348 XEO_NAME K-7174 DME0424 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0424 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0424 XEOTICID XEO01348 DESCRIPT K-7174 inhibits the expression of DME HSD17B7 DME0424 XEOTICID XEO01348 GENEFORM mRNA DME0424 XEOTICID XEO01348 MOACRIVE Inhibition DME0424 XEOTICID XEO01436 XEO_NAME PP242 DME0424 XEOTICID XEO01436 XEO_TYPE Pharmaceutical Agent(s) DME0424 XEOTICID XEO01436 XEO_CLAS Investigative Agent DME0424 XEOTICID XEO01436 DESCRIPT PP242 inhibits the expression of DME HSD17B7 DME0424 XEOTICID XEO01436 GENEFORM mRNA DME0424 XEOTICID XEO01436 MOACRIVE Inhibition DME0425 DME___ID DME0425 DME0425 DME_NAME Methylsterol monooxygenase 1 (MSMO1) DME0425 SPESNAME Homo sapiens DME0425 XEOTICID XEO00007 XEO_NAME Azathioprine DME0425 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00007 DESCRIPT Azathioprine inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00007 GENEFORM mRNA DME0425 XEOTICID XEO00007 MOACRIVE Inhibition DME0425 XEOTICID XEO00029 XEO_NAME Valproic acid DME0425 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00029 DESCRIPT Valproic acid inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00029 GENEFORM mRNA DME0425 XEOTICID XEO00029 MOACRIVE Inhibition DME0425 XEOTICID XEO00047 XEO_NAME Indomethacin DME0425 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00047 DESCRIPT Indomethacin up-regulates the expression of DME MSMO1 DME0425 XEOTICID XEO00047 GENEFORM mRNA DME0425 XEOTICID XEO00047 MOACRIVE Induction DME0425 XEOTICID XEO00053 XEO_NAME Leflunomide DME0425 XEOTICID XEO00053 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00053 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00053 DESCRIPT Leflunomide inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00053 GENEFORM mRNA DME0425 XEOTICID XEO00053 MOACRIVE Inhibition DME0425 XEOTICID XEO00094 XEO_NAME Progesterone DME0425 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00094 DESCRIPT Progesterone induces the drug-metabolizing activity of DME MSMO1 DME0425 XEOTICID XEO00094 GENEFORM Protein DME0425 XEOTICID XEO00094 MOACRIVE Induction DME0425 XEOTICID XEO00095 XEO_NAME Testosterone DME0425 XEOTICID XEO00095 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00095 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00095 DESCRIPT Testosterone up-regulates the expression of DME MSMO1 DME0425 XEOTICID XEO00095 GENEFORM mRNA DME0425 XEOTICID XEO00095 MOACRIVE Induction DME0425 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0425 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00117 GENEFORM mRNA DME0425 XEOTICID XEO00117 MOACRIVE Inhibition DME0425 XEOTICID XEO00168 XEO_NAME Decitabine DME0425 XEOTICID XEO00168 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00168 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00168 DESCRIPT Decitabine inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00168 GENEFORM mRNA DME0425 XEOTICID XEO00168 MOACRIVE Inhibition DME0425 XEOTICID XEO00178 XEO_NAME Capsaicin DME0425 XEOTICID XEO00178 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00178 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00178 DESCRIPT Capsaicin up-regulates the expression of DME MSMO1 DME0425 XEOTICID XEO00178 GENEFORM mRNA DME0425 XEOTICID XEO00178 MOACRIVE Induction DME0425 XEOTICID XEO00184 XEO_NAME Calcitriol DME0425 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME MSMO1 DME0425 XEOTICID XEO00184 GENEFORM mRNA DME0425 XEOTICID XEO00184 MOACRIVE Induction DME0425 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0425 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00186 GENEFORM mRNA DME0425 XEOTICID XEO00186 MOACRIVE Inhibition DME0425 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0425 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00217 GENEFORM mRNA DME0425 XEOTICID XEO00217 MOACRIVE Inhibition DME0425 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0425 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00241 GENEFORM mRNA DME0425 XEOTICID XEO00241 MOACRIVE Inhibition DME0425 XEOTICID XEO00253 XEO_NAME Tretinoin DME0425 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00253 GENEFORM mRNA DME0425 XEOTICID XEO00253 MOACRIVE Inhibition DME0425 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0425 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00292 GENEFORM mRNA DME0425 XEOTICID XEO00292 MOACRIVE Inhibition DME0425 XEOTICID XEO00334 XEO_NAME Cisplatin DME0425 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00334 GENEFORM mRNA DME0425 XEOTICID XEO00334 MOACRIVE Inhibition DME0425 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0425 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0425 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00339 GENEFORM mRNA DME0425 XEOTICID XEO00339 MOACRIVE Inhibition DME0425 XEOTICID XEO00536 XEO_NAME Dihydrotestosterone DME0425 XEOTICID XEO00536 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00536 XEO_CLAS Drug in Phase 1 Clinical Trial DME0425 XEOTICID XEO00536 DESCRIPT Dihydrotestosterone up-regulates the expression of DME MSMO1 DME0425 XEOTICID XEO00536 GENEFORM mRNA DME0425 XEOTICID XEO00536 MOACRIVE Induction DME0425 XEOTICID XEO00545 XEO_NAME Lucanthone DME0425 XEOTICID XEO00545 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00545 XEO_CLAS Drug in Phase 2 Clinical Trial DME0425 XEOTICID XEO00545 DESCRIPT Lucanthone up-regulates the expression of DME MSMO1 DME0425 XEOTICID XEO00545 GENEFORM mRNA DME0425 XEOTICID XEO00545 MOACRIVE Induction DME0425 XEOTICID XEO00568 XEO_NAME Resveratrol DME0425 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME0425 XEOTICID XEO00568 DESCRIPT Resveratrol up-regulates the expression of DME MSMO1 DME0425 XEOTICID XEO00568 GENEFORM mRNA DME0425 XEOTICID XEO00568 MOACRIVE Induction DME0425 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0425 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0425 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME MSMO1 DME0425 XEOTICID XEO00632 GENEFORM mRNA DME0425 XEOTICID XEO00632 MOACRIVE Induction DME0425 XEOTICID XEO00721 XEO_NAME MRK-003 DME0425 XEOTICID XEO00721 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO00721 XEO_CLAS Preclinical/Patented Drug DME0425 XEOTICID XEO00721 DESCRIPT MRK-003 inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00721 GENEFORM mRNA DME0425 XEOTICID XEO00721 MOACRIVE Inhibition DME0425 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0425 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0425 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0425 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00772 GENEFORM mRNA DME0425 XEOTICID XEO00772 MOACRIVE Inhibition DME0425 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0425 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0425 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0425 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00806 GENEFORM mRNA DME0425 XEOTICID XEO00806 MOACRIVE Inhibition DME0425 XEOTICID XEO00809 XEO_NAME Thapsigargin DME0425 XEOTICID XEO00809 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0425 XEOTICID XEO00809 XEO_CLAS Natural Product DME0425 XEOTICID XEO00809 DESCRIPT Thapsigargin inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00809 GENEFORM mRNA DME0425 XEOTICID XEO00809 MOACRIVE Inhibition DME0425 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0425 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0425 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0425 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00898 GENEFORM mRNA DME0425 XEOTICID XEO00898 MOACRIVE Inhibition DME0425 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0425 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0425 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0425 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO00905 GENEFORM mRNA DME0425 XEOTICID XEO00905 MOACRIVE Inhibition DME0425 XEOTICID XEO01004 XEO_NAME Diethylhexyl phthalate DME0425 XEOTICID XEO01004 XEO_TYPE Health or Environmental Toxicant(s) DME0425 XEOTICID XEO01004 XEO_CLAS Health Hazard/Toxicant DME0425 XEOTICID XEO01004 DESCRIPT Diethylhexyl phthalate inhibits the drug-metabolizing activity of DME MSMO1 DME0425 XEOTICID XEO01004 GENEFORM Protein DME0425 XEOTICID XEO01004 MOACRIVE Inhibition DME0425 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0425 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0425 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0425 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO01050 GENEFORM mRNA DME0425 XEOTICID XEO01050 MOACRIVE Inhibition DME0425 XEOTICID XEO01205 XEO_NAME Archazolid B DME0425 XEOTICID XEO01205 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO01205 XEO_CLAS Investigative Agent DME0425 XEOTICID XEO01205 DESCRIPT Archazolid B up-regulates the expression of DME MSMO1 DME0425 XEOTICID XEO01205 GENEFORM mRNA DME0425 XEOTICID XEO01205 MOACRIVE Induction DME0425 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0425 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0425 XEOTICID XEO01226 DESCRIPT Bisphenol A up-regulates the expression of DME MSMO1 DME0425 XEOTICID XEO01226 GENEFORM mRNA DME0425 XEOTICID XEO01226 MOACRIVE Induction DME0425 XEOTICID XEO01299 XEO_NAME Fatostatin DME0425 XEOTICID XEO01299 XEO_TYPE Health or Environmental Toxicant(s) DME0425 XEOTICID XEO01299 XEO_CLAS Acute Toxic Substance DME0425 XEOTICID XEO01299 DESCRIPT Fatostatin inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO01299 GENEFORM mRNA DME0425 XEOTICID XEO01299 MOACRIVE Inhibition DME0425 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0425 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0425 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0425 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO01305 GENEFORM mRNA DME0425 XEOTICID XEO01305 MOACRIVE Inhibition DME0425 XEOTICID XEO01310 XEO_NAME Ganoderic acid A DME0425 XEOTICID XEO01310 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0425 XEOTICID XEO01310 XEO_CLAS Natural Product DME0425 XEOTICID XEO01310 DESCRIPT Ganoderic acid A inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO01310 GENEFORM mRNA DME0425 XEOTICID XEO01310 MOACRIVE Inhibition DME0425 XEOTICID XEO01311 XEO_NAME Gedunin DME0425 XEOTICID XEO01311 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0425 XEOTICID XEO01311 XEO_CLAS Natural Product DME0425 XEOTICID XEO01311 DESCRIPT Gedunin up-regulates the expression of DME MSMO1 DME0425 XEOTICID XEO01311 GENEFORM mRNA DME0425 XEOTICID XEO01311 MOACRIVE Induction DME0425 XEOTICID XEO01336 XEO_NAME ICG-001 DME0425 XEOTICID XEO01336 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO01336 XEO_CLAS Preclinical/Patented Drug DME0425 XEOTICID XEO01336 DESCRIPT ICG-001 inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO01336 GENEFORM mRNA DME0425 XEOTICID XEO01336 MOACRIVE Inhibition DME0425 XEOTICID XEO01397 XEO_NAME Nickel chloride DME0425 XEOTICID XEO01397 XEO_TYPE Health or Environmental Toxicant(s) DME0425 XEOTICID XEO01397 XEO_CLAS Acute Toxic Substance DME0425 XEOTICID XEO01397 DESCRIPT Nickel chloride inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO01397 GENEFORM mRNA DME0425 XEOTICID XEO01397 MOACRIVE Inhibition DME0425 XEOTICID XEO01419 XEO_NAME Oxyquinoline DME0425 XEOTICID XEO01419 XEO_TYPE Health or Environmental Toxicant(s) DME0425 XEOTICID XEO01419 XEO_CLAS Acute Toxic Substance DME0425 XEOTICID XEO01419 DESCRIPT Oxyquinoline inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO01419 GENEFORM mRNA DME0425 XEOTICID XEO01419 MOACRIVE Inhibition DME0425 XEOTICID XEO01436 XEO_NAME PP242 DME0425 XEOTICID XEO01436 XEO_TYPE Pharmaceutical Agent(s) DME0425 XEOTICID XEO01436 XEO_CLAS Investigative Agent DME0425 XEOTICID XEO01436 DESCRIPT PP242 inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO01436 GENEFORM mRNA DME0425 XEOTICID XEO01436 MOACRIVE Inhibition DME0425 XEOTICID XEO01494 XEO_NAME Tunicamycin A DME0425 XEOTICID XEO01494 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0425 XEOTICID XEO01494 XEO_CLAS Natural Product DME0425 XEOTICID XEO01494 DESCRIPT Tunicamycin A inhibits the expression of DME MSMO1 DME0425 XEOTICID XEO01494 GENEFORM mRNA DME0425 XEOTICID XEO01494 MOACRIVE Inhibition DME0426 DME___ID DME0426 DME0426 DME_NAME Methylarsonite methyltransferase N6AMT1 (N6AMT1) DME0426 SPESNAME Homo sapiens DME0426 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0426 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0426 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0426 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME N6AMT1 DME0426 XEOTICID XEO00241 GENEFORM mRNA DME0426 XEOTICID XEO00241 MOACRIVE Inhibition DME0426 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0426 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0426 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0426 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME N6AMT1 DME0426 XEOTICID XEO00292 GENEFORM mRNA DME0426 XEOTICID XEO00292 MOACRIVE Inhibition DME0426 XEOTICID XEO00538 XEO_NAME Quercetin DME0426 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME0426 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME0426 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the expression of DME N6AMT1 DME0426 XEOTICID XEO00538 GENEFORM mRNA DME0426 XEOTICID XEO00538 MOACRIVE Inhibition DME0426 XEOTICID XEO00723 XEO_NAME (+)-JQ1 DME0426 XEOTICID XEO00723 XEO_TYPE Pharmaceutical Agent(s) DME0426 XEOTICID XEO00723 XEO_CLAS Preclinical/Patented Drug DME0426 XEOTICID XEO00723 DESCRIPT (+)-JQ1 up-regulates the expression of DME N6AMT1 DME0426 XEOTICID XEO00723 GENEFORM mRNA DME0426 XEOTICID XEO00723 MOACRIVE Induction DME0426 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0426 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0426 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0426 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME N6AMT1 DME0426 XEOTICID XEO00772 GENEFORM mRNA DME0426 XEOTICID XEO00772 MOACRIVE Inhibition DME0426 XEOTICID XEO00905 XEO_NAME Cylindrospermopsin DME0426 XEOTICID XEO00905 XEO_TYPE Health or Environmental Toxicant(s) DME0426 XEOTICID XEO00905 XEO_CLAS Biotoxin DME0426 XEOTICID XEO00905 DESCRIPT Cylindrospermopsin up-regulates the expression of DME N6AMT1 DME0426 XEOTICID XEO00905 GENEFORM mRNA DME0426 XEOTICID XEO00905 MOACRIVE Induction DME0426 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0426 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0426 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0426 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME N6AMT1 DME0426 XEOTICID XEO01050 GENEFORM mRNA DME0426 XEOTICID XEO01050 MOACRIVE Inhibition DME0426 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0426 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0426 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0426 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME N6AMT1 DME0426 XEOTICID XEO01305 GENEFORM mRNA DME0426 XEOTICID XEO01305 MOACRIVE Inhibition DME0426 XEOTICID XEO01453 XEO_NAME Resorcinol DME0426 XEOTICID XEO01453 XEO_TYPE Health or Environmental Toxicant(s) DME0426 XEOTICID XEO01453 XEO_CLAS Environmental Pollutant DME0426 XEOTICID XEO01453 DESCRIPT Resorcinol inhibits the expression of DME N6AMT1 DME0426 XEOTICID XEO01453 GENEFORM mRNA DME0426 XEOTICID XEO01453 MOACRIVE Inhibition DME0427 DME___ID DME0427 DME0427 DME_NAME Mevalonate pyrophosphate decarboxylase (MPD) DME0427 SPESNAME Homo sapiens DME0427 XEOTICID XEO00012 XEO_NAME Carmustine DME0427 XEOTICID XEO00012 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00012 XEO_CLAS Approved/Marketed Drug DME0427 XEOTICID XEO00012 DESCRIPT Carmustine inhibits the expression of DME MVD DME0427 XEOTICID XEO00012 GENEFORM mRNA DME0427 XEOTICID XEO00012 MOACRIVE Inhibition DME0427 XEOTICID XEO00013 XEO_NAME Celecoxib DME0427 XEOTICID XEO00013 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00013 XEO_CLAS Approved/Marketed Drug DME0427 XEOTICID XEO00013 DESCRIPT Celecoxib inhibits the drug-metabolizing activity of DME MVD DME0427 XEOTICID XEO00013 GENEFORM Protein DME0427 XEOTICID XEO00013 MOACRIVE Inhibition DME0427 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0427 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0427 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME MVD DME0427 XEOTICID XEO00117 GENEFORM mRNA DME0427 XEOTICID XEO00117 MOACRIVE Inhibition DME0427 XEOTICID XEO00140 XEO_NAME Zoledronic acid DME0427 XEOTICID XEO00140 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00140 XEO_CLAS Approved/Marketed Drug DME0427 XEOTICID XEO00140 DESCRIPT Zoledronic acid up-regulates the expression of DME MVD DME0427 XEOTICID XEO00140 GENEFORM mRNA DME0427 XEOTICID XEO00140 MOACRIVE Induction DME0427 XEOTICID XEO00165 XEO_NAME Obeticholic acid DME0427 XEOTICID XEO00165 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00165 XEO_CLAS Approved/Marketed Drug DME0427 XEOTICID XEO00165 DESCRIPT Obeticholic acid inhibits the drug-metabolizing activity of DME MVD DME0427 XEOTICID XEO00165 GENEFORM Protein DME0427 XEOTICID XEO00165 MOACRIVE Inhibition DME0427 XEOTICID XEO00186 XEO_NAME Isotretinoin DME0427 XEOTICID XEO00186 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00186 XEO_CLAS Approved/Marketed Drug DME0427 XEOTICID XEO00186 DESCRIPT Isotretinoin inhibits the expression of DME MVD DME0427 XEOTICID XEO00186 GENEFORM mRNA DME0427 XEOTICID XEO00186 MOACRIVE Inhibition DME0427 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0427 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0427 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME MVD DME0427 XEOTICID XEO00217 GENEFORM mRNA DME0427 XEOTICID XEO00217 MOACRIVE Induction DME0427 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0427 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0427 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME MVD DME0427 XEOTICID XEO00241 GENEFORM mRNA DME0427 XEOTICID XEO00241 MOACRIVE Inhibition DME0427 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0427 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0427 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME MVD DME0427 XEOTICID XEO00292 GENEFORM mRNA DME0427 XEOTICID XEO00292 MOACRIVE Inhibition DME0427 XEOTICID XEO00334 XEO_NAME Cisplatin DME0427 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0427 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME MVD DME0427 XEOTICID XEO00334 GENEFORM mRNA DME0427 XEOTICID XEO00334 MOACRIVE Inhibition DME0427 XEOTICID XEO00411 XEO_NAME Avobenzone DME0427 XEOTICID XEO00411 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00411 XEO_CLAS Approved/Marketed Drug DME0427 XEOTICID XEO00411 DESCRIPT Avobenzone up-regulates the expression of DME MVD DME0427 XEOTICID XEO00411 GENEFORM mRNA DME0427 XEOTICID XEO00411 MOACRIVE Induction DME0427 XEOTICID XEO00461 XEO_NAME Arbutin DME0427 XEOTICID XEO00461 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00461 XEO_CLAS Approved/Marketed Drug DME0427 XEOTICID XEO00461 DESCRIPT Arbutin inhibits the expression of DME MVD DME0427 XEOTICID XEO00461 GENEFORM mRNA DME0427 XEOTICID XEO00461 MOACRIVE Inhibition DME0427 XEOTICID XEO00557 XEO_NAME Genistein DME0427 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME0427 XEOTICID XEO00557 DESCRIPT Genistein inhibits the expression of DME MVD DME0427 XEOTICID XEO00557 GENEFORM mRNA DME0427 XEOTICID XEO00557 MOACRIVE Inhibition DME0427 XEOTICID XEO00683 XEO_NAME Curcumin DME0427 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME0427 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the expression of DME MVD DME0427 XEOTICID XEO00683 GENEFORM mRNA DME0427 XEOTICID XEO00683 MOACRIVE Inhibition DME0427 XEOTICID XEO00720 XEO_NAME SGA-360 DME0427 XEOTICID XEO00720 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO00720 XEO_CLAS Preclinical/Patented Drug DME0427 XEOTICID XEO00720 DESCRIPT SGA-360 inhibits the expression of DME MVD DME0427 XEOTICID XEO00720 GENEFORM mRNA DME0427 XEOTICID XEO00720 MOACRIVE Inhibition DME0427 XEOTICID XEO00760 XEO_NAME Jinfukang DME0427 XEOTICID XEO00760 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0427 XEOTICID XEO00760 XEO_CLAS Traditional Medicine DME0427 XEOTICID XEO00760 DESCRIPT Jinfukang up-regulates the expression of DME MVD DME0427 XEOTICID XEO00760 GENEFORM mRNA DME0427 XEOTICID XEO00760 MOACRIVE Induction DME0427 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0427 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0427 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0427 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME MVD DME0427 XEOTICID XEO00772 GENEFORM mRNA DME0427 XEOTICID XEO00772 MOACRIVE Inhibition DME0427 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0427 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0427 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0427 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 inhibits the expression of DME MVD DME0427 XEOTICID XEO00806 GENEFORM mRNA DME0427 XEOTICID XEO00806 MOACRIVE Inhibition DME0427 XEOTICID XEO00813 XEO_NAME Dinophysistoxin 1 DME0427 XEOTICID XEO00813 XEO_TYPE Health or Environmental Toxicant(s) DME0427 XEOTICID XEO00813 XEO_CLAS Biotoxin DME0427 XEOTICID XEO00813 DESCRIPT Dinophysistoxin 1 inhibits the expression of DME MVD DME0427 XEOTICID XEO00813 GENEFORM mRNA DME0427 XEOTICID XEO00813 MOACRIVE Inhibition DME0427 XEOTICID XEO00840 XEO_NAME Cupric oxide DME0427 XEOTICID XEO00840 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0427 XEOTICID XEO00840 XEO_CLAS Chemical Compound DME0427 XEOTICID XEO00840 DESCRIPT Cupric oxide up-regulates the expression of DME MVD DME0427 XEOTICID XEO00840 GENEFORM mRNA DME0427 XEOTICID XEO00840 MOACRIVE Induction DME0427 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0427 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0427 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0427 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME MVD DME0427 XEOTICID XEO00898 GENEFORM mRNA DME0427 XEOTICID XEO00898 MOACRIVE Inhibition DME0427 XEOTICID XEO01205 XEO_NAME Archazolid B DME0427 XEOTICID XEO01205 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO01205 XEO_CLAS Investigative Agent DME0427 XEOTICID XEO01205 DESCRIPT Archazolid B up-regulates the expression of DME MVD DME0427 XEOTICID XEO01205 GENEFORM mRNA DME0427 XEOTICID XEO01205 MOACRIVE Induction DME0427 XEOTICID XEO01220 XEO_NAME Beta-naphthoflavone DME0427 XEOTICID XEO01220 XEO_TYPE Pharmaceutical Agent(s) DME0427 XEOTICID XEO01220 XEO_CLAS Investigative Agent DME0427 XEOTICID XEO01220 DESCRIPT Beta-naphthoflavone inhibits the expression of DME MVD DME0427 XEOTICID XEO01220 GENEFORM mRNA DME0427 XEOTICID XEO01220 MOACRIVE Inhibition DME0427 XEOTICID XEO01299 XEO_NAME Fatostatin DME0427 XEOTICID XEO01299 XEO_TYPE Health or Environmental Toxicant(s) DME0427 XEOTICID XEO01299 XEO_CLAS Acute Toxic Substance DME0427 XEOTICID XEO01299 DESCRIPT Fatostatin inhibits the expression of DME MVD DME0427 XEOTICID XEO01299 GENEFORM mRNA DME0427 XEOTICID XEO01299 MOACRIVE Inhibition DME0427 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0427 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0427 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0427 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME MVD DME0427 XEOTICID XEO01305 GENEFORM mRNA DME0427 XEOTICID XEO01305 MOACRIVE Inhibition DME0427 XEOTICID XEO01409 XEO_NAME Okadaic acid DME0427 XEOTICID XEO01409 XEO_TYPE Health or Environmental Toxicant(s) DME0427 XEOTICID XEO01409 XEO_CLAS Acute Toxic Substance DME0427 XEOTICID XEO01409 DESCRIPT Okadaic acid inhibits the expression of DME MVD DME0427 XEOTICID XEO01409 GENEFORM mRNA DME0427 XEOTICID XEO01409 MOACRIVE Inhibition DME0428 DME___ID DME0428 DME0428 DME_NAME Uracil phosphoribosyltransferase (UPRT) DME0428 SPESNAME Homo sapiens DME0428 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0428 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0428 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0428 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the expression of DME UPRT DME0428 XEOTICID XEO00117 GENEFORM mRNA DME0428 XEOTICID XEO00117 MOACRIVE Inhibition DME0428 XEOTICID XEO00184 XEO_NAME Calcitriol DME0428 XEOTICID XEO00184 XEO_TYPE Pharmaceutical Agent(s) DME0428 XEOTICID XEO00184 XEO_CLAS Approved/Marketed Drug DME0428 XEOTICID XEO00184 DESCRIPT Calcitriol up-regulates the expression of DME UPRT DME0428 XEOTICID XEO00184 GENEFORM mRNA DME0428 XEOTICID XEO00184 MOACRIVE Induction DME0428 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0428 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0428 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0428 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME UPRT DME0428 XEOTICID XEO00241 GENEFORM mRNA DME0428 XEOTICID XEO00241 MOACRIVE Inhibition DME0428 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0428 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0428 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0428 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME UPRT DME0428 XEOTICID XEO00292 GENEFORM mRNA DME0428 XEOTICID XEO00292 MOACRIVE Inhibition DME0428 XEOTICID XEO00919 XEO_NAME Particulate matter DME0428 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0428 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0428 XEOTICID XEO00919 DESCRIPT Particulate matter up-regulates the expression of DME UPRT DME0428 XEOTICID XEO00919 GENEFORM mRNA DME0428 XEOTICID XEO00919 MOACRIVE Induction DME0428 XEOTICID XEO00969 XEO_NAME Atrazine DME0428 XEOTICID XEO00969 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0428 XEOTICID XEO00969 XEO_CLAS Herbicide DME0428 XEOTICID XEO00969 DESCRIPT Atrazine inhibits the expression of DME UPRT DME0428 XEOTICID XEO00969 GENEFORM mRNA DME0428 XEOTICID XEO00969 MOACRIVE Inhibition DME0428 XEOTICID XEO01574 XEO_NAME Plant extracts DME0428 XEOTICID XEO01574 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0428 XEOTICID XEO01574 XEO_CLAS Plant Extract DME0428 XEOTICID XEO01574 DESCRIPT Plant extracts up-regulates the expression of DME UPRT DME0428 XEOTICID XEO01574 GENEFORM mRNA DME0428 XEOTICID XEO01574 MOACRIVE Induction DME0429 DME___ID DME0429 DME0429 DME_NAME Prostaglandin reductase 1 (PTGR1) DME0429 SPESNAME Homo sapiens DME0429 XEOTICID XEO00007 XEO_NAME Azathioprine DME0429 XEOTICID XEO00007 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00007 XEO_CLAS Approved/Marketed Drug DME0429 XEOTICID XEO00007 DESCRIPT Azathioprine up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO00007 GENEFORM mRNA DME0429 XEOTICID XEO00007 MOACRIVE Induction DME0429 XEOTICID XEO00028 XEO_NAME Disulfiram DME0429 XEOTICID XEO00028 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00028 XEO_CLAS Approved/Marketed Drug DME0429 XEOTICID XEO00028 DESCRIPT Disulfiram up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO00028 GENEFORM mRNA DME0429 XEOTICID XEO00028 MOACRIVE Induction DME0429 XEOTICID XEO00037 XEO_NAME Fluorouracil DME0429 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME0429 XEOTICID XEO00037 DESCRIPT Fluorouracil induces the drug-metabolizing activity of DME PTGR1 DME0429 XEOTICID XEO00037 GENEFORM Protein DME0429 XEOTICID XEO00037 MOACRIVE Induction DME0429 XEOTICID XEO00047 XEO_NAME Indomethacin DME0429 XEOTICID XEO00047 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00047 XEO_CLAS Approved/Marketed Drug DME0429 XEOTICID XEO00047 DESCRIPT Indomethacin inhibits the drug-metabolizing activity of DME PTGR1 DME0429 XEOTICID XEO00047 GENEFORM Protein DME0429 XEOTICID XEO00047 MOACRIVE Inhibition DME0429 XEOTICID XEO00079 XEO_NAME Vorinostat DME0429 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0429 XEOTICID XEO00079 DESCRIPT Vorinostat up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO00079 GENEFORM mRNA DME0429 XEOTICID XEO00079 MOACRIVE Induction DME0429 XEOTICID XEO00096 XEO_NAME Ampicillin DME0429 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME0429 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the expression of DME PTGR1 DME0429 XEOTICID XEO00096 GENEFORM mRNA DME0429 XEOTICID XEO00096 MOACRIVE Inhibition DME0429 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0429 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0429 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO00117 GENEFORM mRNA DME0429 XEOTICID XEO00117 MOACRIVE Induction DME0429 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0429 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0429 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME PTGR1 DME0429 XEOTICID XEO00217 GENEFORM mRNA DME0429 XEOTICID XEO00217 MOACRIVE Inhibition DME0429 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0429 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0429 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO00241 GENEFORM mRNA DME0429 XEOTICID XEO00241 MOACRIVE Induction DME0429 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0429 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0429 XEOTICID XEO00339 DESCRIPT Arsenic trioxide up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO00339 GENEFORM mRNA DME0429 XEOTICID XEO00339 MOACRIVE Induction DME0429 XEOTICID XEO00352 XEO_NAME Diclofenac DME0429 XEOTICID XEO00352 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00352 XEO_CLAS Approved/Marketed Drug DME0429 XEOTICID XEO00352 DESCRIPT Diclof DMEenac inhibits the drug-metabolizing activity of DME PTGR1 DME0429 XEOTICID XEO00352 GENEFORM Protein DME0429 XEOTICID XEO00352 MOACRIVE Inhibition DME0429 XEOTICID XEO00428 XEO_NAME Menadione DME0429 XEOTICID XEO00428 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00428 XEO_CLAS Approved/Marketed Drug DME0429 XEOTICID XEO00428 DESCRIPT Menadione induces the drug-metabolizing activity of DME PTGR1 DME0429 XEOTICID XEO00428 GENEFORM Protein DME0429 XEOTICID XEO00428 MOACRIVE Induction DME0429 XEOTICID XEO00447 XEO_NAME Benzoic acid DME0429 XEOTICID XEO00447 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00447 XEO_CLAS Approved/Marketed Drug DME0429 XEOTICID XEO00447 DESCRIPT Benzoic acid up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO00447 GENEFORM mRNA DME0429 XEOTICID XEO00447 MOACRIVE Induction DME0429 XEOTICID XEO00510 XEO_NAME Gamolenic acid DME0429 XEOTICID XEO00510 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00510 XEO_CLAS Approved/Marketed Drug DME0429 XEOTICID XEO00510 DESCRIPT Gamolenic acid up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO00510 GENEFORM mRNA DME0429 XEOTICID XEO00510 MOACRIVE Induction DME0429 XEOTICID XEO00571 XEO_NAME Dinitrochlorobenzene DME0429 XEOTICID XEO00571 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00571 XEO_CLAS Drug in Phase 1 Clinical Trial DME0429 XEOTICID XEO00571 DESCRIPT Dinitrochlorobenzene up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO00571 GENEFORM mRNA DME0429 XEOTICID XEO00571 MOACRIVE Induction DME0429 XEOTICID XEO00885 XEO_NAME Eugenol DME0429 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME0429 XEOTICID XEO00885 DESCRIPT Eugenol up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO00885 GENEFORM mRNA DME0429 XEOTICID XEO00885 MOACRIVE Induction DME0429 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0429 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0429 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0429 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO00898 GENEFORM mRNA DME0429 XEOTICID XEO00898 MOACRIVE Induction DME0429 XEOTICID XEO00919 XEO_NAME Particulate matter DME0429 XEOTICID XEO00919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME0429 XEOTICID XEO00919 XEO_CLAS Natural Mixture DME0429 XEOTICID XEO00919 DESCRIPT Particulate matter up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO00919 GENEFORM mRNA DME0429 XEOTICID XEO00919 MOACRIVE Induction DME0429 XEOTICID XEO00985 XEO_NAME Hexyl cinnamic aldehyde DME0429 XEOTICID XEO00985 XEO_TYPE Health or Environmental Toxicant(s) DME0429 XEOTICID XEO00985 XEO_CLAS Environmental Pollutant DME0429 XEOTICID XEO00985 DESCRIPT Hexyl cinnamic aldehyde up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO00985 GENEFORM mRNA DME0429 XEOTICID XEO00985 MOACRIVE Induction DME0429 XEOTICID XEO01009 XEO_NAME Glycidamide DME0429 XEOTICID XEO01009 XEO_TYPE Health or Environmental Toxicant(s) DME0429 XEOTICID XEO01009 XEO_CLAS Health Hazard/Toxicant DME0429 XEOTICID XEO01009 DESCRIPT Glycidamide up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO01009 GENEFORM mRNA DME0429 XEOTICID XEO01009 MOACRIVE Induction DME0429 XEOTICID XEO01016 XEO_NAME N-hexane DME0429 XEOTICID XEO01016 XEO_TYPE Health or Environmental Toxicant(s) DME0429 XEOTICID XEO01016 XEO_CLAS Health Hazard/Toxicant DME0429 XEOTICID XEO01016 DESCRIPT N-hexane up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO01016 GENEFORM mRNA DME0429 XEOTICID XEO01016 MOACRIVE Induction DME0429 XEOTICID XEO01128 XEO_NAME Isopropanol DME0429 XEOTICID XEO01128 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO01128 XEO_CLAS Investigative Agent DME0429 XEOTICID XEO01128 DESCRIPT Isopropanol up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO01128 GENEFORM mRNA DME0429 XEOTICID XEO01128 MOACRIVE Induction DME0429 XEOTICID XEO01247 XEO_NAME Chloropicrin DME0429 XEOTICID XEO01247 XEO_TYPE Health or Environmental Toxicant(s) DME0429 XEOTICID XEO01247 XEO_CLAS Acute Toxic Substance DME0429 XEOTICID XEO01247 DESCRIPT Chloropicrin up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO01247 GENEFORM mRNA DME0429 XEOTICID XEO01247 MOACRIVE Induction DME0429 XEOTICID XEO01348 XEO_NAME K-7174 DME0429 XEOTICID XEO01348 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO01348 XEO_CLAS Preclinical/Patented Drug DME0429 XEOTICID XEO01348 DESCRIPT K-7174 up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO01348 GENEFORM mRNA DME0429 XEOTICID XEO01348 MOACRIVE Induction DME0429 XEOTICID XEO01453 XEO_NAME Resorcinol DME0429 XEOTICID XEO01453 XEO_TYPE Health or Environmental Toxicant(s) DME0429 XEOTICID XEO01453 XEO_CLAS Environmental Pollutant DME0429 XEOTICID XEO01453 DESCRIPT Resorcinol up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO01453 GENEFORM mRNA DME0429 XEOTICID XEO01453 MOACRIVE Induction DME0429 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0429 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0429 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0429 XEOTICID XEO01492 DESCRIPT Trichostatin A up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO01492 GENEFORM mRNA DME0429 XEOTICID XEO01492 MOACRIVE Induction DME0429 XEOTICID XEO01504 XEO_NAME Gold DME0429 XEOTICID XEO01504 XEO_TYPE Other Chemical Compound(s) or Element(s) DME0429 XEOTICID XEO01504 XEO_CLAS Chemical Compound DME0429 XEOTICID XEO01504 DESCRIPT Gold up-regulates the expression of DME PTGR1 DME0429 XEOTICID XEO01504 GENEFORM mRNA DME0429 XEOTICID XEO01504 MOACRIVE Induction DME0431 DME___ID DME0431 DME0431 DME_NAME Methionine synthase reductase (MTRR) DME0431 SPESNAME Homo sapiens DME0431 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0431 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0431 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0431 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME MTRR DME0431 XEOTICID XEO00217 GENEFORM mRNA DME0431 XEOTICID XEO00217 MOACRIVE Inhibition DME0431 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0431 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0431 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0431 XEOTICID XEO00241 DESCRIPT Cyclosporine inhibits the expression of DME MTRR DME0431 XEOTICID XEO00241 GENEFORM mRNA DME0431 XEOTICID XEO00241 MOACRIVE Inhibition DME0431 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0431 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0431 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0431 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME MTRR DME0431 XEOTICID XEO00292 GENEFORM mRNA DME0431 XEOTICID XEO00292 MOACRIVE Inhibition DME0431 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0431 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0431 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0431 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME MTRR DME0431 XEOTICID XEO00999 GENEFORM mRNA DME0431 XEOTICID XEO00999 MOACRIVE Inhibition DME0432 DME___ID DME0432 DME0432 DME_NAME Gamma-glutamyltranspeptidase 5 (GGT5) DME0432 SPESNAME Homo sapiens DME0432 XEOTICID XEO00094 XEO_NAME Progesterone DME0432 XEOTICID XEO00094 XEO_TYPE Pharmaceutical Agent(s) DME0432 XEOTICID XEO00094 XEO_CLAS Approved/Marketed Drug DME0432 XEOTICID XEO00094 DESCRIPT Progesterone up-regulates the expression of DME GGT5 DME0432 XEOTICID XEO00094 GENEFORM mRNA DME0432 XEOTICID XEO00094 MOACRIVE Induction DME0432 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0432 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0432 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0432 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME GGT5 DME0432 XEOTICID XEO00241 GENEFORM mRNA DME0432 XEOTICID XEO00241 MOACRIVE Induction DME0432 XEOTICID XEO00278 XEO_NAME Beclomethasone dipropionate DME0432 XEOTICID XEO00278 XEO_TYPE Pharmaceutical Agent(s) DME0432 XEOTICID XEO00278 XEO_CLAS Approved/Marketed Drug DME0432 XEOTICID XEO00278 DESCRIPT Beclomethasone dipropionate induces the drug-metabolizing activity of DME GGT5 DME0432 XEOTICID XEO00278 GENEFORM Protein DME0432 XEOTICID XEO00278 MOACRIVE Induction DME0432 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0432 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0432 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0432 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME GGT5 DME0432 XEOTICID XEO00292 GENEFORM mRNA DME0432 XEOTICID XEO00292 MOACRIVE Inhibition DME0432 XEOTICID XEO00297 XEO_NAME Fluticasone furoate DME0432 XEOTICID XEO00297 XEO_TYPE Pharmaceutical Agent(s) DME0432 XEOTICID XEO00297 XEO_CLAS Approved/Marketed Drug DME0432 XEOTICID XEO00297 DESCRIPT Fluticasone furoate induces the drug-metabolizing activity of DME GGT5 DME0432 XEOTICID XEO00297 GENEFORM Protein DME0432 XEOTICID XEO00297 MOACRIVE Induction DME0432 XEOTICID XEO00560 XEO_NAME Triclosan DME0432 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME0432 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME0432 XEOTICID XEO00560 DESCRIPT Triclosan induces the drug-metabolizing activity of DME GGT5 DME0432 XEOTICID XEO00560 GENEFORM Protein DME0432 XEOTICID XEO00560 MOACRIVE Induction DME0432 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0432 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0432 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0432 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene inhibits the expression of DME GGT5 DME0432 XEOTICID XEO00898 GENEFORM mRNA DME0432 XEOTICID XEO00898 MOACRIVE Inhibition DME0437 DME___ID DME0437 DME0437 DME_NAME Purine nucleoside phosphorylase (PNP) DME0437 SPESNAME Homo sapiens DME0437 XEOTICID XEO00029 XEO_NAME Valproic acid DME0437 XEOTICID XEO00029 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO00029 XEO_CLAS Approved/Marketed Drug DME0437 XEOTICID XEO00029 DESCRIPT Valproic acid up-regulates the expression of DME PNP DME0437 XEOTICID XEO00029 GENEFORM mRNA DME0437 XEOTICID XEO00029 MOACRIVE Induction DME0437 XEOTICID XEO00079 XEO_NAME Vorinostat DME0437 XEOTICID XEO00079 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO00079 XEO_CLAS Approved/Marketed Drug DME0437 XEOTICID XEO00079 DESCRIPT Vorinostat up-regulates the expression of DME PNP DME0437 XEOTICID XEO00079 GENEFORM mRNA DME0437 XEOTICID XEO00079 MOACRIVE Induction DME0437 XEOTICID XEO00090 XEO_NAME Estradiol DME0437 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0437 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME PNP DME0437 XEOTICID XEO00090 GENEFORM mRNA DME0437 XEOTICID XEO00090 MOACRIVE Induction DME0437 XEOTICID XEO00117 XEO_NAME Copper sulfate DME0437 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME0437 XEOTICID XEO00117 DESCRIPT Copper sulfate up-regulates the expression of DME PNP DME0437 XEOTICID XEO00117 GENEFORM mRNA DME0437 XEOTICID XEO00117 MOACRIVE Induction DME0437 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0437 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0437 XEOTICID XEO00217 DESCRIPT Acetaminophen up-regulates the expression of DME PNP DME0437 XEOTICID XEO00217 GENEFORM mRNA DME0437 XEOTICID XEO00217 MOACRIVE Induction DME0437 XEOTICID XEO00241 XEO_NAME Cyclosporine DME0437 XEOTICID XEO00241 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO00241 XEO_CLAS Approved/Marketed Drug DME0437 XEOTICID XEO00241 DESCRIPT Cyclosporine up-regulates the expression of DME PNP DME0437 XEOTICID XEO00241 GENEFORM mRNA DME0437 XEOTICID XEO00241 MOACRIVE Induction DME0437 XEOTICID XEO00253 XEO_NAME Tretinoin DME0437 XEOTICID XEO00253 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO00253 XEO_CLAS Approved/Marketed Drug DME0437 XEOTICID XEO00253 DESCRIPT Tretinoin inhibits the expression of DME PNP DME0437 XEOTICID XEO00253 GENEFORM mRNA DME0437 XEOTICID XEO00253 MOACRIVE Inhibition DME0437 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0437 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0437 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME PNP DME0437 XEOTICID XEO00292 GENEFORM mRNA DME0437 XEOTICID XEO00292 MOACRIVE Inhibition DME0437 XEOTICID XEO00334 XEO_NAME Cisplatin DME0437 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0437 XEOTICID XEO00334 DESCRIPT Cisplatin up-regulates the expression of DME PNP DME0437 XEOTICID XEO00334 GENEFORM mRNA DME0437 XEOTICID XEO00334 MOACRIVE Induction DME0437 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0437 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0437 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the drug-metabolizing activity of DME PNP DME0437 XEOTICID XEO00339 GENEFORM Protein DME0437 XEOTICID XEO00339 MOACRIVE Inhibition DME0437 XEOTICID XEO00547 XEO_NAME Vitamin E DME0437 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME0437 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of DME PNP DME0437 XEOTICID XEO00547 GENEFORM Protein DME0437 XEOTICID XEO00547 MOACRIVE Inhibition DME0437 XEOTICID XEO00632 XEO_NAME Sodium arsenite DME0437 XEOTICID XEO00632 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO00632 XEO_CLAS Drug in Phase 1 Clinical Trial DME0437 XEOTICID XEO00632 DESCRIPT Sodium arsenite up-regulates the expression of DME PNP DME0437 XEOTICID XEO00632 GENEFORM mRNA DME0437 XEOTICID XEO00632 MOACRIVE Induction DME0437 XEOTICID XEO00806 XEO_NAME Aflatoxin B1 DME0437 XEOTICID XEO00806 XEO_TYPE Health or Environmental Toxicant(s) DME0437 XEOTICID XEO00806 XEO_CLAS Carcinogen DME0437 XEOTICID XEO00806 DESCRIPT Aflatoxin B1 up-regulates the expression of DME PNP DME0437 XEOTICID XEO00806 GENEFORM mRNA DME0437 XEOTICID XEO00806 MOACRIVE Induction DME0437 XEOTICID XEO00898 XEO_NAME Benzo(a)pyrene DME0437 XEOTICID XEO00898 XEO_TYPE Health or Environmental Toxicant(s) DME0437 XEOTICID XEO00898 XEO_CLAS Carcinogen DME0437 XEOTICID XEO00898 DESCRIPT Benzo(a)pyrene up-regulates the expression of DME PNP DME0437 XEOTICID XEO00898 GENEFORM mRNA DME0437 XEOTICID XEO00898 MOACRIVE Induction DME0437 XEOTICID XEO01050 XEO_NAME Dicrotophos DME0437 XEOTICID XEO01050 XEO_TYPE Fungicide(s), Herbicide(s) or Insecticide(s) DME0437 XEOTICID XEO01050 XEO_CLAS Pesticide/Insecticide DME0437 XEOTICID XEO01050 DESCRIPT Dicrotophos inhibits the expression of DME PNP DME0437 XEOTICID XEO01050 GENEFORM mRNA DME0437 XEOTICID XEO01050 MOACRIVE Inhibition DME0437 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0437 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0437 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME PNP DME0437 XEOTICID XEO01226 GENEFORM mRNA DME0437 XEOTICID XEO01226 MOACRIVE Inhibition DME0437 XEOTICID XEO01251 XEO_NAME CI-972 DME0437 XEOTICID XEO01251 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO01251 XEO_CLAS Drug in Phase 1 Clinical Trial DME0437 XEOTICID XEO01251 DESCRIPT CI-972 inhibits the drug-metabolizing activity of DME PNP DME0437 XEOTICID XEO01251 GENEFORM Protein DME0437 XEOTICID XEO01251 MOACRIVE Inhibition DME0437 XEOTICID XEO01261 XEO_NAME Coumestrol DME0437 XEOTICID XEO01261 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO01261 XEO_CLAS Investigative Agent DME0437 XEOTICID XEO01261 DESCRIPT Coumestrol up-regulates the expression of DME PNP DME0437 XEOTICID XEO01261 GENEFORM mRNA DME0437 XEOTICID XEO01261 MOACRIVE Induction DME0437 XEOTICID XEO01324 XEO_NAME GSK-J4 DME0437 XEOTICID XEO01324 XEO_TYPE Pharmaceutical Agent(s) DME0437 XEOTICID XEO01324 XEO_CLAS Preclinical/Patented Drug DME0437 XEOTICID XEO01324 DESCRIPT GSK-J4 inhibits the expression of DME PNP DME0437 XEOTICID XEO01324 GENEFORM mRNA DME0437 XEOTICID XEO01324 MOACRIVE Inhibition DME0438 DME___ID DME0438 DME0438 DME_NAME Phosphodiesterase 7B (PDE7B) DME0438 SPESNAME Homo sapiens DME0438 XEOTICID XEO00090 XEO_NAME Estradiol DME0438 XEOTICID XEO00090 XEO_TYPE Pharmaceutical Agent(s) DME0438 XEOTICID XEO00090 XEO_CLAS Approved/Marketed Drug DME0438 XEOTICID XEO00090 DESCRIPT Estradiol up-regulates the expression of DME PDE7B DME0438 XEOTICID XEO00090 GENEFORM mRNA DME0438 XEOTICID XEO00090 MOACRIVE Induction DME0438 XEOTICID XEO00193 XEO_NAME Belinostat DME0438 XEOTICID XEO00193 XEO_TYPE Pharmaceutical Agent(s) DME0438 XEOTICID XEO00193 XEO_CLAS Approved/Marketed Drug DME0438 XEOTICID XEO00193 DESCRIPT Belinostat up-regulates the expression of DME PDE7B DME0438 XEOTICID XEO00193 GENEFORM mRNA DME0438 XEOTICID XEO00193 MOACRIVE Induction DME0438 XEOTICID XEO00217 XEO_NAME Acetaminophen DME0438 XEOTICID XEO00217 XEO_TYPE Pharmaceutical Agent(s) DME0438 XEOTICID XEO00217 XEO_CLAS Approved/Marketed Drug DME0438 XEOTICID XEO00217 DESCRIPT Acetaminophen inhibits the expression of DME PDE7B DME0438 XEOTICID XEO00217 GENEFORM mRNA DME0438 XEOTICID XEO00217 MOACRIVE Inhibition DME0438 XEOTICID XEO00277 XEO_NAME Amiodarone hydrochloride DME0438 XEOTICID XEO00277 XEO_TYPE Pharmaceutical Agent(s) DME0438 XEOTICID XEO00277 XEO_CLAS Approved/Marketed Drug DME0438 XEOTICID XEO00277 DESCRIPT Amiodarone hydrochloride up-regulates the expression of DME PDE7B DME0438 XEOTICID XEO00277 GENEFORM mRNA DME0438 XEOTICID XEO00277 MOACRIVE Induction DME0438 XEOTICID XEO00292 XEO_NAME Doxorubicin hydrochloride DME0438 XEOTICID XEO00292 XEO_TYPE Pharmaceutical Agent(s) DME0438 XEOTICID XEO00292 XEO_CLAS Approved/Marketed Drug DME0438 XEOTICID XEO00292 DESCRIPT Doxorubicin hydrochloride inhibits the expression of DME PDE7B DME0438 XEOTICID XEO00292 GENEFORM mRNA DME0438 XEOTICID XEO00292 MOACRIVE Inhibition DME0438 XEOTICID XEO00334 XEO_NAME Cisplatin DME0438 XEOTICID XEO00334 XEO_TYPE Pharmaceutical Agent(s) DME0438 XEOTICID XEO00334 XEO_CLAS Approved/Marketed Drug DME0438 XEOTICID XEO00334 DESCRIPT Cisplatin inhibits the expression of DME PDE7B DME0438 XEOTICID XEO00334 GENEFORM mRNA DME0438 XEOTICID XEO00334 MOACRIVE Inhibition DME0438 XEOTICID XEO00339 XEO_NAME Arsenic trioxide DME0438 XEOTICID XEO00339 XEO_TYPE Pharmaceutical Agent(s) DME0438 XEOTICID XEO00339 XEO_CLAS Approved/Marketed Drug DME0438 XEOTICID XEO00339 DESCRIPT Arsenic trioxide inhibits the expression of DME PDE7B DME0438 XEOTICID XEO00339 GENEFORM mRNA DME0438 XEOTICID XEO00339 MOACRIVE Inhibition DME0438 XEOTICID XEO00366 XEO_NAME Methotrexate DME0438 XEOTICID XEO00366 XEO_TYPE Pharmaceutical Agent(s) DME0438 XEOTICID XEO00366 XEO_CLAS Approved/Marketed Drug DME0438 XEOTICID XEO00366 DESCRIPT Methotrexate induces the drug-metabolizing activity of DME PDE7B DME0438 XEOTICID XEO00366 GENEFORM Protein DME0438 XEOTICID XEO00366 MOACRIVE Induction DME0438 XEOTICID XEO00999 XEO_NAME Butyraldehyde DME0438 XEOTICID XEO00999 XEO_TYPE Health or Environmental Toxicant(s) DME0438 XEOTICID XEO00999 XEO_CLAS Health Hazard/Toxicant DME0438 XEOTICID XEO00999 DESCRIPT Butyraldehyde inhibits the expression of DME PDE7B DME0438 XEOTICID XEO00999 GENEFORM mRNA DME0438 XEOTICID XEO00999 MOACRIVE Inhibition DME0438 XEOTICID XEO01492 XEO_NAME Trichostatin A DME0438 XEOTICID XEO01492 XEO_TYPE Pharmaceutical Agent(s) DME0438 XEOTICID XEO01492 XEO_CLAS Drug in Phase 1 Clinical Trial DME0438 XEOTICID XEO01492 DESCRIPT Trichostatin A inhibits the expression of DME PDE7B DME0438 XEOTICID XEO01492 GENEFORM mRNA DME0438 XEOTICID XEO01492 MOACRIVE Inhibition DME0438 XEOTICID XEO01505 XEO_NAME Lead DME0438 XEOTICID XEO01505 XEO_TYPE Health or Environmental Toxicant(s) DME0438 XEOTICID XEO01505 XEO_CLAS Health Hazard/Toxicant DME0438 XEOTICID XEO01505 DESCRIPT Lead up-regulates the expression of DME PDE7B DME0438 XEOTICID XEO01505 GENEFORM mRNA DME0438 XEOTICID XEO01505 MOACRIVE Induction DME0440 DME___ID DME0440 DME0440 DME_NAME VKORC1-like protein 1 (VKORC1L1) DME0440 SPESNAME Homo sapiens DME0440 XEOTICID XEO00206 XEO_NAME Phenprocoumon DME0440 XEOTICID XEO00206 XEO_TYPE Pharmaceutical Agent(s) DME0440 XEOTICID XEO00206 XEO_CLAS Approved/Marketed Drug DME0440 XEOTICID XEO00206 DESCRIPT Phenprocoumon inhibits the drug-metabolizing activity of DME VKORC1L1 DME0440 XEOTICID XEO00206 GENEFORM Protein DME0440 XEOTICID XEO00206 MOACRIVE Inhibition DME0440 XEOTICID XEO00471 XEO_NAME Fluindione DME0440 XEOTICID XEO00471 XEO_TYPE Pharmaceutical Agent(s) DME0440 XEOTICID XEO00471 XEO_CLAS Approved/Marketed Drug DME0440 XEOTICID XEO00471 DESCRIPT Fluindione inhibits the drug-metabolizing activity of DME VKORC1L1 DME0440 XEOTICID XEO00471 GENEFORM Protein DME0440 XEOTICID XEO00471 MOACRIVE Inhibition DME0440 XEOTICID XEO00513 XEO_NAME Acenocoumarol DME0440 XEOTICID XEO00513 XEO_TYPE Pharmaceutical Agent(s) DME0440 XEOTICID XEO00513 XEO_CLAS Approved/Marketed Drug DME0440 XEOTICID XEO00513 DESCRIPT Acenocoumarol inhibits the drug-metabolizing activity of DME VKORC1L1 DME0440 XEOTICID XEO00513 GENEFORM Protein DME0440 XEOTICID XEO00513 MOACRIVE Inhibition DME0440 XEOTICID XEO00772 XEO_NAME Ethyl methanesulfonate DME0440 XEOTICID XEO00772 XEO_TYPE Health or Environmental Toxicant(s) DME0440 XEOTICID XEO00772 XEO_CLAS Carcinogen DME0440 XEOTICID XEO00772 DESCRIPT Ethyl methanesulfonate inhibits the expression of DME VKORC1L1 DME0440 XEOTICID XEO00772 GENEFORM mRNA DME0440 XEOTICID XEO00772 MOACRIVE Inhibition DME0440 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME0440 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME0440 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME0440 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of DME VKORC1L1 DME0440 XEOTICID XEO00866 GENEFORM Protein DME0440 XEOTICID XEO00866 MOACRIVE Inhibition DME0440 XEOTICID XEO01226 XEO_NAME Bisphenol A DME0440 XEOTICID XEO01226 XEO_TYPE Pharmaceutical Agent(s) DME0440 XEOTICID XEO01226 XEO_CLAS Drug in Phase 2 Clinical Trial DME0440 XEOTICID XEO01226 DESCRIPT Bisphenol A inhibits the expression of DME VKORC1L1 DME0440 XEOTICID XEO01226 GENEFORM mRNA DME0440 XEOTICID XEO01226 MOACRIVE Inhibition DME0440 XEOTICID XEO01305 XEO_NAME Formaldehyde DME0440 XEOTICID XEO01305 XEO_TYPE Health or Environmental Toxicant(s) DME0440 XEOTICID XEO01305 XEO_CLAS Acute Toxic Substance DME0440 XEOTICID XEO01305 DESCRIPT Formaldehyde inhibits the expression of DME VKORC1L1 DME0440 XEOTICID XEO01305 GENEFORM mRNA DME0440 XEOTICID XEO01305 MOACRIVE Inhibition DME0440 XEOTICID XEO01616 XEO_NAME Bromadiolone DME0440 XEOTICID XEO01616 XEO_TYPE Health or Environmental Toxicant(s) DME0440 XEOTICID XEO01616 XEO_CLAS Acute Toxic Substance DME0440 XEOTICID XEO01616 DESCRIPT Bromadiolone inhibits the drug-metabolizing activity of DME VKORC1L1 DME0440 XEOTICID XEO01616 GENEFORM Protein DME0440 XEOTICID XEO01616 MOACRIVE Inhibition DME0440 XEOTICID XEO01617 XEO_NAME Coumatetralyl DME0440 XEOTICID XEO01617 XEO_TYPE Health or Environmental Toxicant(s) DME0440 XEOTICID XEO01617 XEO_CLAS Acute Toxic Substance DME0440 XEOTICID XEO01617 DESCRIPT Coumatetralyl inhibits the drug-metabolizing activity of DME VKORC1L1 DME0440 XEOTICID XEO01617 GENEFORM Protein DME0440 XEOTICID XEO01617 MOACRIVE Inhibition DME1002 DME___ID DME1002 DME1002 DME_NAME Dipeptidase (pepV) DME1002 SPESNAME Lactococcus lactis DME1002 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1002 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO02298 XEO_CLAS Peptide DME1002 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis (MIC > 128 ug/ml) DME1002 XEOTICID XEO02298 GENEFORM Protein DME1002 XEOTICID XEO02298 MOACRIVE Inhibition DME1002 XEOTICID XEO02335 XEO_NAME Aurein-1.1 DME1002 XEOTICID XEO02335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO02335 XEO_CLAS Peptide DME1002 XEOTICID XEO02335 DESCRIPT Aurein-1.1 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis (MIC = 25 ug/ml) DME1002 XEOTICID XEO02335 GENEFORM Protein DME1002 XEOTICID XEO02335 MOACRIVE Inhibition DME1002 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1002 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO02721 XEO_CLAS Peptide DME1002 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO02721 GENEFORM Protein DME1002 XEOTICID XEO02721 MOACRIVE Inhibition DME1002 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1002 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03111 XEO_CLAS Peptide DME1002 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO03111 GENEFORM Protein DME1002 XEOTICID XEO03111 MOACRIVE Inhibition DME1002 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1002 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03250 XEO_CLAS Peptide DME1002 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO03250 GENEFORM Protein DME1002 XEOTICID XEO03250 MOACRIVE Inhibition DME1002 XEOTICID XEO03255 XEO_NAME Enterocin L50A DME1002 XEOTICID XEO03255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03255 XEO_CLAS Peptide DME1002 XEOTICID XEO03255 DESCRIPT Enterocin L50A inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO03255 GENEFORM Protein DME1002 XEOTICID XEO03255 MOACRIVE Inhibition DME1002 XEOTICID XEO03256 XEO_NAME Enterocin L50B DME1002 XEOTICID XEO03256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03256 XEO_CLAS Peptide DME1002 XEOTICID XEO03256 DESCRIPT Enterocin L50B inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO03256 GENEFORM Protein DME1002 XEOTICID XEO03256 MOACRIVE Inhibition DME1002 XEOTICID XEO03257 XEO_NAME Enterocin P DME1002 XEOTICID XEO03257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03257 XEO_CLAS Peptide DME1002 XEOTICID XEO03257 DESCRIPT Enterocin P inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis (MIC = 0.022 ug/ml) DME1002 XEOTICID XEO03257 GENEFORM Protein DME1002 XEOTICID XEO03257 MOACRIVE Inhibition DME1002 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1002 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03258 XEO_CLAS Peptide DME1002 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO03258 GENEFORM Protein DME1002 XEOTICID XEO03258 MOACRIVE Inhibition DME1002 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME1002 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03259 XEO_CLAS Peptide DME1002 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis (MIC = 0.813 microM) DME1002 XEOTICID XEO03259 GENEFORM Protein DME1002 XEOTICID XEO03259 MOACRIVE Inhibition DME1002 XEOTICID XEO03381 XEO_NAME Fallaxidin 3.1 DME1002 XEOTICID XEO03381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03381 XEO_CLAS Peptide DME1002 XEOTICID XEO03381 DESCRIPT Fallaxidin 3.1 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis (MIC = 100 microM) DME1002 XEOTICID XEO03381 GENEFORM Protein DME1002 XEOTICID XEO03381 MOACRIVE Inhibition DME1002 XEOTICID XEO03382 XEO_NAME Fallaxidin 3.2 DME1002 XEOTICID XEO03382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03382 XEO_CLAS Peptide DME1002 XEOTICID XEO03382 DESCRIPT Fallaxidin 3.2 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis (MIC = 500 microM) DME1002 XEOTICID XEO03382 GENEFORM Protein DME1002 XEOTICID XEO03382 MOACRIVE Inhibition DME1002 XEOTICID XEO03383 XEO_NAME Fallaxidin 4.1 DME1002 XEOTICID XEO03383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03383 XEO_CLAS Peptide DME1002 XEOTICID XEO03383 DESCRIPT Fallaxidin 4.1 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis (MIC = 12 microM) DME1002 XEOTICID XEO03383 GENEFORM Protein DME1002 XEOTICID XEO03383 MOACRIVE Inhibition DME1002 XEOTICID XEO03473 XEO_NAME Garvicin ML DME1002 XEOTICID XEO03473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03473 XEO_CLAS Peptide DME1002 XEOTICID XEO03473 DESCRIPT Garvicin ML inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO03473 GENEFORM Protein DME1002 XEOTICID XEO03473 MOACRIVE Inhibition DME1002 XEOTICID XEO03478 XEO_NAME Geobacillin I DME1002 XEOTICID XEO03478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03478 XEO_CLAS Peptide DME1002 XEOTICID XEO03478 DESCRIPT Geobacillin I inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO03478 GENEFORM Protein DME1002 XEOTICID XEO03478 MOACRIVE Inhibition DME1002 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1002 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03771 XEO_CLAS Peptide DME1002 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO03771 GENEFORM Protein DME1002 XEOTICID XEO03771 MOACRIVE Inhibition DME1002 XEOTICID XEO03773 XEO_NAME Lactococcin Q alpha DME1002 XEOTICID XEO03773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03773 XEO_CLAS Peptide DME1002 XEOTICID XEO03773 DESCRIPT Lactococcin Q alpha inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis (MIC > 1 microM) DME1002 XEOTICID XEO03773 GENEFORM Protein DME1002 XEOTICID XEO03773 MOACRIVE Inhibition DME1002 XEOTICID XEO03774 XEO_NAME Lactococcin Q beta DME1002 XEOTICID XEO03774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03774 XEO_CLAS Peptide DME1002 XEOTICID XEO03774 DESCRIPT Lactococcin Q beta inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis (MIC > 1 microM) DME1002 XEOTICID XEO03774 GENEFORM Protein DME1002 XEOTICID XEO03774 MOACRIVE Inhibition DME1002 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1002 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03775 XEO_CLAS Peptide DME1002 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis (MIC = 0.141 microM) DME1002 XEOTICID XEO03775 GENEFORM Protein DME1002 XEOTICID XEO03775 MOACRIVE Inhibition DME1002 XEOTICID XEO03806 XEO_NAME Lantibiotic paenibacillin DME1002 XEOTICID XEO03806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03806 XEO_CLAS Peptide DME1002 XEOTICID XEO03806 DESCRIPT Lantibiotic paenibacillin inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO03806 GENEFORM Protein DME1002 XEOTICID XEO03806 MOACRIVE Inhibition DME1002 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1002 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO03857 XEO_CLAS Peptide DME1002 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis (MIC = 0.038 microM) DME1002 XEOTICID XEO03857 GENEFORM Protein DME1002 XEOTICID XEO03857 MOACRIVE Inhibition DME1002 XEOTICID XEO04320 XEO_NAME Nisin U DME1002 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04320 XEO_CLAS Peptide DME1002 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04320 GENEFORM Protein DME1002 XEOTICID XEO04320 MOACRIVE Inhibition DME1002 XEOTICID XEO04622 XEO_NAME Plantaricin W alpha DME1002 XEOTICID XEO04622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04622 XEO_CLAS Peptide DME1002 XEOTICID XEO04622 DESCRIPT Plantaricin W alpha inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04622 GENEFORM Protein DME1002 XEOTICID XEO04622 MOACRIVE Inhibition DME1002 XEOTICID XEO04623 XEO_NAME Plantaricin W beta DME1002 XEOTICID XEO04623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04623 XEO_CLAS Peptide DME1002 XEOTICID XEO04623 DESCRIPT Plantaricin W beta inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04623 GENEFORM Protein DME1002 XEOTICID XEO04623 MOACRIVE Inhibition DME1002 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1002 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04695 XEO_CLAS Peptide DME1002 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04695 GENEFORM Protein DME1002 XEOTICID XEO04695 MOACRIVE Inhibition DME1002 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1002 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04696 XEO_CLAS Peptide DME1002 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04696 GENEFORM Protein DME1002 XEOTICID XEO04696 MOACRIVE Inhibition DME1002 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1002 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04697 XEO_CLAS Peptide DME1002 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04697 GENEFORM Protein DME1002 XEOTICID XEO04697 MOACRIVE Inhibition DME1002 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1002 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04698 XEO_CLAS Peptide DME1002 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04698 GENEFORM Protein DME1002 XEOTICID XEO04698 MOACRIVE Inhibition DME1002 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1002 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04699 XEO_CLAS Peptide DME1002 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04699 GENEFORM Protein DME1002 XEOTICID XEO04699 MOACRIVE Inhibition DME1002 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1002 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04700 XEO_CLAS Peptide DME1002 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04700 GENEFORM Protein DME1002 XEOTICID XEO04700 MOACRIVE Inhibition DME1002 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1002 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04701 XEO_CLAS Peptide DME1002 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04701 GENEFORM Protein DME1002 XEOTICID XEO04701 MOACRIVE Inhibition DME1002 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1002 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04702 XEO_CLAS Peptide DME1002 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04702 GENEFORM Protein DME1002 XEOTICID XEO04702 MOACRIVE Inhibition DME1002 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1002 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04703 XEO_CLAS Peptide DME1002 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04703 GENEFORM Protein DME1002 XEOTICID XEO04703 MOACRIVE Inhibition DME1002 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1002 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04704 XEO_CLAS Peptide DME1002 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04704 GENEFORM Protein DME1002 XEOTICID XEO04704 MOACRIVE Inhibition DME1002 XEOTICID XEO04810 XEO_NAME Ranatuerin-2AVa DME1002 XEOTICID XEO04810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04810 XEO_CLAS Peptide DME1002 XEOTICID XEO04810 DESCRIPT Ranatuerin-2AVa inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04810 GENEFORM Protein DME1002 XEOTICID XEO04810 MOACRIVE Inhibition DME1002 XEOTICID XEO04856 XEO_NAME Riparin-2.1 DME1002 XEOTICID XEO04856 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04856 XEO_CLAS Peptide DME1002 XEOTICID XEO04856 DESCRIPT Riparin-2.1 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis (MIC = 25 microM) DME1002 XEOTICID XEO04856 GENEFORM Protein DME1002 XEOTICID XEO04856 MOACRIVE Inhibition DME1002 XEOTICID XEO04897 XEO_NAME Sakacin G DME1002 XEOTICID XEO04897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO04897 XEO_CLAS Peptide DME1002 XEOTICID XEO04897 DESCRIPT Sakacin G inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO04897 GENEFORM Protein DME1002 XEOTICID XEO04897 MOACRIVE Inhibition DME1002 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1002 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO05139 XEO_CLAS Peptide DME1002 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO05139 GENEFORM Protein DME1002 XEOTICID XEO05139 MOACRIVE Inhibition DME1002 XEOTICID XEO05196 XEO_NAME Ubericin-A DME1002 XEOTICID XEO05196 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO05196 XEO_CLAS Peptide DME1002 XEOTICID XEO05196 DESCRIPT Ubericin-A inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO05196 GENEFORM Protein DME1002 XEOTICID XEO05196 MOACRIVE Inhibition DME1002 XEOTICID XEO05201 XEO_NAME Uperin-3.5 DME1002 XEOTICID XEO05201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO05201 XEO_CLAS Peptide DME1002 XEOTICID XEO05201 DESCRIPT Uperin-3.5 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis (MIC = 3 ug/ml) DME1002 XEOTICID XEO05201 GENEFORM Protein DME1002 XEOTICID XEO05201 MOACRIVE Inhibition DME1002 XEOTICID XEO05202 XEO_NAME Uperin-3.6 DME1002 XEOTICID XEO05202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO05202 XEO_CLAS Peptide DME1002 XEOTICID XEO05202 DESCRIPT Uperin-3.6 inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis (MIC = 3 ug/ml) DME1002 XEOTICID XEO05202 GENEFORM Protein DME1002 XEOTICID XEO05202 MOACRIVE Inhibition DME1002 XEOTICID XEO05228 XEO_NAME Variacin DME1002 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO05228 XEO_CLAS Peptide DME1002 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO05228 GENEFORM Protein DME1002 XEOTICID XEO05228 MOACRIVE Inhibition DME1002 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1002 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1002 XEOTICID XEO05283 XEO_CLAS Peptide DME1002 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Dipeptidase (pepV) from Lactococcus lactis DME1002 XEOTICID XEO05283 GENEFORM Protein DME1002 XEOTICID XEO05283 MOACRIVE Inhibition DME1004 DME___ID DME1004 DME1004 DME_NAME Beta-lactamase (blaB) DME1004 SPESNAME Enterobacter cloacae DME1004 XEOTICID XEO02226 XEO_NAME Andropin DME1004 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02226 XEO_CLAS Peptide DME1004 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC > 300 microM) DME1004 XEOTICID XEO02226 GENEFORM Protein DME1004 XEOTICID XEO02226 MOACRIVE Inhibition DME1004 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1004 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02230 XEO_CLAS Peptide DME1004 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 0.5-1 microM) DME1004 XEOTICID XEO02230 GENEFORM Protein DME1004 XEOTICID XEO02230 MOACRIVE Inhibition DME1004 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1004 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02275 XEO_CLAS Peptide DME1004 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 35 microM) DME1004 XEOTICID XEO02275 GENEFORM Protein DME1004 XEOTICID XEO02275 MOACRIVE Inhibition DME1004 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1004 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02284 XEO_CLAS Peptide DME1004 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 47.9 microM) DME1004 XEOTICID XEO02284 GENEFORM Protein DME1004 XEOTICID XEO02284 MOACRIVE Inhibition DME1004 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1004 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02285 XEO_CLAS Peptide DME1004 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 47.9 microM) DME1004 XEOTICID XEO02285 GENEFORM Protein DME1004 XEOTICID XEO02285 MOACRIVE Inhibition DME1004 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1004 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02286 XEO_CLAS Peptide DME1004 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 47.9 microM) DME1004 XEOTICID XEO02286 GENEFORM Protein DME1004 XEOTICID XEO02286 MOACRIVE Inhibition DME1004 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1004 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02287 XEO_CLAS Peptide DME1004 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 47.9 microM) DME1004 XEOTICID XEO02287 GENEFORM Protein DME1004 XEOTICID XEO02287 MOACRIVE Inhibition DME1004 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1004 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02319 XEO_CLAS Peptide DME1004 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO02319 GENEFORM Protein DME1004 XEOTICID XEO02319 MOACRIVE Inhibition DME1004 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1004 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02325 XEO_CLAS Peptide DME1004 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 6 microM) DME1004 XEOTICID XEO02325 GENEFORM Protein DME1004 XEOTICID XEO02325 MOACRIVE Inhibition DME1004 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1004 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02333 XEO_CLAS Peptide DME1004 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC > 200 microM) DME1004 XEOTICID XEO02333 GENEFORM Protein DME1004 XEOTICID XEO02333 MOACRIVE Inhibition DME1004 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1004 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02371 XEO_CLAS Peptide DME1004 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 25 ug/ml) DME1004 XEOTICID XEO02371 GENEFORM Protein DME1004 XEOTICID XEO02371 MOACRIVE Inhibition DME1004 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1004 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02473 XEO_CLAS Peptide DME1004 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO02473 GENEFORM Protein DME1004 XEOTICID XEO02473 MOACRIVE Inhibition DME1004 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1004 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02496 XEO_CLAS Peptide DME1004 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 13 microM) DME1004 XEOTICID XEO02496 GENEFORM Protein DME1004 XEOTICID XEO02496 MOACRIVE Inhibition DME1004 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1004 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02497 XEO_CLAS Peptide DME1004 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 25 microM) DME1004 XEOTICID XEO02497 GENEFORM Protein DME1004 XEOTICID XEO02497 MOACRIVE Inhibition DME1004 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1004 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02566 XEO_CLAS Peptide DME1004 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 50 microM) DME1004 XEOTICID XEO02566 GENEFORM Protein DME1004 XEOTICID XEO02566 MOACRIVE Inhibition DME1004 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1004 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02637 XEO_CLAS Peptide DME1004 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 6 microM) DME1004 XEOTICID XEO02637 GENEFORM Protein DME1004 XEOTICID XEO02637 MOACRIVE Inhibition DME1004 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1004 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02688 XEO_CLAS Peptide DME1004 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 50 microM) DME1004 XEOTICID XEO02688 GENEFORM Protein DME1004 XEOTICID XEO02688 MOACRIVE Inhibition DME1004 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1004 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02745 XEO_CLAS Peptide DME1004 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO02745 GENEFORM Protein DME1004 XEOTICID XEO02745 MOACRIVE Inhibition DME1004 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1004 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02746 XEO_CLAS Peptide DME1004 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO02746 GENEFORM Protein DME1004 XEOTICID XEO02746 MOACRIVE Inhibition DME1004 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1004 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO02768 XEO_CLAS Peptide DME1004 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 50-100 ug/ml) DME1004 XEOTICID XEO02768 GENEFORM Protein DME1004 XEOTICID XEO02768 MOACRIVE Inhibition DME1004 XEOTICID XEO03114 XEO_NAME Defensin AaeDefA DME1004 XEOTICID XEO03114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03114 XEO_CLAS Peptide DME1004 XEOTICID XEO03114 DESCRIPT Defensin AaeDefA inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 1.2-2.4 microM) DME1004 XEOTICID XEO03114 GENEFORM Protein DME1004 XEOTICID XEO03114 MOACRIVE Inhibition DME1004 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1004 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03137 XEO_CLAS Peptide DME1004 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO03137 GENEFORM Protein DME1004 XEOTICID XEO03137 MOACRIVE Inhibition DME1004 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1004 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03162 XEO_CLAS Peptide DME1004 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 12.5 microM) DME1004 XEOTICID XEO03162 GENEFORM Protein DME1004 XEOTICID XEO03162 MOACRIVE Inhibition DME1004 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1004 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03223 XEO_CLAS Peptide DME1004 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 1.0 microM) DME1004 XEOTICID XEO03223 GENEFORM Protein DME1004 XEOTICID XEO03223 MOACRIVE Inhibition DME1004 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1004 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03224 XEO_CLAS Peptide DME1004 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 0.5-1 microM) DME1004 XEOTICID XEO03224 GENEFORM Protein DME1004 XEOTICID XEO03224 MOACRIVE Inhibition DME1004 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1004 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03225 XEO_CLAS Peptide DME1004 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 0.4 microM) DME1004 XEOTICID XEO03225 GENEFORM Protein DME1004 XEOTICID XEO03225 MOACRIVE Inhibition DME1004 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1004 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03250 XEO_CLAS Peptide DME1004 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO03250 GENEFORM Protein DME1004 XEOTICID XEO03250 MOACRIVE Inhibition DME1004 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1004 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03251 XEO_CLAS Peptide DME1004 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO03251 GENEFORM Protein DME1004 XEOTICID XEO03251 MOACRIVE Inhibition DME1004 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1004 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03497 XEO_CLAS Peptide DME1004 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 3.15-6.25 microM) DME1004 XEOTICID XEO03497 GENEFORM Protein DME1004 XEOTICID XEO03497 MOACRIVE Inhibition DME1004 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1004 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03498 XEO_CLAS Peptide DME1004 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 3.15-6.25 microM) DME1004 XEOTICID XEO03498 GENEFORM Protein DME1004 XEOTICID XEO03498 MOACRIVE Inhibition DME1004 XEOTICID XEO03519 XEO_NAME Hadrurin DME1004 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03519 XEO_CLAS Peptide DME1004 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO03519 GENEFORM Protein DME1004 XEOTICID XEO03519 MOACRIVE Inhibition DME1004 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1004 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03540 XEO_CLAS Peptide DME1004 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 8-16 ug/ml) DME1004 XEOTICID XEO03540 GENEFORM Protein DME1004 XEOTICID XEO03540 MOACRIVE Inhibition DME1004 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1004 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03556 XEO_CLAS Peptide DME1004 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 8-16 ug/ml) DME1004 XEOTICID XEO03556 GENEFORM Protein DME1004 XEOTICID XEO03556 MOACRIVE Inhibition DME1004 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1004 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03557 XEO_CLAS Peptide DME1004 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 8-16 ug/ml) DME1004 XEOTICID XEO03557 GENEFORM Protein DME1004 XEOTICID XEO03557 MOACRIVE Inhibition DME1004 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1004 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03561 XEO_CLAS Peptide DME1004 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO03561 GENEFORM Protein DME1004 XEOTICID XEO03561 MOACRIVE Inhibition DME1004 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1004 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03585 XEO_CLAS Peptide DME1004 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 62.5 ug/ml) DME1004 XEOTICID XEO03585 GENEFORM Protein DME1004 XEOTICID XEO03585 MOACRIVE Inhibition DME1004 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1004 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03609 XEO_CLAS Peptide DME1004 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO03609 GENEFORM Protein DME1004 XEOTICID XEO03609 MOACRIVE Inhibition DME1004 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1004 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03672 XEO_CLAS Peptide DME1004 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 10 ug/ml) DME1004 XEOTICID XEO03672 GENEFORM Protein DME1004 XEOTICID XEO03672 MOACRIVE Inhibition DME1004 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1004 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03673 XEO_CLAS Peptide DME1004 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 15 ug/ml) DME1004 XEOTICID XEO03673 GENEFORM Protein DME1004 XEOTICID XEO03673 MOACRIVE Inhibition DME1004 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1004 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03674 XEO_CLAS Peptide DME1004 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO03674 GENEFORM Protein DME1004 XEOTICID XEO03674 MOACRIVE Inhibition DME1004 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1004 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03675 XEO_CLAS Peptide DME1004 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 40 microM) DME1004 XEOTICID XEO03675 GENEFORM Protein DME1004 XEOTICID XEO03675 MOACRIVE Inhibition DME1004 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1004 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03681 XEO_CLAS Peptide DME1004 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 1.2-2.5 microM) DME1004 XEOTICID XEO03681 GENEFORM Protein DME1004 XEOTICID XEO03681 MOACRIVE Inhibition DME1004 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1004 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03697 XEO_CLAS Peptide DME1004 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 6.25 microM) DME1004 XEOTICID XEO03697 GENEFORM Protein DME1004 XEOTICID XEO03697 MOACRIVE Inhibition DME1004 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1004 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO03985 XEO_CLAS Peptide DME1004 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 50 ug/ml) DME1004 XEOTICID XEO03985 GENEFORM Protein DME1004 XEOTICID XEO03985 MOACRIVE Inhibition DME1004 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1004 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04348 XEO_CLAS Peptide DME1004 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 20 microM) DME1004 XEOTICID XEO04348 GENEFORM Protein DME1004 XEOTICID XEO04348 MOACRIVE Inhibition DME1004 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1004 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04349 XEO_CLAS Peptide DME1004 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 50 microM) DME1004 XEOTICID XEO04349 GENEFORM Protein DME1004 XEOTICID XEO04349 MOACRIVE Inhibition DME1004 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1004 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04612 XEO_CLAS Peptide DME1004 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 10-20 microM) DME1004 XEOTICID XEO04612 GENEFORM Protein DME1004 XEOTICID XEO04612 MOACRIVE Inhibition DME1004 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1004 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04613 XEO_CLAS Peptide DME1004 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 10-20 microM) DME1004 XEOTICID XEO04613 GENEFORM Protein DME1004 XEOTICID XEO04613 MOACRIVE Inhibition DME1004 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1004 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04627 XEO_CLAS Peptide DME1004 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 12.5 microM) DME1004 XEOTICID XEO04627 GENEFORM Protein DME1004 XEOTICID XEO04627 MOACRIVE Inhibition DME1004 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1004 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04695 XEO_CLAS Peptide DME1004 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO04695 GENEFORM Protein DME1004 XEOTICID XEO04695 MOACRIVE Inhibition DME1004 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1004 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04696 XEO_CLAS Peptide DME1004 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO04696 GENEFORM Protein DME1004 XEOTICID XEO04696 MOACRIVE Inhibition DME1004 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1004 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04699 XEO_CLAS Peptide DME1004 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO04699 GENEFORM Protein DME1004 XEOTICID XEO04699 MOACRIVE Inhibition DME1004 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1004 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04700 XEO_CLAS Peptide DME1004 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO04700 GENEFORM Protein DME1004 XEOTICID XEO04700 MOACRIVE Inhibition DME1004 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1004 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04701 XEO_CLAS Peptide DME1004 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO04701 GENEFORM Protein DME1004 XEOTICID XEO04701 MOACRIVE Inhibition DME1004 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1004 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04702 XEO_CLAS Peptide DME1004 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO04702 GENEFORM Protein DME1004 XEOTICID XEO04702 MOACRIVE Inhibition DME1004 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1004 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04703 XEO_CLAS Peptide DME1004 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO04703 GENEFORM Protein DME1004 XEOTICID XEO04703 MOACRIVE Inhibition DME1004 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1004 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04809 XEO_CLAS Peptide DME1004 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 5 microM) DME1004 XEOTICID XEO04809 GENEFORM Protein DME1004 XEOTICID XEO04809 MOACRIVE Inhibition DME1004 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1004 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04938 XEO_CLAS Peptide DME1004 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC <= 100 microM) DME1004 XEOTICID XEO04938 GENEFORM Protein DME1004 XEOTICID XEO04938 MOACRIVE Inhibition DME1004 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1004 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO04995 XEO_CLAS Peptide DME1004 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 3.12-6.25 microM) DME1004 XEOTICID XEO04995 GENEFORM Protein DME1004 XEOTICID XEO04995 MOACRIVE Inhibition DME1004 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1004 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO05073 XEO_CLAS Peptide DME1004 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 40 microM) DME1004 XEOTICID XEO05073 GENEFORM Protein DME1004 XEOTICID XEO05073 MOACRIVE Inhibition DME1004 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1004 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO05075 XEO_CLAS Peptide DME1004 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 40 microM) DME1004 XEOTICID XEO05075 GENEFORM Protein DME1004 XEOTICID XEO05075 MOACRIVE Inhibition DME1004 XEOTICID XEO05120 XEO_NAME Thanatin DME1004 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO05120 XEO_CLAS Peptide DME1004 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 1.2-2.5 microM) DME1004 XEOTICID XEO05120 GENEFORM Protein DME1004 XEOTICID XEO05120 MOACRIVE Inhibition DME1004 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1004 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO05139 XEO_CLAS Peptide DME1004 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae DME1004 XEOTICID XEO05139 GENEFORM Protein DME1004 XEOTICID XEO05139 MOACRIVE Inhibition DME1004 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1004 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO05220 XEO_CLAS Peptide DME1004 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 5-10 microM) DME1004 XEOTICID XEO05220 GENEFORM Protein DME1004 XEOTICID XEO05220 MOACRIVE Inhibition DME1004 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1004 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1004 XEOTICID XEO05308 XEO_CLAS Peptide DME1004 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cloacae (MIC = 12.0 ug/ml) DME1004 XEOTICID XEO05308 GENEFORM Protein DME1004 XEOTICID XEO05308 MOACRIVE Inhibition DME1005 DME___ID DME1005 DME1005 DME_NAME L-arabinose isomerase (araA) DME1005 SPESNAME Lactobacillus fermentum DME1005 XEOTICID XEO02126 XEO_NAME Acidocin A DME1005 XEOTICID XEO02126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1005 XEOTICID XEO02126 XEO_CLAS Peptide DME1005 XEOTICID XEO02126 DESCRIPT Acidocin A inhibits the drug-metabolizing activity of L-arabinose isomerase (araA) from Lactobacillus fermentum DME1005 XEOTICID XEO02126 GENEFORM Protein DME1005 XEOTICID XEO02126 MOACRIVE Inhibition DME1005 XEOTICID XEO02127 XEO_NAME Acidocin B DME1005 XEOTICID XEO02127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1005 XEOTICID XEO02127 XEO_CLAS Peptide DME1005 XEOTICID XEO02127 DESCRIPT Acidocin B inhibits the drug-metabolizing activity of L-arabinose isomerase (araA) from Lactobacillus fermentum DME1005 XEOTICID XEO02127 GENEFORM Protein DME1005 XEOTICID XEO02127 MOACRIVE Inhibition DME1005 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1005 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1005 XEOTICID XEO02958 XEO_CLAS Peptide DME1005 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of L-arabinose isomerase (araA) from Lactobacillus fermentum DME1005 XEOTICID XEO02958 GENEFORM Protein DME1005 XEOTICID XEO02958 MOACRIVE Inhibition DME1005 XEOTICID XEO05136 XEO_NAME Thuricin CDalpha DME1005 XEOTICID XEO05136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1005 XEOTICID XEO05136 XEO_CLAS Peptide DME1005 XEOTICID XEO05136 DESCRIPT Thuricin CDalpha inhibits the drug-metabolizing activity of L-arabinose isomerase (araA) from Lactobacillus fermentum DME1005 XEOTICID XEO05136 GENEFORM Protein DME1005 XEOTICID XEO05136 MOACRIVE Inhibition DME1005 XEOTICID XEO05137 XEO_NAME Thuricin CDdbeta DME1005 XEOTICID XEO05137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1005 XEOTICID XEO05137 XEO_CLAS Peptide DME1005 XEOTICID XEO05137 DESCRIPT Thuricin CDdbeta inhibits the drug-metabolizing activity of L-arabinose isomerase (araA) from Lactobacillus fermentum DME1005 XEOTICID XEO05137 GENEFORM Protein DME1005 XEOTICID XEO05137 MOACRIVE Inhibition DME1008 DME___ID DME1008 DME1008 DME_NAME Tripeptidase (pepT) DME1008 SPESNAME Lactococcus lactis DME1008 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1008 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO02298 XEO_CLAS Peptide DME1008 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis (MIC > 128 ug/ml) DME1008 XEOTICID XEO02298 GENEFORM Protein DME1008 XEOTICID XEO02298 MOACRIVE Inhibition DME1008 XEOTICID XEO02335 XEO_NAME Aurein-1.1 DME1008 XEOTICID XEO02335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO02335 XEO_CLAS Peptide DME1008 XEOTICID XEO02335 DESCRIPT Aurein-1.1 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis (MIC = 25 ug/ml) DME1008 XEOTICID XEO02335 GENEFORM Protein DME1008 XEOTICID XEO02335 MOACRIVE Inhibition DME1008 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1008 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO02721 XEO_CLAS Peptide DME1008 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO02721 GENEFORM Protein DME1008 XEOTICID XEO02721 MOACRIVE Inhibition DME1008 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1008 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03111 XEO_CLAS Peptide DME1008 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO03111 GENEFORM Protein DME1008 XEOTICID XEO03111 MOACRIVE Inhibition DME1008 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1008 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03250 XEO_CLAS Peptide DME1008 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO03250 GENEFORM Protein DME1008 XEOTICID XEO03250 MOACRIVE Inhibition DME1008 XEOTICID XEO03255 XEO_NAME Enterocin L50A DME1008 XEOTICID XEO03255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03255 XEO_CLAS Peptide DME1008 XEOTICID XEO03255 DESCRIPT Enterocin L50A inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO03255 GENEFORM Protein DME1008 XEOTICID XEO03255 MOACRIVE Inhibition DME1008 XEOTICID XEO03256 XEO_NAME Enterocin L50B DME1008 XEOTICID XEO03256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03256 XEO_CLAS Peptide DME1008 XEOTICID XEO03256 DESCRIPT Enterocin L50B inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO03256 GENEFORM Protein DME1008 XEOTICID XEO03256 MOACRIVE Inhibition DME1008 XEOTICID XEO03257 XEO_NAME Enterocin P DME1008 XEOTICID XEO03257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03257 XEO_CLAS Peptide DME1008 XEOTICID XEO03257 DESCRIPT Enterocin P inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis (MIC = 0.022 ug/ml) DME1008 XEOTICID XEO03257 GENEFORM Protein DME1008 XEOTICID XEO03257 MOACRIVE Inhibition DME1008 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1008 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03258 XEO_CLAS Peptide DME1008 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO03258 GENEFORM Protein DME1008 XEOTICID XEO03258 MOACRIVE Inhibition DME1008 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME1008 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03259 XEO_CLAS Peptide DME1008 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis (MIC = 0.813 microM) DME1008 XEOTICID XEO03259 GENEFORM Protein DME1008 XEOTICID XEO03259 MOACRIVE Inhibition DME1008 XEOTICID XEO03381 XEO_NAME Fallaxidin 3.1 DME1008 XEOTICID XEO03381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03381 XEO_CLAS Peptide DME1008 XEOTICID XEO03381 DESCRIPT Fallaxidin 3.1 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis (MIC = 100 microM) DME1008 XEOTICID XEO03381 GENEFORM Protein DME1008 XEOTICID XEO03381 MOACRIVE Inhibition DME1008 XEOTICID XEO03382 XEO_NAME Fallaxidin 3.2 DME1008 XEOTICID XEO03382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03382 XEO_CLAS Peptide DME1008 XEOTICID XEO03382 DESCRIPT Fallaxidin 3.2 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis (MIC = 500 microM) DME1008 XEOTICID XEO03382 GENEFORM Protein DME1008 XEOTICID XEO03382 MOACRIVE Inhibition DME1008 XEOTICID XEO03383 XEO_NAME Fallaxidin 4.1 DME1008 XEOTICID XEO03383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03383 XEO_CLAS Peptide DME1008 XEOTICID XEO03383 DESCRIPT Fallaxidin 4.1 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis (MIC = 12 microM) DME1008 XEOTICID XEO03383 GENEFORM Protein DME1008 XEOTICID XEO03383 MOACRIVE Inhibition DME1008 XEOTICID XEO03473 XEO_NAME Garvicin ML DME1008 XEOTICID XEO03473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03473 XEO_CLAS Peptide DME1008 XEOTICID XEO03473 DESCRIPT Garvicin ML inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO03473 GENEFORM Protein DME1008 XEOTICID XEO03473 MOACRIVE Inhibition DME1008 XEOTICID XEO03478 XEO_NAME Geobacillin I DME1008 XEOTICID XEO03478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03478 XEO_CLAS Peptide DME1008 XEOTICID XEO03478 DESCRIPT Geobacillin I inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO03478 GENEFORM Protein DME1008 XEOTICID XEO03478 MOACRIVE Inhibition DME1008 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1008 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03771 XEO_CLAS Peptide DME1008 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO03771 GENEFORM Protein DME1008 XEOTICID XEO03771 MOACRIVE Inhibition DME1008 XEOTICID XEO03773 XEO_NAME Lactococcin Q alpha DME1008 XEOTICID XEO03773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03773 XEO_CLAS Peptide DME1008 XEOTICID XEO03773 DESCRIPT Lactococcin Q alpha inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis (MIC > 1 microM) DME1008 XEOTICID XEO03773 GENEFORM Protein DME1008 XEOTICID XEO03773 MOACRIVE Inhibition DME1008 XEOTICID XEO03774 XEO_NAME Lactococcin Q beta DME1008 XEOTICID XEO03774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03774 XEO_CLAS Peptide DME1008 XEOTICID XEO03774 DESCRIPT Lactococcin Q beta inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis (MIC > 1 microM) DME1008 XEOTICID XEO03774 GENEFORM Protein DME1008 XEOTICID XEO03774 MOACRIVE Inhibition DME1008 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1008 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03775 XEO_CLAS Peptide DME1008 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis (MIC = 0.141 microM) DME1008 XEOTICID XEO03775 GENEFORM Protein DME1008 XEOTICID XEO03775 MOACRIVE Inhibition DME1008 XEOTICID XEO03806 XEO_NAME Lantibiotic paenibacillin DME1008 XEOTICID XEO03806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03806 XEO_CLAS Peptide DME1008 XEOTICID XEO03806 DESCRIPT Lantibiotic paenibacillin inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO03806 GENEFORM Protein DME1008 XEOTICID XEO03806 MOACRIVE Inhibition DME1008 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1008 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO03857 XEO_CLAS Peptide DME1008 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis (MIC = 0.038 microM) DME1008 XEOTICID XEO03857 GENEFORM Protein DME1008 XEOTICID XEO03857 MOACRIVE Inhibition DME1008 XEOTICID XEO04320 XEO_NAME Nisin U DME1008 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04320 XEO_CLAS Peptide DME1008 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04320 GENEFORM Protein DME1008 XEOTICID XEO04320 MOACRIVE Inhibition DME1008 XEOTICID XEO04622 XEO_NAME Plantaricin W alpha DME1008 XEOTICID XEO04622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04622 XEO_CLAS Peptide DME1008 XEOTICID XEO04622 DESCRIPT Plantaricin W alpha inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04622 GENEFORM Protein DME1008 XEOTICID XEO04622 MOACRIVE Inhibition DME1008 XEOTICID XEO04623 XEO_NAME Plantaricin W beta DME1008 XEOTICID XEO04623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04623 XEO_CLAS Peptide DME1008 XEOTICID XEO04623 DESCRIPT Plantaricin W beta inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04623 GENEFORM Protein DME1008 XEOTICID XEO04623 MOACRIVE Inhibition DME1008 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1008 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04695 XEO_CLAS Peptide DME1008 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04695 GENEFORM Protein DME1008 XEOTICID XEO04695 MOACRIVE Inhibition DME1008 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1008 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04696 XEO_CLAS Peptide DME1008 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04696 GENEFORM Protein DME1008 XEOTICID XEO04696 MOACRIVE Inhibition DME1008 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1008 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04697 XEO_CLAS Peptide DME1008 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04697 GENEFORM Protein DME1008 XEOTICID XEO04697 MOACRIVE Inhibition DME1008 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1008 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04698 XEO_CLAS Peptide DME1008 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04698 GENEFORM Protein DME1008 XEOTICID XEO04698 MOACRIVE Inhibition DME1008 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1008 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04699 XEO_CLAS Peptide DME1008 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04699 GENEFORM Protein DME1008 XEOTICID XEO04699 MOACRIVE Inhibition DME1008 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1008 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04700 XEO_CLAS Peptide DME1008 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04700 GENEFORM Protein DME1008 XEOTICID XEO04700 MOACRIVE Inhibition DME1008 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1008 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04701 XEO_CLAS Peptide DME1008 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04701 GENEFORM Protein DME1008 XEOTICID XEO04701 MOACRIVE Inhibition DME1008 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1008 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04702 XEO_CLAS Peptide DME1008 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04702 GENEFORM Protein DME1008 XEOTICID XEO04702 MOACRIVE Inhibition DME1008 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1008 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04703 XEO_CLAS Peptide DME1008 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04703 GENEFORM Protein DME1008 XEOTICID XEO04703 MOACRIVE Inhibition DME1008 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1008 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04704 XEO_CLAS Peptide DME1008 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04704 GENEFORM Protein DME1008 XEOTICID XEO04704 MOACRIVE Inhibition DME1008 XEOTICID XEO04810 XEO_NAME Ranatuerin-2AVa DME1008 XEOTICID XEO04810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04810 XEO_CLAS Peptide DME1008 XEOTICID XEO04810 DESCRIPT Ranatuerin-2AVa inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04810 GENEFORM Protein DME1008 XEOTICID XEO04810 MOACRIVE Inhibition DME1008 XEOTICID XEO04856 XEO_NAME Riparin-2.1 DME1008 XEOTICID XEO04856 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04856 XEO_CLAS Peptide DME1008 XEOTICID XEO04856 DESCRIPT Riparin-2.1 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis (MIC = 25 microM) DME1008 XEOTICID XEO04856 GENEFORM Protein DME1008 XEOTICID XEO04856 MOACRIVE Inhibition DME1008 XEOTICID XEO04897 XEO_NAME Sakacin G DME1008 XEOTICID XEO04897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO04897 XEO_CLAS Peptide DME1008 XEOTICID XEO04897 DESCRIPT Sakacin G inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO04897 GENEFORM Protein DME1008 XEOTICID XEO04897 MOACRIVE Inhibition DME1008 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1008 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO05139 XEO_CLAS Peptide DME1008 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO05139 GENEFORM Protein DME1008 XEOTICID XEO05139 MOACRIVE Inhibition DME1008 XEOTICID XEO05196 XEO_NAME Ubericin-A DME1008 XEOTICID XEO05196 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO05196 XEO_CLAS Peptide DME1008 XEOTICID XEO05196 DESCRIPT Ubericin-A inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO05196 GENEFORM Protein DME1008 XEOTICID XEO05196 MOACRIVE Inhibition DME1008 XEOTICID XEO05201 XEO_NAME Uperin-3.5 DME1008 XEOTICID XEO05201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO05201 XEO_CLAS Peptide DME1008 XEOTICID XEO05201 DESCRIPT Uperin-3.5 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis (MIC = 3 ug/ml) DME1008 XEOTICID XEO05201 GENEFORM Protein DME1008 XEOTICID XEO05201 MOACRIVE Inhibition DME1008 XEOTICID XEO05202 XEO_NAME Uperin-3.6 DME1008 XEOTICID XEO05202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO05202 XEO_CLAS Peptide DME1008 XEOTICID XEO05202 DESCRIPT Uperin-3.6 inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis (MIC = 3 ug/ml) DME1008 XEOTICID XEO05202 GENEFORM Protein DME1008 XEOTICID XEO05202 MOACRIVE Inhibition DME1008 XEOTICID XEO05228 XEO_NAME Variacin DME1008 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO05228 XEO_CLAS Peptide DME1008 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO05228 GENEFORM Protein DME1008 XEOTICID XEO05228 MOACRIVE Inhibition DME1008 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1008 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1008 XEOTICID XEO05283 XEO_CLAS Peptide DME1008 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Tripeptidase (pepT) from Lactococcus lactis DME1008 XEOTICID XEO05283 GENEFORM Protein DME1008 XEOTICID XEO05283 MOACRIVE Inhibition DME1016 DME___ID DME1016 DME1016 DME_NAME Beta-lactamase (blaB) DME1016 SPESNAME Prevotella melaninogenica DME1016 XEOTICID XEO03020 XEO_NAME Lactobacillus brevis culture supernatant DME1016 XEOTICID XEO03020 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1016 XEOTICID XEO03020 XEO_CLAS Bacterial Extract DME1016 XEOTICID XEO03020 DESCRIPT Lactobacillus brevis culture supernatant inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Prevotella melaninogenica DME1016 XEOTICID XEO03020 GENEFORM Protein DME1016 XEOTICID XEO03020 MOACRIVE Inhibition DME1022 DME___ID DME1022 DME1022 DME_NAME Tyramine oxidase (tynA) DME1022 SPESNAME Escherichia coli DME1022 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1022 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00117 GENEFORM Protein DME1022 XEOTICID XEO00117 MOACRIVE Inhibition DME1022 XEOTICID XEO00122 XEO_NAME Amikacin DME1022 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00122 GENEFORM Protein DME1022 XEOTICID XEO00122 MOACRIVE Inhibition DME1022 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1022 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00136 GENEFORM Protein DME1022 XEOTICID XEO00136 MOACRIVE Inhibition DME1022 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1022 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00237 GENEFORM Protein DME1022 XEOTICID XEO00237 MOACRIVE Inhibition DME1022 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1022 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00349 GENEFORM Protein DME1022 XEOTICID XEO00349 MOACRIVE Inhibition DME1022 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1022 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00425 GENEFORM Protein DME1022 XEOTICID XEO00425 MOACRIVE Inhibition DME1022 XEOTICID XEO00439 XEO_NAME Daidzein DME1022 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00439 GENEFORM Protein DME1022 XEOTICID XEO00439 MOACRIVE Inhibition DME1022 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1022 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00460 GENEFORM Protein DME1022 XEOTICID XEO00460 MOACRIVE Inhibition DME1022 XEOTICID XEO00487 XEO_NAME Thymol DME1022 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00487 GENEFORM Protein DME1022 XEOTICID XEO00487 MOACRIVE Inhibition DME1022 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1022 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00511 GENEFORM Protein DME1022 XEOTICID XEO00511 MOACRIVE Inhibition DME1022 XEOTICID XEO00537 XEO_NAME Luteolin DME1022 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1022 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00537 GENEFORM Protein DME1022 XEOTICID XEO00537 MOACRIVE Inhibition DME1022 XEOTICID XEO00538 XEO_NAME Quercetin DME1022 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1022 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00538 GENEFORM Protein DME1022 XEOTICID XEO00538 MOACRIVE Inhibition DME1022 XEOTICID XEO00547 XEO_NAME Vitamin E DME1022 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1022 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00547 GENEFORM Protein DME1022 XEOTICID XEO00547 MOACRIVE Inhibition DME1022 XEOTICID XEO00557 XEO_NAME Genistein DME1022 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1022 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00557 GENEFORM Protein DME1022 XEOTICID XEO00557 MOACRIVE Inhibition DME1022 XEOTICID XEO00566 XEO_NAME Guaiacol DME1022 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1022 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00566 GENEFORM Protein DME1022 XEOTICID XEO00566 MOACRIVE Inhibition DME1022 XEOTICID XEO00568 XEO_NAME Resveratrol DME1022 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1022 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00568 GENEFORM Protein DME1022 XEOTICID XEO00568 MOACRIVE Inhibition DME1022 XEOTICID XEO00573 XEO_NAME Naringenin DME1022 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1022 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00573 GENEFORM Protein DME1022 XEOTICID XEO00573 MOACRIVE Inhibition DME1022 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1022 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1022 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00574 GENEFORM Protein DME1022 XEOTICID XEO00574 MOACRIVE Inhibition DME1022 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1022 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1022 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00611 GENEFORM Protein DME1022 XEOTICID XEO00611 MOACRIVE Inhibition DME1022 XEOTICID XEO00621 XEO_NAME Chitosan DME1022 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1022 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00621 GENEFORM Protein DME1022 XEOTICID XEO00621 MOACRIVE Inhibition DME1022 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1022 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1022 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00646 GENEFORM Protein DME1022 XEOTICID XEO00646 MOACRIVE Inhibition DME1022 XEOTICID XEO00683 XEO_NAME Curcumin DME1022 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1022 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00683 GENEFORM Protein DME1022 XEOTICID XEO00683 MOACRIVE Inhibition DME1022 XEOTICID XEO00727 XEO_NAME Vanillin DME1022 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1022 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00727 GENEFORM Protein DME1022 XEOTICID XEO00727 MOACRIVE Inhibition DME1022 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1022 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1022 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00730 GENEFORM Protein DME1022 XEOTICID XEO00730 MOACRIVE Inhibition DME1022 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1022 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO00782 XEO_CLAS Natural Product DME1022 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00782 GENEFORM Protein DME1022 XEOTICID XEO00782 MOACRIVE Inhibition DME1022 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1022 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1022 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00866 GENEFORM Protein DME1022 XEOTICID XEO00866 MOACRIVE Inhibition DME1022 XEOTICID XEO00878 XEO_NAME Chrysin DME1022 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO00878 XEO_CLAS Natural Product DME1022 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00878 GENEFORM Protein DME1022 XEOTICID XEO00878 MOACRIVE Inhibition DME1022 XEOTICID XEO00879 XEO_NAME Coumarin DME1022 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1022 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1022 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00879 GENEFORM Protein DME1022 XEOTICID XEO00879 MOACRIVE Inhibition DME1022 XEOTICID XEO00883 XEO_NAME Phloretin DME1022 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO00883 XEO_CLAS Natural Product DME1022 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00883 GENEFORM Protein DME1022 XEOTICID XEO00883 MOACRIVE Inhibition DME1022 XEOTICID XEO00885 XEO_NAME Eugenol DME1022 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1022 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO00885 GENEFORM Protein DME1022 XEOTICID XEO00885 MOACRIVE Inhibition DME1022 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1022 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1022 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1022 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01032 GENEFORM Protein DME1022 XEOTICID XEO01032 MOACRIVE Inhibition DME1022 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1022 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01174 XEO_CLAS Natural Product DME1022 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01174 GENEFORM Protein DME1022 XEOTICID XEO01174 MOACRIVE Inhibition DME1022 XEOTICID XEO01203 XEO_NAME Apigenin DME1022 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01203 XEO_CLAS Natural Product DME1022 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01203 GENEFORM Protein DME1022 XEOTICID XEO01203 MOACRIVE Inhibition DME1022 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1022 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1022 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1022 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01232 GENEFORM Protein DME1022 XEOTICID XEO01232 MOACRIVE Inhibition DME1022 XEOTICID XEO01237 XEO_NAME Carvacrol DME1022 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1022 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01237 GENEFORM Protein DME1022 XEOTICID XEO01237 MOACRIVE Inhibition DME1022 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1022 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1022 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01287 GENEFORM Protein DME1022 XEOTICID XEO01287 MOACRIVE Inhibition DME1022 XEOTICID XEO01291 XEO_NAME Esculetin DME1022 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1022 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01291 GENEFORM Protein DME1022 XEOTICID XEO01291 MOACRIVE Inhibition DME1022 XEOTICID XEO01304 XEO_NAME Flavone DME1022 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01304 XEO_CLAS Natural Product DME1022 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01304 GENEFORM Protein DME1022 XEOTICID XEO01304 MOACRIVE Inhibition DME1022 XEOTICID XEO01309 XEO_NAME Gallic acid DME1022 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01309 XEO_CLAS Natural Product DME1022 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01309 GENEFORM Protein DME1022 XEOTICID XEO01309 MOACRIVE Inhibition DME1022 XEOTICID XEO01340 XEO_NAME Imperatorin DME1022 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01340 XEO_CLAS Natural Product DME1022 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01340 GENEFORM Protein DME1022 XEOTICID XEO01340 MOACRIVE Inhibition DME1022 XEOTICID XEO01353 XEO_NAME Kaempferol DME1022 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1022 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1022 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01353 GENEFORM Protein DME1022 XEOTICID XEO01353 MOACRIVE Inhibition DME1022 XEOTICID XEO01366 XEO_NAME Linalool DME1022 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01366 XEO_CLAS Natural Product DME1022 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01366 GENEFORM Protein DME1022 XEOTICID XEO01366 MOACRIVE Inhibition DME1022 XEOTICID XEO01391 XEO_NAME Naringin DME1022 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01391 XEO_CLAS Natural Product DME1022 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01391 GENEFORM Protein DME1022 XEOTICID XEO01391 MOACRIVE Inhibition DME1022 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1022 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1022 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01420 GENEFORM Protein DME1022 XEOTICID XEO01420 MOACRIVE Inhibition DME1022 XEOTICID XEO01463 XEO_NAME Rutin DME1022 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01463 XEO_CLAS Natural Product DME1022 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01463 GENEFORM Protein DME1022 XEOTICID XEO01463 MOACRIVE Inhibition DME1022 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1022 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1022 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01496 GENEFORM Protein DME1022 XEOTICID XEO01496 MOACRIVE Inhibition DME1022 XEOTICID XEO01512 XEO_NAME Zinc DME1022 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1022 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1022 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01512 GENEFORM Protein DME1022 XEOTICID XEO01512 MOACRIVE Inhibition DME1022 XEOTICID XEO01527 XEO_NAME Bergamottin DME1022 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01527 XEO_CLAS Natural Product DME1022 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01527 GENEFORM Protein DME1022 XEOTICID XEO01527 MOACRIVE Inhibition DME1022 XEOTICID XEO01531 XEO_NAME Clove oil DME1022 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01531 XEO_CLAS Natural Product DME1022 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01531 GENEFORM Protein DME1022 XEOTICID XEO01531 MOACRIVE Inhibition DME1022 XEOTICID XEO01559 XEO_NAME Limonene DME1022 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01559 XEO_CLAS Natural Product DME1022 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01559 GENEFORM Protein DME1022 XEOTICID XEO01559 MOACRIVE Inhibition DME1022 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1022 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01563 XEO_CLAS Natural Product DME1022 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01563 GENEFORM Protein DME1022 XEOTICID XEO01563 MOACRIVE Inhibition DME1022 XEOTICID XEO01566 XEO_NAME Nobiletin DME1022 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01566 XEO_CLAS Natural Product DME1022 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01566 GENEFORM Protein DME1022 XEOTICID XEO01566 MOACRIVE Inhibition DME1022 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1022 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01778 XEO_CLAS Natural Product DME1022 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01778 GENEFORM Protein DME1022 XEOTICID XEO01778 MOACRIVE Inhibition DME1022 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1022 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01779 XEO_CLAS Peptide DME1022 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 128 microM) DME1022 XEOTICID XEO01779 GENEFORM Protein DME1022 XEOTICID XEO01779 MOACRIVE Inhibition DME1022 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1022 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01810 XEO_CLAS Peptide DME1022 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.0 microM) DME1022 XEOTICID XEO01810 GENEFORM Protein DME1022 XEOTICID XEO01810 MOACRIVE Inhibition DME1022 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1022 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01811 XEO_CLAS Peptide DME1022 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 microM) DME1022 XEOTICID XEO01811 GENEFORM Protein DME1022 XEOTICID XEO01811 MOACRIVE Inhibition DME1022 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1022 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01812 XEO_CLAS Peptide DME1022 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10.4 microM) DME1022 XEOTICID XEO01812 GENEFORM Protein DME1022 XEOTICID XEO01812 MOACRIVE Inhibition DME1022 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1022 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01813 XEO_CLAS Peptide DME1022 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.1 microM) DME1022 XEOTICID XEO01813 GENEFORM Protein DME1022 XEOTICID XEO01813 MOACRIVE Inhibition DME1022 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1022 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01814 XEO_CLAS Peptide DME1022 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.5 microM) DME1022 XEOTICID XEO01814 GENEFORM Protein DME1022 XEOTICID XEO01814 MOACRIVE Inhibition DME1022 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1022 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01815 XEO_CLAS Peptide DME1022 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9.8 microM) DME1022 XEOTICID XEO01815 GENEFORM Protein DME1022 XEOTICID XEO01815 MOACRIVE Inhibition DME1022 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1022 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01816 XEO_CLAS Peptide DME1022 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO01816 GENEFORM Protein DME1022 XEOTICID XEO01816 MOACRIVE Inhibition DME1022 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1022 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01817 XEO_CLAS Peptide DME1022 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.0 microM) DME1022 XEOTICID XEO01817 GENEFORM Protein DME1022 XEOTICID XEO01817 MOACRIVE Inhibition DME1022 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1022 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01818 XEO_CLAS Peptide DME1022 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4.0 microM) DME1022 XEOTICID XEO01818 GENEFORM Protein DME1022 XEOTICID XEO01818 MOACRIVE Inhibition DME1022 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1022 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01819 XEO_CLAS Peptide DME1022 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO01819 GENEFORM Protein DME1022 XEOTICID XEO01819 MOACRIVE Inhibition DME1022 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1022 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01820 XEO_CLAS Peptide DME1022 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO01820 GENEFORM Protein DME1022 XEOTICID XEO01820 MOACRIVE Inhibition DME1022 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1022 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01821 XEO_CLAS Peptide DME1022 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO01821 GENEFORM Protein DME1022 XEOTICID XEO01821 MOACRIVE Inhibition DME1022 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1022 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01822 XEO_CLAS Peptide DME1022 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 microM) DME1022 XEOTICID XEO01822 GENEFORM Protein DME1022 XEOTICID XEO01822 MOACRIVE Inhibition DME1022 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1022 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01823 XEO_CLAS Peptide DME1022 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO01823 GENEFORM Protein DME1022 XEOTICID XEO01823 MOACRIVE Inhibition DME1022 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1022 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01824 XEO_CLAS Peptide DME1022 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO01824 GENEFORM Protein DME1022 XEOTICID XEO01824 MOACRIVE Inhibition DME1022 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1022 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01825 XEO_CLAS Peptide DME1022 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25.0 microM) DME1022 XEOTICID XEO01825 GENEFORM Protein DME1022 XEOTICID XEO01825 MOACRIVE Inhibition DME1022 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1022 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01827 XEO_CLAS Peptide DME1022 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.12-6.25 microM) DME1022 XEOTICID XEO01827 GENEFORM Protein DME1022 XEOTICID XEO01827 MOACRIVE Inhibition DME1022 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1022 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1022 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1022 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01829 GENEFORM Protein DME1022 XEOTICID XEO01829 MOACRIVE Inhibition DME1022 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1022 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01927 XEO_CLAS Peptide DME1022 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 ug/ml) DME1022 XEOTICID XEO01927 GENEFORM Protein DME1022 XEOTICID XEO01927 MOACRIVE Inhibition DME1022 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1022 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01945 XEO_CLAS Peptide DME1022 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.1 microM) DME1022 XEOTICID XEO01945 GENEFORM Protein DME1022 XEOTICID XEO01945 MOACRIVE Inhibition DME1022 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1022 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01946 XEO_CLAS Peptide DME1022 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.2 microM) DME1022 XEOTICID XEO01946 GENEFORM Protein DME1022 XEOTICID XEO01946 MOACRIVE Inhibition DME1022 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1022 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO01947 XEO_CLAS Natural Product DME1022 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01947 GENEFORM Protein DME1022 XEOTICID XEO01947 MOACRIVE Inhibition DME1022 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1022 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1022 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1022 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01950 GENEFORM Protein DME1022 XEOTICID XEO01950 MOACRIVE Inhibition DME1022 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1022 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1022 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1022 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01961 GENEFORM Protein DME1022 XEOTICID XEO01961 MOACRIVE Inhibition DME1022 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1022 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1022 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1022 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO01966 GENEFORM Protein DME1022 XEOTICID XEO01966 MOACRIVE Inhibition DME1022 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1022 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01996 XEO_CLAS Peptide DME1022 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.7 microM) DME1022 XEOTICID XEO01996 GENEFORM Protein DME1022 XEOTICID XEO01996 MOACRIVE Inhibition DME1022 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1022 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01997 XEO_CLAS Peptide DME1022 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.9 microM) DME1022 XEOTICID XEO01997 GENEFORM Protein DME1022 XEOTICID XEO01997 MOACRIVE Inhibition DME1022 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1022 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01998 XEO_CLAS Peptide DME1022 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO01998 GENEFORM Protein DME1022 XEOTICID XEO01998 MOACRIVE Inhibition DME1022 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1022 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO01999 XEO_CLAS Peptide DME1022 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.5 microM) DME1022 XEOTICID XEO01999 GENEFORM Protein DME1022 XEOTICID XEO01999 MOACRIVE Inhibition DME1022 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1022 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02013 XEO_CLAS Peptide DME1022 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02013 GENEFORM Protein DME1022 XEOTICID XEO02013 MOACRIVE Inhibition DME1022 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1022 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02032 XEO_CLAS Natural Product DME1022 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02032 GENEFORM Protein DME1022 XEOTICID XEO02032 MOACRIVE Inhibition DME1022 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1022 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02033 XEO_CLAS Natural Product DME1022 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02033 GENEFORM Protein DME1022 XEOTICID XEO02033 MOACRIVE Inhibition DME1022 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1022 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02079 XEO_CLAS Natural Product DME1022 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02079 GENEFORM Protein DME1022 XEOTICID XEO02079 MOACRIVE Inhibition DME1022 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1022 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1022 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02085 GENEFORM Protein DME1022 XEOTICID XEO02085 MOACRIVE Inhibition DME1022 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1022 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02111 XEO_CLAS Peptide DME1022 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2-4 ug/ml) DME1022 XEOTICID XEO02111 GENEFORM Protein DME1022 XEOTICID XEO02111 MOACRIVE Inhibition DME1022 XEOTICID XEO02113 XEO_NAME Abaecin DME1022 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02113 XEO_CLAS Peptide DME1022 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02113 GENEFORM Protein DME1022 XEOTICID XEO02113 MOACRIVE Inhibition DME1022 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1022 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02114 XEO_CLAS Peptide DME1022 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-25 ug/ml) DME1022 XEOTICID XEO02114 GENEFORM Protein DME1022 XEOTICID XEO02114 MOACRIVE Inhibition DME1022 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1022 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02115 XEO_CLAS Peptide DME1022 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02115 GENEFORM Protein DME1022 XEOTICID XEO02115 MOACRIVE Inhibition DME1022 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1022 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02117 XEO_CLAS Peptide DME1022 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02117 GENEFORM Protein DME1022 XEOTICID XEO02117 MOACRIVE Inhibition DME1022 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1022 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02118 XEO_CLAS Peptide DME1022 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02118 GENEFORM Protein DME1022 XEOTICID XEO02118 MOACRIVE Inhibition DME1022 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1022 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02119 XEO_CLAS Peptide DME1022 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02119 GENEFORM Protein DME1022 XEOTICID XEO02119 MOACRIVE Inhibition DME1022 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1022 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02120 XEO_CLAS Peptide DME1022 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02120 GENEFORM Protein DME1022 XEOTICID XEO02120 MOACRIVE Inhibition DME1022 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1022 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02121 XEO_CLAS Peptide DME1022 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02121 GENEFORM Protein DME1022 XEOTICID XEO02121 MOACRIVE Inhibition DME1022 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1022 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02122 XEO_CLAS Peptide DME1022 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 ug/ml) DME1022 XEOTICID XEO02122 GENEFORM Protein DME1022 XEOTICID XEO02122 MOACRIVE Inhibition DME1022 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1022 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02130 XEO_CLAS Peptide DME1022 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.7 microM) DME1022 XEOTICID XEO02130 GENEFORM Protein DME1022 XEOTICID XEO02130 MOACRIVE Inhibition DME1022 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1022 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02131 XEO_CLAS Peptide DME1022 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.3 microM) DME1022 XEOTICID XEO02131 GENEFORM Protein DME1022 XEOTICID XEO02131 MOACRIVE Inhibition DME1022 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1022 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02132 XEO_CLAS Peptide DME1022 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.5 microM) DME1022 XEOTICID XEO02132 GENEFORM Protein DME1022 XEOTICID XEO02132 MOACRIVE Inhibition DME1022 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1022 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02136 XEO_CLAS Peptide DME1022 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 ug/ml) DME1022 XEOTICID XEO02136 GENEFORM Protein DME1022 XEOTICID XEO02136 MOACRIVE Inhibition DME1022 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1022 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02147 XEO_CLAS Peptide DME1022 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 382 ug/ml) DME1022 XEOTICID XEO02147 GENEFORM Protein DME1022 XEOTICID XEO02147 MOACRIVE Inhibition DME1022 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1022 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02149 XEO_CLAS Peptide DME1022 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 47.35 microM) DME1022 XEOTICID XEO02149 GENEFORM Protein DME1022 XEOTICID XEO02149 MOACRIVE Inhibition DME1022 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1022 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02164 XEO_CLAS Peptide DME1022 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02164 GENEFORM Protein DME1022 XEOTICID XEO02164 MOACRIVE Inhibition DME1022 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1022 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02165 XEO_CLAS Peptide DME1022 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02165 GENEFORM Protein DME1022 XEOTICID XEO02165 MOACRIVE Inhibition DME1022 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1022 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02166 XEO_CLAS Peptide DME1022 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02166 GENEFORM Protein DME1022 XEOTICID XEO02166 MOACRIVE Inhibition DME1022 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1022 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02167 XEO_CLAS Peptide DME1022 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02167 GENEFORM Protein DME1022 XEOTICID XEO02167 MOACRIVE Inhibition DME1022 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1022 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02168 XEO_CLAS Peptide DME1022 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02168 GENEFORM Protein DME1022 XEOTICID XEO02168 MOACRIVE Inhibition DME1022 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1022 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02169 XEO_CLAS Peptide DME1022 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02169 GENEFORM Protein DME1022 XEOTICID XEO02169 MOACRIVE Inhibition DME1022 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1022 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02170 XEO_CLAS Peptide DME1022 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.4 microM) DME1022 XEOTICID XEO02170 GENEFORM Protein DME1022 XEOTICID XEO02170 MOACRIVE Inhibition DME1022 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1022 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02175 XEO_CLAS Natural Product DME1022 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02175 GENEFORM Protein DME1022 XEOTICID XEO02175 MOACRIVE Inhibition DME1022 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1022 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02177 XEO_CLAS Peptide DME1022 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO02177 GENEFORM Protein DME1022 XEOTICID XEO02177 MOACRIVE Inhibition DME1022 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1022 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02178 XEO_CLAS Peptide DME1022 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO02178 GENEFORM Protein DME1022 XEOTICID XEO02178 MOACRIVE Inhibition DME1022 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1022 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02179 XEO_CLAS Peptide DME1022 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO02179 GENEFORM Protein DME1022 XEOTICID XEO02179 MOACRIVE Inhibition DME1022 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1022 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02180 XEO_CLAS Peptide DME1022 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 214 microM) DME1022 XEOTICID XEO02180 GENEFORM Protein DME1022 XEOTICID XEO02180 MOACRIVE Inhibition DME1022 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1022 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02181 XEO_CLAS Peptide DME1022 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 217 microM) DME1022 XEOTICID XEO02181 GENEFORM Protein DME1022 XEOTICID XEO02181 MOACRIVE Inhibition DME1022 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1022 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02183 XEO_CLAS Peptide DME1022 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 38.4 microM) DME1022 XEOTICID XEO02183 GENEFORM Protein DME1022 XEOTICID XEO02183 MOACRIVE Inhibition DME1022 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1022 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02185 XEO_CLAS Peptide DME1022 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 microM) DME1022 XEOTICID XEO02185 GENEFORM Protein DME1022 XEOTICID XEO02185 MOACRIVE Inhibition DME1022 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1022 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02187 GENEFORM Protein DME1022 XEOTICID XEO02187 MOACRIVE Inhibition DME1022 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1022 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02191 XEO_CLAS Peptide DME1022 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02191 GENEFORM Protein DME1022 XEOTICID XEO02191 MOACRIVE Inhibition DME1022 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1022 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02192 XEO_CLAS Peptide DME1022 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.50 ug/ml) DME1022 XEOTICID XEO02192 GENEFORM Protein DME1022 XEOTICID XEO02192 MOACRIVE Inhibition DME1022 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1022 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02193 XEO_CLAS Peptide DME1022 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02193 GENEFORM Protein DME1022 XEOTICID XEO02193 MOACRIVE Inhibition DME1022 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1022 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02194 XEO_CLAS Peptide DME1022 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02194 GENEFORM Protein DME1022 XEOTICID XEO02194 MOACRIVE Inhibition DME1022 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1022 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02195 XEO_CLAS Peptide DME1022 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.00 ug/ml) DME1022 XEOTICID XEO02195 GENEFORM Protein DME1022 XEOTICID XEO02195 MOACRIVE Inhibition DME1022 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1022 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02197 XEO_CLAS Peptide DME1022 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02197 GENEFORM Protein DME1022 XEOTICID XEO02197 MOACRIVE Inhibition DME1022 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1022 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02200 XEO_CLAS Peptide DME1022 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 ug/ml) DME1022 XEOTICID XEO02200 GENEFORM Protein DME1022 XEOTICID XEO02200 MOACRIVE Inhibition DME1022 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1022 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02201 XEO_CLAS Peptide DME1022 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 ug/ml) DME1022 XEOTICID XEO02201 GENEFORM Protein DME1022 XEOTICID XEO02201 MOACRIVE Inhibition DME1022 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1022 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02202 XEO_CLAS Peptide DME1022 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO02202 GENEFORM Protein DME1022 XEOTICID XEO02202 MOACRIVE Inhibition DME1022 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1022 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02203 XEO_CLAS Peptide DME1022 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 microM) DME1022 XEOTICID XEO02203 GENEFORM Protein DME1022 XEOTICID XEO02203 MOACRIVE Inhibition DME1022 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1022 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02207 XEO_CLAS Peptide DME1022 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.78 ug/ml) DME1022 XEOTICID XEO02207 GENEFORM Protein DME1022 XEOTICID XEO02207 MOACRIVE Inhibition DME1022 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1022 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02208 XEO_CLAS Peptide DME1022 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.13 ug/ml) DME1022 XEOTICID XEO02208 GENEFORM Protein DME1022 XEOTICID XEO02208 MOACRIVE Inhibition DME1022 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1022 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02209 XEO_CLAS Peptide DME1022 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.56 ug/ml) DME1022 XEOTICID XEO02209 GENEFORM Protein DME1022 XEOTICID XEO02209 MOACRIVE Inhibition DME1022 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1022 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02210 XEO_CLAS Peptide DME1022 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 ug/ml) DME1022 XEOTICID XEO02210 GENEFORM Protein DME1022 XEOTICID XEO02210 MOACRIVE Inhibition DME1022 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1022 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02211 XEO_CLAS Peptide DME1022 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25 ug/ml) DME1022 XEOTICID XEO02211 GENEFORM Protein DME1022 XEOTICID XEO02211 MOACRIVE Inhibition DME1022 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1022 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02212 XEO_CLAS Peptide DME1022 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.13 ug/ml) DME1022 XEOTICID XEO02212 GENEFORM Protein DME1022 XEOTICID XEO02212 MOACRIVE Inhibition DME1022 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1022 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02213 XEO_CLAS Peptide DME1022 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.13 ug/ml) DME1022 XEOTICID XEO02213 GENEFORM Protein DME1022 XEOTICID XEO02213 MOACRIVE Inhibition DME1022 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1022 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02214 XEO_CLAS Peptide DME1022 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02214 GENEFORM Protein DME1022 XEOTICID XEO02214 MOACRIVE Inhibition DME1022 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1022 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02215 XEO_CLAS Peptide DME1022 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 ug/ml) DME1022 XEOTICID XEO02215 GENEFORM Protein DME1022 XEOTICID XEO02215 MOACRIVE Inhibition DME1022 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1022 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02216 XEO_CLAS Peptide DME1022 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 126 ug/ml) DME1022 XEOTICID XEO02216 GENEFORM Protein DME1022 XEOTICID XEO02216 MOACRIVE Inhibition DME1022 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1022 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02217 XEO_CLAS Peptide DME1022 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 200 ug/ml) DME1022 XEOTICID XEO02217 GENEFORM Protein DME1022 XEOTICID XEO02217 MOACRIVE Inhibition DME1022 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1022 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02218 XEO_CLAS Peptide DME1022 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 200 ug/ml) DME1022 XEOTICID XEO02218 GENEFORM Protein DME1022 XEOTICID XEO02218 MOACRIVE Inhibition DME1022 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1022 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02219 XEO_CLAS Peptide DME1022 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 200 ug/ml) DME1022 XEOTICID XEO02219 GENEFORM Protein DME1022 XEOTICID XEO02219 MOACRIVE Inhibition DME1022 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1022 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02220 XEO_CLAS Peptide DME1022 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 23.5 ug/ml) DME1022 XEOTICID XEO02220 GENEFORM Protein DME1022 XEOTICID XEO02220 MOACRIVE Inhibition DME1022 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1022 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02221 XEO_CLAS Peptide DME1022 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20.2 ug/ml) DME1022 XEOTICID XEO02221 GENEFORM Protein DME1022 XEOTICID XEO02221 MOACRIVE Inhibition DME1022 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1022 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02222 XEO_CLAS Peptide DME1022 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30.5 ug/ml) DME1022 XEOTICID XEO02222 GENEFORM Protein DME1022 XEOTICID XEO02222 MOACRIVE Inhibition DME1022 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1022 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02223 XEO_CLAS Peptide DME1022 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.2 ug/ml) DME1022 XEOTICID XEO02223 GENEFORM Protein DME1022 XEOTICID XEO02223 MOACRIVE Inhibition DME1022 XEOTICID XEO02224 XEO_NAME Androctonin DME1022 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02224 XEO_CLAS Peptide DME1022 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02224 GENEFORM Protein DME1022 XEOTICID XEO02224 MOACRIVE Inhibition DME1022 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1022 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02225 XEO_CLAS Peptide DME1022 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02225 GENEFORM Protein DME1022 XEOTICID XEO02225 MOACRIVE Inhibition DME1022 XEOTICID XEO02226 XEO_NAME Andropin DME1022 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02226 XEO_CLAS Peptide DME1022 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 140 microM) DME1022 XEOTICID XEO02226 GENEFORM Protein DME1022 XEOTICID XEO02226 MOACRIVE Inhibition DME1022 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1022 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02230 XEO_CLAS Peptide DME1022 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.05-0.1 microM) DME1022 XEOTICID XEO02230 GENEFORM Protein DME1022 XEOTICID XEO02230 MOACRIVE Inhibition DME1022 XEOTICID XEO02232 XEO_NAME Anoplin DME1022 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02232 XEO_CLAS Peptide DME1022 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 13 ug/ml) DME1022 XEOTICID XEO02232 GENEFORM Protein DME1022 XEOTICID XEO02232 MOACRIVE Inhibition DME1022 XEOTICID XEO02233 XEO_NAME Antapin DME1022 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02233 XEO_CLAS Peptide DME1022 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02233 GENEFORM Protein DME1022 XEOTICID XEO02233 MOACRIVE Inhibition DME1022 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1022 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02236 XEO_CLAS Peptide DME1022 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02236 GENEFORM Protein DME1022 XEOTICID XEO02236 MOACRIVE Inhibition DME1022 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1022 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02239 XEO_CLAS Peptide DME1022 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 250 microM) DME1022 XEOTICID XEO02239 GENEFORM Protein DME1022 XEOTICID XEO02239 MOACRIVE Inhibition DME1022 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1022 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02240 XEO_CLAS Peptide DME1022 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 microM) DME1022 XEOTICID XEO02240 GENEFORM Protein DME1022 XEOTICID XEO02240 MOACRIVE Inhibition DME1022 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1022 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02241 XEO_CLAS Peptide DME1022 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02241 GENEFORM Protein DME1022 XEOTICID XEO02241 MOACRIVE Inhibition DME1022 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1022 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02242 XEO_CLAS Peptide DME1022 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO02242 GENEFORM Protein DME1022 XEOTICID XEO02242 MOACRIVE Inhibition DME1022 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1022 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02243 XEO_CLAS Peptide DME1022 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 microM) DME1022 XEOTICID XEO02243 GENEFORM Protein DME1022 XEOTICID XEO02243 MOACRIVE Inhibition DME1022 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1022 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02244 XEO_CLAS Peptide DME1022 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1 microM) DME1022 XEOTICID XEO02244 GENEFORM Protein DME1022 XEOTICID XEO02244 MOACRIVE Inhibition DME1022 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1022 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02245 XEO_CLAS Peptide DME1022 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02245 GENEFORM Protein DME1022 XEOTICID XEO02245 MOACRIVE Inhibition DME1022 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1022 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02246 XEO_CLAS Peptide DME1022 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 microM) DME1022 XEOTICID XEO02246 GENEFORM Protein DME1022 XEOTICID XEO02246 MOACRIVE Inhibition DME1022 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1022 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02247 XEO_CLAS Peptide DME1022 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02247 GENEFORM Protein DME1022 XEOTICID XEO02247 MOACRIVE Inhibition DME1022 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1022 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02248 XEO_CLAS Peptide DME1022 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.3 microM) DME1022 XEOTICID XEO02248 GENEFORM Protein DME1022 XEOTICID XEO02248 MOACRIVE Inhibition DME1022 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1022 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02253 XEO_CLAS Peptide DME1022 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02253 GENEFORM Protein DME1022 XEOTICID XEO02253 MOACRIVE Inhibition DME1022 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1022 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02258 XEO_CLAS Peptide DME1022 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 150 microM) DME1022 XEOTICID XEO02258 GENEFORM Protein DME1022 XEOTICID XEO02258 MOACRIVE Inhibition DME1022 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1022 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02261 XEO_CLAS Peptide DME1022 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 82 ug/ml) DME1022 XEOTICID XEO02261 GENEFORM Protein DME1022 XEOTICID XEO02261 MOACRIVE Inhibition DME1022 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1022 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02263 XEO_CLAS Peptide DME1022 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO02263 GENEFORM Protein DME1022 XEOTICID XEO02263 MOACRIVE Inhibition DME1022 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1022 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02266 XEO_CLAS Peptide DME1022 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 120 microM) DME1022 XEOTICID XEO02266 GENEFORM Protein DME1022 XEOTICID XEO02266 MOACRIVE Inhibition DME1022 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1022 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02268 XEO_CLAS Peptide DME1022 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 170 ug/ml) DME1022 XEOTICID XEO02268 GENEFORM Protein DME1022 XEOTICID XEO02268 MOACRIVE Inhibition DME1022 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1022 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02270 XEO_CLAS Peptide DME1022 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 microM) DME1022 XEOTICID XEO02270 GENEFORM Protein DME1022 XEOTICID XEO02270 MOACRIVE Inhibition DME1022 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1022 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02271 XEO_CLAS Peptide DME1022 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 302 ug/ml) DME1022 XEOTICID XEO02271 GENEFORM Protein DME1022 XEOTICID XEO02271 MOACRIVE Inhibition DME1022 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1022 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02273 XEO_CLAS Peptide DME1022 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 18 microM) DME1022 XEOTICID XEO02273 GENEFORM Protein DME1022 XEOTICID XEO02273 MOACRIVE Inhibition DME1022 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1022 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02274 XEO_CLAS Peptide DME1022 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO02274 GENEFORM Protein DME1022 XEOTICID XEO02274 MOACRIVE Inhibition DME1022 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1022 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02275 XEO_CLAS Peptide DME1022 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 microM) DME1022 XEOTICID XEO02275 GENEFORM Protein DME1022 XEOTICID XEO02275 MOACRIVE Inhibition DME1022 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1022 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02276 XEO_CLAS Peptide DME1022 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 microM) DME1022 XEOTICID XEO02276 GENEFORM Protein DME1022 XEOTICID XEO02276 MOACRIVE Inhibition DME1022 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1022 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02280 XEO_CLAS Peptide DME1022 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02280 GENEFORM Protein DME1022 XEOTICID XEO02280 MOACRIVE Inhibition DME1022 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1022 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02281 XEO_CLAS Peptide DME1022 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02281 GENEFORM Protein DME1022 XEOTICID XEO02281 MOACRIVE Inhibition DME1022 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1022 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02283 XEO_CLAS Peptide DME1022 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.13 ug/ml) DME1022 XEOTICID XEO02283 GENEFORM Protein DME1022 XEOTICID XEO02283 MOACRIVE Inhibition DME1022 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1022 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02284 XEO_CLAS Peptide DME1022 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50.4 microM) DME1022 XEOTICID XEO02284 GENEFORM Protein DME1022 XEOTICID XEO02284 MOACRIVE Inhibition DME1022 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1022 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02285 XEO_CLAS Peptide DME1022 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50.4 microM) DME1022 XEOTICID XEO02285 GENEFORM Protein DME1022 XEOTICID XEO02285 MOACRIVE Inhibition DME1022 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1022 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02286 XEO_CLAS Peptide DME1022 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50.4 microM) DME1022 XEOTICID XEO02286 GENEFORM Protein DME1022 XEOTICID XEO02286 MOACRIVE Inhibition DME1022 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1022 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02287 XEO_CLAS Peptide DME1022 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50.4 microM) DME1022 XEOTICID XEO02287 GENEFORM Protein DME1022 XEOTICID XEO02287 MOACRIVE Inhibition DME1022 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1022 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02288 XEO_CLAS Peptide DME1022 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.2 ug/ml) DME1022 XEOTICID XEO02288 GENEFORM Protein DME1022 XEOTICID XEO02288 MOACRIVE Inhibition DME1022 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1022 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02289 XEO_CLAS Peptide DME1022 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 ug/ml) DME1022 XEOTICID XEO02289 GENEFORM Protein DME1022 XEOTICID XEO02289 MOACRIVE Inhibition DME1022 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1022 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02290 XEO_CLAS Peptide DME1022 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO02290 GENEFORM Protein DME1022 XEOTICID XEO02290 MOACRIVE Inhibition DME1022 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1022 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02291 XEO_CLAS Peptide DME1022 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02291 GENEFORM Protein DME1022 XEOTICID XEO02291 MOACRIVE Inhibition DME1022 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1022 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02293 XEO_CLAS Peptide DME1022 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 microM) DME1022 XEOTICID XEO02293 GENEFORM Protein DME1022 XEOTICID XEO02293 MOACRIVE Inhibition DME1022 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1022 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02294 XEO_CLAS Peptide DME1022 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 62-250 ug/ml) DME1022 XEOTICID XEO02294 GENEFORM Protein DME1022 XEOTICID XEO02294 MOACRIVE Inhibition DME1022 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1022 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02295 XEO_CLAS Peptide DME1022 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 ug/ml) DME1022 XEOTICID XEO02295 GENEFORM Protein DME1022 XEOTICID XEO02295 MOACRIVE Inhibition DME1022 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1022 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02296 XEO_CLAS Peptide DME1022 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02296 GENEFORM Protein DME1022 XEOTICID XEO02296 MOACRIVE Inhibition DME1022 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1022 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02297 XEO_CLAS Peptide DME1022 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC < 50 ug/ml) DME1022 XEOTICID XEO02297 GENEFORM Protein DME1022 XEOTICID XEO02297 MOACRIVE Inhibition DME1022 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1022 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02298 XEO_CLAS Peptide DME1022 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO02298 GENEFORM Protein DME1022 XEOTICID XEO02298 MOACRIVE Inhibition DME1022 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1022 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02303 XEO_CLAS Peptide DME1022 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02303 GENEFORM Protein DME1022 XEOTICID XEO02303 MOACRIVE Inhibition DME1022 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1022 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02304 XEO_CLAS Peptide DME1022 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.1 ug/ml) DME1022 XEOTICID XEO02304 GENEFORM Protein DME1022 XEOTICID XEO02304 MOACRIVE Inhibition DME1022 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1022 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02305 XEO_CLAS Peptide DME1022 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC <= 1 ug/ml) DME1022 XEOTICID XEO02305 GENEFORM Protein DME1022 XEOTICID XEO02305 MOACRIVE Inhibition DME1022 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1022 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02306 XEO_CLAS Peptide DME1022 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.2 ug/ml) DME1022 XEOTICID XEO02306 GENEFORM Protein DME1022 XEOTICID XEO02306 MOACRIVE Inhibition DME1022 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1022 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02309 XEO_CLAS Peptide DME1022 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02309 GENEFORM Protein DME1022 XEOTICID XEO02309 MOACRIVE Inhibition DME1022 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1022 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02310 XEO_CLAS Peptide DME1022 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02310 GENEFORM Protein DME1022 XEOTICID XEO02310 MOACRIVE Inhibition DME1022 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1022 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02315 XEO_CLAS Peptide DME1022 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO02315 GENEFORM Protein DME1022 XEOTICID XEO02315 MOACRIVE Inhibition DME1022 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1022 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02316 XEO_CLAS Peptide DME1022 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 50 microM) DME1022 XEOTICID XEO02316 GENEFORM Protein DME1022 XEOTICID XEO02316 MOACRIVE Inhibition DME1022 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1022 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02317 XEO_CLAS Peptide DME1022 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 300 microM) DME1022 XEOTICID XEO02317 GENEFORM Protein DME1022 XEOTICID XEO02317 MOACRIVE Inhibition DME1022 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1022 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02318 XEO_CLAS Peptide DME1022 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02318 GENEFORM Protein DME1022 XEOTICID XEO02318 MOACRIVE Inhibition DME1022 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1022 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02319 XEO_CLAS Peptide DME1022 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02319 GENEFORM Protein DME1022 XEOTICID XEO02319 MOACRIVE Inhibition DME1022 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1022 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02320 XEO_CLAS Peptide DME1022 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02320 GENEFORM Protein DME1022 XEOTICID XEO02320 MOACRIVE Inhibition DME1022 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1022 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02321 XEO_CLAS Peptide DME1022 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO02321 GENEFORM Protein DME1022 XEOTICID XEO02321 MOACRIVE Inhibition DME1022 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1022 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02322 XEO_CLAS Peptide DME1022 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02322 GENEFORM Protein DME1022 XEOTICID XEO02322 MOACRIVE Inhibition DME1022 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1022 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02323 XEO_CLAS Peptide DME1022 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO02323 GENEFORM Protein DME1022 XEOTICID XEO02323 MOACRIVE Inhibition DME1022 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1022 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02324 XEO_CLAS Peptide DME1022 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02324 GENEFORM Protein DME1022 XEOTICID XEO02324 MOACRIVE Inhibition DME1022 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1022 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02325 XEO_CLAS Peptide DME1022 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO02325 GENEFORM Protein DME1022 XEOTICID XEO02325 MOACRIVE Inhibition DME1022 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1022 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02326 XEO_CLAS Peptide DME1022 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02326 GENEFORM Protein DME1022 XEOTICID XEO02326 MOACRIVE Inhibition DME1022 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1022 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02327 XEO_CLAS Peptide DME1022 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO02327 GENEFORM Protein DME1022 XEOTICID XEO02327 MOACRIVE Inhibition DME1022 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1022 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02328 XEO_CLAS Peptide DME1022 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO02328 GENEFORM Protein DME1022 XEOTICID XEO02328 MOACRIVE Inhibition DME1022 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1022 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02332 XEO_CLAS Peptide DME1022 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.9 ug/ml) DME1022 XEOTICID XEO02332 GENEFORM Protein DME1022 XEOTICID XEO02332 MOACRIVE Inhibition DME1022 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1022 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02333 XEO_CLAS Peptide DME1022 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 200 microM) DME1022 XEOTICID XEO02333 GENEFORM Protein DME1022 XEOTICID XEO02333 MOACRIVE Inhibition DME1022 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1022 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02336 XEO_CLAS Peptide DME1022 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 microM) DME1022 XEOTICID XEO02336 GENEFORM Protein DME1022 XEOTICID XEO02336 MOACRIVE Inhibition DME1022 XEOTICID XEO02346 XEO_NAME Aurelin DME1022 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02346 XEO_CLAS Peptide DME1022 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 7.66 ug/ml) DME1022 XEOTICID XEO02346 GENEFORM Protein DME1022 XEOTICID XEO02346 MOACRIVE Inhibition DME1022 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1022 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02352 XEO_CLAS Peptide DME1022 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 11 ug/ml) DME1022 XEOTICID XEO02352 GENEFORM Protein DME1022 XEOTICID XEO02352 MOACRIVE Inhibition DME1022 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1022 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02353 XEO_CLAS Peptide DME1022 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 ug/ml) DME1022 XEOTICID XEO02353 GENEFORM Protein DME1022 XEOTICID XEO02353 MOACRIVE Inhibition DME1022 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1022 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02354 XEO_CLAS Peptide DME1022 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 ug/ml) DME1022 XEOTICID XEO02354 GENEFORM Protein DME1022 XEOTICID XEO02354 MOACRIVE Inhibition DME1022 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1022 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02355 XEO_CLAS Peptide DME1022 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 17 ug/ml) DME1022 XEOTICID XEO02355 GENEFORM Protein DME1022 XEOTICID XEO02355 MOACRIVE Inhibition DME1022 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1022 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02356 XEO_CLAS Peptide DME1022 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO02356 GENEFORM Protein DME1022 XEOTICID XEO02356 MOACRIVE Inhibition DME1022 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1022 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02357 XEO_CLAS Peptide DME1022 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO02357 GENEFORM Protein DME1022 XEOTICID XEO02357 MOACRIVE Inhibition DME1022 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1022 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02358 XEO_CLAS Peptide DME1022 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO02358 GENEFORM Protein DME1022 XEOTICID XEO02358 MOACRIVE Inhibition DME1022 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1022 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02360 XEO_CLAS Peptide DME1022 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02360 GENEFORM Protein DME1022 XEOTICID XEO02360 MOACRIVE Inhibition DME1022 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1022 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02361 XEO_CLAS Peptide DME1022 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 ug/ml) DME1022 XEOTICID XEO02361 GENEFORM Protein DME1022 XEOTICID XEO02361 MOACRIVE Inhibition DME1022 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1022 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02365 XEO_CLAS Peptide DME1022 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 32 ug/ml) DME1022 XEOTICID XEO02365 GENEFORM Protein DME1022 XEOTICID XEO02365 MOACRIVE Inhibition DME1022 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1022 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02366 XEO_CLAS Peptide DME1022 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO02366 GENEFORM Protein DME1022 XEOTICID XEO02366 MOACRIVE Inhibition DME1022 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1022 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02367 XEO_CLAS Peptide DME1022 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02367 GENEFORM Protein DME1022 XEOTICID XEO02367 MOACRIVE Inhibition DME1022 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1022 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02368 XEO_CLAS Peptide DME1022 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02368 GENEFORM Protein DME1022 XEOTICID XEO02368 MOACRIVE Inhibition DME1022 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1022 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02369 XEO_CLAS Peptide DME1022 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02369 GENEFORM Protein DME1022 XEOTICID XEO02369 MOACRIVE Inhibition DME1022 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1022 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02370 XEO_CLAS Peptide DME1022 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02370 GENEFORM Protein DME1022 XEOTICID XEO02370 MOACRIVE Inhibition DME1022 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1022 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02371 XEO_CLAS Peptide DME1022 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 ug/ml) DME1022 XEOTICID XEO02371 GENEFORM Protein DME1022 XEOTICID XEO02371 MOACRIVE Inhibition DME1022 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1022 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02374 XEO_CLAS Peptide DME1022 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02374 GENEFORM Protein DME1022 XEOTICID XEO02374 MOACRIVE Inhibition DME1022 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1022 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02376 XEO_CLAS Peptide DME1022 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02376 GENEFORM Protein DME1022 XEOTICID XEO02376 MOACRIVE Inhibition DME1022 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1022 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02378 XEO_CLAS Peptide DME1022 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.19 ug/ml) DME1022 XEOTICID XEO02378 GENEFORM Protein DME1022 XEOTICID XEO02378 MOACRIVE Inhibition DME1022 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1022 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02388 XEO_CLAS Peptide DME1022 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO02388 GENEFORM Protein DME1022 XEOTICID XEO02388 MOACRIVE Inhibition DME1022 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1022 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02389 XEO_CLAS Peptide DME1022 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02389 GENEFORM Protein DME1022 XEOTICID XEO02389 MOACRIVE Inhibition DME1022 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1022 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02415 XEO_CLAS Peptide DME1022 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02415 GENEFORM Protein DME1022 XEOTICID XEO02415 MOACRIVE Inhibition DME1022 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1022 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02416 XEO_CLAS Peptide DME1022 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 11 microM) DME1022 XEOTICID XEO02416 GENEFORM Protein DME1022 XEOTICID XEO02416 MOACRIVE Inhibition DME1022 XEOTICID XEO02419 XEO_NAME Bay oil DME1022 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1022 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02419 GENEFORM Protein DME1022 XEOTICID XEO02419 MOACRIVE Inhibition DME1022 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1022 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02435 XEO_CLAS Peptide DME1022 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02435 GENEFORM Protein DME1022 XEOTICID XEO02435 MOACRIVE Inhibition DME1022 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1022 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02436 XEO_CLAS Peptide DME1022 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02436 GENEFORM Protein DME1022 XEOTICID XEO02436 MOACRIVE Inhibition DME1022 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1022 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02437 XEO_CLAS Peptide DME1022 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02437 GENEFORM Protein DME1022 XEOTICID XEO02437 MOACRIVE Inhibition DME1022 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1022 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02438 XEO_CLAS Peptide DME1022 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02438 GENEFORM Protein DME1022 XEOTICID XEO02438 MOACRIVE Inhibition DME1022 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1022 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02439 XEO_CLAS Peptide DME1022 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02439 GENEFORM Protein DME1022 XEOTICID XEO02439 MOACRIVE Inhibition DME1022 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1022 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02440 XEO_CLAS Peptide DME1022 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02440 GENEFORM Protein DME1022 XEOTICID XEO02440 MOACRIVE Inhibition DME1022 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1022 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02441 XEO_CLAS Peptide DME1022 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02441 GENEFORM Protein DME1022 XEOTICID XEO02441 MOACRIVE Inhibition DME1022 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1022 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02442 XEO_CLAS Peptide DME1022 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO02442 GENEFORM Protein DME1022 XEOTICID XEO02442 MOACRIVE Inhibition DME1022 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1022 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02443 XEO_CLAS Peptide DME1022 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02443 GENEFORM Protein DME1022 XEOTICID XEO02443 MOACRIVE Inhibition DME1022 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1022 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02444 XEO_CLAS Peptide DME1022 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02444 GENEFORM Protein DME1022 XEOTICID XEO02444 MOACRIVE Inhibition DME1022 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1022 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1022 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02447 GENEFORM Protein DME1022 XEOTICID XEO02447 MOACRIVE Inhibition DME1022 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1022 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02452 XEO_CLAS Peptide DME1022 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 76800 ug/ml) DME1022 XEOTICID XEO02452 GENEFORM Protein DME1022 XEOTICID XEO02452 MOACRIVE Inhibition DME1022 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1022 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02453 XEO_CLAS Peptide DME1022 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02453 GENEFORM Protein DME1022 XEOTICID XEO02453 MOACRIVE Inhibition DME1022 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1022 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02463 XEO_CLAS Peptide DME1022 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.63 microM) DME1022 XEOTICID XEO02463 GENEFORM Protein DME1022 XEOTICID XEO02463 MOACRIVE Inhibition DME1022 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1022 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02466 XEO_CLAS Peptide DME1022 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.5 microM) DME1022 XEOTICID XEO02466 GENEFORM Protein DME1022 XEOTICID XEO02466 MOACRIVE Inhibition DME1022 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1022 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02467 XEO_CLAS Peptide DME1022 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8.4 microM) DME1022 XEOTICID XEO02467 GENEFORM Protein DME1022 XEOTICID XEO02467 MOACRIVE Inhibition DME1022 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1022 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02468 XEO_CLAS Peptide DME1022 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.7 microM) DME1022 XEOTICID XEO02468 GENEFORM Protein DME1022 XEOTICID XEO02468 MOACRIVE Inhibition DME1022 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1022 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02469 XEO_CLAS Peptide DME1022 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO02469 GENEFORM Protein DME1022 XEOTICID XEO02469 MOACRIVE Inhibition DME1022 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1022 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02470 XEO_CLAS Peptide DME1022 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.8 microM) DME1022 XEOTICID XEO02470 GENEFORM Protein DME1022 XEOTICID XEO02470 MOACRIVE Inhibition DME1022 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1022 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02471 XEO_CLAS Peptide DME1022 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4.8 microM) DME1022 XEOTICID XEO02471 GENEFORM Protein DME1022 XEOTICID XEO02471 MOACRIVE Inhibition DME1022 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1022 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02472 XEO_CLAS Peptide DME1022 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.0 microM) DME1022 XEOTICID XEO02472 GENEFORM Protein DME1022 XEOTICID XEO02472 MOACRIVE Inhibition DME1022 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1022 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02473 XEO_CLAS Peptide DME1022 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02473 GENEFORM Protein DME1022 XEOTICID XEO02473 MOACRIVE Inhibition DME1022 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1022 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02474 XEO_CLAS Peptide DME1022 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.5 microM) DME1022 XEOTICID XEO02474 GENEFORM Protein DME1022 XEOTICID XEO02474 MOACRIVE Inhibition DME1022 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1022 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02475 XEO_CLAS Peptide DME1022 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.5 microM) DME1022 XEOTICID XEO02475 GENEFORM Protein DME1022 XEOTICID XEO02475 MOACRIVE Inhibition DME1022 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1022 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02477 XEO_CLAS Peptide DME1022 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-300 ug/ml) DME1022 XEOTICID XEO02477 GENEFORM Protein DME1022 XEOTICID XEO02477 MOACRIVE Inhibition DME1022 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1022 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02478 XEO_CLAS Peptide DME1022 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-300 ug/ml) DME1022 XEOTICID XEO02478 GENEFORM Protein DME1022 XEOTICID XEO02478 MOACRIVE Inhibition DME1022 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1022 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02479 XEO_CLAS Peptide DME1022 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-300 ug/ml) DME1022 XEOTICID XEO02479 GENEFORM Protein DME1022 XEOTICID XEO02479 MOACRIVE Inhibition DME1022 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1022 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02480 XEO_CLAS Peptide DME1022 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-300 ug/ml) DME1022 XEOTICID XEO02480 GENEFORM Protein DME1022 XEOTICID XEO02480 MOACRIVE Inhibition DME1022 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1022 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02481 XEO_CLAS Peptide DME1022 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-300 ug/ml) DME1022 XEOTICID XEO02481 GENEFORM Protein DME1022 XEOTICID XEO02481 MOACRIVE Inhibition DME1022 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1022 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02482 XEO_CLAS Peptide DME1022 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-300 ug/ml) DME1022 XEOTICID XEO02482 GENEFORM Protein DME1022 XEOTICID XEO02482 MOACRIVE Inhibition DME1022 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1022 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02483 XEO_CLAS Peptide DME1022 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-300 ug/ml) DME1022 XEOTICID XEO02483 GENEFORM Protein DME1022 XEOTICID XEO02483 MOACRIVE Inhibition DME1022 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1022 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02484 XEO_CLAS Peptide DME1022 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-300 ug/ml) DME1022 XEOTICID XEO02484 GENEFORM Protein DME1022 XEOTICID XEO02484 MOACRIVE Inhibition DME1022 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1022 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02485 XEO_CLAS Peptide DME1022 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-300 ug/ml) DME1022 XEOTICID XEO02485 GENEFORM Protein DME1022 XEOTICID XEO02485 MOACRIVE Inhibition DME1022 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1022 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02486 XEO_CLAS Peptide DME1022 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-300 ug/ml) DME1022 XEOTICID XEO02486 GENEFORM Protein DME1022 XEOTICID XEO02486 MOACRIVE Inhibition DME1022 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1022 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02487 XEO_CLAS Peptide DME1022 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02487 GENEFORM Protein DME1022 XEOTICID XEO02487 MOACRIVE Inhibition DME1022 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1022 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02488 XEO_CLAS Peptide DME1022 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-300 ug/ml) DME1022 XEOTICID XEO02488 GENEFORM Protein DME1022 XEOTICID XEO02488 MOACRIVE Inhibition DME1022 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1022 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02489 XEO_CLAS Peptide DME1022 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-301 ug/ml) DME1022 XEOTICID XEO02489 GENEFORM Protein DME1022 XEOTICID XEO02489 MOACRIVE Inhibition DME1022 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1022 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02491 XEO_CLAS Peptide DME1022 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.3 microM) DME1022 XEOTICID XEO02491 GENEFORM Protein DME1022 XEOTICID XEO02491 MOACRIVE Inhibition DME1022 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1022 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02492 XEO_CLAS Peptide DME1022 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 ug/ml) DME1022 XEOTICID XEO02492 GENEFORM Protein DME1022 XEOTICID XEO02492 MOACRIVE Inhibition DME1022 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1022 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02493 XEO_CLAS Peptide DME1022 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 ug/ml) DME1022 XEOTICID XEO02493 GENEFORM Protein DME1022 XEOTICID XEO02493 MOACRIVE Inhibition DME1022 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1022 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02494 XEO_CLAS Peptide DME1022 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 ug/ml) DME1022 XEOTICID XEO02494 GENEFORM Protein DME1022 XEOTICID XEO02494 MOACRIVE Inhibition DME1022 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1022 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02495 XEO_CLAS Peptide DME1022 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 34 ug/ml) DME1022 XEOTICID XEO02495 GENEFORM Protein DME1022 XEOTICID XEO02495 MOACRIVE Inhibition DME1022 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1022 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02496 XEO_CLAS Peptide DME1022 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 13 microM) DME1022 XEOTICID XEO02496 GENEFORM Protein DME1022 XEOTICID XEO02496 MOACRIVE Inhibition DME1022 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1022 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02497 XEO_CLAS Peptide DME1022 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO02497 GENEFORM Protein DME1022 XEOTICID XEO02497 MOACRIVE Inhibition DME1022 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1022 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02499 XEO_CLAS Peptide DME1022 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO02499 GENEFORM Protein DME1022 XEOTICID XEO02499 MOACRIVE Inhibition DME1022 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1022 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02501 XEO_CLAS Peptide DME1022 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 7 microM) DME1022 XEOTICID XEO02501 GENEFORM Protein DME1022 XEOTICID XEO02501 MOACRIVE Inhibition DME1022 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1022 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02502 XEO_CLAS Peptide DME1022 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 microM) DME1022 XEOTICID XEO02502 GENEFORM Protein DME1022 XEOTICID XEO02502 MOACRIVE Inhibition DME1022 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1022 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02503 XEO_CLAS Peptide DME1022 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 19 microM) DME1022 XEOTICID XEO02503 GENEFORM Protein DME1022 XEOTICID XEO02503 MOACRIVE Inhibition DME1022 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1022 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02504 XEO_CLAS Peptide DME1022 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02504 GENEFORM Protein DME1022 XEOTICID XEO02504 MOACRIVE Inhibition DME1022 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1022 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02505 XEO_CLAS Peptide DME1022 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO02505 GENEFORM Protein DME1022 XEOTICID XEO02505 MOACRIVE Inhibition DME1022 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1022 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02507 XEO_CLAS Peptide DME1022 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO02507 GENEFORM Protein DME1022 XEOTICID XEO02507 MOACRIVE Inhibition DME1022 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1022 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02508 XEO_CLAS Peptide DME1022 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 150 microM) DME1022 XEOTICID XEO02508 GENEFORM Protein DME1022 XEOTICID XEO02508 MOACRIVE Inhibition DME1022 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1022 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02509 XEO_CLAS Peptide DME1022 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 150 microM) DME1022 XEOTICID XEO02509 GENEFORM Protein DME1022 XEOTICID XEO02509 MOACRIVE Inhibition DME1022 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1022 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02510 XEO_CLAS Peptide DME1022 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 150 microM) DME1022 XEOTICID XEO02510 GENEFORM Protein DME1022 XEOTICID XEO02510 MOACRIVE Inhibition DME1022 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1022 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02511 XEO_CLAS Peptide DME1022 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 150 microM) DME1022 XEOTICID XEO02511 GENEFORM Protein DME1022 XEOTICID XEO02511 MOACRIVE Inhibition DME1022 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1022 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02512 XEO_CLAS Peptide DME1022 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 75 microM) DME1022 XEOTICID XEO02512 GENEFORM Protein DME1022 XEOTICID XEO02512 MOACRIVE Inhibition DME1022 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1022 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02513 XEO_CLAS Peptide DME1022 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO02513 GENEFORM Protein DME1022 XEOTICID XEO02513 MOACRIVE Inhibition DME1022 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1022 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02514 XEO_CLAS Peptide DME1022 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO02514 GENEFORM Protein DME1022 XEOTICID XEO02514 MOACRIVE Inhibition DME1022 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1022 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02515 XEO_CLAS Peptide DME1022 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 80 microM) DME1022 XEOTICID XEO02515 GENEFORM Protein DME1022 XEOTICID XEO02515 MOACRIVE Inhibition DME1022 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1022 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02516 XEO_CLAS Peptide DME1022 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 32 microM) DME1022 XEOTICID XEO02516 GENEFORM Protein DME1022 XEOTICID XEO02516 MOACRIVE Inhibition DME1022 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1022 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02517 XEO_CLAS Peptide DME1022 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 microM) DME1022 XEOTICID XEO02517 GENEFORM Protein DME1022 XEOTICID XEO02517 MOACRIVE Inhibition DME1022 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1022 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02518 XEO_CLAS Peptide DME1022 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC < 15 microM) DME1022 XEOTICID XEO02518 GENEFORM Protein DME1022 XEOTICID XEO02518 MOACRIVE Inhibition DME1022 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1022 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02519 XEO_CLAS Peptide DME1022 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC < 15 microM) DME1022 XEOTICID XEO02519 GENEFORM Protein DME1022 XEOTICID XEO02519 MOACRIVE Inhibition DME1022 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1022 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02520 XEO_CLAS Peptide DME1022 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC < 15 microM) DME1022 XEOTICID XEO02520 GENEFORM Protein DME1022 XEOTICID XEO02520 MOACRIVE Inhibition DME1022 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1022 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02523 XEO_CLAS Peptide DME1022 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO02523 GENEFORM Protein DME1022 XEOTICID XEO02523 MOACRIVE Inhibition DME1022 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1022 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02524 XEO_CLAS Peptide DME1022 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 150 microM) DME1022 XEOTICID XEO02524 GENEFORM Protein DME1022 XEOTICID XEO02524 MOACRIVE Inhibition DME1022 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1022 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02525 XEO_CLAS Peptide DME1022 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 24 microM) DME1022 XEOTICID XEO02525 GENEFORM Protein DME1022 XEOTICID XEO02525 MOACRIVE Inhibition DME1022 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1022 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02526 XEO_CLAS Peptide DME1022 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 48 microM) DME1022 XEOTICID XEO02526 GENEFORM Protein DME1022 XEOTICID XEO02526 MOACRIVE Inhibition DME1022 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1022 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02527 XEO_CLAS Peptide DME1022 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 119 microM) DME1022 XEOTICID XEO02527 GENEFORM Protein DME1022 XEOTICID XEO02527 MOACRIVE Inhibition DME1022 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1022 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02528 XEO_CLAS Peptide DME1022 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 128 ug/ml) DME1022 XEOTICID XEO02528 GENEFORM Protein DME1022 XEOTICID XEO02528 MOACRIVE Inhibition DME1022 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1022 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02529 XEO_CLAS Peptide DME1022 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 128 ug/ml) DME1022 XEOTICID XEO02529 GENEFORM Protein DME1022 XEOTICID XEO02529 MOACRIVE Inhibition DME1022 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1022 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02530 XEO_CLAS Peptide DME1022 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02530 GENEFORM Protein DME1022 XEOTICID XEO02530 MOACRIVE Inhibition DME1022 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1022 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02531 XEO_CLAS Peptide DME1022 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 microM) DME1022 XEOTICID XEO02531 GENEFORM Protein DME1022 XEOTICID XEO02531 MOACRIVE Inhibition DME1022 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1022 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02533 XEO_CLAS Peptide DME1022 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.2 ug/ml) DME1022 XEOTICID XEO02533 GENEFORM Protein DME1022 XEOTICID XEO02533 MOACRIVE Inhibition DME1022 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1022 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02534 XEO_CLAS Peptide DME1022 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.6 ug/ml) DME1022 XEOTICID XEO02534 GENEFORM Protein DME1022 XEOTICID XEO02534 MOACRIVE Inhibition DME1022 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1022 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02535 XEO_CLAS Peptide DME1022 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.3 ug/ml) DME1022 XEOTICID XEO02535 GENEFORM Protein DME1022 XEOTICID XEO02535 MOACRIVE Inhibition DME1022 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1022 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02536 XEO_CLAS Peptide DME1022 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.4 ug/ml) DME1022 XEOTICID XEO02536 GENEFORM Protein DME1022 XEOTICID XEO02536 MOACRIVE Inhibition DME1022 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1022 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02537 XEO_CLAS Peptide DME1022 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.2 ug/ml) DME1022 XEOTICID XEO02537 GENEFORM Protein DME1022 XEOTICID XEO02537 MOACRIVE Inhibition DME1022 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1022 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02538 XEO_CLAS Peptide DME1022 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9.1 ug/ml) DME1022 XEOTICID XEO02538 GENEFORM Protein DME1022 XEOTICID XEO02538 MOACRIVE Inhibition DME1022 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1022 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02539 XEO_CLAS Peptide DME1022 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8.6 ug/ml) DME1022 XEOTICID XEO02539 GENEFORM Protein DME1022 XEOTICID XEO02539 MOACRIVE Inhibition DME1022 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1022 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02540 XEO_CLAS Peptide DME1022 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15.2 ug/ml) DME1022 XEOTICID XEO02540 GENEFORM Protein DME1022 XEOTICID XEO02540 MOACRIVE Inhibition DME1022 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1022 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02541 XEO_CLAS Peptide DME1022 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 11.1 ug/ml) DME1022 XEOTICID XEO02541 GENEFORM Protein DME1022 XEOTICID XEO02541 MOACRIVE Inhibition DME1022 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1022 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02542 XEO_CLAS Peptide DME1022 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.7 ug/ml) DME1022 XEOTICID XEO02542 GENEFORM Protein DME1022 XEOTICID XEO02542 MOACRIVE Inhibition DME1022 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1022 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02543 XEO_CLAS Peptide DME1022 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 13.1 ug/ml) DME1022 XEOTICID XEO02543 GENEFORM Protein DME1022 XEOTICID XEO02543 MOACRIVE Inhibition DME1022 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1022 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02544 XEO_CLAS Peptide DME1022 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9.8 ug/ml) DME1022 XEOTICID XEO02544 GENEFORM Protein DME1022 XEOTICID XEO02544 MOACRIVE Inhibition DME1022 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1022 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02545 XEO_CLAS Peptide DME1022 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 14 microM) DME1022 XEOTICID XEO02545 GENEFORM Protein DME1022 XEOTICID XEO02545 MOACRIVE Inhibition DME1022 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1022 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02546 XEO_CLAS Peptide DME1022 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 14 microM) DME1022 XEOTICID XEO02546 GENEFORM Protein DME1022 XEOTICID XEO02546 MOACRIVE Inhibition DME1022 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1022 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02547 XEO_CLAS Peptide DME1022 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 microM) DME1022 XEOTICID XEO02547 GENEFORM Protein DME1022 XEOTICID XEO02547 MOACRIVE Inhibition DME1022 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1022 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02548 XEO_CLAS Peptide DME1022 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 78 microM) DME1022 XEOTICID XEO02548 GENEFORM Protein DME1022 XEOTICID XEO02548 MOACRIVE Inhibition DME1022 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1022 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02549 XEO_CLAS Peptide DME1022 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02549 GENEFORM Protein DME1022 XEOTICID XEO02549 MOACRIVE Inhibition DME1022 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1022 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02552 XEO_CLAS Peptide DME1022 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 24 microM) DME1022 XEOTICID XEO02552 GENEFORM Protein DME1022 XEOTICID XEO02552 MOACRIVE Inhibition DME1022 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1022 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02553 XEO_CLAS Peptide DME1022 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02553 GENEFORM Protein DME1022 XEOTICID XEO02553 MOACRIVE Inhibition DME1022 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1022 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02556 XEO_CLAS Peptide DME1022 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 55 microM) DME1022 XEOTICID XEO02556 GENEFORM Protein DME1022 XEOTICID XEO02556 MOACRIVE Inhibition DME1022 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1022 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02557 XEO_CLAS Peptide DME1022 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 17 microM) DME1022 XEOTICID XEO02557 GENEFORM Protein DME1022 XEOTICID XEO02557 MOACRIVE Inhibition DME1022 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1022 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02558 XEO_CLAS Peptide DME1022 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 14 microM) DME1022 XEOTICID XEO02558 GENEFORM Protein DME1022 XEOTICID XEO02558 MOACRIVE Inhibition DME1022 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1022 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02559 XEO_CLAS Peptide DME1022 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02559 GENEFORM Protein DME1022 XEOTICID XEO02559 MOACRIVE Inhibition DME1022 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1022 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02560 XEO_CLAS Peptide DME1022 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 13 microM) DME1022 XEOTICID XEO02560 GENEFORM Protein DME1022 XEOTICID XEO02560 MOACRIVE Inhibition DME1022 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1022 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02561 XEO_CLAS Peptide DME1022 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO02561 GENEFORM Protein DME1022 XEOTICID XEO02561 MOACRIVE Inhibition DME1022 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1022 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02562 XEO_CLAS Peptide DME1022 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 13 microM) DME1022 XEOTICID XEO02562 GENEFORM Protein DME1022 XEOTICID XEO02562 MOACRIVE Inhibition DME1022 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1022 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02563 XEO_CLAS Peptide DME1022 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 45 microM) DME1022 XEOTICID XEO02563 GENEFORM Protein DME1022 XEOTICID XEO02563 MOACRIVE Inhibition DME1022 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1022 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02564 XEO_CLAS Peptide DME1022 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 ug/ml) DME1022 XEOTICID XEO02564 GENEFORM Protein DME1022 XEOTICID XEO02564 MOACRIVE Inhibition DME1022 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1022 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02565 XEO_CLAS Peptide DME1022 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 microM) DME1022 XEOTICID XEO02565 GENEFORM Protein DME1022 XEOTICID XEO02565 MOACRIVE Inhibition DME1022 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1022 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02566 XEO_CLAS Peptide DME1022 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO02566 GENEFORM Protein DME1022 XEOTICID XEO02566 MOACRIVE Inhibition DME1022 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1022 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02568 XEO_CLAS Peptide DME1022 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO02568 GENEFORM Protein DME1022 XEOTICID XEO02568 MOACRIVE Inhibition DME1022 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1022 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02569 XEO_CLAS Peptide DME1022 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO02569 GENEFORM Protein DME1022 XEOTICID XEO02569 MOACRIVE Inhibition DME1022 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1022 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02570 XEO_CLAS Peptide DME1022 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO02570 GENEFORM Protein DME1022 XEOTICID XEO02570 MOACRIVE Inhibition DME1022 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1022 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02571 XEO_CLAS Peptide DME1022 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO02571 GENEFORM Protein DME1022 XEOTICID XEO02571 MOACRIVE Inhibition DME1022 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1022 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02572 XEO_CLAS Peptide DME1022 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02572 GENEFORM Protein DME1022 XEOTICID XEO02572 MOACRIVE Inhibition DME1022 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1022 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02573 XEO_CLAS Peptide DME1022 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02573 GENEFORM Protein DME1022 XEOTICID XEO02573 MOACRIVE Inhibition DME1022 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1022 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02574 XEO_CLAS Peptide DME1022 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 microM) DME1022 XEOTICID XEO02574 GENEFORM Protein DME1022 XEOTICID XEO02574 MOACRIVE Inhibition DME1022 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1022 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02575 XEO_CLAS Peptide DME1022 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 microM) DME1022 XEOTICID XEO02575 GENEFORM Protein DME1022 XEOTICID XEO02575 MOACRIVE Inhibition DME1022 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1022 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02576 XEO_CLAS Peptide DME1022 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 33 microM) DME1022 XEOTICID XEO02576 GENEFORM Protein DME1022 XEOTICID XEO02576 MOACRIVE Inhibition DME1022 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1022 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02577 XEO_CLAS Peptide DME1022 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO02577 GENEFORM Protein DME1022 XEOTICID XEO02577 MOACRIVE Inhibition DME1022 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1022 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02578 XEO_CLAS Peptide DME1022 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02578 GENEFORM Protein DME1022 XEOTICID XEO02578 MOACRIVE Inhibition DME1022 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1022 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02579 XEO_CLAS Peptide DME1022 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02579 GENEFORM Protein DME1022 XEOTICID XEO02579 MOACRIVE Inhibition DME1022 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1022 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02580 XEO_CLAS Peptide DME1022 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC < 15 microM) DME1022 XEOTICID XEO02580 GENEFORM Protein DME1022 XEOTICID XEO02580 MOACRIVE Inhibition DME1022 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1022 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02581 XEO_CLAS Peptide DME1022 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 microM) DME1022 XEOTICID XEO02581 GENEFORM Protein DME1022 XEOTICID XEO02581 MOACRIVE Inhibition DME1022 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1022 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02582 XEO_CLAS Peptide DME1022 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 microM) DME1022 XEOTICID XEO02582 GENEFORM Protein DME1022 XEOTICID XEO02582 MOACRIVE Inhibition DME1022 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1022 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02583 XEO_CLAS Peptide DME1022 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 microM) DME1022 XEOTICID XEO02583 GENEFORM Protein DME1022 XEOTICID XEO02583 MOACRIVE Inhibition DME1022 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1022 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02584 XEO_CLAS Peptide DME1022 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 microM) DME1022 XEOTICID XEO02584 GENEFORM Protein DME1022 XEOTICID XEO02584 MOACRIVE Inhibition DME1022 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1022 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02585 XEO_CLAS Peptide DME1022 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO02585 GENEFORM Protein DME1022 XEOTICID XEO02585 MOACRIVE Inhibition DME1022 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1022 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02586 XEO_CLAS Peptide DME1022 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO02586 GENEFORM Protein DME1022 XEOTICID XEO02586 MOACRIVE Inhibition DME1022 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1022 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02587 XEO_CLAS Peptide DME1022 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02587 GENEFORM Protein DME1022 XEOTICID XEO02587 MOACRIVE Inhibition DME1022 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1022 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02589 XEO_CLAS Peptide DME1022 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8.2 ug/ml) DME1022 XEOTICID XEO02589 GENEFORM Protein DME1022 XEOTICID XEO02589 MOACRIVE Inhibition DME1022 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1022 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02590 XEO_CLAS Peptide DME1022 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9.8 ug/ml) DME1022 XEOTICID XEO02590 GENEFORM Protein DME1022 XEOTICID XEO02590 MOACRIVE Inhibition DME1022 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1022 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02591 XEO_CLAS Peptide DME1022 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO02591 GENEFORM Protein DME1022 XEOTICID XEO02591 MOACRIVE Inhibition DME1022 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1022 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02593 XEO_CLAS Peptide DME1022 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 36 microM) DME1022 XEOTICID XEO02593 GENEFORM Protein DME1022 XEOTICID XEO02593 MOACRIVE Inhibition DME1022 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1022 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02594 XEO_CLAS Peptide DME1022 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02594 GENEFORM Protein DME1022 XEOTICID XEO02594 MOACRIVE Inhibition DME1022 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1022 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02595 XEO_CLAS Peptide DME1022 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO02595 GENEFORM Protein DME1022 XEOTICID XEO02595 MOACRIVE Inhibition DME1022 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1022 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02596 XEO_CLAS Peptide DME1022 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO02596 GENEFORM Protein DME1022 XEOTICID XEO02596 MOACRIVE Inhibition DME1022 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1022 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02597 XEO_CLAS Peptide DME1022 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO02597 GENEFORM Protein DME1022 XEOTICID XEO02597 MOACRIVE Inhibition DME1022 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1022 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02598 XEO_CLAS Peptide DME1022 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 32.5 microM) DME1022 XEOTICID XEO02598 GENEFORM Protein DME1022 XEOTICID XEO02598 MOACRIVE Inhibition DME1022 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1022 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02599 XEO_CLAS Peptide DME1022 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 microM) DME1022 XEOTICID XEO02599 GENEFORM Protein DME1022 XEOTICID XEO02599 MOACRIVE Inhibition DME1022 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1022 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02601 XEO_CLAS Peptide DME1022 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.1 ug/ml) DME1022 XEOTICID XEO02601 GENEFORM Protein DME1022 XEOTICID XEO02601 MOACRIVE Inhibition DME1022 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1022 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02602 XEO_CLAS Peptide DME1022 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 13.2 ug/ml) DME1022 XEOTICID XEO02602 GENEFORM Protein DME1022 XEOTICID XEO02602 MOACRIVE Inhibition DME1022 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1022 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02603 XEO_CLAS Peptide DME1022 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.3 ug/ml) DME1022 XEOTICID XEO02603 GENEFORM Protein DME1022 XEOTICID XEO02603 MOACRIVE Inhibition DME1022 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1022 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02604 XEO_CLAS Peptide DME1022 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO02604 GENEFORM Protein DME1022 XEOTICID XEO02604 MOACRIVE Inhibition DME1022 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1022 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02605 XEO_CLAS Peptide DME1022 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30.6 ug/ml) DME1022 XEOTICID XEO02605 GENEFORM Protein DME1022 XEOTICID XEO02605 MOACRIVE Inhibition DME1022 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1022 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02606 XEO_CLAS Peptide DME1022 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 11.2 ug/ml) DME1022 XEOTICID XEO02606 GENEFORM Protein DME1022 XEOTICID XEO02606 MOACRIVE Inhibition DME1022 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1022 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02607 XEO_CLAS Peptide DME1022 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.8 ug/ml) DME1022 XEOTICID XEO02607 GENEFORM Protein DME1022 XEOTICID XEO02607 MOACRIVE Inhibition DME1022 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1022 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02608 XEO_CLAS Peptide DME1022 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 7.9 ug/ml) DME1022 XEOTICID XEO02608 GENEFORM Protein DME1022 XEOTICID XEO02608 MOACRIVE Inhibition DME1022 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1022 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02609 XEO_CLAS Peptide DME1022 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15.8 ug/ml) DME1022 XEOTICID XEO02609 GENEFORM Protein DME1022 XEOTICID XEO02609 MOACRIVE Inhibition DME1022 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1022 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02610 XEO_CLAS Peptide DME1022 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.1 ug/ml) DME1022 XEOTICID XEO02610 GENEFORM Protein DME1022 XEOTICID XEO02610 MOACRIVE Inhibition DME1022 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1022 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02611 XEO_CLAS Peptide DME1022 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20.6 ug/ml) DME1022 XEOTICID XEO02611 GENEFORM Protein DME1022 XEOTICID XEO02611 MOACRIVE Inhibition DME1022 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1022 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02612 XEO_CLAS Peptide DME1022 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 11.8 ug/ml) DME1022 XEOTICID XEO02612 GENEFORM Protein DME1022 XEOTICID XEO02612 MOACRIVE Inhibition DME1022 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1022 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02613 XEO_CLAS Peptide DME1022 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 13.2 ug/ml) DME1022 XEOTICID XEO02613 GENEFORM Protein DME1022 XEOTICID XEO02613 MOACRIVE Inhibition DME1022 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1022 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02614 XEO_CLAS Peptide DME1022 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.8 ug/ml) DME1022 XEOTICID XEO02614 GENEFORM Protein DME1022 XEOTICID XEO02614 MOACRIVE Inhibition DME1022 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1022 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02615 XEO_CLAS Peptide DME1022 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8.6 ug/ml) DME1022 XEOTICID XEO02615 GENEFORM Protein DME1022 XEOTICID XEO02615 MOACRIVE Inhibition DME1022 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1022 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02616 XEO_CLAS Peptide DME1022 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20.4 ug/ml) DME1022 XEOTICID XEO02616 GENEFORM Protein DME1022 XEOTICID XEO02616 MOACRIVE Inhibition DME1022 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1022 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02617 XEO_CLAS Peptide DME1022 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4.7 ug/ml) DME1022 XEOTICID XEO02617 GENEFORM Protein DME1022 XEOTICID XEO02617 MOACRIVE Inhibition DME1022 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1022 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02618 XEO_CLAS Peptide DME1022 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.6 ug/ml) DME1022 XEOTICID XEO02618 GENEFORM Protein DME1022 XEOTICID XEO02618 MOACRIVE Inhibition DME1022 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1022 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02619 XEO_CLAS Peptide DME1022 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10.5 ug/ml) DME1022 XEOTICID XEO02619 GENEFORM Protein DME1022 XEOTICID XEO02619 MOACRIVE Inhibition DME1022 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1022 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02620 XEO_CLAS Peptide DME1022 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO02620 GENEFORM Protein DME1022 XEOTICID XEO02620 MOACRIVE Inhibition DME1022 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1022 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02621 XEO_CLAS Peptide DME1022 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO02621 GENEFORM Protein DME1022 XEOTICID XEO02621 MOACRIVE Inhibition DME1022 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1022 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02622 XEO_CLAS Peptide DME1022 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO02622 GENEFORM Protein DME1022 XEOTICID XEO02622 MOACRIVE Inhibition DME1022 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1022 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02623 XEO_CLAS Peptide DME1022 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO02623 GENEFORM Protein DME1022 XEOTICID XEO02623 MOACRIVE Inhibition DME1022 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1022 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02624 XEO_CLAS Peptide DME1022 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 18 microM) DME1022 XEOTICID XEO02624 GENEFORM Protein DME1022 XEOTICID XEO02624 MOACRIVE Inhibition DME1022 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1022 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02625 XEO_CLAS Peptide DME1022 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9 microM) DME1022 XEOTICID XEO02625 GENEFORM Protein DME1022 XEOTICID XEO02625 MOACRIVE Inhibition DME1022 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1022 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02626 XEO_CLAS Peptide DME1022 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 18 microM) DME1022 XEOTICID XEO02626 GENEFORM Protein DME1022 XEOTICID XEO02626 MOACRIVE Inhibition DME1022 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1022 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02627 XEO_CLAS Peptide DME1022 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02627 GENEFORM Protein DME1022 XEOTICID XEO02627 MOACRIVE Inhibition DME1022 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1022 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02628 XEO_CLAS Peptide DME1022 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 18 microM) DME1022 XEOTICID XEO02628 GENEFORM Protein DME1022 XEOTICID XEO02628 MOACRIVE Inhibition DME1022 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1022 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02629 XEO_CLAS Peptide DME1022 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 13 microM) DME1022 XEOTICID XEO02629 GENEFORM Protein DME1022 XEOTICID XEO02629 MOACRIVE Inhibition DME1022 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1022 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02630 XEO_CLAS Peptide DME1022 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 ug/ml) DME1022 XEOTICID XEO02630 GENEFORM Protein DME1022 XEOTICID XEO02630 MOACRIVE Inhibition DME1022 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1022 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02631 XEO_CLAS Peptide DME1022 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 ug/ml) DME1022 XEOTICID XEO02631 GENEFORM Protein DME1022 XEOTICID XEO02631 MOACRIVE Inhibition DME1022 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1022 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02634 XEO_CLAS Peptide DME1022 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO02634 GENEFORM Protein DME1022 XEOTICID XEO02634 MOACRIVE Inhibition DME1022 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1022 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02635 XEO_CLAS Peptide DME1022 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40 ug/ml) DME1022 XEOTICID XEO02635 GENEFORM Protein DME1022 XEOTICID XEO02635 MOACRIVE Inhibition DME1022 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1022 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02636 XEO_CLAS Peptide DME1022 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO02636 GENEFORM Protein DME1022 XEOTICID XEO02636 MOACRIVE Inhibition DME1022 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1022 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02637 XEO_CLAS Peptide DME1022 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO02637 GENEFORM Protein DME1022 XEOTICID XEO02637 MOACRIVE Inhibition DME1022 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1022 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02638 XEO_CLAS Peptide DME1022 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 microM) DME1022 XEOTICID XEO02638 GENEFORM Protein DME1022 XEOTICID XEO02638 MOACRIVE Inhibition DME1022 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1022 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02639 XEO_CLAS Peptide DME1022 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 microM) DME1022 XEOTICID XEO02639 GENEFORM Protein DME1022 XEOTICID XEO02639 MOACRIVE Inhibition DME1022 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1022 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02644 XEO_CLAS Peptide DME1022 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02644 GENEFORM Protein DME1022 XEOTICID XEO02644 MOACRIVE Inhibition DME1022 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1022 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02645 XEO_CLAS Peptide DME1022 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02645 GENEFORM Protein DME1022 XEOTICID XEO02645 MOACRIVE Inhibition DME1022 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1022 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02646 XEO_CLAS Peptide DME1022 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02646 GENEFORM Protein DME1022 XEOTICID XEO02646 MOACRIVE Inhibition DME1022 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1022 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02647 XEO_CLAS Peptide DME1022 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02647 GENEFORM Protein DME1022 XEOTICID XEO02647 MOACRIVE Inhibition DME1022 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1022 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02649 XEO_CLAS Peptide DME1022 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO02649 GENEFORM Protein DME1022 XEOTICID XEO02649 MOACRIVE Inhibition DME1022 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1022 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02650 XEO_CLAS Peptide DME1022 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO02650 GENEFORM Protein DME1022 XEOTICID XEO02650 MOACRIVE Inhibition DME1022 XEOTICID XEO02658 XEO_NAME Buthinin DME1022 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02658 XEO_CLAS Peptide DME1022 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02658 GENEFORM Protein DME1022 XEOTICID XEO02658 MOACRIVE Inhibition DME1022 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1022 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02663 XEO_CLAS Peptide DME1022 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25 microM) DME1022 XEOTICID XEO02663 GENEFORM Protein DME1022 XEOTICID XEO02663 MOACRIVE Inhibition DME1022 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1022 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02664 XEO_CLAS Peptide DME1022 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25 microM) DME1022 XEOTICID XEO02664 GENEFORM Protein DME1022 XEOTICID XEO02664 MOACRIVE Inhibition DME1022 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1022 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02672 XEO_CLAS Peptide DME1022 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25 microM) DME1022 XEOTICID XEO02672 GENEFORM Protein DME1022 XEOTICID XEO02672 MOACRIVE Inhibition DME1022 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1022 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02673 XEO_CLAS Peptide DME1022 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1022 XEOTICID XEO02673 GENEFORM Protein DME1022 XEOTICID XEO02673 MOACRIVE Inhibition DME1022 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1022 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02674 XEO_CLAS Peptide DME1022 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.125-6.25 microM) DME1022 XEOTICID XEO02674 GENEFORM Protein DME1022 XEOTICID XEO02674 MOACRIVE Inhibition DME1022 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1022 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02676 XEO_CLAS Peptide DME1022 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO02676 GENEFORM Protein DME1022 XEOTICID XEO02676 MOACRIVE Inhibition DME1022 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1022 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02677 XEO_CLAS Peptide DME1022 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1022 XEOTICID XEO02677 GENEFORM Protein DME1022 XEOTICID XEO02677 MOACRIVE Inhibition DME1022 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1022 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02679 XEO_CLAS Peptide DME1022 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1022 XEOTICID XEO02679 GENEFORM Protein DME1022 XEOTICID XEO02679 MOACRIVE Inhibition DME1022 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1022 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02680 XEO_CLAS Peptide DME1022 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25 microM) DME1022 XEOTICID XEO02680 GENEFORM Protein DME1022 XEOTICID XEO02680 MOACRIVE Inhibition DME1022 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1022 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02683 XEO_CLAS Peptide DME1022 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO02683 GENEFORM Protein DME1022 XEOTICID XEO02683 MOACRIVE Inhibition DME1022 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1022 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02688 XEO_CLAS Peptide DME1022 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO02688 GENEFORM Protein DME1022 XEOTICID XEO02688 MOACRIVE Inhibition DME1022 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1022 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02693 XEO_CLAS Peptide DME1022 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 ug/ml) DME1022 XEOTICID XEO02693 GENEFORM Protein DME1022 XEOTICID XEO02693 MOACRIVE Inhibition DME1022 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1022 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02699 XEO_CLAS Peptide DME1022 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 ug/ml) DME1022 XEOTICID XEO02699 GENEFORM Protein DME1022 XEOTICID XEO02699 MOACRIVE Inhibition DME1022 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1022 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02700 XEO_CLAS Peptide DME1022 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 ug/ml) DME1022 XEOTICID XEO02700 GENEFORM Protein DME1022 XEOTICID XEO02700 MOACRIVE Inhibition DME1022 XEOTICID XEO02703 XEO_NAME Calcitermin DME1022 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02703 XEO_CLAS Peptide DME1022 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02703 GENEFORM Protein DME1022 XEOTICID XEO02703 MOACRIVE Inhibition DME1022 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1022 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02708 XEO_CLAS Peptide DME1022 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO02708 GENEFORM Protein DME1022 XEOTICID XEO02708 MOACRIVE Inhibition DME1022 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1022 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02709 XEO_CLAS Peptide DME1022 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.05 microM) DME1022 XEOTICID XEO02709 GENEFORM Protein DME1022 XEOTICID XEO02709 MOACRIVE Inhibition DME1022 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1022 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1022 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02713 GENEFORM Protein DME1022 XEOTICID XEO02713 MOACRIVE Inhibition DME1022 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1022 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1022 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02714 GENEFORM Protein DME1022 XEOTICID XEO02714 MOACRIVE Inhibition DME1022 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1022 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02726 XEO_CLAS Peptide DME1022 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02726 GENEFORM Protein DME1022 XEOTICID XEO02726 MOACRIVE Inhibition DME1022 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1022 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02731 XEO_CLAS Peptide DME1022 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1 microM) DME1022 XEOTICID XEO02731 GENEFORM Protein DME1022 XEOTICID XEO02731 MOACRIVE Inhibition DME1022 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1022 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02732 XEO_CLAS Peptide DME1022 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.25 microM) DME1022 XEOTICID XEO02732 GENEFORM Protein DME1022 XEOTICID XEO02732 MOACRIVE Inhibition DME1022 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1022 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02733 XEO_CLAS Peptide DME1022 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8-25 ug/ml) DME1022 XEOTICID XEO02733 GENEFORM Protein DME1022 XEOTICID XEO02733 MOACRIVE Inhibition DME1022 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1022 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02735 XEO_CLAS Peptide DME1022 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1 ug/ml) DME1022 XEOTICID XEO02735 GENEFORM Protein DME1022 XEOTICID XEO02735 MOACRIVE Inhibition DME1022 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1022 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02737 XEO_CLAS Peptide DME1022 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02737 GENEFORM Protein DME1022 XEOTICID XEO02737 MOACRIVE Inhibition DME1022 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1022 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02738 XEO_CLAS Peptide DME1022 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO02738 GENEFORM Protein DME1022 XEOTICID XEO02738 MOACRIVE Inhibition DME1022 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1022 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02739 XEO_CLAS Peptide DME1022 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 microM) DME1022 XEOTICID XEO02739 GENEFORM Protein DME1022 XEOTICID XEO02739 MOACRIVE Inhibition DME1022 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1022 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02740 XEO_CLAS Peptide DME1022 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.25 ug/ml) DME1022 XEOTICID XEO02740 GENEFORM Protein DME1022 XEOTICID XEO02740 MOACRIVE Inhibition DME1022 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1022 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02741 XEO_CLAS Peptide DME1022 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 ug/ml) DME1022 XEOTICID XEO02741 GENEFORM Protein DME1022 XEOTICID XEO02741 MOACRIVE Inhibition DME1022 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1022 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02743 XEO_CLAS Peptide DME1022 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.6 ug/ml) DME1022 XEOTICID XEO02743 GENEFORM Protein DME1022 XEOTICID XEO02743 MOACRIVE Inhibition DME1022 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1022 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02744 XEO_CLAS Peptide DME1022 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 18.7 ug/ml) DME1022 XEOTICID XEO02744 GENEFORM Protein DME1022 XEOTICID XEO02744 MOACRIVE Inhibition DME1022 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1022 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02745 XEO_CLAS Peptide DME1022 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02745 GENEFORM Protein DME1022 XEOTICID XEO02745 MOACRIVE Inhibition DME1022 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1022 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02746 XEO_CLAS Peptide DME1022 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02746 GENEFORM Protein DME1022 XEOTICID XEO02746 MOACRIVE Inhibition DME1022 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1022 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02748 XEO_CLAS Peptide DME1022 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02748 GENEFORM Protein DME1022 XEOTICID XEO02748 MOACRIVE Inhibition DME1022 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1022 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02749 XEO_CLAS Peptide DME1022 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20-25 mug/ml) DME1022 XEOTICID XEO02749 GENEFORM Protein DME1022 XEOTICID XEO02749 MOACRIVE Inhibition DME1022 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1022 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02750 XEO_CLAS Peptide DME1022 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02750 GENEFORM Protein DME1022 XEOTICID XEO02750 MOACRIVE Inhibition DME1022 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1022 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02752 XEO_CLAS Peptide DME1022 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02752 GENEFORM Protein DME1022 XEOTICID XEO02752 MOACRIVE Inhibition DME1022 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1022 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02753 XEO_CLAS Peptide DME1022 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02753 GENEFORM Protein DME1022 XEOTICID XEO02753 MOACRIVE Inhibition DME1022 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1022 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02754 XEO_CLAS Peptide DME1022 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 microM) DME1022 XEOTICID XEO02754 GENEFORM Protein DME1022 XEOTICID XEO02754 MOACRIVE Inhibition DME1022 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1022 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02756 XEO_CLAS Peptide DME1022 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 microM) DME1022 XEOTICID XEO02756 GENEFORM Protein DME1022 XEOTICID XEO02756 MOACRIVE Inhibition DME1022 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1022 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02757 XEO_CLAS Peptide DME1022 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1 microM) DME1022 XEOTICID XEO02757 GENEFORM Protein DME1022 XEOTICID XEO02757 MOACRIVE Inhibition DME1022 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1022 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02758 XEO_CLAS Peptide DME1022 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO02758 GENEFORM Protein DME1022 XEOTICID XEO02758 MOACRIVE Inhibition DME1022 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1022 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02759 XEO_CLAS Peptide DME1022 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.6 microM) DME1022 XEOTICID XEO02759 GENEFORM Protein DME1022 XEOTICID XEO02759 MOACRIVE Inhibition DME1022 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1022 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02760 XEO_CLAS Peptide DME1022 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 microM) DME1022 XEOTICID XEO02760 GENEFORM Protein DME1022 XEOTICID XEO02760 MOACRIVE Inhibition DME1022 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1022 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02761 XEO_CLAS Peptide DME1022 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO02761 GENEFORM Protein DME1022 XEOTICID XEO02761 MOACRIVE Inhibition DME1022 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1022 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02762 XEO_CLAS Peptide DME1022 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 microM) DME1022 XEOTICID XEO02762 GENEFORM Protein DME1022 XEOTICID XEO02762 MOACRIVE Inhibition DME1022 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1022 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02763 XEO_CLAS Peptide DME1022 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.4 microM) DME1022 XEOTICID XEO02763 GENEFORM Protein DME1022 XEOTICID XEO02763 MOACRIVE Inhibition DME1022 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1022 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02764 XEO_CLAS Peptide DME1022 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 microM) DME1022 XEOTICID XEO02764 GENEFORM Protein DME1022 XEOTICID XEO02764 MOACRIVE Inhibition DME1022 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1022 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02765 XEO_CLAS Peptide DME1022 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.3 microM) DME1022 XEOTICID XEO02765 GENEFORM Protein DME1022 XEOTICID XEO02765 MOACRIVE Inhibition DME1022 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1022 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02767 XEO_CLAS Peptide DME1022 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02767 GENEFORM Protein DME1022 XEOTICID XEO02767 MOACRIVE Inhibition DME1022 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1022 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02768 XEO_CLAS Peptide DME1022 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1022 XEOTICID XEO02768 GENEFORM Protein DME1022 XEOTICID XEO02768 MOACRIVE Inhibition DME1022 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1022 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02769 XEO_CLAS Peptide DME1022 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.32 microM) DME1022 XEOTICID XEO02769 GENEFORM Protein DME1022 XEOTICID XEO02769 MOACRIVE Inhibition DME1022 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1022 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02770 XEO_CLAS Peptide DME1022 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.30 microM) DME1022 XEOTICID XEO02770 GENEFORM Protein DME1022 XEOTICID XEO02770 MOACRIVE Inhibition DME1022 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1022 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02771 XEO_CLAS Peptide DME1022 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.21 microM) DME1022 XEOTICID XEO02771 GENEFORM Protein DME1022 XEOTICID XEO02771 MOACRIVE Inhibition DME1022 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1022 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02772 XEO_CLAS Peptide DME1022 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02772 GENEFORM Protein DME1022 XEOTICID XEO02772 MOACRIVE Inhibition DME1022 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1022 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02773 XEO_CLAS Peptide DME1022 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.9-8.6 microM) DME1022 XEOTICID XEO02773 GENEFORM Protein DME1022 XEOTICID XEO02773 MOACRIVE Inhibition DME1022 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1022 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02774 XEO_CLAS Peptide DME1022 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.3 microM) DME1022 XEOTICID XEO02774 GENEFORM Protein DME1022 XEOTICID XEO02774 MOACRIVE Inhibition DME1022 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1022 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02789 GENEFORM Protein DME1022 XEOTICID XEO02789 MOACRIVE Inhibition DME1022 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1022 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02790 GENEFORM Protein DME1022 XEOTICID XEO02790 MOACRIVE Inhibition DME1022 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1022 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02791 GENEFORM Protein DME1022 XEOTICID XEO02791 MOACRIVE Inhibition DME1022 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1022 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02792 GENEFORM Protein DME1022 XEOTICID XEO02792 MOACRIVE Inhibition DME1022 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1022 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02793 GENEFORM Protein DME1022 XEOTICID XEO02793 MOACRIVE Inhibition DME1022 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1022 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02794 GENEFORM Protein DME1022 XEOTICID XEO02794 MOACRIVE Inhibition DME1022 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1022 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02795 GENEFORM Protein DME1022 XEOTICID XEO02795 MOACRIVE Inhibition DME1022 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1022 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02796 GENEFORM Protein DME1022 XEOTICID XEO02796 MOACRIVE Inhibition DME1022 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1022 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02797 GENEFORM Protein DME1022 XEOTICID XEO02797 MOACRIVE Inhibition DME1022 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1022 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02799 XEO_CLAS Peptide DME1022 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02799 GENEFORM Protein DME1022 XEOTICID XEO02799 MOACRIVE Inhibition DME1022 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1022 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02800 XEO_CLAS Peptide DME1022 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02800 GENEFORM Protein DME1022 XEOTICID XEO02800 MOACRIVE Inhibition DME1022 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1022 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02802 XEO_CLAS Peptide DME1022 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 microM) DME1022 XEOTICID XEO02802 GENEFORM Protein DME1022 XEOTICID XEO02802 MOACRIVE Inhibition DME1022 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1022 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02807 XEO_CLAS Peptide DME1022 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.2 microM) DME1022 XEOTICID XEO02807 GENEFORM Protein DME1022 XEOTICID XEO02807 MOACRIVE Inhibition DME1022 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1022 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02813 XEO_CLAS Peptide DME1022 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 80 microM) DME1022 XEOTICID XEO02813 GENEFORM Protein DME1022 XEOTICID XEO02813 MOACRIVE Inhibition DME1022 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1022 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02814 XEO_CLAS Peptide DME1022 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 80 microM) DME1022 XEOTICID XEO02814 GENEFORM Protein DME1022 XEOTICID XEO02814 MOACRIVE Inhibition DME1022 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1022 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02815 XEO_CLAS Peptide DME1022 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8.5 microM) DME1022 XEOTICID XEO02815 GENEFORM Protein DME1022 XEOTICID XEO02815 MOACRIVE Inhibition DME1022 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1022 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02816 XEO_CLAS Peptide DME1022 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 80 microM) DME1022 XEOTICID XEO02816 GENEFORM Protein DME1022 XEOTICID XEO02816 MOACRIVE Inhibition DME1022 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1022 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02817 XEO_CLAS Peptide DME1022 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 80 microM) DME1022 XEOTICID XEO02817 GENEFORM Protein DME1022 XEOTICID XEO02817 MOACRIVE Inhibition DME1022 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1022 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02818 XEO_CLAS Peptide DME1022 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.4 microM) DME1022 XEOTICID XEO02818 GENEFORM Protein DME1022 XEOTICID XEO02818 MOACRIVE Inhibition DME1022 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1022 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02819 XEO_CLAS Peptide DME1022 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.6 microM) DME1022 XEOTICID XEO02819 GENEFORM Protein DME1022 XEOTICID XEO02819 MOACRIVE Inhibition DME1022 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1022 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02820 XEO_CLAS Peptide DME1022 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO02820 GENEFORM Protein DME1022 XEOTICID XEO02820 MOACRIVE Inhibition DME1022 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1022 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02821 XEO_CLAS Peptide DME1022 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02821 GENEFORM Protein DME1022 XEOTICID XEO02821 MOACRIVE Inhibition DME1022 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1022 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02824 XEO_CLAS Peptide DME1022 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 35 microM) DME1022 XEOTICID XEO02824 GENEFORM Protein DME1022 XEOTICID XEO02824 MOACRIVE Inhibition DME1022 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1022 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02826 XEO_CLAS Peptide DME1022 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.7 ug/ml) DME1022 XEOTICID XEO02826 GENEFORM Protein DME1022 XEOTICID XEO02826 MOACRIVE Inhibition DME1022 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1022 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02834 GENEFORM Protein DME1022 XEOTICID XEO02834 MOACRIVE Inhibition DME1022 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1022 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02839 XEO_CLAS Peptide DME1022 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.25 microM) DME1022 XEOTICID XEO02839 GENEFORM Protein DME1022 XEOTICID XEO02839 MOACRIVE Inhibition DME1022 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1022 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02841 XEO_CLAS Peptide DME1022 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.25 microM) DME1022 XEOTICID XEO02841 GENEFORM Protein DME1022 XEOTICID XEO02841 MOACRIVE Inhibition DME1022 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1022 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02842 XEO_CLAS Peptide DME1022 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.25 microM) DME1022 XEOTICID XEO02842 GENEFORM Protein DME1022 XEOTICID XEO02842 MOACRIVE Inhibition DME1022 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1022 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02843 XEO_CLAS Peptide DME1022 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02843 GENEFORM Protein DME1022 XEOTICID XEO02843 MOACRIVE Inhibition DME1022 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1022 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02849 GENEFORM Protein DME1022 XEOTICID XEO02849 MOACRIVE Inhibition DME1022 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1022 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02857 XEO_CLAS Peptide DME1022 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 53 microM) DME1022 XEOTICID XEO02857 GENEFORM Protein DME1022 XEOTICID XEO02857 MOACRIVE Inhibition DME1022 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1022 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02858 XEO_CLAS Peptide DME1022 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 53 microM) DME1022 XEOTICID XEO02858 GENEFORM Protein DME1022 XEOTICID XEO02858 MOACRIVE Inhibition DME1022 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1022 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02860 XEO_CLAS Peptide DME1022 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 ug/ml) DME1022 XEOTICID XEO02860 GENEFORM Protein DME1022 XEOTICID XEO02860 MOACRIVE Inhibition DME1022 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1022 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02867 XEO_CLAS Peptide DME1022 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02867 GENEFORM Protein DME1022 XEOTICID XEO02867 MOACRIVE Inhibition DME1022 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1022 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02868 XEO_CLAS Peptide DME1022 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02868 GENEFORM Protein DME1022 XEOTICID XEO02868 MOACRIVE Inhibition DME1022 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1022 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02869 XEO_CLAS Peptide DME1022 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02869 GENEFORM Protein DME1022 XEOTICID XEO02869 MOACRIVE Inhibition DME1022 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1022 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02870 XEO_CLAS Peptide DME1022 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02870 GENEFORM Protein DME1022 XEOTICID XEO02870 MOACRIVE Inhibition DME1022 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1022 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02871 XEO_CLAS Peptide DME1022 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02871 GENEFORM Protein DME1022 XEOTICID XEO02871 MOACRIVE Inhibition DME1022 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1022 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02872 XEO_CLAS Peptide DME1022 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 308 microM) DME1022 XEOTICID XEO02872 GENEFORM Protein DME1022 XEOTICID XEO02872 MOACRIVE Inhibition DME1022 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1022 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02875 XEO_CLAS Peptide DME1022 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.1 microM) DME1022 XEOTICID XEO02875 GENEFORM Protein DME1022 XEOTICID XEO02875 MOACRIVE Inhibition DME1022 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1022 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02876 XEO_CLAS Peptide DME1022 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO02876 GENEFORM Protein DME1022 XEOTICID XEO02876 MOACRIVE Inhibition DME1022 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1022 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02877 XEO_CLAS Peptide DME1022 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO02877 GENEFORM Protein DME1022 XEOTICID XEO02877 MOACRIVE Inhibition DME1022 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1022 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02878 XEO_CLAS Peptide DME1022 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.3 microM) DME1022 XEOTICID XEO02878 GENEFORM Protein DME1022 XEOTICID XEO02878 MOACRIVE Inhibition DME1022 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1022 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02885 XEO_CLAS Peptide DME1022 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02885 GENEFORM Protein DME1022 XEOTICID XEO02885 MOACRIVE Inhibition DME1022 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1022 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02886 XEO_CLAS Peptide DME1022 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02886 GENEFORM Protein DME1022 XEOTICID XEO02886 MOACRIVE Inhibition DME1022 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1022 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02887 XEO_CLAS Peptide DME1022 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1 ug/ml) DME1022 XEOTICID XEO02887 GENEFORM Protein DME1022 XEOTICID XEO02887 MOACRIVE Inhibition DME1022 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1022 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02888 XEO_CLAS Peptide DME1022 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 ug/ml) DME1022 XEOTICID XEO02888 GENEFORM Protein DME1022 XEOTICID XEO02888 MOACRIVE Inhibition DME1022 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1022 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02889 XEO_CLAS Peptide DME1022 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 ug/ml) DME1022 XEOTICID XEO02889 GENEFORM Protein DME1022 XEOTICID XEO02889 MOACRIVE Inhibition DME1022 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1022 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02890 XEO_CLAS Peptide DME1022 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02890 GENEFORM Protein DME1022 XEOTICID XEO02890 MOACRIVE Inhibition DME1022 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1022 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02891 XEO_CLAS Peptide DME1022 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02891 GENEFORM Protein DME1022 XEOTICID XEO02891 MOACRIVE Inhibition DME1022 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1022 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02895 XEO_CLAS Peptide DME1022 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO02895 GENEFORM Protein DME1022 XEOTICID XEO02895 MOACRIVE Inhibition DME1022 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1022 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02896 XEO_CLAS Peptide DME1022 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO02896 GENEFORM Protein DME1022 XEOTICID XEO02896 MOACRIVE Inhibition DME1022 XEOTICID XEO02899 XEO_NAME Coladonin DME1022 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1022 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1022 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02899 GENEFORM Protein DME1022 XEOTICID XEO02899 MOACRIVE Inhibition DME1022 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1022 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02900 XEO_CLAS Peptide DME1022 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02900 GENEFORM Protein DME1022 XEOTICID XEO02900 MOACRIVE Inhibition DME1022 XEOTICID XEO02901 XEO_NAME Colicin-V DME1022 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02901 XEO_CLAS Peptide DME1022 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02901 GENEFORM Protein DME1022 XEOTICID XEO02901 MOACRIVE Inhibition DME1022 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1022 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02904 GENEFORM Protein DME1022 XEOTICID XEO02904 MOACRIVE Inhibition DME1022 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1022 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02908 XEO_CLAS Peptide DME1022 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 50 microM) DME1022 XEOTICID XEO02908 GENEFORM Protein DME1022 XEOTICID XEO02908 MOACRIVE Inhibition DME1022 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1022 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02923 XEO_CLAS Peptide DME1022 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02923 GENEFORM Protein DME1022 XEOTICID XEO02923 MOACRIVE Inhibition DME1022 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1022 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02924 XEO_CLAS Peptide DME1022 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 32 microM) DME1022 XEOTICID XEO02924 GENEFORM Protein DME1022 XEOTICID XEO02924 MOACRIVE Inhibition DME1022 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1022 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1022 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02927 GENEFORM Protein DME1022 XEOTICID XEO02927 MOACRIVE Inhibition DME1022 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1022 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02931 XEO_CLAS Peptide DME1022 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 ug/ml) DME1022 XEOTICID XEO02931 GENEFORM Protein DME1022 XEOTICID XEO02931 MOACRIVE Inhibition DME1022 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1022 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02933 XEO_CLAS Peptide DME1022 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO02933 GENEFORM Protein DME1022 XEOTICID XEO02933 MOACRIVE Inhibition DME1022 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1022 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02934 XEO_CLAS Peptide DME1022 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02934 GENEFORM Protein DME1022 XEOTICID XEO02934 MOACRIVE Inhibition DME1022 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1022 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02935 XEO_CLAS Peptide DME1022 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02935 GENEFORM Protein DME1022 XEOTICID XEO02935 MOACRIVE Inhibition DME1022 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1022 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02936 XEO_CLAS Peptide DME1022 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO02936 GENEFORM Protein DME1022 XEOTICID XEO02936 MOACRIVE Inhibition DME1022 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1022 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02937 XEO_CLAS Peptide DME1022 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02937 GENEFORM Protein DME1022 XEOTICID XEO02937 MOACRIVE Inhibition DME1022 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1022 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02938 XEO_CLAS Peptide DME1022 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 32 ug/ml) DME1022 XEOTICID XEO02938 GENEFORM Protein DME1022 XEOTICID XEO02938 MOACRIVE Inhibition DME1022 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1022 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02939 XEO_CLAS Peptide DME1022 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 11 ug/ml) DME1022 XEOTICID XEO02939 GENEFORM Protein DME1022 XEOTICID XEO02939 MOACRIVE Inhibition DME1022 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1022 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02940 XEO_CLAS Peptide DME1022 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1 ug/ml) DME1022 XEOTICID XEO02940 GENEFORM Protein DME1022 XEOTICID XEO02940 MOACRIVE Inhibition DME1022 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1022 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02941 XEO_CLAS Peptide DME1022 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02941 GENEFORM Protein DME1022 XEOTICID XEO02941 MOACRIVE Inhibition DME1022 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1022 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02944 XEO_CLAS Peptide DME1022 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 microM) DME1022 XEOTICID XEO02944 GENEFORM Protein DME1022 XEOTICID XEO02944 MOACRIVE Inhibition DME1022 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1022 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02945 XEO_CLAS Peptide DME1022 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 microM) DME1022 XEOTICID XEO02945 GENEFORM Protein DME1022 XEOTICID XEO02945 MOACRIVE Inhibition DME1022 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1022 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02946 XEO_CLAS Peptide DME1022 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 microM) DME1022 XEOTICID XEO02946 GENEFORM Protein DME1022 XEOTICID XEO02946 MOACRIVE Inhibition DME1022 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1022 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02947 XEO_CLAS Peptide DME1022 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02947 GENEFORM Protein DME1022 XEOTICID XEO02947 MOACRIVE Inhibition DME1022 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1022 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02948 XEO_CLAS Peptide DME1022 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO02948 GENEFORM Protein DME1022 XEOTICID XEO02948 MOACRIVE Inhibition DME1022 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1022 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02949 XEO_CLAS Peptide DME1022 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO02949 GENEFORM Protein DME1022 XEOTICID XEO02949 MOACRIVE Inhibition DME1022 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1022 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02954 XEO_CLAS Peptide DME1022 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02954 GENEFORM Protein DME1022 XEOTICID XEO02954 MOACRIVE Inhibition DME1022 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1022 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02958 XEO_CLAS Peptide DME1022 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02958 GENEFORM Protein DME1022 XEOTICID XEO02958 MOACRIVE Inhibition DME1022 XEOTICID XEO02962 XEO_NAME Cryptonin DME1022 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02962 XEO_CLAS Peptide DME1022 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.12 ug/ml) DME1022 XEOTICID XEO02962 GENEFORM Protein DME1022 XEOTICID XEO02962 MOACRIVE Inhibition DME1022 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1022 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02965 XEO_CLAS Peptide DME1022 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 ug/ml) DME1022 XEOTICID XEO02965 GENEFORM Protein DME1022 XEOTICID XEO02965 MOACRIVE Inhibition DME1022 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1022 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02969 XEO_CLAS Peptide DME1022 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 microM) DME1022 XEOTICID XEO02969 GENEFORM Protein DME1022 XEOTICID XEO02969 MOACRIVE Inhibition DME1022 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1022 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02971 XEO_CLAS Peptide DME1022 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 microM) DME1022 XEOTICID XEO02971 GENEFORM Protein DME1022 XEOTICID XEO02971 MOACRIVE Inhibition DME1022 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1022 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO02972 XEO_CLAS Peptide DME1022 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.4 microM) DME1022 XEOTICID XEO02972 GENEFORM Protein DME1022 XEOTICID XEO02972 MOACRIVE Inhibition DME1022 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1022 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02990 GENEFORM Protein DME1022 XEOTICID XEO02990 MOACRIVE Inhibition DME1022 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1022 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02991 GENEFORM Protein DME1022 XEOTICID XEO02991 MOACRIVE Inhibition DME1022 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1022 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02992 GENEFORM Protein DME1022 XEOTICID XEO02992 MOACRIVE Inhibition DME1022 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1022 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02993 GENEFORM Protein DME1022 XEOTICID XEO02993 MOACRIVE Inhibition DME1022 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1022 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02994 GENEFORM Protein DME1022 XEOTICID XEO02994 MOACRIVE Inhibition DME1022 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1022 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02995 GENEFORM Protein DME1022 XEOTICID XEO02995 MOACRIVE Inhibition DME1022 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1022 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02996 GENEFORM Protein DME1022 XEOTICID XEO02996 MOACRIVE Inhibition DME1022 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1022 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02997 GENEFORM Protein DME1022 XEOTICID XEO02997 MOACRIVE Inhibition DME1022 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1022 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02998 GENEFORM Protein DME1022 XEOTICID XEO02998 MOACRIVE Inhibition DME1022 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1022 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1022 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO02999 GENEFORM Protein DME1022 XEOTICID XEO02999 MOACRIVE Inhibition DME1022 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1022 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03021 XEO_CLAS Peptide DME1022 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1022 XEOTICID XEO03021 GENEFORM Protein DME1022 XEOTICID XEO03021 MOACRIVE Inhibition DME1022 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1022 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03029 XEO_CLAS Peptide DME1022 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.005 microM) DME1022 XEOTICID XEO03029 GENEFORM Protein DME1022 XEOTICID XEO03029 MOACRIVE Inhibition DME1022 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1022 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03030 XEO_CLAS Peptide DME1022 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.005 microM) DME1022 XEOTICID XEO03030 GENEFORM Protein DME1022 XEOTICID XEO03030 MOACRIVE Inhibition DME1022 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1022 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03031 XEO_CLAS Peptide DME1022 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.3 microM) DME1022 XEOTICID XEO03031 GENEFORM Protein DME1022 XEOTICID XEO03031 MOACRIVE Inhibition DME1022 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1022 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03032 XEO_CLAS Peptide DME1022 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.01 microM) DME1022 XEOTICID XEO03032 GENEFORM Protein DME1022 XEOTICID XEO03032 MOACRIVE Inhibition DME1022 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1022 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03033 XEO_CLAS Peptide DME1022 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.173 microM) DME1022 XEOTICID XEO03033 GENEFORM Protein DME1022 XEOTICID XEO03033 MOACRIVE Inhibition DME1022 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1022 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03034 XEO_CLAS Peptide DME1022 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.518 microM) DME1022 XEOTICID XEO03034 GENEFORM Protein DME1022 XEOTICID XEO03034 MOACRIVE Inhibition DME1022 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1022 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03035 XEO_CLAS Peptide DME1022 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.114 microM) DME1022 XEOTICID XEO03035 GENEFORM Protein DME1022 XEOTICID XEO03035 MOACRIVE Inhibition DME1022 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1022 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03039 XEO_CLAS Peptide DME1022 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.55 microM) DME1022 XEOTICID XEO03039 GENEFORM Protein DME1022 XEOTICID XEO03039 MOACRIVE Inhibition DME1022 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1022 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03043 XEO_CLAS Peptide DME1022 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 microM) DME1022 XEOTICID XEO03043 GENEFORM Protein DME1022 XEOTICID XEO03043 MOACRIVE Inhibition DME1022 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1022 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03044 XEO_CLAS Peptide DME1022 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03044 GENEFORM Protein DME1022 XEOTICID XEO03044 MOACRIVE Inhibition DME1022 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1022 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03045 XEO_CLAS Peptide DME1022 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03045 GENEFORM Protein DME1022 XEOTICID XEO03045 MOACRIVE Inhibition DME1022 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1022 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03046 XEO_CLAS Peptide DME1022 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03046 GENEFORM Protein DME1022 XEOTICID XEO03046 MOACRIVE Inhibition DME1022 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1022 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03049 XEO_CLAS Peptide DME1022 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 microM) DME1022 XEOTICID XEO03049 GENEFORM Protein DME1022 XEOTICID XEO03049 MOACRIVE Inhibition DME1022 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1022 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03055 XEO_CLAS Peptide DME1022 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 microM) DME1022 XEOTICID XEO03055 GENEFORM Protein DME1022 XEOTICID XEO03055 MOACRIVE Inhibition DME1022 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1022 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03059 XEO_CLAS Peptide DME1022 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO03059 GENEFORM Protein DME1022 XEOTICID XEO03059 MOACRIVE Inhibition DME1022 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1022 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03060 XEO_CLAS Peptide DME1022 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO03060 GENEFORM Protein DME1022 XEOTICID XEO03060 MOACRIVE Inhibition DME1022 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1022 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03062 XEO_CLAS Peptide DME1022 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO03062 GENEFORM Protein DME1022 XEOTICID XEO03062 MOACRIVE Inhibition DME1022 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1022 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03064 XEO_CLAS Peptide DME1022 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO03064 GENEFORM Protein DME1022 XEOTICID XEO03064 MOACRIVE Inhibition DME1022 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1022 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03066 XEO_CLAS Peptide DME1022 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO03066 GENEFORM Protein DME1022 XEOTICID XEO03066 MOACRIVE Inhibition DME1022 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1022 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03068 XEO_CLAS Peptide DME1022 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO03068 GENEFORM Protein DME1022 XEOTICID XEO03068 MOACRIVE Inhibition DME1022 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1022 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03073 XEO_CLAS Peptide DME1022 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8-16 ug/ml) DME1022 XEOTICID XEO03073 GENEFORM Protein DME1022 XEOTICID XEO03073 MOACRIVE Inhibition DME1022 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1022 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03081 XEO_CLAS Peptide DME1022 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 microM) DME1022 XEOTICID XEO03081 GENEFORM Protein DME1022 XEOTICID XEO03081 MOACRIVE Inhibition DME1022 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1022 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03082 XEO_CLAS Peptide DME1022 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03082 GENEFORM Protein DME1022 XEOTICID XEO03082 MOACRIVE Inhibition DME1022 XEOTICID XEO03089 XEO_NAME Decoralin DME1022 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03089 XEO_CLAS Peptide DME1022 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 80 microM) DME1022 XEOTICID XEO03089 GENEFORM Protein DME1022 XEOTICID XEO03089 MOACRIVE Inhibition DME1022 XEOTICID XEO03098 XEO_NAME Insect defensin DME1022 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03098 XEO_CLAS Peptide DME1022 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 ug/ml) DME1022 XEOTICID XEO03098 GENEFORM Protein DME1022 XEOTICID XEO03098 MOACRIVE Inhibition DME1022 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1022 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03100 XEO_CLAS Peptide DME1022 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03100 GENEFORM Protein DME1022 XEOTICID XEO03100 MOACRIVE Inhibition DME1022 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1022 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03103 XEO_CLAS Peptide DME1022 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03103 GENEFORM Protein DME1022 XEOTICID XEO03103 MOACRIVE Inhibition DME1022 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1022 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03105 XEO_CLAS Peptide DME1022 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03105 GENEFORM Protein DME1022 XEOTICID XEO03105 MOACRIVE Inhibition DME1022 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1022 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03110 XEO_CLAS Peptide DME1022 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.2 microM) DME1022 XEOTICID XEO03110 GENEFORM Protein DME1022 XEOTICID XEO03110 MOACRIVE Inhibition DME1022 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1022 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03111 XEO_CLAS Peptide DME1022 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03111 GENEFORM Protein DME1022 XEOTICID XEO03111 MOACRIVE Inhibition DME1022 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1022 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03112 XEO_CLAS Peptide DME1022 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 50 ug/ml) DME1022 XEOTICID XEO03112 GENEFORM Protein DME1022 XEOTICID XEO03112 MOACRIVE Inhibition DME1022 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1022 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03115 XEO_CLAS Peptide DME1022 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03115 GENEFORM Protein DME1022 XEOTICID XEO03115 MOACRIVE Inhibition DME1022 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1022 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03116 XEO_CLAS Peptide DME1022 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 40 microM) DME1022 XEOTICID XEO03116 GENEFORM Protein DME1022 XEOTICID XEO03116 MOACRIVE Inhibition DME1022 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1022 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03118 XEO_CLAS Peptide DME1022 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03118 GENEFORM Protein DME1022 XEOTICID XEO03118 MOACRIVE Inhibition DME1022 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1022 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03119 XEO_CLAS Peptide DME1022 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03119 GENEFORM Protein DME1022 XEOTICID XEO03119 MOACRIVE Inhibition DME1022 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1022 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03121 XEO_CLAS Peptide DME1022 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03121 GENEFORM Protein DME1022 XEOTICID XEO03121 MOACRIVE Inhibition DME1022 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1022 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03122 XEO_CLAS Peptide DME1022 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64000 ug/ml) DME1022 XEOTICID XEO03122 GENEFORM Protein DME1022 XEOTICID XEO03122 MOACRIVE Inhibition DME1022 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1022 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03124 XEO_CLAS Peptide DME1022 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03124 GENEFORM Protein DME1022 XEOTICID XEO03124 MOACRIVE Inhibition DME1022 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1022 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03125 XEO_CLAS Peptide DME1022 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03125 GENEFORM Protein DME1022 XEOTICID XEO03125 MOACRIVE Inhibition DME1022 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1022 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03126 XEO_CLAS Peptide DME1022 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.86 microM) DME1022 XEOTICID XEO03126 GENEFORM Protein DME1022 XEOTICID XEO03126 MOACRIVE Inhibition DME1022 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1022 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03127 XEO_CLAS Peptide DME1022 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03127 GENEFORM Protein DME1022 XEOTICID XEO03127 MOACRIVE Inhibition DME1022 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1022 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03128 XEO_CLAS Peptide DME1022 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 256 ug/ml) DME1022 XEOTICID XEO03128 GENEFORM Protein DME1022 XEOTICID XEO03128 MOACRIVE Inhibition DME1022 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1022 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03129 XEO_CLAS Peptide DME1022 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 256 ug/ml) DME1022 XEOTICID XEO03129 GENEFORM Protein DME1022 XEOTICID XEO03129 MOACRIVE Inhibition DME1022 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1022 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03130 XEO_CLAS Peptide DME1022 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 256 ug/ml) DME1022 XEOTICID XEO03130 GENEFORM Protein DME1022 XEOTICID XEO03130 MOACRIVE Inhibition DME1022 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1022 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03131 XEO_CLAS Peptide DME1022 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 256 ug/ml) DME1022 XEOTICID XEO03131 GENEFORM Protein DME1022 XEOTICID XEO03131 MOACRIVE Inhibition DME1022 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1022 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03132 XEO_CLAS Peptide DME1022 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 256 ug/ml) DME1022 XEOTICID XEO03132 GENEFORM Protein DME1022 XEOTICID XEO03132 MOACRIVE Inhibition DME1022 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1022 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03137 XEO_CLAS Peptide DME1022 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03137 GENEFORM Protein DME1022 XEOTICID XEO03137 MOACRIVE Inhibition DME1022 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1022 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03143 XEO_CLAS Peptide DME1022 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.6 microM) DME1022 XEOTICID XEO03143 GENEFORM Protein DME1022 XEOTICID XEO03143 MOACRIVE Inhibition DME1022 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1022 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03145 XEO_CLAS Peptide DME1022 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.6 microM) DME1022 XEOTICID XEO03145 GENEFORM Protein DME1022 XEOTICID XEO03145 MOACRIVE Inhibition DME1022 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1022 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03146 XEO_CLAS Peptide DME1022 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.5 microM) DME1022 XEOTICID XEO03146 GENEFORM Protein DME1022 XEOTICID XEO03146 MOACRIVE Inhibition DME1022 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1022 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03147 XEO_CLAS Peptide DME1022 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9.7 microM) DME1022 XEOTICID XEO03147 GENEFORM Protein DME1022 XEOTICID XEO03147 MOACRIVE Inhibition DME1022 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1022 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03148 XEO_CLAS Peptide DME1022 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.3 microM) DME1022 XEOTICID XEO03148 GENEFORM Protein DME1022 XEOTICID XEO03148 MOACRIVE Inhibition DME1022 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1022 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03149 XEO_CLAS Peptide DME1022 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.6 microM) DME1022 XEOTICID XEO03149 GENEFORM Protein DME1022 XEOTICID XEO03149 MOACRIVE Inhibition DME1022 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1022 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03150 XEO_CLAS Peptide DME1022 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9-3 microM) DME1022 XEOTICID XEO03150 GENEFORM Protein DME1022 XEOTICID XEO03150 MOACRIVE Inhibition DME1022 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1022 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03151 XEO_CLAS Peptide DME1022 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 ug/ml) DME1022 XEOTICID XEO03151 GENEFORM Protein DME1022 XEOTICID XEO03151 MOACRIVE Inhibition DME1022 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1022 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03152 XEO_CLAS Peptide DME1022 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO03152 GENEFORM Protein DME1022 XEOTICID XEO03152 MOACRIVE Inhibition DME1022 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1022 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03155 XEO_CLAS Peptide DME1022 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.4 microM) DME1022 XEOTICID XEO03155 GENEFORM Protein DME1022 XEOTICID XEO03155 MOACRIVE Inhibition DME1022 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1022 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03156 XEO_CLAS Peptide DME1022 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.3 microM) DME1022 XEOTICID XEO03156 GENEFORM Protein DME1022 XEOTICID XEO03156 MOACRIVE Inhibition DME1022 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1022 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03157 XEO_CLAS Peptide DME1022 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.3 microM) DME1022 XEOTICID XEO03157 GENEFORM Protein DME1022 XEOTICID XEO03157 MOACRIVE Inhibition DME1022 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1022 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03158 XEO_CLAS Peptide DME1022 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 ug/ml) DME1022 XEOTICID XEO03158 GENEFORM Protein DME1022 XEOTICID XEO03158 MOACRIVE Inhibition DME1022 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1022 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03159 XEO_CLAS Peptide DME1022 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03159 GENEFORM Protein DME1022 XEOTICID XEO03159 MOACRIVE Inhibition DME1022 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1022 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03161 XEO_CLAS Peptide DME1022 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 microM) DME1022 XEOTICID XEO03161 GENEFORM Protein DME1022 XEOTICID XEO03161 MOACRIVE Inhibition DME1022 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1022 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03162 XEO_CLAS Peptide DME1022 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.5 microM) DME1022 XEOTICID XEO03162 GENEFORM Protein DME1022 XEOTICID XEO03162 MOACRIVE Inhibition DME1022 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1022 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03169 XEO_CLAS Peptide DME1022 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO03169 GENEFORM Protein DME1022 XEOTICID XEO03169 MOACRIVE Inhibition DME1022 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1022 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03193 XEO_CLAS Peptide DME1022 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25 ug/ml) DME1022 XEOTICID XEO03193 GENEFORM Protein DME1022 XEOTICID XEO03193 MOACRIVE Inhibition DME1022 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1022 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03194 XEO_CLAS Peptide DME1022 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03194 GENEFORM Protein DME1022 XEOTICID XEO03194 MOACRIVE Inhibition DME1022 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1022 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03195 XEO_CLAS Peptide DME1022 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03195 GENEFORM Protein DME1022 XEOTICID XEO03195 MOACRIVE Inhibition DME1022 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1022 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03197 XEO_CLAS Peptide DME1022 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 14.5 microM) DME1022 XEOTICID XEO03197 GENEFORM Protein DME1022 XEOTICID XEO03197 MOACRIVE Inhibition DME1022 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1022 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03202 XEO_CLAS Peptide DME1022 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.51 microM) DME1022 XEOTICID XEO03202 GENEFORM Protein DME1022 XEOTICID XEO03202 MOACRIVE Inhibition DME1022 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1022 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03203 XEO_CLAS Peptide DME1022 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.62 microM) DME1022 XEOTICID XEO03203 GENEFORM Protein DME1022 XEOTICID XEO03203 MOACRIVE Inhibition DME1022 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1022 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03204 XEO_CLAS Peptide DME1022 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.38 microM) DME1022 XEOTICID XEO03204 GENEFORM Protein DME1022 XEOTICID XEO03204 MOACRIVE Inhibition DME1022 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1022 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03205 XEO_CLAS Peptide DME1022 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.29 microM) DME1022 XEOTICID XEO03205 GENEFORM Protein DME1022 XEOTICID XEO03205 MOACRIVE Inhibition DME1022 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1022 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03206 XEO_CLAS Peptide DME1022 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.40 microM) DME1022 XEOTICID XEO03206 GENEFORM Protein DME1022 XEOTICID XEO03206 MOACRIVE Inhibition DME1022 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1022 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03207 XEO_CLAS Peptide DME1022 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.58 microM) DME1022 XEOTICID XEO03207 GENEFORM Protein DME1022 XEOTICID XEO03207 MOACRIVE Inhibition DME1022 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1022 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03208 XEO_CLAS Peptide DME1022 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.76 microM) DME1022 XEOTICID XEO03208 GENEFORM Protein DME1022 XEOTICID XEO03208 MOACRIVE Inhibition DME1022 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1022 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03209 XEO_CLAS Peptide DME1022 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.49 microM) DME1022 XEOTICID XEO03209 GENEFORM Protein DME1022 XEOTICID XEO03209 MOACRIVE Inhibition DME1022 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1022 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03210 XEO_CLAS Peptide DME1022 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 7.07 microM) DME1022 XEOTICID XEO03210 GENEFORM Protein DME1022 XEOTICID XEO03210 MOACRIVE Inhibition DME1022 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1022 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03211 XEO_CLAS Peptide DME1022 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.40 microM) DME1022 XEOTICID XEO03211 GENEFORM Protein DME1022 XEOTICID XEO03211 MOACRIVE Inhibition DME1022 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1022 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03215 XEO_CLAS Peptide DME1022 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20.0 ug/ml) DME1022 XEOTICID XEO03215 GENEFORM Protein DME1022 XEOTICID XEO03215 MOACRIVE Inhibition DME1022 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1022 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03216 XEO_CLAS Peptide DME1022 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO03216 GENEFORM Protein DME1022 XEOTICID XEO03216 MOACRIVE Inhibition DME1022 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1022 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03217 XEO_CLAS Peptide DME1022 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO03217 GENEFORM Protein DME1022 XEOTICID XEO03217 MOACRIVE Inhibition DME1022 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1022 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03223 XEO_CLAS Peptide DME1022 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.8 microM) DME1022 XEOTICID XEO03223 GENEFORM Protein DME1022 XEOTICID XEO03223 MOACRIVE Inhibition DME1022 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1022 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03224 XEO_CLAS Peptide DME1022 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.1-0.25 microM) DME1022 XEOTICID XEO03224 GENEFORM Protein DME1022 XEOTICID XEO03224 MOACRIVE Inhibition DME1022 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1022 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03225 XEO_CLAS Peptide DME1022 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.3 microM) DME1022 XEOTICID XEO03225 GENEFORM Protein DME1022 XEOTICID XEO03225 MOACRIVE Inhibition DME1022 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1022 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03227 XEO_CLAS Peptide DME1022 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.3 microM) DME1022 XEOTICID XEO03227 GENEFORM Protein DME1022 XEOTICID XEO03227 MOACRIVE Inhibition DME1022 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1022 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03231 XEO_CLAS Peptide DME1022 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03231 GENEFORM Protein DME1022 XEOTICID XEO03231 MOACRIVE Inhibition DME1022 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1022 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03232 XEO_CLAS Peptide DME1022 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03232 GENEFORM Protein DME1022 XEOTICID XEO03232 MOACRIVE Inhibition DME1022 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1022 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03234 XEO_CLAS Peptide DME1022 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO03234 GENEFORM Protein DME1022 XEOTICID XEO03234 MOACRIVE Inhibition DME1022 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1022 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03235 XEO_CLAS Peptide DME1022 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 60 ug/ml) DME1022 XEOTICID XEO03235 GENEFORM Protein DME1022 XEOTICID XEO03235 MOACRIVE Inhibition DME1022 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1022 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03236 XEO_CLAS Peptide DME1022 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO03236 GENEFORM Protein DME1022 XEOTICID XEO03236 MOACRIVE Inhibition DME1022 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1022 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03237 XEO_CLAS Peptide DME1022 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 ug/ml) DME1022 XEOTICID XEO03237 GENEFORM Protein DME1022 XEOTICID XEO03237 MOACRIVE Inhibition DME1022 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1022 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03238 XEO_CLAS Peptide DME1022 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 ug/ml) DME1022 XEOTICID XEO03238 GENEFORM Protein DME1022 XEOTICID XEO03238 MOACRIVE Inhibition DME1022 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1022 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03239 XEO_CLAS Peptide DME1022 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 60 ug/ml) DME1022 XEOTICID XEO03239 GENEFORM Protein DME1022 XEOTICID XEO03239 MOACRIVE Inhibition DME1022 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1022 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03241 XEO_CLAS Peptide DME1022 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 128 microM) DME1022 XEOTICID XEO03241 GENEFORM Protein DME1022 XEOTICID XEO03241 MOACRIVE Inhibition DME1022 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1022 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03250 XEO_CLAS Peptide DME1022 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03250 GENEFORM Protein DME1022 XEOTICID XEO03250 MOACRIVE Inhibition DME1022 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1022 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03251 XEO_CLAS Peptide DME1022 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03251 GENEFORM Protein DME1022 XEOTICID XEO03251 MOACRIVE Inhibition DME1022 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1022 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03253 XEO_CLAS Peptide DME1022 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.1 ug/ml) DME1022 XEOTICID XEO03253 GENEFORM Protein DME1022 XEOTICID XEO03253 MOACRIVE Inhibition DME1022 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1022 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03274 XEO_CLAS Peptide DME1022 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.2 microM) DME1022 XEOTICID XEO03274 GENEFORM Protein DME1022 XEOTICID XEO03274 MOACRIVE Inhibition DME1022 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1022 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03275 XEO_CLAS Peptide DME1022 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO03275 GENEFORM Protein DME1022 XEOTICID XEO03275 MOACRIVE Inhibition DME1022 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1022 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03276 XEO_CLAS Peptide DME1022 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO03276 GENEFORM Protein DME1022 XEOTICID XEO03276 MOACRIVE Inhibition DME1022 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1022 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03277 XEO_CLAS Peptide DME1022 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.2 microM) DME1022 XEOTICID XEO03277 GENEFORM Protein DME1022 XEOTICID XEO03277 MOACRIVE Inhibition DME1022 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1022 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03278 XEO_CLAS Peptide DME1022 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO03278 GENEFORM Protein DME1022 XEOTICID XEO03278 MOACRIVE Inhibition DME1022 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1022 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03279 XEO_CLAS Peptide DME1022 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO03279 GENEFORM Protein DME1022 XEOTICID XEO03279 MOACRIVE Inhibition DME1022 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1022 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03280 XEO_CLAS Peptide DME1022 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 microM) DME1022 XEOTICID XEO03280 GENEFORM Protein DME1022 XEOTICID XEO03280 MOACRIVE Inhibition DME1022 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1022 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03281 XEO_CLAS Peptide DME1022 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.3 microM) DME1022 XEOTICID XEO03281 GENEFORM Protein DME1022 XEOTICID XEO03281 MOACRIVE Inhibition DME1022 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1022 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03282 XEO_CLAS Peptide DME1022 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.1 microM) DME1022 XEOTICID XEO03282 GENEFORM Protein DME1022 XEOTICID XEO03282 MOACRIVE Inhibition DME1022 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1022 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03283 XEO_CLAS Peptide DME1022 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 microM) DME1022 XEOTICID XEO03283 GENEFORM Protein DME1022 XEOTICID XEO03283 MOACRIVE Inhibition DME1022 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1022 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03284 XEO_CLAS Peptide DME1022 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.2 ug/ml) DME1022 XEOTICID XEO03284 GENEFORM Protein DME1022 XEOTICID XEO03284 MOACRIVE Inhibition DME1022 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1022 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03285 XEO_CLAS Peptide DME1022 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.5 ug/ml) DME1022 XEOTICID XEO03285 GENEFORM Protein DME1022 XEOTICID XEO03285 MOACRIVE Inhibition DME1022 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1022 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03286 XEO_CLAS Peptide DME1022 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.4 ug/ml) DME1022 XEOTICID XEO03286 GENEFORM Protein DME1022 XEOTICID XEO03286 MOACRIVE Inhibition DME1022 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1022 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03287 XEO_CLAS Peptide DME1022 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.6 ug/ml) DME1022 XEOTICID XEO03287 GENEFORM Protein DME1022 XEOTICID XEO03287 MOACRIVE Inhibition DME1022 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1022 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03288 XEO_CLAS Peptide DME1022 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.4 ug/ml) DME1022 XEOTICID XEO03288 GENEFORM Protein DME1022 XEOTICID XEO03288 MOACRIVE Inhibition DME1022 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1022 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03289 XEO_CLAS Peptide DME1022 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8.8 ug/ml) DME1022 XEOTICID XEO03289 GENEFORM Protein DME1022 XEOTICID XEO03289 MOACRIVE Inhibition DME1022 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1022 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03290 XEO_CLAS Peptide DME1022 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.5 ug/ml) DME1022 XEOTICID XEO03290 GENEFORM Protein DME1022 XEOTICID XEO03290 MOACRIVE Inhibition DME1022 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1022 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03291 XEO_CLAS Peptide DME1022 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8.6 ug/ml) DME1022 XEOTICID XEO03291 GENEFORM Protein DME1022 XEOTICID XEO03291 MOACRIVE Inhibition DME1022 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1022 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03292 XEO_CLAS Peptide DME1022 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4.1 ug/ml) DME1022 XEOTICID XEO03292 GENEFORM Protein DME1022 XEOTICID XEO03292 MOACRIVE Inhibition DME1022 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1022 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03293 XEO_CLAS Peptide DME1022 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1 microM) DME1022 XEOTICID XEO03293 GENEFORM Protein DME1022 XEOTICID XEO03293 MOACRIVE Inhibition DME1022 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1022 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03294 XEO_CLAS Peptide DME1022 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1 microM) DME1022 XEOTICID XEO03294 GENEFORM Protein DME1022 XEOTICID XEO03294 MOACRIVE Inhibition DME1022 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1022 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03295 XEO_CLAS Peptide DME1022 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.7 microM) DME1022 XEOTICID XEO03295 GENEFORM Protein DME1022 XEOTICID XEO03295 MOACRIVE Inhibition DME1022 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1022 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03296 XEO_CLAS Peptide DME1022 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03296 GENEFORM Protein DME1022 XEOTICID XEO03296 MOACRIVE Inhibition DME1022 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1022 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03297 XEO_CLAS Peptide DME1022 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03297 GENEFORM Protein DME1022 XEOTICID XEO03297 MOACRIVE Inhibition DME1022 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1022 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03298 XEO_CLAS Peptide DME1022 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.2 microM) DME1022 XEOTICID XEO03298 GENEFORM Protein DME1022 XEOTICID XEO03298 MOACRIVE Inhibition DME1022 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1022 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03299 XEO_CLAS Peptide DME1022 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.4 microM) DME1022 XEOTICID XEO03299 GENEFORM Protein DME1022 XEOTICID XEO03299 MOACRIVE Inhibition DME1022 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1022 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03300 XEO_CLAS Peptide DME1022 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 ug/ml) DME1022 XEOTICID XEO03300 GENEFORM Protein DME1022 XEOTICID XEO03300 MOACRIVE Inhibition DME1022 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1022 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03301 XEO_CLAS Peptide DME1022 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 ug/ml) DME1022 XEOTICID XEO03301 GENEFORM Protein DME1022 XEOTICID XEO03301 MOACRIVE Inhibition DME1022 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1022 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03302 XEO_CLAS Peptide DME1022 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1 microM) DME1022 XEOTICID XEO03302 GENEFORM Protein DME1022 XEOTICID XEO03302 MOACRIVE Inhibition DME1022 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1022 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03303 XEO_CLAS Peptide DME1022 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 microM) DME1022 XEOTICID XEO03303 GENEFORM Protein DME1022 XEOTICID XEO03303 MOACRIVE Inhibition DME1022 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1022 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03304 XEO_CLAS Peptide DME1022 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO03304 GENEFORM Protein DME1022 XEOTICID XEO03304 MOACRIVE Inhibition DME1022 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1022 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03305 XEO_CLAS Peptide DME1022 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 microM) DME1022 XEOTICID XEO03305 GENEFORM Protein DME1022 XEOTICID XEO03305 MOACRIVE Inhibition DME1022 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1022 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03306 XEO_CLAS Peptide DME1022 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO03306 GENEFORM Protein DME1022 XEOTICID XEO03306 MOACRIVE Inhibition DME1022 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1022 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03307 XEO_CLAS Peptide DME1022 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 34 ug/ml) DME1022 XEOTICID XEO03307 GENEFORM Protein DME1022 XEOTICID XEO03307 MOACRIVE Inhibition DME1022 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1022 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03308 XEO_CLAS Peptide DME1022 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO03308 GENEFORM Protein DME1022 XEOTICID XEO03308 MOACRIVE Inhibition DME1022 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1022 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03310 XEO_CLAS Peptide DME1022 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8.5 ug/ml) DME1022 XEOTICID XEO03310 GENEFORM Protein DME1022 XEOTICID XEO03310 MOACRIVE Inhibition DME1022 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1022 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03311 XEO_CLAS Peptide DME1022 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10.8 ug/ml) DME1022 XEOTICID XEO03311 GENEFORM Protein DME1022 XEOTICID XEO03311 MOACRIVE Inhibition DME1022 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1022 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03312 XEO_CLAS Peptide DME1022 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10.8 ug/ml) DME1022 XEOTICID XEO03312 GENEFORM Protein DME1022 XEOTICID XEO03312 MOACRIVE Inhibition DME1022 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1022 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03313 XEO_CLAS Peptide DME1022 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8.1 ug/ml) DME1022 XEOTICID XEO03313 GENEFORM Protein DME1022 XEOTICID XEO03313 MOACRIVE Inhibition DME1022 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1022 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03314 XEO_CLAS Peptide DME1022 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 7.9 ug/ml) DME1022 XEOTICID XEO03314 GENEFORM Protein DME1022 XEOTICID XEO03314 MOACRIVE Inhibition DME1022 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1022 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03315 XEO_CLAS Peptide DME1022 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.6 ug/ml) DME1022 XEOTICID XEO03315 GENEFORM Protein DME1022 XEOTICID XEO03315 MOACRIVE Inhibition DME1022 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1022 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03316 XEO_CLAS Peptide DME1022 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15.8 ug/ml) DME1022 XEOTICID XEO03316 GENEFORM Protein DME1022 XEOTICID XEO03316 MOACRIVE Inhibition DME1022 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1022 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03317 XEO_CLAS Peptide DME1022 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO03317 GENEFORM Protein DME1022 XEOTICID XEO03317 MOACRIVE Inhibition DME1022 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1022 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03318 XEO_CLAS Peptide DME1022 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1 microM) DME1022 XEOTICID XEO03318 GENEFORM Protein DME1022 XEOTICID XEO03318 MOACRIVE Inhibition DME1022 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1022 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03319 XEO_CLAS Peptide DME1022 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03319 GENEFORM Protein DME1022 XEOTICID XEO03319 MOACRIVE Inhibition DME1022 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1022 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03320 XEO_CLAS Peptide DME1022 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.1 microM) DME1022 XEOTICID XEO03320 GENEFORM Protein DME1022 XEOTICID XEO03320 MOACRIVE Inhibition DME1022 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1022 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03321 XEO_CLAS Peptide DME1022 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.8 microM) DME1022 XEOTICID XEO03321 GENEFORM Protein DME1022 XEOTICID XEO03321 MOACRIVE Inhibition DME1022 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1022 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1022 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03348 GENEFORM Protein DME1022 XEOTICID XEO03348 MOACRIVE Inhibition DME1022 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1022 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03362 XEO_CLAS Peptide DME1022 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO03362 GENEFORM Protein DME1022 XEOTICID XEO03362 MOACRIVE Inhibition DME1022 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1022 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03363 XEO_CLAS Peptide DME1022 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 microM) DME1022 XEOTICID XEO03363 GENEFORM Protein DME1022 XEOTICID XEO03363 MOACRIVE Inhibition DME1022 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1022 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03364 XEO_CLAS Peptide DME1022 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 microM) DME1022 XEOTICID XEO03364 GENEFORM Protein DME1022 XEOTICID XEO03364 MOACRIVE Inhibition DME1022 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1022 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03365 XEO_CLAS Peptide DME1022 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03365 GENEFORM Protein DME1022 XEOTICID XEO03365 MOACRIVE Inhibition DME1022 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1022 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03366 XEO_CLAS Peptide DME1022 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO03366 GENEFORM Protein DME1022 XEOTICID XEO03366 MOACRIVE Inhibition DME1022 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1022 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03367 XEO_CLAS Peptide DME1022 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 microM) DME1022 XEOTICID XEO03367 GENEFORM Protein DME1022 XEOTICID XEO03367 MOACRIVE Inhibition DME1022 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1022 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03368 XEO_CLAS Peptide DME1022 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 microM) DME1022 XEOTICID XEO03368 GENEFORM Protein DME1022 XEOTICID XEO03368 MOACRIVE Inhibition DME1022 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1022 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03379 XEO_CLAS Peptide DME1022 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.6 ug/ml) DME1022 XEOTICID XEO03379 GENEFORM Protein DME1022 XEOTICID XEO03379 MOACRIVE Inhibition DME1022 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1022 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03396 XEO_CLAS Peptide DME1022 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03396 GENEFORM Protein DME1022 XEOTICID XEO03396 MOACRIVE Inhibition DME1022 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1022 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03398 XEO_CLAS Peptide DME1022 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03398 GENEFORM Protein DME1022 XEOTICID XEO03398 MOACRIVE Inhibition DME1022 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1022 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03399 XEO_CLAS Peptide DME1022 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03399 GENEFORM Protein DME1022 XEOTICID XEO03399 MOACRIVE Inhibition DME1022 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1022 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03406 XEO_CLAS Peptide DME1022 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 ug/ml) DME1022 XEOTICID XEO03406 GENEFORM Protein DME1022 XEOTICID XEO03406 MOACRIVE Inhibition DME1022 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1022 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03424 XEO_CLAS Peptide DME1022 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03424 GENEFORM Protein DME1022 XEOTICID XEO03424 MOACRIVE Inhibition DME1022 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1022 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03426 XEO_CLAS Peptide DME1022 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO03426 GENEFORM Protein DME1022 XEOTICID XEO03426 MOACRIVE Inhibition DME1022 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1022 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03427 XEO_CLAS Peptide DME1022 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 microM) DME1022 XEOTICID XEO03427 GENEFORM Protein DME1022 XEOTICID XEO03427 MOACRIVE Inhibition DME1022 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1022 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03428 XEO_CLAS Peptide DME1022 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 ug/ml) DME1022 XEOTICID XEO03428 GENEFORM Protein DME1022 XEOTICID XEO03428 MOACRIVE Inhibition DME1022 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1022 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03430 XEO_CLAS Peptide DME1022 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 ug/ml) DME1022 XEOTICID XEO03430 GENEFORM Protein DME1022 XEOTICID XEO03430 MOACRIVE Inhibition DME1022 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1022 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03434 XEO_CLAS Peptide DME1022 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO03434 GENEFORM Protein DME1022 XEOTICID XEO03434 MOACRIVE Inhibition DME1022 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1022 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03442 XEO_CLAS Peptide DME1022 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 18.75 ug/ml) DME1022 XEOTICID XEO03442 GENEFORM Protein DME1022 XEOTICID XEO03442 MOACRIVE Inhibition DME1022 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1022 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03444 XEO_CLAS Peptide DME1022 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 37.50 ug/ml) DME1022 XEOTICID XEO03444 GENEFORM Protein DME1022 XEOTICID XEO03444 MOACRIVE Inhibition DME1022 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1022 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03459 XEO_CLAS Peptide DME1022 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03459 GENEFORM Protein DME1022 XEOTICID XEO03459 MOACRIVE Inhibition DME1022 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1022 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03460 XEO_CLAS Peptide DME1022 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03460 GENEFORM Protein DME1022 XEOTICID XEO03460 MOACRIVE Inhibition DME1022 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1022 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03461 XEO_CLAS Peptide DME1022 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.05 microM) DME1022 XEOTICID XEO03461 GENEFORM Protein DME1022 XEOTICID XEO03461 MOACRIVE Inhibition DME1022 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1022 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03462 XEO_CLAS Peptide DME1022 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03462 GENEFORM Protein DME1022 XEOTICID XEO03462 MOACRIVE Inhibition DME1022 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1022 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03463 XEO_CLAS Peptide DME1022 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03463 GENEFORM Protein DME1022 XEOTICID XEO03463 MOACRIVE Inhibition DME1022 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1022 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03467 XEO_CLAS Peptide DME1022 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03467 GENEFORM Protein DME1022 XEOTICID XEO03467 MOACRIVE Inhibition DME1022 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1022 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03468 XEO_CLAS Peptide DME1022 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03468 GENEFORM Protein DME1022 XEOTICID XEO03468 MOACRIVE Inhibition DME1022 XEOTICID XEO03471 XEO_NAME Gambicin DME1022 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03471 XEO_CLAS Peptide DME1022 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1022 XEOTICID XEO03471 GENEFORM Protein DME1022 XEOTICID XEO03471 MOACRIVE Inhibition DME1022 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1022 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03485 XEO_CLAS Peptide DME1022 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4.07 ug/ml) DME1022 XEOTICID XEO03485 GENEFORM Protein DME1022 XEOTICID XEO03485 MOACRIVE Inhibition DME1022 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1022 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03486 XEO_CLAS Peptide DME1022 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.80 ug/ml) DME1022 XEOTICID XEO03486 GENEFORM Protein DME1022 XEOTICID XEO03486 MOACRIVE Inhibition DME1022 XEOTICID XEO03488 XEO_NAME GLK-19 DME1022 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03488 XEO_CLAS Peptide DME1022 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO03488 GENEFORM Protein DME1022 XEOTICID XEO03488 MOACRIVE Inhibition DME1022 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1022 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03497 XEO_CLAS Peptide DME1022 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1022 XEOTICID XEO03497 GENEFORM Protein DME1022 XEOTICID XEO03497 MOACRIVE Inhibition DME1022 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1022 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03498 XEO_CLAS Peptide DME1022 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1022 XEOTICID XEO03498 GENEFORM Protein DME1022 XEOTICID XEO03498 MOACRIVE Inhibition DME1022 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1022 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03500 XEO_CLAS Peptide DME1022 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-30 ug/ml) DME1022 XEOTICID XEO03500 GENEFORM Protein DME1022 XEOTICID XEO03500 MOACRIVE Inhibition DME1022 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1022 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03504 XEO_CLAS Peptide DME1022 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 ug/ml) DME1022 XEOTICID XEO03504 GENEFORM Protein DME1022 XEOTICID XEO03504 MOACRIVE Inhibition DME1022 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1022 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03505 XEO_CLAS Peptide DME1022 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 ug/ml) DME1022 XEOTICID XEO03505 GENEFORM Protein DME1022 XEOTICID XEO03505 MOACRIVE Inhibition DME1022 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1022 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03506 XEO_CLAS Peptide DME1022 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 ug/ml) DME1022 XEOTICID XEO03506 GENEFORM Protein DME1022 XEOTICID XEO03506 MOACRIVE Inhibition DME1022 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1022 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03513 XEO_CLAS Peptide DME1022 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO03513 GENEFORM Protein DME1022 XEOTICID XEO03513 MOACRIVE Inhibition DME1022 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1022 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03514 XEO_CLAS Peptide DME1022 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03514 GENEFORM Protein DME1022 XEOTICID XEO03514 MOACRIVE Inhibition DME1022 XEOTICID XEO03519 XEO_NAME Hadrurin DME1022 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03519 XEO_CLAS Peptide DME1022 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03519 GENEFORM Protein DME1022 XEOTICID XEO03519 MOACRIVE Inhibition DME1022 XEOTICID XEO03522 XEO_NAME Halocyntin DME1022 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03522 XEO_CLAS Peptide DME1022 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03522 GENEFORM Protein DME1022 XEOTICID XEO03522 MOACRIVE Inhibition DME1022 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1022 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03524 XEO_CLAS Peptide DME1022 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03524 GENEFORM Protein DME1022 XEOTICID XEO03524 MOACRIVE Inhibition DME1022 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1022 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03525 XEO_CLAS Peptide DME1022 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03525 GENEFORM Protein DME1022 XEOTICID XEO03525 MOACRIVE Inhibition DME1022 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1022 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03530 XEO_CLAS Peptide DME1022 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03530 GENEFORM Protein DME1022 XEOTICID XEO03530 MOACRIVE Inhibition DME1022 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1022 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03535 XEO_CLAS Peptide DME1022 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.4 microM) DME1022 XEOTICID XEO03535 GENEFORM Protein DME1022 XEOTICID XEO03535 MOACRIVE Inhibition DME1022 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1022 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03536 XEO_CLAS Peptide DME1022 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 80 microM) DME1022 XEOTICID XEO03536 GENEFORM Protein DME1022 XEOTICID XEO03536 MOACRIVE Inhibition DME1022 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1022 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03537 XEO_CLAS Peptide DME1022 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 ug/ml) DME1022 XEOTICID XEO03537 GENEFORM Protein DME1022 XEOTICID XEO03537 MOACRIVE Inhibition DME1022 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1022 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03538 XEO_CLAS Peptide DME1022 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 ug/ml) DME1022 XEOTICID XEO03538 GENEFORM Protein DME1022 XEOTICID XEO03538 MOACRIVE Inhibition DME1022 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1022 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03540 XEO_CLAS Peptide DME1022 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO03540 GENEFORM Protein DME1022 XEOTICID XEO03540 MOACRIVE Inhibition DME1022 XEOTICID XEO03542 XEO_NAME Hepcidin DME1022 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03542 XEO_CLAS Peptide DME1022 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 24 microM) DME1022 XEOTICID XEO03542 GENEFORM Protein DME1022 XEOTICID XEO03542 MOACRIVE Inhibition DME1022 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1022 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03544 XEO_CLAS Peptide DME1022 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03544 GENEFORM Protein DME1022 XEOTICID XEO03544 MOACRIVE Inhibition DME1022 XEOTICID XEO03548 XEO_NAME Hesperidin DME1022 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03548 GENEFORM Protein DME1022 XEOTICID XEO03548 MOACRIVE Inhibition DME1022 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1022 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1022 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03552 GENEFORM Protein DME1022 XEOTICID XEO03552 MOACRIVE Inhibition DME1022 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1022 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03556 XEO_CLAS Peptide DME1022 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO03556 GENEFORM Protein DME1022 XEOTICID XEO03556 MOACRIVE Inhibition DME1022 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1022 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03557 XEO_CLAS Peptide DME1022 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO03557 GENEFORM Protein DME1022 XEOTICID XEO03557 MOACRIVE Inhibition DME1022 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1022 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03558 XEO_CLAS Peptide DME1022 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 microM) DME1022 XEOTICID XEO03558 GENEFORM Protein DME1022 XEOTICID XEO03558 MOACRIVE Inhibition DME1022 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1022 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03559 XEO_CLAS Peptide DME1022 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 microM) DME1022 XEOTICID XEO03559 GENEFORM Protein DME1022 XEOTICID XEO03559 MOACRIVE Inhibition DME1022 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1022 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03560 XEO_CLAS Peptide DME1022 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 microM) DME1022 XEOTICID XEO03560 GENEFORM Protein DME1022 XEOTICID XEO03560 MOACRIVE Inhibition DME1022 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1022 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03561 XEO_CLAS Peptide DME1022 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03561 GENEFORM Protein DME1022 XEOTICID XEO03561 MOACRIVE Inhibition DME1022 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1022 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03567 XEO_CLAS Peptide DME1022 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03567 GENEFORM Protein DME1022 XEOTICID XEO03567 MOACRIVE Inhibition DME1022 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1022 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03569 XEO_CLAS Peptide DME1022 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 300 microM) DME1022 XEOTICID XEO03569 GENEFORM Protein DME1022 XEOTICID XEO03569 MOACRIVE Inhibition DME1022 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1022 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03570 XEO_CLAS Peptide DME1022 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03570 GENEFORM Protein DME1022 XEOTICID XEO03570 MOACRIVE Inhibition DME1022 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1022 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03572 XEO_CLAS Peptide DME1022 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1022 XEOTICID XEO03572 GENEFORM Protein DME1022 XEOTICID XEO03572 MOACRIVE Inhibition DME1022 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1022 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03573 XEO_CLAS Peptide DME1022 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 28.1 ug/ml) DME1022 XEOTICID XEO03573 GENEFORM Protein DME1022 XEOTICID XEO03573 MOACRIVE Inhibition DME1022 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1022 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03574 XEO_CLAS Peptide DME1022 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 500 microM) DME1022 XEOTICID XEO03574 GENEFORM Protein DME1022 XEOTICID XEO03574 MOACRIVE Inhibition DME1022 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1022 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03575 XEO_CLAS Peptide DME1022 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 18 microM) DME1022 XEOTICID XEO03575 GENEFORM Protein DME1022 XEOTICID XEO03575 MOACRIVE Inhibition DME1022 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1022 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03576 XEO_CLAS Peptide DME1022 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 750 microM) DME1022 XEOTICID XEO03576 GENEFORM Protein DME1022 XEOTICID XEO03576 MOACRIVE Inhibition DME1022 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1022 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03578 XEO_CLAS Peptide DME1022 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1022 XEOTICID XEO03578 GENEFORM Protein DME1022 XEOTICID XEO03578 MOACRIVE Inhibition DME1022 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1022 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03579 XEO_CLAS Peptide DME1022 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03579 GENEFORM Protein DME1022 XEOTICID XEO03579 MOACRIVE Inhibition DME1022 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1022 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03580 XEO_CLAS Peptide DME1022 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03580 GENEFORM Protein DME1022 XEOTICID XEO03580 MOACRIVE Inhibition DME1022 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1022 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03585 XEO_CLAS Peptide DME1022 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 125 ug/ml) DME1022 XEOTICID XEO03585 GENEFORM Protein DME1022 XEOTICID XEO03585 MOACRIVE Inhibition DME1022 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1022 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03588 XEO_CLAS Peptide DME1022 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 62 ug/ml) DME1022 XEOTICID XEO03588 GENEFORM Protein DME1022 XEOTICID XEO03588 MOACRIVE Inhibition DME1022 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1022 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03589 XEO_CLAS Peptide DME1022 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03589 GENEFORM Protein DME1022 XEOTICID XEO03589 MOACRIVE Inhibition DME1022 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1022 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03590 XEO_CLAS Peptide DME1022 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03590 GENEFORM Protein DME1022 XEOTICID XEO03590 MOACRIVE Inhibition DME1022 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1022 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03591 XEO_CLAS Peptide DME1022 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 37.5 ug/ml) DME1022 XEOTICID XEO03591 GENEFORM Protein DME1022 XEOTICID XEO03591 MOACRIVE Inhibition DME1022 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1022 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03593 XEO_CLAS Peptide DME1022 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9.4 ug/ml) DME1022 XEOTICID XEO03593 GENEFORM Protein DME1022 XEOTICID XEO03593 MOACRIVE Inhibition DME1022 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1022 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03594 XEO_CLAS Peptide DME1022 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 ug/ml) DME1022 XEOTICID XEO03594 GENEFORM Protein DME1022 XEOTICID XEO03594 MOACRIVE Inhibition DME1022 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1022 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03595 XEO_CLAS Peptide DME1022 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03595 GENEFORM Protein DME1022 XEOTICID XEO03595 MOACRIVE Inhibition DME1022 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1022 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03596 XEO_CLAS Peptide DME1022 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03596 GENEFORM Protein DME1022 XEOTICID XEO03596 MOACRIVE Inhibition DME1022 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1022 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03598 XEO_CLAS Peptide DME1022 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03598 GENEFORM Protein DME1022 XEOTICID XEO03598 MOACRIVE Inhibition DME1022 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1022 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03599 XEO_CLAS Peptide DME1022 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03599 GENEFORM Protein DME1022 XEOTICID XEO03599 MOACRIVE Inhibition DME1022 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1022 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03600 XEO_CLAS Peptide DME1022 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03600 GENEFORM Protein DME1022 XEOTICID XEO03600 MOACRIVE Inhibition DME1022 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1022 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03606 XEO_CLAS Peptide DME1022 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03606 GENEFORM Protein DME1022 XEOTICID XEO03606 MOACRIVE Inhibition DME1022 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1022 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03607 XEO_CLAS Peptide DME1022 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03607 GENEFORM Protein DME1022 XEOTICID XEO03607 MOACRIVE Inhibition DME1022 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1022 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03609 XEO_CLAS Peptide DME1022 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03609 GENEFORM Protein DME1022 XEOTICID XEO03609 MOACRIVE Inhibition DME1022 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1022 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03615 XEO_CLAS Peptide DME1022 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1022 XEOTICID XEO03615 GENEFORM Protein DME1022 XEOTICID XEO03615 MOACRIVE Inhibition DME1022 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1022 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03616 XEO_CLAS Peptide DME1022 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 32 microM) DME1022 XEOTICID XEO03616 GENEFORM Protein DME1022 XEOTICID XEO03616 MOACRIVE Inhibition DME1022 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1022 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03617 XEO_CLAS Peptide DME1022 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40 microM) DME1022 XEOTICID XEO03617 GENEFORM Protein DME1022 XEOTICID XEO03617 MOACRIVE Inhibition DME1022 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1022 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03618 XEO_CLAS Peptide DME1022 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5-1 microM) DME1022 XEOTICID XEO03618 GENEFORM Protein DME1022 XEOTICID XEO03618 MOACRIVE Inhibition DME1022 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1022 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03622 XEO_CLAS Peptide DME1022 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20-40 microM) DME1022 XEOTICID XEO03622 GENEFORM Protein DME1022 XEOTICID XEO03622 MOACRIVE Inhibition DME1022 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1022 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03627 XEO_CLAS Peptide DME1022 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1022 XEOTICID XEO03627 GENEFORM Protein DME1022 XEOTICID XEO03627 MOACRIVE Inhibition DME1022 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1022 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03630 XEO_CLAS Peptide DME1022 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03630 GENEFORM Protein DME1022 XEOTICID XEO03630 MOACRIVE Inhibition DME1022 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1022 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03631 XEO_CLAS Peptide DME1022 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03631 GENEFORM Protein DME1022 XEOTICID XEO03631 MOACRIVE Inhibition DME1022 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1022 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03632 XEO_CLAS Peptide DME1022 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03632 GENEFORM Protein DME1022 XEOTICID XEO03632 MOACRIVE Inhibition DME1022 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1022 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03633 XEO_CLAS Peptide DME1022 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03633 GENEFORM Protein DME1022 XEOTICID XEO03633 MOACRIVE Inhibition DME1022 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1022 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03634 XEO_CLAS Peptide DME1022 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03634 GENEFORM Protein DME1022 XEOTICID XEO03634 MOACRIVE Inhibition DME1022 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1022 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03635 XEO_CLAS Peptide DME1022 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03635 GENEFORM Protein DME1022 XEOTICID XEO03635 MOACRIVE Inhibition DME1022 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1022 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03636 XEO_CLAS Peptide DME1022 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03636 GENEFORM Protein DME1022 XEOTICID XEO03636 MOACRIVE Inhibition DME1022 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1022 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03637 XEO_CLAS Peptide DME1022 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03637 GENEFORM Protein DME1022 XEOTICID XEO03637 MOACRIVE Inhibition DME1022 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1022 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03638 XEO_CLAS Peptide DME1022 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03638 GENEFORM Protein DME1022 XEOTICID XEO03638 MOACRIVE Inhibition DME1022 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1022 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03639 XEO_CLAS Peptide DME1022 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03639 GENEFORM Protein DME1022 XEOTICID XEO03639 MOACRIVE Inhibition DME1022 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1022 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03640 XEO_CLAS Peptide DME1022 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03640 GENEFORM Protein DME1022 XEOTICID XEO03640 MOACRIVE Inhibition DME1022 XEOTICID XEO03644 XEO_NAME Indole DME1022 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1022 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1022 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03644 GENEFORM Protein DME1022 XEOTICID XEO03644 MOACRIVE Inhibition DME1022 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1022 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03650 XEO_CLAS Peptide DME1022 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03650 GENEFORM Protein DME1022 XEOTICID XEO03650 MOACRIVE Inhibition DME1022 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1022 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO03655 XEO_CLAS Natural Product DME1022 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03655 GENEFORM Protein DME1022 XEOTICID XEO03655 MOACRIVE Inhibition DME1022 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1022 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03666 XEO_CLAS Peptide DME1022 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 ug/ml) DME1022 XEOTICID XEO03666 GENEFORM Protein DME1022 XEOTICID XEO03666 MOACRIVE Inhibition DME1022 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1022 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03667 XEO_CLAS Peptide DME1022 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 ug/ml) DME1022 XEOTICID XEO03667 GENEFORM Protein DME1022 XEOTICID XEO03667 MOACRIVE Inhibition DME1022 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1022 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03668 XEO_CLAS Peptide DME1022 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 microM) DME1022 XEOTICID XEO03668 GENEFORM Protein DME1022 XEOTICID XEO03668 MOACRIVE Inhibition DME1022 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1022 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03669 XEO_CLAS Peptide DME1022 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO03669 GENEFORM Protein DME1022 XEOTICID XEO03669 MOACRIVE Inhibition DME1022 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1022 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03670 XEO_CLAS Peptide DME1022 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 microM) DME1022 XEOTICID XEO03670 GENEFORM Protein DME1022 XEOTICID XEO03670 MOACRIVE Inhibition DME1022 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1022 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03672 XEO_CLAS Peptide DME1022 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.5 ug/ml) DME1022 XEOTICID XEO03672 GENEFORM Protein DME1022 XEOTICID XEO03672 MOACRIVE Inhibition DME1022 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1022 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03673 XEO_CLAS Peptide DME1022 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 ug/ml) DME1022 XEOTICID XEO03673 GENEFORM Protein DME1022 XEOTICID XEO03673 MOACRIVE Inhibition DME1022 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1022 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03674 XEO_CLAS Peptide DME1022 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 ug/ml) DME1022 XEOTICID XEO03674 GENEFORM Protein DME1022 XEOTICID XEO03674 MOACRIVE Inhibition DME1022 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1022 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03675 XEO_CLAS Peptide DME1022 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO03675 GENEFORM Protein DME1022 XEOTICID XEO03675 MOACRIVE Inhibition DME1022 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1022 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03678 XEO_CLAS Peptide DME1022 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 ug/ml) DME1022 XEOTICID XEO03678 GENEFORM Protein DME1022 XEOTICID XEO03678 MOACRIVE Inhibition DME1022 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1022 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03679 XEO_CLAS Peptide DME1022 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 ug/ml) DME1022 XEOTICID XEO03679 GENEFORM Protein DME1022 XEOTICID XEO03679 MOACRIVE Inhibition DME1022 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1022 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03681 XEO_CLAS Peptide DME1022 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1022 XEOTICID XEO03681 GENEFORM Protein DME1022 XEOTICID XEO03681 MOACRIVE Inhibition DME1022 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1022 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03684 XEO_CLAS Peptide DME1022 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 ug/ml) DME1022 XEOTICID XEO03684 GENEFORM Protein DME1022 XEOTICID XEO03684 MOACRIVE Inhibition DME1022 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1022 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03694 XEO_CLAS Peptide DME1022 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03694 GENEFORM Protein DME1022 XEOTICID XEO03694 MOACRIVE Inhibition DME1022 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1022 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03697 XEO_CLAS Peptide DME1022 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25 microM) DME1022 XEOTICID XEO03697 GENEFORM Protein DME1022 XEOTICID XEO03697 MOACRIVE Inhibition DME1022 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1022 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03698 XEO_CLAS Peptide DME1022 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03698 GENEFORM Protein DME1022 XEOTICID XEO03698 MOACRIVE Inhibition DME1022 XEOTICID XEO03703 XEO_NAME Kasstasin DME1022 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03703 XEO_CLAS Peptide DME1022 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 110 microM) DME1022 XEOTICID XEO03703 GENEFORM Protein DME1022 XEOTICID XEO03703 MOACRIVE Inhibition DME1022 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1022 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03706 XEO_CLAS Peptide DME1022 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03706 GENEFORM Protein DME1022 XEOTICID XEO03706 MOACRIVE Inhibition DME1022 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1022 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03707 XEO_CLAS Peptide DME1022 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03707 GENEFORM Protein DME1022 XEOTICID XEO03707 MOACRIVE Inhibition DME1022 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1022 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03709 XEO_CLAS Peptide DME1022 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 ug/ml) DME1022 XEOTICID XEO03709 GENEFORM Protein DME1022 XEOTICID XEO03709 MOACRIVE Inhibition DME1022 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1022 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03712 XEO_CLAS Peptide DME1022 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03712 GENEFORM Protein DME1022 XEOTICID XEO03712 MOACRIVE Inhibition DME1022 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1022 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03713 XEO_CLAS Peptide DME1022 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 64 microM) DME1022 XEOTICID XEO03713 GENEFORM Protein DME1022 XEOTICID XEO03713 MOACRIVE Inhibition DME1022 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1022 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03714 XEO_CLAS Peptide DME1022 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03714 GENEFORM Protein DME1022 XEOTICID XEO03714 MOACRIVE Inhibition DME1022 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1022 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03715 XEO_CLAS Peptide DME1022 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 microM) DME1022 XEOTICID XEO03715 GENEFORM Protein DME1022 XEOTICID XEO03715 MOACRIVE Inhibition DME1022 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1022 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03719 XEO_CLAS Peptide DME1022 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 microM) DME1022 XEOTICID XEO03719 GENEFORM Protein DME1022 XEOTICID XEO03719 MOACRIVE Inhibition DME1022 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1022 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03720 XEO_CLAS Peptide DME1022 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 microM) DME1022 XEOTICID XEO03720 GENEFORM Protein DME1022 XEOTICID XEO03720 MOACRIVE Inhibition DME1022 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1022 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03723 XEO_CLAS Peptide DME1022 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 62.36 microM) DME1022 XEOTICID XEO03723 GENEFORM Protein DME1022 XEOTICID XEO03723 MOACRIVE Inhibition DME1022 XEOTICID XEO03724 XEO_NAME L10 peptide DME1022 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03724 XEO_CLAS Peptide DME1022 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.8 microM) DME1022 XEOTICID XEO03724 GENEFORM Protein DME1022 XEOTICID XEO03724 MOACRIVE Inhibition DME1022 XEOTICID XEO03726 XEO_NAME L2 peptide DME1022 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03726 XEO_CLAS Peptide DME1022 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 129.66 microM) DME1022 XEOTICID XEO03726 GENEFORM Protein DME1022 XEOTICID XEO03726 MOACRIVE Inhibition DME1022 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1022 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03727 XEO_CLAS Peptide DME1022 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 80 ug/ml) DME1022 XEOTICID XEO03727 GENEFORM Protein DME1022 XEOTICID XEO03727 MOACRIVE Inhibition DME1022 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1022 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03728 XEO_CLAS Peptide DME1022 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40 ug/ml) DME1022 XEOTICID XEO03728 GENEFORM Protein DME1022 XEOTICID XEO03728 MOACRIVE Inhibition DME1022 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1022 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03729 XEO_CLAS Peptide DME1022 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 80 ug/ml) DME1022 XEOTICID XEO03729 GENEFORM Protein DME1022 XEOTICID XEO03729 MOACRIVE Inhibition DME1022 XEOTICID XEO03730 XEO_NAME L3 peptide DME1022 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03730 XEO_CLAS Peptide DME1022 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64.11 microM) DME1022 XEOTICID XEO03730 GENEFORM Protein DME1022 XEOTICID XEO03730 MOACRIVE Inhibition DME1022 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1022 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03731 XEO_CLAS Peptide DME1022 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40 ug/ml) DME1022 XEOTICID XEO03731 GENEFORM Protein DME1022 XEOTICID XEO03731 MOACRIVE Inhibition DME1022 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1022 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03733 XEO_CLAS Peptide DME1022 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40 ug/ml) DME1022 XEOTICID XEO03733 GENEFORM Protein DME1022 XEOTICID XEO03733 MOACRIVE Inhibition DME1022 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1022 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03734 XEO_CLAS Peptide DME1022 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO03734 GENEFORM Protein DME1022 XEOTICID XEO03734 MOACRIVE Inhibition DME1022 XEOTICID XEO03735 XEO_NAME L4 peptide DME1022 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03735 XEO_CLAS Peptide DME1022 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 31.61 microM) DME1022 XEOTICID XEO03735 GENEFORM Protein DME1022 XEOTICID XEO03735 MOACRIVE Inhibition DME1022 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1022 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03738 XEO_CLAS Peptide DME1022 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 ug/ml) DME1022 XEOTICID XEO03738 GENEFORM Protein DME1022 XEOTICID XEO03738 MOACRIVE Inhibition DME1022 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1022 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03741 XEO_CLAS Peptide DME1022 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40 ug/ml) DME1022 XEOTICID XEO03741 GENEFORM Protein DME1022 XEOTICID XEO03741 MOACRIVE Inhibition DME1022 XEOTICID XEO03742 XEO_NAME L5 peptide DME1022 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03742 XEO_CLAS Peptide DME1022 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 7.79 microM) DME1022 XEOTICID XEO03742 GENEFORM Protein DME1022 XEOTICID XEO03742 MOACRIVE Inhibition DME1022 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1022 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03743 XEO_CLAS Peptide DME1022 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 ug/ml) DME1022 XEOTICID XEO03743 GENEFORM Protein DME1022 XEOTICID XEO03743 MOACRIVE Inhibition DME1022 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1022 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03744 XEO_CLAS Peptide DME1022 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 ug/ml) DME1022 XEOTICID XEO03744 GENEFORM Protein DME1022 XEOTICID XEO03744 MOACRIVE Inhibition DME1022 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1022 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03745 XEO_CLAS Peptide DME1022 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 ug/ml) DME1022 XEOTICID XEO03745 GENEFORM Protein DME1022 XEOTICID XEO03745 MOACRIVE Inhibition DME1022 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1022 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03746 XEO_CLAS Peptide DME1022 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO03746 GENEFORM Protein DME1022 XEOTICID XEO03746 MOACRIVE Inhibition DME1022 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1022 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03747 XEO_CLAS Peptide DME1022 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO03747 GENEFORM Protein DME1022 XEOTICID XEO03747 MOACRIVE Inhibition DME1022 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1022 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03748 XEO_CLAS Peptide DME1022 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO03748 GENEFORM Protein DME1022 XEOTICID XEO03748 MOACRIVE Inhibition DME1022 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1022 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03749 XEO_CLAS Peptide DME1022 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO03749 GENEFORM Protein DME1022 XEOTICID XEO03749 MOACRIVE Inhibition DME1022 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1022 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03750 XEO_CLAS Peptide DME1022 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO03750 GENEFORM Protein DME1022 XEOTICID XEO03750 MOACRIVE Inhibition DME1022 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1022 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03751 XEO_CLAS Peptide DME1022 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO03751 GENEFORM Protein DME1022 XEOTICID XEO03751 MOACRIVE Inhibition DME1022 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1022 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03752 XEO_CLAS Peptide DME1022 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO03752 GENEFORM Protein DME1022 XEOTICID XEO03752 MOACRIVE Inhibition DME1022 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1022 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03753 XEO_CLAS Peptide DME1022 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 ug/ml) DME1022 XEOTICID XEO03753 GENEFORM Protein DME1022 XEOTICID XEO03753 MOACRIVE Inhibition DME1022 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1022 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03754 XEO_CLAS Peptide DME1022 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO03754 GENEFORM Protein DME1022 XEOTICID XEO03754 MOACRIVE Inhibition DME1022 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1022 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03755 XEO_CLAS Peptide DME1022 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO03755 GENEFORM Protein DME1022 XEOTICID XEO03755 MOACRIVE Inhibition DME1022 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1022 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03756 XEO_CLAS Peptide DME1022 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO03756 GENEFORM Protein DME1022 XEOTICID XEO03756 MOACRIVE Inhibition DME1022 XEOTICID XEO03757 XEO_NAME L6 peptide DME1022 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03757 XEO_CLAS Peptide DME1022 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15.17 microM) DME1022 XEOTICID XEO03757 GENEFORM Protein DME1022 XEOTICID XEO03757 MOACRIVE Inhibition DME1022 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1022 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03758 XEO_CLAS Peptide DME1022 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 80 ug/ml) DME1022 XEOTICID XEO03758 GENEFORM Protein DME1022 XEOTICID XEO03758 MOACRIVE Inhibition DME1022 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1022 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03759 XEO_CLAS Peptide DME1022 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.3 ug/ml) DME1022 XEOTICID XEO03759 GENEFORM Protein DME1022 XEOTICID XEO03759 MOACRIVE Inhibition DME1022 XEOTICID XEO03760 XEO_NAME L7 peptide DME1022 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03760 XEO_CLAS Peptide DME1022 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16.02 microM) DME1022 XEOTICID XEO03760 GENEFORM Protein DME1022 XEOTICID XEO03760 MOACRIVE Inhibition DME1022 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1022 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03761 XEO_CLAS Peptide DME1022 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 ug/ml) DME1022 XEOTICID XEO03761 GENEFORM Protein DME1022 XEOTICID XEO03761 MOACRIVE Inhibition DME1022 XEOTICID XEO03763 XEO_NAME L8 peptide DME1022 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03763 XEO_CLAS Peptide DME1022 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.71 microM) DME1022 XEOTICID XEO03763 GENEFORM Protein DME1022 XEOTICID XEO03763 MOACRIVE Inhibition DME1022 XEOTICID XEO03765 XEO_NAME L9 peptide DME1022 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03765 XEO_CLAS Peptide DME1022 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.78 microM) DME1022 XEOTICID XEO03765 GENEFORM Protein DME1022 XEOTICID XEO03765 MOACRIVE Inhibition DME1022 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1022 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03775 XEO_CLAS Peptide DME1022 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 17.3 microM) DME1022 XEOTICID XEO03775 GENEFORM Protein DME1022 XEOTICID XEO03775 MOACRIVE Inhibition DME1022 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1022 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03776 XEO_CLAS Peptide DME1022 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03776 GENEFORM Protein DME1022 XEOTICID XEO03776 MOACRIVE Inhibition DME1022 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1022 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03781 XEO_CLAS Peptide DME1022 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.47 microM) DME1022 XEOTICID XEO03781 GENEFORM Protein DME1022 XEOTICID XEO03781 MOACRIVE Inhibition DME1022 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1022 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03782 XEO_CLAS Peptide DME1022 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.47 microM) DME1022 XEOTICID XEO03782 GENEFORM Protein DME1022 XEOTICID XEO03782 MOACRIVE Inhibition DME1022 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1022 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03783 XEO_CLAS Peptide DME1022 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.68 microM) DME1022 XEOTICID XEO03783 GENEFORM Protein DME1022 XEOTICID XEO03783 MOACRIVE Inhibition DME1022 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1022 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03784 XEO_CLAS Peptide DME1022 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.45 microM) DME1022 XEOTICID XEO03784 GENEFORM Protein DME1022 XEOTICID XEO03784 MOACRIVE Inhibition DME1022 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1022 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03785 XEO_CLAS Peptide DME1022 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.73 microM) DME1022 XEOTICID XEO03785 GENEFORM Protein DME1022 XEOTICID XEO03785 MOACRIVE Inhibition DME1022 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1022 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03786 XEO_CLAS Peptide DME1022 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.45 microM) DME1022 XEOTICID XEO03786 GENEFORM Protein DME1022 XEOTICID XEO03786 MOACRIVE Inhibition DME1022 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1022 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03787 XEO_CLAS Peptide DME1022 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.38 microM) DME1022 XEOTICID XEO03787 GENEFORM Protein DME1022 XEOTICID XEO03787 MOACRIVE Inhibition DME1022 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1022 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03788 XEO_CLAS Peptide DME1022 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.46 microM) DME1022 XEOTICID XEO03788 GENEFORM Protein DME1022 XEOTICID XEO03788 MOACRIVE Inhibition DME1022 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1022 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03789 XEO_CLAS Peptide DME1022 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 13.05 microM) DME1022 XEOTICID XEO03789 GENEFORM Protein DME1022 XEOTICID XEO03789 MOACRIVE Inhibition DME1022 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1022 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03790 XEO_CLAS Peptide DME1022 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.82 microM) DME1022 XEOTICID XEO03790 GENEFORM Protein DME1022 XEOTICID XEO03790 MOACRIVE Inhibition DME1022 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1022 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03791 XEO_CLAS Peptide DME1022 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.80 microM) DME1022 XEOTICID XEO03791 GENEFORM Protein DME1022 XEOTICID XEO03791 MOACRIVE Inhibition DME1022 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1022 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03792 XEO_CLAS Peptide DME1022 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.26 microM) DME1022 XEOTICID XEO03792 GENEFORM Protein DME1022 XEOTICID XEO03792 MOACRIVE Inhibition DME1022 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1022 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03793 XEO_CLAS Peptide DME1022 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 microM) DME1022 XEOTICID XEO03793 GENEFORM Protein DME1022 XEOTICID XEO03793 MOACRIVE Inhibition DME1022 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1022 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03797 XEO_CLAS Peptide DME1022 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.4 microM) DME1022 XEOTICID XEO03797 GENEFORM Protein DME1022 XEOTICID XEO03797 MOACRIVE Inhibition DME1022 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1022 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03798 XEO_CLAS Peptide DME1022 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03798 GENEFORM Protein DME1022 XEOTICID XEO03798 MOACRIVE Inhibition DME1022 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1022 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03799 XEO_CLAS Peptide DME1022 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03799 GENEFORM Protein DME1022 XEOTICID XEO03799 MOACRIVE Inhibition DME1022 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1022 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03810 XEO_CLAS Peptide DME1022 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03810 GENEFORM Protein DME1022 XEOTICID XEO03810 MOACRIVE Inhibition DME1022 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1022 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03846 XEO_CLAS Peptide DME1022 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03846 GENEFORM Protein DME1022 XEOTICID XEO03846 MOACRIVE Inhibition DME1022 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1022 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03847 XEO_CLAS Peptide DME1022 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03847 GENEFORM Protein DME1022 XEOTICID XEO03847 MOACRIVE Inhibition DME1022 XEOTICID XEO03850 XEO_NAME Lemon DME1022 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1022 XEOTICID XEO03850 XEO_CLAS Food Additive DME1022 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03850 GENEFORM Protein DME1022 XEOTICID XEO03850 MOACRIVE Inhibition DME1022 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1022 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03853 XEO_CLAS Peptide DME1022 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO03853 GENEFORM Protein DME1022 XEOTICID XEO03853 MOACRIVE Inhibition DME1022 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1022 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03857 XEO_CLAS Peptide DME1022 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 38.49 microM) DME1022 XEOTICID XEO03857 GENEFORM Protein DME1022 XEOTICID XEO03857 MOACRIVE Inhibition DME1022 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1022 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03860 XEO_CLAS Peptide DME1022 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 24 microM) DME1022 XEOTICID XEO03860 GENEFORM Protein DME1022 XEOTICID XEO03860 MOACRIVE Inhibition DME1022 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1022 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03861 XEO_CLAS Peptide DME1022 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 35 microM) DME1022 XEOTICID XEO03861 GENEFORM Protein DME1022 XEOTICID XEO03861 MOACRIVE Inhibition DME1022 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1022 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03862 XEO_CLAS Peptide DME1022 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 70 microM) DME1022 XEOTICID XEO03862 GENEFORM Protein DME1022 XEOTICID XEO03862 MOACRIVE Inhibition DME1022 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1022 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03863 XEO_CLAS Peptide DME1022 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 35 microM) DME1022 XEOTICID XEO03863 GENEFORM Protein DME1022 XEOTICID XEO03863 MOACRIVE Inhibition DME1022 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1022 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03864 XEO_CLAS Peptide DME1022 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO03864 GENEFORM Protein DME1022 XEOTICID XEO03864 MOACRIVE Inhibition DME1022 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1022 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03865 XEO_CLAS Peptide DME1022 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO03865 GENEFORM Protein DME1022 XEOTICID XEO03865 MOACRIVE Inhibition DME1022 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1022 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03866 XEO_CLAS Peptide DME1022 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 microM) DME1022 XEOTICID XEO03866 GENEFORM Protein DME1022 XEOTICID XEO03866 MOACRIVE Inhibition DME1022 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1022 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03867 XEO_CLAS Peptide DME1022 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40 microM) DME1022 XEOTICID XEO03867 GENEFORM Protein DME1022 XEOTICID XEO03867 MOACRIVE Inhibition DME1022 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1022 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03868 XEO_CLAS Peptide DME1022 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 51 microM) DME1022 XEOTICID XEO03868 GENEFORM Protein DME1022 XEOTICID XEO03868 MOACRIVE Inhibition DME1022 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1022 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03869 XEO_CLAS Peptide DME1022 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 35 microM) DME1022 XEOTICID XEO03869 GENEFORM Protein DME1022 XEOTICID XEO03869 MOACRIVE Inhibition DME1022 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1022 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03870 XEO_CLAS Peptide DME1022 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 61 microM) DME1022 XEOTICID XEO03870 GENEFORM Protein DME1022 XEOTICID XEO03870 MOACRIVE Inhibition DME1022 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1022 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03871 XEO_CLAS Peptide DME1022 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 microM) DME1022 XEOTICID XEO03871 GENEFORM Protein DME1022 XEOTICID XEO03871 MOACRIVE Inhibition DME1022 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1022 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03872 XEO_CLAS Peptide DME1022 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 28 microM) DME1022 XEOTICID XEO03872 GENEFORM Protein DME1022 XEOTICID XEO03872 MOACRIVE Inhibition DME1022 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1022 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03873 XEO_CLAS Peptide DME1022 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 22.5 microM) DME1022 XEOTICID XEO03873 GENEFORM Protein DME1022 XEOTICID XEO03873 MOACRIVE Inhibition DME1022 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1022 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03874 XEO_CLAS Peptide DME1022 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 11.25 microM) DME1022 XEOTICID XEO03874 GENEFORM Protein DME1022 XEOTICID XEO03874 MOACRIVE Inhibition DME1022 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1022 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03875 XEO_CLAS Peptide DME1022 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 microM) DME1022 XEOTICID XEO03875 GENEFORM Protein DME1022 XEOTICID XEO03875 MOACRIVE Inhibition DME1022 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1022 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03876 XEO_CLAS Peptide DME1022 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.75 microM) DME1022 XEOTICID XEO03876 GENEFORM Protein DME1022 XEOTICID XEO03876 MOACRIVE Inhibition DME1022 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1022 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03877 XEO_CLAS Peptide DME1022 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 microM) DME1022 XEOTICID XEO03877 GENEFORM Protein DME1022 XEOTICID XEO03877 MOACRIVE Inhibition DME1022 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1022 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03878 XEO_CLAS Peptide DME1022 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 microM) DME1022 XEOTICID XEO03878 GENEFORM Protein DME1022 XEOTICID XEO03878 MOACRIVE Inhibition DME1022 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1022 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03879 XEO_CLAS Peptide DME1022 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 252 microM) DME1022 XEOTICID XEO03879 GENEFORM Protein DME1022 XEOTICID XEO03879 MOACRIVE Inhibition DME1022 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1022 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03880 XEO_CLAS Peptide DME1022 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 174 microM) DME1022 XEOTICID XEO03880 GENEFORM Protein DME1022 XEOTICID XEO03880 MOACRIVE Inhibition DME1022 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1022 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03883 XEO_CLAS Peptide DME1022 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 74 microM) DME1022 XEOTICID XEO03883 GENEFORM Protein DME1022 XEOTICID XEO03883 MOACRIVE Inhibition DME1022 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1022 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03884 XEO_CLAS Peptide DME1022 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 31 microM) DME1022 XEOTICID XEO03884 GENEFORM Protein DME1022 XEOTICID XEO03884 MOACRIVE Inhibition DME1022 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1022 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03885 XEO_CLAS Peptide DME1022 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO03885 GENEFORM Protein DME1022 XEOTICID XEO03885 MOACRIVE Inhibition DME1022 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1022 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03886 XEO_CLAS Peptide DME1022 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 391 microM) DME1022 XEOTICID XEO03886 GENEFORM Protein DME1022 XEOTICID XEO03886 MOACRIVE Inhibition DME1022 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1022 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03887 XEO_CLAS Peptide DME1022 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 151 microM) DME1022 XEOTICID XEO03887 GENEFORM Protein DME1022 XEOTICID XEO03887 MOACRIVE Inhibition DME1022 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1022 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03888 XEO_CLAS Peptide DME1022 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 134 microM) DME1022 XEOTICID XEO03888 GENEFORM Protein DME1022 XEOTICID XEO03888 MOACRIVE Inhibition DME1022 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1022 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03889 XEO_CLAS Peptide DME1022 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 88 microM) DME1022 XEOTICID XEO03889 GENEFORM Protein DME1022 XEOTICID XEO03889 MOACRIVE Inhibition DME1022 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1022 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03890 XEO_CLAS Peptide DME1022 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 31 microM) DME1022 XEOTICID XEO03890 GENEFORM Protein DME1022 XEOTICID XEO03890 MOACRIVE Inhibition DME1022 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1022 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03891 XEO_CLAS Peptide DME1022 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 microM) DME1022 XEOTICID XEO03891 GENEFORM Protein DME1022 XEOTICID XEO03891 MOACRIVE Inhibition DME1022 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1022 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03892 XEO_CLAS Peptide DME1022 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 37 microM) DME1022 XEOTICID XEO03892 GENEFORM Protein DME1022 XEOTICID XEO03892 MOACRIVE Inhibition DME1022 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1022 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03893 XEO_CLAS Peptide DME1022 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 19 microM) DME1022 XEOTICID XEO03893 GENEFORM Protein DME1022 XEOTICID XEO03893 MOACRIVE Inhibition DME1022 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1022 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03894 XEO_CLAS Peptide DME1022 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO03894 GENEFORM Protein DME1022 XEOTICID XEO03894 MOACRIVE Inhibition DME1022 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1022 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03895 XEO_CLAS Peptide DME1022 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO03895 GENEFORM Protein DME1022 XEOTICID XEO03895 MOACRIVE Inhibition DME1022 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1022 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03896 XEO_CLAS Peptide DME1022 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 microM) DME1022 XEOTICID XEO03896 GENEFORM Protein DME1022 XEOTICID XEO03896 MOACRIVE Inhibition DME1022 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1022 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03897 XEO_CLAS Peptide DME1022 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 63 microM) DME1022 XEOTICID XEO03897 GENEFORM Protein DME1022 XEOTICID XEO03897 MOACRIVE Inhibition DME1022 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1022 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03898 XEO_CLAS Peptide DME1022 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 219 microM) DME1022 XEOTICID XEO03898 GENEFORM Protein DME1022 XEOTICID XEO03898 MOACRIVE Inhibition DME1022 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1022 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03901 XEO_CLAS Peptide DME1022 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 35 microM) DME1022 XEOTICID XEO03901 GENEFORM Protein DME1022 XEOTICID XEO03901 MOACRIVE Inhibition DME1022 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1022 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03902 XEO_CLAS Peptide DME1022 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 70 microM) DME1022 XEOTICID XEO03902 GENEFORM Protein DME1022 XEOTICID XEO03902 MOACRIVE Inhibition DME1022 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1022 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03904 XEO_CLAS Peptide DME1022 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO03904 GENEFORM Protein DME1022 XEOTICID XEO03904 MOACRIVE Inhibition DME1022 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1022 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03905 XEO_CLAS Peptide DME1022 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO03905 GENEFORM Protein DME1022 XEOTICID XEO03905 MOACRIVE Inhibition DME1022 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1022 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03908 XEO_CLAS Peptide DME1022 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03908 GENEFORM Protein DME1022 XEOTICID XEO03908 MOACRIVE Inhibition DME1022 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1022 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03915 XEO_CLAS Peptide DME1022 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03915 GENEFORM Protein DME1022 XEOTICID XEO03915 MOACRIVE Inhibition DME1022 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1022 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03916 XEO_CLAS Peptide DME1022 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.8 ug/ml) DME1022 XEOTICID XEO03916 GENEFORM Protein DME1022 XEOTICID XEO03916 MOACRIVE Inhibition DME1022 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1022 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03917 XEO_CLAS Peptide DME1022 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 13.1 ug/ml) DME1022 XEOTICID XEO03917 GENEFORM Protein DME1022 XEOTICID XEO03917 MOACRIVE Inhibition DME1022 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1022 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03918 XEO_CLAS Peptide DME1022 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.5 ug/ml) DME1022 XEOTICID XEO03918 GENEFORM Protein DME1022 XEOTICID XEO03918 MOACRIVE Inhibition DME1022 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1022 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03919 XEO_CLAS Peptide DME1022 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 80 ug/ml) DME1022 XEOTICID XEO03919 GENEFORM Protein DME1022 XEOTICID XEO03919 MOACRIVE Inhibition DME1022 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1022 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03922 XEO_CLAS Peptide DME1022 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9 microM) DME1022 XEOTICID XEO03922 GENEFORM Protein DME1022 XEOTICID XEO03922 MOACRIVE Inhibition DME1022 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1022 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03923 XEO_CLAS Peptide DME1022 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 80 microM) DME1022 XEOTICID XEO03923 GENEFORM Protein DME1022 XEOTICID XEO03923 MOACRIVE Inhibition DME1022 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1022 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03924 XEO_CLAS Peptide DME1022 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO03924 GENEFORM Protein DME1022 XEOTICID XEO03924 MOACRIVE Inhibition DME1022 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1022 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03927 XEO_CLAS Peptide DME1022 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 80 microM) DME1022 XEOTICID XEO03927 GENEFORM Protein DME1022 XEOTICID XEO03927 MOACRIVE Inhibition DME1022 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1022 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03928 XEO_CLAS Peptide DME1022 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 microM) DME1022 XEOTICID XEO03928 GENEFORM Protein DME1022 XEOTICID XEO03928 MOACRIVE Inhibition DME1022 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1022 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03929 XEO_CLAS Peptide DME1022 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 microM) DME1022 XEOTICID XEO03929 GENEFORM Protein DME1022 XEOTICID XEO03929 MOACRIVE Inhibition DME1022 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1022 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03930 XEO_CLAS Peptide DME1022 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 microM) DME1022 XEOTICID XEO03930 GENEFORM Protein DME1022 XEOTICID XEO03930 MOACRIVE Inhibition DME1022 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1022 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03931 XEO_CLAS Peptide DME1022 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 microM) DME1022 XEOTICID XEO03931 GENEFORM Protein DME1022 XEOTICID XEO03931 MOACRIVE Inhibition DME1022 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1022 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03933 XEO_CLAS Peptide DME1022 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.5 microM) DME1022 XEOTICID XEO03933 GENEFORM Protein DME1022 XEOTICID XEO03933 MOACRIVE Inhibition DME1022 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1022 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03934 XEO_CLAS Peptide DME1022 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.7 microM) DME1022 XEOTICID XEO03934 GENEFORM Protein DME1022 XEOTICID XEO03934 MOACRIVE Inhibition DME1022 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1022 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03935 XEO_CLAS Peptide DME1022 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.7 microM) DME1022 XEOTICID XEO03935 GENEFORM Protein DME1022 XEOTICID XEO03935 MOACRIVE Inhibition DME1022 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1022 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03936 XEO_CLAS Peptide DME1022 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.0 microM) DME1022 XEOTICID XEO03936 GENEFORM Protein DME1022 XEOTICID XEO03936 MOACRIVE Inhibition DME1022 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1022 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03937 XEO_CLAS Peptide DME1022 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.1 microM) DME1022 XEOTICID XEO03937 GENEFORM Protein DME1022 XEOTICID XEO03937 MOACRIVE Inhibition DME1022 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1022 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03938 XEO_CLAS Peptide DME1022 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.7 microM) DME1022 XEOTICID XEO03938 GENEFORM Protein DME1022 XEOTICID XEO03938 MOACRIVE Inhibition DME1022 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1022 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03939 XEO_CLAS Peptide DME1022 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.7 microM) DME1022 XEOTICID XEO03939 GENEFORM Protein DME1022 XEOTICID XEO03939 MOACRIVE Inhibition DME1022 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1022 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03940 XEO_CLAS Peptide DME1022 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.5 microM) DME1022 XEOTICID XEO03940 GENEFORM Protein DME1022 XEOTICID XEO03940 MOACRIVE Inhibition DME1022 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1022 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03941 XEO_CLAS Peptide DME1022 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.4 microM) DME1022 XEOTICID XEO03941 GENEFORM Protein DME1022 XEOTICID XEO03941 MOACRIVE Inhibition DME1022 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1022 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03943 XEO_CLAS Peptide DME1022 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.4 microM) DME1022 XEOTICID XEO03943 GENEFORM Protein DME1022 XEOTICID XEO03943 MOACRIVE Inhibition DME1022 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1022 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03944 XEO_CLAS Peptide DME1022 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.7 microM) DME1022 XEOTICID XEO03944 GENEFORM Protein DME1022 XEOTICID XEO03944 MOACRIVE Inhibition DME1022 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1022 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03945 XEO_CLAS Peptide DME1022 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.2 microM) DME1022 XEOTICID XEO03945 GENEFORM Protein DME1022 XEOTICID XEO03945 MOACRIVE Inhibition DME1022 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1022 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03947 XEO_CLAS Peptide DME1022 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.0 microM) DME1022 XEOTICID XEO03947 GENEFORM Protein DME1022 XEOTICID XEO03947 MOACRIVE Inhibition DME1022 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1022 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03948 XEO_CLAS Peptide DME1022 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 23.3 microM) DME1022 XEOTICID XEO03948 GENEFORM Protein DME1022 XEOTICID XEO03948 MOACRIVE Inhibition DME1022 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1022 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03950 XEO_CLAS Peptide DME1022 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4.4 microM) DME1022 XEOTICID XEO03950 GENEFORM Protein DME1022 XEOTICID XEO03950 MOACRIVE Inhibition DME1022 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1022 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03951 XEO_CLAS Peptide DME1022 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8.8 microM) DME1022 XEOTICID XEO03951 GENEFORM Protein DME1022 XEOTICID XEO03951 MOACRIVE Inhibition DME1022 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1022 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03952 XEO_CLAS Peptide DME1022 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.2 microM) DME1022 XEOTICID XEO03952 GENEFORM Protein DME1022 XEOTICID XEO03952 MOACRIVE Inhibition DME1022 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1022 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03953 XEO_CLAS Peptide DME1022 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 microM) DME1022 XEOTICID XEO03953 GENEFORM Protein DME1022 XEOTICID XEO03953 MOACRIVE Inhibition DME1022 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1022 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03958 XEO_CLAS Peptide DME1022 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03958 GENEFORM Protein DME1022 XEOTICID XEO03958 MOACRIVE Inhibition DME1022 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1022 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03965 XEO_CLAS Peptide DME1022 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 128 microM) DME1022 XEOTICID XEO03965 GENEFORM Protein DME1022 XEOTICID XEO03965 MOACRIVE Inhibition DME1022 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1022 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03966 XEO_CLAS Peptide DME1022 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 microM) DME1022 XEOTICID XEO03966 GENEFORM Protein DME1022 XEOTICID XEO03966 MOACRIVE Inhibition DME1022 XEOTICID XEO03971 XEO_NAME Lumbrican DME1022 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03971 XEO_CLAS Peptide DME1022 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03971 GENEFORM Protein DME1022 XEOTICID XEO03971 MOACRIVE Inhibition DME1022 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1022 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03972 XEO_CLAS Peptide DME1022 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO03972 GENEFORM Protein DME1022 XEOTICID XEO03972 MOACRIVE Inhibition DME1022 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1022 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03980 XEO_CLAS Peptide DME1022 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 32 microM) DME1022 XEOTICID XEO03980 GENEFORM Protein DME1022 XEOTICID XEO03980 MOACRIVE Inhibition DME1022 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1022 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03985 XEO_CLAS Peptide DME1022 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 ug/ml) DME1022 XEOTICID XEO03985 GENEFORM Protein DME1022 XEOTICID XEO03985 MOACRIVE Inhibition DME1022 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1022 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03991 XEO_CLAS Peptide DME1022 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03991 GENEFORM Protein DME1022 XEOTICID XEO03991 MOACRIVE Inhibition DME1022 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1022 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03992 XEO_CLAS Peptide DME1022 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03992 GENEFORM Protein DME1022 XEOTICID XEO03992 MOACRIVE Inhibition DME1022 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1022 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03993 XEO_CLAS Peptide DME1022 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03993 GENEFORM Protein DME1022 XEOTICID XEO03993 MOACRIVE Inhibition DME1022 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1022 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03994 XEO_CLAS Peptide DME1022 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO03994 GENEFORM Protein DME1022 XEOTICID XEO03994 MOACRIVE Inhibition DME1022 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1022 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03996 XEO_CLAS Peptide DME1022 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 65 microM) DME1022 XEOTICID XEO03996 GENEFORM Protein DME1022 XEOTICID XEO03996 MOACRIVE Inhibition DME1022 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1022 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03997 XEO_CLAS Peptide DME1022 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 7.5 microM) DME1022 XEOTICID XEO03997 GENEFORM Protein DME1022 XEOTICID XEO03997 MOACRIVE Inhibition DME1022 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1022 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03998 XEO_CLAS Peptide DME1022 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15.5 microM) DME1022 XEOTICID XEO03998 GENEFORM Protein DME1022 XEOTICID XEO03998 MOACRIVE Inhibition DME1022 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1022 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO03999 XEO_CLAS Peptide DME1022 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25.8 microM) DME1022 XEOTICID XEO03999 GENEFORM Protein DME1022 XEOTICID XEO03999 MOACRIVE Inhibition DME1022 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1022 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04000 XEO_CLAS Peptide DME1022 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO04000 GENEFORM Protein DME1022 XEOTICID XEO04000 MOACRIVE Inhibition DME1022 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1022 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04001 XEO_CLAS Peptide DME1022 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO04001 GENEFORM Protein DME1022 XEOTICID XEO04001 MOACRIVE Inhibition DME1022 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1022 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04002 XEO_CLAS Peptide DME1022 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 7.5 ug/ml) DME1022 XEOTICID XEO04002 GENEFORM Protein DME1022 XEOTICID XEO04002 MOACRIVE Inhibition DME1022 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1022 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04003 XEO_CLAS Peptide DME1022 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 ug/ml) DME1022 XEOTICID XEO04003 GENEFORM Protein DME1022 XEOTICID XEO04003 MOACRIVE Inhibition DME1022 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1022 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04004 XEO_CLAS Peptide DME1022 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.0 ug/ml) DME1022 XEOTICID XEO04004 GENEFORM Protein DME1022 XEOTICID XEO04004 MOACRIVE Inhibition DME1022 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1022 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04005 XEO_CLAS Peptide DME1022 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.0 ug/ml) DME1022 XEOTICID XEO04005 GENEFORM Protein DME1022 XEOTICID XEO04005 MOACRIVE Inhibition DME1022 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1022 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04007 XEO_CLAS Peptide DME1022 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 19.5 ug/ml) DME1022 XEOTICID XEO04007 GENEFORM Protein DME1022 XEOTICID XEO04007 MOACRIVE Inhibition DME1022 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1022 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04011 XEO_CLAS Peptide DME1022 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 19.5 ug/ml) DME1022 XEOTICID XEO04011 GENEFORM Protein DME1022 XEOTICID XEO04011 MOACRIVE Inhibition DME1022 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1022 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04012 XEO_CLAS Peptide DME1022 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.9 ug/ml) DME1022 XEOTICID XEO04012 GENEFORM Protein DME1022 XEOTICID XEO04012 MOACRIVE Inhibition DME1022 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1022 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04013 XEO_CLAS Peptide DME1022 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.7 ug/ml) DME1022 XEOTICID XEO04013 GENEFORM Protein DME1022 XEOTICID XEO04013 MOACRIVE Inhibition DME1022 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1022 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04018 XEO_CLAS Peptide DME1022 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9 ug/ml) DME1022 XEOTICID XEO04018 GENEFORM Protein DME1022 XEOTICID XEO04018 MOACRIVE Inhibition DME1022 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1022 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04026 XEO_CLAS Peptide DME1022 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO04026 GENEFORM Protein DME1022 XEOTICID XEO04026 MOACRIVE Inhibition DME1022 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1022 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04027 XEO_CLAS Peptide DME1022 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO04027 GENEFORM Protein DME1022 XEOTICID XEO04027 MOACRIVE Inhibition DME1022 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1022 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04028 XEO_CLAS Peptide DME1022 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 ug/ml) DME1022 XEOTICID XEO04028 GENEFORM Protein DME1022 XEOTICID XEO04028 MOACRIVE Inhibition DME1022 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1022 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04038 XEO_CLAS Peptide DME1022 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04038 GENEFORM Protein DME1022 XEOTICID XEO04038 MOACRIVE Inhibition DME1022 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1022 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04039 XEO_CLAS Peptide DME1022 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 microM) DME1022 XEOTICID XEO04039 GENEFORM Protein DME1022 XEOTICID XEO04039 MOACRIVE Inhibition DME1022 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1022 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04051 XEO_CLAS Peptide DME1022 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1022 XEOTICID XEO04051 GENEFORM Protein DME1022 XEOTICID XEO04051 MOACRIVE Inhibition DME1022 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1022 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04052 XEO_CLAS Peptide DME1022 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04052 GENEFORM Protein DME1022 XEOTICID XEO04052 MOACRIVE Inhibition DME1022 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1022 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04053 XEO_CLAS Peptide DME1022 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.08-0.16 microM) DME1022 XEOTICID XEO04053 GENEFORM Protein DME1022 XEOTICID XEO04053 MOACRIVE Inhibition DME1022 XEOTICID XEO04055 XEO_NAME Melectin DME1022 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04055 XEO_CLAS Peptide DME1022 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.0 microM) DME1022 XEOTICID XEO04055 GENEFORM Protein DME1022 XEOTICID XEO04055 MOACRIVE Inhibition DME1022 XEOTICID XEO04057 XEO_NAME Melittin DME1022 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04057 XEO_CLAS Peptide DME1022 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.8 microM) DME1022 XEOTICID XEO04057 GENEFORM Protein DME1022 XEOTICID XEO04057 MOACRIVE Inhibition DME1022 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1022 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04061 XEO_CLAS Peptide DME1022 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.9 microM) DME1022 XEOTICID XEO04061 GENEFORM Protein DME1022 XEOTICID XEO04061 MOACRIVE Inhibition DME1022 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1022 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04062 XEO_CLAS Peptide DME1022 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.5 microM) DME1022 XEOTICID XEO04062 GENEFORM Protein DME1022 XEOTICID XEO04062 MOACRIVE Inhibition DME1022 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1022 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04063 XEO_CLAS Peptide DME1022 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 7.8 microM) DME1022 XEOTICID XEO04063 GENEFORM Protein DME1022 XEOTICID XEO04063 MOACRIVE Inhibition DME1022 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1022 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04064 XEO_CLAS Peptide DME1022 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 46.7 microM) DME1022 XEOTICID XEO04064 GENEFORM Protein DME1022 XEOTICID XEO04064 MOACRIVE Inhibition DME1022 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1022 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04066 XEO_CLAS Peptide DME1022 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16.3 microM) DME1022 XEOTICID XEO04066 GENEFORM Protein DME1022 XEOTICID XEO04066 MOACRIVE Inhibition DME1022 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1022 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04067 XEO_CLAS Peptide DME1022 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.6 microM) DME1022 XEOTICID XEO04067 GENEFORM Protein DME1022 XEOTICID XEO04067 MOACRIVE Inhibition DME1022 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1022 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04068 XEO_CLAS Peptide DME1022 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.6 microM) DME1022 XEOTICID XEO04068 GENEFORM Protein DME1022 XEOTICID XEO04068 MOACRIVE Inhibition DME1022 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1022 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04086 GENEFORM Protein DME1022 XEOTICID XEO04086 MOACRIVE Inhibition DME1022 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1022 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04087 GENEFORM Protein DME1022 XEOTICID XEO04087 MOACRIVE Inhibition DME1022 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1022 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04089 GENEFORM Protein DME1022 XEOTICID XEO04089 MOACRIVE Inhibition DME1022 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1022 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04094 GENEFORM Protein DME1022 XEOTICID XEO04094 MOACRIVE Inhibition DME1022 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1022 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04096 GENEFORM Protein DME1022 XEOTICID XEO04096 MOACRIVE Inhibition DME1022 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1022 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04098 GENEFORM Protein DME1022 XEOTICID XEO04098 MOACRIVE Inhibition DME1022 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1022 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04111 XEO_CLAS Peptide DME1022 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04111 GENEFORM Protein DME1022 XEOTICID XEO04111 MOACRIVE Inhibition DME1022 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1022 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04112 XEO_CLAS Peptide DME1022 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.02 microM) DME1022 XEOTICID XEO04112 GENEFORM Protein DME1022 XEOTICID XEO04112 MOACRIVE Inhibition DME1022 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1022 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04113 XEO_CLAS Peptide DME1022 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.02 ug/ml) DME1022 XEOTICID XEO04113 GENEFORM Protein DME1022 XEOTICID XEO04113 MOACRIVE Inhibition DME1022 XEOTICID XEO04114 XEO_NAME Microcin L DME1022 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04114 XEO_CLAS Peptide DME1022 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04114 GENEFORM Protein DME1022 XEOTICID XEO04114 MOACRIVE Inhibition DME1022 XEOTICID XEO04117 XEO_NAME Misgurin DME1022 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04117 XEO_CLAS Peptide DME1022 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04117 GENEFORM Protein DME1022 XEOTICID XEO04117 MOACRIVE Inhibition DME1022 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1022 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04118 XEO_CLAS Peptide DME1022 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 300 microM) DME1022 XEOTICID XEO04118 GENEFORM Protein DME1022 XEOTICID XEO04118 MOACRIVE Inhibition DME1022 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1022 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04119 XEO_CLAS Peptide DME1022 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-20 microM) DME1022 XEOTICID XEO04119 GENEFORM Protein DME1022 XEOTICID XEO04119 MOACRIVE Inhibition DME1022 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1022 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04120 XEO_CLAS Peptide DME1022 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC < 10 microM) DME1022 XEOTICID XEO04120 GENEFORM Protein DME1022 XEOTICID XEO04120 MOACRIVE Inhibition DME1022 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1022 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04121 XEO_CLAS Peptide DME1022 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.2-6.4 microM) DME1022 XEOTICID XEO04121 GENEFORM Protein DME1022 XEOTICID XEO04121 MOACRIVE Inhibition DME1022 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1022 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04122 XEO_CLAS Peptide DME1022 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.14-6.29 microM) DME1022 XEOTICID XEO04122 GENEFORM Protein DME1022 XEOTICID XEO04122 MOACRIVE Inhibition DME1022 XEOTICID XEO04123 XEO_NAME Modified defensin DME1022 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04123 XEO_CLAS Peptide DME1022 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO04123 GENEFORM Protein DME1022 XEOTICID XEO04123 MOACRIVE Inhibition DME1022 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1022 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04128 XEO_CLAS Peptide DME1022 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.31 microM) DME1022 XEOTICID XEO04128 GENEFORM Protein DME1022 XEOTICID XEO04128 MOACRIVE Inhibition DME1022 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1022 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04129 XEO_CLAS Peptide DME1022 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO04129 GENEFORM Protein DME1022 XEOTICID XEO04129 MOACRIVE Inhibition DME1022 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1022 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04130 XEO_CLAS Peptide DME1022 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO04130 GENEFORM Protein DME1022 XEOTICID XEO04130 MOACRIVE Inhibition DME1022 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1022 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04131 XEO_CLAS Peptide DME1022 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 microM) DME1022 XEOTICID XEO04131 GENEFORM Protein DME1022 XEOTICID XEO04131 MOACRIVE Inhibition DME1022 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1022 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04132 XEO_CLAS Peptide DME1022 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 microM) DME1022 XEOTICID XEO04132 GENEFORM Protein DME1022 XEOTICID XEO04132 MOACRIVE Inhibition DME1022 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1022 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04133 XEO_CLAS Peptide DME1022 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO04133 GENEFORM Protein DME1022 XEOTICID XEO04133 MOACRIVE Inhibition DME1022 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1022 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04134 XEO_CLAS Peptide DME1022 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO04134 GENEFORM Protein DME1022 XEOTICID XEO04134 MOACRIVE Inhibition DME1022 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1022 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04135 XEO_CLAS Peptide DME1022 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 microM) DME1022 XEOTICID XEO04135 GENEFORM Protein DME1022 XEOTICID XEO04135 MOACRIVE Inhibition DME1022 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1022 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04137 XEO_CLAS Peptide DME1022 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.6 microM) DME1022 XEOTICID XEO04137 GENEFORM Protein DME1022 XEOTICID XEO04137 MOACRIVE Inhibition DME1022 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1022 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04138 XEO_CLAS Peptide DME1022 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 microM) DME1022 XEOTICID XEO04138 GENEFORM Protein DME1022 XEOTICID XEO04138 MOACRIVE Inhibition DME1022 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1022 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04139 XEO_CLAS Peptide DME1022 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 microM) DME1022 XEOTICID XEO04139 GENEFORM Protein DME1022 XEOTICID XEO04139 MOACRIVE Inhibition DME1022 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1022 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04140 XEO_CLAS Peptide DME1022 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 70 microM) DME1022 XEOTICID XEO04140 GENEFORM Protein DME1022 XEOTICID XEO04140 MOACRIVE Inhibition DME1022 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1022 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04141 XEO_CLAS Peptide DME1022 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 microM) DME1022 XEOTICID XEO04141 GENEFORM Protein DME1022 XEOTICID XEO04141 MOACRIVE Inhibition DME1022 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1022 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04142 XEO_CLAS Peptide DME1022 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8-16 microM) DME1022 XEOTICID XEO04142 GENEFORM Protein DME1022 XEOTICID XEO04142 MOACRIVE Inhibition DME1022 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1022 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04146 XEO_CLAS Peptide DME1022 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04146 GENEFORM Protein DME1022 XEOTICID XEO04146 MOACRIVE Inhibition DME1022 XEOTICID XEO04149 XEO_NAME Mucroporin DME1022 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04149 XEO_CLAS Peptide DME1022 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 ug/ml) DME1022 XEOTICID XEO04149 GENEFORM Protein DME1022 XEOTICID XEO04149 MOACRIVE Inhibition DME1022 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1022 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04158 XEO_CLAS Peptide DME1022 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO04158 GENEFORM Protein DME1022 XEOTICID XEO04158 MOACRIVE Inhibition DME1022 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1022 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04159 XEO_CLAS Peptide DME1022 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 microM) DME1022 XEOTICID XEO04159 GENEFORM Protein DME1022 XEOTICID XEO04159 MOACRIVE Inhibition DME1022 XEOTICID XEO04167 XEO_NAME Myticin-B DME1022 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04167 XEO_CLAS Peptide DME1022 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04167 GENEFORM Protein DME1022 XEOTICID XEO04167 MOACRIVE Inhibition DME1022 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1022 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04168 XEO_CLAS Peptide DME1022 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.7-12.5 microM) DME1022 XEOTICID XEO04168 GENEFORM Protein DME1022 XEOTICID XEO04168 MOACRIVE Inhibition DME1022 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1022 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04169 XEO_CLAS Peptide DME1022 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04169 GENEFORM Protein DME1022 XEOTICID XEO04169 MOACRIVE Inhibition DME1022 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1022 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04170 XEO_CLAS Peptide DME1022 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04170 GENEFORM Protein DME1022 XEOTICID XEO04170 MOACRIVE Inhibition DME1022 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1022 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04171 XEO_CLAS Peptide DME1022 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04171 GENEFORM Protein DME1022 XEOTICID XEO04171 MOACRIVE Inhibition DME1022 XEOTICID XEO04172 XEO_NAME Myxinidin DME1022 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04172 XEO_CLAS Peptide DME1022 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04172 GENEFORM Protein DME1022 XEOTICID XEO04172 MOACRIVE Inhibition DME1022 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1022 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04177 XEO_CLAS Peptide DME1022 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.7 microM) DME1022 XEOTICID XEO04177 GENEFORM Protein DME1022 XEOTICID XEO04177 MOACRIVE Inhibition DME1022 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1022 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04178 XEO_CLAS Peptide DME1022 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.7 microM) DME1022 XEOTICID XEO04178 GENEFORM Protein DME1022 XEOTICID XEO04178 MOACRIVE Inhibition DME1022 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1022 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04179 XEO_CLAS Peptide DME1022 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.5 microM) DME1022 XEOTICID XEO04179 GENEFORM Protein DME1022 XEOTICID XEO04179 MOACRIVE Inhibition DME1022 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1022 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04180 XEO_CLAS Peptide DME1022 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 23 microM) DME1022 XEOTICID XEO04180 GENEFORM Protein DME1022 XEOTICID XEO04180 MOACRIVE Inhibition DME1022 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1022 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04181 XEO_CLAS Peptide DME1022 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.2 microM) DME1022 XEOTICID XEO04181 GENEFORM Protein DME1022 XEOTICID XEO04181 MOACRIVE Inhibition DME1022 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1022 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04182 XEO_CLAS Peptide DME1022 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4.4 microM) DME1022 XEOTICID XEO04182 GENEFORM Protein DME1022 XEOTICID XEO04182 MOACRIVE Inhibition DME1022 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1022 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04183 XEO_CLAS Peptide DME1022 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.6 microM) DME1022 XEOTICID XEO04183 GENEFORM Protein DME1022 XEOTICID XEO04183 MOACRIVE Inhibition DME1022 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1022 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04184 XEO_CLAS Peptide DME1022 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 microM) DME1022 XEOTICID XEO04184 GENEFORM Protein DME1022 XEOTICID XEO04184 MOACRIVE Inhibition DME1022 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1022 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04185 XEO_CLAS Peptide DME1022 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04185 GENEFORM Protein DME1022 XEOTICID XEO04185 MOACRIVE Inhibition DME1022 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1022 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04186 XEO_CLAS Peptide DME1022 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04186 GENEFORM Protein DME1022 XEOTICID XEO04186 MOACRIVE Inhibition DME1022 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1022 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04187 XEO_CLAS Peptide DME1022 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04187 GENEFORM Protein DME1022 XEOTICID XEO04187 MOACRIVE Inhibition DME1022 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1022 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04188 XEO_CLAS Peptide DME1022 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04188 GENEFORM Protein DME1022 XEOTICID XEO04188 MOACRIVE Inhibition DME1022 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1022 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04206 XEO_CLAS Peptide DME1022 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25 microM) DME1022 XEOTICID XEO04206 GENEFORM Protein DME1022 XEOTICID XEO04206 MOACRIVE Inhibition DME1022 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1022 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04214 XEO_CLAS Peptide DME1022 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25 microM) DME1022 XEOTICID XEO04214 GENEFORM Protein DME1022 XEOTICID XEO04214 MOACRIVE Inhibition DME1022 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1022 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04216 XEO_CLAS Peptide DME1022 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO04216 GENEFORM Protein DME1022 XEOTICID XEO04216 MOACRIVE Inhibition DME1022 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1022 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04218 XEO_CLAS Peptide DME1022 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.125 microM) DME1022 XEOTICID XEO04218 GENEFORM Protein DME1022 XEOTICID XEO04218 MOACRIVE Inhibition DME1022 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1022 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04219 XEO_CLAS Peptide DME1022 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO04219 GENEFORM Protein DME1022 XEOTICID XEO04219 MOACRIVE Inhibition DME1022 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1022 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04220 XEO_CLAS Peptide DME1022 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.125 microM) DME1022 XEOTICID XEO04220 GENEFORM Protein DME1022 XEOTICID XEO04220 MOACRIVE Inhibition DME1022 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1022 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04221 XEO_CLAS Peptide DME1022 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO04221 GENEFORM Protein DME1022 XEOTICID XEO04221 MOACRIVE Inhibition DME1022 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1022 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04222 XEO_CLAS Peptide DME1022 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25 microM) DME1022 XEOTICID XEO04222 GENEFORM Protein DME1022 XEOTICID XEO04222 MOACRIVE Inhibition DME1022 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1022 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04233 XEO_CLAS Peptide DME1022 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04233 GENEFORM Protein DME1022 XEOTICID XEO04233 MOACRIVE Inhibition DME1022 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1022 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04234 XEO_CLAS Peptide DME1022 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04234 GENEFORM Protein DME1022 XEOTICID XEO04234 MOACRIVE Inhibition DME1022 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1022 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04241 XEO_CLAS Peptide DME1022 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04241 GENEFORM Protein DME1022 XEOTICID XEO04241 MOACRIVE Inhibition DME1022 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1022 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04242 XEO_CLAS Peptide DME1022 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04242 GENEFORM Protein DME1022 XEOTICID XEO04242 MOACRIVE Inhibition DME1022 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1022 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04245 XEO_CLAS Natural Product DME1022 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04245 GENEFORM Protein DME1022 XEOTICID XEO04245 MOACRIVE Inhibition DME1022 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1022 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04246 XEO_CLAS Natural Product DME1022 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04246 GENEFORM Protein DME1022 XEOTICID XEO04246 MOACRIVE Inhibition DME1022 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1022 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04249 XEO_CLAS Peptide DME1022 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 500 ug/ml) DME1022 XEOTICID XEO04249 GENEFORM Protein DME1022 XEOTICID XEO04249 MOACRIVE Inhibition DME1022 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1022 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04251 XEO_CLAS Peptide DME1022 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04251 GENEFORM Protein DME1022 XEOTICID XEO04251 MOACRIVE Inhibition DME1022 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1022 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04253 XEO_CLAS Peptide DME1022 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04253 GENEFORM Protein DME1022 XEOTICID XEO04253 MOACRIVE Inhibition DME1022 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1022 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04254 XEO_CLAS Peptide DME1022 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04254 GENEFORM Protein DME1022 XEOTICID XEO04254 MOACRIVE Inhibition DME1022 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1022 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04255 XEO_CLAS Peptide DME1022 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04255 GENEFORM Protein DME1022 XEOTICID XEO04255 MOACRIVE Inhibition DME1022 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1022 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04256 XEO_CLAS Peptide DME1022 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04256 GENEFORM Protein DME1022 XEOTICID XEO04256 MOACRIVE Inhibition DME1022 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1022 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04257 XEO_CLAS Peptide DME1022 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04257 GENEFORM Protein DME1022 XEOTICID XEO04257 MOACRIVE Inhibition DME1022 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1022 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04258 XEO_CLAS Peptide DME1022 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04258 GENEFORM Protein DME1022 XEOTICID XEO04258 MOACRIVE Inhibition DME1022 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1022 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04259 XEO_CLAS Peptide DME1022 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04259 GENEFORM Protein DME1022 XEOTICID XEO04259 MOACRIVE Inhibition DME1022 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1022 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04260 XEO_CLAS Peptide DME1022 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04260 GENEFORM Protein DME1022 XEOTICID XEO04260 MOACRIVE Inhibition DME1022 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1022 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04261 XEO_CLAS Peptide DME1022 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04261 GENEFORM Protein DME1022 XEOTICID XEO04261 MOACRIVE Inhibition DME1022 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1022 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04262 XEO_CLAS Peptide DME1022 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04262 GENEFORM Protein DME1022 XEOTICID XEO04262 MOACRIVE Inhibition DME1022 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1022 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04263 XEO_CLAS Peptide DME1022 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04263 GENEFORM Protein DME1022 XEOTICID XEO04263 MOACRIVE Inhibition DME1022 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1022 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04264 XEO_CLAS Peptide DME1022 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04264 GENEFORM Protein DME1022 XEOTICID XEO04264 MOACRIVE Inhibition DME1022 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1022 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04265 XEO_CLAS Peptide DME1022 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04265 GENEFORM Protein DME1022 XEOTICID XEO04265 MOACRIVE Inhibition DME1022 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1022 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04266 XEO_CLAS Peptide DME1022 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04266 GENEFORM Protein DME1022 XEOTICID XEO04266 MOACRIVE Inhibition DME1022 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1022 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04267 XEO_CLAS Peptide DME1022 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04267 GENEFORM Protein DME1022 XEOTICID XEO04267 MOACRIVE Inhibition DME1022 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1022 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04268 XEO_CLAS Peptide DME1022 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04268 GENEFORM Protein DME1022 XEOTICID XEO04268 MOACRIVE Inhibition DME1022 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1022 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04269 XEO_CLAS Peptide DME1022 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04269 GENEFORM Protein DME1022 XEOTICID XEO04269 MOACRIVE Inhibition DME1022 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1022 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04270 XEO_CLAS Peptide DME1022 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04270 GENEFORM Protein DME1022 XEOTICID XEO04270 MOACRIVE Inhibition DME1022 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1022 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04271 XEO_CLAS Peptide DME1022 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04271 GENEFORM Protein DME1022 XEOTICID XEO04271 MOACRIVE Inhibition DME1022 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1022 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04272 XEO_CLAS Peptide DME1022 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04272 GENEFORM Protein DME1022 XEOTICID XEO04272 MOACRIVE Inhibition DME1022 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1022 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04277 XEO_CLAS Peptide DME1022 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 110.00 ug/ml) DME1022 XEOTICID XEO04277 GENEFORM Protein DME1022 XEOTICID XEO04277 MOACRIVE Inhibition DME1022 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1022 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04280 XEO_CLAS Peptide DME1022 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 37.50 ug/ml) DME1022 XEOTICID XEO04280 GENEFORM Protein DME1022 XEOTICID XEO04280 MOACRIVE Inhibition DME1022 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1022 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04281 XEO_CLAS Peptide DME1022 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25.00 ug/ml) DME1022 XEOTICID XEO04281 GENEFORM Protein DME1022 XEOTICID XEO04281 MOACRIVE Inhibition DME1022 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1022 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04282 XEO_CLAS Peptide DME1022 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.2 ug/ml) DME1022 XEOTICID XEO04282 GENEFORM Protein DME1022 XEOTICID XEO04282 MOACRIVE Inhibition DME1022 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1022 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04283 XEO_CLAS Peptide DME1022 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.3 ug/ml) DME1022 XEOTICID XEO04283 GENEFORM Protein DME1022 XEOTICID XEO04283 MOACRIVE Inhibition DME1022 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1022 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04284 XEO_CLAS Peptide DME1022 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10.8 ug/ml) DME1022 XEOTICID XEO04284 GENEFORM Protein DME1022 XEOTICID XEO04284 MOACRIVE Inhibition DME1022 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1022 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04285 XEO_CLAS Peptide DME1022 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 11.5 ug/ml) DME1022 XEOTICID XEO04285 GENEFORM Protein DME1022 XEOTICID XEO04285 MOACRIVE Inhibition DME1022 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1022 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04286 XEO_CLAS Peptide DME1022 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8.6 ug/ml) DME1022 XEOTICID XEO04286 GENEFORM Protein DME1022 XEOTICID XEO04286 MOACRIVE Inhibition DME1022 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1022 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04287 XEO_CLAS Peptide DME1022 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10.2 ug/ml) DME1022 XEOTICID XEO04287 GENEFORM Protein DME1022 XEOTICID XEO04287 MOACRIVE Inhibition DME1022 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1022 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04288 XEO_CLAS Peptide DME1022 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4.4 ug/ml) DME1022 XEOTICID XEO04288 GENEFORM Protein DME1022 XEOTICID XEO04288 MOACRIVE Inhibition DME1022 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1022 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04289 XEO_CLAS Peptide DME1022 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.2 ug/ml) DME1022 XEOTICID XEO04289 GENEFORM Protein DME1022 XEOTICID XEO04289 MOACRIVE Inhibition DME1022 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1022 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04290 XEO_CLAS Peptide DME1022 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 11.3 ug/ml) DME1022 XEOTICID XEO04290 GENEFORM Protein DME1022 XEOTICID XEO04290 MOACRIVE Inhibition DME1022 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1022 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04291 XEO_CLAS Peptide DME1022 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 7.2 ug/ml) DME1022 XEOTICID XEO04291 GENEFORM Protein DME1022 XEOTICID XEO04291 MOACRIVE Inhibition DME1022 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1022 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04292 XEO_CLAS Peptide DME1022 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.1 ug/ml) DME1022 XEOTICID XEO04292 GENEFORM Protein DME1022 XEOTICID XEO04292 MOACRIVE Inhibition DME1022 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1022 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04293 XEO_CLAS Peptide DME1022 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO04293 GENEFORM Protein DME1022 XEOTICID XEO04293 MOACRIVE Inhibition DME1022 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1022 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04294 XEO_CLAS Peptide DME1022 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO04294 GENEFORM Protein DME1022 XEOTICID XEO04294 MOACRIVE Inhibition DME1022 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1022 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04295 XEO_CLAS Peptide DME1022 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO04295 GENEFORM Protein DME1022 XEOTICID XEO04295 MOACRIVE Inhibition DME1022 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1022 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04296 XEO_CLAS Peptide DME1022 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 28 microM) DME1022 XEOTICID XEO04296 GENEFORM Protein DME1022 XEOTICID XEO04296 MOACRIVE Inhibition DME1022 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1022 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04297 XEO_CLAS Peptide DME1022 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 14 microM) DME1022 XEOTICID XEO04297 GENEFORM Protein DME1022 XEOTICID XEO04297 MOACRIVE Inhibition DME1022 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1022 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04298 XEO_CLAS Peptide DME1022 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO04298 GENEFORM Protein DME1022 XEOTICID XEO04298 MOACRIVE Inhibition DME1022 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1022 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04299 XEO_CLAS Peptide DME1022 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO04299 GENEFORM Protein DME1022 XEOTICID XEO04299 MOACRIVE Inhibition DME1022 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1022 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04300 XEO_CLAS Peptide DME1022 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO04300 GENEFORM Protein DME1022 XEOTICID XEO04300 MOACRIVE Inhibition DME1022 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1022 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04301 XEO_CLAS Peptide DME1022 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 microM) DME1022 XEOTICID XEO04301 GENEFORM Protein DME1022 XEOTICID XEO04301 MOACRIVE Inhibition DME1022 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1022 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04302 XEO_CLAS Peptide DME1022 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 microM) DME1022 XEOTICID XEO04302 GENEFORM Protein DME1022 XEOTICID XEO04302 MOACRIVE Inhibition DME1022 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1022 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04303 XEO_CLAS Peptide DME1022 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 microM) DME1022 XEOTICID XEO04303 GENEFORM Protein DME1022 XEOTICID XEO04303 MOACRIVE Inhibition DME1022 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1022 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04304 XEO_CLAS Peptide DME1022 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO04304 GENEFORM Protein DME1022 XEOTICID XEO04304 MOACRIVE Inhibition DME1022 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1022 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04305 XEO_CLAS Peptide DME1022 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 70 microM) DME1022 XEOTICID XEO04305 GENEFORM Protein DME1022 XEOTICID XEO04305 MOACRIVE Inhibition DME1022 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1022 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04306 XEO_CLAS Peptide DME1022 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO04306 GENEFORM Protein DME1022 XEOTICID XEO04306 MOACRIVE Inhibition DME1022 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1022 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04307 XEO_CLAS Peptide DME1022 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 ug/ml) DME1022 XEOTICID XEO04307 GENEFORM Protein DME1022 XEOTICID XEO04307 MOACRIVE Inhibition DME1022 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1022 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04308 XEO_CLAS Peptide DME1022 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9.37 ug/ml) DME1022 XEOTICID XEO04308 GENEFORM Protein DME1022 XEOTICID XEO04308 MOACRIVE Inhibition DME1022 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1022 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04309 XEO_CLAS Peptide DME1022 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 microM) DME1022 XEOTICID XEO04309 GENEFORM Protein DME1022 XEOTICID XEO04309 MOACRIVE Inhibition DME1022 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1022 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04310 XEO_CLAS Peptide DME1022 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO04310 GENEFORM Protein DME1022 XEOTICID XEO04310 MOACRIVE Inhibition DME1022 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1022 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04311 XEO_CLAS Peptide DME1022 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO04311 GENEFORM Protein DME1022 XEOTICID XEO04311 MOACRIVE Inhibition DME1022 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1022 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04312 XEO_CLAS Peptide DME1022 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4.68 ug/ml) DME1022 XEOTICID XEO04312 GENEFORM Protein DME1022 XEOTICID XEO04312 MOACRIVE Inhibition DME1022 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1022 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04313 XEO_CLAS Peptide DME1022 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4.68 ug/ml) DME1022 XEOTICID XEO04313 GENEFORM Protein DME1022 XEOTICID XEO04313 MOACRIVE Inhibition DME1022 XEOTICID XEO04331 XEO_NAME Norspermidine DME1022 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1022 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04331 GENEFORM Protein DME1022 XEOTICID XEO04331 MOACRIVE Inhibition DME1022 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1022 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04335 XEO_CLAS Peptide DME1022 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 32 ug/ml) DME1022 XEOTICID XEO04335 GENEFORM Protein DME1022 XEOTICID XEO04335 MOACRIVE Inhibition DME1022 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1022 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04336 XEO_CLAS Peptide DME1022 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 32 ug/ml) DME1022 XEOTICID XEO04336 GENEFORM Protein DME1022 XEOTICID XEO04336 MOACRIVE Inhibition DME1022 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1022 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04338 XEO_CLAS Peptide DME1022 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 ug/ml) DME1022 XEOTICID XEO04338 GENEFORM Protein DME1022 XEOTICID XEO04338 MOACRIVE Inhibition DME1022 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1022 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04339 XEO_CLAS Peptide DME1022 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 ug/ml) DME1022 XEOTICID XEO04339 GENEFORM Protein DME1022 XEOTICID XEO04339 MOACRIVE Inhibition DME1022 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1022 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04340 XEO_CLAS Peptide DME1022 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO04340 GENEFORM Protein DME1022 XEOTICID XEO04340 MOACRIVE Inhibition DME1022 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1022 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04344 XEO_CLAS Peptide DME1022 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04344 GENEFORM Protein DME1022 XEOTICID XEO04344 MOACRIVE Inhibition DME1022 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1022 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04345 XEO_CLAS Peptide DME1022 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04345 GENEFORM Protein DME1022 XEOTICID XEO04345 MOACRIVE Inhibition DME1022 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1022 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04346 XEO_CLAS Peptide DME1022 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04346 GENEFORM Protein DME1022 XEOTICID XEO04346 MOACRIVE Inhibition DME1022 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1022 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04347 XEO_CLAS Peptide DME1022 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 microM) DME1022 XEOTICID XEO04347 GENEFORM Protein DME1022 XEOTICID XEO04347 MOACRIVE Inhibition DME1022 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1022 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04348 XEO_CLAS Peptide DME1022 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40 microM) DME1022 XEOTICID XEO04348 GENEFORM Protein DME1022 XEOTICID XEO04348 MOACRIVE Inhibition DME1022 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1022 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04349 XEO_CLAS Peptide DME1022 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO04349 GENEFORM Protein DME1022 XEOTICID XEO04349 MOACRIVE Inhibition DME1022 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1022 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04354 XEO_CLAS Peptide DME1022 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 35.2 ug/ml) DME1022 XEOTICID XEO04354 GENEFORM Protein DME1022 XEOTICID XEO04354 MOACRIVE Inhibition DME1022 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1022 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04355 XEO_CLAS Peptide DME1022 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.21 ug/ml) DME1022 XEOTICID XEO04355 GENEFORM Protein DME1022 XEOTICID XEO04355 MOACRIVE Inhibition DME1022 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1022 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04356 XEO_CLAS Peptide DME1022 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8.21 ug/ml) DME1022 XEOTICID XEO04356 GENEFORM Protein DME1022 XEOTICID XEO04356 MOACRIVE Inhibition DME1022 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1022 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04357 XEO_CLAS Peptide DME1022 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16.32 ug/ml) DME1022 XEOTICID XEO04357 GENEFORM Protein DME1022 XEOTICID XEO04357 MOACRIVE Inhibition DME1022 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1022 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04358 XEO_CLAS Peptide DME1022 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9.37 ug/ml) DME1022 XEOTICID XEO04358 GENEFORM Protein DME1022 XEOTICID XEO04358 MOACRIVE Inhibition DME1022 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1022 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04359 XEO_CLAS Peptide DME1022 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4.20 ug/ml) DME1022 XEOTICID XEO04359 GENEFORM Protein DME1022 XEOTICID XEO04359 MOACRIVE Inhibition DME1022 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1022 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04360 XEO_CLAS Peptide DME1022 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 ug/ml) DME1022 XEOTICID XEO04360 GENEFORM Protein DME1022 XEOTICID XEO04360 MOACRIVE Inhibition DME1022 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1022 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04361 XEO_CLAS Peptide DME1022 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 7.5 ug/ml) DME1022 XEOTICID XEO04361 GENEFORM Protein DME1022 XEOTICID XEO04361 MOACRIVE Inhibition DME1022 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1022 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04362 XEO_CLAS Peptide DME1022 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.6 ug/ml) DME1022 XEOTICID XEO04362 GENEFORM Protein DME1022 XEOTICID XEO04362 MOACRIVE Inhibition DME1022 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1022 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04363 XEO_CLAS Peptide DME1022 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8.2 ug/ml) DME1022 XEOTICID XEO04363 GENEFORM Protein DME1022 XEOTICID XEO04363 MOACRIVE Inhibition DME1022 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1022 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04364 XEO_CLAS Peptide DME1022 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO04364 GENEFORM Protein DME1022 XEOTICID XEO04364 MOACRIVE Inhibition DME1022 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1022 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04365 XEO_CLAS Peptide DME1022 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4.68 ug/ml) DME1022 XEOTICID XEO04365 GENEFORM Protein DME1022 XEOTICID XEO04365 MOACRIVE Inhibition DME1022 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1022 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04366 XEO_CLAS Peptide DME1022 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 23.60 ug/ml) DME1022 XEOTICID XEO04366 GENEFORM Protein DME1022 XEOTICID XEO04366 MOACRIVE Inhibition DME1022 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1022 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04367 XEO_CLAS Peptide DME1022 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 35.60 ug/ml) DME1022 XEOTICID XEO04367 GENEFORM Protein DME1022 XEOTICID XEO04367 MOACRIVE Inhibition DME1022 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1022 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04368 XEO_CLAS Peptide DME1022 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40.2 ug/ml) DME1022 XEOTICID XEO04368 GENEFORM Protein DME1022 XEOTICID XEO04368 MOACRIVE Inhibition DME1022 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1022 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04369 XEO_CLAS Peptide DME1022 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40.2 ug/ml) DME1022 XEOTICID XEO04369 GENEFORM Protein DME1022 XEOTICID XEO04369 MOACRIVE Inhibition DME1022 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1022 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04370 XEO_CLAS Peptide DME1022 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4.68 ug/ml) DME1022 XEOTICID XEO04370 GENEFORM Protein DME1022 XEOTICID XEO04370 MOACRIVE Inhibition DME1022 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1022 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04371 XEO_CLAS Peptide DME1022 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9.37 ug/ml) DME1022 XEOTICID XEO04371 GENEFORM Protein DME1022 XEOTICID XEO04371 MOACRIVE Inhibition DME1022 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1022 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04373 XEO_CLAS Peptide DME1022 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 ug/ml) DME1022 XEOTICID XEO04373 GENEFORM Protein DME1022 XEOTICID XEO04373 MOACRIVE Inhibition DME1022 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1022 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04374 XEO_CLAS Peptide DME1022 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.50 ug/ml) DME1022 XEOTICID XEO04374 GENEFORM Protein DME1022 XEOTICID XEO04374 MOACRIVE Inhibition DME1022 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1022 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04375 XEO_CLAS Peptide DME1022 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25 ug/ml) DME1022 XEOTICID XEO04375 GENEFORM Protein DME1022 XEOTICID XEO04375 MOACRIVE Inhibition DME1022 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1022 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04377 XEO_CLAS Peptide DME1022 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 42.50 ug/ml) DME1022 XEOTICID XEO04377 GENEFORM Protein DME1022 XEOTICID XEO04377 MOACRIVE Inhibition DME1022 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1022 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04378 XEO_CLAS Peptide DME1022 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 17.50 ug/ml) DME1022 XEOTICID XEO04378 GENEFORM Protein DME1022 XEOTICID XEO04378 MOACRIVE Inhibition DME1022 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1022 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04379 XEO_CLAS Peptide DME1022 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 ug/ml) DME1022 XEOTICID XEO04379 GENEFORM Protein DME1022 XEOTICID XEO04379 MOACRIVE Inhibition DME1022 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1022 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04380 XEO_CLAS Peptide DME1022 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 36.00 ug/ml) DME1022 XEOTICID XEO04380 GENEFORM Protein DME1022 XEOTICID XEO04380 MOACRIVE Inhibition DME1022 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1022 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04381 XEO_CLAS Peptide DME1022 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.60 ug/ml) DME1022 XEOTICID XEO04381 GENEFORM Protein DME1022 XEOTICID XEO04381 MOACRIVE Inhibition DME1022 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1022 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04382 XEO_CLAS Peptide DME1022 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 ug/ml) DME1022 XEOTICID XEO04382 GENEFORM Protein DME1022 XEOTICID XEO04382 MOACRIVE Inhibition DME1022 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1022 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04383 XEO_CLAS Peptide DME1022 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO04383 GENEFORM Protein DME1022 XEOTICID XEO04383 MOACRIVE Inhibition DME1022 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1022 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04384 XEO_CLAS Peptide DME1022 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO04384 GENEFORM Protein DME1022 XEOTICID XEO04384 MOACRIVE Inhibition DME1022 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1022 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04385 XEO_CLAS Peptide DME1022 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.25 ug/ml) DME1022 XEOTICID XEO04385 GENEFORM Protein DME1022 XEOTICID XEO04385 MOACRIVE Inhibition DME1022 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1022 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04395 XEO_CLAS Peptide DME1022 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1022 XEOTICID XEO04395 GENEFORM Protein DME1022 XEOTICID XEO04395 MOACRIVE Inhibition DME1022 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1022 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04396 XEO_CLAS Peptide DME1022 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1022 XEOTICID XEO04396 GENEFORM Protein DME1022 XEOTICID XEO04396 MOACRIVE Inhibition DME1022 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1022 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04397 XEO_CLAS Peptide DME1022 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1022 XEOTICID XEO04397 GENEFORM Protein DME1022 XEOTICID XEO04397 MOACRIVE Inhibition DME1022 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1022 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04398 XEO_CLAS Peptide DME1022 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 microM) DME1022 XEOTICID XEO04398 GENEFORM Protein DME1022 XEOTICID XEO04398 MOACRIVE Inhibition DME1022 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1022 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04399 XEO_CLAS Peptide DME1022 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO04399 GENEFORM Protein DME1022 XEOTICID XEO04399 MOACRIVE Inhibition DME1022 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1022 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04400 XEO_CLAS Peptide DME1022 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 ug/ml) DME1022 XEOTICID XEO04400 GENEFORM Protein DME1022 XEOTICID XEO04400 MOACRIVE Inhibition DME1022 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1022 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04401 XEO_CLAS Peptide DME1022 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.6 ug/ml) DME1022 XEOTICID XEO04401 GENEFORM Protein DME1022 XEOTICID XEO04401 MOACRIVE Inhibition DME1022 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1022 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04402 XEO_CLAS Peptide DME1022 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 ug/ml) DME1022 XEOTICID XEO04402 GENEFORM Protein DME1022 XEOTICID XEO04402 MOACRIVE Inhibition DME1022 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1022 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04403 XEO_CLAS Peptide DME1022 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.6 ug/ml) DME1022 XEOTICID XEO04403 GENEFORM Protein DME1022 XEOTICID XEO04403 MOACRIVE Inhibition DME1022 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1022 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04404 XEO_CLAS Peptide DME1022 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.6 ug/ml) DME1022 XEOTICID XEO04404 GENEFORM Protein DME1022 XEOTICID XEO04404 MOACRIVE Inhibition DME1022 XEOTICID XEO04410 XEO_NAME Insect osmin DME1022 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04410 XEO_CLAS Peptide DME1022 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.125-1.56 microM) DME1022 XEOTICID XEO04410 GENEFORM Protein DME1022 XEOTICID XEO04410 MOACRIVE Inhibition DME1022 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1022 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04412 XEO_CLAS Peptide DME1022 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04412 GENEFORM Protein DME1022 XEOTICID XEO04412 MOACRIVE Inhibition DME1022 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1022 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04414 XEO_CLAS Peptide DME1022 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04414 GENEFORM Protein DME1022 XEOTICID XEO04414 MOACRIVE Inhibition DME1022 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1022 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04415 XEO_CLAS Peptide DME1022 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04415 GENEFORM Protein DME1022 XEOTICID XEO04415 MOACRIVE Inhibition DME1022 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1022 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04421 XEO_CLAS Peptide DME1022 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 microM) DME1022 XEOTICID XEO04421 GENEFORM Protein DME1022 XEOTICID XEO04421 MOACRIVE Inhibition DME1022 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1022 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04426 XEO_CLAS Peptide DME1022 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO04426 GENEFORM Protein DME1022 XEOTICID XEO04426 MOACRIVE Inhibition DME1022 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1022 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04428 XEO_CLAS Peptide DME1022 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.3 ug/ml) DME1022 XEOTICID XEO04428 GENEFORM Protein DME1022 XEOTICID XEO04428 MOACRIVE Inhibition DME1022 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1022 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04430 XEO_CLAS Peptide DME1022 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25 microM) DME1022 XEOTICID XEO04430 GENEFORM Protein DME1022 XEOTICID XEO04430 MOACRIVE Inhibition DME1022 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1022 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04433 XEO_CLAS Peptide DME1022 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 160 microM) DME1022 XEOTICID XEO04433 GENEFORM Protein DME1022 XEOTICID XEO04433 MOACRIVE Inhibition DME1022 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1022 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04435 XEO_CLAS Peptide DME1022 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 160 microM) DME1022 XEOTICID XEO04435 GENEFORM Protein DME1022 XEOTICID XEO04435 MOACRIVE Inhibition DME1022 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1022 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1022 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04438 GENEFORM Protein DME1022 XEOTICID XEO04438 MOACRIVE Inhibition DME1022 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1022 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04439 XEO_CLAS Peptide DME1022 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04439 GENEFORM Protein DME1022 XEOTICID XEO04439 MOACRIVE Inhibition DME1022 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1022 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04440 XEO_CLAS Peptide DME1022 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 microM) DME1022 XEOTICID XEO04440 GENEFORM Protein DME1022 XEOTICID XEO04440 MOACRIVE Inhibition DME1022 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1022 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04441 XEO_CLAS Peptide DME1022 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 28 microM) DME1022 XEOTICID XEO04441 GENEFORM Protein DME1022 XEOTICID XEO04441 MOACRIVE Inhibition DME1022 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1022 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04442 XEO_CLAS Peptide DME1022 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 28 microM) DME1022 XEOTICID XEO04442 GENEFORM Protein DME1022 XEOTICID XEO04442 MOACRIVE Inhibition DME1022 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1022 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04443 XEO_CLAS Peptide DME1022 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04443 GENEFORM Protein DME1022 XEOTICID XEO04443 MOACRIVE Inhibition DME1022 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1022 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04444 XEO_CLAS Peptide DME1022 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 13 microM) DME1022 XEOTICID XEO04444 GENEFORM Protein DME1022 XEOTICID XEO04444 MOACRIVE Inhibition DME1022 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1022 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04445 XEO_CLAS Peptide DME1022 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04445 GENEFORM Protein DME1022 XEOTICID XEO04445 MOACRIVE Inhibition DME1022 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1022 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04446 XEO_CLAS Peptide DME1022 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 78 microM) DME1022 XEOTICID XEO04446 GENEFORM Protein DME1022 XEOTICID XEO04446 MOACRIVE Inhibition DME1022 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1022 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04447 XEO_CLAS Peptide DME1022 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 120 microM) DME1022 XEOTICID XEO04447 GENEFORM Protein DME1022 XEOTICID XEO04447 MOACRIVE Inhibition DME1022 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1022 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04448 XEO_CLAS Peptide DME1022 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 microM) DME1022 XEOTICID XEO04448 GENEFORM Protein DME1022 XEOTICID XEO04448 MOACRIVE Inhibition DME1022 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1022 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04449 XEO_CLAS Peptide DME1022 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.3 microM) DME1022 XEOTICID XEO04449 GENEFORM Protein DME1022 XEOTICID XEO04449 MOACRIVE Inhibition DME1022 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1022 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04450 XEO_CLAS Peptide DME1022 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.3 microM) DME1022 XEOTICID XEO04450 GENEFORM Protein DME1022 XEOTICID XEO04450 MOACRIVE Inhibition DME1022 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1022 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04451 XEO_CLAS Peptide DME1022 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO04451 GENEFORM Protein DME1022 XEOTICID XEO04451 MOACRIVE Inhibition DME1022 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1022 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04452 XEO_CLAS Peptide DME1022 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.1 microM) DME1022 XEOTICID XEO04452 GENEFORM Protein DME1022 XEOTICID XEO04452 MOACRIVE Inhibition DME1022 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1022 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04453 XEO_CLAS Peptide DME1022 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO04453 GENEFORM Protein DME1022 XEOTICID XEO04453 MOACRIVE Inhibition DME1022 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1022 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04455 XEO_CLAS Peptide DME1022 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 microM) DME1022 XEOTICID XEO04455 GENEFORM Protein DME1022 XEOTICID XEO04455 MOACRIVE Inhibition DME1022 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1022 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04457 XEO_CLAS Peptide DME1022 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.3 microM) DME1022 XEOTICID XEO04457 GENEFORM Protein DME1022 XEOTICID XEO04457 MOACRIVE Inhibition DME1022 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1022 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04458 XEO_CLAS Peptide DME1022 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1 microM) DME1022 XEOTICID XEO04458 GENEFORM Protein DME1022 XEOTICID XEO04458 MOACRIVE Inhibition DME1022 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1022 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04459 XEO_CLAS Peptide DME1022 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1 microM) DME1022 XEOTICID XEO04459 GENEFORM Protein DME1022 XEOTICID XEO04459 MOACRIVE Inhibition DME1022 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1022 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04461 XEO_CLAS Peptide DME1022 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20.8 microM) DME1022 XEOTICID XEO04461 GENEFORM Protein DME1022 XEOTICID XEO04461 MOACRIVE Inhibition DME1022 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1022 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04462 XEO_CLAS Peptide DME1022 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 19.1 microM) DME1022 XEOTICID XEO04462 GENEFORM Protein DME1022 XEOTICID XEO04462 MOACRIVE Inhibition DME1022 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1022 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04463 XEO_CLAS Peptide DME1022 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04463 GENEFORM Protein DME1022 XEOTICID XEO04463 MOACRIVE Inhibition DME1022 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1022 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04464 XEO_CLAS Peptide DME1022 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.5 microM) DME1022 XEOTICID XEO04464 GENEFORM Protein DME1022 XEOTICID XEO04464 MOACRIVE Inhibition DME1022 XEOTICID XEO04466 XEO_NAME Panusin DME1022 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04466 XEO_CLAS Peptide DME1022 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04466 GENEFORM Protein DME1022 XEOTICID XEO04466 MOACRIVE Inhibition DME1022 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1022 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04467 XEO_CLAS Peptide DME1022 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4.8 microM) DME1022 XEOTICID XEO04467 GENEFORM Protein DME1022 XEOTICID XEO04467 MOACRIVE Inhibition DME1022 XEOTICID XEO04468 XEO_NAME Papillosin DME1022 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04468 XEO_CLAS Peptide DME1022 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04468 GENEFORM Protein DME1022 XEOTICID XEO04468 MOACRIVE Inhibition DME1022 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1022 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04471 XEO_CLAS Peptide DME1022 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.1 microM) DME1022 XEOTICID XEO04471 GENEFORM Protein DME1022 XEOTICID XEO04471 MOACRIVE Inhibition DME1022 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1022 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04480 XEO_CLAS Peptide DME1022 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 ug/ml) DME1022 XEOTICID XEO04480 GENEFORM Protein DME1022 XEOTICID XEO04480 MOACRIVE Inhibition DME1022 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1022 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1022 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04482 GENEFORM Protein DME1022 XEOTICID XEO04482 MOACRIVE Inhibition DME1022 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1022 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04484 XEO_CLAS Peptide DME1022 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 microM) DME1022 XEOTICID XEO04484 GENEFORM Protein DME1022 XEOTICID XEO04484 MOACRIVE Inhibition DME1022 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1022 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04485 XEO_CLAS Peptide DME1022 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO04485 GENEFORM Protein DME1022 XEOTICID XEO04485 MOACRIVE Inhibition DME1022 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1022 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04486 XEO_CLAS Peptide DME1022 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 microM) DME1022 XEOTICID XEO04486 GENEFORM Protein DME1022 XEOTICID XEO04486 MOACRIVE Inhibition DME1022 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1022 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04487 XEO_CLAS Peptide DME1022 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO04487 GENEFORM Protein DME1022 XEOTICID XEO04487 MOACRIVE Inhibition DME1022 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1022 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04488 XEO_CLAS Peptide DME1022 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9 microM) DME1022 XEOTICID XEO04488 GENEFORM Protein DME1022 XEOTICID XEO04488 MOACRIVE Inhibition DME1022 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1022 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04489 XEO_CLAS Peptide DME1022 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 13 microM) DME1022 XEOTICID XEO04489 GENEFORM Protein DME1022 XEOTICID XEO04489 MOACRIVE Inhibition DME1022 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1022 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04490 XEO_CLAS Peptide DME1022 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 47.5 microM) DME1022 XEOTICID XEO04490 GENEFORM Protein DME1022 XEOTICID XEO04490 MOACRIVE Inhibition DME1022 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1022 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04491 XEO_CLAS Peptide DME1022 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO04491 GENEFORM Protein DME1022 XEOTICID XEO04491 MOACRIVE Inhibition DME1022 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1022 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04492 XEO_CLAS Peptide DME1022 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 35 microM) DME1022 XEOTICID XEO04492 GENEFORM Protein DME1022 XEOTICID XEO04492 MOACRIVE Inhibition DME1022 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1022 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04493 XEO_CLAS Peptide DME1022 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 microM) DME1022 XEOTICID XEO04493 GENEFORM Protein DME1022 XEOTICID XEO04493 MOACRIVE Inhibition DME1022 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1022 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04494 XEO_CLAS Peptide DME1022 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO04494 GENEFORM Protein DME1022 XEOTICID XEO04494 MOACRIVE Inhibition DME1022 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1022 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04495 XEO_CLAS Peptide DME1022 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO04495 GENEFORM Protein DME1022 XEOTICID XEO04495 MOACRIVE Inhibition DME1022 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1022 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04496 XEO_CLAS Peptide DME1022 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 67.5 microM) DME1022 XEOTICID XEO04496 GENEFORM Protein DME1022 XEOTICID XEO04496 MOACRIVE Inhibition DME1022 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1022 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04497 XEO_CLAS Peptide DME1022 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO04497 GENEFORM Protein DME1022 XEOTICID XEO04497 MOACRIVE Inhibition DME1022 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1022 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04498 XEO_CLAS Peptide DME1022 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO04498 GENEFORM Protein DME1022 XEOTICID XEO04498 MOACRIVE Inhibition DME1022 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1022 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04499 XEO_CLAS Peptide DME1022 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 43 microM) DME1022 XEOTICID XEO04499 GENEFORM Protein DME1022 XEOTICID XEO04499 MOACRIVE Inhibition DME1022 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1022 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04500 XEO_CLAS Peptide DME1022 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO04500 GENEFORM Protein DME1022 XEOTICID XEO04500 MOACRIVE Inhibition DME1022 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1022 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04504 XEO_CLAS Peptide DME1022 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04504 GENEFORM Protein DME1022 XEOTICID XEO04504 MOACRIVE Inhibition DME1022 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1022 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04505 XEO_CLAS Peptide DME1022 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04505 GENEFORM Protein DME1022 XEOTICID XEO04505 MOACRIVE Inhibition DME1022 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1022 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04506 XEO_CLAS Peptide DME1022 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 40 microM) DME1022 XEOTICID XEO04506 GENEFORM Protein DME1022 XEOTICID XEO04506 MOACRIVE Inhibition DME1022 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1022 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04507 XEO_CLAS Peptide DME1022 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10-20 microM) DME1022 XEOTICID XEO04507 GENEFORM Protein DME1022 XEOTICID XEO04507 MOACRIVE Inhibition DME1022 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1022 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04508 XEO_CLAS Peptide DME1022 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04508 GENEFORM Protein DME1022 XEOTICID XEO04508 MOACRIVE Inhibition DME1022 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1022 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04509 XEO_CLAS Peptide DME1022 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04509 GENEFORM Protein DME1022 XEOTICID XEO04509 MOACRIVE Inhibition DME1022 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1022 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04510 XEO_CLAS Peptide DME1022 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 22-33 microM) DME1022 XEOTICID XEO04510 GENEFORM Protein DME1022 XEOTICID XEO04510 MOACRIVE Inhibition DME1022 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1022 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04525 XEO_CLAS Peptide DME1022 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 32.0 microM) DME1022 XEOTICID XEO04525 GENEFORM Protein DME1022 XEOTICID XEO04525 MOACRIVE Inhibition DME1022 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1022 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04526 XEO_CLAS Peptide DME1022 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.0 microM) DME1022 XEOTICID XEO04526 GENEFORM Protein DME1022 XEOTICID XEO04526 MOACRIVE Inhibition DME1022 XEOTICID XEO04527 XEO_NAME Pepcon DME1022 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04527 XEO_CLAS Peptide DME1022 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO04527 GENEFORM Protein DME1022 XEOTICID XEO04527 MOACRIVE Inhibition DME1022 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1022 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04532 XEO_CLAS Peptide DME1022 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04532 GENEFORM Protein DME1022 XEOTICID XEO04532 MOACRIVE Inhibition DME1022 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1022 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04540 XEO_CLAS Peptide DME1022 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 18.1 ug/ml) DME1022 XEOTICID XEO04540 GENEFORM Protein DME1022 XEOTICID XEO04540 MOACRIVE Inhibition DME1022 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1022 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04541 XEO_CLAS Peptide DME1022 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.5 ug/ml) DME1022 XEOTICID XEO04541 GENEFORM Protein DME1022 XEOTICID XEO04541 MOACRIVE Inhibition DME1022 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1022 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04542 XEO_CLAS Peptide DME1022 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04542 GENEFORM Protein DME1022 XEOTICID XEO04542 MOACRIVE Inhibition DME1022 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1022 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04543 XEO_CLAS Peptide DME1022 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04543 GENEFORM Protein DME1022 XEOTICID XEO04543 MOACRIVE Inhibition DME1022 XEOTICID XEO04546 XEO_NAME Perinerin DME1022 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04546 XEO_CLAS Peptide DME1022 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04546 GENEFORM Protein DME1022 XEOTICID XEO04546 MOACRIVE Inhibition DME1022 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1022 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04548 XEO_CLAS Peptide DME1022 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 72000 ug/ml) DME1022 XEOTICID XEO04548 GENEFORM Protein DME1022 XEOTICID XEO04548 MOACRIVE Inhibition DME1022 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1022 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04549 XEO_CLAS Peptide DME1022 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 62-125 ug/ml) DME1022 XEOTICID XEO04549 GENEFORM Protein DME1022 XEOTICID XEO04549 MOACRIVE Inhibition DME1022 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1022 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04550 XEO_CLAS Peptide DME1022 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO04550 GENEFORM Protein DME1022 XEOTICID XEO04550 MOACRIVE Inhibition DME1022 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1022 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04551 XEO_CLAS Peptide DME1022 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 23.6 ug/ml) DME1022 XEOTICID XEO04551 GENEFORM Protein DME1022 XEOTICID XEO04551 MOACRIVE Inhibition DME1022 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1022 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04552 XEO_CLAS Peptide DME1022 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04552 GENEFORM Protein DME1022 XEOTICID XEO04552 MOACRIVE Inhibition DME1022 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1022 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04553 XEO_CLAS Peptide DME1022 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04553 GENEFORM Protein DME1022 XEOTICID XEO04553 MOACRIVE Inhibition DME1022 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1022 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04554 XEO_CLAS Peptide DME1022 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04554 GENEFORM Protein DME1022 XEOTICID XEO04554 MOACRIVE Inhibition DME1022 XEOTICID XEO04563 XEO_NAME Phosphate DME1022 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1022 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04563 GENEFORM Protein DME1022 XEOTICID XEO04563 MOACRIVE Inhibition DME1022 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1022 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04565 XEO_CLAS Peptide DME1022 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.5 microM) DME1022 XEOTICID XEO04565 GENEFORM Protein DME1022 XEOTICID XEO04565 MOACRIVE Inhibition DME1022 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1022 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04566 XEO_CLAS Peptide DME1022 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.7 microM) DME1022 XEOTICID XEO04566 GENEFORM Protein DME1022 XEOTICID XEO04566 MOACRIVE Inhibition DME1022 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1022 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04569 XEO_CLAS Peptide DME1022 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 7.9 microM) DME1022 XEOTICID XEO04569 GENEFORM Protein DME1022 XEOTICID XEO04569 MOACRIVE Inhibition DME1022 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1022 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04570 XEO_CLAS Peptide DME1022 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04570 GENEFORM Protein DME1022 XEOTICID XEO04570 MOACRIVE Inhibition DME1022 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1022 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04571 XEO_CLAS Peptide DME1022 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04571 GENEFORM Protein DME1022 XEOTICID XEO04571 MOACRIVE Inhibition DME1022 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1022 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04572 XEO_CLAS Peptide DME1022 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04572 GENEFORM Protein DME1022 XEOTICID XEO04572 MOACRIVE Inhibition DME1022 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1022 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04573 XEO_CLAS Peptide DME1022 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 microM) DME1022 XEOTICID XEO04573 GENEFORM Protein DME1022 XEOTICID XEO04573 MOACRIVE Inhibition DME1022 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1022 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04574 XEO_CLAS Peptide DME1022 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 128 ug/ml) DME1022 XEOTICID XEO04574 GENEFORM Protein DME1022 XEOTICID XEO04574 MOACRIVE Inhibition DME1022 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1022 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04575 XEO_CLAS Peptide DME1022 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO04575 GENEFORM Protein DME1022 XEOTICID XEO04575 MOACRIVE Inhibition DME1022 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1022 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04578 GENEFORM Protein DME1022 XEOTICID XEO04578 MOACRIVE Inhibition DME1022 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1022 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04579 GENEFORM Protein DME1022 XEOTICID XEO04579 MOACRIVE Inhibition DME1022 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1022 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04580 GENEFORM Protein DME1022 XEOTICID XEO04580 MOACRIVE Inhibition DME1022 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1022 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04583 GENEFORM Protein DME1022 XEOTICID XEO04583 MOACRIVE Inhibition DME1022 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1022 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04588 GENEFORM Protein DME1022 XEOTICID XEO04588 MOACRIVE Inhibition DME1022 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1022 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04589 GENEFORM Protein DME1022 XEOTICID XEO04589 MOACRIVE Inhibition DME1022 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1022 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04590 GENEFORM Protein DME1022 XEOTICID XEO04590 MOACRIVE Inhibition DME1022 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1022 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04591 GENEFORM Protein DME1022 XEOTICID XEO04591 MOACRIVE Inhibition DME1022 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1022 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04592 GENEFORM Protein DME1022 XEOTICID XEO04592 MOACRIVE Inhibition DME1022 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1022 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04593 GENEFORM Protein DME1022 XEOTICID XEO04593 MOACRIVE Inhibition DME1022 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1022 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04594 GENEFORM Protein DME1022 XEOTICID XEO04594 MOACRIVE Inhibition DME1022 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1022 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04595 GENEFORM Protein DME1022 XEOTICID XEO04595 MOACRIVE Inhibition DME1022 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1022 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04596 GENEFORM Protein DME1022 XEOTICID XEO04596 MOACRIVE Inhibition DME1022 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1022 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04597 GENEFORM Protein DME1022 XEOTICID XEO04597 MOACRIVE Inhibition DME1022 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1022 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04598 GENEFORM Protein DME1022 XEOTICID XEO04598 MOACRIVE Inhibition DME1022 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1022 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04599 GENEFORM Protein DME1022 XEOTICID XEO04599 MOACRIVE Inhibition DME1022 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1022 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04601 XEO_CLAS Peptide DME1022 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 18.75 ug/ml) DME1022 XEOTICID XEO04601 GENEFORM Protein DME1022 XEOTICID XEO04601 MOACRIVE Inhibition DME1022 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1022 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04602 XEO_CLAS Peptide DME1022 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 37.5 ug/ml) DME1022 XEOTICID XEO04602 GENEFORM Protein DME1022 XEOTICID XEO04602 MOACRIVE Inhibition DME1022 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1022 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04604 XEO_CLAS Peptide DME1022 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC < 25 microM) DME1022 XEOTICID XEO04604 GENEFORM Protein DME1022 XEOTICID XEO04604 MOACRIVE Inhibition DME1022 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1022 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04605 XEO_CLAS Peptide DME1022 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC < 6.25 microM) DME1022 XEOTICID XEO04605 GENEFORM Protein DME1022 XEOTICID XEO04605 MOACRIVE Inhibition DME1022 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1022 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04606 XEO_CLAS Peptide DME1022 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO04606 GENEFORM Protein DME1022 XEOTICID XEO04606 MOACRIVE Inhibition DME1022 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1022 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1022 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04607 GENEFORM Protein DME1022 XEOTICID XEO04607 MOACRIVE Inhibition DME1022 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1022 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04612 XEO_CLAS Peptide DME1022 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5-10 microM) DME1022 XEOTICID XEO04612 GENEFORM Protein DME1022 XEOTICID XEO04612 MOACRIVE Inhibition DME1022 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1022 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04613 XEO_CLAS Peptide DME1022 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5-10 microM) DME1022 XEOTICID XEO04613 GENEFORM Protein DME1022 XEOTICID XEO04613 MOACRIVE Inhibition DME1022 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1022 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04625 XEO_CLAS Peptide DME1022 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO04625 GENEFORM Protein DME1022 XEOTICID XEO04625 MOACRIVE Inhibition DME1022 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1022 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04626 XEO_CLAS Peptide DME1022 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO04626 GENEFORM Protein DME1022 XEOTICID XEO04626 MOACRIVE Inhibition DME1022 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1022 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04627 XEO_CLAS Peptide DME1022 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.5 microM) DME1022 XEOTICID XEO04627 GENEFORM Protein DME1022 XEOTICID XEO04627 MOACRIVE Inhibition DME1022 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1022 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04630 XEO_CLAS Peptide DME1022 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 60 ug/ml) DME1022 XEOTICID XEO04630 GENEFORM Protein DME1022 XEOTICID XEO04630 MOACRIVE Inhibition DME1022 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1022 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04631 XEO_CLAS Peptide DME1022 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 60 ug/ml) DME1022 XEOTICID XEO04631 GENEFORM Protein DME1022 XEOTICID XEO04631 MOACRIVE Inhibition DME1022 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1022 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04633 XEO_CLAS Peptide DME1022 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 ug/ml) DME1022 XEOTICID XEO04633 GENEFORM Protein DME1022 XEOTICID XEO04633 MOACRIVE Inhibition DME1022 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1022 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04634 XEO_CLAS Peptide DME1022 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 ug/ml) DME1022 XEOTICID XEO04634 GENEFORM Protein DME1022 XEOTICID XEO04634 MOACRIVE Inhibition DME1022 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1022 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04635 XEO_CLAS Peptide DME1022 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 ug/ml) DME1022 XEOTICID XEO04635 GENEFORM Protein DME1022 XEOTICID XEO04635 MOACRIVE Inhibition DME1022 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1022 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04636 XEO_CLAS Peptide DME1022 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 ug/ml) DME1022 XEOTICID XEO04636 GENEFORM Protein DME1022 XEOTICID XEO04636 MOACRIVE Inhibition DME1022 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1022 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04637 XEO_CLAS Peptide DME1022 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 ug/ml) DME1022 XEOTICID XEO04637 GENEFORM Protein DME1022 XEOTICID XEO04637 MOACRIVE Inhibition DME1022 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1022 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04638 XEO_CLAS Peptide DME1022 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 ug/ml) DME1022 XEOTICID XEO04638 GENEFORM Protein DME1022 XEOTICID XEO04638 MOACRIVE Inhibition DME1022 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1022 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04639 XEO_CLAS Peptide DME1022 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 ug/ml) DME1022 XEOTICID XEO04639 GENEFORM Protein DME1022 XEOTICID XEO04639 MOACRIVE Inhibition DME1022 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1022 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04640 XEO_CLAS Peptide DME1022 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.2-3.3 microM) DME1022 XEOTICID XEO04640 GENEFORM Protein DME1022 XEOTICID XEO04640 MOACRIVE Inhibition DME1022 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1022 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04642 XEO_CLAS Peptide DME1022 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO04642 GENEFORM Protein DME1022 XEOTICID XEO04642 MOACRIVE Inhibition DME1022 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1022 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04643 XEO_CLAS Peptide DME1022 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO04643 GENEFORM Protein DME1022 XEOTICID XEO04643 MOACRIVE Inhibition DME1022 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1022 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04644 XEO_CLAS Peptide DME1022 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO04644 GENEFORM Protein DME1022 XEOTICID XEO04644 MOACRIVE Inhibition DME1022 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1022 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04645 XEO_CLAS Peptide DME1022 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 ug/ml) DME1022 XEOTICID XEO04645 GENEFORM Protein DME1022 XEOTICID XEO04645 MOACRIVE Inhibition DME1022 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1022 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04646 XEO_CLAS Peptide DME1022 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1 ug/ml) DME1022 XEOTICID XEO04646 GENEFORM Protein DME1022 XEOTICID XEO04646 MOACRIVE Inhibition DME1022 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1022 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04647 XEO_CLAS Peptide DME1022 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO04647 GENEFORM Protein DME1022 XEOTICID XEO04647 MOACRIVE Inhibition DME1022 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1022 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04648 XEO_CLAS Peptide DME1022 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 ug/ml) DME1022 XEOTICID XEO04648 GENEFORM Protein DME1022 XEOTICID XEO04648 MOACRIVE Inhibition DME1022 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1022 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04649 XEO_CLAS Peptide DME1022 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 64 ug/ml) DME1022 XEOTICID XEO04649 GENEFORM Protein DME1022 XEOTICID XEO04649 MOACRIVE Inhibition DME1022 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1022 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04650 XEO_CLAS Peptide DME1022 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 ug/ml) DME1022 XEOTICID XEO04650 GENEFORM Protein DME1022 XEOTICID XEO04650 MOACRIVE Inhibition DME1022 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1022 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04651 XEO_CLAS Peptide DME1022 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 ug/ml) DME1022 XEOTICID XEO04651 GENEFORM Protein DME1022 XEOTICID XEO04651 MOACRIVE Inhibition DME1022 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1022 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04652 XEO_CLAS Peptide DME1022 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO04652 GENEFORM Protein DME1022 XEOTICID XEO04652 MOACRIVE Inhibition DME1022 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1022 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04653 XEO_CLAS Peptide DME1022 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 64 ug/ml) DME1022 XEOTICID XEO04653 GENEFORM Protein DME1022 XEOTICID XEO04653 MOACRIVE Inhibition DME1022 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1022 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04654 XEO_CLAS Peptide DME1022 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 ug/ml) DME1022 XEOTICID XEO04654 GENEFORM Protein DME1022 XEOTICID XEO04654 MOACRIVE Inhibition DME1022 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1022 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04655 XEO_CLAS Peptide DME1022 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO04655 GENEFORM Protein DME1022 XEOTICID XEO04655 MOACRIVE Inhibition DME1022 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1022 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04657 XEO_CLAS Peptide DME1022 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 300 microM) DME1022 XEOTICID XEO04657 GENEFORM Protein DME1022 XEOTICID XEO04657 MOACRIVE Inhibition DME1022 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1022 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04660 XEO_CLAS Peptide DME1022 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO04660 GENEFORM Protein DME1022 XEOTICID XEO04660 MOACRIVE Inhibition DME1022 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1022 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04661 XEO_CLAS Peptide DME1022 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 microM) DME1022 XEOTICID XEO04661 GENEFORM Protein DME1022 XEOTICID XEO04661 MOACRIVE Inhibition DME1022 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1022 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04662 XEO_CLAS Peptide DME1022 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 microM) DME1022 XEOTICID XEO04662 GENEFORM Protein DME1022 XEOTICID XEO04662 MOACRIVE Inhibition DME1022 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1022 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04663 XEO_CLAS Peptide DME1022 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 microM) DME1022 XEOTICID XEO04663 GENEFORM Protein DME1022 XEOTICID XEO04663 MOACRIVE Inhibition DME1022 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1022 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04664 XEO_CLAS Peptide DME1022 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5.5 microM) DME1022 XEOTICID XEO04664 GENEFORM Protein DME1022 XEOTICID XEO04664 MOACRIVE Inhibition DME1022 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1022 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04665 XEO_CLAS Peptide DME1022 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 microM) DME1022 XEOTICID XEO04665 GENEFORM Protein DME1022 XEOTICID XEO04665 MOACRIVE Inhibition DME1022 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1022 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04666 XEO_CLAS Peptide DME1022 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO04666 GENEFORM Protein DME1022 XEOTICID XEO04666 MOACRIVE Inhibition DME1022 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1022 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04667 XEO_CLAS Peptide DME1022 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6.25 microM) DME1022 XEOTICID XEO04667 GENEFORM Protein DME1022 XEOTICID XEO04667 MOACRIVE Inhibition DME1022 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1022 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04668 XEO_CLAS Peptide DME1022 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 microM) DME1022 XEOTICID XEO04668 GENEFORM Protein DME1022 XEOTICID XEO04668 MOACRIVE Inhibition DME1022 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1022 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04669 XEO_CLAS Peptide DME1022 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO04669 GENEFORM Protein DME1022 XEOTICID XEO04669 MOACRIVE Inhibition DME1022 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1022 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04670 XEO_CLAS Peptide DME1022 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 21 microM) DME1022 XEOTICID XEO04670 GENEFORM Protein DME1022 XEOTICID XEO04670 MOACRIVE Inhibition DME1022 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1022 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04671 XEO_CLAS Peptide DME1022 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 62 microM) DME1022 XEOTICID XEO04671 GENEFORM Protein DME1022 XEOTICID XEO04671 MOACRIVE Inhibition DME1022 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1022 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04672 XEO_CLAS Peptide DME1022 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO04672 GENEFORM Protein DME1022 XEOTICID XEO04672 MOACRIVE Inhibition DME1022 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1022 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04673 XEO_CLAS Peptide DME1022 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO04673 GENEFORM Protein DME1022 XEOTICID XEO04673 MOACRIVE Inhibition DME1022 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1022 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04674 XEO_CLAS Peptide DME1022 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 75 microM) DME1022 XEOTICID XEO04674 GENEFORM Protein DME1022 XEOTICID XEO04674 MOACRIVE Inhibition DME1022 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1022 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04675 XEO_CLAS Peptide DME1022 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 microM) DME1022 XEOTICID XEO04675 GENEFORM Protein DME1022 XEOTICID XEO04675 MOACRIVE Inhibition DME1022 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1022 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04676 XEO_CLAS Peptide DME1022 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 microM) DME1022 XEOTICID XEO04676 GENEFORM Protein DME1022 XEOTICID XEO04676 MOACRIVE Inhibition DME1022 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1022 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04677 XEO_CLAS Peptide DME1022 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO04677 GENEFORM Protein DME1022 XEOTICID XEO04677 MOACRIVE Inhibition DME1022 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1022 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04680 XEO_CLAS Peptide DME1022 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 microM) DME1022 XEOTICID XEO04680 GENEFORM Protein DME1022 XEOTICID XEO04680 MOACRIVE Inhibition DME1022 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1022 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04682 XEO_CLAS Peptide DME1022 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 microM) DME1022 XEOTICID XEO04682 GENEFORM Protein DME1022 XEOTICID XEO04682 MOACRIVE Inhibition DME1022 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1022 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04683 XEO_CLAS Peptide DME1022 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 microM) DME1022 XEOTICID XEO04683 GENEFORM Protein DME1022 XEOTICID XEO04683 MOACRIVE Inhibition DME1022 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1022 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04684 XEO_CLAS Peptide DME1022 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 38 microM) DME1022 XEOTICID XEO04684 GENEFORM Protein DME1022 XEOTICID XEO04684 MOACRIVE Inhibition DME1022 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1022 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04690 XEO_CLAS Peptide DME1022 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.5 ug/ml) DME1022 XEOTICID XEO04690 GENEFORM Protein DME1022 XEOTICID XEO04690 MOACRIVE Inhibition DME1022 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1022 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04695 XEO_CLAS Peptide DME1022 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04695 GENEFORM Protein DME1022 XEOTICID XEO04695 MOACRIVE Inhibition DME1022 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1022 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04696 XEO_CLAS Peptide DME1022 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04696 GENEFORM Protein DME1022 XEOTICID XEO04696 MOACRIVE Inhibition DME1022 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1022 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04712 XEO_CLAS Peptide DME1022 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16.7 microM) DME1022 XEOTICID XEO04712 GENEFORM Protein DME1022 XEOTICID XEO04712 MOACRIVE Inhibition DME1022 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1022 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04713 XEO_CLAS Peptide DME1022 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16.7 microM) DME1022 XEOTICID XEO04713 GENEFORM Protein DME1022 XEOTICID XEO04713 MOACRIVE Inhibition DME1022 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1022 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04714 XEO_CLAS Peptide DME1022 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 23.3 microM) DME1022 XEOTICID XEO04714 GENEFORM Protein DME1022 XEOTICID XEO04714 MOACRIVE Inhibition DME1022 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1022 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04716 XEO_CLAS Peptide DME1022 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 microM) DME1022 XEOTICID XEO04716 GENEFORM Protein DME1022 XEOTICID XEO04716 MOACRIVE Inhibition DME1022 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1022 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04717 XEO_CLAS Peptide DME1022 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 50 microM) DME1022 XEOTICID XEO04717 GENEFORM Protein DME1022 XEOTICID XEO04717 MOACRIVE Inhibition DME1022 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1022 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04725 XEO_CLAS Peptide DME1022 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04725 GENEFORM Protein DME1022 XEOTICID XEO04725 MOACRIVE Inhibition DME1022 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1022 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04726 XEO_CLAS Peptide DME1022 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04726 GENEFORM Protein DME1022 XEOTICID XEO04726 MOACRIVE Inhibition DME1022 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1022 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04731 XEO_CLAS Peptide DME1022 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 ug/ml) DME1022 XEOTICID XEO04731 GENEFORM Protein DME1022 XEOTICID XEO04731 MOACRIVE Inhibition DME1022 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1022 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04732 XEO_CLAS Peptide DME1022 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 25 ug/ml) DME1022 XEOTICID XEO04732 GENEFORM Protein DME1022 XEOTICID XEO04732 MOACRIVE Inhibition DME1022 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1022 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04733 XEO_CLAS Peptide DME1022 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04733 GENEFORM Protein DME1022 XEOTICID XEO04733 MOACRIVE Inhibition DME1022 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1022 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04734 XEO_CLAS Peptide DME1022 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04734 GENEFORM Protein DME1022 XEOTICID XEO04734 MOACRIVE Inhibition DME1022 XEOTICID XEO04737 XEO_NAME Protonectin DME1022 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04737 XEO_CLAS Peptide DME1022 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 ug/ml) DME1022 XEOTICID XEO04737 GENEFORM Protein DME1022 XEOTICID XEO04737 MOACRIVE Inhibition DME1022 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1022 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04739 XEO_CLAS Peptide DME1022 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04739 GENEFORM Protein DME1022 XEOTICID XEO04739 MOACRIVE Inhibition DME1022 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1022 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04740 XEO_CLAS Peptide DME1022 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04740 GENEFORM Protein DME1022 XEOTICID XEO04740 MOACRIVE Inhibition DME1022 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1022 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04741 XEO_CLAS Peptide DME1022 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04741 GENEFORM Protein DME1022 XEOTICID XEO04741 MOACRIVE Inhibition DME1022 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1022 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04742 XEO_CLAS Peptide DME1022 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04742 GENEFORM Protein DME1022 XEOTICID XEO04742 MOACRIVE Inhibition DME1022 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1022 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04762 XEO_CLAS Peptide DME1022 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.8 microM) DME1022 XEOTICID XEO04762 GENEFORM Protein DME1022 XEOTICID XEO04762 MOACRIVE Inhibition DME1022 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1022 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04766 XEO_CLAS Peptide DME1022 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.1 microM) DME1022 XEOTICID XEO04766 GENEFORM Protein DME1022 XEOTICID XEO04766 MOACRIVE Inhibition DME1022 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1022 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04767 XEO_CLAS Peptide DME1022 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.1 ug/ml) DME1022 XEOTICID XEO04767 GENEFORM Protein DME1022 XEOTICID XEO04767 MOACRIVE Inhibition DME1022 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1022 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04779 XEO_CLAS Peptide DME1022 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04779 GENEFORM Protein DME1022 XEOTICID XEO04779 MOACRIVE Inhibition DME1022 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1022 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04780 XEO_CLAS Peptide DME1022 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04780 GENEFORM Protein DME1022 XEOTICID XEO04780 MOACRIVE Inhibition DME1022 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1022 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04781 XEO_CLAS Peptide DME1022 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04781 GENEFORM Protein DME1022 XEOTICID XEO04781 MOACRIVE Inhibition DME1022 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1022 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04782 XEO_CLAS Peptide DME1022 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 ug/ml) DME1022 XEOTICID XEO04782 GENEFORM Protein DME1022 XEOTICID XEO04782 MOACRIVE Inhibition DME1022 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1022 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04783 XEO_CLAS Peptide DME1022 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO04783 GENEFORM Protein DME1022 XEOTICID XEO04783 MOACRIVE Inhibition DME1022 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1022 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04784 XEO_CLAS Peptide DME1022 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO04784 GENEFORM Protein DME1022 XEOTICID XEO04784 MOACRIVE Inhibition DME1022 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1022 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04785 XEO_CLAS Peptide DME1022 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO04785 GENEFORM Protein DME1022 XEOTICID XEO04785 MOACRIVE Inhibition DME1022 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1022 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04786 XEO_CLAS Peptide DME1022 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 ug/ml) DME1022 XEOTICID XEO04786 GENEFORM Protein DME1022 XEOTICID XEO04786 MOACRIVE Inhibition DME1022 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1022 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04787 XEO_CLAS Peptide DME1022 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04787 GENEFORM Protein DME1022 XEOTICID XEO04787 MOACRIVE Inhibition DME1022 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1022 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04793 XEO_CLAS Peptide DME1022 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04793 GENEFORM Protein DME1022 XEOTICID XEO04793 MOACRIVE Inhibition DME1022 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1022 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04798 XEO_CLAS Peptide DME1022 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 microM) DME1022 XEOTICID XEO04798 GENEFORM Protein DME1022 XEOTICID XEO04798 MOACRIVE Inhibition DME1022 XEOTICID XEO04799 XEO_NAME Ranalexin DME1022 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04799 XEO_CLAS Peptide DME1022 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 32 ug/ml) DME1022 XEOTICID XEO04799 GENEFORM Protein DME1022 XEOTICID XEO04799 MOACRIVE Inhibition DME1022 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1022 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04800 XEO_CLAS Peptide DME1022 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 microM) DME1022 XEOTICID XEO04800 GENEFORM Protein DME1022 XEOTICID XEO04800 MOACRIVE Inhibition DME1022 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1022 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04801 XEO_CLAS Peptide DME1022 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 9 microM) DME1022 XEOTICID XEO04801 GENEFORM Protein DME1022 XEOTICID XEO04801 MOACRIVE Inhibition DME1022 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1022 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04802 XEO_CLAS Peptide DME1022 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12 microM) DME1022 XEOTICID XEO04802 GENEFORM Protein DME1022 XEOTICID XEO04802 MOACRIVE Inhibition DME1022 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1022 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04803 XEO_CLAS Peptide DME1022 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO04803 GENEFORM Protein DME1022 XEOTICID XEO04803 MOACRIVE Inhibition DME1022 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1022 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04804 XEO_CLAS Peptide DME1022 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO04804 GENEFORM Protein DME1022 XEOTICID XEO04804 MOACRIVE Inhibition DME1022 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1022 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04805 XEO_CLAS Peptide DME1022 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.5 microM) DME1022 XEOTICID XEO04805 GENEFORM Protein DME1022 XEOTICID XEO04805 MOACRIVE Inhibition DME1022 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1022 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04806 XEO_CLAS Peptide DME1022 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.5 microM) DME1022 XEOTICID XEO04806 GENEFORM Protein DME1022 XEOTICID XEO04806 MOACRIVE Inhibition DME1022 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1022 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04807 XEO_CLAS Peptide DME1022 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04807 GENEFORM Protein DME1022 XEOTICID XEO04807 MOACRIVE Inhibition DME1022 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1022 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04809 XEO_CLAS Peptide DME1022 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 microM) DME1022 XEOTICID XEO04809 GENEFORM Protein DME1022 XEOTICID XEO04809 MOACRIVE Inhibition DME1022 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1022 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04811 XEO_CLAS Peptide DME1022 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO04811 GENEFORM Protein DME1022 XEOTICID XEO04811 MOACRIVE Inhibition DME1022 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1022 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04812 XEO_CLAS Peptide DME1022 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO04812 GENEFORM Protein DME1022 XEOTICID XEO04812 MOACRIVE Inhibition DME1022 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1022 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04813 XEO_CLAS Peptide DME1022 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 microM) DME1022 XEOTICID XEO04813 GENEFORM Protein DME1022 XEOTICID XEO04813 MOACRIVE Inhibition DME1022 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1022 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04814 XEO_CLAS Peptide DME1022 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 19 microM) DME1022 XEOTICID XEO04814 GENEFORM Protein DME1022 XEOTICID XEO04814 MOACRIVE Inhibition DME1022 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1022 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04815 XEO_CLAS Peptide DME1022 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 microM) DME1022 XEOTICID XEO04815 GENEFORM Protein DME1022 XEOTICID XEO04815 MOACRIVE Inhibition DME1022 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1022 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04816 XEO_CLAS Peptide DME1022 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 microM) DME1022 XEOTICID XEO04816 GENEFORM Protein DME1022 XEOTICID XEO04816 MOACRIVE Inhibition DME1022 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1022 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04817 XEO_CLAS Peptide DME1022 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 13 microM) DME1022 XEOTICID XEO04817 GENEFORM Protein DME1022 XEOTICID XEO04817 MOACRIVE Inhibition DME1022 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1022 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04818 XEO_CLAS Peptide DME1022 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO04818 GENEFORM Protein DME1022 XEOTICID XEO04818 MOACRIVE Inhibition DME1022 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1022 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04819 XEO_CLAS Peptide DME1022 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO04819 GENEFORM Protein DME1022 XEOTICID XEO04819 MOACRIVE Inhibition DME1022 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1022 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04820 XEO_CLAS Peptide DME1022 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3 microM) DME1022 XEOTICID XEO04820 GENEFORM Protein DME1022 XEOTICID XEO04820 MOACRIVE Inhibition DME1022 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1022 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04821 XEO_CLAS Peptide DME1022 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 microM) DME1022 XEOTICID XEO04821 GENEFORM Protein DME1022 XEOTICID XEO04821 MOACRIVE Inhibition DME1022 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1022 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04822 XEO_CLAS Peptide DME1022 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO04822 GENEFORM Protein DME1022 XEOTICID XEO04822 MOACRIVE Inhibition DME1022 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1022 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04823 XEO_CLAS Peptide DME1022 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 23 microM) DME1022 XEOTICID XEO04823 GENEFORM Protein DME1022 XEOTICID XEO04823 MOACRIVE Inhibition DME1022 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1022 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04824 XEO_CLAS Peptide DME1022 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04824 GENEFORM Protein DME1022 XEOTICID XEO04824 MOACRIVE Inhibition DME1022 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1022 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04825 XEO_CLAS Peptide DME1022 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04825 GENEFORM Protein DME1022 XEOTICID XEO04825 MOACRIVE Inhibition DME1022 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1022 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04826 XEO_CLAS Peptide DME1022 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO04826 GENEFORM Protein DME1022 XEOTICID XEO04826 MOACRIVE Inhibition DME1022 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1022 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04827 XEO_CLAS Peptide DME1022 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO04827 GENEFORM Protein DME1022 XEOTICID XEO04827 MOACRIVE Inhibition DME1022 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1022 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04835 XEO_CLAS Peptide DME1022 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04835 GENEFORM Protein DME1022 XEOTICID XEO04835 MOACRIVE Inhibition DME1022 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1022 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04836 XEO_CLAS Peptide DME1022 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04836 GENEFORM Protein DME1022 XEOTICID XEO04836 MOACRIVE Inhibition DME1022 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1022 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04837 XEO_CLAS Peptide DME1022 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 microM) DME1022 XEOTICID XEO04837 GENEFORM Protein DME1022 XEOTICID XEO04837 MOACRIVE Inhibition DME1022 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1022 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04839 XEO_CLAS Peptide DME1022 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04839 GENEFORM Protein DME1022 XEOTICID XEO04839 MOACRIVE Inhibition DME1022 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1022 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04840 XEO_CLAS Peptide DME1022 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 35-20 microM) DME1022 XEOTICID XEO04840 GENEFORM Protein DME1022 XEOTICID XEO04840 MOACRIVE Inhibition DME1022 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1022 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04847 XEO_CLAS Peptide DME1022 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04847 GENEFORM Protein DME1022 XEOTICID XEO04847 MOACRIVE Inhibition DME1022 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1022 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04848 XEO_CLAS Peptide DME1022 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04848 GENEFORM Protein DME1022 XEOTICID XEO04848 MOACRIVE Inhibition DME1022 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1022 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04849 XEO_CLAS Peptide DME1022 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04849 GENEFORM Protein DME1022 XEOTICID XEO04849 MOACRIVE Inhibition DME1022 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1022 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04850 XEO_CLAS Peptide DME1022 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04850 GENEFORM Protein DME1022 XEOTICID XEO04850 MOACRIVE Inhibition DME1022 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1022 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04851 XEO_CLAS Peptide DME1022 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1 ug/ml) DME1022 XEOTICID XEO04851 GENEFORM Protein DME1022 XEOTICID XEO04851 MOACRIVE Inhibition DME1022 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1022 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04857 XEO_CLAS Peptide DME1022 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 microM) DME1022 XEOTICID XEO04857 GENEFORM Protein DME1022 XEOTICID XEO04857 MOACRIVE Inhibition DME1022 XEOTICID XEO04863 XEO_NAME RTD peptide DME1022 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04863 XEO_CLAS Peptide DME1022 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.0 microM) DME1022 XEOTICID XEO04863 GENEFORM Protein DME1022 XEOTICID XEO04863 MOACRIVE Inhibition DME1022 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1022 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04865 XEO_CLAS Peptide DME1022 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 ug/ml) DME1022 XEOTICID XEO04865 GENEFORM Protein DME1022 XEOTICID XEO04865 MOACRIVE Inhibition DME1022 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1022 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04866 XEO_CLAS Peptide DME1022 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12.5 ug/ml) DME1022 XEOTICID XEO04866 GENEFORM Protein DME1022 XEOTICID XEO04866 MOACRIVE Inhibition DME1022 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1022 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04868 XEO_CLAS Peptide DME1022 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25.00 ug/ml) DME1022 XEOTICID XEO04868 GENEFORM Protein DME1022 XEOTICID XEO04868 MOACRIVE Inhibition DME1022 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1022 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04869 XEO_CLAS Peptide DME1022 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25.00 ug/ml) DME1022 XEOTICID XEO04869 GENEFORM Protein DME1022 XEOTICID XEO04869 MOACRIVE Inhibition DME1022 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1022 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04870 XEO_CLAS Peptide DME1022 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25.00 ug/ml) DME1022 XEOTICID XEO04870 GENEFORM Protein DME1022 XEOTICID XEO04870 MOACRIVE Inhibition DME1022 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1022 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04877 XEO_CLAS Peptide DME1022 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04877 GENEFORM Protein DME1022 XEOTICID XEO04877 MOACRIVE Inhibition DME1022 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1022 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04880 XEO_CLAS Peptide DME1022 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.5 ug/ml) DME1022 XEOTICID XEO04880 GENEFORM Protein DME1022 XEOTICID XEO04880 MOACRIVE Inhibition DME1022 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1022 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04886 XEO_CLAS Peptide DME1022 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.6 ug/ml) DME1022 XEOTICID XEO04886 GENEFORM Protein DME1022 XEOTICID XEO04886 MOACRIVE Inhibition DME1022 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1022 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04891 XEO_CLAS Peptide DME1022 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04891 GENEFORM Protein DME1022 XEOTICID XEO04891 MOACRIVE Inhibition DME1022 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1022 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04895 XEO_CLAS Peptide DME1022 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04895 GENEFORM Protein DME1022 XEOTICID XEO04895 MOACRIVE Inhibition DME1022 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1022 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04901 XEO_CLAS Peptide DME1022 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 microM) DME1022 XEOTICID XEO04901 GENEFORM Protein DME1022 XEOTICID XEO04901 MOACRIVE Inhibition DME1022 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1022 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04904 XEO_CLAS Peptide DME1022 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 78 ug/ml) DME1022 XEOTICID XEO04904 GENEFORM Protein DME1022 XEOTICID XEO04904 MOACRIVE Inhibition DME1022 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1022 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04905 XEO_CLAS Peptide DME1022 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04905 GENEFORM Protein DME1022 XEOTICID XEO04905 MOACRIVE Inhibition DME1022 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1022 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04906 XEO_CLAS Peptide DME1022 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04906 GENEFORM Protein DME1022 XEOTICID XEO04906 MOACRIVE Inhibition DME1022 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1022 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04907 XEO_CLAS Peptide DME1022 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04907 GENEFORM Protein DME1022 XEOTICID XEO04907 MOACRIVE Inhibition DME1022 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1022 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04908 XEO_CLAS Peptide DME1022 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04908 GENEFORM Protein DME1022 XEOTICID XEO04908 MOACRIVE Inhibition DME1022 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1022 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04909 XEO_CLAS Peptide DME1022 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04909 GENEFORM Protein DME1022 XEOTICID XEO04909 MOACRIVE Inhibition DME1022 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1022 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04915 XEO_CLAS Peptide DME1022 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 100 ug/ml) DME1022 XEOTICID XEO04915 GENEFORM Protein DME1022 XEOTICID XEO04915 MOACRIVE Inhibition DME1022 XEOTICID XEO04916 XEO_NAME Scopoletin DME1022 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1022 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04916 GENEFORM Protein DME1022 XEOTICID XEO04916 MOACRIVE Inhibition DME1022 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1022 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04926 XEO_CLAS Peptide DME1022 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04926 GENEFORM Protein DME1022 XEOTICID XEO04926 MOACRIVE Inhibition DME1022 XEOTICID XEO04931 XEO_NAME Shepherin I DME1022 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04931 XEO_CLAS Peptide DME1022 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04931 GENEFORM Protein DME1022 XEOTICID XEO04931 MOACRIVE Inhibition DME1022 XEOTICID XEO04932 XEO_NAME shepherin II DME1022 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04932 XEO_CLAS Peptide DME1022 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04932 GENEFORM Protein DME1022 XEOTICID XEO04932 MOACRIVE Inhibition DME1022 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1022 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04938 XEO_CLAS Peptide DME1022 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC <= 100 microM) DME1022 XEOTICID XEO04938 GENEFORM Protein DME1022 XEOTICID XEO04938 MOACRIVE Inhibition DME1022 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1022 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04947 XEO_CLAS Natural Product DME1022 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04947 GENEFORM Protein DME1022 XEOTICID XEO04947 MOACRIVE Inhibition DME1022 XEOTICID XEO04948 XEO_NAME Sinensetin DME1022 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1022 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1022 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04948 GENEFORM Protein DME1022 XEOTICID XEO04948 MOACRIVE Inhibition DME1022 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1022 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04950 XEO_CLAS Peptide DME1022 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 ug/ml) DME1022 XEOTICID XEO04950 GENEFORM Protein DME1022 XEOTICID XEO04950 MOACRIVE Inhibition DME1022 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1022 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04955 XEO_CLAS Peptide DME1022 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.07 microM) DME1022 XEOTICID XEO04955 GENEFORM Protein DME1022 XEOTICID XEO04955 MOACRIVE Inhibition DME1022 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1022 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04956 XEO_CLAS Peptide DME1022 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16.0 microM) DME1022 XEOTICID XEO04956 GENEFORM Protein DME1022 XEOTICID XEO04956 MOACRIVE Inhibition DME1022 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1022 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04957 XEO_CLAS Peptide DME1022 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.23 microM) DME1022 XEOTICID XEO04957 GENEFORM Protein DME1022 XEOTICID XEO04957 MOACRIVE Inhibition DME1022 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1022 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04958 XEO_CLAS Peptide DME1022 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 ug/ml) DME1022 XEOTICID XEO04958 GENEFORM Protein DME1022 XEOTICID XEO04958 MOACRIVE Inhibition DME1022 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1022 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04959 XEO_CLAS Peptide DME1022 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04959 GENEFORM Protein DME1022 XEOTICID XEO04959 MOACRIVE Inhibition DME1022 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1022 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04967 XEO_CLAS Peptide DME1022 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 28 microM) DME1022 XEOTICID XEO04967 GENEFORM Protein DME1022 XEOTICID XEO04967 MOACRIVE Inhibition DME1022 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1022 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04969 XEO_CLAS Peptide DME1022 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50-100 ug/ml) DME1022 XEOTICID XEO04969 GENEFORM Protein DME1022 XEOTICID XEO04969 MOACRIVE Inhibition DME1022 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1022 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04970 XEO_CLAS Peptide DME1022 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04970 GENEFORM Protein DME1022 XEOTICID XEO04970 MOACRIVE Inhibition DME1022 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1022 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04971 XEO_CLAS Peptide DME1022 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.8-1.5 microM) DME1022 XEOTICID XEO04971 GENEFORM Protein DME1022 XEOTICID XEO04971 MOACRIVE Inhibition DME1022 XEOTICID XEO04974 XEO_NAME Spinigerin DME1022 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04974 XEO_CLAS Peptide DME1022 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3-6 microM) DME1022 XEOTICID XEO04974 GENEFORM Protein DME1022 XEOTICID XEO04974 MOACRIVE Inhibition DME1022 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1022 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1022 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04975 GENEFORM Protein DME1022 XEOTICID XEO04975 MOACRIVE Inhibition DME1022 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1022 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1022 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04976 GENEFORM Protein DME1022 XEOTICID XEO04976 MOACRIVE Inhibition DME1022 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1022 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1022 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04977 GENEFORM Protein DME1022 XEOTICID XEO04977 MOACRIVE Inhibition DME1022 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1022 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1022 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04978 GENEFORM Protein DME1022 XEOTICID XEO04978 MOACRIVE Inhibition DME1022 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1022 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1022 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04979 GENEFORM Protein DME1022 XEOTICID XEO04979 MOACRIVE Inhibition DME1022 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1022 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04981 XEO_CLAS Peptide DME1022 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10.1 microM) DME1022 XEOTICID XEO04981 GENEFORM Protein DME1022 XEOTICID XEO04981 MOACRIVE Inhibition DME1022 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1022 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04982 XEO_CLAS Peptide DME1022 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40.5 microM) DME1022 XEOTICID XEO04982 GENEFORM Protein DME1022 XEOTICID XEO04982 MOACRIVE Inhibition DME1022 XEOTICID XEO04994 XEO_NAME Stilbene DME1022 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1022 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1022 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO04994 GENEFORM Protein DME1022 XEOTICID XEO04994 MOACRIVE Inhibition DME1022 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1022 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04995 XEO_CLAS Peptide DME1022 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC < 0.19 microM) DME1022 XEOTICID XEO04995 GENEFORM Protein DME1022 XEOTICID XEO04995 MOACRIVE Inhibition DME1022 XEOTICID XEO04998 XEO_NAME Styelin A DME1022 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04998 XEO_CLAS Peptide DME1022 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.7 ug/ml) DME1022 XEOTICID XEO04998 GENEFORM Protein DME1022 XEOTICID XEO04998 MOACRIVE Inhibition DME1022 XEOTICID XEO04999 XEO_NAME Styelin B DME1022 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO04999 XEO_CLAS Peptide DME1022 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.7 ug/ml) DME1022 XEOTICID XEO04999 GENEFORM Protein DME1022 XEOTICID XEO04999 MOACRIVE Inhibition DME1022 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1022 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05000 XEO_CLAS Peptide DME1022 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO05000 GENEFORM Protein DME1022 XEOTICID XEO05000 MOACRIVE Inhibition DME1022 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1022 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05001 XEO_CLAS Peptide DME1022 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.5 ug/ml) DME1022 XEOTICID XEO05001 GENEFORM Protein DME1022 XEOTICID XEO05001 MOACRIVE Inhibition DME1022 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1022 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05002 XEO_CLAS Peptide DME1022 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO05002 GENEFORM Protein DME1022 XEOTICID XEO05002 MOACRIVE Inhibition DME1022 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1022 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05003 XEO_CLAS Peptide DME1022 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO05003 GENEFORM Protein DME1022 XEOTICID XEO05003 MOACRIVE Inhibition DME1022 XEOTICID XEO05006 XEO_NAME Substance P DME1022 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05006 XEO_CLAS Peptide DME1022 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05006 GENEFORM Protein DME1022 XEOTICID XEO05006 MOACRIVE Inhibition DME1022 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1022 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05007 XEO_CLAS Peptide DME1022 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05007 GENEFORM Protein DME1022 XEOTICID XEO05007 MOACRIVE Inhibition DME1022 XEOTICID XEO05008 XEO_NAME Subtilosin DME1022 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05008 XEO_CLAS Peptide DME1022 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05008 GENEFORM Protein DME1022 XEOTICID XEO05008 MOACRIVE Inhibition DME1022 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1022 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05013 XEO_CLAS Peptide DME1022 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO05013 GENEFORM Protein DME1022 XEOTICID XEO05013 MOACRIVE Inhibition DME1022 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1022 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05014 XEO_CLAS Peptide DME1022 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO05014 GENEFORM Protein DME1022 XEOTICID XEO05014 MOACRIVE Inhibition DME1022 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1022 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05015 XEO_CLAS Peptide DME1022 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO05015 GENEFORM Protein DME1022 XEOTICID XEO05015 MOACRIVE Inhibition DME1022 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1022 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05016 XEO_CLAS Peptide DME1022 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO05016 GENEFORM Protein DME1022 XEOTICID XEO05016 MOACRIVE Inhibition DME1022 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1022 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05017 XEO_CLAS Peptide DME1022 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 20 ug/ml) DME1022 XEOTICID XEO05017 GENEFORM Protein DME1022 XEOTICID XEO05017 MOACRIVE Inhibition DME1022 XEOTICID XEO05018 XEO_NAME Syringic acid DME1022 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1022 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05018 GENEFORM Protein DME1022 XEOTICID XEO05018 MOACRIVE Inhibition DME1022 XEOTICID XEO05020 XEO_NAME Tachycitin DME1022 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05020 XEO_CLAS Peptide DME1022 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05020 GENEFORM Protein DME1022 XEOTICID XEO05020 MOACRIVE Inhibition DME1022 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1022 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05023 XEO_CLAS Peptide DME1022 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05023 GENEFORM Protein DME1022 XEOTICID XEO05023 MOACRIVE Inhibition DME1022 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1022 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05024 XEO_CLAS Peptide DME1022 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05024 GENEFORM Protein DME1022 XEOTICID XEO05024 MOACRIVE Inhibition DME1022 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1022 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05027 XEO_CLAS Peptide DME1022 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05027 GENEFORM Protein DME1022 XEOTICID XEO05027 MOACRIVE Inhibition DME1022 XEOTICID XEO05031 XEO_NAME Tannic acid DME1022 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1022 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05031 GENEFORM Protein DME1022 XEOTICID XEO05031 MOACRIVE Inhibition DME1022 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1022 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05033 XEO_CLAS Peptide DME1022 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05033 GENEFORM Protein DME1022 XEOTICID XEO05033 MOACRIVE Inhibition DME1022 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1022 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05042 XEO_CLAS Peptide DME1022 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO05042 GENEFORM Protein DME1022 XEOTICID XEO05042 MOACRIVE Inhibition DME1022 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1022 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05043 XEO_CLAS Peptide DME1022 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO05043 GENEFORM Protein DME1022 XEOTICID XEO05043 MOACRIVE Inhibition DME1022 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1022 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05044 XEO_CLAS Peptide DME1022 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 128 microM) DME1022 XEOTICID XEO05044 GENEFORM Protein DME1022 XEOTICID XEO05044 MOACRIVE Inhibition DME1022 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1022 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05045 XEO_CLAS Peptide DME1022 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 128 microM) DME1022 XEOTICID XEO05045 GENEFORM Protein DME1022 XEOTICID XEO05045 MOACRIVE Inhibition DME1022 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1022 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05046 XEO_CLAS Peptide DME1022 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 microM) DME1022 XEOTICID XEO05046 GENEFORM Protein DME1022 XEOTICID XEO05046 MOACRIVE Inhibition DME1022 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1022 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05047 XEO_CLAS Peptide DME1022 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 60 microM) DME1022 XEOTICID XEO05047 GENEFORM Protein DME1022 XEOTICID XEO05047 MOACRIVE Inhibition DME1022 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1022 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05051 XEO_CLAS Peptide DME1022 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05051 GENEFORM Protein DME1022 XEOTICID XEO05051 MOACRIVE Inhibition DME1022 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1022 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05055 XEO_CLAS Peptide DME1022 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 70 microM) DME1022 XEOTICID XEO05055 GENEFORM Protein DME1022 XEOTICID XEO05055 MOACRIVE Inhibition DME1022 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1022 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05056 XEO_CLAS Peptide DME1022 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05056 GENEFORM Protein DME1022 XEOTICID XEO05056 MOACRIVE Inhibition DME1022 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1022 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05059 XEO_CLAS Peptide DME1022 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05059 GENEFORM Protein DME1022 XEOTICID XEO05059 MOACRIVE Inhibition DME1022 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1022 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05061 XEO_CLAS Peptide DME1022 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO05061 GENEFORM Protein DME1022 XEOTICID XEO05061 MOACRIVE Inhibition DME1022 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1022 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05062 XEO_CLAS Peptide DME1022 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05062 GENEFORM Protein DME1022 XEOTICID XEO05062 MOACRIVE Inhibition DME1022 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1022 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05063 XEO_CLAS Peptide DME1022 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO05063 GENEFORM Protein DME1022 XEOTICID XEO05063 MOACRIVE Inhibition DME1022 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1022 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05064 XEO_CLAS Peptide DME1022 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 231 microM) DME1022 XEOTICID XEO05064 GENEFORM Protein DME1022 XEOTICID XEO05064 MOACRIVE Inhibition DME1022 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1022 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05065 XEO_CLAS Peptide DME1022 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 161 ug/ml) DME1022 XEOTICID XEO05065 GENEFORM Protein DME1022 XEOTICID XEO05065 MOACRIVE Inhibition DME1022 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1022 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05069 XEO_CLAS Peptide DME1022 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO05069 GENEFORM Protein DME1022 XEOTICID XEO05069 MOACRIVE Inhibition DME1022 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1022 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05070 XEO_CLAS Peptide DME1022 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 37.5 microM) DME1022 XEOTICID XEO05070 GENEFORM Protein DME1022 XEOTICID XEO05070 MOACRIVE Inhibition DME1022 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1022 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05071 XEO_CLAS Peptide DME1022 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 150 microM) DME1022 XEOTICID XEO05071 GENEFORM Protein DME1022 XEOTICID XEO05071 MOACRIVE Inhibition DME1022 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1022 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05072 XEO_CLAS Peptide DME1022 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO05072 GENEFORM Protein DME1022 XEOTICID XEO05072 MOACRIVE Inhibition DME1022 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1022 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05073 XEO_CLAS Peptide DME1022 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40 microM) DME1022 XEOTICID XEO05073 GENEFORM Protein DME1022 XEOTICID XEO05073 MOACRIVE Inhibition DME1022 XEOTICID XEO05076 XEO_NAME Temporin-A DME1022 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05076 XEO_CLAS Peptide DME1022 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 11.9 microM) DME1022 XEOTICID XEO05076 GENEFORM Protein DME1022 XEOTICID XEO05076 MOACRIVE Inhibition DME1022 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1022 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05077 XEO_CLAS Peptide DME1022 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.25 ug/ml) DME1022 XEOTICID XEO05077 GENEFORM Protein DME1022 XEOTICID XEO05077 MOACRIVE Inhibition DME1022 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1022 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05078 XEO_CLAS Peptide DME1022 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.25 ug/ml) DME1022 XEOTICID XEO05078 GENEFORM Protein DME1022 XEOTICID XEO05078 MOACRIVE Inhibition DME1022 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1022 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05079 XEO_CLAS Peptide DME1022 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.5 ug/ml) DME1022 XEOTICID XEO05079 GENEFORM Protein DME1022 XEOTICID XEO05079 MOACRIVE Inhibition DME1022 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1022 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05080 XEO_CLAS Peptide DME1022 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 ug/ml) DME1022 XEOTICID XEO05080 GENEFORM Protein DME1022 XEOTICID XEO05080 MOACRIVE Inhibition DME1022 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1022 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05081 XEO_CLAS Peptide DME1022 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 5 ug/ml) DME1022 XEOTICID XEO05081 GENEFORM Protein DME1022 XEOTICID XEO05081 MOACRIVE Inhibition DME1022 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1022 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05082 XEO_CLAS Peptide DME1022 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 7.5 ug/ml) DME1022 XEOTICID XEO05082 GENEFORM Protein DME1022 XEOTICID XEO05082 MOACRIVE Inhibition DME1022 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1022 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05083 XEO_CLAS Peptide DME1022 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 ug/ml) DME1022 XEOTICID XEO05083 GENEFORM Protein DME1022 XEOTICID XEO05083 MOACRIVE Inhibition DME1022 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1022 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05084 XEO_CLAS Peptide DME1022 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 ug/ml) DME1022 XEOTICID XEO05084 GENEFORM Protein DME1022 XEOTICID XEO05084 MOACRIVE Inhibition DME1022 XEOTICID XEO05085 XEO_NAME Temporin-B DME1022 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05085 XEO_CLAS Peptide DME1022 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 21.0 ug/ml) DME1022 XEOTICID XEO05085 GENEFORM Protein DME1022 XEOTICID XEO05085 MOACRIVE Inhibition DME1022 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1022 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05086 XEO_CLAS Peptide DME1022 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC > 100 microM) DME1022 XEOTICID XEO05086 GENEFORM Protein DME1022 XEOTICID XEO05086 MOACRIVE Inhibition DME1022 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1022 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05087 XEO_CLAS Peptide DME1022 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO05087 GENEFORM Protein DME1022 XEOTICID XEO05087 MOACRIVE Inhibition DME1022 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1022 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05097 XEO_CLAS Peptide DME1022 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16.0 microM) DME1022 XEOTICID XEO05097 GENEFORM Protein DME1022 XEOTICID XEO05097 MOACRIVE Inhibition DME1022 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1022 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05099 XEO_CLAS Peptide DME1022 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.0 microM) DME1022 XEOTICID XEO05099 GENEFORM Protein DME1022 XEOTICID XEO05099 MOACRIVE Inhibition DME1022 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1022 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05100 XEO_CLAS Peptide DME1022 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05100 GENEFORM Protein DME1022 XEOTICID XEO05100 MOACRIVE Inhibition DME1022 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1022 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05101 XEO_CLAS Peptide DME1022 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 24.2 ug/ml) DME1022 XEOTICID XEO05101 GENEFORM Protein DME1022 XEOTICID XEO05101 MOACRIVE Inhibition DME1022 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1022 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05102 XEO_CLAS Peptide DME1022 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 34.5 ug/ml) DME1022 XEOTICID XEO05102 GENEFORM Protein DME1022 XEOTICID XEO05102 MOACRIVE Inhibition DME1022 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1022 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05105 XEO_CLAS Peptide DME1022 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO05105 GENEFORM Protein DME1022 XEOTICID XEO05105 MOACRIVE Inhibition DME1022 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1022 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05106 XEO_CLAS Peptide DME1022 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25-200 microM) DME1022 XEOTICID XEO05106 GENEFORM Protein DME1022 XEOTICID XEO05106 MOACRIVE Inhibition DME1022 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1022 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05108 XEO_CLAS Peptide DME1022 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40 microM) DME1022 XEOTICID XEO05108 GENEFORM Protein DME1022 XEOTICID XEO05108 MOACRIVE Inhibition DME1022 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1022 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1022 XEOTICID XEO05111 XEO_CLAS Natural Product DME1022 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05111 GENEFORM Protein DME1022 XEOTICID XEO05111 MOACRIVE Inhibition DME1022 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1022 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05119 XEO_CLAS Peptide DME1022 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05119 GENEFORM Protein DME1022 XEOTICID XEO05119 MOACRIVE Inhibition DME1022 XEOTICID XEO05120 XEO_NAME Thanatin DME1022 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05120 XEO_CLAS Peptide DME1022 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1022 XEOTICID XEO05120 GENEFORM Protein DME1022 XEOTICID XEO05120 MOACRIVE Inhibition DME1022 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1022 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05121 XEO_CLAS Peptide DME1022 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 62.5 ug/ml) DME1022 XEOTICID XEO05121 GENEFORM Protein DME1022 XEOTICID XEO05121 MOACRIVE Inhibition DME1022 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1022 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05125 XEO_CLAS Peptide DME1022 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05125 GENEFORM Protein DME1022 XEOTICID XEO05125 MOACRIVE Inhibition DME1022 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1022 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05130 XEO_CLAS Peptide DME1022 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05130 GENEFORM Protein DME1022 XEOTICID XEO05130 MOACRIVE Inhibition DME1022 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1022 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05144 XEO_CLAS Peptide DME1022 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40 ug/ml) DME1022 XEOTICID XEO05144 GENEFORM Protein DME1022 XEOTICID XEO05144 MOACRIVE Inhibition DME1022 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1022 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05145 XEO_CLAS Peptide DME1022 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 ug/ml) DME1022 XEOTICID XEO05145 GENEFORM Protein DME1022 XEOTICID XEO05145 MOACRIVE Inhibition DME1022 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1022 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05146 XEO_CLAS Peptide DME1022 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 40 ug/ml) DME1022 XEOTICID XEO05146 GENEFORM Protein DME1022 XEOTICID XEO05146 MOACRIVE Inhibition DME1022 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1022 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05147 XEO_CLAS Peptide DME1022 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 60 ug/ml) DME1022 XEOTICID XEO05147 GENEFORM Protein DME1022 XEOTICID XEO05147 MOACRIVE Inhibition DME1022 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1022 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05158 XEO_CLAS Peptide DME1022 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05158 GENEFORM Protein DME1022 XEOTICID XEO05158 MOACRIVE Inhibition DME1022 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1022 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05161 XEO_CLAS Peptide DME1022 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 32 ug/ml) DME1022 XEOTICID XEO05161 GENEFORM Protein DME1022 XEOTICID XEO05161 MOACRIVE Inhibition DME1022 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1022 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05162 XEO_CLAS Peptide DME1022 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 32 ug/ml) DME1022 XEOTICID XEO05162 GENEFORM Protein DME1022 XEOTICID XEO05162 MOACRIVE Inhibition DME1022 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1022 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05163 XEO_CLAS Peptide DME1022 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 12-25 ug/ml) DME1022 XEOTICID XEO05163 GENEFORM Protein DME1022 XEOTICID XEO05163 MOACRIVE Inhibition DME1022 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1022 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05170 XEO_CLAS Peptide DME1022 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 3.0 microM) DME1022 XEOTICID XEO05170 GENEFORM Protein DME1022 XEOTICID XEO05170 MOACRIVE Inhibition DME1022 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1022 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05171 XEO_CLAS Peptide DME1022 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 50 microM) DME1022 XEOTICID XEO05171 GENEFORM Protein DME1022 XEOTICID XEO05171 MOACRIVE Inhibition DME1022 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1022 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05179 XEO_CLAS Peptide DME1022 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05179 GENEFORM Protein DME1022 XEOTICID XEO05179 MOACRIVE Inhibition DME1022 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1022 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05180 XEO_CLAS Peptide DME1022 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 160 microM) DME1022 XEOTICID XEO05180 GENEFORM Protein DME1022 XEOTICID XEO05180 MOACRIVE Inhibition DME1022 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1022 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05182 XEO_CLAS Peptide DME1022 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 microM) DME1022 XEOTICID XEO05182 GENEFORM Protein DME1022 XEOTICID XEO05182 MOACRIVE Inhibition DME1022 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1022 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05183 XEO_CLAS Peptide DME1022 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 microM) DME1022 XEOTICID XEO05183 GENEFORM Protein DME1022 XEOTICID XEO05183 MOACRIVE Inhibition DME1022 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1022 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05184 XEO_CLAS Peptide DME1022 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 microM) DME1022 XEOTICID XEO05184 GENEFORM Protein DME1022 XEOTICID XEO05184 MOACRIVE Inhibition DME1022 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1022 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05185 XEO_CLAS Peptide DME1022 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 microM) DME1022 XEOTICID XEO05185 GENEFORM Protein DME1022 XEOTICID XEO05185 MOACRIVE Inhibition DME1022 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1022 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05186 XEO_CLAS Peptide DME1022 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 microM) DME1022 XEOTICID XEO05186 GENEFORM Protein DME1022 XEOTICID XEO05186 MOACRIVE Inhibition DME1022 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1022 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05187 XEO_CLAS Peptide DME1022 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16 microM) DME1022 XEOTICID XEO05187 GENEFORM Protein DME1022 XEOTICID XEO05187 MOACRIVE Inhibition DME1022 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1022 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05188 XEO_CLAS Peptide DME1022 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 64 microM) DME1022 XEOTICID XEO05188 GENEFORM Protein DME1022 XEOTICID XEO05188 MOACRIVE Inhibition DME1022 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1022 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05190 XEO_CLAS Peptide DME1022 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05190 GENEFORM Protein DME1022 XEOTICID XEO05190 MOACRIVE Inhibition DME1022 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1022 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05193 XEO_CLAS Peptide DME1022 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO05193 GENEFORM Protein DME1022 XEOTICID XEO05193 MOACRIVE Inhibition DME1022 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1022 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05197 XEO_CLAS Peptide DME1022 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05197 GENEFORM Protein DME1022 XEOTICID XEO05197 MOACRIVE Inhibition DME1022 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1022 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05205 XEO_CLAS Peptide DME1022 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05205 GENEFORM Protein DME1022 XEOTICID XEO05205 MOACRIVE Inhibition DME1022 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1022 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05206 XEO_CLAS Peptide DME1022 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 10 microM) DME1022 XEOTICID XEO05206 GENEFORM Protein DME1022 XEOTICID XEO05206 MOACRIVE Inhibition DME1022 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1022 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05207 XEO_CLAS Peptide DME1022 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 25 microM) DME1022 XEOTICID XEO05207 GENEFORM Protein DME1022 XEOTICID XEO05207 MOACRIVE Inhibition DME1022 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1022 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05208 XEO_CLAS Peptide DME1022 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 microM) DME1022 XEOTICID XEO05208 GENEFORM Protein DME1022 XEOTICID XEO05208 MOACRIVE Inhibition DME1022 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1022 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05209 XEO_CLAS Peptide DME1022 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 15 microM) DME1022 XEOTICID XEO05209 GENEFORM Protein DME1022 XEOTICID XEO05209 MOACRIVE Inhibition DME1022 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1022 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05212 XEO_CLAS Peptide DME1022 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.5 ug/ml) DME1022 XEOTICID XEO05212 GENEFORM Protein DME1022 XEOTICID XEO05212 MOACRIVE Inhibition DME1022 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1022 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05220 XEO_CLAS Peptide DME1022 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.6-1.2 microM) DME1022 XEOTICID XEO05220 GENEFORM Protein DME1022 XEOTICID XEO05220 MOACRIVE Inhibition DME1022 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1022 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05230 XEO_CLAS Peptide DME1022 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 7.90 microM) DME1022 XEOTICID XEO05230 GENEFORM Protein DME1022 XEOTICID XEO05230 MOACRIVE Inhibition DME1022 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1022 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05231 XEO_CLAS Peptide DME1022 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2.40 microM) DME1022 XEOTICID XEO05231 GENEFORM Protein DME1022 XEOTICID XEO05231 MOACRIVE Inhibition DME1022 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1022 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05232 XEO_CLAS Peptide DME1022 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05232 GENEFORM Protein DME1022 XEOTICID XEO05232 MOACRIVE Inhibition DME1022 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1022 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05233 XEO_CLAS Peptide DME1022 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 ug/ml) DME1022 XEOTICID XEO05233 GENEFORM Protein DME1022 XEOTICID XEO05233 MOACRIVE Inhibition DME1022 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1022 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05234 XEO_CLAS Peptide DME1022 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 ug/ml) DME1022 XEOTICID XEO05234 GENEFORM Protein DME1022 XEOTICID XEO05234 MOACRIVE Inhibition DME1022 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1022 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05235 XEO_CLAS Peptide DME1022 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 30 ug/ml) DME1022 XEOTICID XEO05235 GENEFORM Protein DME1022 XEOTICID XEO05235 MOACRIVE Inhibition DME1022 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1022 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05237 XEO_CLAS Peptide DME1022 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 microM) DME1022 XEOTICID XEO05237 GENEFORM Protein DME1022 XEOTICID XEO05237 MOACRIVE Inhibition DME1022 XEOTICID XEO05245 XEO_NAME Viresin DME1022 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05245 XEO_CLAS Peptide DME1022 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05245 GENEFORM Protein DME1022 XEOTICID XEO05245 MOACRIVE Inhibition DME1022 XEOTICID XEO05248 XEO_NAME Vitamin C DME1022 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1022 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1022 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05248 GENEFORM Protein DME1022 XEOTICID XEO05248 MOACRIVE Inhibition DME1022 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1022 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05264 XEO_CLAS Peptide DME1022 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 4 ug/ml) DME1022 XEOTICID XEO05264 GENEFORM Protein DME1022 XEOTICID XEO05264 MOACRIVE Inhibition DME1022 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1022 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05267 XEO_CLAS Peptide DME1022 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 2 ug/ml) DME1022 XEOTICID XEO05267 GENEFORM Protein DME1022 XEOTICID XEO05267 MOACRIVE Inhibition DME1022 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1022 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05268 XEO_CLAS Peptide DME1022 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 1.6 ug/ml) DME1022 XEOTICID XEO05268 GENEFORM Protein DME1022 XEOTICID XEO05268 MOACRIVE Inhibition DME1022 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1022 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05269 XEO_CLAS Peptide DME1022 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 6 ug/ml) DME1022 XEOTICID XEO05269 GENEFORM Protein DME1022 XEOTICID XEO05269 MOACRIVE Inhibition DME1022 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1022 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05273 XEO_CLAS Peptide DME1022 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05273 GENEFORM Protein DME1022 XEOTICID XEO05273 MOACRIVE Inhibition DME1022 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1022 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05274 XEO_CLAS Peptide DME1022 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05274 GENEFORM Protein DME1022 XEOTICID XEO05274 MOACRIVE Inhibition DME1022 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1022 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05287 XEO_CLAS Peptide DME1022 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli DME1022 XEOTICID XEO05287 GENEFORM Protein DME1022 XEOTICID XEO05287 MOACRIVE Inhibition DME1022 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1022 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05303 XEO_CLAS Peptide DME1022 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 16-31 ug/ml) DME1022 XEOTICID XEO05303 GENEFORM Protein DME1022 XEOTICID XEO05303 MOACRIVE Inhibition DME1022 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1022 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05306 XEO_CLAS Peptide DME1022 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 8 ug/ml) DME1022 XEOTICID XEO05306 GENEFORM Protein DME1022 XEOTICID XEO05306 MOACRIVE Inhibition DME1022 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1022 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1022 XEOTICID XEO05308 XEO_CLAS Peptide DME1022 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Tyramine oxidase (tynA) from Escherichia coli (MIC = 0.4 ug/ml) DME1022 XEOTICID XEO05308 GENEFORM Protein DME1022 XEOTICID XEO05308 MOACRIVE Inhibition DME1023 DME___ID DME1023 DME1023 DME_NAME Beta-lactamase (blaB) DME1023 SPESNAME Klebsiella pneumoniae DME1023 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1023 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1023 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1023 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO00546 GENEFORM Protein DME1023 XEOTICID XEO00546 MOACRIVE Inhibition DME1023 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1023 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1023 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1023 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO00574 GENEFORM Protein DME1023 XEOTICID XEO00574 MOACRIVE Inhibition DME1023 XEOTICID XEO01266 XEO_NAME Cyanidin DME1023 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME1023 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME1023 XEOTICID XEO01266 DESCRIPT Cyanidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO01266 GENEFORM Protein DME1023 XEOTICID XEO01266 MOACRIVE Inhibition DME1023 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1023 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO01816 XEO_CLAS Peptide DME1023 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 6.25 microM) DME1023 XEOTICID XEO01816 GENEFORM Protein DME1023 XEOTICID XEO01816 MOACRIVE Inhibition DME1023 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1023 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO01827 XEO_CLAS Peptide DME1023 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC > 50 microM) DME1023 XEOTICID XEO01827 GENEFORM Protein DME1023 XEOTICID XEO01827 MOACRIVE Inhibition DME1023 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1023 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02115 XEO_CLAS Peptide DME1023 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO02115 GENEFORM Protein DME1023 XEOTICID XEO02115 MOACRIVE Inhibition DME1023 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1023 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02230 XEO_CLAS Peptide DME1023 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1023 XEOTICID XEO02230 GENEFORM Protein DME1023 XEOTICID XEO02230 MOACRIVE Inhibition DME1023 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1023 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02280 XEO_CLAS Peptide DME1023 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO02280 GENEFORM Protein DME1023 XEOTICID XEO02280 MOACRIVE Inhibition DME1023 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1023 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02325 XEO_CLAS Peptide DME1023 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 13 microM) DME1023 XEOTICID XEO02325 GENEFORM Protein DME1023 XEOTICID XEO02325 MOACRIVE Inhibition DME1023 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1023 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02370 XEO_CLAS Peptide DME1023 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO02370 GENEFORM Protein DME1023 XEOTICID XEO02370 MOACRIVE Inhibition DME1023 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1023 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02371 XEO_CLAS Peptide DME1023 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 12 ug/ml) DME1023 XEOTICID XEO02371 GENEFORM Protein DME1023 XEOTICID XEO02371 MOACRIVE Inhibition DME1023 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1023 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02378 XEO_CLAS Peptide DME1023 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 0.76 ug/ml) DME1023 XEOTICID XEO02378 GENEFORM Protein DME1023 XEOTICID XEO02378 MOACRIVE Inhibition DME1023 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1023 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02416 XEO_CLAS Peptide DME1023 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO02416 GENEFORM Protein DME1023 XEOTICID XEO02416 MOACRIVE Inhibition DME1023 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1023 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02451 XEO_CLAS Peptide DME1023 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO02451 GENEFORM Protein DME1023 XEOTICID XEO02451 MOACRIVE Inhibition DME1023 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1023 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02473 XEO_CLAS Peptide DME1023 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO02473 GENEFORM Protein DME1023 XEOTICID XEO02473 MOACRIVE Inhibition DME1023 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1023 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02491 XEO_CLAS Peptide DME1023 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 2.8 microM) DME1023 XEOTICID XEO02491 GENEFORM Protein DME1023 XEOTICID XEO02491 MOACRIVE Inhibition DME1023 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1023 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02496 XEO_CLAS Peptide DME1023 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 50 microM) DME1023 XEOTICID XEO02496 GENEFORM Protein DME1023 XEOTICID XEO02496 MOACRIVE Inhibition DME1023 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1023 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02497 XEO_CLAS Peptide DME1023 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC > 50 microM) DME1023 XEOTICID XEO02497 GENEFORM Protein DME1023 XEOTICID XEO02497 MOACRIVE Inhibition DME1023 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1023 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02512 XEO_CLAS Peptide DME1023 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 150 microM) DME1023 XEOTICID XEO02512 GENEFORM Protein DME1023 XEOTICID XEO02512 MOACRIVE Inhibition DME1023 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1023 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02566 XEO_CLAS Peptide DME1023 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC > 100 microM) DME1023 XEOTICID XEO02566 GENEFORM Protein DME1023 XEOTICID XEO02566 MOACRIVE Inhibition DME1023 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1023 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02637 XEO_CLAS Peptide DME1023 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 6 microM) DME1023 XEOTICID XEO02637 GENEFORM Protein DME1023 XEOTICID XEO02637 MOACRIVE Inhibition DME1023 XEOTICID XEO02656 XEO_NAME Himatanthus drasticus butanolic extract DME1023 XEOTICID XEO02656 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1023 XEOTICID XEO02656 XEO_CLAS Plant Extract DME1023 XEOTICID XEO02656 DESCRIPT Himatanthus drasticus butanolic extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO02656 GENEFORM Protein DME1023 XEOTICID XEO02656 MOACRIVE Inhibition DME1023 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1023 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02688 XEO_CLAS Peptide DME1023 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 25 microM) DME1023 XEOTICID XEO02688 GENEFORM Protein DME1023 XEOTICID XEO02688 MOACRIVE Inhibition DME1023 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1023 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02708 XEO_CLAS Peptide DME1023 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 20 ug/ml) DME1023 XEOTICID XEO02708 GENEFORM Protein DME1023 XEOTICID XEO02708 MOACRIVE Inhibition DME1023 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1023 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02732 XEO_CLAS Peptide DME1023 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 1.25 microM) DME1023 XEOTICID XEO02732 GENEFORM Protein DME1023 XEOTICID XEO02732 MOACRIVE Inhibition DME1023 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1023 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02734 XEO_CLAS Peptide DME1023 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 0.40 microM) DME1023 XEOTICID XEO02734 GENEFORM Protein DME1023 XEOTICID XEO02734 MOACRIVE Inhibition DME1023 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1023 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02736 XEO_CLAS Peptide DME1023 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 0.66 microM) DME1023 XEOTICID XEO02736 GENEFORM Protein DME1023 XEOTICID XEO02736 MOACRIVE Inhibition DME1023 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1023 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02738 XEO_CLAS Peptide DME1023 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 1 microM) DME1023 XEOTICID XEO02738 GENEFORM Protein DME1023 XEOTICID XEO02738 MOACRIVE Inhibition DME1023 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1023 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02743 XEO_CLAS Peptide DME1023 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 4.7 ug/ml) DME1023 XEOTICID XEO02743 GENEFORM Protein DME1023 XEOTICID XEO02743 MOACRIVE Inhibition DME1023 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1023 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02749 XEO_CLAS Peptide DME1023 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 20 mug/ml) DME1023 XEOTICID XEO02749 GENEFORM Protein DME1023 XEOTICID XEO02749 MOACRIVE Inhibition DME1023 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1023 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02767 XEO_CLAS Peptide DME1023 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO02767 GENEFORM Protein DME1023 XEOTICID XEO02767 MOACRIVE Inhibition DME1023 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1023 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02768 XEO_CLAS Peptide DME1023 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 1-2.5 ug/ml) DME1023 XEOTICID XEO02768 GENEFORM Protein DME1023 XEOTICID XEO02768 MOACRIVE Inhibition DME1023 XEOTICID XEO02780 XEO_NAME Cefixime DME1023 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1023 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1023 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO02780 GENEFORM Protein DME1023 XEOTICID XEO02780 MOACRIVE Inhibition DME1023 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1023 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO02942 XEO_CLAS Peptide DME1023 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO02942 GENEFORM Protein DME1023 XEOTICID XEO02942 MOACRIVE Inhibition DME1023 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1023 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03029 XEO_CLAS Peptide DME1023 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 0.145 microM) DME1023 XEOTICID XEO03029 GENEFORM Protein DME1023 XEOTICID XEO03029 MOACRIVE Inhibition DME1023 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1023 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03030 XEO_CLAS Peptide DME1023 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 0.643 microM) DME1023 XEOTICID XEO03030 GENEFORM Protein DME1023 XEOTICID XEO03030 MOACRIVE Inhibition DME1023 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1023 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03031 XEO_CLAS Peptide DME1023 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 0.01 microM) DME1023 XEOTICID XEO03031 GENEFORM Protein DME1023 XEOTICID XEO03031 MOACRIVE Inhibition DME1023 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1023 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03032 XEO_CLAS Peptide DME1023 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC < 0.005 microM) DME1023 XEOTICID XEO03032 GENEFORM Protein DME1023 XEOTICID XEO03032 MOACRIVE Inhibition DME1023 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1023 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03033 XEO_CLAS Peptide DME1023 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC > 0.692 microM) DME1023 XEOTICID XEO03033 GENEFORM Protein DME1023 XEOTICID XEO03033 MOACRIVE Inhibition DME1023 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1023 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03034 XEO_CLAS Peptide DME1023 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 0.004 microM) DME1023 XEOTICID XEO03034 GENEFORM Protein DME1023 XEOTICID XEO03034 MOACRIVE Inhibition DME1023 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1023 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03035 XEO_CLAS Peptide DME1023 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 0.458 microM) DME1023 XEOTICID XEO03035 GENEFORM Protein DME1023 XEOTICID XEO03035 MOACRIVE Inhibition DME1023 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1023 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03051 XEO_CLAS Peptide DME1023 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1023 XEOTICID XEO03051 GENEFORM Protein DME1023 XEOTICID XEO03051 MOACRIVE Inhibition DME1023 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1023 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03052 XEO_CLAS Peptide DME1023 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1023 XEOTICID XEO03052 GENEFORM Protein DME1023 XEOTICID XEO03052 MOACRIVE Inhibition DME1023 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1023 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03053 XEO_CLAS Peptide DME1023 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1023 XEOTICID XEO03053 GENEFORM Protein DME1023 XEOTICID XEO03053 MOACRIVE Inhibition DME1023 XEOTICID XEO03089 XEO_NAME Decoralin DME1023 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03089 XEO_CLAS Peptide DME1023 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 80 microM) DME1023 XEOTICID XEO03089 GENEFORM Protein DME1023 XEOTICID XEO03089 MOACRIVE Inhibition DME1023 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1023 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03112 XEO_CLAS Peptide DME1023 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC > 50 ug/ml) DME1023 XEOTICID XEO03112 GENEFORM Protein DME1023 XEOTICID XEO03112 MOACRIVE Inhibition DME1023 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1023 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03137 XEO_CLAS Peptide DME1023 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03137 GENEFORM Protein DME1023 XEOTICID XEO03137 MOACRIVE Inhibition DME1023 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1023 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03162 XEO_CLAS Peptide DME1023 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 0.8 microM) DME1023 XEOTICID XEO03162 GENEFORM Protein DME1023 XEOTICID XEO03162 MOACRIVE Inhibition DME1023 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1023 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03224 XEO_CLAS Peptide DME1023 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1023 XEOTICID XEO03224 GENEFORM Protein DME1023 XEOTICID XEO03224 MOACRIVE Inhibition DME1023 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1023 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03235 XEO_CLAS Peptide DME1023 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 60 ug/ml) DME1023 XEOTICID XEO03235 GENEFORM Protein DME1023 XEOTICID XEO03235 MOACRIVE Inhibition DME1023 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1023 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03237 XEO_CLAS Peptide DME1023 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC > 100 ug/ml) DME1023 XEOTICID XEO03237 GENEFORM Protein DME1023 XEOTICID XEO03237 MOACRIVE Inhibition DME1023 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1023 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03238 XEO_CLAS Peptide DME1023 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1023 XEOTICID XEO03238 GENEFORM Protein DME1023 XEOTICID XEO03238 MOACRIVE Inhibition DME1023 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1023 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03239 XEO_CLAS Peptide DME1023 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1023 XEOTICID XEO03239 GENEFORM Protein DME1023 XEOTICID XEO03239 MOACRIVE Inhibition DME1023 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1023 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03250 XEO_CLAS Peptide DME1023 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03250 GENEFORM Protein DME1023 XEOTICID XEO03250 MOACRIVE Inhibition DME1023 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1023 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03251 XEO_CLAS Peptide DME1023 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03251 GENEFORM Protein DME1023 XEOTICID XEO03251 MOACRIVE Inhibition DME1023 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1023 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03253 XEO_CLAS Peptide DME1023 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 3.2 ug/ml) DME1023 XEOTICID XEO03253 GENEFORM Protein DME1023 XEOTICID XEO03253 MOACRIVE Inhibition DME1023 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1023 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1023 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1023 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03348 GENEFORM Protein DME1023 XEOTICID XEO03348 MOACRIVE Inhibition DME1023 XEOTICID XEO03387 XEO_NAME Ferric chloride DME1023 XEOTICID XEO03387 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1023 XEOTICID XEO03387 XEO_CLAS Chemical Compound DME1023 XEOTICID XEO03387 DESCRIPT Ferric chloride inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03387 GENEFORM Protein DME1023 XEOTICID XEO03387 MOACRIVE Inhibition DME1023 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1023 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03436 XEO_CLAS Peptide DME1023 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1023 XEOTICID XEO03436 GENEFORM Protein DME1023 XEOTICID XEO03436 MOACRIVE Inhibition DME1023 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1023 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03437 XEO_CLAS Peptide DME1023 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1023 XEOTICID XEO03437 GENEFORM Protein DME1023 XEOTICID XEO03437 MOACRIVE Inhibition DME1023 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1023 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03438 XEO_CLAS Peptide DME1023 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1023 XEOTICID XEO03438 GENEFORM Protein DME1023 XEOTICID XEO03438 MOACRIVE Inhibition DME1023 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1023 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03439 XEO_CLAS Peptide DME1023 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1023 XEOTICID XEO03439 GENEFORM Protein DME1023 XEOTICID XEO03439 MOACRIVE Inhibition DME1023 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1023 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03440 XEO_CLAS Peptide DME1023 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1023 XEOTICID XEO03440 GENEFORM Protein DME1023 XEOTICID XEO03440 MOACRIVE Inhibition DME1023 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1023 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03441 XEO_CLAS Peptide DME1023 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1023 XEOTICID XEO03441 GENEFORM Protein DME1023 XEOTICID XEO03441 MOACRIVE Inhibition DME1023 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1023 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03497 XEO_CLAS Peptide DME1023 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1023 XEOTICID XEO03497 GENEFORM Protein DME1023 XEOTICID XEO03497 MOACRIVE Inhibition DME1023 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1023 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03498 XEO_CLAS Peptide DME1023 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1023 XEOTICID XEO03498 GENEFORM Protein DME1023 XEOTICID XEO03498 MOACRIVE Inhibition DME1023 XEOTICID XEO03519 XEO_NAME Hadrurin DME1023 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03519 XEO_CLAS Peptide DME1023 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03519 GENEFORM Protein DME1023 XEOTICID XEO03519 MOACRIVE Inhibition DME1023 XEOTICID XEO03522 XEO_NAME Halocyntin DME1023 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03522 XEO_CLAS Peptide DME1023 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03522 GENEFORM Protein DME1023 XEOTICID XEO03522 MOACRIVE Inhibition DME1023 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1023 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03540 XEO_CLAS Peptide DME1023 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1023 XEOTICID XEO03540 GENEFORM Protein DME1023 XEOTICID XEO03540 MOACRIVE Inhibition DME1023 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1023 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03549 XEO_CLAS Peptide DME1023 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03549 GENEFORM Protein DME1023 XEOTICID XEO03549 MOACRIVE Inhibition DME1023 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1023 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1023 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1023 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03552 GENEFORM Protein DME1023 XEOTICID XEO03552 MOACRIVE Inhibition DME1023 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1023 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03556 XEO_CLAS Peptide DME1023 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1023 XEOTICID XEO03556 GENEFORM Protein DME1023 XEOTICID XEO03556 MOACRIVE Inhibition DME1023 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1023 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03557 XEO_CLAS Peptide DME1023 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1023 XEOTICID XEO03557 GENEFORM Protein DME1023 XEOTICID XEO03557 MOACRIVE Inhibition DME1023 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1023 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03591 XEO_CLAS Peptide DME1023 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1023 XEOTICID XEO03591 GENEFORM Protein DME1023 XEOTICID XEO03591 MOACRIVE Inhibition DME1023 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1023 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03593 XEO_CLAS Peptide DME1023 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1023 XEOTICID XEO03593 GENEFORM Protein DME1023 XEOTICID XEO03593 MOACRIVE Inhibition DME1023 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1023 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03609 XEO_CLAS Peptide DME1023 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03609 GENEFORM Protein DME1023 XEOTICID XEO03609 MOACRIVE Inhibition DME1023 XEOTICID XEO03611 XEO_NAME Himatanthus drasticus hydroalcoholic extract DME1023 XEOTICID XEO03611 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1023 XEOTICID XEO03611 XEO_CLAS Plant Extract DME1023 XEOTICID XEO03611 DESCRIPT Himatanthus drasticus hydroalcoholic extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03611 GENEFORM Protein DME1023 XEOTICID XEO03611 MOACRIVE Inhibition DME1023 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1023 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03622 XEO_CLAS Peptide DME1023 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 20-40 microM) DME1023 XEOTICID XEO03622 GENEFORM Protein DME1023 XEOTICID XEO03622 MOACRIVE Inhibition DME1023 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1023 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03630 XEO_CLAS Peptide DME1023 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03630 GENEFORM Protein DME1023 XEOTICID XEO03630 MOACRIVE Inhibition DME1023 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1023 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03631 XEO_CLAS Peptide DME1023 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03631 GENEFORM Protein DME1023 XEOTICID XEO03631 MOACRIVE Inhibition DME1023 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1023 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03632 XEO_CLAS Peptide DME1023 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03632 GENEFORM Protein DME1023 XEOTICID XEO03632 MOACRIVE Inhibition DME1023 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1023 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03633 XEO_CLAS Peptide DME1023 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03633 GENEFORM Protein DME1023 XEOTICID XEO03633 MOACRIVE Inhibition DME1023 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1023 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03634 XEO_CLAS Peptide DME1023 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03634 GENEFORM Protein DME1023 XEOTICID XEO03634 MOACRIVE Inhibition DME1023 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1023 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03635 XEO_CLAS Peptide DME1023 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03635 GENEFORM Protein DME1023 XEOTICID XEO03635 MOACRIVE Inhibition DME1023 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1023 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03636 XEO_CLAS Peptide DME1023 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03636 GENEFORM Protein DME1023 XEOTICID XEO03636 MOACRIVE Inhibition DME1023 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1023 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03637 XEO_CLAS Peptide DME1023 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03637 GENEFORM Protein DME1023 XEOTICID XEO03637 MOACRIVE Inhibition DME1023 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1023 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03638 XEO_CLAS Peptide DME1023 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03638 GENEFORM Protein DME1023 XEOTICID XEO03638 MOACRIVE Inhibition DME1023 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1023 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03639 XEO_CLAS Peptide DME1023 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03639 GENEFORM Protein DME1023 XEOTICID XEO03639 MOACRIVE Inhibition DME1023 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1023 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03640 XEO_CLAS Peptide DME1023 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03640 GENEFORM Protein DME1023 XEOTICID XEO03640 MOACRIVE Inhibition DME1023 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1023 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03672 XEO_CLAS Peptide DME1023 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1023 XEOTICID XEO03672 GENEFORM Protein DME1023 XEOTICID XEO03672 MOACRIVE Inhibition DME1023 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1023 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03673 XEO_CLAS Peptide DME1023 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1023 XEOTICID XEO03673 GENEFORM Protein DME1023 XEOTICID XEO03673 MOACRIVE Inhibition DME1023 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1023 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03674 XEO_CLAS Peptide DME1023 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO03674 GENEFORM Protein DME1023 XEOTICID XEO03674 MOACRIVE Inhibition DME1023 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1023 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03675 XEO_CLAS Peptide DME1023 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 15 microM) DME1023 XEOTICID XEO03675 GENEFORM Protein DME1023 XEOTICID XEO03675 MOACRIVE Inhibition DME1023 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1023 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03678 XEO_CLAS Peptide DME1023 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1023 XEOTICID XEO03678 GENEFORM Protein DME1023 XEOTICID XEO03678 MOACRIVE Inhibition DME1023 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1023 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03681 XEO_CLAS Peptide DME1023 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 1.2-2.5 microM) DME1023 XEOTICID XEO03681 GENEFORM Protein DME1023 XEOTICID XEO03681 MOACRIVE Inhibition DME1023 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1023 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03697 XEO_CLAS Peptide DME1023 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 25 microM) DME1023 XEOTICID XEO03697 GENEFORM Protein DME1023 XEOTICID XEO03697 MOACRIVE Inhibition DME1023 XEOTICID XEO03724 XEO_NAME L10 peptide DME1023 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03724 XEO_CLAS Peptide DME1023 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 3.35 microM) DME1023 XEOTICID XEO03724 GENEFORM Protein DME1023 XEOTICID XEO03724 MOACRIVE Inhibition DME1023 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1023 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03744 XEO_CLAS Peptide DME1023 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1023 XEOTICID XEO03744 GENEFORM Protein DME1023 XEOTICID XEO03744 MOACRIVE Inhibition DME1023 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1023 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03746 XEO_CLAS Peptide DME1023 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1023 XEOTICID XEO03746 GENEFORM Protein DME1023 XEOTICID XEO03746 MOACRIVE Inhibition DME1023 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1023 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03747 XEO_CLAS Peptide DME1023 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1023 XEOTICID XEO03747 GENEFORM Protein DME1023 XEOTICID XEO03747 MOACRIVE Inhibition DME1023 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1023 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03748 XEO_CLAS Peptide DME1023 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1023 XEOTICID XEO03748 GENEFORM Protein DME1023 XEOTICID XEO03748 MOACRIVE Inhibition DME1023 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1023 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03749 XEO_CLAS Peptide DME1023 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1023 XEOTICID XEO03749 GENEFORM Protein DME1023 XEOTICID XEO03749 MOACRIVE Inhibition DME1023 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1023 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03750 XEO_CLAS Peptide DME1023 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1023 XEOTICID XEO03750 GENEFORM Protein DME1023 XEOTICID XEO03750 MOACRIVE Inhibition DME1023 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1023 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03751 XEO_CLAS Peptide DME1023 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1023 XEOTICID XEO03751 GENEFORM Protein DME1023 XEOTICID XEO03751 MOACRIVE Inhibition DME1023 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1023 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03752 XEO_CLAS Peptide DME1023 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1023 XEOTICID XEO03752 GENEFORM Protein DME1023 XEOTICID XEO03752 MOACRIVE Inhibition DME1023 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1023 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03753 XEO_CLAS Peptide DME1023 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1023 XEOTICID XEO03753 GENEFORM Protein DME1023 XEOTICID XEO03753 MOACRIVE Inhibition DME1023 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1023 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03754 XEO_CLAS Peptide DME1023 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1023 XEOTICID XEO03754 GENEFORM Protein DME1023 XEOTICID XEO03754 MOACRIVE Inhibition DME1023 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1023 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03755 XEO_CLAS Peptide DME1023 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1023 XEOTICID XEO03755 GENEFORM Protein DME1023 XEOTICID XEO03755 MOACRIVE Inhibition DME1023 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1023 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03756 XEO_CLAS Peptide DME1023 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1023 XEOTICID XEO03756 GENEFORM Protein DME1023 XEOTICID XEO03756 MOACRIVE Inhibition DME1023 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1023 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03759 XEO_CLAS Peptide DME1023 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1023 XEOTICID XEO03759 GENEFORM Protein DME1023 XEOTICID XEO03759 MOACRIVE Inhibition DME1023 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1023 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03761 XEO_CLAS Peptide DME1023 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1023 XEOTICID XEO03761 GENEFORM Protein DME1023 XEOTICID XEO03761 MOACRIVE Inhibition DME1023 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1023 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO03985 XEO_CLAS Peptide DME1023 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1023 XEOTICID XEO03985 GENEFORM Protein DME1023 XEOTICID XEO03985 MOACRIVE Inhibition DME1023 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1023 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04001 XEO_CLAS Peptide DME1023 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 12.5 microM) DME1023 XEOTICID XEO04001 GENEFORM Protein DME1023 XEOTICID XEO04001 MOACRIVE Inhibition DME1023 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1023 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04007 XEO_CLAS Peptide DME1023 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1023 XEOTICID XEO04007 GENEFORM Protein DME1023 XEOTICID XEO04007 MOACRIVE Inhibition DME1023 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1023 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04011 XEO_CLAS Peptide DME1023 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1023 XEOTICID XEO04011 GENEFORM Protein DME1023 XEOTICID XEO04011 MOACRIVE Inhibition DME1023 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1023 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04012 XEO_CLAS Peptide DME1023 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1023 XEOTICID XEO04012 GENEFORM Protein DME1023 XEOTICID XEO04012 MOACRIVE Inhibition DME1023 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1023 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04013 XEO_CLAS Peptide DME1023 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1023 XEOTICID XEO04013 GENEFORM Protein DME1023 XEOTICID XEO04013 MOACRIVE Inhibition DME1023 XEOTICID XEO04014 XEO_NAME Maximin-5 DME1023 XEOTICID XEO04014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04014 XEO_CLAS Peptide DME1023 XEOTICID XEO04014 DESCRIPT Maximin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 3.6 ug/ml) DME1023 XEOTICID XEO04014 GENEFORM Protein DME1023 XEOTICID XEO04014 MOACRIVE Inhibition DME1023 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1023 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1023 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1023 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04087 GENEFORM Protein DME1023 XEOTICID XEO04087 MOACRIVE Inhibition DME1023 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1023 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04111 XEO_CLAS Peptide DME1023 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04111 GENEFORM Protein DME1023 XEOTICID XEO04111 MOACRIVE Inhibition DME1023 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1023 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04241 XEO_CLAS Peptide DME1023 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04241 GENEFORM Protein DME1023 XEOTICID XEO04241 MOACRIVE Inhibition DME1023 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1023 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04242 XEO_CLAS Peptide DME1023 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04242 GENEFORM Protein DME1023 XEOTICID XEO04242 MOACRIVE Inhibition DME1023 XEOTICID XEO04331 XEO_NAME Norspermidine DME1023 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1023 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1023 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04331 GENEFORM Protein DME1023 XEOTICID XEO04331 MOACRIVE Inhibition DME1023 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1023 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04348 XEO_CLAS Peptide DME1023 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 80 microM) DME1023 XEOTICID XEO04348 GENEFORM Protein DME1023 XEOTICID XEO04348 MOACRIVE Inhibition DME1023 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1023 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04349 XEO_CLAS Peptide DME1023 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 100 microM) DME1023 XEOTICID XEO04349 GENEFORM Protein DME1023 XEOTICID XEO04349 MOACRIVE Inhibition DME1023 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1023 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04399 XEO_CLAS Peptide DME1023 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 6.3 microM) DME1023 XEOTICID XEO04399 GENEFORM Protein DME1023 XEOTICID XEO04399 MOACRIVE Inhibition DME1023 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1023 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04426 XEO_CLAS Peptide DME1023 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 2 microM) DME1023 XEOTICID XEO04426 GENEFORM Protein DME1023 XEOTICID XEO04426 MOACRIVE Inhibition DME1023 XEOTICID XEO04468 XEO_NAME Papillosin DME1023 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04468 XEO_CLAS Peptide DME1023 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04468 GENEFORM Protein DME1023 XEOTICID XEO04468 MOACRIVE Inhibition DME1023 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1023 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04471 XEO_CLAS Peptide DME1023 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 1.6 microM) DME1023 XEOTICID XEO04471 GENEFORM Protein DME1023 XEOTICID XEO04471 MOACRIVE Inhibition DME1023 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1023 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04506 XEO_CLAS Peptide DME1023 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC > 20 microM) DME1023 XEOTICID XEO04506 GENEFORM Protein DME1023 XEOTICID XEO04506 MOACRIVE Inhibition DME1023 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1023 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04507 XEO_CLAS Peptide DME1023 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC > 40 microM) DME1023 XEOTICID XEO04507 GENEFORM Protein DME1023 XEOTICID XEO04507 MOACRIVE Inhibition DME1023 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1023 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04510 XEO_CLAS Peptide DME1023 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC > 50 microM) DME1023 XEOTICID XEO04510 GENEFORM Protein DME1023 XEOTICID XEO04510 MOACRIVE Inhibition DME1023 XEOTICID XEO04531 XEO_NAME Mollusca/molluscs/mollusks peptide 2 DME1023 XEOTICID XEO04531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04531 XEO_CLAS Peptide DME1023 XEOTICID XEO04531 DESCRIPT Mollusca/molluscs/mollusks peptide 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04531 GENEFORM Protein DME1023 XEOTICID XEO04531 MOACRIVE Inhibition DME1023 XEOTICID XEO04533 XEO_NAME Mollusca/molluscs/mollusks peptide 3 DME1023 XEOTICID XEO04533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04533 XEO_CLAS Peptide DME1023 XEOTICID XEO04533 DESCRIPT Mollusca/molluscs/mollusks peptide 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04533 GENEFORM Protein DME1023 XEOTICID XEO04533 MOACRIVE Inhibition DME1023 XEOTICID XEO04534 XEO_NAME Mollusca/molluscs/mollusks peptide 4 DME1023 XEOTICID XEO04534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04534 XEO_CLAS Peptide DME1023 XEOTICID XEO04534 DESCRIPT Mollusca/molluscs/mollusks peptide 4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04534 GENEFORM Protein DME1023 XEOTICID XEO04534 MOACRIVE Inhibition DME1023 XEOTICID XEO04535 XEO_NAME Mollusca/molluscs/mollusks peptide 5 DME1023 XEOTICID XEO04535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04535 XEO_CLAS Peptide DME1023 XEOTICID XEO04535 DESCRIPT Mollusca/molluscs/mollusks peptide 5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04535 GENEFORM Protein DME1023 XEOTICID XEO04535 MOACRIVE Inhibition DME1023 XEOTICID XEO04536 XEO_NAME Mollusca/molluscs/mollusks peptide 6 DME1023 XEOTICID XEO04536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04536 XEO_CLAS Peptide DME1023 XEOTICID XEO04536 DESCRIPT Mollusca/molluscs/mollusks peptide 6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04536 GENEFORM Protein DME1023 XEOTICID XEO04536 MOACRIVE Inhibition DME1023 XEOTICID XEO04537 XEO_NAME Mollusca/molluscs/mollusks peptide 7 DME1023 XEOTICID XEO04537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04537 XEO_CLAS Peptide DME1023 XEOTICID XEO04537 DESCRIPT Mollusca/molluscs/mollusks peptide 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04537 GENEFORM Protein DME1023 XEOTICID XEO04537 MOACRIVE Inhibition DME1023 XEOTICID XEO04538 XEO_NAME Mollusca/molluscs/mollusks peptide 8 DME1023 XEOTICID XEO04538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04538 XEO_CLAS Peptide DME1023 XEOTICID XEO04538 DESCRIPT Mollusca/molluscs/mollusks peptide 8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04538 GENEFORM Protein DME1023 XEOTICID XEO04538 MOACRIVE Inhibition DME1023 XEOTICID XEO04539 XEO_NAME Mollusca/molluscs/mollusks peptide 9 DME1023 XEOTICID XEO04539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04539 XEO_CLAS Peptide DME1023 XEOTICID XEO04539 DESCRIPT Mollusca/molluscs/mollusks peptide 9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04539 GENEFORM Protein DME1023 XEOTICID XEO04539 MOACRIVE Inhibition DME1023 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1023 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04548 XEO_CLAS Peptide DME1023 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 32000 ug/ml) DME1023 XEOTICID XEO04548 GENEFORM Protein DME1023 XEOTICID XEO04548 MOACRIVE Inhibition DME1023 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1023 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04549 XEO_CLAS Peptide DME1023 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 250-500 ug/ml) DME1023 XEOTICID XEO04549 GENEFORM Protein DME1023 XEOTICID XEO04549 MOACRIVE Inhibition DME1023 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1023 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04571 XEO_CLAS Peptide DME1023 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04571 GENEFORM Protein DME1023 XEOTICID XEO04571 MOACRIVE Inhibition DME1023 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1023 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04572 XEO_CLAS Peptide DME1023 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04572 GENEFORM Protein DME1023 XEOTICID XEO04572 MOACRIVE Inhibition DME1023 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1023 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04606 XEO_CLAS Peptide DME1023 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 2 microM) DME1023 XEOTICID XEO04606 GENEFORM Protein DME1023 XEOTICID XEO04606 MOACRIVE Inhibition DME1023 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1023 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04612 XEO_CLAS Peptide DME1023 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1023 XEOTICID XEO04612 GENEFORM Protein DME1023 XEOTICID XEO04612 MOACRIVE Inhibition DME1023 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1023 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04613 XEO_CLAS Peptide DME1023 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1023 XEOTICID XEO04613 GENEFORM Protein DME1023 XEOTICID XEO04613 MOACRIVE Inhibition DME1023 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1023 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04695 XEO_CLAS Peptide DME1023 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04695 GENEFORM Protein DME1023 XEOTICID XEO04695 MOACRIVE Inhibition DME1023 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1023 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04696 XEO_CLAS Peptide DME1023 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04696 GENEFORM Protein DME1023 XEOTICID XEO04696 MOACRIVE Inhibition DME1023 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1023 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04697 XEO_CLAS Peptide DME1023 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04697 GENEFORM Protein DME1023 XEOTICID XEO04697 MOACRIVE Inhibition DME1023 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1023 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04698 XEO_CLAS Peptide DME1023 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04698 GENEFORM Protein DME1023 XEOTICID XEO04698 MOACRIVE Inhibition DME1023 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1023 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04699 XEO_CLAS Peptide DME1023 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04699 GENEFORM Protein DME1023 XEOTICID XEO04699 MOACRIVE Inhibition DME1023 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1023 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04700 XEO_CLAS Peptide DME1023 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04700 GENEFORM Protein DME1023 XEOTICID XEO04700 MOACRIVE Inhibition DME1023 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1023 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04701 XEO_CLAS Peptide DME1023 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04701 GENEFORM Protein DME1023 XEOTICID XEO04701 MOACRIVE Inhibition DME1023 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1023 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04702 XEO_CLAS Peptide DME1023 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04702 GENEFORM Protein DME1023 XEOTICID XEO04702 MOACRIVE Inhibition DME1023 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1023 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04703 XEO_CLAS Peptide DME1023 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04703 GENEFORM Protein DME1023 XEOTICID XEO04703 MOACRIVE Inhibition DME1023 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1023 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04762 XEO_CLAS Peptide DME1023 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC > 25 microM) DME1023 XEOTICID XEO04762 GENEFORM Protein DME1023 XEOTICID XEO04762 MOACRIVE Inhibition DME1023 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1023 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04809 XEO_CLAS Peptide DME1023 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 10 microM) DME1023 XEOTICID XEO04809 GENEFORM Protein DME1023 XEOTICID XEO04809 MOACRIVE Inhibition DME1023 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1023 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04891 XEO_CLAS Peptide DME1023 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04891 GENEFORM Protein DME1023 XEOTICID XEO04891 MOACRIVE Inhibition DME1023 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1023 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04905 XEO_CLAS Peptide DME1023 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04905 GENEFORM Protein DME1023 XEOTICID XEO04905 MOACRIVE Inhibition DME1023 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1023 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04906 XEO_CLAS Peptide DME1023 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO04906 GENEFORM Protein DME1023 XEOTICID XEO04906 MOACRIVE Inhibition DME1023 XEOTICID XEO04917 XEO_NAME Scorpine DME1023 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04917 XEO_CLAS Peptide DME1023 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 10 microM) DME1023 XEOTICID XEO04917 GENEFORM Protein DME1023 XEOTICID XEO04917 MOACRIVE Inhibition DME1023 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1023 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04971 XEO_CLAS Peptide DME1023 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1023 XEOTICID XEO04971 GENEFORM Protein DME1023 XEOTICID XEO04971 MOACRIVE Inhibition DME1023 XEOTICID XEO04974 XEO_NAME Spinigerin DME1023 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04974 XEO_CLAS Peptide DME1023 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1023 XEOTICID XEO04974 GENEFORM Protein DME1023 XEOTICID XEO04974 MOACRIVE Inhibition DME1023 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1023 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO04995 XEO_CLAS Peptide DME1023 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 0.78-1.56 microM) DME1023 XEOTICID XEO04995 GENEFORM Protein DME1023 XEOTICID XEO04995 MOACRIVE Inhibition DME1023 XEOTICID XEO05020 XEO_NAME Tachycitin DME1023 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO05020 XEO_CLAS Peptide DME1023 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae DME1023 XEOTICID XEO05020 GENEFORM Protein DME1023 XEOTICID XEO05020 MOACRIVE Inhibition DME1023 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1023 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO05073 XEO_CLAS Peptide DME1023 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 80 microM) DME1023 XEOTICID XEO05073 GENEFORM Protein DME1023 XEOTICID XEO05073 MOACRIVE Inhibition DME1023 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1023 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO05075 XEO_CLAS Peptide DME1023 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 80 microM) DME1023 XEOTICID XEO05075 GENEFORM Protein DME1023 XEOTICID XEO05075 MOACRIVE Inhibition DME1023 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1023 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO05101 XEO_CLAS Peptide DME1023 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 31.2 ug/ml) DME1023 XEOTICID XEO05101 GENEFORM Protein DME1023 XEOTICID XEO05101 MOACRIVE Inhibition DME1023 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1023 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO05102 XEO_CLAS Peptide DME1023 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 35.1 ug/ml) DME1023 XEOTICID XEO05102 GENEFORM Protein DME1023 XEOTICID XEO05102 MOACRIVE Inhibition DME1023 XEOTICID XEO05120 XEO_NAME Thanatin DME1023 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO05120 XEO_CLAS Peptide DME1023 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 0.6-1.2 microM) DME1023 XEOTICID XEO05120 GENEFORM Protein DME1023 XEOTICID XEO05120 MOACRIVE Inhibition DME1023 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1023 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO05163 XEO_CLAS Peptide DME1023 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 12-25 ug/ml) DME1023 XEOTICID XEO05163 GENEFORM Protein DME1023 XEOTICID XEO05163 MOACRIVE Inhibition DME1023 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1023 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1023 XEOTICID XEO05220 XEO_CLAS Peptide DME1023 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1023 XEOTICID XEO05220 GENEFORM Protein DME1023 XEOTICID XEO05220 MOACRIVE Inhibition DME1024 DME___ID DME1024 DME1024 DME_NAME Beta-lactamase (blaB) DME1024 SPESNAME Klebsiella variicola DME1024 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1024 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1024 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1024 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO00546 GENEFORM Protein DME1024 XEOTICID XEO00546 MOACRIVE Inhibition DME1024 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1024 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1024 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1024 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO00574 GENEFORM Protein DME1024 XEOTICID XEO00574 MOACRIVE Inhibition DME1024 XEOTICID XEO01266 XEO_NAME Cyanidin DME1024 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME1024 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME1024 XEOTICID XEO01266 DESCRIPT Cyanidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO01266 GENEFORM Protein DME1024 XEOTICID XEO01266 MOACRIVE Inhibition DME1024 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1024 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO01816 XEO_CLAS Peptide DME1024 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 6.25 microM) DME1024 XEOTICID XEO01816 GENEFORM Protein DME1024 XEOTICID XEO01816 MOACRIVE Inhibition DME1024 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1024 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO01827 XEO_CLAS Peptide DME1024 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC > 50 microM) DME1024 XEOTICID XEO01827 GENEFORM Protein DME1024 XEOTICID XEO01827 MOACRIVE Inhibition DME1024 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1024 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02115 XEO_CLAS Peptide DME1024 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO02115 GENEFORM Protein DME1024 XEOTICID XEO02115 MOACRIVE Inhibition DME1024 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1024 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02230 XEO_CLAS Peptide DME1024 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 1-2.5 microM) DME1024 XEOTICID XEO02230 GENEFORM Protein DME1024 XEOTICID XEO02230 MOACRIVE Inhibition DME1024 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1024 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02280 XEO_CLAS Peptide DME1024 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO02280 GENEFORM Protein DME1024 XEOTICID XEO02280 MOACRIVE Inhibition DME1024 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1024 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02325 XEO_CLAS Peptide DME1024 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 13 microM) DME1024 XEOTICID XEO02325 GENEFORM Protein DME1024 XEOTICID XEO02325 MOACRIVE Inhibition DME1024 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1024 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02370 XEO_CLAS Peptide DME1024 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO02370 GENEFORM Protein DME1024 XEOTICID XEO02370 MOACRIVE Inhibition DME1024 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1024 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02371 XEO_CLAS Peptide DME1024 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 12 ug/ml) DME1024 XEOTICID XEO02371 GENEFORM Protein DME1024 XEOTICID XEO02371 MOACRIVE Inhibition DME1024 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1024 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02378 XEO_CLAS Peptide DME1024 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 0.76 ug/ml) DME1024 XEOTICID XEO02378 GENEFORM Protein DME1024 XEOTICID XEO02378 MOACRIVE Inhibition DME1024 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1024 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02416 XEO_CLAS Peptide DME1024 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO02416 GENEFORM Protein DME1024 XEOTICID XEO02416 MOACRIVE Inhibition DME1024 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1024 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02451 XEO_CLAS Peptide DME1024 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO02451 GENEFORM Protein DME1024 XEOTICID XEO02451 MOACRIVE Inhibition DME1024 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1024 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02473 XEO_CLAS Peptide DME1024 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO02473 GENEFORM Protein DME1024 XEOTICID XEO02473 MOACRIVE Inhibition DME1024 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1024 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02491 XEO_CLAS Peptide DME1024 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 2.8 microM) DME1024 XEOTICID XEO02491 GENEFORM Protein DME1024 XEOTICID XEO02491 MOACRIVE Inhibition DME1024 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1024 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02496 XEO_CLAS Peptide DME1024 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 50 microM) DME1024 XEOTICID XEO02496 GENEFORM Protein DME1024 XEOTICID XEO02496 MOACRIVE Inhibition DME1024 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1024 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02497 XEO_CLAS Peptide DME1024 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC > 50 microM) DME1024 XEOTICID XEO02497 GENEFORM Protein DME1024 XEOTICID XEO02497 MOACRIVE Inhibition DME1024 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1024 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02512 XEO_CLAS Peptide DME1024 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 150 microM) DME1024 XEOTICID XEO02512 GENEFORM Protein DME1024 XEOTICID XEO02512 MOACRIVE Inhibition DME1024 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1024 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02566 XEO_CLAS Peptide DME1024 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC > 100 microM) DME1024 XEOTICID XEO02566 GENEFORM Protein DME1024 XEOTICID XEO02566 MOACRIVE Inhibition DME1024 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1024 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02637 XEO_CLAS Peptide DME1024 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 6 microM) DME1024 XEOTICID XEO02637 GENEFORM Protein DME1024 XEOTICID XEO02637 MOACRIVE Inhibition DME1024 XEOTICID XEO02656 XEO_NAME Himatanthus drasticus butanolic extract DME1024 XEOTICID XEO02656 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1024 XEOTICID XEO02656 XEO_CLAS Plant Extract DME1024 XEOTICID XEO02656 DESCRIPT Himatanthus drasticus butanolic extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO02656 GENEFORM Protein DME1024 XEOTICID XEO02656 MOACRIVE Inhibition DME1024 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1024 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02688 XEO_CLAS Peptide DME1024 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 25 microM) DME1024 XEOTICID XEO02688 GENEFORM Protein DME1024 XEOTICID XEO02688 MOACRIVE Inhibition DME1024 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1024 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02708 XEO_CLAS Peptide DME1024 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 20 ug/ml) DME1024 XEOTICID XEO02708 GENEFORM Protein DME1024 XEOTICID XEO02708 MOACRIVE Inhibition DME1024 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1024 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02732 XEO_CLAS Peptide DME1024 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 1.25 microM) DME1024 XEOTICID XEO02732 GENEFORM Protein DME1024 XEOTICID XEO02732 MOACRIVE Inhibition DME1024 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1024 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02734 XEO_CLAS Peptide DME1024 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 0.40 microM) DME1024 XEOTICID XEO02734 GENEFORM Protein DME1024 XEOTICID XEO02734 MOACRIVE Inhibition DME1024 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1024 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02736 XEO_CLAS Peptide DME1024 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 0.66 microM) DME1024 XEOTICID XEO02736 GENEFORM Protein DME1024 XEOTICID XEO02736 MOACRIVE Inhibition DME1024 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1024 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02738 XEO_CLAS Peptide DME1024 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 1 microM) DME1024 XEOTICID XEO02738 GENEFORM Protein DME1024 XEOTICID XEO02738 MOACRIVE Inhibition DME1024 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1024 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02743 XEO_CLAS Peptide DME1024 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 4.7 ug/ml) DME1024 XEOTICID XEO02743 GENEFORM Protein DME1024 XEOTICID XEO02743 MOACRIVE Inhibition DME1024 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1024 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02749 XEO_CLAS Peptide DME1024 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 20 mug/ml) DME1024 XEOTICID XEO02749 GENEFORM Protein DME1024 XEOTICID XEO02749 MOACRIVE Inhibition DME1024 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1024 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02767 XEO_CLAS Peptide DME1024 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO02767 GENEFORM Protein DME1024 XEOTICID XEO02767 MOACRIVE Inhibition DME1024 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1024 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02768 XEO_CLAS Peptide DME1024 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 1-2.5 ug/ml) DME1024 XEOTICID XEO02768 GENEFORM Protein DME1024 XEOTICID XEO02768 MOACRIVE Inhibition DME1024 XEOTICID XEO02780 XEO_NAME Cefixime DME1024 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1024 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1024 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO02780 GENEFORM Protein DME1024 XEOTICID XEO02780 MOACRIVE Inhibition DME1024 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1024 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO02942 XEO_CLAS Peptide DME1024 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO02942 GENEFORM Protein DME1024 XEOTICID XEO02942 MOACRIVE Inhibition DME1024 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1024 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03029 XEO_CLAS Peptide DME1024 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 0.145 microM) DME1024 XEOTICID XEO03029 GENEFORM Protein DME1024 XEOTICID XEO03029 MOACRIVE Inhibition DME1024 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1024 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03030 XEO_CLAS Peptide DME1024 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 0.643 microM) DME1024 XEOTICID XEO03030 GENEFORM Protein DME1024 XEOTICID XEO03030 MOACRIVE Inhibition DME1024 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1024 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03031 XEO_CLAS Peptide DME1024 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 0.01 microM) DME1024 XEOTICID XEO03031 GENEFORM Protein DME1024 XEOTICID XEO03031 MOACRIVE Inhibition DME1024 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1024 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03032 XEO_CLAS Peptide DME1024 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC < 0.005 microM) DME1024 XEOTICID XEO03032 GENEFORM Protein DME1024 XEOTICID XEO03032 MOACRIVE Inhibition DME1024 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1024 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03033 XEO_CLAS Peptide DME1024 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC > 0.692 microM) DME1024 XEOTICID XEO03033 GENEFORM Protein DME1024 XEOTICID XEO03033 MOACRIVE Inhibition DME1024 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1024 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03034 XEO_CLAS Peptide DME1024 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 0.004 microM) DME1024 XEOTICID XEO03034 GENEFORM Protein DME1024 XEOTICID XEO03034 MOACRIVE Inhibition DME1024 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1024 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03035 XEO_CLAS Peptide DME1024 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 0.458 microM) DME1024 XEOTICID XEO03035 GENEFORM Protein DME1024 XEOTICID XEO03035 MOACRIVE Inhibition DME1024 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1024 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03051 XEO_CLAS Peptide DME1024 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 100 ug/ml) DME1024 XEOTICID XEO03051 GENEFORM Protein DME1024 XEOTICID XEO03051 MOACRIVE Inhibition DME1024 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1024 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03052 XEO_CLAS Peptide DME1024 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 10 ug/ml) DME1024 XEOTICID XEO03052 GENEFORM Protein DME1024 XEOTICID XEO03052 MOACRIVE Inhibition DME1024 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1024 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03053 XEO_CLAS Peptide DME1024 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 25 ug/ml) DME1024 XEOTICID XEO03053 GENEFORM Protein DME1024 XEOTICID XEO03053 MOACRIVE Inhibition DME1024 XEOTICID XEO03089 XEO_NAME Decoralin DME1024 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03089 XEO_CLAS Peptide DME1024 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 80 microM) DME1024 XEOTICID XEO03089 GENEFORM Protein DME1024 XEOTICID XEO03089 MOACRIVE Inhibition DME1024 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1024 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03112 XEO_CLAS Peptide DME1024 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC > 50 ug/ml) DME1024 XEOTICID XEO03112 GENEFORM Protein DME1024 XEOTICID XEO03112 MOACRIVE Inhibition DME1024 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1024 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03137 XEO_CLAS Peptide DME1024 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03137 GENEFORM Protein DME1024 XEOTICID XEO03137 MOACRIVE Inhibition DME1024 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1024 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03162 XEO_CLAS Peptide DME1024 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 0.8 microM) DME1024 XEOTICID XEO03162 GENEFORM Protein DME1024 XEOTICID XEO03162 MOACRIVE Inhibition DME1024 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1024 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03224 XEO_CLAS Peptide DME1024 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 1-2.5 microM) DME1024 XEOTICID XEO03224 GENEFORM Protein DME1024 XEOTICID XEO03224 MOACRIVE Inhibition DME1024 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1024 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03235 XEO_CLAS Peptide DME1024 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 60 ug/ml) DME1024 XEOTICID XEO03235 GENEFORM Protein DME1024 XEOTICID XEO03235 MOACRIVE Inhibition DME1024 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1024 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03237 XEO_CLAS Peptide DME1024 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC > 100 ug/ml) DME1024 XEOTICID XEO03237 GENEFORM Protein DME1024 XEOTICID XEO03237 MOACRIVE Inhibition DME1024 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1024 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03238 XEO_CLAS Peptide DME1024 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 15 ug/ml) DME1024 XEOTICID XEO03238 GENEFORM Protein DME1024 XEOTICID XEO03238 MOACRIVE Inhibition DME1024 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1024 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03239 XEO_CLAS Peptide DME1024 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 50 ug/ml) DME1024 XEOTICID XEO03239 GENEFORM Protein DME1024 XEOTICID XEO03239 MOACRIVE Inhibition DME1024 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1024 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03250 XEO_CLAS Peptide DME1024 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03250 GENEFORM Protein DME1024 XEOTICID XEO03250 MOACRIVE Inhibition DME1024 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1024 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03251 XEO_CLAS Peptide DME1024 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03251 GENEFORM Protein DME1024 XEOTICID XEO03251 MOACRIVE Inhibition DME1024 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1024 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03253 XEO_CLAS Peptide DME1024 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 3.2 ug/ml) DME1024 XEOTICID XEO03253 GENEFORM Protein DME1024 XEOTICID XEO03253 MOACRIVE Inhibition DME1024 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1024 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1024 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1024 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03348 GENEFORM Protein DME1024 XEOTICID XEO03348 MOACRIVE Inhibition DME1024 XEOTICID XEO03387 XEO_NAME Ferric chloride DME1024 XEOTICID XEO03387 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1024 XEOTICID XEO03387 XEO_CLAS Chemical Compound DME1024 XEOTICID XEO03387 DESCRIPT Ferric chloride inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03387 GENEFORM Protein DME1024 XEOTICID XEO03387 MOACRIVE Inhibition DME1024 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1024 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03436 XEO_CLAS Peptide DME1024 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 100 ug/ml) DME1024 XEOTICID XEO03436 GENEFORM Protein DME1024 XEOTICID XEO03436 MOACRIVE Inhibition DME1024 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1024 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03437 XEO_CLAS Peptide DME1024 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 25 ug/ml) DME1024 XEOTICID XEO03437 GENEFORM Protein DME1024 XEOTICID XEO03437 MOACRIVE Inhibition DME1024 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1024 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03438 XEO_CLAS Peptide DME1024 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 25 ug/ml) DME1024 XEOTICID XEO03438 GENEFORM Protein DME1024 XEOTICID XEO03438 MOACRIVE Inhibition DME1024 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1024 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03439 XEO_CLAS Peptide DME1024 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 25 ug/ml) DME1024 XEOTICID XEO03439 GENEFORM Protein DME1024 XEOTICID XEO03439 MOACRIVE Inhibition DME1024 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1024 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03440 XEO_CLAS Peptide DME1024 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 50 ug/ml) DME1024 XEOTICID XEO03440 GENEFORM Protein DME1024 XEOTICID XEO03440 MOACRIVE Inhibition DME1024 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1024 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03441 XEO_CLAS Peptide DME1024 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 50 ug/ml) DME1024 XEOTICID XEO03441 GENEFORM Protein DME1024 XEOTICID XEO03441 MOACRIVE Inhibition DME1024 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1024 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03497 XEO_CLAS Peptide DME1024 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 3.15-6.25 microM) DME1024 XEOTICID XEO03497 GENEFORM Protein DME1024 XEOTICID XEO03497 MOACRIVE Inhibition DME1024 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1024 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03498 XEO_CLAS Peptide DME1024 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 3.15-6.25 microM) DME1024 XEOTICID XEO03498 GENEFORM Protein DME1024 XEOTICID XEO03498 MOACRIVE Inhibition DME1024 XEOTICID XEO03519 XEO_NAME Hadrurin DME1024 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03519 XEO_CLAS Peptide DME1024 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03519 GENEFORM Protein DME1024 XEOTICID XEO03519 MOACRIVE Inhibition DME1024 XEOTICID XEO03522 XEO_NAME Halocyntin DME1024 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03522 XEO_CLAS Peptide DME1024 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03522 GENEFORM Protein DME1024 XEOTICID XEO03522 MOACRIVE Inhibition DME1024 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1024 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03540 XEO_CLAS Peptide DME1024 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 8-16 ug/ml) DME1024 XEOTICID XEO03540 GENEFORM Protein DME1024 XEOTICID XEO03540 MOACRIVE Inhibition DME1024 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1024 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03549 XEO_CLAS Peptide DME1024 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03549 GENEFORM Protein DME1024 XEOTICID XEO03549 MOACRIVE Inhibition DME1024 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1024 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1024 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1024 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03552 GENEFORM Protein DME1024 XEOTICID XEO03552 MOACRIVE Inhibition DME1024 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1024 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03556 XEO_CLAS Peptide DME1024 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 8-16 ug/ml) DME1024 XEOTICID XEO03556 GENEFORM Protein DME1024 XEOTICID XEO03556 MOACRIVE Inhibition DME1024 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1024 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03557 XEO_CLAS Peptide DME1024 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 8-16 ug/ml) DME1024 XEOTICID XEO03557 GENEFORM Protein DME1024 XEOTICID XEO03557 MOACRIVE Inhibition DME1024 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1024 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03591 XEO_CLAS Peptide DME1024 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 50 ug/ml) DME1024 XEOTICID XEO03591 GENEFORM Protein DME1024 XEOTICID XEO03591 MOACRIVE Inhibition DME1024 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1024 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03593 XEO_CLAS Peptide DME1024 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 25 ug/ml) DME1024 XEOTICID XEO03593 GENEFORM Protein DME1024 XEOTICID XEO03593 MOACRIVE Inhibition DME1024 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1024 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03609 XEO_CLAS Peptide DME1024 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03609 GENEFORM Protein DME1024 XEOTICID XEO03609 MOACRIVE Inhibition DME1024 XEOTICID XEO03611 XEO_NAME Himatanthus drasticus hydroalcoholic extract DME1024 XEOTICID XEO03611 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1024 XEOTICID XEO03611 XEO_CLAS Plant Extract DME1024 XEOTICID XEO03611 DESCRIPT Himatanthus drasticus hydroalcoholic extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03611 GENEFORM Protein DME1024 XEOTICID XEO03611 MOACRIVE Inhibition DME1024 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1024 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03622 XEO_CLAS Peptide DME1024 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 20-40 microM) DME1024 XEOTICID XEO03622 GENEFORM Protein DME1024 XEOTICID XEO03622 MOACRIVE Inhibition DME1024 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1024 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03630 XEO_CLAS Peptide DME1024 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03630 GENEFORM Protein DME1024 XEOTICID XEO03630 MOACRIVE Inhibition DME1024 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1024 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03631 XEO_CLAS Peptide DME1024 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03631 GENEFORM Protein DME1024 XEOTICID XEO03631 MOACRIVE Inhibition DME1024 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1024 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03632 XEO_CLAS Peptide DME1024 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03632 GENEFORM Protein DME1024 XEOTICID XEO03632 MOACRIVE Inhibition DME1024 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1024 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03633 XEO_CLAS Peptide DME1024 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03633 GENEFORM Protein DME1024 XEOTICID XEO03633 MOACRIVE Inhibition DME1024 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1024 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03634 XEO_CLAS Peptide DME1024 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03634 GENEFORM Protein DME1024 XEOTICID XEO03634 MOACRIVE Inhibition DME1024 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1024 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03635 XEO_CLAS Peptide DME1024 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03635 GENEFORM Protein DME1024 XEOTICID XEO03635 MOACRIVE Inhibition DME1024 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1024 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03636 XEO_CLAS Peptide DME1024 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03636 GENEFORM Protein DME1024 XEOTICID XEO03636 MOACRIVE Inhibition DME1024 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1024 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03637 XEO_CLAS Peptide DME1024 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03637 GENEFORM Protein DME1024 XEOTICID XEO03637 MOACRIVE Inhibition DME1024 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1024 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03638 XEO_CLAS Peptide DME1024 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03638 GENEFORM Protein DME1024 XEOTICID XEO03638 MOACRIVE Inhibition DME1024 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1024 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03639 XEO_CLAS Peptide DME1024 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03639 GENEFORM Protein DME1024 XEOTICID XEO03639 MOACRIVE Inhibition DME1024 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1024 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03640 XEO_CLAS Peptide DME1024 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03640 GENEFORM Protein DME1024 XEOTICID XEO03640 MOACRIVE Inhibition DME1024 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1024 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03672 XEO_CLAS Peptide DME1024 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 10 ug/ml) DME1024 XEOTICID XEO03672 GENEFORM Protein DME1024 XEOTICID XEO03672 MOACRIVE Inhibition DME1024 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1024 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03673 XEO_CLAS Peptide DME1024 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 15 ug/ml) DME1024 XEOTICID XEO03673 GENEFORM Protein DME1024 XEOTICID XEO03673 MOACRIVE Inhibition DME1024 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1024 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03674 XEO_CLAS Peptide DME1024 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO03674 GENEFORM Protein DME1024 XEOTICID XEO03674 MOACRIVE Inhibition DME1024 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1024 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03675 XEO_CLAS Peptide DME1024 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 15 microM) DME1024 XEOTICID XEO03675 GENEFORM Protein DME1024 XEOTICID XEO03675 MOACRIVE Inhibition DME1024 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1024 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03678 XEO_CLAS Peptide DME1024 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 2 ug/ml) DME1024 XEOTICID XEO03678 GENEFORM Protein DME1024 XEOTICID XEO03678 MOACRIVE Inhibition DME1024 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1024 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03681 XEO_CLAS Peptide DME1024 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 1.2-2.5 microM) DME1024 XEOTICID XEO03681 GENEFORM Protein DME1024 XEOTICID XEO03681 MOACRIVE Inhibition DME1024 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1024 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03697 XEO_CLAS Peptide DME1024 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 25 microM) DME1024 XEOTICID XEO03697 GENEFORM Protein DME1024 XEOTICID XEO03697 MOACRIVE Inhibition DME1024 XEOTICID XEO03724 XEO_NAME L10 peptide DME1024 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03724 XEO_CLAS Peptide DME1024 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 3.35 microM) DME1024 XEOTICID XEO03724 GENEFORM Protein DME1024 XEOTICID XEO03724 MOACRIVE Inhibition DME1024 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1024 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03744 XEO_CLAS Peptide DME1024 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 6.3 ug/ml) DME1024 XEOTICID XEO03744 GENEFORM Protein DME1024 XEOTICID XEO03744 MOACRIVE Inhibition DME1024 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1024 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03746 XEO_CLAS Peptide DME1024 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 2 ug/ml) DME1024 XEOTICID XEO03746 GENEFORM Protein DME1024 XEOTICID XEO03746 MOACRIVE Inhibition DME1024 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1024 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03747 XEO_CLAS Peptide DME1024 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 2 ug/ml) DME1024 XEOTICID XEO03747 GENEFORM Protein DME1024 XEOTICID XEO03747 MOACRIVE Inhibition DME1024 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1024 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03748 XEO_CLAS Peptide DME1024 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 4 ug/ml) DME1024 XEOTICID XEO03748 GENEFORM Protein DME1024 XEOTICID XEO03748 MOACRIVE Inhibition DME1024 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1024 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03749 XEO_CLAS Peptide DME1024 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 2 ug/ml) DME1024 XEOTICID XEO03749 GENEFORM Protein DME1024 XEOTICID XEO03749 MOACRIVE Inhibition DME1024 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1024 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03750 XEO_CLAS Peptide DME1024 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 2 ug/ml) DME1024 XEOTICID XEO03750 GENEFORM Protein DME1024 XEOTICID XEO03750 MOACRIVE Inhibition DME1024 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1024 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03751 XEO_CLAS Peptide DME1024 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 4 ug/ml) DME1024 XEOTICID XEO03751 GENEFORM Protein DME1024 XEOTICID XEO03751 MOACRIVE Inhibition DME1024 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1024 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03752 XEO_CLAS Peptide DME1024 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 2 ug/ml) DME1024 XEOTICID XEO03752 GENEFORM Protein DME1024 XEOTICID XEO03752 MOACRIVE Inhibition DME1024 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1024 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03753 XEO_CLAS Peptide DME1024 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 6.3 ug/ml) DME1024 XEOTICID XEO03753 GENEFORM Protein DME1024 XEOTICID XEO03753 MOACRIVE Inhibition DME1024 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1024 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03754 XEO_CLAS Peptide DME1024 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 2 ug/ml) DME1024 XEOTICID XEO03754 GENEFORM Protein DME1024 XEOTICID XEO03754 MOACRIVE Inhibition DME1024 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1024 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03755 XEO_CLAS Peptide DME1024 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 4 ug/ml) DME1024 XEOTICID XEO03755 GENEFORM Protein DME1024 XEOTICID XEO03755 MOACRIVE Inhibition DME1024 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1024 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03756 XEO_CLAS Peptide DME1024 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 2 ug/ml) DME1024 XEOTICID XEO03756 GENEFORM Protein DME1024 XEOTICID XEO03756 MOACRIVE Inhibition DME1024 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1024 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03759 XEO_CLAS Peptide DME1024 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 3.1 ug/ml) DME1024 XEOTICID XEO03759 GENEFORM Protein DME1024 XEOTICID XEO03759 MOACRIVE Inhibition DME1024 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1024 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03761 XEO_CLAS Peptide DME1024 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 50 ug/ml) DME1024 XEOTICID XEO03761 GENEFORM Protein DME1024 XEOTICID XEO03761 MOACRIVE Inhibition DME1024 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1024 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO03985 XEO_CLAS Peptide DME1024 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 10 ug/ml) DME1024 XEOTICID XEO03985 GENEFORM Protein DME1024 XEOTICID XEO03985 MOACRIVE Inhibition DME1024 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1024 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04001 XEO_CLAS Peptide DME1024 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 12.5 microM) DME1024 XEOTICID XEO04001 GENEFORM Protein DME1024 XEOTICID XEO04001 MOACRIVE Inhibition DME1024 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1024 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04007 XEO_CLAS Peptide DME1024 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 9 ug/ml) DME1024 XEOTICID XEO04007 GENEFORM Protein DME1024 XEOTICID XEO04007 MOACRIVE Inhibition DME1024 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1024 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04011 XEO_CLAS Peptide DME1024 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 9 ug/ml) DME1024 XEOTICID XEO04011 GENEFORM Protein DME1024 XEOTICID XEO04011 MOACRIVE Inhibition DME1024 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1024 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04012 XEO_CLAS Peptide DME1024 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 3.1 ug/ml) DME1024 XEOTICID XEO04012 GENEFORM Protein DME1024 XEOTICID XEO04012 MOACRIVE Inhibition DME1024 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1024 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04013 XEO_CLAS Peptide DME1024 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 15 ug/ml) DME1024 XEOTICID XEO04013 GENEFORM Protein DME1024 XEOTICID XEO04013 MOACRIVE Inhibition DME1024 XEOTICID XEO04014 XEO_NAME Maximin-5 DME1024 XEOTICID XEO04014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04014 XEO_CLAS Peptide DME1024 XEOTICID XEO04014 DESCRIPT Maximin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 3.6 ug/ml) DME1024 XEOTICID XEO04014 GENEFORM Protein DME1024 XEOTICID XEO04014 MOACRIVE Inhibition DME1024 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1024 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1024 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1024 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04087 GENEFORM Protein DME1024 XEOTICID XEO04087 MOACRIVE Inhibition DME1024 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1024 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04111 XEO_CLAS Peptide DME1024 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04111 GENEFORM Protein DME1024 XEOTICID XEO04111 MOACRIVE Inhibition DME1024 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1024 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04241 XEO_CLAS Peptide DME1024 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04241 GENEFORM Protein DME1024 XEOTICID XEO04241 MOACRIVE Inhibition DME1024 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1024 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04242 XEO_CLAS Peptide DME1024 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04242 GENEFORM Protein DME1024 XEOTICID XEO04242 MOACRIVE Inhibition DME1024 XEOTICID XEO04331 XEO_NAME Norspermidine DME1024 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1024 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1024 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04331 GENEFORM Protein DME1024 XEOTICID XEO04331 MOACRIVE Inhibition DME1024 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1024 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04348 XEO_CLAS Peptide DME1024 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 80 microM) DME1024 XEOTICID XEO04348 GENEFORM Protein DME1024 XEOTICID XEO04348 MOACRIVE Inhibition DME1024 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1024 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04349 XEO_CLAS Peptide DME1024 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 100 microM) DME1024 XEOTICID XEO04349 GENEFORM Protein DME1024 XEOTICID XEO04349 MOACRIVE Inhibition DME1024 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1024 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04399 XEO_CLAS Peptide DME1024 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 6.3 microM) DME1024 XEOTICID XEO04399 GENEFORM Protein DME1024 XEOTICID XEO04399 MOACRIVE Inhibition DME1024 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1024 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04426 XEO_CLAS Peptide DME1024 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 2 microM) DME1024 XEOTICID XEO04426 GENEFORM Protein DME1024 XEOTICID XEO04426 MOACRIVE Inhibition DME1024 XEOTICID XEO04468 XEO_NAME Papillosin DME1024 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04468 XEO_CLAS Peptide DME1024 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04468 GENEFORM Protein DME1024 XEOTICID XEO04468 MOACRIVE Inhibition DME1024 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1024 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04471 XEO_CLAS Peptide DME1024 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 1.6 microM) DME1024 XEOTICID XEO04471 GENEFORM Protein DME1024 XEOTICID XEO04471 MOACRIVE Inhibition DME1024 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1024 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04506 XEO_CLAS Peptide DME1024 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC > 20 microM) DME1024 XEOTICID XEO04506 GENEFORM Protein DME1024 XEOTICID XEO04506 MOACRIVE Inhibition DME1024 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1024 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04507 XEO_CLAS Peptide DME1024 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC > 40 microM) DME1024 XEOTICID XEO04507 GENEFORM Protein DME1024 XEOTICID XEO04507 MOACRIVE Inhibition DME1024 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1024 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04510 XEO_CLAS Peptide DME1024 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC > 50 microM) DME1024 XEOTICID XEO04510 GENEFORM Protein DME1024 XEOTICID XEO04510 MOACRIVE Inhibition DME1024 XEOTICID XEO04531 XEO_NAME Mollusca/molluscs/mollusks peptide 2 DME1024 XEOTICID XEO04531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04531 XEO_CLAS Peptide DME1024 XEOTICID XEO04531 DESCRIPT Mollusca/molluscs/mollusks peptide 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04531 GENEFORM Protein DME1024 XEOTICID XEO04531 MOACRIVE Inhibition DME1024 XEOTICID XEO04533 XEO_NAME Mollusca/molluscs/mollusks peptide 3 DME1024 XEOTICID XEO04533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04533 XEO_CLAS Peptide DME1024 XEOTICID XEO04533 DESCRIPT Mollusca/molluscs/mollusks peptide 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04533 GENEFORM Protein DME1024 XEOTICID XEO04533 MOACRIVE Inhibition DME1024 XEOTICID XEO04534 XEO_NAME Mollusca/molluscs/mollusks peptide 4 DME1024 XEOTICID XEO04534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04534 XEO_CLAS Peptide DME1024 XEOTICID XEO04534 DESCRIPT Mollusca/molluscs/mollusks peptide 4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04534 GENEFORM Protein DME1024 XEOTICID XEO04534 MOACRIVE Inhibition DME1024 XEOTICID XEO04535 XEO_NAME Mollusca/molluscs/mollusks peptide 5 DME1024 XEOTICID XEO04535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04535 XEO_CLAS Peptide DME1024 XEOTICID XEO04535 DESCRIPT Mollusca/molluscs/mollusks peptide 5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04535 GENEFORM Protein DME1024 XEOTICID XEO04535 MOACRIVE Inhibition DME1024 XEOTICID XEO04536 XEO_NAME Mollusca/molluscs/mollusks peptide 6 DME1024 XEOTICID XEO04536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04536 XEO_CLAS Peptide DME1024 XEOTICID XEO04536 DESCRIPT Mollusca/molluscs/mollusks peptide 6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04536 GENEFORM Protein DME1024 XEOTICID XEO04536 MOACRIVE Inhibition DME1024 XEOTICID XEO04537 XEO_NAME Mollusca/molluscs/mollusks peptide 7 DME1024 XEOTICID XEO04537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04537 XEO_CLAS Peptide DME1024 XEOTICID XEO04537 DESCRIPT Mollusca/molluscs/mollusks peptide 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04537 GENEFORM Protein DME1024 XEOTICID XEO04537 MOACRIVE Inhibition DME1024 XEOTICID XEO04538 XEO_NAME Mollusca/molluscs/mollusks peptide 8 DME1024 XEOTICID XEO04538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04538 XEO_CLAS Peptide DME1024 XEOTICID XEO04538 DESCRIPT Mollusca/molluscs/mollusks peptide 8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04538 GENEFORM Protein DME1024 XEOTICID XEO04538 MOACRIVE Inhibition DME1024 XEOTICID XEO04539 XEO_NAME Mollusca/molluscs/mollusks peptide 9 DME1024 XEOTICID XEO04539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04539 XEO_CLAS Peptide DME1024 XEOTICID XEO04539 DESCRIPT Mollusca/molluscs/mollusks peptide 9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04539 GENEFORM Protein DME1024 XEOTICID XEO04539 MOACRIVE Inhibition DME1024 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1024 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04548 XEO_CLAS Peptide DME1024 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 32000 ug/ml) DME1024 XEOTICID XEO04548 GENEFORM Protein DME1024 XEOTICID XEO04548 MOACRIVE Inhibition DME1024 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1024 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04549 XEO_CLAS Peptide DME1024 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 250-500 ug/ml) DME1024 XEOTICID XEO04549 GENEFORM Protein DME1024 XEOTICID XEO04549 MOACRIVE Inhibition DME1024 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1024 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04571 XEO_CLAS Peptide DME1024 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04571 GENEFORM Protein DME1024 XEOTICID XEO04571 MOACRIVE Inhibition DME1024 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1024 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04572 XEO_CLAS Peptide DME1024 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04572 GENEFORM Protein DME1024 XEOTICID XEO04572 MOACRIVE Inhibition DME1024 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1024 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04606 XEO_CLAS Peptide DME1024 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 2 microM) DME1024 XEOTICID XEO04606 GENEFORM Protein DME1024 XEOTICID XEO04606 MOACRIVE Inhibition DME1024 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1024 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04612 XEO_CLAS Peptide DME1024 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 2.5-5 microM) DME1024 XEOTICID XEO04612 GENEFORM Protein DME1024 XEOTICID XEO04612 MOACRIVE Inhibition DME1024 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1024 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04613 XEO_CLAS Peptide DME1024 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 2.5-5 microM) DME1024 XEOTICID XEO04613 GENEFORM Protein DME1024 XEOTICID XEO04613 MOACRIVE Inhibition DME1024 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1024 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04695 XEO_CLAS Peptide DME1024 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04695 GENEFORM Protein DME1024 XEOTICID XEO04695 MOACRIVE Inhibition DME1024 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1024 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04696 XEO_CLAS Peptide DME1024 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04696 GENEFORM Protein DME1024 XEOTICID XEO04696 MOACRIVE Inhibition DME1024 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1024 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04697 XEO_CLAS Peptide DME1024 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04697 GENEFORM Protein DME1024 XEOTICID XEO04697 MOACRIVE Inhibition DME1024 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1024 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04698 XEO_CLAS Peptide DME1024 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04698 GENEFORM Protein DME1024 XEOTICID XEO04698 MOACRIVE Inhibition DME1024 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1024 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04699 XEO_CLAS Peptide DME1024 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04699 GENEFORM Protein DME1024 XEOTICID XEO04699 MOACRIVE Inhibition DME1024 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1024 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04700 XEO_CLAS Peptide DME1024 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04700 GENEFORM Protein DME1024 XEOTICID XEO04700 MOACRIVE Inhibition DME1024 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1024 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04701 XEO_CLAS Peptide DME1024 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04701 GENEFORM Protein DME1024 XEOTICID XEO04701 MOACRIVE Inhibition DME1024 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1024 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04702 XEO_CLAS Peptide DME1024 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04702 GENEFORM Protein DME1024 XEOTICID XEO04702 MOACRIVE Inhibition DME1024 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1024 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04703 XEO_CLAS Peptide DME1024 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04703 GENEFORM Protein DME1024 XEOTICID XEO04703 MOACRIVE Inhibition DME1024 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1024 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04762 XEO_CLAS Peptide DME1024 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC > 25 microM) DME1024 XEOTICID XEO04762 GENEFORM Protein DME1024 XEOTICID XEO04762 MOACRIVE Inhibition DME1024 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1024 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04809 XEO_CLAS Peptide DME1024 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 10 microM) DME1024 XEOTICID XEO04809 GENEFORM Protein DME1024 XEOTICID XEO04809 MOACRIVE Inhibition DME1024 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1024 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04891 XEO_CLAS Peptide DME1024 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04891 GENEFORM Protein DME1024 XEOTICID XEO04891 MOACRIVE Inhibition DME1024 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1024 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04905 XEO_CLAS Peptide DME1024 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04905 GENEFORM Protein DME1024 XEOTICID XEO04905 MOACRIVE Inhibition DME1024 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1024 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04906 XEO_CLAS Peptide DME1024 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO04906 GENEFORM Protein DME1024 XEOTICID XEO04906 MOACRIVE Inhibition DME1024 XEOTICID XEO04917 XEO_NAME Scorpine DME1024 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04917 XEO_CLAS Peptide DME1024 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 10 microM) DME1024 XEOTICID XEO04917 GENEFORM Protein DME1024 XEOTICID XEO04917 MOACRIVE Inhibition DME1024 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1024 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04971 XEO_CLAS Peptide DME1024 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 50-100 microM) DME1024 XEOTICID XEO04971 GENEFORM Protein DME1024 XEOTICID XEO04971 MOACRIVE Inhibition DME1024 XEOTICID XEO04974 XEO_NAME Spinigerin DME1024 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04974 XEO_CLAS Peptide DME1024 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 50-100 microM) DME1024 XEOTICID XEO04974 GENEFORM Protein DME1024 XEOTICID XEO04974 MOACRIVE Inhibition DME1024 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1024 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO04995 XEO_CLAS Peptide DME1024 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 0.78-1.56 microM) DME1024 XEOTICID XEO04995 GENEFORM Protein DME1024 XEOTICID XEO04995 MOACRIVE Inhibition DME1024 XEOTICID XEO05020 XEO_NAME Tachycitin DME1024 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO05020 XEO_CLAS Peptide DME1024 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola DME1024 XEOTICID XEO05020 GENEFORM Protein DME1024 XEOTICID XEO05020 MOACRIVE Inhibition DME1024 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1024 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO05073 XEO_CLAS Peptide DME1024 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 80 microM) DME1024 XEOTICID XEO05073 GENEFORM Protein DME1024 XEOTICID XEO05073 MOACRIVE Inhibition DME1024 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1024 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO05075 XEO_CLAS Peptide DME1024 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 80 microM) DME1024 XEOTICID XEO05075 GENEFORM Protein DME1024 XEOTICID XEO05075 MOACRIVE Inhibition DME1024 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1024 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO05101 XEO_CLAS Peptide DME1024 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 31.2 ug/ml) DME1024 XEOTICID XEO05101 GENEFORM Protein DME1024 XEOTICID XEO05101 MOACRIVE Inhibition DME1024 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1024 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO05102 XEO_CLAS Peptide DME1024 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 35.1 ug/ml) DME1024 XEOTICID XEO05102 GENEFORM Protein DME1024 XEOTICID XEO05102 MOACRIVE Inhibition DME1024 XEOTICID XEO05120 XEO_NAME Thanatin DME1024 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO05120 XEO_CLAS Peptide DME1024 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 0.6-1.2 microM) DME1024 XEOTICID XEO05120 GENEFORM Protein DME1024 XEOTICID XEO05120 MOACRIVE Inhibition DME1024 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1024 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO05163 XEO_CLAS Peptide DME1024 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 12-25 ug/ml) DME1024 XEOTICID XEO05163 GENEFORM Protein DME1024 XEOTICID XEO05163 MOACRIVE Inhibition DME1024 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1024 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1024 XEOTICID XEO05220 XEO_CLAS Peptide DME1024 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella variicola (MIC = 2.5-5 microM) DME1024 XEOTICID XEO05220 GENEFORM Protein DME1024 XEOTICID XEO05220 MOACRIVE Inhibition DME1028 DME___ID DME1028 DME1028 DME_NAME Chloramphenicolase (chlR) DME1028 SPESNAME Escherichia coli DME1028 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1028 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00117 GENEFORM Protein DME1028 XEOTICID XEO00117 MOACRIVE Inhibition DME1028 XEOTICID XEO00122 XEO_NAME Amikacin DME1028 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00122 GENEFORM Protein DME1028 XEOTICID XEO00122 MOACRIVE Inhibition DME1028 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1028 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00136 GENEFORM Protein DME1028 XEOTICID XEO00136 MOACRIVE Inhibition DME1028 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1028 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00237 GENEFORM Protein DME1028 XEOTICID XEO00237 MOACRIVE Inhibition DME1028 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1028 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00349 GENEFORM Protein DME1028 XEOTICID XEO00349 MOACRIVE Inhibition DME1028 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1028 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00425 GENEFORM Protein DME1028 XEOTICID XEO00425 MOACRIVE Inhibition DME1028 XEOTICID XEO00439 XEO_NAME Daidzein DME1028 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00439 GENEFORM Protein DME1028 XEOTICID XEO00439 MOACRIVE Inhibition DME1028 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1028 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00460 GENEFORM Protein DME1028 XEOTICID XEO00460 MOACRIVE Inhibition DME1028 XEOTICID XEO00487 XEO_NAME Thymol DME1028 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00487 GENEFORM Protein DME1028 XEOTICID XEO00487 MOACRIVE Inhibition DME1028 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1028 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00511 GENEFORM Protein DME1028 XEOTICID XEO00511 MOACRIVE Inhibition DME1028 XEOTICID XEO00537 XEO_NAME Luteolin DME1028 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1028 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00537 GENEFORM Protein DME1028 XEOTICID XEO00537 MOACRIVE Inhibition DME1028 XEOTICID XEO00538 XEO_NAME Quercetin DME1028 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1028 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00538 GENEFORM Protein DME1028 XEOTICID XEO00538 MOACRIVE Inhibition DME1028 XEOTICID XEO00547 XEO_NAME Vitamin E DME1028 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1028 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00547 GENEFORM Protein DME1028 XEOTICID XEO00547 MOACRIVE Inhibition DME1028 XEOTICID XEO00557 XEO_NAME Genistein DME1028 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1028 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00557 GENEFORM Protein DME1028 XEOTICID XEO00557 MOACRIVE Inhibition DME1028 XEOTICID XEO00566 XEO_NAME Guaiacol DME1028 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1028 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00566 GENEFORM Protein DME1028 XEOTICID XEO00566 MOACRIVE Inhibition DME1028 XEOTICID XEO00568 XEO_NAME Resveratrol DME1028 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1028 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00568 GENEFORM Protein DME1028 XEOTICID XEO00568 MOACRIVE Inhibition DME1028 XEOTICID XEO00573 XEO_NAME Naringenin DME1028 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1028 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00573 GENEFORM Protein DME1028 XEOTICID XEO00573 MOACRIVE Inhibition DME1028 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1028 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1028 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00574 GENEFORM Protein DME1028 XEOTICID XEO00574 MOACRIVE Inhibition DME1028 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1028 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1028 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00611 GENEFORM Protein DME1028 XEOTICID XEO00611 MOACRIVE Inhibition DME1028 XEOTICID XEO00621 XEO_NAME Chitosan DME1028 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1028 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00621 GENEFORM Protein DME1028 XEOTICID XEO00621 MOACRIVE Inhibition DME1028 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1028 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1028 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00646 GENEFORM Protein DME1028 XEOTICID XEO00646 MOACRIVE Inhibition DME1028 XEOTICID XEO00683 XEO_NAME Curcumin DME1028 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1028 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00683 GENEFORM Protein DME1028 XEOTICID XEO00683 MOACRIVE Inhibition DME1028 XEOTICID XEO00727 XEO_NAME Vanillin DME1028 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1028 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00727 GENEFORM Protein DME1028 XEOTICID XEO00727 MOACRIVE Inhibition DME1028 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1028 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1028 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00730 GENEFORM Protein DME1028 XEOTICID XEO00730 MOACRIVE Inhibition DME1028 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1028 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO00782 XEO_CLAS Natural Product DME1028 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00782 GENEFORM Protein DME1028 XEOTICID XEO00782 MOACRIVE Inhibition DME1028 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1028 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1028 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00866 GENEFORM Protein DME1028 XEOTICID XEO00866 MOACRIVE Inhibition DME1028 XEOTICID XEO00878 XEO_NAME Chrysin DME1028 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO00878 XEO_CLAS Natural Product DME1028 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00878 GENEFORM Protein DME1028 XEOTICID XEO00878 MOACRIVE Inhibition DME1028 XEOTICID XEO00879 XEO_NAME Coumarin DME1028 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1028 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1028 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00879 GENEFORM Protein DME1028 XEOTICID XEO00879 MOACRIVE Inhibition DME1028 XEOTICID XEO00883 XEO_NAME Phloretin DME1028 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO00883 XEO_CLAS Natural Product DME1028 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00883 GENEFORM Protein DME1028 XEOTICID XEO00883 MOACRIVE Inhibition DME1028 XEOTICID XEO00885 XEO_NAME Eugenol DME1028 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1028 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO00885 GENEFORM Protein DME1028 XEOTICID XEO00885 MOACRIVE Inhibition DME1028 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1028 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1028 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1028 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01032 GENEFORM Protein DME1028 XEOTICID XEO01032 MOACRIVE Inhibition DME1028 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1028 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01174 XEO_CLAS Natural Product DME1028 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01174 GENEFORM Protein DME1028 XEOTICID XEO01174 MOACRIVE Inhibition DME1028 XEOTICID XEO01203 XEO_NAME Apigenin DME1028 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01203 XEO_CLAS Natural Product DME1028 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01203 GENEFORM Protein DME1028 XEOTICID XEO01203 MOACRIVE Inhibition DME1028 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1028 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1028 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1028 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01232 GENEFORM Protein DME1028 XEOTICID XEO01232 MOACRIVE Inhibition DME1028 XEOTICID XEO01237 XEO_NAME Carvacrol DME1028 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1028 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01237 GENEFORM Protein DME1028 XEOTICID XEO01237 MOACRIVE Inhibition DME1028 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1028 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1028 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01287 GENEFORM Protein DME1028 XEOTICID XEO01287 MOACRIVE Inhibition DME1028 XEOTICID XEO01291 XEO_NAME Esculetin DME1028 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1028 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01291 GENEFORM Protein DME1028 XEOTICID XEO01291 MOACRIVE Inhibition DME1028 XEOTICID XEO01304 XEO_NAME Flavone DME1028 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01304 XEO_CLAS Natural Product DME1028 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01304 GENEFORM Protein DME1028 XEOTICID XEO01304 MOACRIVE Inhibition DME1028 XEOTICID XEO01309 XEO_NAME Gallic acid DME1028 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01309 XEO_CLAS Natural Product DME1028 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01309 GENEFORM Protein DME1028 XEOTICID XEO01309 MOACRIVE Inhibition DME1028 XEOTICID XEO01340 XEO_NAME Imperatorin DME1028 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01340 XEO_CLAS Natural Product DME1028 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01340 GENEFORM Protein DME1028 XEOTICID XEO01340 MOACRIVE Inhibition DME1028 XEOTICID XEO01353 XEO_NAME Kaempferol DME1028 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1028 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1028 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01353 GENEFORM Protein DME1028 XEOTICID XEO01353 MOACRIVE Inhibition DME1028 XEOTICID XEO01366 XEO_NAME Linalool DME1028 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01366 XEO_CLAS Natural Product DME1028 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01366 GENEFORM Protein DME1028 XEOTICID XEO01366 MOACRIVE Inhibition DME1028 XEOTICID XEO01391 XEO_NAME Naringin DME1028 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01391 XEO_CLAS Natural Product DME1028 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01391 GENEFORM Protein DME1028 XEOTICID XEO01391 MOACRIVE Inhibition DME1028 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1028 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1028 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01420 GENEFORM Protein DME1028 XEOTICID XEO01420 MOACRIVE Inhibition DME1028 XEOTICID XEO01463 XEO_NAME Rutin DME1028 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01463 XEO_CLAS Natural Product DME1028 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01463 GENEFORM Protein DME1028 XEOTICID XEO01463 MOACRIVE Inhibition DME1028 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1028 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1028 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01496 GENEFORM Protein DME1028 XEOTICID XEO01496 MOACRIVE Inhibition DME1028 XEOTICID XEO01512 XEO_NAME Zinc DME1028 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1028 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1028 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01512 GENEFORM Protein DME1028 XEOTICID XEO01512 MOACRIVE Inhibition DME1028 XEOTICID XEO01527 XEO_NAME Bergamottin DME1028 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01527 XEO_CLAS Natural Product DME1028 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01527 GENEFORM Protein DME1028 XEOTICID XEO01527 MOACRIVE Inhibition DME1028 XEOTICID XEO01531 XEO_NAME Clove oil DME1028 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01531 XEO_CLAS Natural Product DME1028 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01531 GENEFORM Protein DME1028 XEOTICID XEO01531 MOACRIVE Inhibition DME1028 XEOTICID XEO01559 XEO_NAME Limonene DME1028 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01559 XEO_CLAS Natural Product DME1028 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01559 GENEFORM Protein DME1028 XEOTICID XEO01559 MOACRIVE Inhibition DME1028 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1028 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01563 XEO_CLAS Natural Product DME1028 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01563 GENEFORM Protein DME1028 XEOTICID XEO01563 MOACRIVE Inhibition DME1028 XEOTICID XEO01566 XEO_NAME Nobiletin DME1028 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01566 XEO_CLAS Natural Product DME1028 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01566 GENEFORM Protein DME1028 XEOTICID XEO01566 MOACRIVE Inhibition DME1028 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1028 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01778 XEO_CLAS Natural Product DME1028 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01778 GENEFORM Protein DME1028 XEOTICID XEO01778 MOACRIVE Inhibition DME1028 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1028 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01779 XEO_CLAS Peptide DME1028 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 128 microM) DME1028 XEOTICID XEO01779 GENEFORM Protein DME1028 XEOTICID XEO01779 MOACRIVE Inhibition DME1028 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1028 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01810 XEO_CLAS Peptide DME1028 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.0 microM) DME1028 XEOTICID XEO01810 GENEFORM Protein DME1028 XEOTICID XEO01810 MOACRIVE Inhibition DME1028 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1028 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01811 XEO_CLAS Peptide DME1028 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 microM) DME1028 XEOTICID XEO01811 GENEFORM Protein DME1028 XEOTICID XEO01811 MOACRIVE Inhibition DME1028 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1028 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01812 XEO_CLAS Peptide DME1028 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10.4 microM) DME1028 XEOTICID XEO01812 GENEFORM Protein DME1028 XEOTICID XEO01812 MOACRIVE Inhibition DME1028 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1028 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01813 XEO_CLAS Peptide DME1028 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.1 microM) DME1028 XEOTICID XEO01813 GENEFORM Protein DME1028 XEOTICID XEO01813 MOACRIVE Inhibition DME1028 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1028 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01814 XEO_CLAS Peptide DME1028 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.5 microM) DME1028 XEOTICID XEO01814 GENEFORM Protein DME1028 XEOTICID XEO01814 MOACRIVE Inhibition DME1028 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1028 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01815 XEO_CLAS Peptide DME1028 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9.8 microM) DME1028 XEOTICID XEO01815 GENEFORM Protein DME1028 XEOTICID XEO01815 MOACRIVE Inhibition DME1028 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1028 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01816 XEO_CLAS Peptide DME1028 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO01816 GENEFORM Protein DME1028 XEOTICID XEO01816 MOACRIVE Inhibition DME1028 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1028 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01817 XEO_CLAS Peptide DME1028 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.0 microM) DME1028 XEOTICID XEO01817 GENEFORM Protein DME1028 XEOTICID XEO01817 MOACRIVE Inhibition DME1028 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1028 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01818 XEO_CLAS Peptide DME1028 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4.0 microM) DME1028 XEOTICID XEO01818 GENEFORM Protein DME1028 XEOTICID XEO01818 MOACRIVE Inhibition DME1028 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1028 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01819 XEO_CLAS Peptide DME1028 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO01819 GENEFORM Protein DME1028 XEOTICID XEO01819 MOACRIVE Inhibition DME1028 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1028 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01820 XEO_CLAS Peptide DME1028 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO01820 GENEFORM Protein DME1028 XEOTICID XEO01820 MOACRIVE Inhibition DME1028 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1028 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01821 XEO_CLAS Peptide DME1028 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO01821 GENEFORM Protein DME1028 XEOTICID XEO01821 MOACRIVE Inhibition DME1028 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1028 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01822 XEO_CLAS Peptide DME1028 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 microM) DME1028 XEOTICID XEO01822 GENEFORM Protein DME1028 XEOTICID XEO01822 MOACRIVE Inhibition DME1028 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1028 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01823 XEO_CLAS Peptide DME1028 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO01823 GENEFORM Protein DME1028 XEOTICID XEO01823 MOACRIVE Inhibition DME1028 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1028 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01824 XEO_CLAS Peptide DME1028 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO01824 GENEFORM Protein DME1028 XEOTICID XEO01824 MOACRIVE Inhibition DME1028 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1028 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01825 XEO_CLAS Peptide DME1028 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25.0 microM) DME1028 XEOTICID XEO01825 GENEFORM Protein DME1028 XEOTICID XEO01825 MOACRIVE Inhibition DME1028 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1028 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01827 XEO_CLAS Peptide DME1028 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.12-6.25 microM) DME1028 XEOTICID XEO01827 GENEFORM Protein DME1028 XEOTICID XEO01827 MOACRIVE Inhibition DME1028 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1028 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1028 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1028 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01829 GENEFORM Protein DME1028 XEOTICID XEO01829 MOACRIVE Inhibition DME1028 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1028 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01927 XEO_CLAS Peptide DME1028 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 ug/ml) DME1028 XEOTICID XEO01927 GENEFORM Protein DME1028 XEOTICID XEO01927 MOACRIVE Inhibition DME1028 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1028 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01945 XEO_CLAS Peptide DME1028 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.1 microM) DME1028 XEOTICID XEO01945 GENEFORM Protein DME1028 XEOTICID XEO01945 MOACRIVE Inhibition DME1028 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1028 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01946 XEO_CLAS Peptide DME1028 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.2 microM) DME1028 XEOTICID XEO01946 GENEFORM Protein DME1028 XEOTICID XEO01946 MOACRIVE Inhibition DME1028 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1028 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO01947 XEO_CLAS Natural Product DME1028 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01947 GENEFORM Protein DME1028 XEOTICID XEO01947 MOACRIVE Inhibition DME1028 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1028 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1028 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1028 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01950 GENEFORM Protein DME1028 XEOTICID XEO01950 MOACRIVE Inhibition DME1028 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1028 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1028 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1028 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01961 GENEFORM Protein DME1028 XEOTICID XEO01961 MOACRIVE Inhibition DME1028 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1028 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1028 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1028 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO01966 GENEFORM Protein DME1028 XEOTICID XEO01966 MOACRIVE Inhibition DME1028 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1028 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01996 XEO_CLAS Peptide DME1028 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.7 microM) DME1028 XEOTICID XEO01996 GENEFORM Protein DME1028 XEOTICID XEO01996 MOACRIVE Inhibition DME1028 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1028 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01997 XEO_CLAS Peptide DME1028 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.9 microM) DME1028 XEOTICID XEO01997 GENEFORM Protein DME1028 XEOTICID XEO01997 MOACRIVE Inhibition DME1028 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1028 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01998 XEO_CLAS Peptide DME1028 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO01998 GENEFORM Protein DME1028 XEOTICID XEO01998 MOACRIVE Inhibition DME1028 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1028 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO01999 XEO_CLAS Peptide DME1028 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.5 microM) DME1028 XEOTICID XEO01999 GENEFORM Protein DME1028 XEOTICID XEO01999 MOACRIVE Inhibition DME1028 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1028 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02013 XEO_CLAS Peptide DME1028 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02013 GENEFORM Protein DME1028 XEOTICID XEO02013 MOACRIVE Inhibition DME1028 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1028 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02032 XEO_CLAS Natural Product DME1028 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02032 GENEFORM Protein DME1028 XEOTICID XEO02032 MOACRIVE Inhibition DME1028 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1028 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02033 XEO_CLAS Natural Product DME1028 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02033 GENEFORM Protein DME1028 XEOTICID XEO02033 MOACRIVE Inhibition DME1028 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1028 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02079 XEO_CLAS Natural Product DME1028 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02079 GENEFORM Protein DME1028 XEOTICID XEO02079 MOACRIVE Inhibition DME1028 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1028 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1028 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02085 GENEFORM Protein DME1028 XEOTICID XEO02085 MOACRIVE Inhibition DME1028 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1028 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02111 XEO_CLAS Peptide DME1028 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2-4 ug/ml) DME1028 XEOTICID XEO02111 GENEFORM Protein DME1028 XEOTICID XEO02111 MOACRIVE Inhibition DME1028 XEOTICID XEO02113 XEO_NAME Abaecin DME1028 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02113 XEO_CLAS Peptide DME1028 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02113 GENEFORM Protein DME1028 XEOTICID XEO02113 MOACRIVE Inhibition DME1028 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1028 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02114 XEO_CLAS Peptide DME1028 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-25 ug/ml) DME1028 XEOTICID XEO02114 GENEFORM Protein DME1028 XEOTICID XEO02114 MOACRIVE Inhibition DME1028 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1028 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02115 XEO_CLAS Peptide DME1028 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02115 GENEFORM Protein DME1028 XEOTICID XEO02115 MOACRIVE Inhibition DME1028 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1028 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02117 XEO_CLAS Peptide DME1028 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02117 GENEFORM Protein DME1028 XEOTICID XEO02117 MOACRIVE Inhibition DME1028 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1028 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02118 XEO_CLAS Peptide DME1028 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02118 GENEFORM Protein DME1028 XEOTICID XEO02118 MOACRIVE Inhibition DME1028 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1028 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02119 XEO_CLAS Peptide DME1028 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02119 GENEFORM Protein DME1028 XEOTICID XEO02119 MOACRIVE Inhibition DME1028 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1028 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02120 XEO_CLAS Peptide DME1028 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02120 GENEFORM Protein DME1028 XEOTICID XEO02120 MOACRIVE Inhibition DME1028 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1028 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02121 XEO_CLAS Peptide DME1028 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02121 GENEFORM Protein DME1028 XEOTICID XEO02121 MOACRIVE Inhibition DME1028 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1028 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02122 XEO_CLAS Peptide DME1028 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 ug/ml) DME1028 XEOTICID XEO02122 GENEFORM Protein DME1028 XEOTICID XEO02122 MOACRIVE Inhibition DME1028 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1028 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02130 XEO_CLAS Peptide DME1028 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.7 microM) DME1028 XEOTICID XEO02130 GENEFORM Protein DME1028 XEOTICID XEO02130 MOACRIVE Inhibition DME1028 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1028 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02131 XEO_CLAS Peptide DME1028 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.3 microM) DME1028 XEOTICID XEO02131 GENEFORM Protein DME1028 XEOTICID XEO02131 MOACRIVE Inhibition DME1028 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1028 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02132 XEO_CLAS Peptide DME1028 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.5 microM) DME1028 XEOTICID XEO02132 GENEFORM Protein DME1028 XEOTICID XEO02132 MOACRIVE Inhibition DME1028 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1028 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02136 XEO_CLAS Peptide DME1028 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 ug/ml) DME1028 XEOTICID XEO02136 GENEFORM Protein DME1028 XEOTICID XEO02136 MOACRIVE Inhibition DME1028 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1028 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02147 XEO_CLAS Peptide DME1028 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 382 ug/ml) DME1028 XEOTICID XEO02147 GENEFORM Protein DME1028 XEOTICID XEO02147 MOACRIVE Inhibition DME1028 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1028 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02149 XEO_CLAS Peptide DME1028 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 47.35 microM) DME1028 XEOTICID XEO02149 GENEFORM Protein DME1028 XEOTICID XEO02149 MOACRIVE Inhibition DME1028 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1028 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02164 XEO_CLAS Peptide DME1028 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02164 GENEFORM Protein DME1028 XEOTICID XEO02164 MOACRIVE Inhibition DME1028 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1028 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02165 XEO_CLAS Peptide DME1028 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02165 GENEFORM Protein DME1028 XEOTICID XEO02165 MOACRIVE Inhibition DME1028 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1028 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02166 XEO_CLAS Peptide DME1028 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02166 GENEFORM Protein DME1028 XEOTICID XEO02166 MOACRIVE Inhibition DME1028 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1028 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02167 XEO_CLAS Peptide DME1028 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02167 GENEFORM Protein DME1028 XEOTICID XEO02167 MOACRIVE Inhibition DME1028 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1028 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02168 XEO_CLAS Peptide DME1028 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02168 GENEFORM Protein DME1028 XEOTICID XEO02168 MOACRIVE Inhibition DME1028 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1028 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02169 XEO_CLAS Peptide DME1028 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02169 GENEFORM Protein DME1028 XEOTICID XEO02169 MOACRIVE Inhibition DME1028 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1028 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02170 XEO_CLAS Peptide DME1028 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.4 microM) DME1028 XEOTICID XEO02170 GENEFORM Protein DME1028 XEOTICID XEO02170 MOACRIVE Inhibition DME1028 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1028 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02175 XEO_CLAS Natural Product DME1028 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02175 GENEFORM Protein DME1028 XEOTICID XEO02175 MOACRIVE Inhibition DME1028 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1028 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02177 XEO_CLAS Peptide DME1028 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO02177 GENEFORM Protein DME1028 XEOTICID XEO02177 MOACRIVE Inhibition DME1028 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1028 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02178 XEO_CLAS Peptide DME1028 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO02178 GENEFORM Protein DME1028 XEOTICID XEO02178 MOACRIVE Inhibition DME1028 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1028 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02179 XEO_CLAS Peptide DME1028 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO02179 GENEFORM Protein DME1028 XEOTICID XEO02179 MOACRIVE Inhibition DME1028 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1028 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02180 XEO_CLAS Peptide DME1028 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 214 microM) DME1028 XEOTICID XEO02180 GENEFORM Protein DME1028 XEOTICID XEO02180 MOACRIVE Inhibition DME1028 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1028 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02181 XEO_CLAS Peptide DME1028 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 217 microM) DME1028 XEOTICID XEO02181 GENEFORM Protein DME1028 XEOTICID XEO02181 MOACRIVE Inhibition DME1028 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1028 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02183 XEO_CLAS Peptide DME1028 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 38.4 microM) DME1028 XEOTICID XEO02183 GENEFORM Protein DME1028 XEOTICID XEO02183 MOACRIVE Inhibition DME1028 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1028 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02185 XEO_CLAS Peptide DME1028 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 microM) DME1028 XEOTICID XEO02185 GENEFORM Protein DME1028 XEOTICID XEO02185 MOACRIVE Inhibition DME1028 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1028 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02187 GENEFORM Protein DME1028 XEOTICID XEO02187 MOACRIVE Inhibition DME1028 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1028 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02191 XEO_CLAS Peptide DME1028 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02191 GENEFORM Protein DME1028 XEOTICID XEO02191 MOACRIVE Inhibition DME1028 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1028 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02192 XEO_CLAS Peptide DME1028 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.50 ug/ml) DME1028 XEOTICID XEO02192 GENEFORM Protein DME1028 XEOTICID XEO02192 MOACRIVE Inhibition DME1028 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1028 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02193 XEO_CLAS Peptide DME1028 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02193 GENEFORM Protein DME1028 XEOTICID XEO02193 MOACRIVE Inhibition DME1028 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1028 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02194 XEO_CLAS Peptide DME1028 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02194 GENEFORM Protein DME1028 XEOTICID XEO02194 MOACRIVE Inhibition DME1028 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1028 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02195 XEO_CLAS Peptide DME1028 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.00 ug/ml) DME1028 XEOTICID XEO02195 GENEFORM Protein DME1028 XEOTICID XEO02195 MOACRIVE Inhibition DME1028 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1028 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02197 XEO_CLAS Peptide DME1028 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02197 GENEFORM Protein DME1028 XEOTICID XEO02197 MOACRIVE Inhibition DME1028 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1028 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02200 XEO_CLAS Peptide DME1028 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 ug/ml) DME1028 XEOTICID XEO02200 GENEFORM Protein DME1028 XEOTICID XEO02200 MOACRIVE Inhibition DME1028 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1028 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02201 XEO_CLAS Peptide DME1028 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 ug/ml) DME1028 XEOTICID XEO02201 GENEFORM Protein DME1028 XEOTICID XEO02201 MOACRIVE Inhibition DME1028 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1028 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02202 XEO_CLAS Peptide DME1028 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO02202 GENEFORM Protein DME1028 XEOTICID XEO02202 MOACRIVE Inhibition DME1028 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1028 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02203 XEO_CLAS Peptide DME1028 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 microM) DME1028 XEOTICID XEO02203 GENEFORM Protein DME1028 XEOTICID XEO02203 MOACRIVE Inhibition DME1028 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1028 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02207 XEO_CLAS Peptide DME1028 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.78 ug/ml) DME1028 XEOTICID XEO02207 GENEFORM Protein DME1028 XEOTICID XEO02207 MOACRIVE Inhibition DME1028 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1028 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02208 XEO_CLAS Peptide DME1028 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.13 ug/ml) DME1028 XEOTICID XEO02208 GENEFORM Protein DME1028 XEOTICID XEO02208 MOACRIVE Inhibition DME1028 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1028 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02209 XEO_CLAS Peptide DME1028 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.56 ug/ml) DME1028 XEOTICID XEO02209 GENEFORM Protein DME1028 XEOTICID XEO02209 MOACRIVE Inhibition DME1028 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1028 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02210 XEO_CLAS Peptide DME1028 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 ug/ml) DME1028 XEOTICID XEO02210 GENEFORM Protein DME1028 XEOTICID XEO02210 MOACRIVE Inhibition DME1028 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1028 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02211 XEO_CLAS Peptide DME1028 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25 ug/ml) DME1028 XEOTICID XEO02211 GENEFORM Protein DME1028 XEOTICID XEO02211 MOACRIVE Inhibition DME1028 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1028 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02212 XEO_CLAS Peptide DME1028 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.13 ug/ml) DME1028 XEOTICID XEO02212 GENEFORM Protein DME1028 XEOTICID XEO02212 MOACRIVE Inhibition DME1028 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1028 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02213 XEO_CLAS Peptide DME1028 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.13 ug/ml) DME1028 XEOTICID XEO02213 GENEFORM Protein DME1028 XEOTICID XEO02213 MOACRIVE Inhibition DME1028 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1028 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02214 XEO_CLAS Peptide DME1028 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02214 GENEFORM Protein DME1028 XEOTICID XEO02214 MOACRIVE Inhibition DME1028 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1028 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02215 XEO_CLAS Peptide DME1028 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 ug/ml) DME1028 XEOTICID XEO02215 GENEFORM Protein DME1028 XEOTICID XEO02215 MOACRIVE Inhibition DME1028 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1028 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02216 XEO_CLAS Peptide DME1028 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 126 ug/ml) DME1028 XEOTICID XEO02216 GENEFORM Protein DME1028 XEOTICID XEO02216 MOACRIVE Inhibition DME1028 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1028 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02217 XEO_CLAS Peptide DME1028 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 200 ug/ml) DME1028 XEOTICID XEO02217 GENEFORM Protein DME1028 XEOTICID XEO02217 MOACRIVE Inhibition DME1028 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1028 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02218 XEO_CLAS Peptide DME1028 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 200 ug/ml) DME1028 XEOTICID XEO02218 GENEFORM Protein DME1028 XEOTICID XEO02218 MOACRIVE Inhibition DME1028 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1028 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02219 XEO_CLAS Peptide DME1028 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 200 ug/ml) DME1028 XEOTICID XEO02219 GENEFORM Protein DME1028 XEOTICID XEO02219 MOACRIVE Inhibition DME1028 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1028 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02220 XEO_CLAS Peptide DME1028 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 23.5 ug/ml) DME1028 XEOTICID XEO02220 GENEFORM Protein DME1028 XEOTICID XEO02220 MOACRIVE Inhibition DME1028 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1028 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02221 XEO_CLAS Peptide DME1028 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20.2 ug/ml) DME1028 XEOTICID XEO02221 GENEFORM Protein DME1028 XEOTICID XEO02221 MOACRIVE Inhibition DME1028 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1028 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02222 XEO_CLAS Peptide DME1028 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30.5 ug/ml) DME1028 XEOTICID XEO02222 GENEFORM Protein DME1028 XEOTICID XEO02222 MOACRIVE Inhibition DME1028 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1028 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02223 XEO_CLAS Peptide DME1028 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.2 ug/ml) DME1028 XEOTICID XEO02223 GENEFORM Protein DME1028 XEOTICID XEO02223 MOACRIVE Inhibition DME1028 XEOTICID XEO02224 XEO_NAME Androctonin DME1028 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02224 XEO_CLAS Peptide DME1028 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02224 GENEFORM Protein DME1028 XEOTICID XEO02224 MOACRIVE Inhibition DME1028 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1028 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02225 XEO_CLAS Peptide DME1028 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02225 GENEFORM Protein DME1028 XEOTICID XEO02225 MOACRIVE Inhibition DME1028 XEOTICID XEO02226 XEO_NAME Andropin DME1028 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02226 XEO_CLAS Peptide DME1028 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 140 microM) DME1028 XEOTICID XEO02226 GENEFORM Protein DME1028 XEOTICID XEO02226 MOACRIVE Inhibition DME1028 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1028 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02230 XEO_CLAS Peptide DME1028 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.05-0.1 microM) DME1028 XEOTICID XEO02230 GENEFORM Protein DME1028 XEOTICID XEO02230 MOACRIVE Inhibition DME1028 XEOTICID XEO02232 XEO_NAME Anoplin DME1028 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02232 XEO_CLAS Peptide DME1028 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 13 ug/ml) DME1028 XEOTICID XEO02232 GENEFORM Protein DME1028 XEOTICID XEO02232 MOACRIVE Inhibition DME1028 XEOTICID XEO02233 XEO_NAME Antapin DME1028 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02233 XEO_CLAS Peptide DME1028 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02233 GENEFORM Protein DME1028 XEOTICID XEO02233 MOACRIVE Inhibition DME1028 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1028 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02236 XEO_CLAS Peptide DME1028 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02236 GENEFORM Protein DME1028 XEOTICID XEO02236 MOACRIVE Inhibition DME1028 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1028 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02239 XEO_CLAS Peptide DME1028 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 250 microM) DME1028 XEOTICID XEO02239 GENEFORM Protein DME1028 XEOTICID XEO02239 MOACRIVE Inhibition DME1028 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1028 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02240 XEO_CLAS Peptide DME1028 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 microM) DME1028 XEOTICID XEO02240 GENEFORM Protein DME1028 XEOTICID XEO02240 MOACRIVE Inhibition DME1028 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1028 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02241 XEO_CLAS Peptide DME1028 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02241 GENEFORM Protein DME1028 XEOTICID XEO02241 MOACRIVE Inhibition DME1028 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1028 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02242 XEO_CLAS Peptide DME1028 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO02242 GENEFORM Protein DME1028 XEOTICID XEO02242 MOACRIVE Inhibition DME1028 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1028 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02243 XEO_CLAS Peptide DME1028 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 microM) DME1028 XEOTICID XEO02243 GENEFORM Protein DME1028 XEOTICID XEO02243 MOACRIVE Inhibition DME1028 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1028 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02244 XEO_CLAS Peptide DME1028 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1 microM) DME1028 XEOTICID XEO02244 GENEFORM Protein DME1028 XEOTICID XEO02244 MOACRIVE Inhibition DME1028 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1028 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02245 XEO_CLAS Peptide DME1028 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02245 GENEFORM Protein DME1028 XEOTICID XEO02245 MOACRIVE Inhibition DME1028 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1028 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02246 XEO_CLAS Peptide DME1028 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 microM) DME1028 XEOTICID XEO02246 GENEFORM Protein DME1028 XEOTICID XEO02246 MOACRIVE Inhibition DME1028 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1028 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02247 XEO_CLAS Peptide DME1028 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02247 GENEFORM Protein DME1028 XEOTICID XEO02247 MOACRIVE Inhibition DME1028 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1028 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02248 XEO_CLAS Peptide DME1028 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.3 microM) DME1028 XEOTICID XEO02248 GENEFORM Protein DME1028 XEOTICID XEO02248 MOACRIVE Inhibition DME1028 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1028 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02253 XEO_CLAS Peptide DME1028 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02253 GENEFORM Protein DME1028 XEOTICID XEO02253 MOACRIVE Inhibition DME1028 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1028 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02258 XEO_CLAS Peptide DME1028 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 150 microM) DME1028 XEOTICID XEO02258 GENEFORM Protein DME1028 XEOTICID XEO02258 MOACRIVE Inhibition DME1028 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1028 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02261 XEO_CLAS Peptide DME1028 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 82 ug/ml) DME1028 XEOTICID XEO02261 GENEFORM Protein DME1028 XEOTICID XEO02261 MOACRIVE Inhibition DME1028 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1028 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02263 XEO_CLAS Peptide DME1028 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO02263 GENEFORM Protein DME1028 XEOTICID XEO02263 MOACRIVE Inhibition DME1028 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1028 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02266 XEO_CLAS Peptide DME1028 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 120 microM) DME1028 XEOTICID XEO02266 GENEFORM Protein DME1028 XEOTICID XEO02266 MOACRIVE Inhibition DME1028 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1028 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02268 XEO_CLAS Peptide DME1028 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 170 ug/ml) DME1028 XEOTICID XEO02268 GENEFORM Protein DME1028 XEOTICID XEO02268 MOACRIVE Inhibition DME1028 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1028 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02270 XEO_CLAS Peptide DME1028 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 microM) DME1028 XEOTICID XEO02270 GENEFORM Protein DME1028 XEOTICID XEO02270 MOACRIVE Inhibition DME1028 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1028 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02271 XEO_CLAS Peptide DME1028 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 302 ug/ml) DME1028 XEOTICID XEO02271 GENEFORM Protein DME1028 XEOTICID XEO02271 MOACRIVE Inhibition DME1028 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1028 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02273 XEO_CLAS Peptide DME1028 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 18 microM) DME1028 XEOTICID XEO02273 GENEFORM Protein DME1028 XEOTICID XEO02273 MOACRIVE Inhibition DME1028 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1028 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02274 XEO_CLAS Peptide DME1028 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO02274 GENEFORM Protein DME1028 XEOTICID XEO02274 MOACRIVE Inhibition DME1028 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1028 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02275 XEO_CLAS Peptide DME1028 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 microM) DME1028 XEOTICID XEO02275 GENEFORM Protein DME1028 XEOTICID XEO02275 MOACRIVE Inhibition DME1028 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1028 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02276 XEO_CLAS Peptide DME1028 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 microM) DME1028 XEOTICID XEO02276 GENEFORM Protein DME1028 XEOTICID XEO02276 MOACRIVE Inhibition DME1028 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1028 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02280 XEO_CLAS Peptide DME1028 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02280 GENEFORM Protein DME1028 XEOTICID XEO02280 MOACRIVE Inhibition DME1028 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1028 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02281 XEO_CLAS Peptide DME1028 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02281 GENEFORM Protein DME1028 XEOTICID XEO02281 MOACRIVE Inhibition DME1028 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1028 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02283 XEO_CLAS Peptide DME1028 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 ug/ml) DME1028 XEOTICID XEO02283 GENEFORM Protein DME1028 XEOTICID XEO02283 MOACRIVE Inhibition DME1028 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1028 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02284 XEO_CLAS Peptide DME1028 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50.4 microM) DME1028 XEOTICID XEO02284 GENEFORM Protein DME1028 XEOTICID XEO02284 MOACRIVE Inhibition DME1028 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1028 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02285 XEO_CLAS Peptide DME1028 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50.4 microM) DME1028 XEOTICID XEO02285 GENEFORM Protein DME1028 XEOTICID XEO02285 MOACRIVE Inhibition DME1028 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1028 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02286 XEO_CLAS Peptide DME1028 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50.4 microM) DME1028 XEOTICID XEO02286 GENEFORM Protein DME1028 XEOTICID XEO02286 MOACRIVE Inhibition DME1028 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1028 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02287 XEO_CLAS Peptide DME1028 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50.4 microM) DME1028 XEOTICID XEO02287 GENEFORM Protein DME1028 XEOTICID XEO02287 MOACRIVE Inhibition DME1028 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1028 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02288 XEO_CLAS Peptide DME1028 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.2 ug/ml) DME1028 XEOTICID XEO02288 GENEFORM Protein DME1028 XEOTICID XEO02288 MOACRIVE Inhibition DME1028 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1028 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02289 XEO_CLAS Peptide DME1028 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 ug/ml) DME1028 XEOTICID XEO02289 GENEFORM Protein DME1028 XEOTICID XEO02289 MOACRIVE Inhibition DME1028 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1028 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02290 XEO_CLAS Peptide DME1028 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO02290 GENEFORM Protein DME1028 XEOTICID XEO02290 MOACRIVE Inhibition DME1028 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1028 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02291 XEO_CLAS Peptide DME1028 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02291 GENEFORM Protein DME1028 XEOTICID XEO02291 MOACRIVE Inhibition DME1028 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1028 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02293 XEO_CLAS Peptide DME1028 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 microM) DME1028 XEOTICID XEO02293 GENEFORM Protein DME1028 XEOTICID XEO02293 MOACRIVE Inhibition DME1028 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1028 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02294 XEO_CLAS Peptide DME1028 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 62-250 ug/ml) DME1028 XEOTICID XEO02294 GENEFORM Protein DME1028 XEOTICID XEO02294 MOACRIVE Inhibition DME1028 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1028 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02295 XEO_CLAS Peptide DME1028 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 ug/ml) DME1028 XEOTICID XEO02295 GENEFORM Protein DME1028 XEOTICID XEO02295 MOACRIVE Inhibition DME1028 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1028 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02296 XEO_CLAS Peptide DME1028 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02296 GENEFORM Protein DME1028 XEOTICID XEO02296 MOACRIVE Inhibition DME1028 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1028 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02297 XEO_CLAS Peptide DME1028 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC < 50 ug/ml) DME1028 XEOTICID XEO02297 GENEFORM Protein DME1028 XEOTICID XEO02297 MOACRIVE Inhibition DME1028 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1028 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02298 XEO_CLAS Peptide DME1028 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO02298 GENEFORM Protein DME1028 XEOTICID XEO02298 MOACRIVE Inhibition DME1028 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1028 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02303 XEO_CLAS Peptide DME1028 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02303 GENEFORM Protein DME1028 XEOTICID XEO02303 MOACRIVE Inhibition DME1028 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1028 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02304 XEO_CLAS Peptide DME1028 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.1 ug/ml) DME1028 XEOTICID XEO02304 GENEFORM Protein DME1028 XEOTICID XEO02304 MOACRIVE Inhibition DME1028 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1028 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02305 XEO_CLAS Peptide DME1028 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC <= 1 ug/ml) DME1028 XEOTICID XEO02305 GENEFORM Protein DME1028 XEOTICID XEO02305 MOACRIVE Inhibition DME1028 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1028 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02306 XEO_CLAS Peptide DME1028 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.2 ug/ml) DME1028 XEOTICID XEO02306 GENEFORM Protein DME1028 XEOTICID XEO02306 MOACRIVE Inhibition DME1028 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1028 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02309 XEO_CLAS Peptide DME1028 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02309 GENEFORM Protein DME1028 XEOTICID XEO02309 MOACRIVE Inhibition DME1028 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1028 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02310 XEO_CLAS Peptide DME1028 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02310 GENEFORM Protein DME1028 XEOTICID XEO02310 MOACRIVE Inhibition DME1028 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1028 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02315 XEO_CLAS Peptide DME1028 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO02315 GENEFORM Protein DME1028 XEOTICID XEO02315 MOACRIVE Inhibition DME1028 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1028 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02316 XEO_CLAS Peptide DME1028 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 50 microM) DME1028 XEOTICID XEO02316 GENEFORM Protein DME1028 XEOTICID XEO02316 MOACRIVE Inhibition DME1028 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1028 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02317 XEO_CLAS Peptide DME1028 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 300 microM) DME1028 XEOTICID XEO02317 GENEFORM Protein DME1028 XEOTICID XEO02317 MOACRIVE Inhibition DME1028 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1028 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02318 XEO_CLAS Peptide DME1028 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02318 GENEFORM Protein DME1028 XEOTICID XEO02318 MOACRIVE Inhibition DME1028 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1028 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02319 XEO_CLAS Peptide DME1028 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02319 GENEFORM Protein DME1028 XEOTICID XEO02319 MOACRIVE Inhibition DME1028 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1028 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02320 XEO_CLAS Peptide DME1028 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02320 GENEFORM Protein DME1028 XEOTICID XEO02320 MOACRIVE Inhibition DME1028 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1028 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02321 XEO_CLAS Peptide DME1028 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO02321 GENEFORM Protein DME1028 XEOTICID XEO02321 MOACRIVE Inhibition DME1028 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1028 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02322 XEO_CLAS Peptide DME1028 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02322 GENEFORM Protein DME1028 XEOTICID XEO02322 MOACRIVE Inhibition DME1028 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1028 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02323 XEO_CLAS Peptide DME1028 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO02323 GENEFORM Protein DME1028 XEOTICID XEO02323 MOACRIVE Inhibition DME1028 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1028 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02324 XEO_CLAS Peptide DME1028 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02324 GENEFORM Protein DME1028 XEOTICID XEO02324 MOACRIVE Inhibition DME1028 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1028 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02325 XEO_CLAS Peptide DME1028 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO02325 GENEFORM Protein DME1028 XEOTICID XEO02325 MOACRIVE Inhibition DME1028 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1028 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02326 XEO_CLAS Peptide DME1028 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02326 GENEFORM Protein DME1028 XEOTICID XEO02326 MOACRIVE Inhibition DME1028 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1028 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02327 XEO_CLAS Peptide DME1028 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO02327 GENEFORM Protein DME1028 XEOTICID XEO02327 MOACRIVE Inhibition DME1028 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1028 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02328 XEO_CLAS Peptide DME1028 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO02328 GENEFORM Protein DME1028 XEOTICID XEO02328 MOACRIVE Inhibition DME1028 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1028 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02332 XEO_CLAS Peptide DME1028 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.9 ug/ml) DME1028 XEOTICID XEO02332 GENEFORM Protein DME1028 XEOTICID XEO02332 MOACRIVE Inhibition DME1028 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1028 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02333 XEO_CLAS Peptide DME1028 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 200 microM) DME1028 XEOTICID XEO02333 GENEFORM Protein DME1028 XEOTICID XEO02333 MOACRIVE Inhibition DME1028 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1028 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02336 XEO_CLAS Peptide DME1028 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 microM) DME1028 XEOTICID XEO02336 GENEFORM Protein DME1028 XEOTICID XEO02336 MOACRIVE Inhibition DME1028 XEOTICID XEO02346 XEO_NAME Aurelin DME1028 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02346 XEO_CLAS Peptide DME1028 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7.66 ug/ml) DME1028 XEOTICID XEO02346 GENEFORM Protein DME1028 XEOTICID XEO02346 MOACRIVE Inhibition DME1028 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1028 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02352 XEO_CLAS Peptide DME1028 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 11 ug/ml) DME1028 XEOTICID XEO02352 GENEFORM Protein DME1028 XEOTICID XEO02352 MOACRIVE Inhibition DME1028 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1028 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02353 XEO_CLAS Peptide DME1028 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 ug/ml) DME1028 XEOTICID XEO02353 GENEFORM Protein DME1028 XEOTICID XEO02353 MOACRIVE Inhibition DME1028 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1028 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02354 XEO_CLAS Peptide DME1028 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 ug/ml) DME1028 XEOTICID XEO02354 GENEFORM Protein DME1028 XEOTICID XEO02354 MOACRIVE Inhibition DME1028 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1028 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02355 XEO_CLAS Peptide DME1028 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 17 ug/ml) DME1028 XEOTICID XEO02355 GENEFORM Protein DME1028 XEOTICID XEO02355 MOACRIVE Inhibition DME1028 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1028 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02356 XEO_CLAS Peptide DME1028 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO02356 GENEFORM Protein DME1028 XEOTICID XEO02356 MOACRIVE Inhibition DME1028 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1028 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02357 XEO_CLAS Peptide DME1028 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO02357 GENEFORM Protein DME1028 XEOTICID XEO02357 MOACRIVE Inhibition DME1028 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1028 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02358 XEO_CLAS Peptide DME1028 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO02358 GENEFORM Protein DME1028 XEOTICID XEO02358 MOACRIVE Inhibition DME1028 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1028 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02360 XEO_CLAS Peptide DME1028 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02360 GENEFORM Protein DME1028 XEOTICID XEO02360 MOACRIVE Inhibition DME1028 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1028 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02361 XEO_CLAS Peptide DME1028 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 ug/ml) DME1028 XEOTICID XEO02361 GENEFORM Protein DME1028 XEOTICID XEO02361 MOACRIVE Inhibition DME1028 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1028 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02365 XEO_CLAS Peptide DME1028 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 32 ug/ml) DME1028 XEOTICID XEO02365 GENEFORM Protein DME1028 XEOTICID XEO02365 MOACRIVE Inhibition DME1028 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1028 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02366 XEO_CLAS Peptide DME1028 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO02366 GENEFORM Protein DME1028 XEOTICID XEO02366 MOACRIVE Inhibition DME1028 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1028 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02367 XEO_CLAS Peptide DME1028 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02367 GENEFORM Protein DME1028 XEOTICID XEO02367 MOACRIVE Inhibition DME1028 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1028 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02368 XEO_CLAS Peptide DME1028 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02368 GENEFORM Protein DME1028 XEOTICID XEO02368 MOACRIVE Inhibition DME1028 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1028 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02369 XEO_CLAS Peptide DME1028 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02369 GENEFORM Protein DME1028 XEOTICID XEO02369 MOACRIVE Inhibition DME1028 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1028 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02370 XEO_CLAS Peptide DME1028 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02370 GENEFORM Protein DME1028 XEOTICID XEO02370 MOACRIVE Inhibition DME1028 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1028 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02371 XEO_CLAS Peptide DME1028 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 ug/ml) DME1028 XEOTICID XEO02371 GENEFORM Protein DME1028 XEOTICID XEO02371 MOACRIVE Inhibition DME1028 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1028 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02374 XEO_CLAS Peptide DME1028 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02374 GENEFORM Protein DME1028 XEOTICID XEO02374 MOACRIVE Inhibition DME1028 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1028 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02376 XEO_CLAS Peptide DME1028 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02376 GENEFORM Protein DME1028 XEOTICID XEO02376 MOACRIVE Inhibition DME1028 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1028 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02378 XEO_CLAS Peptide DME1028 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.19 ug/ml) DME1028 XEOTICID XEO02378 GENEFORM Protein DME1028 XEOTICID XEO02378 MOACRIVE Inhibition DME1028 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1028 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02388 XEO_CLAS Peptide DME1028 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO02388 GENEFORM Protein DME1028 XEOTICID XEO02388 MOACRIVE Inhibition DME1028 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1028 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02389 XEO_CLAS Peptide DME1028 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02389 GENEFORM Protein DME1028 XEOTICID XEO02389 MOACRIVE Inhibition DME1028 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1028 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02415 XEO_CLAS Peptide DME1028 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02415 GENEFORM Protein DME1028 XEOTICID XEO02415 MOACRIVE Inhibition DME1028 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1028 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02416 XEO_CLAS Peptide DME1028 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 11 microM) DME1028 XEOTICID XEO02416 GENEFORM Protein DME1028 XEOTICID XEO02416 MOACRIVE Inhibition DME1028 XEOTICID XEO02419 XEO_NAME Bay oil DME1028 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1028 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02419 GENEFORM Protein DME1028 XEOTICID XEO02419 MOACRIVE Inhibition DME1028 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1028 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02435 XEO_CLAS Peptide DME1028 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02435 GENEFORM Protein DME1028 XEOTICID XEO02435 MOACRIVE Inhibition DME1028 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1028 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02436 XEO_CLAS Peptide DME1028 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02436 GENEFORM Protein DME1028 XEOTICID XEO02436 MOACRIVE Inhibition DME1028 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1028 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02437 XEO_CLAS Peptide DME1028 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02437 GENEFORM Protein DME1028 XEOTICID XEO02437 MOACRIVE Inhibition DME1028 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1028 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02438 XEO_CLAS Peptide DME1028 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02438 GENEFORM Protein DME1028 XEOTICID XEO02438 MOACRIVE Inhibition DME1028 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1028 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02439 XEO_CLAS Peptide DME1028 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02439 GENEFORM Protein DME1028 XEOTICID XEO02439 MOACRIVE Inhibition DME1028 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1028 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02440 XEO_CLAS Peptide DME1028 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02440 GENEFORM Protein DME1028 XEOTICID XEO02440 MOACRIVE Inhibition DME1028 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1028 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02441 XEO_CLAS Peptide DME1028 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02441 GENEFORM Protein DME1028 XEOTICID XEO02441 MOACRIVE Inhibition DME1028 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1028 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02442 XEO_CLAS Peptide DME1028 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO02442 GENEFORM Protein DME1028 XEOTICID XEO02442 MOACRIVE Inhibition DME1028 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1028 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02443 XEO_CLAS Peptide DME1028 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02443 GENEFORM Protein DME1028 XEOTICID XEO02443 MOACRIVE Inhibition DME1028 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1028 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02444 XEO_CLAS Peptide DME1028 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02444 GENEFORM Protein DME1028 XEOTICID XEO02444 MOACRIVE Inhibition DME1028 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1028 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1028 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02447 GENEFORM Protein DME1028 XEOTICID XEO02447 MOACRIVE Inhibition DME1028 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1028 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02452 XEO_CLAS Peptide DME1028 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 76800 ug/ml) DME1028 XEOTICID XEO02452 GENEFORM Protein DME1028 XEOTICID XEO02452 MOACRIVE Inhibition DME1028 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1028 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02453 XEO_CLAS Peptide DME1028 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02453 GENEFORM Protein DME1028 XEOTICID XEO02453 MOACRIVE Inhibition DME1028 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1028 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02463 XEO_CLAS Peptide DME1028 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 11.25 microM) DME1028 XEOTICID XEO02463 GENEFORM Protein DME1028 XEOTICID XEO02463 MOACRIVE Inhibition DME1028 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1028 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02466 XEO_CLAS Peptide DME1028 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.5 microM) DME1028 XEOTICID XEO02466 GENEFORM Protein DME1028 XEOTICID XEO02466 MOACRIVE Inhibition DME1028 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1028 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02467 XEO_CLAS Peptide DME1028 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8.4 microM) DME1028 XEOTICID XEO02467 GENEFORM Protein DME1028 XEOTICID XEO02467 MOACRIVE Inhibition DME1028 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1028 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02468 XEO_CLAS Peptide DME1028 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.7 microM) DME1028 XEOTICID XEO02468 GENEFORM Protein DME1028 XEOTICID XEO02468 MOACRIVE Inhibition DME1028 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1028 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02469 XEO_CLAS Peptide DME1028 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO02469 GENEFORM Protein DME1028 XEOTICID XEO02469 MOACRIVE Inhibition DME1028 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1028 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02470 XEO_CLAS Peptide DME1028 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.8 microM) DME1028 XEOTICID XEO02470 GENEFORM Protein DME1028 XEOTICID XEO02470 MOACRIVE Inhibition DME1028 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1028 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02471 XEO_CLAS Peptide DME1028 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4.8 microM) DME1028 XEOTICID XEO02471 GENEFORM Protein DME1028 XEOTICID XEO02471 MOACRIVE Inhibition DME1028 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1028 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02472 XEO_CLAS Peptide DME1028 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.0 microM) DME1028 XEOTICID XEO02472 GENEFORM Protein DME1028 XEOTICID XEO02472 MOACRIVE Inhibition DME1028 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1028 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02473 XEO_CLAS Peptide DME1028 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02473 GENEFORM Protein DME1028 XEOTICID XEO02473 MOACRIVE Inhibition DME1028 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1028 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02474 XEO_CLAS Peptide DME1028 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.5 microM) DME1028 XEOTICID XEO02474 GENEFORM Protein DME1028 XEOTICID XEO02474 MOACRIVE Inhibition DME1028 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1028 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02475 XEO_CLAS Peptide DME1028 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.5 microM) DME1028 XEOTICID XEO02475 GENEFORM Protein DME1028 XEOTICID XEO02475 MOACRIVE Inhibition DME1028 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1028 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02477 XEO_CLAS Peptide DME1028 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-300 ug/ml) DME1028 XEOTICID XEO02477 GENEFORM Protein DME1028 XEOTICID XEO02477 MOACRIVE Inhibition DME1028 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1028 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02478 XEO_CLAS Peptide DME1028 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-300 ug/ml) DME1028 XEOTICID XEO02478 GENEFORM Protein DME1028 XEOTICID XEO02478 MOACRIVE Inhibition DME1028 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1028 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02479 XEO_CLAS Peptide DME1028 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-300 ug/ml) DME1028 XEOTICID XEO02479 GENEFORM Protein DME1028 XEOTICID XEO02479 MOACRIVE Inhibition DME1028 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1028 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02480 XEO_CLAS Peptide DME1028 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-300 ug/ml) DME1028 XEOTICID XEO02480 GENEFORM Protein DME1028 XEOTICID XEO02480 MOACRIVE Inhibition DME1028 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1028 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02481 XEO_CLAS Peptide DME1028 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-300 ug/ml) DME1028 XEOTICID XEO02481 GENEFORM Protein DME1028 XEOTICID XEO02481 MOACRIVE Inhibition DME1028 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1028 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02482 XEO_CLAS Peptide DME1028 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-300 ug/ml) DME1028 XEOTICID XEO02482 GENEFORM Protein DME1028 XEOTICID XEO02482 MOACRIVE Inhibition DME1028 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1028 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02483 XEO_CLAS Peptide DME1028 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-300 ug/ml) DME1028 XEOTICID XEO02483 GENEFORM Protein DME1028 XEOTICID XEO02483 MOACRIVE Inhibition DME1028 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1028 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02484 XEO_CLAS Peptide DME1028 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-300 ug/ml) DME1028 XEOTICID XEO02484 GENEFORM Protein DME1028 XEOTICID XEO02484 MOACRIVE Inhibition DME1028 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1028 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02485 XEO_CLAS Peptide DME1028 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-300 ug/ml) DME1028 XEOTICID XEO02485 GENEFORM Protein DME1028 XEOTICID XEO02485 MOACRIVE Inhibition DME1028 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1028 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02486 XEO_CLAS Peptide DME1028 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-300 ug/ml) DME1028 XEOTICID XEO02486 GENEFORM Protein DME1028 XEOTICID XEO02486 MOACRIVE Inhibition DME1028 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1028 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02487 XEO_CLAS Peptide DME1028 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02487 GENEFORM Protein DME1028 XEOTICID XEO02487 MOACRIVE Inhibition DME1028 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1028 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02488 XEO_CLAS Peptide DME1028 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-300 ug/ml) DME1028 XEOTICID XEO02488 GENEFORM Protein DME1028 XEOTICID XEO02488 MOACRIVE Inhibition DME1028 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1028 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02489 XEO_CLAS Peptide DME1028 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-301 ug/ml) DME1028 XEOTICID XEO02489 GENEFORM Protein DME1028 XEOTICID XEO02489 MOACRIVE Inhibition DME1028 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1028 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02491 XEO_CLAS Peptide DME1028 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.3 microM) DME1028 XEOTICID XEO02491 GENEFORM Protein DME1028 XEOTICID XEO02491 MOACRIVE Inhibition DME1028 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1028 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02492 XEO_CLAS Peptide DME1028 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 ug/ml) DME1028 XEOTICID XEO02492 GENEFORM Protein DME1028 XEOTICID XEO02492 MOACRIVE Inhibition DME1028 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1028 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02493 XEO_CLAS Peptide DME1028 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 ug/ml) DME1028 XEOTICID XEO02493 GENEFORM Protein DME1028 XEOTICID XEO02493 MOACRIVE Inhibition DME1028 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1028 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02494 XEO_CLAS Peptide DME1028 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 ug/ml) DME1028 XEOTICID XEO02494 GENEFORM Protein DME1028 XEOTICID XEO02494 MOACRIVE Inhibition DME1028 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1028 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02495 XEO_CLAS Peptide DME1028 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 34 ug/ml) DME1028 XEOTICID XEO02495 GENEFORM Protein DME1028 XEOTICID XEO02495 MOACRIVE Inhibition DME1028 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1028 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02496 XEO_CLAS Peptide DME1028 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 13 microM) DME1028 XEOTICID XEO02496 GENEFORM Protein DME1028 XEOTICID XEO02496 MOACRIVE Inhibition DME1028 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1028 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02497 XEO_CLAS Peptide DME1028 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO02497 GENEFORM Protein DME1028 XEOTICID XEO02497 MOACRIVE Inhibition DME1028 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1028 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02499 XEO_CLAS Peptide DME1028 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO02499 GENEFORM Protein DME1028 XEOTICID XEO02499 MOACRIVE Inhibition DME1028 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1028 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02501 XEO_CLAS Peptide DME1028 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7 microM) DME1028 XEOTICID XEO02501 GENEFORM Protein DME1028 XEOTICID XEO02501 MOACRIVE Inhibition DME1028 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1028 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02502 XEO_CLAS Peptide DME1028 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 microM) DME1028 XEOTICID XEO02502 GENEFORM Protein DME1028 XEOTICID XEO02502 MOACRIVE Inhibition DME1028 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1028 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02503 XEO_CLAS Peptide DME1028 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 19 microM) DME1028 XEOTICID XEO02503 GENEFORM Protein DME1028 XEOTICID XEO02503 MOACRIVE Inhibition DME1028 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1028 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02504 XEO_CLAS Peptide DME1028 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02504 GENEFORM Protein DME1028 XEOTICID XEO02504 MOACRIVE Inhibition DME1028 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1028 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02505 XEO_CLAS Peptide DME1028 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO02505 GENEFORM Protein DME1028 XEOTICID XEO02505 MOACRIVE Inhibition DME1028 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1028 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02507 XEO_CLAS Peptide DME1028 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO02507 GENEFORM Protein DME1028 XEOTICID XEO02507 MOACRIVE Inhibition DME1028 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1028 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02508 XEO_CLAS Peptide DME1028 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 150 microM) DME1028 XEOTICID XEO02508 GENEFORM Protein DME1028 XEOTICID XEO02508 MOACRIVE Inhibition DME1028 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1028 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02509 XEO_CLAS Peptide DME1028 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 150 microM) DME1028 XEOTICID XEO02509 GENEFORM Protein DME1028 XEOTICID XEO02509 MOACRIVE Inhibition DME1028 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1028 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02510 XEO_CLAS Peptide DME1028 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 150 microM) DME1028 XEOTICID XEO02510 GENEFORM Protein DME1028 XEOTICID XEO02510 MOACRIVE Inhibition DME1028 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1028 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02511 XEO_CLAS Peptide DME1028 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 150 microM) DME1028 XEOTICID XEO02511 GENEFORM Protein DME1028 XEOTICID XEO02511 MOACRIVE Inhibition DME1028 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1028 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02512 XEO_CLAS Peptide DME1028 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 75 microM) DME1028 XEOTICID XEO02512 GENEFORM Protein DME1028 XEOTICID XEO02512 MOACRIVE Inhibition DME1028 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1028 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02513 XEO_CLAS Peptide DME1028 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO02513 GENEFORM Protein DME1028 XEOTICID XEO02513 MOACRIVE Inhibition DME1028 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1028 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02514 XEO_CLAS Peptide DME1028 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO02514 GENEFORM Protein DME1028 XEOTICID XEO02514 MOACRIVE Inhibition DME1028 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1028 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02515 XEO_CLAS Peptide DME1028 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 80 microM) DME1028 XEOTICID XEO02515 GENEFORM Protein DME1028 XEOTICID XEO02515 MOACRIVE Inhibition DME1028 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1028 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02516 XEO_CLAS Peptide DME1028 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 32 microM) DME1028 XEOTICID XEO02516 GENEFORM Protein DME1028 XEOTICID XEO02516 MOACRIVE Inhibition DME1028 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1028 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02517 XEO_CLAS Peptide DME1028 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 microM) DME1028 XEOTICID XEO02517 GENEFORM Protein DME1028 XEOTICID XEO02517 MOACRIVE Inhibition DME1028 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1028 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02518 XEO_CLAS Peptide DME1028 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC < 15 microM) DME1028 XEOTICID XEO02518 GENEFORM Protein DME1028 XEOTICID XEO02518 MOACRIVE Inhibition DME1028 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1028 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02519 XEO_CLAS Peptide DME1028 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC < 15 microM) DME1028 XEOTICID XEO02519 GENEFORM Protein DME1028 XEOTICID XEO02519 MOACRIVE Inhibition DME1028 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1028 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02520 XEO_CLAS Peptide DME1028 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC < 15 microM) DME1028 XEOTICID XEO02520 GENEFORM Protein DME1028 XEOTICID XEO02520 MOACRIVE Inhibition DME1028 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1028 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02523 XEO_CLAS Peptide DME1028 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO02523 GENEFORM Protein DME1028 XEOTICID XEO02523 MOACRIVE Inhibition DME1028 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1028 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02524 XEO_CLAS Peptide DME1028 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 150 microM) DME1028 XEOTICID XEO02524 GENEFORM Protein DME1028 XEOTICID XEO02524 MOACRIVE Inhibition DME1028 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1028 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02525 XEO_CLAS Peptide DME1028 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 24 microM) DME1028 XEOTICID XEO02525 GENEFORM Protein DME1028 XEOTICID XEO02525 MOACRIVE Inhibition DME1028 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1028 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02526 XEO_CLAS Peptide DME1028 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 48 microM) DME1028 XEOTICID XEO02526 GENEFORM Protein DME1028 XEOTICID XEO02526 MOACRIVE Inhibition DME1028 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1028 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02527 XEO_CLAS Peptide DME1028 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 119 microM) DME1028 XEOTICID XEO02527 GENEFORM Protein DME1028 XEOTICID XEO02527 MOACRIVE Inhibition DME1028 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1028 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02528 XEO_CLAS Peptide DME1028 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 128 ug/ml) DME1028 XEOTICID XEO02528 GENEFORM Protein DME1028 XEOTICID XEO02528 MOACRIVE Inhibition DME1028 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1028 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02529 XEO_CLAS Peptide DME1028 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 128 ug/ml) DME1028 XEOTICID XEO02529 GENEFORM Protein DME1028 XEOTICID XEO02529 MOACRIVE Inhibition DME1028 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1028 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02530 XEO_CLAS Peptide DME1028 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02530 GENEFORM Protein DME1028 XEOTICID XEO02530 MOACRIVE Inhibition DME1028 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1028 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02531 XEO_CLAS Peptide DME1028 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 microM) DME1028 XEOTICID XEO02531 GENEFORM Protein DME1028 XEOTICID XEO02531 MOACRIVE Inhibition DME1028 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1028 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02533 XEO_CLAS Peptide DME1028 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.2 ug/ml) DME1028 XEOTICID XEO02533 GENEFORM Protein DME1028 XEOTICID XEO02533 MOACRIVE Inhibition DME1028 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1028 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02534 XEO_CLAS Peptide DME1028 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.6 ug/ml) DME1028 XEOTICID XEO02534 GENEFORM Protein DME1028 XEOTICID XEO02534 MOACRIVE Inhibition DME1028 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1028 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02535 XEO_CLAS Peptide DME1028 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.3 ug/ml) DME1028 XEOTICID XEO02535 GENEFORM Protein DME1028 XEOTICID XEO02535 MOACRIVE Inhibition DME1028 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1028 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02536 XEO_CLAS Peptide DME1028 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.4 ug/ml) DME1028 XEOTICID XEO02536 GENEFORM Protein DME1028 XEOTICID XEO02536 MOACRIVE Inhibition DME1028 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1028 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02537 XEO_CLAS Peptide DME1028 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.2 ug/ml) DME1028 XEOTICID XEO02537 GENEFORM Protein DME1028 XEOTICID XEO02537 MOACRIVE Inhibition DME1028 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1028 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02538 XEO_CLAS Peptide DME1028 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9.1 ug/ml) DME1028 XEOTICID XEO02538 GENEFORM Protein DME1028 XEOTICID XEO02538 MOACRIVE Inhibition DME1028 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1028 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02539 XEO_CLAS Peptide DME1028 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8.6 ug/ml) DME1028 XEOTICID XEO02539 GENEFORM Protein DME1028 XEOTICID XEO02539 MOACRIVE Inhibition DME1028 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1028 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02540 XEO_CLAS Peptide DME1028 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15.2 ug/ml) DME1028 XEOTICID XEO02540 GENEFORM Protein DME1028 XEOTICID XEO02540 MOACRIVE Inhibition DME1028 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1028 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02541 XEO_CLAS Peptide DME1028 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 11.1 ug/ml) DME1028 XEOTICID XEO02541 GENEFORM Protein DME1028 XEOTICID XEO02541 MOACRIVE Inhibition DME1028 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1028 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02542 XEO_CLAS Peptide DME1028 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.7 ug/ml) DME1028 XEOTICID XEO02542 GENEFORM Protein DME1028 XEOTICID XEO02542 MOACRIVE Inhibition DME1028 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1028 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02543 XEO_CLAS Peptide DME1028 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 13.1 ug/ml) DME1028 XEOTICID XEO02543 GENEFORM Protein DME1028 XEOTICID XEO02543 MOACRIVE Inhibition DME1028 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1028 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02544 XEO_CLAS Peptide DME1028 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9.8 ug/ml) DME1028 XEOTICID XEO02544 GENEFORM Protein DME1028 XEOTICID XEO02544 MOACRIVE Inhibition DME1028 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1028 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02545 XEO_CLAS Peptide DME1028 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 14 microM) DME1028 XEOTICID XEO02545 GENEFORM Protein DME1028 XEOTICID XEO02545 MOACRIVE Inhibition DME1028 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1028 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02546 XEO_CLAS Peptide DME1028 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 14 microM) DME1028 XEOTICID XEO02546 GENEFORM Protein DME1028 XEOTICID XEO02546 MOACRIVE Inhibition DME1028 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1028 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02547 XEO_CLAS Peptide DME1028 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 microM) DME1028 XEOTICID XEO02547 GENEFORM Protein DME1028 XEOTICID XEO02547 MOACRIVE Inhibition DME1028 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1028 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02548 XEO_CLAS Peptide DME1028 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 78 microM) DME1028 XEOTICID XEO02548 GENEFORM Protein DME1028 XEOTICID XEO02548 MOACRIVE Inhibition DME1028 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1028 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02549 XEO_CLAS Peptide DME1028 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02549 GENEFORM Protein DME1028 XEOTICID XEO02549 MOACRIVE Inhibition DME1028 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1028 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02552 XEO_CLAS Peptide DME1028 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 24 microM) DME1028 XEOTICID XEO02552 GENEFORM Protein DME1028 XEOTICID XEO02552 MOACRIVE Inhibition DME1028 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1028 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02553 XEO_CLAS Peptide DME1028 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02553 GENEFORM Protein DME1028 XEOTICID XEO02553 MOACRIVE Inhibition DME1028 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1028 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02556 XEO_CLAS Peptide DME1028 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 55 microM) DME1028 XEOTICID XEO02556 GENEFORM Protein DME1028 XEOTICID XEO02556 MOACRIVE Inhibition DME1028 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1028 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02557 XEO_CLAS Peptide DME1028 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 17 microM) DME1028 XEOTICID XEO02557 GENEFORM Protein DME1028 XEOTICID XEO02557 MOACRIVE Inhibition DME1028 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1028 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02558 XEO_CLAS Peptide DME1028 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 14 microM) DME1028 XEOTICID XEO02558 GENEFORM Protein DME1028 XEOTICID XEO02558 MOACRIVE Inhibition DME1028 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1028 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02559 XEO_CLAS Peptide DME1028 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02559 GENEFORM Protein DME1028 XEOTICID XEO02559 MOACRIVE Inhibition DME1028 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1028 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02560 XEO_CLAS Peptide DME1028 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 13 microM) DME1028 XEOTICID XEO02560 GENEFORM Protein DME1028 XEOTICID XEO02560 MOACRIVE Inhibition DME1028 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1028 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02561 XEO_CLAS Peptide DME1028 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO02561 GENEFORM Protein DME1028 XEOTICID XEO02561 MOACRIVE Inhibition DME1028 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1028 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02562 XEO_CLAS Peptide DME1028 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 13 microM) DME1028 XEOTICID XEO02562 GENEFORM Protein DME1028 XEOTICID XEO02562 MOACRIVE Inhibition DME1028 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1028 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02563 XEO_CLAS Peptide DME1028 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 45 microM) DME1028 XEOTICID XEO02563 GENEFORM Protein DME1028 XEOTICID XEO02563 MOACRIVE Inhibition DME1028 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1028 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02564 XEO_CLAS Peptide DME1028 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 ug/ml) DME1028 XEOTICID XEO02564 GENEFORM Protein DME1028 XEOTICID XEO02564 MOACRIVE Inhibition DME1028 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1028 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02565 XEO_CLAS Peptide DME1028 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 microM) DME1028 XEOTICID XEO02565 GENEFORM Protein DME1028 XEOTICID XEO02565 MOACRIVE Inhibition DME1028 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1028 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02566 XEO_CLAS Peptide DME1028 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO02566 GENEFORM Protein DME1028 XEOTICID XEO02566 MOACRIVE Inhibition DME1028 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1028 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02568 XEO_CLAS Peptide DME1028 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO02568 GENEFORM Protein DME1028 XEOTICID XEO02568 MOACRIVE Inhibition DME1028 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1028 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02569 XEO_CLAS Peptide DME1028 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO02569 GENEFORM Protein DME1028 XEOTICID XEO02569 MOACRIVE Inhibition DME1028 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1028 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02570 XEO_CLAS Peptide DME1028 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO02570 GENEFORM Protein DME1028 XEOTICID XEO02570 MOACRIVE Inhibition DME1028 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1028 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02571 XEO_CLAS Peptide DME1028 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO02571 GENEFORM Protein DME1028 XEOTICID XEO02571 MOACRIVE Inhibition DME1028 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1028 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02572 XEO_CLAS Peptide DME1028 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02572 GENEFORM Protein DME1028 XEOTICID XEO02572 MOACRIVE Inhibition DME1028 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1028 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02573 XEO_CLAS Peptide DME1028 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02573 GENEFORM Protein DME1028 XEOTICID XEO02573 MOACRIVE Inhibition DME1028 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1028 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02574 XEO_CLAS Peptide DME1028 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 microM) DME1028 XEOTICID XEO02574 GENEFORM Protein DME1028 XEOTICID XEO02574 MOACRIVE Inhibition DME1028 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1028 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02575 XEO_CLAS Peptide DME1028 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 microM) DME1028 XEOTICID XEO02575 GENEFORM Protein DME1028 XEOTICID XEO02575 MOACRIVE Inhibition DME1028 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1028 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02576 XEO_CLAS Peptide DME1028 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 33 microM) DME1028 XEOTICID XEO02576 GENEFORM Protein DME1028 XEOTICID XEO02576 MOACRIVE Inhibition DME1028 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1028 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02577 XEO_CLAS Peptide DME1028 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO02577 GENEFORM Protein DME1028 XEOTICID XEO02577 MOACRIVE Inhibition DME1028 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1028 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02578 XEO_CLAS Peptide DME1028 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02578 GENEFORM Protein DME1028 XEOTICID XEO02578 MOACRIVE Inhibition DME1028 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1028 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02579 XEO_CLAS Peptide DME1028 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02579 GENEFORM Protein DME1028 XEOTICID XEO02579 MOACRIVE Inhibition DME1028 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1028 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02580 XEO_CLAS Peptide DME1028 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC < 15 microM) DME1028 XEOTICID XEO02580 GENEFORM Protein DME1028 XEOTICID XEO02580 MOACRIVE Inhibition DME1028 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1028 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02581 XEO_CLAS Peptide DME1028 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 microM) DME1028 XEOTICID XEO02581 GENEFORM Protein DME1028 XEOTICID XEO02581 MOACRIVE Inhibition DME1028 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1028 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02582 XEO_CLAS Peptide DME1028 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 microM) DME1028 XEOTICID XEO02582 GENEFORM Protein DME1028 XEOTICID XEO02582 MOACRIVE Inhibition DME1028 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1028 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02583 XEO_CLAS Peptide DME1028 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 microM) DME1028 XEOTICID XEO02583 GENEFORM Protein DME1028 XEOTICID XEO02583 MOACRIVE Inhibition DME1028 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1028 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02584 XEO_CLAS Peptide DME1028 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 microM) DME1028 XEOTICID XEO02584 GENEFORM Protein DME1028 XEOTICID XEO02584 MOACRIVE Inhibition DME1028 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1028 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02585 XEO_CLAS Peptide DME1028 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO02585 GENEFORM Protein DME1028 XEOTICID XEO02585 MOACRIVE Inhibition DME1028 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1028 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02586 XEO_CLAS Peptide DME1028 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO02586 GENEFORM Protein DME1028 XEOTICID XEO02586 MOACRIVE Inhibition DME1028 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1028 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02587 XEO_CLAS Peptide DME1028 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02587 GENEFORM Protein DME1028 XEOTICID XEO02587 MOACRIVE Inhibition DME1028 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1028 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02589 XEO_CLAS Peptide DME1028 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8.2 ug/ml) DME1028 XEOTICID XEO02589 GENEFORM Protein DME1028 XEOTICID XEO02589 MOACRIVE Inhibition DME1028 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1028 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02590 XEO_CLAS Peptide DME1028 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 19.6 ug/ml) DME1028 XEOTICID XEO02590 GENEFORM Protein DME1028 XEOTICID XEO02590 MOACRIVE Inhibition DME1028 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1028 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02591 XEO_CLAS Peptide DME1028 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO02591 GENEFORM Protein DME1028 XEOTICID XEO02591 MOACRIVE Inhibition DME1028 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1028 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02593 XEO_CLAS Peptide DME1028 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 36 microM) DME1028 XEOTICID XEO02593 GENEFORM Protein DME1028 XEOTICID XEO02593 MOACRIVE Inhibition DME1028 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1028 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02594 XEO_CLAS Peptide DME1028 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02594 GENEFORM Protein DME1028 XEOTICID XEO02594 MOACRIVE Inhibition DME1028 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1028 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02595 XEO_CLAS Peptide DME1028 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO02595 GENEFORM Protein DME1028 XEOTICID XEO02595 MOACRIVE Inhibition DME1028 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1028 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02596 XEO_CLAS Peptide DME1028 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO02596 GENEFORM Protein DME1028 XEOTICID XEO02596 MOACRIVE Inhibition DME1028 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1028 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02597 XEO_CLAS Peptide DME1028 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO02597 GENEFORM Protein DME1028 XEOTICID XEO02597 MOACRIVE Inhibition DME1028 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1028 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02598 XEO_CLAS Peptide DME1028 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 32.5 microM) DME1028 XEOTICID XEO02598 GENEFORM Protein DME1028 XEOTICID XEO02598 MOACRIVE Inhibition DME1028 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1028 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02599 XEO_CLAS Peptide DME1028 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 microM) DME1028 XEOTICID XEO02599 GENEFORM Protein DME1028 XEOTICID XEO02599 MOACRIVE Inhibition DME1028 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1028 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02601 XEO_CLAS Peptide DME1028 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.1 ug/ml) DME1028 XEOTICID XEO02601 GENEFORM Protein DME1028 XEOTICID XEO02601 MOACRIVE Inhibition DME1028 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1028 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02602 XEO_CLAS Peptide DME1028 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 13.2 ug/ml) DME1028 XEOTICID XEO02602 GENEFORM Protein DME1028 XEOTICID XEO02602 MOACRIVE Inhibition DME1028 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1028 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02603 XEO_CLAS Peptide DME1028 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.3 ug/ml) DME1028 XEOTICID XEO02603 GENEFORM Protein DME1028 XEOTICID XEO02603 MOACRIVE Inhibition DME1028 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1028 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02604 XEO_CLAS Peptide DME1028 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO02604 GENEFORM Protein DME1028 XEOTICID XEO02604 MOACRIVE Inhibition DME1028 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1028 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02605 XEO_CLAS Peptide DME1028 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30.6 ug/ml) DME1028 XEOTICID XEO02605 GENEFORM Protein DME1028 XEOTICID XEO02605 MOACRIVE Inhibition DME1028 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1028 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02606 XEO_CLAS Peptide DME1028 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 11.2 ug/ml) DME1028 XEOTICID XEO02606 GENEFORM Protein DME1028 XEOTICID XEO02606 MOACRIVE Inhibition DME1028 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1028 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02607 XEO_CLAS Peptide DME1028 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.8 ug/ml) DME1028 XEOTICID XEO02607 GENEFORM Protein DME1028 XEOTICID XEO02607 MOACRIVE Inhibition DME1028 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1028 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02608 XEO_CLAS Peptide DME1028 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7.9 ug/ml) DME1028 XEOTICID XEO02608 GENEFORM Protein DME1028 XEOTICID XEO02608 MOACRIVE Inhibition DME1028 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1028 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02609 XEO_CLAS Peptide DME1028 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15.8 ug/ml) DME1028 XEOTICID XEO02609 GENEFORM Protein DME1028 XEOTICID XEO02609 MOACRIVE Inhibition DME1028 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1028 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02610 XEO_CLAS Peptide DME1028 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.1 ug/ml) DME1028 XEOTICID XEO02610 GENEFORM Protein DME1028 XEOTICID XEO02610 MOACRIVE Inhibition DME1028 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1028 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02611 XEO_CLAS Peptide DME1028 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20.6 ug/ml) DME1028 XEOTICID XEO02611 GENEFORM Protein DME1028 XEOTICID XEO02611 MOACRIVE Inhibition DME1028 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1028 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02612 XEO_CLAS Peptide DME1028 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 11.8 ug/ml) DME1028 XEOTICID XEO02612 GENEFORM Protein DME1028 XEOTICID XEO02612 MOACRIVE Inhibition DME1028 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1028 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02613 XEO_CLAS Peptide DME1028 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 13.2 ug/ml) DME1028 XEOTICID XEO02613 GENEFORM Protein DME1028 XEOTICID XEO02613 MOACRIVE Inhibition DME1028 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1028 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02614 XEO_CLAS Peptide DME1028 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.8 ug/ml) DME1028 XEOTICID XEO02614 GENEFORM Protein DME1028 XEOTICID XEO02614 MOACRIVE Inhibition DME1028 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1028 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02615 XEO_CLAS Peptide DME1028 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8.6 ug/ml) DME1028 XEOTICID XEO02615 GENEFORM Protein DME1028 XEOTICID XEO02615 MOACRIVE Inhibition DME1028 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1028 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02616 XEO_CLAS Peptide DME1028 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20.4 ug/ml) DME1028 XEOTICID XEO02616 GENEFORM Protein DME1028 XEOTICID XEO02616 MOACRIVE Inhibition DME1028 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1028 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02617 XEO_CLAS Peptide DME1028 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4.7 ug/ml) DME1028 XEOTICID XEO02617 GENEFORM Protein DME1028 XEOTICID XEO02617 MOACRIVE Inhibition DME1028 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1028 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02618 XEO_CLAS Peptide DME1028 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.6 ug/ml) DME1028 XEOTICID XEO02618 GENEFORM Protein DME1028 XEOTICID XEO02618 MOACRIVE Inhibition DME1028 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1028 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02619 XEO_CLAS Peptide DME1028 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10.5 ug/ml) DME1028 XEOTICID XEO02619 GENEFORM Protein DME1028 XEOTICID XEO02619 MOACRIVE Inhibition DME1028 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1028 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02620 XEO_CLAS Peptide DME1028 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO02620 GENEFORM Protein DME1028 XEOTICID XEO02620 MOACRIVE Inhibition DME1028 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1028 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02621 XEO_CLAS Peptide DME1028 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO02621 GENEFORM Protein DME1028 XEOTICID XEO02621 MOACRIVE Inhibition DME1028 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1028 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02622 XEO_CLAS Peptide DME1028 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO02622 GENEFORM Protein DME1028 XEOTICID XEO02622 MOACRIVE Inhibition DME1028 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1028 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02623 XEO_CLAS Peptide DME1028 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO02623 GENEFORM Protein DME1028 XEOTICID XEO02623 MOACRIVE Inhibition DME1028 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1028 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02624 XEO_CLAS Peptide DME1028 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 18 microM) DME1028 XEOTICID XEO02624 GENEFORM Protein DME1028 XEOTICID XEO02624 MOACRIVE Inhibition DME1028 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1028 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02625 XEO_CLAS Peptide DME1028 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9 microM) DME1028 XEOTICID XEO02625 GENEFORM Protein DME1028 XEOTICID XEO02625 MOACRIVE Inhibition DME1028 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1028 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02626 XEO_CLAS Peptide DME1028 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 18 microM) DME1028 XEOTICID XEO02626 GENEFORM Protein DME1028 XEOTICID XEO02626 MOACRIVE Inhibition DME1028 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1028 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02627 XEO_CLAS Peptide DME1028 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02627 GENEFORM Protein DME1028 XEOTICID XEO02627 MOACRIVE Inhibition DME1028 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1028 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02628 XEO_CLAS Peptide DME1028 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 18 microM) DME1028 XEOTICID XEO02628 GENEFORM Protein DME1028 XEOTICID XEO02628 MOACRIVE Inhibition DME1028 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1028 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02629 XEO_CLAS Peptide DME1028 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 13 microM) DME1028 XEOTICID XEO02629 GENEFORM Protein DME1028 XEOTICID XEO02629 MOACRIVE Inhibition DME1028 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1028 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02630 XEO_CLAS Peptide DME1028 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 ug/ml) DME1028 XEOTICID XEO02630 GENEFORM Protein DME1028 XEOTICID XEO02630 MOACRIVE Inhibition DME1028 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1028 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02631 XEO_CLAS Peptide DME1028 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 ug/ml) DME1028 XEOTICID XEO02631 GENEFORM Protein DME1028 XEOTICID XEO02631 MOACRIVE Inhibition DME1028 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1028 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02634 XEO_CLAS Peptide DME1028 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO02634 GENEFORM Protein DME1028 XEOTICID XEO02634 MOACRIVE Inhibition DME1028 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1028 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02635 XEO_CLAS Peptide DME1028 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40 ug/ml) DME1028 XEOTICID XEO02635 GENEFORM Protein DME1028 XEOTICID XEO02635 MOACRIVE Inhibition DME1028 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1028 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02636 XEO_CLAS Peptide DME1028 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO02636 GENEFORM Protein DME1028 XEOTICID XEO02636 MOACRIVE Inhibition DME1028 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1028 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02637 XEO_CLAS Peptide DME1028 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO02637 GENEFORM Protein DME1028 XEOTICID XEO02637 MOACRIVE Inhibition DME1028 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1028 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02638 XEO_CLAS Peptide DME1028 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 microM) DME1028 XEOTICID XEO02638 GENEFORM Protein DME1028 XEOTICID XEO02638 MOACRIVE Inhibition DME1028 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1028 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02639 XEO_CLAS Peptide DME1028 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 microM) DME1028 XEOTICID XEO02639 GENEFORM Protein DME1028 XEOTICID XEO02639 MOACRIVE Inhibition DME1028 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1028 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02644 XEO_CLAS Peptide DME1028 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02644 GENEFORM Protein DME1028 XEOTICID XEO02644 MOACRIVE Inhibition DME1028 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1028 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02645 XEO_CLAS Peptide DME1028 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02645 GENEFORM Protein DME1028 XEOTICID XEO02645 MOACRIVE Inhibition DME1028 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1028 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02646 XEO_CLAS Peptide DME1028 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02646 GENEFORM Protein DME1028 XEOTICID XEO02646 MOACRIVE Inhibition DME1028 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1028 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02647 XEO_CLAS Peptide DME1028 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02647 GENEFORM Protein DME1028 XEOTICID XEO02647 MOACRIVE Inhibition DME1028 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1028 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02649 XEO_CLAS Peptide DME1028 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO02649 GENEFORM Protein DME1028 XEOTICID XEO02649 MOACRIVE Inhibition DME1028 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1028 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02650 XEO_CLAS Peptide DME1028 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO02650 GENEFORM Protein DME1028 XEOTICID XEO02650 MOACRIVE Inhibition DME1028 XEOTICID XEO02658 XEO_NAME Buthinin DME1028 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02658 XEO_CLAS Peptide DME1028 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02658 GENEFORM Protein DME1028 XEOTICID XEO02658 MOACRIVE Inhibition DME1028 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1028 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02663 XEO_CLAS Peptide DME1028 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25 microM) DME1028 XEOTICID XEO02663 GENEFORM Protein DME1028 XEOTICID XEO02663 MOACRIVE Inhibition DME1028 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1028 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02664 XEO_CLAS Peptide DME1028 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25 microM) DME1028 XEOTICID XEO02664 GENEFORM Protein DME1028 XEOTICID XEO02664 MOACRIVE Inhibition DME1028 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1028 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02672 XEO_CLAS Peptide DME1028 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25 microM) DME1028 XEOTICID XEO02672 GENEFORM Protein DME1028 XEOTICID XEO02672 MOACRIVE Inhibition DME1028 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1028 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02673 XEO_CLAS Peptide DME1028 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25-12.5 microM) DME1028 XEOTICID XEO02673 GENEFORM Protein DME1028 XEOTICID XEO02673 MOACRIVE Inhibition DME1028 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1028 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02674 XEO_CLAS Peptide DME1028 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.125-6.25 microM) DME1028 XEOTICID XEO02674 GENEFORM Protein DME1028 XEOTICID XEO02674 MOACRIVE Inhibition DME1028 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1028 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02676 XEO_CLAS Peptide DME1028 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO02676 GENEFORM Protein DME1028 XEOTICID XEO02676 MOACRIVE Inhibition DME1028 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1028 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02677 XEO_CLAS Peptide DME1028 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25-12.5 microM) DME1028 XEOTICID XEO02677 GENEFORM Protein DME1028 XEOTICID XEO02677 MOACRIVE Inhibition DME1028 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1028 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02679 XEO_CLAS Peptide DME1028 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25-12.5 microM) DME1028 XEOTICID XEO02679 GENEFORM Protein DME1028 XEOTICID XEO02679 MOACRIVE Inhibition DME1028 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1028 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02680 XEO_CLAS Peptide DME1028 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25 microM) DME1028 XEOTICID XEO02680 GENEFORM Protein DME1028 XEOTICID XEO02680 MOACRIVE Inhibition DME1028 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1028 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02683 XEO_CLAS Peptide DME1028 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO02683 GENEFORM Protein DME1028 XEOTICID XEO02683 MOACRIVE Inhibition DME1028 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1028 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02688 XEO_CLAS Peptide DME1028 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO02688 GENEFORM Protein DME1028 XEOTICID XEO02688 MOACRIVE Inhibition DME1028 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1028 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02693 XEO_CLAS Peptide DME1028 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 ug/ml) DME1028 XEOTICID XEO02693 GENEFORM Protein DME1028 XEOTICID XEO02693 MOACRIVE Inhibition DME1028 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1028 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02699 XEO_CLAS Peptide DME1028 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 ug/ml) DME1028 XEOTICID XEO02699 GENEFORM Protein DME1028 XEOTICID XEO02699 MOACRIVE Inhibition DME1028 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1028 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02700 XEO_CLAS Peptide DME1028 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 ug/ml) DME1028 XEOTICID XEO02700 GENEFORM Protein DME1028 XEOTICID XEO02700 MOACRIVE Inhibition DME1028 XEOTICID XEO02703 XEO_NAME Calcitermin DME1028 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02703 XEO_CLAS Peptide DME1028 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02703 GENEFORM Protein DME1028 XEOTICID XEO02703 MOACRIVE Inhibition DME1028 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1028 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02708 XEO_CLAS Peptide DME1028 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO02708 GENEFORM Protein DME1028 XEOTICID XEO02708 MOACRIVE Inhibition DME1028 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1028 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02709 XEO_CLAS Peptide DME1028 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.05 microM) DME1028 XEOTICID XEO02709 GENEFORM Protein DME1028 XEOTICID XEO02709 MOACRIVE Inhibition DME1028 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1028 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1028 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02713 GENEFORM Protein DME1028 XEOTICID XEO02713 MOACRIVE Inhibition DME1028 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1028 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1028 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02714 GENEFORM Protein DME1028 XEOTICID XEO02714 MOACRIVE Inhibition DME1028 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1028 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02726 XEO_CLAS Peptide DME1028 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02726 GENEFORM Protein DME1028 XEOTICID XEO02726 MOACRIVE Inhibition DME1028 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1028 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02731 XEO_CLAS Peptide DME1028 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1 microM) DME1028 XEOTICID XEO02731 GENEFORM Protein DME1028 XEOTICID XEO02731 MOACRIVE Inhibition DME1028 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1028 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02732 XEO_CLAS Peptide DME1028 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.25 microM) DME1028 XEOTICID XEO02732 GENEFORM Protein DME1028 XEOTICID XEO02732 MOACRIVE Inhibition DME1028 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1028 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02733 XEO_CLAS Peptide DME1028 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8-25 ug/ml) DME1028 XEOTICID XEO02733 GENEFORM Protein DME1028 XEOTICID XEO02733 MOACRIVE Inhibition DME1028 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1028 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02735 XEO_CLAS Peptide DME1028 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1 ug/ml) DME1028 XEOTICID XEO02735 GENEFORM Protein DME1028 XEOTICID XEO02735 MOACRIVE Inhibition DME1028 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1028 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02737 XEO_CLAS Peptide DME1028 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02737 GENEFORM Protein DME1028 XEOTICID XEO02737 MOACRIVE Inhibition DME1028 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1028 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02738 XEO_CLAS Peptide DME1028 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO02738 GENEFORM Protein DME1028 XEOTICID XEO02738 MOACRIVE Inhibition DME1028 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1028 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02739 XEO_CLAS Peptide DME1028 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 microM) DME1028 XEOTICID XEO02739 GENEFORM Protein DME1028 XEOTICID XEO02739 MOACRIVE Inhibition DME1028 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1028 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02740 XEO_CLAS Peptide DME1028 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.25 ug/ml) DME1028 XEOTICID XEO02740 GENEFORM Protein DME1028 XEOTICID XEO02740 MOACRIVE Inhibition DME1028 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1028 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02741 XEO_CLAS Peptide DME1028 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 ug/ml) DME1028 XEOTICID XEO02741 GENEFORM Protein DME1028 XEOTICID XEO02741 MOACRIVE Inhibition DME1028 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1028 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02743 XEO_CLAS Peptide DME1028 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.6 ug/ml) DME1028 XEOTICID XEO02743 GENEFORM Protein DME1028 XEOTICID XEO02743 MOACRIVE Inhibition DME1028 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1028 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02744 XEO_CLAS Peptide DME1028 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 18.7 ug/ml) DME1028 XEOTICID XEO02744 GENEFORM Protein DME1028 XEOTICID XEO02744 MOACRIVE Inhibition DME1028 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1028 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02745 XEO_CLAS Peptide DME1028 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02745 GENEFORM Protein DME1028 XEOTICID XEO02745 MOACRIVE Inhibition DME1028 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1028 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02746 XEO_CLAS Peptide DME1028 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02746 GENEFORM Protein DME1028 XEOTICID XEO02746 MOACRIVE Inhibition DME1028 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1028 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02748 XEO_CLAS Peptide DME1028 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02748 GENEFORM Protein DME1028 XEOTICID XEO02748 MOACRIVE Inhibition DME1028 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1028 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02749 XEO_CLAS Peptide DME1028 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20-25 mug/ml) DME1028 XEOTICID XEO02749 GENEFORM Protein DME1028 XEOTICID XEO02749 MOACRIVE Inhibition DME1028 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1028 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02750 XEO_CLAS Peptide DME1028 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02750 GENEFORM Protein DME1028 XEOTICID XEO02750 MOACRIVE Inhibition DME1028 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1028 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02752 XEO_CLAS Peptide DME1028 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02752 GENEFORM Protein DME1028 XEOTICID XEO02752 MOACRIVE Inhibition DME1028 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1028 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02753 XEO_CLAS Peptide DME1028 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02753 GENEFORM Protein DME1028 XEOTICID XEO02753 MOACRIVE Inhibition DME1028 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1028 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02754 XEO_CLAS Peptide DME1028 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 microM) DME1028 XEOTICID XEO02754 GENEFORM Protein DME1028 XEOTICID XEO02754 MOACRIVE Inhibition DME1028 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1028 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02756 XEO_CLAS Peptide DME1028 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 microM) DME1028 XEOTICID XEO02756 GENEFORM Protein DME1028 XEOTICID XEO02756 MOACRIVE Inhibition DME1028 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1028 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02757 XEO_CLAS Peptide DME1028 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1 microM) DME1028 XEOTICID XEO02757 GENEFORM Protein DME1028 XEOTICID XEO02757 MOACRIVE Inhibition DME1028 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1028 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02758 XEO_CLAS Peptide DME1028 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO02758 GENEFORM Protein DME1028 XEOTICID XEO02758 MOACRIVE Inhibition DME1028 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1028 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02759 XEO_CLAS Peptide DME1028 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.6 microM) DME1028 XEOTICID XEO02759 GENEFORM Protein DME1028 XEOTICID XEO02759 MOACRIVE Inhibition DME1028 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1028 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02760 XEO_CLAS Peptide DME1028 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 microM) DME1028 XEOTICID XEO02760 GENEFORM Protein DME1028 XEOTICID XEO02760 MOACRIVE Inhibition DME1028 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1028 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02761 XEO_CLAS Peptide DME1028 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO02761 GENEFORM Protein DME1028 XEOTICID XEO02761 MOACRIVE Inhibition DME1028 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1028 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02762 XEO_CLAS Peptide DME1028 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 microM) DME1028 XEOTICID XEO02762 GENEFORM Protein DME1028 XEOTICID XEO02762 MOACRIVE Inhibition DME1028 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1028 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02763 XEO_CLAS Peptide DME1028 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.4 microM) DME1028 XEOTICID XEO02763 GENEFORM Protein DME1028 XEOTICID XEO02763 MOACRIVE Inhibition DME1028 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1028 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02764 XEO_CLAS Peptide DME1028 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 microM) DME1028 XEOTICID XEO02764 GENEFORM Protein DME1028 XEOTICID XEO02764 MOACRIVE Inhibition DME1028 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1028 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02765 XEO_CLAS Peptide DME1028 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.3 microM) DME1028 XEOTICID XEO02765 GENEFORM Protein DME1028 XEOTICID XEO02765 MOACRIVE Inhibition DME1028 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1028 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02767 XEO_CLAS Peptide DME1028 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02767 GENEFORM Protein DME1028 XEOTICID XEO02767 MOACRIVE Inhibition DME1028 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1028 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02768 XEO_CLAS Peptide DME1028 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1028 XEOTICID XEO02768 GENEFORM Protein DME1028 XEOTICID XEO02768 MOACRIVE Inhibition DME1028 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1028 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02769 XEO_CLAS Peptide DME1028 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.32 microM) DME1028 XEOTICID XEO02769 GENEFORM Protein DME1028 XEOTICID XEO02769 MOACRIVE Inhibition DME1028 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1028 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02770 XEO_CLAS Peptide DME1028 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.30 microM) DME1028 XEOTICID XEO02770 GENEFORM Protein DME1028 XEOTICID XEO02770 MOACRIVE Inhibition DME1028 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1028 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02771 XEO_CLAS Peptide DME1028 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.21 microM) DME1028 XEOTICID XEO02771 GENEFORM Protein DME1028 XEOTICID XEO02771 MOACRIVE Inhibition DME1028 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1028 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02772 XEO_CLAS Peptide DME1028 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02772 GENEFORM Protein DME1028 XEOTICID XEO02772 MOACRIVE Inhibition DME1028 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1028 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02773 XEO_CLAS Peptide DME1028 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.9-8.6 microM) DME1028 XEOTICID XEO02773 GENEFORM Protein DME1028 XEOTICID XEO02773 MOACRIVE Inhibition DME1028 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1028 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02774 XEO_CLAS Peptide DME1028 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.3 microM) DME1028 XEOTICID XEO02774 GENEFORM Protein DME1028 XEOTICID XEO02774 MOACRIVE Inhibition DME1028 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1028 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02789 GENEFORM Protein DME1028 XEOTICID XEO02789 MOACRIVE Inhibition DME1028 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1028 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02790 GENEFORM Protein DME1028 XEOTICID XEO02790 MOACRIVE Inhibition DME1028 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1028 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02791 GENEFORM Protein DME1028 XEOTICID XEO02791 MOACRIVE Inhibition DME1028 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1028 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02792 GENEFORM Protein DME1028 XEOTICID XEO02792 MOACRIVE Inhibition DME1028 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1028 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02793 GENEFORM Protein DME1028 XEOTICID XEO02793 MOACRIVE Inhibition DME1028 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1028 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02794 GENEFORM Protein DME1028 XEOTICID XEO02794 MOACRIVE Inhibition DME1028 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1028 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02795 GENEFORM Protein DME1028 XEOTICID XEO02795 MOACRIVE Inhibition DME1028 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1028 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02796 GENEFORM Protein DME1028 XEOTICID XEO02796 MOACRIVE Inhibition DME1028 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1028 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02797 GENEFORM Protein DME1028 XEOTICID XEO02797 MOACRIVE Inhibition DME1028 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1028 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02799 XEO_CLAS Peptide DME1028 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02799 GENEFORM Protein DME1028 XEOTICID XEO02799 MOACRIVE Inhibition DME1028 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1028 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02800 XEO_CLAS Peptide DME1028 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02800 GENEFORM Protein DME1028 XEOTICID XEO02800 MOACRIVE Inhibition DME1028 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1028 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02802 XEO_CLAS Peptide DME1028 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 13.6 microM) DME1028 XEOTICID XEO02802 GENEFORM Protein DME1028 XEOTICID XEO02802 MOACRIVE Inhibition DME1028 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1028 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02807 XEO_CLAS Peptide DME1028 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.2 microM) DME1028 XEOTICID XEO02807 GENEFORM Protein DME1028 XEOTICID XEO02807 MOACRIVE Inhibition DME1028 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1028 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02813 XEO_CLAS Peptide DME1028 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 80 microM) DME1028 XEOTICID XEO02813 GENEFORM Protein DME1028 XEOTICID XEO02813 MOACRIVE Inhibition DME1028 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1028 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02814 XEO_CLAS Peptide DME1028 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 80 microM) DME1028 XEOTICID XEO02814 GENEFORM Protein DME1028 XEOTICID XEO02814 MOACRIVE Inhibition DME1028 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1028 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02815 XEO_CLAS Peptide DME1028 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8.5 microM) DME1028 XEOTICID XEO02815 GENEFORM Protein DME1028 XEOTICID XEO02815 MOACRIVE Inhibition DME1028 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1028 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02816 XEO_CLAS Peptide DME1028 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 80 microM) DME1028 XEOTICID XEO02816 GENEFORM Protein DME1028 XEOTICID XEO02816 MOACRIVE Inhibition DME1028 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1028 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02817 XEO_CLAS Peptide DME1028 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 80 microM) DME1028 XEOTICID XEO02817 GENEFORM Protein DME1028 XEOTICID XEO02817 MOACRIVE Inhibition DME1028 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1028 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02818 XEO_CLAS Peptide DME1028 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.4 microM) DME1028 XEOTICID XEO02818 GENEFORM Protein DME1028 XEOTICID XEO02818 MOACRIVE Inhibition DME1028 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1028 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02819 XEO_CLAS Peptide DME1028 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.6 microM) DME1028 XEOTICID XEO02819 GENEFORM Protein DME1028 XEOTICID XEO02819 MOACRIVE Inhibition DME1028 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1028 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02820 XEO_CLAS Peptide DME1028 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO02820 GENEFORM Protein DME1028 XEOTICID XEO02820 MOACRIVE Inhibition DME1028 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1028 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02821 XEO_CLAS Peptide DME1028 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02821 GENEFORM Protein DME1028 XEOTICID XEO02821 MOACRIVE Inhibition DME1028 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1028 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02824 XEO_CLAS Peptide DME1028 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 35 microM) DME1028 XEOTICID XEO02824 GENEFORM Protein DME1028 XEOTICID XEO02824 MOACRIVE Inhibition DME1028 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1028 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02826 XEO_CLAS Peptide DME1028 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.7 ug/ml) DME1028 XEOTICID XEO02826 GENEFORM Protein DME1028 XEOTICID XEO02826 MOACRIVE Inhibition DME1028 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1028 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02834 GENEFORM Protein DME1028 XEOTICID XEO02834 MOACRIVE Inhibition DME1028 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1028 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02839 XEO_CLAS Peptide DME1028 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.25 microM) DME1028 XEOTICID XEO02839 GENEFORM Protein DME1028 XEOTICID XEO02839 MOACRIVE Inhibition DME1028 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1028 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02841 XEO_CLAS Peptide DME1028 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.25 microM) DME1028 XEOTICID XEO02841 GENEFORM Protein DME1028 XEOTICID XEO02841 MOACRIVE Inhibition DME1028 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1028 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02842 XEO_CLAS Peptide DME1028 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.25 microM) DME1028 XEOTICID XEO02842 GENEFORM Protein DME1028 XEOTICID XEO02842 MOACRIVE Inhibition DME1028 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1028 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02843 XEO_CLAS Peptide DME1028 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02843 GENEFORM Protein DME1028 XEOTICID XEO02843 MOACRIVE Inhibition DME1028 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1028 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02849 GENEFORM Protein DME1028 XEOTICID XEO02849 MOACRIVE Inhibition DME1028 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1028 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02857 XEO_CLAS Peptide DME1028 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 53 microM) DME1028 XEOTICID XEO02857 GENEFORM Protein DME1028 XEOTICID XEO02857 MOACRIVE Inhibition DME1028 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1028 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02858 XEO_CLAS Peptide DME1028 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 53 microM) DME1028 XEOTICID XEO02858 GENEFORM Protein DME1028 XEOTICID XEO02858 MOACRIVE Inhibition DME1028 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1028 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02860 XEO_CLAS Peptide DME1028 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 ug/ml) DME1028 XEOTICID XEO02860 GENEFORM Protein DME1028 XEOTICID XEO02860 MOACRIVE Inhibition DME1028 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1028 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02867 XEO_CLAS Peptide DME1028 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02867 GENEFORM Protein DME1028 XEOTICID XEO02867 MOACRIVE Inhibition DME1028 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1028 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02868 XEO_CLAS Peptide DME1028 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02868 GENEFORM Protein DME1028 XEOTICID XEO02868 MOACRIVE Inhibition DME1028 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1028 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02869 XEO_CLAS Peptide DME1028 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02869 GENEFORM Protein DME1028 XEOTICID XEO02869 MOACRIVE Inhibition DME1028 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1028 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02870 XEO_CLAS Peptide DME1028 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02870 GENEFORM Protein DME1028 XEOTICID XEO02870 MOACRIVE Inhibition DME1028 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1028 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02871 XEO_CLAS Peptide DME1028 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02871 GENEFORM Protein DME1028 XEOTICID XEO02871 MOACRIVE Inhibition DME1028 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1028 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02872 XEO_CLAS Peptide DME1028 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 308 microM) DME1028 XEOTICID XEO02872 GENEFORM Protein DME1028 XEOTICID XEO02872 MOACRIVE Inhibition DME1028 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1028 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02875 XEO_CLAS Peptide DME1028 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.1 microM) DME1028 XEOTICID XEO02875 GENEFORM Protein DME1028 XEOTICID XEO02875 MOACRIVE Inhibition DME1028 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1028 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02876 XEO_CLAS Peptide DME1028 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO02876 GENEFORM Protein DME1028 XEOTICID XEO02876 MOACRIVE Inhibition DME1028 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1028 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02877 XEO_CLAS Peptide DME1028 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO02877 GENEFORM Protein DME1028 XEOTICID XEO02877 MOACRIVE Inhibition DME1028 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1028 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02878 XEO_CLAS Peptide DME1028 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.3 microM) DME1028 XEOTICID XEO02878 GENEFORM Protein DME1028 XEOTICID XEO02878 MOACRIVE Inhibition DME1028 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1028 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02885 XEO_CLAS Peptide DME1028 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02885 GENEFORM Protein DME1028 XEOTICID XEO02885 MOACRIVE Inhibition DME1028 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1028 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02886 XEO_CLAS Peptide DME1028 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02886 GENEFORM Protein DME1028 XEOTICID XEO02886 MOACRIVE Inhibition DME1028 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1028 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02887 XEO_CLAS Peptide DME1028 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1 ug/ml) DME1028 XEOTICID XEO02887 GENEFORM Protein DME1028 XEOTICID XEO02887 MOACRIVE Inhibition DME1028 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1028 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02888 XEO_CLAS Peptide DME1028 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 ug/ml) DME1028 XEOTICID XEO02888 GENEFORM Protein DME1028 XEOTICID XEO02888 MOACRIVE Inhibition DME1028 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1028 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02889 XEO_CLAS Peptide DME1028 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 ug/ml) DME1028 XEOTICID XEO02889 GENEFORM Protein DME1028 XEOTICID XEO02889 MOACRIVE Inhibition DME1028 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1028 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02890 XEO_CLAS Peptide DME1028 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02890 GENEFORM Protein DME1028 XEOTICID XEO02890 MOACRIVE Inhibition DME1028 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1028 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02891 XEO_CLAS Peptide DME1028 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02891 GENEFORM Protein DME1028 XEOTICID XEO02891 MOACRIVE Inhibition DME1028 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1028 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02895 XEO_CLAS Peptide DME1028 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO02895 GENEFORM Protein DME1028 XEOTICID XEO02895 MOACRIVE Inhibition DME1028 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1028 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02896 XEO_CLAS Peptide DME1028 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO02896 GENEFORM Protein DME1028 XEOTICID XEO02896 MOACRIVE Inhibition DME1028 XEOTICID XEO02899 XEO_NAME Coladonin DME1028 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1028 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1028 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02899 GENEFORM Protein DME1028 XEOTICID XEO02899 MOACRIVE Inhibition DME1028 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1028 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02900 XEO_CLAS Peptide DME1028 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02900 GENEFORM Protein DME1028 XEOTICID XEO02900 MOACRIVE Inhibition DME1028 XEOTICID XEO02901 XEO_NAME Colicin-V DME1028 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02901 XEO_CLAS Peptide DME1028 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02901 GENEFORM Protein DME1028 XEOTICID XEO02901 MOACRIVE Inhibition DME1028 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1028 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02904 GENEFORM Protein DME1028 XEOTICID XEO02904 MOACRIVE Inhibition DME1028 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1028 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02908 XEO_CLAS Peptide DME1028 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 50 microM) DME1028 XEOTICID XEO02908 GENEFORM Protein DME1028 XEOTICID XEO02908 MOACRIVE Inhibition DME1028 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1028 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02923 XEO_CLAS Peptide DME1028 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02923 GENEFORM Protein DME1028 XEOTICID XEO02923 MOACRIVE Inhibition DME1028 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1028 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02924 XEO_CLAS Peptide DME1028 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 32 microM) DME1028 XEOTICID XEO02924 GENEFORM Protein DME1028 XEOTICID XEO02924 MOACRIVE Inhibition DME1028 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1028 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1028 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02927 GENEFORM Protein DME1028 XEOTICID XEO02927 MOACRIVE Inhibition DME1028 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1028 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02931 XEO_CLAS Peptide DME1028 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 ug/ml) DME1028 XEOTICID XEO02931 GENEFORM Protein DME1028 XEOTICID XEO02931 MOACRIVE Inhibition DME1028 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1028 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02933 XEO_CLAS Peptide DME1028 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO02933 GENEFORM Protein DME1028 XEOTICID XEO02933 MOACRIVE Inhibition DME1028 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1028 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02934 XEO_CLAS Peptide DME1028 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02934 GENEFORM Protein DME1028 XEOTICID XEO02934 MOACRIVE Inhibition DME1028 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1028 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02935 XEO_CLAS Peptide DME1028 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02935 GENEFORM Protein DME1028 XEOTICID XEO02935 MOACRIVE Inhibition DME1028 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1028 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02936 XEO_CLAS Peptide DME1028 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO02936 GENEFORM Protein DME1028 XEOTICID XEO02936 MOACRIVE Inhibition DME1028 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1028 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02937 XEO_CLAS Peptide DME1028 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02937 GENEFORM Protein DME1028 XEOTICID XEO02937 MOACRIVE Inhibition DME1028 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1028 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02938 XEO_CLAS Peptide DME1028 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 32 ug/ml) DME1028 XEOTICID XEO02938 GENEFORM Protein DME1028 XEOTICID XEO02938 MOACRIVE Inhibition DME1028 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1028 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02939 XEO_CLAS Peptide DME1028 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 11 ug/ml) DME1028 XEOTICID XEO02939 GENEFORM Protein DME1028 XEOTICID XEO02939 MOACRIVE Inhibition DME1028 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1028 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02940 XEO_CLAS Peptide DME1028 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1 ug/ml) DME1028 XEOTICID XEO02940 GENEFORM Protein DME1028 XEOTICID XEO02940 MOACRIVE Inhibition DME1028 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1028 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02941 XEO_CLAS Peptide DME1028 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02941 GENEFORM Protein DME1028 XEOTICID XEO02941 MOACRIVE Inhibition DME1028 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1028 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02944 XEO_CLAS Peptide DME1028 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 microM) DME1028 XEOTICID XEO02944 GENEFORM Protein DME1028 XEOTICID XEO02944 MOACRIVE Inhibition DME1028 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1028 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02945 XEO_CLAS Peptide DME1028 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 microM) DME1028 XEOTICID XEO02945 GENEFORM Protein DME1028 XEOTICID XEO02945 MOACRIVE Inhibition DME1028 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1028 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02946 XEO_CLAS Peptide DME1028 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 microM) DME1028 XEOTICID XEO02946 GENEFORM Protein DME1028 XEOTICID XEO02946 MOACRIVE Inhibition DME1028 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1028 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02947 XEO_CLAS Peptide DME1028 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02947 GENEFORM Protein DME1028 XEOTICID XEO02947 MOACRIVE Inhibition DME1028 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1028 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02948 XEO_CLAS Peptide DME1028 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO02948 GENEFORM Protein DME1028 XEOTICID XEO02948 MOACRIVE Inhibition DME1028 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1028 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02949 XEO_CLAS Peptide DME1028 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO02949 GENEFORM Protein DME1028 XEOTICID XEO02949 MOACRIVE Inhibition DME1028 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1028 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02954 XEO_CLAS Peptide DME1028 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02954 GENEFORM Protein DME1028 XEOTICID XEO02954 MOACRIVE Inhibition DME1028 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1028 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02958 XEO_CLAS Peptide DME1028 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02958 GENEFORM Protein DME1028 XEOTICID XEO02958 MOACRIVE Inhibition DME1028 XEOTICID XEO02962 XEO_NAME Cryptonin DME1028 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02962 XEO_CLAS Peptide DME1028 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.12 ug/ml) DME1028 XEOTICID XEO02962 GENEFORM Protein DME1028 XEOTICID XEO02962 MOACRIVE Inhibition DME1028 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1028 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02965 XEO_CLAS Peptide DME1028 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 ug/ml) DME1028 XEOTICID XEO02965 GENEFORM Protein DME1028 XEOTICID XEO02965 MOACRIVE Inhibition DME1028 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1028 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02969 XEO_CLAS Peptide DME1028 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 microM) DME1028 XEOTICID XEO02969 GENEFORM Protein DME1028 XEOTICID XEO02969 MOACRIVE Inhibition DME1028 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1028 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02971 XEO_CLAS Peptide DME1028 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 microM) DME1028 XEOTICID XEO02971 GENEFORM Protein DME1028 XEOTICID XEO02971 MOACRIVE Inhibition DME1028 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1028 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO02972 XEO_CLAS Peptide DME1028 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.4 microM) DME1028 XEOTICID XEO02972 GENEFORM Protein DME1028 XEOTICID XEO02972 MOACRIVE Inhibition DME1028 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1028 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02990 GENEFORM Protein DME1028 XEOTICID XEO02990 MOACRIVE Inhibition DME1028 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1028 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02991 GENEFORM Protein DME1028 XEOTICID XEO02991 MOACRIVE Inhibition DME1028 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1028 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02992 GENEFORM Protein DME1028 XEOTICID XEO02992 MOACRIVE Inhibition DME1028 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1028 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02993 GENEFORM Protein DME1028 XEOTICID XEO02993 MOACRIVE Inhibition DME1028 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1028 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02994 GENEFORM Protein DME1028 XEOTICID XEO02994 MOACRIVE Inhibition DME1028 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1028 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02995 GENEFORM Protein DME1028 XEOTICID XEO02995 MOACRIVE Inhibition DME1028 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1028 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02996 GENEFORM Protein DME1028 XEOTICID XEO02996 MOACRIVE Inhibition DME1028 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1028 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02997 GENEFORM Protein DME1028 XEOTICID XEO02997 MOACRIVE Inhibition DME1028 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1028 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02998 GENEFORM Protein DME1028 XEOTICID XEO02998 MOACRIVE Inhibition DME1028 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1028 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1028 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO02999 GENEFORM Protein DME1028 XEOTICID XEO02999 MOACRIVE Inhibition DME1028 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1028 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03021 XEO_CLAS Peptide DME1028 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.31-0.63 microM) DME1028 XEOTICID XEO03021 GENEFORM Protein DME1028 XEOTICID XEO03021 MOACRIVE Inhibition DME1028 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1028 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03029 XEO_CLAS Peptide DME1028 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.005 microM) DME1028 XEOTICID XEO03029 GENEFORM Protein DME1028 XEOTICID XEO03029 MOACRIVE Inhibition DME1028 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1028 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03030 XEO_CLAS Peptide DME1028 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.005 microM) DME1028 XEOTICID XEO03030 GENEFORM Protein DME1028 XEOTICID XEO03030 MOACRIVE Inhibition DME1028 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1028 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03031 XEO_CLAS Peptide DME1028 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.3 microM) DME1028 XEOTICID XEO03031 GENEFORM Protein DME1028 XEOTICID XEO03031 MOACRIVE Inhibition DME1028 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1028 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03032 XEO_CLAS Peptide DME1028 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.01 microM) DME1028 XEOTICID XEO03032 GENEFORM Protein DME1028 XEOTICID XEO03032 MOACRIVE Inhibition DME1028 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1028 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03033 XEO_CLAS Peptide DME1028 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.173 microM) DME1028 XEOTICID XEO03033 GENEFORM Protein DME1028 XEOTICID XEO03033 MOACRIVE Inhibition DME1028 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1028 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03034 XEO_CLAS Peptide DME1028 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.518 microM) DME1028 XEOTICID XEO03034 GENEFORM Protein DME1028 XEOTICID XEO03034 MOACRIVE Inhibition DME1028 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1028 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03035 XEO_CLAS Peptide DME1028 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.114 microM) DME1028 XEOTICID XEO03035 GENEFORM Protein DME1028 XEOTICID XEO03035 MOACRIVE Inhibition DME1028 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1028 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03039 XEO_CLAS Peptide DME1028 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.55 microM) DME1028 XEOTICID XEO03039 GENEFORM Protein DME1028 XEOTICID XEO03039 MOACRIVE Inhibition DME1028 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1028 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03043 XEO_CLAS Peptide DME1028 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 microM) DME1028 XEOTICID XEO03043 GENEFORM Protein DME1028 XEOTICID XEO03043 MOACRIVE Inhibition DME1028 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1028 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03044 XEO_CLAS Peptide DME1028 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03044 GENEFORM Protein DME1028 XEOTICID XEO03044 MOACRIVE Inhibition DME1028 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1028 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03045 XEO_CLAS Peptide DME1028 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03045 GENEFORM Protein DME1028 XEOTICID XEO03045 MOACRIVE Inhibition DME1028 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1028 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03046 XEO_CLAS Peptide DME1028 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03046 GENEFORM Protein DME1028 XEOTICID XEO03046 MOACRIVE Inhibition DME1028 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1028 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03049 XEO_CLAS Peptide DME1028 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 microM) DME1028 XEOTICID XEO03049 GENEFORM Protein DME1028 XEOTICID XEO03049 MOACRIVE Inhibition DME1028 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1028 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03055 XEO_CLAS Peptide DME1028 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 microM) DME1028 XEOTICID XEO03055 GENEFORM Protein DME1028 XEOTICID XEO03055 MOACRIVE Inhibition DME1028 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1028 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03059 XEO_CLAS Peptide DME1028 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO03059 GENEFORM Protein DME1028 XEOTICID XEO03059 MOACRIVE Inhibition DME1028 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1028 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03060 XEO_CLAS Peptide DME1028 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO03060 GENEFORM Protein DME1028 XEOTICID XEO03060 MOACRIVE Inhibition DME1028 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1028 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03062 XEO_CLAS Peptide DME1028 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO03062 GENEFORM Protein DME1028 XEOTICID XEO03062 MOACRIVE Inhibition DME1028 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1028 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03064 XEO_CLAS Peptide DME1028 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO03064 GENEFORM Protein DME1028 XEOTICID XEO03064 MOACRIVE Inhibition DME1028 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1028 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03066 XEO_CLAS Peptide DME1028 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO03066 GENEFORM Protein DME1028 XEOTICID XEO03066 MOACRIVE Inhibition DME1028 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1028 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03068 XEO_CLAS Peptide DME1028 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO03068 GENEFORM Protein DME1028 XEOTICID XEO03068 MOACRIVE Inhibition DME1028 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1028 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03073 XEO_CLAS Peptide DME1028 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8-16 ug/ml) DME1028 XEOTICID XEO03073 GENEFORM Protein DME1028 XEOTICID XEO03073 MOACRIVE Inhibition DME1028 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1028 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03081 XEO_CLAS Peptide DME1028 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 microM) DME1028 XEOTICID XEO03081 GENEFORM Protein DME1028 XEOTICID XEO03081 MOACRIVE Inhibition DME1028 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1028 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03082 XEO_CLAS Peptide DME1028 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03082 GENEFORM Protein DME1028 XEOTICID XEO03082 MOACRIVE Inhibition DME1028 XEOTICID XEO03089 XEO_NAME Decoralin DME1028 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03089 XEO_CLAS Peptide DME1028 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 160 microM) DME1028 XEOTICID XEO03089 GENEFORM Protein DME1028 XEOTICID XEO03089 MOACRIVE Inhibition DME1028 XEOTICID XEO03098 XEO_NAME Insect defensin DME1028 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03098 XEO_CLAS Peptide DME1028 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 ug/ml) DME1028 XEOTICID XEO03098 GENEFORM Protein DME1028 XEOTICID XEO03098 MOACRIVE Inhibition DME1028 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1028 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03100 XEO_CLAS Peptide DME1028 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03100 GENEFORM Protein DME1028 XEOTICID XEO03100 MOACRIVE Inhibition DME1028 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1028 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03103 XEO_CLAS Peptide DME1028 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03103 GENEFORM Protein DME1028 XEOTICID XEO03103 MOACRIVE Inhibition DME1028 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1028 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03105 XEO_CLAS Peptide DME1028 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03105 GENEFORM Protein DME1028 XEOTICID XEO03105 MOACRIVE Inhibition DME1028 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1028 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03110 XEO_CLAS Peptide DME1028 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.2 microM) DME1028 XEOTICID XEO03110 GENEFORM Protein DME1028 XEOTICID XEO03110 MOACRIVE Inhibition DME1028 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1028 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03111 XEO_CLAS Peptide DME1028 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03111 GENEFORM Protein DME1028 XEOTICID XEO03111 MOACRIVE Inhibition DME1028 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1028 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03112 XEO_CLAS Peptide DME1028 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 50 ug/ml) DME1028 XEOTICID XEO03112 GENEFORM Protein DME1028 XEOTICID XEO03112 MOACRIVE Inhibition DME1028 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1028 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03115 XEO_CLAS Peptide DME1028 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03115 GENEFORM Protein DME1028 XEOTICID XEO03115 MOACRIVE Inhibition DME1028 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1028 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03116 XEO_CLAS Peptide DME1028 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 40 microM) DME1028 XEOTICID XEO03116 GENEFORM Protein DME1028 XEOTICID XEO03116 MOACRIVE Inhibition DME1028 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1028 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03118 XEO_CLAS Peptide DME1028 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03118 GENEFORM Protein DME1028 XEOTICID XEO03118 MOACRIVE Inhibition DME1028 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1028 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03119 XEO_CLAS Peptide DME1028 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03119 GENEFORM Protein DME1028 XEOTICID XEO03119 MOACRIVE Inhibition DME1028 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1028 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03121 XEO_CLAS Peptide DME1028 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03121 GENEFORM Protein DME1028 XEOTICID XEO03121 MOACRIVE Inhibition DME1028 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1028 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03122 XEO_CLAS Peptide DME1028 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64000 ug/ml) DME1028 XEOTICID XEO03122 GENEFORM Protein DME1028 XEOTICID XEO03122 MOACRIVE Inhibition DME1028 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1028 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03124 XEO_CLAS Peptide DME1028 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03124 GENEFORM Protein DME1028 XEOTICID XEO03124 MOACRIVE Inhibition DME1028 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1028 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03125 XEO_CLAS Peptide DME1028 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03125 GENEFORM Protein DME1028 XEOTICID XEO03125 MOACRIVE Inhibition DME1028 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1028 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03126 XEO_CLAS Peptide DME1028 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.86 microM) DME1028 XEOTICID XEO03126 GENEFORM Protein DME1028 XEOTICID XEO03126 MOACRIVE Inhibition DME1028 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1028 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03127 XEO_CLAS Peptide DME1028 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03127 GENEFORM Protein DME1028 XEOTICID XEO03127 MOACRIVE Inhibition DME1028 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1028 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03128 XEO_CLAS Peptide DME1028 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 256 ug/ml) DME1028 XEOTICID XEO03128 GENEFORM Protein DME1028 XEOTICID XEO03128 MOACRIVE Inhibition DME1028 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1028 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03129 XEO_CLAS Peptide DME1028 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 256 ug/ml) DME1028 XEOTICID XEO03129 GENEFORM Protein DME1028 XEOTICID XEO03129 MOACRIVE Inhibition DME1028 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1028 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03130 XEO_CLAS Peptide DME1028 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 256 ug/ml) DME1028 XEOTICID XEO03130 GENEFORM Protein DME1028 XEOTICID XEO03130 MOACRIVE Inhibition DME1028 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1028 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03131 XEO_CLAS Peptide DME1028 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 256 ug/ml) DME1028 XEOTICID XEO03131 GENEFORM Protein DME1028 XEOTICID XEO03131 MOACRIVE Inhibition DME1028 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1028 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03132 XEO_CLAS Peptide DME1028 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 256 ug/ml) DME1028 XEOTICID XEO03132 GENEFORM Protein DME1028 XEOTICID XEO03132 MOACRIVE Inhibition DME1028 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1028 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03137 XEO_CLAS Peptide DME1028 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03137 GENEFORM Protein DME1028 XEOTICID XEO03137 MOACRIVE Inhibition DME1028 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1028 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03143 XEO_CLAS Peptide DME1028 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.6 microM) DME1028 XEOTICID XEO03143 GENEFORM Protein DME1028 XEOTICID XEO03143 MOACRIVE Inhibition DME1028 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1028 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03145 XEO_CLAS Peptide DME1028 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.6 microM) DME1028 XEOTICID XEO03145 GENEFORM Protein DME1028 XEOTICID XEO03145 MOACRIVE Inhibition DME1028 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1028 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03146 XEO_CLAS Peptide DME1028 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.5 microM) DME1028 XEOTICID XEO03146 GENEFORM Protein DME1028 XEOTICID XEO03146 MOACRIVE Inhibition DME1028 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1028 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03147 XEO_CLAS Peptide DME1028 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9.7 microM) DME1028 XEOTICID XEO03147 GENEFORM Protein DME1028 XEOTICID XEO03147 MOACRIVE Inhibition DME1028 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1028 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03148 XEO_CLAS Peptide DME1028 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.3 microM) DME1028 XEOTICID XEO03148 GENEFORM Protein DME1028 XEOTICID XEO03148 MOACRIVE Inhibition DME1028 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1028 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03149 XEO_CLAS Peptide DME1028 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.6 microM) DME1028 XEOTICID XEO03149 GENEFORM Protein DME1028 XEOTICID XEO03149 MOACRIVE Inhibition DME1028 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1028 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03150 XEO_CLAS Peptide DME1028 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9-3 microM) DME1028 XEOTICID XEO03150 GENEFORM Protein DME1028 XEOTICID XEO03150 MOACRIVE Inhibition DME1028 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1028 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03151 XEO_CLAS Peptide DME1028 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 ug/ml) DME1028 XEOTICID XEO03151 GENEFORM Protein DME1028 XEOTICID XEO03151 MOACRIVE Inhibition DME1028 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1028 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03152 XEO_CLAS Peptide DME1028 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO03152 GENEFORM Protein DME1028 XEOTICID XEO03152 MOACRIVE Inhibition DME1028 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1028 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03155 XEO_CLAS Peptide DME1028 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.4 microM) DME1028 XEOTICID XEO03155 GENEFORM Protein DME1028 XEOTICID XEO03155 MOACRIVE Inhibition DME1028 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1028 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03156 XEO_CLAS Peptide DME1028 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.3 microM) DME1028 XEOTICID XEO03156 GENEFORM Protein DME1028 XEOTICID XEO03156 MOACRIVE Inhibition DME1028 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1028 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03157 XEO_CLAS Peptide DME1028 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.3 microM) DME1028 XEOTICID XEO03157 GENEFORM Protein DME1028 XEOTICID XEO03157 MOACRIVE Inhibition DME1028 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1028 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03158 XEO_CLAS Peptide DME1028 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 ug/ml) DME1028 XEOTICID XEO03158 GENEFORM Protein DME1028 XEOTICID XEO03158 MOACRIVE Inhibition DME1028 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1028 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03159 XEO_CLAS Peptide DME1028 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03159 GENEFORM Protein DME1028 XEOTICID XEO03159 MOACRIVE Inhibition DME1028 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1028 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03161 XEO_CLAS Peptide DME1028 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 microM) DME1028 XEOTICID XEO03161 GENEFORM Protein DME1028 XEOTICID XEO03161 MOACRIVE Inhibition DME1028 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1028 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03162 XEO_CLAS Peptide DME1028 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.5 microM) DME1028 XEOTICID XEO03162 GENEFORM Protein DME1028 XEOTICID XEO03162 MOACRIVE Inhibition DME1028 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1028 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03169 XEO_CLAS Peptide DME1028 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO03169 GENEFORM Protein DME1028 XEOTICID XEO03169 MOACRIVE Inhibition DME1028 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1028 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03193 XEO_CLAS Peptide DME1028 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25 ug/ml) DME1028 XEOTICID XEO03193 GENEFORM Protein DME1028 XEOTICID XEO03193 MOACRIVE Inhibition DME1028 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1028 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03194 XEO_CLAS Peptide DME1028 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03194 GENEFORM Protein DME1028 XEOTICID XEO03194 MOACRIVE Inhibition DME1028 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1028 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03195 XEO_CLAS Peptide DME1028 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03195 GENEFORM Protein DME1028 XEOTICID XEO03195 MOACRIVE Inhibition DME1028 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1028 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03197 XEO_CLAS Peptide DME1028 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 14.5 microM) DME1028 XEOTICID XEO03197 GENEFORM Protein DME1028 XEOTICID XEO03197 MOACRIVE Inhibition DME1028 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1028 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03202 XEO_CLAS Peptide DME1028 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.51 microM) DME1028 XEOTICID XEO03202 GENEFORM Protein DME1028 XEOTICID XEO03202 MOACRIVE Inhibition DME1028 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1028 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03203 XEO_CLAS Peptide DME1028 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.62 microM) DME1028 XEOTICID XEO03203 GENEFORM Protein DME1028 XEOTICID XEO03203 MOACRIVE Inhibition DME1028 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1028 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03204 XEO_CLAS Peptide DME1028 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.38 microM) DME1028 XEOTICID XEO03204 GENEFORM Protein DME1028 XEOTICID XEO03204 MOACRIVE Inhibition DME1028 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1028 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03205 XEO_CLAS Peptide DME1028 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.29 microM) DME1028 XEOTICID XEO03205 GENEFORM Protein DME1028 XEOTICID XEO03205 MOACRIVE Inhibition DME1028 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1028 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03206 XEO_CLAS Peptide DME1028 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.40 microM) DME1028 XEOTICID XEO03206 GENEFORM Protein DME1028 XEOTICID XEO03206 MOACRIVE Inhibition DME1028 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1028 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03207 XEO_CLAS Peptide DME1028 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.58 microM) DME1028 XEOTICID XEO03207 GENEFORM Protein DME1028 XEOTICID XEO03207 MOACRIVE Inhibition DME1028 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1028 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03208 XEO_CLAS Peptide DME1028 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.76 microM) DME1028 XEOTICID XEO03208 GENEFORM Protein DME1028 XEOTICID XEO03208 MOACRIVE Inhibition DME1028 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1028 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03209 XEO_CLAS Peptide DME1028 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.49 microM) DME1028 XEOTICID XEO03209 GENEFORM Protein DME1028 XEOTICID XEO03209 MOACRIVE Inhibition DME1028 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1028 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03210 XEO_CLAS Peptide DME1028 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7.07 microM) DME1028 XEOTICID XEO03210 GENEFORM Protein DME1028 XEOTICID XEO03210 MOACRIVE Inhibition DME1028 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1028 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03211 XEO_CLAS Peptide DME1028 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.40 microM) DME1028 XEOTICID XEO03211 GENEFORM Protein DME1028 XEOTICID XEO03211 MOACRIVE Inhibition DME1028 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1028 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03215 XEO_CLAS Peptide DME1028 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20.0 ug/ml) DME1028 XEOTICID XEO03215 GENEFORM Protein DME1028 XEOTICID XEO03215 MOACRIVE Inhibition DME1028 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1028 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03216 XEO_CLAS Peptide DME1028 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO03216 GENEFORM Protein DME1028 XEOTICID XEO03216 MOACRIVE Inhibition DME1028 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1028 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03217 XEO_CLAS Peptide DME1028 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO03217 GENEFORM Protein DME1028 XEOTICID XEO03217 MOACRIVE Inhibition DME1028 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1028 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03223 XEO_CLAS Peptide DME1028 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.8 microM) DME1028 XEOTICID XEO03223 GENEFORM Protein DME1028 XEOTICID XEO03223 MOACRIVE Inhibition DME1028 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1028 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03224 XEO_CLAS Peptide DME1028 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.1-0.25 microM) DME1028 XEOTICID XEO03224 GENEFORM Protein DME1028 XEOTICID XEO03224 MOACRIVE Inhibition DME1028 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1028 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03225 XEO_CLAS Peptide DME1028 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.3 microM) DME1028 XEOTICID XEO03225 GENEFORM Protein DME1028 XEOTICID XEO03225 MOACRIVE Inhibition DME1028 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1028 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03227 XEO_CLAS Peptide DME1028 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.3 microM) DME1028 XEOTICID XEO03227 GENEFORM Protein DME1028 XEOTICID XEO03227 MOACRIVE Inhibition DME1028 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1028 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03231 XEO_CLAS Peptide DME1028 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03231 GENEFORM Protein DME1028 XEOTICID XEO03231 MOACRIVE Inhibition DME1028 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1028 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03232 XEO_CLAS Peptide DME1028 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03232 GENEFORM Protein DME1028 XEOTICID XEO03232 MOACRIVE Inhibition DME1028 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1028 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03234 XEO_CLAS Peptide DME1028 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO03234 GENEFORM Protein DME1028 XEOTICID XEO03234 MOACRIVE Inhibition DME1028 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1028 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03235 XEO_CLAS Peptide DME1028 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 60 ug/ml) DME1028 XEOTICID XEO03235 GENEFORM Protein DME1028 XEOTICID XEO03235 MOACRIVE Inhibition DME1028 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1028 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03236 XEO_CLAS Peptide DME1028 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO03236 GENEFORM Protein DME1028 XEOTICID XEO03236 MOACRIVE Inhibition DME1028 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1028 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03237 XEO_CLAS Peptide DME1028 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 ug/ml) DME1028 XEOTICID XEO03237 GENEFORM Protein DME1028 XEOTICID XEO03237 MOACRIVE Inhibition DME1028 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1028 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03238 XEO_CLAS Peptide DME1028 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 ug/ml) DME1028 XEOTICID XEO03238 GENEFORM Protein DME1028 XEOTICID XEO03238 MOACRIVE Inhibition DME1028 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1028 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03239 XEO_CLAS Peptide DME1028 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 60 ug/ml) DME1028 XEOTICID XEO03239 GENEFORM Protein DME1028 XEOTICID XEO03239 MOACRIVE Inhibition DME1028 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1028 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03241 XEO_CLAS Peptide DME1028 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 128 microM) DME1028 XEOTICID XEO03241 GENEFORM Protein DME1028 XEOTICID XEO03241 MOACRIVE Inhibition DME1028 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1028 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03250 XEO_CLAS Peptide DME1028 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03250 GENEFORM Protein DME1028 XEOTICID XEO03250 MOACRIVE Inhibition DME1028 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1028 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03251 XEO_CLAS Peptide DME1028 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03251 GENEFORM Protein DME1028 XEOTICID XEO03251 MOACRIVE Inhibition DME1028 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1028 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03253 XEO_CLAS Peptide DME1028 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.1 ug/ml) DME1028 XEOTICID XEO03253 GENEFORM Protein DME1028 XEOTICID XEO03253 MOACRIVE Inhibition DME1028 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1028 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03274 XEO_CLAS Peptide DME1028 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.2 microM) DME1028 XEOTICID XEO03274 GENEFORM Protein DME1028 XEOTICID XEO03274 MOACRIVE Inhibition DME1028 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1028 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03275 XEO_CLAS Peptide DME1028 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO03275 GENEFORM Protein DME1028 XEOTICID XEO03275 MOACRIVE Inhibition DME1028 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1028 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03276 XEO_CLAS Peptide DME1028 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO03276 GENEFORM Protein DME1028 XEOTICID XEO03276 MOACRIVE Inhibition DME1028 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1028 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03277 XEO_CLAS Peptide DME1028 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.2 microM) DME1028 XEOTICID XEO03277 GENEFORM Protein DME1028 XEOTICID XEO03277 MOACRIVE Inhibition DME1028 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1028 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03278 XEO_CLAS Peptide DME1028 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO03278 GENEFORM Protein DME1028 XEOTICID XEO03278 MOACRIVE Inhibition DME1028 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1028 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03279 XEO_CLAS Peptide DME1028 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO03279 GENEFORM Protein DME1028 XEOTICID XEO03279 MOACRIVE Inhibition DME1028 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1028 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03280 XEO_CLAS Peptide DME1028 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 microM) DME1028 XEOTICID XEO03280 GENEFORM Protein DME1028 XEOTICID XEO03280 MOACRIVE Inhibition DME1028 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1028 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03281 XEO_CLAS Peptide DME1028 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.3 microM) DME1028 XEOTICID XEO03281 GENEFORM Protein DME1028 XEOTICID XEO03281 MOACRIVE Inhibition DME1028 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1028 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03282 XEO_CLAS Peptide DME1028 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.1 microM) DME1028 XEOTICID XEO03282 GENEFORM Protein DME1028 XEOTICID XEO03282 MOACRIVE Inhibition DME1028 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1028 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03283 XEO_CLAS Peptide DME1028 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 microM) DME1028 XEOTICID XEO03283 GENEFORM Protein DME1028 XEOTICID XEO03283 MOACRIVE Inhibition DME1028 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1028 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03284 XEO_CLAS Peptide DME1028 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.2 ug/ml) DME1028 XEOTICID XEO03284 GENEFORM Protein DME1028 XEOTICID XEO03284 MOACRIVE Inhibition DME1028 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1028 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03285 XEO_CLAS Peptide DME1028 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.5 ug/ml) DME1028 XEOTICID XEO03285 GENEFORM Protein DME1028 XEOTICID XEO03285 MOACRIVE Inhibition DME1028 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1028 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03286 XEO_CLAS Peptide DME1028 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.4 ug/ml) DME1028 XEOTICID XEO03286 GENEFORM Protein DME1028 XEOTICID XEO03286 MOACRIVE Inhibition DME1028 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1028 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03287 XEO_CLAS Peptide DME1028 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.6 ug/ml) DME1028 XEOTICID XEO03287 GENEFORM Protein DME1028 XEOTICID XEO03287 MOACRIVE Inhibition DME1028 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1028 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03288 XEO_CLAS Peptide DME1028 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.4 ug/ml) DME1028 XEOTICID XEO03288 GENEFORM Protein DME1028 XEOTICID XEO03288 MOACRIVE Inhibition DME1028 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1028 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03289 XEO_CLAS Peptide DME1028 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8.8 ug/ml) DME1028 XEOTICID XEO03289 GENEFORM Protein DME1028 XEOTICID XEO03289 MOACRIVE Inhibition DME1028 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1028 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03290 XEO_CLAS Peptide DME1028 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.5 ug/ml) DME1028 XEOTICID XEO03290 GENEFORM Protein DME1028 XEOTICID XEO03290 MOACRIVE Inhibition DME1028 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1028 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03291 XEO_CLAS Peptide DME1028 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8.6 ug/ml) DME1028 XEOTICID XEO03291 GENEFORM Protein DME1028 XEOTICID XEO03291 MOACRIVE Inhibition DME1028 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1028 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03292 XEO_CLAS Peptide DME1028 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4.1 ug/ml) DME1028 XEOTICID XEO03292 GENEFORM Protein DME1028 XEOTICID XEO03292 MOACRIVE Inhibition DME1028 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1028 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03293 XEO_CLAS Peptide DME1028 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1 microM) DME1028 XEOTICID XEO03293 GENEFORM Protein DME1028 XEOTICID XEO03293 MOACRIVE Inhibition DME1028 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1028 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03294 XEO_CLAS Peptide DME1028 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1 microM) DME1028 XEOTICID XEO03294 GENEFORM Protein DME1028 XEOTICID XEO03294 MOACRIVE Inhibition DME1028 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1028 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03295 XEO_CLAS Peptide DME1028 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.7 microM) DME1028 XEOTICID XEO03295 GENEFORM Protein DME1028 XEOTICID XEO03295 MOACRIVE Inhibition DME1028 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1028 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03296 XEO_CLAS Peptide DME1028 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03296 GENEFORM Protein DME1028 XEOTICID XEO03296 MOACRIVE Inhibition DME1028 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1028 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03297 XEO_CLAS Peptide DME1028 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03297 GENEFORM Protein DME1028 XEOTICID XEO03297 MOACRIVE Inhibition DME1028 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1028 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03298 XEO_CLAS Peptide DME1028 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.2 microM) DME1028 XEOTICID XEO03298 GENEFORM Protein DME1028 XEOTICID XEO03298 MOACRIVE Inhibition DME1028 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1028 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03299 XEO_CLAS Peptide DME1028 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.4 microM) DME1028 XEOTICID XEO03299 GENEFORM Protein DME1028 XEOTICID XEO03299 MOACRIVE Inhibition DME1028 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1028 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03300 XEO_CLAS Peptide DME1028 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 ug/ml) DME1028 XEOTICID XEO03300 GENEFORM Protein DME1028 XEOTICID XEO03300 MOACRIVE Inhibition DME1028 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1028 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03301 XEO_CLAS Peptide DME1028 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 ug/ml) DME1028 XEOTICID XEO03301 GENEFORM Protein DME1028 XEOTICID XEO03301 MOACRIVE Inhibition DME1028 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1028 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03302 XEO_CLAS Peptide DME1028 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1 microM) DME1028 XEOTICID XEO03302 GENEFORM Protein DME1028 XEOTICID XEO03302 MOACRIVE Inhibition DME1028 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1028 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03303 XEO_CLAS Peptide DME1028 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 microM) DME1028 XEOTICID XEO03303 GENEFORM Protein DME1028 XEOTICID XEO03303 MOACRIVE Inhibition DME1028 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1028 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03304 XEO_CLAS Peptide DME1028 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO03304 GENEFORM Protein DME1028 XEOTICID XEO03304 MOACRIVE Inhibition DME1028 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1028 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03305 XEO_CLAS Peptide DME1028 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 microM) DME1028 XEOTICID XEO03305 GENEFORM Protein DME1028 XEOTICID XEO03305 MOACRIVE Inhibition DME1028 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1028 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03306 XEO_CLAS Peptide DME1028 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO03306 GENEFORM Protein DME1028 XEOTICID XEO03306 MOACRIVE Inhibition DME1028 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1028 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03307 XEO_CLAS Peptide DME1028 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 34 ug/ml) DME1028 XEOTICID XEO03307 GENEFORM Protein DME1028 XEOTICID XEO03307 MOACRIVE Inhibition DME1028 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1028 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03308 XEO_CLAS Peptide DME1028 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO03308 GENEFORM Protein DME1028 XEOTICID XEO03308 MOACRIVE Inhibition DME1028 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1028 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03310 XEO_CLAS Peptide DME1028 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8.5 ug/ml) DME1028 XEOTICID XEO03310 GENEFORM Protein DME1028 XEOTICID XEO03310 MOACRIVE Inhibition DME1028 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1028 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03311 XEO_CLAS Peptide DME1028 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10.8 ug/ml) DME1028 XEOTICID XEO03311 GENEFORM Protein DME1028 XEOTICID XEO03311 MOACRIVE Inhibition DME1028 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1028 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03312 XEO_CLAS Peptide DME1028 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10.8 ug/ml) DME1028 XEOTICID XEO03312 GENEFORM Protein DME1028 XEOTICID XEO03312 MOACRIVE Inhibition DME1028 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1028 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03313 XEO_CLAS Peptide DME1028 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8.1 ug/ml) DME1028 XEOTICID XEO03313 GENEFORM Protein DME1028 XEOTICID XEO03313 MOACRIVE Inhibition DME1028 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1028 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03314 XEO_CLAS Peptide DME1028 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7.9 ug/ml) DME1028 XEOTICID XEO03314 GENEFORM Protein DME1028 XEOTICID XEO03314 MOACRIVE Inhibition DME1028 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1028 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03315 XEO_CLAS Peptide DME1028 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.6 ug/ml) DME1028 XEOTICID XEO03315 GENEFORM Protein DME1028 XEOTICID XEO03315 MOACRIVE Inhibition DME1028 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1028 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03316 XEO_CLAS Peptide DME1028 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15.8 ug/ml) DME1028 XEOTICID XEO03316 GENEFORM Protein DME1028 XEOTICID XEO03316 MOACRIVE Inhibition DME1028 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1028 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03317 XEO_CLAS Peptide DME1028 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO03317 GENEFORM Protein DME1028 XEOTICID XEO03317 MOACRIVE Inhibition DME1028 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1028 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03318 XEO_CLAS Peptide DME1028 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1 microM) DME1028 XEOTICID XEO03318 GENEFORM Protein DME1028 XEOTICID XEO03318 MOACRIVE Inhibition DME1028 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1028 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03319 XEO_CLAS Peptide DME1028 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03319 GENEFORM Protein DME1028 XEOTICID XEO03319 MOACRIVE Inhibition DME1028 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1028 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03320 XEO_CLAS Peptide DME1028 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.1 microM) DME1028 XEOTICID XEO03320 GENEFORM Protein DME1028 XEOTICID XEO03320 MOACRIVE Inhibition DME1028 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1028 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03321 XEO_CLAS Peptide DME1028 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.8 microM) DME1028 XEOTICID XEO03321 GENEFORM Protein DME1028 XEOTICID XEO03321 MOACRIVE Inhibition DME1028 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1028 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1028 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03348 GENEFORM Protein DME1028 XEOTICID XEO03348 MOACRIVE Inhibition DME1028 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1028 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03362 XEO_CLAS Peptide DME1028 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO03362 GENEFORM Protein DME1028 XEOTICID XEO03362 MOACRIVE Inhibition DME1028 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1028 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03363 XEO_CLAS Peptide DME1028 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 microM) DME1028 XEOTICID XEO03363 GENEFORM Protein DME1028 XEOTICID XEO03363 MOACRIVE Inhibition DME1028 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1028 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03364 XEO_CLAS Peptide DME1028 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 microM) DME1028 XEOTICID XEO03364 GENEFORM Protein DME1028 XEOTICID XEO03364 MOACRIVE Inhibition DME1028 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1028 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03365 XEO_CLAS Peptide DME1028 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03365 GENEFORM Protein DME1028 XEOTICID XEO03365 MOACRIVE Inhibition DME1028 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1028 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03366 XEO_CLAS Peptide DME1028 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO03366 GENEFORM Protein DME1028 XEOTICID XEO03366 MOACRIVE Inhibition DME1028 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1028 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03367 XEO_CLAS Peptide DME1028 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 microM) DME1028 XEOTICID XEO03367 GENEFORM Protein DME1028 XEOTICID XEO03367 MOACRIVE Inhibition DME1028 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1028 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03368 XEO_CLAS Peptide DME1028 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 microM) DME1028 XEOTICID XEO03368 GENEFORM Protein DME1028 XEOTICID XEO03368 MOACRIVE Inhibition DME1028 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1028 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03379 XEO_CLAS Peptide DME1028 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.6 ug/ml) DME1028 XEOTICID XEO03379 GENEFORM Protein DME1028 XEOTICID XEO03379 MOACRIVE Inhibition DME1028 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1028 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03396 XEO_CLAS Peptide DME1028 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03396 GENEFORM Protein DME1028 XEOTICID XEO03396 MOACRIVE Inhibition DME1028 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1028 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03398 XEO_CLAS Peptide DME1028 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03398 GENEFORM Protein DME1028 XEOTICID XEO03398 MOACRIVE Inhibition DME1028 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1028 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03399 XEO_CLAS Peptide DME1028 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03399 GENEFORM Protein DME1028 XEOTICID XEO03399 MOACRIVE Inhibition DME1028 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1028 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03406 XEO_CLAS Peptide DME1028 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 ug/ml) DME1028 XEOTICID XEO03406 GENEFORM Protein DME1028 XEOTICID XEO03406 MOACRIVE Inhibition DME1028 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1028 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03424 XEO_CLAS Peptide DME1028 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03424 GENEFORM Protein DME1028 XEOTICID XEO03424 MOACRIVE Inhibition DME1028 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1028 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03426 XEO_CLAS Peptide DME1028 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO03426 GENEFORM Protein DME1028 XEOTICID XEO03426 MOACRIVE Inhibition DME1028 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1028 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03427 XEO_CLAS Peptide DME1028 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 microM) DME1028 XEOTICID XEO03427 GENEFORM Protein DME1028 XEOTICID XEO03427 MOACRIVE Inhibition DME1028 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1028 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03428 XEO_CLAS Peptide DME1028 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 ug/ml) DME1028 XEOTICID XEO03428 GENEFORM Protein DME1028 XEOTICID XEO03428 MOACRIVE Inhibition DME1028 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1028 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03430 XEO_CLAS Peptide DME1028 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 ug/ml) DME1028 XEOTICID XEO03430 GENEFORM Protein DME1028 XEOTICID XEO03430 MOACRIVE Inhibition DME1028 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1028 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03434 XEO_CLAS Peptide DME1028 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO03434 GENEFORM Protein DME1028 XEOTICID XEO03434 MOACRIVE Inhibition DME1028 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1028 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03442 XEO_CLAS Peptide DME1028 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 18.75 ug/ml) DME1028 XEOTICID XEO03442 GENEFORM Protein DME1028 XEOTICID XEO03442 MOACRIVE Inhibition DME1028 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1028 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03444 XEO_CLAS Peptide DME1028 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 37.50 ug/ml) DME1028 XEOTICID XEO03444 GENEFORM Protein DME1028 XEOTICID XEO03444 MOACRIVE Inhibition DME1028 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1028 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03459 XEO_CLAS Peptide DME1028 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03459 GENEFORM Protein DME1028 XEOTICID XEO03459 MOACRIVE Inhibition DME1028 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1028 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03460 XEO_CLAS Peptide DME1028 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03460 GENEFORM Protein DME1028 XEOTICID XEO03460 MOACRIVE Inhibition DME1028 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1028 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03461 XEO_CLAS Peptide DME1028 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.05 microM) DME1028 XEOTICID XEO03461 GENEFORM Protein DME1028 XEOTICID XEO03461 MOACRIVE Inhibition DME1028 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1028 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03462 XEO_CLAS Peptide DME1028 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03462 GENEFORM Protein DME1028 XEOTICID XEO03462 MOACRIVE Inhibition DME1028 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1028 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03463 XEO_CLAS Peptide DME1028 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03463 GENEFORM Protein DME1028 XEOTICID XEO03463 MOACRIVE Inhibition DME1028 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1028 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03467 XEO_CLAS Peptide DME1028 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03467 GENEFORM Protein DME1028 XEOTICID XEO03467 MOACRIVE Inhibition DME1028 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1028 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03468 XEO_CLAS Peptide DME1028 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03468 GENEFORM Protein DME1028 XEOTICID XEO03468 MOACRIVE Inhibition DME1028 XEOTICID XEO03471 XEO_NAME Gambicin DME1028 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03471 XEO_CLAS Peptide DME1028 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25-12.5 microM) DME1028 XEOTICID XEO03471 GENEFORM Protein DME1028 XEOTICID XEO03471 MOACRIVE Inhibition DME1028 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1028 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03485 XEO_CLAS Peptide DME1028 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4.07 ug/ml) DME1028 XEOTICID XEO03485 GENEFORM Protein DME1028 XEOTICID XEO03485 MOACRIVE Inhibition DME1028 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1028 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03486 XEO_CLAS Peptide DME1028 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.80 ug/ml) DME1028 XEOTICID XEO03486 GENEFORM Protein DME1028 XEOTICID XEO03486 MOACRIVE Inhibition DME1028 XEOTICID XEO03488 XEO_NAME GLK-19 DME1028 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03488 XEO_CLAS Peptide DME1028 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO03488 GENEFORM Protein DME1028 XEOTICID XEO03488 MOACRIVE Inhibition DME1028 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1028 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03497 XEO_CLAS Peptide DME1028 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.4-0.8 microM) DME1028 XEOTICID XEO03497 GENEFORM Protein DME1028 XEOTICID XEO03497 MOACRIVE Inhibition DME1028 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1028 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03498 XEO_CLAS Peptide DME1028 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.4-0.8 microM) DME1028 XEOTICID XEO03498 GENEFORM Protein DME1028 XEOTICID XEO03498 MOACRIVE Inhibition DME1028 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1028 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03500 XEO_CLAS Peptide DME1028 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-30 ug/ml) DME1028 XEOTICID XEO03500 GENEFORM Protein DME1028 XEOTICID XEO03500 MOACRIVE Inhibition DME1028 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1028 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03504 XEO_CLAS Peptide DME1028 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 ug/ml) DME1028 XEOTICID XEO03504 GENEFORM Protein DME1028 XEOTICID XEO03504 MOACRIVE Inhibition DME1028 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1028 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03505 XEO_CLAS Peptide DME1028 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 ug/ml) DME1028 XEOTICID XEO03505 GENEFORM Protein DME1028 XEOTICID XEO03505 MOACRIVE Inhibition DME1028 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1028 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03506 XEO_CLAS Peptide DME1028 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 ug/ml) DME1028 XEOTICID XEO03506 GENEFORM Protein DME1028 XEOTICID XEO03506 MOACRIVE Inhibition DME1028 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1028 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03513 XEO_CLAS Peptide DME1028 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO03513 GENEFORM Protein DME1028 XEOTICID XEO03513 MOACRIVE Inhibition DME1028 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1028 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03514 XEO_CLAS Peptide DME1028 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03514 GENEFORM Protein DME1028 XEOTICID XEO03514 MOACRIVE Inhibition DME1028 XEOTICID XEO03519 XEO_NAME Hadrurin DME1028 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03519 XEO_CLAS Peptide DME1028 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03519 GENEFORM Protein DME1028 XEOTICID XEO03519 MOACRIVE Inhibition DME1028 XEOTICID XEO03522 XEO_NAME Halocyntin DME1028 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03522 XEO_CLAS Peptide DME1028 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03522 GENEFORM Protein DME1028 XEOTICID XEO03522 MOACRIVE Inhibition DME1028 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1028 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03524 XEO_CLAS Peptide DME1028 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03524 GENEFORM Protein DME1028 XEOTICID XEO03524 MOACRIVE Inhibition DME1028 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1028 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03525 XEO_CLAS Peptide DME1028 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03525 GENEFORM Protein DME1028 XEOTICID XEO03525 MOACRIVE Inhibition DME1028 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1028 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03530 XEO_CLAS Peptide DME1028 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03530 GENEFORM Protein DME1028 XEOTICID XEO03530 MOACRIVE Inhibition DME1028 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1028 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03535 XEO_CLAS Peptide DME1028 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.4 microM) DME1028 XEOTICID XEO03535 GENEFORM Protein DME1028 XEOTICID XEO03535 MOACRIVE Inhibition DME1028 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1028 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03536 XEO_CLAS Peptide DME1028 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 80 microM) DME1028 XEOTICID XEO03536 GENEFORM Protein DME1028 XEOTICID XEO03536 MOACRIVE Inhibition DME1028 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1028 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03537 XEO_CLAS Peptide DME1028 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 ug/ml) DME1028 XEOTICID XEO03537 GENEFORM Protein DME1028 XEOTICID XEO03537 MOACRIVE Inhibition DME1028 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1028 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03538 XEO_CLAS Peptide DME1028 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 ug/ml) DME1028 XEOTICID XEO03538 GENEFORM Protein DME1028 XEOTICID XEO03538 MOACRIVE Inhibition DME1028 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1028 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03540 XEO_CLAS Peptide DME1028 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO03540 GENEFORM Protein DME1028 XEOTICID XEO03540 MOACRIVE Inhibition DME1028 XEOTICID XEO03542 XEO_NAME Hepcidin DME1028 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03542 XEO_CLAS Peptide DME1028 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO03542 GENEFORM Protein DME1028 XEOTICID XEO03542 MOACRIVE Inhibition DME1028 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1028 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03544 XEO_CLAS Peptide DME1028 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03544 GENEFORM Protein DME1028 XEOTICID XEO03544 MOACRIVE Inhibition DME1028 XEOTICID XEO03548 XEO_NAME Hesperidin DME1028 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03548 GENEFORM Protein DME1028 XEOTICID XEO03548 MOACRIVE Inhibition DME1028 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1028 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1028 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03552 GENEFORM Protein DME1028 XEOTICID XEO03552 MOACRIVE Inhibition DME1028 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1028 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03556 XEO_CLAS Peptide DME1028 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO03556 GENEFORM Protein DME1028 XEOTICID XEO03556 MOACRIVE Inhibition DME1028 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1028 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03557 XEO_CLAS Peptide DME1028 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO03557 GENEFORM Protein DME1028 XEOTICID XEO03557 MOACRIVE Inhibition DME1028 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1028 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03558 XEO_CLAS Peptide DME1028 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 microM) DME1028 XEOTICID XEO03558 GENEFORM Protein DME1028 XEOTICID XEO03558 MOACRIVE Inhibition DME1028 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1028 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03559 XEO_CLAS Peptide DME1028 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 microM) DME1028 XEOTICID XEO03559 GENEFORM Protein DME1028 XEOTICID XEO03559 MOACRIVE Inhibition DME1028 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1028 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03560 XEO_CLAS Peptide DME1028 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 microM) DME1028 XEOTICID XEO03560 GENEFORM Protein DME1028 XEOTICID XEO03560 MOACRIVE Inhibition DME1028 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1028 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03561 XEO_CLAS Peptide DME1028 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03561 GENEFORM Protein DME1028 XEOTICID XEO03561 MOACRIVE Inhibition DME1028 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1028 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03567 XEO_CLAS Peptide DME1028 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03567 GENEFORM Protein DME1028 XEOTICID XEO03567 MOACRIVE Inhibition DME1028 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1028 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03569 XEO_CLAS Peptide DME1028 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 300 microM) DME1028 XEOTICID XEO03569 GENEFORM Protein DME1028 XEOTICID XEO03569 MOACRIVE Inhibition DME1028 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1028 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03570 XEO_CLAS Peptide DME1028 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03570 GENEFORM Protein DME1028 XEOTICID XEO03570 MOACRIVE Inhibition DME1028 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1028 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03572 XEO_CLAS Peptide DME1028 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1028 XEOTICID XEO03572 GENEFORM Protein DME1028 XEOTICID XEO03572 MOACRIVE Inhibition DME1028 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1028 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03573 XEO_CLAS Peptide DME1028 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 28.1 ug/ml) DME1028 XEOTICID XEO03573 GENEFORM Protein DME1028 XEOTICID XEO03573 MOACRIVE Inhibition DME1028 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1028 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03574 XEO_CLAS Peptide DME1028 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 500 microM) DME1028 XEOTICID XEO03574 GENEFORM Protein DME1028 XEOTICID XEO03574 MOACRIVE Inhibition DME1028 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1028 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03575 XEO_CLAS Peptide DME1028 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 18 microM) DME1028 XEOTICID XEO03575 GENEFORM Protein DME1028 XEOTICID XEO03575 MOACRIVE Inhibition DME1028 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1028 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03576 XEO_CLAS Peptide DME1028 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 750 microM) DME1028 XEOTICID XEO03576 GENEFORM Protein DME1028 XEOTICID XEO03576 MOACRIVE Inhibition DME1028 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1028 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03578 XEO_CLAS Peptide DME1028 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1028 XEOTICID XEO03578 GENEFORM Protein DME1028 XEOTICID XEO03578 MOACRIVE Inhibition DME1028 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1028 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03579 XEO_CLAS Peptide DME1028 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03579 GENEFORM Protein DME1028 XEOTICID XEO03579 MOACRIVE Inhibition DME1028 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1028 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03580 XEO_CLAS Peptide DME1028 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03580 GENEFORM Protein DME1028 XEOTICID XEO03580 MOACRIVE Inhibition DME1028 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1028 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03585 XEO_CLAS Peptide DME1028 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 62.5 ug/ml) DME1028 XEOTICID XEO03585 GENEFORM Protein DME1028 XEOTICID XEO03585 MOACRIVE Inhibition DME1028 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1028 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03588 XEO_CLAS Peptide DME1028 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 62 ug/ml) DME1028 XEOTICID XEO03588 GENEFORM Protein DME1028 XEOTICID XEO03588 MOACRIVE Inhibition DME1028 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1028 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03589 XEO_CLAS Peptide DME1028 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03589 GENEFORM Protein DME1028 XEOTICID XEO03589 MOACRIVE Inhibition DME1028 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1028 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03590 XEO_CLAS Peptide DME1028 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03590 GENEFORM Protein DME1028 XEOTICID XEO03590 MOACRIVE Inhibition DME1028 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1028 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03591 XEO_CLAS Peptide DME1028 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 37.5 ug/ml) DME1028 XEOTICID XEO03591 GENEFORM Protein DME1028 XEOTICID XEO03591 MOACRIVE Inhibition DME1028 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1028 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03593 XEO_CLAS Peptide DME1028 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9.4 ug/ml) DME1028 XEOTICID XEO03593 GENEFORM Protein DME1028 XEOTICID XEO03593 MOACRIVE Inhibition DME1028 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1028 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03594 XEO_CLAS Peptide DME1028 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 ug/ml) DME1028 XEOTICID XEO03594 GENEFORM Protein DME1028 XEOTICID XEO03594 MOACRIVE Inhibition DME1028 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1028 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03595 XEO_CLAS Peptide DME1028 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03595 GENEFORM Protein DME1028 XEOTICID XEO03595 MOACRIVE Inhibition DME1028 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1028 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03596 XEO_CLAS Peptide DME1028 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03596 GENEFORM Protein DME1028 XEOTICID XEO03596 MOACRIVE Inhibition DME1028 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1028 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03598 XEO_CLAS Peptide DME1028 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03598 GENEFORM Protein DME1028 XEOTICID XEO03598 MOACRIVE Inhibition DME1028 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1028 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03599 XEO_CLAS Peptide DME1028 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03599 GENEFORM Protein DME1028 XEOTICID XEO03599 MOACRIVE Inhibition DME1028 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1028 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03600 XEO_CLAS Peptide DME1028 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03600 GENEFORM Protein DME1028 XEOTICID XEO03600 MOACRIVE Inhibition DME1028 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1028 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03606 XEO_CLAS Peptide DME1028 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03606 GENEFORM Protein DME1028 XEOTICID XEO03606 MOACRIVE Inhibition DME1028 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1028 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03607 XEO_CLAS Peptide DME1028 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03607 GENEFORM Protein DME1028 XEOTICID XEO03607 MOACRIVE Inhibition DME1028 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1028 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03609 XEO_CLAS Peptide DME1028 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03609 GENEFORM Protein DME1028 XEOTICID XEO03609 MOACRIVE Inhibition DME1028 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1028 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03615 XEO_CLAS Peptide DME1028 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1028 XEOTICID XEO03615 GENEFORM Protein DME1028 XEOTICID XEO03615 MOACRIVE Inhibition DME1028 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1028 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03616 XEO_CLAS Peptide DME1028 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 32 microM) DME1028 XEOTICID XEO03616 GENEFORM Protein DME1028 XEOTICID XEO03616 MOACRIVE Inhibition DME1028 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1028 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03617 XEO_CLAS Peptide DME1028 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40 microM) DME1028 XEOTICID XEO03617 GENEFORM Protein DME1028 XEOTICID XEO03617 MOACRIVE Inhibition DME1028 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1028 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03618 XEO_CLAS Peptide DME1028 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5-1 microM) DME1028 XEOTICID XEO03618 GENEFORM Protein DME1028 XEOTICID XEO03618 MOACRIVE Inhibition DME1028 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1028 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03622 XEO_CLAS Peptide DME1028 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20-40 microM) DME1028 XEOTICID XEO03622 GENEFORM Protein DME1028 XEOTICID XEO03622 MOACRIVE Inhibition DME1028 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1028 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03627 XEO_CLAS Peptide DME1028 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.4-0.8 microM) DME1028 XEOTICID XEO03627 GENEFORM Protein DME1028 XEOTICID XEO03627 MOACRIVE Inhibition DME1028 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1028 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03630 XEO_CLAS Peptide DME1028 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03630 GENEFORM Protein DME1028 XEOTICID XEO03630 MOACRIVE Inhibition DME1028 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1028 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03631 XEO_CLAS Peptide DME1028 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03631 GENEFORM Protein DME1028 XEOTICID XEO03631 MOACRIVE Inhibition DME1028 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1028 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03632 XEO_CLAS Peptide DME1028 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03632 GENEFORM Protein DME1028 XEOTICID XEO03632 MOACRIVE Inhibition DME1028 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1028 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03633 XEO_CLAS Peptide DME1028 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03633 GENEFORM Protein DME1028 XEOTICID XEO03633 MOACRIVE Inhibition DME1028 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1028 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03634 XEO_CLAS Peptide DME1028 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03634 GENEFORM Protein DME1028 XEOTICID XEO03634 MOACRIVE Inhibition DME1028 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1028 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03635 XEO_CLAS Peptide DME1028 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03635 GENEFORM Protein DME1028 XEOTICID XEO03635 MOACRIVE Inhibition DME1028 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1028 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03636 XEO_CLAS Peptide DME1028 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03636 GENEFORM Protein DME1028 XEOTICID XEO03636 MOACRIVE Inhibition DME1028 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1028 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03637 XEO_CLAS Peptide DME1028 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03637 GENEFORM Protein DME1028 XEOTICID XEO03637 MOACRIVE Inhibition DME1028 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1028 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03638 XEO_CLAS Peptide DME1028 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03638 GENEFORM Protein DME1028 XEOTICID XEO03638 MOACRIVE Inhibition DME1028 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1028 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03639 XEO_CLAS Peptide DME1028 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03639 GENEFORM Protein DME1028 XEOTICID XEO03639 MOACRIVE Inhibition DME1028 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1028 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03640 XEO_CLAS Peptide DME1028 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03640 GENEFORM Protein DME1028 XEOTICID XEO03640 MOACRIVE Inhibition DME1028 XEOTICID XEO03644 XEO_NAME Indole DME1028 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1028 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1028 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03644 GENEFORM Protein DME1028 XEOTICID XEO03644 MOACRIVE Inhibition DME1028 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1028 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03650 XEO_CLAS Peptide DME1028 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03650 GENEFORM Protein DME1028 XEOTICID XEO03650 MOACRIVE Inhibition DME1028 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1028 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO03655 XEO_CLAS Natural Product DME1028 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03655 GENEFORM Protein DME1028 XEOTICID XEO03655 MOACRIVE Inhibition DME1028 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1028 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03666 XEO_CLAS Peptide DME1028 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 ug/ml) DME1028 XEOTICID XEO03666 GENEFORM Protein DME1028 XEOTICID XEO03666 MOACRIVE Inhibition DME1028 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1028 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03667 XEO_CLAS Peptide DME1028 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 ug/ml) DME1028 XEOTICID XEO03667 GENEFORM Protein DME1028 XEOTICID XEO03667 MOACRIVE Inhibition DME1028 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1028 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03668 XEO_CLAS Peptide DME1028 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 microM) DME1028 XEOTICID XEO03668 GENEFORM Protein DME1028 XEOTICID XEO03668 MOACRIVE Inhibition DME1028 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1028 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03669 XEO_CLAS Peptide DME1028 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO03669 GENEFORM Protein DME1028 XEOTICID XEO03669 MOACRIVE Inhibition DME1028 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1028 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03670 XEO_CLAS Peptide DME1028 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 microM) DME1028 XEOTICID XEO03670 GENEFORM Protein DME1028 XEOTICID XEO03670 MOACRIVE Inhibition DME1028 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1028 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03672 XEO_CLAS Peptide DME1028 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.5 ug/ml) DME1028 XEOTICID XEO03672 GENEFORM Protein DME1028 XEOTICID XEO03672 MOACRIVE Inhibition DME1028 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1028 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03673 XEO_CLAS Peptide DME1028 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 ug/ml) DME1028 XEOTICID XEO03673 GENEFORM Protein DME1028 XEOTICID XEO03673 MOACRIVE Inhibition DME1028 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1028 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03674 XEO_CLAS Peptide DME1028 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 ug/ml) DME1028 XEOTICID XEO03674 GENEFORM Protein DME1028 XEOTICID XEO03674 MOACRIVE Inhibition DME1028 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1028 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03675 XEO_CLAS Peptide DME1028 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO03675 GENEFORM Protein DME1028 XEOTICID XEO03675 MOACRIVE Inhibition DME1028 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1028 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03678 XEO_CLAS Peptide DME1028 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 ug/ml) DME1028 XEOTICID XEO03678 GENEFORM Protein DME1028 XEOTICID XEO03678 MOACRIVE Inhibition DME1028 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1028 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03679 XEO_CLAS Peptide DME1028 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 ug/ml) DME1028 XEOTICID XEO03679 GENEFORM Protein DME1028 XEOTICID XEO03679 MOACRIVE Inhibition DME1028 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1028 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03681 XEO_CLAS Peptide DME1028 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.3-0.6 microM) DME1028 XEOTICID XEO03681 GENEFORM Protein DME1028 XEOTICID XEO03681 MOACRIVE Inhibition DME1028 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1028 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03684 XEO_CLAS Peptide DME1028 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 ug/ml) DME1028 XEOTICID XEO03684 GENEFORM Protein DME1028 XEOTICID XEO03684 MOACRIVE Inhibition DME1028 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1028 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03694 XEO_CLAS Peptide DME1028 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03694 GENEFORM Protein DME1028 XEOTICID XEO03694 MOACRIVE Inhibition DME1028 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1028 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03697 XEO_CLAS Peptide DME1028 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25 microM) DME1028 XEOTICID XEO03697 GENEFORM Protein DME1028 XEOTICID XEO03697 MOACRIVE Inhibition DME1028 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1028 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03698 XEO_CLAS Peptide DME1028 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03698 GENEFORM Protein DME1028 XEOTICID XEO03698 MOACRIVE Inhibition DME1028 XEOTICID XEO03703 XEO_NAME Kasstasin DME1028 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03703 XEO_CLAS Peptide DME1028 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 110 microM) DME1028 XEOTICID XEO03703 GENEFORM Protein DME1028 XEOTICID XEO03703 MOACRIVE Inhibition DME1028 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1028 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03706 XEO_CLAS Peptide DME1028 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03706 GENEFORM Protein DME1028 XEOTICID XEO03706 MOACRIVE Inhibition DME1028 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1028 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03707 XEO_CLAS Peptide DME1028 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03707 GENEFORM Protein DME1028 XEOTICID XEO03707 MOACRIVE Inhibition DME1028 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1028 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03709 XEO_CLAS Peptide DME1028 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25 ug/ml) DME1028 XEOTICID XEO03709 GENEFORM Protein DME1028 XEOTICID XEO03709 MOACRIVE Inhibition DME1028 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1028 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03712 XEO_CLAS Peptide DME1028 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03712 GENEFORM Protein DME1028 XEOTICID XEO03712 MOACRIVE Inhibition DME1028 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1028 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03713 XEO_CLAS Peptide DME1028 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 64 microM) DME1028 XEOTICID XEO03713 GENEFORM Protein DME1028 XEOTICID XEO03713 MOACRIVE Inhibition DME1028 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1028 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03714 XEO_CLAS Peptide DME1028 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03714 GENEFORM Protein DME1028 XEOTICID XEO03714 MOACRIVE Inhibition DME1028 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1028 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03715 XEO_CLAS Peptide DME1028 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 microM) DME1028 XEOTICID XEO03715 GENEFORM Protein DME1028 XEOTICID XEO03715 MOACRIVE Inhibition DME1028 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1028 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03719 XEO_CLAS Peptide DME1028 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 microM) DME1028 XEOTICID XEO03719 GENEFORM Protein DME1028 XEOTICID XEO03719 MOACRIVE Inhibition DME1028 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1028 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03720 XEO_CLAS Peptide DME1028 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 microM) DME1028 XEOTICID XEO03720 GENEFORM Protein DME1028 XEOTICID XEO03720 MOACRIVE Inhibition DME1028 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1028 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03723 XEO_CLAS Peptide DME1028 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 62.36 microM) DME1028 XEOTICID XEO03723 GENEFORM Protein DME1028 XEOTICID XEO03723 MOACRIVE Inhibition DME1028 XEOTICID XEO03724 XEO_NAME L10 peptide DME1028 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03724 XEO_CLAS Peptide DME1028 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.8 microM) DME1028 XEOTICID XEO03724 GENEFORM Protein DME1028 XEOTICID XEO03724 MOACRIVE Inhibition DME1028 XEOTICID XEO03726 XEO_NAME L2 peptide DME1028 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03726 XEO_CLAS Peptide DME1028 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 129.66 microM) DME1028 XEOTICID XEO03726 GENEFORM Protein DME1028 XEOTICID XEO03726 MOACRIVE Inhibition DME1028 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1028 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03727 XEO_CLAS Peptide DME1028 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 80 ug/ml) DME1028 XEOTICID XEO03727 GENEFORM Protein DME1028 XEOTICID XEO03727 MOACRIVE Inhibition DME1028 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1028 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03728 XEO_CLAS Peptide DME1028 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40 ug/ml) DME1028 XEOTICID XEO03728 GENEFORM Protein DME1028 XEOTICID XEO03728 MOACRIVE Inhibition DME1028 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1028 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03729 XEO_CLAS Peptide DME1028 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 80 ug/ml) DME1028 XEOTICID XEO03729 GENEFORM Protein DME1028 XEOTICID XEO03729 MOACRIVE Inhibition DME1028 XEOTICID XEO03730 XEO_NAME L3 peptide DME1028 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03730 XEO_CLAS Peptide DME1028 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64.11 microM) DME1028 XEOTICID XEO03730 GENEFORM Protein DME1028 XEOTICID XEO03730 MOACRIVE Inhibition DME1028 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1028 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03731 XEO_CLAS Peptide DME1028 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40 ug/ml) DME1028 XEOTICID XEO03731 GENEFORM Protein DME1028 XEOTICID XEO03731 MOACRIVE Inhibition DME1028 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1028 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03733 XEO_CLAS Peptide DME1028 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40 ug/ml) DME1028 XEOTICID XEO03733 GENEFORM Protein DME1028 XEOTICID XEO03733 MOACRIVE Inhibition DME1028 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1028 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03734 XEO_CLAS Peptide DME1028 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO03734 GENEFORM Protein DME1028 XEOTICID XEO03734 MOACRIVE Inhibition DME1028 XEOTICID XEO03735 XEO_NAME L4 peptide DME1028 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03735 XEO_CLAS Peptide DME1028 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 31.61 microM) DME1028 XEOTICID XEO03735 GENEFORM Protein DME1028 XEOTICID XEO03735 MOACRIVE Inhibition DME1028 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1028 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03738 XEO_CLAS Peptide DME1028 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 ug/ml) DME1028 XEOTICID XEO03738 GENEFORM Protein DME1028 XEOTICID XEO03738 MOACRIVE Inhibition DME1028 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1028 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03741 XEO_CLAS Peptide DME1028 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40 ug/ml) DME1028 XEOTICID XEO03741 GENEFORM Protein DME1028 XEOTICID XEO03741 MOACRIVE Inhibition DME1028 XEOTICID XEO03742 XEO_NAME L5 peptide DME1028 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03742 XEO_CLAS Peptide DME1028 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7.79 microM) DME1028 XEOTICID XEO03742 GENEFORM Protein DME1028 XEOTICID XEO03742 MOACRIVE Inhibition DME1028 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1028 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03743 XEO_CLAS Peptide DME1028 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 ug/ml) DME1028 XEOTICID XEO03743 GENEFORM Protein DME1028 XEOTICID XEO03743 MOACRIVE Inhibition DME1028 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1028 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03744 XEO_CLAS Peptide DME1028 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 ug/ml) DME1028 XEOTICID XEO03744 GENEFORM Protein DME1028 XEOTICID XEO03744 MOACRIVE Inhibition DME1028 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1028 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03745 XEO_CLAS Peptide DME1028 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 ug/ml) DME1028 XEOTICID XEO03745 GENEFORM Protein DME1028 XEOTICID XEO03745 MOACRIVE Inhibition DME1028 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1028 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03746 XEO_CLAS Peptide DME1028 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO03746 GENEFORM Protein DME1028 XEOTICID XEO03746 MOACRIVE Inhibition DME1028 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1028 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03747 XEO_CLAS Peptide DME1028 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO03747 GENEFORM Protein DME1028 XEOTICID XEO03747 MOACRIVE Inhibition DME1028 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1028 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03748 XEO_CLAS Peptide DME1028 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO03748 GENEFORM Protein DME1028 XEOTICID XEO03748 MOACRIVE Inhibition DME1028 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1028 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03749 XEO_CLAS Peptide DME1028 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO03749 GENEFORM Protein DME1028 XEOTICID XEO03749 MOACRIVE Inhibition DME1028 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1028 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03750 XEO_CLAS Peptide DME1028 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO03750 GENEFORM Protein DME1028 XEOTICID XEO03750 MOACRIVE Inhibition DME1028 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1028 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03751 XEO_CLAS Peptide DME1028 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO03751 GENEFORM Protein DME1028 XEOTICID XEO03751 MOACRIVE Inhibition DME1028 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1028 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03752 XEO_CLAS Peptide DME1028 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO03752 GENEFORM Protein DME1028 XEOTICID XEO03752 MOACRIVE Inhibition DME1028 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1028 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03753 XEO_CLAS Peptide DME1028 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 ug/ml) DME1028 XEOTICID XEO03753 GENEFORM Protein DME1028 XEOTICID XEO03753 MOACRIVE Inhibition DME1028 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1028 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03754 XEO_CLAS Peptide DME1028 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO03754 GENEFORM Protein DME1028 XEOTICID XEO03754 MOACRIVE Inhibition DME1028 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1028 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03755 XEO_CLAS Peptide DME1028 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO03755 GENEFORM Protein DME1028 XEOTICID XEO03755 MOACRIVE Inhibition DME1028 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1028 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03756 XEO_CLAS Peptide DME1028 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO03756 GENEFORM Protein DME1028 XEOTICID XEO03756 MOACRIVE Inhibition DME1028 XEOTICID XEO03757 XEO_NAME L6 peptide DME1028 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03757 XEO_CLAS Peptide DME1028 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15.17 microM) DME1028 XEOTICID XEO03757 GENEFORM Protein DME1028 XEOTICID XEO03757 MOACRIVE Inhibition DME1028 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1028 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03758 XEO_CLAS Peptide DME1028 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 80 ug/ml) DME1028 XEOTICID XEO03758 GENEFORM Protein DME1028 XEOTICID XEO03758 MOACRIVE Inhibition DME1028 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1028 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03759 XEO_CLAS Peptide DME1028 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.3 ug/ml) DME1028 XEOTICID XEO03759 GENEFORM Protein DME1028 XEOTICID XEO03759 MOACRIVE Inhibition DME1028 XEOTICID XEO03760 XEO_NAME L7 peptide DME1028 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03760 XEO_CLAS Peptide DME1028 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16.02 microM) DME1028 XEOTICID XEO03760 GENEFORM Protein DME1028 XEOTICID XEO03760 MOACRIVE Inhibition DME1028 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1028 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03761 XEO_CLAS Peptide DME1028 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 ug/ml) DME1028 XEOTICID XEO03761 GENEFORM Protein DME1028 XEOTICID XEO03761 MOACRIVE Inhibition DME1028 XEOTICID XEO03763 XEO_NAME L8 peptide DME1028 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03763 XEO_CLAS Peptide DME1028 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.71 microM) DME1028 XEOTICID XEO03763 GENEFORM Protein DME1028 XEOTICID XEO03763 MOACRIVE Inhibition DME1028 XEOTICID XEO03765 XEO_NAME L9 peptide DME1028 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03765 XEO_CLAS Peptide DME1028 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.78 microM) DME1028 XEOTICID XEO03765 GENEFORM Protein DME1028 XEOTICID XEO03765 MOACRIVE Inhibition DME1028 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1028 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03775 XEO_CLAS Peptide DME1028 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 17.3 microM) DME1028 XEOTICID XEO03775 GENEFORM Protein DME1028 XEOTICID XEO03775 MOACRIVE Inhibition DME1028 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1028 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03776 XEO_CLAS Peptide DME1028 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03776 GENEFORM Protein DME1028 XEOTICID XEO03776 MOACRIVE Inhibition DME1028 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1028 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03781 XEO_CLAS Peptide DME1028 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.47 microM) DME1028 XEOTICID XEO03781 GENEFORM Protein DME1028 XEOTICID XEO03781 MOACRIVE Inhibition DME1028 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1028 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03782 XEO_CLAS Peptide DME1028 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.47 microM) DME1028 XEOTICID XEO03782 GENEFORM Protein DME1028 XEOTICID XEO03782 MOACRIVE Inhibition DME1028 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1028 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03783 XEO_CLAS Peptide DME1028 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.68 microM) DME1028 XEOTICID XEO03783 GENEFORM Protein DME1028 XEOTICID XEO03783 MOACRIVE Inhibition DME1028 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1028 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03784 XEO_CLAS Peptide DME1028 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.45 microM) DME1028 XEOTICID XEO03784 GENEFORM Protein DME1028 XEOTICID XEO03784 MOACRIVE Inhibition DME1028 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1028 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03785 XEO_CLAS Peptide DME1028 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.73 microM) DME1028 XEOTICID XEO03785 GENEFORM Protein DME1028 XEOTICID XEO03785 MOACRIVE Inhibition DME1028 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1028 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03786 XEO_CLAS Peptide DME1028 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.45 microM) DME1028 XEOTICID XEO03786 GENEFORM Protein DME1028 XEOTICID XEO03786 MOACRIVE Inhibition DME1028 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1028 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03787 XEO_CLAS Peptide DME1028 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.38 microM) DME1028 XEOTICID XEO03787 GENEFORM Protein DME1028 XEOTICID XEO03787 MOACRIVE Inhibition DME1028 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1028 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03788 XEO_CLAS Peptide DME1028 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.46 microM) DME1028 XEOTICID XEO03788 GENEFORM Protein DME1028 XEOTICID XEO03788 MOACRIVE Inhibition DME1028 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1028 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03789 XEO_CLAS Peptide DME1028 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 13.05 microM) DME1028 XEOTICID XEO03789 GENEFORM Protein DME1028 XEOTICID XEO03789 MOACRIVE Inhibition DME1028 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1028 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03790 XEO_CLAS Peptide DME1028 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.82 microM) DME1028 XEOTICID XEO03790 GENEFORM Protein DME1028 XEOTICID XEO03790 MOACRIVE Inhibition DME1028 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1028 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03791 XEO_CLAS Peptide DME1028 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.80 microM) DME1028 XEOTICID XEO03791 GENEFORM Protein DME1028 XEOTICID XEO03791 MOACRIVE Inhibition DME1028 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1028 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03792 XEO_CLAS Peptide DME1028 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.26 microM) DME1028 XEOTICID XEO03792 GENEFORM Protein DME1028 XEOTICID XEO03792 MOACRIVE Inhibition DME1028 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1028 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03793 XEO_CLAS Peptide DME1028 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 microM) DME1028 XEOTICID XEO03793 GENEFORM Protein DME1028 XEOTICID XEO03793 MOACRIVE Inhibition DME1028 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1028 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03797 XEO_CLAS Peptide DME1028 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.4 microM) DME1028 XEOTICID XEO03797 GENEFORM Protein DME1028 XEOTICID XEO03797 MOACRIVE Inhibition DME1028 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1028 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03798 XEO_CLAS Peptide DME1028 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03798 GENEFORM Protein DME1028 XEOTICID XEO03798 MOACRIVE Inhibition DME1028 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1028 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03799 XEO_CLAS Peptide DME1028 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03799 GENEFORM Protein DME1028 XEOTICID XEO03799 MOACRIVE Inhibition DME1028 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1028 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03810 XEO_CLAS Peptide DME1028 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03810 GENEFORM Protein DME1028 XEOTICID XEO03810 MOACRIVE Inhibition DME1028 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1028 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03846 XEO_CLAS Peptide DME1028 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03846 GENEFORM Protein DME1028 XEOTICID XEO03846 MOACRIVE Inhibition DME1028 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1028 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03847 XEO_CLAS Peptide DME1028 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03847 GENEFORM Protein DME1028 XEOTICID XEO03847 MOACRIVE Inhibition DME1028 XEOTICID XEO03850 XEO_NAME Lemon DME1028 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1028 XEOTICID XEO03850 XEO_CLAS Food Additive DME1028 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03850 GENEFORM Protein DME1028 XEOTICID XEO03850 MOACRIVE Inhibition DME1028 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1028 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03853 XEO_CLAS Peptide DME1028 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO03853 GENEFORM Protein DME1028 XEOTICID XEO03853 MOACRIVE Inhibition DME1028 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1028 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03857 XEO_CLAS Peptide DME1028 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 38.49 microM) DME1028 XEOTICID XEO03857 GENEFORM Protein DME1028 XEOTICID XEO03857 MOACRIVE Inhibition DME1028 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1028 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03860 XEO_CLAS Peptide DME1028 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 24 microM) DME1028 XEOTICID XEO03860 GENEFORM Protein DME1028 XEOTICID XEO03860 MOACRIVE Inhibition DME1028 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1028 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03861 XEO_CLAS Peptide DME1028 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 35 microM) DME1028 XEOTICID XEO03861 GENEFORM Protein DME1028 XEOTICID XEO03861 MOACRIVE Inhibition DME1028 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1028 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03862 XEO_CLAS Peptide DME1028 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 70 microM) DME1028 XEOTICID XEO03862 GENEFORM Protein DME1028 XEOTICID XEO03862 MOACRIVE Inhibition DME1028 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1028 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03863 XEO_CLAS Peptide DME1028 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 35 microM) DME1028 XEOTICID XEO03863 GENEFORM Protein DME1028 XEOTICID XEO03863 MOACRIVE Inhibition DME1028 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1028 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03864 XEO_CLAS Peptide DME1028 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO03864 GENEFORM Protein DME1028 XEOTICID XEO03864 MOACRIVE Inhibition DME1028 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1028 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03865 XEO_CLAS Peptide DME1028 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO03865 GENEFORM Protein DME1028 XEOTICID XEO03865 MOACRIVE Inhibition DME1028 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1028 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03866 XEO_CLAS Peptide DME1028 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 microM) DME1028 XEOTICID XEO03866 GENEFORM Protein DME1028 XEOTICID XEO03866 MOACRIVE Inhibition DME1028 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1028 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03867 XEO_CLAS Peptide DME1028 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40 microM) DME1028 XEOTICID XEO03867 GENEFORM Protein DME1028 XEOTICID XEO03867 MOACRIVE Inhibition DME1028 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1028 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03868 XEO_CLAS Peptide DME1028 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 51 microM) DME1028 XEOTICID XEO03868 GENEFORM Protein DME1028 XEOTICID XEO03868 MOACRIVE Inhibition DME1028 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1028 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03869 XEO_CLAS Peptide DME1028 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 35 microM) DME1028 XEOTICID XEO03869 GENEFORM Protein DME1028 XEOTICID XEO03869 MOACRIVE Inhibition DME1028 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1028 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03870 XEO_CLAS Peptide DME1028 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 61 microM) DME1028 XEOTICID XEO03870 GENEFORM Protein DME1028 XEOTICID XEO03870 MOACRIVE Inhibition DME1028 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1028 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03871 XEO_CLAS Peptide DME1028 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 microM) DME1028 XEOTICID XEO03871 GENEFORM Protein DME1028 XEOTICID XEO03871 MOACRIVE Inhibition DME1028 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1028 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03872 XEO_CLAS Peptide DME1028 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 28 microM) DME1028 XEOTICID XEO03872 GENEFORM Protein DME1028 XEOTICID XEO03872 MOACRIVE Inhibition DME1028 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1028 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03873 XEO_CLAS Peptide DME1028 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 22.5 microM) DME1028 XEOTICID XEO03873 GENEFORM Protein DME1028 XEOTICID XEO03873 MOACRIVE Inhibition DME1028 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1028 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03874 XEO_CLAS Peptide DME1028 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7.50 microM) DME1028 XEOTICID XEO03874 GENEFORM Protein DME1028 XEOTICID XEO03874 MOACRIVE Inhibition DME1028 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1028 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03875 XEO_CLAS Peptide DME1028 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 microM) DME1028 XEOTICID XEO03875 GENEFORM Protein DME1028 XEOTICID XEO03875 MOACRIVE Inhibition DME1028 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1028 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03876 XEO_CLAS Peptide DME1028 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.75 microM) DME1028 XEOTICID XEO03876 GENEFORM Protein DME1028 XEOTICID XEO03876 MOACRIVE Inhibition DME1028 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1028 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03877 XEO_CLAS Peptide DME1028 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 microM) DME1028 XEOTICID XEO03877 GENEFORM Protein DME1028 XEOTICID XEO03877 MOACRIVE Inhibition DME1028 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1028 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03878 XEO_CLAS Peptide DME1028 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 microM) DME1028 XEOTICID XEO03878 GENEFORM Protein DME1028 XEOTICID XEO03878 MOACRIVE Inhibition DME1028 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1028 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03879 XEO_CLAS Peptide DME1028 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 252 microM) DME1028 XEOTICID XEO03879 GENEFORM Protein DME1028 XEOTICID XEO03879 MOACRIVE Inhibition DME1028 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1028 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03880 XEO_CLAS Peptide DME1028 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 174 microM) DME1028 XEOTICID XEO03880 GENEFORM Protein DME1028 XEOTICID XEO03880 MOACRIVE Inhibition DME1028 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1028 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03883 XEO_CLAS Peptide DME1028 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 74 microM) DME1028 XEOTICID XEO03883 GENEFORM Protein DME1028 XEOTICID XEO03883 MOACRIVE Inhibition DME1028 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1028 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03884 XEO_CLAS Peptide DME1028 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 31 microM) DME1028 XEOTICID XEO03884 GENEFORM Protein DME1028 XEOTICID XEO03884 MOACRIVE Inhibition DME1028 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1028 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03885 XEO_CLAS Peptide DME1028 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO03885 GENEFORM Protein DME1028 XEOTICID XEO03885 MOACRIVE Inhibition DME1028 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1028 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03886 XEO_CLAS Peptide DME1028 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 391 microM) DME1028 XEOTICID XEO03886 GENEFORM Protein DME1028 XEOTICID XEO03886 MOACRIVE Inhibition DME1028 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1028 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03887 XEO_CLAS Peptide DME1028 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 151 microM) DME1028 XEOTICID XEO03887 GENEFORM Protein DME1028 XEOTICID XEO03887 MOACRIVE Inhibition DME1028 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1028 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03888 XEO_CLAS Peptide DME1028 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 134 microM) DME1028 XEOTICID XEO03888 GENEFORM Protein DME1028 XEOTICID XEO03888 MOACRIVE Inhibition DME1028 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1028 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03889 XEO_CLAS Peptide DME1028 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 88 microM) DME1028 XEOTICID XEO03889 GENEFORM Protein DME1028 XEOTICID XEO03889 MOACRIVE Inhibition DME1028 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1028 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03890 XEO_CLAS Peptide DME1028 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 31 microM) DME1028 XEOTICID XEO03890 GENEFORM Protein DME1028 XEOTICID XEO03890 MOACRIVE Inhibition DME1028 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1028 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03891 XEO_CLAS Peptide DME1028 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 microM) DME1028 XEOTICID XEO03891 GENEFORM Protein DME1028 XEOTICID XEO03891 MOACRIVE Inhibition DME1028 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1028 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03892 XEO_CLAS Peptide DME1028 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 37 microM) DME1028 XEOTICID XEO03892 GENEFORM Protein DME1028 XEOTICID XEO03892 MOACRIVE Inhibition DME1028 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1028 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03893 XEO_CLAS Peptide DME1028 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 19 microM) DME1028 XEOTICID XEO03893 GENEFORM Protein DME1028 XEOTICID XEO03893 MOACRIVE Inhibition DME1028 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1028 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03894 XEO_CLAS Peptide DME1028 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO03894 GENEFORM Protein DME1028 XEOTICID XEO03894 MOACRIVE Inhibition DME1028 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1028 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03895 XEO_CLAS Peptide DME1028 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO03895 GENEFORM Protein DME1028 XEOTICID XEO03895 MOACRIVE Inhibition DME1028 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1028 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03896 XEO_CLAS Peptide DME1028 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 microM) DME1028 XEOTICID XEO03896 GENEFORM Protein DME1028 XEOTICID XEO03896 MOACRIVE Inhibition DME1028 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1028 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03897 XEO_CLAS Peptide DME1028 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 63 microM) DME1028 XEOTICID XEO03897 GENEFORM Protein DME1028 XEOTICID XEO03897 MOACRIVE Inhibition DME1028 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1028 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03898 XEO_CLAS Peptide DME1028 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 219 microM) DME1028 XEOTICID XEO03898 GENEFORM Protein DME1028 XEOTICID XEO03898 MOACRIVE Inhibition DME1028 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1028 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03901 XEO_CLAS Peptide DME1028 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 35 microM) DME1028 XEOTICID XEO03901 GENEFORM Protein DME1028 XEOTICID XEO03901 MOACRIVE Inhibition DME1028 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1028 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03902 XEO_CLAS Peptide DME1028 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 70 microM) DME1028 XEOTICID XEO03902 GENEFORM Protein DME1028 XEOTICID XEO03902 MOACRIVE Inhibition DME1028 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1028 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03904 XEO_CLAS Peptide DME1028 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO03904 GENEFORM Protein DME1028 XEOTICID XEO03904 MOACRIVE Inhibition DME1028 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1028 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03905 XEO_CLAS Peptide DME1028 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO03905 GENEFORM Protein DME1028 XEOTICID XEO03905 MOACRIVE Inhibition DME1028 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1028 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03908 XEO_CLAS Peptide DME1028 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03908 GENEFORM Protein DME1028 XEOTICID XEO03908 MOACRIVE Inhibition DME1028 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1028 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03915 XEO_CLAS Peptide DME1028 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03915 GENEFORM Protein DME1028 XEOTICID XEO03915 MOACRIVE Inhibition DME1028 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1028 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03916 XEO_CLAS Peptide DME1028 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.8 ug/ml) DME1028 XEOTICID XEO03916 GENEFORM Protein DME1028 XEOTICID XEO03916 MOACRIVE Inhibition DME1028 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1028 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03917 XEO_CLAS Peptide DME1028 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 13.1 ug/ml) DME1028 XEOTICID XEO03917 GENEFORM Protein DME1028 XEOTICID XEO03917 MOACRIVE Inhibition DME1028 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1028 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03918 XEO_CLAS Peptide DME1028 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.5 ug/ml) DME1028 XEOTICID XEO03918 GENEFORM Protein DME1028 XEOTICID XEO03918 MOACRIVE Inhibition DME1028 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1028 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03919 XEO_CLAS Peptide DME1028 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 80 ug/ml) DME1028 XEOTICID XEO03919 GENEFORM Protein DME1028 XEOTICID XEO03919 MOACRIVE Inhibition DME1028 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1028 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03922 XEO_CLAS Peptide DME1028 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9 microM) DME1028 XEOTICID XEO03922 GENEFORM Protein DME1028 XEOTICID XEO03922 MOACRIVE Inhibition DME1028 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1028 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03923 XEO_CLAS Peptide DME1028 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9 microM) DME1028 XEOTICID XEO03923 GENEFORM Protein DME1028 XEOTICID XEO03923 MOACRIVE Inhibition DME1028 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1028 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03924 XEO_CLAS Peptide DME1028 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO03924 GENEFORM Protein DME1028 XEOTICID XEO03924 MOACRIVE Inhibition DME1028 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1028 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03927 XEO_CLAS Peptide DME1028 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 80 microM) DME1028 XEOTICID XEO03927 GENEFORM Protein DME1028 XEOTICID XEO03927 MOACRIVE Inhibition DME1028 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1028 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03928 XEO_CLAS Peptide DME1028 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 microM) DME1028 XEOTICID XEO03928 GENEFORM Protein DME1028 XEOTICID XEO03928 MOACRIVE Inhibition DME1028 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1028 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03929 XEO_CLAS Peptide DME1028 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 microM) DME1028 XEOTICID XEO03929 GENEFORM Protein DME1028 XEOTICID XEO03929 MOACRIVE Inhibition DME1028 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1028 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03930 XEO_CLAS Peptide DME1028 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO03930 GENEFORM Protein DME1028 XEOTICID XEO03930 MOACRIVE Inhibition DME1028 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1028 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03931 XEO_CLAS Peptide DME1028 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 microM) DME1028 XEOTICID XEO03931 GENEFORM Protein DME1028 XEOTICID XEO03931 MOACRIVE Inhibition DME1028 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1028 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03933 XEO_CLAS Peptide DME1028 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.5 microM) DME1028 XEOTICID XEO03933 GENEFORM Protein DME1028 XEOTICID XEO03933 MOACRIVE Inhibition DME1028 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1028 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03934 XEO_CLAS Peptide DME1028 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.7 microM) DME1028 XEOTICID XEO03934 GENEFORM Protein DME1028 XEOTICID XEO03934 MOACRIVE Inhibition DME1028 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1028 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03935 XEO_CLAS Peptide DME1028 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.7 microM) DME1028 XEOTICID XEO03935 GENEFORM Protein DME1028 XEOTICID XEO03935 MOACRIVE Inhibition DME1028 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1028 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03936 XEO_CLAS Peptide DME1028 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.0 microM) DME1028 XEOTICID XEO03936 GENEFORM Protein DME1028 XEOTICID XEO03936 MOACRIVE Inhibition DME1028 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1028 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03937 XEO_CLAS Peptide DME1028 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.1 microM) DME1028 XEOTICID XEO03937 GENEFORM Protein DME1028 XEOTICID XEO03937 MOACRIVE Inhibition DME1028 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1028 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03938 XEO_CLAS Peptide DME1028 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.7 microM) DME1028 XEOTICID XEO03938 GENEFORM Protein DME1028 XEOTICID XEO03938 MOACRIVE Inhibition DME1028 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1028 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03939 XEO_CLAS Peptide DME1028 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.7 microM) DME1028 XEOTICID XEO03939 GENEFORM Protein DME1028 XEOTICID XEO03939 MOACRIVE Inhibition DME1028 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1028 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03940 XEO_CLAS Peptide DME1028 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.5 microM) DME1028 XEOTICID XEO03940 GENEFORM Protein DME1028 XEOTICID XEO03940 MOACRIVE Inhibition DME1028 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1028 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03941 XEO_CLAS Peptide DME1028 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.4 microM) DME1028 XEOTICID XEO03941 GENEFORM Protein DME1028 XEOTICID XEO03941 MOACRIVE Inhibition DME1028 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1028 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03943 XEO_CLAS Peptide DME1028 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.4 microM) DME1028 XEOTICID XEO03943 GENEFORM Protein DME1028 XEOTICID XEO03943 MOACRIVE Inhibition DME1028 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1028 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03944 XEO_CLAS Peptide DME1028 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.7 microM) DME1028 XEOTICID XEO03944 GENEFORM Protein DME1028 XEOTICID XEO03944 MOACRIVE Inhibition DME1028 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1028 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03945 XEO_CLAS Peptide DME1028 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.2 microM) DME1028 XEOTICID XEO03945 GENEFORM Protein DME1028 XEOTICID XEO03945 MOACRIVE Inhibition DME1028 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1028 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03947 XEO_CLAS Peptide DME1028 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.0 microM) DME1028 XEOTICID XEO03947 GENEFORM Protein DME1028 XEOTICID XEO03947 MOACRIVE Inhibition DME1028 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1028 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03948 XEO_CLAS Peptide DME1028 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 23.3 microM) DME1028 XEOTICID XEO03948 GENEFORM Protein DME1028 XEOTICID XEO03948 MOACRIVE Inhibition DME1028 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1028 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03950 XEO_CLAS Peptide DME1028 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4.4 microM) DME1028 XEOTICID XEO03950 GENEFORM Protein DME1028 XEOTICID XEO03950 MOACRIVE Inhibition DME1028 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1028 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03951 XEO_CLAS Peptide DME1028 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8.8 microM) DME1028 XEOTICID XEO03951 GENEFORM Protein DME1028 XEOTICID XEO03951 MOACRIVE Inhibition DME1028 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1028 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03952 XEO_CLAS Peptide DME1028 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.2 microM) DME1028 XEOTICID XEO03952 GENEFORM Protein DME1028 XEOTICID XEO03952 MOACRIVE Inhibition DME1028 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1028 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03953 XEO_CLAS Peptide DME1028 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 microM) DME1028 XEOTICID XEO03953 GENEFORM Protein DME1028 XEOTICID XEO03953 MOACRIVE Inhibition DME1028 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1028 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03958 XEO_CLAS Peptide DME1028 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03958 GENEFORM Protein DME1028 XEOTICID XEO03958 MOACRIVE Inhibition DME1028 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1028 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03965 XEO_CLAS Peptide DME1028 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 128 microM) DME1028 XEOTICID XEO03965 GENEFORM Protein DME1028 XEOTICID XEO03965 MOACRIVE Inhibition DME1028 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1028 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03966 XEO_CLAS Peptide DME1028 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 microM) DME1028 XEOTICID XEO03966 GENEFORM Protein DME1028 XEOTICID XEO03966 MOACRIVE Inhibition DME1028 XEOTICID XEO03971 XEO_NAME Lumbrican DME1028 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03971 XEO_CLAS Peptide DME1028 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03971 GENEFORM Protein DME1028 XEOTICID XEO03971 MOACRIVE Inhibition DME1028 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1028 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03972 XEO_CLAS Peptide DME1028 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO03972 GENEFORM Protein DME1028 XEOTICID XEO03972 MOACRIVE Inhibition DME1028 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1028 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03980 XEO_CLAS Peptide DME1028 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 32 microM) DME1028 XEOTICID XEO03980 GENEFORM Protein DME1028 XEOTICID XEO03980 MOACRIVE Inhibition DME1028 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1028 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03985 XEO_CLAS Peptide DME1028 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 ug/ml) DME1028 XEOTICID XEO03985 GENEFORM Protein DME1028 XEOTICID XEO03985 MOACRIVE Inhibition DME1028 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1028 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03991 XEO_CLAS Peptide DME1028 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03991 GENEFORM Protein DME1028 XEOTICID XEO03991 MOACRIVE Inhibition DME1028 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1028 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03992 XEO_CLAS Peptide DME1028 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03992 GENEFORM Protein DME1028 XEOTICID XEO03992 MOACRIVE Inhibition DME1028 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1028 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03993 XEO_CLAS Peptide DME1028 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03993 GENEFORM Protein DME1028 XEOTICID XEO03993 MOACRIVE Inhibition DME1028 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1028 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03994 XEO_CLAS Peptide DME1028 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO03994 GENEFORM Protein DME1028 XEOTICID XEO03994 MOACRIVE Inhibition DME1028 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1028 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03996 XEO_CLAS Peptide DME1028 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 65 microM) DME1028 XEOTICID XEO03996 GENEFORM Protein DME1028 XEOTICID XEO03996 MOACRIVE Inhibition DME1028 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1028 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03997 XEO_CLAS Peptide DME1028 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7.5 microM) DME1028 XEOTICID XEO03997 GENEFORM Protein DME1028 XEOTICID XEO03997 MOACRIVE Inhibition DME1028 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1028 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03998 XEO_CLAS Peptide DME1028 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15.5 microM) DME1028 XEOTICID XEO03998 GENEFORM Protein DME1028 XEOTICID XEO03998 MOACRIVE Inhibition DME1028 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1028 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO03999 XEO_CLAS Peptide DME1028 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25.8 microM) DME1028 XEOTICID XEO03999 GENEFORM Protein DME1028 XEOTICID XEO03999 MOACRIVE Inhibition DME1028 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1028 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04000 XEO_CLAS Peptide DME1028 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO04000 GENEFORM Protein DME1028 XEOTICID XEO04000 MOACRIVE Inhibition DME1028 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1028 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04001 XEO_CLAS Peptide DME1028 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO04001 GENEFORM Protein DME1028 XEOTICID XEO04001 MOACRIVE Inhibition DME1028 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1028 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04002 XEO_CLAS Peptide DME1028 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7.5 ug/ml) DME1028 XEOTICID XEO04002 GENEFORM Protein DME1028 XEOTICID XEO04002 MOACRIVE Inhibition DME1028 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1028 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04003 XEO_CLAS Peptide DME1028 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 ug/ml) DME1028 XEOTICID XEO04003 GENEFORM Protein DME1028 XEOTICID XEO04003 MOACRIVE Inhibition DME1028 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1028 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04004 XEO_CLAS Peptide DME1028 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.0 ug/ml) DME1028 XEOTICID XEO04004 GENEFORM Protein DME1028 XEOTICID XEO04004 MOACRIVE Inhibition DME1028 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1028 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04005 XEO_CLAS Peptide DME1028 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.0 ug/ml) DME1028 XEOTICID XEO04005 GENEFORM Protein DME1028 XEOTICID XEO04005 MOACRIVE Inhibition DME1028 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1028 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04007 XEO_CLAS Peptide DME1028 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 19.5 ug/ml) DME1028 XEOTICID XEO04007 GENEFORM Protein DME1028 XEOTICID XEO04007 MOACRIVE Inhibition DME1028 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1028 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04011 XEO_CLAS Peptide DME1028 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 19.5 ug/ml) DME1028 XEOTICID XEO04011 GENEFORM Protein DME1028 XEOTICID XEO04011 MOACRIVE Inhibition DME1028 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1028 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04012 XEO_CLAS Peptide DME1028 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.9 ug/ml) DME1028 XEOTICID XEO04012 GENEFORM Protein DME1028 XEOTICID XEO04012 MOACRIVE Inhibition DME1028 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1028 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04013 XEO_CLAS Peptide DME1028 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.7 ug/ml) DME1028 XEOTICID XEO04013 GENEFORM Protein DME1028 XEOTICID XEO04013 MOACRIVE Inhibition DME1028 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1028 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04018 XEO_CLAS Peptide DME1028 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9 ug/ml) DME1028 XEOTICID XEO04018 GENEFORM Protein DME1028 XEOTICID XEO04018 MOACRIVE Inhibition DME1028 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1028 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04026 XEO_CLAS Peptide DME1028 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO04026 GENEFORM Protein DME1028 XEOTICID XEO04026 MOACRIVE Inhibition DME1028 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1028 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04027 XEO_CLAS Peptide DME1028 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO04027 GENEFORM Protein DME1028 XEOTICID XEO04027 MOACRIVE Inhibition DME1028 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1028 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04028 XEO_CLAS Peptide DME1028 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 ug/ml) DME1028 XEOTICID XEO04028 GENEFORM Protein DME1028 XEOTICID XEO04028 MOACRIVE Inhibition DME1028 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1028 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04038 XEO_CLAS Peptide DME1028 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04038 GENEFORM Protein DME1028 XEOTICID XEO04038 MOACRIVE Inhibition DME1028 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1028 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04039 XEO_CLAS Peptide DME1028 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 microM) DME1028 XEOTICID XEO04039 GENEFORM Protein DME1028 XEOTICID XEO04039 MOACRIVE Inhibition DME1028 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1028 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04051 XEO_CLAS Peptide DME1028 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.31-0.63 microM) DME1028 XEOTICID XEO04051 GENEFORM Protein DME1028 XEOTICID XEO04051 MOACRIVE Inhibition DME1028 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1028 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04052 XEO_CLAS Peptide DME1028 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04052 GENEFORM Protein DME1028 XEOTICID XEO04052 MOACRIVE Inhibition DME1028 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1028 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04053 XEO_CLAS Peptide DME1028 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.08-0.16 microM) DME1028 XEOTICID XEO04053 GENEFORM Protein DME1028 XEOTICID XEO04053 MOACRIVE Inhibition DME1028 XEOTICID XEO04055 XEO_NAME Melectin DME1028 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04055 XEO_CLAS Peptide DME1028 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.0 microM) DME1028 XEOTICID XEO04055 GENEFORM Protein DME1028 XEOTICID XEO04055 MOACRIVE Inhibition DME1028 XEOTICID XEO04057 XEO_NAME Melittin DME1028 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04057 XEO_CLAS Peptide DME1028 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.8 microM) DME1028 XEOTICID XEO04057 GENEFORM Protein DME1028 XEOTICID XEO04057 MOACRIVE Inhibition DME1028 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1028 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04061 XEO_CLAS Peptide DME1028 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.9 microM) DME1028 XEOTICID XEO04061 GENEFORM Protein DME1028 XEOTICID XEO04061 MOACRIVE Inhibition DME1028 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1028 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04062 XEO_CLAS Peptide DME1028 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.5 microM) DME1028 XEOTICID XEO04062 GENEFORM Protein DME1028 XEOTICID XEO04062 MOACRIVE Inhibition DME1028 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1028 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04063 XEO_CLAS Peptide DME1028 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7.8 microM) DME1028 XEOTICID XEO04063 GENEFORM Protein DME1028 XEOTICID XEO04063 MOACRIVE Inhibition DME1028 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1028 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04064 XEO_CLAS Peptide DME1028 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 46.7 microM) DME1028 XEOTICID XEO04064 GENEFORM Protein DME1028 XEOTICID XEO04064 MOACRIVE Inhibition DME1028 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1028 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04066 XEO_CLAS Peptide DME1028 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8.1 microM) DME1028 XEOTICID XEO04066 GENEFORM Protein DME1028 XEOTICID XEO04066 MOACRIVE Inhibition DME1028 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1028 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04067 XEO_CLAS Peptide DME1028 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.6 microM) DME1028 XEOTICID XEO04067 GENEFORM Protein DME1028 XEOTICID XEO04067 MOACRIVE Inhibition DME1028 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1028 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04068 XEO_CLAS Peptide DME1028 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.6 microM) DME1028 XEOTICID XEO04068 GENEFORM Protein DME1028 XEOTICID XEO04068 MOACRIVE Inhibition DME1028 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1028 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04086 GENEFORM Protein DME1028 XEOTICID XEO04086 MOACRIVE Inhibition DME1028 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1028 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04087 GENEFORM Protein DME1028 XEOTICID XEO04087 MOACRIVE Inhibition DME1028 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1028 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04089 GENEFORM Protein DME1028 XEOTICID XEO04089 MOACRIVE Inhibition DME1028 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1028 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04094 GENEFORM Protein DME1028 XEOTICID XEO04094 MOACRIVE Inhibition DME1028 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1028 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04096 GENEFORM Protein DME1028 XEOTICID XEO04096 MOACRIVE Inhibition DME1028 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1028 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04098 GENEFORM Protein DME1028 XEOTICID XEO04098 MOACRIVE Inhibition DME1028 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1028 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04111 XEO_CLAS Peptide DME1028 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04111 GENEFORM Protein DME1028 XEOTICID XEO04111 MOACRIVE Inhibition DME1028 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1028 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04112 XEO_CLAS Peptide DME1028 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.02 microM) DME1028 XEOTICID XEO04112 GENEFORM Protein DME1028 XEOTICID XEO04112 MOACRIVE Inhibition DME1028 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1028 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04113 XEO_CLAS Peptide DME1028 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.02 ug/ml) DME1028 XEOTICID XEO04113 GENEFORM Protein DME1028 XEOTICID XEO04113 MOACRIVE Inhibition DME1028 XEOTICID XEO04114 XEO_NAME Microcin L DME1028 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04114 XEO_CLAS Peptide DME1028 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04114 GENEFORM Protein DME1028 XEOTICID XEO04114 MOACRIVE Inhibition DME1028 XEOTICID XEO04117 XEO_NAME Misgurin DME1028 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04117 XEO_CLAS Peptide DME1028 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04117 GENEFORM Protein DME1028 XEOTICID XEO04117 MOACRIVE Inhibition DME1028 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1028 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04118 XEO_CLAS Peptide DME1028 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 300 microM) DME1028 XEOTICID XEO04118 GENEFORM Protein DME1028 XEOTICID XEO04118 MOACRIVE Inhibition DME1028 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1028 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04119 XEO_CLAS Peptide DME1028 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-20 microM) DME1028 XEOTICID XEO04119 GENEFORM Protein DME1028 XEOTICID XEO04119 MOACRIVE Inhibition DME1028 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1028 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04120 XEO_CLAS Peptide DME1028 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC < 10 microM) DME1028 XEOTICID XEO04120 GENEFORM Protein DME1028 XEOTICID XEO04120 MOACRIVE Inhibition DME1028 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1028 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04121 XEO_CLAS Peptide DME1028 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.2-6.4 microM) DME1028 XEOTICID XEO04121 GENEFORM Protein DME1028 XEOTICID XEO04121 MOACRIVE Inhibition DME1028 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1028 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04122 XEO_CLAS Peptide DME1028 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.14-6.29 microM) DME1028 XEOTICID XEO04122 GENEFORM Protein DME1028 XEOTICID XEO04122 MOACRIVE Inhibition DME1028 XEOTICID XEO04123 XEO_NAME Modified defensin DME1028 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04123 XEO_CLAS Peptide DME1028 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO04123 GENEFORM Protein DME1028 XEOTICID XEO04123 MOACRIVE Inhibition DME1028 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1028 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04128 XEO_CLAS Peptide DME1028 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.31 microM) DME1028 XEOTICID XEO04128 GENEFORM Protein DME1028 XEOTICID XEO04128 MOACRIVE Inhibition DME1028 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1028 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04129 XEO_CLAS Peptide DME1028 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO04129 GENEFORM Protein DME1028 XEOTICID XEO04129 MOACRIVE Inhibition DME1028 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1028 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04130 XEO_CLAS Peptide DME1028 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO04130 GENEFORM Protein DME1028 XEOTICID XEO04130 MOACRIVE Inhibition DME1028 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1028 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04131 XEO_CLAS Peptide DME1028 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 microM) DME1028 XEOTICID XEO04131 GENEFORM Protein DME1028 XEOTICID XEO04131 MOACRIVE Inhibition DME1028 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1028 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04132 XEO_CLAS Peptide DME1028 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 microM) DME1028 XEOTICID XEO04132 GENEFORM Protein DME1028 XEOTICID XEO04132 MOACRIVE Inhibition DME1028 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1028 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04133 XEO_CLAS Peptide DME1028 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO04133 GENEFORM Protein DME1028 XEOTICID XEO04133 MOACRIVE Inhibition DME1028 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1028 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04134 XEO_CLAS Peptide DME1028 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO04134 GENEFORM Protein DME1028 XEOTICID XEO04134 MOACRIVE Inhibition DME1028 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1028 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04135 XEO_CLAS Peptide DME1028 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 microM) DME1028 XEOTICID XEO04135 GENEFORM Protein DME1028 XEOTICID XEO04135 MOACRIVE Inhibition DME1028 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1028 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04137 XEO_CLAS Peptide DME1028 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.6 microM) DME1028 XEOTICID XEO04137 GENEFORM Protein DME1028 XEOTICID XEO04137 MOACRIVE Inhibition DME1028 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1028 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04138 XEO_CLAS Peptide DME1028 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 microM) DME1028 XEOTICID XEO04138 GENEFORM Protein DME1028 XEOTICID XEO04138 MOACRIVE Inhibition DME1028 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1028 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04139 XEO_CLAS Peptide DME1028 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 microM) DME1028 XEOTICID XEO04139 GENEFORM Protein DME1028 XEOTICID XEO04139 MOACRIVE Inhibition DME1028 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1028 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04140 XEO_CLAS Peptide DME1028 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 70 microM) DME1028 XEOTICID XEO04140 GENEFORM Protein DME1028 XEOTICID XEO04140 MOACRIVE Inhibition DME1028 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1028 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04141 XEO_CLAS Peptide DME1028 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 microM) DME1028 XEOTICID XEO04141 GENEFORM Protein DME1028 XEOTICID XEO04141 MOACRIVE Inhibition DME1028 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1028 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04142 XEO_CLAS Peptide DME1028 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8-16 microM) DME1028 XEOTICID XEO04142 GENEFORM Protein DME1028 XEOTICID XEO04142 MOACRIVE Inhibition DME1028 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1028 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04146 XEO_CLAS Peptide DME1028 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04146 GENEFORM Protein DME1028 XEOTICID XEO04146 MOACRIVE Inhibition DME1028 XEOTICID XEO04149 XEO_NAME Mucroporin DME1028 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04149 XEO_CLAS Peptide DME1028 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 ug/ml) DME1028 XEOTICID XEO04149 GENEFORM Protein DME1028 XEOTICID XEO04149 MOACRIVE Inhibition DME1028 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1028 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04158 XEO_CLAS Peptide DME1028 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO04158 GENEFORM Protein DME1028 XEOTICID XEO04158 MOACRIVE Inhibition DME1028 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1028 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04159 XEO_CLAS Peptide DME1028 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 microM) DME1028 XEOTICID XEO04159 GENEFORM Protein DME1028 XEOTICID XEO04159 MOACRIVE Inhibition DME1028 XEOTICID XEO04167 XEO_NAME Myticin-B DME1028 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04167 XEO_CLAS Peptide DME1028 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04167 GENEFORM Protein DME1028 XEOTICID XEO04167 MOACRIVE Inhibition DME1028 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1028 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04168 XEO_CLAS Peptide DME1028 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.7-12.5 microM) DME1028 XEOTICID XEO04168 GENEFORM Protein DME1028 XEOTICID XEO04168 MOACRIVE Inhibition DME1028 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1028 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04169 XEO_CLAS Peptide DME1028 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04169 GENEFORM Protein DME1028 XEOTICID XEO04169 MOACRIVE Inhibition DME1028 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1028 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04170 XEO_CLAS Peptide DME1028 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04170 GENEFORM Protein DME1028 XEOTICID XEO04170 MOACRIVE Inhibition DME1028 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1028 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04171 XEO_CLAS Peptide DME1028 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04171 GENEFORM Protein DME1028 XEOTICID XEO04171 MOACRIVE Inhibition DME1028 XEOTICID XEO04172 XEO_NAME Myxinidin DME1028 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04172 XEO_CLAS Peptide DME1028 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04172 GENEFORM Protein DME1028 XEOTICID XEO04172 MOACRIVE Inhibition DME1028 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1028 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04177 XEO_CLAS Peptide DME1028 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.7 microM) DME1028 XEOTICID XEO04177 GENEFORM Protein DME1028 XEOTICID XEO04177 MOACRIVE Inhibition DME1028 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1028 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04178 XEO_CLAS Peptide DME1028 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.7 microM) DME1028 XEOTICID XEO04178 GENEFORM Protein DME1028 XEOTICID XEO04178 MOACRIVE Inhibition DME1028 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1028 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04179 XEO_CLAS Peptide DME1028 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.5 microM) DME1028 XEOTICID XEO04179 GENEFORM Protein DME1028 XEOTICID XEO04179 MOACRIVE Inhibition DME1028 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1028 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04180 XEO_CLAS Peptide DME1028 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 23 microM) DME1028 XEOTICID XEO04180 GENEFORM Protein DME1028 XEOTICID XEO04180 MOACRIVE Inhibition DME1028 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1028 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04181 XEO_CLAS Peptide DME1028 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.2 microM) DME1028 XEOTICID XEO04181 GENEFORM Protein DME1028 XEOTICID XEO04181 MOACRIVE Inhibition DME1028 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1028 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04182 XEO_CLAS Peptide DME1028 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4.4 microM) DME1028 XEOTICID XEO04182 GENEFORM Protein DME1028 XEOTICID XEO04182 MOACRIVE Inhibition DME1028 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1028 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04183 XEO_CLAS Peptide DME1028 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.6 microM) DME1028 XEOTICID XEO04183 GENEFORM Protein DME1028 XEOTICID XEO04183 MOACRIVE Inhibition DME1028 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1028 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04184 XEO_CLAS Peptide DME1028 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 microM) DME1028 XEOTICID XEO04184 GENEFORM Protein DME1028 XEOTICID XEO04184 MOACRIVE Inhibition DME1028 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1028 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04185 XEO_CLAS Peptide DME1028 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04185 GENEFORM Protein DME1028 XEOTICID XEO04185 MOACRIVE Inhibition DME1028 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1028 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04186 XEO_CLAS Peptide DME1028 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04186 GENEFORM Protein DME1028 XEOTICID XEO04186 MOACRIVE Inhibition DME1028 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1028 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04187 XEO_CLAS Peptide DME1028 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04187 GENEFORM Protein DME1028 XEOTICID XEO04187 MOACRIVE Inhibition DME1028 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1028 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04188 XEO_CLAS Peptide DME1028 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04188 GENEFORM Protein DME1028 XEOTICID XEO04188 MOACRIVE Inhibition DME1028 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1028 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04206 XEO_CLAS Peptide DME1028 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25 microM) DME1028 XEOTICID XEO04206 GENEFORM Protein DME1028 XEOTICID XEO04206 MOACRIVE Inhibition DME1028 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1028 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04214 XEO_CLAS Peptide DME1028 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25 microM) DME1028 XEOTICID XEO04214 GENEFORM Protein DME1028 XEOTICID XEO04214 MOACRIVE Inhibition DME1028 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1028 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04216 XEO_CLAS Peptide DME1028 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO04216 GENEFORM Protein DME1028 XEOTICID XEO04216 MOACRIVE Inhibition DME1028 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1028 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04218 XEO_CLAS Peptide DME1028 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.125 microM) DME1028 XEOTICID XEO04218 GENEFORM Protein DME1028 XEOTICID XEO04218 MOACRIVE Inhibition DME1028 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1028 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04219 XEO_CLAS Peptide DME1028 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO04219 GENEFORM Protein DME1028 XEOTICID XEO04219 MOACRIVE Inhibition DME1028 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1028 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04220 XEO_CLAS Peptide DME1028 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.125 microM) DME1028 XEOTICID XEO04220 GENEFORM Protein DME1028 XEOTICID XEO04220 MOACRIVE Inhibition DME1028 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1028 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04221 XEO_CLAS Peptide DME1028 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO04221 GENEFORM Protein DME1028 XEOTICID XEO04221 MOACRIVE Inhibition DME1028 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1028 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04222 XEO_CLAS Peptide DME1028 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25 microM) DME1028 XEOTICID XEO04222 GENEFORM Protein DME1028 XEOTICID XEO04222 MOACRIVE Inhibition DME1028 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1028 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04233 XEO_CLAS Peptide DME1028 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04233 GENEFORM Protein DME1028 XEOTICID XEO04233 MOACRIVE Inhibition DME1028 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1028 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04234 XEO_CLAS Peptide DME1028 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04234 GENEFORM Protein DME1028 XEOTICID XEO04234 MOACRIVE Inhibition DME1028 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1028 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04241 XEO_CLAS Peptide DME1028 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04241 GENEFORM Protein DME1028 XEOTICID XEO04241 MOACRIVE Inhibition DME1028 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1028 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04242 XEO_CLAS Peptide DME1028 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04242 GENEFORM Protein DME1028 XEOTICID XEO04242 MOACRIVE Inhibition DME1028 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1028 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04245 XEO_CLAS Natural Product DME1028 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04245 GENEFORM Protein DME1028 XEOTICID XEO04245 MOACRIVE Inhibition DME1028 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1028 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04246 XEO_CLAS Natural Product DME1028 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04246 GENEFORM Protein DME1028 XEOTICID XEO04246 MOACRIVE Inhibition DME1028 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1028 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04249 XEO_CLAS Peptide DME1028 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 500 ug/ml) DME1028 XEOTICID XEO04249 GENEFORM Protein DME1028 XEOTICID XEO04249 MOACRIVE Inhibition DME1028 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1028 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04251 XEO_CLAS Peptide DME1028 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04251 GENEFORM Protein DME1028 XEOTICID XEO04251 MOACRIVE Inhibition DME1028 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1028 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04253 XEO_CLAS Peptide DME1028 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04253 GENEFORM Protein DME1028 XEOTICID XEO04253 MOACRIVE Inhibition DME1028 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1028 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04254 XEO_CLAS Peptide DME1028 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04254 GENEFORM Protein DME1028 XEOTICID XEO04254 MOACRIVE Inhibition DME1028 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1028 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04255 XEO_CLAS Peptide DME1028 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04255 GENEFORM Protein DME1028 XEOTICID XEO04255 MOACRIVE Inhibition DME1028 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1028 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04256 XEO_CLAS Peptide DME1028 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04256 GENEFORM Protein DME1028 XEOTICID XEO04256 MOACRIVE Inhibition DME1028 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1028 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04257 XEO_CLAS Peptide DME1028 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04257 GENEFORM Protein DME1028 XEOTICID XEO04257 MOACRIVE Inhibition DME1028 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1028 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04258 XEO_CLAS Peptide DME1028 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04258 GENEFORM Protein DME1028 XEOTICID XEO04258 MOACRIVE Inhibition DME1028 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1028 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04259 XEO_CLAS Peptide DME1028 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04259 GENEFORM Protein DME1028 XEOTICID XEO04259 MOACRIVE Inhibition DME1028 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1028 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04260 XEO_CLAS Peptide DME1028 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04260 GENEFORM Protein DME1028 XEOTICID XEO04260 MOACRIVE Inhibition DME1028 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1028 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04261 XEO_CLAS Peptide DME1028 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04261 GENEFORM Protein DME1028 XEOTICID XEO04261 MOACRIVE Inhibition DME1028 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1028 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04262 XEO_CLAS Peptide DME1028 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04262 GENEFORM Protein DME1028 XEOTICID XEO04262 MOACRIVE Inhibition DME1028 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1028 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04263 XEO_CLAS Peptide DME1028 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04263 GENEFORM Protein DME1028 XEOTICID XEO04263 MOACRIVE Inhibition DME1028 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1028 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04264 XEO_CLAS Peptide DME1028 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04264 GENEFORM Protein DME1028 XEOTICID XEO04264 MOACRIVE Inhibition DME1028 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1028 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04265 XEO_CLAS Peptide DME1028 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04265 GENEFORM Protein DME1028 XEOTICID XEO04265 MOACRIVE Inhibition DME1028 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1028 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04266 XEO_CLAS Peptide DME1028 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04266 GENEFORM Protein DME1028 XEOTICID XEO04266 MOACRIVE Inhibition DME1028 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1028 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04267 XEO_CLAS Peptide DME1028 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04267 GENEFORM Protein DME1028 XEOTICID XEO04267 MOACRIVE Inhibition DME1028 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1028 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04268 XEO_CLAS Peptide DME1028 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04268 GENEFORM Protein DME1028 XEOTICID XEO04268 MOACRIVE Inhibition DME1028 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1028 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04269 XEO_CLAS Peptide DME1028 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04269 GENEFORM Protein DME1028 XEOTICID XEO04269 MOACRIVE Inhibition DME1028 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1028 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04270 XEO_CLAS Peptide DME1028 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04270 GENEFORM Protein DME1028 XEOTICID XEO04270 MOACRIVE Inhibition DME1028 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1028 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04271 XEO_CLAS Peptide DME1028 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04271 GENEFORM Protein DME1028 XEOTICID XEO04271 MOACRIVE Inhibition DME1028 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1028 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04272 XEO_CLAS Peptide DME1028 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04272 GENEFORM Protein DME1028 XEOTICID XEO04272 MOACRIVE Inhibition DME1028 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1028 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04277 XEO_CLAS Peptide DME1028 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 110.00 ug/ml) DME1028 XEOTICID XEO04277 GENEFORM Protein DME1028 XEOTICID XEO04277 MOACRIVE Inhibition DME1028 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1028 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04280 XEO_CLAS Peptide DME1028 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 37.50 ug/ml) DME1028 XEOTICID XEO04280 GENEFORM Protein DME1028 XEOTICID XEO04280 MOACRIVE Inhibition DME1028 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1028 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04281 XEO_CLAS Peptide DME1028 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25.00 ug/ml) DME1028 XEOTICID XEO04281 GENEFORM Protein DME1028 XEOTICID XEO04281 MOACRIVE Inhibition DME1028 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1028 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04282 XEO_CLAS Peptide DME1028 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.2 ug/ml) DME1028 XEOTICID XEO04282 GENEFORM Protein DME1028 XEOTICID XEO04282 MOACRIVE Inhibition DME1028 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1028 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04283 XEO_CLAS Peptide DME1028 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.3 ug/ml) DME1028 XEOTICID XEO04283 GENEFORM Protein DME1028 XEOTICID XEO04283 MOACRIVE Inhibition DME1028 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1028 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04284 XEO_CLAS Peptide DME1028 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10.8 ug/ml) DME1028 XEOTICID XEO04284 GENEFORM Protein DME1028 XEOTICID XEO04284 MOACRIVE Inhibition DME1028 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1028 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04285 XEO_CLAS Peptide DME1028 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 11.5 ug/ml) DME1028 XEOTICID XEO04285 GENEFORM Protein DME1028 XEOTICID XEO04285 MOACRIVE Inhibition DME1028 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1028 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04286 XEO_CLAS Peptide DME1028 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8.6 ug/ml) DME1028 XEOTICID XEO04286 GENEFORM Protein DME1028 XEOTICID XEO04286 MOACRIVE Inhibition DME1028 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1028 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04287 XEO_CLAS Peptide DME1028 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10.2 ug/ml) DME1028 XEOTICID XEO04287 GENEFORM Protein DME1028 XEOTICID XEO04287 MOACRIVE Inhibition DME1028 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1028 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04288 XEO_CLAS Peptide DME1028 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4.4 ug/ml) DME1028 XEOTICID XEO04288 GENEFORM Protein DME1028 XEOTICID XEO04288 MOACRIVE Inhibition DME1028 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1028 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04289 XEO_CLAS Peptide DME1028 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.2 ug/ml) DME1028 XEOTICID XEO04289 GENEFORM Protein DME1028 XEOTICID XEO04289 MOACRIVE Inhibition DME1028 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1028 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04290 XEO_CLAS Peptide DME1028 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 11.3 ug/ml) DME1028 XEOTICID XEO04290 GENEFORM Protein DME1028 XEOTICID XEO04290 MOACRIVE Inhibition DME1028 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1028 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04291 XEO_CLAS Peptide DME1028 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7.2 ug/ml) DME1028 XEOTICID XEO04291 GENEFORM Protein DME1028 XEOTICID XEO04291 MOACRIVE Inhibition DME1028 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1028 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04292 XEO_CLAS Peptide DME1028 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.1 ug/ml) DME1028 XEOTICID XEO04292 GENEFORM Protein DME1028 XEOTICID XEO04292 MOACRIVE Inhibition DME1028 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1028 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04293 XEO_CLAS Peptide DME1028 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO04293 GENEFORM Protein DME1028 XEOTICID XEO04293 MOACRIVE Inhibition DME1028 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1028 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04294 XEO_CLAS Peptide DME1028 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO04294 GENEFORM Protein DME1028 XEOTICID XEO04294 MOACRIVE Inhibition DME1028 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1028 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04295 XEO_CLAS Peptide DME1028 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO04295 GENEFORM Protein DME1028 XEOTICID XEO04295 MOACRIVE Inhibition DME1028 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1028 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04296 XEO_CLAS Peptide DME1028 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 28 microM) DME1028 XEOTICID XEO04296 GENEFORM Protein DME1028 XEOTICID XEO04296 MOACRIVE Inhibition DME1028 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1028 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04297 XEO_CLAS Peptide DME1028 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 14 microM) DME1028 XEOTICID XEO04297 GENEFORM Protein DME1028 XEOTICID XEO04297 MOACRIVE Inhibition DME1028 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1028 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04298 XEO_CLAS Peptide DME1028 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO04298 GENEFORM Protein DME1028 XEOTICID XEO04298 MOACRIVE Inhibition DME1028 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1028 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04299 XEO_CLAS Peptide DME1028 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO04299 GENEFORM Protein DME1028 XEOTICID XEO04299 MOACRIVE Inhibition DME1028 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1028 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04300 XEO_CLAS Peptide DME1028 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO04300 GENEFORM Protein DME1028 XEOTICID XEO04300 MOACRIVE Inhibition DME1028 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1028 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04301 XEO_CLAS Peptide DME1028 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 microM) DME1028 XEOTICID XEO04301 GENEFORM Protein DME1028 XEOTICID XEO04301 MOACRIVE Inhibition DME1028 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1028 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04302 XEO_CLAS Peptide DME1028 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 microM) DME1028 XEOTICID XEO04302 GENEFORM Protein DME1028 XEOTICID XEO04302 MOACRIVE Inhibition DME1028 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1028 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04303 XEO_CLAS Peptide DME1028 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 microM) DME1028 XEOTICID XEO04303 GENEFORM Protein DME1028 XEOTICID XEO04303 MOACRIVE Inhibition DME1028 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1028 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04304 XEO_CLAS Peptide DME1028 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO04304 GENEFORM Protein DME1028 XEOTICID XEO04304 MOACRIVE Inhibition DME1028 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1028 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04305 XEO_CLAS Peptide DME1028 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 70 microM) DME1028 XEOTICID XEO04305 GENEFORM Protein DME1028 XEOTICID XEO04305 MOACRIVE Inhibition DME1028 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1028 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04306 XEO_CLAS Peptide DME1028 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO04306 GENEFORM Protein DME1028 XEOTICID XEO04306 MOACRIVE Inhibition DME1028 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1028 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04307 XEO_CLAS Peptide DME1028 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 ug/ml) DME1028 XEOTICID XEO04307 GENEFORM Protein DME1028 XEOTICID XEO04307 MOACRIVE Inhibition DME1028 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1028 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04308 XEO_CLAS Peptide DME1028 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9.37 ug/ml) DME1028 XEOTICID XEO04308 GENEFORM Protein DME1028 XEOTICID XEO04308 MOACRIVE Inhibition DME1028 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1028 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04309 XEO_CLAS Peptide DME1028 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 microM) DME1028 XEOTICID XEO04309 GENEFORM Protein DME1028 XEOTICID XEO04309 MOACRIVE Inhibition DME1028 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1028 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04310 XEO_CLAS Peptide DME1028 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO04310 GENEFORM Protein DME1028 XEOTICID XEO04310 MOACRIVE Inhibition DME1028 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1028 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04311 XEO_CLAS Peptide DME1028 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO04311 GENEFORM Protein DME1028 XEOTICID XEO04311 MOACRIVE Inhibition DME1028 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1028 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04312 XEO_CLAS Peptide DME1028 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4.68 ug/ml) DME1028 XEOTICID XEO04312 GENEFORM Protein DME1028 XEOTICID XEO04312 MOACRIVE Inhibition DME1028 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1028 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04313 XEO_CLAS Peptide DME1028 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4.68 ug/ml) DME1028 XEOTICID XEO04313 GENEFORM Protein DME1028 XEOTICID XEO04313 MOACRIVE Inhibition DME1028 XEOTICID XEO04331 XEO_NAME Norspermidine DME1028 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1028 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04331 GENEFORM Protein DME1028 XEOTICID XEO04331 MOACRIVE Inhibition DME1028 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1028 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04335 XEO_CLAS Peptide DME1028 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 32 ug/ml) DME1028 XEOTICID XEO04335 GENEFORM Protein DME1028 XEOTICID XEO04335 MOACRIVE Inhibition DME1028 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1028 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04336 XEO_CLAS Peptide DME1028 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 32 ug/ml) DME1028 XEOTICID XEO04336 GENEFORM Protein DME1028 XEOTICID XEO04336 MOACRIVE Inhibition DME1028 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1028 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04338 XEO_CLAS Peptide DME1028 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 ug/ml) DME1028 XEOTICID XEO04338 GENEFORM Protein DME1028 XEOTICID XEO04338 MOACRIVE Inhibition DME1028 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1028 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04339 XEO_CLAS Peptide DME1028 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 ug/ml) DME1028 XEOTICID XEO04339 GENEFORM Protein DME1028 XEOTICID XEO04339 MOACRIVE Inhibition DME1028 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1028 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04340 XEO_CLAS Peptide DME1028 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO04340 GENEFORM Protein DME1028 XEOTICID XEO04340 MOACRIVE Inhibition DME1028 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1028 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04344 XEO_CLAS Peptide DME1028 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04344 GENEFORM Protein DME1028 XEOTICID XEO04344 MOACRIVE Inhibition DME1028 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1028 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04345 XEO_CLAS Peptide DME1028 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04345 GENEFORM Protein DME1028 XEOTICID XEO04345 MOACRIVE Inhibition DME1028 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1028 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04346 XEO_CLAS Peptide DME1028 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04346 GENEFORM Protein DME1028 XEOTICID XEO04346 MOACRIVE Inhibition DME1028 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1028 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04347 XEO_CLAS Peptide DME1028 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 microM) DME1028 XEOTICID XEO04347 GENEFORM Protein DME1028 XEOTICID XEO04347 MOACRIVE Inhibition DME1028 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1028 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04348 XEO_CLAS Peptide DME1028 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40 microM) DME1028 XEOTICID XEO04348 GENEFORM Protein DME1028 XEOTICID XEO04348 MOACRIVE Inhibition DME1028 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1028 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04349 XEO_CLAS Peptide DME1028 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO04349 GENEFORM Protein DME1028 XEOTICID XEO04349 MOACRIVE Inhibition DME1028 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1028 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04354 XEO_CLAS Peptide DME1028 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 35.2 ug/ml) DME1028 XEOTICID XEO04354 GENEFORM Protein DME1028 XEOTICID XEO04354 MOACRIVE Inhibition DME1028 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1028 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04355 XEO_CLAS Peptide DME1028 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.21 ug/ml) DME1028 XEOTICID XEO04355 GENEFORM Protein DME1028 XEOTICID XEO04355 MOACRIVE Inhibition DME1028 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1028 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04356 XEO_CLAS Peptide DME1028 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8.21 ug/ml) DME1028 XEOTICID XEO04356 GENEFORM Protein DME1028 XEOTICID XEO04356 MOACRIVE Inhibition DME1028 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1028 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04357 XEO_CLAS Peptide DME1028 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16.32 ug/ml) DME1028 XEOTICID XEO04357 GENEFORM Protein DME1028 XEOTICID XEO04357 MOACRIVE Inhibition DME1028 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1028 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04358 XEO_CLAS Peptide DME1028 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9.37 ug/ml) DME1028 XEOTICID XEO04358 GENEFORM Protein DME1028 XEOTICID XEO04358 MOACRIVE Inhibition DME1028 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1028 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04359 XEO_CLAS Peptide DME1028 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4.20 ug/ml) DME1028 XEOTICID XEO04359 GENEFORM Protein DME1028 XEOTICID XEO04359 MOACRIVE Inhibition DME1028 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1028 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04360 XEO_CLAS Peptide DME1028 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 ug/ml) DME1028 XEOTICID XEO04360 GENEFORM Protein DME1028 XEOTICID XEO04360 MOACRIVE Inhibition DME1028 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1028 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04361 XEO_CLAS Peptide DME1028 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7.5 ug/ml) DME1028 XEOTICID XEO04361 GENEFORM Protein DME1028 XEOTICID XEO04361 MOACRIVE Inhibition DME1028 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1028 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04362 XEO_CLAS Peptide DME1028 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.6 ug/ml) DME1028 XEOTICID XEO04362 GENEFORM Protein DME1028 XEOTICID XEO04362 MOACRIVE Inhibition DME1028 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1028 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04363 XEO_CLAS Peptide DME1028 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8.2 ug/ml) DME1028 XEOTICID XEO04363 GENEFORM Protein DME1028 XEOTICID XEO04363 MOACRIVE Inhibition DME1028 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1028 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04364 XEO_CLAS Peptide DME1028 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO04364 GENEFORM Protein DME1028 XEOTICID XEO04364 MOACRIVE Inhibition DME1028 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1028 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04365 XEO_CLAS Peptide DME1028 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4.68 ug/ml) DME1028 XEOTICID XEO04365 GENEFORM Protein DME1028 XEOTICID XEO04365 MOACRIVE Inhibition DME1028 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1028 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04366 XEO_CLAS Peptide DME1028 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 23.60 ug/ml) DME1028 XEOTICID XEO04366 GENEFORM Protein DME1028 XEOTICID XEO04366 MOACRIVE Inhibition DME1028 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1028 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04367 XEO_CLAS Peptide DME1028 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 35.60 ug/ml) DME1028 XEOTICID XEO04367 GENEFORM Protein DME1028 XEOTICID XEO04367 MOACRIVE Inhibition DME1028 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1028 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04368 XEO_CLAS Peptide DME1028 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40.2 ug/ml) DME1028 XEOTICID XEO04368 GENEFORM Protein DME1028 XEOTICID XEO04368 MOACRIVE Inhibition DME1028 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1028 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04369 XEO_CLAS Peptide DME1028 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40.2 ug/ml) DME1028 XEOTICID XEO04369 GENEFORM Protein DME1028 XEOTICID XEO04369 MOACRIVE Inhibition DME1028 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1028 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04370 XEO_CLAS Peptide DME1028 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4.68 ug/ml) DME1028 XEOTICID XEO04370 GENEFORM Protein DME1028 XEOTICID XEO04370 MOACRIVE Inhibition DME1028 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1028 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04371 XEO_CLAS Peptide DME1028 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9.37 ug/ml) DME1028 XEOTICID XEO04371 GENEFORM Protein DME1028 XEOTICID XEO04371 MOACRIVE Inhibition DME1028 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1028 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04373 XEO_CLAS Peptide DME1028 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 ug/ml) DME1028 XEOTICID XEO04373 GENEFORM Protein DME1028 XEOTICID XEO04373 MOACRIVE Inhibition DME1028 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1028 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04374 XEO_CLAS Peptide DME1028 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.50 ug/ml) DME1028 XEOTICID XEO04374 GENEFORM Protein DME1028 XEOTICID XEO04374 MOACRIVE Inhibition DME1028 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1028 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04375 XEO_CLAS Peptide DME1028 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25 ug/ml) DME1028 XEOTICID XEO04375 GENEFORM Protein DME1028 XEOTICID XEO04375 MOACRIVE Inhibition DME1028 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1028 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04377 XEO_CLAS Peptide DME1028 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 42.50 ug/ml) DME1028 XEOTICID XEO04377 GENEFORM Protein DME1028 XEOTICID XEO04377 MOACRIVE Inhibition DME1028 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1028 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04378 XEO_CLAS Peptide DME1028 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 17.50 ug/ml) DME1028 XEOTICID XEO04378 GENEFORM Protein DME1028 XEOTICID XEO04378 MOACRIVE Inhibition DME1028 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1028 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04379 XEO_CLAS Peptide DME1028 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 ug/ml) DME1028 XEOTICID XEO04379 GENEFORM Protein DME1028 XEOTICID XEO04379 MOACRIVE Inhibition DME1028 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1028 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04380 XEO_CLAS Peptide DME1028 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 36.00 ug/ml) DME1028 XEOTICID XEO04380 GENEFORM Protein DME1028 XEOTICID XEO04380 MOACRIVE Inhibition DME1028 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1028 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04381 XEO_CLAS Peptide DME1028 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.60 ug/ml) DME1028 XEOTICID XEO04381 GENEFORM Protein DME1028 XEOTICID XEO04381 MOACRIVE Inhibition DME1028 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1028 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04382 XEO_CLAS Peptide DME1028 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 ug/ml) DME1028 XEOTICID XEO04382 GENEFORM Protein DME1028 XEOTICID XEO04382 MOACRIVE Inhibition DME1028 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1028 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04383 XEO_CLAS Peptide DME1028 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO04383 GENEFORM Protein DME1028 XEOTICID XEO04383 MOACRIVE Inhibition DME1028 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1028 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04384 XEO_CLAS Peptide DME1028 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO04384 GENEFORM Protein DME1028 XEOTICID XEO04384 MOACRIVE Inhibition DME1028 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1028 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04385 XEO_CLAS Peptide DME1028 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.25 ug/ml) DME1028 XEOTICID XEO04385 GENEFORM Protein DME1028 XEOTICID XEO04385 MOACRIVE Inhibition DME1028 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1028 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04395 XEO_CLAS Peptide DME1028 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.4-0.8 microM) DME1028 XEOTICID XEO04395 GENEFORM Protein DME1028 XEOTICID XEO04395 MOACRIVE Inhibition DME1028 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1028 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04396 XEO_CLAS Peptide DME1028 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.25-0.5 microM) DME1028 XEOTICID XEO04396 GENEFORM Protein DME1028 XEOTICID XEO04396 MOACRIVE Inhibition DME1028 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1028 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04397 XEO_CLAS Peptide DME1028 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.25-0.5 microM) DME1028 XEOTICID XEO04397 GENEFORM Protein DME1028 XEOTICID XEO04397 MOACRIVE Inhibition DME1028 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1028 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04398 XEO_CLAS Peptide DME1028 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 microM) DME1028 XEOTICID XEO04398 GENEFORM Protein DME1028 XEOTICID XEO04398 MOACRIVE Inhibition DME1028 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1028 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04399 XEO_CLAS Peptide DME1028 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO04399 GENEFORM Protein DME1028 XEOTICID XEO04399 MOACRIVE Inhibition DME1028 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1028 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04400 XEO_CLAS Peptide DME1028 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 ug/ml) DME1028 XEOTICID XEO04400 GENEFORM Protein DME1028 XEOTICID XEO04400 MOACRIVE Inhibition DME1028 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1028 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04401 XEO_CLAS Peptide DME1028 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.6 ug/ml) DME1028 XEOTICID XEO04401 GENEFORM Protein DME1028 XEOTICID XEO04401 MOACRIVE Inhibition DME1028 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1028 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04402 XEO_CLAS Peptide DME1028 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 ug/ml) DME1028 XEOTICID XEO04402 GENEFORM Protein DME1028 XEOTICID XEO04402 MOACRIVE Inhibition DME1028 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1028 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04403 XEO_CLAS Peptide DME1028 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.6 ug/ml) DME1028 XEOTICID XEO04403 GENEFORM Protein DME1028 XEOTICID XEO04403 MOACRIVE Inhibition DME1028 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1028 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04404 XEO_CLAS Peptide DME1028 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.6 ug/ml) DME1028 XEOTICID XEO04404 GENEFORM Protein DME1028 XEOTICID XEO04404 MOACRIVE Inhibition DME1028 XEOTICID XEO04410 XEO_NAME Insect osmin DME1028 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04410 XEO_CLAS Peptide DME1028 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.125-1.56 microM) DME1028 XEOTICID XEO04410 GENEFORM Protein DME1028 XEOTICID XEO04410 MOACRIVE Inhibition DME1028 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1028 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04412 XEO_CLAS Peptide DME1028 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04412 GENEFORM Protein DME1028 XEOTICID XEO04412 MOACRIVE Inhibition DME1028 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1028 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04414 XEO_CLAS Peptide DME1028 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04414 GENEFORM Protein DME1028 XEOTICID XEO04414 MOACRIVE Inhibition DME1028 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1028 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04415 XEO_CLAS Peptide DME1028 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04415 GENEFORM Protein DME1028 XEOTICID XEO04415 MOACRIVE Inhibition DME1028 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1028 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04421 XEO_CLAS Peptide DME1028 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 microM) DME1028 XEOTICID XEO04421 GENEFORM Protein DME1028 XEOTICID XEO04421 MOACRIVE Inhibition DME1028 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1028 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04426 XEO_CLAS Peptide DME1028 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO04426 GENEFORM Protein DME1028 XEOTICID XEO04426 MOACRIVE Inhibition DME1028 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1028 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04428 XEO_CLAS Peptide DME1028 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.3 ug/ml) DME1028 XEOTICID XEO04428 GENEFORM Protein DME1028 XEOTICID XEO04428 MOACRIVE Inhibition DME1028 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1028 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04430 XEO_CLAS Peptide DME1028 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25 microM) DME1028 XEOTICID XEO04430 GENEFORM Protein DME1028 XEOTICID XEO04430 MOACRIVE Inhibition DME1028 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1028 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04433 XEO_CLAS Peptide DME1028 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 160 microM) DME1028 XEOTICID XEO04433 GENEFORM Protein DME1028 XEOTICID XEO04433 MOACRIVE Inhibition DME1028 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1028 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04435 XEO_CLAS Peptide DME1028 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 160 microM) DME1028 XEOTICID XEO04435 GENEFORM Protein DME1028 XEOTICID XEO04435 MOACRIVE Inhibition DME1028 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1028 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1028 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04438 GENEFORM Protein DME1028 XEOTICID XEO04438 MOACRIVE Inhibition DME1028 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1028 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04439 XEO_CLAS Peptide DME1028 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04439 GENEFORM Protein DME1028 XEOTICID XEO04439 MOACRIVE Inhibition DME1028 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1028 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04440 XEO_CLAS Peptide DME1028 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 microM) DME1028 XEOTICID XEO04440 GENEFORM Protein DME1028 XEOTICID XEO04440 MOACRIVE Inhibition DME1028 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1028 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04441 XEO_CLAS Peptide DME1028 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 28 microM) DME1028 XEOTICID XEO04441 GENEFORM Protein DME1028 XEOTICID XEO04441 MOACRIVE Inhibition DME1028 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1028 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04442 XEO_CLAS Peptide DME1028 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 28 microM) DME1028 XEOTICID XEO04442 GENEFORM Protein DME1028 XEOTICID XEO04442 MOACRIVE Inhibition DME1028 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1028 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04443 XEO_CLAS Peptide DME1028 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04443 GENEFORM Protein DME1028 XEOTICID XEO04443 MOACRIVE Inhibition DME1028 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1028 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04444 XEO_CLAS Peptide DME1028 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 13 microM) DME1028 XEOTICID XEO04444 GENEFORM Protein DME1028 XEOTICID XEO04444 MOACRIVE Inhibition DME1028 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1028 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04445 XEO_CLAS Peptide DME1028 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04445 GENEFORM Protein DME1028 XEOTICID XEO04445 MOACRIVE Inhibition DME1028 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1028 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04446 XEO_CLAS Peptide DME1028 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 78 microM) DME1028 XEOTICID XEO04446 GENEFORM Protein DME1028 XEOTICID XEO04446 MOACRIVE Inhibition DME1028 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1028 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04447 XEO_CLAS Peptide DME1028 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 120 microM) DME1028 XEOTICID XEO04447 GENEFORM Protein DME1028 XEOTICID XEO04447 MOACRIVE Inhibition DME1028 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1028 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04448 XEO_CLAS Peptide DME1028 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 microM) DME1028 XEOTICID XEO04448 GENEFORM Protein DME1028 XEOTICID XEO04448 MOACRIVE Inhibition DME1028 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1028 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04449 XEO_CLAS Peptide DME1028 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.3 microM) DME1028 XEOTICID XEO04449 GENEFORM Protein DME1028 XEOTICID XEO04449 MOACRIVE Inhibition DME1028 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1028 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04450 XEO_CLAS Peptide DME1028 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.3 microM) DME1028 XEOTICID XEO04450 GENEFORM Protein DME1028 XEOTICID XEO04450 MOACRIVE Inhibition DME1028 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1028 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04451 XEO_CLAS Peptide DME1028 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO04451 GENEFORM Protein DME1028 XEOTICID XEO04451 MOACRIVE Inhibition DME1028 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1028 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04452 XEO_CLAS Peptide DME1028 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.1 microM) DME1028 XEOTICID XEO04452 GENEFORM Protein DME1028 XEOTICID XEO04452 MOACRIVE Inhibition DME1028 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1028 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04453 XEO_CLAS Peptide DME1028 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO04453 GENEFORM Protein DME1028 XEOTICID XEO04453 MOACRIVE Inhibition DME1028 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1028 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04455 XEO_CLAS Peptide DME1028 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 microM) DME1028 XEOTICID XEO04455 GENEFORM Protein DME1028 XEOTICID XEO04455 MOACRIVE Inhibition DME1028 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1028 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04457 XEO_CLAS Peptide DME1028 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.3 microM) DME1028 XEOTICID XEO04457 GENEFORM Protein DME1028 XEOTICID XEO04457 MOACRIVE Inhibition DME1028 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1028 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04458 XEO_CLAS Peptide DME1028 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1 microM) DME1028 XEOTICID XEO04458 GENEFORM Protein DME1028 XEOTICID XEO04458 MOACRIVE Inhibition DME1028 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1028 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04459 XEO_CLAS Peptide DME1028 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1 microM) DME1028 XEOTICID XEO04459 GENEFORM Protein DME1028 XEOTICID XEO04459 MOACRIVE Inhibition DME1028 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1028 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04461 XEO_CLAS Peptide DME1028 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20.8 microM) DME1028 XEOTICID XEO04461 GENEFORM Protein DME1028 XEOTICID XEO04461 MOACRIVE Inhibition DME1028 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1028 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04462 XEO_CLAS Peptide DME1028 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 19.1 microM) DME1028 XEOTICID XEO04462 GENEFORM Protein DME1028 XEOTICID XEO04462 MOACRIVE Inhibition DME1028 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1028 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04463 XEO_CLAS Peptide DME1028 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04463 GENEFORM Protein DME1028 XEOTICID XEO04463 MOACRIVE Inhibition DME1028 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1028 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04464 XEO_CLAS Peptide DME1028 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.5 microM) DME1028 XEOTICID XEO04464 GENEFORM Protein DME1028 XEOTICID XEO04464 MOACRIVE Inhibition DME1028 XEOTICID XEO04466 XEO_NAME Panusin DME1028 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04466 XEO_CLAS Peptide DME1028 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04466 GENEFORM Protein DME1028 XEOTICID XEO04466 MOACRIVE Inhibition DME1028 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1028 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04467 XEO_CLAS Peptide DME1028 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4.8 microM) DME1028 XEOTICID XEO04467 GENEFORM Protein DME1028 XEOTICID XEO04467 MOACRIVE Inhibition DME1028 XEOTICID XEO04468 XEO_NAME Papillosin DME1028 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04468 XEO_CLAS Peptide DME1028 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04468 GENEFORM Protein DME1028 XEOTICID XEO04468 MOACRIVE Inhibition DME1028 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1028 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04471 XEO_CLAS Peptide DME1028 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.1 microM) DME1028 XEOTICID XEO04471 GENEFORM Protein DME1028 XEOTICID XEO04471 MOACRIVE Inhibition DME1028 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1028 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04480 XEO_CLAS Peptide DME1028 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 ug/ml) DME1028 XEOTICID XEO04480 GENEFORM Protein DME1028 XEOTICID XEO04480 MOACRIVE Inhibition DME1028 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1028 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1028 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04482 GENEFORM Protein DME1028 XEOTICID XEO04482 MOACRIVE Inhibition DME1028 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1028 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04484 XEO_CLAS Peptide DME1028 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 microM) DME1028 XEOTICID XEO04484 GENEFORM Protein DME1028 XEOTICID XEO04484 MOACRIVE Inhibition DME1028 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1028 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04485 XEO_CLAS Peptide DME1028 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO04485 GENEFORM Protein DME1028 XEOTICID XEO04485 MOACRIVE Inhibition DME1028 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1028 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04486 XEO_CLAS Peptide DME1028 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 microM) DME1028 XEOTICID XEO04486 GENEFORM Protein DME1028 XEOTICID XEO04486 MOACRIVE Inhibition DME1028 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1028 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04487 XEO_CLAS Peptide DME1028 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO04487 GENEFORM Protein DME1028 XEOTICID XEO04487 MOACRIVE Inhibition DME1028 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1028 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04488 XEO_CLAS Peptide DME1028 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9 microM) DME1028 XEOTICID XEO04488 GENEFORM Protein DME1028 XEOTICID XEO04488 MOACRIVE Inhibition DME1028 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1028 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04489 XEO_CLAS Peptide DME1028 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 13 microM) DME1028 XEOTICID XEO04489 GENEFORM Protein DME1028 XEOTICID XEO04489 MOACRIVE Inhibition DME1028 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1028 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04490 XEO_CLAS Peptide DME1028 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 47.5 microM) DME1028 XEOTICID XEO04490 GENEFORM Protein DME1028 XEOTICID XEO04490 MOACRIVE Inhibition DME1028 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1028 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04491 XEO_CLAS Peptide DME1028 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO04491 GENEFORM Protein DME1028 XEOTICID XEO04491 MOACRIVE Inhibition DME1028 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1028 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04492 XEO_CLAS Peptide DME1028 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 35 microM) DME1028 XEOTICID XEO04492 GENEFORM Protein DME1028 XEOTICID XEO04492 MOACRIVE Inhibition DME1028 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1028 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04493 XEO_CLAS Peptide DME1028 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 microM) DME1028 XEOTICID XEO04493 GENEFORM Protein DME1028 XEOTICID XEO04493 MOACRIVE Inhibition DME1028 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1028 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04494 XEO_CLAS Peptide DME1028 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO04494 GENEFORM Protein DME1028 XEOTICID XEO04494 MOACRIVE Inhibition DME1028 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1028 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04495 XEO_CLAS Peptide DME1028 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO04495 GENEFORM Protein DME1028 XEOTICID XEO04495 MOACRIVE Inhibition DME1028 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1028 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04496 XEO_CLAS Peptide DME1028 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 67.5 microM) DME1028 XEOTICID XEO04496 GENEFORM Protein DME1028 XEOTICID XEO04496 MOACRIVE Inhibition DME1028 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1028 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04497 XEO_CLAS Peptide DME1028 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO04497 GENEFORM Protein DME1028 XEOTICID XEO04497 MOACRIVE Inhibition DME1028 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1028 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04498 XEO_CLAS Peptide DME1028 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO04498 GENEFORM Protein DME1028 XEOTICID XEO04498 MOACRIVE Inhibition DME1028 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1028 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04499 XEO_CLAS Peptide DME1028 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 43 microM) DME1028 XEOTICID XEO04499 GENEFORM Protein DME1028 XEOTICID XEO04499 MOACRIVE Inhibition DME1028 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1028 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04500 XEO_CLAS Peptide DME1028 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO04500 GENEFORM Protein DME1028 XEOTICID XEO04500 MOACRIVE Inhibition DME1028 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1028 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04504 XEO_CLAS Peptide DME1028 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04504 GENEFORM Protein DME1028 XEOTICID XEO04504 MOACRIVE Inhibition DME1028 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1028 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04505 XEO_CLAS Peptide DME1028 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04505 GENEFORM Protein DME1028 XEOTICID XEO04505 MOACRIVE Inhibition DME1028 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1028 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04506 XEO_CLAS Peptide DME1028 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 40 microM) DME1028 XEOTICID XEO04506 GENEFORM Protein DME1028 XEOTICID XEO04506 MOACRIVE Inhibition DME1028 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1028 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04507 XEO_CLAS Peptide DME1028 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10-20 microM) DME1028 XEOTICID XEO04507 GENEFORM Protein DME1028 XEOTICID XEO04507 MOACRIVE Inhibition DME1028 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1028 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04508 XEO_CLAS Peptide DME1028 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04508 GENEFORM Protein DME1028 XEOTICID XEO04508 MOACRIVE Inhibition DME1028 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1028 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04509 XEO_CLAS Peptide DME1028 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04509 GENEFORM Protein DME1028 XEOTICID XEO04509 MOACRIVE Inhibition DME1028 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1028 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04510 XEO_CLAS Peptide DME1028 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 22-33 microM) DME1028 XEOTICID XEO04510 GENEFORM Protein DME1028 XEOTICID XEO04510 MOACRIVE Inhibition DME1028 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1028 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04525 XEO_CLAS Peptide DME1028 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 32.0 microM) DME1028 XEOTICID XEO04525 GENEFORM Protein DME1028 XEOTICID XEO04525 MOACRIVE Inhibition DME1028 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1028 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04526 XEO_CLAS Peptide DME1028 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.0 microM) DME1028 XEOTICID XEO04526 GENEFORM Protein DME1028 XEOTICID XEO04526 MOACRIVE Inhibition DME1028 XEOTICID XEO04527 XEO_NAME Pepcon DME1028 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04527 XEO_CLAS Peptide DME1028 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO04527 GENEFORM Protein DME1028 XEOTICID XEO04527 MOACRIVE Inhibition DME1028 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1028 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04532 XEO_CLAS Peptide DME1028 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04532 GENEFORM Protein DME1028 XEOTICID XEO04532 MOACRIVE Inhibition DME1028 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1028 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04540 XEO_CLAS Peptide DME1028 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 18.1 ug/ml) DME1028 XEOTICID XEO04540 GENEFORM Protein DME1028 XEOTICID XEO04540 MOACRIVE Inhibition DME1028 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1028 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04541 XEO_CLAS Peptide DME1028 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.5 ug/ml) DME1028 XEOTICID XEO04541 GENEFORM Protein DME1028 XEOTICID XEO04541 MOACRIVE Inhibition DME1028 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1028 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04542 XEO_CLAS Peptide DME1028 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04542 GENEFORM Protein DME1028 XEOTICID XEO04542 MOACRIVE Inhibition DME1028 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1028 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04543 XEO_CLAS Peptide DME1028 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04543 GENEFORM Protein DME1028 XEOTICID XEO04543 MOACRIVE Inhibition DME1028 XEOTICID XEO04546 XEO_NAME Perinerin DME1028 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04546 XEO_CLAS Peptide DME1028 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04546 GENEFORM Protein DME1028 XEOTICID XEO04546 MOACRIVE Inhibition DME1028 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1028 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04548 XEO_CLAS Peptide DME1028 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 72000 ug/ml) DME1028 XEOTICID XEO04548 GENEFORM Protein DME1028 XEOTICID XEO04548 MOACRIVE Inhibition DME1028 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1028 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04549 XEO_CLAS Peptide DME1028 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 62-125 ug/ml) DME1028 XEOTICID XEO04549 GENEFORM Protein DME1028 XEOTICID XEO04549 MOACRIVE Inhibition DME1028 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1028 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04550 XEO_CLAS Peptide DME1028 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO04550 GENEFORM Protein DME1028 XEOTICID XEO04550 MOACRIVE Inhibition DME1028 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1028 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04551 XEO_CLAS Peptide DME1028 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 23.6 ug/ml) DME1028 XEOTICID XEO04551 GENEFORM Protein DME1028 XEOTICID XEO04551 MOACRIVE Inhibition DME1028 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1028 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04552 XEO_CLAS Peptide DME1028 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04552 GENEFORM Protein DME1028 XEOTICID XEO04552 MOACRIVE Inhibition DME1028 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1028 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04553 XEO_CLAS Peptide DME1028 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04553 GENEFORM Protein DME1028 XEOTICID XEO04553 MOACRIVE Inhibition DME1028 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1028 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04554 XEO_CLAS Peptide DME1028 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04554 GENEFORM Protein DME1028 XEOTICID XEO04554 MOACRIVE Inhibition DME1028 XEOTICID XEO04563 XEO_NAME Phosphate DME1028 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1028 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04563 GENEFORM Protein DME1028 XEOTICID XEO04563 MOACRIVE Inhibition DME1028 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1028 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04565 XEO_CLAS Peptide DME1028 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.5 microM) DME1028 XEOTICID XEO04565 GENEFORM Protein DME1028 XEOTICID XEO04565 MOACRIVE Inhibition DME1028 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1028 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04566 XEO_CLAS Peptide DME1028 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.7 microM) DME1028 XEOTICID XEO04566 GENEFORM Protein DME1028 XEOTICID XEO04566 MOACRIVE Inhibition DME1028 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1028 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04569 XEO_CLAS Peptide DME1028 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7.9 microM) DME1028 XEOTICID XEO04569 GENEFORM Protein DME1028 XEOTICID XEO04569 MOACRIVE Inhibition DME1028 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1028 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04570 XEO_CLAS Peptide DME1028 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04570 GENEFORM Protein DME1028 XEOTICID XEO04570 MOACRIVE Inhibition DME1028 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1028 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04571 XEO_CLAS Peptide DME1028 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04571 GENEFORM Protein DME1028 XEOTICID XEO04571 MOACRIVE Inhibition DME1028 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1028 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04572 XEO_CLAS Peptide DME1028 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04572 GENEFORM Protein DME1028 XEOTICID XEO04572 MOACRIVE Inhibition DME1028 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1028 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04573 XEO_CLAS Peptide DME1028 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 microM) DME1028 XEOTICID XEO04573 GENEFORM Protein DME1028 XEOTICID XEO04573 MOACRIVE Inhibition DME1028 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1028 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04574 XEO_CLAS Peptide DME1028 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 128 ug/ml) DME1028 XEOTICID XEO04574 GENEFORM Protein DME1028 XEOTICID XEO04574 MOACRIVE Inhibition DME1028 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1028 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04575 XEO_CLAS Peptide DME1028 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO04575 GENEFORM Protein DME1028 XEOTICID XEO04575 MOACRIVE Inhibition DME1028 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1028 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04578 GENEFORM Protein DME1028 XEOTICID XEO04578 MOACRIVE Inhibition DME1028 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1028 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04579 GENEFORM Protein DME1028 XEOTICID XEO04579 MOACRIVE Inhibition DME1028 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1028 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04580 GENEFORM Protein DME1028 XEOTICID XEO04580 MOACRIVE Inhibition DME1028 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1028 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04583 GENEFORM Protein DME1028 XEOTICID XEO04583 MOACRIVE Inhibition DME1028 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1028 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04588 GENEFORM Protein DME1028 XEOTICID XEO04588 MOACRIVE Inhibition DME1028 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1028 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04589 GENEFORM Protein DME1028 XEOTICID XEO04589 MOACRIVE Inhibition DME1028 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1028 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04590 GENEFORM Protein DME1028 XEOTICID XEO04590 MOACRIVE Inhibition DME1028 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1028 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04591 GENEFORM Protein DME1028 XEOTICID XEO04591 MOACRIVE Inhibition DME1028 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1028 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04592 GENEFORM Protein DME1028 XEOTICID XEO04592 MOACRIVE Inhibition DME1028 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1028 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04593 GENEFORM Protein DME1028 XEOTICID XEO04593 MOACRIVE Inhibition DME1028 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1028 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04594 GENEFORM Protein DME1028 XEOTICID XEO04594 MOACRIVE Inhibition DME1028 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1028 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04595 GENEFORM Protein DME1028 XEOTICID XEO04595 MOACRIVE Inhibition DME1028 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1028 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04596 GENEFORM Protein DME1028 XEOTICID XEO04596 MOACRIVE Inhibition DME1028 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1028 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04597 GENEFORM Protein DME1028 XEOTICID XEO04597 MOACRIVE Inhibition DME1028 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1028 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04598 GENEFORM Protein DME1028 XEOTICID XEO04598 MOACRIVE Inhibition DME1028 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1028 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04599 GENEFORM Protein DME1028 XEOTICID XEO04599 MOACRIVE Inhibition DME1028 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1028 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04601 XEO_CLAS Peptide DME1028 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 18.75 ug/ml) DME1028 XEOTICID XEO04601 GENEFORM Protein DME1028 XEOTICID XEO04601 MOACRIVE Inhibition DME1028 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1028 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04602 XEO_CLAS Peptide DME1028 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 37.5 ug/ml) DME1028 XEOTICID XEO04602 GENEFORM Protein DME1028 XEOTICID XEO04602 MOACRIVE Inhibition DME1028 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1028 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04604 XEO_CLAS Peptide DME1028 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC < 25 microM) DME1028 XEOTICID XEO04604 GENEFORM Protein DME1028 XEOTICID XEO04604 MOACRIVE Inhibition DME1028 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1028 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04605 XEO_CLAS Peptide DME1028 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC < 6.25 microM) DME1028 XEOTICID XEO04605 GENEFORM Protein DME1028 XEOTICID XEO04605 MOACRIVE Inhibition DME1028 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1028 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04606 XEO_CLAS Peptide DME1028 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO04606 GENEFORM Protein DME1028 XEOTICID XEO04606 MOACRIVE Inhibition DME1028 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1028 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1028 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04607 GENEFORM Protein DME1028 XEOTICID XEO04607 MOACRIVE Inhibition DME1028 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1028 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04612 XEO_CLAS Peptide DME1028 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5-10 microM) DME1028 XEOTICID XEO04612 GENEFORM Protein DME1028 XEOTICID XEO04612 MOACRIVE Inhibition DME1028 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1028 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04613 XEO_CLAS Peptide DME1028 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5-10 microM) DME1028 XEOTICID XEO04613 GENEFORM Protein DME1028 XEOTICID XEO04613 MOACRIVE Inhibition DME1028 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1028 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04625 XEO_CLAS Peptide DME1028 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO04625 GENEFORM Protein DME1028 XEOTICID XEO04625 MOACRIVE Inhibition DME1028 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1028 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04626 XEO_CLAS Peptide DME1028 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO04626 GENEFORM Protein DME1028 XEOTICID XEO04626 MOACRIVE Inhibition DME1028 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1028 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04627 XEO_CLAS Peptide DME1028 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.5 microM) DME1028 XEOTICID XEO04627 GENEFORM Protein DME1028 XEOTICID XEO04627 MOACRIVE Inhibition DME1028 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1028 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04630 XEO_CLAS Peptide DME1028 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 60 ug/ml) DME1028 XEOTICID XEO04630 GENEFORM Protein DME1028 XEOTICID XEO04630 MOACRIVE Inhibition DME1028 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1028 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04631 XEO_CLAS Peptide DME1028 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 60 ug/ml) DME1028 XEOTICID XEO04631 GENEFORM Protein DME1028 XEOTICID XEO04631 MOACRIVE Inhibition DME1028 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1028 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04633 XEO_CLAS Peptide DME1028 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 ug/ml) DME1028 XEOTICID XEO04633 GENEFORM Protein DME1028 XEOTICID XEO04633 MOACRIVE Inhibition DME1028 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1028 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04634 XEO_CLAS Peptide DME1028 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 ug/ml) DME1028 XEOTICID XEO04634 GENEFORM Protein DME1028 XEOTICID XEO04634 MOACRIVE Inhibition DME1028 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1028 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04635 XEO_CLAS Peptide DME1028 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 ug/ml) DME1028 XEOTICID XEO04635 GENEFORM Protein DME1028 XEOTICID XEO04635 MOACRIVE Inhibition DME1028 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1028 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04636 XEO_CLAS Peptide DME1028 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 ug/ml) DME1028 XEOTICID XEO04636 GENEFORM Protein DME1028 XEOTICID XEO04636 MOACRIVE Inhibition DME1028 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1028 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04637 XEO_CLAS Peptide DME1028 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 ug/ml) DME1028 XEOTICID XEO04637 GENEFORM Protein DME1028 XEOTICID XEO04637 MOACRIVE Inhibition DME1028 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1028 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04638 XEO_CLAS Peptide DME1028 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 ug/ml) DME1028 XEOTICID XEO04638 GENEFORM Protein DME1028 XEOTICID XEO04638 MOACRIVE Inhibition DME1028 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1028 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04639 XEO_CLAS Peptide DME1028 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 ug/ml) DME1028 XEOTICID XEO04639 GENEFORM Protein DME1028 XEOTICID XEO04639 MOACRIVE Inhibition DME1028 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1028 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04640 XEO_CLAS Peptide DME1028 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.2-3.3 microM) DME1028 XEOTICID XEO04640 GENEFORM Protein DME1028 XEOTICID XEO04640 MOACRIVE Inhibition DME1028 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1028 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04642 XEO_CLAS Peptide DME1028 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 ug/ml) DME1028 XEOTICID XEO04642 GENEFORM Protein DME1028 XEOTICID XEO04642 MOACRIVE Inhibition DME1028 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1028 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04643 XEO_CLAS Peptide DME1028 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO04643 GENEFORM Protein DME1028 XEOTICID XEO04643 MOACRIVE Inhibition DME1028 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1028 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04644 XEO_CLAS Peptide DME1028 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO04644 GENEFORM Protein DME1028 XEOTICID XEO04644 MOACRIVE Inhibition DME1028 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1028 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04645 XEO_CLAS Peptide DME1028 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 ug/ml) DME1028 XEOTICID XEO04645 GENEFORM Protein DME1028 XEOTICID XEO04645 MOACRIVE Inhibition DME1028 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1028 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04646 XEO_CLAS Peptide DME1028 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1 ug/ml) DME1028 XEOTICID XEO04646 GENEFORM Protein DME1028 XEOTICID XEO04646 MOACRIVE Inhibition DME1028 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1028 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04647 XEO_CLAS Peptide DME1028 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO04647 GENEFORM Protein DME1028 XEOTICID XEO04647 MOACRIVE Inhibition DME1028 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1028 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04648 XEO_CLAS Peptide DME1028 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 ug/ml) DME1028 XEOTICID XEO04648 GENEFORM Protein DME1028 XEOTICID XEO04648 MOACRIVE Inhibition DME1028 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1028 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04649 XEO_CLAS Peptide DME1028 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 64 ug/ml) DME1028 XEOTICID XEO04649 GENEFORM Protein DME1028 XEOTICID XEO04649 MOACRIVE Inhibition DME1028 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1028 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04650 XEO_CLAS Peptide DME1028 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 ug/ml) DME1028 XEOTICID XEO04650 GENEFORM Protein DME1028 XEOTICID XEO04650 MOACRIVE Inhibition DME1028 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1028 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04651 XEO_CLAS Peptide DME1028 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 ug/ml) DME1028 XEOTICID XEO04651 GENEFORM Protein DME1028 XEOTICID XEO04651 MOACRIVE Inhibition DME1028 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1028 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04652 XEO_CLAS Peptide DME1028 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO04652 GENEFORM Protein DME1028 XEOTICID XEO04652 MOACRIVE Inhibition DME1028 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1028 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04653 XEO_CLAS Peptide DME1028 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 64 ug/ml) DME1028 XEOTICID XEO04653 GENEFORM Protein DME1028 XEOTICID XEO04653 MOACRIVE Inhibition DME1028 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1028 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04654 XEO_CLAS Peptide DME1028 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 ug/ml) DME1028 XEOTICID XEO04654 GENEFORM Protein DME1028 XEOTICID XEO04654 MOACRIVE Inhibition DME1028 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1028 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04655 XEO_CLAS Peptide DME1028 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO04655 GENEFORM Protein DME1028 XEOTICID XEO04655 MOACRIVE Inhibition DME1028 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1028 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04657 XEO_CLAS Peptide DME1028 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 300 microM) DME1028 XEOTICID XEO04657 GENEFORM Protein DME1028 XEOTICID XEO04657 MOACRIVE Inhibition DME1028 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1028 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04660 XEO_CLAS Peptide DME1028 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO04660 GENEFORM Protein DME1028 XEOTICID XEO04660 MOACRIVE Inhibition DME1028 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1028 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04661 XEO_CLAS Peptide DME1028 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 microM) DME1028 XEOTICID XEO04661 GENEFORM Protein DME1028 XEOTICID XEO04661 MOACRIVE Inhibition DME1028 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1028 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04662 XEO_CLAS Peptide DME1028 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 microM) DME1028 XEOTICID XEO04662 GENEFORM Protein DME1028 XEOTICID XEO04662 MOACRIVE Inhibition DME1028 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1028 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04663 XEO_CLAS Peptide DME1028 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 microM) DME1028 XEOTICID XEO04663 GENEFORM Protein DME1028 XEOTICID XEO04663 MOACRIVE Inhibition DME1028 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1028 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04664 XEO_CLAS Peptide DME1028 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5.5 microM) DME1028 XEOTICID XEO04664 GENEFORM Protein DME1028 XEOTICID XEO04664 MOACRIVE Inhibition DME1028 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1028 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04665 XEO_CLAS Peptide DME1028 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 microM) DME1028 XEOTICID XEO04665 GENEFORM Protein DME1028 XEOTICID XEO04665 MOACRIVE Inhibition DME1028 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1028 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04666 XEO_CLAS Peptide DME1028 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO04666 GENEFORM Protein DME1028 XEOTICID XEO04666 MOACRIVE Inhibition DME1028 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1028 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04667 XEO_CLAS Peptide DME1028 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6.25 microM) DME1028 XEOTICID XEO04667 GENEFORM Protein DME1028 XEOTICID XEO04667 MOACRIVE Inhibition DME1028 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1028 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04668 XEO_CLAS Peptide DME1028 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 microM) DME1028 XEOTICID XEO04668 GENEFORM Protein DME1028 XEOTICID XEO04668 MOACRIVE Inhibition DME1028 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1028 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04669 XEO_CLAS Peptide DME1028 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO04669 GENEFORM Protein DME1028 XEOTICID XEO04669 MOACRIVE Inhibition DME1028 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1028 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04670 XEO_CLAS Peptide DME1028 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 21 microM) DME1028 XEOTICID XEO04670 GENEFORM Protein DME1028 XEOTICID XEO04670 MOACRIVE Inhibition DME1028 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1028 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04671 XEO_CLAS Peptide DME1028 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 62 microM) DME1028 XEOTICID XEO04671 GENEFORM Protein DME1028 XEOTICID XEO04671 MOACRIVE Inhibition DME1028 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1028 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04672 XEO_CLAS Peptide DME1028 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO04672 GENEFORM Protein DME1028 XEOTICID XEO04672 MOACRIVE Inhibition DME1028 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1028 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04673 XEO_CLAS Peptide DME1028 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO04673 GENEFORM Protein DME1028 XEOTICID XEO04673 MOACRIVE Inhibition DME1028 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1028 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04674 XEO_CLAS Peptide DME1028 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 75 microM) DME1028 XEOTICID XEO04674 GENEFORM Protein DME1028 XEOTICID XEO04674 MOACRIVE Inhibition DME1028 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1028 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04675 XEO_CLAS Peptide DME1028 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 microM) DME1028 XEOTICID XEO04675 GENEFORM Protein DME1028 XEOTICID XEO04675 MOACRIVE Inhibition DME1028 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1028 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04676 XEO_CLAS Peptide DME1028 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 microM) DME1028 XEOTICID XEO04676 GENEFORM Protein DME1028 XEOTICID XEO04676 MOACRIVE Inhibition DME1028 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1028 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04677 XEO_CLAS Peptide DME1028 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO04677 GENEFORM Protein DME1028 XEOTICID XEO04677 MOACRIVE Inhibition DME1028 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1028 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04680 XEO_CLAS Peptide DME1028 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 microM) DME1028 XEOTICID XEO04680 GENEFORM Protein DME1028 XEOTICID XEO04680 MOACRIVE Inhibition DME1028 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1028 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04682 XEO_CLAS Peptide DME1028 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 microM) DME1028 XEOTICID XEO04682 GENEFORM Protein DME1028 XEOTICID XEO04682 MOACRIVE Inhibition DME1028 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1028 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04683 XEO_CLAS Peptide DME1028 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 microM) DME1028 XEOTICID XEO04683 GENEFORM Protein DME1028 XEOTICID XEO04683 MOACRIVE Inhibition DME1028 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1028 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04684 XEO_CLAS Peptide DME1028 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 38 microM) DME1028 XEOTICID XEO04684 GENEFORM Protein DME1028 XEOTICID XEO04684 MOACRIVE Inhibition DME1028 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1028 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04690 XEO_CLAS Peptide DME1028 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.5 ug/ml) DME1028 XEOTICID XEO04690 GENEFORM Protein DME1028 XEOTICID XEO04690 MOACRIVE Inhibition DME1028 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1028 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04695 XEO_CLAS Peptide DME1028 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04695 GENEFORM Protein DME1028 XEOTICID XEO04695 MOACRIVE Inhibition DME1028 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1028 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04696 XEO_CLAS Peptide DME1028 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04696 GENEFORM Protein DME1028 XEOTICID XEO04696 MOACRIVE Inhibition DME1028 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1028 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04712 XEO_CLAS Peptide DME1028 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16.7 microM) DME1028 XEOTICID XEO04712 GENEFORM Protein DME1028 XEOTICID XEO04712 MOACRIVE Inhibition DME1028 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1028 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04713 XEO_CLAS Peptide DME1028 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16.7 microM) DME1028 XEOTICID XEO04713 GENEFORM Protein DME1028 XEOTICID XEO04713 MOACRIVE Inhibition DME1028 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1028 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04714 XEO_CLAS Peptide DME1028 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 23.3 microM) DME1028 XEOTICID XEO04714 GENEFORM Protein DME1028 XEOTICID XEO04714 MOACRIVE Inhibition DME1028 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1028 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04716 XEO_CLAS Peptide DME1028 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 microM) DME1028 XEOTICID XEO04716 GENEFORM Protein DME1028 XEOTICID XEO04716 MOACRIVE Inhibition DME1028 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1028 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04717 XEO_CLAS Peptide DME1028 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 50 microM) DME1028 XEOTICID XEO04717 GENEFORM Protein DME1028 XEOTICID XEO04717 MOACRIVE Inhibition DME1028 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1028 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04725 XEO_CLAS Peptide DME1028 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04725 GENEFORM Protein DME1028 XEOTICID XEO04725 MOACRIVE Inhibition DME1028 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1028 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04726 XEO_CLAS Peptide DME1028 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04726 GENEFORM Protein DME1028 XEOTICID XEO04726 MOACRIVE Inhibition DME1028 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1028 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04731 XEO_CLAS Peptide DME1028 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 ug/ml) DME1028 XEOTICID XEO04731 GENEFORM Protein DME1028 XEOTICID XEO04731 MOACRIVE Inhibition DME1028 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1028 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04732 XEO_CLAS Peptide DME1028 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 25 ug/ml) DME1028 XEOTICID XEO04732 GENEFORM Protein DME1028 XEOTICID XEO04732 MOACRIVE Inhibition DME1028 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1028 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04733 XEO_CLAS Peptide DME1028 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04733 GENEFORM Protein DME1028 XEOTICID XEO04733 MOACRIVE Inhibition DME1028 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1028 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04734 XEO_CLAS Peptide DME1028 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04734 GENEFORM Protein DME1028 XEOTICID XEO04734 MOACRIVE Inhibition DME1028 XEOTICID XEO04737 XEO_NAME Protonectin DME1028 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04737 XEO_CLAS Peptide DME1028 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 ug/ml) DME1028 XEOTICID XEO04737 GENEFORM Protein DME1028 XEOTICID XEO04737 MOACRIVE Inhibition DME1028 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1028 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04739 XEO_CLAS Peptide DME1028 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04739 GENEFORM Protein DME1028 XEOTICID XEO04739 MOACRIVE Inhibition DME1028 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1028 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04740 XEO_CLAS Peptide DME1028 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04740 GENEFORM Protein DME1028 XEOTICID XEO04740 MOACRIVE Inhibition DME1028 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1028 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04741 XEO_CLAS Peptide DME1028 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04741 GENEFORM Protein DME1028 XEOTICID XEO04741 MOACRIVE Inhibition DME1028 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1028 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04742 XEO_CLAS Peptide DME1028 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04742 GENEFORM Protein DME1028 XEOTICID XEO04742 MOACRIVE Inhibition DME1028 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1028 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04762 XEO_CLAS Peptide DME1028 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.8 microM) DME1028 XEOTICID XEO04762 GENEFORM Protein DME1028 XEOTICID XEO04762 MOACRIVE Inhibition DME1028 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1028 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04766 XEO_CLAS Peptide DME1028 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.1 microM) DME1028 XEOTICID XEO04766 GENEFORM Protein DME1028 XEOTICID XEO04766 MOACRIVE Inhibition DME1028 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1028 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04767 XEO_CLAS Peptide DME1028 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.1 ug/ml) DME1028 XEOTICID XEO04767 GENEFORM Protein DME1028 XEOTICID XEO04767 MOACRIVE Inhibition DME1028 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1028 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04779 XEO_CLAS Peptide DME1028 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04779 GENEFORM Protein DME1028 XEOTICID XEO04779 MOACRIVE Inhibition DME1028 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1028 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04780 XEO_CLAS Peptide DME1028 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04780 GENEFORM Protein DME1028 XEOTICID XEO04780 MOACRIVE Inhibition DME1028 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1028 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04781 XEO_CLAS Peptide DME1028 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04781 GENEFORM Protein DME1028 XEOTICID XEO04781 MOACRIVE Inhibition DME1028 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1028 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04782 XEO_CLAS Peptide DME1028 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 ug/ml) DME1028 XEOTICID XEO04782 GENEFORM Protein DME1028 XEOTICID XEO04782 MOACRIVE Inhibition DME1028 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1028 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04783 XEO_CLAS Peptide DME1028 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO04783 GENEFORM Protein DME1028 XEOTICID XEO04783 MOACRIVE Inhibition DME1028 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1028 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04784 XEO_CLAS Peptide DME1028 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO04784 GENEFORM Protein DME1028 XEOTICID XEO04784 MOACRIVE Inhibition DME1028 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1028 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04785 XEO_CLAS Peptide DME1028 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO04785 GENEFORM Protein DME1028 XEOTICID XEO04785 MOACRIVE Inhibition DME1028 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1028 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04786 XEO_CLAS Peptide DME1028 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 ug/ml) DME1028 XEOTICID XEO04786 GENEFORM Protein DME1028 XEOTICID XEO04786 MOACRIVE Inhibition DME1028 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1028 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04787 XEO_CLAS Peptide DME1028 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04787 GENEFORM Protein DME1028 XEOTICID XEO04787 MOACRIVE Inhibition DME1028 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1028 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04793 XEO_CLAS Peptide DME1028 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04793 GENEFORM Protein DME1028 XEOTICID XEO04793 MOACRIVE Inhibition DME1028 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1028 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04798 XEO_CLAS Peptide DME1028 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 microM) DME1028 XEOTICID XEO04798 GENEFORM Protein DME1028 XEOTICID XEO04798 MOACRIVE Inhibition DME1028 XEOTICID XEO04799 XEO_NAME Ranalexin DME1028 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04799 XEO_CLAS Peptide DME1028 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 32 ug/ml) DME1028 XEOTICID XEO04799 GENEFORM Protein DME1028 XEOTICID XEO04799 MOACRIVE Inhibition DME1028 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1028 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04800 XEO_CLAS Peptide DME1028 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 microM) DME1028 XEOTICID XEO04800 GENEFORM Protein DME1028 XEOTICID XEO04800 MOACRIVE Inhibition DME1028 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1028 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04801 XEO_CLAS Peptide DME1028 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 9 microM) DME1028 XEOTICID XEO04801 GENEFORM Protein DME1028 XEOTICID XEO04801 MOACRIVE Inhibition DME1028 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1028 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04802 XEO_CLAS Peptide DME1028 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12 microM) DME1028 XEOTICID XEO04802 GENEFORM Protein DME1028 XEOTICID XEO04802 MOACRIVE Inhibition DME1028 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1028 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04803 XEO_CLAS Peptide DME1028 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO04803 GENEFORM Protein DME1028 XEOTICID XEO04803 MOACRIVE Inhibition DME1028 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1028 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04804 XEO_CLAS Peptide DME1028 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO04804 GENEFORM Protein DME1028 XEOTICID XEO04804 MOACRIVE Inhibition DME1028 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1028 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04805 XEO_CLAS Peptide DME1028 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.5 microM) DME1028 XEOTICID XEO04805 GENEFORM Protein DME1028 XEOTICID XEO04805 MOACRIVE Inhibition DME1028 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1028 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04806 XEO_CLAS Peptide DME1028 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.5 microM) DME1028 XEOTICID XEO04806 GENEFORM Protein DME1028 XEOTICID XEO04806 MOACRIVE Inhibition DME1028 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1028 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04807 XEO_CLAS Peptide DME1028 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04807 GENEFORM Protein DME1028 XEOTICID XEO04807 MOACRIVE Inhibition DME1028 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1028 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04809 XEO_CLAS Peptide DME1028 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 microM) DME1028 XEOTICID XEO04809 GENEFORM Protein DME1028 XEOTICID XEO04809 MOACRIVE Inhibition DME1028 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1028 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04811 XEO_CLAS Peptide DME1028 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO04811 GENEFORM Protein DME1028 XEOTICID XEO04811 MOACRIVE Inhibition DME1028 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1028 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04812 XEO_CLAS Peptide DME1028 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO04812 GENEFORM Protein DME1028 XEOTICID XEO04812 MOACRIVE Inhibition DME1028 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1028 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04813 XEO_CLAS Peptide DME1028 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 microM) DME1028 XEOTICID XEO04813 GENEFORM Protein DME1028 XEOTICID XEO04813 MOACRIVE Inhibition DME1028 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1028 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04814 XEO_CLAS Peptide DME1028 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 19 microM) DME1028 XEOTICID XEO04814 GENEFORM Protein DME1028 XEOTICID XEO04814 MOACRIVE Inhibition DME1028 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1028 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04815 XEO_CLAS Peptide DME1028 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 microM) DME1028 XEOTICID XEO04815 GENEFORM Protein DME1028 XEOTICID XEO04815 MOACRIVE Inhibition DME1028 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1028 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04816 XEO_CLAS Peptide DME1028 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 microM) DME1028 XEOTICID XEO04816 GENEFORM Protein DME1028 XEOTICID XEO04816 MOACRIVE Inhibition DME1028 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1028 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04817 XEO_CLAS Peptide DME1028 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 13 microM) DME1028 XEOTICID XEO04817 GENEFORM Protein DME1028 XEOTICID XEO04817 MOACRIVE Inhibition DME1028 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1028 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04818 XEO_CLAS Peptide DME1028 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO04818 GENEFORM Protein DME1028 XEOTICID XEO04818 MOACRIVE Inhibition DME1028 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1028 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04819 XEO_CLAS Peptide DME1028 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO04819 GENEFORM Protein DME1028 XEOTICID XEO04819 MOACRIVE Inhibition DME1028 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1028 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04820 XEO_CLAS Peptide DME1028 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3 microM) DME1028 XEOTICID XEO04820 GENEFORM Protein DME1028 XEOTICID XEO04820 MOACRIVE Inhibition DME1028 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1028 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04821 XEO_CLAS Peptide DME1028 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 microM) DME1028 XEOTICID XEO04821 GENEFORM Protein DME1028 XEOTICID XEO04821 MOACRIVE Inhibition DME1028 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1028 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04822 XEO_CLAS Peptide DME1028 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO04822 GENEFORM Protein DME1028 XEOTICID XEO04822 MOACRIVE Inhibition DME1028 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1028 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04823 XEO_CLAS Peptide DME1028 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 23 microM) DME1028 XEOTICID XEO04823 GENEFORM Protein DME1028 XEOTICID XEO04823 MOACRIVE Inhibition DME1028 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1028 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04824 XEO_CLAS Peptide DME1028 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04824 GENEFORM Protein DME1028 XEOTICID XEO04824 MOACRIVE Inhibition DME1028 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1028 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04825 XEO_CLAS Peptide DME1028 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04825 GENEFORM Protein DME1028 XEOTICID XEO04825 MOACRIVE Inhibition DME1028 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1028 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04826 XEO_CLAS Peptide DME1028 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO04826 GENEFORM Protein DME1028 XEOTICID XEO04826 MOACRIVE Inhibition DME1028 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1028 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04827 XEO_CLAS Peptide DME1028 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO04827 GENEFORM Protein DME1028 XEOTICID XEO04827 MOACRIVE Inhibition DME1028 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1028 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04835 XEO_CLAS Peptide DME1028 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04835 GENEFORM Protein DME1028 XEOTICID XEO04835 MOACRIVE Inhibition DME1028 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1028 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04836 XEO_CLAS Peptide DME1028 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04836 GENEFORM Protein DME1028 XEOTICID XEO04836 MOACRIVE Inhibition DME1028 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1028 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04837 XEO_CLAS Peptide DME1028 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 microM) DME1028 XEOTICID XEO04837 GENEFORM Protein DME1028 XEOTICID XEO04837 MOACRIVE Inhibition DME1028 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1028 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04839 XEO_CLAS Peptide DME1028 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04839 GENEFORM Protein DME1028 XEOTICID XEO04839 MOACRIVE Inhibition DME1028 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1028 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04840 XEO_CLAS Peptide DME1028 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 35-20 microM) DME1028 XEOTICID XEO04840 GENEFORM Protein DME1028 XEOTICID XEO04840 MOACRIVE Inhibition DME1028 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1028 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04847 XEO_CLAS Peptide DME1028 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04847 GENEFORM Protein DME1028 XEOTICID XEO04847 MOACRIVE Inhibition DME1028 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1028 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04848 XEO_CLAS Peptide DME1028 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04848 GENEFORM Protein DME1028 XEOTICID XEO04848 MOACRIVE Inhibition DME1028 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1028 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04849 XEO_CLAS Peptide DME1028 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04849 GENEFORM Protein DME1028 XEOTICID XEO04849 MOACRIVE Inhibition DME1028 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1028 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04850 XEO_CLAS Peptide DME1028 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04850 GENEFORM Protein DME1028 XEOTICID XEO04850 MOACRIVE Inhibition DME1028 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1028 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04851 XEO_CLAS Peptide DME1028 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1 ug/ml) DME1028 XEOTICID XEO04851 GENEFORM Protein DME1028 XEOTICID XEO04851 MOACRIVE Inhibition DME1028 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1028 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04857 XEO_CLAS Peptide DME1028 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 microM) DME1028 XEOTICID XEO04857 GENEFORM Protein DME1028 XEOTICID XEO04857 MOACRIVE Inhibition DME1028 XEOTICID XEO04863 XEO_NAME RTD peptide DME1028 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04863 XEO_CLAS Peptide DME1028 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.0 microM) DME1028 XEOTICID XEO04863 GENEFORM Protein DME1028 XEOTICID XEO04863 MOACRIVE Inhibition DME1028 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1028 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04865 XEO_CLAS Peptide DME1028 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 ug/ml) DME1028 XEOTICID XEO04865 GENEFORM Protein DME1028 XEOTICID XEO04865 MOACRIVE Inhibition DME1028 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1028 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04866 XEO_CLAS Peptide DME1028 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12.5 ug/ml) DME1028 XEOTICID XEO04866 GENEFORM Protein DME1028 XEOTICID XEO04866 MOACRIVE Inhibition DME1028 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1028 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04868 XEO_CLAS Peptide DME1028 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25.00 ug/ml) DME1028 XEOTICID XEO04868 GENEFORM Protein DME1028 XEOTICID XEO04868 MOACRIVE Inhibition DME1028 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1028 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04869 XEO_CLAS Peptide DME1028 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25.00 ug/ml) DME1028 XEOTICID XEO04869 GENEFORM Protein DME1028 XEOTICID XEO04869 MOACRIVE Inhibition DME1028 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1028 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04870 XEO_CLAS Peptide DME1028 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25.00 ug/ml) DME1028 XEOTICID XEO04870 GENEFORM Protein DME1028 XEOTICID XEO04870 MOACRIVE Inhibition DME1028 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1028 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04877 XEO_CLAS Peptide DME1028 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04877 GENEFORM Protein DME1028 XEOTICID XEO04877 MOACRIVE Inhibition DME1028 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1028 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04880 XEO_CLAS Peptide DME1028 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.5 ug/ml) DME1028 XEOTICID XEO04880 GENEFORM Protein DME1028 XEOTICID XEO04880 MOACRIVE Inhibition DME1028 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1028 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04886 XEO_CLAS Peptide DME1028 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.6 ug/ml) DME1028 XEOTICID XEO04886 GENEFORM Protein DME1028 XEOTICID XEO04886 MOACRIVE Inhibition DME1028 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1028 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04891 XEO_CLAS Peptide DME1028 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04891 GENEFORM Protein DME1028 XEOTICID XEO04891 MOACRIVE Inhibition DME1028 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1028 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04895 XEO_CLAS Peptide DME1028 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04895 GENEFORM Protein DME1028 XEOTICID XEO04895 MOACRIVE Inhibition DME1028 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1028 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04901 XEO_CLAS Peptide DME1028 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 microM) DME1028 XEOTICID XEO04901 GENEFORM Protein DME1028 XEOTICID XEO04901 MOACRIVE Inhibition DME1028 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1028 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04904 XEO_CLAS Peptide DME1028 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 78 ug/ml) DME1028 XEOTICID XEO04904 GENEFORM Protein DME1028 XEOTICID XEO04904 MOACRIVE Inhibition DME1028 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1028 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04905 XEO_CLAS Peptide DME1028 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04905 GENEFORM Protein DME1028 XEOTICID XEO04905 MOACRIVE Inhibition DME1028 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1028 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04906 XEO_CLAS Peptide DME1028 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04906 GENEFORM Protein DME1028 XEOTICID XEO04906 MOACRIVE Inhibition DME1028 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1028 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04907 XEO_CLAS Peptide DME1028 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04907 GENEFORM Protein DME1028 XEOTICID XEO04907 MOACRIVE Inhibition DME1028 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1028 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04908 XEO_CLAS Peptide DME1028 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04908 GENEFORM Protein DME1028 XEOTICID XEO04908 MOACRIVE Inhibition DME1028 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1028 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04909 XEO_CLAS Peptide DME1028 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04909 GENEFORM Protein DME1028 XEOTICID XEO04909 MOACRIVE Inhibition DME1028 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1028 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04915 XEO_CLAS Peptide DME1028 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 100 ug/ml) DME1028 XEOTICID XEO04915 GENEFORM Protein DME1028 XEOTICID XEO04915 MOACRIVE Inhibition DME1028 XEOTICID XEO04916 XEO_NAME Scopoletin DME1028 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1028 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04916 GENEFORM Protein DME1028 XEOTICID XEO04916 MOACRIVE Inhibition DME1028 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1028 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04926 XEO_CLAS Peptide DME1028 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04926 GENEFORM Protein DME1028 XEOTICID XEO04926 MOACRIVE Inhibition DME1028 XEOTICID XEO04931 XEO_NAME Shepherin I DME1028 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04931 XEO_CLAS Peptide DME1028 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04931 GENEFORM Protein DME1028 XEOTICID XEO04931 MOACRIVE Inhibition DME1028 XEOTICID XEO04932 XEO_NAME shepherin II DME1028 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04932 XEO_CLAS Peptide DME1028 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04932 GENEFORM Protein DME1028 XEOTICID XEO04932 MOACRIVE Inhibition DME1028 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1028 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04938 XEO_CLAS Peptide DME1028 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC <= 100 microM) DME1028 XEOTICID XEO04938 GENEFORM Protein DME1028 XEOTICID XEO04938 MOACRIVE Inhibition DME1028 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1028 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04947 XEO_CLAS Natural Product DME1028 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04947 GENEFORM Protein DME1028 XEOTICID XEO04947 MOACRIVE Inhibition DME1028 XEOTICID XEO04948 XEO_NAME Sinensetin DME1028 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1028 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1028 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04948 GENEFORM Protein DME1028 XEOTICID XEO04948 MOACRIVE Inhibition DME1028 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1028 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04950 XEO_CLAS Peptide DME1028 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 ug/ml) DME1028 XEOTICID XEO04950 GENEFORM Protein DME1028 XEOTICID XEO04950 MOACRIVE Inhibition DME1028 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1028 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04955 XEO_CLAS Peptide DME1028 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.07 microM) DME1028 XEOTICID XEO04955 GENEFORM Protein DME1028 XEOTICID XEO04955 MOACRIVE Inhibition DME1028 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1028 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04956 XEO_CLAS Peptide DME1028 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16.0 microM) DME1028 XEOTICID XEO04956 GENEFORM Protein DME1028 XEOTICID XEO04956 MOACRIVE Inhibition DME1028 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1028 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04957 XEO_CLAS Peptide DME1028 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.23 microM) DME1028 XEOTICID XEO04957 GENEFORM Protein DME1028 XEOTICID XEO04957 MOACRIVE Inhibition DME1028 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1028 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04958 XEO_CLAS Peptide DME1028 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 ug/ml) DME1028 XEOTICID XEO04958 GENEFORM Protein DME1028 XEOTICID XEO04958 MOACRIVE Inhibition DME1028 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1028 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04959 XEO_CLAS Peptide DME1028 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04959 GENEFORM Protein DME1028 XEOTICID XEO04959 MOACRIVE Inhibition DME1028 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1028 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04967 XEO_CLAS Peptide DME1028 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 28 microM) DME1028 XEOTICID XEO04967 GENEFORM Protein DME1028 XEOTICID XEO04967 MOACRIVE Inhibition DME1028 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1028 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04969 XEO_CLAS Peptide DME1028 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50-100 ug/ml) DME1028 XEOTICID XEO04969 GENEFORM Protein DME1028 XEOTICID XEO04969 MOACRIVE Inhibition DME1028 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1028 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04970 XEO_CLAS Peptide DME1028 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04970 GENEFORM Protein DME1028 XEOTICID XEO04970 MOACRIVE Inhibition DME1028 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1028 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04971 XEO_CLAS Peptide DME1028 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.8-1.5 microM) DME1028 XEOTICID XEO04971 GENEFORM Protein DME1028 XEOTICID XEO04971 MOACRIVE Inhibition DME1028 XEOTICID XEO04974 XEO_NAME Spinigerin DME1028 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04974 XEO_CLAS Peptide DME1028 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3-6 microM) DME1028 XEOTICID XEO04974 GENEFORM Protein DME1028 XEOTICID XEO04974 MOACRIVE Inhibition DME1028 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1028 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1028 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04975 GENEFORM Protein DME1028 XEOTICID XEO04975 MOACRIVE Inhibition DME1028 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1028 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1028 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04976 GENEFORM Protein DME1028 XEOTICID XEO04976 MOACRIVE Inhibition DME1028 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1028 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1028 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04977 GENEFORM Protein DME1028 XEOTICID XEO04977 MOACRIVE Inhibition DME1028 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1028 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1028 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04978 GENEFORM Protein DME1028 XEOTICID XEO04978 MOACRIVE Inhibition DME1028 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1028 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1028 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04979 GENEFORM Protein DME1028 XEOTICID XEO04979 MOACRIVE Inhibition DME1028 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1028 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04981 XEO_CLAS Peptide DME1028 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10.1 microM) DME1028 XEOTICID XEO04981 GENEFORM Protein DME1028 XEOTICID XEO04981 MOACRIVE Inhibition DME1028 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1028 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04982 XEO_CLAS Peptide DME1028 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40.5 microM) DME1028 XEOTICID XEO04982 GENEFORM Protein DME1028 XEOTICID XEO04982 MOACRIVE Inhibition DME1028 XEOTICID XEO04994 XEO_NAME Stilbene DME1028 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1028 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1028 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO04994 GENEFORM Protein DME1028 XEOTICID XEO04994 MOACRIVE Inhibition DME1028 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1028 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04995 XEO_CLAS Peptide DME1028 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.19-0.39 microM) DME1028 XEOTICID XEO04995 GENEFORM Protein DME1028 XEOTICID XEO04995 MOACRIVE Inhibition DME1028 XEOTICID XEO04998 XEO_NAME Styelin A DME1028 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04998 XEO_CLAS Peptide DME1028 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.7 ug/ml) DME1028 XEOTICID XEO04998 GENEFORM Protein DME1028 XEOTICID XEO04998 MOACRIVE Inhibition DME1028 XEOTICID XEO04999 XEO_NAME Styelin B DME1028 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO04999 XEO_CLAS Peptide DME1028 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.7 ug/ml) DME1028 XEOTICID XEO04999 GENEFORM Protein DME1028 XEOTICID XEO04999 MOACRIVE Inhibition DME1028 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1028 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05000 XEO_CLAS Peptide DME1028 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO05000 GENEFORM Protein DME1028 XEOTICID XEO05000 MOACRIVE Inhibition DME1028 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1028 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05001 XEO_CLAS Peptide DME1028 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.5 ug/ml) DME1028 XEOTICID XEO05001 GENEFORM Protein DME1028 XEOTICID XEO05001 MOACRIVE Inhibition DME1028 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1028 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05002 XEO_CLAS Peptide DME1028 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO05002 GENEFORM Protein DME1028 XEOTICID XEO05002 MOACRIVE Inhibition DME1028 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1028 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05003 XEO_CLAS Peptide DME1028 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO05003 GENEFORM Protein DME1028 XEOTICID XEO05003 MOACRIVE Inhibition DME1028 XEOTICID XEO05006 XEO_NAME Substance P DME1028 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05006 XEO_CLAS Peptide DME1028 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05006 GENEFORM Protein DME1028 XEOTICID XEO05006 MOACRIVE Inhibition DME1028 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1028 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05007 XEO_CLAS Peptide DME1028 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05007 GENEFORM Protein DME1028 XEOTICID XEO05007 MOACRIVE Inhibition DME1028 XEOTICID XEO05008 XEO_NAME Subtilosin DME1028 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05008 XEO_CLAS Peptide DME1028 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05008 GENEFORM Protein DME1028 XEOTICID XEO05008 MOACRIVE Inhibition DME1028 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1028 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05013 XEO_CLAS Peptide DME1028 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO05013 GENEFORM Protein DME1028 XEOTICID XEO05013 MOACRIVE Inhibition DME1028 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1028 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05014 XEO_CLAS Peptide DME1028 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO05014 GENEFORM Protein DME1028 XEOTICID XEO05014 MOACRIVE Inhibition DME1028 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1028 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05015 XEO_CLAS Peptide DME1028 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO05015 GENEFORM Protein DME1028 XEOTICID XEO05015 MOACRIVE Inhibition DME1028 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1028 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05016 XEO_CLAS Peptide DME1028 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO05016 GENEFORM Protein DME1028 XEOTICID XEO05016 MOACRIVE Inhibition DME1028 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1028 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05017 XEO_CLAS Peptide DME1028 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 20 ug/ml) DME1028 XEOTICID XEO05017 GENEFORM Protein DME1028 XEOTICID XEO05017 MOACRIVE Inhibition DME1028 XEOTICID XEO05018 XEO_NAME Syringic acid DME1028 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1028 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05018 GENEFORM Protein DME1028 XEOTICID XEO05018 MOACRIVE Inhibition DME1028 XEOTICID XEO05020 XEO_NAME Tachycitin DME1028 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05020 XEO_CLAS Peptide DME1028 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05020 GENEFORM Protein DME1028 XEOTICID XEO05020 MOACRIVE Inhibition DME1028 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1028 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05023 XEO_CLAS Peptide DME1028 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05023 GENEFORM Protein DME1028 XEOTICID XEO05023 MOACRIVE Inhibition DME1028 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1028 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05024 XEO_CLAS Peptide DME1028 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05024 GENEFORM Protein DME1028 XEOTICID XEO05024 MOACRIVE Inhibition DME1028 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1028 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05027 XEO_CLAS Peptide DME1028 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05027 GENEFORM Protein DME1028 XEOTICID XEO05027 MOACRIVE Inhibition DME1028 XEOTICID XEO05031 XEO_NAME Tannic acid DME1028 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1028 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05031 GENEFORM Protein DME1028 XEOTICID XEO05031 MOACRIVE Inhibition DME1028 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1028 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05033 XEO_CLAS Peptide DME1028 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05033 GENEFORM Protein DME1028 XEOTICID XEO05033 MOACRIVE Inhibition DME1028 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1028 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05042 XEO_CLAS Peptide DME1028 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO05042 GENEFORM Protein DME1028 XEOTICID XEO05042 MOACRIVE Inhibition DME1028 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1028 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05043 XEO_CLAS Peptide DME1028 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO05043 GENEFORM Protein DME1028 XEOTICID XEO05043 MOACRIVE Inhibition DME1028 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1028 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05044 XEO_CLAS Peptide DME1028 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 128 microM) DME1028 XEOTICID XEO05044 GENEFORM Protein DME1028 XEOTICID XEO05044 MOACRIVE Inhibition DME1028 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1028 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05045 XEO_CLAS Peptide DME1028 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 128 microM) DME1028 XEOTICID XEO05045 GENEFORM Protein DME1028 XEOTICID XEO05045 MOACRIVE Inhibition DME1028 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1028 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05046 XEO_CLAS Peptide DME1028 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 microM) DME1028 XEOTICID XEO05046 GENEFORM Protein DME1028 XEOTICID XEO05046 MOACRIVE Inhibition DME1028 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1028 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05047 XEO_CLAS Peptide DME1028 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 60 microM) DME1028 XEOTICID XEO05047 GENEFORM Protein DME1028 XEOTICID XEO05047 MOACRIVE Inhibition DME1028 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1028 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05051 XEO_CLAS Peptide DME1028 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05051 GENEFORM Protein DME1028 XEOTICID XEO05051 MOACRIVE Inhibition DME1028 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1028 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05055 XEO_CLAS Peptide DME1028 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 70 microM) DME1028 XEOTICID XEO05055 GENEFORM Protein DME1028 XEOTICID XEO05055 MOACRIVE Inhibition DME1028 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1028 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05056 XEO_CLAS Peptide DME1028 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05056 GENEFORM Protein DME1028 XEOTICID XEO05056 MOACRIVE Inhibition DME1028 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1028 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05059 XEO_CLAS Peptide DME1028 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05059 GENEFORM Protein DME1028 XEOTICID XEO05059 MOACRIVE Inhibition DME1028 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1028 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05061 XEO_CLAS Peptide DME1028 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO05061 GENEFORM Protein DME1028 XEOTICID XEO05061 MOACRIVE Inhibition DME1028 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1028 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05062 XEO_CLAS Peptide DME1028 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05062 GENEFORM Protein DME1028 XEOTICID XEO05062 MOACRIVE Inhibition DME1028 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1028 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05063 XEO_CLAS Peptide DME1028 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO05063 GENEFORM Protein DME1028 XEOTICID XEO05063 MOACRIVE Inhibition DME1028 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1028 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05064 XEO_CLAS Peptide DME1028 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 231 microM) DME1028 XEOTICID XEO05064 GENEFORM Protein DME1028 XEOTICID XEO05064 MOACRIVE Inhibition DME1028 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1028 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05065 XEO_CLAS Peptide DME1028 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 161 ug/ml) DME1028 XEOTICID XEO05065 GENEFORM Protein DME1028 XEOTICID XEO05065 MOACRIVE Inhibition DME1028 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1028 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05069 XEO_CLAS Peptide DME1028 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO05069 GENEFORM Protein DME1028 XEOTICID XEO05069 MOACRIVE Inhibition DME1028 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1028 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05070 XEO_CLAS Peptide DME1028 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 37.5 microM) DME1028 XEOTICID XEO05070 GENEFORM Protein DME1028 XEOTICID XEO05070 MOACRIVE Inhibition DME1028 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1028 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05071 XEO_CLAS Peptide DME1028 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 150 microM) DME1028 XEOTICID XEO05071 GENEFORM Protein DME1028 XEOTICID XEO05071 MOACRIVE Inhibition DME1028 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1028 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05072 XEO_CLAS Peptide DME1028 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO05072 GENEFORM Protein DME1028 XEOTICID XEO05072 MOACRIVE Inhibition DME1028 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1028 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05073 XEO_CLAS Peptide DME1028 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40 microM) DME1028 XEOTICID XEO05073 GENEFORM Protein DME1028 XEOTICID XEO05073 MOACRIVE Inhibition DME1028 XEOTICID XEO05076 XEO_NAME Temporin-A DME1028 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05076 XEO_CLAS Peptide DME1028 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 11.9 microM) DME1028 XEOTICID XEO05076 GENEFORM Protein DME1028 XEOTICID XEO05076 MOACRIVE Inhibition DME1028 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1028 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05077 XEO_CLAS Peptide DME1028 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.25 ug/ml) DME1028 XEOTICID XEO05077 GENEFORM Protein DME1028 XEOTICID XEO05077 MOACRIVE Inhibition DME1028 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1028 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05078 XEO_CLAS Peptide DME1028 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.25 ug/ml) DME1028 XEOTICID XEO05078 GENEFORM Protein DME1028 XEOTICID XEO05078 MOACRIVE Inhibition DME1028 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1028 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05079 XEO_CLAS Peptide DME1028 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.5 ug/ml) DME1028 XEOTICID XEO05079 GENEFORM Protein DME1028 XEOTICID XEO05079 MOACRIVE Inhibition DME1028 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1028 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05080 XEO_CLAS Peptide DME1028 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 ug/ml) DME1028 XEOTICID XEO05080 GENEFORM Protein DME1028 XEOTICID XEO05080 MOACRIVE Inhibition DME1028 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1028 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05081 XEO_CLAS Peptide DME1028 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 5 ug/ml) DME1028 XEOTICID XEO05081 GENEFORM Protein DME1028 XEOTICID XEO05081 MOACRIVE Inhibition DME1028 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1028 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05082 XEO_CLAS Peptide DME1028 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7.5 ug/ml) DME1028 XEOTICID XEO05082 GENEFORM Protein DME1028 XEOTICID XEO05082 MOACRIVE Inhibition DME1028 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1028 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05083 XEO_CLAS Peptide DME1028 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 ug/ml) DME1028 XEOTICID XEO05083 GENEFORM Protein DME1028 XEOTICID XEO05083 MOACRIVE Inhibition DME1028 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1028 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05084 XEO_CLAS Peptide DME1028 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 ug/ml) DME1028 XEOTICID XEO05084 GENEFORM Protein DME1028 XEOTICID XEO05084 MOACRIVE Inhibition DME1028 XEOTICID XEO05085 XEO_NAME Temporin-B DME1028 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05085 XEO_CLAS Peptide DME1028 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 21.0 ug/ml) DME1028 XEOTICID XEO05085 GENEFORM Protein DME1028 XEOTICID XEO05085 MOACRIVE Inhibition DME1028 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1028 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05086 XEO_CLAS Peptide DME1028 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC > 100 microM) DME1028 XEOTICID XEO05086 GENEFORM Protein DME1028 XEOTICID XEO05086 MOACRIVE Inhibition DME1028 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1028 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05087 XEO_CLAS Peptide DME1028 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO05087 GENEFORM Protein DME1028 XEOTICID XEO05087 MOACRIVE Inhibition DME1028 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1028 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05097 XEO_CLAS Peptide DME1028 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16.0 microM) DME1028 XEOTICID XEO05097 GENEFORM Protein DME1028 XEOTICID XEO05097 MOACRIVE Inhibition DME1028 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1028 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05099 XEO_CLAS Peptide DME1028 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.0 microM) DME1028 XEOTICID XEO05099 GENEFORM Protein DME1028 XEOTICID XEO05099 MOACRIVE Inhibition DME1028 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1028 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05100 XEO_CLAS Peptide DME1028 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05100 GENEFORM Protein DME1028 XEOTICID XEO05100 MOACRIVE Inhibition DME1028 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1028 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05101 XEO_CLAS Peptide DME1028 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 24.2 ug/ml) DME1028 XEOTICID XEO05101 GENEFORM Protein DME1028 XEOTICID XEO05101 MOACRIVE Inhibition DME1028 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1028 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05102 XEO_CLAS Peptide DME1028 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 34.5 ug/ml) DME1028 XEOTICID XEO05102 GENEFORM Protein DME1028 XEOTICID XEO05102 MOACRIVE Inhibition DME1028 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1028 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05105 XEO_CLAS Peptide DME1028 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO05105 GENEFORM Protein DME1028 XEOTICID XEO05105 MOACRIVE Inhibition DME1028 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1028 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05106 XEO_CLAS Peptide DME1028 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25-200 microM) DME1028 XEOTICID XEO05106 GENEFORM Protein DME1028 XEOTICID XEO05106 MOACRIVE Inhibition DME1028 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1028 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05108 XEO_CLAS Peptide DME1028 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40 microM) DME1028 XEOTICID XEO05108 GENEFORM Protein DME1028 XEOTICID XEO05108 MOACRIVE Inhibition DME1028 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1028 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1028 XEOTICID XEO05111 XEO_CLAS Natural Product DME1028 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05111 GENEFORM Protein DME1028 XEOTICID XEO05111 MOACRIVE Inhibition DME1028 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1028 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05119 XEO_CLAS Peptide DME1028 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05119 GENEFORM Protein DME1028 XEOTICID XEO05119 MOACRIVE Inhibition DME1028 XEOTICID XEO05120 XEO_NAME Thanatin DME1028 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05120 XEO_CLAS Peptide DME1028 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.3-0.6 microM) DME1028 XEOTICID XEO05120 GENEFORM Protein DME1028 XEOTICID XEO05120 MOACRIVE Inhibition DME1028 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1028 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05121 XEO_CLAS Peptide DME1028 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 62.5 ug/ml) DME1028 XEOTICID XEO05121 GENEFORM Protein DME1028 XEOTICID XEO05121 MOACRIVE Inhibition DME1028 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1028 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05125 XEO_CLAS Peptide DME1028 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05125 GENEFORM Protein DME1028 XEOTICID XEO05125 MOACRIVE Inhibition DME1028 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1028 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05130 XEO_CLAS Peptide DME1028 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05130 GENEFORM Protein DME1028 XEOTICID XEO05130 MOACRIVE Inhibition DME1028 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1028 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05144 XEO_CLAS Peptide DME1028 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40 ug/ml) DME1028 XEOTICID XEO05144 GENEFORM Protein DME1028 XEOTICID XEO05144 MOACRIVE Inhibition DME1028 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1028 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05145 XEO_CLAS Peptide DME1028 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 ug/ml) DME1028 XEOTICID XEO05145 GENEFORM Protein DME1028 XEOTICID XEO05145 MOACRIVE Inhibition DME1028 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1028 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05146 XEO_CLAS Peptide DME1028 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 40 ug/ml) DME1028 XEOTICID XEO05146 GENEFORM Protein DME1028 XEOTICID XEO05146 MOACRIVE Inhibition DME1028 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1028 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05147 XEO_CLAS Peptide DME1028 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 60 ug/ml) DME1028 XEOTICID XEO05147 GENEFORM Protein DME1028 XEOTICID XEO05147 MOACRIVE Inhibition DME1028 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1028 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05158 XEO_CLAS Peptide DME1028 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05158 GENEFORM Protein DME1028 XEOTICID XEO05158 MOACRIVE Inhibition DME1028 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1028 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05161 XEO_CLAS Peptide DME1028 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 32 ug/ml) DME1028 XEOTICID XEO05161 GENEFORM Protein DME1028 XEOTICID XEO05161 MOACRIVE Inhibition DME1028 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1028 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05162 XEO_CLAS Peptide DME1028 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 32 ug/ml) DME1028 XEOTICID XEO05162 GENEFORM Protein DME1028 XEOTICID XEO05162 MOACRIVE Inhibition DME1028 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1028 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05163 XEO_CLAS Peptide DME1028 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 12-25 ug/ml) DME1028 XEOTICID XEO05163 GENEFORM Protein DME1028 XEOTICID XEO05163 MOACRIVE Inhibition DME1028 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1028 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05170 XEO_CLAS Peptide DME1028 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 3.0 microM) DME1028 XEOTICID XEO05170 GENEFORM Protein DME1028 XEOTICID XEO05170 MOACRIVE Inhibition DME1028 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1028 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05171 XEO_CLAS Peptide DME1028 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 50 microM) DME1028 XEOTICID XEO05171 GENEFORM Protein DME1028 XEOTICID XEO05171 MOACRIVE Inhibition DME1028 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1028 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05179 XEO_CLAS Peptide DME1028 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05179 GENEFORM Protein DME1028 XEOTICID XEO05179 MOACRIVE Inhibition DME1028 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1028 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05180 XEO_CLAS Peptide DME1028 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 160 microM) DME1028 XEOTICID XEO05180 GENEFORM Protein DME1028 XEOTICID XEO05180 MOACRIVE Inhibition DME1028 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1028 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05182 XEO_CLAS Peptide DME1028 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 microM) DME1028 XEOTICID XEO05182 GENEFORM Protein DME1028 XEOTICID XEO05182 MOACRIVE Inhibition DME1028 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1028 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05183 XEO_CLAS Peptide DME1028 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 microM) DME1028 XEOTICID XEO05183 GENEFORM Protein DME1028 XEOTICID XEO05183 MOACRIVE Inhibition DME1028 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1028 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05184 XEO_CLAS Peptide DME1028 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 microM) DME1028 XEOTICID XEO05184 GENEFORM Protein DME1028 XEOTICID XEO05184 MOACRIVE Inhibition DME1028 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1028 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05185 XEO_CLAS Peptide DME1028 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 microM) DME1028 XEOTICID XEO05185 GENEFORM Protein DME1028 XEOTICID XEO05185 MOACRIVE Inhibition DME1028 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1028 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05186 XEO_CLAS Peptide DME1028 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 microM) DME1028 XEOTICID XEO05186 GENEFORM Protein DME1028 XEOTICID XEO05186 MOACRIVE Inhibition DME1028 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1028 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05187 XEO_CLAS Peptide DME1028 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16 microM) DME1028 XEOTICID XEO05187 GENEFORM Protein DME1028 XEOTICID XEO05187 MOACRIVE Inhibition DME1028 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1028 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05188 XEO_CLAS Peptide DME1028 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 64 microM) DME1028 XEOTICID XEO05188 GENEFORM Protein DME1028 XEOTICID XEO05188 MOACRIVE Inhibition DME1028 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1028 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05190 XEO_CLAS Peptide DME1028 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05190 GENEFORM Protein DME1028 XEOTICID XEO05190 MOACRIVE Inhibition DME1028 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1028 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05193 XEO_CLAS Peptide DME1028 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO05193 GENEFORM Protein DME1028 XEOTICID XEO05193 MOACRIVE Inhibition DME1028 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1028 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05197 XEO_CLAS Peptide DME1028 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05197 GENEFORM Protein DME1028 XEOTICID XEO05197 MOACRIVE Inhibition DME1028 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1028 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05205 XEO_CLAS Peptide DME1028 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05205 GENEFORM Protein DME1028 XEOTICID XEO05205 MOACRIVE Inhibition DME1028 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1028 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05206 XEO_CLAS Peptide DME1028 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 10 microM) DME1028 XEOTICID XEO05206 GENEFORM Protein DME1028 XEOTICID XEO05206 MOACRIVE Inhibition DME1028 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1028 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05207 XEO_CLAS Peptide DME1028 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 25 microM) DME1028 XEOTICID XEO05207 GENEFORM Protein DME1028 XEOTICID XEO05207 MOACRIVE Inhibition DME1028 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1028 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05208 XEO_CLAS Peptide DME1028 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 microM) DME1028 XEOTICID XEO05208 GENEFORM Protein DME1028 XEOTICID XEO05208 MOACRIVE Inhibition DME1028 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1028 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05209 XEO_CLAS Peptide DME1028 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 15 microM) DME1028 XEOTICID XEO05209 GENEFORM Protein DME1028 XEOTICID XEO05209 MOACRIVE Inhibition DME1028 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1028 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05212 XEO_CLAS Peptide DME1028 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.5 ug/ml) DME1028 XEOTICID XEO05212 GENEFORM Protein DME1028 XEOTICID XEO05212 MOACRIVE Inhibition DME1028 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1028 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05220 XEO_CLAS Peptide DME1028 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.6-1.2 microM) DME1028 XEOTICID XEO05220 GENEFORM Protein DME1028 XEOTICID XEO05220 MOACRIVE Inhibition DME1028 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1028 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05230 XEO_CLAS Peptide DME1028 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 7.90 microM) DME1028 XEOTICID XEO05230 GENEFORM Protein DME1028 XEOTICID XEO05230 MOACRIVE Inhibition DME1028 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1028 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05231 XEO_CLAS Peptide DME1028 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2.40 microM) DME1028 XEOTICID XEO05231 GENEFORM Protein DME1028 XEOTICID XEO05231 MOACRIVE Inhibition DME1028 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1028 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05232 XEO_CLAS Peptide DME1028 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05232 GENEFORM Protein DME1028 XEOTICID XEO05232 MOACRIVE Inhibition DME1028 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1028 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05233 XEO_CLAS Peptide DME1028 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 ug/ml) DME1028 XEOTICID XEO05233 GENEFORM Protein DME1028 XEOTICID XEO05233 MOACRIVE Inhibition DME1028 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1028 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05234 XEO_CLAS Peptide DME1028 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 ug/ml) DME1028 XEOTICID XEO05234 GENEFORM Protein DME1028 XEOTICID XEO05234 MOACRIVE Inhibition DME1028 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1028 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05235 XEO_CLAS Peptide DME1028 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 30 ug/ml) DME1028 XEOTICID XEO05235 GENEFORM Protein DME1028 XEOTICID XEO05235 MOACRIVE Inhibition DME1028 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1028 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05237 XEO_CLAS Peptide DME1028 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 microM) DME1028 XEOTICID XEO05237 GENEFORM Protein DME1028 XEOTICID XEO05237 MOACRIVE Inhibition DME1028 XEOTICID XEO05245 XEO_NAME Viresin DME1028 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05245 XEO_CLAS Peptide DME1028 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05245 GENEFORM Protein DME1028 XEOTICID XEO05245 MOACRIVE Inhibition DME1028 XEOTICID XEO05248 XEO_NAME Vitamin C DME1028 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1028 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1028 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05248 GENEFORM Protein DME1028 XEOTICID XEO05248 MOACRIVE Inhibition DME1028 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1028 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05264 XEO_CLAS Peptide DME1028 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 4 ug/ml) DME1028 XEOTICID XEO05264 GENEFORM Protein DME1028 XEOTICID XEO05264 MOACRIVE Inhibition DME1028 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1028 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05267 XEO_CLAS Peptide DME1028 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 2 ug/ml) DME1028 XEOTICID XEO05267 GENEFORM Protein DME1028 XEOTICID XEO05267 MOACRIVE Inhibition DME1028 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1028 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05268 XEO_CLAS Peptide DME1028 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 1.6 ug/ml) DME1028 XEOTICID XEO05268 GENEFORM Protein DME1028 XEOTICID XEO05268 MOACRIVE Inhibition DME1028 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1028 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05269 XEO_CLAS Peptide DME1028 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 6 ug/ml) DME1028 XEOTICID XEO05269 GENEFORM Protein DME1028 XEOTICID XEO05269 MOACRIVE Inhibition DME1028 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1028 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05273 XEO_CLAS Peptide DME1028 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05273 GENEFORM Protein DME1028 XEOTICID XEO05273 MOACRIVE Inhibition DME1028 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1028 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05274 XEO_CLAS Peptide DME1028 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05274 GENEFORM Protein DME1028 XEOTICID XEO05274 MOACRIVE Inhibition DME1028 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1028 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05287 XEO_CLAS Peptide DME1028 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli DME1028 XEOTICID XEO05287 GENEFORM Protein DME1028 XEOTICID XEO05287 MOACRIVE Inhibition DME1028 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1028 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05303 XEO_CLAS Peptide DME1028 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 16-31 ug/ml) DME1028 XEOTICID XEO05303 GENEFORM Protein DME1028 XEOTICID XEO05303 MOACRIVE Inhibition DME1028 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1028 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05306 XEO_CLAS Peptide DME1028 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 8 ug/ml) DME1028 XEOTICID XEO05306 GENEFORM Protein DME1028 XEOTICID XEO05306 MOACRIVE Inhibition DME1028 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1028 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1028 XEOTICID XEO05308 XEO_CLAS Peptide DME1028 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Escherichia coli (MIC = 0.4 ug/ml) DME1028 XEOTICID XEO05308 GENEFORM Protein DME1028 XEOTICID XEO05308 MOACRIVE Inhibition DME1029 DME___ID DME1029 DME1029 DME_NAME Glycerol-3-phosphate dehydrogenase (gpsA) DME1029 SPESNAME Erysipelothrix rhusiopathiae DME1029 XEOTICID XEO04481 XEO_NAME Porcine beta-defensin pBD-2 DME1029 XEOTICID XEO04481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1029 XEOTICID XEO04481 XEO_CLAS Peptide DME1029 XEOTICID XEO04481 DESCRIPT Porcine beta-defensin pBD-2 inhibits the drug-metabolizing activity of Glycerol-3-phosphate dehydrogenase (gpsA) from Erysipelothrix rhusiopathiae DME1029 XEOTICID XEO04481 GENEFORM Protein DME1029 XEOTICID XEO04481 MOACRIVE Inhibition DME1030 DME___ID DME1030 DME1030 DME_NAME Chloramphenicolase (chlR) DME1030 SPESNAME Bacillus pumilus DME1030 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1030 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1030 XEOTICID XEO05230 XEO_CLAS Peptide DME1030 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Bacillus pumilus (MIC = 2 microM) DME1030 XEOTICID XEO05230 GENEFORM Protein DME1030 XEOTICID XEO05230 MOACRIVE Inhibition DME1030 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1030 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1030 XEOTICID XEO05231 XEO_CLAS Peptide DME1030 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Bacillus pumilus (MIC = 0.60 microM) DME1030 XEOTICID XEO05231 GENEFORM Protein DME1030 XEOTICID XEO05231 MOACRIVE Inhibition DME1030 XEOTICID XEO05260 XEO_NAME V. philippinarum beta defensin VpBD DME1030 XEOTICID XEO05260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1030 XEOTICID XEO05260 XEO_CLAS Peptide DME1030 XEOTICID XEO05260 DESCRIPT V. philippinarum beta defensin VpBD inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Bacillus pumilus (MIC = 13.13-26.26 microM) DME1030 XEOTICID XEO05260 GENEFORM Protein DME1030 XEOTICID XEO05260 MOACRIVE Inhibition DME1031 DME___ID DME1031 DME1031 DME_NAME Chloramphenicolase (chlR) DME1031 SPESNAME Proteus penneri DME1031 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1031 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1031 XEOTICID XEO04548 XEO_CLAS Peptide DME1031 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Chloramphenicolase (chlR) from Proteus penneri DME1031 XEOTICID XEO04548 GENEFORM Protein DME1031 XEOTICID XEO04548 MOACRIVE Inhibition DME1033 DME___ID DME1033 DME1033 DME_NAME Beta-lactamase (blaB) DME1033 SPESNAME Edwardsiella tarda DME1033 XEOTICID XEO00879 XEO_NAME Coumarin DME1033 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1033 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1033 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Edwardsiella tarda DME1033 XEOTICID XEO00879 GENEFORM Protein DME1033 XEOTICID XEO00879 MOACRIVE Inhibition DME1033 XEOTICID XEO04758 XEO_NAME Anti-lipopolysaccharide factor PtALF5 DME1033 XEOTICID XEO04758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1033 XEOTICID XEO04758 XEO_CLAS Peptide DME1033 XEOTICID XEO04758 DESCRIPT Anti-lipopolysaccharide factor PtALF5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Edwardsiella tarda (MIC = 7.78-15.54 microM) DME1033 XEOTICID XEO04758 GENEFORM Protein DME1033 XEOTICID XEO04758 MOACRIVE Inhibition DME1033 XEOTICID XEO04760 XEO_NAME Anti-lipopolysaccharide factor PtALF7 DME1033 XEOTICID XEO04760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1033 XEOTICID XEO04760 XEO_CLAS Peptide DME1033 XEOTICID XEO04760 DESCRIPT Anti-lipopolysaccharide factor PtALF7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Edwardsiella tarda (MIC = 2.04-4.07 microM) DME1033 XEOTICID XEO04760 GENEFORM Protein DME1033 XEOTICID XEO04760 MOACRIVE Inhibition DME1039 DME___ID DME1039 DME1039 DME_NAME Molybdopterin-dependent enzyme (molD) DME1039 SPESNAME Klebsiella pneumoniae DME1039 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1039 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1039 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1039 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO00546 GENEFORM Protein DME1039 XEOTICID XEO00546 MOACRIVE Inhibition DME1039 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1039 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1039 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1039 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO00574 GENEFORM Protein DME1039 XEOTICID XEO00574 MOACRIVE Inhibition DME1039 XEOTICID XEO01266 XEO_NAME Cyanidin DME1039 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME1039 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME1039 XEOTICID XEO01266 DESCRIPT Cyanidin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO01266 GENEFORM Protein DME1039 XEOTICID XEO01266 MOACRIVE Inhibition DME1039 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1039 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO01816 XEO_CLAS Peptide DME1039 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 6.25 microM) DME1039 XEOTICID XEO01816 GENEFORM Protein DME1039 XEOTICID XEO01816 MOACRIVE Inhibition DME1039 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1039 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO01827 XEO_CLAS Peptide DME1039 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC > 50 microM) DME1039 XEOTICID XEO01827 GENEFORM Protein DME1039 XEOTICID XEO01827 MOACRIVE Inhibition DME1039 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1039 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02115 XEO_CLAS Peptide DME1039 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO02115 GENEFORM Protein DME1039 XEOTICID XEO02115 MOACRIVE Inhibition DME1039 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1039 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02230 XEO_CLAS Peptide DME1039 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1039 XEOTICID XEO02230 GENEFORM Protein DME1039 XEOTICID XEO02230 MOACRIVE Inhibition DME1039 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1039 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02280 XEO_CLAS Peptide DME1039 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO02280 GENEFORM Protein DME1039 XEOTICID XEO02280 MOACRIVE Inhibition DME1039 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1039 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02325 XEO_CLAS Peptide DME1039 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 13 microM) DME1039 XEOTICID XEO02325 GENEFORM Protein DME1039 XEOTICID XEO02325 MOACRIVE Inhibition DME1039 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1039 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02370 XEO_CLAS Peptide DME1039 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO02370 GENEFORM Protein DME1039 XEOTICID XEO02370 MOACRIVE Inhibition DME1039 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1039 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02371 XEO_CLAS Peptide DME1039 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 12 ug/ml) DME1039 XEOTICID XEO02371 GENEFORM Protein DME1039 XEOTICID XEO02371 MOACRIVE Inhibition DME1039 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1039 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02378 XEO_CLAS Peptide DME1039 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 0.76 ug/ml) DME1039 XEOTICID XEO02378 GENEFORM Protein DME1039 XEOTICID XEO02378 MOACRIVE Inhibition DME1039 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1039 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02416 XEO_CLAS Peptide DME1039 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO02416 GENEFORM Protein DME1039 XEOTICID XEO02416 MOACRIVE Inhibition DME1039 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1039 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02451 XEO_CLAS Peptide DME1039 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO02451 GENEFORM Protein DME1039 XEOTICID XEO02451 MOACRIVE Inhibition DME1039 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1039 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02473 XEO_CLAS Peptide DME1039 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO02473 GENEFORM Protein DME1039 XEOTICID XEO02473 MOACRIVE Inhibition DME1039 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1039 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02491 XEO_CLAS Peptide DME1039 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 2.8 microM) DME1039 XEOTICID XEO02491 GENEFORM Protein DME1039 XEOTICID XEO02491 MOACRIVE Inhibition DME1039 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1039 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02496 XEO_CLAS Peptide DME1039 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 50 microM) DME1039 XEOTICID XEO02496 GENEFORM Protein DME1039 XEOTICID XEO02496 MOACRIVE Inhibition DME1039 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1039 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02497 XEO_CLAS Peptide DME1039 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC > 50 microM) DME1039 XEOTICID XEO02497 GENEFORM Protein DME1039 XEOTICID XEO02497 MOACRIVE Inhibition DME1039 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1039 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02512 XEO_CLAS Peptide DME1039 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 150 microM) DME1039 XEOTICID XEO02512 GENEFORM Protein DME1039 XEOTICID XEO02512 MOACRIVE Inhibition DME1039 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1039 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02566 XEO_CLAS Peptide DME1039 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC > 100 microM) DME1039 XEOTICID XEO02566 GENEFORM Protein DME1039 XEOTICID XEO02566 MOACRIVE Inhibition DME1039 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1039 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02637 XEO_CLAS Peptide DME1039 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 6 microM) DME1039 XEOTICID XEO02637 GENEFORM Protein DME1039 XEOTICID XEO02637 MOACRIVE Inhibition DME1039 XEOTICID XEO02656 XEO_NAME Himatanthus drasticus butanolic extract DME1039 XEOTICID XEO02656 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1039 XEOTICID XEO02656 XEO_CLAS Plant Extract DME1039 XEOTICID XEO02656 DESCRIPT Himatanthus drasticus butanolic extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO02656 GENEFORM Protein DME1039 XEOTICID XEO02656 MOACRIVE Inhibition DME1039 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1039 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02688 XEO_CLAS Peptide DME1039 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 25 microM) DME1039 XEOTICID XEO02688 GENEFORM Protein DME1039 XEOTICID XEO02688 MOACRIVE Inhibition DME1039 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1039 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02708 XEO_CLAS Peptide DME1039 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 20 ug/ml) DME1039 XEOTICID XEO02708 GENEFORM Protein DME1039 XEOTICID XEO02708 MOACRIVE Inhibition DME1039 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1039 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02732 XEO_CLAS Peptide DME1039 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 1.25 microM) DME1039 XEOTICID XEO02732 GENEFORM Protein DME1039 XEOTICID XEO02732 MOACRIVE Inhibition DME1039 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1039 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02734 XEO_CLAS Peptide DME1039 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 0.40 microM) DME1039 XEOTICID XEO02734 GENEFORM Protein DME1039 XEOTICID XEO02734 MOACRIVE Inhibition DME1039 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1039 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02736 XEO_CLAS Peptide DME1039 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 0.66 microM) DME1039 XEOTICID XEO02736 GENEFORM Protein DME1039 XEOTICID XEO02736 MOACRIVE Inhibition DME1039 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1039 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02738 XEO_CLAS Peptide DME1039 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 1 microM) DME1039 XEOTICID XEO02738 GENEFORM Protein DME1039 XEOTICID XEO02738 MOACRIVE Inhibition DME1039 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1039 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02743 XEO_CLAS Peptide DME1039 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 4.7 ug/ml) DME1039 XEOTICID XEO02743 GENEFORM Protein DME1039 XEOTICID XEO02743 MOACRIVE Inhibition DME1039 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1039 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02749 XEO_CLAS Peptide DME1039 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 20 mug/ml) DME1039 XEOTICID XEO02749 GENEFORM Protein DME1039 XEOTICID XEO02749 MOACRIVE Inhibition DME1039 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1039 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02767 XEO_CLAS Peptide DME1039 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO02767 GENEFORM Protein DME1039 XEOTICID XEO02767 MOACRIVE Inhibition DME1039 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1039 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02768 XEO_CLAS Peptide DME1039 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 1-2.5 ug/ml) DME1039 XEOTICID XEO02768 GENEFORM Protein DME1039 XEOTICID XEO02768 MOACRIVE Inhibition DME1039 XEOTICID XEO02780 XEO_NAME Cefixime DME1039 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1039 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1039 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO02780 GENEFORM Protein DME1039 XEOTICID XEO02780 MOACRIVE Inhibition DME1039 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1039 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO02942 XEO_CLAS Peptide DME1039 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO02942 GENEFORM Protein DME1039 XEOTICID XEO02942 MOACRIVE Inhibition DME1039 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1039 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03029 XEO_CLAS Peptide DME1039 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 0.145 microM) DME1039 XEOTICID XEO03029 GENEFORM Protein DME1039 XEOTICID XEO03029 MOACRIVE Inhibition DME1039 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1039 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03030 XEO_CLAS Peptide DME1039 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 0.643 microM) DME1039 XEOTICID XEO03030 GENEFORM Protein DME1039 XEOTICID XEO03030 MOACRIVE Inhibition DME1039 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1039 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03031 XEO_CLAS Peptide DME1039 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 0.01 microM) DME1039 XEOTICID XEO03031 GENEFORM Protein DME1039 XEOTICID XEO03031 MOACRIVE Inhibition DME1039 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1039 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03032 XEO_CLAS Peptide DME1039 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC < 0.005 microM) DME1039 XEOTICID XEO03032 GENEFORM Protein DME1039 XEOTICID XEO03032 MOACRIVE Inhibition DME1039 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1039 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03033 XEO_CLAS Peptide DME1039 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC > 0.692 microM) DME1039 XEOTICID XEO03033 GENEFORM Protein DME1039 XEOTICID XEO03033 MOACRIVE Inhibition DME1039 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1039 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03034 XEO_CLAS Peptide DME1039 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 0.004 microM) DME1039 XEOTICID XEO03034 GENEFORM Protein DME1039 XEOTICID XEO03034 MOACRIVE Inhibition DME1039 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1039 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03035 XEO_CLAS Peptide DME1039 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 0.458 microM) DME1039 XEOTICID XEO03035 GENEFORM Protein DME1039 XEOTICID XEO03035 MOACRIVE Inhibition DME1039 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1039 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03051 XEO_CLAS Peptide DME1039 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1039 XEOTICID XEO03051 GENEFORM Protein DME1039 XEOTICID XEO03051 MOACRIVE Inhibition DME1039 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1039 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03052 XEO_CLAS Peptide DME1039 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1039 XEOTICID XEO03052 GENEFORM Protein DME1039 XEOTICID XEO03052 MOACRIVE Inhibition DME1039 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1039 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03053 XEO_CLAS Peptide DME1039 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1039 XEOTICID XEO03053 GENEFORM Protein DME1039 XEOTICID XEO03053 MOACRIVE Inhibition DME1039 XEOTICID XEO03089 XEO_NAME Decoralin DME1039 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03089 XEO_CLAS Peptide DME1039 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 80 microM) DME1039 XEOTICID XEO03089 GENEFORM Protein DME1039 XEOTICID XEO03089 MOACRIVE Inhibition DME1039 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1039 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03112 XEO_CLAS Peptide DME1039 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC > 50 ug/ml) DME1039 XEOTICID XEO03112 GENEFORM Protein DME1039 XEOTICID XEO03112 MOACRIVE Inhibition DME1039 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1039 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03137 XEO_CLAS Peptide DME1039 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03137 GENEFORM Protein DME1039 XEOTICID XEO03137 MOACRIVE Inhibition DME1039 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1039 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03162 XEO_CLAS Peptide DME1039 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 0.8 microM) DME1039 XEOTICID XEO03162 GENEFORM Protein DME1039 XEOTICID XEO03162 MOACRIVE Inhibition DME1039 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1039 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03224 XEO_CLAS Peptide DME1039 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1039 XEOTICID XEO03224 GENEFORM Protein DME1039 XEOTICID XEO03224 MOACRIVE Inhibition DME1039 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1039 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03235 XEO_CLAS Peptide DME1039 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 60 ug/ml) DME1039 XEOTICID XEO03235 GENEFORM Protein DME1039 XEOTICID XEO03235 MOACRIVE Inhibition DME1039 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1039 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03237 XEO_CLAS Peptide DME1039 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC > 100 ug/ml) DME1039 XEOTICID XEO03237 GENEFORM Protein DME1039 XEOTICID XEO03237 MOACRIVE Inhibition DME1039 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1039 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03238 XEO_CLAS Peptide DME1039 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1039 XEOTICID XEO03238 GENEFORM Protein DME1039 XEOTICID XEO03238 MOACRIVE Inhibition DME1039 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1039 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03239 XEO_CLAS Peptide DME1039 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1039 XEOTICID XEO03239 GENEFORM Protein DME1039 XEOTICID XEO03239 MOACRIVE Inhibition DME1039 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1039 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03250 XEO_CLAS Peptide DME1039 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03250 GENEFORM Protein DME1039 XEOTICID XEO03250 MOACRIVE Inhibition DME1039 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1039 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03251 XEO_CLAS Peptide DME1039 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03251 GENEFORM Protein DME1039 XEOTICID XEO03251 MOACRIVE Inhibition DME1039 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1039 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03253 XEO_CLAS Peptide DME1039 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 3.2 ug/ml) DME1039 XEOTICID XEO03253 GENEFORM Protein DME1039 XEOTICID XEO03253 MOACRIVE Inhibition DME1039 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1039 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1039 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1039 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03348 GENEFORM Protein DME1039 XEOTICID XEO03348 MOACRIVE Inhibition DME1039 XEOTICID XEO03387 XEO_NAME Ferric chloride DME1039 XEOTICID XEO03387 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1039 XEOTICID XEO03387 XEO_CLAS Chemical Compound DME1039 XEOTICID XEO03387 DESCRIPT Ferric chloride inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03387 GENEFORM Protein DME1039 XEOTICID XEO03387 MOACRIVE Inhibition DME1039 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1039 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03436 XEO_CLAS Peptide DME1039 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1039 XEOTICID XEO03436 GENEFORM Protein DME1039 XEOTICID XEO03436 MOACRIVE Inhibition DME1039 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1039 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03437 XEO_CLAS Peptide DME1039 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1039 XEOTICID XEO03437 GENEFORM Protein DME1039 XEOTICID XEO03437 MOACRIVE Inhibition DME1039 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1039 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03438 XEO_CLAS Peptide DME1039 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1039 XEOTICID XEO03438 GENEFORM Protein DME1039 XEOTICID XEO03438 MOACRIVE Inhibition DME1039 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1039 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03439 XEO_CLAS Peptide DME1039 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1039 XEOTICID XEO03439 GENEFORM Protein DME1039 XEOTICID XEO03439 MOACRIVE Inhibition DME1039 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1039 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03440 XEO_CLAS Peptide DME1039 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1039 XEOTICID XEO03440 GENEFORM Protein DME1039 XEOTICID XEO03440 MOACRIVE Inhibition DME1039 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1039 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03441 XEO_CLAS Peptide DME1039 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1039 XEOTICID XEO03441 GENEFORM Protein DME1039 XEOTICID XEO03441 MOACRIVE Inhibition DME1039 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1039 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03497 XEO_CLAS Peptide DME1039 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1039 XEOTICID XEO03497 GENEFORM Protein DME1039 XEOTICID XEO03497 MOACRIVE Inhibition DME1039 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1039 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03498 XEO_CLAS Peptide DME1039 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1039 XEOTICID XEO03498 GENEFORM Protein DME1039 XEOTICID XEO03498 MOACRIVE Inhibition DME1039 XEOTICID XEO03519 XEO_NAME Hadrurin DME1039 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03519 XEO_CLAS Peptide DME1039 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03519 GENEFORM Protein DME1039 XEOTICID XEO03519 MOACRIVE Inhibition DME1039 XEOTICID XEO03522 XEO_NAME Halocyntin DME1039 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03522 XEO_CLAS Peptide DME1039 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03522 GENEFORM Protein DME1039 XEOTICID XEO03522 MOACRIVE Inhibition DME1039 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1039 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03540 XEO_CLAS Peptide DME1039 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1039 XEOTICID XEO03540 GENEFORM Protein DME1039 XEOTICID XEO03540 MOACRIVE Inhibition DME1039 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1039 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03549 XEO_CLAS Peptide DME1039 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03549 GENEFORM Protein DME1039 XEOTICID XEO03549 MOACRIVE Inhibition DME1039 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1039 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1039 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1039 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03552 GENEFORM Protein DME1039 XEOTICID XEO03552 MOACRIVE Inhibition DME1039 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1039 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03556 XEO_CLAS Peptide DME1039 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1039 XEOTICID XEO03556 GENEFORM Protein DME1039 XEOTICID XEO03556 MOACRIVE Inhibition DME1039 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1039 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03557 XEO_CLAS Peptide DME1039 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1039 XEOTICID XEO03557 GENEFORM Protein DME1039 XEOTICID XEO03557 MOACRIVE Inhibition DME1039 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1039 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03591 XEO_CLAS Peptide DME1039 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1039 XEOTICID XEO03591 GENEFORM Protein DME1039 XEOTICID XEO03591 MOACRIVE Inhibition DME1039 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1039 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03593 XEO_CLAS Peptide DME1039 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1039 XEOTICID XEO03593 GENEFORM Protein DME1039 XEOTICID XEO03593 MOACRIVE Inhibition DME1039 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1039 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03609 XEO_CLAS Peptide DME1039 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03609 GENEFORM Protein DME1039 XEOTICID XEO03609 MOACRIVE Inhibition DME1039 XEOTICID XEO03611 XEO_NAME Himatanthus drasticus hydroalcoholic extract DME1039 XEOTICID XEO03611 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1039 XEOTICID XEO03611 XEO_CLAS Plant Extract DME1039 XEOTICID XEO03611 DESCRIPT Himatanthus drasticus hydroalcoholic extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03611 GENEFORM Protein DME1039 XEOTICID XEO03611 MOACRIVE Inhibition DME1039 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1039 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03622 XEO_CLAS Peptide DME1039 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 20-40 microM) DME1039 XEOTICID XEO03622 GENEFORM Protein DME1039 XEOTICID XEO03622 MOACRIVE Inhibition DME1039 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1039 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03630 XEO_CLAS Peptide DME1039 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03630 GENEFORM Protein DME1039 XEOTICID XEO03630 MOACRIVE Inhibition DME1039 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1039 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03631 XEO_CLAS Peptide DME1039 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03631 GENEFORM Protein DME1039 XEOTICID XEO03631 MOACRIVE Inhibition DME1039 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1039 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03632 XEO_CLAS Peptide DME1039 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03632 GENEFORM Protein DME1039 XEOTICID XEO03632 MOACRIVE Inhibition DME1039 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1039 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03633 XEO_CLAS Peptide DME1039 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03633 GENEFORM Protein DME1039 XEOTICID XEO03633 MOACRIVE Inhibition DME1039 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1039 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03634 XEO_CLAS Peptide DME1039 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03634 GENEFORM Protein DME1039 XEOTICID XEO03634 MOACRIVE Inhibition DME1039 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1039 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03635 XEO_CLAS Peptide DME1039 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03635 GENEFORM Protein DME1039 XEOTICID XEO03635 MOACRIVE Inhibition DME1039 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1039 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03636 XEO_CLAS Peptide DME1039 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03636 GENEFORM Protein DME1039 XEOTICID XEO03636 MOACRIVE Inhibition DME1039 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1039 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03637 XEO_CLAS Peptide DME1039 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03637 GENEFORM Protein DME1039 XEOTICID XEO03637 MOACRIVE Inhibition DME1039 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1039 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03638 XEO_CLAS Peptide DME1039 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03638 GENEFORM Protein DME1039 XEOTICID XEO03638 MOACRIVE Inhibition DME1039 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1039 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03639 XEO_CLAS Peptide DME1039 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03639 GENEFORM Protein DME1039 XEOTICID XEO03639 MOACRIVE Inhibition DME1039 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1039 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03640 XEO_CLAS Peptide DME1039 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03640 GENEFORM Protein DME1039 XEOTICID XEO03640 MOACRIVE Inhibition DME1039 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1039 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03672 XEO_CLAS Peptide DME1039 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1039 XEOTICID XEO03672 GENEFORM Protein DME1039 XEOTICID XEO03672 MOACRIVE Inhibition DME1039 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1039 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03673 XEO_CLAS Peptide DME1039 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1039 XEOTICID XEO03673 GENEFORM Protein DME1039 XEOTICID XEO03673 MOACRIVE Inhibition DME1039 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1039 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03674 XEO_CLAS Peptide DME1039 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO03674 GENEFORM Protein DME1039 XEOTICID XEO03674 MOACRIVE Inhibition DME1039 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1039 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03675 XEO_CLAS Peptide DME1039 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 15 microM) DME1039 XEOTICID XEO03675 GENEFORM Protein DME1039 XEOTICID XEO03675 MOACRIVE Inhibition DME1039 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1039 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03678 XEO_CLAS Peptide DME1039 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1039 XEOTICID XEO03678 GENEFORM Protein DME1039 XEOTICID XEO03678 MOACRIVE Inhibition DME1039 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1039 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03681 XEO_CLAS Peptide DME1039 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 1.2-2.5 microM) DME1039 XEOTICID XEO03681 GENEFORM Protein DME1039 XEOTICID XEO03681 MOACRIVE Inhibition DME1039 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1039 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03697 XEO_CLAS Peptide DME1039 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 25 microM) DME1039 XEOTICID XEO03697 GENEFORM Protein DME1039 XEOTICID XEO03697 MOACRIVE Inhibition DME1039 XEOTICID XEO03724 XEO_NAME L10 peptide DME1039 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03724 XEO_CLAS Peptide DME1039 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 3.35 microM) DME1039 XEOTICID XEO03724 GENEFORM Protein DME1039 XEOTICID XEO03724 MOACRIVE Inhibition DME1039 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1039 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03744 XEO_CLAS Peptide DME1039 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1039 XEOTICID XEO03744 GENEFORM Protein DME1039 XEOTICID XEO03744 MOACRIVE Inhibition DME1039 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1039 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03746 XEO_CLAS Peptide DME1039 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1039 XEOTICID XEO03746 GENEFORM Protein DME1039 XEOTICID XEO03746 MOACRIVE Inhibition DME1039 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1039 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03747 XEO_CLAS Peptide DME1039 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1039 XEOTICID XEO03747 GENEFORM Protein DME1039 XEOTICID XEO03747 MOACRIVE Inhibition DME1039 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1039 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03748 XEO_CLAS Peptide DME1039 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1039 XEOTICID XEO03748 GENEFORM Protein DME1039 XEOTICID XEO03748 MOACRIVE Inhibition DME1039 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1039 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03749 XEO_CLAS Peptide DME1039 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1039 XEOTICID XEO03749 GENEFORM Protein DME1039 XEOTICID XEO03749 MOACRIVE Inhibition DME1039 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1039 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03750 XEO_CLAS Peptide DME1039 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1039 XEOTICID XEO03750 GENEFORM Protein DME1039 XEOTICID XEO03750 MOACRIVE Inhibition DME1039 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1039 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03751 XEO_CLAS Peptide DME1039 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1039 XEOTICID XEO03751 GENEFORM Protein DME1039 XEOTICID XEO03751 MOACRIVE Inhibition DME1039 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1039 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03752 XEO_CLAS Peptide DME1039 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1039 XEOTICID XEO03752 GENEFORM Protein DME1039 XEOTICID XEO03752 MOACRIVE Inhibition DME1039 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1039 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03753 XEO_CLAS Peptide DME1039 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1039 XEOTICID XEO03753 GENEFORM Protein DME1039 XEOTICID XEO03753 MOACRIVE Inhibition DME1039 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1039 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03754 XEO_CLAS Peptide DME1039 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1039 XEOTICID XEO03754 GENEFORM Protein DME1039 XEOTICID XEO03754 MOACRIVE Inhibition DME1039 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1039 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03755 XEO_CLAS Peptide DME1039 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1039 XEOTICID XEO03755 GENEFORM Protein DME1039 XEOTICID XEO03755 MOACRIVE Inhibition DME1039 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1039 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03756 XEO_CLAS Peptide DME1039 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1039 XEOTICID XEO03756 GENEFORM Protein DME1039 XEOTICID XEO03756 MOACRIVE Inhibition DME1039 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1039 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03759 XEO_CLAS Peptide DME1039 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1039 XEOTICID XEO03759 GENEFORM Protein DME1039 XEOTICID XEO03759 MOACRIVE Inhibition DME1039 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1039 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03761 XEO_CLAS Peptide DME1039 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1039 XEOTICID XEO03761 GENEFORM Protein DME1039 XEOTICID XEO03761 MOACRIVE Inhibition DME1039 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1039 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO03985 XEO_CLAS Peptide DME1039 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1039 XEOTICID XEO03985 GENEFORM Protein DME1039 XEOTICID XEO03985 MOACRIVE Inhibition DME1039 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1039 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04001 XEO_CLAS Peptide DME1039 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 12.5 microM) DME1039 XEOTICID XEO04001 GENEFORM Protein DME1039 XEOTICID XEO04001 MOACRIVE Inhibition DME1039 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1039 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04007 XEO_CLAS Peptide DME1039 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1039 XEOTICID XEO04007 GENEFORM Protein DME1039 XEOTICID XEO04007 MOACRIVE Inhibition DME1039 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1039 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04011 XEO_CLAS Peptide DME1039 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1039 XEOTICID XEO04011 GENEFORM Protein DME1039 XEOTICID XEO04011 MOACRIVE Inhibition DME1039 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1039 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04012 XEO_CLAS Peptide DME1039 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1039 XEOTICID XEO04012 GENEFORM Protein DME1039 XEOTICID XEO04012 MOACRIVE Inhibition DME1039 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1039 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04013 XEO_CLAS Peptide DME1039 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1039 XEOTICID XEO04013 GENEFORM Protein DME1039 XEOTICID XEO04013 MOACRIVE Inhibition DME1039 XEOTICID XEO04014 XEO_NAME Maximin-5 DME1039 XEOTICID XEO04014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04014 XEO_CLAS Peptide DME1039 XEOTICID XEO04014 DESCRIPT Maximin-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 3.6 ug/ml) DME1039 XEOTICID XEO04014 GENEFORM Protein DME1039 XEOTICID XEO04014 MOACRIVE Inhibition DME1039 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1039 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1039 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1039 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04087 GENEFORM Protein DME1039 XEOTICID XEO04087 MOACRIVE Inhibition DME1039 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1039 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04111 XEO_CLAS Peptide DME1039 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04111 GENEFORM Protein DME1039 XEOTICID XEO04111 MOACRIVE Inhibition DME1039 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1039 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04241 XEO_CLAS Peptide DME1039 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04241 GENEFORM Protein DME1039 XEOTICID XEO04241 MOACRIVE Inhibition DME1039 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1039 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04242 XEO_CLAS Peptide DME1039 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04242 GENEFORM Protein DME1039 XEOTICID XEO04242 MOACRIVE Inhibition DME1039 XEOTICID XEO04331 XEO_NAME Norspermidine DME1039 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1039 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1039 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04331 GENEFORM Protein DME1039 XEOTICID XEO04331 MOACRIVE Inhibition DME1039 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1039 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04348 XEO_CLAS Peptide DME1039 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 80 microM) DME1039 XEOTICID XEO04348 GENEFORM Protein DME1039 XEOTICID XEO04348 MOACRIVE Inhibition DME1039 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1039 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04349 XEO_CLAS Peptide DME1039 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 100 microM) DME1039 XEOTICID XEO04349 GENEFORM Protein DME1039 XEOTICID XEO04349 MOACRIVE Inhibition DME1039 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1039 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04399 XEO_CLAS Peptide DME1039 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 6.3 microM) DME1039 XEOTICID XEO04399 GENEFORM Protein DME1039 XEOTICID XEO04399 MOACRIVE Inhibition DME1039 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1039 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04426 XEO_CLAS Peptide DME1039 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 2 microM) DME1039 XEOTICID XEO04426 GENEFORM Protein DME1039 XEOTICID XEO04426 MOACRIVE Inhibition DME1039 XEOTICID XEO04468 XEO_NAME Papillosin DME1039 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04468 XEO_CLAS Peptide DME1039 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04468 GENEFORM Protein DME1039 XEOTICID XEO04468 MOACRIVE Inhibition DME1039 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1039 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04471 XEO_CLAS Peptide DME1039 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 1.6 microM) DME1039 XEOTICID XEO04471 GENEFORM Protein DME1039 XEOTICID XEO04471 MOACRIVE Inhibition DME1039 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1039 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04506 XEO_CLAS Peptide DME1039 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC > 20 microM) DME1039 XEOTICID XEO04506 GENEFORM Protein DME1039 XEOTICID XEO04506 MOACRIVE Inhibition DME1039 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1039 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04507 XEO_CLAS Peptide DME1039 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC > 40 microM) DME1039 XEOTICID XEO04507 GENEFORM Protein DME1039 XEOTICID XEO04507 MOACRIVE Inhibition DME1039 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1039 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04510 XEO_CLAS Peptide DME1039 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC > 50 microM) DME1039 XEOTICID XEO04510 GENEFORM Protein DME1039 XEOTICID XEO04510 MOACRIVE Inhibition DME1039 XEOTICID XEO04531 XEO_NAME Mollusca/molluscs/mollusks peptide 2 DME1039 XEOTICID XEO04531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04531 XEO_CLAS Peptide DME1039 XEOTICID XEO04531 DESCRIPT Mollusca/molluscs/mollusks peptide 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04531 GENEFORM Protein DME1039 XEOTICID XEO04531 MOACRIVE Inhibition DME1039 XEOTICID XEO04533 XEO_NAME Mollusca/molluscs/mollusks peptide 3 DME1039 XEOTICID XEO04533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04533 XEO_CLAS Peptide DME1039 XEOTICID XEO04533 DESCRIPT Mollusca/molluscs/mollusks peptide 3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04533 GENEFORM Protein DME1039 XEOTICID XEO04533 MOACRIVE Inhibition DME1039 XEOTICID XEO04534 XEO_NAME Mollusca/molluscs/mollusks peptide 4 DME1039 XEOTICID XEO04534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04534 XEO_CLAS Peptide DME1039 XEOTICID XEO04534 DESCRIPT Mollusca/molluscs/mollusks peptide 4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04534 GENEFORM Protein DME1039 XEOTICID XEO04534 MOACRIVE Inhibition DME1039 XEOTICID XEO04535 XEO_NAME Mollusca/molluscs/mollusks peptide 5 DME1039 XEOTICID XEO04535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04535 XEO_CLAS Peptide DME1039 XEOTICID XEO04535 DESCRIPT Mollusca/molluscs/mollusks peptide 5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04535 GENEFORM Protein DME1039 XEOTICID XEO04535 MOACRIVE Inhibition DME1039 XEOTICID XEO04536 XEO_NAME Mollusca/molluscs/mollusks peptide 6 DME1039 XEOTICID XEO04536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04536 XEO_CLAS Peptide DME1039 XEOTICID XEO04536 DESCRIPT Mollusca/molluscs/mollusks peptide 6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04536 GENEFORM Protein DME1039 XEOTICID XEO04536 MOACRIVE Inhibition DME1039 XEOTICID XEO04537 XEO_NAME Mollusca/molluscs/mollusks peptide 7 DME1039 XEOTICID XEO04537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04537 XEO_CLAS Peptide DME1039 XEOTICID XEO04537 DESCRIPT Mollusca/molluscs/mollusks peptide 7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04537 GENEFORM Protein DME1039 XEOTICID XEO04537 MOACRIVE Inhibition DME1039 XEOTICID XEO04538 XEO_NAME Mollusca/molluscs/mollusks peptide 8 DME1039 XEOTICID XEO04538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04538 XEO_CLAS Peptide DME1039 XEOTICID XEO04538 DESCRIPT Mollusca/molluscs/mollusks peptide 8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04538 GENEFORM Protein DME1039 XEOTICID XEO04538 MOACRIVE Inhibition DME1039 XEOTICID XEO04539 XEO_NAME Mollusca/molluscs/mollusks peptide 9 DME1039 XEOTICID XEO04539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04539 XEO_CLAS Peptide DME1039 XEOTICID XEO04539 DESCRIPT Mollusca/molluscs/mollusks peptide 9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04539 GENEFORM Protein DME1039 XEOTICID XEO04539 MOACRIVE Inhibition DME1039 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1039 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04548 XEO_CLAS Peptide DME1039 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 32000 ug/ml) DME1039 XEOTICID XEO04548 GENEFORM Protein DME1039 XEOTICID XEO04548 MOACRIVE Inhibition DME1039 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1039 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04549 XEO_CLAS Peptide DME1039 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 250-500 ug/ml) DME1039 XEOTICID XEO04549 GENEFORM Protein DME1039 XEOTICID XEO04549 MOACRIVE Inhibition DME1039 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1039 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04571 XEO_CLAS Peptide DME1039 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04571 GENEFORM Protein DME1039 XEOTICID XEO04571 MOACRIVE Inhibition DME1039 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1039 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04572 XEO_CLAS Peptide DME1039 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04572 GENEFORM Protein DME1039 XEOTICID XEO04572 MOACRIVE Inhibition DME1039 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1039 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04606 XEO_CLAS Peptide DME1039 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 2 microM) DME1039 XEOTICID XEO04606 GENEFORM Protein DME1039 XEOTICID XEO04606 MOACRIVE Inhibition DME1039 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1039 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04612 XEO_CLAS Peptide DME1039 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1039 XEOTICID XEO04612 GENEFORM Protein DME1039 XEOTICID XEO04612 MOACRIVE Inhibition DME1039 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1039 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04613 XEO_CLAS Peptide DME1039 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1039 XEOTICID XEO04613 GENEFORM Protein DME1039 XEOTICID XEO04613 MOACRIVE Inhibition DME1039 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1039 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04695 XEO_CLAS Peptide DME1039 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04695 GENEFORM Protein DME1039 XEOTICID XEO04695 MOACRIVE Inhibition DME1039 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1039 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04696 XEO_CLAS Peptide DME1039 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04696 GENEFORM Protein DME1039 XEOTICID XEO04696 MOACRIVE Inhibition DME1039 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1039 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04697 XEO_CLAS Peptide DME1039 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04697 GENEFORM Protein DME1039 XEOTICID XEO04697 MOACRIVE Inhibition DME1039 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1039 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04698 XEO_CLAS Peptide DME1039 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04698 GENEFORM Protein DME1039 XEOTICID XEO04698 MOACRIVE Inhibition DME1039 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1039 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04699 XEO_CLAS Peptide DME1039 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04699 GENEFORM Protein DME1039 XEOTICID XEO04699 MOACRIVE Inhibition DME1039 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1039 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04700 XEO_CLAS Peptide DME1039 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04700 GENEFORM Protein DME1039 XEOTICID XEO04700 MOACRIVE Inhibition DME1039 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1039 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04701 XEO_CLAS Peptide DME1039 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04701 GENEFORM Protein DME1039 XEOTICID XEO04701 MOACRIVE Inhibition DME1039 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1039 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04702 XEO_CLAS Peptide DME1039 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04702 GENEFORM Protein DME1039 XEOTICID XEO04702 MOACRIVE Inhibition DME1039 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1039 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04703 XEO_CLAS Peptide DME1039 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04703 GENEFORM Protein DME1039 XEOTICID XEO04703 MOACRIVE Inhibition DME1039 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1039 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04762 XEO_CLAS Peptide DME1039 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC > 25 microM) DME1039 XEOTICID XEO04762 GENEFORM Protein DME1039 XEOTICID XEO04762 MOACRIVE Inhibition DME1039 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1039 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04809 XEO_CLAS Peptide DME1039 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 10 microM) DME1039 XEOTICID XEO04809 GENEFORM Protein DME1039 XEOTICID XEO04809 MOACRIVE Inhibition DME1039 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1039 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04891 XEO_CLAS Peptide DME1039 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04891 GENEFORM Protein DME1039 XEOTICID XEO04891 MOACRIVE Inhibition DME1039 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1039 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04905 XEO_CLAS Peptide DME1039 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04905 GENEFORM Protein DME1039 XEOTICID XEO04905 MOACRIVE Inhibition DME1039 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1039 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04906 XEO_CLAS Peptide DME1039 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO04906 GENEFORM Protein DME1039 XEOTICID XEO04906 MOACRIVE Inhibition DME1039 XEOTICID XEO04917 XEO_NAME Scorpine DME1039 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04917 XEO_CLAS Peptide DME1039 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 10 microM) DME1039 XEOTICID XEO04917 GENEFORM Protein DME1039 XEOTICID XEO04917 MOACRIVE Inhibition DME1039 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1039 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04971 XEO_CLAS Peptide DME1039 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1039 XEOTICID XEO04971 GENEFORM Protein DME1039 XEOTICID XEO04971 MOACRIVE Inhibition DME1039 XEOTICID XEO04974 XEO_NAME Spinigerin DME1039 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04974 XEO_CLAS Peptide DME1039 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1039 XEOTICID XEO04974 GENEFORM Protein DME1039 XEOTICID XEO04974 MOACRIVE Inhibition DME1039 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1039 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO04995 XEO_CLAS Peptide DME1039 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 0.78-1.56 microM) DME1039 XEOTICID XEO04995 GENEFORM Protein DME1039 XEOTICID XEO04995 MOACRIVE Inhibition DME1039 XEOTICID XEO05020 XEO_NAME Tachycitin DME1039 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO05020 XEO_CLAS Peptide DME1039 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae DME1039 XEOTICID XEO05020 GENEFORM Protein DME1039 XEOTICID XEO05020 MOACRIVE Inhibition DME1039 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1039 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO05073 XEO_CLAS Peptide DME1039 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 80 microM) DME1039 XEOTICID XEO05073 GENEFORM Protein DME1039 XEOTICID XEO05073 MOACRIVE Inhibition DME1039 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1039 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO05075 XEO_CLAS Peptide DME1039 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 80 microM) DME1039 XEOTICID XEO05075 GENEFORM Protein DME1039 XEOTICID XEO05075 MOACRIVE Inhibition DME1039 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1039 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO05101 XEO_CLAS Peptide DME1039 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 31.2 ug/ml) DME1039 XEOTICID XEO05101 GENEFORM Protein DME1039 XEOTICID XEO05101 MOACRIVE Inhibition DME1039 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1039 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO05102 XEO_CLAS Peptide DME1039 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 35.1 ug/ml) DME1039 XEOTICID XEO05102 GENEFORM Protein DME1039 XEOTICID XEO05102 MOACRIVE Inhibition DME1039 XEOTICID XEO05120 XEO_NAME Thanatin DME1039 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO05120 XEO_CLAS Peptide DME1039 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 0.6-1.2 microM) DME1039 XEOTICID XEO05120 GENEFORM Protein DME1039 XEOTICID XEO05120 MOACRIVE Inhibition DME1039 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1039 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO05163 XEO_CLAS Peptide DME1039 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 12-25 ug/ml) DME1039 XEOTICID XEO05163 GENEFORM Protein DME1039 XEOTICID XEO05163 MOACRIVE Inhibition DME1039 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1039 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1039 XEOTICID XEO05220 XEO_CLAS Peptide DME1039 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1039 XEOTICID XEO05220 GENEFORM Protein DME1039 XEOTICID XEO05220 MOACRIVE Inhibition DME1041 DME___ID DME1041 DME1041 DME_NAME NADH dehydrogenase (nuoE) DME1041 SPESNAME Streptomyces griseus DME1041 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1041 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00117 GENEFORM Protein DME1041 XEOTICID XEO00117 MOACRIVE Inhibition DME1041 XEOTICID XEO00122 XEO_NAME Amikacin DME1041 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00122 GENEFORM Protein DME1041 XEOTICID XEO00122 MOACRIVE Inhibition DME1041 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1041 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00136 GENEFORM Protein DME1041 XEOTICID XEO00136 MOACRIVE Inhibition DME1041 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1041 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00237 GENEFORM Protein DME1041 XEOTICID XEO00237 MOACRIVE Inhibition DME1041 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1041 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00349 GENEFORM Protein DME1041 XEOTICID XEO00349 MOACRIVE Inhibition DME1041 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1041 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00425 GENEFORM Protein DME1041 XEOTICID XEO00425 MOACRIVE Inhibition DME1041 XEOTICID XEO00439 XEO_NAME Daidzein DME1041 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00439 GENEFORM Protein DME1041 XEOTICID XEO00439 MOACRIVE Inhibition DME1041 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1041 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00460 GENEFORM Protein DME1041 XEOTICID XEO00460 MOACRIVE Inhibition DME1041 XEOTICID XEO00487 XEO_NAME Thymol DME1041 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00487 GENEFORM Protein DME1041 XEOTICID XEO00487 MOACRIVE Inhibition DME1041 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1041 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00511 GENEFORM Protein DME1041 XEOTICID XEO00511 MOACRIVE Inhibition DME1041 XEOTICID XEO00537 XEO_NAME Luteolin DME1041 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1041 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00537 GENEFORM Protein DME1041 XEOTICID XEO00537 MOACRIVE Inhibition DME1041 XEOTICID XEO00538 XEO_NAME Quercetin DME1041 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1041 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00538 GENEFORM Protein DME1041 XEOTICID XEO00538 MOACRIVE Inhibition DME1041 XEOTICID XEO00547 XEO_NAME Vitamin E DME1041 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1041 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00547 GENEFORM Protein DME1041 XEOTICID XEO00547 MOACRIVE Inhibition DME1041 XEOTICID XEO00557 XEO_NAME Genistein DME1041 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1041 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00557 GENEFORM Protein DME1041 XEOTICID XEO00557 MOACRIVE Inhibition DME1041 XEOTICID XEO00566 XEO_NAME Guaiacol DME1041 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1041 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00566 GENEFORM Protein DME1041 XEOTICID XEO00566 MOACRIVE Inhibition DME1041 XEOTICID XEO00568 XEO_NAME Resveratrol DME1041 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1041 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00568 GENEFORM Protein DME1041 XEOTICID XEO00568 MOACRIVE Inhibition DME1041 XEOTICID XEO00573 XEO_NAME Naringenin DME1041 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1041 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00573 GENEFORM Protein DME1041 XEOTICID XEO00573 MOACRIVE Inhibition DME1041 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1041 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1041 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00574 GENEFORM Protein DME1041 XEOTICID XEO00574 MOACRIVE Inhibition DME1041 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1041 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1041 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00611 GENEFORM Protein DME1041 XEOTICID XEO00611 MOACRIVE Inhibition DME1041 XEOTICID XEO00621 XEO_NAME Chitosan DME1041 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1041 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00621 GENEFORM Protein DME1041 XEOTICID XEO00621 MOACRIVE Inhibition DME1041 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1041 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1041 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00646 GENEFORM Protein DME1041 XEOTICID XEO00646 MOACRIVE Inhibition DME1041 XEOTICID XEO00683 XEO_NAME Curcumin DME1041 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1041 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00683 GENEFORM Protein DME1041 XEOTICID XEO00683 MOACRIVE Inhibition DME1041 XEOTICID XEO00727 XEO_NAME Vanillin DME1041 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1041 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00727 GENEFORM Protein DME1041 XEOTICID XEO00727 MOACRIVE Inhibition DME1041 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1041 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1041 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00730 GENEFORM Protein DME1041 XEOTICID XEO00730 MOACRIVE Inhibition DME1041 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1041 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO00782 XEO_CLAS Natural Product DME1041 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00782 GENEFORM Protein DME1041 XEOTICID XEO00782 MOACRIVE Inhibition DME1041 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1041 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1041 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00866 GENEFORM Protein DME1041 XEOTICID XEO00866 MOACRIVE Inhibition DME1041 XEOTICID XEO00878 XEO_NAME Chrysin DME1041 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO00878 XEO_CLAS Natural Product DME1041 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00878 GENEFORM Protein DME1041 XEOTICID XEO00878 MOACRIVE Inhibition DME1041 XEOTICID XEO00879 XEO_NAME Coumarin DME1041 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1041 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1041 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00879 GENEFORM Protein DME1041 XEOTICID XEO00879 MOACRIVE Inhibition DME1041 XEOTICID XEO00883 XEO_NAME Phloretin DME1041 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO00883 XEO_CLAS Natural Product DME1041 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00883 GENEFORM Protein DME1041 XEOTICID XEO00883 MOACRIVE Inhibition DME1041 XEOTICID XEO00885 XEO_NAME Eugenol DME1041 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1041 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO00885 GENEFORM Protein DME1041 XEOTICID XEO00885 MOACRIVE Inhibition DME1041 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1041 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1041 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1041 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01032 GENEFORM Protein DME1041 XEOTICID XEO01032 MOACRIVE Inhibition DME1041 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1041 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01174 XEO_CLAS Natural Product DME1041 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01174 GENEFORM Protein DME1041 XEOTICID XEO01174 MOACRIVE Inhibition DME1041 XEOTICID XEO01203 XEO_NAME Apigenin DME1041 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01203 XEO_CLAS Natural Product DME1041 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01203 GENEFORM Protein DME1041 XEOTICID XEO01203 MOACRIVE Inhibition DME1041 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1041 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1041 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1041 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01232 GENEFORM Protein DME1041 XEOTICID XEO01232 MOACRIVE Inhibition DME1041 XEOTICID XEO01237 XEO_NAME Carvacrol DME1041 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1041 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01237 GENEFORM Protein DME1041 XEOTICID XEO01237 MOACRIVE Inhibition DME1041 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1041 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1041 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01287 GENEFORM Protein DME1041 XEOTICID XEO01287 MOACRIVE Inhibition DME1041 XEOTICID XEO01291 XEO_NAME Esculetin DME1041 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1041 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01291 GENEFORM Protein DME1041 XEOTICID XEO01291 MOACRIVE Inhibition DME1041 XEOTICID XEO01304 XEO_NAME Flavone DME1041 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01304 XEO_CLAS Natural Product DME1041 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01304 GENEFORM Protein DME1041 XEOTICID XEO01304 MOACRIVE Inhibition DME1041 XEOTICID XEO01309 XEO_NAME Gallic acid DME1041 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01309 XEO_CLAS Natural Product DME1041 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01309 GENEFORM Protein DME1041 XEOTICID XEO01309 MOACRIVE Inhibition DME1041 XEOTICID XEO01340 XEO_NAME Imperatorin DME1041 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01340 XEO_CLAS Natural Product DME1041 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01340 GENEFORM Protein DME1041 XEOTICID XEO01340 MOACRIVE Inhibition DME1041 XEOTICID XEO01353 XEO_NAME Kaempferol DME1041 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1041 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1041 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01353 GENEFORM Protein DME1041 XEOTICID XEO01353 MOACRIVE Inhibition DME1041 XEOTICID XEO01366 XEO_NAME Linalool DME1041 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01366 XEO_CLAS Natural Product DME1041 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01366 GENEFORM Protein DME1041 XEOTICID XEO01366 MOACRIVE Inhibition DME1041 XEOTICID XEO01391 XEO_NAME Naringin DME1041 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01391 XEO_CLAS Natural Product DME1041 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01391 GENEFORM Protein DME1041 XEOTICID XEO01391 MOACRIVE Inhibition DME1041 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1041 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1041 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01420 GENEFORM Protein DME1041 XEOTICID XEO01420 MOACRIVE Inhibition DME1041 XEOTICID XEO01463 XEO_NAME Rutin DME1041 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01463 XEO_CLAS Natural Product DME1041 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01463 GENEFORM Protein DME1041 XEOTICID XEO01463 MOACRIVE Inhibition DME1041 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1041 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1041 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01496 GENEFORM Protein DME1041 XEOTICID XEO01496 MOACRIVE Inhibition DME1041 XEOTICID XEO01512 XEO_NAME Zinc DME1041 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1041 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1041 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01512 GENEFORM Protein DME1041 XEOTICID XEO01512 MOACRIVE Inhibition DME1041 XEOTICID XEO01527 XEO_NAME Bergamottin DME1041 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01527 XEO_CLAS Natural Product DME1041 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01527 GENEFORM Protein DME1041 XEOTICID XEO01527 MOACRIVE Inhibition DME1041 XEOTICID XEO01531 XEO_NAME Clove oil DME1041 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01531 XEO_CLAS Natural Product DME1041 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01531 GENEFORM Protein DME1041 XEOTICID XEO01531 MOACRIVE Inhibition DME1041 XEOTICID XEO01559 XEO_NAME Limonene DME1041 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01559 XEO_CLAS Natural Product DME1041 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01559 GENEFORM Protein DME1041 XEOTICID XEO01559 MOACRIVE Inhibition DME1041 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1041 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01563 XEO_CLAS Natural Product DME1041 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01563 GENEFORM Protein DME1041 XEOTICID XEO01563 MOACRIVE Inhibition DME1041 XEOTICID XEO01566 XEO_NAME Nobiletin DME1041 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01566 XEO_CLAS Natural Product DME1041 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01566 GENEFORM Protein DME1041 XEOTICID XEO01566 MOACRIVE Inhibition DME1041 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1041 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01778 XEO_CLAS Natural Product DME1041 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01778 GENEFORM Protein DME1041 XEOTICID XEO01778 MOACRIVE Inhibition DME1041 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1041 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01779 XEO_CLAS Peptide DME1041 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 128 microM) DME1041 XEOTICID XEO01779 GENEFORM Protein DME1041 XEOTICID XEO01779 MOACRIVE Inhibition DME1041 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1041 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01810 XEO_CLAS Peptide DME1041 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.0 microM) DME1041 XEOTICID XEO01810 GENEFORM Protein DME1041 XEOTICID XEO01810 MOACRIVE Inhibition DME1041 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1041 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01811 XEO_CLAS Peptide DME1041 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 microM) DME1041 XEOTICID XEO01811 GENEFORM Protein DME1041 XEOTICID XEO01811 MOACRIVE Inhibition DME1041 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1041 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01812 XEO_CLAS Peptide DME1041 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10.4 microM) DME1041 XEOTICID XEO01812 GENEFORM Protein DME1041 XEOTICID XEO01812 MOACRIVE Inhibition DME1041 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1041 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01813 XEO_CLAS Peptide DME1041 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.1 microM) DME1041 XEOTICID XEO01813 GENEFORM Protein DME1041 XEOTICID XEO01813 MOACRIVE Inhibition DME1041 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1041 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01814 XEO_CLAS Peptide DME1041 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.5 microM) DME1041 XEOTICID XEO01814 GENEFORM Protein DME1041 XEOTICID XEO01814 MOACRIVE Inhibition DME1041 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1041 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01815 XEO_CLAS Peptide DME1041 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9.8 microM) DME1041 XEOTICID XEO01815 GENEFORM Protein DME1041 XEOTICID XEO01815 MOACRIVE Inhibition DME1041 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1041 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01816 XEO_CLAS Peptide DME1041 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO01816 GENEFORM Protein DME1041 XEOTICID XEO01816 MOACRIVE Inhibition DME1041 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1041 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01817 XEO_CLAS Peptide DME1041 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.0 microM) DME1041 XEOTICID XEO01817 GENEFORM Protein DME1041 XEOTICID XEO01817 MOACRIVE Inhibition DME1041 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1041 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01818 XEO_CLAS Peptide DME1041 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4.0 microM) DME1041 XEOTICID XEO01818 GENEFORM Protein DME1041 XEOTICID XEO01818 MOACRIVE Inhibition DME1041 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1041 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01819 XEO_CLAS Peptide DME1041 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO01819 GENEFORM Protein DME1041 XEOTICID XEO01819 MOACRIVE Inhibition DME1041 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1041 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01820 XEO_CLAS Peptide DME1041 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO01820 GENEFORM Protein DME1041 XEOTICID XEO01820 MOACRIVE Inhibition DME1041 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1041 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01821 XEO_CLAS Peptide DME1041 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO01821 GENEFORM Protein DME1041 XEOTICID XEO01821 MOACRIVE Inhibition DME1041 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1041 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01822 XEO_CLAS Peptide DME1041 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 microM) DME1041 XEOTICID XEO01822 GENEFORM Protein DME1041 XEOTICID XEO01822 MOACRIVE Inhibition DME1041 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1041 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01823 XEO_CLAS Peptide DME1041 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO01823 GENEFORM Protein DME1041 XEOTICID XEO01823 MOACRIVE Inhibition DME1041 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1041 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01824 XEO_CLAS Peptide DME1041 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO01824 GENEFORM Protein DME1041 XEOTICID XEO01824 MOACRIVE Inhibition DME1041 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1041 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01825 XEO_CLAS Peptide DME1041 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25.0 microM) DME1041 XEOTICID XEO01825 GENEFORM Protein DME1041 XEOTICID XEO01825 MOACRIVE Inhibition DME1041 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1041 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01827 XEO_CLAS Peptide DME1041 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.12-6.25 microM) DME1041 XEOTICID XEO01827 GENEFORM Protein DME1041 XEOTICID XEO01827 MOACRIVE Inhibition DME1041 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1041 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1041 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1041 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01829 GENEFORM Protein DME1041 XEOTICID XEO01829 MOACRIVE Inhibition DME1041 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1041 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01927 XEO_CLAS Peptide DME1041 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 ug/ml) DME1041 XEOTICID XEO01927 GENEFORM Protein DME1041 XEOTICID XEO01927 MOACRIVE Inhibition DME1041 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1041 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01945 XEO_CLAS Peptide DME1041 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.1 microM) DME1041 XEOTICID XEO01945 GENEFORM Protein DME1041 XEOTICID XEO01945 MOACRIVE Inhibition DME1041 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1041 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01946 XEO_CLAS Peptide DME1041 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.2 microM) DME1041 XEOTICID XEO01946 GENEFORM Protein DME1041 XEOTICID XEO01946 MOACRIVE Inhibition DME1041 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1041 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO01947 XEO_CLAS Natural Product DME1041 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01947 GENEFORM Protein DME1041 XEOTICID XEO01947 MOACRIVE Inhibition DME1041 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1041 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1041 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1041 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01950 GENEFORM Protein DME1041 XEOTICID XEO01950 MOACRIVE Inhibition DME1041 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1041 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1041 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1041 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01961 GENEFORM Protein DME1041 XEOTICID XEO01961 MOACRIVE Inhibition DME1041 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1041 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1041 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1041 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO01966 GENEFORM Protein DME1041 XEOTICID XEO01966 MOACRIVE Inhibition DME1041 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1041 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01996 XEO_CLAS Peptide DME1041 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.7 microM) DME1041 XEOTICID XEO01996 GENEFORM Protein DME1041 XEOTICID XEO01996 MOACRIVE Inhibition DME1041 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1041 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01997 XEO_CLAS Peptide DME1041 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.9 microM) DME1041 XEOTICID XEO01997 GENEFORM Protein DME1041 XEOTICID XEO01997 MOACRIVE Inhibition DME1041 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1041 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01998 XEO_CLAS Peptide DME1041 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO01998 GENEFORM Protein DME1041 XEOTICID XEO01998 MOACRIVE Inhibition DME1041 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1041 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO01999 XEO_CLAS Peptide DME1041 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.5 microM) DME1041 XEOTICID XEO01999 GENEFORM Protein DME1041 XEOTICID XEO01999 MOACRIVE Inhibition DME1041 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1041 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02013 XEO_CLAS Peptide DME1041 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02013 GENEFORM Protein DME1041 XEOTICID XEO02013 MOACRIVE Inhibition DME1041 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1041 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02032 XEO_CLAS Natural Product DME1041 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02032 GENEFORM Protein DME1041 XEOTICID XEO02032 MOACRIVE Inhibition DME1041 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1041 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02033 XEO_CLAS Natural Product DME1041 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02033 GENEFORM Protein DME1041 XEOTICID XEO02033 MOACRIVE Inhibition DME1041 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1041 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02079 XEO_CLAS Natural Product DME1041 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02079 GENEFORM Protein DME1041 XEOTICID XEO02079 MOACRIVE Inhibition DME1041 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1041 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1041 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02085 GENEFORM Protein DME1041 XEOTICID XEO02085 MOACRIVE Inhibition DME1041 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1041 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02111 XEO_CLAS Peptide DME1041 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2-4 ug/ml) DME1041 XEOTICID XEO02111 GENEFORM Protein DME1041 XEOTICID XEO02111 MOACRIVE Inhibition DME1041 XEOTICID XEO02113 XEO_NAME Abaecin DME1041 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02113 XEO_CLAS Peptide DME1041 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02113 GENEFORM Protein DME1041 XEOTICID XEO02113 MOACRIVE Inhibition DME1041 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1041 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02114 XEO_CLAS Peptide DME1041 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-25 ug/ml) DME1041 XEOTICID XEO02114 GENEFORM Protein DME1041 XEOTICID XEO02114 MOACRIVE Inhibition DME1041 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1041 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02115 XEO_CLAS Peptide DME1041 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02115 GENEFORM Protein DME1041 XEOTICID XEO02115 MOACRIVE Inhibition DME1041 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1041 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02117 XEO_CLAS Peptide DME1041 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02117 GENEFORM Protein DME1041 XEOTICID XEO02117 MOACRIVE Inhibition DME1041 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1041 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02118 XEO_CLAS Peptide DME1041 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02118 GENEFORM Protein DME1041 XEOTICID XEO02118 MOACRIVE Inhibition DME1041 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1041 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02119 XEO_CLAS Peptide DME1041 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02119 GENEFORM Protein DME1041 XEOTICID XEO02119 MOACRIVE Inhibition DME1041 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1041 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02120 XEO_CLAS Peptide DME1041 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02120 GENEFORM Protein DME1041 XEOTICID XEO02120 MOACRIVE Inhibition DME1041 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1041 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02121 XEO_CLAS Peptide DME1041 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02121 GENEFORM Protein DME1041 XEOTICID XEO02121 MOACRIVE Inhibition DME1041 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1041 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02122 XEO_CLAS Peptide DME1041 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 ug/ml) DME1041 XEOTICID XEO02122 GENEFORM Protein DME1041 XEOTICID XEO02122 MOACRIVE Inhibition DME1041 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1041 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02130 XEO_CLAS Peptide DME1041 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.7 microM) DME1041 XEOTICID XEO02130 GENEFORM Protein DME1041 XEOTICID XEO02130 MOACRIVE Inhibition DME1041 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1041 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02131 XEO_CLAS Peptide DME1041 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.3 microM) DME1041 XEOTICID XEO02131 GENEFORM Protein DME1041 XEOTICID XEO02131 MOACRIVE Inhibition DME1041 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1041 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02132 XEO_CLAS Peptide DME1041 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.5 microM) DME1041 XEOTICID XEO02132 GENEFORM Protein DME1041 XEOTICID XEO02132 MOACRIVE Inhibition DME1041 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1041 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02136 XEO_CLAS Peptide DME1041 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 ug/ml) DME1041 XEOTICID XEO02136 GENEFORM Protein DME1041 XEOTICID XEO02136 MOACRIVE Inhibition DME1041 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1041 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02147 XEO_CLAS Peptide DME1041 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 382 ug/ml) DME1041 XEOTICID XEO02147 GENEFORM Protein DME1041 XEOTICID XEO02147 MOACRIVE Inhibition DME1041 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1041 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02149 XEO_CLAS Peptide DME1041 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 47.35 microM) DME1041 XEOTICID XEO02149 GENEFORM Protein DME1041 XEOTICID XEO02149 MOACRIVE Inhibition DME1041 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1041 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02164 XEO_CLAS Peptide DME1041 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02164 GENEFORM Protein DME1041 XEOTICID XEO02164 MOACRIVE Inhibition DME1041 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1041 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02165 XEO_CLAS Peptide DME1041 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02165 GENEFORM Protein DME1041 XEOTICID XEO02165 MOACRIVE Inhibition DME1041 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1041 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02166 XEO_CLAS Peptide DME1041 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02166 GENEFORM Protein DME1041 XEOTICID XEO02166 MOACRIVE Inhibition DME1041 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1041 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02167 XEO_CLAS Peptide DME1041 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02167 GENEFORM Protein DME1041 XEOTICID XEO02167 MOACRIVE Inhibition DME1041 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1041 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02168 XEO_CLAS Peptide DME1041 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02168 GENEFORM Protein DME1041 XEOTICID XEO02168 MOACRIVE Inhibition DME1041 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1041 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02169 XEO_CLAS Peptide DME1041 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02169 GENEFORM Protein DME1041 XEOTICID XEO02169 MOACRIVE Inhibition DME1041 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1041 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02170 XEO_CLAS Peptide DME1041 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.4 microM) DME1041 XEOTICID XEO02170 GENEFORM Protein DME1041 XEOTICID XEO02170 MOACRIVE Inhibition DME1041 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1041 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02175 XEO_CLAS Natural Product DME1041 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02175 GENEFORM Protein DME1041 XEOTICID XEO02175 MOACRIVE Inhibition DME1041 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1041 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02177 XEO_CLAS Peptide DME1041 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO02177 GENEFORM Protein DME1041 XEOTICID XEO02177 MOACRIVE Inhibition DME1041 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1041 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02178 XEO_CLAS Peptide DME1041 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO02178 GENEFORM Protein DME1041 XEOTICID XEO02178 MOACRIVE Inhibition DME1041 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1041 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02179 XEO_CLAS Peptide DME1041 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO02179 GENEFORM Protein DME1041 XEOTICID XEO02179 MOACRIVE Inhibition DME1041 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1041 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02180 XEO_CLAS Peptide DME1041 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 214 microM) DME1041 XEOTICID XEO02180 GENEFORM Protein DME1041 XEOTICID XEO02180 MOACRIVE Inhibition DME1041 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1041 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02181 XEO_CLAS Peptide DME1041 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 217 microM) DME1041 XEOTICID XEO02181 GENEFORM Protein DME1041 XEOTICID XEO02181 MOACRIVE Inhibition DME1041 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1041 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02183 XEO_CLAS Peptide DME1041 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 38.4 microM) DME1041 XEOTICID XEO02183 GENEFORM Protein DME1041 XEOTICID XEO02183 MOACRIVE Inhibition DME1041 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1041 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02185 XEO_CLAS Peptide DME1041 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 microM) DME1041 XEOTICID XEO02185 GENEFORM Protein DME1041 XEOTICID XEO02185 MOACRIVE Inhibition DME1041 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1041 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02187 GENEFORM Protein DME1041 XEOTICID XEO02187 MOACRIVE Inhibition DME1041 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1041 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02191 XEO_CLAS Peptide DME1041 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02191 GENEFORM Protein DME1041 XEOTICID XEO02191 MOACRIVE Inhibition DME1041 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1041 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02192 XEO_CLAS Peptide DME1041 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.50 ug/ml) DME1041 XEOTICID XEO02192 GENEFORM Protein DME1041 XEOTICID XEO02192 MOACRIVE Inhibition DME1041 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1041 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02193 XEO_CLAS Peptide DME1041 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02193 GENEFORM Protein DME1041 XEOTICID XEO02193 MOACRIVE Inhibition DME1041 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1041 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02194 XEO_CLAS Peptide DME1041 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02194 GENEFORM Protein DME1041 XEOTICID XEO02194 MOACRIVE Inhibition DME1041 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1041 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02195 XEO_CLAS Peptide DME1041 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.00 ug/ml) DME1041 XEOTICID XEO02195 GENEFORM Protein DME1041 XEOTICID XEO02195 MOACRIVE Inhibition DME1041 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1041 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02197 XEO_CLAS Peptide DME1041 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02197 GENEFORM Protein DME1041 XEOTICID XEO02197 MOACRIVE Inhibition DME1041 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1041 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02200 XEO_CLAS Peptide DME1041 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 ug/ml) DME1041 XEOTICID XEO02200 GENEFORM Protein DME1041 XEOTICID XEO02200 MOACRIVE Inhibition DME1041 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1041 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02201 XEO_CLAS Peptide DME1041 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 ug/ml) DME1041 XEOTICID XEO02201 GENEFORM Protein DME1041 XEOTICID XEO02201 MOACRIVE Inhibition DME1041 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1041 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02202 XEO_CLAS Peptide DME1041 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO02202 GENEFORM Protein DME1041 XEOTICID XEO02202 MOACRIVE Inhibition DME1041 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1041 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02203 XEO_CLAS Peptide DME1041 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 microM) DME1041 XEOTICID XEO02203 GENEFORM Protein DME1041 XEOTICID XEO02203 MOACRIVE Inhibition DME1041 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1041 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02207 XEO_CLAS Peptide DME1041 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.78 ug/ml) DME1041 XEOTICID XEO02207 GENEFORM Protein DME1041 XEOTICID XEO02207 MOACRIVE Inhibition DME1041 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1041 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02208 XEO_CLAS Peptide DME1041 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.13 ug/ml) DME1041 XEOTICID XEO02208 GENEFORM Protein DME1041 XEOTICID XEO02208 MOACRIVE Inhibition DME1041 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1041 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02209 XEO_CLAS Peptide DME1041 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.56 ug/ml) DME1041 XEOTICID XEO02209 GENEFORM Protein DME1041 XEOTICID XEO02209 MOACRIVE Inhibition DME1041 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1041 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02210 XEO_CLAS Peptide DME1041 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 ug/ml) DME1041 XEOTICID XEO02210 GENEFORM Protein DME1041 XEOTICID XEO02210 MOACRIVE Inhibition DME1041 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1041 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02211 XEO_CLAS Peptide DME1041 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25 ug/ml) DME1041 XEOTICID XEO02211 GENEFORM Protein DME1041 XEOTICID XEO02211 MOACRIVE Inhibition DME1041 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1041 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02212 XEO_CLAS Peptide DME1041 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.13 ug/ml) DME1041 XEOTICID XEO02212 GENEFORM Protein DME1041 XEOTICID XEO02212 MOACRIVE Inhibition DME1041 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1041 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02213 XEO_CLAS Peptide DME1041 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.13 ug/ml) DME1041 XEOTICID XEO02213 GENEFORM Protein DME1041 XEOTICID XEO02213 MOACRIVE Inhibition DME1041 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1041 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02214 XEO_CLAS Peptide DME1041 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02214 GENEFORM Protein DME1041 XEOTICID XEO02214 MOACRIVE Inhibition DME1041 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1041 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02215 XEO_CLAS Peptide DME1041 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 ug/ml) DME1041 XEOTICID XEO02215 GENEFORM Protein DME1041 XEOTICID XEO02215 MOACRIVE Inhibition DME1041 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1041 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02216 XEO_CLAS Peptide DME1041 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 126 ug/ml) DME1041 XEOTICID XEO02216 GENEFORM Protein DME1041 XEOTICID XEO02216 MOACRIVE Inhibition DME1041 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1041 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02217 XEO_CLAS Peptide DME1041 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 200 ug/ml) DME1041 XEOTICID XEO02217 GENEFORM Protein DME1041 XEOTICID XEO02217 MOACRIVE Inhibition DME1041 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1041 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02218 XEO_CLAS Peptide DME1041 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 200 ug/ml) DME1041 XEOTICID XEO02218 GENEFORM Protein DME1041 XEOTICID XEO02218 MOACRIVE Inhibition DME1041 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1041 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02219 XEO_CLAS Peptide DME1041 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 200 ug/ml) DME1041 XEOTICID XEO02219 GENEFORM Protein DME1041 XEOTICID XEO02219 MOACRIVE Inhibition DME1041 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1041 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02220 XEO_CLAS Peptide DME1041 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 23.5 ug/ml) DME1041 XEOTICID XEO02220 GENEFORM Protein DME1041 XEOTICID XEO02220 MOACRIVE Inhibition DME1041 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1041 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02221 XEO_CLAS Peptide DME1041 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20.2 ug/ml) DME1041 XEOTICID XEO02221 GENEFORM Protein DME1041 XEOTICID XEO02221 MOACRIVE Inhibition DME1041 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1041 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02222 XEO_CLAS Peptide DME1041 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30.5 ug/ml) DME1041 XEOTICID XEO02222 GENEFORM Protein DME1041 XEOTICID XEO02222 MOACRIVE Inhibition DME1041 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1041 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02223 XEO_CLAS Peptide DME1041 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.2 ug/ml) DME1041 XEOTICID XEO02223 GENEFORM Protein DME1041 XEOTICID XEO02223 MOACRIVE Inhibition DME1041 XEOTICID XEO02224 XEO_NAME Androctonin DME1041 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02224 XEO_CLAS Peptide DME1041 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02224 GENEFORM Protein DME1041 XEOTICID XEO02224 MOACRIVE Inhibition DME1041 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1041 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02225 XEO_CLAS Peptide DME1041 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02225 GENEFORM Protein DME1041 XEOTICID XEO02225 MOACRIVE Inhibition DME1041 XEOTICID XEO02226 XEO_NAME Andropin DME1041 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02226 XEO_CLAS Peptide DME1041 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 140 microM) DME1041 XEOTICID XEO02226 GENEFORM Protein DME1041 XEOTICID XEO02226 MOACRIVE Inhibition DME1041 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1041 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02230 XEO_CLAS Peptide DME1041 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.05-0.1 microM) DME1041 XEOTICID XEO02230 GENEFORM Protein DME1041 XEOTICID XEO02230 MOACRIVE Inhibition DME1041 XEOTICID XEO02232 XEO_NAME Anoplin DME1041 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02232 XEO_CLAS Peptide DME1041 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 13 ug/ml) DME1041 XEOTICID XEO02232 GENEFORM Protein DME1041 XEOTICID XEO02232 MOACRIVE Inhibition DME1041 XEOTICID XEO02233 XEO_NAME Antapin DME1041 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02233 XEO_CLAS Peptide DME1041 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02233 GENEFORM Protein DME1041 XEOTICID XEO02233 MOACRIVE Inhibition DME1041 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1041 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02236 XEO_CLAS Peptide DME1041 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02236 GENEFORM Protein DME1041 XEOTICID XEO02236 MOACRIVE Inhibition DME1041 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1041 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02239 XEO_CLAS Peptide DME1041 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 250 microM) DME1041 XEOTICID XEO02239 GENEFORM Protein DME1041 XEOTICID XEO02239 MOACRIVE Inhibition DME1041 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1041 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02240 XEO_CLAS Peptide DME1041 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 microM) DME1041 XEOTICID XEO02240 GENEFORM Protein DME1041 XEOTICID XEO02240 MOACRIVE Inhibition DME1041 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1041 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02241 XEO_CLAS Peptide DME1041 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02241 GENEFORM Protein DME1041 XEOTICID XEO02241 MOACRIVE Inhibition DME1041 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1041 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02242 XEO_CLAS Peptide DME1041 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO02242 GENEFORM Protein DME1041 XEOTICID XEO02242 MOACRIVE Inhibition DME1041 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1041 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02243 XEO_CLAS Peptide DME1041 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 microM) DME1041 XEOTICID XEO02243 GENEFORM Protein DME1041 XEOTICID XEO02243 MOACRIVE Inhibition DME1041 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1041 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02244 XEO_CLAS Peptide DME1041 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1 microM) DME1041 XEOTICID XEO02244 GENEFORM Protein DME1041 XEOTICID XEO02244 MOACRIVE Inhibition DME1041 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1041 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02245 XEO_CLAS Peptide DME1041 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02245 GENEFORM Protein DME1041 XEOTICID XEO02245 MOACRIVE Inhibition DME1041 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1041 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02246 XEO_CLAS Peptide DME1041 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 microM) DME1041 XEOTICID XEO02246 GENEFORM Protein DME1041 XEOTICID XEO02246 MOACRIVE Inhibition DME1041 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1041 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02247 XEO_CLAS Peptide DME1041 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02247 GENEFORM Protein DME1041 XEOTICID XEO02247 MOACRIVE Inhibition DME1041 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1041 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02248 XEO_CLAS Peptide DME1041 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.3 microM) DME1041 XEOTICID XEO02248 GENEFORM Protein DME1041 XEOTICID XEO02248 MOACRIVE Inhibition DME1041 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1041 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02253 XEO_CLAS Peptide DME1041 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02253 GENEFORM Protein DME1041 XEOTICID XEO02253 MOACRIVE Inhibition DME1041 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1041 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02258 XEO_CLAS Peptide DME1041 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 150 microM) DME1041 XEOTICID XEO02258 GENEFORM Protein DME1041 XEOTICID XEO02258 MOACRIVE Inhibition DME1041 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1041 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02261 XEO_CLAS Peptide DME1041 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 82 ug/ml) DME1041 XEOTICID XEO02261 GENEFORM Protein DME1041 XEOTICID XEO02261 MOACRIVE Inhibition DME1041 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1041 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02263 XEO_CLAS Peptide DME1041 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO02263 GENEFORM Protein DME1041 XEOTICID XEO02263 MOACRIVE Inhibition DME1041 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1041 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02266 XEO_CLAS Peptide DME1041 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 120 microM) DME1041 XEOTICID XEO02266 GENEFORM Protein DME1041 XEOTICID XEO02266 MOACRIVE Inhibition DME1041 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1041 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02268 XEO_CLAS Peptide DME1041 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 170 ug/ml) DME1041 XEOTICID XEO02268 GENEFORM Protein DME1041 XEOTICID XEO02268 MOACRIVE Inhibition DME1041 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1041 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02270 XEO_CLAS Peptide DME1041 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 microM) DME1041 XEOTICID XEO02270 GENEFORM Protein DME1041 XEOTICID XEO02270 MOACRIVE Inhibition DME1041 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1041 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02271 XEO_CLAS Peptide DME1041 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 302 ug/ml) DME1041 XEOTICID XEO02271 GENEFORM Protein DME1041 XEOTICID XEO02271 MOACRIVE Inhibition DME1041 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1041 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02273 XEO_CLAS Peptide DME1041 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 18 microM) DME1041 XEOTICID XEO02273 GENEFORM Protein DME1041 XEOTICID XEO02273 MOACRIVE Inhibition DME1041 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1041 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02274 XEO_CLAS Peptide DME1041 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO02274 GENEFORM Protein DME1041 XEOTICID XEO02274 MOACRIVE Inhibition DME1041 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1041 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02275 XEO_CLAS Peptide DME1041 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 microM) DME1041 XEOTICID XEO02275 GENEFORM Protein DME1041 XEOTICID XEO02275 MOACRIVE Inhibition DME1041 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1041 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02276 XEO_CLAS Peptide DME1041 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 microM) DME1041 XEOTICID XEO02276 GENEFORM Protein DME1041 XEOTICID XEO02276 MOACRIVE Inhibition DME1041 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1041 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02280 XEO_CLAS Peptide DME1041 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02280 GENEFORM Protein DME1041 XEOTICID XEO02280 MOACRIVE Inhibition DME1041 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1041 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02281 XEO_CLAS Peptide DME1041 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02281 GENEFORM Protein DME1041 XEOTICID XEO02281 MOACRIVE Inhibition DME1041 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1041 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02283 XEO_CLAS Peptide DME1041 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.13 ug/ml) DME1041 XEOTICID XEO02283 GENEFORM Protein DME1041 XEOTICID XEO02283 MOACRIVE Inhibition DME1041 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1041 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02284 XEO_CLAS Peptide DME1041 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50.4 microM) DME1041 XEOTICID XEO02284 GENEFORM Protein DME1041 XEOTICID XEO02284 MOACRIVE Inhibition DME1041 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1041 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02285 XEO_CLAS Peptide DME1041 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50.4 microM) DME1041 XEOTICID XEO02285 GENEFORM Protein DME1041 XEOTICID XEO02285 MOACRIVE Inhibition DME1041 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1041 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02286 XEO_CLAS Peptide DME1041 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50.4 microM) DME1041 XEOTICID XEO02286 GENEFORM Protein DME1041 XEOTICID XEO02286 MOACRIVE Inhibition DME1041 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1041 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02287 XEO_CLAS Peptide DME1041 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50.4 microM) DME1041 XEOTICID XEO02287 GENEFORM Protein DME1041 XEOTICID XEO02287 MOACRIVE Inhibition DME1041 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1041 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02288 XEO_CLAS Peptide DME1041 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.2 ug/ml) DME1041 XEOTICID XEO02288 GENEFORM Protein DME1041 XEOTICID XEO02288 MOACRIVE Inhibition DME1041 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1041 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02289 XEO_CLAS Peptide DME1041 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 ug/ml) DME1041 XEOTICID XEO02289 GENEFORM Protein DME1041 XEOTICID XEO02289 MOACRIVE Inhibition DME1041 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1041 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02290 XEO_CLAS Peptide DME1041 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO02290 GENEFORM Protein DME1041 XEOTICID XEO02290 MOACRIVE Inhibition DME1041 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1041 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02291 XEO_CLAS Peptide DME1041 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02291 GENEFORM Protein DME1041 XEOTICID XEO02291 MOACRIVE Inhibition DME1041 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1041 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02293 XEO_CLAS Peptide DME1041 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 microM) DME1041 XEOTICID XEO02293 GENEFORM Protein DME1041 XEOTICID XEO02293 MOACRIVE Inhibition DME1041 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1041 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02294 XEO_CLAS Peptide DME1041 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 62-250 ug/ml) DME1041 XEOTICID XEO02294 GENEFORM Protein DME1041 XEOTICID XEO02294 MOACRIVE Inhibition DME1041 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1041 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02295 XEO_CLAS Peptide DME1041 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 ug/ml) DME1041 XEOTICID XEO02295 GENEFORM Protein DME1041 XEOTICID XEO02295 MOACRIVE Inhibition DME1041 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1041 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02296 XEO_CLAS Peptide DME1041 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02296 GENEFORM Protein DME1041 XEOTICID XEO02296 MOACRIVE Inhibition DME1041 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1041 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02297 XEO_CLAS Peptide DME1041 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC < 50 ug/ml) DME1041 XEOTICID XEO02297 GENEFORM Protein DME1041 XEOTICID XEO02297 MOACRIVE Inhibition DME1041 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1041 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02298 XEO_CLAS Peptide DME1041 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO02298 GENEFORM Protein DME1041 XEOTICID XEO02298 MOACRIVE Inhibition DME1041 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1041 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02303 XEO_CLAS Peptide DME1041 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02303 GENEFORM Protein DME1041 XEOTICID XEO02303 MOACRIVE Inhibition DME1041 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1041 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02304 XEO_CLAS Peptide DME1041 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.1 ug/ml) DME1041 XEOTICID XEO02304 GENEFORM Protein DME1041 XEOTICID XEO02304 MOACRIVE Inhibition DME1041 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1041 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02305 XEO_CLAS Peptide DME1041 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC <= 1 ug/ml) DME1041 XEOTICID XEO02305 GENEFORM Protein DME1041 XEOTICID XEO02305 MOACRIVE Inhibition DME1041 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1041 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02306 XEO_CLAS Peptide DME1041 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.2 ug/ml) DME1041 XEOTICID XEO02306 GENEFORM Protein DME1041 XEOTICID XEO02306 MOACRIVE Inhibition DME1041 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1041 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02309 XEO_CLAS Peptide DME1041 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02309 GENEFORM Protein DME1041 XEOTICID XEO02309 MOACRIVE Inhibition DME1041 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1041 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02310 XEO_CLAS Peptide DME1041 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02310 GENEFORM Protein DME1041 XEOTICID XEO02310 MOACRIVE Inhibition DME1041 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1041 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02315 XEO_CLAS Peptide DME1041 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO02315 GENEFORM Protein DME1041 XEOTICID XEO02315 MOACRIVE Inhibition DME1041 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1041 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02316 XEO_CLAS Peptide DME1041 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 50 microM) DME1041 XEOTICID XEO02316 GENEFORM Protein DME1041 XEOTICID XEO02316 MOACRIVE Inhibition DME1041 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1041 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02317 XEO_CLAS Peptide DME1041 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 300 microM) DME1041 XEOTICID XEO02317 GENEFORM Protein DME1041 XEOTICID XEO02317 MOACRIVE Inhibition DME1041 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1041 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02318 XEO_CLAS Peptide DME1041 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02318 GENEFORM Protein DME1041 XEOTICID XEO02318 MOACRIVE Inhibition DME1041 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1041 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02319 XEO_CLAS Peptide DME1041 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02319 GENEFORM Protein DME1041 XEOTICID XEO02319 MOACRIVE Inhibition DME1041 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1041 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02320 XEO_CLAS Peptide DME1041 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02320 GENEFORM Protein DME1041 XEOTICID XEO02320 MOACRIVE Inhibition DME1041 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1041 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02321 XEO_CLAS Peptide DME1041 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO02321 GENEFORM Protein DME1041 XEOTICID XEO02321 MOACRIVE Inhibition DME1041 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1041 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02322 XEO_CLAS Peptide DME1041 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02322 GENEFORM Protein DME1041 XEOTICID XEO02322 MOACRIVE Inhibition DME1041 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1041 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02323 XEO_CLAS Peptide DME1041 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO02323 GENEFORM Protein DME1041 XEOTICID XEO02323 MOACRIVE Inhibition DME1041 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1041 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02324 XEO_CLAS Peptide DME1041 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02324 GENEFORM Protein DME1041 XEOTICID XEO02324 MOACRIVE Inhibition DME1041 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1041 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02325 XEO_CLAS Peptide DME1041 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO02325 GENEFORM Protein DME1041 XEOTICID XEO02325 MOACRIVE Inhibition DME1041 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1041 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02326 XEO_CLAS Peptide DME1041 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02326 GENEFORM Protein DME1041 XEOTICID XEO02326 MOACRIVE Inhibition DME1041 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1041 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02327 XEO_CLAS Peptide DME1041 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO02327 GENEFORM Protein DME1041 XEOTICID XEO02327 MOACRIVE Inhibition DME1041 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1041 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02328 XEO_CLAS Peptide DME1041 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO02328 GENEFORM Protein DME1041 XEOTICID XEO02328 MOACRIVE Inhibition DME1041 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1041 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02332 XEO_CLAS Peptide DME1041 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.9 ug/ml) DME1041 XEOTICID XEO02332 GENEFORM Protein DME1041 XEOTICID XEO02332 MOACRIVE Inhibition DME1041 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1041 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02333 XEO_CLAS Peptide DME1041 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC >= 200 microM) DME1041 XEOTICID XEO02333 GENEFORM Protein DME1041 XEOTICID XEO02333 MOACRIVE Inhibition DME1041 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1041 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02336 XEO_CLAS Peptide DME1041 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 microM) DME1041 XEOTICID XEO02336 GENEFORM Protein DME1041 XEOTICID XEO02336 MOACRIVE Inhibition DME1041 XEOTICID XEO02346 XEO_NAME Aurelin DME1041 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02346 XEO_CLAS Peptide DME1041 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 7.66 ug/ml) DME1041 XEOTICID XEO02346 GENEFORM Protein DME1041 XEOTICID XEO02346 MOACRIVE Inhibition DME1041 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1041 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02352 XEO_CLAS Peptide DME1041 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 11 ug/ml) DME1041 XEOTICID XEO02352 GENEFORM Protein DME1041 XEOTICID XEO02352 MOACRIVE Inhibition DME1041 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1041 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02353 XEO_CLAS Peptide DME1041 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 ug/ml) DME1041 XEOTICID XEO02353 GENEFORM Protein DME1041 XEOTICID XEO02353 MOACRIVE Inhibition DME1041 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1041 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02354 XEO_CLAS Peptide DME1041 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 ug/ml) DME1041 XEOTICID XEO02354 GENEFORM Protein DME1041 XEOTICID XEO02354 MOACRIVE Inhibition DME1041 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1041 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02355 XEO_CLAS Peptide DME1041 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 17 ug/ml) DME1041 XEOTICID XEO02355 GENEFORM Protein DME1041 XEOTICID XEO02355 MOACRIVE Inhibition DME1041 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1041 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02356 XEO_CLAS Peptide DME1041 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO02356 GENEFORM Protein DME1041 XEOTICID XEO02356 MOACRIVE Inhibition DME1041 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1041 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02357 XEO_CLAS Peptide DME1041 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO02357 GENEFORM Protein DME1041 XEOTICID XEO02357 MOACRIVE Inhibition DME1041 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1041 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02358 XEO_CLAS Peptide DME1041 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO02358 GENEFORM Protein DME1041 XEOTICID XEO02358 MOACRIVE Inhibition DME1041 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1041 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02360 XEO_CLAS Peptide DME1041 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02360 GENEFORM Protein DME1041 XEOTICID XEO02360 MOACRIVE Inhibition DME1041 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1041 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02361 XEO_CLAS Peptide DME1041 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 ug/ml) DME1041 XEOTICID XEO02361 GENEFORM Protein DME1041 XEOTICID XEO02361 MOACRIVE Inhibition DME1041 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1041 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02365 XEO_CLAS Peptide DME1041 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 32 ug/ml) DME1041 XEOTICID XEO02365 GENEFORM Protein DME1041 XEOTICID XEO02365 MOACRIVE Inhibition DME1041 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1041 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02366 XEO_CLAS Peptide DME1041 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO02366 GENEFORM Protein DME1041 XEOTICID XEO02366 MOACRIVE Inhibition DME1041 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1041 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02367 XEO_CLAS Peptide DME1041 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02367 GENEFORM Protein DME1041 XEOTICID XEO02367 MOACRIVE Inhibition DME1041 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1041 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02368 XEO_CLAS Peptide DME1041 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02368 GENEFORM Protein DME1041 XEOTICID XEO02368 MOACRIVE Inhibition DME1041 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1041 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02369 XEO_CLAS Peptide DME1041 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02369 GENEFORM Protein DME1041 XEOTICID XEO02369 MOACRIVE Inhibition DME1041 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1041 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02370 XEO_CLAS Peptide DME1041 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02370 GENEFORM Protein DME1041 XEOTICID XEO02370 MOACRIVE Inhibition DME1041 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1041 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02371 XEO_CLAS Peptide DME1041 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 ug/ml) DME1041 XEOTICID XEO02371 GENEFORM Protein DME1041 XEOTICID XEO02371 MOACRIVE Inhibition DME1041 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1041 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02374 XEO_CLAS Peptide DME1041 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02374 GENEFORM Protein DME1041 XEOTICID XEO02374 MOACRIVE Inhibition DME1041 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1041 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02376 XEO_CLAS Peptide DME1041 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02376 GENEFORM Protein DME1041 XEOTICID XEO02376 MOACRIVE Inhibition DME1041 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1041 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02378 XEO_CLAS Peptide DME1041 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.19 ug/ml) DME1041 XEOTICID XEO02378 GENEFORM Protein DME1041 XEOTICID XEO02378 MOACRIVE Inhibition DME1041 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1041 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02388 XEO_CLAS Peptide DME1041 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO02388 GENEFORM Protein DME1041 XEOTICID XEO02388 MOACRIVE Inhibition DME1041 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1041 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02389 XEO_CLAS Peptide DME1041 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02389 GENEFORM Protein DME1041 XEOTICID XEO02389 MOACRIVE Inhibition DME1041 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1041 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02415 XEO_CLAS Peptide DME1041 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02415 GENEFORM Protein DME1041 XEOTICID XEO02415 MOACRIVE Inhibition DME1041 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1041 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02416 XEO_CLAS Peptide DME1041 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 11 microM) DME1041 XEOTICID XEO02416 GENEFORM Protein DME1041 XEOTICID XEO02416 MOACRIVE Inhibition DME1041 XEOTICID XEO02419 XEO_NAME Bay oil DME1041 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1041 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02419 GENEFORM Protein DME1041 XEOTICID XEO02419 MOACRIVE Inhibition DME1041 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1041 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02435 XEO_CLAS Peptide DME1041 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02435 GENEFORM Protein DME1041 XEOTICID XEO02435 MOACRIVE Inhibition DME1041 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1041 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02436 XEO_CLAS Peptide DME1041 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02436 GENEFORM Protein DME1041 XEOTICID XEO02436 MOACRIVE Inhibition DME1041 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1041 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02437 XEO_CLAS Peptide DME1041 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02437 GENEFORM Protein DME1041 XEOTICID XEO02437 MOACRIVE Inhibition DME1041 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1041 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02438 XEO_CLAS Peptide DME1041 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02438 GENEFORM Protein DME1041 XEOTICID XEO02438 MOACRIVE Inhibition DME1041 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1041 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02439 XEO_CLAS Peptide DME1041 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02439 GENEFORM Protein DME1041 XEOTICID XEO02439 MOACRIVE Inhibition DME1041 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1041 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02440 XEO_CLAS Peptide DME1041 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02440 GENEFORM Protein DME1041 XEOTICID XEO02440 MOACRIVE Inhibition DME1041 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1041 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02441 XEO_CLAS Peptide DME1041 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02441 GENEFORM Protein DME1041 XEOTICID XEO02441 MOACRIVE Inhibition DME1041 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1041 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02442 XEO_CLAS Peptide DME1041 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO02442 GENEFORM Protein DME1041 XEOTICID XEO02442 MOACRIVE Inhibition DME1041 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1041 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02443 XEO_CLAS Peptide DME1041 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02443 GENEFORM Protein DME1041 XEOTICID XEO02443 MOACRIVE Inhibition DME1041 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1041 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02444 XEO_CLAS Peptide DME1041 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02444 GENEFORM Protein DME1041 XEOTICID XEO02444 MOACRIVE Inhibition DME1041 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1041 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1041 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02447 GENEFORM Protein DME1041 XEOTICID XEO02447 MOACRIVE Inhibition DME1041 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1041 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02452 XEO_CLAS Peptide DME1041 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 76800 ug/ml) DME1041 XEOTICID XEO02452 GENEFORM Protein DME1041 XEOTICID XEO02452 MOACRIVE Inhibition DME1041 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1041 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02453 XEO_CLAS Peptide DME1041 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02453 GENEFORM Protein DME1041 XEOTICID XEO02453 MOACRIVE Inhibition DME1041 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1041 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02463 XEO_CLAS Peptide DME1041 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.63 microM) DME1041 XEOTICID XEO02463 GENEFORM Protein DME1041 XEOTICID XEO02463 MOACRIVE Inhibition DME1041 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1041 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02466 XEO_CLAS Peptide DME1041 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.5 microM) DME1041 XEOTICID XEO02466 GENEFORM Protein DME1041 XEOTICID XEO02466 MOACRIVE Inhibition DME1041 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1041 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02467 XEO_CLAS Peptide DME1041 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8.4 microM) DME1041 XEOTICID XEO02467 GENEFORM Protein DME1041 XEOTICID XEO02467 MOACRIVE Inhibition DME1041 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1041 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02468 XEO_CLAS Peptide DME1041 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.7 microM) DME1041 XEOTICID XEO02468 GENEFORM Protein DME1041 XEOTICID XEO02468 MOACRIVE Inhibition DME1041 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1041 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02469 XEO_CLAS Peptide DME1041 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO02469 GENEFORM Protein DME1041 XEOTICID XEO02469 MOACRIVE Inhibition DME1041 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1041 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02470 XEO_CLAS Peptide DME1041 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.8 microM) DME1041 XEOTICID XEO02470 GENEFORM Protein DME1041 XEOTICID XEO02470 MOACRIVE Inhibition DME1041 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1041 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02471 XEO_CLAS Peptide DME1041 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4.8 microM) DME1041 XEOTICID XEO02471 GENEFORM Protein DME1041 XEOTICID XEO02471 MOACRIVE Inhibition DME1041 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1041 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02472 XEO_CLAS Peptide DME1041 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.0 microM) DME1041 XEOTICID XEO02472 GENEFORM Protein DME1041 XEOTICID XEO02472 MOACRIVE Inhibition DME1041 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1041 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02473 XEO_CLAS Peptide DME1041 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02473 GENEFORM Protein DME1041 XEOTICID XEO02473 MOACRIVE Inhibition DME1041 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1041 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02474 XEO_CLAS Peptide DME1041 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.5 microM) DME1041 XEOTICID XEO02474 GENEFORM Protein DME1041 XEOTICID XEO02474 MOACRIVE Inhibition DME1041 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1041 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02475 XEO_CLAS Peptide DME1041 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.5 microM) DME1041 XEOTICID XEO02475 GENEFORM Protein DME1041 XEOTICID XEO02475 MOACRIVE Inhibition DME1041 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1041 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02477 XEO_CLAS Peptide DME1041 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-300 ug/ml) DME1041 XEOTICID XEO02477 GENEFORM Protein DME1041 XEOTICID XEO02477 MOACRIVE Inhibition DME1041 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1041 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02478 XEO_CLAS Peptide DME1041 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-300 ug/ml) DME1041 XEOTICID XEO02478 GENEFORM Protein DME1041 XEOTICID XEO02478 MOACRIVE Inhibition DME1041 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1041 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02479 XEO_CLAS Peptide DME1041 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-300 ug/ml) DME1041 XEOTICID XEO02479 GENEFORM Protein DME1041 XEOTICID XEO02479 MOACRIVE Inhibition DME1041 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1041 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02480 XEO_CLAS Peptide DME1041 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-300 ug/ml) DME1041 XEOTICID XEO02480 GENEFORM Protein DME1041 XEOTICID XEO02480 MOACRIVE Inhibition DME1041 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1041 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02481 XEO_CLAS Peptide DME1041 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-300 ug/ml) DME1041 XEOTICID XEO02481 GENEFORM Protein DME1041 XEOTICID XEO02481 MOACRIVE Inhibition DME1041 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1041 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02482 XEO_CLAS Peptide DME1041 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-300 ug/ml) DME1041 XEOTICID XEO02482 GENEFORM Protein DME1041 XEOTICID XEO02482 MOACRIVE Inhibition DME1041 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1041 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02483 XEO_CLAS Peptide DME1041 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-300 ug/ml) DME1041 XEOTICID XEO02483 GENEFORM Protein DME1041 XEOTICID XEO02483 MOACRIVE Inhibition DME1041 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1041 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02484 XEO_CLAS Peptide DME1041 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-300 ug/ml) DME1041 XEOTICID XEO02484 GENEFORM Protein DME1041 XEOTICID XEO02484 MOACRIVE Inhibition DME1041 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1041 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02485 XEO_CLAS Peptide DME1041 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-300 ug/ml) DME1041 XEOTICID XEO02485 GENEFORM Protein DME1041 XEOTICID XEO02485 MOACRIVE Inhibition DME1041 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1041 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02486 XEO_CLAS Peptide DME1041 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-300 ug/ml) DME1041 XEOTICID XEO02486 GENEFORM Protein DME1041 XEOTICID XEO02486 MOACRIVE Inhibition DME1041 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1041 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02487 XEO_CLAS Peptide DME1041 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02487 GENEFORM Protein DME1041 XEOTICID XEO02487 MOACRIVE Inhibition DME1041 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1041 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02488 XEO_CLAS Peptide DME1041 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-300 ug/ml) DME1041 XEOTICID XEO02488 GENEFORM Protein DME1041 XEOTICID XEO02488 MOACRIVE Inhibition DME1041 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1041 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02489 XEO_CLAS Peptide DME1041 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-301 ug/ml) DME1041 XEOTICID XEO02489 GENEFORM Protein DME1041 XEOTICID XEO02489 MOACRIVE Inhibition DME1041 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1041 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02491 XEO_CLAS Peptide DME1041 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.3 microM) DME1041 XEOTICID XEO02491 GENEFORM Protein DME1041 XEOTICID XEO02491 MOACRIVE Inhibition DME1041 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1041 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02492 XEO_CLAS Peptide DME1041 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 ug/ml) DME1041 XEOTICID XEO02492 GENEFORM Protein DME1041 XEOTICID XEO02492 MOACRIVE Inhibition DME1041 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1041 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02493 XEO_CLAS Peptide DME1041 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 ug/ml) DME1041 XEOTICID XEO02493 GENEFORM Protein DME1041 XEOTICID XEO02493 MOACRIVE Inhibition DME1041 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1041 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02494 XEO_CLAS Peptide DME1041 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 ug/ml) DME1041 XEOTICID XEO02494 GENEFORM Protein DME1041 XEOTICID XEO02494 MOACRIVE Inhibition DME1041 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1041 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02495 XEO_CLAS Peptide DME1041 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 34 ug/ml) DME1041 XEOTICID XEO02495 GENEFORM Protein DME1041 XEOTICID XEO02495 MOACRIVE Inhibition DME1041 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1041 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02496 XEO_CLAS Peptide DME1041 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 13 microM) DME1041 XEOTICID XEO02496 GENEFORM Protein DME1041 XEOTICID XEO02496 MOACRIVE Inhibition DME1041 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1041 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02497 XEO_CLAS Peptide DME1041 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO02497 GENEFORM Protein DME1041 XEOTICID XEO02497 MOACRIVE Inhibition DME1041 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1041 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02499 XEO_CLAS Peptide DME1041 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO02499 GENEFORM Protein DME1041 XEOTICID XEO02499 MOACRIVE Inhibition DME1041 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1041 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02501 XEO_CLAS Peptide DME1041 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 7 microM) DME1041 XEOTICID XEO02501 GENEFORM Protein DME1041 XEOTICID XEO02501 MOACRIVE Inhibition DME1041 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1041 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02502 XEO_CLAS Peptide DME1041 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 microM) DME1041 XEOTICID XEO02502 GENEFORM Protein DME1041 XEOTICID XEO02502 MOACRIVE Inhibition DME1041 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1041 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02503 XEO_CLAS Peptide DME1041 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 19 microM) DME1041 XEOTICID XEO02503 GENEFORM Protein DME1041 XEOTICID XEO02503 MOACRIVE Inhibition DME1041 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1041 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02504 XEO_CLAS Peptide DME1041 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02504 GENEFORM Protein DME1041 XEOTICID XEO02504 MOACRIVE Inhibition DME1041 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1041 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02505 XEO_CLAS Peptide DME1041 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO02505 GENEFORM Protein DME1041 XEOTICID XEO02505 MOACRIVE Inhibition DME1041 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1041 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02507 XEO_CLAS Peptide DME1041 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO02507 GENEFORM Protein DME1041 XEOTICID XEO02507 MOACRIVE Inhibition DME1041 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1041 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02508 XEO_CLAS Peptide DME1041 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 150 microM) DME1041 XEOTICID XEO02508 GENEFORM Protein DME1041 XEOTICID XEO02508 MOACRIVE Inhibition DME1041 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1041 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02509 XEO_CLAS Peptide DME1041 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 150 microM) DME1041 XEOTICID XEO02509 GENEFORM Protein DME1041 XEOTICID XEO02509 MOACRIVE Inhibition DME1041 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1041 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02510 XEO_CLAS Peptide DME1041 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 150 microM) DME1041 XEOTICID XEO02510 GENEFORM Protein DME1041 XEOTICID XEO02510 MOACRIVE Inhibition DME1041 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1041 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02511 XEO_CLAS Peptide DME1041 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 150 microM) DME1041 XEOTICID XEO02511 GENEFORM Protein DME1041 XEOTICID XEO02511 MOACRIVE Inhibition DME1041 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1041 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02512 XEO_CLAS Peptide DME1041 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 75 microM) DME1041 XEOTICID XEO02512 GENEFORM Protein DME1041 XEOTICID XEO02512 MOACRIVE Inhibition DME1041 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1041 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02513 XEO_CLAS Peptide DME1041 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO02513 GENEFORM Protein DME1041 XEOTICID XEO02513 MOACRIVE Inhibition DME1041 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1041 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02514 XEO_CLAS Peptide DME1041 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO02514 GENEFORM Protein DME1041 XEOTICID XEO02514 MOACRIVE Inhibition DME1041 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1041 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02515 XEO_CLAS Peptide DME1041 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 80 microM) DME1041 XEOTICID XEO02515 GENEFORM Protein DME1041 XEOTICID XEO02515 MOACRIVE Inhibition DME1041 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1041 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02516 XEO_CLAS Peptide DME1041 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 32 microM) DME1041 XEOTICID XEO02516 GENEFORM Protein DME1041 XEOTICID XEO02516 MOACRIVE Inhibition DME1041 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1041 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02517 XEO_CLAS Peptide DME1041 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 microM) DME1041 XEOTICID XEO02517 GENEFORM Protein DME1041 XEOTICID XEO02517 MOACRIVE Inhibition DME1041 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1041 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02518 XEO_CLAS Peptide DME1041 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC < 15 microM) DME1041 XEOTICID XEO02518 GENEFORM Protein DME1041 XEOTICID XEO02518 MOACRIVE Inhibition DME1041 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1041 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02519 XEO_CLAS Peptide DME1041 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC < 15 microM) DME1041 XEOTICID XEO02519 GENEFORM Protein DME1041 XEOTICID XEO02519 MOACRIVE Inhibition DME1041 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1041 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02520 XEO_CLAS Peptide DME1041 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC < 15 microM) DME1041 XEOTICID XEO02520 GENEFORM Protein DME1041 XEOTICID XEO02520 MOACRIVE Inhibition DME1041 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1041 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02523 XEO_CLAS Peptide DME1041 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO02523 GENEFORM Protein DME1041 XEOTICID XEO02523 MOACRIVE Inhibition DME1041 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1041 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02524 XEO_CLAS Peptide DME1041 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 150 microM) DME1041 XEOTICID XEO02524 GENEFORM Protein DME1041 XEOTICID XEO02524 MOACRIVE Inhibition DME1041 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1041 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02525 XEO_CLAS Peptide DME1041 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 24 microM) DME1041 XEOTICID XEO02525 GENEFORM Protein DME1041 XEOTICID XEO02525 MOACRIVE Inhibition DME1041 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1041 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02526 XEO_CLAS Peptide DME1041 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 48 microM) DME1041 XEOTICID XEO02526 GENEFORM Protein DME1041 XEOTICID XEO02526 MOACRIVE Inhibition DME1041 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1041 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02527 XEO_CLAS Peptide DME1041 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 119 microM) DME1041 XEOTICID XEO02527 GENEFORM Protein DME1041 XEOTICID XEO02527 MOACRIVE Inhibition DME1041 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1041 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02528 XEO_CLAS Peptide DME1041 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 128 ug/ml) DME1041 XEOTICID XEO02528 GENEFORM Protein DME1041 XEOTICID XEO02528 MOACRIVE Inhibition DME1041 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1041 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02529 XEO_CLAS Peptide DME1041 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 128 ug/ml) DME1041 XEOTICID XEO02529 GENEFORM Protein DME1041 XEOTICID XEO02529 MOACRIVE Inhibition DME1041 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1041 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02530 XEO_CLAS Peptide DME1041 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02530 GENEFORM Protein DME1041 XEOTICID XEO02530 MOACRIVE Inhibition DME1041 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1041 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02531 XEO_CLAS Peptide DME1041 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 microM) DME1041 XEOTICID XEO02531 GENEFORM Protein DME1041 XEOTICID XEO02531 MOACRIVE Inhibition DME1041 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1041 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02533 XEO_CLAS Peptide DME1041 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.2 ug/ml) DME1041 XEOTICID XEO02533 GENEFORM Protein DME1041 XEOTICID XEO02533 MOACRIVE Inhibition DME1041 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1041 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02534 XEO_CLAS Peptide DME1041 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.6 ug/ml) DME1041 XEOTICID XEO02534 GENEFORM Protein DME1041 XEOTICID XEO02534 MOACRIVE Inhibition DME1041 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1041 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02535 XEO_CLAS Peptide DME1041 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.3 ug/ml) DME1041 XEOTICID XEO02535 GENEFORM Protein DME1041 XEOTICID XEO02535 MOACRIVE Inhibition DME1041 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1041 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02536 XEO_CLAS Peptide DME1041 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.4 ug/ml) DME1041 XEOTICID XEO02536 GENEFORM Protein DME1041 XEOTICID XEO02536 MOACRIVE Inhibition DME1041 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1041 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02537 XEO_CLAS Peptide DME1041 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.2 ug/ml) DME1041 XEOTICID XEO02537 GENEFORM Protein DME1041 XEOTICID XEO02537 MOACRIVE Inhibition DME1041 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1041 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02538 XEO_CLAS Peptide DME1041 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9.1 ug/ml) DME1041 XEOTICID XEO02538 GENEFORM Protein DME1041 XEOTICID XEO02538 MOACRIVE Inhibition DME1041 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1041 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02539 XEO_CLAS Peptide DME1041 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8.6 ug/ml) DME1041 XEOTICID XEO02539 GENEFORM Protein DME1041 XEOTICID XEO02539 MOACRIVE Inhibition DME1041 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1041 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02540 XEO_CLAS Peptide DME1041 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15.2 ug/ml) DME1041 XEOTICID XEO02540 GENEFORM Protein DME1041 XEOTICID XEO02540 MOACRIVE Inhibition DME1041 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1041 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02541 XEO_CLAS Peptide DME1041 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 11.1 ug/ml) DME1041 XEOTICID XEO02541 GENEFORM Protein DME1041 XEOTICID XEO02541 MOACRIVE Inhibition DME1041 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1041 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02542 XEO_CLAS Peptide DME1041 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.7 ug/ml) DME1041 XEOTICID XEO02542 GENEFORM Protein DME1041 XEOTICID XEO02542 MOACRIVE Inhibition DME1041 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1041 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02543 XEO_CLAS Peptide DME1041 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 13.1 ug/ml) DME1041 XEOTICID XEO02543 GENEFORM Protein DME1041 XEOTICID XEO02543 MOACRIVE Inhibition DME1041 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1041 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02544 XEO_CLAS Peptide DME1041 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9.8 ug/ml) DME1041 XEOTICID XEO02544 GENEFORM Protein DME1041 XEOTICID XEO02544 MOACRIVE Inhibition DME1041 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1041 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02545 XEO_CLAS Peptide DME1041 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 14 microM) DME1041 XEOTICID XEO02545 GENEFORM Protein DME1041 XEOTICID XEO02545 MOACRIVE Inhibition DME1041 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1041 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02546 XEO_CLAS Peptide DME1041 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 14 microM) DME1041 XEOTICID XEO02546 GENEFORM Protein DME1041 XEOTICID XEO02546 MOACRIVE Inhibition DME1041 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1041 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02547 XEO_CLAS Peptide DME1041 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 microM) DME1041 XEOTICID XEO02547 GENEFORM Protein DME1041 XEOTICID XEO02547 MOACRIVE Inhibition DME1041 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1041 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02548 XEO_CLAS Peptide DME1041 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 78 microM) DME1041 XEOTICID XEO02548 GENEFORM Protein DME1041 XEOTICID XEO02548 MOACRIVE Inhibition DME1041 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1041 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02549 XEO_CLAS Peptide DME1041 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02549 GENEFORM Protein DME1041 XEOTICID XEO02549 MOACRIVE Inhibition DME1041 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1041 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02552 XEO_CLAS Peptide DME1041 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 24 microM) DME1041 XEOTICID XEO02552 GENEFORM Protein DME1041 XEOTICID XEO02552 MOACRIVE Inhibition DME1041 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1041 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02553 XEO_CLAS Peptide DME1041 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02553 GENEFORM Protein DME1041 XEOTICID XEO02553 MOACRIVE Inhibition DME1041 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1041 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02556 XEO_CLAS Peptide DME1041 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 55 microM) DME1041 XEOTICID XEO02556 GENEFORM Protein DME1041 XEOTICID XEO02556 MOACRIVE Inhibition DME1041 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1041 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02557 XEO_CLAS Peptide DME1041 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 17 microM) DME1041 XEOTICID XEO02557 GENEFORM Protein DME1041 XEOTICID XEO02557 MOACRIVE Inhibition DME1041 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1041 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02558 XEO_CLAS Peptide DME1041 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 14 microM) DME1041 XEOTICID XEO02558 GENEFORM Protein DME1041 XEOTICID XEO02558 MOACRIVE Inhibition DME1041 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1041 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02559 XEO_CLAS Peptide DME1041 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02559 GENEFORM Protein DME1041 XEOTICID XEO02559 MOACRIVE Inhibition DME1041 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1041 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02560 XEO_CLAS Peptide DME1041 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 13 microM) DME1041 XEOTICID XEO02560 GENEFORM Protein DME1041 XEOTICID XEO02560 MOACRIVE Inhibition DME1041 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1041 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02561 XEO_CLAS Peptide DME1041 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO02561 GENEFORM Protein DME1041 XEOTICID XEO02561 MOACRIVE Inhibition DME1041 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1041 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02562 XEO_CLAS Peptide DME1041 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 13 microM) DME1041 XEOTICID XEO02562 GENEFORM Protein DME1041 XEOTICID XEO02562 MOACRIVE Inhibition DME1041 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1041 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02563 XEO_CLAS Peptide DME1041 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 45 microM) DME1041 XEOTICID XEO02563 GENEFORM Protein DME1041 XEOTICID XEO02563 MOACRIVE Inhibition DME1041 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1041 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02564 XEO_CLAS Peptide DME1041 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 ug/ml) DME1041 XEOTICID XEO02564 GENEFORM Protein DME1041 XEOTICID XEO02564 MOACRIVE Inhibition DME1041 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1041 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02565 XEO_CLAS Peptide DME1041 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 microM) DME1041 XEOTICID XEO02565 GENEFORM Protein DME1041 XEOTICID XEO02565 MOACRIVE Inhibition DME1041 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1041 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02566 XEO_CLAS Peptide DME1041 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO02566 GENEFORM Protein DME1041 XEOTICID XEO02566 MOACRIVE Inhibition DME1041 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1041 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02568 XEO_CLAS Peptide DME1041 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO02568 GENEFORM Protein DME1041 XEOTICID XEO02568 MOACRIVE Inhibition DME1041 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1041 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02569 XEO_CLAS Peptide DME1041 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO02569 GENEFORM Protein DME1041 XEOTICID XEO02569 MOACRIVE Inhibition DME1041 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1041 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02570 XEO_CLAS Peptide DME1041 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO02570 GENEFORM Protein DME1041 XEOTICID XEO02570 MOACRIVE Inhibition DME1041 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1041 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02571 XEO_CLAS Peptide DME1041 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO02571 GENEFORM Protein DME1041 XEOTICID XEO02571 MOACRIVE Inhibition DME1041 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1041 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02572 XEO_CLAS Peptide DME1041 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02572 GENEFORM Protein DME1041 XEOTICID XEO02572 MOACRIVE Inhibition DME1041 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1041 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02573 XEO_CLAS Peptide DME1041 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02573 GENEFORM Protein DME1041 XEOTICID XEO02573 MOACRIVE Inhibition DME1041 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1041 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02574 XEO_CLAS Peptide DME1041 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 microM) DME1041 XEOTICID XEO02574 GENEFORM Protein DME1041 XEOTICID XEO02574 MOACRIVE Inhibition DME1041 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1041 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02575 XEO_CLAS Peptide DME1041 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 microM) DME1041 XEOTICID XEO02575 GENEFORM Protein DME1041 XEOTICID XEO02575 MOACRIVE Inhibition DME1041 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1041 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02576 XEO_CLAS Peptide DME1041 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 33 microM) DME1041 XEOTICID XEO02576 GENEFORM Protein DME1041 XEOTICID XEO02576 MOACRIVE Inhibition DME1041 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1041 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02577 XEO_CLAS Peptide DME1041 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO02577 GENEFORM Protein DME1041 XEOTICID XEO02577 MOACRIVE Inhibition DME1041 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1041 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02578 XEO_CLAS Peptide DME1041 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02578 GENEFORM Protein DME1041 XEOTICID XEO02578 MOACRIVE Inhibition DME1041 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1041 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02579 XEO_CLAS Peptide DME1041 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02579 GENEFORM Protein DME1041 XEOTICID XEO02579 MOACRIVE Inhibition DME1041 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1041 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02580 XEO_CLAS Peptide DME1041 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC < 15 microM) DME1041 XEOTICID XEO02580 GENEFORM Protein DME1041 XEOTICID XEO02580 MOACRIVE Inhibition DME1041 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1041 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02581 XEO_CLAS Peptide DME1041 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 microM) DME1041 XEOTICID XEO02581 GENEFORM Protein DME1041 XEOTICID XEO02581 MOACRIVE Inhibition DME1041 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1041 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02582 XEO_CLAS Peptide DME1041 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 microM) DME1041 XEOTICID XEO02582 GENEFORM Protein DME1041 XEOTICID XEO02582 MOACRIVE Inhibition DME1041 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1041 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02583 XEO_CLAS Peptide DME1041 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 microM) DME1041 XEOTICID XEO02583 GENEFORM Protein DME1041 XEOTICID XEO02583 MOACRIVE Inhibition DME1041 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1041 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02584 XEO_CLAS Peptide DME1041 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 microM) DME1041 XEOTICID XEO02584 GENEFORM Protein DME1041 XEOTICID XEO02584 MOACRIVE Inhibition DME1041 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1041 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02585 XEO_CLAS Peptide DME1041 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO02585 GENEFORM Protein DME1041 XEOTICID XEO02585 MOACRIVE Inhibition DME1041 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1041 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02586 XEO_CLAS Peptide DME1041 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO02586 GENEFORM Protein DME1041 XEOTICID XEO02586 MOACRIVE Inhibition DME1041 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1041 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02587 XEO_CLAS Peptide DME1041 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02587 GENEFORM Protein DME1041 XEOTICID XEO02587 MOACRIVE Inhibition DME1041 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1041 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02589 XEO_CLAS Peptide DME1041 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8.2 ug/ml) DME1041 XEOTICID XEO02589 GENEFORM Protein DME1041 XEOTICID XEO02589 MOACRIVE Inhibition DME1041 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1041 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02590 XEO_CLAS Peptide DME1041 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9.8 ug/ml) DME1041 XEOTICID XEO02590 GENEFORM Protein DME1041 XEOTICID XEO02590 MOACRIVE Inhibition DME1041 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1041 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02591 XEO_CLAS Peptide DME1041 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO02591 GENEFORM Protein DME1041 XEOTICID XEO02591 MOACRIVE Inhibition DME1041 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1041 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02593 XEO_CLAS Peptide DME1041 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 36 microM) DME1041 XEOTICID XEO02593 GENEFORM Protein DME1041 XEOTICID XEO02593 MOACRIVE Inhibition DME1041 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1041 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02594 XEO_CLAS Peptide DME1041 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02594 GENEFORM Protein DME1041 XEOTICID XEO02594 MOACRIVE Inhibition DME1041 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1041 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02595 XEO_CLAS Peptide DME1041 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO02595 GENEFORM Protein DME1041 XEOTICID XEO02595 MOACRIVE Inhibition DME1041 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1041 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02596 XEO_CLAS Peptide DME1041 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO02596 GENEFORM Protein DME1041 XEOTICID XEO02596 MOACRIVE Inhibition DME1041 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1041 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02597 XEO_CLAS Peptide DME1041 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO02597 GENEFORM Protein DME1041 XEOTICID XEO02597 MOACRIVE Inhibition DME1041 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1041 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02598 XEO_CLAS Peptide DME1041 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 32.5 microM) DME1041 XEOTICID XEO02598 GENEFORM Protein DME1041 XEOTICID XEO02598 MOACRIVE Inhibition DME1041 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1041 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02599 XEO_CLAS Peptide DME1041 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 microM) DME1041 XEOTICID XEO02599 GENEFORM Protein DME1041 XEOTICID XEO02599 MOACRIVE Inhibition DME1041 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1041 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02601 XEO_CLAS Peptide DME1041 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.1 ug/ml) DME1041 XEOTICID XEO02601 GENEFORM Protein DME1041 XEOTICID XEO02601 MOACRIVE Inhibition DME1041 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1041 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02602 XEO_CLAS Peptide DME1041 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 13.2 ug/ml) DME1041 XEOTICID XEO02602 GENEFORM Protein DME1041 XEOTICID XEO02602 MOACRIVE Inhibition DME1041 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1041 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02603 XEO_CLAS Peptide DME1041 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.3 ug/ml) DME1041 XEOTICID XEO02603 GENEFORM Protein DME1041 XEOTICID XEO02603 MOACRIVE Inhibition DME1041 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1041 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02604 XEO_CLAS Peptide DME1041 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO02604 GENEFORM Protein DME1041 XEOTICID XEO02604 MOACRIVE Inhibition DME1041 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1041 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02605 XEO_CLAS Peptide DME1041 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30.6 ug/ml) DME1041 XEOTICID XEO02605 GENEFORM Protein DME1041 XEOTICID XEO02605 MOACRIVE Inhibition DME1041 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1041 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02606 XEO_CLAS Peptide DME1041 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 11.2 ug/ml) DME1041 XEOTICID XEO02606 GENEFORM Protein DME1041 XEOTICID XEO02606 MOACRIVE Inhibition DME1041 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1041 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02607 XEO_CLAS Peptide DME1041 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.8 ug/ml) DME1041 XEOTICID XEO02607 GENEFORM Protein DME1041 XEOTICID XEO02607 MOACRIVE Inhibition DME1041 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1041 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02608 XEO_CLAS Peptide DME1041 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 7.9 ug/ml) DME1041 XEOTICID XEO02608 GENEFORM Protein DME1041 XEOTICID XEO02608 MOACRIVE Inhibition DME1041 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1041 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02609 XEO_CLAS Peptide DME1041 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15.8 ug/ml) DME1041 XEOTICID XEO02609 GENEFORM Protein DME1041 XEOTICID XEO02609 MOACRIVE Inhibition DME1041 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1041 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02610 XEO_CLAS Peptide DME1041 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.1 ug/ml) DME1041 XEOTICID XEO02610 GENEFORM Protein DME1041 XEOTICID XEO02610 MOACRIVE Inhibition DME1041 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1041 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02611 XEO_CLAS Peptide DME1041 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20.6 ug/ml) DME1041 XEOTICID XEO02611 GENEFORM Protein DME1041 XEOTICID XEO02611 MOACRIVE Inhibition DME1041 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1041 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02612 XEO_CLAS Peptide DME1041 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 11.8 ug/ml) DME1041 XEOTICID XEO02612 GENEFORM Protein DME1041 XEOTICID XEO02612 MOACRIVE Inhibition DME1041 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1041 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02613 XEO_CLAS Peptide DME1041 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 13.2 ug/ml) DME1041 XEOTICID XEO02613 GENEFORM Protein DME1041 XEOTICID XEO02613 MOACRIVE Inhibition DME1041 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1041 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02614 XEO_CLAS Peptide DME1041 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.8 ug/ml) DME1041 XEOTICID XEO02614 GENEFORM Protein DME1041 XEOTICID XEO02614 MOACRIVE Inhibition DME1041 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1041 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02615 XEO_CLAS Peptide DME1041 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8.6 ug/ml) DME1041 XEOTICID XEO02615 GENEFORM Protein DME1041 XEOTICID XEO02615 MOACRIVE Inhibition DME1041 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1041 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02616 XEO_CLAS Peptide DME1041 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20.4 ug/ml) DME1041 XEOTICID XEO02616 GENEFORM Protein DME1041 XEOTICID XEO02616 MOACRIVE Inhibition DME1041 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1041 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02617 XEO_CLAS Peptide DME1041 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4.7 ug/ml) DME1041 XEOTICID XEO02617 GENEFORM Protein DME1041 XEOTICID XEO02617 MOACRIVE Inhibition DME1041 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1041 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02618 XEO_CLAS Peptide DME1041 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.6 ug/ml) DME1041 XEOTICID XEO02618 GENEFORM Protein DME1041 XEOTICID XEO02618 MOACRIVE Inhibition DME1041 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1041 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02619 XEO_CLAS Peptide DME1041 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10.5 ug/ml) DME1041 XEOTICID XEO02619 GENEFORM Protein DME1041 XEOTICID XEO02619 MOACRIVE Inhibition DME1041 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1041 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02620 XEO_CLAS Peptide DME1041 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO02620 GENEFORM Protein DME1041 XEOTICID XEO02620 MOACRIVE Inhibition DME1041 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1041 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02621 XEO_CLAS Peptide DME1041 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO02621 GENEFORM Protein DME1041 XEOTICID XEO02621 MOACRIVE Inhibition DME1041 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1041 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02622 XEO_CLAS Peptide DME1041 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO02622 GENEFORM Protein DME1041 XEOTICID XEO02622 MOACRIVE Inhibition DME1041 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1041 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02623 XEO_CLAS Peptide DME1041 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO02623 GENEFORM Protein DME1041 XEOTICID XEO02623 MOACRIVE Inhibition DME1041 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1041 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02624 XEO_CLAS Peptide DME1041 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 18 microM) DME1041 XEOTICID XEO02624 GENEFORM Protein DME1041 XEOTICID XEO02624 MOACRIVE Inhibition DME1041 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1041 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02625 XEO_CLAS Peptide DME1041 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9 microM) DME1041 XEOTICID XEO02625 GENEFORM Protein DME1041 XEOTICID XEO02625 MOACRIVE Inhibition DME1041 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1041 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02626 XEO_CLAS Peptide DME1041 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 18 microM) DME1041 XEOTICID XEO02626 GENEFORM Protein DME1041 XEOTICID XEO02626 MOACRIVE Inhibition DME1041 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1041 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02627 XEO_CLAS Peptide DME1041 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02627 GENEFORM Protein DME1041 XEOTICID XEO02627 MOACRIVE Inhibition DME1041 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1041 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02628 XEO_CLAS Peptide DME1041 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 18 microM) DME1041 XEOTICID XEO02628 GENEFORM Protein DME1041 XEOTICID XEO02628 MOACRIVE Inhibition DME1041 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1041 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02629 XEO_CLAS Peptide DME1041 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 13 microM) DME1041 XEOTICID XEO02629 GENEFORM Protein DME1041 XEOTICID XEO02629 MOACRIVE Inhibition DME1041 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1041 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02630 XEO_CLAS Peptide DME1041 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 ug/ml) DME1041 XEOTICID XEO02630 GENEFORM Protein DME1041 XEOTICID XEO02630 MOACRIVE Inhibition DME1041 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1041 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02631 XEO_CLAS Peptide DME1041 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 ug/ml) DME1041 XEOTICID XEO02631 GENEFORM Protein DME1041 XEOTICID XEO02631 MOACRIVE Inhibition DME1041 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1041 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02634 XEO_CLAS Peptide DME1041 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO02634 GENEFORM Protein DME1041 XEOTICID XEO02634 MOACRIVE Inhibition DME1041 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1041 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02635 XEO_CLAS Peptide DME1041 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40 ug/ml) DME1041 XEOTICID XEO02635 GENEFORM Protein DME1041 XEOTICID XEO02635 MOACRIVE Inhibition DME1041 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1041 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02636 XEO_CLAS Peptide DME1041 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO02636 GENEFORM Protein DME1041 XEOTICID XEO02636 MOACRIVE Inhibition DME1041 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1041 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02637 XEO_CLAS Peptide DME1041 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO02637 GENEFORM Protein DME1041 XEOTICID XEO02637 MOACRIVE Inhibition DME1041 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1041 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02638 XEO_CLAS Peptide DME1041 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 microM) DME1041 XEOTICID XEO02638 GENEFORM Protein DME1041 XEOTICID XEO02638 MOACRIVE Inhibition DME1041 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1041 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02639 XEO_CLAS Peptide DME1041 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 microM) DME1041 XEOTICID XEO02639 GENEFORM Protein DME1041 XEOTICID XEO02639 MOACRIVE Inhibition DME1041 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1041 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02644 XEO_CLAS Peptide DME1041 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02644 GENEFORM Protein DME1041 XEOTICID XEO02644 MOACRIVE Inhibition DME1041 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1041 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02645 XEO_CLAS Peptide DME1041 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02645 GENEFORM Protein DME1041 XEOTICID XEO02645 MOACRIVE Inhibition DME1041 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1041 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02646 XEO_CLAS Peptide DME1041 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02646 GENEFORM Protein DME1041 XEOTICID XEO02646 MOACRIVE Inhibition DME1041 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1041 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02647 XEO_CLAS Peptide DME1041 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02647 GENEFORM Protein DME1041 XEOTICID XEO02647 MOACRIVE Inhibition DME1041 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1041 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02649 XEO_CLAS Peptide DME1041 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO02649 GENEFORM Protein DME1041 XEOTICID XEO02649 MOACRIVE Inhibition DME1041 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1041 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02650 XEO_CLAS Peptide DME1041 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO02650 GENEFORM Protein DME1041 XEOTICID XEO02650 MOACRIVE Inhibition DME1041 XEOTICID XEO02658 XEO_NAME Buthinin DME1041 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02658 XEO_CLAS Peptide DME1041 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02658 GENEFORM Protein DME1041 XEOTICID XEO02658 MOACRIVE Inhibition DME1041 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1041 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02663 XEO_CLAS Peptide DME1041 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25 microM) DME1041 XEOTICID XEO02663 GENEFORM Protein DME1041 XEOTICID XEO02663 MOACRIVE Inhibition DME1041 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1041 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02664 XEO_CLAS Peptide DME1041 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25 microM) DME1041 XEOTICID XEO02664 GENEFORM Protein DME1041 XEOTICID XEO02664 MOACRIVE Inhibition DME1041 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1041 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02672 XEO_CLAS Peptide DME1041 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25 microM) DME1041 XEOTICID XEO02672 GENEFORM Protein DME1041 XEOTICID XEO02672 MOACRIVE Inhibition DME1041 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1041 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02673 XEO_CLAS Peptide DME1041 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25-12.5 microM) DME1041 XEOTICID XEO02673 GENEFORM Protein DME1041 XEOTICID XEO02673 MOACRIVE Inhibition DME1041 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1041 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02674 XEO_CLAS Peptide DME1041 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.125-6.25 microM) DME1041 XEOTICID XEO02674 GENEFORM Protein DME1041 XEOTICID XEO02674 MOACRIVE Inhibition DME1041 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1041 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02676 XEO_CLAS Peptide DME1041 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO02676 GENEFORM Protein DME1041 XEOTICID XEO02676 MOACRIVE Inhibition DME1041 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1041 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02677 XEO_CLAS Peptide DME1041 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25-12.5 microM) DME1041 XEOTICID XEO02677 GENEFORM Protein DME1041 XEOTICID XEO02677 MOACRIVE Inhibition DME1041 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1041 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02679 XEO_CLAS Peptide DME1041 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25-12.5 microM) DME1041 XEOTICID XEO02679 GENEFORM Protein DME1041 XEOTICID XEO02679 MOACRIVE Inhibition DME1041 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1041 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02680 XEO_CLAS Peptide DME1041 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25 microM) DME1041 XEOTICID XEO02680 GENEFORM Protein DME1041 XEOTICID XEO02680 MOACRIVE Inhibition DME1041 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1041 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02683 XEO_CLAS Peptide DME1041 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO02683 GENEFORM Protein DME1041 XEOTICID XEO02683 MOACRIVE Inhibition DME1041 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1041 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02688 XEO_CLAS Peptide DME1041 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO02688 GENEFORM Protein DME1041 XEOTICID XEO02688 MOACRIVE Inhibition DME1041 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1041 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02693 XEO_CLAS Peptide DME1041 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 ug/ml) DME1041 XEOTICID XEO02693 GENEFORM Protein DME1041 XEOTICID XEO02693 MOACRIVE Inhibition DME1041 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1041 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02699 XEO_CLAS Peptide DME1041 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 ug/ml) DME1041 XEOTICID XEO02699 GENEFORM Protein DME1041 XEOTICID XEO02699 MOACRIVE Inhibition DME1041 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1041 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02700 XEO_CLAS Peptide DME1041 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 ug/ml) DME1041 XEOTICID XEO02700 GENEFORM Protein DME1041 XEOTICID XEO02700 MOACRIVE Inhibition DME1041 XEOTICID XEO02703 XEO_NAME Calcitermin DME1041 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02703 XEO_CLAS Peptide DME1041 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02703 GENEFORM Protein DME1041 XEOTICID XEO02703 MOACRIVE Inhibition DME1041 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1041 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02708 XEO_CLAS Peptide DME1041 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO02708 GENEFORM Protein DME1041 XEOTICID XEO02708 MOACRIVE Inhibition DME1041 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1041 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02709 XEO_CLAS Peptide DME1041 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.05 microM) DME1041 XEOTICID XEO02709 GENEFORM Protein DME1041 XEOTICID XEO02709 MOACRIVE Inhibition DME1041 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1041 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1041 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02713 GENEFORM Protein DME1041 XEOTICID XEO02713 MOACRIVE Inhibition DME1041 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1041 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1041 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02714 GENEFORM Protein DME1041 XEOTICID XEO02714 MOACRIVE Inhibition DME1041 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1041 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02726 XEO_CLAS Peptide DME1041 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02726 GENEFORM Protein DME1041 XEOTICID XEO02726 MOACRIVE Inhibition DME1041 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1041 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02731 XEO_CLAS Peptide DME1041 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1 microM) DME1041 XEOTICID XEO02731 GENEFORM Protein DME1041 XEOTICID XEO02731 MOACRIVE Inhibition DME1041 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1041 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02732 XEO_CLAS Peptide DME1041 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.25 microM) DME1041 XEOTICID XEO02732 GENEFORM Protein DME1041 XEOTICID XEO02732 MOACRIVE Inhibition DME1041 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1041 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02733 XEO_CLAS Peptide DME1041 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8-25 ug/ml) DME1041 XEOTICID XEO02733 GENEFORM Protein DME1041 XEOTICID XEO02733 MOACRIVE Inhibition DME1041 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1041 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02735 XEO_CLAS Peptide DME1041 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1 ug/ml) DME1041 XEOTICID XEO02735 GENEFORM Protein DME1041 XEOTICID XEO02735 MOACRIVE Inhibition DME1041 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1041 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02737 XEO_CLAS Peptide DME1041 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02737 GENEFORM Protein DME1041 XEOTICID XEO02737 MOACRIVE Inhibition DME1041 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1041 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02738 XEO_CLAS Peptide DME1041 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO02738 GENEFORM Protein DME1041 XEOTICID XEO02738 MOACRIVE Inhibition DME1041 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1041 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02739 XEO_CLAS Peptide DME1041 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 microM) DME1041 XEOTICID XEO02739 GENEFORM Protein DME1041 XEOTICID XEO02739 MOACRIVE Inhibition DME1041 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1041 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02740 XEO_CLAS Peptide DME1041 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.25 ug/ml) DME1041 XEOTICID XEO02740 GENEFORM Protein DME1041 XEOTICID XEO02740 MOACRIVE Inhibition DME1041 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1041 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02741 XEO_CLAS Peptide DME1041 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 ug/ml) DME1041 XEOTICID XEO02741 GENEFORM Protein DME1041 XEOTICID XEO02741 MOACRIVE Inhibition DME1041 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1041 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02743 XEO_CLAS Peptide DME1041 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.6 ug/ml) DME1041 XEOTICID XEO02743 GENEFORM Protein DME1041 XEOTICID XEO02743 MOACRIVE Inhibition DME1041 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1041 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02744 XEO_CLAS Peptide DME1041 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 18.7 ug/ml) DME1041 XEOTICID XEO02744 GENEFORM Protein DME1041 XEOTICID XEO02744 MOACRIVE Inhibition DME1041 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1041 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02745 XEO_CLAS Peptide DME1041 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02745 GENEFORM Protein DME1041 XEOTICID XEO02745 MOACRIVE Inhibition DME1041 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1041 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02746 XEO_CLAS Peptide DME1041 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02746 GENEFORM Protein DME1041 XEOTICID XEO02746 MOACRIVE Inhibition DME1041 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1041 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02748 XEO_CLAS Peptide DME1041 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02748 GENEFORM Protein DME1041 XEOTICID XEO02748 MOACRIVE Inhibition DME1041 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1041 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02749 XEO_CLAS Peptide DME1041 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20-25 mug/ml) DME1041 XEOTICID XEO02749 GENEFORM Protein DME1041 XEOTICID XEO02749 MOACRIVE Inhibition DME1041 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1041 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02750 XEO_CLAS Peptide DME1041 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02750 GENEFORM Protein DME1041 XEOTICID XEO02750 MOACRIVE Inhibition DME1041 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1041 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02752 XEO_CLAS Peptide DME1041 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02752 GENEFORM Protein DME1041 XEOTICID XEO02752 MOACRIVE Inhibition DME1041 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1041 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02753 XEO_CLAS Peptide DME1041 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02753 GENEFORM Protein DME1041 XEOTICID XEO02753 MOACRIVE Inhibition DME1041 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1041 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02754 XEO_CLAS Peptide DME1041 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 microM) DME1041 XEOTICID XEO02754 GENEFORM Protein DME1041 XEOTICID XEO02754 MOACRIVE Inhibition DME1041 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1041 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02756 XEO_CLAS Peptide DME1041 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 microM) DME1041 XEOTICID XEO02756 GENEFORM Protein DME1041 XEOTICID XEO02756 MOACRIVE Inhibition DME1041 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1041 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02757 XEO_CLAS Peptide DME1041 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1 microM) DME1041 XEOTICID XEO02757 GENEFORM Protein DME1041 XEOTICID XEO02757 MOACRIVE Inhibition DME1041 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1041 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02758 XEO_CLAS Peptide DME1041 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO02758 GENEFORM Protein DME1041 XEOTICID XEO02758 MOACRIVE Inhibition DME1041 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1041 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02759 XEO_CLAS Peptide DME1041 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.6 microM) DME1041 XEOTICID XEO02759 GENEFORM Protein DME1041 XEOTICID XEO02759 MOACRIVE Inhibition DME1041 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1041 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02760 XEO_CLAS Peptide DME1041 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 microM) DME1041 XEOTICID XEO02760 GENEFORM Protein DME1041 XEOTICID XEO02760 MOACRIVE Inhibition DME1041 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1041 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02761 XEO_CLAS Peptide DME1041 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO02761 GENEFORM Protein DME1041 XEOTICID XEO02761 MOACRIVE Inhibition DME1041 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1041 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02762 XEO_CLAS Peptide DME1041 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 microM) DME1041 XEOTICID XEO02762 GENEFORM Protein DME1041 XEOTICID XEO02762 MOACRIVE Inhibition DME1041 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1041 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02763 XEO_CLAS Peptide DME1041 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.4 microM) DME1041 XEOTICID XEO02763 GENEFORM Protein DME1041 XEOTICID XEO02763 MOACRIVE Inhibition DME1041 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1041 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02764 XEO_CLAS Peptide DME1041 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 microM) DME1041 XEOTICID XEO02764 GENEFORM Protein DME1041 XEOTICID XEO02764 MOACRIVE Inhibition DME1041 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1041 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02765 XEO_CLAS Peptide DME1041 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.3 microM) DME1041 XEOTICID XEO02765 GENEFORM Protein DME1041 XEOTICID XEO02765 MOACRIVE Inhibition DME1041 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1041 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02767 XEO_CLAS Peptide DME1041 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02767 GENEFORM Protein DME1041 XEOTICID XEO02767 MOACRIVE Inhibition DME1041 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1041 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02768 XEO_CLAS Peptide DME1041 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.1-0.25 ug/ml) DME1041 XEOTICID XEO02768 GENEFORM Protein DME1041 XEOTICID XEO02768 MOACRIVE Inhibition DME1041 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1041 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02769 XEO_CLAS Peptide DME1041 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.32 microM) DME1041 XEOTICID XEO02769 GENEFORM Protein DME1041 XEOTICID XEO02769 MOACRIVE Inhibition DME1041 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1041 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02770 XEO_CLAS Peptide DME1041 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.30 microM) DME1041 XEOTICID XEO02770 GENEFORM Protein DME1041 XEOTICID XEO02770 MOACRIVE Inhibition DME1041 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1041 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02771 XEO_CLAS Peptide DME1041 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.21 microM) DME1041 XEOTICID XEO02771 GENEFORM Protein DME1041 XEOTICID XEO02771 MOACRIVE Inhibition DME1041 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1041 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02772 XEO_CLAS Peptide DME1041 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02772 GENEFORM Protein DME1041 XEOTICID XEO02772 MOACRIVE Inhibition DME1041 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1041 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02773 XEO_CLAS Peptide DME1041 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.9-8.6 microM) DME1041 XEOTICID XEO02773 GENEFORM Protein DME1041 XEOTICID XEO02773 MOACRIVE Inhibition DME1041 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1041 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02774 XEO_CLAS Peptide DME1041 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.3 microM) DME1041 XEOTICID XEO02774 GENEFORM Protein DME1041 XEOTICID XEO02774 MOACRIVE Inhibition DME1041 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1041 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02789 GENEFORM Protein DME1041 XEOTICID XEO02789 MOACRIVE Inhibition DME1041 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1041 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02790 GENEFORM Protein DME1041 XEOTICID XEO02790 MOACRIVE Inhibition DME1041 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1041 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02791 GENEFORM Protein DME1041 XEOTICID XEO02791 MOACRIVE Inhibition DME1041 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1041 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02792 GENEFORM Protein DME1041 XEOTICID XEO02792 MOACRIVE Inhibition DME1041 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1041 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02793 GENEFORM Protein DME1041 XEOTICID XEO02793 MOACRIVE Inhibition DME1041 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1041 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02794 GENEFORM Protein DME1041 XEOTICID XEO02794 MOACRIVE Inhibition DME1041 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1041 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02795 GENEFORM Protein DME1041 XEOTICID XEO02795 MOACRIVE Inhibition DME1041 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1041 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02796 GENEFORM Protein DME1041 XEOTICID XEO02796 MOACRIVE Inhibition DME1041 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1041 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02797 GENEFORM Protein DME1041 XEOTICID XEO02797 MOACRIVE Inhibition DME1041 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1041 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02799 XEO_CLAS Peptide DME1041 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02799 GENEFORM Protein DME1041 XEOTICID XEO02799 MOACRIVE Inhibition DME1041 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1041 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02800 XEO_CLAS Peptide DME1041 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02800 GENEFORM Protein DME1041 XEOTICID XEO02800 MOACRIVE Inhibition DME1041 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1041 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02802 XEO_CLAS Peptide DME1041 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 13.6 microM) DME1041 XEOTICID XEO02802 GENEFORM Protein DME1041 XEOTICID XEO02802 MOACRIVE Inhibition DME1041 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1041 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02807 XEO_CLAS Peptide DME1041 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.2 microM) DME1041 XEOTICID XEO02807 GENEFORM Protein DME1041 XEOTICID XEO02807 MOACRIVE Inhibition DME1041 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1041 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02813 XEO_CLAS Peptide DME1041 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 80 microM) DME1041 XEOTICID XEO02813 GENEFORM Protein DME1041 XEOTICID XEO02813 MOACRIVE Inhibition DME1041 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1041 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02814 XEO_CLAS Peptide DME1041 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 80 microM) DME1041 XEOTICID XEO02814 GENEFORM Protein DME1041 XEOTICID XEO02814 MOACRIVE Inhibition DME1041 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1041 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02815 XEO_CLAS Peptide DME1041 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8.5 microM) DME1041 XEOTICID XEO02815 GENEFORM Protein DME1041 XEOTICID XEO02815 MOACRIVE Inhibition DME1041 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1041 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02816 XEO_CLAS Peptide DME1041 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 80 microM) DME1041 XEOTICID XEO02816 GENEFORM Protein DME1041 XEOTICID XEO02816 MOACRIVE Inhibition DME1041 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1041 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02817 XEO_CLAS Peptide DME1041 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 80 microM) DME1041 XEOTICID XEO02817 GENEFORM Protein DME1041 XEOTICID XEO02817 MOACRIVE Inhibition DME1041 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1041 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02818 XEO_CLAS Peptide DME1041 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.4 microM) DME1041 XEOTICID XEO02818 GENEFORM Protein DME1041 XEOTICID XEO02818 MOACRIVE Inhibition DME1041 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1041 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02819 XEO_CLAS Peptide DME1041 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.6 microM) DME1041 XEOTICID XEO02819 GENEFORM Protein DME1041 XEOTICID XEO02819 MOACRIVE Inhibition DME1041 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1041 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02820 XEO_CLAS Peptide DME1041 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO02820 GENEFORM Protein DME1041 XEOTICID XEO02820 MOACRIVE Inhibition DME1041 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1041 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02821 XEO_CLAS Peptide DME1041 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02821 GENEFORM Protein DME1041 XEOTICID XEO02821 MOACRIVE Inhibition DME1041 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1041 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02824 XEO_CLAS Peptide DME1041 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 35 microM) DME1041 XEOTICID XEO02824 GENEFORM Protein DME1041 XEOTICID XEO02824 MOACRIVE Inhibition DME1041 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1041 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02826 XEO_CLAS Peptide DME1041 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.7 ug/ml) DME1041 XEOTICID XEO02826 GENEFORM Protein DME1041 XEOTICID XEO02826 MOACRIVE Inhibition DME1041 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1041 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02834 GENEFORM Protein DME1041 XEOTICID XEO02834 MOACRIVE Inhibition DME1041 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1041 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02839 XEO_CLAS Peptide DME1041 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.25 microM) DME1041 XEOTICID XEO02839 GENEFORM Protein DME1041 XEOTICID XEO02839 MOACRIVE Inhibition DME1041 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1041 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02841 XEO_CLAS Peptide DME1041 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.25 microM) DME1041 XEOTICID XEO02841 GENEFORM Protein DME1041 XEOTICID XEO02841 MOACRIVE Inhibition DME1041 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1041 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02842 XEO_CLAS Peptide DME1041 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.25 microM) DME1041 XEOTICID XEO02842 GENEFORM Protein DME1041 XEOTICID XEO02842 MOACRIVE Inhibition DME1041 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1041 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02843 XEO_CLAS Peptide DME1041 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02843 GENEFORM Protein DME1041 XEOTICID XEO02843 MOACRIVE Inhibition DME1041 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1041 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02849 GENEFORM Protein DME1041 XEOTICID XEO02849 MOACRIVE Inhibition DME1041 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1041 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02857 XEO_CLAS Peptide DME1041 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 53 microM) DME1041 XEOTICID XEO02857 GENEFORM Protein DME1041 XEOTICID XEO02857 MOACRIVE Inhibition DME1041 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1041 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02858 XEO_CLAS Peptide DME1041 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 53 microM) DME1041 XEOTICID XEO02858 GENEFORM Protein DME1041 XEOTICID XEO02858 MOACRIVE Inhibition DME1041 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1041 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02860 XEO_CLAS Peptide DME1041 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 ug/ml) DME1041 XEOTICID XEO02860 GENEFORM Protein DME1041 XEOTICID XEO02860 MOACRIVE Inhibition DME1041 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1041 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02867 XEO_CLAS Peptide DME1041 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02867 GENEFORM Protein DME1041 XEOTICID XEO02867 MOACRIVE Inhibition DME1041 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1041 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02868 XEO_CLAS Peptide DME1041 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02868 GENEFORM Protein DME1041 XEOTICID XEO02868 MOACRIVE Inhibition DME1041 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1041 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02869 XEO_CLAS Peptide DME1041 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02869 GENEFORM Protein DME1041 XEOTICID XEO02869 MOACRIVE Inhibition DME1041 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1041 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02870 XEO_CLAS Peptide DME1041 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02870 GENEFORM Protein DME1041 XEOTICID XEO02870 MOACRIVE Inhibition DME1041 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1041 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02871 XEO_CLAS Peptide DME1041 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02871 GENEFORM Protein DME1041 XEOTICID XEO02871 MOACRIVE Inhibition DME1041 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1041 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02872 XEO_CLAS Peptide DME1041 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 308 microM) DME1041 XEOTICID XEO02872 GENEFORM Protein DME1041 XEOTICID XEO02872 MOACRIVE Inhibition DME1041 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1041 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02875 XEO_CLAS Peptide DME1041 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.1 microM) DME1041 XEOTICID XEO02875 GENEFORM Protein DME1041 XEOTICID XEO02875 MOACRIVE Inhibition DME1041 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1041 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02876 XEO_CLAS Peptide DME1041 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO02876 GENEFORM Protein DME1041 XEOTICID XEO02876 MOACRIVE Inhibition DME1041 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1041 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02877 XEO_CLAS Peptide DME1041 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO02877 GENEFORM Protein DME1041 XEOTICID XEO02877 MOACRIVE Inhibition DME1041 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1041 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02878 XEO_CLAS Peptide DME1041 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.3 microM) DME1041 XEOTICID XEO02878 GENEFORM Protein DME1041 XEOTICID XEO02878 MOACRIVE Inhibition DME1041 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1041 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02885 XEO_CLAS Peptide DME1041 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02885 GENEFORM Protein DME1041 XEOTICID XEO02885 MOACRIVE Inhibition DME1041 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1041 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02886 XEO_CLAS Peptide DME1041 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02886 GENEFORM Protein DME1041 XEOTICID XEO02886 MOACRIVE Inhibition DME1041 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1041 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02887 XEO_CLAS Peptide DME1041 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1 ug/ml) DME1041 XEOTICID XEO02887 GENEFORM Protein DME1041 XEOTICID XEO02887 MOACRIVE Inhibition DME1041 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1041 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02888 XEO_CLAS Peptide DME1041 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 ug/ml) DME1041 XEOTICID XEO02888 GENEFORM Protein DME1041 XEOTICID XEO02888 MOACRIVE Inhibition DME1041 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1041 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02889 XEO_CLAS Peptide DME1041 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 ug/ml) DME1041 XEOTICID XEO02889 GENEFORM Protein DME1041 XEOTICID XEO02889 MOACRIVE Inhibition DME1041 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1041 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02890 XEO_CLAS Peptide DME1041 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02890 GENEFORM Protein DME1041 XEOTICID XEO02890 MOACRIVE Inhibition DME1041 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1041 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02891 XEO_CLAS Peptide DME1041 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02891 GENEFORM Protein DME1041 XEOTICID XEO02891 MOACRIVE Inhibition DME1041 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1041 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02895 XEO_CLAS Peptide DME1041 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO02895 GENEFORM Protein DME1041 XEOTICID XEO02895 MOACRIVE Inhibition DME1041 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1041 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02896 XEO_CLAS Peptide DME1041 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO02896 GENEFORM Protein DME1041 XEOTICID XEO02896 MOACRIVE Inhibition DME1041 XEOTICID XEO02899 XEO_NAME Coladonin DME1041 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1041 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1041 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02899 GENEFORM Protein DME1041 XEOTICID XEO02899 MOACRIVE Inhibition DME1041 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1041 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02900 XEO_CLAS Peptide DME1041 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02900 GENEFORM Protein DME1041 XEOTICID XEO02900 MOACRIVE Inhibition DME1041 XEOTICID XEO02901 XEO_NAME Colicin-V DME1041 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02901 XEO_CLAS Peptide DME1041 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02901 GENEFORM Protein DME1041 XEOTICID XEO02901 MOACRIVE Inhibition DME1041 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1041 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02904 GENEFORM Protein DME1041 XEOTICID XEO02904 MOACRIVE Inhibition DME1041 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1041 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02908 XEO_CLAS Peptide DME1041 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 50 microM) DME1041 XEOTICID XEO02908 GENEFORM Protein DME1041 XEOTICID XEO02908 MOACRIVE Inhibition DME1041 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1041 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02923 XEO_CLAS Peptide DME1041 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02923 GENEFORM Protein DME1041 XEOTICID XEO02923 MOACRIVE Inhibition DME1041 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1041 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02924 XEO_CLAS Peptide DME1041 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 32 microM) DME1041 XEOTICID XEO02924 GENEFORM Protein DME1041 XEOTICID XEO02924 MOACRIVE Inhibition DME1041 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1041 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1041 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02927 GENEFORM Protein DME1041 XEOTICID XEO02927 MOACRIVE Inhibition DME1041 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1041 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02931 XEO_CLAS Peptide DME1041 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 ug/ml) DME1041 XEOTICID XEO02931 GENEFORM Protein DME1041 XEOTICID XEO02931 MOACRIVE Inhibition DME1041 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1041 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02933 XEO_CLAS Peptide DME1041 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO02933 GENEFORM Protein DME1041 XEOTICID XEO02933 MOACRIVE Inhibition DME1041 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1041 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02934 XEO_CLAS Peptide DME1041 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02934 GENEFORM Protein DME1041 XEOTICID XEO02934 MOACRIVE Inhibition DME1041 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1041 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02935 XEO_CLAS Peptide DME1041 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02935 GENEFORM Protein DME1041 XEOTICID XEO02935 MOACRIVE Inhibition DME1041 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1041 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02936 XEO_CLAS Peptide DME1041 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO02936 GENEFORM Protein DME1041 XEOTICID XEO02936 MOACRIVE Inhibition DME1041 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1041 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02937 XEO_CLAS Peptide DME1041 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02937 GENEFORM Protein DME1041 XEOTICID XEO02937 MOACRIVE Inhibition DME1041 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1041 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02938 XEO_CLAS Peptide DME1041 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 32 ug/ml) DME1041 XEOTICID XEO02938 GENEFORM Protein DME1041 XEOTICID XEO02938 MOACRIVE Inhibition DME1041 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1041 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02939 XEO_CLAS Peptide DME1041 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 11 ug/ml) DME1041 XEOTICID XEO02939 GENEFORM Protein DME1041 XEOTICID XEO02939 MOACRIVE Inhibition DME1041 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1041 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02940 XEO_CLAS Peptide DME1041 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1 ug/ml) DME1041 XEOTICID XEO02940 GENEFORM Protein DME1041 XEOTICID XEO02940 MOACRIVE Inhibition DME1041 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1041 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02941 XEO_CLAS Peptide DME1041 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02941 GENEFORM Protein DME1041 XEOTICID XEO02941 MOACRIVE Inhibition DME1041 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1041 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02944 XEO_CLAS Peptide DME1041 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 microM) DME1041 XEOTICID XEO02944 GENEFORM Protein DME1041 XEOTICID XEO02944 MOACRIVE Inhibition DME1041 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1041 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02945 XEO_CLAS Peptide DME1041 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 microM) DME1041 XEOTICID XEO02945 GENEFORM Protein DME1041 XEOTICID XEO02945 MOACRIVE Inhibition DME1041 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1041 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02946 XEO_CLAS Peptide DME1041 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 microM) DME1041 XEOTICID XEO02946 GENEFORM Protein DME1041 XEOTICID XEO02946 MOACRIVE Inhibition DME1041 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1041 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02947 XEO_CLAS Peptide DME1041 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02947 GENEFORM Protein DME1041 XEOTICID XEO02947 MOACRIVE Inhibition DME1041 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1041 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02948 XEO_CLAS Peptide DME1041 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO02948 GENEFORM Protein DME1041 XEOTICID XEO02948 MOACRIVE Inhibition DME1041 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1041 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02949 XEO_CLAS Peptide DME1041 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO02949 GENEFORM Protein DME1041 XEOTICID XEO02949 MOACRIVE Inhibition DME1041 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1041 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02954 XEO_CLAS Peptide DME1041 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02954 GENEFORM Protein DME1041 XEOTICID XEO02954 MOACRIVE Inhibition DME1041 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1041 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02958 XEO_CLAS Peptide DME1041 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02958 GENEFORM Protein DME1041 XEOTICID XEO02958 MOACRIVE Inhibition DME1041 XEOTICID XEO02962 XEO_NAME Cryptonin DME1041 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02962 XEO_CLAS Peptide DME1041 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.12 ug/ml) DME1041 XEOTICID XEO02962 GENEFORM Protein DME1041 XEOTICID XEO02962 MOACRIVE Inhibition DME1041 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1041 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02965 XEO_CLAS Peptide DME1041 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 ug/ml) DME1041 XEOTICID XEO02965 GENEFORM Protein DME1041 XEOTICID XEO02965 MOACRIVE Inhibition DME1041 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1041 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02969 XEO_CLAS Peptide DME1041 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 microM) DME1041 XEOTICID XEO02969 GENEFORM Protein DME1041 XEOTICID XEO02969 MOACRIVE Inhibition DME1041 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1041 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02971 XEO_CLAS Peptide DME1041 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 microM) DME1041 XEOTICID XEO02971 GENEFORM Protein DME1041 XEOTICID XEO02971 MOACRIVE Inhibition DME1041 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1041 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO02972 XEO_CLAS Peptide DME1041 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.4 microM) DME1041 XEOTICID XEO02972 GENEFORM Protein DME1041 XEOTICID XEO02972 MOACRIVE Inhibition DME1041 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1041 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02990 GENEFORM Protein DME1041 XEOTICID XEO02990 MOACRIVE Inhibition DME1041 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1041 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02991 GENEFORM Protein DME1041 XEOTICID XEO02991 MOACRIVE Inhibition DME1041 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1041 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02992 GENEFORM Protein DME1041 XEOTICID XEO02992 MOACRIVE Inhibition DME1041 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1041 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02993 GENEFORM Protein DME1041 XEOTICID XEO02993 MOACRIVE Inhibition DME1041 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1041 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02994 GENEFORM Protein DME1041 XEOTICID XEO02994 MOACRIVE Inhibition DME1041 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1041 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02995 GENEFORM Protein DME1041 XEOTICID XEO02995 MOACRIVE Inhibition DME1041 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1041 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02996 GENEFORM Protein DME1041 XEOTICID XEO02996 MOACRIVE Inhibition DME1041 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1041 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02997 GENEFORM Protein DME1041 XEOTICID XEO02997 MOACRIVE Inhibition DME1041 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1041 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02998 GENEFORM Protein DME1041 XEOTICID XEO02998 MOACRIVE Inhibition DME1041 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1041 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1041 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO02999 GENEFORM Protein DME1041 XEOTICID XEO02999 MOACRIVE Inhibition DME1041 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1041 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03021 XEO_CLAS Peptide DME1041 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.31-0.63 microM) DME1041 XEOTICID XEO03021 GENEFORM Protein DME1041 XEOTICID XEO03021 MOACRIVE Inhibition DME1041 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1041 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03029 XEO_CLAS Peptide DME1041 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.005 microM) DME1041 XEOTICID XEO03029 GENEFORM Protein DME1041 XEOTICID XEO03029 MOACRIVE Inhibition DME1041 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1041 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03030 XEO_CLAS Peptide DME1041 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.005 microM) DME1041 XEOTICID XEO03030 GENEFORM Protein DME1041 XEOTICID XEO03030 MOACRIVE Inhibition DME1041 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1041 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03031 XEO_CLAS Peptide DME1041 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.3 microM) DME1041 XEOTICID XEO03031 GENEFORM Protein DME1041 XEOTICID XEO03031 MOACRIVE Inhibition DME1041 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1041 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03032 XEO_CLAS Peptide DME1041 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.01 microM) DME1041 XEOTICID XEO03032 GENEFORM Protein DME1041 XEOTICID XEO03032 MOACRIVE Inhibition DME1041 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1041 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03033 XEO_CLAS Peptide DME1041 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.173 microM) DME1041 XEOTICID XEO03033 GENEFORM Protein DME1041 XEOTICID XEO03033 MOACRIVE Inhibition DME1041 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1041 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03034 XEO_CLAS Peptide DME1041 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.518 microM) DME1041 XEOTICID XEO03034 GENEFORM Protein DME1041 XEOTICID XEO03034 MOACRIVE Inhibition DME1041 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1041 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03035 XEO_CLAS Peptide DME1041 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.114 microM) DME1041 XEOTICID XEO03035 GENEFORM Protein DME1041 XEOTICID XEO03035 MOACRIVE Inhibition DME1041 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1041 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03039 XEO_CLAS Peptide DME1041 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.55 microM) DME1041 XEOTICID XEO03039 GENEFORM Protein DME1041 XEOTICID XEO03039 MOACRIVE Inhibition DME1041 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1041 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03043 XEO_CLAS Peptide DME1041 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 microM) DME1041 XEOTICID XEO03043 GENEFORM Protein DME1041 XEOTICID XEO03043 MOACRIVE Inhibition DME1041 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1041 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03044 XEO_CLAS Peptide DME1041 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03044 GENEFORM Protein DME1041 XEOTICID XEO03044 MOACRIVE Inhibition DME1041 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1041 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03045 XEO_CLAS Peptide DME1041 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03045 GENEFORM Protein DME1041 XEOTICID XEO03045 MOACRIVE Inhibition DME1041 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1041 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03046 XEO_CLAS Peptide DME1041 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03046 GENEFORM Protein DME1041 XEOTICID XEO03046 MOACRIVE Inhibition DME1041 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1041 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03049 XEO_CLAS Peptide DME1041 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 microM) DME1041 XEOTICID XEO03049 GENEFORM Protein DME1041 XEOTICID XEO03049 MOACRIVE Inhibition DME1041 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1041 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03055 XEO_CLAS Peptide DME1041 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 microM) DME1041 XEOTICID XEO03055 GENEFORM Protein DME1041 XEOTICID XEO03055 MOACRIVE Inhibition DME1041 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1041 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03059 XEO_CLAS Peptide DME1041 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO03059 GENEFORM Protein DME1041 XEOTICID XEO03059 MOACRIVE Inhibition DME1041 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1041 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03060 XEO_CLAS Peptide DME1041 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO03060 GENEFORM Protein DME1041 XEOTICID XEO03060 MOACRIVE Inhibition DME1041 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1041 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03062 XEO_CLAS Peptide DME1041 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO03062 GENEFORM Protein DME1041 XEOTICID XEO03062 MOACRIVE Inhibition DME1041 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1041 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03064 XEO_CLAS Peptide DME1041 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO03064 GENEFORM Protein DME1041 XEOTICID XEO03064 MOACRIVE Inhibition DME1041 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1041 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03066 XEO_CLAS Peptide DME1041 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO03066 GENEFORM Protein DME1041 XEOTICID XEO03066 MOACRIVE Inhibition DME1041 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1041 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03068 XEO_CLAS Peptide DME1041 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO03068 GENEFORM Protein DME1041 XEOTICID XEO03068 MOACRIVE Inhibition DME1041 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1041 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03073 XEO_CLAS Peptide DME1041 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8-16 ug/ml) DME1041 XEOTICID XEO03073 GENEFORM Protein DME1041 XEOTICID XEO03073 MOACRIVE Inhibition DME1041 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1041 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03081 XEO_CLAS Peptide DME1041 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 microM) DME1041 XEOTICID XEO03081 GENEFORM Protein DME1041 XEOTICID XEO03081 MOACRIVE Inhibition DME1041 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1041 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03082 XEO_CLAS Peptide DME1041 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03082 GENEFORM Protein DME1041 XEOTICID XEO03082 MOACRIVE Inhibition DME1041 XEOTICID XEO03089 XEO_NAME Decoralin DME1041 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03089 XEO_CLAS Peptide DME1041 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 160 microM) DME1041 XEOTICID XEO03089 GENEFORM Protein DME1041 XEOTICID XEO03089 MOACRIVE Inhibition DME1041 XEOTICID XEO03098 XEO_NAME Insect defensin DME1041 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03098 XEO_CLAS Peptide DME1041 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 ug/ml) DME1041 XEOTICID XEO03098 GENEFORM Protein DME1041 XEOTICID XEO03098 MOACRIVE Inhibition DME1041 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1041 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03100 XEO_CLAS Peptide DME1041 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03100 GENEFORM Protein DME1041 XEOTICID XEO03100 MOACRIVE Inhibition DME1041 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1041 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03103 XEO_CLAS Peptide DME1041 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03103 GENEFORM Protein DME1041 XEOTICID XEO03103 MOACRIVE Inhibition DME1041 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1041 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03105 XEO_CLAS Peptide DME1041 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03105 GENEFORM Protein DME1041 XEOTICID XEO03105 MOACRIVE Inhibition DME1041 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1041 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03110 XEO_CLAS Peptide DME1041 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.2 microM) DME1041 XEOTICID XEO03110 GENEFORM Protein DME1041 XEOTICID XEO03110 MOACRIVE Inhibition DME1041 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1041 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03111 XEO_CLAS Peptide DME1041 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03111 GENEFORM Protein DME1041 XEOTICID XEO03111 MOACRIVE Inhibition DME1041 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1041 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03112 XEO_CLAS Peptide DME1041 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 50 ug/ml) DME1041 XEOTICID XEO03112 GENEFORM Protein DME1041 XEOTICID XEO03112 MOACRIVE Inhibition DME1041 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1041 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03115 XEO_CLAS Peptide DME1041 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03115 GENEFORM Protein DME1041 XEOTICID XEO03115 MOACRIVE Inhibition DME1041 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1041 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03116 XEO_CLAS Peptide DME1041 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 40 microM) DME1041 XEOTICID XEO03116 GENEFORM Protein DME1041 XEOTICID XEO03116 MOACRIVE Inhibition DME1041 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1041 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03118 XEO_CLAS Peptide DME1041 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03118 GENEFORM Protein DME1041 XEOTICID XEO03118 MOACRIVE Inhibition DME1041 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1041 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03119 XEO_CLAS Peptide DME1041 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03119 GENEFORM Protein DME1041 XEOTICID XEO03119 MOACRIVE Inhibition DME1041 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1041 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03121 XEO_CLAS Peptide DME1041 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03121 GENEFORM Protein DME1041 XEOTICID XEO03121 MOACRIVE Inhibition DME1041 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1041 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03122 XEO_CLAS Peptide DME1041 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64000 ug/ml) DME1041 XEOTICID XEO03122 GENEFORM Protein DME1041 XEOTICID XEO03122 MOACRIVE Inhibition DME1041 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1041 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03124 XEO_CLAS Peptide DME1041 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03124 GENEFORM Protein DME1041 XEOTICID XEO03124 MOACRIVE Inhibition DME1041 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1041 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03125 XEO_CLAS Peptide DME1041 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03125 GENEFORM Protein DME1041 XEOTICID XEO03125 MOACRIVE Inhibition DME1041 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1041 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03126 XEO_CLAS Peptide DME1041 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.86 microM) DME1041 XEOTICID XEO03126 GENEFORM Protein DME1041 XEOTICID XEO03126 MOACRIVE Inhibition DME1041 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1041 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03127 XEO_CLAS Peptide DME1041 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03127 GENEFORM Protein DME1041 XEOTICID XEO03127 MOACRIVE Inhibition DME1041 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1041 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03128 XEO_CLAS Peptide DME1041 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 256 ug/ml) DME1041 XEOTICID XEO03128 GENEFORM Protein DME1041 XEOTICID XEO03128 MOACRIVE Inhibition DME1041 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1041 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03129 XEO_CLAS Peptide DME1041 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 256 ug/ml) DME1041 XEOTICID XEO03129 GENEFORM Protein DME1041 XEOTICID XEO03129 MOACRIVE Inhibition DME1041 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1041 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03130 XEO_CLAS Peptide DME1041 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 256 ug/ml) DME1041 XEOTICID XEO03130 GENEFORM Protein DME1041 XEOTICID XEO03130 MOACRIVE Inhibition DME1041 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1041 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03131 XEO_CLAS Peptide DME1041 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 256 ug/ml) DME1041 XEOTICID XEO03131 GENEFORM Protein DME1041 XEOTICID XEO03131 MOACRIVE Inhibition DME1041 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1041 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03132 XEO_CLAS Peptide DME1041 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 256 ug/ml) DME1041 XEOTICID XEO03132 GENEFORM Protein DME1041 XEOTICID XEO03132 MOACRIVE Inhibition DME1041 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1041 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03137 XEO_CLAS Peptide DME1041 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03137 GENEFORM Protein DME1041 XEOTICID XEO03137 MOACRIVE Inhibition DME1041 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1041 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03143 XEO_CLAS Peptide DME1041 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.6 microM) DME1041 XEOTICID XEO03143 GENEFORM Protein DME1041 XEOTICID XEO03143 MOACRIVE Inhibition DME1041 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1041 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03145 XEO_CLAS Peptide DME1041 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.6 microM) DME1041 XEOTICID XEO03145 GENEFORM Protein DME1041 XEOTICID XEO03145 MOACRIVE Inhibition DME1041 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1041 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03146 XEO_CLAS Peptide DME1041 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.5 microM) DME1041 XEOTICID XEO03146 GENEFORM Protein DME1041 XEOTICID XEO03146 MOACRIVE Inhibition DME1041 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1041 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03147 XEO_CLAS Peptide DME1041 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9.7 microM) DME1041 XEOTICID XEO03147 GENEFORM Protein DME1041 XEOTICID XEO03147 MOACRIVE Inhibition DME1041 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1041 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03148 XEO_CLAS Peptide DME1041 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.3 microM) DME1041 XEOTICID XEO03148 GENEFORM Protein DME1041 XEOTICID XEO03148 MOACRIVE Inhibition DME1041 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1041 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03149 XEO_CLAS Peptide DME1041 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.6 microM) DME1041 XEOTICID XEO03149 GENEFORM Protein DME1041 XEOTICID XEO03149 MOACRIVE Inhibition DME1041 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1041 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03150 XEO_CLAS Peptide DME1041 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9-3 microM) DME1041 XEOTICID XEO03150 GENEFORM Protein DME1041 XEOTICID XEO03150 MOACRIVE Inhibition DME1041 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1041 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03151 XEO_CLAS Peptide DME1041 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 ug/ml) DME1041 XEOTICID XEO03151 GENEFORM Protein DME1041 XEOTICID XEO03151 MOACRIVE Inhibition DME1041 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1041 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03152 XEO_CLAS Peptide DME1041 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO03152 GENEFORM Protein DME1041 XEOTICID XEO03152 MOACRIVE Inhibition DME1041 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1041 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03155 XEO_CLAS Peptide DME1041 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.4 microM) DME1041 XEOTICID XEO03155 GENEFORM Protein DME1041 XEOTICID XEO03155 MOACRIVE Inhibition DME1041 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1041 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03156 XEO_CLAS Peptide DME1041 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.3 microM) DME1041 XEOTICID XEO03156 GENEFORM Protein DME1041 XEOTICID XEO03156 MOACRIVE Inhibition DME1041 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1041 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03157 XEO_CLAS Peptide DME1041 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.3 microM) DME1041 XEOTICID XEO03157 GENEFORM Protein DME1041 XEOTICID XEO03157 MOACRIVE Inhibition DME1041 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1041 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03158 XEO_CLAS Peptide DME1041 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 ug/ml) DME1041 XEOTICID XEO03158 GENEFORM Protein DME1041 XEOTICID XEO03158 MOACRIVE Inhibition DME1041 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1041 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03159 XEO_CLAS Peptide DME1041 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03159 GENEFORM Protein DME1041 XEOTICID XEO03159 MOACRIVE Inhibition DME1041 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1041 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03161 XEO_CLAS Peptide DME1041 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 microM) DME1041 XEOTICID XEO03161 GENEFORM Protein DME1041 XEOTICID XEO03161 MOACRIVE Inhibition DME1041 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1041 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03162 XEO_CLAS Peptide DME1041 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.5 microM) DME1041 XEOTICID XEO03162 GENEFORM Protein DME1041 XEOTICID XEO03162 MOACRIVE Inhibition DME1041 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1041 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03169 XEO_CLAS Peptide DME1041 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO03169 GENEFORM Protein DME1041 XEOTICID XEO03169 MOACRIVE Inhibition DME1041 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1041 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03193 XEO_CLAS Peptide DME1041 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25 ug/ml) DME1041 XEOTICID XEO03193 GENEFORM Protein DME1041 XEOTICID XEO03193 MOACRIVE Inhibition DME1041 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1041 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03194 XEO_CLAS Peptide DME1041 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03194 GENEFORM Protein DME1041 XEOTICID XEO03194 MOACRIVE Inhibition DME1041 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1041 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03195 XEO_CLAS Peptide DME1041 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03195 GENEFORM Protein DME1041 XEOTICID XEO03195 MOACRIVE Inhibition DME1041 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1041 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03197 XEO_CLAS Peptide DME1041 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 14.5 microM) DME1041 XEOTICID XEO03197 GENEFORM Protein DME1041 XEOTICID XEO03197 MOACRIVE Inhibition DME1041 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1041 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03202 XEO_CLAS Peptide DME1041 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.51 microM) DME1041 XEOTICID XEO03202 GENEFORM Protein DME1041 XEOTICID XEO03202 MOACRIVE Inhibition DME1041 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1041 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03203 XEO_CLAS Peptide DME1041 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.62 microM) DME1041 XEOTICID XEO03203 GENEFORM Protein DME1041 XEOTICID XEO03203 MOACRIVE Inhibition DME1041 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1041 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03204 XEO_CLAS Peptide DME1041 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.38 microM) DME1041 XEOTICID XEO03204 GENEFORM Protein DME1041 XEOTICID XEO03204 MOACRIVE Inhibition DME1041 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1041 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03205 XEO_CLAS Peptide DME1041 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.29 microM) DME1041 XEOTICID XEO03205 GENEFORM Protein DME1041 XEOTICID XEO03205 MOACRIVE Inhibition DME1041 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1041 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03206 XEO_CLAS Peptide DME1041 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.40 microM) DME1041 XEOTICID XEO03206 GENEFORM Protein DME1041 XEOTICID XEO03206 MOACRIVE Inhibition DME1041 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1041 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03207 XEO_CLAS Peptide DME1041 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.58 microM) DME1041 XEOTICID XEO03207 GENEFORM Protein DME1041 XEOTICID XEO03207 MOACRIVE Inhibition DME1041 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1041 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03208 XEO_CLAS Peptide DME1041 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.76 microM) DME1041 XEOTICID XEO03208 GENEFORM Protein DME1041 XEOTICID XEO03208 MOACRIVE Inhibition DME1041 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1041 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03209 XEO_CLAS Peptide DME1041 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.49 microM) DME1041 XEOTICID XEO03209 GENEFORM Protein DME1041 XEOTICID XEO03209 MOACRIVE Inhibition DME1041 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1041 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03210 XEO_CLAS Peptide DME1041 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 7.07 microM) DME1041 XEOTICID XEO03210 GENEFORM Protein DME1041 XEOTICID XEO03210 MOACRIVE Inhibition DME1041 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1041 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03211 XEO_CLAS Peptide DME1041 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.40 microM) DME1041 XEOTICID XEO03211 GENEFORM Protein DME1041 XEOTICID XEO03211 MOACRIVE Inhibition DME1041 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1041 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03215 XEO_CLAS Peptide DME1041 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20.0 ug/ml) DME1041 XEOTICID XEO03215 GENEFORM Protein DME1041 XEOTICID XEO03215 MOACRIVE Inhibition DME1041 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1041 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03216 XEO_CLAS Peptide DME1041 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO03216 GENEFORM Protein DME1041 XEOTICID XEO03216 MOACRIVE Inhibition DME1041 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1041 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03217 XEO_CLAS Peptide DME1041 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO03217 GENEFORM Protein DME1041 XEOTICID XEO03217 MOACRIVE Inhibition DME1041 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1041 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03223 XEO_CLAS Peptide DME1041 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.8 microM) DME1041 XEOTICID XEO03223 GENEFORM Protein DME1041 XEOTICID XEO03223 MOACRIVE Inhibition DME1041 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1041 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03224 XEO_CLAS Peptide DME1041 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.1-0.25 microM) DME1041 XEOTICID XEO03224 GENEFORM Protein DME1041 XEOTICID XEO03224 MOACRIVE Inhibition DME1041 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1041 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03225 XEO_CLAS Peptide DME1041 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.3 microM) DME1041 XEOTICID XEO03225 GENEFORM Protein DME1041 XEOTICID XEO03225 MOACRIVE Inhibition DME1041 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1041 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03227 XEO_CLAS Peptide DME1041 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.3 microM) DME1041 XEOTICID XEO03227 GENEFORM Protein DME1041 XEOTICID XEO03227 MOACRIVE Inhibition DME1041 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1041 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03231 XEO_CLAS Peptide DME1041 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03231 GENEFORM Protein DME1041 XEOTICID XEO03231 MOACRIVE Inhibition DME1041 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1041 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03232 XEO_CLAS Peptide DME1041 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03232 GENEFORM Protein DME1041 XEOTICID XEO03232 MOACRIVE Inhibition DME1041 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1041 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03234 XEO_CLAS Peptide DME1041 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO03234 GENEFORM Protein DME1041 XEOTICID XEO03234 MOACRIVE Inhibition DME1041 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1041 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03235 XEO_CLAS Peptide DME1041 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 60 ug/ml) DME1041 XEOTICID XEO03235 GENEFORM Protein DME1041 XEOTICID XEO03235 MOACRIVE Inhibition DME1041 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1041 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03236 XEO_CLAS Peptide DME1041 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO03236 GENEFORM Protein DME1041 XEOTICID XEO03236 MOACRIVE Inhibition DME1041 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1041 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03237 XEO_CLAS Peptide DME1041 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 ug/ml) DME1041 XEOTICID XEO03237 GENEFORM Protein DME1041 XEOTICID XEO03237 MOACRIVE Inhibition DME1041 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1041 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03238 XEO_CLAS Peptide DME1041 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 ug/ml) DME1041 XEOTICID XEO03238 GENEFORM Protein DME1041 XEOTICID XEO03238 MOACRIVE Inhibition DME1041 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1041 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03239 XEO_CLAS Peptide DME1041 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 60 ug/ml) DME1041 XEOTICID XEO03239 GENEFORM Protein DME1041 XEOTICID XEO03239 MOACRIVE Inhibition DME1041 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1041 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03241 XEO_CLAS Peptide DME1041 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 128 microM) DME1041 XEOTICID XEO03241 GENEFORM Protein DME1041 XEOTICID XEO03241 MOACRIVE Inhibition DME1041 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1041 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03250 XEO_CLAS Peptide DME1041 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03250 GENEFORM Protein DME1041 XEOTICID XEO03250 MOACRIVE Inhibition DME1041 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1041 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03251 XEO_CLAS Peptide DME1041 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03251 GENEFORM Protein DME1041 XEOTICID XEO03251 MOACRIVE Inhibition DME1041 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1041 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03253 XEO_CLAS Peptide DME1041 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.1 ug/ml) DME1041 XEOTICID XEO03253 GENEFORM Protein DME1041 XEOTICID XEO03253 MOACRIVE Inhibition DME1041 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1041 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03274 XEO_CLAS Peptide DME1041 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.2 microM) DME1041 XEOTICID XEO03274 GENEFORM Protein DME1041 XEOTICID XEO03274 MOACRIVE Inhibition DME1041 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1041 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03275 XEO_CLAS Peptide DME1041 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO03275 GENEFORM Protein DME1041 XEOTICID XEO03275 MOACRIVE Inhibition DME1041 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1041 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03276 XEO_CLAS Peptide DME1041 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO03276 GENEFORM Protein DME1041 XEOTICID XEO03276 MOACRIVE Inhibition DME1041 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1041 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03277 XEO_CLAS Peptide DME1041 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.2 microM) DME1041 XEOTICID XEO03277 GENEFORM Protein DME1041 XEOTICID XEO03277 MOACRIVE Inhibition DME1041 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1041 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03278 XEO_CLAS Peptide DME1041 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO03278 GENEFORM Protein DME1041 XEOTICID XEO03278 MOACRIVE Inhibition DME1041 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1041 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03279 XEO_CLAS Peptide DME1041 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO03279 GENEFORM Protein DME1041 XEOTICID XEO03279 MOACRIVE Inhibition DME1041 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1041 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03280 XEO_CLAS Peptide DME1041 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 microM) DME1041 XEOTICID XEO03280 GENEFORM Protein DME1041 XEOTICID XEO03280 MOACRIVE Inhibition DME1041 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1041 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03281 XEO_CLAS Peptide DME1041 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.3 microM) DME1041 XEOTICID XEO03281 GENEFORM Protein DME1041 XEOTICID XEO03281 MOACRIVE Inhibition DME1041 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1041 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03282 XEO_CLAS Peptide DME1041 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.1 microM) DME1041 XEOTICID XEO03282 GENEFORM Protein DME1041 XEOTICID XEO03282 MOACRIVE Inhibition DME1041 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1041 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03283 XEO_CLAS Peptide DME1041 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 microM) DME1041 XEOTICID XEO03283 GENEFORM Protein DME1041 XEOTICID XEO03283 MOACRIVE Inhibition DME1041 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1041 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03284 XEO_CLAS Peptide DME1041 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.2 ug/ml) DME1041 XEOTICID XEO03284 GENEFORM Protein DME1041 XEOTICID XEO03284 MOACRIVE Inhibition DME1041 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1041 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03285 XEO_CLAS Peptide DME1041 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.5 ug/ml) DME1041 XEOTICID XEO03285 GENEFORM Protein DME1041 XEOTICID XEO03285 MOACRIVE Inhibition DME1041 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1041 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03286 XEO_CLAS Peptide DME1041 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.4 ug/ml) DME1041 XEOTICID XEO03286 GENEFORM Protein DME1041 XEOTICID XEO03286 MOACRIVE Inhibition DME1041 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1041 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03287 XEO_CLAS Peptide DME1041 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.6 ug/ml) DME1041 XEOTICID XEO03287 GENEFORM Protein DME1041 XEOTICID XEO03287 MOACRIVE Inhibition DME1041 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1041 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03288 XEO_CLAS Peptide DME1041 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.4 ug/ml) DME1041 XEOTICID XEO03288 GENEFORM Protein DME1041 XEOTICID XEO03288 MOACRIVE Inhibition DME1041 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1041 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03289 XEO_CLAS Peptide DME1041 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8.8 ug/ml) DME1041 XEOTICID XEO03289 GENEFORM Protein DME1041 XEOTICID XEO03289 MOACRIVE Inhibition DME1041 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1041 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03290 XEO_CLAS Peptide DME1041 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.5 ug/ml) DME1041 XEOTICID XEO03290 GENEFORM Protein DME1041 XEOTICID XEO03290 MOACRIVE Inhibition DME1041 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1041 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03291 XEO_CLAS Peptide DME1041 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8.6 ug/ml) DME1041 XEOTICID XEO03291 GENEFORM Protein DME1041 XEOTICID XEO03291 MOACRIVE Inhibition DME1041 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1041 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03292 XEO_CLAS Peptide DME1041 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4.1 ug/ml) DME1041 XEOTICID XEO03292 GENEFORM Protein DME1041 XEOTICID XEO03292 MOACRIVE Inhibition DME1041 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1041 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03293 XEO_CLAS Peptide DME1041 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1 microM) DME1041 XEOTICID XEO03293 GENEFORM Protein DME1041 XEOTICID XEO03293 MOACRIVE Inhibition DME1041 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1041 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03294 XEO_CLAS Peptide DME1041 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1 microM) DME1041 XEOTICID XEO03294 GENEFORM Protein DME1041 XEOTICID XEO03294 MOACRIVE Inhibition DME1041 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1041 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03295 XEO_CLAS Peptide DME1041 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.7 microM) DME1041 XEOTICID XEO03295 GENEFORM Protein DME1041 XEOTICID XEO03295 MOACRIVE Inhibition DME1041 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1041 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03296 XEO_CLAS Peptide DME1041 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03296 GENEFORM Protein DME1041 XEOTICID XEO03296 MOACRIVE Inhibition DME1041 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1041 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03297 XEO_CLAS Peptide DME1041 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03297 GENEFORM Protein DME1041 XEOTICID XEO03297 MOACRIVE Inhibition DME1041 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1041 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03298 XEO_CLAS Peptide DME1041 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.2 microM) DME1041 XEOTICID XEO03298 GENEFORM Protein DME1041 XEOTICID XEO03298 MOACRIVE Inhibition DME1041 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1041 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03299 XEO_CLAS Peptide DME1041 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.4 microM) DME1041 XEOTICID XEO03299 GENEFORM Protein DME1041 XEOTICID XEO03299 MOACRIVE Inhibition DME1041 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1041 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03300 XEO_CLAS Peptide DME1041 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 ug/ml) DME1041 XEOTICID XEO03300 GENEFORM Protein DME1041 XEOTICID XEO03300 MOACRIVE Inhibition DME1041 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1041 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03301 XEO_CLAS Peptide DME1041 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 ug/ml) DME1041 XEOTICID XEO03301 GENEFORM Protein DME1041 XEOTICID XEO03301 MOACRIVE Inhibition DME1041 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1041 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03302 XEO_CLAS Peptide DME1041 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1 microM) DME1041 XEOTICID XEO03302 GENEFORM Protein DME1041 XEOTICID XEO03302 MOACRIVE Inhibition DME1041 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1041 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03303 XEO_CLAS Peptide DME1041 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 microM) DME1041 XEOTICID XEO03303 GENEFORM Protein DME1041 XEOTICID XEO03303 MOACRIVE Inhibition DME1041 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1041 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03304 XEO_CLAS Peptide DME1041 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO03304 GENEFORM Protein DME1041 XEOTICID XEO03304 MOACRIVE Inhibition DME1041 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1041 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03305 XEO_CLAS Peptide DME1041 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 microM) DME1041 XEOTICID XEO03305 GENEFORM Protein DME1041 XEOTICID XEO03305 MOACRIVE Inhibition DME1041 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1041 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03306 XEO_CLAS Peptide DME1041 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO03306 GENEFORM Protein DME1041 XEOTICID XEO03306 MOACRIVE Inhibition DME1041 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1041 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03307 XEO_CLAS Peptide DME1041 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 34 ug/ml) DME1041 XEOTICID XEO03307 GENEFORM Protein DME1041 XEOTICID XEO03307 MOACRIVE Inhibition DME1041 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1041 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03308 XEO_CLAS Peptide DME1041 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO03308 GENEFORM Protein DME1041 XEOTICID XEO03308 MOACRIVE Inhibition DME1041 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1041 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03310 XEO_CLAS Peptide DME1041 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8.5 ug/ml) DME1041 XEOTICID XEO03310 GENEFORM Protein DME1041 XEOTICID XEO03310 MOACRIVE Inhibition DME1041 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1041 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03311 XEO_CLAS Peptide DME1041 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10.8 ug/ml) DME1041 XEOTICID XEO03311 GENEFORM Protein DME1041 XEOTICID XEO03311 MOACRIVE Inhibition DME1041 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1041 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03312 XEO_CLAS Peptide DME1041 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10.8 ug/ml) DME1041 XEOTICID XEO03312 GENEFORM Protein DME1041 XEOTICID XEO03312 MOACRIVE Inhibition DME1041 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1041 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03313 XEO_CLAS Peptide DME1041 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8.1 ug/ml) DME1041 XEOTICID XEO03313 GENEFORM Protein DME1041 XEOTICID XEO03313 MOACRIVE Inhibition DME1041 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1041 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03314 XEO_CLAS Peptide DME1041 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 7.9 ug/ml) DME1041 XEOTICID XEO03314 GENEFORM Protein DME1041 XEOTICID XEO03314 MOACRIVE Inhibition DME1041 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1041 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03315 XEO_CLAS Peptide DME1041 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.6 ug/ml) DME1041 XEOTICID XEO03315 GENEFORM Protein DME1041 XEOTICID XEO03315 MOACRIVE Inhibition DME1041 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1041 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03316 XEO_CLAS Peptide DME1041 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15.8 ug/ml) DME1041 XEOTICID XEO03316 GENEFORM Protein DME1041 XEOTICID XEO03316 MOACRIVE Inhibition DME1041 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1041 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03317 XEO_CLAS Peptide DME1041 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO03317 GENEFORM Protein DME1041 XEOTICID XEO03317 MOACRIVE Inhibition DME1041 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1041 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03318 XEO_CLAS Peptide DME1041 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1 microM) DME1041 XEOTICID XEO03318 GENEFORM Protein DME1041 XEOTICID XEO03318 MOACRIVE Inhibition DME1041 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1041 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03319 XEO_CLAS Peptide DME1041 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03319 GENEFORM Protein DME1041 XEOTICID XEO03319 MOACRIVE Inhibition DME1041 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1041 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03320 XEO_CLAS Peptide DME1041 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.1 microM) DME1041 XEOTICID XEO03320 GENEFORM Protein DME1041 XEOTICID XEO03320 MOACRIVE Inhibition DME1041 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1041 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03321 XEO_CLAS Peptide DME1041 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.8 microM) DME1041 XEOTICID XEO03321 GENEFORM Protein DME1041 XEOTICID XEO03321 MOACRIVE Inhibition DME1041 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1041 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1041 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03348 GENEFORM Protein DME1041 XEOTICID XEO03348 MOACRIVE Inhibition DME1041 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1041 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03362 XEO_CLAS Peptide DME1041 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO03362 GENEFORM Protein DME1041 XEOTICID XEO03362 MOACRIVE Inhibition DME1041 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1041 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03363 XEO_CLAS Peptide DME1041 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 microM) DME1041 XEOTICID XEO03363 GENEFORM Protein DME1041 XEOTICID XEO03363 MOACRIVE Inhibition DME1041 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1041 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03364 XEO_CLAS Peptide DME1041 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 microM) DME1041 XEOTICID XEO03364 GENEFORM Protein DME1041 XEOTICID XEO03364 MOACRIVE Inhibition DME1041 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1041 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03365 XEO_CLAS Peptide DME1041 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03365 GENEFORM Protein DME1041 XEOTICID XEO03365 MOACRIVE Inhibition DME1041 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1041 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03366 XEO_CLAS Peptide DME1041 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO03366 GENEFORM Protein DME1041 XEOTICID XEO03366 MOACRIVE Inhibition DME1041 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1041 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03367 XEO_CLAS Peptide DME1041 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 microM) DME1041 XEOTICID XEO03367 GENEFORM Protein DME1041 XEOTICID XEO03367 MOACRIVE Inhibition DME1041 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1041 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03368 XEO_CLAS Peptide DME1041 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 microM) DME1041 XEOTICID XEO03368 GENEFORM Protein DME1041 XEOTICID XEO03368 MOACRIVE Inhibition DME1041 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1041 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03379 XEO_CLAS Peptide DME1041 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.6 ug/ml) DME1041 XEOTICID XEO03379 GENEFORM Protein DME1041 XEOTICID XEO03379 MOACRIVE Inhibition DME1041 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1041 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03396 XEO_CLAS Peptide DME1041 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03396 GENEFORM Protein DME1041 XEOTICID XEO03396 MOACRIVE Inhibition DME1041 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1041 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03398 XEO_CLAS Peptide DME1041 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03398 GENEFORM Protein DME1041 XEOTICID XEO03398 MOACRIVE Inhibition DME1041 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1041 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03399 XEO_CLAS Peptide DME1041 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03399 GENEFORM Protein DME1041 XEOTICID XEO03399 MOACRIVE Inhibition DME1041 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1041 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03406 XEO_CLAS Peptide DME1041 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 ug/ml) DME1041 XEOTICID XEO03406 GENEFORM Protein DME1041 XEOTICID XEO03406 MOACRIVE Inhibition DME1041 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1041 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03424 XEO_CLAS Peptide DME1041 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03424 GENEFORM Protein DME1041 XEOTICID XEO03424 MOACRIVE Inhibition DME1041 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1041 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03426 XEO_CLAS Peptide DME1041 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO03426 GENEFORM Protein DME1041 XEOTICID XEO03426 MOACRIVE Inhibition DME1041 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1041 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03427 XEO_CLAS Peptide DME1041 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 microM) DME1041 XEOTICID XEO03427 GENEFORM Protein DME1041 XEOTICID XEO03427 MOACRIVE Inhibition DME1041 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1041 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03428 XEO_CLAS Peptide DME1041 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 ug/ml) DME1041 XEOTICID XEO03428 GENEFORM Protein DME1041 XEOTICID XEO03428 MOACRIVE Inhibition DME1041 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1041 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03430 XEO_CLAS Peptide DME1041 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 ug/ml) DME1041 XEOTICID XEO03430 GENEFORM Protein DME1041 XEOTICID XEO03430 MOACRIVE Inhibition DME1041 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1041 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03434 XEO_CLAS Peptide DME1041 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO03434 GENEFORM Protein DME1041 XEOTICID XEO03434 MOACRIVE Inhibition DME1041 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1041 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03442 XEO_CLAS Peptide DME1041 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 18.75 ug/ml) DME1041 XEOTICID XEO03442 GENEFORM Protein DME1041 XEOTICID XEO03442 MOACRIVE Inhibition DME1041 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1041 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03444 XEO_CLAS Peptide DME1041 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 37.50 ug/ml) DME1041 XEOTICID XEO03444 GENEFORM Protein DME1041 XEOTICID XEO03444 MOACRIVE Inhibition DME1041 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1041 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03459 XEO_CLAS Peptide DME1041 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03459 GENEFORM Protein DME1041 XEOTICID XEO03459 MOACRIVE Inhibition DME1041 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1041 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03460 XEO_CLAS Peptide DME1041 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03460 GENEFORM Protein DME1041 XEOTICID XEO03460 MOACRIVE Inhibition DME1041 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1041 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03461 XEO_CLAS Peptide DME1041 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.05 microM) DME1041 XEOTICID XEO03461 GENEFORM Protein DME1041 XEOTICID XEO03461 MOACRIVE Inhibition DME1041 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1041 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03462 XEO_CLAS Peptide DME1041 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03462 GENEFORM Protein DME1041 XEOTICID XEO03462 MOACRIVE Inhibition DME1041 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1041 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03463 XEO_CLAS Peptide DME1041 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03463 GENEFORM Protein DME1041 XEOTICID XEO03463 MOACRIVE Inhibition DME1041 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1041 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03467 XEO_CLAS Peptide DME1041 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03467 GENEFORM Protein DME1041 XEOTICID XEO03467 MOACRIVE Inhibition DME1041 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1041 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03468 XEO_CLAS Peptide DME1041 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03468 GENEFORM Protein DME1041 XEOTICID XEO03468 MOACRIVE Inhibition DME1041 XEOTICID XEO03471 XEO_NAME Gambicin DME1041 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03471 XEO_CLAS Peptide DME1041 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25-12.5 microM) DME1041 XEOTICID XEO03471 GENEFORM Protein DME1041 XEOTICID XEO03471 MOACRIVE Inhibition DME1041 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1041 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03485 XEO_CLAS Peptide DME1041 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4.07 ug/ml) DME1041 XEOTICID XEO03485 GENEFORM Protein DME1041 XEOTICID XEO03485 MOACRIVE Inhibition DME1041 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1041 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03486 XEO_CLAS Peptide DME1041 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.80 ug/ml) DME1041 XEOTICID XEO03486 GENEFORM Protein DME1041 XEOTICID XEO03486 MOACRIVE Inhibition DME1041 XEOTICID XEO03488 XEO_NAME GLK-19 DME1041 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03488 XEO_CLAS Peptide DME1041 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO03488 GENEFORM Protein DME1041 XEOTICID XEO03488 MOACRIVE Inhibition DME1041 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1041 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03497 XEO_CLAS Peptide DME1041 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.4-0.8 microM) DME1041 XEOTICID XEO03497 GENEFORM Protein DME1041 XEOTICID XEO03497 MOACRIVE Inhibition DME1041 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1041 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03498 XEO_CLAS Peptide DME1041 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.4-0.8 microM) DME1041 XEOTICID XEO03498 GENEFORM Protein DME1041 XEOTICID XEO03498 MOACRIVE Inhibition DME1041 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1041 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03500 XEO_CLAS Peptide DME1041 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-30 ug/ml) DME1041 XEOTICID XEO03500 GENEFORM Protein DME1041 XEOTICID XEO03500 MOACRIVE Inhibition DME1041 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1041 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03504 XEO_CLAS Peptide DME1041 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 ug/ml) DME1041 XEOTICID XEO03504 GENEFORM Protein DME1041 XEOTICID XEO03504 MOACRIVE Inhibition DME1041 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1041 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03505 XEO_CLAS Peptide DME1041 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 ug/ml) DME1041 XEOTICID XEO03505 GENEFORM Protein DME1041 XEOTICID XEO03505 MOACRIVE Inhibition DME1041 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1041 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03506 XEO_CLAS Peptide DME1041 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 ug/ml) DME1041 XEOTICID XEO03506 GENEFORM Protein DME1041 XEOTICID XEO03506 MOACRIVE Inhibition DME1041 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1041 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03513 XEO_CLAS Peptide DME1041 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO03513 GENEFORM Protein DME1041 XEOTICID XEO03513 MOACRIVE Inhibition DME1041 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1041 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03514 XEO_CLAS Peptide DME1041 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03514 GENEFORM Protein DME1041 XEOTICID XEO03514 MOACRIVE Inhibition DME1041 XEOTICID XEO03519 XEO_NAME Hadrurin DME1041 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03519 XEO_CLAS Peptide DME1041 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03519 GENEFORM Protein DME1041 XEOTICID XEO03519 MOACRIVE Inhibition DME1041 XEOTICID XEO03522 XEO_NAME Halocyntin DME1041 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03522 XEO_CLAS Peptide DME1041 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03522 GENEFORM Protein DME1041 XEOTICID XEO03522 MOACRIVE Inhibition DME1041 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1041 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03524 XEO_CLAS Peptide DME1041 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03524 GENEFORM Protein DME1041 XEOTICID XEO03524 MOACRIVE Inhibition DME1041 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1041 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03525 XEO_CLAS Peptide DME1041 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03525 GENEFORM Protein DME1041 XEOTICID XEO03525 MOACRIVE Inhibition DME1041 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1041 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03530 XEO_CLAS Peptide DME1041 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03530 GENEFORM Protein DME1041 XEOTICID XEO03530 MOACRIVE Inhibition DME1041 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1041 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03535 XEO_CLAS Peptide DME1041 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.4 microM) DME1041 XEOTICID XEO03535 GENEFORM Protein DME1041 XEOTICID XEO03535 MOACRIVE Inhibition DME1041 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1041 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03536 XEO_CLAS Peptide DME1041 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 80 microM) DME1041 XEOTICID XEO03536 GENEFORM Protein DME1041 XEOTICID XEO03536 MOACRIVE Inhibition DME1041 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1041 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03537 XEO_CLAS Peptide DME1041 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 ug/ml) DME1041 XEOTICID XEO03537 GENEFORM Protein DME1041 XEOTICID XEO03537 MOACRIVE Inhibition DME1041 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1041 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03538 XEO_CLAS Peptide DME1041 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 ug/ml) DME1041 XEOTICID XEO03538 GENEFORM Protein DME1041 XEOTICID XEO03538 MOACRIVE Inhibition DME1041 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1041 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03540 XEO_CLAS Peptide DME1041 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO03540 GENEFORM Protein DME1041 XEOTICID XEO03540 MOACRIVE Inhibition DME1041 XEOTICID XEO03542 XEO_NAME Hepcidin DME1041 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03542 XEO_CLAS Peptide DME1041 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO03542 GENEFORM Protein DME1041 XEOTICID XEO03542 MOACRIVE Inhibition DME1041 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1041 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03544 XEO_CLAS Peptide DME1041 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03544 GENEFORM Protein DME1041 XEOTICID XEO03544 MOACRIVE Inhibition DME1041 XEOTICID XEO03548 XEO_NAME Hesperidin DME1041 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03548 GENEFORM Protein DME1041 XEOTICID XEO03548 MOACRIVE Inhibition DME1041 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1041 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1041 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03552 GENEFORM Protein DME1041 XEOTICID XEO03552 MOACRIVE Inhibition DME1041 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1041 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03556 XEO_CLAS Peptide DME1041 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO03556 GENEFORM Protein DME1041 XEOTICID XEO03556 MOACRIVE Inhibition DME1041 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1041 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03557 XEO_CLAS Peptide DME1041 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO03557 GENEFORM Protein DME1041 XEOTICID XEO03557 MOACRIVE Inhibition DME1041 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1041 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03558 XEO_CLAS Peptide DME1041 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 microM) DME1041 XEOTICID XEO03558 GENEFORM Protein DME1041 XEOTICID XEO03558 MOACRIVE Inhibition DME1041 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1041 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03559 XEO_CLAS Peptide DME1041 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 microM) DME1041 XEOTICID XEO03559 GENEFORM Protein DME1041 XEOTICID XEO03559 MOACRIVE Inhibition DME1041 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1041 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03560 XEO_CLAS Peptide DME1041 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 microM) DME1041 XEOTICID XEO03560 GENEFORM Protein DME1041 XEOTICID XEO03560 MOACRIVE Inhibition DME1041 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1041 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03561 XEO_CLAS Peptide DME1041 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03561 GENEFORM Protein DME1041 XEOTICID XEO03561 MOACRIVE Inhibition DME1041 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1041 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03567 XEO_CLAS Peptide DME1041 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03567 GENEFORM Protein DME1041 XEOTICID XEO03567 MOACRIVE Inhibition DME1041 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1041 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03569 XEO_CLAS Peptide DME1041 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 300 microM) DME1041 XEOTICID XEO03569 GENEFORM Protein DME1041 XEOTICID XEO03569 MOACRIVE Inhibition DME1041 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1041 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03570 XEO_CLAS Peptide DME1041 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03570 GENEFORM Protein DME1041 XEOTICID XEO03570 MOACRIVE Inhibition DME1041 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1041 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03572 XEO_CLAS Peptide DME1041 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10000-25000 ug/ml) DME1041 XEOTICID XEO03572 GENEFORM Protein DME1041 XEOTICID XEO03572 MOACRIVE Inhibition DME1041 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1041 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03573 XEO_CLAS Peptide DME1041 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 28.1 ug/ml) DME1041 XEOTICID XEO03573 GENEFORM Protein DME1041 XEOTICID XEO03573 MOACRIVE Inhibition DME1041 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1041 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03574 XEO_CLAS Peptide DME1041 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 500 microM) DME1041 XEOTICID XEO03574 GENEFORM Protein DME1041 XEOTICID XEO03574 MOACRIVE Inhibition DME1041 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1041 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03575 XEO_CLAS Peptide DME1041 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 18 microM) DME1041 XEOTICID XEO03575 GENEFORM Protein DME1041 XEOTICID XEO03575 MOACRIVE Inhibition DME1041 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1041 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03576 XEO_CLAS Peptide DME1041 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 750 microM) DME1041 XEOTICID XEO03576 GENEFORM Protein DME1041 XEOTICID XEO03576 MOACRIVE Inhibition DME1041 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1041 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03578 XEO_CLAS Peptide DME1041 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10000-25000 ug/ml) DME1041 XEOTICID XEO03578 GENEFORM Protein DME1041 XEOTICID XEO03578 MOACRIVE Inhibition DME1041 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1041 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03579 XEO_CLAS Peptide DME1041 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03579 GENEFORM Protein DME1041 XEOTICID XEO03579 MOACRIVE Inhibition DME1041 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1041 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03580 XEO_CLAS Peptide DME1041 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03580 GENEFORM Protein DME1041 XEOTICID XEO03580 MOACRIVE Inhibition DME1041 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1041 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03585 XEO_CLAS Peptide DME1041 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 62.5 ug/ml) DME1041 XEOTICID XEO03585 GENEFORM Protein DME1041 XEOTICID XEO03585 MOACRIVE Inhibition DME1041 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1041 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03588 XEO_CLAS Peptide DME1041 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 62 ug/ml) DME1041 XEOTICID XEO03588 GENEFORM Protein DME1041 XEOTICID XEO03588 MOACRIVE Inhibition DME1041 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1041 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03589 XEO_CLAS Peptide DME1041 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03589 GENEFORM Protein DME1041 XEOTICID XEO03589 MOACRIVE Inhibition DME1041 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1041 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03590 XEO_CLAS Peptide DME1041 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03590 GENEFORM Protein DME1041 XEOTICID XEO03590 MOACRIVE Inhibition DME1041 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1041 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03591 XEO_CLAS Peptide DME1041 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 37.5 ug/ml) DME1041 XEOTICID XEO03591 GENEFORM Protein DME1041 XEOTICID XEO03591 MOACRIVE Inhibition DME1041 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1041 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03593 XEO_CLAS Peptide DME1041 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9.4 ug/ml) DME1041 XEOTICID XEO03593 GENEFORM Protein DME1041 XEOTICID XEO03593 MOACRIVE Inhibition DME1041 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1041 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03594 XEO_CLAS Peptide DME1041 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 ug/ml) DME1041 XEOTICID XEO03594 GENEFORM Protein DME1041 XEOTICID XEO03594 MOACRIVE Inhibition DME1041 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1041 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03595 XEO_CLAS Peptide DME1041 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03595 GENEFORM Protein DME1041 XEOTICID XEO03595 MOACRIVE Inhibition DME1041 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1041 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03596 XEO_CLAS Peptide DME1041 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03596 GENEFORM Protein DME1041 XEOTICID XEO03596 MOACRIVE Inhibition DME1041 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1041 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03598 XEO_CLAS Peptide DME1041 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03598 GENEFORM Protein DME1041 XEOTICID XEO03598 MOACRIVE Inhibition DME1041 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1041 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03599 XEO_CLAS Peptide DME1041 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03599 GENEFORM Protein DME1041 XEOTICID XEO03599 MOACRIVE Inhibition DME1041 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1041 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03600 XEO_CLAS Peptide DME1041 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03600 GENEFORM Protein DME1041 XEOTICID XEO03600 MOACRIVE Inhibition DME1041 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1041 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03606 XEO_CLAS Peptide DME1041 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03606 GENEFORM Protein DME1041 XEOTICID XEO03606 MOACRIVE Inhibition DME1041 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1041 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03607 XEO_CLAS Peptide DME1041 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03607 GENEFORM Protein DME1041 XEOTICID XEO03607 MOACRIVE Inhibition DME1041 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1041 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03609 XEO_CLAS Peptide DME1041 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03609 GENEFORM Protein DME1041 XEOTICID XEO03609 MOACRIVE Inhibition DME1041 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1041 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03615 XEO_CLAS Peptide DME1041 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 24.4-32.0 ug/ml) DME1041 XEOTICID XEO03615 GENEFORM Protein DME1041 XEOTICID XEO03615 MOACRIVE Inhibition DME1041 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1041 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03616 XEO_CLAS Peptide DME1041 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 32 microM) DME1041 XEOTICID XEO03616 GENEFORM Protein DME1041 XEOTICID XEO03616 MOACRIVE Inhibition DME1041 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1041 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03617 XEO_CLAS Peptide DME1041 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40 microM) DME1041 XEOTICID XEO03617 GENEFORM Protein DME1041 XEOTICID XEO03617 MOACRIVE Inhibition DME1041 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1041 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03618 XEO_CLAS Peptide DME1041 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5-1 microM) DME1041 XEOTICID XEO03618 GENEFORM Protein DME1041 XEOTICID XEO03618 MOACRIVE Inhibition DME1041 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1041 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03622 XEO_CLAS Peptide DME1041 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20-40 microM) DME1041 XEOTICID XEO03622 GENEFORM Protein DME1041 XEOTICID XEO03622 MOACRIVE Inhibition DME1041 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1041 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03627 XEO_CLAS Peptide DME1041 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.4-0.8 microM) DME1041 XEOTICID XEO03627 GENEFORM Protein DME1041 XEOTICID XEO03627 MOACRIVE Inhibition DME1041 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1041 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03630 XEO_CLAS Peptide DME1041 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03630 GENEFORM Protein DME1041 XEOTICID XEO03630 MOACRIVE Inhibition DME1041 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1041 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03631 XEO_CLAS Peptide DME1041 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03631 GENEFORM Protein DME1041 XEOTICID XEO03631 MOACRIVE Inhibition DME1041 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1041 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03632 XEO_CLAS Peptide DME1041 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03632 GENEFORM Protein DME1041 XEOTICID XEO03632 MOACRIVE Inhibition DME1041 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1041 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03633 XEO_CLAS Peptide DME1041 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03633 GENEFORM Protein DME1041 XEOTICID XEO03633 MOACRIVE Inhibition DME1041 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1041 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03634 XEO_CLAS Peptide DME1041 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03634 GENEFORM Protein DME1041 XEOTICID XEO03634 MOACRIVE Inhibition DME1041 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1041 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03635 XEO_CLAS Peptide DME1041 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03635 GENEFORM Protein DME1041 XEOTICID XEO03635 MOACRIVE Inhibition DME1041 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1041 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03636 XEO_CLAS Peptide DME1041 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03636 GENEFORM Protein DME1041 XEOTICID XEO03636 MOACRIVE Inhibition DME1041 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1041 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03637 XEO_CLAS Peptide DME1041 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03637 GENEFORM Protein DME1041 XEOTICID XEO03637 MOACRIVE Inhibition DME1041 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1041 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03638 XEO_CLAS Peptide DME1041 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03638 GENEFORM Protein DME1041 XEOTICID XEO03638 MOACRIVE Inhibition DME1041 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1041 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03639 XEO_CLAS Peptide DME1041 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03639 GENEFORM Protein DME1041 XEOTICID XEO03639 MOACRIVE Inhibition DME1041 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1041 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03640 XEO_CLAS Peptide DME1041 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03640 GENEFORM Protein DME1041 XEOTICID XEO03640 MOACRIVE Inhibition DME1041 XEOTICID XEO03644 XEO_NAME Indole DME1041 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1041 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1041 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03644 GENEFORM Protein DME1041 XEOTICID XEO03644 MOACRIVE Inhibition DME1041 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1041 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03650 XEO_CLAS Peptide DME1041 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03650 GENEFORM Protein DME1041 XEOTICID XEO03650 MOACRIVE Inhibition DME1041 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1041 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO03655 XEO_CLAS Natural Product DME1041 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03655 GENEFORM Protein DME1041 XEOTICID XEO03655 MOACRIVE Inhibition DME1041 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1041 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03666 XEO_CLAS Peptide DME1041 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 ug/ml) DME1041 XEOTICID XEO03666 GENEFORM Protein DME1041 XEOTICID XEO03666 MOACRIVE Inhibition DME1041 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1041 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03667 XEO_CLAS Peptide DME1041 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 ug/ml) DME1041 XEOTICID XEO03667 GENEFORM Protein DME1041 XEOTICID XEO03667 MOACRIVE Inhibition DME1041 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1041 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03668 XEO_CLAS Peptide DME1041 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 microM) DME1041 XEOTICID XEO03668 GENEFORM Protein DME1041 XEOTICID XEO03668 MOACRIVE Inhibition DME1041 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1041 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03669 XEO_CLAS Peptide DME1041 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO03669 GENEFORM Protein DME1041 XEOTICID XEO03669 MOACRIVE Inhibition DME1041 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1041 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03670 XEO_CLAS Peptide DME1041 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 microM) DME1041 XEOTICID XEO03670 GENEFORM Protein DME1041 XEOTICID XEO03670 MOACRIVE Inhibition DME1041 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1041 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03672 XEO_CLAS Peptide DME1041 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.5 ug/ml) DME1041 XEOTICID XEO03672 GENEFORM Protein DME1041 XEOTICID XEO03672 MOACRIVE Inhibition DME1041 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1041 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03673 XEO_CLAS Peptide DME1041 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 ug/ml) DME1041 XEOTICID XEO03673 GENEFORM Protein DME1041 XEOTICID XEO03673 MOACRIVE Inhibition DME1041 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1041 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03674 XEO_CLAS Peptide DME1041 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 ug/ml) DME1041 XEOTICID XEO03674 GENEFORM Protein DME1041 XEOTICID XEO03674 MOACRIVE Inhibition DME1041 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1041 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03675 XEO_CLAS Peptide DME1041 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO03675 GENEFORM Protein DME1041 XEOTICID XEO03675 MOACRIVE Inhibition DME1041 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1041 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03678 XEO_CLAS Peptide DME1041 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 ug/ml) DME1041 XEOTICID XEO03678 GENEFORM Protein DME1041 XEOTICID XEO03678 MOACRIVE Inhibition DME1041 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1041 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03679 XEO_CLAS Peptide DME1041 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 ug/ml) DME1041 XEOTICID XEO03679 GENEFORM Protein DME1041 XEOTICID XEO03679 MOACRIVE Inhibition DME1041 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1041 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03681 XEO_CLAS Peptide DME1041 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.3-0.6 microM) DME1041 XEOTICID XEO03681 GENEFORM Protein DME1041 XEOTICID XEO03681 MOACRIVE Inhibition DME1041 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1041 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03684 XEO_CLAS Peptide DME1041 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 ug/ml) DME1041 XEOTICID XEO03684 GENEFORM Protein DME1041 XEOTICID XEO03684 MOACRIVE Inhibition DME1041 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1041 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03694 XEO_CLAS Peptide DME1041 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03694 GENEFORM Protein DME1041 XEOTICID XEO03694 MOACRIVE Inhibition DME1041 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1041 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03697 XEO_CLAS Peptide DME1041 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25 microM) DME1041 XEOTICID XEO03697 GENEFORM Protein DME1041 XEOTICID XEO03697 MOACRIVE Inhibition DME1041 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1041 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03698 XEO_CLAS Peptide DME1041 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03698 GENEFORM Protein DME1041 XEOTICID XEO03698 MOACRIVE Inhibition DME1041 XEOTICID XEO03703 XEO_NAME Kasstasin DME1041 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03703 XEO_CLAS Peptide DME1041 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 110 microM) DME1041 XEOTICID XEO03703 GENEFORM Protein DME1041 XEOTICID XEO03703 MOACRIVE Inhibition DME1041 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1041 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03706 XEO_CLAS Peptide DME1041 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03706 GENEFORM Protein DME1041 XEOTICID XEO03706 MOACRIVE Inhibition DME1041 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1041 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03707 XEO_CLAS Peptide DME1041 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03707 GENEFORM Protein DME1041 XEOTICID XEO03707 MOACRIVE Inhibition DME1041 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1041 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03709 XEO_CLAS Peptide DME1041 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 ug/ml) DME1041 XEOTICID XEO03709 GENEFORM Protein DME1041 XEOTICID XEO03709 MOACRIVE Inhibition DME1041 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1041 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03712 XEO_CLAS Peptide DME1041 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03712 GENEFORM Protein DME1041 XEOTICID XEO03712 MOACRIVE Inhibition DME1041 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1041 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03713 XEO_CLAS Peptide DME1041 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 64 microM) DME1041 XEOTICID XEO03713 GENEFORM Protein DME1041 XEOTICID XEO03713 MOACRIVE Inhibition DME1041 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1041 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03714 XEO_CLAS Peptide DME1041 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03714 GENEFORM Protein DME1041 XEOTICID XEO03714 MOACRIVE Inhibition DME1041 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1041 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03715 XEO_CLAS Peptide DME1041 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 microM) DME1041 XEOTICID XEO03715 GENEFORM Protein DME1041 XEOTICID XEO03715 MOACRIVE Inhibition DME1041 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1041 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03719 XEO_CLAS Peptide DME1041 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 microM) DME1041 XEOTICID XEO03719 GENEFORM Protein DME1041 XEOTICID XEO03719 MOACRIVE Inhibition DME1041 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1041 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03720 XEO_CLAS Peptide DME1041 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 microM) DME1041 XEOTICID XEO03720 GENEFORM Protein DME1041 XEOTICID XEO03720 MOACRIVE Inhibition DME1041 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1041 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03723 XEO_CLAS Peptide DME1041 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 62.36 microM) DME1041 XEOTICID XEO03723 GENEFORM Protein DME1041 XEOTICID XEO03723 MOACRIVE Inhibition DME1041 XEOTICID XEO03724 XEO_NAME L10 peptide DME1041 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03724 XEO_CLAS Peptide DME1041 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.8 microM) DME1041 XEOTICID XEO03724 GENEFORM Protein DME1041 XEOTICID XEO03724 MOACRIVE Inhibition DME1041 XEOTICID XEO03726 XEO_NAME L2 peptide DME1041 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03726 XEO_CLAS Peptide DME1041 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 129.66 microM) DME1041 XEOTICID XEO03726 GENEFORM Protein DME1041 XEOTICID XEO03726 MOACRIVE Inhibition DME1041 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1041 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03727 XEO_CLAS Peptide DME1041 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 80 ug/ml) DME1041 XEOTICID XEO03727 GENEFORM Protein DME1041 XEOTICID XEO03727 MOACRIVE Inhibition DME1041 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1041 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03728 XEO_CLAS Peptide DME1041 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40 ug/ml) DME1041 XEOTICID XEO03728 GENEFORM Protein DME1041 XEOTICID XEO03728 MOACRIVE Inhibition DME1041 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1041 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03729 XEO_CLAS Peptide DME1041 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 80 ug/ml) DME1041 XEOTICID XEO03729 GENEFORM Protein DME1041 XEOTICID XEO03729 MOACRIVE Inhibition DME1041 XEOTICID XEO03730 XEO_NAME L3 peptide DME1041 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03730 XEO_CLAS Peptide DME1041 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64.11 microM) DME1041 XEOTICID XEO03730 GENEFORM Protein DME1041 XEOTICID XEO03730 MOACRIVE Inhibition DME1041 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1041 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03731 XEO_CLAS Peptide DME1041 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40 ug/ml) DME1041 XEOTICID XEO03731 GENEFORM Protein DME1041 XEOTICID XEO03731 MOACRIVE Inhibition DME1041 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1041 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03733 XEO_CLAS Peptide DME1041 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40 ug/ml) DME1041 XEOTICID XEO03733 GENEFORM Protein DME1041 XEOTICID XEO03733 MOACRIVE Inhibition DME1041 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1041 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03734 XEO_CLAS Peptide DME1041 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO03734 GENEFORM Protein DME1041 XEOTICID XEO03734 MOACRIVE Inhibition DME1041 XEOTICID XEO03735 XEO_NAME L4 peptide DME1041 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03735 XEO_CLAS Peptide DME1041 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 31.61 microM) DME1041 XEOTICID XEO03735 GENEFORM Protein DME1041 XEOTICID XEO03735 MOACRIVE Inhibition DME1041 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1041 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03738 XEO_CLAS Peptide DME1041 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 ug/ml) DME1041 XEOTICID XEO03738 GENEFORM Protein DME1041 XEOTICID XEO03738 MOACRIVE Inhibition DME1041 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1041 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03741 XEO_CLAS Peptide DME1041 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40 ug/ml) DME1041 XEOTICID XEO03741 GENEFORM Protein DME1041 XEOTICID XEO03741 MOACRIVE Inhibition DME1041 XEOTICID XEO03742 XEO_NAME L5 peptide DME1041 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03742 XEO_CLAS Peptide DME1041 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 7.79 microM) DME1041 XEOTICID XEO03742 GENEFORM Protein DME1041 XEOTICID XEO03742 MOACRIVE Inhibition DME1041 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1041 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03743 XEO_CLAS Peptide DME1041 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 ug/ml) DME1041 XEOTICID XEO03743 GENEFORM Protein DME1041 XEOTICID XEO03743 MOACRIVE Inhibition DME1041 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1041 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03744 XEO_CLAS Peptide DME1041 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 ug/ml) DME1041 XEOTICID XEO03744 GENEFORM Protein DME1041 XEOTICID XEO03744 MOACRIVE Inhibition DME1041 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1041 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03745 XEO_CLAS Peptide DME1041 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 ug/ml) DME1041 XEOTICID XEO03745 GENEFORM Protein DME1041 XEOTICID XEO03745 MOACRIVE Inhibition DME1041 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1041 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03746 XEO_CLAS Peptide DME1041 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO03746 GENEFORM Protein DME1041 XEOTICID XEO03746 MOACRIVE Inhibition DME1041 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1041 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03747 XEO_CLAS Peptide DME1041 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO03747 GENEFORM Protein DME1041 XEOTICID XEO03747 MOACRIVE Inhibition DME1041 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1041 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03748 XEO_CLAS Peptide DME1041 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO03748 GENEFORM Protein DME1041 XEOTICID XEO03748 MOACRIVE Inhibition DME1041 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1041 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03749 XEO_CLAS Peptide DME1041 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO03749 GENEFORM Protein DME1041 XEOTICID XEO03749 MOACRIVE Inhibition DME1041 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1041 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03750 XEO_CLAS Peptide DME1041 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO03750 GENEFORM Protein DME1041 XEOTICID XEO03750 MOACRIVE Inhibition DME1041 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1041 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03751 XEO_CLAS Peptide DME1041 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO03751 GENEFORM Protein DME1041 XEOTICID XEO03751 MOACRIVE Inhibition DME1041 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1041 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03752 XEO_CLAS Peptide DME1041 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO03752 GENEFORM Protein DME1041 XEOTICID XEO03752 MOACRIVE Inhibition DME1041 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1041 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03753 XEO_CLAS Peptide DME1041 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 ug/ml) DME1041 XEOTICID XEO03753 GENEFORM Protein DME1041 XEOTICID XEO03753 MOACRIVE Inhibition DME1041 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1041 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03754 XEO_CLAS Peptide DME1041 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO03754 GENEFORM Protein DME1041 XEOTICID XEO03754 MOACRIVE Inhibition DME1041 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1041 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03755 XEO_CLAS Peptide DME1041 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO03755 GENEFORM Protein DME1041 XEOTICID XEO03755 MOACRIVE Inhibition DME1041 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1041 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03756 XEO_CLAS Peptide DME1041 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO03756 GENEFORM Protein DME1041 XEOTICID XEO03756 MOACRIVE Inhibition DME1041 XEOTICID XEO03757 XEO_NAME L6 peptide DME1041 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03757 XEO_CLAS Peptide DME1041 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15.17 microM) DME1041 XEOTICID XEO03757 GENEFORM Protein DME1041 XEOTICID XEO03757 MOACRIVE Inhibition DME1041 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1041 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03758 XEO_CLAS Peptide DME1041 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 80 ug/ml) DME1041 XEOTICID XEO03758 GENEFORM Protein DME1041 XEOTICID XEO03758 MOACRIVE Inhibition DME1041 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1041 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03759 XEO_CLAS Peptide DME1041 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.3 ug/ml) DME1041 XEOTICID XEO03759 GENEFORM Protein DME1041 XEOTICID XEO03759 MOACRIVE Inhibition DME1041 XEOTICID XEO03760 XEO_NAME L7 peptide DME1041 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03760 XEO_CLAS Peptide DME1041 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16.02 microM) DME1041 XEOTICID XEO03760 GENEFORM Protein DME1041 XEOTICID XEO03760 MOACRIVE Inhibition DME1041 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1041 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03761 XEO_CLAS Peptide DME1041 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 ug/ml) DME1041 XEOTICID XEO03761 GENEFORM Protein DME1041 XEOTICID XEO03761 MOACRIVE Inhibition DME1041 XEOTICID XEO03763 XEO_NAME L8 peptide DME1041 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03763 XEO_CLAS Peptide DME1041 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.71 microM) DME1041 XEOTICID XEO03763 GENEFORM Protein DME1041 XEOTICID XEO03763 MOACRIVE Inhibition DME1041 XEOTICID XEO03765 XEO_NAME L9 peptide DME1041 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03765 XEO_CLAS Peptide DME1041 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.78 microM) DME1041 XEOTICID XEO03765 GENEFORM Protein DME1041 XEOTICID XEO03765 MOACRIVE Inhibition DME1041 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1041 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03775 XEO_CLAS Peptide DME1041 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 17.3 microM) DME1041 XEOTICID XEO03775 GENEFORM Protein DME1041 XEOTICID XEO03775 MOACRIVE Inhibition DME1041 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1041 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03776 XEO_CLAS Peptide DME1041 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03776 GENEFORM Protein DME1041 XEOTICID XEO03776 MOACRIVE Inhibition DME1041 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1041 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03781 XEO_CLAS Peptide DME1041 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.47 microM) DME1041 XEOTICID XEO03781 GENEFORM Protein DME1041 XEOTICID XEO03781 MOACRIVE Inhibition DME1041 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1041 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03782 XEO_CLAS Peptide DME1041 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.47 microM) DME1041 XEOTICID XEO03782 GENEFORM Protein DME1041 XEOTICID XEO03782 MOACRIVE Inhibition DME1041 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1041 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03783 XEO_CLAS Peptide DME1041 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.68 microM) DME1041 XEOTICID XEO03783 GENEFORM Protein DME1041 XEOTICID XEO03783 MOACRIVE Inhibition DME1041 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1041 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03784 XEO_CLAS Peptide DME1041 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.45 microM) DME1041 XEOTICID XEO03784 GENEFORM Protein DME1041 XEOTICID XEO03784 MOACRIVE Inhibition DME1041 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1041 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03785 XEO_CLAS Peptide DME1041 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.73 microM) DME1041 XEOTICID XEO03785 GENEFORM Protein DME1041 XEOTICID XEO03785 MOACRIVE Inhibition DME1041 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1041 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03786 XEO_CLAS Peptide DME1041 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.45 microM) DME1041 XEOTICID XEO03786 GENEFORM Protein DME1041 XEOTICID XEO03786 MOACRIVE Inhibition DME1041 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1041 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03787 XEO_CLAS Peptide DME1041 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.38 microM) DME1041 XEOTICID XEO03787 GENEFORM Protein DME1041 XEOTICID XEO03787 MOACRIVE Inhibition DME1041 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1041 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03788 XEO_CLAS Peptide DME1041 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.46 microM) DME1041 XEOTICID XEO03788 GENEFORM Protein DME1041 XEOTICID XEO03788 MOACRIVE Inhibition DME1041 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1041 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03789 XEO_CLAS Peptide DME1041 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 13.05 microM) DME1041 XEOTICID XEO03789 GENEFORM Protein DME1041 XEOTICID XEO03789 MOACRIVE Inhibition DME1041 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1041 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03790 XEO_CLAS Peptide DME1041 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.82 microM) DME1041 XEOTICID XEO03790 GENEFORM Protein DME1041 XEOTICID XEO03790 MOACRIVE Inhibition DME1041 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1041 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03791 XEO_CLAS Peptide DME1041 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.80 microM) DME1041 XEOTICID XEO03791 GENEFORM Protein DME1041 XEOTICID XEO03791 MOACRIVE Inhibition DME1041 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1041 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03792 XEO_CLAS Peptide DME1041 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.26 microM) DME1041 XEOTICID XEO03792 GENEFORM Protein DME1041 XEOTICID XEO03792 MOACRIVE Inhibition DME1041 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1041 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03793 XEO_CLAS Peptide DME1041 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 microM) DME1041 XEOTICID XEO03793 GENEFORM Protein DME1041 XEOTICID XEO03793 MOACRIVE Inhibition DME1041 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1041 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03797 XEO_CLAS Peptide DME1041 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.4 microM) DME1041 XEOTICID XEO03797 GENEFORM Protein DME1041 XEOTICID XEO03797 MOACRIVE Inhibition DME1041 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1041 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03798 XEO_CLAS Peptide DME1041 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03798 GENEFORM Protein DME1041 XEOTICID XEO03798 MOACRIVE Inhibition DME1041 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1041 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03799 XEO_CLAS Peptide DME1041 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03799 GENEFORM Protein DME1041 XEOTICID XEO03799 MOACRIVE Inhibition DME1041 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1041 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03810 XEO_CLAS Peptide DME1041 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03810 GENEFORM Protein DME1041 XEOTICID XEO03810 MOACRIVE Inhibition DME1041 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1041 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03846 XEO_CLAS Peptide DME1041 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03846 GENEFORM Protein DME1041 XEOTICID XEO03846 MOACRIVE Inhibition DME1041 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1041 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03847 XEO_CLAS Peptide DME1041 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03847 GENEFORM Protein DME1041 XEOTICID XEO03847 MOACRIVE Inhibition DME1041 XEOTICID XEO03850 XEO_NAME Lemon DME1041 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1041 XEOTICID XEO03850 XEO_CLAS Food Additive DME1041 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03850 GENEFORM Protein DME1041 XEOTICID XEO03850 MOACRIVE Inhibition DME1041 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1041 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03853 XEO_CLAS Peptide DME1041 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO03853 GENEFORM Protein DME1041 XEOTICID XEO03853 MOACRIVE Inhibition DME1041 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1041 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03857 XEO_CLAS Peptide DME1041 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 38.49 microM) DME1041 XEOTICID XEO03857 GENEFORM Protein DME1041 XEOTICID XEO03857 MOACRIVE Inhibition DME1041 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1041 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03860 XEO_CLAS Peptide DME1041 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 24 microM) DME1041 XEOTICID XEO03860 GENEFORM Protein DME1041 XEOTICID XEO03860 MOACRIVE Inhibition DME1041 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1041 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03861 XEO_CLAS Peptide DME1041 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 35 microM) DME1041 XEOTICID XEO03861 GENEFORM Protein DME1041 XEOTICID XEO03861 MOACRIVE Inhibition DME1041 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1041 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03862 XEO_CLAS Peptide DME1041 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 70 microM) DME1041 XEOTICID XEO03862 GENEFORM Protein DME1041 XEOTICID XEO03862 MOACRIVE Inhibition DME1041 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1041 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03863 XEO_CLAS Peptide DME1041 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 35 microM) DME1041 XEOTICID XEO03863 GENEFORM Protein DME1041 XEOTICID XEO03863 MOACRIVE Inhibition DME1041 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1041 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03864 XEO_CLAS Peptide DME1041 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO03864 GENEFORM Protein DME1041 XEOTICID XEO03864 MOACRIVE Inhibition DME1041 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1041 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03865 XEO_CLAS Peptide DME1041 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO03865 GENEFORM Protein DME1041 XEOTICID XEO03865 MOACRIVE Inhibition DME1041 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1041 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03866 XEO_CLAS Peptide DME1041 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 microM) DME1041 XEOTICID XEO03866 GENEFORM Protein DME1041 XEOTICID XEO03866 MOACRIVE Inhibition DME1041 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1041 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03867 XEO_CLAS Peptide DME1041 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40 microM) DME1041 XEOTICID XEO03867 GENEFORM Protein DME1041 XEOTICID XEO03867 MOACRIVE Inhibition DME1041 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1041 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03868 XEO_CLAS Peptide DME1041 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 51 microM) DME1041 XEOTICID XEO03868 GENEFORM Protein DME1041 XEOTICID XEO03868 MOACRIVE Inhibition DME1041 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1041 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03869 XEO_CLAS Peptide DME1041 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 35 microM) DME1041 XEOTICID XEO03869 GENEFORM Protein DME1041 XEOTICID XEO03869 MOACRIVE Inhibition DME1041 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1041 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03870 XEO_CLAS Peptide DME1041 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 61 microM) DME1041 XEOTICID XEO03870 GENEFORM Protein DME1041 XEOTICID XEO03870 MOACRIVE Inhibition DME1041 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1041 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03871 XEO_CLAS Peptide DME1041 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 microM) DME1041 XEOTICID XEO03871 GENEFORM Protein DME1041 XEOTICID XEO03871 MOACRIVE Inhibition DME1041 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1041 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03872 XEO_CLAS Peptide DME1041 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 28 microM) DME1041 XEOTICID XEO03872 GENEFORM Protein DME1041 XEOTICID XEO03872 MOACRIVE Inhibition DME1041 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1041 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03873 XEO_CLAS Peptide DME1041 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 22.5 microM) DME1041 XEOTICID XEO03873 GENEFORM Protein DME1041 XEOTICID XEO03873 MOACRIVE Inhibition DME1041 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1041 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03874 XEO_CLAS Peptide DME1041 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 11.25 microM) DME1041 XEOTICID XEO03874 GENEFORM Protein DME1041 XEOTICID XEO03874 MOACRIVE Inhibition DME1041 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1041 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03875 XEO_CLAS Peptide DME1041 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 microM) DME1041 XEOTICID XEO03875 GENEFORM Protein DME1041 XEOTICID XEO03875 MOACRIVE Inhibition DME1041 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1041 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03876 XEO_CLAS Peptide DME1041 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.75 microM) DME1041 XEOTICID XEO03876 GENEFORM Protein DME1041 XEOTICID XEO03876 MOACRIVE Inhibition DME1041 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1041 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03877 XEO_CLAS Peptide DME1041 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 microM) DME1041 XEOTICID XEO03877 GENEFORM Protein DME1041 XEOTICID XEO03877 MOACRIVE Inhibition DME1041 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1041 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03878 XEO_CLAS Peptide DME1041 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 microM) DME1041 XEOTICID XEO03878 GENEFORM Protein DME1041 XEOTICID XEO03878 MOACRIVE Inhibition DME1041 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1041 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03879 XEO_CLAS Peptide DME1041 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 252 microM) DME1041 XEOTICID XEO03879 GENEFORM Protein DME1041 XEOTICID XEO03879 MOACRIVE Inhibition DME1041 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1041 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03880 XEO_CLAS Peptide DME1041 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 174 microM) DME1041 XEOTICID XEO03880 GENEFORM Protein DME1041 XEOTICID XEO03880 MOACRIVE Inhibition DME1041 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1041 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03883 XEO_CLAS Peptide DME1041 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 74 microM) DME1041 XEOTICID XEO03883 GENEFORM Protein DME1041 XEOTICID XEO03883 MOACRIVE Inhibition DME1041 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1041 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03884 XEO_CLAS Peptide DME1041 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 31 microM) DME1041 XEOTICID XEO03884 GENEFORM Protein DME1041 XEOTICID XEO03884 MOACRIVE Inhibition DME1041 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1041 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03885 XEO_CLAS Peptide DME1041 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO03885 GENEFORM Protein DME1041 XEOTICID XEO03885 MOACRIVE Inhibition DME1041 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1041 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03886 XEO_CLAS Peptide DME1041 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 391 microM) DME1041 XEOTICID XEO03886 GENEFORM Protein DME1041 XEOTICID XEO03886 MOACRIVE Inhibition DME1041 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1041 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03887 XEO_CLAS Peptide DME1041 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 151 microM) DME1041 XEOTICID XEO03887 GENEFORM Protein DME1041 XEOTICID XEO03887 MOACRIVE Inhibition DME1041 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1041 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03888 XEO_CLAS Peptide DME1041 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 134 microM) DME1041 XEOTICID XEO03888 GENEFORM Protein DME1041 XEOTICID XEO03888 MOACRIVE Inhibition DME1041 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1041 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03889 XEO_CLAS Peptide DME1041 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 88 microM) DME1041 XEOTICID XEO03889 GENEFORM Protein DME1041 XEOTICID XEO03889 MOACRIVE Inhibition DME1041 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1041 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03890 XEO_CLAS Peptide DME1041 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 31 microM) DME1041 XEOTICID XEO03890 GENEFORM Protein DME1041 XEOTICID XEO03890 MOACRIVE Inhibition DME1041 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1041 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03891 XEO_CLAS Peptide DME1041 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 microM) DME1041 XEOTICID XEO03891 GENEFORM Protein DME1041 XEOTICID XEO03891 MOACRIVE Inhibition DME1041 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1041 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03892 XEO_CLAS Peptide DME1041 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 37 microM) DME1041 XEOTICID XEO03892 GENEFORM Protein DME1041 XEOTICID XEO03892 MOACRIVE Inhibition DME1041 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1041 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03893 XEO_CLAS Peptide DME1041 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 19 microM) DME1041 XEOTICID XEO03893 GENEFORM Protein DME1041 XEOTICID XEO03893 MOACRIVE Inhibition DME1041 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1041 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03894 XEO_CLAS Peptide DME1041 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO03894 GENEFORM Protein DME1041 XEOTICID XEO03894 MOACRIVE Inhibition DME1041 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1041 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03895 XEO_CLAS Peptide DME1041 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO03895 GENEFORM Protein DME1041 XEOTICID XEO03895 MOACRIVE Inhibition DME1041 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1041 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03896 XEO_CLAS Peptide DME1041 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 microM) DME1041 XEOTICID XEO03896 GENEFORM Protein DME1041 XEOTICID XEO03896 MOACRIVE Inhibition DME1041 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1041 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03897 XEO_CLAS Peptide DME1041 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 63 microM) DME1041 XEOTICID XEO03897 GENEFORM Protein DME1041 XEOTICID XEO03897 MOACRIVE Inhibition DME1041 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1041 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03898 XEO_CLAS Peptide DME1041 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 219 microM) DME1041 XEOTICID XEO03898 GENEFORM Protein DME1041 XEOTICID XEO03898 MOACRIVE Inhibition DME1041 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1041 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03901 XEO_CLAS Peptide DME1041 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 35 microM) DME1041 XEOTICID XEO03901 GENEFORM Protein DME1041 XEOTICID XEO03901 MOACRIVE Inhibition DME1041 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1041 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03902 XEO_CLAS Peptide DME1041 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 70 microM) DME1041 XEOTICID XEO03902 GENEFORM Protein DME1041 XEOTICID XEO03902 MOACRIVE Inhibition DME1041 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1041 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03904 XEO_CLAS Peptide DME1041 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO03904 GENEFORM Protein DME1041 XEOTICID XEO03904 MOACRIVE Inhibition DME1041 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1041 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03905 XEO_CLAS Peptide DME1041 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO03905 GENEFORM Protein DME1041 XEOTICID XEO03905 MOACRIVE Inhibition DME1041 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1041 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03908 XEO_CLAS Peptide DME1041 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03908 GENEFORM Protein DME1041 XEOTICID XEO03908 MOACRIVE Inhibition DME1041 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1041 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03915 XEO_CLAS Peptide DME1041 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03915 GENEFORM Protein DME1041 XEOTICID XEO03915 MOACRIVE Inhibition DME1041 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1041 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03916 XEO_CLAS Peptide DME1041 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.8 ug/ml) DME1041 XEOTICID XEO03916 GENEFORM Protein DME1041 XEOTICID XEO03916 MOACRIVE Inhibition DME1041 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1041 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03917 XEO_CLAS Peptide DME1041 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 13.1 ug/ml) DME1041 XEOTICID XEO03917 GENEFORM Protein DME1041 XEOTICID XEO03917 MOACRIVE Inhibition DME1041 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1041 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03918 XEO_CLAS Peptide DME1041 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.5 ug/ml) DME1041 XEOTICID XEO03918 GENEFORM Protein DME1041 XEOTICID XEO03918 MOACRIVE Inhibition DME1041 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1041 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03919 XEO_CLAS Peptide DME1041 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 80 ug/ml) DME1041 XEOTICID XEO03919 GENEFORM Protein DME1041 XEOTICID XEO03919 MOACRIVE Inhibition DME1041 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1041 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03922 XEO_CLAS Peptide DME1041 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9 microM) DME1041 XEOTICID XEO03922 GENEFORM Protein DME1041 XEOTICID XEO03922 MOACRIVE Inhibition DME1041 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1041 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03923 XEO_CLAS Peptide DME1041 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 80 microM) DME1041 XEOTICID XEO03923 GENEFORM Protein DME1041 XEOTICID XEO03923 MOACRIVE Inhibition DME1041 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1041 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03924 XEO_CLAS Peptide DME1041 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO03924 GENEFORM Protein DME1041 XEOTICID XEO03924 MOACRIVE Inhibition DME1041 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1041 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03927 XEO_CLAS Peptide DME1041 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 80 microM) DME1041 XEOTICID XEO03927 GENEFORM Protein DME1041 XEOTICID XEO03927 MOACRIVE Inhibition DME1041 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1041 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03928 XEO_CLAS Peptide DME1041 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 microM) DME1041 XEOTICID XEO03928 GENEFORM Protein DME1041 XEOTICID XEO03928 MOACRIVE Inhibition DME1041 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1041 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03929 XEO_CLAS Peptide DME1041 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 microM) DME1041 XEOTICID XEO03929 GENEFORM Protein DME1041 XEOTICID XEO03929 MOACRIVE Inhibition DME1041 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1041 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03930 XEO_CLAS Peptide DME1041 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 microM) DME1041 XEOTICID XEO03930 GENEFORM Protein DME1041 XEOTICID XEO03930 MOACRIVE Inhibition DME1041 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1041 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03931 XEO_CLAS Peptide DME1041 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 microM) DME1041 XEOTICID XEO03931 GENEFORM Protein DME1041 XEOTICID XEO03931 MOACRIVE Inhibition DME1041 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1041 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03933 XEO_CLAS Peptide DME1041 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.5 microM) DME1041 XEOTICID XEO03933 GENEFORM Protein DME1041 XEOTICID XEO03933 MOACRIVE Inhibition DME1041 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1041 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03934 XEO_CLAS Peptide DME1041 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.7 microM) DME1041 XEOTICID XEO03934 GENEFORM Protein DME1041 XEOTICID XEO03934 MOACRIVE Inhibition DME1041 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1041 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03935 XEO_CLAS Peptide DME1041 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.7 microM) DME1041 XEOTICID XEO03935 GENEFORM Protein DME1041 XEOTICID XEO03935 MOACRIVE Inhibition DME1041 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1041 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03936 XEO_CLAS Peptide DME1041 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.0 microM) DME1041 XEOTICID XEO03936 GENEFORM Protein DME1041 XEOTICID XEO03936 MOACRIVE Inhibition DME1041 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1041 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03937 XEO_CLAS Peptide DME1041 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.1 microM) DME1041 XEOTICID XEO03937 GENEFORM Protein DME1041 XEOTICID XEO03937 MOACRIVE Inhibition DME1041 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1041 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03938 XEO_CLAS Peptide DME1041 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.7 microM) DME1041 XEOTICID XEO03938 GENEFORM Protein DME1041 XEOTICID XEO03938 MOACRIVE Inhibition DME1041 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1041 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03939 XEO_CLAS Peptide DME1041 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.7 microM) DME1041 XEOTICID XEO03939 GENEFORM Protein DME1041 XEOTICID XEO03939 MOACRIVE Inhibition DME1041 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1041 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03940 XEO_CLAS Peptide DME1041 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.5 microM) DME1041 XEOTICID XEO03940 GENEFORM Protein DME1041 XEOTICID XEO03940 MOACRIVE Inhibition DME1041 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1041 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03941 XEO_CLAS Peptide DME1041 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.4 microM) DME1041 XEOTICID XEO03941 GENEFORM Protein DME1041 XEOTICID XEO03941 MOACRIVE Inhibition DME1041 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1041 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03943 XEO_CLAS Peptide DME1041 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.4 microM) DME1041 XEOTICID XEO03943 GENEFORM Protein DME1041 XEOTICID XEO03943 MOACRIVE Inhibition DME1041 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1041 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03944 XEO_CLAS Peptide DME1041 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.7 microM) DME1041 XEOTICID XEO03944 GENEFORM Protein DME1041 XEOTICID XEO03944 MOACRIVE Inhibition DME1041 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1041 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03945 XEO_CLAS Peptide DME1041 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.2 microM) DME1041 XEOTICID XEO03945 GENEFORM Protein DME1041 XEOTICID XEO03945 MOACRIVE Inhibition DME1041 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1041 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03947 XEO_CLAS Peptide DME1041 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.0 microM) DME1041 XEOTICID XEO03947 GENEFORM Protein DME1041 XEOTICID XEO03947 MOACRIVE Inhibition DME1041 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1041 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03948 XEO_CLAS Peptide DME1041 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 23.3 microM) DME1041 XEOTICID XEO03948 GENEFORM Protein DME1041 XEOTICID XEO03948 MOACRIVE Inhibition DME1041 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1041 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03950 XEO_CLAS Peptide DME1041 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4.4 microM) DME1041 XEOTICID XEO03950 GENEFORM Protein DME1041 XEOTICID XEO03950 MOACRIVE Inhibition DME1041 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1041 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03951 XEO_CLAS Peptide DME1041 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8.8 microM) DME1041 XEOTICID XEO03951 GENEFORM Protein DME1041 XEOTICID XEO03951 MOACRIVE Inhibition DME1041 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1041 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03952 XEO_CLAS Peptide DME1041 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.2 microM) DME1041 XEOTICID XEO03952 GENEFORM Protein DME1041 XEOTICID XEO03952 MOACRIVE Inhibition DME1041 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1041 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03953 XEO_CLAS Peptide DME1041 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 microM) DME1041 XEOTICID XEO03953 GENEFORM Protein DME1041 XEOTICID XEO03953 MOACRIVE Inhibition DME1041 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1041 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03958 XEO_CLAS Peptide DME1041 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03958 GENEFORM Protein DME1041 XEOTICID XEO03958 MOACRIVE Inhibition DME1041 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1041 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03965 XEO_CLAS Peptide DME1041 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 128 microM) DME1041 XEOTICID XEO03965 GENEFORM Protein DME1041 XEOTICID XEO03965 MOACRIVE Inhibition DME1041 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1041 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03966 XEO_CLAS Peptide DME1041 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 microM) DME1041 XEOTICID XEO03966 GENEFORM Protein DME1041 XEOTICID XEO03966 MOACRIVE Inhibition DME1041 XEOTICID XEO03971 XEO_NAME Lumbrican DME1041 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03971 XEO_CLAS Peptide DME1041 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03971 GENEFORM Protein DME1041 XEOTICID XEO03971 MOACRIVE Inhibition DME1041 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1041 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03972 XEO_CLAS Peptide DME1041 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO03972 GENEFORM Protein DME1041 XEOTICID XEO03972 MOACRIVE Inhibition DME1041 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1041 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03980 XEO_CLAS Peptide DME1041 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 32 microM) DME1041 XEOTICID XEO03980 GENEFORM Protein DME1041 XEOTICID XEO03980 MOACRIVE Inhibition DME1041 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1041 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03985 XEO_CLAS Peptide DME1041 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 ug/ml) DME1041 XEOTICID XEO03985 GENEFORM Protein DME1041 XEOTICID XEO03985 MOACRIVE Inhibition DME1041 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1041 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03991 XEO_CLAS Peptide DME1041 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03991 GENEFORM Protein DME1041 XEOTICID XEO03991 MOACRIVE Inhibition DME1041 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1041 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03992 XEO_CLAS Peptide DME1041 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03992 GENEFORM Protein DME1041 XEOTICID XEO03992 MOACRIVE Inhibition DME1041 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1041 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03993 XEO_CLAS Peptide DME1041 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03993 GENEFORM Protein DME1041 XEOTICID XEO03993 MOACRIVE Inhibition DME1041 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1041 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03994 XEO_CLAS Peptide DME1041 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO03994 GENEFORM Protein DME1041 XEOTICID XEO03994 MOACRIVE Inhibition DME1041 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1041 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03996 XEO_CLAS Peptide DME1041 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 65 microM) DME1041 XEOTICID XEO03996 GENEFORM Protein DME1041 XEOTICID XEO03996 MOACRIVE Inhibition DME1041 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1041 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03997 XEO_CLAS Peptide DME1041 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 7.5 microM) DME1041 XEOTICID XEO03997 GENEFORM Protein DME1041 XEOTICID XEO03997 MOACRIVE Inhibition DME1041 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1041 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03998 XEO_CLAS Peptide DME1041 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15.5 microM) DME1041 XEOTICID XEO03998 GENEFORM Protein DME1041 XEOTICID XEO03998 MOACRIVE Inhibition DME1041 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1041 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO03999 XEO_CLAS Peptide DME1041 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25.8 microM) DME1041 XEOTICID XEO03999 GENEFORM Protein DME1041 XEOTICID XEO03999 MOACRIVE Inhibition DME1041 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1041 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04000 XEO_CLAS Peptide DME1041 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO04000 GENEFORM Protein DME1041 XEOTICID XEO04000 MOACRIVE Inhibition DME1041 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1041 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04001 XEO_CLAS Peptide DME1041 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO04001 GENEFORM Protein DME1041 XEOTICID XEO04001 MOACRIVE Inhibition DME1041 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1041 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04002 XEO_CLAS Peptide DME1041 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 7.5 ug/ml) DME1041 XEOTICID XEO04002 GENEFORM Protein DME1041 XEOTICID XEO04002 MOACRIVE Inhibition DME1041 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1041 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04003 XEO_CLAS Peptide DME1041 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 ug/ml) DME1041 XEOTICID XEO04003 GENEFORM Protein DME1041 XEOTICID XEO04003 MOACRIVE Inhibition DME1041 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1041 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04004 XEO_CLAS Peptide DME1041 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.0 ug/ml) DME1041 XEOTICID XEO04004 GENEFORM Protein DME1041 XEOTICID XEO04004 MOACRIVE Inhibition DME1041 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1041 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04005 XEO_CLAS Peptide DME1041 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.0 ug/ml) DME1041 XEOTICID XEO04005 GENEFORM Protein DME1041 XEOTICID XEO04005 MOACRIVE Inhibition DME1041 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1041 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04007 XEO_CLAS Peptide DME1041 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 19.5 ug/ml) DME1041 XEOTICID XEO04007 GENEFORM Protein DME1041 XEOTICID XEO04007 MOACRIVE Inhibition DME1041 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1041 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04011 XEO_CLAS Peptide DME1041 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 19.5 ug/ml) DME1041 XEOTICID XEO04011 GENEFORM Protein DME1041 XEOTICID XEO04011 MOACRIVE Inhibition DME1041 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1041 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04012 XEO_CLAS Peptide DME1041 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.9 ug/ml) DME1041 XEOTICID XEO04012 GENEFORM Protein DME1041 XEOTICID XEO04012 MOACRIVE Inhibition DME1041 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1041 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04013 XEO_CLAS Peptide DME1041 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.7 ug/ml) DME1041 XEOTICID XEO04013 GENEFORM Protein DME1041 XEOTICID XEO04013 MOACRIVE Inhibition DME1041 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1041 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04018 XEO_CLAS Peptide DME1041 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9 ug/ml) DME1041 XEOTICID XEO04018 GENEFORM Protein DME1041 XEOTICID XEO04018 MOACRIVE Inhibition DME1041 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1041 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04026 XEO_CLAS Peptide DME1041 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO04026 GENEFORM Protein DME1041 XEOTICID XEO04026 MOACRIVE Inhibition DME1041 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1041 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04027 XEO_CLAS Peptide DME1041 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO04027 GENEFORM Protein DME1041 XEOTICID XEO04027 MOACRIVE Inhibition DME1041 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1041 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04028 XEO_CLAS Peptide DME1041 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 ug/ml) DME1041 XEOTICID XEO04028 GENEFORM Protein DME1041 XEOTICID XEO04028 MOACRIVE Inhibition DME1041 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1041 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04038 XEO_CLAS Peptide DME1041 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04038 GENEFORM Protein DME1041 XEOTICID XEO04038 MOACRIVE Inhibition DME1041 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1041 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04039 XEO_CLAS Peptide DME1041 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 microM) DME1041 XEOTICID XEO04039 GENEFORM Protein DME1041 XEOTICID XEO04039 MOACRIVE Inhibition DME1041 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1041 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04051 XEO_CLAS Peptide DME1041 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.31-0.63 microM) DME1041 XEOTICID XEO04051 GENEFORM Protein DME1041 XEOTICID XEO04051 MOACRIVE Inhibition DME1041 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1041 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04052 XEO_CLAS Peptide DME1041 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04052 GENEFORM Protein DME1041 XEOTICID XEO04052 MOACRIVE Inhibition DME1041 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1041 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04053 XEO_CLAS Peptide DME1041 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.08-0.16 microM) DME1041 XEOTICID XEO04053 GENEFORM Protein DME1041 XEOTICID XEO04053 MOACRIVE Inhibition DME1041 XEOTICID XEO04055 XEO_NAME Melectin DME1041 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04055 XEO_CLAS Peptide DME1041 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.0 microM) DME1041 XEOTICID XEO04055 GENEFORM Protein DME1041 XEOTICID XEO04055 MOACRIVE Inhibition DME1041 XEOTICID XEO04057 XEO_NAME Melittin DME1041 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04057 XEO_CLAS Peptide DME1041 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.8 microM) DME1041 XEOTICID XEO04057 GENEFORM Protein DME1041 XEOTICID XEO04057 MOACRIVE Inhibition DME1041 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1041 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04061 XEO_CLAS Peptide DME1041 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.9 microM) DME1041 XEOTICID XEO04061 GENEFORM Protein DME1041 XEOTICID XEO04061 MOACRIVE Inhibition DME1041 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1041 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04062 XEO_CLAS Peptide DME1041 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.5 microM) DME1041 XEOTICID XEO04062 GENEFORM Protein DME1041 XEOTICID XEO04062 MOACRIVE Inhibition DME1041 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1041 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04063 XEO_CLAS Peptide DME1041 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 7.8 microM) DME1041 XEOTICID XEO04063 GENEFORM Protein DME1041 XEOTICID XEO04063 MOACRIVE Inhibition DME1041 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1041 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04064 XEO_CLAS Peptide DME1041 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 46.7 microM) DME1041 XEOTICID XEO04064 GENEFORM Protein DME1041 XEOTICID XEO04064 MOACRIVE Inhibition DME1041 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1041 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04066 XEO_CLAS Peptide DME1041 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16.3 microM) DME1041 XEOTICID XEO04066 GENEFORM Protein DME1041 XEOTICID XEO04066 MOACRIVE Inhibition DME1041 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1041 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04067 XEO_CLAS Peptide DME1041 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.6 microM) DME1041 XEOTICID XEO04067 GENEFORM Protein DME1041 XEOTICID XEO04067 MOACRIVE Inhibition DME1041 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1041 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04068 XEO_CLAS Peptide DME1041 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.6 microM) DME1041 XEOTICID XEO04068 GENEFORM Protein DME1041 XEOTICID XEO04068 MOACRIVE Inhibition DME1041 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1041 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04086 GENEFORM Protein DME1041 XEOTICID XEO04086 MOACRIVE Inhibition DME1041 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1041 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04087 GENEFORM Protein DME1041 XEOTICID XEO04087 MOACRIVE Inhibition DME1041 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1041 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04089 GENEFORM Protein DME1041 XEOTICID XEO04089 MOACRIVE Inhibition DME1041 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1041 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04094 GENEFORM Protein DME1041 XEOTICID XEO04094 MOACRIVE Inhibition DME1041 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1041 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04096 GENEFORM Protein DME1041 XEOTICID XEO04096 MOACRIVE Inhibition DME1041 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1041 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04098 GENEFORM Protein DME1041 XEOTICID XEO04098 MOACRIVE Inhibition DME1041 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1041 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04111 XEO_CLAS Peptide DME1041 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04111 GENEFORM Protein DME1041 XEOTICID XEO04111 MOACRIVE Inhibition DME1041 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1041 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04112 XEO_CLAS Peptide DME1041 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.02 microM) DME1041 XEOTICID XEO04112 GENEFORM Protein DME1041 XEOTICID XEO04112 MOACRIVE Inhibition DME1041 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1041 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04113 XEO_CLAS Peptide DME1041 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.02 ug/ml) DME1041 XEOTICID XEO04113 GENEFORM Protein DME1041 XEOTICID XEO04113 MOACRIVE Inhibition DME1041 XEOTICID XEO04114 XEO_NAME Microcin L DME1041 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04114 XEO_CLAS Peptide DME1041 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04114 GENEFORM Protein DME1041 XEOTICID XEO04114 MOACRIVE Inhibition DME1041 XEOTICID XEO04117 XEO_NAME Misgurin DME1041 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04117 XEO_CLAS Peptide DME1041 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04117 GENEFORM Protein DME1041 XEOTICID XEO04117 MOACRIVE Inhibition DME1041 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1041 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04118 XEO_CLAS Peptide DME1041 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 300 microM) DME1041 XEOTICID XEO04118 GENEFORM Protein DME1041 XEOTICID XEO04118 MOACRIVE Inhibition DME1041 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1041 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04119 XEO_CLAS Peptide DME1041 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-20 microM) DME1041 XEOTICID XEO04119 GENEFORM Protein DME1041 XEOTICID XEO04119 MOACRIVE Inhibition DME1041 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1041 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04120 XEO_CLAS Peptide DME1041 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC < 10 microM) DME1041 XEOTICID XEO04120 GENEFORM Protein DME1041 XEOTICID XEO04120 MOACRIVE Inhibition DME1041 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1041 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04121 XEO_CLAS Peptide DME1041 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.2-6.4 microM) DME1041 XEOTICID XEO04121 GENEFORM Protein DME1041 XEOTICID XEO04121 MOACRIVE Inhibition DME1041 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1041 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04122 XEO_CLAS Peptide DME1041 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.14-6.29 microM) DME1041 XEOTICID XEO04122 GENEFORM Protein DME1041 XEOTICID XEO04122 MOACRIVE Inhibition DME1041 XEOTICID XEO04123 XEO_NAME Modified defensin DME1041 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04123 XEO_CLAS Peptide DME1041 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO04123 GENEFORM Protein DME1041 XEOTICID XEO04123 MOACRIVE Inhibition DME1041 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1041 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04128 XEO_CLAS Peptide DME1041 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.31 microM) DME1041 XEOTICID XEO04128 GENEFORM Protein DME1041 XEOTICID XEO04128 MOACRIVE Inhibition DME1041 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1041 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04129 XEO_CLAS Peptide DME1041 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO04129 GENEFORM Protein DME1041 XEOTICID XEO04129 MOACRIVE Inhibition DME1041 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1041 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04130 XEO_CLAS Peptide DME1041 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO04130 GENEFORM Protein DME1041 XEOTICID XEO04130 MOACRIVE Inhibition DME1041 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1041 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04131 XEO_CLAS Peptide DME1041 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 microM) DME1041 XEOTICID XEO04131 GENEFORM Protein DME1041 XEOTICID XEO04131 MOACRIVE Inhibition DME1041 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1041 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04132 XEO_CLAS Peptide DME1041 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 microM) DME1041 XEOTICID XEO04132 GENEFORM Protein DME1041 XEOTICID XEO04132 MOACRIVE Inhibition DME1041 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1041 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04133 XEO_CLAS Peptide DME1041 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO04133 GENEFORM Protein DME1041 XEOTICID XEO04133 MOACRIVE Inhibition DME1041 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1041 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04134 XEO_CLAS Peptide DME1041 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO04134 GENEFORM Protein DME1041 XEOTICID XEO04134 MOACRIVE Inhibition DME1041 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1041 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04135 XEO_CLAS Peptide DME1041 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 microM) DME1041 XEOTICID XEO04135 GENEFORM Protein DME1041 XEOTICID XEO04135 MOACRIVE Inhibition DME1041 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1041 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04137 XEO_CLAS Peptide DME1041 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.6 microM) DME1041 XEOTICID XEO04137 GENEFORM Protein DME1041 XEOTICID XEO04137 MOACRIVE Inhibition DME1041 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1041 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04138 XEO_CLAS Peptide DME1041 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 microM) DME1041 XEOTICID XEO04138 GENEFORM Protein DME1041 XEOTICID XEO04138 MOACRIVE Inhibition DME1041 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1041 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04139 XEO_CLAS Peptide DME1041 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 microM) DME1041 XEOTICID XEO04139 GENEFORM Protein DME1041 XEOTICID XEO04139 MOACRIVE Inhibition DME1041 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1041 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04140 XEO_CLAS Peptide DME1041 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 70 microM) DME1041 XEOTICID XEO04140 GENEFORM Protein DME1041 XEOTICID XEO04140 MOACRIVE Inhibition DME1041 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1041 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04141 XEO_CLAS Peptide DME1041 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 microM) DME1041 XEOTICID XEO04141 GENEFORM Protein DME1041 XEOTICID XEO04141 MOACRIVE Inhibition DME1041 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1041 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04142 XEO_CLAS Peptide DME1041 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8-16 microM) DME1041 XEOTICID XEO04142 GENEFORM Protein DME1041 XEOTICID XEO04142 MOACRIVE Inhibition DME1041 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1041 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04146 XEO_CLAS Peptide DME1041 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04146 GENEFORM Protein DME1041 XEOTICID XEO04146 MOACRIVE Inhibition DME1041 XEOTICID XEO04149 XEO_NAME Mucroporin DME1041 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04149 XEO_CLAS Peptide DME1041 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 ug/ml) DME1041 XEOTICID XEO04149 GENEFORM Protein DME1041 XEOTICID XEO04149 MOACRIVE Inhibition DME1041 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1041 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04158 XEO_CLAS Peptide DME1041 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO04158 GENEFORM Protein DME1041 XEOTICID XEO04158 MOACRIVE Inhibition DME1041 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1041 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04159 XEO_CLAS Peptide DME1041 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 microM) DME1041 XEOTICID XEO04159 GENEFORM Protein DME1041 XEOTICID XEO04159 MOACRIVE Inhibition DME1041 XEOTICID XEO04167 XEO_NAME Myticin-B DME1041 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04167 XEO_CLAS Peptide DME1041 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04167 GENEFORM Protein DME1041 XEOTICID XEO04167 MOACRIVE Inhibition DME1041 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1041 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04168 XEO_CLAS Peptide DME1041 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.7-12.5 microM) DME1041 XEOTICID XEO04168 GENEFORM Protein DME1041 XEOTICID XEO04168 MOACRIVE Inhibition DME1041 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1041 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04169 XEO_CLAS Peptide DME1041 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04169 GENEFORM Protein DME1041 XEOTICID XEO04169 MOACRIVE Inhibition DME1041 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1041 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04170 XEO_CLAS Peptide DME1041 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04170 GENEFORM Protein DME1041 XEOTICID XEO04170 MOACRIVE Inhibition DME1041 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1041 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04171 XEO_CLAS Peptide DME1041 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04171 GENEFORM Protein DME1041 XEOTICID XEO04171 MOACRIVE Inhibition DME1041 XEOTICID XEO04172 XEO_NAME Myxinidin DME1041 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04172 XEO_CLAS Peptide DME1041 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04172 GENEFORM Protein DME1041 XEOTICID XEO04172 MOACRIVE Inhibition DME1041 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1041 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04177 XEO_CLAS Peptide DME1041 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.7 microM) DME1041 XEOTICID XEO04177 GENEFORM Protein DME1041 XEOTICID XEO04177 MOACRIVE Inhibition DME1041 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1041 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04178 XEO_CLAS Peptide DME1041 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.7 microM) DME1041 XEOTICID XEO04178 GENEFORM Protein DME1041 XEOTICID XEO04178 MOACRIVE Inhibition DME1041 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1041 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04179 XEO_CLAS Peptide DME1041 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.5 microM) DME1041 XEOTICID XEO04179 GENEFORM Protein DME1041 XEOTICID XEO04179 MOACRIVE Inhibition DME1041 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1041 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04180 XEO_CLAS Peptide DME1041 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 23 microM) DME1041 XEOTICID XEO04180 GENEFORM Protein DME1041 XEOTICID XEO04180 MOACRIVE Inhibition DME1041 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1041 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04181 XEO_CLAS Peptide DME1041 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.2 microM) DME1041 XEOTICID XEO04181 GENEFORM Protein DME1041 XEOTICID XEO04181 MOACRIVE Inhibition DME1041 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1041 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04182 XEO_CLAS Peptide DME1041 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4.4 microM) DME1041 XEOTICID XEO04182 GENEFORM Protein DME1041 XEOTICID XEO04182 MOACRIVE Inhibition DME1041 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1041 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04183 XEO_CLAS Peptide DME1041 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.6 microM) DME1041 XEOTICID XEO04183 GENEFORM Protein DME1041 XEOTICID XEO04183 MOACRIVE Inhibition DME1041 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1041 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04184 XEO_CLAS Peptide DME1041 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 microM) DME1041 XEOTICID XEO04184 GENEFORM Protein DME1041 XEOTICID XEO04184 MOACRIVE Inhibition DME1041 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1041 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04185 XEO_CLAS Peptide DME1041 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04185 GENEFORM Protein DME1041 XEOTICID XEO04185 MOACRIVE Inhibition DME1041 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1041 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04186 XEO_CLAS Peptide DME1041 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04186 GENEFORM Protein DME1041 XEOTICID XEO04186 MOACRIVE Inhibition DME1041 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1041 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04187 XEO_CLAS Peptide DME1041 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04187 GENEFORM Protein DME1041 XEOTICID XEO04187 MOACRIVE Inhibition DME1041 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1041 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04188 XEO_CLAS Peptide DME1041 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04188 GENEFORM Protein DME1041 XEOTICID XEO04188 MOACRIVE Inhibition DME1041 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1041 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04206 XEO_CLAS Peptide DME1041 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25 microM) DME1041 XEOTICID XEO04206 GENEFORM Protein DME1041 XEOTICID XEO04206 MOACRIVE Inhibition DME1041 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1041 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04214 XEO_CLAS Peptide DME1041 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25 microM) DME1041 XEOTICID XEO04214 GENEFORM Protein DME1041 XEOTICID XEO04214 MOACRIVE Inhibition DME1041 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1041 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04216 XEO_CLAS Peptide DME1041 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO04216 GENEFORM Protein DME1041 XEOTICID XEO04216 MOACRIVE Inhibition DME1041 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1041 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04218 XEO_CLAS Peptide DME1041 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.125 microM) DME1041 XEOTICID XEO04218 GENEFORM Protein DME1041 XEOTICID XEO04218 MOACRIVE Inhibition DME1041 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1041 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04219 XEO_CLAS Peptide DME1041 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO04219 GENEFORM Protein DME1041 XEOTICID XEO04219 MOACRIVE Inhibition DME1041 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1041 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04220 XEO_CLAS Peptide DME1041 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.125 microM) DME1041 XEOTICID XEO04220 GENEFORM Protein DME1041 XEOTICID XEO04220 MOACRIVE Inhibition DME1041 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1041 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04221 XEO_CLAS Peptide DME1041 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO04221 GENEFORM Protein DME1041 XEOTICID XEO04221 MOACRIVE Inhibition DME1041 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1041 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04222 XEO_CLAS Peptide DME1041 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25 microM) DME1041 XEOTICID XEO04222 GENEFORM Protein DME1041 XEOTICID XEO04222 MOACRIVE Inhibition DME1041 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1041 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04233 XEO_CLAS Peptide DME1041 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04233 GENEFORM Protein DME1041 XEOTICID XEO04233 MOACRIVE Inhibition DME1041 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1041 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04234 XEO_CLAS Peptide DME1041 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04234 GENEFORM Protein DME1041 XEOTICID XEO04234 MOACRIVE Inhibition DME1041 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1041 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04241 XEO_CLAS Peptide DME1041 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04241 GENEFORM Protein DME1041 XEOTICID XEO04241 MOACRIVE Inhibition DME1041 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1041 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04242 XEO_CLAS Peptide DME1041 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04242 GENEFORM Protein DME1041 XEOTICID XEO04242 MOACRIVE Inhibition DME1041 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1041 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04245 XEO_CLAS Natural Product DME1041 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04245 GENEFORM Protein DME1041 XEOTICID XEO04245 MOACRIVE Inhibition DME1041 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1041 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04246 XEO_CLAS Natural Product DME1041 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04246 GENEFORM Protein DME1041 XEOTICID XEO04246 MOACRIVE Inhibition DME1041 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1041 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04249 XEO_CLAS Peptide DME1041 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 500 ug/ml) DME1041 XEOTICID XEO04249 GENEFORM Protein DME1041 XEOTICID XEO04249 MOACRIVE Inhibition DME1041 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1041 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04251 XEO_CLAS Peptide DME1041 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04251 GENEFORM Protein DME1041 XEOTICID XEO04251 MOACRIVE Inhibition DME1041 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1041 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04253 XEO_CLAS Peptide DME1041 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04253 GENEFORM Protein DME1041 XEOTICID XEO04253 MOACRIVE Inhibition DME1041 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1041 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04254 XEO_CLAS Peptide DME1041 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04254 GENEFORM Protein DME1041 XEOTICID XEO04254 MOACRIVE Inhibition DME1041 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1041 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04255 XEO_CLAS Peptide DME1041 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04255 GENEFORM Protein DME1041 XEOTICID XEO04255 MOACRIVE Inhibition DME1041 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1041 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04256 XEO_CLAS Peptide DME1041 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04256 GENEFORM Protein DME1041 XEOTICID XEO04256 MOACRIVE Inhibition DME1041 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1041 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04257 XEO_CLAS Peptide DME1041 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04257 GENEFORM Protein DME1041 XEOTICID XEO04257 MOACRIVE Inhibition DME1041 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1041 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04258 XEO_CLAS Peptide DME1041 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04258 GENEFORM Protein DME1041 XEOTICID XEO04258 MOACRIVE Inhibition DME1041 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1041 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04259 XEO_CLAS Peptide DME1041 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04259 GENEFORM Protein DME1041 XEOTICID XEO04259 MOACRIVE Inhibition DME1041 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1041 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04260 XEO_CLAS Peptide DME1041 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04260 GENEFORM Protein DME1041 XEOTICID XEO04260 MOACRIVE Inhibition DME1041 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1041 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04261 XEO_CLAS Peptide DME1041 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04261 GENEFORM Protein DME1041 XEOTICID XEO04261 MOACRIVE Inhibition DME1041 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1041 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04262 XEO_CLAS Peptide DME1041 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04262 GENEFORM Protein DME1041 XEOTICID XEO04262 MOACRIVE Inhibition DME1041 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1041 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04263 XEO_CLAS Peptide DME1041 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04263 GENEFORM Protein DME1041 XEOTICID XEO04263 MOACRIVE Inhibition DME1041 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1041 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04264 XEO_CLAS Peptide DME1041 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04264 GENEFORM Protein DME1041 XEOTICID XEO04264 MOACRIVE Inhibition DME1041 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1041 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04265 XEO_CLAS Peptide DME1041 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04265 GENEFORM Protein DME1041 XEOTICID XEO04265 MOACRIVE Inhibition DME1041 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1041 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04266 XEO_CLAS Peptide DME1041 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04266 GENEFORM Protein DME1041 XEOTICID XEO04266 MOACRIVE Inhibition DME1041 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1041 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04267 XEO_CLAS Peptide DME1041 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04267 GENEFORM Protein DME1041 XEOTICID XEO04267 MOACRIVE Inhibition DME1041 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1041 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04268 XEO_CLAS Peptide DME1041 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04268 GENEFORM Protein DME1041 XEOTICID XEO04268 MOACRIVE Inhibition DME1041 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1041 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04269 XEO_CLAS Peptide DME1041 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04269 GENEFORM Protein DME1041 XEOTICID XEO04269 MOACRIVE Inhibition DME1041 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1041 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04270 XEO_CLAS Peptide DME1041 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04270 GENEFORM Protein DME1041 XEOTICID XEO04270 MOACRIVE Inhibition DME1041 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1041 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04271 XEO_CLAS Peptide DME1041 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04271 GENEFORM Protein DME1041 XEOTICID XEO04271 MOACRIVE Inhibition DME1041 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1041 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04272 XEO_CLAS Peptide DME1041 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04272 GENEFORM Protein DME1041 XEOTICID XEO04272 MOACRIVE Inhibition DME1041 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1041 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04277 XEO_CLAS Peptide DME1041 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 110.00 ug/ml) DME1041 XEOTICID XEO04277 GENEFORM Protein DME1041 XEOTICID XEO04277 MOACRIVE Inhibition DME1041 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1041 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04280 XEO_CLAS Peptide DME1041 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 37.50 ug/ml) DME1041 XEOTICID XEO04280 GENEFORM Protein DME1041 XEOTICID XEO04280 MOACRIVE Inhibition DME1041 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1041 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04281 XEO_CLAS Peptide DME1041 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25.00 ug/ml) DME1041 XEOTICID XEO04281 GENEFORM Protein DME1041 XEOTICID XEO04281 MOACRIVE Inhibition DME1041 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1041 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04282 XEO_CLAS Peptide DME1041 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.2 ug/ml) DME1041 XEOTICID XEO04282 GENEFORM Protein DME1041 XEOTICID XEO04282 MOACRIVE Inhibition DME1041 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1041 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04283 XEO_CLAS Peptide DME1041 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.3 ug/ml) DME1041 XEOTICID XEO04283 GENEFORM Protein DME1041 XEOTICID XEO04283 MOACRIVE Inhibition DME1041 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1041 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04284 XEO_CLAS Peptide DME1041 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10.8 ug/ml) DME1041 XEOTICID XEO04284 GENEFORM Protein DME1041 XEOTICID XEO04284 MOACRIVE Inhibition DME1041 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1041 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04285 XEO_CLAS Peptide DME1041 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 11.5 ug/ml) DME1041 XEOTICID XEO04285 GENEFORM Protein DME1041 XEOTICID XEO04285 MOACRIVE Inhibition DME1041 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1041 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04286 XEO_CLAS Peptide DME1041 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8.6 ug/ml) DME1041 XEOTICID XEO04286 GENEFORM Protein DME1041 XEOTICID XEO04286 MOACRIVE Inhibition DME1041 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1041 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04287 XEO_CLAS Peptide DME1041 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10.2 ug/ml) DME1041 XEOTICID XEO04287 GENEFORM Protein DME1041 XEOTICID XEO04287 MOACRIVE Inhibition DME1041 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1041 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04288 XEO_CLAS Peptide DME1041 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4.4 ug/ml) DME1041 XEOTICID XEO04288 GENEFORM Protein DME1041 XEOTICID XEO04288 MOACRIVE Inhibition DME1041 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1041 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04289 XEO_CLAS Peptide DME1041 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.2 ug/ml) DME1041 XEOTICID XEO04289 GENEFORM Protein DME1041 XEOTICID XEO04289 MOACRIVE Inhibition DME1041 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1041 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04290 XEO_CLAS Peptide DME1041 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 11.3 ug/ml) DME1041 XEOTICID XEO04290 GENEFORM Protein DME1041 XEOTICID XEO04290 MOACRIVE Inhibition DME1041 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1041 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04291 XEO_CLAS Peptide DME1041 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 7.2 ug/ml) DME1041 XEOTICID XEO04291 GENEFORM Protein DME1041 XEOTICID XEO04291 MOACRIVE Inhibition DME1041 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1041 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04292 XEO_CLAS Peptide DME1041 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.1 ug/ml) DME1041 XEOTICID XEO04292 GENEFORM Protein DME1041 XEOTICID XEO04292 MOACRIVE Inhibition DME1041 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1041 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04293 XEO_CLAS Peptide DME1041 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO04293 GENEFORM Protein DME1041 XEOTICID XEO04293 MOACRIVE Inhibition DME1041 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1041 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04294 XEO_CLAS Peptide DME1041 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO04294 GENEFORM Protein DME1041 XEOTICID XEO04294 MOACRIVE Inhibition DME1041 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1041 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04295 XEO_CLAS Peptide DME1041 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO04295 GENEFORM Protein DME1041 XEOTICID XEO04295 MOACRIVE Inhibition DME1041 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1041 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04296 XEO_CLAS Peptide DME1041 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 28 microM) DME1041 XEOTICID XEO04296 GENEFORM Protein DME1041 XEOTICID XEO04296 MOACRIVE Inhibition DME1041 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1041 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04297 XEO_CLAS Peptide DME1041 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 14 microM) DME1041 XEOTICID XEO04297 GENEFORM Protein DME1041 XEOTICID XEO04297 MOACRIVE Inhibition DME1041 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1041 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04298 XEO_CLAS Peptide DME1041 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO04298 GENEFORM Protein DME1041 XEOTICID XEO04298 MOACRIVE Inhibition DME1041 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1041 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04299 XEO_CLAS Peptide DME1041 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO04299 GENEFORM Protein DME1041 XEOTICID XEO04299 MOACRIVE Inhibition DME1041 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1041 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04300 XEO_CLAS Peptide DME1041 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO04300 GENEFORM Protein DME1041 XEOTICID XEO04300 MOACRIVE Inhibition DME1041 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1041 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04301 XEO_CLAS Peptide DME1041 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 microM) DME1041 XEOTICID XEO04301 GENEFORM Protein DME1041 XEOTICID XEO04301 MOACRIVE Inhibition DME1041 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1041 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04302 XEO_CLAS Peptide DME1041 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 microM) DME1041 XEOTICID XEO04302 GENEFORM Protein DME1041 XEOTICID XEO04302 MOACRIVE Inhibition DME1041 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1041 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04303 XEO_CLAS Peptide DME1041 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 microM) DME1041 XEOTICID XEO04303 GENEFORM Protein DME1041 XEOTICID XEO04303 MOACRIVE Inhibition DME1041 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1041 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04304 XEO_CLAS Peptide DME1041 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO04304 GENEFORM Protein DME1041 XEOTICID XEO04304 MOACRIVE Inhibition DME1041 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1041 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04305 XEO_CLAS Peptide DME1041 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 70 microM) DME1041 XEOTICID XEO04305 GENEFORM Protein DME1041 XEOTICID XEO04305 MOACRIVE Inhibition DME1041 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1041 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04306 XEO_CLAS Peptide DME1041 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO04306 GENEFORM Protein DME1041 XEOTICID XEO04306 MOACRIVE Inhibition DME1041 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1041 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04307 XEO_CLAS Peptide DME1041 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 ug/ml) DME1041 XEOTICID XEO04307 GENEFORM Protein DME1041 XEOTICID XEO04307 MOACRIVE Inhibition DME1041 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1041 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04308 XEO_CLAS Peptide DME1041 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9.37 ug/ml) DME1041 XEOTICID XEO04308 GENEFORM Protein DME1041 XEOTICID XEO04308 MOACRIVE Inhibition DME1041 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1041 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04309 XEO_CLAS Peptide DME1041 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 microM) DME1041 XEOTICID XEO04309 GENEFORM Protein DME1041 XEOTICID XEO04309 MOACRIVE Inhibition DME1041 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1041 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04310 XEO_CLAS Peptide DME1041 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO04310 GENEFORM Protein DME1041 XEOTICID XEO04310 MOACRIVE Inhibition DME1041 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1041 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04311 XEO_CLAS Peptide DME1041 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO04311 GENEFORM Protein DME1041 XEOTICID XEO04311 MOACRIVE Inhibition DME1041 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1041 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04312 XEO_CLAS Peptide DME1041 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4.68 ug/ml) DME1041 XEOTICID XEO04312 GENEFORM Protein DME1041 XEOTICID XEO04312 MOACRIVE Inhibition DME1041 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1041 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04313 XEO_CLAS Peptide DME1041 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4.68 ug/ml) DME1041 XEOTICID XEO04313 GENEFORM Protein DME1041 XEOTICID XEO04313 MOACRIVE Inhibition DME1041 XEOTICID XEO04331 XEO_NAME Norspermidine DME1041 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1041 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04331 GENEFORM Protein DME1041 XEOTICID XEO04331 MOACRIVE Inhibition DME1041 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1041 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04335 XEO_CLAS Peptide DME1041 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 32 ug/ml) DME1041 XEOTICID XEO04335 GENEFORM Protein DME1041 XEOTICID XEO04335 MOACRIVE Inhibition DME1041 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1041 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04336 XEO_CLAS Peptide DME1041 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 32 ug/ml) DME1041 XEOTICID XEO04336 GENEFORM Protein DME1041 XEOTICID XEO04336 MOACRIVE Inhibition DME1041 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1041 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04338 XEO_CLAS Peptide DME1041 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 ug/ml) DME1041 XEOTICID XEO04338 GENEFORM Protein DME1041 XEOTICID XEO04338 MOACRIVE Inhibition DME1041 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1041 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04339 XEO_CLAS Peptide DME1041 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 ug/ml) DME1041 XEOTICID XEO04339 GENEFORM Protein DME1041 XEOTICID XEO04339 MOACRIVE Inhibition DME1041 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1041 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04340 XEO_CLAS Peptide DME1041 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO04340 GENEFORM Protein DME1041 XEOTICID XEO04340 MOACRIVE Inhibition DME1041 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1041 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04344 XEO_CLAS Peptide DME1041 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04344 GENEFORM Protein DME1041 XEOTICID XEO04344 MOACRIVE Inhibition DME1041 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1041 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04345 XEO_CLAS Peptide DME1041 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04345 GENEFORM Protein DME1041 XEOTICID XEO04345 MOACRIVE Inhibition DME1041 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1041 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04346 XEO_CLAS Peptide DME1041 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04346 GENEFORM Protein DME1041 XEOTICID XEO04346 MOACRIVE Inhibition DME1041 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1041 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04347 XEO_CLAS Peptide DME1041 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 microM) DME1041 XEOTICID XEO04347 GENEFORM Protein DME1041 XEOTICID XEO04347 MOACRIVE Inhibition DME1041 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1041 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04348 XEO_CLAS Peptide DME1041 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40 microM) DME1041 XEOTICID XEO04348 GENEFORM Protein DME1041 XEOTICID XEO04348 MOACRIVE Inhibition DME1041 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1041 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04349 XEO_CLAS Peptide DME1041 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO04349 GENEFORM Protein DME1041 XEOTICID XEO04349 MOACRIVE Inhibition DME1041 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1041 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04354 XEO_CLAS Peptide DME1041 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 35.2 ug/ml) DME1041 XEOTICID XEO04354 GENEFORM Protein DME1041 XEOTICID XEO04354 MOACRIVE Inhibition DME1041 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1041 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04355 XEO_CLAS Peptide DME1041 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.21 ug/ml) DME1041 XEOTICID XEO04355 GENEFORM Protein DME1041 XEOTICID XEO04355 MOACRIVE Inhibition DME1041 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1041 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04356 XEO_CLAS Peptide DME1041 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8.21 ug/ml) DME1041 XEOTICID XEO04356 GENEFORM Protein DME1041 XEOTICID XEO04356 MOACRIVE Inhibition DME1041 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1041 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04357 XEO_CLAS Peptide DME1041 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16.32 ug/ml) DME1041 XEOTICID XEO04357 GENEFORM Protein DME1041 XEOTICID XEO04357 MOACRIVE Inhibition DME1041 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1041 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04358 XEO_CLAS Peptide DME1041 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9.37 ug/ml) DME1041 XEOTICID XEO04358 GENEFORM Protein DME1041 XEOTICID XEO04358 MOACRIVE Inhibition DME1041 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1041 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04359 XEO_CLAS Peptide DME1041 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4.20 ug/ml) DME1041 XEOTICID XEO04359 GENEFORM Protein DME1041 XEOTICID XEO04359 MOACRIVE Inhibition DME1041 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1041 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04360 XEO_CLAS Peptide DME1041 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 ug/ml) DME1041 XEOTICID XEO04360 GENEFORM Protein DME1041 XEOTICID XEO04360 MOACRIVE Inhibition DME1041 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1041 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04361 XEO_CLAS Peptide DME1041 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 7.5 ug/ml) DME1041 XEOTICID XEO04361 GENEFORM Protein DME1041 XEOTICID XEO04361 MOACRIVE Inhibition DME1041 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1041 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04362 XEO_CLAS Peptide DME1041 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.6 ug/ml) DME1041 XEOTICID XEO04362 GENEFORM Protein DME1041 XEOTICID XEO04362 MOACRIVE Inhibition DME1041 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1041 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04363 XEO_CLAS Peptide DME1041 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8.2 ug/ml) DME1041 XEOTICID XEO04363 GENEFORM Protein DME1041 XEOTICID XEO04363 MOACRIVE Inhibition DME1041 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1041 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04364 XEO_CLAS Peptide DME1041 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO04364 GENEFORM Protein DME1041 XEOTICID XEO04364 MOACRIVE Inhibition DME1041 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1041 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04365 XEO_CLAS Peptide DME1041 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4.68 ug/ml) DME1041 XEOTICID XEO04365 GENEFORM Protein DME1041 XEOTICID XEO04365 MOACRIVE Inhibition DME1041 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1041 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04366 XEO_CLAS Peptide DME1041 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 23.60 ug/ml) DME1041 XEOTICID XEO04366 GENEFORM Protein DME1041 XEOTICID XEO04366 MOACRIVE Inhibition DME1041 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1041 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04367 XEO_CLAS Peptide DME1041 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 35.60 ug/ml) DME1041 XEOTICID XEO04367 GENEFORM Protein DME1041 XEOTICID XEO04367 MOACRIVE Inhibition DME1041 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1041 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04368 XEO_CLAS Peptide DME1041 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40.2 ug/ml) DME1041 XEOTICID XEO04368 GENEFORM Protein DME1041 XEOTICID XEO04368 MOACRIVE Inhibition DME1041 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1041 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04369 XEO_CLAS Peptide DME1041 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40.2 ug/ml) DME1041 XEOTICID XEO04369 GENEFORM Protein DME1041 XEOTICID XEO04369 MOACRIVE Inhibition DME1041 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1041 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04370 XEO_CLAS Peptide DME1041 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4.68 ug/ml) DME1041 XEOTICID XEO04370 GENEFORM Protein DME1041 XEOTICID XEO04370 MOACRIVE Inhibition DME1041 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1041 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04371 XEO_CLAS Peptide DME1041 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9.37 ug/ml) DME1041 XEOTICID XEO04371 GENEFORM Protein DME1041 XEOTICID XEO04371 MOACRIVE Inhibition DME1041 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1041 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04373 XEO_CLAS Peptide DME1041 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 ug/ml) DME1041 XEOTICID XEO04373 GENEFORM Protein DME1041 XEOTICID XEO04373 MOACRIVE Inhibition DME1041 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1041 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04374 XEO_CLAS Peptide DME1041 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.50 ug/ml) DME1041 XEOTICID XEO04374 GENEFORM Protein DME1041 XEOTICID XEO04374 MOACRIVE Inhibition DME1041 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1041 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04375 XEO_CLAS Peptide DME1041 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25 ug/ml) DME1041 XEOTICID XEO04375 GENEFORM Protein DME1041 XEOTICID XEO04375 MOACRIVE Inhibition DME1041 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1041 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04377 XEO_CLAS Peptide DME1041 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 42.50 ug/ml) DME1041 XEOTICID XEO04377 GENEFORM Protein DME1041 XEOTICID XEO04377 MOACRIVE Inhibition DME1041 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1041 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04378 XEO_CLAS Peptide DME1041 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 17.50 ug/ml) DME1041 XEOTICID XEO04378 GENEFORM Protein DME1041 XEOTICID XEO04378 MOACRIVE Inhibition DME1041 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1041 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04379 XEO_CLAS Peptide DME1041 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 ug/ml) DME1041 XEOTICID XEO04379 GENEFORM Protein DME1041 XEOTICID XEO04379 MOACRIVE Inhibition DME1041 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1041 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04380 XEO_CLAS Peptide DME1041 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 36.00 ug/ml) DME1041 XEOTICID XEO04380 GENEFORM Protein DME1041 XEOTICID XEO04380 MOACRIVE Inhibition DME1041 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1041 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04381 XEO_CLAS Peptide DME1041 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.60 ug/ml) DME1041 XEOTICID XEO04381 GENEFORM Protein DME1041 XEOTICID XEO04381 MOACRIVE Inhibition DME1041 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1041 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04382 XEO_CLAS Peptide DME1041 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 ug/ml) DME1041 XEOTICID XEO04382 GENEFORM Protein DME1041 XEOTICID XEO04382 MOACRIVE Inhibition DME1041 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1041 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04383 XEO_CLAS Peptide DME1041 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO04383 GENEFORM Protein DME1041 XEOTICID XEO04383 MOACRIVE Inhibition DME1041 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1041 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04384 XEO_CLAS Peptide DME1041 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO04384 GENEFORM Protein DME1041 XEOTICID XEO04384 MOACRIVE Inhibition DME1041 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1041 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04385 XEO_CLAS Peptide DME1041 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.25 ug/ml) DME1041 XEOTICID XEO04385 GENEFORM Protein DME1041 XEOTICID XEO04385 MOACRIVE Inhibition DME1041 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1041 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04395 XEO_CLAS Peptide DME1041 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.4-0.8 microM) DME1041 XEOTICID XEO04395 GENEFORM Protein DME1041 XEOTICID XEO04395 MOACRIVE Inhibition DME1041 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1041 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04396 XEO_CLAS Peptide DME1041 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.25-0.5 microM) DME1041 XEOTICID XEO04396 GENEFORM Protein DME1041 XEOTICID XEO04396 MOACRIVE Inhibition DME1041 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1041 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04397 XEO_CLAS Peptide DME1041 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.25-0.5 microM) DME1041 XEOTICID XEO04397 GENEFORM Protein DME1041 XEOTICID XEO04397 MOACRIVE Inhibition DME1041 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1041 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04398 XEO_CLAS Peptide DME1041 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 microM) DME1041 XEOTICID XEO04398 GENEFORM Protein DME1041 XEOTICID XEO04398 MOACRIVE Inhibition DME1041 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1041 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04399 XEO_CLAS Peptide DME1041 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO04399 GENEFORM Protein DME1041 XEOTICID XEO04399 MOACRIVE Inhibition DME1041 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1041 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04400 XEO_CLAS Peptide DME1041 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 ug/ml) DME1041 XEOTICID XEO04400 GENEFORM Protein DME1041 XEOTICID XEO04400 MOACRIVE Inhibition DME1041 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1041 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04401 XEO_CLAS Peptide DME1041 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.6 ug/ml) DME1041 XEOTICID XEO04401 GENEFORM Protein DME1041 XEOTICID XEO04401 MOACRIVE Inhibition DME1041 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1041 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04402 XEO_CLAS Peptide DME1041 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 ug/ml) DME1041 XEOTICID XEO04402 GENEFORM Protein DME1041 XEOTICID XEO04402 MOACRIVE Inhibition DME1041 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1041 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04403 XEO_CLAS Peptide DME1041 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.6 ug/ml) DME1041 XEOTICID XEO04403 GENEFORM Protein DME1041 XEOTICID XEO04403 MOACRIVE Inhibition DME1041 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1041 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04404 XEO_CLAS Peptide DME1041 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.6 ug/ml) DME1041 XEOTICID XEO04404 GENEFORM Protein DME1041 XEOTICID XEO04404 MOACRIVE Inhibition DME1041 XEOTICID XEO04410 XEO_NAME Insect osmin DME1041 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04410 XEO_CLAS Peptide DME1041 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.125-1.56 microM) DME1041 XEOTICID XEO04410 GENEFORM Protein DME1041 XEOTICID XEO04410 MOACRIVE Inhibition DME1041 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1041 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04412 XEO_CLAS Peptide DME1041 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04412 GENEFORM Protein DME1041 XEOTICID XEO04412 MOACRIVE Inhibition DME1041 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1041 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04414 XEO_CLAS Peptide DME1041 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04414 GENEFORM Protein DME1041 XEOTICID XEO04414 MOACRIVE Inhibition DME1041 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1041 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04415 XEO_CLAS Peptide DME1041 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04415 GENEFORM Protein DME1041 XEOTICID XEO04415 MOACRIVE Inhibition DME1041 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1041 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04421 XEO_CLAS Peptide DME1041 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 microM) DME1041 XEOTICID XEO04421 GENEFORM Protein DME1041 XEOTICID XEO04421 MOACRIVE Inhibition DME1041 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1041 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04426 XEO_CLAS Peptide DME1041 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO04426 GENEFORM Protein DME1041 XEOTICID XEO04426 MOACRIVE Inhibition DME1041 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1041 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04428 XEO_CLAS Peptide DME1041 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.3 ug/ml) DME1041 XEOTICID XEO04428 GENEFORM Protein DME1041 XEOTICID XEO04428 MOACRIVE Inhibition DME1041 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1041 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04430 XEO_CLAS Peptide DME1041 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25 microM) DME1041 XEOTICID XEO04430 GENEFORM Protein DME1041 XEOTICID XEO04430 MOACRIVE Inhibition DME1041 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1041 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04433 XEO_CLAS Peptide DME1041 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 160 microM) DME1041 XEOTICID XEO04433 GENEFORM Protein DME1041 XEOTICID XEO04433 MOACRIVE Inhibition DME1041 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1041 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04435 XEO_CLAS Peptide DME1041 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 160 microM) DME1041 XEOTICID XEO04435 GENEFORM Protein DME1041 XEOTICID XEO04435 MOACRIVE Inhibition DME1041 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1041 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1041 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04438 GENEFORM Protein DME1041 XEOTICID XEO04438 MOACRIVE Inhibition DME1041 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1041 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04439 XEO_CLAS Peptide DME1041 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04439 GENEFORM Protein DME1041 XEOTICID XEO04439 MOACRIVE Inhibition DME1041 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1041 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04440 XEO_CLAS Peptide DME1041 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 microM) DME1041 XEOTICID XEO04440 GENEFORM Protein DME1041 XEOTICID XEO04440 MOACRIVE Inhibition DME1041 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1041 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04441 XEO_CLAS Peptide DME1041 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 28 microM) DME1041 XEOTICID XEO04441 GENEFORM Protein DME1041 XEOTICID XEO04441 MOACRIVE Inhibition DME1041 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1041 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04442 XEO_CLAS Peptide DME1041 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 28 microM) DME1041 XEOTICID XEO04442 GENEFORM Protein DME1041 XEOTICID XEO04442 MOACRIVE Inhibition DME1041 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1041 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04443 XEO_CLAS Peptide DME1041 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04443 GENEFORM Protein DME1041 XEOTICID XEO04443 MOACRIVE Inhibition DME1041 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1041 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04444 XEO_CLAS Peptide DME1041 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 13 microM) DME1041 XEOTICID XEO04444 GENEFORM Protein DME1041 XEOTICID XEO04444 MOACRIVE Inhibition DME1041 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1041 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04445 XEO_CLAS Peptide DME1041 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04445 GENEFORM Protein DME1041 XEOTICID XEO04445 MOACRIVE Inhibition DME1041 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1041 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04446 XEO_CLAS Peptide DME1041 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 78 microM) DME1041 XEOTICID XEO04446 GENEFORM Protein DME1041 XEOTICID XEO04446 MOACRIVE Inhibition DME1041 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1041 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04447 XEO_CLAS Peptide DME1041 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 120 microM) DME1041 XEOTICID XEO04447 GENEFORM Protein DME1041 XEOTICID XEO04447 MOACRIVE Inhibition DME1041 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1041 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04448 XEO_CLAS Peptide DME1041 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 microM) DME1041 XEOTICID XEO04448 GENEFORM Protein DME1041 XEOTICID XEO04448 MOACRIVE Inhibition DME1041 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1041 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04449 XEO_CLAS Peptide DME1041 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.3 microM) DME1041 XEOTICID XEO04449 GENEFORM Protein DME1041 XEOTICID XEO04449 MOACRIVE Inhibition DME1041 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1041 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04450 XEO_CLAS Peptide DME1041 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.3 microM) DME1041 XEOTICID XEO04450 GENEFORM Protein DME1041 XEOTICID XEO04450 MOACRIVE Inhibition DME1041 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1041 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04451 XEO_CLAS Peptide DME1041 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO04451 GENEFORM Protein DME1041 XEOTICID XEO04451 MOACRIVE Inhibition DME1041 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1041 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04452 XEO_CLAS Peptide DME1041 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.1 microM) DME1041 XEOTICID XEO04452 GENEFORM Protein DME1041 XEOTICID XEO04452 MOACRIVE Inhibition DME1041 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1041 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04453 XEO_CLAS Peptide DME1041 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO04453 GENEFORM Protein DME1041 XEOTICID XEO04453 MOACRIVE Inhibition DME1041 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1041 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04455 XEO_CLAS Peptide DME1041 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 microM) DME1041 XEOTICID XEO04455 GENEFORM Protein DME1041 XEOTICID XEO04455 MOACRIVE Inhibition DME1041 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1041 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04457 XEO_CLAS Peptide DME1041 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.3 microM) DME1041 XEOTICID XEO04457 GENEFORM Protein DME1041 XEOTICID XEO04457 MOACRIVE Inhibition DME1041 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1041 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04458 XEO_CLAS Peptide DME1041 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1 microM) DME1041 XEOTICID XEO04458 GENEFORM Protein DME1041 XEOTICID XEO04458 MOACRIVE Inhibition DME1041 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1041 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04459 XEO_CLAS Peptide DME1041 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1 microM) DME1041 XEOTICID XEO04459 GENEFORM Protein DME1041 XEOTICID XEO04459 MOACRIVE Inhibition DME1041 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1041 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04461 XEO_CLAS Peptide DME1041 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20.8 microM) DME1041 XEOTICID XEO04461 GENEFORM Protein DME1041 XEOTICID XEO04461 MOACRIVE Inhibition DME1041 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1041 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04462 XEO_CLAS Peptide DME1041 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 19.1 microM) DME1041 XEOTICID XEO04462 GENEFORM Protein DME1041 XEOTICID XEO04462 MOACRIVE Inhibition DME1041 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1041 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04463 XEO_CLAS Peptide DME1041 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04463 GENEFORM Protein DME1041 XEOTICID XEO04463 MOACRIVE Inhibition DME1041 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1041 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04464 XEO_CLAS Peptide DME1041 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.5 microM) DME1041 XEOTICID XEO04464 GENEFORM Protein DME1041 XEOTICID XEO04464 MOACRIVE Inhibition DME1041 XEOTICID XEO04466 XEO_NAME Panusin DME1041 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04466 XEO_CLAS Peptide DME1041 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04466 GENEFORM Protein DME1041 XEOTICID XEO04466 MOACRIVE Inhibition DME1041 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1041 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04467 XEO_CLAS Peptide DME1041 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4.8 microM) DME1041 XEOTICID XEO04467 GENEFORM Protein DME1041 XEOTICID XEO04467 MOACRIVE Inhibition DME1041 XEOTICID XEO04468 XEO_NAME Papillosin DME1041 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04468 XEO_CLAS Peptide DME1041 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04468 GENEFORM Protein DME1041 XEOTICID XEO04468 MOACRIVE Inhibition DME1041 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1041 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04471 XEO_CLAS Peptide DME1041 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.1 microM) DME1041 XEOTICID XEO04471 GENEFORM Protein DME1041 XEOTICID XEO04471 MOACRIVE Inhibition DME1041 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1041 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04480 XEO_CLAS Peptide DME1041 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 ug/ml) DME1041 XEOTICID XEO04480 GENEFORM Protein DME1041 XEOTICID XEO04480 MOACRIVE Inhibition DME1041 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1041 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1041 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04482 GENEFORM Protein DME1041 XEOTICID XEO04482 MOACRIVE Inhibition DME1041 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1041 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04484 XEO_CLAS Peptide DME1041 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 microM) DME1041 XEOTICID XEO04484 GENEFORM Protein DME1041 XEOTICID XEO04484 MOACRIVE Inhibition DME1041 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1041 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04485 XEO_CLAS Peptide DME1041 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO04485 GENEFORM Protein DME1041 XEOTICID XEO04485 MOACRIVE Inhibition DME1041 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1041 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04486 XEO_CLAS Peptide DME1041 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 microM) DME1041 XEOTICID XEO04486 GENEFORM Protein DME1041 XEOTICID XEO04486 MOACRIVE Inhibition DME1041 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1041 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04487 XEO_CLAS Peptide DME1041 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO04487 GENEFORM Protein DME1041 XEOTICID XEO04487 MOACRIVE Inhibition DME1041 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1041 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04488 XEO_CLAS Peptide DME1041 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9 microM) DME1041 XEOTICID XEO04488 GENEFORM Protein DME1041 XEOTICID XEO04488 MOACRIVE Inhibition DME1041 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1041 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04489 XEO_CLAS Peptide DME1041 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 13 microM) DME1041 XEOTICID XEO04489 GENEFORM Protein DME1041 XEOTICID XEO04489 MOACRIVE Inhibition DME1041 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1041 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04490 XEO_CLAS Peptide DME1041 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 47.5 microM) DME1041 XEOTICID XEO04490 GENEFORM Protein DME1041 XEOTICID XEO04490 MOACRIVE Inhibition DME1041 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1041 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04491 XEO_CLAS Peptide DME1041 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO04491 GENEFORM Protein DME1041 XEOTICID XEO04491 MOACRIVE Inhibition DME1041 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1041 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04492 XEO_CLAS Peptide DME1041 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 35 microM) DME1041 XEOTICID XEO04492 GENEFORM Protein DME1041 XEOTICID XEO04492 MOACRIVE Inhibition DME1041 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1041 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04493 XEO_CLAS Peptide DME1041 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 microM) DME1041 XEOTICID XEO04493 GENEFORM Protein DME1041 XEOTICID XEO04493 MOACRIVE Inhibition DME1041 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1041 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04494 XEO_CLAS Peptide DME1041 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO04494 GENEFORM Protein DME1041 XEOTICID XEO04494 MOACRIVE Inhibition DME1041 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1041 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04495 XEO_CLAS Peptide DME1041 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO04495 GENEFORM Protein DME1041 XEOTICID XEO04495 MOACRIVE Inhibition DME1041 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1041 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04496 XEO_CLAS Peptide DME1041 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 67.5 microM) DME1041 XEOTICID XEO04496 GENEFORM Protein DME1041 XEOTICID XEO04496 MOACRIVE Inhibition DME1041 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1041 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04497 XEO_CLAS Peptide DME1041 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO04497 GENEFORM Protein DME1041 XEOTICID XEO04497 MOACRIVE Inhibition DME1041 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1041 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04498 XEO_CLAS Peptide DME1041 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO04498 GENEFORM Protein DME1041 XEOTICID XEO04498 MOACRIVE Inhibition DME1041 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1041 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04499 XEO_CLAS Peptide DME1041 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 43 microM) DME1041 XEOTICID XEO04499 GENEFORM Protein DME1041 XEOTICID XEO04499 MOACRIVE Inhibition DME1041 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1041 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04500 XEO_CLAS Peptide DME1041 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO04500 GENEFORM Protein DME1041 XEOTICID XEO04500 MOACRIVE Inhibition DME1041 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1041 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04504 XEO_CLAS Peptide DME1041 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04504 GENEFORM Protein DME1041 XEOTICID XEO04504 MOACRIVE Inhibition DME1041 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1041 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04505 XEO_CLAS Peptide DME1041 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04505 GENEFORM Protein DME1041 XEOTICID XEO04505 MOACRIVE Inhibition DME1041 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1041 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04506 XEO_CLAS Peptide DME1041 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 40 microM) DME1041 XEOTICID XEO04506 GENEFORM Protein DME1041 XEOTICID XEO04506 MOACRIVE Inhibition DME1041 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1041 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04507 XEO_CLAS Peptide DME1041 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10-20 microM) DME1041 XEOTICID XEO04507 GENEFORM Protein DME1041 XEOTICID XEO04507 MOACRIVE Inhibition DME1041 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1041 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04508 XEO_CLAS Peptide DME1041 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04508 GENEFORM Protein DME1041 XEOTICID XEO04508 MOACRIVE Inhibition DME1041 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1041 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04509 XEO_CLAS Peptide DME1041 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04509 GENEFORM Protein DME1041 XEOTICID XEO04509 MOACRIVE Inhibition DME1041 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1041 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04510 XEO_CLAS Peptide DME1041 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 22-33 microM) DME1041 XEOTICID XEO04510 GENEFORM Protein DME1041 XEOTICID XEO04510 MOACRIVE Inhibition DME1041 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1041 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04525 XEO_CLAS Peptide DME1041 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 32.0 microM) DME1041 XEOTICID XEO04525 GENEFORM Protein DME1041 XEOTICID XEO04525 MOACRIVE Inhibition DME1041 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1041 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04526 XEO_CLAS Peptide DME1041 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.0 microM) DME1041 XEOTICID XEO04526 GENEFORM Protein DME1041 XEOTICID XEO04526 MOACRIVE Inhibition DME1041 XEOTICID XEO04527 XEO_NAME Pepcon DME1041 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04527 XEO_CLAS Peptide DME1041 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO04527 GENEFORM Protein DME1041 XEOTICID XEO04527 MOACRIVE Inhibition DME1041 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1041 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04532 XEO_CLAS Peptide DME1041 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04532 GENEFORM Protein DME1041 XEOTICID XEO04532 MOACRIVE Inhibition DME1041 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1041 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04540 XEO_CLAS Peptide DME1041 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 18.1 ug/ml) DME1041 XEOTICID XEO04540 GENEFORM Protein DME1041 XEOTICID XEO04540 MOACRIVE Inhibition DME1041 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1041 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04541 XEO_CLAS Peptide DME1041 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.5 ug/ml) DME1041 XEOTICID XEO04541 GENEFORM Protein DME1041 XEOTICID XEO04541 MOACRIVE Inhibition DME1041 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1041 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04542 XEO_CLAS Peptide DME1041 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04542 GENEFORM Protein DME1041 XEOTICID XEO04542 MOACRIVE Inhibition DME1041 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1041 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04543 XEO_CLAS Peptide DME1041 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04543 GENEFORM Protein DME1041 XEOTICID XEO04543 MOACRIVE Inhibition DME1041 XEOTICID XEO04546 XEO_NAME Perinerin DME1041 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04546 XEO_CLAS Peptide DME1041 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04546 GENEFORM Protein DME1041 XEOTICID XEO04546 MOACRIVE Inhibition DME1041 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1041 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04548 XEO_CLAS Peptide DME1041 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 72000 ug/ml) DME1041 XEOTICID XEO04548 GENEFORM Protein DME1041 XEOTICID XEO04548 MOACRIVE Inhibition DME1041 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1041 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04549 XEO_CLAS Peptide DME1041 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 62-125 ug/ml) DME1041 XEOTICID XEO04549 GENEFORM Protein DME1041 XEOTICID XEO04549 MOACRIVE Inhibition DME1041 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1041 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04550 XEO_CLAS Peptide DME1041 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO04550 GENEFORM Protein DME1041 XEOTICID XEO04550 MOACRIVE Inhibition DME1041 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1041 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04551 XEO_CLAS Peptide DME1041 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 23.6 ug/ml) DME1041 XEOTICID XEO04551 GENEFORM Protein DME1041 XEOTICID XEO04551 MOACRIVE Inhibition DME1041 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1041 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04552 XEO_CLAS Peptide DME1041 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04552 GENEFORM Protein DME1041 XEOTICID XEO04552 MOACRIVE Inhibition DME1041 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1041 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04553 XEO_CLAS Peptide DME1041 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04553 GENEFORM Protein DME1041 XEOTICID XEO04553 MOACRIVE Inhibition DME1041 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1041 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04554 XEO_CLAS Peptide DME1041 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04554 GENEFORM Protein DME1041 XEOTICID XEO04554 MOACRIVE Inhibition DME1041 XEOTICID XEO04563 XEO_NAME Phosphate DME1041 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1041 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04563 GENEFORM Protein DME1041 XEOTICID XEO04563 MOACRIVE Inhibition DME1041 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1041 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04565 XEO_CLAS Peptide DME1041 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.5 microM) DME1041 XEOTICID XEO04565 GENEFORM Protein DME1041 XEOTICID XEO04565 MOACRIVE Inhibition DME1041 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1041 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04566 XEO_CLAS Peptide DME1041 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.7 microM) DME1041 XEOTICID XEO04566 GENEFORM Protein DME1041 XEOTICID XEO04566 MOACRIVE Inhibition DME1041 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1041 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04569 XEO_CLAS Peptide DME1041 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 7.9 microM) DME1041 XEOTICID XEO04569 GENEFORM Protein DME1041 XEOTICID XEO04569 MOACRIVE Inhibition DME1041 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1041 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04570 XEO_CLAS Peptide DME1041 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04570 GENEFORM Protein DME1041 XEOTICID XEO04570 MOACRIVE Inhibition DME1041 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1041 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04571 XEO_CLAS Peptide DME1041 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04571 GENEFORM Protein DME1041 XEOTICID XEO04571 MOACRIVE Inhibition DME1041 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1041 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04572 XEO_CLAS Peptide DME1041 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04572 GENEFORM Protein DME1041 XEOTICID XEO04572 MOACRIVE Inhibition DME1041 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1041 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04573 XEO_CLAS Peptide DME1041 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 microM) DME1041 XEOTICID XEO04573 GENEFORM Protein DME1041 XEOTICID XEO04573 MOACRIVE Inhibition DME1041 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1041 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04574 XEO_CLAS Peptide DME1041 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 128 ug/ml) DME1041 XEOTICID XEO04574 GENEFORM Protein DME1041 XEOTICID XEO04574 MOACRIVE Inhibition DME1041 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1041 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04575 XEO_CLAS Peptide DME1041 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO04575 GENEFORM Protein DME1041 XEOTICID XEO04575 MOACRIVE Inhibition DME1041 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1041 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04578 GENEFORM Protein DME1041 XEOTICID XEO04578 MOACRIVE Inhibition DME1041 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1041 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04579 GENEFORM Protein DME1041 XEOTICID XEO04579 MOACRIVE Inhibition DME1041 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1041 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04580 GENEFORM Protein DME1041 XEOTICID XEO04580 MOACRIVE Inhibition DME1041 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1041 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04583 GENEFORM Protein DME1041 XEOTICID XEO04583 MOACRIVE Inhibition DME1041 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1041 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04588 GENEFORM Protein DME1041 XEOTICID XEO04588 MOACRIVE Inhibition DME1041 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1041 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04589 GENEFORM Protein DME1041 XEOTICID XEO04589 MOACRIVE Inhibition DME1041 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1041 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04590 GENEFORM Protein DME1041 XEOTICID XEO04590 MOACRIVE Inhibition DME1041 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1041 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04591 GENEFORM Protein DME1041 XEOTICID XEO04591 MOACRIVE Inhibition DME1041 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1041 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04592 GENEFORM Protein DME1041 XEOTICID XEO04592 MOACRIVE Inhibition DME1041 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1041 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04593 GENEFORM Protein DME1041 XEOTICID XEO04593 MOACRIVE Inhibition DME1041 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1041 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04594 GENEFORM Protein DME1041 XEOTICID XEO04594 MOACRIVE Inhibition DME1041 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1041 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04595 GENEFORM Protein DME1041 XEOTICID XEO04595 MOACRIVE Inhibition DME1041 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1041 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04596 GENEFORM Protein DME1041 XEOTICID XEO04596 MOACRIVE Inhibition DME1041 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1041 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04597 GENEFORM Protein DME1041 XEOTICID XEO04597 MOACRIVE Inhibition DME1041 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1041 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04598 GENEFORM Protein DME1041 XEOTICID XEO04598 MOACRIVE Inhibition DME1041 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1041 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04599 GENEFORM Protein DME1041 XEOTICID XEO04599 MOACRIVE Inhibition DME1041 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1041 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04601 XEO_CLAS Peptide DME1041 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 18.75 ug/ml) DME1041 XEOTICID XEO04601 GENEFORM Protein DME1041 XEOTICID XEO04601 MOACRIVE Inhibition DME1041 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1041 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04602 XEO_CLAS Peptide DME1041 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 37.5 ug/ml) DME1041 XEOTICID XEO04602 GENEFORM Protein DME1041 XEOTICID XEO04602 MOACRIVE Inhibition DME1041 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1041 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04604 XEO_CLAS Peptide DME1041 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC < 25 microM) DME1041 XEOTICID XEO04604 GENEFORM Protein DME1041 XEOTICID XEO04604 MOACRIVE Inhibition DME1041 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1041 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04605 XEO_CLAS Peptide DME1041 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC < 6.25 microM) DME1041 XEOTICID XEO04605 GENEFORM Protein DME1041 XEOTICID XEO04605 MOACRIVE Inhibition DME1041 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1041 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04606 XEO_CLAS Peptide DME1041 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO04606 GENEFORM Protein DME1041 XEOTICID XEO04606 MOACRIVE Inhibition DME1041 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1041 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1041 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04607 GENEFORM Protein DME1041 XEOTICID XEO04607 MOACRIVE Inhibition DME1041 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1041 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04612 XEO_CLAS Peptide DME1041 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5-10 microM) DME1041 XEOTICID XEO04612 GENEFORM Protein DME1041 XEOTICID XEO04612 MOACRIVE Inhibition DME1041 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1041 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04613 XEO_CLAS Peptide DME1041 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5-10 microM) DME1041 XEOTICID XEO04613 GENEFORM Protein DME1041 XEOTICID XEO04613 MOACRIVE Inhibition DME1041 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1041 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04625 XEO_CLAS Peptide DME1041 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO04625 GENEFORM Protein DME1041 XEOTICID XEO04625 MOACRIVE Inhibition DME1041 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1041 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04626 XEO_CLAS Peptide DME1041 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO04626 GENEFORM Protein DME1041 XEOTICID XEO04626 MOACRIVE Inhibition DME1041 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1041 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04627 XEO_CLAS Peptide DME1041 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.5 microM) DME1041 XEOTICID XEO04627 GENEFORM Protein DME1041 XEOTICID XEO04627 MOACRIVE Inhibition DME1041 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1041 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04630 XEO_CLAS Peptide DME1041 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 60 ug/ml) DME1041 XEOTICID XEO04630 GENEFORM Protein DME1041 XEOTICID XEO04630 MOACRIVE Inhibition DME1041 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1041 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04631 XEO_CLAS Peptide DME1041 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 60 ug/ml) DME1041 XEOTICID XEO04631 GENEFORM Protein DME1041 XEOTICID XEO04631 MOACRIVE Inhibition DME1041 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1041 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04633 XEO_CLAS Peptide DME1041 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 ug/ml) DME1041 XEOTICID XEO04633 GENEFORM Protein DME1041 XEOTICID XEO04633 MOACRIVE Inhibition DME1041 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1041 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04634 XEO_CLAS Peptide DME1041 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 ug/ml) DME1041 XEOTICID XEO04634 GENEFORM Protein DME1041 XEOTICID XEO04634 MOACRIVE Inhibition DME1041 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1041 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04635 XEO_CLAS Peptide DME1041 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 ug/ml) DME1041 XEOTICID XEO04635 GENEFORM Protein DME1041 XEOTICID XEO04635 MOACRIVE Inhibition DME1041 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1041 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04636 XEO_CLAS Peptide DME1041 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 ug/ml) DME1041 XEOTICID XEO04636 GENEFORM Protein DME1041 XEOTICID XEO04636 MOACRIVE Inhibition DME1041 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1041 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04637 XEO_CLAS Peptide DME1041 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 ug/ml) DME1041 XEOTICID XEO04637 GENEFORM Protein DME1041 XEOTICID XEO04637 MOACRIVE Inhibition DME1041 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1041 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04638 XEO_CLAS Peptide DME1041 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 ug/ml) DME1041 XEOTICID XEO04638 GENEFORM Protein DME1041 XEOTICID XEO04638 MOACRIVE Inhibition DME1041 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1041 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04639 XEO_CLAS Peptide DME1041 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 ug/ml) DME1041 XEOTICID XEO04639 GENEFORM Protein DME1041 XEOTICID XEO04639 MOACRIVE Inhibition DME1041 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1041 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04640 XEO_CLAS Peptide DME1041 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.2-3.3 microM) DME1041 XEOTICID XEO04640 GENEFORM Protein DME1041 XEOTICID XEO04640 MOACRIVE Inhibition DME1041 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1041 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04642 XEO_CLAS Peptide DME1041 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 ug/ml) DME1041 XEOTICID XEO04642 GENEFORM Protein DME1041 XEOTICID XEO04642 MOACRIVE Inhibition DME1041 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1041 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04643 XEO_CLAS Peptide DME1041 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO04643 GENEFORM Protein DME1041 XEOTICID XEO04643 MOACRIVE Inhibition DME1041 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1041 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04644 XEO_CLAS Peptide DME1041 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO04644 GENEFORM Protein DME1041 XEOTICID XEO04644 MOACRIVE Inhibition DME1041 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1041 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04645 XEO_CLAS Peptide DME1041 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 ug/ml) DME1041 XEOTICID XEO04645 GENEFORM Protein DME1041 XEOTICID XEO04645 MOACRIVE Inhibition DME1041 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1041 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04646 XEO_CLAS Peptide DME1041 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1 ug/ml) DME1041 XEOTICID XEO04646 GENEFORM Protein DME1041 XEOTICID XEO04646 MOACRIVE Inhibition DME1041 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1041 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04647 XEO_CLAS Peptide DME1041 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO04647 GENEFORM Protein DME1041 XEOTICID XEO04647 MOACRIVE Inhibition DME1041 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1041 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04648 XEO_CLAS Peptide DME1041 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 ug/ml) DME1041 XEOTICID XEO04648 GENEFORM Protein DME1041 XEOTICID XEO04648 MOACRIVE Inhibition DME1041 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1041 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04649 XEO_CLAS Peptide DME1041 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 64 ug/ml) DME1041 XEOTICID XEO04649 GENEFORM Protein DME1041 XEOTICID XEO04649 MOACRIVE Inhibition DME1041 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1041 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04650 XEO_CLAS Peptide DME1041 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 ug/ml) DME1041 XEOTICID XEO04650 GENEFORM Protein DME1041 XEOTICID XEO04650 MOACRIVE Inhibition DME1041 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1041 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04651 XEO_CLAS Peptide DME1041 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 ug/ml) DME1041 XEOTICID XEO04651 GENEFORM Protein DME1041 XEOTICID XEO04651 MOACRIVE Inhibition DME1041 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1041 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04652 XEO_CLAS Peptide DME1041 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO04652 GENEFORM Protein DME1041 XEOTICID XEO04652 MOACRIVE Inhibition DME1041 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1041 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04653 XEO_CLAS Peptide DME1041 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 64 ug/ml) DME1041 XEOTICID XEO04653 GENEFORM Protein DME1041 XEOTICID XEO04653 MOACRIVE Inhibition DME1041 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1041 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04654 XEO_CLAS Peptide DME1041 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 ug/ml) DME1041 XEOTICID XEO04654 GENEFORM Protein DME1041 XEOTICID XEO04654 MOACRIVE Inhibition DME1041 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1041 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04655 XEO_CLAS Peptide DME1041 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO04655 GENEFORM Protein DME1041 XEOTICID XEO04655 MOACRIVE Inhibition DME1041 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1041 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04657 XEO_CLAS Peptide DME1041 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 300 microM) DME1041 XEOTICID XEO04657 GENEFORM Protein DME1041 XEOTICID XEO04657 MOACRIVE Inhibition DME1041 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1041 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04660 XEO_CLAS Peptide DME1041 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO04660 GENEFORM Protein DME1041 XEOTICID XEO04660 MOACRIVE Inhibition DME1041 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1041 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04661 XEO_CLAS Peptide DME1041 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 microM) DME1041 XEOTICID XEO04661 GENEFORM Protein DME1041 XEOTICID XEO04661 MOACRIVE Inhibition DME1041 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1041 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04662 XEO_CLAS Peptide DME1041 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 microM) DME1041 XEOTICID XEO04662 GENEFORM Protein DME1041 XEOTICID XEO04662 MOACRIVE Inhibition DME1041 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1041 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04663 XEO_CLAS Peptide DME1041 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 microM) DME1041 XEOTICID XEO04663 GENEFORM Protein DME1041 XEOTICID XEO04663 MOACRIVE Inhibition DME1041 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1041 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04664 XEO_CLAS Peptide DME1041 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5.5 microM) DME1041 XEOTICID XEO04664 GENEFORM Protein DME1041 XEOTICID XEO04664 MOACRIVE Inhibition DME1041 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1041 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04665 XEO_CLAS Peptide DME1041 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 microM) DME1041 XEOTICID XEO04665 GENEFORM Protein DME1041 XEOTICID XEO04665 MOACRIVE Inhibition DME1041 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1041 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04666 XEO_CLAS Peptide DME1041 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO04666 GENEFORM Protein DME1041 XEOTICID XEO04666 MOACRIVE Inhibition DME1041 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1041 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04667 XEO_CLAS Peptide DME1041 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6.25 microM) DME1041 XEOTICID XEO04667 GENEFORM Protein DME1041 XEOTICID XEO04667 MOACRIVE Inhibition DME1041 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1041 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04668 XEO_CLAS Peptide DME1041 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 microM) DME1041 XEOTICID XEO04668 GENEFORM Protein DME1041 XEOTICID XEO04668 MOACRIVE Inhibition DME1041 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1041 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04669 XEO_CLAS Peptide DME1041 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO04669 GENEFORM Protein DME1041 XEOTICID XEO04669 MOACRIVE Inhibition DME1041 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1041 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04670 XEO_CLAS Peptide DME1041 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 21 microM) DME1041 XEOTICID XEO04670 GENEFORM Protein DME1041 XEOTICID XEO04670 MOACRIVE Inhibition DME1041 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1041 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04671 XEO_CLAS Peptide DME1041 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 62 microM) DME1041 XEOTICID XEO04671 GENEFORM Protein DME1041 XEOTICID XEO04671 MOACRIVE Inhibition DME1041 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1041 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04672 XEO_CLAS Peptide DME1041 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO04672 GENEFORM Protein DME1041 XEOTICID XEO04672 MOACRIVE Inhibition DME1041 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1041 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04673 XEO_CLAS Peptide DME1041 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO04673 GENEFORM Protein DME1041 XEOTICID XEO04673 MOACRIVE Inhibition DME1041 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1041 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04674 XEO_CLAS Peptide DME1041 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 75 microM) DME1041 XEOTICID XEO04674 GENEFORM Protein DME1041 XEOTICID XEO04674 MOACRIVE Inhibition DME1041 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1041 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04675 XEO_CLAS Peptide DME1041 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 microM) DME1041 XEOTICID XEO04675 GENEFORM Protein DME1041 XEOTICID XEO04675 MOACRIVE Inhibition DME1041 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1041 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04676 XEO_CLAS Peptide DME1041 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 microM) DME1041 XEOTICID XEO04676 GENEFORM Protein DME1041 XEOTICID XEO04676 MOACRIVE Inhibition DME1041 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1041 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04677 XEO_CLAS Peptide DME1041 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO04677 GENEFORM Protein DME1041 XEOTICID XEO04677 MOACRIVE Inhibition DME1041 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1041 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04680 XEO_CLAS Peptide DME1041 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 microM) DME1041 XEOTICID XEO04680 GENEFORM Protein DME1041 XEOTICID XEO04680 MOACRIVE Inhibition DME1041 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1041 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04682 XEO_CLAS Peptide DME1041 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 microM) DME1041 XEOTICID XEO04682 GENEFORM Protein DME1041 XEOTICID XEO04682 MOACRIVE Inhibition DME1041 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1041 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04683 XEO_CLAS Peptide DME1041 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 microM) DME1041 XEOTICID XEO04683 GENEFORM Protein DME1041 XEOTICID XEO04683 MOACRIVE Inhibition DME1041 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1041 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04684 XEO_CLAS Peptide DME1041 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 38 microM) DME1041 XEOTICID XEO04684 GENEFORM Protein DME1041 XEOTICID XEO04684 MOACRIVE Inhibition DME1041 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1041 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04690 XEO_CLAS Peptide DME1041 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.5 ug/ml) DME1041 XEOTICID XEO04690 GENEFORM Protein DME1041 XEOTICID XEO04690 MOACRIVE Inhibition DME1041 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1041 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04695 XEO_CLAS Peptide DME1041 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04695 GENEFORM Protein DME1041 XEOTICID XEO04695 MOACRIVE Inhibition DME1041 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1041 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04696 XEO_CLAS Peptide DME1041 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04696 GENEFORM Protein DME1041 XEOTICID XEO04696 MOACRIVE Inhibition DME1041 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1041 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04712 XEO_CLAS Peptide DME1041 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16.7 microM) DME1041 XEOTICID XEO04712 GENEFORM Protein DME1041 XEOTICID XEO04712 MOACRIVE Inhibition DME1041 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1041 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04713 XEO_CLAS Peptide DME1041 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16.7 microM) DME1041 XEOTICID XEO04713 GENEFORM Protein DME1041 XEOTICID XEO04713 MOACRIVE Inhibition DME1041 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1041 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04714 XEO_CLAS Peptide DME1041 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 23.3 microM) DME1041 XEOTICID XEO04714 GENEFORM Protein DME1041 XEOTICID XEO04714 MOACRIVE Inhibition DME1041 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1041 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04716 XEO_CLAS Peptide DME1041 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 microM) DME1041 XEOTICID XEO04716 GENEFORM Protein DME1041 XEOTICID XEO04716 MOACRIVE Inhibition DME1041 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1041 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04717 XEO_CLAS Peptide DME1041 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 50 microM) DME1041 XEOTICID XEO04717 GENEFORM Protein DME1041 XEOTICID XEO04717 MOACRIVE Inhibition DME1041 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1041 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04725 XEO_CLAS Peptide DME1041 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04725 GENEFORM Protein DME1041 XEOTICID XEO04725 MOACRIVE Inhibition DME1041 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1041 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04726 XEO_CLAS Peptide DME1041 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04726 GENEFORM Protein DME1041 XEOTICID XEO04726 MOACRIVE Inhibition DME1041 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1041 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04731 XEO_CLAS Peptide DME1041 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 ug/ml) DME1041 XEOTICID XEO04731 GENEFORM Protein DME1041 XEOTICID XEO04731 MOACRIVE Inhibition DME1041 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1041 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04732 XEO_CLAS Peptide DME1041 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 25 ug/ml) DME1041 XEOTICID XEO04732 GENEFORM Protein DME1041 XEOTICID XEO04732 MOACRIVE Inhibition DME1041 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1041 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04733 XEO_CLAS Peptide DME1041 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04733 GENEFORM Protein DME1041 XEOTICID XEO04733 MOACRIVE Inhibition DME1041 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1041 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04734 XEO_CLAS Peptide DME1041 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04734 GENEFORM Protein DME1041 XEOTICID XEO04734 MOACRIVE Inhibition DME1041 XEOTICID XEO04737 XEO_NAME Protonectin DME1041 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04737 XEO_CLAS Peptide DME1041 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 ug/ml) DME1041 XEOTICID XEO04737 GENEFORM Protein DME1041 XEOTICID XEO04737 MOACRIVE Inhibition DME1041 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1041 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04739 XEO_CLAS Peptide DME1041 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04739 GENEFORM Protein DME1041 XEOTICID XEO04739 MOACRIVE Inhibition DME1041 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1041 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04740 XEO_CLAS Peptide DME1041 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04740 GENEFORM Protein DME1041 XEOTICID XEO04740 MOACRIVE Inhibition DME1041 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1041 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04741 XEO_CLAS Peptide DME1041 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04741 GENEFORM Protein DME1041 XEOTICID XEO04741 MOACRIVE Inhibition DME1041 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1041 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04742 XEO_CLAS Peptide DME1041 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04742 GENEFORM Protein DME1041 XEOTICID XEO04742 MOACRIVE Inhibition DME1041 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1041 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04762 XEO_CLAS Peptide DME1041 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.8 microM) DME1041 XEOTICID XEO04762 GENEFORM Protein DME1041 XEOTICID XEO04762 MOACRIVE Inhibition DME1041 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1041 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04766 XEO_CLAS Peptide DME1041 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.1 microM) DME1041 XEOTICID XEO04766 GENEFORM Protein DME1041 XEOTICID XEO04766 MOACRIVE Inhibition DME1041 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1041 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04767 XEO_CLAS Peptide DME1041 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.1 ug/ml) DME1041 XEOTICID XEO04767 GENEFORM Protein DME1041 XEOTICID XEO04767 MOACRIVE Inhibition DME1041 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1041 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04779 XEO_CLAS Peptide DME1041 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04779 GENEFORM Protein DME1041 XEOTICID XEO04779 MOACRIVE Inhibition DME1041 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1041 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04780 XEO_CLAS Peptide DME1041 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04780 GENEFORM Protein DME1041 XEOTICID XEO04780 MOACRIVE Inhibition DME1041 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1041 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04781 XEO_CLAS Peptide DME1041 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04781 GENEFORM Protein DME1041 XEOTICID XEO04781 MOACRIVE Inhibition DME1041 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1041 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04782 XEO_CLAS Peptide DME1041 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 ug/ml) DME1041 XEOTICID XEO04782 GENEFORM Protein DME1041 XEOTICID XEO04782 MOACRIVE Inhibition DME1041 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1041 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04783 XEO_CLAS Peptide DME1041 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO04783 GENEFORM Protein DME1041 XEOTICID XEO04783 MOACRIVE Inhibition DME1041 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1041 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04784 XEO_CLAS Peptide DME1041 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO04784 GENEFORM Protein DME1041 XEOTICID XEO04784 MOACRIVE Inhibition DME1041 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1041 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04785 XEO_CLAS Peptide DME1041 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO04785 GENEFORM Protein DME1041 XEOTICID XEO04785 MOACRIVE Inhibition DME1041 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1041 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04786 XEO_CLAS Peptide DME1041 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 ug/ml) DME1041 XEOTICID XEO04786 GENEFORM Protein DME1041 XEOTICID XEO04786 MOACRIVE Inhibition DME1041 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1041 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04787 XEO_CLAS Peptide DME1041 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04787 GENEFORM Protein DME1041 XEOTICID XEO04787 MOACRIVE Inhibition DME1041 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1041 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04793 XEO_CLAS Peptide DME1041 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04793 GENEFORM Protein DME1041 XEOTICID XEO04793 MOACRIVE Inhibition DME1041 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1041 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04798 XEO_CLAS Peptide DME1041 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 microM) DME1041 XEOTICID XEO04798 GENEFORM Protein DME1041 XEOTICID XEO04798 MOACRIVE Inhibition DME1041 XEOTICID XEO04799 XEO_NAME Ranalexin DME1041 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04799 XEO_CLAS Peptide DME1041 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 32 ug/ml) DME1041 XEOTICID XEO04799 GENEFORM Protein DME1041 XEOTICID XEO04799 MOACRIVE Inhibition DME1041 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1041 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04800 XEO_CLAS Peptide DME1041 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 microM) DME1041 XEOTICID XEO04800 GENEFORM Protein DME1041 XEOTICID XEO04800 MOACRIVE Inhibition DME1041 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1041 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04801 XEO_CLAS Peptide DME1041 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 9 microM) DME1041 XEOTICID XEO04801 GENEFORM Protein DME1041 XEOTICID XEO04801 MOACRIVE Inhibition DME1041 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1041 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04802 XEO_CLAS Peptide DME1041 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12 microM) DME1041 XEOTICID XEO04802 GENEFORM Protein DME1041 XEOTICID XEO04802 MOACRIVE Inhibition DME1041 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1041 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04803 XEO_CLAS Peptide DME1041 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO04803 GENEFORM Protein DME1041 XEOTICID XEO04803 MOACRIVE Inhibition DME1041 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1041 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04804 XEO_CLAS Peptide DME1041 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO04804 GENEFORM Protein DME1041 XEOTICID XEO04804 MOACRIVE Inhibition DME1041 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1041 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04805 XEO_CLAS Peptide DME1041 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.5 microM) DME1041 XEOTICID XEO04805 GENEFORM Protein DME1041 XEOTICID XEO04805 MOACRIVE Inhibition DME1041 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1041 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04806 XEO_CLAS Peptide DME1041 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.5 microM) DME1041 XEOTICID XEO04806 GENEFORM Protein DME1041 XEOTICID XEO04806 MOACRIVE Inhibition DME1041 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1041 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04807 XEO_CLAS Peptide DME1041 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04807 GENEFORM Protein DME1041 XEOTICID XEO04807 MOACRIVE Inhibition DME1041 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1041 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04809 XEO_CLAS Peptide DME1041 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 microM) DME1041 XEOTICID XEO04809 GENEFORM Protein DME1041 XEOTICID XEO04809 MOACRIVE Inhibition DME1041 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1041 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04811 XEO_CLAS Peptide DME1041 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO04811 GENEFORM Protein DME1041 XEOTICID XEO04811 MOACRIVE Inhibition DME1041 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1041 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04812 XEO_CLAS Peptide DME1041 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO04812 GENEFORM Protein DME1041 XEOTICID XEO04812 MOACRIVE Inhibition DME1041 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1041 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04813 XEO_CLAS Peptide DME1041 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 microM) DME1041 XEOTICID XEO04813 GENEFORM Protein DME1041 XEOTICID XEO04813 MOACRIVE Inhibition DME1041 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1041 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04814 XEO_CLAS Peptide DME1041 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 19 microM) DME1041 XEOTICID XEO04814 GENEFORM Protein DME1041 XEOTICID XEO04814 MOACRIVE Inhibition DME1041 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1041 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04815 XEO_CLAS Peptide DME1041 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 microM) DME1041 XEOTICID XEO04815 GENEFORM Protein DME1041 XEOTICID XEO04815 MOACRIVE Inhibition DME1041 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1041 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04816 XEO_CLAS Peptide DME1041 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 microM) DME1041 XEOTICID XEO04816 GENEFORM Protein DME1041 XEOTICID XEO04816 MOACRIVE Inhibition DME1041 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1041 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04817 XEO_CLAS Peptide DME1041 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 13 microM) DME1041 XEOTICID XEO04817 GENEFORM Protein DME1041 XEOTICID XEO04817 MOACRIVE Inhibition DME1041 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1041 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04818 XEO_CLAS Peptide DME1041 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO04818 GENEFORM Protein DME1041 XEOTICID XEO04818 MOACRIVE Inhibition DME1041 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1041 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04819 XEO_CLAS Peptide DME1041 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO04819 GENEFORM Protein DME1041 XEOTICID XEO04819 MOACRIVE Inhibition DME1041 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1041 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04820 XEO_CLAS Peptide DME1041 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3 microM) DME1041 XEOTICID XEO04820 GENEFORM Protein DME1041 XEOTICID XEO04820 MOACRIVE Inhibition DME1041 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1041 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04821 XEO_CLAS Peptide DME1041 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 microM) DME1041 XEOTICID XEO04821 GENEFORM Protein DME1041 XEOTICID XEO04821 MOACRIVE Inhibition DME1041 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1041 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04822 XEO_CLAS Peptide DME1041 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO04822 GENEFORM Protein DME1041 XEOTICID XEO04822 MOACRIVE Inhibition DME1041 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1041 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04823 XEO_CLAS Peptide DME1041 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 23 microM) DME1041 XEOTICID XEO04823 GENEFORM Protein DME1041 XEOTICID XEO04823 MOACRIVE Inhibition DME1041 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1041 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04824 XEO_CLAS Peptide DME1041 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04824 GENEFORM Protein DME1041 XEOTICID XEO04824 MOACRIVE Inhibition DME1041 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1041 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04825 XEO_CLAS Peptide DME1041 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04825 GENEFORM Protein DME1041 XEOTICID XEO04825 MOACRIVE Inhibition DME1041 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1041 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04826 XEO_CLAS Peptide DME1041 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO04826 GENEFORM Protein DME1041 XEOTICID XEO04826 MOACRIVE Inhibition DME1041 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1041 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04827 XEO_CLAS Peptide DME1041 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO04827 GENEFORM Protein DME1041 XEOTICID XEO04827 MOACRIVE Inhibition DME1041 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1041 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04835 XEO_CLAS Peptide DME1041 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04835 GENEFORM Protein DME1041 XEOTICID XEO04835 MOACRIVE Inhibition DME1041 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1041 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04836 XEO_CLAS Peptide DME1041 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04836 GENEFORM Protein DME1041 XEOTICID XEO04836 MOACRIVE Inhibition DME1041 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1041 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04837 XEO_CLAS Peptide DME1041 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 microM) DME1041 XEOTICID XEO04837 GENEFORM Protein DME1041 XEOTICID XEO04837 MOACRIVE Inhibition DME1041 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1041 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04839 XEO_CLAS Peptide DME1041 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04839 GENEFORM Protein DME1041 XEOTICID XEO04839 MOACRIVE Inhibition DME1041 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1041 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04840 XEO_CLAS Peptide DME1041 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 35-20 microM) DME1041 XEOTICID XEO04840 GENEFORM Protein DME1041 XEOTICID XEO04840 MOACRIVE Inhibition DME1041 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1041 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04847 XEO_CLAS Peptide DME1041 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04847 GENEFORM Protein DME1041 XEOTICID XEO04847 MOACRIVE Inhibition DME1041 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1041 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04848 XEO_CLAS Peptide DME1041 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04848 GENEFORM Protein DME1041 XEOTICID XEO04848 MOACRIVE Inhibition DME1041 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1041 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04849 XEO_CLAS Peptide DME1041 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04849 GENEFORM Protein DME1041 XEOTICID XEO04849 MOACRIVE Inhibition DME1041 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1041 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04850 XEO_CLAS Peptide DME1041 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04850 GENEFORM Protein DME1041 XEOTICID XEO04850 MOACRIVE Inhibition DME1041 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1041 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04851 XEO_CLAS Peptide DME1041 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1 ug/ml) DME1041 XEOTICID XEO04851 GENEFORM Protein DME1041 XEOTICID XEO04851 MOACRIVE Inhibition DME1041 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1041 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04857 XEO_CLAS Peptide DME1041 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 microM) DME1041 XEOTICID XEO04857 GENEFORM Protein DME1041 XEOTICID XEO04857 MOACRIVE Inhibition DME1041 XEOTICID XEO04863 XEO_NAME RTD peptide DME1041 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04863 XEO_CLAS Peptide DME1041 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.0 microM) DME1041 XEOTICID XEO04863 GENEFORM Protein DME1041 XEOTICID XEO04863 MOACRIVE Inhibition DME1041 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1041 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04865 XEO_CLAS Peptide DME1041 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 ug/ml) DME1041 XEOTICID XEO04865 GENEFORM Protein DME1041 XEOTICID XEO04865 MOACRIVE Inhibition DME1041 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1041 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04866 XEO_CLAS Peptide DME1041 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12.5 ug/ml) DME1041 XEOTICID XEO04866 GENEFORM Protein DME1041 XEOTICID XEO04866 MOACRIVE Inhibition DME1041 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1041 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04868 XEO_CLAS Peptide DME1041 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25.00 ug/ml) DME1041 XEOTICID XEO04868 GENEFORM Protein DME1041 XEOTICID XEO04868 MOACRIVE Inhibition DME1041 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1041 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04869 XEO_CLAS Peptide DME1041 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25.00 ug/ml) DME1041 XEOTICID XEO04869 GENEFORM Protein DME1041 XEOTICID XEO04869 MOACRIVE Inhibition DME1041 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1041 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04870 XEO_CLAS Peptide DME1041 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25.00 ug/ml) DME1041 XEOTICID XEO04870 GENEFORM Protein DME1041 XEOTICID XEO04870 MOACRIVE Inhibition DME1041 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1041 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04877 XEO_CLAS Peptide DME1041 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04877 GENEFORM Protein DME1041 XEOTICID XEO04877 MOACRIVE Inhibition DME1041 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1041 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04880 XEO_CLAS Peptide DME1041 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.5 ug/ml) DME1041 XEOTICID XEO04880 GENEFORM Protein DME1041 XEOTICID XEO04880 MOACRIVE Inhibition DME1041 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1041 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04886 XEO_CLAS Peptide DME1041 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.6 ug/ml) DME1041 XEOTICID XEO04886 GENEFORM Protein DME1041 XEOTICID XEO04886 MOACRIVE Inhibition DME1041 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1041 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04891 XEO_CLAS Peptide DME1041 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04891 GENEFORM Protein DME1041 XEOTICID XEO04891 MOACRIVE Inhibition DME1041 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1041 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04895 XEO_CLAS Peptide DME1041 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04895 GENEFORM Protein DME1041 XEOTICID XEO04895 MOACRIVE Inhibition DME1041 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1041 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04901 XEO_CLAS Peptide DME1041 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 microM) DME1041 XEOTICID XEO04901 GENEFORM Protein DME1041 XEOTICID XEO04901 MOACRIVE Inhibition DME1041 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1041 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04904 XEO_CLAS Peptide DME1041 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 78 ug/ml) DME1041 XEOTICID XEO04904 GENEFORM Protein DME1041 XEOTICID XEO04904 MOACRIVE Inhibition DME1041 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1041 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04905 XEO_CLAS Peptide DME1041 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04905 GENEFORM Protein DME1041 XEOTICID XEO04905 MOACRIVE Inhibition DME1041 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1041 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04906 XEO_CLAS Peptide DME1041 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04906 GENEFORM Protein DME1041 XEOTICID XEO04906 MOACRIVE Inhibition DME1041 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1041 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04907 XEO_CLAS Peptide DME1041 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04907 GENEFORM Protein DME1041 XEOTICID XEO04907 MOACRIVE Inhibition DME1041 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1041 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04908 XEO_CLAS Peptide DME1041 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04908 GENEFORM Protein DME1041 XEOTICID XEO04908 MOACRIVE Inhibition DME1041 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1041 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04909 XEO_CLAS Peptide DME1041 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04909 GENEFORM Protein DME1041 XEOTICID XEO04909 MOACRIVE Inhibition DME1041 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1041 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04915 XEO_CLAS Peptide DME1041 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 100 ug/ml) DME1041 XEOTICID XEO04915 GENEFORM Protein DME1041 XEOTICID XEO04915 MOACRIVE Inhibition DME1041 XEOTICID XEO04916 XEO_NAME Scopoletin DME1041 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1041 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04916 GENEFORM Protein DME1041 XEOTICID XEO04916 MOACRIVE Inhibition DME1041 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1041 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04926 XEO_CLAS Peptide DME1041 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04926 GENEFORM Protein DME1041 XEOTICID XEO04926 MOACRIVE Inhibition DME1041 XEOTICID XEO04931 XEO_NAME Shepherin I DME1041 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04931 XEO_CLAS Peptide DME1041 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04931 GENEFORM Protein DME1041 XEOTICID XEO04931 MOACRIVE Inhibition DME1041 XEOTICID XEO04932 XEO_NAME shepherin II DME1041 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04932 XEO_CLAS Peptide DME1041 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04932 GENEFORM Protein DME1041 XEOTICID XEO04932 MOACRIVE Inhibition DME1041 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1041 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04938 XEO_CLAS Peptide DME1041 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC <= 100 microM) DME1041 XEOTICID XEO04938 GENEFORM Protein DME1041 XEOTICID XEO04938 MOACRIVE Inhibition DME1041 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1041 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04947 XEO_CLAS Natural Product DME1041 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04947 GENEFORM Protein DME1041 XEOTICID XEO04947 MOACRIVE Inhibition DME1041 XEOTICID XEO04948 XEO_NAME Sinensetin DME1041 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1041 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1041 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04948 GENEFORM Protein DME1041 XEOTICID XEO04948 MOACRIVE Inhibition DME1041 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1041 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04950 XEO_CLAS Peptide DME1041 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 ug/ml) DME1041 XEOTICID XEO04950 GENEFORM Protein DME1041 XEOTICID XEO04950 MOACRIVE Inhibition DME1041 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1041 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04955 XEO_CLAS Peptide DME1041 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.07 microM) DME1041 XEOTICID XEO04955 GENEFORM Protein DME1041 XEOTICID XEO04955 MOACRIVE Inhibition DME1041 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1041 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04956 XEO_CLAS Peptide DME1041 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16.0 microM) DME1041 XEOTICID XEO04956 GENEFORM Protein DME1041 XEOTICID XEO04956 MOACRIVE Inhibition DME1041 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1041 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04957 XEO_CLAS Peptide DME1041 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.23 microM) DME1041 XEOTICID XEO04957 GENEFORM Protein DME1041 XEOTICID XEO04957 MOACRIVE Inhibition DME1041 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1041 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04958 XEO_CLAS Peptide DME1041 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 ug/ml) DME1041 XEOTICID XEO04958 GENEFORM Protein DME1041 XEOTICID XEO04958 MOACRIVE Inhibition DME1041 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1041 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04959 XEO_CLAS Peptide DME1041 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04959 GENEFORM Protein DME1041 XEOTICID XEO04959 MOACRIVE Inhibition DME1041 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1041 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04967 XEO_CLAS Peptide DME1041 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 28 microM) DME1041 XEOTICID XEO04967 GENEFORM Protein DME1041 XEOTICID XEO04967 MOACRIVE Inhibition DME1041 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1041 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04969 XEO_CLAS Peptide DME1041 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50-100 ug/ml) DME1041 XEOTICID XEO04969 GENEFORM Protein DME1041 XEOTICID XEO04969 MOACRIVE Inhibition DME1041 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1041 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04970 XEO_CLAS Peptide DME1041 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04970 GENEFORM Protein DME1041 XEOTICID XEO04970 MOACRIVE Inhibition DME1041 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1041 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04971 XEO_CLAS Peptide DME1041 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.8-1.5 microM) DME1041 XEOTICID XEO04971 GENEFORM Protein DME1041 XEOTICID XEO04971 MOACRIVE Inhibition DME1041 XEOTICID XEO04974 XEO_NAME Spinigerin DME1041 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04974 XEO_CLAS Peptide DME1041 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3-6 microM) DME1041 XEOTICID XEO04974 GENEFORM Protein DME1041 XEOTICID XEO04974 MOACRIVE Inhibition DME1041 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1041 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1041 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04975 GENEFORM Protein DME1041 XEOTICID XEO04975 MOACRIVE Inhibition DME1041 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1041 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1041 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04976 GENEFORM Protein DME1041 XEOTICID XEO04976 MOACRIVE Inhibition DME1041 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1041 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1041 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04977 GENEFORM Protein DME1041 XEOTICID XEO04977 MOACRIVE Inhibition DME1041 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1041 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1041 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04978 GENEFORM Protein DME1041 XEOTICID XEO04978 MOACRIVE Inhibition DME1041 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1041 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1041 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04979 GENEFORM Protein DME1041 XEOTICID XEO04979 MOACRIVE Inhibition DME1041 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1041 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04981 XEO_CLAS Peptide DME1041 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10.1 microM) DME1041 XEOTICID XEO04981 GENEFORM Protein DME1041 XEOTICID XEO04981 MOACRIVE Inhibition DME1041 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1041 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04982 XEO_CLAS Peptide DME1041 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40.5 microM) DME1041 XEOTICID XEO04982 GENEFORM Protein DME1041 XEOTICID XEO04982 MOACRIVE Inhibition DME1041 XEOTICID XEO04994 XEO_NAME Stilbene DME1041 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1041 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1041 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO04994 GENEFORM Protein DME1041 XEOTICID XEO04994 MOACRIVE Inhibition DME1041 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1041 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04995 XEO_CLAS Peptide DME1041 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC < 0.19 microM) DME1041 XEOTICID XEO04995 GENEFORM Protein DME1041 XEOTICID XEO04995 MOACRIVE Inhibition DME1041 XEOTICID XEO04998 XEO_NAME Styelin A DME1041 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04998 XEO_CLAS Peptide DME1041 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.7 ug/ml) DME1041 XEOTICID XEO04998 GENEFORM Protein DME1041 XEOTICID XEO04998 MOACRIVE Inhibition DME1041 XEOTICID XEO04999 XEO_NAME Styelin B DME1041 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO04999 XEO_CLAS Peptide DME1041 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.7 ug/ml) DME1041 XEOTICID XEO04999 GENEFORM Protein DME1041 XEOTICID XEO04999 MOACRIVE Inhibition DME1041 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1041 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05000 XEO_CLAS Peptide DME1041 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO05000 GENEFORM Protein DME1041 XEOTICID XEO05000 MOACRIVE Inhibition DME1041 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1041 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05001 XEO_CLAS Peptide DME1041 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.5 ug/ml) DME1041 XEOTICID XEO05001 GENEFORM Protein DME1041 XEOTICID XEO05001 MOACRIVE Inhibition DME1041 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1041 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05002 XEO_CLAS Peptide DME1041 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO05002 GENEFORM Protein DME1041 XEOTICID XEO05002 MOACRIVE Inhibition DME1041 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1041 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05003 XEO_CLAS Peptide DME1041 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO05003 GENEFORM Protein DME1041 XEOTICID XEO05003 MOACRIVE Inhibition DME1041 XEOTICID XEO05006 XEO_NAME Substance P DME1041 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05006 XEO_CLAS Peptide DME1041 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05006 GENEFORM Protein DME1041 XEOTICID XEO05006 MOACRIVE Inhibition DME1041 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1041 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05007 XEO_CLAS Peptide DME1041 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05007 GENEFORM Protein DME1041 XEOTICID XEO05007 MOACRIVE Inhibition DME1041 XEOTICID XEO05008 XEO_NAME Subtilosin DME1041 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05008 XEO_CLAS Peptide DME1041 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05008 GENEFORM Protein DME1041 XEOTICID XEO05008 MOACRIVE Inhibition DME1041 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1041 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05013 XEO_CLAS Peptide DME1041 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO05013 GENEFORM Protein DME1041 XEOTICID XEO05013 MOACRIVE Inhibition DME1041 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1041 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05014 XEO_CLAS Peptide DME1041 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO05014 GENEFORM Protein DME1041 XEOTICID XEO05014 MOACRIVE Inhibition DME1041 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1041 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05015 XEO_CLAS Peptide DME1041 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO05015 GENEFORM Protein DME1041 XEOTICID XEO05015 MOACRIVE Inhibition DME1041 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1041 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05016 XEO_CLAS Peptide DME1041 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO05016 GENEFORM Protein DME1041 XEOTICID XEO05016 MOACRIVE Inhibition DME1041 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1041 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05017 XEO_CLAS Peptide DME1041 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 20 ug/ml) DME1041 XEOTICID XEO05017 GENEFORM Protein DME1041 XEOTICID XEO05017 MOACRIVE Inhibition DME1041 XEOTICID XEO05018 XEO_NAME Syringic acid DME1041 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1041 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05018 GENEFORM Protein DME1041 XEOTICID XEO05018 MOACRIVE Inhibition DME1041 XEOTICID XEO05020 XEO_NAME Tachycitin DME1041 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05020 XEO_CLAS Peptide DME1041 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05020 GENEFORM Protein DME1041 XEOTICID XEO05020 MOACRIVE Inhibition DME1041 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1041 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05023 XEO_CLAS Peptide DME1041 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05023 GENEFORM Protein DME1041 XEOTICID XEO05023 MOACRIVE Inhibition DME1041 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1041 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05024 XEO_CLAS Peptide DME1041 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05024 GENEFORM Protein DME1041 XEOTICID XEO05024 MOACRIVE Inhibition DME1041 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1041 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05027 XEO_CLAS Peptide DME1041 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05027 GENEFORM Protein DME1041 XEOTICID XEO05027 MOACRIVE Inhibition DME1041 XEOTICID XEO05031 XEO_NAME Tannic acid DME1041 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1041 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05031 GENEFORM Protein DME1041 XEOTICID XEO05031 MOACRIVE Inhibition DME1041 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1041 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05033 XEO_CLAS Peptide DME1041 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05033 GENEFORM Protein DME1041 XEOTICID XEO05033 MOACRIVE Inhibition DME1041 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1041 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05042 XEO_CLAS Peptide DME1041 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO05042 GENEFORM Protein DME1041 XEOTICID XEO05042 MOACRIVE Inhibition DME1041 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1041 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05043 XEO_CLAS Peptide DME1041 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO05043 GENEFORM Protein DME1041 XEOTICID XEO05043 MOACRIVE Inhibition DME1041 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1041 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05044 XEO_CLAS Peptide DME1041 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 128 microM) DME1041 XEOTICID XEO05044 GENEFORM Protein DME1041 XEOTICID XEO05044 MOACRIVE Inhibition DME1041 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1041 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05045 XEO_CLAS Peptide DME1041 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 128 microM) DME1041 XEOTICID XEO05045 GENEFORM Protein DME1041 XEOTICID XEO05045 MOACRIVE Inhibition DME1041 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1041 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05046 XEO_CLAS Peptide DME1041 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 microM) DME1041 XEOTICID XEO05046 GENEFORM Protein DME1041 XEOTICID XEO05046 MOACRIVE Inhibition DME1041 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1041 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05047 XEO_CLAS Peptide DME1041 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 60 microM) DME1041 XEOTICID XEO05047 GENEFORM Protein DME1041 XEOTICID XEO05047 MOACRIVE Inhibition DME1041 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1041 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05051 XEO_CLAS Peptide DME1041 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05051 GENEFORM Protein DME1041 XEOTICID XEO05051 MOACRIVE Inhibition DME1041 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1041 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05055 XEO_CLAS Peptide DME1041 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 70 microM) DME1041 XEOTICID XEO05055 GENEFORM Protein DME1041 XEOTICID XEO05055 MOACRIVE Inhibition DME1041 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1041 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05056 XEO_CLAS Peptide DME1041 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05056 GENEFORM Protein DME1041 XEOTICID XEO05056 MOACRIVE Inhibition DME1041 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1041 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05059 XEO_CLAS Peptide DME1041 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05059 GENEFORM Protein DME1041 XEOTICID XEO05059 MOACRIVE Inhibition DME1041 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1041 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05061 XEO_CLAS Peptide DME1041 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO05061 GENEFORM Protein DME1041 XEOTICID XEO05061 MOACRIVE Inhibition DME1041 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1041 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05062 XEO_CLAS Peptide DME1041 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05062 GENEFORM Protein DME1041 XEOTICID XEO05062 MOACRIVE Inhibition DME1041 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1041 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05063 XEO_CLAS Peptide DME1041 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO05063 GENEFORM Protein DME1041 XEOTICID XEO05063 MOACRIVE Inhibition DME1041 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1041 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05064 XEO_CLAS Peptide DME1041 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 231 microM) DME1041 XEOTICID XEO05064 GENEFORM Protein DME1041 XEOTICID XEO05064 MOACRIVE Inhibition DME1041 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1041 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05065 XEO_CLAS Peptide DME1041 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 161 ug/ml) DME1041 XEOTICID XEO05065 GENEFORM Protein DME1041 XEOTICID XEO05065 MOACRIVE Inhibition DME1041 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1041 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05069 XEO_CLAS Peptide DME1041 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO05069 GENEFORM Protein DME1041 XEOTICID XEO05069 MOACRIVE Inhibition DME1041 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1041 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05070 XEO_CLAS Peptide DME1041 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 37.5 microM) DME1041 XEOTICID XEO05070 GENEFORM Protein DME1041 XEOTICID XEO05070 MOACRIVE Inhibition DME1041 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1041 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05071 XEO_CLAS Peptide DME1041 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 150 microM) DME1041 XEOTICID XEO05071 GENEFORM Protein DME1041 XEOTICID XEO05071 MOACRIVE Inhibition DME1041 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1041 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05072 XEO_CLAS Peptide DME1041 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO05072 GENEFORM Protein DME1041 XEOTICID XEO05072 MOACRIVE Inhibition DME1041 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1041 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05073 XEO_CLAS Peptide DME1041 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40 microM) DME1041 XEOTICID XEO05073 GENEFORM Protein DME1041 XEOTICID XEO05073 MOACRIVE Inhibition DME1041 XEOTICID XEO05076 XEO_NAME Temporin-A DME1041 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05076 XEO_CLAS Peptide DME1041 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 11.9 microM) DME1041 XEOTICID XEO05076 GENEFORM Protein DME1041 XEOTICID XEO05076 MOACRIVE Inhibition DME1041 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1041 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05077 XEO_CLAS Peptide DME1041 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.25 ug/ml) DME1041 XEOTICID XEO05077 GENEFORM Protein DME1041 XEOTICID XEO05077 MOACRIVE Inhibition DME1041 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1041 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05078 XEO_CLAS Peptide DME1041 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.25 ug/ml) DME1041 XEOTICID XEO05078 GENEFORM Protein DME1041 XEOTICID XEO05078 MOACRIVE Inhibition DME1041 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1041 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05079 XEO_CLAS Peptide DME1041 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.5 ug/ml) DME1041 XEOTICID XEO05079 GENEFORM Protein DME1041 XEOTICID XEO05079 MOACRIVE Inhibition DME1041 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1041 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05080 XEO_CLAS Peptide DME1041 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 ug/ml) DME1041 XEOTICID XEO05080 GENEFORM Protein DME1041 XEOTICID XEO05080 MOACRIVE Inhibition DME1041 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1041 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05081 XEO_CLAS Peptide DME1041 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 5 ug/ml) DME1041 XEOTICID XEO05081 GENEFORM Protein DME1041 XEOTICID XEO05081 MOACRIVE Inhibition DME1041 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1041 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05082 XEO_CLAS Peptide DME1041 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 7.5 ug/ml) DME1041 XEOTICID XEO05082 GENEFORM Protein DME1041 XEOTICID XEO05082 MOACRIVE Inhibition DME1041 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1041 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05083 XEO_CLAS Peptide DME1041 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 ug/ml) DME1041 XEOTICID XEO05083 GENEFORM Protein DME1041 XEOTICID XEO05083 MOACRIVE Inhibition DME1041 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1041 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05084 XEO_CLAS Peptide DME1041 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 ug/ml) DME1041 XEOTICID XEO05084 GENEFORM Protein DME1041 XEOTICID XEO05084 MOACRIVE Inhibition DME1041 XEOTICID XEO05085 XEO_NAME Temporin-B DME1041 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05085 XEO_CLAS Peptide DME1041 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 21.0 ug/ml) DME1041 XEOTICID XEO05085 GENEFORM Protein DME1041 XEOTICID XEO05085 MOACRIVE Inhibition DME1041 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1041 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05086 XEO_CLAS Peptide DME1041 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC > 100 microM) DME1041 XEOTICID XEO05086 GENEFORM Protein DME1041 XEOTICID XEO05086 MOACRIVE Inhibition DME1041 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1041 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05087 XEO_CLAS Peptide DME1041 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO05087 GENEFORM Protein DME1041 XEOTICID XEO05087 MOACRIVE Inhibition DME1041 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1041 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05097 XEO_CLAS Peptide DME1041 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16.0 microM) DME1041 XEOTICID XEO05097 GENEFORM Protein DME1041 XEOTICID XEO05097 MOACRIVE Inhibition DME1041 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1041 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05099 XEO_CLAS Peptide DME1041 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.0 microM) DME1041 XEOTICID XEO05099 GENEFORM Protein DME1041 XEOTICID XEO05099 MOACRIVE Inhibition DME1041 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1041 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05100 XEO_CLAS Peptide DME1041 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05100 GENEFORM Protein DME1041 XEOTICID XEO05100 MOACRIVE Inhibition DME1041 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1041 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05101 XEO_CLAS Peptide DME1041 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 24.2 ug/ml) DME1041 XEOTICID XEO05101 GENEFORM Protein DME1041 XEOTICID XEO05101 MOACRIVE Inhibition DME1041 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1041 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05102 XEO_CLAS Peptide DME1041 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 34.5 ug/ml) DME1041 XEOTICID XEO05102 GENEFORM Protein DME1041 XEOTICID XEO05102 MOACRIVE Inhibition DME1041 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1041 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05105 XEO_CLAS Peptide DME1041 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO05105 GENEFORM Protein DME1041 XEOTICID XEO05105 MOACRIVE Inhibition DME1041 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1041 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05106 XEO_CLAS Peptide DME1041 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25-200 microM) DME1041 XEOTICID XEO05106 GENEFORM Protein DME1041 XEOTICID XEO05106 MOACRIVE Inhibition DME1041 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1041 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05108 XEO_CLAS Peptide DME1041 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40 microM) DME1041 XEOTICID XEO05108 GENEFORM Protein DME1041 XEOTICID XEO05108 MOACRIVE Inhibition DME1041 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1041 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1041 XEOTICID XEO05111 XEO_CLAS Natural Product DME1041 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05111 GENEFORM Protein DME1041 XEOTICID XEO05111 MOACRIVE Inhibition DME1041 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1041 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05119 XEO_CLAS Peptide DME1041 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05119 GENEFORM Protein DME1041 XEOTICID XEO05119 MOACRIVE Inhibition DME1041 XEOTICID XEO05120 XEO_NAME Thanatin DME1041 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05120 XEO_CLAS Peptide DME1041 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.3-0.6 microM) DME1041 XEOTICID XEO05120 GENEFORM Protein DME1041 XEOTICID XEO05120 MOACRIVE Inhibition DME1041 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1041 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05121 XEO_CLAS Peptide DME1041 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 62.5 ug/ml) DME1041 XEOTICID XEO05121 GENEFORM Protein DME1041 XEOTICID XEO05121 MOACRIVE Inhibition DME1041 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1041 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05125 XEO_CLAS Peptide DME1041 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05125 GENEFORM Protein DME1041 XEOTICID XEO05125 MOACRIVE Inhibition DME1041 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1041 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05130 XEO_CLAS Peptide DME1041 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05130 GENEFORM Protein DME1041 XEOTICID XEO05130 MOACRIVE Inhibition DME1041 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1041 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05144 XEO_CLAS Peptide DME1041 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40 ug/ml) DME1041 XEOTICID XEO05144 GENEFORM Protein DME1041 XEOTICID XEO05144 MOACRIVE Inhibition DME1041 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1041 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05145 XEO_CLAS Peptide DME1041 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 ug/ml) DME1041 XEOTICID XEO05145 GENEFORM Protein DME1041 XEOTICID XEO05145 MOACRIVE Inhibition DME1041 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1041 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05146 XEO_CLAS Peptide DME1041 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 40 ug/ml) DME1041 XEOTICID XEO05146 GENEFORM Protein DME1041 XEOTICID XEO05146 MOACRIVE Inhibition DME1041 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1041 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05147 XEO_CLAS Peptide DME1041 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 60 ug/ml) DME1041 XEOTICID XEO05147 GENEFORM Protein DME1041 XEOTICID XEO05147 MOACRIVE Inhibition DME1041 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1041 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05158 XEO_CLAS Peptide DME1041 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05158 GENEFORM Protein DME1041 XEOTICID XEO05158 MOACRIVE Inhibition DME1041 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1041 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05161 XEO_CLAS Peptide DME1041 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 32 ug/ml) DME1041 XEOTICID XEO05161 GENEFORM Protein DME1041 XEOTICID XEO05161 MOACRIVE Inhibition DME1041 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1041 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05162 XEO_CLAS Peptide DME1041 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 32 ug/ml) DME1041 XEOTICID XEO05162 GENEFORM Protein DME1041 XEOTICID XEO05162 MOACRIVE Inhibition DME1041 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1041 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05163 XEO_CLAS Peptide DME1041 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 12-25 ug/ml) DME1041 XEOTICID XEO05163 GENEFORM Protein DME1041 XEOTICID XEO05163 MOACRIVE Inhibition DME1041 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1041 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05170 XEO_CLAS Peptide DME1041 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 3.0 microM) DME1041 XEOTICID XEO05170 GENEFORM Protein DME1041 XEOTICID XEO05170 MOACRIVE Inhibition DME1041 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1041 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05171 XEO_CLAS Peptide DME1041 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 50 microM) DME1041 XEOTICID XEO05171 GENEFORM Protein DME1041 XEOTICID XEO05171 MOACRIVE Inhibition DME1041 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1041 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05179 XEO_CLAS Peptide DME1041 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05179 GENEFORM Protein DME1041 XEOTICID XEO05179 MOACRIVE Inhibition DME1041 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1041 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05180 XEO_CLAS Peptide DME1041 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 160 microM) DME1041 XEOTICID XEO05180 GENEFORM Protein DME1041 XEOTICID XEO05180 MOACRIVE Inhibition DME1041 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1041 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05182 XEO_CLAS Peptide DME1041 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 microM) DME1041 XEOTICID XEO05182 GENEFORM Protein DME1041 XEOTICID XEO05182 MOACRIVE Inhibition DME1041 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1041 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05183 XEO_CLAS Peptide DME1041 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 microM) DME1041 XEOTICID XEO05183 GENEFORM Protein DME1041 XEOTICID XEO05183 MOACRIVE Inhibition DME1041 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1041 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05184 XEO_CLAS Peptide DME1041 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 microM) DME1041 XEOTICID XEO05184 GENEFORM Protein DME1041 XEOTICID XEO05184 MOACRIVE Inhibition DME1041 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1041 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05185 XEO_CLAS Peptide DME1041 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 microM) DME1041 XEOTICID XEO05185 GENEFORM Protein DME1041 XEOTICID XEO05185 MOACRIVE Inhibition DME1041 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1041 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05186 XEO_CLAS Peptide DME1041 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 microM) DME1041 XEOTICID XEO05186 GENEFORM Protein DME1041 XEOTICID XEO05186 MOACRIVE Inhibition DME1041 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1041 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05187 XEO_CLAS Peptide DME1041 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16 microM) DME1041 XEOTICID XEO05187 GENEFORM Protein DME1041 XEOTICID XEO05187 MOACRIVE Inhibition DME1041 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1041 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05188 XEO_CLAS Peptide DME1041 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 64 microM) DME1041 XEOTICID XEO05188 GENEFORM Protein DME1041 XEOTICID XEO05188 MOACRIVE Inhibition DME1041 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1041 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05190 XEO_CLAS Peptide DME1041 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05190 GENEFORM Protein DME1041 XEOTICID XEO05190 MOACRIVE Inhibition DME1041 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1041 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05193 XEO_CLAS Peptide DME1041 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO05193 GENEFORM Protein DME1041 XEOTICID XEO05193 MOACRIVE Inhibition DME1041 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1041 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05197 XEO_CLAS Peptide DME1041 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05197 GENEFORM Protein DME1041 XEOTICID XEO05197 MOACRIVE Inhibition DME1041 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1041 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05205 XEO_CLAS Peptide DME1041 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05205 GENEFORM Protein DME1041 XEOTICID XEO05205 MOACRIVE Inhibition DME1041 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1041 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05206 XEO_CLAS Peptide DME1041 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 10 microM) DME1041 XEOTICID XEO05206 GENEFORM Protein DME1041 XEOTICID XEO05206 MOACRIVE Inhibition DME1041 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1041 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05207 XEO_CLAS Peptide DME1041 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 25 microM) DME1041 XEOTICID XEO05207 GENEFORM Protein DME1041 XEOTICID XEO05207 MOACRIVE Inhibition DME1041 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1041 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05208 XEO_CLAS Peptide DME1041 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 microM) DME1041 XEOTICID XEO05208 GENEFORM Protein DME1041 XEOTICID XEO05208 MOACRIVE Inhibition DME1041 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1041 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05209 XEO_CLAS Peptide DME1041 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 15 microM) DME1041 XEOTICID XEO05209 GENEFORM Protein DME1041 XEOTICID XEO05209 MOACRIVE Inhibition DME1041 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1041 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05212 XEO_CLAS Peptide DME1041 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.5 ug/ml) DME1041 XEOTICID XEO05212 GENEFORM Protein DME1041 XEOTICID XEO05212 MOACRIVE Inhibition DME1041 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1041 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05220 XEO_CLAS Peptide DME1041 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.6-1.2 microM) DME1041 XEOTICID XEO05220 GENEFORM Protein DME1041 XEOTICID XEO05220 MOACRIVE Inhibition DME1041 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1041 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05230 XEO_CLAS Peptide DME1041 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 7.90 microM) DME1041 XEOTICID XEO05230 GENEFORM Protein DME1041 XEOTICID XEO05230 MOACRIVE Inhibition DME1041 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1041 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05231 XEO_CLAS Peptide DME1041 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2.40 microM) DME1041 XEOTICID XEO05231 GENEFORM Protein DME1041 XEOTICID XEO05231 MOACRIVE Inhibition DME1041 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1041 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05232 XEO_CLAS Peptide DME1041 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05232 GENEFORM Protein DME1041 XEOTICID XEO05232 MOACRIVE Inhibition DME1041 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1041 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05233 XEO_CLAS Peptide DME1041 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 ug/ml) DME1041 XEOTICID XEO05233 GENEFORM Protein DME1041 XEOTICID XEO05233 MOACRIVE Inhibition DME1041 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1041 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05234 XEO_CLAS Peptide DME1041 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 ug/ml) DME1041 XEOTICID XEO05234 GENEFORM Protein DME1041 XEOTICID XEO05234 MOACRIVE Inhibition DME1041 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1041 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05235 XEO_CLAS Peptide DME1041 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 30 ug/ml) DME1041 XEOTICID XEO05235 GENEFORM Protein DME1041 XEOTICID XEO05235 MOACRIVE Inhibition DME1041 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1041 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05237 XEO_CLAS Peptide DME1041 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 microM) DME1041 XEOTICID XEO05237 GENEFORM Protein DME1041 XEOTICID XEO05237 MOACRIVE Inhibition DME1041 XEOTICID XEO05245 XEO_NAME Viresin DME1041 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05245 XEO_CLAS Peptide DME1041 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05245 GENEFORM Protein DME1041 XEOTICID XEO05245 MOACRIVE Inhibition DME1041 XEOTICID XEO05248 XEO_NAME Vitamin C DME1041 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1041 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1041 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05248 GENEFORM Protein DME1041 XEOTICID XEO05248 MOACRIVE Inhibition DME1041 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1041 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05264 XEO_CLAS Peptide DME1041 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 4 ug/ml) DME1041 XEOTICID XEO05264 GENEFORM Protein DME1041 XEOTICID XEO05264 MOACRIVE Inhibition DME1041 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1041 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05267 XEO_CLAS Peptide DME1041 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 2 ug/ml) DME1041 XEOTICID XEO05267 GENEFORM Protein DME1041 XEOTICID XEO05267 MOACRIVE Inhibition DME1041 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1041 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05268 XEO_CLAS Peptide DME1041 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 1.6 ug/ml) DME1041 XEOTICID XEO05268 GENEFORM Protein DME1041 XEOTICID XEO05268 MOACRIVE Inhibition DME1041 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1041 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05269 XEO_CLAS Peptide DME1041 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 6 ug/ml) DME1041 XEOTICID XEO05269 GENEFORM Protein DME1041 XEOTICID XEO05269 MOACRIVE Inhibition DME1041 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1041 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05273 XEO_CLAS Peptide DME1041 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05273 GENEFORM Protein DME1041 XEOTICID XEO05273 MOACRIVE Inhibition DME1041 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1041 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05274 XEO_CLAS Peptide DME1041 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05274 GENEFORM Protein DME1041 XEOTICID XEO05274 MOACRIVE Inhibition DME1041 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1041 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05287 XEO_CLAS Peptide DME1041 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus DME1041 XEOTICID XEO05287 GENEFORM Protein DME1041 XEOTICID XEO05287 MOACRIVE Inhibition DME1041 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1041 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05303 XEO_CLAS Peptide DME1041 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 16-31 ug/ml) DME1041 XEOTICID XEO05303 GENEFORM Protein DME1041 XEOTICID XEO05303 MOACRIVE Inhibition DME1041 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1041 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05306 XEO_CLAS Peptide DME1041 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 8 ug/ml) DME1041 XEOTICID XEO05306 GENEFORM Protein DME1041 XEOTICID XEO05306 MOACRIVE Inhibition DME1041 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1041 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1041 XEOTICID XEO05308 XEO_CLAS Peptide DME1041 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of NADH dehydrogenase (nuoE) from Streptomyces griseus (MIC = 0.4 ug/ml) DME1041 XEOTICID XEO05308 GENEFORM Protein DME1041 XEOTICID XEO05308 MOACRIVE Inhibition DME1042 DME___ID DME1042 DME1042 DME_NAME Beta-glucuronidase (uidA) DME1042 SPESNAME Lactobacillus sakei DME1042 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1042 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1042 XEOTICID XEO03775 XEO_CLAS Peptide DME1042 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Lactobacillus sakei (MIC = 0.015 microM) DME1042 XEOTICID XEO03775 GENEFORM Protein DME1042 XEOTICID XEO03775 MOACRIVE Inhibition DME1042 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1042 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1042 XEOTICID XEO03803 XEO_CLAS Peptide DME1042 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Lactobacillus sakei DME1042 XEOTICID XEO03803 GENEFORM Protein DME1042 XEOTICID XEO03803 MOACRIVE Inhibition DME1042 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1042 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1042 XEOTICID XEO03854 XEO_CLAS Peptide DME1042 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Lactobacillus sakei (MIC = 1.30 microM) DME1042 XEOTICID XEO03854 GENEFORM Protein DME1042 XEOTICID XEO03854 MOACRIVE Inhibition DME1042 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1042 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1042 XEOTICID XEO03855 XEO_CLAS Peptide DME1042 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Lactobacillus sakei (MIC = 1.04 microM) DME1042 XEOTICID XEO03855 GENEFORM Protein DME1042 XEOTICID XEO03855 MOACRIVE Inhibition DME1042 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1042 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1042 XEOTICID XEO03857 XEO_CLAS Peptide DME1042 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Lactobacillus sakei (MIC = 0.038 microM) DME1042 XEOTICID XEO03857 GENEFORM Protein DME1042 XEOTICID XEO03857 MOACRIVE Inhibition DME1042 XEOTICID XEO04501 XEO_NAME Pediocin PA-1 DME1042 XEOTICID XEO04501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1042 XEOTICID XEO04501 XEO_CLAS Peptide DME1042 XEOTICID XEO04501 DESCRIPT Pediocin PA-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Lactobacillus sakei DME1042 XEOTICID XEO04501 GENEFORM Protein DME1042 XEOTICID XEO04501 MOACRIVE Inhibition DME1042 XEOTICID XEO04616 XEO_NAME Plantaricin E DME1042 XEOTICID XEO04616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1042 XEOTICID XEO04616 XEO_CLAS Peptide DME1042 XEOTICID XEO04616 DESCRIPT Plantaricin E inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Lactobacillus sakei (MIC = 0.004 microM) DME1042 XEOTICID XEO04616 GENEFORM Protein DME1042 XEOTICID XEO04616 MOACRIVE Inhibition DME1042 XEOTICID XEO04617 XEO_NAME Plantaricin F DME1042 XEOTICID XEO04617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1042 XEOTICID XEO04617 XEO_CLAS Peptide DME1042 XEOTICID XEO04617 DESCRIPT Plantaricin F inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Lactobacillus sakei (MIC = 0.004 microM) DME1042 XEOTICID XEO04617 GENEFORM Protein DME1042 XEOTICID XEO04617 MOACRIVE Inhibition DME1047 DME___ID DME1047 DME1047 DME_NAME Beta-glucosidase (bglA) DME1047 SPESNAME Trichophyton rubrum DME1047 XEOTICID XEO02250 XEO_NAME Antifungal peptide Cm-p1 DME1047 XEOTICID XEO02250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1047 XEOTICID XEO02250 XEO_CLAS Peptide DME1047 XEOTICID XEO02250 DESCRIPT Antifungal peptide Cm-p1 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Trichophyton rubrum (MIC = 3 microM) DME1047 XEOTICID XEO02250 GENEFORM Protein DME1047 XEOTICID XEO02250 MOACRIVE Inhibition DME1047 XEOTICID XEO02892 XEO_NAME Cm-p1 derivative Cm-p3 DME1047 XEOTICID XEO02892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1047 XEOTICID XEO02892 XEO_CLAS Peptide DME1047 XEOTICID XEO02892 DESCRIPT Cm-p1 derivative Cm-p3 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Trichophyton rubrum (MIC = 128 ug/ml) DME1047 XEOTICID XEO02892 GENEFORM Protein DME1047 XEOTICID XEO02892 MOACRIVE Inhibition DME1047 XEOTICID XEO02893 XEO_NAME Cm-p1 derivative Cm-p4 DME1047 XEOTICID XEO02893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1047 XEOTICID XEO02893 XEO_CLAS Peptide DME1047 XEOTICID XEO02893 DESCRIPT Cm-p1 derivative Cm-p4 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Trichophyton rubrum (MIC = 32 ug/ml) DME1047 XEOTICID XEO02893 GENEFORM Protein DME1047 XEOTICID XEO02893 MOACRIVE Inhibition DME1047 XEOTICID XEO02894 XEO_NAME Cm-p1 derivative Cm-p5 DME1047 XEOTICID XEO02894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1047 XEOTICID XEO02894 XEO_CLAS Peptide DME1047 XEOTICID XEO02894 DESCRIPT Cm-p1 derivative Cm-p5 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Trichophyton rubrum (MIC = 10 ug/ml) DME1047 XEOTICID XEO02894 GENEFORM Protein DME1047 XEOTICID XEO02894 MOACRIVE Inhibition DME1047 XEOTICID XEO03176 XEO_NAME Diapause-specific peptide DME1047 XEOTICID XEO03176 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1047 XEOTICID XEO03176 XEO_CLAS Peptide DME1047 XEOTICID XEO03176 DESCRIPT Diapause-specific peptide inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Trichophyton rubrum DME1047 XEOTICID XEO03176 GENEFORM Protein DME1047 XEOTICID XEO03176 MOACRIVE Inhibition DME1047 XEOTICID XEO03849 XEO_NAME Lectin DME1047 XEOTICID XEO03849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1047 XEOTICID XEO03849 XEO_CLAS Peptide DME1047 XEOTICID XEO03849 DESCRIPT Lectin inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Trichophyton rubrum (MIC = 65 ug/ml) DME1047 XEOTICID XEO03849 GENEFORM Protein DME1047 XEOTICID XEO03849 MOACRIVE Inhibition DME1047 XEOTICID XEO05261 XEO_NAME V. radiata defensin VrD1 DME1047 XEOTICID XEO05261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1047 XEOTICID XEO05261 XEO_CLAS Peptide DME1047 XEOTICID XEO05261 DESCRIPT V. radiata defensin VrD1 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Trichophyton rubrum DME1047 XEOTICID XEO05261 GENEFORM Protein DME1047 XEOTICID XEO05261 MOACRIVE Inhibition DME1048 DME___ID DME1048 DME1048 DME_NAME Oxygen-insensitive NADPH nitroreductase B (nfsB) DME1048 SPESNAME Escherichia coli DME1048 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1048 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00117 GENEFORM Protein DME1048 XEOTICID XEO00117 MOACRIVE Inhibition DME1048 XEOTICID XEO00122 XEO_NAME Amikacin DME1048 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00122 GENEFORM Protein DME1048 XEOTICID XEO00122 MOACRIVE Inhibition DME1048 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1048 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00136 GENEFORM Protein DME1048 XEOTICID XEO00136 MOACRIVE Inhibition DME1048 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1048 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00237 GENEFORM Protein DME1048 XEOTICID XEO00237 MOACRIVE Inhibition DME1048 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1048 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00349 GENEFORM Protein DME1048 XEOTICID XEO00349 MOACRIVE Inhibition DME1048 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1048 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00425 GENEFORM Protein DME1048 XEOTICID XEO00425 MOACRIVE Inhibition DME1048 XEOTICID XEO00439 XEO_NAME Daidzein DME1048 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00439 GENEFORM Protein DME1048 XEOTICID XEO00439 MOACRIVE Inhibition DME1048 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1048 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00460 GENEFORM Protein DME1048 XEOTICID XEO00460 MOACRIVE Inhibition DME1048 XEOTICID XEO00487 XEO_NAME Thymol DME1048 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00487 GENEFORM Protein DME1048 XEOTICID XEO00487 MOACRIVE Inhibition DME1048 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1048 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00511 GENEFORM Protein DME1048 XEOTICID XEO00511 MOACRIVE Inhibition DME1048 XEOTICID XEO00537 XEO_NAME Luteolin DME1048 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1048 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00537 GENEFORM Protein DME1048 XEOTICID XEO00537 MOACRIVE Inhibition DME1048 XEOTICID XEO00538 XEO_NAME Quercetin DME1048 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1048 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00538 GENEFORM Protein DME1048 XEOTICID XEO00538 MOACRIVE Inhibition DME1048 XEOTICID XEO00547 XEO_NAME Vitamin E DME1048 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1048 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00547 GENEFORM Protein DME1048 XEOTICID XEO00547 MOACRIVE Inhibition DME1048 XEOTICID XEO00557 XEO_NAME Genistein DME1048 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1048 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00557 GENEFORM Protein DME1048 XEOTICID XEO00557 MOACRIVE Inhibition DME1048 XEOTICID XEO00566 XEO_NAME Guaiacol DME1048 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1048 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00566 GENEFORM Protein DME1048 XEOTICID XEO00566 MOACRIVE Inhibition DME1048 XEOTICID XEO00568 XEO_NAME Resveratrol DME1048 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1048 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00568 GENEFORM Protein DME1048 XEOTICID XEO00568 MOACRIVE Inhibition DME1048 XEOTICID XEO00573 XEO_NAME Naringenin DME1048 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1048 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00573 GENEFORM Protein DME1048 XEOTICID XEO00573 MOACRIVE Inhibition DME1048 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1048 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1048 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00574 GENEFORM Protein DME1048 XEOTICID XEO00574 MOACRIVE Inhibition DME1048 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1048 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1048 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00611 GENEFORM Protein DME1048 XEOTICID XEO00611 MOACRIVE Inhibition DME1048 XEOTICID XEO00621 XEO_NAME Chitosan DME1048 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1048 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00621 GENEFORM Protein DME1048 XEOTICID XEO00621 MOACRIVE Inhibition DME1048 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1048 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1048 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00646 GENEFORM Protein DME1048 XEOTICID XEO00646 MOACRIVE Inhibition DME1048 XEOTICID XEO00683 XEO_NAME Curcumin DME1048 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1048 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00683 GENEFORM Protein DME1048 XEOTICID XEO00683 MOACRIVE Inhibition DME1048 XEOTICID XEO00727 XEO_NAME Vanillin DME1048 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1048 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00727 GENEFORM Protein DME1048 XEOTICID XEO00727 MOACRIVE Inhibition DME1048 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1048 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1048 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00730 GENEFORM Protein DME1048 XEOTICID XEO00730 MOACRIVE Inhibition DME1048 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1048 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO00782 XEO_CLAS Natural Product DME1048 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00782 GENEFORM Protein DME1048 XEOTICID XEO00782 MOACRIVE Inhibition DME1048 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1048 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1048 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00866 GENEFORM Protein DME1048 XEOTICID XEO00866 MOACRIVE Inhibition DME1048 XEOTICID XEO00878 XEO_NAME Chrysin DME1048 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO00878 XEO_CLAS Natural Product DME1048 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00878 GENEFORM Protein DME1048 XEOTICID XEO00878 MOACRIVE Inhibition DME1048 XEOTICID XEO00879 XEO_NAME Coumarin DME1048 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1048 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1048 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00879 GENEFORM Protein DME1048 XEOTICID XEO00879 MOACRIVE Inhibition DME1048 XEOTICID XEO00883 XEO_NAME Phloretin DME1048 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO00883 XEO_CLAS Natural Product DME1048 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00883 GENEFORM Protein DME1048 XEOTICID XEO00883 MOACRIVE Inhibition DME1048 XEOTICID XEO00885 XEO_NAME Eugenol DME1048 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1048 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO00885 GENEFORM Protein DME1048 XEOTICID XEO00885 MOACRIVE Inhibition DME1048 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1048 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1048 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1048 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01032 GENEFORM Protein DME1048 XEOTICID XEO01032 MOACRIVE Inhibition DME1048 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1048 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01174 XEO_CLAS Natural Product DME1048 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01174 GENEFORM Protein DME1048 XEOTICID XEO01174 MOACRIVE Inhibition DME1048 XEOTICID XEO01203 XEO_NAME Apigenin DME1048 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01203 XEO_CLAS Natural Product DME1048 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01203 GENEFORM Protein DME1048 XEOTICID XEO01203 MOACRIVE Inhibition DME1048 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1048 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1048 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1048 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01232 GENEFORM Protein DME1048 XEOTICID XEO01232 MOACRIVE Inhibition DME1048 XEOTICID XEO01237 XEO_NAME Carvacrol DME1048 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1048 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01237 GENEFORM Protein DME1048 XEOTICID XEO01237 MOACRIVE Inhibition DME1048 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1048 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1048 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01287 GENEFORM Protein DME1048 XEOTICID XEO01287 MOACRIVE Inhibition DME1048 XEOTICID XEO01291 XEO_NAME Esculetin DME1048 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1048 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01291 GENEFORM Protein DME1048 XEOTICID XEO01291 MOACRIVE Inhibition DME1048 XEOTICID XEO01304 XEO_NAME Flavone DME1048 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01304 XEO_CLAS Natural Product DME1048 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01304 GENEFORM Protein DME1048 XEOTICID XEO01304 MOACRIVE Inhibition DME1048 XEOTICID XEO01309 XEO_NAME Gallic acid DME1048 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01309 XEO_CLAS Natural Product DME1048 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01309 GENEFORM Protein DME1048 XEOTICID XEO01309 MOACRIVE Inhibition DME1048 XEOTICID XEO01340 XEO_NAME Imperatorin DME1048 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01340 XEO_CLAS Natural Product DME1048 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01340 GENEFORM Protein DME1048 XEOTICID XEO01340 MOACRIVE Inhibition DME1048 XEOTICID XEO01353 XEO_NAME Kaempferol DME1048 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1048 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1048 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01353 GENEFORM Protein DME1048 XEOTICID XEO01353 MOACRIVE Inhibition DME1048 XEOTICID XEO01366 XEO_NAME Linalool DME1048 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01366 XEO_CLAS Natural Product DME1048 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01366 GENEFORM Protein DME1048 XEOTICID XEO01366 MOACRIVE Inhibition DME1048 XEOTICID XEO01391 XEO_NAME Naringin DME1048 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01391 XEO_CLAS Natural Product DME1048 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01391 GENEFORM Protein DME1048 XEOTICID XEO01391 MOACRIVE Inhibition DME1048 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1048 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1048 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01420 GENEFORM Protein DME1048 XEOTICID XEO01420 MOACRIVE Inhibition DME1048 XEOTICID XEO01463 XEO_NAME Rutin DME1048 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01463 XEO_CLAS Natural Product DME1048 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01463 GENEFORM Protein DME1048 XEOTICID XEO01463 MOACRIVE Inhibition DME1048 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1048 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1048 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01496 GENEFORM Protein DME1048 XEOTICID XEO01496 MOACRIVE Inhibition DME1048 XEOTICID XEO01512 XEO_NAME Zinc DME1048 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1048 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1048 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01512 GENEFORM Protein DME1048 XEOTICID XEO01512 MOACRIVE Inhibition DME1048 XEOTICID XEO01527 XEO_NAME Bergamottin DME1048 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01527 XEO_CLAS Natural Product DME1048 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01527 GENEFORM Protein DME1048 XEOTICID XEO01527 MOACRIVE Inhibition DME1048 XEOTICID XEO01531 XEO_NAME Clove oil DME1048 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01531 XEO_CLAS Natural Product DME1048 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01531 GENEFORM Protein DME1048 XEOTICID XEO01531 MOACRIVE Inhibition DME1048 XEOTICID XEO01559 XEO_NAME Limonene DME1048 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01559 XEO_CLAS Natural Product DME1048 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01559 GENEFORM Protein DME1048 XEOTICID XEO01559 MOACRIVE Inhibition DME1048 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1048 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01563 XEO_CLAS Natural Product DME1048 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01563 GENEFORM Protein DME1048 XEOTICID XEO01563 MOACRIVE Inhibition DME1048 XEOTICID XEO01566 XEO_NAME Nobiletin DME1048 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01566 XEO_CLAS Natural Product DME1048 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01566 GENEFORM Protein DME1048 XEOTICID XEO01566 MOACRIVE Inhibition DME1048 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1048 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01778 XEO_CLAS Natural Product DME1048 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01778 GENEFORM Protein DME1048 XEOTICID XEO01778 MOACRIVE Inhibition DME1048 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1048 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01779 XEO_CLAS Peptide DME1048 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 128 microM) DME1048 XEOTICID XEO01779 GENEFORM Protein DME1048 XEOTICID XEO01779 MOACRIVE Inhibition DME1048 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1048 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01810 XEO_CLAS Peptide DME1048 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.0 microM) DME1048 XEOTICID XEO01810 GENEFORM Protein DME1048 XEOTICID XEO01810 MOACRIVE Inhibition DME1048 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1048 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01811 XEO_CLAS Peptide DME1048 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 microM) DME1048 XEOTICID XEO01811 GENEFORM Protein DME1048 XEOTICID XEO01811 MOACRIVE Inhibition DME1048 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1048 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01812 XEO_CLAS Peptide DME1048 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10.4 microM) DME1048 XEOTICID XEO01812 GENEFORM Protein DME1048 XEOTICID XEO01812 MOACRIVE Inhibition DME1048 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1048 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01813 XEO_CLAS Peptide DME1048 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.1 microM) DME1048 XEOTICID XEO01813 GENEFORM Protein DME1048 XEOTICID XEO01813 MOACRIVE Inhibition DME1048 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1048 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01814 XEO_CLAS Peptide DME1048 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.5 microM) DME1048 XEOTICID XEO01814 GENEFORM Protein DME1048 XEOTICID XEO01814 MOACRIVE Inhibition DME1048 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1048 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01815 XEO_CLAS Peptide DME1048 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 9.8 microM) DME1048 XEOTICID XEO01815 GENEFORM Protein DME1048 XEOTICID XEO01815 MOACRIVE Inhibition DME1048 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1048 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01816 XEO_CLAS Peptide DME1048 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO01816 GENEFORM Protein DME1048 XEOTICID XEO01816 MOACRIVE Inhibition DME1048 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1048 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01817 XEO_CLAS Peptide DME1048 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.0 microM) DME1048 XEOTICID XEO01817 GENEFORM Protein DME1048 XEOTICID XEO01817 MOACRIVE Inhibition DME1048 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1048 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01818 XEO_CLAS Peptide DME1048 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4.0 microM) DME1048 XEOTICID XEO01818 GENEFORM Protein DME1048 XEOTICID XEO01818 MOACRIVE Inhibition DME1048 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1048 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01819 XEO_CLAS Peptide DME1048 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO01819 GENEFORM Protein DME1048 XEOTICID XEO01819 MOACRIVE Inhibition DME1048 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1048 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01820 XEO_CLAS Peptide DME1048 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO01820 GENEFORM Protein DME1048 XEOTICID XEO01820 MOACRIVE Inhibition DME1048 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1048 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01821 XEO_CLAS Peptide DME1048 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO01821 GENEFORM Protein DME1048 XEOTICID XEO01821 MOACRIVE Inhibition DME1048 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1048 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01822 XEO_CLAS Peptide DME1048 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 microM) DME1048 XEOTICID XEO01822 GENEFORM Protein DME1048 XEOTICID XEO01822 MOACRIVE Inhibition DME1048 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1048 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01823 XEO_CLAS Peptide DME1048 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO01823 GENEFORM Protein DME1048 XEOTICID XEO01823 MOACRIVE Inhibition DME1048 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1048 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01824 XEO_CLAS Peptide DME1048 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO01824 GENEFORM Protein DME1048 XEOTICID XEO01824 MOACRIVE Inhibition DME1048 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1048 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01825 XEO_CLAS Peptide DME1048 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25.0 microM) DME1048 XEOTICID XEO01825 GENEFORM Protein DME1048 XEOTICID XEO01825 MOACRIVE Inhibition DME1048 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1048 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01827 XEO_CLAS Peptide DME1048 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.12-6.25 microM) DME1048 XEOTICID XEO01827 GENEFORM Protein DME1048 XEOTICID XEO01827 MOACRIVE Inhibition DME1048 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1048 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1048 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1048 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01829 GENEFORM Protein DME1048 XEOTICID XEO01829 MOACRIVE Inhibition DME1048 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1048 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01927 XEO_CLAS Peptide DME1048 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 ug/ml) DME1048 XEOTICID XEO01927 GENEFORM Protein DME1048 XEOTICID XEO01927 MOACRIVE Inhibition DME1048 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1048 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01945 XEO_CLAS Peptide DME1048 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.1 microM) DME1048 XEOTICID XEO01945 GENEFORM Protein DME1048 XEOTICID XEO01945 MOACRIVE Inhibition DME1048 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1048 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01946 XEO_CLAS Peptide DME1048 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.2 microM) DME1048 XEOTICID XEO01946 GENEFORM Protein DME1048 XEOTICID XEO01946 MOACRIVE Inhibition DME1048 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1048 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO01947 XEO_CLAS Natural Product DME1048 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01947 GENEFORM Protein DME1048 XEOTICID XEO01947 MOACRIVE Inhibition DME1048 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1048 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1048 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1048 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01950 GENEFORM Protein DME1048 XEOTICID XEO01950 MOACRIVE Inhibition DME1048 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1048 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1048 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1048 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01961 GENEFORM Protein DME1048 XEOTICID XEO01961 MOACRIVE Inhibition DME1048 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1048 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1048 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1048 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO01966 GENEFORM Protein DME1048 XEOTICID XEO01966 MOACRIVE Inhibition DME1048 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1048 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01996 XEO_CLAS Peptide DME1048 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.7 microM) DME1048 XEOTICID XEO01996 GENEFORM Protein DME1048 XEOTICID XEO01996 MOACRIVE Inhibition DME1048 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1048 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01997 XEO_CLAS Peptide DME1048 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.9 microM) DME1048 XEOTICID XEO01997 GENEFORM Protein DME1048 XEOTICID XEO01997 MOACRIVE Inhibition DME1048 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1048 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01998 XEO_CLAS Peptide DME1048 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO01998 GENEFORM Protein DME1048 XEOTICID XEO01998 MOACRIVE Inhibition DME1048 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1048 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO01999 XEO_CLAS Peptide DME1048 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.5 microM) DME1048 XEOTICID XEO01999 GENEFORM Protein DME1048 XEOTICID XEO01999 MOACRIVE Inhibition DME1048 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1048 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02013 XEO_CLAS Peptide DME1048 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02013 GENEFORM Protein DME1048 XEOTICID XEO02013 MOACRIVE Inhibition DME1048 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1048 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02032 XEO_CLAS Natural Product DME1048 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02032 GENEFORM Protein DME1048 XEOTICID XEO02032 MOACRIVE Inhibition DME1048 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1048 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02033 XEO_CLAS Natural Product DME1048 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02033 GENEFORM Protein DME1048 XEOTICID XEO02033 MOACRIVE Inhibition DME1048 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1048 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02079 XEO_CLAS Natural Product DME1048 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02079 GENEFORM Protein DME1048 XEOTICID XEO02079 MOACRIVE Inhibition DME1048 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1048 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1048 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02085 GENEFORM Protein DME1048 XEOTICID XEO02085 MOACRIVE Inhibition DME1048 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1048 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02111 XEO_CLAS Peptide DME1048 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2-4 ug/ml) DME1048 XEOTICID XEO02111 GENEFORM Protein DME1048 XEOTICID XEO02111 MOACRIVE Inhibition DME1048 XEOTICID XEO02113 XEO_NAME Abaecin DME1048 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02113 XEO_CLAS Peptide DME1048 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02113 GENEFORM Protein DME1048 XEOTICID XEO02113 MOACRIVE Inhibition DME1048 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1048 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02114 XEO_CLAS Peptide DME1048 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-25 ug/ml) DME1048 XEOTICID XEO02114 GENEFORM Protein DME1048 XEOTICID XEO02114 MOACRIVE Inhibition DME1048 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1048 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02115 XEO_CLAS Peptide DME1048 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02115 GENEFORM Protein DME1048 XEOTICID XEO02115 MOACRIVE Inhibition DME1048 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1048 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02117 XEO_CLAS Peptide DME1048 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02117 GENEFORM Protein DME1048 XEOTICID XEO02117 MOACRIVE Inhibition DME1048 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1048 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02118 XEO_CLAS Peptide DME1048 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02118 GENEFORM Protein DME1048 XEOTICID XEO02118 MOACRIVE Inhibition DME1048 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1048 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02119 XEO_CLAS Peptide DME1048 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02119 GENEFORM Protein DME1048 XEOTICID XEO02119 MOACRIVE Inhibition DME1048 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1048 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02120 XEO_CLAS Peptide DME1048 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02120 GENEFORM Protein DME1048 XEOTICID XEO02120 MOACRIVE Inhibition DME1048 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1048 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02121 XEO_CLAS Peptide DME1048 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02121 GENEFORM Protein DME1048 XEOTICID XEO02121 MOACRIVE Inhibition DME1048 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1048 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02122 XEO_CLAS Peptide DME1048 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 ug/ml) DME1048 XEOTICID XEO02122 GENEFORM Protein DME1048 XEOTICID XEO02122 MOACRIVE Inhibition DME1048 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1048 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02130 XEO_CLAS Peptide DME1048 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.7 microM) DME1048 XEOTICID XEO02130 GENEFORM Protein DME1048 XEOTICID XEO02130 MOACRIVE Inhibition DME1048 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1048 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02131 XEO_CLAS Peptide DME1048 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.3 microM) DME1048 XEOTICID XEO02131 GENEFORM Protein DME1048 XEOTICID XEO02131 MOACRIVE Inhibition DME1048 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1048 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02132 XEO_CLAS Peptide DME1048 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.5 microM) DME1048 XEOTICID XEO02132 GENEFORM Protein DME1048 XEOTICID XEO02132 MOACRIVE Inhibition DME1048 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1048 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02136 XEO_CLAS Peptide DME1048 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 ug/ml) DME1048 XEOTICID XEO02136 GENEFORM Protein DME1048 XEOTICID XEO02136 MOACRIVE Inhibition DME1048 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1048 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02147 XEO_CLAS Peptide DME1048 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 382 ug/ml) DME1048 XEOTICID XEO02147 GENEFORM Protein DME1048 XEOTICID XEO02147 MOACRIVE Inhibition DME1048 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1048 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02149 XEO_CLAS Peptide DME1048 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 47.35 microM) DME1048 XEOTICID XEO02149 GENEFORM Protein DME1048 XEOTICID XEO02149 MOACRIVE Inhibition DME1048 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1048 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02164 XEO_CLAS Peptide DME1048 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02164 GENEFORM Protein DME1048 XEOTICID XEO02164 MOACRIVE Inhibition DME1048 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1048 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02165 XEO_CLAS Peptide DME1048 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02165 GENEFORM Protein DME1048 XEOTICID XEO02165 MOACRIVE Inhibition DME1048 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1048 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02166 XEO_CLAS Peptide DME1048 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02166 GENEFORM Protein DME1048 XEOTICID XEO02166 MOACRIVE Inhibition DME1048 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1048 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02167 XEO_CLAS Peptide DME1048 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02167 GENEFORM Protein DME1048 XEOTICID XEO02167 MOACRIVE Inhibition DME1048 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1048 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02168 XEO_CLAS Peptide DME1048 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02168 GENEFORM Protein DME1048 XEOTICID XEO02168 MOACRIVE Inhibition DME1048 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1048 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02169 XEO_CLAS Peptide DME1048 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02169 GENEFORM Protein DME1048 XEOTICID XEO02169 MOACRIVE Inhibition DME1048 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1048 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02170 XEO_CLAS Peptide DME1048 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.4 microM) DME1048 XEOTICID XEO02170 GENEFORM Protein DME1048 XEOTICID XEO02170 MOACRIVE Inhibition DME1048 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1048 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02175 XEO_CLAS Natural Product DME1048 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02175 GENEFORM Protein DME1048 XEOTICID XEO02175 MOACRIVE Inhibition DME1048 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1048 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02177 XEO_CLAS Peptide DME1048 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO02177 GENEFORM Protein DME1048 XEOTICID XEO02177 MOACRIVE Inhibition DME1048 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1048 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02178 XEO_CLAS Peptide DME1048 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO02178 GENEFORM Protein DME1048 XEOTICID XEO02178 MOACRIVE Inhibition DME1048 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1048 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02179 XEO_CLAS Peptide DME1048 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO02179 GENEFORM Protein DME1048 XEOTICID XEO02179 MOACRIVE Inhibition DME1048 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1048 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02180 XEO_CLAS Peptide DME1048 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 214 microM) DME1048 XEOTICID XEO02180 GENEFORM Protein DME1048 XEOTICID XEO02180 MOACRIVE Inhibition DME1048 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1048 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02181 XEO_CLAS Peptide DME1048 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 217 microM) DME1048 XEOTICID XEO02181 GENEFORM Protein DME1048 XEOTICID XEO02181 MOACRIVE Inhibition DME1048 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1048 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02183 XEO_CLAS Peptide DME1048 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 38.4 microM) DME1048 XEOTICID XEO02183 GENEFORM Protein DME1048 XEOTICID XEO02183 MOACRIVE Inhibition DME1048 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1048 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02185 XEO_CLAS Peptide DME1048 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 microM) DME1048 XEOTICID XEO02185 GENEFORM Protein DME1048 XEOTICID XEO02185 MOACRIVE Inhibition DME1048 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1048 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02187 GENEFORM Protein DME1048 XEOTICID XEO02187 MOACRIVE Inhibition DME1048 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1048 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02191 XEO_CLAS Peptide DME1048 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02191 GENEFORM Protein DME1048 XEOTICID XEO02191 MOACRIVE Inhibition DME1048 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1048 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02192 XEO_CLAS Peptide DME1048 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.50 ug/ml) DME1048 XEOTICID XEO02192 GENEFORM Protein DME1048 XEOTICID XEO02192 MOACRIVE Inhibition DME1048 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1048 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02193 XEO_CLAS Peptide DME1048 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02193 GENEFORM Protein DME1048 XEOTICID XEO02193 MOACRIVE Inhibition DME1048 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1048 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02194 XEO_CLAS Peptide DME1048 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02194 GENEFORM Protein DME1048 XEOTICID XEO02194 MOACRIVE Inhibition DME1048 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1048 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02195 XEO_CLAS Peptide DME1048 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.00 ug/ml) DME1048 XEOTICID XEO02195 GENEFORM Protein DME1048 XEOTICID XEO02195 MOACRIVE Inhibition DME1048 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1048 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02197 XEO_CLAS Peptide DME1048 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02197 GENEFORM Protein DME1048 XEOTICID XEO02197 MOACRIVE Inhibition DME1048 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1048 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02200 XEO_CLAS Peptide DME1048 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 ug/ml) DME1048 XEOTICID XEO02200 GENEFORM Protein DME1048 XEOTICID XEO02200 MOACRIVE Inhibition DME1048 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1048 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02201 XEO_CLAS Peptide DME1048 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 ug/ml) DME1048 XEOTICID XEO02201 GENEFORM Protein DME1048 XEOTICID XEO02201 MOACRIVE Inhibition DME1048 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1048 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02202 XEO_CLAS Peptide DME1048 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO02202 GENEFORM Protein DME1048 XEOTICID XEO02202 MOACRIVE Inhibition DME1048 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1048 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02203 XEO_CLAS Peptide DME1048 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 microM) DME1048 XEOTICID XEO02203 GENEFORM Protein DME1048 XEOTICID XEO02203 MOACRIVE Inhibition DME1048 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1048 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02207 XEO_CLAS Peptide DME1048 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.78 ug/ml) DME1048 XEOTICID XEO02207 GENEFORM Protein DME1048 XEOTICID XEO02207 MOACRIVE Inhibition DME1048 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1048 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02208 XEO_CLAS Peptide DME1048 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.13 ug/ml) DME1048 XEOTICID XEO02208 GENEFORM Protein DME1048 XEOTICID XEO02208 MOACRIVE Inhibition DME1048 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1048 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02209 XEO_CLAS Peptide DME1048 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.56 ug/ml) DME1048 XEOTICID XEO02209 GENEFORM Protein DME1048 XEOTICID XEO02209 MOACRIVE Inhibition DME1048 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1048 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02210 XEO_CLAS Peptide DME1048 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 ug/ml) DME1048 XEOTICID XEO02210 GENEFORM Protein DME1048 XEOTICID XEO02210 MOACRIVE Inhibition DME1048 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1048 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02211 XEO_CLAS Peptide DME1048 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25 ug/ml) DME1048 XEOTICID XEO02211 GENEFORM Protein DME1048 XEOTICID XEO02211 MOACRIVE Inhibition DME1048 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1048 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02212 XEO_CLAS Peptide DME1048 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.13 ug/ml) DME1048 XEOTICID XEO02212 GENEFORM Protein DME1048 XEOTICID XEO02212 MOACRIVE Inhibition DME1048 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1048 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02213 XEO_CLAS Peptide DME1048 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.13 ug/ml) DME1048 XEOTICID XEO02213 GENEFORM Protein DME1048 XEOTICID XEO02213 MOACRIVE Inhibition DME1048 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1048 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02214 XEO_CLAS Peptide DME1048 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02214 GENEFORM Protein DME1048 XEOTICID XEO02214 MOACRIVE Inhibition DME1048 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1048 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02215 XEO_CLAS Peptide DME1048 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 ug/ml) DME1048 XEOTICID XEO02215 GENEFORM Protein DME1048 XEOTICID XEO02215 MOACRIVE Inhibition DME1048 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1048 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02216 XEO_CLAS Peptide DME1048 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 126 ug/ml) DME1048 XEOTICID XEO02216 GENEFORM Protein DME1048 XEOTICID XEO02216 MOACRIVE Inhibition DME1048 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1048 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02217 XEO_CLAS Peptide DME1048 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 200 ug/ml) DME1048 XEOTICID XEO02217 GENEFORM Protein DME1048 XEOTICID XEO02217 MOACRIVE Inhibition DME1048 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1048 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02218 XEO_CLAS Peptide DME1048 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 200 ug/ml) DME1048 XEOTICID XEO02218 GENEFORM Protein DME1048 XEOTICID XEO02218 MOACRIVE Inhibition DME1048 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1048 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02219 XEO_CLAS Peptide DME1048 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 200 ug/ml) DME1048 XEOTICID XEO02219 GENEFORM Protein DME1048 XEOTICID XEO02219 MOACRIVE Inhibition DME1048 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1048 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02220 XEO_CLAS Peptide DME1048 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 23.5 ug/ml) DME1048 XEOTICID XEO02220 GENEFORM Protein DME1048 XEOTICID XEO02220 MOACRIVE Inhibition DME1048 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1048 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02221 XEO_CLAS Peptide DME1048 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20.2 ug/ml) DME1048 XEOTICID XEO02221 GENEFORM Protein DME1048 XEOTICID XEO02221 MOACRIVE Inhibition DME1048 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1048 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02222 XEO_CLAS Peptide DME1048 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30.5 ug/ml) DME1048 XEOTICID XEO02222 GENEFORM Protein DME1048 XEOTICID XEO02222 MOACRIVE Inhibition DME1048 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1048 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02223 XEO_CLAS Peptide DME1048 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.2 ug/ml) DME1048 XEOTICID XEO02223 GENEFORM Protein DME1048 XEOTICID XEO02223 MOACRIVE Inhibition DME1048 XEOTICID XEO02224 XEO_NAME Androctonin DME1048 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02224 XEO_CLAS Peptide DME1048 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02224 GENEFORM Protein DME1048 XEOTICID XEO02224 MOACRIVE Inhibition DME1048 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1048 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02225 XEO_CLAS Peptide DME1048 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02225 GENEFORM Protein DME1048 XEOTICID XEO02225 MOACRIVE Inhibition DME1048 XEOTICID XEO02226 XEO_NAME Andropin DME1048 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02226 XEO_CLAS Peptide DME1048 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 140 microM) DME1048 XEOTICID XEO02226 GENEFORM Protein DME1048 XEOTICID XEO02226 MOACRIVE Inhibition DME1048 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1048 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02230 XEO_CLAS Peptide DME1048 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.05-0.1 microM) DME1048 XEOTICID XEO02230 GENEFORM Protein DME1048 XEOTICID XEO02230 MOACRIVE Inhibition DME1048 XEOTICID XEO02232 XEO_NAME Anoplin DME1048 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02232 XEO_CLAS Peptide DME1048 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 13 ug/ml) DME1048 XEOTICID XEO02232 GENEFORM Protein DME1048 XEOTICID XEO02232 MOACRIVE Inhibition DME1048 XEOTICID XEO02233 XEO_NAME Antapin DME1048 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02233 XEO_CLAS Peptide DME1048 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02233 GENEFORM Protein DME1048 XEOTICID XEO02233 MOACRIVE Inhibition DME1048 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1048 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02236 XEO_CLAS Peptide DME1048 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02236 GENEFORM Protein DME1048 XEOTICID XEO02236 MOACRIVE Inhibition DME1048 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1048 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02239 XEO_CLAS Peptide DME1048 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 250 microM) DME1048 XEOTICID XEO02239 GENEFORM Protein DME1048 XEOTICID XEO02239 MOACRIVE Inhibition DME1048 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1048 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02240 XEO_CLAS Peptide DME1048 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 microM) DME1048 XEOTICID XEO02240 GENEFORM Protein DME1048 XEOTICID XEO02240 MOACRIVE Inhibition DME1048 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1048 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02241 XEO_CLAS Peptide DME1048 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02241 GENEFORM Protein DME1048 XEOTICID XEO02241 MOACRIVE Inhibition DME1048 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1048 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02242 XEO_CLAS Peptide DME1048 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO02242 GENEFORM Protein DME1048 XEOTICID XEO02242 MOACRIVE Inhibition DME1048 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1048 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02243 XEO_CLAS Peptide DME1048 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 microM) DME1048 XEOTICID XEO02243 GENEFORM Protein DME1048 XEOTICID XEO02243 MOACRIVE Inhibition DME1048 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1048 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02244 XEO_CLAS Peptide DME1048 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1 microM) DME1048 XEOTICID XEO02244 GENEFORM Protein DME1048 XEOTICID XEO02244 MOACRIVE Inhibition DME1048 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1048 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02245 XEO_CLAS Peptide DME1048 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02245 GENEFORM Protein DME1048 XEOTICID XEO02245 MOACRIVE Inhibition DME1048 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1048 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02246 XEO_CLAS Peptide DME1048 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 microM) DME1048 XEOTICID XEO02246 GENEFORM Protein DME1048 XEOTICID XEO02246 MOACRIVE Inhibition DME1048 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1048 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02247 XEO_CLAS Peptide DME1048 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02247 GENEFORM Protein DME1048 XEOTICID XEO02247 MOACRIVE Inhibition DME1048 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1048 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02248 XEO_CLAS Peptide DME1048 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.3 microM) DME1048 XEOTICID XEO02248 GENEFORM Protein DME1048 XEOTICID XEO02248 MOACRIVE Inhibition DME1048 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1048 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02253 XEO_CLAS Peptide DME1048 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02253 GENEFORM Protein DME1048 XEOTICID XEO02253 MOACRIVE Inhibition DME1048 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1048 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02258 XEO_CLAS Peptide DME1048 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 150 microM) DME1048 XEOTICID XEO02258 GENEFORM Protein DME1048 XEOTICID XEO02258 MOACRIVE Inhibition DME1048 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1048 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02261 XEO_CLAS Peptide DME1048 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 82 ug/ml) DME1048 XEOTICID XEO02261 GENEFORM Protein DME1048 XEOTICID XEO02261 MOACRIVE Inhibition DME1048 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1048 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02263 XEO_CLAS Peptide DME1048 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO02263 GENEFORM Protein DME1048 XEOTICID XEO02263 MOACRIVE Inhibition DME1048 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1048 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02266 XEO_CLAS Peptide DME1048 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 120 microM) DME1048 XEOTICID XEO02266 GENEFORM Protein DME1048 XEOTICID XEO02266 MOACRIVE Inhibition DME1048 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1048 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02268 XEO_CLAS Peptide DME1048 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 170 ug/ml) DME1048 XEOTICID XEO02268 GENEFORM Protein DME1048 XEOTICID XEO02268 MOACRIVE Inhibition DME1048 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1048 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02270 XEO_CLAS Peptide DME1048 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 microM) DME1048 XEOTICID XEO02270 GENEFORM Protein DME1048 XEOTICID XEO02270 MOACRIVE Inhibition DME1048 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1048 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02271 XEO_CLAS Peptide DME1048 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 302 ug/ml) DME1048 XEOTICID XEO02271 GENEFORM Protein DME1048 XEOTICID XEO02271 MOACRIVE Inhibition DME1048 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1048 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02273 XEO_CLAS Peptide DME1048 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 18 microM) DME1048 XEOTICID XEO02273 GENEFORM Protein DME1048 XEOTICID XEO02273 MOACRIVE Inhibition DME1048 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1048 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02274 XEO_CLAS Peptide DME1048 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO02274 GENEFORM Protein DME1048 XEOTICID XEO02274 MOACRIVE Inhibition DME1048 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1048 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02275 XEO_CLAS Peptide DME1048 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 microM) DME1048 XEOTICID XEO02275 GENEFORM Protein DME1048 XEOTICID XEO02275 MOACRIVE Inhibition DME1048 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1048 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02276 XEO_CLAS Peptide DME1048 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 microM) DME1048 XEOTICID XEO02276 GENEFORM Protein DME1048 XEOTICID XEO02276 MOACRIVE Inhibition DME1048 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1048 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02280 XEO_CLAS Peptide DME1048 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02280 GENEFORM Protein DME1048 XEOTICID XEO02280 MOACRIVE Inhibition DME1048 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1048 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02281 XEO_CLAS Peptide DME1048 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02281 GENEFORM Protein DME1048 XEOTICID XEO02281 MOACRIVE Inhibition DME1048 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1048 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02283 XEO_CLAS Peptide DME1048 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 ug/ml) DME1048 XEOTICID XEO02283 GENEFORM Protein DME1048 XEOTICID XEO02283 MOACRIVE Inhibition DME1048 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1048 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02284 XEO_CLAS Peptide DME1048 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50.4 microM) DME1048 XEOTICID XEO02284 GENEFORM Protein DME1048 XEOTICID XEO02284 MOACRIVE Inhibition DME1048 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1048 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02285 XEO_CLAS Peptide DME1048 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50.4 microM) DME1048 XEOTICID XEO02285 GENEFORM Protein DME1048 XEOTICID XEO02285 MOACRIVE Inhibition DME1048 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1048 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02286 XEO_CLAS Peptide DME1048 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50.4 microM) DME1048 XEOTICID XEO02286 GENEFORM Protein DME1048 XEOTICID XEO02286 MOACRIVE Inhibition DME1048 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1048 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02287 XEO_CLAS Peptide DME1048 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50.4 microM) DME1048 XEOTICID XEO02287 GENEFORM Protein DME1048 XEOTICID XEO02287 MOACRIVE Inhibition DME1048 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1048 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02288 XEO_CLAS Peptide DME1048 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.2 ug/ml) DME1048 XEOTICID XEO02288 GENEFORM Protein DME1048 XEOTICID XEO02288 MOACRIVE Inhibition DME1048 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1048 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02289 XEO_CLAS Peptide DME1048 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 ug/ml) DME1048 XEOTICID XEO02289 GENEFORM Protein DME1048 XEOTICID XEO02289 MOACRIVE Inhibition DME1048 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1048 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02290 XEO_CLAS Peptide DME1048 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO02290 GENEFORM Protein DME1048 XEOTICID XEO02290 MOACRIVE Inhibition DME1048 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1048 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02291 XEO_CLAS Peptide DME1048 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02291 GENEFORM Protein DME1048 XEOTICID XEO02291 MOACRIVE Inhibition DME1048 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1048 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02293 XEO_CLAS Peptide DME1048 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 microM) DME1048 XEOTICID XEO02293 GENEFORM Protein DME1048 XEOTICID XEO02293 MOACRIVE Inhibition DME1048 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1048 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02294 XEO_CLAS Peptide DME1048 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 62-250 ug/ml) DME1048 XEOTICID XEO02294 GENEFORM Protein DME1048 XEOTICID XEO02294 MOACRIVE Inhibition DME1048 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1048 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02295 XEO_CLAS Peptide DME1048 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 ug/ml) DME1048 XEOTICID XEO02295 GENEFORM Protein DME1048 XEOTICID XEO02295 MOACRIVE Inhibition DME1048 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1048 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02296 XEO_CLAS Peptide DME1048 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02296 GENEFORM Protein DME1048 XEOTICID XEO02296 MOACRIVE Inhibition DME1048 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1048 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02297 XEO_CLAS Peptide DME1048 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC < 50 ug/ml) DME1048 XEOTICID XEO02297 GENEFORM Protein DME1048 XEOTICID XEO02297 MOACRIVE Inhibition DME1048 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1048 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02298 XEO_CLAS Peptide DME1048 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO02298 GENEFORM Protein DME1048 XEOTICID XEO02298 MOACRIVE Inhibition DME1048 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1048 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02303 XEO_CLAS Peptide DME1048 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02303 GENEFORM Protein DME1048 XEOTICID XEO02303 MOACRIVE Inhibition DME1048 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1048 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02304 XEO_CLAS Peptide DME1048 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.1 ug/ml) DME1048 XEOTICID XEO02304 GENEFORM Protein DME1048 XEOTICID XEO02304 MOACRIVE Inhibition DME1048 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1048 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02305 XEO_CLAS Peptide DME1048 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC <= 1 ug/ml) DME1048 XEOTICID XEO02305 GENEFORM Protein DME1048 XEOTICID XEO02305 MOACRIVE Inhibition DME1048 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1048 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02306 XEO_CLAS Peptide DME1048 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.2 ug/ml) DME1048 XEOTICID XEO02306 GENEFORM Protein DME1048 XEOTICID XEO02306 MOACRIVE Inhibition DME1048 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1048 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02309 XEO_CLAS Peptide DME1048 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02309 GENEFORM Protein DME1048 XEOTICID XEO02309 MOACRIVE Inhibition DME1048 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1048 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02310 XEO_CLAS Peptide DME1048 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02310 GENEFORM Protein DME1048 XEOTICID XEO02310 MOACRIVE Inhibition DME1048 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1048 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02315 XEO_CLAS Peptide DME1048 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO02315 GENEFORM Protein DME1048 XEOTICID XEO02315 MOACRIVE Inhibition DME1048 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1048 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02316 XEO_CLAS Peptide DME1048 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 50 microM) DME1048 XEOTICID XEO02316 GENEFORM Protein DME1048 XEOTICID XEO02316 MOACRIVE Inhibition DME1048 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1048 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02317 XEO_CLAS Peptide DME1048 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 300 microM) DME1048 XEOTICID XEO02317 GENEFORM Protein DME1048 XEOTICID XEO02317 MOACRIVE Inhibition DME1048 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1048 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02318 XEO_CLAS Peptide DME1048 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02318 GENEFORM Protein DME1048 XEOTICID XEO02318 MOACRIVE Inhibition DME1048 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1048 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02319 XEO_CLAS Peptide DME1048 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02319 GENEFORM Protein DME1048 XEOTICID XEO02319 MOACRIVE Inhibition DME1048 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1048 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02320 XEO_CLAS Peptide DME1048 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02320 GENEFORM Protein DME1048 XEOTICID XEO02320 MOACRIVE Inhibition DME1048 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1048 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02321 XEO_CLAS Peptide DME1048 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO02321 GENEFORM Protein DME1048 XEOTICID XEO02321 MOACRIVE Inhibition DME1048 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1048 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02322 XEO_CLAS Peptide DME1048 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02322 GENEFORM Protein DME1048 XEOTICID XEO02322 MOACRIVE Inhibition DME1048 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1048 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02323 XEO_CLAS Peptide DME1048 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO02323 GENEFORM Protein DME1048 XEOTICID XEO02323 MOACRIVE Inhibition DME1048 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1048 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02324 XEO_CLAS Peptide DME1048 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02324 GENEFORM Protein DME1048 XEOTICID XEO02324 MOACRIVE Inhibition DME1048 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1048 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02325 XEO_CLAS Peptide DME1048 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO02325 GENEFORM Protein DME1048 XEOTICID XEO02325 MOACRIVE Inhibition DME1048 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1048 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02326 XEO_CLAS Peptide DME1048 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02326 GENEFORM Protein DME1048 XEOTICID XEO02326 MOACRIVE Inhibition DME1048 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1048 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02327 XEO_CLAS Peptide DME1048 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO02327 GENEFORM Protein DME1048 XEOTICID XEO02327 MOACRIVE Inhibition DME1048 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1048 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02328 XEO_CLAS Peptide DME1048 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO02328 GENEFORM Protein DME1048 XEOTICID XEO02328 MOACRIVE Inhibition DME1048 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1048 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02332 XEO_CLAS Peptide DME1048 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.9 ug/ml) DME1048 XEOTICID XEO02332 GENEFORM Protein DME1048 XEOTICID XEO02332 MOACRIVE Inhibition DME1048 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1048 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02333 XEO_CLAS Peptide DME1048 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 200 microM) DME1048 XEOTICID XEO02333 GENEFORM Protein DME1048 XEOTICID XEO02333 MOACRIVE Inhibition DME1048 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1048 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02336 XEO_CLAS Peptide DME1048 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 microM) DME1048 XEOTICID XEO02336 GENEFORM Protein DME1048 XEOTICID XEO02336 MOACRIVE Inhibition DME1048 XEOTICID XEO02346 XEO_NAME Aurelin DME1048 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02346 XEO_CLAS Peptide DME1048 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 7.66 ug/ml) DME1048 XEOTICID XEO02346 GENEFORM Protein DME1048 XEOTICID XEO02346 MOACRIVE Inhibition DME1048 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1048 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02352 XEO_CLAS Peptide DME1048 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 11 ug/ml) DME1048 XEOTICID XEO02352 GENEFORM Protein DME1048 XEOTICID XEO02352 MOACRIVE Inhibition DME1048 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1048 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02353 XEO_CLAS Peptide DME1048 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 ug/ml) DME1048 XEOTICID XEO02353 GENEFORM Protein DME1048 XEOTICID XEO02353 MOACRIVE Inhibition DME1048 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1048 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02354 XEO_CLAS Peptide DME1048 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 ug/ml) DME1048 XEOTICID XEO02354 GENEFORM Protein DME1048 XEOTICID XEO02354 MOACRIVE Inhibition DME1048 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1048 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02355 XEO_CLAS Peptide DME1048 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 17 ug/ml) DME1048 XEOTICID XEO02355 GENEFORM Protein DME1048 XEOTICID XEO02355 MOACRIVE Inhibition DME1048 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1048 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02356 XEO_CLAS Peptide DME1048 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO02356 GENEFORM Protein DME1048 XEOTICID XEO02356 MOACRIVE Inhibition DME1048 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1048 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02357 XEO_CLAS Peptide DME1048 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO02357 GENEFORM Protein DME1048 XEOTICID XEO02357 MOACRIVE Inhibition DME1048 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1048 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02358 XEO_CLAS Peptide DME1048 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO02358 GENEFORM Protein DME1048 XEOTICID XEO02358 MOACRIVE Inhibition DME1048 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1048 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02360 XEO_CLAS Peptide DME1048 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02360 GENEFORM Protein DME1048 XEOTICID XEO02360 MOACRIVE Inhibition DME1048 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1048 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02361 XEO_CLAS Peptide DME1048 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 ug/ml) DME1048 XEOTICID XEO02361 GENEFORM Protein DME1048 XEOTICID XEO02361 MOACRIVE Inhibition DME1048 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1048 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02365 XEO_CLAS Peptide DME1048 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 32 ug/ml) DME1048 XEOTICID XEO02365 GENEFORM Protein DME1048 XEOTICID XEO02365 MOACRIVE Inhibition DME1048 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1048 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02366 XEO_CLAS Peptide DME1048 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO02366 GENEFORM Protein DME1048 XEOTICID XEO02366 MOACRIVE Inhibition DME1048 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1048 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02367 XEO_CLAS Peptide DME1048 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02367 GENEFORM Protein DME1048 XEOTICID XEO02367 MOACRIVE Inhibition DME1048 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1048 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02368 XEO_CLAS Peptide DME1048 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02368 GENEFORM Protein DME1048 XEOTICID XEO02368 MOACRIVE Inhibition DME1048 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1048 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02369 XEO_CLAS Peptide DME1048 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02369 GENEFORM Protein DME1048 XEOTICID XEO02369 MOACRIVE Inhibition DME1048 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1048 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02370 XEO_CLAS Peptide DME1048 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02370 GENEFORM Protein DME1048 XEOTICID XEO02370 MOACRIVE Inhibition DME1048 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1048 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02371 XEO_CLAS Peptide DME1048 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 ug/ml) DME1048 XEOTICID XEO02371 GENEFORM Protein DME1048 XEOTICID XEO02371 MOACRIVE Inhibition DME1048 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1048 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02374 XEO_CLAS Peptide DME1048 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02374 GENEFORM Protein DME1048 XEOTICID XEO02374 MOACRIVE Inhibition DME1048 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1048 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02376 XEO_CLAS Peptide DME1048 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02376 GENEFORM Protein DME1048 XEOTICID XEO02376 MOACRIVE Inhibition DME1048 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1048 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02378 XEO_CLAS Peptide DME1048 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.19 ug/ml) DME1048 XEOTICID XEO02378 GENEFORM Protein DME1048 XEOTICID XEO02378 MOACRIVE Inhibition DME1048 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1048 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02388 XEO_CLAS Peptide DME1048 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO02388 GENEFORM Protein DME1048 XEOTICID XEO02388 MOACRIVE Inhibition DME1048 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1048 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02389 XEO_CLAS Peptide DME1048 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02389 GENEFORM Protein DME1048 XEOTICID XEO02389 MOACRIVE Inhibition DME1048 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1048 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02415 XEO_CLAS Peptide DME1048 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02415 GENEFORM Protein DME1048 XEOTICID XEO02415 MOACRIVE Inhibition DME1048 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1048 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02416 XEO_CLAS Peptide DME1048 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 11 microM) DME1048 XEOTICID XEO02416 GENEFORM Protein DME1048 XEOTICID XEO02416 MOACRIVE Inhibition DME1048 XEOTICID XEO02419 XEO_NAME Bay oil DME1048 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1048 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02419 GENEFORM Protein DME1048 XEOTICID XEO02419 MOACRIVE Inhibition DME1048 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1048 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02435 XEO_CLAS Peptide DME1048 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02435 GENEFORM Protein DME1048 XEOTICID XEO02435 MOACRIVE Inhibition DME1048 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1048 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02436 XEO_CLAS Peptide DME1048 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02436 GENEFORM Protein DME1048 XEOTICID XEO02436 MOACRIVE Inhibition DME1048 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1048 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02437 XEO_CLAS Peptide DME1048 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02437 GENEFORM Protein DME1048 XEOTICID XEO02437 MOACRIVE Inhibition DME1048 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1048 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02438 XEO_CLAS Peptide DME1048 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02438 GENEFORM Protein DME1048 XEOTICID XEO02438 MOACRIVE Inhibition DME1048 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1048 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02439 XEO_CLAS Peptide DME1048 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02439 GENEFORM Protein DME1048 XEOTICID XEO02439 MOACRIVE Inhibition DME1048 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1048 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02440 XEO_CLAS Peptide DME1048 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02440 GENEFORM Protein DME1048 XEOTICID XEO02440 MOACRIVE Inhibition DME1048 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1048 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02441 XEO_CLAS Peptide DME1048 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02441 GENEFORM Protein DME1048 XEOTICID XEO02441 MOACRIVE Inhibition DME1048 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1048 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02442 XEO_CLAS Peptide DME1048 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO02442 GENEFORM Protein DME1048 XEOTICID XEO02442 MOACRIVE Inhibition DME1048 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1048 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02443 XEO_CLAS Peptide DME1048 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02443 GENEFORM Protein DME1048 XEOTICID XEO02443 MOACRIVE Inhibition DME1048 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1048 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02444 XEO_CLAS Peptide DME1048 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02444 GENEFORM Protein DME1048 XEOTICID XEO02444 MOACRIVE Inhibition DME1048 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1048 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1048 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02447 GENEFORM Protein DME1048 XEOTICID XEO02447 MOACRIVE Inhibition DME1048 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1048 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02452 XEO_CLAS Peptide DME1048 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 76800 ug/ml) DME1048 XEOTICID XEO02452 GENEFORM Protein DME1048 XEOTICID XEO02452 MOACRIVE Inhibition DME1048 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1048 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02453 XEO_CLAS Peptide DME1048 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02453 GENEFORM Protein DME1048 XEOTICID XEO02453 MOACRIVE Inhibition DME1048 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1048 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02463 XEO_CLAS Peptide DME1048 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 11.25 microM) DME1048 XEOTICID XEO02463 GENEFORM Protein DME1048 XEOTICID XEO02463 MOACRIVE Inhibition DME1048 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1048 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02466 XEO_CLAS Peptide DME1048 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.5 microM) DME1048 XEOTICID XEO02466 GENEFORM Protein DME1048 XEOTICID XEO02466 MOACRIVE Inhibition DME1048 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1048 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02467 XEO_CLAS Peptide DME1048 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8.4 microM) DME1048 XEOTICID XEO02467 GENEFORM Protein DME1048 XEOTICID XEO02467 MOACRIVE Inhibition DME1048 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1048 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02468 XEO_CLAS Peptide DME1048 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.7 microM) DME1048 XEOTICID XEO02468 GENEFORM Protein DME1048 XEOTICID XEO02468 MOACRIVE Inhibition DME1048 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1048 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02469 XEO_CLAS Peptide DME1048 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO02469 GENEFORM Protein DME1048 XEOTICID XEO02469 MOACRIVE Inhibition DME1048 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1048 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02470 XEO_CLAS Peptide DME1048 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.8 microM) DME1048 XEOTICID XEO02470 GENEFORM Protein DME1048 XEOTICID XEO02470 MOACRIVE Inhibition DME1048 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1048 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02471 XEO_CLAS Peptide DME1048 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4.8 microM) DME1048 XEOTICID XEO02471 GENEFORM Protein DME1048 XEOTICID XEO02471 MOACRIVE Inhibition DME1048 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1048 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02472 XEO_CLAS Peptide DME1048 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.0 microM) DME1048 XEOTICID XEO02472 GENEFORM Protein DME1048 XEOTICID XEO02472 MOACRIVE Inhibition DME1048 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1048 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02473 XEO_CLAS Peptide DME1048 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02473 GENEFORM Protein DME1048 XEOTICID XEO02473 MOACRIVE Inhibition DME1048 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1048 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02474 XEO_CLAS Peptide DME1048 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.5 microM) DME1048 XEOTICID XEO02474 GENEFORM Protein DME1048 XEOTICID XEO02474 MOACRIVE Inhibition DME1048 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1048 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02475 XEO_CLAS Peptide DME1048 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.5 microM) DME1048 XEOTICID XEO02475 GENEFORM Protein DME1048 XEOTICID XEO02475 MOACRIVE Inhibition DME1048 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1048 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02477 XEO_CLAS Peptide DME1048 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-300 ug/ml) DME1048 XEOTICID XEO02477 GENEFORM Protein DME1048 XEOTICID XEO02477 MOACRIVE Inhibition DME1048 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1048 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02478 XEO_CLAS Peptide DME1048 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-300 ug/ml) DME1048 XEOTICID XEO02478 GENEFORM Protein DME1048 XEOTICID XEO02478 MOACRIVE Inhibition DME1048 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1048 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02479 XEO_CLAS Peptide DME1048 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-300 ug/ml) DME1048 XEOTICID XEO02479 GENEFORM Protein DME1048 XEOTICID XEO02479 MOACRIVE Inhibition DME1048 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1048 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02480 XEO_CLAS Peptide DME1048 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-300 ug/ml) DME1048 XEOTICID XEO02480 GENEFORM Protein DME1048 XEOTICID XEO02480 MOACRIVE Inhibition DME1048 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1048 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02481 XEO_CLAS Peptide DME1048 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-300 ug/ml) DME1048 XEOTICID XEO02481 GENEFORM Protein DME1048 XEOTICID XEO02481 MOACRIVE Inhibition DME1048 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1048 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02482 XEO_CLAS Peptide DME1048 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-300 ug/ml) DME1048 XEOTICID XEO02482 GENEFORM Protein DME1048 XEOTICID XEO02482 MOACRIVE Inhibition DME1048 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1048 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02483 XEO_CLAS Peptide DME1048 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-300 ug/ml) DME1048 XEOTICID XEO02483 GENEFORM Protein DME1048 XEOTICID XEO02483 MOACRIVE Inhibition DME1048 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1048 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02484 XEO_CLAS Peptide DME1048 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-300 ug/ml) DME1048 XEOTICID XEO02484 GENEFORM Protein DME1048 XEOTICID XEO02484 MOACRIVE Inhibition DME1048 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1048 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02485 XEO_CLAS Peptide DME1048 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-300 ug/ml) DME1048 XEOTICID XEO02485 GENEFORM Protein DME1048 XEOTICID XEO02485 MOACRIVE Inhibition DME1048 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1048 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02486 XEO_CLAS Peptide DME1048 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-300 ug/ml) DME1048 XEOTICID XEO02486 GENEFORM Protein DME1048 XEOTICID XEO02486 MOACRIVE Inhibition DME1048 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1048 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02487 XEO_CLAS Peptide DME1048 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02487 GENEFORM Protein DME1048 XEOTICID XEO02487 MOACRIVE Inhibition DME1048 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1048 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02488 XEO_CLAS Peptide DME1048 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-300 ug/ml) DME1048 XEOTICID XEO02488 GENEFORM Protein DME1048 XEOTICID XEO02488 MOACRIVE Inhibition DME1048 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1048 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02489 XEO_CLAS Peptide DME1048 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-301 ug/ml) DME1048 XEOTICID XEO02489 GENEFORM Protein DME1048 XEOTICID XEO02489 MOACRIVE Inhibition DME1048 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1048 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02491 XEO_CLAS Peptide DME1048 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.3 microM) DME1048 XEOTICID XEO02491 GENEFORM Protein DME1048 XEOTICID XEO02491 MOACRIVE Inhibition DME1048 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1048 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02492 XEO_CLAS Peptide DME1048 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 ug/ml) DME1048 XEOTICID XEO02492 GENEFORM Protein DME1048 XEOTICID XEO02492 MOACRIVE Inhibition DME1048 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1048 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02493 XEO_CLAS Peptide DME1048 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 ug/ml) DME1048 XEOTICID XEO02493 GENEFORM Protein DME1048 XEOTICID XEO02493 MOACRIVE Inhibition DME1048 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1048 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02494 XEO_CLAS Peptide DME1048 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 ug/ml) DME1048 XEOTICID XEO02494 GENEFORM Protein DME1048 XEOTICID XEO02494 MOACRIVE Inhibition DME1048 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1048 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02495 XEO_CLAS Peptide DME1048 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 34 ug/ml) DME1048 XEOTICID XEO02495 GENEFORM Protein DME1048 XEOTICID XEO02495 MOACRIVE Inhibition DME1048 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1048 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02496 XEO_CLAS Peptide DME1048 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 13 microM) DME1048 XEOTICID XEO02496 GENEFORM Protein DME1048 XEOTICID XEO02496 MOACRIVE Inhibition DME1048 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1048 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02497 XEO_CLAS Peptide DME1048 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO02497 GENEFORM Protein DME1048 XEOTICID XEO02497 MOACRIVE Inhibition DME1048 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1048 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02499 XEO_CLAS Peptide DME1048 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO02499 GENEFORM Protein DME1048 XEOTICID XEO02499 MOACRIVE Inhibition DME1048 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1048 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02501 XEO_CLAS Peptide DME1048 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 7 microM) DME1048 XEOTICID XEO02501 GENEFORM Protein DME1048 XEOTICID XEO02501 MOACRIVE Inhibition DME1048 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1048 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02502 XEO_CLAS Peptide DME1048 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 microM) DME1048 XEOTICID XEO02502 GENEFORM Protein DME1048 XEOTICID XEO02502 MOACRIVE Inhibition DME1048 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1048 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02503 XEO_CLAS Peptide DME1048 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 19 microM) DME1048 XEOTICID XEO02503 GENEFORM Protein DME1048 XEOTICID XEO02503 MOACRIVE Inhibition DME1048 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1048 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02504 XEO_CLAS Peptide DME1048 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02504 GENEFORM Protein DME1048 XEOTICID XEO02504 MOACRIVE Inhibition DME1048 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1048 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02505 XEO_CLAS Peptide DME1048 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO02505 GENEFORM Protein DME1048 XEOTICID XEO02505 MOACRIVE Inhibition DME1048 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1048 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02507 XEO_CLAS Peptide DME1048 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO02507 GENEFORM Protein DME1048 XEOTICID XEO02507 MOACRIVE Inhibition DME1048 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1048 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02508 XEO_CLAS Peptide DME1048 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 150 microM) DME1048 XEOTICID XEO02508 GENEFORM Protein DME1048 XEOTICID XEO02508 MOACRIVE Inhibition DME1048 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1048 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02509 XEO_CLAS Peptide DME1048 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 150 microM) DME1048 XEOTICID XEO02509 GENEFORM Protein DME1048 XEOTICID XEO02509 MOACRIVE Inhibition DME1048 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1048 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02510 XEO_CLAS Peptide DME1048 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 150 microM) DME1048 XEOTICID XEO02510 GENEFORM Protein DME1048 XEOTICID XEO02510 MOACRIVE Inhibition DME1048 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1048 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02511 XEO_CLAS Peptide DME1048 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 150 microM) DME1048 XEOTICID XEO02511 GENEFORM Protein DME1048 XEOTICID XEO02511 MOACRIVE Inhibition DME1048 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1048 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02512 XEO_CLAS Peptide DME1048 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 75 microM) DME1048 XEOTICID XEO02512 GENEFORM Protein DME1048 XEOTICID XEO02512 MOACRIVE Inhibition DME1048 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1048 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02513 XEO_CLAS Peptide DME1048 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO02513 GENEFORM Protein DME1048 XEOTICID XEO02513 MOACRIVE Inhibition DME1048 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1048 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02514 XEO_CLAS Peptide DME1048 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO02514 GENEFORM Protein DME1048 XEOTICID XEO02514 MOACRIVE Inhibition DME1048 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1048 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02515 XEO_CLAS Peptide DME1048 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 80 microM) DME1048 XEOTICID XEO02515 GENEFORM Protein DME1048 XEOTICID XEO02515 MOACRIVE Inhibition DME1048 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1048 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02516 XEO_CLAS Peptide DME1048 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 32 microM) DME1048 XEOTICID XEO02516 GENEFORM Protein DME1048 XEOTICID XEO02516 MOACRIVE Inhibition DME1048 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1048 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02517 XEO_CLAS Peptide DME1048 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 microM) DME1048 XEOTICID XEO02517 GENEFORM Protein DME1048 XEOTICID XEO02517 MOACRIVE Inhibition DME1048 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1048 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02518 XEO_CLAS Peptide DME1048 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC < 15 microM) DME1048 XEOTICID XEO02518 GENEFORM Protein DME1048 XEOTICID XEO02518 MOACRIVE Inhibition DME1048 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1048 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02519 XEO_CLAS Peptide DME1048 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC < 15 microM) DME1048 XEOTICID XEO02519 GENEFORM Protein DME1048 XEOTICID XEO02519 MOACRIVE Inhibition DME1048 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1048 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02520 XEO_CLAS Peptide DME1048 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC < 15 microM) DME1048 XEOTICID XEO02520 GENEFORM Protein DME1048 XEOTICID XEO02520 MOACRIVE Inhibition DME1048 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1048 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02523 XEO_CLAS Peptide DME1048 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO02523 GENEFORM Protein DME1048 XEOTICID XEO02523 MOACRIVE Inhibition DME1048 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1048 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02524 XEO_CLAS Peptide DME1048 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 150 microM) DME1048 XEOTICID XEO02524 GENEFORM Protein DME1048 XEOTICID XEO02524 MOACRIVE Inhibition DME1048 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1048 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02525 XEO_CLAS Peptide DME1048 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 24 microM) DME1048 XEOTICID XEO02525 GENEFORM Protein DME1048 XEOTICID XEO02525 MOACRIVE Inhibition DME1048 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1048 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02526 XEO_CLAS Peptide DME1048 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 48 microM) DME1048 XEOTICID XEO02526 GENEFORM Protein DME1048 XEOTICID XEO02526 MOACRIVE Inhibition DME1048 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1048 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02527 XEO_CLAS Peptide DME1048 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 119 microM) DME1048 XEOTICID XEO02527 GENEFORM Protein DME1048 XEOTICID XEO02527 MOACRIVE Inhibition DME1048 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1048 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02528 XEO_CLAS Peptide DME1048 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 128 ug/ml) DME1048 XEOTICID XEO02528 GENEFORM Protein DME1048 XEOTICID XEO02528 MOACRIVE Inhibition DME1048 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1048 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02529 XEO_CLAS Peptide DME1048 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 128 ug/ml) DME1048 XEOTICID XEO02529 GENEFORM Protein DME1048 XEOTICID XEO02529 MOACRIVE Inhibition DME1048 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1048 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02530 XEO_CLAS Peptide DME1048 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02530 GENEFORM Protein DME1048 XEOTICID XEO02530 MOACRIVE Inhibition DME1048 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1048 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02531 XEO_CLAS Peptide DME1048 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 microM) DME1048 XEOTICID XEO02531 GENEFORM Protein DME1048 XEOTICID XEO02531 MOACRIVE Inhibition DME1048 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1048 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02533 XEO_CLAS Peptide DME1048 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.2 ug/ml) DME1048 XEOTICID XEO02533 GENEFORM Protein DME1048 XEOTICID XEO02533 MOACRIVE Inhibition DME1048 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1048 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02534 XEO_CLAS Peptide DME1048 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.6 ug/ml) DME1048 XEOTICID XEO02534 GENEFORM Protein DME1048 XEOTICID XEO02534 MOACRIVE Inhibition DME1048 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1048 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02535 XEO_CLAS Peptide DME1048 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.3 ug/ml) DME1048 XEOTICID XEO02535 GENEFORM Protein DME1048 XEOTICID XEO02535 MOACRIVE Inhibition DME1048 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1048 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02536 XEO_CLAS Peptide DME1048 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.4 ug/ml) DME1048 XEOTICID XEO02536 GENEFORM Protein DME1048 XEOTICID XEO02536 MOACRIVE Inhibition DME1048 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1048 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02537 XEO_CLAS Peptide DME1048 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.2 ug/ml) DME1048 XEOTICID XEO02537 GENEFORM Protein DME1048 XEOTICID XEO02537 MOACRIVE Inhibition DME1048 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1048 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02538 XEO_CLAS Peptide DME1048 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 9.1 ug/ml) DME1048 XEOTICID XEO02538 GENEFORM Protein DME1048 XEOTICID XEO02538 MOACRIVE Inhibition DME1048 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1048 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02539 XEO_CLAS Peptide DME1048 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8.6 ug/ml) DME1048 XEOTICID XEO02539 GENEFORM Protein DME1048 XEOTICID XEO02539 MOACRIVE Inhibition DME1048 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1048 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02540 XEO_CLAS Peptide DME1048 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15.2 ug/ml) DME1048 XEOTICID XEO02540 GENEFORM Protein DME1048 XEOTICID XEO02540 MOACRIVE Inhibition DME1048 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1048 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02541 XEO_CLAS Peptide DME1048 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 11.1 ug/ml) DME1048 XEOTICID XEO02541 GENEFORM Protein DME1048 XEOTICID XEO02541 MOACRIVE Inhibition DME1048 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1048 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02542 XEO_CLAS Peptide DME1048 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.7 ug/ml) DME1048 XEOTICID XEO02542 GENEFORM Protein DME1048 XEOTICID XEO02542 MOACRIVE Inhibition DME1048 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1048 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02543 XEO_CLAS Peptide DME1048 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 13.1 ug/ml) DME1048 XEOTICID XEO02543 GENEFORM Protein DME1048 XEOTICID XEO02543 MOACRIVE Inhibition DME1048 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1048 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02544 XEO_CLAS Peptide DME1048 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 9.8 ug/ml) DME1048 XEOTICID XEO02544 GENEFORM Protein DME1048 XEOTICID XEO02544 MOACRIVE Inhibition DME1048 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1048 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02545 XEO_CLAS Peptide DME1048 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 14 microM) DME1048 XEOTICID XEO02545 GENEFORM Protein DME1048 XEOTICID XEO02545 MOACRIVE Inhibition DME1048 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1048 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02546 XEO_CLAS Peptide DME1048 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 14 microM) DME1048 XEOTICID XEO02546 GENEFORM Protein DME1048 XEOTICID XEO02546 MOACRIVE Inhibition DME1048 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1048 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02547 XEO_CLAS Peptide DME1048 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 microM) DME1048 XEOTICID XEO02547 GENEFORM Protein DME1048 XEOTICID XEO02547 MOACRIVE Inhibition DME1048 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1048 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02548 XEO_CLAS Peptide DME1048 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 78 microM) DME1048 XEOTICID XEO02548 GENEFORM Protein DME1048 XEOTICID XEO02548 MOACRIVE Inhibition DME1048 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1048 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02549 XEO_CLAS Peptide DME1048 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02549 GENEFORM Protein DME1048 XEOTICID XEO02549 MOACRIVE Inhibition DME1048 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1048 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02552 XEO_CLAS Peptide DME1048 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 24 microM) DME1048 XEOTICID XEO02552 GENEFORM Protein DME1048 XEOTICID XEO02552 MOACRIVE Inhibition DME1048 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1048 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02553 XEO_CLAS Peptide DME1048 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02553 GENEFORM Protein DME1048 XEOTICID XEO02553 MOACRIVE Inhibition DME1048 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1048 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02556 XEO_CLAS Peptide DME1048 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 55 microM) DME1048 XEOTICID XEO02556 GENEFORM Protein DME1048 XEOTICID XEO02556 MOACRIVE Inhibition DME1048 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1048 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02557 XEO_CLAS Peptide DME1048 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 17 microM) DME1048 XEOTICID XEO02557 GENEFORM Protein DME1048 XEOTICID XEO02557 MOACRIVE Inhibition DME1048 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1048 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02558 XEO_CLAS Peptide DME1048 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 14 microM) DME1048 XEOTICID XEO02558 GENEFORM Protein DME1048 XEOTICID XEO02558 MOACRIVE Inhibition DME1048 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1048 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02559 XEO_CLAS Peptide DME1048 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02559 GENEFORM Protein DME1048 XEOTICID XEO02559 MOACRIVE Inhibition DME1048 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1048 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02560 XEO_CLAS Peptide DME1048 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 13 microM) DME1048 XEOTICID XEO02560 GENEFORM Protein DME1048 XEOTICID XEO02560 MOACRIVE Inhibition DME1048 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1048 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02561 XEO_CLAS Peptide DME1048 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO02561 GENEFORM Protein DME1048 XEOTICID XEO02561 MOACRIVE Inhibition DME1048 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1048 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02562 XEO_CLAS Peptide DME1048 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 13 microM) DME1048 XEOTICID XEO02562 GENEFORM Protein DME1048 XEOTICID XEO02562 MOACRIVE Inhibition DME1048 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1048 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02563 XEO_CLAS Peptide DME1048 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 45 microM) DME1048 XEOTICID XEO02563 GENEFORM Protein DME1048 XEOTICID XEO02563 MOACRIVE Inhibition DME1048 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1048 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02564 XEO_CLAS Peptide DME1048 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 ug/ml) DME1048 XEOTICID XEO02564 GENEFORM Protein DME1048 XEOTICID XEO02564 MOACRIVE Inhibition DME1048 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1048 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02565 XEO_CLAS Peptide DME1048 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 microM) DME1048 XEOTICID XEO02565 GENEFORM Protein DME1048 XEOTICID XEO02565 MOACRIVE Inhibition DME1048 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1048 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02566 XEO_CLAS Peptide DME1048 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO02566 GENEFORM Protein DME1048 XEOTICID XEO02566 MOACRIVE Inhibition DME1048 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1048 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02568 XEO_CLAS Peptide DME1048 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO02568 GENEFORM Protein DME1048 XEOTICID XEO02568 MOACRIVE Inhibition DME1048 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1048 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02569 XEO_CLAS Peptide DME1048 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO02569 GENEFORM Protein DME1048 XEOTICID XEO02569 MOACRIVE Inhibition DME1048 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1048 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02570 XEO_CLAS Peptide DME1048 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO02570 GENEFORM Protein DME1048 XEOTICID XEO02570 MOACRIVE Inhibition DME1048 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1048 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02571 XEO_CLAS Peptide DME1048 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO02571 GENEFORM Protein DME1048 XEOTICID XEO02571 MOACRIVE Inhibition DME1048 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1048 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02572 XEO_CLAS Peptide DME1048 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02572 GENEFORM Protein DME1048 XEOTICID XEO02572 MOACRIVE Inhibition DME1048 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1048 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02573 XEO_CLAS Peptide DME1048 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02573 GENEFORM Protein DME1048 XEOTICID XEO02573 MOACRIVE Inhibition DME1048 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1048 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02574 XEO_CLAS Peptide DME1048 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 microM) DME1048 XEOTICID XEO02574 GENEFORM Protein DME1048 XEOTICID XEO02574 MOACRIVE Inhibition DME1048 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1048 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02575 XEO_CLAS Peptide DME1048 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 microM) DME1048 XEOTICID XEO02575 GENEFORM Protein DME1048 XEOTICID XEO02575 MOACRIVE Inhibition DME1048 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1048 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02576 XEO_CLAS Peptide DME1048 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 33 microM) DME1048 XEOTICID XEO02576 GENEFORM Protein DME1048 XEOTICID XEO02576 MOACRIVE Inhibition DME1048 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1048 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02577 XEO_CLAS Peptide DME1048 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO02577 GENEFORM Protein DME1048 XEOTICID XEO02577 MOACRIVE Inhibition DME1048 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1048 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02578 XEO_CLAS Peptide DME1048 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02578 GENEFORM Protein DME1048 XEOTICID XEO02578 MOACRIVE Inhibition DME1048 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1048 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02579 XEO_CLAS Peptide DME1048 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02579 GENEFORM Protein DME1048 XEOTICID XEO02579 MOACRIVE Inhibition DME1048 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1048 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02580 XEO_CLAS Peptide DME1048 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC < 15 microM) DME1048 XEOTICID XEO02580 GENEFORM Protein DME1048 XEOTICID XEO02580 MOACRIVE Inhibition DME1048 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1048 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02581 XEO_CLAS Peptide DME1048 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 microM) DME1048 XEOTICID XEO02581 GENEFORM Protein DME1048 XEOTICID XEO02581 MOACRIVE Inhibition DME1048 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1048 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02582 XEO_CLAS Peptide DME1048 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 microM) DME1048 XEOTICID XEO02582 GENEFORM Protein DME1048 XEOTICID XEO02582 MOACRIVE Inhibition DME1048 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1048 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02583 XEO_CLAS Peptide DME1048 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 microM) DME1048 XEOTICID XEO02583 GENEFORM Protein DME1048 XEOTICID XEO02583 MOACRIVE Inhibition DME1048 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1048 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02584 XEO_CLAS Peptide DME1048 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 microM) DME1048 XEOTICID XEO02584 GENEFORM Protein DME1048 XEOTICID XEO02584 MOACRIVE Inhibition DME1048 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1048 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02585 XEO_CLAS Peptide DME1048 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO02585 GENEFORM Protein DME1048 XEOTICID XEO02585 MOACRIVE Inhibition DME1048 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1048 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02586 XEO_CLAS Peptide DME1048 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO02586 GENEFORM Protein DME1048 XEOTICID XEO02586 MOACRIVE Inhibition DME1048 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1048 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02587 XEO_CLAS Peptide DME1048 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02587 GENEFORM Protein DME1048 XEOTICID XEO02587 MOACRIVE Inhibition DME1048 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1048 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02589 XEO_CLAS Peptide DME1048 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8.2 ug/ml) DME1048 XEOTICID XEO02589 GENEFORM Protein DME1048 XEOTICID XEO02589 MOACRIVE Inhibition DME1048 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1048 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02590 XEO_CLAS Peptide DME1048 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 19.6 ug/ml) DME1048 XEOTICID XEO02590 GENEFORM Protein DME1048 XEOTICID XEO02590 MOACRIVE Inhibition DME1048 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1048 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02591 XEO_CLAS Peptide DME1048 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO02591 GENEFORM Protein DME1048 XEOTICID XEO02591 MOACRIVE Inhibition DME1048 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1048 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02593 XEO_CLAS Peptide DME1048 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 36 microM) DME1048 XEOTICID XEO02593 GENEFORM Protein DME1048 XEOTICID XEO02593 MOACRIVE Inhibition DME1048 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1048 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02594 XEO_CLAS Peptide DME1048 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02594 GENEFORM Protein DME1048 XEOTICID XEO02594 MOACRIVE Inhibition DME1048 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1048 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02595 XEO_CLAS Peptide DME1048 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO02595 GENEFORM Protein DME1048 XEOTICID XEO02595 MOACRIVE Inhibition DME1048 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1048 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02596 XEO_CLAS Peptide DME1048 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO02596 GENEFORM Protein DME1048 XEOTICID XEO02596 MOACRIVE Inhibition DME1048 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1048 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02597 XEO_CLAS Peptide DME1048 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO02597 GENEFORM Protein DME1048 XEOTICID XEO02597 MOACRIVE Inhibition DME1048 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1048 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02598 XEO_CLAS Peptide DME1048 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 32.5 microM) DME1048 XEOTICID XEO02598 GENEFORM Protein DME1048 XEOTICID XEO02598 MOACRIVE Inhibition DME1048 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1048 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02599 XEO_CLAS Peptide DME1048 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 microM) DME1048 XEOTICID XEO02599 GENEFORM Protein DME1048 XEOTICID XEO02599 MOACRIVE Inhibition DME1048 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1048 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02601 XEO_CLAS Peptide DME1048 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.1 ug/ml) DME1048 XEOTICID XEO02601 GENEFORM Protein DME1048 XEOTICID XEO02601 MOACRIVE Inhibition DME1048 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1048 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02602 XEO_CLAS Peptide DME1048 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 13.2 ug/ml) DME1048 XEOTICID XEO02602 GENEFORM Protein DME1048 XEOTICID XEO02602 MOACRIVE Inhibition DME1048 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1048 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02603 XEO_CLAS Peptide DME1048 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.3 ug/ml) DME1048 XEOTICID XEO02603 GENEFORM Protein DME1048 XEOTICID XEO02603 MOACRIVE Inhibition DME1048 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1048 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02604 XEO_CLAS Peptide DME1048 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO02604 GENEFORM Protein DME1048 XEOTICID XEO02604 MOACRIVE Inhibition DME1048 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1048 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02605 XEO_CLAS Peptide DME1048 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30.6 ug/ml) DME1048 XEOTICID XEO02605 GENEFORM Protein DME1048 XEOTICID XEO02605 MOACRIVE Inhibition DME1048 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1048 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02606 XEO_CLAS Peptide DME1048 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 11.2 ug/ml) DME1048 XEOTICID XEO02606 GENEFORM Protein DME1048 XEOTICID XEO02606 MOACRIVE Inhibition DME1048 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1048 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02607 XEO_CLAS Peptide DME1048 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.8 ug/ml) DME1048 XEOTICID XEO02607 GENEFORM Protein DME1048 XEOTICID XEO02607 MOACRIVE Inhibition DME1048 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1048 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02608 XEO_CLAS Peptide DME1048 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 7.9 ug/ml) DME1048 XEOTICID XEO02608 GENEFORM Protein DME1048 XEOTICID XEO02608 MOACRIVE Inhibition DME1048 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1048 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02609 XEO_CLAS Peptide DME1048 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15.8 ug/ml) DME1048 XEOTICID XEO02609 GENEFORM Protein DME1048 XEOTICID XEO02609 MOACRIVE Inhibition DME1048 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1048 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02610 XEO_CLAS Peptide DME1048 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.1 ug/ml) DME1048 XEOTICID XEO02610 GENEFORM Protein DME1048 XEOTICID XEO02610 MOACRIVE Inhibition DME1048 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1048 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02611 XEO_CLAS Peptide DME1048 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20.6 ug/ml) DME1048 XEOTICID XEO02611 GENEFORM Protein DME1048 XEOTICID XEO02611 MOACRIVE Inhibition DME1048 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1048 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02612 XEO_CLAS Peptide DME1048 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 11.8 ug/ml) DME1048 XEOTICID XEO02612 GENEFORM Protein DME1048 XEOTICID XEO02612 MOACRIVE Inhibition DME1048 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1048 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02613 XEO_CLAS Peptide DME1048 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 13.2 ug/ml) DME1048 XEOTICID XEO02613 GENEFORM Protein DME1048 XEOTICID XEO02613 MOACRIVE Inhibition DME1048 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1048 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02614 XEO_CLAS Peptide DME1048 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.8 ug/ml) DME1048 XEOTICID XEO02614 GENEFORM Protein DME1048 XEOTICID XEO02614 MOACRIVE Inhibition DME1048 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1048 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02615 XEO_CLAS Peptide DME1048 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8.6 ug/ml) DME1048 XEOTICID XEO02615 GENEFORM Protein DME1048 XEOTICID XEO02615 MOACRIVE Inhibition DME1048 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1048 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02616 XEO_CLAS Peptide DME1048 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20.4 ug/ml) DME1048 XEOTICID XEO02616 GENEFORM Protein DME1048 XEOTICID XEO02616 MOACRIVE Inhibition DME1048 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1048 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02617 XEO_CLAS Peptide DME1048 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4.7 ug/ml) DME1048 XEOTICID XEO02617 GENEFORM Protein DME1048 XEOTICID XEO02617 MOACRIVE Inhibition DME1048 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1048 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02618 XEO_CLAS Peptide DME1048 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.6 ug/ml) DME1048 XEOTICID XEO02618 GENEFORM Protein DME1048 XEOTICID XEO02618 MOACRIVE Inhibition DME1048 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1048 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02619 XEO_CLAS Peptide DME1048 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10.5 ug/ml) DME1048 XEOTICID XEO02619 GENEFORM Protein DME1048 XEOTICID XEO02619 MOACRIVE Inhibition DME1048 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1048 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02620 XEO_CLAS Peptide DME1048 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO02620 GENEFORM Protein DME1048 XEOTICID XEO02620 MOACRIVE Inhibition DME1048 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1048 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02621 XEO_CLAS Peptide DME1048 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO02621 GENEFORM Protein DME1048 XEOTICID XEO02621 MOACRIVE Inhibition DME1048 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1048 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02622 XEO_CLAS Peptide DME1048 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO02622 GENEFORM Protein DME1048 XEOTICID XEO02622 MOACRIVE Inhibition DME1048 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1048 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02623 XEO_CLAS Peptide DME1048 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO02623 GENEFORM Protein DME1048 XEOTICID XEO02623 MOACRIVE Inhibition DME1048 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1048 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02624 XEO_CLAS Peptide DME1048 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 18 microM) DME1048 XEOTICID XEO02624 GENEFORM Protein DME1048 XEOTICID XEO02624 MOACRIVE Inhibition DME1048 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1048 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02625 XEO_CLAS Peptide DME1048 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 9 microM) DME1048 XEOTICID XEO02625 GENEFORM Protein DME1048 XEOTICID XEO02625 MOACRIVE Inhibition DME1048 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1048 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02626 XEO_CLAS Peptide DME1048 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 18 microM) DME1048 XEOTICID XEO02626 GENEFORM Protein DME1048 XEOTICID XEO02626 MOACRIVE Inhibition DME1048 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1048 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02627 XEO_CLAS Peptide DME1048 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02627 GENEFORM Protein DME1048 XEOTICID XEO02627 MOACRIVE Inhibition DME1048 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1048 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02628 XEO_CLAS Peptide DME1048 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 18 microM) DME1048 XEOTICID XEO02628 GENEFORM Protein DME1048 XEOTICID XEO02628 MOACRIVE Inhibition DME1048 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1048 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02629 XEO_CLAS Peptide DME1048 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 13 microM) DME1048 XEOTICID XEO02629 GENEFORM Protein DME1048 XEOTICID XEO02629 MOACRIVE Inhibition DME1048 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1048 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02630 XEO_CLAS Peptide DME1048 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 ug/ml) DME1048 XEOTICID XEO02630 GENEFORM Protein DME1048 XEOTICID XEO02630 MOACRIVE Inhibition DME1048 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1048 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02631 XEO_CLAS Peptide DME1048 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 ug/ml) DME1048 XEOTICID XEO02631 GENEFORM Protein DME1048 XEOTICID XEO02631 MOACRIVE Inhibition DME1048 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1048 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02634 XEO_CLAS Peptide DME1048 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO02634 GENEFORM Protein DME1048 XEOTICID XEO02634 MOACRIVE Inhibition DME1048 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1048 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02635 XEO_CLAS Peptide DME1048 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40 ug/ml) DME1048 XEOTICID XEO02635 GENEFORM Protein DME1048 XEOTICID XEO02635 MOACRIVE Inhibition DME1048 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1048 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02636 XEO_CLAS Peptide DME1048 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO02636 GENEFORM Protein DME1048 XEOTICID XEO02636 MOACRIVE Inhibition DME1048 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1048 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02637 XEO_CLAS Peptide DME1048 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO02637 GENEFORM Protein DME1048 XEOTICID XEO02637 MOACRIVE Inhibition DME1048 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1048 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02638 XEO_CLAS Peptide DME1048 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 microM) DME1048 XEOTICID XEO02638 GENEFORM Protein DME1048 XEOTICID XEO02638 MOACRIVE Inhibition DME1048 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1048 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02639 XEO_CLAS Peptide DME1048 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 microM) DME1048 XEOTICID XEO02639 GENEFORM Protein DME1048 XEOTICID XEO02639 MOACRIVE Inhibition DME1048 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1048 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02644 XEO_CLAS Peptide DME1048 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02644 GENEFORM Protein DME1048 XEOTICID XEO02644 MOACRIVE Inhibition DME1048 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1048 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02645 XEO_CLAS Peptide DME1048 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02645 GENEFORM Protein DME1048 XEOTICID XEO02645 MOACRIVE Inhibition DME1048 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1048 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02646 XEO_CLAS Peptide DME1048 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02646 GENEFORM Protein DME1048 XEOTICID XEO02646 MOACRIVE Inhibition DME1048 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1048 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02647 XEO_CLAS Peptide DME1048 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02647 GENEFORM Protein DME1048 XEOTICID XEO02647 MOACRIVE Inhibition DME1048 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1048 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02649 XEO_CLAS Peptide DME1048 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO02649 GENEFORM Protein DME1048 XEOTICID XEO02649 MOACRIVE Inhibition DME1048 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1048 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02650 XEO_CLAS Peptide DME1048 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO02650 GENEFORM Protein DME1048 XEOTICID XEO02650 MOACRIVE Inhibition DME1048 XEOTICID XEO02658 XEO_NAME Buthinin DME1048 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02658 XEO_CLAS Peptide DME1048 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02658 GENEFORM Protein DME1048 XEOTICID XEO02658 MOACRIVE Inhibition DME1048 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1048 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02663 XEO_CLAS Peptide DME1048 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25 microM) DME1048 XEOTICID XEO02663 GENEFORM Protein DME1048 XEOTICID XEO02663 MOACRIVE Inhibition DME1048 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1048 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02664 XEO_CLAS Peptide DME1048 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25 microM) DME1048 XEOTICID XEO02664 GENEFORM Protein DME1048 XEOTICID XEO02664 MOACRIVE Inhibition DME1048 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1048 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02672 XEO_CLAS Peptide DME1048 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25 microM) DME1048 XEOTICID XEO02672 GENEFORM Protein DME1048 XEOTICID XEO02672 MOACRIVE Inhibition DME1048 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1048 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02673 XEO_CLAS Peptide DME1048 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25-12.5 microM) DME1048 XEOTICID XEO02673 GENEFORM Protein DME1048 XEOTICID XEO02673 MOACRIVE Inhibition DME1048 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1048 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02674 XEO_CLAS Peptide DME1048 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.125-6.25 microM) DME1048 XEOTICID XEO02674 GENEFORM Protein DME1048 XEOTICID XEO02674 MOACRIVE Inhibition DME1048 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1048 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02676 XEO_CLAS Peptide DME1048 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO02676 GENEFORM Protein DME1048 XEOTICID XEO02676 MOACRIVE Inhibition DME1048 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1048 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02677 XEO_CLAS Peptide DME1048 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25-12.5 microM) DME1048 XEOTICID XEO02677 GENEFORM Protein DME1048 XEOTICID XEO02677 MOACRIVE Inhibition DME1048 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1048 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02679 XEO_CLAS Peptide DME1048 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25-12.5 microM) DME1048 XEOTICID XEO02679 GENEFORM Protein DME1048 XEOTICID XEO02679 MOACRIVE Inhibition DME1048 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1048 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02680 XEO_CLAS Peptide DME1048 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25 microM) DME1048 XEOTICID XEO02680 GENEFORM Protein DME1048 XEOTICID XEO02680 MOACRIVE Inhibition DME1048 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1048 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02683 XEO_CLAS Peptide DME1048 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO02683 GENEFORM Protein DME1048 XEOTICID XEO02683 MOACRIVE Inhibition DME1048 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1048 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02688 XEO_CLAS Peptide DME1048 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO02688 GENEFORM Protein DME1048 XEOTICID XEO02688 MOACRIVE Inhibition DME1048 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1048 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02693 XEO_CLAS Peptide DME1048 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 ug/ml) DME1048 XEOTICID XEO02693 GENEFORM Protein DME1048 XEOTICID XEO02693 MOACRIVE Inhibition DME1048 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1048 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02699 XEO_CLAS Peptide DME1048 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 ug/ml) DME1048 XEOTICID XEO02699 GENEFORM Protein DME1048 XEOTICID XEO02699 MOACRIVE Inhibition DME1048 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1048 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02700 XEO_CLAS Peptide DME1048 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 ug/ml) DME1048 XEOTICID XEO02700 GENEFORM Protein DME1048 XEOTICID XEO02700 MOACRIVE Inhibition DME1048 XEOTICID XEO02703 XEO_NAME Calcitermin DME1048 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02703 XEO_CLAS Peptide DME1048 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02703 GENEFORM Protein DME1048 XEOTICID XEO02703 MOACRIVE Inhibition DME1048 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1048 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02708 XEO_CLAS Peptide DME1048 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO02708 GENEFORM Protein DME1048 XEOTICID XEO02708 MOACRIVE Inhibition DME1048 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1048 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02709 XEO_CLAS Peptide DME1048 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.05 microM) DME1048 XEOTICID XEO02709 GENEFORM Protein DME1048 XEOTICID XEO02709 MOACRIVE Inhibition DME1048 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1048 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1048 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02713 GENEFORM Protein DME1048 XEOTICID XEO02713 MOACRIVE Inhibition DME1048 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1048 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1048 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02714 GENEFORM Protein DME1048 XEOTICID XEO02714 MOACRIVE Inhibition DME1048 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1048 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02726 XEO_CLAS Peptide DME1048 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02726 GENEFORM Protein DME1048 XEOTICID XEO02726 MOACRIVE Inhibition DME1048 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1048 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02731 XEO_CLAS Peptide DME1048 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1 microM) DME1048 XEOTICID XEO02731 GENEFORM Protein DME1048 XEOTICID XEO02731 MOACRIVE Inhibition DME1048 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1048 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02732 XEO_CLAS Peptide DME1048 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.25 microM) DME1048 XEOTICID XEO02732 GENEFORM Protein DME1048 XEOTICID XEO02732 MOACRIVE Inhibition DME1048 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1048 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02733 XEO_CLAS Peptide DME1048 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8-25 ug/ml) DME1048 XEOTICID XEO02733 GENEFORM Protein DME1048 XEOTICID XEO02733 MOACRIVE Inhibition DME1048 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1048 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02735 XEO_CLAS Peptide DME1048 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1 ug/ml) DME1048 XEOTICID XEO02735 GENEFORM Protein DME1048 XEOTICID XEO02735 MOACRIVE Inhibition DME1048 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1048 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02737 XEO_CLAS Peptide DME1048 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02737 GENEFORM Protein DME1048 XEOTICID XEO02737 MOACRIVE Inhibition DME1048 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1048 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02738 XEO_CLAS Peptide DME1048 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO02738 GENEFORM Protein DME1048 XEOTICID XEO02738 MOACRIVE Inhibition DME1048 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1048 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02739 XEO_CLAS Peptide DME1048 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 microM) DME1048 XEOTICID XEO02739 GENEFORM Protein DME1048 XEOTICID XEO02739 MOACRIVE Inhibition DME1048 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1048 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02740 XEO_CLAS Peptide DME1048 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.25 ug/ml) DME1048 XEOTICID XEO02740 GENEFORM Protein DME1048 XEOTICID XEO02740 MOACRIVE Inhibition DME1048 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1048 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02741 XEO_CLAS Peptide DME1048 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 ug/ml) DME1048 XEOTICID XEO02741 GENEFORM Protein DME1048 XEOTICID XEO02741 MOACRIVE Inhibition DME1048 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1048 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02743 XEO_CLAS Peptide DME1048 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.6 ug/ml) DME1048 XEOTICID XEO02743 GENEFORM Protein DME1048 XEOTICID XEO02743 MOACRIVE Inhibition DME1048 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1048 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02744 XEO_CLAS Peptide DME1048 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 18.7 ug/ml) DME1048 XEOTICID XEO02744 GENEFORM Protein DME1048 XEOTICID XEO02744 MOACRIVE Inhibition DME1048 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1048 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02745 XEO_CLAS Peptide DME1048 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02745 GENEFORM Protein DME1048 XEOTICID XEO02745 MOACRIVE Inhibition DME1048 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1048 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02746 XEO_CLAS Peptide DME1048 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02746 GENEFORM Protein DME1048 XEOTICID XEO02746 MOACRIVE Inhibition DME1048 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1048 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02748 XEO_CLAS Peptide DME1048 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02748 GENEFORM Protein DME1048 XEOTICID XEO02748 MOACRIVE Inhibition DME1048 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1048 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02749 XEO_CLAS Peptide DME1048 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20-25 mug/ml) DME1048 XEOTICID XEO02749 GENEFORM Protein DME1048 XEOTICID XEO02749 MOACRIVE Inhibition DME1048 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1048 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02750 XEO_CLAS Peptide DME1048 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02750 GENEFORM Protein DME1048 XEOTICID XEO02750 MOACRIVE Inhibition DME1048 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1048 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02752 XEO_CLAS Peptide DME1048 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02752 GENEFORM Protein DME1048 XEOTICID XEO02752 MOACRIVE Inhibition DME1048 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1048 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02753 XEO_CLAS Peptide DME1048 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02753 GENEFORM Protein DME1048 XEOTICID XEO02753 MOACRIVE Inhibition DME1048 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1048 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02754 XEO_CLAS Peptide DME1048 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 microM) DME1048 XEOTICID XEO02754 GENEFORM Protein DME1048 XEOTICID XEO02754 MOACRIVE Inhibition DME1048 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1048 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02756 XEO_CLAS Peptide DME1048 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 microM) DME1048 XEOTICID XEO02756 GENEFORM Protein DME1048 XEOTICID XEO02756 MOACRIVE Inhibition DME1048 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1048 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02757 XEO_CLAS Peptide DME1048 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1 microM) DME1048 XEOTICID XEO02757 GENEFORM Protein DME1048 XEOTICID XEO02757 MOACRIVE Inhibition DME1048 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1048 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02758 XEO_CLAS Peptide DME1048 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO02758 GENEFORM Protein DME1048 XEOTICID XEO02758 MOACRIVE Inhibition DME1048 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1048 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02759 XEO_CLAS Peptide DME1048 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.6 microM) DME1048 XEOTICID XEO02759 GENEFORM Protein DME1048 XEOTICID XEO02759 MOACRIVE Inhibition DME1048 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1048 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02760 XEO_CLAS Peptide DME1048 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 microM) DME1048 XEOTICID XEO02760 GENEFORM Protein DME1048 XEOTICID XEO02760 MOACRIVE Inhibition DME1048 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1048 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02761 XEO_CLAS Peptide DME1048 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO02761 GENEFORM Protein DME1048 XEOTICID XEO02761 MOACRIVE Inhibition DME1048 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1048 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02762 XEO_CLAS Peptide DME1048 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 microM) DME1048 XEOTICID XEO02762 GENEFORM Protein DME1048 XEOTICID XEO02762 MOACRIVE Inhibition DME1048 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1048 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02763 XEO_CLAS Peptide DME1048 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.4 microM) DME1048 XEOTICID XEO02763 GENEFORM Protein DME1048 XEOTICID XEO02763 MOACRIVE Inhibition DME1048 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1048 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02764 XEO_CLAS Peptide DME1048 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 microM) DME1048 XEOTICID XEO02764 GENEFORM Protein DME1048 XEOTICID XEO02764 MOACRIVE Inhibition DME1048 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1048 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02765 XEO_CLAS Peptide DME1048 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.3 microM) DME1048 XEOTICID XEO02765 GENEFORM Protein DME1048 XEOTICID XEO02765 MOACRIVE Inhibition DME1048 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1048 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02767 XEO_CLAS Peptide DME1048 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02767 GENEFORM Protein DME1048 XEOTICID XEO02767 MOACRIVE Inhibition DME1048 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1048 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02768 XEO_CLAS Peptide DME1048 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1048 XEOTICID XEO02768 GENEFORM Protein DME1048 XEOTICID XEO02768 MOACRIVE Inhibition DME1048 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1048 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02769 XEO_CLAS Peptide DME1048 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.32 microM) DME1048 XEOTICID XEO02769 GENEFORM Protein DME1048 XEOTICID XEO02769 MOACRIVE Inhibition DME1048 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1048 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02770 XEO_CLAS Peptide DME1048 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.30 microM) DME1048 XEOTICID XEO02770 GENEFORM Protein DME1048 XEOTICID XEO02770 MOACRIVE Inhibition DME1048 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1048 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02771 XEO_CLAS Peptide DME1048 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.21 microM) DME1048 XEOTICID XEO02771 GENEFORM Protein DME1048 XEOTICID XEO02771 MOACRIVE Inhibition DME1048 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1048 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02772 XEO_CLAS Peptide DME1048 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02772 GENEFORM Protein DME1048 XEOTICID XEO02772 MOACRIVE Inhibition DME1048 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1048 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02773 XEO_CLAS Peptide DME1048 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.9-8.6 microM) DME1048 XEOTICID XEO02773 GENEFORM Protein DME1048 XEOTICID XEO02773 MOACRIVE Inhibition DME1048 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1048 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02774 XEO_CLAS Peptide DME1048 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.3 microM) DME1048 XEOTICID XEO02774 GENEFORM Protein DME1048 XEOTICID XEO02774 MOACRIVE Inhibition DME1048 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1048 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02789 GENEFORM Protein DME1048 XEOTICID XEO02789 MOACRIVE Inhibition DME1048 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1048 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02790 GENEFORM Protein DME1048 XEOTICID XEO02790 MOACRIVE Inhibition DME1048 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1048 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02791 GENEFORM Protein DME1048 XEOTICID XEO02791 MOACRIVE Inhibition DME1048 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1048 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02792 GENEFORM Protein DME1048 XEOTICID XEO02792 MOACRIVE Inhibition DME1048 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1048 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02793 GENEFORM Protein DME1048 XEOTICID XEO02793 MOACRIVE Inhibition DME1048 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1048 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02794 GENEFORM Protein DME1048 XEOTICID XEO02794 MOACRIVE Inhibition DME1048 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1048 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02795 GENEFORM Protein DME1048 XEOTICID XEO02795 MOACRIVE Inhibition DME1048 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1048 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02796 GENEFORM Protein DME1048 XEOTICID XEO02796 MOACRIVE Inhibition DME1048 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1048 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02797 GENEFORM Protein DME1048 XEOTICID XEO02797 MOACRIVE Inhibition DME1048 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1048 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02799 XEO_CLAS Peptide DME1048 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02799 GENEFORM Protein DME1048 XEOTICID XEO02799 MOACRIVE Inhibition DME1048 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1048 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02800 XEO_CLAS Peptide DME1048 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02800 GENEFORM Protein DME1048 XEOTICID XEO02800 MOACRIVE Inhibition DME1048 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1048 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02802 XEO_CLAS Peptide DME1048 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 13.6 microM) DME1048 XEOTICID XEO02802 GENEFORM Protein DME1048 XEOTICID XEO02802 MOACRIVE Inhibition DME1048 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1048 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02807 XEO_CLAS Peptide DME1048 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.2 microM) DME1048 XEOTICID XEO02807 GENEFORM Protein DME1048 XEOTICID XEO02807 MOACRIVE Inhibition DME1048 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1048 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02813 XEO_CLAS Peptide DME1048 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 80 microM) DME1048 XEOTICID XEO02813 GENEFORM Protein DME1048 XEOTICID XEO02813 MOACRIVE Inhibition DME1048 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1048 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02814 XEO_CLAS Peptide DME1048 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 80 microM) DME1048 XEOTICID XEO02814 GENEFORM Protein DME1048 XEOTICID XEO02814 MOACRIVE Inhibition DME1048 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1048 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02815 XEO_CLAS Peptide DME1048 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8.5 microM) DME1048 XEOTICID XEO02815 GENEFORM Protein DME1048 XEOTICID XEO02815 MOACRIVE Inhibition DME1048 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1048 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02816 XEO_CLAS Peptide DME1048 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 80 microM) DME1048 XEOTICID XEO02816 GENEFORM Protein DME1048 XEOTICID XEO02816 MOACRIVE Inhibition DME1048 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1048 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02817 XEO_CLAS Peptide DME1048 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 80 microM) DME1048 XEOTICID XEO02817 GENEFORM Protein DME1048 XEOTICID XEO02817 MOACRIVE Inhibition DME1048 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1048 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02818 XEO_CLAS Peptide DME1048 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.4 microM) DME1048 XEOTICID XEO02818 GENEFORM Protein DME1048 XEOTICID XEO02818 MOACRIVE Inhibition DME1048 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1048 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02819 XEO_CLAS Peptide DME1048 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.6 microM) DME1048 XEOTICID XEO02819 GENEFORM Protein DME1048 XEOTICID XEO02819 MOACRIVE Inhibition DME1048 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1048 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02820 XEO_CLAS Peptide DME1048 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO02820 GENEFORM Protein DME1048 XEOTICID XEO02820 MOACRIVE Inhibition DME1048 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1048 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02821 XEO_CLAS Peptide DME1048 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02821 GENEFORM Protein DME1048 XEOTICID XEO02821 MOACRIVE Inhibition DME1048 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1048 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02824 XEO_CLAS Peptide DME1048 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 35 microM) DME1048 XEOTICID XEO02824 GENEFORM Protein DME1048 XEOTICID XEO02824 MOACRIVE Inhibition DME1048 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1048 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02826 XEO_CLAS Peptide DME1048 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.7 ug/ml) DME1048 XEOTICID XEO02826 GENEFORM Protein DME1048 XEOTICID XEO02826 MOACRIVE Inhibition DME1048 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1048 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02834 GENEFORM Protein DME1048 XEOTICID XEO02834 MOACRIVE Inhibition DME1048 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1048 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02839 XEO_CLAS Peptide DME1048 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.25 microM) DME1048 XEOTICID XEO02839 GENEFORM Protein DME1048 XEOTICID XEO02839 MOACRIVE Inhibition DME1048 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1048 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02841 XEO_CLAS Peptide DME1048 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.25 microM) DME1048 XEOTICID XEO02841 GENEFORM Protein DME1048 XEOTICID XEO02841 MOACRIVE Inhibition DME1048 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1048 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02842 XEO_CLAS Peptide DME1048 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.25 microM) DME1048 XEOTICID XEO02842 GENEFORM Protein DME1048 XEOTICID XEO02842 MOACRIVE Inhibition DME1048 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1048 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02843 XEO_CLAS Peptide DME1048 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02843 GENEFORM Protein DME1048 XEOTICID XEO02843 MOACRIVE Inhibition DME1048 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1048 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02849 GENEFORM Protein DME1048 XEOTICID XEO02849 MOACRIVE Inhibition DME1048 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1048 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02857 XEO_CLAS Peptide DME1048 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 53 microM) DME1048 XEOTICID XEO02857 GENEFORM Protein DME1048 XEOTICID XEO02857 MOACRIVE Inhibition DME1048 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1048 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02858 XEO_CLAS Peptide DME1048 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 53 microM) DME1048 XEOTICID XEO02858 GENEFORM Protein DME1048 XEOTICID XEO02858 MOACRIVE Inhibition DME1048 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1048 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02860 XEO_CLAS Peptide DME1048 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 ug/ml) DME1048 XEOTICID XEO02860 GENEFORM Protein DME1048 XEOTICID XEO02860 MOACRIVE Inhibition DME1048 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1048 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02867 XEO_CLAS Peptide DME1048 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02867 GENEFORM Protein DME1048 XEOTICID XEO02867 MOACRIVE Inhibition DME1048 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1048 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02868 XEO_CLAS Peptide DME1048 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02868 GENEFORM Protein DME1048 XEOTICID XEO02868 MOACRIVE Inhibition DME1048 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1048 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02869 XEO_CLAS Peptide DME1048 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02869 GENEFORM Protein DME1048 XEOTICID XEO02869 MOACRIVE Inhibition DME1048 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1048 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02870 XEO_CLAS Peptide DME1048 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02870 GENEFORM Protein DME1048 XEOTICID XEO02870 MOACRIVE Inhibition DME1048 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1048 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02871 XEO_CLAS Peptide DME1048 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02871 GENEFORM Protein DME1048 XEOTICID XEO02871 MOACRIVE Inhibition DME1048 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1048 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02872 XEO_CLAS Peptide DME1048 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 308 microM) DME1048 XEOTICID XEO02872 GENEFORM Protein DME1048 XEOTICID XEO02872 MOACRIVE Inhibition DME1048 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1048 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02875 XEO_CLAS Peptide DME1048 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.1 microM) DME1048 XEOTICID XEO02875 GENEFORM Protein DME1048 XEOTICID XEO02875 MOACRIVE Inhibition DME1048 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1048 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02876 XEO_CLAS Peptide DME1048 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO02876 GENEFORM Protein DME1048 XEOTICID XEO02876 MOACRIVE Inhibition DME1048 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1048 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02877 XEO_CLAS Peptide DME1048 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO02877 GENEFORM Protein DME1048 XEOTICID XEO02877 MOACRIVE Inhibition DME1048 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1048 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02878 XEO_CLAS Peptide DME1048 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.3 microM) DME1048 XEOTICID XEO02878 GENEFORM Protein DME1048 XEOTICID XEO02878 MOACRIVE Inhibition DME1048 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1048 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02885 XEO_CLAS Peptide DME1048 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02885 GENEFORM Protein DME1048 XEOTICID XEO02885 MOACRIVE Inhibition DME1048 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1048 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02886 XEO_CLAS Peptide DME1048 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02886 GENEFORM Protein DME1048 XEOTICID XEO02886 MOACRIVE Inhibition DME1048 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1048 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02887 XEO_CLAS Peptide DME1048 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1 ug/ml) DME1048 XEOTICID XEO02887 GENEFORM Protein DME1048 XEOTICID XEO02887 MOACRIVE Inhibition DME1048 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1048 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02888 XEO_CLAS Peptide DME1048 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 ug/ml) DME1048 XEOTICID XEO02888 GENEFORM Protein DME1048 XEOTICID XEO02888 MOACRIVE Inhibition DME1048 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1048 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02889 XEO_CLAS Peptide DME1048 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 ug/ml) DME1048 XEOTICID XEO02889 GENEFORM Protein DME1048 XEOTICID XEO02889 MOACRIVE Inhibition DME1048 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1048 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02890 XEO_CLAS Peptide DME1048 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02890 GENEFORM Protein DME1048 XEOTICID XEO02890 MOACRIVE Inhibition DME1048 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1048 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02891 XEO_CLAS Peptide DME1048 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02891 GENEFORM Protein DME1048 XEOTICID XEO02891 MOACRIVE Inhibition DME1048 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1048 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02895 XEO_CLAS Peptide DME1048 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO02895 GENEFORM Protein DME1048 XEOTICID XEO02895 MOACRIVE Inhibition DME1048 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1048 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02896 XEO_CLAS Peptide DME1048 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO02896 GENEFORM Protein DME1048 XEOTICID XEO02896 MOACRIVE Inhibition DME1048 XEOTICID XEO02899 XEO_NAME Coladonin DME1048 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1048 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1048 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02899 GENEFORM Protein DME1048 XEOTICID XEO02899 MOACRIVE Inhibition DME1048 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1048 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02900 XEO_CLAS Peptide DME1048 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02900 GENEFORM Protein DME1048 XEOTICID XEO02900 MOACRIVE Inhibition DME1048 XEOTICID XEO02901 XEO_NAME Colicin-V DME1048 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02901 XEO_CLAS Peptide DME1048 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02901 GENEFORM Protein DME1048 XEOTICID XEO02901 MOACRIVE Inhibition DME1048 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1048 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02904 GENEFORM Protein DME1048 XEOTICID XEO02904 MOACRIVE Inhibition DME1048 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1048 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02908 XEO_CLAS Peptide DME1048 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 50 microM) DME1048 XEOTICID XEO02908 GENEFORM Protein DME1048 XEOTICID XEO02908 MOACRIVE Inhibition DME1048 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1048 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02923 XEO_CLAS Peptide DME1048 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02923 GENEFORM Protein DME1048 XEOTICID XEO02923 MOACRIVE Inhibition DME1048 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1048 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02924 XEO_CLAS Peptide DME1048 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 32 microM) DME1048 XEOTICID XEO02924 GENEFORM Protein DME1048 XEOTICID XEO02924 MOACRIVE Inhibition DME1048 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1048 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1048 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02927 GENEFORM Protein DME1048 XEOTICID XEO02927 MOACRIVE Inhibition DME1048 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1048 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02931 XEO_CLAS Peptide DME1048 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 ug/ml) DME1048 XEOTICID XEO02931 GENEFORM Protein DME1048 XEOTICID XEO02931 MOACRIVE Inhibition DME1048 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1048 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02933 XEO_CLAS Peptide DME1048 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO02933 GENEFORM Protein DME1048 XEOTICID XEO02933 MOACRIVE Inhibition DME1048 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1048 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02934 XEO_CLAS Peptide DME1048 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02934 GENEFORM Protein DME1048 XEOTICID XEO02934 MOACRIVE Inhibition DME1048 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1048 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02935 XEO_CLAS Peptide DME1048 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02935 GENEFORM Protein DME1048 XEOTICID XEO02935 MOACRIVE Inhibition DME1048 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1048 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02936 XEO_CLAS Peptide DME1048 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO02936 GENEFORM Protein DME1048 XEOTICID XEO02936 MOACRIVE Inhibition DME1048 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1048 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02937 XEO_CLAS Peptide DME1048 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02937 GENEFORM Protein DME1048 XEOTICID XEO02937 MOACRIVE Inhibition DME1048 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1048 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02938 XEO_CLAS Peptide DME1048 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 32 ug/ml) DME1048 XEOTICID XEO02938 GENEFORM Protein DME1048 XEOTICID XEO02938 MOACRIVE Inhibition DME1048 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1048 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02939 XEO_CLAS Peptide DME1048 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 11 ug/ml) DME1048 XEOTICID XEO02939 GENEFORM Protein DME1048 XEOTICID XEO02939 MOACRIVE Inhibition DME1048 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1048 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02940 XEO_CLAS Peptide DME1048 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1 ug/ml) DME1048 XEOTICID XEO02940 GENEFORM Protein DME1048 XEOTICID XEO02940 MOACRIVE Inhibition DME1048 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1048 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02941 XEO_CLAS Peptide DME1048 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02941 GENEFORM Protein DME1048 XEOTICID XEO02941 MOACRIVE Inhibition DME1048 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1048 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02944 XEO_CLAS Peptide DME1048 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 microM) DME1048 XEOTICID XEO02944 GENEFORM Protein DME1048 XEOTICID XEO02944 MOACRIVE Inhibition DME1048 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1048 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02945 XEO_CLAS Peptide DME1048 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 microM) DME1048 XEOTICID XEO02945 GENEFORM Protein DME1048 XEOTICID XEO02945 MOACRIVE Inhibition DME1048 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1048 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02946 XEO_CLAS Peptide DME1048 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 microM) DME1048 XEOTICID XEO02946 GENEFORM Protein DME1048 XEOTICID XEO02946 MOACRIVE Inhibition DME1048 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1048 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02947 XEO_CLAS Peptide DME1048 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02947 GENEFORM Protein DME1048 XEOTICID XEO02947 MOACRIVE Inhibition DME1048 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1048 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02948 XEO_CLAS Peptide DME1048 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO02948 GENEFORM Protein DME1048 XEOTICID XEO02948 MOACRIVE Inhibition DME1048 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1048 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02949 XEO_CLAS Peptide DME1048 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO02949 GENEFORM Protein DME1048 XEOTICID XEO02949 MOACRIVE Inhibition DME1048 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1048 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02954 XEO_CLAS Peptide DME1048 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02954 GENEFORM Protein DME1048 XEOTICID XEO02954 MOACRIVE Inhibition DME1048 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1048 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02958 XEO_CLAS Peptide DME1048 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02958 GENEFORM Protein DME1048 XEOTICID XEO02958 MOACRIVE Inhibition DME1048 XEOTICID XEO02962 XEO_NAME Cryptonin DME1048 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02962 XEO_CLAS Peptide DME1048 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.12 ug/ml) DME1048 XEOTICID XEO02962 GENEFORM Protein DME1048 XEOTICID XEO02962 MOACRIVE Inhibition DME1048 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1048 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02965 XEO_CLAS Peptide DME1048 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 ug/ml) DME1048 XEOTICID XEO02965 GENEFORM Protein DME1048 XEOTICID XEO02965 MOACRIVE Inhibition DME1048 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1048 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02969 XEO_CLAS Peptide DME1048 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 microM) DME1048 XEOTICID XEO02969 GENEFORM Protein DME1048 XEOTICID XEO02969 MOACRIVE Inhibition DME1048 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1048 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02971 XEO_CLAS Peptide DME1048 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 microM) DME1048 XEOTICID XEO02971 GENEFORM Protein DME1048 XEOTICID XEO02971 MOACRIVE Inhibition DME1048 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1048 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO02972 XEO_CLAS Peptide DME1048 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.4 microM) DME1048 XEOTICID XEO02972 GENEFORM Protein DME1048 XEOTICID XEO02972 MOACRIVE Inhibition DME1048 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1048 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02990 GENEFORM Protein DME1048 XEOTICID XEO02990 MOACRIVE Inhibition DME1048 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1048 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02991 GENEFORM Protein DME1048 XEOTICID XEO02991 MOACRIVE Inhibition DME1048 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1048 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02992 GENEFORM Protein DME1048 XEOTICID XEO02992 MOACRIVE Inhibition DME1048 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1048 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02993 GENEFORM Protein DME1048 XEOTICID XEO02993 MOACRIVE Inhibition DME1048 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1048 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02994 GENEFORM Protein DME1048 XEOTICID XEO02994 MOACRIVE Inhibition DME1048 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1048 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02995 GENEFORM Protein DME1048 XEOTICID XEO02995 MOACRIVE Inhibition DME1048 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1048 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02996 GENEFORM Protein DME1048 XEOTICID XEO02996 MOACRIVE Inhibition DME1048 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1048 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02997 GENEFORM Protein DME1048 XEOTICID XEO02997 MOACRIVE Inhibition DME1048 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1048 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02998 GENEFORM Protein DME1048 XEOTICID XEO02998 MOACRIVE Inhibition DME1048 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1048 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1048 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO02999 GENEFORM Protein DME1048 XEOTICID XEO02999 MOACRIVE Inhibition DME1048 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1048 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03021 XEO_CLAS Peptide DME1048 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.31-0.63 microM) DME1048 XEOTICID XEO03021 GENEFORM Protein DME1048 XEOTICID XEO03021 MOACRIVE Inhibition DME1048 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1048 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03029 XEO_CLAS Peptide DME1048 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.005 microM) DME1048 XEOTICID XEO03029 GENEFORM Protein DME1048 XEOTICID XEO03029 MOACRIVE Inhibition DME1048 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1048 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03030 XEO_CLAS Peptide DME1048 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.005 microM) DME1048 XEOTICID XEO03030 GENEFORM Protein DME1048 XEOTICID XEO03030 MOACRIVE Inhibition DME1048 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1048 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03031 XEO_CLAS Peptide DME1048 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.3 microM) DME1048 XEOTICID XEO03031 GENEFORM Protein DME1048 XEOTICID XEO03031 MOACRIVE Inhibition DME1048 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1048 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03032 XEO_CLAS Peptide DME1048 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.01 microM) DME1048 XEOTICID XEO03032 GENEFORM Protein DME1048 XEOTICID XEO03032 MOACRIVE Inhibition DME1048 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1048 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03033 XEO_CLAS Peptide DME1048 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.173 microM) DME1048 XEOTICID XEO03033 GENEFORM Protein DME1048 XEOTICID XEO03033 MOACRIVE Inhibition DME1048 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1048 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03034 XEO_CLAS Peptide DME1048 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.518 microM) DME1048 XEOTICID XEO03034 GENEFORM Protein DME1048 XEOTICID XEO03034 MOACRIVE Inhibition DME1048 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1048 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03035 XEO_CLAS Peptide DME1048 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.114 microM) DME1048 XEOTICID XEO03035 GENEFORM Protein DME1048 XEOTICID XEO03035 MOACRIVE Inhibition DME1048 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1048 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03039 XEO_CLAS Peptide DME1048 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.55 microM) DME1048 XEOTICID XEO03039 GENEFORM Protein DME1048 XEOTICID XEO03039 MOACRIVE Inhibition DME1048 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1048 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03043 XEO_CLAS Peptide DME1048 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 microM) DME1048 XEOTICID XEO03043 GENEFORM Protein DME1048 XEOTICID XEO03043 MOACRIVE Inhibition DME1048 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1048 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03044 XEO_CLAS Peptide DME1048 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03044 GENEFORM Protein DME1048 XEOTICID XEO03044 MOACRIVE Inhibition DME1048 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1048 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03045 XEO_CLAS Peptide DME1048 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03045 GENEFORM Protein DME1048 XEOTICID XEO03045 MOACRIVE Inhibition DME1048 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1048 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03046 XEO_CLAS Peptide DME1048 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03046 GENEFORM Protein DME1048 XEOTICID XEO03046 MOACRIVE Inhibition DME1048 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1048 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03049 XEO_CLAS Peptide DME1048 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 microM) DME1048 XEOTICID XEO03049 GENEFORM Protein DME1048 XEOTICID XEO03049 MOACRIVE Inhibition DME1048 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1048 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03055 XEO_CLAS Peptide DME1048 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 microM) DME1048 XEOTICID XEO03055 GENEFORM Protein DME1048 XEOTICID XEO03055 MOACRIVE Inhibition DME1048 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1048 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03059 XEO_CLAS Peptide DME1048 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO03059 GENEFORM Protein DME1048 XEOTICID XEO03059 MOACRIVE Inhibition DME1048 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1048 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03060 XEO_CLAS Peptide DME1048 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO03060 GENEFORM Protein DME1048 XEOTICID XEO03060 MOACRIVE Inhibition DME1048 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1048 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03062 XEO_CLAS Peptide DME1048 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO03062 GENEFORM Protein DME1048 XEOTICID XEO03062 MOACRIVE Inhibition DME1048 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1048 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03064 XEO_CLAS Peptide DME1048 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO03064 GENEFORM Protein DME1048 XEOTICID XEO03064 MOACRIVE Inhibition DME1048 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1048 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03066 XEO_CLAS Peptide DME1048 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO03066 GENEFORM Protein DME1048 XEOTICID XEO03066 MOACRIVE Inhibition DME1048 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1048 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03068 XEO_CLAS Peptide DME1048 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO03068 GENEFORM Protein DME1048 XEOTICID XEO03068 MOACRIVE Inhibition DME1048 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1048 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03073 XEO_CLAS Peptide DME1048 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8-16 ug/ml) DME1048 XEOTICID XEO03073 GENEFORM Protein DME1048 XEOTICID XEO03073 MOACRIVE Inhibition DME1048 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1048 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03081 XEO_CLAS Peptide DME1048 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 microM) DME1048 XEOTICID XEO03081 GENEFORM Protein DME1048 XEOTICID XEO03081 MOACRIVE Inhibition DME1048 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1048 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03082 XEO_CLAS Peptide DME1048 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03082 GENEFORM Protein DME1048 XEOTICID XEO03082 MOACRIVE Inhibition DME1048 XEOTICID XEO03089 XEO_NAME Decoralin DME1048 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03089 XEO_CLAS Peptide DME1048 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 160 microM) DME1048 XEOTICID XEO03089 GENEFORM Protein DME1048 XEOTICID XEO03089 MOACRIVE Inhibition DME1048 XEOTICID XEO03098 XEO_NAME Insect defensin DME1048 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03098 XEO_CLAS Peptide DME1048 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 ug/ml) DME1048 XEOTICID XEO03098 GENEFORM Protein DME1048 XEOTICID XEO03098 MOACRIVE Inhibition DME1048 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1048 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03100 XEO_CLAS Peptide DME1048 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03100 GENEFORM Protein DME1048 XEOTICID XEO03100 MOACRIVE Inhibition DME1048 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1048 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03103 XEO_CLAS Peptide DME1048 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03103 GENEFORM Protein DME1048 XEOTICID XEO03103 MOACRIVE Inhibition DME1048 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1048 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03105 XEO_CLAS Peptide DME1048 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03105 GENEFORM Protein DME1048 XEOTICID XEO03105 MOACRIVE Inhibition DME1048 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1048 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03110 XEO_CLAS Peptide DME1048 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.2 microM) DME1048 XEOTICID XEO03110 GENEFORM Protein DME1048 XEOTICID XEO03110 MOACRIVE Inhibition DME1048 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1048 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03111 XEO_CLAS Peptide DME1048 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03111 GENEFORM Protein DME1048 XEOTICID XEO03111 MOACRIVE Inhibition DME1048 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1048 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03112 XEO_CLAS Peptide DME1048 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 50 ug/ml) DME1048 XEOTICID XEO03112 GENEFORM Protein DME1048 XEOTICID XEO03112 MOACRIVE Inhibition DME1048 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1048 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03115 XEO_CLAS Peptide DME1048 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03115 GENEFORM Protein DME1048 XEOTICID XEO03115 MOACRIVE Inhibition DME1048 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1048 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03116 XEO_CLAS Peptide DME1048 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 40 microM) DME1048 XEOTICID XEO03116 GENEFORM Protein DME1048 XEOTICID XEO03116 MOACRIVE Inhibition DME1048 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1048 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03118 XEO_CLAS Peptide DME1048 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03118 GENEFORM Protein DME1048 XEOTICID XEO03118 MOACRIVE Inhibition DME1048 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1048 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03119 XEO_CLAS Peptide DME1048 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03119 GENEFORM Protein DME1048 XEOTICID XEO03119 MOACRIVE Inhibition DME1048 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1048 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03121 XEO_CLAS Peptide DME1048 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03121 GENEFORM Protein DME1048 XEOTICID XEO03121 MOACRIVE Inhibition DME1048 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1048 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03122 XEO_CLAS Peptide DME1048 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64000 ug/ml) DME1048 XEOTICID XEO03122 GENEFORM Protein DME1048 XEOTICID XEO03122 MOACRIVE Inhibition DME1048 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1048 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03124 XEO_CLAS Peptide DME1048 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03124 GENEFORM Protein DME1048 XEOTICID XEO03124 MOACRIVE Inhibition DME1048 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1048 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03125 XEO_CLAS Peptide DME1048 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03125 GENEFORM Protein DME1048 XEOTICID XEO03125 MOACRIVE Inhibition DME1048 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1048 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03126 XEO_CLAS Peptide DME1048 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.86 microM) DME1048 XEOTICID XEO03126 GENEFORM Protein DME1048 XEOTICID XEO03126 MOACRIVE Inhibition DME1048 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1048 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03127 XEO_CLAS Peptide DME1048 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03127 GENEFORM Protein DME1048 XEOTICID XEO03127 MOACRIVE Inhibition DME1048 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1048 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03128 XEO_CLAS Peptide DME1048 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 256 ug/ml) DME1048 XEOTICID XEO03128 GENEFORM Protein DME1048 XEOTICID XEO03128 MOACRIVE Inhibition DME1048 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1048 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03129 XEO_CLAS Peptide DME1048 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 256 ug/ml) DME1048 XEOTICID XEO03129 GENEFORM Protein DME1048 XEOTICID XEO03129 MOACRIVE Inhibition DME1048 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1048 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03130 XEO_CLAS Peptide DME1048 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 256 ug/ml) DME1048 XEOTICID XEO03130 GENEFORM Protein DME1048 XEOTICID XEO03130 MOACRIVE Inhibition DME1048 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1048 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03131 XEO_CLAS Peptide DME1048 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 256 ug/ml) DME1048 XEOTICID XEO03131 GENEFORM Protein DME1048 XEOTICID XEO03131 MOACRIVE Inhibition DME1048 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1048 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03132 XEO_CLAS Peptide DME1048 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 256 ug/ml) DME1048 XEOTICID XEO03132 GENEFORM Protein DME1048 XEOTICID XEO03132 MOACRIVE Inhibition DME1048 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1048 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03137 XEO_CLAS Peptide DME1048 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03137 GENEFORM Protein DME1048 XEOTICID XEO03137 MOACRIVE Inhibition DME1048 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1048 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03143 XEO_CLAS Peptide DME1048 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.6 microM) DME1048 XEOTICID XEO03143 GENEFORM Protein DME1048 XEOTICID XEO03143 MOACRIVE Inhibition DME1048 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1048 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03145 XEO_CLAS Peptide DME1048 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.6 microM) DME1048 XEOTICID XEO03145 GENEFORM Protein DME1048 XEOTICID XEO03145 MOACRIVE Inhibition DME1048 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1048 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03146 XEO_CLAS Peptide DME1048 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.5 microM) DME1048 XEOTICID XEO03146 GENEFORM Protein DME1048 XEOTICID XEO03146 MOACRIVE Inhibition DME1048 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1048 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03147 XEO_CLAS Peptide DME1048 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 9.7 microM) DME1048 XEOTICID XEO03147 GENEFORM Protein DME1048 XEOTICID XEO03147 MOACRIVE Inhibition DME1048 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1048 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03148 XEO_CLAS Peptide DME1048 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.3 microM) DME1048 XEOTICID XEO03148 GENEFORM Protein DME1048 XEOTICID XEO03148 MOACRIVE Inhibition DME1048 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1048 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03149 XEO_CLAS Peptide DME1048 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.6 microM) DME1048 XEOTICID XEO03149 GENEFORM Protein DME1048 XEOTICID XEO03149 MOACRIVE Inhibition DME1048 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1048 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03150 XEO_CLAS Peptide DME1048 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 9-3 microM) DME1048 XEOTICID XEO03150 GENEFORM Protein DME1048 XEOTICID XEO03150 MOACRIVE Inhibition DME1048 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1048 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03151 XEO_CLAS Peptide DME1048 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 ug/ml) DME1048 XEOTICID XEO03151 GENEFORM Protein DME1048 XEOTICID XEO03151 MOACRIVE Inhibition DME1048 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1048 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03152 XEO_CLAS Peptide DME1048 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO03152 GENEFORM Protein DME1048 XEOTICID XEO03152 MOACRIVE Inhibition DME1048 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1048 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03155 XEO_CLAS Peptide DME1048 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.4 microM) DME1048 XEOTICID XEO03155 GENEFORM Protein DME1048 XEOTICID XEO03155 MOACRIVE Inhibition DME1048 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1048 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03156 XEO_CLAS Peptide DME1048 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.3 microM) DME1048 XEOTICID XEO03156 GENEFORM Protein DME1048 XEOTICID XEO03156 MOACRIVE Inhibition DME1048 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1048 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03157 XEO_CLAS Peptide DME1048 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.3 microM) DME1048 XEOTICID XEO03157 GENEFORM Protein DME1048 XEOTICID XEO03157 MOACRIVE Inhibition DME1048 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1048 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03158 XEO_CLAS Peptide DME1048 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 ug/ml) DME1048 XEOTICID XEO03158 GENEFORM Protein DME1048 XEOTICID XEO03158 MOACRIVE Inhibition DME1048 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1048 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03159 XEO_CLAS Peptide DME1048 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03159 GENEFORM Protein DME1048 XEOTICID XEO03159 MOACRIVE Inhibition DME1048 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1048 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03161 XEO_CLAS Peptide DME1048 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 microM) DME1048 XEOTICID XEO03161 GENEFORM Protein DME1048 XEOTICID XEO03161 MOACRIVE Inhibition DME1048 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1048 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03162 XEO_CLAS Peptide DME1048 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.5 microM) DME1048 XEOTICID XEO03162 GENEFORM Protein DME1048 XEOTICID XEO03162 MOACRIVE Inhibition DME1048 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1048 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03169 XEO_CLAS Peptide DME1048 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO03169 GENEFORM Protein DME1048 XEOTICID XEO03169 MOACRIVE Inhibition DME1048 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1048 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03193 XEO_CLAS Peptide DME1048 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25 ug/ml) DME1048 XEOTICID XEO03193 GENEFORM Protein DME1048 XEOTICID XEO03193 MOACRIVE Inhibition DME1048 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1048 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03194 XEO_CLAS Peptide DME1048 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03194 GENEFORM Protein DME1048 XEOTICID XEO03194 MOACRIVE Inhibition DME1048 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1048 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03195 XEO_CLAS Peptide DME1048 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03195 GENEFORM Protein DME1048 XEOTICID XEO03195 MOACRIVE Inhibition DME1048 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1048 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03197 XEO_CLAS Peptide DME1048 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 14.5 microM) DME1048 XEOTICID XEO03197 GENEFORM Protein DME1048 XEOTICID XEO03197 MOACRIVE Inhibition DME1048 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1048 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03202 XEO_CLAS Peptide DME1048 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.51 microM) DME1048 XEOTICID XEO03202 GENEFORM Protein DME1048 XEOTICID XEO03202 MOACRIVE Inhibition DME1048 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1048 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03203 XEO_CLAS Peptide DME1048 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.62 microM) DME1048 XEOTICID XEO03203 GENEFORM Protein DME1048 XEOTICID XEO03203 MOACRIVE Inhibition DME1048 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1048 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03204 XEO_CLAS Peptide DME1048 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.38 microM) DME1048 XEOTICID XEO03204 GENEFORM Protein DME1048 XEOTICID XEO03204 MOACRIVE Inhibition DME1048 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1048 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03205 XEO_CLAS Peptide DME1048 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.29 microM) DME1048 XEOTICID XEO03205 GENEFORM Protein DME1048 XEOTICID XEO03205 MOACRIVE Inhibition DME1048 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1048 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03206 XEO_CLAS Peptide DME1048 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.40 microM) DME1048 XEOTICID XEO03206 GENEFORM Protein DME1048 XEOTICID XEO03206 MOACRIVE Inhibition DME1048 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1048 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03207 XEO_CLAS Peptide DME1048 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.58 microM) DME1048 XEOTICID XEO03207 GENEFORM Protein DME1048 XEOTICID XEO03207 MOACRIVE Inhibition DME1048 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1048 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03208 XEO_CLAS Peptide DME1048 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.76 microM) DME1048 XEOTICID XEO03208 GENEFORM Protein DME1048 XEOTICID XEO03208 MOACRIVE Inhibition DME1048 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1048 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03209 XEO_CLAS Peptide DME1048 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.49 microM) DME1048 XEOTICID XEO03209 GENEFORM Protein DME1048 XEOTICID XEO03209 MOACRIVE Inhibition DME1048 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1048 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03210 XEO_CLAS Peptide DME1048 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 7.07 microM) DME1048 XEOTICID XEO03210 GENEFORM Protein DME1048 XEOTICID XEO03210 MOACRIVE Inhibition DME1048 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1048 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03211 XEO_CLAS Peptide DME1048 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.40 microM) DME1048 XEOTICID XEO03211 GENEFORM Protein DME1048 XEOTICID XEO03211 MOACRIVE Inhibition DME1048 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1048 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03215 XEO_CLAS Peptide DME1048 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20.0 ug/ml) DME1048 XEOTICID XEO03215 GENEFORM Protein DME1048 XEOTICID XEO03215 MOACRIVE Inhibition DME1048 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1048 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03216 XEO_CLAS Peptide DME1048 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO03216 GENEFORM Protein DME1048 XEOTICID XEO03216 MOACRIVE Inhibition DME1048 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1048 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03217 XEO_CLAS Peptide DME1048 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO03217 GENEFORM Protein DME1048 XEOTICID XEO03217 MOACRIVE Inhibition DME1048 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1048 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03223 XEO_CLAS Peptide DME1048 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.8 microM) DME1048 XEOTICID XEO03223 GENEFORM Protein DME1048 XEOTICID XEO03223 MOACRIVE Inhibition DME1048 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1048 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03224 XEO_CLAS Peptide DME1048 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.1-0.25 microM) DME1048 XEOTICID XEO03224 GENEFORM Protein DME1048 XEOTICID XEO03224 MOACRIVE Inhibition DME1048 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1048 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03225 XEO_CLAS Peptide DME1048 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.3 microM) DME1048 XEOTICID XEO03225 GENEFORM Protein DME1048 XEOTICID XEO03225 MOACRIVE Inhibition DME1048 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1048 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03227 XEO_CLAS Peptide DME1048 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.3 microM) DME1048 XEOTICID XEO03227 GENEFORM Protein DME1048 XEOTICID XEO03227 MOACRIVE Inhibition DME1048 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1048 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03231 XEO_CLAS Peptide DME1048 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03231 GENEFORM Protein DME1048 XEOTICID XEO03231 MOACRIVE Inhibition DME1048 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1048 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03232 XEO_CLAS Peptide DME1048 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03232 GENEFORM Protein DME1048 XEOTICID XEO03232 MOACRIVE Inhibition DME1048 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1048 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03234 XEO_CLAS Peptide DME1048 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO03234 GENEFORM Protein DME1048 XEOTICID XEO03234 MOACRIVE Inhibition DME1048 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1048 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03235 XEO_CLAS Peptide DME1048 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 60 ug/ml) DME1048 XEOTICID XEO03235 GENEFORM Protein DME1048 XEOTICID XEO03235 MOACRIVE Inhibition DME1048 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1048 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03236 XEO_CLAS Peptide DME1048 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO03236 GENEFORM Protein DME1048 XEOTICID XEO03236 MOACRIVE Inhibition DME1048 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1048 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03237 XEO_CLAS Peptide DME1048 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 ug/ml) DME1048 XEOTICID XEO03237 GENEFORM Protein DME1048 XEOTICID XEO03237 MOACRIVE Inhibition DME1048 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1048 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03238 XEO_CLAS Peptide DME1048 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 ug/ml) DME1048 XEOTICID XEO03238 GENEFORM Protein DME1048 XEOTICID XEO03238 MOACRIVE Inhibition DME1048 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1048 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03239 XEO_CLAS Peptide DME1048 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 60 ug/ml) DME1048 XEOTICID XEO03239 GENEFORM Protein DME1048 XEOTICID XEO03239 MOACRIVE Inhibition DME1048 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1048 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03241 XEO_CLAS Peptide DME1048 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 128 microM) DME1048 XEOTICID XEO03241 GENEFORM Protein DME1048 XEOTICID XEO03241 MOACRIVE Inhibition DME1048 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1048 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03250 XEO_CLAS Peptide DME1048 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03250 GENEFORM Protein DME1048 XEOTICID XEO03250 MOACRIVE Inhibition DME1048 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1048 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03251 XEO_CLAS Peptide DME1048 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03251 GENEFORM Protein DME1048 XEOTICID XEO03251 MOACRIVE Inhibition DME1048 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1048 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03253 XEO_CLAS Peptide DME1048 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.1 ug/ml) DME1048 XEOTICID XEO03253 GENEFORM Protein DME1048 XEOTICID XEO03253 MOACRIVE Inhibition DME1048 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1048 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03274 XEO_CLAS Peptide DME1048 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.2 microM) DME1048 XEOTICID XEO03274 GENEFORM Protein DME1048 XEOTICID XEO03274 MOACRIVE Inhibition DME1048 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1048 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03275 XEO_CLAS Peptide DME1048 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO03275 GENEFORM Protein DME1048 XEOTICID XEO03275 MOACRIVE Inhibition DME1048 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1048 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03276 XEO_CLAS Peptide DME1048 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO03276 GENEFORM Protein DME1048 XEOTICID XEO03276 MOACRIVE Inhibition DME1048 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1048 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03277 XEO_CLAS Peptide DME1048 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.2 microM) DME1048 XEOTICID XEO03277 GENEFORM Protein DME1048 XEOTICID XEO03277 MOACRIVE Inhibition DME1048 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1048 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03278 XEO_CLAS Peptide DME1048 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO03278 GENEFORM Protein DME1048 XEOTICID XEO03278 MOACRIVE Inhibition DME1048 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1048 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03279 XEO_CLAS Peptide DME1048 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO03279 GENEFORM Protein DME1048 XEOTICID XEO03279 MOACRIVE Inhibition DME1048 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1048 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03280 XEO_CLAS Peptide DME1048 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 microM) DME1048 XEOTICID XEO03280 GENEFORM Protein DME1048 XEOTICID XEO03280 MOACRIVE Inhibition DME1048 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1048 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03281 XEO_CLAS Peptide DME1048 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.3 microM) DME1048 XEOTICID XEO03281 GENEFORM Protein DME1048 XEOTICID XEO03281 MOACRIVE Inhibition DME1048 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1048 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03282 XEO_CLAS Peptide DME1048 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.1 microM) DME1048 XEOTICID XEO03282 GENEFORM Protein DME1048 XEOTICID XEO03282 MOACRIVE Inhibition DME1048 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1048 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03283 XEO_CLAS Peptide DME1048 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 microM) DME1048 XEOTICID XEO03283 GENEFORM Protein DME1048 XEOTICID XEO03283 MOACRIVE Inhibition DME1048 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1048 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03284 XEO_CLAS Peptide DME1048 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.2 ug/ml) DME1048 XEOTICID XEO03284 GENEFORM Protein DME1048 XEOTICID XEO03284 MOACRIVE Inhibition DME1048 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1048 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03285 XEO_CLAS Peptide DME1048 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.5 ug/ml) DME1048 XEOTICID XEO03285 GENEFORM Protein DME1048 XEOTICID XEO03285 MOACRIVE Inhibition DME1048 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1048 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03286 XEO_CLAS Peptide DME1048 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.4 ug/ml) DME1048 XEOTICID XEO03286 GENEFORM Protein DME1048 XEOTICID XEO03286 MOACRIVE Inhibition DME1048 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1048 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03287 XEO_CLAS Peptide DME1048 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.6 ug/ml) DME1048 XEOTICID XEO03287 GENEFORM Protein DME1048 XEOTICID XEO03287 MOACRIVE Inhibition DME1048 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1048 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03288 XEO_CLAS Peptide DME1048 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.4 ug/ml) DME1048 XEOTICID XEO03288 GENEFORM Protein DME1048 XEOTICID XEO03288 MOACRIVE Inhibition DME1048 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1048 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03289 XEO_CLAS Peptide DME1048 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8.8 ug/ml) DME1048 XEOTICID XEO03289 GENEFORM Protein DME1048 XEOTICID XEO03289 MOACRIVE Inhibition DME1048 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1048 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03290 XEO_CLAS Peptide DME1048 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.5 ug/ml) DME1048 XEOTICID XEO03290 GENEFORM Protein DME1048 XEOTICID XEO03290 MOACRIVE Inhibition DME1048 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1048 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03291 XEO_CLAS Peptide DME1048 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8.6 ug/ml) DME1048 XEOTICID XEO03291 GENEFORM Protein DME1048 XEOTICID XEO03291 MOACRIVE Inhibition DME1048 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1048 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03292 XEO_CLAS Peptide DME1048 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4.1 ug/ml) DME1048 XEOTICID XEO03292 GENEFORM Protein DME1048 XEOTICID XEO03292 MOACRIVE Inhibition DME1048 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1048 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03293 XEO_CLAS Peptide DME1048 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1 microM) DME1048 XEOTICID XEO03293 GENEFORM Protein DME1048 XEOTICID XEO03293 MOACRIVE Inhibition DME1048 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1048 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03294 XEO_CLAS Peptide DME1048 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1 microM) DME1048 XEOTICID XEO03294 GENEFORM Protein DME1048 XEOTICID XEO03294 MOACRIVE Inhibition DME1048 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1048 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03295 XEO_CLAS Peptide DME1048 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.7 microM) DME1048 XEOTICID XEO03295 GENEFORM Protein DME1048 XEOTICID XEO03295 MOACRIVE Inhibition DME1048 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1048 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03296 XEO_CLAS Peptide DME1048 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03296 GENEFORM Protein DME1048 XEOTICID XEO03296 MOACRIVE Inhibition DME1048 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1048 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03297 XEO_CLAS Peptide DME1048 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03297 GENEFORM Protein DME1048 XEOTICID XEO03297 MOACRIVE Inhibition DME1048 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1048 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03298 XEO_CLAS Peptide DME1048 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.2 microM) DME1048 XEOTICID XEO03298 GENEFORM Protein DME1048 XEOTICID XEO03298 MOACRIVE Inhibition DME1048 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1048 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03299 XEO_CLAS Peptide DME1048 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.4 microM) DME1048 XEOTICID XEO03299 GENEFORM Protein DME1048 XEOTICID XEO03299 MOACRIVE Inhibition DME1048 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1048 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03300 XEO_CLAS Peptide DME1048 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 ug/ml) DME1048 XEOTICID XEO03300 GENEFORM Protein DME1048 XEOTICID XEO03300 MOACRIVE Inhibition DME1048 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1048 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03301 XEO_CLAS Peptide DME1048 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 ug/ml) DME1048 XEOTICID XEO03301 GENEFORM Protein DME1048 XEOTICID XEO03301 MOACRIVE Inhibition DME1048 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1048 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03302 XEO_CLAS Peptide DME1048 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1 microM) DME1048 XEOTICID XEO03302 GENEFORM Protein DME1048 XEOTICID XEO03302 MOACRIVE Inhibition DME1048 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1048 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03303 XEO_CLAS Peptide DME1048 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 microM) DME1048 XEOTICID XEO03303 GENEFORM Protein DME1048 XEOTICID XEO03303 MOACRIVE Inhibition DME1048 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1048 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03304 XEO_CLAS Peptide DME1048 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO03304 GENEFORM Protein DME1048 XEOTICID XEO03304 MOACRIVE Inhibition DME1048 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1048 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03305 XEO_CLAS Peptide DME1048 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 microM) DME1048 XEOTICID XEO03305 GENEFORM Protein DME1048 XEOTICID XEO03305 MOACRIVE Inhibition DME1048 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1048 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03306 XEO_CLAS Peptide DME1048 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO03306 GENEFORM Protein DME1048 XEOTICID XEO03306 MOACRIVE Inhibition DME1048 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1048 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03307 XEO_CLAS Peptide DME1048 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 34 ug/ml) DME1048 XEOTICID XEO03307 GENEFORM Protein DME1048 XEOTICID XEO03307 MOACRIVE Inhibition DME1048 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1048 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03308 XEO_CLAS Peptide DME1048 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO03308 GENEFORM Protein DME1048 XEOTICID XEO03308 MOACRIVE Inhibition DME1048 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1048 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03310 XEO_CLAS Peptide DME1048 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8.5 ug/ml) DME1048 XEOTICID XEO03310 GENEFORM Protein DME1048 XEOTICID XEO03310 MOACRIVE Inhibition DME1048 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1048 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03311 XEO_CLAS Peptide DME1048 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10.8 ug/ml) DME1048 XEOTICID XEO03311 GENEFORM Protein DME1048 XEOTICID XEO03311 MOACRIVE Inhibition DME1048 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1048 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03312 XEO_CLAS Peptide DME1048 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10.8 ug/ml) DME1048 XEOTICID XEO03312 GENEFORM Protein DME1048 XEOTICID XEO03312 MOACRIVE Inhibition DME1048 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1048 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03313 XEO_CLAS Peptide DME1048 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8.1 ug/ml) DME1048 XEOTICID XEO03313 GENEFORM Protein DME1048 XEOTICID XEO03313 MOACRIVE Inhibition DME1048 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1048 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03314 XEO_CLAS Peptide DME1048 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 7.9 ug/ml) DME1048 XEOTICID XEO03314 GENEFORM Protein DME1048 XEOTICID XEO03314 MOACRIVE Inhibition DME1048 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1048 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03315 XEO_CLAS Peptide DME1048 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.6 ug/ml) DME1048 XEOTICID XEO03315 GENEFORM Protein DME1048 XEOTICID XEO03315 MOACRIVE Inhibition DME1048 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1048 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03316 XEO_CLAS Peptide DME1048 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15.8 ug/ml) DME1048 XEOTICID XEO03316 GENEFORM Protein DME1048 XEOTICID XEO03316 MOACRIVE Inhibition DME1048 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1048 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03317 XEO_CLAS Peptide DME1048 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO03317 GENEFORM Protein DME1048 XEOTICID XEO03317 MOACRIVE Inhibition DME1048 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1048 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03318 XEO_CLAS Peptide DME1048 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1 microM) DME1048 XEOTICID XEO03318 GENEFORM Protein DME1048 XEOTICID XEO03318 MOACRIVE Inhibition DME1048 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1048 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03319 XEO_CLAS Peptide DME1048 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03319 GENEFORM Protein DME1048 XEOTICID XEO03319 MOACRIVE Inhibition DME1048 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1048 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03320 XEO_CLAS Peptide DME1048 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.1 microM) DME1048 XEOTICID XEO03320 GENEFORM Protein DME1048 XEOTICID XEO03320 MOACRIVE Inhibition DME1048 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1048 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03321 XEO_CLAS Peptide DME1048 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.8 microM) DME1048 XEOTICID XEO03321 GENEFORM Protein DME1048 XEOTICID XEO03321 MOACRIVE Inhibition DME1048 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1048 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1048 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03348 GENEFORM Protein DME1048 XEOTICID XEO03348 MOACRIVE Inhibition DME1048 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1048 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03362 XEO_CLAS Peptide DME1048 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO03362 GENEFORM Protein DME1048 XEOTICID XEO03362 MOACRIVE Inhibition DME1048 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1048 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03363 XEO_CLAS Peptide DME1048 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 microM) DME1048 XEOTICID XEO03363 GENEFORM Protein DME1048 XEOTICID XEO03363 MOACRIVE Inhibition DME1048 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1048 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03364 XEO_CLAS Peptide DME1048 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 microM) DME1048 XEOTICID XEO03364 GENEFORM Protein DME1048 XEOTICID XEO03364 MOACRIVE Inhibition DME1048 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1048 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03365 XEO_CLAS Peptide DME1048 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03365 GENEFORM Protein DME1048 XEOTICID XEO03365 MOACRIVE Inhibition DME1048 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1048 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03366 XEO_CLAS Peptide DME1048 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO03366 GENEFORM Protein DME1048 XEOTICID XEO03366 MOACRIVE Inhibition DME1048 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1048 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03367 XEO_CLAS Peptide DME1048 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 microM) DME1048 XEOTICID XEO03367 GENEFORM Protein DME1048 XEOTICID XEO03367 MOACRIVE Inhibition DME1048 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1048 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03368 XEO_CLAS Peptide DME1048 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 microM) DME1048 XEOTICID XEO03368 GENEFORM Protein DME1048 XEOTICID XEO03368 MOACRIVE Inhibition DME1048 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1048 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03379 XEO_CLAS Peptide DME1048 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.6 ug/ml) DME1048 XEOTICID XEO03379 GENEFORM Protein DME1048 XEOTICID XEO03379 MOACRIVE Inhibition DME1048 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1048 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03396 XEO_CLAS Peptide DME1048 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03396 GENEFORM Protein DME1048 XEOTICID XEO03396 MOACRIVE Inhibition DME1048 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1048 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03398 XEO_CLAS Peptide DME1048 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03398 GENEFORM Protein DME1048 XEOTICID XEO03398 MOACRIVE Inhibition DME1048 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1048 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03399 XEO_CLAS Peptide DME1048 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03399 GENEFORM Protein DME1048 XEOTICID XEO03399 MOACRIVE Inhibition DME1048 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1048 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03406 XEO_CLAS Peptide DME1048 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 ug/ml) DME1048 XEOTICID XEO03406 GENEFORM Protein DME1048 XEOTICID XEO03406 MOACRIVE Inhibition DME1048 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1048 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03424 XEO_CLAS Peptide DME1048 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03424 GENEFORM Protein DME1048 XEOTICID XEO03424 MOACRIVE Inhibition DME1048 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1048 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03426 XEO_CLAS Peptide DME1048 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO03426 GENEFORM Protein DME1048 XEOTICID XEO03426 MOACRIVE Inhibition DME1048 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1048 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03427 XEO_CLAS Peptide DME1048 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 microM) DME1048 XEOTICID XEO03427 GENEFORM Protein DME1048 XEOTICID XEO03427 MOACRIVE Inhibition DME1048 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1048 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03428 XEO_CLAS Peptide DME1048 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 ug/ml) DME1048 XEOTICID XEO03428 GENEFORM Protein DME1048 XEOTICID XEO03428 MOACRIVE Inhibition DME1048 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1048 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03430 XEO_CLAS Peptide DME1048 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 ug/ml) DME1048 XEOTICID XEO03430 GENEFORM Protein DME1048 XEOTICID XEO03430 MOACRIVE Inhibition DME1048 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1048 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03434 XEO_CLAS Peptide DME1048 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO03434 GENEFORM Protein DME1048 XEOTICID XEO03434 MOACRIVE Inhibition DME1048 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1048 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03442 XEO_CLAS Peptide DME1048 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 18.75 ug/ml) DME1048 XEOTICID XEO03442 GENEFORM Protein DME1048 XEOTICID XEO03442 MOACRIVE Inhibition DME1048 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1048 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03444 XEO_CLAS Peptide DME1048 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 37.50 ug/ml) DME1048 XEOTICID XEO03444 GENEFORM Protein DME1048 XEOTICID XEO03444 MOACRIVE Inhibition DME1048 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1048 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03459 XEO_CLAS Peptide DME1048 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03459 GENEFORM Protein DME1048 XEOTICID XEO03459 MOACRIVE Inhibition DME1048 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1048 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03460 XEO_CLAS Peptide DME1048 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03460 GENEFORM Protein DME1048 XEOTICID XEO03460 MOACRIVE Inhibition DME1048 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1048 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03461 XEO_CLAS Peptide DME1048 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.05 microM) DME1048 XEOTICID XEO03461 GENEFORM Protein DME1048 XEOTICID XEO03461 MOACRIVE Inhibition DME1048 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1048 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03462 XEO_CLAS Peptide DME1048 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03462 GENEFORM Protein DME1048 XEOTICID XEO03462 MOACRIVE Inhibition DME1048 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1048 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03463 XEO_CLAS Peptide DME1048 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03463 GENEFORM Protein DME1048 XEOTICID XEO03463 MOACRIVE Inhibition DME1048 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1048 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03467 XEO_CLAS Peptide DME1048 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03467 GENEFORM Protein DME1048 XEOTICID XEO03467 MOACRIVE Inhibition DME1048 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1048 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03468 XEO_CLAS Peptide DME1048 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03468 GENEFORM Protein DME1048 XEOTICID XEO03468 MOACRIVE Inhibition DME1048 XEOTICID XEO03471 XEO_NAME Gambicin DME1048 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03471 XEO_CLAS Peptide DME1048 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25-12.5 microM) DME1048 XEOTICID XEO03471 GENEFORM Protein DME1048 XEOTICID XEO03471 MOACRIVE Inhibition DME1048 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1048 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03485 XEO_CLAS Peptide DME1048 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4.07 ug/ml) DME1048 XEOTICID XEO03485 GENEFORM Protein DME1048 XEOTICID XEO03485 MOACRIVE Inhibition DME1048 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1048 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03486 XEO_CLAS Peptide DME1048 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.80 ug/ml) DME1048 XEOTICID XEO03486 GENEFORM Protein DME1048 XEOTICID XEO03486 MOACRIVE Inhibition DME1048 XEOTICID XEO03488 XEO_NAME GLK-19 DME1048 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03488 XEO_CLAS Peptide DME1048 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO03488 GENEFORM Protein DME1048 XEOTICID XEO03488 MOACRIVE Inhibition DME1048 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1048 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03497 XEO_CLAS Peptide DME1048 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.4-0.8 microM) DME1048 XEOTICID XEO03497 GENEFORM Protein DME1048 XEOTICID XEO03497 MOACRIVE Inhibition DME1048 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1048 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03498 XEO_CLAS Peptide DME1048 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.4-0.8 microM) DME1048 XEOTICID XEO03498 GENEFORM Protein DME1048 XEOTICID XEO03498 MOACRIVE Inhibition DME1048 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1048 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03500 XEO_CLAS Peptide DME1048 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-30 ug/ml) DME1048 XEOTICID XEO03500 GENEFORM Protein DME1048 XEOTICID XEO03500 MOACRIVE Inhibition DME1048 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1048 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03504 XEO_CLAS Peptide DME1048 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 ug/ml) DME1048 XEOTICID XEO03504 GENEFORM Protein DME1048 XEOTICID XEO03504 MOACRIVE Inhibition DME1048 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1048 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03505 XEO_CLAS Peptide DME1048 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 ug/ml) DME1048 XEOTICID XEO03505 GENEFORM Protein DME1048 XEOTICID XEO03505 MOACRIVE Inhibition DME1048 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1048 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03506 XEO_CLAS Peptide DME1048 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 ug/ml) DME1048 XEOTICID XEO03506 GENEFORM Protein DME1048 XEOTICID XEO03506 MOACRIVE Inhibition DME1048 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1048 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03513 XEO_CLAS Peptide DME1048 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO03513 GENEFORM Protein DME1048 XEOTICID XEO03513 MOACRIVE Inhibition DME1048 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1048 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03514 XEO_CLAS Peptide DME1048 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03514 GENEFORM Protein DME1048 XEOTICID XEO03514 MOACRIVE Inhibition DME1048 XEOTICID XEO03519 XEO_NAME Hadrurin DME1048 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03519 XEO_CLAS Peptide DME1048 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03519 GENEFORM Protein DME1048 XEOTICID XEO03519 MOACRIVE Inhibition DME1048 XEOTICID XEO03522 XEO_NAME Halocyntin DME1048 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03522 XEO_CLAS Peptide DME1048 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03522 GENEFORM Protein DME1048 XEOTICID XEO03522 MOACRIVE Inhibition DME1048 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1048 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03524 XEO_CLAS Peptide DME1048 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03524 GENEFORM Protein DME1048 XEOTICID XEO03524 MOACRIVE Inhibition DME1048 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1048 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03525 XEO_CLAS Peptide DME1048 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03525 GENEFORM Protein DME1048 XEOTICID XEO03525 MOACRIVE Inhibition DME1048 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1048 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03530 XEO_CLAS Peptide DME1048 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03530 GENEFORM Protein DME1048 XEOTICID XEO03530 MOACRIVE Inhibition DME1048 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1048 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03535 XEO_CLAS Peptide DME1048 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.4 microM) DME1048 XEOTICID XEO03535 GENEFORM Protein DME1048 XEOTICID XEO03535 MOACRIVE Inhibition DME1048 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1048 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03536 XEO_CLAS Peptide DME1048 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 80 microM) DME1048 XEOTICID XEO03536 GENEFORM Protein DME1048 XEOTICID XEO03536 MOACRIVE Inhibition DME1048 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1048 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03537 XEO_CLAS Peptide DME1048 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 ug/ml) DME1048 XEOTICID XEO03537 GENEFORM Protein DME1048 XEOTICID XEO03537 MOACRIVE Inhibition DME1048 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1048 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03538 XEO_CLAS Peptide DME1048 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 ug/ml) DME1048 XEOTICID XEO03538 GENEFORM Protein DME1048 XEOTICID XEO03538 MOACRIVE Inhibition DME1048 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1048 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03540 XEO_CLAS Peptide DME1048 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO03540 GENEFORM Protein DME1048 XEOTICID XEO03540 MOACRIVE Inhibition DME1048 XEOTICID XEO03542 XEO_NAME Hepcidin DME1048 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03542 XEO_CLAS Peptide DME1048 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 24 microM) DME1048 XEOTICID XEO03542 GENEFORM Protein DME1048 XEOTICID XEO03542 MOACRIVE Inhibition DME1048 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1048 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03544 XEO_CLAS Peptide DME1048 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03544 GENEFORM Protein DME1048 XEOTICID XEO03544 MOACRIVE Inhibition DME1048 XEOTICID XEO03548 XEO_NAME Hesperidin DME1048 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03548 GENEFORM Protein DME1048 XEOTICID XEO03548 MOACRIVE Inhibition DME1048 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1048 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1048 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03552 GENEFORM Protein DME1048 XEOTICID XEO03552 MOACRIVE Inhibition DME1048 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1048 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03556 XEO_CLAS Peptide DME1048 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO03556 GENEFORM Protein DME1048 XEOTICID XEO03556 MOACRIVE Inhibition DME1048 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1048 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03557 XEO_CLAS Peptide DME1048 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO03557 GENEFORM Protein DME1048 XEOTICID XEO03557 MOACRIVE Inhibition DME1048 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1048 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03558 XEO_CLAS Peptide DME1048 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 microM) DME1048 XEOTICID XEO03558 GENEFORM Protein DME1048 XEOTICID XEO03558 MOACRIVE Inhibition DME1048 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1048 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03559 XEO_CLAS Peptide DME1048 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 microM) DME1048 XEOTICID XEO03559 GENEFORM Protein DME1048 XEOTICID XEO03559 MOACRIVE Inhibition DME1048 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1048 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03560 XEO_CLAS Peptide DME1048 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 microM) DME1048 XEOTICID XEO03560 GENEFORM Protein DME1048 XEOTICID XEO03560 MOACRIVE Inhibition DME1048 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1048 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03561 XEO_CLAS Peptide DME1048 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03561 GENEFORM Protein DME1048 XEOTICID XEO03561 MOACRIVE Inhibition DME1048 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1048 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03567 XEO_CLAS Peptide DME1048 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03567 GENEFORM Protein DME1048 XEOTICID XEO03567 MOACRIVE Inhibition DME1048 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1048 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03569 XEO_CLAS Peptide DME1048 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 300 microM) DME1048 XEOTICID XEO03569 GENEFORM Protein DME1048 XEOTICID XEO03569 MOACRIVE Inhibition DME1048 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1048 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03570 XEO_CLAS Peptide DME1048 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03570 GENEFORM Protein DME1048 XEOTICID XEO03570 MOACRIVE Inhibition DME1048 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1048 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03572 XEO_CLAS Peptide DME1048 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1048 XEOTICID XEO03572 GENEFORM Protein DME1048 XEOTICID XEO03572 MOACRIVE Inhibition DME1048 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1048 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03573 XEO_CLAS Peptide DME1048 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 28.1 ug/ml) DME1048 XEOTICID XEO03573 GENEFORM Protein DME1048 XEOTICID XEO03573 MOACRIVE Inhibition DME1048 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1048 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03574 XEO_CLAS Peptide DME1048 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 500 microM) DME1048 XEOTICID XEO03574 GENEFORM Protein DME1048 XEOTICID XEO03574 MOACRIVE Inhibition DME1048 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1048 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03575 XEO_CLAS Peptide DME1048 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 18 microM) DME1048 XEOTICID XEO03575 GENEFORM Protein DME1048 XEOTICID XEO03575 MOACRIVE Inhibition DME1048 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1048 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03576 XEO_CLAS Peptide DME1048 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 750 microM) DME1048 XEOTICID XEO03576 GENEFORM Protein DME1048 XEOTICID XEO03576 MOACRIVE Inhibition DME1048 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1048 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03578 XEO_CLAS Peptide DME1048 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1048 XEOTICID XEO03578 GENEFORM Protein DME1048 XEOTICID XEO03578 MOACRIVE Inhibition DME1048 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1048 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03579 XEO_CLAS Peptide DME1048 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03579 GENEFORM Protein DME1048 XEOTICID XEO03579 MOACRIVE Inhibition DME1048 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1048 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03580 XEO_CLAS Peptide DME1048 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03580 GENEFORM Protein DME1048 XEOTICID XEO03580 MOACRIVE Inhibition DME1048 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1048 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03585 XEO_CLAS Peptide DME1048 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 125 ug/ml) DME1048 XEOTICID XEO03585 GENEFORM Protein DME1048 XEOTICID XEO03585 MOACRIVE Inhibition DME1048 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1048 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03588 XEO_CLAS Peptide DME1048 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 62 ug/ml) DME1048 XEOTICID XEO03588 GENEFORM Protein DME1048 XEOTICID XEO03588 MOACRIVE Inhibition DME1048 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1048 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03589 XEO_CLAS Peptide DME1048 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03589 GENEFORM Protein DME1048 XEOTICID XEO03589 MOACRIVE Inhibition DME1048 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1048 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03590 XEO_CLAS Peptide DME1048 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03590 GENEFORM Protein DME1048 XEOTICID XEO03590 MOACRIVE Inhibition DME1048 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1048 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03591 XEO_CLAS Peptide DME1048 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 37.5 ug/ml) DME1048 XEOTICID XEO03591 GENEFORM Protein DME1048 XEOTICID XEO03591 MOACRIVE Inhibition DME1048 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1048 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03593 XEO_CLAS Peptide DME1048 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 9.4 ug/ml) DME1048 XEOTICID XEO03593 GENEFORM Protein DME1048 XEOTICID XEO03593 MOACRIVE Inhibition DME1048 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1048 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03594 XEO_CLAS Peptide DME1048 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 ug/ml) DME1048 XEOTICID XEO03594 GENEFORM Protein DME1048 XEOTICID XEO03594 MOACRIVE Inhibition DME1048 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1048 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03595 XEO_CLAS Peptide DME1048 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03595 GENEFORM Protein DME1048 XEOTICID XEO03595 MOACRIVE Inhibition DME1048 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1048 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03596 XEO_CLAS Peptide DME1048 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03596 GENEFORM Protein DME1048 XEOTICID XEO03596 MOACRIVE Inhibition DME1048 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1048 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03598 XEO_CLAS Peptide DME1048 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03598 GENEFORM Protein DME1048 XEOTICID XEO03598 MOACRIVE Inhibition DME1048 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1048 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03599 XEO_CLAS Peptide DME1048 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03599 GENEFORM Protein DME1048 XEOTICID XEO03599 MOACRIVE Inhibition DME1048 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1048 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03600 XEO_CLAS Peptide DME1048 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03600 GENEFORM Protein DME1048 XEOTICID XEO03600 MOACRIVE Inhibition DME1048 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1048 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03606 XEO_CLAS Peptide DME1048 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03606 GENEFORM Protein DME1048 XEOTICID XEO03606 MOACRIVE Inhibition DME1048 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1048 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03607 XEO_CLAS Peptide DME1048 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03607 GENEFORM Protein DME1048 XEOTICID XEO03607 MOACRIVE Inhibition DME1048 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1048 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03609 XEO_CLAS Peptide DME1048 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03609 GENEFORM Protein DME1048 XEOTICID XEO03609 MOACRIVE Inhibition DME1048 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1048 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03615 XEO_CLAS Peptide DME1048 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1048 XEOTICID XEO03615 GENEFORM Protein DME1048 XEOTICID XEO03615 MOACRIVE Inhibition DME1048 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1048 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03616 XEO_CLAS Peptide DME1048 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 32 microM) DME1048 XEOTICID XEO03616 GENEFORM Protein DME1048 XEOTICID XEO03616 MOACRIVE Inhibition DME1048 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1048 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03617 XEO_CLAS Peptide DME1048 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40 microM) DME1048 XEOTICID XEO03617 GENEFORM Protein DME1048 XEOTICID XEO03617 MOACRIVE Inhibition DME1048 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1048 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03618 XEO_CLAS Peptide DME1048 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5-1 microM) DME1048 XEOTICID XEO03618 GENEFORM Protein DME1048 XEOTICID XEO03618 MOACRIVE Inhibition DME1048 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1048 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03622 XEO_CLAS Peptide DME1048 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20-40 microM) DME1048 XEOTICID XEO03622 GENEFORM Protein DME1048 XEOTICID XEO03622 MOACRIVE Inhibition DME1048 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1048 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03627 XEO_CLAS Peptide DME1048 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.4-0.8 microM) DME1048 XEOTICID XEO03627 GENEFORM Protein DME1048 XEOTICID XEO03627 MOACRIVE Inhibition DME1048 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1048 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03630 XEO_CLAS Peptide DME1048 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03630 GENEFORM Protein DME1048 XEOTICID XEO03630 MOACRIVE Inhibition DME1048 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1048 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03631 XEO_CLAS Peptide DME1048 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03631 GENEFORM Protein DME1048 XEOTICID XEO03631 MOACRIVE Inhibition DME1048 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1048 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03632 XEO_CLAS Peptide DME1048 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03632 GENEFORM Protein DME1048 XEOTICID XEO03632 MOACRIVE Inhibition DME1048 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1048 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03633 XEO_CLAS Peptide DME1048 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03633 GENEFORM Protein DME1048 XEOTICID XEO03633 MOACRIVE Inhibition DME1048 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1048 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03634 XEO_CLAS Peptide DME1048 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03634 GENEFORM Protein DME1048 XEOTICID XEO03634 MOACRIVE Inhibition DME1048 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1048 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03635 XEO_CLAS Peptide DME1048 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03635 GENEFORM Protein DME1048 XEOTICID XEO03635 MOACRIVE Inhibition DME1048 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1048 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03636 XEO_CLAS Peptide DME1048 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03636 GENEFORM Protein DME1048 XEOTICID XEO03636 MOACRIVE Inhibition DME1048 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1048 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03637 XEO_CLAS Peptide DME1048 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03637 GENEFORM Protein DME1048 XEOTICID XEO03637 MOACRIVE Inhibition DME1048 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1048 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03638 XEO_CLAS Peptide DME1048 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03638 GENEFORM Protein DME1048 XEOTICID XEO03638 MOACRIVE Inhibition DME1048 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1048 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03639 XEO_CLAS Peptide DME1048 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03639 GENEFORM Protein DME1048 XEOTICID XEO03639 MOACRIVE Inhibition DME1048 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1048 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03640 XEO_CLAS Peptide DME1048 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03640 GENEFORM Protein DME1048 XEOTICID XEO03640 MOACRIVE Inhibition DME1048 XEOTICID XEO03644 XEO_NAME Indole DME1048 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1048 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1048 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03644 GENEFORM Protein DME1048 XEOTICID XEO03644 MOACRIVE Inhibition DME1048 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1048 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03650 XEO_CLAS Peptide DME1048 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03650 GENEFORM Protein DME1048 XEOTICID XEO03650 MOACRIVE Inhibition DME1048 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1048 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO03655 XEO_CLAS Natural Product DME1048 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03655 GENEFORM Protein DME1048 XEOTICID XEO03655 MOACRIVE Inhibition DME1048 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1048 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03666 XEO_CLAS Peptide DME1048 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 ug/ml) DME1048 XEOTICID XEO03666 GENEFORM Protein DME1048 XEOTICID XEO03666 MOACRIVE Inhibition DME1048 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1048 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03667 XEO_CLAS Peptide DME1048 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 ug/ml) DME1048 XEOTICID XEO03667 GENEFORM Protein DME1048 XEOTICID XEO03667 MOACRIVE Inhibition DME1048 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1048 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03668 XEO_CLAS Peptide DME1048 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 microM) DME1048 XEOTICID XEO03668 GENEFORM Protein DME1048 XEOTICID XEO03668 MOACRIVE Inhibition DME1048 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1048 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03669 XEO_CLAS Peptide DME1048 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO03669 GENEFORM Protein DME1048 XEOTICID XEO03669 MOACRIVE Inhibition DME1048 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1048 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03670 XEO_CLAS Peptide DME1048 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 microM) DME1048 XEOTICID XEO03670 GENEFORM Protein DME1048 XEOTICID XEO03670 MOACRIVE Inhibition DME1048 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1048 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03672 XEO_CLAS Peptide DME1048 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.5 ug/ml) DME1048 XEOTICID XEO03672 GENEFORM Protein DME1048 XEOTICID XEO03672 MOACRIVE Inhibition DME1048 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1048 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03673 XEO_CLAS Peptide DME1048 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 ug/ml) DME1048 XEOTICID XEO03673 GENEFORM Protein DME1048 XEOTICID XEO03673 MOACRIVE Inhibition DME1048 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1048 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03674 XEO_CLAS Peptide DME1048 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 ug/ml) DME1048 XEOTICID XEO03674 GENEFORM Protein DME1048 XEOTICID XEO03674 MOACRIVE Inhibition DME1048 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1048 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03675 XEO_CLAS Peptide DME1048 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO03675 GENEFORM Protein DME1048 XEOTICID XEO03675 MOACRIVE Inhibition DME1048 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1048 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03678 XEO_CLAS Peptide DME1048 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 ug/ml) DME1048 XEOTICID XEO03678 GENEFORM Protein DME1048 XEOTICID XEO03678 MOACRIVE Inhibition DME1048 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1048 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03679 XEO_CLAS Peptide DME1048 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 ug/ml) DME1048 XEOTICID XEO03679 GENEFORM Protein DME1048 XEOTICID XEO03679 MOACRIVE Inhibition DME1048 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1048 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03681 XEO_CLAS Peptide DME1048 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.3-0.6 microM) DME1048 XEOTICID XEO03681 GENEFORM Protein DME1048 XEOTICID XEO03681 MOACRIVE Inhibition DME1048 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1048 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03684 XEO_CLAS Peptide DME1048 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 ug/ml) DME1048 XEOTICID XEO03684 GENEFORM Protein DME1048 XEOTICID XEO03684 MOACRIVE Inhibition DME1048 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1048 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03694 XEO_CLAS Peptide DME1048 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03694 GENEFORM Protein DME1048 XEOTICID XEO03694 MOACRIVE Inhibition DME1048 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1048 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03697 XEO_CLAS Peptide DME1048 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25 microM) DME1048 XEOTICID XEO03697 GENEFORM Protein DME1048 XEOTICID XEO03697 MOACRIVE Inhibition DME1048 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1048 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03698 XEO_CLAS Peptide DME1048 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03698 GENEFORM Protein DME1048 XEOTICID XEO03698 MOACRIVE Inhibition DME1048 XEOTICID XEO03703 XEO_NAME Kasstasin DME1048 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03703 XEO_CLAS Peptide DME1048 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 110 microM) DME1048 XEOTICID XEO03703 GENEFORM Protein DME1048 XEOTICID XEO03703 MOACRIVE Inhibition DME1048 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1048 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03706 XEO_CLAS Peptide DME1048 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03706 GENEFORM Protein DME1048 XEOTICID XEO03706 MOACRIVE Inhibition DME1048 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1048 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03707 XEO_CLAS Peptide DME1048 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03707 GENEFORM Protein DME1048 XEOTICID XEO03707 MOACRIVE Inhibition DME1048 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1048 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03709 XEO_CLAS Peptide DME1048 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 ug/ml) DME1048 XEOTICID XEO03709 GENEFORM Protein DME1048 XEOTICID XEO03709 MOACRIVE Inhibition DME1048 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1048 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03712 XEO_CLAS Peptide DME1048 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03712 GENEFORM Protein DME1048 XEOTICID XEO03712 MOACRIVE Inhibition DME1048 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1048 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03713 XEO_CLAS Peptide DME1048 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 64 microM) DME1048 XEOTICID XEO03713 GENEFORM Protein DME1048 XEOTICID XEO03713 MOACRIVE Inhibition DME1048 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1048 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03714 XEO_CLAS Peptide DME1048 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03714 GENEFORM Protein DME1048 XEOTICID XEO03714 MOACRIVE Inhibition DME1048 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1048 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03715 XEO_CLAS Peptide DME1048 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 microM) DME1048 XEOTICID XEO03715 GENEFORM Protein DME1048 XEOTICID XEO03715 MOACRIVE Inhibition DME1048 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1048 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03719 XEO_CLAS Peptide DME1048 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 microM) DME1048 XEOTICID XEO03719 GENEFORM Protein DME1048 XEOTICID XEO03719 MOACRIVE Inhibition DME1048 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1048 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03720 XEO_CLAS Peptide DME1048 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 microM) DME1048 XEOTICID XEO03720 GENEFORM Protein DME1048 XEOTICID XEO03720 MOACRIVE Inhibition DME1048 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1048 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03723 XEO_CLAS Peptide DME1048 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 62.36 microM) DME1048 XEOTICID XEO03723 GENEFORM Protein DME1048 XEOTICID XEO03723 MOACRIVE Inhibition DME1048 XEOTICID XEO03724 XEO_NAME L10 peptide DME1048 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03724 XEO_CLAS Peptide DME1048 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.8 microM) DME1048 XEOTICID XEO03724 GENEFORM Protein DME1048 XEOTICID XEO03724 MOACRIVE Inhibition DME1048 XEOTICID XEO03726 XEO_NAME L2 peptide DME1048 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03726 XEO_CLAS Peptide DME1048 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 129.66 microM) DME1048 XEOTICID XEO03726 GENEFORM Protein DME1048 XEOTICID XEO03726 MOACRIVE Inhibition DME1048 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1048 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03727 XEO_CLAS Peptide DME1048 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 80 ug/ml) DME1048 XEOTICID XEO03727 GENEFORM Protein DME1048 XEOTICID XEO03727 MOACRIVE Inhibition DME1048 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1048 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03728 XEO_CLAS Peptide DME1048 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40 ug/ml) DME1048 XEOTICID XEO03728 GENEFORM Protein DME1048 XEOTICID XEO03728 MOACRIVE Inhibition DME1048 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1048 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03729 XEO_CLAS Peptide DME1048 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 80 ug/ml) DME1048 XEOTICID XEO03729 GENEFORM Protein DME1048 XEOTICID XEO03729 MOACRIVE Inhibition DME1048 XEOTICID XEO03730 XEO_NAME L3 peptide DME1048 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03730 XEO_CLAS Peptide DME1048 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64.11 microM) DME1048 XEOTICID XEO03730 GENEFORM Protein DME1048 XEOTICID XEO03730 MOACRIVE Inhibition DME1048 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1048 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03731 XEO_CLAS Peptide DME1048 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40 ug/ml) DME1048 XEOTICID XEO03731 GENEFORM Protein DME1048 XEOTICID XEO03731 MOACRIVE Inhibition DME1048 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1048 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03733 XEO_CLAS Peptide DME1048 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40 ug/ml) DME1048 XEOTICID XEO03733 GENEFORM Protein DME1048 XEOTICID XEO03733 MOACRIVE Inhibition DME1048 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1048 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03734 XEO_CLAS Peptide DME1048 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO03734 GENEFORM Protein DME1048 XEOTICID XEO03734 MOACRIVE Inhibition DME1048 XEOTICID XEO03735 XEO_NAME L4 peptide DME1048 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03735 XEO_CLAS Peptide DME1048 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 31.61 microM) DME1048 XEOTICID XEO03735 GENEFORM Protein DME1048 XEOTICID XEO03735 MOACRIVE Inhibition DME1048 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1048 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03738 XEO_CLAS Peptide DME1048 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 ug/ml) DME1048 XEOTICID XEO03738 GENEFORM Protein DME1048 XEOTICID XEO03738 MOACRIVE Inhibition DME1048 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1048 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03741 XEO_CLAS Peptide DME1048 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40 ug/ml) DME1048 XEOTICID XEO03741 GENEFORM Protein DME1048 XEOTICID XEO03741 MOACRIVE Inhibition DME1048 XEOTICID XEO03742 XEO_NAME L5 peptide DME1048 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03742 XEO_CLAS Peptide DME1048 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 7.79 microM) DME1048 XEOTICID XEO03742 GENEFORM Protein DME1048 XEOTICID XEO03742 MOACRIVE Inhibition DME1048 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1048 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03743 XEO_CLAS Peptide DME1048 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 ug/ml) DME1048 XEOTICID XEO03743 GENEFORM Protein DME1048 XEOTICID XEO03743 MOACRIVE Inhibition DME1048 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1048 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03744 XEO_CLAS Peptide DME1048 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 ug/ml) DME1048 XEOTICID XEO03744 GENEFORM Protein DME1048 XEOTICID XEO03744 MOACRIVE Inhibition DME1048 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1048 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03745 XEO_CLAS Peptide DME1048 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 ug/ml) DME1048 XEOTICID XEO03745 GENEFORM Protein DME1048 XEOTICID XEO03745 MOACRIVE Inhibition DME1048 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1048 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03746 XEO_CLAS Peptide DME1048 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO03746 GENEFORM Protein DME1048 XEOTICID XEO03746 MOACRIVE Inhibition DME1048 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1048 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03747 XEO_CLAS Peptide DME1048 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO03747 GENEFORM Protein DME1048 XEOTICID XEO03747 MOACRIVE Inhibition DME1048 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1048 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03748 XEO_CLAS Peptide DME1048 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO03748 GENEFORM Protein DME1048 XEOTICID XEO03748 MOACRIVE Inhibition DME1048 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1048 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03749 XEO_CLAS Peptide DME1048 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO03749 GENEFORM Protein DME1048 XEOTICID XEO03749 MOACRIVE Inhibition DME1048 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1048 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03750 XEO_CLAS Peptide DME1048 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO03750 GENEFORM Protein DME1048 XEOTICID XEO03750 MOACRIVE Inhibition DME1048 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1048 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03751 XEO_CLAS Peptide DME1048 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO03751 GENEFORM Protein DME1048 XEOTICID XEO03751 MOACRIVE Inhibition DME1048 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1048 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03752 XEO_CLAS Peptide DME1048 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO03752 GENEFORM Protein DME1048 XEOTICID XEO03752 MOACRIVE Inhibition DME1048 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1048 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03753 XEO_CLAS Peptide DME1048 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 ug/ml) DME1048 XEOTICID XEO03753 GENEFORM Protein DME1048 XEOTICID XEO03753 MOACRIVE Inhibition DME1048 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1048 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03754 XEO_CLAS Peptide DME1048 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO03754 GENEFORM Protein DME1048 XEOTICID XEO03754 MOACRIVE Inhibition DME1048 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1048 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03755 XEO_CLAS Peptide DME1048 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO03755 GENEFORM Protein DME1048 XEOTICID XEO03755 MOACRIVE Inhibition DME1048 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1048 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03756 XEO_CLAS Peptide DME1048 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO03756 GENEFORM Protein DME1048 XEOTICID XEO03756 MOACRIVE Inhibition DME1048 XEOTICID XEO03757 XEO_NAME L6 peptide DME1048 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03757 XEO_CLAS Peptide DME1048 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15.17 microM) DME1048 XEOTICID XEO03757 GENEFORM Protein DME1048 XEOTICID XEO03757 MOACRIVE Inhibition DME1048 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1048 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03758 XEO_CLAS Peptide DME1048 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 80 ug/ml) DME1048 XEOTICID XEO03758 GENEFORM Protein DME1048 XEOTICID XEO03758 MOACRIVE Inhibition DME1048 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1048 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03759 XEO_CLAS Peptide DME1048 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.3 ug/ml) DME1048 XEOTICID XEO03759 GENEFORM Protein DME1048 XEOTICID XEO03759 MOACRIVE Inhibition DME1048 XEOTICID XEO03760 XEO_NAME L7 peptide DME1048 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03760 XEO_CLAS Peptide DME1048 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16.02 microM) DME1048 XEOTICID XEO03760 GENEFORM Protein DME1048 XEOTICID XEO03760 MOACRIVE Inhibition DME1048 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1048 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03761 XEO_CLAS Peptide DME1048 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 ug/ml) DME1048 XEOTICID XEO03761 GENEFORM Protein DME1048 XEOTICID XEO03761 MOACRIVE Inhibition DME1048 XEOTICID XEO03763 XEO_NAME L8 peptide DME1048 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03763 XEO_CLAS Peptide DME1048 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.71 microM) DME1048 XEOTICID XEO03763 GENEFORM Protein DME1048 XEOTICID XEO03763 MOACRIVE Inhibition DME1048 XEOTICID XEO03765 XEO_NAME L9 peptide DME1048 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03765 XEO_CLAS Peptide DME1048 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.78 microM) DME1048 XEOTICID XEO03765 GENEFORM Protein DME1048 XEOTICID XEO03765 MOACRIVE Inhibition DME1048 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1048 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03775 XEO_CLAS Peptide DME1048 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 17.3 microM) DME1048 XEOTICID XEO03775 GENEFORM Protein DME1048 XEOTICID XEO03775 MOACRIVE Inhibition DME1048 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1048 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03776 XEO_CLAS Peptide DME1048 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03776 GENEFORM Protein DME1048 XEOTICID XEO03776 MOACRIVE Inhibition DME1048 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1048 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03781 XEO_CLAS Peptide DME1048 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.47 microM) DME1048 XEOTICID XEO03781 GENEFORM Protein DME1048 XEOTICID XEO03781 MOACRIVE Inhibition DME1048 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1048 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03782 XEO_CLAS Peptide DME1048 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.47 microM) DME1048 XEOTICID XEO03782 GENEFORM Protein DME1048 XEOTICID XEO03782 MOACRIVE Inhibition DME1048 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1048 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03783 XEO_CLAS Peptide DME1048 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.68 microM) DME1048 XEOTICID XEO03783 GENEFORM Protein DME1048 XEOTICID XEO03783 MOACRIVE Inhibition DME1048 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1048 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03784 XEO_CLAS Peptide DME1048 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.45 microM) DME1048 XEOTICID XEO03784 GENEFORM Protein DME1048 XEOTICID XEO03784 MOACRIVE Inhibition DME1048 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1048 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03785 XEO_CLAS Peptide DME1048 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.73 microM) DME1048 XEOTICID XEO03785 GENEFORM Protein DME1048 XEOTICID XEO03785 MOACRIVE Inhibition DME1048 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1048 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03786 XEO_CLAS Peptide DME1048 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.45 microM) DME1048 XEOTICID XEO03786 GENEFORM Protein DME1048 XEOTICID XEO03786 MOACRIVE Inhibition DME1048 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1048 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03787 XEO_CLAS Peptide DME1048 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.38 microM) DME1048 XEOTICID XEO03787 GENEFORM Protein DME1048 XEOTICID XEO03787 MOACRIVE Inhibition DME1048 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1048 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03788 XEO_CLAS Peptide DME1048 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.46 microM) DME1048 XEOTICID XEO03788 GENEFORM Protein DME1048 XEOTICID XEO03788 MOACRIVE Inhibition DME1048 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1048 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03789 XEO_CLAS Peptide DME1048 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 13.05 microM) DME1048 XEOTICID XEO03789 GENEFORM Protein DME1048 XEOTICID XEO03789 MOACRIVE Inhibition DME1048 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1048 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03790 XEO_CLAS Peptide DME1048 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.82 microM) DME1048 XEOTICID XEO03790 GENEFORM Protein DME1048 XEOTICID XEO03790 MOACRIVE Inhibition DME1048 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1048 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03791 XEO_CLAS Peptide DME1048 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.80 microM) DME1048 XEOTICID XEO03791 GENEFORM Protein DME1048 XEOTICID XEO03791 MOACRIVE Inhibition DME1048 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1048 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03792 XEO_CLAS Peptide DME1048 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.26 microM) DME1048 XEOTICID XEO03792 GENEFORM Protein DME1048 XEOTICID XEO03792 MOACRIVE Inhibition DME1048 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1048 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03793 XEO_CLAS Peptide DME1048 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 microM) DME1048 XEOTICID XEO03793 GENEFORM Protein DME1048 XEOTICID XEO03793 MOACRIVE Inhibition DME1048 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1048 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03797 XEO_CLAS Peptide DME1048 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.4 microM) DME1048 XEOTICID XEO03797 GENEFORM Protein DME1048 XEOTICID XEO03797 MOACRIVE Inhibition DME1048 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1048 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03798 XEO_CLAS Peptide DME1048 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03798 GENEFORM Protein DME1048 XEOTICID XEO03798 MOACRIVE Inhibition DME1048 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1048 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03799 XEO_CLAS Peptide DME1048 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03799 GENEFORM Protein DME1048 XEOTICID XEO03799 MOACRIVE Inhibition DME1048 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1048 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03810 XEO_CLAS Peptide DME1048 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03810 GENEFORM Protein DME1048 XEOTICID XEO03810 MOACRIVE Inhibition DME1048 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1048 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03846 XEO_CLAS Peptide DME1048 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03846 GENEFORM Protein DME1048 XEOTICID XEO03846 MOACRIVE Inhibition DME1048 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1048 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03847 XEO_CLAS Peptide DME1048 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03847 GENEFORM Protein DME1048 XEOTICID XEO03847 MOACRIVE Inhibition DME1048 XEOTICID XEO03850 XEO_NAME Lemon DME1048 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1048 XEOTICID XEO03850 XEO_CLAS Food Additive DME1048 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03850 GENEFORM Protein DME1048 XEOTICID XEO03850 MOACRIVE Inhibition DME1048 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1048 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03853 XEO_CLAS Peptide DME1048 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO03853 GENEFORM Protein DME1048 XEOTICID XEO03853 MOACRIVE Inhibition DME1048 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1048 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03857 XEO_CLAS Peptide DME1048 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 38.49 microM) DME1048 XEOTICID XEO03857 GENEFORM Protein DME1048 XEOTICID XEO03857 MOACRIVE Inhibition DME1048 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1048 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03860 XEO_CLAS Peptide DME1048 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 24 microM) DME1048 XEOTICID XEO03860 GENEFORM Protein DME1048 XEOTICID XEO03860 MOACRIVE Inhibition DME1048 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1048 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03861 XEO_CLAS Peptide DME1048 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 35 microM) DME1048 XEOTICID XEO03861 GENEFORM Protein DME1048 XEOTICID XEO03861 MOACRIVE Inhibition DME1048 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1048 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03862 XEO_CLAS Peptide DME1048 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 70 microM) DME1048 XEOTICID XEO03862 GENEFORM Protein DME1048 XEOTICID XEO03862 MOACRIVE Inhibition DME1048 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1048 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03863 XEO_CLAS Peptide DME1048 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 35 microM) DME1048 XEOTICID XEO03863 GENEFORM Protein DME1048 XEOTICID XEO03863 MOACRIVE Inhibition DME1048 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1048 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03864 XEO_CLAS Peptide DME1048 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO03864 GENEFORM Protein DME1048 XEOTICID XEO03864 MOACRIVE Inhibition DME1048 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1048 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03865 XEO_CLAS Peptide DME1048 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO03865 GENEFORM Protein DME1048 XEOTICID XEO03865 MOACRIVE Inhibition DME1048 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1048 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03866 XEO_CLAS Peptide DME1048 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 microM) DME1048 XEOTICID XEO03866 GENEFORM Protein DME1048 XEOTICID XEO03866 MOACRIVE Inhibition DME1048 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1048 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03867 XEO_CLAS Peptide DME1048 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40 microM) DME1048 XEOTICID XEO03867 GENEFORM Protein DME1048 XEOTICID XEO03867 MOACRIVE Inhibition DME1048 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1048 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03868 XEO_CLAS Peptide DME1048 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 51 microM) DME1048 XEOTICID XEO03868 GENEFORM Protein DME1048 XEOTICID XEO03868 MOACRIVE Inhibition DME1048 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1048 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03869 XEO_CLAS Peptide DME1048 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 35 microM) DME1048 XEOTICID XEO03869 GENEFORM Protein DME1048 XEOTICID XEO03869 MOACRIVE Inhibition DME1048 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1048 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03870 XEO_CLAS Peptide DME1048 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 61 microM) DME1048 XEOTICID XEO03870 GENEFORM Protein DME1048 XEOTICID XEO03870 MOACRIVE Inhibition DME1048 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1048 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03871 XEO_CLAS Peptide DME1048 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 microM) DME1048 XEOTICID XEO03871 GENEFORM Protein DME1048 XEOTICID XEO03871 MOACRIVE Inhibition DME1048 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1048 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03872 XEO_CLAS Peptide DME1048 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 28 microM) DME1048 XEOTICID XEO03872 GENEFORM Protein DME1048 XEOTICID XEO03872 MOACRIVE Inhibition DME1048 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1048 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03873 XEO_CLAS Peptide DME1048 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 22.5 microM) DME1048 XEOTICID XEO03873 GENEFORM Protein DME1048 XEOTICID XEO03873 MOACRIVE Inhibition DME1048 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1048 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03874 XEO_CLAS Peptide DME1048 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 11.25 microM) DME1048 XEOTICID XEO03874 GENEFORM Protein DME1048 XEOTICID XEO03874 MOACRIVE Inhibition DME1048 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1048 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03875 XEO_CLAS Peptide DME1048 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 microM) DME1048 XEOTICID XEO03875 GENEFORM Protein DME1048 XEOTICID XEO03875 MOACRIVE Inhibition DME1048 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1048 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03876 XEO_CLAS Peptide DME1048 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.75 microM) DME1048 XEOTICID XEO03876 GENEFORM Protein DME1048 XEOTICID XEO03876 MOACRIVE Inhibition DME1048 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1048 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03877 XEO_CLAS Peptide DME1048 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 microM) DME1048 XEOTICID XEO03877 GENEFORM Protein DME1048 XEOTICID XEO03877 MOACRIVE Inhibition DME1048 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1048 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03878 XEO_CLAS Peptide DME1048 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 microM) DME1048 XEOTICID XEO03878 GENEFORM Protein DME1048 XEOTICID XEO03878 MOACRIVE Inhibition DME1048 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1048 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03879 XEO_CLAS Peptide DME1048 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 252 microM) DME1048 XEOTICID XEO03879 GENEFORM Protein DME1048 XEOTICID XEO03879 MOACRIVE Inhibition DME1048 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1048 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03880 XEO_CLAS Peptide DME1048 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 174 microM) DME1048 XEOTICID XEO03880 GENEFORM Protein DME1048 XEOTICID XEO03880 MOACRIVE Inhibition DME1048 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1048 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03883 XEO_CLAS Peptide DME1048 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 74 microM) DME1048 XEOTICID XEO03883 GENEFORM Protein DME1048 XEOTICID XEO03883 MOACRIVE Inhibition DME1048 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1048 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03884 XEO_CLAS Peptide DME1048 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 31 microM) DME1048 XEOTICID XEO03884 GENEFORM Protein DME1048 XEOTICID XEO03884 MOACRIVE Inhibition DME1048 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1048 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03885 XEO_CLAS Peptide DME1048 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO03885 GENEFORM Protein DME1048 XEOTICID XEO03885 MOACRIVE Inhibition DME1048 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1048 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03886 XEO_CLAS Peptide DME1048 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 391 microM) DME1048 XEOTICID XEO03886 GENEFORM Protein DME1048 XEOTICID XEO03886 MOACRIVE Inhibition DME1048 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1048 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03887 XEO_CLAS Peptide DME1048 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 151 microM) DME1048 XEOTICID XEO03887 GENEFORM Protein DME1048 XEOTICID XEO03887 MOACRIVE Inhibition DME1048 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1048 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03888 XEO_CLAS Peptide DME1048 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 134 microM) DME1048 XEOTICID XEO03888 GENEFORM Protein DME1048 XEOTICID XEO03888 MOACRIVE Inhibition DME1048 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1048 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03889 XEO_CLAS Peptide DME1048 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 88 microM) DME1048 XEOTICID XEO03889 GENEFORM Protein DME1048 XEOTICID XEO03889 MOACRIVE Inhibition DME1048 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1048 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03890 XEO_CLAS Peptide DME1048 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 31 microM) DME1048 XEOTICID XEO03890 GENEFORM Protein DME1048 XEOTICID XEO03890 MOACRIVE Inhibition DME1048 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1048 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03891 XEO_CLAS Peptide DME1048 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 microM) DME1048 XEOTICID XEO03891 GENEFORM Protein DME1048 XEOTICID XEO03891 MOACRIVE Inhibition DME1048 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1048 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03892 XEO_CLAS Peptide DME1048 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 37 microM) DME1048 XEOTICID XEO03892 GENEFORM Protein DME1048 XEOTICID XEO03892 MOACRIVE Inhibition DME1048 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1048 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03893 XEO_CLAS Peptide DME1048 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 19 microM) DME1048 XEOTICID XEO03893 GENEFORM Protein DME1048 XEOTICID XEO03893 MOACRIVE Inhibition DME1048 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1048 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03894 XEO_CLAS Peptide DME1048 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO03894 GENEFORM Protein DME1048 XEOTICID XEO03894 MOACRIVE Inhibition DME1048 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1048 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03895 XEO_CLAS Peptide DME1048 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO03895 GENEFORM Protein DME1048 XEOTICID XEO03895 MOACRIVE Inhibition DME1048 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1048 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03896 XEO_CLAS Peptide DME1048 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 microM) DME1048 XEOTICID XEO03896 GENEFORM Protein DME1048 XEOTICID XEO03896 MOACRIVE Inhibition DME1048 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1048 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03897 XEO_CLAS Peptide DME1048 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 63 microM) DME1048 XEOTICID XEO03897 GENEFORM Protein DME1048 XEOTICID XEO03897 MOACRIVE Inhibition DME1048 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1048 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03898 XEO_CLAS Peptide DME1048 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 219 microM) DME1048 XEOTICID XEO03898 GENEFORM Protein DME1048 XEOTICID XEO03898 MOACRIVE Inhibition DME1048 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1048 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03901 XEO_CLAS Peptide DME1048 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 35 microM) DME1048 XEOTICID XEO03901 GENEFORM Protein DME1048 XEOTICID XEO03901 MOACRIVE Inhibition DME1048 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1048 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03902 XEO_CLAS Peptide DME1048 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 70 microM) DME1048 XEOTICID XEO03902 GENEFORM Protein DME1048 XEOTICID XEO03902 MOACRIVE Inhibition DME1048 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1048 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03904 XEO_CLAS Peptide DME1048 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO03904 GENEFORM Protein DME1048 XEOTICID XEO03904 MOACRIVE Inhibition DME1048 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1048 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03905 XEO_CLAS Peptide DME1048 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO03905 GENEFORM Protein DME1048 XEOTICID XEO03905 MOACRIVE Inhibition DME1048 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1048 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03908 XEO_CLAS Peptide DME1048 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03908 GENEFORM Protein DME1048 XEOTICID XEO03908 MOACRIVE Inhibition DME1048 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1048 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03915 XEO_CLAS Peptide DME1048 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03915 GENEFORM Protein DME1048 XEOTICID XEO03915 MOACRIVE Inhibition DME1048 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1048 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03916 XEO_CLAS Peptide DME1048 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.8 ug/ml) DME1048 XEOTICID XEO03916 GENEFORM Protein DME1048 XEOTICID XEO03916 MOACRIVE Inhibition DME1048 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1048 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03917 XEO_CLAS Peptide DME1048 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 13.1 ug/ml) DME1048 XEOTICID XEO03917 GENEFORM Protein DME1048 XEOTICID XEO03917 MOACRIVE Inhibition DME1048 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1048 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03918 XEO_CLAS Peptide DME1048 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.5 ug/ml) DME1048 XEOTICID XEO03918 GENEFORM Protein DME1048 XEOTICID XEO03918 MOACRIVE Inhibition DME1048 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1048 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03919 XEO_CLAS Peptide DME1048 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 80 ug/ml) DME1048 XEOTICID XEO03919 GENEFORM Protein DME1048 XEOTICID XEO03919 MOACRIVE Inhibition DME1048 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1048 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03922 XEO_CLAS Peptide DME1048 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 9 microM) DME1048 XEOTICID XEO03922 GENEFORM Protein DME1048 XEOTICID XEO03922 MOACRIVE Inhibition DME1048 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1048 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03923 XEO_CLAS Peptide DME1048 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 80 microM) DME1048 XEOTICID XEO03923 GENEFORM Protein DME1048 XEOTICID XEO03923 MOACRIVE Inhibition DME1048 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1048 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03924 XEO_CLAS Peptide DME1048 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO03924 GENEFORM Protein DME1048 XEOTICID XEO03924 MOACRIVE Inhibition DME1048 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1048 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03927 XEO_CLAS Peptide DME1048 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 80 microM) DME1048 XEOTICID XEO03927 GENEFORM Protein DME1048 XEOTICID XEO03927 MOACRIVE Inhibition DME1048 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1048 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03928 XEO_CLAS Peptide DME1048 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 microM) DME1048 XEOTICID XEO03928 GENEFORM Protein DME1048 XEOTICID XEO03928 MOACRIVE Inhibition DME1048 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1048 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03929 XEO_CLAS Peptide DME1048 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 microM) DME1048 XEOTICID XEO03929 GENEFORM Protein DME1048 XEOTICID XEO03929 MOACRIVE Inhibition DME1048 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1048 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03930 XEO_CLAS Peptide DME1048 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 microM) DME1048 XEOTICID XEO03930 GENEFORM Protein DME1048 XEOTICID XEO03930 MOACRIVE Inhibition DME1048 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1048 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03931 XEO_CLAS Peptide DME1048 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 microM) DME1048 XEOTICID XEO03931 GENEFORM Protein DME1048 XEOTICID XEO03931 MOACRIVE Inhibition DME1048 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1048 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03933 XEO_CLAS Peptide DME1048 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.5 microM) DME1048 XEOTICID XEO03933 GENEFORM Protein DME1048 XEOTICID XEO03933 MOACRIVE Inhibition DME1048 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1048 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03934 XEO_CLAS Peptide DME1048 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.7 microM) DME1048 XEOTICID XEO03934 GENEFORM Protein DME1048 XEOTICID XEO03934 MOACRIVE Inhibition DME1048 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1048 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03935 XEO_CLAS Peptide DME1048 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.7 microM) DME1048 XEOTICID XEO03935 GENEFORM Protein DME1048 XEOTICID XEO03935 MOACRIVE Inhibition DME1048 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1048 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03936 XEO_CLAS Peptide DME1048 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.0 microM) DME1048 XEOTICID XEO03936 GENEFORM Protein DME1048 XEOTICID XEO03936 MOACRIVE Inhibition DME1048 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1048 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03937 XEO_CLAS Peptide DME1048 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.1 microM) DME1048 XEOTICID XEO03937 GENEFORM Protein DME1048 XEOTICID XEO03937 MOACRIVE Inhibition DME1048 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1048 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03938 XEO_CLAS Peptide DME1048 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.7 microM) DME1048 XEOTICID XEO03938 GENEFORM Protein DME1048 XEOTICID XEO03938 MOACRIVE Inhibition DME1048 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1048 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03939 XEO_CLAS Peptide DME1048 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.7 microM) DME1048 XEOTICID XEO03939 GENEFORM Protein DME1048 XEOTICID XEO03939 MOACRIVE Inhibition DME1048 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1048 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03940 XEO_CLAS Peptide DME1048 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.5 microM) DME1048 XEOTICID XEO03940 GENEFORM Protein DME1048 XEOTICID XEO03940 MOACRIVE Inhibition DME1048 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1048 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03941 XEO_CLAS Peptide DME1048 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.4 microM) DME1048 XEOTICID XEO03941 GENEFORM Protein DME1048 XEOTICID XEO03941 MOACRIVE Inhibition DME1048 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1048 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03943 XEO_CLAS Peptide DME1048 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.4 microM) DME1048 XEOTICID XEO03943 GENEFORM Protein DME1048 XEOTICID XEO03943 MOACRIVE Inhibition DME1048 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1048 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03944 XEO_CLAS Peptide DME1048 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.7 microM) DME1048 XEOTICID XEO03944 GENEFORM Protein DME1048 XEOTICID XEO03944 MOACRIVE Inhibition DME1048 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1048 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03945 XEO_CLAS Peptide DME1048 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.2 microM) DME1048 XEOTICID XEO03945 GENEFORM Protein DME1048 XEOTICID XEO03945 MOACRIVE Inhibition DME1048 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1048 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03947 XEO_CLAS Peptide DME1048 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.0 microM) DME1048 XEOTICID XEO03947 GENEFORM Protein DME1048 XEOTICID XEO03947 MOACRIVE Inhibition DME1048 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1048 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03948 XEO_CLAS Peptide DME1048 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 23.3 microM) DME1048 XEOTICID XEO03948 GENEFORM Protein DME1048 XEOTICID XEO03948 MOACRIVE Inhibition DME1048 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1048 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03950 XEO_CLAS Peptide DME1048 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4.4 microM) DME1048 XEOTICID XEO03950 GENEFORM Protein DME1048 XEOTICID XEO03950 MOACRIVE Inhibition DME1048 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1048 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03951 XEO_CLAS Peptide DME1048 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8.8 microM) DME1048 XEOTICID XEO03951 GENEFORM Protein DME1048 XEOTICID XEO03951 MOACRIVE Inhibition DME1048 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1048 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03952 XEO_CLAS Peptide DME1048 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.2 microM) DME1048 XEOTICID XEO03952 GENEFORM Protein DME1048 XEOTICID XEO03952 MOACRIVE Inhibition DME1048 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1048 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03953 XEO_CLAS Peptide DME1048 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 microM) DME1048 XEOTICID XEO03953 GENEFORM Protein DME1048 XEOTICID XEO03953 MOACRIVE Inhibition DME1048 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1048 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03958 XEO_CLAS Peptide DME1048 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03958 GENEFORM Protein DME1048 XEOTICID XEO03958 MOACRIVE Inhibition DME1048 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1048 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03965 XEO_CLAS Peptide DME1048 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 128 microM) DME1048 XEOTICID XEO03965 GENEFORM Protein DME1048 XEOTICID XEO03965 MOACRIVE Inhibition DME1048 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1048 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03966 XEO_CLAS Peptide DME1048 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 microM) DME1048 XEOTICID XEO03966 GENEFORM Protein DME1048 XEOTICID XEO03966 MOACRIVE Inhibition DME1048 XEOTICID XEO03971 XEO_NAME Lumbrican DME1048 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03971 XEO_CLAS Peptide DME1048 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03971 GENEFORM Protein DME1048 XEOTICID XEO03971 MOACRIVE Inhibition DME1048 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1048 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03972 XEO_CLAS Peptide DME1048 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO03972 GENEFORM Protein DME1048 XEOTICID XEO03972 MOACRIVE Inhibition DME1048 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1048 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03980 XEO_CLAS Peptide DME1048 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 32 microM) DME1048 XEOTICID XEO03980 GENEFORM Protein DME1048 XEOTICID XEO03980 MOACRIVE Inhibition DME1048 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1048 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03985 XEO_CLAS Peptide DME1048 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 ug/ml) DME1048 XEOTICID XEO03985 GENEFORM Protein DME1048 XEOTICID XEO03985 MOACRIVE Inhibition DME1048 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1048 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03991 XEO_CLAS Peptide DME1048 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03991 GENEFORM Protein DME1048 XEOTICID XEO03991 MOACRIVE Inhibition DME1048 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1048 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03992 XEO_CLAS Peptide DME1048 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03992 GENEFORM Protein DME1048 XEOTICID XEO03992 MOACRIVE Inhibition DME1048 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1048 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03993 XEO_CLAS Peptide DME1048 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03993 GENEFORM Protein DME1048 XEOTICID XEO03993 MOACRIVE Inhibition DME1048 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1048 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03994 XEO_CLAS Peptide DME1048 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO03994 GENEFORM Protein DME1048 XEOTICID XEO03994 MOACRIVE Inhibition DME1048 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1048 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03996 XEO_CLAS Peptide DME1048 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 65 microM) DME1048 XEOTICID XEO03996 GENEFORM Protein DME1048 XEOTICID XEO03996 MOACRIVE Inhibition DME1048 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1048 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03997 XEO_CLAS Peptide DME1048 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 7.5 microM) DME1048 XEOTICID XEO03997 GENEFORM Protein DME1048 XEOTICID XEO03997 MOACRIVE Inhibition DME1048 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1048 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03998 XEO_CLAS Peptide DME1048 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15.5 microM) DME1048 XEOTICID XEO03998 GENEFORM Protein DME1048 XEOTICID XEO03998 MOACRIVE Inhibition DME1048 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1048 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO03999 XEO_CLAS Peptide DME1048 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25.8 microM) DME1048 XEOTICID XEO03999 GENEFORM Protein DME1048 XEOTICID XEO03999 MOACRIVE Inhibition DME1048 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1048 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04000 XEO_CLAS Peptide DME1048 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO04000 GENEFORM Protein DME1048 XEOTICID XEO04000 MOACRIVE Inhibition DME1048 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1048 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04001 XEO_CLAS Peptide DME1048 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO04001 GENEFORM Protein DME1048 XEOTICID XEO04001 MOACRIVE Inhibition DME1048 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1048 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04002 XEO_CLAS Peptide DME1048 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 7.5 ug/ml) DME1048 XEOTICID XEO04002 GENEFORM Protein DME1048 XEOTICID XEO04002 MOACRIVE Inhibition DME1048 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1048 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04003 XEO_CLAS Peptide DME1048 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 ug/ml) DME1048 XEOTICID XEO04003 GENEFORM Protein DME1048 XEOTICID XEO04003 MOACRIVE Inhibition DME1048 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1048 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04004 XEO_CLAS Peptide DME1048 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.0 ug/ml) DME1048 XEOTICID XEO04004 GENEFORM Protein DME1048 XEOTICID XEO04004 MOACRIVE Inhibition DME1048 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1048 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04005 XEO_CLAS Peptide DME1048 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.0 ug/ml) DME1048 XEOTICID XEO04005 GENEFORM Protein DME1048 XEOTICID XEO04005 MOACRIVE Inhibition DME1048 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1048 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04007 XEO_CLAS Peptide DME1048 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 19.5 ug/ml) DME1048 XEOTICID XEO04007 GENEFORM Protein DME1048 XEOTICID XEO04007 MOACRIVE Inhibition DME1048 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1048 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04011 XEO_CLAS Peptide DME1048 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 19.5 ug/ml) DME1048 XEOTICID XEO04011 GENEFORM Protein DME1048 XEOTICID XEO04011 MOACRIVE Inhibition DME1048 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1048 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04012 XEO_CLAS Peptide DME1048 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.9 ug/ml) DME1048 XEOTICID XEO04012 GENEFORM Protein DME1048 XEOTICID XEO04012 MOACRIVE Inhibition DME1048 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1048 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04013 XEO_CLAS Peptide DME1048 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.7 ug/ml) DME1048 XEOTICID XEO04013 GENEFORM Protein DME1048 XEOTICID XEO04013 MOACRIVE Inhibition DME1048 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1048 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04018 XEO_CLAS Peptide DME1048 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 9 ug/ml) DME1048 XEOTICID XEO04018 GENEFORM Protein DME1048 XEOTICID XEO04018 MOACRIVE Inhibition DME1048 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1048 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04026 XEO_CLAS Peptide DME1048 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO04026 GENEFORM Protein DME1048 XEOTICID XEO04026 MOACRIVE Inhibition DME1048 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1048 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04027 XEO_CLAS Peptide DME1048 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO04027 GENEFORM Protein DME1048 XEOTICID XEO04027 MOACRIVE Inhibition DME1048 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1048 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04028 XEO_CLAS Peptide DME1048 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 ug/ml) DME1048 XEOTICID XEO04028 GENEFORM Protein DME1048 XEOTICID XEO04028 MOACRIVE Inhibition DME1048 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1048 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04038 XEO_CLAS Peptide DME1048 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04038 GENEFORM Protein DME1048 XEOTICID XEO04038 MOACRIVE Inhibition DME1048 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1048 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04039 XEO_CLAS Peptide DME1048 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 microM) DME1048 XEOTICID XEO04039 GENEFORM Protein DME1048 XEOTICID XEO04039 MOACRIVE Inhibition DME1048 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1048 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04051 XEO_CLAS Peptide DME1048 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.31-0.63 microM) DME1048 XEOTICID XEO04051 GENEFORM Protein DME1048 XEOTICID XEO04051 MOACRIVE Inhibition DME1048 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1048 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04052 XEO_CLAS Peptide DME1048 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04052 GENEFORM Protein DME1048 XEOTICID XEO04052 MOACRIVE Inhibition DME1048 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1048 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04053 XEO_CLAS Peptide DME1048 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.08-0.16 microM) DME1048 XEOTICID XEO04053 GENEFORM Protein DME1048 XEOTICID XEO04053 MOACRIVE Inhibition DME1048 XEOTICID XEO04055 XEO_NAME Melectin DME1048 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04055 XEO_CLAS Peptide DME1048 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.0 microM) DME1048 XEOTICID XEO04055 GENEFORM Protein DME1048 XEOTICID XEO04055 MOACRIVE Inhibition DME1048 XEOTICID XEO04057 XEO_NAME Melittin DME1048 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04057 XEO_CLAS Peptide DME1048 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.8 microM) DME1048 XEOTICID XEO04057 GENEFORM Protein DME1048 XEOTICID XEO04057 MOACRIVE Inhibition DME1048 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1048 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04061 XEO_CLAS Peptide DME1048 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.9 microM) DME1048 XEOTICID XEO04061 GENEFORM Protein DME1048 XEOTICID XEO04061 MOACRIVE Inhibition DME1048 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1048 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04062 XEO_CLAS Peptide DME1048 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.5 microM) DME1048 XEOTICID XEO04062 GENEFORM Protein DME1048 XEOTICID XEO04062 MOACRIVE Inhibition DME1048 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1048 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04063 XEO_CLAS Peptide DME1048 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 7.8 microM) DME1048 XEOTICID XEO04063 GENEFORM Protein DME1048 XEOTICID XEO04063 MOACRIVE Inhibition DME1048 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1048 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04064 XEO_CLAS Peptide DME1048 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 46.7 microM) DME1048 XEOTICID XEO04064 GENEFORM Protein DME1048 XEOTICID XEO04064 MOACRIVE Inhibition DME1048 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1048 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04066 XEO_CLAS Peptide DME1048 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16.3 microM) DME1048 XEOTICID XEO04066 GENEFORM Protein DME1048 XEOTICID XEO04066 MOACRIVE Inhibition DME1048 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1048 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04067 XEO_CLAS Peptide DME1048 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.6 microM) DME1048 XEOTICID XEO04067 GENEFORM Protein DME1048 XEOTICID XEO04067 MOACRIVE Inhibition DME1048 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1048 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04068 XEO_CLAS Peptide DME1048 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.6 microM) DME1048 XEOTICID XEO04068 GENEFORM Protein DME1048 XEOTICID XEO04068 MOACRIVE Inhibition DME1048 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1048 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04086 GENEFORM Protein DME1048 XEOTICID XEO04086 MOACRIVE Inhibition DME1048 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1048 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04087 GENEFORM Protein DME1048 XEOTICID XEO04087 MOACRIVE Inhibition DME1048 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1048 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04089 GENEFORM Protein DME1048 XEOTICID XEO04089 MOACRIVE Inhibition DME1048 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1048 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04094 GENEFORM Protein DME1048 XEOTICID XEO04094 MOACRIVE Inhibition DME1048 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1048 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04096 GENEFORM Protein DME1048 XEOTICID XEO04096 MOACRIVE Inhibition DME1048 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1048 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04098 GENEFORM Protein DME1048 XEOTICID XEO04098 MOACRIVE Inhibition DME1048 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1048 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04111 XEO_CLAS Peptide DME1048 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04111 GENEFORM Protein DME1048 XEOTICID XEO04111 MOACRIVE Inhibition DME1048 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1048 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04112 XEO_CLAS Peptide DME1048 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.02 microM) DME1048 XEOTICID XEO04112 GENEFORM Protein DME1048 XEOTICID XEO04112 MOACRIVE Inhibition DME1048 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1048 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04113 XEO_CLAS Peptide DME1048 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.02 ug/ml) DME1048 XEOTICID XEO04113 GENEFORM Protein DME1048 XEOTICID XEO04113 MOACRIVE Inhibition DME1048 XEOTICID XEO04114 XEO_NAME Microcin L DME1048 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04114 XEO_CLAS Peptide DME1048 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04114 GENEFORM Protein DME1048 XEOTICID XEO04114 MOACRIVE Inhibition DME1048 XEOTICID XEO04117 XEO_NAME Misgurin DME1048 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04117 XEO_CLAS Peptide DME1048 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04117 GENEFORM Protein DME1048 XEOTICID XEO04117 MOACRIVE Inhibition DME1048 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1048 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04118 XEO_CLAS Peptide DME1048 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 300 microM) DME1048 XEOTICID XEO04118 GENEFORM Protein DME1048 XEOTICID XEO04118 MOACRIVE Inhibition DME1048 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1048 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04119 XEO_CLAS Peptide DME1048 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-20 microM) DME1048 XEOTICID XEO04119 GENEFORM Protein DME1048 XEOTICID XEO04119 MOACRIVE Inhibition DME1048 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1048 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04120 XEO_CLAS Peptide DME1048 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC < 10 microM) DME1048 XEOTICID XEO04120 GENEFORM Protein DME1048 XEOTICID XEO04120 MOACRIVE Inhibition DME1048 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1048 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04121 XEO_CLAS Peptide DME1048 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.2-6.4 microM) DME1048 XEOTICID XEO04121 GENEFORM Protein DME1048 XEOTICID XEO04121 MOACRIVE Inhibition DME1048 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1048 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04122 XEO_CLAS Peptide DME1048 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.14-6.29 microM) DME1048 XEOTICID XEO04122 GENEFORM Protein DME1048 XEOTICID XEO04122 MOACRIVE Inhibition DME1048 XEOTICID XEO04123 XEO_NAME Modified defensin DME1048 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04123 XEO_CLAS Peptide DME1048 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO04123 GENEFORM Protein DME1048 XEOTICID XEO04123 MOACRIVE Inhibition DME1048 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1048 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04128 XEO_CLAS Peptide DME1048 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.31 microM) DME1048 XEOTICID XEO04128 GENEFORM Protein DME1048 XEOTICID XEO04128 MOACRIVE Inhibition DME1048 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1048 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04129 XEO_CLAS Peptide DME1048 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO04129 GENEFORM Protein DME1048 XEOTICID XEO04129 MOACRIVE Inhibition DME1048 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1048 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04130 XEO_CLAS Peptide DME1048 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO04130 GENEFORM Protein DME1048 XEOTICID XEO04130 MOACRIVE Inhibition DME1048 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1048 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04131 XEO_CLAS Peptide DME1048 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 microM) DME1048 XEOTICID XEO04131 GENEFORM Protein DME1048 XEOTICID XEO04131 MOACRIVE Inhibition DME1048 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1048 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04132 XEO_CLAS Peptide DME1048 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 microM) DME1048 XEOTICID XEO04132 GENEFORM Protein DME1048 XEOTICID XEO04132 MOACRIVE Inhibition DME1048 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1048 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04133 XEO_CLAS Peptide DME1048 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO04133 GENEFORM Protein DME1048 XEOTICID XEO04133 MOACRIVE Inhibition DME1048 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1048 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04134 XEO_CLAS Peptide DME1048 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO04134 GENEFORM Protein DME1048 XEOTICID XEO04134 MOACRIVE Inhibition DME1048 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1048 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04135 XEO_CLAS Peptide DME1048 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 microM) DME1048 XEOTICID XEO04135 GENEFORM Protein DME1048 XEOTICID XEO04135 MOACRIVE Inhibition DME1048 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1048 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04137 XEO_CLAS Peptide DME1048 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.6 microM) DME1048 XEOTICID XEO04137 GENEFORM Protein DME1048 XEOTICID XEO04137 MOACRIVE Inhibition DME1048 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1048 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04138 XEO_CLAS Peptide DME1048 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 microM) DME1048 XEOTICID XEO04138 GENEFORM Protein DME1048 XEOTICID XEO04138 MOACRIVE Inhibition DME1048 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1048 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04139 XEO_CLAS Peptide DME1048 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 microM) DME1048 XEOTICID XEO04139 GENEFORM Protein DME1048 XEOTICID XEO04139 MOACRIVE Inhibition DME1048 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1048 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04140 XEO_CLAS Peptide DME1048 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 70 microM) DME1048 XEOTICID XEO04140 GENEFORM Protein DME1048 XEOTICID XEO04140 MOACRIVE Inhibition DME1048 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1048 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04141 XEO_CLAS Peptide DME1048 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 microM) DME1048 XEOTICID XEO04141 GENEFORM Protein DME1048 XEOTICID XEO04141 MOACRIVE Inhibition DME1048 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1048 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04142 XEO_CLAS Peptide DME1048 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8-16 microM) DME1048 XEOTICID XEO04142 GENEFORM Protein DME1048 XEOTICID XEO04142 MOACRIVE Inhibition DME1048 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1048 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04146 XEO_CLAS Peptide DME1048 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04146 GENEFORM Protein DME1048 XEOTICID XEO04146 MOACRIVE Inhibition DME1048 XEOTICID XEO04149 XEO_NAME Mucroporin DME1048 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04149 XEO_CLAS Peptide DME1048 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 ug/ml) DME1048 XEOTICID XEO04149 GENEFORM Protein DME1048 XEOTICID XEO04149 MOACRIVE Inhibition DME1048 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1048 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04158 XEO_CLAS Peptide DME1048 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO04158 GENEFORM Protein DME1048 XEOTICID XEO04158 MOACRIVE Inhibition DME1048 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1048 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04159 XEO_CLAS Peptide DME1048 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 microM) DME1048 XEOTICID XEO04159 GENEFORM Protein DME1048 XEOTICID XEO04159 MOACRIVE Inhibition DME1048 XEOTICID XEO04167 XEO_NAME Myticin-B DME1048 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04167 XEO_CLAS Peptide DME1048 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04167 GENEFORM Protein DME1048 XEOTICID XEO04167 MOACRIVE Inhibition DME1048 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1048 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04168 XEO_CLAS Peptide DME1048 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.7-12.5 microM) DME1048 XEOTICID XEO04168 GENEFORM Protein DME1048 XEOTICID XEO04168 MOACRIVE Inhibition DME1048 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1048 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04169 XEO_CLAS Peptide DME1048 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04169 GENEFORM Protein DME1048 XEOTICID XEO04169 MOACRIVE Inhibition DME1048 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1048 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04170 XEO_CLAS Peptide DME1048 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04170 GENEFORM Protein DME1048 XEOTICID XEO04170 MOACRIVE Inhibition DME1048 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1048 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04171 XEO_CLAS Peptide DME1048 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04171 GENEFORM Protein DME1048 XEOTICID XEO04171 MOACRIVE Inhibition DME1048 XEOTICID XEO04172 XEO_NAME Myxinidin DME1048 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04172 XEO_CLAS Peptide DME1048 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04172 GENEFORM Protein DME1048 XEOTICID XEO04172 MOACRIVE Inhibition DME1048 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1048 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04177 XEO_CLAS Peptide DME1048 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.7 microM) DME1048 XEOTICID XEO04177 GENEFORM Protein DME1048 XEOTICID XEO04177 MOACRIVE Inhibition DME1048 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1048 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04178 XEO_CLAS Peptide DME1048 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.7 microM) DME1048 XEOTICID XEO04178 GENEFORM Protein DME1048 XEOTICID XEO04178 MOACRIVE Inhibition DME1048 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1048 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04179 XEO_CLAS Peptide DME1048 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.5 microM) DME1048 XEOTICID XEO04179 GENEFORM Protein DME1048 XEOTICID XEO04179 MOACRIVE Inhibition DME1048 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1048 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04180 XEO_CLAS Peptide DME1048 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 23 microM) DME1048 XEOTICID XEO04180 GENEFORM Protein DME1048 XEOTICID XEO04180 MOACRIVE Inhibition DME1048 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1048 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04181 XEO_CLAS Peptide DME1048 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.2 microM) DME1048 XEOTICID XEO04181 GENEFORM Protein DME1048 XEOTICID XEO04181 MOACRIVE Inhibition DME1048 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1048 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04182 XEO_CLAS Peptide DME1048 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4.4 microM) DME1048 XEOTICID XEO04182 GENEFORM Protein DME1048 XEOTICID XEO04182 MOACRIVE Inhibition DME1048 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1048 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04183 XEO_CLAS Peptide DME1048 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.6 microM) DME1048 XEOTICID XEO04183 GENEFORM Protein DME1048 XEOTICID XEO04183 MOACRIVE Inhibition DME1048 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1048 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04184 XEO_CLAS Peptide DME1048 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 microM) DME1048 XEOTICID XEO04184 GENEFORM Protein DME1048 XEOTICID XEO04184 MOACRIVE Inhibition DME1048 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1048 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04185 XEO_CLAS Peptide DME1048 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04185 GENEFORM Protein DME1048 XEOTICID XEO04185 MOACRIVE Inhibition DME1048 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1048 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04186 XEO_CLAS Peptide DME1048 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04186 GENEFORM Protein DME1048 XEOTICID XEO04186 MOACRIVE Inhibition DME1048 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1048 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04187 XEO_CLAS Peptide DME1048 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04187 GENEFORM Protein DME1048 XEOTICID XEO04187 MOACRIVE Inhibition DME1048 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1048 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04188 XEO_CLAS Peptide DME1048 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04188 GENEFORM Protein DME1048 XEOTICID XEO04188 MOACRIVE Inhibition DME1048 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1048 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04206 XEO_CLAS Peptide DME1048 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25 microM) DME1048 XEOTICID XEO04206 GENEFORM Protein DME1048 XEOTICID XEO04206 MOACRIVE Inhibition DME1048 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1048 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04214 XEO_CLAS Peptide DME1048 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25 microM) DME1048 XEOTICID XEO04214 GENEFORM Protein DME1048 XEOTICID XEO04214 MOACRIVE Inhibition DME1048 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1048 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04216 XEO_CLAS Peptide DME1048 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO04216 GENEFORM Protein DME1048 XEOTICID XEO04216 MOACRIVE Inhibition DME1048 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1048 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04218 XEO_CLAS Peptide DME1048 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.125 microM) DME1048 XEOTICID XEO04218 GENEFORM Protein DME1048 XEOTICID XEO04218 MOACRIVE Inhibition DME1048 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1048 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04219 XEO_CLAS Peptide DME1048 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO04219 GENEFORM Protein DME1048 XEOTICID XEO04219 MOACRIVE Inhibition DME1048 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1048 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04220 XEO_CLAS Peptide DME1048 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.125 microM) DME1048 XEOTICID XEO04220 GENEFORM Protein DME1048 XEOTICID XEO04220 MOACRIVE Inhibition DME1048 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1048 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04221 XEO_CLAS Peptide DME1048 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO04221 GENEFORM Protein DME1048 XEOTICID XEO04221 MOACRIVE Inhibition DME1048 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1048 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04222 XEO_CLAS Peptide DME1048 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25 microM) DME1048 XEOTICID XEO04222 GENEFORM Protein DME1048 XEOTICID XEO04222 MOACRIVE Inhibition DME1048 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1048 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04233 XEO_CLAS Peptide DME1048 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04233 GENEFORM Protein DME1048 XEOTICID XEO04233 MOACRIVE Inhibition DME1048 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1048 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04234 XEO_CLAS Peptide DME1048 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04234 GENEFORM Protein DME1048 XEOTICID XEO04234 MOACRIVE Inhibition DME1048 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1048 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04241 XEO_CLAS Peptide DME1048 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04241 GENEFORM Protein DME1048 XEOTICID XEO04241 MOACRIVE Inhibition DME1048 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1048 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04242 XEO_CLAS Peptide DME1048 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04242 GENEFORM Protein DME1048 XEOTICID XEO04242 MOACRIVE Inhibition DME1048 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1048 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04245 XEO_CLAS Natural Product DME1048 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04245 GENEFORM Protein DME1048 XEOTICID XEO04245 MOACRIVE Inhibition DME1048 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1048 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04246 XEO_CLAS Natural Product DME1048 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04246 GENEFORM Protein DME1048 XEOTICID XEO04246 MOACRIVE Inhibition DME1048 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1048 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04249 XEO_CLAS Peptide DME1048 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 500 ug/ml) DME1048 XEOTICID XEO04249 GENEFORM Protein DME1048 XEOTICID XEO04249 MOACRIVE Inhibition DME1048 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1048 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04251 XEO_CLAS Peptide DME1048 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04251 GENEFORM Protein DME1048 XEOTICID XEO04251 MOACRIVE Inhibition DME1048 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1048 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04253 XEO_CLAS Peptide DME1048 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04253 GENEFORM Protein DME1048 XEOTICID XEO04253 MOACRIVE Inhibition DME1048 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1048 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04254 XEO_CLAS Peptide DME1048 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04254 GENEFORM Protein DME1048 XEOTICID XEO04254 MOACRIVE Inhibition DME1048 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1048 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04255 XEO_CLAS Peptide DME1048 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04255 GENEFORM Protein DME1048 XEOTICID XEO04255 MOACRIVE Inhibition DME1048 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1048 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04256 XEO_CLAS Peptide DME1048 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04256 GENEFORM Protein DME1048 XEOTICID XEO04256 MOACRIVE Inhibition DME1048 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1048 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04257 XEO_CLAS Peptide DME1048 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04257 GENEFORM Protein DME1048 XEOTICID XEO04257 MOACRIVE Inhibition DME1048 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1048 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04258 XEO_CLAS Peptide DME1048 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04258 GENEFORM Protein DME1048 XEOTICID XEO04258 MOACRIVE Inhibition DME1048 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1048 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04259 XEO_CLAS Peptide DME1048 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04259 GENEFORM Protein DME1048 XEOTICID XEO04259 MOACRIVE Inhibition DME1048 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1048 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04260 XEO_CLAS Peptide DME1048 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04260 GENEFORM Protein DME1048 XEOTICID XEO04260 MOACRIVE Inhibition DME1048 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1048 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04261 XEO_CLAS Peptide DME1048 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04261 GENEFORM Protein DME1048 XEOTICID XEO04261 MOACRIVE Inhibition DME1048 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1048 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04262 XEO_CLAS Peptide DME1048 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04262 GENEFORM Protein DME1048 XEOTICID XEO04262 MOACRIVE Inhibition DME1048 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1048 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04263 XEO_CLAS Peptide DME1048 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04263 GENEFORM Protein DME1048 XEOTICID XEO04263 MOACRIVE Inhibition DME1048 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1048 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04264 XEO_CLAS Peptide DME1048 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04264 GENEFORM Protein DME1048 XEOTICID XEO04264 MOACRIVE Inhibition DME1048 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1048 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04265 XEO_CLAS Peptide DME1048 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04265 GENEFORM Protein DME1048 XEOTICID XEO04265 MOACRIVE Inhibition DME1048 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1048 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04266 XEO_CLAS Peptide DME1048 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04266 GENEFORM Protein DME1048 XEOTICID XEO04266 MOACRIVE Inhibition DME1048 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1048 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04267 XEO_CLAS Peptide DME1048 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04267 GENEFORM Protein DME1048 XEOTICID XEO04267 MOACRIVE Inhibition DME1048 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1048 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04268 XEO_CLAS Peptide DME1048 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04268 GENEFORM Protein DME1048 XEOTICID XEO04268 MOACRIVE Inhibition DME1048 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1048 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04269 XEO_CLAS Peptide DME1048 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04269 GENEFORM Protein DME1048 XEOTICID XEO04269 MOACRIVE Inhibition DME1048 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1048 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04270 XEO_CLAS Peptide DME1048 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04270 GENEFORM Protein DME1048 XEOTICID XEO04270 MOACRIVE Inhibition DME1048 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1048 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04271 XEO_CLAS Peptide DME1048 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04271 GENEFORM Protein DME1048 XEOTICID XEO04271 MOACRIVE Inhibition DME1048 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1048 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04272 XEO_CLAS Peptide DME1048 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04272 GENEFORM Protein DME1048 XEOTICID XEO04272 MOACRIVE Inhibition DME1048 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1048 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04277 XEO_CLAS Peptide DME1048 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 110.00 ug/ml) DME1048 XEOTICID XEO04277 GENEFORM Protein DME1048 XEOTICID XEO04277 MOACRIVE Inhibition DME1048 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1048 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04280 XEO_CLAS Peptide DME1048 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 37.50 ug/ml) DME1048 XEOTICID XEO04280 GENEFORM Protein DME1048 XEOTICID XEO04280 MOACRIVE Inhibition DME1048 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1048 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04281 XEO_CLAS Peptide DME1048 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25.00 ug/ml) DME1048 XEOTICID XEO04281 GENEFORM Protein DME1048 XEOTICID XEO04281 MOACRIVE Inhibition DME1048 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1048 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04282 XEO_CLAS Peptide DME1048 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.2 ug/ml) DME1048 XEOTICID XEO04282 GENEFORM Protein DME1048 XEOTICID XEO04282 MOACRIVE Inhibition DME1048 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1048 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04283 XEO_CLAS Peptide DME1048 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.3 ug/ml) DME1048 XEOTICID XEO04283 GENEFORM Protein DME1048 XEOTICID XEO04283 MOACRIVE Inhibition DME1048 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1048 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04284 XEO_CLAS Peptide DME1048 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10.8 ug/ml) DME1048 XEOTICID XEO04284 GENEFORM Protein DME1048 XEOTICID XEO04284 MOACRIVE Inhibition DME1048 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1048 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04285 XEO_CLAS Peptide DME1048 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 11.5 ug/ml) DME1048 XEOTICID XEO04285 GENEFORM Protein DME1048 XEOTICID XEO04285 MOACRIVE Inhibition DME1048 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1048 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04286 XEO_CLAS Peptide DME1048 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8.6 ug/ml) DME1048 XEOTICID XEO04286 GENEFORM Protein DME1048 XEOTICID XEO04286 MOACRIVE Inhibition DME1048 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1048 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04287 XEO_CLAS Peptide DME1048 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10.2 ug/ml) DME1048 XEOTICID XEO04287 GENEFORM Protein DME1048 XEOTICID XEO04287 MOACRIVE Inhibition DME1048 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1048 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04288 XEO_CLAS Peptide DME1048 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4.4 ug/ml) DME1048 XEOTICID XEO04288 GENEFORM Protein DME1048 XEOTICID XEO04288 MOACRIVE Inhibition DME1048 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1048 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04289 XEO_CLAS Peptide DME1048 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.2 ug/ml) DME1048 XEOTICID XEO04289 GENEFORM Protein DME1048 XEOTICID XEO04289 MOACRIVE Inhibition DME1048 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1048 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04290 XEO_CLAS Peptide DME1048 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 11.3 ug/ml) DME1048 XEOTICID XEO04290 GENEFORM Protein DME1048 XEOTICID XEO04290 MOACRIVE Inhibition DME1048 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1048 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04291 XEO_CLAS Peptide DME1048 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 7.2 ug/ml) DME1048 XEOTICID XEO04291 GENEFORM Protein DME1048 XEOTICID XEO04291 MOACRIVE Inhibition DME1048 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1048 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04292 XEO_CLAS Peptide DME1048 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.1 ug/ml) DME1048 XEOTICID XEO04292 GENEFORM Protein DME1048 XEOTICID XEO04292 MOACRIVE Inhibition DME1048 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1048 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04293 XEO_CLAS Peptide DME1048 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO04293 GENEFORM Protein DME1048 XEOTICID XEO04293 MOACRIVE Inhibition DME1048 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1048 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04294 XEO_CLAS Peptide DME1048 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO04294 GENEFORM Protein DME1048 XEOTICID XEO04294 MOACRIVE Inhibition DME1048 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1048 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04295 XEO_CLAS Peptide DME1048 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO04295 GENEFORM Protein DME1048 XEOTICID XEO04295 MOACRIVE Inhibition DME1048 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1048 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04296 XEO_CLAS Peptide DME1048 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 28 microM) DME1048 XEOTICID XEO04296 GENEFORM Protein DME1048 XEOTICID XEO04296 MOACRIVE Inhibition DME1048 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1048 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04297 XEO_CLAS Peptide DME1048 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 14 microM) DME1048 XEOTICID XEO04297 GENEFORM Protein DME1048 XEOTICID XEO04297 MOACRIVE Inhibition DME1048 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1048 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04298 XEO_CLAS Peptide DME1048 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO04298 GENEFORM Protein DME1048 XEOTICID XEO04298 MOACRIVE Inhibition DME1048 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1048 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04299 XEO_CLAS Peptide DME1048 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO04299 GENEFORM Protein DME1048 XEOTICID XEO04299 MOACRIVE Inhibition DME1048 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1048 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04300 XEO_CLAS Peptide DME1048 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO04300 GENEFORM Protein DME1048 XEOTICID XEO04300 MOACRIVE Inhibition DME1048 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1048 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04301 XEO_CLAS Peptide DME1048 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 microM) DME1048 XEOTICID XEO04301 GENEFORM Protein DME1048 XEOTICID XEO04301 MOACRIVE Inhibition DME1048 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1048 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04302 XEO_CLAS Peptide DME1048 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 microM) DME1048 XEOTICID XEO04302 GENEFORM Protein DME1048 XEOTICID XEO04302 MOACRIVE Inhibition DME1048 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1048 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04303 XEO_CLAS Peptide DME1048 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 microM) DME1048 XEOTICID XEO04303 GENEFORM Protein DME1048 XEOTICID XEO04303 MOACRIVE Inhibition DME1048 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1048 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04304 XEO_CLAS Peptide DME1048 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO04304 GENEFORM Protein DME1048 XEOTICID XEO04304 MOACRIVE Inhibition DME1048 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1048 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04305 XEO_CLAS Peptide DME1048 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 70 microM) DME1048 XEOTICID XEO04305 GENEFORM Protein DME1048 XEOTICID XEO04305 MOACRIVE Inhibition DME1048 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1048 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04306 XEO_CLAS Peptide DME1048 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO04306 GENEFORM Protein DME1048 XEOTICID XEO04306 MOACRIVE Inhibition DME1048 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1048 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04307 XEO_CLAS Peptide DME1048 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 ug/ml) DME1048 XEOTICID XEO04307 GENEFORM Protein DME1048 XEOTICID XEO04307 MOACRIVE Inhibition DME1048 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1048 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04308 XEO_CLAS Peptide DME1048 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 9.37 ug/ml) DME1048 XEOTICID XEO04308 GENEFORM Protein DME1048 XEOTICID XEO04308 MOACRIVE Inhibition DME1048 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1048 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04309 XEO_CLAS Peptide DME1048 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 microM) DME1048 XEOTICID XEO04309 GENEFORM Protein DME1048 XEOTICID XEO04309 MOACRIVE Inhibition DME1048 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1048 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04310 XEO_CLAS Peptide DME1048 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO04310 GENEFORM Protein DME1048 XEOTICID XEO04310 MOACRIVE Inhibition DME1048 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1048 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04311 XEO_CLAS Peptide DME1048 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO04311 GENEFORM Protein DME1048 XEOTICID XEO04311 MOACRIVE Inhibition DME1048 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1048 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04312 XEO_CLAS Peptide DME1048 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4.68 ug/ml) DME1048 XEOTICID XEO04312 GENEFORM Protein DME1048 XEOTICID XEO04312 MOACRIVE Inhibition DME1048 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1048 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04313 XEO_CLAS Peptide DME1048 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4.68 ug/ml) DME1048 XEOTICID XEO04313 GENEFORM Protein DME1048 XEOTICID XEO04313 MOACRIVE Inhibition DME1048 XEOTICID XEO04331 XEO_NAME Norspermidine DME1048 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1048 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04331 GENEFORM Protein DME1048 XEOTICID XEO04331 MOACRIVE Inhibition DME1048 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1048 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04335 XEO_CLAS Peptide DME1048 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 32 ug/ml) DME1048 XEOTICID XEO04335 GENEFORM Protein DME1048 XEOTICID XEO04335 MOACRIVE Inhibition DME1048 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1048 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04336 XEO_CLAS Peptide DME1048 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 32 ug/ml) DME1048 XEOTICID XEO04336 GENEFORM Protein DME1048 XEOTICID XEO04336 MOACRIVE Inhibition DME1048 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1048 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04338 XEO_CLAS Peptide DME1048 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 ug/ml) DME1048 XEOTICID XEO04338 GENEFORM Protein DME1048 XEOTICID XEO04338 MOACRIVE Inhibition DME1048 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1048 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04339 XEO_CLAS Peptide DME1048 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 ug/ml) DME1048 XEOTICID XEO04339 GENEFORM Protein DME1048 XEOTICID XEO04339 MOACRIVE Inhibition DME1048 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1048 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04340 XEO_CLAS Peptide DME1048 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO04340 GENEFORM Protein DME1048 XEOTICID XEO04340 MOACRIVE Inhibition DME1048 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1048 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04344 XEO_CLAS Peptide DME1048 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04344 GENEFORM Protein DME1048 XEOTICID XEO04344 MOACRIVE Inhibition DME1048 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1048 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04345 XEO_CLAS Peptide DME1048 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04345 GENEFORM Protein DME1048 XEOTICID XEO04345 MOACRIVE Inhibition DME1048 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1048 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04346 XEO_CLAS Peptide DME1048 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04346 GENEFORM Protein DME1048 XEOTICID XEO04346 MOACRIVE Inhibition DME1048 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1048 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04347 XEO_CLAS Peptide DME1048 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 microM) DME1048 XEOTICID XEO04347 GENEFORM Protein DME1048 XEOTICID XEO04347 MOACRIVE Inhibition DME1048 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1048 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04348 XEO_CLAS Peptide DME1048 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40 microM) DME1048 XEOTICID XEO04348 GENEFORM Protein DME1048 XEOTICID XEO04348 MOACRIVE Inhibition DME1048 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1048 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04349 XEO_CLAS Peptide DME1048 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO04349 GENEFORM Protein DME1048 XEOTICID XEO04349 MOACRIVE Inhibition DME1048 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1048 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04354 XEO_CLAS Peptide DME1048 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 35.2 ug/ml) DME1048 XEOTICID XEO04354 GENEFORM Protein DME1048 XEOTICID XEO04354 MOACRIVE Inhibition DME1048 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1048 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04355 XEO_CLAS Peptide DME1048 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.21 ug/ml) DME1048 XEOTICID XEO04355 GENEFORM Protein DME1048 XEOTICID XEO04355 MOACRIVE Inhibition DME1048 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1048 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04356 XEO_CLAS Peptide DME1048 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8.21 ug/ml) DME1048 XEOTICID XEO04356 GENEFORM Protein DME1048 XEOTICID XEO04356 MOACRIVE Inhibition DME1048 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1048 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04357 XEO_CLAS Peptide DME1048 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16.32 ug/ml) DME1048 XEOTICID XEO04357 GENEFORM Protein DME1048 XEOTICID XEO04357 MOACRIVE Inhibition DME1048 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1048 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04358 XEO_CLAS Peptide DME1048 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 9.37 ug/ml) DME1048 XEOTICID XEO04358 GENEFORM Protein DME1048 XEOTICID XEO04358 MOACRIVE Inhibition DME1048 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1048 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04359 XEO_CLAS Peptide DME1048 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4.20 ug/ml) DME1048 XEOTICID XEO04359 GENEFORM Protein DME1048 XEOTICID XEO04359 MOACRIVE Inhibition DME1048 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1048 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04360 XEO_CLAS Peptide DME1048 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 ug/ml) DME1048 XEOTICID XEO04360 GENEFORM Protein DME1048 XEOTICID XEO04360 MOACRIVE Inhibition DME1048 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1048 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04361 XEO_CLAS Peptide DME1048 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 7.5 ug/ml) DME1048 XEOTICID XEO04361 GENEFORM Protein DME1048 XEOTICID XEO04361 MOACRIVE Inhibition DME1048 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1048 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04362 XEO_CLAS Peptide DME1048 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.6 ug/ml) DME1048 XEOTICID XEO04362 GENEFORM Protein DME1048 XEOTICID XEO04362 MOACRIVE Inhibition DME1048 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1048 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04363 XEO_CLAS Peptide DME1048 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8.2 ug/ml) DME1048 XEOTICID XEO04363 GENEFORM Protein DME1048 XEOTICID XEO04363 MOACRIVE Inhibition DME1048 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1048 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04364 XEO_CLAS Peptide DME1048 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO04364 GENEFORM Protein DME1048 XEOTICID XEO04364 MOACRIVE Inhibition DME1048 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1048 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04365 XEO_CLAS Peptide DME1048 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4.68 ug/ml) DME1048 XEOTICID XEO04365 GENEFORM Protein DME1048 XEOTICID XEO04365 MOACRIVE Inhibition DME1048 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1048 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04366 XEO_CLAS Peptide DME1048 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 23.60 ug/ml) DME1048 XEOTICID XEO04366 GENEFORM Protein DME1048 XEOTICID XEO04366 MOACRIVE Inhibition DME1048 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1048 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04367 XEO_CLAS Peptide DME1048 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 35.60 ug/ml) DME1048 XEOTICID XEO04367 GENEFORM Protein DME1048 XEOTICID XEO04367 MOACRIVE Inhibition DME1048 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1048 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04368 XEO_CLAS Peptide DME1048 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40.2 ug/ml) DME1048 XEOTICID XEO04368 GENEFORM Protein DME1048 XEOTICID XEO04368 MOACRIVE Inhibition DME1048 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1048 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04369 XEO_CLAS Peptide DME1048 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40.2 ug/ml) DME1048 XEOTICID XEO04369 GENEFORM Protein DME1048 XEOTICID XEO04369 MOACRIVE Inhibition DME1048 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1048 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04370 XEO_CLAS Peptide DME1048 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4.68 ug/ml) DME1048 XEOTICID XEO04370 GENEFORM Protein DME1048 XEOTICID XEO04370 MOACRIVE Inhibition DME1048 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1048 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04371 XEO_CLAS Peptide DME1048 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 9.37 ug/ml) DME1048 XEOTICID XEO04371 GENEFORM Protein DME1048 XEOTICID XEO04371 MOACRIVE Inhibition DME1048 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1048 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04373 XEO_CLAS Peptide DME1048 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 ug/ml) DME1048 XEOTICID XEO04373 GENEFORM Protein DME1048 XEOTICID XEO04373 MOACRIVE Inhibition DME1048 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1048 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04374 XEO_CLAS Peptide DME1048 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.50 ug/ml) DME1048 XEOTICID XEO04374 GENEFORM Protein DME1048 XEOTICID XEO04374 MOACRIVE Inhibition DME1048 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1048 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04375 XEO_CLAS Peptide DME1048 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25 ug/ml) DME1048 XEOTICID XEO04375 GENEFORM Protein DME1048 XEOTICID XEO04375 MOACRIVE Inhibition DME1048 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1048 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04377 XEO_CLAS Peptide DME1048 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 42.50 ug/ml) DME1048 XEOTICID XEO04377 GENEFORM Protein DME1048 XEOTICID XEO04377 MOACRIVE Inhibition DME1048 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1048 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04378 XEO_CLAS Peptide DME1048 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 17.50 ug/ml) DME1048 XEOTICID XEO04378 GENEFORM Protein DME1048 XEOTICID XEO04378 MOACRIVE Inhibition DME1048 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1048 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04379 XEO_CLAS Peptide DME1048 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 ug/ml) DME1048 XEOTICID XEO04379 GENEFORM Protein DME1048 XEOTICID XEO04379 MOACRIVE Inhibition DME1048 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1048 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04380 XEO_CLAS Peptide DME1048 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 36.00 ug/ml) DME1048 XEOTICID XEO04380 GENEFORM Protein DME1048 XEOTICID XEO04380 MOACRIVE Inhibition DME1048 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1048 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04381 XEO_CLAS Peptide DME1048 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.60 ug/ml) DME1048 XEOTICID XEO04381 GENEFORM Protein DME1048 XEOTICID XEO04381 MOACRIVE Inhibition DME1048 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1048 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04382 XEO_CLAS Peptide DME1048 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 ug/ml) DME1048 XEOTICID XEO04382 GENEFORM Protein DME1048 XEOTICID XEO04382 MOACRIVE Inhibition DME1048 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1048 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04383 XEO_CLAS Peptide DME1048 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO04383 GENEFORM Protein DME1048 XEOTICID XEO04383 MOACRIVE Inhibition DME1048 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1048 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04384 XEO_CLAS Peptide DME1048 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO04384 GENEFORM Protein DME1048 XEOTICID XEO04384 MOACRIVE Inhibition DME1048 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1048 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04385 XEO_CLAS Peptide DME1048 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.25 ug/ml) DME1048 XEOTICID XEO04385 GENEFORM Protein DME1048 XEOTICID XEO04385 MOACRIVE Inhibition DME1048 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1048 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04395 XEO_CLAS Peptide DME1048 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.4-0.8 microM) DME1048 XEOTICID XEO04395 GENEFORM Protein DME1048 XEOTICID XEO04395 MOACRIVE Inhibition DME1048 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1048 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04396 XEO_CLAS Peptide DME1048 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.25-0.5 microM) DME1048 XEOTICID XEO04396 GENEFORM Protein DME1048 XEOTICID XEO04396 MOACRIVE Inhibition DME1048 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1048 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04397 XEO_CLAS Peptide DME1048 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.25-0.5 microM) DME1048 XEOTICID XEO04397 GENEFORM Protein DME1048 XEOTICID XEO04397 MOACRIVE Inhibition DME1048 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1048 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04398 XEO_CLAS Peptide DME1048 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 microM) DME1048 XEOTICID XEO04398 GENEFORM Protein DME1048 XEOTICID XEO04398 MOACRIVE Inhibition DME1048 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1048 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04399 XEO_CLAS Peptide DME1048 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO04399 GENEFORM Protein DME1048 XEOTICID XEO04399 MOACRIVE Inhibition DME1048 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1048 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04400 XEO_CLAS Peptide DME1048 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 ug/ml) DME1048 XEOTICID XEO04400 GENEFORM Protein DME1048 XEOTICID XEO04400 MOACRIVE Inhibition DME1048 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1048 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04401 XEO_CLAS Peptide DME1048 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.6 ug/ml) DME1048 XEOTICID XEO04401 GENEFORM Protein DME1048 XEOTICID XEO04401 MOACRIVE Inhibition DME1048 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1048 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04402 XEO_CLAS Peptide DME1048 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 ug/ml) DME1048 XEOTICID XEO04402 GENEFORM Protein DME1048 XEOTICID XEO04402 MOACRIVE Inhibition DME1048 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1048 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04403 XEO_CLAS Peptide DME1048 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.6 ug/ml) DME1048 XEOTICID XEO04403 GENEFORM Protein DME1048 XEOTICID XEO04403 MOACRIVE Inhibition DME1048 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1048 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04404 XEO_CLAS Peptide DME1048 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.6 ug/ml) DME1048 XEOTICID XEO04404 GENEFORM Protein DME1048 XEOTICID XEO04404 MOACRIVE Inhibition DME1048 XEOTICID XEO04410 XEO_NAME Insect osmin DME1048 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04410 XEO_CLAS Peptide DME1048 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.125-1.56 microM) DME1048 XEOTICID XEO04410 GENEFORM Protein DME1048 XEOTICID XEO04410 MOACRIVE Inhibition DME1048 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1048 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04412 XEO_CLAS Peptide DME1048 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04412 GENEFORM Protein DME1048 XEOTICID XEO04412 MOACRIVE Inhibition DME1048 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1048 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04414 XEO_CLAS Peptide DME1048 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04414 GENEFORM Protein DME1048 XEOTICID XEO04414 MOACRIVE Inhibition DME1048 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1048 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04415 XEO_CLAS Peptide DME1048 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04415 GENEFORM Protein DME1048 XEOTICID XEO04415 MOACRIVE Inhibition DME1048 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1048 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04421 XEO_CLAS Peptide DME1048 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 microM) DME1048 XEOTICID XEO04421 GENEFORM Protein DME1048 XEOTICID XEO04421 MOACRIVE Inhibition DME1048 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1048 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04426 XEO_CLAS Peptide DME1048 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO04426 GENEFORM Protein DME1048 XEOTICID XEO04426 MOACRIVE Inhibition DME1048 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1048 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04428 XEO_CLAS Peptide DME1048 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.3 ug/ml) DME1048 XEOTICID XEO04428 GENEFORM Protein DME1048 XEOTICID XEO04428 MOACRIVE Inhibition DME1048 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1048 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04430 XEO_CLAS Peptide DME1048 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25 microM) DME1048 XEOTICID XEO04430 GENEFORM Protein DME1048 XEOTICID XEO04430 MOACRIVE Inhibition DME1048 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1048 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04433 XEO_CLAS Peptide DME1048 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 160 microM) DME1048 XEOTICID XEO04433 GENEFORM Protein DME1048 XEOTICID XEO04433 MOACRIVE Inhibition DME1048 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1048 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04435 XEO_CLAS Peptide DME1048 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 160 microM) DME1048 XEOTICID XEO04435 GENEFORM Protein DME1048 XEOTICID XEO04435 MOACRIVE Inhibition DME1048 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1048 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1048 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04438 GENEFORM Protein DME1048 XEOTICID XEO04438 MOACRIVE Inhibition DME1048 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1048 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04439 XEO_CLAS Peptide DME1048 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04439 GENEFORM Protein DME1048 XEOTICID XEO04439 MOACRIVE Inhibition DME1048 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1048 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04440 XEO_CLAS Peptide DME1048 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 microM) DME1048 XEOTICID XEO04440 GENEFORM Protein DME1048 XEOTICID XEO04440 MOACRIVE Inhibition DME1048 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1048 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04441 XEO_CLAS Peptide DME1048 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 28 microM) DME1048 XEOTICID XEO04441 GENEFORM Protein DME1048 XEOTICID XEO04441 MOACRIVE Inhibition DME1048 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1048 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04442 XEO_CLAS Peptide DME1048 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 28 microM) DME1048 XEOTICID XEO04442 GENEFORM Protein DME1048 XEOTICID XEO04442 MOACRIVE Inhibition DME1048 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1048 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04443 XEO_CLAS Peptide DME1048 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04443 GENEFORM Protein DME1048 XEOTICID XEO04443 MOACRIVE Inhibition DME1048 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1048 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04444 XEO_CLAS Peptide DME1048 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 13 microM) DME1048 XEOTICID XEO04444 GENEFORM Protein DME1048 XEOTICID XEO04444 MOACRIVE Inhibition DME1048 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1048 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04445 XEO_CLAS Peptide DME1048 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04445 GENEFORM Protein DME1048 XEOTICID XEO04445 MOACRIVE Inhibition DME1048 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1048 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04446 XEO_CLAS Peptide DME1048 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 78 microM) DME1048 XEOTICID XEO04446 GENEFORM Protein DME1048 XEOTICID XEO04446 MOACRIVE Inhibition DME1048 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1048 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04447 XEO_CLAS Peptide DME1048 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 120 microM) DME1048 XEOTICID XEO04447 GENEFORM Protein DME1048 XEOTICID XEO04447 MOACRIVE Inhibition DME1048 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1048 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04448 XEO_CLAS Peptide DME1048 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 microM) DME1048 XEOTICID XEO04448 GENEFORM Protein DME1048 XEOTICID XEO04448 MOACRIVE Inhibition DME1048 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1048 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04449 XEO_CLAS Peptide DME1048 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.3 microM) DME1048 XEOTICID XEO04449 GENEFORM Protein DME1048 XEOTICID XEO04449 MOACRIVE Inhibition DME1048 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1048 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04450 XEO_CLAS Peptide DME1048 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.3 microM) DME1048 XEOTICID XEO04450 GENEFORM Protein DME1048 XEOTICID XEO04450 MOACRIVE Inhibition DME1048 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1048 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04451 XEO_CLAS Peptide DME1048 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO04451 GENEFORM Protein DME1048 XEOTICID XEO04451 MOACRIVE Inhibition DME1048 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1048 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04452 XEO_CLAS Peptide DME1048 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.1 microM) DME1048 XEOTICID XEO04452 GENEFORM Protein DME1048 XEOTICID XEO04452 MOACRIVE Inhibition DME1048 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1048 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04453 XEO_CLAS Peptide DME1048 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO04453 GENEFORM Protein DME1048 XEOTICID XEO04453 MOACRIVE Inhibition DME1048 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1048 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04455 XEO_CLAS Peptide DME1048 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 microM) DME1048 XEOTICID XEO04455 GENEFORM Protein DME1048 XEOTICID XEO04455 MOACRIVE Inhibition DME1048 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1048 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04457 XEO_CLAS Peptide DME1048 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.3 microM) DME1048 XEOTICID XEO04457 GENEFORM Protein DME1048 XEOTICID XEO04457 MOACRIVE Inhibition DME1048 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1048 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04458 XEO_CLAS Peptide DME1048 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1 microM) DME1048 XEOTICID XEO04458 GENEFORM Protein DME1048 XEOTICID XEO04458 MOACRIVE Inhibition DME1048 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1048 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04459 XEO_CLAS Peptide DME1048 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1 microM) DME1048 XEOTICID XEO04459 GENEFORM Protein DME1048 XEOTICID XEO04459 MOACRIVE Inhibition DME1048 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1048 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04461 XEO_CLAS Peptide DME1048 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20.8 microM) DME1048 XEOTICID XEO04461 GENEFORM Protein DME1048 XEOTICID XEO04461 MOACRIVE Inhibition DME1048 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1048 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04462 XEO_CLAS Peptide DME1048 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 19.1 microM) DME1048 XEOTICID XEO04462 GENEFORM Protein DME1048 XEOTICID XEO04462 MOACRIVE Inhibition DME1048 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1048 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04463 XEO_CLAS Peptide DME1048 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04463 GENEFORM Protein DME1048 XEOTICID XEO04463 MOACRIVE Inhibition DME1048 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1048 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04464 XEO_CLAS Peptide DME1048 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.5 microM) DME1048 XEOTICID XEO04464 GENEFORM Protein DME1048 XEOTICID XEO04464 MOACRIVE Inhibition DME1048 XEOTICID XEO04466 XEO_NAME Panusin DME1048 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04466 XEO_CLAS Peptide DME1048 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04466 GENEFORM Protein DME1048 XEOTICID XEO04466 MOACRIVE Inhibition DME1048 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1048 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04467 XEO_CLAS Peptide DME1048 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4.8 microM) DME1048 XEOTICID XEO04467 GENEFORM Protein DME1048 XEOTICID XEO04467 MOACRIVE Inhibition DME1048 XEOTICID XEO04468 XEO_NAME Papillosin DME1048 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04468 XEO_CLAS Peptide DME1048 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04468 GENEFORM Protein DME1048 XEOTICID XEO04468 MOACRIVE Inhibition DME1048 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1048 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04471 XEO_CLAS Peptide DME1048 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.1 microM) DME1048 XEOTICID XEO04471 GENEFORM Protein DME1048 XEOTICID XEO04471 MOACRIVE Inhibition DME1048 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1048 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04480 XEO_CLAS Peptide DME1048 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 ug/ml) DME1048 XEOTICID XEO04480 GENEFORM Protein DME1048 XEOTICID XEO04480 MOACRIVE Inhibition DME1048 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1048 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1048 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04482 GENEFORM Protein DME1048 XEOTICID XEO04482 MOACRIVE Inhibition DME1048 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1048 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04484 XEO_CLAS Peptide DME1048 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 microM) DME1048 XEOTICID XEO04484 GENEFORM Protein DME1048 XEOTICID XEO04484 MOACRIVE Inhibition DME1048 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1048 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04485 XEO_CLAS Peptide DME1048 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO04485 GENEFORM Protein DME1048 XEOTICID XEO04485 MOACRIVE Inhibition DME1048 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1048 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04486 XEO_CLAS Peptide DME1048 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 microM) DME1048 XEOTICID XEO04486 GENEFORM Protein DME1048 XEOTICID XEO04486 MOACRIVE Inhibition DME1048 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1048 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04487 XEO_CLAS Peptide DME1048 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO04487 GENEFORM Protein DME1048 XEOTICID XEO04487 MOACRIVE Inhibition DME1048 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1048 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04488 XEO_CLAS Peptide DME1048 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 9 microM) DME1048 XEOTICID XEO04488 GENEFORM Protein DME1048 XEOTICID XEO04488 MOACRIVE Inhibition DME1048 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1048 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04489 XEO_CLAS Peptide DME1048 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 13 microM) DME1048 XEOTICID XEO04489 GENEFORM Protein DME1048 XEOTICID XEO04489 MOACRIVE Inhibition DME1048 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1048 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04490 XEO_CLAS Peptide DME1048 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 47.5 microM) DME1048 XEOTICID XEO04490 GENEFORM Protein DME1048 XEOTICID XEO04490 MOACRIVE Inhibition DME1048 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1048 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04491 XEO_CLAS Peptide DME1048 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO04491 GENEFORM Protein DME1048 XEOTICID XEO04491 MOACRIVE Inhibition DME1048 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1048 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04492 XEO_CLAS Peptide DME1048 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 35 microM) DME1048 XEOTICID XEO04492 GENEFORM Protein DME1048 XEOTICID XEO04492 MOACRIVE Inhibition DME1048 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1048 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04493 XEO_CLAS Peptide DME1048 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 microM) DME1048 XEOTICID XEO04493 GENEFORM Protein DME1048 XEOTICID XEO04493 MOACRIVE Inhibition DME1048 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1048 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04494 XEO_CLAS Peptide DME1048 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO04494 GENEFORM Protein DME1048 XEOTICID XEO04494 MOACRIVE Inhibition DME1048 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1048 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04495 XEO_CLAS Peptide DME1048 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO04495 GENEFORM Protein DME1048 XEOTICID XEO04495 MOACRIVE Inhibition DME1048 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1048 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04496 XEO_CLAS Peptide DME1048 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 67.5 microM) DME1048 XEOTICID XEO04496 GENEFORM Protein DME1048 XEOTICID XEO04496 MOACRIVE Inhibition DME1048 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1048 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04497 XEO_CLAS Peptide DME1048 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO04497 GENEFORM Protein DME1048 XEOTICID XEO04497 MOACRIVE Inhibition DME1048 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1048 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04498 XEO_CLAS Peptide DME1048 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO04498 GENEFORM Protein DME1048 XEOTICID XEO04498 MOACRIVE Inhibition DME1048 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1048 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04499 XEO_CLAS Peptide DME1048 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 43 microM) DME1048 XEOTICID XEO04499 GENEFORM Protein DME1048 XEOTICID XEO04499 MOACRIVE Inhibition DME1048 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1048 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04500 XEO_CLAS Peptide DME1048 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO04500 GENEFORM Protein DME1048 XEOTICID XEO04500 MOACRIVE Inhibition DME1048 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1048 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04504 XEO_CLAS Peptide DME1048 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04504 GENEFORM Protein DME1048 XEOTICID XEO04504 MOACRIVE Inhibition DME1048 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1048 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04505 XEO_CLAS Peptide DME1048 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04505 GENEFORM Protein DME1048 XEOTICID XEO04505 MOACRIVE Inhibition DME1048 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1048 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04506 XEO_CLAS Peptide DME1048 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 40 microM) DME1048 XEOTICID XEO04506 GENEFORM Protein DME1048 XEOTICID XEO04506 MOACRIVE Inhibition DME1048 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1048 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04507 XEO_CLAS Peptide DME1048 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10-20 microM) DME1048 XEOTICID XEO04507 GENEFORM Protein DME1048 XEOTICID XEO04507 MOACRIVE Inhibition DME1048 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1048 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04508 XEO_CLAS Peptide DME1048 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04508 GENEFORM Protein DME1048 XEOTICID XEO04508 MOACRIVE Inhibition DME1048 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1048 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04509 XEO_CLAS Peptide DME1048 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04509 GENEFORM Protein DME1048 XEOTICID XEO04509 MOACRIVE Inhibition DME1048 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1048 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04510 XEO_CLAS Peptide DME1048 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 22-33 microM) DME1048 XEOTICID XEO04510 GENEFORM Protein DME1048 XEOTICID XEO04510 MOACRIVE Inhibition DME1048 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1048 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04525 XEO_CLAS Peptide DME1048 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 32.0 microM) DME1048 XEOTICID XEO04525 GENEFORM Protein DME1048 XEOTICID XEO04525 MOACRIVE Inhibition DME1048 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1048 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04526 XEO_CLAS Peptide DME1048 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.0 microM) DME1048 XEOTICID XEO04526 GENEFORM Protein DME1048 XEOTICID XEO04526 MOACRIVE Inhibition DME1048 XEOTICID XEO04527 XEO_NAME Pepcon DME1048 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04527 XEO_CLAS Peptide DME1048 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO04527 GENEFORM Protein DME1048 XEOTICID XEO04527 MOACRIVE Inhibition DME1048 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1048 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04532 XEO_CLAS Peptide DME1048 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04532 GENEFORM Protein DME1048 XEOTICID XEO04532 MOACRIVE Inhibition DME1048 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1048 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04540 XEO_CLAS Peptide DME1048 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 18.1 ug/ml) DME1048 XEOTICID XEO04540 GENEFORM Protein DME1048 XEOTICID XEO04540 MOACRIVE Inhibition DME1048 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1048 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04541 XEO_CLAS Peptide DME1048 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.5 ug/ml) DME1048 XEOTICID XEO04541 GENEFORM Protein DME1048 XEOTICID XEO04541 MOACRIVE Inhibition DME1048 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1048 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04542 XEO_CLAS Peptide DME1048 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04542 GENEFORM Protein DME1048 XEOTICID XEO04542 MOACRIVE Inhibition DME1048 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1048 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04543 XEO_CLAS Peptide DME1048 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04543 GENEFORM Protein DME1048 XEOTICID XEO04543 MOACRIVE Inhibition DME1048 XEOTICID XEO04546 XEO_NAME Perinerin DME1048 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04546 XEO_CLAS Peptide DME1048 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04546 GENEFORM Protein DME1048 XEOTICID XEO04546 MOACRIVE Inhibition DME1048 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1048 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04548 XEO_CLAS Peptide DME1048 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 72000 ug/ml) DME1048 XEOTICID XEO04548 GENEFORM Protein DME1048 XEOTICID XEO04548 MOACRIVE Inhibition DME1048 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1048 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04549 XEO_CLAS Peptide DME1048 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 62-125 ug/ml) DME1048 XEOTICID XEO04549 GENEFORM Protein DME1048 XEOTICID XEO04549 MOACRIVE Inhibition DME1048 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1048 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04550 XEO_CLAS Peptide DME1048 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO04550 GENEFORM Protein DME1048 XEOTICID XEO04550 MOACRIVE Inhibition DME1048 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1048 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04551 XEO_CLAS Peptide DME1048 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 23.6 ug/ml) DME1048 XEOTICID XEO04551 GENEFORM Protein DME1048 XEOTICID XEO04551 MOACRIVE Inhibition DME1048 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1048 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04552 XEO_CLAS Peptide DME1048 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04552 GENEFORM Protein DME1048 XEOTICID XEO04552 MOACRIVE Inhibition DME1048 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1048 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04553 XEO_CLAS Peptide DME1048 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04553 GENEFORM Protein DME1048 XEOTICID XEO04553 MOACRIVE Inhibition DME1048 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1048 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04554 XEO_CLAS Peptide DME1048 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04554 GENEFORM Protein DME1048 XEOTICID XEO04554 MOACRIVE Inhibition DME1048 XEOTICID XEO04563 XEO_NAME Phosphate DME1048 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1048 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04563 GENEFORM Protein DME1048 XEOTICID XEO04563 MOACRIVE Inhibition DME1048 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1048 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04565 XEO_CLAS Peptide DME1048 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.5 microM) DME1048 XEOTICID XEO04565 GENEFORM Protein DME1048 XEOTICID XEO04565 MOACRIVE Inhibition DME1048 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1048 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04566 XEO_CLAS Peptide DME1048 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.7 microM) DME1048 XEOTICID XEO04566 GENEFORM Protein DME1048 XEOTICID XEO04566 MOACRIVE Inhibition DME1048 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1048 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04569 XEO_CLAS Peptide DME1048 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 7.9 microM) DME1048 XEOTICID XEO04569 GENEFORM Protein DME1048 XEOTICID XEO04569 MOACRIVE Inhibition DME1048 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1048 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04570 XEO_CLAS Peptide DME1048 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04570 GENEFORM Protein DME1048 XEOTICID XEO04570 MOACRIVE Inhibition DME1048 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1048 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04571 XEO_CLAS Peptide DME1048 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04571 GENEFORM Protein DME1048 XEOTICID XEO04571 MOACRIVE Inhibition DME1048 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1048 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04572 XEO_CLAS Peptide DME1048 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04572 GENEFORM Protein DME1048 XEOTICID XEO04572 MOACRIVE Inhibition DME1048 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1048 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04573 XEO_CLAS Peptide DME1048 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 microM) DME1048 XEOTICID XEO04573 GENEFORM Protein DME1048 XEOTICID XEO04573 MOACRIVE Inhibition DME1048 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1048 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04574 XEO_CLAS Peptide DME1048 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 128 ug/ml) DME1048 XEOTICID XEO04574 GENEFORM Protein DME1048 XEOTICID XEO04574 MOACRIVE Inhibition DME1048 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1048 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04575 XEO_CLAS Peptide DME1048 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO04575 GENEFORM Protein DME1048 XEOTICID XEO04575 MOACRIVE Inhibition DME1048 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1048 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04578 GENEFORM Protein DME1048 XEOTICID XEO04578 MOACRIVE Inhibition DME1048 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1048 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04579 GENEFORM Protein DME1048 XEOTICID XEO04579 MOACRIVE Inhibition DME1048 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1048 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04580 GENEFORM Protein DME1048 XEOTICID XEO04580 MOACRIVE Inhibition DME1048 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1048 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04583 GENEFORM Protein DME1048 XEOTICID XEO04583 MOACRIVE Inhibition DME1048 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1048 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04588 GENEFORM Protein DME1048 XEOTICID XEO04588 MOACRIVE Inhibition DME1048 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1048 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04589 GENEFORM Protein DME1048 XEOTICID XEO04589 MOACRIVE Inhibition DME1048 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1048 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04590 GENEFORM Protein DME1048 XEOTICID XEO04590 MOACRIVE Inhibition DME1048 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1048 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04591 GENEFORM Protein DME1048 XEOTICID XEO04591 MOACRIVE Inhibition DME1048 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1048 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04592 GENEFORM Protein DME1048 XEOTICID XEO04592 MOACRIVE Inhibition DME1048 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1048 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04593 GENEFORM Protein DME1048 XEOTICID XEO04593 MOACRIVE Inhibition DME1048 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1048 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04594 GENEFORM Protein DME1048 XEOTICID XEO04594 MOACRIVE Inhibition DME1048 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1048 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04595 GENEFORM Protein DME1048 XEOTICID XEO04595 MOACRIVE Inhibition DME1048 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1048 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04596 GENEFORM Protein DME1048 XEOTICID XEO04596 MOACRIVE Inhibition DME1048 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1048 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04597 GENEFORM Protein DME1048 XEOTICID XEO04597 MOACRIVE Inhibition DME1048 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1048 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04598 GENEFORM Protein DME1048 XEOTICID XEO04598 MOACRIVE Inhibition DME1048 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1048 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04599 GENEFORM Protein DME1048 XEOTICID XEO04599 MOACRIVE Inhibition DME1048 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1048 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04601 XEO_CLAS Peptide DME1048 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 18.75 ug/ml) DME1048 XEOTICID XEO04601 GENEFORM Protein DME1048 XEOTICID XEO04601 MOACRIVE Inhibition DME1048 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1048 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04602 XEO_CLAS Peptide DME1048 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 37.5 ug/ml) DME1048 XEOTICID XEO04602 GENEFORM Protein DME1048 XEOTICID XEO04602 MOACRIVE Inhibition DME1048 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1048 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04604 XEO_CLAS Peptide DME1048 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC < 25 microM) DME1048 XEOTICID XEO04604 GENEFORM Protein DME1048 XEOTICID XEO04604 MOACRIVE Inhibition DME1048 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1048 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04605 XEO_CLAS Peptide DME1048 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC < 6.25 microM) DME1048 XEOTICID XEO04605 GENEFORM Protein DME1048 XEOTICID XEO04605 MOACRIVE Inhibition DME1048 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1048 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04606 XEO_CLAS Peptide DME1048 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO04606 GENEFORM Protein DME1048 XEOTICID XEO04606 MOACRIVE Inhibition DME1048 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1048 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1048 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04607 GENEFORM Protein DME1048 XEOTICID XEO04607 MOACRIVE Inhibition DME1048 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1048 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04612 XEO_CLAS Peptide DME1048 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5-10 microM) DME1048 XEOTICID XEO04612 GENEFORM Protein DME1048 XEOTICID XEO04612 MOACRIVE Inhibition DME1048 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1048 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04613 XEO_CLAS Peptide DME1048 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5-10 microM) DME1048 XEOTICID XEO04613 GENEFORM Protein DME1048 XEOTICID XEO04613 MOACRIVE Inhibition DME1048 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1048 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04625 XEO_CLAS Peptide DME1048 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO04625 GENEFORM Protein DME1048 XEOTICID XEO04625 MOACRIVE Inhibition DME1048 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1048 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04626 XEO_CLAS Peptide DME1048 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO04626 GENEFORM Protein DME1048 XEOTICID XEO04626 MOACRIVE Inhibition DME1048 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1048 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04627 XEO_CLAS Peptide DME1048 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.5 microM) DME1048 XEOTICID XEO04627 GENEFORM Protein DME1048 XEOTICID XEO04627 MOACRIVE Inhibition DME1048 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1048 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04630 XEO_CLAS Peptide DME1048 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 60 ug/ml) DME1048 XEOTICID XEO04630 GENEFORM Protein DME1048 XEOTICID XEO04630 MOACRIVE Inhibition DME1048 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1048 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04631 XEO_CLAS Peptide DME1048 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 60 ug/ml) DME1048 XEOTICID XEO04631 GENEFORM Protein DME1048 XEOTICID XEO04631 MOACRIVE Inhibition DME1048 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1048 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04633 XEO_CLAS Peptide DME1048 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 ug/ml) DME1048 XEOTICID XEO04633 GENEFORM Protein DME1048 XEOTICID XEO04633 MOACRIVE Inhibition DME1048 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1048 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04634 XEO_CLAS Peptide DME1048 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 ug/ml) DME1048 XEOTICID XEO04634 GENEFORM Protein DME1048 XEOTICID XEO04634 MOACRIVE Inhibition DME1048 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1048 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04635 XEO_CLAS Peptide DME1048 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 ug/ml) DME1048 XEOTICID XEO04635 GENEFORM Protein DME1048 XEOTICID XEO04635 MOACRIVE Inhibition DME1048 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1048 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04636 XEO_CLAS Peptide DME1048 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 ug/ml) DME1048 XEOTICID XEO04636 GENEFORM Protein DME1048 XEOTICID XEO04636 MOACRIVE Inhibition DME1048 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1048 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04637 XEO_CLAS Peptide DME1048 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 ug/ml) DME1048 XEOTICID XEO04637 GENEFORM Protein DME1048 XEOTICID XEO04637 MOACRIVE Inhibition DME1048 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1048 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04638 XEO_CLAS Peptide DME1048 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 ug/ml) DME1048 XEOTICID XEO04638 GENEFORM Protein DME1048 XEOTICID XEO04638 MOACRIVE Inhibition DME1048 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1048 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04639 XEO_CLAS Peptide DME1048 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 ug/ml) DME1048 XEOTICID XEO04639 GENEFORM Protein DME1048 XEOTICID XEO04639 MOACRIVE Inhibition DME1048 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1048 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04640 XEO_CLAS Peptide DME1048 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.2-3.3 microM) DME1048 XEOTICID XEO04640 GENEFORM Protein DME1048 XEOTICID XEO04640 MOACRIVE Inhibition DME1048 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1048 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04642 XEO_CLAS Peptide DME1048 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 ug/ml) DME1048 XEOTICID XEO04642 GENEFORM Protein DME1048 XEOTICID XEO04642 MOACRIVE Inhibition DME1048 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1048 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04643 XEO_CLAS Peptide DME1048 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO04643 GENEFORM Protein DME1048 XEOTICID XEO04643 MOACRIVE Inhibition DME1048 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1048 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04644 XEO_CLAS Peptide DME1048 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO04644 GENEFORM Protein DME1048 XEOTICID XEO04644 MOACRIVE Inhibition DME1048 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1048 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04645 XEO_CLAS Peptide DME1048 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 ug/ml) DME1048 XEOTICID XEO04645 GENEFORM Protein DME1048 XEOTICID XEO04645 MOACRIVE Inhibition DME1048 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1048 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04646 XEO_CLAS Peptide DME1048 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1 ug/ml) DME1048 XEOTICID XEO04646 GENEFORM Protein DME1048 XEOTICID XEO04646 MOACRIVE Inhibition DME1048 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1048 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04647 XEO_CLAS Peptide DME1048 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO04647 GENEFORM Protein DME1048 XEOTICID XEO04647 MOACRIVE Inhibition DME1048 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1048 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04648 XEO_CLAS Peptide DME1048 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 ug/ml) DME1048 XEOTICID XEO04648 GENEFORM Protein DME1048 XEOTICID XEO04648 MOACRIVE Inhibition DME1048 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1048 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04649 XEO_CLAS Peptide DME1048 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 64 ug/ml) DME1048 XEOTICID XEO04649 GENEFORM Protein DME1048 XEOTICID XEO04649 MOACRIVE Inhibition DME1048 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1048 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04650 XEO_CLAS Peptide DME1048 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 ug/ml) DME1048 XEOTICID XEO04650 GENEFORM Protein DME1048 XEOTICID XEO04650 MOACRIVE Inhibition DME1048 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1048 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04651 XEO_CLAS Peptide DME1048 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 ug/ml) DME1048 XEOTICID XEO04651 GENEFORM Protein DME1048 XEOTICID XEO04651 MOACRIVE Inhibition DME1048 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1048 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04652 XEO_CLAS Peptide DME1048 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO04652 GENEFORM Protein DME1048 XEOTICID XEO04652 MOACRIVE Inhibition DME1048 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1048 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04653 XEO_CLAS Peptide DME1048 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 64 ug/ml) DME1048 XEOTICID XEO04653 GENEFORM Protein DME1048 XEOTICID XEO04653 MOACRIVE Inhibition DME1048 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1048 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04654 XEO_CLAS Peptide DME1048 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 ug/ml) DME1048 XEOTICID XEO04654 GENEFORM Protein DME1048 XEOTICID XEO04654 MOACRIVE Inhibition DME1048 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1048 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04655 XEO_CLAS Peptide DME1048 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO04655 GENEFORM Protein DME1048 XEOTICID XEO04655 MOACRIVE Inhibition DME1048 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1048 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04657 XEO_CLAS Peptide DME1048 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 300 microM) DME1048 XEOTICID XEO04657 GENEFORM Protein DME1048 XEOTICID XEO04657 MOACRIVE Inhibition DME1048 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1048 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04660 XEO_CLAS Peptide DME1048 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO04660 GENEFORM Protein DME1048 XEOTICID XEO04660 MOACRIVE Inhibition DME1048 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1048 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04661 XEO_CLAS Peptide DME1048 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 microM) DME1048 XEOTICID XEO04661 GENEFORM Protein DME1048 XEOTICID XEO04661 MOACRIVE Inhibition DME1048 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1048 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04662 XEO_CLAS Peptide DME1048 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 microM) DME1048 XEOTICID XEO04662 GENEFORM Protein DME1048 XEOTICID XEO04662 MOACRIVE Inhibition DME1048 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1048 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04663 XEO_CLAS Peptide DME1048 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 microM) DME1048 XEOTICID XEO04663 GENEFORM Protein DME1048 XEOTICID XEO04663 MOACRIVE Inhibition DME1048 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1048 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04664 XEO_CLAS Peptide DME1048 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5.5 microM) DME1048 XEOTICID XEO04664 GENEFORM Protein DME1048 XEOTICID XEO04664 MOACRIVE Inhibition DME1048 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1048 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04665 XEO_CLAS Peptide DME1048 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 microM) DME1048 XEOTICID XEO04665 GENEFORM Protein DME1048 XEOTICID XEO04665 MOACRIVE Inhibition DME1048 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1048 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04666 XEO_CLAS Peptide DME1048 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO04666 GENEFORM Protein DME1048 XEOTICID XEO04666 MOACRIVE Inhibition DME1048 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1048 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04667 XEO_CLAS Peptide DME1048 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6.25 microM) DME1048 XEOTICID XEO04667 GENEFORM Protein DME1048 XEOTICID XEO04667 MOACRIVE Inhibition DME1048 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1048 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04668 XEO_CLAS Peptide DME1048 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 microM) DME1048 XEOTICID XEO04668 GENEFORM Protein DME1048 XEOTICID XEO04668 MOACRIVE Inhibition DME1048 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1048 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04669 XEO_CLAS Peptide DME1048 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO04669 GENEFORM Protein DME1048 XEOTICID XEO04669 MOACRIVE Inhibition DME1048 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1048 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04670 XEO_CLAS Peptide DME1048 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 21 microM) DME1048 XEOTICID XEO04670 GENEFORM Protein DME1048 XEOTICID XEO04670 MOACRIVE Inhibition DME1048 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1048 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04671 XEO_CLAS Peptide DME1048 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 62 microM) DME1048 XEOTICID XEO04671 GENEFORM Protein DME1048 XEOTICID XEO04671 MOACRIVE Inhibition DME1048 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1048 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04672 XEO_CLAS Peptide DME1048 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO04672 GENEFORM Protein DME1048 XEOTICID XEO04672 MOACRIVE Inhibition DME1048 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1048 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04673 XEO_CLAS Peptide DME1048 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO04673 GENEFORM Protein DME1048 XEOTICID XEO04673 MOACRIVE Inhibition DME1048 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1048 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04674 XEO_CLAS Peptide DME1048 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 75 microM) DME1048 XEOTICID XEO04674 GENEFORM Protein DME1048 XEOTICID XEO04674 MOACRIVE Inhibition DME1048 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1048 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04675 XEO_CLAS Peptide DME1048 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 microM) DME1048 XEOTICID XEO04675 GENEFORM Protein DME1048 XEOTICID XEO04675 MOACRIVE Inhibition DME1048 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1048 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04676 XEO_CLAS Peptide DME1048 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 microM) DME1048 XEOTICID XEO04676 GENEFORM Protein DME1048 XEOTICID XEO04676 MOACRIVE Inhibition DME1048 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1048 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04677 XEO_CLAS Peptide DME1048 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO04677 GENEFORM Protein DME1048 XEOTICID XEO04677 MOACRIVE Inhibition DME1048 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1048 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04680 XEO_CLAS Peptide DME1048 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 microM) DME1048 XEOTICID XEO04680 GENEFORM Protein DME1048 XEOTICID XEO04680 MOACRIVE Inhibition DME1048 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1048 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04682 XEO_CLAS Peptide DME1048 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 microM) DME1048 XEOTICID XEO04682 GENEFORM Protein DME1048 XEOTICID XEO04682 MOACRIVE Inhibition DME1048 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1048 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04683 XEO_CLAS Peptide DME1048 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 microM) DME1048 XEOTICID XEO04683 GENEFORM Protein DME1048 XEOTICID XEO04683 MOACRIVE Inhibition DME1048 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1048 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04684 XEO_CLAS Peptide DME1048 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 38 microM) DME1048 XEOTICID XEO04684 GENEFORM Protein DME1048 XEOTICID XEO04684 MOACRIVE Inhibition DME1048 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1048 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04690 XEO_CLAS Peptide DME1048 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.5 ug/ml) DME1048 XEOTICID XEO04690 GENEFORM Protein DME1048 XEOTICID XEO04690 MOACRIVE Inhibition DME1048 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1048 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04695 XEO_CLAS Peptide DME1048 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04695 GENEFORM Protein DME1048 XEOTICID XEO04695 MOACRIVE Inhibition DME1048 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1048 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04696 XEO_CLAS Peptide DME1048 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04696 GENEFORM Protein DME1048 XEOTICID XEO04696 MOACRIVE Inhibition DME1048 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1048 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04712 XEO_CLAS Peptide DME1048 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16.7 microM) DME1048 XEOTICID XEO04712 GENEFORM Protein DME1048 XEOTICID XEO04712 MOACRIVE Inhibition DME1048 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1048 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04713 XEO_CLAS Peptide DME1048 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16.7 microM) DME1048 XEOTICID XEO04713 GENEFORM Protein DME1048 XEOTICID XEO04713 MOACRIVE Inhibition DME1048 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1048 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04714 XEO_CLAS Peptide DME1048 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 23.3 microM) DME1048 XEOTICID XEO04714 GENEFORM Protein DME1048 XEOTICID XEO04714 MOACRIVE Inhibition DME1048 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1048 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04716 XEO_CLAS Peptide DME1048 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 microM) DME1048 XEOTICID XEO04716 GENEFORM Protein DME1048 XEOTICID XEO04716 MOACRIVE Inhibition DME1048 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1048 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04717 XEO_CLAS Peptide DME1048 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 50 microM) DME1048 XEOTICID XEO04717 GENEFORM Protein DME1048 XEOTICID XEO04717 MOACRIVE Inhibition DME1048 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1048 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04725 XEO_CLAS Peptide DME1048 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04725 GENEFORM Protein DME1048 XEOTICID XEO04725 MOACRIVE Inhibition DME1048 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1048 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04726 XEO_CLAS Peptide DME1048 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04726 GENEFORM Protein DME1048 XEOTICID XEO04726 MOACRIVE Inhibition DME1048 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1048 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04731 XEO_CLAS Peptide DME1048 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 ug/ml) DME1048 XEOTICID XEO04731 GENEFORM Protein DME1048 XEOTICID XEO04731 MOACRIVE Inhibition DME1048 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1048 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04732 XEO_CLAS Peptide DME1048 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 25 ug/ml) DME1048 XEOTICID XEO04732 GENEFORM Protein DME1048 XEOTICID XEO04732 MOACRIVE Inhibition DME1048 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1048 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04733 XEO_CLAS Peptide DME1048 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04733 GENEFORM Protein DME1048 XEOTICID XEO04733 MOACRIVE Inhibition DME1048 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1048 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04734 XEO_CLAS Peptide DME1048 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04734 GENEFORM Protein DME1048 XEOTICID XEO04734 MOACRIVE Inhibition DME1048 XEOTICID XEO04737 XEO_NAME Protonectin DME1048 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04737 XEO_CLAS Peptide DME1048 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 ug/ml) DME1048 XEOTICID XEO04737 GENEFORM Protein DME1048 XEOTICID XEO04737 MOACRIVE Inhibition DME1048 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1048 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04739 XEO_CLAS Peptide DME1048 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04739 GENEFORM Protein DME1048 XEOTICID XEO04739 MOACRIVE Inhibition DME1048 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1048 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04740 XEO_CLAS Peptide DME1048 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04740 GENEFORM Protein DME1048 XEOTICID XEO04740 MOACRIVE Inhibition DME1048 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1048 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04741 XEO_CLAS Peptide DME1048 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04741 GENEFORM Protein DME1048 XEOTICID XEO04741 MOACRIVE Inhibition DME1048 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1048 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04742 XEO_CLAS Peptide DME1048 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04742 GENEFORM Protein DME1048 XEOTICID XEO04742 MOACRIVE Inhibition DME1048 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1048 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04762 XEO_CLAS Peptide DME1048 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.8 microM) DME1048 XEOTICID XEO04762 GENEFORM Protein DME1048 XEOTICID XEO04762 MOACRIVE Inhibition DME1048 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1048 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04766 XEO_CLAS Peptide DME1048 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.1 microM) DME1048 XEOTICID XEO04766 GENEFORM Protein DME1048 XEOTICID XEO04766 MOACRIVE Inhibition DME1048 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1048 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04767 XEO_CLAS Peptide DME1048 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.1 ug/ml) DME1048 XEOTICID XEO04767 GENEFORM Protein DME1048 XEOTICID XEO04767 MOACRIVE Inhibition DME1048 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1048 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04779 XEO_CLAS Peptide DME1048 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04779 GENEFORM Protein DME1048 XEOTICID XEO04779 MOACRIVE Inhibition DME1048 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1048 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04780 XEO_CLAS Peptide DME1048 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04780 GENEFORM Protein DME1048 XEOTICID XEO04780 MOACRIVE Inhibition DME1048 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1048 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04781 XEO_CLAS Peptide DME1048 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04781 GENEFORM Protein DME1048 XEOTICID XEO04781 MOACRIVE Inhibition DME1048 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1048 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04782 XEO_CLAS Peptide DME1048 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 ug/ml) DME1048 XEOTICID XEO04782 GENEFORM Protein DME1048 XEOTICID XEO04782 MOACRIVE Inhibition DME1048 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1048 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04783 XEO_CLAS Peptide DME1048 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO04783 GENEFORM Protein DME1048 XEOTICID XEO04783 MOACRIVE Inhibition DME1048 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1048 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04784 XEO_CLAS Peptide DME1048 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO04784 GENEFORM Protein DME1048 XEOTICID XEO04784 MOACRIVE Inhibition DME1048 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1048 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04785 XEO_CLAS Peptide DME1048 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO04785 GENEFORM Protein DME1048 XEOTICID XEO04785 MOACRIVE Inhibition DME1048 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1048 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04786 XEO_CLAS Peptide DME1048 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 ug/ml) DME1048 XEOTICID XEO04786 GENEFORM Protein DME1048 XEOTICID XEO04786 MOACRIVE Inhibition DME1048 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1048 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04787 XEO_CLAS Peptide DME1048 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04787 GENEFORM Protein DME1048 XEOTICID XEO04787 MOACRIVE Inhibition DME1048 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1048 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04793 XEO_CLAS Peptide DME1048 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04793 GENEFORM Protein DME1048 XEOTICID XEO04793 MOACRIVE Inhibition DME1048 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1048 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04798 XEO_CLAS Peptide DME1048 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 microM) DME1048 XEOTICID XEO04798 GENEFORM Protein DME1048 XEOTICID XEO04798 MOACRIVE Inhibition DME1048 XEOTICID XEO04799 XEO_NAME Ranalexin DME1048 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04799 XEO_CLAS Peptide DME1048 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 32 ug/ml) DME1048 XEOTICID XEO04799 GENEFORM Protein DME1048 XEOTICID XEO04799 MOACRIVE Inhibition DME1048 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1048 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04800 XEO_CLAS Peptide DME1048 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 microM) DME1048 XEOTICID XEO04800 GENEFORM Protein DME1048 XEOTICID XEO04800 MOACRIVE Inhibition DME1048 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1048 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04801 XEO_CLAS Peptide DME1048 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 9 microM) DME1048 XEOTICID XEO04801 GENEFORM Protein DME1048 XEOTICID XEO04801 MOACRIVE Inhibition DME1048 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1048 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04802 XEO_CLAS Peptide DME1048 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12 microM) DME1048 XEOTICID XEO04802 GENEFORM Protein DME1048 XEOTICID XEO04802 MOACRIVE Inhibition DME1048 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1048 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04803 XEO_CLAS Peptide DME1048 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO04803 GENEFORM Protein DME1048 XEOTICID XEO04803 MOACRIVE Inhibition DME1048 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1048 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04804 XEO_CLAS Peptide DME1048 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO04804 GENEFORM Protein DME1048 XEOTICID XEO04804 MOACRIVE Inhibition DME1048 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1048 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04805 XEO_CLAS Peptide DME1048 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.5 microM) DME1048 XEOTICID XEO04805 GENEFORM Protein DME1048 XEOTICID XEO04805 MOACRIVE Inhibition DME1048 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1048 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04806 XEO_CLAS Peptide DME1048 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.5 microM) DME1048 XEOTICID XEO04806 GENEFORM Protein DME1048 XEOTICID XEO04806 MOACRIVE Inhibition DME1048 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1048 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04807 XEO_CLAS Peptide DME1048 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04807 GENEFORM Protein DME1048 XEOTICID XEO04807 MOACRIVE Inhibition DME1048 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1048 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04809 XEO_CLAS Peptide DME1048 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 microM) DME1048 XEOTICID XEO04809 GENEFORM Protein DME1048 XEOTICID XEO04809 MOACRIVE Inhibition DME1048 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1048 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04811 XEO_CLAS Peptide DME1048 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO04811 GENEFORM Protein DME1048 XEOTICID XEO04811 MOACRIVE Inhibition DME1048 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1048 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04812 XEO_CLAS Peptide DME1048 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO04812 GENEFORM Protein DME1048 XEOTICID XEO04812 MOACRIVE Inhibition DME1048 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1048 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04813 XEO_CLAS Peptide DME1048 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 microM) DME1048 XEOTICID XEO04813 GENEFORM Protein DME1048 XEOTICID XEO04813 MOACRIVE Inhibition DME1048 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1048 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04814 XEO_CLAS Peptide DME1048 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 19 microM) DME1048 XEOTICID XEO04814 GENEFORM Protein DME1048 XEOTICID XEO04814 MOACRIVE Inhibition DME1048 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1048 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04815 XEO_CLAS Peptide DME1048 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 microM) DME1048 XEOTICID XEO04815 GENEFORM Protein DME1048 XEOTICID XEO04815 MOACRIVE Inhibition DME1048 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1048 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04816 XEO_CLAS Peptide DME1048 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 microM) DME1048 XEOTICID XEO04816 GENEFORM Protein DME1048 XEOTICID XEO04816 MOACRIVE Inhibition DME1048 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1048 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04817 XEO_CLAS Peptide DME1048 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 13 microM) DME1048 XEOTICID XEO04817 GENEFORM Protein DME1048 XEOTICID XEO04817 MOACRIVE Inhibition DME1048 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1048 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04818 XEO_CLAS Peptide DME1048 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO04818 GENEFORM Protein DME1048 XEOTICID XEO04818 MOACRIVE Inhibition DME1048 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1048 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04819 XEO_CLAS Peptide DME1048 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO04819 GENEFORM Protein DME1048 XEOTICID XEO04819 MOACRIVE Inhibition DME1048 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1048 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04820 XEO_CLAS Peptide DME1048 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3 microM) DME1048 XEOTICID XEO04820 GENEFORM Protein DME1048 XEOTICID XEO04820 MOACRIVE Inhibition DME1048 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1048 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04821 XEO_CLAS Peptide DME1048 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 microM) DME1048 XEOTICID XEO04821 GENEFORM Protein DME1048 XEOTICID XEO04821 MOACRIVE Inhibition DME1048 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1048 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04822 XEO_CLAS Peptide DME1048 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO04822 GENEFORM Protein DME1048 XEOTICID XEO04822 MOACRIVE Inhibition DME1048 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1048 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04823 XEO_CLAS Peptide DME1048 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 23 microM) DME1048 XEOTICID XEO04823 GENEFORM Protein DME1048 XEOTICID XEO04823 MOACRIVE Inhibition DME1048 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1048 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04824 XEO_CLAS Peptide DME1048 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04824 GENEFORM Protein DME1048 XEOTICID XEO04824 MOACRIVE Inhibition DME1048 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1048 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04825 XEO_CLAS Peptide DME1048 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04825 GENEFORM Protein DME1048 XEOTICID XEO04825 MOACRIVE Inhibition DME1048 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1048 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04826 XEO_CLAS Peptide DME1048 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO04826 GENEFORM Protein DME1048 XEOTICID XEO04826 MOACRIVE Inhibition DME1048 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1048 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04827 XEO_CLAS Peptide DME1048 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO04827 GENEFORM Protein DME1048 XEOTICID XEO04827 MOACRIVE Inhibition DME1048 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1048 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04835 XEO_CLAS Peptide DME1048 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04835 GENEFORM Protein DME1048 XEOTICID XEO04835 MOACRIVE Inhibition DME1048 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1048 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04836 XEO_CLAS Peptide DME1048 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04836 GENEFORM Protein DME1048 XEOTICID XEO04836 MOACRIVE Inhibition DME1048 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1048 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04837 XEO_CLAS Peptide DME1048 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 microM) DME1048 XEOTICID XEO04837 GENEFORM Protein DME1048 XEOTICID XEO04837 MOACRIVE Inhibition DME1048 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1048 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04839 XEO_CLAS Peptide DME1048 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04839 GENEFORM Protein DME1048 XEOTICID XEO04839 MOACRIVE Inhibition DME1048 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1048 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04840 XEO_CLAS Peptide DME1048 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 35-20 microM) DME1048 XEOTICID XEO04840 GENEFORM Protein DME1048 XEOTICID XEO04840 MOACRIVE Inhibition DME1048 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1048 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04847 XEO_CLAS Peptide DME1048 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04847 GENEFORM Protein DME1048 XEOTICID XEO04847 MOACRIVE Inhibition DME1048 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1048 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04848 XEO_CLAS Peptide DME1048 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04848 GENEFORM Protein DME1048 XEOTICID XEO04848 MOACRIVE Inhibition DME1048 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1048 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04849 XEO_CLAS Peptide DME1048 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04849 GENEFORM Protein DME1048 XEOTICID XEO04849 MOACRIVE Inhibition DME1048 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1048 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04850 XEO_CLAS Peptide DME1048 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04850 GENEFORM Protein DME1048 XEOTICID XEO04850 MOACRIVE Inhibition DME1048 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1048 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04851 XEO_CLAS Peptide DME1048 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1 ug/ml) DME1048 XEOTICID XEO04851 GENEFORM Protein DME1048 XEOTICID XEO04851 MOACRIVE Inhibition DME1048 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1048 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04857 XEO_CLAS Peptide DME1048 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 microM) DME1048 XEOTICID XEO04857 GENEFORM Protein DME1048 XEOTICID XEO04857 MOACRIVE Inhibition DME1048 XEOTICID XEO04863 XEO_NAME RTD peptide DME1048 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04863 XEO_CLAS Peptide DME1048 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.0 microM) DME1048 XEOTICID XEO04863 GENEFORM Protein DME1048 XEOTICID XEO04863 MOACRIVE Inhibition DME1048 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1048 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04865 XEO_CLAS Peptide DME1048 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 ug/ml) DME1048 XEOTICID XEO04865 GENEFORM Protein DME1048 XEOTICID XEO04865 MOACRIVE Inhibition DME1048 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1048 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04866 XEO_CLAS Peptide DME1048 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12.5 ug/ml) DME1048 XEOTICID XEO04866 GENEFORM Protein DME1048 XEOTICID XEO04866 MOACRIVE Inhibition DME1048 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1048 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04868 XEO_CLAS Peptide DME1048 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25.00 ug/ml) DME1048 XEOTICID XEO04868 GENEFORM Protein DME1048 XEOTICID XEO04868 MOACRIVE Inhibition DME1048 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1048 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04869 XEO_CLAS Peptide DME1048 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25.00 ug/ml) DME1048 XEOTICID XEO04869 GENEFORM Protein DME1048 XEOTICID XEO04869 MOACRIVE Inhibition DME1048 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1048 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04870 XEO_CLAS Peptide DME1048 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25.00 ug/ml) DME1048 XEOTICID XEO04870 GENEFORM Protein DME1048 XEOTICID XEO04870 MOACRIVE Inhibition DME1048 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1048 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04877 XEO_CLAS Peptide DME1048 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04877 GENEFORM Protein DME1048 XEOTICID XEO04877 MOACRIVE Inhibition DME1048 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1048 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04880 XEO_CLAS Peptide DME1048 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.5 ug/ml) DME1048 XEOTICID XEO04880 GENEFORM Protein DME1048 XEOTICID XEO04880 MOACRIVE Inhibition DME1048 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1048 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04886 XEO_CLAS Peptide DME1048 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.6 ug/ml) DME1048 XEOTICID XEO04886 GENEFORM Protein DME1048 XEOTICID XEO04886 MOACRIVE Inhibition DME1048 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1048 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04891 XEO_CLAS Peptide DME1048 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04891 GENEFORM Protein DME1048 XEOTICID XEO04891 MOACRIVE Inhibition DME1048 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1048 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04895 XEO_CLAS Peptide DME1048 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04895 GENEFORM Protein DME1048 XEOTICID XEO04895 MOACRIVE Inhibition DME1048 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1048 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04901 XEO_CLAS Peptide DME1048 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 microM) DME1048 XEOTICID XEO04901 GENEFORM Protein DME1048 XEOTICID XEO04901 MOACRIVE Inhibition DME1048 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1048 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04904 XEO_CLAS Peptide DME1048 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 78 ug/ml) DME1048 XEOTICID XEO04904 GENEFORM Protein DME1048 XEOTICID XEO04904 MOACRIVE Inhibition DME1048 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1048 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04905 XEO_CLAS Peptide DME1048 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04905 GENEFORM Protein DME1048 XEOTICID XEO04905 MOACRIVE Inhibition DME1048 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1048 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04906 XEO_CLAS Peptide DME1048 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04906 GENEFORM Protein DME1048 XEOTICID XEO04906 MOACRIVE Inhibition DME1048 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1048 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04907 XEO_CLAS Peptide DME1048 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04907 GENEFORM Protein DME1048 XEOTICID XEO04907 MOACRIVE Inhibition DME1048 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1048 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04908 XEO_CLAS Peptide DME1048 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04908 GENEFORM Protein DME1048 XEOTICID XEO04908 MOACRIVE Inhibition DME1048 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1048 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04909 XEO_CLAS Peptide DME1048 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04909 GENEFORM Protein DME1048 XEOTICID XEO04909 MOACRIVE Inhibition DME1048 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1048 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04915 XEO_CLAS Peptide DME1048 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 100 ug/ml) DME1048 XEOTICID XEO04915 GENEFORM Protein DME1048 XEOTICID XEO04915 MOACRIVE Inhibition DME1048 XEOTICID XEO04916 XEO_NAME Scopoletin DME1048 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1048 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04916 GENEFORM Protein DME1048 XEOTICID XEO04916 MOACRIVE Inhibition DME1048 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1048 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04926 XEO_CLAS Peptide DME1048 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04926 GENEFORM Protein DME1048 XEOTICID XEO04926 MOACRIVE Inhibition DME1048 XEOTICID XEO04931 XEO_NAME Shepherin I DME1048 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04931 XEO_CLAS Peptide DME1048 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04931 GENEFORM Protein DME1048 XEOTICID XEO04931 MOACRIVE Inhibition DME1048 XEOTICID XEO04932 XEO_NAME shepherin II DME1048 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04932 XEO_CLAS Peptide DME1048 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04932 GENEFORM Protein DME1048 XEOTICID XEO04932 MOACRIVE Inhibition DME1048 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1048 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04938 XEO_CLAS Peptide DME1048 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC <= 100 microM) DME1048 XEOTICID XEO04938 GENEFORM Protein DME1048 XEOTICID XEO04938 MOACRIVE Inhibition DME1048 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1048 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04947 XEO_CLAS Natural Product DME1048 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04947 GENEFORM Protein DME1048 XEOTICID XEO04947 MOACRIVE Inhibition DME1048 XEOTICID XEO04948 XEO_NAME Sinensetin DME1048 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1048 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1048 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04948 GENEFORM Protein DME1048 XEOTICID XEO04948 MOACRIVE Inhibition DME1048 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1048 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04950 XEO_CLAS Peptide DME1048 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 ug/ml) DME1048 XEOTICID XEO04950 GENEFORM Protein DME1048 XEOTICID XEO04950 MOACRIVE Inhibition DME1048 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1048 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04955 XEO_CLAS Peptide DME1048 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.07 microM) DME1048 XEOTICID XEO04955 GENEFORM Protein DME1048 XEOTICID XEO04955 MOACRIVE Inhibition DME1048 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1048 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04956 XEO_CLAS Peptide DME1048 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16.0 microM) DME1048 XEOTICID XEO04956 GENEFORM Protein DME1048 XEOTICID XEO04956 MOACRIVE Inhibition DME1048 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1048 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04957 XEO_CLAS Peptide DME1048 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.23 microM) DME1048 XEOTICID XEO04957 GENEFORM Protein DME1048 XEOTICID XEO04957 MOACRIVE Inhibition DME1048 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1048 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04958 XEO_CLAS Peptide DME1048 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 ug/ml) DME1048 XEOTICID XEO04958 GENEFORM Protein DME1048 XEOTICID XEO04958 MOACRIVE Inhibition DME1048 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1048 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04959 XEO_CLAS Peptide DME1048 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04959 GENEFORM Protein DME1048 XEOTICID XEO04959 MOACRIVE Inhibition DME1048 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1048 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04967 XEO_CLAS Peptide DME1048 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 28 microM) DME1048 XEOTICID XEO04967 GENEFORM Protein DME1048 XEOTICID XEO04967 MOACRIVE Inhibition DME1048 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1048 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04969 XEO_CLAS Peptide DME1048 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50-100 ug/ml) DME1048 XEOTICID XEO04969 GENEFORM Protein DME1048 XEOTICID XEO04969 MOACRIVE Inhibition DME1048 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1048 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04970 XEO_CLAS Peptide DME1048 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04970 GENEFORM Protein DME1048 XEOTICID XEO04970 MOACRIVE Inhibition DME1048 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1048 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04971 XEO_CLAS Peptide DME1048 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.8-1.5 microM) DME1048 XEOTICID XEO04971 GENEFORM Protein DME1048 XEOTICID XEO04971 MOACRIVE Inhibition DME1048 XEOTICID XEO04974 XEO_NAME Spinigerin DME1048 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04974 XEO_CLAS Peptide DME1048 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3-6 microM) DME1048 XEOTICID XEO04974 GENEFORM Protein DME1048 XEOTICID XEO04974 MOACRIVE Inhibition DME1048 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1048 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1048 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04975 GENEFORM Protein DME1048 XEOTICID XEO04975 MOACRIVE Inhibition DME1048 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1048 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1048 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04976 GENEFORM Protein DME1048 XEOTICID XEO04976 MOACRIVE Inhibition DME1048 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1048 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1048 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04977 GENEFORM Protein DME1048 XEOTICID XEO04977 MOACRIVE Inhibition DME1048 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1048 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1048 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04978 GENEFORM Protein DME1048 XEOTICID XEO04978 MOACRIVE Inhibition DME1048 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1048 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1048 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04979 GENEFORM Protein DME1048 XEOTICID XEO04979 MOACRIVE Inhibition DME1048 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1048 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04981 XEO_CLAS Peptide DME1048 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10.1 microM) DME1048 XEOTICID XEO04981 GENEFORM Protein DME1048 XEOTICID XEO04981 MOACRIVE Inhibition DME1048 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1048 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04982 XEO_CLAS Peptide DME1048 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40.5 microM) DME1048 XEOTICID XEO04982 GENEFORM Protein DME1048 XEOTICID XEO04982 MOACRIVE Inhibition DME1048 XEOTICID XEO04994 XEO_NAME Stilbene DME1048 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1048 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1048 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO04994 GENEFORM Protein DME1048 XEOTICID XEO04994 MOACRIVE Inhibition DME1048 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1048 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04995 XEO_CLAS Peptide DME1048 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC < 0.19 microM) DME1048 XEOTICID XEO04995 GENEFORM Protein DME1048 XEOTICID XEO04995 MOACRIVE Inhibition DME1048 XEOTICID XEO04998 XEO_NAME Styelin A DME1048 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04998 XEO_CLAS Peptide DME1048 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.7 ug/ml) DME1048 XEOTICID XEO04998 GENEFORM Protein DME1048 XEOTICID XEO04998 MOACRIVE Inhibition DME1048 XEOTICID XEO04999 XEO_NAME Styelin B DME1048 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO04999 XEO_CLAS Peptide DME1048 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.7 ug/ml) DME1048 XEOTICID XEO04999 GENEFORM Protein DME1048 XEOTICID XEO04999 MOACRIVE Inhibition DME1048 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1048 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05000 XEO_CLAS Peptide DME1048 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO05000 GENEFORM Protein DME1048 XEOTICID XEO05000 MOACRIVE Inhibition DME1048 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1048 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05001 XEO_CLAS Peptide DME1048 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.5 ug/ml) DME1048 XEOTICID XEO05001 GENEFORM Protein DME1048 XEOTICID XEO05001 MOACRIVE Inhibition DME1048 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1048 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05002 XEO_CLAS Peptide DME1048 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO05002 GENEFORM Protein DME1048 XEOTICID XEO05002 MOACRIVE Inhibition DME1048 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1048 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05003 XEO_CLAS Peptide DME1048 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO05003 GENEFORM Protein DME1048 XEOTICID XEO05003 MOACRIVE Inhibition DME1048 XEOTICID XEO05006 XEO_NAME Substance P DME1048 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05006 XEO_CLAS Peptide DME1048 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05006 GENEFORM Protein DME1048 XEOTICID XEO05006 MOACRIVE Inhibition DME1048 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1048 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05007 XEO_CLAS Peptide DME1048 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05007 GENEFORM Protein DME1048 XEOTICID XEO05007 MOACRIVE Inhibition DME1048 XEOTICID XEO05008 XEO_NAME Subtilosin DME1048 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05008 XEO_CLAS Peptide DME1048 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05008 GENEFORM Protein DME1048 XEOTICID XEO05008 MOACRIVE Inhibition DME1048 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1048 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05013 XEO_CLAS Peptide DME1048 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO05013 GENEFORM Protein DME1048 XEOTICID XEO05013 MOACRIVE Inhibition DME1048 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1048 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05014 XEO_CLAS Peptide DME1048 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO05014 GENEFORM Protein DME1048 XEOTICID XEO05014 MOACRIVE Inhibition DME1048 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1048 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05015 XEO_CLAS Peptide DME1048 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO05015 GENEFORM Protein DME1048 XEOTICID XEO05015 MOACRIVE Inhibition DME1048 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1048 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05016 XEO_CLAS Peptide DME1048 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO05016 GENEFORM Protein DME1048 XEOTICID XEO05016 MOACRIVE Inhibition DME1048 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1048 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05017 XEO_CLAS Peptide DME1048 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 20 ug/ml) DME1048 XEOTICID XEO05017 GENEFORM Protein DME1048 XEOTICID XEO05017 MOACRIVE Inhibition DME1048 XEOTICID XEO05018 XEO_NAME Syringic acid DME1048 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1048 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05018 GENEFORM Protein DME1048 XEOTICID XEO05018 MOACRIVE Inhibition DME1048 XEOTICID XEO05020 XEO_NAME Tachycitin DME1048 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05020 XEO_CLAS Peptide DME1048 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05020 GENEFORM Protein DME1048 XEOTICID XEO05020 MOACRIVE Inhibition DME1048 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1048 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05023 XEO_CLAS Peptide DME1048 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05023 GENEFORM Protein DME1048 XEOTICID XEO05023 MOACRIVE Inhibition DME1048 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1048 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05024 XEO_CLAS Peptide DME1048 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05024 GENEFORM Protein DME1048 XEOTICID XEO05024 MOACRIVE Inhibition DME1048 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1048 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05027 XEO_CLAS Peptide DME1048 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05027 GENEFORM Protein DME1048 XEOTICID XEO05027 MOACRIVE Inhibition DME1048 XEOTICID XEO05031 XEO_NAME Tannic acid DME1048 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1048 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05031 GENEFORM Protein DME1048 XEOTICID XEO05031 MOACRIVE Inhibition DME1048 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1048 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05033 XEO_CLAS Peptide DME1048 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05033 GENEFORM Protein DME1048 XEOTICID XEO05033 MOACRIVE Inhibition DME1048 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1048 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05042 XEO_CLAS Peptide DME1048 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO05042 GENEFORM Protein DME1048 XEOTICID XEO05042 MOACRIVE Inhibition DME1048 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1048 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05043 XEO_CLAS Peptide DME1048 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO05043 GENEFORM Protein DME1048 XEOTICID XEO05043 MOACRIVE Inhibition DME1048 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1048 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05044 XEO_CLAS Peptide DME1048 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 128 microM) DME1048 XEOTICID XEO05044 GENEFORM Protein DME1048 XEOTICID XEO05044 MOACRIVE Inhibition DME1048 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1048 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05045 XEO_CLAS Peptide DME1048 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 128 microM) DME1048 XEOTICID XEO05045 GENEFORM Protein DME1048 XEOTICID XEO05045 MOACRIVE Inhibition DME1048 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1048 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05046 XEO_CLAS Peptide DME1048 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 microM) DME1048 XEOTICID XEO05046 GENEFORM Protein DME1048 XEOTICID XEO05046 MOACRIVE Inhibition DME1048 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1048 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05047 XEO_CLAS Peptide DME1048 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 60 microM) DME1048 XEOTICID XEO05047 GENEFORM Protein DME1048 XEOTICID XEO05047 MOACRIVE Inhibition DME1048 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1048 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05051 XEO_CLAS Peptide DME1048 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05051 GENEFORM Protein DME1048 XEOTICID XEO05051 MOACRIVE Inhibition DME1048 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1048 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05055 XEO_CLAS Peptide DME1048 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 70 microM) DME1048 XEOTICID XEO05055 GENEFORM Protein DME1048 XEOTICID XEO05055 MOACRIVE Inhibition DME1048 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1048 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05056 XEO_CLAS Peptide DME1048 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05056 GENEFORM Protein DME1048 XEOTICID XEO05056 MOACRIVE Inhibition DME1048 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1048 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05059 XEO_CLAS Peptide DME1048 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05059 GENEFORM Protein DME1048 XEOTICID XEO05059 MOACRIVE Inhibition DME1048 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1048 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05061 XEO_CLAS Peptide DME1048 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO05061 GENEFORM Protein DME1048 XEOTICID XEO05061 MOACRIVE Inhibition DME1048 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1048 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05062 XEO_CLAS Peptide DME1048 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05062 GENEFORM Protein DME1048 XEOTICID XEO05062 MOACRIVE Inhibition DME1048 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1048 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05063 XEO_CLAS Peptide DME1048 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO05063 GENEFORM Protein DME1048 XEOTICID XEO05063 MOACRIVE Inhibition DME1048 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1048 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05064 XEO_CLAS Peptide DME1048 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 231 microM) DME1048 XEOTICID XEO05064 GENEFORM Protein DME1048 XEOTICID XEO05064 MOACRIVE Inhibition DME1048 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1048 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05065 XEO_CLAS Peptide DME1048 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 161 ug/ml) DME1048 XEOTICID XEO05065 GENEFORM Protein DME1048 XEOTICID XEO05065 MOACRIVE Inhibition DME1048 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1048 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05069 XEO_CLAS Peptide DME1048 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO05069 GENEFORM Protein DME1048 XEOTICID XEO05069 MOACRIVE Inhibition DME1048 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1048 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05070 XEO_CLAS Peptide DME1048 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 37.5 microM) DME1048 XEOTICID XEO05070 GENEFORM Protein DME1048 XEOTICID XEO05070 MOACRIVE Inhibition DME1048 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1048 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05071 XEO_CLAS Peptide DME1048 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 150 microM) DME1048 XEOTICID XEO05071 GENEFORM Protein DME1048 XEOTICID XEO05071 MOACRIVE Inhibition DME1048 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1048 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05072 XEO_CLAS Peptide DME1048 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO05072 GENEFORM Protein DME1048 XEOTICID XEO05072 MOACRIVE Inhibition DME1048 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1048 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05073 XEO_CLAS Peptide DME1048 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40 microM) DME1048 XEOTICID XEO05073 GENEFORM Protein DME1048 XEOTICID XEO05073 MOACRIVE Inhibition DME1048 XEOTICID XEO05076 XEO_NAME Temporin-A DME1048 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05076 XEO_CLAS Peptide DME1048 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 11.9 microM) DME1048 XEOTICID XEO05076 GENEFORM Protein DME1048 XEOTICID XEO05076 MOACRIVE Inhibition DME1048 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1048 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05077 XEO_CLAS Peptide DME1048 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.25 ug/ml) DME1048 XEOTICID XEO05077 GENEFORM Protein DME1048 XEOTICID XEO05077 MOACRIVE Inhibition DME1048 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1048 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05078 XEO_CLAS Peptide DME1048 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.25 ug/ml) DME1048 XEOTICID XEO05078 GENEFORM Protein DME1048 XEOTICID XEO05078 MOACRIVE Inhibition DME1048 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1048 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05079 XEO_CLAS Peptide DME1048 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.5 ug/ml) DME1048 XEOTICID XEO05079 GENEFORM Protein DME1048 XEOTICID XEO05079 MOACRIVE Inhibition DME1048 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1048 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05080 XEO_CLAS Peptide DME1048 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 ug/ml) DME1048 XEOTICID XEO05080 GENEFORM Protein DME1048 XEOTICID XEO05080 MOACRIVE Inhibition DME1048 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1048 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05081 XEO_CLAS Peptide DME1048 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 5 ug/ml) DME1048 XEOTICID XEO05081 GENEFORM Protein DME1048 XEOTICID XEO05081 MOACRIVE Inhibition DME1048 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1048 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05082 XEO_CLAS Peptide DME1048 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 7.5 ug/ml) DME1048 XEOTICID XEO05082 GENEFORM Protein DME1048 XEOTICID XEO05082 MOACRIVE Inhibition DME1048 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1048 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05083 XEO_CLAS Peptide DME1048 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 ug/ml) DME1048 XEOTICID XEO05083 GENEFORM Protein DME1048 XEOTICID XEO05083 MOACRIVE Inhibition DME1048 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1048 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05084 XEO_CLAS Peptide DME1048 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 ug/ml) DME1048 XEOTICID XEO05084 GENEFORM Protein DME1048 XEOTICID XEO05084 MOACRIVE Inhibition DME1048 XEOTICID XEO05085 XEO_NAME Temporin-B DME1048 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05085 XEO_CLAS Peptide DME1048 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 21.0 ug/ml) DME1048 XEOTICID XEO05085 GENEFORM Protein DME1048 XEOTICID XEO05085 MOACRIVE Inhibition DME1048 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1048 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05086 XEO_CLAS Peptide DME1048 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC > 100 microM) DME1048 XEOTICID XEO05086 GENEFORM Protein DME1048 XEOTICID XEO05086 MOACRIVE Inhibition DME1048 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1048 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05087 XEO_CLAS Peptide DME1048 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO05087 GENEFORM Protein DME1048 XEOTICID XEO05087 MOACRIVE Inhibition DME1048 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1048 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05097 XEO_CLAS Peptide DME1048 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16.0 microM) DME1048 XEOTICID XEO05097 GENEFORM Protein DME1048 XEOTICID XEO05097 MOACRIVE Inhibition DME1048 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1048 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05099 XEO_CLAS Peptide DME1048 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.0 microM) DME1048 XEOTICID XEO05099 GENEFORM Protein DME1048 XEOTICID XEO05099 MOACRIVE Inhibition DME1048 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1048 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05100 XEO_CLAS Peptide DME1048 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05100 GENEFORM Protein DME1048 XEOTICID XEO05100 MOACRIVE Inhibition DME1048 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1048 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05101 XEO_CLAS Peptide DME1048 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 24.2 ug/ml) DME1048 XEOTICID XEO05101 GENEFORM Protein DME1048 XEOTICID XEO05101 MOACRIVE Inhibition DME1048 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1048 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05102 XEO_CLAS Peptide DME1048 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 34.5 ug/ml) DME1048 XEOTICID XEO05102 GENEFORM Protein DME1048 XEOTICID XEO05102 MOACRIVE Inhibition DME1048 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1048 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05105 XEO_CLAS Peptide DME1048 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO05105 GENEFORM Protein DME1048 XEOTICID XEO05105 MOACRIVE Inhibition DME1048 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1048 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05106 XEO_CLAS Peptide DME1048 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25-200 microM) DME1048 XEOTICID XEO05106 GENEFORM Protein DME1048 XEOTICID XEO05106 MOACRIVE Inhibition DME1048 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1048 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05108 XEO_CLAS Peptide DME1048 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40 microM) DME1048 XEOTICID XEO05108 GENEFORM Protein DME1048 XEOTICID XEO05108 MOACRIVE Inhibition DME1048 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1048 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1048 XEOTICID XEO05111 XEO_CLAS Natural Product DME1048 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05111 GENEFORM Protein DME1048 XEOTICID XEO05111 MOACRIVE Inhibition DME1048 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1048 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05119 XEO_CLAS Peptide DME1048 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05119 GENEFORM Protein DME1048 XEOTICID XEO05119 MOACRIVE Inhibition DME1048 XEOTICID XEO05120 XEO_NAME Thanatin DME1048 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05120 XEO_CLAS Peptide DME1048 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.3-0.6 microM) DME1048 XEOTICID XEO05120 GENEFORM Protein DME1048 XEOTICID XEO05120 MOACRIVE Inhibition DME1048 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1048 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05121 XEO_CLAS Peptide DME1048 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 62.5 ug/ml) DME1048 XEOTICID XEO05121 GENEFORM Protein DME1048 XEOTICID XEO05121 MOACRIVE Inhibition DME1048 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1048 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05125 XEO_CLAS Peptide DME1048 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05125 GENEFORM Protein DME1048 XEOTICID XEO05125 MOACRIVE Inhibition DME1048 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1048 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05130 XEO_CLAS Peptide DME1048 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05130 GENEFORM Protein DME1048 XEOTICID XEO05130 MOACRIVE Inhibition DME1048 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1048 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05144 XEO_CLAS Peptide DME1048 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40 ug/ml) DME1048 XEOTICID XEO05144 GENEFORM Protein DME1048 XEOTICID XEO05144 MOACRIVE Inhibition DME1048 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1048 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05145 XEO_CLAS Peptide DME1048 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 ug/ml) DME1048 XEOTICID XEO05145 GENEFORM Protein DME1048 XEOTICID XEO05145 MOACRIVE Inhibition DME1048 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1048 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05146 XEO_CLAS Peptide DME1048 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 40 ug/ml) DME1048 XEOTICID XEO05146 GENEFORM Protein DME1048 XEOTICID XEO05146 MOACRIVE Inhibition DME1048 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1048 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05147 XEO_CLAS Peptide DME1048 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 60 ug/ml) DME1048 XEOTICID XEO05147 GENEFORM Protein DME1048 XEOTICID XEO05147 MOACRIVE Inhibition DME1048 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1048 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05158 XEO_CLAS Peptide DME1048 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05158 GENEFORM Protein DME1048 XEOTICID XEO05158 MOACRIVE Inhibition DME1048 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1048 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05161 XEO_CLAS Peptide DME1048 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 32 ug/ml) DME1048 XEOTICID XEO05161 GENEFORM Protein DME1048 XEOTICID XEO05161 MOACRIVE Inhibition DME1048 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1048 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05162 XEO_CLAS Peptide DME1048 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 32 ug/ml) DME1048 XEOTICID XEO05162 GENEFORM Protein DME1048 XEOTICID XEO05162 MOACRIVE Inhibition DME1048 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1048 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05163 XEO_CLAS Peptide DME1048 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 12-25 ug/ml) DME1048 XEOTICID XEO05163 GENEFORM Protein DME1048 XEOTICID XEO05163 MOACRIVE Inhibition DME1048 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1048 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05170 XEO_CLAS Peptide DME1048 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 3.0 microM) DME1048 XEOTICID XEO05170 GENEFORM Protein DME1048 XEOTICID XEO05170 MOACRIVE Inhibition DME1048 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1048 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05171 XEO_CLAS Peptide DME1048 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 50 microM) DME1048 XEOTICID XEO05171 GENEFORM Protein DME1048 XEOTICID XEO05171 MOACRIVE Inhibition DME1048 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1048 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05179 XEO_CLAS Peptide DME1048 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05179 GENEFORM Protein DME1048 XEOTICID XEO05179 MOACRIVE Inhibition DME1048 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1048 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05180 XEO_CLAS Peptide DME1048 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 160 microM) DME1048 XEOTICID XEO05180 GENEFORM Protein DME1048 XEOTICID XEO05180 MOACRIVE Inhibition DME1048 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1048 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05182 XEO_CLAS Peptide DME1048 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 microM) DME1048 XEOTICID XEO05182 GENEFORM Protein DME1048 XEOTICID XEO05182 MOACRIVE Inhibition DME1048 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1048 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05183 XEO_CLAS Peptide DME1048 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 microM) DME1048 XEOTICID XEO05183 GENEFORM Protein DME1048 XEOTICID XEO05183 MOACRIVE Inhibition DME1048 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1048 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05184 XEO_CLAS Peptide DME1048 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 microM) DME1048 XEOTICID XEO05184 GENEFORM Protein DME1048 XEOTICID XEO05184 MOACRIVE Inhibition DME1048 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1048 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05185 XEO_CLAS Peptide DME1048 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 microM) DME1048 XEOTICID XEO05185 GENEFORM Protein DME1048 XEOTICID XEO05185 MOACRIVE Inhibition DME1048 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1048 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05186 XEO_CLAS Peptide DME1048 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 microM) DME1048 XEOTICID XEO05186 GENEFORM Protein DME1048 XEOTICID XEO05186 MOACRIVE Inhibition DME1048 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1048 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05187 XEO_CLAS Peptide DME1048 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16 microM) DME1048 XEOTICID XEO05187 GENEFORM Protein DME1048 XEOTICID XEO05187 MOACRIVE Inhibition DME1048 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1048 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05188 XEO_CLAS Peptide DME1048 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 64 microM) DME1048 XEOTICID XEO05188 GENEFORM Protein DME1048 XEOTICID XEO05188 MOACRIVE Inhibition DME1048 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1048 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05190 XEO_CLAS Peptide DME1048 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05190 GENEFORM Protein DME1048 XEOTICID XEO05190 MOACRIVE Inhibition DME1048 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1048 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05193 XEO_CLAS Peptide DME1048 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO05193 GENEFORM Protein DME1048 XEOTICID XEO05193 MOACRIVE Inhibition DME1048 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1048 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05197 XEO_CLAS Peptide DME1048 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05197 GENEFORM Protein DME1048 XEOTICID XEO05197 MOACRIVE Inhibition DME1048 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1048 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05205 XEO_CLAS Peptide DME1048 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05205 GENEFORM Protein DME1048 XEOTICID XEO05205 MOACRIVE Inhibition DME1048 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1048 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05206 XEO_CLAS Peptide DME1048 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 10 microM) DME1048 XEOTICID XEO05206 GENEFORM Protein DME1048 XEOTICID XEO05206 MOACRIVE Inhibition DME1048 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1048 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05207 XEO_CLAS Peptide DME1048 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 25 microM) DME1048 XEOTICID XEO05207 GENEFORM Protein DME1048 XEOTICID XEO05207 MOACRIVE Inhibition DME1048 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1048 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05208 XEO_CLAS Peptide DME1048 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 microM) DME1048 XEOTICID XEO05208 GENEFORM Protein DME1048 XEOTICID XEO05208 MOACRIVE Inhibition DME1048 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1048 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05209 XEO_CLAS Peptide DME1048 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 15 microM) DME1048 XEOTICID XEO05209 GENEFORM Protein DME1048 XEOTICID XEO05209 MOACRIVE Inhibition DME1048 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1048 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05212 XEO_CLAS Peptide DME1048 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.5 ug/ml) DME1048 XEOTICID XEO05212 GENEFORM Protein DME1048 XEOTICID XEO05212 MOACRIVE Inhibition DME1048 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1048 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05220 XEO_CLAS Peptide DME1048 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.6-1.2 microM) DME1048 XEOTICID XEO05220 GENEFORM Protein DME1048 XEOTICID XEO05220 MOACRIVE Inhibition DME1048 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1048 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05230 XEO_CLAS Peptide DME1048 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 7.90 microM) DME1048 XEOTICID XEO05230 GENEFORM Protein DME1048 XEOTICID XEO05230 MOACRIVE Inhibition DME1048 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1048 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05231 XEO_CLAS Peptide DME1048 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2.40 microM) DME1048 XEOTICID XEO05231 GENEFORM Protein DME1048 XEOTICID XEO05231 MOACRIVE Inhibition DME1048 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1048 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05232 XEO_CLAS Peptide DME1048 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05232 GENEFORM Protein DME1048 XEOTICID XEO05232 MOACRIVE Inhibition DME1048 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1048 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05233 XEO_CLAS Peptide DME1048 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 ug/ml) DME1048 XEOTICID XEO05233 GENEFORM Protein DME1048 XEOTICID XEO05233 MOACRIVE Inhibition DME1048 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1048 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05234 XEO_CLAS Peptide DME1048 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 ug/ml) DME1048 XEOTICID XEO05234 GENEFORM Protein DME1048 XEOTICID XEO05234 MOACRIVE Inhibition DME1048 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1048 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05235 XEO_CLAS Peptide DME1048 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 30 ug/ml) DME1048 XEOTICID XEO05235 GENEFORM Protein DME1048 XEOTICID XEO05235 MOACRIVE Inhibition DME1048 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1048 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05237 XEO_CLAS Peptide DME1048 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 microM) DME1048 XEOTICID XEO05237 GENEFORM Protein DME1048 XEOTICID XEO05237 MOACRIVE Inhibition DME1048 XEOTICID XEO05245 XEO_NAME Viresin DME1048 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05245 XEO_CLAS Peptide DME1048 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05245 GENEFORM Protein DME1048 XEOTICID XEO05245 MOACRIVE Inhibition DME1048 XEOTICID XEO05248 XEO_NAME Vitamin C DME1048 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1048 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1048 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05248 GENEFORM Protein DME1048 XEOTICID XEO05248 MOACRIVE Inhibition DME1048 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1048 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05264 XEO_CLAS Peptide DME1048 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 4 ug/ml) DME1048 XEOTICID XEO05264 GENEFORM Protein DME1048 XEOTICID XEO05264 MOACRIVE Inhibition DME1048 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1048 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05267 XEO_CLAS Peptide DME1048 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 2 ug/ml) DME1048 XEOTICID XEO05267 GENEFORM Protein DME1048 XEOTICID XEO05267 MOACRIVE Inhibition DME1048 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1048 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05268 XEO_CLAS Peptide DME1048 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 1.6 ug/ml) DME1048 XEOTICID XEO05268 GENEFORM Protein DME1048 XEOTICID XEO05268 MOACRIVE Inhibition DME1048 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1048 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05269 XEO_CLAS Peptide DME1048 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 6 ug/ml) DME1048 XEOTICID XEO05269 GENEFORM Protein DME1048 XEOTICID XEO05269 MOACRIVE Inhibition DME1048 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1048 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05273 XEO_CLAS Peptide DME1048 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05273 GENEFORM Protein DME1048 XEOTICID XEO05273 MOACRIVE Inhibition DME1048 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1048 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05274 XEO_CLAS Peptide DME1048 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05274 GENEFORM Protein DME1048 XEOTICID XEO05274 MOACRIVE Inhibition DME1048 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1048 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05287 XEO_CLAS Peptide DME1048 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli DME1048 XEOTICID XEO05287 GENEFORM Protein DME1048 XEOTICID XEO05287 MOACRIVE Inhibition DME1048 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1048 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05303 XEO_CLAS Peptide DME1048 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 16-31 ug/ml) DME1048 XEOTICID XEO05303 GENEFORM Protein DME1048 XEOTICID XEO05303 MOACRIVE Inhibition DME1048 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1048 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05306 XEO_CLAS Peptide DME1048 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 8 ug/ml) DME1048 XEOTICID XEO05306 GENEFORM Protein DME1048 XEOTICID XEO05306 MOACRIVE Inhibition DME1048 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1048 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1048 XEOTICID XEO05308 XEO_CLAS Peptide DME1048 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Escherichia coli (MIC = 0.4 ug/ml) DME1048 XEOTICID XEO05308 GENEFORM Protein DME1048 XEOTICID XEO05308 MOACRIVE Inhibition DME1049 DME___ID DME1049 DME1049 DME_NAME Dihydrofolate reductase (folA) DME1049 SPESNAME Escherichia coli DME1049 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1049 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1049 XEOTICID XEO03771 XEO_CLAS Peptide DME1049 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Escherichia coli DME1049 XEOTICID XEO03771 GENEFORM Protein DME1049 XEOTICID XEO03771 MOACRIVE Inhibition DME1049 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1049 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1049 XEOTICID XEO03775 XEO_CLAS Peptide DME1049 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Escherichia coli (MIC = 2.27 microM) DME1049 XEOTICID XEO03775 GENEFORM Protein DME1049 XEOTICID XEO03775 MOACRIVE Inhibition DME1049 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1049 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1049 XEOTICID XEO03803 XEO_CLAS Peptide DME1049 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Escherichia coli DME1049 XEOTICID XEO03803 GENEFORM Protein DME1049 XEOTICID XEO03803 MOACRIVE Inhibition DME1049 XEOTICID XEO03967 XEO_NAME Bacteriocin LSEI_2163 DME1049 XEOTICID XEO03967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1049 XEOTICID XEO03967 XEO_CLAS Peptide DME1049 XEOTICID XEO03967 DESCRIPT Bacteriocin LSEI_2163 inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Escherichia coli DME1049 XEOTICID XEO03967 GENEFORM Protein DME1049 XEOTICID XEO03967 MOACRIVE Inhibition DME1049 XEOTICID XEO04332 XEO_NAME Nosiheptide DME1049 XEOTICID XEO04332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1049 XEOTICID XEO04332 XEO_CLAS Peptide DME1049 XEOTICID XEO04332 DESCRIPT Nosiheptide inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Escherichia coli (MIC = 0.003 ug/ml) DME1049 XEOTICID XEO04332 GENEFORM Protein DME1049 XEOTICID XEO04332 MOACRIVE Inhibition DME1049 XEOTICID XEO04521 XEO_NAME Penocin A DME1049 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1049 XEOTICID XEO04521 XEO_CLAS Peptide DME1049 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Escherichia coli DME1049 XEOTICID XEO04521 GENEFORM Protein DME1049 XEOTICID XEO04521 MOACRIVE Inhibition DME1049 XEOTICID XEO04616 XEO_NAME Plantaricin E DME1049 XEOTICID XEO04616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1049 XEOTICID XEO04616 XEO_CLAS Peptide DME1049 XEOTICID XEO04616 DESCRIPT Plantaricin E inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Escherichia coli (MIC = 0.02 microM) DME1049 XEOTICID XEO04616 GENEFORM Protein DME1049 XEOTICID XEO04616 MOACRIVE Inhibition DME1049 XEOTICID XEO04617 XEO_NAME Plantaricin F DME1049 XEOTICID XEO04617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1049 XEOTICID XEO04617 XEO_CLAS Peptide DME1049 XEOTICID XEO04617 DESCRIPT Plantaricin F inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Escherichia coli (MIC = 0.02 microM) DME1049 XEOTICID XEO04617 GENEFORM Protein DME1049 XEOTICID XEO04617 MOACRIVE Inhibition DME1049 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1049 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1049 XEOTICID XEO05004 XEO_CLAS Peptide DME1049 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Escherichia coli DME1049 XEOTICID XEO05004 GENEFORM Protein DME1049 XEOTICID XEO05004 MOACRIVE Inhibition DME1049 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1049 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1049 XEOTICID XEO05005 XEO_CLAS Peptide DME1049 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Escherichia coli DME1049 XEOTICID XEO05005 GENEFORM Protein DME1049 XEOTICID XEO05005 MOACRIVE Inhibition DME1049 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1049 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1049 XEOTICID XEO05283 XEO_CLAS Peptide DME1049 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Escherichia coli DME1049 XEOTICID XEO05283 GENEFORM Protein DME1049 XEOTICID XEO05283 MOACRIVE Inhibition DME1050 DME___ID DME1050 DME1050 DME_NAME Dihydrofolate reductase (folA) DME1050 SPESNAME Lactobacillus casei DME1050 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1050 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1050 XEOTICID XEO03771 XEO_CLAS Peptide DME1050 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Lactobacillus casei DME1050 XEOTICID XEO03771 GENEFORM Protein DME1050 XEOTICID XEO03771 MOACRIVE Inhibition DME1050 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1050 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1050 XEOTICID XEO03775 XEO_CLAS Peptide DME1050 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Lactobacillus casei (MIC = 2.27 microM) DME1050 XEOTICID XEO03775 GENEFORM Protein DME1050 XEOTICID XEO03775 MOACRIVE Inhibition DME1050 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1050 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1050 XEOTICID XEO03803 XEO_CLAS Peptide DME1050 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Lactobacillus casei DME1050 XEOTICID XEO03803 GENEFORM Protein DME1050 XEOTICID XEO03803 MOACRIVE Inhibition DME1050 XEOTICID XEO03967 XEO_NAME Bacteriocin LSEI_2163 DME1050 XEOTICID XEO03967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1050 XEOTICID XEO03967 XEO_CLAS Peptide DME1050 XEOTICID XEO03967 DESCRIPT Bacteriocin LSEI_2163 inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Lactobacillus casei DME1050 XEOTICID XEO03967 GENEFORM Protein DME1050 XEOTICID XEO03967 MOACRIVE Inhibition DME1050 XEOTICID XEO04332 XEO_NAME Nosiheptide DME1050 XEOTICID XEO04332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1050 XEOTICID XEO04332 XEO_CLAS Peptide DME1050 XEOTICID XEO04332 DESCRIPT Nosiheptide inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Lactobacillus casei (MIC = 0.003 ug/ml) DME1050 XEOTICID XEO04332 GENEFORM Protein DME1050 XEOTICID XEO04332 MOACRIVE Inhibition DME1050 XEOTICID XEO04521 XEO_NAME Penocin A DME1050 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1050 XEOTICID XEO04521 XEO_CLAS Peptide DME1050 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Lactobacillus casei DME1050 XEOTICID XEO04521 GENEFORM Protein DME1050 XEOTICID XEO04521 MOACRIVE Inhibition DME1050 XEOTICID XEO04616 XEO_NAME Plantaricin E DME1050 XEOTICID XEO04616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1050 XEOTICID XEO04616 XEO_CLAS Peptide DME1050 XEOTICID XEO04616 DESCRIPT Plantaricin E inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Lactobacillus casei (MIC = 0.02 microM) DME1050 XEOTICID XEO04616 GENEFORM Protein DME1050 XEOTICID XEO04616 MOACRIVE Inhibition DME1050 XEOTICID XEO04617 XEO_NAME Plantaricin F DME1050 XEOTICID XEO04617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1050 XEOTICID XEO04617 XEO_CLAS Peptide DME1050 XEOTICID XEO04617 DESCRIPT Plantaricin F inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Lactobacillus casei (MIC = 0.02 microM) DME1050 XEOTICID XEO04617 GENEFORM Protein DME1050 XEOTICID XEO04617 MOACRIVE Inhibition DME1050 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1050 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1050 XEOTICID XEO05004 XEO_CLAS Peptide DME1050 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Lactobacillus casei DME1050 XEOTICID XEO05004 GENEFORM Protein DME1050 XEOTICID XEO05004 MOACRIVE Inhibition DME1050 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1050 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1050 XEOTICID XEO05005 XEO_CLAS Peptide DME1050 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Lactobacillus casei DME1050 XEOTICID XEO05005 GENEFORM Protein DME1050 XEOTICID XEO05005 MOACRIVE Inhibition DME1050 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1050 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1050 XEOTICID XEO05283 XEO_CLAS Peptide DME1050 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Dihydrofolate reductase (folA) from Lactobacillus casei DME1050 XEOTICID XEO05283 GENEFORM Protein DME1050 XEOTICID XEO05283 MOACRIVE Inhibition DME1052 DME___ID DME1052 DME1052 DME_NAME Glyceraldehyde-3-phosphate dehydrogenase (gap) DME1052 SPESNAME Lactobacillus acidophilus DME1052 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1052 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1052 XEOTICID XEO03771 XEO_CLAS Peptide DME1052 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Glyceraldehyde-3-phosphate dehydrogenase (gap) from Lactobacillus acidophilus DME1052 XEOTICID XEO03771 GENEFORM Protein DME1052 XEOTICID XEO03771 MOACRIVE Inhibition DME1052 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1052 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1052 XEOTICID XEO03803 XEO_CLAS Peptide DME1052 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Glyceraldehyde-3-phosphate dehydrogenase (gap) from Lactobacillus acidophilus DME1052 XEOTICID XEO03803 GENEFORM Protein DME1052 XEOTICID XEO03803 MOACRIVE Inhibition DME1052 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1052 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1052 XEOTICID XEO04249 XEO_CLAS Peptide DME1052 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Glyceraldehyde-3-phosphate dehydrogenase (gap) from Lactobacillus acidophilus (MIC > 500 ug/ml) DME1052 XEOTICID XEO04249 GENEFORM Protein DME1052 XEOTICID XEO04249 MOACRIVE Inhibition DME1052 XEOTICID XEO04320 XEO_NAME Nisin U DME1052 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1052 XEOTICID XEO04320 XEO_CLAS Peptide DME1052 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of Glyceraldehyde-3-phosphate dehydrogenase (gap) from Lactobacillus acidophilus DME1052 XEOTICID XEO04320 GENEFORM Protein DME1052 XEOTICID XEO04320 MOACRIVE Inhibition DME1052 XEOTICID XEO05228 XEO_NAME Variacin DME1052 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1052 XEOTICID XEO05228 XEO_CLAS Peptide DME1052 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Glyceraldehyde-3-phosphate dehydrogenase (gap) from Lactobacillus acidophilus DME1052 XEOTICID XEO05228 GENEFORM Protein DME1052 XEOTICID XEO05228 MOACRIVE Inhibition DME1053 DME___ID DME1053 DME1053 DME_NAME L-arabinose isomerase (araA) DME1053 SPESNAME Lactobacillus sakei DME1053 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1053 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1053 XEOTICID XEO03775 XEO_CLAS Peptide DME1053 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of L-arabinose isomerase (araA) from Lactobacillus sakei (MIC = 0.015 microM) DME1053 XEOTICID XEO03775 GENEFORM Protein DME1053 XEOTICID XEO03775 MOACRIVE Inhibition DME1053 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1053 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1053 XEOTICID XEO03803 XEO_CLAS Peptide DME1053 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of L-arabinose isomerase (araA) from Lactobacillus sakei DME1053 XEOTICID XEO03803 GENEFORM Protein DME1053 XEOTICID XEO03803 MOACRIVE Inhibition DME1053 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1053 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1053 XEOTICID XEO03854 XEO_CLAS Peptide DME1053 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of L-arabinose isomerase (araA) from Lactobacillus sakei (MIC = 1.30 microM) DME1053 XEOTICID XEO03854 GENEFORM Protein DME1053 XEOTICID XEO03854 MOACRIVE Inhibition DME1053 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1053 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1053 XEOTICID XEO03855 XEO_CLAS Peptide DME1053 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of L-arabinose isomerase (araA) from Lactobacillus sakei (MIC = 1.04 microM) DME1053 XEOTICID XEO03855 GENEFORM Protein DME1053 XEOTICID XEO03855 MOACRIVE Inhibition DME1053 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1053 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1053 XEOTICID XEO03857 XEO_CLAS Peptide DME1053 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of L-arabinose isomerase (araA) from Lactobacillus sakei (MIC = 0.038 microM) DME1053 XEOTICID XEO03857 GENEFORM Protein DME1053 XEOTICID XEO03857 MOACRIVE Inhibition DME1053 XEOTICID XEO04501 XEO_NAME Pediocin PA-1 DME1053 XEOTICID XEO04501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1053 XEOTICID XEO04501 XEO_CLAS Peptide DME1053 XEOTICID XEO04501 DESCRIPT Pediocin PA-1 inhibits the drug-metabolizing activity of L-arabinose isomerase (araA) from Lactobacillus sakei DME1053 XEOTICID XEO04501 GENEFORM Protein DME1053 XEOTICID XEO04501 MOACRIVE Inhibition DME1053 XEOTICID XEO04616 XEO_NAME Plantaricin E DME1053 XEOTICID XEO04616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1053 XEOTICID XEO04616 XEO_CLAS Peptide DME1053 XEOTICID XEO04616 DESCRIPT Plantaricin E inhibits the drug-metabolizing activity of L-arabinose isomerase (araA) from Lactobacillus sakei (MIC = 0.004 microM) DME1053 XEOTICID XEO04616 GENEFORM Protein DME1053 XEOTICID XEO04616 MOACRIVE Inhibition DME1053 XEOTICID XEO04617 XEO_NAME Plantaricin F DME1053 XEOTICID XEO04617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1053 XEOTICID XEO04617 XEO_CLAS Peptide DME1053 XEOTICID XEO04617 DESCRIPT Plantaricin F inhibits the drug-metabolizing activity of L-arabinose isomerase (araA) from Lactobacillus sakei (MIC = 0.004 microM) DME1053 XEOTICID XEO04617 GENEFORM Protein DME1053 XEOTICID XEO04617 MOACRIVE Inhibition DME1055 DME___ID DME1055 DME1055 DME_NAME Cytidine deaminase (cdd) DME1055 SPESNAME Escherichia coli DME1055 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1055 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1055 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1055 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO00546 GENEFORM Protein DME1055 XEOTICID XEO00546 MOACRIVE Inhibition DME1055 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1055 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1055 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1055 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO00574 GENEFORM Protein DME1055 XEOTICID XEO00574 MOACRIVE Inhibition DME1055 XEOTICID XEO01266 XEO_NAME Cyanidin DME1055 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME1055 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME1055 XEOTICID XEO01266 DESCRIPT Cyanidin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO01266 GENEFORM Protein DME1055 XEOTICID XEO01266 MOACRIVE Inhibition DME1055 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1055 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO01816 XEO_CLAS Peptide DME1055 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 6.25 microM) DME1055 XEOTICID XEO01816 GENEFORM Protein DME1055 XEOTICID XEO01816 MOACRIVE Inhibition DME1055 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1055 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO01827 XEO_CLAS Peptide DME1055 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC > 50 microM) DME1055 XEOTICID XEO01827 GENEFORM Protein DME1055 XEOTICID XEO01827 MOACRIVE Inhibition DME1055 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1055 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02115 XEO_CLAS Peptide DME1055 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO02115 GENEFORM Protein DME1055 XEOTICID XEO02115 MOACRIVE Inhibition DME1055 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1055 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02230 XEO_CLAS Peptide DME1055 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 1-2.5 microM) DME1055 XEOTICID XEO02230 GENEFORM Protein DME1055 XEOTICID XEO02230 MOACRIVE Inhibition DME1055 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1055 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02280 XEO_CLAS Peptide DME1055 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO02280 GENEFORM Protein DME1055 XEOTICID XEO02280 MOACRIVE Inhibition DME1055 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1055 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02325 XEO_CLAS Peptide DME1055 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 13 microM) DME1055 XEOTICID XEO02325 GENEFORM Protein DME1055 XEOTICID XEO02325 MOACRIVE Inhibition DME1055 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1055 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02370 XEO_CLAS Peptide DME1055 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO02370 GENEFORM Protein DME1055 XEOTICID XEO02370 MOACRIVE Inhibition DME1055 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1055 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02371 XEO_CLAS Peptide DME1055 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 12 ug/ml) DME1055 XEOTICID XEO02371 GENEFORM Protein DME1055 XEOTICID XEO02371 MOACRIVE Inhibition DME1055 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1055 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02378 XEO_CLAS Peptide DME1055 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 0.76 ug/ml) DME1055 XEOTICID XEO02378 GENEFORM Protein DME1055 XEOTICID XEO02378 MOACRIVE Inhibition DME1055 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1055 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02416 XEO_CLAS Peptide DME1055 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO02416 GENEFORM Protein DME1055 XEOTICID XEO02416 MOACRIVE Inhibition DME1055 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1055 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02451 XEO_CLAS Peptide DME1055 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO02451 GENEFORM Protein DME1055 XEOTICID XEO02451 MOACRIVE Inhibition DME1055 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1055 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02473 XEO_CLAS Peptide DME1055 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO02473 GENEFORM Protein DME1055 XEOTICID XEO02473 MOACRIVE Inhibition DME1055 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1055 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02491 XEO_CLAS Peptide DME1055 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 2.8 microM) DME1055 XEOTICID XEO02491 GENEFORM Protein DME1055 XEOTICID XEO02491 MOACRIVE Inhibition DME1055 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1055 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02496 XEO_CLAS Peptide DME1055 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 50 microM) DME1055 XEOTICID XEO02496 GENEFORM Protein DME1055 XEOTICID XEO02496 MOACRIVE Inhibition DME1055 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1055 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02497 XEO_CLAS Peptide DME1055 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC > 50 microM) DME1055 XEOTICID XEO02497 GENEFORM Protein DME1055 XEOTICID XEO02497 MOACRIVE Inhibition DME1055 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1055 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02512 XEO_CLAS Peptide DME1055 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 150 microM) DME1055 XEOTICID XEO02512 GENEFORM Protein DME1055 XEOTICID XEO02512 MOACRIVE Inhibition DME1055 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1055 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02566 XEO_CLAS Peptide DME1055 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC > 100 microM) DME1055 XEOTICID XEO02566 GENEFORM Protein DME1055 XEOTICID XEO02566 MOACRIVE Inhibition DME1055 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1055 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02637 XEO_CLAS Peptide DME1055 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 6 microM) DME1055 XEOTICID XEO02637 GENEFORM Protein DME1055 XEOTICID XEO02637 MOACRIVE Inhibition DME1055 XEOTICID XEO02656 XEO_NAME Himatanthus drasticus butanolic extract DME1055 XEOTICID XEO02656 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1055 XEOTICID XEO02656 XEO_CLAS Plant Extract DME1055 XEOTICID XEO02656 DESCRIPT Himatanthus drasticus butanolic extract inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO02656 GENEFORM Protein DME1055 XEOTICID XEO02656 MOACRIVE Inhibition DME1055 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1055 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02688 XEO_CLAS Peptide DME1055 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 25 microM) DME1055 XEOTICID XEO02688 GENEFORM Protein DME1055 XEOTICID XEO02688 MOACRIVE Inhibition DME1055 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1055 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02708 XEO_CLAS Peptide DME1055 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 20 ug/ml) DME1055 XEOTICID XEO02708 GENEFORM Protein DME1055 XEOTICID XEO02708 MOACRIVE Inhibition DME1055 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1055 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02732 XEO_CLAS Peptide DME1055 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 1.25 microM) DME1055 XEOTICID XEO02732 GENEFORM Protein DME1055 XEOTICID XEO02732 MOACRIVE Inhibition DME1055 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1055 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02734 XEO_CLAS Peptide DME1055 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 0.40 microM) DME1055 XEOTICID XEO02734 GENEFORM Protein DME1055 XEOTICID XEO02734 MOACRIVE Inhibition DME1055 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1055 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02736 XEO_CLAS Peptide DME1055 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 0.66 microM) DME1055 XEOTICID XEO02736 GENEFORM Protein DME1055 XEOTICID XEO02736 MOACRIVE Inhibition DME1055 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1055 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02738 XEO_CLAS Peptide DME1055 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 1 microM) DME1055 XEOTICID XEO02738 GENEFORM Protein DME1055 XEOTICID XEO02738 MOACRIVE Inhibition DME1055 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1055 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02743 XEO_CLAS Peptide DME1055 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 4.7 ug/ml) DME1055 XEOTICID XEO02743 GENEFORM Protein DME1055 XEOTICID XEO02743 MOACRIVE Inhibition DME1055 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1055 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02749 XEO_CLAS Peptide DME1055 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 20 mug/ml) DME1055 XEOTICID XEO02749 GENEFORM Protein DME1055 XEOTICID XEO02749 MOACRIVE Inhibition DME1055 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1055 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02767 XEO_CLAS Peptide DME1055 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO02767 GENEFORM Protein DME1055 XEOTICID XEO02767 MOACRIVE Inhibition DME1055 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1055 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02768 XEO_CLAS Peptide DME1055 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 1-2.5 ug/ml) DME1055 XEOTICID XEO02768 GENEFORM Protein DME1055 XEOTICID XEO02768 MOACRIVE Inhibition DME1055 XEOTICID XEO02780 XEO_NAME Cefixime DME1055 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1055 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1055 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO02780 GENEFORM Protein DME1055 XEOTICID XEO02780 MOACRIVE Inhibition DME1055 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1055 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO02942 XEO_CLAS Peptide DME1055 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO02942 GENEFORM Protein DME1055 XEOTICID XEO02942 MOACRIVE Inhibition DME1055 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1055 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03029 XEO_CLAS Peptide DME1055 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 0.145 microM) DME1055 XEOTICID XEO03029 GENEFORM Protein DME1055 XEOTICID XEO03029 MOACRIVE Inhibition DME1055 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1055 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03030 XEO_CLAS Peptide DME1055 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 0.643 microM) DME1055 XEOTICID XEO03030 GENEFORM Protein DME1055 XEOTICID XEO03030 MOACRIVE Inhibition DME1055 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1055 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03031 XEO_CLAS Peptide DME1055 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 0.01 microM) DME1055 XEOTICID XEO03031 GENEFORM Protein DME1055 XEOTICID XEO03031 MOACRIVE Inhibition DME1055 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1055 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03032 XEO_CLAS Peptide DME1055 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC < 0.005 microM) DME1055 XEOTICID XEO03032 GENEFORM Protein DME1055 XEOTICID XEO03032 MOACRIVE Inhibition DME1055 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1055 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03033 XEO_CLAS Peptide DME1055 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC > 0.692 microM) DME1055 XEOTICID XEO03033 GENEFORM Protein DME1055 XEOTICID XEO03033 MOACRIVE Inhibition DME1055 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1055 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03034 XEO_CLAS Peptide DME1055 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 0.004 microM) DME1055 XEOTICID XEO03034 GENEFORM Protein DME1055 XEOTICID XEO03034 MOACRIVE Inhibition DME1055 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1055 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03035 XEO_CLAS Peptide DME1055 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 0.458 microM) DME1055 XEOTICID XEO03035 GENEFORM Protein DME1055 XEOTICID XEO03035 MOACRIVE Inhibition DME1055 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1055 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03051 XEO_CLAS Peptide DME1055 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 100 ug/ml) DME1055 XEOTICID XEO03051 GENEFORM Protein DME1055 XEOTICID XEO03051 MOACRIVE Inhibition DME1055 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1055 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03052 XEO_CLAS Peptide DME1055 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 10 ug/ml) DME1055 XEOTICID XEO03052 GENEFORM Protein DME1055 XEOTICID XEO03052 MOACRIVE Inhibition DME1055 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1055 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03053 XEO_CLAS Peptide DME1055 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 25 ug/ml) DME1055 XEOTICID XEO03053 GENEFORM Protein DME1055 XEOTICID XEO03053 MOACRIVE Inhibition DME1055 XEOTICID XEO03089 XEO_NAME Decoralin DME1055 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03089 XEO_CLAS Peptide DME1055 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 80 microM) DME1055 XEOTICID XEO03089 GENEFORM Protein DME1055 XEOTICID XEO03089 MOACRIVE Inhibition DME1055 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1055 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03112 XEO_CLAS Peptide DME1055 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC > 50 ug/ml) DME1055 XEOTICID XEO03112 GENEFORM Protein DME1055 XEOTICID XEO03112 MOACRIVE Inhibition DME1055 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1055 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03137 XEO_CLAS Peptide DME1055 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03137 GENEFORM Protein DME1055 XEOTICID XEO03137 MOACRIVE Inhibition DME1055 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1055 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03162 XEO_CLAS Peptide DME1055 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 0.8 microM) DME1055 XEOTICID XEO03162 GENEFORM Protein DME1055 XEOTICID XEO03162 MOACRIVE Inhibition DME1055 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1055 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03224 XEO_CLAS Peptide DME1055 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 1-2.5 microM) DME1055 XEOTICID XEO03224 GENEFORM Protein DME1055 XEOTICID XEO03224 MOACRIVE Inhibition DME1055 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1055 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03235 XEO_CLAS Peptide DME1055 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 60 ug/ml) DME1055 XEOTICID XEO03235 GENEFORM Protein DME1055 XEOTICID XEO03235 MOACRIVE Inhibition DME1055 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1055 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03237 XEO_CLAS Peptide DME1055 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC > 100 ug/ml) DME1055 XEOTICID XEO03237 GENEFORM Protein DME1055 XEOTICID XEO03237 MOACRIVE Inhibition DME1055 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1055 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03238 XEO_CLAS Peptide DME1055 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 15 ug/ml) DME1055 XEOTICID XEO03238 GENEFORM Protein DME1055 XEOTICID XEO03238 MOACRIVE Inhibition DME1055 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1055 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03239 XEO_CLAS Peptide DME1055 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 50 ug/ml) DME1055 XEOTICID XEO03239 GENEFORM Protein DME1055 XEOTICID XEO03239 MOACRIVE Inhibition DME1055 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1055 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03250 XEO_CLAS Peptide DME1055 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03250 GENEFORM Protein DME1055 XEOTICID XEO03250 MOACRIVE Inhibition DME1055 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1055 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03251 XEO_CLAS Peptide DME1055 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03251 GENEFORM Protein DME1055 XEOTICID XEO03251 MOACRIVE Inhibition DME1055 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1055 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03253 XEO_CLAS Peptide DME1055 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 3.2 ug/ml) DME1055 XEOTICID XEO03253 GENEFORM Protein DME1055 XEOTICID XEO03253 MOACRIVE Inhibition DME1055 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1055 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1055 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1055 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03348 GENEFORM Protein DME1055 XEOTICID XEO03348 MOACRIVE Inhibition DME1055 XEOTICID XEO03387 XEO_NAME Ferric chloride DME1055 XEOTICID XEO03387 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1055 XEOTICID XEO03387 XEO_CLAS Chemical Compound DME1055 XEOTICID XEO03387 DESCRIPT Ferric chloride inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03387 GENEFORM Protein DME1055 XEOTICID XEO03387 MOACRIVE Inhibition DME1055 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1055 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03436 XEO_CLAS Peptide DME1055 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 100 ug/ml) DME1055 XEOTICID XEO03436 GENEFORM Protein DME1055 XEOTICID XEO03436 MOACRIVE Inhibition DME1055 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1055 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03437 XEO_CLAS Peptide DME1055 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 25 ug/ml) DME1055 XEOTICID XEO03437 GENEFORM Protein DME1055 XEOTICID XEO03437 MOACRIVE Inhibition DME1055 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1055 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03438 XEO_CLAS Peptide DME1055 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 25 ug/ml) DME1055 XEOTICID XEO03438 GENEFORM Protein DME1055 XEOTICID XEO03438 MOACRIVE Inhibition DME1055 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1055 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03439 XEO_CLAS Peptide DME1055 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 25 ug/ml) DME1055 XEOTICID XEO03439 GENEFORM Protein DME1055 XEOTICID XEO03439 MOACRIVE Inhibition DME1055 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1055 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03440 XEO_CLAS Peptide DME1055 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 50 ug/ml) DME1055 XEOTICID XEO03440 GENEFORM Protein DME1055 XEOTICID XEO03440 MOACRIVE Inhibition DME1055 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1055 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03441 XEO_CLAS Peptide DME1055 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 50 ug/ml) DME1055 XEOTICID XEO03441 GENEFORM Protein DME1055 XEOTICID XEO03441 MOACRIVE Inhibition DME1055 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1055 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03497 XEO_CLAS Peptide DME1055 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 3.15-6.25 microM) DME1055 XEOTICID XEO03497 GENEFORM Protein DME1055 XEOTICID XEO03497 MOACRIVE Inhibition DME1055 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1055 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03498 XEO_CLAS Peptide DME1055 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 3.15-6.25 microM) DME1055 XEOTICID XEO03498 GENEFORM Protein DME1055 XEOTICID XEO03498 MOACRIVE Inhibition DME1055 XEOTICID XEO03519 XEO_NAME Hadrurin DME1055 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03519 XEO_CLAS Peptide DME1055 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03519 GENEFORM Protein DME1055 XEOTICID XEO03519 MOACRIVE Inhibition DME1055 XEOTICID XEO03522 XEO_NAME Halocyntin DME1055 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03522 XEO_CLAS Peptide DME1055 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03522 GENEFORM Protein DME1055 XEOTICID XEO03522 MOACRIVE Inhibition DME1055 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1055 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03540 XEO_CLAS Peptide DME1055 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 8-16 ug/ml) DME1055 XEOTICID XEO03540 GENEFORM Protein DME1055 XEOTICID XEO03540 MOACRIVE Inhibition DME1055 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1055 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03549 XEO_CLAS Peptide DME1055 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03549 GENEFORM Protein DME1055 XEOTICID XEO03549 MOACRIVE Inhibition DME1055 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1055 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1055 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1055 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03552 GENEFORM Protein DME1055 XEOTICID XEO03552 MOACRIVE Inhibition DME1055 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1055 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03556 XEO_CLAS Peptide DME1055 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 8-16 ug/ml) DME1055 XEOTICID XEO03556 GENEFORM Protein DME1055 XEOTICID XEO03556 MOACRIVE Inhibition DME1055 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1055 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03557 XEO_CLAS Peptide DME1055 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 8-16 ug/ml) DME1055 XEOTICID XEO03557 GENEFORM Protein DME1055 XEOTICID XEO03557 MOACRIVE Inhibition DME1055 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1055 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03591 XEO_CLAS Peptide DME1055 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 50 ug/ml) DME1055 XEOTICID XEO03591 GENEFORM Protein DME1055 XEOTICID XEO03591 MOACRIVE Inhibition DME1055 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1055 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03593 XEO_CLAS Peptide DME1055 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 25 ug/ml) DME1055 XEOTICID XEO03593 GENEFORM Protein DME1055 XEOTICID XEO03593 MOACRIVE Inhibition DME1055 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1055 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03609 XEO_CLAS Peptide DME1055 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03609 GENEFORM Protein DME1055 XEOTICID XEO03609 MOACRIVE Inhibition DME1055 XEOTICID XEO03611 XEO_NAME Himatanthus drasticus hydroalcoholic extract DME1055 XEOTICID XEO03611 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1055 XEOTICID XEO03611 XEO_CLAS Plant Extract DME1055 XEOTICID XEO03611 DESCRIPT Himatanthus drasticus hydroalcoholic extract inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03611 GENEFORM Protein DME1055 XEOTICID XEO03611 MOACRIVE Inhibition DME1055 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1055 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03622 XEO_CLAS Peptide DME1055 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 20-40 microM) DME1055 XEOTICID XEO03622 GENEFORM Protein DME1055 XEOTICID XEO03622 MOACRIVE Inhibition DME1055 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1055 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03630 XEO_CLAS Peptide DME1055 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03630 GENEFORM Protein DME1055 XEOTICID XEO03630 MOACRIVE Inhibition DME1055 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1055 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03631 XEO_CLAS Peptide DME1055 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03631 GENEFORM Protein DME1055 XEOTICID XEO03631 MOACRIVE Inhibition DME1055 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1055 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03632 XEO_CLAS Peptide DME1055 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03632 GENEFORM Protein DME1055 XEOTICID XEO03632 MOACRIVE Inhibition DME1055 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1055 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03633 XEO_CLAS Peptide DME1055 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03633 GENEFORM Protein DME1055 XEOTICID XEO03633 MOACRIVE Inhibition DME1055 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1055 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03634 XEO_CLAS Peptide DME1055 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03634 GENEFORM Protein DME1055 XEOTICID XEO03634 MOACRIVE Inhibition DME1055 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1055 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03635 XEO_CLAS Peptide DME1055 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03635 GENEFORM Protein DME1055 XEOTICID XEO03635 MOACRIVE Inhibition DME1055 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1055 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03636 XEO_CLAS Peptide DME1055 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03636 GENEFORM Protein DME1055 XEOTICID XEO03636 MOACRIVE Inhibition DME1055 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1055 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03637 XEO_CLAS Peptide DME1055 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03637 GENEFORM Protein DME1055 XEOTICID XEO03637 MOACRIVE Inhibition DME1055 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1055 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03638 XEO_CLAS Peptide DME1055 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03638 GENEFORM Protein DME1055 XEOTICID XEO03638 MOACRIVE Inhibition DME1055 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1055 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03639 XEO_CLAS Peptide DME1055 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03639 GENEFORM Protein DME1055 XEOTICID XEO03639 MOACRIVE Inhibition DME1055 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1055 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03640 XEO_CLAS Peptide DME1055 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03640 GENEFORM Protein DME1055 XEOTICID XEO03640 MOACRIVE Inhibition DME1055 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1055 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03672 XEO_CLAS Peptide DME1055 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 10 ug/ml) DME1055 XEOTICID XEO03672 GENEFORM Protein DME1055 XEOTICID XEO03672 MOACRIVE Inhibition DME1055 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1055 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03673 XEO_CLAS Peptide DME1055 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 15 ug/ml) DME1055 XEOTICID XEO03673 GENEFORM Protein DME1055 XEOTICID XEO03673 MOACRIVE Inhibition DME1055 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1055 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03674 XEO_CLAS Peptide DME1055 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO03674 GENEFORM Protein DME1055 XEOTICID XEO03674 MOACRIVE Inhibition DME1055 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1055 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03675 XEO_CLAS Peptide DME1055 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 15 microM) DME1055 XEOTICID XEO03675 GENEFORM Protein DME1055 XEOTICID XEO03675 MOACRIVE Inhibition DME1055 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1055 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03678 XEO_CLAS Peptide DME1055 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 2 ug/ml) DME1055 XEOTICID XEO03678 GENEFORM Protein DME1055 XEOTICID XEO03678 MOACRIVE Inhibition DME1055 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1055 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03681 XEO_CLAS Peptide DME1055 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 1.2-2.5 microM) DME1055 XEOTICID XEO03681 GENEFORM Protein DME1055 XEOTICID XEO03681 MOACRIVE Inhibition DME1055 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1055 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03697 XEO_CLAS Peptide DME1055 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 25 microM) DME1055 XEOTICID XEO03697 GENEFORM Protein DME1055 XEOTICID XEO03697 MOACRIVE Inhibition DME1055 XEOTICID XEO03724 XEO_NAME L10 peptide DME1055 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03724 XEO_CLAS Peptide DME1055 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 3.35 microM) DME1055 XEOTICID XEO03724 GENEFORM Protein DME1055 XEOTICID XEO03724 MOACRIVE Inhibition DME1055 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1055 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03744 XEO_CLAS Peptide DME1055 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 6.3 ug/ml) DME1055 XEOTICID XEO03744 GENEFORM Protein DME1055 XEOTICID XEO03744 MOACRIVE Inhibition DME1055 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1055 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03746 XEO_CLAS Peptide DME1055 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 2 ug/ml) DME1055 XEOTICID XEO03746 GENEFORM Protein DME1055 XEOTICID XEO03746 MOACRIVE Inhibition DME1055 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1055 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03747 XEO_CLAS Peptide DME1055 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 2 ug/ml) DME1055 XEOTICID XEO03747 GENEFORM Protein DME1055 XEOTICID XEO03747 MOACRIVE Inhibition DME1055 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1055 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03748 XEO_CLAS Peptide DME1055 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 4 ug/ml) DME1055 XEOTICID XEO03748 GENEFORM Protein DME1055 XEOTICID XEO03748 MOACRIVE Inhibition DME1055 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1055 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03749 XEO_CLAS Peptide DME1055 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 2 ug/ml) DME1055 XEOTICID XEO03749 GENEFORM Protein DME1055 XEOTICID XEO03749 MOACRIVE Inhibition DME1055 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1055 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03750 XEO_CLAS Peptide DME1055 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 2 ug/ml) DME1055 XEOTICID XEO03750 GENEFORM Protein DME1055 XEOTICID XEO03750 MOACRIVE Inhibition DME1055 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1055 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03751 XEO_CLAS Peptide DME1055 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 4 ug/ml) DME1055 XEOTICID XEO03751 GENEFORM Protein DME1055 XEOTICID XEO03751 MOACRIVE Inhibition DME1055 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1055 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03752 XEO_CLAS Peptide DME1055 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 2 ug/ml) DME1055 XEOTICID XEO03752 GENEFORM Protein DME1055 XEOTICID XEO03752 MOACRIVE Inhibition DME1055 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1055 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03753 XEO_CLAS Peptide DME1055 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 6.3 ug/ml) DME1055 XEOTICID XEO03753 GENEFORM Protein DME1055 XEOTICID XEO03753 MOACRIVE Inhibition DME1055 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1055 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03754 XEO_CLAS Peptide DME1055 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 2 ug/ml) DME1055 XEOTICID XEO03754 GENEFORM Protein DME1055 XEOTICID XEO03754 MOACRIVE Inhibition DME1055 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1055 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03755 XEO_CLAS Peptide DME1055 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 4 ug/ml) DME1055 XEOTICID XEO03755 GENEFORM Protein DME1055 XEOTICID XEO03755 MOACRIVE Inhibition DME1055 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1055 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03756 XEO_CLAS Peptide DME1055 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 2 ug/ml) DME1055 XEOTICID XEO03756 GENEFORM Protein DME1055 XEOTICID XEO03756 MOACRIVE Inhibition DME1055 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1055 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03759 XEO_CLAS Peptide DME1055 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 3.1 ug/ml) DME1055 XEOTICID XEO03759 GENEFORM Protein DME1055 XEOTICID XEO03759 MOACRIVE Inhibition DME1055 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1055 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03761 XEO_CLAS Peptide DME1055 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 50 ug/ml) DME1055 XEOTICID XEO03761 GENEFORM Protein DME1055 XEOTICID XEO03761 MOACRIVE Inhibition DME1055 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1055 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO03985 XEO_CLAS Peptide DME1055 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 10 ug/ml) DME1055 XEOTICID XEO03985 GENEFORM Protein DME1055 XEOTICID XEO03985 MOACRIVE Inhibition DME1055 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1055 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04001 XEO_CLAS Peptide DME1055 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 12.5 microM) DME1055 XEOTICID XEO04001 GENEFORM Protein DME1055 XEOTICID XEO04001 MOACRIVE Inhibition DME1055 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1055 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04007 XEO_CLAS Peptide DME1055 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 9 ug/ml) DME1055 XEOTICID XEO04007 GENEFORM Protein DME1055 XEOTICID XEO04007 MOACRIVE Inhibition DME1055 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1055 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04011 XEO_CLAS Peptide DME1055 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 9 ug/ml) DME1055 XEOTICID XEO04011 GENEFORM Protein DME1055 XEOTICID XEO04011 MOACRIVE Inhibition DME1055 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1055 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04012 XEO_CLAS Peptide DME1055 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 3.1 ug/ml) DME1055 XEOTICID XEO04012 GENEFORM Protein DME1055 XEOTICID XEO04012 MOACRIVE Inhibition DME1055 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1055 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04013 XEO_CLAS Peptide DME1055 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 15 ug/ml) DME1055 XEOTICID XEO04013 GENEFORM Protein DME1055 XEOTICID XEO04013 MOACRIVE Inhibition DME1055 XEOTICID XEO04014 XEO_NAME Maximin-5 DME1055 XEOTICID XEO04014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04014 XEO_CLAS Peptide DME1055 XEOTICID XEO04014 DESCRIPT Maximin-5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 3.6 ug/ml) DME1055 XEOTICID XEO04014 GENEFORM Protein DME1055 XEOTICID XEO04014 MOACRIVE Inhibition DME1055 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1055 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1055 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1055 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04087 GENEFORM Protein DME1055 XEOTICID XEO04087 MOACRIVE Inhibition DME1055 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1055 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04111 XEO_CLAS Peptide DME1055 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04111 GENEFORM Protein DME1055 XEOTICID XEO04111 MOACRIVE Inhibition DME1055 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1055 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04241 XEO_CLAS Peptide DME1055 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04241 GENEFORM Protein DME1055 XEOTICID XEO04241 MOACRIVE Inhibition DME1055 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1055 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04242 XEO_CLAS Peptide DME1055 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04242 GENEFORM Protein DME1055 XEOTICID XEO04242 MOACRIVE Inhibition DME1055 XEOTICID XEO04331 XEO_NAME Norspermidine DME1055 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1055 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1055 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04331 GENEFORM Protein DME1055 XEOTICID XEO04331 MOACRIVE Inhibition DME1055 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1055 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04348 XEO_CLAS Peptide DME1055 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 80 microM) DME1055 XEOTICID XEO04348 GENEFORM Protein DME1055 XEOTICID XEO04348 MOACRIVE Inhibition DME1055 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1055 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04349 XEO_CLAS Peptide DME1055 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 100 microM) DME1055 XEOTICID XEO04349 GENEFORM Protein DME1055 XEOTICID XEO04349 MOACRIVE Inhibition DME1055 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1055 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04399 XEO_CLAS Peptide DME1055 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 6.3 microM) DME1055 XEOTICID XEO04399 GENEFORM Protein DME1055 XEOTICID XEO04399 MOACRIVE Inhibition DME1055 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1055 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04426 XEO_CLAS Peptide DME1055 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 2 microM) DME1055 XEOTICID XEO04426 GENEFORM Protein DME1055 XEOTICID XEO04426 MOACRIVE Inhibition DME1055 XEOTICID XEO04468 XEO_NAME Papillosin DME1055 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04468 XEO_CLAS Peptide DME1055 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04468 GENEFORM Protein DME1055 XEOTICID XEO04468 MOACRIVE Inhibition DME1055 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1055 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04471 XEO_CLAS Peptide DME1055 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 1.6 microM) DME1055 XEOTICID XEO04471 GENEFORM Protein DME1055 XEOTICID XEO04471 MOACRIVE Inhibition DME1055 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1055 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04506 XEO_CLAS Peptide DME1055 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC > 20 microM) DME1055 XEOTICID XEO04506 GENEFORM Protein DME1055 XEOTICID XEO04506 MOACRIVE Inhibition DME1055 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1055 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04507 XEO_CLAS Peptide DME1055 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC > 40 microM) DME1055 XEOTICID XEO04507 GENEFORM Protein DME1055 XEOTICID XEO04507 MOACRIVE Inhibition DME1055 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1055 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04510 XEO_CLAS Peptide DME1055 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC > 50 microM) DME1055 XEOTICID XEO04510 GENEFORM Protein DME1055 XEOTICID XEO04510 MOACRIVE Inhibition DME1055 XEOTICID XEO04531 XEO_NAME Mollusca/molluscs/mollusks peptide 2 DME1055 XEOTICID XEO04531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04531 XEO_CLAS Peptide DME1055 XEOTICID XEO04531 DESCRIPT Mollusca/molluscs/mollusks peptide 2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04531 GENEFORM Protein DME1055 XEOTICID XEO04531 MOACRIVE Inhibition DME1055 XEOTICID XEO04533 XEO_NAME Mollusca/molluscs/mollusks peptide 3 DME1055 XEOTICID XEO04533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04533 XEO_CLAS Peptide DME1055 XEOTICID XEO04533 DESCRIPT Mollusca/molluscs/mollusks peptide 3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04533 GENEFORM Protein DME1055 XEOTICID XEO04533 MOACRIVE Inhibition DME1055 XEOTICID XEO04534 XEO_NAME Mollusca/molluscs/mollusks peptide 4 DME1055 XEOTICID XEO04534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04534 XEO_CLAS Peptide DME1055 XEOTICID XEO04534 DESCRIPT Mollusca/molluscs/mollusks peptide 4 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04534 GENEFORM Protein DME1055 XEOTICID XEO04534 MOACRIVE Inhibition DME1055 XEOTICID XEO04535 XEO_NAME Mollusca/molluscs/mollusks peptide 5 DME1055 XEOTICID XEO04535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04535 XEO_CLAS Peptide DME1055 XEOTICID XEO04535 DESCRIPT Mollusca/molluscs/mollusks peptide 5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04535 GENEFORM Protein DME1055 XEOTICID XEO04535 MOACRIVE Inhibition DME1055 XEOTICID XEO04536 XEO_NAME Mollusca/molluscs/mollusks peptide 6 DME1055 XEOTICID XEO04536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04536 XEO_CLAS Peptide DME1055 XEOTICID XEO04536 DESCRIPT Mollusca/molluscs/mollusks peptide 6 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04536 GENEFORM Protein DME1055 XEOTICID XEO04536 MOACRIVE Inhibition DME1055 XEOTICID XEO04537 XEO_NAME Mollusca/molluscs/mollusks peptide 7 DME1055 XEOTICID XEO04537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04537 XEO_CLAS Peptide DME1055 XEOTICID XEO04537 DESCRIPT Mollusca/molluscs/mollusks peptide 7 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04537 GENEFORM Protein DME1055 XEOTICID XEO04537 MOACRIVE Inhibition DME1055 XEOTICID XEO04538 XEO_NAME Mollusca/molluscs/mollusks peptide 8 DME1055 XEOTICID XEO04538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04538 XEO_CLAS Peptide DME1055 XEOTICID XEO04538 DESCRIPT Mollusca/molluscs/mollusks peptide 8 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04538 GENEFORM Protein DME1055 XEOTICID XEO04538 MOACRIVE Inhibition DME1055 XEOTICID XEO04539 XEO_NAME Mollusca/molluscs/mollusks peptide 9 DME1055 XEOTICID XEO04539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04539 XEO_CLAS Peptide DME1055 XEOTICID XEO04539 DESCRIPT Mollusca/molluscs/mollusks peptide 9 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04539 GENEFORM Protein DME1055 XEOTICID XEO04539 MOACRIVE Inhibition DME1055 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1055 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04548 XEO_CLAS Peptide DME1055 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 32000 ug/ml) DME1055 XEOTICID XEO04548 GENEFORM Protein DME1055 XEOTICID XEO04548 MOACRIVE Inhibition DME1055 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1055 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04549 XEO_CLAS Peptide DME1055 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 250-500 ug/ml) DME1055 XEOTICID XEO04549 GENEFORM Protein DME1055 XEOTICID XEO04549 MOACRIVE Inhibition DME1055 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1055 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04571 XEO_CLAS Peptide DME1055 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04571 GENEFORM Protein DME1055 XEOTICID XEO04571 MOACRIVE Inhibition DME1055 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1055 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04572 XEO_CLAS Peptide DME1055 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04572 GENEFORM Protein DME1055 XEOTICID XEO04572 MOACRIVE Inhibition DME1055 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1055 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04606 XEO_CLAS Peptide DME1055 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 2 microM) DME1055 XEOTICID XEO04606 GENEFORM Protein DME1055 XEOTICID XEO04606 MOACRIVE Inhibition DME1055 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1055 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04612 XEO_CLAS Peptide DME1055 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 2.5-5 microM) DME1055 XEOTICID XEO04612 GENEFORM Protein DME1055 XEOTICID XEO04612 MOACRIVE Inhibition DME1055 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1055 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04613 XEO_CLAS Peptide DME1055 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 2.5-5 microM) DME1055 XEOTICID XEO04613 GENEFORM Protein DME1055 XEOTICID XEO04613 MOACRIVE Inhibition DME1055 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1055 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04695 XEO_CLAS Peptide DME1055 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04695 GENEFORM Protein DME1055 XEOTICID XEO04695 MOACRIVE Inhibition DME1055 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1055 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04696 XEO_CLAS Peptide DME1055 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04696 GENEFORM Protein DME1055 XEOTICID XEO04696 MOACRIVE Inhibition DME1055 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1055 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04697 XEO_CLAS Peptide DME1055 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04697 GENEFORM Protein DME1055 XEOTICID XEO04697 MOACRIVE Inhibition DME1055 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1055 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04698 XEO_CLAS Peptide DME1055 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04698 GENEFORM Protein DME1055 XEOTICID XEO04698 MOACRIVE Inhibition DME1055 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1055 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04699 XEO_CLAS Peptide DME1055 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04699 GENEFORM Protein DME1055 XEOTICID XEO04699 MOACRIVE Inhibition DME1055 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1055 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04700 XEO_CLAS Peptide DME1055 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04700 GENEFORM Protein DME1055 XEOTICID XEO04700 MOACRIVE Inhibition DME1055 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1055 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04701 XEO_CLAS Peptide DME1055 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04701 GENEFORM Protein DME1055 XEOTICID XEO04701 MOACRIVE Inhibition DME1055 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1055 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04702 XEO_CLAS Peptide DME1055 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04702 GENEFORM Protein DME1055 XEOTICID XEO04702 MOACRIVE Inhibition DME1055 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1055 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04703 XEO_CLAS Peptide DME1055 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04703 GENEFORM Protein DME1055 XEOTICID XEO04703 MOACRIVE Inhibition DME1055 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1055 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04762 XEO_CLAS Peptide DME1055 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC > 25 microM) DME1055 XEOTICID XEO04762 GENEFORM Protein DME1055 XEOTICID XEO04762 MOACRIVE Inhibition DME1055 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1055 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04809 XEO_CLAS Peptide DME1055 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 10 microM) DME1055 XEOTICID XEO04809 GENEFORM Protein DME1055 XEOTICID XEO04809 MOACRIVE Inhibition DME1055 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1055 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04891 XEO_CLAS Peptide DME1055 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04891 GENEFORM Protein DME1055 XEOTICID XEO04891 MOACRIVE Inhibition DME1055 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1055 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04905 XEO_CLAS Peptide DME1055 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04905 GENEFORM Protein DME1055 XEOTICID XEO04905 MOACRIVE Inhibition DME1055 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1055 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04906 XEO_CLAS Peptide DME1055 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO04906 GENEFORM Protein DME1055 XEOTICID XEO04906 MOACRIVE Inhibition DME1055 XEOTICID XEO04917 XEO_NAME Scorpine DME1055 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04917 XEO_CLAS Peptide DME1055 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 10 microM) DME1055 XEOTICID XEO04917 GENEFORM Protein DME1055 XEOTICID XEO04917 MOACRIVE Inhibition DME1055 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1055 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04971 XEO_CLAS Peptide DME1055 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 50-100 microM) DME1055 XEOTICID XEO04971 GENEFORM Protein DME1055 XEOTICID XEO04971 MOACRIVE Inhibition DME1055 XEOTICID XEO04974 XEO_NAME Spinigerin DME1055 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04974 XEO_CLAS Peptide DME1055 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 50-100 microM) DME1055 XEOTICID XEO04974 GENEFORM Protein DME1055 XEOTICID XEO04974 MOACRIVE Inhibition DME1055 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1055 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO04995 XEO_CLAS Peptide DME1055 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 0.78-1.56 microM) DME1055 XEOTICID XEO04995 GENEFORM Protein DME1055 XEOTICID XEO04995 MOACRIVE Inhibition DME1055 XEOTICID XEO05020 XEO_NAME Tachycitin DME1055 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO05020 XEO_CLAS Peptide DME1055 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli DME1055 XEOTICID XEO05020 GENEFORM Protein DME1055 XEOTICID XEO05020 MOACRIVE Inhibition DME1055 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1055 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO05073 XEO_CLAS Peptide DME1055 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 80 microM) DME1055 XEOTICID XEO05073 GENEFORM Protein DME1055 XEOTICID XEO05073 MOACRIVE Inhibition DME1055 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1055 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO05075 XEO_CLAS Peptide DME1055 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 80 microM) DME1055 XEOTICID XEO05075 GENEFORM Protein DME1055 XEOTICID XEO05075 MOACRIVE Inhibition DME1055 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1055 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO05101 XEO_CLAS Peptide DME1055 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 31.2 ug/ml) DME1055 XEOTICID XEO05101 GENEFORM Protein DME1055 XEOTICID XEO05101 MOACRIVE Inhibition DME1055 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1055 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO05102 XEO_CLAS Peptide DME1055 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 35.1 ug/ml) DME1055 XEOTICID XEO05102 GENEFORM Protein DME1055 XEOTICID XEO05102 MOACRIVE Inhibition DME1055 XEOTICID XEO05120 XEO_NAME Thanatin DME1055 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO05120 XEO_CLAS Peptide DME1055 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 0.6-1.2 microM) DME1055 XEOTICID XEO05120 GENEFORM Protein DME1055 XEOTICID XEO05120 MOACRIVE Inhibition DME1055 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1055 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO05163 XEO_CLAS Peptide DME1055 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 12-25 ug/ml) DME1055 XEOTICID XEO05163 GENEFORM Protein DME1055 XEOTICID XEO05163 MOACRIVE Inhibition DME1055 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1055 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1055 XEOTICID XEO05220 XEO_CLAS Peptide DME1055 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Escherichia coli (MIC = 2.5-5 microM) DME1055 XEOTICID XEO05220 GENEFORM Protein DME1055 XEOTICID XEO05220 MOACRIVE Inhibition DME1056 DME___ID DME1056 DME1056 DME_NAME Cytidine deaminase (cdd) DME1056 SPESNAME Klebsiella pneumoniae DME1056 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1056 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1056 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1056 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO00546 GENEFORM Protein DME1056 XEOTICID XEO00546 MOACRIVE Inhibition DME1056 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1056 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1056 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1056 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO00574 GENEFORM Protein DME1056 XEOTICID XEO00574 MOACRIVE Inhibition DME1056 XEOTICID XEO01266 XEO_NAME Cyanidin DME1056 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME1056 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME1056 XEOTICID XEO01266 DESCRIPT Cyanidin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO01266 GENEFORM Protein DME1056 XEOTICID XEO01266 MOACRIVE Inhibition DME1056 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1056 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO01816 XEO_CLAS Peptide DME1056 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 6.25 microM) DME1056 XEOTICID XEO01816 GENEFORM Protein DME1056 XEOTICID XEO01816 MOACRIVE Inhibition DME1056 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1056 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO01827 XEO_CLAS Peptide DME1056 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC > 50 microM) DME1056 XEOTICID XEO01827 GENEFORM Protein DME1056 XEOTICID XEO01827 MOACRIVE Inhibition DME1056 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1056 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02115 XEO_CLAS Peptide DME1056 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO02115 GENEFORM Protein DME1056 XEOTICID XEO02115 MOACRIVE Inhibition DME1056 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1056 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02230 XEO_CLAS Peptide DME1056 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1056 XEOTICID XEO02230 GENEFORM Protein DME1056 XEOTICID XEO02230 MOACRIVE Inhibition DME1056 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1056 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02280 XEO_CLAS Peptide DME1056 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO02280 GENEFORM Protein DME1056 XEOTICID XEO02280 MOACRIVE Inhibition DME1056 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1056 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02325 XEO_CLAS Peptide DME1056 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 13 microM) DME1056 XEOTICID XEO02325 GENEFORM Protein DME1056 XEOTICID XEO02325 MOACRIVE Inhibition DME1056 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1056 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02370 XEO_CLAS Peptide DME1056 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO02370 GENEFORM Protein DME1056 XEOTICID XEO02370 MOACRIVE Inhibition DME1056 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1056 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02371 XEO_CLAS Peptide DME1056 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 12 ug/ml) DME1056 XEOTICID XEO02371 GENEFORM Protein DME1056 XEOTICID XEO02371 MOACRIVE Inhibition DME1056 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1056 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02378 XEO_CLAS Peptide DME1056 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 0.76 ug/ml) DME1056 XEOTICID XEO02378 GENEFORM Protein DME1056 XEOTICID XEO02378 MOACRIVE Inhibition DME1056 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1056 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02416 XEO_CLAS Peptide DME1056 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO02416 GENEFORM Protein DME1056 XEOTICID XEO02416 MOACRIVE Inhibition DME1056 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1056 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02451 XEO_CLAS Peptide DME1056 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO02451 GENEFORM Protein DME1056 XEOTICID XEO02451 MOACRIVE Inhibition DME1056 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1056 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02473 XEO_CLAS Peptide DME1056 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO02473 GENEFORM Protein DME1056 XEOTICID XEO02473 MOACRIVE Inhibition DME1056 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1056 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02491 XEO_CLAS Peptide DME1056 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 2.8 microM) DME1056 XEOTICID XEO02491 GENEFORM Protein DME1056 XEOTICID XEO02491 MOACRIVE Inhibition DME1056 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1056 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02496 XEO_CLAS Peptide DME1056 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 50 microM) DME1056 XEOTICID XEO02496 GENEFORM Protein DME1056 XEOTICID XEO02496 MOACRIVE Inhibition DME1056 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1056 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02497 XEO_CLAS Peptide DME1056 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC > 50 microM) DME1056 XEOTICID XEO02497 GENEFORM Protein DME1056 XEOTICID XEO02497 MOACRIVE Inhibition DME1056 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1056 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02512 XEO_CLAS Peptide DME1056 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 150 microM) DME1056 XEOTICID XEO02512 GENEFORM Protein DME1056 XEOTICID XEO02512 MOACRIVE Inhibition DME1056 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1056 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02566 XEO_CLAS Peptide DME1056 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC > 100 microM) DME1056 XEOTICID XEO02566 GENEFORM Protein DME1056 XEOTICID XEO02566 MOACRIVE Inhibition DME1056 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1056 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02637 XEO_CLAS Peptide DME1056 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 6 microM) DME1056 XEOTICID XEO02637 GENEFORM Protein DME1056 XEOTICID XEO02637 MOACRIVE Inhibition DME1056 XEOTICID XEO02656 XEO_NAME Himatanthus drasticus butanolic extract DME1056 XEOTICID XEO02656 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1056 XEOTICID XEO02656 XEO_CLAS Plant Extract DME1056 XEOTICID XEO02656 DESCRIPT Himatanthus drasticus butanolic extract inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO02656 GENEFORM Protein DME1056 XEOTICID XEO02656 MOACRIVE Inhibition DME1056 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1056 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02688 XEO_CLAS Peptide DME1056 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 25 microM) DME1056 XEOTICID XEO02688 GENEFORM Protein DME1056 XEOTICID XEO02688 MOACRIVE Inhibition DME1056 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1056 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02708 XEO_CLAS Peptide DME1056 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 20 ug/ml) DME1056 XEOTICID XEO02708 GENEFORM Protein DME1056 XEOTICID XEO02708 MOACRIVE Inhibition DME1056 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1056 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02732 XEO_CLAS Peptide DME1056 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 1.25 microM) DME1056 XEOTICID XEO02732 GENEFORM Protein DME1056 XEOTICID XEO02732 MOACRIVE Inhibition DME1056 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1056 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02734 XEO_CLAS Peptide DME1056 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 0.40 microM) DME1056 XEOTICID XEO02734 GENEFORM Protein DME1056 XEOTICID XEO02734 MOACRIVE Inhibition DME1056 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1056 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02736 XEO_CLAS Peptide DME1056 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 0.66 microM) DME1056 XEOTICID XEO02736 GENEFORM Protein DME1056 XEOTICID XEO02736 MOACRIVE Inhibition DME1056 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1056 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02738 XEO_CLAS Peptide DME1056 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 1 microM) DME1056 XEOTICID XEO02738 GENEFORM Protein DME1056 XEOTICID XEO02738 MOACRIVE Inhibition DME1056 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1056 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02743 XEO_CLAS Peptide DME1056 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 4.7 ug/ml) DME1056 XEOTICID XEO02743 GENEFORM Protein DME1056 XEOTICID XEO02743 MOACRIVE Inhibition DME1056 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1056 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02749 XEO_CLAS Peptide DME1056 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 20 mug/ml) DME1056 XEOTICID XEO02749 GENEFORM Protein DME1056 XEOTICID XEO02749 MOACRIVE Inhibition DME1056 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1056 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02767 XEO_CLAS Peptide DME1056 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO02767 GENEFORM Protein DME1056 XEOTICID XEO02767 MOACRIVE Inhibition DME1056 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1056 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02768 XEO_CLAS Peptide DME1056 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 1-2.5 ug/ml) DME1056 XEOTICID XEO02768 GENEFORM Protein DME1056 XEOTICID XEO02768 MOACRIVE Inhibition DME1056 XEOTICID XEO02780 XEO_NAME Cefixime DME1056 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1056 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1056 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO02780 GENEFORM Protein DME1056 XEOTICID XEO02780 MOACRIVE Inhibition DME1056 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1056 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO02942 XEO_CLAS Peptide DME1056 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO02942 GENEFORM Protein DME1056 XEOTICID XEO02942 MOACRIVE Inhibition DME1056 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1056 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03029 XEO_CLAS Peptide DME1056 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 0.145 microM) DME1056 XEOTICID XEO03029 GENEFORM Protein DME1056 XEOTICID XEO03029 MOACRIVE Inhibition DME1056 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1056 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03030 XEO_CLAS Peptide DME1056 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 0.643 microM) DME1056 XEOTICID XEO03030 GENEFORM Protein DME1056 XEOTICID XEO03030 MOACRIVE Inhibition DME1056 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1056 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03031 XEO_CLAS Peptide DME1056 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 0.01 microM) DME1056 XEOTICID XEO03031 GENEFORM Protein DME1056 XEOTICID XEO03031 MOACRIVE Inhibition DME1056 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1056 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03032 XEO_CLAS Peptide DME1056 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC < 0.005 microM) DME1056 XEOTICID XEO03032 GENEFORM Protein DME1056 XEOTICID XEO03032 MOACRIVE Inhibition DME1056 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1056 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03033 XEO_CLAS Peptide DME1056 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC > 0.692 microM) DME1056 XEOTICID XEO03033 GENEFORM Protein DME1056 XEOTICID XEO03033 MOACRIVE Inhibition DME1056 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1056 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03034 XEO_CLAS Peptide DME1056 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 0.004 microM) DME1056 XEOTICID XEO03034 GENEFORM Protein DME1056 XEOTICID XEO03034 MOACRIVE Inhibition DME1056 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1056 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03035 XEO_CLAS Peptide DME1056 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 0.458 microM) DME1056 XEOTICID XEO03035 GENEFORM Protein DME1056 XEOTICID XEO03035 MOACRIVE Inhibition DME1056 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1056 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03051 XEO_CLAS Peptide DME1056 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1056 XEOTICID XEO03051 GENEFORM Protein DME1056 XEOTICID XEO03051 MOACRIVE Inhibition DME1056 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1056 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03052 XEO_CLAS Peptide DME1056 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1056 XEOTICID XEO03052 GENEFORM Protein DME1056 XEOTICID XEO03052 MOACRIVE Inhibition DME1056 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1056 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03053 XEO_CLAS Peptide DME1056 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1056 XEOTICID XEO03053 GENEFORM Protein DME1056 XEOTICID XEO03053 MOACRIVE Inhibition DME1056 XEOTICID XEO03089 XEO_NAME Decoralin DME1056 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03089 XEO_CLAS Peptide DME1056 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 80 microM) DME1056 XEOTICID XEO03089 GENEFORM Protein DME1056 XEOTICID XEO03089 MOACRIVE Inhibition DME1056 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1056 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03112 XEO_CLAS Peptide DME1056 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC > 50 ug/ml) DME1056 XEOTICID XEO03112 GENEFORM Protein DME1056 XEOTICID XEO03112 MOACRIVE Inhibition DME1056 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1056 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03137 XEO_CLAS Peptide DME1056 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03137 GENEFORM Protein DME1056 XEOTICID XEO03137 MOACRIVE Inhibition DME1056 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1056 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03162 XEO_CLAS Peptide DME1056 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 0.8 microM) DME1056 XEOTICID XEO03162 GENEFORM Protein DME1056 XEOTICID XEO03162 MOACRIVE Inhibition DME1056 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1056 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03224 XEO_CLAS Peptide DME1056 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1056 XEOTICID XEO03224 GENEFORM Protein DME1056 XEOTICID XEO03224 MOACRIVE Inhibition DME1056 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1056 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03235 XEO_CLAS Peptide DME1056 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 60 ug/ml) DME1056 XEOTICID XEO03235 GENEFORM Protein DME1056 XEOTICID XEO03235 MOACRIVE Inhibition DME1056 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1056 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03237 XEO_CLAS Peptide DME1056 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC > 100 ug/ml) DME1056 XEOTICID XEO03237 GENEFORM Protein DME1056 XEOTICID XEO03237 MOACRIVE Inhibition DME1056 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1056 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03238 XEO_CLAS Peptide DME1056 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1056 XEOTICID XEO03238 GENEFORM Protein DME1056 XEOTICID XEO03238 MOACRIVE Inhibition DME1056 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1056 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03239 XEO_CLAS Peptide DME1056 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1056 XEOTICID XEO03239 GENEFORM Protein DME1056 XEOTICID XEO03239 MOACRIVE Inhibition DME1056 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1056 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03250 XEO_CLAS Peptide DME1056 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03250 GENEFORM Protein DME1056 XEOTICID XEO03250 MOACRIVE Inhibition DME1056 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1056 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03251 XEO_CLAS Peptide DME1056 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03251 GENEFORM Protein DME1056 XEOTICID XEO03251 MOACRIVE Inhibition DME1056 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1056 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03253 XEO_CLAS Peptide DME1056 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 3.2 ug/ml) DME1056 XEOTICID XEO03253 GENEFORM Protein DME1056 XEOTICID XEO03253 MOACRIVE Inhibition DME1056 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1056 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1056 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1056 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03348 GENEFORM Protein DME1056 XEOTICID XEO03348 MOACRIVE Inhibition DME1056 XEOTICID XEO03387 XEO_NAME Ferric chloride DME1056 XEOTICID XEO03387 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1056 XEOTICID XEO03387 XEO_CLAS Chemical Compound DME1056 XEOTICID XEO03387 DESCRIPT Ferric chloride inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03387 GENEFORM Protein DME1056 XEOTICID XEO03387 MOACRIVE Inhibition DME1056 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1056 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03436 XEO_CLAS Peptide DME1056 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1056 XEOTICID XEO03436 GENEFORM Protein DME1056 XEOTICID XEO03436 MOACRIVE Inhibition DME1056 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1056 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03437 XEO_CLAS Peptide DME1056 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1056 XEOTICID XEO03437 GENEFORM Protein DME1056 XEOTICID XEO03437 MOACRIVE Inhibition DME1056 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1056 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03438 XEO_CLAS Peptide DME1056 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1056 XEOTICID XEO03438 GENEFORM Protein DME1056 XEOTICID XEO03438 MOACRIVE Inhibition DME1056 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1056 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03439 XEO_CLAS Peptide DME1056 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1056 XEOTICID XEO03439 GENEFORM Protein DME1056 XEOTICID XEO03439 MOACRIVE Inhibition DME1056 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1056 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03440 XEO_CLAS Peptide DME1056 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1056 XEOTICID XEO03440 GENEFORM Protein DME1056 XEOTICID XEO03440 MOACRIVE Inhibition DME1056 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1056 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03441 XEO_CLAS Peptide DME1056 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1056 XEOTICID XEO03441 GENEFORM Protein DME1056 XEOTICID XEO03441 MOACRIVE Inhibition DME1056 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1056 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03497 XEO_CLAS Peptide DME1056 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1056 XEOTICID XEO03497 GENEFORM Protein DME1056 XEOTICID XEO03497 MOACRIVE Inhibition DME1056 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1056 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03498 XEO_CLAS Peptide DME1056 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1056 XEOTICID XEO03498 GENEFORM Protein DME1056 XEOTICID XEO03498 MOACRIVE Inhibition DME1056 XEOTICID XEO03519 XEO_NAME Hadrurin DME1056 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03519 XEO_CLAS Peptide DME1056 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03519 GENEFORM Protein DME1056 XEOTICID XEO03519 MOACRIVE Inhibition DME1056 XEOTICID XEO03522 XEO_NAME Halocyntin DME1056 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03522 XEO_CLAS Peptide DME1056 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03522 GENEFORM Protein DME1056 XEOTICID XEO03522 MOACRIVE Inhibition DME1056 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1056 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03540 XEO_CLAS Peptide DME1056 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1056 XEOTICID XEO03540 GENEFORM Protein DME1056 XEOTICID XEO03540 MOACRIVE Inhibition DME1056 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1056 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03549 XEO_CLAS Peptide DME1056 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03549 GENEFORM Protein DME1056 XEOTICID XEO03549 MOACRIVE Inhibition DME1056 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1056 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1056 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1056 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03552 GENEFORM Protein DME1056 XEOTICID XEO03552 MOACRIVE Inhibition DME1056 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1056 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03556 XEO_CLAS Peptide DME1056 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1056 XEOTICID XEO03556 GENEFORM Protein DME1056 XEOTICID XEO03556 MOACRIVE Inhibition DME1056 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1056 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03557 XEO_CLAS Peptide DME1056 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1056 XEOTICID XEO03557 GENEFORM Protein DME1056 XEOTICID XEO03557 MOACRIVE Inhibition DME1056 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1056 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03591 XEO_CLAS Peptide DME1056 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1056 XEOTICID XEO03591 GENEFORM Protein DME1056 XEOTICID XEO03591 MOACRIVE Inhibition DME1056 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1056 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03593 XEO_CLAS Peptide DME1056 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1056 XEOTICID XEO03593 GENEFORM Protein DME1056 XEOTICID XEO03593 MOACRIVE Inhibition DME1056 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1056 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03609 XEO_CLAS Peptide DME1056 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03609 GENEFORM Protein DME1056 XEOTICID XEO03609 MOACRIVE Inhibition DME1056 XEOTICID XEO03611 XEO_NAME Himatanthus drasticus hydroalcoholic extract DME1056 XEOTICID XEO03611 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1056 XEOTICID XEO03611 XEO_CLAS Plant Extract DME1056 XEOTICID XEO03611 DESCRIPT Himatanthus drasticus hydroalcoholic extract inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03611 GENEFORM Protein DME1056 XEOTICID XEO03611 MOACRIVE Inhibition DME1056 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1056 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03622 XEO_CLAS Peptide DME1056 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 20-40 microM) DME1056 XEOTICID XEO03622 GENEFORM Protein DME1056 XEOTICID XEO03622 MOACRIVE Inhibition DME1056 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1056 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03630 XEO_CLAS Peptide DME1056 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03630 GENEFORM Protein DME1056 XEOTICID XEO03630 MOACRIVE Inhibition DME1056 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1056 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03631 XEO_CLAS Peptide DME1056 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03631 GENEFORM Protein DME1056 XEOTICID XEO03631 MOACRIVE Inhibition DME1056 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1056 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03632 XEO_CLAS Peptide DME1056 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03632 GENEFORM Protein DME1056 XEOTICID XEO03632 MOACRIVE Inhibition DME1056 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1056 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03633 XEO_CLAS Peptide DME1056 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03633 GENEFORM Protein DME1056 XEOTICID XEO03633 MOACRIVE Inhibition DME1056 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1056 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03634 XEO_CLAS Peptide DME1056 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03634 GENEFORM Protein DME1056 XEOTICID XEO03634 MOACRIVE Inhibition DME1056 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1056 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03635 XEO_CLAS Peptide DME1056 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03635 GENEFORM Protein DME1056 XEOTICID XEO03635 MOACRIVE Inhibition DME1056 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1056 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03636 XEO_CLAS Peptide DME1056 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03636 GENEFORM Protein DME1056 XEOTICID XEO03636 MOACRIVE Inhibition DME1056 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1056 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03637 XEO_CLAS Peptide DME1056 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03637 GENEFORM Protein DME1056 XEOTICID XEO03637 MOACRIVE Inhibition DME1056 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1056 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03638 XEO_CLAS Peptide DME1056 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03638 GENEFORM Protein DME1056 XEOTICID XEO03638 MOACRIVE Inhibition DME1056 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1056 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03639 XEO_CLAS Peptide DME1056 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03639 GENEFORM Protein DME1056 XEOTICID XEO03639 MOACRIVE Inhibition DME1056 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1056 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03640 XEO_CLAS Peptide DME1056 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03640 GENEFORM Protein DME1056 XEOTICID XEO03640 MOACRIVE Inhibition DME1056 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1056 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03672 XEO_CLAS Peptide DME1056 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1056 XEOTICID XEO03672 GENEFORM Protein DME1056 XEOTICID XEO03672 MOACRIVE Inhibition DME1056 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1056 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03673 XEO_CLAS Peptide DME1056 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1056 XEOTICID XEO03673 GENEFORM Protein DME1056 XEOTICID XEO03673 MOACRIVE Inhibition DME1056 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1056 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03674 XEO_CLAS Peptide DME1056 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO03674 GENEFORM Protein DME1056 XEOTICID XEO03674 MOACRIVE Inhibition DME1056 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1056 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03675 XEO_CLAS Peptide DME1056 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 15 microM) DME1056 XEOTICID XEO03675 GENEFORM Protein DME1056 XEOTICID XEO03675 MOACRIVE Inhibition DME1056 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1056 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03678 XEO_CLAS Peptide DME1056 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1056 XEOTICID XEO03678 GENEFORM Protein DME1056 XEOTICID XEO03678 MOACRIVE Inhibition DME1056 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1056 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03681 XEO_CLAS Peptide DME1056 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 1.2-2.5 microM) DME1056 XEOTICID XEO03681 GENEFORM Protein DME1056 XEOTICID XEO03681 MOACRIVE Inhibition DME1056 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1056 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03697 XEO_CLAS Peptide DME1056 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 25 microM) DME1056 XEOTICID XEO03697 GENEFORM Protein DME1056 XEOTICID XEO03697 MOACRIVE Inhibition DME1056 XEOTICID XEO03724 XEO_NAME L10 peptide DME1056 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03724 XEO_CLAS Peptide DME1056 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 3.35 microM) DME1056 XEOTICID XEO03724 GENEFORM Protein DME1056 XEOTICID XEO03724 MOACRIVE Inhibition DME1056 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1056 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03744 XEO_CLAS Peptide DME1056 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1056 XEOTICID XEO03744 GENEFORM Protein DME1056 XEOTICID XEO03744 MOACRIVE Inhibition DME1056 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1056 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03746 XEO_CLAS Peptide DME1056 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1056 XEOTICID XEO03746 GENEFORM Protein DME1056 XEOTICID XEO03746 MOACRIVE Inhibition DME1056 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1056 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03747 XEO_CLAS Peptide DME1056 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1056 XEOTICID XEO03747 GENEFORM Protein DME1056 XEOTICID XEO03747 MOACRIVE Inhibition DME1056 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1056 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03748 XEO_CLAS Peptide DME1056 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1056 XEOTICID XEO03748 GENEFORM Protein DME1056 XEOTICID XEO03748 MOACRIVE Inhibition DME1056 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1056 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03749 XEO_CLAS Peptide DME1056 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1056 XEOTICID XEO03749 GENEFORM Protein DME1056 XEOTICID XEO03749 MOACRIVE Inhibition DME1056 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1056 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03750 XEO_CLAS Peptide DME1056 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1056 XEOTICID XEO03750 GENEFORM Protein DME1056 XEOTICID XEO03750 MOACRIVE Inhibition DME1056 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1056 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03751 XEO_CLAS Peptide DME1056 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1056 XEOTICID XEO03751 GENEFORM Protein DME1056 XEOTICID XEO03751 MOACRIVE Inhibition DME1056 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1056 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03752 XEO_CLAS Peptide DME1056 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1056 XEOTICID XEO03752 GENEFORM Protein DME1056 XEOTICID XEO03752 MOACRIVE Inhibition DME1056 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1056 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03753 XEO_CLAS Peptide DME1056 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1056 XEOTICID XEO03753 GENEFORM Protein DME1056 XEOTICID XEO03753 MOACRIVE Inhibition DME1056 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1056 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03754 XEO_CLAS Peptide DME1056 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1056 XEOTICID XEO03754 GENEFORM Protein DME1056 XEOTICID XEO03754 MOACRIVE Inhibition DME1056 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1056 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03755 XEO_CLAS Peptide DME1056 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1056 XEOTICID XEO03755 GENEFORM Protein DME1056 XEOTICID XEO03755 MOACRIVE Inhibition DME1056 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1056 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03756 XEO_CLAS Peptide DME1056 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1056 XEOTICID XEO03756 GENEFORM Protein DME1056 XEOTICID XEO03756 MOACRIVE Inhibition DME1056 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1056 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03759 XEO_CLAS Peptide DME1056 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1056 XEOTICID XEO03759 GENEFORM Protein DME1056 XEOTICID XEO03759 MOACRIVE Inhibition DME1056 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1056 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03761 XEO_CLAS Peptide DME1056 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1056 XEOTICID XEO03761 GENEFORM Protein DME1056 XEOTICID XEO03761 MOACRIVE Inhibition DME1056 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1056 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO03985 XEO_CLAS Peptide DME1056 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1056 XEOTICID XEO03985 GENEFORM Protein DME1056 XEOTICID XEO03985 MOACRIVE Inhibition DME1056 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1056 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04001 XEO_CLAS Peptide DME1056 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 12.5 microM) DME1056 XEOTICID XEO04001 GENEFORM Protein DME1056 XEOTICID XEO04001 MOACRIVE Inhibition DME1056 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1056 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04007 XEO_CLAS Peptide DME1056 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1056 XEOTICID XEO04007 GENEFORM Protein DME1056 XEOTICID XEO04007 MOACRIVE Inhibition DME1056 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1056 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04011 XEO_CLAS Peptide DME1056 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1056 XEOTICID XEO04011 GENEFORM Protein DME1056 XEOTICID XEO04011 MOACRIVE Inhibition DME1056 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1056 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04012 XEO_CLAS Peptide DME1056 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1056 XEOTICID XEO04012 GENEFORM Protein DME1056 XEOTICID XEO04012 MOACRIVE Inhibition DME1056 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1056 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04013 XEO_CLAS Peptide DME1056 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1056 XEOTICID XEO04013 GENEFORM Protein DME1056 XEOTICID XEO04013 MOACRIVE Inhibition DME1056 XEOTICID XEO04014 XEO_NAME Maximin-5 DME1056 XEOTICID XEO04014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04014 XEO_CLAS Peptide DME1056 XEOTICID XEO04014 DESCRIPT Maximin-5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 3.6 ug/ml) DME1056 XEOTICID XEO04014 GENEFORM Protein DME1056 XEOTICID XEO04014 MOACRIVE Inhibition DME1056 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1056 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1056 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1056 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04087 GENEFORM Protein DME1056 XEOTICID XEO04087 MOACRIVE Inhibition DME1056 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1056 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04111 XEO_CLAS Peptide DME1056 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04111 GENEFORM Protein DME1056 XEOTICID XEO04111 MOACRIVE Inhibition DME1056 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1056 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04241 XEO_CLAS Peptide DME1056 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04241 GENEFORM Protein DME1056 XEOTICID XEO04241 MOACRIVE Inhibition DME1056 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1056 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04242 XEO_CLAS Peptide DME1056 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04242 GENEFORM Protein DME1056 XEOTICID XEO04242 MOACRIVE Inhibition DME1056 XEOTICID XEO04331 XEO_NAME Norspermidine DME1056 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1056 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1056 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04331 GENEFORM Protein DME1056 XEOTICID XEO04331 MOACRIVE Inhibition DME1056 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1056 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04348 XEO_CLAS Peptide DME1056 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 80 microM) DME1056 XEOTICID XEO04348 GENEFORM Protein DME1056 XEOTICID XEO04348 MOACRIVE Inhibition DME1056 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1056 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04349 XEO_CLAS Peptide DME1056 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 100 microM) DME1056 XEOTICID XEO04349 GENEFORM Protein DME1056 XEOTICID XEO04349 MOACRIVE Inhibition DME1056 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1056 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04399 XEO_CLAS Peptide DME1056 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 6.3 microM) DME1056 XEOTICID XEO04399 GENEFORM Protein DME1056 XEOTICID XEO04399 MOACRIVE Inhibition DME1056 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1056 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04426 XEO_CLAS Peptide DME1056 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 2 microM) DME1056 XEOTICID XEO04426 GENEFORM Protein DME1056 XEOTICID XEO04426 MOACRIVE Inhibition DME1056 XEOTICID XEO04468 XEO_NAME Papillosin DME1056 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04468 XEO_CLAS Peptide DME1056 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04468 GENEFORM Protein DME1056 XEOTICID XEO04468 MOACRIVE Inhibition DME1056 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1056 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04471 XEO_CLAS Peptide DME1056 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 1.6 microM) DME1056 XEOTICID XEO04471 GENEFORM Protein DME1056 XEOTICID XEO04471 MOACRIVE Inhibition DME1056 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1056 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04506 XEO_CLAS Peptide DME1056 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC > 20 microM) DME1056 XEOTICID XEO04506 GENEFORM Protein DME1056 XEOTICID XEO04506 MOACRIVE Inhibition DME1056 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1056 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04507 XEO_CLAS Peptide DME1056 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC > 40 microM) DME1056 XEOTICID XEO04507 GENEFORM Protein DME1056 XEOTICID XEO04507 MOACRIVE Inhibition DME1056 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1056 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04510 XEO_CLAS Peptide DME1056 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC > 50 microM) DME1056 XEOTICID XEO04510 GENEFORM Protein DME1056 XEOTICID XEO04510 MOACRIVE Inhibition DME1056 XEOTICID XEO04531 XEO_NAME Mollusca/molluscs/mollusks peptide 2 DME1056 XEOTICID XEO04531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04531 XEO_CLAS Peptide DME1056 XEOTICID XEO04531 DESCRIPT Mollusca/molluscs/mollusks peptide 2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04531 GENEFORM Protein DME1056 XEOTICID XEO04531 MOACRIVE Inhibition DME1056 XEOTICID XEO04533 XEO_NAME Mollusca/molluscs/mollusks peptide 3 DME1056 XEOTICID XEO04533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04533 XEO_CLAS Peptide DME1056 XEOTICID XEO04533 DESCRIPT Mollusca/molluscs/mollusks peptide 3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04533 GENEFORM Protein DME1056 XEOTICID XEO04533 MOACRIVE Inhibition DME1056 XEOTICID XEO04534 XEO_NAME Mollusca/molluscs/mollusks peptide 4 DME1056 XEOTICID XEO04534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04534 XEO_CLAS Peptide DME1056 XEOTICID XEO04534 DESCRIPT Mollusca/molluscs/mollusks peptide 4 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04534 GENEFORM Protein DME1056 XEOTICID XEO04534 MOACRIVE Inhibition DME1056 XEOTICID XEO04535 XEO_NAME Mollusca/molluscs/mollusks peptide 5 DME1056 XEOTICID XEO04535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04535 XEO_CLAS Peptide DME1056 XEOTICID XEO04535 DESCRIPT Mollusca/molluscs/mollusks peptide 5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04535 GENEFORM Protein DME1056 XEOTICID XEO04535 MOACRIVE Inhibition DME1056 XEOTICID XEO04536 XEO_NAME Mollusca/molluscs/mollusks peptide 6 DME1056 XEOTICID XEO04536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04536 XEO_CLAS Peptide DME1056 XEOTICID XEO04536 DESCRIPT Mollusca/molluscs/mollusks peptide 6 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04536 GENEFORM Protein DME1056 XEOTICID XEO04536 MOACRIVE Inhibition DME1056 XEOTICID XEO04537 XEO_NAME Mollusca/molluscs/mollusks peptide 7 DME1056 XEOTICID XEO04537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04537 XEO_CLAS Peptide DME1056 XEOTICID XEO04537 DESCRIPT Mollusca/molluscs/mollusks peptide 7 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04537 GENEFORM Protein DME1056 XEOTICID XEO04537 MOACRIVE Inhibition DME1056 XEOTICID XEO04538 XEO_NAME Mollusca/molluscs/mollusks peptide 8 DME1056 XEOTICID XEO04538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04538 XEO_CLAS Peptide DME1056 XEOTICID XEO04538 DESCRIPT Mollusca/molluscs/mollusks peptide 8 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04538 GENEFORM Protein DME1056 XEOTICID XEO04538 MOACRIVE Inhibition DME1056 XEOTICID XEO04539 XEO_NAME Mollusca/molluscs/mollusks peptide 9 DME1056 XEOTICID XEO04539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04539 XEO_CLAS Peptide DME1056 XEOTICID XEO04539 DESCRIPT Mollusca/molluscs/mollusks peptide 9 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04539 GENEFORM Protein DME1056 XEOTICID XEO04539 MOACRIVE Inhibition DME1056 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1056 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04548 XEO_CLAS Peptide DME1056 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 32000 ug/ml) DME1056 XEOTICID XEO04548 GENEFORM Protein DME1056 XEOTICID XEO04548 MOACRIVE Inhibition DME1056 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1056 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04549 XEO_CLAS Peptide DME1056 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 250-500 ug/ml) DME1056 XEOTICID XEO04549 GENEFORM Protein DME1056 XEOTICID XEO04549 MOACRIVE Inhibition DME1056 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1056 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04571 XEO_CLAS Peptide DME1056 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04571 GENEFORM Protein DME1056 XEOTICID XEO04571 MOACRIVE Inhibition DME1056 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1056 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04572 XEO_CLAS Peptide DME1056 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04572 GENEFORM Protein DME1056 XEOTICID XEO04572 MOACRIVE Inhibition DME1056 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1056 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04606 XEO_CLAS Peptide DME1056 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 2 microM) DME1056 XEOTICID XEO04606 GENEFORM Protein DME1056 XEOTICID XEO04606 MOACRIVE Inhibition DME1056 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1056 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04612 XEO_CLAS Peptide DME1056 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1056 XEOTICID XEO04612 GENEFORM Protein DME1056 XEOTICID XEO04612 MOACRIVE Inhibition DME1056 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1056 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04613 XEO_CLAS Peptide DME1056 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1056 XEOTICID XEO04613 GENEFORM Protein DME1056 XEOTICID XEO04613 MOACRIVE Inhibition DME1056 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1056 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04695 XEO_CLAS Peptide DME1056 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04695 GENEFORM Protein DME1056 XEOTICID XEO04695 MOACRIVE Inhibition DME1056 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1056 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04696 XEO_CLAS Peptide DME1056 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04696 GENEFORM Protein DME1056 XEOTICID XEO04696 MOACRIVE Inhibition DME1056 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1056 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04697 XEO_CLAS Peptide DME1056 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04697 GENEFORM Protein DME1056 XEOTICID XEO04697 MOACRIVE Inhibition DME1056 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1056 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04698 XEO_CLAS Peptide DME1056 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04698 GENEFORM Protein DME1056 XEOTICID XEO04698 MOACRIVE Inhibition DME1056 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1056 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04699 XEO_CLAS Peptide DME1056 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04699 GENEFORM Protein DME1056 XEOTICID XEO04699 MOACRIVE Inhibition DME1056 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1056 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04700 XEO_CLAS Peptide DME1056 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04700 GENEFORM Protein DME1056 XEOTICID XEO04700 MOACRIVE Inhibition DME1056 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1056 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04701 XEO_CLAS Peptide DME1056 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04701 GENEFORM Protein DME1056 XEOTICID XEO04701 MOACRIVE Inhibition DME1056 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1056 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04702 XEO_CLAS Peptide DME1056 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04702 GENEFORM Protein DME1056 XEOTICID XEO04702 MOACRIVE Inhibition DME1056 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1056 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04703 XEO_CLAS Peptide DME1056 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04703 GENEFORM Protein DME1056 XEOTICID XEO04703 MOACRIVE Inhibition DME1056 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1056 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04762 XEO_CLAS Peptide DME1056 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC > 25 microM) DME1056 XEOTICID XEO04762 GENEFORM Protein DME1056 XEOTICID XEO04762 MOACRIVE Inhibition DME1056 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1056 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04809 XEO_CLAS Peptide DME1056 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 10 microM) DME1056 XEOTICID XEO04809 GENEFORM Protein DME1056 XEOTICID XEO04809 MOACRIVE Inhibition DME1056 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1056 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04891 XEO_CLAS Peptide DME1056 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04891 GENEFORM Protein DME1056 XEOTICID XEO04891 MOACRIVE Inhibition DME1056 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1056 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04905 XEO_CLAS Peptide DME1056 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04905 GENEFORM Protein DME1056 XEOTICID XEO04905 MOACRIVE Inhibition DME1056 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1056 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04906 XEO_CLAS Peptide DME1056 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO04906 GENEFORM Protein DME1056 XEOTICID XEO04906 MOACRIVE Inhibition DME1056 XEOTICID XEO04917 XEO_NAME Scorpine DME1056 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04917 XEO_CLAS Peptide DME1056 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 10 microM) DME1056 XEOTICID XEO04917 GENEFORM Protein DME1056 XEOTICID XEO04917 MOACRIVE Inhibition DME1056 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1056 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04971 XEO_CLAS Peptide DME1056 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1056 XEOTICID XEO04971 GENEFORM Protein DME1056 XEOTICID XEO04971 MOACRIVE Inhibition DME1056 XEOTICID XEO04974 XEO_NAME Spinigerin DME1056 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04974 XEO_CLAS Peptide DME1056 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1056 XEOTICID XEO04974 GENEFORM Protein DME1056 XEOTICID XEO04974 MOACRIVE Inhibition DME1056 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1056 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO04995 XEO_CLAS Peptide DME1056 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 0.78-1.56 microM) DME1056 XEOTICID XEO04995 GENEFORM Protein DME1056 XEOTICID XEO04995 MOACRIVE Inhibition DME1056 XEOTICID XEO05020 XEO_NAME Tachycitin DME1056 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO05020 XEO_CLAS Peptide DME1056 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae DME1056 XEOTICID XEO05020 GENEFORM Protein DME1056 XEOTICID XEO05020 MOACRIVE Inhibition DME1056 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1056 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO05073 XEO_CLAS Peptide DME1056 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 80 microM) DME1056 XEOTICID XEO05073 GENEFORM Protein DME1056 XEOTICID XEO05073 MOACRIVE Inhibition DME1056 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1056 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO05075 XEO_CLAS Peptide DME1056 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 80 microM) DME1056 XEOTICID XEO05075 GENEFORM Protein DME1056 XEOTICID XEO05075 MOACRIVE Inhibition DME1056 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1056 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO05101 XEO_CLAS Peptide DME1056 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 31.2 ug/ml) DME1056 XEOTICID XEO05101 GENEFORM Protein DME1056 XEOTICID XEO05101 MOACRIVE Inhibition DME1056 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1056 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO05102 XEO_CLAS Peptide DME1056 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 35.1 ug/ml) DME1056 XEOTICID XEO05102 GENEFORM Protein DME1056 XEOTICID XEO05102 MOACRIVE Inhibition DME1056 XEOTICID XEO05120 XEO_NAME Thanatin DME1056 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO05120 XEO_CLAS Peptide DME1056 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 0.6-1.2 microM) DME1056 XEOTICID XEO05120 GENEFORM Protein DME1056 XEOTICID XEO05120 MOACRIVE Inhibition DME1056 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1056 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO05163 XEO_CLAS Peptide DME1056 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 12-25 ug/ml) DME1056 XEOTICID XEO05163 GENEFORM Protein DME1056 XEOTICID XEO05163 MOACRIVE Inhibition DME1056 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1056 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1056 XEOTICID XEO05220 XEO_CLAS Peptide DME1056 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Cytidine deaminase (cdd) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1056 XEOTICID XEO05220 GENEFORM Protein DME1056 XEOTICID XEO05220 MOACRIVE Inhibition DME1057 DME___ID DME1057 DME1057 DME_NAME Catechol-2,3-dioxygenase (caD) DME1057 SPESNAME Bacillus pumilus DME1057 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1057 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1057 XEOTICID XEO05230 XEO_CLAS Peptide DME1057 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Catechol-2,3-dioxygenase (caD) from Bacillus pumilus (MIC = 2 microM) DME1057 XEOTICID XEO05230 GENEFORM Protein DME1057 XEOTICID XEO05230 MOACRIVE Inhibition DME1057 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1057 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1057 XEOTICID XEO05231 XEO_CLAS Peptide DME1057 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Catechol-2,3-dioxygenase (caD) from Bacillus pumilus (MIC = 0.60 microM) DME1057 XEOTICID XEO05231 GENEFORM Protein DME1057 XEOTICID XEO05231 MOACRIVE Inhibition DME1057 XEOTICID XEO05260 XEO_NAME V. philippinarum beta defensin VpBD DME1057 XEOTICID XEO05260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1057 XEOTICID XEO05260 XEO_CLAS Peptide DME1057 XEOTICID XEO05260 DESCRIPT V. philippinarum beta defensin VpBD inhibits the drug-metabolizing activity of Catechol-2,3-dioxygenase (caD) from Bacillus pumilus (MIC = 13.13-26.26 microM) DME1057 XEOTICID XEO05260 GENEFORM Protein DME1057 XEOTICID XEO05260 MOACRIVE Inhibition DME1058 DME___ID DME1058 DME1058 DME_NAME Propanediol dehydrogenase (dhaT) DME1058 SPESNAME Lactobacillus brevis DME1058 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1058 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1058 XEOTICID XEO03771 XEO_CLAS Peptide DME1058 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Propanediol dehydrogenase (dhaT) from Lactobacillus brevis DME1058 XEOTICID XEO03771 GENEFORM Protein DME1058 XEOTICID XEO03771 MOACRIVE Inhibition DME1061 DME___ID DME1061 DME1061 DME_NAME Tyrosine decarboxylase (tdc) DME1061 SPESNAME Enterococcus faecalis DME1061 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1061 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1061 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1061 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO00546 GENEFORM Protein DME1061 XEOTICID XEO00546 MOACRIVE Inhibition DME1061 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1061 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO01812 XEO_CLAS Peptide DME1061 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 1.9 microM) DME1061 XEOTICID XEO01812 GENEFORM Protein DME1061 XEOTICID XEO01812 MOACRIVE Inhibition DME1061 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1061 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO01813 XEO_CLAS Peptide DME1061 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 1.4 microM) DME1061 XEOTICID XEO01813 GENEFORM Protein DME1061 XEOTICID XEO01813 MOACRIVE Inhibition DME1061 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1061 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO01814 XEO_CLAS Peptide DME1061 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 0.7 microM) DME1061 XEOTICID XEO01814 GENEFORM Protein DME1061 XEOTICID XEO01814 MOACRIVE Inhibition DME1061 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1061 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO01815 XEO_CLAS Peptide DME1061 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 1.0 microM) DME1061 XEOTICID XEO01815 GENEFORM Protein DME1061 XEOTICID XEO01815 MOACRIVE Inhibition DME1061 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1061 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1061 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1061 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO01961 GENEFORM Protein DME1061 XEOTICID XEO01961 MOACRIVE Inhibition DME1061 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1061 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1061 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1061 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO01966 GENEFORM Protein DME1061 XEOTICID XEO01966 MOACRIVE Inhibition DME1061 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1061 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02122 XEO_CLAS Peptide DME1061 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 50 ug/ml) DME1061 XEOTICID XEO02122 GENEFORM Protein DME1061 XEOTICID XEO02122 MOACRIVE Inhibition DME1061 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1061 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02247 XEO_CLAS Peptide DME1061 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02247 GENEFORM Protein DME1061 XEOTICID XEO02247 MOACRIVE Inhibition DME1061 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1061 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02319 XEO_CLAS Peptide DME1061 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02319 GENEFORM Protein DME1061 XEOTICID XEO02319 MOACRIVE Inhibition DME1061 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1061 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02325 XEO_CLAS Peptide DME1061 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 100 microM) DME1061 XEOTICID XEO02325 GENEFORM Protein DME1061 XEOTICID XEO02325 MOACRIVE Inhibition DME1061 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1061 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02355 XEO_CLAS Peptide DME1061 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 17 ug/ml) DME1061 XEOTICID XEO02355 GENEFORM Protein DME1061 XEOTICID XEO02355 MOACRIVE Inhibition DME1061 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1061 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02356 XEO_CLAS Peptide DME1061 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 32 ug/ml) DME1061 XEOTICID XEO02356 GENEFORM Protein DME1061 XEOTICID XEO02356 MOACRIVE Inhibition DME1061 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1061 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02357 XEO_CLAS Peptide DME1061 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 16 ug/ml) DME1061 XEOTICID XEO02357 GENEFORM Protein DME1061 XEOTICID XEO02357 MOACRIVE Inhibition DME1061 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1061 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02358 XEO_CLAS Peptide DME1061 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 8 ug/ml) DME1061 XEOTICID XEO02358 GENEFORM Protein DME1061 XEOTICID XEO02358 MOACRIVE Inhibition DME1061 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1061 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02360 XEO_CLAS Peptide DME1061 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 2 ug/ml) DME1061 XEOTICID XEO02360 GENEFORM Protein DME1061 XEOTICID XEO02360 MOACRIVE Inhibition DME1061 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1061 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02361 XEO_CLAS Peptide DME1061 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 32 ug/ml) DME1061 XEOTICID XEO02361 GENEFORM Protein DME1061 XEOTICID XEO02361 MOACRIVE Inhibition DME1061 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1061 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02365 XEO_CLAS Peptide DME1061 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 64 ug/ml) DME1061 XEOTICID XEO02365 GENEFORM Protein DME1061 XEOTICID XEO02365 MOACRIVE Inhibition DME1061 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1061 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02366 XEO_CLAS Peptide DME1061 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 32 ug/ml) DME1061 XEOTICID XEO02366 GENEFORM Protein DME1061 XEOTICID XEO02366 MOACRIVE Inhibition DME1061 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1061 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02367 XEO_CLAS Peptide DME1061 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 32 ug/ml) DME1061 XEOTICID XEO02367 GENEFORM Protein DME1061 XEOTICID XEO02367 MOACRIVE Inhibition DME1061 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1061 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02368 XEO_CLAS Peptide DME1061 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 64 ug/ml) DME1061 XEOTICID XEO02368 GENEFORM Protein DME1061 XEOTICID XEO02368 MOACRIVE Inhibition DME1061 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1061 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02369 XEO_CLAS Peptide DME1061 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 32 ug/ml) DME1061 XEOTICID XEO02369 GENEFORM Protein DME1061 XEOTICID XEO02369 MOACRIVE Inhibition DME1061 XEOTICID XEO02377 XEO_NAME Bacteriocin hiracin-JM79 DME1061 XEOTICID XEO02377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02377 XEO_CLAS Peptide DME1061 XEOTICID XEO02377 DESCRIPT Bacteriocin hiracin-JM79 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02377 GENEFORM Protein DME1061 XEOTICID XEO02377 MOACRIVE Inhibition DME1061 XEOTICID XEO02382 XEO_NAME Bacteriocin plantarican ASM1 DME1061 XEOTICID XEO02382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02382 XEO_CLAS Peptide DME1061 XEOTICID XEO02382 DESCRIPT Bacteriocin plantarican ASM1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02382 GENEFORM Protein DME1061 XEOTICID XEO02382 MOACRIVE Inhibition DME1061 XEOTICID XEO02386 XEO_NAME Bactridin-1 DME1061 XEOTICID XEO02386 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02386 XEO_CLAS Peptide DME1061 XEOTICID XEO02386 DESCRIPT Bactridin-1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 34 microM) DME1061 XEOTICID XEO02386 GENEFORM Protein DME1061 XEOTICID XEO02386 MOACRIVE Inhibition DME1061 XEOTICID XEO02387 XEO_NAME Bactridin-2 DME1061 XEOTICID XEO02387 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02387 XEO_CLAS Peptide DME1061 XEOTICID XEO02387 DESCRIPT Bactridin-2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 65 microM) DME1061 XEOTICID XEO02387 GENEFORM Protein DME1061 XEOTICID XEO02387 MOACRIVE Inhibition DME1061 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1061 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02388 XEO_CLAS Peptide DME1061 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 8 ug/ml) DME1061 XEOTICID XEO02388 GENEFORM Protein DME1061 XEOTICID XEO02388 MOACRIVE Inhibition DME1061 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1061 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02389 XEO_CLAS Peptide DME1061 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 2 ug/ml) DME1061 XEOTICID XEO02389 GENEFORM Protein DME1061 XEOTICID XEO02389 MOACRIVE Inhibition DME1061 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1061 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02463 XEO_CLAS Peptide DME1061 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 15 microM) DME1061 XEOTICID XEO02463 GENEFORM Protein DME1061 XEOTICID XEO02463 MOACRIVE Inhibition DME1061 XEOTICID XEO02465 XEO_NAME BMAP-28 DME1061 XEOTICID XEO02465 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02465 XEO_CLAS Peptide DME1061 XEOTICID XEO02465 DESCRIPT BMAP-28 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02465 GENEFORM Protein DME1061 XEOTICID XEO02465 MOACRIVE Inhibition DME1061 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1061 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02491 XEO_CLAS Peptide DME1061 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 57.1 microM) DME1061 XEOTICID XEO02491 GENEFORM Protein DME1061 XEOTICID XEO02491 MOACRIVE Inhibition DME1061 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1061 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02496 XEO_CLAS Peptide DME1061 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 13 microM) DME1061 XEOTICID XEO02496 GENEFORM Protein DME1061 XEOTICID XEO02496 MOACRIVE Inhibition DME1061 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1061 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02497 XEO_CLAS Peptide DME1061 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 6 microM) DME1061 XEOTICID XEO02497 GENEFORM Protein DME1061 XEOTICID XEO02497 MOACRIVE Inhibition DME1061 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1061 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02509 XEO_CLAS Peptide DME1061 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 19 microM) DME1061 XEOTICID XEO02509 GENEFORM Protein DME1061 XEOTICID XEO02509 MOACRIVE Inhibition DME1061 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1061 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02510 XEO_CLAS Peptide DME1061 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 75 microM) DME1061 XEOTICID XEO02510 GENEFORM Protein DME1061 XEOTICID XEO02510 MOACRIVE Inhibition DME1061 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1061 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02511 XEO_CLAS Peptide DME1061 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 9 microM) DME1061 XEOTICID XEO02511 GENEFORM Protein DME1061 XEOTICID XEO02511 MOACRIVE Inhibition DME1061 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1061 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02512 XEO_CLAS Peptide DME1061 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 9 microM) DME1061 XEOTICID XEO02512 GENEFORM Protein DME1061 XEOTICID XEO02512 MOACRIVE Inhibition DME1061 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1061 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02524 XEO_CLAS Peptide DME1061 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 19 microM) DME1061 XEOTICID XEO02524 GENEFORM Protein DME1061 XEOTICID XEO02524 MOACRIVE Inhibition DME1061 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1061 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02566 XEO_CLAS Peptide DME1061 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 50 microM) DME1061 XEOTICID XEO02566 GENEFORM Protein DME1061 XEOTICID XEO02566 MOACRIVE Inhibition DME1061 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1061 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02637 XEO_CLAS Peptide DME1061 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 25 microM) DME1061 XEOTICID XEO02637 GENEFORM Protein DME1061 XEOTICID XEO02637 MOACRIVE Inhibition DME1061 XEOTICID XEO02660 XEO_NAME Butyl gallate DME1061 XEOTICID XEO02660 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1061 XEOTICID XEO02660 XEO_CLAS Chemical Compound DME1061 XEOTICID XEO02660 DESCRIPT Butyl gallate inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02660 GENEFORM Protein DME1061 XEOTICID XEO02660 MOACRIVE Inhibition DME1061 XEOTICID XEO02718 XEO_NAME Carnobacteriocin CbnB2 DME1061 XEOTICID XEO02718 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02718 XEO_CLAS Peptide DME1061 XEOTICID XEO02718 DESCRIPT Carnobacteriocin CbnB2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02718 GENEFORM Protein DME1061 XEOTICID XEO02718 MOACRIVE Inhibition DME1061 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1061 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02721 XEO_CLAS Peptide DME1061 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02721 GENEFORM Protein DME1061 XEOTICID XEO02721 MOACRIVE Inhibition DME1061 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1061 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02820 XEO_CLAS Peptide DME1061 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 64 ug/ml) DME1061 XEOTICID XEO02820 GENEFORM Protein DME1061 XEOTICID XEO02820 MOACRIVE Inhibition DME1061 XEOTICID XEO02864 XEO_NAME Cathelicidin cjaRL-37 DME1061 XEOTICID XEO02864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02864 XEO_CLAS Peptide DME1061 XEOTICID XEO02864 DESCRIPT Cathelicidin cjaRL-37 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 32 microM) DME1061 XEOTICID XEO02864 GENEFORM Protein DME1061 XEOTICID XEO02864 MOACRIVE Inhibition DME1061 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1061 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02872 XEO_CLAS Peptide DME1061 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 300 microM) DME1061 XEOTICID XEO02872 GENEFORM Protein DME1061 XEOTICID XEO02872 MOACRIVE Inhibition DME1061 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1061 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02875 XEO_CLAS Peptide DME1061 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02875 GENEFORM Protein DME1061 XEOTICID XEO02875 MOACRIVE Inhibition DME1061 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1061 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02876 XEO_CLAS Peptide DME1061 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02876 GENEFORM Protein DME1061 XEOTICID XEO02876 MOACRIVE Inhibition DME1061 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1061 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02877 XEO_CLAS Peptide DME1061 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02877 GENEFORM Protein DME1061 XEOTICID XEO02877 MOACRIVE Inhibition DME1061 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1061 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02878 XEO_CLAS Peptide DME1061 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02878 GENEFORM Protein DME1061 XEOTICID XEO02878 MOACRIVE Inhibition DME1061 XEOTICID XEO02930 XEO_NAME Indolicidin derivative CP10A DME1061 XEOTICID XEO02930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02930 XEO_CLAS Peptide DME1061 XEOTICID XEO02930 DESCRIPT Indolicidin derivative CP10A inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 8 ug/ml) DME1061 XEOTICID XEO02930 GENEFORM Protein DME1061 XEOTICID XEO02930 MOACRIVE Inhibition DME1061 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1061 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02931 XEO_CLAS Peptide DME1061 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 64 ug/ml) DME1061 XEOTICID XEO02931 GENEFORM Protein DME1061 XEOTICID XEO02931 MOACRIVE Inhibition DME1061 XEOTICID XEO02932 XEO_NAME CP11CN peptide DME1061 XEOTICID XEO02932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02932 XEO_CLAS Peptide DME1061 XEOTICID XEO02932 DESCRIPT CP11CN peptide inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 64 ug/ml) DME1061 XEOTICID XEO02932 GENEFORM Protein DME1061 XEOTICID XEO02932 MOACRIVE Inhibition DME1061 XEOTICID XEO02955 XEO_NAME Cryptdin related sequence CRS4C-3c DME1061 XEOTICID XEO02955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02955 XEO_CLAS Peptide DME1061 XEOTICID XEO02955 DESCRIPT Cryptdin related sequence CRS4C-3c inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02955 GENEFORM Protein DME1061 XEOTICID XEO02955 MOACRIVE Inhibition DME1061 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1061 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02958 XEO_CLAS Peptide DME1061 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02958 GENEFORM Protein DME1061 XEOTICID XEO02958 MOACRIVE Inhibition DME1061 XEOTICID XEO02959 XEO_NAME Cryptdin related peptide CRS4C-1d DME1061 XEOTICID XEO02959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02959 XEO_CLAS Peptide DME1061 XEOTICID XEO02959 DESCRIPT Cryptdin related peptide CRS4C-1d inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02959 GENEFORM Protein DME1061 XEOTICID XEO02959 MOACRIVE Inhibition DME1061 XEOTICID XEO02960 XEO_NAME Cryptdin related peptide CRS4C-2 DME1061 XEOTICID XEO02960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02960 XEO_CLAS Peptide DME1061 XEOTICID XEO02960 DESCRIPT Cryptdin related peptide CRS4C-2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02960 GENEFORM Protein DME1061 XEOTICID XEO02960 MOACRIVE Inhibition DME1061 XEOTICID XEO02961 XEO_NAME Cryptdin related peptide CRS4C-2b DME1061 XEOTICID XEO02961 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO02961 XEO_CLAS Peptide DME1061 XEOTICID XEO02961 DESCRIPT Cryptdin related peptide CRS4C-2b inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO02961 GENEFORM Protein DME1061 XEOTICID XEO02961 MOACRIVE Inhibition DME1061 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1061 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03021 XEO_CLAS Peptide DME1061 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 1.25-2.50 microM) DME1061 XEOTICID XEO03021 GENEFORM Protein DME1061 XEOTICID XEO03021 MOACRIVE Inhibition DME1061 XEOTICID XEO03025 XEO_NAME Curvacin A DME1061 XEOTICID XEO03025 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03025 XEO_CLAS Peptide DME1061 XEOTICID XEO03025 DESCRIPT Curvacin A inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO03025 GENEFORM Protein DME1061 XEOTICID XEO03025 MOACRIVE Inhibition DME1061 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1061 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03073 XEO_CLAS Peptide DME1061 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 16 ug/ml) DME1061 XEOTICID XEO03073 GENEFORM Protein DME1061 XEOTICID XEO03073 MOACRIVE Inhibition DME1061 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1061 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03082 XEO_CLAS Peptide DME1061 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO03082 GENEFORM Protein DME1061 XEOTICID XEO03082 MOACRIVE Inhibition DME1061 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1061 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03137 XEO_CLAS Peptide DME1061 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO03137 GENEFORM Protein DME1061 XEOTICID XEO03137 MOACRIVE Inhibition DME1061 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1061 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03146 XEO_CLAS Peptide DME1061 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 10 microM) DME1061 XEOTICID XEO03146 GENEFORM Protein DME1061 XEOTICID XEO03146 MOACRIVE Inhibition DME1061 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1061 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03147 XEO_CLAS Peptide DME1061 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 38 microM) DME1061 XEOTICID XEO03147 GENEFORM Protein DME1061 XEOTICID XEO03147 MOACRIVE Inhibition DME1061 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1061 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03148 XEO_CLAS Peptide DME1061 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 22 microM) DME1061 XEOTICID XEO03148 GENEFORM Protein DME1061 XEOTICID XEO03148 MOACRIVE Inhibition DME1061 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1061 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03149 XEO_CLAS Peptide DME1061 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 11 microM) DME1061 XEOTICID XEO03149 GENEFORM Protein DME1061 XEOTICID XEO03149 MOACRIVE Inhibition DME1061 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1061 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03197 XEO_CLAS Peptide DME1061 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 14.5 microM) DME1061 XEOTICID XEO03197 GENEFORM Protein DME1061 XEOTICID XEO03197 MOACRIVE Inhibition DME1061 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1061 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03250 XEO_CLAS Peptide DME1061 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO03250 GENEFORM Protein DME1061 XEOTICID XEO03250 MOACRIVE Inhibition DME1061 XEOTICID XEO03252 XEO_NAME Enterocin B DME1061 XEOTICID XEO03252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03252 XEO_CLAS Peptide DME1061 XEOTICID XEO03252 DESCRIPT Enterocin B inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 0.0869 microM) DME1061 XEOTICID XEO03252 GENEFORM Protein DME1061 XEOTICID XEO03252 MOACRIVE Inhibition DME1061 XEOTICID XEO03254 XEO_NAME Enterocin EJ97 DME1061 XEOTICID XEO03254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03254 XEO_CLAS Peptide DME1061 XEOTICID XEO03254 DESCRIPT Enterocin EJ97 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 6 ug/ml) DME1061 XEOTICID XEO03254 GENEFORM Protein DME1061 XEOTICID XEO03254 MOACRIVE Inhibition DME1061 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1061 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03258 XEO_CLAS Peptide DME1061 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO03258 GENEFORM Protein DME1061 XEOTICID XEO03258 MOACRIVE Inhibition DME1061 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME1061 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03259 XEO_CLAS Peptide DME1061 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 0.0508 microM) DME1061 XEOTICID XEO03259 GENEFORM Protein DME1061 XEOTICID XEO03259 MOACRIVE Inhibition DME1061 XEOTICID XEO03260 XEO_NAME Enterocin X beta DME1061 XEOTICID XEO03260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03260 XEO_CLAS Peptide DME1061 XEOTICID XEO03260 DESCRIPT Enterocin X beta inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 0.813 microM) DME1061 XEOTICID XEO03260 GENEFORM Protein DME1061 XEOTICID XEO03260 MOACRIVE Inhibition DME1061 XEOTICID XEO03357 XEO_NAME Ethyl gallate DME1061 XEOTICID XEO03357 XEO_TYPE Pharmaceutical Agent(s) DME1061 XEOTICID XEO03357 XEO_CLAS Investigative Agent DME1061 XEOTICID XEO03357 DESCRIPT Ethyl gallate inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO03357 GENEFORM Protein DME1061 XEOTICID XEO03357 MOACRIVE Inhibition DME1061 XEOTICID XEO03381 XEO_NAME Fallaxidin 3.1 DME1061 XEOTICID XEO03381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03381 XEO_CLAS Peptide DME1061 XEOTICID XEO03381 DESCRIPT Fallaxidin 3.1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 100 microM) DME1061 XEOTICID XEO03381 GENEFORM Protein DME1061 XEOTICID XEO03381 MOACRIVE Inhibition DME1061 XEOTICID XEO03382 XEO_NAME Fallaxidin 3.2 DME1061 XEOTICID XEO03382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03382 XEO_CLAS Peptide DME1061 XEOTICID XEO03382 DESCRIPT Fallaxidin 3.2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 100 microM) DME1061 XEOTICID XEO03382 GENEFORM Protein DME1061 XEOTICID XEO03382 MOACRIVE Inhibition DME1061 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1061 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03428 XEO_CLAS Peptide DME1061 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 31 ug/ml) DME1061 XEOTICID XEO03428 GENEFORM Protein DME1061 XEOTICID XEO03428 MOACRIVE Inhibition DME1061 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1061 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03430 XEO_CLAS Peptide DME1061 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 31 ug/ml) DME1061 XEOTICID XEO03430 GENEFORM Protein DME1061 XEOTICID XEO03430 MOACRIVE Inhibition DME1061 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1061 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03434 XEO_CLAS Peptide DME1061 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 31 ug/ml) DME1061 XEOTICID XEO03434 GENEFORM Protein DME1061 XEOTICID XEO03434 MOACRIVE Inhibition DME1061 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1061 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03497 XEO_CLAS Peptide DME1061 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 6.2-12.5 microM) DME1061 XEOTICID XEO03497 GENEFORM Protein DME1061 XEOTICID XEO03497 MOACRIVE Inhibition DME1061 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1061 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03498 XEO_CLAS Peptide DME1061 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 6.2-12.5 microM) DME1061 XEOTICID XEO03498 GENEFORM Protein DME1061 XEOTICID XEO03498 MOACRIVE Inhibition DME1061 XEOTICID XEO03522 XEO_NAME Halocyntin DME1061 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03522 XEO_CLAS Peptide DME1061 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO03522 GENEFORM Protein DME1061 XEOTICID XEO03522 MOACRIVE Inhibition DME1061 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1061 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03540 XEO_CLAS Peptide DME1061 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 32 ug/ml) DME1061 XEOTICID XEO03540 GENEFORM Protein DME1061 XEOTICID XEO03540 MOACRIVE Inhibition DME1061 XEOTICID XEO03555 XEO_NAME Hexyl gallate DME1061 XEOTICID XEO03555 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1061 XEOTICID XEO03555 XEO_CLAS Chemical Compound DME1061 XEOTICID XEO03555 DESCRIPT Hexyl gallate inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO03555 GENEFORM Protein DME1061 XEOTICID XEO03555 MOACRIVE Inhibition DME1061 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1061 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03556 XEO_CLAS Peptide DME1061 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 32 ug/ml) DME1061 XEOTICID XEO03556 GENEFORM Protein DME1061 XEOTICID XEO03556 MOACRIVE Inhibition DME1061 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1061 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03557 XEO_CLAS Peptide DME1061 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 32 ug/ml) DME1061 XEOTICID XEO03557 GENEFORM Protein DME1061 XEOTICID XEO03557 MOACRIVE Inhibition DME1061 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1061 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03569 XEO_CLAS Peptide DME1061 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 300 microM) DME1061 XEOTICID XEO03569 GENEFORM Protein DME1061 XEOTICID XEO03569 MOACRIVE Inhibition DME1061 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1061 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03579 XEO_CLAS Peptide DME1061 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO03579 GENEFORM Protein DME1061 XEOTICID XEO03579 MOACRIVE Inhibition DME1061 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1061 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03588 XEO_CLAS Peptide DME1061 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 15 ug/ml) DME1061 XEOTICID XEO03588 GENEFORM Protein DME1061 XEOTICID XEO03588 MOACRIVE Inhibition DME1061 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1061 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03609 XEO_CLAS Peptide DME1061 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO03609 GENEFORM Protein DME1061 XEOTICID XEO03609 MOACRIVE Inhibition DME1061 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1061 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03616 XEO_CLAS Peptide DME1061 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 16 microM) DME1061 XEOTICID XEO03616 GENEFORM Protein DME1061 XEOTICID XEO03616 MOACRIVE Inhibition DME1061 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1061 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03675 XEO_CLAS Peptide DME1061 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 60 microM) DME1061 XEOTICID XEO03675 GENEFORM Protein DME1061 XEOTICID XEO03675 MOACRIVE Inhibition DME1061 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1061 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03684 XEO_CLAS Peptide DME1061 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 125 ug/ml) DME1061 XEOTICID XEO03684 GENEFORM Protein DME1061 XEOTICID XEO03684 MOACRIVE Inhibition DME1061 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1061 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03697 XEO_CLAS Peptide DME1061 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 12.5 microM) DME1061 XEOTICID XEO03697 GENEFORM Protein DME1061 XEOTICID XEO03697 MOACRIVE Inhibition DME1061 XEOTICID XEO03768 XEO_NAME Lactacin-F subunit LafA DME1061 XEOTICID XEO03768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03768 XEO_CLAS Peptide DME1061 XEOTICID XEO03768 DESCRIPT Lactacin-F subunit LafA inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO03768 GENEFORM Protein DME1061 XEOTICID XEO03768 MOACRIVE Inhibition DME1061 XEOTICID XEO03769 XEO_NAME Lactacin-F subunit LafX DME1061 XEOTICID XEO03769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03769 XEO_CLAS Peptide DME1061 XEOTICID XEO03769 DESCRIPT Lactacin-F subunit LafX inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO03769 GENEFORM Protein DME1061 XEOTICID XEO03769 MOACRIVE Inhibition DME1061 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1061 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03771 XEO_CLAS Peptide DME1061 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO03771 GENEFORM Protein DME1061 XEOTICID XEO03771 MOACRIVE Inhibition DME1061 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1061 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03793 XEO_CLAS Peptide DME1061 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 32 microM) DME1061 XEOTICID XEO03793 GENEFORM Protein DME1061 XEOTICID XEO03793 MOACRIVE Inhibition DME1061 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1061 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03854 XEO_CLAS Peptide DME1061 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 5.20 microM) DME1061 XEOTICID XEO03854 GENEFORM Protein DME1061 XEOTICID XEO03854 MOACRIVE Inhibition DME1061 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1061 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03855 XEO_CLAS Peptide DME1061 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 4.10 microM) DME1061 XEOTICID XEO03855 GENEFORM Protein DME1061 XEOTICID XEO03855 MOACRIVE Inhibition DME1061 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1061 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03873 XEO_CLAS Peptide DME1061 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 30 microM) DME1061 XEOTICID XEO03873 GENEFORM Protein DME1061 XEOTICID XEO03873 MOACRIVE Inhibition DME1061 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1061 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03874 XEO_CLAS Peptide DME1061 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 22.5 microM) DME1061 XEOTICID XEO03874 GENEFORM Protein DME1061 XEOTICID XEO03874 MOACRIVE Inhibition DME1061 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1061 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03875 XEO_CLAS Peptide DME1061 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 22.5 microM) DME1061 XEOTICID XEO03875 GENEFORM Protein DME1061 XEOTICID XEO03875 MOACRIVE Inhibition DME1061 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1061 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03876 XEO_CLAS Peptide DME1061 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 15 microM) DME1061 XEOTICID XEO03876 GENEFORM Protein DME1061 XEOTICID XEO03876 MOACRIVE Inhibition DME1061 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1061 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03877 XEO_CLAS Peptide DME1061 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 11.25 microM) DME1061 XEOTICID XEO03877 GENEFORM Protein DME1061 XEOTICID XEO03877 MOACRIVE Inhibition DME1061 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1061 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03878 XEO_CLAS Peptide DME1061 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 22.5 microM) DME1061 XEOTICID XEO03878 GENEFORM Protein DME1061 XEOTICID XEO03878 MOACRIVE Inhibition DME1061 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1061 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03904 XEO_CLAS Peptide DME1061 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 4 ug/ml) DME1061 XEOTICID XEO03904 GENEFORM Protein DME1061 XEOTICID XEO03904 MOACRIVE Inhibition DME1061 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1061 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03905 XEO_CLAS Peptide DME1061 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 16 ug/ml) DME1061 XEOTICID XEO03905 GENEFORM Protein DME1061 XEOTICID XEO03905 MOACRIVE Inhibition DME1061 XEOTICID XEO03986 XEO_NAME Magainin-I peptide DME1061 XEOTICID XEO03986 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO03986 XEO_CLAS Peptide DME1061 XEOTICID XEO03986 DESCRIPT Magainin-I peptide inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO03986 GENEFORM Protein DME1061 XEOTICID XEO03986 MOACRIVE Inhibition DME1061 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1061 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04001 XEO_CLAS Peptide DME1061 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 25 microM) DME1061 XEOTICID XEO04001 GENEFORM Protein DME1061 XEOTICID XEO04001 MOACRIVE Inhibition DME1061 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1061 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04051 XEO_CLAS Peptide DME1061 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 2.50-5.00 microM) DME1061 XEOTICID XEO04051 GENEFORM Protein DME1061 XEOTICID XEO04051 MOACRIVE Inhibition DME1061 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1061 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04052 XEO_CLAS Peptide DME1061 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04052 GENEFORM Protein DME1061 XEOTICID XEO04052 MOACRIVE Inhibition DME1061 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1061 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04053 XEO_CLAS Peptide DME1061 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 1.25-2.50 microM) DME1061 XEOTICID XEO04053 GENEFORM Protein DME1061 XEOTICID XEO04053 MOACRIVE Inhibition DME1061 XEOTICID XEO04106 XEO_NAME Methyl gallate DME1061 XEOTICID XEO04106 XEO_TYPE Pharmaceutical Agent(s) DME1061 XEOTICID XEO04106 XEO_CLAS Investigative Agent DME1061 XEOTICID XEO04106 DESCRIPT Methyl gallate inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04106 GENEFORM Protein DME1061 XEOTICID XEO04106 MOACRIVE Inhibition DME1061 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1061 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04118 XEO_CLAS Peptide DME1061 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 300 microM) DME1061 XEOTICID XEO04118 GENEFORM Protein DME1061 XEOTICID XEO04118 MOACRIVE Inhibition DME1061 XEOTICID XEO04150 XEO_NAME Mundticin ATO6 DME1061 XEOTICID XEO04150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04150 XEO_CLAS Peptide DME1061 XEOTICID XEO04150 DESCRIPT Mundticin ATO6 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04150 GENEFORM Protein DME1061 XEOTICID XEO04150 MOACRIVE Inhibition DME1061 XEOTICID XEO04151 XEO_NAME Mundticin KS DME1061 XEOTICID XEO04151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04151 XEO_CLAS Peptide DME1061 XEOTICID XEO04151 DESCRIPT Mundticin KS inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04151 GENEFORM Protein DME1061 XEOTICID XEO04151 MOACRIVE Inhibition DME1061 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1061 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04169 XEO_CLAS Peptide DME1061 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04169 GENEFORM Protein DME1061 XEOTICID XEO04169 MOACRIVE Inhibition DME1061 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1061 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04249 XEO_CLAS Peptide DME1061 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 500 ug/ml) DME1061 XEOTICID XEO04249 GENEFORM Protein DME1061 XEOTICID XEO04249 MOACRIVE Inhibition DME1061 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1061 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04259 XEO_CLAS Peptide DME1061 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04259 GENEFORM Protein DME1061 XEOTICID XEO04259 MOACRIVE Inhibition DME1061 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1061 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04261 XEO_CLAS Peptide DME1061 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04261 GENEFORM Protein DME1061 XEOTICID XEO04261 MOACRIVE Inhibition DME1061 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1061 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04265 XEO_CLAS Peptide DME1061 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04265 GENEFORM Protein DME1061 XEOTICID XEO04265 MOACRIVE Inhibition DME1061 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1061 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04268 XEO_CLAS Peptide DME1061 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04268 GENEFORM Protein DME1061 XEOTICID XEO04268 MOACRIVE Inhibition DME1061 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1061 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04399 XEO_CLAS Peptide DME1061 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 12.5 microM) DME1061 XEOTICID XEO04399 GENEFORM Protein DME1061 XEOTICID XEO04399 MOACRIVE Inhibition DME1061 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1061 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04444 XEO_CLAS Peptide DME1061 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 20 microM) DME1061 XEOTICID XEO04444 GENEFORM Protein DME1061 XEOTICID XEO04444 MOACRIVE Inhibition DME1061 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1061 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04461 XEO_CLAS Peptide DME1061 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 1.3 microM) DME1061 XEOTICID XEO04461 GENEFORM Protein DME1061 XEOTICID XEO04461 MOACRIVE Inhibition DME1061 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1061 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04462 XEO_CLAS Peptide DME1061 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 2.4 microM) DME1061 XEOTICID XEO04462 GENEFORM Protein DME1061 XEOTICID XEO04462 MOACRIVE Inhibition DME1061 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1061 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04463 XEO_CLAS Peptide DME1061 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04463 GENEFORM Protein DME1061 XEOTICID XEO04463 MOACRIVE Inhibition DME1061 XEOTICID XEO04468 XEO_NAME Papillosin DME1061 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04468 XEO_CLAS Peptide DME1061 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04468 GENEFORM Protein DME1061 XEOTICID XEO04468 MOACRIVE Inhibition DME1061 XEOTICID XEO04521 XEO_NAME Penocin A DME1061 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04521 XEO_CLAS Peptide DME1061 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04521 GENEFORM Protein DME1061 XEOTICID XEO04521 MOACRIVE Inhibition DME1061 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1061 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04569 XEO_CLAS Peptide DME1061 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 4.0 microM) DME1061 XEOTICID XEO04569 GENEFORM Protein DME1061 XEOTICID XEO04569 MOACRIVE Inhibition DME1061 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1061 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04612 XEO_CLAS Peptide DME1061 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 5-10 microM) DME1061 XEOTICID XEO04612 GENEFORM Protein DME1061 XEOTICID XEO04612 MOACRIVE Inhibition DME1061 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1061 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04613 XEO_CLAS Peptide DME1061 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 5-10 microM) DME1061 XEOTICID XEO04613 GENEFORM Protein DME1061 XEOTICID XEO04613 MOACRIVE Inhibition DME1061 XEOTICID XEO04622 XEO_NAME Plantaricin W alpha DME1061 XEOTICID XEO04622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04622 XEO_CLAS Peptide DME1061 XEOTICID XEO04622 DESCRIPT Plantaricin W alpha inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04622 GENEFORM Protein DME1061 XEOTICID XEO04622 MOACRIVE Inhibition DME1061 XEOTICID XEO04623 XEO_NAME Plantaricin W beta DME1061 XEOTICID XEO04623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04623 XEO_CLAS Peptide DME1061 XEOTICID XEO04623 DESCRIPT Plantaricin W beta inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04623 GENEFORM Protein DME1061 XEOTICID XEO04623 MOACRIVE Inhibition DME1061 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1061 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04657 XEO_CLAS Peptide DME1061 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 300 microM) DME1061 XEOTICID XEO04657 GENEFORM Protein DME1061 XEOTICID XEO04657 MOACRIVE Inhibition DME1061 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1061 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04660 XEO_CLAS Peptide DME1061 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 2 ug/ml) DME1061 XEOTICID XEO04660 GENEFORM Protein DME1061 XEOTICID XEO04660 MOACRIVE Inhibition DME1061 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1061 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04680 XEO_CLAS Peptide DME1061 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 1-2 microM) DME1061 XEOTICID XEO04680 GENEFORM Protein DME1061 XEOTICID XEO04680 MOACRIVE Inhibition DME1061 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1061 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04690 XEO_CLAS Peptide DME1061 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 1 ug/ml) DME1061 XEOTICID XEO04690 GENEFORM Protein DME1061 XEOTICID XEO04690 MOACRIVE Inhibition DME1061 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1061 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04695 XEO_CLAS Peptide DME1061 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04695 GENEFORM Protein DME1061 XEOTICID XEO04695 MOACRIVE Inhibition DME1061 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1061 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04696 XEO_CLAS Peptide DME1061 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04696 GENEFORM Protein DME1061 XEOTICID XEO04696 MOACRIVE Inhibition DME1061 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1061 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04699 XEO_CLAS Peptide DME1061 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04699 GENEFORM Protein DME1061 XEOTICID XEO04699 MOACRIVE Inhibition DME1061 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1061 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04700 XEO_CLAS Peptide DME1061 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04700 GENEFORM Protein DME1061 XEOTICID XEO04700 MOACRIVE Inhibition DME1061 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1061 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04701 XEO_CLAS Peptide DME1061 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04701 GENEFORM Protein DME1061 XEOTICID XEO04701 MOACRIVE Inhibition DME1061 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1061 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04702 XEO_CLAS Peptide DME1061 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04702 GENEFORM Protein DME1061 XEOTICID XEO04702 MOACRIVE Inhibition DME1061 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1061 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04703 XEO_CLAS Peptide DME1061 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04703 GENEFORM Protein DME1061 XEOTICID XEO04703 MOACRIVE Inhibition DME1061 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1061 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04704 XEO_CLAS Peptide DME1061 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04704 GENEFORM Protein DME1061 XEOTICID XEO04704 MOACRIVE Inhibition DME1061 XEOTICID XEO04727 XEO_NAME Propyl gallate DME1061 XEOTICID XEO04727 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1061 XEOTICID XEO04727 XEO_CLAS Food Additive DME1061 XEOTICID XEO04727 DESCRIPT Propyl gallate inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04727 GENEFORM Protein DME1061 XEOTICID XEO04727 MOACRIVE Inhibition DME1061 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1061 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04783 XEO_CLAS Peptide DME1061 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 8 ug/ml) DME1061 XEOTICID XEO04783 GENEFORM Protein DME1061 XEOTICID XEO04783 MOACRIVE Inhibition DME1061 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1061 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04784 XEO_CLAS Peptide DME1061 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 16 ug/ml) DME1061 XEOTICID XEO04784 GENEFORM Protein DME1061 XEOTICID XEO04784 MOACRIVE Inhibition DME1061 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1061 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04785 XEO_CLAS Peptide DME1061 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 8 ug/ml) DME1061 XEOTICID XEO04785 GENEFORM Protein DME1061 XEOTICID XEO04785 MOACRIVE Inhibition DME1061 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1061 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04786 XEO_CLAS Peptide DME1061 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 125 ug/ml) DME1061 XEOTICID XEO04786 GENEFORM Protein DME1061 XEOTICID XEO04786 MOACRIVE Inhibition DME1061 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1061 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04809 XEO_CLAS Peptide DME1061 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 40 microM) DME1061 XEOTICID XEO04809 GENEFORM Protein DME1061 XEOTICID XEO04809 MOACRIVE Inhibition DME1061 XEOTICID XEO04863 XEO_NAME RTD peptide DME1061 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04863 XEO_CLAS Peptide DME1061 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 1.2 microM) DME1061 XEOTICID XEO04863 GENEFORM Protein DME1061 XEOTICID XEO04863 MOACRIVE Inhibition DME1061 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1061 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04880 XEO_CLAS Peptide DME1061 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 12.7 ug/ml) DME1061 XEOTICID XEO04880 GENEFORM Protein DME1061 XEOTICID XEO04880 MOACRIVE Inhibition DME1061 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1061 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04886 XEO_CLAS Peptide DME1061 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 12.7 ug/ml) DME1061 XEOTICID XEO04886 GENEFORM Protein DME1061 XEOTICID XEO04886 MOACRIVE Inhibition DME1061 XEOTICID XEO04896 XEO_NAME Sakacin 5X DME1061 XEOTICID XEO04896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04896 XEO_CLAS Peptide DME1061 XEOTICID XEO04896 DESCRIPT Sakacin 5X inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04896 GENEFORM Protein DME1061 XEOTICID XEO04896 MOACRIVE Inhibition DME1061 XEOTICID XEO04898 XEO_NAME Sakacin P DME1061 XEOTICID XEO04898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04898 XEO_CLAS Peptide DME1061 XEOTICID XEO04898 DESCRIPT Sakacin P inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04898 GENEFORM Protein DME1061 XEOTICID XEO04898 MOACRIVE Inhibition DME1061 XEOTICID XEO04936 XEO_NAME Siamycin I DME1061 XEOTICID XEO04936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04936 XEO_CLAS Peptide DME1061 XEOTICID XEO04936 DESCRIPT Siamycin I inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO04936 GENEFORM Protein DME1061 XEOTICID XEO04936 MOACRIVE Inhibition DME1061 XEOTICID XEO04937 XEO_NAME Signiferin-2.1 DME1061 XEOTICID XEO04937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04937 XEO_CLAS Peptide DME1061 XEOTICID XEO04937 DESCRIPT Signiferin-2.1 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 100 microM) DME1061 XEOTICID XEO04937 GENEFORM Protein DME1061 XEOTICID XEO04937 MOACRIVE Inhibition DME1061 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1061 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04950 XEO_CLAS Peptide DME1061 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 10 ug/ml) DME1061 XEOTICID XEO04950 GENEFORM Protein DME1061 XEOTICID XEO04950 MOACRIVE Inhibition DME1061 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1061 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04995 XEO_CLAS Peptide DME1061 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 0.78-1.56 microM) DME1061 XEOTICID XEO04995 GENEFORM Protein DME1061 XEOTICID XEO04995 MOACRIVE Inhibition DME1061 XEOTICID XEO04998 XEO_NAME Styelin A DME1061 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04998 XEO_CLAS Peptide DME1061 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 2 ug/ml) DME1061 XEOTICID XEO04998 GENEFORM Protein DME1061 XEOTICID XEO04998 MOACRIVE Inhibition DME1061 XEOTICID XEO04999 XEO_NAME Styelin B DME1061 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO04999 XEO_CLAS Peptide DME1061 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 2 ug/ml) DME1061 XEOTICID XEO04999 GENEFORM Protein DME1061 XEOTICID XEO04999 MOACRIVE Inhibition DME1061 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1061 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05000 XEO_CLAS Peptide DME1061 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 4 ug/ml) DME1061 XEOTICID XEO05000 GENEFORM Protein DME1061 XEOTICID XEO05000 MOACRIVE Inhibition DME1061 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1061 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05001 XEO_CLAS Peptide DME1061 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 4 ug/ml) DME1061 XEOTICID XEO05001 GENEFORM Protein DME1061 XEOTICID XEO05001 MOACRIVE Inhibition DME1061 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1061 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05002 XEO_CLAS Peptide DME1061 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 2 ug/ml) DME1061 XEOTICID XEO05002 GENEFORM Protein DME1061 XEOTICID XEO05002 MOACRIVE Inhibition DME1061 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1061 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05003 XEO_CLAS Peptide DME1061 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 8 ug/ml) DME1061 XEOTICID XEO05003 GENEFORM Protein DME1061 XEOTICID XEO05003 MOACRIVE Inhibition DME1061 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1061 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05005 XEO_CLAS Peptide DME1061 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO05005 GENEFORM Protein DME1061 XEOTICID XEO05005 MOACRIVE Inhibition DME1061 XEOTICID XEO05006 XEO_NAME Substance P DME1061 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05006 XEO_CLAS Peptide DME1061 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO05006 GENEFORM Protein DME1061 XEOTICID XEO05006 MOACRIVE Inhibition DME1061 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1061 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05007 XEO_CLAS Peptide DME1061 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO05007 GENEFORM Protein DME1061 XEOTICID XEO05007 MOACRIVE Inhibition DME1061 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1061 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05063 XEO_CLAS Peptide DME1061 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 10 microM) DME1061 XEOTICID XEO05063 GENEFORM Protein DME1061 XEOTICID XEO05063 MOACRIVE Inhibition DME1061 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1061 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05064 XEO_CLAS Peptide DME1061 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 116 microM) DME1061 XEOTICID XEO05064 GENEFORM Protein DME1061 XEOTICID XEO05064 MOACRIVE Inhibition DME1061 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1061 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05065 XEO_CLAS Peptide DME1061 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC > 80 ug/ml) DME1061 XEOTICID XEO05065 GENEFORM Protein DME1061 XEOTICID XEO05065 MOACRIVE Inhibition DME1061 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1061 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05073 XEO_CLAS Peptide DME1061 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 40 microM) DME1061 XEOTICID XEO05073 GENEFORM Protein DME1061 XEOTICID XEO05073 MOACRIVE Inhibition DME1061 XEOTICID XEO05074 XEO_NAME Temporin-1Vb DME1061 XEOTICID XEO05074 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05074 XEO_CLAS Peptide DME1061 XEOTICID XEO05074 DESCRIPT Temporin-1Vb inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 20 microM) DME1061 XEOTICID XEO05074 GENEFORM Protein DME1061 XEOTICID XEO05074 MOACRIVE Inhibition DME1061 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1061 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05075 XEO_CLAS Peptide DME1061 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 40 microM) DME1061 XEOTICID XEO05075 GENEFORM Protein DME1061 XEOTICID XEO05075 MOACRIVE Inhibition DME1061 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1061 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05097 XEO_CLAS Peptide DME1061 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 8.0 microM) DME1061 XEOTICID XEO05097 GENEFORM Protein DME1061 XEOTICID XEO05097 MOACRIVE Inhibition DME1061 XEOTICID XEO05098 XEO_NAME Temporin-PEa DME1061 XEOTICID XEO05098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05098 XEO_CLAS Peptide DME1061 XEOTICID XEO05098 DESCRIPT Temporin-PEa inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 2.0 microM) DME1061 XEOTICID XEO05098 GENEFORM Protein DME1061 XEOTICID XEO05098 MOACRIVE Inhibition DME1061 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1061 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05099 XEO_CLAS Peptide DME1061 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 2.0 microM) DME1061 XEOTICID XEO05099 GENEFORM Protein DME1061 XEOTICID XEO05099 MOACRIVE Inhibition DME1061 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1061 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05170 XEO_CLAS Peptide DME1061 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 1.0 microM) DME1061 XEOTICID XEO05170 GENEFORM Protein DME1061 XEOTICID XEO05170 MOACRIVE Inhibition DME1061 XEOTICID XEO05196 XEO_NAME Ubericin-A DME1061 XEOTICID XEO05196 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05196 XEO_CLAS Peptide DME1061 XEOTICID XEO05196 DESCRIPT Ubericin-A inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO05196 GENEFORM Protein DME1061 XEOTICID XEO05196 MOACRIVE Inhibition DME1061 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1061 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05212 XEO_CLAS Peptide DME1061 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 50.8 ug/ml) DME1061 XEOTICID XEO05212 GENEFORM Protein DME1061 XEOTICID XEO05212 MOACRIVE Inhibition DME1061 XEOTICID XEO05224 XEO_NAME Vancomycin DME1061 XEOTICID XEO05224 XEO_TYPE Pharmaceutical Agent(s) DME1061 XEOTICID XEO05224 XEO_CLAS Approved/Marketed Drug DME1061 XEOTICID XEO05224 DESCRIPT Vancomycin inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO05224 GENEFORM Protein DME1061 XEOTICID XEO05224 MOACRIVE Inhibition DME1061 XEOTICID XEO05228 XEO_NAME Variacin DME1061 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05228 XEO_CLAS Peptide DME1061 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO05228 GENEFORM Protein DME1061 XEOTICID XEO05228 MOACRIVE Inhibition DME1061 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1061 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05264 XEO_CLAS Peptide DME1061 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 4 ug/ml) DME1061 XEOTICID XEO05264 GENEFORM Protein DME1061 XEOTICID XEO05264 MOACRIVE Inhibition DME1061 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1061 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05267 XEO_CLAS Peptide DME1061 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis (MIC = 2 ug/ml) DME1061 XEOTICID XEO05267 GENEFORM Protein DME1061 XEOTICID XEO05267 MOACRIVE Inhibition DME1061 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1061 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1061 XEOTICID XEO05283 XEO_CLAS Peptide DME1061 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Enterococcus faecalis DME1061 XEOTICID XEO05283 GENEFORM Protein DME1061 XEOTICID XEO05283 MOACRIVE Inhibition DME1063 DME___ID DME1063 DME1063 DME_NAME Nitroreductase (NTR) DME1063 SPESNAME Salmonella enterica DME1063 XEOTICID XEO01237 XEO_NAME Carvacrol DME1063 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1063 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1063 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO01237 GENEFORM Protein DME1063 XEOTICID XEO01237 MOACRIVE Inhibition DME1063 XEOTICID XEO01802 XEO_NAME (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone DME1063 XEOTICID XEO01802 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1063 XEOTICID XEO01802 XEO_CLAS Chemical Compound DME1063 XEOTICID XEO01802 DESCRIPT (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO01802 GENEFORM Protein DME1063 XEOTICID XEO01802 MOACRIVE Inhibition DME1063 XEOTICID XEO01944 XEO_NAME 2-Hexylmaleic anhydride DME1063 XEOTICID XEO01944 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1063 XEOTICID XEO01944 XEO_CLAS Chemical Compound DME1063 XEOTICID XEO01944 DESCRIPT 2-Hexylmaleic anhydride inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO01944 GENEFORM Protein DME1063 XEOTICID XEO01944 MOACRIVE Inhibition DME1063 XEOTICID XEO01990 XEO_NAME 3-hexyl-4-bromo-5-methylene-2(5H)-furanone DME1063 XEOTICID XEO01990 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1063 XEOTICID XEO01990 XEO_CLAS Chemical Compound DME1063 XEOTICID XEO01990 DESCRIPT 3-hexyl-4-bromo-5-methylene-2(5H)-furanone inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO01990 GENEFORM Protein DME1063 XEOTICID XEO01990 MOACRIVE Inhibition DME1063 XEOTICID XEO02235 XEO_NAME Anthranilate DME1063 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1063 XEOTICID XEO02235 XEO_CLAS Natural Product DME1063 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO02235 GENEFORM Protein DME1063 XEOTICID XEO02235 MOACRIVE Inhibition DME1063 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1063 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO02284 XEO_CLAS Peptide DME1063 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 25.0 microM) DME1063 XEOTICID XEO02284 GENEFORM Protein DME1063 XEOTICID XEO02284 MOACRIVE Inhibition DME1063 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1063 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO02285 XEO_CLAS Peptide DME1063 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 25.0 microM) DME1063 XEOTICID XEO02285 GENEFORM Protein DME1063 XEOTICID XEO02285 MOACRIVE Inhibition DME1063 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1063 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO02286 XEO_CLAS Peptide DME1063 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 25.0 microM) DME1063 XEOTICID XEO02286 GENEFORM Protein DME1063 XEOTICID XEO02286 MOACRIVE Inhibition DME1063 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1063 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO02287 XEO_CLAS Peptide DME1063 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 25.0 microM) DME1063 XEOTICID XEO02287 GENEFORM Protein DME1063 XEOTICID XEO02287 MOACRIVE Inhibition DME1063 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1063 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO02317 XEO_CLAS Peptide DME1063 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 300 microM) DME1063 XEOTICID XEO02317 GENEFORM Protein DME1063 XEOTICID XEO02317 MOACRIVE Inhibition DME1063 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1063 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO02491 XEO_CLAS Peptide DME1063 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 2.3 microM) DME1063 XEOTICID XEO02491 GENEFORM Protein DME1063 XEOTICID XEO02491 MOACRIVE Inhibition DME1063 XEOTICID XEO02641 XEO_NAME Bromohexylmaleic anhydride DME1063 XEOTICID XEO02641 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1063 XEOTICID XEO02641 XEO_CLAS Chemical Compound DME1063 XEOTICID XEO02641 DESCRIPT Bromohexylmaleic anhydride inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO02641 GENEFORM Protein DME1063 XEOTICID XEO02641 MOACRIVE Inhibition DME1063 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1063 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1063 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1063 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO02990 GENEFORM Protein DME1063 XEOTICID XEO02990 MOACRIVE Inhibition DME1063 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1063 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO03029 XEO_CLAS Peptide DME1063 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 0.005 microM) DME1063 XEOTICID XEO03029 GENEFORM Protein DME1063 XEOTICID XEO03029 MOACRIVE Inhibition DME1063 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1063 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO03030 XEO_CLAS Peptide DME1063 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 0.005 microM) DME1063 XEOTICID XEO03030 GENEFORM Protein DME1063 XEOTICID XEO03030 MOACRIVE Inhibition DME1063 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1063 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO03031 XEO_CLAS Peptide DME1063 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 0.3 microM) DME1063 XEOTICID XEO03031 GENEFORM Protein DME1063 XEOTICID XEO03031 MOACRIVE Inhibition DME1063 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1063 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO03032 XEO_CLAS Peptide DME1063 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 0.005 microM) DME1063 XEOTICID XEO03032 GENEFORM Protein DME1063 XEOTICID XEO03032 MOACRIVE Inhibition DME1063 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1063 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO03033 XEO_CLAS Peptide DME1063 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 0.005 microM) DME1063 XEOTICID XEO03033 GENEFORM Protein DME1063 XEOTICID XEO03033 MOACRIVE Inhibition DME1063 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1063 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO03034 XEO_CLAS Peptide DME1063 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 0.528 microM) DME1063 XEOTICID XEO03034 GENEFORM Protein DME1063 XEOTICID XEO03034 MOACRIVE Inhibition DME1063 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1063 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO03035 XEO_CLAS Peptide DME1063 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 0.004 microM) DME1063 XEOTICID XEO03035 GENEFORM Protein DME1063 XEOTICID XEO03035 MOACRIVE Inhibition DME1063 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1063 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO03250 XEO_CLAS Peptide DME1063 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO03250 GENEFORM Protein DME1063 XEOTICID XEO03250 MOACRIVE Inhibition DME1063 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1063 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1063 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1063 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO03968 GENEFORM Protein DME1063 XEOTICID XEO03968 MOACRIVE Inhibition DME1063 XEOTICID XEO04114 XEO_NAME Microcin L DME1063 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04114 XEO_CLAS Peptide DME1063 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO04114 GENEFORM Protein DME1063 XEOTICID XEO04114 MOACRIVE Inhibition DME1063 XEOTICID XEO04172 XEO_NAME Myxinidin DME1063 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04172 XEO_CLAS Peptide DME1063 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO04172 GENEFORM Protein DME1063 XEOTICID XEO04172 MOACRIVE Inhibition DME1063 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1063 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04335 XEO_CLAS Peptide DME1063 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 16 ug/ml) DME1063 XEOTICID XEO04335 GENEFORM Protein DME1063 XEOTICID XEO04335 MOACRIVE Inhibition DME1063 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1063 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04336 XEO_CLAS Peptide DME1063 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 16 ug/ml) DME1063 XEOTICID XEO04336 GENEFORM Protein DME1063 XEOTICID XEO04336 MOACRIVE Inhibition DME1063 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1063 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04338 XEO_CLAS Peptide DME1063 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 0.5 ug/ml) DME1063 XEOTICID XEO04338 GENEFORM Protein DME1063 XEOTICID XEO04338 MOACRIVE Inhibition DME1063 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1063 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04339 XEO_CLAS Peptide DME1063 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 64 ug/ml) DME1063 XEOTICID XEO04339 GENEFORM Protein DME1063 XEOTICID XEO04339 MOACRIVE Inhibition DME1063 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1063 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04340 XEO_CLAS Peptide DME1063 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 2 ug/ml) DME1063 XEOTICID XEO04340 GENEFORM Protein DME1063 XEOTICID XEO04340 MOACRIVE Inhibition DME1063 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1063 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04642 XEO_CLAS Peptide DME1063 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 4 ug/ml) DME1063 XEOTICID XEO04642 GENEFORM Protein DME1063 XEOTICID XEO04642 MOACRIVE Inhibition DME1063 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1063 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04643 XEO_CLAS Peptide DME1063 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 2 ug/ml) DME1063 XEOTICID XEO04643 GENEFORM Protein DME1063 XEOTICID XEO04643 MOACRIVE Inhibition DME1063 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1063 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04644 XEO_CLAS Peptide DME1063 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 2 ug/ml) DME1063 XEOTICID XEO04644 GENEFORM Protein DME1063 XEOTICID XEO04644 MOACRIVE Inhibition DME1063 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1063 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04645 XEO_CLAS Peptide DME1063 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 32 ug/ml) DME1063 XEOTICID XEO04645 GENEFORM Protein DME1063 XEOTICID XEO04645 MOACRIVE Inhibition DME1063 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1063 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04646 XEO_CLAS Peptide DME1063 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 1 ug/ml) DME1063 XEOTICID XEO04646 GENEFORM Protein DME1063 XEOTICID XEO04646 MOACRIVE Inhibition DME1063 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1063 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04647 XEO_CLAS Peptide DME1063 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 4 ug/ml) DME1063 XEOTICID XEO04647 GENEFORM Protein DME1063 XEOTICID XEO04647 MOACRIVE Inhibition DME1063 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1063 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04648 XEO_CLAS Peptide DME1063 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 16 ug/ml) DME1063 XEOTICID XEO04648 GENEFORM Protein DME1063 XEOTICID XEO04648 MOACRIVE Inhibition DME1063 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1063 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04649 XEO_CLAS Peptide DME1063 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC > 64 ug/ml) DME1063 XEOTICID XEO04649 GENEFORM Protein DME1063 XEOTICID XEO04649 MOACRIVE Inhibition DME1063 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1063 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04650 XEO_CLAS Peptide DME1063 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 16 ug/ml) DME1063 XEOTICID XEO04650 GENEFORM Protein DME1063 XEOTICID XEO04650 MOACRIVE Inhibition DME1063 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1063 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04651 XEO_CLAS Peptide DME1063 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 64 ug/ml) DME1063 XEOTICID XEO04651 GENEFORM Protein DME1063 XEOTICID XEO04651 MOACRIVE Inhibition DME1063 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1063 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04652 XEO_CLAS Peptide DME1063 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 4 ug/ml) DME1063 XEOTICID XEO04652 GENEFORM Protein DME1063 XEOTICID XEO04652 MOACRIVE Inhibition DME1063 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1063 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04655 XEO_CLAS Peptide DME1063 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 2 ug/ml) DME1063 XEOTICID XEO04655 GENEFORM Protein DME1063 XEOTICID XEO04655 MOACRIVE Inhibition DME1063 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1063 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04695 XEO_CLAS Peptide DME1063 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO04695 GENEFORM Protein DME1063 XEOTICID XEO04695 MOACRIVE Inhibition DME1063 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1063 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04696 XEO_CLAS Peptide DME1063 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO04696 GENEFORM Protein DME1063 XEOTICID XEO04696 MOACRIVE Inhibition DME1063 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1063 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04699 XEO_CLAS Peptide DME1063 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO04699 GENEFORM Protein DME1063 XEOTICID XEO04699 MOACRIVE Inhibition DME1063 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1063 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04700 XEO_CLAS Peptide DME1063 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO04700 GENEFORM Protein DME1063 XEOTICID XEO04700 MOACRIVE Inhibition DME1063 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1063 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04701 XEO_CLAS Peptide DME1063 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO04701 GENEFORM Protein DME1063 XEOTICID XEO04701 MOACRIVE Inhibition DME1063 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1063 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04702 XEO_CLAS Peptide DME1063 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO04702 GENEFORM Protein DME1063 XEOTICID XEO04702 MOACRIVE Inhibition DME1063 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1063 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO04703 XEO_CLAS Peptide DME1063 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO04703 GENEFORM Protein DME1063 XEOTICID XEO04703 MOACRIVE Inhibition DME1063 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1063 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO05171 XEO_CLAS Peptide DME1063 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica DME1063 XEOTICID XEO05171 GENEFORM Protein DME1063 XEOTICID XEO05171 MOACRIVE Inhibition DME1063 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1063 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1063 XEOTICID XEO05308 XEO_CLAS Peptide DME1063 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella enterica (MIC = 0.9 ug/ml) DME1063 XEOTICID XEO05308 GENEFORM Protein DME1063 XEOTICID XEO05308 MOACRIVE Inhibition DME1068 DME___ID DME1068 DME1068 DME_NAME Aminoglycoside O-phosphotransferase (aphA6) DME1068 SPESNAME Acinetobacter baumannii DME1068 XEOTICID XEO01366 XEO_NAME Linalool DME1068 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1068 XEOTICID XEO01366 XEO_CLAS Natural Product DME1068 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii DME1068 XEOTICID XEO01366 GENEFORM Protein DME1068 XEOTICID XEO01366 MOACRIVE Inhibition DME1068 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1068 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1068 XEOTICID XEO01816 XEO_CLAS Peptide DME1068 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii (MIC = 3 microM) DME1068 XEOTICID XEO01816 GENEFORM Protein DME1068 XEOTICID XEO01816 MOACRIVE Inhibition DME1068 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1068 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1068 XEOTICID XEO01824 XEO_CLAS Peptide DME1068 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii (MIC = 50 microM) DME1068 XEOTICID XEO01824 GENEFORM Protein DME1068 XEOTICID XEO01824 MOACRIVE Inhibition DME1068 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1068 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1068 XEOTICID XEO02731 XEO_CLAS Peptide DME1068 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii DME1068 XEOTICID XEO02731 GENEFORM Protein DME1068 XEOTICID XEO02731 MOACRIVE Inhibition DME1068 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1068 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1068 XEOTICID XEO02900 XEO_CLAS Peptide DME1068 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii DME1068 XEOTICID XEO02900 GENEFORM Protein DME1068 XEOTICID XEO02900 MOACRIVE Inhibition DME1068 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1068 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1068 XEOTICID XEO02942 XEO_CLAS Peptide DME1068 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii DME1068 XEOTICID XEO02942 GENEFORM Protein DME1068 XEOTICID XEO02942 MOACRIVE Inhibition DME1068 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1068 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1068 XEOTICID XEO03540 XEO_CLAS Peptide DME1068 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii (MIC = 8-16 ug/ml) DME1068 XEOTICID XEO03540 GENEFORM Protein DME1068 XEOTICID XEO03540 MOACRIVE Inhibition DME1068 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1068 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1068 XEOTICID XEO03556 XEO_CLAS Peptide DME1068 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii (MIC = 8-16 ug/ml) DME1068 XEOTICID XEO03556 GENEFORM Protein DME1068 XEOTICID XEO03556 MOACRIVE Inhibition DME1068 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1068 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1068 XEOTICID XEO03557 XEO_CLAS Peptide DME1068 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii (MIC = 8-16 ug/ml) DME1068 XEOTICID XEO03557 GENEFORM Protein DME1068 XEOTICID XEO03557 MOACRIVE Inhibition DME1068 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1068 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1068 XEOTICID XEO03609 XEO_CLAS Peptide DME1068 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii DME1068 XEOTICID XEO03609 GENEFORM Protein DME1068 XEOTICID XEO03609 MOACRIVE Inhibition DME1068 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1068 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1068 XEOTICID XEO03678 XEO_CLAS Peptide DME1068 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii (MIC = 0.8 ug/ml) DME1068 XEOTICID XEO03678 GENEFORM Protein DME1068 XEOTICID XEO03678 MOACRIVE Inhibition DME1068 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1068 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1068 XEOTICID XEO04001 XEO_CLAS Peptide DME1068 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii (MIC = 2.7 microM) DME1068 XEOTICID XEO04001 GENEFORM Protein DME1068 XEOTICID XEO04001 MOACRIVE Inhibition DME1068 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1068 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1068 XEOTICID XEO04241 XEO_CLAS Peptide DME1068 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii DME1068 XEOTICID XEO04241 GENEFORM Protein DME1068 XEOTICID XEO04241 MOACRIVE Inhibition DME1068 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1068 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1068 XEOTICID XEO04242 XEO_CLAS Peptide DME1068 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii DME1068 XEOTICID XEO04242 GENEFORM Protein DME1068 XEOTICID XEO04242 MOACRIVE Inhibition DME1068 XEOTICID XEO04331 XEO_NAME Norspermidine DME1068 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1068 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1068 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii DME1068 XEOTICID XEO04331 GENEFORM Protein DME1068 XEOTICID XEO04331 MOACRIVE Inhibition DME1068 XEOTICID XEO04686 XEO_NAME Polyethyleneimine DME1068 XEOTICID XEO04686 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1068 XEOTICID XEO04686 XEO_CLAS Chemical Compound DME1068 XEOTICID XEO04686 DESCRIPT Polyethyleneimine inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii DME1068 XEOTICID XEO04686 GENEFORM Protein DME1068 XEOTICID XEO04686 MOACRIVE Inhibition DME1068 XEOTICID XEO04888 XEO_NAME CP-P derivative S16 DME1068 XEOTICID XEO04888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1068 XEOTICID XEO04888 XEO_CLAS Peptide DME1068 XEOTICID XEO04888 DESCRIPT CP-P derivative S16 inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Acinetobacter baumannii (MIC = 3.125 ug/ml) DME1068 XEOTICID XEO04888 GENEFORM Protein DME1068 XEOTICID XEO04888 MOACRIVE Inhibition DME1069 DME___ID DME1069 DME1069 DME_NAME Nicotinate dehydrogenase (nicA) DME1069 SPESNAME Pseudomonas putida DME1069 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1069 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO02649 XEO_CLAS Peptide DME1069 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 4 ug/ml) DME1069 XEOTICID XEO02649 GENEFORM Protein DME1069 XEOTICID XEO02649 MOACRIVE Inhibition DME1069 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1069 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO02650 XEO_CLAS Peptide DME1069 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 2 ug/ml) DME1069 XEOTICID XEO02650 GENEFORM Protein DME1069 XEOTICID XEO02650 MOACRIVE Inhibition DME1069 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1069 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO02839 XEO_CLAS Peptide DME1069 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 40 microM) DME1069 XEOTICID XEO02839 GENEFORM Protein DME1069 XEOTICID XEO02839 MOACRIVE Inhibition DME1069 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1069 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO02842 XEO_CLAS Peptide DME1069 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 40 microM) DME1069 XEOTICID XEO02842 GENEFORM Protein DME1069 XEOTICID XEO02842 MOACRIVE Inhibition DME1069 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1069 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO03052 XEO_CLAS Peptide DME1069 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 100 ug/ml) DME1069 XEOTICID XEO03052 GENEFORM Protein DME1069 XEOTICID XEO03052 MOACRIVE Inhibition DME1069 XEOTICID XEO03349 XEO_NAME Burdock leaf ethanolic extract DME1069 XEOTICID XEO03349 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1069 XEOTICID XEO03349 XEO_CLAS Plant Extract DME1069 XEOTICID XEO03349 DESCRIPT Burdock leaf ethanolic extract inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida DME1069 XEOTICID XEO03349 GENEFORM Protein DME1069 XEOTICID XEO03349 MOACRIVE Inhibition DME1069 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1069 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO03436 XEO_CLAS Peptide DME1069 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 50 ug/ml) DME1069 XEOTICID XEO03436 GENEFORM Protein DME1069 XEOTICID XEO03436 MOACRIVE Inhibition DME1069 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1069 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO03437 XEO_CLAS Peptide DME1069 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 50 ug/ml) DME1069 XEOTICID XEO03437 GENEFORM Protein DME1069 XEOTICID XEO03437 MOACRIVE Inhibition DME1069 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1069 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO03438 XEO_CLAS Peptide DME1069 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 50 ug/ml) DME1069 XEOTICID XEO03438 GENEFORM Protein DME1069 XEOTICID XEO03438 MOACRIVE Inhibition DME1069 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1069 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO03439 XEO_CLAS Peptide DME1069 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 100 ug/ml) DME1069 XEOTICID XEO03439 GENEFORM Protein DME1069 XEOTICID XEO03439 MOACRIVE Inhibition DME1069 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1069 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO03440 XEO_CLAS Peptide DME1069 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 50 ug/ml) DME1069 XEOTICID XEO03440 GENEFORM Protein DME1069 XEOTICID XEO03440 MOACRIVE Inhibition DME1069 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1069 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO03441 XEO_CLAS Peptide DME1069 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 50 ug/ml) DME1069 XEOTICID XEO03441 GENEFORM Protein DME1069 XEOTICID XEO03441 MOACRIVE Inhibition DME1069 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1069 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO03706 XEO_CLAS Peptide DME1069 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida DME1069 XEOTICID XEO03706 GENEFORM Protein DME1069 XEOTICID XEO03706 MOACRIVE Inhibition DME1069 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1069 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO03707 XEO_CLAS Peptide DME1069 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida DME1069 XEOTICID XEO03707 GENEFORM Protein DME1069 XEOTICID XEO03707 MOACRIVE Inhibition DME1069 XEOTICID XEO03971 XEO_NAME Lumbrican DME1069 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO03971 XEO_CLAS Peptide DME1069 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida DME1069 XEOTICID XEO03971 GENEFORM Protein DME1069 XEOTICID XEO03971 MOACRIVE Inhibition DME1069 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1069 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO03985 XEO_CLAS Peptide DME1069 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 10 ug/ml) DME1069 XEOTICID XEO03985 GENEFORM Protein DME1069 XEOTICID XEO03985 MOACRIVE Inhibition DME1069 XEOTICID XEO04117 XEO_NAME Misgurin DME1069 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO04117 XEO_CLAS Peptide DME1069 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida DME1069 XEOTICID XEO04117 GENEFORM Protein DME1069 XEOTICID XEO04117 MOACRIVE Inhibition DME1069 XEOTICID XEO04931 XEO_NAME Shepherin I DME1069 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO04931 XEO_CLAS Peptide DME1069 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida DME1069 XEOTICID XEO04931 GENEFORM Protein DME1069 XEOTICID XEO04931 MOACRIVE Inhibition DME1069 XEOTICID XEO04932 XEO_NAME shepherin II DME1069 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO04932 XEO_CLAS Peptide DME1069 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida DME1069 XEOTICID XEO04932 GENEFORM Protein DME1069 XEOTICID XEO04932 MOACRIVE Inhibition DME1069 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1069 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1069 XEOTICID XEO05111 XEO_CLAS Natural Product DME1069 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida DME1069 XEOTICID XEO05111 GENEFORM Protein DME1069 XEOTICID XEO05111 MOACRIVE Inhibition DME1069 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1069 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO05144 XEO_CLAS Peptide DME1069 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 40 ug/ml) DME1069 XEOTICID XEO05144 GENEFORM Protein DME1069 XEOTICID XEO05144 MOACRIVE Inhibition DME1069 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1069 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO05145 XEO_CLAS Peptide DME1069 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 50 ug/ml) DME1069 XEOTICID XEO05145 GENEFORM Protein DME1069 XEOTICID XEO05145 MOACRIVE Inhibition DME1069 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1069 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO05146 XEO_CLAS Peptide DME1069 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 40 ug/ml) DME1069 XEOTICID XEO05146 GENEFORM Protein DME1069 XEOTICID XEO05146 MOACRIVE Inhibition DME1069 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1069 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO05147 XEO_CLAS Peptide DME1069 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 60 ug/ml) DME1069 XEOTICID XEO05147 GENEFORM Protein DME1069 XEOTICID XEO05147 MOACRIVE Inhibition DME1069 XEOTICID XEO05260 XEO_NAME V. philippinarum beta defensin VpBD DME1069 XEOTICID XEO05260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1069 XEOTICID XEO05260 XEO_CLAS Peptide DME1069 XEOTICID XEO05260 DESCRIPT V. philippinarum beta defensin VpBD inhibits the drug-metabolizing activity of Nicotinate dehydrogenase (nicA) from Pseudomonas putida (MIC = 1.64-3.28 microM) DME1069 XEOTICID XEO05260 GENEFORM Protein DME1069 XEOTICID XEO05260 MOACRIVE Inhibition DME1072 DME___ID DME1072 DME1072 DME_NAME Cytochrome P450 MEG (cyp106) DME1072 SPESNAME Bacillus megaterium DME1072 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1072 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO01823 XEO_CLAS Peptide DME1072 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) DME1072 XEOTICID XEO01823 GENEFORM Protein DME1072 XEOTICID XEO01823 MOACRIVE Inhibition DME1072 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1072 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO01824 XEO_CLAS Peptide DME1072 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) DME1072 XEOTICID XEO01824 GENEFORM Protein DME1072 XEOTICID XEO01824 MOACRIVE Inhibition DME1072 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1072 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO01825 XEO_CLAS Peptide DME1072 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) DME1072 XEOTICID XEO01825 GENEFORM Protein DME1072 XEOTICID XEO01825 MOACRIVE Inhibition DME1072 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1072 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO01827 XEO_CLAS Peptide DME1072 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.12-6.25 microM) DME1072 XEOTICID XEO01827 GENEFORM Protein DME1072 XEOTICID XEO01827 MOACRIVE Inhibition DME1072 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1072 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02230 XEO_CLAS Peptide DME1072 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.5-1 microM) DME1072 XEOTICID XEO02230 GENEFORM Protein DME1072 XEOTICID XEO02230 MOACRIVE Inhibition DME1072 XEOTICID XEO02237 XEO_NAME Antibacterial napin DME1072 XEOTICID XEO02237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02237 XEO_CLAS Peptide DME1072 XEOTICID XEO02237 DESCRIPT Antibacterial napin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 215 microM) DME1072 XEOTICID XEO02237 GENEFORM Protein DME1072 XEOTICID XEO02237 MOACRIVE Inhibition DME1072 XEOTICID XEO02238 XEO_NAME Antibacterial peptide 3910 DME1072 XEOTICID XEO02238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02238 XEO_CLAS Peptide DME1072 XEOTICID XEO02238 DESCRIPT Antibacterial peptide 3910 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO02238 GENEFORM Protein DME1072 XEOTICID XEO02238 MOACRIVE Inhibition DME1072 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1072 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02242 XEO_CLAS Peptide DME1072 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) DME1072 XEOTICID XEO02242 GENEFORM Protein DME1072 XEOTICID XEO02242 MOACRIVE Inhibition DME1072 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1072 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02243 XEO_CLAS Peptide DME1072 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3 microM) DME1072 XEOTICID XEO02243 GENEFORM Protein DME1072 XEOTICID XEO02243 MOACRIVE Inhibition DME1072 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1072 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02244 XEO_CLAS Peptide DME1072 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 4 microM) DME1072 XEOTICID XEO02244 GENEFORM Protein DME1072 XEOTICID XEO02244 MOACRIVE Inhibition DME1072 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1072 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02248 XEO_CLAS Peptide DME1072 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.3 microM) DME1072 XEOTICID XEO02248 GENEFORM Protein DME1072 XEOTICID XEO02248 MOACRIVE Inhibition DME1072 XEOTICID XEO02259 XEO_NAME Antimicrobial peptide AC-AMP1 DME1072 XEOTICID XEO02259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02259 XEO_CLAS Peptide DME1072 XEOTICID XEO02259 DESCRIPT Antimicrobial peptide AC-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO02259 GENEFORM Protein DME1072 XEOTICID XEO02259 MOACRIVE Inhibition DME1072 XEOTICID XEO02262 XEO_NAME Antimicrobial peptide MJ-AMP1 DME1072 XEOTICID XEO02262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02262 XEO_CLAS Peptide DME1072 XEOTICID XEO02262 DESCRIPT Antimicrobial peptide MJ-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 6 ug/ml) DME1072 XEOTICID XEO02262 GENEFORM Protein DME1072 XEOTICID XEO02262 MOACRIVE Inhibition DME1072 XEOTICID XEO02267 XEO_NAME Antimicrobial peptide AC-AMP2 DME1072 XEOTICID XEO02267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02267 XEO_CLAS Peptide DME1072 XEOTICID XEO02267 DESCRIPT Antimicrobial peptide AC-AMP2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO02267 GENEFORM Protein DME1072 XEOTICID XEO02267 MOACRIVE Inhibition DME1072 XEOTICID XEO02269 XEO_NAME Antimicrobial peptide MJ-AMP2 DME1072 XEOTICID XEO02269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02269 XEO_CLAS Peptide DME1072 XEOTICID XEO02269 DESCRIPT Antimicrobial peptide MJ-AMP2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 ug/ml) DME1072 XEOTICID XEO02269 GENEFORM Protein DME1072 XEOTICID XEO02269 MOACRIVE Inhibition DME1072 XEOTICID XEO02282 XEO_NAME Antimicrobial peptide GP-19 DME1072 XEOTICID XEO02282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02282 XEO_CLAS Peptide DME1072 XEOTICID XEO02282 DESCRIPT Antimicrobial peptide GP-19 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO02282 GENEFORM Protein DME1072 XEOTICID XEO02282 MOACRIVE Inhibition DME1072 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1072 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02293 XEO_CLAS Peptide DME1072 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.8 microM) DME1072 XEOTICID XEO02293 GENEFORM Protein DME1072 XEOTICID XEO02293 MOACRIVE Inhibition DME1072 XEOTICID XEO02299 XEO_NAME Antimicrobial protein Ace-AMP1 DME1072 XEOTICID XEO02299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02299 XEO_CLAS Peptide DME1072 XEOTICID XEO02299 DESCRIPT Antimicrobial protein Ace-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO02299 GENEFORM Protein DME1072 XEOTICID XEO02299 MOACRIVE Inhibition DME1072 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1072 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02304 XEO_CLAS Peptide DME1072 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 150 ug/ml) DME1072 XEOTICID XEO02304 GENEFORM Protein DME1072 XEOTICID XEO02304 MOACRIVE Inhibition DME1072 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1072 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02305 XEO_CLAS Peptide DME1072 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 100 ug/ml) DME1072 XEOTICID XEO02305 GENEFORM Protein DME1072 XEOTICID XEO02305 MOACRIVE Inhibition DME1072 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1072 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02306 XEO_CLAS Peptide DME1072 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 100 ug/ml) DME1072 XEOTICID XEO02306 GENEFORM Protein DME1072 XEOTICID XEO02306 MOACRIVE Inhibition DME1072 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1072 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02319 XEO_CLAS Peptide DME1072 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.5-1.25 microM) DME1072 XEOTICID XEO02319 GENEFORM Protein DME1072 XEOTICID XEO02319 MOACRIVE Inhibition DME1072 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1072 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02333 XEO_CLAS Peptide DME1072 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC > 200 microM) DME1072 XEOTICID XEO02333 GENEFORM Protein DME1072 XEOTICID XEO02333 MOACRIVE Inhibition DME1072 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1072 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02466 XEO_CLAS Peptide DME1072 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3 microM) DME1072 XEOTICID XEO02466 GENEFORM Protein DME1072 XEOTICID XEO02466 MOACRIVE Inhibition DME1072 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1072 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02468 XEO_CLAS Peptide DME1072 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.3 microM) DME1072 XEOTICID XEO02468 GENEFORM Protein DME1072 XEOTICID XEO02468 MOACRIVE Inhibition DME1072 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1072 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02474 XEO_CLAS Peptide DME1072 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.3 microM) DME1072 XEOTICID XEO02474 GENEFORM Protein DME1072 XEOTICID XEO02474 MOACRIVE Inhibition DME1072 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1072 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02475 XEO_CLAS Peptide DME1072 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.3 microM) DME1072 XEOTICID XEO02475 GENEFORM Protein DME1072 XEOTICID XEO02475 MOACRIVE Inhibition DME1072 XEOTICID XEO02476 XEO_NAME Bacteriocin HJ50 DME1072 XEOTICID XEO02476 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02476 XEO_CLAS Peptide DME1072 XEOTICID XEO02476 DESCRIPT Bacteriocin HJ50 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO02476 GENEFORM Protein DME1072 XEOTICID XEO02476 MOACRIVE Inhibition DME1072 XEOTICID XEO02521 XEO_NAME Brevinin-1E DME1072 XEOTICID XEO02521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02521 XEO_CLAS Peptide DME1072 XEOTICID XEO02521 DESCRIPT Brevinin-1E inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.4 microM) DME1072 XEOTICID XEO02521 GENEFORM Protein DME1072 XEOTICID XEO02521 MOACRIVE Inhibition DME1072 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1072 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02584 XEO_CLAS Peptide DME1072 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.2 microM) DME1072 XEOTICID XEO02584 GENEFORM Protein DME1072 XEOTICID XEO02584 MOACRIVE Inhibition DME1072 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1072 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02663 XEO_CLAS Peptide DME1072 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) DME1072 XEOTICID XEO02663 GENEFORM Protein DME1072 XEOTICID XEO02663 MOACRIVE Inhibition DME1072 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1072 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02664 XEO_CLAS Peptide DME1072 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) DME1072 XEOTICID XEO02664 GENEFORM Protein DME1072 XEOTICID XEO02664 MOACRIVE Inhibition DME1072 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1072 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02672 XEO_CLAS Peptide DME1072 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) DME1072 XEOTICID XEO02672 GENEFORM Protein DME1072 XEOTICID XEO02672 MOACRIVE Inhibition DME1072 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1072 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02673 XEO_CLAS Peptide DME1072 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) DME1072 XEOTICID XEO02673 GENEFORM Protein DME1072 XEOTICID XEO02673 MOACRIVE Inhibition DME1072 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1072 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02674 XEO_CLAS Peptide DME1072 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) DME1072 XEOTICID XEO02674 GENEFORM Protein DME1072 XEOTICID XEO02674 MOACRIVE Inhibition DME1072 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1072 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02676 XEO_CLAS Peptide DME1072 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) DME1072 XEOTICID XEO02676 GENEFORM Protein DME1072 XEOTICID XEO02676 MOACRIVE Inhibition DME1072 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1072 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02677 XEO_CLAS Peptide DME1072 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) DME1072 XEOTICID XEO02677 GENEFORM Protein DME1072 XEOTICID XEO02677 MOACRIVE Inhibition DME1072 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1072 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02679 XEO_CLAS Peptide DME1072 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) DME1072 XEOTICID XEO02679 GENEFORM Protein DME1072 XEOTICID XEO02679 MOACRIVE Inhibition DME1072 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1072 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02680 XEO_CLAS Peptide DME1072 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) DME1072 XEOTICID XEO02680 GENEFORM Protein DME1072 XEOTICID XEO02680 MOACRIVE Inhibition DME1072 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1072 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02683 XEO_CLAS Peptide DME1072 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.125 microM) DME1072 XEOTICID XEO02683 GENEFORM Protein DME1072 XEOTICID XEO02683 MOACRIVE Inhibition DME1072 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1072 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02731 XEO_CLAS Peptide DME1072 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 4 microM) DME1072 XEOTICID XEO02731 GENEFORM Protein DME1072 XEOTICID XEO02731 MOACRIVE Inhibition DME1072 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1072 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02739 XEO_CLAS Peptide DME1072 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) DME1072 XEOTICID XEO02739 GENEFORM Protein DME1072 XEOTICID XEO02739 MOACRIVE Inhibition DME1072 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1072 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02740 XEO_CLAS Peptide DME1072 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 ug/ml) DME1072 XEOTICID XEO02740 GENEFORM Protein DME1072 XEOTICID XEO02740 MOACRIVE Inhibition DME1072 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1072 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02756 XEO_CLAS Peptide DME1072 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.8 microM) DME1072 XEOTICID XEO02756 GENEFORM Protein DME1072 XEOTICID XEO02756 MOACRIVE Inhibition DME1072 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1072 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02757 XEO_CLAS Peptide DME1072 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.7 microM) DME1072 XEOTICID XEO02757 GENEFORM Protein DME1072 XEOTICID XEO02757 MOACRIVE Inhibition DME1072 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1072 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02758 XEO_CLAS Peptide DME1072 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.9 microM) DME1072 XEOTICID XEO02758 GENEFORM Protein DME1072 XEOTICID XEO02758 MOACRIVE Inhibition DME1072 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1072 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02759 XEO_CLAS Peptide DME1072 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.5 microM) DME1072 XEOTICID XEO02759 GENEFORM Protein DME1072 XEOTICID XEO02759 MOACRIVE Inhibition DME1072 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1072 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02760 XEO_CLAS Peptide DME1072 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.5 microM) DME1072 XEOTICID XEO02760 GENEFORM Protein DME1072 XEOTICID XEO02760 MOACRIVE Inhibition DME1072 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1072 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02761 XEO_CLAS Peptide DME1072 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.5 microM) DME1072 XEOTICID XEO02761 GENEFORM Protein DME1072 XEOTICID XEO02761 MOACRIVE Inhibition DME1072 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1072 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02762 XEO_CLAS Peptide DME1072 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.5 microM) DME1072 XEOTICID XEO02762 GENEFORM Protein DME1072 XEOTICID XEO02762 MOACRIVE Inhibition DME1072 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1072 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02763 XEO_CLAS Peptide DME1072 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.2 microM) DME1072 XEOTICID XEO02763 GENEFORM Protein DME1072 XEOTICID XEO02763 MOACRIVE Inhibition DME1072 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1072 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02765 XEO_CLAS Peptide DME1072 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.4 microM) DME1072 XEOTICID XEO02765 GENEFORM Protein DME1072 XEOTICID XEO02765 MOACRIVE Inhibition DME1072 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1072 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02768 XEO_CLAS Peptide DME1072 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1-2.5 ug/ml) DME1072 XEOTICID XEO02768 GENEFORM Protein DME1072 XEOTICID XEO02768 MOACRIVE Inhibition DME1072 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1072 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02769 XEO_CLAS Peptide DME1072 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.44 microM) DME1072 XEOTICID XEO02769 GENEFORM Protein DME1072 XEOTICID XEO02769 MOACRIVE Inhibition DME1072 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1072 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02770 XEO_CLAS Peptide DME1072 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.64 microM) DME1072 XEOTICID XEO02770 GENEFORM Protein DME1072 XEOTICID XEO02770 MOACRIVE Inhibition DME1072 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1072 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02771 XEO_CLAS Peptide DME1072 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 24 microM) DME1072 XEOTICID XEO02771 GENEFORM Protein DME1072 XEOTICID XEO02771 MOACRIVE Inhibition DME1072 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1072 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02772 XEO_CLAS Peptide DME1072 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO02772 GENEFORM Protein DME1072 XEOTICID XEO02772 MOACRIVE Inhibition DME1072 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1072 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO02774 XEO_CLAS Peptide DME1072 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.8 microM) DME1072 XEOTICID XEO02774 GENEFORM Protein DME1072 XEOTICID XEO02774 MOACRIVE Inhibition DME1072 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1072 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03081 XEO_CLAS Peptide DME1072 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.69 microM) DME1072 XEOTICID XEO03081 GENEFORM Protein DME1072 XEOTICID XEO03081 MOACRIVE Inhibition DME1072 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1072 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03100 XEO_CLAS Peptide DME1072 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO03100 GENEFORM Protein DME1072 XEOTICID XEO03100 MOACRIVE Inhibition DME1072 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1072 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03110 XEO_CLAS Peptide DME1072 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.8 microM) DME1072 XEOTICID XEO03110 GENEFORM Protein DME1072 XEOTICID XEO03110 MOACRIVE Inhibition DME1072 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1072 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03116 XEO_CLAS Peptide DME1072 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.2-2.5 microM) DME1072 XEOTICID XEO03116 GENEFORM Protein DME1072 XEOTICID XEO03116 MOACRIVE Inhibition DME1072 XEOTICID XEO03117 XEO_NAME Insect defensin B DME1072 XEOTICID XEO03117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03117 XEO_CLAS Peptide DME1072 XEOTICID XEO03117 DESCRIPT Insect defensin B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.2-2.5 microM) DME1072 XEOTICID XEO03117 GENEFORM Protein DME1072 XEOTICID XEO03117 MOACRIVE Inhibition DME1072 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1072 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03119 XEO_CLAS Peptide DME1072 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO03119 GENEFORM Protein DME1072 XEOTICID XEO03119 MOACRIVE Inhibition DME1072 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1072 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03137 XEO_CLAS Peptide DME1072 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO03137 GENEFORM Protein DME1072 XEOTICID XEO03137 MOACRIVE Inhibition DME1072 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1072 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03162 XEO_CLAS Peptide DME1072 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.8 microM) DME1072 XEOTICID XEO03162 GENEFORM Protein DME1072 XEOTICID XEO03162 MOACRIVE Inhibition DME1072 XEOTICID XEO03164 XEO_NAME Dermatoxin DME1072 XEOTICID XEO03164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03164 XEO_CLAS Peptide DME1072 XEOTICID XEO03164 DESCRIPT Dermatoxin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO03164 GENEFORM Protein DME1072 XEOTICID XEO03164 MOACRIVE Inhibition DME1072 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1072 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03224 XEO_CLAS Peptide DME1072 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1-2.5 microM) DME1072 XEOTICID XEO03224 GENEFORM Protein DME1072 XEOTICID XEO03224 MOACRIVE Inhibition DME1072 XEOTICID XEO03243 XEO_NAME Hevein-like antimicrobial peptide Ee-CBPb DME1072 XEOTICID XEO03243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03243 XEO_CLAS Peptide DME1072 XEOTICID XEO03243 DESCRIPT Hevein-like antimicrobial peptide Ee-CBPb inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO03243 GENEFORM Protein DME1072 XEOTICID XEO03243 MOACRIVE Inhibition DME1072 XEOTICID XEO03249 XEO_NAME Enkelytin DME1072 XEOTICID XEO03249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03249 XEO_CLAS Peptide DME1072 XEOTICID XEO03249 DESCRIPT Enkelytin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.2-0.4 microM) DME1072 XEOTICID XEO03249 GENEFORM Protein DME1072 XEOTICID XEO03249 MOACRIVE Inhibition DME1072 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1072 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03251 XEO_CLAS Peptide DME1072 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO03251 GENEFORM Protein DME1072 XEOTICID XEO03251 MOACRIVE Inhibition DME1072 XEOTICID XEO03254 XEO_NAME Enterocin EJ97 DME1072 XEOTICID XEO03254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03254 XEO_CLAS Peptide DME1072 XEOTICID XEO03254 DESCRIPT Enterocin EJ97 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 4 ug/ml) DME1072 XEOTICID XEO03254 GENEFORM Protein DME1072 XEOTICID XEO03254 MOACRIVE Inhibition DME1072 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1072 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03274 XEO_CLAS Peptide DME1072 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.1 microM) DME1072 XEOTICID XEO03274 GENEFORM Protein DME1072 XEOTICID XEO03274 MOACRIVE Inhibition DME1072 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1072 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03277 XEO_CLAS Peptide DME1072 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.1 microM) DME1072 XEOTICID XEO03277 GENEFORM Protein DME1072 XEOTICID XEO03277 MOACRIVE Inhibition DME1072 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1072 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03299 XEO_CLAS Peptide DME1072 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.2 microM) DME1072 XEOTICID XEO03299 GENEFORM Protein DME1072 XEOTICID XEO03299 MOACRIVE Inhibition DME1072 XEOTICID XEO03431 XEO_NAME Thanatin truncated isoform G18C(1-18) DME1072 XEOTICID XEO03431 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03431 XEO_CLAS Peptide DME1072 XEOTICID XEO03431 DESCRIPT Thanatin truncated isoform G18C(1-18) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 5-10 microM) DME1072 XEOTICID XEO03431 GENEFORM Protein DME1072 XEOTICID XEO03431 MOACRIVE Inhibition DME1072 XEOTICID XEO03432 XEO_NAME Thanatin truncated isoform G19Q(1-19) DME1072 XEOTICID XEO03432 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03432 XEO_CLAS Peptide DME1072 XEOTICID XEO03432 DESCRIPT Thanatin truncated isoform G19Q(1-19) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 5-10 microM) DME1072 XEOTICID XEO03432 GENEFORM Protein DME1072 XEOTICID XEO03432 MOACRIVE Inhibition DME1072 XEOTICID XEO03435 XEO_NAME Thanatin truncated isoform G20R(1-20) DME1072 XEOTICID XEO03435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03435 XEO_CLAS Peptide DME1072 XEOTICID XEO03435 DESCRIPT Thanatin truncated isoform G20R(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2.5-5 microM) DME1072 XEOTICID XEO03435 GENEFORM Protein DME1072 XEOTICID XEO03435 MOACRIVE Inhibition DME1072 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1072 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03497 XEO_CLAS Peptide DME1072 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.2-0.4 microM) DME1072 XEOTICID XEO03497 GENEFORM Protein DME1072 XEOTICID XEO03497 MOACRIVE Inhibition DME1072 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1072 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03498 XEO_CLAS Peptide DME1072 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.2-0.4 microM) DME1072 XEOTICID XEO03498 GENEFORM Protein DME1072 XEOTICID XEO03498 MOACRIVE Inhibition DME1072 XEOTICID XEO03522 XEO_NAME Halocyntin DME1072 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03522 XEO_CLAS Peptide DME1072 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO03522 GENEFORM Protein DME1072 XEOTICID XEO03522 MOACRIVE Inhibition DME1072 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1072 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03561 XEO_CLAS Peptide DME1072 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO03561 GENEFORM Protein DME1072 XEOTICID XEO03561 MOACRIVE Inhibition DME1072 XEOTICID XEO03605 XEO_NAME Human recombinant Ser-Thr-Ala-CGA1-78 DME1072 XEOTICID XEO03605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03605 XEO_CLAS Peptide DME1072 XEOTICID XEO03605 DESCRIPT Human recombinant Ser-Thr-Ala-CGA1-78 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 30 microM) DME1072 XEOTICID XEO03605 GENEFORM Protein DME1072 XEOTICID XEO03605 MOACRIVE Inhibition DME1072 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1072 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03618 XEO_CLAS Peptide DME1072 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.5-1 microM) DME1072 XEOTICID XEO03618 GENEFORM Protein DME1072 XEOTICID XEO03618 MOACRIVE Inhibition DME1072 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1072 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03622 XEO_CLAS Peptide DME1072 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 10-20 microM) DME1072 XEOTICID XEO03622 GENEFORM Protein DME1072 XEOTICID XEO03622 MOACRIVE Inhibition DME1072 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1072 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03681 XEO_CLAS Peptide DME1072 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2.5-5 microM) DME1072 XEOTICID XEO03681 GENEFORM Protein DME1072 XEOTICID XEO03681 MOACRIVE Inhibition DME1072 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1072 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03712 XEO_CLAS Peptide DME1072 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO03712 GENEFORM Protein DME1072 XEOTICID XEO03712 MOACRIVE Inhibition DME1072 XEOTICID XEO03804 XEO_NAME Lantibiotic lichenicidin VK21 A1 DME1072 XEOTICID XEO03804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03804 XEO_CLAS Peptide DME1072 XEOTICID XEO03804 DESCRIPT Lantibiotic lichenicidin VK21 A1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO03804 GENEFORM Protein DME1072 XEOTICID XEO03804 MOACRIVE Inhibition DME1072 XEOTICID XEO03805 XEO_NAME Lantibiotic lichenicidin VK21 A2 DME1072 XEOTICID XEO03805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03805 XEO_CLAS Peptide DME1072 XEOTICID XEO03805 DESCRIPT Lantibiotic lichenicidin VK21 A2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO03805 GENEFORM Protein DME1072 XEOTICID XEO03805 MOACRIVE Inhibition DME1072 XEOTICID XEO03973 XEO_NAME Lunatusin DME1072 XEOTICID XEO03973 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO03973 XEO_CLAS Peptide DME1072 XEOTICID XEO03973 DESCRIPT Lunatusin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO03973 GENEFORM Protein DME1072 XEOTICID XEO03973 MOACRIVE Inhibition DME1072 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1072 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04039 XEO_CLAS Peptide DME1072 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) DME1072 XEOTICID XEO04039 GENEFORM Protein DME1072 XEOTICID XEO04039 MOACRIVE Inhibition DME1072 XEOTICID XEO04057 XEO_NAME Melittin DME1072 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04057 XEO_CLAS Peptide DME1072 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.6 microM) DME1072 XEOTICID XEO04057 GENEFORM Protein DME1072 XEOTICID XEO04057 MOACRIVE Inhibition DME1072 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1072 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04128 XEO_CLAS Peptide DME1072 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.09 microM) DME1072 XEOTICID XEO04128 GENEFORM Protein DME1072 XEOTICID XEO04128 MOACRIVE Inhibition DME1072 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1072 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04158 XEO_CLAS Peptide DME1072 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) DME1072 XEOTICID XEO04158 GENEFORM Protein DME1072 XEOTICID XEO04158 MOACRIVE Inhibition DME1072 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1072 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04159 XEO_CLAS Peptide DME1072 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) DME1072 XEOTICID XEO04159 GENEFORM Protein DME1072 XEOTICID XEO04159 MOACRIVE Inhibition DME1072 XEOTICID XEO04166 XEO_NAME Myticin-A DME1072 XEOTICID XEO04166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04166 XEO_CLAS Peptide DME1072 XEOTICID XEO04166 DESCRIPT Myticin-A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO04166 GENEFORM Protein DME1072 XEOTICID XEO04166 MOACRIVE Inhibition DME1072 XEOTICID XEO04167 XEO_NAME Myticin-B DME1072 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04167 XEO_CLAS Peptide DME1072 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO04167 GENEFORM Protein DME1072 XEOTICID XEO04167 MOACRIVE Inhibition DME1072 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1072 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04168 XEO_CLAS Peptide DME1072 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2.5-5.0 microM) DME1072 XEOTICID XEO04168 GENEFORM Protein DME1072 XEOTICID XEO04168 MOACRIVE Inhibition DME1072 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1072 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04169 XEO_CLAS Peptide DME1072 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO04169 GENEFORM Protein DME1072 XEOTICID XEO04169 MOACRIVE Inhibition DME1072 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1072 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04206 XEO_CLAS Peptide DME1072 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) DME1072 XEOTICID XEO04206 GENEFORM Protein DME1072 XEOTICID XEO04206 MOACRIVE Inhibition DME1072 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1072 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04214 XEO_CLAS Peptide DME1072 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.78 microM) DME1072 XEOTICID XEO04214 GENEFORM Protein DME1072 XEOTICID XEO04214 MOACRIVE Inhibition DME1072 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1072 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04216 XEO_CLAS Peptide DME1072 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) DME1072 XEOTICID XEO04216 GENEFORM Protein DME1072 XEOTICID XEO04216 MOACRIVE Inhibition DME1072 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1072 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04218 XEO_CLAS Peptide DME1072 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.78 microM) DME1072 XEOTICID XEO04218 GENEFORM Protein DME1072 XEOTICID XEO04218 MOACRIVE Inhibition DME1072 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1072 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04219 XEO_CLAS Peptide DME1072 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) DME1072 XEOTICID XEO04219 GENEFORM Protein DME1072 XEOTICID XEO04219 MOACRIVE Inhibition DME1072 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1072 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04220 XEO_CLAS Peptide DME1072 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.78 microM) DME1072 XEOTICID XEO04220 GENEFORM Protein DME1072 XEOTICID XEO04220 MOACRIVE Inhibition DME1072 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1072 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04221 XEO_CLAS Peptide DME1072 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) DME1072 XEOTICID XEO04221 GENEFORM Protein DME1072 XEOTICID XEO04221 MOACRIVE Inhibition DME1072 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1072 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04222 XEO_CLAS Peptide DME1072 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.56 microM) DME1072 XEOTICID XEO04222 GENEFORM Protein DME1072 XEOTICID XEO04222 MOACRIVE Inhibition DME1072 XEOTICID XEO04235 XEO_NAME Napin-like polypeptide DME1072 XEOTICID XEO04235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04235 XEO_CLAS Peptide DME1072 XEOTICID XEO04235 DESCRIPT Napin-like polypeptide inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO04235 GENEFORM Protein DME1072 XEOTICID XEO04235 MOACRIVE Inhibition DME1072 XEOTICID XEO04394 XEO_NAME Omwaprin-a DME1072 XEOTICID XEO04394 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04394 XEO_CLAS Peptide DME1072 XEOTICID XEO04394 DESCRIPT Omwaprin-a inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO04394 GENEFORM Protein DME1072 XEOTICID XEO04394 MOACRIVE Inhibition DME1072 XEOTICID XEO04424 XEO_NAME P. americana Pa-AMP-1 DME1072 XEOTICID XEO04424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04424 XEO_CLAS Peptide DME1072 XEOTICID XEO04424 DESCRIPT P. americana Pa-AMP-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO04424 GENEFORM Protein DME1072 XEOTICID XEO04424 MOACRIVE Inhibition DME1072 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1072 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04426 XEO_CLAS Peptide DME1072 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) DME1072 XEOTICID XEO04426 GENEFORM Protein DME1072 XEOTICID XEO04426 MOACRIVE Inhibition DME1072 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1072 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04430 XEO_CLAS Peptide DME1072 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.78 microM) DME1072 XEOTICID XEO04430 GENEFORM Protein DME1072 XEOTICID XEO04430 MOACRIVE Inhibition DME1072 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1072 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04463 XEO_CLAS Peptide DME1072 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO04463 GENEFORM Protein DME1072 XEOTICID XEO04463 MOACRIVE Inhibition DME1072 XEOTICID XEO04468 XEO_NAME Papillosin DME1072 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04468 XEO_CLAS Peptide DME1072 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO04468 GENEFORM Protein DME1072 XEOTICID XEO04468 MOACRIVE Inhibition DME1072 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1072 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04506 XEO_CLAS Peptide DME1072 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2.5-5 microM) DME1072 XEOTICID XEO04506 GENEFORM Protein DME1072 XEOTICID XEO04506 MOACRIVE Inhibition DME1072 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1072 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04507 XEO_CLAS Peptide DME1072 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2.5-5 microM) DME1072 XEOTICID XEO04507 GENEFORM Protein DME1072 XEOTICID XEO04507 MOACRIVE Inhibition DME1072 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1072 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04510 XEO_CLAS Peptide DME1072 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC > 50 microM) DME1072 XEOTICID XEO04510 GENEFORM Protein DME1072 XEOTICID XEO04510 MOACRIVE Inhibition DME1072 XEOTICID XEO04511 XEO_NAME Penaeidin-4d DME1072 XEOTICID XEO04511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04511 XEO_CLAS Peptide DME1072 XEOTICID XEO04511 DESCRIPT Penaeidin-4d inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC > 50 microM) DME1072 XEOTICID XEO04511 GENEFORM Protein DME1072 XEOTICID XEO04511 MOACRIVE Inhibition DME1072 XEOTICID XEO04545 XEO_NAME Peptide leucine arginine DME1072 XEOTICID XEO04545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04545 XEO_CLAS Peptide DME1072 XEOTICID XEO04545 DESCRIPT Peptide leucine arginine inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 20 microM) DME1072 XEOTICID XEO04545 GENEFORM Protein DME1072 XEOTICID XEO04545 MOACRIVE Inhibition DME1072 XEOTICID XEO04546 XEO_NAME Perinerin DME1072 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04546 XEO_CLAS Peptide DME1072 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO04546 GENEFORM Protein DME1072 XEOTICID XEO04546 MOACRIVE Inhibition DME1072 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1072 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04575 XEO_CLAS Peptide DME1072 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3.12 microM) DME1072 XEOTICID XEO04575 GENEFORM Protein DME1072 XEOTICID XEO04575 MOACRIVE Inhibition DME1072 XEOTICID XEO04624 XEO_NAME Plantazolicin DME1072 XEOTICID XEO04624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04624 XEO_CLAS Peptide DME1072 XEOTICID XEO04624 DESCRIPT Plantazolicin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO04624 GENEFORM Protein DME1072 XEOTICID XEO04624 MOACRIVE Inhibition DME1072 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1072 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04625 XEO_CLAS Peptide DME1072 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 12.5 microM) DME1072 XEOTICID XEO04625 GENEFORM Protein DME1072 XEOTICID XEO04625 MOACRIVE Inhibition DME1072 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1072 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04626 XEO_CLAS Peptide DME1072 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 12.5 microM) DME1072 XEOTICID XEO04626 GENEFORM Protein DME1072 XEOTICID XEO04626 MOACRIVE Inhibition DME1072 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1072 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04627 XEO_CLAS Peptide DME1072 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 50.25 microM) DME1072 XEOTICID XEO04627 GENEFORM Protein DME1072 XEOTICID XEO04627 MOACRIVE Inhibition DME1072 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1072 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04661 XEO_CLAS Peptide DME1072 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3 microM) DME1072 XEOTICID XEO04661 GENEFORM Protein DME1072 XEOTICID XEO04661 MOACRIVE Inhibition DME1072 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1072 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04662 XEO_CLAS Peptide DME1072 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1 microM) DME1072 XEOTICID XEO04662 GENEFORM Protein DME1072 XEOTICID XEO04662 MOACRIVE Inhibition DME1072 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1072 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04663 XEO_CLAS Peptide DME1072 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1 microM) DME1072 XEOTICID XEO04663 GENEFORM Protein DME1072 XEOTICID XEO04663 MOACRIVE Inhibition DME1072 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1072 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04695 XEO_CLAS Peptide DME1072 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO04695 GENEFORM Protein DME1072 XEOTICID XEO04695 MOACRIVE Inhibition DME1072 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1072 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04697 XEO_CLAS Peptide DME1072 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO04697 GENEFORM Protein DME1072 XEOTICID XEO04697 MOACRIVE Inhibition DME1072 XEOTICID XEO04707 XEO_NAME Pore-forming peptide ameobapore A DME1072 XEOTICID XEO04707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04707 XEO_CLAS Peptide DME1072 XEOTICID XEO04707 DESCRIPT Pore-forming peptide ameobapore A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 13 microM) DME1072 XEOTICID XEO04707 GENEFORM Protein DME1072 XEOTICID XEO04707 MOACRIVE Inhibition DME1072 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1072 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04762 XEO_CLAS Peptide DME1072 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.1 microM) DME1072 XEOTICID XEO04762 GENEFORM Protein DME1072 XEOTICID XEO04762 MOACRIVE Inhibition DME1072 XEOTICID XEO04770 XEO_NAME Pyrrhocoricin DME1072 XEOTICID XEO04770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04770 XEO_CLAS Peptide DME1072 XEOTICID XEO04770 DESCRIPT Pyrrhocoricin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC > 80 microM) DME1072 XEOTICID XEO04770 GENEFORM Protein DME1072 XEOTICID XEO04770 MOACRIVE Inhibition DME1072 XEOTICID XEO04797 XEO_NAME Ranacyclin-E DME1072 XEOTICID XEO04797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04797 XEO_CLAS Peptide DME1072 XEOTICID XEO04797 DESCRIPT Ranacyclin-E inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3 microM) DME1072 XEOTICID XEO04797 GENEFORM Protein DME1072 XEOTICID XEO04797 MOACRIVE Inhibition DME1072 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1072 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04798 XEO_CLAS Peptide DME1072 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 3 microM) DME1072 XEOTICID XEO04798 GENEFORM Protein DME1072 XEOTICID XEO04798 MOACRIVE Inhibition DME1072 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1072 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04840 XEO_CLAS Peptide DME1072 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC > 20 microM) DME1072 XEOTICID XEO04840 GENEFORM Protein DME1072 XEOTICID XEO04840 MOACRIVE Inhibition DME1072 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1072 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04905 XEO_CLAS Peptide DME1072 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO04905 GENEFORM Protein DME1072 XEOTICID XEO04905 MOACRIVE Inhibition DME1072 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1072 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04906 XEO_CLAS Peptide DME1072 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO04906 GENEFORM Protein DME1072 XEOTICID XEO04906 MOACRIVE Inhibition DME1072 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1072 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04971 XEO_CLAS Peptide DME1072 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.4-0.8 microM) DME1072 XEOTICID XEO04971 GENEFORM Protein DME1072 XEOTICID XEO04971 MOACRIVE Inhibition DME1072 XEOTICID XEO04974 XEO_NAME Spinigerin DME1072 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04974 XEO_CLAS Peptide DME1072 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.8-1.5 microM) DME1072 XEOTICID XEO04974 GENEFORM Protein DME1072 XEOTICID XEO04974 MOACRIVE Inhibition DME1072 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1072 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO04995 XEO_CLAS Peptide DME1072 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.78-1.56 microM) DME1072 XEOTICID XEO04995 GENEFORM Protein DME1072 XEOTICID XEO04995 MOACRIVE Inhibition DME1072 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1072 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05004 XEO_CLAS Peptide DME1072 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO05004 GENEFORM Protein DME1072 XEOTICID XEO05004 MOACRIVE Inhibition DME1072 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1072 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05005 XEO_CLAS Peptide DME1072 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO05005 GENEFORM Protein DME1072 XEOTICID XEO05005 MOACRIVE Inhibition DME1072 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1072 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05063 XEO_CLAS Peptide DME1072 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) DME1072 XEOTICID XEO05063 GENEFORM Protein DME1072 XEOTICID XEO05063 MOACRIVE Inhibition DME1072 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1072 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05064 XEO_CLAS Peptide DME1072 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 46 microM) DME1072 XEOTICID XEO05064 GENEFORM Protein DME1072 XEOTICID XEO05064 MOACRIVE Inhibition DME1072 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1072 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05065 XEO_CLAS Peptide DME1072 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 4 ug/ml) DME1072 XEOTICID XEO05065 GENEFORM Protein DME1072 XEOTICID XEO05065 MOACRIVE Inhibition DME1072 XEOTICID XEO05076 XEO_NAME Temporin-A DME1072 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05076 XEO_CLAS Peptide DME1072 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 1.2 microM) DME1072 XEOTICID XEO05076 GENEFORM Protein DME1072 XEOTICID XEO05076 MOACRIVE Inhibition DME1072 XEOTICID XEO05085 XEO_NAME Temporin-B DME1072 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05085 XEO_CLAS Peptide DME1072 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2.8 ug/ml) DME1072 XEOTICID XEO05085 GENEFORM Protein DME1072 XEOTICID XEO05085 MOACRIVE Inhibition DME1072 XEOTICID XEO05088 XEO_NAME Temporin-D DME1072 XEOTICID XEO05088 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05088 XEO_CLAS Peptide DME1072 XEOTICID XEO05088 DESCRIPT Temporin-D inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO05088 GENEFORM Protein DME1072 XEOTICID XEO05088 MOACRIVE Inhibition DME1072 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1072 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05105 XEO_CLAS Peptide DME1072 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2 microM) DME1072 XEOTICID XEO05105 GENEFORM Protein DME1072 XEOTICID XEO05105 MOACRIVE Inhibition DME1072 XEOTICID XEO05110 XEO_NAME Termicin DME1072 XEOTICID XEO05110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05110 XEO_CLAS Peptide DME1072 XEOTICID XEO05110 DESCRIPT Termicin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO05110 GENEFORM Protein DME1072 XEOTICID XEO05110 MOACRIVE Inhibition DME1072 XEOTICID XEO05120 XEO_NAME Thanatin DME1072 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05120 XEO_CLAS Peptide DME1072 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 2.5-5 microM) DME1072 XEOTICID XEO05120 GENEFORM Protein DME1072 XEOTICID XEO05120 MOACRIVE Inhibition DME1072 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1072 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05125 XEO_CLAS Peptide DME1072 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO05125 GENEFORM Protein DME1072 XEOTICID XEO05125 MOACRIVE Inhibition DME1072 XEOTICID XEO05138 XEO_NAME Thuricin-17 DME1072 XEOTICID XEO05138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05138 XEO_CLAS Peptide DME1072 XEOTICID XEO05138 DESCRIPT Thuricin-17 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium DME1072 XEOTICID XEO05138 GENEFORM Protein DME1072 XEOTICID XEO05138 MOACRIVE Inhibition DME1072 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1072 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05220 XEO_CLAS Peptide DME1072 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 5-10 microM) DME1072 XEOTICID XEO05220 GENEFORM Protein DME1072 XEOTICID XEO05220 MOACRIVE Inhibition DME1072 XEOTICID XEO05229 XEO_NAME Vasostatin-1 DME1072 XEOTICID XEO05229 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05229 XEO_CLAS Peptide DME1072 XEOTICID XEO05229 DESCRIPT Vasostatin-1 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.2 microM) DME1072 XEOTICID XEO05229 GENEFORM Protein DME1072 XEOTICID XEO05229 MOACRIVE Inhibition DME1072 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1072 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05230 XEO_CLAS Peptide DME1072 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.25 microM) DME1072 XEOTICID XEO05230 GENEFORM Protein DME1072 XEOTICID XEO05230 MOACRIVE Inhibition DME1072 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1072 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05231 XEO_CLAS Peptide DME1072 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 0.25 microM) DME1072 XEOTICID XEO05231 GENEFORM Protein DME1072 XEOTICID XEO05231 MOACRIVE Inhibition DME1072 XEOTICID XEO05304 XEO_NAME Thanatin truncated isoform Y12M(10-21) DME1072 XEOTICID XEO05304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1072 XEOTICID XEO05304 XEO_CLAS Peptide DME1072 XEOTICID XEO05304 DESCRIPT Thanatin truncated isoform Y12M(10-21) inhibits the drug-metabolizing activity of Cytochrome P450 MEG (cyp106) from Bacillus megaterium (MIC = 20-40 microM) DME1072 XEOTICID XEO05304 GENEFORM Protein DME1072 XEOTICID XEO05304 MOACRIVE Inhibition DME1075 DME___ID DME1075 DME1075 DME_NAME Cytochrome P450 102A1 (cyp102) DME1075 SPESNAME Bacillus megaterium DME1075 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1075 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO01823 XEO_CLAS Peptide DME1075 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1.56 microM) DME1075 XEOTICID XEO01823 GENEFORM Protein DME1075 XEOTICID XEO01823 MOACRIVE Inhibition DME1075 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1075 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO01824 XEO_CLAS Peptide DME1075 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3.125 microM) DME1075 XEOTICID XEO01824 GENEFORM Protein DME1075 XEOTICID XEO01824 MOACRIVE Inhibition DME1075 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1075 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO01825 XEO_CLAS Peptide DME1075 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3.125 microM) DME1075 XEOTICID XEO01825 GENEFORM Protein DME1075 XEOTICID XEO01825 MOACRIVE Inhibition DME1075 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1075 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO01827 XEO_CLAS Peptide DME1075 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3.12-6.25 microM) DME1075 XEOTICID XEO01827 GENEFORM Protein DME1075 XEOTICID XEO01827 MOACRIVE Inhibition DME1075 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1075 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02230 XEO_CLAS Peptide DME1075 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.5-1 microM) DME1075 XEOTICID XEO02230 GENEFORM Protein DME1075 XEOTICID XEO02230 MOACRIVE Inhibition DME1075 XEOTICID XEO02237 XEO_NAME Antibacterial napin DME1075 XEOTICID XEO02237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02237 XEO_CLAS Peptide DME1075 XEOTICID XEO02237 DESCRIPT Antibacterial napin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 215 microM) DME1075 XEOTICID XEO02237 GENEFORM Protein DME1075 XEOTICID XEO02237 MOACRIVE Inhibition DME1075 XEOTICID XEO02238 XEO_NAME Antibacterial peptide 3910 DME1075 XEOTICID XEO02238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02238 XEO_CLAS Peptide DME1075 XEOTICID XEO02238 DESCRIPT Antibacterial peptide 3910 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO02238 GENEFORM Protein DME1075 XEOTICID XEO02238 MOACRIVE Inhibition DME1075 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1075 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02242 XEO_CLAS Peptide DME1075 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2 microM) DME1075 XEOTICID XEO02242 GENEFORM Protein DME1075 XEOTICID XEO02242 MOACRIVE Inhibition DME1075 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1075 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02243 XEO_CLAS Peptide DME1075 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3 microM) DME1075 XEOTICID XEO02243 GENEFORM Protein DME1075 XEOTICID XEO02243 MOACRIVE Inhibition DME1075 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1075 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02244 XEO_CLAS Peptide DME1075 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 4 microM) DME1075 XEOTICID XEO02244 GENEFORM Protein DME1075 XEOTICID XEO02244 MOACRIVE Inhibition DME1075 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1075 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02248 XEO_CLAS Peptide DME1075 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.3 microM) DME1075 XEOTICID XEO02248 GENEFORM Protein DME1075 XEOTICID XEO02248 MOACRIVE Inhibition DME1075 XEOTICID XEO02259 XEO_NAME Antimicrobial peptide AC-AMP1 DME1075 XEOTICID XEO02259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02259 XEO_CLAS Peptide DME1075 XEOTICID XEO02259 DESCRIPT Antimicrobial peptide AC-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO02259 GENEFORM Protein DME1075 XEOTICID XEO02259 MOACRIVE Inhibition DME1075 XEOTICID XEO02262 XEO_NAME Antimicrobial peptide MJ-AMP1 DME1075 XEOTICID XEO02262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02262 XEO_CLAS Peptide DME1075 XEOTICID XEO02262 DESCRIPT Antimicrobial peptide MJ-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 6 ug/ml) DME1075 XEOTICID XEO02262 GENEFORM Protein DME1075 XEOTICID XEO02262 MOACRIVE Inhibition DME1075 XEOTICID XEO02267 XEO_NAME Antimicrobial peptide AC-AMP2 DME1075 XEOTICID XEO02267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02267 XEO_CLAS Peptide DME1075 XEOTICID XEO02267 DESCRIPT Antimicrobial peptide AC-AMP2 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO02267 GENEFORM Protein DME1075 XEOTICID XEO02267 MOACRIVE Inhibition DME1075 XEOTICID XEO02269 XEO_NAME Antimicrobial peptide MJ-AMP2 DME1075 XEOTICID XEO02269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02269 XEO_CLAS Peptide DME1075 XEOTICID XEO02269 DESCRIPT Antimicrobial peptide MJ-AMP2 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2 ug/ml) DME1075 XEOTICID XEO02269 GENEFORM Protein DME1075 XEOTICID XEO02269 MOACRIVE Inhibition DME1075 XEOTICID XEO02282 XEO_NAME Antimicrobial peptide GP-19 DME1075 XEOTICID XEO02282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02282 XEO_CLAS Peptide DME1075 XEOTICID XEO02282 DESCRIPT Antimicrobial peptide GP-19 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO02282 GENEFORM Protein DME1075 XEOTICID XEO02282 MOACRIVE Inhibition DME1075 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1075 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02293 XEO_CLAS Peptide DME1075 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.8 microM) DME1075 XEOTICID XEO02293 GENEFORM Protein DME1075 XEOTICID XEO02293 MOACRIVE Inhibition DME1075 XEOTICID XEO02299 XEO_NAME Antimicrobial protein Ace-AMP1 DME1075 XEOTICID XEO02299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02299 XEO_CLAS Peptide DME1075 XEOTICID XEO02299 DESCRIPT Antimicrobial protein Ace-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO02299 GENEFORM Protein DME1075 XEOTICID XEO02299 MOACRIVE Inhibition DME1075 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1075 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02304 XEO_CLAS Peptide DME1075 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 150 ug/ml) DME1075 XEOTICID XEO02304 GENEFORM Protein DME1075 XEOTICID XEO02304 MOACRIVE Inhibition DME1075 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1075 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02305 XEO_CLAS Peptide DME1075 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 100 ug/ml) DME1075 XEOTICID XEO02305 GENEFORM Protein DME1075 XEOTICID XEO02305 MOACRIVE Inhibition DME1075 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1075 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02306 XEO_CLAS Peptide DME1075 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 100 ug/ml) DME1075 XEOTICID XEO02306 GENEFORM Protein DME1075 XEOTICID XEO02306 MOACRIVE Inhibition DME1075 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1075 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02319 XEO_CLAS Peptide DME1075 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.5-1.25 microM) DME1075 XEOTICID XEO02319 GENEFORM Protein DME1075 XEOTICID XEO02319 MOACRIVE Inhibition DME1075 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1075 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02333 XEO_CLAS Peptide DME1075 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC > 200 microM) DME1075 XEOTICID XEO02333 GENEFORM Protein DME1075 XEOTICID XEO02333 MOACRIVE Inhibition DME1075 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1075 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02466 XEO_CLAS Peptide DME1075 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3 microM) DME1075 XEOTICID XEO02466 GENEFORM Protein DME1075 XEOTICID XEO02466 MOACRIVE Inhibition DME1075 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1075 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02468 XEO_CLAS Peptide DME1075 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3.3 microM) DME1075 XEOTICID XEO02468 GENEFORM Protein DME1075 XEOTICID XEO02468 MOACRIVE Inhibition DME1075 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1075 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02474 XEO_CLAS Peptide DME1075 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.3 microM) DME1075 XEOTICID XEO02474 GENEFORM Protein DME1075 XEOTICID XEO02474 MOACRIVE Inhibition DME1075 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1075 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02475 XEO_CLAS Peptide DME1075 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.3 microM) DME1075 XEOTICID XEO02475 GENEFORM Protein DME1075 XEOTICID XEO02475 MOACRIVE Inhibition DME1075 XEOTICID XEO02476 XEO_NAME Bacteriocin HJ50 DME1075 XEOTICID XEO02476 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02476 XEO_CLAS Peptide DME1075 XEOTICID XEO02476 DESCRIPT Bacteriocin HJ50 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO02476 GENEFORM Protein DME1075 XEOTICID XEO02476 MOACRIVE Inhibition DME1075 XEOTICID XEO02521 XEO_NAME Brevinin-1E DME1075 XEOTICID XEO02521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02521 XEO_CLAS Peptide DME1075 XEOTICID XEO02521 DESCRIPT Brevinin-1E inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.4 microM) DME1075 XEOTICID XEO02521 GENEFORM Protein DME1075 XEOTICID XEO02521 MOACRIVE Inhibition DME1075 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1075 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02584 XEO_CLAS Peptide DME1075 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.2 microM) DME1075 XEOTICID XEO02584 GENEFORM Protein DME1075 XEOTICID XEO02584 MOACRIVE Inhibition DME1075 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1075 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02663 XEO_CLAS Peptide DME1075 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1.56 microM) DME1075 XEOTICID XEO02663 GENEFORM Protein DME1075 XEOTICID XEO02663 MOACRIVE Inhibition DME1075 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1075 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02664 XEO_CLAS Peptide DME1075 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3.125 microM) DME1075 XEOTICID XEO02664 GENEFORM Protein DME1075 XEOTICID XEO02664 MOACRIVE Inhibition DME1075 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1075 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02672 XEO_CLAS Peptide DME1075 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1.56 microM) DME1075 XEOTICID XEO02672 GENEFORM Protein DME1075 XEOTICID XEO02672 MOACRIVE Inhibition DME1075 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1075 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02673 XEO_CLAS Peptide DME1075 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3.125 microM) DME1075 XEOTICID XEO02673 GENEFORM Protein DME1075 XEOTICID XEO02673 MOACRIVE Inhibition DME1075 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1075 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02674 XEO_CLAS Peptide DME1075 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3.125 microM) DME1075 XEOTICID XEO02674 GENEFORM Protein DME1075 XEOTICID XEO02674 MOACRIVE Inhibition DME1075 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1075 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02676 XEO_CLAS Peptide DME1075 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1.56 microM) DME1075 XEOTICID XEO02676 GENEFORM Protein DME1075 XEOTICID XEO02676 MOACRIVE Inhibition DME1075 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1075 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02677 XEO_CLAS Peptide DME1075 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3.125 microM) DME1075 XEOTICID XEO02677 GENEFORM Protein DME1075 XEOTICID XEO02677 MOACRIVE Inhibition DME1075 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1075 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02679 XEO_CLAS Peptide DME1075 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3.125 microM) DME1075 XEOTICID XEO02679 GENEFORM Protein DME1075 XEOTICID XEO02679 MOACRIVE Inhibition DME1075 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1075 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02680 XEO_CLAS Peptide DME1075 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3.125 microM) DME1075 XEOTICID XEO02680 GENEFORM Protein DME1075 XEOTICID XEO02680 MOACRIVE Inhibition DME1075 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1075 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02683 XEO_CLAS Peptide DME1075 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3.125 microM) DME1075 XEOTICID XEO02683 GENEFORM Protein DME1075 XEOTICID XEO02683 MOACRIVE Inhibition DME1075 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1075 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02731 XEO_CLAS Peptide DME1075 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 4 microM) DME1075 XEOTICID XEO02731 GENEFORM Protein DME1075 XEOTICID XEO02731 MOACRIVE Inhibition DME1075 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1075 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02739 XEO_CLAS Peptide DME1075 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2 microM) DME1075 XEOTICID XEO02739 GENEFORM Protein DME1075 XEOTICID XEO02739 MOACRIVE Inhibition DME1075 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1075 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02740 XEO_CLAS Peptide DME1075 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2 ug/ml) DME1075 XEOTICID XEO02740 GENEFORM Protein DME1075 XEOTICID XEO02740 MOACRIVE Inhibition DME1075 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1075 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02756 XEO_CLAS Peptide DME1075 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.8 microM) DME1075 XEOTICID XEO02756 GENEFORM Protein DME1075 XEOTICID XEO02756 MOACRIVE Inhibition DME1075 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1075 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02757 XEO_CLAS Peptide DME1075 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.7 microM) DME1075 XEOTICID XEO02757 GENEFORM Protein DME1075 XEOTICID XEO02757 MOACRIVE Inhibition DME1075 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1075 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02758 XEO_CLAS Peptide DME1075 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.9 microM) DME1075 XEOTICID XEO02758 GENEFORM Protein DME1075 XEOTICID XEO02758 MOACRIVE Inhibition DME1075 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1075 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02759 XEO_CLAS Peptide DME1075 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.5 microM) DME1075 XEOTICID XEO02759 GENEFORM Protein DME1075 XEOTICID XEO02759 MOACRIVE Inhibition DME1075 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1075 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02760 XEO_CLAS Peptide DME1075 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.5 microM) DME1075 XEOTICID XEO02760 GENEFORM Protein DME1075 XEOTICID XEO02760 MOACRIVE Inhibition DME1075 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1075 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02761 XEO_CLAS Peptide DME1075 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.5 microM) DME1075 XEOTICID XEO02761 GENEFORM Protein DME1075 XEOTICID XEO02761 MOACRIVE Inhibition DME1075 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1075 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02762 XEO_CLAS Peptide DME1075 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.5 microM) DME1075 XEOTICID XEO02762 GENEFORM Protein DME1075 XEOTICID XEO02762 MOACRIVE Inhibition DME1075 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1075 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02763 XEO_CLAS Peptide DME1075 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.2 microM) DME1075 XEOTICID XEO02763 GENEFORM Protein DME1075 XEOTICID XEO02763 MOACRIVE Inhibition DME1075 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1075 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02765 XEO_CLAS Peptide DME1075 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.4 microM) DME1075 XEOTICID XEO02765 GENEFORM Protein DME1075 XEOTICID XEO02765 MOACRIVE Inhibition DME1075 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1075 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02768 XEO_CLAS Peptide DME1075 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1-2.5 ug/ml) DME1075 XEOTICID XEO02768 GENEFORM Protein DME1075 XEOTICID XEO02768 MOACRIVE Inhibition DME1075 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1075 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02769 XEO_CLAS Peptide DME1075 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.44 microM) DME1075 XEOTICID XEO02769 GENEFORM Protein DME1075 XEOTICID XEO02769 MOACRIVE Inhibition DME1075 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1075 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02770 XEO_CLAS Peptide DME1075 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.64 microM) DME1075 XEOTICID XEO02770 GENEFORM Protein DME1075 XEOTICID XEO02770 MOACRIVE Inhibition DME1075 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1075 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02771 XEO_CLAS Peptide DME1075 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 24 microM) DME1075 XEOTICID XEO02771 GENEFORM Protein DME1075 XEOTICID XEO02771 MOACRIVE Inhibition DME1075 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1075 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02772 XEO_CLAS Peptide DME1075 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO02772 GENEFORM Protein DME1075 XEOTICID XEO02772 MOACRIVE Inhibition DME1075 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1075 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO02774 XEO_CLAS Peptide DME1075 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1.8 microM) DME1075 XEOTICID XEO02774 GENEFORM Protein DME1075 XEOTICID XEO02774 MOACRIVE Inhibition DME1075 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1075 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03081 XEO_CLAS Peptide DME1075 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.69 microM) DME1075 XEOTICID XEO03081 GENEFORM Protein DME1075 XEOTICID XEO03081 MOACRIVE Inhibition DME1075 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1075 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03100 XEO_CLAS Peptide DME1075 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO03100 GENEFORM Protein DME1075 XEOTICID XEO03100 MOACRIVE Inhibition DME1075 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1075 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03110 XEO_CLAS Peptide DME1075 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.8 microM) DME1075 XEOTICID XEO03110 GENEFORM Protein DME1075 XEOTICID XEO03110 MOACRIVE Inhibition DME1075 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1075 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03116 XEO_CLAS Peptide DME1075 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1.2-2.5 microM) DME1075 XEOTICID XEO03116 GENEFORM Protein DME1075 XEOTICID XEO03116 MOACRIVE Inhibition DME1075 XEOTICID XEO03117 XEO_NAME Insect defensin B DME1075 XEOTICID XEO03117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03117 XEO_CLAS Peptide DME1075 XEOTICID XEO03117 DESCRIPT Insect defensin B inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1.2-2.5 microM) DME1075 XEOTICID XEO03117 GENEFORM Protein DME1075 XEOTICID XEO03117 MOACRIVE Inhibition DME1075 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1075 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03119 XEO_CLAS Peptide DME1075 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO03119 GENEFORM Protein DME1075 XEOTICID XEO03119 MOACRIVE Inhibition DME1075 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1075 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03137 XEO_CLAS Peptide DME1075 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO03137 GENEFORM Protein DME1075 XEOTICID XEO03137 MOACRIVE Inhibition DME1075 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1075 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03162 XEO_CLAS Peptide DME1075 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.8 microM) DME1075 XEOTICID XEO03162 GENEFORM Protein DME1075 XEOTICID XEO03162 MOACRIVE Inhibition DME1075 XEOTICID XEO03164 XEO_NAME Dermatoxin DME1075 XEOTICID XEO03164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03164 XEO_CLAS Peptide DME1075 XEOTICID XEO03164 DESCRIPT Dermatoxin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO03164 GENEFORM Protein DME1075 XEOTICID XEO03164 MOACRIVE Inhibition DME1075 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1075 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03224 XEO_CLAS Peptide DME1075 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1-2.5 microM) DME1075 XEOTICID XEO03224 GENEFORM Protein DME1075 XEOTICID XEO03224 MOACRIVE Inhibition DME1075 XEOTICID XEO03243 XEO_NAME Hevein-like antimicrobial peptide Ee-CBPb DME1075 XEOTICID XEO03243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03243 XEO_CLAS Peptide DME1075 XEOTICID XEO03243 DESCRIPT Hevein-like antimicrobial peptide Ee-CBPb inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO03243 GENEFORM Protein DME1075 XEOTICID XEO03243 MOACRIVE Inhibition DME1075 XEOTICID XEO03249 XEO_NAME Enkelytin DME1075 XEOTICID XEO03249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03249 XEO_CLAS Peptide DME1075 XEOTICID XEO03249 DESCRIPT Enkelytin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.2-0.4 microM) DME1075 XEOTICID XEO03249 GENEFORM Protein DME1075 XEOTICID XEO03249 MOACRIVE Inhibition DME1075 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1075 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03251 XEO_CLAS Peptide DME1075 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO03251 GENEFORM Protein DME1075 XEOTICID XEO03251 MOACRIVE Inhibition DME1075 XEOTICID XEO03254 XEO_NAME Enterocin EJ97 DME1075 XEOTICID XEO03254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03254 XEO_CLAS Peptide DME1075 XEOTICID XEO03254 DESCRIPT Enterocin EJ97 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 4 ug/ml) DME1075 XEOTICID XEO03254 GENEFORM Protein DME1075 XEOTICID XEO03254 MOACRIVE Inhibition DME1075 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1075 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03274 XEO_CLAS Peptide DME1075 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.1 microM) DME1075 XEOTICID XEO03274 GENEFORM Protein DME1075 XEOTICID XEO03274 MOACRIVE Inhibition DME1075 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1075 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03277 XEO_CLAS Peptide DME1075 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.1 microM) DME1075 XEOTICID XEO03277 GENEFORM Protein DME1075 XEOTICID XEO03277 MOACRIVE Inhibition DME1075 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1075 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03299 XEO_CLAS Peptide DME1075 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.2 microM) DME1075 XEOTICID XEO03299 GENEFORM Protein DME1075 XEOTICID XEO03299 MOACRIVE Inhibition DME1075 XEOTICID XEO03431 XEO_NAME Thanatin truncated isoform G18C(1-18) DME1075 XEOTICID XEO03431 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03431 XEO_CLAS Peptide DME1075 XEOTICID XEO03431 DESCRIPT Thanatin truncated isoform G18C(1-18) inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 5-10 microM) DME1075 XEOTICID XEO03431 GENEFORM Protein DME1075 XEOTICID XEO03431 MOACRIVE Inhibition DME1075 XEOTICID XEO03432 XEO_NAME Thanatin truncated isoform G19Q(1-19) DME1075 XEOTICID XEO03432 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03432 XEO_CLAS Peptide DME1075 XEOTICID XEO03432 DESCRIPT Thanatin truncated isoform G19Q(1-19) inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 5-10 microM) DME1075 XEOTICID XEO03432 GENEFORM Protein DME1075 XEOTICID XEO03432 MOACRIVE Inhibition DME1075 XEOTICID XEO03435 XEO_NAME Thanatin truncated isoform G20R(1-20) DME1075 XEOTICID XEO03435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03435 XEO_CLAS Peptide DME1075 XEOTICID XEO03435 DESCRIPT Thanatin truncated isoform G20R(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2.5-5 microM) DME1075 XEOTICID XEO03435 GENEFORM Protein DME1075 XEOTICID XEO03435 MOACRIVE Inhibition DME1075 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1075 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03497 XEO_CLAS Peptide DME1075 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.2-0.4 microM) DME1075 XEOTICID XEO03497 GENEFORM Protein DME1075 XEOTICID XEO03497 MOACRIVE Inhibition DME1075 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1075 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03498 XEO_CLAS Peptide DME1075 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.2-0.4 microM) DME1075 XEOTICID XEO03498 GENEFORM Protein DME1075 XEOTICID XEO03498 MOACRIVE Inhibition DME1075 XEOTICID XEO03522 XEO_NAME Halocyntin DME1075 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03522 XEO_CLAS Peptide DME1075 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO03522 GENEFORM Protein DME1075 XEOTICID XEO03522 MOACRIVE Inhibition DME1075 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1075 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03561 XEO_CLAS Peptide DME1075 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO03561 GENEFORM Protein DME1075 XEOTICID XEO03561 MOACRIVE Inhibition DME1075 XEOTICID XEO03605 XEO_NAME Human recombinant Ser-Thr-Ala-CGA1-78 DME1075 XEOTICID XEO03605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03605 XEO_CLAS Peptide DME1075 XEOTICID XEO03605 DESCRIPT Human recombinant Ser-Thr-Ala-CGA1-78 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 30 microM) DME1075 XEOTICID XEO03605 GENEFORM Protein DME1075 XEOTICID XEO03605 MOACRIVE Inhibition DME1075 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1075 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03618 XEO_CLAS Peptide DME1075 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.5-1 microM) DME1075 XEOTICID XEO03618 GENEFORM Protein DME1075 XEOTICID XEO03618 MOACRIVE Inhibition DME1075 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1075 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03622 XEO_CLAS Peptide DME1075 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 10-20 microM) DME1075 XEOTICID XEO03622 GENEFORM Protein DME1075 XEOTICID XEO03622 MOACRIVE Inhibition DME1075 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1075 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03681 XEO_CLAS Peptide DME1075 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2.5-5 microM) DME1075 XEOTICID XEO03681 GENEFORM Protein DME1075 XEOTICID XEO03681 MOACRIVE Inhibition DME1075 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1075 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03712 XEO_CLAS Peptide DME1075 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO03712 GENEFORM Protein DME1075 XEOTICID XEO03712 MOACRIVE Inhibition DME1075 XEOTICID XEO03804 XEO_NAME Lantibiotic lichenicidin VK21 A1 DME1075 XEOTICID XEO03804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03804 XEO_CLAS Peptide DME1075 XEOTICID XEO03804 DESCRIPT Lantibiotic lichenicidin VK21 A1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO03804 GENEFORM Protein DME1075 XEOTICID XEO03804 MOACRIVE Inhibition DME1075 XEOTICID XEO03805 XEO_NAME Lantibiotic lichenicidin VK21 A2 DME1075 XEOTICID XEO03805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03805 XEO_CLAS Peptide DME1075 XEOTICID XEO03805 DESCRIPT Lantibiotic lichenicidin VK21 A2 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO03805 GENEFORM Protein DME1075 XEOTICID XEO03805 MOACRIVE Inhibition DME1075 XEOTICID XEO03973 XEO_NAME Lunatusin DME1075 XEOTICID XEO03973 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO03973 XEO_CLAS Peptide DME1075 XEOTICID XEO03973 DESCRIPT Lunatusin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO03973 GENEFORM Protein DME1075 XEOTICID XEO03973 MOACRIVE Inhibition DME1075 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1075 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04039 XEO_CLAS Peptide DME1075 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2 microM) DME1075 XEOTICID XEO04039 GENEFORM Protein DME1075 XEOTICID XEO04039 MOACRIVE Inhibition DME1075 XEOTICID XEO04057 XEO_NAME Melittin DME1075 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04057 XEO_CLAS Peptide DME1075 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.6 microM) DME1075 XEOTICID XEO04057 GENEFORM Protein DME1075 XEOTICID XEO04057 MOACRIVE Inhibition DME1075 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1075 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04128 XEO_CLAS Peptide DME1075 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.09 microM) DME1075 XEOTICID XEO04128 GENEFORM Protein DME1075 XEOTICID XEO04128 MOACRIVE Inhibition DME1075 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1075 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04158 XEO_CLAS Peptide DME1075 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2 microM) DME1075 XEOTICID XEO04158 GENEFORM Protein DME1075 XEOTICID XEO04158 MOACRIVE Inhibition DME1075 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1075 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04159 XEO_CLAS Peptide DME1075 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2 microM) DME1075 XEOTICID XEO04159 GENEFORM Protein DME1075 XEOTICID XEO04159 MOACRIVE Inhibition DME1075 XEOTICID XEO04166 XEO_NAME Myticin-A DME1075 XEOTICID XEO04166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04166 XEO_CLAS Peptide DME1075 XEOTICID XEO04166 DESCRIPT Myticin-A inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO04166 GENEFORM Protein DME1075 XEOTICID XEO04166 MOACRIVE Inhibition DME1075 XEOTICID XEO04167 XEO_NAME Myticin-B DME1075 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04167 XEO_CLAS Peptide DME1075 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO04167 GENEFORM Protein DME1075 XEOTICID XEO04167 MOACRIVE Inhibition DME1075 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1075 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04168 XEO_CLAS Peptide DME1075 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2.5-5.0 microM) DME1075 XEOTICID XEO04168 GENEFORM Protein DME1075 XEOTICID XEO04168 MOACRIVE Inhibition DME1075 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1075 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04169 XEO_CLAS Peptide DME1075 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO04169 GENEFORM Protein DME1075 XEOTICID XEO04169 MOACRIVE Inhibition DME1075 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1075 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04206 XEO_CLAS Peptide DME1075 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1.56 microM) DME1075 XEOTICID XEO04206 GENEFORM Protein DME1075 XEOTICID XEO04206 MOACRIVE Inhibition DME1075 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1075 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04214 XEO_CLAS Peptide DME1075 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.78 microM) DME1075 XEOTICID XEO04214 GENEFORM Protein DME1075 XEOTICID XEO04214 MOACRIVE Inhibition DME1075 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1075 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04216 XEO_CLAS Peptide DME1075 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1.56 microM) DME1075 XEOTICID XEO04216 GENEFORM Protein DME1075 XEOTICID XEO04216 MOACRIVE Inhibition DME1075 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1075 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04218 XEO_CLAS Peptide DME1075 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.78 microM) DME1075 XEOTICID XEO04218 GENEFORM Protein DME1075 XEOTICID XEO04218 MOACRIVE Inhibition DME1075 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1075 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04219 XEO_CLAS Peptide DME1075 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1.56 microM) DME1075 XEOTICID XEO04219 GENEFORM Protein DME1075 XEOTICID XEO04219 MOACRIVE Inhibition DME1075 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1075 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04220 XEO_CLAS Peptide DME1075 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.78 microM) DME1075 XEOTICID XEO04220 GENEFORM Protein DME1075 XEOTICID XEO04220 MOACRIVE Inhibition DME1075 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1075 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04221 XEO_CLAS Peptide DME1075 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1.56 microM) DME1075 XEOTICID XEO04221 GENEFORM Protein DME1075 XEOTICID XEO04221 MOACRIVE Inhibition DME1075 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1075 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04222 XEO_CLAS Peptide DME1075 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1.56 microM) DME1075 XEOTICID XEO04222 GENEFORM Protein DME1075 XEOTICID XEO04222 MOACRIVE Inhibition DME1075 XEOTICID XEO04235 XEO_NAME Napin-like polypeptide DME1075 XEOTICID XEO04235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04235 XEO_CLAS Peptide DME1075 XEOTICID XEO04235 DESCRIPT Napin-like polypeptide inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO04235 GENEFORM Protein DME1075 XEOTICID XEO04235 MOACRIVE Inhibition DME1075 XEOTICID XEO04394 XEO_NAME Omwaprin-a DME1075 XEOTICID XEO04394 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04394 XEO_CLAS Peptide DME1075 XEOTICID XEO04394 DESCRIPT Omwaprin-a inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO04394 GENEFORM Protein DME1075 XEOTICID XEO04394 MOACRIVE Inhibition DME1075 XEOTICID XEO04424 XEO_NAME P. americana Pa-AMP-1 DME1075 XEOTICID XEO04424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04424 XEO_CLAS Peptide DME1075 XEOTICID XEO04424 DESCRIPT P. americana Pa-AMP-1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO04424 GENEFORM Protein DME1075 XEOTICID XEO04424 MOACRIVE Inhibition DME1075 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1075 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04426 XEO_CLAS Peptide DME1075 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2 microM) DME1075 XEOTICID XEO04426 GENEFORM Protein DME1075 XEOTICID XEO04426 MOACRIVE Inhibition DME1075 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1075 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04430 XEO_CLAS Peptide DME1075 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.78 microM) DME1075 XEOTICID XEO04430 GENEFORM Protein DME1075 XEOTICID XEO04430 MOACRIVE Inhibition DME1075 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1075 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04463 XEO_CLAS Peptide DME1075 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO04463 GENEFORM Protein DME1075 XEOTICID XEO04463 MOACRIVE Inhibition DME1075 XEOTICID XEO04468 XEO_NAME Papillosin DME1075 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04468 XEO_CLAS Peptide DME1075 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO04468 GENEFORM Protein DME1075 XEOTICID XEO04468 MOACRIVE Inhibition DME1075 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1075 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04506 XEO_CLAS Peptide DME1075 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2.5-5 microM) DME1075 XEOTICID XEO04506 GENEFORM Protein DME1075 XEOTICID XEO04506 MOACRIVE Inhibition DME1075 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1075 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04507 XEO_CLAS Peptide DME1075 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2.5-5 microM) DME1075 XEOTICID XEO04507 GENEFORM Protein DME1075 XEOTICID XEO04507 MOACRIVE Inhibition DME1075 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1075 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04510 XEO_CLAS Peptide DME1075 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC > 50 microM) DME1075 XEOTICID XEO04510 GENEFORM Protein DME1075 XEOTICID XEO04510 MOACRIVE Inhibition DME1075 XEOTICID XEO04511 XEO_NAME Penaeidin-4d DME1075 XEOTICID XEO04511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04511 XEO_CLAS Peptide DME1075 XEOTICID XEO04511 DESCRIPT Penaeidin-4d inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC > 50 microM) DME1075 XEOTICID XEO04511 GENEFORM Protein DME1075 XEOTICID XEO04511 MOACRIVE Inhibition DME1075 XEOTICID XEO04545 XEO_NAME Peptide leucine arginine DME1075 XEOTICID XEO04545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04545 XEO_CLAS Peptide DME1075 XEOTICID XEO04545 DESCRIPT Peptide leucine arginine inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 20 microM) DME1075 XEOTICID XEO04545 GENEFORM Protein DME1075 XEOTICID XEO04545 MOACRIVE Inhibition DME1075 XEOTICID XEO04546 XEO_NAME Perinerin DME1075 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04546 XEO_CLAS Peptide DME1075 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO04546 GENEFORM Protein DME1075 XEOTICID XEO04546 MOACRIVE Inhibition DME1075 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1075 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04575 XEO_CLAS Peptide DME1075 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3.12 microM) DME1075 XEOTICID XEO04575 GENEFORM Protein DME1075 XEOTICID XEO04575 MOACRIVE Inhibition DME1075 XEOTICID XEO04624 XEO_NAME Plantazolicin DME1075 XEOTICID XEO04624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04624 XEO_CLAS Peptide DME1075 XEOTICID XEO04624 DESCRIPT Plantazolicin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO04624 GENEFORM Protein DME1075 XEOTICID XEO04624 MOACRIVE Inhibition DME1075 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1075 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04625 XEO_CLAS Peptide DME1075 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 12.5 microM) DME1075 XEOTICID XEO04625 GENEFORM Protein DME1075 XEOTICID XEO04625 MOACRIVE Inhibition DME1075 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1075 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04626 XEO_CLAS Peptide DME1075 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 12.5 microM) DME1075 XEOTICID XEO04626 GENEFORM Protein DME1075 XEOTICID XEO04626 MOACRIVE Inhibition DME1075 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1075 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04627 XEO_CLAS Peptide DME1075 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 50.25 microM) DME1075 XEOTICID XEO04627 GENEFORM Protein DME1075 XEOTICID XEO04627 MOACRIVE Inhibition DME1075 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1075 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04661 XEO_CLAS Peptide DME1075 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3 microM) DME1075 XEOTICID XEO04661 GENEFORM Protein DME1075 XEOTICID XEO04661 MOACRIVE Inhibition DME1075 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1075 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04662 XEO_CLAS Peptide DME1075 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1 microM) DME1075 XEOTICID XEO04662 GENEFORM Protein DME1075 XEOTICID XEO04662 MOACRIVE Inhibition DME1075 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1075 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04663 XEO_CLAS Peptide DME1075 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1 microM) DME1075 XEOTICID XEO04663 GENEFORM Protein DME1075 XEOTICID XEO04663 MOACRIVE Inhibition DME1075 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1075 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04695 XEO_CLAS Peptide DME1075 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO04695 GENEFORM Protein DME1075 XEOTICID XEO04695 MOACRIVE Inhibition DME1075 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1075 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04697 XEO_CLAS Peptide DME1075 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO04697 GENEFORM Protein DME1075 XEOTICID XEO04697 MOACRIVE Inhibition DME1075 XEOTICID XEO04707 XEO_NAME Pore-forming peptide ameobapore A DME1075 XEOTICID XEO04707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04707 XEO_CLAS Peptide DME1075 XEOTICID XEO04707 DESCRIPT Pore-forming peptide ameobapore A inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 13 microM) DME1075 XEOTICID XEO04707 GENEFORM Protein DME1075 XEOTICID XEO04707 MOACRIVE Inhibition DME1075 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1075 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04762 XEO_CLAS Peptide DME1075 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.1 microM) DME1075 XEOTICID XEO04762 GENEFORM Protein DME1075 XEOTICID XEO04762 MOACRIVE Inhibition DME1075 XEOTICID XEO04770 XEO_NAME Pyrrhocoricin DME1075 XEOTICID XEO04770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04770 XEO_CLAS Peptide DME1075 XEOTICID XEO04770 DESCRIPT Pyrrhocoricin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC > 80 microM) DME1075 XEOTICID XEO04770 GENEFORM Protein DME1075 XEOTICID XEO04770 MOACRIVE Inhibition DME1075 XEOTICID XEO04797 XEO_NAME Ranacyclin-E DME1075 XEOTICID XEO04797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04797 XEO_CLAS Peptide DME1075 XEOTICID XEO04797 DESCRIPT Ranacyclin-E inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3 microM) DME1075 XEOTICID XEO04797 GENEFORM Protein DME1075 XEOTICID XEO04797 MOACRIVE Inhibition DME1075 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1075 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04798 XEO_CLAS Peptide DME1075 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 3 microM) DME1075 XEOTICID XEO04798 GENEFORM Protein DME1075 XEOTICID XEO04798 MOACRIVE Inhibition DME1075 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1075 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04840 XEO_CLAS Peptide DME1075 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC > 20 microM) DME1075 XEOTICID XEO04840 GENEFORM Protein DME1075 XEOTICID XEO04840 MOACRIVE Inhibition DME1075 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1075 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04905 XEO_CLAS Peptide DME1075 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO04905 GENEFORM Protein DME1075 XEOTICID XEO04905 MOACRIVE Inhibition DME1075 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1075 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04906 XEO_CLAS Peptide DME1075 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO04906 GENEFORM Protein DME1075 XEOTICID XEO04906 MOACRIVE Inhibition DME1075 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1075 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04971 XEO_CLAS Peptide DME1075 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.4-0.8 microM) DME1075 XEOTICID XEO04971 GENEFORM Protein DME1075 XEOTICID XEO04971 MOACRIVE Inhibition DME1075 XEOTICID XEO04974 XEO_NAME Spinigerin DME1075 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04974 XEO_CLAS Peptide DME1075 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.8-1.5 microM) DME1075 XEOTICID XEO04974 GENEFORM Protein DME1075 XEOTICID XEO04974 MOACRIVE Inhibition DME1075 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1075 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO04995 XEO_CLAS Peptide DME1075 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.78-1.56 microM) DME1075 XEOTICID XEO04995 GENEFORM Protein DME1075 XEOTICID XEO04995 MOACRIVE Inhibition DME1075 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1075 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05004 XEO_CLAS Peptide DME1075 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO05004 GENEFORM Protein DME1075 XEOTICID XEO05004 MOACRIVE Inhibition DME1075 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1075 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05005 XEO_CLAS Peptide DME1075 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO05005 GENEFORM Protein DME1075 XEOTICID XEO05005 MOACRIVE Inhibition DME1075 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1075 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05063 XEO_CLAS Peptide DME1075 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2 microM) DME1075 XEOTICID XEO05063 GENEFORM Protein DME1075 XEOTICID XEO05063 MOACRIVE Inhibition DME1075 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1075 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05064 XEO_CLAS Peptide DME1075 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 46 microM) DME1075 XEOTICID XEO05064 GENEFORM Protein DME1075 XEOTICID XEO05064 MOACRIVE Inhibition DME1075 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1075 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05065 XEO_CLAS Peptide DME1075 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 4 ug/ml) DME1075 XEOTICID XEO05065 GENEFORM Protein DME1075 XEOTICID XEO05065 MOACRIVE Inhibition DME1075 XEOTICID XEO05076 XEO_NAME Temporin-A DME1075 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05076 XEO_CLAS Peptide DME1075 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 1.2 microM) DME1075 XEOTICID XEO05076 GENEFORM Protein DME1075 XEOTICID XEO05076 MOACRIVE Inhibition DME1075 XEOTICID XEO05085 XEO_NAME Temporin-B DME1075 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05085 XEO_CLAS Peptide DME1075 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2.8 ug/ml) DME1075 XEOTICID XEO05085 GENEFORM Protein DME1075 XEOTICID XEO05085 MOACRIVE Inhibition DME1075 XEOTICID XEO05088 XEO_NAME Temporin-D DME1075 XEOTICID XEO05088 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05088 XEO_CLAS Peptide DME1075 XEOTICID XEO05088 DESCRIPT Temporin-D inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO05088 GENEFORM Protein DME1075 XEOTICID XEO05088 MOACRIVE Inhibition DME1075 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1075 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05105 XEO_CLAS Peptide DME1075 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2 microM) DME1075 XEOTICID XEO05105 GENEFORM Protein DME1075 XEOTICID XEO05105 MOACRIVE Inhibition DME1075 XEOTICID XEO05110 XEO_NAME Termicin DME1075 XEOTICID XEO05110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05110 XEO_CLAS Peptide DME1075 XEOTICID XEO05110 DESCRIPT Termicin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO05110 GENEFORM Protein DME1075 XEOTICID XEO05110 MOACRIVE Inhibition DME1075 XEOTICID XEO05120 XEO_NAME Thanatin DME1075 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05120 XEO_CLAS Peptide DME1075 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 2.5-5 microM) DME1075 XEOTICID XEO05120 GENEFORM Protein DME1075 XEOTICID XEO05120 MOACRIVE Inhibition DME1075 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1075 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05125 XEO_CLAS Peptide DME1075 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO05125 GENEFORM Protein DME1075 XEOTICID XEO05125 MOACRIVE Inhibition DME1075 XEOTICID XEO05138 XEO_NAME Thuricin-17 DME1075 XEOTICID XEO05138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05138 XEO_CLAS Peptide DME1075 XEOTICID XEO05138 DESCRIPT Thuricin-17 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium DME1075 XEOTICID XEO05138 GENEFORM Protein DME1075 XEOTICID XEO05138 MOACRIVE Inhibition DME1075 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1075 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05220 XEO_CLAS Peptide DME1075 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 5-10 microM) DME1075 XEOTICID XEO05220 GENEFORM Protein DME1075 XEOTICID XEO05220 MOACRIVE Inhibition DME1075 XEOTICID XEO05229 XEO_NAME Vasostatin-1 DME1075 XEOTICID XEO05229 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05229 XEO_CLAS Peptide DME1075 XEOTICID XEO05229 DESCRIPT Vasostatin-1 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.2 microM) DME1075 XEOTICID XEO05229 GENEFORM Protein DME1075 XEOTICID XEO05229 MOACRIVE Inhibition DME1075 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1075 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05230 XEO_CLAS Peptide DME1075 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.25 microM) DME1075 XEOTICID XEO05230 GENEFORM Protein DME1075 XEOTICID XEO05230 MOACRIVE Inhibition DME1075 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1075 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05231 XEO_CLAS Peptide DME1075 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 0.25 microM) DME1075 XEOTICID XEO05231 GENEFORM Protein DME1075 XEOTICID XEO05231 MOACRIVE Inhibition DME1075 XEOTICID XEO05304 XEO_NAME Thanatin truncated isoform Y12M(10-21) DME1075 XEOTICID XEO05304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1075 XEOTICID XEO05304 XEO_CLAS Peptide DME1075 XEOTICID XEO05304 DESCRIPT Thanatin truncated isoform Y12M(10-21) inhibits the drug-metabolizing activity of Cytochrome P450 102A1 (cyp102) from Bacillus megaterium (MIC = 20-40 microM) DME1075 XEOTICID XEO05304 GENEFORM Protein DME1075 XEOTICID XEO05304 MOACRIVE Inhibition DME1076 DME___ID DME1076 DME1076 DME_NAME Nicotinamidase (pncA) DME1076 SPESNAME Acinetobacter baumannii DME1076 XEOTICID XEO01366 XEO_NAME Linalool DME1076 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1076 XEOTICID XEO01366 XEO_CLAS Natural Product DME1076 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii DME1076 XEOTICID XEO01366 GENEFORM Protein DME1076 XEOTICID XEO01366 MOACRIVE Inhibition DME1076 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1076 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1076 XEOTICID XEO01816 XEO_CLAS Peptide DME1076 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii (MIC = 3 microM) DME1076 XEOTICID XEO01816 GENEFORM Protein DME1076 XEOTICID XEO01816 MOACRIVE Inhibition DME1076 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1076 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1076 XEOTICID XEO01824 XEO_CLAS Peptide DME1076 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii (MIC = 50 microM) DME1076 XEOTICID XEO01824 GENEFORM Protein DME1076 XEOTICID XEO01824 MOACRIVE Inhibition DME1076 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1076 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1076 XEOTICID XEO02731 XEO_CLAS Peptide DME1076 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii DME1076 XEOTICID XEO02731 GENEFORM Protein DME1076 XEOTICID XEO02731 MOACRIVE Inhibition DME1076 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1076 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1076 XEOTICID XEO02900 XEO_CLAS Peptide DME1076 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii DME1076 XEOTICID XEO02900 GENEFORM Protein DME1076 XEOTICID XEO02900 MOACRIVE Inhibition DME1076 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1076 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1076 XEOTICID XEO02942 XEO_CLAS Peptide DME1076 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii DME1076 XEOTICID XEO02942 GENEFORM Protein DME1076 XEOTICID XEO02942 MOACRIVE Inhibition DME1076 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1076 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1076 XEOTICID XEO03540 XEO_CLAS Peptide DME1076 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii (MIC = 8-16 ug/ml) DME1076 XEOTICID XEO03540 GENEFORM Protein DME1076 XEOTICID XEO03540 MOACRIVE Inhibition DME1076 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1076 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1076 XEOTICID XEO03556 XEO_CLAS Peptide DME1076 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii (MIC = 8-16 ug/ml) DME1076 XEOTICID XEO03556 GENEFORM Protein DME1076 XEOTICID XEO03556 MOACRIVE Inhibition DME1076 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1076 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1076 XEOTICID XEO03557 XEO_CLAS Peptide DME1076 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii (MIC = 8-16 ug/ml) DME1076 XEOTICID XEO03557 GENEFORM Protein DME1076 XEOTICID XEO03557 MOACRIVE Inhibition DME1076 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1076 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1076 XEOTICID XEO03609 XEO_CLAS Peptide DME1076 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii DME1076 XEOTICID XEO03609 GENEFORM Protein DME1076 XEOTICID XEO03609 MOACRIVE Inhibition DME1076 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1076 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1076 XEOTICID XEO03678 XEO_CLAS Peptide DME1076 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii (MIC = 0.8 ug/ml) DME1076 XEOTICID XEO03678 GENEFORM Protein DME1076 XEOTICID XEO03678 MOACRIVE Inhibition DME1076 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1076 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1076 XEOTICID XEO04001 XEO_CLAS Peptide DME1076 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii (MIC = 2.7 microM) DME1076 XEOTICID XEO04001 GENEFORM Protein DME1076 XEOTICID XEO04001 MOACRIVE Inhibition DME1076 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1076 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1076 XEOTICID XEO04241 XEO_CLAS Peptide DME1076 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii DME1076 XEOTICID XEO04241 GENEFORM Protein DME1076 XEOTICID XEO04241 MOACRIVE Inhibition DME1076 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1076 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1076 XEOTICID XEO04242 XEO_CLAS Peptide DME1076 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii DME1076 XEOTICID XEO04242 GENEFORM Protein DME1076 XEOTICID XEO04242 MOACRIVE Inhibition DME1076 XEOTICID XEO04331 XEO_NAME Norspermidine DME1076 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1076 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1076 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii DME1076 XEOTICID XEO04331 GENEFORM Protein DME1076 XEOTICID XEO04331 MOACRIVE Inhibition DME1076 XEOTICID XEO04686 XEO_NAME Polyethyleneimine DME1076 XEOTICID XEO04686 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1076 XEOTICID XEO04686 XEO_CLAS Chemical Compound DME1076 XEOTICID XEO04686 DESCRIPT Polyethyleneimine inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii DME1076 XEOTICID XEO04686 GENEFORM Protein DME1076 XEOTICID XEO04686 MOACRIVE Inhibition DME1076 XEOTICID XEO04888 XEO_NAME CP-P derivative S16 DME1076 XEOTICID XEO04888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1076 XEOTICID XEO04888 XEO_CLAS Peptide DME1076 XEOTICID XEO04888 DESCRIPT CP-P derivative S16 inhibits the drug-metabolizing activity of Nicotinamidase (pncA) from Acinetobacter baumannii (MIC = 3.125 ug/ml) DME1076 XEOTICID XEO04888 GENEFORM Protein DME1076 XEOTICID XEO04888 MOACRIVE Inhibition DME1077 DME___ID DME1077 DME1077 DME_NAME NADPH-dependent curcumin reductase (curA) DME1077 SPESNAME Escherichia coli DME1077 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1077 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00117 GENEFORM Protein DME1077 XEOTICID XEO00117 MOACRIVE Inhibition DME1077 XEOTICID XEO00122 XEO_NAME Amikacin DME1077 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00122 GENEFORM Protein DME1077 XEOTICID XEO00122 MOACRIVE Inhibition DME1077 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1077 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00136 GENEFORM Protein DME1077 XEOTICID XEO00136 MOACRIVE Inhibition DME1077 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1077 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00237 GENEFORM Protein DME1077 XEOTICID XEO00237 MOACRIVE Inhibition DME1077 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1077 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00349 GENEFORM Protein DME1077 XEOTICID XEO00349 MOACRIVE Inhibition DME1077 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1077 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00425 GENEFORM Protein DME1077 XEOTICID XEO00425 MOACRIVE Inhibition DME1077 XEOTICID XEO00439 XEO_NAME Daidzein DME1077 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00439 GENEFORM Protein DME1077 XEOTICID XEO00439 MOACRIVE Inhibition DME1077 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1077 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00460 GENEFORM Protein DME1077 XEOTICID XEO00460 MOACRIVE Inhibition DME1077 XEOTICID XEO00487 XEO_NAME Thymol DME1077 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00487 GENEFORM Protein DME1077 XEOTICID XEO00487 MOACRIVE Inhibition DME1077 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1077 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00511 GENEFORM Protein DME1077 XEOTICID XEO00511 MOACRIVE Inhibition DME1077 XEOTICID XEO00537 XEO_NAME Luteolin DME1077 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1077 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00537 GENEFORM Protein DME1077 XEOTICID XEO00537 MOACRIVE Inhibition DME1077 XEOTICID XEO00538 XEO_NAME Quercetin DME1077 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1077 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00538 GENEFORM Protein DME1077 XEOTICID XEO00538 MOACRIVE Inhibition DME1077 XEOTICID XEO00547 XEO_NAME Vitamin E DME1077 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1077 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00547 GENEFORM Protein DME1077 XEOTICID XEO00547 MOACRIVE Inhibition DME1077 XEOTICID XEO00557 XEO_NAME Genistein DME1077 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1077 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00557 GENEFORM Protein DME1077 XEOTICID XEO00557 MOACRIVE Inhibition DME1077 XEOTICID XEO00566 XEO_NAME Guaiacol DME1077 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1077 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00566 GENEFORM Protein DME1077 XEOTICID XEO00566 MOACRIVE Inhibition DME1077 XEOTICID XEO00568 XEO_NAME Resveratrol DME1077 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1077 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00568 GENEFORM Protein DME1077 XEOTICID XEO00568 MOACRIVE Inhibition DME1077 XEOTICID XEO00573 XEO_NAME Naringenin DME1077 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1077 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00573 GENEFORM Protein DME1077 XEOTICID XEO00573 MOACRIVE Inhibition DME1077 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1077 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1077 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00574 GENEFORM Protein DME1077 XEOTICID XEO00574 MOACRIVE Inhibition DME1077 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1077 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1077 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00611 GENEFORM Protein DME1077 XEOTICID XEO00611 MOACRIVE Inhibition DME1077 XEOTICID XEO00621 XEO_NAME Chitosan DME1077 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1077 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00621 GENEFORM Protein DME1077 XEOTICID XEO00621 MOACRIVE Inhibition DME1077 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1077 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1077 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00646 GENEFORM Protein DME1077 XEOTICID XEO00646 MOACRIVE Inhibition DME1077 XEOTICID XEO00683 XEO_NAME Curcumin DME1077 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1077 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00683 GENEFORM Protein DME1077 XEOTICID XEO00683 MOACRIVE Inhibition DME1077 XEOTICID XEO00727 XEO_NAME Vanillin DME1077 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1077 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00727 GENEFORM Protein DME1077 XEOTICID XEO00727 MOACRIVE Inhibition DME1077 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1077 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1077 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00730 GENEFORM Protein DME1077 XEOTICID XEO00730 MOACRIVE Inhibition DME1077 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1077 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO00782 XEO_CLAS Natural Product DME1077 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00782 GENEFORM Protein DME1077 XEOTICID XEO00782 MOACRIVE Inhibition DME1077 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1077 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1077 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00866 GENEFORM Protein DME1077 XEOTICID XEO00866 MOACRIVE Inhibition DME1077 XEOTICID XEO00878 XEO_NAME Chrysin DME1077 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO00878 XEO_CLAS Natural Product DME1077 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00878 GENEFORM Protein DME1077 XEOTICID XEO00878 MOACRIVE Inhibition DME1077 XEOTICID XEO00879 XEO_NAME Coumarin DME1077 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1077 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1077 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00879 GENEFORM Protein DME1077 XEOTICID XEO00879 MOACRIVE Inhibition DME1077 XEOTICID XEO00883 XEO_NAME Phloretin DME1077 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO00883 XEO_CLAS Natural Product DME1077 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00883 GENEFORM Protein DME1077 XEOTICID XEO00883 MOACRIVE Inhibition DME1077 XEOTICID XEO00885 XEO_NAME Eugenol DME1077 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1077 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO00885 GENEFORM Protein DME1077 XEOTICID XEO00885 MOACRIVE Inhibition DME1077 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1077 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1077 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1077 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01032 GENEFORM Protein DME1077 XEOTICID XEO01032 MOACRIVE Inhibition DME1077 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1077 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01174 XEO_CLAS Natural Product DME1077 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01174 GENEFORM Protein DME1077 XEOTICID XEO01174 MOACRIVE Inhibition DME1077 XEOTICID XEO01203 XEO_NAME Apigenin DME1077 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01203 XEO_CLAS Natural Product DME1077 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01203 GENEFORM Protein DME1077 XEOTICID XEO01203 MOACRIVE Inhibition DME1077 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1077 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1077 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1077 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01232 GENEFORM Protein DME1077 XEOTICID XEO01232 MOACRIVE Inhibition DME1077 XEOTICID XEO01237 XEO_NAME Carvacrol DME1077 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1077 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01237 GENEFORM Protein DME1077 XEOTICID XEO01237 MOACRIVE Inhibition DME1077 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1077 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1077 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01287 GENEFORM Protein DME1077 XEOTICID XEO01287 MOACRIVE Inhibition DME1077 XEOTICID XEO01291 XEO_NAME Esculetin DME1077 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1077 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01291 GENEFORM Protein DME1077 XEOTICID XEO01291 MOACRIVE Inhibition DME1077 XEOTICID XEO01304 XEO_NAME Flavone DME1077 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01304 XEO_CLAS Natural Product DME1077 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01304 GENEFORM Protein DME1077 XEOTICID XEO01304 MOACRIVE Inhibition DME1077 XEOTICID XEO01309 XEO_NAME Gallic acid DME1077 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01309 XEO_CLAS Natural Product DME1077 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01309 GENEFORM Protein DME1077 XEOTICID XEO01309 MOACRIVE Inhibition DME1077 XEOTICID XEO01340 XEO_NAME Imperatorin DME1077 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01340 XEO_CLAS Natural Product DME1077 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01340 GENEFORM Protein DME1077 XEOTICID XEO01340 MOACRIVE Inhibition DME1077 XEOTICID XEO01353 XEO_NAME Kaempferol DME1077 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1077 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1077 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01353 GENEFORM Protein DME1077 XEOTICID XEO01353 MOACRIVE Inhibition DME1077 XEOTICID XEO01366 XEO_NAME Linalool DME1077 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01366 XEO_CLAS Natural Product DME1077 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01366 GENEFORM Protein DME1077 XEOTICID XEO01366 MOACRIVE Inhibition DME1077 XEOTICID XEO01391 XEO_NAME Naringin DME1077 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01391 XEO_CLAS Natural Product DME1077 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01391 GENEFORM Protein DME1077 XEOTICID XEO01391 MOACRIVE Inhibition DME1077 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1077 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1077 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01420 GENEFORM Protein DME1077 XEOTICID XEO01420 MOACRIVE Inhibition DME1077 XEOTICID XEO01463 XEO_NAME Rutin DME1077 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01463 XEO_CLAS Natural Product DME1077 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01463 GENEFORM Protein DME1077 XEOTICID XEO01463 MOACRIVE Inhibition DME1077 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1077 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1077 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01496 GENEFORM Protein DME1077 XEOTICID XEO01496 MOACRIVE Inhibition DME1077 XEOTICID XEO01512 XEO_NAME Zinc DME1077 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1077 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1077 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01512 GENEFORM Protein DME1077 XEOTICID XEO01512 MOACRIVE Inhibition DME1077 XEOTICID XEO01527 XEO_NAME Bergamottin DME1077 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01527 XEO_CLAS Natural Product DME1077 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01527 GENEFORM Protein DME1077 XEOTICID XEO01527 MOACRIVE Inhibition DME1077 XEOTICID XEO01531 XEO_NAME Clove oil DME1077 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01531 XEO_CLAS Natural Product DME1077 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01531 GENEFORM Protein DME1077 XEOTICID XEO01531 MOACRIVE Inhibition DME1077 XEOTICID XEO01559 XEO_NAME Limonene DME1077 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01559 XEO_CLAS Natural Product DME1077 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01559 GENEFORM Protein DME1077 XEOTICID XEO01559 MOACRIVE Inhibition DME1077 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1077 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01563 XEO_CLAS Natural Product DME1077 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01563 GENEFORM Protein DME1077 XEOTICID XEO01563 MOACRIVE Inhibition DME1077 XEOTICID XEO01566 XEO_NAME Nobiletin DME1077 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01566 XEO_CLAS Natural Product DME1077 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01566 GENEFORM Protein DME1077 XEOTICID XEO01566 MOACRIVE Inhibition DME1077 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1077 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01778 XEO_CLAS Natural Product DME1077 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01778 GENEFORM Protein DME1077 XEOTICID XEO01778 MOACRIVE Inhibition DME1077 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1077 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01779 XEO_CLAS Peptide DME1077 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 128 microM) DME1077 XEOTICID XEO01779 GENEFORM Protein DME1077 XEOTICID XEO01779 MOACRIVE Inhibition DME1077 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1077 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01810 XEO_CLAS Peptide DME1077 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.0 microM) DME1077 XEOTICID XEO01810 GENEFORM Protein DME1077 XEOTICID XEO01810 MOACRIVE Inhibition DME1077 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1077 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01811 XEO_CLAS Peptide DME1077 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 microM) DME1077 XEOTICID XEO01811 GENEFORM Protein DME1077 XEOTICID XEO01811 MOACRIVE Inhibition DME1077 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1077 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01812 XEO_CLAS Peptide DME1077 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10.4 microM) DME1077 XEOTICID XEO01812 GENEFORM Protein DME1077 XEOTICID XEO01812 MOACRIVE Inhibition DME1077 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1077 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01813 XEO_CLAS Peptide DME1077 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.1 microM) DME1077 XEOTICID XEO01813 GENEFORM Protein DME1077 XEOTICID XEO01813 MOACRIVE Inhibition DME1077 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1077 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01814 XEO_CLAS Peptide DME1077 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.5 microM) DME1077 XEOTICID XEO01814 GENEFORM Protein DME1077 XEOTICID XEO01814 MOACRIVE Inhibition DME1077 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1077 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01815 XEO_CLAS Peptide DME1077 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9.8 microM) DME1077 XEOTICID XEO01815 GENEFORM Protein DME1077 XEOTICID XEO01815 MOACRIVE Inhibition DME1077 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1077 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01816 XEO_CLAS Peptide DME1077 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO01816 GENEFORM Protein DME1077 XEOTICID XEO01816 MOACRIVE Inhibition DME1077 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1077 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01817 XEO_CLAS Peptide DME1077 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.0 microM) DME1077 XEOTICID XEO01817 GENEFORM Protein DME1077 XEOTICID XEO01817 MOACRIVE Inhibition DME1077 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1077 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01818 XEO_CLAS Peptide DME1077 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4.0 microM) DME1077 XEOTICID XEO01818 GENEFORM Protein DME1077 XEOTICID XEO01818 MOACRIVE Inhibition DME1077 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1077 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01819 XEO_CLAS Peptide DME1077 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO01819 GENEFORM Protein DME1077 XEOTICID XEO01819 MOACRIVE Inhibition DME1077 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1077 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01820 XEO_CLAS Peptide DME1077 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO01820 GENEFORM Protein DME1077 XEOTICID XEO01820 MOACRIVE Inhibition DME1077 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1077 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01821 XEO_CLAS Peptide DME1077 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO01821 GENEFORM Protein DME1077 XEOTICID XEO01821 MOACRIVE Inhibition DME1077 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1077 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01822 XEO_CLAS Peptide DME1077 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 microM) DME1077 XEOTICID XEO01822 GENEFORM Protein DME1077 XEOTICID XEO01822 MOACRIVE Inhibition DME1077 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1077 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01823 XEO_CLAS Peptide DME1077 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO01823 GENEFORM Protein DME1077 XEOTICID XEO01823 MOACRIVE Inhibition DME1077 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1077 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01824 XEO_CLAS Peptide DME1077 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO01824 GENEFORM Protein DME1077 XEOTICID XEO01824 MOACRIVE Inhibition DME1077 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1077 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01825 XEO_CLAS Peptide DME1077 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25.0 microM) DME1077 XEOTICID XEO01825 GENEFORM Protein DME1077 XEOTICID XEO01825 MOACRIVE Inhibition DME1077 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1077 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01827 XEO_CLAS Peptide DME1077 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.12-6.25 microM) DME1077 XEOTICID XEO01827 GENEFORM Protein DME1077 XEOTICID XEO01827 MOACRIVE Inhibition DME1077 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1077 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1077 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1077 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01829 GENEFORM Protein DME1077 XEOTICID XEO01829 MOACRIVE Inhibition DME1077 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1077 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01927 XEO_CLAS Peptide DME1077 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 ug/ml) DME1077 XEOTICID XEO01927 GENEFORM Protein DME1077 XEOTICID XEO01927 MOACRIVE Inhibition DME1077 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1077 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01945 XEO_CLAS Peptide DME1077 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.1 microM) DME1077 XEOTICID XEO01945 GENEFORM Protein DME1077 XEOTICID XEO01945 MOACRIVE Inhibition DME1077 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1077 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01946 XEO_CLAS Peptide DME1077 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.2 microM) DME1077 XEOTICID XEO01946 GENEFORM Protein DME1077 XEOTICID XEO01946 MOACRIVE Inhibition DME1077 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1077 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO01947 XEO_CLAS Natural Product DME1077 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01947 GENEFORM Protein DME1077 XEOTICID XEO01947 MOACRIVE Inhibition DME1077 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1077 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1077 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1077 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01950 GENEFORM Protein DME1077 XEOTICID XEO01950 MOACRIVE Inhibition DME1077 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1077 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1077 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1077 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01961 GENEFORM Protein DME1077 XEOTICID XEO01961 MOACRIVE Inhibition DME1077 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1077 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1077 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1077 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO01966 GENEFORM Protein DME1077 XEOTICID XEO01966 MOACRIVE Inhibition DME1077 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1077 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01996 XEO_CLAS Peptide DME1077 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.7 microM) DME1077 XEOTICID XEO01996 GENEFORM Protein DME1077 XEOTICID XEO01996 MOACRIVE Inhibition DME1077 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1077 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01997 XEO_CLAS Peptide DME1077 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.9 microM) DME1077 XEOTICID XEO01997 GENEFORM Protein DME1077 XEOTICID XEO01997 MOACRIVE Inhibition DME1077 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1077 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01998 XEO_CLAS Peptide DME1077 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO01998 GENEFORM Protein DME1077 XEOTICID XEO01998 MOACRIVE Inhibition DME1077 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1077 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO01999 XEO_CLAS Peptide DME1077 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.5 microM) DME1077 XEOTICID XEO01999 GENEFORM Protein DME1077 XEOTICID XEO01999 MOACRIVE Inhibition DME1077 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1077 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02013 XEO_CLAS Peptide DME1077 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02013 GENEFORM Protein DME1077 XEOTICID XEO02013 MOACRIVE Inhibition DME1077 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1077 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02032 XEO_CLAS Natural Product DME1077 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02032 GENEFORM Protein DME1077 XEOTICID XEO02032 MOACRIVE Inhibition DME1077 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1077 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02033 XEO_CLAS Natural Product DME1077 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02033 GENEFORM Protein DME1077 XEOTICID XEO02033 MOACRIVE Inhibition DME1077 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1077 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02079 XEO_CLAS Natural Product DME1077 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02079 GENEFORM Protein DME1077 XEOTICID XEO02079 MOACRIVE Inhibition DME1077 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1077 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1077 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02085 GENEFORM Protein DME1077 XEOTICID XEO02085 MOACRIVE Inhibition DME1077 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1077 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02111 XEO_CLAS Peptide DME1077 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2-4 ug/ml) DME1077 XEOTICID XEO02111 GENEFORM Protein DME1077 XEOTICID XEO02111 MOACRIVE Inhibition DME1077 XEOTICID XEO02113 XEO_NAME Abaecin DME1077 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02113 XEO_CLAS Peptide DME1077 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02113 GENEFORM Protein DME1077 XEOTICID XEO02113 MOACRIVE Inhibition DME1077 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1077 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02114 XEO_CLAS Peptide DME1077 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-25 ug/ml) DME1077 XEOTICID XEO02114 GENEFORM Protein DME1077 XEOTICID XEO02114 MOACRIVE Inhibition DME1077 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1077 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02115 XEO_CLAS Peptide DME1077 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02115 GENEFORM Protein DME1077 XEOTICID XEO02115 MOACRIVE Inhibition DME1077 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1077 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02117 XEO_CLAS Peptide DME1077 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02117 GENEFORM Protein DME1077 XEOTICID XEO02117 MOACRIVE Inhibition DME1077 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1077 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02118 XEO_CLAS Peptide DME1077 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02118 GENEFORM Protein DME1077 XEOTICID XEO02118 MOACRIVE Inhibition DME1077 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1077 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02119 XEO_CLAS Peptide DME1077 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02119 GENEFORM Protein DME1077 XEOTICID XEO02119 MOACRIVE Inhibition DME1077 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1077 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02120 XEO_CLAS Peptide DME1077 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02120 GENEFORM Protein DME1077 XEOTICID XEO02120 MOACRIVE Inhibition DME1077 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1077 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02121 XEO_CLAS Peptide DME1077 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02121 GENEFORM Protein DME1077 XEOTICID XEO02121 MOACRIVE Inhibition DME1077 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1077 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02122 XEO_CLAS Peptide DME1077 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 ug/ml) DME1077 XEOTICID XEO02122 GENEFORM Protein DME1077 XEOTICID XEO02122 MOACRIVE Inhibition DME1077 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1077 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02130 XEO_CLAS Peptide DME1077 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.7 microM) DME1077 XEOTICID XEO02130 GENEFORM Protein DME1077 XEOTICID XEO02130 MOACRIVE Inhibition DME1077 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1077 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02131 XEO_CLAS Peptide DME1077 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.3 microM) DME1077 XEOTICID XEO02131 GENEFORM Protein DME1077 XEOTICID XEO02131 MOACRIVE Inhibition DME1077 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1077 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02132 XEO_CLAS Peptide DME1077 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.5 microM) DME1077 XEOTICID XEO02132 GENEFORM Protein DME1077 XEOTICID XEO02132 MOACRIVE Inhibition DME1077 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1077 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02136 XEO_CLAS Peptide DME1077 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 ug/ml) DME1077 XEOTICID XEO02136 GENEFORM Protein DME1077 XEOTICID XEO02136 MOACRIVE Inhibition DME1077 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1077 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02147 XEO_CLAS Peptide DME1077 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 382 ug/ml) DME1077 XEOTICID XEO02147 GENEFORM Protein DME1077 XEOTICID XEO02147 MOACRIVE Inhibition DME1077 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1077 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02149 XEO_CLAS Peptide DME1077 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 47.35 microM) DME1077 XEOTICID XEO02149 GENEFORM Protein DME1077 XEOTICID XEO02149 MOACRIVE Inhibition DME1077 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1077 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02164 XEO_CLAS Peptide DME1077 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02164 GENEFORM Protein DME1077 XEOTICID XEO02164 MOACRIVE Inhibition DME1077 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1077 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02165 XEO_CLAS Peptide DME1077 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02165 GENEFORM Protein DME1077 XEOTICID XEO02165 MOACRIVE Inhibition DME1077 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1077 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02166 XEO_CLAS Peptide DME1077 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02166 GENEFORM Protein DME1077 XEOTICID XEO02166 MOACRIVE Inhibition DME1077 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1077 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02167 XEO_CLAS Peptide DME1077 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02167 GENEFORM Protein DME1077 XEOTICID XEO02167 MOACRIVE Inhibition DME1077 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1077 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02168 XEO_CLAS Peptide DME1077 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02168 GENEFORM Protein DME1077 XEOTICID XEO02168 MOACRIVE Inhibition DME1077 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1077 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02169 XEO_CLAS Peptide DME1077 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02169 GENEFORM Protein DME1077 XEOTICID XEO02169 MOACRIVE Inhibition DME1077 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1077 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02170 XEO_CLAS Peptide DME1077 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.4 microM) DME1077 XEOTICID XEO02170 GENEFORM Protein DME1077 XEOTICID XEO02170 MOACRIVE Inhibition DME1077 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1077 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02175 XEO_CLAS Natural Product DME1077 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02175 GENEFORM Protein DME1077 XEOTICID XEO02175 MOACRIVE Inhibition DME1077 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1077 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02177 XEO_CLAS Peptide DME1077 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO02177 GENEFORM Protein DME1077 XEOTICID XEO02177 MOACRIVE Inhibition DME1077 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1077 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02178 XEO_CLAS Peptide DME1077 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO02178 GENEFORM Protein DME1077 XEOTICID XEO02178 MOACRIVE Inhibition DME1077 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1077 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02179 XEO_CLAS Peptide DME1077 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO02179 GENEFORM Protein DME1077 XEOTICID XEO02179 MOACRIVE Inhibition DME1077 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1077 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02180 XEO_CLAS Peptide DME1077 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 214 microM) DME1077 XEOTICID XEO02180 GENEFORM Protein DME1077 XEOTICID XEO02180 MOACRIVE Inhibition DME1077 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1077 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02181 XEO_CLAS Peptide DME1077 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 217 microM) DME1077 XEOTICID XEO02181 GENEFORM Protein DME1077 XEOTICID XEO02181 MOACRIVE Inhibition DME1077 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1077 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02183 XEO_CLAS Peptide DME1077 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 38.4 microM) DME1077 XEOTICID XEO02183 GENEFORM Protein DME1077 XEOTICID XEO02183 MOACRIVE Inhibition DME1077 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1077 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02185 XEO_CLAS Peptide DME1077 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 microM) DME1077 XEOTICID XEO02185 GENEFORM Protein DME1077 XEOTICID XEO02185 MOACRIVE Inhibition DME1077 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1077 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02187 GENEFORM Protein DME1077 XEOTICID XEO02187 MOACRIVE Inhibition DME1077 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1077 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02191 XEO_CLAS Peptide DME1077 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02191 GENEFORM Protein DME1077 XEOTICID XEO02191 MOACRIVE Inhibition DME1077 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1077 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02192 XEO_CLAS Peptide DME1077 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.50 ug/ml) DME1077 XEOTICID XEO02192 GENEFORM Protein DME1077 XEOTICID XEO02192 MOACRIVE Inhibition DME1077 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1077 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02193 XEO_CLAS Peptide DME1077 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02193 GENEFORM Protein DME1077 XEOTICID XEO02193 MOACRIVE Inhibition DME1077 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1077 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02194 XEO_CLAS Peptide DME1077 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02194 GENEFORM Protein DME1077 XEOTICID XEO02194 MOACRIVE Inhibition DME1077 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1077 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02195 XEO_CLAS Peptide DME1077 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.00 ug/ml) DME1077 XEOTICID XEO02195 GENEFORM Protein DME1077 XEOTICID XEO02195 MOACRIVE Inhibition DME1077 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1077 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02197 XEO_CLAS Peptide DME1077 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02197 GENEFORM Protein DME1077 XEOTICID XEO02197 MOACRIVE Inhibition DME1077 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1077 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02200 XEO_CLAS Peptide DME1077 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 ug/ml) DME1077 XEOTICID XEO02200 GENEFORM Protein DME1077 XEOTICID XEO02200 MOACRIVE Inhibition DME1077 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1077 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02201 XEO_CLAS Peptide DME1077 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 ug/ml) DME1077 XEOTICID XEO02201 GENEFORM Protein DME1077 XEOTICID XEO02201 MOACRIVE Inhibition DME1077 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1077 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02202 XEO_CLAS Peptide DME1077 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO02202 GENEFORM Protein DME1077 XEOTICID XEO02202 MOACRIVE Inhibition DME1077 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1077 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02203 XEO_CLAS Peptide DME1077 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 microM) DME1077 XEOTICID XEO02203 GENEFORM Protein DME1077 XEOTICID XEO02203 MOACRIVE Inhibition DME1077 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1077 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02207 XEO_CLAS Peptide DME1077 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.78 ug/ml) DME1077 XEOTICID XEO02207 GENEFORM Protein DME1077 XEOTICID XEO02207 MOACRIVE Inhibition DME1077 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1077 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02208 XEO_CLAS Peptide DME1077 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.13 ug/ml) DME1077 XEOTICID XEO02208 GENEFORM Protein DME1077 XEOTICID XEO02208 MOACRIVE Inhibition DME1077 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1077 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02209 XEO_CLAS Peptide DME1077 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.56 ug/ml) DME1077 XEOTICID XEO02209 GENEFORM Protein DME1077 XEOTICID XEO02209 MOACRIVE Inhibition DME1077 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1077 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02210 XEO_CLAS Peptide DME1077 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 ug/ml) DME1077 XEOTICID XEO02210 GENEFORM Protein DME1077 XEOTICID XEO02210 MOACRIVE Inhibition DME1077 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1077 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02211 XEO_CLAS Peptide DME1077 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25 ug/ml) DME1077 XEOTICID XEO02211 GENEFORM Protein DME1077 XEOTICID XEO02211 MOACRIVE Inhibition DME1077 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1077 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02212 XEO_CLAS Peptide DME1077 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.13 ug/ml) DME1077 XEOTICID XEO02212 GENEFORM Protein DME1077 XEOTICID XEO02212 MOACRIVE Inhibition DME1077 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1077 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02213 XEO_CLAS Peptide DME1077 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.13 ug/ml) DME1077 XEOTICID XEO02213 GENEFORM Protein DME1077 XEOTICID XEO02213 MOACRIVE Inhibition DME1077 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1077 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02214 XEO_CLAS Peptide DME1077 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02214 GENEFORM Protein DME1077 XEOTICID XEO02214 MOACRIVE Inhibition DME1077 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1077 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02215 XEO_CLAS Peptide DME1077 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 ug/ml) DME1077 XEOTICID XEO02215 GENEFORM Protein DME1077 XEOTICID XEO02215 MOACRIVE Inhibition DME1077 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1077 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02216 XEO_CLAS Peptide DME1077 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 126 ug/ml) DME1077 XEOTICID XEO02216 GENEFORM Protein DME1077 XEOTICID XEO02216 MOACRIVE Inhibition DME1077 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1077 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02217 XEO_CLAS Peptide DME1077 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 200 ug/ml) DME1077 XEOTICID XEO02217 GENEFORM Protein DME1077 XEOTICID XEO02217 MOACRIVE Inhibition DME1077 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1077 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02218 XEO_CLAS Peptide DME1077 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 200 ug/ml) DME1077 XEOTICID XEO02218 GENEFORM Protein DME1077 XEOTICID XEO02218 MOACRIVE Inhibition DME1077 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1077 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02219 XEO_CLAS Peptide DME1077 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 200 ug/ml) DME1077 XEOTICID XEO02219 GENEFORM Protein DME1077 XEOTICID XEO02219 MOACRIVE Inhibition DME1077 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1077 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02220 XEO_CLAS Peptide DME1077 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 23.5 ug/ml) DME1077 XEOTICID XEO02220 GENEFORM Protein DME1077 XEOTICID XEO02220 MOACRIVE Inhibition DME1077 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1077 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02221 XEO_CLAS Peptide DME1077 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20.2 ug/ml) DME1077 XEOTICID XEO02221 GENEFORM Protein DME1077 XEOTICID XEO02221 MOACRIVE Inhibition DME1077 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1077 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02222 XEO_CLAS Peptide DME1077 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30.5 ug/ml) DME1077 XEOTICID XEO02222 GENEFORM Protein DME1077 XEOTICID XEO02222 MOACRIVE Inhibition DME1077 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1077 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02223 XEO_CLAS Peptide DME1077 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.2 ug/ml) DME1077 XEOTICID XEO02223 GENEFORM Protein DME1077 XEOTICID XEO02223 MOACRIVE Inhibition DME1077 XEOTICID XEO02224 XEO_NAME Androctonin DME1077 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02224 XEO_CLAS Peptide DME1077 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02224 GENEFORM Protein DME1077 XEOTICID XEO02224 MOACRIVE Inhibition DME1077 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1077 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02225 XEO_CLAS Peptide DME1077 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02225 GENEFORM Protein DME1077 XEOTICID XEO02225 MOACRIVE Inhibition DME1077 XEOTICID XEO02226 XEO_NAME Andropin DME1077 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02226 XEO_CLAS Peptide DME1077 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 140 microM) DME1077 XEOTICID XEO02226 GENEFORM Protein DME1077 XEOTICID XEO02226 MOACRIVE Inhibition DME1077 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1077 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02230 XEO_CLAS Peptide DME1077 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.05-0.1 microM) DME1077 XEOTICID XEO02230 GENEFORM Protein DME1077 XEOTICID XEO02230 MOACRIVE Inhibition DME1077 XEOTICID XEO02232 XEO_NAME Anoplin DME1077 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02232 XEO_CLAS Peptide DME1077 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 13 ug/ml) DME1077 XEOTICID XEO02232 GENEFORM Protein DME1077 XEOTICID XEO02232 MOACRIVE Inhibition DME1077 XEOTICID XEO02233 XEO_NAME Antapin DME1077 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02233 XEO_CLAS Peptide DME1077 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02233 GENEFORM Protein DME1077 XEOTICID XEO02233 MOACRIVE Inhibition DME1077 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1077 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02236 XEO_CLAS Peptide DME1077 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02236 GENEFORM Protein DME1077 XEOTICID XEO02236 MOACRIVE Inhibition DME1077 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1077 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02239 XEO_CLAS Peptide DME1077 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 250 microM) DME1077 XEOTICID XEO02239 GENEFORM Protein DME1077 XEOTICID XEO02239 MOACRIVE Inhibition DME1077 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1077 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02240 XEO_CLAS Peptide DME1077 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 microM) DME1077 XEOTICID XEO02240 GENEFORM Protein DME1077 XEOTICID XEO02240 MOACRIVE Inhibition DME1077 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1077 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02241 XEO_CLAS Peptide DME1077 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02241 GENEFORM Protein DME1077 XEOTICID XEO02241 MOACRIVE Inhibition DME1077 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1077 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02242 XEO_CLAS Peptide DME1077 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO02242 GENEFORM Protein DME1077 XEOTICID XEO02242 MOACRIVE Inhibition DME1077 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1077 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02243 XEO_CLAS Peptide DME1077 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 microM) DME1077 XEOTICID XEO02243 GENEFORM Protein DME1077 XEOTICID XEO02243 MOACRIVE Inhibition DME1077 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1077 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02244 XEO_CLAS Peptide DME1077 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1 microM) DME1077 XEOTICID XEO02244 GENEFORM Protein DME1077 XEOTICID XEO02244 MOACRIVE Inhibition DME1077 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1077 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02245 XEO_CLAS Peptide DME1077 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02245 GENEFORM Protein DME1077 XEOTICID XEO02245 MOACRIVE Inhibition DME1077 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1077 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02246 XEO_CLAS Peptide DME1077 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 microM) DME1077 XEOTICID XEO02246 GENEFORM Protein DME1077 XEOTICID XEO02246 MOACRIVE Inhibition DME1077 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1077 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02247 XEO_CLAS Peptide DME1077 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02247 GENEFORM Protein DME1077 XEOTICID XEO02247 MOACRIVE Inhibition DME1077 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1077 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02248 XEO_CLAS Peptide DME1077 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.3 microM) DME1077 XEOTICID XEO02248 GENEFORM Protein DME1077 XEOTICID XEO02248 MOACRIVE Inhibition DME1077 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1077 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02253 XEO_CLAS Peptide DME1077 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02253 GENEFORM Protein DME1077 XEOTICID XEO02253 MOACRIVE Inhibition DME1077 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1077 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02258 XEO_CLAS Peptide DME1077 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 150 microM) DME1077 XEOTICID XEO02258 GENEFORM Protein DME1077 XEOTICID XEO02258 MOACRIVE Inhibition DME1077 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1077 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02261 XEO_CLAS Peptide DME1077 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 82 ug/ml) DME1077 XEOTICID XEO02261 GENEFORM Protein DME1077 XEOTICID XEO02261 MOACRIVE Inhibition DME1077 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1077 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02263 XEO_CLAS Peptide DME1077 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO02263 GENEFORM Protein DME1077 XEOTICID XEO02263 MOACRIVE Inhibition DME1077 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1077 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02266 XEO_CLAS Peptide DME1077 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 120 microM) DME1077 XEOTICID XEO02266 GENEFORM Protein DME1077 XEOTICID XEO02266 MOACRIVE Inhibition DME1077 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1077 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02268 XEO_CLAS Peptide DME1077 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 170 ug/ml) DME1077 XEOTICID XEO02268 GENEFORM Protein DME1077 XEOTICID XEO02268 MOACRIVE Inhibition DME1077 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1077 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02270 XEO_CLAS Peptide DME1077 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 microM) DME1077 XEOTICID XEO02270 GENEFORM Protein DME1077 XEOTICID XEO02270 MOACRIVE Inhibition DME1077 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1077 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02271 XEO_CLAS Peptide DME1077 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 302 ug/ml) DME1077 XEOTICID XEO02271 GENEFORM Protein DME1077 XEOTICID XEO02271 MOACRIVE Inhibition DME1077 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1077 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02273 XEO_CLAS Peptide DME1077 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 18 microM) DME1077 XEOTICID XEO02273 GENEFORM Protein DME1077 XEOTICID XEO02273 MOACRIVE Inhibition DME1077 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1077 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02274 XEO_CLAS Peptide DME1077 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO02274 GENEFORM Protein DME1077 XEOTICID XEO02274 MOACRIVE Inhibition DME1077 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1077 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02275 XEO_CLAS Peptide DME1077 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 microM) DME1077 XEOTICID XEO02275 GENEFORM Protein DME1077 XEOTICID XEO02275 MOACRIVE Inhibition DME1077 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1077 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02276 XEO_CLAS Peptide DME1077 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 microM) DME1077 XEOTICID XEO02276 GENEFORM Protein DME1077 XEOTICID XEO02276 MOACRIVE Inhibition DME1077 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1077 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02280 XEO_CLAS Peptide DME1077 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02280 GENEFORM Protein DME1077 XEOTICID XEO02280 MOACRIVE Inhibition DME1077 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1077 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02281 XEO_CLAS Peptide DME1077 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02281 GENEFORM Protein DME1077 XEOTICID XEO02281 MOACRIVE Inhibition DME1077 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1077 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02283 XEO_CLAS Peptide DME1077 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 ug/ml) DME1077 XEOTICID XEO02283 GENEFORM Protein DME1077 XEOTICID XEO02283 MOACRIVE Inhibition DME1077 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1077 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02284 XEO_CLAS Peptide DME1077 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50.4 microM) DME1077 XEOTICID XEO02284 GENEFORM Protein DME1077 XEOTICID XEO02284 MOACRIVE Inhibition DME1077 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1077 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02285 XEO_CLAS Peptide DME1077 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50.4 microM) DME1077 XEOTICID XEO02285 GENEFORM Protein DME1077 XEOTICID XEO02285 MOACRIVE Inhibition DME1077 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1077 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02286 XEO_CLAS Peptide DME1077 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50.4 microM) DME1077 XEOTICID XEO02286 GENEFORM Protein DME1077 XEOTICID XEO02286 MOACRIVE Inhibition DME1077 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1077 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02287 XEO_CLAS Peptide DME1077 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50.4 microM) DME1077 XEOTICID XEO02287 GENEFORM Protein DME1077 XEOTICID XEO02287 MOACRIVE Inhibition DME1077 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1077 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02288 XEO_CLAS Peptide DME1077 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.2 ug/ml) DME1077 XEOTICID XEO02288 GENEFORM Protein DME1077 XEOTICID XEO02288 MOACRIVE Inhibition DME1077 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1077 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02289 XEO_CLAS Peptide DME1077 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 ug/ml) DME1077 XEOTICID XEO02289 GENEFORM Protein DME1077 XEOTICID XEO02289 MOACRIVE Inhibition DME1077 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1077 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02290 XEO_CLAS Peptide DME1077 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO02290 GENEFORM Protein DME1077 XEOTICID XEO02290 MOACRIVE Inhibition DME1077 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1077 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02291 XEO_CLAS Peptide DME1077 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02291 GENEFORM Protein DME1077 XEOTICID XEO02291 MOACRIVE Inhibition DME1077 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1077 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02293 XEO_CLAS Peptide DME1077 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 microM) DME1077 XEOTICID XEO02293 GENEFORM Protein DME1077 XEOTICID XEO02293 MOACRIVE Inhibition DME1077 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1077 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02294 XEO_CLAS Peptide DME1077 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 62-250 ug/ml) DME1077 XEOTICID XEO02294 GENEFORM Protein DME1077 XEOTICID XEO02294 MOACRIVE Inhibition DME1077 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1077 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02295 XEO_CLAS Peptide DME1077 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 ug/ml) DME1077 XEOTICID XEO02295 GENEFORM Protein DME1077 XEOTICID XEO02295 MOACRIVE Inhibition DME1077 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1077 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02296 XEO_CLAS Peptide DME1077 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02296 GENEFORM Protein DME1077 XEOTICID XEO02296 MOACRIVE Inhibition DME1077 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1077 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02297 XEO_CLAS Peptide DME1077 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC < 50 ug/ml) DME1077 XEOTICID XEO02297 GENEFORM Protein DME1077 XEOTICID XEO02297 MOACRIVE Inhibition DME1077 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1077 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02298 XEO_CLAS Peptide DME1077 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO02298 GENEFORM Protein DME1077 XEOTICID XEO02298 MOACRIVE Inhibition DME1077 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1077 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02303 XEO_CLAS Peptide DME1077 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02303 GENEFORM Protein DME1077 XEOTICID XEO02303 MOACRIVE Inhibition DME1077 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1077 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02304 XEO_CLAS Peptide DME1077 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.1 ug/ml) DME1077 XEOTICID XEO02304 GENEFORM Protein DME1077 XEOTICID XEO02304 MOACRIVE Inhibition DME1077 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1077 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02305 XEO_CLAS Peptide DME1077 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC <= 1 ug/ml) DME1077 XEOTICID XEO02305 GENEFORM Protein DME1077 XEOTICID XEO02305 MOACRIVE Inhibition DME1077 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1077 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02306 XEO_CLAS Peptide DME1077 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.2 ug/ml) DME1077 XEOTICID XEO02306 GENEFORM Protein DME1077 XEOTICID XEO02306 MOACRIVE Inhibition DME1077 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1077 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02309 XEO_CLAS Peptide DME1077 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02309 GENEFORM Protein DME1077 XEOTICID XEO02309 MOACRIVE Inhibition DME1077 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1077 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02310 XEO_CLAS Peptide DME1077 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02310 GENEFORM Protein DME1077 XEOTICID XEO02310 MOACRIVE Inhibition DME1077 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1077 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02315 XEO_CLAS Peptide DME1077 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO02315 GENEFORM Protein DME1077 XEOTICID XEO02315 MOACRIVE Inhibition DME1077 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1077 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02316 XEO_CLAS Peptide DME1077 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 50 microM) DME1077 XEOTICID XEO02316 GENEFORM Protein DME1077 XEOTICID XEO02316 MOACRIVE Inhibition DME1077 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1077 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02317 XEO_CLAS Peptide DME1077 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 300 microM) DME1077 XEOTICID XEO02317 GENEFORM Protein DME1077 XEOTICID XEO02317 MOACRIVE Inhibition DME1077 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1077 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02318 XEO_CLAS Peptide DME1077 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02318 GENEFORM Protein DME1077 XEOTICID XEO02318 MOACRIVE Inhibition DME1077 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1077 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02319 XEO_CLAS Peptide DME1077 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02319 GENEFORM Protein DME1077 XEOTICID XEO02319 MOACRIVE Inhibition DME1077 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1077 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02320 XEO_CLAS Peptide DME1077 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02320 GENEFORM Protein DME1077 XEOTICID XEO02320 MOACRIVE Inhibition DME1077 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1077 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02321 XEO_CLAS Peptide DME1077 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO02321 GENEFORM Protein DME1077 XEOTICID XEO02321 MOACRIVE Inhibition DME1077 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1077 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02322 XEO_CLAS Peptide DME1077 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02322 GENEFORM Protein DME1077 XEOTICID XEO02322 MOACRIVE Inhibition DME1077 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1077 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02323 XEO_CLAS Peptide DME1077 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO02323 GENEFORM Protein DME1077 XEOTICID XEO02323 MOACRIVE Inhibition DME1077 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1077 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02324 XEO_CLAS Peptide DME1077 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02324 GENEFORM Protein DME1077 XEOTICID XEO02324 MOACRIVE Inhibition DME1077 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1077 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02325 XEO_CLAS Peptide DME1077 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO02325 GENEFORM Protein DME1077 XEOTICID XEO02325 MOACRIVE Inhibition DME1077 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1077 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02326 XEO_CLAS Peptide DME1077 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02326 GENEFORM Protein DME1077 XEOTICID XEO02326 MOACRIVE Inhibition DME1077 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1077 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02327 XEO_CLAS Peptide DME1077 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO02327 GENEFORM Protein DME1077 XEOTICID XEO02327 MOACRIVE Inhibition DME1077 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1077 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02328 XEO_CLAS Peptide DME1077 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO02328 GENEFORM Protein DME1077 XEOTICID XEO02328 MOACRIVE Inhibition DME1077 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1077 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02332 XEO_CLAS Peptide DME1077 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.9 ug/ml) DME1077 XEOTICID XEO02332 GENEFORM Protein DME1077 XEOTICID XEO02332 MOACRIVE Inhibition DME1077 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1077 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02333 XEO_CLAS Peptide DME1077 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 200 microM) DME1077 XEOTICID XEO02333 GENEFORM Protein DME1077 XEOTICID XEO02333 MOACRIVE Inhibition DME1077 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1077 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02336 XEO_CLAS Peptide DME1077 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 microM) DME1077 XEOTICID XEO02336 GENEFORM Protein DME1077 XEOTICID XEO02336 MOACRIVE Inhibition DME1077 XEOTICID XEO02346 XEO_NAME Aurelin DME1077 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02346 XEO_CLAS Peptide DME1077 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7.66 ug/ml) DME1077 XEOTICID XEO02346 GENEFORM Protein DME1077 XEOTICID XEO02346 MOACRIVE Inhibition DME1077 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1077 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02352 XEO_CLAS Peptide DME1077 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 11 ug/ml) DME1077 XEOTICID XEO02352 GENEFORM Protein DME1077 XEOTICID XEO02352 MOACRIVE Inhibition DME1077 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1077 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02353 XEO_CLAS Peptide DME1077 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 ug/ml) DME1077 XEOTICID XEO02353 GENEFORM Protein DME1077 XEOTICID XEO02353 MOACRIVE Inhibition DME1077 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1077 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02354 XEO_CLAS Peptide DME1077 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 ug/ml) DME1077 XEOTICID XEO02354 GENEFORM Protein DME1077 XEOTICID XEO02354 MOACRIVE Inhibition DME1077 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1077 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02355 XEO_CLAS Peptide DME1077 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 17 ug/ml) DME1077 XEOTICID XEO02355 GENEFORM Protein DME1077 XEOTICID XEO02355 MOACRIVE Inhibition DME1077 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1077 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02356 XEO_CLAS Peptide DME1077 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO02356 GENEFORM Protein DME1077 XEOTICID XEO02356 MOACRIVE Inhibition DME1077 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1077 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02357 XEO_CLAS Peptide DME1077 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO02357 GENEFORM Protein DME1077 XEOTICID XEO02357 MOACRIVE Inhibition DME1077 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1077 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02358 XEO_CLAS Peptide DME1077 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO02358 GENEFORM Protein DME1077 XEOTICID XEO02358 MOACRIVE Inhibition DME1077 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1077 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02360 XEO_CLAS Peptide DME1077 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02360 GENEFORM Protein DME1077 XEOTICID XEO02360 MOACRIVE Inhibition DME1077 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1077 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02361 XEO_CLAS Peptide DME1077 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 ug/ml) DME1077 XEOTICID XEO02361 GENEFORM Protein DME1077 XEOTICID XEO02361 MOACRIVE Inhibition DME1077 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1077 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02365 XEO_CLAS Peptide DME1077 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 32 ug/ml) DME1077 XEOTICID XEO02365 GENEFORM Protein DME1077 XEOTICID XEO02365 MOACRIVE Inhibition DME1077 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1077 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02366 XEO_CLAS Peptide DME1077 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO02366 GENEFORM Protein DME1077 XEOTICID XEO02366 MOACRIVE Inhibition DME1077 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1077 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02367 XEO_CLAS Peptide DME1077 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02367 GENEFORM Protein DME1077 XEOTICID XEO02367 MOACRIVE Inhibition DME1077 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1077 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02368 XEO_CLAS Peptide DME1077 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02368 GENEFORM Protein DME1077 XEOTICID XEO02368 MOACRIVE Inhibition DME1077 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1077 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02369 XEO_CLAS Peptide DME1077 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02369 GENEFORM Protein DME1077 XEOTICID XEO02369 MOACRIVE Inhibition DME1077 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1077 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02370 XEO_CLAS Peptide DME1077 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02370 GENEFORM Protein DME1077 XEOTICID XEO02370 MOACRIVE Inhibition DME1077 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1077 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02371 XEO_CLAS Peptide DME1077 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 ug/ml) DME1077 XEOTICID XEO02371 GENEFORM Protein DME1077 XEOTICID XEO02371 MOACRIVE Inhibition DME1077 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1077 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02374 XEO_CLAS Peptide DME1077 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02374 GENEFORM Protein DME1077 XEOTICID XEO02374 MOACRIVE Inhibition DME1077 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1077 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02376 XEO_CLAS Peptide DME1077 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02376 GENEFORM Protein DME1077 XEOTICID XEO02376 MOACRIVE Inhibition DME1077 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1077 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02378 XEO_CLAS Peptide DME1077 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.19 ug/ml) DME1077 XEOTICID XEO02378 GENEFORM Protein DME1077 XEOTICID XEO02378 MOACRIVE Inhibition DME1077 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1077 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02388 XEO_CLAS Peptide DME1077 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO02388 GENEFORM Protein DME1077 XEOTICID XEO02388 MOACRIVE Inhibition DME1077 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1077 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02389 XEO_CLAS Peptide DME1077 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02389 GENEFORM Protein DME1077 XEOTICID XEO02389 MOACRIVE Inhibition DME1077 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1077 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02415 XEO_CLAS Peptide DME1077 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02415 GENEFORM Protein DME1077 XEOTICID XEO02415 MOACRIVE Inhibition DME1077 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1077 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02416 XEO_CLAS Peptide DME1077 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 11 microM) DME1077 XEOTICID XEO02416 GENEFORM Protein DME1077 XEOTICID XEO02416 MOACRIVE Inhibition DME1077 XEOTICID XEO02419 XEO_NAME Bay oil DME1077 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1077 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02419 GENEFORM Protein DME1077 XEOTICID XEO02419 MOACRIVE Inhibition DME1077 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1077 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02435 XEO_CLAS Peptide DME1077 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02435 GENEFORM Protein DME1077 XEOTICID XEO02435 MOACRIVE Inhibition DME1077 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1077 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02436 XEO_CLAS Peptide DME1077 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02436 GENEFORM Protein DME1077 XEOTICID XEO02436 MOACRIVE Inhibition DME1077 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1077 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02437 XEO_CLAS Peptide DME1077 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02437 GENEFORM Protein DME1077 XEOTICID XEO02437 MOACRIVE Inhibition DME1077 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1077 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02438 XEO_CLAS Peptide DME1077 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02438 GENEFORM Protein DME1077 XEOTICID XEO02438 MOACRIVE Inhibition DME1077 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1077 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02439 XEO_CLAS Peptide DME1077 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02439 GENEFORM Protein DME1077 XEOTICID XEO02439 MOACRIVE Inhibition DME1077 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1077 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02440 XEO_CLAS Peptide DME1077 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02440 GENEFORM Protein DME1077 XEOTICID XEO02440 MOACRIVE Inhibition DME1077 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1077 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02441 XEO_CLAS Peptide DME1077 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02441 GENEFORM Protein DME1077 XEOTICID XEO02441 MOACRIVE Inhibition DME1077 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1077 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02442 XEO_CLAS Peptide DME1077 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO02442 GENEFORM Protein DME1077 XEOTICID XEO02442 MOACRIVE Inhibition DME1077 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1077 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02443 XEO_CLAS Peptide DME1077 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02443 GENEFORM Protein DME1077 XEOTICID XEO02443 MOACRIVE Inhibition DME1077 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1077 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02444 XEO_CLAS Peptide DME1077 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02444 GENEFORM Protein DME1077 XEOTICID XEO02444 MOACRIVE Inhibition DME1077 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1077 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1077 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02447 GENEFORM Protein DME1077 XEOTICID XEO02447 MOACRIVE Inhibition DME1077 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1077 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02452 XEO_CLAS Peptide DME1077 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 76800 ug/ml) DME1077 XEOTICID XEO02452 GENEFORM Protein DME1077 XEOTICID XEO02452 MOACRIVE Inhibition DME1077 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1077 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02453 XEO_CLAS Peptide DME1077 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02453 GENEFORM Protein DME1077 XEOTICID XEO02453 MOACRIVE Inhibition DME1077 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1077 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02463 XEO_CLAS Peptide DME1077 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 11.25 microM) DME1077 XEOTICID XEO02463 GENEFORM Protein DME1077 XEOTICID XEO02463 MOACRIVE Inhibition DME1077 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1077 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02466 XEO_CLAS Peptide DME1077 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.5 microM) DME1077 XEOTICID XEO02466 GENEFORM Protein DME1077 XEOTICID XEO02466 MOACRIVE Inhibition DME1077 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1077 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02467 XEO_CLAS Peptide DME1077 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8.4 microM) DME1077 XEOTICID XEO02467 GENEFORM Protein DME1077 XEOTICID XEO02467 MOACRIVE Inhibition DME1077 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1077 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02468 XEO_CLAS Peptide DME1077 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.7 microM) DME1077 XEOTICID XEO02468 GENEFORM Protein DME1077 XEOTICID XEO02468 MOACRIVE Inhibition DME1077 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1077 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02469 XEO_CLAS Peptide DME1077 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO02469 GENEFORM Protein DME1077 XEOTICID XEO02469 MOACRIVE Inhibition DME1077 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1077 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02470 XEO_CLAS Peptide DME1077 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.8 microM) DME1077 XEOTICID XEO02470 GENEFORM Protein DME1077 XEOTICID XEO02470 MOACRIVE Inhibition DME1077 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1077 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02471 XEO_CLAS Peptide DME1077 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4.8 microM) DME1077 XEOTICID XEO02471 GENEFORM Protein DME1077 XEOTICID XEO02471 MOACRIVE Inhibition DME1077 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1077 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02472 XEO_CLAS Peptide DME1077 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.0 microM) DME1077 XEOTICID XEO02472 GENEFORM Protein DME1077 XEOTICID XEO02472 MOACRIVE Inhibition DME1077 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1077 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02473 XEO_CLAS Peptide DME1077 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02473 GENEFORM Protein DME1077 XEOTICID XEO02473 MOACRIVE Inhibition DME1077 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1077 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02474 XEO_CLAS Peptide DME1077 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.5 microM) DME1077 XEOTICID XEO02474 GENEFORM Protein DME1077 XEOTICID XEO02474 MOACRIVE Inhibition DME1077 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1077 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02475 XEO_CLAS Peptide DME1077 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.5 microM) DME1077 XEOTICID XEO02475 GENEFORM Protein DME1077 XEOTICID XEO02475 MOACRIVE Inhibition DME1077 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1077 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02477 XEO_CLAS Peptide DME1077 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-300 ug/ml) DME1077 XEOTICID XEO02477 GENEFORM Protein DME1077 XEOTICID XEO02477 MOACRIVE Inhibition DME1077 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1077 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02478 XEO_CLAS Peptide DME1077 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-300 ug/ml) DME1077 XEOTICID XEO02478 GENEFORM Protein DME1077 XEOTICID XEO02478 MOACRIVE Inhibition DME1077 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1077 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02479 XEO_CLAS Peptide DME1077 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-300 ug/ml) DME1077 XEOTICID XEO02479 GENEFORM Protein DME1077 XEOTICID XEO02479 MOACRIVE Inhibition DME1077 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1077 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02480 XEO_CLAS Peptide DME1077 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-300 ug/ml) DME1077 XEOTICID XEO02480 GENEFORM Protein DME1077 XEOTICID XEO02480 MOACRIVE Inhibition DME1077 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1077 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02481 XEO_CLAS Peptide DME1077 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-300 ug/ml) DME1077 XEOTICID XEO02481 GENEFORM Protein DME1077 XEOTICID XEO02481 MOACRIVE Inhibition DME1077 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1077 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02482 XEO_CLAS Peptide DME1077 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-300 ug/ml) DME1077 XEOTICID XEO02482 GENEFORM Protein DME1077 XEOTICID XEO02482 MOACRIVE Inhibition DME1077 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1077 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02483 XEO_CLAS Peptide DME1077 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-300 ug/ml) DME1077 XEOTICID XEO02483 GENEFORM Protein DME1077 XEOTICID XEO02483 MOACRIVE Inhibition DME1077 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1077 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02484 XEO_CLAS Peptide DME1077 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-300 ug/ml) DME1077 XEOTICID XEO02484 GENEFORM Protein DME1077 XEOTICID XEO02484 MOACRIVE Inhibition DME1077 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1077 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02485 XEO_CLAS Peptide DME1077 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-300 ug/ml) DME1077 XEOTICID XEO02485 GENEFORM Protein DME1077 XEOTICID XEO02485 MOACRIVE Inhibition DME1077 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1077 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02486 XEO_CLAS Peptide DME1077 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-300 ug/ml) DME1077 XEOTICID XEO02486 GENEFORM Protein DME1077 XEOTICID XEO02486 MOACRIVE Inhibition DME1077 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1077 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02487 XEO_CLAS Peptide DME1077 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02487 GENEFORM Protein DME1077 XEOTICID XEO02487 MOACRIVE Inhibition DME1077 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1077 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02488 XEO_CLAS Peptide DME1077 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-300 ug/ml) DME1077 XEOTICID XEO02488 GENEFORM Protein DME1077 XEOTICID XEO02488 MOACRIVE Inhibition DME1077 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1077 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02489 XEO_CLAS Peptide DME1077 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-301 ug/ml) DME1077 XEOTICID XEO02489 GENEFORM Protein DME1077 XEOTICID XEO02489 MOACRIVE Inhibition DME1077 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1077 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02491 XEO_CLAS Peptide DME1077 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.3 microM) DME1077 XEOTICID XEO02491 GENEFORM Protein DME1077 XEOTICID XEO02491 MOACRIVE Inhibition DME1077 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1077 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02492 XEO_CLAS Peptide DME1077 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 ug/ml) DME1077 XEOTICID XEO02492 GENEFORM Protein DME1077 XEOTICID XEO02492 MOACRIVE Inhibition DME1077 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1077 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02493 XEO_CLAS Peptide DME1077 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 ug/ml) DME1077 XEOTICID XEO02493 GENEFORM Protein DME1077 XEOTICID XEO02493 MOACRIVE Inhibition DME1077 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1077 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02494 XEO_CLAS Peptide DME1077 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 ug/ml) DME1077 XEOTICID XEO02494 GENEFORM Protein DME1077 XEOTICID XEO02494 MOACRIVE Inhibition DME1077 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1077 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02495 XEO_CLAS Peptide DME1077 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 34 ug/ml) DME1077 XEOTICID XEO02495 GENEFORM Protein DME1077 XEOTICID XEO02495 MOACRIVE Inhibition DME1077 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1077 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02496 XEO_CLAS Peptide DME1077 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 13 microM) DME1077 XEOTICID XEO02496 GENEFORM Protein DME1077 XEOTICID XEO02496 MOACRIVE Inhibition DME1077 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1077 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02497 XEO_CLAS Peptide DME1077 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO02497 GENEFORM Protein DME1077 XEOTICID XEO02497 MOACRIVE Inhibition DME1077 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1077 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02499 XEO_CLAS Peptide DME1077 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO02499 GENEFORM Protein DME1077 XEOTICID XEO02499 MOACRIVE Inhibition DME1077 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1077 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02501 XEO_CLAS Peptide DME1077 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7 microM) DME1077 XEOTICID XEO02501 GENEFORM Protein DME1077 XEOTICID XEO02501 MOACRIVE Inhibition DME1077 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1077 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02502 XEO_CLAS Peptide DME1077 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 microM) DME1077 XEOTICID XEO02502 GENEFORM Protein DME1077 XEOTICID XEO02502 MOACRIVE Inhibition DME1077 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1077 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02503 XEO_CLAS Peptide DME1077 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 19 microM) DME1077 XEOTICID XEO02503 GENEFORM Protein DME1077 XEOTICID XEO02503 MOACRIVE Inhibition DME1077 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1077 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02504 XEO_CLAS Peptide DME1077 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02504 GENEFORM Protein DME1077 XEOTICID XEO02504 MOACRIVE Inhibition DME1077 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1077 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02505 XEO_CLAS Peptide DME1077 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO02505 GENEFORM Protein DME1077 XEOTICID XEO02505 MOACRIVE Inhibition DME1077 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1077 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02507 XEO_CLAS Peptide DME1077 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO02507 GENEFORM Protein DME1077 XEOTICID XEO02507 MOACRIVE Inhibition DME1077 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1077 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02508 XEO_CLAS Peptide DME1077 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 150 microM) DME1077 XEOTICID XEO02508 GENEFORM Protein DME1077 XEOTICID XEO02508 MOACRIVE Inhibition DME1077 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1077 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02509 XEO_CLAS Peptide DME1077 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 150 microM) DME1077 XEOTICID XEO02509 GENEFORM Protein DME1077 XEOTICID XEO02509 MOACRIVE Inhibition DME1077 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1077 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02510 XEO_CLAS Peptide DME1077 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 150 microM) DME1077 XEOTICID XEO02510 GENEFORM Protein DME1077 XEOTICID XEO02510 MOACRIVE Inhibition DME1077 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1077 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02511 XEO_CLAS Peptide DME1077 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 150 microM) DME1077 XEOTICID XEO02511 GENEFORM Protein DME1077 XEOTICID XEO02511 MOACRIVE Inhibition DME1077 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1077 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02512 XEO_CLAS Peptide DME1077 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 75 microM) DME1077 XEOTICID XEO02512 GENEFORM Protein DME1077 XEOTICID XEO02512 MOACRIVE Inhibition DME1077 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1077 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02513 XEO_CLAS Peptide DME1077 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO02513 GENEFORM Protein DME1077 XEOTICID XEO02513 MOACRIVE Inhibition DME1077 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1077 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02514 XEO_CLAS Peptide DME1077 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO02514 GENEFORM Protein DME1077 XEOTICID XEO02514 MOACRIVE Inhibition DME1077 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1077 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02515 XEO_CLAS Peptide DME1077 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 80 microM) DME1077 XEOTICID XEO02515 GENEFORM Protein DME1077 XEOTICID XEO02515 MOACRIVE Inhibition DME1077 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1077 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02516 XEO_CLAS Peptide DME1077 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 32 microM) DME1077 XEOTICID XEO02516 GENEFORM Protein DME1077 XEOTICID XEO02516 MOACRIVE Inhibition DME1077 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1077 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02517 XEO_CLAS Peptide DME1077 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 microM) DME1077 XEOTICID XEO02517 GENEFORM Protein DME1077 XEOTICID XEO02517 MOACRIVE Inhibition DME1077 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1077 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02518 XEO_CLAS Peptide DME1077 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC < 15 microM) DME1077 XEOTICID XEO02518 GENEFORM Protein DME1077 XEOTICID XEO02518 MOACRIVE Inhibition DME1077 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1077 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02519 XEO_CLAS Peptide DME1077 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC < 15 microM) DME1077 XEOTICID XEO02519 GENEFORM Protein DME1077 XEOTICID XEO02519 MOACRIVE Inhibition DME1077 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1077 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02520 XEO_CLAS Peptide DME1077 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC < 15 microM) DME1077 XEOTICID XEO02520 GENEFORM Protein DME1077 XEOTICID XEO02520 MOACRIVE Inhibition DME1077 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1077 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02523 XEO_CLAS Peptide DME1077 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO02523 GENEFORM Protein DME1077 XEOTICID XEO02523 MOACRIVE Inhibition DME1077 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1077 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02524 XEO_CLAS Peptide DME1077 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 150 microM) DME1077 XEOTICID XEO02524 GENEFORM Protein DME1077 XEOTICID XEO02524 MOACRIVE Inhibition DME1077 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1077 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02525 XEO_CLAS Peptide DME1077 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 24 microM) DME1077 XEOTICID XEO02525 GENEFORM Protein DME1077 XEOTICID XEO02525 MOACRIVE Inhibition DME1077 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1077 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02526 XEO_CLAS Peptide DME1077 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 48 microM) DME1077 XEOTICID XEO02526 GENEFORM Protein DME1077 XEOTICID XEO02526 MOACRIVE Inhibition DME1077 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1077 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02527 XEO_CLAS Peptide DME1077 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 119 microM) DME1077 XEOTICID XEO02527 GENEFORM Protein DME1077 XEOTICID XEO02527 MOACRIVE Inhibition DME1077 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1077 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02528 XEO_CLAS Peptide DME1077 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 128 ug/ml) DME1077 XEOTICID XEO02528 GENEFORM Protein DME1077 XEOTICID XEO02528 MOACRIVE Inhibition DME1077 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1077 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02529 XEO_CLAS Peptide DME1077 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 128 ug/ml) DME1077 XEOTICID XEO02529 GENEFORM Protein DME1077 XEOTICID XEO02529 MOACRIVE Inhibition DME1077 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1077 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02530 XEO_CLAS Peptide DME1077 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02530 GENEFORM Protein DME1077 XEOTICID XEO02530 MOACRIVE Inhibition DME1077 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1077 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02531 XEO_CLAS Peptide DME1077 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 microM) DME1077 XEOTICID XEO02531 GENEFORM Protein DME1077 XEOTICID XEO02531 MOACRIVE Inhibition DME1077 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1077 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02533 XEO_CLAS Peptide DME1077 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.2 ug/ml) DME1077 XEOTICID XEO02533 GENEFORM Protein DME1077 XEOTICID XEO02533 MOACRIVE Inhibition DME1077 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1077 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02534 XEO_CLAS Peptide DME1077 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.6 ug/ml) DME1077 XEOTICID XEO02534 GENEFORM Protein DME1077 XEOTICID XEO02534 MOACRIVE Inhibition DME1077 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1077 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02535 XEO_CLAS Peptide DME1077 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.3 ug/ml) DME1077 XEOTICID XEO02535 GENEFORM Protein DME1077 XEOTICID XEO02535 MOACRIVE Inhibition DME1077 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1077 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02536 XEO_CLAS Peptide DME1077 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.4 ug/ml) DME1077 XEOTICID XEO02536 GENEFORM Protein DME1077 XEOTICID XEO02536 MOACRIVE Inhibition DME1077 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1077 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02537 XEO_CLAS Peptide DME1077 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.2 ug/ml) DME1077 XEOTICID XEO02537 GENEFORM Protein DME1077 XEOTICID XEO02537 MOACRIVE Inhibition DME1077 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1077 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02538 XEO_CLAS Peptide DME1077 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9.1 ug/ml) DME1077 XEOTICID XEO02538 GENEFORM Protein DME1077 XEOTICID XEO02538 MOACRIVE Inhibition DME1077 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1077 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02539 XEO_CLAS Peptide DME1077 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8.6 ug/ml) DME1077 XEOTICID XEO02539 GENEFORM Protein DME1077 XEOTICID XEO02539 MOACRIVE Inhibition DME1077 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1077 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02540 XEO_CLAS Peptide DME1077 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15.2 ug/ml) DME1077 XEOTICID XEO02540 GENEFORM Protein DME1077 XEOTICID XEO02540 MOACRIVE Inhibition DME1077 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1077 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02541 XEO_CLAS Peptide DME1077 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 11.1 ug/ml) DME1077 XEOTICID XEO02541 GENEFORM Protein DME1077 XEOTICID XEO02541 MOACRIVE Inhibition DME1077 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1077 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02542 XEO_CLAS Peptide DME1077 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.7 ug/ml) DME1077 XEOTICID XEO02542 GENEFORM Protein DME1077 XEOTICID XEO02542 MOACRIVE Inhibition DME1077 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1077 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02543 XEO_CLAS Peptide DME1077 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 13.1 ug/ml) DME1077 XEOTICID XEO02543 GENEFORM Protein DME1077 XEOTICID XEO02543 MOACRIVE Inhibition DME1077 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1077 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02544 XEO_CLAS Peptide DME1077 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9.8 ug/ml) DME1077 XEOTICID XEO02544 GENEFORM Protein DME1077 XEOTICID XEO02544 MOACRIVE Inhibition DME1077 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1077 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02545 XEO_CLAS Peptide DME1077 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 14 microM) DME1077 XEOTICID XEO02545 GENEFORM Protein DME1077 XEOTICID XEO02545 MOACRIVE Inhibition DME1077 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1077 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02546 XEO_CLAS Peptide DME1077 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 14 microM) DME1077 XEOTICID XEO02546 GENEFORM Protein DME1077 XEOTICID XEO02546 MOACRIVE Inhibition DME1077 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1077 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02547 XEO_CLAS Peptide DME1077 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 microM) DME1077 XEOTICID XEO02547 GENEFORM Protein DME1077 XEOTICID XEO02547 MOACRIVE Inhibition DME1077 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1077 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02548 XEO_CLAS Peptide DME1077 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 78 microM) DME1077 XEOTICID XEO02548 GENEFORM Protein DME1077 XEOTICID XEO02548 MOACRIVE Inhibition DME1077 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1077 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02549 XEO_CLAS Peptide DME1077 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02549 GENEFORM Protein DME1077 XEOTICID XEO02549 MOACRIVE Inhibition DME1077 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1077 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02552 XEO_CLAS Peptide DME1077 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 24 microM) DME1077 XEOTICID XEO02552 GENEFORM Protein DME1077 XEOTICID XEO02552 MOACRIVE Inhibition DME1077 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1077 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02553 XEO_CLAS Peptide DME1077 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02553 GENEFORM Protein DME1077 XEOTICID XEO02553 MOACRIVE Inhibition DME1077 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1077 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02556 XEO_CLAS Peptide DME1077 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 55 microM) DME1077 XEOTICID XEO02556 GENEFORM Protein DME1077 XEOTICID XEO02556 MOACRIVE Inhibition DME1077 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1077 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02557 XEO_CLAS Peptide DME1077 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 17 microM) DME1077 XEOTICID XEO02557 GENEFORM Protein DME1077 XEOTICID XEO02557 MOACRIVE Inhibition DME1077 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1077 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02558 XEO_CLAS Peptide DME1077 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 14 microM) DME1077 XEOTICID XEO02558 GENEFORM Protein DME1077 XEOTICID XEO02558 MOACRIVE Inhibition DME1077 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1077 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02559 XEO_CLAS Peptide DME1077 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02559 GENEFORM Protein DME1077 XEOTICID XEO02559 MOACRIVE Inhibition DME1077 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1077 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02560 XEO_CLAS Peptide DME1077 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 13 microM) DME1077 XEOTICID XEO02560 GENEFORM Protein DME1077 XEOTICID XEO02560 MOACRIVE Inhibition DME1077 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1077 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02561 XEO_CLAS Peptide DME1077 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO02561 GENEFORM Protein DME1077 XEOTICID XEO02561 MOACRIVE Inhibition DME1077 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1077 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02562 XEO_CLAS Peptide DME1077 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 13 microM) DME1077 XEOTICID XEO02562 GENEFORM Protein DME1077 XEOTICID XEO02562 MOACRIVE Inhibition DME1077 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1077 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02563 XEO_CLAS Peptide DME1077 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 45 microM) DME1077 XEOTICID XEO02563 GENEFORM Protein DME1077 XEOTICID XEO02563 MOACRIVE Inhibition DME1077 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1077 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02564 XEO_CLAS Peptide DME1077 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 ug/ml) DME1077 XEOTICID XEO02564 GENEFORM Protein DME1077 XEOTICID XEO02564 MOACRIVE Inhibition DME1077 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1077 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02565 XEO_CLAS Peptide DME1077 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 microM) DME1077 XEOTICID XEO02565 GENEFORM Protein DME1077 XEOTICID XEO02565 MOACRIVE Inhibition DME1077 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1077 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02566 XEO_CLAS Peptide DME1077 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO02566 GENEFORM Protein DME1077 XEOTICID XEO02566 MOACRIVE Inhibition DME1077 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1077 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02568 XEO_CLAS Peptide DME1077 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO02568 GENEFORM Protein DME1077 XEOTICID XEO02568 MOACRIVE Inhibition DME1077 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1077 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02569 XEO_CLAS Peptide DME1077 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO02569 GENEFORM Protein DME1077 XEOTICID XEO02569 MOACRIVE Inhibition DME1077 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1077 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02570 XEO_CLAS Peptide DME1077 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO02570 GENEFORM Protein DME1077 XEOTICID XEO02570 MOACRIVE Inhibition DME1077 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1077 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02571 XEO_CLAS Peptide DME1077 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO02571 GENEFORM Protein DME1077 XEOTICID XEO02571 MOACRIVE Inhibition DME1077 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1077 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02572 XEO_CLAS Peptide DME1077 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02572 GENEFORM Protein DME1077 XEOTICID XEO02572 MOACRIVE Inhibition DME1077 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1077 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02573 XEO_CLAS Peptide DME1077 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02573 GENEFORM Protein DME1077 XEOTICID XEO02573 MOACRIVE Inhibition DME1077 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1077 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02574 XEO_CLAS Peptide DME1077 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 microM) DME1077 XEOTICID XEO02574 GENEFORM Protein DME1077 XEOTICID XEO02574 MOACRIVE Inhibition DME1077 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1077 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02575 XEO_CLAS Peptide DME1077 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 microM) DME1077 XEOTICID XEO02575 GENEFORM Protein DME1077 XEOTICID XEO02575 MOACRIVE Inhibition DME1077 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1077 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02576 XEO_CLAS Peptide DME1077 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 33 microM) DME1077 XEOTICID XEO02576 GENEFORM Protein DME1077 XEOTICID XEO02576 MOACRIVE Inhibition DME1077 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1077 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02577 XEO_CLAS Peptide DME1077 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO02577 GENEFORM Protein DME1077 XEOTICID XEO02577 MOACRIVE Inhibition DME1077 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1077 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02578 XEO_CLAS Peptide DME1077 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02578 GENEFORM Protein DME1077 XEOTICID XEO02578 MOACRIVE Inhibition DME1077 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1077 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02579 XEO_CLAS Peptide DME1077 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02579 GENEFORM Protein DME1077 XEOTICID XEO02579 MOACRIVE Inhibition DME1077 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1077 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02580 XEO_CLAS Peptide DME1077 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC < 15 microM) DME1077 XEOTICID XEO02580 GENEFORM Protein DME1077 XEOTICID XEO02580 MOACRIVE Inhibition DME1077 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1077 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02581 XEO_CLAS Peptide DME1077 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 microM) DME1077 XEOTICID XEO02581 GENEFORM Protein DME1077 XEOTICID XEO02581 MOACRIVE Inhibition DME1077 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1077 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02582 XEO_CLAS Peptide DME1077 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 microM) DME1077 XEOTICID XEO02582 GENEFORM Protein DME1077 XEOTICID XEO02582 MOACRIVE Inhibition DME1077 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1077 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02583 XEO_CLAS Peptide DME1077 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 microM) DME1077 XEOTICID XEO02583 GENEFORM Protein DME1077 XEOTICID XEO02583 MOACRIVE Inhibition DME1077 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1077 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02584 XEO_CLAS Peptide DME1077 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 microM) DME1077 XEOTICID XEO02584 GENEFORM Protein DME1077 XEOTICID XEO02584 MOACRIVE Inhibition DME1077 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1077 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02585 XEO_CLAS Peptide DME1077 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO02585 GENEFORM Protein DME1077 XEOTICID XEO02585 MOACRIVE Inhibition DME1077 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1077 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02586 XEO_CLAS Peptide DME1077 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO02586 GENEFORM Protein DME1077 XEOTICID XEO02586 MOACRIVE Inhibition DME1077 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1077 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02587 XEO_CLAS Peptide DME1077 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02587 GENEFORM Protein DME1077 XEOTICID XEO02587 MOACRIVE Inhibition DME1077 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1077 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02589 XEO_CLAS Peptide DME1077 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8.2 ug/ml) DME1077 XEOTICID XEO02589 GENEFORM Protein DME1077 XEOTICID XEO02589 MOACRIVE Inhibition DME1077 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1077 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02590 XEO_CLAS Peptide DME1077 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 19.6 ug/ml) DME1077 XEOTICID XEO02590 GENEFORM Protein DME1077 XEOTICID XEO02590 MOACRIVE Inhibition DME1077 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1077 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02591 XEO_CLAS Peptide DME1077 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO02591 GENEFORM Protein DME1077 XEOTICID XEO02591 MOACRIVE Inhibition DME1077 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1077 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02593 XEO_CLAS Peptide DME1077 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 36 microM) DME1077 XEOTICID XEO02593 GENEFORM Protein DME1077 XEOTICID XEO02593 MOACRIVE Inhibition DME1077 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1077 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02594 XEO_CLAS Peptide DME1077 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02594 GENEFORM Protein DME1077 XEOTICID XEO02594 MOACRIVE Inhibition DME1077 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1077 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02595 XEO_CLAS Peptide DME1077 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO02595 GENEFORM Protein DME1077 XEOTICID XEO02595 MOACRIVE Inhibition DME1077 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1077 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02596 XEO_CLAS Peptide DME1077 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO02596 GENEFORM Protein DME1077 XEOTICID XEO02596 MOACRIVE Inhibition DME1077 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1077 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02597 XEO_CLAS Peptide DME1077 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO02597 GENEFORM Protein DME1077 XEOTICID XEO02597 MOACRIVE Inhibition DME1077 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1077 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02598 XEO_CLAS Peptide DME1077 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 32.5 microM) DME1077 XEOTICID XEO02598 GENEFORM Protein DME1077 XEOTICID XEO02598 MOACRIVE Inhibition DME1077 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1077 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02599 XEO_CLAS Peptide DME1077 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 microM) DME1077 XEOTICID XEO02599 GENEFORM Protein DME1077 XEOTICID XEO02599 MOACRIVE Inhibition DME1077 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1077 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02601 XEO_CLAS Peptide DME1077 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.1 ug/ml) DME1077 XEOTICID XEO02601 GENEFORM Protein DME1077 XEOTICID XEO02601 MOACRIVE Inhibition DME1077 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1077 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02602 XEO_CLAS Peptide DME1077 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 13.2 ug/ml) DME1077 XEOTICID XEO02602 GENEFORM Protein DME1077 XEOTICID XEO02602 MOACRIVE Inhibition DME1077 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1077 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02603 XEO_CLAS Peptide DME1077 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.3 ug/ml) DME1077 XEOTICID XEO02603 GENEFORM Protein DME1077 XEOTICID XEO02603 MOACRIVE Inhibition DME1077 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1077 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02604 XEO_CLAS Peptide DME1077 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO02604 GENEFORM Protein DME1077 XEOTICID XEO02604 MOACRIVE Inhibition DME1077 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1077 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02605 XEO_CLAS Peptide DME1077 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30.6 ug/ml) DME1077 XEOTICID XEO02605 GENEFORM Protein DME1077 XEOTICID XEO02605 MOACRIVE Inhibition DME1077 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1077 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02606 XEO_CLAS Peptide DME1077 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 11.2 ug/ml) DME1077 XEOTICID XEO02606 GENEFORM Protein DME1077 XEOTICID XEO02606 MOACRIVE Inhibition DME1077 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1077 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02607 XEO_CLAS Peptide DME1077 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.8 ug/ml) DME1077 XEOTICID XEO02607 GENEFORM Protein DME1077 XEOTICID XEO02607 MOACRIVE Inhibition DME1077 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1077 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02608 XEO_CLAS Peptide DME1077 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7.9 ug/ml) DME1077 XEOTICID XEO02608 GENEFORM Protein DME1077 XEOTICID XEO02608 MOACRIVE Inhibition DME1077 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1077 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02609 XEO_CLAS Peptide DME1077 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15.8 ug/ml) DME1077 XEOTICID XEO02609 GENEFORM Protein DME1077 XEOTICID XEO02609 MOACRIVE Inhibition DME1077 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1077 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02610 XEO_CLAS Peptide DME1077 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.1 ug/ml) DME1077 XEOTICID XEO02610 GENEFORM Protein DME1077 XEOTICID XEO02610 MOACRIVE Inhibition DME1077 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1077 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02611 XEO_CLAS Peptide DME1077 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20.6 ug/ml) DME1077 XEOTICID XEO02611 GENEFORM Protein DME1077 XEOTICID XEO02611 MOACRIVE Inhibition DME1077 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1077 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02612 XEO_CLAS Peptide DME1077 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 11.8 ug/ml) DME1077 XEOTICID XEO02612 GENEFORM Protein DME1077 XEOTICID XEO02612 MOACRIVE Inhibition DME1077 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1077 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02613 XEO_CLAS Peptide DME1077 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 13.2 ug/ml) DME1077 XEOTICID XEO02613 GENEFORM Protein DME1077 XEOTICID XEO02613 MOACRIVE Inhibition DME1077 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1077 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02614 XEO_CLAS Peptide DME1077 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.8 ug/ml) DME1077 XEOTICID XEO02614 GENEFORM Protein DME1077 XEOTICID XEO02614 MOACRIVE Inhibition DME1077 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1077 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02615 XEO_CLAS Peptide DME1077 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8.6 ug/ml) DME1077 XEOTICID XEO02615 GENEFORM Protein DME1077 XEOTICID XEO02615 MOACRIVE Inhibition DME1077 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1077 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02616 XEO_CLAS Peptide DME1077 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20.4 ug/ml) DME1077 XEOTICID XEO02616 GENEFORM Protein DME1077 XEOTICID XEO02616 MOACRIVE Inhibition DME1077 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1077 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02617 XEO_CLAS Peptide DME1077 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4.7 ug/ml) DME1077 XEOTICID XEO02617 GENEFORM Protein DME1077 XEOTICID XEO02617 MOACRIVE Inhibition DME1077 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1077 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02618 XEO_CLAS Peptide DME1077 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.6 ug/ml) DME1077 XEOTICID XEO02618 GENEFORM Protein DME1077 XEOTICID XEO02618 MOACRIVE Inhibition DME1077 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1077 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02619 XEO_CLAS Peptide DME1077 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10.5 ug/ml) DME1077 XEOTICID XEO02619 GENEFORM Protein DME1077 XEOTICID XEO02619 MOACRIVE Inhibition DME1077 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1077 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02620 XEO_CLAS Peptide DME1077 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO02620 GENEFORM Protein DME1077 XEOTICID XEO02620 MOACRIVE Inhibition DME1077 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1077 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02621 XEO_CLAS Peptide DME1077 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO02621 GENEFORM Protein DME1077 XEOTICID XEO02621 MOACRIVE Inhibition DME1077 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1077 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02622 XEO_CLAS Peptide DME1077 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO02622 GENEFORM Protein DME1077 XEOTICID XEO02622 MOACRIVE Inhibition DME1077 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1077 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02623 XEO_CLAS Peptide DME1077 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO02623 GENEFORM Protein DME1077 XEOTICID XEO02623 MOACRIVE Inhibition DME1077 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1077 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02624 XEO_CLAS Peptide DME1077 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 18 microM) DME1077 XEOTICID XEO02624 GENEFORM Protein DME1077 XEOTICID XEO02624 MOACRIVE Inhibition DME1077 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1077 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02625 XEO_CLAS Peptide DME1077 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9 microM) DME1077 XEOTICID XEO02625 GENEFORM Protein DME1077 XEOTICID XEO02625 MOACRIVE Inhibition DME1077 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1077 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02626 XEO_CLAS Peptide DME1077 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 18 microM) DME1077 XEOTICID XEO02626 GENEFORM Protein DME1077 XEOTICID XEO02626 MOACRIVE Inhibition DME1077 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1077 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02627 XEO_CLAS Peptide DME1077 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02627 GENEFORM Protein DME1077 XEOTICID XEO02627 MOACRIVE Inhibition DME1077 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1077 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02628 XEO_CLAS Peptide DME1077 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 18 microM) DME1077 XEOTICID XEO02628 GENEFORM Protein DME1077 XEOTICID XEO02628 MOACRIVE Inhibition DME1077 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1077 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02629 XEO_CLAS Peptide DME1077 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 13 microM) DME1077 XEOTICID XEO02629 GENEFORM Protein DME1077 XEOTICID XEO02629 MOACRIVE Inhibition DME1077 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1077 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02630 XEO_CLAS Peptide DME1077 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 ug/ml) DME1077 XEOTICID XEO02630 GENEFORM Protein DME1077 XEOTICID XEO02630 MOACRIVE Inhibition DME1077 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1077 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02631 XEO_CLAS Peptide DME1077 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 ug/ml) DME1077 XEOTICID XEO02631 GENEFORM Protein DME1077 XEOTICID XEO02631 MOACRIVE Inhibition DME1077 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1077 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02634 XEO_CLAS Peptide DME1077 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO02634 GENEFORM Protein DME1077 XEOTICID XEO02634 MOACRIVE Inhibition DME1077 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1077 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02635 XEO_CLAS Peptide DME1077 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40 ug/ml) DME1077 XEOTICID XEO02635 GENEFORM Protein DME1077 XEOTICID XEO02635 MOACRIVE Inhibition DME1077 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1077 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02636 XEO_CLAS Peptide DME1077 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO02636 GENEFORM Protein DME1077 XEOTICID XEO02636 MOACRIVE Inhibition DME1077 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1077 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02637 XEO_CLAS Peptide DME1077 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO02637 GENEFORM Protein DME1077 XEOTICID XEO02637 MOACRIVE Inhibition DME1077 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1077 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02638 XEO_CLAS Peptide DME1077 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 microM) DME1077 XEOTICID XEO02638 GENEFORM Protein DME1077 XEOTICID XEO02638 MOACRIVE Inhibition DME1077 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1077 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02639 XEO_CLAS Peptide DME1077 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 microM) DME1077 XEOTICID XEO02639 GENEFORM Protein DME1077 XEOTICID XEO02639 MOACRIVE Inhibition DME1077 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1077 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02644 XEO_CLAS Peptide DME1077 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02644 GENEFORM Protein DME1077 XEOTICID XEO02644 MOACRIVE Inhibition DME1077 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1077 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02645 XEO_CLAS Peptide DME1077 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02645 GENEFORM Protein DME1077 XEOTICID XEO02645 MOACRIVE Inhibition DME1077 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1077 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02646 XEO_CLAS Peptide DME1077 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02646 GENEFORM Protein DME1077 XEOTICID XEO02646 MOACRIVE Inhibition DME1077 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1077 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02647 XEO_CLAS Peptide DME1077 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02647 GENEFORM Protein DME1077 XEOTICID XEO02647 MOACRIVE Inhibition DME1077 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1077 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02649 XEO_CLAS Peptide DME1077 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO02649 GENEFORM Protein DME1077 XEOTICID XEO02649 MOACRIVE Inhibition DME1077 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1077 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02650 XEO_CLAS Peptide DME1077 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO02650 GENEFORM Protein DME1077 XEOTICID XEO02650 MOACRIVE Inhibition DME1077 XEOTICID XEO02658 XEO_NAME Buthinin DME1077 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02658 XEO_CLAS Peptide DME1077 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02658 GENEFORM Protein DME1077 XEOTICID XEO02658 MOACRIVE Inhibition DME1077 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1077 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02663 XEO_CLAS Peptide DME1077 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25 microM) DME1077 XEOTICID XEO02663 GENEFORM Protein DME1077 XEOTICID XEO02663 MOACRIVE Inhibition DME1077 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1077 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02664 XEO_CLAS Peptide DME1077 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25 microM) DME1077 XEOTICID XEO02664 GENEFORM Protein DME1077 XEOTICID XEO02664 MOACRIVE Inhibition DME1077 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1077 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02672 XEO_CLAS Peptide DME1077 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25 microM) DME1077 XEOTICID XEO02672 GENEFORM Protein DME1077 XEOTICID XEO02672 MOACRIVE Inhibition DME1077 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1077 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02673 XEO_CLAS Peptide DME1077 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1077 XEOTICID XEO02673 GENEFORM Protein DME1077 XEOTICID XEO02673 MOACRIVE Inhibition DME1077 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1077 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02674 XEO_CLAS Peptide DME1077 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.125-6.25 microM) DME1077 XEOTICID XEO02674 GENEFORM Protein DME1077 XEOTICID XEO02674 MOACRIVE Inhibition DME1077 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1077 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02676 XEO_CLAS Peptide DME1077 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO02676 GENEFORM Protein DME1077 XEOTICID XEO02676 MOACRIVE Inhibition DME1077 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1077 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02677 XEO_CLAS Peptide DME1077 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1077 XEOTICID XEO02677 GENEFORM Protein DME1077 XEOTICID XEO02677 MOACRIVE Inhibition DME1077 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1077 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02679 XEO_CLAS Peptide DME1077 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1077 XEOTICID XEO02679 GENEFORM Protein DME1077 XEOTICID XEO02679 MOACRIVE Inhibition DME1077 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1077 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02680 XEO_CLAS Peptide DME1077 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25 microM) DME1077 XEOTICID XEO02680 GENEFORM Protein DME1077 XEOTICID XEO02680 MOACRIVE Inhibition DME1077 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1077 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02683 XEO_CLAS Peptide DME1077 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO02683 GENEFORM Protein DME1077 XEOTICID XEO02683 MOACRIVE Inhibition DME1077 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1077 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02688 XEO_CLAS Peptide DME1077 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO02688 GENEFORM Protein DME1077 XEOTICID XEO02688 MOACRIVE Inhibition DME1077 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1077 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02693 XEO_CLAS Peptide DME1077 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 ug/ml) DME1077 XEOTICID XEO02693 GENEFORM Protein DME1077 XEOTICID XEO02693 MOACRIVE Inhibition DME1077 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1077 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02699 XEO_CLAS Peptide DME1077 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 ug/ml) DME1077 XEOTICID XEO02699 GENEFORM Protein DME1077 XEOTICID XEO02699 MOACRIVE Inhibition DME1077 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1077 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02700 XEO_CLAS Peptide DME1077 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 ug/ml) DME1077 XEOTICID XEO02700 GENEFORM Protein DME1077 XEOTICID XEO02700 MOACRIVE Inhibition DME1077 XEOTICID XEO02703 XEO_NAME Calcitermin DME1077 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02703 XEO_CLAS Peptide DME1077 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02703 GENEFORM Protein DME1077 XEOTICID XEO02703 MOACRIVE Inhibition DME1077 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1077 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02708 XEO_CLAS Peptide DME1077 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO02708 GENEFORM Protein DME1077 XEOTICID XEO02708 MOACRIVE Inhibition DME1077 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1077 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02709 XEO_CLAS Peptide DME1077 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.05 microM) DME1077 XEOTICID XEO02709 GENEFORM Protein DME1077 XEOTICID XEO02709 MOACRIVE Inhibition DME1077 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1077 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1077 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02713 GENEFORM Protein DME1077 XEOTICID XEO02713 MOACRIVE Inhibition DME1077 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1077 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1077 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02714 GENEFORM Protein DME1077 XEOTICID XEO02714 MOACRIVE Inhibition DME1077 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1077 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02726 XEO_CLAS Peptide DME1077 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02726 GENEFORM Protein DME1077 XEOTICID XEO02726 MOACRIVE Inhibition DME1077 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1077 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02731 XEO_CLAS Peptide DME1077 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1 microM) DME1077 XEOTICID XEO02731 GENEFORM Protein DME1077 XEOTICID XEO02731 MOACRIVE Inhibition DME1077 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1077 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02732 XEO_CLAS Peptide DME1077 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.25 microM) DME1077 XEOTICID XEO02732 GENEFORM Protein DME1077 XEOTICID XEO02732 MOACRIVE Inhibition DME1077 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1077 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02733 XEO_CLAS Peptide DME1077 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8-25 ug/ml) DME1077 XEOTICID XEO02733 GENEFORM Protein DME1077 XEOTICID XEO02733 MOACRIVE Inhibition DME1077 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1077 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02735 XEO_CLAS Peptide DME1077 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1 ug/ml) DME1077 XEOTICID XEO02735 GENEFORM Protein DME1077 XEOTICID XEO02735 MOACRIVE Inhibition DME1077 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1077 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02737 XEO_CLAS Peptide DME1077 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02737 GENEFORM Protein DME1077 XEOTICID XEO02737 MOACRIVE Inhibition DME1077 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1077 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02738 XEO_CLAS Peptide DME1077 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO02738 GENEFORM Protein DME1077 XEOTICID XEO02738 MOACRIVE Inhibition DME1077 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1077 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02739 XEO_CLAS Peptide DME1077 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 microM) DME1077 XEOTICID XEO02739 GENEFORM Protein DME1077 XEOTICID XEO02739 MOACRIVE Inhibition DME1077 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1077 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02740 XEO_CLAS Peptide DME1077 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.25 ug/ml) DME1077 XEOTICID XEO02740 GENEFORM Protein DME1077 XEOTICID XEO02740 MOACRIVE Inhibition DME1077 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1077 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02741 XEO_CLAS Peptide DME1077 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 ug/ml) DME1077 XEOTICID XEO02741 GENEFORM Protein DME1077 XEOTICID XEO02741 MOACRIVE Inhibition DME1077 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1077 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02743 XEO_CLAS Peptide DME1077 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.6 ug/ml) DME1077 XEOTICID XEO02743 GENEFORM Protein DME1077 XEOTICID XEO02743 MOACRIVE Inhibition DME1077 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1077 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02744 XEO_CLAS Peptide DME1077 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 18.7 ug/ml) DME1077 XEOTICID XEO02744 GENEFORM Protein DME1077 XEOTICID XEO02744 MOACRIVE Inhibition DME1077 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1077 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02745 XEO_CLAS Peptide DME1077 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02745 GENEFORM Protein DME1077 XEOTICID XEO02745 MOACRIVE Inhibition DME1077 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1077 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02746 XEO_CLAS Peptide DME1077 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02746 GENEFORM Protein DME1077 XEOTICID XEO02746 MOACRIVE Inhibition DME1077 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1077 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02748 XEO_CLAS Peptide DME1077 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02748 GENEFORM Protein DME1077 XEOTICID XEO02748 MOACRIVE Inhibition DME1077 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1077 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02749 XEO_CLAS Peptide DME1077 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20-25 mug/ml) DME1077 XEOTICID XEO02749 GENEFORM Protein DME1077 XEOTICID XEO02749 MOACRIVE Inhibition DME1077 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1077 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02750 XEO_CLAS Peptide DME1077 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02750 GENEFORM Protein DME1077 XEOTICID XEO02750 MOACRIVE Inhibition DME1077 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1077 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02752 XEO_CLAS Peptide DME1077 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02752 GENEFORM Protein DME1077 XEOTICID XEO02752 MOACRIVE Inhibition DME1077 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1077 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02753 XEO_CLAS Peptide DME1077 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02753 GENEFORM Protein DME1077 XEOTICID XEO02753 MOACRIVE Inhibition DME1077 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1077 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02754 XEO_CLAS Peptide DME1077 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 microM) DME1077 XEOTICID XEO02754 GENEFORM Protein DME1077 XEOTICID XEO02754 MOACRIVE Inhibition DME1077 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1077 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02756 XEO_CLAS Peptide DME1077 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 microM) DME1077 XEOTICID XEO02756 GENEFORM Protein DME1077 XEOTICID XEO02756 MOACRIVE Inhibition DME1077 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1077 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02757 XEO_CLAS Peptide DME1077 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1 microM) DME1077 XEOTICID XEO02757 GENEFORM Protein DME1077 XEOTICID XEO02757 MOACRIVE Inhibition DME1077 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1077 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02758 XEO_CLAS Peptide DME1077 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO02758 GENEFORM Protein DME1077 XEOTICID XEO02758 MOACRIVE Inhibition DME1077 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1077 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02759 XEO_CLAS Peptide DME1077 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.6 microM) DME1077 XEOTICID XEO02759 GENEFORM Protein DME1077 XEOTICID XEO02759 MOACRIVE Inhibition DME1077 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1077 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02760 XEO_CLAS Peptide DME1077 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 microM) DME1077 XEOTICID XEO02760 GENEFORM Protein DME1077 XEOTICID XEO02760 MOACRIVE Inhibition DME1077 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1077 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02761 XEO_CLAS Peptide DME1077 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO02761 GENEFORM Protein DME1077 XEOTICID XEO02761 MOACRIVE Inhibition DME1077 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1077 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02762 XEO_CLAS Peptide DME1077 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 microM) DME1077 XEOTICID XEO02762 GENEFORM Protein DME1077 XEOTICID XEO02762 MOACRIVE Inhibition DME1077 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1077 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02763 XEO_CLAS Peptide DME1077 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.4 microM) DME1077 XEOTICID XEO02763 GENEFORM Protein DME1077 XEOTICID XEO02763 MOACRIVE Inhibition DME1077 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1077 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02764 XEO_CLAS Peptide DME1077 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 microM) DME1077 XEOTICID XEO02764 GENEFORM Protein DME1077 XEOTICID XEO02764 MOACRIVE Inhibition DME1077 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1077 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02765 XEO_CLAS Peptide DME1077 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.3 microM) DME1077 XEOTICID XEO02765 GENEFORM Protein DME1077 XEOTICID XEO02765 MOACRIVE Inhibition DME1077 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1077 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02767 XEO_CLAS Peptide DME1077 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02767 GENEFORM Protein DME1077 XEOTICID XEO02767 MOACRIVE Inhibition DME1077 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1077 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02768 XEO_CLAS Peptide DME1077 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1077 XEOTICID XEO02768 GENEFORM Protein DME1077 XEOTICID XEO02768 MOACRIVE Inhibition DME1077 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1077 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02769 XEO_CLAS Peptide DME1077 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.32 microM) DME1077 XEOTICID XEO02769 GENEFORM Protein DME1077 XEOTICID XEO02769 MOACRIVE Inhibition DME1077 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1077 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02770 XEO_CLAS Peptide DME1077 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.30 microM) DME1077 XEOTICID XEO02770 GENEFORM Protein DME1077 XEOTICID XEO02770 MOACRIVE Inhibition DME1077 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1077 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02771 XEO_CLAS Peptide DME1077 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.21 microM) DME1077 XEOTICID XEO02771 GENEFORM Protein DME1077 XEOTICID XEO02771 MOACRIVE Inhibition DME1077 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1077 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02772 XEO_CLAS Peptide DME1077 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02772 GENEFORM Protein DME1077 XEOTICID XEO02772 MOACRIVE Inhibition DME1077 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1077 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02773 XEO_CLAS Peptide DME1077 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.9-8.6 microM) DME1077 XEOTICID XEO02773 GENEFORM Protein DME1077 XEOTICID XEO02773 MOACRIVE Inhibition DME1077 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1077 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02774 XEO_CLAS Peptide DME1077 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.3 microM) DME1077 XEOTICID XEO02774 GENEFORM Protein DME1077 XEOTICID XEO02774 MOACRIVE Inhibition DME1077 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1077 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02789 GENEFORM Protein DME1077 XEOTICID XEO02789 MOACRIVE Inhibition DME1077 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1077 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02790 GENEFORM Protein DME1077 XEOTICID XEO02790 MOACRIVE Inhibition DME1077 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1077 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02791 GENEFORM Protein DME1077 XEOTICID XEO02791 MOACRIVE Inhibition DME1077 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1077 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02792 GENEFORM Protein DME1077 XEOTICID XEO02792 MOACRIVE Inhibition DME1077 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1077 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02793 GENEFORM Protein DME1077 XEOTICID XEO02793 MOACRIVE Inhibition DME1077 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1077 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02794 GENEFORM Protein DME1077 XEOTICID XEO02794 MOACRIVE Inhibition DME1077 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1077 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02795 GENEFORM Protein DME1077 XEOTICID XEO02795 MOACRIVE Inhibition DME1077 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1077 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02796 GENEFORM Protein DME1077 XEOTICID XEO02796 MOACRIVE Inhibition DME1077 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1077 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02797 GENEFORM Protein DME1077 XEOTICID XEO02797 MOACRIVE Inhibition DME1077 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1077 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02799 XEO_CLAS Peptide DME1077 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02799 GENEFORM Protein DME1077 XEOTICID XEO02799 MOACRIVE Inhibition DME1077 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1077 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02800 XEO_CLAS Peptide DME1077 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02800 GENEFORM Protein DME1077 XEOTICID XEO02800 MOACRIVE Inhibition DME1077 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1077 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02802 XEO_CLAS Peptide DME1077 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 13.6 microM) DME1077 XEOTICID XEO02802 GENEFORM Protein DME1077 XEOTICID XEO02802 MOACRIVE Inhibition DME1077 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1077 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02807 XEO_CLAS Peptide DME1077 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.2 microM) DME1077 XEOTICID XEO02807 GENEFORM Protein DME1077 XEOTICID XEO02807 MOACRIVE Inhibition DME1077 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1077 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02813 XEO_CLAS Peptide DME1077 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 80 microM) DME1077 XEOTICID XEO02813 GENEFORM Protein DME1077 XEOTICID XEO02813 MOACRIVE Inhibition DME1077 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1077 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02814 XEO_CLAS Peptide DME1077 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 80 microM) DME1077 XEOTICID XEO02814 GENEFORM Protein DME1077 XEOTICID XEO02814 MOACRIVE Inhibition DME1077 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1077 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02815 XEO_CLAS Peptide DME1077 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8.5 microM) DME1077 XEOTICID XEO02815 GENEFORM Protein DME1077 XEOTICID XEO02815 MOACRIVE Inhibition DME1077 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1077 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02816 XEO_CLAS Peptide DME1077 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 80 microM) DME1077 XEOTICID XEO02816 GENEFORM Protein DME1077 XEOTICID XEO02816 MOACRIVE Inhibition DME1077 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1077 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02817 XEO_CLAS Peptide DME1077 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 80 microM) DME1077 XEOTICID XEO02817 GENEFORM Protein DME1077 XEOTICID XEO02817 MOACRIVE Inhibition DME1077 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1077 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02818 XEO_CLAS Peptide DME1077 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.4 microM) DME1077 XEOTICID XEO02818 GENEFORM Protein DME1077 XEOTICID XEO02818 MOACRIVE Inhibition DME1077 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1077 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02819 XEO_CLAS Peptide DME1077 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.6 microM) DME1077 XEOTICID XEO02819 GENEFORM Protein DME1077 XEOTICID XEO02819 MOACRIVE Inhibition DME1077 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1077 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02820 XEO_CLAS Peptide DME1077 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO02820 GENEFORM Protein DME1077 XEOTICID XEO02820 MOACRIVE Inhibition DME1077 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1077 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02821 XEO_CLAS Peptide DME1077 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02821 GENEFORM Protein DME1077 XEOTICID XEO02821 MOACRIVE Inhibition DME1077 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1077 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02824 XEO_CLAS Peptide DME1077 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 35 microM) DME1077 XEOTICID XEO02824 GENEFORM Protein DME1077 XEOTICID XEO02824 MOACRIVE Inhibition DME1077 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1077 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02826 XEO_CLAS Peptide DME1077 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.7 ug/ml) DME1077 XEOTICID XEO02826 GENEFORM Protein DME1077 XEOTICID XEO02826 MOACRIVE Inhibition DME1077 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1077 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02834 GENEFORM Protein DME1077 XEOTICID XEO02834 MOACRIVE Inhibition DME1077 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1077 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02839 XEO_CLAS Peptide DME1077 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.25 microM) DME1077 XEOTICID XEO02839 GENEFORM Protein DME1077 XEOTICID XEO02839 MOACRIVE Inhibition DME1077 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1077 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02841 XEO_CLAS Peptide DME1077 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.25 microM) DME1077 XEOTICID XEO02841 GENEFORM Protein DME1077 XEOTICID XEO02841 MOACRIVE Inhibition DME1077 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1077 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02842 XEO_CLAS Peptide DME1077 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.25 microM) DME1077 XEOTICID XEO02842 GENEFORM Protein DME1077 XEOTICID XEO02842 MOACRIVE Inhibition DME1077 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1077 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02843 XEO_CLAS Peptide DME1077 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02843 GENEFORM Protein DME1077 XEOTICID XEO02843 MOACRIVE Inhibition DME1077 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1077 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02849 GENEFORM Protein DME1077 XEOTICID XEO02849 MOACRIVE Inhibition DME1077 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1077 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02857 XEO_CLAS Peptide DME1077 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 53 microM) DME1077 XEOTICID XEO02857 GENEFORM Protein DME1077 XEOTICID XEO02857 MOACRIVE Inhibition DME1077 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1077 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02858 XEO_CLAS Peptide DME1077 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 53 microM) DME1077 XEOTICID XEO02858 GENEFORM Protein DME1077 XEOTICID XEO02858 MOACRIVE Inhibition DME1077 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1077 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02860 XEO_CLAS Peptide DME1077 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 ug/ml) DME1077 XEOTICID XEO02860 GENEFORM Protein DME1077 XEOTICID XEO02860 MOACRIVE Inhibition DME1077 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1077 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02867 XEO_CLAS Peptide DME1077 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02867 GENEFORM Protein DME1077 XEOTICID XEO02867 MOACRIVE Inhibition DME1077 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1077 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02868 XEO_CLAS Peptide DME1077 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02868 GENEFORM Protein DME1077 XEOTICID XEO02868 MOACRIVE Inhibition DME1077 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1077 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02869 XEO_CLAS Peptide DME1077 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02869 GENEFORM Protein DME1077 XEOTICID XEO02869 MOACRIVE Inhibition DME1077 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1077 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02870 XEO_CLAS Peptide DME1077 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02870 GENEFORM Protein DME1077 XEOTICID XEO02870 MOACRIVE Inhibition DME1077 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1077 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02871 XEO_CLAS Peptide DME1077 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02871 GENEFORM Protein DME1077 XEOTICID XEO02871 MOACRIVE Inhibition DME1077 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1077 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02872 XEO_CLAS Peptide DME1077 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 308 microM) DME1077 XEOTICID XEO02872 GENEFORM Protein DME1077 XEOTICID XEO02872 MOACRIVE Inhibition DME1077 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1077 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02875 XEO_CLAS Peptide DME1077 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.1 microM) DME1077 XEOTICID XEO02875 GENEFORM Protein DME1077 XEOTICID XEO02875 MOACRIVE Inhibition DME1077 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1077 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02876 XEO_CLAS Peptide DME1077 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO02876 GENEFORM Protein DME1077 XEOTICID XEO02876 MOACRIVE Inhibition DME1077 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1077 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02877 XEO_CLAS Peptide DME1077 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO02877 GENEFORM Protein DME1077 XEOTICID XEO02877 MOACRIVE Inhibition DME1077 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1077 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02878 XEO_CLAS Peptide DME1077 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.3 microM) DME1077 XEOTICID XEO02878 GENEFORM Protein DME1077 XEOTICID XEO02878 MOACRIVE Inhibition DME1077 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1077 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02885 XEO_CLAS Peptide DME1077 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02885 GENEFORM Protein DME1077 XEOTICID XEO02885 MOACRIVE Inhibition DME1077 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1077 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02886 XEO_CLAS Peptide DME1077 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02886 GENEFORM Protein DME1077 XEOTICID XEO02886 MOACRIVE Inhibition DME1077 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1077 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02887 XEO_CLAS Peptide DME1077 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1 ug/ml) DME1077 XEOTICID XEO02887 GENEFORM Protein DME1077 XEOTICID XEO02887 MOACRIVE Inhibition DME1077 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1077 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02888 XEO_CLAS Peptide DME1077 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 ug/ml) DME1077 XEOTICID XEO02888 GENEFORM Protein DME1077 XEOTICID XEO02888 MOACRIVE Inhibition DME1077 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1077 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02889 XEO_CLAS Peptide DME1077 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 ug/ml) DME1077 XEOTICID XEO02889 GENEFORM Protein DME1077 XEOTICID XEO02889 MOACRIVE Inhibition DME1077 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1077 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02890 XEO_CLAS Peptide DME1077 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02890 GENEFORM Protein DME1077 XEOTICID XEO02890 MOACRIVE Inhibition DME1077 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1077 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02891 XEO_CLAS Peptide DME1077 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02891 GENEFORM Protein DME1077 XEOTICID XEO02891 MOACRIVE Inhibition DME1077 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1077 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02895 XEO_CLAS Peptide DME1077 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO02895 GENEFORM Protein DME1077 XEOTICID XEO02895 MOACRIVE Inhibition DME1077 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1077 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02896 XEO_CLAS Peptide DME1077 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO02896 GENEFORM Protein DME1077 XEOTICID XEO02896 MOACRIVE Inhibition DME1077 XEOTICID XEO02899 XEO_NAME Coladonin DME1077 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1077 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1077 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02899 GENEFORM Protein DME1077 XEOTICID XEO02899 MOACRIVE Inhibition DME1077 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1077 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02900 XEO_CLAS Peptide DME1077 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02900 GENEFORM Protein DME1077 XEOTICID XEO02900 MOACRIVE Inhibition DME1077 XEOTICID XEO02901 XEO_NAME Colicin-V DME1077 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02901 XEO_CLAS Peptide DME1077 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02901 GENEFORM Protein DME1077 XEOTICID XEO02901 MOACRIVE Inhibition DME1077 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1077 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02904 GENEFORM Protein DME1077 XEOTICID XEO02904 MOACRIVE Inhibition DME1077 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1077 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02908 XEO_CLAS Peptide DME1077 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 50 microM) DME1077 XEOTICID XEO02908 GENEFORM Protein DME1077 XEOTICID XEO02908 MOACRIVE Inhibition DME1077 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1077 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02923 XEO_CLAS Peptide DME1077 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02923 GENEFORM Protein DME1077 XEOTICID XEO02923 MOACRIVE Inhibition DME1077 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1077 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02924 XEO_CLAS Peptide DME1077 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 32 microM) DME1077 XEOTICID XEO02924 GENEFORM Protein DME1077 XEOTICID XEO02924 MOACRIVE Inhibition DME1077 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1077 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1077 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02927 GENEFORM Protein DME1077 XEOTICID XEO02927 MOACRIVE Inhibition DME1077 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1077 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02931 XEO_CLAS Peptide DME1077 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 ug/ml) DME1077 XEOTICID XEO02931 GENEFORM Protein DME1077 XEOTICID XEO02931 MOACRIVE Inhibition DME1077 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1077 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02933 XEO_CLAS Peptide DME1077 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO02933 GENEFORM Protein DME1077 XEOTICID XEO02933 MOACRIVE Inhibition DME1077 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1077 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02934 XEO_CLAS Peptide DME1077 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02934 GENEFORM Protein DME1077 XEOTICID XEO02934 MOACRIVE Inhibition DME1077 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1077 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02935 XEO_CLAS Peptide DME1077 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02935 GENEFORM Protein DME1077 XEOTICID XEO02935 MOACRIVE Inhibition DME1077 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1077 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02936 XEO_CLAS Peptide DME1077 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO02936 GENEFORM Protein DME1077 XEOTICID XEO02936 MOACRIVE Inhibition DME1077 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1077 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02937 XEO_CLAS Peptide DME1077 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02937 GENEFORM Protein DME1077 XEOTICID XEO02937 MOACRIVE Inhibition DME1077 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1077 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02938 XEO_CLAS Peptide DME1077 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 32 ug/ml) DME1077 XEOTICID XEO02938 GENEFORM Protein DME1077 XEOTICID XEO02938 MOACRIVE Inhibition DME1077 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1077 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02939 XEO_CLAS Peptide DME1077 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 11 ug/ml) DME1077 XEOTICID XEO02939 GENEFORM Protein DME1077 XEOTICID XEO02939 MOACRIVE Inhibition DME1077 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1077 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02940 XEO_CLAS Peptide DME1077 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1 ug/ml) DME1077 XEOTICID XEO02940 GENEFORM Protein DME1077 XEOTICID XEO02940 MOACRIVE Inhibition DME1077 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1077 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02941 XEO_CLAS Peptide DME1077 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02941 GENEFORM Protein DME1077 XEOTICID XEO02941 MOACRIVE Inhibition DME1077 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1077 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02944 XEO_CLAS Peptide DME1077 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 microM) DME1077 XEOTICID XEO02944 GENEFORM Protein DME1077 XEOTICID XEO02944 MOACRIVE Inhibition DME1077 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1077 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02945 XEO_CLAS Peptide DME1077 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 microM) DME1077 XEOTICID XEO02945 GENEFORM Protein DME1077 XEOTICID XEO02945 MOACRIVE Inhibition DME1077 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1077 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02946 XEO_CLAS Peptide DME1077 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 microM) DME1077 XEOTICID XEO02946 GENEFORM Protein DME1077 XEOTICID XEO02946 MOACRIVE Inhibition DME1077 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1077 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02947 XEO_CLAS Peptide DME1077 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02947 GENEFORM Protein DME1077 XEOTICID XEO02947 MOACRIVE Inhibition DME1077 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1077 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02948 XEO_CLAS Peptide DME1077 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO02948 GENEFORM Protein DME1077 XEOTICID XEO02948 MOACRIVE Inhibition DME1077 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1077 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02949 XEO_CLAS Peptide DME1077 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO02949 GENEFORM Protein DME1077 XEOTICID XEO02949 MOACRIVE Inhibition DME1077 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1077 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02954 XEO_CLAS Peptide DME1077 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02954 GENEFORM Protein DME1077 XEOTICID XEO02954 MOACRIVE Inhibition DME1077 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1077 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02958 XEO_CLAS Peptide DME1077 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02958 GENEFORM Protein DME1077 XEOTICID XEO02958 MOACRIVE Inhibition DME1077 XEOTICID XEO02962 XEO_NAME Cryptonin DME1077 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02962 XEO_CLAS Peptide DME1077 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.12 ug/ml) DME1077 XEOTICID XEO02962 GENEFORM Protein DME1077 XEOTICID XEO02962 MOACRIVE Inhibition DME1077 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1077 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02965 XEO_CLAS Peptide DME1077 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 ug/ml) DME1077 XEOTICID XEO02965 GENEFORM Protein DME1077 XEOTICID XEO02965 MOACRIVE Inhibition DME1077 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1077 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02969 XEO_CLAS Peptide DME1077 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 microM) DME1077 XEOTICID XEO02969 GENEFORM Protein DME1077 XEOTICID XEO02969 MOACRIVE Inhibition DME1077 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1077 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02971 XEO_CLAS Peptide DME1077 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 microM) DME1077 XEOTICID XEO02971 GENEFORM Protein DME1077 XEOTICID XEO02971 MOACRIVE Inhibition DME1077 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1077 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO02972 XEO_CLAS Peptide DME1077 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.4 microM) DME1077 XEOTICID XEO02972 GENEFORM Protein DME1077 XEOTICID XEO02972 MOACRIVE Inhibition DME1077 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1077 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02990 GENEFORM Protein DME1077 XEOTICID XEO02990 MOACRIVE Inhibition DME1077 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1077 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02991 GENEFORM Protein DME1077 XEOTICID XEO02991 MOACRIVE Inhibition DME1077 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1077 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02992 GENEFORM Protein DME1077 XEOTICID XEO02992 MOACRIVE Inhibition DME1077 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1077 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02993 GENEFORM Protein DME1077 XEOTICID XEO02993 MOACRIVE Inhibition DME1077 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1077 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02994 GENEFORM Protein DME1077 XEOTICID XEO02994 MOACRIVE Inhibition DME1077 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1077 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02995 GENEFORM Protein DME1077 XEOTICID XEO02995 MOACRIVE Inhibition DME1077 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1077 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02996 GENEFORM Protein DME1077 XEOTICID XEO02996 MOACRIVE Inhibition DME1077 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1077 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02997 GENEFORM Protein DME1077 XEOTICID XEO02997 MOACRIVE Inhibition DME1077 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1077 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02998 GENEFORM Protein DME1077 XEOTICID XEO02998 MOACRIVE Inhibition DME1077 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1077 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1077 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO02999 GENEFORM Protein DME1077 XEOTICID XEO02999 MOACRIVE Inhibition DME1077 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1077 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03021 XEO_CLAS Peptide DME1077 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1077 XEOTICID XEO03021 GENEFORM Protein DME1077 XEOTICID XEO03021 MOACRIVE Inhibition DME1077 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1077 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03029 XEO_CLAS Peptide DME1077 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.005 microM) DME1077 XEOTICID XEO03029 GENEFORM Protein DME1077 XEOTICID XEO03029 MOACRIVE Inhibition DME1077 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1077 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03030 XEO_CLAS Peptide DME1077 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.005 microM) DME1077 XEOTICID XEO03030 GENEFORM Protein DME1077 XEOTICID XEO03030 MOACRIVE Inhibition DME1077 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1077 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03031 XEO_CLAS Peptide DME1077 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.3 microM) DME1077 XEOTICID XEO03031 GENEFORM Protein DME1077 XEOTICID XEO03031 MOACRIVE Inhibition DME1077 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1077 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03032 XEO_CLAS Peptide DME1077 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.01 microM) DME1077 XEOTICID XEO03032 GENEFORM Protein DME1077 XEOTICID XEO03032 MOACRIVE Inhibition DME1077 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1077 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03033 XEO_CLAS Peptide DME1077 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.173 microM) DME1077 XEOTICID XEO03033 GENEFORM Protein DME1077 XEOTICID XEO03033 MOACRIVE Inhibition DME1077 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1077 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03034 XEO_CLAS Peptide DME1077 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.518 microM) DME1077 XEOTICID XEO03034 GENEFORM Protein DME1077 XEOTICID XEO03034 MOACRIVE Inhibition DME1077 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1077 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03035 XEO_CLAS Peptide DME1077 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.114 microM) DME1077 XEOTICID XEO03035 GENEFORM Protein DME1077 XEOTICID XEO03035 MOACRIVE Inhibition DME1077 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1077 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03039 XEO_CLAS Peptide DME1077 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.55 microM) DME1077 XEOTICID XEO03039 GENEFORM Protein DME1077 XEOTICID XEO03039 MOACRIVE Inhibition DME1077 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1077 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03043 XEO_CLAS Peptide DME1077 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 microM) DME1077 XEOTICID XEO03043 GENEFORM Protein DME1077 XEOTICID XEO03043 MOACRIVE Inhibition DME1077 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1077 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03044 XEO_CLAS Peptide DME1077 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03044 GENEFORM Protein DME1077 XEOTICID XEO03044 MOACRIVE Inhibition DME1077 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1077 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03045 XEO_CLAS Peptide DME1077 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03045 GENEFORM Protein DME1077 XEOTICID XEO03045 MOACRIVE Inhibition DME1077 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1077 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03046 XEO_CLAS Peptide DME1077 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03046 GENEFORM Protein DME1077 XEOTICID XEO03046 MOACRIVE Inhibition DME1077 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1077 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03049 XEO_CLAS Peptide DME1077 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 microM) DME1077 XEOTICID XEO03049 GENEFORM Protein DME1077 XEOTICID XEO03049 MOACRIVE Inhibition DME1077 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1077 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03055 XEO_CLAS Peptide DME1077 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 microM) DME1077 XEOTICID XEO03055 GENEFORM Protein DME1077 XEOTICID XEO03055 MOACRIVE Inhibition DME1077 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1077 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03059 XEO_CLAS Peptide DME1077 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO03059 GENEFORM Protein DME1077 XEOTICID XEO03059 MOACRIVE Inhibition DME1077 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1077 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03060 XEO_CLAS Peptide DME1077 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO03060 GENEFORM Protein DME1077 XEOTICID XEO03060 MOACRIVE Inhibition DME1077 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1077 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03062 XEO_CLAS Peptide DME1077 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO03062 GENEFORM Protein DME1077 XEOTICID XEO03062 MOACRIVE Inhibition DME1077 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1077 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03064 XEO_CLAS Peptide DME1077 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO03064 GENEFORM Protein DME1077 XEOTICID XEO03064 MOACRIVE Inhibition DME1077 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1077 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03066 XEO_CLAS Peptide DME1077 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO03066 GENEFORM Protein DME1077 XEOTICID XEO03066 MOACRIVE Inhibition DME1077 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1077 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03068 XEO_CLAS Peptide DME1077 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO03068 GENEFORM Protein DME1077 XEOTICID XEO03068 MOACRIVE Inhibition DME1077 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1077 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03073 XEO_CLAS Peptide DME1077 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8-16 ug/ml) DME1077 XEOTICID XEO03073 GENEFORM Protein DME1077 XEOTICID XEO03073 MOACRIVE Inhibition DME1077 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1077 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03081 XEO_CLAS Peptide DME1077 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 microM) DME1077 XEOTICID XEO03081 GENEFORM Protein DME1077 XEOTICID XEO03081 MOACRIVE Inhibition DME1077 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1077 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03082 XEO_CLAS Peptide DME1077 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03082 GENEFORM Protein DME1077 XEOTICID XEO03082 MOACRIVE Inhibition DME1077 XEOTICID XEO03089 XEO_NAME Decoralin DME1077 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03089 XEO_CLAS Peptide DME1077 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 160 microM) DME1077 XEOTICID XEO03089 GENEFORM Protein DME1077 XEOTICID XEO03089 MOACRIVE Inhibition DME1077 XEOTICID XEO03098 XEO_NAME Insect defensin DME1077 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03098 XEO_CLAS Peptide DME1077 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 ug/ml) DME1077 XEOTICID XEO03098 GENEFORM Protein DME1077 XEOTICID XEO03098 MOACRIVE Inhibition DME1077 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1077 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03100 XEO_CLAS Peptide DME1077 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03100 GENEFORM Protein DME1077 XEOTICID XEO03100 MOACRIVE Inhibition DME1077 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1077 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03103 XEO_CLAS Peptide DME1077 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03103 GENEFORM Protein DME1077 XEOTICID XEO03103 MOACRIVE Inhibition DME1077 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1077 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03105 XEO_CLAS Peptide DME1077 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03105 GENEFORM Protein DME1077 XEOTICID XEO03105 MOACRIVE Inhibition DME1077 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1077 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03110 XEO_CLAS Peptide DME1077 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.2 microM) DME1077 XEOTICID XEO03110 GENEFORM Protein DME1077 XEOTICID XEO03110 MOACRIVE Inhibition DME1077 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1077 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03111 XEO_CLAS Peptide DME1077 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03111 GENEFORM Protein DME1077 XEOTICID XEO03111 MOACRIVE Inhibition DME1077 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1077 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03112 XEO_CLAS Peptide DME1077 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 50 ug/ml) DME1077 XEOTICID XEO03112 GENEFORM Protein DME1077 XEOTICID XEO03112 MOACRIVE Inhibition DME1077 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1077 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03115 XEO_CLAS Peptide DME1077 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03115 GENEFORM Protein DME1077 XEOTICID XEO03115 MOACRIVE Inhibition DME1077 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1077 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03116 XEO_CLAS Peptide DME1077 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 40 microM) DME1077 XEOTICID XEO03116 GENEFORM Protein DME1077 XEOTICID XEO03116 MOACRIVE Inhibition DME1077 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1077 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03118 XEO_CLAS Peptide DME1077 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03118 GENEFORM Protein DME1077 XEOTICID XEO03118 MOACRIVE Inhibition DME1077 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1077 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03119 XEO_CLAS Peptide DME1077 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03119 GENEFORM Protein DME1077 XEOTICID XEO03119 MOACRIVE Inhibition DME1077 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1077 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03121 XEO_CLAS Peptide DME1077 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03121 GENEFORM Protein DME1077 XEOTICID XEO03121 MOACRIVE Inhibition DME1077 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1077 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03122 XEO_CLAS Peptide DME1077 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64000 ug/ml) DME1077 XEOTICID XEO03122 GENEFORM Protein DME1077 XEOTICID XEO03122 MOACRIVE Inhibition DME1077 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1077 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03124 XEO_CLAS Peptide DME1077 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03124 GENEFORM Protein DME1077 XEOTICID XEO03124 MOACRIVE Inhibition DME1077 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1077 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03125 XEO_CLAS Peptide DME1077 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03125 GENEFORM Protein DME1077 XEOTICID XEO03125 MOACRIVE Inhibition DME1077 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1077 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03126 XEO_CLAS Peptide DME1077 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.86 microM) DME1077 XEOTICID XEO03126 GENEFORM Protein DME1077 XEOTICID XEO03126 MOACRIVE Inhibition DME1077 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1077 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03127 XEO_CLAS Peptide DME1077 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03127 GENEFORM Protein DME1077 XEOTICID XEO03127 MOACRIVE Inhibition DME1077 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1077 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03128 XEO_CLAS Peptide DME1077 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 256 ug/ml) DME1077 XEOTICID XEO03128 GENEFORM Protein DME1077 XEOTICID XEO03128 MOACRIVE Inhibition DME1077 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1077 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03129 XEO_CLAS Peptide DME1077 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 256 ug/ml) DME1077 XEOTICID XEO03129 GENEFORM Protein DME1077 XEOTICID XEO03129 MOACRIVE Inhibition DME1077 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1077 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03130 XEO_CLAS Peptide DME1077 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 256 ug/ml) DME1077 XEOTICID XEO03130 GENEFORM Protein DME1077 XEOTICID XEO03130 MOACRIVE Inhibition DME1077 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1077 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03131 XEO_CLAS Peptide DME1077 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 256 ug/ml) DME1077 XEOTICID XEO03131 GENEFORM Protein DME1077 XEOTICID XEO03131 MOACRIVE Inhibition DME1077 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1077 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03132 XEO_CLAS Peptide DME1077 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 256 ug/ml) DME1077 XEOTICID XEO03132 GENEFORM Protein DME1077 XEOTICID XEO03132 MOACRIVE Inhibition DME1077 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1077 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03137 XEO_CLAS Peptide DME1077 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03137 GENEFORM Protein DME1077 XEOTICID XEO03137 MOACRIVE Inhibition DME1077 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1077 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03143 XEO_CLAS Peptide DME1077 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.6 microM) DME1077 XEOTICID XEO03143 GENEFORM Protein DME1077 XEOTICID XEO03143 MOACRIVE Inhibition DME1077 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1077 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03145 XEO_CLAS Peptide DME1077 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.6 microM) DME1077 XEOTICID XEO03145 GENEFORM Protein DME1077 XEOTICID XEO03145 MOACRIVE Inhibition DME1077 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1077 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03146 XEO_CLAS Peptide DME1077 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.5 microM) DME1077 XEOTICID XEO03146 GENEFORM Protein DME1077 XEOTICID XEO03146 MOACRIVE Inhibition DME1077 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1077 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03147 XEO_CLAS Peptide DME1077 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9.7 microM) DME1077 XEOTICID XEO03147 GENEFORM Protein DME1077 XEOTICID XEO03147 MOACRIVE Inhibition DME1077 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1077 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03148 XEO_CLAS Peptide DME1077 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.3 microM) DME1077 XEOTICID XEO03148 GENEFORM Protein DME1077 XEOTICID XEO03148 MOACRIVE Inhibition DME1077 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1077 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03149 XEO_CLAS Peptide DME1077 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.6 microM) DME1077 XEOTICID XEO03149 GENEFORM Protein DME1077 XEOTICID XEO03149 MOACRIVE Inhibition DME1077 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1077 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03150 XEO_CLAS Peptide DME1077 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9-3 microM) DME1077 XEOTICID XEO03150 GENEFORM Protein DME1077 XEOTICID XEO03150 MOACRIVE Inhibition DME1077 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1077 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03151 XEO_CLAS Peptide DME1077 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 ug/ml) DME1077 XEOTICID XEO03151 GENEFORM Protein DME1077 XEOTICID XEO03151 MOACRIVE Inhibition DME1077 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1077 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03152 XEO_CLAS Peptide DME1077 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO03152 GENEFORM Protein DME1077 XEOTICID XEO03152 MOACRIVE Inhibition DME1077 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1077 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03155 XEO_CLAS Peptide DME1077 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.4 microM) DME1077 XEOTICID XEO03155 GENEFORM Protein DME1077 XEOTICID XEO03155 MOACRIVE Inhibition DME1077 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1077 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03156 XEO_CLAS Peptide DME1077 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.3 microM) DME1077 XEOTICID XEO03156 GENEFORM Protein DME1077 XEOTICID XEO03156 MOACRIVE Inhibition DME1077 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1077 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03157 XEO_CLAS Peptide DME1077 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.3 microM) DME1077 XEOTICID XEO03157 GENEFORM Protein DME1077 XEOTICID XEO03157 MOACRIVE Inhibition DME1077 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1077 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03158 XEO_CLAS Peptide DME1077 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 ug/ml) DME1077 XEOTICID XEO03158 GENEFORM Protein DME1077 XEOTICID XEO03158 MOACRIVE Inhibition DME1077 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1077 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03159 XEO_CLAS Peptide DME1077 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03159 GENEFORM Protein DME1077 XEOTICID XEO03159 MOACRIVE Inhibition DME1077 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1077 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03161 XEO_CLAS Peptide DME1077 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 microM) DME1077 XEOTICID XEO03161 GENEFORM Protein DME1077 XEOTICID XEO03161 MOACRIVE Inhibition DME1077 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1077 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03162 XEO_CLAS Peptide DME1077 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.5 microM) DME1077 XEOTICID XEO03162 GENEFORM Protein DME1077 XEOTICID XEO03162 MOACRIVE Inhibition DME1077 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1077 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03169 XEO_CLAS Peptide DME1077 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO03169 GENEFORM Protein DME1077 XEOTICID XEO03169 MOACRIVE Inhibition DME1077 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1077 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03193 XEO_CLAS Peptide DME1077 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25 ug/ml) DME1077 XEOTICID XEO03193 GENEFORM Protein DME1077 XEOTICID XEO03193 MOACRIVE Inhibition DME1077 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1077 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03194 XEO_CLAS Peptide DME1077 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03194 GENEFORM Protein DME1077 XEOTICID XEO03194 MOACRIVE Inhibition DME1077 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1077 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03195 XEO_CLAS Peptide DME1077 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03195 GENEFORM Protein DME1077 XEOTICID XEO03195 MOACRIVE Inhibition DME1077 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1077 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03197 XEO_CLAS Peptide DME1077 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 14.5 microM) DME1077 XEOTICID XEO03197 GENEFORM Protein DME1077 XEOTICID XEO03197 MOACRIVE Inhibition DME1077 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1077 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03202 XEO_CLAS Peptide DME1077 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.51 microM) DME1077 XEOTICID XEO03202 GENEFORM Protein DME1077 XEOTICID XEO03202 MOACRIVE Inhibition DME1077 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1077 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03203 XEO_CLAS Peptide DME1077 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.62 microM) DME1077 XEOTICID XEO03203 GENEFORM Protein DME1077 XEOTICID XEO03203 MOACRIVE Inhibition DME1077 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1077 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03204 XEO_CLAS Peptide DME1077 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.38 microM) DME1077 XEOTICID XEO03204 GENEFORM Protein DME1077 XEOTICID XEO03204 MOACRIVE Inhibition DME1077 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1077 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03205 XEO_CLAS Peptide DME1077 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.29 microM) DME1077 XEOTICID XEO03205 GENEFORM Protein DME1077 XEOTICID XEO03205 MOACRIVE Inhibition DME1077 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1077 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03206 XEO_CLAS Peptide DME1077 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.40 microM) DME1077 XEOTICID XEO03206 GENEFORM Protein DME1077 XEOTICID XEO03206 MOACRIVE Inhibition DME1077 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1077 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03207 XEO_CLAS Peptide DME1077 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.58 microM) DME1077 XEOTICID XEO03207 GENEFORM Protein DME1077 XEOTICID XEO03207 MOACRIVE Inhibition DME1077 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1077 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03208 XEO_CLAS Peptide DME1077 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.76 microM) DME1077 XEOTICID XEO03208 GENEFORM Protein DME1077 XEOTICID XEO03208 MOACRIVE Inhibition DME1077 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1077 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03209 XEO_CLAS Peptide DME1077 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.49 microM) DME1077 XEOTICID XEO03209 GENEFORM Protein DME1077 XEOTICID XEO03209 MOACRIVE Inhibition DME1077 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1077 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03210 XEO_CLAS Peptide DME1077 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7.07 microM) DME1077 XEOTICID XEO03210 GENEFORM Protein DME1077 XEOTICID XEO03210 MOACRIVE Inhibition DME1077 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1077 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03211 XEO_CLAS Peptide DME1077 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.40 microM) DME1077 XEOTICID XEO03211 GENEFORM Protein DME1077 XEOTICID XEO03211 MOACRIVE Inhibition DME1077 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1077 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03215 XEO_CLAS Peptide DME1077 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20.0 ug/ml) DME1077 XEOTICID XEO03215 GENEFORM Protein DME1077 XEOTICID XEO03215 MOACRIVE Inhibition DME1077 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1077 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03216 XEO_CLAS Peptide DME1077 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO03216 GENEFORM Protein DME1077 XEOTICID XEO03216 MOACRIVE Inhibition DME1077 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1077 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03217 XEO_CLAS Peptide DME1077 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO03217 GENEFORM Protein DME1077 XEOTICID XEO03217 MOACRIVE Inhibition DME1077 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1077 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03223 XEO_CLAS Peptide DME1077 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.8 microM) DME1077 XEOTICID XEO03223 GENEFORM Protein DME1077 XEOTICID XEO03223 MOACRIVE Inhibition DME1077 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1077 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03224 XEO_CLAS Peptide DME1077 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.1-0.25 microM) DME1077 XEOTICID XEO03224 GENEFORM Protein DME1077 XEOTICID XEO03224 MOACRIVE Inhibition DME1077 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1077 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03225 XEO_CLAS Peptide DME1077 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.3 microM) DME1077 XEOTICID XEO03225 GENEFORM Protein DME1077 XEOTICID XEO03225 MOACRIVE Inhibition DME1077 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1077 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03227 XEO_CLAS Peptide DME1077 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.3 microM) DME1077 XEOTICID XEO03227 GENEFORM Protein DME1077 XEOTICID XEO03227 MOACRIVE Inhibition DME1077 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1077 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03231 XEO_CLAS Peptide DME1077 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03231 GENEFORM Protein DME1077 XEOTICID XEO03231 MOACRIVE Inhibition DME1077 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1077 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03232 XEO_CLAS Peptide DME1077 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03232 GENEFORM Protein DME1077 XEOTICID XEO03232 MOACRIVE Inhibition DME1077 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1077 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03234 XEO_CLAS Peptide DME1077 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO03234 GENEFORM Protein DME1077 XEOTICID XEO03234 MOACRIVE Inhibition DME1077 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1077 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03235 XEO_CLAS Peptide DME1077 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 60 ug/ml) DME1077 XEOTICID XEO03235 GENEFORM Protein DME1077 XEOTICID XEO03235 MOACRIVE Inhibition DME1077 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1077 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03236 XEO_CLAS Peptide DME1077 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO03236 GENEFORM Protein DME1077 XEOTICID XEO03236 MOACRIVE Inhibition DME1077 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1077 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03237 XEO_CLAS Peptide DME1077 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 ug/ml) DME1077 XEOTICID XEO03237 GENEFORM Protein DME1077 XEOTICID XEO03237 MOACRIVE Inhibition DME1077 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1077 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03238 XEO_CLAS Peptide DME1077 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 ug/ml) DME1077 XEOTICID XEO03238 GENEFORM Protein DME1077 XEOTICID XEO03238 MOACRIVE Inhibition DME1077 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1077 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03239 XEO_CLAS Peptide DME1077 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 60 ug/ml) DME1077 XEOTICID XEO03239 GENEFORM Protein DME1077 XEOTICID XEO03239 MOACRIVE Inhibition DME1077 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1077 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03241 XEO_CLAS Peptide DME1077 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 128 microM) DME1077 XEOTICID XEO03241 GENEFORM Protein DME1077 XEOTICID XEO03241 MOACRIVE Inhibition DME1077 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1077 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03250 XEO_CLAS Peptide DME1077 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03250 GENEFORM Protein DME1077 XEOTICID XEO03250 MOACRIVE Inhibition DME1077 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1077 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03251 XEO_CLAS Peptide DME1077 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03251 GENEFORM Protein DME1077 XEOTICID XEO03251 MOACRIVE Inhibition DME1077 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1077 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03253 XEO_CLAS Peptide DME1077 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.1 ug/ml) DME1077 XEOTICID XEO03253 GENEFORM Protein DME1077 XEOTICID XEO03253 MOACRIVE Inhibition DME1077 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1077 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03274 XEO_CLAS Peptide DME1077 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.2 microM) DME1077 XEOTICID XEO03274 GENEFORM Protein DME1077 XEOTICID XEO03274 MOACRIVE Inhibition DME1077 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1077 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03275 XEO_CLAS Peptide DME1077 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO03275 GENEFORM Protein DME1077 XEOTICID XEO03275 MOACRIVE Inhibition DME1077 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1077 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03276 XEO_CLAS Peptide DME1077 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO03276 GENEFORM Protein DME1077 XEOTICID XEO03276 MOACRIVE Inhibition DME1077 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1077 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03277 XEO_CLAS Peptide DME1077 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.2 microM) DME1077 XEOTICID XEO03277 GENEFORM Protein DME1077 XEOTICID XEO03277 MOACRIVE Inhibition DME1077 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1077 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03278 XEO_CLAS Peptide DME1077 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO03278 GENEFORM Protein DME1077 XEOTICID XEO03278 MOACRIVE Inhibition DME1077 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1077 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03279 XEO_CLAS Peptide DME1077 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO03279 GENEFORM Protein DME1077 XEOTICID XEO03279 MOACRIVE Inhibition DME1077 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1077 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03280 XEO_CLAS Peptide DME1077 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 microM) DME1077 XEOTICID XEO03280 GENEFORM Protein DME1077 XEOTICID XEO03280 MOACRIVE Inhibition DME1077 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1077 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03281 XEO_CLAS Peptide DME1077 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.3 microM) DME1077 XEOTICID XEO03281 GENEFORM Protein DME1077 XEOTICID XEO03281 MOACRIVE Inhibition DME1077 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1077 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03282 XEO_CLAS Peptide DME1077 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.1 microM) DME1077 XEOTICID XEO03282 GENEFORM Protein DME1077 XEOTICID XEO03282 MOACRIVE Inhibition DME1077 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1077 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03283 XEO_CLAS Peptide DME1077 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 microM) DME1077 XEOTICID XEO03283 GENEFORM Protein DME1077 XEOTICID XEO03283 MOACRIVE Inhibition DME1077 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1077 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03284 XEO_CLAS Peptide DME1077 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.2 ug/ml) DME1077 XEOTICID XEO03284 GENEFORM Protein DME1077 XEOTICID XEO03284 MOACRIVE Inhibition DME1077 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1077 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03285 XEO_CLAS Peptide DME1077 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.5 ug/ml) DME1077 XEOTICID XEO03285 GENEFORM Protein DME1077 XEOTICID XEO03285 MOACRIVE Inhibition DME1077 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1077 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03286 XEO_CLAS Peptide DME1077 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.4 ug/ml) DME1077 XEOTICID XEO03286 GENEFORM Protein DME1077 XEOTICID XEO03286 MOACRIVE Inhibition DME1077 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1077 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03287 XEO_CLAS Peptide DME1077 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.6 ug/ml) DME1077 XEOTICID XEO03287 GENEFORM Protein DME1077 XEOTICID XEO03287 MOACRIVE Inhibition DME1077 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1077 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03288 XEO_CLAS Peptide DME1077 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.4 ug/ml) DME1077 XEOTICID XEO03288 GENEFORM Protein DME1077 XEOTICID XEO03288 MOACRIVE Inhibition DME1077 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1077 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03289 XEO_CLAS Peptide DME1077 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8.8 ug/ml) DME1077 XEOTICID XEO03289 GENEFORM Protein DME1077 XEOTICID XEO03289 MOACRIVE Inhibition DME1077 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1077 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03290 XEO_CLAS Peptide DME1077 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.5 ug/ml) DME1077 XEOTICID XEO03290 GENEFORM Protein DME1077 XEOTICID XEO03290 MOACRIVE Inhibition DME1077 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1077 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03291 XEO_CLAS Peptide DME1077 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8.6 ug/ml) DME1077 XEOTICID XEO03291 GENEFORM Protein DME1077 XEOTICID XEO03291 MOACRIVE Inhibition DME1077 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1077 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03292 XEO_CLAS Peptide DME1077 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4.1 ug/ml) DME1077 XEOTICID XEO03292 GENEFORM Protein DME1077 XEOTICID XEO03292 MOACRIVE Inhibition DME1077 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1077 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03293 XEO_CLAS Peptide DME1077 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1 microM) DME1077 XEOTICID XEO03293 GENEFORM Protein DME1077 XEOTICID XEO03293 MOACRIVE Inhibition DME1077 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1077 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03294 XEO_CLAS Peptide DME1077 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1 microM) DME1077 XEOTICID XEO03294 GENEFORM Protein DME1077 XEOTICID XEO03294 MOACRIVE Inhibition DME1077 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1077 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03295 XEO_CLAS Peptide DME1077 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.7 microM) DME1077 XEOTICID XEO03295 GENEFORM Protein DME1077 XEOTICID XEO03295 MOACRIVE Inhibition DME1077 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1077 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03296 XEO_CLAS Peptide DME1077 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03296 GENEFORM Protein DME1077 XEOTICID XEO03296 MOACRIVE Inhibition DME1077 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1077 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03297 XEO_CLAS Peptide DME1077 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03297 GENEFORM Protein DME1077 XEOTICID XEO03297 MOACRIVE Inhibition DME1077 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1077 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03298 XEO_CLAS Peptide DME1077 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.2 microM) DME1077 XEOTICID XEO03298 GENEFORM Protein DME1077 XEOTICID XEO03298 MOACRIVE Inhibition DME1077 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1077 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03299 XEO_CLAS Peptide DME1077 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.4 microM) DME1077 XEOTICID XEO03299 GENEFORM Protein DME1077 XEOTICID XEO03299 MOACRIVE Inhibition DME1077 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1077 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03300 XEO_CLAS Peptide DME1077 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 ug/ml) DME1077 XEOTICID XEO03300 GENEFORM Protein DME1077 XEOTICID XEO03300 MOACRIVE Inhibition DME1077 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1077 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03301 XEO_CLAS Peptide DME1077 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 ug/ml) DME1077 XEOTICID XEO03301 GENEFORM Protein DME1077 XEOTICID XEO03301 MOACRIVE Inhibition DME1077 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1077 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03302 XEO_CLAS Peptide DME1077 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1 microM) DME1077 XEOTICID XEO03302 GENEFORM Protein DME1077 XEOTICID XEO03302 MOACRIVE Inhibition DME1077 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1077 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03303 XEO_CLAS Peptide DME1077 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 microM) DME1077 XEOTICID XEO03303 GENEFORM Protein DME1077 XEOTICID XEO03303 MOACRIVE Inhibition DME1077 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1077 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03304 XEO_CLAS Peptide DME1077 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO03304 GENEFORM Protein DME1077 XEOTICID XEO03304 MOACRIVE Inhibition DME1077 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1077 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03305 XEO_CLAS Peptide DME1077 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 microM) DME1077 XEOTICID XEO03305 GENEFORM Protein DME1077 XEOTICID XEO03305 MOACRIVE Inhibition DME1077 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1077 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03306 XEO_CLAS Peptide DME1077 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO03306 GENEFORM Protein DME1077 XEOTICID XEO03306 MOACRIVE Inhibition DME1077 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1077 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03307 XEO_CLAS Peptide DME1077 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 34 ug/ml) DME1077 XEOTICID XEO03307 GENEFORM Protein DME1077 XEOTICID XEO03307 MOACRIVE Inhibition DME1077 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1077 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03308 XEO_CLAS Peptide DME1077 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO03308 GENEFORM Protein DME1077 XEOTICID XEO03308 MOACRIVE Inhibition DME1077 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1077 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03310 XEO_CLAS Peptide DME1077 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8.5 ug/ml) DME1077 XEOTICID XEO03310 GENEFORM Protein DME1077 XEOTICID XEO03310 MOACRIVE Inhibition DME1077 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1077 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03311 XEO_CLAS Peptide DME1077 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10.8 ug/ml) DME1077 XEOTICID XEO03311 GENEFORM Protein DME1077 XEOTICID XEO03311 MOACRIVE Inhibition DME1077 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1077 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03312 XEO_CLAS Peptide DME1077 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10.8 ug/ml) DME1077 XEOTICID XEO03312 GENEFORM Protein DME1077 XEOTICID XEO03312 MOACRIVE Inhibition DME1077 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1077 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03313 XEO_CLAS Peptide DME1077 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8.1 ug/ml) DME1077 XEOTICID XEO03313 GENEFORM Protein DME1077 XEOTICID XEO03313 MOACRIVE Inhibition DME1077 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1077 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03314 XEO_CLAS Peptide DME1077 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7.9 ug/ml) DME1077 XEOTICID XEO03314 GENEFORM Protein DME1077 XEOTICID XEO03314 MOACRIVE Inhibition DME1077 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1077 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03315 XEO_CLAS Peptide DME1077 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.6 ug/ml) DME1077 XEOTICID XEO03315 GENEFORM Protein DME1077 XEOTICID XEO03315 MOACRIVE Inhibition DME1077 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1077 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03316 XEO_CLAS Peptide DME1077 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15.8 ug/ml) DME1077 XEOTICID XEO03316 GENEFORM Protein DME1077 XEOTICID XEO03316 MOACRIVE Inhibition DME1077 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1077 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03317 XEO_CLAS Peptide DME1077 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO03317 GENEFORM Protein DME1077 XEOTICID XEO03317 MOACRIVE Inhibition DME1077 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1077 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03318 XEO_CLAS Peptide DME1077 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1 microM) DME1077 XEOTICID XEO03318 GENEFORM Protein DME1077 XEOTICID XEO03318 MOACRIVE Inhibition DME1077 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1077 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03319 XEO_CLAS Peptide DME1077 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03319 GENEFORM Protein DME1077 XEOTICID XEO03319 MOACRIVE Inhibition DME1077 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1077 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03320 XEO_CLAS Peptide DME1077 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.1 microM) DME1077 XEOTICID XEO03320 GENEFORM Protein DME1077 XEOTICID XEO03320 MOACRIVE Inhibition DME1077 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1077 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03321 XEO_CLAS Peptide DME1077 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.8 microM) DME1077 XEOTICID XEO03321 GENEFORM Protein DME1077 XEOTICID XEO03321 MOACRIVE Inhibition DME1077 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1077 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1077 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03348 GENEFORM Protein DME1077 XEOTICID XEO03348 MOACRIVE Inhibition DME1077 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1077 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03362 XEO_CLAS Peptide DME1077 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO03362 GENEFORM Protein DME1077 XEOTICID XEO03362 MOACRIVE Inhibition DME1077 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1077 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03363 XEO_CLAS Peptide DME1077 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 microM) DME1077 XEOTICID XEO03363 GENEFORM Protein DME1077 XEOTICID XEO03363 MOACRIVE Inhibition DME1077 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1077 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03364 XEO_CLAS Peptide DME1077 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 microM) DME1077 XEOTICID XEO03364 GENEFORM Protein DME1077 XEOTICID XEO03364 MOACRIVE Inhibition DME1077 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1077 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03365 XEO_CLAS Peptide DME1077 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03365 GENEFORM Protein DME1077 XEOTICID XEO03365 MOACRIVE Inhibition DME1077 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1077 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03366 XEO_CLAS Peptide DME1077 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO03366 GENEFORM Protein DME1077 XEOTICID XEO03366 MOACRIVE Inhibition DME1077 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1077 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03367 XEO_CLAS Peptide DME1077 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 microM) DME1077 XEOTICID XEO03367 GENEFORM Protein DME1077 XEOTICID XEO03367 MOACRIVE Inhibition DME1077 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1077 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03368 XEO_CLAS Peptide DME1077 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 microM) DME1077 XEOTICID XEO03368 GENEFORM Protein DME1077 XEOTICID XEO03368 MOACRIVE Inhibition DME1077 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1077 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03379 XEO_CLAS Peptide DME1077 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.6 ug/ml) DME1077 XEOTICID XEO03379 GENEFORM Protein DME1077 XEOTICID XEO03379 MOACRIVE Inhibition DME1077 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1077 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03396 XEO_CLAS Peptide DME1077 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03396 GENEFORM Protein DME1077 XEOTICID XEO03396 MOACRIVE Inhibition DME1077 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1077 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03398 XEO_CLAS Peptide DME1077 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03398 GENEFORM Protein DME1077 XEOTICID XEO03398 MOACRIVE Inhibition DME1077 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1077 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03399 XEO_CLAS Peptide DME1077 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03399 GENEFORM Protein DME1077 XEOTICID XEO03399 MOACRIVE Inhibition DME1077 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1077 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03406 XEO_CLAS Peptide DME1077 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 ug/ml) DME1077 XEOTICID XEO03406 GENEFORM Protein DME1077 XEOTICID XEO03406 MOACRIVE Inhibition DME1077 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1077 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03424 XEO_CLAS Peptide DME1077 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03424 GENEFORM Protein DME1077 XEOTICID XEO03424 MOACRIVE Inhibition DME1077 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1077 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03426 XEO_CLAS Peptide DME1077 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO03426 GENEFORM Protein DME1077 XEOTICID XEO03426 MOACRIVE Inhibition DME1077 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1077 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03427 XEO_CLAS Peptide DME1077 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 microM) DME1077 XEOTICID XEO03427 GENEFORM Protein DME1077 XEOTICID XEO03427 MOACRIVE Inhibition DME1077 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1077 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03428 XEO_CLAS Peptide DME1077 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 ug/ml) DME1077 XEOTICID XEO03428 GENEFORM Protein DME1077 XEOTICID XEO03428 MOACRIVE Inhibition DME1077 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1077 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03430 XEO_CLAS Peptide DME1077 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 ug/ml) DME1077 XEOTICID XEO03430 GENEFORM Protein DME1077 XEOTICID XEO03430 MOACRIVE Inhibition DME1077 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1077 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03434 XEO_CLAS Peptide DME1077 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO03434 GENEFORM Protein DME1077 XEOTICID XEO03434 MOACRIVE Inhibition DME1077 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1077 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03442 XEO_CLAS Peptide DME1077 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 18.75 ug/ml) DME1077 XEOTICID XEO03442 GENEFORM Protein DME1077 XEOTICID XEO03442 MOACRIVE Inhibition DME1077 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1077 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03444 XEO_CLAS Peptide DME1077 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 37.50 ug/ml) DME1077 XEOTICID XEO03444 GENEFORM Protein DME1077 XEOTICID XEO03444 MOACRIVE Inhibition DME1077 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1077 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03459 XEO_CLAS Peptide DME1077 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03459 GENEFORM Protein DME1077 XEOTICID XEO03459 MOACRIVE Inhibition DME1077 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1077 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03460 XEO_CLAS Peptide DME1077 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03460 GENEFORM Protein DME1077 XEOTICID XEO03460 MOACRIVE Inhibition DME1077 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1077 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03461 XEO_CLAS Peptide DME1077 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.05 microM) DME1077 XEOTICID XEO03461 GENEFORM Protein DME1077 XEOTICID XEO03461 MOACRIVE Inhibition DME1077 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1077 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03462 XEO_CLAS Peptide DME1077 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03462 GENEFORM Protein DME1077 XEOTICID XEO03462 MOACRIVE Inhibition DME1077 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1077 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03463 XEO_CLAS Peptide DME1077 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03463 GENEFORM Protein DME1077 XEOTICID XEO03463 MOACRIVE Inhibition DME1077 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1077 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03467 XEO_CLAS Peptide DME1077 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03467 GENEFORM Protein DME1077 XEOTICID XEO03467 MOACRIVE Inhibition DME1077 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1077 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03468 XEO_CLAS Peptide DME1077 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03468 GENEFORM Protein DME1077 XEOTICID XEO03468 MOACRIVE Inhibition DME1077 XEOTICID XEO03471 XEO_NAME Gambicin DME1077 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03471 XEO_CLAS Peptide DME1077 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1077 XEOTICID XEO03471 GENEFORM Protein DME1077 XEOTICID XEO03471 MOACRIVE Inhibition DME1077 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1077 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03485 XEO_CLAS Peptide DME1077 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4.07 ug/ml) DME1077 XEOTICID XEO03485 GENEFORM Protein DME1077 XEOTICID XEO03485 MOACRIVE Inhibition DME1077 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1077 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03486 XEO_CLAS Peptide DME1077 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.80 ug/ml) DME1077 XEOTICID XEO03486 GENEFORM Protein DME1077 XEOTICID XEO03486 MOACRIVE Inhibition DME1077 XEOTICID XEO03488 XEO_NAME GLK-19 DME1077 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03488 XEO_CLAS Peptide DME1077 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO03488 GENEFORM Protein DME1077 XEOTICID XEO03488 MOACRIVE Inhibition DME1077 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1077 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03497 XEO_CLAS Peptide DME1077 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1077 XEOTICID XEO03497 GENEFORM Protein DME1077 XEOTICID XEO03497 MOACRIVE Inhibition DME1077 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1077 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03498 XEO_CLAS Peptide DME1077 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1077 XEOTICID XEO03498 GENEFORM Protein DME1077 XEOTICID XEO03498 MOACRIVE Inhibition DME1077 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1077 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03500 XEO_CLAS Peptide DME1077 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-30 ug/ml) DME1077 XEOTICID XEO03500 GENEFORM Protein DME1077 XEOTICID XEO03500 MOACRIVE Inhibition DME1077 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1077 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03504 XEO_CLAS Peptide DME1077 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 ug/ml) DME1077 XEOTICID XEO03504 GENEFORM Protein DME1077 XEOTICID XEO03504 MOACRIVE Inhibition DME1077 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1077 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03505 XEO_CLAS Peptide DME1077 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 ug/ml) DME1077 XEOTICID XEO03505 GENEFORM Protein DME1077 XEOTICID XEO03505 MOACRIVE Inhibition DME1077 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1077 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03506 XEO_CLAS Peptide DME1077 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 ug/ml) DME1077 XEOTICID XEO03506 GENEFORM Protein DME1077 XEOTICID XEO03506 MOACRIVE Inhibition DME1077 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1077 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03513 XEO_CLAS Peptide DME1077 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO03513 GENEFORM Protein DME1077 XEOTICID XEO03513 MOACRIVE Inhibition DME1077 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1077 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03514 XEO_CLAS Peptide DME1077 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03514 GENEFORM Protein DME1077 XEOTICID XEO03514 MOACRIVE Inhibition DME1077 XEOTICID XEO03519 XEO_NAME Hadrurin DME1077 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03519 XEO_CLAS Peptide DME1077 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03519 GENEFORM Protein DME1077 XEOTICID XEO03519 MOACRIVE Inhibition DME1077 XEOTICID XEO03522 XEO_NAME Halocyntin DME1077 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03522 XEO_CLAS Peptide DME1077 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03522 GENEFORM Protein DME1077 XEOTICID XEO03522 MOACRIVE Inhibition DME1077 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1077 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03524 XEO_CLAS Peptide DME1077 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03524 GENEFORM Protein DME1077 XEOTICID XEO03524 MOACRIVE Inhibition DME1077 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1077 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03525 XEO_CLAS Peptide DME1077 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03525 GENEFORM Protein DME1077 XEOTICID XEO03525 MOACRIVE Inhibition DME1077 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1077 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03530 XEO_CLAS Peptide DME1077 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03530 GENEFORM Protein DME1077 XEOTICID XEO03530 MOACRIVE Inhibition DME1077 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1077 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03535 XEO_CLAS Peptide DME1077 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.4 microM) DME1077 XEOTICID XEO03535 GENEFORM Protein DME1077 XEOTICID XEO03535 MOACRIVE Inhibition DME1077 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1077 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03536 XEO_CLAS Peptide DME1077 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 80 microM) DME1077 XEOTICID XEO03536 GENEFORM Protein DME1077 XEOTICID XEO03536 MOACRIVE Inhibition DME1077 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1077 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03537 XEO_CLAS Peptide DME1077 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 ug/ml) DME1077 XEOTICID XEO03537 GENEFORM Protein DME1077 XEOTICID XEO03537 MOACRIVE Inhibition DME1077 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1077 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03538 XEO_CLAS Peptide DME1077 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 ug/ml) DME1077 XEOTICID XEO03538 GENEFORM Protein DME1077 XEOTICID XEO03538 MOACRIVE Inhibition DME1077 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1077 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03540 XEO_CLAS Peptide DME1077 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO03540 GENEFORM Protein DME1077 XEOTICID XEO03540 MOACRIVE Inhibition DME1077 XEOTICID XEO03542 XEO_NAME Hepcidin DME1077 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03542 XEO_CLAS Peptide DME1077 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 24 microM) DME1077 XEOTICID XEO03542 GENEFORM Protein DME1077 XEOTICID XEO03542 MOACRIVE Inhibition DME1077 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1077 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03544 XEO_CLAS Peptide DME1077 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03544 GENEFORM Protein DME1077 XEOTICID XEO03544 MOACRIVE Inhibition DME1077 XEOTICID XEO03548 XEO_NAME Hesperidin DME1077 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03548 GENEFORM Protein DME1077 XEOTICID XEO03548 MOACRIVE Inhibition DME1077 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1077 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1077 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03552 GENEFORM Protein DME1077 XEOTICID XEO03552 MOACRIVE Inhibition DME1077 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1077 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03556 XEO_CLAS Peptide DME1077 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO03556 GENEFORM Protein DME1077 XEOTICID XEO03556 MOACRIVE Inhibition DME1077 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1077 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03557 XEO_CLAS Peptide DME1077 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO03557 GENEFORM Protein DME1077 XEOTICID XEO03557 MOACRIVE Inhibition DME1077 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1077 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03558 XEO_CLAS Peptide DME1077 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 microM) DME1077 XEOTICID XEO03558 GENEFORM Protein DME1077 XEOTICID XEO03558 MOACRIVE Inhibition DME1077 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1077 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03559 XEO_CLAS Peptide DME1077 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 microM) DME1077 XEOTICID XEO03559 GENEFORM Protein DME1077 XEOTICID XEO03559 MOACRIVE Inhibition DME1077 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1077 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03560 XEO_CLAS Peptide DME1077 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 microM) DME1077 XEOTICID XEO03560 GENEFORM Protein DME1077 XEOTICID XEO03560 MOACRIVE Inhibition DME1077 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1077 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03561 XEO_CLAS Peptide DME1077 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03561 GENEFORM Protein DME1077 XEOTICID XEO03561 MOACRIVE Inhibition DME1077 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1077 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03567 XEO_CLAS Peptide DME1077 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03567 GENEFORM Protein DME1077 XEOTICID XEO03567 MOACRIVE Inhibition DME1077 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1077 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03569 XEO_CLAS Peptide DME1077 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 300 microM) DME1077 XEOTICID XEO03569 GENEFORM Protein DME1077 XEOTICID XEO03569 MOACRIVE Inhibition DME1077 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1077 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03570 XEO_CLAS Peptide DME1077 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03570 GENEFORM Protein DME1077 XEOTICID XEO03570 MOACRIVE Inhibition DME1077 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1077 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03572 XEO_CLAS Peptide DME1077 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1077 XEOTICID XEO03572 GENEFORM Protein DME1077 XEOTICID XEO03572 MOACRIVE Inhibition DME1077 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1077 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03573 XEO_CLAS Peptide DME1077 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 28.1 ug/ml) DME1077 XEOTICID XEO03573 GENEFORM Protein DME1077 XEOTICID XEO03573 MOACRIVE Inhibition DME1077 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1077 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03574 XEO_CLAS Peptide DME1077 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 500 microM) DME1077 XEOTICID XEO03574 GENEFORM Protein DME1077 XEOTICID XEO03574 MOACRIVE Inhibition DME1077 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1077 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03575 XEO_CLAS Peptide DME1077 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 18 microM) DME1077 XEOTICID XEO03575 GENEFORM Protein DME1077 XEOTICID XEO03575 MOACRIVE Inhibition DME1077 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1077 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03576 XEO_CLAS Peptide DME1077 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 750 microM) DME1077 XEOTICID XEO03576 GENEFORM Protein DME1077 XEOTICID XEO03576 MOACRIVE Inhibition DME1077 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1077 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03578 XEO_CLAS Peptide DME1077 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1077 XEOTICID XEO03578 GENEFORM Protein DME1077 XEOTICID XEO03578 MOACRIVE Inhibition DME1077 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1077 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03579 XEO_CLAS Peptide DME1077 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03579 GENEFORM Protein DME1077 XEOTICID XEO03579 MOACRIVE Inhibition DME1077 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1077 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03580 XEO_CLAS Peptide DME1077 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03580 GENEFORM Protein DME1077 XEOTICID XEO03580 MOACRIVE Inhibition DME1077 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1077 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03585 XEO_CLAS Peptide DME1077 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 125 ug/ml) DME1077 XEOTICID XEO03585 GENEFORM Protein DME1077 XEOTICID XEO03585 MOACRIVE Inhibition DME1077 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1077 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03588 XEO_CLAS Peptide DME1077 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 62 ug/ml) DME1077 XEOTICID XEO03588 GENEFORM Protein DME1077 XEOTICID XEO03588 MOACRIVE Inhibition DME1077 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1077 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03589 XEO_CLAS Peptide DME1077 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03589 GENEFORM Protein DME1077 XEOTICID XEO03589 MOACRIVE Inhibition DME1077 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1077 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03590 XEO_CLAS Peptide DME1077 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03590 GENEFORM Protein DME1077 XEOTICID XEO03590 MOACRIVE Inhibition DME1077 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1077 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03591 XEO_CLAS Peptide DME1077 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 37.5 ug/ml) DME1077 XEOTICID XEO03591 GENEFORM Protein DME1077 XEOTICID XEO03591 MOACRIVE Inhibition DME1077 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1077 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03593 XEO_CLAS Peptide DME1077 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9.4 ug/ml) DME1077 XEOTICID XEO03593 GENEFORM Protein DME1077 XEOTICID XEO03593 MOACRIVE Inhibition DME1077 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1077 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03594 XEO_CLAS Peptide DME1077 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 ug/ml) DME1077 XEOTICID XEO03594 GENEFORM Protein DME1077 XEOTICID XEO03594 MOACRIVE Inhibition DME1077 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1077 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03595 XEO_CLAS Peptide DME1077 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03595 GENEFORM Protein DME1077 XEOTICID XEO03595 MOACRIVE Inhibition DME1077 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1077 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03596 XEO_CLAS Peptide DME1077 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03596 GENEFORM Protein DME1077 XEOTICID XEO03596 MOACRIVE Inhibition DME1077 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1077 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03598 XEO_CLAS Peptide DME1077 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03598 GENEFORM Protein DME1077 XEOTICID XEO03598 MOACRIVE Inhibition DME1077 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1077 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03599 XEO_CLAS Peptide DME1077 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03599 GENEFORM Protein DME1077 XEOTICID XEO03599 MOACRIVE Inhibition DME1077 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1077 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03600 XEO_CLAS Peptide DME1077 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03600 GENEFORM Protein DME1077 XEOTICID XEO03600 MOACRIVE Inhibition DME1077 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1077 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03606 XEO_CLAS Peptide DME1077 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03606 GENEFORM Protein DME1077 XEOTICID XEO03606 MOACRIVE Inhibition DME1077 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1077 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03607 XEO_CLAS Peptide DME1077 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03607 GENEFORM Protein DME1077 XEOTICID XEO03607 MOACRIVE Inhibition DME1077 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1077 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03609 XEO_CLAS Peptide DME1077 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03609 GENEFORM Protein DME1077 XEOTICID XEO03609 MOACRIVE Inhibition DME1077 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1077 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03615 XEO_CLAS Peptide DME1077 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1077 XEOTICID XEO03615 GENEFORM Protein DME1077 XEOTICID XEO03615 MOACRIVE Inhibition DME1077 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1077 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03616 XEO_CLAS Peptide DME1077 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 32 microM) DME1077 XEOTICID XEO03616 GENEFORM Protein DME1077 XEOTICID XEO03616 MOACRIVE Inhibition DME1077 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1077 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03617 XEO_CLAS Peptide DME1077 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40 microM) DME1077 XEOTICID XEO03617 GENEFORM Protein DME1077 XEOTICID XEO03617 MOACRIVE Inhibition DME1077 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1077 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03618 XEO_CLAS Peptide DME1077 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5-1 microM) DME1077 XEOTICID XEO03618 GENEFORM Protein DME1077 XEOTICID XEO03618 MOACRIVE Inhibition DME1077 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1077 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03622 XEO_CLAS Peptide DME1077 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20-40 microM) DME1077 XEOTICID XEO03622 GENEFORM Protein DME1077 XEOTICID XEO03622 MOACRIVE Inhibition DME1077 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1077 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03627 XEO_CLAS Peptide DME1077 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1077 XEOTICID XEO03627 GENEFORM Protein DME1077 XEOTICID XEO03627 MOACRIVE Inhibition DME1077 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1077 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03630 XEO_CLAS Peptide DME1077 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03630 GENEFORM Protein DME1077 XEOTICID XEO03630 MOACRIVE Inhibition DME1077 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1077 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03631 XEO_CLAS Peptide DME1077 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03631 GENEFORM Protein DME1077 XEOTICID XEO03631 MOACRIVE Inhibition DME1077 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1077 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03632 XEO_CLAS Peptide DME1077 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03632 GENEFORM Protein DME1077 XEOTICID XEO03632 MOACRIVE Inhibition DME1077 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1077 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03633 XEO_CLAS Peptide DME1077 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03633 GENEFORM Protein DME1077 XEOTICID XEO03633 MOACRIVE Inhibition DME1077 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1077 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03634 XEO_CLAS Peptide DME1077 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03634 GENEFORM Protein DME1077 XEOTICID XEO03634 MOACRIVE Inhibition DME1077 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1077 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03635 XEO_CLAS Peptide DME1077 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03635 GENEFORM Protein DME1077 XEOTICID XEO03635 MOACRIVE Inhibition DME1077 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1077 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03636 XEO_CLAS Peptide DME1077 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03636 GENEFORM Protein DME1077 XEOTICID XEO03636 MOACRIVE Inhibition DME1077 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1077 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03637 XEO_CLAS Peptide DME1077 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03637 GENEFORM Protein DME1077 XEOTICID XEO03637 MOACRIVE Inhibition DME1077 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1077 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03638 XEO_CLAS Peptide DME1077 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03638 GENEFORM Protein DME1077 XEOTICID XEO03638 MOACRIVE Inhibition DME1077 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1077 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03639 XEO_CLAS Peptide DME1077 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03639 GENEFORM Protein DME1077 XEOTICID XEO03639 MOACRIVE Inhibition DME1077 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1077 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03640 XEO_CLAS Peptide DME1077 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03640 GENEFORM Protein DME1077 XEOTICID XEO03640 MOACRIVE Inhibition DME1077 XEOTICID XEO03644 XEO_NAME Indole DME1077 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1077 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1077 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03644 GENEFORM Protein DME1077 XEOTICID XEO03644 MOACRIVE Inhibition DME1077 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1077 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03650 XEO_CLAS Peptide DME1077 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03650 GENEFORM Protein DME1077 XEOTICID XEO03650 MOACRIVE Inhibition DME1077 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1077 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO03655 XEO_CLAS Natural Product DME1077 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03655 GENEFORM Protein DME1077 XEOTICID XEO03655 MOACRIVE Inhibition DME1077 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1077 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03666 XEO_CLAS Peptide DME1077 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 ug/ml) DME1077 XEOTICID XEO03666 GENEFORM Protein DME1077 XEOTICID XEO03666 MOACRIVE Inhibition DME1077 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1077 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03667 XEO_CLAS Peptide DME1077 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 ug/ml) DME1077 XEOTICID XEO03667 GENEFORM Protein DME1077 XEOTICID XEO03667 MOACRIVE Inhibition DME1077 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1077 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03668 XEO_CLAS Peptide DME1077 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 microM) DME1077 XEOTICID XEO03668 GENEFORM Protein DME1077 XEOTICID XEO03668 MOACRIVE Inhibition DME1077 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1077 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03669 XEO_CLAS Peptide DME1077 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO03669 GENEFORM Protein DME1077 XEOTICID XEO03669 MOACRIVE Inhibition DME1077 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1077 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03670 XEO_CLAS Peptide DME1077 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 microM) DME1077 XEOTICID XEO03670 GENEFORM Protein DME1077 XEOTICID XEO03670 MOACRIVE Inhibition DME1077 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1077 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03672 XEO_CLAS Peptide DME1077 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.5 ug/ml) DME1077 XEOTICID XEO03672 GENEFORM Protein DME1077 XEOTICID XEO03672 MOACRIVE Inhibition DME1077 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1077 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03673 XEO_CLAS Peptide DME1077 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 ug/ml) DME1077 XEOTICID XEO03673 GENEFORM Protein DME1077 XEOTICID XEO03673 MOACRIVE Inhibition DME1077 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1077 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03674 XEO_CLAS Peptide DME1077 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 ug/ml) DME1077 XEOTICID XEO03674 GENEFORM Protein DME1077 XEOTICID XEO03674 MOACRIVE Inhibition DME1077 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1077 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03675 XEO_CLAS Peptide DME1077 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO03675 GENEFORM Protein DME1077 XEOTICID XEO03675 MOACRIVE Inhibition DME1077 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1077 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03678 XEO_CLAS Peptide DME1077 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 ug/ml) DME1077 XEOTICID XEO03678 GENEFORM Protein DME1077 XEOTICID XEO03678 MOACRIVE Inhibition DME1077 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1077 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03679 XEO_CLAS Peptide DME1077 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 ug/ml) DME1077 XEOTICID XEO03679 GENEFORM Protein DME1077 XEOTICID XEO03679 MOACRIVE Inhibition DME1077 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1077 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03681 XEO_CLAS Peptide DME1077 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1077 XEOTICID XEO03681 GENEFORM Protein DME1077 XEOTICID XEO03681 MOACRIVE Inhibition DME1077 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1077 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03684 XEO_CLAS Peptide DME1077 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 ug/ml) DME1077 XEOTICID XEO03684 GENEFORM Protein DME1077 XEOTICID XEO03684 MOACRIVE Inhibition DME1077 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1077 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03694 XEO_CLAS Peptide DME1077 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03694 GENEFORM Protein DME1077 XEOTICID XEO03694 MOACRIVE Inhibition DME1077 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1077 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03697 XEO_CLAS Peptide DME1077 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25 microM) DME1077 XEOTICID XEO03697 GENEFORM Protein DME1077 XEOTICID XEO03697 MOACRIVE Inhibition DME1077 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1077 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03698 XEO_CLAS Peptide DME1077 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03698 GENEFORM Protein DME1077 XEOTICID XEO03698 MOACRIVE Inhibition DME1077 XEOTICID XEO03703 XEO_NAME Kasstasin DME1077 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03703 XEO_CLAS Peptide DME1077 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 110 microM) DME1077 XEOTICID XEO03703 GENEFORM Protein DME1077 XEOTICID XEO03703 MOACRIVE Inhibition DME1077 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1077 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03706 XEO_CLAS Peptide DME1077 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03706 GENEFORM Protein DME1077 XEOTICID XEO03706 MOACRIVE Inhibition DME1077 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1077 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03707 XEO_CLAS Peptide DME1077 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03707 GENEFORM Protein DME1077 XEOTICID XEO03707 MOACRIVE Inhibition DME1077 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1077 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03709 XEO_CLAS Peptide DME1077 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 ug/ml) DME1077 XEOTICID XEO03709 GENEFORM Protein DME1077 XEOTICID XEO03709 MOACRIVE Inhibition DME1077 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1077 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03712 XEO_CLAS Peptide DME1077 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03712 GENEFORM Protein DME1077 XEOTICID XEO03712 MOACRIVE Inhibition DME1077 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1077 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03713 XEO_CLAS Peptide DME1077 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 64 microM) DME1077 XEOTICID XEO03713 GENEFORM Protein DME1077 XEOTICID XEO03713 MOACRIVE Inhibition DME1077 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1077 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03714 XEO_CLAS Peptide DME1077 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03714 GENEFORM Protein DME1077 XEOTICID XEO03714 MOACRIVE Inhibition DME1077 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1077 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03715 XEO_CLAS Peptide DME1077 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 microM) DME1077 XEOTICID XEO03715 GENEFORM Protein DME1077 XEOTICID XEO03715 MOACRIVE Inhibition DME1077 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1077 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03719 XEO_CLAS Peptide DME1077 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 microM) DME1077 XEOTICID XEO03719 GENEFORM Protein DME1077 XEOTICID XEO03719 MOACRIVE Inhibition DME1077 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1077 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03720 XEO_CLAS Peptide DME1077 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 microM) DME1077 XEOTICID XEO03720 GENEFORM Protein DME1077 XEOTICID XEO03720 MOACRIVE Inhibition DME1077 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1077 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03723 XEO_CLAS Peptide DME1077 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 62.36 microM) DME1077 XEOTICID XEO03723 GENEFORM Protein DME1077 XEOTICID XEO03723 MOACRIVE Inhibition DME1077 XEOTICID XEO03724 XEO_NAME L10 peptide DME1077 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03724 XEO_CLAS Peptide DME1077 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.8 microM) DME1077 XEOTICID XEO03724 GENEFORM Protein DME1077 XEOTICID XEO03724 MOACRIVE Inhibition DME1077 XEOTICID XEO03726 XEO_NAME L2 peptide DME1077 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03726 XEO_CLAS Peptide DME1077 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 129.66 microM) DME1077 XEOTICID XEO03726 GENEFORM Protein DME1077 XEOTICID XEO03726 MOACRIVE Inhibition DME1077 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1077 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03727 XEO_CLAS Peptide DME1077 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 80 ug/ml) DME1077 XEOTICID XEO03727 GENEFORM Protein DME1077 XEOTICID XEO03727 MOACRIVE Inhibition DME1077 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1077 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03728 XEO_CLAS Peptide DME1077 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40 ug/ml) DME1077 XEOTICID XEO03728 GENEFORM Protein DME1077 XEOTICID XEO03728 MOACRIVE Inhibition DME1077 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1077 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03729 XEO_CLAS Peptide DME1077 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 80 ug/ml) DME1077 XEOTICID XEO03729 GENEFORM Protein DME1077 XEOTICID XEO03729 MOACRIVE Inhibition DME1077 XEOTICID XEO03730 XEO_NAME L3 peptide DME1077 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03730 XEO_CLAS Peptide DME1077 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64.11 microM) DME1077 XEOTICID XEO03730 GENEFORM Protein DME1077 XEOTICID XEO03730 MOACRIVE Inhibition DME1077 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1077 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03731 XEO_CLAS Peptide DME1077 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40 ug/ml) DME1077 XEOTICID XEO03731 GENEFORM Protein DME1077 XEOTICID XEO03731 MOACRIVE Inhibition DME1077 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1077 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03733 XEO_CLAS Peptide DME1077 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40 ug/ml) DME1077 XEOTICID XEO03733 GENEFORM Protein DME1077 XEOTICID XEO03733 MOACRIVE Inhibition DME1077 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1077 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03734 XEO_CLAS Peptide DME1077 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO03734 GENEFORM Protein DME1077 XEOTICID XEO03734 MOACRIVE Inhibition DME1077 XEOTICID XEO03735 XEO_NAME L4 peptide DME1077 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03735 XEO_CLAS Peptide DME1077 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 31.61 microM) DME1077 XEOTICID XEO03735 GENEFORM Protein DME1077 XEOTICID XEO03735 MOACRIVE Inhibition DME1077 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1077 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03738 XEO_CLAS Peptide DME1077 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 ug/ml) DME1077 XEOTICID XEO03738 GENEFORM Protein DME1077 XEOTICID XEO03738 MOACRIVE Inhibition DME1077 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1077 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03741 XEO_CLAS Peptide DME1077 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40 ug/ml) DME1077 XEOTICID XEO03741 GENEFORM Protein DME1077 XEOTICID XEO03741 MOACRIVE Inhibition DME1077 XEOTICID XEO03742 XEO_NAME L5 peptide DME1077 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03742 XEO_CLAS Peptide DME1077 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7.79 microM) DME1077 XEOTICID XEO03742 GENEFORM Protein DME1077 XEOTICID XEO03742 MOACRIVE Inhibition DME1077 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1077 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03743 XEO_CLAS Peptide DME1077 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 ug/ml) DME1077 XEOTICID XEO03743 GENEFORM Protein DME1077 XEOTICID XEO03743 MOACRIVE Inhibition DME1077 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1077 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03744 XEO_CLAS Peptide DME1077 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 ug/ml) DME1077 XEOTICID XEO03744 GENEFORM Protein DME1077 XEOTICID XEO03744 MOACRIVE Inhibition DME1077 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1077 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03745 XEO_CLAS Peptide DME1077 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 ug/ml) DME1077 XEOTICID XEO03745 GENEFORM Protein DME1077 XEOTICID XEO03745 MOACRIVE Inhibition DME1077 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1077 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03746 XEO_CLAS Peptide DME1077 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO03746 GENEFORM Protein DME1077 XEOTICID XEO03746 MOACRIVE Inhibition DME1077 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1077 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03747 XEO_CLAS Peptide DME1077 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO03747 GENEFORM Protein DME1077 XEOTICID XEO03747 MOACRIVE Inhibition DME1077 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1077 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03748 XEO_CLAS Peptide DME1077 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO03748 GENEFORM Protein DME1077 XEOTICID XEO03748 MOACRIVE Inhibition DME1077 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1077 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03749 XEO_CLAS Peptide DME1077 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO03749 GENEFORM Protein DME1077 XEOTICID XEO03749 MOACRIVE Inhibition DME1077 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1077 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03750 XEO_CLAS Peptide DME1077 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO03750 GENEFORM Protein DME1077 XEOTICID XEO03750 MOACRIVE Inhibition DME1077 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1077 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03751 XEO_CLAS Peptide DME1077 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO03751 GENEFORM Protein DME1077 XEOTICID XEO03751 MOACRIVE Inhibition DME1077 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1077 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03752 XEO_CLAS Peptide DME1077 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO03752 GENEFORM Protein DME1077 XEOTICID XEO03752 MOACRIVE Inhibition DME1077 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1077 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03753 XEO_CLAS Peptide DME1077 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 ug/ml) DME1077 XEOTICID XEO03753 GENEFORM Protein DME1077 XEOTICID XEO03753 MOACRIVE Inhibition DME1077 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1077 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03754 XEO_CLAS Peptide DME1077 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO03754 GENEFORM Protein DME1077 XEOTICID XEO03754 MOACRIVE Inhibition DME1077 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1077 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03755 XEO_CLAS Peptide DME1077 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO03755 GENEFORM Protein DME1077 XEOTICID XEO03755 MOACRIVE Inhibition DME1077 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1077 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03756 XEO_CLAS Peptide DME1077 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO03756 GENEFORM Protein DME1077 XEOTICID XEO03756 MOACRIVE Inhibition DME1077 XEOTICID XEO03757 XEO_NAME L6 peptide DME1077 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03757 XEO_CLAS Peptide DME1077 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15.17 microM) DME1077 XEOTICID XEO03757 GENEFORM Protein DME1077 XEOTICID XEO03757 MOACRIVE Inhibition DME1077 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1077 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03758 XEO_CLAS Peptide DME1077 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 80 ug/ml) DME1077 XEOTICID XEO03758 GENEFORM Protein DME1077 XEOTICID XEO03758 MOACRIVE Inhibition DME1077 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1077 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03759 XEO_CLAS Peptide DME1077 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.3 ug/ml) DME1077 XEOTICID XEO03759 GENEFORM Protein DME1077 XEOTICID XEO03759 MOACRIVE Inhibition DME1077 XEOTICID XEO03760 XEO_NAME L7 peptide DME1077 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03760 XEO_CLAS Peptide DME1077 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16.02 microM) DME1077 XEOTICID XEO03760 GENEFORM Protein DME1077 XEOTICID XEO03760 MOACRIVE Inhibition DME1077 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1077 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03761 XEO_CLAS Peptide DME1077 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 ug/ml) DME1077 XEOTICID XEO03761 GENEFORM Protein DME1077 XEOTICID XEO03761 MOACRIVE Inhibition DME1077 XEOTICID XEO03763 XEO_NAME L8 peptide DME1077 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03763 XEO_CLAS Peptide DME1077 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.71 microM) DME1077 XEOTICID XEO03763 GENEFORM Protein DME1077 XEOTICID XEO03763 MOACRIVE Inhibition DME1077 XEOTICID XEO03765 XEO_NAME L9 peptide DME1077 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03765 XEO_CLAS Peptide DME1077 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.78 microM) DME1077 XEOTICID XEO03765 GENEFORM Protein DME1077 XEOTICID XEO03765 MOACRIVE Inhibition DME1077 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1077 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03775 XEO_CLAS Peptide DME1077 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 17.3 microM) DME1077 XEOTICID XEO03775 GENEFORM Protein DME1077 XEOTICID XEO03775 MOACRIVE Inhibition DME1077 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1077 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03776 XEO_CLAS Peptide DME1077 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03776 GENEFORM Protein DME1077 XEOTICID XEO03776 MOACRIVE Inhibition DME1077 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1077 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03781 XEO_CLAS Peptide DME1077 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.47 microM) DME1077 XEOTICID XEO03781 GENEFORM Protein DME1077 XEOTICID XEO03781 MOACRIVE Inhibition DME1077 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1077 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03782 XEO_CLAS Peptide DME1077 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.47 microM) DME1077 XEOTICID XEO03782 GENEFORM Protein DME1077 XEOTICID XEO03782 MOACRIVE Inhibition DME1077 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1077 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03783 XEO_CLAS Peptide DME1077 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.68 microM) DME1077 XEOTICID XEO03783 GENEFORM Protein DME1077 XEOTICID XEO03783 MOACRIVE Inhibition DME1077 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1077 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03784 XEO_CLAS Peptide DME1077 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.45 microM) DME1077 XEOTICID XEO03784 GENEFORM Protein DME1077 XEOTICID XEO03784 MOACRIVE Inhibition DME1077 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1077 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03785 XEO_CLAS Peptide DME1077 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.73 microM) DME1077 XEOTICID XEO03785 GENEFORM Protein DME1077 XEOTICID XEO03785 MOACRIVE Inhibition DME1077 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1077 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03786 XEO_CLAS Peptide DME1077 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.45 microM) DME1077 XEOTICID XEO03786 GENEFORM Protein DME1077 XEOTICID XEO03786 MOACRIVE Inhibition DME1077 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1077 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03787 XEO_CLAS Peptide DME1077 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.38 microM) DME1077 XEOTICID XEO03787 GENEFORM Protein DME1077 XEOTICID XEO03787 MOACRIVE Inhibition DME1077 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1077 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03788 XEO_CLAS Peptide DME1077 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.46 microM) DME1077 XEOTICID XEO03788 GENEFORM Protein DME1077 XEOTICID XEO03788 MOACRIVE Inhibition DME1077 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1077 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03789 XEO_CLAS Peptide DME1077 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 13.05 microM) DME1077 XEOTICID XEO03789 GENEFORM Protein DME1077 XEOTICID XEO03789 MOACRIVE Inhibition DME1077 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1077 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03790 XEO_CLAS Peptide DME1077 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.82 microM) DME1077 XEOTICID XEO03790 GENEFORM Protein DME1077 XEOTICID XEO03790 MOACRIVE Inhibition DME1077 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1077 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03791 XEO_CLAS Peptide DME1077 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.80 microM) DME1077 XEOTICID XEO03791 GENEFORM Protein DME1077 XEOTICID XEO03791 MOACRIVE Inhibition DME1077 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1077 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03792 XEO_CLAS Peptide DME1077 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.26 microM) DME1077 XEOTICID XEO03792 GENEFORM Protein DME1077 XEOTICID XEO03792 MOACRIVE Inhibition DME1077 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1077 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03793 XEO_CLAS Peptide DME1077 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 microM) DME1077 XEOTICID XEO03793 GENEFORM Protein DME1077 XEOTICID XEO03793 MOACRIVE Inhibition DME1077 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1077 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03797 XEO_CLAS Peptide DME1077 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.4 microM) DME1077 XEOTICID XEO03797 GENEFORM Protein DME1077 XEOTICID XEO03797 MOACRIVE Inhibition DME1077 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1077 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03798 XEO_CLAS Peptide DME1077 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03798 GENEFORM Protein DME1077 XEOTICID XEO03798 MOACRIVE Inhibition DME1077 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1077 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03799 XEO_CLAS Peptide DME1077 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03799 GENEFORM Protein DME1077 XEOTICID XEO03799 MOACRIVE Inhibition DME1077 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1077 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03810 XEO_CLAS Peptide DME1077 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03810 GENEFORM Protein DME1077 XEOTICID XEO03810 MOACRIVE Inhibition DME1077 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1077 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03846 XEO_CLAS Peptide DME1077 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03846 GENEFORM Protein DME1077 XEOTICID XEO03846 MOACRIVE Inhibition DME1077 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1077 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03847 XEO_CLAS Peptide DME1077 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03847 GENEFORM Protein DME1077 XEOTICID XEO03847 MOACRIVE Inhibition DME1077 XEOTICID XEO03850 XEO_NAME Lemon DME1077 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1077 XEOTICID XEO03850 XEO_CLAS Food Additive DME1077 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03850 GENEFORM Protein DME1077 XEOTICID XEO03850 MOACRIVE Inhibition DME1077 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1077 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03853 XEO_CLAS Peptide DME1077 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO03853 GENEFORM Protein DME1077 XEOTICID XEO03853 MOACRIVE Inhibition DME1077 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1077 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03857 XEO_CLAS Peptide DME1077 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 38.49 microM) DME1077 XEOTICID XEO03857 GENEFORM Protein DME1077 XEOTICID XEO03857 MOACRIVE Inhibition DME1077 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1077 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03860 XEO_CLAS Peptide DME1077 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 24 microM) DME1077 XEOTICID XEO03860 GENEFORM Protein DME1077 XEOTICID XEO03860 MOACRIVE Inhibition DME1077 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1077 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03861 XEO_CLAS Peptide DME1077 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 35 microM) DME1077 XEOTICID XEO03861 GENEFORM Protein DME1077 XEOTICID XEO03861 MOACRIVE Inhibition DME1077 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1077 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03862 XEO_CLAS Peptide DME1077 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 70 microM) DME1077 XEOTICID XEO03862 GENEFORM Protein DME1077 XEOTICID XEO03862 MOACRIVE Inhibition DME1077 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1077 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03863 XEO_CLAS Peptide DME1077 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 35 microM) DME1077 XEOTICID XEO03863 GENEFORM Protein DME1077 XEOTICID XEO03863 MOACRIVE Inhibition DME1077 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1077 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03864 XEO_CLAS Peptide DME1077 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO03864 GENEFORM Protein DME1077 XEOTICID XEO03864 MOACRIVE Inhibition DME1077 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1077 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03865 XEO_CLAS Peptide DME1077 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO03865 GENEFORM Protein DME1077 XEOTICID XEO03865 MOACRIVE Inhibition DME1077 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1077 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03866 XEO_CLAS Peptide DME1077 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 microM) DME1077 XEOTICID XEO03866 GENEFORM Protein DME1077 XEOTICID XEO03866 MOACRIVE Inhibition DME1077 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1077 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03867 XEO_CLAS Peptide DME1077 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40 microM) DME1077 XEOTICID XEO03867 GENEFORM Protein DME1077 XEOTICID XEO03867 MOACRIVE Inhibition DME1077 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1077 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03868 XEO_CLAS Peptide DME1077 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 51 microM) DME1077 XEOTICID XEO03868 GENEFORM Protein DME1077 XEOTICID XEO03868 MOACRIVE Inhibition DME1077 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1077 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03869 XEO_CLAS Peptide DME1077 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 35 microM) DME1077 XEOTICID XEO03869 GENEFORM Protein DME1077 XEOTICID XEO03869 MOACRIVE Inhibition DME1077 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1077 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03870 XEO_CLAS Peptide DME1077 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 61 microM) DME1077 XEOTICID XEO03870 GENEFORM Protein DME1077 XEOTICID XEO03870 MOACRIVE Inhibition DME1077 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1077 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03871 XEO_CLAS Peptide DME1077 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 microM) DME1077 XEOTICID XEO03871 GENEFORM Protein DME1077 XEOTICID XEO03871 MOACRIVE Inhibition DME1077 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1077 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03872 XEO_CLAS Peptide DME1077 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 28 microM) DME1077 XEOTICID XEO03872 GENEFORM Protein DME1077 XEOTICID XEO03872 MOACRIVE Inhibition DME1077 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1077 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03873 XEO_CLAS Peptide DME1077 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 22.5 microM) DME1077 XEOTICID XEO03873 GENEFORM Protein DME1077 XEOTICID XEO03873 MOACRIVE Inhibition DME1077 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1077 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03874 XEO_CLAS Peptide DME1077 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7.50 microM) DME1077 XEOTICID XEO03874 GENEFORM Protein DME1077 XEOTICID XEO03874 MOACRIVE Inhibition DME1077 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1077 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03875 XEO_CLAS Peptide DME1077 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 microM) DME1077 XEOTICID XEO03875 GENEFORM Protein DME1077 XEOTICID XEO03875 MOACRIVE Inhibition DME1077 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1077 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03876 XEO_CLAS Peptide DME1077 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.75 microM) DME1077 XEOTICID XEO03876 GENEFORM Protein DME1077 XEOTICID XEO03876 MOACRIVE Inhibition DME1077 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1077 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03877 XEO_CLAS Peptide DME1077 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.63 microM) DME1077 XEOTICID XEO03877 GENEFORM Protein DME1077 XEOTICID XEO03877 MOACRIVE Inhibition DME1077 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1077 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03878 XEO_CLAS Peptide DME1077 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.63 microM) DME1077 XEOTICID XEO03878 GENEFORM Protein DME1077 XEOTICID XEO03878 MOACRIVE Inhibition DME1077 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1077 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03879 XEO_CLAS Peptide DME1077 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 252 microM) DME1077 XEOTICID XEO03879 GENEFORM Protein DME1077 XEOTICID XEO03879 MOACRIVE Inhibition DME1077 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1077 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03880 XEO_CLAS Peptide DME1077 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 174 microM) DME1077 XEOTICID XEO03880 GENEFORM Protein DME1077 XEOTICID XEO03880 MOACRIVE Inhibition DME1077 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1077 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03883 XEO_CLAS Peptide DME1077 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 74 microM) DME1077 XEOTICID XEO03883 GENEFORM Protein DME1077 XEOTICID XEO03883 MOACRIVE Inhibition DME1077 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1077 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03884 XEO_CLAS Peptide DME1077 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 31 microM) DME1077 XEOTICID XEO03884 GENEFORM Protein DME1077 XEOTICID XEO03884 MOACRIVE Inhibition DME1077 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1077 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03885 XEO_CLAS Peptide DME1077 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO03885 GENEFORM Protein DME1077 XEOTICID XEO03885 MOACRIVE Inhibition DME1077 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1077 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03886 XEO_CLAS Peptide DME1077 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 391 microM) DME1077 XEOTICID XEO03886 GENEFORM Protein DME1077 XEOTICID XEO03886 MOACRIVE Inhibition DME1077 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1077 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03887 XEO_CLAS Peptide DME1077 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 151 microM) DME1077 XEOTICID XEO03887 GENEFORM Protein DME1077 XEOTICID XEO03887 MOACRIVE Inhibition DME1077 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1077 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03888 XEO_CLAS Peptide DME1077 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 134 microM) DME1077 XEOTICID XEO03888 GENEFORM Protein DME1077 XEOTICID XEO03888 MOACRIVE Inhibition DME1077 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1077 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03889 XEO_CLAS Peptide DME1077 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 88 microM) DME1077 XEOTICID XEO03889 GENEFORM Protein DME1077 XEOTICID XEO03889 MOACRIVE Inhibition DME1077 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1077 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03890 XEO_CLAS Peptide DME1077 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 31 microM) DME1077 XEOTICID XEO03890 GENEFORM Protein DME1077 XEOTICID XEO03890 MOACRIVE Inhibition DME1077 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1077 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03891 XEO_CLAS Peptide DME1077 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 microM) DME1077 XEOTICID XEO03891 GENEFORM Protein DME1077 XEOTICID XEO03891 MOACRIVE Inhibition DME1077 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1077 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03892 XEO_CLAS Peptide DME1077 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 37 microM) DME1077 XEOTICID XEO03892 GENEFORM Protein DME1077 XEOTICID XEO03892 MOACRIVE Inhibition DME1077 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1077 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03893 XEO_CLAS Peptide DME1077 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 19 microM) DME1077 XEOTICID XEO03893 GENEFORM Protein DME1077 XEOTICID XEO03893 MOACRIVE Inhibition DME1077 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1077 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03894 XEO_CLAS Peptide DME1077 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO03894 GENEFORM Protein DME1077 XEOTICID XEO03894 MOACRIVE Inhibition DME1077 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1077 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03895 XEO_CLAS Peptide DME1077 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO03895 GENEFORM Protein DME1077 XEOTICID XEO03895 MOACRIVE Inhibition DME1077 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1077 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03896 XEO_CLAS Peptide DME1077 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 microM) DME1077 XEOTICID XEO03896 GENEFORM Protein DME1077 XEOTICID XEO03896 MOACRIVE Inhibition DME1077 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1077 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03897 XEO_CLAS Peptide DME1077 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 63 microM) DME1077 XEOTICID XEO03897 GENEFORM Protein DME1077 XEOTICID XEO03897 MOACRIVE Inhibition DME1077 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1077 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03898 XEO_CLAS Peptide DME1077 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 219 microM) DME1077 XEOTICID XEO03898 GENEFORM Protein DME1077 XEOTICID XEO03898 MOACRIVE Inhibition DME1077 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1077 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03901 XEO_CLAS Peptide DME1077 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 35 microM) DME1077 XEOTICID XEO03901 GENEFORM Protein DME1077 XEOTICID XEO03901 MOACRIVE Inhibition DME1077 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1077 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03902 XEO_CLAS Peptide DME1077 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 70 microM) DME1077 XEOTICID XEO03902 GENEFORM Protein DME1077 XEOTICID XEO03902 MOACRIVE Inhibition DME1077 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1077 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03904 XEO_CLAS Peptide DME1077 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO03904 GENEFORM Protein DME1077 XEOTICID XEO03904 MOACRIVE Inhibition DME1077 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1077 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03905 XEO_CLAS Peptide DME1077 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO03905 GENEFORM Protein DME1077 XEOTICID XEO03905 MOACRIVE Inhibition DME1077 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1077 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03908 XEO_CLAS Peptide DME1077 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03908 GENEFORM Protein DME1077 XEOTICID XEO03908 MOACRIVE Inhibition DME1077 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1077 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03915 XEO_CLAS Peptide DME1077 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03915 GENEFORM Protein DME1077 XEOTICID XEO03915 MOACRIVE Inhibition DME1077 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1077 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03916 XEO_CLAS Peptide DME1077 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.8 ug/ml) DME1077 XEOTICID XEO03916 GENEFORM Protein DME1077 XEOTICID XEO03916 MOACRIVE Inhibition DME1077 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1077 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03917 XEO_CLAS Peptide DME1077 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 13.1 ug/ml) DME1077 XEOTICID XEO03917 GENEFORM Protein DME1077 XEOTICID XEO03917 MOACRIVE Inhibition DME1077 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1077 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03918 XEO_CLAS Peptide DME1077 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.5 ug/ml) DME1077 XEOTICID XEO03918 GENEFORM Protein DME1077 XEOTICID XEO03918 MOACRIVE Inhibition DME1077 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1077 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03919 XEO_CLAS Peptide DME1077 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 80 ug/ml) DME1077 XEOTICID XEO03919 GENEFORM Protein DME1077 XEOTICID XEO03919 MOACRIVE Inhibition DME1077 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1077 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03922 XEO_CLAS Peptide DME1077 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9 microM) DME1077 XEOTICID XEO03922 GENEFORM Protein DME1077 XEOTICID XEO03922 MOACRIVE Inhibition DME1077 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1077 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03923 XEO_CLAS Peptide DME1077 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9 microM) DME1077 XEOTICID XEO03923 GENEFORM Protein DME1077 XEOTICID XEO03923 MOACRIVE Inhibition DME1077 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1077 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03924 XEO_CLAS Peptide DME1077 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO03924 GENEFORM Protein DME1077 XEOTICID XEO03924 MOACRIVE Inhibition DME1077 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1077 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03927 XEO_CLAS Peptide DME1077 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 80 microM) DME1077 XEOTICID XEO03927 GENEFORM Protein DME1077 XEOTICID XEO03927 MOACRIVE Inhibition DME1077 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1077 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03928 XEO_CLAS Peptide DME1077 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 microM) DME1077 XEOTICID XEO03928 GENEFORM Protein DME1077 XEOTICID XEO03928 MOACRIVE Inhibition DME1077 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1077 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03929 XEO_CLAS Peptide DME1077 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 microM) DME1077 XEOTICID XEO03929 GENEFORM Protein DME1077 XEOTICID XEO03929 MOACRIVE Inhibition DME1077 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1077 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03930 XEO_CLAS Peptide DME1077 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 microM) DME1077 XEOTICID XEO03930 GENEFORM Protein DME1077 XEOTICID XEO03930 MOACRIVE Inhibition DME1077 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1077 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03931 XEO_CLAS Peptide DME1077 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 microM) DME1077 XEOTICID XEO03931 GENEFORM Protein DME1077 XEOTICID XEO03931 MOACRIVE Inhibition DME1077 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1077 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03933 XEO_CLAS Peptide DME1077 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.5 microM) DME1077 XEOTICID XEO03933 GENEFORM Protein DME1077 XEOTICID XEO03933 MOACRIVE Inhibition DME1077 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1077 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03934 XEO_CLAS Peptide DME1077 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.7 microM) DME1077 XEOTICID XEO03934 GENEFORM Protein DME1077 XEOTICID XEO03934 MOACRIVE Inhibition DME1077 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1077 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03935 XEO_CLAS Peptide DME1077 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.7 microM) DME1077 XEOTICID XEO03935 GENEFORM Protein DME1077 XEOTICID XEO03935 MOACRIVE Inhibition DME1077 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1077 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03936 XEO_CLAS Peptide DME1077 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.0 microM) DME1077 XEOTICID XEO03936 GENEFORM Protein DME1077 XEOTICID XEO03936 MOACRIVE Inhibition DME1077 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1077 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03937 XEO_CLAS Peptide DME1077 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.1 microM) DME1077 XEOTICID XEO03937 GENEFORM Protein DME1077 XEOTICID XEO03937 MOACRIVE Inhibition DME1077 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1077 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03938 XEO_CLAS Peptide DME1077 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.7 microM) DME1077 XEOTICID XEO03938 GENEFORM Protein DME1077 XEOTICID XEO03938 MOACRIVE Inhibition DME1077 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1077 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03939 XEO_CLAS Peptide DME1077 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.7 microM) DME1077 XEOTICID XEO03939 GENEFORM Protein DME1077 XEOTICID XEO03939 MOACRIVE Inhibition DME1077 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1077 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03940 XEO_CLAS Peptide DME1077 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.5 microM) DME1077 XEOTICID XEO03940 GENEFORM Protein DME1077 XEOTICID XEO03940 MOACRIVE Inhibition DME1077 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1077 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03941 XEO_CLAS Peptide DME1077 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.4 microM) DME1077 XEOTICID XEO03941 GENEFORM Protein DME1077 XEOTICID XEO03941 MOACRIVE Inhibition DME1077 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1077 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03943 XEO_CLAS Peptide DME1077 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.4 microM) DME1077 XEOTICID XEO03943 GENEFORM Protein DME1077 XEOTICID XEO03943 MOACRIVE Inhibition DME1077 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1077 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03944 XEO_CLAS Peptide DME1077 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.7 microM) DME1077 XEOTICID XEO03944 GENEFORM Protein DME1077 XEOTICID XEO03944 MOACRIVE Inhibition DME1077 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1077 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03945 XEO_CLAS Peptide DME1077 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.2 microM) DME1077 XEOTICID XEO03945 GENEFORM Protein DME1077 XEOTICID XEO03945 MOACRIVE Inhibition DME1077 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1077 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03947 XEO_CLAS Peptide DME1077 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.0 microM) DME1077 XEOTICID XEO03947 GENEFORM Protein DME1077 XEOTICID XEO03947 MOACRIVE Inhibition DME1077 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1077 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03948 XEO_CLAS Peptide DME1077 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 23.3 microM) DME1077 XEOTICID XEO03948 GENEFORM Protein DME1077 XEOTICID XEO03948 MOACRIVE Inhibition DME1077 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1077 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03950 XEO_CLAS Peptide DME1077 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4.4 microM) DME1077 XEOTICID XEO03950 GENEFORM Protein DME1077 XEOTICID XEO03950 MOACRIVE Inhibition DME1077 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1077 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03951 XEO_CLAS Peptide DME1077 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8.8 microM) DME1077 XEOTICID XEO03951 GENEFORM Protein DME1077 XEOTICID XEO03951 MOACRIVE Inhibition DME1077 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1077 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03952 XEO_CLAS Peptide DME1077 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.2 microM) DME1077 XEOTICID XEO03952 GENEFORM Protein DME1077 XEOTICID XEO03952 MOACRIVE Inhibition DME1077 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1077 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03953 XEO_CLAS Peptide DME1077 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 microM) DME1077 XEOTICID XEO03953 GENEFORM Protein DME1077 XEOTICID XEO03953 MOACRIVE Inhibition DME1077 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1077 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03958 XEO_CLAS Peptide DME1077 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03958 GENEFORM Protein DME1077 XEOTICID XEO03958 MOACRIVE Inhibition DME1077 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1077 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03965 XEO_CLAS Peptide DME1077 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 128 microM) DME1077 XEOTICID XEO03965 GENEFORM Protein DME1077 XEOTICID XEO03965 MOACRIVE Inhibition DME1077 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1077 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03966 XEO_CLAS Peptide DME1077 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 microM) DME1077 XEOTICID XEO03966 GENEFORM Protein DME1077 XEOTICID XEO03966 MOACRIVE Inhibition DME1077 XEOTICID XEO03971 XEO_NAME Lumbrican DME1077 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03971 XEO_CLAS Peptide DME1077 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03971 GENEFORM Protein DME1077 XEOTICID XEO03971 MOACRIVE Inhibition DME1077 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1077 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03972 XEO_CLAS Peptide DME1077 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO03972 GENEFORM Protein DME1077 XEOTICID XEO03972 MOACRIVE Inhibition DME1077 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1077 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03980 XEO_CLAS Peptide DME1077 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 32 microM) DME1077 XEOTICID XEO03980 GENEFORM Protein DME1077 XEOTICID XEO03980 MOACRIVE Inhibition DME1077 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1077 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03985 XEO_CLAS Peptide DME1077 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 ug/ml) DME1077 XEOTICID XEO03985 GENEFORM Protein DME1077 XEOTICID XEO03985 MOACRIVE Inhibition DME1077 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1077 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03991 XEO_CLAS Peptide DME1077 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03991 GENEFORM Protein DME1077 XEOTICID XEO03991 MOACRIVE Inhibition DME1077 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1077 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03992 XEO_CLAS Peptide DME1077 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03992 GENEFORM Protein DME1077 XEOTICID XEO03992 MOACRIVE Inhibition DME1077 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1077 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03993 XEO_CLAS Peptide DME1077 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03993 GENEFORM Protein DME1077 XEOTICID XEO03993 MOACRIVE Inhibition DME1077 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1077 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03994 XEO_CLAS Peptide DME1077 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO03994 GENEFORM Protein DME1077 XEOTICID XEO03994 MOACRIVE Inhibition DME1077 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1077 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03996 XEO_CLAS Peptide DME1077 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 65 microM) DME1077 XEOTICID XEO03996 GENEFORM Protein DME1077 XEOTICID XEO03996 MOACRIVE Inhibition DME1077 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1077 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03997 XEO_CLAS Peptide DME1077 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7.5 microM) DME1077 XEOTICID XEO03997 GENEFORM Protein DME1077 XEOTICID XEO03997 MOACRIVE Inhibition DME1077 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1077 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03998 XEO_CLAS Peptide DME1077 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15.5 microM) DME1077 XEOTICID XEO03998 GENEFORM Protein DME1077 XEOTICID XEO03998 MOACRIVE Inhibition DME1077 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1077 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO03999 XEO_CLAS Peptide DME1077 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25.8 microM) DME1077 XEOTICID XEO03999 GENEFORM Protein DME1077 XEOTICID XEO03999 MOACRIVE Inhibition DME1077 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1077 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04000 XEO_CLAS Peptide DME1077 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO04000 GENEFORM Protein DME1077 XEOTICID XEO04000 MOACRIVE Inhibition DME1077 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1077 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04001 XEO_CLAS Peptide DME1077 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO04001 GENEFORM Protein DME1077 XEOTICID XEO04001 MOACRIVE Inhibition DME1077 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1077 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04002 XEO_CLAS Peptide DME1077 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7.5 ug/ml) DME1077 XEOTICID XEO04002 GENEFORM Protein DME1077 XEOTICID XEO04002 MOACRIVE Inhibition DME1077 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1077 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04003 XEO_CLAS Peptide DME1077 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 ug/ml) DME1077 XEOTICID XEO04003 GENEFORM Protein DME1077 XEOTICID XEO04003 MOACRIVE Inhibition DME1077 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1077 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04004 XEO_CLAS Peptide DME1077 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.0 ug/ml) DME1077 XEOTICID XEO04004 GENEFORM Protein DME1077 XEOTICID XEO04004 MOACRIVE Inhibition DME1077 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1077 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04005 XEO_CLAS Peptide DME1077 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.0 ug/ml) DME1077 XEOTICID XEO04005 GENEFORM Protein DME1077 XEOTICID XEO04005 MOACRIVE Inhibition DME1077 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1077 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04007 XEO_CLAS Peptide DME1077 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 19.5 ug/ml) DME1077 XEOTICID XEO04007 GENEFORM Protein DME1077 XEOTICID XEO04007 MOACRIVE Inhibition DME1077 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1077 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04011 XEO_CLAS Peptide DME1077 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 19.5 ug/ml) DME1077 XEOTICID XEO04011 GENEFORM Protein DME1077 XEOTICID XEO04011 MOACRIVE Inhibition DME1077 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1077 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04012 XEO_CLAS Peptide DME1077 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.9 ug/ml) DME1077 XEOTICID XEO04012 GENEFORM Protein DME1077 XEOTICID XEO04012 MOACRIVE Inhibition DME1077 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1077 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04013 XEO_CLAS Peptide DME1077 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.7 ug/ml) DME1077 XEOTICID XEO04013 GENEFORM Protein DME1077 XEOTICID XEO04013 MOACRIVE Inhibition DME1077 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1077 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04018 XEO_CLAS Peptide DME1077 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9 ug/ml) DME1077 XEOTICID XEO04018 GENEFORM Protein DME1077 XEOTICID XEO04018 MOACRIVE Inhibition DME1077 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1077 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04026 XEO_CLAS Peptide DME1077 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO04026 GENEFORM Protein DME1077 XEOTICID XEO04026 MOACRIVE Inhibition DME1077 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1077 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04027 XEO_CLAS Peptide DME1077 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO04027 GENEFORM Protein DME1077 XEOTICID XEO04027 MOACRIVE Inhibition DME1077 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1077 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04028 XEO_CLAS Peptide DME1077 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 ug/ml) DME1077 XEOTICID XEO04028 GENEFORM Protein DME1077 XEOTICID XEO04028 MOACRIVE Inhibition DME1077 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1077 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04038 XEO_CLAS Peptide DME1077 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04038 GENEFORM Protein DME1077 XEOTICID XEO04038 MOACRIVE Inhibition DME1077 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1077 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04039 XEO_CLAS Peptide DME1077 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 microM) DME1077 XEOTICID XEO04039 GENEFORM Protein DME1077 XEOTICID XEO04039 MOACRIVE Inhibition DME1077 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1077 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04051 XEO_CLAS Peptide DME1077 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1077 XEOTICID XEO04051 GENEFORM Protein DME1077 XEOTICID XEO04051 MOACRIVE Inhibition DME1077 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1077 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04052 XEO_CLAS Peptide DME1077 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04052 GENEFORM Protein DME1077 XEOTICID XEO04052 MOACRIVE Inhibition DME1077 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1077 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04053 XEO_CLAS Peptide DME1077 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.08-0.16 microM) DME1077 XEOTICID XEO04053 GENEFORM Protein DME1077 XEOTICID XEO04053 MOACRIVE Inhibition DME1077 XEOTICID XEO04055 XEO_NAME Melectin DME1077 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04055 XEO_CLAS Peptide DME1077 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.0 microM) DME1077 XEOTICID XEO04055 GENEFORM Protein DME1077 XEOTICID XEO04055 MOACRIVE Inhibition DME1077 XEOTICID XEO04057 XEO_NAME Melittin DME1077 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04057 XEO_CLAS Peptide DME1077 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.8 microM) DME1077 XEOTICID XEO04057 GENEFORM Protein DME1077 XEOTICID XEO04057 MOACRIVE Inhibition DME1077 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1077 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04061 XEO_CLAS Peptide DME1077 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.9 microM) DME1077 XEOTICID XEO04061 GENEFORM Protein DME1077 XEOTICID XEO04061 MOACRIVE Inhibition DME1077 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1077 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04062 XEO_CLAS Peptide DME1077 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.5 microM) DME1077 XEOTICID XEO04062 GENEFORM Protein DME1077 XEOTICID XEO04062 MOACRIVE Inhibition DME1077 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1077 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04063 XEO_CLAS Peptide DME1077 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7.8 microM) DME1077 XEOTICID XEO04063 GENEFORM Protein DME1077 XEOTICID XEO04063 MOACRIVE Inhibition DME1077 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1077 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04064 XEO_CLAS Peptide DME1077 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 46.7 microM) DME1077 XEOTICID XEO04064 GENEFORM Protein DME1077 XEOTICID XEO04064 MOACRIVE Inhibition DME1077 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1077 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04066 XEO_CLAS Peptide DME1077 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16.3 microM) DME1077 XEOTICID XEO04066 GENEFORM Protein DME1077 XEOTICID XEO04066 MOACRIVE Inhibition DME1077 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1077 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04067 XEO_CLAS Peptide DME1077 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.6 microM) DME1077 XEOTICID XEO04067 GENEFORM Protein DME1077 XEOTICID XEO04067 MOACRIVE Inhibition DME1077 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1077 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04068 XEO_CLAS Peptide DME1077 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.6 microM) DME1077 XEOTICID XEO04068 GENEFORM Protein DME1077 XEOTICID XEO04068 MOACRIVE Inhibition DME1077 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1077 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04086 GENEFORM Protein DME1077 XEOTICID XEO04086 MOACRIVE Inhibition DME1077 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1077 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04087 GENEFORM Protein DME1077 XEOTICID XEO04087 MOACRIVE Inhibition DME1077 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1077 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04089 GENEFORM Protein DME1077 XEOTICID XEO04089 MOACRIVE Inhibition DME1077 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1077 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04094 GENEFORM Protein DME1077 XEOTICID XEO04094 MOACRIVE Inhibition DME1077 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1077 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04096 GENEFORM Protein DME1077 XEOTICID XEO04096 MOACRIVE Inhibition DME1077 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1077 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04098 GENEFORM Protein DME1077 XEOTICID XEO04098 MOACRIVE Inhibition DME1077 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1077 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04111 XEO_CLAS Peptide DME1077 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04111 GENEFORM Protein DME1077 XEOTICID XEO04111 MOACRIVE Inhibition DME1077 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1077 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04112 XEO_CLAS Peptide DME1077 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.02 microM) DME1077 XEOTICID XEO04112 GENEFORM Protein DME1077 XEOTICID XEO04112 MOACRIVE Inhibition DME1077 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1077 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04113 XEO_CLAS Peptide DME1077 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.02 ug/ml) DME1077 XEOTICID XEO04113 GENEFORM Protein DME1077 XEOTICID XEO04113 MOACRIVE Inhibition DME1077 XEOTICID XEO04114 XEO_NAME Microcin L DME1077 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04114 XEO_CLAS Peptide DME1077 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04114 GENEFORM Protein DME1077 XEOTICID XEO04114 MOACRIVE Inhibition DME1077 XEOTICID XEO04117 XEO_NAME Misgurin DME1077 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04117 XEO_CLAS Peptide DME1077 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04117 GENEFORM Protein DME1077 XEOTICID XEO04117 MOACRIVE Inhibition DME1077 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1077 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04118 XEO_CLAS Peptide DME1077 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 300 microM) DME1077 XEOTICID XEO04118 GENEFORM Protein DME1077 XEOTICID XEO04118 MOACRIVE Inhibition DME1077 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1077 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04119 XEO_CLAS Peptide DME1077 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-20 microM) DME1077 XEOTICID XEO04119 GENEFORM Protein DME1077 XEOTICID XEO04119 MOACRIVE Inhibition DME1077 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1077 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04120 XEO_CLAS Peptide DME1077 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC < 10 microM) DME1077 XEOTICID XEO04120 GENEFORM Protein DME1077 XEOTICID XEO04120 MOACRIVE Inhibition DME1077 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1077 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04121 XEO_CLAS Peptide DME1077 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.2-6.4 microM) DME1077 XEOTICID XEO04121 GENEFORM Protein DME1077 XEOTICID XEO04121 MOACRIVE Inhibition DME1077 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1077 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04122 XEO_CLAS Peptide DME1077 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.14-6.29 microM) DME1077 XEOTICID XEO04122 GENEFORM Protein DME1077 XEOTICID XEO04122 MOACRIVE Inhibition DME1077 XEOTICID XEO04123 XEO_NAME Modified defensin DME1077 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04123 XEO_CLAS Peptide DME1077 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO04123 GENEFORM Protein DME1077 XEOTICID XEO04123 MOACRIVE Inhibition DME1077 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1077 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04128 XEO_CLAS Peptide DME1077 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.31 microM) DME1077 XEOTICID XEO04128 GENEFORM Protein DME1077 XEOTICID XEO04128 MOACRIVE Inhibition DME1077 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1077 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04129 XEO_CLAS Peptide DME1077 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO04129 GENEFORM Protein DME1077 XEOTICID XEO04129 MOACRIVE Inhibition DME1077 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1077 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04130 XEO_CLAS Peptide DME1077 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO04130 GENEFORM Protein DME1077 XEOTICID XEO04130 MOACRIVE Inhibition DME1077 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1077 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04131 XEO_CLAS Peptide DME1077 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 microM) DME1077 XEOTICID XEO04131 GENEFORM Protein DME1077 XEOTICID XEO04131 MOACRIVE Inhibition DME1077 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1077 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04132 XEO_CLAS Peptide DME1077 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 microM) DME1077 XEOTICID XEO04132 GENEFORM Protein DME1077 XEOTICID XEO04132 MOACRIVE Inhibition DME1077 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1077 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04133 XEO_CLAS Peptide DME1077 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO04133 GENEFORM Protein DME1077 XEOTICID XEO04133 MOACRIVE Inhibition DME1077 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1077 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04134 XEO_CLAS Peptide DME1077 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO04134 GENEFORM Protein DME1077 XEOTICID XEO04134 MOACRIVE Inhibition DME1077 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1077 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04135 XEO_CLAS Peptide DME1077 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 microM) DME1077 XEOTICID XEO04135 GENEFORM Protein DME1077 XEOTICID XEO04135 MOACRIVE Inhibition DME1077 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1077 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04137 XEO_CLAS Peptide DME1077 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.6 microM) DME1077 XEOTICID XEO04137 GENEFORM Protein DME1077 XEOTICID XEO04137 MOACRIVE Inhibition DME1077 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1077 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04138 XEO_CLAS Peptide DME1077 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 microM) DME1077 XEOTICID XEO04138 GENEFORM Protein DME1077 XEOTICID XEO04138 MOACRIVE Inhibition DME1077 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1077 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04139 XEO_CLAS Peptide DME1077 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 microM) DME1077 XEOTICID XEO04139 GENEFORM Protein DME1077 XEOTICID XEO04139 MOACRIVE Inhibition DME1077 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1077 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04140 XEO_CLAS Peptide DME1077 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 70 microM) DME1077 XEOTICID XEO04140 GENEFORM Protein DME1077 XEOTICID XEO04140 MOACRIVE Inhibition DME1077 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1077 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04141 XEO_CLAS Peptide DME1077 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 microM) DME1077 XEOTICID XEO04141 GENEFORM Protein DME1077 XEOTICID XEO04141 MOACRIVE Inhibition DME1077 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1077 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04142 XEO_CLAS Peptide DME1077 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8-16 microM) DME1077 XEOTICID XEO04142 GENEFORM Protein DME1077 XEOTICID XEO04142 MOACRIVE Inhibition DME1077 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1077 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04146 XEO_CLAS Peptide DME1077 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04146 GENEFORM Protein DME1077 XEOTICID XEO04146 MOACRIVE Inhibition DME1077 XEOTICID XEO04149 XEO_NAME Mucroporin DME1077 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04149 XEO_CLAS Peptide DME1077 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 ug/ml) DME1077 XEOTICID XEO04149 GENEFORM Protein DME1077 XEOTICID XEO04149 MOACRIVE Inhibition DME1077 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1077 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04158 XEO_CLAS Peptide DME1077 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO04158 GENEFORM Protein DME1077 XEOTICID XEO04158 MOACRIVE Inhibition DME1077 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1077 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04159 XEO_CLAS Peptide DME1077 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 microM) DME1077 XEOTICID XEO04159 GENEFORM Protein DME1077 XEOTICID XEO04159 MOACRIVE Inhibition DME1077 XEOTICID XEO04167 XEO_NAME Myticin-B DME1077 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04167 XEO_CLAS Peptide DME1077 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04167 GENEFORM Protein DME1077 XEOTICID XEO04167 MOACRIVE Inhibition DME1077 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1077 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04168 XEO_CLAS Peptide DME1077 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.7-12.5 microM) DME1077 XEOTICID XEO04168 GENEFORM Protein DME1077 XEOTICID XEO04168 MOACRIVE Inhibition DME1077 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1077 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04169 XEO_CLAS Peptide DME1077 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04169 GENEFORM Protein DME1077 XEOTICID XEO04169 MOACRIVE Inhibition DME1077 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1077 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04170 XEO_CLAS Peptide DME1077 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04170 GENEFORM Protein DME1077 XEOTICID XEO04170 MOACRIVE Inhibition DME1077 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1077 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04171 XEO_CLAS Peptide DME1077 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04171 GENEFORM Protein DME1077 XEOTICID XEO04171 MOACRIVE Inhibition DME1077 XEOTICID XEO04172 XEO_NAME Myxinidin DME1077 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04172 XEO_CLAS Peptide DME1077 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04172 GENEFORM Protein DME1077 XEOTICID XEO04172 MOACRIVE Inhibition DME1077 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1077 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04177 XEO_CLAS Peptide DME1077 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.7 microM) DME1077 XEOTICID XEO04177 GENEFORM Protein DME1077 XEOTICID XEO04177 MOACRIVE Inhibition DME1077 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1077 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04178 XEO_CLAS Peptide DME1077 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.7 microM) DME1077 XEOTICID XEO04178 GENEFORM Protein DME1077 XEOTICID XEO04178 MOACRIVE Inhibition DME1077 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1077 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04179 XEO_CLAS Peptide DME1077 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.5 microM) DME1077 XEOTICID XEO04179 GENEFORM Protein DME1077 XEOTICID XEO04179 MOACRIVE Inhibition DME1077 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1077 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04180 XEO_CLAS Peptide DME1077 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 23 microM) DME1077 XEOTICID XEO04180 GENEFORM Protein DME1077 XEOTICID XEO04180 MOACRIVE Inhibition DME1077 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1077 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04181 XEO_CLAS Peptide DME1077 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.2 microM) DME1077 XEOTICID XEO04181 GENEFORM Protein DME1077 XEOTICID XEO04181 MOACRIVE Inhibition DME1077 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1077 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04182 XEO_CLAS Peptide DME1077 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4.4 microM) DME1077 XEOTICID XEO04182 GENEFORM Protein DME1077 XEOTICID XEO04182 MOACRIVE Inhibition DME1077 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1077 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04183 XEO_CLAS Peptide DME1077 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.6 microM) DME1077 XEOTICID XEO04183 GENEFORM Protein DME1077 XEOTICID XEO04183 MOACRIVE Inhibition DME1077 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1077 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04184 XEO_CLAS Peptide DME1077 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 microM) DME1077 XEOTICID XEO04184 GENEFORM Protein DME1077 XEOTICID XEO04184 MOACRIVE Inhibition DME1077 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1077 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04185 XEO_CLAS Peptide DME1077 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04185 GENEFORM Protein DME1077 XEOTICID XEO04185 MOACRIVE Inhibition DME1077 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1077 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04186 XEO_CLAS Peptide DME1077 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04186 GENEFORM Protein DME1077 XEOTICID XEO04186 MOACRIVE Inhibition DME1077 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1077 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04187 XEO_CLAS Peptide DME1077 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04187 GENEFORM Protein DME1077 XEOTICID XEO04187 MOACRIVE Inhibition DME1077 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1077 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04188 XEO_CLAS Peptide DME1077 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04188 GENEFORM Protein DME1077 XEOTICID XEO04188 MOACRIVE Inhibition DME1077 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1077 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04206 XEO_CLAS Peptide DME1077 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25 microM) DME1077 XEOTICID XEO04206 GENEFORM Protein DME1077 XEOTICID XEO04206 MOACRIVE Inhibition DME1077 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1077 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04214 XEO_CLAS Peptide DME1077 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25 microM) DME1077 XEOTICID XEO04214 GENEFORM Protein DME1077 XEOTICID XEO04214 MOACRIVE Inhibition DME1077 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1077 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04216 XEO_CLAS Peptide DME1077 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO04216 GENEFORM Protein DME1077 XEOTICID XEO04216 MOACRIVE Inhibition DME1077 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1077 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04218 XEO_CLAS Peptide DME1077 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.125 microM) DME1077 XEOTICID XEO04218 GENEFORM Protein DME1077 XEOTICID XEO04218 MOACRIVE Inhibition DME1077 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1077 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04219 XEO_CLAS Peptide DME1077 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO04219 GENEFORM Protein DME1077 XEOTICID XEO04219 MOACRIVE Inhibition DME1077 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1077 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04220 XEO_CLAS Peptide DME1077 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.125 microM) DME1077 XEOTICID XEO04220 GENEFORM Protein DME1077 XEOTICID XEO04220 MOACRIVE Inhibition DME1077 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1077 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04221 XEO_CLAS Peptide DME1077 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO04221 GENEFORM Protein DME1077 XEOTICID XEO04221 MOACRIVE Inhibition DME1077 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1077 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04222 XEO_CLAS Peptide DME1077 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25 microM) DME1077 XEOTICID XEO04222 GENEFORM Protein DME1077 XEOTICID XEO04222 MOACRIVE Inhibition DME1077 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1077 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04233 XEO_CLAS Peptide DME1077 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04233 GENEFORM Protein DME1077 XEOTICID XEO04233 MOACRIVE Inhibition DME1077 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1077 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04234 XEO_CLAS Peptide DME1077 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04234 GENEFORM Protein DME1077 XEOTICID XEO04234 MOACRIVE Inhibition DME1077 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1077 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04241 XEO_CLAS Peptide DME1077 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04241 GENEFORM Protein DME1077 XEOTICID XEO04241 MOACRIVE Inhibition DME1077 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1077 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04242 XEO_CLAS Peptide DME1077 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04242 GENEFORM Protein DME1077 XEOTICID XEO04242 MOACRIVE Inhibition DME1077 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1077 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04245 XEO_CLAS Natural Product DME1077 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04245 GENEFORM Protein DME1077 XEOTICID XEO04245 MOACRIVE Inhibition DME1077 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1077 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04246 XEO_CLAS Natural Product DME1077 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04246 GENEFORM Protein DME1077 XEOTICID XEO04246 MOACRIVE Inhibition DME1077 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1077 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04249 XEO_CLAS Peptide DME1077 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 500 ug/ml) DME1077 XEOTICID XEO04249 GENEFORM Protein DME1077 XEOTICID XEO04249 MOACRIVE Inhibition DME1077 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1077 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04251 XEO_CLAS Peptide DME1077 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04251 GENEFORM Protein DME1077 XEOTICID XEO04251 MOACRIVE Inhibition DME1077 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1077 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04253 XEO_CLAS Peptide DME1077 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04253 GENEFORM Protein DME1077 XEOTICID XEO04253 MOACRIVE Inhibition DME1077 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1077 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04254 XEO_CLAS Peptide DME1077 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04254 GENEFORM Protein DME1077 XEOTICID XEO04254 MOACRIVE Inhibition DME1077 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1077 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04255 XEO_CLAS Peptide DME1077 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04255 GENEFORM Protein DME1077 XEOTICID XEO04255 MOACRIVE Inhibition DME1077 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1077 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04256 XEO_CLAS Peptide DME1077 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04256 GENEFORM Protein DME1077 XEOTICID XEO04256 MOACRIVE Inhibition DME1077 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1077 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04257 XEO_CLAS Peptide DME1077 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04257 GENEFORM Protein DME1077 XEOTICID XEO04257 MOACRIVE Inhibition DME1077 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1077 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04258 XEO_CLAS Peptide DME1077 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04258 GENEFORM Protein DME1077 XEOTICID XEO04258 MOACRIVE Inhibition DME1077 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1077 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04259 XEO_CLAS Peptide DME1077 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04259 GENEFORM Protein DME1077 XEOTICID XEO04259 MOACRIVE Inhibition DME1077 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1077 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04260 XEO_CLAS Peptide DME1077 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04260 GENEFORM Protein DME1077 XEOTICID XEO04260 MOACRIVE Inhibition DME1077 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1077 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04261 XEO_CLAS Peptide DME1077 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04261 GENEFORM Protein DME1077 XEOTICID XEO04261 MOACRIVE Inhibition DME1077 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1077 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04262 XEO_CLAS Peptide DME1077 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04262 GENEFORM Protein DME1077 XEOTICID XEO04262 MOACRIVE Inhibition DME1077 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1077 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04263 XEO_CLAS Peptide DME1077 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04263 GENEFORM Protein DME1077 XEOTICID XEO04263 MOACRIVE Inhibition DME1077 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1077 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04264 XEO_CLAS Peptide DME1077 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04264 GENEFORM Protein DME1077 XEOTICID XEO04264 MOACRIVE Inhibition DME1077 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1077 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04265 XEO_CLAS Peptide DME1077 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04265 GENEFORM Protein DME1077 XEOTICID XEO04265 MOACRIVE Inhibition DME1077 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1077 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04266 XEO_CLAS Peptide DME1077 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04266 GENEFORM Protein DME1077 XEOTICID XEO04266 MOACRIVE Inhibition DME1077 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1077 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04267 XEO_CLAS Peptide DME1077 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04267 GENEFORM Protein DME1077 XEOTICID XEO04267 MOACRIVE Inhibition DME1077 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1077 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04268 XEO_CLAS Peptide DME1077 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04268 GENEFORM Protein DME1077 XEOTICID XEO04268 MOACRIVE Inhibition DME1077 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1077 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04269 XEO_CLAS Peptide DME1077 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04269 GENEFORM Protein DME1077 XEOTICID XEO04269 MOACRIVE Inhibition DME1077 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1077 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04270 XEO_CLAS Peptide DME1077 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04270 GENEFORM Protein DME1077 XEOTICID XEO04270 MOACRIVE Inhibition DME1077 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1077 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04271 XEO_CLAS Peptide DME1077 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04271 GENEFORM Protein DME1077 XEOTICID XEO04271 MOACRIVE Inhibition DME1077 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1077 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04272 XEO_CLAS Peptide DME1077 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04272 GENEFORM Protein DME1077 XEOTICID XEO04272 MOACRIVE Inhibition DME1077 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1077 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04277 XEO_CLAS Peptide DME1077 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 110.00 ug/ml) DME1077 XEOTICID XEO04277 GENEFORM Protein DME1077 XEOTICID XEO04277 MOACRIVE Inhibition DME1077 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1077 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04280 XEO_CLAS Peptide DME1077 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 37.50 ug/ml) DME1077 XEOTICID XEO04280 GENEFORM Protein DME1077 XEOTICID XEO04280 MOACRIVE Inhibition DME1077 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1077 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04281 XEO_CLAS Peptide DME1077 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25.00 ug/ml) DME1077 XEOTICID XEO04281 GENEFORM Protein DME1077 XEOTICID XEO04281 MOACRIVE Inhibition DME1077 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1077 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04282 XEO_CLAS Peptide DME1077 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.2 ug/ml) DME1077 XEOTICID XEO04282 GENEFORM Protein DME1077 XEOTICID XEO04282 MOACRIVE Inhibition DME1077 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1077 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04283 XEO_CLAS Peptide DME1077 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.3 ug/ml) DME1077 XEOTICID XEO04283 GENEFORM Protein DME1077 XEOTICID XEO04283 MOACRIVE Inhibition DME1077 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1077 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04284 XEO_CLAS Peptide DME1077 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10.8 ug/ml) DME1077 XEOTICID XEO04284 GENEFORM Protein DME1077 XEOTICID XEO04284 MOACRIVE Inhibition DME1077 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1077 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04285 XEO_CLAS Peptide DME1077 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 11.5 ug/ml) DME1077 XEOTICID XEO04285 GENEFORM Protein DME1077 XEOTICID XEO04285 MOACRIVE Inhibition DME1077 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1077 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04286 XEO_CLAS Peptide DME1077 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8.6 ug/ml) DME1077 XEOTICID XEO04286 GENEFORM Protein DME1077 XEOTICID XEO04286 MOACRIVE Inhibition DME1077 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1077 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04287 XEO_CLAS Peptide DME1077 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10.2 ug/ml) DME1077 XEOTICID XEO04287 GENEFORM Protein DME1077 XEOTICID XEO04287 MOACRIVE Inhibition DME1077 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1077 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04288 XEO_CLAS Peptide DME1077 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4.4 ug/ml) DME1077 XEOTICID XEO04288 GENEFORM Protein DME1077 XEOTICID XEO04288 MOACRIVE Inhibition DME1077 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1077 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04289 XEO_CLAS Peptide DME1077 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.2 ug/ml) DME1077 XEOTICID XEO04289 GENEFORM Protein DME1077 XEOTICID XEO04289 MOACRIVE Inhibition DME1077 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1077 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04290 XEO_CLAS Peptide DME1077 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 11.3 ug/ml) DME1077 XEOTICID XEO04290 GENEFORM Protein DME1077 XEOTICID XEO04290 MOACRIVE Inhibition DME1077 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1077 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04291 XEO_CLAS Peptide DME1077 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7.2 ug/ml) DME1077 XEOTICID XEO04291 GENEFORM Protein DME1077 XEOTICID XEO04291 MOACRIVE Inhibition DME1077 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1077 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04292 XEO_CLAS Peptide DME1077 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.1 ug/ml) DME1077 XEOTICID XEO04292 GENEFORM Protein DME1077 XEOTICID XEO04292 MOACRIVE Inhibition DME1077 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1077 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04293 XEO_CLAS Peptide DME1077 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO04293 GENEFORM Protein DME1077 XEOTICID XEO04293 MOACRIVE Inhibition DME1077 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1077 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04294 XEO_CLAS Peptide DME1077 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO04294 GENEFORM Protein DME1077 XEOTICID XEO04294 MOACRIVE Inhibition DME1077 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1077 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04295 XEO_CLAS Peptide DME1077 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO04295 GENEFORM Protein DME1077 XEOTICID XEO04295 MOACRIVE Inhibition DME1077 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1077 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04296 XEO_CLAS Peptide DME1077 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 28 microM) DME1077 XEOTICID XEO04296 GENEFORM Protein DME1077 XEOTICID XEO04296 MOACRIVE Inhibition DME1077 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1077 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04297 XEO_CLAS Peptide DME1077 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 14 microM) DME1077 XEOTICID XEO04297 GENEFORM Protein DME1077 XEOTICID XEO04297 MOACRIVE Inhibition DME1077 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1077 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04298 XEO_CLAS Peptide DME1077 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO04298 GENEFORM Protein DME1077 XEOTICID XEO04298 MOACRIVE Inhibition DME1077 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1077 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04299 XEO_CLAS Peptide DME1077 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO04299 GENEFORM Protein DME1077 XEOTICID XEO04299 MOACRIVE Inhibition DME1077 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1077 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04300 XEO_CLAS Peptide DME1077 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO04300 GENEFORM Protein DME1077 XEOTICID XEO04300 MOACRIVE Inhibition DME1077 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1077 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04301 XEO_CLAS Peptide DME1077 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 microM) DME1077 XEOTICID XEO04301 GENEFORM Protein DME1077 XEOTICID XEO04301 MOACRIVE Inhibition DME1077 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1077 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04302 XEO_CLAS Peptide DME1077 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 microM) DME1077 XEOTICID XEO04302 GENEFORM Protein DME1077 XEOTICID XEO04302 MOACRIVE Inhibition DME1077 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1077 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04303 XEO_CLAS Peptide DME1077 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 microM) DME1077 XEOTICID XEO04303 GENEFORM Protein DME1077 XEOTICID XEO04303 MOACRIVE Inhibition DME1077 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1077 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04304 XEO_CLAS Peptide DME1077 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO04304 GENEFORM Protein DME1077 XEOTICID XEO04304 MOACRIVE Inhibition DME1077 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1077 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04305 XEO_CLAS Peptide DME1077 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 70 microM) DME1077 XEOTICID XEO04305 GENEFORM Protein DME1077 XEOTICID XEO04305 MOACRIVE Inhibition DME1077 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1077 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04306 XEO_CLAS Peptide DME1077 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO04306 GENEFORM Protein DME1077 XEOTICID XEO04306 MOACRIVE Inhibition DME1077 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1077 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04307 XEO_CLAS Peptide DME1077 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 ug/ml) DME1077 XEOTICID XEO04307 GENEFORM Protein DME1077 XEOTICID XEO04307 MOACRIVE Inhibition DME1077 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1077 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04308 XEO_CLAS Peptide DME1077 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9.37 ug/ml) DME1077 XEOTICID XEO04308 GENEFORM Protein DME1077 XEOTICID XEO04308 MOACRIVE Inhibition DME1077 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1077 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04309 XEO_CLAS Peptide DME1077 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 microM) DME1077 XEOTICID XEO04309 GENEFORM Protein DME1077 XEOTICID XEO04309 MOACRIVE Inhibition DME1077 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1077 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04310 XEO_CLAS Peptide DME1077 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO04310 GENEFORM Protein DME1077 XEOTICID XEO04310 MOACRIVE Inhibition DME1077 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1077 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04311 XEO_CLAS Peptide DME1077 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO04311 GENEFORM Protein DME1077 XEOTICID XEO04311 MOACRIVE Inhibition DME1077 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1077 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04312 XEO_CLAS Peptide DME1077 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4.68 ug/ml) DME1077 XEOTICID XEO04312 GENEFORM Protein DME1077 XEOTICID XEO04312 MOACRIVE Inhibition DME1077 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1077 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04313 XEO_CLAS Peptide DME1077 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4.68 ug/ml) DME1077 XEOTICID XEO04313 GENEFORM Protein DME1077 XEOTICID XEO04313 MOACRIVE Inhibition DME1077 XEOTICID XEO04331 XEO_NAME Norspermidine DME1077 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1077 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04331 GENEFORM Protein DME1077 XEOTICID XEO04331 MOACRIVE Inhibition DME1077 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1077 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04335 XEO_CLAS Peptide DME1077 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 32 ug/ml) DME1077 XEOTICID XEO04335 GENEFORM Protein DME1077 XEOTICID XEO04335 MOACRIVE Inhibition DME1077 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1077 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04336 XEO_CLAS Peptide DME1077 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 32 ug/ml) DME1077 XEOTICID XEO04336 GENEFORM Protein DME1077 XEOTICID XEO04336 MOACRIVE Inhibition DME1077 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1077 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04338 XEO_CLAS Peptide DME1077 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 ug/ml) DME1077 XEOTICID XEO04338 GENEFORM Protein DME1077 XEOTICID XEO04338 MOACRIVE Inhibition DME1077 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1077 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04339 XEO_CLAS Peptide DME1077 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 ug/ml) DME1077 XEOTICID XEO04339 GENEFORM Protein DME1077 XEOTICID XEO04339 MOACRIVE Inhibition DME1077 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1077 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04340 XEO_CLAS Peptide DME1077 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO04340 GENEFORM Protein DME1077 XEOTICID XEO04340 MOACRIVE Inhibition DME1077 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1077 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04344 XEO_CLAS Peptide DME1077 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04344 GENEFORM Protein DME1077 XEOTICID XEO04344 MOACRIVE Inhibition DME1077 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1077 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04345 XEO_CLAS Peptide DME1077 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04345 GENEFORM Protein DME1077 XEOTICID XEO04345 MOACRIVE Inhibition DME1077 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1077 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04346 XEO_CLAS Peptide DME1077 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04346 GENEFORM Protein DME1077 XEOTICID XEO04346 MOACRIVE Inhibition DME1077 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1077 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04347 XEO_CLAS Peptide DME1077 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 microM) DME1077 XEOTICID XEO04347 GENEFORM Protein DME1077 XEOTICID XEO04347 MOACRIVE Inhibition DME1077 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1077 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04348 XEO_CLAS Peptide DME1077 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40 microM) DME1077 XEOTICID XEO04348 GENEFORM Protein DME1077 XEOTICID XEO04348 MOACRIVE Inhibition DME1077 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1077 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04349 XEO_CLAS Peptide DME1077 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO04349 GENEFORM Protein DME1077 XEOTICID XEO04349 MOACRIVE Inhibition DME1077 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1077 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04354 XEO_CLAS Peptide DME1077 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 35.2 ug/ml) DME1077 XEOTICID XEO04354 GENEFORM Protein DME1077 XEOTICID XEO04354 MOACRIVE Inhibition DME1077 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1077 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04355 XEO_CLAS Peptide DME1077 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.21 ug/ml) DME1077 XEOTICID XEO04355 GENEFORM Protein DME1077 XEOTICID XEO04355 MOACRIVE Inhibition DME1077 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1077 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04356 XEO_CLAS Peptide DME1077 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8.21 ug/ml) DME1077 XEOTICID XEO04356 GENEFORM Protein DME1077 XEOTICID XEO04356 MOACRIVE Inhibition DME1077 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1077 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04357 XEO_CLAS Peptide DME1077 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16.32 ug/ml) DME1077 XEOTICID XEO04357 GENEFORM Protein DME1077 XEOTICID XEO04357 MOACRIVE Inhibition DME1077 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1077 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04358 XEO_CLAS Peptide DME1077 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9.37 ug/ml) DME1077 XEOTICID XEO04358 GENEFORM Protein DME1077 XEOTICID XEO04358 MOACRIVE Inhibition DME1077 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1077 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04359 XEO_CLAS Peptide DME1077 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4.20 ug/ml) DME1077 XEOTICID XEO04359 GENEFORM Protein DME1077 XEOTICID XEO04359 MOACRIVE Inhibition DME1077 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1077 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04360 XEO_CLAS Peptide DME1077 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 ug/ml) DME1077 XEOTICID XEO04360 GENEFORM Protein DME1077 XEOTICID XEO04360 MOACRIVE Inhibition DME1077 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1077 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04361 XEO_CLAS Peptide DME1077 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7.5 ug/ml) DME1077 XEOTICID XEO04361 GENEFORM Protein DME1077 XEOTICID XEO04361 MOACRIVE Inhibition DME1077 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1077 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04362 XEO_CLAS Peptide DME1077 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.6 ug/ml) DME1077 XEOTICID XEO04362 GENEFORM Protein DME1077 XEOTICID XEO04362 MOACRIVE Inhibition DME1077 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1077 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04363 XEO_CLAS Peptide DME1077 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8.2 ug/ml) DME1077 XEOTICID XEO04363 GENEFORM Protein DME1077 XEOTICID XEO04363 MOACRIVE Inhibition DME1077 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1077 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04364 XEO_CLAS Peptide DME1077 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO04364 GENEFORM Protein DME1077 XEOTICID XEO04364 MOACRIVE Inhibition DME1077 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1077 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04365 XEO_CLAS Peptide DME1077 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4.68 ug/ml) DME1077 XEOTICID XEO04365 GENEFORM Protein DME1077 XEOTICID XEO04365 MOACRIVE Inhibition DME1077 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1077 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04366 XEO_CLAS Peptide DME1077 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 23.60 ug/ml) DME1077 XEOTICID XEO04366 GENEFORM Protein DME1077 XEOTICID XEO04366 MOACRIVE Inhibition DME1077 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1077 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04367 XEO_CLAS Peptide DME1077 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 35.60 ug/ml) DME1077 XEOTICID XEO04367 GENEFORM Protein DME1077 XEOTICID XEO04367 MOACRIVE Inhibition DME1077 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1077 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04368 XEO_CLAS Peptide DME1077 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40.2 ug/ml) DME1077 XEOTICID XEO04368 GENEFORM Protein DME1077 XEOTICID XEO04368 MOACRIVE Inhibition DME1077 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1077 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04369 XEO_CLAS Peptide DME1077 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40.2 ug/ml) DME1077 XEOTICID XEO04369 GENEFORM Protein DME1077 XEOTICID XEO04369 MOACRIVE Inhibition DME1077 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1077 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04370 XEO_CLAS Peptide DME1077 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4.68 ug/ml) DME1077 XEOTICID XEO04370 GENEFORM Protein DME1077 XEOTICID XEO04370 MOACRIVE Inhibition DME1077 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1077 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04371 XEO_CLAS Peptide DME1077 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9.37 ug/ml) DME1077 XEOTICID XEO04371 GENEFORM Protein DME1077 XEOTICID XEO04371 MOACRIVE Inhibition DME1077 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1077 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04373 XEO_CLAS Peptide DME1077 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 ug/ml) DME1077 XEOTICID XEO04373 GENEFORM Protein DME1077 XEOTICID XEO04373 MOACRIVE Inhibition DME1077 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1077 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04374 XEO_CLAS Peptide DME1077 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.50 ug/ml) DME1077 XEOTICID XEO04374 GENEFORM Protein DME1077 XEOTICID XEO04374 MOACRIVE Inhibition DME1077 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1077 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04375 XEO_CLAS Peptide DME1077 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25 ug/ml) DME1077 XEOTICID XEO04375 GENEFORM Protein DME1077 XEOTICID XEO04375 MOACRIVE Inhibition DME1077 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1077 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04377 XEO_CLAS Peptide DME1077 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 42.50 ug/ml) DME1077 XEOTICID XEO04377 GENEFORM Protein DME1077 XEOTICID XEO04377 MOACRIVE Inhibition DME1077 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1077 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04378 XEO_CLAS Peptide DME1077 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 17.50 ug/ml) DME1077 XEOTICID XEO04378 GENEFORM Protein DME1077 XEOTICID XEO04378 MOACRIVE Inhibition DME1077 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1077 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04379 XEO_CLAS Peptide DME1077 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 ug/ml) DME1077 XEOTICID XEO04379 GENEFORM Protein DME1077 XEOTICID XEO04379 MOACRIVE Inhibition DME1077 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1077 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04380 XEO_CLAS Peptide DME1077 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 36.00 ug/ml) DME1077 XEOTICID XEO04380 GENEFORM Protein DME1077 XEOTICID XEO04380 MOACRIVE Inhibition DME1077 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1077 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04381 XEO_CLAS Peptide DME1077 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.60 ug/ml) DME1077 XEOTICID XEO04381 GENEFORM Protein DME1077 XEOTICID XEO04381 MOACRIVE Inhibition DME1077 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1077 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04382 XEO_CLAS Peptide DME1077 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 ug/ml) DME1077 XEOTICID XEO04382 GENEFORM Protein DME1077 XEOTICID XEO04382 MOACRIVE Inhibition DME1077 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1077 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04383 XEO_CLAS Peptide DME1077 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO04383 GENEFORM Protein DME1077 XEOTICID XEO04383 MOACRIVE Inhibition DME1077 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1077 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04384 XEO_CLAS Peptide DME1077 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO04384 GENEFORM Protein DME1077 XEOTICID XEO04384 MOACRIVE Inhibition DME1077 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1077 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04385 XEO_CLAS Peptide DME1077 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.25 ug/ml) DME1077 XEOTICID XEO04385 GENEFORM Protein DME1077 XEOTICID XEO04385 MOACRIVE Inhibition DME1077 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1077 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04395 XEO_CLAS Peptide DME1077 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1077 XEOTICID XEO04395 GENEFORM Protein DME1077 XEOTICID XEO04395 MOACRIVE Inhibition DME1077 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1077 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04396 XEO_CLAS Peptide DME1077 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1077 XEOTICID XEO04396 GENEFORM Protein DME1077 XEOTICID XEO04396 MOACRIVE Inhibition DME1077 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1077 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04397 XEO_CLAS Peptide DME1077 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1077 XEOTICID XEO04397 GENEFORM Protein DME1077 XEOTICID XEO04397 MOACRIVE Inhibition DME1077 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1077 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04398 XEO_CLAS Peptide DME1077 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 microM) DME1077 XEOTICID XEO04398 GENEFORM Protein DME1077 XEOTICID XEO04398 MOACRIVE Inhibition DME1077 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1077 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04399 XEO_CLAS Peptide DME1077 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO04399 GENEFORM Protein DME1077 XEOTICID XEO04399 MOACRIVE Inhibition DME1077 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1077 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04400 XEO_CLAS Peptide DME1077 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 ug/ml) DME1077 XEOTICID XEO04400 GENEFORM Protein DME1077 XEOTICID XEO04400 MOACRIVE Inhibition DME1077 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1077 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04401 XEO_CLAS Peptide DME1077 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.6 ug/ml) DME1077 XEOTICID XEO04401 GENEFORM Protein DME1077 XEOTICID XEO04401 MOACRIVE Inhibition DME1077 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1077 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04402 XEO_CLAS Peptide DME1077 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 ug/ml) DME1077 XEOTICID XEO04402 GENEFORM Protein DME1077 XEOTICID XEO04402 MOACRIVE Inhibition DME1077 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1077 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04403 XEO_CLAS Peptide DME1077 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.6 ug/ml) DME1077 XEOTICID XEO04403 GENEFORM Protein DME1077 XEOTICID XEO04403 MOACRIVE Inhibition DME1077 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1077 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04404 XEO_CLAS Peptide DME1077 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.6 ug/ml) DME1077 XEOTICID XEO04404 GENEFORM Protein DME1077 XEOTICID XEO04404 MOACRIVE Inhibition DME1077 XEOTICID XEO04410 XEO_NAME Insect osmin DME1077 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04410 XEO_CLAS Peptide DME1077 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.125-1.56 microM) DME1077 XEOTICID XEO04410 GENEFORM Protein DME1077 XEOTICID XEO04410 MOACRIVE Inhibition DME1077 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1077 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04412 XEO_CLAS Peptide DME1077 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04412 GENEFORM Protein DME1077 XEOTICID XEO04412 MOACRIVE Inhibition DME1077 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1077 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04414 XEO_CLAS Peptide DME1077 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04414 GENEFORM Protein DME1077 XEOTICID XEO04414 MOACRIVE Inhibition DME1077 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1077 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04415 XEO_CLAS Peptide DME1077 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04415 GENEFORM Protein DME1077 XEOTICID XEO04415 MOACRIVE Inhibition DME1077 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1077 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04421 XEO_CLAS Peptide DME1077 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 microM) DME1077 XEOTICID XEO04421 GENEFORM Protein DME1077 XEOTICID XEO04421 MOACRIVE Inhibition DME1077 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1077 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04426 XEO_CLAS Peptide DME1077 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO04426 GENEFORM Protein DME1077 XEOTICID XEO04426 MOACRIVE Inhibition DME1077 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1077 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04428 XEO_CLAS Peptide DME1077 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.3 ug/ml) DME1077 XEOTICID XEO04428 GENEFORM Protein DME1077 XEOTICID XEO04428 MOACRIVE Inhibition DME1077 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1077 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04430 XEO_CLAS Peptide DME1077 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25 microM) DME1077 XEOTICID XEO04430 GENEFORM Protein DME1077 XEOTICID XEO04430 MOACRIVE Inhibition DME1077 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1077 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04433 XEO_CLAS Peptide DME1077 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 160 microM) DME1077 XEOTICID XEO04433 GENEFORM Protein DME1077 XEOTICID XEO04433 MOACRIVE Inhibition DME1077 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1077 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04435 XEO_CLAS Peptide DME1077 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 160 microM) DME1077 XEOTICID XEO04435 GENEFORM Protein DME1077 XEOTICID XEO04435 MOACRIVE Inhibition DME1077 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1077 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1077 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04438 GENEFORM Protein DME1077 XEOTICID XEO04438 MOACRIVE Inhibition DME1077 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1077 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04439 XEO_CLAS Peptide DME1077 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04439 GENEFORM Protein DME1077 XEOTICID XEO04439 MOACRIVE Inhibition DME1077 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1077 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04440 XEO_CLAS Peptide DME1077 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 microM) DME1077 XEOTICID XEO04440 GENEFORM Protein DME1077 XEOTICID XEO04440 MOACRIVE Inhibition DME1077 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1077 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04441 XEO_CLAS Peptide DME1077 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 28 microM) DME1077 XEOTICID XEO04441 GENEFORM Protein DME1077 XEOTICID XEO04441 MOACRIVE Inhibition DME1077 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1077 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04442 XEO_CLAS Peptide DME1077 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 28 microM) DME1077 XEOTICID XEO04442 GENEFORM Protein DME1077 XEOTICID XEO04442 MOACRIVE Inhibition DME1077 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1077 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04443 XEO_CLAS Peptide DME1077 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04443 GENEFORM Protein DME1077 XEOTICID XEO04443 MOACRIVE Inhibition DME1077 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1077 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04444 XEO_CLAS Peptide DME1077 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 13 microM) DME1077 XEOTICID XEO04444 GENEFORM Protein DME1077 XEOTICID XEO04444 MOACRIVE Inhibition DME1077 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1077 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04445 XEO_CLAS Peptide DME1077 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04445 GENEFORM Protein DME1077 XEOTICID XEO04445 MOACRIVE Inhibition DME1077 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1077 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04446 XEO_CLAS Peptide DME1077 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 78 microM) DME1077 XEOTICID XEO04446 GENEFORM Protein DME1077 XEOTICID XEO04446 MOACRIVE Inhibition DME1077 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1077 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04447 XEO_CLAS Peptide DME1077 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 120 microM) DME1077 XEOTICID XEO04447 GENEFORM Protein DME1077 XEOTICID XEO04447 MOACRIVE Inhibition DME1077 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1077 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04448 XEO_CLAS Peptide DME1077 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 microM) DME1077 XEOTICID XEO04448 GENEFORM Protein DME1077 XEOTICID XEO04448 MOACRIVE Inhibition DME1077 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1077 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04449 XEO_CLAS Peptide DME1077 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.3 microM) DME1077 XEOTICID XEO04449 GENEFORM Protein DME1077 XEOTICID XEO04449 MOACRIVE Inhibition DME1077 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1077 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04450 XEO_CLAS Peptide DME1077 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.3 microM) DME1077 XEOTICID XEO04450 GENEFORM Protein DME1077 XEOTICID XEO04450 MOACRIVE Inhibition DME1077 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1077 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04451 XEO_CLAS Peptide DME1077 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO04451 GENEFORM Protein DME1077 XEOTICID XEO04451 MOACRIVE Inhibition DME1077 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1077 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04452 XEO_CLAS Peptide DME1077 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.1 microM) DME1077 XEOTICID XEO04452 GENEFORM Protein DME1077 XEOTICID XEO04452 MOACRIVE Inhibition DME1077 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1077 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04453 XEO_CLAS Peptide DME1077 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO04453 GENEFORM Protein DME1077 XEOTICID XEO04453 MOACRIVE Inhibition DME1077 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1077 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04455 XEO_CLAS Peptide DME1077 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 microM) DME1077 XEOTICID XEO04455 GENEFORM Protein DME1077 XEOTICID XEO04455 MOACRIVE Inhibition DME1077 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1077 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04457 XEO_CLAS Peptide DME1077 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.3 microM) DME1077 XEOTICID XEO04457 GENEFORM Protein DME1077 XEOTICID XEO04457 MOACRIVE Inhibition DME1077 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1077 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04458 XEO_CLAS Peptide DME1077 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1 microM) DME1077 XEOTICID XEO04458 GENEFORM Protein DME1077 XEOTICID XEO04458 MOACRIVE Inhibition DME1077 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1077 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04459 XEO_CLAS Peptide DME1077 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1 microM) DME1077 XEOTICID XEO04459 GENEFORM Protein DME1077 XEOTICID XEO04459 MOACRIVE Inhibition DME1077 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1077 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04461 XEO_CLAS Peptide DME1077 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20.8 microM) DME1077 XEOTICID XEO04461 GENEFORM Protein DME1077 XEOTICID XEO04461 MOACRIVE Inhibition DME1077 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1077 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04462 XEO_CLAS Peptide DME1077 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 19.1 microM) DME1077 XEOTICID XEO04462 GENEFORM Protein DME1077 XEOTICID XEO04462 MOACRIVE Inhibition DME1077 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1077 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04463 XEO_CLAS Peptide DME1077 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04463 GENEFORM Protein DME1077 XEOTICID XEO04463 MOACRIVE Inhibition DME1077 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1077 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04464 XEO_CLAS Peptide DME1077 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.5 microM) DME1077 XEOTICID XEO04464 GENEFORM Protein DME1077 XEOTICID XEO04464 MOACRIVE Inhibition DME1077 XEOTICID XEO04466 XEO_NAME Panusin DME1077 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04466 XEO_CLAS Peptide DME1077 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04466 GENEFORM Protein DME1077 XEOTICID XEO04466 MOACRIVE Inhibition DME1077 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1077 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04467 XEO_CLAS Peptide DME1077 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4.8 microM) DME1077 XEOTICID XEO04467 GENEFORM Protein DME1077 XEOTICID XEO04467 MOACRIVE Inhibition DME1077 XEOTICID XEO04468 XEO_NAME Papillosin DME1077 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04468 XEO_CLAS Peptide DME1077 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04468 GENEFORM Protein DME1077 XEOTICID XEO04468 MOACRIVE Inhibition DME1077 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1077 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04471 XEO_CLAS Peptide DME1077 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.1 microM) DME1077 XEOTICID XEO04471 GENEFORM Protein DME1077 XEOTICID XEO04471 MOACRIVE Inhibition DME1077 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1077 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04480 XEO_CLAS Peptide DME1077 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 ug/ml) DME1077 XEOTICID XEO04480 GENEFORM Protein DME1077 XEOTICID XEO04480 MOACRIVE Inhibition DME1077 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1077 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1077 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04482 GENEFORM Protein DME1077 XEOTICID XEO04482 MOACRIVE Inhibition DME1077 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1077 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04484 XEO_CLAS Peptide DME1077 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 microM) DME1077 XEOTICID XEO04484 GENEFORM Protein DME1077 XEOTICID XEO04484 MOACRIVE Inhibition DME1077 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1077 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04485 XEO_CLAS Peptide DME1077 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO04485 GENEFORM Protein DME1077 XEOTICID XEO04485 MOACRIVE Inhibition DME1077 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1077 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04486 XEO_CLAS Peptide DME1077 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 microM) DME1077 XEOTICID XEO04486 GENEFORM Protein DME1077 XEOTICID XEO04486 MOACRIVE Inhibition DME1077 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1077 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04487 XEO_CLAS Peptide DME1077 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO04487 GENEFORM Protein DME1077 XEOTICID XEO04487 MOACRIVE Inhibition DME1077 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1077 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04488 XEO_CLAS Peptide DME1077 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9 microM) DME1077 XEOTICID XEO04488 GENEFORM Protein DME1077 XEOTICID XEO04488 MOACRIVE Inhibition DME1077 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1077 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04489 XEO_CLAS Peptide DME1077 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 13 microM) DME1077 XEOTICID XEO04489 GENEFORM Protein DME1077 XEOTICID XEO04489 MOACRIVE Inhibition DME1077 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1077 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04490 XEO_CLAS Peptide DME1077 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 47.5 microM) DME1077 XEOTICID XEO04490 GENEFORM Protein DME1077 XEOTICID XEO04490 MOACRIVE Inhibition DME1077 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1077 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04491 XEO_CLAS Peptide DME1077 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO04491 GENEFORM Protein DME1077 XEOTICID XEO04491 MOACRIVE Inhibition DME1077 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1077 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04492 XEO_CLAS Peptide DME1077 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 35 microM) DME1077 XEOTICID XEO04492 GENEFORM Protein DME1077 XEOTICID XEO04492 MOACRIVE Inhibition DME1077 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1077 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04493 XEO_CLAS Peptide DME1077 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 microM) DME1077 XEOTICID XEO04493 GENEFORM Protein DME1077 XEOTICID XEO04493 MOACRIVE Inhibition DME1077 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1077 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04494 XEO_CLAS Peptide DME1077 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO04494 GENEFORM Protein DME1077 XEOTICID XEO04494 MOACRIVE Inhibition DME1077 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1077 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04495 XEO_CLAS Peptide DME1077 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO04495 GENEFORM Protein DME1077 XEOTICID XEO04495 MOACRIVE Inhibition DME1077 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1077 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04496 XEO_CLAS Peptide DME1077 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 67.5 microM) DME1077 XEOTICID XEO04496 GENEFORM Protein DME1077 XEOTICID XEO04496 MOACRIVE Inhibition DME1077 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1077 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04497 XEO_CLAS Peptide DME1077 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO04497 GENEFORM Protein DME1077 XEOTICID XEO04497 MOACRIVE Inhibition DME1077 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1077 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04498 XEO_CLAS Peptide DME1077 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO04498 GENEFORM Protein DME1077 XEOTICID XEO04498 MOACRIVE Inhibition DME1077 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1077 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04499 XEO_CLAS Peptide DME1077 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 43 microM) DME1077 XEOTICID XEO04499 GENEFORM Protein DME1077 XEOTICID XEO04499 MOACRIVE Inhibition DME1077 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1077 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04500 XEO_CLAS Peptide DME1077 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO04500 GENEFORM Protein DME1077 XEOTICID XEO04500 MOACRIVE Inhibition DME1077 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1077 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04504 XEO_CLAS Peptide DME1077 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04504 GENEFORM Protein DME1077 XEOTICID XEO04504 MOACRIVE Inhibition DME1077 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1077 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04505 XEO_CLAS Peptide DME1077 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04505 GENEFORM Protein DME1077 XEOTICID XEO04505 MOACRIVE Inhibition DME1077 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1077 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04506 XEO_CLAS Peptide DME1077 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 40 microM) DME1077 XEOTICID XEO04506 GENEFORM Protein DME1077 XEOTICID XEO04506 MOACRIVE Inhibition DME1077 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1077 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04507 XEO_CLAS Peptide DME1077 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10-20 microM) DME1077 XEOTICID XEO04507 GENEFORM Protein DME1077 XEOTICID XEO04507 MOACRIVE Inhibition DME1077 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1077 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04508 XEO_CLAS Peptide DME1077 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04508 GENEFORM Protein DME1077 XEOTICID XEO04508 MOACRIVE Inhibition DME1077 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1077 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04509 XEO_CLAS Peptide DME1077 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04509 GENEFORM Protein DME1077 XEOTICID XEO04509 MOACRIVE Inhibition DME1077 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1077 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04510 XEO_CLAS Peptide DME1077 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 22-33 microM) DME1077 XEOTICID XEO04510 GENEFORM Protein DME1077 XEOTICID XEO04510 MOACRIVE Inhibition DME1077 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1077 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04525 XEO_CLAS Peptide DME1077 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 32.0 microM) DME1077 XEOTICID XEO04525 GENEFORM Protein DME1077 XEOTICID XEO04525 MOACRIVE Inhibition DME1077 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1077 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04526 XEO_CLAS Peptide DME1077 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.0 microM) DME1077 XEOTICID XEO04526 GENEFORM Protein DME1077 XEOTICID XEO04526 MOACRIVE Inhibition DME1077 XEOTICID XEO04527 XEO_NAME Pepcon DME1077 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04527 XEO_CLAS Peptide DME1077 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO04527 GENEFORM Protein DME1077 XEOTICID XEO04527 MOACRIVE Inhibition DME1077 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1077 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04532 XEO_CLAS Peptide DME1077 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04532 GENEFORM Protein DME1077 XEOTICID XEO04532 MOACRIVE Inhibition DME1077 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1077 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04540 XEO_CLAS Peptide DME1077 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 18.1 ug/ml) DME1077 XEOTICID XEO04540 GENEFORM Protein DME1077 XEOTICID XEO04540 MOACRIVE Inhibition DME1077 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1077 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04541 XEO_CLAS Peptide DME1077 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.5 ug/ml) DME1077 XEOTICID XEO04541 GENEFORM Protein DME1077 XEOTICID XEO04541 MOACRIVE Inhibition DME1077 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1077 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04542 XEO_CLAS Peptide DME1077 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04542 GENEFORM Protein DME1077 XEOTICID XEO04542 MOACRIVE Inhibition DME1077 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1077 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04543 XEO_CLAS Peptide DME1077 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04543 GENEFORM Protein DME1077 XEOTICID XEO04543 MOACRIVE Inhibition DME1077 XEOTICID XEO04546 XEO_NAME Perinerin DME1077 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04546 XEO_CLAS Peptide DME1077 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04546 GENEFORM Protein DME1077 XEOTICID XEO04546 MOACRIVE Inhibition DME1077 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1077 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04548 XEO_CLAS Peptide DME1077 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 72000 ug/ml) DME1077 XEOTICID XEO04548 GENEFORM Protein DME1077 XEOTICID XEO04548 MOACRIVE Inhibition DME1077 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1077 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04549 XEO_CLAS Peptide DME1077 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 62-125 ug/ml) DME1077 XEOTICID XEO04549 GENEFORM Protein DME1077 XEOTICID XEO04549 MOACRIVE Inhibition DME1077 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1077 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04550 XEO_CLAS Peptide DME1077 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO04550 GENEFORM Protein DME1077 XEOTICID XEO04550 MOACRIVE Inhibition DME1077 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1077 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04551 XEO_CLAS Peptide DME1077 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 23.6 ug/ml) DME1077 XEOTICID XEO04551 GENEFORM Protein DME1077 XEOTICID XEO04551 MOACRIVE Inhibition DME1077 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1077 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04552 XEO_CLAS Peptide DME1077 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04552 GENEFORM Protein DME1077 XEOTICID XEO04552 MOACRIVE Inhibition DME1077 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1077 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04553 XEO_CLAS Peptide DME1077 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04553 GENEFORM Protein DME1077 XEOTICID XEO04553 MOACRIVE Inhibition DME1077 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1077 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04554 XEO_CLAS Peptide DME1077 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04554 GENEFORM Protein DME1077 XEOTICID XEO04554 MOACRIVE Inhibition DME1077 XEOTICID XEO04563 XEO_NAME Phosphate DME1077 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1077 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04563 GENEFORM Protein DME1077 XEOTICID XEO04563 MOACRIVE Inhibition DME1077 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1077 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04565 XEO_CLAS Peptide DME1077 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.5 microM) DME1077 XEOTICID XEO04565 GENEFORM Protein DME1077 XEOTICID XEO04565 MOACRIVE Inhibition DME1077 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1077 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04566 XEO_CLAS Peptide DME1077 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.7 microM) DME1077 XEOTICID XEO04566 GENEFORM Protein DME1077 XEOTICID XEO04566 MOACRIVE Inhibition DME1077 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1077 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04569 XEO_CLAS Peptide DME1077 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7.9 microM) DME1077 XEOTICID XEO04569 GENEFORM Protein DME1077 XEOTICID XEO04569 MOACRIVE Inhibition DME1077 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1077 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04570 XEO_CLAS Peptide DME1077 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04570 GENEFORM Protein DME1077 XEOTICID XEO04570 MOACRIVE Inhibition DME1077 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1077 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04571 XEO_CLAS Peptide DME1077 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04571 GENEFORM Protein DME1077 XEOTICID XEO04571 MOACRIVE Inhibition DME1077 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1077 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04572 XEO_CLAS Peptide DME1077 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04572 GENEFORM Protein DME1077 XEOTICID XEO04572 MOACRIVE Inhibition DME1077 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1077 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04573 XEO_CLAS Peptide DME1077 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 microM) DME1077 XEOTICID XEO04573 GENEFORM Protein DME1077 XEOTICID XEO04573 MOACRIVE Inhibition DME1077 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1077 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04574 XEO_CLAS Peptide DME1077 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 128 ug/ml) DME1077 XEOTICID XEO04574 GENEFORM Protein DME1077 XEOTICID XEO04574 MOACRIVE Inhibition DME1077 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1077 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04575 XEO_CLAS Peptide DME1077 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO04575 GENEFORM Protein DME1077 XEOTICID XEO04575 MOACRIVE Inhibition DME1077 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1077 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04578 GENEFORM Protein DME1077 XEOTICID XEO04578 MOACRIVE Inhibition DME1077 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1077 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04579 GENEFORM Protein DME1077 XEOTICID XEO04579 MOACRIVE Inhibition DME1077 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1077 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04580 GENEFORM Protein DME1077 XEOTICID XEO04580 MOACRIVE Inhibition DME1077 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1077 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04583 GENEFORM Protein DME1077 XEOTICID XEO04583 MOACRIVE Inhibition DME1077 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1077 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04588 GENEFORM Protein DME1077 XEOTICID XEO04588 MOACRIVE Inhibition DME1077 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1077 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04589 GENEFORM Protein DME1077 XEOTICID XEO04589 MOACRIVE Inhibition DME1077 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1077 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04590 GENEFORM Protein DME1077 XEOTICID XEO04590 MOACRIVE Inhibition DME1077 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1077 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04591 GENEFORM Protein DME1077 XEOTICID XEO04591 MOACRIVE Inhibition DME1077 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1077 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04592 GENEFORM Protein DME1077 XEOTICID XEO04592 MOACRIVE Inhibition DME1077 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1077 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04593 GENEFORM Protein DME1077 XEOTICID XEO04593 MOACRIVE Inhibition DME1077 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1077 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04594 GENEFORM Protein DME1077 XEOTICID XEO04594 MOACRIVE Inhibition DME1077 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1077 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04595 GENEFORM Protein DME1077 XEOTICID XEO04595 MOACRIVE Inhibition DME1077 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1077 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04596 GENEFORM Protein DME1077 XEOTICID XEO04596 MOACRIVE Inhibition DME1077 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1077 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04597 GENEFORM Protein DME1077 XEOTICID XEO04597 MOACRIVE Inhibition DME1077 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1077 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04598 GENEFORM Protein DME1077 XEOTICID XEO04598 MOACRIVE Inhibition DME1077 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1077 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04599 GENEFORM Protein DME1077 XEOTICID XEO04599 MOACRIVE Inhibition DME1077 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1077 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04601 XEO_CLAS Peptide DME1077 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 18.75 ug/ml) DME1077 XEOTICID XEO04601 GENEFORM Protein DME1077 XEOTICID XEO04601 MOACRIVE Inhibition DME1077 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1077 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04602 XEO_CLAS Peptide DME1077 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 37.5 ug/ml) DME1077 XEOTICID XEO04602 GENEFORM Protein DME1077 XEOTICID XEO04602 MOACRIVE Inhibition DME1077 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1077 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04604 XEO_CLAS Peptide DME1077 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC < 25 microM) DME1077 XEOTICID XEO04604 GENEFORM Protein DME1077 XEOTICID XEO04604 MOACRIVE Inhibition DME1077 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1077 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04605 XEO_CLAS Peptide DME1077 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC < 6.25 microM) DME1077 XEOTICID XEO04605 GENEFORM Protein DME1077 XEOTICID XEO04605 MOACRIVE Inhibition DME1077 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1077 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04606 XEO_CLAS Peptide DME1077 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO04606 GENEFORM Protein DME1077 XEOTICID XEO04606 MOACRIVE Inhibition DME1077 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1077 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1077 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04607 GENEFORM Protein DME1077 XEOTICID XEO04607 MOACRIVE Inhibition DME1077 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1077 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04612 XEO_CLAS Peptide DME1077 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5-10 microM) DME1077 XEOTICID XEO04612 GENEFORM Protein DME1077 XEOTICID XEO04612 MOACRIVE Inhibition DME1077 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1077 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04613 XEO_CLAS Peptide DME1077 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5-10 microM) DME1077 XEOTICID XEO04613 GENEFORM Protein DME1077 XEOTICID XEO04613 MOACRIVE Inhibition DME1077 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1077 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04625 XEO_CLAS Peptide DME1077 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO04625 GENEFORM Protein DME1077 XEOTICID XEO04625 MOACRIVE Inhibition DME1077 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1077 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04626 XEO_CLAS Peptide DME1077 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO04626 GENEFORM Protein DME1077 XEOTICID XEO04626 MOACRIVE Inhibition DME1077 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1077 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04627 XEO_CLAS Peptide DME1077 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.5 microM) DME1077 XEOTICID XEO04627 GENEFORM Protein DME1077 XEOTICID XEO04627 MOACRIVE Inhibition DME1077 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1077 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04630 XEO_CLAS Peptide DME1077 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 60 ug/ml) DME1077 XEOTICID XEO04630 GENEFORM Protein DME1077 XEOTICID XEO04630 MOACRIVE Inhibition DME1077 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1077 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04631 XEO_CLAS Peptide DME1077 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 60 ug/ml) DME1077 XEOTICID XEO04631 GENEFORM Protein DME1077 XEOTICID XEO04631 MOACRIVE Inhibition DME1077 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1077 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04633 XEO_CLAS Peptide DME1077 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 ug/ml) DME1077 XEOTICID XEO04633 GENEFORM Protein DME1077 XEOTICID XEO04633 MOACRIVE Inhibition DME1077 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1077 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04634 XEO_CLAS Peptide DME1077 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 ug/ml) DME1077 XEOTICID XEO04634 GENEFORM Protein DME1077 XEOTICID XEO04634 MOACRIVE Inhibition DME1077 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1077 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04635 XEO_CLAS Peptide DME1077 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 ug/ml) DME1077 XEOTICID XEO04635 GENEFORM Protein DME1077 XEOTICID XEO04635 MOACRIVE Inhibition DME1077 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1077 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04636 XEO_CLAS Peptide DME1077 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 ug/ml) DME1077 XEOTICID XEO04636 GENEFORM Protein DME1077 XEOTICID XEO04636 MOACRIVE Inhibition DME1077 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1077 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04637 XEO_CLAS Peptide DME1077 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 ug/ml) DME1077 XEOTICID XEO04637 GENEFORM Protein DME1077 XEOTICID XEO04637 MOACRIVE Inhibition DME1077 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1077 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04638 XEO_CLAS Peptide DME1077 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 ug/ml) DME1077 XEOTICID XEO04638 GENEFORM Protein DME1077 XEOTICID XEO04638 MOACRIVE Inhibition DME1077 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1077 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04639 XEO_CLAS Peptide DME1077 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 ug/ml) DME1077 XEOTICID XEO04639 GENEFORM Protein DME1077 XEOTICID XEO04639 MOACRIVE Inhibition DME1077 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1077 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04640 XEO_CLAS Peptide DME1077 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.2-3.3 microM) DME1077 XEOTICID XEO04640 GENEFORM Protein DME1077 XEOTICID XEO04640 MOACRIVE Inhibition DME1077 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1077 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04642 XEO_CLAS Peptide DME1077 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO04642 GENEFORM Protein DME1077 XEOTICID XEO04642 MOACRIVE Inhibition DME1077 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1077 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04643 XEO_CLAS Peptide DME1077 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO04643 GENEFORM Protein DME1077 XEOTICID XEO04643 MOACRIVE Inhibition DME1077 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1077 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04644 XEO_CLAS Peptide DME1077 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO04644 GENEFORM Protein DME1077 XEOTICID XEO04644 MOACRIVE Inhibition DME1077 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1077 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04645 XEO_CLAS Peptide DME1077 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 ug/ml) DME1077 XEOTICID XEO04645 GENEFORM Protein DME1077 XEOTICID XEO04645 MOACRIVE Inhibition DME1077 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1077 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04646 XEO_CLAS Peptide DME1077 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1 ug/ml) DME1077 XEOTICID XEO04646 GENEFORM Protein DME1077 XEOTICID XEO04646 MOACRIVE Inhibition DME1077 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1077 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04647 XEO_CLAS Peptide DME1077 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO04647 GENEFORM Protein DME1077 XEOTICID XEO04647 MOACRIVE Inhibition DME1077 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1077 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04648 XEO_CLAS Peptide DME1077 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 ug/ml) DME1077 XEOTICID XEO04648 GENEFORM Protein DME1077 XEOTICID XEO04648 MOACRIVE Inhibition DME1077 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1077 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04649 XEO_CLAS Peptide DME1077 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 64 ug/ml) DME1077 XEOTICID XEO04649 GENEFORM Protein DME1077 XEOTICID XEO04649 MOACRIVE Inhibition DME1077 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1077 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04650 XEO_CLAS Peptide DME1077 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 ug/ml) DME1077 XEOTICID XEO04650 GENEFORM Protein DME1077 XEOTICID XEO04650 MOACRIVE Inhibition DME1077 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1077 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04651 XEO_CLAS Peptide DME1077 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 ug/ml) DME1077 XEOTICID XEO04651 GENEFORM Protein DME1077 XEOTICID XEO04651 MOACRIVE Inhibition DME1077 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1077 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04652 XEO_CLAS Peptide DME1077 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO04652 GENEFORM Protein DME1077 XEOTICID XEO04652 MOACRIVE Inhibition DME1077 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1077 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04653 XEO_CLAS Peptide DME1077 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 64 ug/ml) DME1077 XEOTICID XEO04653 GENEFORM Protein DME1077 XEOTICID XEO04653 MOACRIVE Inhibition DME1077 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1077 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04654 XEO_CLAS Peptide DME1077 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 ug/ml) DME1077 XEOTICID XEO04654 GENEFORM Protein DME1077 XEOTICID XEO04654 MOACRIVE Inhibition DME1077 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1077 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04655 XEO_CLAS Peptide DME1077 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO04655 GENEFORM Protein DME1077 XEOTICID XEO04655 MOACRIVE Inhibition DME1077 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1077 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04657 XEO_CLAS Peptide DME1077 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 300 microM) DME1077 XEOTICID XEO04657 GENEFORM Protein DME1077 XEOTICID XEO04657 MOACRIVE Inhibition DME1077 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1077 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04660 XEO_CLAS Peptide DME1077 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO04660 GENEFORM Protein DME1077 XEOTICID XEO04660 MOACRIVE Inhibition DME1077 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1077 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04661 XEO_CLAS Peptide DME1077 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 microM) DME1077 XEOTICID XEO04661 GENEFORM Protein DME1077 XEOTICID XEO04661 MOACRIVE Inhibition DME1077 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1077 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04662 XEO_CLAS Peptide DME1077 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 microM) DME1077 XEOTICID XEO04662 GENEFORM Protein DME1077 XEOTICID XEO04662 MOACRIVE Inhibition DME1077 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1077 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04663 XEO_CLAS Peptide DME1077 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 microM) DME1077 XEOTICID XEO04663 GENEFORM Protein DME1077 XEOTICID XEO04663 MOACRIVE Inhibition DME1077 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1077 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04664 XEO_CLAS Peptide DME1077 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5.5 microM) DME1077 XEOTICID XEO04664 GENEFORM Protein DME1077 XEOTICID XEO04664 MOACRIVE Inhibition DME1077 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1077 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04665 XEO_CLAS Peptide DME1077 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 microM) DME1077 XEOTICID XEO04665 GENEFORM Protein DME1077 XEOTICID XEO04665 MOACRIVE Inhibition DME1077 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1077 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04666 XEO_CLAS Peptide DME1077 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO04666 GENEFORM Protein DME1077 XEOTICID XEO04666 MOACRIVE Inhibition DME1077 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1077 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04667 XEO_CLAS Peptide DME1077 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6.25 microM) DME1077 XEOTICID XEO04667 GENEFORM Protein DME1077 XEOTICID XEO04667 MOACRIVE Inhibition DME1077 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1077 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04668 XEO_CLAS Peptide DME1077 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 microM) DME1077 XEOTICID XEO04668 GENEFORM Protein DME1077 XEOTICID XEO04668 MOACRIVE Inhibition DME1077 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1077 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04669 XEO_CLAS Peptide DME1077 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO04669 GENEFORM Protein DME1077 XEOTICID XEO04669 MOACRIVE Inhibition DME1077 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1077 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04670 XEO_CLAS Peptide DME1077 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 21 microM) DME1077 XEOTICID XEO04670 GENEFORM Protein DME1077 XEOTICID XEO04670 MOACRIVE Inhibition DME1077 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1077 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04671 XEO_CLAS Peptide DME1077 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 62 microM) DME1077 XEOTICID XEO04671 GENEFORM Protein DME1077 XEOTICID XEO04671 MOACRIVE Inhibition DME1077 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1077 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04672 XEO_CLAS Peptide DME1077 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO04672 GENEFORM Protein DME1077 XEOTICID XEO04672 MOACRIVE Inhibition DME1077 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1077 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04673 XEO_CLAS Peptide DME1077 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO04673 GENEFORM Protein DME1077 XEOTICID XEO04673 MOACRIVE Inhibition DME1077 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1077 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04674 XEO_CLAS Peptide DME1077 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 75 microM) DME1077 XEOTICID XEO04674 GENEFORM Protein DME1077 XEOTICID XEO04674 MOACRIVE Inhibition DME1077 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1077 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04675 XEO_CLAS Peptide DME1077 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 microM) DME1077 XEOTICID XEO04675 GENEFORM Protein DME1077 XEOTICID XEO04675 MOACRIVE Inhibition DME1077 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1077 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04676 XEO_CLAS Peptide DME1077 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 microM) DME1077 XEOTICID XEO04676 GENEFORM Protein DME1077 XEOTICID XEO04676 MOACRIVE Inhibition DME1077 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1077 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04677 XEO_CLAS Peptide DME1077 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO04677 GENEFORM Protein DME1077 XEOTICID XEO04677 MOACRIVE Inhibition DME1077 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1077 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04680 XEO_CLAS Peptide DME1077 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 microM) DME1077 XEOTICID XEO04680 GENEFORM Protein DME1077 XEOTICID XEO04680 MOACRIVE Inhibition DME1077 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1077 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04682 XEO_CLAS Peptide DME1077 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 microM) DME1077 XEOTICID XEO04682 GENEFORM Protein DME1077 XEOTICID XEO04682 MOACRIVE Inhibition DME1077 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1077 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04683 XEO_CLAS Peptide DME1077 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 microM) DME1077 XEOTICID XEO04683 GENEFORM Protein DME1077 XEOTICID XEO04683 MOACRIVE Inhibition DME1077 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1077 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04684 XEO_CLAS Peptide DME1077 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 38 microM) DME1077 XEOTICID XEO04684 GENEFORM Protein DME1077 XEOTICID XEO04684 MOACRIVE Inhibition DME1077 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1077 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04690 XEO_CLAS Peptide DME1077 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.5 ug/ml) DME1077 XEOTICID XEO04690 GENEFORM Protein DME1077 XEOTICID XEO04690 MOACRIVE Inhibition DME1077 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1077 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04695 XEO_CLAS Peptide DME1077 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04695 GENEFORM Protein DME1077 XEOTICID XEO04695 MOACRIVE Inhibition DME1077 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1077 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04696 XEO_CLAS Peptide DME1077 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04696 GENEFORM Protein DME1077 XEOTICID XEO04696 MOACRIVE Inhibition DME1077 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1077 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04712 XEO_CLAS Peptide DME1077 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16.7 microM) DME1077 XEOTICID XEO04712 GENEFORM Protein DME1077 XEOTICID XEO04712 MOACRIVE Inhibition DME1077 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1077 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04713 XEO_CLAS Peptide DME1077 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16.7 microM) DME1077 XEOTICID XEO04713 GENEFORM Protein DME1077 XEOTICID XEO04713 MOACRIVE Inhibition DME1077 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1077 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04714 XEO_CLAS Peptide DME1077 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 23.3 microM) DME1077 XEOTICID XEO04714 GENEFORM Protein DME1077 XEOTICID XEO04714 MOACRIVE Inhibition DME1077 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1077 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04716 XEO_CLAS Peptide DME1077 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 microM) DME1077 XEOTICID XEO04716 GENEFORM Protein DME1077 XEOTICID XEO04716 MOACRIVE Inhibition DME1077 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1077 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04717 XEO_CLAS Peptide DME1077 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 50 microM) DME1077 XEOTICID XEO04717 GENEFORM Protein DME1077 XEOTICID XEO04717 MOACRIVE Inhibition DME1077 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1077 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04725 XEO_CLAS Peptide DME1077 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04725 GENEFORM Protein DME1077 XEOTICID XEO04725 MOACRIVE Inhibition DME1077 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1077 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04726 XEO_CLAS Peptide DME1077 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04726 GENEFORM Protein DME1077 XEOTICID XEO04726 MOACRIVE Inhibition DME1077 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1077 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04731 XEO_CLAS Peptide DME1077 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 ug/ml) DME1077 XEOTICID XEO04731 GENEFORM Protein DME1077 XEOTICID XEO04731 MOACRIVE Inhibition DME1077 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1077 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04732 XEO_CLAS Peptide DME1077 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 25 ug/ml) DME1077 XEOTICID XEO04732 GENEFORM Protein DME1077 XEOTICID XEO04732 MOACRIVE Inhibition DME1077 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1077 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04733 XEO_CLAS Peptide DME1077 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04733 GENEFORM Protein DME1077 XEOTICID XEO04733 MOACRIVE Inhibition DME1077 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1077 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04734 XEO_CLAS Peptide DME1077 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04734 GENEFORM Protein DME1077 XEOTICID XEO04734 MOACRIVE Inhibition DME1077 XEOTICID XEO04737 XEO_NAME Protonectin DME1077 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04737 XEO_CLAS Peptide DME1077 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 ug/ml) DME1077 XEOTICID XEO04737 GENEFORM Protein DME1077 XEOTICID XEO04737 MOACRIVE Inhibition DME1077 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1077 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04739 XEO_CLAS Peptide DME1077 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04739 GENEFORM Protein DME1077 XEOTICID XEO04739 MOACRIVE Inhibition DME1077 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1077 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04740 XEO_CLAS Peptide DME1077 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04740 GENEFORM Protein DME1077 XEOTICID XEO04740 MOACRIVE Inhibition DME1077 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1077 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04741 XEO_CLAS Peptide DME1077 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04741 GENEFORM Protein DME1077 XEOTICID XEO04741 MOACRIVE Inhibition DME1077 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1077 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04742 XEO_CLAS Peptide DME1077 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04742 GENEFORM Protein DME1077 XEOTICID XEO04742 MOACRIVE Inhibition DME1077 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1077 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04762 XEO_CLAS Peptide DME1077 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.8 microM) DME1077 XEOTICID XEO04762 GENEFORM Protein DME1077 XEOTICID XEO04762 MOACRIVE Inhibition DME1077 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1077 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04766 XEO_CLAS Peptide DME1077 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.1 microM) DME1077 XEOTICID XEO04766 GENEFORM Protein DME1077 XEOTICID XEO04766 MOACRIVE Inhibition DME1077 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1077 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04767 XEO_CLAS Peptide DME1077 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.1 ug/ml) DME1077 XEOTICID XEO04767 GENEFORM Protein DME1077 XEOTICID XEO04767 MOACRIVE Inhibition DME1077 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1077 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04779 XEO_CLAS Peptide DME1077 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04779 GENEFORM Protein DME1077 XEOTICID XEO04779 MOACRIVE Inhibition DME1077 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1077 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04780 XEO_CLAS Peptide DME1077 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04780 GENEFORM Protein DME1077 XEOTICID XEO04780 MOACRIVE Inhibition DME1077 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1077 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04781 XEO_CLAS Peptide DME1077 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04781 GENEFORM Protein DME1077 XEOTICID XEO04781 MOACRIVE Inhibition DME1077 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1077 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04782 XEO_CLAS Peptide DME1077 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 ug/ml) DME1077 XEOTICID XEO04782 GENEFORM Protein DME1077 XEOTICID XEO04782 MOACRIVE Inhibition DME1077 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1077 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04783 XEO_CLAS Peptide DME1077 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO04783 GENEFORM Protein DME1077 XEOTICID XEO04783 MOACRIVE Inhibition DME1077 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1077 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04784 XEO_CLAS Peptide DME1077 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO04784 GENEFORM Protein DME1077 XEOTICID XEO04784 MOACRIVE Inhibition DME1077 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1077 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04785 XEO_CLAS Peptide DME1077 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO04785 GENEFORM Protein DME1077 XEOTICID XEO04785 MOACRIVE Inhibition DME1077 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1077 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04786 XEO_CLAS Peptide DME1077 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 ug/ml) DME1077 XEOTICID XEO04786 GENEFORM Protein DME1077 XEOTICID XEO04786 MOACRIVE Inhibition DME1077 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1077 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04787 XEO_CLAS Peptide DME1077 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04787 GENEFORM Protein DME1077 XEOTICID XEO04787 MOACRIVE Inhibition DME1077 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1077 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04793 XEO_CLAS Peptide DME1077 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04793 GENEFORM Protein DME1077 XEOTICID XEO04793 MOACRIVE Inhibition DME1077 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1077 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04798 XEO_CLAS Peptide DME1077 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 microM) DME1077 XEOTICID XEO04798 GENEFORM Protein DME1077 XEOTICID XEO04798 MOACRIVE Inhibition DME1077 XEOTICID XEO04799 XEO_NAME Ranalexin DME1077 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04799 XEO_CLAS Peptide DME1077 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 32 ug/ml) DME1077 XEOTICID XEO04799 GENEFORM Protein DME1077 XEOTICID XEO04799 MOACRIVE Inhibition DME1077 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1077 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04800 XEO_CLAS Peptide DME1077 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 microM) DME1077 XEOTICID XEO04800 GENEFORM Protein DME1077 XEOTICID XEO04800 MOACRIVE Inhibition DME1077 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1077 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04801 XEO_CLAS Peptide DME1077 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 9 microM) DME1077 XEOTICID XEO04801 GENEFORM Protein DME1077 XEOTICID XEO04801 MOACRIVE Inhibition DME1077 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1077 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04802 XEO_CLAS Peptide DME1077 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12 microM) DME1077 XEOTICID XEO04802 GENEFORM Protein DME1077 XEOTICID XEO04802 MOACRIVE Inhibition DME1077 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1077 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04803 XEO_CLAS Peptide DME1077 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO04803 GENEFORM Protein DME1077 XEOTICID XEO04803 MOACRIVE Inhibition DME1077 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1077 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04804 XEO_CLAS Peptide DME1077 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO04804 GENEFORM Protein DME1077 XEOTICID XEO04804 MOACRIVE Inhibition DME1077 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1077 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04805 XEO_CLAS Peptide DME1077 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.5 microM) DME1077 XEOTICID XEO04805 GENEFORM Protein DME1077 XEOTICID XEO04805 MOACRIVE Inhibition DME1077 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1077 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04806 XEO_CLAS Peptide DME1077 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.5 microM) DME1077 XEOTICID XEO04806 GENEFORM Protein DME1077 XEOTICID XEO04806 MOACRIVE Inhibition DME1077 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1077 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04807 XEO_CLAS Peptide DME1077 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04807 GENEFORM Protein DME1077 XEOTICID XEO04807 MOACRIVE Inhibition DME1077 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1077 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04809 XEO_CLAS Peptide DME1077 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 microM) DME1077 XEOTICID XEO04809 GENEFORM Protein DME1077 XEOTICID XEO04809 MOACRIVE Inhibition DME1077 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1077 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04811 XEO_CLAS Peptide DME1077 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO04811 GENEFORM Protein DME1077 XEOTICID XEO04811 MOACRIVE Inhibition DME1077 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1077 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04812 XEO_CLAS Peptide DME1077 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO04812 GENEFORM Protein DME1077 XEOTICID XEO04812 MOACRIVE Inhibition DME1077 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1077 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04813 XEO_CLAS Peptide DME1077 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 microM) DME1077 XEOTICID XEO04813 GENEFORM Protein DME1077 XEOTICID XEO04813 MOACRIVE Inhibition DME1077 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1077 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04814 XEO_CLAS Peptide DME1077 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 19 microM) DME1077 XEOTICID XEO04814 GENEFORM Protein DME1077 XEOTICID XEO04814 MOACRIVE Inhibition DME1077 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1077 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04815 XEO_CLAS Peptide DME1077 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 microM) DME1077 XEOTICID XEO04815 GENEFORM Protein DME1077 XEOTICID XEO04815 MOACRIVE Inhibition DME1077 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1077 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04816 XEO_CLAS Peptide DME1077 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 microM) DME1077 XEOTICID XEO04816 GENEFORM Protein DME1077 XEOTICID XEO04816 MOACRIVE Inhibition DME1077 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1077 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04817 XEO_CLAS Peptide DME1077 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 13 microM) DME1077 XEOTICID XEO04817 GENEFORM Protein DME1077 XEOTICID XEO04817 MOACRIVE Inhibition DME1077 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1077 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04818 XEO_CLAS Peptide DME1077 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO04818 GENEFORM Protein DME1077 XEOTICID XEO04818 MOACRIVE Inhibition DME1077 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1077 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04819 XEO_CLAS Peptide DME1077 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO04819 GENEFORM Protein DME1077 XEOTICID XEO04819 MOACRIVE Inhibition DME1077 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1077 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04820 XEO_CLAS Peptide DME1077 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3 microM) DME1077 XEOTICID XEO04820 GENEFORM Protein DME1077 XEOTICID XEO04820 MOACRIVE Inhibition DME1077 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1077 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04821 XEO_CLAS Peptide DME1077 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 microM) DME1077 XEOTICID XEO04821 GENEFORM Protein DME1077 XEOTICID XEO04821 MOACRIVE Inhibition DME1077 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1077 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04822 XEO_CLAS Peptide DME1077 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO04822 GENEFORM Protein DME1077 XEOTICID XEO04822 MOACRIVE Inhibition DME1077 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1077 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04823 XEO_CLAS Peptide DME1077 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 23 microM) DME1077 XEOTICID XEO04823 GENEFORM Protein DME1077 XEOTICID XEO04823 MOACRIVE Inhibition DME1077 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1077 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04824 XEO_CLAS Peptide DME1077 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04824 GENEFORM Protein DME1077 XEOTICID XEO04824 MOACRIVE Inhibition DME1077 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1077 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04825 XEO_CLAS Peptide DME1077 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04825 GENEFORM Protein DME1077 XEOTICID XEO04825 MOACRIVE Inhibition DME1077 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1077 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04826 XEO_CLAS Peptide DME1077 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO04826 GENEFORM Protein DME1077 XEOTICID XEO04826 MOACRIVE Inhibition DME1077 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1077 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04827 XEO_CLAS Peptide DME1077 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO04827 GENEFORM Protein DME1077 XEOTICID XEO04827 MOACRIVE Inhibition DME1077 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1077 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04835 XEO_CLAS Peptide DME1077 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04835 GENEFORM Protein DME1077 XEOTICID XEO04835 MOACRIVE Inhibition DME1077 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1077 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04836 XEO_CLAS Peptide DME1077 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04836 GENEFORM Protein DME1077 XEOTICID XEO04836 MOACRIVE Inhibition DME1077 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1077 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04837 XEO_CLAS Peptide DME1077 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 microM) DME1077 XEOTICID XEO04837 GENEFORM Protein DME1077 XEOTICID XEO04837 MOACRIVE Inhibition DME1077 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1077 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04839 XEO_CLAS Peptide DME1077 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04839 GENEFORM Protein DME1077 XEOTICID XEO04839 MOACRIVE Inhibition DME1077 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1077 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04840 XEO_CLAS Peptide DME1077 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 35-20 microM) DME1077 XEOTICID XEO04840 GENEFORM Protein DME1077 XEOTICID XEO04840 MOACRIVE Inhibition DME1077 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1077 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04847 XEO_CLAS Peptide DME1077 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04847 GENEFORM Protein DME1077 XEOTICID XEO04847 MOACRIVE Inhibition DME1077 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1077 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04848 XEO_CLAS Peptide DME1077 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04848 GENEFORM Protein DME1077 XEOTICID XEO04848 MOACRIVE Inhibition DME1077 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1077 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04849 XEO_CLAS Peptide DME1077 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04849 GENEFORM Protein DME1077 XEOTICID XEO04849 MOACRIVE Inhibition DME1077 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1077 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04850 XEO_CLAS Peptide DME1077 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04850 GENEFORM Protein DME1077 XEOTICID XEO04850 MOACRIVE Inhibition DME1077 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1077 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04851 XEO_CLAS Peptide DME1077 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1 ug/ml) DME1077 XEOTICID XEO04851 GENEFORM Protein DME1077 XEOTICID XEO04851 MOACRIVE Inhibition DME1077 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1077 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04857 XEO_CLAS Peptide DME1077 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 microM) DME1077 XEOTICID XEO04857 GENEFORM Protein DME1077 XEOTICID XEO04857 MOACRIVE Inhibition DME1077 XEOTICID XEO04863 XEO_NAME RTD peptide DME1077 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04863 XEO_CLAS Peptide DME1077 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.0 microM) DME1077 XEOTICID XEO04863 GENEFORM Protein DME1077 XEOTICID XEO04863 MOACRIVE Inhibition DME1077 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1077 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04865 XEO_CLAS Peptide DME1077 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 ug/ml) DME1077 XEOTICID XEO04865 GENEFORM Protein DME1077 XEOTICID XEO04865 MOACRIVE Inhibition DME1077 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1077 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04866 XEO_CLAS Peptide DME1077 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12.5 ug/ml) DME1077 XEOTICID XEO04866 GENEFORM Protein DME1077 XEOTICID XEO04866 MOACRIVE Inhibition DME1077 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1077 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04868 XEO_CLAS Peptide DME1077 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25.00 ug/ml) DME1077 XEOTICID XEO04868 GENEFORM Protein DME1077 XEOTICID XEO04868 MOACRIVE Inhibition DME1077 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1077 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04869 XEO_CLAS Peptide DME1077 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25.00 ug/ml) DME1077 XEOTICID XEO04869 GENEFORM Protein DME1077 XEOTICID XEO04869 MOACRIVE Inhibition DME1077 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1077 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04870 XEO_CLAS Peptide DME1077 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25.00 ug/ml) DME1077 XEOTICID XEO04870 GENEFORM Protein DME1077 XEOTICID XEO04870 MOACRIVE Inhibition DME1077 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1077 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04877 XEO_CLAS Peptide DME1077 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04877 GENEFORM Protein DME1077 XEOTICID XEO04877 MOACRIVE Inhibition DME1077 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1077 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04880 XEO_CLAS Peptide DME1077 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.5 ug/ml) DME1077 XEOTICID XEO04880 GENEFORM Protein DME1077 XEOTICID XEO04880 MOACRIVE Inhibition DME1077 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1077 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04886 XEO_CLAS Peptide DME1077 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.6 ug/ml) DME1077 XEOTICID XEO04886 GENEFORM Protein DME1077 XEOTICID XEO04886 MOACRIVE Inhibition DME1077 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1077 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04891 XEO_CLAS Peptide DME1077 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04891 GENEFORM Protein DME1077 XEOTICID XEO04891 MOACRIVE Inhibition DME1077 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1077 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04895 XEO_CLAS Peptide DME1077 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04895 GENEFORM Protein DME1077 XEOTICID XEO04895 MOACRIVE Inhibition DME1077 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1077 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04901 XEO_CLAS Peptide DME1077 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 microM) DME1077 XEOTICID XEO04901 GENEFORM Protein DME1077 XEOTICID XEO04901 MOACRIVE Inhibition DME1077 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1077 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04904 XEO_CLAS Peptide DME1077 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 78 ug/ml) DME1077 XEOTICID XEO04904 GENEFORM Protein DME1077 XEOTICID XEO04904 MOACRIVE Inhibition DME1077 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1077 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04905 XEO_CLAS Peptide DME1077 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04905 GENEFORM Protein DME1077 XEOTICID XEO04905 MOACRIVE Inhibition DME1077 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1077 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04906 XEO_CLAS Peptide DME1077 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04906 GENEFORM Protein DME1077 XEOTICID XEO04906 MOACRIVE Inhibition DME1077 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1077 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04907 XEO_CLAS Peptide DME1077 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04907 GENEFORM Protein DME1077 XEOTICID XEO04907 MOACRIVE Inhibition DME1077 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1077 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04908 XEO_CLAS Peptide DME1077 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04908 GENEFORM Protein DME1077 XEOTICID XEO04908 MOACRIVE Inhibition DME1077 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1077 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04909 XEO_CLAS Peptide DME1077 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04909 GENEFORM Protein DME1077 XEOTICID XEO04909 MOACRIVE Inhibition DME1077 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1077 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04915 XEO_CLAS Peptide DME1077 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 100 ug/ml) DME1077 XEOTICID XEO04915 GENEFORM Protein DME1077 XEOTICID XEO04915 MOACRIVE Inhibition DME1077 XEOTICID XEO04916 XEO_NAME Scopoletin DME1077 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1077 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04916 GENEFORM Protein DME1077 XEOTICID XEO04916 MOACRIVE Inhibition DME1077 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1077 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04926 XEO_CLAS Peptide DME1077 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04926 GENEFORM Protein DME1077 XEOTICID XEO04926 MOACRIVE Inhibition DME1077 XEOTICID XEO04931 XEO_NAME Shepherin I DME1077 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04931 XEO_CLAS Peptide DME1077 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04931 GENEFORM Protein DME1077 XEOTICID XEO04931 MOACRIVE Inhibition DME1077 XEOTICID XEO04932 XEO_NAME shepherin II DME1077 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04932 XEO_CLAS Peptide DME1077 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04932 GENEFORM Protein DME1077 XEOTICID XEO04932 MOACRIVE Inhibition DME1077 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1077 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04938 XEO_CLAS Peptide DME1077 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC <= 100 microM) DME1077 XEOTICID XEO04938 GENEFORM Protein DME1077 XEOTICID XEO04938 MOACRIVE Inhibition DME1077 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1077 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04947 XEO_CLAS Natural Product DME1077 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04947 GENEFORM Protein DME1077 XEOTICID XEO04947 MOACRIVE Inhibition DME1077 XEOTICID XEO04948 XEO_NAME Sinensetin DME1077 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1077 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1077 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04948 GENEFORM Protein DME1077 XEOTICID XEO04948 MOACRIVE Inhibition DME1077 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1077 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04950 XEO_CLAS Peptide DME1077 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 ug/ml) DME1077 XEOTICID XEO04950 GENEFORM Protein DME1077 XEOTICID XEO04950 MOACRIVE Inhibition DME1077 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1077 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04955 XEO_CLAS Peptide DME1077 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.07 microM) DME1077 XEOTICID XEO04955 GENEFORM Protein DME1077 XEOTICID XEO04955 MOACRIVE Inhibition DME1077 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1077 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04956 XEO_CLAS Peptide DME1077 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16.0 microM) DME1077 XEOTICID XEO04956 GENEFORM Protein DME1077 XEOTICID XEO04956 MOACRIVE Inhibition DME1077 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1077 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04957 XEO_CLAS Peptide DME1077 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.23 microM) DME1077 XEOTICID XEO04957 GENEFORM Protein DME1077 XEOTICID XEO04957 MOACRIVE Inhibition DME1077 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1077 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04958 XEO_CLAS Peptide DME1077 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 ug/ml) DME1077 XEOTICID XEO04958 GENEFORM Protein DME1077 XEOTICID XEO04958 MOACRIVE Inhibition DME1077 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1077 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04959 XEO_CLAS Peptide DME1077 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04959 GENEFORM Protein DME1077 XEOTICID XEO04959 MOACRIVE Inhibition DME1077 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1077 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04967 XEO_CLAS Peptide DME1077 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 28 microM) DME1077 XEOTICID XEO04967 GENEFORM Protein DME1077 XEOTICID XEO04967 MOACRIVE Inhibition DME1077 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1077 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04969 XEO_CLAS Peptide DME1077 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50-100 ug/ml) DME1077 XEOTICID XEO04969 GENEFORM Protein DME1077 XEOTICID XEO04969 MOACRIVE Inhibition DME1077 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1077 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04970 XEO_CLAS Peptide DME1077 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04970 GENEFORM Protein DME1077 XEOTICID XEO04970 MOACRIVE Inhibition DME1077 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1077 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04971 XEO_CLAS Peptide DME1077 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.8-1.5 microM) DME1077 XEOTICID XEO04971 GENEFORM Protein DME1077 XEOTICID XEO04971 MOACRIVE Inhibition DME1077 XEOTICID XEO04974 XEO_NAME Spinigerin DME1077 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04974 XEO_CLAS Peptide DME1077 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3-6 microM) DME1077 XEOTICID XEO04974 GENEFORM Protein DME1077 XEOTICID XEO04974 MOACRIVE Inhibition DME1077 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1077 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1077 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04975 GENEFORM Protein DME1077 XEOTICID XEO04975 MOACRIVE Inhibition DME1077 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1077 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1077 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04976 GENEFORM Protein DME1077 XEOTICID XEO04976 MOACRIVE Inhibition DME1077 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1077 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1077 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04977 GENEFORM Protein DME1077 XEOTICID XEO04977 MOACRIVE Inhibition DME1077 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1077 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1077 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04978 GENEFORM Protein DME1077 XEOTICID XEO04978 MOACRIVE Inhibition DME1077 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1077 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1077 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04979 GENEFORM Protein DME1077 XEOTICID XEO04979 MOACRIVE Inhibition DME1077 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1077 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04981 XEO_CLAS Peptide DME1077 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10.1 microM) DME1077 XEOTICID XEO04981 GENEFORM Protein DME1077 XEOTICID XEO04981 MOACRIVE Inhibition DME1077 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1077 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04982 XEO_CLAS Peptide DME1077 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40.5 microM) DME1077 XEOTICID XEO04982 GENEFORM Protein DME1077 XEOTICID XEO04982 MOACRIVE Inhibition DME1077 XEOTICID XEO04994 XEO_NAME Stilbene DME1077 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1077 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1077 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO04994 GENEFORM Protein DME1077 XEOTICID XEO04994 MOACRIVE Inhibition DME1077 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1077 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04995 XEO_CLAS Peptide DME1077 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC < 0.19 microM) DME1077 XEOTICID XEO04995 GENEFORM Protein DME1077 XEOTICID XEO04995 MOACRIVE Inhibition DME1077 XEOTICID XEO04998 XEO_NAME Styelin A DME1077 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04998 XEO_CLAS Peptide DME1077 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.7 ug/ml) DME1077 XEOTICID XEO04998 GENEFORM Protein DME1077 XEOTICID XEO04998 MOACRIVE Inhibition DME1077 XEOTICID XEO04999 XEO_NAME Styelin B DME1077 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO04999 XEO_CLAS Peptide DME1077 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.7 ug/ml) DME1077 XEOTICID XEO04999 GENEFORM Protein DME1077 XEOTICID XEO04999 MOACRIVE Inhibition DME1077 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1077 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05000 XEO_CLAS Peptide DME1077 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO05000 GENEFORM Protein DME1077 XEOTICID XEO05000 MOACRIVE Inhibition DME1077 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1077 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05001 XEO_CLAS Peptide DME1077 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.5 ug/ml) DME1077 XEOTICID XEO05001 GENEFORM Protein DME1077 XEOTICID XEO05001 MOACRIVE Inhibition DME1077 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1077 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05002 XEO_CLAS Peptide DME1077 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO05002 GENEFORM Protein DME1077 XEOTICID XEO05002 MOACRIVE Inhibition DME1077 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1077 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05003 XEO_CLAS Peptide DME1077 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO05003 GENEFORM Protein DME1077 XEOTICID XEO05003 MOACRIVE Inhibition DME1077 XEOTICID XEO05006 XEO_NAME Substance P DME1077 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05006 XEO_CLAS Peptide DME1077 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05006 GENEFORM Protein DME1077 XEOTICID XEO05006 MOACRIVE Inhibition DME1077 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1077 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05007 XEO_CLAS Peptide DME1077 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05007 GENEFORM Protein DME1077 XEOTICID XEO05007 MOACRIVE Inhibition DME1077 XEOTICID XEO05008 XEO_NAME Subtilosin DME1077 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05008 XEO_CLAS Peptide DME1077 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05008 GENEFORM Protein DME1077 XEOTICID XEO05008 MOACRIVE Inhibition DME1077 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1077 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05013 XEO_CLAS Peptide DME1077 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO05013 GENEFORM Protein DME1077 XEOTICID XEO05013 MOACRIVE Inhibition DME1077 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1077 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05014 XEO_CLAS Peptide DME1077 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO05014 GENEFORM Protein DME1077 XEOTICID XEO05014 MOACRIVE Inhibition DME1077 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1077 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05015 XEO_CLAS Peptide DME1077 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO05015 GENEFORM Protein DME1077 XEOTICID XEO05015 MOACRIVE Inhibition DME1077 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1077 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05016 XEO_CLAS Peptide DME1077 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO05016 GENEFORM Protein DME1077 XEOTICID XEO05016 MOACRIVE Inhibition DME1077 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1077 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05017 XEO_CLAS Peptide DME1077 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 20 ug/ml) DME1077 XEOTICID XEO05017 GENEFORM Protein DME1077 XEOTICID XEO05017 MOACRIVE Inhibition DME1077 XEOTICID XEO05018 XEO_NAME Syringic acid DME1077 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1077 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05018 GENEFORM Protein DME1077 XEOTICID XEO05018 MOACRIVE Inhibition DME1077 XEOTICID XEO05020 XEO_NAME Tachycitin DME1077 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05020 XEO_CLAS Peptide DME1077 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05020 GENEFORM Protein DME1077 XEOTICID XEO05020 MOACRIVE Inhibition DME1077 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1077 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05023 XEO_CLAS Peptide DME1077 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05023 GENEFORM Protein DME1077 XEOTICID XEO05023 MOACRIVE Inhibition DME1077 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1077 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05024 XEO_CLAS Peptide DME1077 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05024 GENEFORM Protein DME1077 XEOTICID XEO05024 MOACRIVE Inhibition DME1077 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1077 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05027 XEO_CLAS Peptide DME1077 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05027 GENEFORM Protein DME1077 XEOTICID XEO05027 MOACRIVE Inhibition DME1077 XEOTICID XEO05031 XEO_NAME Tannic acid DME1077 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1077 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05031 GENEFORM Protein DME1077 XEOTICID XEO05031 MOACRIVE Inhibition DME1077 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1077 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05033 XEO_CLAS Peptide DME1077 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05033 GENEFORM Protein DME1077 XEOTICID XEO05033 MOACRIVE Inhibition DME1077 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1077 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05042 XEO_CLAS Peptide DME1077 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO05042 GENEFORM Protein DME1077 XEOTICID XEO05042 MOACRIVE Inhibition DME1077 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1077 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05043 XEO_CLAS Peptide DME1077 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO05043 GENEFORM Protein DME1077 XEOTICID XEO05043 MOACRIVE Inhibition DME1077 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1077 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05044 XEO_CLAS Peptide DME1077 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 128 microM) DME1077 XEOTICID XEO05044 GENEFORM Protein DME1077 XEOTICID XEO05044 MOACRIVE Inhibition DME1077 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1077 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05045 XEO_CLAS Peptide DME1077 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 128 microM) DME1077 XEOTICID XEO05045 GENEFORM Protein DME1077 XEOTICID XEO05045 MOACRIVE Inhibition DME1077 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1077 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05046 XEO_CLAS Peptide DME1077 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 microM) DME1077 XEOTICID XEO05046 GENEFORM Protein DME1077 XEOTICID XEO05046 MOACRIVE Inhibition DME1077 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1077 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05047 XEO_CLAS Peptide DME1077 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 60 microM) DME1077 XEOTICID XEO05047 GENEFORM Protein DME1077 XEOTICID XEO05047 MOACRIVE Inhibition DME1077 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1077 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05051 XEO_CLAS Peptide DME1077 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05051 GENEFORM Protein DME1077 XEOTICID XEO05051 MOACRIVE Inhibition DME1077 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1077 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05055 XEO_CLAS Peptide DME1077 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 70 microM) DME1077 XEOTICID XEO05055 GENEFORM Protein DME1077 XEOTICID XEO05055 MOACRIVE Inhibition DME1077 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1077 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05056 XEO_CLAS Peptide DME1077 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05056 GENEFORM Protein DME1077 XEOTICID XEO05056 MOACRIVE Inhibition DME1077 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1077 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05059 XEO_CLAS Peptide DME1077 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05059 GENEFORM Protein DME1077 XEOTICID XEO05059 MOACRIVE Inhibition DME1077 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1077 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05061 XEO_CLAS Peptide DME1077 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO05061 GENEFORM Protein DME1077 XEOTICID XEO05061 MOACRIVE Inhibition DME1077 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1077 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05062 XEO_CLAS Peptide DME1077 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05062 GENEFORM Protein DME1077 XEOTICID XEO05062 MOACRIVE Inhibition DME1077 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1077 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05063 XEO_CLAS Peptide DME1077 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO05063 GENEFORM Protein DME1077 XEOTICID XEO05063 MOACRIVE Inhibition DME1077 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1077 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05064 XEO_CLAS Peptide DME1077 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 231 microM) DME1077 XEOTICID XEO05064 GENEFORM Protein DME1077 XEOTICID XEO05064 MOACRIVE Inhibition DME1077 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1077 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05065 XEO_CLAS Peptide DME1077 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 161 ug/ml) DME1077 XEOTICID XEO05065 GENEFORM Protein DME1077 XEOTICID XEO05065 MOACRIVE Inhibition DME1077 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1077 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05069 XEO_CLAS Peptide DME1077 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO05069 GENEFORM Protein DME1077 XEOTICID XEO05069 MOACRIVE Inhibition DME1077 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1077 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05070 XEO_CLAS Peptide DME1077 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 37.5 microM) DME1077 XEOTICID XEO05070 GENEFORM Protein DME1077 XEOTICID XEO05070 MOACRIVE Inhibition DME1077 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1077 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05071 XEO_CLAS Peptide DME1077 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 150 microM) DME1077 XEOTICID XEO05071 GENEFORM Protein DME1077 XEOTICID XEO05071 MOACRIVE Inhibition DME1077 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1077 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05072 XEO_CLAS Peptide DME1077 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO05072 GENEFORM Protein DME1077 XEOTICID XEO05072 MOACRIVE Inhibition DME1077 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1077 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05073 XEO_CLAS Peptide DME1077 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40 microM) DME1077 XEOTICID XEO05073 GENEFORM Protein DME1077 XEOTICID XEO05073 MOACRIVE Inhibition DME1077 XEOTICID XEO05076 XEO_NAME Temporin-A DME1077 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05076 XEO_CLAS Peptide DME1077 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 11.9 microM) DME1077 XEOTICID XEO05076 GENEFORM Protein DME1077 XEOTICID XEO05076 MOACRIVE Inhibition DME1077 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1077 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05077 XEO_CLAS Peptide DME1077 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.25 ug/ml) DME1077 XEOTICID XEO05077 GENEFORM Protein DME1077 XEOTICID XEO05077 MOACRIVE Inhibition DME1077 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1077 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05078 XEO_CLAS Peptide DME1077 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.25 ug/ml) DME1077 XEOTICID XEO05078 GENEFORM Protein DME1077 XEOTICID XEO05078 MOACRIVE Inhibition DME1077 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1077 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05079 XEO_CLAS Peptide DME1077 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.5 ug/ml) DME1077 XEOTICID XEO05079 GENEFORM Protein DME1077 XEOTICID XEO05079 MOACRIVE Inhibition DME1077 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1077 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05080 XEO_CLAS Peptide DME1077 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 ug/ml) DME1077 XEOTICID XEO05080 GENEFORM Protein DME1077 XEOTICID XEO05080 MOACRIVE Inhibition DME1077 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1077 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05081 XEO_CLAS Peptide DME1077 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 5 ug/ml) DME1077 XEOTICID XEO05081 GENEFORM Protein DME1077 XEOTICID XEO05081 MOACRIVE Inhibition DME1077 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1077 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05082 XEO_CLAS Peptide DME1077 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7.5 ug/ml) DME1077 XEOTICID XEO05082 GENEFORM Protein DME1077 XEOTICID XEO05082 MOACRIVE Inhibition DME1077 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1077 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05083 XEO_CLAS Peptide DME1077 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 ug/ml) DME1077 XEOTICID XEO05083 GENEFORM Protein DME1077 XEOTICID XEO05083 MOACRIVE Inhibition DME1077 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1077 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05084 XEO_CLAS Peptide DME1077 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 ug/ml) DME1077 XEOTICID XEO05084 GENEFORM Protein DME1077 XEOTICID XEO05084 MOACRIVE Inhibition DME1077 XEOTICID XEO05085 XEO_NAME Temporin-B DME1077 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05085 XEO_CLAS Peptide DME1077 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 21.0 ug/ml) DME1077 XEOTICID XEO05085 GENEFORM Protein DME1077 XEOTICID XEO05085 MOACRIVE Inhibition DME1077 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1077 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05086 XEO_CLAS Peptide DME1077 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC > 100 microM) DME1077 XEOTICID XEO05086 GENEFORM Protein DME1077 XEOTICID XEO05086 MOACRIVE Inhibition DME1077 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1077 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05087 XEO_CLAS Peptide DME1077 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO05087 GENEFORM Protein DME1077 XEOTICID XEO05087 MOACRIVE Inhibition DME1077 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1077 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05097 XEO_CLAS Peptide DME1077 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16.0 microM) DME1077 XEOTICID XEO05097 GENEFORM Protein DME1077 XEOTICID XEO05097 MOACRIVE Inhibition DME1077 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1077 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05099 XEO_CLAS Peptide DME1077 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.0 microM) DME1077 XEOTICID XEO05099 GENEFORM Protein DME1077 XEOTICID XEO05099 MOACRIVE Inhibition DME1077 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1077 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05100 XEO_CLAS Peptide DME1077 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05100 GENEFORM Protein DME1077 XEOTICID XEO05100 MOACRIVE Inhibition DME1077 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1077 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05101 XEO_CLAS Peptide DME1077 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 24.2 ug/ml) DME1077 XEOTICID XEO05101 GENEFORM Protein DME1077 XEOTICID XEO05101 MOACRIVE Inhibition DME1077 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1077 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05102 XEO_CLAS Peptide DME1077 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 34.5 ug/ml) DME1077 XEOTICID XEO05102 GENEFORM Protein DME1077 XEOTICID XEO05102 MOACRIVE Inhibition DME1077 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1077 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05105 XEO_CLAS Peptide DME1077 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO05105 GENEFORM Protein DME1077 XEOTICID XEO05105 MOACRIVE Inhibition DME1077 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1077 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05106 XEO_CLAS Peptide DME1077 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25-200 microM) DME1077 XEOTICID XEO05106 GENEFORM Protein DME1077 XEOTICID XEO05106 MOACRIVE Inhibition DME1077 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1077 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05108 XEO_CLAS Peptide DME1077 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40 microM) DME1077 XEOTICID XEO05108 GENEFORM Protein DME1077 XEOTICID XEO05108 MOACRIVE Inhibition DME1077 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1077 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1077 XEOTICID XEO05111 XEO_CLAS Natural Product DME1077 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05111 GENEFORM Protein DME1077 XEOTICID XEO05111 MOACRIVE Inhibition DME1077 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1077 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05119 XEO_CLAS Peptide DME1077 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05119 GENEFORM Protein DME1077 XEOTICID XEO05119 MOACRIVE Inhibition DME1077 XEOTICID XEO05120 XEO_NAME Thanatin DME1077 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05120 XEO_CLAS Peptide DME1077 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1077 XEOTICID XEO05120 GENEFORM Protein DME1077 XEOTICID XEO05120 MOACRIVE Inhibition DME1077 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1077 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05121 XEO_CLAS Peptide DME1077 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 62.5 ug/ml) DME1077 XEOTICID XEO05121 GENEFORM Protein DME1077 XEOTICID XEO05121 MOACRIVE Inhibition DME1077 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1077 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05125 XEO_CLAS Peptide DME1077 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05125 GENEFORM Protein DME1077 XEOTICID XEO05125 MOACRIVE Inhibition DME1077 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1077 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05130 XEO_CLAS Peptide DME1077 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05130 GENEFORM Protein DME1077 XEOTICID XEO05130 MOACRIVE Inhibition DME1077 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1077 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05144 XEO_CLAS Peptide DME1077 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40 ug/ml) DME1077 XEOTICID XEO05144 GENEFORM Protein DME1077 XEOTICID XEO05144 MOACRIVE Inhibition DME1077 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1077 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05145 XEO_CLAS Peptide DME1077 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 ug/ml) DME1077 XEOTICID XEO05145 GENEFORM Protein DME1077 XEOTICID XEO05145 MOACRIVE Inhibition DME1077 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1077 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05146 XEO_CLAS Peptide DME1077 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 40 ug/ml) DME1077 XEOTICID XEO05146 GENEFORM Protein DME1077 XEOTICID XEO05146 MOACRIVE Inhibition DME1077 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1077 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05147 XEO_CLAS Peptide DME1077 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 60 ug/ml) DME1077 XEOTICID XEO05147 GENEFORM Protein DME1077 XEOTICID XEO05147 MOACRIVE Inhibition DME1077 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1077 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05158 XEO_CLAS Peptide DME1077 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05158 GENEFORM Protein DME1077 XEOTICID XEO05158 MOACRIVE Inhibition DME1077 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1077 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05161 XEO_CLAS Peptide DME1077 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 32 ug/ml) DME1077 XEOTICID XEO05161 GENEFORM Protein DME1077 XEOTICID XEO05161 MOACRIVE Inhibition DME1077 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1077 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05162 XEO_CLAS Peptide DME1077 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 32 ug/ml) DME1077 XEOTICID XEO05162 GENEFORM Protein DME1077 XEOTICID XEO05162 MOACRIVE Inhibition DME1077 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1077 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05163 XEO_CLAS Peptide DME1077 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 12-25 ug/ml) DME1077 XEOTICID XEO05163 GENEFORM Protein DME1077 XEOTICID XEO05163 MOACRIVE Inhibition DME1077 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1077 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05170 XEO_CLAS Peptide DME1077 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 3.0 microM) DME1077 XEOTICID XEO05170 GENEFORM Protein DME1077 XEOTICID XEO05170 MOACRIVE Inhibition DME1077 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1077 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05171 XEO_CLAS Peptide DME1077 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 50 microM) DME1077 XEOTICID XEO05171 GENEFORM Protein DME1077 XEOTICID XEO05171 MOACRIVE Inhibition DME1077 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1077 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05179 XEO_CLAS Peptide DME1077 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05179 GENEFORM Protein DME1077 XEOTICID XEO05179 MOACRIVE Inhibition DME1077 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1077 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05180 XEO_CLAS Peptide DME1077 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 160 microM) DME1077 XEOTICID XEO05180 GENEFORM Protein DME1077 XEOTICID XEO05180 MOACRIVE Inhibition DME1077 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1077 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05182 XEO_CLAS Peptide DME1077 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 microM) DME1077 XEOTICID XEO05182 GENEFORM Protein DME1077 XEOTICID XEO05182 MOACRIVE Inhibition DME1077 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1077 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05183 XEO_CLAS Peptide DME1077 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 microM) DME1077 XEOTICID XEO05183 GENEFORM Protein DME1077 XEOTICID XEO05183 MOACRIVE Inhibition DME1077 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1077 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05184 XEO_CLAS Peptide DME1077 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 microM) DME1077 XEOTICID XEO05184 GENEFORM Protein DME1077 XEOTICID XEO05184 MOACRIVE Inhibition DME1077 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1077 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05185 XEO_CLAS Peptide DME1077 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 microM) DME1077 XEOTICID XEO05185 GENEFORM Protein DME1077 XEOTICID XEO05185 MOACRIVE Inhibition DME1077 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1077 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05186 XEO_CLAS Peptide DME1077 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 microM) DME1077 XEOTICID XEO05186 GENEFORM Protein DME1077 XEOTICID XEO05186 MOACRIVE Inhibition DME1077 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1077 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05187 XEO_CLAS Peptide DME1077 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16 microM) DME1077 XEOTICID XEO05187 GENEFORM Protein DME1077 XEOTICID XEO05187 MOACRIVE Inhibition DME1077 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1077 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05188 XEO_CLAS Peptide DME1077 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 64 microM) DME1077 XEOTICID XEO05188 GENEFORM Protein DME1077 XEOTICID XEO05188 MOACRIVE Inhibition DME1077 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1077 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05190 XEO_CLAS Peptide DME1077 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05190 GENEFORM Protein DME1077 XEOTICID XEO05190 MOACRIVE Inhibition DME1077 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1077 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05193 XEO_CLAS Peptide DME1077 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO05193 GENEFORM Protein DME1077 XEOTICID XEO05193 MOACRIVE Inhibition DME1077 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1077 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05197 XEO_CLAS Peptide DME1077 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05197 GENEFORM Protein DME1077 XEOTICID XEO05197 MOACRIVE Inhibition DME1077 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1077 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05205 XEO_CLAS Peptide DME1077 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05205 GENEFORM Protein DME1077 XEOTICID XEO05205 MOACRIVE Inhibition DME1077 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1077 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05206 XEO_CLAS Peptide DME1077 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 10 microM) DME1077 XEOTICID XEO05206 GENEFORM Protein DME1077 XEOTICID XEO05206 MOACRIVE Inhibition DME1077 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1077 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05207 XEO_CLAS Peptide DME1077 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 25 microM) DME1077 XEOTICID XEO05207 GENEFORM Protein DME1077 XEOTICID XEO05207 MOACRIVE Inhibition DME1077 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1077 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05208 XEO_CLAS Peptide DME1077 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 microM) DME1077 XEOTICID XEO05208 GENEFORM Protein DME1077 XEOTICID XEO05208 MOACRIVE Inhibition DME1077 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1077 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05209 XEO_CLAS Peptide DME1077 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 15 microM) DME1077 XEOTICID XEO05209 GENEFORM Protein DME1077 XEOTICID XEO05209 MOACRIVE Inhibition DME1077 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1077 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05212 XEO_CLAS Peptide DME1077 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.5 ug/ml) DME1077 XEOTICID XEO05212 GENEFORM Protein DME1077 XEOTICID XEO05212 MOACRIVE Inhibition DME1077 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1077 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05220 XEO_CLAS Peptide DME1077 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.6-1.2 microM) DME1077 XEOTICID XEO05220 GENEFORM Protein DME1077 XEOTICID XEO05220 MOACRIVE Inhibition DME1077 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1077 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05230 XEO_CLAS Peptide DME1077 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 7.90 microM) DME1077 XEOTICID XEO05230 GENEFORM Protein DME1077 XEOTICID XEO05230 MOACRIVE Inhibition DME1077 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1077 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05231 XEO_CLAS Peptide DME1077 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2.40 microM) DME1077 XEOTICID XEO05231 GENEFORM Protein DME1077 XEOTICID XEO05231 MOACRIVE Inhibition DME1077 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1077 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05232 XEO_CLAS Peptide DME1077 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05232 GENEFORM Protein DME1077 XEOTICID XEO05232 MOACRIVE Inhibition DME1077 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1077 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05233 XEO_CLAS Peptide DME1077 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 ug/ml) DME1077 XEOTICID XEO05233 GENEFORM Protein DME1077 XEOTICID XEO05233 MOACRIVE Inhibition DME1077 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1077 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05234 XEO_CLAS Peptide DME1077 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 ug/ml) DME1077 XEOTICID XEO05234 GENEFORM Protein DME1077 XEOTICID XEO05234 MOACRIVE Inhibition DME1077 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1077 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05235 XEO_CLAS Peptide DME1077 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 30 ug/ml) DME1077 XEOTICID XEO05235 GENEFORM Protein DME1077 XEOTICID XEO05235 MOACRIVE Inhibition DME1077 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1077 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05237 XEO_CLAS Peptide DME1077 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 microM) DME1077 XEOTICID XEO05237 GENEFORM Protein DME1077 XEOTICID XEO05237 MOACRIVE Inhibition DME1077 XEOTICID XEO05245 XEO_NAME Viresin DME1077 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05245 XEO_CLAS Peptide DME1077 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05245 GENEFORM Protein DME1077 XEOTICID XEO05245 MOACRIVE Inhibition DME1077 XEOTICID XEO05248 XEO_NAME Vitamin C DME1077 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1077 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1077 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05248 GENEFORM Protein DME1077 XEOTICID XEO05248 MOACRIVE Inhibition DME1077 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1077 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05264 XEO_CLAS Peptide DME1077 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 4 ug/ml) DME1077 XEOTICID XEO05264 GENEFORM Protein DME1077 XEOTICID XEO05264 MOACRIVE Inhibition DME1077 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1077 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05267 XEO_CLAS Peptide DME1077 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 2 ug/ml) DME1077 XEOTICID XEO05267 GENEFORM Protein DME1077 XEOTICID XEO05267 MOACRIVE Inhibition DME1077 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1077 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05268 XEO_CLAS Peptide DME1077 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 1.6 ug/ml) DME1077 XEOTICID XEO05268 GENEFORM Protein DME1077 XEOTICID XEO05268 MOACRIVE Inhibition DME1077 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1077 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05269 XEO_CLAS Peptide DME1077 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 6 ug/ml) DME1077 XEOTICID XEO05269 GENEFORM Protein DME1077 XEOTICID XEO05269 MOACRIVE Inhibition DME1077 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1077 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05273 XEO_CLAS Peptide DME1077 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05273 GENEFORM Protein DME1077 XEOTICID XEO05273 MOACRIVE Inhibition DME1077 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1077 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05274 XEO_CLAS Peptide DME1077 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05274 GENEFORM Protein DME1077 XEOTICID XEO05274 MOACRIVE Inhibition DME1077 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1077 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05287 XEO_CLAS Peptide DME1077 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli DME1077 XEOTICID XEO05287 GENEFORM Protein DME1077 XEOTICID XEO05287 MOACRIVE Inhibition DME1077 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1077 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05303 XEO_CLAS Peptide DME1077 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 16-31 ug/ml) DME1077 XEOTICID XEO05303 GENEFORM Protein DME1077 XEOTICID XEO05303 MOACRIVE Inhibition DME1077 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1077 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05306 XEO_CLAS Peptide DME1077 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 8 ug/ml) DME1077 XEOTICID XEO05306 GENEFORM Protein DME1077 XEOTICID XEO05306 MOACRIVE Inhibition DME1077 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1077 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1077 XEOTICID XEO05308 XEO_CLAS Peptide DME1077 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of NADPH-dependent curcumin reductase (curA) from Escherichia coli (MIC = 0.4 ug/ml) DME1077 XEOTICID XEO05308 GENEFORM Protein DME1077 XEOTICID XEO05308 MOACRIVE Inhibition DME1080 DME___ID DME1080 DME1080 DME_NAME Azoreductase (azoR) DME1080 SPESNAME Streptococcus salivarius DME1080 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1080 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1080 XEOTICID XEO03775 XEO_CLAS Peptide DME1080 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus salivarius (MIC = 22.9 microM) DME1080 XEOTICID XEO03775 GENEFORM Protein DME1080 XEOTICID XEO03775 MOACRIVE Inhibition DME1080 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1080 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1080 XEOTICID XEO03857 XEO_CLAS Peptide DME1080 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus salivarius (MIC = 2.405 microM) DME1080 XEOTICID XEO03857 GENEFORM Protein DME1080 XEOTICID XEO03857 MOACRIVE Inhibition DME1080 XEOTICID XEO04155 XEO_NAME Mutacin-1140 DME1080 XEOTICID XEO04155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1080 XEOTICID XEO04155 XEO_CLAS Peptide DME1080 XEOTICID XEO04155 DESCRIPT Mutacin-1140 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus salivarius DME1080 XEOTICID XEO04155 GENEFORM Protein DME1080 XEOTICID XEO04155 MOACRIVE Inhibition DME1081 DME___ID DME1081 DME1081 DME_NAME Azoreductase (azoR) DME1081 SPESNAME Enterococcus casseliflavus DME1081 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1081 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1081 XEOTICID XEO03258 XEO_CLAS Peptide DME1081 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus casseliflavus DME1081 XEOTICID XEO03258 GENEFORM Protein DME1081 XEOTICID XEO03258 MOACRIVE Inhibition DME1085 DME___ID DME1085 DME1085 DME_NAME VanA ligase (vanA) DME1085 SPESNAME Enterococcus faecalis DME1085 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1085 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1085 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1085 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO00546 GENEFORM Protein DME1085 XEOTICID XEO00546 MOACRIVE Inhibition DME1085 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1085 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO01812 XEO_CLAS Peptide DME1085 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 1.9 microM) DME1085 XEOTICID XEO01812 GENEFORM Protein DME1085 XEOTICID XEO01812 MOACRIVE Inhibition DME1085 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1085 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO01813 XEO_CLAS Peptide DME1085 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 1.4 microM) DME1085 XEOTICID XEO01813 GENEFORM Protein DME1085 XEOTICID XEO01813 MOACRIVE Inhibition DME1085 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1085 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO01814 XEO_CLAS Peptide DME1085 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 0.7 microM) DME1085 XEOTICID XEO01814 GENEFORM Protein DME1085 XEOTICID XEO01814 MOACRIVE Inhibition DME1085 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1085 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO01815 XEO_CLAS Peptide DME1085 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 1.0 microM) DME1085 XEOTICID XEO01815 GENEFORM Protein DME1085 XEOTICID XEO01815 MOACRIVE Inhibition DME1085 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1085 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1085 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1085 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO01961 GENEFORM Protein DME1085 XEOTICID XEO01961 MOACRIVE Inhibition DME1085 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1085 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1085 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1085 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO01966 GENEFORM Protein DME1085 XEOTICID XEO01966 MOACRIVE Inhibition DME1085 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1085 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02122 XEO_CLAS Peptide DME1085 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 50 ug/ml) DME1085 XEOTICID XEO02122 GENEFORM Protein DME1085 XEOTICID XEO02122 MOACRIVE Inhibition DME1085 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1085 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02247 XEO_CLAS Peptide DME1085 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02247 GENEFORM Protein DME1085 XEOTICID XEO02247 MOACRIVE Inhibition DME1085 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1085 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02319 XEO_CLAS Peptide DME1085 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02319 GENEFORM Protein DME1085 XEOTICID XEO02319 MOACRIVE Inhibition DME1085 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1085 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02325 XEO_CLAS Peptide DME1085 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 100 microM) DME1085 XEOTICID XEO02325 GENEFORM Protein DME1085 XEOTICID XEO02325 MOACRIVE Inhibition DME1085 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1085 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02355 XEO_CLAS Peptide DME1085 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 17 ug/ml) DME1085 XEOTICID XEO02355 GENEFORM Protein DME1085 XEOTICID XEO02355 MOACRIVE Inhibition DME1085 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1085 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02356 XEO_CLAS Peptide DME1085 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 32 ug/ml) DME1085 XEOTICID XEO02356 GENEFORM Protein DME1085 XEOTICID XEO02356 MOACRIVE Inhibition DME1085 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1085 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02357 XEO_CLAS Peptide DME1085 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 16 ug/ml) DME1085 XEOTICID XEO02357 GENEFORM Protein DME1085 XEOTICID XEO02357 MOACRIVE Inhibition DME1085 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1085 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02358 XEO_CLAS Peptide DME1085 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 8 ug/ml) DME1085 XEOTICID XEO02358 GENEFORM Protein DME1085 XEOTICID XEO02358 MOACRIVE Inhibition DME1085 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1085 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02360 XEO_CLAS Peptide DME1085 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 2 ug/ml) DME1085 XEOTICID XEO02360 GENEFORM Protein DME1085 XEOTICID XEO02360 MOACRIVE Inhibition DME1085 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1085 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02361 XEO_CLAS Peptide DME1085 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 32 ug/ml) DME1085 XEOTICID XEO02361 GENEFORM Protein DME1085 XEOTICID XEO02361 MOACRIVE Inhibition DME1085 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1085 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02365 XEO_CLAS Peptide DME1085 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 64 ug/ml) DME1085 XEOTICID XEO02365 GENEFORM Protein DME1085 XEOTICID XEO02365 MOACRIVE Inhibition DME1085 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1085 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02366 XEO_CLAS Peptide DME1085 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 32 ug/ml) DME1085 XEOTICID XEO02366 GENEFORM Protein DME1085 XEOTICID XEO02366 MOACRIVE Inhibition DME1085 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1085 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02367 XEO_CLAS Peptide DME1085 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 32 ug/ml) DME1085 XEOTICID XEO02367 GENEFORM Protein DME1085 XEOTICID XEO02367 MOACRIVE Inhibition DME1085 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1085 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02368 XEO_CLAS Peptide DME1085 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 64 ug/ml) DME1085 XEOTICID XEO02368 GENEFORM Protein DME1085 XEOTICID XEO02368 MOACRIVE Inhibition DME1085 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1085 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02369 XEO_CLAS Peptide DME1085 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 32 ug/ml) DME1085 XEOTICID XEO02369 GENEFORM Protein DME1085 XEOTICID XEO02369 MOACRIVE Inhibition DME1085 XEOTICID XEO02377 XEO_NAME Bacteriocin hiracin-JM79 DME1085 XEOTICID XEO02377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02377 XEO_CLAS Peptide DME1085 XEOTICID XEO02377 DESCRIPT Bacteriocin hiracin-JM79 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02377 GENEFORM Protein DME1085 XEOTICID XEO02377 MOACRIVE Inhibition DME1085 XEOTICID XEO02382 XEO_NAME Bacteriocin plantarican ASM1 DME1085 XEOTICID XEO02382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02382 XEO_CLAS Peptide DME1085 XEOTICID XEO02382 DESCRIPT Bacteriocin plantarican ASM1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02382 GENEFORM Protein DME1085 XEOTICID XEO02382 MOACRIVE Inhibition DME1085 XEOTICID XEO02386 XEO_NAME Bactridin-1 DME1085 XEOTICID XEO02386 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02386 XEO_CLAS Peptide DME1085 XEOTICID XEO02386 DESCRIPT Bactridin-1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 34 microM) DME1085 XEOTICID XEO02386 GENEFORM Protein DME1085 XEOTICID XEO02386 MOACRIVE Inhibition DME1085 XEOTICID XEO02387 XEO_NAME Bactridin-2 DME1085 XEOTICID XEO02387 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02387 XEO_CLAS Peptide DME1085 XEOTICID XEO02387 DESCRIPT Bactridin-2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 65 microM) DME1085 XEOTICID XEO02387 GENEFORM Protein DME1085 XEOTICID XEO02387 MOACRIVE Inhibition DME1085 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1085 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02388 XEO_CLAS Peptide DME1085 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 8 ug/ml) DME1085 XEOTICID XEO02388 GENEFORM Protein DME1085 XEOTICID XEO02388 MOACRIVE Inhibition DME1085 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1085 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02389 XEO_CLAS Peptide DME1085 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 2 ug/ml) DME1085 XEOTICID XEO02389 GENEFORM Protein DME1085 XEOTICID XEO02389 MOACRIVE Inhibition DME1085 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1085 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02463 XEO_CLAS Peptide DME1085 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 15 microM) DME1085 XEOTICID XEO02463 GENEFORM Protein DME1085 XEOTICID XEO02463 MOACRIVE Inhibition DME1085 XEOTICID XEO02465 XEO_NAME BMAP-28 DME1085 XEOTICID XEO02465 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02465 XEO_CLAS Peptide DME1085 XEOTICID XEO02465 DESCRIPT BMAP-28 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02465 GENEFORM Protein DME1085 XEOTICID XEO02465 MOACRIVE Inhibition DME1085 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1085 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02491 XEO_CLAS Peptide DME1085 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 57.1 microM) DME1085 XEOTICID XEO02491 GENEFORM Protein DME1085 XEOTICID XEO02491 MOACRIVE Inhibition DME1085 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1085 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02496 XEO_CLAS Peptide DME1085 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 13 microM) DME1085 XEOTICID XEO02496 GENEFORM Protein DME1085 XEOTICID XEO02496 MOACRIVE Inhibition DME1085 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1085 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02497 XEO_CLAS Peptide DME1085 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 6 microM) DME1085 XEOTICID XEO02497 GENEFORM Protein DME1085 XEOTICID XEO02497 MOACRIVE Inhibition DME1085 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1085 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02509 XEO_CLAS Peptide DME1085 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 19 microM) DME1085 XEOTICID XEO02509 GENEFORM Protein DME1085 XEOTICID XEO02509 MOACRIVE Inhibition DME1085 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1085 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02510 XEO_CLAS Peptide DME1085 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 75 microM) DME1085 XEOTICID XEO02510 GENEFORM Protein DME1085 XEOTICID XEO02510 MOACRIVE Inhibition DME1085 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1085 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02511 XEO_CLAS Peptide DME1085 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 9 microM) DME1085 XEOTICID XEO02511 GENEFORM Protein DME1085 XEOTICID XEO02511 MOACRIVE Inhibition DME1085 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1085 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02512 XEO_CLAS Peptide DME1085 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 9 microM) DME1085 XEOTICID XEO02512 GENEFORM Protein DME1085 XEOTICID XEO02512 MOACRIVE Inhibition DME1085 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1085 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02524 XEO_CLAS Peptide DME1085 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 19 microM) DME1085 XEOTICID XEO02524 GENEFORM Protein DME1085 XEOTICID XEO02524 MOACRIVE Inhibition DME1085 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1085 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02566 XEO_CLAS Peptide DME1085 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 50 microM) DME1085 XEOTICID XEO02566 GENEFORM Protein DME1085 XEOTICID XEO02566 MOACRIVE Inhibition DME1085 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1085 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02637 XEO_CLAS Peptide DME1085 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 25 microM) DME1085 XEOTICID XEO02637 GENEFORM Protein DME1085 XEOTICID XEO02637 MOACRIVE Inhibition DME1085 XEOTICID XEO02660 XEO_NAME Butyl gallate DME1085 XEOTICID XEO02660 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1085 XEOTICID XEO02660 XEO_CLAS Chemical Compound DME1085 XEOTICID XEO02660 DESCRIPT Butyl gallate inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02660 GENEFORM Protein DME1085 XEOTICID XEO02660 MOACRIVE Inhibition DME1085 XEOTICID XEO02718 XEO_NAME Carnobacteriocin CbnB2 DME1085 XEOTICID XEO02718 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02718 XEO_CLAS Peptide DME1085 XEOTICID XEO02718 DESCRIPT Carnobacteriocin CbnB2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02718 GENEFORM Protein DME1085 XEOTICID XEO02718 MOACRIVE Inhibition DME1085 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1085 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02721 XEO_CLAS Peptide DME1085 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02721 GENEFORM Protein DME1085 XEOTICID XEO02721 MOACRIVE Inhibition DME1085 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1085 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02820 XEO_CLAS Peptide DME1085 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 64 ug/ml) DME1085 XEOTICID XEO02820 GENEFORM Protein DME1085 XEOTICID XEO02820 MOACRIVE Inhibition DME1085 XEOTICID XEO02864 XEO_NAME Cathelicidin cjaRL-37 DME1085 XEOTICID XEO02864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02864 XEO_CLAS Peptide DME1085 XEOTICID XEO02864 DESCRIPT Cathelicidin cjaRL-37 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 32 microM) DME1085 XEOTICID XEO02864 GENEFORM Protein DME1085 XEOTICID XEO02864 MOACRIVE Inhibition DME1085 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1085 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02872 XEO_CLAS Peptide DME1085 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 300 microM) DME1085 XEOTICID XEO02872 GENEFORM Protein DME1085 XEOTICID XEO02872 MOACRIVE Inhibition DME1085 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1085 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02875 XEO_CLAS Peptide DME1085 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02875 GENEFORM Protein DME1085 XEOTICID XEO02875 MOACRIVE Inhibition DME1085 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1085 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02876 XEO_CLAS Peptide DME1085 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02876 GENEFORM Protein DME1085 XEOTICID XEO02876 MOACRIVE Inhibition DME1085 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1085 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02877 XEO_CLAS Peptide DME1085 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02877 GENEFORM Protein DME1085 XEOTICID XEO02877 MOACRIVE Inhibition DME1085 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1085 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02878 XEO_CLAS Peptide DME1085 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02878 GENEFORM Protein DME1085 XEOTICID XEO02878 MOACRIVE Inhibition DME1085 XEOTICID XEO02930 XEO_NAME Indolicidin derivative CP10A DME1085 XEOTICID XEO02930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02930 XEO_CLAS Peptide DME1085 XEOTICID XEO02930 DESCRIPT Indolicidin derivative CP10A inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 8 ug/ml) DME1085 XEOTICID XEO02930 GENEFORM Protein DME1085 XEOTICID XEO02930 MOACRIVE Inhibition DME1085 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1085 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02931 XEO_CLAS Peptide DME1085 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 64 ug/ml) DME1085 XEOTICID XEO02931 GENEFORM Protein DME1085 XEOTICID XEO02931 MOACRIVE Inhibition DME1085 XEOTICID XEO02932 XEO_NAME CP11CN peptide DME1085 XEOTICID XEO02932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02932 XEO_CLAS Peptide DME1085 XEOTICID XEO02932 DESCRIPT CP11CN peptide inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 64 ug/ml) DME1085 XEOTICID XEO02932 GENEFORM Protein DME1085 XEOTICID XEO02932 MOACRIVE Inhibition DME1085 XEOTICID XEO02955 XEO_NAME Cryptdin related sequence CRS4C-3c DME1085 XEOTICID XEO02955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02955 XEO_CLAS Peptide DME1085 XEOTICID XEO02955 DESCRIPT Cryptdin related sequence CRS4C-3c inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02955 GENEFORM Protein DME1085 XEOTICID XEO02955 MOACRIVE Inhibition DME1085 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1085 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02958 XEO_CLAS Peptide DME1085 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02958 GENEFORM Protein DME1085 XEOTICID XEO02958 MOACRIVE Inhibition DME1085 XEOTICID XEO02959 XEO_NAME Cryptdin related peptide CRS4C-1d DME1085 XEOTICID XEO02959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02959 XEO_CLAS Peptide DME1085 XEOTICID XEO02959 DESCRIPT Cryptdin related peptide CRS4C-1d inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02959 GENEFORM Protein DME1085 XEOTICID XEO02959 MOACRIVE Inhibition DME1085 XEOTICID XEO02960 XEO_NAME Cryptdin related peptide CRS4C-2 DME1085 XEOTICID XEO02960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02960 XEO_CLAS Peptide DME1085 XEOTICID XEO02960 DESCRIPT Cryptdin related peptide CRS4C-2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02960 GENEFORM Protein DME1085 XEOTICID XEO02960 MOACRIVE Inhibition DME1085 XEOTICID XEO02961 XEO_NAME Cryptdin related peptide CRS4C-2b DME1085 XEOTICID XEO02961 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO02961 XEO_CLAS Peptide DME1085 XEOTICID XEO02961 DESCRIPT Cryptdin related peptide CRS4C-2b inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO02961 GENEFORM Protein DME1085 XEOTICID XEO02961 MOACRIVE Inhibition DME1085 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1085 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03021 XEO_CLAS Peptide DME1085 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 1.25-2.50 microM) DME1085 XEOTICID XEO03021 GENEFORM Protein DME1085 XEOTICID XEO03021 MOACRIVE Inhibition DME1085 XEOTICID XEO03025 XEO_NAME Curvacin A DME1085 XEOTICID XEO03025 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03025 XEO_CLAS Peptide DME1085 XEOTICID XEO03025 DESCRIPT Curvacin A inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO03025 GENEFORM Protein DME1085 XEOTICID XEO03025 MOACRIVE Inhibition DME1085 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1085 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03073 XEO_CLAS Peptide DME1085 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 16 ug/ml) DME1085 XEOTICID XEO03073 GENEFORM Protein DME1085 XEOTICID XEO03073 MOACRIVE Inhibition DME1085 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1085 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03082 XEO_CLAS Peptide DME1085 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO03082 GENEFORM Protein DME1085 XEOTICID XEO03082 MOACRIVE Inhibition DME1085 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1085 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03137 XEO_CLAS Peptide DME1085 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO03137 GENEFORM Protein DME1085 XEOTICID XEO03137 MOACRIVE Inhibition DME1085 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1085 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03146 XEO_CLAS Peptide DME1085 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 10 microM) DME1085 XEOTICID XEO03146 GENEFORM Protein DME1085 XEOTICID XEO03146 MOACRIVE Inhibition DME1085 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1085 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03147 XEO_CLAS Peptide DME1085 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 38 microM) DME1085 XEOTICID XEO03147 GENEFORM Protein DME1085 XEOTICID XEO03147 MOACRIVE Inhibition DME1085 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1085 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03148 XEO_CLAS Peptide DME1085 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 22 microM) DME1085 XEOTICID XEO03148 GENEFORM Protein DME1085 XEOTICID XEO03148 MOACRIVE Inhibition DME1085 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1085 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03149 XEO_CLAS Peptide DME1085 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 11 microM) DME1085 XEOTICID XEO03149 GENEFORM Protein DME1085 XEOTICID XEO03149 MOACRIVE Inhibition DME1085 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1085 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03197 XEO_CLAS Peptide DME1085 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 14.5 microM) DME1085 XEOTICID XEO03197 GENEFORM Protein DME1085 XEOTICID XEO03197 MOACRIVE Inhibition DME1085 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1085 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03250 XEO_CLAS Peptide DME1085 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO03250 GENEFORM Protein DME1085 XEOTICID XEO03250 MOACRIVE Inhibition DME1085 XEOTICID XEO03252 XEO_NAME Enterocin B DME1085 XEOTICID XEO03252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03252 XEO_CLAS Peptide DME1085 XEOTICID XEO03252 DESCRIPT Enterocin B inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 0.0869 microM) DME1085 XEOTICID XEO03252 GENEFORM Protein DME1085 XEOTICID XEO03252 MOACRIVE Inhibition DME1085 XEOTICID XEO03254 XEO_NAME Enterocin EJ97 DME1085 XEOTICID XEO03254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03254 XEO_CLAS Peptide DME1085 XEOTICID XEO03254 DESCRIPT Enterocin EJ97 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 6 ug/ml) DME1085 XEOTICID XEO03254 GENEFORM Protein DME1085 XEOTICID XEO03254 MOACRIVE Inhibition DME1085 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1085 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03258 XEO_CLAS Peptide DME1085 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO03258 GENEFORM Protein DME1085 XEOTICID XEO03258 MOACRIVE Inhibition DME1085 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME1085 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03259 XEO_CLAS Peptide DME1085 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 0.0508 microM) DME1085 XEOTICID XEO03259 GENEFORM Protein DME1085 XEOTICID XEO03259 MOACRIVE Inhibition DME1085 XEOTICID XEO03260 XEO_NAME Enterocin X beta DME1085 XEOTICID XEO03260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03260 XEO_CLAS Peptide DME1085 XEOTICID XEO03260 DESCRIPT Enterocin X beta inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 0.813 microM) DME1085 XEOTICID XEO03260 GENEFORM Protein DME1085 XEOTICID XEO03260 MOACRIVE Inhibition DME1085 XEOTICID XEO03357 XEO_NAME Ethyl gallate DME1085 XEOTICID XEO03357 XEO_TYPE Pharmaceutical Agent(s) DME1085 XEOTICID XEO03357 XEO_CLAS Investigative Agent DME1085 XEOTICID XEO03357 DESCRIPT Ethyl gallate inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO03357 GENEFORM Protein DME1085 XEOTICID XEO03357 MOACRIVE Inhibition DME1085 XEOTICID XEO03381 XEO_NAME Fallaxidin 3.1 DME1085 XEOTICID XEO03381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03381 XEO_CLAS Peptide DME1085 XEOTICID XEO03381 DESCRIPT Fallaxidin 3.1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 100 microM) DME1085 XEOTICID XEO03381 GENEFORM Protein DME1085 XEOTICID XEO03381 MOACRIVE Inhibition DME1085 XEOTICID XEO03382 XEO_NAME Fallaxidin 3.2 DME1085 XEOTICID XEO03382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03382 XEO_CLAS Peptide DME1085 XEOTICID XEO03382 DESCRIPT Fallaxidin 3.2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 100 microM) DME1085 XEOTICID XEO03382 GENEFORM Protein DME1085 XEOTICID XEO03382 MOACRIVE Inhibition DME1085 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1085 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03428 XEO_CLAS Peptide DME1085 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 31 ug/ml) DME1085 XEOTICID XEO03428 GENEFORM Protein DME1085 XEOTICID XEO03428 MOACRIVE Inhibition DME1085 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1085 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03430 XEO_CLAS Peptide DME1085 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 31 ug/ml) DME1085 XEOTICID XEO03430 GENEFORM Protein DME1085 XEOTICID XEO03430 MOACRIVE Inhibition DME1085 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1085 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03434 XEO_CLAS Peptide DME1085 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 31 ug/ml) DME1085 XEOTICID XEO03434 GENEFORM Protein DME1085 XEOTICID XEO03434 MOACRIVE Inhibition DME1085 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1085 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03497 XEO_CLAS Peptide DME1085 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 6.2-12.5 microM) DME1085 XEOTICID XEO03497 GENEFORM Protein DME1085 XEOTICID XEO03497 MOACRIVE Inhibition DME1085 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1085 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03498 XEO_CLAS Peptide DME1085 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 6.2-12.5 microM) DME1085 XEOTICID XEO03498 GENEFORM Protein DME1085 XEOTICID XEO03498 MOACRIVE Inhibition DME1085 XEOTICID XEO03522 XEO_NAME Halocyntin DME1085 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03522 XEO_CLAS Peptide DME1085 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO03522 GENEFORM Protein DME1085 XEOTICID XEO03522 MOACRIVE Inhibition DME1085 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1085 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03540 XEO_CLAS Peptide DME1085 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 32 ug/ml) DME1085 XEOTICID XEO03540 GENEFORM Protein DME1085 XEOTICID XEO03540 MOACRIVE Inhibition DME1085 XEOTICID XEO03555 XEO_NAME Hexyl gallate DME1085 XEOTICID XEO03555 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1085 XEOTICID XEO03555 XEO_CLAS Chemical Compound DME1085 XEOTICID XEO03555 DESCRIPT Hexyl gallate inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO03555 GENEFORM Protein DME1085 XEOTICID XEO03555 MOACRIVE Inhibition DME1085 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1085 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03556 XEO_CLAS Peptide DME1085 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 32 ug/ml) DME1085 XEOTICID XEO03556 GENEFORM Protein DME1085 XEOTICID XEO03556 MOACRIVE Inhibition DME1085 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1085 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03557 XEO_CLAS Peptide DME1085 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 32 ug/ml) DME1085 XEOTICID XEO03557 GENEFORM Protein DME1085 XEOTICID XEO03557 MOACRIVE Inhibition DME1085 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1085 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03569 XEO_CLAS Peptide DME1085 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 300 microM) DME1085 XEOTICID XEO03569 GENEFORM Protein DME1085 XEOTICID XEO03569 MOACRIVE Inhibition DME1085 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1085 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03579 XEO_CLAS Peptide DME1085 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO03579 GENEFORM Protein DME1085 XEOTICID XEO03579 MOACRIVE Inhibition DME1085 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1085 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03588 XEO_CLAS Peptide DME1085 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 15 ug/ml) DME1085 XEOTICID XEO03588 GENEFORM Protein DME1085 XEOTICID XEO03588 MOACRIVE Inhibition DME1085 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1085 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03609 XEO_CLAS Peptide DME1085 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO03609 GENEFORM Protein DME1085 XEOTICID XEO03609 MOACRIVE Inhibition DME1085 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1085 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03616 XEO_CLAS Peptide DME1085 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 16 microM) DME1085 XEOTICID XEO03616 GENEFORM Protein DME1085 XEOTICID XEO03616 MOACRIVE Inhibition DME1085 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1085 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03675 XEO_CLAS Peptide DME1085 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 60 microM) DME1085 XEOTICID XEO03675 GENEFORM Protein DME1085 XEOTICID XEO03675 MOACRIVE Inhibition DME1085 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1085 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03684 XEO_CLAS Peptide DME1085 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 125 ug/ml) DME1085 XEOTICID XEO03684 GENEFORM Protein DME1085 XEOTICID XEO03684 MOACRIVE Inhibition DME1085 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1085 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03697 XEO_CLAS Peptide DME1085 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 12.5 microM) DME1085 XEOTICID XEO03697 GENEFORM Protein DME1085 XEOTICID XEO03697 MOACRIVE Inhibition DME1085 XEOTICID XEO03768 XEO_NAME Lactacin-F subunit LafA DME1085 XEOTICID XEO03768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03768 XEO_CLAS Peptide DME1085 XEOTICID XEO03768 DESCRIPT Lactacin-F subunit LafA inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO03768 GENEFORM Protein DME1085 XEOTICID XEO03768 MOACRIVE Inhibition DME1085 XEOTICID XEO03769 XEO_NAME Lactacin-F subunit LafX DME1085 XEOTICID XEO03769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03769 XEO_CLAS Peptide DME1085 XEOTICID XEO03769 DESCRIPT Lactacin-F subunit LafX inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO03769 GENEFORM Protein DME1085 XEOTICID XEO03769 MOACRIVE Inhibition DME1085 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1085 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03771 XEO_CLAS Peptide DME1085 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO03771 GENEFORM Protein DME1085 XEOTICID XEO03771 MOACRIVE Inhibition DME1085 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1085 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03793 XEO_CLAS Peptide DME1085 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 32 microM) DME1085 XEOTICID XEO03793 GENEFORM Protein DME1085 XEOTICID XEO03793 MOACRIVE Inhibition DME1085 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1085 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03854 XEO_CLAS Peptide DME1085 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 5.20 microM) DME1085 XEOTICID XEO03854 GENEFORM Protein DME1085 XEOTICID XEO03854 MOACRIVE Inhibition DME1085 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1085 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03855 XEO_CLAS Peptide DME1085 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 4.10 microM) DME1085 XEOTICID XEO03855 GENEFORM Protein DME1085 XEOTICID XEO03855 MOACRIVE Inhibition DME1085 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1085 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03873 XEO_CLAS Peptide DME1085 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 30 microM) DME1085 XEOTICID XEO03873 GENEFORM Protein DME1085 XEOTICID XEO03873 MOACRIVE Inhibition DME1085 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1085 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03874 XEO_CLAS Peptide DME1085 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 22.5 microM) DME1085 XEOTICID XEO03874 GENEFORM Protein DME1085 XEOTICID XEO03874 MOACRIVE Inhibition DME1085 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1085 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03875 XEO_CLAS Peptide DME1085 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 22.5 microM) DME1085 XEOTICID XEO03875 GENEFORM Protein DME1085 XEOTICID XEO03875 MOACRIVE Inhibition DME1085 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1085 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03876 XEO_CLAS Peptide DME1085 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 15 microM) DME1085 XEOTICID XEO03876 GENEFORM Protein DME1085 XEOTICID XEO03876 MOACRIVE Inhibition DME1085 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1085 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03877 XEO_CLAS Peptide DME1085 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 11.25 microM) DME1085 XEOTICID XEO03877 GENEFORM Protein DME1085 XEOTICID XEO03877 MOACRIVE Inhibition DME1085 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1085 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03878 XEO_CLAS Peptide DME1085 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 22.5 microM) DME1085 XEOTICID XEO03878 GENEFORM Protein DME1085 XEOTICID XEO03878 MOACRIVE Inhibition DME1085 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1085 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03904 XEO_CLAS Peptide DME1085 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 4 ug/ml) DME1085 XEOTICID XEO03904 GENEFORM Protein DME1085 XEOTICID XEO03904 MOACRIVE Inhibition DME1085 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1085 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03905 XEO_CLAS Peptide DME1085 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 16 ug/ml) DME1085 XEOTICID XEO03905 GENEFORM Protein DME1085 XEOTICID XEO03905 MOACRIVE Inhibition DME1085 XEOTICID XEO03986 XEO_NAME Magainin-I peptide DME1085 XEOTICID XEO03986 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO03986 XEO_CLAS Peptide DME1085 XEOTICID XEO03986 DESCRIPT Magainin-I peptide inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO03986 GENEFORM Protein DME1085 XEOTICID XEO03986 MOACRIVE Inhibition DME1085 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1085 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04001 XEO_CLAS Peptide DME1085 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 25 microM) DME1085 XEOTICID XEO04001 GENEFORM Protein DME1085 XEOTICID XEO04001 MOACRIVE Inhibition DME1085 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1085 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04051 XEO_CLAS Peptide DME1085 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 2.50-5.00 microM) DME1085 XEOTICID XEO04051 GENEFORM Protein DME1085 XEOTICID XEO04051 MOACRIVE Inhibition DME1085 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1085 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04052 XEO_CLAS Peptide DME1085 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04052 GENEFORM Protein DME1085 XEOTICID XEO04052 MOACRIVE Inhibition DME1085 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1085 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04053 XEO_CLAS Peptide DME1085 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 1.25-2.50 microM) DME1085 XEOTICID XEO04053 GENEFORM Protein DME1085 XEOTICID XEO04053 MOACRIVE Inhibition DME1085 XEOTICID XEO04106 XEO_NAME Methyl gallate DME1085 XEOTICID XEO04106 XEO_TYPE Pharmaceutical Agent(s) DME1085 XEOTICID XEO04106 XEO_CLAS Investigative Agent DME1085 XEOTICID XEO04106 DESCRIPT Methyl gallate inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04106 GENEFORM Protein DME1085 XEOTICID XEO04106 MOACRIVE Inhibition DME1085 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1085 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04118 XEO_CLAS Peptide DME1085 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 300 microM) DME1085 XEOTICID XEO04118 GENEFORM Protein DME1085 XEOTICID XEO04118 MOACRIVE Inhibition DME1085 XEOTICID XEO04150 XEO_NAME Mundticin ATO6 DME1085 XEOTICID XEO04150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04150 XEO_CLAS Peptide DME1085 XEOTICID XEO04150 DESCRIPT Mundticin ATO6 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04150 GENEFORM Protein DME1085 XEOTICID XEO04150 MOACRIVE Inhibition DME1085 XEOTICID XEO04151 XEO_NAME Mundticin KS DME1085 XEOTICID XEO04151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04151 XEO_CLAS Peptide DME1085 XEOTICID XEO04151 DESCRIPT Mundticin KS inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04151 GENEFORM Protein DME1085 XEOTICID XEO04151 MOACRIVE Inhibition DME1085 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1085 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04169 XEO_CLAS Peptide DME1085 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04169 GENEFORM Protein DME1085 XEOTICID XEO04169 MOACRIVE Inhibition DME1085 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1085 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04249 XEO_CLAS Peptide DME1085 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 500 ug/ml) DME1085 XEOTICID XEO04249 GENEFORM Protein DME1085 XEOTICID XEO04249 MOACRIVE Inhibition DME1085 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1085 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04259 XEO_CLAS Peptide DME1085 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04259 GENEFORM Protein DME1085 XEOTICID XEO04259 MOACRIVE Inhibition DME1085 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1085 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04261 XEO_CLAS Peptide DME1085 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04261 GENEFORM Protein DME1085 XEOTICID XEO04261 MOACRIVE Inhibition DME1085 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1085 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04265 XEO_CLAS Peptide DME1085 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04265 GENEFORM Protein DME1085 XEOTICID XEO04265 MOACRIVE Inhibition DME1085 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1085 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04268 XEO_CLAS Peptide DME1085 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04268 GENEFORM Protein DME1085 XEOTICID XEO04268 MOACRIVE Inhibition DME1085 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1085 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04399 XEO_CLAS Peptide DME1085 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 12.5 microM) DME1085 XEOTICID XEO04399 GENEFORM Protein DME1085 XEOTICID XEO04399 MOACRIVE Inhibition DME1085 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1085 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04444 XEO_CLAS Peptide DME1085 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 20 microM) DME1085 XEOTICID XEO04444 GENEFORM Protein DME1085 XEOTICID XEO04444 MOACRIVE Inhibition DME1085 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1085 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04461 XEO_CLAS Peptide DME1085 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 1.3 microM) DME1085 XEOTICID XEO04461 GENEFORM Protein DME1085 XEOTICID XEO04461 MOACRIVE Inhibition DME1085 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1085 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04462 XEO_CLAS Peptide DME1085 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 2.4 microM) DME1085 XEOTICID XEO04462 GENEFORM Protein DME1085 XEOTICID XEO04462 MOACRIVE Inhibition DME1085 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1085 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04463 XEO_CLAS Peptide DME1085 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04463 GENEFORM Protein DME1085 XEOTICID XEO04463 MOACRIVE Inhibition DME1085 XEOTICID XEO04468 XEO_NAME Papillosin DME1085 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04468 XEO_CLAS Peptide DME1085 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04468 GENEFORM Protein DME1085 XEOTICID XEO04468 MOACRIVE Inhibition DME1085 XEOTICID XEO04521 XEO_NAME Penocin A DME1085 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04521 XEO_CLAS Peptide DME1085 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04521 GENEFORM Protein DME1085 XEOTICID XEO04521 MOACRIVE Inhibition DME1085 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1085 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04569 XEO_CLAS Peptide DME1085 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 4.0 microM) DME1085 XEOTICID XEO04569 GENEFORM Protein DME1085 XEOTICID XEO04569 MOACRIVE Inhibition DME1085 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1085 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04612 XEO_CLAS Peptide DME1085 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 5-10 microM) DME1085 XEOTICID XEO04612 GENEFORM Protein DME1085 XEOTICID XEO04612 MOACRIVE Inhibition DME1085 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1085 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04613 XEO_CLAS Peptide DME1085 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 5-10 microM) DME1085 XEOTICID XEO04613 GENEFORM Protein DME1085 XEOTICID XEO04613 MOACRIVE Inhibition DME1085 XEOTICID XEO04622 XEO_NAME Plantaricin W alpha DME1085 XEOTICID XEO04622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04622 XEO_CLAS Peptide DME1085 XEOTICID XEO04622 DESCRIPT Plantaricin W alpha inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04622 GENEFORM Protein DME1085 XEOTICID XEO04622 MOACRIVE Inhibition DME1085 XEOTICID XEO04623 XEO_NAME Plantaricin W beta DME1085 XEOTICID XEO04623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04623 XEO_CLAS Peptide DME1085 XEOTICID XEO04623 DESCRIPT Plantaricin W beta inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04623 GENEFORM Protein DME1085 XEOTICID XEO04623 MOACRIVE Inhibition DME1085 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1085 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04657 XEO_CLAS Peptide DME1085 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 300 microM) DME1085 XEOTICID XEO04657 GENEFORM Protein DME1085 XEOTICID XEO04657 MOACRIVE Inhibition DME1085 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1085 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04660 XEO_CLAS Peptide DME1085 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 2 ug/ml) DME1085 XEOTICID XEO04660 GENEFORM Protein DME1085 XEOTICID XEO04660 MOACRIVE Inhibition DME1085 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1085 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04680 XEO_CLAS Peptide DME1085 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 1-2 microM) DME1085 XEOTICID XEO04680 GENEFORM Protein DME1085 XEOTICID XEO04680 MOACRIVE Inhibition DME1085 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1085 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04690 XEO_CLAS Peptide DME1085 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 1 ug/ml) DME1085 XEOTICID XEO04690 GENEFORM Protein DME1085 XEOTICID XEO04690 MOACRIVE Inhibition DME1085 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1085 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04695 XEO_CLAS Peptide DME1085 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04695 GENEFORM Protein DME1085 XEOTICID XEO04695 MOACRIVE Inhibition DME1085 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1085 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04696 XEO_CLAS Peptide DME1085 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04696 GENEFORM Protein DME1085 XEOTICID XEO04696 MOACRIVE Inhibition DME1085 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1085 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04699 XEO_CLAS Peptide DME1085 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04699 GENEFORM Protein DME1085 XEOTICID XEO04699 MOACRIVE Inhibition DME1085 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1085 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04700 XEO_CLAS Peptide DME1085 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04700 GENEFORM Protein DME1085 XEOTICID XEO04700 MOACRIVE Inhibition DME1085 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1085 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04701 XEO_CLAS Peptide DME1085 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04701 GENEFORM Protein DME1085 XEOTICID XEO04701 MOACRIVE Inhibition DME1085 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1085 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04702 XEO_CLAS Peptide DME1085 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04702 GENEFORM Protein DME1085 XEOTICID XEO04702 MOACRIVE Inhibition DME1085 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1085 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04703 XEO_CLAS Peptide DME1085 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04703 GENEFORM Protein DME1085 XEOTICID XEO04703 MOACRIVE Inhibition DME1085 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1085 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04704 XEO_CLAS Peptide DME1085 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04704 GENEFORM Protein DME1085 XEOTICID XEO04704 MOACRIVE Inhibition DME1085 XEOTICID XEO04727 XEO_NAME Propyl gallate DME1085 XEOTICID XEO04727 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1085 XEOTICID XEO04727 XEO_CLAS Food Additive DME1085 XEOTICID XEO04727 DESCRIPT Propyl gallate inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04727 GENEFORM Protein DME1085 XEOTICID XEO04727 MOACRIVE Inhibition DME1085 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1085 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04783 XEO_CLAS Peptide DME1085 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 8 ug/ml) DME1085 XEOTICID XEO04783 GENEFORM Protein DME1085 XEOTICID XEO04783 MOACRIVE Inhibition DME1085 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1085 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04784 XEO_CLAS Peptide DME1085 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 16 ug/ml) DME1085 XEOTICID XEO04784 GENEFORM Protein DME1085 XEOTICID XEO04784 MOACRIVE Inhibition DME1085 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1085 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04785 XEO_CLAS Peptide DME1085 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 8 ug/ml) DME1085 XEOTICID XEO04785 GENEFORM Protein DME1085 XEOTICID XEO04785 MOACRIVE Inhibition DME1085 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1085 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04786 XEO_CLAS Peptide DME1085 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 125 ug/ml) DME1085 XEOTICID XEO04786 GENEFORM Protein DME1085 XEOTICID XEO04786 MOACRIVE Inhibition DME1085 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1085 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04809 XEO_CLAS Peptide DME1085 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 40 microM) DME1085 XEOTICID XEO04809 GENEFORM Protein DME1085 XEOTICID XEO04809 MOACRIVE Inhibition DME1085 XEOTICID XEO04863 XEO_NAME RTD peptide DME1085 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04863 XEO_CLAS Peptide DME1085 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 1.2 microM) DME1085 XEOTICID XEO04863 GENEFORM Protein DME1085 XEOTICID XEO04863 MOACRIVE Inhibition DME1085 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1085 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04880 XEO_CLAS Peptide DME1085 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 12.7 ug/ml) DME1085 XEOTICID XEO04880 GENEFORM Protein DME1085 XEOTICID XEO04880 MOACRIVE Inhibition DME1085 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1085 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04886 XEO_CLAS Peptide DME1085 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 12.7 ug/ml) DME1085 XEOTICID XEO04886 GENEFORM Protein DME1085 XEOTICID XEO04886 MOACRIVE Inhibition DME1085 XEOTICID XEO04896 XEO_NAME Sakacin 5X DME1085 XEOTICID XEO04896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04896 XEO_CLAS Peptide DME1085 XEOTICID XEO04896 DESCRIPT Sakacin 5X inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04896 GENEFORM Protein DME1085 XEOTICID XEO04896 MOACRIVE Inhibition DME1085 XEOTICID XEO04898 XEO_NAME Sakacin P DME1085 XEOTICID XEO04898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04898 XEO_CLAS Peptide DME1085 XEOTICID XEO04898 DESCRIPT Sakacin P inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04898 GENEFORM Protein DME1085 XEOTICID XEO04898 MOACRIVE Inhibition DME1085 XEOTICID XEO04936 XEO_NAME Siamycin I DME1085 XEOTICID XEO04936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04936 XEO_CLAS Peptide DME1085 XEOTICID XEO04936 DESCRIPT Siamycin I inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO04936 GENEFORM Protein DME1085 XEOTICID XEO04936 MOACRIVE Inhibition DME1085 XEOTICID XEO04937 XEO_NAME Signiferin-2.1 DME1085 XEOTICID XEO04937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04937 XEO_CLAS Peptide DME1085 XEOTICID XEO04937 DESCRIPT Signiferin-2.1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 100 microM) DME1085 XEOTICID XEO04937 GENEFORM Protein DME1085 XEOTICID XEO04937 MOACRIVE Inhibition DME1085 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1085 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04950 XEO_CLAS Peptide DME1085 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 10 ug/ml) DME1085 XEOTICID XEO04950 GENEFORM Protein DME1085 XEOTICID XEO04950 MOACRIVE Inhibition DME1085 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1085 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04995 XEO_CLAS Peptide DME1085 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 0.78-1.56 microM) DME1085 XEOTICID XEO04995 GENEFORM Protein DME1085 XEOTICID XEO04995 MOACRIVE Inhibition DME1085 XEOTICID XEO04998 XEO_NAME Styelin A DME1085 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04998 XEO_CLAS Peptide DME1085 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 2 ug/ml) DME1085 XEOTICID XEO04998 GENEFORM Protein DME1085 XEOTICID XEO04998 MOACRIVE Inhibition DME1085 XEOTICID XEO04999 XEO_NAME Styelin B DME1085 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO04999 XEO_CLAS Peptide DME1085 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 2 ug/ml) DME1085 XEOTICID XEO04999 GENEFORM Protein DME1085 XEOTICID XEO04999 MOACRIVE Inhibition DME1085 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1085 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05000 XEO_CLAS Peptide DME1085 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 4 ug/ml) DME1085 XEOTICID XEO05000 GENEFORM Protein DME1085 XEOTICID XEO05000 MOACRIVE Inhibition DME1085 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1085 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05001 XEO_CLAS Peptide DME1085 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 4 ug/ml) DME1085 XEOTICID XEO05001 GENEFORM Protein DME1085 XEOTICID XEO05001 MOACRIVE Inhibition DME1085 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1085 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05002 XEO_CLAS Peptide DME1085 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 2 ug/ml) DME1085 XEOTICID XEO05002 GENEFORM Protein DME1085 XEOTICID XEO05002 MOACRIVE Inhibition DME1085 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1085 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05003 XEO_CLAS Peptide DME1085 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 8 ug/ml) DME1085 XEOTICID XEO05003 GENEFORM Protein DME1085 XEOTICID XEO05003 MOACRIVE Inhibition DME1085 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1085 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05005 XEO_CLAS Peptide DME1085 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO05005 GENEFORM Protein DME1085 XEOTICID XEO05005 MOACRIVE Inhibition DME1085 XEOTICID XEO05006 XEO_NAME Substance P DME1085 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05006 XEO_CLAS Peptide DME1085 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO05006 GENEFORM Protein DME1085 XEOTICID XEO05006 MOACRIVE Inhibition DME1085 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1085 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05007 XEO_CLAS Peptide DME1085 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO05007 GENEFORM Protein DME1085 XEOTICID XEO05007 MOACRIVE Inhibition DME1085 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1085 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05063 XEO_CLAS Peptide DME1085 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 10 microM) DME1085 XEOTICID XEO05063 GENEFORM Protein DME1085 XEOTICID XEO05063 MOACRIVE Inhibition DME1085 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1085 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05064 XEO_CLAS Peptide DME1085 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 116 microM) DME1085 XEOTICID XEO05064 GENEFORM Protein DME1085 XEOTICID XEO05064 MOACRIVE Inhibition DME1085 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1085 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05065 XEO_CLAS Peptide DME1085 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC > 80 ug/ml) DME1085 XEOTICID XEO05065 GENEFORM Protein DME1085 XEOTICID XEO05065 MOACRIVE Inhibition DME1085 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1085 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05073 XEO_CLAS Peptide DME1085 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 40 microM) DME1085 XEOTICID XEO05073 GENEFORM Protein DME1085 XEOTICID XEO05073 MOACRIVE Inhibition DME1085 XEOTICID XEO05074 XEO_NAME Temporin-1Vb DME1085 XEOTICID XEO05074 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05074 XEO_CLAS Peptide DME1085 XEOTICID XEO05074 DESCRIPT Temporin-1Vb inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 20 microM) DME1085 XEOTICID XEO05074 GENEFORM Protein DME1085 XEOTICID XEO05074 MOACRIVE Inhibition DME1085 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1085 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05075 XEO_CLAS Peptide DME1085 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 40 microM) DME1085 XEOTICID XEO05075 GENEFORM Protein DME1085 XEOTICID XEO05075 MOACRIVE Inhibition DME1085 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1085 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05097 XEO_CLAS Peptide DME1085 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 8.0 microM) DME1085 XEOTICID XEO05097 GENEFORM Protein DME1085 XEOTICID XEO05097 MOACRIVE Inhibition DME1085 XEOTICID XEO05098 XEO_NAME Temporin-PEa DME1085 XEOTICID XEO05098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05098 XEO_CLAS Peptide DME1085 XEOTICID XEO05098 DESCRIPT Temporin-PEa inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 2.0 microM) DME1085 XEOTICID XEO05098 GENEFORM Protein DME1085 XEOTICID XEO05098 MOACRIVE Inhibition DME1085 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1085 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05099 XEO_CLAS Peptide DME1085 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 2.0 microM) DME1085 XEOTICID XEO05099 GENEFORM Protein DME1085 XEOTICID XEO05099 MOACRIVE Inhibition DME1085 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1085 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05170 XEO_CLAS Peptide DME1085 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 1.0 microM) DME1085 XEOTICID XEO05170 GENEFORM Protein DME1085 XEOTICID XEO05170 MOACRIVE Inhibition DME1085 XEOTICID XEO05196 XEO_NAME Ubericin-A DME1085 XEOTICID XEO05196 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05196 XEO_CLAS Peptide DME1085 XEOTICID XEO05196 DESCRIPT Ubericin-A inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO05196 GENEFORM Protein DME1085 XEOTICID XEO05196 MOACRIVE Inhibition DME1085 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1085 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05212 XEO_CLAS Peptide DME1085 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 50.8 ug/ml) DME1085 XEOTICID XEO05212 GENEFORM Protein DME1085 XEOTICID XEO05212 MOACRIVE Inhibition DME1085 XEOTICID XEO05224 XEO_NAME Vancomycin DME1085 XEOTICID XEO05224 XEO_TYPE Pharmaceutical Agent(s) DME1085 XEOTICID XEO05224 XEO_CLAS Approved/Marketed Drug DME1085 XEOTICID XEO05224 DESCRIPT Vancomycin inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO05224 GENEFORM Protein DME1085 XEOTICID XEO05224 MOACRIVE Inhibition DME1085 XEOTICID XEO05228 XEO_NAME Variacin DME1085 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05228 XEO_CLAS Peptide DME1085 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO05228 GENEFORM Protein DME1085 XEOTICID XEO05228 MOACRIVE Inhibition DME1085 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1085 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05264 XEO_CLAS Peptide DME1085 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 4 ug/ml) DME1085 XEOTICID XEO05264 GENEFORM Protein DME1085 XEOTICID XEO05264 MOACRIVE Inhibition DME1085 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1085 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05267 XEO_CLAS Peptide DME1085 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis (MIC = 2 ug/ml) DME1085 XEOTICID XEO05267 GENEFORM Protein DME1085 XEOTICID XEO05267 MOACRIVE Inhibition DME1085 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1085 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1085 XEOTICID XEO05283 XEO_CLAS Peptide DME1085 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecalis DME1085 XEOTICID XEO05283 GENEFORM Protein DME1085 XEOTICID XEO05283 MOACRIVE Inhibition DME1086 DME___ID DME1086 DME1086 DME_NAME VanA ligase (vanA) DME1086 SPESNAME Enterococcus faecium DME1086 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1086 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1086 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1086 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO01961 GENEFORM Protein DME1086 XEOTICID XEO01961 MOACRIVE Inhibition DME1086 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1086 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1086 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1086 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO01966 GENEFORM Protein DME1086 XEOTICID XEO01966 MOACRIVE Inhibition DME1086 XEOTICID XEO02373 XEO_NAME Bacteriocin 32 DME1086 XEOTICID XEO02373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO02373 XEO_CLAS Peptide DME1086 XEOTICID XEO02373 DESCRIPT Bacteriocin 32 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO02373 GENEFORM Protein DME1086 XEOTICID XEO02373 MOACRIVE Inhibition DME1086 XEOTICID XEO02377 XEO_NAME Bacteriocin hiracin-JM79 DME1086 XEOTICID XEO02377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO02377 XEO_CLAS Peptide DME1086 XEOTICID XEO02377 DESCRIPT Bacteriocin hiracin-JM79 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO02377 GENEFORM Protein DME1086 XEOTICID XEO02377 MOACRIVE Inhibition DME1086 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1086 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO02440 XEO_CLAS Peptide DME1086 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO02440 GENEFORM Protein DME1086 XEOTICID XEO02440 MOACRIVE Inhibition DME1086 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1086 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO02524 XEO_CLAS Peptide DME1086 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium (MIC = 19 microM) DME1086 XEOTICID XEO02524 GENEFORM Protein DME1086 XEOTICID XEO02524 MOACRIVE Inhibition DME1086 XEOTICID XEO02567 XEO_NAME Brevinin-1V DME1086 XEOTICID XEO02567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO02567 XEO_CLAS Peptide DME1086 XEOTICID XEO02567 DESCRIPT Brevinin-1V inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium (MIC = 19 microM) DME1086 XEOTICID XEO02567 GENEFORM Protein DME1086 XEOTICID XEO02567 MOACRIVE Inhibition DME1086 XEOTICID XEO02718 XEO_NAME Carnobacteriocin CbnB2 DME1086 XEOTICID XEO02718 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO02718 XEO_CLAS Peptide DME1086 XEOTICID XEO02718 DESCRIPT Carnobacteriocin CbnB2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO02718 GENEFORM Protein DME1086 XEOTICID XEO02718 MOACRIVE Inhibition DME1086 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1086 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO02743 XEO_CLAS Peptide DME1086 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium (MIC = 150 ug/ml) DME1086 XEOTICID XEO02743 GENEFORM Protein DME1086 XEOTICID XEO02743 MOACRIVE Inhibition DME1086 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1086 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO03073 XEO_CLAS Peptide DME1086 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium (MIC = 4 ug/ml) DME1086 XEOTICID XEO03073 GENEFORM Protein DME1086 XEOTICID XEO03073 MOACRIVE Inhibition DME1086 XEOTICID XEO03255 XEO_NAME Enterocin L50A DME1086 XEOTICID XEO03255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO03255 XEO_CLAS Peptide DME1086 XEOTICID XEO03255 DESCRIPT Enterocin L50A inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO03255 GENEFORM Protein DME1086 XEOTICID XEO03255 MOACRIVE Inhibition DME1086 XEOTICID XEO03256 XEO_NAME Enterocin L50B DME1086 XEOTICID XEO03256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO03256 XEO_CLAS Peptide DME1086 XEOTICID XEO03256 DESCRIPT Enterocin L50B inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO03256 GENEFORM Protein DME1086 XEOTICID XEO03256 MOACRIVE Inhibition DME1086 XEOTICID XEO03257 XEO_NAME Enterocin P DME1086 XEOTICID XEO03257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO03257 XEO_CLAS Peptide DME1086 XEOTICID XEO03257 DESCRIPT Enterocin P inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium (MIC = 0.002 ug/ml) DME1086 XEOTICID XEO03257 GENEFORM Protein DME1086 XEOTICID XEO03257 MOACRIVE Inhibition DME1086 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME1086 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO03259 XEO_CLAS Peptide DME1086 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium (MIC = 0.0508 microM) DME1086 XEOTICID XEO03259 GENEFORM Protein DME1086 XEOTICID XEO03259 MOACRIVE Inhibition DME1086 XEOTICID XEO03473 XEO_NAME Garvicin ML DME1086 XEOTICID XEO03473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO03473 XEO_CLAS Peptide DME1086 XEOTICID XEO03473 DESCRIPT Garvicin ML inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO03473 GENEFORM Protein DME1086 XEOTICID XEO03473 MOACRIVE Inhibition DME1086 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1086 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO03540 XEO_CLAS Peptide DME1086 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium (MIC = 4-8 ug/ml) DME1086 XEOTICID XEO03540 GENEFORM Protein DME1086 XEOTICID XEO03540 MOACRIVE Inhibition DME1086 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1086 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO03556 XEO_CLAS Peptide DME1086 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium (MIC = 4-8 ug/ml) DME1086 XEOTICID XEO03556 GENEFORM Protein DME1086 XEOTICID XEO03556 MOACRIVE Inhibition DME1086 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1086 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO03557 XEO_CLAS Peptide DME1086 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium (MIC = 4-8 ug/ml) DME1086 XEOTICID XEO03557 GENEFORM Protein DME1086 XEOTICID XEO03557 MOACRIVE Inhibition DME1086 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1086 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO03771 XEO_CLAS Peptide DME1086 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO03771 GENEFORM Protein DME1086 XEOTICID XEO03771 MOACRIVE Inhibition DME1086 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1086 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO03775 XEO_CLAS Peptide DME1086 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium (MIC = 0.71 microM) DME1086 XEOTICID XEO03775 GENEFORM Protein DME1086 XEOTICID XEO03775 MOACRIVE Inhibition DME1086 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1086 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO03857 XEO_CLAS Peptide DME1086 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium (MIC = 0.038 microM) DME1086 XEOTICID XEO03857 GENEFORM Protein DME1086 XEOTICID XEO03857 MOACRIVE Inhibition DME1086 XEOTICID XEO04151 XEO_NAME Mundticin KS DME1086 XEOTICID XEO04151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO04151 XEO_CLAS Peptide DME1086 XEOTICID XEO04151 DESCRIPT Mundticin KS inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO04151 GENEFORM Protein DME1086 XEOTICID XEO04151 MOACRIVE Inhibition DME1086 XEOTICID XEO04521 XEO_NAME Penocin A DME1086 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO04521 XEO_CLAS Peptide DME1086 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO04521 GENEFORM Protein DME1086 XEOTICID XEO04521 MOACRIVE Inhibition DME1086 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1086 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO04640 XEO_CLAS Peptide DME1086 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO04640 GENEFORM Protein DME1086 XEOTICID XEO04640 MOACRIVE Inhibition DME1086 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1086 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO04877 XEO_CLAS Peptide DME1086 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO04877 GENEFORM Protein DME1086 XEOTICID XEO04877 MOACRIVE Inhibition DME1086 XEOTICID XEO05169 XEO_NAME Tricyclic peptide MS-271 DME1086 XEOTICID XEO05169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO05169 XEO_CLAS Peptide DME1086 XEOTICID XEO05169 DESCRIPT Tricyclic peptide MS-271 inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO05169 GENEFORM Protein DME1086 XEOTICID XEO05169 MOACRIVE Inhibition DME1086 XEOTICID XEO05228 XEO_NAME Variacin DME1086 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1086 XEOTICID XEO05228 XEO_CLAS Peptide DME1086 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus faecium DME1086 XEOTICID XEO05228 GENEFORM Protein DME1086 XEOTICID XEO05228 MOACRIVE Inhibition DME1087 DME___ID DME1087 DME1087 DME_NAME Hydroxybenzoate 3-monooxygenase (pobA) DME1087 SPESNAME Pseudomonas aeruginosa DME1087 XEOTICID XEO00001 XEO_NAME Dimethyl sulfoxide DME1087 XEOTICID XEO00001 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00001 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00001 DESCRIPT Dimethyl sulfoxide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00001 GENEFORM Protein DME1087 XEOTICID XEO00001 MOACRIVE Inhibition DME1087 XEOTICID XEO00037 XEO_NAME Fluorouracil DME1087 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00037 DESCRIPT Fluorouracil inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00037 GENEFORM Protein DME1087 XEOTICID XEO00037 MOACRIVE Inhibition DME1087 XEOTICID XEO00096 XEO_NAME Ampicillin DME1087 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00096 GENEFORM Protein DME1087 XEOTICID XEO00096 MOACRIVE Inhibition DME1087 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1087 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00117 GENEFORM Protein DME1087 XEOTICID XEO00117 MOACRIVE Inhibition DME1087 XEOTICID XEO00164 XEO_NAME Azithromycin DME1087 XEOTICID XEO00164 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00164 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00164 DESCRIPT Azithromycin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00164 GENEFORM Protein DME1087 XEOTICID XEO00164 MOACRIVE Inhibition DME1087 XEOTICID XEO00199 XEO_NAME Doxycycline DME1087 XEOTICID XEO00199 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00199 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00199 DESCRIPT Doxycycline inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00199 GENEFORM Protein DME1087 XEOTICID XEO00199 MOACRIVE Inhibition DME1087 XEOTICID XEO00218 XEO_NAME Caffeine DME1087 XEOTICID XEO00218 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00218 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00218 DESCRIPT Caffeine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00218 GENEFORM Protein DME1087 XEOTICID XEO00218 MOACRIVE Inhibition DME1087 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1087 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00237 GENEFORM Protein DME1087 XEOTICID XEO00237 MOACRIVE Inhibition DME1087 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1087 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00349 GENEFORM Protein DME1087 XEOTICID XEO00349 MOACRIVE Inhibition DME1087 XEOTICID XEO00375 XEO_NAME Piperacillin DME1087 XEOTICID XEO00375 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00375 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00375 DESCRIPT Piperacillin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00375 GENEFORM Protein DME1087 XEOTICID XEO00375 MOACRIVE Inhibition DME1087 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME1087 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00388 GENEFORM Protein DME1087 XEOTICID XEO00388 MOACRIVE Inhibition DME1087 XEOTICID XEO00396 XEO_NAME Gentamicin DME1087 XEOTICID XEO00396 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00396 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00396 DESCRIPT Gentamicin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00396 GENEFORM Protein DME1087 XEOTICID XEO00396 MOACRIVE Inhibition DME1087 XEOTICID XEO00405 XEO_NAME Niclosamide DME1087 XEOTICID XEO00405 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00405 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00405 DESCRIPT Niclosamide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00405 GENEFORM Protein DME1087 XEOTICID XEO00405 MOACRIVE Inhibition DME1087 XEOTICID XEO00416 XEO_NAME Menthol DME1087 XEOTICID XEO00416 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00416 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00416 DESCRIPT Menthol inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00416 GENEFORM Protein DME1087 XEOTICID XEO00416 MOACRIVE Inhibition DME1087 XEOTICID XEO00444 XEO_NAME Zinc chloride DME1087 XEOTICID XEO00444 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00444 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00444 DESCRIPT Zinc chloride inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00444 GENEFORM Protein DME1087 XEOTICID XEO00444 MOACRIVE Inhibition DME1087 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1087 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00460 GENEFORM Protein DME1087 XEOTICID XEO00460 MOACRIVE Inhibition DME1087 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1087 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00511 GENEFORM Protein DME1087 XEOTICID XEO00511 MOACRIVE Inhibition DME1087 XEOTICID XEO00538 XEO_NAME Quercetin DME1087 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1087 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00538 GENEFORM Protein DME1087 XEOTICID XEO00538 MOACRIVE Inhibition DME1087 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1087 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1087 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00546 GENEFORM Protein DME1087 XEOTICID XEO00546 MOACRIVE Inhibition DME1087 XEOTICID XEO00568 XEO_NAME Resveratrol DME1087 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1087 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00568 GENEFORM Protein DME1087 XEOTICID XEO00568 MOACRIVE Inhibition DME1087 XEOTICID XEO00573 XEO_NAME Naringenin DME1087 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1087 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00573 GENEFORM Protein DME1087 XEOTICID XEO00573 MOACRIVE Inhibition DME1087 XEOTICID XEO00619 XEO_NAME Delphinidin DME1087 XEOTICID XEO00619 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00619 XEO_CLAS Drug in Phase 2 Clinical Trial DME1087 XEOTICID XEO00619 DESCRIPT Delphinidin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00619 GENEFORM Protein DME1087 XEOTICID XEO00619 MOACRIVE Inhibition DME1087 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1087 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1087 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00646 GENEFORM Protein DME1087 XEOTICID XEO00646 MOACRIVE Inhibition DME1087 XEOTICID XEO00683 XEO_NAME Curcumin DME1087 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1087 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00683 GENEFORM Protein DME1087 XEOTICID XEO00683 MOACRIVE Inhibition DME1087 XEOTICID XEO00692 XEO_NAME Emodin DME1087 XEOTICID XEO00692 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00692 XEO_CLAS Preclinical/Patented Drug DME1087 XEOTICID XEO00692 DESCRIPT Emodin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00692 GENEFORM Protein DME1087 XEOTICID XEO00692 MOACRIVE Inhibition DME1087 XEOTICID XEO00702 XEO_NAME Baicalin DME1087 XEOTICID XEO00702 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00702 XEO_CLAS Preclinical/Patented Drug DME1087 XEOTICID XEO00702 DESCRIPT Baicalin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00702 GENEFORM Protein DME1087 XEOTICID XEO00702 MOACRIVE Inhibition DME1087 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1087 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1087 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00730 GENEFORM Protein DME1087 XEOTICID XEO00730 MOACRIVE Inhibition DME1087 XEOTICID XEO00858 XEO_NAME Flavonoids DME1087 XEOTICID XEO00858 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO00858 XEO_CLAS Natural Mixture DME1087 XEOTICID XEO00858 DESCRIPT Flavonoids inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00858 GENEFORM Protein DME1087 XEOTICID XEO00858 MOACRIVE Inhibition DME1087 XEOTICID XEO00879 XEO_NAME Coumarin DME1087 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1087 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1087 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00879 GENEFORM Protein DME1087 XEOTICID XEO00879 MOACRIVE Inhibition DME1087 XEOTICID XEO00880 XEO_NAME Isatin DME1087 XEOTICID XEO00880 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO00880 XEO_CLAS Natural Product DME1087 XEOTICID XEO00880 DESCRIPT Isatin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00880 GENEFORM Protein DME1087 XEOTICID XEO00880 MOACRIVE Inhibition DME1087 XEOTICID XEO00885 XEO_NAME Eugenol DME1087 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1087 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO00885 GENEFORM Protein DME1087 XEOTICID XEO00885 MOACRIVE Inhibition DME1087 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1087 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1087 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1087 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01032 GENEFORM Protein DME1087 XEOTICID XEO01032 MOACRIVE Inhibition DME1087 XEOTICID XEO01212 XEO_NAME Baicalein DME1087 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO01212 XEO_CLAS Natural Product DME1087 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01212 GENEFORM Protein DME1087 XEOTICID XEO01212 MOACRIVE Inhibition DME1087 XEOTICID XEO01221 XEO_NAME Betulin DME1087 XEOTICID XEO01221 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO01221 XEO_CLAS Natural Product DME1087 XEOTICID XEO01221 DESCRIPT Betulin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01221 GENEFORM Protein DME1087 XEOTICID XEO01221 MOACRIVE Inhibition DME1087 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1087 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1087 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1087 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01232 GENEFORM Protein DME1087 XEOTICID XEO01232 MOACRIVE Inhibition DME1087 XEOTICID XEO01237 XEO_NAME Carvacrol DME1087 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1087 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01237 GENEFORM Protein DME1087 XEOTICID XEO01237 MOACRIVE Inhibition DME1087 XEOTICID XEO01239 XEO_NAME Catechin DME1087 XEOTICID XEO01239 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO01239 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO01239 DESCRIPT Catechin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01239 GENEFORM Protein DME1087 XEOTICID XEO01239 MOACRIVE Inhibition DME1087 XEOTICID XEO01252 XEO_NAME Cinnamic acid DME1087 XEOTICID XEO01252 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO01252 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO01252 DESCRIPT Cinnamic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01252 GENEFORM Protein DME1087 XEOTICID XEO01252 MOACRIVE Inhibition DME1087 XEOTICID XEO01266 XEO_NAME Cyanidin DME1087 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME1087 XEOTICID XEO01266 DESCRIPT Cyanidin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01266 GENEFORM Protein DME1087 XEOTICID XEO01266 MOACRIVE Inhibition DME1087 XEOTICID XEO01291 XEO_NAME Esculetin DME1087 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1087 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01291 GENEFORM Protein DME1087 XEOTICID XEO01291 MOACRIVE Inhibition DME1087 XEOTICID XEO01357 XEO_NAME Kojic acid DME1087 XEOTICID XEO01357 XEO_TYPE Health or Environmental Toxicant(s) DME1087 XEOTICID XEO01357 XEO_CLAS Health Hazard/Toxicant DME1087 XEOTICID XEO01357 DESCRIPT Kojic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01357 GENEFORM Protein DME1087 XEOTICID XEO01357 MOACRIVE Inhibition DME1087 XEOTICID XEO01412 XEO_NAME Oleic acid DME1087 XEOTICID XEO01412 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO01412 XEO_CLAS Preclinical/Patented Drug DME1087 XEOTICID XEO01412 DESCRIPT Oleic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01412 GENEFORM Protein DME1087 XEOTICID XEO01412 MOACRIVE Inhibition DME1087 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1087 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1087 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01420 GENEFORM Protein DME1087 XEOTICID XEO01420 MOACRIVE Inhibition DME1087 XEOTICID XEO01424 XEO_NAME Pelargonidin DME1087 XEOTICID XEO01424 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO01424 XEO_CLAS Natural Product DME1087 XEOTICID XEO01424 DESCRIPT Pelargonidin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01424 GENEFORM Protein DME1087 XEOTICID XEO01424 MOACRIVE Inhibition DME1087 XEOTICID XEO01442 XEO_NAME Puag-haad DME1087 XEOTICID XEO01442 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO01442 XEO_CLAS Natural Product DME1087 XEOTICID XEO01442 DESCRIPT Puag-haad inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01442 GENEFORM Protein DME1087 XEOTICID XEO01442 MOACRIVE Inhibition DME1087 XEOTICID XEO01455 XEO_NAME Rhein DME1087 XEOTICID XEO01455 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO01455 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO01455 DESCRIPT Rhein inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01455 GENEFORM Protein DME1087 XEOTICID XEO01455 MOACRIVE Inhibition DME1087 XEOTICID XEO01460 XEO_NAME Rosmarinic acid DME1087 XEOTICID XEO01460 XEO_TYPE Health or Environmental Toxicant(s) DME1087 XEOTICID XEO01460 XEO_CLAS Acute Toxic Substance DME1087 XEOTICID XEO01460 DESCRIPT Rosmarinic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01460 GENEFORM Protein DME1087 XEOTICID XEO01460 MOACRIVE Inhibition DME1087 XEOTICID XEO01463 XEO_NAME Rutin DME1087 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO01463 XEO_CLAS Natural Product DME1087 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01463 GENEFORM Protein DME1087 XEOTICID XEO01463 MOACRIVE Inhibition DME1087 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1087 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1087 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01496 GENEFORM Protein DME1087 XEOTICID XEO01496 MOACRIVE Inhibition DME1087 XEOTICID XEO01528 XEO_NAME Chrysophanic acid DME1087 XEOTICID XEO01528 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO01528 XEO_CLAS Natural Product DME1087 XEOTICID XEO01528 DESCRIPT Chrysophanic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01528 GENEFORM Protein DME1087 XEOTICID XEO01528 MOACRIVE Inhibition DME1087 XEOTICID XEO01531 XEO_NAME Clove oil DME1087 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO01531 XEO_CLAS Natural Product DME1087 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01531 GENEFORM Protein DME1087 XEOTICID XEO01531 MOACRIVE Inhibition DME1087 XEOTICID XEO01571 XEO_NAME Peppermint oil DME1087 XEOTICID XEO01571 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO01571 XEO_CLAS Natural Product DME1087 XEOTICID XEO01571 DESCRIPT Peppermint oil inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01571 GENEFORM Protein DME1087 XEOTICID XEO01571 MOACRIVE Inhibition DME1087 XEOTICID XEO01587 XEO_NAME Shikonin DME1087 XEOTICID XEO01587 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO01587 XEO_CLAS Natural Product DME1087 XEOTICID XEO01587 DESCRIPT Shikonin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01587 GENEFORM Protein DME1087 XEOTICID XEO01587 MOACRIVE Inhibition DME1087 XEOTICID XEO01804 XEO_NAME (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one DME1087 XEOTICID XEO01804 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01804 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01804 DESCRIPT (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01804 GENEFORM Protein DME1087 XEOTICID XEO01804 MOACRIVE Inhibition DME1087 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1087 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01810 XEO_CLAS Peptide DME1087 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4.0 microM) DME1087 XEOTICID XEO01810 GENEFORM Protein DME1087 XEOTICID XEO01810 MOACRIVE Inhibition DME1087 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1087 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01811 XEO_CLAS Peptide DME1087 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 32 microM) DME1087 XEOTICID XEO01811 GENEFORM Protein DME1087 XEOTICID XEO01811 MOACRIVE Inhibition DME1087 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1087 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01812 XEO_CLAS Peptide DME1087 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.2 microM) DME1087 XEOTICID XEO01812 GENEFORM Protein DME1087 XEOTICID XEO01812 MOACRIVE Inhibition DME1087 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1087 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01813 XEO_CLAS Peptide DME1087 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.0 microM) DME1087 XEOTICID XEO01813 GENEFORM Protein DME1087 XEOTICID XEO01813 MOACRIVE Inhibition DME1087 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1087 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01814 XEO_CLAS Peptide DME1087 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3.9 microM) DME1087 XEOTICID XEO01814 GENEFORM Protein DME1087 XEOTICID XEO01814 MOACRIVE Inhibition DME1087 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1087 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01815 XEO_CLAS Peptide DME1087 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8.0 microM) DME1087 XEOTICID XEO01815 GENEFORM Protein DME1087 XEOTICID XEO01815 MOACRIVE Inhibition DME1087 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1087 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01816 XEO_CLAS Peptide DME1087 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1087 XEOTICID XEO01816 GENEFORM Protein DME1087 XEOTICID XEO01816 MOACRIVE Inhibition DME1087 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1087 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01817 XEO_CLAS Peptide DME1087 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3.0 microM) DME1087 XEOTICID XEO01817 GENEFORM Protein DME1087 XEOTICID XEO01817 MOACRIVE Inhibition DME1087 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1087 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01818 XEO_CLAS Peptide DME1087 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4.0 microM) DME1087 XEOTICID XEO01818 GENEFORM Protein DME1087 XEOTICID XEO01818 MOACRIVE Inhibition DME1087 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1087 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01819 XEO_CLAS Peptide DME1087 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1087 XEOTICID XEO01819 GENEFORM Protein DME1087 XEOTICID XEO01819 MOACRIVE Inhibition DME1087 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1087 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01820 XEO_CLAS Peptide DME1087 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1087 XEOTICID XEO01820 GENEFORM Protein DME1087 XEOTICID XEO01820 MOACRIVE Inhibition DME1087 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1087 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01821 XEO_CLAS Peptide DME1087 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1087 XEOTICID XEO01821 GENEFORM Protein DME1087 XEOTICID XEO01821 MOACRIVE Inhibition DME1087 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1087 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01822 XEO_CLAS Peptide DME1087 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 microM) DME1087 XEOTICID XEO01822 GENEFORM Protein DME1087 XEOTICID XEO01822 MOACRIVE Inhibition DME1087 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1087 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01823 XEO_CLAS Peptide DME1087 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3.125 microM) DME1087 XEOTICID XEO01823 GENEFORM Protein DME1087 XEOTICID XEO01823 MOACRIVE Inhibition DME1087 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1087 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO01825 XEO_CLAS Peptide DME1087 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1087 XEOTICID XEO01825 GENEFORM Protein DME1087 XEOTICID XEO01825 MOACRIVE Inhibition DME1087 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1087 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01829 GENEFORM Protein DME1087 XEOTICID XEO01829 MOACRIVE Inhibition DME1087 XEOTICID XEO01831 XEO_NAME 3',5'-Dinitroacetophenone DME1087 XEOTICID XEO01831 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01831 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01831 DESCRIPT 3',5'-Dinitroacetophenone inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01831 GENEFORM Protein DME1087 XEOTICID XEO01831 MOACRIVE Inhibition DME1087 XEOTICID XEO01832 XEO_NAME 1-(4-amino-2-hydroxyphenyl)ethan-1-one DME1087 XEOTICID XEO01832 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01832 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01832 DESCRIPT 1-(4-amino-2-hydroxyphenyl)ethan-1-one inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01832 GENEFORM Protein DME1087 XEOTICID XEO01832 MOACRIVE Inhibition DME1087 XEOTICID XEO01837 XEO_NAME 2-Amino-5-acetylpyridine DME1087 XEOTICID XEO01837 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01837 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01837 DESCRIPT 2-Amino-5-acetylpyridine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01837 GENEFORM Protein DME1087 XEOTICID XEO01837 MOACRIVE Inhibition DME1087 XEOTICID XEO01838 XEO_NAME 1-(pyrazin-2-yl)ethan-1-one DME1087 XEOTICID XEO01838 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01838 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01838 DESCRIPT 1-(pyrazin-2-yl)ethan-1-one inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01838 GENEFORM Protein DME1087 XEOTICID XEO01838 MOACRIVE Inhibition DME1087 XEOTICID XEO01839 XEO_NAME 4-Acetylpyridine DME1087 XEOTICID XEO01839 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01839 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01839 DESCRIPT 4-Acetylpyridine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01839 GENEFORM Protein DME1087 XEOTICID XEO01839 MOACRIVE Inhibition DME1087 XEOTICID XEO01860 XEO_NAME Aseanostatin P5 DME1087 XEOTICID XEO01860 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO01860 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO01860 DESCRIPT Aseanostatin P5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01860 GENEFORM Protein DME1087 XEOTICID XEO01860 MOACRIVE Inhibition DME1087 XEOTICID XEO01869 XEO_NAME Isopentadecylic acid DME1087 XEOTICID XEO01869 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO01869 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO01869 DESCRIPT Isopentadecylic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01869 GENEFORM Protein DME1087 XEOTICID XEO01869 MOACRIVE Inhibition DME1087 XEOTICID XEO01872 XEO_NAME AL-1 DME1087 XEOTICID XEO01872 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO01872 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO01872 DESCRIPT AL-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01872 GENEFORM Protein DME1087 XEOTICID XEO01872 MOACRIVE Inhibition DME1087 XEOTICID XEO01879 XEO_NAME 1-methanesulfonyl-4-methylbenzene DME1087 XEOTICID XEO01879 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01879 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01879 DESCRIPT 1-methanesulfonyl-4-methylbenzene inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01879 GENEFORM Protein DME1087 XEOTICID XEO01879 MOACRIVE Inhibition DME1087 XEOTICID XEO01937 XEO_NAME 2-bromodecanoic acid DME1087 XEOTICID XEO01937 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01937 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01937 DESCRIPT 2-bromodecanoic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01937 GENEFORM Protein DME1087 XEOTICID XEO01937 MOACRIVE Inhibition DME1087 XEOTICID XEO01938 XEO_NAME 2-bromohexanoic acid DME1087 XEOTICID XEO01938 XEO_TYPE Health or Environmental Toxicant(s) DME1087 XEOTICID XEO01938 XEO_CLAS Health Hazard/Toxicant DME1087 XEOTICID XEO01938 DESCRIPT 2-bromohexanoic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01938 GENEFORM Protein DME1087 XEOTICID XEO01938 MOACRIVE Inhibition DME1087 XEOTICID XEO01939 XEO_NAME 2-bromooctanoic acid DME1087 XEOTICID XEO01939 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01939 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01939 DESCRIPT 2-bromooctanoic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01939 GENEFORM Protein DME1087 XEOTICID XEO01939 MOACRIVE Inhibition DME1087 XEOTICID XEO01952 XEO_NAME 2-oxindole DME1087 XEOTICID XEO01952 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01952 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01952 DESCRIPT 2-oxindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01952 GENEFORM Protein DME1087 XEOTICID XEO01952 MOACRIVE Inhibition DME1087 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1087 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01961 GENEFORM Protein DME1087 XEOTICID XEO01961 MOACRIVE Inhibition DME1087 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1087 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01966 GENEFORM Protein DME1087 XEOTICID XEO01966 MOACRIVE Inhibition DME1087 XEOTICID XEO01975 XEO_NAME 3,5-dimethylaniline DME1087 XEOTICID XEO01975 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01975 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01975 DESCRIPT 3,5-dimethylaniline inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01975 GENEFORM Protein DME1087 XEOTICID XEO01975 MOACRIVE Inhibition DME1087 XEOTICID XEO01976 XEO_NAME Allicin DME1087 XEOTICID XEO01976 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO01976 XEO_CLAS Drug in Phase 1 Clinical Trial DME1087 XEOTICID XEO01976 DESCRIPT Allicin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01976 GENEFORM Protein DME1087 XEOTICID XEO01976 MOACRIVE Inhibition DME1087 XEOTICID XEO01987 XEO_NAME 3-fluoroaniline DME1087 XEOTICID XEO01987 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01987 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01987 DESCRIPT 3-fluoroaniline inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01987 GENEFORM Protein DME1087 XEOTICID XEO01987 MOACRIVE Inhibition DME1087 XEOTICID XEO01994 XEO_NAME 3-Indoleacetonitrile DME1087 XEOTICID XEO01994 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO01994 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO01994 DESCRIPT 3-Indoleacetonitrile inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO01994 GENEFORM Protein DME1087 XEOTICID XEO01994 MOACRIVE Inhibition DME1087 XEOTICID XEO02026 XEO_NAME 4-bromoaniline DME1087 XEOTICID XEO02026 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02026 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02026 DESCRIPT 4-bromoaniline inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02026 GENEFORM Protein DME1087 XEOTICID XEO02026 MOACRIVE Inhibition DME1087 XEOTICID XEO02029 XEO_NAME 4-chloro-7-(trifluoromethyl)quinoline DME1087 XEOTICID XEO02029 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02029 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02029 DESCRIPT 4-chloro-7-(trifluoromethyl)quinoline inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02029 GENEFORM Protein DME1087 XEOTICID XEO02029 MOACRIVE Inhibition DME1087 XEOTICID XEO02030 XEO_NAME 4-chloroaniline DME1087 XEOTICID XEO02030 XEO_TYPE Health or Environmental Toxicant(s) DME1087 XEOTICID XEO02030 XEO_CLAS Health Hazard/Toxicant DME1087 XEOTICID XEO02030 DESCRIPT 4-chloroaniline inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02030 GENEFORM Protein DME1087 XEOTICID XEO02030 MOACRIVE Inhibition DME1087 XEOTICID XEO02036 XEO_NAME 4-fluoroindole DME1087 XEOTICID XEO02036 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02036 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02036 DESCRIPT 4-fluoroindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02036 GENEFORM Protein DME1087 XEOTICID XEO02036 MOACRIVE Inhibition DME1087 XEOTICID XEO02040 XEO_NAME Furaneol DME1087 XEOTICID XEO02040 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02040 XEO_CLAS Food Additive DME1087 XEOTICID XEO02040 DESCRIPT Furaneol inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02040 GENEFORM Protein DME1087 XEOTICID XEO02040 MOACRIVE Inhibition DME1087 XEOTICID XEO02042 XEO_NAME 4-methanesulfonylaniline DME1087 XEOTICID XEO02042 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02042 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02042 DESCRIPT 4-methanesulfonylaniline inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02042 GENEFORM Protein DME1087 XEOTICID XEO02042 MOACRIVE Inhibition DME1087 XEOTICID XEO02065 XEO_NAME 5-Bromoindole DME1087 XEOTICID XEO02065 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02065 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02065 DESCRIPT 5-Bromoindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02065 GENEFORM Protein DME1087 XEOTICID XEO02065 MOACRIVE Inhibition DME1087 XEOTICID XEO02068 XEO_NAME 5-Chloro-1-(2-chloroacetyl)indoline-2,3-dione DME1087 XEOTICID XEO02068 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02068 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02068 DESCRIPT 5-Chloro-1-(2-chloroacetyl)indoline-2,3-dione inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02068 GENEFORM Protein DME1087 XEOTICID XEO02068 MOACRIVE Inhibition DME1087 XEOTICID XEO02069 XEO_NAME 5-Chloroindole DME1087 XEOTICID XEO02069 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO02069 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO02069 DESCRIPT 5-Chloroindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02069 GENEFORM Protein DME1087 XEOTICID XEO02069 MOACRIVE Inhibition DME1087 XEOTICID XEO02072 XEO_NAME 5-fluoroindole DME1087 XEOTICID XEO02072 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO02072 XEO_CLAS Preclinical/Patented Drug DME1087 XEOTICID XEO02072 DESCRIPT 5-fluoroindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02072 GENEFORM Protein DME1087 XEOTICID XEO02072 MOACRIVE Inhibition DME1087 XEOTICID XEO02081 XEO_NAME 6-Chloroindole DME1087 XEOTICID XEO02081 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02081 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02081 DESCRIPT 6-Chloroindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02081 GENEFORM Protein DME1087 XEOTICID XEO02081 MOACRIVE Inhibition DME1087 XEOTICID XEO02082 XEO_NAME 6-Chlorooxindole DME1087 XEOTICID XEO02082 XEO_TYPE Health or Environmental Toxicant(s) DME1087 XEOTICID XEO02082 XEO_CLAS Environmental Pollutant DME1087 XEOTICID XEO02082 DESCRIPT 6-Chlorooxindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02082 GENEFORM Protein DME1087 XEOTICID XEO02082 MOACRIVE Inhibition DME1087 XEOTICID XEO02083 XEO_NAME 6-fluoroindole DME1087 XEOTICID XEO02083 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02083 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02083 DESCRIPT 6-fluoroindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02083 GENEFORM Protein DME1087 XEOTICID XEO02083 MOACRIVE Inhibition DME1087 XEOTICID XEO02084 XEO_NAME 6-Gingerol DME1087 XEOTICID XEO02084 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO02084 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO02084 DESCRIPT 6-Gingerol inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02084 GENEFORM Protein DME1087 XEOTICID XEO02084 MOACRIVE Inhibition DME1087 XEOTICID XEO02089 XEO_NAME 7-bromoindole DME1087 XEOTICID XEO02089 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02089 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02089 DESCRIPT 7-bromoindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02089 GENEFORM Protein DME1087 XEOTICID XEO02089 MOACRIVE Inhibition DME1087 XEOTICID XEO02090 XEO_NAME 7-chloroindole DME1087 XEOTICID XEO02090 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02090 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02090 DESCRIPT 7-chloroindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02090 GENEFORM Protein DME1087 XEOTICID XEO02090 MOACRIVE Inhibition DME1087 XEOTICID XEO02092 XEO_NAME 7-fluoroindole DME1087 XEOTICID XEO02092 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02092 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02092 DESCRIPT 7-fluoroindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02092 GENEFORM Protein DME1087 XEOTICID XEO02092 MOACRIVE Inhibition DME1087 XEOTICID XEO02093 XEO_NAME 7-Fluoroisatin DME1087 XEOTICID XEO02093 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02093 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02093 DESCRIPT 7-Fluoroisatin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02093 GENEFORM Protein DME1087 XEOTICID XEO02093 MOACRIVE Inhibition DME1087 XEOTICID XEO02094 XEO_NAME 7-formylindole DME1087 XEOTICID XEO02094 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02094 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02094 DESCRIPT 7-formylindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02094 GENEFORM Protein DME1087 XEOTICID XEO02094 MOACRIVE Inhibition DME1087 XEOTICID XEO02095 XEO_NAME 7-hydroxyindole DME1087 XEOTICID XEO02095 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02095 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02095 DESCRIPT 7-hydroxyindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02095 GENEFORM Protein DME1087 XEOTICID XEO02095 MOACRIVE Inhibition DME1087 XEOTICID XEO02096 XEO_NAME 7-methoxyindole DME1087 XEOTICID XEO02096 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02096 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02096 DESCRIPT 7-methoxyindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02096 GENEFORM Protein DME1087 XEOTICID XEO02096 MOACRIVE Inhibition DME1087 XEOTICID XEO02097 XEO_NAME 7-methylindole DME1087 XEOTICID XEO02097 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02097 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02097 DESCRIPT 7-methylindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02097 GENEFORM Protein DME1087 XEOTICID XEO02097 MOACRIVE Inhibition DME1087 XEOTICID XEO02098 XEO_NAME 7-nitroindole DME1087 XEOTICID XEO02098 XEO_TYPE Health or Environmental Toxicant(s) DME1087 XEOTICID XEO02098 XEO_CLAS Health Hazard/Toxicant DME1087 XEOTICID XEO02098 DESCRIPT 7-nitroindole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02098 GENEFORM Protein DME1087 XEOTICID XEO02098 MOACRIVE Inhibition DME1087 XEOTICID XEO02100 XEO_NAME 8-fluoroquinoline DME1087 XEOTICID XEO02100 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO02100 XEO_CLAS Preclinical/Patented Drug DME1087 XEOTICID XEO02100 DESCRIPT 8-fluoroquinoline inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02100 GENEFORM Protein DME1087 XEOTICID XEO02100 MOACRIVE Inhibition DME1087 XEOTICID XEO02103 XEO_NAME CP-P derivative A10 DME1087 XEOTICID XEO02103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02103 XEO_CLAS Peptide DME1087 XEOTICID XEO02103 DESCRIPT CP-P derivative A10 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1087 XEOTICID XEO02103 GENEFORM Protein DME1087 XEOTICID XEO02103 MOACRIVE Inhibition DME1087 XEOTICID XEO02104 XEO_NAME V13KL peptide derivative A12L DME1087 XEOTICID XEO02104 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02104 XEO_CLAS Peptide DME1087 XEOTICID XEO02104 DESCRIPT V13KL peptide derivative A12L inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 24.8 ug/ml) DME1087 XEOTICID XEO02104 GENEFORM Protein DME1087 XEOTICID XEO02104 MOACRIVE Inhibition DME1087 XEOTICID XEO02105 XEO_NAME V13KL peptide derivative A12L/A20L DME1087 XEOTICID XEO02105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02105 XEO_CLAS Peptide DME1087 XEOTICID XEO02105 DESCRIPT V13KL peptide derivative A12L/A20L inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 125 ug/ml) DME1087 XEOTICID XEO02105 GENEFORM Protein DME1087 XEOTICID XEO02105 MOACRIVE Inhibition DME1087 XEOTICID XEO02106 XEO_NAME V13KL peptide derivative A12L/A23L DME1087 XEOTICID XEO02106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02106 XEO_CLAS Peptide DME1087 XEOTICID XEO02106 DESCRIPT V13KL peptide derivative A12L/A23L inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 31.2 ug/ml) DME1087 XEOTICID XEO02106 GENEFORM Protein DME1087 XEOTICID XEO02106 MOACRIVE Inhibition DME1087 XEOTICID XEO02107 XEO_NAME CP-P derivative A13 DME1087 XEOTICID XEO02107 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02107 XEO_CLAS Peptide DME1087 XEOTICID XEO02107 DESCRIPT CP-P derivative A13 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1087 XEOTICID XEO02107 GENEFORM Protein DME1087 XEOTICID XEO02107 MOACRIVE Inhibition DME1087 XEOTICID XEO02108 XEO_NAME V13KL peptide derivative A20L DME1087 XEOTICID XEO02108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02108 XEO_CLAS Peptide DME1087 XEOTICID XEO02108 DESCRIPT V13KL peptide derivative A20L inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 15.6 ug/ml) DME1087 XEOTICID XEO02108 GENEFORM Protein DME1087 XEOTICID XEO02108 MOACRIVE Inhibition DME1087 XEOTICID XEO02109 XEO_NAME V13KL peptide derivative A23L DME1087 XEOTICID XEO02109 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02109 XEO_CLAS Peptide DME1087 XEOTICID XEO02109 DESCRIPT V13KL peptide derivative A23L inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 35.1 ug/ml) DME1087 XEOTICID XEO02109 GENEFORM Protein DME1087 XEOTICID XEO02109 MOACRIVE Inhibition DME1087 XEOTICID XEO02110 XEO_NAME CP-P derivative A9 DME1087 XEOTICID XEO02110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02110 XEO_CLAS Peptide DME1087 XEOTICID XEO02110 DESCRIPT CP-P derivative A9 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1087 XEOTICID XEO02110 GENEFORM Protein DME1087 XEOTICID XEO02110 MOACRIVE Inhibition DME1087 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1087 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02122 XEO_CLAS Peptide DME1087 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1087 XEOTICID XEO02122 GENEFORM Protein DME1087 XEOTICID XEO02122 MOACRIVE Inhibition DME1087 XEOTICID XEO02123 XEO_NAME Aceroside VIII DME1087 XEOTICID XEO02123 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02123 XEO_CLAS Natural Product DME1087 XEOTICID XEO02123 DESCRIPT Aceroside VIII inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02123 GENEFORM Protein DME1087 XEOTICID XEO02123 MOACRIVE Inhibition DME1087 XEOTICID XEO02134 XEO_NAME Acylase DME1087 XEOTICID XEO02134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02134 XEO_CLAS Peptide DME1087 XEOTICID XEO02134 DESCRIPT Acylase inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02134 GENEFORM Protein DME1087 XEOTICID XEO02134 MOACRIVE Inhibition DME1087 XEOTICID XEO02139 XEO_NAME Clidemia dentata aerial part extract DME1087 XEOTICID XEO02139 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02139 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02139 DESCRIPT Clidemia dentata aerial part extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02139 GENEFORM Protein DME1087 XEOTICID XEO02139 MOACRIVE Inhibition DME1087 XEOTICID XEO02143 XEO_NAME Ossaea brenesii aerial part extract DME1087 XEOTICID XEO02143 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02143 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02143 DESCRIPT Ossaea brenesii aerial part extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02143 GENEFORM Protein DME1087 XEOTICID XEO02143 MOACRIVE Inhibition DME1087 XEOTICID XEO02144 XEO_NAME Piper bisasperatum aerial part extract DME1087 XEOTICID XEO02144 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02144 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02144 DESCRIPT Piper bisasperatum aerial part extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02144 GENEFORM Protein DME1087 XEOTICID XEO02144 MOACRIVE Inhibition DME1087 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1087 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02147 XEO_CLAS Peptide DME1087 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 257 ug/ml) DME1087 XEOTICID XEO02147 GENEFORM Protein DME1087 XEOTICID XEO02147 MOACRIVE Inhibition DME1087 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1087 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02149 XEO_CLAS Peptide DME1087 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 47.35 microM) DME1087 XEOTICID XEO02149 GENEFORM Protein DME1087 XEOTICID XEO02149 MOACRIVE Inhibition DME1087 XEOTICID XEO02150 XEO_NAME AI-hemocidins 3 DME1087 XEOTICID XEO02150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02150 XEO_CLAS Peptide DME1087 XEOTICID XEO02150 DESCRIPT AI-hemocidins 3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 95.37 microM) DME1087 XEOTICID XEO02150 GENEFORM Protein DME1087 XEOTICID XEO02150 MOACRIVE Inhibition DME1087 XEOTICID XEO02152 XEO_NAME Ajoene DME1087 XEOTICID XEO02152 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02152 XEO_CLAS Natural Product DME1087 XEOTICID XEO02152 DESCRIPT Ajoene inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02152 GENEFORM Protein DME1087 XEOTICID XEO02152 MOACRIVE Inhibition DME1087 XEOTICID XEO02188 XEO_NAME Aminocyclopropane DME1087 XEOTICID XEO02188 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02188 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02188 DESCRIPT Aminocyclopropane inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02188 GENEFORM Protein DME1087 XEOTICID XEO02188 MOACRIVE Inhibition DME1087 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1087 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02200 XEO_CLAS Peptide DME1087 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1087 XEOTICID XEO02200 GENEFORM Protein DME1087 XEOTICID XEO02200 MOACRIVE Inhibition DME1087 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1087 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02201 XEO_CLAS Peptide DME1087 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 100 ug/ml) DME1087 XEOTICID XEO02201 GENEFORM Protein DME1087 XEOTICID XEO02201 MOACRIVE Inhibition DME1087 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1087 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02202 XEO_CLAS Peptide DME1087 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 10 microM) DME1087 XEOTICID XEO02202 GENEFORM Protein DME1087 XEOTICID XEO02202 MOACRIVE Inhibition DME1087 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1087 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02203 XEO_CLAS Peptide DME1087 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 10 microM) DME1087 XEOTICID XEO02203 GENEFORM Protein DME1087 XEOTICID XEO02203 MOACRIVE Inhibition DME1087 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1087 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02207 XEO_CLAS Peptide DME1087 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3.13 ug/ml) DME1087 XEOTICID XEO02207 GENEFORM Protein DME1087 XEOTICID XEO02207 MOACRIVE Inhibition DME1087 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1087 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02208 XEO_CLAS Peptide DME1087 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1087 XEOTICID XEO02208 GENEFORM Protein DME1087 XEOTICID XEO02208 MOACRIVE Inhibition DME1087 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1087 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02209 XEO_CLAS Peptide DME1087 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3.13 ug/ml) DME1087 XEOTICID XEO02209 GENEFORM Protein DME1087 XEOTICID XEO02209 MOACRIVE Inhibition DME1087 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1087 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02210 XEO_CLAS Peptide DME1087 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1087 XEOTICID XEO02210 GENEFORM Protein DME1087 XEOTICID XEO02210 MOACRIVE Inhibition DME1087 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1087 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02211 XEO_CLAS Peptide DME1087 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1087 XEOTICID XEO02211 GENEFORM Protein DME1087 XEOTICID XEO02211 MOACRIVE Inhibition DME1087 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1087 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02212 XEO_CLAS Peptide DME1087 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1087 XEOTICID XEO02212 GENEFORM Protein DME1087 XEOTICID XEO02212 MOACRIVE Inhibition DME1087 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1087 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02213 XEO_CLAS Peptide DME1087 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3.13 ug/ml) DME1087 XEOTICID XEO02213 GENEFORM Protein DME1087 XEOTICID XEO02213 MOACRIVE Inhibition DME1087 XEOTICID XEO02226 XEO_NAME Andropin DME1087 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02226 XEO_CLAS Peptide DME1087 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 300 microM) DME1087 XEOTICID XEO02226 GENEFORM Protein DME1087 XEOTICID XEO02226 MOACRIVE Inhibition DME1087 XEOTICID XEO02228 XEO_NAME Aniline DME1087 XEOTICID XEO02228 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02228 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02228 DESCRIPT Aniline inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02228 GENEFORM Protein DME1087 XEOTICID XEO02228 MOACRIVE Inhibition DME1087 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1087 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02230 XEO_CLAS Peptide DME1087 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1-2.5 microM) DME1087 XEOTICID XEO02230 GENEFORM Protein DME1087 XEOTICID XEO02230 MOACRIVE Inhibition DME1087 XEOTICID XEO02235 XEO_NAME Anthranilate DME1087 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02235 XEO_CLAS Natural Product DME1087 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02235 GENEFORM Protein DME1087 XEOTICID XEO02235 MOACRIVE Inhibition DME1087 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1087 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02242 XEO_CLAS Peptide DME1087 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 microM) DME1087 XEOTICID XEO02242 GENEFORM Protein DME1087 XEOTICID XEO02242 MOACRIVE Inhibition DME1087 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1087 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02243 XEO_CLAS Peptide DME1087 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3 microM) DME1087 XEOTICID XEO02243 GENEFORM Protein DME1087 XEOTICID XEO02243 MOACRIVE Inhibition DME1087 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1087 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02244 XEO_CLAS Peptide DME1087 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1087 XEOTICID XEO02244 GENEFORM Protein DME1087 XEOTICID XEO02244 MOACRIVE Inhibition DME1087 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1087 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02247 XEO_CLAS Peptide DME1087 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02247 GENEFORM Protein DME1087 XEOTICID XEO02247 MOACRIVE Inhibition DME1087 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1087 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02248 XEO_CLAS Peptide DME1087 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 200 microM) DME1087 XEOTICID XEO02248 GENEFORM Protein DME1087 XEOTICID XEO02248 MOACRIVE Inhibition DME1087 XEOTICID XEO02249 XEO_NAME Anticancerous peptide Cr-ACP1 DME1087 XEOTICID XEO02249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02249 XEO_CLAS Peptide DME1087 XEOTICID XEO02249 DESCRIPT Anticancerous peptide Cr-ACP1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 30 microM) DME1087 XEOTICID XEO02249 GENEFORM Protein DME1087 XEOTICID XEO02249 MOACRIVE Inhibition DME1087 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1087 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02253 XEO_CLAS Peptide DME1087 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02253 GENEFORM Protein DME1087 XEOTICID XEO02253 MOACRIVE Inhibition DME1087 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1087 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02261 XEO_CLAS Peptide DME1087 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 79 ug/ml) DME1087 XEOTICID XEO02261 GENEFORM Protein DME1087 XEOTICID XEO02261 MOACRIVE Inhibition DME1087 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1087 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02268 XEO_CLAS Peptide DME1087 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 169 ug/ml) DME1087 XEOTICID XEO02268 GENEFORM Protein DME1087 XEOTICID XEO02268 MOACRIVE Inhibition DME1087 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1087 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02271 XEO_CLAS Peptide DME1087 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 259 ug/ml) DME1087 XEOTICID XEO02271 GENEFORM Protein DME1087 XEOTICID XEO02271 MOACRIVE Inhibition DME1087 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1087 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02275 XEO_CLAS Peptide DME1087 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 60 microM) DME1087 XEOTICID XEO02275 GENEFORM Protein DME1087 XEOTICID XEO02275 MOACRIVE Inhibition DME1087 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1087 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02280 XEO_CLAS Peptide DME1087 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02280 GENEFORM Protein DME1087 XEOTICID XEO02280 MOACRIVE Inhibition DME1087 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1087 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02281 XEO_CLAS Peptide DME1087 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02281 GENEFORM Protein DME1087 XEOTICID XEO02281 MOACRIVE Inhibition DME1087 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1087 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02283 XEO_CLAS Peptide DME1087 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1087 XEOTICID XEO02283 GENEFORM Protein DME1087 XEOTICID XEO02283 MOACRIVE Inhibition DME1087 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1087 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02290 XEO_CLAS Peptide DME1087 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.5 ug/ml) DME1087 XEOTICID XEO02290 GENEFORM Protein DME1087 XEOTICID XEO02290 MOACRIVE Inhibition DME1087 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1087 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02294 XEO_CLAS Peptide DME1087 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 250-500 ug/ml) DME1087 XEOTICID XEO02294 GENEFORM Protein DME1087 XEOTICID XEO02294 MOACRIVE Inhibition DME1087 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1087 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02297 XEO_CLAS Peptide DME1087 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC < 25 ug/ml) DME1087 XEOTICID XEO02297 GENEFORM Protein DME1087 XEOTICID XEO02297 MOACRIVE Inhibition DME1087 XEOTICID XEO02301 XEO_NAME Fungus ribonuclease DME1087 XEOTICID XEO02301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02301 XEO_CLAS Peptide DME1087 XEOTICID XEO02301 DESCRIPT Fungus ribonuclease inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02301 GENEFORM Protein DME1087 XEOTICID XEO02301 MOACRIVE Inhibition DME1087 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1087 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02325 XEO_CLAS Peptide DME1087 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 13 microM) DME1087 XEOTICID XEO02325 GENEFORM Protein DME1087 XEOTICID XEO02325 MOACRIVE Inhibition DME1087 XEOTICID XEO02329 XEO_NAME Asperdiol DME1087 XEOTICID XEO02329 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02329 XEO_CLAS Natural Product DME1087 XEOTICID XEO02329 DESCRIPT Asperdiol inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02329 GENEFORM Protein DME1087 XEOTICID XEO02329 MOACRIVE Inhibition DME1087 XEOTICID XEO02330 XEO_NAME Asperdiol acetate DME1087 XEOTICID XEO02330 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02330 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO02330 DESCRIPT Asperdiol acetate inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02330 GENEFORM Protein DME1087 XEOTICID XEO02330 MOACRIVE Inhibition DME1087 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1087 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02333 XEO_CLAS Peptide DME1087 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 200 microM) DME1087 XEOTICID XEO02333 GENEFORM Protein DME1087 XEOTICID XEO02333 MOACRIVE Inhibition DME1087 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1087 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02352 XEO_CLAS Peptide DME1087 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 23 ug/ml) DME1087 XEOTICID XEO02352 GENEFORM Protein DME1087 XEOTICID XEO02352 MOACRIVE Inhibition DME1087 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1087 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02353 XEO_CLAS Peptide DME1087 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 11 ug/ml) DME1087 XEOTICID XEO02353 GENEFORM Protein DME1087 XEOTICID XEO02353 MOACRIVE Inhibition DME1087 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1087 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02354 XEO_CLAS Peptide DME1087 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1087 XEOTICID XEO02354 GENEFORM Protein DME1087 XEOTICID XEO02354 MOACRIVE Inhibition DME1087 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1087 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02355 XEO_CLAS Peptide DME1087 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1087 XEOTICID XEO02355 GENEFORM Protein DME1087 XEOTICID XEO02355 MOACRIVE Inhibition DME1087 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1087 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02356 XEO_CLAS Peptide DME1087 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO02356 GENEFORM Protein DME1087 XEOTICID XEO02356 MOACRIVE Inhibition DME1087 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1087 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02357 XEO_CLAS Peptide DME1087 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO02357 GENEFORM Protein DME1087 XEOTICID XEO02357 MOACRIVE Inhibition DME1087 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1087 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02358 XEO_CLAS Peptide DME1087 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO02358 GENEFORM Protein DME1087 XEOTICID XEO02358 MOACRIVE Inhibition DME1087 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1087 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02360 XEO_CLAS Peptide DME1087 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO02360 GENEFORM Protein DME1087 XEOTICID XEO02360 MOACRIVE Inhibition DME1087 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1087 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02361 XEO_CLAS Peptide DME1087 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 250 ug/ml) DME1087 XEOTICID XEO02361 GENEFORM Protein DME1087 XEOTICID XEO02361 MOACRIVE Inhibition DME1087 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1087 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02365 XEO_CLAS Peptide DME1087 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 64 ug/ml) DME1087 XEOTICID XEO02365 GENEFORM Protein DME1087 XEOTICID XEO02365 MOACRIVE Inhibition DME1087 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1087 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02366 XEO_CLAS Peptide DME1087 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO02366 GENEFORM Protein DME1087 XEOTICID XEO02366 MOACRIVE Inhibition DME1087 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1087 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02367 XEO_CLAS Peptide DME1087 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO02367 GENEFORM Protein DME1087 XEOTICID XEO02367 MOACRIVE Inhibition DME1087 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1087 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02368 XEO_CLAS Peptide DME1087 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO02368 GENEFORM Protein DME1087 XEOTICID XEO02368 MOACRIVE Inhibition DME1087 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1087 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02369 XEO_CLAS Peptide DME1087 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1087 XEOTICID XEO02369 GENEFORM Protein DME1087 XEOTICID XEO02369 MOACRIVE Inhibition DME1087 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1087 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02371 XEO_CLAS Peptide DME1087 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1087 XEOTICID XEO02371 GENEFORM Protein DME1087 XEOTICID XEO02371 MOACRIVE Inhibition DME1087 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1087 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02378 XEO_CLAS Peptide DME1087 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.38 ug/ml) DME1087 XEOTICID XEO02378 GENEFORM Protein DME1087 XEOTICID XEO02378 MOACRIVE Inhibition DME1087 XEOTICID XEO02386 XEO_NAME Bactridin-1 DME1087 XEOTICID XEO02386 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02386 XEO_CLAS Peptide DME1087 XEOTICID XEO02386 DESCRIPT Bactridin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 77 microM) DME1087 XEOTICID XEO02386 GENEFORM Protein DME1087 XEOTICID XEO02386 MOACRIVE Inhibition DME1087 XEOTICID XEO02387 XEO_NAME Bactridin-2 DME1087 XEOTICID XEO02387 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02387 XEO_CLAS Peptide DME1087 XEOTICID XEO02387 DESCRIPT Bactridin-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 54 microM) DME1087 XEOTICID XEO02387 GENEFORM Protein DME1087 XEOTICID XEO02387 MOACRIVE Inhibition DME1087 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1087 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02388 XEO_CLAS Peptide DME1087 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1087 XEOTICID XEO02388 GENEFORM Protein DME1087 XEOTICID XEO02388 MOACRIVE Inhibition DME1087 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1087 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02389 XEO_CLAS Peptide DME1087 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1087 XEOTICID XEO02389 GENEFORM Protein DME1087 XEOTICID XEO02389 MOACRIVE Inhibition DME1087 XEOTICID XEO02393 XEO_NAME Azadirachta indica bark extract DME1087 XEOTICID XEO02393 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02393 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02393 DESCRIPT Azadirachta indica bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02393 GENEFORM Protein DME1087 XEOTICID XEO02393 MOACRIVE Inhibition DME1087 XEOTICID XEO02394 XEO_NAME Cabralea canjerana bark extract DME1087 XEOTICID XEO02394 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02394 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02394 DESCRIPT Cabralea canjerana bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02394 GENEFORM Protein DME1087 XEOTICID XEO02394 MOACRIVE Inhibition DME1087 XEOTICID XEO02395 XEO_NAME Carapa guianensis bark extract DME1087 XEOTICID XEO02395 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02395 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02395 DESCRIPT Carapa guianensis bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02395 GENEFORM Protein DME1087 XEOTICID XEO02395 MOACRIVE Inhibition DME1087 XEOTICID XEO02396 XEO_NAME Cedrela fissilis bark extract DME1087 XEOTICID XEO02396 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02396 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02396 DESCRIPT Cedrela fissilis bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02396 GENEFORM Protein DME1087 XEOTICID XEO02396 MOACRIVE Inhibition DME1087 XEOTICID XEO02397 XEO_NAME Cedrela odorata bark extract DME1087 XEOTICID XEO02397 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02397 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02397 DESCRIPT Cedrela odorata bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02397 GENEFORM Protein DME1087 XEOTICID XEO02397 MOACRIVE Inhibition DME1087 XEOTICID XEO02398 XEO_NAME Cedrela salvadorensis bark extract DME1087 XEOTICID XEO02398 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02398 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02398 DESCRIPT Cedrela salvadorensis bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02398 GENEFORM Protein DME1087 XEOTICID XEO02398 MOACRIVE Inhibition DME1087 XEOTICID XEO02399 XEO_NAME Cedrela tonduzii bark extract DME1087 XEOTICID XEO02399 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02399 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02399 DESCRIPT Cedrela tonduzii bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02399 GENEFORM Protein DME1087 XEOTICID XEO02399 MOACRIVE Inhibition DME1087 XEOTICID XEO02400 XEO_NAME Chukrasia tabularis bark extract DME1087 XEOTICID XEO02400 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02400 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02400 DESCRIPT Chukrasia tabularis bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02400 GENEFORM Protein DME1087 XEOTICID XEO02400 MOACRIVE Inhibition DME1087 XEOTICID XEO02401 XEO_NAME Cupania glabra bark extract DME1087 XEOTICID XEO02401 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02401 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02401 DESCRIPT Cupania glabra bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02401 GENEFORM Protein DME1087 XEOTICID XEO02401 MOACRIVE Inhibition DME1087 XEOTICID XEO02402 XEO_NAME Dalbergia trichocarpa bark extract DME1087 XEOTICID XEO02402 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02402 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02402 DESCRIPT Dalbergia trichocarpa bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02402 GENEFORM Protein DME1087 XEOTICID XEO02402 MOACRIVE Inhibition DME1087 XEOTICID XEO02403 XEO_NAME Guarea glabra bark extract DME1087 XEOTICID XEO02403 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02403 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02403 DESCRIPT Guarea glabra bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02403 GENEFORM Protein DME1087 XEOTICID XEO02403 MOACRIVE Inhibition DME1087 XEOTICID XEO02404 XEO_NAME Guarea grandifolia bark extract DME1087 XEOTICID XEO02404 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02404 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02404 DESCRIPT Guarea grandifolia bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02404 GENEFORM Protein DME1087 XEOTICID XEO02404 MOACRIVE Inhibition DME1087 XEOTICID XEO02405 XEO_NAME Guarea guidonia bark extract DME1087 XEOTICID XEO02405 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02405 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02405 DESCRIPT Guarea guidonia bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02405 GENEFORM Protein DME1087 XEOTICID XEO02405 MOACRIVE Inhibition DME1087 XEOTICID XEO02406 XEO_NAME Guarea pterorhachis bark extract DME1087 XEOTICID XEO02406 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02406 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02406 DESCRIPT Guarea pterorhachis bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02406 GENEFORM Protein DME1087 XEOTICID XEO02406 MOACRIVE Inhibition DME1087 XEOTICID XEO02407 XEO_NAME Guarea pyriformis bark extract DME1087 XEOTICID XEO02407 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02407 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02407 DESCRIPT Guarea pyriformis bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02407 GENEFORM Protein DME1087 XEOTICID XEO02407 MOACRIVE Inhibition DME1087 XEOTICID XEO02408 XEO_NAME Ruptiliocarpon caracolito bark extract DME1087 XEOTICID XEO02408 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02408 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02408 DESCRIPT Ruptiliocarpon caracolito bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02408 GENEFORM Protein DME1087 XEOTICID XEO02408 MOACRIVE Inhibition DME1087 XEOTICID XEO02409 XEO_NAME Simarouba glauca bark extract DME1087 XEOTICID XEO02409 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02409 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02409 DESCRIPT Simarouba glauca bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02409 GENEFORM Protein DME1087 XEOTICID XEO02409 MOACRIVE Inhibition DME1087 XEOTICID XEO02410 XEO_NAME Swietenia macrophylla bark extract DME1087 XEOTICID XEO02410 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02410 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02410 DESCRIPT Swietenia macrophylla bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02410 GENEFORM Protein DME1087 XEOTICID XEO02410 MOACRIVE Inhibition DME1087 XEOTICID XEO02411 XEO_NAME Swietenia mahogani bark extract DME1087 XEOTICID XEO02411 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02411 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02411 DESCRIPT Swietenia mahogani bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02411 GENEFORM Protein DME1087 XEOTICID XEO02411 MOACRIVE Inhibition DME1087 XEOTICID XEO02413 XEO_NAME Trichilia martiana bark extract DME1087 XEOTICID XEO02413 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02413 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02413 DESCRIPT Trichilia martiana bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02413 GENEFORM Protein DME1087 XEOTICID XEO02413 MOACRIVE Inhibition DME1087 XEOTICID XEO02414 XEO_NAME Trichilia pleeana bark extract DME1087 XEOTICID XEO02414 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02414 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02414 DESCRIPT Trichilia pleeana bark extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02414 GENEFORM Protein DME1087 XEOTICID XEO02414 MOACRIVE Inhibition DME1087 XEOTICID XEO02425 XEO_NAME Benzocaine DME1087 XEOTICID XEO02425 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO02425 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO02425 DESCRIPT Benzocaine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02425 GENEFORM Protein DME1087 XEOTICID XEO02425 MOACRIVE Inhibition DME1087 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1087 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02437 XEO_CLAS Peptide DME1087 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02437 GENEFORM Protein DME1087 XEOTICID XEO02437 MOACRIVE Inhibition DME1087 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1087 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02438 XEO_CLAS Peptide DME1087 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02438 GENEFORM Protein DME1087 XEOTICID XEO02438 MOACRIVE Inhibition DME1087 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1087 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02440 XEO_CLAS Peptide DME1087 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02440 GENEFORM Protein DME1087 XEOTICID XEO02440 MOACRIVE Inhibition DME1087 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1087 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02443 XEO_CLAS Peptide DME1087 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02443 GENEFORM Protein DME1087 XEOTICID XEO02443 MOACRIVE Inhibition DME1087 XEOTICID XEO02462 XEO_NAME bLF peptide DME1087 XEOTICID XEO02462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02462 XEO_CLAS Peptide DME1087 XEOTICID XEO02462 DESCRIPT bLF peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02462 GENEFORM Protein DME1087 XEOTICID XEO02462 MOACRIVE Inhibition DME1087 XEOTICID XEO02464 XEO_NAME BMAP-27 DME1087 XEOTICID XEO02464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02464 XEO_CLAS Peptide DME1087 XEOTICID XEO02464 DESCRIPT BMAP-27 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02464 GENEFORM Protein DME1087 XEOTICID XEO02464 MOACRIVE Inhibition DME1087 XEOTICID XEO02465 XEO_NAME BMAP-28 DME1087 XEOTICID XEO02465 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02465 XEO_CLAS Peptide DME1087 XEOTICID XEO02465 DESCRIPT BMAP-28 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02465 GENEFORM Protein DME1087 XEOTICID XEO02465 MOACRIVE Inhibition DME1087 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1087 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02466 XEO_CLAS Peptide DME1087 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC <= 18 microM) DME1087 XEOTICID XEO02466 GENEFORM Protein DME1087 XEOTICID XEO02466 MOACRIVE Inhibition DME1087 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1087 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02473 XEO_CLAS Peptide DME1087 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02473 GENEFORM Protein DME1087 XEOTICID XEO02473 MOACRIVE Inhibition DME1087 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1087 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02474 XEO_CLAS Peptide DME1087 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.3 microM) DME1087 XEOTICID XEO02474 GENEFORM Protein DME1087 XEOTICID XEO02474 MOACRIVE Inhibition DME1087 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1087 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02475 XEO_CLAS Peptide DME1087 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 9.2 microM) DME1087 XEOTICID XEO02475 GENEFORM Protein DME1087 XEOTICID XEO02475 MOACRIVE Inhibition DME1087 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1087 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02491 XEO_CLAS Peptide DME1087 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4.7 microM) DME1087 XEOTICID XEO02491 GENEFORM Protein DME1087 XEOTICID XEO02491 MOACRIVE Inhibition DME1087 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1087 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02492 XEO_CLAS Peptide DME1087 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1087 XEOTICID XEO02492 GENEFORM Protein DME1087 XEOTICID XEO02492 MOACRIVE Inhibition DME1087 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1087 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02493 XEO_CLAS Peptide DME1087 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1087 XEOTICID XEO02493 GENEFORM Protein DME1087 XEOTICID XEO02493 MOACRIVE Inhibition DME1087 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1087 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02494 XEO_CLAS Peptide DME1087 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1087 XEOTICID XEO02494 GENEFORM Protein DME1087 XEOTICID XEO02494 MOACRIVE Inhibition DME1087 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1087 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02496 XEO_CLAS Peptide DME1087 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 25 microM) DME1087 XEOTICID XEO02496 GENEFORM Protein DME1087 XEOTICID XEO02496 MOACRIVE Inhibition DME1087 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1087 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02497 XEO_CLAS Peptide DME1087 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 25 microM) DME1087 XEOTICID XEO02497 GENEFORM Protein DME1087 XEOTICID XEO02497 MOACRIVE Inhibition DME1087 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1087 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02511 XEO_CLAS Peptide DME1087 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 75 microM) DME1087 XEOTICID XEO02511 GENEFORM Protein DME1087 XEOTICID XEO02511 MOACRIVE Inhibition DME1087 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1087 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02512 XEO_CLAS Peptide DME1087 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 75 microM) DME1087 XEOTICID XEO02512 GENEFORM Protein DME1087 XEOTICID XEO02512 MOACRIVE Inhibition DME1087 XEOTICID XEO02521 XEO_NAME Brevinin-1E DME1087 XEOTICID XEO02521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02521 XEO_CLAS Peptide DME1087 XEOTICID XEO02521 DESCRIPT Brevinin-1E inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 30.6 microM) DME1087 XEOTICID XEO02521 GENEFORM Protein DME1087 XEOTICID XEO02521 MOACRIVE Inhibition DME1087 XEOTICID XEO02554 XEO_NAME Brevinin-1RTa DME1087 XEOTICID XEO02554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02554 XEO_CLAS Peptide DME1087 XEOTICID XEO02554 DESCRIPT Brevinin-1RTa inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02554 GENEFORM Protein DME1087 XEOTICID XEO02554 MOACRIVE Inhibition DME1087 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1087 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02566 XEO_CLAS Peptide DME1087 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50 microM) DME1087 XEOTICID XEO02566 GENEFORM Protein DME1087 XEOTICID XEO02566 MOACRIVE Inhibition DME1087 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1087 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02575 XEO_CLAS Peptide DME1087 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 32 microM) DME1087 XEOTICID XEO02575 GENEFORM Protein DME1087 XEOTICID XEO02575 MOACRIVE Inhibition DME1087 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1087 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02576 XEO_CLAS Peptide DME1087 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 44 microM) DME1087 XEOTICID XEO02576 GENEFORM Protein DME1087 XEOTICID XEO02576 MOACRIVE Inhibition DME1087 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1087 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02584 XEO_CLAS Peptide DME1087 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 30 microM) DME1087 XEOTICID XEO02584 GENEFORM Protein DME1087 XEOTICID XEO02584 MOACRIVE Inhibition DME1087 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1087 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02598 XEO_CLAS Peptide DME1087 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 65 microM) DME1087 XEOTICID XEO02598 GENEFORM Protein DME1087 XEOTICID XEO02598 MOACRIVE Inhibition DME1087 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1087 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02599 XEO_CLAS Peptide DME1087 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 30 microM) DME1087 XEOTICID XEO02599 GENEFORM Protein DME1087 XEOTICID XEO02599 MOACRIVE Inhibition DME1087 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1087 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02630 XEO_CLAS Peptide DME1087 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1087 XEOTICID XEO02630 GENEFORM Protein DME1087 XEOTICID XEO02630 MOACRIVE Inhibition DME1087 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1087 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02631 XEO_CLAS Peptide DME1087 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1087 XEOTICID XEO02631 GENEFORM Protein DME1087 XEOTICID XEO02631 MOACRIVE Inhibition DME1087 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1087 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02637 XEO_CLAS Peptide DME1087 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6 microM) DME1087 XEOTICID XEO02637 GENEFORM Protein DME1087 XEOTICID XEO02637 MOACRIVE Inhibition DME1087 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1087 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02639 XEO_CLAS Peptide DME1087 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 5 microM) DME1087 XEOTICID XEO02639 GENEFORM Protein DME1087 XEOTICID XEO02639 MOACRIVE Inhibition DME1087 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1087 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02663 XEO_CLAS Peptide DME1087 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1087 XEOTICID XEO02663 GENEFORM Protein DME1087 XEOTICID XEO02663 MOACRIVE Inhibition DME1087 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1087 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02664 XEO_CLAS Peptide DME1087 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25-12.5 microM) DME1087 XEOTICID XEO02664 GENEFORM Protein DME1087 XEOTICID XEO02664 MOACRIVE Inhibition DME1087 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1087 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02672 XEO_CLAS Peptide DME1087 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1087 XEOTICID XEO02672 GENEFORM Protein DME1087 XEOTICID XEO02672 MOACRIVE Inhibition DME1087 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1087 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02673 XEO_CLAS Peptide DME1087 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1087 XEOTICID XEO02673 GENEFORM Protein DME1087 XEOTICID XEO02673 MOACRIVE Inhibition DME1087 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1087 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02674 XEO_CLAS Peptide DME1087 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1087 XEOTICID XEO02674 GENEFORM Protein DME1087 XEOTICID XEO02674 MOACRIVE Inhibition DME1087 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1087 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02676 XEO_CLAS Peptide DME1087 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1087 XEOTICID XEO02676 GENEFORM Protein DME1087 XEOTICID XEO02676 MOACRIVE Inhibition DME1087 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1087 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02677 XEO_CLAS Peptide DME1087 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1087 XEOTICID XEO02677 GENEFORM Protein DME1087 XEOTICID XEO02677 MOACRIVE Inhibition DME1087 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1087 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02679 XEO_CLAS Peptide DME1087 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1087 XEOTICID XEO02679 GENEFORM Protein DME1087 XEOTICID XEO02679 MOACRIVE Inhibition DME1087 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1087 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02680 XEO_CLAS Peptide DME1087 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1087 XEOTICID XEO02680 GENEFORM Protein DME1087 XEOTICID XEO02680 MOACRIVE Inhibition DME1087 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1087 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02683 XEO_CLAS Peptide DME1087 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1087 XEOTICID XEO02683 GENEFORM Protein DME1087 XEOTICID XEO02683 MOACRIVE Inhibition DME1087 XEOTICID XEO02685 XEO_NAME Cadmium Ion DME1087 XEOTICID XEO02685 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02685 XEO_CLAS Nanoparticle DME1087 XEOTICID XEO02685 DESCRIPT Cadmium Ion inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02685 GENEFORM Protein DME1087 XEOTICID XEO02685 MOACRIVE Inhibition DME1087 XEOTICID XEO02703 XEO_NAME Calcitermin DME1087 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02703 XEO_CLAS Peptide DME1087 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02703 GENEFORM Protein DME1087 XEOTICID XEO02703 MOACRIVE Inhibition DME1087 XEOTICID XEO02705 XEO_NAME CAMA peptide DME1087 XEOTICID XEO02705 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02705 XEO_CLAS Peptide DME1087 XEOTICID XEO02705 DESCRIPT CAMA peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02705 GENEFORM Protein DME1087 XEOTICID XEO02705 MOACRIVE Inhibition DME1087 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1087 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02709 XEO_CLAS Peptide DME1087 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.05 microM) DME1087 XEOTICID XEO02709 GENEFORM Protein DME1087 XEOTICID XEO02709 MOACRIVE Inhibition DME1087 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1087 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1087 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02713 GENEFORM Protein DME1087 XEOTICID XEO02713 MOACRIVE Inhibition DME1087 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1087 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02714 GENEFORM Protein DME1087 XEOTICID XEO02714 MOACRIVE Inhibition DME1087 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1087 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02731 XEO_CLAS Peptide DME1087 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.63 microM) DME1087 XEOTICID XEO02731 GENEFORM Protein DME1087 XEOTICID XEO02731 MOACRIVE Inhibition DME1087 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1087 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02732 XEO_CLAS Peptide DME1087 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.25 microM) DME1087 XEOTICID XEO02732 GENEFORM Protein DME1087 XEOTICID XEO02732 MOACRIVE Inhibition DME1087 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1087 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02734 XEO_CLAS Peptide DME1087 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3.18 microM) DME1087 XEOTICID XEO02734 GENEFORM Protein DME1087 XEOTICID XEO02734 MOACRIVE Inhibition DME1087 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1087 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02735 XEO_CLAS Peptide DME1087 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1087 XEOTICID XEO02735 GENEFORM Protein DME1087 XEOTICID XEO02735 MOACRIVE Inhibition DME1087 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1087 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02736 XEO_CLAS Peptide DME1087 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.66 microM) DME1087 XEOTICID XEO02736 GENEFORM Protein DME1087 XEOTICID XEO02736 MOACRIVE Inhibition DME1087 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1087 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02739 XEO_CLAS Peptide DME1087 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1 microM) DME1087 XEOTICID XEO02739 GENEFORM Protein DME1087 XEOTICID XEO02739 MOACRIVE Inhibition DME1087 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1087 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02740 XEO_CLAS Peptide DME1087 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1087 XEOTICID XEO02740 GENEFORM Protein DME1087 XEOTICID XEO02740 MOACRIVE Inhibition DME1087 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1087 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02743 XEO_CLAS Peptide DME1087 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.2 ug/ml) DME1087 XEOTICID XEO02743 GENEFORM Protein DME1087 XEOTICID XEO02743 MOACRIVE Inhibition DME1087 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1087 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02744 XEO_CLAS Peptide DME1087 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4.7 ug/ml) DME1087 XEOTICID XEO02744 GENEFORM Protein DME1087 XEOTICID XEO02744 MOACRIVE Inhibition DME1087 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1087 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02745 XEO_CLAS Peptide DME1087 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02745 GENEFORM Protein DME1087 XEOTICID XEO02745 MOACRIVE Inhibition DME1087 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1087 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02746 XEO_CLAS Peptide DME1087 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02746 GENEFORM Protein DME1087 XEOTICID XEO02746 MOACRIVE Inhibition DME1087 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1087 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02756 XEO_CLAS Peptide DME1087 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 15 microM) DME1087 XEOTICID XEO02756 GENEFORM Protein DME1087 XEOTICID XEO02756 MOACRIVE Inhibition DME1087 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1087 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02757 XEO_CLAS Peptide DME1087 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 microM) DME1087 XEOTICID XEO02757 GENEFORM Protein DME1087 XEOTICID XEO02757 MOACRIVE Inhibition DME1087 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1087 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02758 XEO_CLAS Peptide DME1087 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 15 microM) DME1087 XEOTICID XEO02758 GENEFORM Protein DME1087 XEOTICID XEO02758 MOACRIVE Inhibition DME1087 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1087 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02759 XEO_CLAS Peptide DME1087 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 microM) DME1087 XEOTICID XEO02759 GENEFORM Protein DME1087 XEOTICID XEO02759 MOACRIVE Inhibition DME1087 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1087 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02760 XEO_CLAS Peptide DME1087 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1087 XEOTICID XEO02760 GENEFORM Protein DME1087 XEOTICID XEO02760 MOACRIVE Inhibition DME1087 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1087 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02761 XEO_CLAS Peptide DME1087 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 microM) DME1087 XEOTICID XEO02761 GENEFORM Protein DME1087 XEOTICID XEO02761 MOACRIVE Inhibition DME1087 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1087 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02762 XEO_CLAS Peptide DME1087 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3 microM) DME1087 XEOTICID XEO02762 GENEFORM Protein DME1087 XEOTICID XEO02762 MOACRIVE Inhibition DME1087 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1087 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02763 XEO_CLAS Peptide DME1087 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.9 microM) DME1087 XEOTICID XEO02763 GENEFORM Protein DME1087 XEOTICID XEO02763 MOACRIVE Inhibition DME1087 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1087 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02764 XEO_CLAS Peptide DME1087 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1 microM) DME1087 XEOTICID XEO02764 GENEFORM Protein DME1087 XEOTICID XEO02764 MOACRIVE Inhibition DME1087 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1087 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02765 XEO_CLAS Peptide DME1087 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.7 microM) DME1087 XEOTICID XEO02765 GENEFORM Protein DME1087 XEOTICID XEO02765 MOACRIVE Inhibition DME1087 XEOTICID XEO02766 XEO_NAME Cecropin-B DME1087 XEOTICID XEO02766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02766 XEO_CLAS Peptide DME1087 XEOTICID XEO02766 DESCRIPT Cecropin-B inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02766 GENEFORM Protein DME1087 XEOTICID XEO02766 MOACRIVE Inhibition DME1087 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1087 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02767 XEO_CLAS Peptide DME1087 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02767 GENEFORM Protein DME1087 XEOTICID XEO02767 MOACRIVE Inhibition DME1087 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1087 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02768 XEO_CLAS Peptide DME1087 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 10-25 ug/ml) DME1087 XEOTICID XEO02768 GENEFORM Protein DME1087 XEOTICID XEO02768 MOACRIVE Inhibition DME1087 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1087 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02769 XEO_CLAS Peptide DME1087 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.9 microM) DME1087 XEOTICID XEO02769 GENEFORM Protein DME1087 XEOTICID XEO02769 MOACRIVE Inhibition DME1087 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1087 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02770 XEO_CLAS Peptide DME1087 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.9 microM) DME1087 XEOTICID XEO02770 GENEFORM Protein DME1087 XEOTICID XEO02770 MOACRIVE Inhibition DME1087 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1087 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02771 XEO_CLAS Peptide DME1087 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 81 microM) DME1087 XEOTICID XEO02771 GENEFORM Protein DME1087 XEOTICID XEO02771 MOACRIVE Inhibition DME1087 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1087 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02772 XEO_CLAS Peptide DME1087 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02772 GENEFORM Protein DME1087 XEOTICID XEO02772 MOACRIVE Inhibition DME1087 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1087 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02774 XEO_CLAS Peptide DME1087 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 5.9 microM) DME1087 XEOTICID XEO02774 GENEFORM Protein DME1087 XEOTICID XEO02774 MOACRIVE Inhibition DME1087 XEOTICID XEO02798 XEO_NAME Enterobacter asburiae cell-free lysate DME1087 XEOTICID XEO02798 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02798 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO02798 DESCRIPT Enterobacter asburiae cell-free lysate inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02798 GENEFORM Protein DME1087 XEOTICID XEO02798 MOACRIVE Inhibition DME1087 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1087 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02799 XEO_CLAS Peptide DME1087 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1087 XEOTICID XEO02799 GENEFORM Protein DME1087 XEOTICID XEO02799 MOACRIVE Inhibition DME1087 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1087 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02800 XEO_CLAS Peptide DME1087 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1087 XEOTICID XEO02800 GENEFORM Protein DME1087 XEOTICID XEO02800 MOACRIVE Inhibition DME1087 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1087 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02802 XEO_CLAS Peptide DME1087 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 50 microM) DME1087 XEOTICID XEO02802 GENEFORM Protein DME1087 XEOTICID XEO02802 MOACRIVE Inhibition DME1087 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1087 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02820 XEO_CLAS Peptide DME1087 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO02820 GENEFORM Protein DME1087 XEOTICID XEO02820 MOACRIVE Inhibition DME1087 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1087 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02824 XEO_CLAS Peptide DME1087 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 9 microM) DME1087 XEOTICID XEO02824 GENEFORM Protein DME1087 XEOTICID XEO02824 MOACRIVE Inhibition DME1087 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1087 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02834 GENEFORM Protein DME1087 XEOTICID XEO02834 MOACRIVE Inhibition DME1087 XEOTICID XEO02836 XEO_NAME Chromate DME1087 XEOTICID XEO02836 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02836 XEO_CLAS Nanoparticle DME1087 XEOTICID XEO02836 DESCRIPT Chromate inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02836 GENEFORM Protein DME1087 XEOTICID XEO02836 MOACRIVE Inhibition DME1087 XEOTICID XEO02847 XEO_NAME Cinnamon oil DME1087 XEOTICID XEO02847 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02847 XEO_CLAS Natural Product DME1087 XEOTICID XEO02847 DESCRIPT Cinnamon oil inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02847 GENEFORM Protein DME1087 XEOTICID XEO02847 MOACRIVE Inhibition DME1087 XEOTICID XEO02852 XEO_NAME Cis-2-dodecenoic acid DME1087 XEOTICID XEO02852 XEO_TYPE Health or Environmental Toxicant(s) DME1087 XEOTICID XEO02852 XEO_CLAS Environmental Pollutant DME1087 XEOTICID XEO02852 DESCRIPT Cis-2-dodecenoic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02852 GENEFORM Protein DME1087 XEOTICID XEO02852 MOACRIVE Inhibition DME1087 XEOTICID XEO02864 XEO_NAME Cathelicidin cjaRL-37 DME1087 XEOTICID XEO02864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02864 XEO_CLAS Peptide DME1087 XEOTICID XEO02864 DESCRIPT Cathelicidin cjaRL-37 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1087 XEOTICID XEO02864 GENEFORM Protein DME1087 XEOTICID XEO02864 MOACRIVE Inhibition DME1087 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1087 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02875 XEO_CLAS Peptide DME1087 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.7 microM) DME1087 XEOTICID XEO02875 GENEFORM Protein DME1087 XEOTICID XEO02875 MOACRIVE Inhibition DME1087 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1087 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02876 XEO_CLAS Peptide DME1087 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1087 XEOTICID XEO02876 GENEFORM Protein DME1087 XEOTICID XEO02876 MOACRIVE Inhibition DME1087 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1087 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02877 XEO_CLAS Peptide DME1087 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1087 XEOTICID XEO02877 GENEFORM Protein DME1087 XEOTICID XEO02877 MOACRIVE Inhibition DME1087 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1087 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02878 XEO_CLAS Peptide DME1087 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.9 microM) DME1087 XEOTICID XEO02878 GENEFORM Protein DME1087 XEOTICID XEO02878 MOACRIVE Inhibition DME1087 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1087 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02885 XEO_CLAS Peptide DME1087 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO02885 GENEFORM Protein DME1087 XEOTICID XEO02885 MOACRIVE Inhibition DME1087 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1087 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02886 XEO_CLAS Peptide DME1087 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1087 XEOTICID XEO02886 GENEFORM Protein DME1087 XEOTICID XEO02886 MOACRIVE Inhibition DME1087 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1087 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02887 XEO_CLAS Peptide DME1087 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1087 XEOTICID XEO02887 GENEFORM Protein DME1087 XEOTICID XEO02887 MOACRIVE Inhibition DME1087 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1087 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02888 XEO_CLAS Peptide DME1087 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1087 XEOTICID XEO02888 GENEFORM Protein DME1087 XEOTICID XEO02888 MOACRIVE Inhibition DME1087 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1087 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02889 XEO_CLAS Peptide DME1087 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 19 ug/ml) DME1087 XEOTICID XEO02889 GENEFORM Protein DME1087 XEOTICID XEO02889 MOACRIVE Inhibition DME1087 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1087 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02890 XEO_CLAS Peptide DME1087 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1087 XEOTICID XEO02890 GENEFORM Protein DME1087 XEOTICID XEO02890 MOACRIVE Inhibition DME1087 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1087 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02891 XEO_CLAS Peptide DME1087 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO02891 GENEFORM Protein DME1087 XEOTICID XEO02891 MOACRIVE Inhibition DME1087 XEOTICID XEO02898 XEO_NAME Cobalt Ion DME1087 XEOTICID XEO02898 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO02898 XEO_CLAS Nanoparticle DME1087 XEOTICID XEO02898 DESCRIPT Cobalt Ion inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02898 GENEFORM Protein DME1087 XEOTICID XEO02898 MOACRIVE Inhibition DME1087 XEOTICID XEO02903 XEO_NAME Colistin DME1087 XEOTICID XEO02903 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO02903 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO02903 DESCRIPT Colistin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02903 GENEFORM Protein DME1087 XEOTICID XEO02903 MOACRIVE Inhibition DME1087 XEOTICID XEO02914 XEO_NAME Coral associated bacteria extract DME1087 XEOTICID XEO02914 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02914 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO02914 DESCRIPT Coral associated bacteria extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02914 GENEFORM Protein DME1087 XEOTICID XEO02914 MOACRIVE Inhibition DME1087 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1087 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02931 XEO_CLAS Peptide DME1087 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1087 XEOTICID XEO02931 GENEFORM Protein DME1087 XEOTICID XEO02931 MOACRIVE Inhibition DME1087 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1087 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02933 XEO_CLAS Peptide DME1087 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO02933 GENEFORM Protein DME1087 XEOTICID XEO02933 MOACRIVE Inhibition DME1087 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1087 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02934 XEO_CLAS Peptide DME1087 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO02934 GENEFORM Protein DME1087 XEOTICID XEO02934 MOACRIVE Inhibition DME1087 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1087 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02935 XEO_CLAS Peptide DME1087 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1087 XEOTICID XEO02935 GENEFORM Protein DME1087 XEOTICID XEO02935 MOACRIVE Inhibition DME1087 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1087 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02936 XEO_CLAS Peptide DME1087 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO02936 GENEFORM Protein DME1087 XEOTICID XEO02936 MOACRIVE Inhibition DME1087 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1087 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02937 XEO_CLAS Peptide DME1087 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1087 XEOTICID XEO02937 GENEFORM Protein DME1087 XEOTICID XEO02937 MOACRIVE Inhibition DME1087 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1087 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02938 XEO_CLAS Peptide DME1087 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1087 XEOTICID XEO02938 GENEFORM Protein DME1087 XEOTICID XEO02938 MOACRIVE Inhibition DME1087 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1087 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02939 XEO_CLAS Peptide DME1087 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1087 XEOTICID XEO02939 GENEFORM Protein DME1087 XEOTICID XEO02939 MOACRIVE Inhibition DME1087 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1087 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02940 XEO_CLAS Peptide DME1087 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1087 XEOTICID XEO02940 GENEFORM Protein DME1087 XEOTICID XEO02940 MOACRIVE Inhibition DME1087 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1087 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02941 XEO_CLAS Peptide DME1087 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1087 XEOTICID XEO02941 GENEFORM Protein DME1087 XEOTICID XEO02941 MOACRIVE Inhibition DME1087 XEOTICID XEO02943 XEO_NAME CP-P peptide DME1087 XEOTICID XEO02943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02943 XEO_CLAS Peptide DME1087 XEOTICID XEO02943 DESCRIPT CP-P peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1087 XEOTICID XEO02943 GENEFORM Protein DME1087 XEOTICID XEO02943 MOACRIVE Inhibition DME1087 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1087 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02947 XEO_CLAS Peptide DME1087 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO02947 GENEFORM Protein DME1087 XEOTICID XEO02947 MOACRIVE Inhibition DME1087 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1087 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02948 XEO_CLAS Peptide DME1087 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1087 XEOTICID XEO02948 GENEFORM Protein DME1087 XEOTICID XEO02948 MOACRIVE Inhibition DME1087 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1087 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02949 XEO_CLAS Peptide DME1087 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO02949 GENEFORM Protein DME1087 XEOTICID XEO02949 MOACRIVE Inhibition DME1087 XEOTICID XEO02953 XEO_NAME Crocin DME1087 XEOTICID XEO02953 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02953 XEO_CLAS Natural Product DME1087 XEOTICID XEO02953 DESCRIPT Crocin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02953 GENEFORM Protein DME1087 XEOTICID XEO02953 MOACRIVE Inhibition DME1087 XEOTICID XEO02957 XEO_NAME Equisetum hyemale crude extract DME1087 XEOTICID XEO02957 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02957 XEO_CLAS Plant Extract DME1087 XEOTICID XEO02957 DESCRIPT Equisetum hyemale crude extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02957 GENEFORM Protein DME1087 XEOTICID XEO02957 MOACRIVE Inhibition DME1087 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1087 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02969 XEO_CLAS Peptide DME1087 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 32 microM) DME1087 XEOTICID XEO02969 GENEFORM Protein DME1087 XEOTICID XEO02969 MOACRIVE Inhibition DME1087 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1087 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO02971 XEO_CLAS Peptide DME1087 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 128 microM) DME1087 XEOTICID XEO02971 GENEFORM Protein DME1087 XEOTICID XEO02971 MOACRIVE Inhibition DME1087 XEOTICID XEO02974 XEO_NAME Bacillus sp. culture extract DME1087 XEOTICID XEO02974 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02974 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO02974 DESCRIPT Bacillus sp. culture extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02974 GENEFORM Protein DME1087 XEOTICID XEO02974 MOACRIVE Inhibition DME1087 XEOTICID XEO02976 XEO_NAME Paenibacillus strain culture extract DME1087 XEOTICID XEO02976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02976 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO02976 DESCRIPT Paenibacillus strain culture extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02976 GENEFORM Protein DME1087 XEOTICID XEO02976 MOACRIVE Inhibition DME1087 XEOTICID XEO02986 XEO_NAME Bacillus aquimaris culture supernatant DME1087 XEOTICID XEO02986 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02986 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO02986 DESCRIPT Bacillus aquimaris culture supernatant inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02986 GENEFORM Protein DME1087 XEOTICID XEO02986 MOACRIVE Inhibition DME1087 XEOTICID XEO02987 XEO_NAME Bacillus arsenicus culture supernatant DME1087 XEOTICID XEO02987 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02987 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO02987 DESCRIPT Bacillus arsenicus culture supernatant inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02987 GENEFORM Protein DME1087 XEOTICID XEO02987 MOACRIVE Inhibition DME1087 XEOTICID XEO02988 XEO_NAME Bacillus cereus culture supernatant DME1087 XEOTICID XEO02988 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02988 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO02988 DESCRIPT Bacillus cereus culture supernatant inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02988 GENEFORM Protein DME1087 XEOTICID XEO02988 MOACRIVE Inhibition DME1087 XEOTICID XEO02989 XEO_NAME Bacillus indicus culture supernatant DME1087 XEOTICID XEO02989 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO02989 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO02989 DESCRIPT Bacillus indicus culture supernatant inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO02989 GENEFORM Protein DME1087 XEOTICID XEO02989 MOACRIVE Inhibition DME1087 XEOTICID XEO03000 XEO_NAME Bacillus niabensis culture supernatant DME1087 XEOTICID XEO03000 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03000 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO03000 DESCRIPT Bacillus niabensis culture supernatant inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03000 GENEFORM Protein DME1087 XEOTICID XEO03000 MOACRIVE Inhibition DME1087 XEOTICID XEO03001 XEO_NAME Bacillus pumilus culture supernatant DME1087 XEOTICID XEO03001 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03001 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO03001 DESCRIPT Bacillus pumilus culture supernatant inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03001 GENEFORM Protein DME1087 XEOTICID XEO03001 MOACRIVE Inhibition DME1087 XEOTICID XEO03002 XEO_NAME Ferrimonas balearica culture supernatant DME1087 XEOTICID XEO03002 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03002 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO03002 DESCRIPT Ferrimonas balearica culture supernatant inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03002 GENEFORM Protein DME1087 XEOTICID XEO03002 MOACRIVE Inhibition DME1087 XEOTICID XEO03003 XEO_NAME Halobacillus trueperi S6-09 culture supernatant DME1087 XEOTICID XEO03003 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03003 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO03003 DESCRIPT Halobacillus trueperi S6-09 culture supernatant inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03003 GENEFORM Protein DME1087 XEOTICID XEO03003 MOACRIVE Inhibition DME1087 XEOTICID XEO03004 XEO_NAME Halobacillus trueperi S6-16 culture supernatant DME1087 XEOTICID XEO03004 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03004 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO03004 DESCRIPT Halobacillus trueperi S6-16 culture supernatant inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03004 GENEFORM Protein DME1087 XEOTICID XEO03004 MOACRIVE Inhibition DME1087 XEOTICID XEO03007 XEO_NAME Marinobacter hydrocarbonoclasticus culture supernatant DME1087 XEOTICID XEO03007 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03007 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO03007 DESCRIPT Marinobacter hydrocarbonoclasticus culture supernatant inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03007 GENEFORM Protein DME1087 XEOTICID XEO03007 MOACRIVE Inhibition DME1087 XEOTICID XEO03008 XEO_NAME Staphylococcus pasteuri culture supernatant DME1087 XEOTICID XEO03008 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03008 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO03008 DESCRIPT Staphylococcus pasteuri culture supernatant inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03008 GENEFORM Protein DME1087 XEOTICID XEO03008 MOACRIVE Inhibition DME1087 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1087 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03021 XEO_CLAS Peptide DME1087 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.31-0.63 microM) DME1087 XEOTICID XEO03021 GENEFORM Protein DME1087 XEOTICID XEO03021 MOACRIVE Inhibition DME1087 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1087 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03029 XEO_CLAS Peptide DME1087 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 0.619 microM) DME1087 XEOTICID XEO03029 GENEFORM Protein DME1087 XEOTICID XEO03029 MOACRIVE Inhibition DME1087 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1087 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03030 XEO_CLAS Peptide DME1087 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 0.643 microM) DME1087 XEOTICID XEO03030 GENEFORM Protein DME1087 XEOTICID XEO03030 MOACRIVE Inhibition DME1087 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1087 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03031 XEO_CLAS Peptide DME1087 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.005 microM) DME1087 XEOTICID XEO03031 GENEFORM Protein DME1087 XEOTICID XEO03031 MOACRIVE Inhibition DME1087 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1087 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03032 XEO_CLAS Peptide DME1087 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.005 microM) DME1087 XEOTICID XEO03032 GENEFORM Protein DME1087 XEOTICID XEO03032 MOACRIVE Inhibition DME1087 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1087 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03033 XEO_CLAS Peptide DME1087 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.005 microM) DME1087 XEOTICID XEO03033 GENEFORM Protein DME1087 XEOTICID XEO03033 MOACRIVE Inhibition DME1087 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1087 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03034 XEO_CLAS Peptide DME1087 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.004 microM) DME1087 XEOTICID XEO03034 GENEFORM Protein DME1087 XEOTICID XEO03034 MOACRIVE Inhibition DME1087 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1087 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03035 XEO_CLAS Peptide DME1087 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.004 microM) DME1087 XEOTICID XEO03035 GENEFORM Protein DME1087 XEOTICID XEO03035 MOACRIVE Inhibition DME1087 XEOTICID XEO03036 XEO_NAME Cyclic protegrin-1-mimetic L27-11 DME1087 XEOTICID XEO03036 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03036 XEO_CLAS Peptide DME1087 XEOTICID XEO03036 DESCRIPT Cyclic protegrin-1-mimetic L27-11 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03036 GENEFORM Protein DME1087 XEOTICID XEO03036 MOACRIVE Inhibition DME1087 XEOTICID XEO03037 XEO_NAME Cyclo(Trp-Ser) DME1087 XEOTICID XEO03037 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03037 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO03037 DESCRIPT Cyclo(Trp-Ser) inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03037 GENEFORM Protein DME1087 XEOTICID XEO03037 MOACRIVE Inhibition DME1087 XEOTICID XEO03038 XEO_NAME Cyclobutanamine DME1087 XEOTICID XEO03038 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO03038 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO03038 DESCRIPT Cyclobutanamine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03038 GENEFORM Protein DME1087 XEOTICID XEO03038 MOACRIVE Inhibition DME1087 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1087 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03039 XEO_CLAS Peptide DME1087 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 13.5 microM) DME1087 XEOTICID XEO03039 GENEFORM Protein DME1087 XEOTICID XEO03039 MOACRIVE Inhibition DME1087 XEOTICID XEO03040 XEO_NAME Cynarin DME1087 XEOTICID XEO03040 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO03040 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO03040 DESCRIPT Cynarin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03040 GENEFORM Protein DME1087 XEOTICID XEO03040 MOACRIVE Inhibition DME1087 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1087 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03043 XEO_CLAS Peptide DME1087 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1087 XEOTICID XEO03043 GENEFORM Protein DME1087 XEOTICID XEO03043 MOACRIVE Inhibition DME1087 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1087 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03049 XEO_CLAS Peptide DME1087 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1087 XEOTICID XEO03049 GENEFORM Protein DME1087 XEOTICID XEO03049 MOACRIVE Inhibition DME1087 XEOTICID XEO03050 XEO_NAME CP-P derivative D11 DME1087 XEOTICID XEO03050 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03050 XEO_CLAS Peptide DME1087 XEOTICID XEO03050 DESCRIPT CP-P derivative D11 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1087 XEOTICID XEO03050 GENEFORM Protein DME1087 XEOTICID XEO03050 MOACRIVE Inhibition DME1087 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1087 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03051 XEO_CLAS Peptide DME1087 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 200 ug/ml) DME1087 XEOTICID XEO03051 GENEFORM Protein DME1087 XEOTICID XEO03051 MOACRIVE Inhibition DME1087 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1087 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03052 XEO_CLAS Peptide DME1087 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1087 XEOTICID XEO03052 GENEFORM Protein DME1087 XEOTICID XEO03052 MOACRIVE Inhibition DME1087 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1087 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03053 XEO_CLAS Peptide DME1087 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 125 ug/ml) DME1087 XEOTICID XEO03053 GENEFORM Protein DME1087 XEOTICID XEO03053 MOACRIVE Inhibition DME1087 XEOTICID XEO03054 XEO_NAME CP-P derivative D18 DME1087 XEOTICID XEO03054 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03054 XEO_CLAS Peptide DME1087 XEOTICID XEO03054 DESCRIPT CP-P derivative D18 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1087 XEOTICID XEO03054 GENEFORM Protein DME1087 XEOTICID XEO03054 MOACRIVE Inhibition DME1087 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1087 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03055 XEO_CLAS Peptide DME1087 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1087 XEOTICID XEO03055 GENEFORM Protein DME1087 XEOTICID XEO03055 MOACRIVE Inhibition DME1087 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1087 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03059 XEO_CLAS Peptide DME1087 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12 microM) DME1087 XEOTICID XEO03059 GENEFORM Protein DME1087 XEOTICID XEO03059 MOACRIVE Inhibition DME1087 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1087 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03060 XEO_CLAS Peptide DME1087 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1087 XEOTICID XEO03060 GENEFORM Protein DME1087 XEOTICID XEO03060 MOACRIVE Inhibition DME1087 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1087 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03062 XEO_CLAS Peptide DME1087 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6 microM) DME1087 XEOTICID XEO03062 GENEFORM Protein DME1087 XEOTICID XEO03062 MOACRIVE Inhibition DME1087 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1087 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03064 XEO_CLAS Peptide DME1087 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6 microM) DME1087 XEOTICID XEO03064 GENEFORM Protein DME1087 XEOTICID XEO03064 MOACRIVE Inhibition DME1087 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1087 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03066 XEO_CLAS Peptide DME1087 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3 microM) DME1087 XEOTICID XEO03066 GENEFORM Protein DME1087 XEOTICID XEO03066 MOACRIVE Inhibition DME1087 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1087 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03068 XEO_CLAS Peptide DME1087 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3 microM) DME1087 XEOTICID XEO03068 GENEFORM Protein DME1087 XEOTICID XEO03068 MOACRIVE Inhibition DME1087 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1087 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03073 XEO_CLAS Peptide DME1087 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16-32 ug/ml) DME1087 XEOTICID XEO03073 GENEFORM Protein DME1087 XEOTICID XEO03073 MOACRIVE Inhibition DME1087 XEOTICID XEO03096 XEO_NAME Frog defensin DME1087 XEOTICID XEO03096 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03096 XEO_CLAS Peptide DME1087 XEOTICID XEO03096 DESCRIPT Frog defensin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03096 GENEFORM Protein DME1087 XEOTICID XEO03096 MOACRIVE Inhibition DME1087 XEOTICID XEO03098 XEO_NAME Insect defensin DME1087 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03098 XEO_CLAS Peptide DME1087 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 50 ug/ml) DME1087 XEOTICID XEO03098 GENEFORM Protein DME1087 XEOTICID XEO03098 MOACRIVE Inhibition DME1087 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1087 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03116 XEO_CLAS Peptide DME1087 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 40 microM) DME1087 XEOTICID XEO03116 GENEFORM Protein DME1087 XEOTICID XEO03116 MOACRIVE Inhibition DME1087 XEOTICID XEO03123 XEO_NAME Defensin-like protein fabatin-2 DME1087 XEOTICID XEO03123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03123 XEO_CLAS Peptide DME1087 XEOTICID XEO03123 DESCRIPT Defensin-like protein fabatin-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03123 GENEFORM Protein DME1087 XEOTICID XEO03123 MOACRIVE Inhibition DME1087 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1087 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03126 XEO_CLAS Peptide DME1087 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 9.3 microM) DME1087 XEOTICID XEO03126 GENEFORM Protein DME1087 XEOTICID XEO03126 MOACRIVE Inhibition DME1087 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1087 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03127 XEO_CLAS Peptide DME1087 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03127 GENEFORM Protein DME1087 XEOTICID XEO03127 MOACRIVE Inhibition DME1087 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1087 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03128 XEO_CLAS Peptide DME1087 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 256 ug/ml) DME1087 XEOTICID XEO03128 GENEFORM Protein DME1087 XEOTICID XEO03128 MOACRIVE Inhibition DME1087 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1087 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03129 XEO_CLAS Peptide DME1087 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 256 ug/ml) DME1087 XEOTICID XEO03129 GENEFORM Protein DME1087 XEOTICID XEO03129 MOACRIVE Inhibition DME1087 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1087 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03130 XEO_CLAS Peptide DME1087 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 256 ug/ml) DME1087 XEOTICID XEO03130 GENEFORM Protein DME1087 XEOTICID XEO03130 MOACRIVE Inhibition DME1087 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1087 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03131 XEO_CLAS Peptide DME1087 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 256 ug/ml) DME1087 XEOTICID XEO03131 GENEFORM Protein DME1087 XEOTICID XEO03131 MOACRIVE Inhibition DME1087 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1087 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03132 XEO_CLAS Peptide DME1087 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 128 ug/ml) DME1087 XEOTICID XEO03132 GENEFORM Protein DME1087 XEOTICID XEO03132 MOACRIVE Inhibition DME1087 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1087 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03137 XEO_CLAS Peptide DME1087 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03137 GENEFORM Protein DME1087 XEOTICID XEO03137 MOACRIVE Inhibition DME1087 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1087 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03145 XEO_CLAS Peptide DME1087 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.4 microM) DME1087 XEOTICID XEO03145 GENEFORM Protein DME1087 XEOTICID XEO03145 MOACRIVE Inhibition DME1087 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1087 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03146 XEO_CLAS Peptide DME1087 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 40 microM) DME1087 XEOTICID XEO03146 GENEFORM Protein DME1087 XEOTICID XEO03146 MOACRIVE Inhibition DME1087 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1087 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03147 XEO_CLAS Peptide DME1087 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 38 microM) DME1087 XEOTICID XEO03147 GENEFORM Protein DME1087 XEOTICID XEO03147 MOACRIVE Inhibition DME1087 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1087 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03148 XEO_CLAS Peptide DME1087 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 5.4 microM) DME1087 XEOTICID XEO03148 GENEFORM Protein DME1087 XEOTICID XEO03148 MOACRIVE Inhibition DME1087 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1087 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03149 XEO_CLAS Peptide DME1087 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 22 microM) DME1087 XEOTICID XEO03149 GENEFORM Protein DME1087 XEOTICID XEO03149 MOACRIVE Inhibition DME1087 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1087 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03152 XEO_CLAS Peptide DME1087 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.6 microM) DME1087 XEOTICID XEO03152 GENEFORM Protein DME1087 XEOTICID XEO03152 MOACRIVE Inhibition DME1087 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1087 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03156 XEO_CLAS Peptide DME1087 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.3 microM) DME1087 XEOTICID XEO03156 GENEFORM Protein DME1087 XEOTICID XEO03156 MOACRIVE Inhibition DME1087 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1087 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03157 XEO_CLAS Peptide DME1087 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 11.6 microM) DME1087 XEOTICID XEO03157 GENEFORM Protein DME1087 XEOTICID XEO03157 MOACRIVE Inhibition DME1087 XEOTICID XEO03164 XEO_NAME Dermatoxin DME1087 XEOTICID XEO03164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03164 XEO_CLAS Peptide DME1087 XEOTICID XEO03164 DESCRIPT Dermatoxin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03164 GENEFORM Protein DME1087 XEOTICID XEO03164 MOACRIVE Inhibition DME1087 XEOTICID XEO03179 XEO_NAME Dibenzyl disulphide DME1087 XEOTICID XEO03179 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO03179 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO03179 DESCRIPT Dibenzyl disulphide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03179 GENEFORM Protein DME1087 XEOTICID XEO03179 MOACRIVE Inhibition DME1087 XEOTICID XEO03184 XEO_NAME Diclofenac sodium DME1087 XEOTICID XEO03184 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO03184 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO03184 DESCRIPT Diclofenac sodium inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03184 GENEFORM Protein DME1087 XEOTICID XEO03184 MOACRIVE Inhibition DME1087 XEOTICID XEO03191 XEO_NAME Diphenyl disulphide DME1087 XEOTICID XEO03191 XEO_TYPE Health or Environmental Toxicant(s) DME1087 XEOTICID XEO03191 XEO_CLAS Environmental Pollutant DME1087 XEOTICID XEO03191 DESCRIPT Diphenyl disulphide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03191 GENEFORM Protein DME1087 XEOTICID XEO03191 MOACRIVE Inhibition DME1087 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1087 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03197 XEO_CLAS Peptide DME1087 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 28.0 microM) DME1087 XEOTICID XEO03197 GENEFORM Protein DME1087 XEOTICID XEO03197 MOACRIVE Inhibition DME1087 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1087 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03202 XEO_CLAS Peptide DME1087 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 7.92 microM) DME1087 XEOTICID XEO03202 GENEFORM Protein DME1087 XEOTICID XEO03202 MOACRIVE Inhibition DME1087 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1087 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03203 XEO_CLAS Peptide DME1087 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.71 microM) DME1087 XEOTICID XEO03203 GENEFORM Protein DME1087 XEOTICID XEO03203 MOACRIVE Inhibition DME1087 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1087 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03204 XEO_CLAS Peptide DME1087 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.83 microM) DME1087 XEOTICID XEO03204 GENEFORM Protein DME1087 XEOTICID XEO03204 MOACRIVE Inhibition DME1087 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1087 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03205 XEO_CLAS Peptide DME1087 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.22 microM) DME1087 XEOTICID XEO03205 GENEFORM Protein DME1087 XEOTICID XEO03205 MOACRIVE Inhibition DME1087 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1087 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03206 XEO_CLAS Peptide DME1087 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.35 microM) DME1087 XEOTICID XEO03206 GENEFORM Protein DME1087 XEOTICID XEO03206 MOACRIVE Inhibition DME1087 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1087 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03207 XEO_CLAS Peptide DME1087 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.42 microM) DME1087 XEOTICID XEO03207 GENEFORM Protein DME1087 XEOTICID XEO03207 MOACRIVE Inhibition DME1087 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1087 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03208 XEO_CLAS Peptide DME1087 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4.69 microM) DME1087 XEOTICID XEO03208 GENEFORM Protein DME1087 XEOTICID XEO03208 MOACRIVE Inhibition DME1087 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1087 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03209 XEO_CLAS Peptide DME1087 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.23 microM) DME1087 XEOTICID XEO03209 GENEFORM Protein DME1087 XEOTICID XEO03209 MOACRIVE Inhibition DME1087 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1087 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03210 XEO_CLAS Peptide DME1087 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 22.62 microM) DME1087 XEOTICID XEO03210 GENEFORM Protein DME1087 XEOTICID XEO03210 MOACRIVE Inhibition DME1087 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1087 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03211 XEO_CLAS Peptide DME1087 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 22.62 microM) DME1087 XEOTICID XEO03211 GENEFORM Protein DME1087 XEOTICID XEO03211 MOACRIVE Inhibition DME1087 XEOTICID XEO03218 XEO_NAME Dorema oil DME1087 XEOTICID XEO03218 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03218 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03218 DESCRIPT Dorema oil inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03218 GENEFORM Protein DME1087 XEOTICID XEO03218 MOACRIVE Inhibition DME1087 XEOTICID XEO03219 XEO_NAME Doripenem DME1087 XEOTICID XEO03219 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO03219 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO03219 DESCRIPT Doripenem inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03219 GENEFORM Protein DME1087 XEOTICID XEO03219 MOACRIVE Inhibition DME1087 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1087 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03223 XEO_CLAS Peptide DME1087 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4.2 microM) DME1087 XEOTICID XEO03223 GENEFORM Protein DME1087 XEOTICID XEO03223 MOACRIVE Inhibition DME1087 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1087 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03224 XEO_CLAS Peptide DME1087 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1-2.5 microM) DME1087 XEOTICID XEO03224 GENEFORM Protein DME1087 XEOTICID XEO03224 MOACRIVE Inhibition DME1087 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1087 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03225 XEO_CLAS Peptide DME1087 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.2 microM) DME1087 XEOTICID XEO03225 GENEFORM Protein DME1087 XEOTICID XEO03225 MOACRIVE Inhibition DME1087 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1087 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03251 XEO_CLAS Peptide DME1087 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03251 GENEFORM Protein DME1087 XEOTICID XEO03251 MOACRIVE Inhibition DME1087 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1087 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03253 XEO_CLAS Peptide DME1087 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03253 GENEFORM Protein DME1087 XEOTICID XEO03253 MOACRIVE Inhibition DME1087 XEOTICID XEO03263 XEO_NAME Ephedrine DME1087 XEOTICID XEO03263 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03263 XEO_CLAS Natural Product DME1087 XEOTICID XEO03263 DESCRIPT Ephedrine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03263 GENEFORM Protein DME1087 XEOTICID XEO03263 MOACRIVE Inhibition DME1087 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1087 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03277 XEO_CLAS Peptide DME1087 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.7 microM) DME1087 XEOTICID XEO03277 GENEFORM Protein DME1087 XEOTICID XEO03277 MOACRIVE Inhibition DME1087 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1087 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03299 XEO_CLAS Peptide DME1087 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3.5 microM) DME1087 XEOTICID XEO03299 GENEFORM Protein DME1087 XEOTICID XEO03299 MOACRIVE Inhibition DME1087 XEOTICID XEO03323 XEO_NAME Esculin DME1087 XEOTICID XEO03323 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO03323 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO03323 DESCRIPT Esculin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03323 GENEFORM Protein DME1087 XEOTICID XEO03323 MOACRIVE Inhibition DME1087 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1087 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03348 GENEFORM Protein DME1087 XEOTICID XEO03348 MOACRIVE Inhibition DME1087 XEOTICID XEO03349 XEO_NAME Burdock leaf ethanolic extract DME1087 XEOTICID XEO03349 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03349 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03349 DESCRIPT Burdock leaf ethanolic extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03349 GENEFORM Protein DME1087 XEOTICID XEO03349 MOACRIVE Inhibition DME1087 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1087 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03362 XEO_CLAS Peptide DME1087 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 20 ug/ml) DME1087 XEOTICID XEO03362 GENEFORM Protein DME1087 XEOTICID XEO03362 MOACRIVE Inhibition DME1087 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1087 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03363 XEO_CLAS Peptide DME1087 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 30 microM) DME1087 XEOTICID XEO03363 GENEFORM Protein DME1087 XEOTICID XEO03363 MOACRIVE Inhibition DME1087 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1087 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03364 XEO_CLAS Peptide DME1087 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 30 microM) DME1087 XEOTICID XEO03364 GENEFORM Protein DME1087 XEOTICID XEO03364 MOACRIVE Inhibition DME1087 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1087 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03366 XEO_CLAS Peptide DME1087 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 30 microM) DME1087 XEOTICID XEO03366 GENEFORM Protein DME1087 XEOTICID XEO03366 MOACRIVE Inhibition DME1087 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1087 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03367 XEO_CLAS Peptide DME1087 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 30 microM) DME1087 XEOTICID XEO03367 GENEFORM Protein DME1087 XEOTICID XEO03367 MOACRIVE Inhibition DME1087 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1087 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03368 XEO_CLAS Peptide DME1087 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 30 microM) DME1087 XEOTICID XEO03368 GENEFORM Protein DME1087 XEOTICID XEO03368 MOACRIVE Inhibition DME1087 XEOTICID XEO03371 XEO_NAME Herba patriniae extract DME1087 XEOTICID XEO03371 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03371 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03371 DESCRIPT Herba patriniae extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03371 GENEFORM Protein DME1087 XEOTICID XEO03371 MOACRIVE Inhibition DME1087 XEOTICID XEO03377 XEO_NAME CP-P derivative F2 DME1087 XEOTICID XEO03377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03377 XEO_CLAS Peptide DME1087 XEOTICID XEO03377 DESCRIPT CP-P derivative F2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1087 XEOTICID XEO03377 GENEFORM Protein DME1087 XEOTICID XEO03377 MOACRIVE Inhibition DME1087 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1087 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03379 XEO_CLAS Peptide DME1087 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1087 XEOTICID XEO03379 GENEFORM Protein DME1087 XEOTICID XEO03379 MOACRIVE Inhibition DME1087 XEOTICID XEO03388 XEO_NAME Ferrous DME1087 XEOTICID XEO03388 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO03388 XEO_CLAS Nanoparticle DME1087 XEOTICID XEO03388 DESCRIPT Ferrous inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03388 GENEFORM Protein DME1087 XEOTICID XEO03388 MOACRIVE Inhibition DME1087 XEOTICID XEO03389 XEO_NAME Ferula oil DME1087 XEOTICID XEO03389 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03389 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03389 DESCRIPT Ferula oil inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03389 GENEFORM Protein DME1087 XEOTICID XEO03389 MOACRIVE Inhibition DME1087 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1087 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03396 XEO_CLAS Peptide DME1087 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03396 GENEFORM Protein DME1087 XEOTICID XEO03396 MOACRIVE Inhibition DME1087 XEOTICID XEO03403 XEO_NAME Fraxin DME1087 XEOTICID XEO03403 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03403 XEO_CLAS Natural Product DME1087 XEOTICID XEO03403 DESCRIPT Fraxin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03403 GENEFORM Protein DME1087 XEOTICID XEO03403 MOACRIVE Inhibition DME1087 XEOTICID XEO03408 XEO_NAME Lagerstroemia speciosa fruit extract DME1087 XEOTICID XEO03408 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03408 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03408 DESCRIPT Lagerstroemia speciosa fruit extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03408 GENEFORM Protein DME1087 XEOTICID XEO03408 MOACRIVE Inhibition DME1087 XEOTICID XEO03409 XEO_NAME Ruptiliocarpon caracolito fruit extract DME1087 XEOTICID XEO03409 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03409 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03409 DESCRIPT Ruptiliocarpon caracolito fruit extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03409 GENEFORM Protein DME1087 XEOTICID XEO03409 MOACRIVE Inhibition DME1087 XEOTICID XEO03410 XEO_NAME Terminalia chebula fruit extract DME1087 XEOTICID XEO03410 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03410 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03410 DESCRIPT Terminalia chebula fruit extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03410 GENEFORM Protein DME1087 XEOTICID XEO03410 MOACRIVE Inhibition DME1087 XEOTICID XEO03411 XEO_NAME Trichilia martiana fruit extract DME1087 XEOTICID XEO03411 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03411 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03411 DESCRIPT Trichilia martiana fruit extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03411 GENEFORM Protein DME1087 XEOTICID XEO03411 MOACRIVE Inhibition DME1087 XEOTICID XEO03413 XEO_NAME Furanone DME1087 XEOTICID XEO03413 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO03413 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO03413 DESCRIPT Furanone inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03413 GENEFORM Protein DME1087 XEOTICID XEO03413 MOACRIVE Inhibition DME1087 XEOTICID XEO03415 XEO_NAME Furanone C-30 DME1087 XEOTICID XEO03415 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO03415 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO03415 DESCRIPT Furanone C-30 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03415 GENEFORM Protein DME1087 XEOTICID XEO03415 MOACRIVE Inhibition DME1087 XEOTICID XEO03422 XEO_NAME Furvina DME1087 XEOTICID XEO03422 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO03422 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO03422 DESCRIPT Furvina inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03422 GENEFORM Protein DME1087 XEOTICID XEO03422 MOACRIVE Inhibition DME1087 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1087 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03424 XEO_CLAS Peptide DME1087 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03424 GENEFORM Protein DME1087 XEOTICID XEO03424 MOACRIVE Inhibition DME1087 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1087 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03428 XEO_CLAS Peptide DME1087 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 125 ug/ml) DME1087 XEOTICID XEO03428 GENEFORM Protein DME1087 XEOTICID XEO03428 MOACRIVE Inhibition DME1087 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1087 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03430 XEO_CLAS Peptide DME1087 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 63 ug/ml) DME1087 XEOTICID XEO03430 GENEFORM Protein DME1087 XEOTICID XEO03430 MOACRIVE Inhibition DME1087 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1087 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03434 XEO_CLAS Peptide DME1087 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 31 ug/ml) DME1087 XEOTICID XEO03434 GENEFORM Protein DME1087 XEOTICID XEO03434 MOACRIVE Inhibition DME1087 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1087 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03436 XEO_CLAS Peptide DME1087 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1087 XEOTICID XEO03436 GENEFORM Protein DME1087 XEOTICID XEO03436 MOACRIVE Inhibition DME1087 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1087 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03437 XEO_CLAS Peptide DME1087 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1087 XEOTICID XEO03437 GENEFORM Protein DME1087 XEOTICID XEO03437 MOACRIVE Inhibition DME1087 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1087 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03438 XEO_CLAS Peptide DME1087 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1087 XEOTICID XEO03438 GENEFORM Protein DME1087 XEOTICID XEO03438 MOACRIVE Inhibition DME1087 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1087 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03439 XEO_CLAS Peptide DME1087 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1087 XEOTICID XEO03439 GENEFORM Protein DME1087 XEOTICID XEO03439 MOACRIVE Inhibition DME1087 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1087 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03440 XEO_CLAS Peptide DME1087 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1087 XEOTICID XEO03440 GENEFORM Protein DME1087 XEOTICID XEO03440 MOACRIVE Inhibition DME1087 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1087 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03441 XEO_CLAS Peptide DME1087 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1087 XEOTICID XEO03441 GENEFORM Protein DME1087 XEOTICID XEO03441 MOACRIVE Inhibition DME1087 XEOTICID XEO03469 XEO_NAME Gallium cation DME1087 XEOTICID XEO03469 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO03469 XEO_CLAS Nanoparticle DME1087 XEOTICID XEO03469 DESCRIPT Gallium cation inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03469 GENEFORM Protein DME1087 XEOTICID XEO03469 MOACRIVE Inhibition DME1087 XEOTICID XEO03472 XEO_NAME Garlic extract DME1087 XEOTICID XEO03472 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03472 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03472 DESCRIPT Garlic extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03472 GENEFORM Protein DME1087 XEOTICID XEO03472 MOACRIVE Inhibition DME1087 XEOTICID XEO03482 XEO_NAME Ginger extract DME1087 XEOTICID XEO03482 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03482 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03482 DESCRIPT Ginger extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03482 GENEFORM Protein DME1087 XEOTICID XEO03482 MOACRIVE Inhibition DME1087 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1087 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03497 XEO_CLAS Peptide DME1087 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.6-3.15 microM) DME1087 XEOTICID XEO03497 GENEFORM Protein DME1087 XEOTICID XEO03497 MOACRIVE Inhibition DME1087 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1087 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03498 XEO_CLAS Peptide DME1087 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.6-3.15 microM) DME1087 XEOTICID XEO03498 GENEFORM Protein DME1087 XEOTICID XEO03498 MOACRIVE Inhibition DME1087 XEOTICID XEO03508 XEO_NAME Gratisin analogue DME1087 XEOTICID XEO03508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03508 XEO_CLAS Peptide DME1087 XEOTICID XEO03508 DESCRIPT Gratisin analogue inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03508 GENEFORM Protein DME1087 XEOTICID XEO03508 MOACRIVE Inhibition DME1087 XEOTICID XEO03517 XEO_NAME Histone H5 peptide derivative H5(61-90) DME1087 XEOTICID XEO03517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03517 XEO_CLAS Peptide DME1087 XEOTICID XEO03517 DESCRIPT Histone H5 peptide derivative H5(61-90) inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO03517 GENEFORM Protein DME1087 XEOTICID XEO03517 MOACRIVE Inhibition DME1087 XEOTICID XEO03519 XEO_NAME Hadrurin DME1087 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03519 XEO_CLAS Peptide DME1087 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03519 GENEFORM Protein DME1087 XEOTICID XEO03519 MOACRIVE Inhibition DME1087 XEOTICID XEO03520 XEO_NAME Halocidin subunit A DME1087 XEOTICID XEO03520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03520 XEO_CLAS Peptide DME1087 XEOTICID XEO03520 DESCRIPT Halocidin subunit A inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03520 GENEFORM Protein DME1087 XEOTICID XEO03520 MOACRIVE Inhibition DME1087 XEOTICID XEO03521 XEO_NAME Halocidin subunit B DME1087 XEOTICID XEO03521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03521 XEO_CLAS Peptide DME1087 XEOTICID XEO03521 DESCRIPT Halocidin subunit B inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03521 GENEFORM Protein DME1087 XEOTICID XEO03521 MOACRIVE Inhibition DME1087 XEOTICID XEO03522 XEO_NAME Halocyntin DME1087 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03522 XEO_CLAS Peptide DME1087 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03522 GENEFORM Protein DME1087 XEOTICID XEO03522 MOACRIVE Inhibition DME1087 XEOTICID XEO03523 XEO_NAME Hamamelitannin DME1087 XEOTICID XEO03523 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO03523 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO03523 DESCRIPT Hamamelitannin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03523 GENEFORM Protein DME1087 XEOTICID XEO03523 MOACRIVE Inhibition DME1087 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1087 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03540 XEO_CLAS Peptide DME1087 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO03540 GENEFORM Protein DME1087 XEOTICID XEO03540 MOACRIVE Inhibition DME1087 XEOTICID XEO03545 XEO_NAME Heptadecanoic acid DME1087 XEOTICID XEO03545 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO03545 XEO_CLAS Food Additive DME1087 XEOTICID XEO03545 DESCRIPT Heptadecanoic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03545 GENEFORM Protein DME1087 XEOTICID XEO03545 MOACRIVE Inhibition DME1087 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1087 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03549 XEO_CLAS Peptide DME1087 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03549 GENEFORM Protein DME1087 XEOTICID XEO03549 MOACRIVE Inhibition DME1087 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1087 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03556 XEO_CLAS Peptide DME1087 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO03556 GENEFORM Protein DME1087 XEOTICID XEO03556 MOACRIVE Inhibition DME1087 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1087 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03557 XEO_CLAS Peptide DME1087 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO03557 GENEFORM Protein DME1087 XEOTICID XEO03557 MOACRIVE Inhibition DME1087 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1087 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03558 XEO_CLAS Peptide DME1087 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 microM) DME1087 XEOTICID XEO03558 GENEFORM Protein DME1087 XEOTICID XEO03558 MOACRIVE Inhibition DME1087 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1087 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03559 XEO_CLAS Peptide DME1087 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 microM) DME1087 XEOTICID XEO03559 GENEFORM Protein DME1087 XEOTICID XEO03559 MOACRIVE Inhibition DME1087 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1087 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03560 XEO_CLAS Peptide DME1087 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 microM) DME1087 XEOTICID XEO03560 GENEFORM Protein DME1087 XEOTICID XEO03560 MOACRIVE Inhibition DME1087 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1087 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03573 XEO_CLAS Peptide DME1087 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 37.5 ug/ml) DME1087 XEOTICID XEO03573 GENEFORM Protein DME1087 XEOTICID XEO03573 MOACRIVE Inhibition DME1087 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1087 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03579 XEO_CLAS Peptide DME1087 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03579 GENEFORM Protein DME1087 XEOTICID XEO03579 MOACRIVE Inhibition DME1087 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1087 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03585 XEO_CLAS Peptide DME1087 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 125 ug/ml) DME1087 XEOTICID XEO03585 GENEFORM Protein DME1087 XEOTICID XEO03585 MOACRIVE Inhibition DME1087 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1087 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03588 XEO_CLAS Peptide DME1087 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 62 ug/ml) DME1087 XEOTICID XEO03588 GENEFORM Protein DME1087 XEOTICID XEO03588 MOACRIVE Inhibition DME1087 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1087 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03591 XEO_CLAS Peptide DME1087 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 37.5 ug/ml) DME1087 XEOTICID XEO03591 GENEFORM Protein DME1087 XEOTICID XEO03591 MOACRIVE Inhibition DME1087 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1087 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03593 XEO_CLAS Peptide DME1087 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 18.75 ug/ml) DME1087 XEOTICID XEO03593 GENEFORM Protein DME1087 XEOTICID XEO03593 MOACRIVE Inhibition DME1087 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1087 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03594 XEO_CLAS Peptide DME1087 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4.1 ug/ml) DME1087 XEOTICID XEO03594 GENEFORM Protein DME1087 XEOTICID XEO03594 MOACRIVE Inhibition DME1087 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1087 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03609 XEO_CLAS Peptide DME1087 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03609 GENEFORM Protein DME1087 XEOTICID XEO03609 MOACRIVE Inhibition DME1087 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1087 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03615 XEO_CLAS Peptide DME1087 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 48.8-64.0 ug/ml) DME1087 XEOTICID XEO03615 GENEFORM Protein DME1087 XEOTICID XEO03615 MOACRIVE Inhibition DME1087 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1087 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03616 XEO_CLAS Peptide DME1087 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 64 microM) DME1087 XEOTICID XEO03616 GENEFORM Protein DME1087 XEOTICID XEO03616 MOACRIVE Inhibition DME1087 XEOTICID XEO03620 XEO_NAME Hyperoside DME1087 XEOTICID XEO03620 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03620 XEO_CLAS Natural Product DME1087 XEOTICID XEO03620 DESCRIPT Hyperoside inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03620 GENEFORM Protein DME1087 XEOTICID XEO03620 MOACRIVE Inhibition DME1087 XEOTICID XEO03642 XEO_NAME Indirubin DME1087 XEOTICID XEO03642 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03642 XEO_CLAS Natural Product DME1087 XEOTICID XEO03642 DESCRIPT Indirubin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03642 GENEFORM Protein DME1087 XEOTICID XEO03642 MOACRIVE Inhibition DME1087 XEOTICID XEO03644 XEO_NAME Indole DME1087 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1087 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1087 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03644 GENEFORM Protein DME1087 XEOTICID XEO03644 MOACRIVE Inhibition DME1087 XEOTICID XEO03645 XEO_NAME Indole-3-acetaldehyde DME1087 XEOTICID XEO03645 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO03645 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO03645 DESCRIPT Indole-3-acetaldehyde inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03645 GENEFORM Protein DME1087 XEOTICID XEO03645 MOACRIVE Inhibition DME1087 XEOTICID XEO03647 XEO_NAME Indole-3-carboxyaldehyde DME1087 XEOTICID XEO03647 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO03647 XEO_CLAS Food Additive DME1087 XEOTICID XEO03647 DESCRIPT Indole-3-carboxyaldehyde inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03647 GENEFORM Protein DME1087 XEOTICID XEO03647 MOACRIVE Inhibition DME1087 XEOTICID XEO03648 XEO_NAME Indole-7-carboxylic acid DME1087 XEOTICID XEO03648 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO03648 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO03648 DESCRIPT Indole-7-carboxylic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03648 GENEFORM Protein DME1087 XEOTICID XEO03648 MOACRIVE Inhibition DME1087 XEOTICID XEO03649 XEO_NAME Indolicidin DME1087 XEOTICID XEO03649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03649 XEO_CLAS Peptide DME1087 XEOTICID XEO03649 DESCRIPT Indolicidin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03649 GENEFORM Protein DME1087 XEOTICID XEO03649 MOACRIVE Inhibition DME1087 XEOTICID XEO03671 XEO_NAME Plant JCpep7 DME1087 XEOTICID XEO03671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03671 XEO_CLAS Peptide DME1087 XEOTICID XEO03671 DESCRIPT Plant JCpep7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1087 XEOTICID XEO03671 GENEFORM Protein DME1087 XEOTICID XEO03671 MOACRIVE Inhibition DME1087 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1087 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03672 XEO_CLAS Peptide DME1087 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 10 ug/ml) DME1087 XEOTICID XEO03672 GENEFORM Protein DME1087 XEOTICID XEO03672 MOACRIVE Inhibition DME1087 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1087 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03673 XEO_CLAS Peptide DME1087 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 15 ug/ml) DME1087 XEOTICID XEO03673 GENEFORM Protein DME1087 XEOTICID XEO03673 MOACRIVE Inhibition DME1087 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1087 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03674 XEO_CLAS Peptide DME1087 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 30 ug/ml) DME1087 XEOTICID XEO03674 GENEFORM Protein DME1087 XEOTICID XEO03674 MOACRIVE Inhibition DME1087 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1087 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03675 XEO_CLAS Peptide DME1087 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 23 microM) DME1087 XEOTICID XEO03675 GENEFORM Protein DME1087 XEOTICID XEO03675 MOACRIVE Inhibition DME1087 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1087 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03678 XEO_CLAS Peptide DME1087 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1087 XEOTICID XEO03678 GENEFORM Protein DME1087 XEOTICID XEO03678 MOACRIVE Inhibition DME1087 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1087 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03679 XEO_CLAS Peptide DME1087 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1087 XEOTICID XEO03679 GENEFORM Protein DME1087 XEOTICID XEO03679 MOACRIVE Inhibition DME1087 XEOTICID XEO03680 XEO_NAME CP-P derivative K17 DME1087 XEOTICID XEO03680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03680 XEO_CLAS Peptide DME1087 XEOTICID XEO03680 DESCRIPT CP-P derivative K17 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1087 XEOTICID XEO03680 GENEFORM Protein DME1087 XEOTICID XEO03680 MOACRIVE Inhibition DME1087 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1087 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03681 XEO_CLAS Peptide DME1087 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 20-40 microM) DME1087 XEOTICID XEO03681 GENEFORM Protein DME1087 XEOTICID XEO03681 MOACRIVE Inhibition DME1087 XEOTICID XEO03683 XEO_NAME CP-P derivative K6 DME1087 XEOTICID XEO03683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03683 XEO_CLAS Peptide DME1087 XEOTICID XEO03683 DESCRIPT CP-P derivative K6 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1087 XEOTICID XEO03683 GENEFORM Protein DME1087 XEOTICID XEO03683 MOACRIVE Inhibition DME1087 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1087 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03684 XEO_CLAS Peptide DME1087 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 31 ug/ml) DME1087 XEOTICID XEO03684 GENEFORM Protein DME1087 XEOTICID XEO03684 MOACRIVE Inhibition DME1087 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1087 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03697 XEO_CLAS Peptide DME1087 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 25 microM) DME1087 XEOTICID XEO03697 GENEFORM Protein DME1087 XEOTICID XEO03697 MOACRIVE Inhibition DME1087 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1087 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03709 XEO_CLAS Peptide DME1087 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1087 XEOTICID XEO03709 GENEFORM Protein DME1087 XEOTICID XEO03709 MOACRIVE Inhibition DME1087 XEOTICID XEO03710 XEO_NAME knightine DME1087 XEOTICID XEO03710 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03710 XEO_CLAS Natural Product DME1087 XEOTICID XEO03710 DESCRIPT knightine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03710 GENEFORM Protein DME1087 XEOTICID XEO03710 MOACRIVE Inhibition DME1087 XEOTICID XEO03725 XEO_NAME CP-P derivative L10 DME1087 XEOTICID XEO03725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03725 XEO_CLAS Peptide DME1087 XEOTICID XEO03725 DESCRIPT CP-P derivative L10 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1087 XEOTICID XEO03725 GENEFORM Protein DME1087 XEOTICID XEO03725 MOACRIVE Inhibition DME1087 XEOTICID XEO03739 XEO_NAME LlKmWn model peptide L4K3W4 DME1087 XEOTICID XEO03739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03739 XEO_CLAS Peptide DME1087 XEOTICID XEO03739 DESCRIPT LlKmWn model peptide L4K3W4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1087 XEOTICID XEO03739 GENEFORM Protein DME1087 XEOTICID XEO03739 MOACRIVE Inhibition DME1087 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1087 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03744 XEO_CLAS Peptide DME1087 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1087 XEOTICID XEO03744 GENEFORM Protein DME1087 XEOTICID XEO03744 MOACRIVE Inhibition DME1087 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1087 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03746 XEO_CLAS Peptide DME1087 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO03746 GENEFORM Protein DME1087 XEOTICID XEO03746 MOACRIVE Inhibition DME1087 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1087 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03747 XEO_CLAS Peptide DME1087 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1087 XEOTICID XEO03747 GENEFORM Protein DME1087 XEOTICID XEO03747 MOACRIVE Inhibition DME1087 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1087 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03748 XEO_CLAS Peptide DME1087 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO03748 GENEFORM Protein DME1087 XEOTICID XEO03748 MOACRIVE Inhibition DME1087 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1087 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03749 XEO_CLAS Peptide DME1087 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO03749 GENEFORM Protein DME1087 XEOTICID XEO03749 MOACRIVE Inhibition DME1087 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1087 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03750 XEO_CLAS Peptide DME1087 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO03750 GENEFORM Protein DME1087 XEOTICID XEO03750 MOACRIVE Inhibition DME1087 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1087 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03751 XEO_CLAS Peptide DME1087 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1087 XEOTICID XEO03751 GENEFORM Protein DME1087 XEOTICID XEO03751 MOACRIVE Inhibition DME1087 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1087 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03752 XEO_CLAS Peptide DME1087 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO03752 GENEFORM Protein DME1087 XEOTICID XEO03752 MOACRIVE Inhibition DME1087 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1087 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03753 XEO_CLAS Peptide DME1087 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1087 XEOTICID XEO03753 GENEFORM Protein DME1087 XEOTICID XEO03753 MOACRIVE Inhibition DME1087 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1087 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03754 XEO_CLAS Peptide DME1087 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO03754 GENEFORM Protein DME1087 XEOTICID XEO03754 MOACRIVE Inhibition DME1087 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1087 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03755 XEO_CLAS Peptide DME1087 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO03755 GENEFORM Protein DME1087 XEOTICID XEO03755 MOACRIVE Inhibition DME1087 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1087 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03756 XEO_CLAS Peptide DME1087 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1087 XEOTICID XEO03756 GENEFORM Protein DME1087 XEOTICID XEO03756 MOACRIVE Inhibition DME1087 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1087 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03759 XEO_CLAS Peptide DME1087 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1087 XEOTICID XEO03759 GENEFORM Protein DME1087 XEOTICID XEO03759 MOACRIVE Inhibition DME1087 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1087 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03781 XEO_CLAS Peptide DME1087 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4.20 microM) DME1087 XEOTICID XEO03781 GENEFORM Protein DME1087 XEOTICID XEO03781 MOACRIVE Inhibition DME1087 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1087 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03782 XEO_CLAS Peptide DME1087 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 9.16 microM) DME1087 XEOTICID XEO03782 GENEFORM Protein DME1087 XEOTICID XEO03782 MOACRIVE Inhibition DME1087 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1087 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03783 XEO_CLAS Peptide DME1087 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.14 microM) DME1087 XEOTICID XEO03783 GENEFORM Protein DME1087 XEOTICID XEO03783 MOACRIVE Inhibition DME1087 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1087 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03784 XEO_CLAS Peptide DME1087 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4.45 microM) DME1087 XEOTICID XEO03784 GENEFORM Protein DME1087 XEOTICID XEO03784 MOACRIVE Inhibition DME1087 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1087 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03785 XEO_CLAS Peptide DME1087 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.23 microM) DME1087 XEOTICID XEO03785 GENEFORM Protein DME1087 XEOTICID XEO03785 MOACRIVE Inhibition DME1087 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1087 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03786 XEO_CLAS Peptide DME1087 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4.14 microM) DME1087 XEOTICID XEO03786 GENEFORM Protein DME1087 XEOTICID XEO03786 MOACRIVE Inhibition DME1087 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1087 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03787 XEO_CLAS Peptide DME1087 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.69 microM) DME1087 XEOTICID XEO03787 GENEFORM Protein DME1087 XEOTICID XEO03787 MOACRIVE Inhibition DME1087 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1087 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03788 XEO_CLAS Peptide DME1087 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.98 microM) DME1087 XEOTICID XEO03788 GENEFORM Protein DME1087 XEOTICID XEO03788 MOACRIVE Inhibition DME1087 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1087 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03790 XEO_CLAS Peptide DME1087 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.18 microM) DME1087 XEOTICID XEO03790 GENEFORM Protein DME1087 XEOTICID XEO03790 MOACRIVE Inhibition DME1087 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1087 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03791 XEO_CLAS Peptide DME1087 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.86 microM) DME1087 XEOTICID XEO03791 GENEFORM Protein DME1087 XEOTICID XEO03791 MOACRIVE Inhibition DME1087 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1087 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03792 XEO_CLAS Peptide DME1087 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.13 microM) DME1087 XEOTICID XEO03792 GENEFORM Protein DME1087 XEOTICID XEO03792 MOACRIVE Inhibition DME1087 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1087 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03793 XEO_CLAS Peptide DME1087 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 microM) DME1087 XEOTICID XEO03793 GENEFORM Protein DME1087 XEOTICID XEO03793 MOACRIVE Inhibition DME1087 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1087 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03797 XEO_CLAS Peptide DME1087 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.2 microM) DME1087 XEOTICID XEO03797 GENEFORM Protein DME1087 XEOTICID XEO03797 MOACRIVE Inhibition DME1087 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1087 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03810 XEO_CLAS Peptide DME1087 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03810 GENEFORM Protein DME1087 XEOTICID XEO03810 MOACRIVE Inhibition DME1087 XEOTICID XEO03815 XEO_NAME Blakea gracilis leaf extract DME1087 XEOTICID XEO03815 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03815 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03815 DESCRIPT Blakea gracilis leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03815 GENEFORM Protein DME1087 XEOTICID XEO03815 MOACRIVE Inhibition DME1087 XEOTICID XEO03816 XEO_NAME Carapa guianensis leaf extract DME1087 XEOTICID XEO03816 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03816 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03816 DESCRIPT Carapa guianensis leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03816 GENEFORM Protein DME1087 XEOTICID XEO03816 MOACRIVE Inhibition DME1087 XEOTICID XEO03817 XEO_NAME Cedrela fissilis leaf extract DME1087 XEOTICID XEO03817 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03817 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03817 DESCRIPT Cedrela fissilis leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03817 GENEFORM Protein DME1087 XEOTICID XEO03817 MOACRIVE Inhibition DME1087 XEOTICID XEO03818 XEO_NAME Cedrela tonduzii leaf extract DME1087 XEOTICID XEO03818 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03818 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03818 DESCRIPT Cedrela tonduzii leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03818 GENEFORM Protein DME1087 XEOTICID XEO03818 MOACRIVE Inhibition DME1087 XEOTICID XEO03819 XEO_NAME Chukrasia tabularis leaf extract DME1087 XEOTICID XEO03819 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03819 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03819 DESCRIPT Chukrasia tabularis leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03819 GENEFORM Protein DME1087 XEOTICID XEO03819 MOACRIVE Inhibition DME1087 XEOTICID XEO03822 XEO_NAME Conostegia rhodopetala leaf extract DME1087 XEOTICID XEO03822 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03822 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03822 DESCRIPT Conostegia rhodopetala leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03822 GENEFORM Protein DME1087 XEOTICID XEO03822 MOACRIVE Inhibition DME1087 XEOTICID XEO03823 XEO_NAME Cupania glabra leaf extract DME1087 XEOTICID XEO03823 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03823 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03823 DESCRIPT Cupania glabra leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03823 GENEFORM Protein DME1087 XEOTICID XEO03823 MOACRIVE Inhibition DME1087 XEOTICID XEO03824 XEO_NAME Guarea bullata leaf extract DME1087 XEOTICID XEO03824 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03824 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03824 DESCRIPT Guarea bullata leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03824 GENEFORM Protein DME1087 XEOTICID XEO03824 MOACRIVE Inhibition DME1087 XEOTICID XEO03825 XEO_NAME Guarea glabra leaf extract DME1087 XEOTICID XEO03825 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03825 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03825 DESCRIPT Guarea glabra leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03825 GENEFORM Protein DME1087 XEOTICID XEO03825 MOACRIVE Inhibition DME1087 XEOTICID XEO03826 XEO_NAME Guarea grandifolia leaf extract DME1087 XEOTICID XEO03826 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03826 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03826 DESCRIPT Guarea grandifolia leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03826 GENEFORM Protein DME1087 XEOTICID XEO03826 MOACRIVE Inhibition DME1087 XEOTICID XEO03827 XEO_NAME Guarea guidonia leaf extract DME1087 XEOTICID XEO03827 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03827 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03827 DESCRIPT Guarea guidonia leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03827 GENEFORM Protein DME1087 XEOTICID XEO03827 MOACRIVE Inhibition DME1087 XEOTICID XEO03828 XEO_NAME Guarea pterorhachis leaf extract DME1087 XEOTICID XEO03828 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03828 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03828 DESCRIPT Guarea pterorhachis leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03828 GENEFORM Protein DME1087 XEOTICID XEO03828 MOACRIVE Inhibition DME1087 XEOTICID XEO03829 XEO_NAME Leandra melanodesma leaf extract DME1087 XEOTICID XEO03829 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03829 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03829 DESCRIPT Leandra melanodesma leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03829 GENEFORM Protein DME1087 XEOTICID XEO03829 MOACRIVE Inhibition DME1087 XEOTICID XEO03830 XEO_NAME Mangifera indica leaf extract DME1087 XEOTICID XEO03830 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03830 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03830 DESCRIPT Mangifera indica leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03830 GENEFORM Protein DME1087 XEOTICID XEO03830 MOACRIVE Inhibition DME1087 XEOTICID XEO03831 XEO_NAME Miconia longifolia leaf extract DME1087 XEOTICID XEO03831 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03831 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03831 DESCRIPT Miconia longifolia leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03831 GENEFORM Protein DME1087 XEOTICID XEO03831 MOACRIVE Inhibition DME1087 XEOTICID XEO03832 XEO_NAME Miconia pittieri leaf extract DME1087 XEOTICID XEO03832 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03832 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03832 DESCRIPT Miconia pittieri leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03832 GENEFORM Protein DME1087 XEOTICID XEO03832 MOACRIVE Inhibition DME1087 XEOTICID XEO03833 XEO_NAME Piper decurrens leaf extract DME1087 XEOTICID XEO03833 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03833 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03833 DESCRIPT Piper decurrens leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03833 GENEFORM Protein DME1087 XEOTICID XEO03833 MOACRIVE Inhibition DME1087 XEOTICID XEO03834 XEO_NAME Piper pseudolindenii leaf extract DME1087 XEOTICID XEO03834 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03834 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03834 DESCRIPT Piper pseudolindenii leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03834 GENEFORM Protein DME1087 XEOTICID XEO03834 MOACRIVE Inhibition DME1087 XEOTICID XEO03835 XEO_NAME Piper reticulatum leaf extract DME1087 XEOTICID XEO03835 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03835 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03835 DESCRIPT Piper reticulatum leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03835 GENEFORM Protein DME1087 XEOTICID XEO03835 MOACRIVE Inhibition DME1087 XEOTICID XEO03836 XEO_NAME Piper urostachyum leaf extract DME1087 XEOTICID XEO03836 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03836 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03836 DESCRIPT Piper urostachyum leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03836 GENEFORM Protein DME1087 XEOTICID XEO03836 MOACRIVE Inhibition DME1087 XEOTICID XEO03838 XEO_NAME Ruptiliocarpon caracolito leaf extract DME1087 XEOTICID XEO03838 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03838 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03838 DESCRIPT Ruptiliocarpon caracolito leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03838 GENEFORM Protein DME1087 XEOTICID XEO03838 MOACRIVE Inhibition DME1087 XEOTICID XEO03839 XEO_NAME Simarouba amara leaf extract DME1087 XEOTICID XEO03839 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03839 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03839 DESCRIPT Simarouba amara leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03839 GENEFORM Protein DME1087 XEOTICID XEO03839 MOACRIVE Inhibition DME1087 XEOTICID XEO03840 XEO_NAME Simarouba glauca leaf extract DME1087 XEOTICID XEO03840 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03840 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03840 DESCRIPT Simarouba glauca leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03840 GENEFORM Protein DME1087 XEOTICID XEO03840 MOACRIVE Inhibition DME1087 XEOTICID XEO03841 XEO_NAME Swietenia macrophylla leaf extract DME1087 XEOTICID XEO03841 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03841 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03841 DESCRIPT Swietenia macrophylla leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03841 GENEFORM Protein DME1087 XEOTICID XEO03841 MOACRIVE Inhibition DME1087 XEOTICID XEO03842 XEO_NAME Swietenia mahogani leaf extract DME1087 XEOTICID XEO03842 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03842 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03842 DESCRIPT Swietenia mahogani leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03842 GENEFORM Protein DME1087 XEOTICID XEO03842 MOACRIVE Inhibition DME1087 XEOTICID XEO03843 XEO_NAME Trichilia martiana leaf extract DME1087 XEOTICID XEO03843 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03843 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03843 DESCRIPT Trichilia martiana leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03843 GENEFORM Protein DME1087 XEOTICID XEO03843 MOACRIVE Inhibition DME1087 XEOTICID XEO03844 XEO_NAME Trichilia pleeana leaf extract DME1087 XEOTICID XEO03844 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03844 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03844 DESCRIPT Trichilia pleeana leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03844 GENEFORM Protein DME1087 XEOTICID XEO03844 MOACRIVE Inhibition DME1087 XEOTICID XEO03845 XEO_NAME Trichilia septentrionalis leaf extract DME1087 XEOTICID XEO03845 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03845 XEO_CLAS Plant Extract DME1087 XEOTICID XEO03845 DESCRIPT Trichilia septentrionalis leaf extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03845 GENEFORM Protein DME1087 XEOTICID XEO03845 MOACRIVE Inhibition DME1087 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1087 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03853 XEO_CLAS Peptide DME1087 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 microM) DME1087 XEOTICID XEO03853 GENEFORM Protein DME1087 XEOTICID XEO03853 MOACRIVE Inhibition DME1087 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1087 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03904 XEO_CLAS Peptide DME1087 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO03904 GENEFORM Protein DME1087 XEOTICID XEO03904 MOACRIVE Inhibition DME1087 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1087 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03905 XEO_CLAS Peptide DME1087 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO03905 GENEFORM Protein DME1087 XEOTICID XEO03905 MOACRIVE Inhibition DME1087 XEOTICID XEO03911 XEO_NAME Lipoic acid DME1087 XEOTICID XEO03911 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO03911 XEO_CLAS Drug in Phase 2 Clinical Trial DME1087 XEOTICID XEO03911 DESCRIPT Lipoic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03911 GENEFORM Protein DME1087 XEOTICID XEO03911 MOACRIVE Inhibition DME1087 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1087 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03928 XEO_CLAS Peptide DME1087 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 microM) DME1087 XEOTICID XEO03928 GENEFORM Protein DME1087 XEOTICID XEO03928 MOACRIVE Inhibition DME1087 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1087 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03933 XEO_CLAS Peptide DME1087 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 22.7 microM) DME1087 XEOTICID XEO03933 GENEFORM Protein DME1087 XEOTICID XEO03933 MOACRIVE Inhibition DME1087 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1087 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03934 XEO_CLAS Peptide DME1087 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 26.9 microM) DME1087 XEOTICID XEO03934 GENEFORM Protein DME1087 XEOTICID XEO03934 MOACRIVE Inhibition DME1087 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1087 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03935 XEO_CLAS Peptide DME1087 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 19.0 microM) DME1087 XEOTICID XEO03935 GENEFORM Protein DME1087 XEOTICID XEO03935 MOACRIVE Inhibition DME1087 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1087 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03936 XEO_CLAS Peptide DME1087 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 100 microM) DME1087 XEOTICID XEO03936 GENEFORM Protein DME1087 XEOTICID XEO03936 MOACRIVE Inhibition DME1087 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1087 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03937 XEO_CLAS Peptide DME1087 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 23.3 microM) DME1087 XEOTICID XEO03937 GENEFORM Protein DME1087 XEOTICID XEO03937 MOACRIVE Inhibition DME1087 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1087 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03938 XEO_CLAS Peptide DME1087 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 22.5 microM) DME1087 XEOTICID XEO03938 GENEFORM Protein DME1087 XEOTICID XEO03938 MOACRIVE Inhibition DME1087 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1087 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03939 XEO_CLAS Peptide DME1087 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 26.1 microM) DME1087 XEOTICID XEO03939 GENEFORM Protein DME1087 XEOTICID XEO03939 MOACRIVE Inhibition DME1087 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1087 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03940 XEO_CLAS Peptide DME1087 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 100 microM) DME1087 XEOTICID XEO03940 GENEFORM Protein DME1087 XEOTICID XEO03940 MOACRIVE Inhibition DME1087 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1087 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03941 XEO_CLAS Peptide DME1087 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 23.1 microM) DME1087 XEOTICID XEO03941 GENEFORM Protein DME1087 XEOTICID XEO03941 MOACRIVE Inhibition DME1087 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1087 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03943 XEO_CLAS Peptide DME1087 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 27.1 microM) DME1087 XEOTICID XEO03943 GENEFORM Protein DME1087 XEOTICID XEO03943 MOACRIVE Inhibition DME1087 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1087 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03944 XEO_CLAS Peptide DME1087 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 26.1 microM) DME1087 XEOTICID XEO03944 GENEFORM Protein DME1087 XEOTICID XEO03944 MOACRIVE Inhibition DME1087 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1087 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03945 XEO_CLAS Peptide DME1087 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 100 microM) DME1087 XEOTICID XEO03945 GENEFORM Protein DME1087 XEOTICID XEO03945 MOACRIVE Inhibition DME1087 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1087 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03947 XEO_CLAS Peptide DME1087 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 22.5 microM) DME1087 XEOTICID XEO03947 GENEFORM Protein DME1087 XEOTICID XEO03947 MOACRIVE Inhibition DME1087 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1087 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03948 XEO_CLAS Peptide DME1087 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 75 microM) DME1087 XEOTICID XEO03948 GENEFORM Protein DME1087 XEOTICID XEO03948 MOACRIVE Inhibition DME1087 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1087 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03950 XEO_CLAS Peptide DME1087 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 78.7 microM) DME1087 XEOTICID XEO03950 GENEFORM Protein DME1087 XEOTICID XEO03950 MOACRIVE Inhibition DME1087 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1087 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03951 XEO_CLAS Peptide DME1087 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 86.7 microM) DME1087 XEOTICID XEO03951 GENEFORM Protein DME1087 XEOTICID XEO03951 MOACRIVE Inhibition DME1087 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1087 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03952 XEO_CLAS Peptide DME1087 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 76.3 microM) DME1087 XEOTICID XEO03952 GENEFORM Protein DME1087 XEOTICID XEO03952 MOACRIVE Inhibition DME1087 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1087 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03958 XEO_CLAS Peptide DME1087 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03958 GENEFORM Protein DME1087 XEOTICID XEO03958 MOACRIVE Inhibition DME1087 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1087 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1087 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03968 GENEFORM Protein DME1087 XEOTICID XEO03968 MOACRIVE Inhibition DME1087 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1087 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO03985 XEO_CLAS Peptide DME1087 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1087 XEOTICID XEO03985 GENEFORM Protein DME1087 XEOTICID XEO03985 MOACRIVE Inhibition DME1087 XEOTICID XEO03988 XEO_NAME Malabaricone C DME1087 XEOTICID XEO03988 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO03988 XEO_CLAS Natural Product DME1087 XEOTICID XEO03988 DESCRIPT Malabaricone C inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO03988 GENEFORM Protein DME1087 XEOTICID XEO03988 MOACRIVE Inhibition DME1087 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1087 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04000 XEO_CLAS Peptide DME1087 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO04000 GENEFORM Protein DME1087 XEOTICID XEO04000 MOACRIVE Inhibition DME1087 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1087 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04001 XEO_CLAS Peptide DME1087 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50 microM) DME1087 XEOTICID XEO04001 GENEFORM Protein DME1087 XEOTICID XEO04001 MOACRIVE Inhibition DME1087 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1087 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04039 XEO_CLAS Peptide DME1087 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.5 microM) DME1087 XEOTICID XEO04039 GENEFORM Protein DME1087 XEOTICID XEO04039 MOACRIVE Inhibition DME1087 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1087 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04051 XEO_CLAS Peptide DME1087 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.31-0.63 microM) DME1087 XEOTICID XEO04051 GENEFORM Protein DME1087 XEOTICID XEO04051 MOACRIVE Inhibition DME1087 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1087 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04052 XEO_CLAS Peptide DME1087 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04052 GENEFORM Protein DME1087 XEOTICID XEO04052 MOACRIVE Inhibition DME1087 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1087 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04053 XEO_CLAS Peptide DME1087 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.16-0.31 microM) DME1087 XEOTICID XEO04053 GENEFORM Protein DME1087 XEOTICID XEO04053 MOACRIVE Inhibition DME1087 XEOTICID XEO04055 XEO_NAME Melectin DME1087 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04055 XEO_CLAS Peptide DME1087 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 18.5 microM) DME1087 XEOTICID XEO04055 GENEFORM Protein DME1087 XEOTICID XEO04055 MOACRIVE Inhibition DME1087 XEOTICID XEO04057 XEO_NAME Melittin DME1087 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04057 XEO_CLAS Peptide DME1087 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3 microM) DME1087 XEOTICID XEO04057 GENEFORM Protein DME1087 XEOTICID XEO04057 MOACRIVE Inhibition DME1087 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1087 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04061 XEO_CLAS Peptide DME1087 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 17.3 microM) DME1087 XEOTICID XEO04061 GENEFORM Protein DME1087 XEOTICID XEO04061 MOACRIVE Inhibition DME1087 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1087 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04062 XEO_CLAS Peptide DME1087 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 77 microM) DME1087 XEOTICID XEO04062 GENEFORM Protein DME1087 XEOTICID XEO04062 MOACRIVE Inhibition DME1087 XEOTICID XEO04073 XEO_NAME meta-toluidine DME1087 XEOTICID XEO04073 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO04073 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO04073 DESCRIPT meta-toluidine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04073 GENEFORM Protein DME1087 XEOTICID XEO04073 MOACRIVE Inhibition DME1087 XEOTICID XEO04076 XEO_NAME methanesulfonylbenzene DME1087 XEOTICID XEO04076 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO04076 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO04076 DESCRIPT methanesulfonylbenzene inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04076 GENEFORM Protein DME1087 XEOTICID XEO04076 MOACRIVE Inhibition DME1087 XEOTICID XEO04078 XEO_NAME Actinomycetes NIO 10058 methanol extract DME1087 XEOTICID XEO04078 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04078 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO04078 DESCRIPT Actinomycetes NIO 10058 methanol extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04078 GENEFORM Protein DME1087 XEOTICID XEO04078 MOACRIVE Inhibition DME1087 XEOTICID XEO04079 XEO_NAME Actinomycetes NIO 10068 methanol extract DME1087 XEOTICID XEO04079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04079 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO04079 DESCRIPT Actinomycetes NIO 10068 methanol extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04079 GENEFORM Protein DME1087 XEOTICID XEO04079 MOACRIVE Inhibition DME1087 XEOTICID XEO04080 XEO_NAME Actinomycetes NIO 10090 methanol extract DME1087 XEOTICID XEO04080 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04080 XEO_CLAS Bacterial Extract DME1087 XEOTICID XEO04080 DESCRIPT Actinomycetes NIO 10090 methanol extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04080 GENEFORM Protein DME1087 XEOTICID XEO04080 MOACRIVE Inhibition DME1087 XEOTICID XEO04084 XEO_NAME Kalanchoe blossfeldiana leaf methanol extract DME1087 XEOTICID XEO04084 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04084 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04084 DESCRIPT Kalanchoe blossfeldiana leaf methanol extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04084 GENEFORM Protein DME1087 XEOTICID XEO04084 MOACRIVE Inhibition DME1087 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1087 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04087 GENEFORM Protein DME1087 XEOTICID XEO04087 MOACRIVE Inhibition DME1087 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1087 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04089 GENEFORM Protein DME1087 XEOTICID XEO04089 MOACRIVE Inhibition DME1087 XEOTICID XEO04106 XEO_NAME Methyl gallate DME1087 XEOTICID XEO04106 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO04106 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO04106 DESCRIPT Methyl gallate inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04106 GENEFORM Protein DME1087 XEOTICID XEO04106 MOACRIVE Inhibition DME1087 XEOTICID XEO04107 XEO_NAME Methyl indole-7-carboxylate DME1087 XEOTICID XEO04107 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO04107 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO04107 DESCRIPT Methyl indole-7-carboxylate inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04107 GENEFORM Protein DME1087 XEOTICID XEO04107 MOACRIVE Inhibition DME1087 XEOTICID XEO04109 XEO_NAME Micafungin DME1087 XEOTICID XEO04109 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO04109 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO04109 DESCRIPT Micafungin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04109 GENEFORM Protein DME1087 XEOTICID XEO04109 MOACRIVE Inhibition DME1087 XEOTICID XEO04114 XEO_NAME Microcin L DME1087 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04114 XEO_CLAS Peptide DME1087 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04114 GENEFORM Protein DME1087 XEOTICID XEO04114 MOACRIVE Inhibition DME1087 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1087 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04121 XEO_CLAS Peptide DME1087 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04121 GENEFORM Protein DME1087 XEOTICID XEO04121 MOACRIVE Inhibition DME1087 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1087 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04122 XEO_CLAS Peptide DME1087 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 5.02-10.05 microM) DME1087 XEOTICID XEO04122 GENEFORM Protein DME1087 XEOTICID XEO04122 MOACRIVE Inhibition DME1087 XEOTICID XEO04123 XEO_NAME Modified defensin DME1087 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04123 XEO_CLAS Peptide DME1087 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1087 XEOTICID XEO04123 GENEFORM Protein DME1087 XEOTICID XEO04123 MOACRIVE Inhibition DME1087 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1087 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04128 XEO_CLAS Peptide DME1087 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.81 microM) DME1087 XEOTICID XEO04128 GENEFORM Protein DME1087 XEOTICID XEO04128 MOACRIVE Inhibition DME1087 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1087 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04142 XEO_CLAS Peptide DME1087 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8-16 microM) DME1087 XEOTICID XEO04142 GENEFORM Protein DME1087 XEOTICID XEO04142 MOACRIVE Inhibition DME1087 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1087 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04146 XEO_CLAS Peptide DME1087 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04146 GENEFORM Protein DME1087 XEOTICID XEO04146 MOACRIVE Inhibition DME1087 XEOTICID XEO04149 XEO_NAME Mucroporin DME1087 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04149 XEO_CLAS Peptide DME1087 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 100 ug/ml) DME1087 XEOTICID XEO04149 GENEFORM Protein DME1087 XEOTICID XEO04149 MOACRIVE Inhibition DME1087 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1087 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04158 XEO_CLAS Peptide DME1087 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1 microM) DME1087 XEOTICID XEO04158 GENEFORM Protein DME1087 XEOTICID XEO04158 MOACRIVE Inhibition DME1087 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1087 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04159 XEO_CLAS Peptide DME1087 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1 microM) DME1087 XEOTICID XEO04159 GENEFORM Protein DME1087 XEOTICID XEO04159 MOACRIVE Inhibition DME1087 XEOTICID XEO04162 XEO_NAME Myristic acid DME1087 XEOTICID XEO04162 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO04162 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO04162 DESCRIPT Myristic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04162 GENEFORM Protein DME1087 XEOTICID XEO04162 MOACRIVE Inhibition DME1087 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1087 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04168 XEO_CLAS Peptide DME1087 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 25.0 microM) DME1087 XEOTICID XEO04168 GENEFORM Protein DME1087 XEOTICID XEO04168 MOACRIVE Inhibition DME1087 XEOTICID XEO04172 XEO_NAME Myxinidin DME1087 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04172 XEO_CLAS Peptide DME1087 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04172 GENEFORM Protein DME1087 XEOTICID XEO04172 MOACRIVE Inhibition DME1087 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1087 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04177 XEO_CLAS Peptide DME1087 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4.1 microM) DME1087 XEOTICID XEO04177 GENEFORM Protein DME1087 XEOTICID XEO04177 MOACRIVE Inhibition DME1087 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1087 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04178 XEO_CLAS Peptide DME1087 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.7 microM) DME1087 XEOTICID XEO04178 GENEFORM Protein DME1087 XEOTICID XEO04178 MOACRIVE Inhibition DME1087 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1087 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04179 XEO_CLAS Peptide DME1087 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 40 microM) DME1087 XEOTICID XEO04179 GENEFORM Protein DME1087 XEOTICID XEO04179 MOACRIVE Inhibition DME1087 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1087 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04180 XEO_CLAS Peptide DME1087 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 45 microM) DME1087 XEOTICID XEO04180 GENEFORM Protein DME1087 XEOTICID XEO04180 MOACRIVE Inhibition DME1087 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1087 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04181 XEO_CLAS Peptide DME1087 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 35 microM) DME1087 XEOTICID XEO04181 GENEFORM Protein DME1087 XEOTICID XEO04181 MOACRIVE Inhibition DME1087 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1087 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04182 XEO_CLAS Peptide DME1087 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 35 microM) DME1087 XEOTICID XEO04182 GENEFORM Protein DME1087 XEOTICID XEO04182 MOACRIVE Inhibition DME1087 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1087 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04183 XEO_CLAS Peptide DME1087 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 18 microM) DME1087 XEOTICID XEO04183 GENEFORM Protein DME1087 XEOTICID XEO04183 MOACRIVE Inhibition DME1087 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1087 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04184 XEO_CLAS Peptide DME1087 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.9 microM) DME1087 XEOTICID XEO04184 GENEFORM Protein DME1087 XEOTICID XEO04184 MOACRIVE Inhibition DME1087 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1087 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04185 XEO_CLAS Peptide DME1087 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04185 GENEFORM Protein DME1087 XEOTICID XEO04185 MOACRIVE Inhibition DME1087 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1087 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04206 XEO_CLAS Peptide DME1087 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1087 XEOTICID XEO04206 GENEFORM Protein DME1087 XEOTICID XEO04206 MOACRIVE Inhibition DME1087 XEOTICID XEO04213 XEO_NAME CP-P derivative N18 DME1087 XEOTICID XEO04213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04213 XEO_CLAS Peptide DME1087 XEOTICID XEO04213 DESCRIPT CP-P derivative N18 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1087 XEOTICID XEO04213 GENEFORM Protein DME1087 XEOTICID XEO04213 MOACRIVE Inhibition DME1087 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1087 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04214 XEO_CLAS Peptide DME1087 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1087 XEOTICID XEO04214 GENEFORM Protein DME1087 XEOTICID XEO04214 MOACRIVE Inhibition DME1087 XEOTICID XEO04215 XEO_NAME CP-P derivative N20 DME1087 XEOTICID XEO04215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04215 XEO_CLAS Peptide DME1087 XEOTICID XEO04215 DESCRIPT CP-P derivative N20 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1087 XEOTICID XEO04215 GENEFORM Protein DME1087 XEOTICID XEO04215 MOACRIVE Inhibition DME1087 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1087 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04216 XEO_CLAS Peptide DME1087 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1087 XEOTICID XEO04216 GENEFORM Protein DME1087 XEOTICID XEO04216 MOACRIVE Inhibition DME1087 XEOTICID XEO04217 XEO_NAME CP-P derivative N3 DME1087 XEOTICID XEO04217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04217 XEO_CLAS Peptide DME1087 XEOTICID XEO04217 DESCRIPT CP-P derivative N3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1087 XEOTICID XEO04217 GENEFORM Protein DME1087 XEOTICID XEO04217 MOACRIVE Inhibition DME1087 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1087 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04218 XEO_CLAS Peptide DME1087 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3.125 microM) DME1087 XEOTICID XEO04218 GENEFORM Protein DME1087 XEOTICID XEO04218 MOACRIVE Inhibition DME1087 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1087 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04219 XEO_CLAS Peptide DME1087 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1087 XEOTICID XEO04219 GENEFORM Protein DME1087 XEOTICID XEO04219 MOACRIVE Inhibition DME1087 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1087 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04220 XEO_CLAS Peptide DME1087 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1087 XEOTICID XEO04220 GENEFORM Protein DME1087 XEOTICID XEO04220 MOACRIVE Inhibition DME1087 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1087 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04221 XEO_CLAS Peptide DME1087 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3.125 microM) DME1087 XEOTICID XEO04221 GENEFORM Protein DME1087 XEOTICID XEO04221 MOACRIVE Inhibition DME1087 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1087 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04222 XEO_CLAS Peptide DME1087 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3.125 microM) DME1087 XEOTICID XEO04222 GENEFORM Protein DME1087 XEOTICID XEO04222 MOACRIVE Inhibition DME1087 XEOTICID XEO04223 XEO_NAME CP-P derivative N7 DME1087 XEOTICID XEO04223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04223 XEO_CLAS Peptide DME1087 XEOTICID XEO04223 DESCRIPT CP-P derivative N7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1087 XEOTICID XEO04223 GENEFORM Protein DME1087 XEOTICID XEO04223 MOACRIVE Inhibition DME1087 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1087 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04241 XEO_CLAS Peptide DME1087 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04241 GENEFORM Protein DME1087 XEOTICID XEO04241 MOACRIVE Inhibition DME1087 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1087 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04242 XEO_CLAS Peptide DME1087 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04242 GENEFORM Protein DME1087 XEOTICID XEO04242 MOACRIVE Inhibition DME1087 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1087 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04249 XEO_CLAS Peptide DME1087 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 500 ug/ml) DME1087 XEOTICID XEO04249 GENEFORM Protein DME1087 XEOTICID XEO04249 MOACRIVE Inhibition DME1087 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1087 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04256 XEO_CLAS Peptide DME1087 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04256 GENEFORM Protein DME1087 XEOTICID XEO04256 MOACRIVE Inhibition DME1087 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1087 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04259 XEO_CLAS Peptide DME1087 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04259 GENEFORM Protein DME1087 XEOTICID XEO04259 MOACRIVE Inhibition DME1087 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1087 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04261 XEO_CLAS Peptide DME1087 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04261 GENEFORM Protein DME1087 XEOTICID XEO04261 MOACRIVE Inhibition DME1087 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1087 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04265 XEO_CLAS Peptide DME1087 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04265 GENEFORM Protein DME1087 XEOTICID XEO04265 MOACRIVE Inhibition DME1087 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1087 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04268 XEO_CLAS Peptide DME1087 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04268 GENEFORM Protein DME1087 XEOTICID XEO04268 MOACRIVE Inhibition DME1087 XEOTICID XEO04276 XEO_NAME Nigroain-B1 DME1087 XEOTICID XEO04276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04276 XEO_CLAS Peptide DME1087 XEOTICID XEO04276 DESCRIPT Nigroain-B1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 25.00 ug/ml) DME1087 XEOTICID XEO04276 GENEFORM Protein DME1087 XEOTICID XEO04276 MOACRIVE Inhibition DME1087 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1087 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04277 XEO_CLAS Peptide DME1087 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 55.00 ug/ml) DME1087 XEOTICID XEO04277 GENEFORM Protein DME1087 XEOTICID XEO04277 MOACRIVE Inhibition DME1087 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1087 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04281 XEO_CLAS Peptide DME1087 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 25.00 ug/ml) DME1087 XEOTICID XEO04281 GENEFORM Protein DME1087 XEOTICID XEO04281 MOACRIVE Inhibition DME1087 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1087 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04309 XEO_CLAS Peptide DME1087 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 7 microM) DME1087 XEOTICID XEO04309 GENEFORM Protein DME1087 XEOTICID XEO04309 MOACRIVE Inhibition DME1087 XEOTICID XEO04325 XEO_NAME Nodakenetin DME1087 XEOTICID XEO04325 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04325 XEO_CLAS Natural Product DME1087 XEOTICID XEO04325 DESCRIPT Nodakenetin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04325 GENEFORM Protein DME1087 XEOTICID XEO04325 MOACRIVE Inhibition DME1087 XEOTICID XEO04331 XEO_NAME Norspermidine DME1087 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04331 GENEFORM Protein DME1087 XEOTICID XEO04331 MOACRIVE Inhibition DME1087 XEOTICID XEO04333 XEO_NAME Novispirin G-10 DME1087 XEOTICID XEO04333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04333 XEO_CLAS Peptide DME1087 XEOTICID XEO04333 DESCRIPT Novispirin G-10 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.11-12.7 ug/ml) DME1087 XEOTICID XEO04333 GENEFORM Protein DME1087 XEOTICID XEO04333 MOACRIVE Inhibition DME1087 XEOTICID XEO04334 XEO_NAME Novispirin T-7 DME1087 XEOTICID XEO04334 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04334 XEO_CLAS Peptide DME1087 XEOTICID XEO04334 DESCRIPT Novispirin T-7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.26-27.8 ug/ml) DME1087 XEOTICID XEO04334 GENEFORM Protein DME1087 XEOTICID XEO04334 MOACRIVE Inhibition DME1087 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1087 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04335 XEO_CLAS Peptide DME1087 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1087 XEOTICID XEO04335 GENEFORM Protein DME1087 XEOTICID XEO04335 MOACRIVE Inhibition DME1087 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1087 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04336 XEO_CLAS Peptide DME1087 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO04336 GENEFORM Protein DME1087 XEOTICID XEO04336 MOACRIVE Inhibition DME1087 XEOTICID XEO04337 XEO_NAME NRC-16 peptide DME1087 XEOTICID XEO04337 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04337 XEO_CLAS Peptide DME1087 XEOTICID XEO04337 DESCRIPT NRC-16 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04337 GENEFORM Protein DME1087 XEOTICID XEO04337 MOACRIVE Inhibition DME1087 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1087 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04338 XEO_CLAS Peptide DME1087 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1087 XEOTICID XEO04338 GENEFORM Protein DME1087 XEOTICID XEO04338 MOACRIVE Inhibition DME1087 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1087 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04339 XEO_CLAS Peptide DME1087 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1087 XEOTICID XEO04339 GENEFORM Protein DME1087 XEOTICID XEO04339 MOACRIVE Inhibition DME1087 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1087 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04340 XEO_CLAS Peptide DME1087 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1087 XEOTICID XEO04340 GENEFORM Protein DME1087 XEOTICID XEO04340 MOACRIVE Inhibition DME1087 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1087 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04348 XEO_CLAS Peptide DME1087 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 80 microM) DME1087 XEOTICID XEO04348 GENEFORM Protein DME1087 XEOTICID XEO04348 MOACRIVE Inhibition DME1087 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1087 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04349 XEO_CLAS Peptide DME1087 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 100 microM) DME1087 XEOTICID XEO04349 GENEFORM Protein DME1087 XEOTICID XEO04349 MOACRIVE Inhibition DME1087 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1087 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04364 XEO_CLAS Peptide DME1087 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 microM) DME1087 XEOTICID XEO04364 GENEFORM Protein DME1087 XEOTICID XEO04364 MOACRIVE Inhibition DME1087 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1087 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04384 XEO_CLAS Peptide DME1087 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1087 XEOTICID XEO04384 GENEFORM Protein DME1087 XEOTICID XEO04384 MOACRIVE Inhibition DME1087 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1087 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04385 XEO_CLAS Peptide DME1087 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 5 ug/ml) DME1087 XEOTICID XEO04385 GENEFORM Protein DME1087 XEOTICID XEO04385 MOACRIVE Inhibition DME1087 XEOTICID XEO04386 XEO_NAME Syzygium aromaticum oil DME1087 XEOTICID XEO04386 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04386 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04386 DESCRIPT Syzygium aromaticum oil inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04386 GENEFORM Protein DME1087 XEOTICID XEO04386 MOACRIVE Inhibition DME1087 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1087 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04399 XEO_CLAS Peptide DME1087 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1087 XEOTICID XEO04399 GENEFORM Protein DME1087 XEOTICID XEO04399 MOACRIVE Inhibition DME1087 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1087 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04400 XEO_CLAS Peptide DME1087 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1087 XEOTICID XEO04400 GENEFORM Protein DME1087 XEOTICID XEO04400 MOACRIVE Inhibition DME1087 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1087 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04401 XEO_CLAS Peptide DME1087 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1087 XEOTICID XEO04401 GENEFORM Protein DME1087 XEOTICID XEO04401 MOACRIVE Inhibition DME1087 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1087 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04402 XEO_CLAS Peptide DME1087 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1087 XEOTICID XEO04402 GENEFORM Protein DME1087 XEOTICID XEO04402 MOACRIVE Inhibition DME1087 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1087 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04403 XEO_CLAS Peptide DME1087 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1087 XEOTICID XEO04403 GENEFORM Protein DME1087 XEOTICID XEO04403 MOACRIVE Inhibition DME1087 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1087 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04404 XEO_CLAS Peptide DME1087 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1087 XEOTICID XEO04404 GENEFORM Protein DME1087 XEOTICID XEO04404 MOACRIVE Inhibition DME1087 XEOTICID XEO04416 XEO_NAME Ovispirin-1 DME1087 XEOTICID XEO04416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04416 XEO_CLAS Peptide DME1087 XEOTICID XEO04416 DESCRIPT Ovispirin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.7-5.6 ug/ml) DME1087 XEOTICID XEO04416 GENEFORM Protein DME1087 XEOTICID XEO04416 MOACRIVE Inhibition DME1087 XEOTICID XEO04417 XEO_NAME Ovispirin-2 DME1087 XEOTICID XEO04417 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04417 XEO_CLAS Peptide DME1087 XEOTICID XEO04417 DESCRIPT Ovispirin-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.03-16 ug/ml) DME1087 XEOTICID XEO04417 GENEFORM Protein DME1087 XEOTICID XEO04417 MOACRIVE Inhibition DME1087 XEOTICID XEO04418 XEO_NAME Ovispirin-3 DME1087 XEOTICID XEO04418 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04418 XEO_CLAS Peptide DME1087 XEOTICID XEO04418 DESCRIPT Ovispirin-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1-8 ug/ml) DME1087 XEOTICID XEO04418 GENEFORM Protein DME1087 XEOTICID XEO04418 MOACRIVE Inhibition DME1087 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1087 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04426 XEO_CLAS Peptide DME1087 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 microM) DME1087 XEOTICID XEO04426 GENEFORM Protein DME1087 XEOTICID XEO04426 MOACRIVE Inhibition DME1087 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1087 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04430 XEO_CLAS Peptide DME1087 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1087 XEOTICID XEO04430 GENEFORM Protein DME1087 XEOTICID XEO04430 MOACRIVE Inhibition DME1087 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1087 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04438 GENEFORM Protein DME1087 XEOTICID XEO04438 MOACRIVE Inhibition DME1087 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1087 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04444 XEO_CLAS Peptide DME1087 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 33 microM) DME1087 XEOTICID XEO04444 GENEFORM Protein DME1087 XEOTICID XEO04444 MOACRIVE Inhibition DME1087 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1087 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04461 XEO_CLAS Peptide DME1087 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 20.8 microM) DME1087 XEOTICID XEO04461 GENEFORM Protein DME1087 XEOTICID XEO04461 MOACRIVE Inhibition DME1087 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1087 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04462 XEO_CLAS Peptide DME1087 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 38.2 microM) DME1087 XEOTICID XEO04462 GENEFORM Protein DME1087 XEOTICID XEO04462 MOACRIVE Inhibition DME1087 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1087 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04463 XEO_CLAS Peptide DME1087 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04463 GENEFORM Protein DME1087 XEOTICID XEO04463 MOACRIVE Inhibition DME1087 XEOTICID XEO04468 XEO_NAME Papillosin DME1087 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04468 XEO_CLAS Peptide DME1087 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04468 GENEFORM Protein DME1087 XEOTICID XEO04468 MOACRIVE Inhibition DME1087 XEOTICID XEO04469 XEO_NAME para-anisidine DME1087 XEOTICID XEO04469 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO04469 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO04469 DESCRIPT para-anisidine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04469 GENEFORM Protein DME1087 XEOTICID XEO04469 MOACRIVE Inhibition DME1087 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1087 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04471 XEO_CLAS Peptide DME1087 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6.3 microM) DME1087 XEOTICID XEO04471 GENEFORM Protein DME1087 XEOTICID XEO04471 MOACRIVE Inhibition DME1087 XEOTICID XEO04473 XEO_NAME para-ethylaniline DME1087 XEOTICID XEO04473 XEO_TYPE Health or Environmental Toxicant(s) DME1087 XEOTICID XEO04473 XEO_CLAS Acute Toxic Substance DME1087 XEOTICID XEO04473 DESCRIPT para-ethylaniline inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04473 GENEFORM Protein DME1087 XEOTICID XEO04473 MOACRIVE Inhibition DME1087 XEOTICID XEO04475 XEO_NAME para-toluidine DME1087 XEOTICID XEO04475 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO04475 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO04475 DESCRIPT para-toluidine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04475 GENEFORM Protein DME1087 XEOTICID XEO04475 MOACRIVE Inhibition DME1087 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1087 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04482 GENEFORM Protein DME1087 XEOTICID XEO04482 MOACRIVE Inhibition DME1087 XEOTICID XEO04503 XEO_NAME Defensin-like AMP pelovaterin DME1087 XEOTICID XEO04503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04503 XEO_CLAS Peptide DME1087 XEOTICID XEO04503 DESCRIPT Defensin-like AMP pelovaterin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04503 GENEFORM Protein DME1087 XEOTICID XEO04503 MOACRIVE Inhibition DME1087 XEOTICID XEO04512 XEO_NAME Penicillenol A1 DME1087 XEOTICID XEO04512 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04512 XEO_CLAS Natural Product DME1087 XEOTICID XEO04512 DESCRIPT Penicillenol A1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04512 GENEFORM Protein DME1087 XEOTICID XEO04512 MOACRIVE Inhibition DME1087 XEOTICID XEO04513 XEO_NAME Penicillenol A2 DME1087 XEOTICID XEO04513 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04513 XEO_CLAS Natural Product DME1087 XEOTICID XEO04513 DESCRIPT Penicillenol A2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04513 GENEFORM Protein DME1087 XEOTICID XEO04513 MOACRIVE Inhibition DME1087 XEOTICID XEO04514 XEO_NAME Penicillenol B1 DME1087 XEOTICID XEO04514 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04514 XEO_CLAS Natural Product DME1087 XEOTICID XEO04514 DESCRIPT Penicillenol B1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04514 GENEFORM Protein DME1087 XEOTICID XEO04514 MOACRIVE Inhibition DME1087 XEOTICID XEO04515 XEO_NAME Penicillenol B2 DME1087 XEOTICID XEO04515 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04515 XEO_CLAS Natural Product DME1087 XEOTICID XEO04515 DESCRIPT Penicillenol B2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04515 GENEFORM Protein DME1087 XEOTICID XEO04515 MOACRIVE Inhibition DME1087 XEOTICID XEO04516 XEO_NAME Penicillenol C1 DME1087 XEOTICID XEO04516 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04516 XEO_CLAS Natural Product DME1087 XEOTICID XEO04516 DESCRIPT Penicillenol C1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04516 GENEFORM Protein DME1087 XEOTICID XEO04516 MOACRIVE Inhibition DME1087 XEOTICID XEO04517 XEO_NAME Penicillenol C2 DME1087 XEOTICID XEO04517 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04517 XEO_CLAS Natural Product DME1087 XEOTICID XEO04517 DESCRIPT Penicillenol C2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04517 GENEFORM Protein DME1087 XEOTICID XEO04517 MOACRIVE Inhibition DME1087 XEOTICID XEO04518 XEO_NAME Penicillic acid DME1087 XEOTICID XEO04518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04518 XEO_CLAS Natural Product DME1087 XEOTICID XEO04518 DESCRIPT Penicillic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04518 GENEFORM Protein DME1087 XEOTICID XEO04518 MOACRIVE Inhibition DME1087 XEOTICID XEO04522 XEO_NAME Pentagalloylglucose DME1087 XEOTICID XEO04522 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO04522 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO04522 DESCRIPT Pentagalloylglucose inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04522 GENEFORM Protein DME1087 XEOTICID XEO04522 MOACRIVE Inhibition DME1087 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1087 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04526 XEO_CLAS Peptide DME1087 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.0 microM) DME1087 XEOTICID XEO04526 GENEFORM Protein DME1087 XEOTICID XEO04526 MOACRIVE Inhibition DME1087 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1087 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04532 XEO_CLAS Peptide DME1087 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04532 GENEFORM Protein DME1087 XEOTICID XEO04532 MOACRIVE Inhibition DME1087 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1087 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04540 XEO_CLAS Peptide DME1087 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 90.8 ug/ml) DME1087 XEOTICID XEO04540 GENEFORM Protein DME1087 XEOTICID XEO04540 MOACRIVE Inhibition DME1087 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1087 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04541 XEO_CLAS Peptide DME1087 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 21.3 ug/ml) DME1087 XEOTICID XEO04541 GENEFORM Protein DME1087 XEOTICID XEO04541 MOACRIVE Inhibition DME1087 XEOTICID XEO04544 XEO_NAME Histone H5 derivative(71-90) DME1087 XEOTICID XEO04544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04544 XEO_CLAS Peptide DME1087 XEOTICID XEO04544 DESCRIPT Histone H5 derivative(71-90) inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 26.7 ug/ml) DME1087 XEOTICID XEO04544 GENEFORM Protein DME1087 XEOTICID XEO04544 MOACRIVE Inhibition DME1087 XEOTICID XEO04546 XEO_NAME Perinerin DME1087 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04546 XEO_CLAS Peptide DME1087 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04546 GENEFORM Protein DME1087 XEOTICID XEO04546 MOACRIVE Inhibition DME1087 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1087 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04549 XEO_CLAS Peptide DME1087 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 250-500 ug/ml) DME1087 XEOTICID XEO04549 GENEFORM Protein DME1087 XEOTICID XEO04549 MOACRIVE Inhibition DME1087 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1087 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04571 XEO_CLAS Peptide DME1087 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04571 GENEFORM Protein DME1087 XEOTICID XEO04571 MOACRIVE Inhibition DME1087 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1087 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04572 XEO_CLAS Peptide DME1087 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04572 GENEFORM Protein DME1087 XEOTICID XEO04572 MOACRIVE Inhibition DME1087 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1087 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04573 XEO_CLAS Peptide DME1087 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6 microM) DME1087 XEOTICID XEO04573 GENEFORM Protein DME1087 XEOTICID XEO04573 MOACRIVE Inhibition DME1087 XEOTICID XEO04581 XEO_NAME Carex arenicola extract DME1087 XEOTICID XEO04581 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04581 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04581 DESCRIPT Carex arenicola extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04581 GENEFORM Protein DME1087 XEOTICID XEO04581 MOACRIVE Inhibition DME1087 XEOTICID XEO04582 XEO_NAME Carex boottiana extract DME1087 XEOTICID XEO04582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04582 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04582 DESCRIPT Carex boottiana extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04582 GENEFORM Protein DME1087 XEOTICID XEO04582 MOACRIVE Inhibition DME1087 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1087 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04583 GENEFORM Protein DME1087 XEOTICID XEO04583 MOACRIVE Inhibition DME1087 XEOTICID XEO04584 XEO_NAME Carex humilis extract DME1087 XEOTICID XEO04584 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04584 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04584 DESCRIPT Carex humilis extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04584 GENEFORM Protein DME1087 XEOTICID XEO04584 MOACRIVE Inhibition DME1087 XEOTICID XEO04585 XEO_NAME Carex lanceolata extract DME1087 XEOTICID XEO04585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04585 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04585 DESCRIPT Carex lanceolata extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04585 GENEFORM Protein DME1087 XEOTICID XEO04585 MOACRIVE Inhibition DME1087 XEOTICID XEO04586 XEO_NAME Carex pumila extract DME1087 XEOTICID XEO04586 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04586 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04586 DESCRIPT Carex pumila extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04586 GENEFORM Protein DME1087 XEOTICID XEO04586 MOACRIVE Inhibition DME1087 XEOTICID XEO04587 XEO_NAME Carex scabrifolia extract DME1087 XEOTICID XEO04587 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04587 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04587 DESCRIPT Carex scabrifolia extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04587 GENEFORM Protein DME1087 XEOTICID XEO04587 MOACRIVE Inhibition DME1087 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1087 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04588 GENEFORM Protein DME1087 XEOTICID XEO04588 MOACRIVE Inhibition DME1087 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1087 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04601 XEO_CLAS Peptide DME1087 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 9.38 ug/ml) DME1087 XEOTICID XEO04601 GENEFORM Protein DME1087 XEOTICID XEO04601 MOACRIVE Inhibition DME1087 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1087 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04602 XEO_CLAS Peptide DME1087 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 18.75 ug/ml) DME1087 XEOTICID XEO04602 GENEFORM Protein DME1087 XEOTICID XEO04602 MOACRIVE Inhibition DME1087 XEOTICID XEO04603 XEO_NAME Picolinic acid DME1087 XEOTICID XEO04603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04603 XEO_CLAS Amino Acid DME1087 XEOTICID XEO04603 DESCRIPT Picolinic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04603 GENEFORM Protein DME1087 XEOTICID XEO04603 MOACRIVE Inhibition DME1087 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1087 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04605 XEO_CLAS Peptide DME1087 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC < 25 microM) DME1087 XEOTICID XEO04605 GENEFORM Protein DME1087 XEOTICID XEO04605 MOACRIVE Inhibition DME1087 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1087 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04606 XEO_CLAS Peptide DME1087 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 microM) DME1087 XEOTICID XEO04606 GENEFORM Protein DME1087 XEOTICID XEO04606 MOACRIVE Inhibition DME1087 XEOTICID XEO04609 XEO_NAME Pinguisenol DME1087 XEOTICID XEO04609 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO04609 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO04609 DESCRIPT Pinguisenol inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04609 GENEFORM Protein DME1087 XEOTICID XEO04609 MOACRIVE Inhibition DME1087 XEOTICID XEO04611 XEO_NAME Piperacillin-Tazobactam DME1087 XEOTICID XEO04611 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO04611 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO04611 DESCRIPT Piperacillin-Tazobactam inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04611 GENEFORM Protein DME1087 XEOTICID XEO04611 MOACRIVE Inhibition DME1087 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1087 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04613 XEO_CLAS Peptide DME1087 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 5-10 microM) DME1087 XEOTICID XEO04613 GENEFORM Protein DME1087 XEOTICID XEO04613 MOACRIVE Inhibition DME1087 XEOTICID XEO04628 XEO_NAME Platinum (IV) ion DME1087 XEOTICID XEO04628 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO04628 XEO_CLAS Nanoparticle DME1087 XEOTICID XEO04628 DESCRIPT Platinum (IV) ion inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04628 GENEFORM Protein DME1087 XEOTICID XEO04628 MOACRIVE Inhibition DME1087 XEOTICID XEO04629 XEO_NAME Platyphylloside DME1087 XEOTICID XEO04629 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04629 XEO_CLAS Natural Product DME1087 XEOTICID XEO04629 DESCRIPT Platyphylloside inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04629 GENEFORM Protein DME1087 XEOTICID XEO04629 MOACRIVE Inhibition DME1087 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1087 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04640 XEO_CLAS Peptide DME1087 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 35.0 microM) DME1087 XEOTICID XEO04640 GENEFORM Protein DME1087 XEOTICID XEO04640 MOACRIVE Inhibition DME1087 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1087 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04642 XEO_CLAS Peptide DME1087 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1087 XEOTICID XEO04642 GENEFORM Protein DME1087 XEOTICID XEO04642 MOACRIVE Inhibition DME1087 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1087 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04643 XEO_CLAS Peptide DME1087 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1087 XEOTICID XEO04643 GENEFORM Protein DME1087 XEOTICID XEO04643 MOACRIVE Inhibition DME1087 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1087 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04644 XEO_CLAS Peptide DME1087 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1087 XEOTICID XEO04644 GENEFORM Protein DME1087 XEOTICID XEO04644 MOACRIVE Inhibition DME1087 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1087 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04645 XEO_CLAS Peptide DME1087 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1087 XEOTICID XEO04645 GENEFORM Protein DME1087 XEOTICID XEO04645 MOACRIVE Inhibition DME1087 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1087 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04646 XEO_CLAS Peptide DME1087 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1087 XEOTICID XEO04646 GENEFORM Protein DME1087 XEOTICID XEO04646 MOACRIVE Inhibition DME1087 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1087 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04647 XEO_CLAS Peptide DME1087 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1087 XEOTICID XEO04647 GENEFORM Protein DME1087 XEOTICID XEO04647 MOACRIVE Inhibition DME1087 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1087 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04648 XEO_CLAS Peptide DME1087 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO04648 GENEFORM Protein DME1087 XEOTICID XEO04648 MOACRIVE Inhibition DME1087 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1087 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04649 XEO_CLAS Peptide DME1087 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1087 XEOTICID XEO04649 GENEFORM Protein DME1087 XEOTICID XEO04649 MOACRIVE Inhibition DME1087 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1087 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04650 XEO_CLAS Peptide DME1087 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO04650 GENEFORM Protein DME1087 XEOTICID XEO04650 MOACRIVE Inhibition DME1087 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1087 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04651 XEO_CLAS Peptide DME1087 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1087 XEOTICID XEO04651 GENEFORM Protein DME1087 XEOTICID XEO04651 MOACRIVE Inhibition DME1087 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1087 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04652 XEO_CLAS Peptide DME1087 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1087 XEOTICID XEO04652 GENEFORM Protein DME1087 XEOTICID XEO04652 MOACRIVE Inhibition DME1087 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1087 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04653 XEO_CLAS Peptide DME1087 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 64 ug/ml) DME1087 XEOTICID XEO04653 GENEFORM Protein DME1087 XEOTICID XEO04653 MOACRIVE Inhibition DME1087 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1087 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04654 XEO_CLAS Peptide DME1087 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1087 XEOTICID XEO04654 GENEFORM Protein DME1087 XEOTICID XEO04654 MOACRIVE Inhibition DME1087 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1087 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04655 XEO_CLAS Peptide DME1087 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1087 XEOTICID XEO04655 GENEFORM Protein DME1087 XEOTICID XEO04655 MOACRIVE Inhibition DME1087 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1087 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04660 XEO_CLAS Peptide DME1087 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1087 XEOTICID XEO04660 GENEFORM Protein DME1087 XEOTICID XEO04660 MOACRIVE Inhibition DME1087 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1087 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04661 XEO_CLAS Peptide DME1087 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3 microM) DME1087 XEOTICID XEO04661 GENEFORM Protein DME1087 XEOTICID XEO04661 MOACRIVE Inhibition DME1087 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1087 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04680 XEO_CLAS Peptide DME1087 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.5-1 microM) DME1087 XEOTICID XEO04680 GENEFORM Protein DME1087 XEOTICID XEO04680 MOACRIVE Inhibition DME1087 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1087 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04682 XEO_CLAS Peptide DME1087 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 5 microM) DME1087 XEOTICID XEO04682 GENEFORM Protein DME1087 XEOTICID XEO04682 MOACRIVE Inhibition DME1087 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1087 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04683 XEO_CLAS Peptide DME1087 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 38 microM) DME1087 XEOTICID XEO04683 GENEFORM Protein DME1087 XEOTICID XEO04683 MOACRIVE Inhibition DME1087 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1087 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04684 XEO_CLAS Peptide DME1087 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 310 microM) DME1087 XEOTICID XEO04684 GENEFORM Protein DME1087 XEOTICID XEO04684 MOACRIVE Inhibition DME1087 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1087 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04690 XEO_CLAS Peptide DME1087 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1087 XEOTICID XEO04690 GENEFORM Protein DME1087 XEOTICID XEO04690 MOACRIVE Inhibition DME1087 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1087 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04695 XEO_CLAS Peptide DME1087 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04695 GENEFORM Protein DME1087 XEOTICID XEO04695 MOACRIVE Inhibition DME1087 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1087 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04696 XEO_CLAS Peptide DME1087 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04696 GENEFORM Protein DME1087 XEOTICID XEO04696 MOACRIVE Inhibition DME1087 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1087 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04697 XEO_CLAS Peptide DME1087 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04697 GENEFORM Protein DME1087 XEOTICID XEO04697 MOACRIVE Inhibition DME1087 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1087 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04698 XEO_CLAS Peptide DME1087 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04698 GENEFORM Protein DME1087 XEOTICID XEO04698 MOACRIVE Inhibition DME1087 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1087 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04699 XEO_CLAS Peptide DME1087 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04699 GENEFORM Protein DME1087 XEOTICID XEO04699 MOACRIVE Inhibition DME1087 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1087 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04700 XEO_CLAS Peptide DME1087 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04700 GENEFORM Protein DME1087 XEOTICID XEO04700 MOACRIVE Inhibition DME1087 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1087 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04701 XEO_CLAS Peptide DME1087 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04701 GENEFORM Protein DME1087 XEOTICID XEO04701 MOACRIVE Inhibition DME1087 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1087 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04702 XEO_CLAS Peptide DME1087 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04702 GENEFORM Protein DME1087 XEOTICID XEO04702 MOACRIVE Inhibition DME1087 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1087 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04703 XEO_CLAS Peptide DME1087 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04703 GENEFORM Protein DME1087 XEOTICID XEO04703 MOACRIVE Inhibition DME1087 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1087 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04704 XEO_CLAS Peptide DME1087 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04704 GENEFORM Protein DME1087 XEOTICID XEO04704 MOACRIVE Inhibition DME1087 XEOTICID XEO04719 XEO_NAME Pro-Gly DME1087 XEOTICID XEO04719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04719 XEO_CLAS Peptide DME1087 XEOTICID XEO04719 DESCRIPT Pro-Gly inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04719 GENEFORM Protein DME1087 XEOTICID XEO04719 MOACRIVE Inhibition DME1087 XEOTICID XEO04736 XEO_NAME Protocatechuic acid DME1087 XEOTICID XEO04736 XEO_TYPE Health or Environmental Toxicant(s) DME1087 XEOTICID XEO04736 XEO_CLAS Environmental Pollutant DME1087 XEOTICID XEO04736 DESCRIPT Protocatechuic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04736 GENEFORM Protein DME1087 XEOTICID XEO04736 MOACRIVE Inhibition DME1087 XEOTICID XEO04737 XEO_NAME Protonectin DME1087 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04737 XEO_CLAS Peptide DME1087 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.7 ug/ml) DME1087 XEOTICID XEO04737 GENEFORM Protein DME1087 XEOTICID XEO04737 MOACRIVE Inhibition DME1087 XEOTICID XEO04757 XEO_NAME Psoralen DME1087 XEOTICID XEO04757 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04757 XEO_CLAS Natural Product DME1087 XEOTICID XEO04757 DESCRIPT Psoralen inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04757 GENEFORM Protein DME1087 XEOTICID XEO04757 MOACRIVE Inhibition DME1087 XEOTICID XEO04758 XEO_NAME Anti-lipopolysaccharide factor PtALF5 DME1087 XEOTICID XEO04758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04758 XEO_CLAS Peptide DME1087 XEOTICID XEO04758 DESCRIPT Anti-lipopolysaccharide factor PtALF5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 15.54-31.08 microM) DME1087 XEOTICID XEO04758 GENEFORM Protein DME1087 XEOTICID XEO04758 MOACRIVE Inhibition DME1087 XEOTICID XEO04759 XEO_NAME Anti-lipopolysaccharide factor PtALF6 DME1087 XEOTICID XEO04759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04759 XEO_CLAS Peptide DME1087 XEOTICID XEO04759 DESCRIPT Anti-lipopolysaccharide factor PtALF6 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 9.32-18.64 microM) DME1087 XEOTICID XEO04759 GENEFORM Protein DME1087 XEOTICID XEO04759 MOACRIVE Inhibition DME1087 XEOTICID XEO04760 XEO_NAME Anti-lipopolysaccharide factor PtALF7 DME1087 XEOTICID XEO04760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04760 XEO_CLAS Peptide DME1087 XEOTICID XEO04760 DESCRIPT Anti-lipopolysaccharide factor PtALF7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 1.02-2.04 microM) DME1087 XEOTICID XEO04760 GENEFORM Protein DME1087 XEOTICID XEO04760 MOACRIVE Inhibition DME1087 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1087 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04762 XEO_CLAS Peptide DME1087 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1087 XEOTICID XEO04762 GENEFORM Protein DME1087 XEOTICID XEO04762 MOACRIVE Inhibition DME1087 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1087 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04782 XEO_CLAS Peptide DME1087 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 12 ug/ml) DME1087 XEOTICID XEO04782 GENEFORM Protein DME1087 XEOTICID XEO04782 MOACRIVE Inhibition DME1087 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1087 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04783 XEO_CLAS Peptide DME1087 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO04783 GENEFORM Protein DME1087 XEOTICID XEO04783 MOACRIVE Inhibition DME1087 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1087 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04784 XEO_CLAS Peptide DME1087 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO04784 GENEFORM Protein DME1087 XEOTICID XEO04784 MOACRIVE Inhibition DME1087 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1087 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04785 XEO_CLAS Peptide DME1087 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO04785 GENEFORM Protein DME1087 XEOTICID XEO04785 MOACRIVE Inhibition DME1087 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1087 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04786 XEO_CLAS Peptide DME1087 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 63 ug/ml) DME1087 XEOTICID XEO04786 GENEFORM Protein DME1087 XEOTICID XEO04786 MOACRIVE Inhibition DME1087 XEOTICID XEO04799 XEO_NAME Ranalexin DME1087 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04799 XEO_CLAS Peptide DME1087 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 128 ug/ml) DME1087 XEOTICID XEO04799 GENEFORM Protein DME1087 XEOTICID XEO04799 MOACRIVE Inhibition DME1087 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1087 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04809 XEO_CLAS Peptide DME1087 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 5 microM) DME1087 XEOTICID XEO04809 GENEFORM Protein DME1087 XEOTICID XEO04809 MOACRIVE Inhibition DME1087 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1087 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04827 XEO_CLAS Peptide DME1087 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6 microM) DME1087 XEOTICID XEO04827 GENEFORM Protein DME1087 XEOTICID XEO04827 MOACRIVE Inhibition DME1087 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1087 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04837 XEO_CLAS Peptide DME1087 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 10 microM) DME1087 XEOTICID XEO04837 GENEFORM Protein DME1087 XEOTICID XEO04837 MOACRIVE Inhibition DME1087 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1087 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04839 XEO_CLAS Peptide DME1087 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04839 GENEFORM Protein DME1087 XEOTICID XEO04839 MOACRIVE Inhibition DME1087 XEOTICID XEO04852 XEO_NAME Rhipicephalus microplus egg-wax DME1087 XEOTICID XEO04852 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04852 XEO_CLAS Parasite Extract DME1087 XEOTICID XEO04852 DESCRIPT Rhipicephalus microplus egg-wax inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04852 GENEFORM Protein DME1087 XEOTICID XEO04852 MOACRIVE Inhibition DME1087 XEOTICID XEO04863 XEO_NAME RTD peptide DME1087 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04863 XEO_CLAS Peptide DME1087 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2.0 microM) DME1087 XEOTICID XEO04863 GENEFORM Protein DME1087 XEOTICID XEO04863 MOACRIVE Inhibition DME1087 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1087 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04865 XEO_CLAS Peptide DME1087 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 100 ug/ml) DME1087 XEOTICID XEO04865 GENEFORM Protein DME1087 XEOTICID XEO04865 MOACRIVE Inhibition DME1087 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1087 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04866 XEO_CLAS Peptide DME1087 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1087 XEOTICID XEO04866 GENEFORM Protein DME1087 XEOTICID XEO04866 MOACRIVE Inhibition DME1087 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1087 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04877 XEO_CLAS Peptide DME1087 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04877 GENEFORM Protein DME1087 XEOTICID XEO04877 MOACRIVE Inhibition DME1087 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1087 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04880 XEO_CLAS Peptide DME1087 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 10.1 ug/ml) DME1087 XEOTICID XEO04880 GENEFORM Protein DME1087 XEOTICID XEO04880 MOACRIVE Inhibition DME1087 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1087 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04886 XEO_CLAS Peptide DME1087 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 10.1 ug/ml) DME1087 XEOTICID XEO04886 GENEFORM Protein DME1087 XEOTICID XEO04886 MOACRIVE Inhibition DME1087 XEOTICID XEO04888 XEO_NAME CP-P derivative S16 DME1087 XEOTICID XEO04888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04888 XEO_CLAS Peptide DME1087 XEOTICID XEO04888 DESCRIPT CP-P derivative S16 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3.125 ug/ml) DME1087 XEOTICID XEO04888 GENEFORM Protein DME1087 XEOTICID XEO04888 MOACRIVE Inhibition DME1087 XEOTICID XEO04890 XEO_NAME CP-P derivative S9 DME1087 XEOTICID XEO04890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04890 XEO_CLAS Peptide DME1087 XEOTICID XEO04890 DESCRIPT CP-P derivative S9 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1087 XEOTICID XEO04890 GENEFORM Protein DME1087 XEOTICID XEO04890 MOACRIVE Inhibition DME1087 XEOTICID XEO04912 XEO_NAME Scandium carbonate DME1087 XEOTICID XEO04912 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO04912 XEO_CLAS Nanoparticle DME1087 XEOTICID XEO04912 DESCRIPT Scandium carbonate inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04912 GENEFORM Protein DME1087 XEOTICID XEO04912 MOACRIVE Inhibition DME1087 XEOTICID XEO04925 XEO_NAME Selenium nanoparticles DME1087 XEOTICID XEO04925 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04925 XEO_CLAS Natural Product DME1087 XEOTICID XEO04925 DESCRIPT Selenium nanoparticles inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04925 GENEFORM Protein DME1087 XEOTICID XEO04925 MOACRIVE Inhibition DME1087 XEOTICID XEO04940 XEO_NAME Silver Ion DME1087 XEOTICID XEO04940 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO04940 XEO_CLAS Nanoparticle DME1087 XEOTICID XEO04940 DESCRIPT Silver Ion inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04940 GENEFORM Protein DME1087 XEOTICID XEO04940 MOACRIVE Inhibition DME1087 XEOTICID XEO04941 XEO_NAME Silver nanoparticle DME1087 XEOTICID XEO04941 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO04941 XEO_CLAS Nanoparticle DME1087 XEOTICID XEO04941 DESCRIPT Silver nanoparticle inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04941 GENEFORM Protein DME1087 XEOTICID XEO04941 MOACRIVE Inhibition DME1087 XEOTICID XEO04954 XEO_NAME SMAP-29 DME1087 XEOTICID XEO04954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04954 XEO_CLAS Peptide DME1087 XEOTICID XEO04954 DESCRIPT SMAP-29 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04954 GENEFORM Protein DME1087 XEOTICID XEO04954 MOACRIVE Inhibition DME1087 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1087 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04955 XEO_CLAS Peptide DME1087 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.08 microM) DME1087 XEOTICID XEO04955 GENEFORM Protein DME1087 XEOTICID XEO04955 MOACRIVE Inhibition DME1087 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1087 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04956 XEO_CLAS Peptide DME1087 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16.0 microM) DME1087 XEOTICID XEO04956 GENEFORM Protein DME1087 XEOTICID XEO04956 MOACRIVE Inhibition DME1087 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1087 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04957 XEO_CLAS Peptide DME1087 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.77 microM) DME1087 XEOTICID XEO04957 GENEFORM Protein DME1087 XEOTICID XEO04957 MOACRIVE Inhibition DME1087 XEOTICID XEO04962 XEO_NAME Sodium ascorbate DME1087 XEOTICID XEO04962 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO04962 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO04962 DESCRIPT Sodium ascorbate inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04962 GENEFORM Protein DME1087 XEOTICID XEO04962 MOACRIVE Inhibition DME1087 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1087 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04971 XEO_CLAS Peptide DME1087 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6-12 microM) DME1087 XEOTICID XEO04971 GENEFORM Protein DME1087 XEOTICID XEO04971 MOACRIVE Inhibition DME1087 XEOTICID XEO04973 XEO_NAME 3-(Phenylsulfinyl)-L-alanine DME1087 XEOTICID XEO04973 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO04973 XEO_CLAS Chemical Compound DME1087 XEOTICID XEO04973 DESCRIPT 3-(Phenylsulfinyl)-L-alanine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04973 GENEFORM Protein DME1087 XEOTICID XEO04973 MOACRIVE Inhibition DME1087 XEOTICID XEO04974 XEO_NAME Spinigerin DME1087 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04974 XEO_CLAS Peptide DME1087 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 50-100 microM) DME1087 XEOTICID XEO04974 GENEFORM Protein DME1087 XEOTICID XEO04974 MOACRIVE Inhibition DME1087 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1087 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1087 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04975 GENEFORM Protein DME1087 XEOTICID XEO04975 MOACRIVE Inhibition DME1087 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1087 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1087 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04976 GENEFORM Protein DME1087 XEOTICID XEO04976 MOACRIVE Inhibition DME1087 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1087 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1087 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04977 GENEFORM Protein DME1087 XEOTICID XEO04977 MOACRIVE Inhibition DME1087 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1087 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1087 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04978 GENEFORM Protein DME1087 XEOTICID XEO04978 MOACRIVE Inhibition DME1087 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1087 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1087 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04979 GENEFORM Protein DME1087 XEOTICID XEO04979 MOACRIVE Inhibition DME1087 XEOTICID XEO04988 XEO_NAME Guarea bullata stem extract DME1087 XEOTICID XEO04988 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04988 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04988 DESCRIPT Guarea bullata stem extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04988 GENEFORM Protein DME1087 XEOTICID XEO04988 MOACRIVE Inhibition DME1087 XEOTICID XEO04989 XEO_NAME Guarea grandifolia stem extract DME1087 XEOTICID XEO04989 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04989 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04989 DESCRIPT Guarea grandifolia stem extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04989 GENEFORM Protein DME1087 XEOTICID XEO04989 MOACRIVE Inhibition DME1087 XEOTICID XEO04990 XEO_NAME Leandra melanodesma stem extract DME1087 XEOTICID XEO04990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04990 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04990 DESCRIPT Leandra melanodesma stem extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04990 GENEFORM Protein DME1087 XEOTICID XEO04990 MOACRIVE Inhibition DME1087 XEOTICID XEO04991 XEO_NAME Miconia pittieri stem extract DME1087 XEOTICID XEO04991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04991 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04991 DESCRIPT Miconia pittieri stem extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04991 GENEFORM Protein DME1087 XEOTICID XEO04991 MOACRIVE Inhibition DME1087 XEOTICID XEO04992 XEO_NAME Piper urostachyum stem extract DME1087 XEOTICID XEO04992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04992 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04992 DESCRIPT Piper urostachyum stem extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04992 GENEFORM Protein DME1087 XEOTICID XEO04992 MOACRIVE Inhibition DME1087 XEOTICID XEO04993 XEO_NAME Trichilia pittieri stem extract DME1087 XEOTICID XEO04993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO04993 XEO_CLAS Plant Extract DME1087 XEOTICID XEO04993 DESCRIPT Trichilia pittieri stem extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04993 GENEFORM Protein DME1087 XEOTICID XEO04993 MOACRIVE Inhibition DME1087 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1087 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04995 XEO_CLAS Peptide DME1087 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 0.39-0.78 microM) DME1087 XEOTICID XEO04995 GENEFORM Protein DME1087 XEOTICID XEO04995 MOACRIVE Inhibition DME1087 XEOTICID XEO04996 XEO_NAME Streptomycin DME1087 XEOTICID XEO04996 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO04996 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO04996 DESCRIPT Streptomycin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO04996 GENEFORM Protein DME1087 XEOTICID XEO04996 MOACRIVE Inhibition DME1087 XEOTICID XEO04998 XEO_NAME Styelin A DME1087 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04998 XEO_CLAS Peptide DME1087 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1087 XEOTICID XEO04998 GENEFORM Protein DME1087 XEOTICID XEO04998 MOACRIVE Inhibition DME1087 XEOTICID XEO04999 XEO_NAME Styelin B DME1087 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO04999 XEO_CLAS Peptide DME1087 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4.5 ug/ml) DME1087 XEOTICID XEO04999 GENEFORM Protein DME1087 XEOTICID XEO04999 MOACRIVE Inhibition DME1087 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1087 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05000 XEO_CLAS Peptide DME1087 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO05000 GENEFORM Protein DME1087 XEOTICID XEO05000 MOACRIVE Inhibition DME1087 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1087 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05001 XEO_CLAS Peptide DME1087 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1087 XEOTICID XEO05001 GENEFORM Protein DME1087 XEOTICID XEO05001 MOACRIVE Inhibition DME1087 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1087 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05002 XEO_CLAS Peptide DME1087 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1087 XEOTICID XEO05002 GENEFORM Protein DME1087 XEOTICID XEO05002 MOACRIVE Inhibition DME1087 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1087 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05003 XEO_CLAS Peptide DME1087 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 31 ug/ml) DME1087 XEOTICID XEO05003 GENEFORM Protein DME1087 XEOTICID XEO05003 MOACRIVE Inhibition DME1087 XEOTICID XEO05006 XEO_NAME Substance P DME1087 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05006 XEO_CLAS Peptide DME1087 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05006 GENEFORM Protein DME1087 XEOTICID XEO05006 MOACRIVE Inhibition DME1087 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1087 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05007 XEO_CLAS Peptide DME1087 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05007 GENEFORM Protein DME1087 XEOTICID XEO05007 MOACRIVE Inhibition DME1087 XEOTICID XEO05021 XEO_NAME Tachyplesin III DME1087 XEOTICID XEO05021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05021 XEO_CLAS Peptide DME1087 XEOTICID XEO05021 DESCRIPT Tachyplesin III inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05021 GENEFORM Protein DME1087 XEOTICID XEO05021 MOACRIVE Inhibition DME1087 XEOTICID XEO05031 XEO_NAME Tannic acid DME1087 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05031 GENEFORM Protein DME1087 XEOTICID XEO05031 MOACRIVE Inhibition DME1087 XEOTICID XEO05037 XEO_NAME Tellurite DME1087 XEOTICID XEO05037 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO05037 XEO_CLAS Nanoparticle DME1087 XEOTICID XEO05037 DESCRIPT Tellurite inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05037 GENEFORM Protein DME1087 XEOTICID XEO05037 MOACRIVE Inhibition DME1087 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1087 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05063 XEO_CLAS Peptide DME1087 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 31 microM) DME1087 XEOTICID XEO05063 GENEFORM Protein DME1087 XEOTICID XEO05063 MOACRIVE Inhibition DME1087 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1087 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05065 XEO_CLAS Peptide DME1087 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 161 ug/ml) DME1087 XEOTICID XEO05065 GENEFORM Protein DME1087 XEOTICID XEO05065 MOACRIVE Inhibition DME1087 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1087 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05073 XEO_CLAS Peptide DME1087 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 160 microM) DME1087 XEOTICID XEO05073 GENEFORM Protein DME1087 XEOTICID XEO05073 MOACRIVE Inhibition DME1087 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1087 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05075 XEO_CLAS Peptide DME1087 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 160 microM) DME1087 XEOTICID XEO05075 GENEFORM Protein DME1087 XEOTICID XEO05075 MOACRIVE Inhibition DME1087 XEOTICID XEO05076 XEO_NAME Temporin-A DME1087 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05076 XEO_CLAS Peptide DME1087 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 360 microM) DME1087 XEOTICID XEO05076 GENEFORM Protein DME1087 XEOTICID XEO05076 MOACRIVE Inhibition DME1087 XEOTICID XEO05085 XEO_NAME Temporin-B DME1087 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05085 XEO_CLAS Peptide DME1087 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 360 microM) DME1087 XEOTICID XEO05085 GENEFORM Protein DME1087 XEOTICID XEO05085 MOACRIVE Inhibition DME1087 XEOTICID XEO05103 XEO_NAME Temporin-RN1 DME1087 XEOTICID XEO05103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05103 XEO_CLAS Peptide DME1087 XEOTICID XEO05103 DESCRIPT Temporin-RN1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 4.7 ug/ml) DME1087 XEOTICID XEO05103 GENEFORM Protein DME1087 XEOTICID XEO05103 MOACRIVE Inhibition DME1087 XEOTICID XEO05104 XEO_NAME Temporin-RN3 DME1087 XEOTICID XEO05104 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05104 XEO_CLAS Peptide DME1087 XEOTICID XEO05104 DESCRIPT Temporin-RN3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 3.75 ug/ml) DME1087 XEOTICID XEO05104 GENEFORM Protein DME1087 XEOTICID XEO05104 MOACRIVE Inhibition DME1087 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1087 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05139 XEO_CLAS Peptide DME1087 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05139 GENEFORM Protein DME1087 XEOTICID XEO05139 MOACRIVE Inhibition DME1087 XEOTICID XEO05156 XEO_NAME Tobramycin DME1087 XEOTICID XEO05156 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO05156 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO05156 DESCRIPT Tobramycin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05156 GENEFORM Protein DME1087 XEOTICID XEO05156 MOACRIVE Inhibition DME1087 XEOTICID XEO05160 XEO_NAME Toremifene DME1087 XEOTICID XEO05160 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO05160 XEO_CLAS Approved/Marketed Drug DME1087 XEOTICID XEO05160 DESCRIPT Toremifene inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05160 GENEFORM Protein DME1087 XEOTICID XEO05160 MOACRIVE Inhibition DME1087 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1087 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05161 XEO_CLAS Peptide DME1087 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1087 XEOTICID XEO05161 GENEFORM Protein DME1087 XEOTICID XEO05161 MOACRIVE Inhibition DME1087 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1087 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05162 XEO_CLAS Peptide DME1087 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1087 XEOTICID XEO05162 GENEFORM Protein DME1087 XEOTICID XEO05162 MOACRIVE Inhibition DME1087 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1087 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05163 XEO_CLAS Peptide DME1087 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 25-50 ug/ml) DME1087 XEOTICID XEO05163 GENEFORM Protein DME1087 XEOTICID XEO05163 MOACRIVE Inhibition DME1087 XEOTICID XEO05167 XEO_NAME Tricaine DME1087 XEOTICID XEO05167 XEO_TYPE Pharmaceutical Agent(s) DME1087 XEOTICID XEO05167 XEO_CLAS Investigative Agent DME1087 XEOTICID XEO05167 DESCRIPT Tricaine inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05167 GENEFORM Protein DME1087 XEOTICID XEO05167 MOACRIVE Inhibition DME1087 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1087 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05170 XEO_CLAS Peptide DME1087 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 5.0 microM) DME1087 XEOTICID XEO05170 GENEFORM Protein DME1087 XEOTICID XEO05170 MOACRIVE Inhibition DME1087 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1087 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05179 XEO_CLAS Peptide DME1087 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05179 GENEFORM Protein DME1087 XEOTICID XEO05179 MOACRIVE Inhibition DME1087 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1087 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05182 XEO_CLAS Peptide DME1087 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1087 XEOTICID XEO05182 GENEFORM Protein DME1087 XEOTICID XEO05182 MOACRIVE Inhibition DME1087 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1087 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05183 XEO_CLAS Peptide DME1087 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1087 XEOTICID XEO05183 GENEFORM Protein DME1087 XEOTICID XEO05183 MOACRIVE Inhibition DME1087 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1087 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05184 XEO_CLAS Peptide DME1087 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1087 XEOTICID XEO05184 GENEFORM Protein DME1087 XEOTICID XEO05184 MOACRIVE Inhibition DME1087 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1087 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05185 XEO_CLAS Peptide DME1087 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 100 microM) DME1087 XEOTICID XEO05185 GENEFORM Protein DME1087 XEOTICID XEO05185 MOACRIVE Inhibition DME1087 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1087 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05186 XEO_CLAS Peptide DME1087 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1087 XEOTICID XEO05186 GENEFORM Protein DME1087 XEOTICID XEO05186 MOACRIVE Inhibition DME1087 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1087 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05187 XEO_CLAS Peptide DME1087 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1087 XEOTICID XEO05187 GENEFORM Protein DME1087 XEOTICID XEO05187 MOACRIVE Inhibition DME1087 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1087 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05188 XEO_CLAS Peptide DME1087 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1087 XEOTICID XEO05188 GENEFORM Protein DME1087 XEOTICID XEO05188 MOACRIVE Inhibition DME1087 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1087 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05193 XEO_CLAS Peptide DME1087 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO05193 GENEFORM Protein DME1087 XEOTICID XEO05193 MOACRIVE Inhibition DME1087 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1087 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05206 XEO_CLAS Peptide DME1087 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 10 microM) DME1087 XEOTICID XEO05206 GENEFORM Protein DME1087 XEOTICID XEO05206 MOACRIVE Inhibition DME1087 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1087 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05207 XEO_CLAS Peptide DME1087 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 40 microM) DME1087 XEOTICID XEO05207 GENEFORM Protein DME1087 XEOTICID XEO05207 MOACRIVE Inhibition DME1087 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1087 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05208 XEO_CLAS Peptide DME1087 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6 microM) DME1087 XEOTICID XEO05208 GENEFORM Protein DME1087 XEOTICID XEO05208 MOACRIVE Inhibition DME1087 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1087 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05209 XEO_CLAS Peptide DME1087 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1087 XEOTICID XEO05209 GENEFORM Protein DME1087 XEOTICID XEO05209 MOACRIVE Inhibition DME1087 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1087 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05212 XEO_CLAS Peptide DME1087 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 10.1 ug/ml) DME1087 XEOTICID XEO05212 GENEFORM Protein DME1087 XEOTICID XEO05212 MOACRIVE Inhibition DME1087 XEOTICID XEO05227 XEO_NAME Vanillylacetone DME1087 XEOTICID XEO05227 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05227 XEO_CLAS Natural Product DME1087 XEOTICID XEO05227 DESCRIPT Vanillylacetone inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05227 GENEFORM Protein DME1087 XEOTICID XEO05227 MOACRIVE Inhibition DME1087 XEOTICID XEO05250 XEO_NAME Vitexin DME1087 XEOTICID XEO05250 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05250 XEO_CLAS Natural Product DME1087 XEOTICID XEO05250 DESCRIPT Vitexin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05250 GENEFORM Protein DME1087 XEOTICID XEO05250 MOACRIVE Inhibition DME1087 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1087 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05264 XEO_CLAS Peptide DME1087 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1087 XEOTICID XEO05264 GENEFORM Protein DME1087 XEOTICID XEO05264 MOACRIVE Inhibition DME1087 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1087 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05267 XEO_CLAS Peptide DME1087 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1087 XEOTICID XEO05267 GENEFORM Protein DME1087 XEOTICID XEO05267 MOACRIVE Inhibition DME1087 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1087 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05268 XEO_CLAS Peptide DME1087 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1087 XEOTICID XEO05268 GENEFORM Protein DME1087 XEOTICID XEO05268 MOACRIVE Inhibition DME1087 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1087 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05269 XEO_CLAS Peptide DME1087 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC > 50 ug/ml) DME1087 XEOTICID XEO05269 GENEFORM Protein DME1087 XEOTICID XEO05269 MOACRIVE Inhibition DME1087 XEOTICID XEO05276 XEO_NAME Agaricus blazei water extract DME1087 XEOTICID XEO05276 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05276 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05276 DESCRIPT Agaricus blazei water extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05276 GENEFORM Protein DME1087 XEOTICID XEO05276 MOACRIVE Inhibition DME1087 XEOTICID XEO05286 XEO_NAME Peperomia vinasiana extract DME1087 XEOTICID XEO05286 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05286 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05286 DESCRIPT Peperomia vinasiana extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05286 GENEFORM Protein DME1087 XEOTICID XEO05286 MOACRIVE Inhibition DME1087 XEOTICID XEO05288 XEO_NAME Azadirachta indica wood extract DME1087 XEOTICID XEO05288 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05288 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05288 DESCRIPT Azadirachta indica wood extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05288 GENEFORM Protein DME1087 XEOTICID XEO05288 MOACRIVE Inhibition DME1087 XEOTICID XEO05289 XEO_NAME Carapa guianensis wood extract DME1087 XEOTICID XEO05289 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05289 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05289 DESCRIPT Carapa guianensis wood extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05289 GENEFORM Protein DME1087 XEOTICID XEO05289 MOACRIVE Inhibition DME1087 XEOTICID XEO05290 XEO_NAME Cedrela odorata wood extract DME1087 XEOTICID XEO05290 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05290 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05290 DESCRIPT Cedrela odorata wood extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05290 GENEFORM Protein DME1087 XEOTICID XEO05290 MOACRIVE Inhibition DME1087 XEOTICID XEO05291 XEO_NAME Cedrela tonduzii wood extract DME1087 XEOTICID XEO05291 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05291 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05291 DESCRIPT Cedrela tonduzii wood extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05291 GENEFORM Protein DME1087 XEOTICID XEO05291 MOACRIVE Inhibition DME1087 XEOTICID XEO05292 XEO_NAME Chukrasia tabularis wood extract DME1087 XEOTICID XEO05292 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05292 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05292 DESCRIPT Chukrasia tabularis wood extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05292 GENEFORM Protein DME1087 XEOTICID XEO05292 MOACRIVE Inhibition DME1087 XEOTICID XEO05293 XEO_NAME Cupania glabra wood extract DME1087 XEOTICID XEO05293 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05293 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05293 DESCRIPT Cupania glabra wood extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05293 GENEFORM Protein DME1087 XEOTICID XEO05293 MOACRIVE Inhibition DME1087 XEOTICID XEO05294 XEO_NAME Ruptiliocarpon caracolito wood extract DME1087 XEOTICID XEO05294 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05294 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05294 DESCRIPT Ruptiliocarpon caracolito wood extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05294 GENEFORM Protein DME1087 XEOTICID XEO05294 MOACRIVE Inhibition DME1087 XEOTICID XEO05295 XEO_NAME Swietenia macrophylla wood extract DME1087 XEOTICID XEO05295 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05295 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05295 DESCRIPT Swietenia macrophylla wood extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05295 GENEFORM Protein DME1087 XEOTICID XEO05295 MOACRIVE Inhibition DME1087 XEOTICID XEO05296 XEO_NAME Swietenia mahogani wood extract DME1087 XEOTICID XEO05296 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05296 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05296 DESCRIPT Swietenia mahogani wood extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05296 GENEFORM Protein DME1087 XEOTICID XEO05296 MOACRIVE Inhibition DME1087 XEOTICID XEO05297 XEO_NAME Toona ciliata wood extract DME1087 XEOTICID XEO05297 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05297 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05297 DESCRIPT Toona ciliata wood extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05297 GENEFORM Protein DME1087 XEOTICID XEO05297 MOACRIVE Inhibition DME1087 XEOTICID XEO05298 XEO_NAME Trichilia glabra wood extract DME1087 XEOTICID XEO05298 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05298 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05298 DESCRIPT Trichilia glabra wood extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05298 GENEFORM Protein DME1087 XEOTICID XEO05298 MOACRIVE Inhibition DME1087 XEOTICID XEO05299 XEO_NAME Trichilia pleeana wood extract DME1087 XEOTICID XEO05299 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05299 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05299 DESCRIPT Trichilia pleeana wood extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05299 GENEFORM Protein DME1087 XEOTICID XEO05299 MOACRIVE Inhibition DME1087 XEOTICID XEO05300 XEO_NAME Trichilia septentrionalis wood extract DME1087 XEOTICID XEO05300 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05300 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05300 DESCRIPT Trichilia septentrionalis wood extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05300 GENEFORM Protein DME1087 XEOTICID XEO05300 MOACRIVE Inhibition DME1087 XEOTICID XEO05301 XEO_NAME Trichilia trifolia wood extract DME1087 XEOTICID XEO05301 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1087 XEOTICID XEO05301 XEO_CLAS Plant Extract DME1087 XEOTICID XEO05301 DESCRIPT Trichilia trifolia wood extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05301 GENEFORM Protein DME1087 XEOTICID XEO05301 MOACRIVE Inhibition DME1087 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1087 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1087 XEOTICID XEO05303 XEO_CLAS Peptide DME1087 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa (MIC = 125-250 ug/ml) DME1087 XEOTICID XEO05303 GENEFORM Protein DME1087 XEOTICID XEO05303 MOACRIVE Inhibition DME1087 XEOTICID XEO05311 XEO_NAME Zeaxanthin DME1087 XEOTICID XEO05311 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO05311 XEO_CLAS Food Additive DME1087 XEOTICID XEO05311 DESCRIPT Zeaxanthin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05311 GENEFORM Protein DME1087 XEOTICID XEO05311 MOACRIVE Inhibition DME1087 XEOTICID XEO05315 XEO_NAME Zinc Nitrate DME1087 XEOTICID XEO05315 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1087 XEOTICID XEO05315 XEO_CLAS Nanoparticle DME1087 XEOTICID XEO05315 DESCRIPT Zinc Nitrate inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas aeruginosa DME1087 XEOTICID XEO05315 GENEFORM Protein DME1087 XEOTICID XEO05315 MOACRIVE Inhibition DME1088 DME___ID DME1088 DME1088 DME_NAME Hydroxybenzoate 3-monooxygenase (pobA) DME1088 SPESNAME Pseudomonas fluorescens DME1088 XEOTICID XEO00837 XEO_NAME Calcium chloride DME1088 XEOTICID XEO00837 XEO_TYPE Pharmaceutical Agent(s) DME1088 XEOTICID XEO00837 XEO_CLAS Approved/Marketed Drug DME1088 XEOTICID XEO00837 DESCRIPT Calcium chloride inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens DME1088 XEOTICID XEO00837 GENEFORM Protein DME1088 XEOTICID XEO00837 MOACRIVE Inhibition DME1088 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1088 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO01927 XEO_CLAS Peptide DME1088 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens (MIC = 10 ug/ml) DME1088 XEOTICID XEO01927 GENEFORM Protein DME1088 XEOTICID XEO01927 MOACRIVE Inhibition DME1088 XEOTICID XEO02161 XEO_NAME Alliumin DME1088 XEOTICID XEO02161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO02161 XEO_CLAS Peptide DME1088 XEOTICID XEO02161 DESCRIPT Alliumin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens DME1088 XEOTICID XEO02161 GENEFORM Protein DME1088 XEOTICID XEO02161 MOACRIVE Inhibition DME1088 XEOTICID XEO02237 XEO_NAME Antibacterial napin DME1088 XEOTICID XEO02237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO02237 XEO_CLAS Peptide DME1088 XEOTICID XEO02237 DESCRIPT Antibacterial napin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens (MIC = 66 microM) DME1088 XEOTICID XEO02237 GENEFORM Protein DME1088 XEOTICID XEO02237 MOACRIVE Inhibition DME1088 XEOTICID XEO02301 XEO_NAME Fungus ribonuclease DME1088 XEOTICID XEO02301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO02301 XEO_CLAS Peptide DME1088 XEOTICID XEO02301 DESCRIPT Fungus ribonuclease inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens DME1088 XEOTICID XEO02301 GENEFORM Protein DME1088 XEOTICID XEO02301 MOACRIVE Inhibition DME1088 XEOTICID XEO02532 XEO_NAME Brevinin-1LT1 DME1088 XEOTICID XEO02532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO02532 XEO_CLAS Peptide DME1088 XEOTICID XEO02532 DESCRIPT Brevinin-1LT1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens (MIC = 100 microM) DME1088 XEOTICID XEO02532 GENEFORM Protein DME1088 XEOTICID XEO02532 MOACRIVE Inhibition DME1088 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1088 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO02895 XEO_CLAS Peptide DME1088 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens (MIC = 50 microM) DME1088 XEOTICID XEO02895 GENEFORM Protein DME1088 XEOTICID XEO02895 MOACRIVE Inhibition DME1088 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1088 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO02896 XEO_CLAS Peptide DME1088 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens (MIC > 100 microM) DME1088 XEOTICID XEO02896 GENEFORM Protein DME1088 XEOTICID XEO02896 MOACRIVE Inhibition DME1088 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1088 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1088 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1088 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens DME1088 XEOTICID XEO02990 GENEFORM Protein DME1088 XEOTICID XEO02990 MOACRIVE Inhibition DME1088 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1088 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO03251 XEO_CLAS Peptide DME1088 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens DME1088 XEOTICID XEO03251 GENEFORM Protein DME1088 XEOTICID XEO03251 MOACRIVE Inhibition DME1088 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1088 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO03776 XEO_CLAS Peptide DME1088 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens (MIC = 10 microM) DME1088 XEOTICID XEO03776 GENEFORM Protein DME1088 XEOTICID XEO03776 MOACRIVE Inhibition DME1088 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1088 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO03846 XEO_CLAS Peptide DME1088 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens DME1088 XEOTICID XEO03846 GENEFORM Protein DME1088 XEOTICID XEO03846 MOACRIVE Inhibition DME1088 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1088 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO03847 XEO_CLAS Peptide DME1088 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens DME1088 XEOTICID XEO03847 GENEFORM Protein DME1088 XEOTICID XEO03847 MOACRIVE Inhibition DME1088 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1088 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO04128 XEO_CLAS Peptide DME1088 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens (MIC = 0.53 microM) DME1088 XEOTICID XEO04128 GENEFORM Protein DME1088 XEOTICID XEO04128 MOACRIVE Inhibition DME1088 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1088 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO04184 XEO_CLAS Peptide DME1088 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens (MIC = 3.8 microM) DME1088 XEOTICID XEO04184 GENEFORM Protein DME1088 XEOTICID XEO04184 MOACRIVE Inhibition DME1088 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1088 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO04185 XEO_CLAS Peptide DME1088 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens DME1088 XEOTICID XEO04185 GENEFORM Protein DME1088 XEOTICID XEO04185 MOACRIVE Inhibition DME1088 XEOTICID XEO04235 XEO_NAME Napin-like polypeptide DME1088 XEOTICID XEO04235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO04235 XEO_CLAS Peptide DME1088 XEOTICID XEO04235 DESCRIPT Napin-like polypeptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens DME1088 XEOTICID XEO04235 GENEFORM Protein DME1088 XEOTICID XEO04235 MOACRIVE Inhibition DME1088 XEOTICID XEO04963 XEO_NAME Sodium chloride DME1088 XEOTICID XEO04963 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1088 XEOTICID XEO04963 XEO_CLAS Chemical Compound DME1088 XEOTICID XEO04963 DESCRIPT Sodium chloride inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens DME1088 XEOTICID XEO04963 GENEFORM Protein DME1088 XEOTICID XEO04963 MOACRIVE Inhibition DME1088 XEOTICID XEO04964 XEO_NAME Sodium sulfate DME1088 XEOTICID XEO04964 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1088 XEOTICID XEO04964 XEO_CLAS Chemical Compound DME1088 XEOTICID XEO04964 DESCRIPT Sodium sulfate inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens DME1088 XEOTICID XEO04964 GENEFORM Protein DME1088 XEOTICID XEO04964 MOACRIVE Inhibition DME1088 XEOTICID XEO05096 XEO_NAME Temporin-LTc DME1088 XEOTICID XEO05096 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1088 XEOTICID XEO05096 XEO_CLAS Peptide DME1088 XEOTICID XEO05096 DESCRIPT Temporin-LTc inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas fluorescens (MIC = 100 ug/ml) DME1088 XEOTICID XEO05096 GENEFORM Protein DME1088 XEOTICID XEO05096 MOACRIVE Inhibition DME1089 DME___ID DME1089 DME1089 DME_NAME Hydroxybenzoate 3-monooxygenase (pobA) DME1089 SPESNAME Pseudomonas putida DME1089 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1089 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO02649 XEO_CLAS Peptide DME1089 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 4 ug/ml) DME1089 XEOTICID XEO02649 GENEFORM Protein DME1089 XEOTICID XEO02649 MOACRIVE Inhibition DME1089 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1089 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO02650 XEO_CLAS Peptide DME1089 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 2 ug/ml) DME1089 XEOTICID XEO02650 GENEFORM Protein DME1089 XEOTICID XEO02650 MOACRIVE Inhibition DME1089 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1089 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO02839 XEO_CLAS Peptide DME1089 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 40 microM) DME1089 XEOTICID XEO02839 GENEFORM Protein DME1089 XEOTICID XEO02839 MOACRIVE Inhibition DME1089 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1089 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO02842 XEO_CLAS Peptide DME1089 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 40 microM) DME1089 XEOTICID XEO02842 GENEFORM Protein DME1089 XEOTICID XEO02842 MOACRIVE Inhibition DME1089 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1089 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO03052 XEO_CLAS Peptide DME1089 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 100 ug/ml) DME1089 XEOTICID XEO03052 GENEFORM Protein DME1089 XEOTICID XEO03052 MOACRIVE Inhibition DME1089 XEOTICID XEO03349 XEO_NAME Burdock leaf ethanolic extract DME1089 XEOTICID XEO03349 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1089 XEOTICID XEO03349 XEO_CLAS Plant Extract DME1089 XEOTICID XEO03349 DESCRIPT Burdock leaf ethanolic extract inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida DME1089 XEOTICID XEO03349 GENEFORM Protein DME1089 XEOTICID XEO03349 MOACRIVE Inhibition DME1089 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1089 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO03436 XEO_CLAS Peptide DME1089 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 50 ug/ml) DME1089 XEOTICID XEO03436 GENEFORM Protein DME1089 XEOTICID XEO03436 MOACRIVE Inhibition DME1089 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1089 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO03437 XEO_CLAS Peptide DME1089 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 50 ug/ml) DME1089 XEOTICID XEO03437 GENEFORM Protein DME1089 XEOTICID XEO03437 MOACRIVE Inhibition DME1089 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1089 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO03438 XEO_CLAS Peptide DME1089 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 50 ug/ml) DME1089 XEOTICID XEO03438 GENEFORM Protein DME1089 XEOTICID XEO03438 MOACRIVE Inhibition DME1089 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1089 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO03439 XEO_CLAS Peptide DME1089 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 100 ug/ml) DME1089 XEOTICID XEO03439 GENEFORM Protein DME1089 XEOTICID XEO03439 MOACRIVE Inhibition DME1089 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1089 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO03440 XEO_CLAS Peptide DME1089 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 50 ug/ml) DME1089 XEOTICID XEO03440 GENEFORM Protein DME1089 XEOTICID XEO03440 MOACRIVE Inhibition DME1089 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1089 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO03441 XEO_CLAS Peptide DME1089 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 50 ug/ml) DME1089 XEOTICID XEO03441 GENEFORM Protein DME1089 XEOTICID XEO03441 MOACRIVE Inhibition DME1089 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1089 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO03706 XEO_CLAS Peptide DME1089 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida DME1089 XEOTICID XEO03706 GENEFORM Protein DME1089 XEOTICID XEO03706 MOACRIVE Inhibition DME1089 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1089 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO03707 XEO_CLAS Peptide DME1089 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida DME1089 XEOTICID XEO03707 GENEFORM Protein DME1089 XEOTICID XEO03707 MOACRIVE Inhibition DME1089 XEOTICID XEO03971 XEO_NAME Lumbrican DME1089 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO03971 XEO_CLAS Peptide DME1089 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida DME1089 XEOTICID XEO03971 GENEFORM Protein DME1089 XEOTICID XEO03971 MOACRIVE Inhibition DME1089 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1089 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO03985 XEO_CLAS Peptide DME1089 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 10 ug/ml) DME1089 XEOTICID XEO03985 GENEFORM Protein DME1089 XEOTICID XEO03985 MOACRIVE Inhibition DME1089 XEOTICID XEO04117 XEO_NAME Misgurin DME1089 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO04117 XEO_CLAS Peptide DME1089 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida DME1089 XEOTICID XEO04117 GENEFORM Protein DME1089 XEOTICID XEO04117 MOACRIVE Inhibition DME1089 XEOTICID XEO04931 XEO_NAME Shepherin I DME1089 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO04931 XEO_CLAS Peptide DME1089 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida DME1089 XEOTICID XEO04931 GENEFORM Protein DME1089 XEOTICID XEO04931 MOACRIVE Inhibition DME1089 XEOTICID XEO04932 XEO_NAME shepherin II DME1089 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO04932 XEO_CLAS Peptide DME1089 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida DME1089 XEOTICID XEO04932 GENEFORM Protein DME1089 XEOTICID XEO04932 MOACRIVE Inhibition DME1089 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1089 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1089 XEOTICID XEO05111 XEO_CLAS Natural Product DME1089 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida DME1089 XEOTICID XEO05111 GENEFORM Protein DME1089 XEOTICID XEO05111 MOACRIVE Inhibition DME1089 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1089 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO05144 XEO_CLAS Peptide DME1089 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 40 ug/ml) DME1089 XEOTICID XEO05144 GENEFORM Protein DME1089 XEOTICID XEO05144 MOACRIVE Inhibition DME1089 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1089 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO05145 XEO_CLAS Peptide DME1089 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 50 ug/ml) DME1089 XEOTICID XEO05145 GENEFORM Protein DME1089 XEOTICID XEO05145 MOACRIVE Inhibition DME1089 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1089 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO05146 XEO_CLAS Peptide DME1089 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 40 ug/ml) DME1089 XEOTICID XEO05146 GENEFORM Protein DME1089 XEOTICID XEO05146 MOACRIVE Inhibition DME1089 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1089 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO05147 XEO_CLAS Peptide DME1089 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 60 ug/ml) DME1089 XEOTICID XEO05147 GENEFORM Protein DME1089 XEOTICID XEO05147 MOACRIVE Inhibition DME1089 XEOTICID XEO05260 XEO_NAME V. philippinarum beta defensin VpBD DME1089 XEOTICID XEO05260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1089 XEOTICID XEO05260 XEO_CLAS Peptide DME1089 XEOTICID XEO05260 DESCRIPT V. philippinarum beta defensin VpBD inhibits the drug-metabolizing activity of Hydroxybenzoate 3-monooxygenase (pobA) from Pseudomonas putida (MIC = 1.64-3.28 microM) DME1089 XEOTICID XEO05260 GENEFORM Protein DME1089 XEOTICID XEO05260 MOACRIVE Inhibition DME1090 DME___ID DME1090 DME1090 DME_NAME Aminoglycoside phosphotransferase (aph-Ib) DME1090 SPESNAME Campylobacter jejuni DME1090 XEOTICID XEO00220 XEO_NAME Chloramphenicol DME1090 XEOTICID XEO00220 XEO_TYPE Pharmaceutical Agent(s) DME1090 XEOTICID XEO00220 XEO_CLAS Approved/Marketed Drug DME1090 XEOTICID XEO00220 DESCRIPT Chloramphenicol inhibits the drug-metabolizing activity of Aminoglycoside phosphotransferase (aph-Ib) from Campylobacter jejuni DME1090 XEOTICID XEO00220 GENEFORM Protein DME1090 XEOTICID XEO00220 MOACRIVE Inhibition DME1090 XEOTICID XEO01462 XEO_NAME Rutecarpine DME1090 XEOTICID XEO01462 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1090 XEOTICID XEO01462 XEO_CLAS Natural Product DME1090 XEOTICID XEO01462 DESCRIPT Rutecarpine inhibits the drug-metabolizing activity of Aminoglycoside phosphotransferase (aph-Ib) from Campylobacter jejuni DME1090 XEOTICID XEO01462 GENEFORM Protein DME1090 XEOTICID XEO01462 MOACRIVE Inhibition DME1090 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1090 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1090 XEOTICID XEO02376 XEO_CLAS Peptide DME1090 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Aminoglycoside phosphotransferase (aph-Ib) from Campylobacter jejuni (MIC = 0.025-6.4 ug/ml) DME1090 XEOTICID XEO02376 GENEFORM Protein DME1090 XEOTICID XEO02376 MOACRIVE Inhibition DME1090 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1090 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1090 XEOTICID XEO02378 XEO_CLAS Peptide DME1090 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Aminoglycoside phosphotransferase (aph-Ib) from Campylobacter jejuni (MIC = 0.09 ug/ml) DME1090 XEOTICID XEO02378 GENEFORM Protein DME1090 XEOTICID XEO02378 MOACRIVE Inhibition DME1090 XEOTICID XEO02381 XEO_NAME Bacteriocin OR-7 DME1090 XEOTICID XEO02381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1090 XEOTICID XEO02381 XEO_CLAS Peptide DME1090 XEOTICID XEO02381 DESCRIPT Bacteriocin OR-7 inhibits the drug-metabolizing activity of Aminoglycoside phosphotransferase (aph-Ib) from Campylobacter jejuni DME1090 XEOTICID XEO02381 GENEFORM Protein DME1090 XEOTICID XEO02381 MOACRIVE Inhibition DME1090 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1090 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1090 XEOTICID XEO03253 XEO_CLAS Peptide DME1090 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Aminoglycoside phosphotransferase (aph-Ib) from Campylobacter jejuni (MIC = 0.1 ug/ml) DME1090 XEOTICID XEO03253 GENEFORM Protein DME1090 XEOTICID XEO03253 MOACRIVE Inhibition DME1090 XEOTICID XEO03369 XEO_NAME Evodiamine DME1090 XEOTICID XEO03369 XEO_TYPE Health or Environmental Toxicant(s) DME1090 XEOTICID XEO03369 XEO_CLAS Acute Toxic Substance DME1090 XEOTICID XEO03369 DESCRIPT Evodiamine inhibits the drug-metabolizing activity of Aminoglycoside phosphotransferase (aph-Ib) from Campylobacter jejuni DME1090 XEOTICID XEO03369 GENEFORM Protein DME1090 XEOTICID XEO03369 MOACRIVE Inhibition DME1090 XEOTICID XEO03407 XEO_NAME Euodia ruticarpa ethanol solution extract DME1090 XEOTICID XEO03407 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1090 XEOTICID XEO03407 XEO_CLAS Plant Extract DME1090 XEOTICID XEO03407 DESCRIPT Euodia ruticarpa ethanol solution extract inhibits the drug-metabolizing activity of Aminoglycoside phosphotransferase (aph-Ib) from Campylobacter jejuni DME1090 XEOTICID XEO03407 GENEFORM Protein DME1090 XEOTICID XEO03407 MOACRIVE Inhibition DME1090 XEOTICID XEO03489 XEO_NAME Glucose DME1090 XEOTICID XEO03489 XEO_TYPE Pharmaceutical Agent(s) DME1090 XEOTICID XEO03489 XEO_CLAS Investigative Agent DME1090 XEOTICID XEO03489 DESCRIPT Glucose inhibits the drug-metabolizing activity of Aminoglycoside phosphotransferase (aph-Ib) from Campylobacter jejuni DME1090 XEOTICID XEO03489 GENEFORM Protein DME1090 XEOTICID XEO03489 MOACRIVE Inhibition DME1090 XEOTICID XEO04156 XEO_NAME Mutacin II mutacin H-29B DME1090 XEOTICID XEO04156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1090 XEOTICID XEO04156 XEO_CLAS Peptide DME1090 XEOTICID XEO04156 DESCRIPT Mutacin II mutacin H-29B inhibits the drug-metabolizing activity of Aminoglycoside phosphotransferase (aph-Ib) from Campylobacter jejuni DME1090 XEOTICID XEO04156 GENEFORM Protein DME1090 XEOTICID XEO04156 MOACRIVE Inhibition DME1090 XEOTICID XEO04963 XEO_NAME Sodium chloride DME1090 XEOTICID XEO04963 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1090 XEOTICID XEO04963 XEO_CLAS Chemical Compound DME1090 XEOTICID XEO04963 DESCRIPT Sodium chloride inhibits the drug-metabolizing activity of Aminoglycoside phosphotransferase (aph-Ib) from Campylobacter jejuni DME1090 XEOTICID XEO04963 GENEFORM Protein DME1090 XEOTICID XEO04963 MOACRIVE Inhibition DME1090 XEOTICID XEO05010 XEO_NAME Sucrose DME1090 XEOTICID XEO05010 XEO_TYPE Pharmaceutical Agent(s) DME1090 XEOTICID XEO05010 XEO_CLAS Investigative Agent DME1090 XEOTICID XEO05010 DESCRIPT Sucrose inhibits the drug-metabolizing activity of Aminoglycoside phosphotransferase (aph-Ib) from Campylobacter jejuni DME1090 XEOTICID XEO05010 GENEFORM Protein DME1090 XEOTICID XEO05010 MOACRIVE Inhibition DME1092 DME___ID DME1092 DME1092 DME_NAME Aldehyde oxidase (AOX) DME1092 SPESNAME Clostridium sporogenes DME1092 XEOTICID XEO02126 XEO_NAME Acidocin A DME1092 XEOTICID XEO02126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1092 XEOTICID XEO02126 XEO_CLAS Peptide DME1092 XEOTICID XEO02126 DESCRIPT Acidocin A inhibits the drug-metabolizing activity of Aldehyde oxidase (AOX) from Clostridium sporogenes DME1092 XEOTICID XEO02126 GENEFORM Protein DME1092 XEOTICID XEO02126 MOACRIVE Inhibition DME1092 XEOTICID XEO02127 XEO_NAME Acidocin B DME1092 XEOTICID XEO02127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1092 XEOTICID XEO02127 XEO_CLAS Peptide DME1092 XEOTICID XEO02127 DESCRIPT Acidocin B inhibits the drug-metabolizing activity of Aldehyde oxidase (AOX) from Clostridium sporogenes DME1092 XEOTICID XEO02127 GENEFORM Protein DME1092 XEOTICID XEO02127 MOACRIVE Inhibition DME1092 XEOTICID XEO03257 XEO_NAME Enterocin P DME1092 XEOTICID XEO03257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1092 XEOTICID XEO03257 XEO_CLAS Peptide DME1092 XEOTICID XEO03257 DESCRIPT Enterocin P inhibits the drug-metabolizing activity of Aldehyde oxidase (AOX) from Clostridium sporogenes (MIC = 0.004 ug/ml) DME1092 XEOTICID XEO03257 GENEFORM Protein DME1092 XEOTICID XEO03257 MOACRIVE Inhibition DME1092 XEOTICID XEO03806 XEO_NAME Lantibiotic paenibacillin DME1092 XEOTICID XEO03806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1092 XEOTICID XEO03806 XEO_CLAS Peptide DME1092 XEOTICID XEO03806 DESCRIPT Lantibiotic paenibacillin inhibits the drug-metabolizing activity of Aldehyde oxidase (AOX) from Clostridium sporogenes DME1092 XEOTICID XEO03806 GENEFORM Protein DME1092 XEOTICID XEO03806 MOACRIVE Inhibition DME1092 XEOTICID XEO04156 XEO_NAME Mutacin II mutacin H-29B DME1092 XEOTICID XEO04156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1092 XEOTICID XEO04156 XEO_CLAS Peptide DME1092 XEOTICID XEO04156 DESCRIPT Mutacin II mutacin H-29B inhibits the drug-metabolizing activity of Aldehyde oxidase (AOX) from Clostridium sporogenes DME1092 XEOTICID XEO04156 GENEFORM Protein DME1092 XEOTICID XEO04156 MOACRIVE Inhibition DME1094 DME___ID DME1094 DME1094 DME_NAME Beta-lactamase (blaB) DME1094 SPESNAME Citrobacter freundii DME1094 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME1094 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME1094 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME1094 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii DME1094 XEOTICID XEO00613 GENEFORM Protein DME1094 XEOTICID XEO00613 MOACRIVE Inhibition DME1094 XEOTICID XEO00683 XEO_NAME Curcumin DME1094 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1094 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1094 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii DME1094 XEOTICID XEO00683 GENEFORM Protein DME1094 XEOTICID XEO00683 MOACRIVE Inhibition DME1094 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1094 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1094 XEOTICID XEO02319 XEO_CLAS Peptide DME1094 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii DME1094 XEOTICID XEO02319 GENEFORM Protein DME1094 XEOTICID XEO02319 MOACRIVE Inhibition DME1094 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1094 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1094 XEOTICID XEO02378 XEO_CLAS Peptide DME1094 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii (MIC = 0.76 ug/ml) DME1094 XEOTICID XEO02378 GENEFORM Protein DME1094 XEOTICID XEO02378 MOACRIVE Inhibition DME1094 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1094 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1094 XEOTICID XEO03253 XEO_CLAS Peptide DME1094 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii (MIC = 1.6 ug/ml) DME1094 XEOTICID XEO03253 GENEFORM Protein DME1094 XEOTICID XEO03253 MOACRIVE Inhibition DME1094 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1094 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1094 XEOTICID XEO03609 XEO_CLAS Peptide DME1094 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii DME1094 XEOTICID XEO03609 GENEFORM Protein DME1094 XEOTICID XEO03609 MOACRIVE Inhibition DME1094 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1094 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1094 XEOTICID XEO03853 XEO_CLAS Peptide DME1094 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii (MIC = 75 microM) DME1094 XEOTICID XEO03853 GENEFORM Protein DME1094 XEOTICID XEO03853 MOACRIVE Inhibition DME1094 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1094 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1094 XEOTICID XEO03985 XEO_CLAS Peptide DME1094 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii (MIC = 30 ug/ml) DME1094 XEOTICID XEO03985 GENEFORM Protein DME1094 XEOTICID XEO03985 MOACRIVE Inhibition DME1094 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1094 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1094 XEOTICID XEO04426 XEO_CLAS Peptide DME1094 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii (MIC = 2 microM) DME1094 XEOTICID XEO04426 GENEFORM Protein DME1094 XEOTICID XEO04426 MOACRIVE Inhibition DME1094 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1094 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1094 XEOTICID XEO04606 XEO_CLAS Peptide DME1094 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii (MIC = 2 microM) DME1094 XEOTICID XEO04606 GENEFORM Protein DME1094 XEOTICID XEO04606 MOACRIVE Inhibition DME1096 DME___ID DME1096 DME1096 DME_NAME Azoreductase (azoR) DME1096 SPESNAME Escherichia coli DME1096 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1096 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00117 GENEFORM Protein DME1096 XEOTICID XEO00117 MOACRIVE Inhibition DME1096 XEOTICID XEO00122 XEO_NAME Amikacin DME1096 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00122 GENEFORM Protein DME1096 XEOTICID XEO00122 MOACRIVE Inhibition DME1096 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1096 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00136 GENEFORM Protein DME1096 XEOTICID XEO00136 MOACRIVE Inhibition DME1096 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1096 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00237 GENEFORM Protein DME1096 XEOTICID XEO00237 MOACRIVE Inhibition DME1096 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1096 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00349 GENEFORM Protein DME1096 XEOTICID XEO00349 MOACRIVE Inhibition DME1096 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1096 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00425 GENEFORM Protein DME1096 XEOTICID XEO00425 MOACRIVE Inhibition DME1096 XEOTICID XEO00439 XEO_NAME Daidzein DME1096 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00439 GENEFORM Protein DME1096 XEOTICID XEO00439 MOACRIVE Inhibition DME1096 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1096 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00460 GENEFORM Protein DME1096 XEOTICID XEO00460 MOACRIVE Inhibition DME1096 XEOTICID XEO00487 XEO_NAME Thymol DME1096 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00487 GENEFORM Protein DME1096 XEOTICID XEO00487 MOACRIVE Inhibition DME1096 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1096 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00511 GENEFORM Protein DME1096 XEOTICID XEO00511 MOACRIVE Inhibition DME1096 XEOTICID XEO00537 XEO_NAME Luteolin DME1096 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1096 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00537 GENEFORM Protein DME1096 XEOTICID XEO00537 MOACRIVE Inhibition DME1096 XEOTICID XEO00538 XEO_NAME Quercetin DME1096 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1096 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00538 GENEFORM Protein DME1096 XEOTICID XEO00538 MOACRIVE Inhibition DME1096 XEOTICID XEO00547 XEO_NAME Vitamin E DME1096 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1096 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00547 GENEFORM Protein DME1096 XEOTICID XEO00547 MOACRIVE Inhibition DME1096 XEOTICID XEO00557 XEO_NAME Genistein DME1096 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1096 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00557 GENEFORM Protein DME1096 XEOTICID XEO00557 MOACRIVE Inhibition DME1096 XEOTICID XEO00566 XEO_NAME Guaiacol DME1096 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1096 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00566 GENEFORM Protein DME1096 XEOTICID XEO00566 MOACRIVE Inhibition DME1096 XEOTICID XEO00568 XEO_NAME Resveratrol DME1096 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1096 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00568 GENEFORM Protein DME1096 XEOTICID XEO00568 MOACRIVE Inhibition DME1096 XEOTICID XEO00573 XEO_NAME Naringenin DME1096 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1096 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00573 GENEFORM Protein DME1096 XEOTICID XEO00573 MOACRIVE Inhibition DME1096 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1096 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1096 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00574 GENEFORM Protein DME1096 XEOTICID XEO00574 MOACRIVE Inhibition DME1096 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1096 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1096 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00611 GENEFORM Protein DME1096 XEOTICID XEO00611 MOACRIVE Inhibition DME1096 XEOTICID XEO00621 XEO_NAME Chitosan DME1096 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1096 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00621 GENEFORM Protein DME1096 XEOTICID XEO00621 MOACRIVE Inhibition DME1096 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1096 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1096 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00646 GENEFORM Protein DME1096 XEOTICID XEO00646 MOACRIVE Inhibition DME1096 XEOTICID XEO00683 XEO_NAME Curcumin DME1096 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1096 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00683 GENEFORM Protein DME1096 XEOTICID XEO00683 MOACRIVE Inhibition DME1096 XEOTICID XEO00727 XEO_NAME Vanillin DME1096 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1096 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00727 GENEFORM Protein DME1096 XEOTICID XEO00727 MOACRIVE Inhibition DME1096 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1096 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1096 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00730 GENEFORM Protein DME1096 XEOTICID XEO00730 MOACRIVE Inhibition DME1096 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1096 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO00782 XEO_CLAS Natural Product DME1096 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00782 GENEFORM Protein DME1096 XEOTICID XEO00782 MOACRIVE Inhibition DME1096 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1096 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1096 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00866 GENEFORM Protein DME1096 XEOTICID XEO00866 MOACRIVE Inhibition DME1096 XEOTICID XEO00878 XEO_NAME Chrysin DME1096 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO00878 XEO_CLAS Natural Product DME1096 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00878 GENEFORM Protein DME1096 XEOTICID XEO00878 MOACRIVE Inhibition DME1096 XEOTICID XEO00879 XEO_NAME Coumarin DME1096 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1096 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1096 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00879 GENEFORM Protein DME1096 XEOTICID XEO00879 MOACRIVE Inhibition DME1096 XEOTICID XEO00883 XEO_NAME Phloretin DME1096 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO00883 XEO_CLAS Natural Product DME1096 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00883 GENEFORM Protein DME1096 XEOTICID XEO00883 MOACRIVE Inhibition DME1096 XEOTICID XEO00885 XEO_NAME Eugenol DME1096 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1096 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO00885 GENEFORM Protein DME1096 XEOTICID XEO00885 MOACRIVE Inhibition DME1096 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1096 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1096 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1096 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01032 GENEFORM Protein DME1096 XEOTICID XEO01032 MOACRIVE Inhibition DME1096 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1096 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01174 XEO_CLAS Natural Product DME1096 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01174 GENEFORM Protein DME1096 XEOTICID XEO01174 MOACRIVE Inhibition DME1096 XEOTICID XEO01203 XEO_NAME Apigenin DME1096 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01203 XEO_CLAS Natural Product DME1096 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01203 GENEFORM Protein DME1096 XEOTICID XEO01203 MOACRIVE Inhibition DME1096 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1096 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1096 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1096 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01232 GENEFORM Protein DME1096 XEOTICID XEO01232 MOACRIVE Inhibition DME1096 XEOTICID XEO01237 XEO_NAME Carvacrol DME1096 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1096 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01237 GENEFORM Protein DME1096 XEOTICID XEO01237 MOACRIVE Inhibition DME1096 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1096 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1096 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01287 GENEFORM Protein DME1096 XEOTICID XEO01287 MOACRIVE Inhibition DME1096 XEOTICID XEO01291 XEO_NAME Esculetin DME1096 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1096 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01291 GENEFORM Protein DME1096 XEOTICID XEO01291 MOACRIVE Inhibition DME1096 XEOTICID XEO01304 XEO_NAME Flavone DME1096 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01304 XEO_CLAS Natural Product DME1096 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01304 GENEFORM Protein DME1096 XEOTICID XEO01304 MOACRIVE Inhibition DME1096 XEOTICID XEO01309 XEO_NAME Gallic acid DME1096 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01309 XEO_CLAS Natural Product DME1096 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01309 GENEFORM Protein DME1096 XEOTICID XEO01309 MOACRIVE Inhibition DME1096 XEOTICID XEO01340 XEO_NAME Imperatorin DME1096 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01340 XEO_CLAS Natural Product DME1096 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01340 GENEFORM Protein DME1096 XEOTICID XEO01340 MOACRIVE Inhibition DME1096 XEOTICID XEO01353 XEO_NAME Kaempferol DME1096 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1096 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1096 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01353 GENEFORM Protein DME1096 XEOTICID XEO01353 MOACRIVE Inhibition DME1096 XEOTICID XEO01366 XEO_NAME Linalool DME1096 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01366 XEO_CLAS Natural Product DME1096 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01366 GENEFORM Protein DME1096 XEOTICID XEO01366 MOACRIVE Inhibition DME1096 XEOTICID XEO01391 XEO_NAME Naringin DME1096 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01391 XEO_CLAS Natural Product DME1096 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01391 GENEFORM Protein DME1096 XEOTICID XEO01391 MOACRIVE Inhibition DME1096 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1096 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1096 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01420 GENEFORM Protein DME1096 XEOTICID XEO01420 MOACRIVE Inhibition DME1096 XEOTICID XEO01463 XEO_NAME Rutin DME1096 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01463 XEO_CLAS Natural Product DME1096 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01463 GENEFORM Protein DME1096 XEOTICID XEO01463 MOACRIVE Inhibition DME1096 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1096 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1096 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01496 GENEFORM Protein DME1096 XEOTICID XEO01496 MOACRIVE Inhibition DME1096 XEOTICID XEO01512 XEO_NAME Zinc DME1096 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1096 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1096 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01512 GENEFORM Protein DME1096 XEOTICID XEO01512 MOACRIVE Inhibition DME1096 XEOTICID XEO01527 XEO_NAME Bergamottin DME1096 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01527 XEO_CLAS Natural Product DME1096 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01527 GENEFORM Protein DME1096 XEOTICID XEO01527 MOACRIVE Inhibition DME1096 XEOTICID XEO01531 XEO_NAME Clove oil DME1096 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01531 XEO_CLAS Natural Product DME1096 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01531 GENEFORM Protein DME1096 XEOTICID XEO01531 MOACRIVE Inhibition DME1096 XEOTICID XEO01559 XEO_NAME Limonene DME1096 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01559 XEO_CLAS Natural Product DME1096 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01559 GENEFORM Protein DME1096 XEOTICID XEO01559 MOACRIVE Inhibition DME1096 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1096 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01563 XEO_CLAS Natural Product DME1096 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01563 GENEFORM Protein DME1096 XEOTICID XEO01563 MOACRIVE Inhibition DME1096 XEOTICID XEO01566 XEO_NAME Nobiletin DME1096 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01566 XEO_CLAS Natural Product DME1096 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01566 GENEFORM Protein DME1096 XEOTICID XEO01566 MOACRIVE Inhibition DME1096 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1096 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01778 XEO_CLAS Natural Product DME1096 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01778 GENEFORM Protein DME1096 XEOTICID XEO01778 MOACRIVE Inhibition DME1096 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1096 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01779 XEO_CLAS Peptide DME1096 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 128 microM) DME1096 XEOTICID XEO01779 GENEFORM Protein DME1096 XEOTICID XEO01779 MOACRIVE Inhibition DME1096 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1096 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01810 XEO_CLAS Peptide DME1096 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.0 microM) DME1096 XEOTICID XEO01810 GENEFORM Protein DME1096 XEOTICID XEO01810 MOACRIVE Inhibition DME1096 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1096 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01811 XEO_CLAS Peptide DME1096 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 microM) DME1096 XEOTICID XEO01811 GENEFORM Protein DME1096 XEOTICID XEO01811 MOACRIVE Inhibition DME1096 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1096 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01812 XEO_CLAS Peptide DME1096 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10.4 microM) DME1096 XEOTICID XEO01812 GENEFORM Protein DME1096 XEOTICID XEO01812 MOACRIVE Inhibition DME1096 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1096 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01813 XEO_CLAS Peptide DME1096 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.1 microM) DME1096 XEOTICID XEO01813 GENEFORM Protein DME1096 XEOTICID XEO01813 MOACRIVE Inhibition DME1096 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1096 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01814 XEO_CLAS Peptide DME1096 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.5 microM) DME1096 XEOTICID XEO01814 GENEFORM Protein DME1096 XEOTICID XEO01814 MOACRIVE Inhibition DME1096 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1096 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01815 XEO_CLAS Peptide DME1096 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 9.8 microM) DME1096 XEOTICID XEO01815 GENEFORM Protein DME1096 XEOTICID XEO01815 MOACRIVE Inhibition DME1096 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1096 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01816 XEO_CLAS Peptide DME1096 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO01816 GENEFORM Protein DME1096 XEOTICID XEO01816 MOACRIVE Inhibition DME1096 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1096 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01817 XEO_CLAS Peptide DME1096 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.0 microM) DME1096 XEOTICID XEO01817 GENEFORM Protein DME1096 XEOTICID XEO01817 MOACRIVE Inhibition DME1096 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1096 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01818 XEO_CLAS Peptide DME1096 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4.0 microM) DME1096 XEOTICID XEO01818 GENEFORM Protein DME1096 XEOTICID XEO01818 MOACRIVE Inhibition DME1096 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1096 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01819 XEO_CLAS Peptide DME1096 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO01819 GENEFORM Protein DME1096 XEOTICID XEO01819 MOACRIVE Inhibition DME1096 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1096 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01820 XEO_CLAS Peptide DME1096 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO01820 GENEFORM Protein DME1096 XEOTICID XEO01820 MOACRIVE Inhibition DME1096 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1096 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01821 XEO_CLAS Peptide DME1096 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO01821 GENEFORM Protein DME1096 XEOTICID XEO01821 MOACRIVE Inhibition DME1096 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1096 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01822 XEO_CLAS Peptide DME1096 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 microM) DME1096 XEOTICID XEO01822 GENEFORM Protein DME1096 XEOTICID XEO01822 MOACRIVE Inhibition DME1096 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1096 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01823 XEO_CLAS Peptide DME1096 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO01823 GENEFORM Protein DME1096 XEOTICID XEO01823 MOACRIVE Inhibition DME1096 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1096 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01824 XEO_CLAS Peptide DME1096 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO01824 GENEFORM Protein DME1096 XEOTICID XEO01824 MOACRIVE Inhibition DME1096 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1096 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01825 XEO_CLAS Peptide DME1096 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25.0 microM) DME1096 XEOTICID XEO01825 GENEFORM Protein DME1096 XEOTICID XEO01825 MOACRIVE Inhibition DME1096 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1096 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01827 XEO_CLAS Peptide DME1096 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.12-6.25 microM) DME1096 XEOTICID XEO01827 GENEFORM Protein DME1096 XEOTICID XEO01827 MOACRIVE Inhibition DME1096 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1096 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1096 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1096 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01829 GENEFORM Protein DME1096 XEOTICID XEO01829 MOACRIVE Inhibition DME1096 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1096 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01927 XEO_CLAS Peptide DME1096 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 ug/ml) DME1096 XEOTICID XEO01927 GENEFORM Protein DME1096 XEOTICID XEO01927 MOACRIVE Inhibition DME1096 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1096 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01945 XEO_CLAS Peptide DME1096 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.1 microM) DME1096 XEOTICID XEO01945 GENEFORM Protein DME1096 XEOTICID XEO01945 MOACRIVE Inhibition DME1096 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1096 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01946 XEO_CLAS Peptide DME1096 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.2 microM) DME1096 XEOTICID XEO01946 GENEFORM Protein DME1096 XEOTICID XEO01946 MOACRIVE Inhibition DME1096 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1096 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO01947 XEO_CLAS Natural Product DME1096 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01947 GENEFORM Protein DME1096 XEOTICID XEO01947 MOACRIVE Inhibition DME1096 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1096 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1096 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1096 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01950 GENEFORM Protein DME1096 XEOTICID XEO01950 MOACRIVE Inhibition DME1096 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1096 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1096 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1096 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01961 GENEFORM Protein DME1096 XEOTICID XEO01961 MOACRIVE Inhibition DME1096 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1096 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1096 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1096 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO01966 GENEFORM Protein DME1096 XEOTICID XEO01966 MOACRIVE Inhibition DME1096 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1096 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01996 XEO_CLAS Peptide DME1096 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.7 microM) DME1096 XEOTICID XEO01996 GENEFORM Protein DME1096 XEOTICID XEO01996 MOACRIVE Inhibition DME1096 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1096 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01997 XEO_CLAS Peptide DME1096 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.9 microM) DME1096 XEOTICID XEO01997 GENEFORM Protein DME1096 XEOTICID XEO01997 MOACRIVE Inhibition DME1096 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1096 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01998 XEO_CLAS Peptide DME1096 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO01998 GENEFORM Protein DME1096 XEOTICID XEO01998 MOACRIVE Inhibition DME1096 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1096 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO01999 XEO_CLAS Peptide DME1096 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.5 microM) DME1096 XEOTICID XEO01999 GENEFORM Protein DME1096 XEOTICID XEO01999 MOACRIVE Inhibition DME1096 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1096 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02013 XEO_CLAS Peptide DME1096 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02013 GENEFORM Protein DME1096 XEOTICID XEO02013 MOACRIVE Inhibition DME1096 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1096 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02032 XEO_CLAS Natural Product DME1096 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02032 GENEFORM Protein DME1096 XEOTICID XEO02032 MOACRIVE Inhibition DME1096 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1096 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02033 XEO_CLAS Natural Product DME1096 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02033 GENEFORM Protein DME1096 XEOTICID XEO02033 MOACRIVE Inhibition DME1096 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1096 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02079 XEO_CLAS Natural Product DME1096 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02079 GENEFORM Protein DME1096 XEOTICID XEO02079 MOACRIVE Inhibition DME1096 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1096 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1096 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02085 GENEFORM Protein DME1096 XEOTICID XEO02085 MOACRIVE Inhibition DME1096 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1096 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02111 XEO_CLAS Peptide DME1096 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2-4 ug/ml) DME1096 XEOTICID XEO02111 GENEFORM Protein DME1096 XEOTICID XEO02111 MOACRIVE Inhibition DME1096 XEOTICID XEO02113 XEO_NAME Abaecin DME1096 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02113 XEO_CLAS Peptide DME1096 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02113 GENEFORM Protein DME1096 XEOTICID XEO02113 MOACRIVE Inhibition DME1096 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1096 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02114 XEO_CLAS Peptide DME1096 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-25 ug/ml) DME1096 XEOTICID XEO02114 GENEFORM Protein DME1096 XEOTICID XEO02114 MOACRIVE Inhibition DME1096 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1096 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02115 XEO_CLAS Peptide DME1096 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02115 GENEFORM Protein DME1096 XEOTICID XEO02115 MOACRIVE Inhibition DME1096 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1096 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02117 XEO_CLAS Peptide DME1096 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02117 GENEFORM Protein DME1096 XEOTICID XEO02117 MOACRIVE Inhibition DME1096 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1096 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02118 XEO_CLAS Peptide DME1096 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02118 GENEFORM Protein DME1096 XEOTICID XEO02118 MOACRIVE Inhibition DME1096 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1096 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02119 XEO_CLAS Peptide DME1096 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02119 GENEFORM Protein DME1096 XEOTICID XEO02119 MOACRIVE Inhibition DME1096 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1096 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02120 XEO_CLAS Peptide DME1096 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02120 GENEFORM Protein DME1096 XEOTICID XEO02120 MOACRIVE Inhibition DME1096 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1096 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02121 XEO_CLAS Peptide DME1096 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02121 GENEFORM Protein DME1096 XEOTICID XEO02121 MOACRIVE Inhibition DME1096 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1096 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02122 XEO_CLAS Peptide DME1096 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 ug/ml) DME1096 XEOTICID XEO02122 GENEFORM Protein DME1096 XEOTICID XEO02122 MOACRIVE Inhibition DME1096 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1096 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02130 XEO_CLAS Peptide DME1096 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.7 microM) DME1096 XEOTICID XEO02130 GENEFORM Protein DME1096 XEOTICID XEO02130 MOACRIVE Inhibition DME1096 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1096 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02131 XEO_CLAS Peptide DME1096 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.3 microM) DME1096 XEOTICID XEO02131 GENEFORM Protein DME1096 XEOTICID XEO02131 MOACRIVE Inhibition DME1096 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1096 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02132 XEO_CLAS Peptide DME1096 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.5 microM) DME1096 XEOTICID XEO02132 GENEFORM Protein DME1096 XEOTICID XEO02132 MOACRIVE Inhibition DME1096 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1096 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02136 XEO_CLAS Peptide DME1096 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 ug/ml) DME1096 XEOTICID XEO02136 GENEFORM Protein DME1096 XEOTICID XEO02136 MOACRIVE Inhibition DME1096 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1096 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02147 XEO_CLAS Peptide DME1096 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 382 ug/ml) DME1096 XEOTICID XEO02147 GENEFORM Protein DME1096 XEOTICID XEO02147 MOACRIVE Inhibition DME1096 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1096 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02149 XEO_CLAS Peptide DME1096 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 47.35 microM) DME1096 XEOTICID XEO02149 GENEFORM Protein DME1096 XEOTICID XEO02149 MOACRIVE Inhibition DME1096 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1096 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02164 XEO_CLAS Peptide DME1096 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02164 GENEFORM Protein DME1096 XEOTICID XEO02164 MOACRIVE Inhibition DME1096 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1096 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02165 XEO_CLAS Peptide DME1096 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02165 GENEFORM Protein DME1096 XEOTICID XEO02165 MOACRIVE Inhibition DME1096 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1096 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02166 XEO_CLAS Peptide DME1096 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02166 GENEFORM Protein DME1096 XEOTICID XEO02166 MOACRIVE Inhibition DME1096 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1096 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02167 XEO_CLAS Peptide DME1096 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02167 GENEFORM Protein DME1096 XEOTICID XEO02167 MOACRIVE Inhibition DME1096 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1096 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02168 XEO_CLAS Peptide DME1096 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02168 GENEFORM Protein DME1096 XEOTICID XEO02168 MOACRIVE Inhibition DME1096 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1096 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02169 XEO_CLAS Peptide DME1096 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02169 GENEFORM Protein DME1096 XEOTICID XEO02169 MOACRIVE Inhibition DME1096 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1096 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02170 XEO_CLAS Peptide DME1096 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.4 microM) DME1096 XEOTICID XEO02170 GENEFORM Protein DME1096 XEOTICID XEO02170 MOACRIVE Inhibition DME1096 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1096 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02175 XEO_CLAS Natural Product DME1096 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02175 GENEFORM Protein DME1096 XEOTICID XEO02175 MOACRIVE Inhibition DME1096 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1096 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02177 XEO_CLAS Peptide DME1096 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO02177 GENEFORM Protein DME1096 XEOTICID XEO02177 MOACRIVE Inhibition DME1096 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1096 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02178 XEO_CLAS Peptide DME1096 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO02178 GENEFORM Protein DME1096 XEOTICID XEO02178 MOACRIVE Inhibition DME1096 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1096 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02179 XEO_CLAS Peptide DME1096 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO02179 GENEFORM Protein DME1096 XEOTICID XEO02179 MOACRIVE Inhibition DME1096 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1096 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02180 XEO_CLAS Peptide DME1096 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 214 microM) DME1096 XEOTICID XEO02180 GENEFORM Protein DME1096 XEOTICID XEO02180 MOACRIVE Inhibition DME1096 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1096 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02181 XEO_CLAS Peptide DME1096 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 217 microM) DME1096 XEOTICID XEO02181 GENEFORM Protein DME1096 XEOTICID XEO02181 MOACRIVE Inhibition DME1096 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1096 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02183 XEO_CLAS Peptide DME1096 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 38.4 microM) DME1096 XEOTICID XEO02183 GENEFORM Protein DME1096 XEOTICID XEO02183 MOACRIVE Inhibition DME1096 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1096 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02185 XEO_CLAS Peptide DME1096 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 microM) DME1096 XEOTICID XEO02185 GENEFORM Protein DME1096 XEOTICID XEO02185 MOACRIVE Inhibition DME1096 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1096 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02187 GENEFORM Protein DME1096 XEOTICID XEO02187 MOACRIVE Inhibition DME1096 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1096 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02191 XEO_CLAS Peptide DME1096 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02191 GENEFORM Protein DME1096 XEOTICID XEO02191 MOACRIVE Inhibition DME1096 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1096 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02192 XEO_CLAS Peptide DME1096 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.50 ug/ml) DME1096 XEOTICID XEO02192 GENEFORM Protein DME1096 XEOTICID XEO02192 MOACRIVE Inhibition DME1096 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1096 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02193 XEO_CLAS Peptide DME1096 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02193 GENEFORM Protein DME1096 XEOTICID XEO02193 MOACRIVE Inhibition DME1096 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1096 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02194 XEO_CLAS Peptide DME1096 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02194 GENEFORM Protein DME1096 XEOTICID XEO02194 MOACRIVE Inhibition DME1096 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1096 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02195 XEO_CLAS Peptide DME1096 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.00 ug/ml) DME1096 XEOTICID XEO02195 GENEFORM Protein DME1096 XEOTICID XEO02195 MOACRIVE Inhibition DME1096 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1096 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02197 XEO_CLAS Peptide DME1096 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02197 GENEFORM Protein DME1096 XEOTICID XEO02197 MOACRIVE Inhibition DME1096 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1096 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02200 XEO_CLAS Peptide DME1096 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 ug/ml) DME1096 XEOTICID XEO02200 GENEFORM Protein DME1096 XEOTICID XEO02200 MOACRIVE Inhibition DME1096 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1096 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02201 XEO_CLAS Peptide DME1096 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 ug/ml) DME1096 XEOTICID XEO02201 GENEFORM Protein DME1096 XEOTICID XEO02201 MOACRIVE Inhibition DME1096 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1096 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02202 XEO_CLAS Peptide DME1096 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO02202 GENEFORM Protein DME1096 XEOTICID XEO02202 MOACRIVE Inhibition DME1096 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1096 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02203 XEO_CLAS Peptide DME1096 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 microM) DME1096 XEOTICID XEO02203 GENEFORM Protein DME1096 XEOTICID XEO02203 MOACRIVE Inhibition DME1096 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1096 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02207 XEO_CLAS Peptide DME1096 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.78 ug/ml) DME1096 XEOTICID XEO02207 GENEFORM Protein DME1096 XEOTICID XEO02207 MOACRIVE Inhibition DME1096 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1096 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02208 XEO_CLAS Peptide DME1096 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.13 ug/ml) DME1096 XEOTICID XEO02208 GENEFORM Protein DME1096 XEOTICID XEO02208 MOACRIVE Inhibition DME1096 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1096 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02209 XEO_CLAS Peptide DME1096 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.56 ug/ml) DME1096 XEOTICID XEO02209 GENEFORM Protein DME1096 XEOTICID XEO02209 MOACRIVE Inhibition DME1096 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1096 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02210 XEO_CLAS Peptide DME1096 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 ug/ml) DME1096 XEOTICID XEO02210 GENEFORM Protein DME1096 XEOTICID XEO02210 MOACRIVE Inhibition DME1096 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1096 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02211 XEO_CLAS Peptide DME1096 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25 ug/ml) DME1096 XEOTICID XEO02211 GENEFORM Protein DME1096 XEOTICID XEO02211 MOACRIVE Inhibition DME1096 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1096 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02212 XEO_CLAS Peptide DME1096 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.13 ug/ml) DME1096 XEOTICID XEO02212 GENEFORM Protein DME1096 XEOTICID XEO02212 MOACRIVE Inhibition DME1096 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1096 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02213 XEO_CLAS Peptide DME1096 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.13 ug/ml) DME1096 XEOTICID XEO02213 GENEFORM Protein DME1096 XEOTICID XEO02213 MOACRIVE Inhibition DME1096 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1096 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02214 XEO_CLAS Peptide DME1096 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02214 GENEFORM Protein DME1096 XEOTICID XEO02214 MOACRIVE Inhibition DME1096 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1096 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02215 XEO_CLAS Peptide DME1096 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 ug/ml) DME1096 XEOTICID XEO02215 GENEFORM Protein DME1096 XEOTICID XEO02215 MOACRIVE Inhibition DME1096 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1096 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02216 XEO_CLAS Peptide DME1096 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 126 ug/ml) DME1096 XEOTICID XEO02216 GENEFORM Protein DME1096 XEOTICID XEO02216 MOACRIVE Inhibition DME1096 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1096 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02217 XEO_CLAS Peptide DME1096 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 200 ug/ml) DME1096 XEOTICID XEO02217 GENEFORM Protein DME1096 XEOTICID XEO02217 MOACRIVE Inhibition DME1096 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1096 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02218 XEO_CLAS Peptide DME1096 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 200 ug/ml) DME1096 XEOTICID XEO02218 GENEFORM Protein DME1096 XEOTICID XEO02218 MOACRIVE Inhibition DME1096 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1096 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02219 XEO_CLAS Peptide DME1096 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 200 ug/ml) DME1096 XEOTICID XEO02219 GENEFORM Protein DME1096 XEOTICID XEO02219 MOACRIVE Inhibition DME1096 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1096 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02220 XEO_CLAS Peptide DME1096 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 23.5 ug/ml) DME1096 XEOTICID XEO02220 GENEFORM Protein DME1096 XEOTICID XEO02220 MOACRIVE Inhibition DME1096 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1096 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02221 XEO_CLAS Peptide DME1096 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20.2 ug/ml) DME1096 XEOTICID XEO02221 GENEFORM Protein DME1096 XEOTICID XEO02221 MOACRIVE Inhibition DME1096 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1096 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02222 XEO_CLAS Peptide DME1096 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30.5 ug/ml) DME1096 XEOTICID XEO02222 GENEFORM Protein DME1096 XEOTICID XEO02222 MOACRIVE Inhibition DME1096 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1096 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02223 XEO_CLAS Peptide DME1096 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.2 ug/ml) DME1096 XEOTICID XEO02223 GENEFORM Protein DME1096 XEOTICID XEO02223 MOACRIVE Inhibition DME1096 XEOTICID XEO02224 XEO_NAME Androctonin DME1096 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02224 XEO_CLAS Peptide DME1096 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02224 GENEFORM Protein DME1096 XEOTICID XEO02224 MOACRIVE Inhibition DME1096 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1096 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02225 XEO_CLAS Peptide DME1096 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02225 GENEFORM Protein DME1096 XEOTICID XEO02225 MOACRIVE Inhibition DME1096 XEOTICID XEO02226 XEO_NAME Andropin DME1096 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02226 XEO_CLAS Peptide DME1096 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 140 microM) DME1096 XEOTICID XEO02226 GENEFORM Protein DME1096 XEOTICID XEO02226 MOACRIVE Inhibition DME1096 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1096 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02230 XEO_CLAS Peptide DME1096 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.05-0.1 microM) DME1096 XEOTICID XEO02230 GENEFORM Protein DME1096 XEOTICID XEO02230 MOACRIVE Inhibition DME1096 XEOTICID XEO02232 XEO_NAME Anoplin DME1096 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02232 XEO_CLAS Peptide DME1096 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 13 ug/ml) DME1096 XEOTICID XEO02232 GENEFORM Protein DME1096 XEOTICID XEO02232 MOACRIVE Inhibition DME1096 XEOTICID XEO02233 XEO_NAME Antapin DME1096 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02233 XEO_CLAS Peptide DME1096 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02233 GENEFORM Protein DME1096 XEOTICID XEO02233 MOACRIVE Inhibition DME1096 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1096 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02236 XEO_CLAS Peptide DME1096 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02236 GENEFORM Protein DME1096 XEOTICID XEO02236 MOACRIVE Inhibition DME1096 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1096 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02239 XEO_CLAS Peptide DME1096 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 250 microM) DME1096 XEOTICID XEO02239 GENEFORM Protein DME1096 XEOTICID XEO02239 MOACRIVE Inhibition DME1096 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1096 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02240 XEO_CLAS Peptide DME1096 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 microM) DME1096 XEOTICID XEO02240 GENEFORM Protein DME1096 XEOTICID XEO02240 MOACRIVE Inhibition DME1096 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1096 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02241 XEO_CLAS Peptide DME1096 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02241 GENEFORM Protein DME1096 XEOTICID XEO02241 MOACRIVE Inhibition DME1096 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1096 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02242 XEO_CLAS Peptide DME1096 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO02242 GENEFORM Protein DME1096 XEOTICID XEO02242 MOACRIVE Inhibition DME1096 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1096 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02243 XEO_CLAS Peptide DME1096 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 microM) DME1096 XEOTICID XEO02243 GENEFORM Protein DME1096 XEOTICID XEO02243 MOACRIVE Inhibition DME1096 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1096 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02244 XEO_CLAS Peptide DME1096 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1 microM) DME1096 XEOTICID XEO02244 GENEFORM Protein DME1096 XEOTICID XEO02244 MOACRIVE Inhibition DME1096 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1096 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02245 XEO_CLAS Peptide DME1096 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02245 GENEFORM Protein DME1096 XEOTICID XEO02245 MOACRIVE Inhibition DME1096 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1096 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02246 XEO_CLAS Peptide DME1096 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 microM) DME1096 XEOTICID XEO02246 GENEFORM Protein DME1096 XEOTICID XEO02246 MOACRIVE Inhibition DME1096 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1096 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02247 XEO_CLAS Peptide DME1096 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02247 GENEFORM Protein DME1096 XEOTICID XEO02247 MOACRIVE Inhibition DME1096 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1096 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02248 XEO_CLAS Peptide DME1096 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.3 microM) DME1096 XEOTICID XEO02248 GENEFORM Protein DME1096 XEOTICID XEO02248 MOACRIVE Inhibition DME1096 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1096 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02253 XEO_CLAS Peptide DME1096 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02253 GENEFORM Protein DME1096 XEOTICID XEO02253 MOACRIVE Inhibition DME1096 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1096 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02258 XEO_CLAS Peptide DME1096 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 150 microM) DME1096 XEOTICID XEO02258 GENEFORM Protein DME1096 XEOTICID XEO02258 MOACRIVE Inhibition DME1096 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1096 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02261 XEO_CLAS Peptide DME1096 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 82 ug/ml) DME1096 XEOTICID XEO02261 GENEFORM Protein DME1096 XEOTICID XEO02261 MOACRIVE Inhibition DME1096 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1096 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02263 XEO_CLAS Peptide DME1096 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO02263 GENEFORM Protein DME1096 XEOTICID XEO02263 MOACRIVE Inhibition DME1096 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1096 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02266 XEO_CLAS Peptide DME1096 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 120 microM) DME1096 XEOTICID XEO02266 GENEFORM Protein DME1096 XEOTICID XEO02266 MOACRIVE Inhibition DME1096 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1096 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02268 XEO_CLAS Peptide DME1096 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 170 ug/ml) DME1096 XEOTICID XEO02268 GENEFORM Protein DME1096 XEOTICID XEO02268 MOACRIVE Inhibition DME1096 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1096 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02270 XEO_CLAS Peptide DME1096 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 microM) DME1096 XEOTICID XEO02270 GENEFORM Protein DME1096 XEOTICID XEO02270 MOACRIVE Inhibition DME1096 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1096 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02271 XEO_CLAS Peptide DME1096 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 302 ug/ml) DME1096 XEOTICID XEO02271 GENEFORM Protein DME1096 XEOTICID XEO02271 MOACRIVE Inhibition DME1096 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1096 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02273 XEO_CLAS Peptide DME1096 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 18 microM) DME1096 XEOTICID XEO02273 GENEFORM Protein DME1096 XEOTICID XEO02273 MOACRIVE Inhibition DME1096 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1096 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02274 XEO_CLAS Peptide DME1096 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO02274 GENEFORM Protein DME1096 XEOTICID XEO02274 MOACRIVE Inhibition DME1096 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1096 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02275 XEO_CLAS Peptide DME1096 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 microM) DME1096 XEOTICID XEO02275 GENEFORM Protein DME1096 XEOTICID XEO02275 MOACRIVE Inhibition DME1096 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1096 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02276 XEO_CLAS Peptide DME1096 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 microM) DME1096 XEOTICID XEO02276 GENEFORM Protein DME1096 XEOTICID XEO02276 MOACRIVE Inhibition DME1096 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1096 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02280 XEO_CLAS Peptide DME1096 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02280 GENEFORM Protein DME1096 XEOTICID XEO02280 MOACRIVE Inhibition DME1096 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1096 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02281 XEO_CLAS Peptide DME1096 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02281 GENEFORM Protein DME1096 XEOTICID XEO02281 MOACRIVE Inhibition DME1096 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1096 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02283 XEO_CLAS Peptide DME1096 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 ug/ml) DME1096 XEOTICID XEO02283 GENEFORM Protein DME1096 XEOTICID XEO02283 MOACRIVE Inhibition DME1096 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1096 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02284 XEO_CLAS Peptide DME1096 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50.4 microM) DME1096 XEOTICID XEO02284 GENEFORM Protein DME1096 XEOTICID XEO02284 MOACRIVE Inhibition DME1096 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1096 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02285 XEO_CLAS Peptide DME1096 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50.4 microM) DME1096 XEOTICID XEO02285 GENEFORM Protein DME1096 XEOTICID XEO02285 MOACRIVE Inhibition DME1096 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1096 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02286 XEO_CLAS Peptide DME1096 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50.4 microM) DME1096 XEOTICID XEO02286 GENEFORM Protein DME1096 XEOTICID XEO02286 MOACRIVE Inhibition DME1096 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1096 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02287 XEO_CLAS Peptide DME1096 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50.4 microM) DME1096 XEOTICID XEO02287 GENEFORM Protein DME1096 XEOTICID XEO02287 MOACRIVE Inhibition DME1096 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1096 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02288 XEO_CLAS Peptide DME1096 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.2 ug/ml) DME1096 XEOTICID XEO02288 GENEFORM Protein DME1096 XEOTICID XEO02288 MOACRIVE Inhibition DME1096 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1096 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02289 XEO_CLAS Peptide DME1096 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 ug/ml) DME1096 XEOTICID XEO02289 GENEFORM Protein DME1096 XEOTICID XEO02289 MOACRIVE Inhibition DME1096 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1096 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02290 XEO_CLAS Peptide DME1096 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO02290 GENEFORM Protein DME1096 XEOTICID XEO02290 MOACRIVE Inhibition DME1096 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1096 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02291 XEO_CLAS Peptide DME1096 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02291 GENEFORM Protein DME1096 XEOTICID XEO02291 MOACRIVE Inhibition DME1096 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1096 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02293 XEO_CLAS Peptide DME1096 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 microM) DME1096 XEOTICID XEO02293 GENEFORM Protein DME1096 XEOTICID XEO02293 MOACRIVE Inhibition DME1096 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1096 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02294 XEO_CLAS Peptide DME1096 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 62-250 ug/ml) DME1096 XEOTICID XEO02294 GENEFORM Protein DME1096 XEOTICID XEO02294 MOACRIVE Inhibition DME1096 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1096 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02295 XEO_CLAS Peptide DME1096 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 ug/ml) DME1096 XEOTICID XEO02295 GENEFORM Protein DME1096 XEOTICID XEO02295 MOACRIVE Inhibition DME1096 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1096 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02296 XEO_CLAS Peptide DME1096 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02296 GENEFORM Protein DME1096 XEOTICID XEO02296 MOACRIVE Inhibition DME1096 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1096 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02297 XEO_CLAS Peptide DME1096 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC < 50 ug/ml) DME1096 XEOTICID XEO02297 GENEFORM Protein DME1096 XEOTICID XEO02297 MOACRIVE Inhibition DME1096 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1096 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02298 XEO_CLAS Peptide DME1096 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO02298 GENEFORM Protein DME1096 XEOTICID XEO02298 MOACRIVE Inhibition DME1096 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1096 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02303 XEO_CLAS Peptide DME1096 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02303 GENEFORM Protein DME1096 XEOTICID XEO02303 MOACRIVE Inhibition DME1096 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1096 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02304 XEO_CLAS Peptide DME1096 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.1 ug/ml) DME1096 XEOTICID XEO02304 GENEFORM Protein DME1096 XEOTICID XEO02304 MOACRIVE Inhibition DME1096 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1096 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02305 XEO_CLAS Peptide DME1096 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC <= 1 ug/ml) DME1096 XEOTICID XEO02305 GENEFORM Protein DME1096 XEOTICID XEO02305 MOACRIVE Inhibition DME1096 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1096 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02306 XEO_CLAS Peptide DME1096 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.2 ug/ml) DME1096 XEOTICID XEO02306 GENEFORM Protein DME1096 XEOTICID XEO02306 MOACRIVE Inhibition DME1096 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1096 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02309 XEO_CLAS Peptide DME1096 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02309 GENEFORM Protein DME1096 XEOTICID XEO02309 MOACRIVE Inhibition DME1096 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1096 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02310 XEO_CLAS Peptide DME1096 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02310 GENEFORM Protein DME1096 XEOTICID XEO02310 MOACRIVE Inhibition DME1096 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1096 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02315 XEO_CLAS Peptide DME1096 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO02315 GENEFORM Protein DME1096 XEOTICID XEO02315 MOACRIVE Inhibition DME1096 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1096 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02316 XEO_CLAS Peptide DME1096 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 50 microM) DME1096 XEOTICID XEO02316 GENEFORM Protein DME1096 XEOTICID XEO02316 MOACRIVE Inhibition DME1096 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1096 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02317 XEO_CLAS Peptide DME1096 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 300 microM) DME1096 XEOTICID XEO02317 GENEFORM Protein DME1096 XEOTICID XEO02317 MOACRIVE Inhibition DME1096 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1096 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02318 XEO_CLAS Peptide DME1096 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02318 GENEFORM Protein DME1096 XEOTICID XEO02318 MOACRIVE Inhibition DME1096 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1096 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02319 XEO_CLAS Peptide DME1096 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02319 GENEFORM Protein DME1096 XEOTICID XEO02319 MOACRIVE Inhibition DME1096 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1096 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02320 XEO_CLAS Peptide DME1096 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02320 GENEFORM Protein DME1096 XEOTICID XEO02320 MOACRIVE Inhibition DME1096 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1096 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02321 XEO_CLAS Peptide DME1096 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO02321 GENEFORM Protein DME1096 XEOTICID XEO02321 MOACRIVE Inhibition DME1096 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1096 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02322 XEO_CLAS Peptide DME1096 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02322 GENEFORM Protein DME1096 XEOTICID XEO02322 MOACRIVE Inhibition DME1096 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1096 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02323 XEO_CLAS Peptide DME1096 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO02323 GENEFORM Protein DME1096 XEOTICID XEO02323 MOACRIVE Inhibition DME1096 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1096 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02324 XEO_CLAS Peptide DME1096 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02324 GENEFORM Protein DME1096 XEOTICID XEO02324 MOACRIVE Inhibition DME1096 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1096 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02325 XEO_CLAS Peptide DME1096 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO02325 GENEFORM Protein DME1096 XEOTICID XEO02325 MOACRIVE Inhibition DME1096 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1096 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02326 XEO_CLAS Peptide DME1096 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02326 GENEFORM Protein DME1096 XEOTICID XEO02326 MOACRIVE Inhibition DME1096 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1096 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02327 XEO_CLAS Peptide DME1096 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO02327 GENEFORM Protein DME1096 XEOTICID XEO02327 MOACRIVE Inhibition DME1096 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1096 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02328 XEO_CLAS Peptide DME1096 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO02328 GENEFORM Protein DME1096 XEOTICID XEO02328 MOACRIVE Inhibition DME1096 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1096 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02332 XEO_CLAS Peptide DME1096 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.9 ug/ml) DME1096 XEOTICID XEO02332 GENEFORM Protein DME1096 XEOTICID XEO02332 MOACRIVE Inhibition DME1096 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1096 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02333 XEO_CLAS Peptide DME1096 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 200 microM) DME1096 XEOTICID XEO02333 GENEFORM Protein DME1096 XEOTICID XEO02333 MOACRIVE Inhibition DME1096 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1096 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02336 XEO_CLAS Peptide DME1096 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 microM) DME1096 XEOTICID XEO02336 GENEFORM Protein DME1096 XEOTICID XEO02336 MOACRIVE Inhibition DME1096 XEOTICID XEO02346 XEO_NAME Aurelin DME1096 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02346 XEO_CLAS Peptide DME1096 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 7.66 ug/ml) DME1096 XEOTICID XEO02346 GENEFORM Protein DME1096 XEOTICID XEO02346 MOACRIVE Inhibition DME1096 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1096 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02352 XEO_CLAS Peptide DME1096 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 11 ug/ml) DME1096 XEOTICID XEO02352 GENEFORM Protein DME1096 XEOTICID XEO02352 MOACRIVE Inhibition DME1096 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1096 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02353 XEO_CLAS Peptide DME1096 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 ug/ml) DME1096 XEOTICID XEO02353 GENEFORM Protein DME1096 XEOTICID XEO02353 MOACRIVE Inhibition DME1096 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1096 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02354 XEO_CLAS Peptide DME1096 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 ug/ml) DME1096 XEOTICID XEO02354 GENEFORM Protein DME1096 XEOTICID XEO02354 MOACRIVE Inhibition DME1096 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1096 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02355 XEO_CLAS Peptide DME1096 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 17 ug/ml) DME1096 XEOTICID XEO02355 GENEFORM Protein DME1096 XEOTICID XEO02355 MOACRIVE Inhibition DME1096 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1096 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02356 XEO_CLAS Peptide DME1096 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO02356 GENEFORM Protein DME1096 XEOTICID XEO02356 MOACRIVE Inhibition DME1096 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1096 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02357 XEO_CLAS Peptide DME1096 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO02357 GENEFORM Protein DME1096 XEOTICID XEO02357 MOACRIVE Inhibition DME1096 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1096 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02358 XEO_CLAS Peptide DME1096 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO02358 GENEFORM Protein DME1096 XEOTICID XEO02358 MOACRIVE Inhibition DME1096 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1096 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02360 XEO_CLAS Peptide DME1096 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02360 GENEFORM Protein DME1096 XEOTICID XEO02360 MOACRIVE Inhibition DME1096 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1096 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02361 XEO_CLAS Peptide DME1096 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 ug/ml) DME1096 XEOTICID XEO02361 GENEFORM Protein DME1096 XEOTICID XEO02361 MOACRIVE Inhibition DME1096 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1096 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02365 XEO_CLAS Peptide DME1096 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 32 ug/ml) DME1096 XEOTICID XEO02365 GENEFORM Protein DME1096 XEOTICID XEO02365 MOACRIVE Inhibition DME1096 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1096 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02366 XEO_CLAS Peptide DME1096 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO02366 GENEFORM Protein DME1096 XEOTICID XEO02366 MOACRIVE Inhibition DME1096 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1096 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02367 XEO_CLAS Peptide DME1096 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02367 GENEFORM Protein DME1096 XEOTICID XEO02367 MOACRIVE Inhibition DME1096 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1096 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02368 XEO_CLAS Peptide DME1096 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02368 GENEFORM Protein DME1096 XEOTICID XEO02368 MOACRIVE Inhibition DME1096 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1096 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02369 XEO_CLAS Peptide DME1096 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02369 GENEFORM Protein DME1096 XEOTICID XEO02369 MOACRIVE Inhibition DME1096 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1096 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02370 XEO_CLAS Peptide DME1096 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02370 GENEFORM Protein DME1096 XEOTICID XEO02370 MOACRIVE Inhibition DME1096 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1096 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02371 XEO_CLAS Peptide DME1096 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 ug/ml) DME1096 XEOTICID XEO02371 GENEFORM Protein DME1096 XEOTICID XEO02371 MOACRIVE Inhibition DME1096 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1096 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02374 XEO_CLAS Peptide DME1096 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02374 GENEFORM Protein DME1096 XEOTICID XEO02374 MOACRIVE Inhibition DME1096 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1096 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02376 XEO_CLAS Peptide DME1096 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02376 GENEFORM Protein DME1096 XEOTICID XEO02376 MOACRIVE Inhibition DME1096 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1096 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02378 XEO_CLAS Peptide DME1096 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.19 ug/ml) DME1096 XEOTICID XEO02378 GENEFORM Protein DME1096 XEOTICID XEO02378 MOACRIVE Inhibition DME1096 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1096 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02388 XEO_CLAS Peptide DME1096 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO02388 GENEFORM Protein DME1096 XEOTICID XEO02388 MOACRIVE Inhibition DME1096 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1096 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02389 XEO_CLAS Peptide DME1096 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02389 GENEFORM Protein DME1096 XEOTICID XEO02389 MOACRIVE Inhibition DME1096 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1096 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02415 XEO_CLAS Peptide DME1096 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02415 GENEFORM Protein DME1096 XEOTICID XEO02415 MOACRIVE Inhibition DME1096 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1096 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02416 XEO_CLAS Peptide DME1096 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 11 microM) DME1096 XEOTICID XEO02416 GENEFORM Protein DME1096 XEOTICID XEO02416 MOACRIVE Inhibition DME1096 XEOTICID XEO02419 XEO_NAME Bay oil DME1096 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1096 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02419 GENEFORM Protein DME1096 XEOTICID XEO02419 MOACRIVE Inhibition DME1096 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1096 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02435 XEO_CLAS Peptide DME1096 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02435 GENEFORM Protein DME1096 XEOTICID XEO02435 MOACRIVE Inhibition DME1096 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1096 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02436 XEO_CLAS Peptide DME1096 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02436 GENEFORM Protein DME1096 XEOTICID XEO02436 MOACRIVE Inhibition DME1096 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1096 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02437 XEO_CLAS Peptide DME1096 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02437 GENEFORM Protein DME1096 XEOTICID XEO02437 MOACRIVE Inhibition DME1096 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1096 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02438 XEO_CLAS Peptide DME1096 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02438 GENEFORM Protein DME1096 XEOTICID XEO02438 MOACRIVE Inhibition DME1096 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1096 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02439 XEO_CLAS Peptide DME1096 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02439 GENEFORM Protein DME1096 XEOTICID XEO02439 MOACRIVE Inhibition DME1096 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1096 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02440 XEO_CLAS Peptide DME1096 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02440 GENEFORM Protein DME1096 XEOTICID XEO02440 MOACRIVE Inhibition DME1096 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1096 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02441 XEO_CLAS Peptide DME1096 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02441 GENEFORM Protein DME1096 XEOTICID XEO02441 MOACRIVE Inhibition DME1096 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1096 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02442 XEO_CLAS Peptide DME1096 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO02442 GENEFORM Protein DME1096 XEOTICID XEO02442 MOACRIVE Inhibition DME1096 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1096 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02443 XEO_CLAS Peptide DME1096 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02443 GENEFORM Protein DME1096 XEOTICID XEO02443 MOACRIVE Inhibition DME1096 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1096 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02444 XEO_CLAS Peptide DME1096 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02444 GENEFORM Protein DME1096 XEOTICID XEO02444 MOACRIVE Inhibition DME1096 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1096 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1096 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02447 GENEFORM Protein DME1096 XEOTICID XEO02447 MOACRIVE Inhibition DME1096 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1096 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02452 XEO_CLAS Peptide DME1096 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 76800 ug/ml) DME1096 XEOTICID XEO02452 GENEFORM Protein DME1096 XEOTICID XEO02452 MOACRIVE Inhibition DME1096 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1096 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02453 XEO_CLAS Peptide DME1096 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02453 GENEFORM Protein DME1096 XEOTICID XEO02453 MOACRIVE Inhibition DME1096 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1096 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02463 XEO_CLAS Peptide DME1096 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 11.25 microM) DME1096 XEOTICID XEO02463 GENEFORM Protein DME1096 XEOTICID XEO02463 MOACRIVE Inhibition DME1096 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1096 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02466 XEO_CLAS Peptide DME1096 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.5 microM) DME1096 XEOTICID XEO02466 GENEFORM Protein DME1096 XEOTICID XEO02466 MOACRIVE Inhibition DME1096 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1096 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02467 XEO_CLAS Peptide DME1096 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8.4 microM) DME1096 XEOTICID XEO02467 GENEFORM Protein DME1096 XEOTICID XEO02467 MOACRIVE Inhibition DME1096 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1096 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02468 XEO_CLAS Peptide DME1096 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.7 microM) DME1096 XEOTICID XEO02468 GENEFORM Protein DME1096 XEOTICID XEO02468 MOACRIVE Inhibition DME1096 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1096 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02469 XEO_CLAS Peptide DME1096 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO02469 GENEFORM Protein DME1096 XEOTICID XEO02469 MOACRIVE Inhibition DME1096 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1096 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02470 XEO_CLAS Peptide DME1096 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.8 microM) DME1096 XEOTICID XEO02470 GENEFORM Protein DME1096 XEOTICID XEO02470 MOACRIVE Inhibition DME1096 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1096 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02471 XEO_CLAS Peptide DME1096 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4.8 microM) DME1096 XEOTICID XEO02471 GENEFORM Protein DME1096 XEOTICID XEO02471 MOACRIVE Inhibition DME1096 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1096 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02472 XEO_CLAS Peptide DME1096 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.0 microM) DME1096 XEOTICID XEO02472 GENEFORM Protein DME1096 XEOTICID XEO02472 MOACRIVE Inhibition DME1096 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1096 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02473 XEO_CLAS Peptide DME1096 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02473 GENEFORM Protein DME1096 XEOTICID XEO02473 MOACRIVE Inhibition DME1096 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1096 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02474 XEO_CLAS Peptide DME1096 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.5 microM) DME1096 XEOTICID XEO02474 GENEFORM Protein DME1096 XEOTICID XEO02474 MOACRIVE Inhibition DME1096 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1096 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02475 XEO_CLAS Peptide DME1096 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.5 microM) DME1096 XEOTICID XEO02475 GENEFORM Protein DME1096 XEOTICID XEO02475 MOACRIVE Inhibition DME1096 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1096 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02477 XEO_CLAS Peptide DME1096 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-300 ug/ml) DME1096 XEOTICID XEO02477 GENEFORM Protein DME1096 XEOTICID XEO02477 MOACRIVE Inhibition DME1096 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1096 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02478 XEO_CLAS Peptide DME1096 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-300 ug/ml) DME1096 XEOTICID XEO02478 GENEFORM Protein DME1096 XEOTICID XEO02478 MOACRIVE Inhibition DME1096 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1096 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02479 XEO_CLAS Peptide DME1096 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-300 ug/ml) DME1096 XEOTICID XEO02479 GENEFORM Protein DME1096 XEOTICID XEO02479 MOACRIVE Inhibition DME1096 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1096 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02480 XEO_CLAS Peptide DME1096 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-300 ug/ml) DME1096 XEOTICID XEO02480 GENEFORM Protein DME1096 XEOTICID XEO02480 MOACRIVE Inhibition DME1096 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1096 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02481 XEO_CLAS Peptide DME1096 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-300 ug/ml) DME1096 XEOTICID XEO02481 GENEFORM Protein DME1096 XEOTICID XEO02481 MOACRIVE Inhibition DME1096 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1096 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02482 XEO_CLAS Peptide DME1096 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-300 ug/ml) DME1096 XEOTICID XEO02482 GENEFORM Protein DME1096 XEOTICID XEO02482 MOACRIVE Inhibition DME1096 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1096 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02483 XEO_CLAS Peptide DME1096 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-300 ug/ml) DME1096 XEOTICID XEO02483 GENEFORM Protein DME1096 XEOTICID XEO02483 MOACRIVE Inhibition DME1096 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1096 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02484 XEO_CLAS Peptide DME1096 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-300 ug/ml) DME1096 XEOTICID XEO02484 GENEFORM Protein DME1096 XEOTICID XEO02484 MOACRIVE Inhibition DME1096 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1096 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02485 XEO_CLAS Peptide DME1096 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-300 ug/ml) DME1096 XEOTICID XEO02485 GENEFORM Protein DME1096 XEOTICID XEO02485 MOACRIVE Inhibition DME1096 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1096 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02486 XEO_CLAS Peptide DME1096 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-300 ug/ml) DME1096 XEOTICID XEO02486 GENEFORM Protein DME1096 XEOTICID XEO02486 MOACRIVE Inhibition DME1096 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1096 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02487 XEO_CLAS Peptide DME1096 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02487 GENEFORM Protein DME1096 XEOTICID XEO02487 MOACRIVE Inhibition DME1096 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1096 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02488 XEO_CLAS Peptide DME1096 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-300 ug/ml) DME1096 XEOTICID XEO02488 GENEFORM Protein DME1096 XEOTICID XEO02488 MOACRIVE Inhibition DME1096 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1096 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02489 XEO_CLAS Peptide DME1096 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-301 ug/ml) DME1096 XEOTICID XEO02489 GENEFORM Protein DME1096 XEOTICID XEO02489 MOACRIVE Inhibition DME1096 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1096 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02491 XEO_CLAS Peptide DME1096 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.3 microM) DME1096 XEOTICID XEO02491 GENEFORM Protein DME1096 XEOTICID XEO02491 MOACRIVE Inhibition DME1096 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1096 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02492 XEO_CLAS Peptide DME1096 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 ug/ml) DME1096 XEOTICID XEO02492 GENEFORM Protein DME1096 XEOTICID XEO02492 MOACRIVE Inhibition DME1096 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1096 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02493 XEO_CLAS Peptide DME1096 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 ug/ml) DME1096 XEOTICID XEO02493 GENEFORM Protein DME1096 XEOTICID XEO02493 MOACRIVE Inhibition DME1096 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1096 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02494 XEO_CLAS Peptide DME1096 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 ug/ml) DME1096 XEOTICID XEO02494 GENEFORM Protein DME1096 XEOTICID XEO02494 MOACRIVE Inhibition DME1096 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1096 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02495 XEO_CLAS Peptide DME1096 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 34 ug/ml) DME1096 XEOTICID XEO02495 GENEFORM Protein DME1096 XEOTICID XEO02495 MOACRIVE Inhibition DME1096 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1096 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02496 XEO_CLAS Peptide DME1096 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 13 microM) DME1096 XEOTICID XEO02496 GENEFORM Protein DME1096 XEOTICID XEO02496 MOACRIVE Inhibition DME1096 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1096 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02497 XEO_CLAS Peptide DME1096 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO02497 GENEFORM Protein DME1096 XEOTICID XEO02497 MOACRIVE Inhibition DME1096 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1096 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02499 XEO_CLAS Peptide DME1096 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO02499 GENEFORM Protein DME1096 XEOTICID XEO02499 MOACRIVE Inhibition DME1096 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1096 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02501 XEO_CLAS Peptide DME1096 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 7 microM) DME1096 XEOTICID XEO02501 GENEFORM Protein DME1096 XEOTICID XEO02501 MOACRIVE Inhibition DME1096 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1096 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02502 XEO_CLAS Peptide DME1096 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 microM) DME1096 XEOTICID XEO02502 GENEFORM Protein DME1096 XEOTICID XEO02502 MOACRIVE Inhibition DME1096 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1096 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02503 XEO_CLAS Peptide DME1096 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 19 microM) DME1096 XEOTICID XEO02503 GENEFORM Protein DME1096 XEOTICID XEO02503 MOACRIVE Inhibition DME1096 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1096 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02504 XEO_CLAS Peptide DME1096 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02504 GENEFORM Protein DME1096 XEOTICID XEO02504 MOACRIVE Inhibition DME1096 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1096 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02505 XEO_CLAS Peptide DME1096 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO02505 GENEFORM Protein DME1096 XEOTICID XEO02505 MOACRIVE Inhibition DME1096 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1096 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02507 XEO_CLAS Peptide DME1096 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO02507 GENEFORM Protein DME1096 XEOTICID XEO02507 MOACRIVE Inhibition DME1096 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1096 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02508 XEO_CLAS Peptide DME1096 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 150 microM) DME1096 XEOTICID XEO02508 GENEFORM Protein DME1096 XEOTICID XEO02508 MOACRIVE Inhibition DME1096 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1096 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02509 XEO_CLAS Peptide DME1096 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 150 microM) DME1096 XEOTICID XEO02509 GENEFORM Protein DME1096 XEOTICID XEO02509 MOACRIVE Inhibition DME1096 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1096 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02510 XEO_CLAS Peptide DME1096 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 150 microM) DME1096 XEOTICID XEO02510 GENEFORM Protein DME1096 XEOTICID XEO02510 MOACRIVE Inhibition DME1096 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1096 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02511 XEO_CLAS Peptide DME1096 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 150 microM) DME1096 XEOTICID XEO02511 GENEFORM Protein DME1096 XEOTICID XEO02511 MOACRIVE Inhibition DME1096 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1096 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02512 XEO_CLAS Peptide DME1096 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 75 microM) DME1096 XEOTICID XEO02512 GENEFORM Protein DME1096 XEOTICID XEO02512 MOACRIVE Inhibition DME1096 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1096 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02513 XEO_CLAS Peptide DME1096 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO02513 GENEFORM Protein DME1096 XEOTICID XEO02513 MOACRIVE Inhibition DME1096 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1096 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02514 XEO_CLAS Peptide DME1096 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO02514 GENEFORM Protein DME1096 XEOTICID XEO02514 MOACRIVE Inhibition DME1096 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1096 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02515 XEO_CLAS Peptide DME1096 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 80 microM) DME1096 XEOTICID XEO02515 GENEFORM Protein DME1096 XEOTICID XEO02515 MOACRIVE Inhibition DME1096 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1096 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02516 XEO_CLAS Peptide DME1096 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 32 microM) DME1096 XEOTICID XEO02516 GENEFORM Protein DME1096 XEOTICID XEO02516 MOACRIVE Inhibition DME1096 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1096 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02517 XEO_CLAS Peptide DME1096 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 microM) DME1096 XEOTICID XEO02517 GENEFORM Protein DME1096 XEOTICID XEO02517 MOACRIVE Inhibition DME1096 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1096 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02518 XEO_CLAS Peptide DME1096 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC < 15 microM) DME1096 XEOTICID XEO02518 GENEFORM Protein DME1096 XEOTICID XEO02518 MOACRIVE Inhibition DME1096 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1096 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02519 XEO_CLAS Peptide DME1096 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC < 15 microM) DME1096 XEOTICID XEO02519 GENEFORM Protein DME1096 XEOTICID XEO02519 MOACRIVE Inhibition DME1096 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1096 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02520 XEO_CLAS Peptide DME1096 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC < 15 microM) DME1096 XEOTICID XEO02520 GENEFORM Protein DME1096 XEOTICID XEO02520 MOACRIVE Inhibition DME1096 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1096 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02523 XEO_CLAS Peptide DME1096 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO02523 GENEFORM Protein DME1096 XEOTICID XEO02523 MOACRIVE Inhibition DME1096 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1096 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02524 XEO_CLAS Peptide DME1096 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 150 microM) DME1096 XEOTICID XEO02524 GENEFORM Protein DME1096 XEOTICID XEO02524 MOACRIVE Inhibition DME1096 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1096 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02525 XEO_CLAS Peptide DME1096 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 24 microM) DME1096 XEOTICID XEO02525 GENEFORM Protein DME1096 XEOTICID XEO02525 MOACRIVE Inhibition DME1096 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1096 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02526 XEO_CLAS Peptide DME1096 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 48 microM) DME1096 XEOTICID XEO02526 GENEFORM Protein DME1096 XEOTICID XEO02526 MOACRIVE Inhibition DME1096 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1096 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02527 XEO_CLAS Peptide DME1096 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 119 microM) DME1096 XEOTICID XEO02527 GENEFORM Protein DME1096 XEOTICID XEO02527 MOACRIVE Inhibition DME1096 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1096 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02528 XEO_CLAS Peptide DME1096 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 128 ug/ml) DME1096 XEOTICID XEO02528 GENEFORM Protein DME1096 XEOTICID XEO02528 MOACRIVE Inhibition DME1096 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1096 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02529 XEO_CLAS Peptide DME1096 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 128 ug/ml) DME1096 XEOTICID XEO02529 GENEFORM Protein DME1096 XEOTICID XEO02529 MOACRIVE Inhibition DME1096 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1096 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02530 XEO_CLAS Peptide DME1096 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02530 GENEFORM Protein DME1096 XEOTICID XEO02530 MOACRIVE Inhibition DME1096 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1096 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02531 XEO_CLAS Peptide DME1096 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 microM) DME1096 XEOTICID XEO02531 GENEFORM Protein DME1096 XEOTICID XEO02531 MOACRIVE Inhibition DME1096 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1096 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02533 XEO_CLAS Peptide DME1096 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.2 ug/ml) DME1096 XEOTICID XEO02533 GENEFORM Protein DME1096 XEOTICID XEO02533 MOACRIVE Inhibition DME1096 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1096 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02534 XEO_CLAS Peptide DME1096 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.6 ug/ml) DME1096 XEOTICID XEO02534 GENEFORM Protein DME1096 XEOTICID XEO02534 MOACRIVE Inhibition DME1096 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1096 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02535 XEO_CLAS Peptide DME1096 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.3 ug/ml) DME1096 XEOTICID XEO02535 GENEFORM Protein DME1096 XEOTICID XEO02535 MOACRIVE Inhibition DME1096 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1096 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02536 XEO_CLAS Peptide DME1096 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.4 ug/ml) DME1096 XEOTICID XEO02536 GENEFORM Protein DME1096 XEOTICID XEO02536 MOACRIVE Inhibition DME1096 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1096 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02537 XEO_CLAS Peptide DME1096 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.2 ug/ml) DME1096 XEOTICID XEO02537 GENEFORM Protein DME1096 XEOTICID XEO02537 MOACRIVE Inhibition DME1096 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1096 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02538 XEO_CLAS Peptide DME1096 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 9.1 ug/ml) DME1096 XEOTICID XEO02538 GENEFORM Protein DME1096 XEOTICID XEO02538 MOACRIVE Inhibition DME1096 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1096 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02539 XEO_CLAS Peptide DME1096 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8.6 ug/ml) DME1096 XEOTICID XEO02539 GENEFORM Protein DME1096 XEOTICID XEO02539 MOACRIVE Inhibition DME1096 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1096 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02540 XEO_CLAS Peptide DME1096 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15.2 ug/ml) DME1096 XEOTICID XEO02540 GENEFORM Protein DME1096 XEOTICID XEO02540 MOACRIVE Inhibition DME1096 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1096 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02541 XEO_CLAS Peptide DME1096 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 11.1 ug/ml) DME1096 XEOTICID XEO02541 GENEFORM Protein DME1096 XEOTICID XEO02541 MOACRIVE Inhibition DME1096 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1096 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02542 XEO_CLAS Peptide DME1096 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.7 ug/ml) DME1096 XEOTICID XEO02542 GENEFORM Protein DME1096 XEOTICID XEO02542 MOACRIVE Inhibition DME1096 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1096 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02543 XEO_CLAS Peptide DME1096 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 13.1 ug/ml) DME1096 XEOTICID XEO02543 GENEFORM Protein DME1096 XEOTICID XEO02543 MOACRIVE Inhibition DME1096 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1096 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02544 XEO_CLAS Peptide DME1096 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 9.8 ug/ml) DME1096 XEOTICID XEO02544 GENEFORM Protein DME1096 XEOTICID XEO02544 MOACRIVE Inhibition DME1096 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1096 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02545 XEO_CLAS Peptide DME1096 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 14 microM) DME1096 XEOTICID XEO02545 GENEFORM Protein DME1096 XEOTICID XEO02545 MOACRIVE Inhibition DME1096 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1096 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02546 XEO_CLAS Peptide DME1096 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 14 microM) DME1096 XEOTICID XEO02546 GENEFORM Protein DME1096 XEOTICID XEO02546 MOACRIVE Inhibition DME1096 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1096 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02547 XEO_CLAS Peptide DME1096 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 microM) DME1096 XEOTICID XEO02547 GENEFORM Protein DME1096 XEOTICID XEO02547 MOACRIVE Inhibition DME1096 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1096 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02548 XEO_CLAS Peptide DME1096 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 78 microM) DME1096 XEOTICID XEO02548 GENEFORM Protein DME1096 XEOTICID XEO02548 MOACRIVE Inhibition DME1096 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1096 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02549 XEO_CLAS Peptide DME1096 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02549 GENEFORM Protein DME1096 XEOTICID XEO02549 MOACRIVE Inhibition DME1096 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1096 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02552 XEO_CLAS Peptide DME1096 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 24 microM) DME1096 XEOTICID XEO02552 GENEFORM Protein DME1096 XEOTICID XEO02552 MOACRIVE Inhibition DME1096 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1096 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02553 XEO_CLAS Peptide DME1096 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02553 GENEFORM Protein DME1096 XEOTICID XEO02553 MOACRIVE Inhibition DME1096 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1096 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02556 XEO_CLAS Peptide DME1096 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 55 microM) DME1096 XEOTICID XEO02556 GENEFORM Protein DME1096 XEOTICID XEO02556 MOACRIVE Inhibition DME1096 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1096 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02557 XEO_CLAS Peptide DME1096 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 17 microM) DME1096 XEOTICID XEO02557 GENEFORM Protein DME1096 XEOTICID XEO02557 MOACRIVE Inhibition DME1096 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1096 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02558 XEO_CLAS Peptide DME1096 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 14 microM) DME1096 XEOTICID XEO02558 GENEFORM Protein DME1096 XEOTICID XEO02558 MOACRIVE Inhibition DME1096 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1096 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02559 XEO_CLAS Peptide DME1096 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02559 GENEFORM Protein DME1096 XEOTICID XEO02559 MOACRIVE Inhibition DME1096 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1096 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02560 XEO_CLAS Peptide DME1096 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 13 microM) DME1096 XEOTICID XEO02560 GENEFORM Protein DME1096 XEOTICID XEO02560 MOACRIVE Inhibition DME1096 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1096 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02561 XEO_CLAS Peptide DME1096 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO02561 GENEFORM Protein DME1096 XEOTICID XEO02561 MOACRIVE Inhibition DME1096 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1096 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02562 XEO_CLAS Peptide DME1096 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 13 microM) DME1096 XEOTICID XEO02562 GENEFORM Protein DME1096 XEOTICID XEO02562 MOACRIVE Inhibition DME1096 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1096 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02563 XEO_CLAS Peptide DME1096 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 45 microM) DME1096 XEOTICID XEO02563 GENEFORM Protein DME1096 XEOTICID XEO02563 MOACRIVE Inhibition DME1096 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1096 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02564 XEO_CLAS Peptide DME1096 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 ug/ml) DME1096 XEOTICID XEO02564 GENEFORM Protein DME1096 XEOTICID XEO02564 MOACRIVE Inhibition DME1096 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1096 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02565 XEO_CLAS Peptide DME1096 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 microM) DME1096 XEOTICID XEO02565 GENEFORM Protein DME1096 XEOTICID XEO02565 MOACRIVE Inhibition DME1096 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1096 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02566 XEO_CLAS Peptide DME1096 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO02566 GENEFORM Protein DME1096 XEOTICID XEO02566 MOACRIVE Inhibition DME1096 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1096 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02568 XEO_CLAS Peptide DME1096 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO02568 GENEFORM Protein DME1096 XEOTICID XEO02568 MOACRIVE Inhibition DME1096 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1096 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02569 XEO_CLAS Peptide DME1096 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO02569 GENEFORM Protein DME1096 XEOTICID XEO02569 MOACRIVE Inhibition DME1096 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1096 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02570 XEO_CLAS Peptide DME1096 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO02570 GENEFORM Protein DME1096 XEOTICID XEO02570 MOACRIVE Inhibition DME1096 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1096 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02571 XEO_CLAS Peptide DME1096 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO02571 GENEFORM Protein DME1096 XEOTICID XEO02571 MOACRIVE Inhibition DME1096 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1096 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02572 XEO_CLAS Peptide DME1096 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02572 GENEFORM Protein DME1096 XEOTICID XEO02572 MOACRIVE Inhibition DME1096 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1096 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02573 XEO_CLAS Peptide DME1096 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02573 GENEFORM Protein DME1096 XEOTICID XEO02573 MOACRIVE Inhibition DME1096 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1096 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02574 XEO_CLAS Peptide DME1096 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 microM) DME1096 XEOTICID XEO02574 GENEFORM Protein DME1096 XEOTICID XEO02574 MOACRIVE Inhibition DME1096 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1096 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02575 XEO_CLAS Peptide DME1096 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 microM) DME1096 XEOTICID XEO02575 GENEFORM Protein DME1096 XEOTICID XEO02575 MOACRIVE Inhibition DME1096 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1096 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02576 XEO_CLAS Peptide DME1096 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 33 microM) DME1096 XEOTICID XEO02576 GENEFORM Protein DME1096 XEOTICID XEO02576 MOACRIVE Inhibition DME1096 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1096 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02577 XEO_CLAS Peptide DME1096 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO02577 GENEFORM Protein DME1096 XEOTICID XEO02577 MOACRIVE Inhibition DME1096 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1096 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02578 XEO_CLAS Peptide DME1096 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02578 GENEFORM Protein DME1096 XEOTICID XEO02578 MOACRIVE Inhibition DME1096 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1096 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02579 XEO_CLAS Peptide DME1096 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02579 GENEFORM Protein DME1096 XEOTICID XEO02579 MOACRIVE Inhibition DME1096 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1096 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02580 XEO_CLAS Peptide DME1096 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC < 15 microM) DME1096 XEOTICID XEO02580 GENEFORM Protein DME1096 XEOTICID XEO02580 MOACRIVE Inhibition DME1096 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1096 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02581 XEO_CLAS Peptide DME1096 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 microM) DME1096 XEOTICID XEO02581 GENEFORM Protein DME1096 XEOTICID XEO02581 MOACRIVE Inhibition DME1096 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1096 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02582 XEO_CLAS Peptide DME1096 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 microM) DME1096 XEOTICID XEO02582 GENEFORM Protein DME1096 XEOTICID XEO02582 MOACRIVE Inhibition DME1096 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1096 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02583 XEO_CLAS Peptide DME1096 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 microM) DME1096 XEOTICID XEO02583 GENEFORM Protein DME1096 XEOTICID XEO02583 MOACRIVE Inhibition DME1096 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1096 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02584 XEO_CLAS Peptide DME1096 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 microM) DME1096 XEOTICID XEO02584 GENEFORM Protein DME1096 XEOTICID XEO02584 MOACRIVE Inhibition DME1096 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1096 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02585 XEO_CLAS Peptide DME1096 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO02585 GENEFORM Protein DME1096 XEOTICID XEO02585 MOACRIVE Inhibition DME1096 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1096 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02586 XEO_CLAS Peptide DME1096 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO02586 GENEFORM Protein DME1096 XEOTICID XEO02586 MOACRIVE Inhibition DME1096 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1096 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02587 XEO_CLAS Peptide DME1096 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02587 GENEFORM Protein DME1096 XEOTICID XEO02587 MOACRIVE Inhibition DME1096 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1096 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02589 XEO_CLAS Peptide DME1096 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8.2 ug/ml) DME1096 XEOTICID XEO02589 GENEFORM Protein DME1096 XEOTICID XEO02589 MOACRIVE Inhibition DME1096 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1096 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02590 XEO_CLAS Peptide DME1096 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 19.6 ug/ml) DME1096 XEOTICID XEO02590 GENEFORM Protein DME1096 XEOTICID XEO02590 MOACRIVE Inhibition DME1096 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1096 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02591 XEO_CLAS Peptide DME1096 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO02591 GENEFORM Protein DME1096 XEOTICID XEO02591 MOACRIVE Inhibition DME1096 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1096 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02593 XEO_CLAS Peptide DME1096 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 36 microM) DME1096 XEOTICID XEO02593 GENEFORM Protein DME1096 XEOTICID XEO02593 MOACRIVE Inhibition DME1096 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1096 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02594 XEO_CLAS Peptide DME1096 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02594 GENEFORM Protein DME1096 XEOTICID XEO02594 MOACRIVE Inhibition DME1096 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1096 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02595 XEO_CLAS Peptide DME1096 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO02595 GENEFORM Protein DME1096 XEOTICID XEO02595 MOACRIVE Inhibition DME1096 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1096 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02596 XEO_CLAS Peptide DME1096 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO02596 GENEFORM Protein DME1096 XEOTICID XEO02596 MOACRIVE Inhibition DME1096 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1096 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02597 XEO_CLAS Peptide DME1096 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO02597 GENEFORM Protein DME1096 XEOTICID XEO02597 MOACRIVE Inhibition DME1096 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1096 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02598 XEO_CLAS Peptide DME1096 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 32.5 microM) DME1096 XEOTICID XEO02598 GENEFORM Protein DME1096 XEOTICID XEO02598 MOACRIVE Inhibition DME1096 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1096 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02599 XEO_CLAS Peptide DME1096 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 microM) DME1096 XEOTICID XEO02599 GENEFORM Protein DME1096 XEOTICID XEO02599 MOACRIVE Inhibition DME1096 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1096 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02601 XEO_CLAS Peptide DME1096 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.1 ug/ml) DME1096 XEOTICID XEO02601 GENEFORM Protein DME1096 XEOTICID XEO02601 MOACRIVE Inhibition DME1096 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1096 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02602 XEO_CLAS Peptide DME1096 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 13.2 ug/ml) DME1096 XEOTICID XEO02602 GENEFORM Protein DME1096 XEOTICID XEO02602 MOACRIVE Inhibition DME1096 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1096 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02603 XEO_CLAS Peptide DME1096 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.3 ug/ml) DME1096 XEOTICID XEO02603 GENEFORM Protein DME1096 XEOTICID XEO02603 MOACRIVE Inhibition DME1096 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1096 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02604 XEO_CLAS Peptide DME1096 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO02604 GENEFORM Protein DME1096 XEOTICID XEO02604 MOACRIVE Inhibition DME1096 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1096 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02605 XEO_CLAS Peptide DME1096 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30.6 ug/ml) DME1096 XEOTICID XEO02605 GENEFORM Protein DME1096 XEOTICID XEO02605 MOACRIVE Inhibition DME1096 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1096 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02606 XEO_CLAS Peptide DME1096 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 11.2 ug/ml) DME1096 XEOTICID XEO02606 GENEFORM Protein DME1096 XEOTICID XEO02606 MOACRIVE Inhibition DME1096 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1096 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02607 XEO_CLAS Peptide DME1096 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.8 ug/ml) DME1096 XEOTICID XEO02607 GENEFORM Protein DME1096 XEOTICID XEO02607 MOACRIVE Inhibition DME1096 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1096 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02608 XEO_CLAS Peptide DME1096 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 7.9 ug/ml) DME1096 XEOTICID XEO02608 GENEFORM Protein DME1096 XEOTICID XEO02608 MOACRIVE Inhibition DME1096 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1096 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02609 XEO_CLAS Peptide DME1096 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15.8 ug/ml) DME1096 XEOTICID XEO02609 GENEFORM Protein DME1096 XEOTICID XEO02609 MOACRIVE Inhibition DME1096 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1096 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02610 XEO_CLAS Peptide DME1096 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.1 ug/ml) DME1096 XEOTICID XEO02610 GENEFORM Protein DME1096 XEOTICID XEO02610 MOACRIVE Inhibition DME1096 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1096 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02611 XEO_CLAS Peptide DME1096 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20.6 ug/ml) DME1096 XEOTICID XEO02611 GENEFORM Protein DME1096 XEOTICID XEO02611 MOACRIVE Inhibition DME1096 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1096 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02612 XEO_CLAS Peptide DME1096 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 11.8 ug/ml) DME1096 XEOTICID XEO02612 GENEFORM Protein DME1096 XEOTICID XEO02612 MOACRIVE Inhibition DME1096 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1096 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02613 XEO_CLAS Peptide DME1096 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 13.2 ug/ml) DME1096 XEOTICID XEO02613 GENEFORM Protein DME1096 XEOTICID XEO02613 MOACRIVE Inhibition DME1096 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1096 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02614 XEO_CLAS Peptide DME1096 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.8 ug/ml) DME1096 XEOTICID XEO02614 GENEFORM Protein DME1096 XEOTICID XEO02614 MOACRIVE Inhibition DME1096 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1096 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02615 XEO_CLAS Peptide DME1096 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8.6 ug/ml) DME1096 XEOTICID XEO02615 GENEFORM Protein DME1096 XEOTICID XEO02615 MOACRIVE Inhibition DME1096 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1096 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02616 XEO_CLAS Peptide DME1096 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20.4 ug/ml) DME1096 XEOTICID XEO02616 GENEFORM Protein DME1096 XEOTICID XEO02616 MOACRIVE Inhibition DME1096 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1096 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02617 XEO_CLAS Peptide DME1096 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4.7 ug/ml) DME1096 XEOTICID XEO02617 GENEFORM Protein DME1096 XEOTICID XEO02617 MOACRIVE Inhibition DME1096 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1096 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02618 XEO_CLAS Peptide DME1096 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.6 ug/ml) DME1096 XEOTICID XEO02618 GENEFORM Protein DME1096 XEOTICID XEO02618 MOACRIVE Inhibition DME1096 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1096 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02619 XEO_CLAS Peptide DME1096 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10.5 ug/ml) DME1096 XEOTICID XEO02619 GENEFORM Protein DME1096 XEOTICID XEO02619 MOACRIVE Inhibition DME1096 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1096 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02620 XEO_CLAS Peptide DME1096 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO02620 GENEFORM Protein DME1096 XEOTICID XEO02620 MOACRIVE Inhibition DME1096 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1096 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02621 XEO_CLAS Peptide DME1096 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO02621 GENEFORM Protein DME1096 XEOTICID XEO02621 MOACRIVE Inhibition DME1096 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1096 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02622 XEO_CLAS Peptide DME1096 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO02622 GENEFORM Protein DME1096 XEOTICID XEO02622 MOACRIVE Inhibition DME1096 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1096 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02623 XEO_CLAS Peptide DME1096 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO02623 GENEFORM Protein DME1096 XEOTICID XEO02623 MOACRIVE Inhibition DME1096 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1096 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02624 XEO_CLAS Peptide DME1096 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 18 microM) DME1096 XEOTICID XEO02624 GENEFORM Protein DME1096 XEOTICID XEO02624 MOACRIVE Inhibition DME1096 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1096 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02625 XEO_CLAS Peptide DME1096 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 9 microM) DME1096 XEOTICID XEO02625 GENEFORM Protein DME1096 XEOTICID XEO02625 MOACRIVE Inhibition DME1096 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1096 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02626 XEO_CLAS Peptide DME1096 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 18 microM) DME1096 XEOTICID XEO02626 GENEFORM Protein DME1096 XEOTICID XEO02626 MOACRIVE Inhibition DME1096 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1096 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02627 XEO_CLAS Peptide DME1096 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02627 GENEFORM Protein DME1096 XEOTICID XEO02627 MOACRIVE Inhibition DME1096 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1096 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02628 XEO_CLAS Peptide DME1096 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 18 microM) DME1096 XEOTICID XEO02628 GENEFORM Protein DME1096 XEOTICID XEO02628 MOACRIVE Inhibition DME1096 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1096 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02629 XEO_CLAS Peptide DME1096 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 13 microM) DME1096 XEOTICID XEO02629 GENEFORM Protein DME1096 XEOTICID XEO02629 MOACRIVE Inhibition DME1096 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1096 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02630 XEO_CLAS Peptide DME1096 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 ug/ml) DME1096 XEOTICID XEO02630 GENEFORM Protein DME1096 XEOTICID XEO02630 MOACRIVE Inhibition DME1096 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1096 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02631 XEO_CLAS Peptide DME1096 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 ug/ml) DME1096 XEOTICID XEO02631 GENEFORM Protein DME1096 XEOTICID XEO02631 MOACRIVE Inhibition DME1096 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1096 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02634 XEO_CLAS Peptide DME1096 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO02634 GENEFORM Protein DME1096 XEOTICID XEO02634 MOACRIVE Inhibition DME1096 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1096 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02635 XEO_CLAS Peptide DME1096 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40 ug/ml) DME1096 XEOTICID XEO02635 GENEFORM Protein DME1096 XEOTICID XEO02635 MOACRIVE Inhibition DME1096 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1096 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02636 XEO_CLAS Peptide DME1096 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO02636 GENEFORM Protein DME1096 XEOTICID XEO02636 MOACRIVE Inhibition DME1096 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1096 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02637 XEO_CLAS Peptide DME1096 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO02637 GENEFORM Protein DME1096 XEOTICID XEO02637 MOACRIVE Inhibition DME1096 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1096 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02638 XEO_CLAS Peptide DME1096 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 microM) DME1096 XEOTICID XEO02638 GENEFORM Protein DME1096 XEOTICID XEO02638 MOACRIVE Inhibition DME1096 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1096 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02639 XEO_CLAS Peptide DME1096 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 microM) DME1096 XEOTICID XEO02639 GENEFORM Protein DME1096 XEOTICID XEO02639 MOACRIVE Inhibition DME1096 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1096 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02644 XEO_CLAS Peptide DME1096 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02644 GENEFORM Protein DME1096 XEOTICID XEO02644 MOACRIVE Inhibition DME1096 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1096 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02645 XEO_CLAS Peptide DME1096 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02645 GENEFORM Protein DME1096 XEOTICID XEO02645 MOACRIVE Inhibition DME1096 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1096 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02646 XEO_CLAS Peptide DME1096 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02646 GENEFORM Protein DME1096 XEOTICID XEO02646 MOACRIVE Inhibition DME1096 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1096 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02647 XEO_CLAS Peptide DME1096 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02647 GENEFORM Protein DME1096 XEOTICID XEO02647 MOACRIVE Inhibition DME1096 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1096 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02649 XEO_CLAS Peptide DME1096 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO02649 GENEFORM Protein DME1096 XEOTICID XEO02649 MOACRIVE Inhibition DME1096 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1096 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02650 XEO_CLAS Peptide DME1096 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO02650 GENEFORM Protein DME1096 XEOTICID XEO02650 MOACRIVE Inhibition DME1096 XEOTICID XEO02658 XEO_NAME Buthinin DME1096 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02658 XEO_CLAS Peptide DME1096 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02658 GENEFORM Protein DME1096 XEOTICID XEO02658 MOACRIVE Inhibition DME1096 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1096 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02663 XEO_CLAS Peptide DME1096 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25 microM) DME1096 XEOTICID XEO02663 GENEFORM Protein DME1096 XEOTICID XEO02663 MOACRIVE Inhibition DME1096 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1096 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02664 XEO_CLAS Peptide DME1096 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25 microM) DME1096 XEOTICID XEO02664 GENEFORM Protein DME1096 XEOTICID XEO02664 MOACRIVE Inhibition DME1096 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1096 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02672 XEO_CLAS Peptide DME1096 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25 microM) DME1096 XEOTICID XEO02672 GENEFORM Protein DME1096 XEOTICID XEO02672 MOACRIVE Inhibition DME1096 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1096 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02673 XEO_CLAS Peptide DME1096 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25-12.5 microM) DME1096 XEOTICID XEO02673 GENEFORM Protein DME1096 XEOTICID XEO02673 MOACRIVE Inhibition DME1096 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1096 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02674 XEO_CLAS Peptide DME1096 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.125-6.25 microM) DME1096 XEOTICID XEO02674 GENEFORM Protein DME1096 XEOTICID XEO02674 MOACRIVE Inhibition DME1096 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1096 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02676 XEO_CLAS Peptide DME1096 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO02676 GENEFORM Protein DME1096 XEOTICID XEO02676 MOACRIVE Inhibition DME1096 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1096 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02677 XEO_CLAS Peptide DME1096 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25-12.5 microM) DME1096 XEOTICID XEO02677 GENEFORM Protein DME1096 XEOTICID XEO02677 MOACRIVE Inhibition DME1096 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1096 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02679 XEO_CLAS Peptide DME1096 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25-12.5 microM) DME1096 XEOTICID XEO02679 GENEFORM Protein DME1096 XEOTICID XEO02679 MOACRIVE Inhibition DME1096 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1096 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02680 XEO_CLAS Peptide DME1096 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25 microM) DME1096 XEOTICID XEO02680 GENEFORM Protein DME1096 XEOTICID XEO02680 MOACRIVE Inhibition DME1096 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1096 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02683 XEO_CLAS Peptide DME1096 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO02683 GENEFORM Protein DME1096 XEOTICID XEO02683 MOACRIVE Inhibition DME1096 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1096 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02688 XEO_CLAS Peptide DME1096 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO02688 GENEFORM Protein DME1096 XEOTICID XEO02688 MOACRIVE Inhibition DME1096 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1096 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02693 XEO_CLAS Peptide DME1096 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 ug/ml) DME1096 XEOTICID XEO02693 GENEFORM Protein DME1096 XEOTICID XEO02693 MOACRIVE Inhibition DME1096 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1096 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02699 XEO_CLAS Peptide DME1096 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 ug/ml) DME1096 XEOTICID XEO02699 GENEFORM Protein DME1096 XEOTICID XEO02699 MOACRIVE Inhibition DME1096 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1096 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02700 XEO_CLAS Peptide DME1096 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 ug/ml) DME1096 XEOTICID XEO02700 GENEFORM Protein DME1096 XEOTICID XEO02700 MOACRIVE Inhibition DME1096 XEOTICID XEO02703 XEO_NAME Calcitermin DME1096 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02703 XEO_CLAS Peptide DME1096 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02703 GENEFORM Protein DME1096 XEOTICID XEO02703 MOACRIVE Inhibition DME1096 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1096 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02708 XEO_CLAS Peptide DME1096 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO02708 GENEFORM Protein DME1096 XEOTICID XEO02708 MOACRIVE Inhibition DME1096 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1096 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02709 XEO_CLAS Peptide DME1096 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.05 microM) DME1096 XEOTICID XEO02709 GENEFORM Protein DME1096 XEOTICID XEO02709 MOACRIVE Inhibition DME1096 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1096 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1096 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02713 GENEFORM Protein DME1096 XEOTICID XEO02713 MOACRIVE Inhibition DME1096 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1096 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1096 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02714 GENEFORM Protein DME1096 XEOTICID XEO02714 MOACRIVE Inhibition DME1096 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1096 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02726 XEO_CLAS Peptide DME1096 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02726 GENEFORM Protein DME1096 XEOTICID XEO02726 MOACRIVE Inhibition DME1096 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1096 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02731 XEO_CLAS Peptide DME1096 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1 microM) DME1096 XEOTICID XEO02731 GENEFORM Protein DME1096 XEOTICID XEO02731 MOACRIVE Inhibition DME1096 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1096 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02732 XEO_CLAS Peptide DME1096 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.25 microM) DME1096 XEOTICID XEO02732 GENEFORM Protein DME1096 XEOTICID XEO02732 MOACRIVE Inhibition DME1096 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1096 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02733 XEO_CLAS Peptide DME1096 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8-25 ug/ml) DME1096 XEOTICID XEO02733 GENEFORM Protein DME1096 XEOTICID XEO02733 MOACRIVE Inhibition DME1096 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1096 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02735 XEO_CLAS Peptide DME1096 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1 ug/ml) DME1096 XEOTICID XEO02735 GENEFORM Protein DME1096 XEOTICID XEO02735 MOACRIVE Inhibition DME1096 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1096 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02737 XEO_CLAS Peptide DME1096 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02737 GENEFORM Protein DME1096 XEOTICID XEO02737 MOACRIVE Inhibition DME1096 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1096 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02738 XEO_CLAS Peptide DME1096 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO02738 GENEFORM Protein DME1096 XEOTICID XEO02738 MOACRIVE Inhibition DME1096 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1096 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02739 XEO_CLAS Peptide DME1096 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 microM) DME1096 XEOTICID XEO02739 GENEFORM Protein DME1096 XEOTICID XEO02739 MOACRIVE Inhibition DME1096 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1096 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02740 XEO_CLAS Peptide DME1096 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.25 ug/ml) DME1096 XEOTICID XEO02740 GENEFORM Protein DME1096 XEOTICID XEO02740 MOACRIVE Inhibition DME1096 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1096 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02741 XEO_CLAS Peptide DME1096 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 ug/ml) DME1096 XEOTICID XEO02741 GENEFORM Protein DME1096 XEOTICID XEO02741 MOACRIVE Inhibition DME1096 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1096 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02743 XEO_CLAS Peptide DME1096 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.6 ug/ml) DME1096 XEOTICID XEO02743 GENEFORM Protein DME1096 XEOTICID XEO02743 MOACRIVE Inhibition DME1096 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1096 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02744 XEO_CLAS Peptide DME1096 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 18.7 ug/ml) DME1096 XEOTICID XEO02744 GENEFORM Protein DME1096 XEOTICID XEO02744 MOACRIVE Inhibition DME1096 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1096 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02745 XEO_CLAS Peptide DME1096 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02745 GENEFORM Protein DME1096 XEOTICID XEO02745 MOACRIVE Inhibition DME1096 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1096 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02746 XEO_CLAS Peptide DME1096 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02746 GENEFORM Protein DME1096 XEOTICID XEO02746 MOACRIVE Inhibition DME1096 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1096 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02748 XEO_CLAS Peptide DME1096 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02748 GENEFORM Protein DME1096 XEOTICID XEO02748 MOACRIVE Inhibition DME1096 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1096 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02749 XEO_CLAS Peptide DME1096 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20-25 mug/ml) DME1096 XEOTICID XEO02749 GENEFORM Protein DME1096 XEOTICID XEO02749 MOACRIVE Inhibition DME1096 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1096 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02750 XEO_CLAS Peptide DME1096 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02750 GENEFORM Protein DME1096 XEOTICID XEO02750 MOACRIVE Inhibition DME1096 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1096 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02752 XEO_CLAS Peptide DME1096 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02752 GENEFORM Protein DME1096 XEOTICID XEO02752 MOACRIVE Inhibition DME1096 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1096 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02753 XEO_CLAS Peptide DME1096 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02753 GENEFORM Protein DME1096 XEOTICID XEO02753 MOACRIVE Inhibition DME1096 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1096 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02754 XEO_CLAS Peptide DME1096 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 microM) DME1096 XEOTICID XEO02754 GENEFORM Protein DME1096 XEOTICID XEO02754 MOACRIVE Inhibition DME1096 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1096 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02756 XEO_CLAS Peptide DME1096 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 microM) DME1096 XEOTICID XEO02756 GENEFORM Protein DME1096 XEOTICID XEO02756 MOACRIVE Inhibition DME1096 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1096 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02757 XEO_CLAS Peptide DME1096 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1 microM) DME1096 XEOTICID XEO02757 GENEFORM Protein DME1096 XEOTICID XEO02757 MOACRIVE Inhibition DME1096 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1096 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02758 XEO_CLAS Peptide DME1096 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO02758 GENEFORM Protein DME1096 XEOTICID XEO02758 MOACRIVE Inhibition DME1096 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1096 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02759 XEO_CLAS Peptide DME1096 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.6 microM) DME1096 XEOTICID XEO02759 GENEFORM Protein DME1096 XEOTICID XEO02759 MOACRIVE Inhibition DME1096 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1096 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02760 XEO_CLAS Peptide DME1096 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 microM) DME1096 XEOTICID XEO02760 GENEFORM Protein DME1096 XEOTICID XEO02760 MOACRIVE Inhibition DME1096 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1096 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02761 XEO_CLAS Peptide DME1096 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO02761 GENEFORM Protein DME1096 XEOTICID XEO02761 MOACRIVE Inhibition DME1096 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1096 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02762 XEO_CLAS Peptide DME1096 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 microM) DME1096 XEOTICID XEO02762 GENEFORM Protein DME1096 XEOTICID XEO02762 MOACRIVE Inhibition DME1096 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1096 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02763 XEO_CLAS Peptide DME1096 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.4 microM) DME1096 XEOTICID XEO02763 GENEFORM Protein DME1096 XEOTICID XEO02763 MOACRIVE Inhibition DME1096 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1096 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02764 XEO_CLAS Peptide DME1096 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 microM) DME1096 XEOTICID XEO02764 GENEFORM Protein DME1096 XEOTICID XEO02764 MOACRIVE Inhibition DME1096 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1096 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02765 XEO_CLAS Peptide DME1096 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.3 microM) DME1096 XEOTICID XEO02765 GENEFORM Protein DME1096 XEOTICID XEO02765 MOACRIVE Inhibition DME1096 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1096 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02767 XEO_CLAS Peptide DME1096 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02767 GENEFORM Protein DME1096 XEOTICID XEO02767 MOACRIVE Inhibition DME1096 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1096 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02768 XEO_CLAS Peptide DME1096 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1096 XEOTICID XEO02768 GENEFORM Protein DME1096 XEOTICID XEO02768 MOACRIVE Inhibition DME1096 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1096 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02769 XEO_CLAS Peptide DME1096 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.32 microM) DME1096 XEOTICID XEO02769 GENEFORM Protein DME1096 XEOTICID XEO02769 MOACRIVE Inhibition DME1096 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1096 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02770 XEO_CLAS Peptide DME1096 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.30 microM) DME1096 XEOTICID XEO02770 GENEFORM Protein DME1096 XEOTICID XEO02770 MOACRIVE Inhibition DME1096 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1096 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02771 XEO_CLAS Peptide DME1096 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.21 microM) DME1096 XEOTICID XEO02771 GENEFORM Protein DME1096 XEOTICID XEO02771 MOACRIVE Inhibition DME1096 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1096 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02772 XEO_CLAS Peptide DME1096 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02772 GENEFORM Protein DME1096 XEOTICID XEO02772 MOACRIVE Inhibition DME1096 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1096 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02773 XEO_CLAS Peptide DME1096 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.9-8.6 microM) DME1096 XEOTICID XEO02773 GENEFORM Protein DME1096 XEOTICID XEO02773 MOACRIVE Inhibition DME1096 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1096 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02774 XEO_CLAS Peptide DME1096 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.3 microM) DME1096 XEOTICID XEO02774 GENEFORM Protein DME1096 XEOTICID XEO02774 MOACRIVE Inhibition DME1096 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1096 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02789 GENEFORM Protein DME1096 XEOTICID XEO02789 MOACRIVE Inhibition DME1096 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1096 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02790 GENEFORM Protein DME1096 XEOTICID XEO02790 MOACRIVE Inhibition DME1096 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1096 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02791 GENEFORM Protein DME1096 XEOTICID XEO02791 MOACRIVE Inhibition DME1096 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1096 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02792 GENEFORM Protein DME1096 XEOTICID XEO02792 MOACRIVE Inhibition DME1096 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1096 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02793 GENEFORM Protein DME1096 XEOTICID XEO02793 MOACRIVE Inhibition DME1096 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1096 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02794 GENEFORM Protein DME1096 XEOTICID XEO02794 MOACRIVE Inhibition DME1096 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1096 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02795 GENEFORM Protein DME1096 XEOTICID XEO02795 MOACRIVE Inhibition DME1096 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1096 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02796 GENEFORM Protein DME1096 XEOTICID XEO02796 MOACRIVE Inhibition DME1096 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1096 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02797 GENEFORM Protein DME1096 XEOTICID XEO02797 MOACRIVE Inhibition DME1096 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1096 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02799 XEO_CLAS Peptide DME1096 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02799 GENEFORM Protein DME1096 XEOTICID XEO02799 MOACRIVE Inhibition DME1096 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1096 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02800 XEO_CLAS Peptide DME1096 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02800 GENEFORM Protein DME1096 XEOTICID XEO02800 MOACRIVE Inhibition DME1096 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1096 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02802 XEO_CLAS Peptide DME1096 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 13.6 microM) DME1096 XEOTICID XEO02802 GENEFORM Protein DME1096 XEOTICID XEO02802 MOACRIVE Inhibition DME1096 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1096 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02807 XEO_CLAS Peptide DME1096 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.2 microM) DME1096 XEOTICID XEO02807 GENEFORM Protein DME1096 XEOTICID XEO02807 MOACRIVE Inhibition DME1096 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1096 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02813 XEO_CLAS Peptide DME1096 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 80 microM) DME1096 XEOTICID XEO02813 GENEFORM Protein DME1096 XEOTICID XEO02813 MOACRIVE Inhibition DME1096 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1096 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02814 XEO_CLAS Peptide DME1096 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 80 microM) DME1096 XEOTICID XEO02814 GENEFORM Protein DME1096 XEOTICID XEO02814 MOACRIVE Inhibition DME1096 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1096 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02815 XEO_CLAS Peptide DME1096 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8.5 microM) DME1096 XEOTICID XEO02815 GENEFORM Protein DME1096 XEOTICID XEO02815 MOACRIVE Inhibition DME1096 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1096 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02816 XEO_CLAS Peptide DME1096 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 80 microM) DME1096 XEOTICID XEO02816 GENEFORM Protein DME1096 XEOTICID XEO02816 MOACRIVE Inhibition DME1096 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1096 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02817 XEO_CLAS Peptide DME1096 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 80 microM) DME1096 XEOTICID XEO02817 GENEFORM Protein DME1096 XEOTICID XEO02817 MOACRIVE Inhibition DME1096 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1096 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02818 XEO_CLAS Peptide DME1096 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.4 microM) DME1096 XEOTICID XEO02818 GENEFORM Protein DME1096 XEOTICID XEO02818 MOACRIVE Inhibition DME1096 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1096 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02819 XEO_CLAS Peptide DME1096 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.6 microM) DME1096 XEOTICID XEO02819 GENEFORM Protein DME1096 XEOTICID XEO02819 MOACRIVE Inhibition DME1096 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1096 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02820 XEO_CLAS Peptide DME1096 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO02820 GENEFORM Protein DME1096 XEOTICID XEO02820 MOACRIVE Inhibition DME1096 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1096 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02821 XEO_CLAS Peptide DME1096 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02821 GENEFORM Protein DME1096 XEOTICID XEO02821 MOACRIVE Inhibition DME1096 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1096 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02824 XEO_CLAS Peptide DME1096 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 35 microM) DME1096 XEOTICID XEO02824 GENEFORM Protein DME1096 XEOTICID XEO02824 MOACRIVE Inhibition DME1096 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1096 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02826 XEO_CLAS Peptide DME1096 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.7 ug/ml) DME1096 XEOTICID XEO02826 GENEFORM Protein DME1096 XEOTICID XEO02826 MOACRIVE Inhibition DME1096 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1096 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02834 GENEFORM Protein DME1096 XEOTICID XEO02834 MOACRIVE Inhibition DME1096 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1096 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02839 XEO_CLAS Peptide DME1096 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.25 microM) DME1096 XEOTICID XEO02839 GENEFORM Protein DME1096 XEOTICID XEO02839 MOACRIVE Inhibition DME1096 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1096 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02841 XEO_CLAS Peptide DME1096 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.25 microM) DME1096 XEOTICID XEO02841 GENEFORM Protein DME1096 XEOTICID XEO02841 MOACRIVE Inhibition DME1096 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1096 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02842 XEO_CLAS Peptide DME1096 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.25 microM) DME1096 XEOTICID XEO02842 GENEFORM Protein DME1096 XEOTICID XEO02842 MOACRIVE Inhibition DME1096 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1096 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02843 XEO_CLAS Peptide DME1096 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02843 GENEFORM Protein DME1096 XEOTICID XEO02843 MOACRIVE Inhibition DME1096 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1096 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02849 GENEFORM Protein DME1096 XEOTICID XEO02849 MOACRIVE Inhibition DME1096 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1096 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02857 XEO_CLAS Peptide DME1096 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 53 microM) DME1096 XEOTICID XEO02857 GENEFORM Protein DME1096 XEOTICID XEO02857 MOACRIVE Inhibition DME1096 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1096 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02858 XEO_CLAS Peptide DME1096 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 53 microM) DME1096 XEOTICID XEO02858 GENEFORM Protein DME1096 XEOTICID XEO02858 MOACRIVE Inhibition DME1096 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1096 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02860 XEO_CLAS Peptide DME1096 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 ug/ml) DME1096 XEOTICID XEO02860 GENEFORM Protein DME1096 XEOTICID XEO02860 MOACRIVE Inhibition DME1096 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1096 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02867 XEO_CLAS Peptide DME1096 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02867 GENEFORM Protein DME1096 XEOTICID XEO02867 MOACRIVE Inhibition DME1096 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1096 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02868 XEO_CLAS Peptide DME1096 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02868 GENEFORM Protein DME1096 XEOTICID XEO02868 MOACRIVE Inhibition DME1096 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1096 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02869 XEO_CLAS Peptide DME1096 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02869 GENEFORM Protein DME1096 XEOTICID XEO02869 MOACRIVE Inhibition DME1096 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1096 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02870 XEO_CLAS Peptide DME1096 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02870 GENEFORM Protein DME1096 XEOTICID XEO02870 MOACRIVE Inhibition DME1096 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1096 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02871 XEO_CLAS Peptide DME1096 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02871 GENEFORM Protein DME1096 XEOTICID XEO02871 MOACRIVE Inhibition DME1096 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1096 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02872 XEO_CLAS Peptide DME1096 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 308 microM) DME1096 XEOTICID XEO02872 GENEFORM Protein DME1096 XEOTICID XEO02872 MOACRIVE Inhibition DME1096 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1096 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02875 XEO_CLAS Peptide DME1096 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.1 microM) DME1096 XEOTICID XEO02875 GENEFORM Protein DME1096 XEOTICID XEO02875 MOACRIVE Inhibition DME1096 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1096 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02876 XEO_CLAS Peptide DME1096 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO02876 GENEFORM Protein DME1096 XEOTICID XEO02876 MOACRIVE Inhibition DME1096 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1096 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02877 XEO_CLAS Peptide DME1096 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO02877 GENEFORM Protein DME1096 XEOTICID XEO02877 MOACRIVE Inhibition DME1096 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1096 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02878 XEO_CLAS Peptide DME1096 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.3 microM) DME1096 XEOTICID XEO02878 GENEFORM Protein DME1096 XEOTICID XEO02878 MOACRIVE Inhibition DME1096 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1096 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02885 XEO_CLAS Peptide DME1096 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02885 GENEFORM Protein DME1096 XEOTICID XEO02885 MOACRIVE Inhibition DME1096 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1096 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02886 XEO_CLAS Peptide DME1096 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02886 GENEFORM Protein DME1096 XEOTICID XEO02886 MOACRIVE Inhibition DME1096 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1096 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02887 XEO_CLAS Peptide DME1096 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1 ug/ml) DME1096 XEOTICID XEO02887 GENEFORM Protein DME1096 XEOTICID XEO02887 MOACRIVE Inhibition DME1096 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1096 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02888 XEO_CLAS Peptide DME1096 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 ug/ml) DME1096 XEOTICID XEO02888 GENEFORM Protein DME1096 XEOTICID XEO02888 MOACRIVE Inhibition DME1096 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1096 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02889 XEO_CLAS Peptide DME1096 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 ug/ml) DME1096 XEOTICID XEO02889 GENEFORM Protein DME1096 XEOTICID XEO02889 MOACRIVE Inhibition DME1096 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1096 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02890 XEO_CLAS Peptide DME1096 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02890 GENEFORM Protein DME1096 XEOTICID XEO02890 MOACRIVE Inhibition DME1096 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1096 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02891 XEO_CLAS Peptide DME1096 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02891 GENEFORM Protein DME1096 XEOTICID XEO02891 MOACRIVE Inhibition DME1096 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1096 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02895 XEO_CLAS Peptide DME1096 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO02895 GENEFORM Protein DME1096 XEOTICID XEO02895 MOACRIVE Inhibition DME1096 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1096 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02896 XEO_CLAS Peptide DME1096 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO02896 GENEFORM Protein DME1096 XEOTICID XEO02896 MOACRIVE Inhibition DME1096 XEOTICID XEO02899 XEO_NAME Coladonin DME1096 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1096 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1096 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02899 GENEFORM Protein DME1096 XEOTICID XEO02899 MOACRIVE Inhibition DME1096 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1096 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02900 XEO_CLAS Peptide DME1096 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02900 GENEFORM Protein DME1096 XEOTICID XEO02900 MOACRIVE Inhibition DME1096 XEOTICID XEO02901 XEO_NAME Colicin-V DME1096 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02901 XEO_CLAS Peptide DME1096 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02901 GENEFORM Protein DME1096 XEOTICID XEO02901 MOACRIVE Inhibition DME1096 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1096 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02904 GENEFORM Protein DME1096 XEOTICID XEO02904 MOACRIVE Inhibition DME1096 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1096 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02908 XEO_CLAS Peptide DME1096 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 50 microM) DME1096 XEOTICID XEO02908 GENEFORM Protein DME1096 XEOTICID XEO02908 MOACRIVE Inhibition DME1096 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1096 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02923 XEO_CLAS Peptide DME1096 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02923 GENEFORM Protein DME1096 XEOTICID XEO02923 MOACRIVE Inhibition DME1096 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1096 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02924 XEO_CLAS Peptide DME1096 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 32 microM) DME1096 XEOTICID XEO02924 GENEFORM Protein DME1096 XEOTICID XEO02924 MOACRIVE Inhibition DME1096 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1096 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1096 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02927 GENEFORM Protein DME1096 XEOTICID XEO02927 MOACRIVE Inhibition DME1096 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1096 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02931 XEO_CLAS Peptide DME1096 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 ug/ml) DME1096 XEOTICID XEO02931 GENEFORM Protein DME1096 XEOTICID XEO02931 MOACRIVE Inhibition DME1096 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1096 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02933 XEO_CLAS Peptide DME1096 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO02933 GENEFORM Protein DME1096 XEOTICID XEO02933 MOACRIVE Inhibition DME1096 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1096 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02934 XEO_CLAS Peptide DME1096 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02934 GENEFORM Protein DME1096 XEOTICID XEO02934 MOACRIVE Inhibition DME1096 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1096 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02935 XEO_CLAS Peptide DME1096 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02935 GENEFORM Protein DME1096 XEOTICID XEO02935 MOACRIVE Inhibition DME1096 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1096 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02936 XEO_CLAS Peptide DME1096 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO02936 GENEFORM Protein DME1096 XEOTICID XEO02936 MOACRIVE Inhibition DME1096 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1096 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02937 XEO_CLAS Peptide DME1096 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02937 GENEFORM Protein DME1096 XEOTICID XEO02937 MOACRIVE Inhibition DME1096 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1096 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02938 XEO_CLAS Peptide DME1096 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 32 ug/ml) DME1096 XEOTICID XEO02938 GENEFORM Protein DME1096 XEOTICID XEO02938 MOACRIVE Inhibition DME1096 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1096 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02939 XEO_CLAS Peptide DME1096 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 11 ug/ml) DME1096 XEOTICID XEO02939 GENEFORM Protein DME1096 XEOTICID XEO02939 MOACRIVE Inhibition DME1096 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1096 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02940 XEO_CLAS Peptide DME1096 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1 ug/ml) DME1096 XEOTICID XEO02940 GENEFORM Protein DME1096 XEOTICID XEO02940 MOACRIVE Inhibition DME1096 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1096 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02941 XEO_CLAS Peptide DME1096 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02941 GENEFORM Protein DME1096 XEOTICID XEO02941 MOACRIVE Inhibition DME1096 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1096 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02944 XEO_CLAS Peptide DME1096 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 microM) DME1096 XEOTICID XEO02944 GENEFORM Protein DME1096 XEOTICID XEO02944 MOACRIVE Inhibition DME1096 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1096 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02945 XEO_CLAS Peptide DME1096 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 microM) DME1096 XEOTICID XEO02945 GENEFORM Protein DME1096 XEOTICID XEO02945 MOACRIVE Inhibition DME1096 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1096 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02946 XEO_CLAS Peptide DME1096 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 microM) DME1096 XEOTICID XEO02946 GENEFORM Protein DME1096 XEOTICID XEO02946 MOACRIVE Inhibition DME1096 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1096 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02947 XEO_CLAS Peptide DME1096 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02947 GENEFORM Protein DME1096 XEOTICID XEO02947 MOACRIVE Inhibition DME1096 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1096 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02948 XEO_CLAS Peptide DME1096 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO02948 GENEFORM Protein DME1096 XEOTICID XEO02948 MOACRIVE Inhibition DME1096 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1096 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02949 XEO_CLAS Peptide DME1096 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO02949 GENEFORM Protein DME1096 XEOTICID XEO02949 MOACRIVE Inhibition DME1096 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1096 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02954 XEO_CLAS Peptide DME1096 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02954 GENEFORM Protein DME1096 XEOTICID XEO02954 MOACRIVE Inhibition DME1096 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1096 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02958 XEO_CLAS Peptide DME1096 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02958 GENEFORM Protein DME1096 XEOTICID XEO02958 MOACRIVE Inhibition DME1096 XEOTICID XEO02962 XEO_NAME Cryptonin DME1096 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02962 XEO_CLAS Peptide DME1096 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.12 ug/ml) DME1096 XEOTICID XEO02962 GENEFORM Protein DME1096 XEOTICID XEO02962 MOACRIVE Inhibition DME1096 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1096 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02965 XEO_CLAS Peptide DME1096 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 ug/ml) DME1096 XEOTICID XEO02965 GENEFORM Protein DME1096 XEOTICID XEO02965 MOACRIVE Inhibition DME1096 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1096 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02969 XEO_CLAS Peptide DME1096 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 microM) DME1096 XEOTICID XEO02969 GENEFORM Protein DME1096 XEOTICID XEO02969 MOACRIVE Inhibition DME1096 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1096 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02971 XEO_CLAS Peptide DME1096 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 microM) DME1096 XEOTICID XEO02971 GENEFORM Protein DME1096 XEOTICID XEO02971 MOACRIVE Inhibition DME1096 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1096 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO02972 XEO_CLAS Peptide DME1096 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.4 microM) DME1096 XEOTICID XEO02972 GENEFORM Protein DME1096 XEOTICID XEO02972 MOACRIVE Inhibition DME1096 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1096 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02990 GENEFORM Protein DME1096 XEOTICID XEO02990 MOACRIVE Inhibition DME1096 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1096 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02991 GENEFORM Protein DME1096 XEOTICID XEO02991 MOACRIVE Inhibition DME1096 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1096 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02992 GENEFORM Protein DME1096 XEOTICID XEO02992 MOACRIVE Inhibition DME1096 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1096 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02993 GENEFORM Protein DME1096 XEOTICID XEO02993 MOACRIVE Inhibition DME1096 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1096 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02994 GENEFORM Protein DME1096 XEOTICID XEO02994 MOACRIVE Inhibition DME1096 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1096 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02995 GENEFORM Protein DME1096 XEOTICID XEO02995 MOACRIVE Inhibition DME1096 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1096 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02996 GENEFORM Protein DME1096 XEOTICID XEO02996 MOACRIVE Inhibition DME1096 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1096 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02997 GENEFORM Protein DME1096 XEOTICID XEO02997 MOACRIVE Inhibition DME1096 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1096 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02998 GENEFORM Protein DME1096 XEOTICID XEO02998 MOACRIVE Inhibition DME1096 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1096 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1096 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO02999 GENEFORM Protein DME1096 XEOTICID XEO02999 MOACRIVE Inhibition DME1096 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1096 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03021 XEO_CLAS Peptide DME1096 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.31-0.63 microM) DME1096 XEOTICID XEO03021 GENEFORM Protein DME1096 XEOTICID XEO03021 MOACRIVE Inhibition DME1096 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1096 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03029 XEO_CLAS Peptide DME1096 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.005 microM) DME1096 XEOTICID XEO03029 GENEFORM Protein DME1096 XEOTICID XEO03029 MOACRIVE Inhibition DME1096 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1096 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03030 XEO_CLAS Peptide DME1096 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.005 microM) DME1096 XEOTICID XEO03030 GENEFORM Protein DME1096 XEOTICID XEO03030 MOACRIVE Inhibition DME1096 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1096 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03031 XEO_CLAS Peptide DME1096 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.3 microM) DME1096 XEOTICID XEO03031 GENEFORM Protein DME1096 XEOTICID XEO03031 MOACRIVE Inhibition DME1096 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1096 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03032 XEO_CLAS Peptide DME1096 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.01 microM) DME1096 XEOTICID XEO03032 GENEFORM Protein DME1096 XEOTICID XEO03032 MOACRIVE Inhibition DME1096 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1096 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03033 XEO_CLAS Peptide DME1096 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.173 microM) DME1096 XEOTICID XEO03033 GENEFORM Protein DME1096 XEOTICID XEO03033 MOACRIVE Inhibition DME1096 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1096 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03034 XEO_CLAS Peptide DME1096 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.518 microM) DME1096 XEOTICID XEO03034 GENEFORM Protein DME1096 XEOTICID XEO03034 MOACRIVE Inhibition DME1096 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1096 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03035 XEO_CLAS Peptide DME1096 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.114 microM) DME1096 XEOTICID XEO03035 GENEFORM Protein DME1096 XEOTICID XEO03035 MOACRIVE Inhibition DME1096 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1096 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03039 XEO_CLAS Peptide DME1096 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.55 microM) DME1096 XEOTICID XEO03039 GENEFORM Protein DME1096 XEOTICID XEO03039 MOACRIVE Inhibition DME1096 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1096 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03043 XEO_CLAS Peptide DME1096 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 microM) DME1096 XEOTICID XEO03043 GENEFORM Protein DME1096 XEOTICID XEO03043 MOACRIVE Inhibition DME1096 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1096 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03044 XEO_CLAS Peptide DME1096 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03044 GENEFORM Protein DME1096 XEOTICID XEO03044 MOACRIVE Inhibition DME1096 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1096 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03045 XEO_CLAS Peptide DME1096 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03045 GENEFORM Protein DME1096 XEOTICID XEO03045 MOACRIVE Inhibition DME1096 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1096 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03046 XEO_CLAS Peptide DME1096 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03046 GENEFORM Protein DME1096 XEOTICID XEO03046 MOACRIVE Inhibition DME1096 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1096 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03049 XEO_CLAS Peptide DME1096 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 microM) DME1096 XEOTICID XEO03049 GENEFORM Protein DME1096 XEOTICID XEO03049 MOACRIVE Inhibition DME1096 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1096 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03055 XEO_CLAS Peptide DME1096 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 microM) DME1096 XEOTICID XEO03055 GENEFORM Protein DME1096 XEOTICID XEO03055 MOACRIVE Inhibition DME1096 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1096 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03059 XEO_CLAS Peptide DME1096 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO03059 GENEFORM Protein DME1096 XEOTICID XEO03059 MOACRIVE Inhibition DME1096 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1096 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03060 XEO_CLAS Peptide DME1096 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO03060 GENEFORM Protein DME1096 XEOTICID XEO03060 MOACRIVE Inhibition DME1096 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1096 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03062 XEO_CLAS Peptide DME1096 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO03062 GENEFORM Protein DME1096 XEOTICID XEO03062 MOACRIVE Inhibition DME1096 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1096 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03064 XEO_CLAS Peptide DME1096 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO03064 GENEFORM Protein DME1096 XEOTICID XEO03064 MOACRIVE Inhibition DME1096 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1096 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03066 XEO_CLAS Peptide DME1096 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO03066 GENEFORM Protein DME1096 XEOTICID XEO03066 MOACRIVE Inhibition DME1096 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1096 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03068 XEO_CLAS Peptide DME1096 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO03068 GENEFORM Protein DME1096 XEOTICID XEO03068 MOACRIVE Inhibition DME1096 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1096 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03073 XEO_CLAS Peptide DME1096 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8-16 ug/ml) DME1096 XEOTICID XEO03073 GENEFORM Protein DME1096 XEOTICID XEO03073 MOACRIVE Inhibition DME1096 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1096 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03081 XEO_CLAS Peptide DME1096 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 microM) DME1096 XEOTICID XEO03081 GENEFORM Protein DME1096 XEOTICID XEO03081 MOACRIVE Inhibition DME1096 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1096 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03082 XEO_CLAS Peptide DME1096 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03082 GENEFORM Protein DME1096 XEOTICID XEO03082 MOACRIVE Inhibition DME1096 XEOTICID XEO03089 XEO_NAME Decoralin DME1096 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03089 XEO_CLAS Peptide DME1096 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 160 microM) DME1096 XEOTICID XEO03089 GENEFORM Protein DME1096 XEOTICID XEO03089 MOACRIVE Inhibition DME1096 XEOTICID XEO03098 XEO_NAME Insect defensin DME1096 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03098 XEO_CLAS Peptide DME1096 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 ug/ml) DME1096 XEOTICID XEO03098 GENEFORM Protein DME1096 XEOTICID XEO03098 MOACRIVE Inhibition DME1096 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1096 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03100 XEO_CLAS Peptide DME1096 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03100 GENEFORM Protein DME1096 XEOTICID XEO03100 MOACRIVE Inhibition DME1096 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1096 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03103 XEO_CLAS Peptide DME1096 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03103 GENEFORM Protein DME1096 XEOTICID XEO03103 MOACRIVE Inhibition DME1096 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1096 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03105 XEO_CLAS Peptide DME1096 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03105 GENEFORM Protein DME1096 XEOTICID XEO03105 MOACRIVE Inhibition DME1096 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1096 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03110 XEO_CLAS Peptide DME1096 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.2 microM) DME1096 XEOTICID XEO03110 GENEFORM Protein DME1096 XEOTICID XEO03110 MOACRIVE Inhibition DME1096 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1096 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03111 XEO_CLAS Peptide DME1096 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03111 GENEFORM Protein DME1096 XEOTICID XEO03111 MOACRIVE Inhibition DME1096 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1096 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03112 XEO_CLAS Peptide DME1096 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 50 ug/ml) DME1096 XEOTICID XEO03112 GENEFORM Protein DME1096 XEOTICID XEO03112 MOACRIVE Inhibition DME1096 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1096 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03115 XEO_CLAS Peptide DME1096 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03115 GENEFORM Protein DME1096 XEOTICID XEO03115 MOACRIVE Inhibition DME1096 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1096 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03116 XEO_CLAS Peptide DME1096 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 40 microM) DME1096 XEOTICID XEO03116 GENEFORM Protein DME1096 XEOTICID XEO03116 MOACRIVE Inhibition DME1096 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1096 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03118 XEO_CLAS Peptide DME1096 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03118 GENEFORM Protein DME1096 XEOTICID XEO03118 MOACRIVE Inhibition DME1096 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1096 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03119 XEO_CLAS Peptide DME1096 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03119 GENEFORM Protein DME1096 XEOTICID XEO03119 MOACRIVE Inhibition DME1096 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1096 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03121 XEO_CLAS Peptide DME1096 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03121 GENEFORM Protein DME1096 XEOTICID XEO03121 MOACRIVE Inhibition DME1096 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1096 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03122 XEO_CLAS Peptide DME1096 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64000 ug/ml) DME1096 XEOTICID XEO03122 GENEFORM Protein DME1096 XEOTICID XEO03122 MOACRIVE Inhibition DME1096 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1096 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03124 XEO_CLAS Peptide DME1096 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03124 GENEFORM Protein DME1096 XEOTICID XEO03124 MOACRIVE Inhibition DME1096 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1096 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03125 XEO_CLAS Peptide DME1096 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03125 GENEFORM Protein DME1096 XEOTICID XEO03125 MOACRIVE Inhibition DME1096 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1096 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03126 XEO_CLAS Peptide DME1096 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.86 microM) DME1096 XEOTICID XEO03126 GENEFORM Protein DME1096 XEOTICID XEO03126 MOACRIVE Inhibition DME1096 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1096 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03127 XEO_CLAS Peptide DME1096 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03127 GENEFORM Protein DME1096 XEOTICID XEO03127 MOACRIVE Inhibition DME1096 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1096 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03128 XEO_CLAS Peptide DME1096 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 256 ug/ml) DME1096 XEOTICID XEO03128 GENEFORM Protein DME1096 XEOTICID XEO03128 MOACRIVE Inhibition DME1096 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1096 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03129 XEO_CLAS Peptide DME1096 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 256 ug/ml) DME1096 XEOTICID XEO03129 GENEFORM Protein DME1096 XEOTICID XEO03129 MOACRIVE Inhibition DME1096 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1096 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03130 XEO_CLAS Peptide DME1096 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 256 ug/ml) DME1096 XEOTICID XEO03130 GENEFORM Protein DME1096 XEOTICID XEO03130 MOACRIVE Inhibition DME1096 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1096 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03131 XEO_CLAS Peptide DME1096 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 256 ug/ml) DME1096 XEOTICID XEO03131 GENEFORM Protein DME1096 XEOTICID XEO03131 MOACRIVE Inhibition DME1096 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1096 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03132 XEO_CLAS Peptide DME1096 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 256 ug/ml) DME1096 XEOTICID XEO03132 GENEFORM Protein DME1096 XEOTICID XEO03132 MOACRIVE Inhibition DME1096 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1096 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03137 XEO_CLAS Peptide DME1096 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03137 GENEFORM Protein DME1096 XEOTICID XEO03137 MOACRIVE Inhibition DME1096 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1096 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03143 XEO_CLAS Peptide DME1096 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.6 microM) DME1096 XEOTICID XEO03143 GENEFORM Protein DME1096 XEOTICID XEO03143 MOACRIVE Inhibition DME1096 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1096 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03145 XEO_CLAS Peptide DME1096 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.6 microM) DME1096 XEOTICID XEO03145 GENEFORM Protein DME1096 XEOTICID XEO03145 MOACRIVE Inhibition DME1096 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1096 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03146 XEO_CLAS Peptide DME1096 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.5 microM) DME1096 XEOTICID XEO03146 GENEFORM Protein DME1096 XEOTICID XEO03146 MOACRIVE Inhibition DME1096 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1096 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03147 XEO_CLAS Peptide DME1096 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 9.7 microM) DME1096 XEOTICID XEO03147 GENEFORM Protein DME1096 XEOTICID XEO03147 MOACRIVE Inhibition DME1096 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1096 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03148 XEO_CLAS Peptide DME1096 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.3 microM) DME1096 XEOTICID XEO03148 GENEFORM Protein DME1096 XEOTICID XEO03148 MOACRIVE Inhibition DME1096 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1096 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03149 XEO_CLAS Peptide DME1096 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.6 microM) DME1096 XEOTICID XEO03149 GENEFORM Protein DME1096 XEOTICID XEO03149 MOACRIVE Inhibition DME1096 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1096 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03150 XEO_CLAS Peptide DME1096 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 9-3 microM) DME1096 XEOTICID XEO03150 GENEFORM Protein DME1096 XEOTICID XEO03150 MOACRIVE Inhibition DME1096 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1096 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03151 XEO_CLAS Peptide DME1096 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 ug/ml) DME1096 XEOTICID XEO03151 GENEFORM Protein DME1096 XEOTICID XEO03151 MOACRIVE Inhibition DME1096 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1096 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03152 XEO_CLAS Peptide DME1096 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO03152 GENEFORM Protein DME1096 XEOTICID XEO03152 MOACRIVE Inhibition DME1096 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1096 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03155 XEO_CLAS Peptide DME1096 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.4 microM) DME1096 XEOTICID XEO03155 GENEFORM Protein DME1096 XEOTICID XEO03155 MOACRIVE Inhibition DME1096 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1096 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03156 XEO_CLAS Peptide DME1096 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.3 microM) DME1096 XEOTICID XEO03156 GENEFORM Protein DME1096 XEOTICID XEO03156 MOACRIVE Inhibition DME1096 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1096 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03157 XEO_CLAS Peptide DME1096 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.3 microM) DME1096 XEOTICID XEO03157 GENEFORM Protein DME1096 XEOTICID XEO03157 MOACRIVE Inhibition DME1096 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1096 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03158 XEO_CLAS Peptide DME1096 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 ug/ml) DME1096 XEOTICID XEO03158 GENEFORM Protein DME1096 XEOTICID XEO03158 MOACRIVE Inhibition DME1096 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1096 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03159 XEO_CLAS Peptide DME1096 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03159 GENEFORM Protein DME1096 XEOTICID XEO03159 MOACRIVE Inhibition DME1096 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1096 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03161 XEO_CLAS Peptide DME1096 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 microM) DME1096 XEOTICID XEO03161 GENEFORM Protein DME1096 XEOTICID XEO03161 MOACRIVE Inhibition DME1096 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1096 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03162 XEO_CLAS Peptide DME1096 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.5 microM) DME1096 XEOTICID XEO03162 GENEFORM Protein DME1096 XEOTICID XEO03162 MOACRIVE Inhibition DME1096 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1096 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03169 XEO_CLAS Peptide DME1096 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO03169 GENEFORM Protein DME1096 XEOTICID XEO03169 MOACRIVE Inhibition DME1096 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1096 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03193 XEO_CLAS Peptide DME1096 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25 ug/ml) DME1096 XEOTICID XEO03193 GENEFORM Protein DME1096 XEOTICID XEO03193 MOACRIVE Inhibition DME1096 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1096 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03194 XEO_CLAS Peptide DME1096 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03194 GENEFORM Protein DME1096 XEOTICID XEO03194 MOACRIVE Inhibition DME1096 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1096 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03195 XEO_CLAS Peptide DME1096 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03195 GENEFORM Protein DME1096 XEOTICID XEO03195 MOACRIVE Inhibition DME1096 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1096 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03197 XEO_CLAS Peptide DME1096 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 14.5 microM) DME1096 XEOTICID XEO03197 GENEFORM Protein DME1096 XEOTICID XEO03197 MOACRIVE Inhibition DME1096 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1096 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03202 XEO_CLAS Peptide DME1096 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.51 microM) DME1096 XEOTICID XEO03202 GENEFORM Protein DME1096 XEOTICID XEO03202 MOACRIVE Inhibition DME1096 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1096 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03203 XEO_CLAS Peptide DME1096 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.62 microM) DME1096 XEOTICID XEO03203 GENEFORM Protein DME1096 XEOTICID XEO03203 MOACRIVE Inhibition DME1096 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1096 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03204 XEO_CLAS Peptide DME1096 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.38 microM) DME1096 XEOTICID XEO03204 GENEFORM Protein DME1096 XEOTICID XEO03204 MOACRIVE Inhibition DME1096 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1096 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03205 XEO_CLAS Peptide DME1096 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.29 microM) DME1096 XEOTICID XEO03205 GENEFORM Protein DME1096 XEOTICID XEO03205 MOACRIVE Inhibition DME1096 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1096 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03206 XEO_CLAS Peptide DME1096 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.40 microM) DME1096 XEOTICID XEO03206 GENEFORM Protein DME1096 XEOTICID XEO03206 MOACRIVE Inhibition DME1096 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1096 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03207 XEO_CLAS Peptide DME1096 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.58 microM) DME1096 XEOTICID XEO03207 GENEFORM Protein DME1096 XEOTICID XEO03207 MOACRIVE Inhibition DME1096 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1096 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03208 XEO_CLAS Peptide DME1096 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.76 microM) DME1096 XEOTICID XEO03208 GENEFORM Protein DME1096 XEOTICID XEO03208 MOACRIVE Inhibition DME1096 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1096 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03209 XEO_CLAS Peptide DME1096 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.49 microM) DME1096 XEOTICID XEO03209 GENEFORM Protein DME1096 XEOTICID XEO03209 MOACRIVE Inhibition DME1096 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1096 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03210 XEO_CLAS Peptide DME1096 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 7.07 microM) DME1096 XEOTICID XEO03210 GENEFORM Protein DME1096 XEOTICID XEO03210 MOACRIVE Inhibition DME1096 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1096 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03211 XEO_CLAS Peptide DME1096 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.40 microM) DME1096 XEOTICID XEO03211 GENEFORM Protein DME1096 XEOTICID XEO03211 MOACRIVE Inhibition DME1096 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1096 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03215 XEO_CLAS Peptide DME1096 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20.0 ug/ml) DME1096 XEOTICID XEO03215 GENEFORM Protein DME1096 XEOTICID XEO03215 MOACRIVE Inhibition DME1096 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1096 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03216 XEO_CLAS Peptide DME1096 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO03216 GENEFORM Protein DME1096 XEOTICID XEO03216 MOACRIVE Inhibition DME1096 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1096 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03217 XEO_CLAS Peptide DME1096 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO03217 GENEFORM Protein DME1096 XEOTICID XEO03217 MOACRIVE Inhibition DME1096 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1096 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03223 XEO_CLAS Peptide DME1096 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.8 microM) DME1096 XEOTICID XEO03223 GENEFORM Protein DME1096 XEOTICID XEO03223 MOACRIVE Inhibition DME1096 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1096 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03224 XEO_CLAS Peptide DME1096 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.1-0.25 microM) DME1096 XEOTICID XEO03224 GENEFORM Protein DME1096 XEOTICID XEO03224 MOACRIVE Inhibition DME1096 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1096 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03225 XEO_CLAS Peptide DME1096 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.3 microM) DME1096 XEOTICID XEO03225 GENEFORM Protein DME1096 XEOTICID XEO03225 MOACRIVE Inhibition DME1096 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1096 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03227 XEO_CLAS Peptide DME1096 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.3 microM) DME1096 XEOTICID XEO03227 GENEFORM Protein DME1096 XEOTICID XEO03227 MOACRIVE Inhibition DME1096 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1096 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03231 XEO_CLAS Peptide DME1096 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03231 GENEFORM Protein DME1096 XEOTICID XEO03231 MOACRIVE Inhibition DME1096 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1096 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03232 XEO_CLAS Peptide DME1096 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03232 GENEFORM Protein DME1096 XEOTICID XEO03232 MOACRIVE Inhibition DME1096 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1096 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03234 XEO_CLAS Peptide DME1096 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO03234 GENEFORM Protein DME1096 XEOTICID XEO03234 MOACRIVE Inhibition DME1096 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1096 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03235 XEO_CLAS Peptide DME1096 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 60 ug/ml) DME1096 XEOTICID XEO03235 GENEFORM Protein DME1096 XEOTICID XEO03235 MOACRIVE Inhibition DME1096 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1096 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03236 XEO_CLAS Peptide DME1096 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO03236 GENEFORM Protein DME1096 XEOTICID XEO03236 MOACRIVE Inhibition DME1096 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1096 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03237 XEO_CLAS Peptide DME1096 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 ug/ml) DME1096 XEOTICID XEO03237 GENEFORM Protein DME1096 XEOTICID XEO03237 MOACRIVE Inhibition DME1096 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1096 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03238 XEO_CLAS Peptide DME1096 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 ug/ml) DME1096 XEOTICID XEO03238 GENEFORM Protein DME1096 XEOTICID XEO03238 MOACRIVE Inhibition DME1096 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1096 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03239 XEO_CLAS Peptide DME1096 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 60 ug/ml) DME1096 XEOTICID XEO03239 GENEFORM Protein DME1096 XEOTICID XEO03239 MOACRIVE Inhibition DME1096 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1096 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03241 XEO_CLAS Peptide DME1096 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 128 microM) DME1096 XEOTICID XEO03241 GENEFORM Protein DME1096 XEOTICID XEO03241 MOACRIVE Inhibition DME1096 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1096 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03250 XEO_CLAS Peptide DME1096 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03250 GENEFORM Protein DME1096 XEOTICID XEO03250 MOACRIVE Inhibition DME1096 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1096 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03251 XEO_CLAS Peptide DME1096 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03251 GENEFORM Protein DME1096 XEOTICID XEO03251 MOACRIVE Inhibition DME1096 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1096 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03253 XEO_CLAS Peptide DME1096 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.1 ug/ml) DME1096 XEOTICID XEO03253 GENEFORM Protein DME1096 XEOTICID XEO03253 MOACRIVE Inhibition DME1096 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1096 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03274 XEO_CLAS Peptide DME1096 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.2 microM) DME1096 XEOTICID XEO03274 GENEFORM Protein DME1096 XEOTICID XEO03274 MOACRIVE Inhibition DME1096 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1096 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03275 XEO_CLAS Peptide DME1096 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO03275 GENEFORM Protein DME1096 XEOTICID XEO03275 MOACRIVE Inhibition DME1096 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1096 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03276 XEO_CLAS Peptide DME1096 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO03276 GENEFORM Protein DME1096 XEOTICID XEO03276 MOACRIVE Inhibition DME1096 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1096 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03277 XEO_CLAS Peptide DME1096 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.2 microM) DME1096 XEOTICID XEO03277 GENEFORM Protein DME1096 XEOTICID XEO03277 MOACRIVE Inhibition DME1096 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1096 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03278 XEO_CLAS Peptide DME1096 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO03278 GENEFORM Protein DME1096 XEOTICID XEO03278 MOACRIVE Inhibition DME1096 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1096 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03279 XEO_CLAS Peptide DME1096 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO03279 GENEFORM Protein DME1096 XEOTICID XEO03279 MOACRIVE Inhibition DME1096 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1096 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03280 XEO_CLAS Peptide DME1096 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 microM) DME1096 XEOTICID XEO03280 GENEFORM Protein DME1096 XEOTICID XEO03280 MOACRIVE Inhibition DME1096 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1096 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03281 XEO_CLAS Peptide DME1096 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.3 microM) DME1096 XEOTICID XEO03281 GENEFORM Protein DME1096 XEOTICID XEO03281 MOACRIVE Inhibition DME1096 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1096 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03282 XEO_CLAS Peptide DME1096 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.1 microM) DME1096 XEOTICID XEO03282 GENEFORM Protein DME1096 XEOTICID XEO03282 MOACRIVE Inhibition DME1096 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1096 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03283 XEO_CLAS Peptide DME1096 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 microM) DME1096 XEOTICID XEO03283 GENEFORM Protein DME1096 XEOTICID XEO03283 MOACRIVE Inhibition DME1096 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1096 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03284 XEO_CLAS Peptide DME1096 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.2 ug/ml) DME1096 XEOTICID XEO03284 GENEFORM Protein DME1096 XEOTICID XEO03284 MOACRIVE Inhibition DME1096 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1096 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03285 XEO_CLAS Peptide DME1096 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.5 ug/ml) DME1096 XEOTICID XEO03285 GENEFORM Protein DME1096 XEOTICID XEO03285 MOACRIVE Inhibition DME1096 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1096 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03286 XEO_CLAS Peptide DME1096 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.4 ug/ml) DME1096 XEOTICID XEO03286 GENEFORM Protein DME1096 XEOTICID XEO03286 MOACRIVE Inhibition DME1096 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1096 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03287 XEO_CLAS Peptide DME1096 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.6 ug/ml) DME1096 XEOTICID XEO03287 GENEFORM Protein DME1096 XEOTICID XEO03287 MOACRIVE Inhibition DME1096 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1096 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03288 XEO_CLAS Peptide DME1096 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.4 ug/ml) DME1096 XEOTICID XEO03288 GENEFORM Protein DME1096 XEOTICID XEO03288 MOACRIVE Inhibition DME1096 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1096 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03289 XEO_CLAS Peptide DME1096 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8.8 ug/ml) DME1096 XEOTICID XEO03289 GENEFORM Protein DME1096 XEOTICID XEO03289 MOACRIVE Inhibition DME1096 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1096 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03290 XEO_CLAS Peptide DME1096 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.5 ug/ml) DME1096 XEOTICID XEO03290 GENEFORM Protein DME1096 XEOTICID XEO03290 MOACRIVE Inhibition DME1096 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1096 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03291 XEO_CLAS Peptide DME1096 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8.6 ug/ml) DME1096 XEOTICID XEO03291 GENEFORM Protein DME1096 XEOTICID XEO03291 MOACRIVE Inhibition DME1096 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1096 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03292 XEO_CLAS Peptide DME1096 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4.1 ug/ml) DME1096 XEOTICID XEO03292 GENEFORM Protein DME1096 XEOTICID XEO03292 MOACRIVE Inhibition DME1096 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1096 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03293 XEO_CLAS Peptide DME1096 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1 microM) DME1096 XEOTICID XEO03293 GENEFORM Protein DME1096 XEOTICID XEO03293 MOACRIVE Inhibition DME1096 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1096 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03294 XEO_CLAS Peptide DME1096 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1 microM) DME1096 XEOTICID XEO03294 GENEFORM Protein DME1096 XEOTICID XEO03294 MOACRIVE Inhibition DME1096 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1096 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03295 XEO_CLAS Peptide DME1096 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.7 microM) DME1096 XEOTICID XEO03295 GENEFORM Protein DME1096 XEOTICID XEO03295 MOACRIVE Inhibition DME1096 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1096 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03296 XEO_CLAS Peptide DME1096 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03296 GENEFORM Protein DME1096 XEOTICID XEO03296 MOACRIVE Inhibition DME1096 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1096 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03297 XEO_CLAS Peptide DME1096 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03297 GENEFORM Protein DME1096 XEOTICID XEO03297 MOACRIVE Inhibition DME1096 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1096 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03298 XEO_CLAS Peptide DME1096 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.2 microM) DME1096 XEOTICID XEO03298 GENEFORM Protein DME1096 XEOTICID XEO03298 MOACRIVE Inhibition DME1096 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1096 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03299 XEO_CLAS Peptide DME1096 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.4 microM) DME1096 XEOTICID XEO03299 GENEFORM Protein DME1096 XEOTICID XEO03299 MOACRIVE Inhibition DME1096 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1096 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03300 XEO_CLAS Peptide DME1096 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 ug/ml) DME1096 XEOTICID XEO03300 GENEFORM Protein DME1096 XEOTICID XEO03300 MOACRIVE Inhibition DME1096 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1096 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03301 XEO_CLAS Peptide DME1096 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 ug/ml) DME1096 XEOTICID XEO03301 GENEFORM Protein DME1096 XEOTICID XEO03301 MOACRIVE Inhibition DME1096 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1096 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03302 XEO_CLAS Peptide DME1096 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1 microM) DME1096 XEOTICID XEO03302 GENEFORM Protein DME1096 XEOTICID XEO03302 MOACRIVE Inhibition DME1096 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1096 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03303 XEO_CLAS Peptide DME1096 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 microM) DME1096 XEOTICID XEO03303 GENEFORM Protein DME1096 XEOTICID XEO03303 MOACRIVE Inhibition DME1096 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1096 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03304 XEO_CLAS Peptide DME1096 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO03304 GENEFORM Protein DME1096 XEOTICID XEO03304 MOACRIVE Inhibition DME1096 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1096 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03305 XEO_CLAS Peptide DME1096 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 microM) DME1096 XEOTICID XEO03305 GENEFORM Protein DME1096 XEOTICID XEO03305 MOACRIVE Inhibition DME1096 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1096 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03306 XEO_CLAS Peptide DME1096 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO03306 GENEFORM Protein DME1096 XEOTICID XEO03306 MOACRIVE Inhibition DME1096 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1096 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03307 XEO_CLAS Peptide DME1096 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 34 ug/ml) DME1096 XEOTICID XEO03307 GENEFORM Protein DME1096 XEOTICID XEO03307 MOACRIVE Inhibition DME1096 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1096 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03308 XEO_CLAS Peptide DME1096 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO03308 GENEFORM Protein DME1096 XEOTICID XEO03308 MOACRIVE Inhibition DME1096 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1096 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03310 XEO_CLAS Peptide DME1096 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8.5 ug/ml) DME1096 XEOTICID XEO03310 GENEFORM Protein DME1096 XEOTICID XEO03310 MOACRIVE Inhibition DME1096 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1096 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03311 XEO_CLAS Peptide DME1096 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10.8 ug/ml) DME1096 XEOTICID XEO03311 GENEFORM Protein DME1096 XEOTICID XEO03311 MOACRIVE Inhibition DME1096 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1096 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03312 XEO_CLAS Peptide DME1096 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10.8 ug/ml) DME1096 XEOTICID XEO03312 GENEFORM Protein DME1096 XEOTICID XEO03312 MOACRIVE Inhibition DME1096 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1096 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03313 XEO_CLAS Peptide DME1096 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8.1 ug/ml) DME1096 XEOTICID XEO03313 GENEFORM Protein DME1096 XEOTICID XEO03313 MOACRIVE Inhibition DME1096 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1096 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03314 XEO_CLAS Peptide DME1096 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 7.9 ug/ml) DME1096 XEOTICID XEO03314 GENEFORM Protein DME1096 XEOTICID XEO03314 MOACRIVE Inhibition DME1096 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1096 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03315 XEO_CLAS Peptide DME1096 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.6 ug/ml) DME1096 XEOTICID XEO03315 GENEFORM Protein DME1096 XEOTICID XEO03315 MOACRIVE Inhibition DME1096 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1096 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03316 XEO_CLAS Peptide DME1096 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15.8 ug/ml) DME1096 XEOTICID XEO03316 GENEFORM Protein DME1096 XEOTICID XEO03316 MOACRIVE Inhibition DME1096 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1096 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03317 XEO_CLAS Peptide DME1096 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO03317 GENEFORM Protein DME1096 XEOTICID XEO03317 MOACRIVE Inhibition DME1096 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1096 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03318 XEO_CLAS Peptide DME1096 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1 microM) DME1096 XEOTICID XEO03318 GENEFORM Protein DME1096 XEOTICID XEO03318 MOACRIVE Inhibition DME1096 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1096 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03319 XEO_CLAS Peptide DME1096 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03319 GENEFORM Protein DME1096 XEOTICID XEO03319 MOACRIVE Inhibition DME1096 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1096 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03320 XEO_CLAS Peptide DME1096 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.1 microM) DME1096 XEOTICID XEO03320 GENEFORM Protein DME1096 XEOTICID XEO03320 MOACRIVE Inhibition DME1096 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1096 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03321 XEO_CLAS Peptide DME1096 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.8 microM) DME1096 XEOTICID XEO03321 GENEFORM Protein DME1096 XEOTICID XEO03321 MOACRIVE Inhibition DME1096 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1096 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1096 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03348 GENEFORM Protein DME1096 XEOTICID XEO03348 MOACRIVE Inhibition DME1096 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1096 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03362 XEO_CLAS Peptide DME1096 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO03362 GENEFORM Protein DME1096 XEOTICID XEO03362 MOACRIVE Inhibition DME1096 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1096 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03363 XEO_CLAS Peptide DME1096 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 microM) DME1096 XEOTICID XEO03363 GENEFORM Protein DME1096 XEOTICID XEO03363 MOACRIVE Inhibition DME1096 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1096 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03364 XEO_CLAS Peptide DME1096 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 microM) DME1096 XEOTICID XEO03364 GENEFORM Protein DME1096 XEOTICID XEO03364 MOACRIVE Inhibition DME1096 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1096 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03365 XEO_CLAS Peptide DME1096 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03365 GENEFORM Protein DME1096 XEOTICID XEO03365 MOACRIVE Inhibition DME1096 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1096 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03366 XEO_CLAS Peptide DME1096 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO03366 GENEFORM Protein DME1096 XEOTICID XEO03366 MOACRIVE Inhibition DME1096 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1096 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03367 XEO_CLAS Peptide DME1096 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 microM) DME1096 XEOTICID XEO03367 GENEFORM Protein DME1096 XEOTICID XEO03367 MOACRIVE Inhibition DME1096 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1096 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03368 XEO_CLAS Peptide DME1096 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 microM) DME1096 XEOTICID XEO03368 GENEFORM Protein DME1096 XEOTICID XEO03368 MOACRIVE Inhibition DME1096 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1096 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03379 XEO_CLAS Peptide DME1096 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.6 ug/ml) DME1096 XEOTICID XEO03379 GENEFORM Protein DME1096 XEOTICID XEO03379 MOACRIVE Inhibition DME1096 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1096 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03396 XEO_CLAS Peptide DME1096 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03396 GENEFORM Protein DME1096 XEOTICID XEO03396 MOACRIVE Inhibition DME1096 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1096 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03398 XEO_CLAS Peptide DME1096 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03398 GENEFORM Protein DME1096 XEOTICID XEO03398 MOACRIVE Inhibition DME1096 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1096 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03399 XEO_CLAS Peptide DME1096 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03399 GENEFORM Protein DME1096 XEOTICID XEO03399 MOACRIVE Inhibition DME1096 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1096 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03406 XEO_CLAS Peptide DME1096 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 ug/ml) DME1096 XEOTICID XEO03406 GENEFORM Protein DME1096 XEOTICID XEO03406 MOACRIVE Inhibition DME1096 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1096 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03424 XEO_CLAS Peptide DME1096 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03424 GENEFORM Protein DME1096 XEOTICID XEO03424 MOACRIVE Inhibition DME1096 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1096 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03426 XEO_CLAS Peptide DME1096 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO03426 GENEFORM Protein DME1096 XEOTICID XEO03426 MOACRIVE Inhibition DME1096 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1096 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03427 XEO_CLAS Peptide DME1096 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 microM) DME1096 XEOTICID XEO03427 GENEFORM Protein DME1096 XEOTICID XEO03427 MOACRIVE Inhibition DME1096 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1096 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03428 XEO_CLAS Peptide DME1096 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 ug/ml) DME1096 XEOTICID XEO03428 GENEFORM Protein DME1096 XEOTICID XEO03428 MOACRIVE Inhibition DME1096 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1096 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03430 XEO_CLAS Peptide DME1096 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 ug/ml) DME1096 XEOTICID XEO03430 GENEFORM Protein DME1096 XEOTICID XEO03430 MOACRIVE Inhibition DME1096 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1096 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03434 XEO_CLAS Peptide DME1096 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO03434 GENEFORM Protein DME1096 XEOTICID XEO03434 MOACRIVE Inhibition DME1096 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1096 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03442 XEO_CLAS Peptide DME1096 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 18.75 ug/ml) DME1096 XEOTICID XEO03442 GENEFORM Protein DME1096 XEOTICID XEO03442 MOACRIVE Inhibition DME1096 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1096 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03444 XEO_CLAS Peptide DME1096 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 37.50 ug/ml) DME1096 XEOTICID XEO03444 GENEFORM Protein DME1096 XEOTICID XEO03444 MOACRIVE Inhibition DME1096 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1096 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03459 XEO_CLAS Peptide DME1096 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03459 GENEFORM Protein DME1096 XEOTICID XEO03459 MOACRIVE Inhibition DME1096 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1096 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03460 XEO_CLAS Peptide DME1096 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03460 GENEFORM Protein DME1096 XEOTICID XEO03460 MOACRIVE Inhibition DME1096 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1096 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03461 XEO_CLAS Peptide DME1096 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.05 microM) DME1096 XEOTICID XEO03461 GENEFORM Protein DME1096 XEOTICID XEO03461 MOACRIVE Inhibition DME1096 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1096 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03462 XEO_CLAS Peptide DME1096 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03462 GENEFORM Protein DME1096 XEOTICID XEO03462 MOACRIVE Inhibition DME1096 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1096 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03463 XEO_CLAS Peptide DME1096 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03463 GENEFORM Protein DME1096 XEOTICID XEO03463 MOACRIVE Inhibition DME1096 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1096 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03467 XEO_CLAS Peptide DME1096 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03467 GENEFORM Protein DME1096 XEOTICID XEO03467 MOACRIVE Inhibition DME1096 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1096 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03468 XEO_CLAS Peptide DME1096 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03468 GENEFORM Protein DME1096 XEOTICID XEO03468 MOACRIVE Inhibition DME1096 XEOTICID XEO03471 XEO_NAME Gambicin DME1096 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03471 XEO_CLAS Peptide DME1096 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25-12.5 microM) DME1096 XEOTICID XEO03471 GENEFORM Protein DME1096 XEOTICID XEO03471 MOACRIVE Inhibition DME1096 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1096 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03485 XEO_CLAS Peptide DME1096 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4.07 ug/ml) DME1096 XEOTICID XEO03485 GENEFORM Protein DME1096 XEOTICID XEO03485 MOACRIVE Inhibition DME1096 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1096 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03486 XEO_CLAS Peptide DME1096 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.80 ug/ml) DME1096 XEOTICID XEO03486 GENEFORM Protein DME1096 XEOTICID XEO03486 MOACRIVE Inhibition DME1096 XEOTICID XEO03488 XEO_NAME GLK-19 DME1096 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03488 XEO_CLAS Peptide DME1096 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO03488 GENEFORM Protein DME1096 XEOTICID XEO03488 MOACRIVE Inhibition DME1096 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1096 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03497 XEO_CLAS Peptide DME1096 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.4-0.8 microM) DME1096 XEOTICID XEO03497 GENEFORM Protein DME1096 XEOTICID XEO03497 MOACRIVE Inhibition DME1096 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1096 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03498 XEO_CLAS Peptide DME1096 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.4-0.8 microM) DME1096 XEOTICID XEO03498 GENEFORM Protein DME1096 XEOTICID XEO03498 MOACRIVE Inhibition DME1096 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1096 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03500 XEO_CLAS Peptide DME1096 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-30 ug/ml) DME1096 XEOTICID XEO03500 GENEFORM Protein DME1096 XEOTICID XEO03500 MOACRIVE Inhibition DME1096 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1096 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03504 XEO_CLAS Peptide DME1096 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 ug/ml) DME1096 XEOTICID XEO03504 GENEFORM Protein DME1096 XEOTICID XEO03504 MOACRIVE Inhibition DME1096 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1096 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03505 XEO_CLAS Peptide DME1096 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 ug/ml) DME1096 XEOTICID XEO03505 GENEFORM Protein DME1096 XEOTICID XEO03505 MOACRIVE Inhibition DME1096 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1096 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03506 XEO_CLAS Peptide DME1096 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 ug/ml) DME1096 XEOTICID XEO03506 GENEFORM Protein DME1096 XEOTICID XEO03506 MOACRIVE Inhibition DME1096 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1096 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03513 XEO_CLAS Peptide DME1096 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO03513 GENEFORM Protein DME1096 XEOTICID XEO03513 MOACRIVE Inhibition DME1096 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1096 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03514 XEO_CLAS Peptide DME1096 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03514 GENEFORM Protein DME1096 XEOTICID XEO03514 MOACRIVE Inhibition DME1096 XEOTICID XEO03519 XEO_NAME Hadrurin DME1096 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03519 XEO_CLAS Peptide DME1096 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03519 GENEFORM Protein DME1096 XEOTICID XEO03519 MOACRIVE Inhibition DME1096 XEOTICID XEO03522 XEO_NAME Halocyntin DME1096 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03522 XEO_CLAS Peptide DME1096 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03522 GENEFORM Protein DME1096 XEOTICID XEO03522 MOACRIVE Inhibition DME1096 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1096 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03524 XEO_CLAS Peptide DME1096 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03524 GENEFORM Protein DME1096 XEOTICID XEO03524 MOACRIVE Inhibition DME1096 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1096 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03525 XEO_CLAS Peptide DME1096 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03525 GENEFORM Protein DME1096 XEOTICID XEO03525 MOACRIVE Inhibition DME1096 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1096 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03530 XEO_CLAS Peptide DME1096 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03530 GENEFORM Protein DME1096 XEOTICID XEO03530 MOACRIVE Inhibition DME1096 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1096 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03535 XEO_CLAS Peptide DME1096 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.4 microM) DME1096 XEOTICID XEO03535 GENEFORM Protein DME1096 XEOTICID XEO03535 MOACRIVE Inhibition DME1096 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1096 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03536 XEO_CLAS Peptide DME1096 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 80 microM) DME1096 XEOTICID XEO03536 GENEFORM Protein DME1096 XEOTICID XEO03536 MOACRIVE Inhibition DME1096 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1096 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03537 XEO_CLAS Peptide DME1096 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 ug/ml) DME1096 XEOTICID XEO03537 GENEFORM Protein DME1096 XEOTICID XEO03537 MOACRIVE Inhibition DME1096 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1096 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03538 XEO_CLAS Peptide DME1096 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 ug/ml) DME1096 XEOTICID XEO03538 GENEFORM Protein DME1096 XEOTICID XEO03538 MOACRIVE Inhibition DME1096 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1096 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03540 XEO_CLAS Peptide DME1096 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO03540 GENEFORM Protein DME1096 XEOTICID XEO03540 MOACRIVE Inhibition DME1096 XEOTICID XEO03542 XEO_NAME Hepcidin DME1096 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03542 XEO_CLAS Peptide DME1096 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 24 microM) DME1096 XEOTICID XEO03542 GENEFORM Protein DME1096 XEOTICID XEO03542 MOACRIVE Inhibition DME1096 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1096 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03544 XEO_CLAS Peptide DME1096 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03544 GENEFORM Protein DME1096 XEOTICID XEO03544 MOACRIVE Inhibition DME1096 XEOTICID XEO03548 XEO_NAME Hesperidin DME1096 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03548 GENEFORM Protein DME1096 XEOTICID XEO03548 MOACRIVE Inhibition DME1096 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1096 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1096 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03552 GENEFORM Protein DME1096 XEOTICID XEO03552 MOACRIVE Inhibition DME1096 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1096 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03556 XEO_CLAS Peptide DME1096 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO03556 GENEFORM Protein DME1096 XEOTICID XEO03556 MOACRIVE Inhibition DME1096 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1096 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03557 XEO_CLAS Peptide DME1096 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO03557 GENEFORM Protein DME1096 XEOTICID XEO03557 MOACRIVE Inhibition DME1096 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1096 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03558 XEO_CLAS Peptide DME1096 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 microM) DME1096 XEOTICID XEO03558 GENEFORM Protein DME1096 XEOTICID XEO03558 MOACRIVE Inhibition DME1096 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1096 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03559 XEO_CLAS Peptide DME1096 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 microM) DME1096 XEOTICID XEO03559 GENEFORM Protein DME1096 XEOTICID XEO03559 MOACRIVE Inhibition DME1096 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1096 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03560 XEO_CLAS Peptide DME1096 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 microM) DME1096 XEOTICID XEO03560 GENEFORM Protein DME1096 XEOTICID XEO03560 MOACRIVE Inhibition DME1096 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1096 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03561 XEO_CLAS Peptide DME1096 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03561 GENEFORM Protein DME1096 XEOTICID XEO03561 MOACRIVE Inhibition DME1096 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1096 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03567 XEO_CLAS Peptide DME1096 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03567 GENEFORM Protein DME1096 XEOTICID XEO03567 MOACRIVE Inhibition DME1096 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1096 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03569 XEO_CLAS Peptide DME1096 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 300 microM) DME1096 XEOTICID XEO03569 GENEFORM Protein DME1096 XEOTICID XEO03569 MOACRIVE Inhibition DME1096 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1096 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03570 XEO_CLAS Peptide DME1096 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03570 GENEFORM Protein DME1096 XEOTICID XEO03570 MOACRIVE Inhibition DME1096 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1096 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03572 XEO_CLAS Peptide DME1096 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1096 XEOTICID XEO03572 GENEFORM Protein DME1096 XEOTICID XEO03572 MOACRIVE Inhibition DME1096 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1096 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03573 XEO_CLAS Peptide DME1096 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 28.1 ug/ml) DME1096 XEOTICID XEO03573 GENEFORM Protein DME1096 XEOTICID XEO03573 MOACRIVE Inhibition DME1096 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1096 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03574 XEO_CLAS Peptide DME1096 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 500 microM) DME1096 XEOTICID XEO03574 GENEFORM Protein DME1096 XEOTICID XEO03574 MOACRIVE Inhibition DME1096 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1096 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03575 XEO_CLAS Peptide DME1096 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 18 microM) DME1096 XEOTICID XEO03575 GENEFORM Protein DME1096 XEOTICID XEO03575 MOACRIVE Inhibition DME1096 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1096 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03576 XEO_CLAS Peptide DME1096 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 750 microM) DME1096 XEOTICID XEO03576 GENEFORM Protein DME1096 XEOTICID XEO03576 MOACRIVE Inhibition DME1096 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1096 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03578 XEO_CLAS Peptide DME1096 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1096 XEOTICID XEO03578 GENEFORM Protein DME1096 XEOTICID XEO03578 MOACRIVE Inhibition DME1096 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1096 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03579 XEO_CLAS Peptide DME1096 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03579 GENEFORM Protein DME1096 XEOTICID XEO03579 MOACRIVE Inhibition DME1096 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1096 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03580 XEO_CLAS Peptide DME1096 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03580 GENEFORM Protein DME1096 XEOTICID XEO03580 MOACRIVE Inhibition DME1096 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1096 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03585 XEO_CLAS Peptide DME1096 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 125 ug/ml) DME1096 XEOTICID XEO03585 GENEFORM Protein DME1096 XEOTICID XEO03585 MOACRIVE Inhibition DME1096 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1096 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03588 XEO_CLAS Peptide DME1096 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 62 ug/ml) DME1096 XEOTICID XEO03588 GENEFORM Protein DME1096 XEOTICID XEO03588 MOACRIVE Inhibition DME1096 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1096 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03589 XEO_CLAS Peptide DME1096 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03589 GENEFORM Protein DME1096 XEOTICID XEO03589 MOACRIVE Inhibition DME1096 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1096 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03590 XEO_CLAS Peptide DME1096 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03590 GENEFORM Protein DME1096 XEOTICID XEO03590 MOACRIVE Inhibition DME1096 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1096 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03591 XEO_CLAS Peptide DME1096 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 37.5 ug/ml) DME1096 XEOTICID XEO03591 GENEFORM Protein DME1096 XEOTICID XEO03591 MOACRIVE Inhibition DME1096 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1096 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03593 XEO_CLAS Peptide DME1096 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 9.4 ug/ml) DME1096 XEOTICID XEO03593 GENEFORM Protein DME1096 XEOTICID XEO03593 MOACRIVE Inhibition DME1096 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1096 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03594 XEO_CLAS Peptide DME1096 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 ug/ml) DME1096 XEOTICID XEO03594 GENEFORM Protein DME1096 XEOTICID XEO03594 MOACRIVE Inhibition DME1096 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1096 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03595 XEO_CLAS Peptide DME1096 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03595 GENEFORM Protein DME1096 XEOTICID XEO03595 MOACRIVE Inhibition DME1096 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1096 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03596 XEO_CLAS Peptide DME1096 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03596 GENEFORM Protein DME1096 XEOTICID XEO03596 MOACRIVE Inhibition DME1096 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1096 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03598 XEO_CLAS Peptide DME1096 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03598 GENEFORM Protein DME1096 XEOTICID XEO03598 MOACRIVE Inhibition DME1096 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1096 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03599 XEO_CLAS Peptide DME1096 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03599 GENEFORM Protein DME1096 XEOTICID XEO03599 MOACRIVE Inhibition DME1096 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1096 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03600 XEO_CLAS Peptide DME1096 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03600 GENEFORM Protein DME1096 XEOTICID XEO03600 MOACRIVE Inhibition DME1096 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1096 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03606 XEO_CLAS Peptide DME1096 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03606 GENEFORM Protein DME1096 XEOTICID XEO03606 MOACRIVE Inhibition DME1096 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1096 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03607 XEO_CLAS Peptide DME1096 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03607 GENEFORM Protein DME1096 XEOTICID XEO03607 MOACRIVE Inhibition DME1096 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1096 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03609 XEO_CLAS Peptide DME1096 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03609 GENEFORM Protein DME1096 XEOTICID XEO03609 MOACRIVE Inhibition DME1096 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1096 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03615 XEO_CLAS Peptide DME1096 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1096 XEOTICID XEO03615 GENEFORM Protein DME1096 XEOTICID XEO03615 MOACRIVE Inhibition DME1096 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1096 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03616 XEO_CLAS Peptide DME1096 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 32 microM) DME1096 XEOTICID XEO03616 GENEFORM Protein DME1096 XEOTICID XEO03616 MOACRIVE Inhibition DME1096 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1096 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03617 XEO_CLAS Peptide DME1096 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40 microM) DME1096 XEOTICID XEO03617 GENEFORM Protein DME1096 XEOTICID XEO03617 MOACRIVE Inhibition DME1096 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1096 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03618 XEO_CLAS Peptide DME1096 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5-1 microM) DME1096 XEOTICID XEO03618 GENEFORM Protein DME1096 XEOTICID XEO03618 MOACRIVE Inhibition DME1096 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1096 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03622 XEO_CLAS Peptide DME1096 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20-40 microM) DME1096 XEOTICID XEO03622 GENEFORM Protein DME1096 XEOTICID XEO03622 MOACRIVE Inhibition DME1096 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1096 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03627 XEO_CLAS Peptide DME1096 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.4-0.8 microM) DME1096 XEOTICID XEO03627 GENEFORM Protein DME1096 XEOTICID XEO03627 MOACRIVE Inhibition DME1096 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1096 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03630 XEO_CLAS Peptide DME1096 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03630 GENEFORM Protein DME1096 XEOTICID XEO03630 MOACRIVE Inhibition DME1096 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1096 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03631 XEO_CLAS Peptide DME1096 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03631 GENEFORM Protein DME1096 XEOTICID XEO03631 MOACRIVE Inhibition DME1096 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1096 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03632 XEO_CLAS Peptide DME1096 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03632 GENEFORM Protein DME1096 XEOTICID XEO03632 MOACRIVE Inhibition DME1096 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1096 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03633 XEO_CLAS Peptide DME1096 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03633 GENEFORM Protein DME1096 XEOTICID XEO03633 MOACRIVE Inhibition DME1096 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1096 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03634 XEO_CLAS Peptide DME1096 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03634 GENEFORM Protein DME1096 XEOTICID XEO03634 MOACRIVE Inhibition DME1096 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1096 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03635 XEO_CLAS Peptide DME1096 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03635 GENEFORM Protein DME1096 XEOTICID XEO03635 MOACRIVE Inhibition DME1096 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1096 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03636 XEO_CLAS Peptide DME1096 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03636 GENEFORM Protein DME1096 XEOTICID XEO03636 MOACRIVE Inhibition DME1096 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1096 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03637 XEO_CLAS Peptide DME1096 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03637 GENEFORM Protein DME1096 XEOTICID XEO03637 MOACRIVE Inhibition DME1096 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1096 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03638 XEO_CLAS Peptide DME1096 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03638 GENEFORM Protein DME1096 XEOTICID XEO03638 MOACRIVE Inhibition DME1096 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1096 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03639 XEO_CLAS Peptide DME1096 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03639 GENEFORM Protein DME1096 XEOTICID XEO03639 MOACRIVE Inhibition DME1096 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1096 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03640 XEO_CLAS Peptide DME1096 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03640 GENEFORM Protein DME1096 XEOTICID XEO03640 MOACRIVE Inhibition DME1096 XEOTICID XEO03644 XEO_NAME Indole DME1096 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1096 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1096 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03644 GENEFORM Protein DME1096 XEOTICID XEO03644 MOACRIVE Inhibition DME1096 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1096 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03650 XEO_CLAS Peptide DME1096 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03650 GENEFORM Protein DME1096 XEOTICID XEO03650 MOACRIVE Inhibition DME1096 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1096 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO03655 XEO_CLAS Natural Product DME1096 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03655 GENEFORM Protein DME1096 XEOTICID XEO03655 MOACRIVE Inhibition DME1096 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1096 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03666 XEO_CLAS Peptide DME1096 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 ug/ml) DME1096 XEOTICID XEO03666 GENEFORM Protein DME1096 XEOTICID XEO03666 MOACRIVE Inhibition DME1096 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1096 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03667 XEO_CLAS Peptide DME1096 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 ug/ml) DME1096 XEOTICID XEO03667 GENEFORM Protein DME1096 XEOTICID XEO03667 MOACRIVE Inhibition DME1096 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1096 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03668 XEO_CLAS Peptide DME1096 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 microM) DME1096 XEOTICID XEO03668 GENEFORM Protein DME1096 XEOTICID XEO03668 MOACRIVE Inhibition DME1096 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1096 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03669 XEO_CLAS Peptide DME1096 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO03669 GENEFORM Protein DME1096 XEOTICID XEO03669 MOACRIVE Inhibition DME1096 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1096 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03670 XEO_CLAS Peptide DME1096 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 microM) DME1096 XEOTICID XEO03670 GENEFORM Protein DME1096 XEOTICID XEO03670 MOACRIVE Inhibition DME1096 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1096 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03672 XEO_CLAS Peptide DME1096 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.5 ug/ml) DME1096 XEOTICID XEO03672 GENEFORM Protein DME1096 XEOTICID XEO03672 MOACRIVE Inhibition DME1096 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1096 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03673 XEO_CLAS Peptide DME1096 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 ug/ml) DME1096 XEOTICID XEO03673 GENEFORM Protein DME1096 XEOTICID XEO03673 MOACRIVE Inhibition DME1096 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1096 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03674 XEO_CLAS Peptide DME1096 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 ug/ml) DME1096 XEOTICID XEO03674 GENEFORM Protein DME1096 XEOTICID XEO03674 MOACRIVE Inhibition DME1096 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1096 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03675 XEO_CLAS Peptide DME1096 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO03675 GENEFORM Protein DME1096 XEOTICID XEO03675 MOACRIVE Inhibition DME1096 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1096 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03678 XEO_CLAS Peptide DME1096 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 ug/ml) DME1096 XEOTICID XEO03678 GENEFORM Protein DME1096 XEOTICID XEO03678 MOACRIVE Inhibition DME1096 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1096 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03679 XEO_CLAS Peptide DME1096 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 ug/ml) DME1096 XEOTICID XEO03679 GENEFORM Protein DME1096 XEOTICID XEO03679 MOACRIVE Inhibition DME1096 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1096 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03681 XEO_CLAS Peptide DME1096 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.3-0.6 microM) DME1096 XEOTICID XEO03681 GENEFORM Protein DME1096 XEOTICID XEO03681 MOACRIVE Inhibition DME1096 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1096 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03684 XEO_CLAS Peptide DME1096 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 ug/ml) DME1096 XEOTICID XEO03684 GENEFORM Protein DME1096 XEOTICID XEO03684 MOACRIVE Inhibition DME1096 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1096 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03694 XEO_CLAS Peptide DME1096 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03694 GENEFORM Protein DME1096 XEOTICID XEO03694 MOACRIVE Inhibition DME1096 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1096 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03697 XEO_CLAS Peptide DME1096 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25 microM) DME1096 XEOTICID XEO03697 GENEFORM Protein DME1096 XEOTICID XEO03697 MOACRIVE Inhibition DME1096 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1096 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03698 XEO_CLAS Peptide DME1096 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03698 GENEFORM Protein DME1096 XEOTICID XEO03698 MOACRIVE Inhibition DME1096 XEOTICID XEO03703 XEO_NAME Kasstasin DME1096 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03703 XEO_CLAS Peptide DME1096 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 110 microM) DME1096 XEOTICID XEO03703 GENEFORM Protein DME1096 XEOTICID XEO03703 MOACRIVE Inhibition DME1096 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1096 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03706 XEO_CLAS Peptide DME1096 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03706 GENEFORM Protein DME1096 XEOTICID XEO03706 MOACRIVE Inhibition DME1096 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1096 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03707 XEO_CLAS Peptide DME1096 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03707 GENEFORM Protein DME1096 XEOTICID XEO03707 MOACRIVE Inhibition DME1096 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1096 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03709 XEO_CLAS Peptide DME1096 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 ug/ml) DME1096 XEOTICID XEO03709 GENEFORM Protein DME1096 XEOTICID XEO03709 MOACRIVE Inhibition DME1096 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1096 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03712 XEO_CLAS Peptide DME1096 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03712 GENEFORM Protein DME1096 XEOTICID XEO03712 MOACRIVE Inhibition DME1096 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1096 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03713 XEO_CLAS Peptide DME1096 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 64 microM) DME1096 XEOTICID XEO03713 GENEFORM Protein DME1096 XEOTICID XEO03713 MOACRIVE Inhibition DME1096 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1096 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03714 XEO_CLAS Peptide DME1096 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03714 GENEFORM Protein DME1096 XEOTICID XEO03714 MOACRIVE Inhibition DME1096 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1096 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03715 XEO_CLAS Peptide DME1096 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 microM) DME1096 XEOTICID XEO03715 GENEFORM Protein DME1096 XEOTICID XEO03715 MOACRIVE Inhibition DME1096 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1096 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03719 XEO_CLAS Peptide DME1096 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 microM) DME1096 XEOTICID XEO03719 GENEFORM Protein DME1096 XEOTICID XEO03719 MOACRIVE Inhibition DME1096 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1096 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03720 XEO_CLAS Peptide DME1096 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 microM) DME1096 XEOTICID XEO03720 GENEFORM Protein DME1096 XEOTICID XEO03720 MOACRIVE Inhibition DME1096 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1096 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03723 XEO_CLAS Peptide DME1096 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 62.36 microM) DME1096 XEOTICID XEO03723 GENEFORM Protein DME1096 XEOTICID XEO03723 MOACRIVE Inhibition DME1096 XEOTICID XEO03724 XEO_NAME L10 peptide DME1096 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03724 XEO_CLAS Peptide DME1096 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.8 microM) DME1096 XEOTICID XEO03724 GENEFORM Protein DME1096 XEOTICID XEO03724 MOACRIVE Inhibition DME1096 XEOTICID XEO03726 XEO_NAME L2 peptide DME1096 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03726 XEO_CLAS Peptide DME1096 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 129.66 microM) DME1096 XEOTICID XEO03726 GENEFORM Protein DME1096 XEOTICID XEO03726 MOACRIVE Inhibition DME1096 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1096 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03727 XEO_CLAS Peptide DME1096 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 80 ug/ml) DME1096 XEOTICID XEO03727 GENEFORM Protein DME1096 XEOTICID XEO03727 MOACRIVE Inhibition DME1096 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1096 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03728 XEO_CLAS Peptide DME1096 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40 ug/ml) DME1096 XEOTICID XEO03728 GENEFORM Protein DME1096 XEOTICID XEO03728 MOACRIVE Inhibition DME1096 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1096 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03729 XEO_CLAS Peptide DME1096 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 80 ug/ml) DME1096 XEOTICID XEO03729 GENEFORM Protein DME1096 XEOTICID XEO03729 MOACRIVE Inhibition DME1096 XEOTICID XEO03730 XEO_NAME L3 peptide DME1096 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03730 XEO_CLAS Peptide DME1096 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64.11 microM) DME1096 XEOTICID XEO03730 GENEFORM Protein DME1096 XEOTICID XEO03730 MOACRIVE Inhibition DME1096 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1096 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03731 XEO_CLAS Peptide DME1096 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40 ug/ml) DME1096 XEOTICID XEO03731 GENEFORM Protein DME1096 XEOTICID XEO03731 MOACRIVE Inhibition DME1096 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1096 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03733 XEO_CLAS Peptide DME1096 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40 ug/ml) DME1096 XEOTICID XEO03733 GENEFORM Protein DME1096 XEOTICID XEO03733 MOACRIVE Inhibition DME1096 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1096 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03734 XEO_CLAS Peptide DME1096 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO03734 GENEFORM Protein DME1096 XEOTICID XEO03734 MOACRIVE Inhibition DME1096 XEOTICID XEO03735 XEO_NAME L4 peptide DME1096 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03735 XEO_CLAS Peptide DME1096 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 31.61 microM) DME1096 XEOTICID XEO03735 GENEFORM Protein DME1096 XEOTICID XEO03735 MOACRIVE Inhibition DME1096 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1096 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03738 XEO_CLAS Peptide DME1096 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 ug/ml) DME1096 XEOTICID XEO03738 GENEFORM Protein DME1096 XEOTICID XEO03738 MOACRIVE Inhibition DME1096 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1096 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03741 XEO_CLAS Peptide DME1096 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40 ug/ml) DME1096 XEOTICID XEO03741 GENEFORM Protein DME1096 XEOTICID XEO03741 MOACRIVE Inhibition DME1096 XEOTICID XEO03742 XEO_NAME L5 peptide DME1096 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03742 XEO_CLAS Peptide DME1096 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 7.79 microM) DME1096 XEOTICID XEO03742 GENEFORM Protein DME1096 XEOTICID XEO03742 MOACRIVE Inhibition DME1096 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1096 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03743 XEO_CLAS Peptide DME1096 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 ug/ml) DME1096 XEOTICID XEO03743 GENEFORM Protein DME1096 XEOTICID XEO03743 MOACRIVE Inhibition DME1096 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1096 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03744 XEO_CLAS Peptide DME1096 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 ug/ml) DME1096 XEOTICID XEO03744 GENEFORM Protein DME1096 XEOTICID XEO03744 MOACRIVE Inhibition DME1096 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1096 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03745 XEO_CLAS Peptide DME1096 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 ug/ml) DME1096 XEOTICID XEO03745 GENEFORM Protein DME1096 XEOTICID XEO03745 MOACRIVE Inhibition DME1096 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1096 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03746 XEO_CLAS Peptide DME1096 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO03746 GENEFORM Protein DME1096 XEOTICID XEO03746 MOACRIVE Inhibition DME1096 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1096 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03747 XEO_CLAS Peptide DME1096 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO03747 GENEFORM Protein DME1096 XEOTICID XEO03747 MOACRIVE Inhibition DME1096 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1096 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03748 XEO_CLAS Peptide DME1096 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO03748 GENEFORM Protein DME1096 XEOTICID XEO03748 MOACRIVE Inhibition DME1096 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1096 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03749 XEO_CLAS Peptide DME1096 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO03749 GENEFORM Protein DME1096 XEOTICID XEO03749 MOACRIVE Inhibition DME1096 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1096 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03750 XEO_CLAS Peptide DME1096 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO03750 GENEFORM Protein DME1096 XEOTICID XEO03750 MOACRIVE Inhibition DME1096 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1096 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03751 XEO_CLAS Peptide DME1096 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO03751 GENEFORM Protein DME1096 XEOTICID XEO03751 MOACRIVE Inhibition DME1096 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1096 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03752 XEO_CLAS Peptide DME1096 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO03752 GENEFORM Protein DME1096 XEOTICID XEO03752 MOACRIVE Inhibition DME1096 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1096 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03753 XEO_CLAS Peptide DME1096 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 ug/ml) DME1096 XEOTICID XEO03753 GENEFORM Protein DME1096 XEOTICID XEO03753 MOACRIVE Inhibition DME1096 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1096 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03754 XEO_CLAS Peptide DME1096 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO03754 GENEFORM Protein DME1096 XEOTICID XEO03754 MOACRIVE Inhibition DME1096 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1096 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03755 XEO_CLAS Peptide DME1096 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO03755 GENEFORM Protein DME1096 XEOTICID XEO03755 MOACRIVE Inhibition DME1096 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1096 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03756 XEO_CLAS Peptide DME1096 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO03756 GENEFORM Protein DME1096 XEOTICID XEO03756 MOACRIVE Inhibition DME1096 XEOTICID XEO03757 XEO_NAME L6 peptide DME1096 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03757 XEO_CLAS Peptide DME1096 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15.17 microM) DME1096 XEOTICID XEO03757 GENEFORM Protein DME1096 XEOTICID XEO03757 MOACRIVE Inhibition DME1096 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1096 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03758 XEO_CLAS Peptide DME1096 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 80 ug/ml) DME1096 XEOTICID XEO03758 GENEFORM Protein DME1096 XEOTICID XEO03758 MOACRIVE Inhibition DME1096 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1096 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03759 XEO_CLAS Peptide DME1096 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.3 ug/ml) DME1096 XEOTICID XEO03759 GENEFORM Protein DME1096 XEOTICID XEO03759 MOACRIVE Inhibition DME1096 XEOTICID XEO03760 XEO_NAME L7 peptide DME1096 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03760 XEO_CLAS Peptide DME1096 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16.02 microM) DME1096 XEOTICID XEO03760 GENEFORM Protein DME1096 XEOTICID XEO03760 MOACRIVE Inhibition DME1096 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1096 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03761 XEO_CLAS Peptide DME1096 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 ug/ml) DME1096 XEOTICID XEO03761 GENEFORM Protein DME1096 XEOTICID XEO03761 MOACRIVE Inhibition DME1096 XEOTICID XEO03763 XEO_NAME L8 peptide DME1096 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03763 XEO_CLAS Peptide DME1096 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.71 microM) DME1096 XEOTICID XEO03763 GENEFORM Protein DME1096 XEOTICID XEO03763 MOACRIVE Inhibition DME1096 XEOTICID XEO03765 XEO_NAME L9 peptide DME1096 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03765 XEO_CLAS Peptide DME1096 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.78 microM) DME1096 XEOTICID XEO03765 GENEFORM Protein DME1096 XEOTICID XEO03765 MOACRIVE Inhibition DME1096 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1096 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03775 XEO_CLAS Peptide DME1096 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 17.3 microM) DME1096 XEOTICID XEO03775 GENEFORM Protein DME1096 XEOTICID XEO03775 MOACRIVE Inhibition DME1096 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1096 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03776 XEO_CLAS Peptide DME1096 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03776 GENEFORM Protein DME1096 XEOTICID XEO03776 MOACRIVE Inhibition DME1096 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1096 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03781 XEO_CLAS Peptide DME1096 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.47 microM) DME1096 XEOTICID XEO03781 GENEFORM Protein DME1096 XEOTICID XEO03781 MOACRIVE Inhibition DME1096 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1096 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03782 XEO_CLAS Peptide DME1096 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.47 microM) DME1096 XEOTICID XEO03782 GENEFORM Protein DME1096 XEOTICID XEO03782 MOACRIVE Inhibition DME1096 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1096 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03783 XEO_CLAS Peptide DME1096 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.68 microM) DME1096 XEOTICID XEO03783 GENEFORM Protein DME1096 XEOTICID XEO03783 MOACRIVE Inhibition DME1096 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1096 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03784 XEO_CLAS Peptide DME1096 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.45 microM) DME1096 XEOTICID XEO03784 GENEFORM Protein DME1096 XEOTICID XEO03784 MOACRIVE Inhibition DME1096 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1096 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03785 XEO_CLAS Peptide DME1096 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.73 microM) DME1096 XEOTICID XEO03785 GENEFORM Protein DME1096 XEOTICID XEO03785 MOACRIVE Inhibition DME1096 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1096 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03786 XEO_CLAS Peptide DME1096 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.45 microM) DME1096 XEOTICID XEO03786 GENEFORM Protein DME1096 XEOTICID XEO03786 MOACRIVE Inhibition DME1096 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1096 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03787 XEO_CLAS Peptide DME1096 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.38 microM) DME1096 XEOTICID XEO03787 GENEFORM Protein DME1096 XEOTICID XEO03787 MOACRIVE Inhibition DME1096 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1096 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03788 XEO_CLAS Peptide DME1096 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.46 microM) DME1096 XEOTICID XEO03788 GENEFORM Protein DME1096 XEOTICID XEO03788 MOACRIVE Inhibition DME1096 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1096 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03789 XEO_CLAS Peptide DME1096 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 13.05 microM) DME1096 XEOTICID XEO03789 GENEFORM Protein DME1096 XEOTICID XEO03789 MOACRIVE Inhibition DME1096 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1096 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03790 XEO_CLAS Peptide DME1096 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.82 microM) DME1096 XEOTICID XEO03790 GENEFORM Protein DME1096 XEOTICID XEO03790 MOACRIVE Inhibition DME1096 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1096 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03791 XEO_CLAS Peptide DME1096 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.80 microM) DME1096 XEOTICID XEO03791 GENEFORM Protein DME1096 XEOTICID XEO03791 MOACRIVE Inhibition DME1096 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1096 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03792 XEO_CLAS Peptide DME1096 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.26 microM) DME1096 XEOTICID XEO03792 GENEFORM Protein DME1096 XEOTICID XEO03792 MOACRIVE Inhibition DME1096 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1096 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03793 XEO_CLAS Peptide DME1096 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 microM) DME1096 XEOTICID XEO03793 GENEFORM Protein DME1096 XEOTICID XEO03793 MOACRIVE Inhibition DME1096 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1096 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03797 XEO_CLAS Peptide DME1096 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.4 microM) DME1096 XEOTICID XEO03797 GENEFORM Protein DME1096 XEOTICID XEO03797 MOACRIVE Inhibition DME1096 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1096 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03798 XEO_CLAS Peptide DME1096 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03798 GENEFORM Protein DME1096 XEOTICID XEO03798 MOACRIVE Inhibition DME1096 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1096 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03799 XEO_CLAS Peptide DME1096 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03799 GENEFORM Protein DME1096 XEOTICID XEO03799 MOACRIVE Inhibition DME1096 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1096 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03810 XEO_CLAS Peptide DME1096 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03810 GENEFORM Protein DME1096 XEOTICID XEO03810 MOACRIVE Inhibition DME1096 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1096 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03846 XEO_CLAS Peptide DME1096 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03846 GENEFORM Protein DME1096 XEOTICID XEO03846 MOACRIVE Inhibition DME1096 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1096 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03847 XEO_CLAS Peptide DME1096 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03847 GENEFORM Protein DME1096 XEOTICID XEO03847 MOACRIVE Inhibition DME1096 XEOTICID XEO03850 XEO_NAME Lemon DME1096 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1096 XEOTICID XEO03850 XEO_CLAS Food Additive DME1096 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03850 GENEFORM Protein DME1096 XEOTICID XEO03850 MOACRIVE Inhibition DME1096 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1096 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03853 XEO_CLAS Peptide DME1096 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO03853 GENEFORM Protein DME1096 XEOTICID XEO03853 MOACRIVE Inhibition DME1096 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1096 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03857 XEO_CLAS Peptide DME1096 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 38.49 microM) DME1096 XEOTICID XEO03857 GENEFORM Protein DME1096 XEOTICID XEO03857 MOACRIVE Inhibition DME1096 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1096 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03860 XEO_CLAS Peptide DME1096 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 24 microM) DME1096 XEOTICID XEO03860 GENEFORM Protein DME1096 XEOTICID XEO03860 MOACRIVE Inhibition DME1096 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1096 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03861 XEO_CLAS Peptide DME1096 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 35 microM) DME1096 XEOTICID XEO03861 GENEFORM Protein DME1096 XEOTICID XEO03861 MOACRIVE Inhibition DME1096 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1096 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03862 XEO_CLAS Peptide DME1096 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 70 microM) DME1096 XEOTICID XEO03862 GENEFORM Protein DME1096 XEOTICID XEO03862 MOACRIVE Inhibition DME1096 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1096 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03863 XEO_CLAS Peptide DME1096 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 35 microM) DME1096 XEOTICID XEO03863 GENEFORM Protein DME1096 XEOTICID XEO03863 MOACRIVE Inhibition DME1096 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1096 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03864 XEO_CLAS Peptide DME1096 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO03864 GENEFORM Protein DME1096 XEOTICID XEO03864 MOACRIVE Inhibition DME1096 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1096 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03865 XEO_CLAS Peptide DME1096 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO03865 GENEFORM Protein DME1096 XEOTICID XEO03865 MOACRIVE Inhibition DME1096 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1096 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03866 XEO_CLAS Peptide DME1096 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 microM) DME1096 XEOTICID XEO03866 GENEFORM Protein DME1096 XEOTICID XEO03866 MOACRIVE Inhibition DME1096 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1096 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03867 XEO_CLAS Peptide DME1096 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40 microM) DME1096 XEOTICID XEO03867 GENEFORM Protein DME1096 XEOTICID XEO03867 MOACRIVE Inhibition DME1096 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1096 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03868 XEO_CLAS Peptide DME1096 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 51 microM) DME1096 XEOTICID XEO03868 GENEFORM Protein DME1096 XEOTICID XEO03868 MOACRIVE Inhibition DME1096 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1096 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03869 XEO_CLAS Peptide DME1096 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 35 microM) DME1096 XEOTICID XEO03869 GENEFORM Protein DME1096 XEOTICID XEO03869 MOACRIVE Inhibition DME1096 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1096 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03870 XEO_CLAS Peptide DME1096 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 61 microM) DME1096 XEOTICID XEO03870 GENEFORM Protein DME1096 XEOTICID XEO03870 MOACRIVE Inhibition DME1096 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1096 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03871 XEO_CLAS Peptide DME1096 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 microM) DME1096 XEOTICID XEO03871 GENEFORM Protein DME1096 XEOTICID XEO03871 MOACRIVE Inhibition DME1096 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1096 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03872 XEO_CLAS Peptide DME1096 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 28 microM) DME1096 XEOTICID XEO03872 GENEFORM Protein DME1096 XEOTICID XEO03872 MOACRIVE Inhibition DME1096 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1096 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03873 XEO_CLAS Peptide DME1096 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 22.5 microM) DME1096 XEOTICID XEO03873 GENEFORM Protein DME1096 XEOTICID XEO03873 MOACRIVE Inhibition DME1096 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1096 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03874 XEO_CLAS Peptide DME1096 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 11.25 microM) DME1096 XEOTICID XEO03874 GENEFORM Protein DME1096 XEOTICID XEO03874 MOACRIVE Inhibition DME1096 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1096 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03875 XEO_CLAS Peptide DME1096 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 microM) DME1096 XEOTICID XEO03875 GENEFORM Protein DME1096 XEOTICID XEO03875 MOACRIVE Inhibition DME1096 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1096 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03876 XEO_CLAS Peptide DME1096 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.75 microM) DME1096 XEOTICID XEO03876 GENEFORM Protein DME1096 XEOTICID XEO03876 MOACRIVE Inhibition DME1096 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1096 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03877 XEO_CLAS Peptide DME1096 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 microM) DME1096 XEOTICID XEO03877 GENEFORM Protein DME1096 XEOTICID XEO03877 MOACRIVE Inhibition DME1096 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1096 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03878 XEO_CLAS Peptide DME1096 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 microM) DME1096 XEOTICID XEO03878 GENEFORM Protein DME1096 XEOTICID XEO03878 MOACRIVE Inhibition DME1096 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1096 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03879 XEO_CLAS Peptide DME1096 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 252 microM) DME1096 XEOTICID XEO03879 GENEFORM Protein DME1096 XEOTICID XEO03879 MOACRIVE Inhibition DME1096 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1096 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03880 XEO_CLAS Peptide DME1096 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 174 microM) DME1096 XEOTICID XEO03880 GENEFORM Protein DME1096 XEOTICID XEO03880 MOACRIVE Inhibition DME1096 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1096 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03883 XEO_CLAS Peptide DME1096 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 74 microM) DME1096 XEOTICID XEO03883 GENEFORM Protein DME1096 XEOTICID XEO03883 MOACRIVE Inhibition DME1096 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1096 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03884 XEO_CLAS Peptide DME1096 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 31 microM) DME1096 XEOTICID XEO03884 GENEFORM Protein DME1096 XEOTICID XEO03884 MOACRIVE Inhibition DME1096 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1096 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03885 XEO_CLAS Peptide DME1096 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO03885 GENEFORM Protein DME1096 XEOTICID XEO03885 MOACRIVE Inhibition DME1096 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1096 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03886 XEO_CLAS Peptide DME1096 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 391 microM) DME1096 XEOTICID XEO03886 GENEFORM Protein DME1096 XEOTICID XEO03886 MOACRIVE Inhibition DME1096 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1096 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03887 XEO_CLAS Peptide DME1096 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 151 microM) DME1096 XEOTICID XEO03887 GENEFORM Protein DME1096 XEOTICID XEO03887 MOACRIVE Inhibition DME1096 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1096 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03888 XEO_CLAS Peptide DME1096 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 134 microM) DME1096 XEOTICID XEO03888 GENEFORM Protein DME1096 XEOTICID XEO03888 MOACRIVE Inhibition DME1096 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1096 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03889 XEO_CLAS Peptide DME1096 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 88 microM) DME1096 XEOTICID XEO03889 GENEFORM Protein DME1096 XEOTICID XEO03889 MOACRIVE Inhibition DME1096 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1096 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03890 XEO_CLAS Peptide DME1096 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 31 microM) DME1096 XEOTICID XEO03890 GENEFORM Protein DME1096 XEOTICID XEO03890 MOACRIVE Inhibition DME1096 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1096 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03891 XEO_CLAS Peptide DME1096 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 microM) DME1096 XEOTICID XEO03891 GENEFORM Protein DME1096 XEOTICID XEO03891 MOACRIVE Inhibition DME1096 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1096 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03892 XEO_CLAS Peptide DME1096 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 37 microM) DME1096 XEOTICID XEO03892 GENEFORM Protein DME1096 XEOTICID XEO03892 MOACRIVE Inhibition DME1096 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1096 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03893 XEO_CLAS Peptide DME1096 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 19 microM) DME1096 XEOTICID XEO03893 GENEFORM Protein DME1096 XEOTICID XEO03893 MOACRIVE Inhibition DME1096 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1096 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03894 XEO_CLAS Peptide DME1096 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO03894 GENEFORM Protein DME1096 XEOTICID XEO03894 MOACRIVE Inhibition DME1096 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1096 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03895 XEO_CLAS Peptide DME1096 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO03895 GENEFORM Protein DME1096 XEOTICID XEO03895 MOACRIVE Inhibition DME1096 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1096 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03896 XEO_CLAS Peptide DME1096 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 microM) DME1096 XEOTICID XEO03896 GENEFORM Protein DME1096 XEOTICID XEO03896 MOACRIVE Inhibition DME1096 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1096 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03897 XEO_CLAS Peptide DME1096 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 63 microM) DME1096 XEOTICID XEO03897 GENEFORM Protein DME1096 XEOTICID XEO03897 MOACRIVE Inhibition DME1096 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1096 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03898 XEO_CLAS Peptide DME1096 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 219 microM) DME1096 XEOTICID XEO03898 GENEFORM Protein DME1096 XEOTICID XEO03898 MOACRIVE Inhibition DME1096 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1096 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03901 XEO_CLAS Peptide DME1096 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 35 microM) DME1096 XEOTICID XEO03901 GENEFORM Protein DME1096 XEOTICID XEO03901 MOACRIVE Inhibition DME1096 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1096 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03902 XEO_CLAS Peptide DME1096 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 70 microM) DME1096 XEOTICID XEO03902 GENEFORM Protein DME1096 XEOTICID XEO03902 MOACRIVE Inhibition DME1096 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1096 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03904 XEO_CLAS Peptide DME1096 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO03904 GENEFORM Protein DME1096 XEOTICID XEO03904 MOACRIVE Inhibition DME1096 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1096 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03905 XEO_CLAS Peptide DME1096 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO03905 GENEFORM Protein DME1096 XEOTICID XEO03905 MOACRIVE Inhibition DME1096 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1096 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03908 XEO_CLAS Peptide DME1096 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03908 GENEFORM Protein DME1096 XEOTICID XEO03908 MOACRIVE Inhibition DME1096 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1096 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03915 XEO_CLAS Peptide DME1096 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03915 GENEFORM Protein DME1096 XEOTICID XEO03915 MOACRIVE Inhibition DME1096 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1096 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03916 XEO_CLAS Peptide DME1096 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.8 ug/ml) DME1096 XEOTICID XEO03916 GENEFORM Protein DME1096 XEOTICID XEO03916 MOACRIVE Inhibition DME1096 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1096 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03917 XEO_CLAS Peptide DME1096 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 13.1 ug/ml) DME1096 XEOTICID XEO03917 GENEFORM Protein DME1096 XEOTICID XEO03917 MOACRIVE Inhibition DME1096 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1096 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03918 XEO_CLAS Peptide DME1096 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.5 ug/ml) DME1096 XEOTICID XEO03918 GENEFORM Protein DME1096 XEOTICID XEO03918 MOACRIVE Inhibition DME1096 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1096 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03919 XEO_CLAS Peptide DME1096 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 80 ug/ml) DME1096 XEOTICID XEO03919 GENEFORM Protein DME1096 XEOTICID XEO03919 MOACRIVE Inhibition DME1096 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1096 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03922 XEO_CLAS Peptide DME1096 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 9 microM) DME1096 XEOTICID XEO03922 GENEFORM Protein DME1096 XEOTICID XEO03922 MOACRIVE Inhibition DME1096 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1096 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03923 XEO_CLAS Peptide DME1096 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 80 microM) DME1096 XEOTICID XEO03923 GENEFORM Protein DME1096 XEOTICID XEO03923 MOACRIVE Inhibition DME1096 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1096 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03924 XEO_CLAS Peptide DME1096 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO03924 GENEFORM Protein DME1096 XEOTICID XEO03924 MOACRIVE Inhibition DME1096 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1096 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03927 XEO_CLAS Peptide DME1096 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 80 microM) DME1096 XEOTICID XEO03927 GENEFORM Protein DME1096 XEOTICID XEO03927 MOACRIVE Inhibition DME1096 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1096 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03928 XEO_CLAS Peptide DME1096 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 microM) DME1096 XEOTICID XEO03928 GENEFORM Protein DME1096 XEOTICID XEO03928 MOACRIVE Inhibition DME1096 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1096 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03929 XEO_CLAS Peptide DME1096 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 microM) DME1096 XEOTICID XEO03929 GENEFORM Protein DME1096 XEOTICID XEO03929 MOACRIVE Inhibition DME1096 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1096 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03930 XEO_CLAS Peptide DME1096 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 microM) DME1096 XEOTICID XEO03930 GENEFORM Protein DME1096 XEOTICID XEO03930 MOACRIVE Inhibition DME1096 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1096 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03931 XEO_CLAS Peptide DME1096 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 microM) DME1096 XEOTICID XEO03931 GENEFORM Protein DME1096 XEOTICID XEO03931 MOACRIVE Inhibition DME1096 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1096 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03933 XEO_CLAS Peptide DME1096 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.5 microM) DME1096 XEOTICID XEO03933 GENEFORM Protein DME1096 XEOTICID XEO03933 MOACRIVE Inhibition DME1096 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1096 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03934 XEO_CLAS Peptide DME1096 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.7 microM) DME1096 XEOTICID XEO03934 GENEFORM Protein DME1096 XEOTICID XEO03934 MOACRIVE Inhibition DME1096 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1096 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03935 XEO_CLAS Peptide DME1096 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.7 microM) DME1096 XEOTICID XEO03935 GENEFORM Protein DME1096 XEOTICID XEO03935 MOACRIVE Inhibition DME1096 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1096 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03936 XEO_CLAS Peptide DME1096 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.0 microM) DME1096 XEOTICID XEO03936 GENEFORM Protein DME1096 XEOTICID XEO03936 MOACRIVE Inhibition DME1096 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1096 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03937 XEO_CLAS Peptide DME1096 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.1 microM) DME1096 XEOTICID XEO03937 GENEFORM Protein DME1096 XEOTICID XEO03937 MOACRIVE Inhibition DME1096 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1096 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03938 XEO_CLAS Peptide DME1096 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.7 microM) DME1096 XEOTICID XEO03938 GENEFORM Protein DME1096 XEOTICID XEO03938 MOACRIVE Inhibition DME1096 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1096 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03939 XEO_CLAS Peptide DME1096 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.7 microM) DME1096 XEOTICID XEO03939 GENEFORM Protein DME1096 XEOTICID XEO03939 MOACRIVE Inhibition DME1096 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1096 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03940 XEO_CLAS Peptide DME1096 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.5 microM) DME1096 XEOTICID XEO03940 GENEFORM Protein DME1096 XEOTICID XEO03940 MOACRIVE Inhibition DME1096 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1096 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03941 XEO_CLAS Peptide DME1096 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.4 microM) DME1096 XEOTICID XEO03941 GENEFORM Protein DME1096 XEOTICID XEO03941 MOACRIVE Inhibition DME1096 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1096 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03943 XEO_CLAS Peptide DME1096 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.4 microM) DME1096 XEOTICID XEO03943 GENEFORM Protein DME1096 XEOTICID XEO03943 MOACRIVE Inhibition DME1096 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1096 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03944 XEO_CLAS Peptide DME1096 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.7 microM) DME1096 XEOTICID XEO03944 GENEFORM Protein DME1096 XEOTICID XEO03944 MOACRIVE Inhibition DME1096 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1096 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03945 XEO_CLAS Peptide DME1096 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.2 microM) DME1096 XEOTICID XEO03945 GENEFORM Protein DME1096 XEOTICID XEO03945 MOACRIVE Inhibition DME1096 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1096 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03947 XEO_CLAS Peptide DME1096 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.0 microM) DME1096 XEOTICID XEO03947 GENEFORM Protein DME1096 XEOTICID XEO03947 MOACRIVE Inhibition DME1096 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1096 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03948 XEO_CLAS Peptide DME1096 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 23.3 microM) DME1096 XEOTICID XEO03948 GENEFORM Protein DME1096 XEOTICID XEO03948 MOACRIVE Inhibition DME1096 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1096 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03950 XEO_CLAS Peptide DME1096 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4.4 microM) DME1096 XEOTICID XEO03950 GENEFORM Protein DME1096 XEOTICID XEO03950 MOACRIVE Inhibition DME1096 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1096 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03951 XEO_CLAS Peptide DME1096 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8.8 microM) DME1096 XEOTICID XEO03951 GENEFORM Protein DME1096 XEOTICID XEO03951 MOACRIVE Inhibition DME1096 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1096 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03952 XEO_CLAS Peptide DME1096 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.2 microM) DME1096 XEOTICID XEO03952 GENEFORM Protein DME1096 XEOTICID XEO03952 MOACRIVE Inhibition DME1096 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1096 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03953 XEO_CLAS Peptide DME1096 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 microM) DME1096 XEOTICID XEO03953 GENEFORM Protein DME1096 XEOTICID XEO03953 MOACRIVE Inhibition DME1096 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1096 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03958 XEO_CLAS Peptide DME1096 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03958 GENEFORM Protein DME1096 XEOTICID XEO03958 MOACRIVE Inhibition DME1096 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1096 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03965 XEO_CLAS Peptide DME1096 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 128 microM) DME1096 XEOTICID XEO03965 GENEFORM Protein DME1096 XEOTICID XEO03965 MOACRIVE Inhibition DME1096 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1096 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03966 XEO_CLAS Peptide DME1096 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 microM) DME1096 XEOTICID XEO03966 GENEFORM Protein DME1096 XEOTICID XEO03966 MOACRIVE Inhibition DME1096 XEOTICID XEO03971 XEO_NAME Lumbrican DME1096 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03971 XEO_CLAS Peptide DME1096 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03971 GENEFORM Protein DME1096 XEOTICID XEO03971 MOACRIVE Inhibition DME1096 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1096 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03972 XEO_CLAS Peptide DME1096 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO03972 GENEFORM Protein DME1096 XEOTICID XEO03972 MOACRIVE Inhibition DME1096 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1096 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03980 XEO_CLAS Peptide DME1096 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 32 microM) DME1096 XEOTICID XEO03980 GENEFORM Protein DME1096 XEOTICID XEO03980 MOACRIVE Inhibition DME1096 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1096 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03985 XEO_CLAS Peptide DME1096 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 ug/ml) DME1096 XEOTICID XEO03985 GENEFORM Protein DME1096 XEOTICID XEO03985 MOACRIVE Inhibition DME1096 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1096 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03991 XEO_CLAS Peptide DME1096 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03991 GENEFORM Protein DME1096 XEOTICID XEO03991 MOACRIVE Inhibition DME1096 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1096 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03992 XEO_CLAS Peptide DME1096 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03992 GENEFORM Protein DME1096 XEOTICID XEO03992 MOACRIVE Inhibition DME1096 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1096 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03993 XEO_CLAS Peptide DME1096 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03993 GENEFORM Protein DME1096 XEOTICID XEO03993 MOACRIVE Inhibition DME1096 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1096 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03994 XEO_CLAS Peptide DME1096 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO03994 GENEFORM Protein DME1096 XEOTICID XEO03994 MOACRIVE Inhibition DME1096 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1096 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03996 XEO_CLAS Peptide DME1096 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 65 microM) DME1096 XEOTICID XEO03996 GENEFORM Protein DME1096 XEOTICID XEO03996 MOACRIVE Inhibition DME1096 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1096 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03997 XEO_CLAS Peptide DME1096 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 7.5 microM) DME1096 XEOTICID XEO03997 GENEFORM Protein DME1096 XEOTICID XEO03997 MOACRIVE Inhibition DME1096 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1096 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03998 XEO_CLAS Peptide DME1096 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15.5 microM) DME1096 XEOTICID XEO03998 GENEFORM Protein DME1096 XEOTICID XEO03998 MOACRIVE Inhibition DME1096 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1096 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO03999 XEO_CLAS Peptide DME1096 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25.8 microM) DME1096 XEOTICID XEO03999 GENEFORM Protein DME1096 XEOTICID XEO03999 MOACRIVE Inhibition DME1096 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1096 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04000 XEO_CLAS Peptide DME1096 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO04000 GENEFORM Protein DME1096 XEOTICID XEO04000 MOACRIVE Inhibition DME1096 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1096 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04001 XEO_CLAS Peptide DME1096 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO04001 GENEFORM Protein DME1096 XEOTICID XEO04001 MOACRIVE Inhibition DME1096 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1096 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04002 XEO_CLAS Peptide DME1096 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 7.5 ug/ml) DME1096 XEOTICID XEO04002 GENEFORM Protein DME1096 XEOTICID XEO04002 MOACRIVE Inhibition DME1096 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1096 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04003 XEO_CLAS Peptide DME1096 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 ug/ml) DME1096 XEOTICID XEO04003 GENEFORM Protein DME1096 XEOTICID XEO04003 MOACRIVE Inhibition DME1096 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1096 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04004 XEO_CLAS Peptide DME1096 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.0 ug/ml) DME1096 XEOTICID XEO04004 GENEFORM Protein DME1096 XEOTICID XEO04004 MOACRIVE Inhibition DME1096 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1096 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04005 XEO_CLAS Peptide DME1096 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.0 ug/ml) DME1096 XEOTICID XEO04005 GENEFORM Protein DME1096 XEOTICID XEO04005 MOACRIVE Inhibition DME1096 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1096 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04007 XEO_CLAS Peptide DME1096 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 19.5 ug/ml) DME1096 XEOTICID XEO04007 GENEFORM Protein DME1096 XEOTICID XEO04007 MOACRIVE Inhibition DME1096 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1096 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04011 XEO_CLAS Peptide DME1096 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 19.5 ug/ml) DME1096 XEOTICID XEO04011 GENEFORM Protein DME1096 XEOTICID XEO04011 MOACRIVE Inhibition DME1096 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1096 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04012 XEO_CLAS Peptide DME1096 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.9 ug/ml) DME1096 XEOTICID XEO04012 GENEFORM Protein DME1096 XEOTICID XEO04012 MOACRIVE Inhibition DME1096 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1096 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04013 XEO_CLAS Peptide DME1096 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.7 ug/ml) DME1096 XEOTICID XEO04013 GENEFORM Protein DME1096 XEOTICID XEO04013 MOACRIVE Inhibition DME1096 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1096 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04018 XEO_CLAS Peptide DME1096 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 9 ug/ml) DME1096 XEOTICID XEO04018 GENEFORM Protein DME1096 XEOTICID XEO04018 MOACRIVE Inhibition DME1096 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1096 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04026 XEO_CLAS Peptide DME1096 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO04026 GENEFORM Protein DME1096 XEOTICID XEO04026 MOACRIVE Inhibition DME1096 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1096 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04027 XEO_CLAS Peptide DME1096 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO04027 GENEFORM Protein DME1096 XEOTICID XEO04027 MOACRIVE Inhibition DME1096 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1096 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04028 XEO_CLAS Peptide DME1096 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 ug/ml) DME1096 XEOTICID XEO04028 GENEFORM Protein DME1096 XEOTICID XEO04028 MOACRIVE Inhibition DME1096 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1096 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04038 XEO_CLAS Peptide DME1096 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04038 GENEFORM Protein DME1096 XEOTICID XEO04038 MOACRIVE Inhibition DME1096 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1096 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04039 XEO_CLAS Peptide DME1096 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 microM) DME1096 XEOTICID XEO04039 GENEFORM Protein DME1096 XEOTICID XEO04039 MOACRIVE Inhibition DME1096 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1096 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04051 XEO_CLAS Peptide DME1096 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.31-0.63 microM) DME1096 XEOTICID XEO04051 GENEFORM Protein DME1096 XEOTICID XEO04051 MOACRIVE Inhibition DME1096 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1096 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04052 XEO_CLAS Peptide DME1096 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04052 GENEFORM Protein DME1096 XEOTICID XEO04052 MOACRIVE Inhibition DME1096 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1096 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04053 XEO_CLAS Peptide DME1096 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.08-0.16 microM) DME1096 XEOTICID XEO04053 GENEFORM Protein DME1096 XEOTICID XEO04053 MOACRIVE Inhibition DME1096 XEOTICID XEO04055 XEO_NAME Melectin DME1096 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04055 XEO_CLAS Peptide DME1096 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.0 microM) DME1096 XEOTICID XEO04055 GENEFORM Protein DME1096 XEOTICID XEO04055 MOACRIVE Inhibition DME1096 XEOTICID XEO04057 XEO_NAME Melittin DME1096 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04057 XEO_CLAS Peptide DME1096 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.8 microM) DME1096 XEOTICID XEO04057 GENEFORM Protein DME1096 XEOTICID XEO04057 MOACRIVE Inhibition DME1096 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1096 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04061 XEO_CLAS Peptide DME1096 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.9 microM) DME1096 XEOTICID XEO04061 GENEFORM Protein DME1096 XEOTICID XEO04061 MOACRIVE Inhibition DME1096 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1096 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04062 XEO_CLAS Peptide DME1096 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.5 microM) DME1096 XEOTICID XEO04062 GENEFORM Protein DME1096 XEOTICID XEO04062 MOACRIVE Inhibition DME1096 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1096 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04063 XEO_CLAS Peptide DME1096 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 7.8 microM) DME1096 XEOTICID XEO04063 GENEFORM Protein DME1096 XEOTICID XEO04063 MOACRIVE Inhibition DME1096 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1096 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04064 XEO_CLAS Peptide DME1096 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 46.7 microM) DME1096 XEOTICID XEO04064 GENEFORM Protein DME1096 XEOTICID XEO04064 MOACRIVE Inhibition DME1096 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1096 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04066 XEO_CLAS Peptide DME1096 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16.3 microM) DME1096 XEOTICID XEO04066 GENEFORM Protein DME1096 XEOTICID XEO04066 MOACRIVE Inhibition DME1096 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1096 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04067 XEO_CLAS Peptide DME1096 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.6 microM) DME1096 XEOTICID XEO04067 GENEFORM Protein DME1096 XEOTICID XEO04067 MOACRIVE Inhibition DME1096 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1096 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04068 XEO_CLAS Peptide DME1096 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.6 microM) DME1096 XEOTICID XEO04068 GENEFORM Protein DME1096 XEOTICID XEO04068 MOACRIVE Inhibition DME1096 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1096 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04086 GENEFORM Protein DME1096 XEOTICID XEO04086 MOACRIVE Inhibition DME1096 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1096 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04087 GENEFORM Protein DME1096 XEOTICID XEO04087 MOACRIVE Inhibition DME1096 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1096 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04089 GENEFORM Protein DME1096 XEOTICID XEO04089 MOACRIVE Inhibition DME1096 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1096 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04094 GENEFORM Protein DME1096 XEOTICID XEO04094 MOACRIVE Inhibition DME1096 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1096 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04096 GENEFORM Protein DME1096 XEOTICID XEO04096 MOACRIVE Inhibition DME1096 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1096 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04098 GENEFORM Protein DME1096 XEOTICID XEO04098 MOACRIVE Inhibition DME1096 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1096 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04111 XEO_CLAS Peptide DME1096 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04111 GENEFORM Protein DME1096 XEOTICID XEO04111 MOACRIVE Inhibition DME1096 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1096 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04112 XEO_CLAS Peptide DME1096 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.02 microM) DME1096 XEOTICID XEO04112 GENEFORM Protein DME1096 XEOTICID XEO04112 MOACRIVE Inhibition DME1096 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1096 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04113 XEO_CLAS Peptide DME1096 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.02 ug/ml) DME1096 XEOTICID XEO04113 GENEFORM Protein DME1096 XEOTICID XEO04113 MOACRIVE Inhibition DME1096 XEOTICID XEO04114 XEO_NAME Microcin L DME1096 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04114 XEO_CLAS Peptide DME1096 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04114 GENEFORM Protein DME1096 XEOTICID XEO04114 MOACRIVE Inhibition DME1096 XEOTICID XEO04117 XEO_NAME Misgurin DME1096 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04117 XEO_CLAS Peptide DME1096 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04117 GENEFORM Protein DME1096 XEOTICID XEO04117 MOACRIVE Inhibition DME1096 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1096 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04118 XEO_CLAS Peptide DME1096 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 300 microM) DME1096 XEOTICID XEO04118 GENEFORM Protein DME1096 XEOTICID XEO04118 MOACRIVE Inhibition DME1096 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1096 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04119 XEO_CLAS Peptide DME1096 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-20 microM) DME1096 XEOTICID XEO04119 GENEFORM Protein DME1096 XEOTICID XEO04119 MOACRIVE Inhibition DME1096 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1096 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04120 XEO_CLAS Peptide DME1096 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC < 10 microM) DME1096 XEOTICID XEO04120 GENEFORM Protein DME1096 XEOTICID XEO04120 MOACRIVE Inhibition DME1096 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1096 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04121 XEO_CLAS Peptide DME1096 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.2-6.4 microM) DME1096 XEOTICID XEO04121 GENEFORM Protein DME1096 XEOTICID XEO04121 MOACRIVE Inhibition DME1096 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1096 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04122 XEO_CLAS Peptide DME1096 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.14-6.29 microM) DME1096 XEOTICID XEO04122 GENEFORM Protein DME1096 XEOTICID XEO04122 MOACRIVE Inhibition DME1096 XEOTICID XEO04123 XEO_NAME Modified defensin DME1096 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04123 XEO_CLAS Peptide DME1096 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO04123 GENEFORM Protein DME1096 XEOTICID XEO04123 MOACRIVE Inhibition DME1096 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1096 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04128 XEO_CLAS Peptide DME1096 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.31 microM) DME1096 XEOTICID XEO04128 GENEFORM Protein DME1096 XEOTICID XEO04128 MOACRIVE Inhibition DME1096 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1096 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04129 XEO_CLAS Peptide DME1096 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO04129 GENEFORM Protein DME1096 XEOTICID XEO04129 MOACRIVE Inhibition DME1096 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1096 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04130 XEO_CLAS Peptide DME1096 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO04130 GENEFORM Protein DME1096 XEOTICID XEO04130 MOACRIVE Inhibition DME1096 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1096 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04131 XEO_CLAS Peptide DME1096 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 microM) DME1096 XEOTICID XEO04131 GENEFORM Protein DME1096 XEOTICID XEO04131 MOACRIVE Inhibition DME1096 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1096 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04132 XEO_CLAS Peptide DME1096 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 microM) DME1096 XEOTICID XEO04132 GENEFORM Protein DME1096 XEOTICID XEO04132 MOACRIVE Inhibition DME1096 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1096 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04133 XEO_CLAS Peptide DME1096 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO04133 GENEFORM Protein DME1096 XEOTICID XEO04133 MOACRIVE Inhibition DME1096 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1096 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04134 XEO_CLAS Peptide DME1096 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO04134 GENEFORM Protein DME1096 XEOTICID XEO04134 MOACRIVE Inhibition DME1096 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1096 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04135 XEO_CLAS Peptide DME1096 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 microM) DME1096 XEOTICID XEO04135 GENEFORM Protein DME1096 XEOTICID XEO04135 MOACRIVE Inhibition DME1096 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1096 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04137 XEO_CLAS Peptide DME1096 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.6 microM) DME1096 XEOTICID XEO04137 GENEFORM Protein DME1096 XEOTICID XEO04137 MOACRIVE Inhibition DME1096 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1096 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04138 XEO_CLAS Peptide DME1096 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 microM) DME1096 XEOTICID XEO04138 GENEFORM Protein DME1096 XEOTICID XEO04138 MOACRIVE Inhibition DME1096 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1096 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04139 XEO_CLAS Peptide DME1096 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 microM) DME1096 XEOTICID XEO04139 GENEFORM Protein DME1096 XEOTICID XEO04139 MOACRIVE Inhibition DME1096 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1096 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04140 XEO_CLAS Peptide DME1096 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 70 microM) DME1096 XEOTICID XEO04140 GENEFORM Protein DME1096 XEOTICID XEO04140 MOACRIVE Inhibition DME1096 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1096 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04141 XEO_CLAS Peptide DME1096 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 microM) DME1096 XEOTICID XEO04141 GENEFORM Protein DME1096 XEOTICID XEO04141 MOACRIVE Inhibition DME1096 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1096 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04142 XEO_CLAS Peptide DME1096 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8-16 microM) DME1096 XEOTICID XEO04142 GENEFORM Protein DME1096 XEOTICID XEO04142 MOACRIVE Inhibition DME1096 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1096 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04146 XEO_CLAS Peptide DME1096 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04146 GENEFORM Protein DME1096 XEOTICID XEO04146 MOACRIVE Inhibition DME1096 XEOTICID XEO04149 XEO_NAME Mucroporin DME1096 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04149 XEO_CLAS Peptide DME1096 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 ug/ml) DME1096 XEOTICID XEO04149 GENEFORM Protein DME1096 XEOTICID XEO04149 MOACRIVE Inhibition DME1096 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1096 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04158 XEO_CLAS Peptide DME1096 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO04158 GENEFORM Protein DME1096 XEOTICID XEO04158 MOACRIVE Inhibition DME1096 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1096 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04159 XEO_CLAS Peptide DME1096 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 microM) DME1096 XEOTICID XEO04159 GENEFORM Protein DME1096 XEOTICID XEO04159 MOACRIVE Inhibition DME1096 XEOTICID XEO04167 XEO_NAME Myticin-B DME1096 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04167 XEO_CLAS Peptide DME1096 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04167 GENEFORM Protein DME1096 XEOTICID XEO04167 MOACRIVE Inhibition DME1096 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1096 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04168 XEO_CLAS Peptide DME1096 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.7-12.5 microM) DME1096 XEOTICID XEO04168 GENEFORM Protein DME1096 XEOTICID XEO04168 MOACRIVE Inhibition DME1096 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1096 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04169 XEO_CLAS Peptide DME1096 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04169 GENEFORM Protein DME1096 XEOTICID XEO04169 MOACRIVE Inhibition DME1096 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1096 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04170 XEO_CLAS Peptide DME1096 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04170 GENEFORM Protein DME1096 XEOTICID XEO04170 MOACRIVE Inhibition DME1096 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1096 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04171 XEO_CLAS Peptide DME1096 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04171 GENEFORM Protein DME1096 XEOTICID XEO04171 MOACRIVE Inhibition DME1096 XEOTICID XEO04172 XEO_NAME Myxinidin DME1096 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04172 XEO_CLAS Peptide DME1096 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04172 GENEFORM Protein DME1096 XEOTICID XEO04172 MOACRIVE Inhibition DME1096 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1096 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04177 XEO_CLAS Peptide DME1096 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.7 microM) DME1096 XEOTICID XEO04177 GENEFORM Protein DME1096 XEOTICID XEO04177 MOACRIVE Inhibition DME1096 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1096 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04178 XEO_CLAS Peptide DME1096 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.7 microM) DME1096 XEOTICID XEO04178 GENEFORM Protein DME1096 XEOTICID XEO04178 MOACRIVE Inhibition DME1096 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1096 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04179 XEO_CLAS Peptide DME1096 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.5 microM) DME1096 XEOTICID XEO04179 GENEFORM Protein DME1096 XEOTICID XEO04179 MOACRIVE Inhibition DME1096 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1096 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04180 XEO_CLAS Peptide DME1096 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 23 microM) DME1096 XEOTICID XEO04180 GENEFORM Protein DME1096 XEOTICID XEO04180 MOACRIVE Inhibition DME1096 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1096 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04181 XEO_CLAS Peptide DME1096 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.2 microM) DME1096 XEOTICID XEO04181 GENEFORM Protein DME1096 XEOTICID XEO04181 MOACRIVE Inhibition DME1096 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1096 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04182 XEO_CLAS Peptide DME1096 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4.4 microM) DME1096 XEOTICID XEO04182 GENEFORM Protein DME1096 XEOTICID XEO04182 MOACRIVE Inhibition DME1096 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1096 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04183 XEO_CLAS Peptide DME1096 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.6 microM) DME1096 XEOTICID XEO04183 GENEFORM Protein DME1096 XEOTICID XEO04183 MOACRIVE Inhibition DME1096 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1096 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04184 XEO_CLAS Peptide DME1096 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 microM) DME1096 XEOTICID XEO04184 GENEFORM Protein DME1096 XEOTICID XEO04184 MOACRIVE Inhibition DME1096 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1096 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04185 XEO_CLAS Peptide DME1096 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04185 GENEFORM Protein DME1096 XEOTICID XEO04185 MOACRIVE Inhibition DME1096 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1096 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04186 XEO_CLAS Peptide DME1096 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04186 GENEFORM Protein DME1096 XEOTICID XEO04186 MOACRIVE Inhibition DME1096 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1096 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04187 XEO_CLAS Peptide DME1096 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04187 GENEFORM Protein DME1096 XEOTICID XEO04187 MOACRIVE Inhibition DME1096 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1096 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04188 XEO_CLAS Peptide DME1096 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04188 GENEFORM Protein DME1096 XEOTICID XEO04188 MOACRIVE Inhibition DME1096 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1096 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04206 XEO_CLAS Peptide DME1096 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25 microM) DME1096 XEOTICID XEO04206 GENEFORM Protein DME1096 XEOTICID XEO04206 MOACRIVE Inhibition DME1096 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1096 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04214 XEO_CLAS Peptide DME1096 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25 microM) DME1096 XEOTICID XEO04214 GENEFORM Protein DME1096 XEOTICID XEO04214 MOACRIVE Inhibition DME1096 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1096 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04216 XEO_CLAS Peptide DME1096 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO04216 GENEFORM Protein DME1096 XEOTICID XEO04216 MOACRIVE Inhibition DME1096 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1096 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04218 XEO_CLAS Peptide DME1096 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.125 microM) DME1096 XEOTICID XEO04218 GENEFORM Protein DME1096 XEOTICID XEO04218 MOACRIVE Inhibition DME1096 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1096 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04219 XEO_CLAS Peptide DME1096 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO04219 GENEFORM Protein DME1096 XEOTICID XEO04219 MOACRIVE Inhibition DME1096 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1096 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04220 XEO_CLAS Peptide DME1096 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.125 microM) DME1096 XEOTICID XEO04220 GENEFORM Protein DME1096 XEOTICID XEO04220 MOACRIVE Inhibition DME1096 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1096 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04221 XEO_CLAS Peptide DME1096 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO04221 GENEFORM Protein DME1096 XEOTICID XEO04221 MOACRIVE Inhibition DME1096 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1096 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04222 XEO_CLAS Peptide DME1096 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25 microM) DME1096 XEOTICID XEO04222 GENEFORM Protein DME1096 XEOTICID XEO04222 MOACRIVE Inhibition DME1096 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1096 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04233 XEO_CLAS Peptide DME1096 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04233 GENEFORM Protein DME1096 XEOTICID XEO04233 MOACRIVE Inhibition DME1096 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1096 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04234 XEO_CLAS Peptide DME1096 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04234 GENEFORM Protein DME1096 XEOTICID XEO04234 MOACRIVE Inhibition DME1096 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1096 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04241 XEO_CLAS Peptide DME1096 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04241 GENEFORM Protein DME1096 XEOTICID XEO04241 MOACRIVE Inhibition DME1096 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1096 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04242 XEO_CLAS Peptide DME1096 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04242 GENEFORM Protein DME1096 XEOTICID XEO04242 MOACRIVE Inhibition DME1096 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1096 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04245 XEO_CLAS Natural Product DME1096 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04245 GENEFORM Protein DME1096 XEOTICID XEO04245 MOACRIVE Inhibition DME1096 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1096 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04246 XEO_CLAS Natural Product DME1096 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04246 GENEFORM Protein DME1096 XEOTICID XEO04246 MOACRIVE Inhibition DME1096 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1096 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04249 XEO_CLAS Peptide DME1096 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 500 ug/ml) DME1096 XEOTICID XEO04249 GENEFORM Protein DME1096 XEOTICID XEO04249 MOACRIVE Inhibition DME1096 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1096 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04251 XEO_CLAS Peptide DME1096 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04251 GENEFORM Protein DME1096 XEOTICID XEO04251 MOACRIVE Inhibition DME1096 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1096 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04253 XEO_CLAS Peptide DME1096 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04253 GENEFORM Protein DME1096 XEOTICID XEO04253 MOACRIVE Inhibition DME1096 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1096 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04254 XEO_CLAS Peptide DME1096 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04254 GENEFORM Protein DME1096 XEOTICID XEO04254 MOACRIVE Inhibition DME1096 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1096 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04255 XEO_CLAS Peptide DME1096 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04255 GENEFORM Protein DME1096 XEOTICID XEO04255 MOACRIVE Inhibition DME1096 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1096 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04256 XEO_CLAS Peptide DME1096 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04256 GENEFORM Protein DME1096 XEOTICID XEO04256 MOACRIVE Inhibition DME1096 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1096 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04257 XEO_CLAS Peptide DME1096 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04257 GENEFORM Protein DME1096 XEOTICID XEO04257 MOACRIVE Inhibition DME1096 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1096 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04258 XEO_CLAS Peptide DME1096 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04258 GENEFORM Protein DME1096 XEOTICID XEO04258 MOACRIVE Inhibition DME1096 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1096 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04259 XEO_CLAS Peptide DME1096 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04259 GENEFORM Protein DME1096 XEOTICID XEO04259 MOACRIVE Inhibition DME1096 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1096 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04260 XEO_CLAS Peptide DME1096 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04260 GENEFORM Protein DME1096 XEOTICID XEO04260 MOACRIVE Inhibition DME1096 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1096 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04261 XEO_CLAS Peptide DME1096 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04261 GENEFORM Protein DME1096 XEOTICID XEO04261 MOACRIVE Inhibition DME1096 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1096 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04262 XEO_CLAS Peptide DME1096 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04262 GENEFORM Protein DME1096 XEOTICID XEO04262 MOACRIVE Inhibition DME1096 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1096 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04263 XEO_CLAS Peptide DME1096 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04263 GENEFORM Protein DME1096 XEOTICID XEO04263 MOACRIVE Inhibition DME1096 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1096 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04264 XEO_CLAS Peptide DME1096 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04264 GENEFORM Protein DME1096 XEOTICID XEO04264 MOACRIVE Inhibition DME1096 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1096 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04265 XEO_CLAS Peptide DME1096 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04265 GENEFORM Protein DME1096 XEOTICID XEO04265 MOACRIVE Inhibition DME1096 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1096 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04266 XEO_CLAS Peptide DME1096 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04266 GENEFORM Protein DME1096 XEOTICID XEO04266 MOACRIVE Inhibition DME1096 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1096 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04267 XEO_CLAS Peptide DME1096 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04267 GENEFORM Protein DME1096 XEOTICID XEO04267 MOACRIVE Inhibition DME1096 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1096 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04268 XEO_CLAS Peptide DME1096 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04268 GENEFORM Protein DME1096 XEOTICID XEO04268 MOACRIVE Inhibition DME1096 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1096 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04269 XEO_CLAS Peptide DME1096 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04269 GENEFORM Protein DME1096 XEOTICID XEO04269 MOACRIVE Inhibition DME1096 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1096 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04270 XEO_CLAS Peptide DME1096 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04270 GENEFORM Protein DME1096 XEOTICID XEO04270 MOACRIVE Inhibition DME1096 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1096 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04271 XEO_CLAS Peptide DME1096 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04271 GENEFORM Protein DME1096 XEOTICID XEO04271 MOACRIVE Inhibition DME1096 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1096 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04272 XEO_CLAS Peptide DME1096 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04272 GENEFORM Protein DME1096 XEOTICID XEO04272 MOACRIVE Inhibition DME1096 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1096 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04277 XEO_CLAS Peptide DME1096 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 110.00 ug/ml) DME1096 XEOTICID XEO04277 GENEFORM Protein DME1096 XEOTICID XEO04277 MOACRIVE Inhibition DME1096 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1096 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04280 XEO_CLAS Peptide DME1096 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 37.50 ug/ml) DME1096 XEOTICID XEO04280 GENEFORM Protein DME1096 XEOTICID XEO04280 MOACRIVE Inhibition DME1096 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1096 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04281 XEO_CLAS Peptide DME1096 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25.00 ug/ml) DME1096 XEOTICID XEO04281 GENEFORM Protein DME1096 XEOTICID XEO04281 MOACRIVE Inhibition DME1096 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1096 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04282 XEO_CLAS Peptide DME1096 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.2 ug/ml) DME1096 XEOTICID XEO04282 GENEFORM Protein DME1096 XEOTICID XEO04282 MOACRIVE Inhibition DME1096 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1096 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04283 XEO_CLAS Peptide DME1096 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.3 ug/ml) DME1096 XEOTICID XEO04283 GENEFORM Protein DME1096 XEOTICID XEO04283 MOACRIVE Inhibition DME1096 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1096 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04284 XEO_CLAS Peptide DME1096 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10.8 ug/ml) DME1096 XEOTICID XEO04284 GENEFORM Protein DME1096 XEOTICID XEO04284 MOACRIVE Inhibition DME1096 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1096 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04285 XEO_CLAS Peptide DME1096 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 11.5 ug/ml) DME1096 XEOTICID XEO04285 GENEFORM Protein DME1096 XEOTICID XEO04285 MOACRIVE Inhibition DME1096 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1096 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04286 XEO_CLAS Peptide DME1096 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8.6 ug/ml) DME1096 XEOTICID XEO04286 GENEFORM Protein DME1096 XEOTICID XEO04286 MOACRIVE Inhibition DME1096 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1096 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04287 XEO_CLAS Peptide DME1096 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10.2 ug/ml) DME1096 XEOTICID XEO04287 GENEFORM Protein DME1096 XEOTICID XEO04287 MOACRIVE Inhibition DME1096 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1096 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04288 XEO_CLAS Peptide DME1096 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4.4 ug/ml) DME1096 XEOTICID XEO04288 GENEFORM Protein DME1096 XEOTICID XEO04288 MOACRIVE Inhibition DME1096 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1096 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04289 XEO_CLAS Peptide DME1096 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.2 ug/ml) DME1096 XEOTICID XEO04289 GENEFORM Protein DME1096 XEOTICID XEO04289 MOACRIVE Inhibition DME1096 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1096 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04290 XEO_CLAS Peptide DME1096 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 11.3 ug/ml) DME1096 XEOTICID XEO04290 GENEFORM Protein DME1096 XEOTICID XEO04290 MOACRIVE Inhibition DME1096 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1096 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04291 XEO_CLAS Peptide DME1096 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 7.2 ug/ml) DME1096 XEOTICID XEO04291 GENEFORM Protein DME1096 XEOTICID XEO04291 MOACRIVE Inhibition DME1096 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1096 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04292 XEO_CLAS Peptide DME1096 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.1 ug/ml) DME1096 XEOTICID XEO04292 GENEFORM Protein DME1096 XEOTICID XEO04292 MOACRIVE Inhibition DME1096 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1096 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04293 XEO_CLAS Peptide DME1096 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO04293 GENEFORM Protein DME1096 XEOTICID XEO04293 MOACRIVE Inhibition DME1096 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1096 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04294 XEO_CLAS Peptide DME1096 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO04294 GENEFORM Protein DME1096 XEOTICID XEO04294 MOACRIVE Inhibition DME1096 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1096 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04295 XEO_CLAS Peptide DME1096 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO04295 GENEFORM Protein DME1096 XEOTICID XEO04295 MOACRIVE Inhibition DME1096 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1096 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04296 XEO_CLAS Peptide DME1096 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 28 microM) DME1096 XEOTICID XEO04296 GENEFORM Protein DME1096 XEOTICID XEO04296 MOACRIVE Inhibition DME1096 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1096 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04297 XEO_CLAS Peptide DME1096 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 14 microM) DME1096 XEOTICID XEO04297 GENEFORM Protein DME1096 XEOTICID XEO04297 MOACRIVE Inhibition DME1096 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1096 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04298 XEO_CLAS Peptide DME1096 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO04298 GENEFORM Protein DME1096 XEOTICID XEO04298 MOACRIVE Inhibition DME1096 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1096 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04299 XEO_CLAS Peptide DME1096 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO04299 GENEFORM Protein DME1096 XEOTICID XEO04299 MOACRIVE Inhibition DME1096 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1096 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04300 XEO_CLAS Peptide DME1096 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO04300 GENEFORM Protein DME1096 XEOTICID XEO04300 MOACRIVE Inhibition DME1096 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1096 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04301 XEO_CLAS Peptide DME1096 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 microM) DME1096 XEOTICID XEO04301 GENEFORM Protein DME1096 XEOTICID XEO04301 MOACRIVE Inhibition DME1096 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1096 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04302 XEO_CLAS Peptide DME1096 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 microM) DME1096 XEOTICID XEO04302 GENEFORM Protein DME1096 XEOTICID XEO04302 MOACRIVE Inhibition DME1096 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1096 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04303 XEO_CLAS Peptide DME1096 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 microM) DME1096 XEOTICID XEO04303 GENEFORM Protein DME1096 XEOTICID XEO04303 MOACRIVE Inhibition DME1096 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1096 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04304 XEO_CLAS Peptide DME1096 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO04304 GENEFORM Protein DME1096 XEOTICID XEO04304 MOACRIVE Inhibition DME1096 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1096 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04305 XEO_CLAS Peptide DME1096 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 70 microM) DME1096 XEOTICID XEO04305 GENEFORM Protein DME1096 XEOTICID XEO04305 MOACRIVE Inhibition DME1096 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1096 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04306 XEO_CLAS Peptide DME1096 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO04306 GENEFORM Protein DME1096 XEOTICID XEO04306 MOACRIVE Inhibition DME1096 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1096 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04307 XEO_CLAS Peptide DME1096 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 ug/ml) DME1096 XEOTICID XEO04307 GENEFORM Protein DME1096 XEOTICID XEO04307 MOACRIVE Inhibition DME1096 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1096 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04308 XEO_CLAS Peptide DME1096 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 9.37 ug/ml) DME1096 XEOTICID XEO04308 GENEFORM Protein DME1096 XEOTICID XEO04308 MOACRIVE Inhibition DME1096 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1096 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04309 XEO_CLAS Peptide DME1096 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 microM) DME1096 XEOTICID XEO04309 GENEFORM Protein DME1096 XEOTICID XEO04309 MOACRIVE Inhibition DME1096 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1096 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04310 XEO_CLAS Peptide DME1096 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO04310 GENEFORM Protein DME1096 XEOTICID XEO04310 MOACRIVE Inhibition DME1096 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1096 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04311 XEO_CLAS Peptide DME1096 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO04311 GENEFORM Protein DME1096 XEOTICID XEO04311 MOACRIVE Inhibition DME1096 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1096 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04312 XEO_CLAS Peptide DME1096 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4.68 ug/ml) DME1096 XEOTICID XEO04312 GENEFORM Protein DME1096 XEOTICID XEO04312 MOACRIVE Inhibition DME1096 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1096 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04313 XEO_CLAS Peptide DME1096 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4.68 ug/ml) DME1096 XEOTICID XEO04313 GENEFORM Protein DME1096 XEOTICID XEO04313 MOACRIVE Inhibition DME1096 XEOTICID XEO04331 XEO_NAME Norspermidine DME1096 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1096 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04331 GENEFORM Protein DME1096 XEOTICID XEO04331 MOACRIVE Inhibition DME1096 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1096 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04335 XEO_CLAS Peptide DME1096 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 32 ug/ml) DME1096 XEOTICID XEO04335 GENEFORM Protein DME1096 XEOTICID XEO04335 MOACRIVE Inhibition DME1096 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1096 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04336 XEO_CLAS Peptide DME1096 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 32 ug/ml) DME1096 XEOTICID XEO04336 GENEFORM Protein DME1096 XEOTICID XEO04336 MOACRIVE Inhibition DME1096 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1096 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04338 XEO_CLAS Peptide DME1096 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 ug/ml) DME1096 XEOTICID XEO04338 GENEFORM Protein DME1096 XEOTICID XEO04338 MOACRIVE Inhibition DME1096 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1096 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04339 XEO_CLAS Peptide DME1096 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 ug/ml) DME1096 XEOTICID XEO04339 GENEFORM Protein DME1096 XEOTICID XEO04339 MOACRIVE Inhibition DME1096 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1096 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04340 XEO_CLAS Peptide DME1096 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO04340 GENEFORM Protein DME1096 XEOTICID XEO04340 MOACRIVE Inhibition DME1096 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1096 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04344 XEO_CLAS Peptide DME1096 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04344 GENEFORM Protein DME1096 XEOTICID XEO04344 MOACRIVE Inhibition DME1096 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1096 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04345 XEO_CLAS Peptide DME1096 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04345 GENEFORM Protein DME1096 XEOTICID XEO04345 MOACRIVE Inhibition DME1096 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1096 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04346 XEO_CLAS Peptide DME1096 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04346 GENEFORM Protein DME1096 XEOTICID XEO04346 MOACRIVE Inhibition DME1096 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1096 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04347 XEO_CLAS Peptide DME1096 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 microM) DME1096 XEOTICID XEO04347 GENEFORM Protein DME1096 XEOTICID XEO04347 MOACRIVE Inhibition DME1096 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1096 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04348 XEO_CLAS Peptide DME1096 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40 microM) DME1096 XEOTICID XEO04348 GENEFORM Protein DME1096 XEOTICID XEO04348 MOACRIVE Inhibition DME1096 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1096 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04349 XEO_CLAS Peptide DME1096 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO04349 GENEFORM Protein DME1096 XEOTICID XEO04349 MOACRIVE Inhibition DME1096 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1096 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04354 XEO_CLAS Peptide DME1096 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 35.2 ug/ml) DME1096 XEOTICID XEO04354 GENEFORM Protein DME1096 XEOTICID XEO04354 MOACRIVE Inhibition DME1096 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1096 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04355 XEO_CLAS Peptide DME1096 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.21 ug/ml) DME1096 XEOTICID XEO04355 GENEFORM Protein DME1096 XEOTICID XEO04355 MOACRIVE Inhibition DME1096 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1096 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04356 XEO_CLAS Peptide DME1096 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8.21 ug/ml) DME1096 XEOTICID XEO04356 GENEFORM Protein DME1096 XEOTICID XEO04356 MOACRIVE Inhibition DME1096 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1096 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04357 XEO_CLAS Peptide DME1096 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16.32 ug/ml) DME1096 XEOTICID XEO04357 GENEFORM Protein DME1096 XEOTICID XEO04357 MOACRIVE Inhibition DME1096 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1096 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04358 XEO_CLAS Peptide DME1096 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 9.37 ug/ml) DME1096 XEOTICID XEO04358 GENEFORM Protein DME1096 XEOTICID XEO04358 MOACRIVE Inhibition DME1096 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1096 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04359 XEO_CLAS Peptide DME1096 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4.20 ug/ml) DME1096 XEOTICID XEO04359 GENEFORM Protein DME1096 XEOTICID XEO04359 MOACRIVE Inhibition DME1096 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1096 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04360 XEO_CLAS Peptide DME1096 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 ug/ml) DME1096 XEOTICID XEO04360 GENEFORM Protein DME1096 XEOTICID XEO04360 MOACRIVE Inhibition DME1096 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1096 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04361 XEO_CLAS Peptide DME1096 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 7.5 ug/ml) DME1096 XEOTICID XEO04361 GENEFORM Protein DME1096 XEOTICID XEO04361 MOACRIVE Inhibition DME1096 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1096 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04362 XEO_CLAS Peptide DME1096 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.6 ug/ml) DME1096 XEOTICID XEO04362 GENEFORM Protein DME1096 XEOTICID XEO04362 MOACRIVE Inhibition DME1096 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1096 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04363 XEO_CLAS Peptide DME1096 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8.2 ug/ml) DME1096 XEOTICID XEO04363 GENEFORM Protein DME1096 XEOTICID XEO04363 MOACRIVE Inhibition DME1096 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1096 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04364 XEO_CLAS Peptide DME1096 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO04364 GENEFORM Protein DME1096 XEOTICID XEO04364 MOACRIVE Inhibition DME1096 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1096 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04365 XEO_CLAS Peptide DME1096 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4.68 ug/ml) DME1096 XEOTICID XEO04365 GENEFORM Protein DME1096 XEOTICID XEO04365 MOACRIVE Inhibition DME1096 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1096 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04366 XEO_CLAS Peptide DME1096 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 23.60 ug/ml) DME1096 XEOTICID XEO04366 GENEFORM Protein DME1096 XEOTICID XEO04366 MOACRIVE Inhibition DME1096 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1096 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04367 XEO_CLAS Peptide DME1096 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 35.60 ug/ml) DME1096 XEOTICID XEO04367 GENEFORM Protein DME1096 XEOTICID XEO04367 MOACRIVE Inhibition DME1096 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1096 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04368 XEO_CLAS Peptide DME1096 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40.2 ug/ml) DME1096 XEOTICID XEO04368 GENEFORM Protein DME1096 XEOTICID XEO04368 MOACRIVE Inhibition DME1096 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1096 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04369 XEO_CLAS Peptide DME1096 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40.2 ug/ml) DME1096 XEOTICID XEO04369 GENEFORM Protein DME1096 XEOTICID XEO04369 MOACRIVE Inhibition DME1096 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1096 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04370 XEO_CLAS Peptide DME1096 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4.68 ug/ml) DME1096 XEOTICID XEO04370 GENEFORM Protein DME1096 XEOTICID XEO04370 MOACRIVE Inhibition DME1096 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1096 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04371 XEO_CLAS Peptide DME1096 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 9.37 ug/ml) DME1096 XEOTICID XEO04371 GENEFORM Protein DME1096 XEOTICID XEO04371 MOACRIVE Inhibition DME1096 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1096 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04373 XEO_CLAS Peptide DME1096 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 ug/ml) DME1096 XEOTICID XEO04373 GENEFORM Protein DME1096 XEOTICID XEO04373 MOACRIVE Inhibition DME1096 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1096 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04374 XEO_CLAS Peptide DME1096 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.50 ug/ml) DME1096 XEOTICID XEO04374 GENEFORM Protein DME1096 XEOTICID XEO04374 MOACRIVE Inhibition DME1096 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1096 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04375 XEO_CLAS Peptide DME1096 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25 ug/ml) DME1096 XEOTICID XEO04375 GENEFORM Protein DME1096 XEOTICID XEO04375 MOACRIVE Inhibition DME1096 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1096 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04377 XEO_CLAS Peptide DME1096 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 42.50 ug/ml) DME1096 XEOTICID XEO04377 GENEFORM Protein DME1096 XEOTICID XEO04377 MOACRIVE Inhibition DME1096 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1096 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04378 XEO_CLAS Peptide DME1096 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 17.50 ug/ml) DME1096 XEOTICID XEO04378 GENEFORM Protein DME1096 XEOTICID XEO04378 MOACRIVE Inhibition DME1096 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1096 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04379 XEO_CLAS Peptide DME1096 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 ug/ml) DME1096 XEOTICID XEO04379 GENEFORM Protein DME1096 XEOTICID XEO04379 MOACRIVE Inhibition DME1096 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1096 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04380 XEO_CLAS Peptide DME1096 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 36.00 ug/ml) DME1096 XEOTICID XEO04380 GENEFORM Protein DME1096 XEOTICID XEO04380 MOACRIVE Inhibition DME1096 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1096 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04381 XEO_CLAS Peptide DME1096 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.60 ug/ml) DME1096 XEOTICID XEO04381 GENEFORM Protein DME1096 XEOTICID XEO04381 MOACRIVE Inhibition DME1096 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1096 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04382 XEO_CLAS Peptide DME1096 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 ug/ml) DME1096 XEOTICID XEO04382 GENEFORM Protein DME1096 XEOTICID XEO04382 MOACRIVE Inhibition DME1096 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1096 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04383 XEO_CLAS Peptide DME1096 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO04383 GENEFORM Protein DME1096 XEOTICID XEO04383 MOACRIVE Inhibition DME1096 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1096 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04384 XEO_CLAS Peptide DME1096 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO04384 GENEFORM Protein DME1096 XEOTICID XEO04384 MOACRIVE Inhibition DME1096 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1096 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04385 XEO_CLAS Peptide DME1096 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.25 ug/ml) DME1096 XEOTICID XEO04385 GENEFORM Protein DME1096 XEOTICID XEO04385 MOACRIVE Inhibition DME1096 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1096 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04395 XEO_CLAS Peptide DME1096 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.4-0.8 microM) DME1096 XEOTICID XEO04395 GENEFORM Protein DME1096 XEOTICID XEO04395 MOACRIVE Inhibition DME1096 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1096 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04396 XEO_CLAS Peptide DME1096 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.25-0.5 microM) DME1096 XEOTICID XEO04396 GENEFORM Protein DME1096 XEOTICID XEO04396 MOACRIVE Inhibition DME1096 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1096 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04397 XEO_CLAS Peptide DME1096 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.25-0.5 microM) DME1096 XEOTICID XEO04397 GENEFORM Protein DME1096 XEOTICID XEO04397 MOACRIVE Inhibition DME1096 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1096 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04398 XEO_CLAS Peptide DME1096 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 microM) DME1096 XEOTICID XEO04398 GENEFORM Protein DME1096 XEOTICID XEO04398 MOACRIVE Inhibition DME1096 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1096 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04399 XEO_CLAS Peptide DME1096 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO04399 GENEFORM Protein DME1096 XEOTICID XEO04399 MOACRIVE Inhibition DME1096 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1096 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04400 XEO_CLAS Peptide DME1096 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 ug/ml) DME1096 XEOTICID XEO04400 GENEFORM Protein DME1096 XEOTICID XEO04400 MOACRIVE Inhibition DME1096 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1096 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04401 XEO_CLAS Peptide DME1096 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.6 ug/ml) DME1096 XEOTICID XEO04401 GENEFORM Protein DME1096 XEOTICID XEO04401 MOACRIVE Inhibition DME1096 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1096 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04402 XEO_CLAS Peptide DME1096 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 ug/ml) DME1096 XEOTICID XEO04402 GENEFORM Protein DME1096 XEOTICID XEO04402 MOACRIVE Inhibition DME1096 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1096 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04403 XEO_CLAS Peptide DME1096 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.6 ug/ml) DME1096 XEOTICID XEO04403 GENEFORM Protein DME1096 XEOTICID XEO04403 MOACRIVE Inhibition DME1096 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1096 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04404 XEO_CLAS Peptide DME1096 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.6 ug/ml) DME1096 XEOTICID XEO04404 GENEFORM Protein DME1096 XEOTICID XEO04404 MOACRIVE Inhibition DME1096 XEOTICID XEO04410 XEO_NAME Insect osmin DME1096 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04410 XEO_CLAS Peptide DME1096 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.125-1.56 microM) DME1096 XEOTICID XEO04410 GENEFORM Protein DME1096 XEOTICID XEO04410 MOACRIVE Inhibition DME1096 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1096 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04412 XEO_CLAS Peptide DME1096 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04412 GENEFORM Protein DME1096 XEOTICID XEO04412 MOACRIVE Inhibition DME1096 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1096 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04414 XEO_CLAS Peptide DME1096 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04414 GENEFORM Protein DME1096 XEOTICID XEO04414 MOACRIVE Inhibition DME1096 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1096 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04415 XEO_CLAS Peptide DME1096 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04415 GENEFORM Protein DME1096 XEOTICID XEO04415 MOACRIVE Inhibition DME1096 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1096 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04421 XEO_CLAS Peptide DME1096 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 microM) DME1096 XEOTICID XEO04421 GENEFORM Protein DME1096 XEOTICID XEO04421 MOACRIVE Inhibition DME1096 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1096 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04426 XEO_CLAS Peptide DME1096 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO04426 GENEFORM Protein DME1096 XEOTICID XEO04426 MOACRIVE Inhibition DME1096 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1096 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04428 XEO_CLAS Peptide DME1096 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.3 ug/ml) DME1096 XEOTICID XEO04428 GENEFORM Protein DME1096 XEOTICID XEO04428 MOACRIVE Inhibition DME1096 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1096 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04430 XEO_CLAS Peptide DME1096 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25 microM) DME1096 XEOTICID XEO04430 GENEFORM Protein DME1096 XEOTICID XEO04430 MOACRIVE Inhibition DME1096 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1096 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04433 XEO_CLAS Peptide DME1096 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 160 microM) DME1096 XEOTICID XEO04433 GENEFORM Protein DME1096 XEOTICID XEO04433 MOACRIVE Inhibition DME1096 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1096 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04435 XEO_CLAS Peptide DME1096 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 160 microM) DME1096 XEOTICID XEO04435 GENEFORM Protein DME1096 XEOTICID XEO04435 MOACRIVE Inhibition DME1096 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1096 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1096 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04438 GENEFORM Protein DME1096 XEOTICID XEO04438 MOACRIVE Inhibition DME1096 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1096 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04439 XEO_CLAS Peptide DME1096 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04439 GENEFORM Protein DME1096 XEOTICID XEO04439 MOACRIVE Inhibition DME1096 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1096 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04440 XEO_CLAS Peptide DME1096 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 microM) DME1096 XEOTICID XEO04440 GENEFORM Protein DME1096 XEOTICID XEO04440 MOACRIVE Inhibition DME1096 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1096 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04441 XEO_CLAS Peptide DME1096 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 28 microM) DME1096 XEOTICID XEO04441 GENEFORM Protein DME1096 XEOTICID XEO04441 MOACRIVE Inhibition DME1096 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1096 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04442 XEO_CLAS Peptide DME1096 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 28 microM) DME1096 XEOTICID XEO04442 GENEFORM Protein DME1096 XEOTICID XEO04442 MOACRIVE Inhibition DME1096 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1096 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04443 XEO_CLAS Peptide DME1096 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04443 GENEFORM Protein DME1096 XEOTICID XEO04443 MOACRIVE Inhibition DME1096 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1096 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04444 XEO_CLAS Peptide DME1096 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 13 microM) DME1096 XEOTICID XEO04444 GENEFORM Protein DME1096 XEOTICID XEO04444 MOACRIVE Inhibition DME1096 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1096 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04445 XEO_CLAS Peptide DME1096 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04445 GENEFORM Protein DME1096 XEOTICID XEO04445 MOACRIVE Inhibition DME1096 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1096 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04446 XEO_CLAS Peptide DME1096 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 78 microM) DME1096 XEOTICID XEO04446 GENEFORM Protein DME1096 XEOTICID XEO04446 MOACRIVE Inhibition DME1096 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1096 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04447 XEO_CLAS Peptide DME1096 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 120 microM) DME1096 XEOTICID XEO04447 GENEFORM Protein DME1096 XEOTICID XEO04447 MOACRIVE Inhibition DME1096 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1096 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04448 XEO_CLAS Peptide DME1096 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 microM) DME1096 XEOTICID XEO04448 GENEFORM Protein DME1096 XEOTICID XEO04448 MOACRIVE Inhibition DME1096 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1096 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04449 XEO_CLAS Peptide DME1096 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.3 microM) DME1096 XEOTICID XEO04449 GENEFORM Protein DME1096 XEOTICID XEO04449 MOACRIVE Inhibition DME1096 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1096 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04450 XEO_CLAS Peptide DME1096 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.3 microM) DME1096 XEOTICID XEO04450 GENEFORM Protein DME1096 XEOTICID XEO04450 MOACRIVE Inhibition DME1096 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1096 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04451 XEO_CLAS Peptide DME1096 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO04451 GENEFORM Protein DME1096 XEOTICID XEO04451 MOACRIVE Inhibition DME1096 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1096 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04452 XEO_CLAS Peptide DME1096 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.1 microM) DME1096 XEOTICID XEO04452 GENEFORM Protein DME1096 XEOTICID XEO04452 MOACRIVE Inhibition DME1096 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1096 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04453 XEO_CLAS Peptide DME1096 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO04453 GENEFORM Protein DME1096 XEOTICID XEO04453 MOACRIVE Inhibition DME1096 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1096 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04455 XEO_CLAS Peptide DME1096 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 microM) DME1096 XEOTICID XEO04455 GENEFORM Protein DME1096 XEOTICID XEO04455 MOACRIVE Inhibition DME1096 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1096 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04457 XEO_CLAS Peptide DME1096 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.3 microM) DME1096 XEOTICID XEO04457 GENEFORM Protein DME1096 XEOTICID XEO04457 MOACRIVE Inhibition DME1096 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1096 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04458 XEO_CLAS Peptide DME1096 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1 microM) DME1096 XEOTICID XEO04458 GENEFORM Protein DME1096 XEOTICID XEO04458 MOACRIVE Inhibition DME1096 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1096 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04459 XEO_CLAS Peptide DME1096 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1 microM) DME1096 XEOTICID XEO04459 GENEFORM Protein DME1096 XEOTICID XEO04459 MOACRIVE Inhibition DME1096 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1096 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04461 XEO_CLAS Peptide DME1096 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20.8 microM) DME1096 XEOTICID XEO04461 GENEFORM Protein DME1096 XEOTICID XEO04461 MOACRIVE Inhibition DME1096 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1096 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04462 XEO_CLAS Peptide DME1096 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 19.1 microM) DME1096 XEOTICID XEO04462 GENEFORM Protein DME1096 XEOTICID XEO04462 MOACRIVE Inhibition DME1096 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1096 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04463 XEO_CLAS Peptide DME1096 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04463 GENEFORM Protein DME1096 XEOTICID XEO04463 MOACRIVE Inhibition DME1096 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1096 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04464 XEO_CLAS Peptide DME1096 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.5 microM) DME1096 XEOTICID XEO04464 GENEFORM Protein DME1096 XEOTICID XEO04464 MOACRIVE Inhibition DME1096 XEOTICID XEO04466 XEO_NAME Panusin DME1096 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04466 XEO_CLAS Peptide DME1096 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04466 GENEFORM Protein DME1096 XEOTICID XEO04466 MOACRIVE Inhibition DME1096 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1096 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04467 XEO_CLAS Peptide DME1096 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4.8 microM) DME1096 XEOTICID XEO04467 GENEFORM Protein DME1096 XEOTICID XEO04467 MOACRIVE Inhibition DME1096 XEOTICID XEO04468 XEO_NAME Papillosin DME1096 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04468 XEO_CLAS Peptide DME1096 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04468 GENEFORM Protein DME1096 XEOTICID XEO04468 MOACRIVE Inhibition DME1096 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1096 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04471 XEO_CLAS Peptide DME1096 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.1 microM) DME1096 XEOTICID XEO04471 GENEFORM Protein DME1096 XEOTICID XEO04471 MOACRIVE Inhibition DME1096 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1096 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04480 XEO_CLAS Peptide DME1096 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 ug/ml) DME1096 XEOTICID XEO04480 GENEFORM Protein DME1096 XEOTICID XEO04480 MOACRIVE Inhibition DME1096 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1096 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1096 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04482 GENEFORM Protein DME1096 XEOTICID XEO04482 MOACRIVE Inhibition DME1096 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1096 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04484 XEO_CLAS Peptide DME1096 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 microM) DME1096 XEOTICID XEO04484 GENEFORM Protein DME1096 XEOTICID XEO04484 MOACRIVE Inhibition DME1096 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1096 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04485 XEO_CLAS Peptide DME1096 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO04485 GENEFORM Protein DME1096 XEOTICID XEO04485 MOACRIVE Inhibition DME1096 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1096 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04486 XEO_CLAS Peptide DME1096 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 microM) DME1096 XEOTICID XEO04486 GENEFORM Protein DME1096 XEOTICID XEO04486 MOACRIVE Inhibition DME1096 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1096 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04487 XEO_CLAS Peptide DME1096 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO04487 GENEFORM Protein DME1096 XEOTICID XEO04487 MOACRIVE Inhibition DME1096 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1096 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04488 XEO_CLAS Peptide DME1096 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 9 microM) DME1096 XEOTICID XEO04488 GENEFORM Protein DME1096 XEOTICID XEO04488 MOACRIVE Inhibition DME1096 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1096 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04489 XEO_CLAS Peptide DME1096 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 13 microM) DME1096 XEOTICID XEO04489 GENEFORM Protein DME1096 XEOTICID XEO04489 MOACRIVE Inhibition DME1096 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1096 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04490 XEO_CLAS Peptide DME1096 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 47.5 microM) DME1096 XEOTICID XEO04490 GENEFORM Protein DME1096 XEOTICID XEO04490 MOACRIVE Inhibition DME1096 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1096 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04491 XEO_CLAS Peptide DME1096 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO04491 GENEFORM Protein DME1096 XEOTICID XEO04491 MOACRIVE Inhibition DME1096 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1096 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04492 XEO_CLAS Peptide DME1096 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 35 microM) DME1096 XEOTICID XEO04492 GENEFORM Protein DME1096 XEOTICID XEO04492 MOACRIVE Inhibition DME1096 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1096 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04493 XEO_CLAS Peptide DME1096 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 microM) DME1096 XEOTICID XEO04493 GENEFORM Protein DME1096 XEOTICID XEO04493 MOACRIVE Inhibition DME1096 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1096 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04494 XEO_CLAS Peptide DME1096 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO04494 GENEFORM Protein DME1096 XEOTICID XEO04494 MOACRIVE Inhibition DME1096 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1096 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04495 XEO_CLAS Peptide DME1096 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO04495 GENEFORM Protein DME1096 XEOTICID XEO04495 MOACRIVE Inhibition DME1096 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1096 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04496 XEO_CLAS Peptide DME1096 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 67.5 microM) DME1096 XEOTICID XEO04496 GENEFORM Protein DME1096 XEOTICID XEO04496 MOACRIVE Inhibition DME1096 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1096 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04497 XEO_CLAS Peptide DME1096 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO04497 GENEFORM Protein DME1096 XEOTICID XEO04497 MOACRIVE Inhibition DME1096 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1096 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04498 XEO_CLAS Peptide DME1096 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO04498 GENEFORM Protein DME1096 XEOTICID XEO04498 MOACRIVE Inhibition DME1096 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1096 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04499 XEO_CLAS Peptide DME1096 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 43 microM) DME1096 XEOTICID XEO04499 GENEFORM Protein DME1096 XEOTICID XEO04499 MOACRIVE Inhibition DME1096 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1096 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04500 XEO_CLAS Peptide DME1096 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO04500 GENEFORM Protein DME1096 XEOTICID XEO04500 MOACRIVE Inhibition DME1096 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1096 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04504 XEO_CLAS Peptide DME1096 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04504 GENEFORM Protein DME1096 XEOTICID XEO04504 MOACRIVE Inhibition DME1096 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1096 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04505 XEO_CLAS Peptide DME1096 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04505 GENEFORM Protein DME1096 XEOTICID XEO04505 MOACRIVE Inhibition DME1096 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1096 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04506 XEO_CLAS Peptide DME1096 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 40 microM) DME1096 XEOTICID XEO04506 GENEFORM Protein DME1096 XEOTICID XEO04506 MOACRIVE Inhibition DME1096 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1096 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04507 XEO_CLAS Peptide DME1096 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10-20 microM) DME1096 XEOTICID XEO04507 GENEFORM Protein DME1096 XEOTICID XEO04507 MOACRIVE Inhibition DME1096 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1096 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04508 XEO_CLAS Peptide DME1096 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04508 GENEFORM Protein DME1096 XEOTICID XEO04508 MOACRIVE Inhibition DME1096 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1096 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04509 XEO_CLAS Peptide DME1096 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04509 GENEFORM Protein DME1096 XEOTICID XEO04509 MOACRIVE Inhibition DME1096 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1096 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04510 XEO_CLAS Peptide DME1096 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 22-33 microM) DME1096 XEOTICID XEO04510 GENEFORM Protein DME1096 XEOTICID XEO04510 MOACRIVE Inhibition DME1096 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1096 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04525 XEO_CLAS Peptide DME1096 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 32.0 microM) DME1096 XEOTICID XEO04525 GENEFORM Protein DME1096 XEOTICID XEO04525 MOACRIVE Inhibition DME1096 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1096 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04526 XEO_CLAS Peptide DME1096 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.0 microM) DME1096 XEOTICID XEO04526 GENEFORM Protein DME1096 XEOTICID XEO04526 MOACRIVE Inhibition DME1096 XEOTICID XEO04527 XEO_NAME Pepcon DME1096 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04527 XEO_CLAS Peptide DME1096 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO04527 GENEFORM Protein DME1096 XEOTICID XEO04527 MOACRIVE Inhibition DME1096 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1096 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04532 XEO_CLAS Peptide DME1096 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04532 GENEFORM Protein DME1096 XEOTICID XEO04532 MOACRIVE Inhibition DME1096 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1096 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04540 XEO_CLAS Peptide DME1096 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 18.1 ug/ml) DME1096 XEOTICID XEO04540 GENEFORM Protein DME1096 XEOTICID XEO04540 MOACRIVE Inhibition DME1096 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1096 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04541 XEO_CLAS Peptide DME1096 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.5 ug/ml) DME1096 XEOTICID XEO04541 GENEFORM Protein DME1096 XEOTICID XEO04541 MOACRIVE Inhibition DME1096 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1096 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04542 XEO_CLAS Peptide DME1096 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04542 GENEFORM Protein DME1096 XEOTICID XEO04542 MOACRIVE Inhibition DME1096 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1096 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04543 XEO_CLAS Peptide DME1096 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04543 GENEFORM Protein DME1096 XEOTICID XEO04543 MOACRIVE Inhibition DME1096 XEOTICID XEO04546 XEO_NAME Perinerin DME1096 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04546 XEO_CLAS Peptide DME1096 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04546 GENEFORM Protein DME1096 XEOTICID XEO04546 MOACRIVE Inhibition DME1096 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1096 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04548 XEO_CLAS Peptide DME1096 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 72000 ug/ml) DME1096 XEOTICID XEO04548 GENEFORM Protein DME1096 XEOTICID XEO04548 MOACRIVE Inhibition DME1096 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1096 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04549 XEO_CLAS Peptide DME1096 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 62-125 ug/ml) DME1096 XEOTICID XEO04549 GENEFORM Protein DME1096 XEOTICID XEO04549 MOACRIVE Inhibition DME1096 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1096 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04550 XEO_CLAS Peptide DME1096 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO04550 GENEFORM Protein DME1096 XEOTICID XEO04550 MOACRIVE Inhibition DME1096 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1096 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04551 XEO_CLAS Peptide DME1096 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 23.6 ug/ml) DME1096 XEOTICID XEO04551 GENEFORM Protein DME1096 XEOTICID XEO04551 MOACRIVE Inhibition DME1096 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1096 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04552 XEO_CLAS Peptide DME1096 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04552 GENEFORM Protein DME1096 XEOTICID XEO04552 MOACRIVE Inhibition DME1096 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1096 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04553 XEO_CLAS Peptide DME1096 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04553 GENEFORM Protein DME1096 XEOTICID XEO04553 MOACRIVE Inhibition DME1096 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1096 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04554 XEO_CLAS Peptide DME1096 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04554 GENEFORM Protein DME1096 XEOTICID XEO04554 MOACRIVE Inhibition DME1096 XEOTICID XEO04563 XEO_NAME Phosphate DME1096 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1096 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04563 GENEFORM Protein DME1096 XEOTICID XEO04563 MOACRIVE Inhibition DME1096 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1096 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04565 XEO_CLAS Peptide DME1096 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.5 microM) DME1096 XEOTICID XEO04565 GENEFORM Protein DME1096 XEOTICID XEO04565 MOACRIVE Inhibition DME1096 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1096 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04566 XEO_CLAS Peptide DME1096 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.7 microM) DME1096 XEOTICID XEO04566 GENEFORM Protein DME1096 XEOTICID XEO04566 MOACRIVE Inhibition DME1096 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1096 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04569 XEO_CLAS Peptide DME1096 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 7.9 microM) DME1096 XEOTICID XEO04569 GENEFORM Protein DME1096 XEOTICID XEO04569 MOACRIVE Inhibition DME1096 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1096 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04570 XEO_CLAS Peptide DME1096 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04570 GENEFORM Protein DME1096 XEOTICID XEO04570 MOACRIVE Inhibition DME1096 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1096 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04571 XEO_CLAS Peptide DME1096 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04571 GENEFORM Protein DME1096 XEOTICID XEO04571 MOACRIVE Inhibition DME1096 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1096 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04572 XEO_CLAS Peptide DME1096 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04572 GENEFORM Protein DME1096 XEOTICID XEO04572 MOACRIVE Inhibition DME1096 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1096 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04573 XEO_CLAS Peptide DME1096 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 microM) DME1096 XEOTICID XEO04573 GENEFORM Protein DME1096 XEOTICID XEO04573 MOACRIVE Inhibition DME1096 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1096 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04574 XEO_CLAS Peptide DME1096 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 128 ug/ml) DME1096 XEOTICID XEO04574 GENEFORM Protein DME1096 XEOTICID XEO04574 MOACRIVE Inhibition DME1096 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1096 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04575 XEO_CLAS Peptide DME1096 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO04575 GENEFORM Protein DME1096 XEOTICID XEO04575 MOACRIVE Inhibition DME1096 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1096 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04578 GENEFORM Protein DME1096 XEOTICID XEO04578 MOACRIVE Inhibition DME1096 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1096 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04579 GENEFORM Protein DME1096 XEOTICID XEO04579 MOACRIVE Inhibition DME1096 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1096 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04580 GENEFORM Protein DME1096 XEOTICID XEO04580 MOACRIVE Inhibition DME1096 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1096 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04583 GENEFORM Protein DME1096 XEOTICID XEO04583 MOACRIVE Inhibition DME1096 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1096 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04588 GENEFORM Protein DME1096 XEOTICID XEO04588 MOACRIVE Inhibition DME1096 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1096 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04589 GENEFORM Protein DME1096 XEOTICID XEO04589 MOACRIVE Inhibition DME1096 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1096 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04590 GENEFORM Protein DME1096 XEOTICID XEO04590 MOACRIVE Inhibition DME1096 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1096 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04591 GENEFORM Protein DME1096 XEOTICID XEO04591 MOACRIVE Inhibition DME1096 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1096 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04592 GENEFORM Protein DME1096 XEOTICID XEO04592 MOACRIVE Inhibition DME1096 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1096 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04593 GENEFORM Protein DME1096 XEOTICID XEO04593 MOACRIVE Inhibition DME1096 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1096 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04594 GENEFORM Protein DME1096 XEOTICID XEO04594 MOACRIVE Inhibition DME1096 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1096 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04595 GENEFORM Protein DME1096 XEOTICID XEO04595 MOACRIVE Inhibition DME1096 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1096 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04596 GENEFORM Protein DME1096 XEOTICID XEO04596 MOACRIVE Inhibition DME1096 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1096 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04597 GENEFORM Protein DME1096 XEOTICID XEO04597 MOACRIVE Inhibition DME1096 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1096 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04598 GENEFORM Protein DME1096 XEOTICID XEO04598 MOACRIVE Inhibition DME1096 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1096 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04599 GENEFORM Protein DME1096 XEOTICID XEO04599 MOACRIVE Inhibition DME1096 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1096 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04601 XEO_CLAS Peptide DME1096 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 18.75 ug/ml) DME1096 XEOTICID XEO04601 GENEFORM Protein DME1096 XEOTICID XEO04601 MOACRIVE Inhibition DME1096 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1096 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04602 XEO_CLAS Peptide DME1096 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 37.5 ug/ml) DME1096 XEOTICID XEO04602 GENEFORM Protein DME1096 XEOTICID XEO04602 MOACRIVE Inhibition DME1096 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1096 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04604 XEO_CLAS Peptide DME1096 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC < 25 microM) DME1096 XEOTICID XEO04604 GENEFORM Protein DME1096 XEOTICID XEO04604 MOACRIVE Inhibition DME1096 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1096 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04605 XEO_CLAS Peptide DME1096 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC < 6.25 microM) DME1096 XEOTICID XEO04605 GENEFORM Protein DME1096 XEOTICID XEO04605 MOACRIVE Inhibition DME1096 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1096 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04606 XEO_CLAS Peptide DME1096 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO04606 GENEFORM Protein DME1096 XEOTICID XEO04606 MOACRIVE Inhibition DME1096 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1096 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1096 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04607 GENEFORM Protein DME1096 XEOTICID XEO04607 MOACRIVE Inhibition DME1096 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1096 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04612 XEO_CLAS Peptide DME1096 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5-10 microM) DME1096 XEOTICID XEO04612 GENEFORM Protein DME1096 XEOTICID XEO04612 MOACRIVE Inhibition DME1096 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1096 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04613 XEO_CLAS Peptide DME1096 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5-10 microM) DME1096 XEOTICID XEO04613 GENEFORM Protein DME1096 XEOTICID XEO04613 MOACRIVE Inhibition DME1096 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1096 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04625 XEO_CLAS Peptide DME1096 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO04625 GENEFORM Protein DME1096 XEOTICID XEO04625 MOACRIVE Inhibition DME1096 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1096 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04626 XEO_CLAS Peptide DME1096 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO04626 GENEFORM Protein DME1096 XEOTICID XEO04626 MOACRIVE Inhibition DME1096 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1096 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04627 XEO_CLAS Peptide DME1096 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.5 microM) DME1096 XEOTICID XEO04627 GENEFORM Protein DME1096 XEOTICID XEO04627 MOACRIVE Inhibition DME1096 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1096 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04630 XEO_CLAS Peptide DME1096 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 60 ug/ml) DME1096 XEOTICID XEO04630 GENEFORM Protein DME1096 XEOTICID XEO04630 MOACRIVE Inhibition DME1096 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1096 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04631 XEO_CLAS Peptide DME1096 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 60 ug/ml) DME1096 XEOTICID XEO04631 GENEFORM Protein DME1096 XEOTICID XEO04631 MOACRIVE Inhibition DME1096 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1096 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04633 XEO_CLAS Peptide DME1096 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 ug/ml) DME1096 XEOTICID XEO04633 GENEFORM Protein DME1096 XEOTICID XEO04633 MOACRIVE Inhibition DME1096 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1096 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04634 XEO_CLAS Peptide DME1096 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 ug/ml) DME1096 XEOTICID XEO04634 GENEFORM Protein DME1096 XEOTICID XEO04634 MOACRIVE Inhibition DME1096 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1096 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04635 XEO_CLAS Peptide DME1096 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 ug/ml) DME1096 XEOTICID XEO04635 GENEFORM Protein DME1096 XEOTICID XEO04635 MOACRIVE Inhibition DME1096 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1096 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04636 XEO_CLAS Peptide DME1096 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 ug/ml) DME1096 XEOTICID XEO04636 GENEFORM Protein DME1096 XEOTICID XEO04636 MOACRIVE Inhibition DME1096 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1096 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04637 XEO_CLAS Peptide DME1096 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 ug/ml) DME1096 XEOTICID XEO04637 GENEFORM Protein DME1096 XEOTICID XEO04637 MOACRIVE Inhibition DME1096 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1096 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04638 XEO_CLAS Peptide DME1096 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 ug/ml) DME1096 XEOTICID XEO04638 GENEFORM Protein DME1096 XEOTICID XEO04638 MOACRIVE Inhibition DME1096 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1096 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04639 XEO_CLAS Peptide DME1096 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 ug/ml) DME1096 XEOTICID XEO04639 GENEFORM Protein DME1096 XEOTICID XEO04639 MOACRIVE Inhibition DME1096 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1096 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04640 XEO_CLAS Peptide DME1096 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.2-3.3 microM) DME1096 XEOTICID XEO04640 GENEFORM Protein DME1096 XEOTICID XEO04640 MOACRIVE Inhibition DME1096 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1096 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04642 XEO_CLAS Peptide DME1096 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 ug/ml) DME1096 XEOTICID XEO04642 GENEFORM Protein DME1096 XEOTICID XEO04642 MOACRIVE Inhibition DME1096 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1096 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04643 XEO_CLAS Peptide DME1096 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO04643 GENEFORM Protein DME1096 XEOTICID XEO04643 MOACRIVE Inhibition DME1096 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1096 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04644 XEO_CLAS Peptide DME1096 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO04644 GENEFORM Protein DME1096 XEOTICID XEO04644 MOACRIVE Inhibition DME1096 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1096 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04645 XEO_CLAS Peptide DME1096 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 ug/ml) DME1096 XEOTICID XEO04645 GENEFORM Protein DME1096 XEOTICID XEO04645 MOACRIVE Inhibition DME1096 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1096 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04646 XEO_CLAS Peptide DME1096 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1 ug/ml) DME1096 XEOTICID XEO04646 GENEFORM Protein DME1096 XEOTICID XEO04646 MOACRIVE Inhibition DME1096 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1096 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04647 XEO_CLAS Peptide DME1096 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO04647 GENEFORM Protein DME1096 XEOTICID XEO04647 MOACRIVE Inhibition DME1096 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1096 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04648 XEO_CLAS Peptide DME1096 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 ug/ml) DME1096 XEOTICID XEO04648 GENEFORM Protein DME1096 XEOTICID XEO04648 MOACRIVE Inhibition DME1096 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1096 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04649 XEO_CLAS Peptide DME1096 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 64 ug/ml) DME1096 XEOTICID XEO04649 GENEFORM Protein DME1096 XEOTICID XEO04649 MOACRIVE Inhibition DME1096 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1096 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04650 XEO_CLAS Peptide DME1096 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 ug/ml) DME1096 XEOTICID XEO04650 GENEFORM Protein DME1096 XEOTICID XEO04650 MOACRIVE Inhibition DME1096 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1096 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04651 XEO_CLAS Peptide DME1096 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 ug/ml) DME1096 XEOTICID XEO04651 GENEFORM Protein DME1096 XEOTICID XEO04651 MOACRIVE Inhibition DME1096 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1096 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04652 XEO_CLAS Peptide DME1096 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO04652 GENEFORM Protein DME1096 XEOTICID XEO04652 MOACRIVE Inhibition DME1096 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1096 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04653 XEO_CLAS Peptide DME1096 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 64 ug/ml) DME1096 XEOTICID XEO04653 GENEFORM Protein DME1096 XEOTICID XEO04653 MOACRIVE Inhibition DME1096 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1096 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04654 XEO_CLAS Peptide DME1096 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 ug/ml) DME1096 XEOTICID XEO04654 GENEFORM Protein DME1096 XEOTICID XEO04654 MOACRIVE Inhibition DME1096 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1096 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04655 XEO_CLAS Peptide DME1096 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO04655 GENEFORM Protein DME1096 XEOTICID XEO04655 MOACRIVE Inhibition DME1096 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1096 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04657 XEO_CLAS Peptide DME1096 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 300 microM) DME1096 XEOTICID XEO04657 GENEFORM Protein DME1096 XEOTICID XEO04657 MOACRIVE Inhibition DME1096 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1096 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04660 XEO_CLAS Peptide DME1096 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO04660 GENEFORM Protein DME1096 XEOTICID XEO04660 MOACRIVE Inhibition DME1096 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1096 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04661 XEO_CLAS Peptide DME1096 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 microM) DME1096 XEOTICID XEO04661 GENEFORM Protein DME1096 XEOTICID XEO04661 MOACRIVE Inhibition DME1096 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1096 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04662 XEO_CLAS Peptide DME1096 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 microM) DME1096 XEOTICID XEO04662 GENEFORM Protein DME1096 XEOTICID XEO04662 MOACRIVE Inhibition DME1096 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1096 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04663 XEO_CLAS Peptide DME1096 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 microM) DME1096 XEOTICID XEO04663 GENEFORM Protein DME1096 XEOTICID XEO04663 MOACRIVE Inhibition DME1096 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1096 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04664 XEO_CLAS Peptide DME1096 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5.5 microM) DME1096 XEOTICID XEO04664 GENEFORM Protein DME1096 XEOTICID XEO04664 MOACRIVE Inhibition DME1096 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1096 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04665 XEO_CLAS Peptide DME1096 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 microM) DME1096 XEOTICID XEO04665 GENEFORM Protein DME1096 XEOTICID XEO04665 MOACRIVE Inhibition DME1096 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1096 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04666 XEO_CLAS Peptide DME1096 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO04666 GENEFORM Protein DME1096 XEOTICID XEO04666 MOACRIVE Inhibition DME1096 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1096 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04667 XEO_CLAS Peptide DME1096 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6.25 microM) DME1096 XEOTICID XEO04667 GENEFORM Protein DME1096 XEOTICID XEO04667 MOACRIVE Inhibition DME1096 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1096 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04668 XEO_CLAS Peptide DME1096 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 microM) DME1096 XEOTICID XEO04668 GENEFORM Protein DME1096 XEOTICID XEO04668 MOACRIVE Inhibition DME1096 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1096 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04669 XEO_CLAS Peptide DME1096 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO04669 GENEFORM Protein DME1096 XEOTICID XEO04669 MOACRIVE Inhibition DME1096 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1096 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04670 XEO_CLAS Peptide DME1096 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 21 microM) DME1096 XEOTICID XEO04670 GENEFORM Protein DME1096 XEOTICID XEO04670 MOACRIVE Inhibition DME1096 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1096 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04671 XEO_CLAS Peptide DME1096 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 62 microM) DME1096 XEOTICID XEO04671 GENEFORM Protein DME1096 XEOTICID XEO04671 MOACRIVE Inhibition DME1096 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1096 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04672 XEO_CLAS Peptide DME1096 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO04672 GENEFORM Protein DME1096 XEOTICID XEO04672 MOACRIVE Inhibition DME1096 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1096 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04673 XEO_CLAS Peptide DME1096 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO04673 GENEFORM Protein DME1096 XEOTICID XEO04673 MOACRIVE Inhibition DME1096 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1096 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04674 XEO_CLAS Peptide DME1096 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 75 microM) DME1096 XEOTICID XEO04674 GENEFORM Protein DME1096 XEOTICID XEO04674 MOACRIVE Inhibition DME1096 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1096 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04675 XEO_CLAS Peptide DME1096 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 microM) DME1096 XEOTICID XEO04675 GENEFORM Protein DME1096 XEOTICID XEO04675 MOACRIVE Inhibition DME1096 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1096 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04676 XEO_CLAS Peptide DME1096 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 microM) DME1096 XEOTICID XEO04676 GENEFORM Protein DME1096 XEOTICID XEO04676 MOACRIVE Inhibition DME1096 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1096 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04677 XEO_CLAS Peptide DME1096 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO04677 GENEFORM Protein DME1096 XEOTICID XEO04677 MOACRIVE Inhibition DME1096 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1096 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04680 XEO_CLAS Peptide DME1096 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 microM) DME1096 XEOTICID XEO04680 GENEFORM Protein DME1096 XEOTICID XEO04680 MOACRIVE Inhibition DME1096 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1096 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04682 XEO_CLAS Peptide DME1096 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 microM) DME1096 XEOTICID XEO04682 GENEFORM Protein DME1096 XEOTICID XEO04682 MOACRIVE Inhibition DME1096 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1096 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04683 XEO_CLAS Peptide DME1096 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 microM) DME1096 XEOTICID XEO04683 GENEFORM Protein DME1096 XEOTICID XEO04683 MOACRIVE Inhibition DME1096 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1096 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04684 XEO_CLAS Peptide DME1096 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 38 microM) DME1096 XEOTICID XEO04684 GENEFORM Protein DME1096 XEOTICID XEO04684 MOACRIVE Inhibition DME1096 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1096 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04690 XEO_CLAS Peptide DME1096 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.5 ug/ml) DME1096 XEOTICID XEO04690 GENEFORM Protein DME1096 XEOTICID XEO04690 MOACRIVE Inhibition DME1096 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1096 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04695 XEO_CLAS Peptide DME1096 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04695 GENEFORM Protein DME1096 XEOTICID XEO04695 MOACRIVE Inhibition DME1096 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1096 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04696 XEO_CLAS Peptide DME1096 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04696 GENEFORM Protein DME1096 XEOTICID XEO04696 MOACRIVE Inhibition DME1096 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1096 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04712 XEO_CLAS Peptide DME1096 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16.7 microM) DME1096 XEOTICID XEO04712 GENEFORM Protein DME1096 XEOTICID XEO04712 MOACRIVE Inhibition DME1096 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1096 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04713 XEO_CLAS Peptide DME1096 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16.7 microM) DME1096 XEOTICID XEO04713 GENEFORM Protein DME1096 XEOTICID XEO04713 MOACRIVE Inhibition DME1096 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1096 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04714 XEO_CLAS Peptide DME1096 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 23.3 microM) DME1096 XEOTICID XEO04714 GENEFORM Protein DME1096 XEOTICID XEO04714 MOACRIVE Inhibition DME1096 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1096 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04716 XEO_CLAS Peptide DME1096 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 microM) DME1096 XEOTICID XEO04716 GENEFORM Protein DME1096 XEOTICID XEO04716 MOACRIVE Inhibition DME1096 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1096 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04717 XEO_CLAS Peptide DME1096 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 50 microM) DME1096 XEOTICID XEO04717 GENEFORM Protein DME1096 XEOTICID XEO04717 MOACRIVE Inhibition DME1096 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1096 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04725 XEO_CLAS Peptide DME1096 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04725 GENEFORM Protein DME1096 XEOTICID XEO04725 MOACRIVE Inhibition DME1096 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1096 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04726 XEO_CLAS Peptide DME1096 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04726 GENEFORM Protein DME1096 XEOTICID XEO04726 MOACRIVE Inhibition DME1096 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1096 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04731 XEO_CLAS Peptide DME1096 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 ug/ml) DME1096 XEOTICID XEO04731 GENEFORM Protein DME1096 XEOTICID XEO04731 MOACRIVE Inhibition DME1096 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1096 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04732 XEO_CLAS Peptide DME1096 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 25 ug/ml) DME1096 XEOTICID XEO04732 GENEFORM Protein DME1096 XEOTICID XEO04732 MOACRIVE Inhibition DME1096 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1096 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04733 XEO_CLAS Peptide DME1096 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04733 GENEFORM Protein DME1096 XEOTICID XEO04733 MOACRIVE Inhibition DME1096 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1096 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04734 XEO_CLAS Peptide DME1096 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04734 GENEFORM Protein DME1096 XEOTICID XEO04734 MOACRIVE Inhibition DME1096 XEOTICID XEO04737 XEO_NAME Protonectin DME1096 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04737 XEO_CLAS Peptide DME1096 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 ug/ml) DME1096 XEOTICID XEO04737 GENEFORM Protein DME1096 XEOTICID XEO04737 MOACRIVE Inhibition DME1096 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1096 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04739 XEO_CLAS Peptide DME1096 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04739 GENEFORM Protein DME1096 XEOTICID XEO04739 MOACRIVE Inhibition DME1096 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1096 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04740 XEO_CLAS Peptide DME1096 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04740 GENEFORM Protein DME1096 XEOTICID XEO04740 MOACRIVE Inhibition DME1096 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1096 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04741 XEO_CLAS Peptide DME1096 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04741 GENEFORM Protein DME1096 XEOTICID XEO04741 MOACRIVE Inhibition DME1096 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1096 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04742 XEO_CLAS Peptide DME1096 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04742 GENEFORM Protein DME1096 XEOTICID XEO04742 MOACRIVE Inhibition DME1096 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1096 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04762 XEO_CLAS Peptide DME1096 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.8 microM) DME1096 XEOTICID XEO04762 GENEFORM Protein DME1096 XEOTICID XEO04762 MOACRIVE Inhibition DME1096 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1096 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04766 XEO_CLAS Peptide DME1096 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.1 microM) DME1096 XEOTICID XEO04766 GENEFORM Protein DME1096 XEOTICID XEO04766 MOACRIVE Inhibition DME1096 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1096 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04767 XEO_CLAS Peptide DME1096 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.1 ug/ml) DME1096 XEOTICID XEO04767 GENEFORM Protein DME1096 XEOTICID XEO04767 MOACRIVE Inhibition DME1096 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1096 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04779 XEO_CLAS Peptide DME1096 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04779 GENEFORM Protein DME1096 XEOTICID XEO04779 MOACRIVE Inhibition DME1096 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1096 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04780 XEO_CLAS Peptide DME1096 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04780 GENEFORM Protein DME1096 XEOTICID XEO04780 MOACRIVE Inhibition DME1096 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1096 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04781 XEO_CLAS Peptide DME1096 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04781 GENEFORM Protein DME1096 XEOTICID XEO04781 MOACRIVE Inhibition DME1096 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1096 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04782 XEO_CLAS Peptide DME1096 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 ug/ml) DME1096 XEOTICID XEO04782 GENEFORM Protein DME1096 XEOTICID XEO04782 MOACRIVE Inhibition DME1096 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1096 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04783 XEO_CLAS Peptide DME1096 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO04783 GENEFORM Protein DME1096 XEOTICID XEO04783 MOACRIVE Inhibition DME1096 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1096 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04784 XEO_CLAS Peptide DME1096 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO04784 GENEFORM Protein DME1096 XEOTICID XEO04784 MOACRIVE Inhibition DME1096 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1096 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04785 XEO_CLAS Peptide DME1096 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO04785 GENEFORM Protein DME1096 XEOTICID XEO04785 MOACRIVE Inhibition DME1096 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1096 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04786 XEO_CLAS Peptide DME1096 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 ug/ml) DME1096 XEOTICID XEO04786 GENEFORM Protein DME1096 XEOTICID XEO04786 MOACRIVE Inhibition DME1096 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1096 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04787 XEO_CLAS Peptide DME1096 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04787 GENEFORM Protein DME1096 XEOTICID XEO04787 MOACRIVE Inhibition DME1096 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1096 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04793 XEO_CLAS Peptide DME1096 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04793 GENEFORM Protein DME1096 XEOTICID XEO04793 MOACRIVE Inhibition DME1096 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1096 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04798 XEO_CLAS Peptide DME1096 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 microM) DME1096 XEOTICID XEO04798 GENEFORM Protein DME1096 XEOTICID XEO04798 MOACRIVE Inhibition DME1096 XEOTICID XEO04799 XEO_NAME Ranalexin DME1096 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04799 XEO_CLAS Peptide DME1096 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 32 ug/ml) DME1096 XEOTICID XEO04799 GENEFORM Protein DME1096 XEOTICID XEO04799 MOACRIVE Inhibition DME1096 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1096 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04800 XEO_CLAS Peptide DME1096 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 microM) DME1096 XEOTICID XEO04800 GENEFORM Protein DME1096 XEOTICID XEO04800 MOACRIVE Inhibition DME1096 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1096 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04801 XEO_CLAS Peptide DME1096 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 9 microM) DME1096 XEOTICID XEO04801 GENEFORM Protein DME1096 XEOTICID XEO04801 MOACRIVE Inhibition DME1096 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1096 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04802 XEO_CLAS Peptide DME1096 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12 microM) DME1096 XEOTICID XEO04802 GENEFORM Protein DME1096 XEOTICID XEO04802 MOACRIVE Inhibition DME1096 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1096 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04803 XEO_CLAS Peptide DME1096 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO04803 GENEFORM Protein DME1096 XEOTICID XEO04803 MOACRIVE Inhibition DME1096 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1096 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04804 XEO_CLAS Peptide DME1096 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO04804 GENEFORM Protein DME1096 XEOTICID XEO04804 MOACRIVE Inhibition DME1096 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1096 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04805 XEO_CLAS Peptide DME1096 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.5 microM) DME1096 XEOTICID XEO04805 GENEFORM Protein DME1096 XEOTICID XEO04805 MOACRIVE Inhibition DME1096 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1096 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04806 XEO_CLAS Peptide DME1096 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.5 microM) DME1096 XEOTICID XEO04806 GENEFORM Protein DME1096 XEOTICID XEO04806 MOACRIVE Inhibition DME1096 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1096 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04807 XEO_CLAS Peptide DME1096 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04807 GENEFORM Protein DME1096 XEOTICID XEO04807 MOACRIVE Inhibition DME1096 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1096 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04809 XEO_CLAS Peptide DME1096 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 microM) DME1096 XEOTICID XEO04809 GENEFORM Protein DME1096 XEOTICID XEO04809 MOACRIVE Inhibition DME1096 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1096 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04811 XEO_CLAS Peptide DME1096 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO04811 GENEFORM Protein DME1096 XEOTICID XEO04811 MOACRIVE Inhibition DME1096 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1096 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04812 XEO_CLAS Peptide DME1096 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO04812 GENEFORM Protein DME1096 XEOTICID XEO04812 MOACRIVE Inhibition DME1096 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1096 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04813 XEO_CLAS Peptide DME1096 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 microM) DME1096 XEOTICID XEO04813 GENEFORM Protein DME1096 XEOTICID XEO04813 MOACRIVE Inhibition DME1096 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1096 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04814 XEO_CLAS Peptide DME1096 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 19 microM) DME1096 XEOTICID XEO04814 GENEFORM Protein DME1096 XEOTICID XEO04814 MOACRIVE Inhibition DME1096 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1096 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04815 XEO_CLAS Peptide DME1096 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 microM) DME1096 XEOTICID XEO04815 GENEFORM Protein DME1096 XEOTICID XEO04815 MOACRIVE Inhibition DME1096 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1096 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04816 XEO_CLAS Peptide DME1096 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 microM) DME1096 XEOTICID XEO04816 GENEFORM Protein DME1096 XEOTICID XEO04816 MOACRIVE Inhibition DME1096 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1096 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04817 XEO_CLAS Peptide DME1096 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 13 microM) DME1096 XEOTICID XEO04817 GENEFORM Protein DME1096 XEOTICID XEO04817 MOACRIVE Inhibition DME1096 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1096 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04818 XEO_CLAS Peptide DME1096 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO04818 GENEFORM Protein DME1096 XEOTICID XEO04818 MOACRIVE Inhibition DME1096 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1096 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04819 XEO_CLAS Peptide DME1096 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO04819 GENEFORM Protein DME1096 XEOTICID XEO04819 MOACRIVE Inhibition DME1096 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1096 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04820 XEO_CLAS Peptide DME1096 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3 microM) DME1096 XEOTICID XEO04820 GENEFORM Protein DME1096 XEOTICID XEO04820 MOACRIVE Inhibition DME1096 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1096 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04821 XEO_CLAS Peptide DME1096 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 microM) DME1096 XEOTICID XEO04821 GENEFORM Protein DME1096 XEOTICID XEO04821 MOACRIVE Inhibition DME1096 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1096 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04822 XEO_CLAS Peptide DME1096 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO04822 GENEFORM Protein DME1096 XEOTICID XEO04822 MOACRIVE Inhibition DME1096 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1096 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04823 XEO_CLAS Peptide DME1096 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 23 microM) DME1096 XEOTICID XEO04823 GENEFORM Protein DME1096 XEOTICID XEO04823 MOACRIVE Inhibition DME1096 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1096 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04824 XEO_CLAS Peptide DME1096 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04824 GENEFORM Protein DME1096 XEOTICID XEO04824 MOACRIVE Inhibition DME1096 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1096 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04825 XEO_CLAS Peptide DME1096 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04825 GENEFORM Protein DME1096 XEOTICID XEO04825 MOACRIVE Inhibition DME1096 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1096 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04826 XEO_CLAS Peptide DME1096 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO04826 GENEFORM Protein DME1096 XEOTICID XEO04826 MOACRIVE Inhibition DME1096 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1096 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04827 XEO_CLAS Peptide DME1096 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO04827 GENEFORM Protein DME1096 XEOTICID XEO04827 MOACRIVE Inhibition DME1096 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1096 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04835 XEO_CLAS Peptide DME1096 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04835 GENEFORM Protein DME1096 XEOTICID XEO04835 MOACRIVE Inhibition DME1096 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1096 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04836 XEO_CLAS Peptide DME1096 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04836 GENEFORM Protein DME1096 XEOTICID XEO04836 MOACRIVE Inhibition DME1096 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1096 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04837 XEO_CLAS Peptide DME1096 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 microM) DME1096 XEOTICID XEO04837 GENEFORM Protein DME1096 XEOTICID XEO04837 MOACRIVE Inhibition DME1096 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1096 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04839 XEO_CLAS Peptide DME1096 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04839 GENEFORM Protein DME1096 XEOTICID XEO04839 MOACRIVE Inhibition DME1096 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1096 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04840 XEO_CLAS Peptide DME1096 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 35-20 microM) DME1096 XEOTICID XEO04840 GENEFORM Protein DME1096 XEOTICID XEO04840 MOACRIVE Inhibition DME1096 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1096 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04847 XEO_CLAS Peptide DME1096 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04847 GENEFORM Protein DME1096 XEOTICID XEO04847 MOACRIVE Inhibition DME1096 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1096 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04848 XEO_CLAS Peptide DME1096 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04848 GENEFORM Protein DME1096 XEOTICID XEO04848 MOACRIVE Inhibition DME1096 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1096 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04849 XEO_CLAS Peptide DME1096 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04849 GENEFORM Protein DME1096 XEOTICID XEO04849 MOACRIVE Inhibition DME1096 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1096 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04850 XEO_CLAS Peptide DME1096 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04850 GENEFORM Protein DME1096 XEOTICID XEO04850 MOACRIVE Inhibition DME1096 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1096 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04851 XEO_CLAS Peptide DME1096 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1 ug/ml) DME1096 XEOTICID XEO04851 GENEFORM Protein DME1096 XEOTICID XEO04851 MOACRIVE Inhibition DME1096 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1096 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04857 XEO_CLAS Peptide DME1096 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 microM) DME1096 XEOTICID XEO04857 GENEFORM Protein DME1096 XEOTICID XEO04857 MOACRIVE Inhibition DME1096 XEOTICID XEO04863 XEO_NAME RTD peptide DME1096 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04863 XEO_CLAS Peptide DME1096 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.0 microM) DME1096 XEOTICID XEO04863 GENEFORM Protein DME1096 XEOTICID XEO04863 MOACRIVE Inhibition DME1096 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1096 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04865 XEO_CLAS Peptide DME1096 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 ug/ml) DME1096 XEOTICID XEO04865 GENEFORM Protein DME1096 XEOTICID XEO04865 MOACRIVE Inhibition DME1096 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1096 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04866 XEO_CLAS Peptide DME1096 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12.5 ug/ml) DME1096 XEOTICID XEO04866 GENEFORM Protein DME1096 XEOTICID XEO04866 MOACRIVE Inhibition DME1096 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1096 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04868 XEO_CLAS Peptide DME1096 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25.00 ug/ml) DME1096 XEOTICID XEO04868 GENEFORM Protein DME1096 XEOTICID XEO04868 MOACRIVE Inhibition DME1096 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1096 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04869 XEO_CLAS Peptide DME1096 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25.00 ug/ml) DME1096 XEOTICID XEO04869 GENEFORM Protein DME1096 XEOTICID XEO04869 MOACRIVE Inhibition DME1096 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1096 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04870 XEO_CLAS Peptide DME1096 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25.00 ug/ml) DME1096 XEOTICID XEO04870 GENEFORM Protein DME1096 XEOTICID XEO04870 MOACRIVE Inhibition DME1096 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1096 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04877 XEO_CLAS Peptide DME1096 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04877 GENEFORM Protein DME1096 XEOTICID XEO04877 MOACRIVE Inhibition DME1096 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1096 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04880 XEO_CLAS Peptide DME1096 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.5 ug/ml) DME1096 XEOTICID XEO04880 GENEFORM Protein DME1096 XEOTICID XEO04880 MOACRIVE Inhibition DME1096 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1096 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04886 XEO_CLAS Peptide DME1096 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.6 ug/ml) DME1096 XEOTICID XEO04886 GENEFORM Protein DME1096 XEOTICID XEO04886 MOACRIVE Inhibition DME1096 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1096 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04891 XEO_CLAS Peptide DME1096 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04891 GENEFORM Protein DME1096 XEOTICID XEO04891 MOACRIVE Inhibition DME1096 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1096 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04895 XEO_CLAS Peptide DME1096 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04895 GENEFORM Protein DME1096 XEOTICID XEO04895 MOACRIVE Inhibition DME1096 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1096 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04901 XEO_CLAS Peptide DME1096 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 microM) DME1096 XEOTICID XEO04901 GENEFORM Protein DME1096 XEOTICID XEO04901 MOACRIVE Inhibition DME1096 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1096 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04904 XEO_CLAS Peptide DME1096 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 78 ug/ml) DME1096 XEOTICID XEO04904 GENEFORM Protein DME1096 XEOTICID XEO04904 MOACRIVE Inhibition DME1096 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1096 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04905 XEO_CLAS Peptide DME1096 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04905 GENEFORM Protein DME1096 XEOTICID XEO04905 MOACRIVE Inhibition DME1096 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1096 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04906 XEO_CLAS Peptide DME1096 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04906 GENEFORM Protein DME1096 XEOTICID XEO04906 MOACRIVE Inhibition DME1096 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1096 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04907 XEO_CLAS Peptide DME1096 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04907 GENEFORM Protein DME1096 XEOTICID XEO04907 MOACRIVE Inhibition DME1096 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1096 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04908 XEO_CLAS Peptide DME1096 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04908 GENEFORM Protein DME1096 XEOTICID XEO04908 MOACRIVE Inhibition DME1096 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1096 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04909 XEO_CLAS Peptide DME1096 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04909 GENEFORM Protein DME1096 XEOTICID XEO04909 MOACRIVE Inhibition DME1096 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1096 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04915 XEO_CLAS Peptide DME1096 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 100 ug/ml) DME1096 XEOTICID XEO04915 GENEFORM Protein DME1096 XEOTICID XEO04915 MOACRIVE Inhibition DME1096 XEOTICID XEO04916 XEO_NAME Scopoletin DME1096 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1096 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04916 GENEFORM Protein DME1096 XEOTICID XEO04916 MOACRIVE Inhibition DME1096 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1096 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04926 XEO_CLAS Peptide DME1096 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04926 GENEFORM Protein DME1096 XEOTICID XEO04926 MOACRIVE Inhibition DME1096 XEOTICID XEO04931 XEO_NAME Shepherin I DME1096 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04931 XEO_CLAS Peptide DME1096 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04931 GENEFORM Protein DME1096 XEOTICID XEO04931 MOACRIVE Inhibition DME1096 XEOTICID XEO04932 XEO_NAME shepherin II DME1096 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04932 XEO_CLAS Peptide DME1096 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04932 GENEFORM Protein DME1096 XEOTICID XEO04932 MOACRIVE Inhibition DME1096 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1096 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04938 XEO_CLAS Peptide DME1096 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC <= 100 microM) DME1096 XEOTICID XEO04938 GENEFORM Protein DME1096 XEOTICID XEO04938 MOACRIVE Inhibition DME1096 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1096 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04947 XEO_CLAS Natural Product DME1096 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04947 GENEFORM Protein DME1096 XEOTICID XEO04947 MOACRIVE Inhibition DME1096 XEOTICID XEO04948 XEO_NAME Sinensetin DME1096 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1096 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1096 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04948 GENEFORM Protein DME1096 XEOTICID XEO04948 MOACRIVE Inhibition DME1096 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1096 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04950 XEO_CLAS Peptide DME1096 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 ug/ml) DME1096 XEOTICID XEO04950 GENEFORM Protein DME1096 XEOTICID XEO04950 MOACRIVE Inhibition DME1096 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1096 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04955 XEO_CLAS Peptide DME1096 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.07 microM) DME1096 XEOTICID XEO04955 GENEFORM Protein DME1096 XEOTICID XEO04955 MOACRIVE Inhibition DME1096 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1096 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04956 XEO_CLAS Peptide DME1096 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16.0 microM) DME1096 XEOTICID XEO04956 GENEFORM Protein DME1096 XEOTICID XEO04956 MOACRIVE Inhibition DME1096 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1096 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04957 XEO_CLAS Peptide DME1096 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.23 microM) DME1096 XEOTICID XEO04957 GENEFORM Protein DME1096 XEOTICID XEO04957 MOACRIVE Inhibition DME1096 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1096 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04958 XEO_CLAS Peptide DME1096 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 ug/ml) DME1096 XEOTICID XEO04958 GENEFORM Protein DME1096 XEOTICID XEO04958 MOACRIVE Inhibition DME1096 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1096 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04959 XEO_CLAS Peptide DME1096 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04959 GENEFORM Protein DME1096 XEOTICID XEO04959 MOACRIVE Inhibition DME1096 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1096 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04967 XEO_CLAS Peptide DME1096 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 28 microM) DME1096 XEOTICID XEO04967 GENEFORM Protein DME1096 XEOTICID XEO04967 MOACRIVE Inhibition DME1096 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1096 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04969 XEO_CLAS Peptide DME1096 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50-100 ug/ml) DME1096 XEOTICID XEO04969 GENEFORM Protein DME1096 XEOTICID XEO04969 MOACRIVE Inhibition DME1096 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1096 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04970 XEO_CLAS Peptide DME1096 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04970 GENEFORM Protein DME1096 XEOTICID XEO04970 MOACRIVE Inhibition DME1096 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1096 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04971 XEO_CLAS Peptide DME1096 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.8-1.5 microM) DME1096 XEOTICID XEO04971 GENEFORM Protein DME1096 XEOTICID XEO04971 MOACRIVE Inhibition DME1096 XEOTICID XEO04974 XEO_NAME Spinigerin DME1096 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04974 XEO_CLAS Peptide DME1096 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3-6 microM) DME1096 XEOTICID XEO04974 GENEFORM Protein DME1096 XEOTICID XEO04974 MOACRIVE Inhibition DME1096 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1096 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1096 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04975 GENEFORM Protein DME1096 XEOTICID XEO04975 MOACRIVE Inhibition DME1096 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1096 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1096 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04976 GENEFORM Protein DME1096 XEOTICID XEO04976 MOACRIVE Inhibition DME1096 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1096 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1096 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04977 GENEFORM Protein DME1096 XEOTICID XEO04977 MOACRIVE Inhibition DME1096 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1096 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1096 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04978 GENEFORM Protein DME1096 XEOTICID XEO04978 MOACRIVE Inhibition DME1096 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1096 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1096 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04979 GENEFORM Protein DME1096 XEOTICID XEO04979 MOACRIVE Inhibition DME1096 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1096 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04981 XEO_CLAS Peptide DME1096 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10.1 microM) DME1096 XEOTICID XEO04981 GENEFORM Protein DME1096 XEOTICID XEO04981 MOACRIVE Inhibition DME1096 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1096 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04982 XEO_CLAS Peptide DME1096 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40.5 microM) DME1096 XEOTICID XEO04982 GENEFORM Protein DME1096 XEOTICID XEO04982 MOACRIVE Inhibition DME1096 XEOTICID XEO04994 XEO_NAME Stilbene DME1096 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1096 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1096 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO04994 GENEFORM Protein DME1096 XEOTICID XEO04994 MOACRIVE Inhibition DME1096 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1096 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04995 XEO_CLAS Peptide DME1096 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC < 0.19 microM) DME1096 XEOTICID XEO04995 GENEFORM Protein DME1096 XEOTICID XEO04995 MOACRIVE Inhibition DME1096 XEOTICID XEO04998 XEO_NAME Styelin A DME1096 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04998 XEO_CLAS Peptide DME1096 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.7 ug/ml) DME1096 XEOTICID XEO04998 GENEFORM Protein DME1096 XEOTICID XEO04998 MOACRIVE Inhibition DME1096 XEOTICID XEO04999 XEO_NAME Styelin B DME1096 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO04999 XEO_CLAS Peptide DME1096 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.7 ug/ml) DME1096 XEOTICID XEO04999 GENEFORM Protein DME1096 XEOTICID XEO04999 MOACRIVE Inhibition DME1096 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1096 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05000 XEO_CLAS Peptide DME1096 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO05000 GENEFORM Protein DME1096 XEOTICID XEO05000 MOACRIVE Inhibition DME1096 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1096 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05001 XEO_CLAS Peptide DME1096 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.5 ug/ml) DME1096 XEOTICID XEO05001 GENEFORM Protein DME1096 XEOTICID XEO05001 MOACRIVE Inhibition DME1096 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1096 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05002 XEO_CLAS Peptide DME1096 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO05002 GENEFORM Protein DME1096 XEOTICID XEO05002 MOACRIVE Inhibition DME1096 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1096 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05003 XEO_CLAS Peptide DME1096 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO05003 GENEFORM Protein DME1096 XEOTICID XEO05003 MOACRIVE Inhibition DME1096 XEOTICID XEO05006 XEO_NAME Substance P DME1096 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05006 XEO_CLAS Peptide DME1096 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05006 GENEFORM Protein DME1096 XEOTICID XEO05006 MOACRIVE Inhibition DME1096 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1096 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05007 XEO_CLAS Peptide DME1096 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05007 GENEFORM Protein DME1096 XEOTICID XEO05007 MOACRIVE Inhibition DME1096 XEOTICID XEO05008 XEO_NAME Subtilosin DME1096 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05008 XEO_CLAS Peptide DME1096 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05008 GENEFORM Protein DME1096 XEOTICID XEO05008 MOACRIVE Inhibition DME1096 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1096 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05013 XEO_CLAS Peptide DME1096 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO05013 GENEFORM Protein DME1096 XEOTICID XEO05013 MOACRIVE Inhibition DME1096 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1096 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05014 XEO_CLAS Peptide DME1096 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO05014 GENEFORM Protein DME1096 XEOTICID XEO05014 MOACRIVE Inhibition DME1096 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1096 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05015 XEO_CLAS Peptide DME1096 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO05015 GENEFORM Protein DME1096 XEOTICID XEO05015 MOACRIVE Inhibition DME1096 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1096 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05016 XEO_CLAS Peptide DME1096 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO05016 GENEFORM Protein DME1096 XEOTICID XEO05016 MOACRIVE Inhibition DME1096 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1096 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05017 XEO_CLAS Peptide DME1096 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 20 ug/ml) DME1096 XEOTICID XEO05017 GENEFORM Protein DME1096 XEOTICID XEO05017 MOACRIVE Inhibition DME1096 XEOTICID XEO05018 XEO_NAME Syringic acid DME1096 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1096 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05018 GENEFORM Protein DME1096 XEOTICID XEO05018 MOACRIVE Inhibition DME1096 XEOTICID XEO05020 XEO_NAME Tachycitin DME1096 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05020 XEO_CLAS Peptide DME1096 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05020 GENEFORM Protein DME1096 XEOTICID XEO05020 MOACRIVE Inhibition DME1096 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1096 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05023 XEO_CLAS Peptide DME1096 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05023 GENEFORM Protein DME1096 XEOTICID XEO05023 MOACRIVE Inhibition DME1096 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1096 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05024 XEO_CLAS Peptide DME1096 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05024 GENEFORM Protein DME1096 XEOTICID XEO05024 MOACRIVE Inhibition DME1096 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1096 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05027 XEO_CLAS Peptide DME1096 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05027 GENEFORM Protein DME1096 XEOTICID XEO05027 MOACRIVE Inhibition DME1096 XEOTICID XEO05031 XEO_NAME Tannic acid DME1096 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1096 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05031 GENEFORM Protein DME1096 XEOTICID XEO05031 MOACRIVE Inhibition DME1096 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1096 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05033 XEO_CLAS Peptide DME1096 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05033 GENEFORM Protein DME1096 XEOTICID XEO05033 MOACRIVE Inhibition DME1096 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1096 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05042 XEO_CLAS Peptide DME1096 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO05042 GENEFORM Protein DME1096 XEOTICID XEO05042 MOACRIVE Inhibition DME1096 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1096 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05043 XEO_CLAS Peptide DME1096 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO05043 GENEFORM Protein DME1096 XEOTICID XEO05043 MOACRIVE Inhibition DME1096 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1096 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05044 XEO_CLAS Peptide DME1096 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 128 microM) DME1096 XEOTICID XEO05044 GENEFORM Protein DME1096 XEOTICID XEO05044 MOACRIVE Inhibition DME1096 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1096 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05045 XEO_CLAS Peptide DME1096 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 128 microM) DME1096 XEOTICID XEO05045 GENEFORM Protein DME1096 XEOTICID XEO05045 MOACRIVE Inhibition DME1096 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1096 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05046 XEO_CLAS Peptide DME1096 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 microM) DME1096 XEOTICID XEO05046 GENEFORM Protein DME1096 XEOTICID XEO05046 MOACRIVE Inhibition DME1096 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1096 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05047 XEO_CLAS Peptide DME1096 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 60 microM) DME1096 XEOTICID XEO05047 GENEFORM Protein DME1096 XEOTICID XEO05047 MOACRIVE Inhibition DME1096 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1096 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05051 XEO_CLAS Peptide DME1096 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05051 GENEFORM Protein DME1096 XEOTICID XEO05051 MOACRIVE Inhibition DME1096 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1096 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05055 XEO_CLAS Peptide DME1096 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 70 microM) DME1096 XEOTICID XEO05055 GENEFORM Protein DME1096 XEOTICID XEO05055 MOACRIVE Inhibition DME1096 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1096 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05056 XEO_CLAS Peptide DME1096 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05056 GENEFORM Protein DME1096 XEOTICID XEO05056 MOACRIVE Inhibition DME1096 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1096 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05059 XEO_CLAS Peptide DME1096 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05059 GENEFORM Protein DME1096 XEOTICID XEO05059 MOACRIVE Inhibition DME1096 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1096 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05061 XEO_CLAS Peptide DME1096 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO05061 GENEFORM Protein DME1096 XEOTICID XEO05061 MOACRIVE Inhibition DME1096 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1096 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05062 XEO_CLAS Peptide DME1096 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05062 GENEFORM Protein DME1096 XEOTICID XEO05062 MOACRIVE Inhibition DME1096 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1096 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05063 XEO_CLAS Peptide DME1096 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO05063 GENEFORM Protein DME1096 XEOTICID XEO05063 MOACRIVE Inhibition DME1096 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1096 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05064 XEO_CLAS Peptide DME1096 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 231 microM) DME1096 XEOTICID XEO05064 GENEFORM Protein DME1096 XEOTICID XEO05064 MOACRIVE Inhibition DME1096 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1096 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05065 XEO_CLAS Peptide DME1096 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 161 ug/ml) DME1096 XEOTICID XEO05065 GENEFORM Protein DME1096 XEOTICID XEO05065 MOACRIVE Inhibition DME1096 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1096 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05069 XEO_CLAS Peptide DME1096 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO05069 GENEFORM Protein DME1096 XEOTICID XEO05069 MOACRIVE Inhibition DME1096 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1096 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05070 XEO_CLAS Peptide DME1096 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 37.5 microM) DME1096 XEOTICID XEO05070 GENEFORM Protein DME1096 XEOTICID XEO05070 MOACRIVE Inhibition DME1096 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1096 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05071 XEO_CLAS Peptide DME1096 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 150 microM) DME1096 XEOTICID XEO05071 GENEFORM Protein DME1096 XEOTICID XEO05071 MOACRIVE Inhibition DME1096 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1096 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05072 XEO_CLAS Peptide DME1096 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO05072 GENEFORM Protein DME1096 XEOTICID XEO05072 MOACRIVE Inhibition DME1096 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1096 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05073 XEO_CLAS Peptide DME1096 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40 microM) DME1096 XEOTICID XEO05073 GENEFORM Protein DME1096 XEOTICID XEO05073 MOACRIVE Inhibition DME1096 XEOTICID XEO05076 XEO_NAME Temporin-A DME1096 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05076 XEO_CLAS Peptide DME1096 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 11.9 microM) DME1096 XEOTICID XEO05076 GENEFORM Protein DME1096 XEOTICID XEO05076 MOACRIVE Inhibition DME1096 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1096 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05077 XEO_CLAS Peptide DME1096 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.25 ug/ml) DME1096 XEOTICID XEO05077 GENEFORM Protein DME1096 XEOTICID XEO05077 MOACRIVE Inhibition DME1096 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1096 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05078 XEO_CLAS Peptide DME1096 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.25 ug/ml) DME1096 XEOTICID XEO05078 GENEFORM Protein DME1096 XEOTICID XEO05078 MOACRIVE Inhibition DME1096 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1096 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05079 XEO_CLAS Peptide DME1096 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.5 ug/ml) DME1096 XEOTICID XEO05079 GENEFORM Protein DME1096 XEOTICID XEO05079 MOACRIVE Inhibition DME1096 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1096 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05080 XEO_CLAS Peptide DME1096 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 ug/ml) DME1096 XEOTICID XEO05080 GENEFORM Protein DME1096 XEOTICID XEO05080 MOACRIVE Inhibition DME1096 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1096 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05081 XEO_CLAS Peptide DME1096 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 5 ug/ml) DME1096 XEOTICID XEO05081 GENEFORM Protein DME1096 XEOTICID XEO05081 MOACRIVE Inhibition DME1096 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1096 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05082 XEO_CLAS Peptide DME1096 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 7.5 ug/ml) DME1096 XEOTICID XEO05082 GENEFORM Protein DME1096 XEOTICID XEO05082 MOACRIVE Inhibition DME1096 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1096 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05083 XEO_CLAS Peptide DME1096 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 ug/ml) DME1096 XEOTICID XEO05083 GENEFORM Protein DME1096 XEOTICID XEO05083 MOACRIVE Inhibition DME1096 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1096 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05084 XEO_CLAS Peptide DME1096 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 ug/ml) DME1096 XEOTICID XEO05084 GENEFORM Protein DME1096 XEOTICID XEO05084 MOACRIVE Inhibition DME1096 XEOTICID XEO05085 XEO_NAME Temporin-B DME1096 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05085 XEO_CLAS Peptide DME1096 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 21.0 ug/ml) DME1096 XEOTICID XEO05085 GENEFORM Protein DME1096 XEOTICID XEO05085 MOACRIVE Inhibition DME1096 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1096 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05086 XEO_CLAS Peptide DME1096 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC > 100 microM) DME1096 XEOTICID XEO05086 GENEFORM Protein DME1096 XEOTICID XEO05086 MOACRIVE Inhibition DME1096 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1096 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05087 XEO_CLAS Peptide DME1096 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO05087 GENEFORM Protein DME1096 XEOTICID XEO05087 MOACRIVE Inhibition DME1096 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1096 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05097 XEO_CLAS Peptide DME1096 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16.0 microM) DME1096 XEOTICID XEO05097 GENEFORM Protein DME1096 XEOTICID XEO05097 MOACRIVE Inhibition DME1096 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1096 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05099 XEO_CLAS Peptide DME1096 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.0 microM) DME1096 XEOTICID XEO05099 GENEFORM Protein DME1096 XEOTICID XEO05099 MOACRIVE Inhibition DME1096 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1096 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05100 XEO_CLAS Peptide DME1096 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05100 GENEFORM Protein DME1096 XEOTICID XEO05100 MOACRIVE Inhibition DME1096 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1096 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05101 XEO_CLAS Peptide DME1096 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 24.2 ug/ml) DME1096 XEOTICID XEO05101 GENEFORM Protein DME1096 XEOTICID XEO05101 MOACRIVE Inhibition DME1096 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1096 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05102 XEO_CLAS Peptide DME1096 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 34.5 ug/ml) DME1096 XEOTICID XEO05102 GENEFORM Protein DME1096 XEOTICID XEO05102 MOACRIVE Inhibition DME1096 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1096 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05105 XEO_CLAS Peptide DME1096 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO05105 GENEFORM Protein DME1096 XEOTICID XEO05105 MOACRIVE Inhibition DME1096 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1096 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05106 XEO_CLAS Peptide DME1096 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25-200 microM) DME1096 XEOTICID XEO05106 GENEFORM Protein DME1096 XEOTICID XEO05106 MOACRIVE Inhibition DME1096 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1096 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05108 XEO_CLAS Peptide DME1096 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40 microM) DME1096 XEOTICID XEO05108 GENEFORM Protein DME1096 XEOTICID XEO05108 MOACRIVE Inhibition DME1096 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1096 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1096 XEOTICID XEO05111 XEO_CLAS Natural Product DME1096 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05111 GENEFORM Protein DME1096 XEOTICID XEO05111 MOACRIVE Inhibition DME1096 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1096 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05119 XEO_CLAS Peptide DME1096 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05119 GENEFORM Protein DME1096 XEOTICID XEO05119 MOACRIVE Inhibition DME1096 XEOTICID XEO05120 XEO_NAME Thanatin DME1096 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05120 XEO_CLAS Peptide DME1096 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.3-0.6 microM) DME1096 XEOTICID XEO05120 GENEFORM Protein DME1096 XEOTICID XEO05120 MOACRIVE Inhibition DME1096 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1096 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05121 XEO_CLAS Peptide DME1096 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 62.5 ug/ml) DME1096 XEOTICID XEO05121 GENEFORM Protein DME1096 XEOTICID XEO05121 MOACRIVE Inhibition DME1096 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1096 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05125 XEO_CLAS Peptide DME1096 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05125 GENEFORM Protein DME1096 XEOTICID XEO05125 MOACRIVE Inhibition DME1096 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1096 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05130 XEO_CLAS Peptide DME1096 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05130 GENEFORM Protein DME1096 XEOTICID XEO05130 MOACRIVE Inhibition DME1096 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1096 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05144 XEO_CLAS Peptide DME1096 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40 ug/ml) DME1096 XEOTICID XEO05144 GENEFORM Protein DME1096 XEOTICID XEO05144 MOACRIVE Inhibition DME1096 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1096 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05145 XEO_CLAS Peptide DME1096 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 ug/ml) DME1096 XEOTICID XEO05145 GENEFORM Protein DME1096 XEOTICID XEO05145 MOACRIVE Inhibition DME1096 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1096 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05146 XEO_CLAS Peptide DME1096 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 40 ug/ml) DME1096 XEOTICID XEO05146 GENEFORM Protein DME1096 XEOTICID XEO05146 MOACRIVE Inhibition DME1096 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1096 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05147 XEO_CLAS Peptide DME1096 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 60 ug/ml) DME1096 XEOTICID XEO05147 GENEFORM Protein DME1096 XEOTICID XEO05147 MOACRIVE Inhibition DME1096 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1096 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05158 XEO_CLAS Peptide DME1096 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05158 GENEFORM Protein DME1096 XEOTICID XEO05158 MOACRIVE Inhibition DME1096 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1096 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05161 XEO_CLAS Peptide DME1096 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 32 ug/ml) DME1096 XEOTICID XEO05161 GENEFORM Protein DME1096 XEOTICID XEO05161 MOACRIVE Inhibition DME1096 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1096 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05162 XEO_CLAS Peptide DME1096 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 32 ug/ml) DME1096 XEOTICID XEO05162 GENEFORM Protein DME1096 XEOTICID XEO05162 MOACRIVE Inhibition DME1096 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1096 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05163 XEO_CLAS Peptide DME1096 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 12-25 ug/ml) DME1096 XEOTICID XEO05163 GENEFORM Protein DME1096 XEOTICID XEO05163 MOACRIVE Inhibition DME1096 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1096 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05170 XEO_CLAS Peptide DME1096 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 3.0 microM) DME1096 XEOTICID XEO05170 GENEFORM Protein DME1096 XEOTICID XEO05170 MOACRIVE Inhibition DME1096 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1096 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05171 XEO_CLAS Peptide DME1096 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 50 microM) DME1096 XEOTICID XEO05171 GENEFORM Protein DME1096 XEOTICID XEO05171 MOACRIVE Inhibition DME1096 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1096 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05179 XEO_CLAS Peptide DME1096 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05179 GENEFORM Protein DME1096 XEOTICID XEO05179 MOACRIVE Inhibition DME1096 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1096 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05180 XEO_CLAS Peptide DME1096 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 160 microM) DME1096 XEOTICID XEO05180 GENEFORM Protein DME1096 XEOTICID XEO05180 MOACRIVE Inhibition DME1096 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1096 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05182 XEO_CLAS Peptide DME1096 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 microM) DME1096 XEOTICID XEO05182 GENEFORM Protein DME1096 XEOTICID XEO05182 MOACRIVE Inhibition DME1096 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1096 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05183 XEO_CLAS Peptide DME1096 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 microM) DME1096 XEOTICID XEO05183 GENEFORM Protein DME1096 XEOTICID XEO05183 MOACRIVE Inhibition DME1096 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1096 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05184 XEO_CLAS Peptide DME1096 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 microM) DME1096 XEOTICID XEO05184 GENEFORM Protein DME1096 XEOTICID XEO05184 MOACRIVE Inhibition DME1096 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1096 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05185 XEO_CLAS Peptide DME1096 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 microM) DME1096 XEOTICID XEO05185 GENEFORM Protein DME1096 XEOTICID XEO05185 MOACRIVE Inhibition DME1096 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1096 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05186 XEO_CLAS Peptide DME1096 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 microM) DME1096 XEOTICID XEO05186 GENEFORM Protein DME1096 XEOTICID XEO05186 MOACRIVE Inhibition DME1096 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1096 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05187 XEO_CLAS Peptide DME1096 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16 microM) DME1096 XEOTICID XEO05187 GENEFORM Protein DME1096 XEOTICID XEO05187 MOACRIVE Inhibition DME1096 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1096 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05188 XEO_CLAS Peptide DME1096 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 64 microM) DME1096 XEOTICID XEO05188 GENEFORM Protein DME1096 XEOTICID XEO05188 MOACRIVE Inhibition DME1096 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1096 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05190 XEO_CLAS Peptide DME1096 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05190 GENEFORM Protein DME1096 XEOTICID XEO05190 MOACRIVE Inhibition DME1096 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1096 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05193 XEO_CLAS Peptide DME1096 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO05193 GENEFORM Protein DME1096 XEOTICID XEO05193 MOACRIVE Inhibition DME1096 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1096 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05197 XEO_CLAS Peptide DME1096 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05197 GENEFORM Protein DME1096 XEOTICID XEO05197 MOACRIVE Inhibition DME1096 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1096 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05205 XEO_CLAS Peptide DME1096 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05205 GENEFORM Protein DME1096 XEOTICID XEO05205 MOACRIVE Inhibition DME1096 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1096 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05206 XEO_CLAS Peptide DME1096 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 10 microM) DME1096 XEOTICID XEO05206 GENEFORM Protein DME1096 XEOTICID XEO05206 MOACRIVE Inhibition DME1096 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1096 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05207 XEO_CLAS Peptide DME1096 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 25 microM) DME1096 XEOTICID XEO05207 GENEFORM Protein DME1096 XEOTICID XEO05207 MOACRIVE Inhibition DME1096 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1096 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05208 XEO_CLAS Peptide DME1096 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 microM) DME1096 XEOTICID XEO05208 GENEFORM Protein DME1096 XEOTICID XEO05208 MOACRIVE Inhibition DME1096 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1096 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05209 XEO_CLAS Peptide DME1096 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 15 microM) DME1096 XEOTICID XEO05209 GENEFORM Protein DME1096 XEOTICID XEO05209 MOACRIVE Inhibition DME1096 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1096 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05212 XEO_CLAS Peptide DME1096 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.5 ug/ml) DME1096 XEOTICID XEO05212 GENEFORM Protein DME1096 XEOTICID XEO05212 MOACRIVE Inhibition DME1096 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1096 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05220 XEO_CLAS Peptide DME1096 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.6-1.2 microM) DME1096 XEOTICID XEO05220 GENEFORM Protein DME1096 XEOTICID XEO05220 MOACRIVE Inhibition DME1096 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1096 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05230 XEO_CLAS Peptide DME1096 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 7.90 microM) DME1096 XEOTICID XEO05230 GENEFORM Protein DME1096 XEOTICID XEO05230 MOACRIVE Inhibition DME1096 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1096 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05231 XEO_CLAS Peptide DME1096 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2.40 microM) DME1096 XEOTICID XEO05231 GENEFORM Protein DME1096 XEOTICID XEO05231 MOACRIVE Inhibition DME1096 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1096 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05232 XEO_CLAS Peptide DME1096 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05232 GENEFORM Protein DME1096 XEOTICID XEO05232 MOACRIVE Inhibition DME1096 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1096 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05233 XEO_CLAS Peptide DME1096 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 ug/ml) DME1096 XEOTICID XEO05233 GENEFORM Protein DME1096 XEOTICID XEO05233 MOACRIVE Inhibition DME1096 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1096 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05234 XEO_CLAS Peptide DME1096 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 ug/ml) DME1096 XEOTICID XEO05234 GENEFORM Protein DME1096 XEOTICID XEO05234 MOACRIVE Inhibition DME1096 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1096 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05235 XEO_CLAS Peptide DME1096 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 30 ug/ml) DME1096 XEOTICID XEO05235 GENEFORM Protein DME1096 XEOTICID XEO05235 MOACRIVE Inhibition DME1096 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1096 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05237 XEO_CLAS Peptide DME1096 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 microM) DME1096 XEOTICID XEO05237 GENEFORM Protein DME1096 XEOTICID XEO05237 MOACRIVE Inhibition DME1096 XEOTICID XEO05245 XEO_NAME Viresin DME1096 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05245 XEO_CLAS Peptide DME1096 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05245 GENEFORM Protein DME1096 XEOTICID XEO05245 MOACRIVE Inhibition DME1096 XEOTICID XEO05248 XEO_NAME Vitamin C DME1096 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1096 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1096 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05248 GENEFORM Protein DME1096 XEOTICID XEO05248 MOACRIVE Inhibition DME1096 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1096 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05264 XEO_CLAS Peptide DME1096 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 4 ug/ml) DME1096 XEOTICID XEO05264 GENEFORM Protein DME1096 XEOTICID XEO05264 MOACRIVE Inhibition DME1096 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1096 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05267 XEO_CLAS Peptide DME1096 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 2 ug/ml) DME1096 XEOTICID XEO05267 GENEFORM Protein DME1096 XEOTICID XEO05267 MOACRIVE Inhibition DME1096 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1096 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05268 XEO_CLAS Peptide DME1096 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 1.6 ug/ml) DME1096 XEOTICID XEO05268 GENEFORM Protein DME1096 XEOTICID XEO05268 MOACRIVE Inhibition DME1096 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1096 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05269 XEO_CLAS Peptide DME1096 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 6 ug/ml) DME1096 XEOTICID XEO05269 GENEFORM Protein DME1096 XEOTICID XEO05269 MOACRIVE Inhibition DME1096 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1096 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05273 XEO_CLAS Peptide DME1096 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05273 GENEFORM Protein DME1096 XEOTICID XEO05273 MOACRIVE Inhibition DME1096 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1096 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05274 XEO_CLAS Peptide DME1096 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05274 GENEFORM Protein DME1096 XEOTICID XEO05274 MOACRIVE Inhibition DME1096 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1096 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05287 XEO_CLAS Peptide DME1096 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli DME1096 XEOTICID XEO05287 GENEFORM Protein DME1096 XEOTICID XEO05287 MOACRIVE Inhibition DME1096 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1096 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05303 XEO_CLAS Peptide DME1096 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 16-31 ug/ml) DME1096 XEOTICID XEO05303 GENEFORM Protein DME1096 XEOTICID XEO05303 MOACRIVE Inhibition DME1096 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1096 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05306 XEO_CLAS Peptide DME1096 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 8 ug/ml) DME1096 XEOTICID XEO05306 GENEFORM Protein DME1096 XEOTICID XEO05306 MOACRIVE Inhibition DME1096 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1096 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1096 XEOTICID XEO05308 XEO_CLAS Peptide DME1096 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Azoreductase (azoR) from Escherichia coli (MIC = 0.4 ug/ml) DME1096 XEOTICID XEO05308 GENEFORM Protein DME1096 XEOTICID XEO05308 MOACRIVE Inhibition DME1097 DME___ID DME1097 DME1097 DME_NAME N-ethylmaleimide reductase (nemA) DME1097 SPESNAME Escherichia coli DME1097 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1097 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00117 GENEFORM Protein DME1097 XEOTICID XEO00117 MOACRIVE Inhibition DME1097 XEOTICID XEO00122 XEO_NAME Amikacin DME1097 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00122 GENEFORM Protein DME1097 XEOTICID XEO00122 MOACRIVE Inhibition DME1097 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1097 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00136 GENEFORM Protein DME1097 XEOTICID XEO00136 MOACRIVE Inhibition DME1097 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1097 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00237 GENEFORM Protein DME1097 XEOTICID XEO00237 MOACRIVE Inhibition DME1097 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1097 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00349 GENEFORM Protein DME1097 XEOTICID XEO00349 MOACRIVE Inhibition DME1097 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1097 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00425 GENEFORM Protein DME1097 XEOTICID XEO00425 MOACRIVE Inhibition DME1097 XEOTICID XEO00439 XEO_NAME Daidzein DME1097 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00439 GENEFORM Protein DME1097 XEOTICID XEO00439 MOACRIVE Inhibition DME1097 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1097 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00460 GENEFORM Protein DME1097 XEOTICID XEO00460 MOACRIVE Inhibition DME1097 XEOTICID XEO00487 XEO_NAME Thymol DME1097 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00487 GENEFORM Protein DME1097 XEOTICID XEO00487 MOACRIVE Inhibition DME1097 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1097 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00511 GENEFORM Protein DME1097 XEOTICID XEO00511 MOACRIVE Inhibition DME1097 XEOTICID XEO00537 XEO_NAME Luteolin DME1097 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1097 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00537 GENEFORM Protein DME1097 XEOTICID XEO00537 MOACRIVE Inhibition DME1097 XEOTICID XEO00538 XEO_NAME Quercetin DME1097 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1097 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00538 GENEFORM Protein DME1097 XEOTICID XEO00538 MOACRIVE Inhibition DME1097 XEOTICID XEO00547 XEO_NAME Vitamin E DME1097 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1097 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00547 GENEFORM Protein DME1097 XEOTICID XEO00547 MOACRIVE Inhibition DME1097 XEOTICID XEO00557 XEO_NAME Genistein DME1097 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1097 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00557 GENEFORM Protein DME1097 XEOTICID XEO00557 MOACRIVE Inhibition DME1097 XEOTICID XEO00566 XEO_NAME Guaiacol DME1097 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1097 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00566 GENEFORM Protein DME1097 XEOTICID XEO00566 MOACRIVE Inhibition DME1097 XEOTICID XEO00568 XEO_NAME Resveratrol DME1097 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1097 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00568 GENEFORM Protein DME1097 XEOTICID XEO00568 MOACRIVE Inhibition DME1097 XEOTICID XEO00573 XEO_NAME Naringenin DME1097 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1097 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00573 GENEFORM Protein DME1097 XEOTICID XEO00573 MOACRIVE Inhibition DME1097 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1097 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1097 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00574 GENEFORM Protein DME1097 XEOTICID XEO00574 MOACRIVE Inhibition DME1097 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1097 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1097 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00611 GENEFORM Protein DME1097 XEOTICID XEO00611 MOACRIVE Inhibition DME1097 XEOTICID XEO00621 XEO_NAME Chitosan DME1097 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1097 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00621 GENEFORM Protein DME1097 XEOTICID XEO00621 MOACRIVE Inhibition DME1097 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1097 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1097 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00646 GENEFORM Protein DME1097 XEOTICID XEO00646 MOACRIVE Inhibition DME1097 XEOTICID XEO00683 XEO_NAME Curcumin DME1097 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1097 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00683 GENEFORM Protein DME1097 XEOTICID XEO00683 MOACRIVE Inhibition DME1097 XEOTICID XEO00727 XEO_NAME Vanillin DME1097 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1097 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00727 GENEFORM Protein DME1097 XEOTICID XEO00727 MOACRIVE Inhibition DME1097 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1097 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1097 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00730 GENEFORM Protein DME1097 XEOTICID XEO00730 MOACRIVE Inhibition DME1097 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1097 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO00782 XEO_CLAS Natural Product DME1097 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00782 GENEFORM Protein DME1097 XEOTICID XEO00782 MOACRIVE Inhibition DME1097 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1097 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1097 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00866 GENEFORM Protein DME1097 XEOTICID XEO00866 MOACRIVE Inhibition DME1097 XEOTICID XEO00878 XEO_NAME Chrysin DME1097 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO00878 XEO_CLAS Natural Product DME1097 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00878 GENEFORM Protein DME1097 XEOTICID XEO00878 MOACRIVE Inhibition DME1097 XEOTICID XEO00879 XEO_NAME Coumarin DME1097 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1097 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1097 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00879 GENEFORM Protein DME1097 XEOTICID XEO00879 MOACRIVE Inhibition DME1097 XEOTICID XEO00883 XEO_NAME Phloretin DME1097 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO00883 XEO_CLAS Natural Product DME1097 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00883 GENEFORM Protein DME1097 XEOTICID XEO00883 MOACRIVE Inhibition DME1097 XEOTICID XEO00885 XEO_NAME Eugenol DME1097 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1097 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO00885 GENEFORM Protein DME1097 XEOTICID XEO00885 MOACRIVE Inhibition DME1097 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1097 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1097 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1097 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01032 GENEFORM Protein DME1097 XEOTICID XEO01032 MOACRIVE Inhibition DME1097 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1097 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01174 XEO_CLAS Natural Product DME1097 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01174 GENEFORM Protein DME1097 XEOTICID XEO01174 MOACRIVE Inhibition DME1097 XEOTICID XEO01203 XEO_NAME Apigenin DME1097 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01203 XEO_CLAS Natural Product DME1097 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01203 GENEFORM Protein DME1097 XEOTICID XEO01203 MOACRIVE Inhibition DME1097 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1097 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1097 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1097 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01232 GENEFORM Protein DME1097 XEOTICID XEO01232 MOACRIVE Inhibition DME1097 XEOTICID XEO01237 XEO_NAME Carvacrol DME1097 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1097 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01237 GENEFORM Protein DME1097 XEOTICID XEO01237 MOACRIVE Inhibition DME1097 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1097 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1097 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01287 GENEFORM Protein DME1097 XEOTICID XEO01287 MOACRIVE Inhibition DME1097 XEOTICID XEO01291 XEO_NAME Esculetin DME1097 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1097 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01291 GENEFORM Protein DME1097 XEOTICID XEO01291 MOACRIVE Inhibition DME1097 XEOTICID XEO01304 XEO_NAME Flavone DME1097 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01304 XEO_CLAS Natural Product DME1097 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01304 GENEFORM Protein DME1097 XEOTICID XEO01304 MOACRIVE Inhibition DME1097 XEOTICID XEO01309 XEO_NAME Gallic acid DME1097 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01309 XEO_CLAS Natural Product DME1097 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01309 GENEFORM Protein DME1097 XEOTICID XEO01309 MOACRIVE Inhibition DME1097 XEOTICID XEO01340 XEO_NAME Imperatorin DME1097 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01340 XEO_CLAS Natural Product DME1097 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01340 GENEFORM Protein DME1097 XEOTICID XEO01340 MOACRIVE Inhibition DME1097 XEOTICID XEO01353 XEO_NAME Kaempferol DME1097 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1097 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1097 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01353 GENEFORM Protein DME1097 XEOTICID XEO01353 MOACRIVE Inhibition DME1097 XEOTICID XEO01366 XEO_NAME Linalool DME1097 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01366 XEO_CLAS Natural Product DME1097 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01366 GENEFORM Protein DME1097 XEOTICID XEO01366 MOACRIVE Inhibition DME1097 XEOTICID XEO01391 XEO_NAME Naringin DME1097 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01391 XEO_CLAS Natural Product DME1097 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01391 GENEFORM Protein DME1097 XEOTICID XEO01391 MOACRIVE Inhibition DME1097 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1097 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1097 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01420 GENEFORM Protein DME1097 XEOTICID XEO01420 MOACRIVE Inhibition DME1097 XEOTICID XEO01463 XEO_NAME Rutin DME1097 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01463 XEO_CLAS Natural Product DME1097 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01463 GENEFORM Protein DME1097 XEOTICID XEO01463 MOACRIVE Inhibition DME1097 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1097 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1097 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01496 GENEFORM Protein DME1097 XEOTICID XEO01496 MOACRIVE Inhibition DME1097 XEOTICID XEO01512 XEO_NAME Zinc DME1097 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1097 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1097 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01512 GENEFORM Protein DME1097 XEOTICID XEO01512 MOACRIVE Inhibition DME1097 XEOTICID XEO01527 XEO_NAME Bergamottin DME1097 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01527 XEO_CLAS Natural Product DME1097 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01527 GENEFORM Protein DME1097 XEOTICID XEO01527 MOACRIVE Inhibition DME1097 XEOTICID XEO01531 XEO_NAME Clove oil DME1097 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01531 XEO_CLAS Natural Product DME1097 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01531 GENEFORM Protein DME1097 XEOTICID XEO01531 MOACRIVE Inhibition DME1097 XEOTICID XEO01559 XEO_NAME Limonene DME1097 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01559 XEO_CLAS Natural Product DME1097 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01559 GENEFORM Protein DME1097 XEOTICID XEO01559 MOACRIVE Inhibition DME1097 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1097 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01563 XEO_CLAS Natural Product DME1097 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01563 GENEFORM Protein DME1097 XEOTICID XEO01563 MOACRIVE Inhibition DME1097 XEOTICID XEO01566 XEO_NAME Nobiletin DME1097 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01566 XEO_CLAS Natural Product DME1097 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01566 GENEFORM Protein DME1097 XEOTICID XEO01566 MOACRIVE Inhibition DME1097 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1097 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01778 XEO_CLAS Natural Product DME1097 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01778 GENEFORM Protein DME1097 XEOTICID XEO01778 MOACRIVE Inhibition DME1097 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1097 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01779 XEO_CLAS Peptide DME1097 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 128 microM) DME1097 XEOTICID XEO01779 GENEFORM Protein DME1097 XEOTICID XEO01779 MOACRIVE Inhibition DME1097 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1097 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01810 XEO_CLAS Peptide DME1097 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.0 microM) DME1097 XEOTICID XEO01810 GENEFORM Protein DME1097 XEOTICID XEO01810 MOACRIVE Inhibition DME1097 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1097 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01811 XEO_CLAS Peptide DME1097 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 microM) DME1097 XEOTICID XEO01811 GENEFORM Protein DME1097 XEOTICID XEO01811 MOACRIVE Inhibition DME1097 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1097 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01812 XEO_CLAS Peptide DME1097 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10.4 microM) DME1097 XEOTICID XEO01812 GENEFORM Protein DME1097 XEOTICID XEO01812 MOACRIVE Inhibition DME1097 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1097 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01813 XEO_CLAS Peptide DME1097 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.1 microM) DME1097 XEOTICID XEO01813 GENEFORM Protein DME1097 XEOTICID XEO01813 MOACRIVE Inhibition DME1097 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1097 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01814 XEO_CLAS Peptide DME1097 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.5 microM) DME1097 XEOTICID XEO01814 GENEFORM Protein DME1097 XEOTICID XEO01814 MOACRIVE Inhibition DME1097 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1097 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01815 XEO_CLAS Peptide DME1097 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 9.8 microM) DME1097 XEOTICID XEO01815 GENEFORM Protein DME1097 XEOTICID XEO01815 MOACRIVE Inhibition DME1097 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1097 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01816 XEO_CLAS Peptide DME1097 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO01816 GENEFORM Protein DME1097 XEOTICID XEO01816 MOACRIVE Inhibition DME1097 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1097 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01817 XEO_CLAS Peptide DME1097 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.0 microM) DME1097 XEOTICID XEO01817 GENEFORM Protein DME1097 XEOTICID XEO01817 MOACRIVE Inhibition DME1097 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1097 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01818 XEO_CLAS Peptide DME1097 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4.0 microM) DME1097 XEOTICID XEO01818 GENEFORM Protein DME1097 XEOTICID XEO01818 MOACRIVE Inhibition DME1097 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1097 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01819 XEO_CLAS Peptide DME1097 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO01819 GENEFORM Protein DME1097 XEOTICID XEO01819 MOACRIVE Inhibition DME1097 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1097 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01820 XEO_CLAS Peptide DME1097 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO01820 GENEFORM Protein DME1097 XEOTICID XEO01820 MOACRIVE Inhibition DME1097 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1097 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01821 XEO_CLAS Peptide DME1097 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO01821 GENEFORM Protein DME1097 XEOTICID XEO01821 MOACRIVE Inhibition DME1097 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1097 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01822 XEO_CLAS Peptide DME1097 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 microM) DME1097 XEOTICID XEO01822 GENEFORM Protein DME1097 XEOTICID XEO01822 MOACRIVE Inhibition DME1097 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1097 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01823 XEO_CLAS Peptide DME1097 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO01823 GENEFORM Protein DME1097 XEOTICID XEO01823 MOACRIVE Inhibition DME1097 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1097 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01824 XEO_CLAS Peptide DME1097 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO01824 GENEFORM Protein DME1097 XEOTICID XEO01824 MOACRIVE Inhibition DME1097 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1097 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01825 XEO_CLAS Peptide DME1097 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25.0 microM) DME1097 XEOTICID XEO01825 GENEFORM Protein DME1097 XEOTICID XEO01825 MOACRIVE Inhibition DME1097 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1097 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01827 XEO_CLAS Peptide DME1097 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.12-6.25 microM) DME1097 XEOTICID XEO01827 GENEFORM Protein DME1097 XEOTICID XEO01827 MOACRIVE Inhibition DME1097 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1097 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1097 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1097 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01829 GENEFORM Protein DME1097 XEOTICID XEO01829 MOACRIVE Inhibition DME1097 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1097 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01927 XEO_CLAS Peptide DME1097 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 ug/ml) DME1097 XEOTICID XEO01927 GENEFORM Protein DME1097 XEOTICID XEO01927 MOACRIVE Inhibition DME1097 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1097 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01945 XEO_CLAS Peptide DME1097 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.1 microM) DME1097 XEOTICID XEO01945 GENEFORM Protein DME1097 XEOTICID XEO01945 MOACRIVE Inhibition DME1097 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1097 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01946 XEO_CLAS Peptide DME1097 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.2 microM) DME1097 XEOTICID XEO01946 GENEFORM Protein DME1097 XEOTICID XEO01946 MOACRIVE Inhibition DME1097 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1097 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO01947 XEO_CLAS Natural Product DME1097 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01947 GENEFORM Protein DME1097 XEOTICID XEO01947 MOACRIVE Inhibition DME1097 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1097 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1097 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1097 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01950 GENEFORM Protein DME1097 XEOTICID XEO01950 MOACRIVE Inhibition DME1097 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1097 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1097 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1097 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01961 GENEFORM Protein DME1097 XEOTICID XEO01961 MOACRIVE Inhibition DME1097 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1097 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1097 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1097 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO01966 GENEFORM Protein DME1097 XEOTICID XEO01966 MOACRIVE Inhibition DME1097 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1097 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01996 XEO_CLAS Peptide DME1097 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.7 microM) DME1097 XEOTICID XEO01996 GENEFORM Protein DME1097 XEOTICID XEO01996 MOACRIVE Inhibition DME1097 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1097 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01997 XEO_CLAS Peptide DME1097 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.9 microM) DME1097 XEOTICID XEO01997 GENEFORM Protein DME1097 XEOTICID XEO01997 MOACRIVE Inhibition DME1097 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1097 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01998 XEO_CLAS Peptide DME1097 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO01998 GENEFORM Protein DME1097 XEOTICID XEO01998 MOACRIVE Inhibition DME1097 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1097 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO01999 XEO_CLAS Peptide DME1097 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.5 microM) DME1097 XEOTICID XEO01999 GENEFORM Protein DME1097 XEOTICID XEO01999 MOACRIVE Inhibition DME1097 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1097 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02013 XEO_CLAS Peptide DME1097 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02013 GENEFORM Protein DME1097 XEOTICID XEO02013 MOACRIVE Inhibition DME1097 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1097 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02032 XEO_CLAS Natural Product DME1097 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02032 GENEFORM Protein DME1097 XEOTICID XEO02032 MOACRIVE Inhibition DME1097 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1097 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02033 XEO_CLAS Natural Product DME1097 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02033 GENEFORM Protein DME1097 XEOTICID XEO02033 MOACRIVE Inhibition DME1097 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1097 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02079 XEO_CLAS Natural Product DME1097 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02079 GENEFORM Protein DME1097 XEOTICID XEO02079 MOACRIVE Inhibition DME1097 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1097 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1097 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02085 GENEFORM Protein DME1097 XEOTICID XEO02085 MOACRIVE Inhibition DME1097 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1097 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02111 XEO_CLAS Peptide DME1097 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2-4 ug/ml) DME1097 XEOTICID XEO02111 GENEFORM Protein DME1097 XEOTICID XEO02111 MOACRIVE Inhibition DME1097 XEOTICID XEO02113 XEO_NAME Abaecin DME1097 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02113 XEO_CLAS Peptide DME1097 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02113 GENEFORM Protein DME1097 XEOTICID XEO02113 MOACRIVE Inhibition DME1097 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1097 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02114 XEO_CLAS Peptide DME1097 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-25 ug/ml) DME1097 XEOTICID XEO02114 GENEFORM Protein DME1097 XEOTICID XEO02114 MOACRIVE Inhibition DME1097 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1097 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02115 XEO_CLAS Peptide DME1097 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02115 GENEFORM Protein DME1097 XEOTICID XEO02115 MOACRIVE Inhibition DME1097 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1097 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02117 XEO_CLAS Peptide DME1097 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02117 GENEFORM Protein DME1097 XEOTICID XEO02117 MOACRIVE Inhibition DME1097 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1097 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02118 XEO_CLAS Peptide DME1097 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02118 GENEFORM Protein DME1097 XEOTICID XEO02118 MOACRIVE Inhibition DME1097 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1097 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02119 XEO_CLAS Peptide DME1097 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02119 GENEFORM Protein DME1097 XEOTICID XEO02119 MOACRIVE Inhibition DME1097 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1097 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02120 XEO_CLAS Peptide DME1097 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02120 GENEFORM Protein DME1097 XEOTICID XEO02120 MOACRIVE Inhibition DME1097 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1097 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02121 XEO_CLAS Peptide DME1097 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02121 GENEFORM Protein DME1097 XEOTICID XEO02121 MOACRIVE Inhibition DME1097 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1097 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02122 XEO_CLAS Peptide DME1097 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 ug/ml) DME1097 XEOTICID XEO02122 GENEFORM Protein DME1097 XEOTICID XEO02122 MOACRIVE Inhibition DME1097 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1097 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02130 XEO_CLAS Peptide DME1097 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.7 microM) DME1097 XEOTICID XEO02130 GENEFORM Protein DME1097 XEOTICID XEO02130 MOACRIVE Inhibition DME1097 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1097 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02131 XEO_CLAS Peptide DME1097 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.3 microM) DME1097 XEOTICID XEO02131 GENEFORM Protein DME1097 XEOTICID XEO02131 MOACRIVE Inhibition DME1097 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1097 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02132 XEO_CLAS Peptide DME1097 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.5 microM) DME1097 XEOTICID XEO02132 GENEFORM Protein DME1097 XEOTICID XEO02132 MOACRIVE Inhibition DME1097 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1097 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02136 XEO_CLAS Peptide DME1097 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 ug/ml) DME1097 XEOTICID XEO02136 GENEFORM Protein DME1097 XEOTICID XEO02136 MOACRIVE Inhibition DME1097 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1097 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02147 XEO_CLAS Peptide DME1097 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 382 ug/ml) DME1097 XEOTICID XEO02147 GENEFORM Protein DME1097 XEOTICID XEO02147 MOACRIVE Inhibition DME1097 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1097 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02149 XEO_CLAS Peptide DME1097 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 47.35 microM) DME1097 XEOTICID XEO02149 GENEFORM Protein DME1097 XEOTICID XEO02149 MOACRIVE Inhibition DME1097 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1097 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02164 XEO_CLAS Peptide DME1097 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02164 GENEFORM Protein DME1097 XEOTICID XEO02164 MOACRIVE Inhibition DME1097 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1097 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02165 XEO_CLAS Peptide DME1097 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02165 GENEFORM Protein DME1097 XEOTICID XEO02165 MOACRIVE Inhibition DME1097 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1097 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02166 XEO_CLAS Peptide DME1097 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02166 GENEFORM Protein DME1097 XEOTICID XEO02166 MOACRIVE Inhibition DME1097 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1097 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02167 XEO_CLAS Peptide DME1097 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02167 GENEFORM Protein DME1097 XEOTICID XEO02167 MOACRIVE Inhibition DME1097 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1097 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02168 XEO_CLAS Peptide DME1097 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02168 GENEFORM Protein DME1097 XEOTICID XEO02168 MOACRIVE Inhibition DME1097 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1097 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02169 XEO_CLAS Peptide DME1097 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02169 GENEFORM Protein DME1097 XEOTICID XEO02169 MOACRIVE Inhibition DME1097 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1097 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02170 XEO_CLAS Peptide DME1097 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.4 microM) DME1097 XEOTICID XEO02170 GENEFORM Protein DME1097 XEOTICID XEO02170 MOACRIVE Inhibition DME1097 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1097 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02175 XEO_CLAS Natural Product DME1097 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02175 GENEFORM Protein DME1097 XEOTICID XEO02175 MOACRIVE Inhibition DME1097 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1097 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02177 XEO_CLAS Peptide DME1097 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO02177 GENEFORM Protein DME1097 XEOTICID XEO02177 MOACRIVE Inhibition DME1097 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1097 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02178 XEO_CLAS Peptide DME1097 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO02178 GENEFORM Protein DME1097 XEOTICID XEO02178 MOACRIVE Inhibition DME1097 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1097 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02179 XEO_CLAS Peptide DME1097 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO02179 GENEFORM Protein DME1097 XEOTICID XEO02179 MOACRIVE Inhibition DME1097 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1097 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02180 XEO_CLAS Peptide DME1097 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 214 microM) DME1097 XEOTICID XEO02180 GENEFORM Protein DME1097 XEOTICID XEO02180 MOACRIVE Inhibition DME1097 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1097 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02181 XEO_CLAS Peptide DME1097 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 217 microM) DME1097 XEOTICID XEO02181 GENEFORM Protein DME1097 XEOTICID XEO02181 MOACRIVE Inhibition DME1097 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1097 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02183 XEO_CLAS Peptide DME1097 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 38.4 microM) DME1097 XEOTICID XEO02183 GENEFORM Protein DME1097 XEOTICID XEO02183 MOACRIVE Inhibition DME1097 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1097 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02185 XEO_CLAS Peptide DME1097 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 microM) DME1097 XEOTICID XEO02185 GENEFORM Protein DME1097 XEOTICID XEO02185 MOACRIVE Inhibition DME1097 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1097 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02187 GENEFORM Protein DME1097 XEOTICID XEO02187 MOACRIVE Inhibition DME1097 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1097 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02191 XEO_CLAS Peptide DME1097 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02191 GENEFORM Protein DME1097 XEOTICID XEO02191 MOACRIVE Inhibition DME1097 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1097 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02192 XEO_CLAS Peptide DME1097 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.50 ug/ml) DME1097 XEOTICID XEO02192 GENEFORM Protein DME1097 XEOTICID XEO02192 MOACRIVE Inhibition DME1097 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1097 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02193 XEO_CLAS Peptide DME1097 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02193 GENEFORM Protein DME1097 XEOTICID XEO02193 MOACRIVE Inhibition DME1097 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1097 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02194 XEO_CLAS Peptide DME1097 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02194 GENEFORM Protein DME1097 XEOTICID XEO02194 MOACRIVE Inhibition DME1097 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1097 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02195 XEO_CLAS Peptide DME1097 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.00 ug/ml) DME1097 XEOTICID XEO02195 GENEFORM Protein DME1097 XEOTICID XEO02195 MOACRIVE Inhibition DME1097 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1097 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02197 XEO_CLAS Peptide DME1097 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02197 GENEFORM Protein DME1097 XEOTICID XEO02197 MOACRIVE Inhibition DME1097 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1097 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02200 XEO_CLAS Peptide DME1097 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 ug/ml) DME1097 XEOTICID XEO02200 GENEFORM Protein DME1097 XEOTICID XEO02200 MOACRIVE Inhibition DME1097 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1097 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02201 XEO_CLAS Peptide DME1097 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 ug/ml) DME1097 XEOTICID XEO02201 GENEFORM Protein DME1097 XEOTICID XEO02201 MOACRIVE Inhibition DME1097 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1097 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02202 XEO_CLAS Peptide DME1097 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO02202 GENEFORM Protein DME1097 XEOTICID XEO02202 MOACRIVE Inhibition DME1097 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1097 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02203 XEO_CLAS Peptide DME1097 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 microM) DME1097 XEOTICID XEO02203 GENEFORM Protein DME1097 XEOTICID XEO02203 MOACRIVE Inhibition DME1097 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1097 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02207 XEO_CLAS Peptide DME1097 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.78 ug/ml) DME1097 XEOTICID XEO02207 GENEFORM Protein DME1097 XEOTICID XEO02207 MOACRIVE Inhibition DME1097 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1097 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02208 XEO_CLAS Peptide DME1097 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.13 ug/ml) DME1097 XEOTICID XEO02208 GENEFORM Protein DME1097 XEOTICID XEO02208 MOACRIVE Inhibition DME1097 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1097 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02209 XEO_CLAS Peptide DME1097 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.56 ug/ml) DME1097 XEOTICID XEO02209 GENEFORM Protein DME1097 XEOTICID XEO02209 MOACRIVE Inhibition DME1097 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1097 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02210 XEO_CLAS Peptide DME1097 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 ug/ml) DME1097 XEOTICID XEO02210 GENEFORM Protein DME1097 XEOTICID XEO02210 MOACRIVE Inhibition DME1097 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1097 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02211 XEO_CLAS Peptide DME1097 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25 ug/ml) DME1097 XEOTICID XEO02211 GENEFORM Protein DME1097 XEOTICID XEO02211 MOACRIVE Inhibition DME1097 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1097 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02212 XEO_CLAS Peptide DME1097 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.13 ug/ml) DME1097 XEOTICID XEO02212 GENEFORM Protein DME1097 XEOTICID XEO02212 MOACRIVE Inhibition DME1097 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1097 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02213 XEO_CLAS Peptide DME1097 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.13 ug/ml) DME1097 XEOTICID XEO02213 GENEFORM Protein DME1097 XEOTICID XEO02213 MOACRIVE Inhibition DME1097 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1097 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02214 XEO_CLAS Peptide DME1097 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02214 GENEFORM Protein DME1097 XEOTICID XEO02214 MOACRIVE Inhibition DME1097 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1097 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02215 XEO_CLAS Peptide DME1097 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 ug/ml) DME1097 XEOTICID XEO02215 GENEFORM Protein DME1097 XEOTICID XEO02215 MOACRIVE Inhibition DME1097 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1097 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02216 XEO_CLAS Peptide DME1097 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 126 ug/ml) DME1097 XEOTICID XEO02216 GENEFORM Protein DME1097 XEOTICID XEO02216 MOACRIVE Inhibition DME1097 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1097 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02217 XEO_CLAS Peptide DME1097 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 200 ug/ml) DME1097 XEOTICID XEO02217 GENEFORM Protein DME1097 XEOTICID XEO02217 MOACRIVE Inhibition DME1097 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1097 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02218 XEO_CLAS Peptide DME1097 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 200 ug/ml) DME1097 XEOTICID XEO02218 GENEFORM Protein DME1097 XEOTICID XEO02218 MOACRIVE Inhibition DME1097 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1097 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02219 XEO_CLAS Peptide DME1097 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 200 ug/ml) DME1097 XEOTICID XEO02219 GENEFORM Protein DME1097 XEOTICID XEO02219 MOACRIVE Inhibition DME1097 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1097 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02220 XEO_CLAS Peptide DME1097 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 23.5 ug/ml) DME1097 XEOTICID XEO02220 GENEFORM Protein DME1097 XEOTICID XEO02220 MOACRIVE Inhibition DME1097 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1097 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02221 XEO_CLAS Peptide DME1097 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20.2 ug/ml) DME1097 XEOTICID XEO02221 GENEFORM Protein DME1097 XEOTICID XEO02221 MOACRIVE Inhibition DME1097 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1097 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02222 XEO_CLAS Peptide DME1097 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30.5 ug/ml) DME1097 XEOTICID XEO02222 GENEFORM Protein DME1097 XEOTICID XEO02222 MOACRIVE Inhibition DME1097 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1097 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02223 XEO_CLAS Peptide DME1097 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.2 ug/ml) DME1097 XEOTICID XEO02223 GENEFORM Protein DME1097 XEOTICID XEO02223 MOACRIVE Inhibition DME1097 XEOTICID XEO02224 XEO_NAME Androctonin DME1097 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02224 XEO_CLAS Peptide DME1097 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02224 GENEFORM Protein DME1097 XEOTICID XEO02224 MOACRIVE Inhibition DME1097 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1097 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02225 XEO_CLAS Peptide DME1097 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02225 GENEFORM Protein DME1097 XEOTICID XEO02225 MOACRIVE Inhibition DME1097 XEOTICID XEO02226 XEO_NAME Andropin DME1097 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02226 XEO_CLAS Peptide DME1097 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 140 microM) DME1097 XEOTICID XEO02226 GENEFORM Protein DME1097 XEOTICID XEO02226 MOACRIVE Inhibition DME1097 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1097 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02230 XEO_CLAS Peptide DME1097 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.05-0.1 microM) DME1097 XEOTICID XEO02230 GENEFORM Protein DME1097 XEOTICID XEO02230 MOACRIVE Inhibition DME1097 XEOTICID XEO02232 XEO_NAME Anoplin DME1097 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02232 XEO_CLAS Peptide DME1097 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 13 ug/ml) DME1097 XEOTICID XEO02232 GENEFORM Protein DME1097 XEOTICID XEO02232 MOACRIVE Inhibition DME1097 XEOTICID XEO02233 XEO_NAME Antapin DME1097 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02233 XEO_CLAS Peptide DME1097 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02233 GENEFORM Protein DME1097 XEOTICID XEO02233 MOACRIVE Inhibition DME1097 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1097 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02236 XEO_CLAS Peptide DME1097 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02236 GENEFORM Protein DME1097 XEOTICID XEO02236 MOACRIVE Inhibition DME1097 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1097 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02239 XEO_CLAS Peptide DME1097 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 250 microM) DME1097 XEOTICID XEO02239 GENEFORM Protein DME1097 XEOTICID XEO02239 MOACRIVE Inhibition DME1097 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1097 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02240 XEO_CLAS Peptide DME1097 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 microM) DME1097 XEOTICID XEO02240 GENEFORM Protein DME1097 XEOTICID XEO02240 MOACRIVE Inhibition DME1097 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1097 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02241 XEO_CLAS Peptide DME1097 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02241 GENEFORM Protein DME1097 XEOTICID XEO02241 MOACRIVE Inhibition DME1097 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1097 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02242 XEO_CLAS Peptide DME1097 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO02242 GENEFORM Protein DME1097 XEOTICID XEO02242 MOACRIVE Inhibition DME1097 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1097 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02243 XEO_CLAS Peptide DME1097 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 microM) DME1097 XEOTICID XEO02243 GENEFORM Protein DME1097 XEOTICID XEO02243 MOACRIVE Inhibition DME1097 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1097 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02244 XEO_CLAS Peptide DME1097 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1 microM) DME1097 XEOTICID XEO02244 GENEFORM Protein DME1097 XEOTICID XEO02244 MOACRIVE Inhibition DME1097 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1097 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02245 XEO_CLAS Peptide DME1097 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02245 GENEFORM Protein DME1097 XEOTICID XEO02245 MOACRIVE Inhibition DME1097 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1097 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02246 XEO_CLAS Peptide DME1097 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 microM) DME1097 XEOTICID XEO02246 GENEFORM Protein DME1097 XEOTICID XEO02246 MOACRIVE Inhibition DME1097 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1097 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02247 XEO_CLAS Peptide DME1097 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02247 GENEFORM Protein DME1097 XEOTICID XEO02247 MOACRIVE Inhibition DME1097 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1097 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02248 XEO_CLAS Peptide DME1097 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.3 microM) DME1097 XEOTICID XEO02248 GENEFORM Protein DME1097 XEOTICID XEO02248 MOACRIVE Inhibition DME1097 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1097 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02253 XEO_CLAS Peptide DME1097 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02253 GENEFORM Protein DME1097 XEOTICID XEO02253 MOACRIVE Inhibition DME1097 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1097 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02258 XEO_CLAS Peptide DME1097 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 150 microM) DME1097 XEOTICID XEO02258 GENEFORM Protein DME1097 XEOTICID XEO02258 MOACRIVE Inhibition DME1097 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1097 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02261 XEO_CLAS Peptide DME1097 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 82 ug/ml) DME1097 XEOTICID XEO02261 GENEFORM Protein DME1097 XEOTICID XEO02261 MOACRIVE Inhibition DME1097 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1097 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02263 XEO_CLAS Peptide DME1097 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO02263 GENEFORM Protein DME1097 XEOTICID XEO02263 MOACRIVE Inhibition DME1097 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1097 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02266 XEO_CLAS Peptide DME1097 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 120 microM) DME1097 XEOTICID XEO02266 GENEFORM Protein DME1097 XEOTICID XEO02266 MOACRIVE Inhibition DME1097 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1097 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02268 XEO_CLAS Peptide DME1097 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 170 ug/ml) DME1097 XEOTICID XEO02268 GENEFORM Protein DME1097 XEOTICID XEO02268 MOACRIVE Inhibition DME1097 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1097 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02270 XEO_CLAS Peptide DME1097 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 microM) DME1097 XEOTICID XEO02270 GENEFORM Protein DME1097 XEOTICID XEO02270 MOACRIVE Inhibition DME1097 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1097 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02271 XEO_CLAS Peptide DME1097 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 302 ug/ml) DME1097 XEOTICID XEO02271 GENEFORM Protein DME1097 XEOTICID XEO02271 MOACRIVE Inhibition DME1097 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1097 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02273 XEO_CLAS Peptide DME1097 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 18 microM) DME1097 XEOTICID XEO02273 GENEFORM Protein DME1097 XEOTICID XEO02273 MOACRIVE Inhibition DME1097 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1097 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02274 XEO_CLAS Peptide DME1097 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO02274 GENEFORM Protein DME1097 XEOTICID XEO02274 MOACRIVE Inhibition DME1097 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1097 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02275 XEO_CLAS Peptide DME1097 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 microM) DME1097 XEOTICID XEO02275 GENEFORM Protein DME1097 XEOTICID XEO02275 MOACRIVE Inhibition DME1097 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1097 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02276 XEO_CLAS Peptide DME1097 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 microM) DME1097 XEOTICID XEO02276 GENEFORM Protein DME1097 XEOTICID XEO02276 MOACRIVE Inhibition DME1097 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1097 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02280 XEO_CLAS Peptide DME1097 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02280 GENEFORM Protein DME1097 XEOTICID XEO02280 MOACRIVE Inhibition DME1097 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1097 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02281 XEO_CLAS Peptide DME1097 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02281 GENEFORM Protein DME1097 XEOTICID XEO02281 MOACRIVE Inhibition DME1097 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1097 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02283 XEO_CLAS Peptide DME1097 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 ug/ml) DME1097 XEOTICID XEO02283 GENEFORM Protein DME1097 XEOTICID XEO02283 MOACRIVE Inhibition DME1097 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1097 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02284 XEO_CLAS Peptide DME1097 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50.4 microM) DME1097 XEOTICID XEO02284 GENEFORM Protein DME1097 XEOTICID XEO02284 MOACRIVE Inhibition DME1097 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1097 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02285 XEO_CLAS Peptide DME1097 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50.4 microM) DME1097 XEOTICID XEO02285 GENEFORM Protein DME1097 XEOTICID XEO02285 MOACRIVE Inhibition DME1097 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1097 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02286 XEO_CLAS Peptide DME1097 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50.4 microM) DME1097 XEOTICID XEO02286 GENEFORM Protein DME1097 XEOTICID XEO02286 MOACRIVE Inhibition DME1097 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1097 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02287 XEO_CLAS Peptide DME1097 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50.4 microM) DME1097 XEOTICID XEO02287 GENEFORM Protein DME1097 XEOTICID XEO02287 MOACRIVE Inhibition DME1097 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1097 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02288 XEO_CLAS Peptide DME1097 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.2 ug/ml) DME1097 XEOTICID XEO02288 GENEFORM Protein DME1097 XEOTICID XEO02288 MOACRIVE Inhibition DME1097 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1097 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02289 XEO_CLAS Peptide DME1097 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 ug/ml) DME1097 XEOTICID XEO02289 GENEFORM Protein DME1097 XEOTICID XEO02289 MOACRIVE Inhibition DME1097 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1097 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02290 XEO_CLAS Peptide DME1097 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO02290 GENEFORM Protein DME1097 XEOTICID XEO02290 MOACRIVE Inhibition DME1097 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1097 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02291 XEO_CLAS Peptide DME1097 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02291 GENEFORM Protein DME1097 XEOTICID XEO02291 MOACRIVE Inhibition DME1097 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1097 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02293 XEO_CLAS Peptide DME1097 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 microM) DME1097 XEOTICID XEO02293 GENEFORM Protein DME1097 XEOTICID XEO02293 MOACRIVE Inhibition DME1097 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1097 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02294 XEO_CLAS Peptide DME1097 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 62-250 ug/ml) DME1097 XEOTICID XEO02294 GENEFORM Protein DME1097 XEOTICID XEO02294 MOACRIVE Inhibition DME1097 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1097 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02295 XEO_CLAS Peptide DME1097 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 ug/ml) DME1097 XEOTICID XEO02295 GENEFORM Protein DME1097 XEOTICID XEO02295 MOACRIVE Inhibition DME1097 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1097 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02296 XEO_CLAS Peptide DME1097 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02296 GENEFORM Protein DME1097 XEOTICID XEO02296 MOACRIVE Inhibition DME1097 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1097 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02297 XEO_CLAS Peptide DME1097 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC < 50 ug/ml) DME1097 XEOTICID XEO02297 GENEFORM Protein DME1097 XEOTICID XEO02297 MOACRIVE Inhibition DME1097 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1097 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02298 XEO_CLAS Peptide DME1097 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO02298 GENEFORM Protein DME1097 XEOTICID XEO02298 MOACRIVE Inhibition DME1097 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1097 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02303 XEO_CLAS Peptide DME1097 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02303 GENEFORM Protein DME1097 XEOTICID XEO02303 MOACRIVE Inhibition DME1097 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1097 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02304 XEO_CLAS Peptide DME1097 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.1 ug/ml) DME1097 XEOTICID XEO02304 GENEFORM Protein DME1097 XEOTICID XEO02304 MOACRIVE Inhibition DME1097 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1097 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02305 XEO_CLAS Peptide DME1097 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC <= 1 ug/ml) DME1097 XEOTICID XEO02305 GENEFORM Protein DME1097 XEOTICID XEO02305 MOACRIVE Inhibition DME1097 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1097 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02306 XEO_CLAS Peptide DME1097 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.2 ug/ml) DME1097 XEOTICID XEO02306 GENEFORM Protein DME1097 XEOTICID XEO02306 MOACRIVE Inhibition DME1097 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1097 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02309 XEO_CLAS Peptide DME1097 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02309 GENEFORM Protein DME1097 XEOTICID XEO02309 MOACRIVE Inhibition DME1097 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1097 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02310 XEO_CLAS Peptide DME1097 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02310 GENEFORM Protein DME1097 XEOTICID XEO02310 MOACRIVE Inhibition DME1097 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1097 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02315 XEO_CLAS Peptide DME1097 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO02315 GENEFORM Protein DME1097 XEOTICID XEO02315 MOACRIVE Inhibition DME1097 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1097 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02316 XEO_CLAS Peptide DME1097 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 50 microM) DME1097 XEOTICID XEO02316 GENEFORM Protein DME1097 XEOTICID XEO02316 MOACRIVE Inhibition DME1097 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1097 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02317 XEO_CLAS Peptide DME1097 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 300 microM) DME1097 XEOTICID XEO02317 GENEFORM Protein DME1097 XEOTICID XEO02317 MOACRIVE Inhibition DME1097 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1097 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02318 XEO_CLAS Peptide DME1097 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02318 GENEFORM Protein DME1097 XEOTICID XEO02318 MOACRIVE Inhibition DME1097 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1097 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02319 XEO_CLAS Peptide DME1097 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02319 GENEFORM Protein DME1097 XEOTICID XEO02319 MOACRIVE Inhibition DME1097 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1097 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02320 XEO_CLAS Peptide DME1097 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02320 GENEFORM Protein DME1097 XEOTICID XEO02320 MOACRIVE Inhibition DME1097 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1097 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02321 XEO_CLAS Peptide DME1097 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO02321 GENEFORM Protein DME1097 XEOTICID XEO02321 MOACRIVE Inhibition DME1097 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1097 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02322 XEO_CLAS Peptide DME1097 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02322 GENEFORM Protein DME1097 XEOTICID XEO02322 MOACRIVE Inhibition DME1097 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1097 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02323 XEO_CLAS Peptide DME1097 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO02323 GENEFORM Protein DME1097 XEOTICID XEO02323 MOACRIVE Inhibition DME1097 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1097 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02324 XEO_CLAS Peptide DME1097 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02324 GENEFORM Protein DME1097 XEOTICID XEO02324 MOACRIVE Inhibition DME1097 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1097 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02325 XEO_CLAS Peptide DME1097 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO02325 GENEFORM Protein DME1097 XEOTICID XEO02325 MOACRIVE Inhibition DME1097 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1097 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02326 XEO_CLAS Peptide DME1097 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02326 GENEFORM Protein DME1097 XEOTICID XEO02326 MOACRIVE Inhibition DME1097 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1097 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02327 XEO_CLAS Peptide DME1097 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO02327 GENEFORM Protein DME1097 XEOTICID XEO02327 MOACRIVE Inhibition DME1097 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1097 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02328 XEO_CLAS Peptide DME1097 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO02328 GENEFORM Protein DME1097 XEOTICID XEO02328 MOACRIVE Inhibition DME1097 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1097 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02332 XEO_CLAS Peptide DME1097 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.9 ug/ml) DME1097 XEOTICID XEO02332 GENEFORM Protein DME1097 XEOTICID XEO02332 MOACRIVE Inhibition DME1097 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1097 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02333 XEO_CLAS Peptide DME1097 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 200 microM) DME1097 XEOTICID XEO02333 GENEFORM Protein DME1097 XEOTICID XEO02333 MOACRIVE Inhibition DME1097 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1097 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02336 XEO_CLAS Peptide DME1097 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 microM) DME1097 XEOTICID XEO02336 GENEFORM Protein DME1097 XEOTICID XEO02336 MOACRIVE Inhibition DME1097 XEOTICID XEO02346 XEO_NAME Aurelin DME1097 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02346 XEO_CLAS Peptide DME1097 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 7.66 ug/ml) DME1097 XEOTICID XEO02346 GENEFORM Protein DME1097 XEOTICID XEO02346 MOACRIVE Inhibition DME1097 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1097 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02352 XEO_CLAS Peptide DME1097 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 11 ug/ml) DME1097 XEOTICID XEO02352 GENEFORM Protein DME1097 XEOTICID XEO02352 MOACRIVE Inhibition DME1097 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1097 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02353 XEO_CLAS Peptide DME1097 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 ug/ml) DME1097 XEOTICID XEO02353 GENEFORM Protein DME1097 XEOTICID XEO02353 MOACRIVE Inhibition DME1097 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1097 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02354 XEO_CLAS Peptide DME1097 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 ug/ml) DME1097 XEOTICID XEO02354 GENEFORM Protein DME1097 XEOTICID XEO02354 MOACRIVE Inhibition DME1097 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1097 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02355 XEO_CLAS Peptide DME1097 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 17 ug/ml) DME1097 XEOTICID XEO02355 GENEFORM Protein DME1097 XEOTICID XEO02355 MOACRIVE Inhibition DME1097 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1097 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02356 XEO_CLAS Peptide DME1097 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO02356 GENEFORM Protein DME1097 XEOTICID XEO02356 MOACRIVE Inhibition DME1097 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1097 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02357 XEO_CLAS Peptide DME1097 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO02357 GENEFORM Protein DME1097 XEOTICID XEO02357 MOACRIVE Inhibition DME1097 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1097 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02358 XEO_CLAS Peptide DME1097 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO02358 GENEFORM Protein DME1097 XEOTICID XEO02358 MOACRIVE Inhibition DME1097 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1097 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02360 XEO_CLAS Peptide DME1097 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02360 GENEFORM Protein DME1097 XEOTICID XEO02360 MOACRIVE Inhibition DME1097 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1097 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02361 XEO_CLAS Peptide DME1097 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 ug/ml) DME1097 XEOTICID XEO02361 GENEFORM Protein DME1097 XEOTICID XEO02361 MOACRIVE Inhibition DME1097 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1097 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02365 XEO_CLAS Peptide DME1097 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 32 ug/ml) DME1097 XEOTICID XEO02365 GENEFORM Protein DME1097 XEOTICID XEO02365 MOACRIVE Inhibition DME1097 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1097 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02366 XEO_CLAS Peptide DME1097 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO02366 GENEFORM Protein DME1097 XEOTICID XEO02366 MOACRIVE Inhibition DME1097 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1097 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02367 XEO_CLAS Peptide DME1097 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02367 GENEFORM Protein DME1097 XEOTICID XEO02367 MOACRIVE Inhibition DME1097 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1097 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02368 XEO_CLAS Peptide DME1097 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02368 GENEFORM Protein DME1097 XEOTICID XEO02368 MOACRIVE Inhibition DME1097 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1097 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02369 XEO_CLAS Peptide DME1097 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02369 GENEFORM Protein DME1097 XEOTICID XEO02369 MOACRIVE Inhibition DME1097 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1097 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02370 XEO_CLAS Peptide DME1097 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02370 GENEFORM Protein DME1097 XEOTICID XEO02370 MOACRIVE Inhibition DME1097 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1097 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02371 XEO_CLAS Peptide DME1097 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 ug/ml) DME1097 XEOTICID XEO02371 GENEFORM Protein DME1097 XEOTICID XEO02371 MOACRIVE Inhibition DME1097 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1097 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02374 XEO_CLAS Peptide DME1097 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02374 GENEFORM Protein DME1097 XEOTICID XEO02374 MOACRIVE Inhibition DME1097 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1097 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02376 XEO_CLAS Peptide DME1097 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02376 GENEFORM Protein DME1097 XEOTICID XEO02376 MOACRIVE Inhibition DME1097 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1097 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02378 XEO_CLAS Peptide DME1097 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.19 ug/ml) DME1097 XEOTICID XEO02378 GENEFORM Protein DME1097 XEOTICID XEO02378 MOACRIVE Inhibition DME1097 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1097 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02388 XEO_CLAS Peptide DME1097 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO02388 GENEFORM Protein DME1097 XEOTICID XEO02388 MOACRIVE Inhibition DME1097 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1097 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02389 XEO_CLAS Peptide DME1097 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02389 GENEFORM Protein DME1097 XEOTICID XEO02389 MOACRIVE Inhibition DME1097 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1097 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02415 XEO_CLAS Peptide DME1097 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02415 GENEFORM Protein DME1097 XEOTICID XEO02415 MOACRIVE Inhibition DME1097 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1097 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02416 XEO_CLAS Peptide DME1097 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 11 microM) DME1097 XEOTICID XEO02416 GENEFORM Protein DME1097 XEOTICID XEO02416 MOACRIVE Inhibition DME1097 XEOTICID XEO02419 XEO_NAME Bay oil DME1097 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1097 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02419 GENEFORM Protein DME1097 XEOTICID XEO02419 MOACRIVE Inhibition DME1097 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1097 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02435 XEO_CLAS Peptide DME1097 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02435 GENEFORM Protein DME1097 XEOTICID XEO02435 MOACRIVE Inhibition DME1097 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1097 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02436 XEO_CLAS Peptide DME1097 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02436 GENEFORM Protein DME1097 XEOTICID XEO02436 MOACRIVE Inhibition DME1097 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1097 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02437 XEO_CLAS Peptide DME1097 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02437 GENEFORM Protein DME1097 XEOTICID XEO02437 MOACRIVE Inhibition DME1097 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1097 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02438 XEO_CLAS Peptide DME1097 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02438 GENEFORM Protein DME1097 XEOTICID XEO02438 MOACRIVE Inhibition DME1097 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1097 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02439 XEO_CLAS Peptide DME1097 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02439 GENEFORM Protein DME1097 XEOTICID XEO02439 MOACRIVE Inhibition DME1097 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1097 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02440 XEO_CLAS Peptide DME1097 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02440 GENEFORM Protein DME1097 XEOTICID XEO02440 MOACRIVE Inhibition DME1097 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1097 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02441 XEO_CLAS Peptide DME1097 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02441 GENEFORM Protein DME1097 XEOTICID XEO02441 MOACRIVE Inhibition DME1097 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1097 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02442 XEO_CLAS Peptide DME1097 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO02442 GENEFORM Protein DME1097 XEOTICID XEO02442 MOACRIVE Inhibition DME1097 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1097 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02443 XEO_CLAS Peptide DME1097 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02443 GENEFORM Protein DME1097 XEOTICID XEO02443 MOACRIVE Inhibition DME1097 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1097 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02444 XEO_CLAS Peptide DME1097 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02444 GENEFORM Protein DME1097 XEOTICID XEO02444 MOACRIVE Inhibition DME1097 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1097 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1097 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02447 GENEFORM Protein DME1097 XEOTICID XEO02447 MOACRIVE Inhibition DME1097 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1097 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02452 XEO_CLAS Peptide DME1097 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 76800 ug/ml) DME1097 XEOTICID XEO02452 GENEFORM Protein DME1097 XEOTICID XEO02452 MOACRIVE Inhibition DME1097 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1097 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02453 XEO_CLAS Peptide DME1097 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02453 GENEFORM Protein DME1097 XEOTICID XEO02453 MOACRIVE Inhibition DME1097 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1097 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02463 XEO_CLAS Peptide DME1097 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 11.25 microM) DME1097 XEOTICID XEO02463 GENEFORM Protein DME1097 XEOTICID XEO02463 MOACRIVE Inhibition DME1097 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1097 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02466 XEO_CLAS Peptide DME1097 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.5 microM) DME1097 XEOTICID XEO02466 GENEFORM Protein DME1097 XEOTICID XEO02466 MOACRIVE Inhibition DME1097 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1097 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02467 XEO_CLAS Peptide DME1097 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8.4 microM) DME1097 XEOTICID XEO02467 GENEFORM Protein DME1097 XEOTICID XEO02467 MOACRIVE Inhibition DME1097 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1097 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02468 XEO_CLAS Peptide DME1097 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.7 microM) DME1097 XEOTICID XEO02468 GENEFORM Protein DME1097 XEOTICID XEO02468 MOACRIVE Inhibition DME1097 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1097 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02469 XEO_CLAS Peptide DME1097 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO02469 GENEFORM Protein DME1097 XEOTICID XEO02469 MOACRIVE Inhibition DME1097 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1097 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02470 XEO_CLAS Peptide DME1097 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.8 microM) DME1097 XEOTICID XEO02470 GENEFORM Protein DME1097 XEOTICID XEO02470 MOACRIVE Inhibition DME1097 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1097 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02471 XEO_CLAS Peptide DME1097 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4.8 microM) DME1097 XEOTICID XEO02471 GENEFORM Protein DME1097 XEOTICID XEO02471 MOACRIVE Inhibition DME1097 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1097 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02472 XEO_CLAS Peptide DME1097 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.0 microM) DME1097 XEOTICID XEO02472 GENEFORM Protein DME1097 XEOTICID XEO02472 MOACRIVE Inhibition DME1097 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1097 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02473 XEO_CLAS Peptide DME1097 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02473 GENEFORM Protein DME1097 XEOTICID XEO02473 MOACRIVE Inhibition DME1097 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1097 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02474 XEO_CLAS Peptide DME1097 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.5 microM) DME1097 XEOTICID XEO02474 GENEFORM Protein DME1097 XEOTICID XEO02474 MOACRIVE Inhibition DME1097 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1097 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02475 XEO_CLAS Peptide DME1097 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.5 microM) DME1097 XEOTICID XEO02475 GENEFORM Protein DME1097 XEOTICID XEO02475 MOACRIVE Inhibition DME1097 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1097 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02477 XEO_CLAS Peptide DME1097 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-300 ug/ml) DME1097 XEOTICID XEO02477 GENEFORM Protein DME1097 XEOTICID XEO02477 MOACRIVE Inhibition DME1097 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1097 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02478 XEO_CLAS Peptide DME1097 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-300 ug/ml) DME1097 XEOTICID XEO02478 GENEFORM Protein DME1097 XEOTICID XEO02478 MOACRIVE Inhibition DME1097 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1097 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02479 XEO_CLAS Peptide DME1097 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-300 ug/ml) DME1097 XEOTICID XEO02479 GENEFORM Protein DME1097 XEOTICID XEO02479 MOACRIVE Inhibition DME1097 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1097 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02480 XEO_CLAS Peptide DME1097 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-300 ug/ml) DME1097 XEOTICID XEO02480 GENEFORM Protein DME1097 XEOTICID XEO02480 MOACRIVE Inhibition DME1097 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1097 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02481 XEO_CLAS Peptide DME1097 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-300 ug/ml) DME1097 XEOTICID XEO02481 GENEFORM Protein DME1097 XEOTICID XEO02481 MOACRIVE Inhibition DME1097 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1097 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02482 XEO_CLAS Peptide DME1097 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-300 ug/ml) DME1097 XEOTICID XEO02482 GENEFORM Protein DME1097 XEOTICID XEO02482 MOACRIVE Inhibition DME1097 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1097 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02483 XEO_CLAS Peptide DME1097 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-300 ug/ml) DME1097 XEOTICID XEO02483 GENEFORM Protein DME1097 XEOTICID XEO02483 MOACRIVE Inhibition DME1097 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1097 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02484 XEO_CLAS Peptide DME1097 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-300 ug/ml) DME1097 XEOTICID XEO02484 GENEFORM Protein DME1097 XEOTICID XEO02484 MOACRIVE Inhibition DME1097 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1097 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02485 XEO_CLAS Peptide DME1097 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-300 ug/ml) DME1097 XEOTICID XEO02485 GENEFORM Protein DME1097 XEOTICID XEO02485 MOACRIVE Inhibition DME1097 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1097 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02486 XEO_CLAS Peptide DME1097 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-300 ug/ml) DME1097 XEOTICID XEO02486 GENEFORM Protein DME1097 XEOTICID XEO02486 MOACRIVE Inhibition DME1097 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1097 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02487 XEO_CLAS Peptide DME1097 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02487 GENEFORM Protein DME1097 XEOTICID XEO02487 MOACRIVE Inhibition DME1097 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1097 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02488 XEO_CLAS Peptide DME1097 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-300 ug/ml) DME1097 XEOTICID XEO02488 GENEFORM Protein DME1097 XEOTICID XEO02488 MOACRIVE Inhibition DME1097 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1097 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02489 XEO_CLAS Peptide DME1097 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-301 ug/ml) DME1097 XEOTICID XEO02489 GENEFORM Protein DME1097 XEOTICID XEO02489 MOACRIVE Inhibition DME1097 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1097 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02491 XEO_CLAS Peptide DME1097 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.3 microM) DME1097 XEOTICID XEO02491 GENEFORM Protein DME1097 XEOTICID XEO02491 MOACRIVE Inhibition DME1097 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1097 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02492 XEO_CLAS Peptide DME1097 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 ug/ml) DME1097 XEOTICID XEO02492 GENEFORM Protein DME1097 XEOTICID XEO02492 MOACRIVE Inhibition DME1097 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1097 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02493 XEO_CLAS Peptide DME1097 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 ug/ml) DME1097 XEOTICID XEO02493 GENEFORM Protein DME1097 XEOTICID XEO02493 MOACRIVE Inhibition DME1097 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1097 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02494 XEO_CLAS Peptide DME1097 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 ug/ml) DME1097 XEOTICID XEO02494 GENEFORM Protein DME1097 XEOTICID XEO02494 MOACRIVE Inhibition DME1097 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1097 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02495 XEO_CLAS Peptide DME1097 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 34 ug/ml) DME1097 XEOTICID XEO02495 GENEFORM Protein DME1097 XEOTICID XEO02495 MOACRIVE Inhibition DME1097 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1097 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02496 XEO_CLAS Peptide DME1097 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 13 microM) DME1097 XEOTICID XEO02496 GENEFORM Protein DME1097 XEOTICID XEO02496 MOACRIVE Inhibition DME1097 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1097 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02497 XEO_CLAS Peptide DME1097 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO02497 GENEFORM Protein DME1097 XEOTICID XEO02497 MOACRIVE Inhibition DME1097 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1097 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02499 XEO_CLAS Peptide DME1097 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO02499 GENEFORM Protein DME1097 XEOTICID XEO02499 MOACRIVE Inhibition DME1097 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1097 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02501 XEO_CLAS Peptide DME1097 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 7 microM) DME1097 XEOTICID XEO02501 GENEFORM Protein DME1097 XEOTICID XEO02501 MOACRIVE Inhibition DME1097 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1097 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02502 XEO_CLAS Peptide DME1097 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 microM) DME1097 XEOTICID XEO02502 GENEFORM Protein DME1097 XEOTICID XEO02502 MOACRIVE Inhibition DME1097 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1097 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02503 XEO_CLAS Peptide DME1097 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 19 microM) DME1097 XEOTICID XEO02503 GENEFORM Protein DME1097 XEOTICID XEO02503 MOACRIVE Inhibition DME1097 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1097 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02504 XEO_CLAS Peptide DME1097 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02504 GENEFORM Protein DME1097 XEOTICID XEO02504 MOACRIVE Inhibition DME1097 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1097 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02505 XEO_CLAS Peptide DME1097 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO02505 GENEFORM Protein DME1097 XEOTICID XEO02505 MOACRIVE Inhibition DME1097 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1097 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02507 XEO_CLAS Peptide DME1097 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO02507 GENEFORM Protein DME1097 XEOTICID XEO02507 MOACRIVE Inhibition DME1097 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1097 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02508 XEO_CLAS Peptide DME1097 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 150 microM) DME1097 XEOTICID XEO02508 GENEFORM Protein DME1097 XEOTICID XEO02508 MOACRIVE Inhibition DME1097 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1097 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02509 XEO_CLAS Peptide DME1097 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 150 microM) DME1097 XEOTICID XEO02509 GENEFORM Protein DME1097 XEOTICID XEO02509 MOACRIVE Inhibition DME1097 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1097 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02510 XEO_CLAS Peptide DME1097 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 150 microM) DME1097 XEOTICID XEO02510 GENEFORM Protein DME1097 XEOTICID XEO02510 MOACRIVE Inhibition DME1097 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1097 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02511 XEO_CLAS Peptide DME1097 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 150 microM) DME1097 XEOTICID XEO02511 GENEFORM Protein DME1097 XEOTICID XEO02511 MOACRIVE Inhibition DME1097 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1097 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02512 XEO_CLAS Peptide DME1097 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 75 microM) DME1097 XEOTICID XEO02512 GENEFORM Protein DME1097 XEOTICID XEO02512 MOACRIVE Inhibition DME1097 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1097 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02513 XEO_CLAS Peptide DME1097 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO02513 GENEFORM Protein DME1097 XEOTICID XEO02513 MOACRIVE Inhibition DME1097 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1097 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02514 XEO_CLAS Peptide DME1097 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO02514 GENEFORM Protein DME1097 XEOTICID XEO02514 MOACRIVE Inhibition DME1097 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1097 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02515 XEO_CLAS Peptide DME1097 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 80 microM) DME1097 XEOTICID XEO02515 GENEFORM Protein DME1097 XEOTICID XEO02515 MOACRIVE Inhibition DME1097 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1097 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02516 XEO_CLAS Peptide DME1097 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 32 microM) DME1097 XEOTICID XEO02516 GENEFORM Protein DME1097 XEOTICID XEO02516 MOACRIVE Inhibition DME1097 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1097 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02517 XEO_CLAS Peptide DME1097 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 microM) DME1097 XEOTICID XEO02517 GENEFORM Protein DME1097 XEOTICID XEO02517 MOACRIVE Inhibition DME1097 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1097 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02518 XEO_CLAS Peptide DME1097 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC < 15 microM) DME1097 XEOTICID XEO02518 GENEFORM Protein DME1097 XEOTICID XEO02518 MOACRIVE Inhibition DME1097 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1097 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02519 XEO_CLAS Peptide DME1097 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC < 15 microM) DME1097 XEOTICID XEO02519 GENEFORM Protein DME1097 XEOTICID XEO02519 MOACRIVE Inhibition DME1097 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1097 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02520 XEO_CLAS Peptide DME1097 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC < 15 microM) DME1097 XEOTICID XEO02520 GENEFORM Protein DME1097 XEOTICID XEO02520 MOACRIVE Inhibition DME1097 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1097 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02523 XEO_CLAS Peptide DME1097 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO02523 GENEFORM Protein DME1097 XEOTICID XEO02523 MOACRIVE Inhibition DME1097 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1097 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02524 XEO_CLAS Peptide DME1097 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 150 microM) DME1097 XEOTICID XEO02524 GENEFORM Protein DME1097 XEOTICID XEO02524 MOACRIVE Inhibition DME1097 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1097 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02525 XEO_CLAS Peptide DME1097 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 24 microM) DME1097 XEOTICID XEO02525 GENEFORM Protein DME1097 XEOTICID XEO02525 MOACRIVE Inhibition DME1097 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1097 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02526 XEO_CLAS Peptide DME1097 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 48 microM) DME1097 XEOTICID XEO02526 GENEFORM Protein DME1097 XEOTICID XEO02526 MOACRIVE Inhibition DME1097 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1097 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02527 XEO_CLAS Peptide DME1097 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 119 microM) DME1097 XEOTICID XEO02527 GENEFORM Protein DME1097 XEOTICID XEO02527 MOACRIVE Inhibition DME1097 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1097 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02528 XEO_CLAS Peptide DME1097 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 128 ug/ml) DME1097 XEOTICID XEO02528 GENEFORM Protein DME1097 XEOTICID XEO02528 MOACRIVE Inhibition DME1097 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1097 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02529 XEO_CLAS Peptide DME1097 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 128 ug/ml) DME1097 XEOTICID XEO02529 GENEFORM Protein DME1097 XEOTICID XEO02529 MOACRIVE Inhibition DME1097 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1097 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02530 XEO_CLAS Peptide DME1097 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02530 GENEFORM Protein DME1097 XEOTICID XEO02530 MOACRIVE Inhibition DME1097 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1097 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02531 XEO_CLAS Peptide DME1097 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 microM) DME1097 XEOTICID XEO02531 GENEFORM Protein DME1097 XEOTICID XEO02531 MOACRIVE Inhibition DME1097 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1097 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02533 XEO_CLAS Peptide DME1097 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.2 ug/ml) DME1097 XEOTICID XEO02533 GENEFORM Protein DME1097 XEOTICID XEO02533 MOACRIVE Inhibition DME1097 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1097 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02534 XEO_CLAS Peptide DME1097 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.6 ug/ml) DME1097 XEOTICID XEO02534 GENEFORM Protein DME1097 XEOTICID XEO02534 MOACRIVE Inhibition DME1097 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1097 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02535 XEO_CLAS Peptide DME1097 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.3 ug/ml) DME1097 XEOTICID XEO02535 GENEFORM Protein DME1097 XEOTICID XEO02535 MOACRIVE Inhibition DME1097 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1097 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02536 XEO_CLAS Peptide DME1097 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.4 ug/ml) DME1097 XEOTICID XEO02536 GENEFORM Protein DME1097 XEOTICID XEO02536 MOACRIVE Inhibition DME1097 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1097 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02537 XEO_CLAS Peptide DME1097 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.2 ug/ml) DME1097 XEOTICID XEO02537 GENEFORM Protein DME1097 XEOTICID XEO02537 MOACRIVE Inhibition DME1097 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1097 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02538 XEO_CLAS Peptide DME1097 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 9.1 ug/ml) DME1097 XEOTICID XEO02538 GENEFORM Protein DME1097 XEOTICID XEO02538 MOACRIVE Inhibition DME1097 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1097 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02539 XEO_CLAS Peptide DME1097 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8.6 ug/ml) DME1097 XEOTICID XEO02539 GENEFORM Protein DME1097 XEOTICID XEO02539 MOACRIVE Inhibition DME1097 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1097 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02540 XEO_CLAS Peptide DME1097 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15.2 ug/ml) DME1097 XEOTICID XEO02540 GENEFORM Protein DME1097 XEOTICID XEO02540 MOACRIVE Inhibition DME1097 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1097 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02541 XEO_CLAS Peptide DME1097 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 11.1 ug/ml) DME1097 XEOTICID XEO02541 GENEFORM Protein DME1097 XEOTICID XEO02541 MOACRIVE Inhibition DME1097 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1097 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02542 XEO_CLAS Peptide DME1097 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.7 ug/ml) DME1097 XEOTICID XEO02542 GENEFORM Protein DME1097 XEOTICID XEO02542 MOACRIVE Inhibition DME1097 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1097 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02543 XEO_CLAS Peptide DME1097 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 13.1 ug/ml) DME1097 XEOTICID XEO02543 GENEFORM Protein DME1097 XEOTICID XEO02543 MOACRIVE Inhibition DME1097 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1097 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02544 XEO_CLAS Peptide DME1097 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 9.8 ug/ml) DME1097 XEOTICID XEO02544 GENEFORM Protein DME1097 XEOTICID XEO02544 MOACRIVE Inhibition DME1097 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1097 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02545 XEO_CLAS Peptide DME1097 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 14 microM) DME1097 XEOTICID XEO02545 GENEFORM Protein DME1097 XEOTICID XEO02545 MOACRIVE Inhibition DME1097 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1097 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02546 XEO_CLAS Peptide DME1097 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 14 microM) DME1097 XEOTICID XEO02546 GENEFORM Protein DME1097 XEOTICID XEO02546 MOACRIVE Inhibition DME1097 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1097 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02547 XEO_CLAS Peptide DME1097 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 microM) DME1097 XEOTICID XEO02547 GENEFORM Protein DME1097 XEOTICID XEO02547 MOACRIVE Inhibition DME1097 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1097 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02548 XEO_CLAS Peptide DME1097 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 78 microM) DME1097 XEOTICID XEO02548 GENEFORM Protein DME1097 XEOTICID XEO02548 MOACRIVE Inhibition DME1097 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1097 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02549 XEO_CLAS Peptide DME1097 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02549 GENEFORM Protein DME1097 XEOTICID XEO02549 MOACRIVE Inhibition DME1097 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1097 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02552 XEO_CLAS Peptide DME1097 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 24 microM) DME1097 XEOTICID XEO02552 GENEFORM Protein DME1097 XEOTICID XEO02552 MOACRIVE Inhibition DME1097 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1097 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02553 XEO_CLAS Peptide DME1097 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02553 GENEFORM Protein DME1097 XEOTICID XEO02553 MOACRIVE Inhibition DME1097 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1097 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02556 XEO_CLAS Peptide DME1097 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 55 microM) DME1097 XEOTICID XEO02556 GENEFORM Protein DME1097 XEOTICID XEO02556 MOACRIVE Inhibition DME1097 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1097 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02557 XEO_CLAS Peptide DME1097 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 17 microM) DME1097 XEOTICID XEO02557 GENEFORM Protein DME1097 XEOTICID XEO02557 MOACRIVE Inhibition DME1097 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1097 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02558 XEO_CLAS Peptide DME1097 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 14 microM) DME1097 XEOTICID XEO02558 GENEFORM Protein DME1097 XEOTICID XEO02558 MOACRIVE Inhibition DME1097 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1097 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02559 XEO_CLAS Peptide DME1097 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02559 GENEFORM Protein DME1097 XEOTICID XEO02559 MOACRIVE Inhibition DME1097 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1097 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02560 XEO_CLAS Peptide DME1097 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 13 microM) DME1097 XEOTICID XEO02560 GENEFORM Protein DME1097 XEOTICID XEO02560 MOACRIVE Inhibition DME1097 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1097 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02561 XEO_CLAS Peptide DME1097 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO02561 GENEFORM Protein DME1097 XEOTICID XEO02561 MOACRIVE Inhibition DME1097 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1097 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02562 XEO_CLAS Peptide DME1097 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 13 microM) DME1097 XEOTICID XEO02562 GENEFORM Protein DME1097 XEOTICID XEO02562 MOACRIVE Inhibition DME1097 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1097 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02563 XEO_CLAS Peptide DME1097 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 45 microM) DME1097 XEOTICID XEO02563 GENEFORM Protein DME1097 XEOTICID XEO02563 MOACRIVE Inhibition DME1097 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1097 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02564 XEO_CLAS Peptide DME1097 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 ug/ml) DME1097 XEOTICID XEO02564 GENEFORM Protein DME1097 XEOTICID XEO02564 MOACRIVE Inhibition DME1097 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1097 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02565 XEO_CLAS Peptide DME1097 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 microM) DME1097 XEOTICID XEO02565 GENEFORM Protein DME1097 XEOTICID XEO02565 MOACRIVE Inhibition DME1097 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1097 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02566 XEO_CLAS Peptide DME1097 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO02566 GENEFORM Protein DME1097 XEOTICID XEO02566 MOACRIVE Inhibition DME1097 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1097 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02568 XEO_CLAS Peptide DME1097 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO02568 GENEFORM Protein DME1097 XEOTICID XEO02568 MOACRIVE Inhibition DME1097 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1097 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02569 XEO_CLAS Peptide DME1097 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO02569 GENEFORM Protein DME1097 XEOTICID XEO02569 MOACRIVE Inhibition DME1097 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1097 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02570 XEO_CLAS Peptide DME1097 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO02570 GENEFORM Protein DME1097 XEOTICID XEO02570 MOACRIVE Inhibition DME1097 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1097 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02571 XEO_CLAS Peptide DME1097 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO02571 GENEFORM Protein DME1097 XEOTICID XEO02571 MOACRIVE Inhibition DME1097 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1097 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02572 XEO_CLAS Peptide DME1097 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02572 GENEFORM Protein DME1097 XEOTICID XEO02572 MOACRIVE Inhibition DME1097 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1097 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02573 XEO_CLAS Peptide DME1097 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02573 GENEFORM Protein DME1097 XEOTICID XEO02573 MOACRIVE Inhibition DME1097 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1097 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02574 XEO_CLAS Peptide DME1097 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 microM) DME1097 XEOTICID XEO02574 GENEFORM Protein DME1097 XEOTICID XEO02574 MOACRIVE Inhibition DME1097 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1097 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02575 XEO_CLAS Peptide DME1097 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 microM) DME1097 XEOTICID XEO02575 GENEFORM Protein DME1097 XEOTICID XEO02575 MOACRIVE Inhibition DME1097 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1097 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02576 XEO_CLAS Peptide DME1097 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 33 microM) DME1097 XEOTICID XEO02576 GENEFORM Protein DME1097 XEOTICID XEO02576 MOACRIVE Inhibition DME1097 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1097 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02577 XEO_CLAS Peptide DME1097 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO02577 GENEFORM Protein DME1097 XEOTICID XEO02577 MOACRIVE Inhibition DME1097 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1097 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02578 XEO_CLAS Peptide DME1097 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02578 GENEFORM Protein DME1097 XEOTICID XEO02578 MOACRIVE Inhibition DME1097 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1097 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02579 XEO_CLAS Peptide DME1097 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02579 GENEFORM Protein DME1097 XEOTICID XEO02579 MOACRIVE Inhibition DME1097 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1097 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02580 XEO_CLAS Peptide DME1097 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC < 15 microM) DME1097 XEOTICID XEO02580 GENEFORM Protein DME1097 XEOTICID XEO02580 MOACRIVE Inhibition DME1097 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1097 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02581 XEO_CLAS Peptide DME1097 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 microM) DME1097 XEOTICID XEO02581 GENEFORM Protein DME1097 XEOTICID XEO02581 MOACRIVE Inhibition DME1097 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1097 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02582 XEO_CLAS Peptide DME1097 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 microM) DME1097 XEOTICID XEO02582 GENEFORM Protein DME1097 XEOTICID XEO02582 MOACRIVE Inhibition DME1097 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1097 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02583 XEO_CLAS Peptide DME1097 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 microM) DME1097 XEOTICID XEO02583 GENEFORM Protein DME1097 XEOTICID XEO02583 MOACRIVE Inhibition DME1097 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1097 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02584 XEO_CLAS Peptide DME1097 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 microM) DME1097 XEOTICID XEO02584 GENEFORM Protein DME1097 XEOTICID XEO02584 MOACRIVE Inhibition DME1097 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1097 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02585 XEO_CLAS Peptide DME1097 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO02585 GENEFORM Protein DME1097 XEOTICID XEO02585 MOACRIVE Inhibition DME1097 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1097 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02586 XEO_CLAS Peptide DME1097 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO02586 GENEFORM Protein DME1097 XEOTICID XEO02586 MOACRIVE Inhibition DME1097 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1097 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02587 XEO_CLAS Peptide DME1097 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02587 GENEFORM Protein DME1097 XEOTICID XEO02587 MOACRIVE Inhibition DME1097 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1097 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02589 XEO_CLAS Peptide DME1097 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8.2 ug/ml) DME1097 XEOTICID XEO02589 GENEFORM Protein DME1097 XEOTICID XEO02589 MOACRIVE Inhibition DME1097 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1097 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02590 XEO_CLAS Peptide DME1097 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 19.6 ug/ml) DME1097 XEOTICID XEO02590 GENEFORM Protein DME1097 XEOTICID XEO02590 MOACRIVE Inhibition DME1097 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1097 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02591 XEO_CLAS Peptide DME1097 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO02591 GENEFORM Protein DME1097 XEOTICID XEO02591 MOACRIVE Inhibition DME1097 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1097 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02593 XEO_CLAS Peptide DME1097 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 36 microM) DME1097 XEOTICID XEO02593 GENEFORM Protein DME1097 XEOTICID XEO02593 MOACRIVE Inhibition DME1097 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1097 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02594 XEO_CLAS Peptide DME1097 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02594 GENEFORM Protein DME1097 XEOTICID XEO02594 MOACRIVE Inhibition DME1097 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1097 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02595 XEO_CLAS Peptide DME1097 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO02595 GENEFORM Protein DME1097 XEOTICID XEO02595 MOACRIVE Inhibition DME1097 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1097 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02596 XEO_CLAS Peptide DME1097 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO02596 GENEFORM Protein DME1097 XEOTICID XEO02596 MOACRIVE Inhibition DME1097 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1097 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02597 XEO_CLAS Peptide DME1097 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO02597 GENEFORM Protein DME1097 XEOTICID XEO02597 MOACRIVE Inhibition DME1097 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1097 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02598 XEO_CLAS Peptide DME1097 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 32.5 microM) DME1097 XEOTICID XEO02598 GENEFORM Protein DME1097 XEOTICID XEO02598 MOACRIVE Inhibition DME1097 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1097 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02599 XEO_CLAS Peptide DME1097 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 microM) DME1097 XEOTICID XEO02599 GENEFORM Protein DME1097 XEOTICID XEO02599 MOACRIVE Inhibition DME1097 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1097 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02601 XEO_CLAS Peptide DME1097 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.1 ug/ml) DME1097 XEOTICID XEO02601 GENEFORM Protein DME1097 XEOTICID XEO02601 MOACRIVE Inhibition DME1097 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1097 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02602 XEO_CLAS Peptide DME1097 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 13.2 ug/ml) DME1097 XEOTICID XEO02602 GENEFORM Protein DME1097 XEOTICID XEO02602 MOACRIVE Inhibition DME1097 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1097 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02603 XEO_CLAS Peptide DME1097 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.3 ug/ml) DME1097 XEOTICID XEO02603 GENEFORM Protein DME1097 XEOTICID XEO02603 MOACRIVE Inhibition DME1097 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1097 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02604 XEO_CLAS Peptide DME1097 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO02604 GENEFORM Protein DME1097 XEOTICID XEO02604 MOACRIVE Inhibition DME1097 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1097 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02605 XEO_CLAS Peptide DME1097 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30.6 ug/ml) DME1097 XEOTICID XEO02605 GENEFORM Protein DME1097 XEOTICID XEO02605 MOACRIVE Inhibition DME1097 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1097 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02606 XEO_CLAS Peptide DME1097 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 11.2 ug/ml) DME1097 XEOTICID XEO02606 GENEFORM Protein DME1097 XEOTICID XEO02606 MOACRIVE Inhibition DME1097 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1097 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02607 XEO_CLAS Peptide DME1097 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.8 ug/ml) DME1097 XEOTICID XEO02607 GENEFORM Protein DME1097 XEOTICID XEO02607 MOACRIVE Inhibition DME1097 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1097 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02608 XEO_CLAS Peptide DME1097 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 7.9 ug/ml) DME1097 XEOTICID XEO02608 GENEFORM Protein DME1097 XEOTICID XEO02608 MOACRIVE Inhibition DME1097 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1097 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02609 XEO_CLAS Peptide DME1097 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15.8 ug/ml) DME1097 XEOTICID XEO02609 GENEFORM Protein DME1097 XEOTICID XEO02609 MOACRIVE Inhibition DME1097 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1097 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02610 XEO_CLAS Peptide DME1097 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.1 ug/ml) DME1097 XEOTICID XEO02610 GENEFORM Protein DME1097 XEOTICID XEO02610 MOACRIVE Inhibition DME1097 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1097 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02611 XEO_CLAS Peptide DME1097 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20.6 ug/ml) DME1097 XEOTICID XEO02611 GENEFORM Protein DME1097 XEOTICID XEO02611 MOACRIVE Inhibition DME1097 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1097 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02612 XEO_CLAS Peptide DME1097 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 11.8 ug/ml) DME1097 XEOTICID XEO02612 GENEFORM Protein DME1097 XEOTICID XEO02612 MOACRIVE Inhibition DME1097 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1097 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02613 XEO_CLAS Peptide DME1097 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 13.2 ug/ml) DME1097 XEOTICID XEO02613 GENEFORM Protein DME1097 XEOTICID XEO02613 MOACRIVE Inhibition DME1097 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1097 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02614 XEO_CLAS Peptide DME1097 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.8 ug/ml) DME1097 XEOTICID XEO02614 GENEFORM Protein DME1097 XEOTICID XEO02614 MOACRIVE Inhibition DME1097 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1097 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02615 XEO_CLAS Peptide DME1097 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8.6 ug/ml) DME1097 XEOTICID XEO02615 GENEFORM Protein DME1097 XEOTICID XEO02615 MOACRIVE Inhibition DME1097 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1097 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02616 XEO_CLAS Peptide DME1097 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20.4 ug/ml) DME1097 XEOTICID XEO02616 GENEFORM Protein DME1097 XEOTICID XEO02616 MOACRIVE Inhibition DME1097 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1097 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02617 XEO_CLAS Peptide DME1097 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4.7 ug/ml) DME1097 XEOTICID XEO02617 GENEFORM Protein DME1097 XEOTICID XEO02617 MOACRIVE Inhibition DME1097 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1097 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02618 XEO_CLAS Peptide DME1097 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.6 ug/ml) DME1097 XEOTICID XEO02618 GENEFORM Protein DME1097 XEOTICID XEO02618 MOACRIVE Inhibition DME1097 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1097 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02619 XEO_CLAS Peptide DME1097 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10.5 ug/ml) DME1097 XEOTICID XEO02619 GENEFORM Protein DME1097 XEOTICID XEO02619 MOACRIVE Inhibition DME1097 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1097 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02620 XEO_CLAS Peptide DME1097 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO02620 GENEFORM Protein DME1097 XEOTICID XEO02620 MOACRIVE Inhibition DME1097 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1097 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02621 XEO_CLAS Peptide DME1097 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO02621 GENEFORM Protein DME1097 XEOTICID XEO02621 MOACRIVE Inhibition DME1097 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1097 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02622 XEO_CLAS Peptide DME1097 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO02622 GENEFORM Protein DME1097 XEOTICID XEO02622 MOACRIVE Inhibition DME1097 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1097 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02623 XEO_CLAS Peptide DME1097 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO02623 GENEFORM Protein DME1097 XEOTICID XEO02623 MOACRIVE Inhibition DME1097 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1097 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02624 XEO_CLAS Peptide DME1097 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 18 microM) DME1097 XEOTICID XEO02624 GENEFORM Protein DME1097 XEOTICID XEO02624 MOACRIVE Inhibition DME1097 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1097 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02625 XEO_CLAS Peptide DME1097 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 9 microM) DME1097 XEOTICID XEO02625 GENEFORM Protein DME1097 XEOTICID XEO02625 MOACRIVE Inhibition DME1097 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1097 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02626 XEO_CLAS Peptide DME1097 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 18 microM) DME1097 XEOTICID XEO02626 GENEFORM Protein DME1097 XEOTICID XEO02626 MOACRIVE Inhibition DME1097 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1097 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02627 XEO_CLAS Peptide DME1097 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02627 GENEFORM Protein DME1097 XEOTICID XEO02627 MOACRIVE Inhibition DME1097 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1097 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02628 XEO_CLAS Peptide DME1097 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 18 microM) DME1097 XEOTICID XEO02628 GENEFORM Protein DME1097 XEOTICID XEO02628 MOACRIVE Inhibition DME1097 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1097 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02629 XEO_CLAS Peptide DME1097 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 13 microM) DME1097 XEOTICID XEO02629 GENEFORM Protein DME1097 XEOTICID XEO02629 MOACRIVE Inhibition DME1097 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1097 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02630 XEO_CLAS Peptide DME1097 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 ug/ml) DME1097 XEOTICID XEO02630 GENEFORM Protein DME1097 XEOTICID XEO02630 MOACRIVE Inhibition DME1097 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1097 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02631 XEO_CLAS Peptide DME1097 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 ug/ml) DME1097 XEOTICID XEO02631 GENEFORM Protein DME1097 XEOTICID XEO02631 MOACRIVE Inhibition DME1097 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1097 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02634 XEO_CLAS Peptide DME1097 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO02634 GENEFORM Protein DME1097 XEOTICID XEO02634 MOACRIVE Inhibition DME1097 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1097 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02635 XEO_CLAS Peptide DME1097 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40 ug/ml) DME1097 XEOTICID XEO02635 GENEFORM Protein DME1097 XEOTICID XEO02635 MOACRIVE Inhibition DME1097 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1097 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02636 XEO_CLAS Peptide DME1097 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO02636 GENEFORM Protein DME1097 XEOTICID XEO02636 MOACRIVE Inhibition DME1097 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1097 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02637 XEO_CLAS Peptide DME1097 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO02637 GENEFORM Protein DME1097 XEOTICID XEO02637 MOACRIVE Inhibition DME1097 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1097 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02638 XEO_CLAS Peptide DME1097 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 microM) DME1097 XEOTICID XEO02638 GENEFORM Protein DME1097 XEOTICID XEO02638 MOACRIVE Inhibition DME1097 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1097 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02639 XEO_CLAS Peptide DME1097 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 microM) DME1097 XEOTICID XEO02639 GENEFORM Protein DME1097 XEOTICID XEO02639 MOACRIVE Inhibition DME1097 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1097 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02644 XEO_CLAS Peptide DME1097 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02644 GENEFORM Protein DME1097 XEOTICID XEO02644 MOACRIVE Inhibition DME1097 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1097 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02645 XEO_CLAS Peptide DME1097 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02645 GENEFORM Protein DME1097 XEOTICID XEO02645 MOACRIVE Inhibition DME1097 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1097 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02646 XEO_CLAS Peptide DME1097 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02646 GENEFORM Protein DME1097 XEOTICID XEO02646 MOACRIVE Inhibition DME1097 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1097 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02647 XEO_CLAS Peptide DME1097 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02647 GENEFORM Protein DME1097 XEOTICID XEO02647 MOACRIVE Inhibition DME1097 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1097 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02649 XEO_CLAS Peptide DME1097 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO02649 GENEFORM Protein DME1097 XEOTICID XEO02649 MOACRIVE Inhibition DME1097 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1097 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02650 XEO_CLAS Peptide DME1097 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO02650 GENEFORM Protein DME1097 XEOTICID XEO02650 MOACRIVE Inhibition DME1097 XEOTICID XEO02658 XEO_NAME Buthinin DME1097 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02658 XEO_CLAS Peptide DME1097 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02658 GENEFORM Protein DME1097 XEOTICID XEO02658 MOACRIVE Inhibition DME1097 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1097 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02663 XEO_CLAS Peptide DME1097 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25 microM) DME1097 XEOTICID XEO02663 GENEFORM Protein DME1097 XEOTICID XEO02663 MOACRIVE Inhibition DME1097 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1097 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02664 XEO_CLAS Peptide DME1097 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25 microM) DME1097 XEOTICID XEO02664 GENEFORM Protein DME1097 XEOTICID XEO02664 MOACRIVE Inhibition DME1097 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1097 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02672 XEO_CLAS Peptide DME1097 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25 microM) DME1097 XEOTICID XEO02672 GENEFORM Protein DME1097 XEOTICID XEO02672 MOACRIVE Inhibition DME1097 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1097 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02673 XEO_CLAS Peptide DME1097 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1097 XEOTICID XEO02673 GENEFORM Protein DME1097 XEOTICID XEO02673 MOACRIVE Inhibition DME1097 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1097 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02674 XEO_CLAS Peptide DME1097 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.125-6.25 microM) DME1097 XEOTICID XEO02674 GENEFORM Protein DME1097 XEOTICID XEO02674 MOACRIVE Inhibition DME1097 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1097 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02676 XEO_CLAS Peptide DME1097 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO02676 GENEFORM Protein DME1097 XEOTICID XEO02676 MOACRIVE Inhibition DME1097 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1097 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02677 XEO_CLAS Peptide DME1097 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1097 XEOTICID XEO02677 GENEFORM Protein DME1097 XEOTICID XEO02677 MOACRIVE Inhibition DME1097 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1097 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02679 XEO_CLAS Peptide DME1097 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1097 XEOTICID XEO02679 GENEFORM Protein DME1097 XEOTICID XEO02679 MOACRIVE Inhibition DME1097 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1097 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02680 XEO_CLAS Peptide DME1097 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25 microM) DME1097 XEOTICID XEO02680 GENEFORM Protein DME1097 XEOTICID XEO02680 MOACRIVE Inhibition DME1097 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1097 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02683 XEO_CLAS Peptide DME1097 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO02683 GENEFORM Protein DME1097 XEOTICID XEO02683 MOACRIVE Inhibition DME1097 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1097 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02688 XEO_CLAS Peptide DME1097 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO02688 GENEFORM Protein DME1097 XEOTICID XEO02688 MOACRIVE Inhibition DME1097 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1097 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02693 XEO_CLAS Peptide DME1097 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 ug/ml) DME1097 XEOTICID XEO02693 GENEFORM Protein DME1097 XEOTICID XEO02693 MOACRIVE Inhibition DME1097 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1097 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02699 XEO_CLAS Peptide DME1097 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 ug/ml) DME1097 XEOTICID XEO02699 GENEFORM Protein DME1097 XEOTICID XEO02699 MOACRIVE Inhibition DME1097 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1097 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02700 XEO_CLAS Peptide DME1097 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 ug/ml) DME1097 XEOTICID XEO02700 GENEFORM Protein DME1097 XEOTICID XEO02700 MOACRIVE Inhibition DME1097 XEOTICID XEO02703 XEO_NAME Calcitermin DME1097 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02703 XEO_CLAS Peptide DME1097 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02703 GENEFORM Protein DME1097 XEOTICID XEO02703 MOACRIVE Inhibition DME1097 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1097 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02708 XEO_CLAS Peptide DME1097 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO02708 GENEFORM Protein DME1097 XEOTICID XEO02708 MOACRIVE Inhibition DME1097 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1097 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02709 XEO_CLAS Peptide DME1097 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.05 microM) DME1097 XEOTICID XEO02709 GENEFORM Protein DME1097 XEOTICID XEO02709 MOACRIVE Inhibition DME1097 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1097 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1097 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02713 GENEFORM Protein DME1097 XEOTICID XEO02713 MOACRIVE Inhibition DME1097 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1097 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1097 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02714 GENEFORM Protein DME1097 XEOTICID XEO02714 MOACRIVE Inhibition DME1097 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1097 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02726 XEO_CLAS Peptide DME1097 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02726 GENEFORM Protein DME1097 XEOTICID XEO02726 MOACRIVE Inhibition DME1097 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1097 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02731 XEO_CLAS Peptide DME1097 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1 microM) DME1097 XEOTICID XEO02731 GENEFORM Protein DME1097 XEOTICID XEO02731 MOACRIVE Inhibition DME1097 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1097 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02732 XEO_CLAS Peptide DME1097 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.25 microM) DME1097 XEOTICID XEO02732 GENEFORM Protein DME1097 XEOTICID XEO02732 MOACRIVE Inhibition DME1097 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1097 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02733 XEO_CLAS Peptide DME1097 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8-25 ug/ml) DME1097 XEOTICID XEO02733 GENEFORM Protein DME1097 XEOTICID XEO02733 MOACRIVE Inhibition DME1097 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1097 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02735 XEO_CLAS Peptide DME1097 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1 ug/ml) DME1097 XEOTICID XEO02735 GENEFORM Protein DME1097 XEOTICID XEO02735 MOACRIVE Inhibition DME1097 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1097 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02737 XEO_CLAS Peptide DME1097 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02737 GENEFORM Protein DME1097 XEOTICID XEO02737 MOACRIVE Inhibition DME1097 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1097 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02738 XEO_CLAS Peptide DME1097 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO02738 GENEFORM Protein DME1097 XEOTICID XEO02738 MOACRIVE Inhibition DME1097 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1097 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02739 XEO_CLAS Peptide DME1097 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 microM) DME1097 XEOTICID XEO02739 GENEFORM Protein DME1097 XEOTICID XEO02739 MOACRIVE Inhibition DME1097 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1097 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02740 XEO_CLAS Peptide DME1097 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.25 ug/ml) DME1097 XEOTICID XEO02740 GENEFORM Protein DME1097 XEOTICID XEO02740 MOACRIVE Inhibition DME1097 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1097 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02741 XEO_CLAS Peptide DME1097 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 ug/ml) DME1097 XEOTICID XEO02741 GENEFORM Protein DME1097 XEOTICID XEO02741 MOACRIVE Inhibition DME1097 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1097 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02743 XEO_CLAS Peptide DME1097 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.6 ug/ml) DME1097 XEOTICID XEO02743 GENEFORM Protein DME1097 XEOTICID XEO02743 MOACRIVE Inhibition DME1097 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1097 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02744 XEO_CLAS Peptide DME1097 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 18.7 ug/ml) DME1097 XEOTICID XEO02744 GENEFORM Protein DME1097 XEOTICID XEO02744 MOACRIVE Inhibition DME1097 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1097 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02745 XEO_CLAS Peptide DME1097 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02745 GENEFORM Protein DME1097 XEOTICID XEO02745 MOACRIVE Inhibition DME1097 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1097 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02746 XEO_CLAS Peptide DME1097 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02746 GENEFORM Protein DME1097 XEOTICID XEO02746 MOACRIVE Inhibition DME1097 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1097 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02748 XEO_CLAS Peptide DME1097 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02748 GENEFORM Protein DME1097 XEOTICID XEO02748 MOACRIVE Inhibition DME1097 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1097 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02749 XEO_CLAS Peptide DME1097 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20-25 mug/ml) DME1097 XEOTICID XEO02749 GENEFORM Protein DME1097 XEOTICID XEO02749 MOACRIVE Inhibition DME1097 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1097 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02750 XEO_CLAS Peptide DME1097 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02750 GENEFORM Protein DME1097 XEOTICID XEO02750 MOACRIVE Inhibition DME1097 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1097 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02752 XEO_CLAS Peptide DME1097 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02752 GENEFORM Protein DME1097 XEOTICID XEO02752 MOACRIVE Inhibition DME1097 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1097 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02753 XEO_CLAS Peptide DME1097 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02753 GENEFORM Protein DME1097 XEOTICID XEO02753 MOACRIVE Inhibition DME1097 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1097 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02754 XEO_CLAS Peptide DME1097 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 microM) DME1097 XEOTICID XEO02754 GENEFORM Protein DME1097 XEOTICID XEO02754 MOACRIVE Inhibition DME1097 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1097 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02756 XEO_CLAS Peptide DME1097 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 microM) DME1097 XEOTICID XEO02756 GENEFORM Protein DME1097 XEOTICID XEO02756 MOACRIVE Inhibition DME1097 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1097 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02757 XEO_CLAS Peptide DME1097 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1 microM) DME1097 XEOTICID XEO02757 GENEFORM Protein DME1097 XEOTICID XEO02757 MOACRIVE Inhibition DME1097 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1097 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02758 XEO_CLAS Peptide DME1097 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO02758 GENEFORM Protein DME1097 XEOTICID XEO02758 MOACRIVE Inhibition DME1097 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1097 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02759 XEO_CLAS Peptide DME1097 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.6 microM) DME1097 XEOTICID XEO02759 GENEFORM Protein DME1097 XEOTICID XEO02759 MOACRIVE Inhibition DME1097 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1097 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02760 XEO_CLAS Peptide DME1097 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 microM) DME1097 XEOTICID XEO02760 GENEFORM Protein DME1097 XEOTICID XEO02760 MOACRIVE Inhibition DME1097 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1097 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02761 XEO_CLAS Peptide DME1097 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO02761 GENEFORM Protein DME1097 XEOTICID XEO02761 MOACRIVE Inhibition DME1097 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1097 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02762 XEO_CLAS Peptide DME1097 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 microM) DME1097 XEOTICID XEO02762 GENEFORM Protein DME1097 XEOTICID XEO02762 MOACRIVE Inhibition DME1097 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1097 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02763 XEO_CLAS Peptide DME1097 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.4 microM) DME1097 XEOTICID XEO02763 GENEFORM Protein DME1097 XEOTICID XEO02763 MOACRIVE Inhibition DME1097 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1097 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02764 XEO_CLAS Peptide DME1097 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 microM) DME1097 XEOTICID XEO02764 GENEFORM Protein DME1097 XEOTICID XEO02764 MOACRIVE Inhibition DME1097 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1097 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02765 XEO_CLAS Peptide DME1097 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.3 microM) DME1097 XEOTICID XEO02765 GENEFORM Protein DME1097 XEOTICID XEO02765 MOACRIVE Inhibition DME1097 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1097 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02767 XEO_CLAS Peptide DME1097 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02767 GENEFORM Protein DME1097 XEOTICID XEO02767 MOACRIVE Inhibition DME1097 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1097 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02768 XEO_CLAS Peptide DME1097 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1097 XEOTICID XEO02768 GENEFORM Protein DME1097 XEOTICID XEO02768 MOACRIVE Inhibition DME1097 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1097 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02769 XEO_CLAS Peptide DME1097 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.32 microM) DME1097 XEOTICID XEO02769 GENEFORM Protein DME1097 XEOTICID XEO02769 MOACRIVE Inhibition DME1097 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1097 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02770 XEO_CLAS Peptide DME1097 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.30 microM) DME1097 XEOTICID XEO02770 GENEFORM Protein DME1097 XEOTICID XEO02770 MOACRIVE Inhibition DME1097 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1097 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02771 XEO_CLAS Peptide DME1097 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.21 microM) DME1097 XEOTICID XEO02771 GENEFORM Protein DME1097 XEOTICID XEO02771 MOACRIVE Inhibition DME1097 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1097 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02772 XEO_CLAS Peptide DME1097 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02772 GENEFORM Protein DME1097 XEOTICID XEO02772 MOACRIVE Inhibition DME1097 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1097 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02773 XEO_CLAS Peptide DME1097 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.9-8.6 microM) DME1097 XEOTICID XEO02773 GENEFORM Protein DME1097 XEOTICID XEO02773 MOACRIVE Inhibition DME1097 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1097 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02774 XEO_CLAS Peptide DME1097 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.3 microM) DME1097 XEOTICID XEO02774 GENEFORM Protein DME1097 XEOTICID XEO02774 MOACRIVE Inhibition DME1097 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1097 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02789 GENEFORM Protein DME1097 XEOTICID XEO02789 MOACRIVE Inhibition DME1097 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1097 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02790 GENEFORM Protein DME1097 XEOTICID XEO02790 MOACRIVE Inhibition DME1097 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1097 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02791 GENEFORM Protein DME1097 XEOTICID XEO02791 MOACRIVE Inhibition DME1097 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1097 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02792 GENEFORM Protein DME1097 XEOTICID XEO02792 MOACRIVE Inhibition DME1097 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1097 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02793 GENEFORM Protein DME1097 XEOTICID XEO02793 MOACRIVE Inhibition DME1097 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1097 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02794 GENEFORM Protein DME1097 XEOTICID XEO02794 MOACRIVE Inhibition DME1097 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1097 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02795 GENEFORM Protein DME1097 XEOTICID XEO02795 MOACRIVE Inhibition DME1097 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1097 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02796 GENEFORM Protein DME1097 XEOTICID XEO02796 MOACRIVE Inhibition DME1097 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1097 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02797 GENEFORM Protein DME1097 XEOTICID XEO02797 MOACRIVE Inhibition DME1097 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1097 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02799 XEO_CLAS Peptide DME1097 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02799 GENEFORM Protein DME1097 XEOTICID XEO02799 MOACRIVE Inhibition DME1097 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1097 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02800 XEO_CLAS Peptide DME1097 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02800 GENEFORM Protein DME1097 XEOTICID XEO02800 MOACRIVE Inhibition DME1097 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1097 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02802 XEO_CLAS Peptide DME1097 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 13.6 microM) DME1097 XEOTICID XEO02802 GENEFORM Protein DME1097 XEOTICID XEO02802 MOACRIVE Inhibition DME1097 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1097 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02807 XEO_CLAS Peptide DME1097 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.2 microM) DME1097 XEOTICID XEO02807 GENEFORM Protein DME1097 XEOTICID XEO02807 MOACRIVE Inhibition DME1097 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1097 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02813 XEO_CLAS Peptide DME1097 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 80 microM) DME1097 XEOTICID XEO02813 GENEFORM Protein DME1097 XEOTICID XEO02813 MOACRIVE Inhibition DME1097 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1097 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02814 XEO_CLAS Peptide DME1097 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 80 microM) DME1097 XEOTICID XEO02814 GENEFORM Protein DME1097 XEOTICID XEO02814 MOACRIVE Inhibition DME1097 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1097 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02815 XEO_CLAS Peptide DME1097 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8.5 microM) DME1097 XEOTICID XEO02815 GENEFORM Protein DME1097 XEOTICID XEO02815 MOACRIVE Inhibition DME1097 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1097 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02816 XEO_CLAS Peptide DME1097 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 80 microM) DME1097 XEOTICID XEO02816 GENEFORM Protein DME1097 XEOTICID XEO02816 MOACRIVE Inhibition DME1097 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1097 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02817 XEO_CLAS Peptide DME1097 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 80 microM) DME1097 XEOTICID XEO02817 GENEFORM Protein DME1097 XEOTICID XEO02817 MOACRIVE Inhibition DME1097 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1097 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02818 XEO_CLAS Peptide DME1097 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.4 microM) DME1097 XEOTICID XEO02818 GENEFORM Protein DME1097 XEOTICID XEO02818 MOACRIVE Inhibition DME1097 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1097 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02819 XEO_CLAS Peptide DME1097 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.6 microM) DME1097 XEOTICID XEO02819 GENEFORM Protein DME1097 XEOTICID XEO02819 MOACRIVE Inhibition DME1097 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1097 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02820 XEO_CLAS Peptide DME1097 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO02820 GENEFORM Protein DME1097 XEOTICID XEO02820 MOACRIVE Inhibition DME1097 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1097 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02821 XEO_CLAS Peptide DME1097 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02821 GENEFORM Protein DME1097 XEOTICID XEO02821 MOACRIVE Inhibition DME1097 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1097 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02824 XEO_CLAS Peptide DME1097 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 35 microM) DME1097 XEOTICID XEO02824 GENEFORM Protein DME1097 XEOTICID XEO02824 MOACRIVE Inhibition DME1097 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1097 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02826 XEO_CLAS Peptide DME1097 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.7 ug/ml) DME1097 XEOTICID XEO02826 GENEFORM Protein DME1097 XEOTICID XEO02826 MOACRIVE Inhibition DME1097 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1097 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02834 GENEFORM Protein DME1097 XEOTICID XEO02834 MOACRIVE Inhibition DME1097 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1097 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02839 XEO_CLAS Peptide DME1097 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.25 microM) DME1097 XEOTICID XEO02839 GENEFORM Protein DME1097 XEOTICID XEO02839 MOACRIVE Inhibition DME1097 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1097 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02841 XEO_CLAS Peptide DME1097 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.25 microM) DME1097 XEOTICID XEO02841 GENEFORM Protein DME1097 XEOTICID XEO02841 MOACRIVE Inhibition DME1097 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1097 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02842 XEO_CLAS Peptide DME1097 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.25 microM) DME1097 XEOTICID XEO02842 GENEFORM Protein DME1097 XEOTICID XEO02842 MOACRIVE Inhibition DME1097 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1097 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02843 XEO_CLAS Peptide DME1097 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02843 GENEFORM Protein DME1097 XEOTICID XEO02843 MOACRIVE Inhibition DME1097 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1097 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02849 GENEFORM Protein DME1097 XEOTICID XEO02849 MOACRIVE Inhibition DME1097 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1097 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02857 XEO_CLAS Peptide DME1097 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 53 microM) DME1097 XEOTICID XEO02857 GENEFORM Protein DME1097 XEOTICID XEO02857 MOACRIVE Inhibition DME1097 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1097 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02858 XEO_CLAS Peptide DME1097 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 53 microM) DME1097 XEOTICID XEO02858 GENEFORM Protein DME1097 XEOTICID XEO02858 MOACRIVE Inhibition DME1097 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1097 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02860 XEO_CLAS Peptide DME1097 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 ug/ml) DME1097 XEOTICID XEO02860 GENEFORM Protein DME1097 XEOTICID XEO02860 MOACRIVE Inhibition DME1097 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1097 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02867 XEO_CLAS Peptide DME1097 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02867 GENEFORM Protein DME1097 XEOTICID XEO02867 MOACRIVE Inhibition DME1097 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1097 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02868 XEO_CLAS Peptide DME1097 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02868 GENEFORM Protein DME1097 XEOTICID XEO02868 MOACRIVE Inhibition DME1097 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1097 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02869 XEO_CLAS Peptide DME1097 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02869 GENEFORM Protein DME1097 XEOTICID XEO02869 MOACRIVE Inhibition DME1097 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1097 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02870 XEO_CLAS Peptide DME1097 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02870 GENEFORM Protein DME1097 XEOTICID XEO02870 MOACRIVE Inhibition DME1097 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1097 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02871 XEO_CLAS Peptide DME1097 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02871 GENEFORM Protein DME1097 XEOTICID XEO02871 MOACRIVE Inhibition DME1097 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1097 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02872 XEO_CLAS Peptide DME1097 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 308 microM) DME1097 XEOTICID XEO02872 GENEFORM Protein DME1097 XEOTICID XEO02872 MOACRIVE Inhibition DME1097 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1097 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02875 XEO_CLAS Peptide DME1097 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.1 microM) DME1097 XEOTICID XEO02875 GENEFORM Protein DME1097 XEOTICID XEO02875 MOACRIVE Inhibition DME1097 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1097 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02876 XEO_CLAS Peptide DME1097 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO02876 GENEFORM Protein DME1097 XEOTICID XEO02876 MOACRIVE Inhibition DME1097 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1097 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02877 XEO_CLAS Peptide DME1097 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO02877 GENEFORM Protein DME1097 XEOTICID XEO02877 MOACRIVE Inhibition DME1097 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1097 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02878 XEO_CLAS Peptide DME1097 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.3 microM) DME1097 XEOTICID XEO02878 GENEFORM Protein DME1097 XEOTICID XEO02878 MOACRIVE Inhibition DME1097 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1097 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02885 XEO_CLAS Peptide DME1097 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02885 GENEFORM Protein DME1097 XEOTICID XEO02885 MOACRIVE Inhibition DME1097 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1097 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02886 XEO_CLAS Peptide DME1097 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02886 GENEFORM Protein DME1097 XEOTICID XEO02886 MOACRIVE Inhibition DME1097 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1097 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02887 XEO_CLAS Peptide DME1097 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1 ug/ml) DME1097 XEOTICID XEO02887 GENEFORM Protein DME1097 XEOTICID XEO02887 MOACRIVE Inhibition DME1097 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1097 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02888 XEO_CLAS Peptide DME1097 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 ug/ml) DME1097 XEOTICID XEO02888 GENEFORM Protein DME1097 XEOTICID XEO02888 MOACRIVE Inhibition DME1097 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1097 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02889 XEO_CLAS Peptide DME1097 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 ug/ml) DME1097 XEOTICID XEO02889 GENEFORM Protein DME1097 XEOTICID XEO02889 MOACRIVE Inhibition DME1097 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1097 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02890 XEO_CLAS Peptide DME1097 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02890 GENEFORM Protein DME1097 XEOTICID XEO02890 MOACRIVE Inhibition DME1097 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1097 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02891 XEO_CLAS Peptide DME1097 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02891 GENEFORM Protein DME1097 XEOTICID XEO02891 MOACRIVE Inhibition DME1097 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1097 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02895 XEO_CLAS Peptide DME1097 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO02895 GENEFORM Protein DME1097 XEOTICID XEO02895 MOACRIVE Inhibition DME1097 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1097 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02896 XEO_CLAS Peptide DME1097 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO02896 GENEFORM Protein DME1097 XEOTICID XEO02896 MOACRIVE Inhibition DME1097 XEOTICID XEO02899 XEO_NAME Coladonin DME1097 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1097 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1097 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02899 GENEFORM Protein DME1097 XEOTICID XEO02899 MOACRIVE Inhibition DME1097 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1097 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02900 XEO_CLAS Peptide DME1097 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02900 GENEFORM Protein DME1097 XEOTICID XEO02900 MOACRIVE Inhibition DME1097 XEOTICID XEO02901 XEO_NAME Colicin-V DME1097 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02901 XEO_CLAS Peptide DME1097 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02901 GENEFORM Protein DME1097 XEOTICID XEO02901 MOACRIVE Inhibition DME1097 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1097 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02904 GENEFORM Protein DME1097 XEOTICID XEO02904 MOACRIVE Inhibition DME1097 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1097 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02908 XEO_CLAS Peptide DME1097 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 50 microM) DME1097 XEOTICID XEO02908 GENEFORM Protein DME1097 XEOTICID XEO02908 MOACRIVE Inhibition DME1097 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1097 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02923 XEO_CLAS Peptide DME1097 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02923 GENEFORM Protein DME1097 XEOTICID XEO02923 MOACRIVE Inhibition DME1097 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1097 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02924 XEO_CLAS Peptide DME1097 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 32 microM) DME1097 XEOTICID XEO02924 GENEFORM Protein DME1097 XEOTICID XEO02924 MOACRIVE Inhibition DME1097 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1097 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1097 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02927 GENEFORM Protein DME1097 XEOTICID XEO02927 MOACRIVE Inhibition DME1097 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1097 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02931 XEO_CLAS Peptide DME1097 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 ug/ml) DME1097 XEOTICID XEO02931 GENEFORM Protein DME1097 XEOTICID XEO02931 MOACRIVE Inhibition DME1097 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1097 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02933 XEO_CLAS Peptide DME1097 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO02933 GENEFORM Protein DME1097 XEOTICID XEO02933 MOACRIVE Inhibition DME1097 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1097 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02934 XEO_CLAS Peptide DME1097 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02934 GENEFORM Protein DME1097 XEOTICID XEO02934 MOACRIVE Inhibition DME1097 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1097 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02935 XEO_CLAS Peptide DME1097 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02935 GENEFORM Protein DME1097 XEOTICID XEO02935 MOACRIVE Inhibition DME1097 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1097 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02936 XEO_CLAS Peptide DME1097 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO02936 GENEFORM Protein DME1097 XEOTICID XEO02936 MOACRIVE Inhibition DME1097 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1097 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02937 XEO_CLAS Peptide DME1097 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02937 GENEFORM Protein DME1097 XEOTICID XEO02937 MOACRIVE Inhibition DME1097 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1097 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02938 XEO_CLAS Peptide DME1097 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 32 ug/ml) DME1097 XEOTICID XEO02938 GENEFORM Protein DME1097 XEOTICID XEO02938 MOACRIVE Inhibition DME1097 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1097 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02939 XEO_CLAS Peptide DME1097 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 11 ug/ml) DME1097 XEOTICID XEO02939 GENEFORM Protein DME1097 XEOTICID XEO02939 MOACRIVE Inhibition DME1097 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1097 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02940 XEO_CLAS Peptide DME1097 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1 ug/ml) DME1097 XEOTICID XEO02940 GENEFORM Protein DME1097 XEOTICID XEO02940 MOACRIVE Inhibition DME1097 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1097 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02941 XEO_CLAS Peptide DME1097 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02941 GENEFORM Protein DME1097 XEOTICID XEO02941 MOACRIVE Inhibition DME1097 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1097 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02944 XEO_CLAS Peptide DME1097 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 microM) DME1097 XEOTICID XEO02944 GENEFORM Protein DME1097 XEOTICID XEO02944 MOACRIVE Inhibition DME1097 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1097 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02945 XEO_CLAS Peptide DME1097 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 microM) DME1097 XEOTICID XEO02945 GENEFORM Protein DME1097 XEOTICID XEO02945 MOACRIVE Inhibition DME1097 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1097 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02946 XEO_CLAS Peptide DME1097 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 microM) DME1097 XEOTICID XEO02946 GENEFORM Protein DME1097 XEOTICID XEO02946 MOACRIVE Inhibition DME1097 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1097 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02947 XEO_CLAS Peptide DME1097 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02947 GENEFORM Protein DME1097 XEOTICID XEO02947 MOACRIVE Inhibition DME1097 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1097 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02948 XEO_CLAS Peptide DME1097 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO02948 GENEFORM Protein DME1097 XEOTICID XEO02948 MOACRIVE Inhibition DME1097 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1097 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02949 XEO_CLAS Peptide DME1097 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO02949 GENEFORM Protein DME1097 XEOTICID XEO02949 MOACRIVE Inhibition DME1097 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1097 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02954 XEO_CLAS Peptide DME1097 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02954 GENEFORM Protein DME1097 XEOTICID XEO02954 MOACRIVE Inhibition DME1097 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1097 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02958 XEO_CLAS Peptide DME1097 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02958 GENEFORM Protein DME1097 XEOTICID XEO02958 MOACRIVE Inhibition DME1097 XEOTICID XEO02962 XEO_NAME Cryptonin DME1097 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02962 XEO_CLAS Peptide DME1097 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.12 ug/ml) DME1097 XEOTICID XEO02962 GENEFORM Protein DME1097 XEOTICID XEO02962 MOACRIVE Inhibition DME1097 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1097 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02965 XEO_CLAS Peptide DME1097 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 ug/ml) DME1097 XEOTICID XEO02965 GENEFORM Protein DME1097 XEOTICID XEO02965 MOACRIVE Inhibition DME1097 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1097 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02969 XEO_CLAS Peptide DME1097 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 microM) DME1097 XEOTICID XEO02969 GENEFORM Protein DME1097 XEOTICID XEO02969 MOACRIVE Inhibition DME1097 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1097 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02971 XEO_CLAS Peptide DME1097 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 microM) DME1097 XEOTICID XEO02971 GENEFORM Protein DME1097 XEOTICID XEO02971 MOACRIVE Inhibition DME1097 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1097 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO02972 XEO_CLAS Peptide DME1097 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.4 microM) DME1097 XEOTICID XEO02972 GENEFORM Protein DME1097 XEOTICID XEO02972 MOACRIVE Inhibition DME1097 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1097 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02990 GENEFORM Protein DME1097 XEOTICID XEO02990 MOACRIVE Inhibition DME1097 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1097 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02991 GENEFORM Protein DME1097 XEOTICID XEO02991 MOACRIVE Inhibition DME1097 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1097 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02992 GENEFORM Protein DME1097 XEOTICID XEO02992 MOACRIVE Inhibition DME1097 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1097 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02993 GENEFORM Protein DME1097 XEOTICID XEO02993 MOACRIVE Inhibition DME1097 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1097 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02994 GENEFORM Protein DME1097 XEOTICID XEO02994 MOACRIVE Inhibition DME1097 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1097 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02995 GENEFORM Protein DME1097 XEOTICID XEO02995 MOACRIVE Inhibition DME1097 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1097 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02996 GENEFORM Protein DME1097 XEOTICID XEO02996 MOACRIVE Inhibition DME1097 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1097 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02997 GENEFORM Protein DME1097 XEOTICID XEO02997 MOACRIVE Inhibition DME1097 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1097 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02998 GENEFORM Protein DME1097 XEOTICID XEO02998 MOACRIVE Inhibition DME1097 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1097 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1097 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO02999 GENEFORM Protein DME1097 XEOTICID XEO02999 MOACRIVE Inhibition DME1097 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1097 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03021 XEO_CLAS Peptide DME1097 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1097 XEOTICID XEO03021 GENEFORM Protein DME1097 XEOTICID XEO03021 MOACRIVE Inhibition DME1097 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1097 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03029 XEO_CLAS Peptide DME1097 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.005 microM) DME1097 XEOTICID XEO03029 GENEFORM Protein DME1097 XEOTICID XEO03029 MOACRIVE Inhibition DME1097 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1097 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03030 XEO_CLAS Peptide DME1097 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.005 microM) DME1097 XEOTICID XEO03030 GENEFORM Protein DME1097 XEOTICID XEO03030 MOACRIVE Inhibition DME1097 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1097 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03031 XEO_CLAS Peptide DME1097 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.3 microM) DME1097 XEOTICID XEO03031 GENEFORM Protein DME1097 XEOTICID XEO03031 MOACRIVE Inhibition DME1097 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1097 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03032 XEO_CLAS Peptide DME1097 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.01 microM) DME1097 XEOTICID XEO03032 GENEFORM Protein DME1097 XEOTICID XEO03032 MOACRIVE Inhibition DME1097 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1097 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03033 XEO_CLAS Peptide DME1097 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.173 microM) DME1097 XEOTICID XEO03033 GENEFORM Protein DME1097 XEOTICID XEO03033 MOACRIVE Inhibition DME1097 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1097 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03034 XEO_CLAS Peptide DME1097 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.518 microM) DME1097 XEOTICID XEO03034 GENEFORM Protein DME1097 XEOTICID XEO03034 MOACRIVE Inhibition DME1097 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1097 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03035 XEO_CLAS Peptide DME1097 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.114 microM) DME1097 XEOTICID XEO03035 GENEFORM Protein DME1097 XEOTICID XEO03035 MOACRIVE Inhibition DME1097 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1097 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03039 XEO_CLAS Peptide DME1097 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.55 microM) DME1097 XEOTICID XEO03039 GENEFORM Protein DME1097 XEOTICID XEO03039 MOACRIVE Inhibition DME1097 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1097 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03043 XEO_CLAS Peptide DME1097 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 microM) DME1097 XEOTICID XEO03043 GENEFORM Protein DME1097 XEOTICID XEO03043 MOACRIVE Inhibition DME1097 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1097 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03044 XEO_CLAS Peptide DME1097 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03044 GENEFORM Protein DME1097 XEOTICID XEO03044 MOACRIVE Inhibition DME1097 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1097 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03045 XEO_CLAS Peptide DME1097 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03045 GENEFORM Protein DME1097 XEOTICID XEO03045 MOACRIVE Inhibition DME1097 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1097 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03046 XEO_CLAS Peptide DME1097 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03046 GENEFORM Protein DME1097 XEOTICID XEO03046 MOACRIVE Inhibition DME1097 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1097 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03049 XEO_CLAS Peptide DME1097 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 microM) DME1097 XEOTICID XEO03049 GENEFORM Protein DME1097 XEOTICID XEO03049 MOACRIVE Inhibition DME1097 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1097 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03055 XEO_CLAS Peptide DME1097 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 microM) DME1097 XEOTICID XEO03055 GENEFORM Protein DME1097 XEOTICID XEO03055 MOACRIVE Inhibition DME1097 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1097 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03059 XEO_CLAS Peptide DME1097 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO03059 GENEFORM Protein DME1097 XEOTICID XEO03059 MOACRIVE Inhibition DME1097 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1097 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03060 XEO_CLAS Peptide DME1097 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO03060 GENEFORM Protein DME1097 XEOTICID XEO03060 MOACRIVE Inhibition DME1097 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1097 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03062 XEO_CLAS Peptide DME1097 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO03062 GENEFORM Protein DME1097 XEOTICID XEO03062 MOACRIVE Inhibition DME1097 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1097 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03064 XEO_CLAS Peptide DME1097 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO03064 GENEFORM Protein DME1097 XEOTICID XEO03064 MOACRIVE Inhibition DME1097 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1097 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03066 XEO_CLAS Peptide DME1097 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO03066 GENEFORM Protein DME1097 XEOTICID XEO03066 MOACRIVE Inhibition DME1097 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1097 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03068 XEO_CLAS Peptide DME1097 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO03068 GENEFORM Protein DME1097 XEOTICID XEO03068 MOACRIVE Inhibition DME1097 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1097 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03073 XEO_CLAS Peptide DME1097 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8-16 ug/ml) DME1097 XEOTICID XEO03073 GENEFORM Protein DME1097 XEOTICID XEO03073 MOACRIVE Inhibition DME1097 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1097 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03081 XEO_CLAS Peptide DME1097 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 microM) DME1097 XEOTICID XEO03081 GENEFORM Protein DME1097 XEOTICID XEO03081 MOACRIVE Inhibition DME1097 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1097 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03082 XEO_CLAS Peptide DME1097 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03082 GENEFORM Protein DME1097 XEOTICID XEO03082 MOACRIVE Inhibition DME1097 XEOTICID XEO03089 XEO_NAME Decoralin DME1097 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03089 XEO_CLAS Peptide DME1097 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 160 microM) DME1097 XEOTICID XEO03089 GENEFORM Protein DME1097 XEOTICID XEO03089 MOACRIVE Inhibition DME1097 XEOTICID XEO03098 XEO_NAME Insect defensin DME1097 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03098 XEO_CLAS Peptide DME1097 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 ug/ml) DME1097 XEOTICID XEO03098 GENEFORM Protein DME1097 XEOTICID XEO03098 MOACRIVE Inhibition DME1097 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1097 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03100 XEO_CLAS Peptide DME1097 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03100 GENEFORM Protein DME1097 XEOTICID XEO03100 MOACRIVE Inhibition DME1097 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1097 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03103 XEO_CLAS Peptide DME1097 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03103 GENEFORM Protein DME1097 XEOTICID XEO03103 MOACRIVE Inhibition DME1097 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1097 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03105 XEO_CLAS Peptide DME1097 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03105 GENEFORM Protein DME1097 XEOTICID XEO03105 MOACRIVE Inhibition DME1097 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1097 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03110 XEO_CLAS Peptide DME1097 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.2 microM) DME1097 XEOTICID XEO03110 GENEFORM Protein DME1097 XEOTICID XEO03110 MOACRIVE Inhibition DME1097 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1097 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03111 XEO_CLAS Peptide DME1097 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03111 GENEFORM Protein DME1097 XEOTICID XEO03111 MOACRIVE Inhibition DME1097 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1097 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03112 XEO_CLAS Peptide DME1097 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 50 ug/ml) DME1097 XEOTICID XEO03112 GENEFORM Protein DME1097 XEOTICID XEO03112 MOACRIVE Inhibition DME1097 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1097 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03115 XEO_CLAS Peptide DME1097 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03115 GENEFORM Protein DME1097 XEOTICID XEO03115 MOACRIVE Inhibition DME1097 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1097 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03116 XEO_CLAS Peptide DME1097 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 40 microM) DME1097 XEOTICID XEO03116 GENEFORM Protein DME1097 XEOTICID XEO03116 MOACRIVE Inhibition DME1097 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1097 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03118 XEO_CLAS Peptide DME1097 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03118 GENEFORM Protein DME1097 XEOTICID XEO03118 MOACRIVE Inhibition DME1097 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1097 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03119 XEO_CLAS Peptide DME1097 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03119 GENEFORM Protein DME1097 XEOTICID XEO03119 MOACRIVE Inhibition DME1097 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1097 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03121 XEO_CLAS Peptide DME1097 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03121 GENEFORM Protein DME1097 XEOTICID XEO03121 MOACRIVE Inhibition DME1097 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1097 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03122 XEO_CLAS Peptide DME1097 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64000 ug/ml) DME1097 XEOTICID XEO03122 GENEFORM Protein DME1097 XEOTICID XEO03122 MOACRIVE Inhibition DME1097 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1097 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03124 XEO_CLAS Peptide DME1097 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03124 GENEFORM Protein DME1097 XEOTICID XEO03124 MOACRIVE Inhibition DME1097 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1097 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03125 XEO_CLAS Peptide DME1097 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03125 GENEFORM Protein DME1097 XEOTICID XEO03125 MOACRIVE Inhibition DME1097 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1097 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03126 XEO_CLAS Peptide DME1097 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.86 microM) DME1097 XEOTICID XEO03126 GENEFORM Protein DME1097 XEOTICID XEO03126 MOACRIVE Inhibition DME1097 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1097 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03127 XEO_CLAS Peptide DME1097 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03127 GENEFORM Protein DME1097 XEOTICID XEO03127 MOACRIVE Inhibition DME1097 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1097 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03128 XEO_CLAS Peptide DME1097 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 256 ug/ml) DME1097 XEOTICID XEO03128 GENEFORM Protein DME1097 XEOTICID XEO03128 MOACRIVE Inhibition DME1097 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1097 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03129 XEO_CLAS Peptide DME1097 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 256 ug/ml) DME1097 XEOTICID XEO03129 GENEFORM Protein DME1097 XEOTICID XEO03129 MOACRIVE Inhibition DME1097 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1097 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03130 XEO_CLAS Peptide DME1097 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 256 ug/ml) DME1097 XEOTICID XEO03130 GENEFORM Protein DME1097 XEOTICID XEO03130 MOACRIVE Inhibition DME1097 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1097 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03131 XEO_CLAS Peptide DME1097 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 256 ug/ml) DME1097 XEOTICID XEO03131 GENEFORM Protein DME1097 XEOTICID XEO03131 MOACRIVE Inhibition DME1097 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1097 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03132 XEO_CLAS Peptide DME1097 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 256 ug/ml) DME1097 XEOTICID XEO03132 GENEFORM Protein DME1097 XEOTICID XEO03132 MOACRIVE Inhibition DME1097 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1097 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03137 XEO_CLAS Peptide DME1097 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03137 GENEFORM Protein DME1097 XEOTICID XEO03137 MOACRIVE Inhibition DME1097 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1097 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03143 XEO_CLAS Peptide DME1097 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.6 microM) DME1097 XEOTICID XEO03143 GENEFORM Protein DME1097 XEOTICID XEO03143 MOACRIVE Inhibition DME1097 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1097 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03145 XEO_CLAS Peptide DME1097 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.6 microM) DME1097 XEOTICID XEO03145 GENEFORM Protein DME1097 XEOTICID XEO03145 MOACRIVE Inhibition DME1097 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1097 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03146 XEO_CLAS Peptide DME1097 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.5 microM) DME1097 XEOTICID XEO03146 GENEFORM Protein DME1097 XEOTICID XEO03146 MOACRIVE Inhibition DME1097 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1097 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03147 XEO_CLAS Peptide DME1097 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 9.7 microM) DME1097 XEOTICID XEO03147 GENEFORM Protein DME1097 XEOTICID XEO03147 MOACRIVE Inhibition DME1097 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1097 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03148 XEO_CLAS Peptide DME1097 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.3 microM) DME1097 XEOTICID XEO03148 GENEFORM Protein DME1097 XEOTICID XEO03148 MOACRIVE Inhibition DME1097 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1097 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03149 XEO_CLAS Peptide DME1097 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.6 microM) DME1097 XEOTICID XEO03149 GENEFORM Protein DME1097 XEOTICID XEO03149 MOACRIVE Inhibition DME1097 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1097 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03150 XEO_CLAS Peptide DME1097 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 9-3 microM) DME1097 XEOTICID XEO03150 GENEFORM Protein DME1097 XEOTICID XEO03150 MOACRIVE Inhibition DME1097 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1097 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03151 XEO_CLAS Peptide DME1097 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 ug/ml) DME1097 XEOTICID XEO03151 GENEFORM Protein DME1097 XEOTICID XEO03151 MOACRIVE Inhibition DME1097 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1097 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03152 XEO_CLAS Peptide DME1097 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO03152 GENEFORM Protein DME1097 XEOTICID XEO03152 MOACRIVE Inhibition DME1097 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1097 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03155 XEO_CLAS Peptide DME1097 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.4 microM) DME1097 XEOTICID XEO03155 GENEFORM Protein DME1097 XEOTICID XEO03155 MOACRIVE Inhibition DME1097 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1097 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03156 XEO_CLAS Peptide DME1097 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.3 microM) DME1097 XEOTICID XEO03156 GENEFORM Protein DME1097 XEOTICID XEO03156 MOACRIVE Inhibition DME1097 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1097 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03157 XEO_CLAS Peptide DME1097 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.3 microM) DME1097 XEOTICID XEO03157 GENEFORM Protein DME1097 XEOTICID XEO03157 MOACRIVE Inhibition DME1097 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1097 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03158 XEO_CLAS Peptide DME1097 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 ug/ml) DME1097 XEOTICID XEO03158 GENEFORM Protein DME1097 XEOTICID XEO03158 MOACRIVE Inhibition DME1097 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1097 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03159 XEO_CLAS Peptide DME1097 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03159 GENEFORM Protein DME1097 XEOTICID XEO03159 MOACRIVE Inhibition DME1097 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1097 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03161 XEO_CLAS Peptide DME1097 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 microM) DME1097 XEOTICID XEO03161 GENEFORM Protein DME1097 XEOTICID XEO03161 MOACRIVE Inhibition DME1097 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1097 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03162 XEO_CLAS Peptide DME1097 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.5 microM) DME1097 XEOTICID XEO03162 GENEFORM Protein DME1097 XEOTICID XEO03162 MOACRIVE Inhibition DME1097 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1097 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03169 XEO_CLAS Peptide DME1097 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO03169 GENEFORM Protein DME1097 XEOTICID XEO03169 MOACRIVE Inhibition DME1097 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1097 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03193 XEO_CLAS Peptide DME1097 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25 ug/ml) DME1097 XEOTICID XEO03193 GENEFORM Protein DME1097 XEOTICID XEO03193 MOACRIVE Inhibition DME1097 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1097 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03194 XEO_CLAS Peptide DME1097 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03194 GENEFORM Protein DME1097 XEOTICID XEO03194 MOACRIVE Inhibition DME1097 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1097 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03195 XEO_CLAS Peptide DME1097 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03195 GENEFORM Protein DME1097 XEOTICID XEO03195 MOACRIVE Inhibition DME1097 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1097 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03197 XEO_CLAS Peptide DME1097 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 14.5 microM) DME1097 XEOTICID XEO03197 GENEFORM Protein DME1097 XEOTICID XEO03197 MOACRIVE Inhibition DME1097 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1097 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03202 XEO_CLAS Peptide DME1097 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.51 microM) DME1097 XEOTICID XEO03202 GENEFORM Protein DME1097 XEOTICID XEO03202 MOACRIVE Inhibition DME1097 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1097 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03203 XEO_CLAS Peptide DME1097 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.62 microM) DME1097 XEOTICID XEO03203 GENEFORM Protein DME1097 XEOTICID XEO03203 MOACRIVE Inhibition DME1097 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1097 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03204 XEO_CLAS Peptide DME1097 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.38 microM) DME1097 XEOTICID XEO03204 GENEFORM Protein DME1097 XEOTICID XEO03204 MOACRIVE Inhibition DME1097 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1097 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03205 XEO_CLAS Peptide DME1097 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.29 microM) DME1097 XEOTICID XEO03205 GENEFORM Protein DME1097 XEOTICID XEO03205 MOACRIVE Inhibition DME1097 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1097 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03206 XEO_CLAS Peptide DME1097 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.40 microM) DME1097 XEOTICID XEO03206 GENEFORM Protein DME1097 XEOTICID XEO03206 MOACRIVE Inhibition DME1097 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1097 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03207 XEO_CLAS Peptide DME1097 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.58 microM) DME1097 XEOTICID XEO03207 GENEFORM Protein DME1097 XEOTICID XEO03207 MOACRIVE Inhibition DME1097 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1097 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03208 XEO_CLAS Peptide DME1097 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.76 microM) DME1097 XEOTICID XEO03208 GENEFORM Protein DME1097 XEOTICID XEO03208 MOACRIVE Inhibition DME1097 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1097 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03209 XEO_CLAS Peptide DME1097 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.49 microM) DME1097 XEOTICID XEO03209 GENEFORM Protein DME1097 XEOTICID XEO03209 MOACRIVE Inhibition DME1097 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1097 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03210 XEO_CLAS Peptide DME1097 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 7.07 microM) DME1097 XEOTICID XEO03210 GENEFORM Protein DME1097 XEOTICID XEO03210 MOACRIVE Inhibition DME1097 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1097 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03211 XEO_CLAS Peptide DME1097 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.40 microM) DME1097 XEOTICID XEO03211 GENEFORM Protein DME1097 XEOTICID XEO03211 MOACRIVE Inhibition DME1097 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1097 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03215 XEO_CLAS Peptide DME1097 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20.0 ug/ml) DME1097 XEOTICID XEO03215 GENEFORM Protein DME1097 XEOTICID XEO03215 MOACRIVE Inhibition DME1097 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1097 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03216 XEO_CLAS Peptide DME1097 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO03216 GENEFORM Protein DME1097 XEOTICID XEO03216 MOACRIVE Inhibition DME1097 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1097 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03217 XEO_CLAS Peptide DME1097 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO03217 GENEFORM Protein DME1097 XEOTICID XEO03217 MOACRIVE Inhibition DME1097 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1097 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03223 XEO_CLAS Peptide DME1097 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.8 microM) DME1097 XEOTICID XEO03223 GENEFORM Protein DME1097 XEOTICID XEO03223 MOACRIVE Inhibition DME1097 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1097 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03224 XEO_CLAS Peptide DME1097 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.1-0.25 microM) DME1097 XEOTICID XEO03224 GENEFORM Protein DME1097 XEOTICID XEO03224 MOACRIVE Inhibition DME1097 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1097 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03225 XEO_CLAS Peptide DME1097 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.3 microM) DME1097 XEOTICID XEO03225 GENEFORM Protein DME1097 XEOTICID XEO03225 MOACRIVE Inhibition DME1097 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1097 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03227 XEO_CLAS Peptide DME1097 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.3 microM) DME1097 XEOTICID XEO03227 GENEFORM Protein DME1097 XEOTICID XEO03227 MOACRIVE Inhibition DME1097 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1097 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03231 XEO_CLAS Peptide DME1097 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03231 GENEFORM Protein DME1097 XEOTICID XEO03231 MOACRIVE Inhibition DME1097 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1097 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03232 XEO_CLAS Peptide DME1097 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03232 GENEFORM Protein DME1097 XEOTICID XEO03232 MOACRIVE Inhibition DME1097 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1097 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03234 XEO_CLAS Peptide DME1097 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO03234 GENEFORM Protein DME1097 XEOTICID XEO03234 MOACRIVE Inhibition DME1097 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1097 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03235 XEO_CLAS Peptide DME1097 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 60 ug/ml) DME1097 XEOTICID XEO03235 GENEFORM Protein DME1097 XEOTICID XEO03235 MOACRIVE Inhibition DME1097 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1097 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03236 XEO_CLAS Peptide DME1097 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO03236 GENEFORM Protein DME1097 XEOTICID XEO03236 MOACRIVE Inhibition DME1097 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1097 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03237 XEO_CLAS Peptide DME1097 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 ug/ml) DME1097 XEOTICID XEO03237 GENEFORM Protein DME1097 XEOTICID XEO03237 MOACRIVE Inhibition DME1097 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1097 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03238 XEO_CLAS Peptide DME1097 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 ug/ml) DME1097 XEOTICID XEO03238 GENEFORM Protein DME1097 XEOTICID XEO03238 MOACRIVE Inhibition DME1097 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1097 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03239 XEO_CLAS Peptide DME1097 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 60 ug/ml) DME1097 XEOTICID XEO03239 GENEFORM Protein DME1097 XEOTICID XEO03239 MOACRIVE Inhibition DME1097 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1097 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03241 XEO_CLAS Peptide DME1097 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 128 microM) DME1097 XEOTICID XEO03241 GENEFORM Protein DME1097 XEOTICID XEO03241 MOACRIVE Inhibition DME1097 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1097 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03250 XEO_CLAS Peptide DME1097 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03250 GENEFORM Protein DME1097 XEOTICID XEO03250 MOACRIVE Inhibition DME1097 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1097 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03251 XEO_CLAS Peptide DME1097 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03251 GENEFORM Protein DME1097 XEOTICID XEO03251 MOACRIVE Inhibition DME1097 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1097 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03253 XEO_CLAS Peptide DME1097 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.1 ug/ml) DME1097 XEOTICID XEO03253 GENEFORM Protein DME1097 XEOTICID XEO03253 MOACRIVE Inhibition DME1097 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1097 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03274 XEO_CLAS Peptide DME1097 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.2 microM) DME1097 XEOTICID XEO03274 GENEFORM Protein DME1097 XEOTICID XEO03274 MOACRIVE Inhibition DME1097 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1097 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03275 XEO_CLAS Peptide DME1097 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO03275 GENEFORM Protein DME1097 XEOTICID XEO03275 MOACRIVE Inhibition DME1097 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1097 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03276 XEO_CLAS Peptide DME1097 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO03276 GENEFORM Protein DME1097 XEOTICID XEO03276 MOACRIVE Inhibition DME1097 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1097 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03277 XEO_CLAS Peptide DME1097 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.2 microM) DME1097 XEOTICID XEO03277 GENEFORM Protein DME1097 XEOTICID XEO03277 MOACRIVE Inhibition DME1097 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1097 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03278 XEO_CLAS Peptide DME1097 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO03278 GENEFORM Protein DME1097 XEOTICID XEO03278 MOACRIVE Inhibition DME1097 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1097 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03279 XEO_CLAS Peptide DME1097 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO03279 GENEFORM Protein DME1097 XEOTICID XEO03279 MOACRIVE Inhibition DME1097 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1097 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03280 XEO_CLAS Peptide DME1097 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 microM) DME1097 XEOTICID XEO03280 GENEFORM Protein DME1097 XEOTICID XEO03280 MOACRIVE Inhibition DME1097 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1097 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03281 XEO_CLAS Peptide DME1097 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.3 microM) DME1097 XEOTICID XEO03281 GENEFORM Protein DME1097 XEOTICID XEO03281 MOACRIVE Inhibition DME1097 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1097 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03282 XEO_CLAS Peptide DME1097 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.1 microM) DME1097 XEOTICID XEO03282 GENEFORM Protein DME1097 XEOTICID XEO03282 MOACRIVE Inhibition DME1097 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1097 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03283 XEO_CLAS Peptide DME1097 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 microM) DME1097 XEOTICID XEO03283 GENEFORM Protein DME1097 XEOTICID XEO03283 MOACRIVE Inhibition DME1097 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1097 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03284 XEO_CLAS Peptide DME1097 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.2 ug/ml) DME1097 XEOTICID XEO03284 GENEFORM Protein DME1097 XEOTICID XEO03284 MOACRIVE Inhibition DME1097 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1097 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03285 XEO_CLAS Peptide DME1097 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.5 ug/ml) DME1097 XEOTICID XEO03285 GENEFORM Protein DME1097 XEOTICID XEO03285 MOACRIVE Inhibition DME1097 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1097 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03286 XEO_CLAS Peptide DME1097 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.4 ug/ml) DME1097 XEOTICID XEO03286 GENEFORM Protein DME1097 XEOTICID XEO03286 MOACRIVE Inhibition DME1097 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1097 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03287 XEO_CLAS Peptide DME1097 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.6 ug/ml) DME1097 XEOTICID XEO03287 GENEFORM Protein DME1097 XEOTICID XEO03287 MOACRIVE Inhibition DME1097 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1097 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03288 XEO_CLAS Peptide DME1097 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.4 ug/ml) DME1097 XEOTICID XEO03288 GENEFORM Protein DME1097 XEOTICID XEO03288 MOACRIVE Inhibition DME1097 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1097 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03289 XEO_CLAS Peptide DME1097 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8.8 ug/ml) DME1097 XEOTICID XEO03289 GENEFORM Protein DME1097 XEOTICID XEO03289 MOACRIVE Inhibition DME1097 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1097 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03290 XEO_CLAS Peptide DME1097 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.5 ug/ml) DME1097 XEOTICID XEO03290 GENEFORM Protein DME1097 XEOTICID XEO03290 MOACRIVE Inhibition DME1097 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1097 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03291 XEO_CLAS Peptide DME1097 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8.6 ug/ml) DME1097 XEOTICID XEO03291 GENEFORM Protein DME1097 XEOTICID XEO03291 MOACRIVE Inhibition DME1097 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1097 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03292 XEO_CLAS Peptide DME1097 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4.1 ug/ml) DME1097 XEOTICID XEO03292 GENEFORM Protein DME1097 XEOTICID XEO03292 MOACRIVE Inhibition DME1097 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1097 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03293 XEO_CLAS Peptide DME1097 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1 microM) DME1097 XEOTICID XEO03293 GENEFORM Protein DME1097 XEOTICID XEO03293 MOACRIVE Inhibition DME1097 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1097 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03294 XEO_CLAS Peptide DME1097 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1 microM) DME1097 XEOTICID XEO03294 GENEFORM Protein DME1097 XEOTICID XEO03294 MOACRIVE Inhibition DME1097 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1097 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03295 XEO_CLAS Peptide DME1097 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.7 microM) DME1097 XEOTICID XEO03295 GENEFORM Protein DME1097 XEOTICID XEO03295 MOACRIVE Inhibition DME1097 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1097 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03296 XEO_CLAS Peptide DME1097 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03296 GENEFORM Protein DME1097 XEOTICID XEO03296 MOACRIVE Inhibition DME1097 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1097 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03297 XEO_CLAS Peptide DME1097 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03297 GENEFORM Protein DME1097 XEOTICID XEO03297 MOACRIVE Inhibition DME1097 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1097 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03298 XEO_CLAS Peptide DME1097 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.2 microM) DME1097 XEOTICID XEO03298 GENEFORM Protein DME1097 XEOTICID XEO03298 MOACRIVE Inhibition DME1097 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1097 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03299 XEO_CLAS Peptide DME1097 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.4 microM) DME1097 XEOTICID XEO03299 GENEFORM Protein DME1097 XEOTICID XEO03299 MOACRIVE Inhibition DME1097 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1097 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03300 XEO_CLAS Peptide DME1097 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 ug/ml) DME1097 XEOTICID XEO03300 GENEFORM Protein DME1097 XEOTICID XEO03300 MOACRIVE Inhibition DME1097 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1097 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03301 XEO_CLAS Peptide DME1097 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 ug/ml) DME1097 XEOTICID XEO03301 GENEFORM Protein DME1097 XEOTICID XEO03301 MOACRIVE Inhibition DME1097 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1097 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03302 XEO_CLAS Peptide DME1097 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1 microM) DME1097 XEOTICID XEO03302 GENEFORM Protein DME1097 XEOTICID XEO03302 MOACRIVE Inhibition DME1097 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1097 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03303 XEO_CLAS Peptide DME1097 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 microM) DME1097 XEOTICID XEO03303 GENEFORM Protein DME1097 XEOTICID XEO03303 MOACRIVE Inhibition DME1097 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1097 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03304 XEO_CLAS Peptide DME1097 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO03304 GENEFORM Protein DME1097 XEOTICID XEO03304 MOACRIVE Inhibition DME1097 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1097 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03305 XEO_CLAS Peptide DME1097 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 microM) DME1097 XEOTICID XEO03305 GENEFORM Protein DME1097 XEOTICID XEO03305 MOACRIVE Inhibition DME1097 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1097 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03306 XEO_CLAS Peptide DME1097 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO03306 GENEFORM Protein DME1097 XEOTICID XEO03306 MOACRIVE Inhibition DME1097 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1097 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03307 XEO_CLAS Peptide DME1097 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 34 ug/ml) DME1097 XEOTICID XEO03307 GENEFORM Protein DME1097 XEOTICID XEO03307 MOACRIVE Inhibition DME1097 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1097 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03308 XEO_CLAS Peptide DME1097 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO03308 GENEFORM Protein DME1097 XEOTICID XEO03308 MOACRIVE Inhibition DME1097 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1097 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03310 XEO_CLAS Peptide DME1097 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8.5 ug/ml) DME1097 XEOTICID XEO03310 GENEFORM Protein DME1097 XEOTICID XEO03310 MOACRIVE Inhibition DME1097 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1097 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03311 XEO_CLAS Peptide DME1097 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10.8 ug/ml) DME1097 XEOTICID XEO03311 GENEFORM Protein DME1097 XEOTICID XEO03311 MOACRIVE Inhibition DME1097 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1097 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03312 XEO_CLAS Peptide DME1097 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10.8 ug/ml) DME1097 XEOTICID XEO03312 GENEFORM Protein DME1097 XEOTICID XEO03312 MOACRIVE Inhibition DME1097 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1097 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03313 XEO_CLAS Peptide DME1097 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8.1 ug/ml) DME1097 XEOTICID XEO03313 GENEFORM Protein DME1097 XEOTICID XEO03313 MOACRIVE Inhibition DME1097 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1097 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03314 XEO_CLAS Peptide DME1097 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 7.9 ug/ml) DME1097 XEOTICID XEO03314 GENEFORM Protein DME1097 XEOTICID XEO03314 MOACRIVE Inhibition DME1097 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1097 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03315 XEO_CLAS Peptide DME1097 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.6 ug/ml) DME1097 XEOTICID XEO03315 GENEFORM Protein DME1097 XEOTICID XEO03315 MOACRIVE Inhibition DME1097 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1097 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03316 XEO_CLAS Peptide DME1097 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15.8 ug/ml) DME1097 XEOTICID XEO03316 GENEFORM Protein DME1097 XEOTICID XEO03316 MOACRIVE Inhibition DME1097 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1097 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03317 XEO_CLAS Peptide DME1097 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO03317 GENEFORM Protein DME1097 XEOTICID XEO03317 MOACRIVE Inhibition DME1097 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1097 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03318 XEO_CLAS Peptide DME1097 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1 microM) DME1097 XEOTICID XEO03318 GENEFORM Protein DME1097 XEOTICID XEO03318 MOACRIVE Inhibition DME1097 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1097 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03319 XEO_CLAS Peptide DME1097 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03319 GENEFORM Protein DME1097 XEOTICID XEO03319 MOACRIVE Inhibition DME1097 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1097 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03320 XEO_CLAS Peptide DME1097 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.1 microM) DME1097 XEOTICID XEO03320 GENEFORM Protein DME1097 XEOTICID XEO03320 MOACRIVE Inhibition DME1097 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1097 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03321 XEO_CLAS Peptide DME1097 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.8 microM) DME1097 XEOTICID XEO03321 GENEFORM Protein DME1097 XEOTICID XEO03321 MOACRIVE Inhibition DME1097 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1097 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1097 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03348 GENEFORM Protein DME1097 XEOTICID XEO03348 MOACRIVE Inhibition DME1097 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1097 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03362 XEO_CLAS Peptide DME1097 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO03362 GENEFORM Protein DME1097 XEOTICID XEO03362 MOACRIVE Inhibition DME1097 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1097 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03363 XEO_CLAS Peptide DME1097 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 microM) DME1097 XEOTICID XEO03363 GENEFORM Protein DME1097 XEOTICID XEO03363 MOACRIVE Inhibition DME1097 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1097 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03364 XEO_CLAS Peptide DME1097 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 microM) DME1097 XEOTICID XEO03364 GENEFORM Protein DME1097 XEOTICID XEO03364 MOACRIVE Inhibition DME1097 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1097 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03365 XEO_CLAS Peptide DME1097 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03365 GENEFORM Protein DME1097 XEOTICID XEO03365 MOACRIVE Inhibition DME1097 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1097 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03366 XEO_CLAS Peptide DME1097 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO03366 GENEFORM Protein DME1097 XEOTICID XEO03366 MOACRIVE Inhibition DME1097 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1097 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03367 XEO_CLAS Peptide DME1097 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 microM) DME1097 XEOTICID XEO03367 GENEFORM Protein DME1097 XEOTICID XEO03367 MOACRIVE Inhibition DME1097 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1097 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03368 XEO_CLAS Peptide DME1097 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 microM) DME1097 XEOTICID XEO03368 GENEFORM Protein DME1097 XEOTICID XEO03368 MOACRIVE Inhibition DME1097 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1097 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03379 XEO_CLAS Peptide DME1097 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.6 ug/ml) DME1097 XEOTICID XEO03379 GENEFORM Protein DME1097 XEOTICID XEO03379 MOACRIVE Inhibition DME1097 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1097 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03396 XEO_CLAS Peptide DME1097 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03396 GENEFORM Protein DME1097 XEOTICID XEO03396 MOACRIVE Inhibition DME1097 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1097 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03398 XEO_CLAS Peptide DME1097 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03398 GENEFORM Protein DME1097 XEOTICID XEO03398 MOACRIVE Inhibition DME1097 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1097 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03399 XEO_CLAS Peptide DME1097 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03399 GENEFORM Protein DME1097 XEOTICID XEO03399 MOACRIVE Inhibition DME1097 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1097 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03406 XEO_CLAS Peptide DME1097 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 ug/ml) DME1097 XEOTICID XEO03406 GENEFORM Protein DME1097 XEOTICID XEO03406 MOACRIVE Inhibition DME1097 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1097 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03424 XEO_CLAS Peptide DME1097 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03424 GENEFORM Protein DME1097 XEOTICID XEO03424 MOACRIVE Inhibition DME1097 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1097 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03426 XEO_CLAS Peptide DME1097 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO03426 GENEFORM Protein DME1097 XEOTICID XEO03426 MOACRIVE Inhibition DME1097 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1097 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03427 XEO_CLAS Peptide DME1097 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 microM) DME1097 XEOTICID XEO03427 GENEFORM Protein DME1097 XEOTICID XEO03427 MOACRIVE Inhibition DME1097 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1097 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03428 XEO_CLAS Peptide DME1097 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 ug/ml) DME1097 XEOTICID XEO03428 GENEFORM Protein DME1097 XEOTICID XEO03428 MOACRIVE Inhibition DME1097 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1097 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03430 XEO_CLAS Peptide DME1097 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 ug/ml) DME1097 XEOTICID XEO03430 GENEFORM Protein DME1097 XEOTICID XEO03430 MOACRIVE Inhibition DME1097 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1097 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03434 XEO_CLAS Peptide DME1097 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO03434 GENEFORM Protein DME1097 XEOTICID XEO03434 MOACRIVE Inhibition DME1097 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1097 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03442 XEO_CLAS Peptide DME1097 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 18.75 ug/ml) DME1097 XEOTICID XEO03442 GENEFORM Protein DME1097 XEOTICID XEO03442 MOACRIVE Inhibition DME1097 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1097 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03444 XEO_CLAS Peptide DME1097 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 37.50 ug/ml) DME1097 XEOTICID XEO03444 GENEFORM Protein DME1097 XEOTICID XEO03444 MOACRIVE Inhibition DME1097 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1097 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03459 XEO_CLAS Peptide DME1097 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03459 GENEFORM Protein DME1097 XEOTICID XEO03459 MOACRIVE Inhibition DME1097 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1097 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03460 XEO_CLAS Peptide DME1097 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03460 GENEFORM Protein DME1097 XEOTICID XEO03460 MOACRIVE Inhibition DME1097 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1097 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03461 XEO_CLAS Peptide DME1097 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.05 microM) DME1097 XEOTICID XEO03461 GENEFORM Protein DME1097 XEOTICID XEO03461 MOACRIVE Inhibition DME1097 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1097 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03462 XEO_CLAS Peptide DME1097 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03462 GENEFORM Protein DME1097 XEOTICID XEO03462 MOACRIVE Inhibition DME1097 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1097 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03463 XEO_CLAS Peptide DME1097 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03463 GENEFORM Protein DME1097 XEOTICID XEO03463 MOACRIVE Inhibition DME1097 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1097 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03467 XEO_CLAS Peptide DME1097 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03467 GENEFORM Protein DME1097 XEOTICID XEO03467 MOACRIVE Inhibition DME1097 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1097 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03468 XEO_CLAS Peptide DME1097 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03468 GENEFORM Protein DME1097 XEOTICID XEO03468 MOACRIVE Inhibition DME1097 XEOTICID XEO03471 XEO_NAME Gambicin DME1097 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03471 XEO_CLAS Peptide DME1097 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1097 XEOTICID XEO03471 GENEFORM Protein DME1097 XEOTICID XEO03471 MOACRIVE Inhibition DME1097 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1097 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03485 XEO_CLAS Peptide DME1097 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4.07 ug/ml) DME1097 XEOTICID XEO03485 GENEFORM Protein DME1097 XEOTICID XEO03485 MOACRIVE Inhibition DME1097 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1097 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03486 XEO_CLAS Peptide DME1097 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.80 ug/ml) DME1097 XEOTICID XEO03486 GENEFORM Protein DME1097 XEOTICID XEO03486 MOACRIVE Inhibition DME1097 XEOTICID XEO03488 XEO_NAME GLK-19 DME1097 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03488 XEO_CLAS Peptide DME1097 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO03488 GENEFORM Protein DME1097 XEOTICID XEO03488 MOACRIVE Inhibition DME1097 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1097 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03497 XEO_CLAS Peptide DME1097 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1097 XEOTICID XEO03497 GENEFORM Protein DME1097 XEOTICID XEO03497 MOACRIVE Inhibition DME1097 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1097 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03498 XEO_CLAS Peptide DME1097 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1097 XEOTICID XEO03498 GENEFORM Protein DME1097 XEOTICID XEO03498 MOACRIVE Inhibition DME1097 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1097 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03500 XEO_CLAS Peptide DME1097 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-30 ug/ml) DME1097 XEOTICID XEO03500 GENEFORM Protein DME1097 XEOTICID XEO03500 MOACRIVE Inhibition DME1097 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1097 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03504 XEO_CLAS Peptide DME1097 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 ug/ml) DME1097 XEOTICID XEO03504 GENEFORM Protein DME1097 XEOTICID XEO03504 MOACRIVE Inhibition DME1097 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1097 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03505 XEO_CLAS Peptide DME1097 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 ug/ml) DME1097 XEOTICID XEO03505 GENEFORM Protein DME1097 XEOTICID XEO03505 MOACRIVE Inhibition DME1097 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1097 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03506 XEO_CLAS Peptide DME1097 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 ug/ml) DME1097 XEOTICID XEO03506 GENEFORM Protein DME1097 XEOTICID XEO03506 MOACRIVE Inhibition DME1097 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1097 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03513 XEO_CLAS Peptide DME1097 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO03513 GENEFORM Protein DME1097 XEOTICID XEO03513 MOACRIVE Inhibition DME1097 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1097 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03514 XEO_CLAS Peptide DME1097 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03514 GENEFORM Protein DME1097 XEOTICID XEO03514 MOACRIVE Inhibition DME1097 XEOTICID XEO03519 XEO_NAME Hadrurin DME1097 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03519 XEO_CLAS Peptide DME1097 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03519 GENEFORM Protein DME1097 XEOTICID XEO03519 MOACRIVE Inhibition DME1097 XEOTICID XEO03522 XEO_NAME Halocyntin DME1097 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03522 XEO_CLAS Peptide DME1097 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03522 GENEFORM Protein DME1097 XEOTICID XEO03522 MOACRIVE Inhibition DME1097 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1097 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03524 XEO_CLAS Peptide DME1097 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03524 GENEFORM Protein DME1097 XEOTICID XEO03524 MOACRIVE Inhibition DME1097 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1097 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03525 XEO_CLAS Peptide DME1097 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03525 GENEFORM Protein DME1097 XEOTICID XEO03525 MOACRIVE Inhibition DME1097 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1097 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03530 XEO_CLAS Peptide DME1097 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03530 GENEFORM Protein DME1097 XEOTICID XEO03530 MOACRIVE Inhibition DME1097 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1097 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03535 XEO_CLAS Peptide DME1097 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.4 microM) DME1097 XEOTICID XEO03535 GENEFORM Protein DME1097 XEOTICID XEO03535 MOACRIVE Inhibition DME1097 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1097 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03536 XEO_CLAS Peptide DME1097 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 80 microM) DME1097 XEOTICID XEO03536 GENEFORM Protein DME1097 XEOTICID XEO03536 MOACRIVE Inhibition DME1097 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1097 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03537 XEO_CLAS Peptide DME1097 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 ug/ml) DME1097 XEOTICID XEO03537 GENEFORM Protein DME1097 XEOTICID XEO03537 MOACRIVE Inhibition DME1097 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1097 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03538 XEO_CLAS Peptide DME1097 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 ug/ml) DME1097 XEOTICID XEO03538 GENEFORM Protein DME1097 XEOTICID XEO03538 MOACRIVE Inhibition DME1097 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1097 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03540 XEO_CLAS Peptide DME1097 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO03540 GENEFORM Protein DME1097 XEOTICID XEO03540 MOACRIVE Inhibition DME1097 XEOTICID XEO03542 XEO_NAME Hepcidin DME1097 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03542 XEO_CLAS Peptide DME1097 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 24 microM) DME1097 XEOTICID XEO03542 GENEFORM Protein DME1097 XEOTICID XEO03542 MOACRIVE Inhibition DME1097 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1097 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03544 XEO_CLAS Peptide DME1097 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03544 GENEFORM Protein DME1097 XEOTICID XEO03544 MOACRIVE Inhibition DME1097 XEOTICID XEO03548 XEO_NAME Hesperidin DME1097 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03548 GENEFORM Protein DME1097 XEOTICID XEO03548 MOACRIVE Inhibition DME1097 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1097 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1097 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03552 GENEFORM Protein DME1097 XEOTICID XEO03552 MOACRIVE Inhibition DME1097 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1097 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03556 XEO_CLAS Peptide DME1097 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO03556 GENEFORM Protein DME1097 XEOTICID XEO03556 MOACRIVE Inhibition DME1097 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1097 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03557 XEO_CLAS Peptide DME1097 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO03557 GENEFORM Protein DME1097 XEOTICID XEO03557 MOACRIVE Inhibition DME1097 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1097 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03558 XEO_CLAS Peptide DME1097 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 microM) DME1097 XEOTICID XEO03558 GENEFORM Protein DME1097 XEOTICID XEO03558 MOACRIVE Inhibition DME1097 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1097 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03559 XEO_CLAS Peptide DME1097 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 microM) DME1097 XEOTICID XEO03559 GENEFORM Protein DME1097 XEOTICID XEO03559 MOACRIVE Inhibition DME1097 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1097 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03560 XEO_CLAS Peptide DME1097 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 microM) DME1097 XEOTICID XEO03560 GENEFORM Protein DME1097 XEOTICID XEO03560 MOACRIVE Inhibition DME1097 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1097 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03561 XEO_CLAS Peptide DME1097 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03561 GENEFORM Protein DME1097 XEOTICID XEO03561 MOACRIVE Inhibition DME1097 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1097 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03567 XEO_CLAS Peptide DME1097 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03567 GENEFORM Protein DME1097 XEOTICID XEO03567 MOACRIVE Inhibition DME1097 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1097 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03569 XEO_CLAS Peptide DME1097 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 300 microM) DME1097 XEOTICID XEO03569 GENEFORM Protein DME1097 XEOTICID XEO03569 MOACRIVE Inhibition DME1097 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1097 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03570 XEO_CLAS Peptide DME1097 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03570 GENEFORM Protein DME1097 XEOTICID XEO03570 MOACRIVE Inhibition DME1097 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1097 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03572 XEO_CLAS Peptide DME1097 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1097 XEOTICID XEO03572 GENEFORM Protein DME1097 XEOTICID XEO03572 MOACRIVE Inhibition DME1097 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1097 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03573 XEO_CLAS Peptide DME1097 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 28.1 ug/ml) DME1097 XEOTICID XEO03573 GENEFORM Protein DME1097 XEOTICID XEO03573 MOACRIVE Inhibition DME1097 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1097 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03574 XEO_CLAS Peptide DME1097 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 500 microM) DME1097 XEOTICID XEO03574 GENEFORM Protein DME1097 XEOTICID XEO03574 MOACRIVE Inhibition DME1097 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1097 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03575 XEO_CLAS Peptide DME1097 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 18 microM) DME1097 XEOTICID XEO03575 GENEFORM Protein DME1097 XEOTICID XEO03575 MOACRIVE Inhibition DME1097 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1097 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03576 XEO_CLAS Peptide DME1097 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 750 microM) DME1097 XEOTICID XEO03576 GENEFORM Protein DME1097 XEOTICID XEO03576 MOACRIVE Inhibition DME1097 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1097 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03578 XEO_CLAS Peptide DME1097 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1097 XEOTICID XEO03578 GENEFORM Protein DME1097 XEOTICID XEO03578 MOACRIVE Inhibition DME1097 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1097 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03579 XEO_CLAS Peptide DME1097 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03579 GENEFORM Protein DME1097 XEOTICID XEO03579 MOACRIVE Inhibition DME1097 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1097 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03580 XEO_CLAS Peptide DME1097 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03580 GENEFORM Protein DME1097 XEOTICID XEO03580 MOACRIVE Inhibition DME1097 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1097 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03585 XEO_CLAS Peptide DME1097 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 125 ug/ml) DME1097 XEOTICID XEO03585 GENEFORM Protein DME1097 XEOTICID XEO03585 MOACRIVE Inhibition DME1097 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1097 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03588 XEO_CLAS Peptide DME1097 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 62 ug/ml) DME1097 XEOTICID XEO03588 GENEFORM Protein DME1097 XEOTICID XEO03588 MOACRIVE Inhibition DME1097 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1097 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03589 XEO_CLAS Peptide DME1097 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03589 GENEFORM Protein DME1097 XEOTICID XEO03589 MOACRIVE Inhibition DME1097 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1097 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03590 XEO_CLAS Peptide DME1097 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03590 GENEFORM Protein DME1097 XEOTICID XEO03590 MOACRIVE Inhibition DME1097 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1097 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03591 XEO_CLAS Peptide DME1097 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 37.5 ug/ml) DME1097 XEOTICID XEO03591 GENEFORM Protein DME1097 XEOTICID XEO03591 MOACRIVE Inhibition DME1097 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1097 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03593 XEO_CLAS Peptide DME1097 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 9.4 ug/ml) DME1097 XEOTICID XEO03593 GENEFORM Protein DME1097 XEOTICID XEO03593 MOACRIVE Inhibition DME1097 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1097 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03594 XEO_CLAS Peptide DME1097 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 ug/ml) DME1097 XEOTICID XEO03594 GENEFORM Protein DME1097 XEOTICID XEO03594 MOACRIVE Inhibition DME1097 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1097 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03595 XEO_CLAS Peptide DME1097 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03595 GENEFORM Protein DME1097 XEOTICID XEO03595 MOACRIVE Inhibition DME1097 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1097 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03596 XEO_CLAS Peptide DME1097 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03596 GENEFORM Protein DME1097 XEOTICID XEO03596 MOACRIVE Inhibition DME1097 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1097 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03598 XEO_CLAS Peptide DME1097 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03598 GENEFORM Protein DME1097 XEOTICID XEO03598 MOACRIVE Inhibition DME1097 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1097 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03599 XEO_CLAS Peptide DME1097 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03599 GENEFORM Protein DME1097 XEOTICID XEO03599 MOACRIVE Inhibition DME1097 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1097 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03600 XEO_CLAS Peptide DME1097 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03600 GENEFORM Protein DME1097 XEOTICID XEO03600 MOACRIVE Inhibition DME1097 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1097 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03606 XEO_CLAS Peptide DME1097 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03606 GENEFORM Protein DME1097 XEOTICID XEO03606 MOACRIVE Inhibition DME1097 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1097 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03607 XEO_CLAS Peptide DME1097 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03607 GENEFORM Protein DME1097 XEOTICID XEO03607 MOACRIVE Inhibition DME1097 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1097 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03609 XEO_CLAS Peptide DME1097 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03609 GENEFORM Protein DME1097 XEOTICID XEO03609 MOACRIVE Inhibition DME1097 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1097 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03615 XEO_CLAS Peptide DME1097 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1097 XEOTICID XEO03615 GENEFORM Protein DME1097 XEOTICID XEO03615 MOACRIVE Inhibition DME1097 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1097 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03616 XEO_CLAS Peptide DME1097 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 32 microM) DME1097 XEOTICID XEO03616 GENEFORM Protein DME1097 XEOTICID XEO03616 MOACRIVE Inhibition DME1097 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1097 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03617 XEO_CLAS Peptide DME1097 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40 microM) DME1097 XEOTICID XEO03617 GENEFORM Protein DME1097 XEOTICID XEO03617 MOACRIVE Inhibition DME1097 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1097 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03618 XEO_CLAS Peptide DME1097 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5-1 microM) DME1097 XEOTICID XEO03618 GENEFORM Protein DME1097 XEOTICID XEO03618 MOACRIVE Inhibition DME1097 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1097 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03622 XEO_CLAS Peptide DME1097 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20-40 microM) DME1097 XEOTICID XEO03622 GENEFORM Protein DME1097 XEOTICID XEO03622 MOACRIVE Inhibition DME1097 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1097 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03627 XEO_CLAS Peptide DME1097 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1097 XEOTICID XEO03627 GENEFORM Protein DME1097 XEOTICID XEO03627 MOACRIVE Inhibition DME1097 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1097 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03630 XEO_CLAS Peptide DME1097 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03630 GENEFORM Protein DME1097 XEOTICID XEO03630 MOACRIVE Inhibition DME1097 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1097 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03631 XEO_CLAS Peptide DME1097 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03631 GENEFORM Protein DME1097 XEOTICID XEO03631 MOACRIVE Inhibition DME1097 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1097 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03632 XEO_CLAS Peptide DME1097 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03632 GENEFORM Protein DME1097 XEOTICID XEO03632 MOACRIVE Inhibition DME1097 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1097 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03633 XEO_CLAS Peptide DME1097 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03633 GENEFORM Protein DME1097 XEOTICID XEO03633 MOACRIVE Inhibition DME1097 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1097 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03634 XEO_CLAS Peptide DME1097 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03634 GENEFORM Protein DME1097 XEOTICID XEO03634 MOACRIVE Inhibition DME1097 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1097 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03635 XEO_CLAS Peptide DME1097 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03635 GENEFORM Protein DME1097 XEOTICID XEO03635 MOACRIVE Inhibition DME1097 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1097 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03636 XEO_CLAS Peptide DME1097 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03636 GENEFORM Protein DME1097 XEOTICID XEO03636 MOACRIVE Inhibition DME1097 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1097 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03637 XEO_CLAS Peptide DME1097 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03637 GENEFORM Protein DME1097 XEOTICID XEO03637 MOACRIVE Inhibition DME1097 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1097 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03638 XEO_CLAS Peptide DME1097 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03638 GENEFORM Protein DME1097 XEOTICID XEO03638 MOACRIVE Inhibition DME1097 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1097 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03639 XEO_CLAS Peptide DME1097 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03639 GENEFORM Protein DME1097 XEOTICID XEO03639 MOACRIVE Inhibition DME1097 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1097 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03640 XEO_CLAS Peptide DME1097 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03640 GENEFORM Protein DME1097 XEOTICID XEO03640 MOACRIVE Inhibition DME1097 XEOTICID XEO03644 XEO_NAME Indole DME1097 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1097 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1097 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03644 GENEFORM Protein DME1097 XEOTICID XEO03644 MOACRIVE Inhibition DME1097 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1097 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03650 XEO_CLAS Peptide DME1097 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03650 GENEFORM Protein DME1097 XEOTICID XEO03650 MOACRIVE Inhibition DME1097 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1097 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO03655 XEO_CLAS Natural Product DME1097 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03655 GENEFORM Protein DME1097 XEOTICID XEO03655 MOACRIVE Inhibition DME1097 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1097 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03666 XEO_CLAS Peptide DME1097 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 ug/ml) DME1097 XEOTICID XEO03666 GENEFORM Protein DME1097 XEOTICID XEO03666 MOACRIVE Inhibition DME1097 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1097 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03667 XEO_CLAS Peptide DME1097 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 ug/ml) DME1097 XEOTICID XEO03667 GENEFORM Protein DME1097 XEOTICID XEO03667 MOACRIVE Inhibition DME1097 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1097 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03668 XEO_CLAS Peptide DME1097 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 microM) DME1097 XEOTICID XEO03668 GENEFORM Protein DME1097 XEOTICID XEO03668 MOACRIVE Inhibition DME1097 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1097 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03669 XEO_CLAS Peptide DME1097 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO03669 GENEFORM Protein DME1097 XEOTICID XEO03669 MOACRIVE Inhibition DME1097 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1097 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03670 XEO_CLAS Peptide DME1097 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 microM) DME1097 XEOTICID XEO03670 GENEFORM Protein DME1097 XEOTICID XEO03670 MOACRIVE Inhibition DME1097 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1097 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03672 XEO_CLAS Peptide DME1097 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.5 ug/ml) DME1097 XEOTICID XEO03672 GENEFORM Protein DME1097 XEOTICID XEO03672 MOACRIVE Inhibition DME1097 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1097 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03673 XEO_CLAS Peptide DME1097 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 ug/ml) DME1097 XEOTICID XEO03673 GENEFORM Protein DME1097 XEOTICID XEO03673 MOACRIVE Inhibition DME1097 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1097 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03674 XEO_CLAS Peptide DME1097 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 ug/ml) DME1097 XEOTICID XEO03674 GENEFORM Protein DME1097 XEOTICID XEO03674 MOACRIVE Inhibition DME1097 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1097 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03675 XEO_CLAS Peptide DME1097 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO03675 GENEFORM Protein DME1097 XEOTICID XEO03675 MOACRIVE Inhibition DME1097 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1097 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03678 XEO_CLAS Peptide DME1097 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 ug/ml) DME1097 XEOTICID XEO03678 GENEFORM Protein DME1097 XEOTICID XEO03678 MOACRIVE Inhibition DME1097 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1097 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03679 XEO_CLAS Peptide DME1097 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 ug/ml) DME1097 XEOTICID XEO03679 GENEFORM Protein DME1097 XEOTICID XEO03679 MOACRIVE Inhibition DME1097 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1097 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03681 XEO_CLAS Peptide DME1097 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1097 XEOTICID XEO03681 GENEFORM Protein DME1097 XEOTICID XEO03681 MOACRIVE Inhibition DME1097 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1097 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03684 XEO_CLAS Peptide DME1097 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 ug/ml) DME1097 XEOTICID XEO03684 GENEFORM Protein DME1097 XEOTICID XEO03684 MOACRIVE Inhibition DME1097 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1097 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03694 XEO_CLAS Peptide DME1097 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03694 GENEFORM Protein DME1097 XEOTICID XEO03694 MOACRIVE Inhibition DME1097 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1097 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03697 XEO_CLAS Peptide DME1097 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25 microM) DME1097 XEOTICID XEO03697 GENEFORM Protein DME1097 XEOTICID XEO03697 MOACRIVE Inhibition DME1097 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1097 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03698 XEO_CLAS Peptide DME1097 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03698 GENEFORM Protein DME1097 XEOTICID XEO03698 MOACRIVE Inhibition DME1097 XEOTICID XEO03703 XEO_NAME Kasstasin DME1097 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03703 XEO_CLAS Peptide DME1097 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 110 microM) DME1097 XEOTICID XEO03703 GENEFORM Protein DME1097 XEOTICID XEO03703 MOACRIVE Inhibition DME1097 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1097 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03706 XEO_CLAS Peptide DME1097 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03706 GENEFORM Protein DME1097 XEOTICID XEO03706 MOACRIVE Inhibition DME1097 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1097 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03707 XEO_CLAS Peptide DME1097 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03707 GENEFORM Protein DME1097 XEOTICID XEO03707 MOACRIVE Inhibition DME1097 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1097 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03709 XEO_CLAS Peptide DME1097 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 ug/ml) DME1097 XEOTICID XEO03709 GENEFORM Protein DME1097 XEOTICID XEO03709 MOACRIVE Inhibition DME1097 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1097 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03712 XEO_CLAS Peptide DME1097 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03712 GENEFORM Protein DME1097 XEOTICID XEO03712 MOACRIVE Inhibition DME1097 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1097 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03713 XEO_CLAS Peptide DME1097 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 64 microM) DME1097 XEOTICID XEO03713 GENEFORM Protein DME1097 XEOTICID XEO03713 MOACRIVE Inhibition DME1097 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1097 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03714 XEO_CLAS Peptide DME1097 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03714 GENEFORM Protein DME1097 XEOTICID XEO03714 MOACRIVE Inhibition DME1097 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1097 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03715 XEO_CLAS Peptide DME1097 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 microM) DME1097 XEOTICID XEO03715 GENEFORM Protein DME1097 XEOTICID XEO03715 MOACRIVE Inhibition DME1097 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1097 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03719 XEO_CLAS Peptide DME1097 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 microM) DME1097 XEOTICID XEO03719 GENEFORM Protein DME1097 XEOTICID XEO03719 MOACRIVE Inhibition DME1097 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1097 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03720 XEO_CLAS Peptide DME1097 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 microM) DME1097 XEOTICID XEO03720 GENEFORM Protein DME1097 XEOTICID XEO03720 MOACRIVE Inhibition DME1097 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1097 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03723 XEO_CLAS Peptide DME1097 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 62.36 microM) DME1097 XEOTICID XEO03723 GENEFORM Protein DME1097 XEOTICID XEO03723 MOACRIVE Inhibition DME1097 XEOTICID XEO03724 XEO_NAME L10 peptide DME1097 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03724 XEO_CLAS Peptide DME1097 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.8 microM) DME1097 XEOTICID XEO03724 GENEFORM Protein DME1097 XEOTICID XEO03724 MOACRIVE Inhibition DME1097 XEOTICID XEO03726 XEO_NAME L2 peptide DME1097 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03726 XEO_CLAS Peptide DME1097 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 129.66 microM) DME1097 XEOTICID XEO03726 GENEFORM Protein DME1097 XEOTICID XEO03726 MOACRIVE Inhibition DME1097 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1097 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03727 XEO_CLAS Peptide DME1097 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 80 ug/ml) DME1097 XEOTICID XEO03727 GENEFORM Protein DME1097 XEOTICID XEO03727 MOACRIVE Inhibition DME1097 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1097 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03728 XEO_CLAS Peptide DME1097 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40 ug/ml) DME1097 XEOTICID XEO03728 GENEFORM Protein DME1097 XEOTICID XEO03728 MOACRIVE Inhibition DME1097 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1097 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03729 XEO_CLAS Peptide DME1097 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 80 ug/ml) DME1097 XEOTICID XEO03729 GENEFORM Protein DME1097 XEOTICID XEO03729 MOACRIVE Inhibition DME1097 XEOTICID XEO03730 XEO_NAME L3 peptide DME1097 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03730 XEO_CLAS Peptide DME1097 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64.11 microM) DME1097 XEOTICID XEO03730 GENEFORM Protein DME1097 XEOTICID XEO03730 MOACRIVE Inhibition DME1097 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1097 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03731 XEO_CLAS Peptide DME1097 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40 ug/ml) DME1097 XEOTICID XEO03731 GENEFORM Protein DME1097 XEOTICID XEO03731 MOACRIVE Inhibition DME1097 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1097 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03733 XEO_CLAS Peptide DME1097 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40 ug/ml) DME1097 XEOTICID XEO03733 GENEFORM Protein DME1097 XEOTICID XEO03733 MOACRIVE Inhibition DME1097 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1097 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03734 XEO_CLAS Peptide DME1097 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO03734 GENEFORM Protein DME1097 XEOTICID XEO03734 MOACRIVE Inhibition DME1097 XEOTICID XEO03735 XEO_NAME L4 peptide DME1097 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03735 XEO_CLAS Peptide DME1097 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 31.61 microM) DME1097 XEOTICID XEO03735 GENEFORM Protein DME1097 XEOTICID XEO03735 MOACRIVE Inhibition DME1097 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1097 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03738 XEO_CLAS Peptide DME1097 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 ug/ml) DME1097 XEOTICID XEO03738 GENEFORM Protein DME1097 XEOTICID XEO03738 MOACRIVE Inhibition DME1097 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1097 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03741 XEO_CLAS Peptide DME1097 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40 ug/ml) DME1097 XEOTICID XEO03741 GENEFORM Protein DME1097 XEOTICID XEO03741 MOACRIVE Inhibition DME1097 XEOTICID XEO03742 XEO_NAME L5 peptide DME1097 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03742 XEO_CLAS Peptide DME1097 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 7.79 microM) DME1097 XEOTICID XEO03742 GENEFORM Protein DME1097 XEOTICID XEO03742 MOACRIVE Inhibition DME1097 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1097 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03743 XEO_CLAS Peptide DME1097 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 ug/ml) DME1097 XEOTICID XEO03743 GENEFORM Protein DME1097 XEOTICID XEO03743 MOACRIVE Inhibition DME1097 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1097 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03744 XEO_CLAS Peptide DME1097 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 ug/ml) DME1097 XEOTICID XEO03744 GENEFORM Protein DME1097 XEOTICID XEO03744 MOACRIVE Inhibition DME1097 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1097 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03745 XEO_CLAS Peptide DME1097 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 ug/ml) DME1097 XEOTICID XEO03745 GENEFORM Protein DME1097 XEOTICID XEO03745 MOACRIVE Inhibition DME1097 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1097 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03746 XEO_CLAS Peptide DME1097 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO03746 GENEFORM Protein DME1097 XEOTICID XEO03746 MOACRIVE Inhibition DME1097 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1097 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03747 XEO_CLAS Peptide DME1097 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO03747 GENEFORM Protein DME1097 XEOTICID XEO03747 MOACRIVE Inhibition DME1097 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1097 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03748 XEO_CLAS Peptide DME1097 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO03748 GENEFORM Protein DME1097 XEOTICID XEO03748 MOACRIVE Inhibition DME1097 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1097 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03749 XEO_CLAS Peptide DME1097 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO03749 GENEFORM Protein DME1097 XEOTICID XEO03749 MOACRIVE Inhibition DME1097 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1097 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03750 XEO_CLAS Peptide DME1097 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO03750 GENEFORM Protein DME1097 XEOTICID XEO03750 MOACRIVE Inhibition DME1097 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1097 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03751 XEO_CLAS Peptide DME1097 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO03751 GENEFORM Protein DME1097 XEOTICID XEO03751 MOACRIVE Inhibition DME1097 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1097 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03752 XEO_CLAS Peptide DME1097 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO03752 GENEFORM Protein DME1097 XEOTICID XEO03752 MOACRIVE Inhibition DME1097 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1097 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03753 XEO_CLAS Peptide DME1097 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 ug/ml) DME1097 XEOTICID XEO03753 GENEFORM Protein DME1097 XEOTICID XEO03753 MOACRIVE Inhibition DME1097 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1097 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03754 XEO_CLAS Peptide DME1097 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO03754 GENEFORM Protein DME1097 XEOTICID XEO03754 MOACRIVE Inhibition DME1097 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1097 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03755 XEO_CLAS Peptide DME1097 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO03755 GENEFORM Protein DME1097 XEOTICID XEO03755 MOACRIVE Inhibition DME1097 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1097 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03756 XEO_CLAS Peptide DME1097 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO03756 GENEFORM Protein DME1097 XEOTICID XEO03756 MOACRIVE Inhibition DME1097 XEOTICID XEO03757 XEO_NAME L6 peptide DME1097 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03757 XEO_CLAS Peptide DME1097 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15.17 microM) DME1097 XEOTICID XEO03757 GENEFORM Protein DME1097 XEOTICID XEO03757 MOACRIVE Inhibition DME1097 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1097 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03758 XEO_CLAS Peptide DME1097 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 80 ug/ml) DME1097 XEOTICID XEO03758 GENEFORM Protein DME1097 XEOTICID XEO03758 MOACRIVE Inhibition DME1097 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1097 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03759 XEO_CLAS Peptide DME1097 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.3 ug/ml) DME1097 XEOTICID XEO03759 GENEFORM Protein DME1097 XEOTICID XEO03759 MOACRIVE Inhibition DME1097 XEOTICID XEO03760 XEO_NAME L7 peptide DME1097 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03760 XEO_CLAS Peptide DME1097 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16.02 microM) DME1097 XEOTICID XEO03760 GENEFORM Protein DME1097 XEOTICID XEO03760 MOACRIVE Inhibition DME1097 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1097 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03761 XEO_CLAS Peptide DME1097 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 ug/ml) DME1097 XEOTICID XEO03761 GENEFORM Protein DME1097 XEOTICID XEO03761 MOACRIVE Inhibition DME1097 XEOTICID XEO03763 XEO_NAME L8 peptide DME1097 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03763 XEO_CLAS Peptide DME1097 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.71 microM) DME1097 XEOTICID XEO03763 GENEFORM Protein DME1097 XEOTICID XEO03763 MOACRIVE Inhibition DME1097 XEOTICID XEO03765 XEO_NAME L9 peptide DME1097 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03765 XEO_CLAS Peptide DME1097 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.78 microM) DME1097 XEOTICID XEO03765 GENEFORM Protein DME1097 XEOTICID XEO03765 MOACRIVE Inhibition DME1097 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1097 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03775 XEO_CLAS Peptide DME1097 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 17.3 microM) DME1097 XEOTICID XEO03775 GENEFORM Protein DME1097 XEOTICID XEO03775 MOACRIVE Inhibition DME1097 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1097 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03776 XEO_CLAS Peptide DME1097 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03776 GENEFORM Protein DME1097 XEOTICID XEO03776 MOACRIVE Inhibition DME1097 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1097 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03781 XEO_CLAS Peptide DME1097 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.47 microM) DME1097 XEOTICID XEO03781 GENEFORM Protein DME1097 XEOTICID XEO03781 MOACRIVE Inhibition DME1097 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1097 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03782 XEO_CLAS Peptide DME1097 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.47 microM) DME1097 XEOTICID XEO03782 GENEFORM Protein DME1097 XEOTICID XEO03782 MOACRIVE Inhibition DME1097 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1097 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03783 XEO_CLAS Peptide DME1097 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.68 microM) DME1097 XEOTICID XEO03783 GENEFORM Protein DME1097 XEOTICID XEO03783 MOACRIVE Inhibition DME1097 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1097 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03784 XEO_CLAS Peptide DME1097 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.45 microM) DME1097 XEOTICID XEO03784 GENEFORM Protein DME1097 XEOTICID XEO03784 MOACRIVE Inhibition DME1097 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1097 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03785 XEO_CLAS Peptide DME1097 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.73 microM) DME1097 XEOTICID XEO03785 GENEFORM Protein DME1097 XEOTICID XEO03785 MOACRIVE Inhibition DME1097 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1097 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03786 XEO_CLAS Peptide DME1097 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.45 microM) DME1097 XEOTICID XEO03786 GENEFORM Protein DME1097 XEOTICID XEO03786 MOACRIVE Inhibition DME1097 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1097 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03787 XEO_CLAS Peptide DME1097 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.38 microM) DME1097 XEOTICID XEO03787 GENEFORM Protein DME1097 XEOTICID XEO03787 MOACRIVE Inhibition DME1097 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1097 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03788 XEO_CLAS Peptide DME1097 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.46 microM) DME1097 XEOTICID XEO03788 GENEFORM Protein DME1097 XEOTICID XEO03788 MOACRIVE Inhibition DME1097 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1097 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03789 XEO_CLAS Peptide DME1097 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 13.05 microM) DME1097 XEOTICID XEO03789 GENEFORM Protein DME1097 XEOTICID XEO03789 MOACRIVE Inhibition DME1097 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1097 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03790 XEO_CLAS Peptide DME1097 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.82 microM) DME1097 XEOTICID XEO03790 GENEFORM Protein DME1097 XEOTICID XEO03790 MOACRIVE Inhibition DME1097 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1097 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03791 XEO_CLAS Peptide DME1097 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.80 microM) DME1097 XEOTICID XEO03791 GENEFORM Protein DME1097 XEOTICID XEO03791 MOACRIVE Inhibition DME1097 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1097 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03792 XEO_CLAS Peptide DME1097 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.26 microM) DME1097 XEOTICID XEO03792 GENEFORM Protein DME1097 XEOTICID XEO03792 MOACRIVE Inhibition DME1097 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1097 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03793 XEO_CLAS Peptide DME1097 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 microM) DME1097 XEOTICID XEO03793 GENEFORM Protein DME1097 XEOTICID XEO03793 MOACRIVE Inhibition DME1097 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1097 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03797 XEO_CLAS Peptide DME1097 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.4 microM) DME1097 XEOTICID XEO03797 GENEFORM Protein DME1097 XEOTICID XEO03797 MOACRIVE Inhibition DME1097 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1097 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03798 XEO_CLAS Peptide DME1097 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03798 GENEFORM Protein DME1097 XEOTICID XEO03798 MOACRIVE Inhibition DME1097 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1097 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03799 XEO_CLAS Peptide DME1097 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03799 GENEFORM Protein DME1097 XEOTICID XEO03799 MOACRIVE Inhibition DME1097 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1097 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03810 XEO_CLAS Peptide DME1097 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03810 GENEFORM Protein DME1097 XEOTICID XEO03810 MOACRIVE Inhibition DME1097 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1097 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03846 XEO_CLAS Peptide DME1097 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03846 GENEFORM Protein DME1097 XEOTICID XEO03846 MOACRIVE Inhibition DME1097 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1097 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03847 XEO_CLAS Peptide DME1097 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03847 GENEFORM Protein DME1097 XEOTICID XEO03847 MOACRIVE Inhibition DME1097 XEOTICID XEO03850 XEO_NAME Lemon DME1097 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1097 XEOTICID XEO03850 XEO_CLAS Food Additive DME1097 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03850 GENEFORM Protein DME1097 XEOTICID XEO03850 MOACRIVE Inhibition DME1097 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1097 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03853 XEO_CLAS Peptide DME1097 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO03853 GENEFORM Protein DME1097 XEOTICID XEO03853 MOACRIVE Inhibition DME1097 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1097 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03857 XEO_CLAS Peptide DME1097 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 38.49 microM) DME1097 XEOTICID XEO03857 GENEFORM Protein DME1097 XEOTICID XEO03857 MOACRIVE Inhibition DME1097 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1097 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03860 XEO_CLAS Peptide DME1097 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 24 microM) DME1097 XEOTICID XEO03860 GENEFORM Protein DME1097 XEOTICID XEO03860 MOACRIVE Inhibition DME1097 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1097 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03861 XEO_CLAS Peptide DME1097 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 35 microM) DME1097 XEOTICID XEO03861 GENEFORM Protein DME1097 XEOTICID XEO03861 MOACRIVE Inhibition DME1097 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1097 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03862 XEO_CLAS Peptide DME1097 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 70 microM) DME1097 XEOTICID XEO03862 GENEFORM Protein DME1097 XEOTICID XEO03862 MOACRIVE Inhibition DME1097 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1097 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03863 XEO_CLAS Peptide DME1097 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 35 microM) DME1097 XEOTICID XEO03863 GENEFORM Protein DME1097 XEOTICID XEO03863 MOACRIVE Inhibition DME1097 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1097 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03864 XEO_CLAS Peptide DME1097 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO03864 GENEFORM Protein DME1097 XEOTICID XEO03864 MOACRIVE Inhibition DME1097 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1097 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03865 XEO_CLAS Peptide DME1097 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO03865 GENEFORM Protein DME1097 XEOTICID XEO03865 MOACRIVE Inhibition DME1097 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1097 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03866 XEO_CLAS Peptide DME1097 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 microM) DME1097 XEOTICID XEO03866 GENEFORM Protein DME1097 XEOTICID XEO03866 MOACRIVE Inhibition DME1097 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1097 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03867 XEO_CLAS Peptide DME1097 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40 microM) DME1097 XEOTICID XEO03867 GENEFORM Protein DME1097 XEOTICID XEO03867 MOACRIVE Inhibition DME1097 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1097 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03868 XEO_CLAS Peptide DME1097 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 51 microM) DME1097 XEOTICID XEO03868 GENEFORM Protein DME1097 XEOTICID XEO03868 MOACRIVE Inhibition DME1097 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1097 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03869 XEO_CLAS Peptide DME1097 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 35 microM) DME1097 XEOTICID XEO03869 GENEFORM Protein DME1097 XEOTICID XEO03869 MOACRIVE Inhibition DME1097 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1097 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03870 XEO_CLAS Peptide DME1097 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 61 microM) DME1097 XEOTICID XEO03870 GENEFORM Protein DME1097 XEOTICID XEO03870 MOACRIVE Inhibition DME1097 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1097 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03871 XEO_CLAS Peptide DME1097 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 microM) DME1097 XEOTICID XEO03871 GENEFORM Protein DME1097 XEOTICID XEO03871 MOACRIVE Inhibition DME1097 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1097 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03872 XEO_CLAS Peptide DME1097 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 28 microM) DME1097 XEOTICID XEO03872 GENEFORM Protein DME1097 XEOTICID XEO03872 MOACRIVE Inhibition DME1097 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1097 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03873 XEO_CLAS Peptide DME1097 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 22.5 microM) DME1097 XEOTICID XEO03873 GENEFORM Protein DME1097 XEOTICID XEO03873 MOACRIVE Inhibition DME1097 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1097 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03874 XEO_CLAS Peptide DME1097 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 11.25 microM) DME1097 XEOTICID XEO03874 GENEFORM Protein DME1097 XEOTICID XEO03874 MOACRIVE Inhibition DME1097 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1097 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03875 XEO_CLAS Peptide DME1097 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 microM) DME1097 XEOTICID XEO03875 GENEFORM Protein DME1097 XEOTICID XEO03875 MOACRIVE Inhibition DME1097 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1097 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03876 XEO_CLAS Peptide DME1097 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.75 microM) DME1097 XEOTICID XEO03876 GENEFORM Protein DME1097 XEOTICID XEO03876 MOACRIVE Inhibition DME1097 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1097 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03877 XEO_CLAS Peptide DME1097 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 microM) DME1097 XEOTICID XEO03877 GENEFORM Protein DME1097 XEOTICID XEO03877 MOACRIVE Inhibition DME1097 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1097 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03878 XEO_CLAS Peptide DME1097 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 microM) DME1097 XEOTICID XEO03878 GENEFORM Protein DME1097 XEOTICID XEO03878 MOACRIVE Inhibition DME1097 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1097 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03879 XEO_CLAS Peptide DME1097 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 252 microM) DME1097 XEOTICID XEO03879 GENEFORM Protein DME1097 XEOTICID XEO03879 MOACRIVE Inhibition DME1097 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1097 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03880 XEO_CLAS Peptide DME1097 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 174 microM) DME1097 XEOTICID XEO03880 GENEFORM Protein DME1097 XEOTICID XEO03880 MOACRIVE Inhibition DME1097 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1097 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03883 XEO_CLAS Peptide DME1097 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 74 microM) DME1097 XEOTICID XEO03883 GENEFORM Protein DME1097 XEOTICID XEO03883 MOACRIVE Inhibition DME1097 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1097 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03884 XEO_CLAS Peptide DME1097 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 31 microM) DME1097 XEOTICID XEO03884 GENEFORM Protein DME1097 XEOTICID XEO03884 MOACRIVE Inhibition DME1097 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1097 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03885 XEO_CLAS Peptide DME1097 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO03885 GENEFORM Protein DME1097 XEOTICID XEO03885 MOACRIVE Inhibition DME1097 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1097 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03886 XEO_CLAS Peptide DME1097 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 391 microM) DME1097 XEOTICID XEO03886 GENEFORM Protein DME1097 XEOTICID XEO03886 MOACRIVE Inhibition DME1097 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1097 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03887 XEO_CLAS Peptide DME1097 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 151 microM) DME1097 XEOTICID XEO03887 GENEFORM Protein DME1097 XEOTICID XEO03887 MOACRIVE Inhibition DME1097 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1097 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03888 XEO_CLAS Peptide DME1097 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 134 microM) DME1097 XEOTICID XEO03888 GENEFORM Protein DME1097 XEOTICID XEO03888 MOACRIVE Inhibition DME1097 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1097 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03889 XEO_CLAS Peptide DME1097 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 88 microM) DME1097 XEOTICID XEO03889 GENEFORM Protein DME1097 XEOTICID XEO03889 MOACRIVE Inhibition DME1097 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1097 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03890 XEO_CLAS Peptide DME1097 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 31 microM) DME1097 XEOTICID XEO03890 GENEFORM Protein DME1097 XEOTICID XEO03890 MOACRIVE Inhibition DME1097 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1097 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03891 XEO_CLAS Peptide DME1097 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 microM) DME1097 XEOTICID XEO03891 GENEFORM Protein DME1097 XEOTICID XEO03891 MOACRIVE Inhibition DME1097 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1097 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03892 XEO_CLAS Peptide DME1097 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 37 microM) DME1097 XEOTICID XEO03892 GENEFORM Protein DME1097 XEOTICID XEO03892 MOACRIVE Inhibition DME1097 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1097 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03893 XEO_CLAS Peptide DME1097 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 19 microM) DME1097 XEOTICID XEO03893 GENEFORM Protein DME1097 XEOTICID XEO03893 MOACRIVE Inhibition DME1097 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1097 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03894 XEO_CLAS Peptide DME1097 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO03894 GENEFORM Protein DME1097 XEOTICID XEO03894 MOACRIVE Inhibition DME1097 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1097 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03895 XEO_CLAS Peptide DME1097 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO03895 GENEFORM Protein DME1097 XEOTICID XEO03895 MOACRIVE Inhibition DME1097 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1097 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03896 XEO_CLAS Peptide DME1097 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 microM) DME1097 XEOTICID XEO03896 GENEFORM Protein DME1097 XEOTICID XEO03896 MOACRIVE Inhibition DME1097 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1097 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03897 XEO_CLAS Peptide DME1097 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 63 microM) DME1097 XEOTICID XEO03897 GENEFORM Protein DME1097 XEOTICID XEO03897 MOACRIVE Inhibition DME1097 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1097 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03898 XEO_CLAS Peptide DME1097 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 219 microM) DME1097 XEOTICID XEO03898 GENEFORM Protein DME1097 XEOTICID XEO03898 MOACRIVE Inhibition DME1097 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1097 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03901 XEO_CLAS Peptide DME1097 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 35 microM) DME1097 XEOTICID XEO03901 GENEFORM Protein DME1097 XEOTICID XEO03901 MOACRIVE Inhibition DME1097 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1097 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03902 XEO_CLAS Peptide DME1097 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 70 microM) DME1097 XEOTICID XEO03902 GENEFORM Protein DME1097 XEOTICID XEO03902 MOACRIVE Inhibition DME1097 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1097 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03904 XEO_CLAS Peptide DME1097 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO03904 GENEFORM Protein DME1097 XEOTICID XEO03904 MOACRIVE Inhibition DME1097 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1097 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03905 XEO_CLAS Peptide DME1097 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO03905 GENEFORM Protein DME1097 XEOTICID XEO03905 MOACRIVE Inhibition DME1097 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1097 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03908 XEO_CLAS Peptide DME1097 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03908 GENEFORM Protein DME1097 XEOTICID XEO03908 MOACRIVE Inhibition DME1097 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1097 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03915 XEO_CLAS Peptide DME1097 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03915 GENEFORM Protein DME1097 XEOTICID XEO03915 MOACRIVE Inhibition DME1097 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1097 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03916 XEO_CLAS Peptide DME1097 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.8 ug/ml) DME1097 XEOTICID XEO03916 GENEFORM Protein DME1097 XEOTICID XEO03916 MOACRIVE Inhibition DME1097 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1097 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03917 XEO_CLAS Peptide DME1097 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 13.1 ug/ml) DME1097 XEOTICID XEO03917 GENEFORM Protein DME1097 XEOTICID XEO03917 MOACRIVE Inhibition DME1097 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1097 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03918 XEO_CLAS Peptide DME1097 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.5 ug/ml) DME1097 XEOTICID XEO03918 GENEFORM Protein DME1097 XEOTICID XEO03918 MOACRIVE Inhibition DME1097 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1097 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03919 XEO_CLAS Peptide DME1097 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 80 ug/ml) DME1097 XEOTICID XEO03919 GENEFORM Protein DME1097 XEOTICID XEO03919 MOACRIVE Inhibition DME1097 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1097 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03922 XEO_CLAS Peptide DME1097 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 9 microM) DME1097 XEOTICID XEO03922 GENEFORM Protein DME1097 XEOTICID XEO03922 MOACRIVE Inhibition DME1097 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1097 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03923 XEO_CLAS Peptide DME1097 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 80 microM) DME1097 XEOTICID XEO03923 GENEFORM Protein DME1097 XEOTICID XEO03923 MOACRIVE Inhibition DME1097 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1097 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03924 XEO_CLAS Peptide DME1097 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO03924 GENEFORM Protein DME1097 XEOTICID XEO03924 MOACRIVE Inhibition DME1097 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1097 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03927 XEO_CLAS Peptide DME1097 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 80 microM) DME1097 XEOTICID XEO03927 GENEFORM Protein DME1097 XEOTICID XEO03927 MOACRIVE Inhibition DME1097 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1097 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03928 XEO_CLAS Peptide DME1097 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 microM) DME1097 XEOTICID XEO03928 GENEFORM Protein DME1097 XEOTICID XEO03928 MOACRIVE Inhibition DME1097 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1097 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03929 XEO_CLAS Peptide DME1097 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 microM) DME1097 XEOTICID XEO03929 GENEFORM Protein DME1097 XEOTICID XEO03929 MOACRIVE Inhibition DME1097 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1097 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03930 XEO_CLAS Peptide DME1097 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 microM) DME1097 XEOTICID XEO03930 GENEFORM Protein DME1097 XEOTICID XEO03930 MOACRIVE Inhibition DME1097 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1097 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03931 XEO_CLAS Peptide DME1097 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 microM) DME1097 XEOTICID XEO03931 GENEFORM Protein DME1097 XEOTICID XEO03931 MOACRIVE Inhibition DME1097 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1097 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03933 XEO_CLAS Peptide DME1097 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.5 microM) DME1097 XEOTICID XEO03933 GENEFORM Protein DME1097 XEOTICID XEO03933 MOACRIVE Inhibition DME1097 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1097 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03934 XEO_CLAS Peptide DME1097 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.7 microM) DME1097 XEOTICID XEO03934 GENEFORM Protein DME1097 XEOTICID XEO03934 MOACRIVE Inhibition DME1097 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1097 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03935 XEO_CLAS Peptide DME1097 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.7 microM) DME1097 XEOTICID XEO03935 GENEFORM Protein DME1097 XEOTICID XEO03935 MOACRIVE Inhibition DME1097 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1097 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03936 XEO_CLAS Peptide DME1097 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.0 microM) DME1097 XEOTICID XEO03936 GENEFORM Protein DME1097 XEOTICID XEO03936 MOACRIVE Inhibition DME1097 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1097 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03937 XEO_CLAS Peptide DME1097 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.1 microM) DME1097 XEOTICID XEO03937 GENEFORM Protein DME1097 XEOTICID XEO03937 MOACRIVE Inhibition DME1097 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1097 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03938 XEO_CLAS Peptide DME1097 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.7 microM) DME1097 XEOTICID XEO03938 GENEFORM Protein DME1097 XEOTICID XEO03938 MOACRIVE Inhibition DME1097 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1097 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03939 XEO_CLAS Peptide DME1097 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.7 microM) DME1097 XEOTICID XEO03939 GENEFORM Protein DME1097 XEOTICID XEO03939 MOACRIVE Inhibition DME1097 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1097 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03940 XEO_CLAS Peptide DME1097 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.5 microM) DME1097 XEOTICID XEO03940 GENEFORM Protein DME1097 XEOTICID XEO03940 MOACRIVE Inhibition DME1097 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1097 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03941 XEO_CLAS Peptide DME1097 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.4 microM) DME1097 XEOTICID XEO03941 GENEFORM Protein DME1097 XEOTICID XEO03941 MOACRIVE Inhibition DME1097 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1097 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03943 XEO_CLAS Peptide DME1097 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.4 microM) DME1097 XEOTICID XEO03943 GENEFORM Protein DME1097 XEOTICID XEO03943 MOACRIVE Inhibition DME1097 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1097 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03944 XEO_CLAS Peptide DME1097 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.7 microM) DME1097 XEOTICID XEO03944 GENEFORM Protein DME1097 XEOTICID XEO03944 MOACRIVE Inhibition DME1097 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1097 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03945 XEO_CLAS Peptide DME1097 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.2 microM) DME1097 XEOTICID XEO03945 GENEFORM Protein DME1097 XEOTICID XEO03945 MOACRIVE Inhibition DME1097 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1097 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03947 XEO_CLAS Peptide DME1097 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.0 microM) DME1097 XEOTICID XEO03947 GENEFORM Protein DME1097 XEOTICID XEO03947 MOACRIVE Inhibition DME1097 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1097 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03948 XEO_CLAS Peptide DME1097 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 23.3 microM) DME1097 XEOTICID XEO03948 GENEFORM Protein DME1097 XEOTICID XEO03948 MOACRIVE Inhibition DME1097 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1097 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03950 XEO_CLAS Peptide DME1097 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4.4 microM) DME1097 XEOTICID XEO03950 GENEFORM Protein DME1097 XEOTICID XEO03950 MOACRIVE Inhibition DME1097 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1097 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03951 XEO_CLAS Peptide DME1097 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8.8 microM) DME1097 XEOTICID XEO03951 GENEFORM Protein DME1097 XEOTICID XEO03951 MOACRIVE Inhibition DME1097 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1097 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03952 XEO_CLAS Peptide DME1097 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.2 microM) DME1097 XEOTICID XEO03952 GENEFORM Protein DME1097 XEOTICID XEO03952 MOACRIVE Inhibition DME1097 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1097 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03953 XEO_CLAS Peptide DME1097 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 microM) DME1097 XEOTICID XEO03953 GENEFORM Protein DME1097 XEOTICID XEO03953 MOACRIVE Inhibition DME1097 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1097 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03958 XEO_CLAS Peptide DME1097 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03958 GENEFORM Protein DME1097 XEOTICID XEO03958 MOACRIVE Inhibition DME1097 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1097 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03965 XEO_CLAS Peptide DME1097 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 128 microM) DME1097 XEOTICID XEO03965 GENEFORM Protein DME1097 XEOTICID XEO03965 MOACRIVE Inhibition DME1097 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1097 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03966 XEO_CLAS Peptide DME1097 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 microM) DME1097 XEOTICID XEO03966 GENEFORM Protein DME1097 XEOTICID XEO03966 MOACRIVE Inhibition DME1097 XEOTICID XEO03971 XEO_NAME Lumbrican DME1097 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03971 XEO_CLAS Peptide DME1097 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03971 GENEFORM Protein DME1097 XEOTICID XEO03971 MOACRIVE Inhibition DME1097 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1097 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03972 XEO_CLAS Peptide DME1097 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO03972 GENEFORM Protein DME1097 XEOTICID XEO03972 MOACRIVE Inhibition DME1097 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1097 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03980 XEO_CLAS Peptide DME1097 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 32 microM) DME1097 XEOTICID XEO03980 GENEFORM Protein DME1097 XEOTICID XEO03980 MOACRIVE Inhibition DME1097 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1097 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03985 XEO_CLAS Peptide DME1097 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 ug/ml) DME1097 XEOTICID XEO03985 GENEFORM Protein DME1097 XEOTICID XEO03985 MOACRIVE Inhibition DME1097 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1097 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03991 XEO_CLAS Peptide DME1097 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03991 GENEFORM Protein DME1097 XEOTICID XEO03991 MOACRIVE Inhibition DME1097 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1097 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03992 XEO_CLAS Peptide DME1097 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03992 GENEFORM Protein DME1097 XEOTICID XEO03992 MOACRIVE Inhibition DME1097 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1097 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03993 XEO_CLAS Peptide DME1097 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03993 GENEFORM Protein DME1097 XEOTICID XEO03993 MOACRIVE Inhibition DME1097 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1097 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03994 XEO_CLAS Peptide DME1097 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO03994 GENEFORM Protein DME1097 XEOTICID XEO03994 MOACRIVE Inhibition DME1097 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1097 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03996 XEO_CLAS Peptide DME1097 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 65 microM) DME1097 XEOTICID XEO03996 GENEFORM Protein DME1097 XEOTICID XEO03996 MOACRIVE Inhibition DME1097 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1097 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03997 XEO_CLAS Peptide DME1097 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 7.5 microM) DME1097 XEOTICID XEO03997 GENEFORM Protein DME1097 XEOTICID XEO03997 MOACRIVE Inhibition DME1097 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1097 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03998 XEO_CLAS Peptide DME1097 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15.5 microM) DME1097 XEOTICID XEO03998 GENEFORM Protein DME1097 XEOTICID XEO03998 MOACRIVE Inhibition DME1097 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1097 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO03999 XEO_CLAS Peptide DME1097 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25.8 microM) DME1097 XEOTICID XEO03999 GENEFORM Protein DME1097 XEOTICID XEO03999 MOACRIVE Inhibition DME1097 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1097 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04000 XEO_CLAS Peptide DME1097 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO04000 GENEFORM Protein DME1097 XEOTICID XEO04000 MOACRIVE Inhibition DME1097 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1097 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04001 XEO_CLAS Peptide DME1097 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO04001 GENEFORM Protein DME1097 XEOTICID XEO04001 MOACRIVE Inhibition DME1097 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1097 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04002 XEO_CLAS Peptide DME1097 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 7.5 ug/ml) DME1097 XEOTICID XEO04002 GENEFORM Protein DME1097 XEOTICID XEO04002 MOACRIVE Inhibition DME1097 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1097 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04003 XEO_CLAS Peptide DME1097 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 ug/ml) DME1097 XEOTICID XEO04003 GENEFORM Protein DME1097 XEOTICID XEO04003 MOACRIVE Inhibition DME1097 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1097 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04004 XEO_CLAS Peptide DME1097 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.0 ug/ml) DME1097 XEOTICID XEO04004 GENEFORM Protein DME1097 XEOTICID XEO04004 MOACRIVE Inhibition DME1097 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1097 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04005 XEO_CLAS Peptide DME1097 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.0 ug/ml) DME1097 XEOTICID XEO04005 GENEFORM Protein DME1097 XEOTICID XEO04005 MOACRIVE Inhibition DME1097 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1097 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04007 XEO_CLAS Peptide DME1097 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 19.5 ug/ml) DME1097 XEOTICID XEO04007 GENEFORM Protein DME1097 XEOTICID XEO04007 MOACRIVE Inhibition DME1097 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1097 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04011 XEO_CLAS Peptide DME1097 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 19.5 ug/ml) DME1097 XEOTICID XEO04011 GENEFORM Protein DME1097 XEOTICID XEO04011 MOACRIVE Inhibition DME1097 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1097 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04012 XEO_CLAS Peptide DME1097 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.9 ug/ml) DME1097 XEOTICID XEO04012 GENEFORM Protein DME1097 XEOTICID XEO04012 MOACRIVE Inhibition DME1097 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1097 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04013 XEO_CLAS Peptide DME1097 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.7 ug/ml) DME1097 XEOTICID XEO04013 GENEFORM Protein DME1097 XEOTICID XEO04013 MOACRIVE Inhibition DME1097 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1097 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04018 XEO_CLAS Peptide DME1097 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 9 ug/ml) DME1097 XEOTICID XEO04018 GENEFORM Protein DME1097 XEOTICID XEO04018 MOACRIVE Inhibition DME1097 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1097 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04026 XEO_CLAS Peptide DME1097 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO04026 GENEFORM Protein DME1097 XEOTICID XEO04026 MOACRIVE Inhibition DME1097 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1097 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04027 XEO_CLAS Peptide DME1097 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO04027 GENEFORM Protein DME1097 XEOTICID XEO04027 MOACRIVE Inhibition DME1097 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1097 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04028 XEO_CLAS Peptide DME1097 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 ug/ml) DME1097 XEOTICID XEO04028 GENEFORM Protein DME1097 XEOTICID XEO04028 MOACRIVE Inhibition DME1097 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1097 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04038 XEO_CLAS Peptide DME1097 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04038 GENEFORM Protein DME1097 XEOTICID XEO04038 MOACRIVE Inhibition DME1097 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1097 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04039 XEO_CLAS Peptide DME1097 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 microM) DME1097 XEOTICID XEO04039 GENEFORM Protein DME1097 XEOTICID XEO04039 MOACRIVE Inhibition DME1097 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1097 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04051 XEO_CLAS Peptide DME1097 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1097 XEOTICID XEO04051 GENEFORM Protein DME1097 XEOTICID XEO04051 MOACRIVE Inhibition DME1097 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1097 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04052 XEO_CLAS Peptide DME1097 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04052 GENEFORM Protein DME1097 XEOTICID XEO04052 MOACRIVE Inhibition DME1097 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1097 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04053 XEO_CLAS Peptide DME1097 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.08-0.16 microM) DME1097 XEOTICID XEO04053 GENEFORM Protein DME1097 XEOTICID XEO04053 MOACRIVE Inhibition DME1097 XEOTICID XEO04055 XEO_NAME Melectin DME1097 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04055 XEO_CLAS Peptide DME1097 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.0 microM) DME1097 XEOTICID XEO04055 GENEFORM Protein DME1097 XEOTICID XEO04055 MOACRIVE Inhibition DME1097 XEOTICID XEO04057 XEO_NAME Melittin DME1097 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04057 XEO_CLAS Peptide DME1097 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.8 microM) DME1097 XEOTICID XEO04057 GENEFORM Protein DME1097 XEOTICID XEO04057 MOACRIVE Inhibition DME1097 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1097 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04061 XEO_CLAS Peptide DME1097 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.9 microM) DME1097 XEOTICID XEO04061 GENEFORM Protein DME1097 XEOTICID XEO04061 MOACRIVE Inhibition DME1097 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1097 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04062 XEO_CLAS Peptide DME1097 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.5 microM) DME1097 XEOTICID XEO04062 GENEFORM Protein DME1097 XEOTICID XEO04062 MOACRIVE Inhibition DME1097 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1097 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04063 XEO_CLAS Peptide DME1097 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 7.8 microM) DME1097 XEOTICID XEO04063 GENEFORM Protein DME1097 XEOTICID XEO04063 MOACRIVE Inhibition DME1097 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1097 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04064 XEO_CLAS Peptide DME1097 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 46.7 microM) DME1097 XEOTICID XEO04064 GENEFORM Protein DME1097 XEOTICID XEO04064 MOACRIVE Inhibition DME1097 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1097 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04066 XEO_CLAS Peptide DME1097 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16.3 microM) DME1097 XEOTICID XEO04066 GENEFORM Protein DME1097 XEOTICID XEO04066 MOACRIVE Inhibition DME1097 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1097 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04067 XEO_CLAS Peptide DME1097 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.6 microM) DME1097 XEOTICID XEO04067 GENEFORM Protein DME1097 XEOTICID XEO04067 MOACRIVE Inhibition DME1097 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1097 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04068 XEO_CLAS Peptide DME1097 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.6 microM) DME1097 XEOTICID XEO04068 GENEFORM Protein DME1097 XEOTICID XEO04068 MOACRIVE Inhibition DME1097 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1097 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04086 GENEFORM Protein DME1097 XEOTICID XEO04086 MOACRIVE Inhibition DME1097 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1097 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04087 GENEFORM Protein DME1097 XEOTICID XEO04087 MOACRIVE Inhibition DME1097 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1097 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04089 GENEFORM Protein DME1097 XEOTICID XEO04089 MOACRIVE Inhibition DME1097 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1097 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04094 GENEFORM Protein DME1097 XEOTICID XEO04094 MOACRIVE Inhibition DME1097 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1097 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04096 GENEFORM Protein DME1097 XEOTICID XEO04096 MOACRIVE Inhibition DME1097 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1097 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04098 GENEFORM Protein DME1097 XEOTICID XEO04098 MOACRIVE Inhibition DME1097 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1097 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04111 XEO_CLAS Peptide DME1097 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04111 GENEFORM Protein DME1097 XEOTICID XEO04111 MOACRIVE Inhibition DME1097 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1097 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04112 XEO_CLAS Peptide DME1097 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.02 microM) DME1097 XEOTICID XEO04112 GENEFORM Protein DME1097 XEOTICID XEO04112 MOACRIVE Inhibition DME1097 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1097 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04113 XEO_CLAS Peptide DME1097 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.02 ug/ml) DME1097 XEOTICID XEO04113 GENEFORM Protein DME1097 XEOTICID XEO04113 MOACRIVE Inhibition DME1097 XEOTICID XEO04114 XEO_NAME Microcin L DME1097 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04114 XEO_CLAS Peptide DME1097 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04114 GENEFORM Protein DME1097 XEOTICID XEO04114 MOACRIVE Inhibition DME1097 XEOTICID XEO04117 XEO_NAME Misgurin DME1097 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04117 XEO_CLAS Peptide DME1097 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04117 GENEFORM Protein DME1097 XEOTICID XEO04117 MOACRIVE Inhibition DME1097 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1097 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04118 XEO_CLAS Peptide DME1097 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 300 microM) DME1097 XEOTICID XEO04118 GENEFORM Protein DME1097 XEOTICID XEO04118 MOACRIVE Inhibition DME1097 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1097 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04119 XEO_CLAS Peptide DME1097 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-20 microM) DME1097 XEOTICID XEO04119 GENEFORM Protein DME1097 XEOTICID XEO04119 MOACRIVE Inhibition DME1097 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1097 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04120 XEO_CLAS Peptide DME1097 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC < 10 microM) DME1097 XEOTICID XEO04120 GENEFORM Protein DME1097 XEOTICID XEO04120 MOACRIVE Inhibition DME1097 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1097 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04121 XEO_CLAS Peptide DME1097 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.2-6.4 microM) DME1097 XEOTICID XEO04121 GENEFORM Protein DME1097 XEOTICID XEO04121 MOACRIVE Inhibition DME1097 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1097 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04122 XEO_CLAS Peptide DME1097 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.14-6.29 microM) DME1097 XEOTICID XEO04122 GENEFORM Protein DME1097 XEOTICID XEO04122 MOACRIVE Inhibition DME1097 XEOTICID XEO04123 XEO_NAME Modified defensin DME1097 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04123 XEO_CLAS Peptide DME1097 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO04123 GENEFORM Protein DME1097 XEOTICID XEO04123 MOACRIVE Inhibition DME1097 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1097 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04128 XEO_CLAS Peptide DME1097 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.31 microM) DME1097 XEOTICID XEO04128 GENEFORM Protein DME1097 XEOTICID XEO04128 MOACRIVE Inhibition DME1097 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1097 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04129 XEO_CLAS Peptide DME1097 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO04129 GENEFORM Protein DME1097 XEOTICID XEO04129 MOACRIVE Inhibition DME1097 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1097 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04130 XEO_CLAS Peptide DME1097 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO04130 GENEFORM Protein DME1097 XEOTICID XEO04130 MOACRIVE Inhibition DME1097 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1097 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04131 XEO_CLAS Peptide DME1097 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 microM) DME1097 XEOTICID XEO04131 GENEFORM Protein DME1097 XEOTICID XEO04131 MOACRIVE Inhibition DME1097 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1097 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04132 XEO_CLAS Peptide DME1097 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 microM) DME1097 XEOTICID XEO04132 GENEFORM Protein DME1097 XEOTICID XEO04132 MOACRIVE Inhibition DME1097 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1097 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04133 XEO_CLAS Peptide DME1097 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO04133 GENEFORM Protein DME1097 XEOTICID XEO04133 MOACRIVE Inhibition DME1097 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1097 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04134 XEO_CLAS Peptide DME1097 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO04134 GENEFORM Protein DME1097 XEOTICID XEO04134 MOACRIVE Inhibition DME1097 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1097 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04135 XEO_CLAS Peptide DME1097 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 microM) DME1097 XEOTICID XEO04135 GENEFORM Protein DME1097 XEOTICID XEO04135 MOACRIVE Inhibition DME1097 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1097 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04137 XEO_CLAS Peptide DME1097 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.6 microM) DME1097 XEOTICID XEO04137 GENEFORM Protein DME1097 XEOTICID XEO04137 MOACRIVE Inhibition DME1097 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1097 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04138 XEO_CLAS Peptide DME1097 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 microM) DME1097 XEOTICID XEO04138 GENEFORM Protein DME1097 XEOTICID XEO04138 MOACRIVE Inhibition DME1097 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1097 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04139 XEO_CLAS Peptide DME1097 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 microM) DME1097 XEOTICID XEO04139 GENEFORM Protein DME1097 XEOTICID XEO04139 MOACRIVE Inhibition DME1097 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1097 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04140 XEO_CLAS Peptide DME1097 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 70 microM) DME1097 XEOTICID XEO04140 GENEFORM Protein DME1097 XEOTICID XEO04140 MOACRIVE Inhibition DME1097 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1097 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04141 XEO_CLAS Peptide DME1097 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 microM) DME1097 XEOTICID XEO04141 GENEFORM Protein DME1097 XEOTICID XEO04141 MOACRIVE Inhibition DME1097 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1097 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04142 XEO_CLAS Peptide DME1097 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8-16 microM) DME1097 XEOTICID XEO04142 GENEFORM Protein DME1097 XEOTICID XEO04142 MOACRIVE Inhibition DME1097 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1097 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04146 XEO_CLAS Peptide DME1097 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04146 GENEFORM Protein DME1097 XEOTICID XEO04146 MOACRIVE Inhibition DME1097 XEOTICID XEO04149 XEO_NAME Mucroporin DME1097 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04149 XEO_CLAS Peptide DME1097 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 ug/ml) DME1097 XEOTICID XEO04149 GENEFORM Protein DME1097 XEOTICID XEO04149 MOACRIVE Inhibition DME1097 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1097 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04158 XEO_CLAS Peptide DME1097 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO04158 GENEFORM Protein DME1097 XEOTICID XEO04158 MOACRIVE Inhibition DME1097 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1097 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04159 XEO_CLAS Peptide DME1097 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 microM) DME1097 XEOTICID XEO04159 GENEFORM Protein DME1097 XEOTICID XEO04159 MOACRIVE Inhibition DME1097 XEOTICID XEO04167 XEO_NAME Myticin-B DME1097 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04167 XEO_CLAS Peptide DME1097 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04167 GENEFORM Protein DME1097 XEOTICID XEO04167 MOACRIVE Inhibition DME1097 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1097 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04168 XEO_CLAS Peptide DME1097 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.7-12.5 microM) DME1097 XEOTICID XEO04168 GENEFORM Protein DME1097 XEOTICID XEO04168 MOACRIVE Inhibition DME1097 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1097 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04169 XEO_CLAS Peptide DME1097 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04169 GENEFORM Protein DME1097 XEOTICID XEO04169 MOACRIVE Inhibition DME1097 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1097 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04170 XEO_CLAS Peptide DME1097 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04170 GENEFORM Protein DME1097 XEOTICID XEO04170 MOACRIVE Inhibition DME1097 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1097 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04171 XEO_CLAS Peptide DME1097 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04171 GENEFORM Protein DME1097 XEOTICID XEO04171 MOACRIVE Inhibition DME1097 XEOTICID XEO04172 XEO_NAME Myxinidin DME1097 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04172 XEO_CLAS Peptide DME1097 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04172 GENEFORM Protein DME1097 XEOTICID XEO04172 MOACRIVE Inhibition DME1097 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1097 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04177 XEO_CLAS Peptide DME1097 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.7 microM) DME1097 XEOTICID XEO04177 GENEFORM Protein DME1097 XEOTICID XEO04177 MOACRIVE Inhibition DME1097 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1097 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04178 XEO_CLAS Peptide DME1097 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.7 microM) DME1097 XEOTICID XEO04178 GENEFORM Protein DME1097 XEOTICID XEO04178 MOACRIVE Inhibition DME1097 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1097 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04179 XEO_CLAS Peptide DME1097 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.5 microM) DME1097 XEOTICID XEO04179 GENEFORM Protein DME1097 XEOTICID XEO04179 MOACRIVE Inhibition DME1097 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1097 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04180 XEO_CLAS Peptide DME1097 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 23 microM) DME1097 XEOTICID XEO04180 GENEFORM Protein DME1097 XEOTICID XEO04180 MOACRIVE Inhibition DME1097 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1097 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04181 XEO_CLAS Peptide DME1097 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.2 microM) DME1097 XEOTICID XEO04181 GENEFORM Protein DME1097 XEOTICID XEO04181 MOACRIVE Inhibition DME1097 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1097 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04182 XEO_CLAS Peptide DME1097 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4.4 microM) DME1097 XEOTICID XEO04182 GENEFORM Protein DME1097 XEOTICID XEO04182 MOACRIVE Inhibition DME1097 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1097 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04183 XEO_CLAS Peptide DME1097 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.6 microM) DME1097 XEOTICID XEO04183 GENEFORM Protein DME1097 XEOTICID XEO04183 MOACRIVE Inhibition DME1097 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1097 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04184 XEO_CLAS Peptide DME1097 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 microM) DME1097 XEOTICID XEO04184 GENEFORM Protein DME1097 XEOTICID XEO04184 MOACRIVE Inhibition DME1097 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1097 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04185 XEO_CLAS Peptide DME1097 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04185 GENEFORM Protein DME1097 XEOTICID XEO04185 MOACRIVE Inhibition DME1097 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1097 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04186 XEO_CLAS Peptide DME1097 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04186 GENEFORM Protein DME1097 XEOTICID XEO04186 MOACRIVE Inhibition DME1097 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1097 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04187 XEO_CLAS Peptide DME1097 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04187 GENEFORM Protein DME1097 XEOTICID XEO04187 MOACRIVE Inhibition DME1097 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1097 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04188 XEO_CLAS Peptide DME1097 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04188 GENEFORM Protein DME1097 XEOTICID XEO04188 MOACRIVE Inhibition DME1097 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1097 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04206 XEO_CLAS Peptide DME1097 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25 microM) DME1097 XEOTICID XEO04206 GENEFORM Protein DME1097 XEOTICID XEO04206 MOACRIVE Inhibition DME1097 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1097 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04214 XEO_CLAS Peptide DME1097 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25 microM) DME1097 XEOTICID XEO04214 GENEFORM Protein DME1097 XEOTICID XEO04214 MOACRIVE Inhibition DME1097 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1097 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04216 XEO_CLAS Peptide DME1097 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO04216 GENEFORM Protein DME1097 XEOTICID XEO04216 MOACRIVE Inhibition DME1097 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1097 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04218 XEO_CLAS Peptide DME1097 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.125 microM) DME1097 XEOTICID XEO04218 GENEFORM Protein DME1097 XEOTICID XEO04218 MOACRIVE Inhibition DME1097 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1097 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04219 XEO_CLAS Peptide DME1097 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO04219 GENEFORM Protein DME1097 XEOTICID XEO04219 MOACRIVE Inhibition DME1097 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1097 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04220 XEO_CLAS Peptide DME1097 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.125 microM) DME1097 XEOTICID XEO04220 GENEFORM Protein DME1097 XEOTICID XEO04220 MOACRIVE Inhibition DME1097 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1097 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04221 XEO_CLAS Peptide DME1097 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO04221 GENEFORM Protein DME1097 XEOTICID XEO04221 MOACRIVE Inhibition DME1097 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1097 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04222 XEO_CLAS Peptide DME1097 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25 microM) DME1097 XEOTICID XEO04222 GENEFORM Protein DME1097 XEOTICID XEO04222 MOACRIVE Inhibition DME1097 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1097 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04233 XEO_CLAS Peptide DME1097 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04233 GENEFORM Protein DME1097 XEOTICID XEO04233 MOACRIVE Inhibition DME1097 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1097 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04234 XEO_CLAS Peptide DME1097 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04234 GENEFORM Protein DME1097 XEOTICID XEO04234 MOACRIVE Inhibition DME1097 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1097 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04241 XEO_CLAS Peptide DME1097 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04241 GENEFORM Protein DME1097 XEOTICID XEO04241 MOACRIVE Inhibition DME1097 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1097 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04242 XEO_CLAS Peptide DME1097 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04242 GENEFORM Protein DME1097 XEOTICID XEO04242 MOACRIVE Inhibition DME1097 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1097 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04245 XEO_CLAS Natural Product DME1097 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04245 GENEFORM Protein DME1097 XEOTICID XEO04245 MOACRIVE Inhibition DME1097 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1097 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04246 XEO_CLAS Natural Product DME1097 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04246 GENEFORM Protein DME1097 XEOTICID XEO04246 MOACRIVE Inhibition DME1097 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1097 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04249 XEO_CLAS Peptide DME1097 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 500 ug/ml) DME1097 XEOTICID XEO04249 GENEFORM Protein DME1097 XEOTICID XEO04249 MOACRIVE Inhibition DME1097 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1097 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04251 XEO_CLAS Peptide DME1097 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04251 GENEFORM Protein DME1097 XEOTICID XEO04251 MOACRIVE Inhibition DME1097 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1097 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04253 XEO_CLAS Peptide DME1097 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04253 GENEFORM Protein DME1097 XEOTICID XEO04253 MOACRIVE Inhibition DME1097 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1097 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04254 XEO_CLAS Peptide DME1097 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04254 GENEFORM Protein DME1097 XEOTICID XEO04254 MOACRIVE Inhibition DME1097 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1097 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04255 XEO_CLAS Peptide DME1097 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04255 GENEFORM Protein DME1097 XEOTICID XEO04255 MOACRIVE Inhibition DME1097 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1097 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04256 XEO_CLAS Peptide DME1097 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04256 GENEFORM Protein DME1097 XEOTICID XEO04256 MOACRIVE Inhibition DME1097 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1097 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04257 XEO_CLAS Peptide DME1097 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04257 GENEFORM Protein DME1097 XEOTICID XEO04257 MOACRIVE Inhibition DME1097 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1097 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04258 XEO_CLAS Peptide DME1097 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04258 GENEFORM Protein DME1097 XEOTICID XEO04258 MOACRIVE Inhibition DME1097 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1097 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04259 XEO_CLAS Peptide DME1097 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04259 GENEFORM Protein DME1097 XEOTICID XEO04259 MOACRIVE Inhibition DME1097 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1097 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04260 XEO_CLAS Peptide DME1097 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04260 GENEFORM Protein DME1097 XEOTICID XEO04260 MOACRIVE Inhibition DME1097 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1097 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04261 XEO_CLAS Peptide DME1097 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04261 GENEFORM Protein DME1097 XEOTICID XEO04261 MOACRIVE Inhibition DME1097 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1097 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04262 XEO_CLAS Peptide DME1097 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04262 GENEFORM Protein DME1097 XEOTICID XEO04262 MOACRIVE Inhibition DME1097 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1097 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04263 XEO_CLAS Peptide DME1097 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04263 GENEFORM Protein DME1097 XEOTICID XEO04263 MOACRIVE Inhibition DME1097 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1097 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04264 XEO_CLAS Peptide DME1097 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04264 GENEFORM Protein DME1097 XEOTICID XEO04264 MOACRIVE Inhibition DME1097 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1097 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04265 XEO_CLAS Peptide DME1097 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04265 GENEFORM Protein DME1097 XEOTICID XEO04265 MOACRIVE Inhibition DME1097 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1097 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04266 XEO_CLAS Peptide DME1097 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04266 GENEFORM Protein DME1097 XEOTICID XEO04266 MOACRIVE Inhibition DME1097 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1097 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04267 XEO_CLAS Peptide DME1097 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04267 GENEFORM Protein DME1097 XEOTICID XEO04267 MOACRIVE Inhibition DME1097 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1097 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04268 XEO_CLAS Peptide DME1097 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04268 GENEFORM Protein DME1097 XEOTICID XEO04268 MOACRIVE Inhibition DME1097 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1097 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04269 XEO_CLAS Peptide DME1097 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04269 GENEFORM Protein DME1097 XEOTICID XEO04269 MOACRIVE Inhibition DME1097 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1097 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04270 XEO_CLAS Peptide DME1097 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04270 GENEFORM Protein DME1097 XEOTICID XEO04270 MOACRIVE Inhibition DME1097 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1097 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04271 XEO_CLAS Peptide DME1097 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04271 GENEFORM Protein DME1097 XEOTICID XEO04271 MOACRIVE Inhibition DME1097 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1097 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04272 XEO_CLAS Peptide DME1097 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04272 GENEFORM Protein DME1097 XEOTICID XEO04272 MOACRIVE Inhibition DME1097 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1097 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04277 XEO_CLAS Peptide DME1097 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 110.00 ug/ml) DME1097 XEOTICID XEO04277 GENEFORM Protein DME1097 XEOTICID XEO04277 MOACRIVE Inhibition DME1097 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1097 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04280 XEO_CLAS Peptide DME1097 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 37.50 ug/ml) DME1097 XEOTICID XEO04280 GENEFORM Protein DME1097 XEOTICID XEO04280 MOACRIVE Inhibition DME1097 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1097 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04281 XEO_CLAS Peptide DME1097 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25.00 ug/ml) DME1097 XEOTICID XEO04281 GENEFORM Protein DME1097 XEOTICID XEO04281 MOACRIVE Inhibition DME1097 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1097 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04282 XEO_CLAS Peptide DME1097 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.2 ug/ml) DME1097 XEOTICID XEO04282 GENEFORM Protein DME1097 XEOTICID XEO04282 MOACRIVE Inhibition DME1097 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1097 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04283 XEO_CLAS Peptide DME1097 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.3 ug/ml) DME1097 XEOTICID XEO04283 GENEFORM Protein DME1097 XEOTICID XEO04283 MOACRIVE Inhibition DME1097 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1097 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04284 XEO_CLAS Peptide DME1097 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10.8 ug/ml) DME1097 XEOTICID XEO04284 GENEFORM Protein DME1097 XEOTICID XEO04284 MOACRIVE Inhibition DME1097 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1097 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04285 XEO_CLAS Peptide DME1097 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 11.5 ug/ml) DME1097 XEOTICID XEO04285 GENEFORM Protein DME1097 XEOTICID XEO04285 MOACRIVE Inhibition DME1097 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1097 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04286 XEO_CLAS Peptide DME1097 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8.6 ug/ml) DME1097 XEOTICID XEO04286 GENEFORM Protein DME1097 XEOTICID XEO04286 MOACRIVE Inhibition DME1097 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1097 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04287 XEO_CLAS Peptide DME1097 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10.2 ug/ml) DME1097 XEOTICID XEO04287 GENEFORM Protein DME1097 XEOTICID XEO04287 MOACRIVE Inhibition DME1097 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1097 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04288 XEO_CLAS Peptide DME1097 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4.4 ug/ml) DME1097 XEOTICID XEO04288 GENEFORM Protein DME1097 XEOTICID XEO04288 MOACRIVE Inhibition DME1097 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1097 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04289 XEO_CLAS Peptide DME1097 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.2 ug/ml) DME1097 XEOTICID XEO04289 GENEFORM Protein DME1097 XEOTICID XEO04289 MOACRIVE Inhibition DME1097 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1097 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04290 XEO_CLAS Peptide DME1097 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 11.3 ug/ml) DME1097 XEOTICID XEO04290 GENEFORM Protein DME1097 XEOTICID XEO04290 MOACRIVE Inhibition DME1097 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1097 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04291 XEO_CLAS Peptide DME1097 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 7.2 ug/ml) DME1097 XEOTICID XEO04291 GENEFORM Protein DME1097 XEOTICID XEO04291 MOACRIVE Inhibition DME1097 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1097 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04292 XEO_CLAS Peptide DME1097 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.1 ug/ml) DME1097 XEOTICID XEO04292 GENEFORM Protein DME1097 XEOTICID XEO04292 MOACRIVE Inhibition DME1097 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1097 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04293 XEO_CLAS Peptide DME1097 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO04293 GENEFORM Protein DME1097 XEOTICID XEO04293 MOACRIVE Inhibition DME1097 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1097 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04294 XEO_CLAS Peptide DME1097 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO04294 GENEFORM Protein DME1097 XEOTICID XEO04294 MOACRIVE Inhibition DME1097 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1097 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04295 XEO_CLAS Peptide DME1097 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO04295 GENEFORM Protein DME1097 XEOTICID XEO04295 MOACRIVE Inhibition DME1097 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1097 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04296 XEO_CLAS Peptide DME1097 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 28 microM) DME1097 XEOTICID XEO04296 GENEFORM Protein DME1097 XEOTICID XEO04296 MOACRIVE Inhibition DME1097 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1097 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04297 XEO_CLAS Peptide DME1097 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 14 microM) DME1097 XEOTICID XEO04297 GENEFORM Protein DME1097 XEOTICID XEO04297 MOACRIVE Inhibition DME1097 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1097 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04298 XEO_CLAS Peptide DME1097 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO04298 GENEFORM Protein DME1097 XEOTICID XEO04298 MOACRIVE Inhibition DME1097 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1097 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04299 XEO_CLAS Peptide DME1097 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO04299 GENEFORM Protein DME1097 XEOTICID XEO04299 MOACRIVE Inhibition DME1097 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1097 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04300 XEO_CLAS Peptide DME1097 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO04300 GENEFORM Protein DME1097 XEOTICID XEO04300 MOACRIVE Inhibition DME1097 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1097 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04301 XEO_CLAS Peptide DME1097 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 microM) DME1097 XEOTICID XEO04301 GENEFORM Protein DME1097 XEOTICID XEO04301 MOACRIVE Inhibition DME1097 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1097 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04302 XEO_CLAS Peptide DME1097 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 microM) DME1097 XEOTICID XEO04302 GENEFORM Protein DME1097 XEOTICID XEO04302 MOACRIVE Inhibition DME1097 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1097 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04303 XEO_CLAS Peptide DME1097 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 microM) DME1097 XEOTICID XEO04303 GENEFORM Protein DME1097 XEOTICID XEO04303 MOACRIVE Inhibition DME1097 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1097 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04304 XEO_CLAS Peptide DME1097 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO04304 GENEFORM Protein DME1097 XEOTICID XEO04304 MOACRIVE Inhibition DME1097 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1097 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04305 XEO_CLAS Peptide DME1097 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 70 microM) DME1097 XEOTICID XEO04305 GENEFORM Protein DME1097 XEOTICID XEO04305 MOACRIVE Inhibition DME1097 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1097 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04306 XEO_CLAS Peptide DME1097 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO04306 GENEFORM Protein DME1097 XEOTICID XEO04306 MOACRIVE Inhibition DME1097 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1097 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04307 XEO_CLAS Peptide DME1097 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 ug/ml) DME1097 XEOTICID XEO04307 GENEFORM Protein DME1097 XEOTICID XEO04307 MOACRIVE Inhibition DME1097 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1097 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04308 XEO_CLAS Peptide DME1097 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 9.37 ug/ml) DME1097 XEOTICID XEO04308 GENEFORM Protein DME1097 XEOTICID XEO04308 MOACRIVE Inhibition DME1097 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1097 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04309 XEO_CLAS Peptide DME1097 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 microM) DME1097 XEOTICID XEO04309 GENEFORM Protein DME1097 XEOTICID XEO04309 MOACRIVE Inhibition DME1097 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1097 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04310 XEO_CLAS Peptide DME1097 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO04310 GENEFORM Protein DME1097 XEOTICID XEO04310 MOACRIVE Inhibition DME1097 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1097 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04311 XEO_CLAS Peptide DME1097 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO04311 GENEFORM Protein DME1097 XEOTICID XEO04311 MOACRIVE Inhibition DME1097 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1097 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04312 XEO_CLAS Peptide DME1097 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4.68 ug/ml) DME1097 XEOTICID XEO04312 GENEFORM Protein DME1097 XEOTICID XEO04312 MOACRIVE Inhibition DME1097 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1097 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04313 XEO_CLAS Peptide DME1097 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4.68 ug/ml) DME1097 XEOTICID XEO04313 GENEFORM Protein DME1097 XEOTICID XEO04313 MOACRIVE Inhibition DME1097 XEOTICID XEO04331 XEO_NAME Norspermidine DME1097 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1097 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04331 GENEFORM Protein DME1097 XEOTICID XEO04331 MOACRIVE Inhibition DME1097 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1097 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04335 XEO_CLAS Peptide DME1097 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 32 ug/ml) DME1097 XEOTICID XEO04335 GENEFORM Protein DME1097 XEOTICID XEO04335 MOACRIVE Inhibition DME1097 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1097 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04336 XEO_CLAS Peptide DME1097 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 32 ug/ml) DME1097 XEOTICID XEO04336 GENEFORM Protein DME1097 XEOTICID XEO04336 MOACRIVE Inhibition DME1097 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1097 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04338 XEO_CLAS Peptide DME1097 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 ug/ml) DME1097 XEOTICID XEO04338 GENEFORM Protein DME1097 XEOTICID XEO04338 MOACRIVE Inhibition DME1097 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1097 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04339 XEO_CLAS Peptide DME1097 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 ug/ml) DME1097 XEOTICID XEO04339 GENEFORM Protein DME1097 XEOTICID XEO04339 MOACRIVE Inhibition DME1097 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1097 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04340 XEO_CLAS Peptide DME1097 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO04340 GENEFORM Protein DME1097 XEOTICID XEO04340 MOACRIVE Inhibition DME1097 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1097 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04344 XEO_CLAS Peptide DME1097 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04344 GENEFORM Protein DME1097 XEOTICID XEO04344 MOACRIVE Inhibition DME1097 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1097 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04345 XEO_CLAS Peptide DME1097 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04345 GENEFORM Protein DME1097 XEOTICID XEO04345 MOACRIVE Inhibition DME1097 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1097 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04346 XEO_CLAS Peptide DME1097 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04346 GENEFORM Protein DME1097 XEOTICID XEO04346 MOACRIVE Inhibition DME1097 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1097 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04347 XEO_CLAS Peptide DME1097 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 microM) DME1097 XEOTICID XEO04347 GENEFORM Protein DME1097 XEOTICID XEO04347 MOACRIVE Inhibition DME1097 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1097 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04348 XEO_CLAS Peptide DME1097 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40 microM) DME1097 XEOTICID XEO04348 GENEFORM Protein DME1097 XEOTICID XEO04348 MOACRIVE Inhibition DME1097 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1097 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04349 XEO_CLAS Peptide DME1097 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO04349 GENEFORM Protein DME1097 XEOTICID XEO04349 MOACRIVE Inhibition DME1097 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1097 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04354 XEO_CLAS Peptide DME1097 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 35.2 ug/ml) DME1097 XEOTICID XEO04354 GENEFORM Protein DME1097 XEOTICID XEO04354 MOACRIVE Inhibition DME1097 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1097 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04355 XEO_CLAS Peptide DME1097 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.21 ug/ml) DME1097 XEOTICID XEO04355 GENEFORM Protein DME1097 XEOTICID XEO04355 MOACRIVE Inhibition DME1097 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1097 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04356 XEO_CLAS Peptide DME1097 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8.21 ug/ml) DME1097 XEOTICID XEO04356 GENEFORM Protein DME1097 XEOTICID XEO04356 MOACRIVE Inhibition DME1097 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1097 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04357 XEO_CLAS Peptide DME1097 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16.32 ug/ml) DME1097 XEOTICID XEO04357 GENEFORM Protein DME1097 XEOTICID XEO04357 MOACRIVE Inhibition DME1097 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1097 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04358 XEO_CLAS Peptide DME1097 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 9.37 ug/ml) DME1097 XEOTICID XEO04358 GENEFORM Protein DME1097 XEOTICID XEO04358 MOACRIVE Inhibition DME1097 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1097 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04359 XEO_CLAS Peptide DME1097 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4.20 ug/ml) DME1097 XEOTICID XEO04359 GENEFORM Protein DME1097 XEOTICID XEO04359 MOACRIVE Inhibition DME1097 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1097 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04360 XEO_CLAS Peptide DME1097 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 ug/ml) DME1097 XEOTICID XEO04360 GENEFORM Protein DME1097 XEOTICID XEO04360 MOACRIVE Inhibition DME1097 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1097 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04361 XEO_CLAS Peptide DME1097 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 7.5 ug/ml) DME1097 XEOTICID XEO04361 GENEFORM Protein DME1097 XEOTICID XEO04361 MOACRIVE Inhibition DME1097 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1097 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04362 XEO_CLAS Peptide DME1097 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.6 ug/ml) DME1097 XEOTICID XEO04362 GENEFORM Protein DME1097 XEOTICID XEO04362 MOACRIVE Inhibition DME1097 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1097 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04363 XEO_CLAS Peptide DME1097 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8.2 ug/ml) DME1097 XEOTICID XEO04363 GENEFORM Protein DME1097 XEOTICID XEO04363 MOACRIVE Inhibition DME1097 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1097 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04364 XEO_CLAS Peptide DME1097 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO04364 GENEFORM Protein DME1097 XEOTICID XEO04364 MOACRIVE Inhibition DME1097 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1097 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04365 XEO_CLAS Peptide DME1097 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4.68 ug/ml) DME1097 XEOTICID XEO04365 GENEFORM Protein DME1097 XEOTICID XEO04365 MOACRIVE Inhibition DME1097 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1097 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04366 XEO_CLAS Peptide DME1097 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 23.60 ug/ml) DME1097 XEOTICID XEO04366 GENEFORM Protein DME1097 XEOTICID XEO04366 MOACRIVE Inhibition DME1097 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1097 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04367 XEO_CLAS Peptide DME1097 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 35.60 ug/ml) DME1097 XEOTICID XEO04367 GENEFORM Protein DME1097 XEOTICID XEO04367 MOACRIVE Inhibition DME1097 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1097 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04368 XEO_CLAS Peptide DME1097 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40.2 ug/ml) DME1097 XEOTICID XEO04368 GENEFORM Protein DME1097 XEOTICID XEO04368 MOACRIVE Inhibition DME1097 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1097 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04369 XEO_CLAS Peptide DME1097 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40.2 ug/ml) DME1097 XEOTICID XEO04369 GENEFORM Protein DME1097 XEOTICID XEO04369 MOACRIVE Inhibition DME1097 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1097 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04370 XEO_CLAS Peptide DME1097 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4.68 ug/ml) DME1097 XEOTICID XEO04370 GENEFORM Protein DME1097 XEOTICID XEO04370 MOACRIVE Inhibition DME1097 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1097 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04371 XEO_CLAS Peptide DME1097 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 9.37 ug/ml) DME1097 XEOTICID XEO04371 GENEFORM Protein DME1097 XEOTICID XEO04371 MOACRIVE Inhibition DME1097 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1097 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04373 XEO_CLAS Peptide DME1097 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 ug/ml) DME1097 XEOTICID XEO04373 GENEFORM Protein DME1097 XEOTICID XEO04373 MOACRIVE Inhibition DME1097 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1097 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04374 XEO_CLAS Peptide DME1097 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.50 ug/ml) DME1097 XEOTICID XEO04374 GENEFORM Protein DME1097 XEOTICID XEO04374 MOACRIVE Inhibition DME1097 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1097 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04375 XEO_CLAS Peptide DME1097 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25 ug/ml) DME1097 XEOTICID XEO04375 GENEFORM Protein DME1097 XEOTICID XEO04375 MOACRIVE Inhibition DME1097 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1097 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04377 XEO_CLAS Peptide DME1097 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 42.50 ug/ml) DME1097 XEOTICID XEO04377 GENEFORM Protein DME1097 XEOTICID XEO04377 MOACRIVE Inhibition DME1097 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1097 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04378 XEO_CLAS Peptide DME1097 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 17.50 ug/ml) DME1097 XEOTICID XEO04378 GENEFORM Protein DME1097 XEOTICID XEO04378 MOACRIVE Inhibition DME1097 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1097 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04379 XEO_CLAS Peptide DME1097 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 ug/ml) DME1097 XEOTICID XEO04379 GENEFORM Protein DME1097 XEOTICID XEO04379 MOACRIVE Inhibition DME1097 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1097 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04380 XEO_CLAS Peptide DME1097 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 36.00 ug/ml) DME1097 XEOTICID XEO04380 GENEFORM Protein DME1097 XEOTICID XEO04380 MOACRIVE Inhibition DME1097 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1097 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04381 XEO_CLAS Peptide DME1097 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.60 ug/ml) DME1097 XEOTICID XEO04381 GENEFORM Protein DME1097 XEOTICID XEO04381 MOACRIVE Inhibition DME1097 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1097 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04382 XEO_CLAS Peptide DME1097 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 ug/ml) DME1097 XEOTICID XEO04382 GENEFORM Protein DME1097 XEOTICID XEO04382 MOACRIVE Inhibition DME1097 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1097 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04383 XEO_CLAS Peptide DME1097 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO04383 GENEFORM Protein DME1097 XEOTICID XEO04383 MOACRIVE Inhibition DME1097 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1097 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04384 XEO_CLAS Peptide DME1097 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO04384 GENEFORM Protein DME1097 XEOTICID XEO04384 MOACRIVE Inhibition DME1097 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1097 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04385 XEO_CLAS Peptide DME1097 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.25 ug/ml) DME1097 XEOTICID XEO04385 GENEFORM Protein DME1097 XEOTICID XEO04385 MOACRIVE Inhibition DME1097 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1097 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04395 XEO_CLAS Peptide DME1097 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1097 XEOTICID XEO04395 GENEFORM Protein DME1097 XEOTICID XEO04395 MOACRIVE Inhibition DME1097 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1097 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04396 XEO_CLAS Peptide DME1097 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1097 XEOTICID XEO04396 GENEFORM Protein DME1097 XEOTICID XEO04396 MOACRIVE Inhibition DME1097 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1097 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04397 XEO_CLAS Peptide DME1097 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1097 XEOTICID XEO04397 GENEFORM Protein DME1097 XEOTICID XEO04397 MOACRIVE Inhibition DME1097 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1097 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04398 XEO_CLAS Peptide DME1097 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 microM) DME1097 XEOTICID XEO04398 GENEFORM Protein DME1097 XEOTICID XEO04398 MOACRIVE Inhibition DME1097 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1097 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04399 XEO_CLAS Peptide DME1097 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO04399 GENEFORM Protein DME1097 XEOTICID XEO04399 MOACRIVE Inhibition DME1097 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1097 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04400 XEO_CLAS Peptide DME1097 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 ug/ml) DME1097 XEOTICID XEO04400 GENEFORM Protein DME1097 XEOTICID XEO04400 MOACRIVE Inhibition DME1097 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1097 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04401 XEO_CLAS Peptide DME1097 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.6 ug/ml) DME1097 XEOTICID XEO04401 GENEFORM Protein DME1097 XEOTICID XEO04401 MOACRIVE Inhibition DME1097 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1097 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04402 XEO_CLAS Peptide DME1097 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 ug/ml) DME1097 XEOTICID XEO04402 GENEFORM Protein DME1097 XEOTICID XEO04402 MOACRIVE Inhibition DME1097 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1097 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04403 XEO_CLAS Peptide DME1097 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.6 ug/ml) DME1097 XEOTICID XEO04403 GENEFORM Protein DME1097 XEOTICID XEO04403 MOACRIVE Inhibition DME1097 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1097 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04404 XEO_CLAS Peptide DME1097 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.6 ug/ml) DME1097 XEOTICID XEO04404 GENEFORM Protein DME1097 XEOTICID XEO04404 MOACRIVE Inhibition DME1097 XEOTICID XEO04410 XEO_NAME Insect osmin DME1097 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04410 XEO_CLAS Peptide DME1097 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.125-1.56 microM) DME1097 XEOTICID XEO04410 GENEFORM Protein DME1097 XEOTICID XEO04410 MOACRIVE Inhibition DME1097 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1097 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04412 XEO_CLAS Peptide DME1097 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04412 GENEFORM Protein DME1097 XEOTICID XEO04412 MOACRIVE Inhibition DME1097 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1097 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04414 XEO_CLAS Peptide DME1097 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04414 GENEFORM Protein DME1097 XEOTICID XEO04414 MOACRIVE Inhibition DME1097 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1097 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04415 XEO_CLAS Peptide DME1097 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04415 GENEFORM Protein DME1097 XEOTICID XEO04415 MOACRIVE Inhibition DME1097 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1097 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04421 XEO_CLAS Peptide DME1097 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 microM) DME1097 XEOTICID XEO04421 GENEFORM Protein DME1097 XEOTICID XEO04421 MOACRIVE Inhibition DME1097 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1097 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04426 XEO_CLAS Peptide DME1097 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO04426 GENEFORM Protein DME1097 XEOTICID XEO04426 MOACRIVE Inhibition DME1097 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1097 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04428 XEO_CLAS Peptide DME1097 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.3 ug/ml) DME1097 XEOTICID XEO04428 GENEFORM Protein DME1097 XEOTICID XEO04428 MOACRIVE Inhibition DME1097 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1097 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04430 XEO_CLAS Peptide DME1097 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25 microM) DME1097 XEOTICID XEO04430 GENEFORM Protein DME1097 XEOTICID XEO04430 MOACRIVE Inhibition DME1097 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1097 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04433 XEO_CLAS Peptide DME1097 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 160 microM) DME1097 XEOTICID XEO04433 GENEFORM Protein DME1097 XEOTICID XEO04433 MOACRIVE Inhibition DME1097 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1097 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04435 XEO_CLAS Peptide DME1097 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 160 microM) DME1097 XEOTICID XEO04435 GENEFORM Protein DME1097 XEOTICID XEO04435 MOACRIVE Inhibition DME1097 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1097 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1097 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04438 GENEFORM Protein DME1097 XEOTICID XEO04438 MOACRIVE Inhibition DME1097 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1097 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04439 XEO_CLAS Peptide DME1097 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04439 GENEFORM Protein DME1097 XEOTICID XEO04439 MOACRIVE Inhibition DME1097 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1097 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04440 XEO_CLAS Peptide DME1097 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 microM) DME1097 XEOTICID XEO04440 GENEFORM Protein DME1097 XEOTICID XEO04440 MOACRIVE Inhibition DME1097 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1097 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04441 XEO_CLAS Peptide DME1097 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 28 microM) DME1097 XEOTICID XEO04441 GENEFORM Protein DME1097 XEOTICID XEO04441 MOACRIVE Inhibition DME1097 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1097 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04442 XEO_CLAS Peptide DME1097 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 28 microM) DME1097 XEOTICID XEO04442 GENEFORM Protein DME1097 XEOTICID XEO04442 MOACRIVE Inhibition DME1097 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1097 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04443 XEO_CLAS Peptide DME1097 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04443 GENEFORM Protein DME1097 XEOTICID XEO04443 MOACRIVE Inhibition DME1097 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1097 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04444 XEO_CLAS Peptide DME1097 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 13 microM) DME1097 XEOTICID XEO04444 GENEFORM Protein DME1097 XEOTICID XEO04444 MOACRIVE Inhibition DME1097 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1097 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04445 XEO_CLAS Peptide DME1097 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04445 GENEFORM Protein DME1097 XEOTICID XEO04445 MOACRIVE Inhibition DME1097 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1097 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04446 XEO_CLAS Peptide DME1097 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 78 microM) DME1097 XEOTICID XEO04446 GENEFORM Protein DME1097 XEOTICID XEO04446 MOACRIVE Inhibition DME1097 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1097 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04447 XEO_CLAS Peptide DME1097 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 120 microM) DME1097 XEOTICID XEO04447 GENEFORM Protein DME1097 XEOTICID XEO04447 MOACRIVE Inhibition DME1097 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1097 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04448 XEO_CLAS Peptide DME1097 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 microM) DME1097 XEOTICID XEO04448 GENEFORM Protein DME1097 XEOTICID XEO04448 MOACRIVE Inhibition DME1097 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1097 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04449 XEO_CLAS Peptide DME1097 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.3 microM) DME1097 XEOTICID XEO04449 GENEFORM Protein DME1097 XEOTICID XEO04449 MOACRIVE Inhibition DME1097 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1097 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04450 XEO_CLAS Peptide DME1097 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.3 microM) DME1097 XEOTICID XEO04450 GENEFORM Protein DME1097 XEOTICID XEO04450 MOACRIVE Inhibition DME1097 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1097 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04451 XEO_CLAS Peptide DME1097 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO04451 GENEFORM Protein DME1097 XEOTICID XEO04451 MOACRIVE Inhibition DME1097 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1097 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04452 XEO_CLAS Peptide DME1097 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.1 microM) DME1097 XEOTICID XEO04452 GENEFORM Protein DME1097 XEOTICID XEO04452 MOACRIVE Inhibition DME1097 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1097 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04453 XEO_CLAS Peptide DME1097 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO04453 GENEFORM Protein DME1097 XEOTICID XEO04453 MOACRIVE Inhibition DME1097 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1097 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04455 XEO_CLAS Peptide DME1097 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 microM) DME1097 XEOTICID XEO04455 GENEFORM Protein DME1097 XEOTICID XEO04455 MOACRIVE Inhibition DME1097 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1097 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04457 XEO_CLAS Peptide DME1097 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.3 microM) DME1097 XEOTICID XEO04457 GENEFORM Protein DME1097 XEOTICID XEO04457 MOACRIVE Inhibition DME1097 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1097 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04458 XEO_CLAS Peptide DME1097 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1 microM) DME1097 XEOTICID XEO04458 GENEFORM Protein DME1097 XEOTICID XEO04458 MOACRIVE Inhibition DME1097 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1097 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04459 XEO_CLAS Peptide DME1097 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1 microM) DME1097 XEOTICID XEO04459 GENEFORM Protein DME1097 XEOTICID XEO04459 MOACRIVE Inhibition DME1097 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1097 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04461 XEO_CLAS Peptide DME1097 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20.8 microM) DME1097 XEOTICID XEO04461 GENEFORM Protein DME1097 XEOTICID XEO04461 MOACRIVE Inhibition DME1097 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1097 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04462 XEO_CLAS Peptide DME1097 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 19.1 microM) DME1097 XEOTICID XEO04462 GENEFORM Protein DME1097 XEOTICID XEO04462 MOACRIVE Inhibition DME1097 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1097 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04463 XEO_CLAS Peptide DME1097 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04463 GENEFORM Protein DME1097 XEOTICID XEO04463 MOACRIVE Inhibition DME1097 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1097 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04464 XEO_CLAS Peptide DME1097 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.5 microM) DME1097 XEOTICID XEO04464 GENEFORM Protein DME1097 XEOTICID XEO04464 MOACRIVE Inhibition DME1097 XEOTICID XEO04466 XEO_NAME Panusin DME1097 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04466 XEO_CLAS Peptide DME1097 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04466 GENEFORM Protein DME1097 XEOTICID XEO04466 MOACRIVE Inhibition DME1097 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1097 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04467 XEO_CLAS Peptide DME1097 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4.8 microM) DME1097 XEOTICID XEO04467 GENEFORM Protein DME1097 XEOTICID XEO04467 MOACRIVE Inhibition DME1097 XEOTICID XEO04468 XEO_NAME Papillosin DME1097 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04468 XEO_CLAS Peptide DME1097 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04468 GENEFORM Protein DME1097 XEOTICID XEO04468 MOACRIVE Inhibition DME1097 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1097 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04471 XEO_CLAS Peptide DME1097 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.1 microM) DME1097 XEOTICID XEO04471 GENEFORM Protein DME1097 XEOTICID XEO04471 MOACRIVE Inhibition DME1097 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1097 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04480 XEO_CLAS Peptide DME1097 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 ug/ml) DME1097 XEOTICID XEO04480 GENEFORM Protein DME1097 XEOTICID XEO04480 MOACRIVE Inhibition DME1097 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1097 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1097 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04482 GENEFORM Protein DME1097 XEOTICID XEO04482 MOACRIVE Inhibition DME1097 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1097 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04484 XEO_CLAS Peptide DME1097 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 microM) DME1097 XEOTICID XEO04484 GENEFORM Protein DME1097 XEOTICID XEO04484 MOACRIVE Inhibition DME1097 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1097 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04485 XEO_CLAS Peptide DME1097 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO04485 GENEFORM Protein DME1097 XEOTICID XEO04485 MOACRIVE Inhibition DME1097 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1097 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04486 XEO_CLAS Peptide DME1097 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 microM) DME1097 XEOTICID XEO04486 GENEFORM Protein DME1097 XEOTICID XEO04486 MOACRIVE Inhibition DME1097 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1097 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04487 XEO_CLAS Peptide DME1097 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO04487 GENEFORM Protein DME1097 XEOTICID XEO04487 MOACRIVE Inhibition DME1097 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1097 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04488 XEO_CLAS Peptide DME1097 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 9 microM) DME1097 XEOTICID XEO04488 GENEFORM Protein DME1097 XEOTICID XEO04488 MOACRIVE Inhibition DME1097 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1097 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04489 XEO_CLAS Peptide DME1097 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 13 microM) DME1097 XEOTICID XEO04489 GENEFORM Protein DME1097 XEOTICID XEO04489 MOACRIVE Inhibition DME1097 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1097 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04490 XEO_CLAS Peptide DME1097 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 47.5 microM) DME1097 XEOTICID XEO04490 GENEFORM Protein DME1097 XEOTICID XEO04490 MOACRIVE Inhibition DME1097 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1097 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04491 XEO_CLAS Peptide DME1097 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO04491 GENEFORM Protein DME1097 XEOTICID XEO04491 MOACRIVE Inhibition DME1097 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1097 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04492 XEO_CLAS Peptide DME1097 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 35 microM) DME1097 XEOTICID XEO04492 GENEFORM Protein DME1097 XEOTICID XEO04492 MOACRIVE Inhibition DME1097 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1097 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04493 XEO_CLAS Peptide DME1097 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 microM) DME1097 XEOTICID XEO04493 GENEFORM Protein DME1097 XEOTICID XEO04493 MOACRIVE Inhibition DME1097 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1097 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04494 XEO_CLAS Peptide DME1097 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO04494 GENEFORM Protein DME1097 XEOTICID XEO04494 MOACRIVE Inhibition DME1097 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1097 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04495 XEO_CLAS Peptide DME1097 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO04495 GENEFORM Protein DME1097 XEOTICID XEO04495 MOACRIVE Inhibition DME1097 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1097 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04496 XEO_CLAS Peptide DME1097 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 67.5 microM) DME1097 XEOTICID XEO04496 GENEFORM Protein DME1097 XEOTICID XEO04496 MOACRIVE Inhibition DME1097 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1097 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04497 XEO_CLAS Peptide DME1097 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO04497 GENEFORM Protein DME1097 XEOTICID XEO04497 MOACRIVE Inhibition DME1097 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1097 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04498 XEO_CLAS Peptide DME1097 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO04498 GENEFORM Protein DME1097 XEOTICID XEO04498 MOACRIVE Inhibition DME1097 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1097 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04499 XEO_CLAS Peptide DME1097 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 43 microM) DME1097 XEOTICID XEO04499 GENEFORM Protein DME1097 XEOTICID XEO04499 MOACRIVE Inhibition DME1097 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1097 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04500 XEO_CLAS Peptide DME1097 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO04500 GENEFORM Protein DME1097 XEOTICID XEO04500 MOACRIVE Inhibition DME1097 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1097 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04504 XEO_CLAS Peptide DME1097 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04504 GENEFORM Protein DME1097 XEOTICID XEO04504 MOACRIVE Inhibition DME1097 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1097 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04505 XEO_CLAS Peptide DME1097 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04505 GENEFORM Protein DME1097 XEOTICID XEO04505 MOACRIVE Inhibition DME1097 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1097 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04506 XEO_CLAS Peptide DME1097 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 40 microM) DME1097 XEOTICID XEO04506 GENEFORM Protein DME1097 XEOTICID XEO04506 MOACRIVE Inhibition DME1097 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1097 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04507 XEO_CLAS Peptide DME1097 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10-20 microM) DME1097 XEOTICID XEO04507 GENEFORM Protein DME1097 XEOTICID XEO04507 MOACRIVE Inhibition DME1097 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1097 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04508 XEO_CLAS Peptide DME1097 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04508 GENEFORM Protein DME1097 XEOTICID XEO04508 MOACRIVE Inhibition DME1097 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1097 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04509 XEO_CLAS Peptide DME1097 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04509 GENEFORM Protein DME1097 XEOTICID XEO04509 MOACRIVE Inhibition DME1097 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1097 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04510 XEO_CLAS Peptide DME1097 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 22-33 microM) DME1097 XEOTICID XEO04510 GENEFORM Protein DME1097 XEOTICID XEO04510 MOACRIVE Inhibition DME1097 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1097 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04525 XEO_CLAS Peptide DME1097 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 32.0 microM) DME1097 XEOTICID XEO04525 GENEFORM Protein DME1097 XEOTICID XEO04525 MOACRIVE Inhibition DME1097 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1097 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04526 XEO_CLAS Peptide DME1097 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.0 microM) DME1097 XEOTICID XEO04526 GENEFORM Protein DME1097 XEOTICID XEO04526 MOACRIVE Inhibition DME1097 XEOTICID XEO04527 XEO_NAME Pepcon DME1097 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04527 XEO_CLAS Peptide DME1097 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO04527 GENEFORM Protein DME1097 XEOTICID XEO04527 MOACRIVE Inhibition DME1097 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1097 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04532 XEO_CLAS Peptide DME1097 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04532 GENEFORM Protein DME1097 XEOTICID XEO04532 MOACRIVE Inhibition DME1097 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1097 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04540 XEO_CLAS Peptide DME1097 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 18.1 ug/ml) DME1097 XEOTICID XEO04540 GENEFORM Protein DME1097 XEOTICID XEO04540 MOACRIVE Inhibition DME1097 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1097 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04541 XEO_CLAS Peptide DME1097 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.5 ug/ml) DME1097 XEOTICID XEO04541 GENEFORM Protein DME1097 XEOTICID XEO04541 MOACRIVE Inhibition DME1097 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1097 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04542 XEO_CLAS Peptide DME1097 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04542 GENEFORM Protein DME1097 XEOTICID XEO04542 MOACRIVE Inhibition DME1097 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1097 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04543 XEO_CLAS Peptide DME1097 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04543 GENEFORM Protein DME1097 XEOTICID XEO04543 MOACRIVE Inhibition DME1097 XEOTICID XEO04546 XEO_NAME Perinerin DME1097 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04546 XEO_CLAS Peptide DME1097 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04546 GENEFORM Protein DME1097 XEOTICID XEO04546 MOACRIVE Inhibition DME1097 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1097 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04548 XEO_CLAS Peptide DME1097 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 72000 ug/ml) DME1097 XEOTICID XEO04548 GENEFORM Protein DME1097 XEOTICID XEO04548 MOACRIVE Inhibition DME1097 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1097 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04549 XEO_CLAS Peptide DME1097 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 62-125 ug/ml) DME1097 XEOTICID XEO04549 GENEFORM Protein DME1097 XEOTICID XEO04549 MOACRIVE Inhibition DME1097 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1097 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04550 XEO_CLAS Peptide DME1097 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO04550 GENEFORM Protein DME1097 XEOTICID XEO04550 MOACRIVE Inhibition DME1097 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1097 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04551 XEO_CLAS Peptide DME1097 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 23.6 ug/ml) DME1097 XEOTICID XEO04551 GENEFORM Protein DME1097 XEOTICID XEO04551 MOACRIVE Inhibition DME1097 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1097 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04552 XEO_CLAS Peptide DME1097 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04552 GENEFORM Protein DME1097 XEOTICID XEO04552 MOACRIVE Inhibition DME1097 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1097 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04553 XEO_CLAS Peptide DME1097 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04553 GENEFORM Protein DME1097 XEOTICID XEO04553 MOACRIVE Inhibition DME1097 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1097 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04554 XEO_CLAS Peptide DME1097 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04554 GENEFORM Protein DME1097 XEOTICID XEO04554 MOACRIVE Inhibition DME1097 XEOTICID XEO04563 XEO_NAME Phosphate DME1097 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1097 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04563 GENEFORM Protein DME1097 XEOTICID XEO04563 MOACRIVE Inhibition DME1097 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1097 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04565 XEO_CLAS Peptide DME1097 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.5 microM) DME1097 XEOTICID XEO04565 GENEFORM Protein DME1097 XEOTICID XEO04565 MOACRIVE Inhibition DME1097 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1097 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04566 XEO_CLAS Peptide DME1097 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.7 microM) DME1097 XEOTICID XEO04566 GENEFORM Protein DME1097 XEOTICID XEO04566 MOACRIVE Inhibition DME1097 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1097 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04569 XEO_CLAS Peptide DME1097 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 7.9 microM) DME1097 XEOTICID XEO04569 GENEFORM Protein DME1097 XEOTICID XEO04569 MOACRIVE Inhibition DME1097 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1097 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04570 XEO_CLAS Peptide DME1097 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04570 GENEFORM Protein DME1097 XEOTICID XEO04570 MOACRIVE Inhibition DME1097 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1097 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04571 XEO_CLAS Peptide DME1097 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04571 GENEFORM Protein DME1097 XEOTICID XEO04571 MOACRIVE Inhibition DME1097 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1097 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04572 XEO_CLAS Peptide DME1097 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04572 GENEFORM Protein DME1097 XEOTICID XEO04572 MOACRIVE Inhibition DME1097 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1097 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04573 XEO_CLAS Peptide DME1097 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 microM) DME1097 XEOTICID XEO04573 GENEFORM Protein DME1097 XEOTICID XEO04573 MOACRIVE Inhibition DME1097 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1097 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04574 XEO_CLAS Peptide DME1097 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 128 ug/ml) DME1097 XEOTICID XEO04574 GENEFORM Protein DME1097 XEOTICID XEO04574 MOACRIVE Inhibition DME1097 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1097 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04575 XEO_CLAS Peptide DME1097 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO04575 GENEFORM Protein DME1097 XEOTICID XEO04575 MOACRIVE Inhibition DME1097 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1097 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04578 GENEFORM Protein DME1097 XEOTICID XEO04578 MOACRIVE Inhibition DME1097 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1097 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04579 GENEFORM Protein DME1097 XEOTICID XEO04579 MOACRIVE Inhibition DME1097 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1097 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04580 GENEFORM Protein DME1097 XEOTICID XEO04580 MOACRIVE Inhibition DME1097 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1097 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04583 GENEFORM Protein DME1097 XEOTICID XEO04583 MOACRIVE Inhibition DME1097 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1097 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04588 GENEFORM Protein DME1097 XEOTICID XEO04588 MOACRIVE Inhibition DME1097 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1097 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04589 GENEFORM Protein DME1097 XEOTICID XEO04589 MOACRIVE Inhibition DME1097 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1097 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04590 GENEFORM Protein DME1097 XEOTICID XEO04590 MOACRIVE Inhibition DME1097 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1097 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04591 GENEFORM Protein DME1097 XEOTICID XEO04591 MOACRIVE Inhibition DME1097 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1097 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04592 GENEFORM Protein DME1097 XEOTICID XEO04592 MOACRIVE Inhibition DME1097 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1097 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04593 GENEFORM Protein DME1097 XEOTICID XEO04593 MOACRIVE Inhibition DME1097 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1097 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04594 GENEFORM Protein DME1097 XEOTICID XEO04594 MOACRIVE Inhibition DME1097 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1097 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04595 GENEFORM Protein DME1097 XEOTICID XEO04595 MOACRIVE Inhibition DME1097 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1097 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04596 GENEFORM Protein DME1097 XEOTICID XEO04596 MOACRIVE Inhibition DME1097 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1097 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04597 GENEFORM Protein DME1097 XEOTICID XEO04597 MOACRIVE Inhibition DME1097 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1097 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04598 GENEFORM Protein DME1097 XEOTICID XEO04598 MOACRIVE Inhibition DME1097 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1097 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04599 GENEFORM Protein DME1097 XEOTICID XEO04599 MOACRIVE Inhibition DME1097 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1097 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04601 XEO_CLAS Peptide DME1097 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 18.75 ug/ml) DME1097 XEOTICID XEO04601 GENEFORM Protein DME1097 XEOTICID XEO04601 MOACRIVE Inhibition DME1097 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1097 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04602 XEO_CLAS Peptide DME1097 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 37.5 ug/ml) DME1097 XEOTICID XEO04602 GENEFORM Protein DME1097 XEOTICID XEO04602 MOACRIVE Inhibition DME1097 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1097 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04604 XEO_CLAS Peptide DME1097 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC < 25 microM) DME1097 XEOTICID XEO04604 GENEFORM Protein DME1097 XEOTICID XEO04604 MOACRIVE Inhibition DME1097 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1097 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04605 XEO_CLAS Peptide DME1097 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC < 6.25 microM) DME1097 XEOTICID XEO04605 GENEFORM Protein DME1097 XEOTICID XEO04605 MOACRIVE Inhibition DME1097 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1097 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04606 XEO_CLAS Peptide DME1097 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO04606 GENEFORM Protein DME1097 XEOTICID XEO04606 MOACRIVE Inhibition DME1097 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1097 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1097 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04607 GENEFORM Protein DME1097 XEOTICID XEO04607 MOACRIVE Inhibition DME1097 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1097 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04612 XEO_CLAS Peptide DME1097 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5-10 microM) DME1097 XEOTICID XEO04612 GENEFORM Protein DME1097 XEOTICID XEO04612 MOACRIVE Inhibition DME1097 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1097 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04613 XEO_CLAS Peptide DME1097 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5-10 microM) DME1097 XEOTICID XEO04613 GENEFORM Protein DME1097 XEOTICID XEO04613 MOACRIVE Inhibition DME1097 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1097 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04625 XEO_CLAS Peptide DME1097 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO04625 GENEFORM Protein DME1097 XEOTICID XEO04625 MOACRIVE Inhibition DME1097 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1097 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04626 XEO_CLAS Peptide DME1097 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO04626 GENEFORM Protein DME1097 XEOTICID XEO04626 MOACRIVE Inhibition DME1097 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1097 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04627 XEO_CLAS Peptide DME1097 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.5 microM) DME1097 XEOTICID XEO04627 GENEFORM Protein DME1097 XEOTICID XEO04627 MOACRIVE Inhibition DME1097 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1097 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04630 XEO_CLAS Peptide DME1097 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 60 ug/ml) DME1097 XEOTICID XEO04630 GENEFORM Protein DME1097 XEOTICID XEO04630 MOACRIVE Inhibition DME1097 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1097 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04631 XEO_CLAS Peptide DME1097 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 60 ug/ml) DME1097 XEOTICID XEO04631 GENEFORM Protein DME1097 XEOTICID XEO04631 MOACRIVE Inhibition DME1097 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1097 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04633 XEO_CLAS Peptide DME1097 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 ug/ml) DME1097 XEOTICID XEO04633 GENEFORM Protein DME1097 XEOTICID XEO04633 MOACRIVE Inhibition DME1097 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1097 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04634 XEO_CLAS Peptide DME1097 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 ug/ml) DME1097 XEOTICID XEO04634 GENEFORM Protein DME1097 XEOTICID XEO04634 MOACRIVE Inhibition DME1097 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1097 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04635 XEO_CLAS Peptide DME1097 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 ug/ml) DME1097 XEOTICID XEO04635 GENEFORM Protein DME1097 XEOTICID XEO04635 MOACRIVE Inhibition DME1097 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1097 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04636 XEO_CLAS Peptide DME1097 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 ug/ml) DME1097 XEOTICID XEO04636 GENEFORM Protein DME1097 XEOTICID XEO04636 MOACRIVE Inhibition DME1097 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1097 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04637 XEO_CLAS Peptide DME1097 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 ug/ml) DME1097 XEOTICID XEO04637 GENEFORM Protein DME1097 XEOTICID XEO04637 MOACRIVE Inhibition DME1097 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1097 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04638 XEO_CLAS Peptide DME1097 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 ug/ml) DME1097 XEOTICID XEO04638 GENEFORM Protein DME1097 XEOTICID XEO04638 MOACRIVE Inhibition DME1097 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1097 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04639 XEO_CLAS Peptide DME1097 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 ug/ml) DME1097 XEOTICID XEO04639 GENEFORM Protein DME1097 XEOTICID XEO04639 MOACRIVE Inhibition DME1097 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1097 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04640 XEO_CLAS Peptide DME1097 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.2-3.3 microM) DME1097 XEOTICID XEO04640 GENEFORM Protein DME1097 XEOTICID XEO04640 MOACRIVE Inhibition DME1097 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1097 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04642 XEO_CLAS Peptide DME1097 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 ug/ml) DME1097 XEOTICID XEO04642 GENEFORM Protein DME1097 XEOTICID XEO04642 MOACRIVE Inhibition DME1097 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1097 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04643 XEO_CLAS Peptide DME1097 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO04643 GENEFORM Protein DME1097 XEOTICID XEO04643 MOACRIVE Inhibition DME1097 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1097 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04644 XEO_CLAS Peptide DME1097 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO04644 GENEFORM Protein DME1097 XEOTICID XEO04644 MOACRIVE Inhibition DME1097 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1097 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04645 XEO_CLAS Peptide DME1097 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 ug/ml) DME1097 XEOTICID XEO04645 GENEFORM Protein DME1097 XEOTICID XEO04645 MOACRIVE Inhibition DME1097 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1097 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04646 XEO_CLAS Peptide DME1097 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1 ug/ml) DME1097 XEOTICID XEO04646 GENEFORM Protein DME1097 XEOTICID XEO04646 MOACRIVE Inhibition DME1097 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1097 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04647 XEO_CLAS Peptide DME1097 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO04647 GENEFORM Protein DME1097 XEOTICID XEO04647 MOACRIVE Inhibition DME1097 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1097 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04648 XEO_CLAS Peptide DME1097 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 ug/ml) DME1097 XEOTICID XEO04648 GENEFORM Protein DME1097 XEOTICID XEO04648 MOACRIVE Inhibition DME1097 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1097 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04649 XEO_CLAS Peptide DME1097 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 64 ug/ml) DME1097 XEOTICID XEO04649 GENEFORM Protein DME1097 XEOTICID XEO04649 MOACRIVE Inhibition DME1097 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1097 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04650 XEO_CLAS Peptide DME1097 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 ug/ml) DME1097 XEOTICID XEO04650 GENEFORM Protein DME1097 XEOTICID XEO04650 MOACRIVE Inhibition DME1097 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1097 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04651 XEO_CLAS Peptide DME1097 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 ug/ml) DME1097 XEOTICID XEO04651 GENEFORM Protein DME1097 XEOTICID XEO04651 MOACRIVE Inhibition DME1097 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1097 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04652 XEO_CLAS Peptide DME1097 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO04652 GENEFORM Protein DME1097 XEOTICID XEO04652 MOACRIVE Inhibition DME1097 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1097 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04653 XEO_CLAS Peptide DME1097 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 64 ug/ml) DME1097 XEOTICID XEO04653 GENEFORM Protein DME1097 XEOTICID XEO04653 MOACRIVE Inhibition DME1097 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1097 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04654 XEO_CLAS Peptide DME1097 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 ug/ml) DME1097 XEOTICID XEO04654 GENEFORM Protein DME1097 XEOTICID XEO04654 MOACRIVE Inhibition DME1097 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1097 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04655 XEO_CLAS Peptide DME1097 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO04655 GENEFORM Protein DME1097 XEOTICID XEO04655 MOACRIVE Inhibition DME1097 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1097 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04657 XEO_CLAS Peptide DME1097 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 300 microM) DME1097 XEOTICID XEO04657 GENEFORM Protein DME1097 XEOTICID XEO04657 MOACRIVE Inhibition DME1097 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1097 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04660 XEO_CLAS Peptide DME1097 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO04660 GENEFORM Protein DME1097 XEOTICID XEO04660 MOACRIVE Inhibition DME1097 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1097 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04661 XEO_CLAS Peptide DME1097 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 microM) DME1097 XEOTICID XEO04661 GENEFORM Protein DME1097 XEOTICID XEO04661 MOACRIVE Inhibition DME1097 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1097 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04662 XEO_CLAS Peptide DME1097 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 microM) DME1097 XEOTICID XEO04662 GENEFORM Protein DME1097 XEOTICID XEO04662 MOACRIVE Inhibition DME1097 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1097 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04663 XEO_CLAS Peptide DME1097 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 microM) DME1097 XEOTICID XEO04663 GENEFORM Protein DME1097 XEOTICID XEO04663 MOACRIVE Inhibition DME1097 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1097 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04664 XEO_CLAS Peptide DME1097 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5.5 microM) DME1097 XEOTICID XEO04664 GENEFORM Protein DME1097 XEOTICID XEO04664 MOACRIVE Inhibition DME1097 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1097 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04665 XEO_CLAS Peptide DME1097 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 microM) DME1097 XEOTICID XEO04665 GENEFORM Protein DME1097 XEOTICID XEO04665 MOACRIVE Inhibition DME1097 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1097 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04666 XEO_CLAS Peptide DME1097 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO04666 GENEFORM Protein DME1097 XEOTICID XEO04666 MOACRIVE Inhibition DME1097 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1097 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04667 XEO_CLAS Peptide DME1097 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6.25 microM) DME1097 XEOTICID XEO04667 GENEFORM Protein DME1097 XEOTICID XEO04667 MOACRIVE Inhibition DME1097 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1097 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04668 XEO_CLAS Peptide DME1097 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 microM) DME1097 XEOTICID XEO04668 GENEFORM Protein DME1097 XEOTICID XEO04668 MOACRIVE Inhibition DME1097 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1097 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04669 XEO_CLAS Peptide DME1097 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO04669 GENEFORM Protein DME1097 XEOTICID XEO04669 MOACRIVE Inhibition DME1097 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1097 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04670 XEO_CLAS Peptide DME1097 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 21 microM) DME1097 XEOTICID XEO04670 GENEFORM Protein DME1097 XEOTICID XEO04670 MOACRIVE Inhibition DME1097 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1097 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04671 XEO_CLAS Peptide DME1097 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 62 microM) DME1097 XEOTICID XEO04671 GENEFORM Protein DME1097 XEOTICID XEO04671 MOACRIVE Inhibition DME1097 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1097 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04672 XEO_CLAS Peptide DME1097 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO04672 GENEFORM Protein DME1097 XEOTICID XEO04672 MOACRIVE Inhibition DME1097 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1097 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04673 XEO_CLAS Peptide DME1097 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO04673 GENEFORM Protein DME1097 XEOTICID XEO04673 MOACRIVE Inhibition DME1097 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1097 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04674 XEO_CLAS Peptide DME1097 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 75 microM) DME1097 XEOTICID XEO04674 GENEFORM Protein DME1097 XEOTICID XEO04674 MOACRIVE Inhibition DME1097 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1097 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04675 XEO_CLAS Peptide DME1097 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 microM) DME1097 XEOTICID XEO04675 GENEFORM Protein DME1097 XEOTICID XEO04675 MOACRIVE Inhibition DME1097 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1097 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04676 XEO_CLAS Peptide DME1097 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 microM) DME1097 XEOTICID XEO04676 GENEFORM Protein DME1097 XEOTICID XEO04676 MOACRIVE Inhibition DME1097 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1097 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04677 XEO_CLAS Peptide DME1097 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO04677 GENEFORM Protein DME1097 XEOTICID XEO04677 MOACRIVE Inhibition DME1097 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1097 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04680 XEO_CLAS Peptide DME1097 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 microM) DME1097 XEOTICID XEO04680 GENEFORM Protein DME1097 XEOTICID XEO04680 MOACRIVE Inhibition DME1097 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1097 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04682 XEO_CLAS Peptide DME1097 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 microM) DME1097 XEOTICID XEO04682 GENEFORM Protein DME1097 XEOTICID XEO04682 MOACRIVE Inhibition DME1097 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1097 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04683 XEO_CLAS Peptide DME1097 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 microM) DME1097 XEOTICID XEO04683 GENEFORM Protein DME1097 XEOTICID XEO04683 MOACRIVE Inhibition DME1097 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1097 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04684 XEO_CLAS Peptide DME1097 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 38 microM) DME1097 XEOTICID XEO04684 GENEFORM Protein DME1097 XEOTICID XEO04684 MOACRIVE Inhibition DME1097 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1097 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04690 XEO_CLAS Peptide DME1097 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.5 ug/ml) DME1097 XEOTICID XEO04690 GENEFORM Protein DME1097 XEOTICID XEO04690 MOACRIVE Inhibition DME1097 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1097 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04695 XEO_CLAS Peptide DME1097 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04695 GENEFORM Protein DME1097 XEOTICID XEO04695 MOACRIVE Inhibition DME1097 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1097 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04696 XEO_CLAS Peptide DME1097 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04696 GENEFORM Protein DME1097 XEOTICID XEO04696 MOACRIVE Inhibition DME1097 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1097 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04712 XEO_CLAS Peptide DME1097 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16.7 microM) DME1097 XEOTICID XEO04712 GENEFORM Protein DME1097 XEOTICID XEO04712 MOACRIVE Inhibition DME1097 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1097 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04713 XEO_CLAS Peptide DME1097 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16.7 microM) DME1097 XEOTICID XEO04713 GENEFORM Protein DME1097 XEOTICID XEO04713 MOACRIVE Inhibition DME1097 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1097 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04714 XEO_CLAS Peptide DME1097 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 23.3 microM) DME1097 XEOTICID XEO04714 GENEFORM Protein DME1097 XEOTICID XEO04714 MOACRIVE Inhibition DME1097 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1097 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04716 XEO_CLAS Peptide DME1097 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 microM) DME1097 XEOTICID XEO04716 GENEFORM Protein DME1097 XEOTICID XEO04716 MOACRIVE Inhibition DME1097 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1097 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04717 XEO_CLAS Peptide DME1097 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 50 microM) DME1097 XEOTICID XEO04717 GENEFORM Protein DME1097 XEOTICID XEO04717 MOACRIVE Inhibition DME1097 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1097 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04725 XEO_CLAS Peptide DME1097 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04725 GENEFORM Protein DME1097 XEOTICID XEO04725 MOACRIVE Inhibition DME1097 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1097 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04726 XEO_CLAS Peptide DME1097 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04726 GENEFORM Protein DME1097 XEOTICID XEO04726 MOACRIVE Inhibition DME1097 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1097 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04731 XEO_CLAS Peptide DME1097 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 ug/ml) DME1097 XEOTICID XEO04731 GENEFORM Protein DME1097 XEOTICID XEO04731 MOACRIVE Inhibition DME1097 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1097 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04732 XEO_CLAS Peptide DME1097 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 25 ug/ml) DME1097 XEOTICID XEO04732 GENEFORM Protein DME1097 XEOTICID XEO04732 MOACRIVE Inhibition DME1097 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1097 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04733 XEO_CLAS Peptide DME1097 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04733 GENEFORM Protein DME1097 XEOTICID XEO04733 MOACRIVE Inhibition DME1097 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1097 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04734 XEO_CLAS Peptide DME1097 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04734 GENEFORM Protein DME1097 XEOTICID XEO04734 MOACRIVE Inhibition DME1097 XEOTICID XEO04737 XEO_NAME Protonectin DME1097 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04737 XEO_CLAS Peptide DME1097 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 ug/ml) DME1097 XEOTICID XEO04737 GENEFORM Protein DME1097 XEOTICID XEO04737 MOACRIVE Inhibition DME1097 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1097 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04739 XEO_CLAS Peptide DME1097 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04739 GENEFORM Protein DME1097 XEOTICID XEO04739 MOACRIVE Inhibition DME1097 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1097 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04740 XEO_CLAS Peptide DME1097 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04740 GENEFORM Protein DME1097 XEOTICID XEO04740 MOACRIVE Inhibition DME1097 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1097 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04741 XEO_CLAS Peptide DME1097 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04741 GENEFORM Protein DME1097 XEOTICID XEO04741 MOACRIVE Inhibition DME1097 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1097 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04742 XEO_CLAS Peptide DME1097 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04742 GENEFORM Protein DME1097 XEOTICID XEO04742 MOACRIVE Inhibition DME1097 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1097 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04762 XEO_CLAS Peptide DME1097 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.8 microM) DME1097 XEOTICID XEO04762 GENEFORM Protein DME1097 XEOTICID XEO04762 MOACRIVE Inhibition DME1097 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1097 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04766 XEO_CLAS Peptide DME1097 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.1 microM) DME1097 XEOTICID XEO04766 GENEFORM Protein DME1097 XEOTICID XEO04766 MOACRIVE Inhibition DME1097 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1097 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04767 XEO_CLAS Peptide DME1097 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.1 ug/ml) DME1097 XEOTICID XEO04767 GENEFORM Protein DME1097 XEOTICID XEO04767 MOACRIVE Inhibition DME1097 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1097 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04779 XEO_CLAS Peptide DME1097 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04779 GENEFORM Protein DME1097 XEOTICID XEO04779 MOACRIVE Inhibition DME1097 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1097 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04780 XEO_CLAS Peptide DME1097 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04780 GENEFORM Protein DME1097 XEOTICID XEO04780 MOACRIVE Inhibition DME1097 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1097 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04781 XEO_CLAS Peptide DME1097 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04781 GENEFORM Protein DME1097 XEOTICID XEO04781 MOACRIVE Inhibition DME1097 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1097 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04782 XEO_CLAS Peptide DME1097 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 ug/ml) DME1097 XEOTICID XEO04782 GENEFORM Protein DME1097 XEOTICID XEO04782 MOACRIVE Inhibition DME1097 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1097 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04783 XEO_CLAS Peptide DME1097 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO04783 GENEFORM Protein DME1097 XEOTICID XEO04783 MOACRIVE Inhibition DME1097 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1097 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04784 XEO_CLAS Peptide DME1097 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO04784 GENEFORM Protein DME1097 XEOTICID XEO04784 MOACRIVE Inhibition DME1097 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1097 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04785 XEO_CLAS Peptide DME1097 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO04785 GENEFORM Protein DME1097 XEOTICID XEO04785 MOACRIVE Inhibition DME1097 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1097 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04786 XEO_CLAS Peptide DME1097 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 ug/ml) DME1097 XEOTICID XEO04786 GENEFORM Protein DME1097 XEOTICID XEO04786 MOACRIVE Inhibition DME1097 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1097 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04787 XEO_CLAS Peptide DME1097 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04787 GENEFORM Protein DME1097 XEOTICID XEO04787 MOACRIVE Inhibition DME1097 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1097 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04793 XEO_CLAS Peptide DME1097 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04793 GENEFORM Protein DME1097 XEOTICID XEO04793 MOACRIVE Inhibition DME1097 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1097 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04798 XEO_CLAS Peptide DME1097 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 microM) DME1097 XEOTICID XEO04798 GENEFORM Protein DME1097 XEOTICID XEO04798 MOACRIVE Inhibition DME1097 XEOTICID XEO04799 XEO_NAME Ranalexin DME1097 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04799 XEO_CLAS Peptide DME1097 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 32 ug/ml) DME1097 XEOTICID XEO04799 GENEFORM Protein DME1097 XEOTICID XEO04799 MOACRIVE Inhibition DME1097 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1097 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04800 XEO_CLAS Peptide DME1097 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 microM) DME1097 XEOTICID XEO04800 GENEFORM Protein DME1097 XEOTICID XEO04800 MOACRIVE Inhibition DME1097 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1097 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04801 XEO_CLAS Peptide DME1097 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 9 microM) DME1097 XEOTICID XEO04801 GENEFORM Protein DME1097 XEOTICID XEO04801 MOACRIVE Inhibition DME1097 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1097 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04802 XEO_CLAS Peptide DME1097 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12 microM) DME1097 XEOTICID XEO04802 GENEFORM Protein DME1097 XEOTICID XEO04802 MOACRIVE Inhibition DME1097 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1097 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04803 XEO_CLAS Peptide DME1097 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO04803 GENEFORM Protein DME1097 XEOTICID XEO04803 MOACRIVE Inhibition DME1097 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1097 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04804 XEO_CLAS Peptide DME1097 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO04804 GENEFORM Protein DME1097 XEOTICID XEO04804 MOACRIVE Inhibition DME1097 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1097 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04805 XEO_CLAS Peptide DME1097 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.5 microM) DME1097 XEOTICID XEO04805 GENEFORM Protein DME1097 XEOTICID XEO04805 MOACRIVE Inhibition DME1097 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1097 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04806 XEO_CLAS Peptide DME1097 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.5 microM) DME1097 XEOTICID XEO04806 GENEFORM Protein DME1097 XEOTICID XEO04806 MOACRIVE Inhibition DME1097 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1097 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04807 XEO_CLAS Peptide DME1097 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04807 GENEFORM Protein DME1097 XEOTICID XEO04807 MOACRIVE Inhibition DME1097 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1097 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04809 XEO_CLAS Peptide DME1097 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 microM) DME1097 XEOTICID XEO04809 GENEFORM Protein DME1097 XEOTICID XEO04809 MOACRIVE Inhibition DME1097 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1097 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04811 XEO_CLAS Peptide DME1097 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO04811 GENEFORM Protein DME1097 XEOTICID XEO04811 MOACRIVE Inhibition DME1097 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1097 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04812 XEO_CLAS Peptide DME1097 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO04812 GENEFORM Protein DME1097 XEOTICID XEO04812 MOACRIVE Inhibition DME1097 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1097 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04813 XEO_CLAS Peptide DME1097 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 microM) DME1097 XEOTICID XEO04813 GENEFORM Protein DME1097 XEOTICID XEO04813 MOACRIVE Inhibition DME1097 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1097 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04814 XEO_CLAS Peptide DME1097 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 19 microM) DME1097 XEOTICID XEO04814 GENEFORM Protein DME1097 XEOTICID XEO04814 MOACRIVE Inhibition DME1097 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1097 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04815 XEO_CLAS Peptide DME1097 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 microM) DME1097 XEOTICID XEO04815 GENEFORM Protein DME1097 XEOTICID XEO04815 MOACRIVE Inhibition DME1097 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1097 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04816 XEO_CLAS Peptide DME1097 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 microM) DME1097 XEOTICID XEO04816 GENEFORM Protein DME1097 XEOTICID XEO04816 MOACRIVE Inhibition DME1097 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1097 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04817 XEO_CLAS Peptide DME1097 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 13 microM) DME1097 XEOTICID XEO04817 GENEFORM Protein DME1097 XEOTICID XEO04817 MOACRIVE Inhibition DME1097 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1097 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04818 XEO_CLAS Peptide DME1097 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO04818 GENEFORM Protein DME1097 XEOTICID XEO04818 MOACRIVE Inhibition DME1097 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1097 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04819 XEO_CLAS Peptide DME1097 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO04819 GENEFORM Protein DME1097 XEOTICID XEO04819 MOACRIVE Inhibition DME1097 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1097 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04820 XEO_CLAS Peptide DME1097 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3 microM) DME1097 XEOTICID XEO04820 GENEFORM Protein DME1097 XEOTICID XEO04820 MOACRIVE Inhibition DME1097 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1097 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04821 XEO_CLAS Peptide DME1097 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 microM) DME1097 XEOTICID XEO04821 GENEFORM Protein DME1097 XEOTICID XEO04821 MOACRIVE Inhibition DME1097 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1097 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04822 XEO_CLAS Peptide DME1097 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO04822 GENEFORM Protein DME1097 XEOTICID XEO04822 MOACRIVE Inhibition DME1097 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1097 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04823 XEO_CLAS Peptide DME1097 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 23 microM) DME1097 XEOTICID XEO04823 GENEFORM Protein DME1097 XEOTICID XEO04823 MOACRIVE Inhibition DME1097 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1097 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04824 XEO_CLAS Peptide DME1097 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04824 GENEFORM Protein DME1097 XEOTICID XEO04824 MOACRIVE Inhibition DME1097 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1097 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04825 XEO_CLAS Peptide DME1097 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04825 GENEFORM Protein DME1097 XEOTICID XEO04825 MOACRIVE Inhibition DME1097 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1097 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04826 XEO_CLAS Peptide DME1097 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO04826 GENEFORM Protein DME1097 XEOTICID XEO04826 MOACRIVE Inhibition DME1097 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1097 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04827 XEO_CLAS Peptide DME1097 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO04827 GENEFORM Protein DME1097 XEOTICID XEO04827 MOACRIVE Inhibition DME1097 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1097 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04835 XEO_CLAS Peptide DME1097 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04835 GENEFORM Protein DME1097 XEOTICID XEO04835 MOACRIVE Inhibition DME1097 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1097 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04836 XEO_CLAS Peptide DME1097 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04836 GENEFORM Protein DME1097 XEOTICID XEO04836 MOACRIVE Inhibition DME1097 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1097 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04837 XEO_CLAS Peptide DME1097 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 microM) DME1097 XEOTICID XEO04837 GENEFORM Protein DME1097 XEOTICID XEO04837 MOACRIVE Inhibition DME1097 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1097 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04839 XEO_CLAS Peptide DME1097 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04839 GENEFORM Protein DME1097 XEOTICID XEO04839 MOACRIVE Inhibition DME1097 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1097 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04840 XEO_CLAS Peptide DME1097 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 35-20 microM) DME1097 XEOTICID XEO04840 GENEFORM Protein DME1097 XEOTICID XEO04840 MOACRIVE Inhibition DME1097 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1097 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04847 XEO_CLAS Peptide DME1097 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04847 GENEFORM Protein DME1097 XEOTICID XEO04847 MOACRIVE Inhibition DME1097 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1097 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04848 XEO_CLAS Peptide DME1097 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04848 GENEFORM Protein DME1097 XEOTICID XEO04848 MOACRIVE Inhibition DME1097 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1097 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04849 XEO_CLAS Peptide DME1097 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04849 GENEFORM Protein DME1097 XEOTICID XEO04849 MOACRIVE Inhibition DME1097 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1097 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04850 XEO_CLAS Peptide DME1097 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04850 GENEFORM Protein DME1097 XEOTICID XEO04850 MOACRIVE Inhibition DME1097 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1097 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04851 XEO_CLAS Peptide DME1097 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1 ug/ml) DME1097 XEOTICID XEO04851 GENEFORM Protein DME1097 XEOTICID XEO04851 MOACRIVE Inhibition DME1097 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1097 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04857 XEO_CLAS Peptide DME1097 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 microM) DME1097 XEOTICID XEO04857 GENEFORM Protein DME1097 XEOTICID XEO04857 MOACRIVE Inhibition DME1097 XEOTICID XEO04863 XEO_NAME RTD peptide DME1097 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04863 XEO_CLAS Peptide DME1097 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.0 microM) DME1097 XEOTICID XEO04863 GENEFORM Protein DME1097 XEOTICID XEO04863 MOACRIVE Inhibition DME1097 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1097 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04865 XEO_CLAS Peptide DME1097 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 ug/ml) DME1097 XEOTICID XEO04865 GENEFORM Protein DME1097 XEOTICID XEO04865 MOACRIVE Inhibition DME1097 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1097 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04866 XEO_CLAS Peptide DME1097 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12.5 ug/ml) DME1097 XEOTICID XEO04866 GENEFORM Protein DME1097 XEOTICID XEO04866 MOACRIVE Inhibition DME1097 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1097 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04868 XEO_CLAS Peptide DME1097 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25.00 ug/ml) DME1097 XEOTICID XEO04868 GENEFORM Protein DME1097 XEOTICID XEO04868 MOACRIVE Inhibition DME1097 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1097 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04869 XEO_CLAS Peptide DME1097 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25.00 ug/ml) DME1097 XEOTICID XEO04869 GENEFORM Protein DME1097 XEOTICID XEO04869 MOACRIVE Inhibition DME1097 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1097 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04870 XEO_CLAS Peptide DME1097 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25.00 ug/ml) DME1097 XEOTICID XEO04870 GENEFORM Protein DME1097 XEOTICID XEO04870 MOACRIVE Inhibition DME1097 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1097 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04877 XEO_CLAS Peptide DME1097 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04877 GENEFORM Protein DME1097 XEOTICID XEO04877 MOACRIVE Inhibition DME1097 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1097 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04880 XEO_CLAS Peptide DME1097 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.5 ug/ml) DME1097 XEOTICID XEO04880 GENEFORM Protein DME1097 XEOTICID XEO04880 MOACRIVE Inhibition DME1097 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1097 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04886 XEO_CLAS Peptide DME1097 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.6 ug/ml) DME1097 XEOTICID XEO04886 GENEFORM Protein DME1097 XEOTICID XEO04886 MOACRIVE Inhibition DME1097 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1097 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04891 XEO_CLAS Peptide DME1097 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04891 GENEFORM Protein DME1097 XEOTICID XEO04891 MOACRIVE Inhibition DME1097 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1097 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04895 XEO_CLAS Peptide DME1097 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04895 GENEFORM Protein DME1097 XEOTICID XEO04895 MOACRIVE Inhibition DME1097 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1097 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04901 XEO_CLAS Peptide DME1097 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 microM) DME1097 XEOTICID XEO04901 GENEFORM Protein DME1097 XEOTICID XEO04901 MOACRIVE Inhibition DME1097 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1097 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04904 XEO_CLAS Peptide DME1097 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 78 ug/ml) DME1097 XEOTICID XEO04904 GENEFORM Protein DME1097 XEOTICID XEO04904 MOACRIVE Inhibition DME1097 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1097 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04905 XEO_CLAS Peptide DME1097 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04905 GENEFORM Protein DME1097 XEOTICID XEO04905 MOACRIVE Inhibition DME1097 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1097 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04906 XEO_CLAS Peptide DME1097 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04906 GENEFORM Protein DME1097 XEOTICID XEO04906 MOACRIVE Inhibition DME1097 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1097 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04907 XEO_CLAS Peptide DME1097 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04907 GENEFORM Protein DME1097 XEOTICID XEO04907 MOACRIVE Inhibition DME1097 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1097 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04908 XEO_CLAS Peptide DME1097 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04908 GENEFORM Protein DME1097 XEOTICID XEO04908 MOACRIVE Inhibition DME1097 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1097 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04909 XEO_CLAS Peptide DME1097 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04909 GENEFORM Protein DME1097 XEOTICID XEO04909 MOACRIVE Inhibition DME1097 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1097 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04915 XEO_CLAS Peptide DME1097 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 100 ug/ml) DME1097 XEOTICID XEO04915 GENEFORM Protein DME1097 XEOTICID XEO04915 MOACRIVE Inhibition DME1097 XEOTICID XEO04916 XEO_NAME Scopoletin DME1097 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1097 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04916 GENEFORM Protein DME1097 XEOTICID XEO04916 MOACRIVE Inhibition DME1097 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1097 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04926 XEO_CLAS Peptide DME1097 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04926 GENEFORM Protein DME1097 XEOTICID XEO04926 MOACRIVE Inhibition DME1097 XEOTICID XEO04931 XEO_NAME Shepherin I DME1097 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04931 XEO_CLAS Peptide DME1097 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04931 GENEFORM Protein DME1097 XEOTICID XEO04931 MOACRIVE Inhibition DME1097 XEOTICID XEO04932 XEO_NAME shepherin II DME1097 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04932 XEO_CLAS Peptide DME1097 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04932 GENEFORM Protein DME1097 XEOTICID XEO04932 MOACRIVE Inhibition DME1097 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1097 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04938 XEO_CLAS Peptide DME1097 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC <= 100 microM) DME1097 XEOTICID XEO04938 GENEFORM Protein DME1097 XEOTICID XEO04938 MOACRIVE Inhibition DME1097 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1097 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04947 XEO_CLAS Natural Product DME1097 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04947 GENEFORM Protein DME1097 XEOTICID XEO04947 MOACRIVE Inhibition DME1097 XEOTICID XEO04948 XEO_NAME Sinensetin DME1097 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1097 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1097 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04948 GENEFORM Protein DME1097 XEOTICID XEO04948 MOACRIVE Inhibition DME1097 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1097 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04950 XEO_CLAS Peptide DME1097 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 ug/ml) DME1097 XEOTICID XEO04950 GENEFORM Protein DME1097 XEOTICID XEO04950 MOACRIVE Inhibition DME1097 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1097 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04955 XEO_CLAS Peptide DME1097 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.07 microM) DME1097 XEOTICID XEO04955 GENEFORM Protein DME1097 XEOTICID XEO04955 MOACRIVE Inhibition DME1097 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1097 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04956 XEO_CLAS Peptide DME1097 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16.0 microM) DME1097 XEOTICID XEO04956 GENEFORM Protein DME1097 XEOTICID XEO04956 MOACRIVE Inhibition DME1097 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1097 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04957 XEO_CLAS Peptide DME1097 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.23 microM) DME1097 XEOTICID XEO04957 GENEFORM Protein DME1097 XEOTICID XEO04957 MOACRIVE Inhibition DME1097 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1097 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04958 XEO_CLAS Peptide DME1097 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 ug/ml) DME1097 XEOTICID XEO04958 GENEFORM Protein DME1097 XEOTICID XEO04958 MOACRIVE Inhibition DME1097 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1097 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04959 XEO_CLAS Peptide DME1097 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04959 GENEFORM Protein DME1097 XEOTICID XEO04959 MOACRIVE Inhibition DME1097 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1097 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04967 XEO_CLAS Peptide DME1097 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 28 microM) DME1097 XEOTICID XEO04967 GENEFORM Protein DME1097 XEOTICID XEO04967 MOACRIVE Inhibition DME1097 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1097 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04969 XEO_CLAS Peptide DME1097 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50-100 ug/ml) DME1097 XEOTICID XEO04969 GENEFORM Protein DME1097 XEOTICID XEO04969 MOACRIVE Inhibition DME1097 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1097 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04970 XEO_CLAS Peptide DME1097 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04970 GENEFORM Protein DME1097 XEOTICID XEO04970 MOACRIVE Inhibition DME1097 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1097 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04971 XEO_CLAS Peptide DME1097 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.8-1.5 microM) DME1097 XEOTICID XEO04971 GENEFORM Protein DME1097 XEOTICID XEO04971 MOACRIVE Inhibition DME1097 XEOTICID XEO04974 XEO_NAME Spinigerin DME1097 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04974 XEO_CLAS Peptide DME1097 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3-6 microM) DME1097 XEOTICID XEO04974 GENEFORM Protein DME1097 XEOTICID XEO04974 MOACRIVE Inhibition DME1097 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1097 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1097 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04975 GENEFORM Protein DME1097 XEOTICID XEO04975 MOACRIVE Inhibition DME1097 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1097 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1097 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04976 GENEFORM Protein DME1097 XEOTICID XEO04976 MOACRIVE Inhibition DME1097 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1097 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1097 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04977 GENEFORM Protein DME1097 XEOTICID XEO04977 MOACRIVE Inhibition DME1097 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1097 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1097 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04978 GENEFORM Protein DME1097 XEOTICID XEO04978 MOACRIVE Inhibition DME1097 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1097 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1097 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04979 GENEFORM Protein DME1097 XEOTICID XEO04979 MOACRIVE Inhibition DME1097 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1097 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04981 XEO_CLAS Peptide DME1097 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10.1 microM) DME1097 XEOTICID XEO04981 GENEFORM Protein DME1097 XEOTICID XEO04981 MOACRIVE Inhibition DME1097 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1097 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04982 XEO_CLAS Peptide DME1097 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40.5 microM) DME1097 XEOTICID XEO04982 GENEFORM Protein DME1097 XEOTICID XEO04982 MOACRIVE Inhibition DME1097 XEOTICID XEO04994 XEO_NAME Stilbene DME1097 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1097 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1097 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO04994 GENEFORM Protein DME1097 XEOTICID XEO04994 MOACRIVE Inhibition DME1097 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1097 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04995 XEO_CLAS Peptide DME1097 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC < 0.19 microM) DME1097 XEOTICID XEO04995 GENEFORM Protein DME1097 XEOTICID XEO04995 MOACRIVE Inhibition DME1097 XEOTICID XEO04998 XEO_NAME Styelin A DME1097 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04998 XEO_CLAS Peptide DME1097 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.7 ug/ml) DME1097 XEOTICID XEO04998 GENEFORM Protein DME1097 XEOTICID XEO04998 MOACRIVE Inhibition DME1097 XEOTICID XEO04999 XEO_NAME Styelin B DME1097 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO04999 XEO_CLAS Peptide DME1097 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.7 ug/ml) DME1097 XEOTICID XEO04999 GENEFORM Protein DME1097 XEOTICID XEO04999 MOACRIVE Inhibition DME1097 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1097 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05000 XEO_CLAS Peptide DME1097 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO05000 GENEFORM Protein DME1097 XEOTICID XEO05000 MOACRIVE Inhibition DME1097 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1097 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05001 XEO_CLAS Peptide DME1097 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.5 ug/ml) DME1097 XEOTICID XEO05001 GENEFORM Protein DME1097 XEOTICID XEO05001 MOACRIVE Inhibition DME1097 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1097 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05002 XEO_CLAS Peptide DME1097 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO05002 GENEFORM Protein DME1097 XEOTICID XEO05002 MOACRIVE Inhibition DME1097 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1097 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05003 XEO_CLAS Peptide DME1097 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO05003 GENEFORM Protein DME1097 XEOTICID XEO05003 MOACRIVE Inhibition DME1097 XEOTICID XEO05006 XEO_NAME Substance P DME1097 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05006 XEO_CLAS Peptide DME1097 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05006 GENEFORM Protein DME1097 XEOTICID XEO05006 MOACRIVE Inhibition DME1097 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1097 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05007 XEO_CLAS Peptide DME1097 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05007 GENEFORM Protein DME1097 XEOTICID XEO05007 MOACRIVE Inhibition DME1097 XEOTICID XEO05008 XEO_NAME Subtilosin DME1097 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05008 XEO_CLAS Peptide DME1097 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05008 GENEFORM Protein DME1097 XEOTICID XEO05008 MOACRIVE Inhibition DME1097 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1097 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05013 XEO_CLAS Peptide DME1097 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO05013 GENEFORM Protein DME1097 XEOTICID XEO05013 MOACRIVE Inhibition DME1097 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1097 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05014 XEO_CLAS Peptide DME1097 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO05014 GENEFORM Protein DME1097 XEOTICID XEO05014 MOACRIVE Inhibition DME1097 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1097 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05015 XEO_CLAS Peptide DME1097 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO05015 GENEFORM Protein DME1097 XEOTICID XEO05015 MOACRIVE Inhibition DME1097 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1097 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05016 XEO_CLAS Peptide DME1097 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO05016 GENEFORM Protein DME1097 XEOTICID XEO05016 MOACRIVE Inhibition DME1097 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1097 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05017 XEO_CLAS Peptide DME1097 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 20 ug/ml) DME1097 XEOTICID XEO05017 GENEFORM Protein DME1097 XEOTICID XEO05017 MOACRIVE Inhibition DME1097 XEOTICID XEO05018 XEO_NAME Syringic acid DME1097 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1097 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05018 GENEFORM Protein DME1097 XEOTICID XEO05018 MOACRIVE Inhibition DME1097 XEOTICID XEO05020 XEO_NAME Tachycitin DME1097 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05020 XEO_CLAS Peptide DME1097 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05020 GENEFORM Protein DME1097 XEOTICID XEO05020 MOACRIVE Inhibition DME1097 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1097 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05023 XEO_CLAS Peptide DME1097 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05023 GENEFORM Protein DME1097 XEOTICID XEO05023 MOACRIVE Inhibition DME1097 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1097 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05024 XEO_CLAS Peptide DME1097 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05024 GENEFORM Protein DME1097 XEOTICID XEO05024 MOACRIVE Inhibition DME1097 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1097 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05027 XEO_CLAS Peptide DME1097 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05027 GENEFORM Protein DME1097 XEOTICID XEO05027 MOACRIVE Inhibition DME1097 XEOTICID XEO05031 XEO_NAME Tannic acid DME1097 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1097 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05031 GENEFORM Protein DME1097 XEOTICID XEO05031 MOACRIVE Inhibition DME1097 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1097 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05033 XEO_CLAS Peptide DME1097 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05033 GENEFORM Protein DME1097 XEOTICID XEO05033 MOACRIVE Inhibition DME1097 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1097 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05042 XEO_CLAS Peptide DME1097 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO05042 GENEFORM Protein DME1097 XEOTICID XEO05042 MOACRIVE Inhibition DME1097 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1097 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05043 XEO_CLAS Peptide DME1097 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO05043 GENEFORM Protein DME1097 XEOTICID XEO05043 MOACRIVE Inhibition DME1097 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1097 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05044 XEO_CLAS Peptide DME1097 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 128 microM) DME1097 XEOTICID XEO05044 GENEFORM Protein DME1097 XEOTICID XEO05044 MOACRIVE Inhibition DME1097 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1097 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05045 XEO_CLAS Peptide DME1097 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 128 microM) DME1097 XEOTICID XEO05045 GENEFORM Protein DME1097 XEOTICID XEO05045 MOACRIVE Inhibition DME1097 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1097 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05046 XEO_CLAS Peptide DME1097 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 microM) DME1097 XEOTICID XEO05046 GENEFORM Protein DME1097 XEOTICID XEO05046 MOACRIVE Inhibition DME1097 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1097 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05047 XEO_CLAS Peptide DME1097 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 60 microM) DME1097 XEOTICID XEO05047 GENEFORM Protein DME1097 XEOTICID XEO05047 MOACRIVE Inhibition DME1097 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1097 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05051 XEO_CLAS Peptide DME1097 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05051 GENEFORM Protein DME1097 XEOTICID XEO05051 MOACRIVE Inhibition DME1097 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1097 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05055 XEO_CLAS Peptide DME1097 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 70 microM) DME1097 XEOTICID XEO05055 GENEFORM Protein DME1097 XEOTICID XEO05055 MOACRIVE Inhibition DME1097 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1097 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05056 XEO_CLAS Peptide DME1097 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05056 GENEFORM Protein DME1097 XEOTICID XEO05056 MOACRIVE Inhibition DME1097 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1097 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05059 XEO_CLAS Peptide DME1097 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05059 GENEFORM Protein DME1097 XEOTICID XEO05059 MOACRIVE Inhibition DME1097 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1097 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05061 XEO_CLAS Peptide DME1097 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO05061 GENEFORM Protein DME1097 XEOTICID XEO05061 MOACRIVE Inhibition DME1097 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1097 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05062 XEO_CLAS Peptide DME1097 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05062 GENEFORM Protein DME1097 XEOTICID XEO05062 MOACRIVE Inhibition DME1097 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1097 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05063 XEO_CLAS Peptide DME1097 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO05063 GENEFORM Protein DME1097 XEOTICID XEO05063 MOACRIVE Inhibition DME1097 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1097 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05064 XEO_CLAS Peptide DME1097 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 231 microM) DME1097 XEOTICID XEO05064 GENEFORM Protein DME1097 XEOTICID XEO05064 MOACRIVE Inhibition DME1097 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1097 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05065 XEO_CLAS Peptide DME1097 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 161 ug/ml) DME1097 XEOTICID XEO05065 GENEFORM Protein DME1097 XEOTICID XEO05065 MOACRIVE Inhibition DME1097 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1097 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05069 XEO_CLAS Peptide DME1097 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO05069 GENEFORM Protein DME1097 XEOTICID XEO05069 MOACRIVE Inhibition DME1097 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1097 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05070 XEO_CLAS Peptide DME1097 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 37.5 microM) DME1097 XEOTICID XEO05070 GENEFORM Protein DME1097 XEOTICID XEO05070 MOACRIVE Inhibition DME1097 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1097 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05071 XEO_CLAS Peptide DME1097 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 150 microM) DME1097 XEOTICID XEO05071 GENEFORM Protein DME1097 XEOTICID XEO05071 MOACRIVE Inhibition DME1097 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1097 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05072 XEO_CLAS Peptide DME1097 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO05072 GENEFORM Protein DME1097 XEOTICID XEO05072 MOACRIVE Inhibition DME1097 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1097 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05073 XEO_CLAS Peptide DME1097 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40 microM) DME1097 XEOTICID XEO05073 GENEFORM Protein DME1097 XEOTICID XEO05073 MOACRIVE Inhibition DME1097 XEOTICID XEO05076 XEO_NAME Temporin-A DME1097 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05076 XEO_CLAS Peptide DME1097 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 11.9 microM) DME1097 XEOTICID XEO05076 GENEFORM Protein DME1097 XEOTICID XEO05076 MOACRIVE Inhibition DME1097 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1097 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05077 XEO_CLAS Peptide DME1097 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.25 ug/ml) DME1097 XEOTICID XEO05077 GENEFORM Protein DME1097 XEOTICID XEO05077 MOACRIVE Inhibition DME1097 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1097 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05078 XEO_CLAS Peptide DME1097 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.25 ug/ml) DME1097 XEOTICID XEO05078 GENEFORM Protein DME1097 XEOTICID XEO05078 MOACRIVE Inhibition DME1097 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1097 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05079 XEO_CLAS Peptide DME1097 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.5 ug/ml) DME1097 XEOTICID XEO05079 GENEFORM Protein DME1097 XEOTICID XEO05079 MOACRIVE Inhibition DME1097 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1097 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05080 XEO_CLAS Peptide DME1097 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 ug/ml) DME1097 XEOTICID XEO05080 GENEFORM Protein DME1097 XEOTICID XEO05080 MOACRIVE Inhibition DME1097 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1097 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05081 XEO_CLAS Peptide DME1097 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 5 ug/ml) DME1097 XEOTICID XEO05081 GENEFORM Protein DME1097 XEOTICID XEO05081 MOACRIVE Inhibition DME1097 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1097 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05082 XEO_CLAS Peptide DME1097 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 7.5 ug/ml) DME1097 XEOTICID XEO05082 GENEFORM Protein DME1097 XEOTICID XEO05082 MOACRIVE Inhibition DME1097 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1097 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05083 XEO_CLAS Peptide DME1097 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 ug/ml) DME1097 XEOTICID XEO05083 GENEFORM Protein DME1097 XEOTICID XEO05083 MOACRIVE Inhibition DME1097 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1097 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05084 XEO_CLAS Peptide DME1097 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 ug/ml) DME1097 XEOTICID XEO05084 GENEFORM Protein DME1097 XEOTICID XEO05084 MOACRIVE Inhibition DME1097 XEOTICID XEO05085 XEO_NAME Temporin-B DME1097 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05085 XEO_CLAS Peptide DME1097 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 21.0 ug/ml) DME1097 XEOTICID XEO05085 GENEFORM Protein DME1097 XEOTICID XEO05085 MOACRIVE Inhibition DME1097 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1097 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05086 XEO_CLAS Peptide DME1097 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC > 100 microM) DME1097 XEOTICID XEO05086 GENEFORM Protein DME1097 XEOTICID XEO05086 MOACRIVE Inhibition DME1097 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1097 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05087 XEO_CLAS Peptide DME1097 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO05087 GENEFORM Protein DME1097 XEOTICID XEO05087 MOACRIVE Inhibition DME1097 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1097 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05097 XEO_CLAS Peptide DME1097 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16.0 microM) DME1097 XEOTICID XEO05097 GENEFORM Protein DME1097 XEOTICID XEO05097 MOACRIVE Inhibition DME1097 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1097 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05099 XEO_CLAS Peptide DME1097 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.0 microM) DME1097 XEOTICID XEO05099 GENEFORM Protein DME1097 XEOTICID XEO05099 MOACRIVE Inhibition DME1097 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1097 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05100 XEO_CLAS Peptide DME1097 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05100 GENEFORM Protein DME1097 XEOTICID XEO05100 MOACRIVE Inhibition DME1097 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1097 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05101 XEO_CLAS Peptide DME1097 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 24.2 ug/ml) DME1097 XEOTICID XEO05101 GENEFORM Protein DME1097 XEOTICID XEO05101 MOACRIVE Inhibition DME1097 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1097 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05102 XEO_CLAS Peptide DME1097 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 34.5 ug/ml) DME1097 XEOTICID XEO05102 GENEFORM Protein DME1097 XEOTICID XEO05102 MOACRIVE Inhibition DME1097 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1097 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05105 XEO_CLAS Peptide DME1097 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO05105 GENEFORM Protein DME1097 XEOTICID XEO05105 MOACRIVE Inhibition DME1097 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1097 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05106 XEO_CLAS Peptide DME1097 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25-200 microM) DME1097 XEOTICID XEO05106 GENEFORM Protein DME1097 XEOTICID XEO05106 MOACRIVE Inhibition DME1097 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1097 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05108 XEO_CLAS Peptide DME1097 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40 microM) DME1097 XEOTICID XEO05108 GENEFORM Protein DME1097 XEOTICID XEO05108 MOACRIVE Inhibition DME1097 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1097 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1097 XEOTICID XEO05111 XEO_CLAS Natural Product DME1097 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05111 GENEFORM Protein DME1097 XEOTICID XEO05111 MOACRIVE Inhibition DME1097 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1097 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05119 XEO_CLAS Peptide DME1097 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05119 GENEFORM Protein DME1097 XEOTICID XEO05119 MOACRIVE Inhibition DME1097 XEOTICID XEO05120 XEO_NAME Thanatin DME1097 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05120 XEO_CLAS Peptide DME1097 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1097 XEOTICID XEO05120 GENEFORM Protein DME1097 XEOTICID XEO05120 MOACRIVE Inhibition DME1097 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1097 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05121 XEO_CLAS Peptide DME1097 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 62.5 ug/ml) DME1097 XEOTICID XEO05121 GENEFORM Protein DME1097 XEOTICID XEO05121 MOACRIVE Inhibition DME1097 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1097 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05125 XEO_CLAS Peptide DME1097 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05125 GENEFORM Protein DME1097 XEOTICID XEO05125 MOACRIVE Inhibition DME1097 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1097 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05130 XEO_CLAS Peptide DME1097 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05130 GENEFORM Protein DME1097 XEOTICID XEO05130 MOACRIVE Inhibition DME1097 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1097 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05144 XEO_CLAS Peptide DME1097 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40 ug/ml) DME1097 XEOTICID XEO05144 GENEFORM Protein DME1097 XEOTICID XEO05144 MOACRIVE Inhibition DME1097 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1097 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05145 XEO_CLAS Peptide DME1097 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 ug/ml) DME1097 XEOTICID XEO05145 GENEFORM Protein DME1097 XEOTICID XEO05145 MOACRIVE Inhibition DME1097 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1097 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05146 XEO_CLAS Peptide DME1097 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 40 ug/ml) DME1097 XEOTICID XEO05146 GENEFORM Protein DME1097 XEOTICID XEO05146 MOACRIVE Inhibition DME1097 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1097 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05147 XEO_CLAS Peptide DME1097 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 60 ug/ml) DME1097 XEOTICID XEO05147 GENEFORM Protein DME1097 XEOTICID XEO05147 MOACRIVE Inhibition DME1097 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1097 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05158 XEO_CLAS Peptide DME1097 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05158 GENEFORM Protein DME1097 XEOTICID XEO05158 MOACRIVE Inhibition DME1097 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1097 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05161 XEO_CLAS Peptide DME1097 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 32 ug/ml) DME1097 XEOTICID XEO05161 GENEFORM Protein DME1097 XEOTICID XEO05161 MOACRIVE Inhibition DME1097 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1097 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05162 XEO_CLAS Peptide DME1097 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 32 ug/ml) DME1097 XEOTICID XEO05162 GENEFORM Protein DME1097 XEOTICID XEO05162 MOACRIVE Inhibition DME1097 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1097 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05163 XEO_CLAS Peptide DME1097 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 12-25 ug/ml) DME1097 XEOTICID XEO05163 GENEFORM Protein DME1097 XEOTICID XEO05163 MOACRIVE Inhibition DME1097 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1097 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05170 XEO_CLAS Peptide DME1097 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 3.0 microM) DME1097 XEOTICID XEO05170 GENEFORM Protein DME1097 XEOTICID XEO05170 MOACRIVE Inhibition DME1097 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1097 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05171 XEO_CLAS Peptide DME1097 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 50 microM) DME1097 XEOTICID XEO05171 GENEFORM Protein DME1097 XEOTICID XEO05171 MOACRIVE Inhibition DME1097 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1097 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05179 XEO_CLAS Peptide DME1097 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05179 GENEFORM Protein DME1097 XEOTICID XEO05179 MOACRIVE Inhibition DME1097 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1097 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05180 XEO_CLAS Peptide DME1097 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 160 microM) DME1097 XEOTICID XEO05180 GENEFORM Protein DME1097 XEOTICID XEO05180 MOACRIVE Inhibition DME1097 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1097 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05182 XEO_CLAS Peptide DME1097 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 microM) DME1097 XEOTICID XEO05182 GENEFORM Protein DME1097 XEOTICID XEO05182 MOACRIVE Inhibition DME1097 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1097 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05183 XEO_CLAS Peptide DME1097 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 microM) DME1097 XEOTICID XEO05183 GENEFORM Protein DME1097 XEOTICID XEO05183 MOACRIVE Inhibition DME1097 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1097 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05184 XEO_CLAS Peptide DME1097 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 microM) DME1097 XEOTICID XEO05184 GENEFORM Protein DME1097 XEOTICID XEO05184 MOACRIVE Inhibition DME1097 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1097 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05185 XEO_CLAS Peptide DME1097 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 microM) DME1097 XEOTICID XEO05185 GENEFORM Protein DME1097 XEOTICID XEO05185 MOACRIVE Inhibition DME1097 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1097 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05186 XEO_CLAS Peptide DME1097 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 microM) DME1097 XEOTICID XEO05186 GENEFORM Protein DME1097 XEOTICID XEO05186 MOACRIVE Inhibition DME1097 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1097 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05187 XEO_CLAS Peptide DME1097 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16 microM) DME1097 XEOTICID XEO05187 GENEFORM Protein DME1097 XEOTICID XEO05187 MOACRIVE Inhibition DME1097 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1097 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05188 XEO_CLAS Peptide DME1097 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 64 microM) DME1097 XEOTICID XEO05188 GENEFORM Protein DME1097 XEOTICID XEO05188 MOACRIVE Inhibition DME1097 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1097 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05190 XEO_CLAS Peptide DME1097 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05190 GENEFORM Protein DME1097 XEOTICID XEO05190 MOACRIVE Inhibition DME1097 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1097 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05193 XEO_CLAS Peptide DME1097 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO05193 GENEFORM Protein DME1097 XEOTICID XEO05193 MOACRIVE Inhibition DME1097 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1097 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05197 XEO_CLAS Peptide DME1097 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05197 GENEFORM Protein DME1097 XEOTICID XEO05197 MOACRIVE Inhibition DME1097 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1097 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05205 XEO_CLAS Peptide DME1097 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05205 GENEFORM Protein DME1097 XEOTICID XEO05205 MOACRIVE Inhibition DME1097 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1097 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05206 XEO_CLAS Peptide DME1097 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 10 microM) DME1097 XEOTICID XEO05206 GENEFORM Protein DME1097 XEOTICID XEO05206 MOACRIVE Inhibition DME1097 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1097 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05207 XEO_CLAS Peptide DME1097 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 25 microM) DME1097 XEOTICID XEO05207 GENEFORM Protein DME1097 XEOTICID XEO05207 MOACRIVE Inhibition DME1097 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1097 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05208 XEO_CLAS Peptide DME1097 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 microM) DME1097 XEOTICID XEO05208 GENEFORM Protein DME1097 XEOTICID XEO05208 MOACRIVE Inhibition DME1097 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1097 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05209 XEO_CLAS Peptide DME1097 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 15 microM) DME1097 XEOTICID XEO05209 GENEFORM Protein DME1097 XEOTICID XEO05209 MOACRIVE Inhibition DME1097 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1097 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05212 XEO_CLAS Peptide DME1097 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.5 ug/ml) DME1097 XEOTICID XEO05212 GENEFORM Protein DME1097 XEOTICID XEO05212 MOACRIVE Inhibition DME1097 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1097 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05220 XEO_CLAS Peptide DME1097 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.6-1.2 microM) DME1097 XEOTICID XEO05220 GENEFORM Protein DME1097 XEOTICID XEO05220 MOACRIVE Inhibition DME1097 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1097 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05230 XEO_CLAS Peptide DME1097 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 7.90 microM) DME1097 XEOTICID XEO05230 GENEFORM Protein DME1097 XEOTICID XEO05230 MOACRIVE Inhibition DME1097 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1097 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05231 XEO_CLAS Peptide DME1097 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2.40 microM) DME1097 XEOTICID XEO05231 GENEFORM Protein DME1097 XEOTICID XEO05231 MOACRIVE Inhibition DME1097 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1097 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05232 XEO_CLAS Peptide DME1097 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05232 GENEFORM Protein DME1097 XEOTICID XEO05232 MOACRIVE Inhibition DME1097 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1097 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05233 XEO_CLAS Peptide DME1097 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 ug/ml) DME1097 XEOTICID XEO05233 GENEFORM Protein DME1097 XEOTICID XEO05233 MOACRIVE Inhibition DME1097 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1097 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05234 XEO_CLAS Peptide DME1097 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 ug/ml) DME1097 XEOTICID XEO05234 GENEFORM Protein DME1097 XEOTICID XEO05234 MOACRIVE Inhibition DME1097 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1097 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05235 XEO_CLAS Peptide DME1097 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 30 ug/ml) DME1097 XEOTICID XEO05235 GENEFORM Protein DME1097 XEOTICID XEO05235 MOACRIVE Inhibition DME1097 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1097 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05237 XEO_CLAS Peptide DME1097 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 microM) DME1097 XEOTICID XEO05237 GENEFORM Protein DME1097 XEOTICID XEO05237 MOACRIVE Inhibition DME1097 XEOTICID XEO05245 XEO_NAME Viresin DME1097 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05245 XEO_CLAS Peptide DME1097 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05245 GENEFORM Protein DME1097 XEOTICID XEO05245 MOACRIVE Inhibition DME1097 XEOTICID XEO05248 XEO_NAME Vitamin C DME1097 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1097 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1097 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05248 GENEFORM Protein DME1097 XEOTICID XEO05248 MOACRIVE Inhibition DME1097 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1097 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05264 XEO_CLAS Peptide DME1097 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 4 ug/ml) DME1097 XEOTICID XEO05264 GENEFORM Protein DME1097 XEOTICID XEO05264 MOACRIVE Inhibition DME1097 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1097 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05267 XEO_CLAS Peptide DME1097 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 2 ug/ml) DME1097 XEOTICID XEO05267 GENEFORM Protein DME1097 XEOTICID XEO05267 MOACRIVE Inhibition DME1097 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1097 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05268 XEO_CLAS Peptide DME1097 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 1.6 ug/ml) DME1097 XEOTICID XEO05268 GENEFORM Protein DME1097 XEOTICID XEO05268 MOACRIVE Inhibition DME1097 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1097 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05269 XEO_CLAS Peptide DME1097 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 6 ug/ml) DME1097 XEOTICID XEO05269 GENEFORM Protein DME1097 XEOTICID XEO05269 MOACRIVE Inhibition DME1097 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1097 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05273 XEO_CLAS Peptide DME1097 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05273 GENEFORM Protein DME1097 XEOTICID XEO05273 MOACRIVE Inhibition DME1097 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1097 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05274 XEO_CLAS Peptide DME1097 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05274 GENEFORM Protein DME1097 XEOTICID XEO05274 MOACRIVE Inhibition DME1097 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1097 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05287 XEO_CLAS Peptide DME1097 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli DME1097 XEOTICID XEO05287 GENEFORM Protein DME1097 XEOTICID XEO05287 MOACRIVE Inhibition DME1097 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1097 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05303 XEO_CLAS Peptide DME1097 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 16-31 ug/ml) DME1097 XEOTICID XEO05303 GENEFORM Protein DME1097 XEOTICID XEO05303 MOACRIVE Inhibition DME1097 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1097 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05306 XEO_CLAS Peptide DME1097 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 8 ug/ml) DME1097 XEOTICID XEO05306 GENEFORM Protein DME1097 XEOTICID XEO05306 MOACRIVE Inhibition DME1097 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1097 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1097 XEOTICID XEO05308 XEO_CLAS Peptide DME1097 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of N-ethylmaleimide reductase (nemA) from Escherichia coli (MIC = 0.4 ug/ml) DME1097 XEOTICID XEO05308 GENEFORM Protein DME1097 XEOTICID XEO05308 MOACRIVE Inhibition DME1098 DME___ID DME1098 DME1098 DME_NAME Oxygen-insensitive NADPH nitroreductase A (nfsA) DME1098 SPESNAME Escherichia coli DME1098 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1098 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00117 GENEFORM Protein DME1098 XEOTICID XEO00117 MOACRIVE Inhibition DME1098 XEOTICID XEO00122 XEO_NAME Amikacin DME1098 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00122 GENEFORM Protein DME1098 XEOTICID XEO00122 MOACRIVE Inhibition DME1098 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1098 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00136 GENEFORM Protein DME1098 XEOTICID XEO00136 MOACRIVE Inhibition DME1098 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1098 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00237 GENEFORM Protein DME1098 XEOTICID XEO00237 MOACRIVE Inhibition DME1098 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1098 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00349 GENEFORM Protein DME1098 XEOTICID XEO00349 MOACRIVE Inhibition DME1098 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1098 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00425 GENEFORM Protein DME1098 XEOTICID XEO00425 MOACRIVE Inhibition DME1098 XEOTICID XEO00439 XEO_NAME Daidzein DME1098 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00439 GENEFORM Protein DME1098 XEOTICID XEO00439 MOACRIVE Inhibition DME1098 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1098 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00460 GENEFORM Protein DME1098 XEOTICID XEO00460 MOACRIVE Inhibition DME1098 XEOTICID XEO00487 XEO_NAME Thymol DME1098 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00487 GENEFORM Protein DME1098 XEOTICID XEO00487 MOACRIVE Inhibition DME1098 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1098 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00511 GENEFORM Protein DME1098 XEOTICID XEO00511 MOACRIVE Inhibition DME1098 XEOTICID XEO00537 XEO_NAME Luteolin DME1098 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1098 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00537 GENEFORM Protein DME1098 XEOTICID XEO00537 MOACRIVE Inhibition DME1098 XEOTICID XEO00538 XEO_NAME Quercetin DME1098 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1098 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00538 GENEFORM Protein DME1098 XEOTICID XEO00538 MOACRIVE Inhibition DME1098 XEOTICID XEO00547 XEO_NAME Vitamin E DME1098 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1098 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00547 GENEFORM Protein DME1098 XEOTICID XEO00547 MOACRIVE Inhibition DME1098 XEOTICID XEO00557 XEO_NAME Genistein DME1098 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1098 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00557 GENEFORM Protein DME1098 XEOTICID XEO00557 MOACRIVE Inhibition DME1098 XEOTICID XEO00566 XEO_NAME Guaiacol DME1098 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1098 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00566 GENEFORM Protein DME1098 XEOTICID XEO00566 MOACRIVE Inhibition DME1098 XEOTICID XEO00568 XEO_NAME Resveratrol DME1098 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1098 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00568 GENEFORM Protein DME1098 XEOTICID XEO00568 MOACRIVE Inhibition DME1098 XEOTICID XEO00573 XEO_NAME Naringenin DME1098 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1098 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00573 GENEFORM Protein DME1098 XEOTICID XEO00573 MOACRIVE Inhibition DME1098 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1098 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1098 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00574 GENEFORM Protein DME1098 XEOTICID XEO00574 MOACRIVE Inhibition DME1098 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1098 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1098 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00611 GENEFORM Protein DME1098 XEOTICID XEO00611 MOACRIVE Inhibition DME1098 XEOTICID XEO00621 XEO_NAME Chitosan DME1098 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1098 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00621 GENEFORM Protein DME1098 XEOTICID XEO00621 MOACRIVE Inhibition DME1098 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1098 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1098 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00646 GENEFORM Protein DME1098 XEOTICID XEO00646 MOACRIVE Inhibition DME1098 XEOTICID XEO00683 XEO_NAME Curcumin DME1098 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1098 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00683 GENEFORM Protein DME1098 XEOTICID XEO00683 MOACRIVE Inhibition DME1098 XEOTICID XEO00727 XEO_NAME Vanillin DME1098 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1098 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00727 GENEFORM Protein DME1098 XEOTICID XEO00727 MOACRIVE Inhibition DME1098 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1098 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1098 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00730 GENEFORM Protein DME1098 XEOTICID XEO00730 MOACRIVE Inhibition DME1098 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1098 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO00782 XEO_CLAS Natural Product DME1098 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00782 GENEFORM Protein DME1098 XEOTICID XEO00782 MOACRIVE Inhibition DME1098 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1098 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1098 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00866 GENEFORM Protein DME1098 XEOTICID XEO00866 MOACRIVE Inhibition DME1098 XEOTICID XEO00878 XEO_NAME Chrysin DME1098 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO00878 XEO_CLAS Natural Product DME1098 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00878 GENEFORM Protein DME1098 XEOTICID XEO00878 MOACRIVE Inhibition DME1098 XEOTICID XEO00879 XEO_NAME Coumarin DME1098 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1098 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1098 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00879 GENEFORM Protein DME1098 XEOTICID XEO00879 MOACRIVE Inhibition DME1098 XEOTICID XEO00883 XEO_NAME Phloretin DME1098 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO00883 XEO_CLAS Natural Product DME1098 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00883 GENEFORM Protein DME1098 XEOTICID XEO00883 MOACRIVE Inhibition DME1098 XEOTICID XEO00885 XEO_NAME Eugenol DME1098 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1098 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO00885 GENEFORM Protein DME1098 XEOTICID XEO00885 MOACRIVE Inhibition DME1098 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1098 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1098 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1098 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01032 GENEFORM Protein DME1098 XEOTICID XEO01032 MOACRIVE Inhibition DME1098 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1098 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01174 XEO_CLAS Natural Product DME1098 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01174 GENEFORM Protein DME1098 XEOTICID XEO01174 MOACRIVE Inhibition DME1098 XEOTICID XEO01203 XEO_NAME Apigenin DME1098 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01203 XEO_CLAS Natural Product DME1098 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01203 GENEFORM Protein DME1098 XEOTICID XEO01203 MOACRIVE Inhibition DME1098 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1098 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1098 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1098 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01232 GENEFORM Protein DME1098 XEOTICID XEO01232 MOACRIVE Inhibition DME1098 XEOTICID XEO01237 XEO_NAME Carvacrol DME1098 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1098 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01237 GENEFORM Protein DME1098 XEOTICID XEO01237 MOACRIVE Inhibition DME1098 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1098 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1098 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01287 GENEFORM Protein DME1098 XEOTICID XEO01287 MOACRIVE Inhibition DME1098 XEOTICID XEO01291 XEO_NAME Esculetin DME1098 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1098 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01291 GENEFORM Protein DME1098 XEOTICID XEO01291 MOACRIVE Inhibition DME1098 XEOTICID XEO01304 XEO_NAME Flavone DME1098 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01304 XEO_CLAS Natural Product DME1098 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01304 GENEFORM Protein DME1098 XEOTICID XEO01304 MOACRIVE Inhibition DME1098 XEOTICID XEO01309 XEO_NAME Gallic acid DME1098 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01309 XEO_CLAS Natural Product DME1098 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01309 GENEFORM Protein DME1098 XEOTICID XEO01309 MOACRIVE Inhibition DME1098 XEOTICID XEO01340 XEO_NAME Imperatorin DME1098 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01340 XEO_CLAS Natural Product DME1098 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01340 GENEFORM Protein DME1098 XEOTICID XEO01340 MOACRIVE Inhibition DME1098 XEOTICID XEO01353 XEO_NAME Kaempferol DME1098 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1098 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1098 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01353 GENEFORM Protein DME1098 XEOTICID XEO01353 MOACRIVE Inhibition DME1098 XEOTICID XEO01366 XEO_NAME Linalool DME1098 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01366 XEO_CLAS Natural Product DME1098 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01366 GENEFORM Protein DME1098 XEOTICID XEO01366 MOACRIVE Inhibition DME1098 XEOTICID XEO01391 XEO_NAME Naringin DME1098 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01391 XEO_CLAS Natural Product DME1098 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01391 GENEFORM Protein DME1098 XEOTICID XEO01391 MOACRIVE Inhibition DME1098 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1098 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1098 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01420 GENEFORM Protein DME1098 XEOTICID XEO01420 MOACRIVE Inhibition DME1098 XEOTICID XEO01463 XEO_NAME Rutin DME1098 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01463 XEO_CLAS Natural Product DME1098 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01463 GENEFORM Protein DME1098 XEOTICID XEO01463 MOACRIVE Inhibition DME1098 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1098 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1098 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01496 GENEFORM Protein DME1098 XEOTICID XEO01496 MOACRIVE Inhibition DME1098 XEOTICID XEO01512 XEO_NAME Zinc DME1098 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1098 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1098 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01512 GENEFORM Protein DME1098 XEOTICID XEO01512 MOACRIVE Inhibition DME1098 XEOTICID XEO01527 XEO_NAME Bergamottin DME1098 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01527 XEO_CLAS Natural Product DME1098 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01527 GENEFORM Protein DME1098 XEOTICID XEO01527 MOACRIVE Inhibition DME1098 XEOTICID XEO01531 XEO_NAME Clove oil DME1098 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01531 XEO_CLAS Natural Product DME1098 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01531 GENEFORM Protein DME1098 XEOTICID XEO01531 MOACRIVE Inhibition DME1098 XEOTICID XEO01559 XEO_NAME Limonene DME1098 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01559 XEO_CLAS Natural Product DME1098 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01559 GENEFORM Protein DME1098 XEOTICID XEO01559 MOACRIVE Inhibition DME1098 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1098 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01563 XEO_CLAS Natural Product DME1098 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01563 GENEFORM Protein DME1098 XEOTICID XEO01563 MOACRIVE Inhibition DME1098 XEOTICID XEO01566 XEO_NAME Nobiletin DME1098 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01566 XEO_CLAS Natural Product DME1098 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01566 GENEFORM Protein DME1098 XEOTICID XEO01566 MOACRIVE Inhibition DME1098 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1098 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01778 XEO_CLAS Natural Product DME1098 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01778 GENEFORM Protein DME1098 XEOTICID XEO01778 MOACRIVE Inhibition DME1098 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1098 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01779 XEO_CLAS Peptide DME1098 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 128 microM) DME1098 XEOTICID XEO01779 GENEFORM Protein DME1098 XEOTICID XEO01779 MOACRIVE Inhibition DME1098 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1098 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01810 XEO_CLAS Peptide DME1098 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.0 microM) DME1098 XEOTICID XEO01810 GENEFORM Protein DME1098 XEOTICID XEO01810 MOACRIVE Inhibition DME1098 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1098 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01811 XEO_CLAS Peptide DME1098 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 microM) DME1098 XEOTICID XEO01811 GENEFORM Protein DME1098 XEOTICID XEO01811 MOACRIVE Inhibition DME1098 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1098 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01812 XEO_CLAS Peptide DME1098 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10.4 microM) DME1098 XEOTICID XEO01812 GENEFORM Protein DME1098 XEOTICID XEO01812 MOACRIVE Inhibition DME1098 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1098 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01813 XEO_CLAS Peptide DME1098 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.1 microM) DME1098 XEOTICID XEO01813 GENEFORM Protein DME1098 XEOTICID XEO01813 MOACRIVE Inhibition DME1098 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1098 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01814 XEO_CLAS Peptide DME1098 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.5 microM) DME1098 XEOTICID XEO01814 GENEFORM Protein DME1098 XEOTICID XEO01814 MOACRIVE Inhibition DME1098 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1098 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01815 XEO_CLAS Peptide DME1098 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 9.8 microM) DME1098 XEOTICID XEO01815 GENEFORM Protein DME1098 XEOTICID XEO01815 MOACRIVE Inhibition DME1098 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1098 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01816 XEO_CLAS Peptide DME1098 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO01816 GENEFORM Protein DME1098 XEOTICID XEO01816 MOACRIVE Inhibition DME1098 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1098 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01817 XEO_CLAS Peptide DME1098 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.0 microM) DME1098 XEOTICID XEO01817 GENEFORM Protein DME1098 XEOTICID XEO01817 MOACRIVE Inhibition DME1098 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1098 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01818 XEO_CLAS Peptide DME1098 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4.0 microM) DME1098 XEOTICID XEO01818 GENEFORM Protein DME1098 XEOTICID XEO01818 MOACRIVE Inhibition DME1098 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1098 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01819 XEO_CLAS Peptide DME1098 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO01819 GENEFORM Protein DME1098 XEOTICID XEO01819 MOACRIVE Inhibition DME1098 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1098 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01820 XEO_CLAS Peptide DME1098 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO01820 GENEFORM Protein DME1098 XEOTICID XEO01820 MOACRIVE Inhibition DME1098 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1098 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01821 XEO_CLAS Peptide DME1098 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO01821 GENEFORM Protein DME1098 XEOTICID XEO01821 MOACRIVE Inhibition DME1098 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1098 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01822 XEO_CLAS Peptide DME1098 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 microM) DME1098 XEOTICID XEO01822 GENEFORM Protein DME1098 XEOTICID XEO01822 MOACRIVE Inhibition DME1098 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1098 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01823 XEO_CLAS Peptide DME1098 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO01823 GENEFORM Protein DME1098 XEOTICID XEO01823 MOACRIVE Inhibition DME1098 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1098 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01824 XEO_CLAS Peptide DME1098 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO01824 GENEFORM Protein DME1098 XEOTICID XEO01824 MOACRIVE Inhibition DME1098 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1098 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01825 XEO_CLAS Peptide DME1098 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25.0 microM) DME1098 XEOTICID XEO01825 GENEFORM Protein DME1098 XEOTICID XEO01825 MOACRIVE Inhibition DME1098 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1098 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01827 XEO_CLAS Peptide DME1098 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.12-6.25 microM) DME1098 XEOTICID XEO01827 GENEFORM Protein DME1098 XEOTICID XEO01827 MOACRIVE Inhibition DME1098 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1098 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1098 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1098 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01829 GENEFORM Protein DME1098 XEOTICID XEO01829 MOACRIVE Inhibition DME1098 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1098 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01927 XEO_CLAS Peptide DME1098 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 ug/ml) DME1098 XEOTICID XEO01927 GENEFORM Protein DME1098 XEOTICID XEO01927 MOACRIVE Inhibition DME1098 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1098 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01945 XEO_CLAS Peptide DME1098 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.1 microM) DME1098 XEOTICID XEO01945 GENEFORM Protein DME1098 XEOTICID XEO01945 MOACRIVE Inhibition DME1098 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1098 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01946 XEO_CLAS Peptide DME1098 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.2 microM) DME1098 XEOTICID XEO01946 GENEFORM Protein DME1098 XEOTICID XEO01946 MOACRIVE Inhibition DME1098 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1098 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO01947 XEO_CLAS Natural Product DME1098 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01947 GENEFORM Protein DME1098 XEOTICID XEO01947 MOACRIVE Inhibition DME1098 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1098 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1098 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1098 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01950 GENEFORM Protein DME1098 XEOTICID XEO01950 MOACRIVE Inhibition DME1098 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1098 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1098 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1098 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01961 GENEFORM Protein DME1098 XEOTICID XEO01961 MOACRIVE Inhibition DME1098 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1098 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1098 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1098 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO01966 GENEFORM Protein DME1098 XEOTICID XEO01966 MOACRIVE Inhibition DME1098 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1098 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01996 XEO_CLAS Peptide DME1098 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.7 microM) DME1098 XEOTICID XEO01996 GENEFORM Protein DME1098 XEOTICID XEO01996 MOACRIVE Inhibition DME1098 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1098 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01997 XEO_CLAS Peptide DME1098 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.9 microM) DME1098 XEOTICID XEO01997 GENEFORM Protein DME1098 XEOTICID XEO01997 MOACRIVE Inhibition DME1098 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1098 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01998 XEO_CLAS Peptide DME1098 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO01998 GENEFORM Protein DME1098 XEOTICID XEO01998 MOACRIVE Inhibition DME1098 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1098 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO01999 XEO_CLAS Peptide DME1098 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.5 microM) DME1098 XEOTICID XEO01999 GENEFORM Protein DME1098 XEOTICID XEO01999 MOACRIVE Inhibition DME1098 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1098 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02013 XEO_CLAS Peptide DME1098 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02013 GENEFORM Protein DME1098 XEOTICID XEO02013 MOACRIVE Inhibition DME1098 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1098 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02032 XEO_CLAS Natural Product DME1098 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02032 GENEFORM Protein DME1098 XEOTICID XEO02032 MOACRIVE Inhibition DME1098 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1098 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02033 XEO_CLAS Natural Product DME1098 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02033 GENEFORM Protein DME1098 XEOTICID XEO02033 MOACRIVE Inhibition DME1098 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1098 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02079 XEO_CLAS Natural Product DME1098 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02079 GENEFORM Protein DME1098 XEOTICID XEO02079 MOACRIVE Inhibition DME1098 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1098 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1098 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02085 GENEFORM Protein DME1098 XEOTICID XEO02085 MOACRIVE Inhibition DME1098 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1098 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02111 XEO_CLAS Peptide DME1098 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2-4 ug/ml) DME1098 XEOTICID XEO02111 GENEFORM Protein DME1098 XEOTICID XEO02111 MOACRIVE Inhibition DME1098 XEOTICID XEO02113 XEO_NAME Abaecin DME1098 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02113 XEO_CLAS Peptide DME1098 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02113 GENEFORM Protein DME1098 XEOTICID XEO02113 MOACRIVE Inhibition DME1098 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1098 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02114 XEO_CLAS Peptide DME1098 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-25 ug/ml) DME1098 XEOTICID XEO02114 GENEFORM Protein DME1098 XEOTICID XEO02114 MOACRIVE Inhibition DME1098 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1098 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02115 XEO_CLAS Peptide DME1098 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02115 GENEFORM Protein DME1098 XEOTICID XEO02115 MOACRIVE Inhibition DME1098 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1098 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02117 XEO_CLAS Peptide DME1098 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02117 GENEFORM Protein DME1098 XEOTICID XEO02117 MOACRIVE Inhibition DME1098 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1098 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02118 XEO_CLAS Peptide DME1098 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02118 GENEFORM Protein DME1098 XEOTICID XEO02118 MOACRIVE Inhibition DME1098 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1098 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02119 XEO_CLAS Peptide DME1098 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02119 GENEFORM Protein DME1098 XEOTICID XEO02119 MOACRIVE Inhibition DME1098 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1098 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02120 XEO_CLAS Peptide DME1098 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02120 GENEFORM Protein DME1098 XEOTICID XEO02120 MOACRIVE Inhibition DME1098 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1098 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02121 XEO_CLAS Peptide DME1098 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02121 GENEFORM Protein DME1098 XEOTICID XEO02121 MOACRIVE Inhibition DME1098 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1098 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02122 XEO_CLAS Peptide DME1098 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 ug/ml) DME1098 XEOTICID XEO02122 GENEFORM Protein DME1098 XEOTICID XEO02122 MOACRIVE Inhibition DME1098 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1098 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02130 XEO_CLAS Peptide DME1098 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.7 microM) DME1098 XEOTICID XEO02130 GENEFORM Protein DME1098 XEOTICID XEO02130 MOACRIVE Inhibition DME1098 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1098 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02131 XEO_CLAS Peptide DME1098 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.3 microM) DME1098 XEOTICID XEO02131 GENEFORM Protein DME1098 XEOTICID XEO02131 MOACRIVE Inhibition DME1098 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1098 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02132 XEO_CLAS Peptide DME1098 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.5 microM) DME1098 XEOTICID XEO02132 GENEFORM Protein DME1098 XEOTICID XEO02132 MOACRIVE Inhibition DME1098 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1098 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02136 XEO_CLAS Peptide DME1098 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 ug/ml) DME1098 XEOTICID XEO02136 GENEFORM Protein DME1098 XEOTICID XEO02136 MOACRIVE Inhibition DME1098 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1098 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02147 XEO_CLAS Peptide DME1098 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 382 ug/ml) DME1098 XEOTICID XEO02147 GENEFORM Protein DME1098 XEOTICID XEO02147 MOACRIVE Inhibition DME1098 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1098 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02149 XEO_CLAS Peptide DME1098 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 47.35 microM) DME1098 XEOTICID XEO02149 GENEFORM Protein DME1098 XEOTICID XEO02149 MOACRIVE Inhibition DME1098 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1098 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02164 XEO_CLAS Peptide DME1098 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02164 GENEFORM Protein DME1098 XEOTICID XEO02164 MOACRIVE Inhibition DME1098 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1098 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02165 XEO_CLAS Peptide DME1098 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02165 GENEFORM Protein DME1098 XEOTICID XEO02165 MOACRIVE Inhibition DME1098 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1098 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02166 XEO_CLAS Peptide DME1098 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02166 GENEFORM Protein DME1098 XEOTICID XEO02166 MOACRIVE Inhibition DME1098 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1098 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02167 XEO_CLAS Peptide DME1098 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02167 GENEFORM Protein DME1098 XEOTICID XEO02167 MOACRIVE Inhibition DME1098 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1098 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02168 XEO_CLAS Peptide DME1098 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02168 GENEFORM Protein DME1098 XEOTICID XEO02168 MOACRIVE Inhibition DME1098 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1098 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02169 XEO_CLAS Peptide DME1098 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02169 GENEFORM Protein DME1098 XEOTICID XEO02169 MOACRIVE Inhibition DME1098 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1098 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02170 XEO_CLAS Peptide DME1098 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.4 microM) DME1098 XEOTICID XEO02170 GENEFORM Protein DME1098 XEOTICID XEO02170 MOACRIVE Inhibition DME1098 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1098 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02175 XEO_CLAS Natural Product DME1098 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02175 GENEFORM Protein DME1098 XEOTICID XEO02175 MOACRIVE Inhibition DME1098 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1098 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02177 XEO_CLAS Peptide DME1098 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO02177 GENEFORM Protein DME1098 XEOTICID XEO02177 MOACRIVE Inhibition DME1098 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1098 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02178 XEO_CLAS Peptide DME1098 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO02178 GENEFORM Protein DME1098 XEOTICID XEO02178 MOACRIVE Inhibition DME1098 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1098 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02179 XEO_CLAS Peptide DME1098 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO02179 GENEFORM Protein DME1098 XEOTICID XEO02179 MOACRIVE Inhibition DME1098 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1098 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02180 XEO_CLAS Peptide DME1098 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 214 microM) DME1098 XEOTICID XEO02180 GENEFORM Protein DME1098 XEOTICID XEO02180 MOACRIVE Inhibition DME1098 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1098 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02181 XEO_CLAS Peptide DME1098 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 217 microM) DME1098 XEOTICID XEO02181 GENEFORM Protein DME1098 XEOTICID XEO02181 MOACRIVE Inhibition DME1098 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1098 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02183 XEO_CLAS Peptide DME1098 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 38.4 microM) DME1098 XEOTICID XEO02183 GENEFORM Protein DME1098 XEOTICID XEO02183 MOACRIVE Inhibition DME1098 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1098 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02185 XEO_CLAS Peptide DME1098 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 microM) DME1098 XEOTICID XEO02185 GENEFORM Protein DME1098 XEOTICID XEO02185 MOACRIVE Inhibition DME1098 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1098 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02187 GENEFORM Protein DME1098 XEOTICID XEO02187 MOACRIVE Inhibition DME1098 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1098 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02191 XEO_CLAS Peptide DME1098 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02191 GENEFORM Protein DME1098 XEOTICID XEO02191 MOACRIVE Inhibition DME1098 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1098 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02192 XEO_CLAS Peptide DME1098 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.50 ug/ml) DME1098 XEOTICID XEO02192 GENEFORM Protein DME1098 XEOTICID XEO02192 MOACRIVE Inhibition DME1098 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1098 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02193 XEO_CLAS Peptide DME1098 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02193 GENEFORM Protein DME1098 XEOTICID XEO02193 MOACRIVE Inhibition DME1098 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1098 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02194 XEO_CLAS Peptide DME1098 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02194 GENEFORM Protein DME1098 XEOTICID XEO02194 MOACRIVE Inhibition DME1098 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1098 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02195 XEO_CLAS Peptide DME1098 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.00 ug/ml) DME1098 XEOTICID XEO02195 GENEFORM Protein DME1098 XEOTICID XEO02195 MOACRIVE Inhibition DME1098 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1098 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02197 XEO_CLAS Peptide DME1098 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02197 GENEFORM Protein DME1098 XEOTICID XEO02197 MOACRIVE Inhibition DME1098 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1098 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02200 XEO_CLAS Peptide DME1098 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 ug/ml) DME1098 XEOTICID XEO02200 GENEFORM Protein DME1098 XEOTICID XEO02200 MOACRIVE Inhibition DME1098 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1098 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02201 XEO_CLAS Peptide DME1098 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 ug/ml) DME1098 XEOTICID XEO02201 GENEFORM Protein DME1098 XEOTICID XEO02201 MOACRIVE Inhibition DME1098 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1098 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02202 XEO_CLAS Peptide DME1098 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO02202 GENEFORM Protein DME1098 XEOTICID XEO02202 MOACRIVE Inhibition DME1098 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1098 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02203 XEO_CLAS Peptide DME1098 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 microM) DME1098 XEOTICID XEO02203 GENEFORM Protein DME1098 XEOTICID XEO02203 MOACRIVE Inhibition DME1098 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1098 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02207 XEO_CLAS Peptide DME1098 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.78 ug/ml) DME1098 XEOTICID XEO02207 GENEFORM Protein DME1098 XEOTICID XEO02207 MOACRIVE Inhibition DME1098 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1098 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02208 XEO_CLAS Peptide DME1098 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.13 ug/ml) DME1098 XEOTICID XEO02208 GENEFORM Protein DME1098 XEOTICID XEO02208 MOACRIVE Inhibition DME1098 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1098 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02209 XEO_CLAS Peptide DME1098 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.56 ug/ml) DME1098 XEOTICID XEO02209 GENEFORM Protein DME1098 XEOTICID XEO02209 MOACRIVE Inhibition DME1098 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1098 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02210 XEO_CLAS Peptide DME1098 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 ug/ml) DME1098 XEOTICID XEO02210 GENEFORM Protein DME1098 XEOTICID XEO02210 MOACRIVE Inhibition DME1098 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1098 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02211 XEO_CLAS Peptide DME1098 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25 ug/ml) DME1098 XEOTICID XEO02211 GENEFORM Protein DME1098 XEOTICID XEO02211 MOACRIVE Inhibition DME1098 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1098 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02212 XEO_CLAS Peptide DME1098 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.13 ug/ml) DME1098 XEOTICID XEO02212 GENEFORM Protein DME1098 XEOTICID XEO02212 MOACRIVE Inhibition DME1098 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1098 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02213 XEO_CLAS Peptide DME1098 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.13 ug/ml) DME1098 XEOTICID XEO02213 GENEFORM Protein DME1098 XEOTICID XEO02213 MOACRIVE Inhibition DME1098 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1098 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02214 XEO_CLAS Peptide DME1098 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02214 GENEFORM Protein DME1098 XEOTICID XEO02214 MOACRIVE Inhibition DME1098 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1098 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02215 XEO_CLAS Peptide DME1098 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 ug/ml) DME1098 XEOTICID XEO02215 GENEFORM Protein DME1098 XEOTICID XEO02215 MOACRIVE Inhibition DME1098 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1098 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02216 XEO_CLAS Peptide DME1098 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 126 ug/ml) DME1098 XEOTICID XEO02216 GENEFORM Protein DME1098 XEOTICID XEO02216 MOACRIVE Inhibition DME1098 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1098 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02217 XEO_CLAS Peptide DME1098 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 200 ug/ml) DME1098 XEOTICID XEO02217 GENEFORM Protein DME1098 XEOTICID XEO02217 MOACRIVE Inhibition DME1098 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1098 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02218 XEO_CLAS Peptide DME1098 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 200 ug/ml) DME1098 XEOTICID XEO02218 GENEFORM Protein DME1098 XEOTICID XEO02218 MOACRIVE Inhibition DME1098 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1098 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02219 XEO_CLAS Peptide DME1098 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 200 ug/ml) DME1098 XEOTICID XEO02219 GENEFORM Protein DME1098 XEOTICID XEO02219 MOACRIVE Inhibition DME1098 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1098 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02220 XEO_CLAS Peptide DME1098 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 23.5 ug/ml) DME1098 XEOTICID XEO02220 GENEFORM Protein DME1098 XEOTICID XEO02220 MOACRIVE Inhibition DME1098 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1098 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02221 XEO_CLAS Peptide DME1098 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20.2 ug/ml) DME1098 XEOTICID XEO02221 GENEFORM Protein DME1098 XEOTICID XEO02221 MOACRIVE Inhibition DME1098 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1098 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02222 XEO_CLAS Peptide DME1098 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30.5 ug/ml) DME1098 XEOTICID XEO02222 GENEFORM Protein DME1098 XEOTICID XEO02222 MOACRIVE Inhibition DME1098 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1098 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02223 XEO_CLAS Peptide DME1098 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.2 ug/ml) DME1098 XEOTICID XEO02223 GENEFORM Protein DME1098 XEOTICID XEO02223 MOACRIVE Inhibition DME1098 XEOTICID XEO02224 XEO_NAME Androctonin DME1098 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02224 XEO_CLAS Peptide DME1098 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02224 GENEFORM Protein DME1098 XEOTICID XEO02224 MOACRIVE Inhibition DME1098 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1098 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02225 XEO_CLAS Peptide DME1098 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02225 GENEFORM Protein DME1098 XEOTICID XEO02225 MOACRIVE Inhibition DME1098 XEOTICID XEO02226 XEO_NAME Andropin DME1098 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02226 XEO_CLAS Peptide DME1098 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 140 microM) DME1098 XEOTICID XEO02226 GENEFORM Protein DME1098 XEOTICID XEO02226 MOACRIVE Inhibition DME1098 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1098 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02230 XEO_CLAS Peptide DME1098 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.05-0.1 microM) DME1098 XEOTICID XEO02230 GENEFORM Protein DME1098 XEOTICID XEO02230 MOACRIVE Inhibition DME1098 XEOTICID XEO02232 XEO_NAME Anoplin DME1098 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02232 XEO_CLAS Peptide DME1098 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 13 ug/ml) DME1098 XEOTICID XEO02232 GENEFORM Protein DME1098 XEOTICID XEO02232 MOACRIVE Inhibition DME1098 XEOTICID XEO02233 XEO_NAME Antapin DME1098 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02233 XEO_CLAS Peptide DME1098 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02233 GENEFORM Protein DME1098 XEOTICID XEO02233 MOACRIVE Inhibition DME1098 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1098 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02236 XEO_CLAS Peptide DME1098 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02236 GENEFORM Protein DME1098 XEOTICID XEO02236 MOACRIVE Inhibition DME1098 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1098 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02239 XEO_CLAS Peptide DME1098 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 250 microM) DME1098 XEOTICID XEO02239 GENEFORM Protein DME1098 XEOTICID XEO02239 MOACRIVE Inhibition DME1098 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1098 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02240 XEO_CLAS Peptide DME1098 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 microM) DME1098 XEOTICID XEO02240 GENEFORM Protein DME1098 XEOTICID XEO02240 MOACRIVE Inhibition DME1098 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1098 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02241 XEO_CLAS Peptide DME1098 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02241 GENEFORM Protein DME1098 XEOTICID XEO02241 MOACRIVE Inhibition DME1098 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1098 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02242 XEO_CLAS Peptide DME1098 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO02242 GENEFORM Protein DME1098 XEOTICID XEO02242 MOACRIVE Inhibition DME1098 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1098 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02243 XEO_CLAS Peptide DME1098 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 microM) DME1098 XEOTICID XEO02243 GENEFORM Protein DME1098 XEOTICID XEO02243 MOACRIVE Inhibition DME1098 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1098 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02244 XEO_CLAS Peptide DME1098 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1 microM) DME1098 XEOTICID XEO02244 GENEFORM Protein DME1098 XEOTICID XEO02244 MOACRIVE Inhibition DME1098 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1098 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02245 XEO_CLAS Peptide DME1098 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02245 GENEFORM Protein DME1098 XEOTICID XEO02245 MOACRIVE Inhibition DME1098 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1098 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02246 XEO_CLAS Peptide DME1098 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 microM) DME1098 XEOTICID XEO02246 GENEFORM Protein DME1098 XEOTICID XEO02246 MOACRIVE Inhibition DME1098 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1098 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02247 XEO_CLAS Peptide DME1098 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02247 GENEFORM Protein DME1098 XEOTICID XEO02247 MOACRIVE Inhibition DME1098 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1098 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02248 XEO_CLAS Peptide DME1098 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.3 microM) DME1098 XEOTICID XEO02248 GENEFORM Protein DME1098 XEOTICID XEO02248 MOACRIVE Inhibition DME1098 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1098 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02253 XEO_CLAS Peptide DME1098 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02253 GENEFORM Protein DME1098 XEOTICID XEO02253 MOACRIVE Inhibition DME1098 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1098 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02258 XEO_CLAS Peptide DME1098 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 150 microM) DME1098 XEOTICID XEO02258 GENEFORM Protein DME1098 XEOTICID XEO02258 MOACRIVE Inhibition DME1098 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1098 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02261 XEO_CLAS Peptide DME1098 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 82 ug/ml) DME1098 XEOTICID XEO02261 GENEFORM Protein DME1098 XEOTICID XEO02261 MOACRIVE Inhibition DME1098 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1098 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02263 XEO_CLAS Peptide DME1098 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO02263 GENEFORM Protein DME1098 XEOTICID XEO02263 MOACRIVE Inhibition DME1098 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1098 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02266 XEO_CLAS Peptide DME1098 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 120 microM) DME1098 XEOTICID XEO02266 GENEFORM Protein DME1098 XEOTICID XEO02266 MOACRIVE Inhibition DME1098 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1098 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02268 XEO_CLAS Peptide DME1098 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 170 ug/ml) DME1098 XEOTICID XEO02268 GENEFORM Protein DME1098 XEOTICID XEO02268 MOACRIVE Inhibition DME1098 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1098 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02270 XEO_CLAS Peptide DME1098 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 microM) DME1098 XEOTICID XEO02270 GENEFORM Protein DME1098 XEOTICID XEO02270 MOACRIVE Inhibition DME1098 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1098 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02271 XEO_CLAS Peptide DME1098 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 302 ug/ml) DME1098 XEOTICID XEO02271 GENEFORM Protein DME1098 XEOTICID XEO02271 MOACRIVE Inhibition DME1098 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1098 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02273 XEO_CLAS Peptide DME1098 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 18 microM) DME1098 XEOTICID XEO02273 GENEFORM Protein DME1098 XEOTICID XEO02273 MOACRIVE Inhibition DME1098 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1098 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02274 XEO_CLAS Peptide DME1098 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO02274 GENEFORM Protein DME1098 XEOTICID XEO02274 MOACRIVE Inhibition DME1098 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1098 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02275 XEO_CLAS Peptide DME1098 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 microM) DME1098 XEOTICID XEO02275 GENEFORM Protein DME1098 XEOTICID XEO02275 MOACRIVE Inhibition DME1098 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1098 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02276 XEO_CLAS Peptide DME1098 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 microM) DME1098 XEOTICID XEO02276 GENEFORM Protein DME1098 XEOTICID XEO02276 MOACRIVE Inhibition DME1098 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1098 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02280 XEO_CLAS Peptide DME1098 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02280 GENEFORM Protein DME1098 XEOTICID XEO02280 MOACRIVE Inhibition DME1098 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1098 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02281 XEO_CLAS Peptide DME1098 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02281 GENEFORM Protein DME1098 XEOTICID XEO02281 MOACRIVE Inhibition DME1098 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1098 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02283 XEO_CLAS Peptide DME1098 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 ug/ml) DME1098 XEOTICID XEO02283 GENEFORM Protein DME1098 XEOTICID XEO02283 MOACRIVE Inhibition DME1098 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1098 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02284 XEO_CLAS Peptide DME1098 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50.4 microM) DME1098 XEOTICID XEO02284 GENEFORM Protein DME1098 XEOTICID XEO02284 MOACRIVE Inhibition DME1098 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1098 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02285 XEO_CLAS Peptide DME1098 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50.4 microM) DME1098 XEOTICID XEO02285 GENEFORM Protein DME1098 XEOTICID XEO02285 MOACRIVE Inhibition DME1098 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1098 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02286 XEO_CLAS Peptide DME1098 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50.4 microM) DME1098 XEOTICID XEO02286 GENEFORM Protein DME1098 XEOTICID XEO02286 MOACRIVE Inhibition DME1098 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1098 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02287 XEO_CLAS Peptide DME1098 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50.4 microM) DME1098 XEOTICID XEO02287 GENEFORM Protein DME1098 XEOTICID XEO02287 MOACRIVE Inhibition DME1098 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1098 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02288 XEO_CLAS Peptide DME1098 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.2 ug/ml) DME1098 XEOTICID XEO02288 GENEFORM Protein DME1098 XEOTICID XEO02288 MOACRIVE Inhibition DME1098 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1098 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02289 XEO_CLAS Peptide DME1098 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 ug/ml) DME1098 XEOTICID XEO02289 GENEFORM Protein DME1098 XEOTICID XEO02289 MOACRIVE Inhibition DME1098 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1098 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02290 XEO_CLAS Peptide DME1098 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO02290 GENEFORM Protein DME1098 XEOTICID XEO02290 MOACRIVE Inhibition DME1098 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1098 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02291 XEO_CLAS Peptide DME1098 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02291 GENEFORM Protein DME1098 XEOTICID XEO02291 MOACRIVE Inhibition DME1098 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1098 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02293 XEO_CLAS Peptide DME1098 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 microM) DME1098 XEOTICID XEO02293 GENEFORM Protein DME1098 XEOTICID XEO02293 MOACRIVE Inhibition DME1098 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1098 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02294 XEO_CLAS Peptide DME1098 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 62-250 ug/ml) DME1098 XEOTICID XEO02294 GENEFORM Protein DME1098 XEOTICID XEO02294 MOACRIVE Inhibition DME1098 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1098 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02295 XEO_CLAS Peptide DME1098 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 ug/ml) DME1098 XEOTICID XEO02295 GENEFORM Protein DME1098 XEOTICID XEO02295 MOACRIVE Inhibition DME1098 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1098 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02296 XEO_CLAS Peptide DME1098 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02296 GENEFORM Protein DME1098 XEOTICID XEO02296 MOACRIVE Inhibition DME1098 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1098 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02297 XEO_CLAS Peptide DME1098 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC < 50 ug/ml) DME1098 XEOTICID XEO02297 GENEFORM Protein DME1098 XEOTICID XEO02297 MOACRIVE Inhibition DME1098 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1098 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02298 XEO_CLAS Peptide DME1098 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO02298 GENEFORM Protein DME1098 XEOTICID XEO02298 MOACRIVE Inhibition DME1098 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1098 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02303 XEO_CLAS Peptide DME1098 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02303 GENEFORM Protein DME1098 XEOTICID XEO02303 MOACRIVE Inhibition DME1098 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1098 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02304 XEO_CLAS Peptide DME1098 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.1 ug/ml) DME1098 XEOTICID XEO02304 GENEFORM Protein DME1098 XEOTICID XEO02304 MOACRIVE Inhibition DME1098 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1098 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02305 XEO_CLAS Peptide DME1098 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC <= 1 ug/ml) DME1098 XEOTICID XEO02305 GENEFORM Protein DME1098 XEOTICID XEO02305 MOACRIVE Inhibition DME1098 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1098 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02306 XEO_CLAS Peptide DME1098 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.2 ug/ml) DME1098 XEOTICID XEO02306 GENEFORM Protein DME1098 XEOTICID XEO02306 MOACRIVE Inhibition DME1098 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1098 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02309 XEO_CLAS Peptide DME1098 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02309 GENEFORM Protein DME1098 XEOTICID XEO02309 MOACRIVE Inhibition DME1098 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1098 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02310 XEO_CLAS Peptide DME1098 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02310 GENEFORM Protein DME1098 XEOTICID XEO02310 MOACRIVE Inhibition DME1098 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1098 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02315 XEO_CLAS Peptide DME1098 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO02315 GENEFORM Protein DME1098 XEOTICID XEO02315 MOACRIVE Inhibition DME1098 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1098 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02316 XEO_CLAS Peptide DME1098 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 50 microM) DME1098 XEOTICID XEO02316 GENEFORM Protein DME1098 XEOTICID XEO02316 MOACRIVE Inhibition DME1098 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1098 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02317 XEO_CLAS Peptide DME1098 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 300 microM) DME1098 XEOTICID XEO02317 GENEFORM Protein DME1098 XEOTICID XEO02317 MOACRIVE Inhibition DME1098 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1098 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02318 XEO_CLAS Peptide DME1098 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02318 GENEFORM Protein DME1098 XEOTICID XEO02318 MOACRIVE Inhibition DME1098 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1098 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02319 XEO_CLAS Peptide DME1098 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02319 GENEFORM Protein DME1098 XEOTICID XEO02319 MOACRIVE Inhibition DME1098 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1098 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02320 XEO_CLAS Peptide DME1098 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02320 GENEFORM Protein DME1098 XEOTICID XEO02320 MOACRIVE Inhibition DME1098 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1098 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02321 XEO_CLAS Peptide DME1098 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO02321 GENEFORM Protein DME1098 XEOTICID XEO02321 MOACRIVE Inhibition DME1098 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1098 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02322 XEO_CLAS Peptide DME1098 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02322 GENEFORM Protein DME1098 XEOTICID XEO02322 MOACRIVE Inhibition DME1098 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1098 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02323 XEO_CLAS Peptide DME1098 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO02323 GENEFORM Protein DME1098 XEOTICID XEO02323 MOACRIVE Inhibition DME1098 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1098 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02324 XEO_CLAS Peptide DME1098 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02324 GENEFORM Protein DME1098 XEOTICID XEO02324 MOACRIVE Inhibition DME1098 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1098 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02325 XEO_CLAS Peptide DME1098 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO02325 GENEFORM Protein DME1098 XEOTICID XEO02325 MOACRIVE Inhibition DME1098 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1098 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02326 XEO_CLAS Peptide DME1098 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02326 GENEFORM Protein DME1098 XEOTICID XEO02326 MOACRIVE Inhibition DME1098 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1098 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02327 XEO_CLAS Peptide DME1098 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO02327 GENEFORM Protein DME1098 XEOTICID XEO02327 MOACRIVE Inhibition DME1098 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1098 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02328 XEO_CLAS Peptide DME1098 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO02328 GENEFORM Protein DME1098 XEOTICID XEO02328 MOACRIVE Inhibition DME1098 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1098 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02332 XEO_CLAS Peptide DME1098 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.9 ug/ml) DME1098 XEOTICID XEO02332 GENEFORM Protein DME1098 XEOTICID XEO02332 MOACRIVE Inhibition DME1098 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1098 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02333 XEO_CLAS Peptide DME1098 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 200 microM) DME1098 XEOTICID XEO02333 GENEFORM Protein DME1098 XEOTICID XEO02333 MOACRIVE Inhibition DME1098 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1098 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02336 XEO_CLAS Peptide DME1098 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 microM) DME1098 XEOTICID XEO02336 GENEFORM Protein DME1098 XEOTICID XEO02336 MOACRIVE Inhibition DME1098 XEOTICID XEO02346 XEO_NAME Aurelin DME1098 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02346 XEO_CLAS Peptide DME1098 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 7.66 ug/ml) DME1098 XEOTICID XEO02346 GENEFORM Protein DME1098 XEOTICID XEO02346 MOACRIVE Inhibition DME1098 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1098 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02352 XEO_CLAS Peptide DME1098 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 11 ug/ml) DME1098 XEOTICID XEO02352 GENEFORM Protein DME1098 XEOTICID XEO02352 MOACRIVE Inhibition DME1098 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1098 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02353 XEO_CLAS Peptide DME1098 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 ug/ml) DME1098 XEOTICID XEO02353 GENEFORM Protein DME1098 XEOTICID XEO02353 MOACRIVE Inhibition DME1098 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1098 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02354 XEO_CLAS Peptide DME1098 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 ug/ml) DME1098 XEOTICID XEO02354 GENEFORM Protein DME1098 XEOTICID XEO02354 MOACRIVE Inhibition DME1098 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1098 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02355 XEO_CLAS Peptide DME1098 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 17 ug/ml) DME1098 XEOTICID XEO02355 GENEFORM Protein DME1098 XEOTICID XEO02355 MOACRIVE Inhibition DME1098 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1098 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02356 XEO_CLAS Peptide DME1098 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO02356 GENEFORM Protein DME1098 XEOTICID XEO02356 MOACRIVE Inhibition DME1098 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1098 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02357 XEO_CLAS Peptide DME1098 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO02357 GENEFORM Protein DME1098 XEOTICID XEO02357 MOACRIVE Inhibition DME1098 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1098 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02358 XEO_CLAS Peptide DME1098 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO02358 GENEFORM Protein DME1098 XEOTICID XEO02358 MOACRIVE Inhibition DME1098 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1098 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02360 XEO_CLAS Peptide DME1098 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02360 GENEFORM Protein DME1098 XEOTICID XEO02360 MOACRIVE Inhibition DME1098 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1098 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02361 XEO_CLAS Peptide DME1098 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 ug/ml) DME1098 XEOTICID XEO02361 GENEFORM Protein DME1098 XEOTICID XEO02361 MOACRIVE Inhibition DME1098 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1098 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02365 XEO_CLAS Peptide DME1098 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 32 ug/ml) DME1098 XEOTICID XEO02365 GENEFORM Protein DME1098 XEOTICID XEO02365 MOACRIVE Inhibition DME1098 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1098 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02366 XEO_CLAS Peptide DME1098 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO02366 GENEFORM Protein DME1098 XEOTICID XEO02366 MOACRIVE Inhibition DME1098 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1098 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02367 XEO_CLAS Peptide DME1098 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02367 GENEFORM Protein DME1098 XEOTICID XEO02367 MOACRIVE Inhibition DME1098 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1098 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02368 XEO_CLAS Peptide DME1098 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02368 GENEFORM Protein DME1098 XEOTICID XEO02368 MOACRIVE Inhibition DME1098 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1098 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02369 XEO_CLAS Peptide DME1098 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02369 GENEFORM Protein DME1098 XEOTICID XEO02369 MOACRIVE Inhibition DME1098 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1098 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02370 XEO_CLAS Peptide DME1098 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02370 GENEFORM Protein DME1098 XEOTICID XEO02370 MOACRIVE Inhibition DME1098 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1098 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02371 XEO_CLAS Peptide DME1098 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 ug/ml) DME1098 XEOTICID XEO02371 GENEFORM Protein DME1098 XEOTICID XEO02371 MOACRIVE Inhibition DME1098 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1098 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02374 XEO_CLAS Peptide DME1098 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02374 GENEFORM Protein DME1098 XEOTICID XEO02374 MOACRIVE Inhibition DME1098 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1098 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02376 XEO_CLAS Peptide DME1098 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02376 GENEFORM Protein DME1098 XEOTICID XEO02376 MOACRIVE Inhibition DME1098 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1098 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02378 XEO_CLAS Peptide DME1098 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.19 ug/ml) DME1098 XEOTICID XEO02378 GENEFORM Protein DME1098 XEOTICID XEO02378 MOACRIVE Inhibition DME1098 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1098 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02388 XEO_CLAS Peptide DME1098 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO02388 GENEFORM Protein DME1098 XEOTICID XEO02388 MOACRIVE Inhibition DME1098 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1098 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02389 XEO_CLAS Peptide DME1098 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02389 GENEFORM Protein DME1098 XEOTICID XEO02389 MOACRIVE Inhibition DME1098 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1098 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02415 XEO_CLAS Peptide DME1098 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02415 GENEFORM Protein DME1098 XEOTICID XEO02415 MOACRIVE Inhibition DME1098 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1098 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02416 XEO_CLAS Peptide DME1098 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 11 microM) DME1098 XEOTICID XEO02416 GENEFORM Protein DME1098 XEOTICID XEO02416 MOACRIVE Inhibition DME1098 XEOTICID XEO02419 XEO_NAME Bay oil DME1098 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1098 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02419 GENEFORM Protein DME1098 XEOTICID XEO02419 MOACRIVE Inhibition DME1098 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1098 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02435 XEO_CLAS Peptide DME1098 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02435 GENEFORM Protein DME1098 XEOTICID XEO02435 MOACRIVE Inhibition DME1098 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1098 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02436 XEO_CLAS Peptide DME1098 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02436 GENEFORM Protein DME1098 XEOTICID XEO02436 MOACRIVE Inhibition DME1098 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1098 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02437 XEO_CLAS Peptide DME1098 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02437 GENEFORM Protein DME1098 XEOTICID XEO02437 MOACRIVE Inhibition DME1098 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1098 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02438 XEO_CLAS Peptide DME1098 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02438 GENEFORM Protein DME1098 XEOTICID XEO02438 MOACRIVE Inhibition DME1098 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1098 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02439 XEO_CLAS Peptide DME1098 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02439 GENEFORM Protein DME1098 XEOTICID XEO02439 MOACRIVE Inhibition DME1098 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1098 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02440 XEO_CLAS Peptide DME1098 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02440 GENEFORM Protein DME1098 XEOTICID XEO02440 MOACRIVE Inhibition DME1098 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1098 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02441 XEO_CLAS Peptide DME1098 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02441 GENEFORM Protein DME1098 XEOTICID XEO02441 MOACRIVE Inhibition DME1098 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1098 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02442 XEO_CLAS Peptide DME1098 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO02442 GENEFORM Protein DME1098 XEOTICID XEO02442 MOACRIVE Inhibition DME1098 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1098 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02443 XEO_CLAS Peptide DME1098 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02443 GENEFORM Protein DME1098 XEOTICID XEO02443 MOACRIVE Inhibition DME1098 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1098 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02444 XEO_CLAS Peptide DME1098 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02444 GENEFORM Protein DME1098 XEOTICID XEO02444 MOACRIVE Inhibition DME1098 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1098 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1098 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02447 GENEFORM Protein DME1098 XEOTICID XEO02447 MOACRIVE Inhibition DME1098 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1098 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02452 XEO_CLAS Peptide DME1098 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 76800 ug/ml) DME1098 XEOTICID XEO02452 GENEFORM Protein DME1098 XEOTICID XEO02452 MOACRIVE Inhibition DME1098 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1098 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02453 XEO_CLAS Peptide DME1098 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02453 GENEFORM Protein DME1098 XEOTICID XEO02453 MOACRIVE Inhibition DME1098 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1098 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02463 XEO_CLAS Peptide DME1098 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 11.25 microM) DME1098 XEOTICID XEO02463 GENEFORM Protein DME1098 XEOTICID XEO02463 MOACRIVE Inhibition DME1098 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1098 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02466 XEO_CLAS Peptide DME1098 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.5 microM) DME1098 XEOTICID XEO02466 GENEFORM Protein DME1098 XEOTICID XEO02466 MOACRIVE Inhibition DME1098 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1098 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02467 XEO_CLAS Peptide DME1098 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8.4 microM) DME1098 XEOTICID XEO02467 GENEFORM Protein DME1098 XEOTICID XEO02467 MOACRIVE Inhibition DME1098 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1098 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02468 XEO_CLAS Peptide DME1098 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.7 microM) DME1098 XEOTICID XEO02468 GENEFORM Protein DME1098 XEOTICID XEO02468 MOACRIVE Inhibition DME1098 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1098 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02469 XEO_CLAS Peptide DME1098 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO02469 GENEFORM Protein DME1098 XEOTICID XEO02469 MOACRIVE Inhibition DME1098 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1098 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02470 XEO_CLAS Peptide DME1098 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.8 microM) DME1098 XEOTICID XEO02470 GENEFORM Protein DME1098 XEOTICID XEO02470 MOACRIVE Inhibition DME1098 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1098 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02471 XEO_CLAS Peptide DME1098 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4.8 microM) DME1098 XEOTICID XEO02471 GENEFORM Protein DME1098 XEOTICID XEO02471 MOACRIVE Inhibition DME1098 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1098 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02472 XEO_CLAS Peptide DME1098 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.0 microM) DME1098 XEOTICID XEO02472 GENEFORM Protein DME1098 XEOTICID XEO02472 MOACRIVE Inhibition DME1098 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1098 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02473 XEO_CLAS Peptide DME1098 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02473 GENEFORM Protein DME1098 XEOTICID XEO02473 MOACRIVE Inhibition DME1098 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1098 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02474 XEO_CLAS Peptide DME1098 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.5 microM) DME1098 XEOTICID XEO02474 GENEFORM Protein DME1098 XEOTICID XEO02474 MOACRIVE Inhibition DME1098 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1098 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02475 XEO_CLAS Peptide DME1098 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.5 microM) DME1098 XEOTICID XEO02475 GENEFORM Protein DME1098 XEOTICID XEO02475 MOACRIVE Inhibition DME1098 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1098 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02477 XEO_CLAS Peptide DME1098 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-300 ug/ml) DME1098 XEOTICID XEO02477 GENEFORM Protein DME1098 XEOTICID XEO02477 MOACRIVE Inhibition DME1098 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1098 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02478 XEO_CLAS Peptide DME1098 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-300 ug/ml) DME1098 XEOTICID XEO02478 GENEFORM Protein DME1098 XEOTICID XEO02478 MOACRIVE Inhibition DME1098 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1098 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02479 XEO_CLAS Peptide DME1098 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-300 ug/ml) DME1098 XEOTICID XEO02479 GENEFORM Protein DME1098 XEOTICID XEO02479 MOACRIVE Inhibition DME1098 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1098 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02480 XEO_CLAS Peptide DME1098 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-300 ug/ml) DME1098 XEOTICID XEO02480 GENEFORM Protein DME1098 XEOTICID XEO02480 MOACRIVE Inhibition DME1098 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1098 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02481 XEO_CLAS Peptide DME1098 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-300 ug/ml) DME1098 XEOTICID XEO02481 GENEFORM Protein DME1098 XEOTICID XEO02481 MOACRIVE Inhibition DME1098 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1098 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02482 XEO_CLAS Peptide DME1098 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-300 ug/ml) DME1098 XEOTICID XEO02482 GENEFORM Protein DME1098 XEOTICID XEO02482 MOACRIVE Inhibition DME1098 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1098 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02483 XEO_CLAS Peptide DME1098 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-300 ug/ml) DME1098 XEOTICID XEO02483 GENEFORM Protein DME1098 XEOTICID XEO02483 MOACRIVE Inhibition DME1098 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1098 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02484 XEO_CLAS Peptide DME1098 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-300 ug/ml) DME1098 XEOTICID XEO02484 GENEFORM Protein DME1098 XEOTICID XEO02484 MOACRIVE Inhibition DME1098 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1098 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02485 XEO_CLAS Peptide DME1098 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-300 ug/ml) DME1098 XEOTICID XEO02485 GENEFORM Protein DME1098 XEOTICID XEO02485 MOACRIVE Inhibition DME1098 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1098 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02486 XEO_CLAS Peptide DME1098 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-300 ug/ml) DME1098 XEOTICID XEO02486 GENEFORM Protein DME1098 XEOTICID XEO02486 MOACRIVE Inhibition DME1098 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1098 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02487 XEO_CLAS Peptide DME1098 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02487 GENEFORM Protein DME1098 XEOTICID XEO02487 MOACRIVE Inhibition DME1098 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1098 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02488 XEO_CLAS Peptide DME1098 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-300 ug/ml) DME1098 XEOTICID XEO02488 GENEFORM Protein DME1098 XEOTICID XEO02488 MOACRIVE Inhibition DME1098 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1098 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02489 XEO_CLAS Peptide DME1098 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-301 ug/ml) DME1098 XEOTICID XEO02489 GENEFORM Protein DME1098 XEOTICID XEO02489 MOACRIVE Inhibition DME1098 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1098 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02491 XEO_CLAS Peptide DME1098 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.3 microM) DME1098 XEOTICID XEO02491 GENEFORM Protein DME1098 XEOTICID XEO02491 MOACRIVE Inhibition DME1098 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1098 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02492 XEO_CLAS Peptide DME1098 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 ug/ml) DME1098 XEOTICID XEO02492 GENEFORM Protein DME1098 XEOTICID XEO02492 MOACRIVE Inhibition DME1098 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1098 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02493 XEO_CLAS Peptide DME1098 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 ug/ml) DME1098 XEOTICID XEO02493 GENEFORM Protein DME1098 XEOTICID XEO02493 MOACRIVE Inhibition DME1098 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1098 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02494 XEO_CLAS Peptide DME1098 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 ug/ml) DME1098 XEOTICID XEO02494 GENEFORM Protein DME1098 XEOTICID XEO02494 MOACRIVE Inhibition DME1098 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1098 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02495 XEO_CLAS Peptide DME1098 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 34 ug/ml) DME1098 XEOTICID XEO02495 GENEFORM Protein DME1098 XEOTICID XEO02495 MOACRIVE Inhibition DME1098 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1098 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02496 XEO_CLAS Peptide DME1098 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 13 microM) DME1098 XEOTICID XEO02496 GENEFORM Protein DME1098 XEOTICID XEO02496 MOACRIVE Inhibition DME1098 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1098 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02497 XEO_CLAS Peptide DME1098 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO02497 GENEFORM Protein DME1098 XEOTICID XEO02497 MOACRIVE Inhibition DME1098 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1098 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02499 XEO_CLAS Peptide DME1098 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO02499 GENEFORM Protein DME1098 XEOTICID XEO02499 MOACRIVE Inhibition DME1098 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1098 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02501 XEO_CLAS Peptide DME1098 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 7 microM) DME1098 XEOTICID XEO02501 GENEFORM Protein DME1098 XEOTICID XEO02501 MOACRIVE Inhibition DME1098 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1098 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02502 XEO_CLAS Peptide DME1098 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 microM) DME1098 XEOTICID XEO02502 GENEFORM Protein DME1098 XEOTICID XEO02502 MOACRIVE Inhibition DME1098 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1098 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02503 XEO_CLAS Peptide DME1098 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 19 microM) DME1098 XEOTICID XEO02503 GENEFORM Protein DME1098 XEOTICID XEO02503 MOACRIVE Inhibition DME1098 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1098 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02504 XEO_CLAS Peptide DME1098 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02504 GENEFORM Protein DME1098 XEOTICID XEO02504 MOACRIVE Inhibition DME1098 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1098 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02505 XEO_CLAS Peptide DME1098 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO02505 GENEFORM Protein DME1098 XEOTICID XEO02505 MOACRIVE Inhibition DME1098 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1098 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02507 XEO_CLAS Peptide DME1098 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO02507 GENEFORM Protein DME1098 XEOTICID XEO02507 MOACRIVE Inhibition DME1098 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1098 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02508 XEO_CLAS Peptide DME1098 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 150 microM) DME1098 XEOTICID XEO02508 GENEFORM Protein DME1098 XEOTICID XEO02508 MOACRIVE Inhibition DME1098 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1098 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02509 XEO_CLAS Peptide DME1098 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 150 microM) DME1098 XEOTICID XEO02509 GENEFORM Protein DME1098 XEOTICID XEO02509 MOACRIVE Inhibition DME1098 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1098 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02510 XEO_CLAS Peptide DME1098 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 150 microM) DME1098 XEOTICID XEO02510 GENEFORM Protein DME1098 XEOTICID XEO02510 MOACRIVE Inhibition DME1098 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1098 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02511 XEO_CLAS Peptide DME1098 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 150 microM) DME1098 XEOTICID XEO02511 GENEFORM Protein DME1098 XEOTICID XEO02511 MOACRIVE Inhibition DME1098 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1098 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02512 XEO_CLAS Peptide DME1098 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 75 microM) DME1098 XEOTICID XEO02512 GENEFORM Protein DME1098 XEOTICID XEO02512 MOACRIVE Inhibition DME1098 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1098 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02513 XEO_CLAS Peptide DME1098 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO02513 GENEFORM Protein DME1098 XEOTICID XEO02513 MOACRIVE Inhibition DME1098 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1098 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02514 XEO_CLAS Peptide DME1098 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO02514 GENEFORM Protein DME1098 XEOTICID XEO02514 MOACRIVE Inhibition DME1098 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1098 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02515 XEO_CLAS Peptide DME1098 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 80 microM) DME1098 XEOTICID XEO02515 GENEFORM Protein DME1098 XEOTICID XEO02515 MOACRIVE Inhibition DME1098 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1098 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02516 XEO_CLAS Peptide DME1098 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 32 microM) DME1098 XEOTICID XEO02516 GENEFORM Protein DME1098 XEOTICID XEO02516 MOACRIVE Inhibition DME1098 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1098 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02517 XEO_CLAS Peptide DME1098 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 microM) DME1098 XEOTICID XEO02517 GENEFORM Protein DME1098 XEOTICID XEO02517 MOACRIVE Inhibition DME1098 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1098 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02518 XEO_CLAS Peptide DME1098 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC < 15 microM) DME1098 XEOTICID XEO02518 GENEFORM Protein DME1098 XEOTICID XEO02518 MOACRIVE Inhibition DME1098 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1098 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02519 XEO_CLAS Peptide DME1098 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC < 15 microM) DME1098 XEOTICID XEO02519 GENEFORM Protein DME1098 XEOTICID XEO02519 MOACRIVE Inhibition DME1098 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1098 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02520 XEO_CLAS Peptide DME1098 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC < 15 microM) DME1098 XEOTICID XEO02520 GENEFORM Protein DME1098 XEOTICID XEO02520 MOACRIVE Inhibition DME1098 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1098 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02523 XEO_CLAS Peptide DME1098 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO02523 GENEFORM Protein DME1098 XEOTICID XEO02523 MOACRIVE Inhibition DME1098 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1098 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02524 XEO_CLAS Peptide DME1098 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 150 microM) DME1098 XEOTICID XEO02524 GENEFORM Protein DME1098 XEOTICID XEO02524 MOACRIVE Inhibition DME1098 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1098 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02525 XEO_CLAS Peptide DME1098 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 24 microM) DME1098 XEOTICID XEO02525 GENEFORM Protein DME1098 XEOTICID XEO02525 MOACRIVE Inhibition DME1098 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1098 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02526 XEO_CLAS Peptide DME1098 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 48 microM) DME1098 XEOTICID XEO02526 GENEFORM Protein DME1098 XEOTICID XEO02526 MOACRIVE Inhibition DME1098 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1098 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02527 XEO_CLAS Peptide DME1098 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 119 microM) DME1098 XEOTICID XEO02527 GENEFORM Protein DME1098 XEOTICID XEO02527 MOACRIVE Inhibition DME1098 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1098 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02528 XEO_CLAS Peptide DME1098 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 128 ug/ml) DME1098 XEOTICID XEO02528 GENEFORM Protein DME1098 XEOTICID XEO02528 MOACRIVE Inhibition DME1098 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1098 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02529 XEO_CLAS Peptide DME1098 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 128 ug/ml) DME1098 XEOTICID XEO02529 GENEFORM Protein DME1098 XEOTICID XEO02529 MOACRIVE Inhibition DME1098 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1098 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02530 XEO_CLAS Peptide DME1098 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02530 GENEFORM Protein DME1098 XEOTICID XEO02530 MOACRIVE Inhibition DME1098 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1098 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02531 XEO_CLAS Peptide DME1098 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 microM) DME1098 XEOTICID XEO02531 GENEFORM Protein DME1098 XEOTICID XEO02531 MOACRIVE Inhibition DME1098 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1098 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02533 XEO_CLAS Peptide DME1098 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.2 ug/ml) DME1098 XEOTICID XEO02533 GENEFORM Protein DME1098 XEOTICID XEO02533 MOACRIVE Inhibition DME1098 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1098 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02534 XEO_CLAS Peptide DME1098 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.6 ug/ml) DME1098 XEOTICID XEO02534 GENEFORM Protein DME1098 XEOTICID XEO02534 MOACRIVE Inhibition DME1098 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1098 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02535 XEO_CLAS Peptide DME1098 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.3 ug/ml) DME1098 XEOTICID XEO02535 GENEFORM Protein DME1098 XEOTICID XEO02535 MOACRIVE Inhibition DME1098 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1098 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02536 XEO_CLAS Peptide DME1098 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.4 ug/ml) DME1098 XEOTICID XEO02536 GENEFORM Protein DME1098 XEOTICID XEO02536 MOACRIVE Inhibition DME1098 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1098 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02537 XEO_CLAS Peptide DME1098 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.2 ug/ml) DME1098 XEOTICID XEO02537 GENEFORM Protein DME1098 XEOTICID XEO02537 MOACRIVE Inhibition DME1098 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1098 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02538 XEO_CLAS Peptide DME1098 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 9.1 ug/ml) DME1098 XEOTICID XEO02538 GENEFORM Protein DME1098 XEOTICID XEO02538 MOACRIVE Inhibition DME1098 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1098 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02539 XEO_CLAS Peptide DME1098 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8.6 ug/ml) DME1098 XEOTICID XEO02539 GENEFORM Protein DME1098 XEOTICID XEO02539 MOACRIVE Inhibition DME1098 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1098 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02540 XEO_CLAS Peptide DME1098 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15.2 ug/ml) DME1098 XEOTICID XEO02540 GENEFORM Protein DME1098 XEOTICID XEO02540 MOACRIVE Inhibition DME1098 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1098 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02541 XEO_CLAS Peptide DME1098 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 11.1 ug/ml) DME1098 XEOTICID XEO02541 GENEFORM Protein DME1098 XEOTICID XEO02541 MOACRIVE Inhibition DME1098 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1098 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02542 XEO_CLAS Peptide DME1098 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.7 ug/ml) DME1098 XEOTICID XEO02542 GENEFORM Protein DME1098 XEOTICID XEO02542 MOACRIVE Inhibition DME1098 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1098 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02543 XEO_CLAS Peptide DME1098 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 13.1 ug/ml) DME1098 XEOTICID XEO02543 GENEFORM Protein DME1098 XEOTICID XEO02543 MOACRIVE Inhibition DME1098 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1098 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02544 XEO_CLAS Peptide DME1098 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 9.8 ug/ml) DME1098 XEOTICID XEO02544 GENEFORM Protein DME1098 XEOTICID XEO02544 MOACRIVE Inhibition DME1098 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1098 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02545 XEO_CLAS Peptide DME1098 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 14 microM) DME1098 XEOTICID XEO02545 GENEFORM Protein DME1098 XEOTICID XEO02545 MOACRIVE Inhibition DME1098 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1098 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02546 XEO_CLAS Peptide DME1098 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 14 microM) DME1098 XEOTICID XEO02546 GENEFORM Protein DME1098 XEOTICID XEO02546 MOACRIVE Inhibition DME1098 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1098 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02547 XEO_CLAS Peptide DME1098 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 microM) DME1098 XEOTICID XEO02547 GENEFORM Protein DME1098 XEOTICID XEO02547 MOACRIVE Inhibition DME1098 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1098 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02548 XEO_CLAS Peptide DME1098 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 78 microM) DME1098 XEOTICID XEO02548 GENEFORM Protein DME1098 XEOTICID XEO02548 MOACRIVE Inhibition DME1098 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1098 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02549 XEO_CLAS Peptide DME1098 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02549 GENEFORM Protein DME1098 XEOTICID XEO02549 MOACRIVE Inhibition DME1098 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1098 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02552 XEO_CLAS Peptide DME1098 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 24 microM) DME1098 XEOTICID XEO02552 GENEFORM Protein DME1098 XEOTICID XEO02552 MOACRIVE Inhibition DME1098 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1098 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02553 XEO_CLAS Peptide DME1098 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02553 GENEFORM Protein DME1098 XEOTICID XEO02553 MOACRIVE Inhibition DME1098 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1098 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02556 XEO_CLAS Peptide DME1098 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 55 microM) DME1098 XEOTICID XEO02556 GENEFORM Protein DME1098 XEOTICID XEO02556 MOACRIVE Inhibition DME1098 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1098 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02557 XEO_CLAS Peptide DME1098 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 17 microM) DME1098 XEOTICID XEO02557 GENEFORM Protein DME1098 XEOTICID XEO02557 MOACRIVE Inhibition DME1098 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1098 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02558 XEO_CLAS Peptide DME1098 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 14 microM) DME1098 XEOTICID XEO02558 GENEFORM Protein DME1098 XEOTICID XEO02558 MOACRIVE Inhibition DME1098 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1098 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02559 XEO_CLAS Peptide DME1098 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02559 GENEFORM Protein DME1098 XEOTICID XEO02559 MOACRIVE Inhibition DME1098 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1098 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02560 XEO_CLAS Peptide DME1098 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 13 microM) DME1098 XEOTICID XEO02560 GENEFORM Protein DME1098 XEOTICID XEO02560 MOACRIVE Inhibition DME1098 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1098 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02561 XEO_CLAS Peptide DME1098 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO02561 GENEFORM Protein DME1098 XEOTICID XEO02561 MOACRIVE Inhibition DME1098 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1098 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02562 XEO_CLAS Peptide DME1098 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 13 microM) DME1098 XEOTICID XEO02562 GENEFORM Protein DME1098 XEOTICID XEO02562 MOACRIVE Inhibition DME1098 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1098 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02563 XEO_CLAS Peptide DME1098 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 45 microM) DME1098 XEOTICID XEO02563 GENEFORM Protein DME1098 XEOTICID XEO02563 MOACRIVE Inhibition DME1098 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1098 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02564 XEO_CLAS Peptide DME1098 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 ug/ml) DME1098 XEOTICID XEO02564 GENEFORM Protein DME1098 XEOTICID XEO02564 MOACRIVE Inhibition DME1098 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1098 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02565 XEO_CLAS Peptide DME1098 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 microM) DME1098 XEOTICID XEO02565 GENEFORM Protein DME1098 XEOTICID XEO02565 MOACRIVE Inhibition DME1098 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1098 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02566 XEO_CLAS Peptide DME1098 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO02566 GENEFORM Protein DME1098 XEOTICID XEO02566 MOACRIVE Inhibition DME1098 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1098 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02568 XEO_CLAS Peptide DME1098 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO02568 GENEFORM Protein DME1098 XEOTICID XEO02568 MOACRIVE Inhibition DME1098 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1098 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02569 XEO_CLAS Peptide DME1098 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO02569 GENEFORM Protein DME1098 XEOTICID XEO02569 MOACRIVE Inhibition DME1098 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1098 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02570 XEO_CLAS Peptide DME1098 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO02570 GENEFORM Protein DME1098 XEOTICID XEO02570 MOACRIVE Inhibition DME1098 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1098 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02571 XEO_CLAS Peptide DME1098 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO02571 GENEFORM Protein DME1098 XEOTICID XEO02571 MOACRIVE Inhibition DME1098 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1098 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02572 XEO_CLAS Peptide DME1098 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02572 GENEFORM Protein DME1098 XEOTICID XEO02572 MOACRIVE Inhibition DME1098 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1098 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02573 XEO_CLAS Peptide DME1098 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02573 GENEFORM Protein DME1098 XEOTICID XEO02573 MOACRIVE Inhibition DME1098 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1098 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02574 XEO_CLAS Peptide DME1098 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 microM) DME1098 XEOTICID XEO02574 GENEFORM Protein DME1098 XEOTICID XEO02574 MOACRIVE Inhibition DME1098 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1098 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02575 XEO_CLAS Peptide DME1098 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 microM) DME1098 XEOTICID XEO02575 GENEFORM Protein DME1098 XEOTICID XEO02575 MOACRIVE Inhibition DME1098 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1098 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02576 XEO_CLAS Peptide DME1098 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 33 microM) DME1098 XEOTICID XEO02576 GENEFORM Protein DME1098 XEOTICID XEO02576 MOACRIVE Inhibition DME1098 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1098 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02577 XEO_CLAS Peptide DME1098 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO02577 GENEFORM Protein DME1098 XEOTICID XEO02577 MOACRIVE Inhibition DME1098 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1098 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02578 XEO_CLAS Peptide DME1098 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02578 GENEFORM Protein DME1098 XEOTICID XEO02578 MOACRIVE Inhibition DME1098 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1098 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02579 XEO_CLAS Peptide DME1098 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02579 GENEFORM Protein DME1098 XEOTICID XEO02579 MOACRIVE Inhibition DME1098 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1098 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02580 XEO_CLAS Peptide DME1098 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC < 15 microM) DME1098 XEOTICID XEO02580 GENEFORM Protein DME1098 XEOTICID XEO02580 MOACRIVE Inhibition DME1098 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1098 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02581 XEO_CLAS Peptide DME1098 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 microM) DME1098 XEOTICID XEO02581 GENEFORM Protein DME1098 XEOTICID XEO02581 MOACRIVE Inhibition DME1098 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1098 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02582 XEO_CLAS Peptide DME1098 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 microM) DME1098 XEOTICID XEO02582 GENEFORM Protein DME1098 XEOTICID XEO02582 MOACRIVE Inhibition DME1098 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1098 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02583 XEO_CLAS Peptide DME1098 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 microM) DME1098 XEOTICID XEO02583 GENEFORM Protein DME1098 XEOTICID XEO02583 MOACRIVE Inhibition DME1098 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1098 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02584 XEO_CLAS Peptide DME1098 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 microM) DME1098 XEOTICID XEO02584 GENEFORM Protein DME1098 XEOTICID XEO02584 MOACRIVE Inhibition DME1098 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1098 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02585 XEO_CLAS Peptide DME1098 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO02585 GENEFORM Protein DME1098 XEOTICID XEO02585 MOACRIVE Inhibition DME1098 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1098 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02586 XEO_CLAS Peptide DME1098 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO02586 GENEFORM Protein DME1098 XEOTICID XEO02586 MOACRIVE Inhibition DME1098 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1098 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02587 XEO_CLAS Peptide DME1098 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02587 GENEFORM Protein DME1098 XEOTICID XEO02587 MOACRIVE Inhibition DME1098 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1098 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02589 XEO_CLAS Peptide DME1098 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8.2 ug/ml) DME1098 XEOTICID XEO02589 GENEFORM Protein DME1098 XEOTICID XEO02589 MOACRIVE Inhibition DME1098 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1098 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02590 XEO_CLAS Peptide DME1098 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 19.6 ug/ml) DME1098 XEOTICID XEO02590 GENEFORM Protein DME1098 XEOTICID XEO02590 MOACRIVE Inhibition DME1098 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1098 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02591 XEO_CLAS Peptide DME1098 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO02591 GENEFORM Protein DME1098 XEOTICID XEO02591 MOACRIVE Inhibition DME1098 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1098 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02593 XEO_CLAS Peptide DME1098 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 36 microM) DME1098 XEOTICID XEO02593 GENEFORM Protein DME1098 XEOTICID XEO02593 MOACRIVE Inhibition DME1098 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1098 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02594 XEO_CLAS Peptide DME1098 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02594 GENEFORM Protein DME1098 XEOTICID XEO02594 MOACRIVE Inhibition DME1098 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1098 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02595 XEO_CLAS Peptide DME1098 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO02595 GENEFORM Protein DME1098 XEOTICID XEO02595 MOACRIVE Inhibition DME1098 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1098 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02596 XEO_CLAS Peptide DME1098 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO02596 GENEFORM Protein DME1098 XEOTICID XEO02596 MOACRIVE Inhibition DME1098 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1098 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02597 XEO_CLAS Peptide DME1098 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO02597 GENEFORM Protein DME1098 XEOTICID XEO02597 MOACRIVE Inhibition DME1098 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1098 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02598 XEO_CLAS Peptide DME1098 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 32.5 microM) DME1098 XEOTICID XEO02598 GENEFORM Protein DME1098 XEOTICID XEO02598 MOACRIVE Inhibition DME1098 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1098 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02599 XEO_CLAS Peptide DME1098 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 microM) DME1098 XEOTICID XEO02599 GENEFORM Protein DME1098 XEOTICID XEO02599 MOACRIVE Inhibition DME1098 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1098 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02601 XEO_CLAS Peptide DME1098 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.1 ug/ml) DME1098 XEOTICID XEO02601 GENEFORM Protein DME1098 XEOTICID XEO02601 MOACRIVE Inhibition DME1098 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1098 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02602 XEO_CLAS Peptide DME1098 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 13.2 ug/ml) DME1098 XEOTICID XEO02602 GENEFORM Protein DME1098 XEOTICID XEO02602 MOACRIVE Inhibition DME1098 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1098 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02603 XEO_CLAS Peptide DME1098 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.3 ug/ml) DME1098 XEOTICID XEO02603 GENEFORM Protein DME1098 XEOTICID XEO02603 MOACRIVE Inhibition DME1098 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1098 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02604 XEO_CLAS Peptide DME1098 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO02604 GENEFORM Protein DME1098 XEOTICID XEO02604 MOACRIVE Inhibition DME1098 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1098 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02605 XEO_CLAS Peptide DME1098 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30.6 ug/ml) DME1098 XEOTICID XEO02605 GENEFORM Protein DME1098 XEOTICID XEO02605 MOACRIVE Inhibition DME1098 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1098 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02606 XEO_CLAS Peptide DME1098 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 11.2 ug/ml) DME1098 XEOTICID XEO02606 GENEFORM Protein DME1098 XEOTICID XEO02606 MOACRIVE Inhibition DME1098 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1098 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02607 XEO_CLAS Peptide DME1098 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.8 ug/ml) DME1098 XEOTICID XEO02607 GENEFORM Protein DME1098 XEOTICID XEO02607 MOACRIVE Inhibition DME1098 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1098 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02608 XEO_CLAS Peptide DME1098 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 7.9 ug/ml) DME1098 XEOTICID XEO02608 GENEFORM Protein DME1098 XEOTICID XEO02608 MOACRIVE Inhibition DME1098 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1098 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02609 XEO_CLAS Peptide DME1098 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15.8 ug/ml) DME1098 XEOTICID XEO02609 GENEFORM Protein DME1098 XEOTICID XEO02609 MOACRIVE Inhibition DME1098 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1098 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02610 XEO_CLAS Peptide DME1098 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.1 ug/ml) DME1098 XEOTICID XEO02610 GENEFORM Protein DME1098 XEOTICID XEO02610 MOACRIVE Inhibition DME1098 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1098 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02611 XEO_CLAS Peptide DME1098 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20.6 ug/ml) DME1098 XEOTICID XEO02611 GENEFORM Protein DME1098 XEOTICID XEO02611 MOACRIVE Inhibition DME1098 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1098 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02612 XEO_CLAS Peptide DME1098 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 11.8 ug/ml) DME1098 XEOTICID XEO02612 GENEFORM Protein DME1098 XEOTICID XEO02612 MOACRIVE Inhibition DME1098 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1098 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02613 XEO_CLAS Peptide DME1098 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 13.2 ug/ml) DME1098 XEOTICID XEO02613 GENEFORM Protein DME1098 XEOTICID XEO02613 MOACRIVE Inhibition DME1098 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1098 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02614 XEO_CLAS Peptide DME1098 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.8 ug/ml) DME1098 XEOTICID XEO02614 GENEFORM Protein DME1098 XEOTICID XEO02614 MOACRIVE Inhibition DME1098 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1098 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02615 XEO_CLAS Peptide DME1098 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8.6 ug/ml) DME1098 XEOTICID XEO02615 GENEFORM Protein DME1098 XEOTICID XEO02615 MOACRIVE Inhibition DME1098 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1098 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02616 XEO_CLAS Peptide DME1098 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20.4 ug/ml) DME1098 XEOTICID XEO02616 GENEFORM Protein DME1098 XEOTICID XEO02616 MOACRIVE Inhibition DME1098 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1098 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02617 XEO_CLAS Peptide DME1098 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4.7 ug/ml) DME1098 XEOTICID XEO02617 GENEFORM Protein DME1098 XEOTICID XEO02617 MOACRIVE Inhibition DME1098 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1098 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02618 XEO_CLAS Peptide DME1098 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.6 ug/ml) DME1098 XEOTICID XEO02618 GENEFORM Protein DME1098 XEOTICID XEO02618 MOACRIVE Inhibition DME1098 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1098 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02619 XEO_CLAS Peptide DME1098 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10.5 ug/ml) DME1098 XEOTICID XEO02619 GENEFORM Protein DME1098 XEOTICID XEO02619 MOACRIVE Inhibition DME1098 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1098 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02620 XEO_CLAS Peptide DME1098 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO02620 GENEFORM Protein DME1098 XEOTICID XEO02620 MOACRIVE Inhibition DME1098 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1098 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02621 XEO_CLAS Peptide DME1098 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO02621 GENEFORM Protein DME1098 XEOTICID XEO02621 MOACRIVE Inhibition DME1098 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1098 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02622 XEO_CLAS Peptide DME1098 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO02622 GENEFORM Protein DME1098 XEOTICID XEO02622 MOACRIVE Inhibition DME1098 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1098 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02623 XEO_CLAS Peptide DME1098 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO02623 GENEFORM Protein DME1098 XEOTICID XEO02623 MOACRIVE Inhibition DME1098 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1098 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02624 XEO_CLAS Peptide DME1098 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 18 microM) DME1098 XEOTICID XEO02624 GENEFORM Protein DME1098 XEOTICID XEO02624 MOACRIVE Inhibition DME1098 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1098 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02625 XEO_CLAS Peptide DME1098 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 9 microM) DME1098 XEOTICID XEO02625 GENEFORM Protein DME1098 XEOTICID XEO02625 MOACRIVE Inhibition DME1098 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1098 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02626 XEO_CLAS Peptide DME1098 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 18 microM) DME1098 XEOTICID XEO02626 GENEFORM Protein DME1098 XEOTICID XEO02626 MOACRIVE Inhibition DME1098 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1098 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02627 XEO_CLAS Peptide DME1098 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02627 GENEFORM Protein DME1098 XEOTICID XEO02627 MOACRIVE Inhibition DME1098 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1098 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02628 XEO_CLAS Peptide DME1098 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 18 microM) DME1098 XEOTICID XEO02628 GENEFORM Protein DME1098 XEOTICID XEO02628 MOACRIVE Inhibition DME1098 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1098 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02629 XEO_CLAS Peptide DME1098 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 13 microM) DME1098 XEOTICID XEO02629 GENEFORM Protein DME1098 XEOTICID XEO02629 MOACRIVE Inhibition DME1098 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1098 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02630 XEO_CLAS Peptide DME1098 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 ug/ml) DME1098 XEOTICID XEO02630 GENEFORM Protein DME1098 XEOTICID XEO02630 MOACRIVE Inhibition DME1098 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1098 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02631 XEO_CLAS Peptide DME1098 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 ug/ml) DME1098 XEOTICID XEO02631 GENEFORM Protein DME1098 XEOTICID XEO02631 MOACRIVE Inhibition DME1098 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1098 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02634 XEO_CLAS Peptide DME1098 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO02634 GENEFORM Protein DME1098 XEOTICID XEO02634 MOACRIVE Inhibition DME1098 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1098 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02635 XEO_CLAS Peptide DME1098 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40 ug/ml) DME1098 XEOTICID XEO02635 GENEFORM Protein DME1098 XEOTICID XEO02635 MOACRIVE Inhibition DME1098 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1098 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02636 XEO_CLAS Peptide DME1098 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO02636 GENEFORM Protein DME1098 XEOTICID XEO02636 MOACRIVE Inhibition DME1098 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1098 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02637 XEO_CLAS Peptide DME1098 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO02637 GENEFORM Protein DME1098 XEOTICID XEO02637 MOACRIVE Inhibition DME1098 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1098 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02638 XEO_CLAS Peptide DME1098 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 microM) DME1098 XEOTICID XEO02638 GENEFORM Protein DME1098 XEOTICID XEO02638 MOACRIVE Inhibition DME1098 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1098 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02639 XEO_CLAS Peptide DME1098 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 microM) DME1098 XEOTICID XEO02639 GENEFORM Protein DME1098 XEOTICID XEO02639 MOACRIVE Inhibition DME1098 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1098 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02644 XEO_CLAS Peptide DME1098 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02644 GENEFORM Protein DME1098 XEOTICID XEO02644 MOACRIVE Inhibition DME1098 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1098 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02645 XEO_CLAS Peptide DME1098 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02645 GENEFORM Protein DME1098 XEOTICID XEO02645 MOACRIVE Inhibition DME1098 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1098 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02646 XEO_CLAS Peptide DME1098 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02646 GENEFORM Protein DME1098 XEOTICID XEO02646 MOACRIVE Inhibition DME1098 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1098 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02647 XEO_CLAS Peptide DME1098 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02647 GENEFORM Protein DME1098 XEOTICID XEO02647 MOACRIVE Inhibition DME1098 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1098 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02649 XEO_CLAS Peptide DME1098 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO02649 GENEFORM Protein DME1098 XEOTICID XEO02649 MOACRIVE Inhibition DME1098 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1098 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02650 XEO_CLAS Peptide DME1098 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO02650 GENEFORM Protein DME1098 XEOTICID XEO02650 MOACRIVE Inhibition DME1098 XEOTICID XEO02658 XEO_NAME Buthinin DME1098 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02658 XEO_CLAS Peptide DME1098 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02658 GENEFORM Protein DME1098 XEOTICID XEO02658 MOACRIVE Inhibition DME1098 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1098 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02663 XEO_CLAS Peptide DME1098 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25 microM) DME1098 XEOTICID XEO02663 GENEFORM Protein DME1098 XEOTICID XEO02663 MOACRIVE Inhibition DME1098 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1098 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02664 XEO_CLAS Peptide DME1098 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25 microM) DME1098 XEOTICID XEO02664 GENEFORM Protein DME1098 XEOTICID XEO02664 MOACRIVE Inhibition DME1098 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1098 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02672 XEO_CLAS Peptide DME1098 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25 microM) DME1098 XEOTICID XEO02672 GENEFORM Protein DME1098 XEOTICID XEO02672 MOACRIVE Inhibition DME1098 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1098 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02673 XEO_CLAS Peptide DME1098 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1098 XEOTICID XEO02673 GENEFORM Protein DME1098 XEOTICID XEO02673 MOACRIVE Inhibition DME1098 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1098 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02674 XEO_CLAS Peptide DME1098 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.125-6.25 microM) DME1098 XEOTICID XEO02674 GENEFORM Protein DME1098 XEOTICID XEO02674 MOACRIVE Inhibition DME1098 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1098 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02676 XEO_CLAS Peptide DME1098 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO02676 GENEFORM Protein DME1098 XEOTICID XEO02676 MOACRIVE Inhibition DME1098 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1098 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02677 XEO_CLAS Peptide DME1098 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1098 XEOTICID XEO02677 GENEFORM Protein DME1098 XEOTICID XEO02677 MOACRIVE Inhibition DME1098 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1098 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02679 XEO_CLAS Peptide DME1098 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1098 XEOTICID XEO02679 GENEFORM Protein DME1098 XEOTICID XEO02679 MOACRIVE Inhibition DME1098 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1098 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02680 XEO_CLAS Peptide DME1098 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25 microM) DME1098 XEOTICID XEO02680 GENEFORM Protein DME1098 XEOTICID XEO02680 MOACRIVE Inhibition DME1098 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1098 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02683 XEO_CLAS Peptide DME1098 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO02683 GENEFORM Protein DME1098 XEOTICID XEO02683 MOACRIVE Inhibition DME1098 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1098 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02688 XEO_CLAS Peptide DME1098 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO02688 GENEFORM Protein DME1098 XEOTICID XEO02688 MOACRIVE Inhibition DME1098 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1098 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02693 XEO_CLAS Peptide DME1098 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 ug/ml) DME1098 XEOTICID XEO02693 GENEFORM Protein DME1098 XEOTICID XEO02693 MOACRIVE Inhibition DME1098 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1098 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02699 XEO_CLAS Peptide DME1098 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 ug/ml) DME1098 XEOTICID XEO02699 GENEFORM Protein DME1098 XEOTICID XEO02699 MOACRIVE Inhibition DME1098 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1098 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02700 XEO_CLAS Peptide DME1098 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 ug/ml) DME1098 XEOTICID XEO02700 GENEFORM Protein DME1098 XEOTICID XEO02700 MOACRIVE Inhibition DME1098 XEOTICID XEO02703 XEO_NAME Calcitermin DME1098 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02703 XEO_CLAS Peptide DME1098 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02703 GENEFORM Protein DME1098 XEOTICID XEO02703 MOACRIVE Inhibition DME1098 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1098 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02708 XEO_CLAS Peptide DME1098 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO02708 GENEFORM Protein DME1098 XEOTICID XEO02708 MOACRIVE Inhibition DME1098 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1098 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02709 XEO_CLAS Peptide DME1098 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.05 microM) DME1098 XEOTICID XEO02709 GENEFORM Protein DME1098 XEOTICID XEO02709 MOACRIVE Inhibition DME1098 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1098 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1098 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02713 GENEFORM Protein DME1098 XEOTICID XEO02713 MOACRIVE Inhibition DME1098 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1098 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1098 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02714 GENEFORM Protein DME1098 XEOTICID XEO02714 MOACRIVE Inhibition DME1098 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1098 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02726 XEO_CLAS Peptide DME1098 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02726 GENEFORM Protein DME1098 XEOTICID XEO02726 MOACRIVE Inhibition DME1098 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1098 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02731 XEO_CLAS Peptide DME1098 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1 microM) DME1098 XEOTICID XEO02731 GENEFORM Protein DME1098 XEOTICID XEO02731 MOACRIVE Inhibition DME1098 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1098 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02732 XEO_CLAS Peptide DME1098 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.25 microM) DME1098 XEOTICID XEO02732 GENEFORM Protein DME1098 XEOTICID XEO02732 MOACRIVE Inhibition DME1098 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1098 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02733 XEO_CLAS Peptide DME1098 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8-25 ug/ml) DME1098 XEOTICID XEO02733 GENEFORM Protein DME1098 XEOTICID XEO02733 MOACRIVE Inhibition DME1098 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1098 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02735 XEO_CLAS Peptide DME1098 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1 ug/ml) DME1098 XEOTICID XEO02735 GENEFORM Protein DME1098 XEOTICID XEO02735 MOACRIVE Inhibition DME1098 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1098 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02737 XEO_CLAS Peptide DME1098 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02737 GENEFORM Protein DME1098 XEOTICID XEO02737 MOACRIVE Inhibition DME1098 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1098 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02738 XEO_CLAS Peptide DME1098 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO02738 GENEFORM Protein DME1098 XEOTICID XEO02738 MOACRIVE Inhibition DME1098 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1098 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02739 XEO_CLAS Peptide DME1098 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 microM) DME1098 XEOTICID XEO02739 GENEFORM Protein DME1098 XEOTICID XEO02739 MOACRIVE Inhibition DME1098 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1098 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02740 XEO_CLAS Peptide DME1098 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.25 ug/ml) DME1098 XEOTICID XEO02740 GENEFORM Protein DME1098 XEOTICID XEO02740 MOACRIVE Inhibition DME1098 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1098 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02741 XEO_CLAS Peptide DME1098 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 ug/ml) DME1098 XEOTICID XEO02741 GENEFORM Protein DME1098 XEOTICID XEO02741 MOACRIVE Inhibition DME1098 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1098 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02743 XEO_CLAS Peptide DME1098 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.6 ug/ml) DME1098 XEOTICID XEO02743 GENEFORM Protein DME1098 XEOTICID XEO02743 MOACRIVE Inhibition DME1098 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1098 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02744 XEO_CLAS Peptide DME1098 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 18.7 ug/ml) DME1098 XEOTICID XEO02744 GENEFORM Protein DME1098 XEOTICID XEO02744 MOACRIVE Inhibition DME1098 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1098 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02745 XEO_CLAS Peptide DME1098 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02745 GENEFORM Protein DME1098 XEOTICID XEO02745 MOACRIVE Inhibition DME1098 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1098 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02746 XEO_CLAS Peptide DME1098 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02746 GENEFORM Protein DME1098 XEOTICID XEO02746 MOACRIVE Inhibition DME1098 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1098 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02748 XEO_CLAS Peptide DME1098 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02748 GENEFORM Protein DME1098 XEOTICID XEO02748 MOACRIVE Inhibition DME1098 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1098 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02749 XEO_CLAS Peptide DME1098 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20-25 mug/ml) DME1098 XEOTICID XEO02749 GENEFORM Protein DME1098 XEOTICID XEO02749 MOACRIVE Inhibition DME1098 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1098 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02750 XEO_CLAS Peptide DME1098 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02750 GENEFORM Protein DME1098 XEOTICID XEO02750 MOACRIVE Inhibition DME1098 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1098 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02752 XEO_CLAS Peptide DME1098 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02752 GENEFORM Protein DME1098 XEOTICID XEO02752 MOACRIVE Inhibition DME1098 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1098 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02753 XEO_CLAS Peptide DME1098 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02753 GENEFORM Protein DME1098 XEOTICID XEO02753 MOACRIVE Inhibition DME1098 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1098 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02754 XEO_CLAS Peptide DME1098 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 microM) DME1098 XEOTICID XEO02754 GENEFORM Protein DME1098 XEOTICID XEO02754 MOACRIVE Inhibition DME1098 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1098 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02756 XEO_CLAS Peptide DME1098 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 microM) DME1098 XEOTICID XEO02756 GENEFORM Protein DME1098 XEOTICID XEO02756 MOACRIVE Inhibition DME1098 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1098 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02757 XEO_CLAS Peptide DME1098 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1 microM) DME1098 XEOTICID XEO02757 GENEFORM Protein DME1098 XEOTICID XEO02757 MOACRIVE Inhibition DME1098 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1098 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02758 XEO_CLAS Peptide DME1098 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO02758 GENEFORM Protein DME1098 XEOTICID XEO02758 MOACRIVE Inhibition DME1098 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1098 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02759 XEO_CLAS Peptide DME1098 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.6 microM) DME1098 XEOTICID XEO02759 GENEFORM Protein DME1098 XEOTICID XEO02759 MOACRIVE Inhibition DME1098 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1098 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02760 XEO_CLAS Peptide DME1098 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 microM) DME1098 XEOTICID XEO02760 GENEFORM Protein DME1098 XEOTICID XEO02760 MOACRIVE Inhibition DME1098 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1098 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02761 XEO_CLAS Peptide DME1098 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO02761 GENEFORM Protein DME1098 XEOTICID XEO02761 MOACRIVE Inhibition DME1098 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1098 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02762 XEO_CLAS Peptide DME1098 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 microM) DME1098 XEOTICID XEO02762 GENEFORM Protein DME1098 XEOTICID XEO02762 MOACRIVE Inhibition DME1098 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1098 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02763 XEO_CLAS Peptide DME1098 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.4 microM) DME1098 XEOTICID XEO02763 GENEFORM Protein DME1098 XEOTICID XEO02763 MOACRIVE Inhibition DME1098 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1098 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02764 XEO_CLAS Peptide DME1098 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 microM) DME1098 XEOTICID XEO02764 GENEFORM Protein DME1098 XEOTICID XEO02764 MOACRIVE Inhibition DME1098 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1098 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02765 XEO_CLAS Peptide DME1098 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.3 microM) DME1098 XEOTICID XEO02765 GENEFORM Protein DME1098 XEOTICID XEO02765 MOACRIVE Inhibition DME1098 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1098 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02767 XEO_CLAS Peptide DME1098 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02767 GENEFORM Protein DME1098 XEOTICID XEO02767 MOACRIVE Inhibition DME1098 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1098 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02768 XEO_CLAS Peptide DME1098 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1098 XEOTICID XEO02768 GENEFORM Protein DME1098 XEOTICID XEO02768 MOACRIVE Inhibition DME1098 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1098 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02769 XEO_CLAS Peptide DME1098 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.32 microM) DME1098 XEOTICID XEO02769 GENEFORM Protein DME1098 XEOTICID XEO02769 MOACRIVE Inhibition DME1098 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1098 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02770 XEO_CLAS Peptide DME1098 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.30 microM) DME1098 XEOTICID XEO02770 GENEFORM Protein DME1098 XEOTICID XEO02770 MOACRIVE Inhibition DME1098 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1098 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02771 XEO_CLAS Peptide DME1098 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.21 microM) DME1098 XEOTICID XEO02771 GENEFORM Protein DME1098 XEOTICID XEO02771 MOACRIVE Inhibition DME1098 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1098 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02772 XEO_CLAS Peptide DME1098 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02772 GENEFORM Protein DME1098 XEOTICID XEO02772 MOACRIVE Inhibition DME1098 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1098 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02773 XEO_CLAS Peptide DME1098 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.9-8.6 microM) DME1098 XEOTICID XEO02773 GENEFORM Protein DME1098 XEOTICID XEO02773 MOACRIVE Inhibition DME1098 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1098 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02774 XEO_CLAS Peptide DME1098 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.3 microM) DME1098 XEOTICID XEO02774 GENEFORM Protein DME1098 XEOTICID XEO02774 MOACRIVE Inhibition DME1098 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1098 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02789 GENEFORM Protein DME1098 XEOTICID XEO02789 MOACRIVE Inhibition DME1098 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1098 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02790 GENEFORM Protein DME1098 XEOTICID XEO02790 MOACRIVE Inhibition DME1098 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1098 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02791 GENEFORM Protein DME1098 XEOTICID XEO02791 MOACRIVE Inhibition DME1098 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1098 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02792 GENEFORM Protein DME1098 XEOTICID XEO02792 MOACRIVE Inhibition DME1098 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1098 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02793 GENEFORM Protein DME1098 XEOTICID XEO02793 MOACRIVE Inhibition DME1098 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1098 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02794 GENEFORM Protein DME1098 XEOTICID XEO02794 MOACRIVE Inhibition DME1098 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1098 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02795 GENEFORM Protein DME1098 XEOTICID XEO02795 MOACRIVE Inhibition DME1098 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1098 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02796 GENEFORM Protein DME1098 XEOTICID XEO02796 MOACRIVE Inhibition DME1098 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1098 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02797 GENEFORM Protein DME1098 XEOTICID XEO02797 MOACRIVE Inhibition DME1098 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1098 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02799 XEO_CLAS Peptide DME1098 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02799 GENEFORM Protein DME1098 XEOTICID XEO02799 MOACRIVE Inhibition DME1098 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1098 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02800 XEO_CLAS Peptide DME1098 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02800 GENEFORM Protein DME1098 XEOTICID XEO02800 MOACRIVE Inhibition DME1098 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1098 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02802 XEO_CLAS Peptide DME1098 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 13.6 microM) DME1098 XEOTICID XEO02802 GENEFORM Protein DME1098 XEOTICID XEO02802 MOACRIVE Inhibition DME1098 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1098 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02807 XEO_CLAS Peptide DME1098 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.2 microM) DME1098 XEOTICID XEO02807 GENEFORM Protein DME1098 XEOTICID XEO02807 MOACRIVE Inhibition DME1098 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1098 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02813 XEO_CLAS Peptide DME1098 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 80 microM) DME1098 XEOTICID XEO02813 GENEFORM Protein DME1098 XEOTICID XEO02813 MOACRIVE Inhibition DME1098 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1098 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02814 XEO_CLAS Peptide DME1098 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 80 microM) DME1098 XEOTICID XEO02814 GENEFORM Protein DME1098 XEOTICID XEO02814 MOACRIVE Inhibition DME1098 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1098 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02815 XEO_CLAS Peptide DME1098 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8.5 microM) DME1098 XEOTICID XEO02815 GENEFORM Protein DME1098 XEOTICID XEO02815 MOACRIVE Inhibition DME1098 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1098 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02816 XEO_CLAS Peptide DME1098 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 80 microM) DME1098 XEOTICID XEO02816 GENEFORM Protein DME1098 XEOTICID XEO02816 MOACRIVE Inhibition DME1098 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1098 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02817 XEO_CLAS Peptide DME1098 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 80 microM) DME1098 XEOTICID XEO02817 GENEFORM Protein DME1098 XEOTICID XEO02817 MOACRIVE Inhibition DME1098 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1098 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02818 XEO_CLAS Peptide DME1098 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.4 microM) DME1098 XEOTICID XEO02818 GENEFORM Protein DME1098 XEOTICID XEO02818 MOACRIVE Inhibition DME1098 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1098 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02819 XEO_CLAS Peptide DME1098 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.6 microM) DME1098 XEOTICID XEO02819 GENEFORM Protein DME1098 XEOTICID XEO02819 MOACRIVE Inhibition DME1098 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1098 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02820 XEO_CLAS Peptide DME1098 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO02820 GENEFORM Protein DME1098 XEOTICID XEO02820 MOACRIVE Inhibition DME1098 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1098 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02821 XEO_CLAS Peptide DME1098 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02821 GENEFORM Protein DME1098 XEOTICID XEO02821 MOACRIVE Inhibition DME1098 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1098 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02824 XEO_CLAS Peptide DME1098 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 35 microM) DME1098 XEOTICID XEO02824 GENEFORM Protein DME1098 XEOTICID XEO02824 MOACRIVE Inhibition DME1098 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1098 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02826 XEO_CLAS Peptide DME1098 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.7 ug/ml) DME1098 XEOTICID XEO02826 GENEFORM Protein DME1098 XEOTICID XEO02826 MOACRIVE Inhibition DME1098 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1098 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02834 GENEFORM Protein DME1098 XEOTICID XEO02834 MOACRIVE Inhibition DME1098 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1098 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02839 XEO_CLAS Peptide DME1098 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.25 microM) DME1098 XEOTICID XEO02839 GENEFORM Protein DME1098 XEOTICID XEO02839 MOACRIVE Inhibition DME1098 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1098 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02841 XEO_CLAS Peptide DME1098 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.25 microM) DME1098 XEOTICID XEO02841 GENEFORM Protein DME1098 XEOTICID XEO02841 MOACRIVE Inhibition DME1098 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1098 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02842 XEO_CLAS Peptide DME1098 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.25 microM) DME1098 XEOTICID XEO02842 GENEFORM Protein DME1098 XEOTICID XEO02842 MOACRIVE Inhibition DME1098 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1098 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02843 XEO_CLAS Peptide DME1098 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02843 GENEFORM Protein DME1098 XEOTICID XEO02843 MOACRIVE Inhibition DME1098 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1098 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02849 GENEFORM Protein DME1098 XEOTICID XEO02849 MOACRIVE Inhibition DME1098 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1098 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02857 XEO_CLAS Peptide DME1098 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 53 microM) DME1098 XEOTICID XEO02857 GENEFORM Protein DME1098 XEOTICID XEO02857 MOACRIVE Inhibition DME1098 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1098 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02858 XEO_CLAS Peptide DME1098 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 53 microM) DME1098 XEOTICID XEO02858 GENEFORM Protein DME1098 XEOTICID XEO02858 MOACRIVE Inhibition DME1098 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1098 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02860 XEO_CLAS Peptide DME1098 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 ug/ml) DME1098 XEOTICID XEO02860 GENEFORM Protein DME1098 XEOTICID XEO02860 MOACRIVE Inhibition DME1098 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1098 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02867 XEO_CLAS Peptide DME1098 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02867 GENEFORM Protein DME1098 XEOTICID XEO02867 MOACRIVE Inhibition DME1098 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1098 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02868 XEO_CLAS Peptide DME1098 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02868 GENEFORM Protein DME1098 XEOTICID XEO02868 MOACRIVE Inhibition DME1098 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1098 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02869 XEO_CLAS Peptide DME1098 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02869 GENEFORM Protein DME1098 XEOTICID XEO02869 MOACRIVE Inhibition DME1098 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1098 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02870 XEO_CLAS Peptide DME1098 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02870 GENEFORM Protein DME1098 XEOTICID XEO02870 MOACRIVE Inhibition DME1098 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1098 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02871 XEO_CLAS Peptide DME1098 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02871 GENEFORM Protein DME1098 XEOTICID XEO02871 MOACRIVE Inhibition DME1098 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1098 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02872 XEO_CLAS Peptide DME1098 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 308 microM) DME1098 XEOTICID XEO02872 GENEFORM Protein DME1098 XEOTICID XEO02872 MOACRIVE Inhibition DME1098 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1098 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02875 XEO_CLAS Peptide DME1098 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.1 microM) DME1098 XEOTICID XEO02875 GENEFORM Protein DME1098 XEOTICID XEO02875 MOACRIVE Inhibition DME1098 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1098 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02876 XEO_CLAS Peptide DME1098 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO02876 GENEFORM Protein DME1098 XEOTICID XEO02876 MOACRIVE Inhibition DME1098 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1098 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02877 XEO_CLAS Peptide DME1098 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO02877 GENEFORM Protein DME1098 XEOTICID XEO02877 MOACRIVE Inhibition DME1098 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1098 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02878 XEO_CLAS Peptide DME1098 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.3 microM) DME1098 XEOTICID XEO02878 GENEFORM Protein DME1098 XEOTICID XEO02878 MOACRIVE Inhibition DME1098 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1098 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02885 XEO_CLAS Peptide DME1098 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02885 GENEFORM Protein DME1098 XEOTICID XEO02885 MOACRIVE Inhibition DME1098 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1098 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02886 XEO_CLAS Peptide DME1098 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02886 GENEFORM Protein DME1098 XEOTICID XEO02886 MOACRIVE Inhibition DME1098 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1098 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02887 XEO_CLAS Peptide DME1098 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1 ug/ml) DME1098 XEOTICID XEO02887 GENEFORM Protein DME1098 XEOTICID XEO02887 MOACRIVE Inhibition DME1098 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1098 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02888 XEO_CLAS Peptide DME1098 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 ug/ml) DME1098 XEOTICID XEO02888 GENEFORM Protein DME1098 XEOTICID XEO02888 MOACRIVE Inhibition DME1098 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1098 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02889 XEO_CLAS Peptide DME1098 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 ug/ml) DME1098 XEOTICID XEO02889 GENEFORM Protein DME1098 XEOTICID XEO02889 MOACRIVE Inhibition DME1098 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1098 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02890 XEO_CLAS Peptide DME1098 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02890 GENEFORM Protein DME1098 XEOTICID XEO02890 MOACRIVE Inhibition DME1098 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1098 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02891 XEO_CLAS Peptide DME1098 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02891 GENEFORM Protein DME1098 XEOTICID XEO02891 MOACRIVE Inhibition DME1098 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1098 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02895 XEO_CLAS Peptide DME1098 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO02895 GENEFORM Protein DME1098 XEOTICID XEO02895 MOACRIVE Inhibition DME1098 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1098 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02896 XEO_CLAS Peptide DME1098 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO02896 GENEFORM Protein DME1098 XEOTICID XEO02896 MOACRIVE Inhibition DME1098 XEOTICID XEO02899 XEO_NAME Coladonin DME1098 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1098 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1098 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02899 GENEFORM Protein DME1098 XEOTICID XEO02899 MOACRIVE Inhibition DME1098 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1098 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02900 XEO_CLAS Peptide DME1098 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02900 GENEFORM Protein DME1098 XEOTICID XEO02900 MOACRIVE Inhibition DME1098 XEOTICID XEO02901 XEO_NAME Colicin-V DME1098 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02901 XEO_CLAS Peptide DME1098 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02901 GENEFORM Protein DME1098 XEOTICID XEO02901 MOACRIVE Inhibition DME1098 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1098 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02904 GENEFORM Protein DME1098 XEOTICID XEO02904 MOACRIVE Inhibition DME1098 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1098 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02908 XEO_CLAS Peptide DME1098 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 50 microM) DME1098 XEOTICID XEO02908 GENEFORM Protein DME1098 XEOTICID XEO02908 MOACRIVE Inhibition DME1098 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1098 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02923 XEO_CLAS Peptide DME1098 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02923 GENEFORM Protein DME1098 XEOTICID XEO02923 MOACRIVE Inhibition DME1098 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1098 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02924 XEO_CLAS Peptide DME1098 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 32 microM) DME1098 XEOTICID XEO02924 GENEFORM Protein DME1098 XEOTICID XEO02924 MOACRIVE Inhibition DME1098 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1098 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1098 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02927 GENEFORM Protein DME1098 XEOTICID XEO02927 MOACRIVE Inhibition DME1098 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1098 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02931 XEO_CLAS Peptide DME1098 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 ug/ml) DME1098 XEOTICID XEO02931 GENEFORM Protein DME1098 XEOTICID XEO02931 MOACRIVE Inhibition DME1098 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1098 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02933 XEO_CLAS Peptide DME1098 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO02933 GENEFORM Protein DME1098 XEOTICID XEO02933 MOACRIVE Inhibition DME1098 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1098 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02934 XEO_CLAS Peptide DME1098 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02934 GENEFORM Protein DME1098 XEOTICID XEO02934 MOACRIVE Inhibition DME1098 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1098 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02935 XEO_CLAS Peptide DME1098 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02935 GENEFORM Protein DME1098 XEOTICID XEO02935 MOACRIVE Inhibition DME1098 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1098 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02936 XEO_CLAS Peptide DME1098 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO02936 GENEFORM Protein DME1098 XEOTICID XEO02936 MOACRIVE Inhibition DME1098 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1098 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02937 XEO_CLAS Peptide DME1098 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02937 GENEFORM Protein DME1098 XEOTICID XEO02937 MOACRIVE Inhibition DME1098 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1098 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02938 XEO_CLAS Peptide DME1098 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 32 ug/ml) DME1098 XEOTICID XEO02938 GENEFORM Protein DME1098 XEOTICID XEO02938 MOACRIVE Inhibition DME1098 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1098 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02939 XEO_CLAS Peptide DME1098 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 11 ug/ml) DME1098 XEOTICID XEO02939 GENEFORM Protein DME1098 XEOTICID XEO02939 MOACRIVE Inhibition DME1098 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1098 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02940 XEO_CLAS Peptide DME1098 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1 ug/ml) DME1098 XEOTICID XEO02940 GENEFORM Protein DME1098 XEOTICID XEO02940 MOACRIVE Inhibition DME1098 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1098 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02941 XEO_CLAS Peptide DME1098 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02941 GENEFORM Protein DME1098 XEOTICID XEO02941 MOACRIVE Inhibition DME1098 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1098 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02944 XEO_CLAS Peptide DME1098 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 microM) DME1098 XEOTICID XEO02944 GENEFORM Protein DME1098 XEOTICID XEO02944 MOACRIVE Inhibition DME1098 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1098 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02945 XEO_CLAS Peptide DME1098 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 microM) DME1098 XEOTICID XEO02945 GENEFORM Protein DME1098 XEOTICID XEO02945 MOACRIVE Inhibition DME1098 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1098 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02946 XEO_CLAS Peptide DME1098 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 microM) DME1098 XEOTICID XEO02946 GENEFORM Protein DME1098 XEOTICID XEO02946 MOACRIVE Inhibition DME1098 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1098 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02947 XEO_CLAS Peptide DME1098 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02947 GENEFORM Protein DME1098 XEOTICID XEO02947 MOACRIVE Inhibition DME1098 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1098 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02948 XEO_CLAS Peptide DME1098 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO02948 GENEFORM Protein DME1098 XEOTICID XEO02948 MOACRIVE Inhibition DME1098 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1098 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02949 XEO_CLAS Peptide DME1098 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO02949 GENEFORM Protein DME1098 XEOTICID XEO02949 MOACRIVE Inhibition DME1098 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1098 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02954 XEO_CLAS Peptide DME1098 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02954 GENEFORM Protein DME1098 XEOTICID XEO02954 MOACRIVE Inhibition DME1098 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1098 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02958 XEO_CLAS Peptide DME1098 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02958 GENEFORM Protein DME1098 XEOTICID XEO02958 MOACRIVE Inhibition DME1098 XEOTICID XEO02962 XEO_NAME Cryptonin DME1098 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02962 XEO_CLAS Peptide DME1098 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.12 ug/ml) DME1098 XEOTICID XEO02962 GENEFORM Protein DME1098 XEOTICID XEO02962 MOACRIVE Inhibition DME1098 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1098 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02965 XEO_CLAS Peptide DME1098 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 ug/ml) DME1098 XEOTICID XEO02965 GENEFORM Protein DME1098 XEOTICID XEO02965 MOACRIVE Inhibition DME1098 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1098 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02969 XEO_CLAS Peptide DME1098 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 microM) DME1098 XEOTICID XEO02969 GENEFORM Protein DME1098 XEOTICID XEO02969 MOACRIVE Inhibition DME1098 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1098 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02971 XEO_CLAS Peptide DME1098 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 microM) DME1098 XEOTICID XEO02971 GENEFORM Protein DME1098 XEOTICID XEO02971 MOACRIVE Inhibition DME1098 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1098 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO02972 XEO_CLAS Peptide DME1098 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.4 microM) DME1098 XEOTICID XEO02972 GENEFORM Protein DME1098 XEOTICID XEO02972 MOACRIVE Inhibition DME1098 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1098 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02990 GENEFORM Protein DME1098 XEOTICID XEO02990 MOACRIVE Inhibition DME1098 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1098 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02991 GENEFORM Protein DME1098 XEOTICID XEO02991 MOACRIVE Inhibition DME1098 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1098 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02992 GENEFORM Protein DME1098 XEOTICID XEO02992 MOACRIVE Inhibition DME1098 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1098 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02993 GENEFORM Protein DME1098 XEOTICID XEO02993 MOACRIVE Inhibition DME1098 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1098 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02994 GENEFORM Protein DME1098 XEOTICID XEO02994 MOACRIVE Inhibition DME1098 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1098 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02995 GENEFORM Protein DME1098 XEOTICID XEO02995 MOACRIVE Inhibition DME1098 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1098 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02996 GENEFORM Protein DME1098 XEOTICID XEO02996 MOACRIVE Inhibition DME1098 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1098 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02997 GENEFORM Protein DME1098 XEOTICID XEO02997 MOACRIVE Inhibition DME1098 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1098 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02998 GENEFORM Protein DME1098 XEOTICID XEO02998 MOACRIVE Inhibition DME1098 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1098 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1098 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO02999 GENEFORM Protein DME1098 XEOTICID XEO02999 MOACRIVE Inhibition DME1098 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1098 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03021 XEO_CLAS Peptide DME1098 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1098 XEOTICID XEO03021 GENEFORM Protein DME1098 XEOTICID XEO03021 MOACRIVE Inhibition DME1098 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1098 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03029 XEO_CLAS Peptide DME1098 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.005 microM) DME1098 XEOTICID XEO03029 GENEFORM Protein DME1098 XEOTICID XEO03029 MOACRIVE Inhibition DME1098 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1098 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03030 XEO_CLAS Peptide DME1098 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.005 microM) DME1098 XEOTICID XEO03030 GENEFORM Protein DME1098 XEOTICID XEO03030 MOACRIVE Inhibition DME1098 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1098 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03031 XEO_CLAS Peptide DME1098 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.3 microM) DME1098 XEOTICID XEO03031 GENEFORM Protein DME1098 XEOTICID XEO03031 MOACRIVE Inhibition DME1098 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1098 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03032 XEO_CLAS Peptide DME1098 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.01 microM) DME1098 XEOTICID XEO03032 GENEFORM Protein DME1098 XEOTICID XEO03032 MOACRIVE Inhibition DME1098 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1098 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03033 XEO_CLAS Peptide DME1098 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.173 microM) DME1098 XEOTICID XEO03033 GENEFORM Protein DME1098 XEOTICID XEO03033 MOACRIVE Inhibition DME1098 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1098 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03034 XEO_CLAS Peptide DME1098 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.518 microM) DME1098 XEOTICID XEO03034 GENEFORM Protein DME1098 XEOTICID XEO03034 MOACRIVE Inhibition DME1098 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1098 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03035 XEO_CLAS Peptide DME1098 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.114 microM) DME1098 XEOTICID XEO03035 GENEFORM Protein DME1098 XEOTICID XEO03035 MOACRIVE Inhibition DME1098 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1098 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03039 XEO_CLAS Peptide DME1098 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.55 microM) DME1098 XEOTICID XEO03039 GENEFORM Protein DME1098 XEOTICID XEO03039 MOACRIVE Inhibition DME1098 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1098 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03043 XEO_CLAS Peptide DME1098 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 microM) DME1098 XEOTICID XEO03043 GENEFORM Protein DME1098 XEOTICID XEO03043 MOACRIVE Inhibition DME1098 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1098 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03044 XEO_CLAS Peptide DME1098 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03044 GENEFORM Protein DME1098 XEOTICID XEO03044 MOACRIVE Inhibition DME1098 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1098 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03045 XEO_CLAS Peptide DME1098 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03045 GENEFORM Protein DME1098 XEOTICID XEO03045 MOACRIVE Inhibition DME1098 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1098 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03046 XEO_CLAS Peptide DME1098 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03046 GENEFORM Protein DME1098 XEOTICID XEO03046 MOACRIVE Inhibition DME1098 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1098 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03049 XEO_CLAS Peptide DME1098 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 microM) DME1098 XEOTICID XEO03049 GENEFORM Protein DME1098 XEOTICID XEO03049 MOACRIVE Inhibition DME1098 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1098 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03055 XEO_CLAS Peptide DME1098 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 microM) DME1098 XEOTICID XEO03055 GENEFORM Protein DME1098 XEOTICID XEO03055 MOACRIVE Inhibition DME1098 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1098 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03059 XEO_CLAS Peptide DME1098 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO03059 GENEFORM Protein DME1098 XEOTICID XEO03059 MOACRIVE Inhibition DME1098 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1098 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03060 XEO_CLAS Peptide DME1098 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO03060 GENEFORM Protein DME1098 XEOTICID XEO03060 MOACRIVE Inhibition DME1098 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1098 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03062 XEO_CLAS Peptide DME1098 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO03062 GENEFORM Protein DME1098 XEOTICID XEO03062 MOACRIVE Inhibition DME1098 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1098 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03064 XEO_CLAS Peptide DME1098 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO03064 GENEFORM Protein DME1098 XEOTICID XEO03064 MOACRIVE Inhibition DME1098 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1098 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03066 XEO_CLAS Peptide DME1098 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO03066 GENEFORM Protein DME1098 XEOTICID XEO03066 MOACRIVE Inhibition DME1098 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1098 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03068 XEO_CLAS Peptide DME1098 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO03068 GENEFORM Protein DME1098 XEOTICID XEO03068 MOACRIVE Inhibition DME1098 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1098 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03073 XEO_CLAS Peptide DME1098 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8-16 ug/ml) DME1098 XEOTICID XEO03073 GENEFORM Protein DME1098 XEOTICID XEO03073 MOACRIVE Inhibition DME1098 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1098 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03081 XEO_CLAS Peptide DME1098 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 microM) DME1098 XEOTICID XEO03081 GENEFORM Protein DME1098 XEOTICID XEO03081 MOACRIVE Inhibition DME1098 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1098 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03082 XEO_CLAS Peptide DME1098 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03082 GENEFORM Protein DME1098 XEOTICID XEO03082 MOACRIVE Inhibition DME1098 XEOTICID XEO03089 XEO_NAME Decoralin DME1098 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03089 XEO_CLAS Peptide DME1098 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 160 microM) DME1098 XEOTICID XEO03089 GENEFORM Protein DME1098 XEOTICID XEO03089 MOACRIVE Inhibition DME1098 XEOTICID XEO03098 XEO_NAME Insect defensin DME1098 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03098 XEO_CLAS Peptide DME1098 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 ug/ml) DME1098 XEOTICID XEO03098 GENEFORM Protein DME1098 XEOTICID XEO03098 MOACRIVE Inhibition DME1098 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1098 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03100 XEO_CLAS Peptide DME1098 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03100 GENEFORM Protein DME1098 XEOTICID XEO03100 MOACRIVE Inhibition DME1098 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1098 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03103 XEO_CLAS Peptide DME1098 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03103 GENEFORM Protein DME1098 XEOTICID XEO03103 MOACRIVE Inhibition DME1098 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1098 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03105 XEO_CLAS Peptide DME1098 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03105 GENEFORM Protein DME1098 XEOTICID XEO03105 MOACRIVE Inhibition DME1098 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1098 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03110 XEO_CLAS Peptide DME1098 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.2 microM) DME1098 XEOTICID XEO03110 GENEFORM Protein DME1098 XEOTICID XEO03110 MOACRIVE Inhibition DME1098 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1098 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03111 XEO_CLAS Peptide DME1098 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03111 GENEFORM Protein DME1098 XEOTICID XEO03111 MOACRIVE Inhibition DME1098 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1098 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03112 XEO_CLAS Peptide DME1098 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 50 ug/ml) DME1098 XEOTICID XEO03112 GENEFORM Protein DME1098 XEOTICID XEO03112 MOACRIVE Inhibition DME1098 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1098 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03115 XEO_CLAS Peptide DME1098 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03115 GENEFORM Protein DME1098 XEOTICID XEO03115 MOACRIVE Inhibition DME1098 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1098 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03116 XEO_CLAS Peptide DME1098 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 40 microM) DME1098 XEOTICID XEO03116 GENEFORM Protein DME1098 XEOTICID XEO03116 MOACRIVE Inhibition DME1098 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1098 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03118 XEO_CLAS Peptide DME1098 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03118 GENEFORM Protein DME1098 XEOTICID XEO03118 MOACRIVE Inhibition DME1098 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1098 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03119 XEO_CLAS Peptide DME1098 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03119 GENEFORM Protein DME1098 XEOTICID XEO03119 MOACRIVE Inhibition DME1098 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1098 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03121 XEO_CLAS Peptide DME1098 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03121 GENEFORM Protein DME1098 XEOTICID XEO03121 MOACRIVE Inhibition DME1098 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1098 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03122 XEO_CLAS Peptide DME1098 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64000 ug/ml) DME1098 XEOTICID XEO03122 GENEFORM Protein DME1098 XEOTICID XEO03122 MOACRIVE Inhibition DME1098 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1098 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03124 XEO_CLAS Peptide DME1098 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03124 GENEFORM Protein DME1098 XEOTICID XEO03124 MOACRIVE Inhibition DME1098 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1098 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03125 XEO_CLAS Peptide DME1098 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03125 GENEFORM Protein DME1098 XEOTICID XEO03125 MOACRIVE Inhibition DME1098 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1098 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03126 XEO_CLAS Peptide DME1098 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.86 microM) DME1098 XEOTICID XEO03126 GENEFORM Protein DME1098 XEOTICID XEO03126 MOACRIVE Inhibition DME1098 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1098 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03127 XEO_CLAS Peptide DME1098 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03127 GENEFORM Protein DME1098 XEOTICID XEO03127 MOACRIVE Inhibition DME1098 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1098 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03128 XEO_CLAS Peptide DME1098 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 256 ug/ml) DME1098 XEOTICID XEO03128 GENEFORM Protein DME1098 XEOTICID XEO03128 MOACRIVE Inhibition DME1098 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1098 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03129 XEO_CLAS Peptide DME1098 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 256 ug/ml) DME1098 XEOTICID XEO03129 GENEFORM Protein DME1098 XEOTICID XEO03129 MOACRIVE Inhibition DME1098 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1098 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03130 XEO_CLAS Peptide DME1098 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 256 ug/ml) DME1098 XEOTICID XEO03130 GENEFORM Protein DME1098 XEOTICID XEO03130 MOACRIVE Inhibition DME1098 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1098 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03131 XEO_CLAS Peptide DME1098 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 256 ug/ml) DME1098 XEOTICID XEO03131 GENEFORM Protein DME1098 XEOTICID XEO03131 MOACRIVE Inhibition DME1098 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1098 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03132 XEO_CLAS Peptide DME1098 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 256 ug/ml) DME1098 XEOTICID XEO03132 GENEFORM Protein DME1098 XEOTICID XEO03132 MOACRIVE Inhibition DME1098 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1098 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03137 XEO_CLAS Peptide DME1098 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03137 GENEFORM Protein DME1098 XEOTICID XEO03137 MOACRIVE Inhibition DME1098 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1098 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03143 XEO_CLAS Peptide DME1098 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.6 microM) DME1098 XEOTICID XEO03143 GENEFORM Protein DME1098 XEOTICID XEO03143 MOACRIVE Inhibition DME1098 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1098 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03145 XEO_CLAS Peptide DME1098 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.6 microM) DME1098 XEOTICID XEO03145 GENEFORM Protein DME1098 XEOTICID XEO03145 MOACRIVE Inhibition DME1098 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1098 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03146 XEO_CLAS Peptide DME1098 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.5 microM) DME1098 XEOTICID XEO03146 GENEFORM Protein DME1098 XEOTICID XEO03146 MOACRIVE Inhibition DME1098 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1098 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03147 XEO_CLAS Peptide DME1098 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 9.7 microM) DME1098 XEOTICID XEO03147 GENEFORM Protein DME1098 XEOTICID XEO03147 MOACRIVE Inhibition DME1098 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1098 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03148 XEO_CLAS Peptide DME1098 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.3 microM) DME1098 XEOTICID XEO03148 GENEFORM Protein DME1098 XEOTICID XEO03148 MOACRIVE Inhibition DME1098 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1098 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03149 XEO_CLAS Peptide DME1098 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.6 microM) DME1098 XEOTICID XEO03149 GENEFORM Protein DME1098 XEOTICID XEO03149 MOACRIVE Inhibition DME1098 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1098 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03150 XEO_CLAS Peptide DME1098 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 9-3 microM) DME1098 XEOTICID XEO03150 GENEFORM Protein DME1098 XEOTICID XEO03150 MOACRIVE Inhibition DME1098 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1098 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03151 XEO_CLAS Peptide DME1098 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 ug/ml) DME1098 XEOTICID XEO03151 GENEFORM Protein DME1098 XEOTICID XEO03151 MOACRIVE Inhibition DME1098 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1098 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03152 XEO_CLAS Peptide DME1098 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO03152 GENEFORM Protein DME1098 XEOTICID XEO03152 MOACRIVE Inhibition DME1098 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1098 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03155 XEO_CLAS Peptide DME1098 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.4 microM) DME1098 XEOTICID XEO03155 GENEFORM Protein DME1098 XEOTICID XEO03155 MOACRIVE Inhibition DME1098 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1098 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03156 XEO_CLAS Peptide DME1098 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.3 microM) DME1098 XEOTICID XEO03156 GENEFORM Protein DME1098 XEOTICID XEO03156 MOACRIVE Inhibition DME1098 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1098 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03157 XEO_CLAS Peptide DME1098 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.3 microM) DME1098 XEOTICID XEO03157 GENEFORM Protein DME1098 XEOTICID XEO03157 MOACRIVE Inhibition DME1098 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1098 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03158 XEO_CLAS Peptide DME1098 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 ug/ml) DME1098 XEOTICID XEO03158 GENEFORM Protein DME1098 XEOTICID XEO03158 MOACRIVE Inhibition DME1098 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1098 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03159 XEO_CLAS Peptide DME1098 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03159 GENEFORM Protein DME1098 XEOTICID XEO03159 MOACRIVE Inhibition DME1098 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1098 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03161 XEO_CLAS Peptide DME1098 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 microM) DME1098 XEOTICID XEO03161 GENEFORM Protein DME1098 XEOTICID XEO03161 MOACRIVE Inhibition DME1098 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1098 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03162 XEO_CLAS Peptide DME1098 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.5 microM) DME1098 XEOTICID XEO03162 GENEFORM Protein DME1098 XEOTICID XEO03162 MOACRIVE Inhibition DME1098 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1098 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03169 XEO_CLAS Peptide DME1098 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO03169 GENEFORM Protein DME1098 XEOTICID XEO03169 MOACRIVE Inhibition DME1098 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1098 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03193 XEO_CLAS Peptide DME1098 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25 ug/ml) DME1098 XEOTICID XEO03193 GENEFORM Protein DME1098 XEOTICID XEO03193 MOACRIVE Inhibition DME1098 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1098 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03194 XEO_CLAS Peptide DME1098 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03194 GENEFORM Protein DME1098 XEOTICID XEO03194 MOACRIVE Inhibition DME1098 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1098 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03195 XEO_CLAS Peptide DME1098 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03195 GENEFORM Protein DME1098 XEOTICID XEO03195 MOACRIVE Inhibition DME1098 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1098 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03197 XEO_CLAS Peptide DME1098 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 14.5 microM) DME1098 XEOTICID XEO03197 GENEFORM Protein DME1098 XEOTICID XEO03197 MOACRIVE Inhibition DME1098 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1098 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03202 XEO_CLAS Peptide DME1098 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.51 microM) DME1098 XEOTICID XEO03202 GENEFORM Protein DME1098 XEOTICID XEO03202 MOACRIVE Inhibition DME1098 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1098 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03203 XEO_CLAS Peptide DME1098 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.62 microM) DME1098 XEOTICID XEO03203 GENEFORM Protein DME1098 XEOTICID XEO03203 MOACRIVE Inhibition DME1098 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1098 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03204 XEO_CLAS Peptide DME1098 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.38 microM) DME1098 XEOTICID XEO03204 GENEFORM Protein DME1098 XEOTICID XEO03204 MOACRIVE Inhibition DME1098 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1098 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03205 XEO_CLAS Peptide DME1098 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.29 microM) DME1098 XEOTICID XEO03205 GENEFORM Protein DME1098 XEOTICID XEO03205 MOACRIVE Inhibition DME1098 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1098 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03206 XEO_CLAS Peptide DME1098 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.40 microM) DME1098 XEOTICID XEO03206 GENEFORM Protein DME1098 XEOTICID XEO03206 MOACRIVE Inhibition DME1098 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1098 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03207 XEO_CLAS Peptide DME1098 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.58 microM) DME1098 XEOTICID XEO03207 GENEFORM Protein DME1098 XEOTICID XEO03207 MOACRIVE Inhibition DME1098 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1098 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03208 XEO_CLAS Peptide DME1098 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.76 microM) DME1098 XEOTICID XEO03208 GENEFORM Protein DME1098 XEOTICID XEO03208 MOACRIVE Inhibition DME1098 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1098 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03209 XEO_CLAS Peptide DME1098 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.49 microM) DME1098 XEOTICID XEO03209 GENEFORM Protein DME1098 XEOTICID XEO03209 MOACRIVE Inhibition DME1098 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1098 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03210 XEO_CLAS Peptide DME1098 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 7.07 microM) DME1098 XEOTICID XEO03210 GENEFORM Protein DME1098 XEOTICID XEO03210 MOACRIVE Inhibition DME1098 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1098 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03211 XEO_CLAS Peptide DME1098 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.40 microM) DME1098 XEOTICID XEO03211 GENEFORM Protein DME1098 XEOTICID XEO03211 MOACRIVE Inhibition DME1098 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1098 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03215 XEO_CLAS Peptide DME1098 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20.0 ug/ml) DME1098 XEOTICID XEO03215 GENEFORM Protein DME1098 XEOTICID XEO03215 MOACRIVE Inhibition DME1098 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1098 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03216 XEO_CLAS Peptide DME1098 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO03216 GENEFORM Protein DME1098 XEOTICID XEO03216 MOACRIVE Inhibition DME1098 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1098 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03217 XEO_CLAS Peptide DME1098 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO03217 GENEFORM Protein DME1098 XEOTICID XEO03217 MOACRIVE Inhibition DME1098 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1098 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03223 XEO_CLAS Peptide DME1098 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.8 microM) DME1098 XEOTICID XEO03223 GENEFORM Protein DME1098 XEOTICID XEO03223 MOACRIVE Inhibition DME1098 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1098 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03224 XEO_CLAS Peptide DME1098 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.1-0.25 microM) DME1098 XEOTICID XEO03224 GENEFORM Protein DME1098 XEOTICID XEO03224 MOACRIVE Inhibition DME1098 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1098 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03225 XEO_CLAS Peptide DME1098 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.3 microM) DME1098 XEOTICID XEO03225 GENEFORM Protein DME1098 XEOTICID XEO03225 MOACRIVE Inhibition DME1098 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1098 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03227 XEO_CLAS Peptide DME1098 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.3 microM) DME1098 XEOTICID XEO03227 GENEFORM Protein DME1098 XEOTICID XEO03227 MOACRIVE Inhibition DME1098 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1098 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03231 XEO_CLAS Peptide DME1098 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03231 GENEFORM Protein DME1098 XEOTICID XEO03231 MOACRIVE Inhibition DME1098 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1098 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03232 XEO_CLAS Peptide DME1098 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03232 GENEFORM Protein DME1098 XEOTICID XEO03232 MOACRIVE Inhibition DME1098 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1098 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03234 XEO_CLAS Peptide DME1098 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO03234 GENEFORM Protein DME1098 XEOTICID XEO03234 MOACRIVE Inhibition DME1098 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1098 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03235 XEO_CLAS Peptide DME1098 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 60 ug/ml) DME1098 XEOTICID XEO03235 GENEFORM Protein DME1098 XEOTICID XEO03235 MOACRIVE Inhibition DME1098 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1098 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03236 XEO_CLAS Peptide DME1098 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO03236 GENEFORM Protein DME1098 XEOTICID XEO03236 MOACRIVE Inhibition DME1098 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1098 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03237 XEO_CLAS Peptide DME1098 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 ug/ml) DME1098 XEOTICID XEO03237 GENEFORM Protein DME1098 XEOTICID XEO03237 MOACRIVE Inhibition DME1098 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1098 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03238 XEO_CLAS Peptide DME1098 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 ug/ml) DME1098 XEOTICID XEO03238 GENEFORM Protein DME1098 XEOTICID XEO03238 MOACRIVE Inhibition DME1098 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1098 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03239 XEO_CLAS Peptide DME1098 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 60 ug/ml) DME1098 XEOTICID XEO03239 GENEFORM Protein DME1098 XEOTICID XEO03239 MOACRIVE Inhibition DME1098 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1098 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03241 XEO_CLAS Peptide DME1098 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 128 microM) DME1098 XEOTICID XEO03241 GENEFORM Protein DME1098 XEOTICID XEO03241 MOACRIVE Inhibition DME1098 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1098 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03250 XEO_CLAS Peptide DME1098 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03250 GENEFORM Protein DME1098 XEOTICID XEO03250 MOACRIVE Inhibition DME1098 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1098 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03251 XEO_CLAS Peptide DME1098 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03251 GENEFORM Protein DME1098 XEOTICID XEO03251 MOACRIVE Inhibition DME1098 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1098 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03253 XEO_CLAS Peptide DME1098 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.1 ug/ml) DME1098 XEOTICID XEO03253 GENEFORM Protein DME1098 XEOTICID XEO03253 MOACRIVE Inhibition DME1098 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1098 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03274 XEO_CLAS Peptide DME1098 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.2 microM) DME1098 XEOTICID XEO03274 GENEFORM Protein DME1098 XEOTICID XEO03274 MOACRIVE Inhibition DME1098 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1098 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03275 XEO_CLAS Peptide DME1098 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO03275 GENEFORM Protein DME1098 XEOTICID XEO03275 MOACRIVE Inhibition DME1098 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1098 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03276 XEO_CLAS Peptide DME1098 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO03276 GENEFORM Protein DME1098 XEOTICID XEO03276 MOACRIVE Inhibition DME1098 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1098 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03277 XEO_CLAS Peptide DME1098 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.2 microM) DME1098 XEOTICID XEO03277 GENEFORM Protein DME1098 XEOTICID XEO03277 MOACRIVE Inhibition DME1098 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1098 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03278 XEO_CLAS Peptide DME1098 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO03278 GENEFORM Protein DME1098 XEOTICID XEO03278 MOACRIVE Inhibition DME1098 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1098 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03279 XEO_CLAS Peptide DME1098 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO03279 GENEFORM Protein DME1098 XEOTICID XEO03279 MOACRIVE Inhibition DME1098 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1098 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03280 XEO_CLAS Peptide DME1098 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 microM) DME1098 XEOTICID XEO03280 GENEFORM Protein DME1098 XEOTICID XEO03280 MOACRIVE Inhibition DME1098 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1098 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03281 XEO_CLAS Peptide DME1098 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.3 microM) DME1098 XEOTICID XEO03281 GENEFORM Protein DME1098 XEOTICID XEO03281 MOACRIVE Inhibition DME1098 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1098 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03282 XEO_CLAS Peptide DME1098 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.1 microM) DME1098 XEOTICID XEO03282 GENEFORM Protein DME1098 XEOTICID XEO03282 MOACRIVE Inhibition DME1098 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1098 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03283 XEO_CLAS Peptide DME1098 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 microM) DME1098 XEOTICID XEO03283 GENEFORM Protein DME1098 XEOTICID XEO03283 MOACRIVE Inhibition DME1098 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1098 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03284 XEO_CLAS Peptide DME1098 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.2 ug/ml) DME1098 XEOTICID XEO03284 GENEFORM Protein DME1098 XEOTICID XEO03284 MOACRIVE Inhibition DME1098 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1098 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03285 XEO_CLAS Peptide DME1098 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.5 ug/ml) DME1098 XEOTICID XEO03285 GENEFORM Protein DME1098 XEOTICID XEO03285 MOACRIVE Inhibition DME1098 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1098 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03286 XEO_CLAS Peptide DME1098 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.4 ug/ml) DME1098 XEOTICID XEO03286 GENEFORM Protein DME1098 XEOTICID XEO03286 MOACRIVE Inhibition DME1098 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1098 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03287 XEO_CLAS Peptide DME1098 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.6 ug/ml) DME1098 XEOTICID XEO03287 GENEFORM Protein DME1098 XEOTICID XEO03287 MOACRIVE Inhibition DME1098 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1098 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03288 XEO_CLAS Peptide DME1098 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.4 ug/ml) DME1098 XEOTICID XEO03288 GENEFORM Protein DME1098 XEOTICID XEO03288 MOACRIVE Inhibition DME1098 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1098 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03289 XEO_CLAS Peptide DME1098 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8.8 ug/ml) DME1098 XEOTICID XEO03289 GENEFORM Protein DME1098 XEOTICID XEO03289 MOACRIVE Inhibition DME1098 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1098 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03290 XEO_CLAS Peptide DME1098 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.5 ug/ml) DME1098 XEOTICID XEO03290 GENEFORM Protein DME1098 XEOTICID XEO03290 MOACRIVE Inhibition DME1098 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1098 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03291 XEO_CLAS Peptide DME1098 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8.6 ug/ml) DME1098 XEOTICID XEO03291 GENEFORM Protein DME1098 XEOTICID XEO03291 MOACRIVE Inhibition DME1098 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1098 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03292 XEO_CLAS Peptide DME1098 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4.1 ug/ml) DME1098 XEOTICID XEO03292 GENEFORM Protein DME1098 XEOTICID XEO03292 MOACRIVE Inhibition DME1098 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1098 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03293 XEO_CLAS Peptide DME1098 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1 microM) DME1098 XEOTICID XEO03293 GENEFORM Protein DME1098 XEOTICID XEO03293 MOACRIVE Inhibition DME1098 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1098 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03294 XEO_CLAS Peptide DME1098 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1 microM) DME1098 XEOTICID XEO03294 GENEFORM Protein DME1098 XEOTICID XEO03294 MOACRIVE Inhibition DME1098 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1098 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03295 XEO_CLAS Peptide DME1098 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.7 microM) DME1098 XEOTICID XEO03295 GENEFORM Protein DME1098 XEOTICID XEO03295 MOACRIVE Inhibition DME1098 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1098 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03296 XEO_CLAS Peptide DME1098 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03296 GENEFORM Protein DME1098 XEOTICID XEO03296 MOACRIVE Inhibition DME1098 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1098 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03297 XEO_CLAS Peptide DME1098 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03297 GENEFORM Protein DME1098 XEOTICID XEO03297 MOACRIVE Inhibition DME1098 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1098 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03298 XEO_CLAS Peptide DME1098 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.2 microM) DME1098 XEOTICID XEO03298 GENEFORM Protein DME1098 XEOTICID XEO03298 MOACRIVE Inhibition DME1098 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1098 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03299 XEO_CLAS Peptide DME1098 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.4 microM) DME1098 XEOTICID XEO03299 GENEFORM Protein DME1098 XEOTICID XEO03299 MOACRIVE Inhibition DME1098 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1098 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03300 XEO_CLAS Peptide DME1098 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 ug/ml) DME1098 XEOTICID XEO03300 GENEFORM Protein DME1098 XEOTICID XEO03300 MOACRIVE Inhibition DME1098 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1098 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03301 XEO_CLAS Peptide DME1098 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 ug/ml) DME1098 XEOTICID XEO03301 GENEFORM Protein DME1098 XEOTICID XEO03301 MOACRIVE Inhibition DME1098 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1098 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03302 XEO_CLAS Peptide DME1098 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1 microM) DME1098 XEOTICID XEO03302 GENEFORM Protein DME1098 XEOTICID XEO03302 MOACRIVE Inhibition DME1098 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1098 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03303 XEO_CLAS Peptide DME1098 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 microM) DME1098 XEOTICID XEO03303 GENEFORM Protein DME1098 XEOTICID XEO03303 MOACRIVE Inhibition DME1098 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1098 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03304 XEO_CLAS Peptide DME1098 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO03304 GENEFORM Protein DME1098 XEOTICID XEO03304 MOACRIVE Inhibition DME1098 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1098 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03305 XEO_CLAS Peptide DME1098 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 microM) DME1098 XEOTICID XEO03305 GENEFORM Protein DME1098 XEOTICID XEO03305 MOACRIVE Inhibition DME1098 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1098 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03306 XEO_CLAS Peptide DME1098 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO03306 GENEFORM Protein DME1098 XEOTICID XEO03306 MOACRIVE Inhibition DME1098 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1098 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03307 XEO_CLAS Peptide DME1098 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 34 ug/ml) DME1098 XEOTICID XEO03307 GENEFORM Protein DME1098 XEOTICID XEO03307 MOACRIVE Inhibition DME1098 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1098 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03308 XEO_CLAS Peptide DME1098 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO03308 GENEFORM Protein DME1098 XEOTICID XEO03308 MOACRIVE Inhibition DME1098 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1098 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03310 XEO_CLAS Peptide DME1098 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8.5 ug/ml) DME1098 XEOTICID XEO03310 GENEFORM Protein DME1098 XEOTICID XEO03310 MOACRIVE Inhibition DME1098 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1098 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03311 XEO_CLAS Peptide DME1098 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10.8 ug/ml) DME1098 XEOTICID XEO03311 GENEFORM Protein DME1098 XEOTICID XEO03311 MOACRIVE Inhibition DME1098 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1098 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03312 XEO_CLAS Peptide DME1098 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10.8 ug/ml) DME1098 XEOTICID XEO03312 GENEFORM Protein DME1098 XEOTICID XEO03312 MOACRIVE Inhibition DME1098 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1098 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03313 XEO_CLAS Peptide DME1098 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8.1 ug/ml) DME1098 XEOTICID XEO03313 GENEFORM Protein DME1098 XEOTICID XEO03313 MOACRIVE Inhibition DME1098 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1098 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03314 XEO_CLAS Peptide DME1098 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 7.9 ug/ml) DME1098 XEOTICID XEO03314 GENEFORM Protein DME1098 XEOTICID XEO03314 MOACRIVE Inhibition DME1098 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1098 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03315 XEO_CLAS Peptide DME1098 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.6 ug/ml) DME1098 XEOTICID XEO03315 GENEFORM Protein DME1098 XEOTICID XEO03315 MOACRIVE Inhibition DME1098 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1098 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03316 XEO_CLAS Peptide DME1098 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15.8 ug/ml) DME1098 XEOTICID XEO03316 GENEFORM Protein DME1098 XEOTICID XEO03316 MOACRIVE Inhibition DME1098 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1098 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03317 XEO_CLAS Peptide DME1098 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO03317 GENEFORM Protein DME1098 XEOTICID XEO03317 MOACRIVE Inhibition DME1098 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1098 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03318 XEO_CLAS Peptide DME1098 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1 microM) DME1098 XEOTICID XEO03318 GENEFORM Protein DME1098 XEOTICID XEO03318 MOACRIVE Inhibition DME1098 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1098 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03319 XEO_CLAS Peptide DME1098 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03319 GENEFORM Protein DME1098 XEOTICID XEO03319 MOACRIVE Inhibition DME1098 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1098 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03320 XEO_CLAS Peptide DME1098 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.1 microM) DME1098 XEOTICID XEO03320 GENEFORM Protein DME1098 XEOTICID XEO03320 MOACRIVE Inhibition DME1098 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1098 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03321 XEO_CLAS Peptide DME1098 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.8 microM) DME1098 XEOTICID XEO03321 GENEFORM Protein DME1098 XEOTICID XEO03321 MOACRIVE Inhibition DME1098 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1098 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1098 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03348 GENEFORM Protein DME1098 XEOTICID XEO03348 MOACRIVE Inhibition DME1098 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1098 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03362 XEO_CLAS Peptide DME1098 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO03362 GENEFORM Protein DME1098 XEOTICID XEO03362 MOACRIVE Inhibition DME1098 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1098 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03363 XEO_CLAS Peptide DME1098 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 microM) DME1098 XEOTICID XEO03363 GENEFORM Protein DME1098 XEOTICID XEO03363 MOACRIVE Inhibition DME1098 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1098 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03364 XEO_CLAS Peptide DME1098 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 microM) DME1098 XEOTICID XEO03364 GENEFORM Protein DME1098 XEOTICID XEO03364 MOACRIVE Inhibition DME1098 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1098 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03365 XEO_CLAS Peptide DME1098 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03365 GENEFORM Protein DME1098 XEOTICID XEO03365 MOACRIVE Inhibition DME1098 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1098 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03366 XEO_CLAS Peptide DME1098 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO03366 GENEFORM Protein DME1098 XEOTICID XEO03366 MOACRIVE Inhibition DME1098 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1098 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03367 XEO_CLAS Peptide DME1098 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 microM) DME1098 XEOTICID XEO03367 GENEFORM Protein DME1098 XEOTICID XEO03367 MOACRIVE Inhibition DME1098 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1098 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03368 XEO_CLAS Peptide DME1098 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 microM) DME1098 XEOTICID XEO03368 GENEFORM Protein DME1098 XEOTICID XEO03368 MOACRIVE Inhibition DME1098 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1098 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03379 XEO_CLAS Peptide DME1098 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.6 ug/ml) DME1098 XEOTICID XEO03379 GENEFORM Protein DME1098 XEOTICID XEO03379 MOACRIVE Inhibition DME1098 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1098 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03396 XEO_CLAS Peptide DME1098 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03396 GENEFORM Protein DME1098 XEOTICID XEO03396 MOACRIVE Inhibition DME1098 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1098 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03398 XEO_CLAS Peptide DME1098 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03398 GENEFORM Protein DME1098 XEOTICID XEO03398 MOACRIVE Inhibition DME1098 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1098 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03399 XEO_CLAS Peptide DME1098 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03399 GENEFORM Protein DME1098 XEOTICID XEO03399 MOACRIVE Inhibition DME1098 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1098 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03406 XEO_CLAS Peptide DME1098 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 ug/ml) DME1098 XEOTICID XEO03406 GENEFORM Protein DME1098 XEOTICID XEO03406 MOACRIVE Inhibition DME1098 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1098 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03424 XEO_CLAS Peptide DME1098 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03424 GENEFORM Protein DME1098 XEOTICID XEO03424 MOACRIVE Inhibition DME1098 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1098 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03426 XEO_CLAS Peptide DME1098 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO03426 GENEFORM Protein DME1098 XEOTICID XEO03426 MOACRIVE Inhibition DME1098 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1098 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03427 XEO_CLAS Peptide DME1098 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 microM) DME1098 XEOTICID XEO03427 GENEFORM Protein DME1098 XEOTICID XEO03427 MOACRIVE Inhibition DME1098 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1098 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03428 XEO_CLAS Peptide DME1098 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 ug/ml) DME1098 XEOTICID XEO03428 GENEFORM Protein DME1098 XEOTICID XEO03428 MOACRIVE Inhibition DME1098 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1098 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03430 XEO_CLAS Peptide DME1098 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 ug/ml) DME1098 XEOTICID XEO03430 GENEFORM Protein DME1098 XEOTICID XEO03430 MOACRIVE Inhibition DME1098 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1098 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03434 XEO_CLAS Peptide DME1098 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO03434 GENEFORM Protein DME1098 XEOTICID XEO03434 MOACRIVE Inhibition DME1098 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1098 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03442 XEO_CLAS Peptide DME1098 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 18.75 ug/ml) DME1098 XEOTICID XEO03442 GENEFORM Protein DME1098 XEOTICID XEO03442 MOACRIVE Inhibition DME1098 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1098 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03444 XEO_CLAS Peptide DME1098 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 37.50 ug/ml) DME1098 XEOTICID XEO03444 GENEFORM Protein DME1098 XEOTICID XEO03444 MOACRIVE Inhibition DME1098 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1098 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03459 XEO_CLAS Peptide DME1098 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03459 GENEFORM Protein DME1098 XEOTICID XEO03459 MOACRIVE Inhibition DME1098 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1098 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03460 XEO_CLAS Peptide DME1098 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03460 GENEFORM Protein DME1098 XEOTICID XEO03460 MOACRIVE Inhibition DME1098 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1098 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03461 XEO_CLAS Peptide DME1098 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.05 microM) DME1098 XEOTICID XEO03461 GENEFORM Protein DME1098 XEOTICID XEO03461 MOACRIVE Inhibition DME1098 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1098 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03462 XEO_CLAS Peptide DME1098 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03462 GENEFORM Protein DME1098 XEOTICID XEO03462 MOACRIVE Inhibition DME1098 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1098 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03463 XEO_CLAS Peptide DME1098 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03463 GENEFORM Protein DME1098 XEOTICID XEO03463 MOACRIVE Inhibition DME1098 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1098 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03467 XEO_CLAS Peptide DME1098 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03467 GENEFORM Protein DME1098 XEOTICID XEO03467 MOACRIVE Inhibition DME1098 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1098 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03468 XEO_CLAS Peptide DME1098 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03468 GENEFORM Protein DME1098 XEOTICID XEO03468 MOACRIVE Inhibition DME1098 XEOTICID XEO03471 XEO_NAME Gambicin DME1098 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03471 XEO_CLAS Peptide DME1098 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1098 XEOTICID XEO03471 GENEFORM Protein DME1098 XEOTICID XEO03471 MOACRIVE Inhibition DME1098 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1098 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03485 XEO_CLAS Peptide DME1098 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4.07 ug/ml) DME1098 XEOTICID XEO03485 GENEFORM Protein DME1098 XEOTICID XEO03485 MOACRIVE Inhibition DME1098 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1098 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03486 XEO_CLAS Peptide DME1098 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.80 ug/ml) DME1098 XEOTICID XEO03486 GENEFORM Protein DME1098 XEOTICID XEO03486 MOACRIVE Inhibition DME1098 XEOTICID XEO03488 XEO_NAME GLK-19 DME1098 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03488 XEO_CLAS Peptide DME1098 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO03488 GENEFORM Protein DME1098 XEOTICID XEO03488 MOACRIVE Inhibition DME1098 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1098 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03497 XEO_CLAS Peptide DME1098 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1098 XEOTICID XEO03497 GENEFORM Protein DME1098 XEOTICID XEO03497 MOACRIVE Inhibition DME1098 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1098 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03498 XEO_CLAS Peptide DME1098 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1098 XEOTICID XEO03498 GENEFORM Protein DME1098 XEOTICID XEO03498 MOACRIVE Inhibition DME1098 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1098 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03500 XEO_CLAS Peptide DME1098 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-30 ug/ml) DME1098 XEOTICID XEO03500 GENEFORM Protein DME1098 XEOTICID XEO03500 MOACRIVE Inhibition DME1098 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1098 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03504 XEO_CLAS Peptide DME1098 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 ug/ml) DME1098 XEOTICID XEO03504 GENEFORM Protein DME1098 XEOTICID XEO03504 MOACRIVE Inhibition DME1098 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1098 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03505 XEO_CLAS Peptide DME1098 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 ug/ml) DME1098 XEOTICID XEO03505 GENEFORM Protein DME1098 XEOTICID XEO03505 MOACRIVE Inhibition DME1098 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1098 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03506 XEO_CLAS Peptide DME1098 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 ug/ml) DME1098 XEOTICID XEO03506 GENEFORM Protein DME1098 XEOTICID XEO03506 MOACRIVE Inhibition DME1098 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1098 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03513 XEO_CLAS Peptide DME1098 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO03513 GENEFORM Protein DME1098 XEOTICID XEO03513 MOACRIVE Inhibition DME1098 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1098 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03514 XEO_CLAS Peptide DME1098 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03514 GENEFORM Protein DME1098 XEOTICID XEO03514 MOACRIVE Inhibition DME1098 XEOTICID XEO03519 XEO_NAME Hadrurin DME1098 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03519 XEO_CLAS Peptide DME1098 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03519 GENEFORM Protein DME1098 XEOTICID XEO03519 MOACRIVE Inhibition DME1098 XEOTICID XEO03522 XEO_NAME Halocyntin DME1098 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03522 XEO_CLAS Peptide DME1098 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03522 GENEFORM Protein DME1098 XEOTICID XEO03522 MOACRIVE Inhibition DME1098 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1098 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03524 XEO_CLAS Peptide DME1098 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03524 GENEFORM Protein DME1098 XEOTICID XEO03524 MOACRIVE Inhibition DME1098 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1098 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03525 XEO_CLAS Peptide DME1098 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03525 GENEFORM Protein DME1098 XEOTICID XEO03525 MOACRIVE Inhibition DME1098 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1098 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03530 XEO_CLAS Peptide DME1098 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03530 GENEFORM Protein DME1098 XEOTICID XEO03530 MOACRIVE Inhibition DME1098 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1098 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03535 XEO_CLAS Peptide DME1098 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.4 microM) DME1098 XEOTICID XEO03535 GENEFORM Protein DME1098 XEOTICID XEO03535 MOACRIVE Inhibition DME1098 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1098 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03536 XEO_CLAS Peptide DME1098 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 80 microM) DME1098 XEOTICID XEO03536 GENEFORM Protein DME1098 XEOTICID XEO03536 MOACRIVE Inhibition DME1098 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1098 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03537 XEO_CLAS Peptide DME1098 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 ug/ml) DME1098 XEOTICID XEO03537 GENEFORM Protein DME1098 XEOTICID XEO03537 MOACRIVE Inhibition DME1098 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1098 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03538 XEO_CLAS Peptide DME1098 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 ug/ml) DME1098 XEOTICID XEO03538 GENEFORM Protein DME1098 XEOTICID XEO03538 MOACRIVE Inhibition DME1098 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1098 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03540 XEO_CLAS Peptide DME1098 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO03540 GENEFORM Protein DME1098 XEOTICID XEO03540 MOACRIVE Inhibition DME1098 XEOTICID XEO03542 XEO_NAME Hepcidin DME1098 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03542 XEO_CLAS Peptide DME1098 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 24 microM) DME1098 XEOTICID XEO03542 GENEFORM Protein DME1098 XEOTICID XEO03542 MOACRIVE Inhibition DME1098 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1098 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03544 XEO_CLAS Peptide DME1098 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03544 GENEFORM Protein DME1098 XEOTICID XEO03544 MOACRIVE Inhibition DME1098 XEOTICID XEO03548 XEO_NAME Hesperidin DME1098 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03548 GENEFORM Protein DME1098 XEOTICID XEO03548 MOACRIVE Inhibition DME1098 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1098 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1098 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03552 GENEFORM Protein DME1098 XEOTICID XEO03552 MOACRIVE Inhibition DME1098 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1098 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03556 XEO_CLAS Peptide DME1098 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO03556 GENEFORM Protein DME1098 XEOTICID XEO03556 MOACRIVE Inhibition DME1098 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1098 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03557 XEO_CLAS Peptide DME1098 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO03557 GENEFORM Protein DME1098 XEOTICID XEO03557 MOACRIVE Inhibition DME1098 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1098 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03558 XEO_CLAS Peptide DME1098 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 microM) DME1098 XEOTICID XEO03558 GENEFORM Protein DME1098 XEOTICID XEO03558 MOACRIVE Inhibition DME1098 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1098 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03559 XEO_CLAS Peptide DME1098 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 microM) DME1098 XEOTICID XEO03559 GENEFORM Protein DME1098 XEOTICID XEO03559 MOACRIVE Inhibition DME1098 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1098 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03560 XEO_CLAS Peptide DME1098 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 microM) DME1098 XEOTICID XEO03560 GENEFORM Protein DME1098 XEOTICID XEO03560 MOACRIVE Inhibition DME1098 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1098 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03561 XEO_CLAS Peptide DME1098 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03561 GENEFORM Protein DME1098 XEOTICID XEO03561 MOACRIVE Inhibition DME1098 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1098 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03567 XEO_CLAS Peptide DME1098 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03567 GENEFORM Protein DME1098 XEOTICID XEO03567 MOACRIVE Inhibition DME1098 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1098 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03569 XEO_CLAS Peptide DME1098 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 300 microM) DME1098 XEOTICID XEO03569 GENEFORM Protein DME1098 XEOTICID XEO03569 MOACRIVE Inhibition DME1098 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1098 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03570 XEO_CLAS Peptide DME1098 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03570 GENEFORM Protein DME1098 XEOTICID XEO03570 MOACRIVE Inhibition DME1098 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1098 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03572 XEO_CLAS Peptide DME1098 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1098 XEOTICID XEO03572 GENEFORM Protein DME1098 XEOTICID XEO03572 MOACRIVE Inhibition DME1098 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1098 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03573 XEO_CLAS Peptide DME1098 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 28.1 ug/ml) DME1098 XEOTICID XEO03573 GENEFORM Protein DME1098 XEOTICID XEO03573 MOACRIVE Inhibition DME1098 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1098 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03574 XEO_CLAS Peptide DME1098 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 500 microM) DME1098 XEOTICID XEO03574 GENEFORM Protein DME1098 XEOTICID XEO03574 MOACRIVE Inhibition DME1098 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1098 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03575 XEO_CLAS Peptide DME1098 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 18 microM) DME1098 XEOTICID XEO03575 GENEFORM Protein DME1098 XEOTICID XEO03575 MOACRIVE Inhibition DME1098 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1098 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03576 XEO_CLAS Peptide DME1098 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 750 microM) DME1098 XEOTICID XEO03576 GENEFORM Protein DME1098 XEOTICID XEO03576 MOACRIVE Inhibition DME1098 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1098 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03578 XEO_CLAS Peptide DME1098 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1098 XEOTICID XEO03578 GENEFORM Protein DME1098 XEOTICID XEO03578 MOACRIVE Inhibition DME1098 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1098 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03579 XEO_CLAS Peptide DME1098 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03579 GENEFORM Protein DME1098 XEOTICID XEO03579 MOACRIVE Inhibition DME1098 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1098 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03580 XEO_CLAS Peptide DME1098 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03580 GENEFORM Protein DME1098 XEOTICID XEO03580 MOACRIVE Inhibition DME1098 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1098 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03585 XEO_CLAS Peptide DME1098 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 125 ug/ml) DME1098 XEOTICID XEO03585 GENEFORM Protein DME1098 XEOTICID XEO03585 MOACRIVE Inhibition DME1098 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1098 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03588 XEO_CLAS Peptide DME1098 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 62 ug/ml) DME1098 XEOTICID XEO03588 GENEFORM Protein DME1098 XEOTICID XEO03588 MOACRIVE Inhibition DME1098 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1098 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03589 XEO_CLAS Peptide DME1098 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03589 GENEFORM Protein DME1098 XEOTICID XEO03589 MOACRIVE Inhibition DME1098 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1098 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03590 XEO_CLAS Peptide DME1098 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03590 GENEFORM Protein DME1098 XEOTICID XEO03590 MOACRIVE Inhibition DME1098 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1098 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03591 XEO_CLAS Peptide DME1098 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 37.5 ug/ml) DME1098 XEOTICID XEO03591 GENEFORM Protein DME1098 XEOTICID XEO03591 MOACRIVE Inhibition DME1098 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1098 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03593 XEO_CLAS Peptide DME1098 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 9.4 ug/ml) DME1098 XEOTICID XEO03593 GENEFORM Protein DME1098 XEOTICID XEO03593 MOACRIVE Inhibition DME1098 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1098 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03594 XEO_CLAS Peptide DME1098 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 ug/ml) DME1098 XEOTICID XEO03594 GENEFORM Protein DME1098 XEOTICID XEO03594 MOACRIVE Inhibition DME1098 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1098 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03595 XEO_CLAS Peptide DME1098 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03595 GENEFORM Protein DME1098 XEOTICID XEO03595 MOACRIVE Inhibition DME1098 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1098 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03596 XEO_CLAS Peptide DME1098 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03596 GENEFORM Protein DME1098 XEOTICID XEO03596 MOACRIVE Inhibition DME1098 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1098 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03598 XEO_CLAS Peptide DME1098 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03598 GENEFORM Protein DME1098 XEOTICID XEO03598 MOACRIVE Inhibition DME1098 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1098 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03599 XEO_CLAS Peptide DME1098 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03599 GENEFORM Protein DME1098 XEOTICID XEO03599 MOACRIVE Inhibition DME1098 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1098 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03600 XEO_CLAS Peptide DME1098 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03600 GENEFORM Protein DME1098 XEOTICID XEO03600 MOACRIVE Inhibition DME1098 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1098 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03606 XEO_CLAS Peptide DME1098 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03606 GENEFORM Protein DME1098 XEOTICID XEO03606 MOACRIVE Inhibition DME1098 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1098 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03607 XEO_CLAS Peptide DME1098 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03607 GENEFORM Protein DME1098 XEOTICID XEO03607 MOACRIVE Inhibition DME1098 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1098 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03609 XEO_CLAS Peptide DME1098 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03609 GENEFORM Protein DME1098 XEOTICID XEO03609 MOACRIVE Inhibition DME1098 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1098 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03615 XEO_CLAS Peptide DME1098 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1098 XEOTICID XEO03615 GENEFORM Protein DME1098 XEOTICID XEO03615 MOACRIVE Inhibition DME1098 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1098 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03616 XEO_CLAS Peptide DME1098 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 32 microM) DME1098 XEOTICID XEO03616 GENEFORM Protein DME1098 XEOTICID XEO03616 MOACRIVE Inhibition DME1098 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1098 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03617 XEO_CLAS Peptide DME1098 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40 microM) DME1098 XEOTICID XEO03617 GENEFORM Protein DME1098 XEOTICID XEO03617 MOACRIVE Inhibition DME1098 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1098 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03618 XEO_CLAS Peptide DME1098 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5-1 microM) DME1098 XEOTICID XEO03618 GENEFORM Protein DME1098 XEOTICID XEO03618 MOACRIVE Inhibition DME1098 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1098 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03622 XEO_CLAS Peptide DME1098 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20-40 microM) DME1098 XEOTICID XEO03622 GENEFORM Protein DME1098 XEOTICID XEO03622 MOACRIVE Inhibition DME1098 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1098 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03627 XEO_CLAS Peptide DME1098 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1098 XEOTICID XEO03627 GENEFORM Protein DME1098 XEOTICID XEO03627 MOACRIVE Inhibition DME1098 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1098 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03630 XEO_CLAS Peptide DME1098 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03630 GENEFORM Protein DME1098 XEOTICID XEO03630 MOACRIVE Inhibition DME1098 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1098 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03631 XEO_CLAS Peptide DME1098 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03631 GENEFORM Protein DME1098 XEOTICID XEO03631 MOACRIVE Inhibition DME1098 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1098 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03632 XEO_CLAS Peptide DME1098 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03632 GENEFORM Protein DME1098 XEOTICID XEO03632 MOACRIVE Inhibition DME1098 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1098 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03633 XEO_CLAS Peptide DME1098 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03633 GENEFORM Protein DME1098 XEOTICID XEO03633 MOACRIVE Inhibition DME1098 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1098 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03634 XEO_CLAS Peptide DME1098 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03634 GENEFORM Protein DME1098 XEOTICID XEO03634 MOACRIVE Inhibition DME1098 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1098 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03635 XEO_CLAS Peptide DME1098 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03635 GENEFORM Protein DME1098 XEOTICID XEO03635 MOACRIVE Inhibition DME1098 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1098 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03636 XEO_CLAS Peptide DME1098 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03636 GENEFORM Protein DME1098 XEOTICID XEO03636 MOACRIVE Inhibition DME1098 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1098 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03637 XEO_CLAS Peptide DME1098 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03637 GENEFORM Protein DME1098 XEOTICID XEO03637 MOACRIVE Inhibition DME1098 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1098 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03638 XEO_CLAS Peptide DME1098 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03638 GENEFORM Protein DME1098 XEOTICID XEO03638 MOACRIVE Inhibition DME1098 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1098 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03639 XEO_CLAS Peptide DME1098 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03639 GENEFORM Protein DME1098 XEOTICID XEO03639 MOACRIVE Inhibition DME1098 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1098 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03640 XEO_CLAS Peptide DME1098 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03640 GENEFORM Protein DME1098 XEOTICID XEO03640 MOACRIVE Inhibition DME1098 XEOTICID XEO03644 XEO_NAME Indole DME1098 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1098 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1098 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03644 GENEFORM Protein DME1098 XEOTICID XEO03644 MOACRIVE Inhibition DME1098 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1098 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03650 XEO_CLAS Peptide DME1098 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03650 GENEFORM Protein DME1098 XEOTICID XEO03650 MOACRIVE Inhibition DME1098 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1098 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO03655 XEO_CLAS Natural Product DME1098 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03655 GENEFORM Protein DME1098 XEOTICID XEO03655 MOACRIVE Inhibition DME1098 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1098 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03666 XEO_CLAS Peptide DME1098 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 ug/ml) DME1098 XEOTICID XEO03666 GENEFORM Protein DME1098 XEOTICID XEO03666 MOACRIVE Inhibition DME1098 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1098 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03667 XEO_CLAS Peptide DME1098 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 ug/ml) DME1098 XEOTICID XEO03667 GENEFORM Protein DME1098 XEOTICID XEO03667 MOACRIVE Inhibition DME1098 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1098 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03668 XEO_CLAS Peptide DME1098 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 microM) DME1098 XEOTICID XEO03668 GENEFORM Protein DME1098 XEOTICID XEO03668 MOACRIVE Inhibition DME1098 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1098 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03669 XEO_CLAS Peptide DME1098 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO03669 GENEFORM Protein DME1098 XEOTICID XEO03669 MOACRIVE Inhibition DME1098 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1098 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03670 XEO_CLAS Peptide DME1098 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 microM) DME1098 XEOTICID XEO03670 GENEFORM Protein DME1098 XEOTICID XEO03670 MOACRIVE Inhibition DME1098 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1098 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03672 XEO_CLAS Peptide DME1098 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.5 ug/ml) DME1098 XEOTICID XEO03672 GENEFORM Protein DME1098 XEOTICID XEO03672 MOACRIVE Inhibition DME1098 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1098 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03673 XEO_CLAS Peptide DME1098 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 ug/ml) DME1098 XEOTICID XEO03673 GENEFORM Protein DME1098 XEOTICID XEO03673 MOACRIVE Inhibition DME1098 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1098 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03674 XEO_CLAS Peptide DME1098 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 ug/ml) DME1098 XEOTICID XEO03674 GENEFORM Protein DME1098 XEOTICID XEO03674 MOACRIVE Inhibition DME1098 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1098 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03675 XEO_CLAS Peptide DME1098 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO03675 GENEFORM Protein DME1098 XEOTICID XEO03675 MOACRIVE Inhibition DME1098 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1098 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03678 XEO_CLAS Peptide DME1098 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 ug/ml) DME1098 XEOTICID XEO03678 GENEFORM Protein DME1098 XEOTICID XEO03678 MOACRIVE Inhibition DME1098 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1098 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03679 XEO_CLAS Peptide DME1098 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 ug/ml) DME1098 XEOTICID XEO03679 GENEFORM Protein DME1098 XEOTICID XEO03679 MOACRIVE Inhibition DME1098 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1098 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03681 XEO_CLAS Peptide DME1098 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1098 XEOTICID XEO03681 GENEFORM Protein DME1098 XEOTICID XEO03681 MOACRIVE Inhibition DME1098 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1098 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03684 XEO_CLAS Peptide DME1098 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 ug/ml) DME1098 XEOTICID XEO03684 GENEFORM Protein DME1098 XEOTICID XEO03684 MOACRIVE Inhibition DME1098 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1098 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03694 XEO_CLAS Peptide DME1098 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03694 GENEFORM Protein DME1098 XEOTICID XEO03694 MOACRIVE Inhibition DME1098 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1098 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03697 XEO_CLAS Peptide DME1098 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25 microM) DME1098 XEOTICID XEO03697 GENEFORM Protein DME1098 XEOTICID XEO03697 MOACRIVE Inhibition DME1098 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1098 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03698 XEO_CLAS Peptide DME1098 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03698 GENEFORM Protein DME1098 XEOTICID XEO03698 MOACRIVE Inhibition DME1098 XEOTICID XEO03703 XEO_NAME Kasstasin DME1098 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03703 XEO_CLAS Peptide DME1098 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 110 microM) DME1098 XEOTICID XEO03703 GENEFORM Protein DME1098 XEOTICID XEO03703 MOACRIVE Inhibition DME1098 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1098 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03706 XEO_CLAS Peptide DME1098 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03706 GENEFORM Protein DME1098 XEOTICID XEO03706 MOACRIVE Inhibition DME1098 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1098 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03707 XEO_CLAS Peptide DME1098 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03707 GENEFORM Protein DME1098 XEOTICID XEO03707 MOACRIVE Inhibition DME1098 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1098 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03709 XEO_CLAS Peptide DME1098 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 ug/ml) DME1098 XEOTICID XEO03709 GENEFORM Protein DME1098 XEOTICID XEO03709 MOACRIVE Inhibition DME1098 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1098 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03712 XEO_CLAS Peptide DME1098 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03712 GENEFORM Protein DME1098 XEOTICID XEO03712 MOACRIVE Inhibition DME1098 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1098 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03713 XEO_CLAS Peptide DME1098 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 64 microM) DME1098 XEOTICID XEO03713 GENEFORM Protein DME1098 XEOTICID XEO03713 MOACRIVE Inhibition DME1098 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1098 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03714 XEO_CLAS Peptide DME1098 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03714 GENEFORM Protein DME1098 XEOTICID XEO03714 MOACRIVE Inhibition DME1098 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1098 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03715 XEO_CLAS Peptide DME1098 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 microM) DME1098 XEOTICID XEO03715 GENEFORM Protein DME1098 XEOTICID XEO03715 MOACRIVE Inhibition DME1098 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1098 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03719 XEO_CLAS Peptide DME1098 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 microM) DME1098 XEOTICID XEO03719 GENEFORM Protein DME1098 XEOTICID XEO03719 MOACRIVE Inhibition DME1098 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1098 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03720 XEO_CLAS Peptide DME1098 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 microM) DME1098 XEOTICID XEO03720 GENEFORM Protein DME1098 XEOTICID XEO03720 MOACRIVE Inhibition DME1098 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1098 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03723 XEO_CLAS Peptide DME1098 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 62.36 microM) DME1098 XEOTICID XEO03723 GENEFORM Protein DME1098 XEOTICID XEO03723 MOACRIVE Inhibition DME1098 XEOTICID XEO03724 XEO_NAME L10 peptide DME1098 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03724 XEO_CLAS Peptide DME1098 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.8 microM) DME1098 XEOTICID XEO03724 GENEFORM Protein DME1098 XEOTICID XEO03724 MOACRIVE Inhibition DME1098 XEOTICID XEO03726 XEO_NAME L2 peptide DME1098 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03726 XEO_CLAS Peptide DME1098 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 129.66 microM) DME1098 XEOTICID XEO03726 GENEFORM Protein DME1098 XEOTICID XEO03726 MOACRIVE Inhibition DME1098 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1098 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03727 XEO_CLAS Peptide DME1098 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 80 ug/ml) DME1098 XEOTICID XEO03727 GENEFORM Protein DME1098 XEOTICID XEO03727 MOACRIVE Inhibition DME1098 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1098 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03728 XEO_CLAS Peptide DME1098 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40 ug/ml) DME1098 XEOTICID XEO03728 GENEFORM Protein DME1098 XEOTICID XEO03728 MOACRIVE Inhibition DME1098 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1098 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03729 XEO_CLAS Peptide DME1098 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 80 ug/ml) DME1098 XEOTICID XEO03729 GENEFORM Protein DME1098 XEOTICID XEO03729 MOACRIVE Inhibition DME1098 XEOTICID XEO03730 XEO_NAME L3 peptide DME1098 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03730 XEO_CLAS Peptide DME1098 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64.11 microM) DME1098 XEOTICID XEO03730 GENEFORM Protein DME1098 XEOTICID XEO03730 MOACRIVE Inhibition DME1098 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1098 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03731 XEO_CLAS Peptide DME1098 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40 ug/ml) DME1098 XEOTICID XEO03731 GENEFORM Protein DME1098 XEOTICID XEO03731 MOACRIVE Inhibition DME1098 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1098 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03733 XEO_CLAS Peptide DME1098 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40 ug/ml) DME1098 XEOTICID XEO03733 GENEFORM Protein DME1098 XEOTICID XEO03733 MOACRIVE Inhibition DME1098 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1098 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03734 XEO_CLAS Peptide DME1098 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO03734 GENEFORM Protein DME1098 XEOTICID XEO03734 MOACRIVE Inhibition DME1098 XEOTICID XEO03735 XEO_NAME L4 peptide DME1098 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03735 XEO_CLAS Peptide DME1098 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 31.61 microM) DME1098 XEOTICID XEO03735 GENEFORM Protein DME1098 XEOTICID XEO03735 MOACRIVE Inhibition DME1098 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1098 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03738 XEO_CLAS Peptide DME1098 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 ug/ml) DME1098 XEOTICID XEO03738 GENEFORM Protein DME1098 XEOTICID XEO03738 MOACRIVE Inhibition DME1098 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1098 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03741 XEO_CLAS Peptide DME1098 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40 ug/ml) DME1098 XEOTICID XEO03741 GENEFORM Protein DME1098 XEOTICID XEO03741 MOACRIVE Inhibition DME1098 XEOTICID XEO03742 XEO_NAME L5 peptide DME1098 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03742 XEO_CLAS Peptide DME1098 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 7.79 microM) DME1098 XEOTICID XEO03742 GENEFORM Protein DME1098 XEOTICID XEO03742 MOACRIVE Inhibition DME1098 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1098 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03743 XEO_CLAS Peptide DME1098 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 ug/ml) DME1098 XEOTICID XEO03743 GENEFORM Protein DME1098 XEOTICID XEO03743 MOACRIVE Inhibition DME1098 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1098 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03744 XEO_CLAS Peptide DME1098 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 ug/ml) DME1098 XEOTICID XEO03744 GENEFORM Protein DME1098 XEOTICID XEO03744 MOACRIVE Inhibition DME1098 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1098 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03745 XEO_CLAS Peptide DME1098 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 ug/ml) DME1098 XEOTICID XEO03745 GENEFORM Protein DME1098 XEOTICID XEO03745 MOACRIVE Inhibition DME1098 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1098 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03746 XEO_CLAS Peptide DME1098 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO03746 GENEFORM Protein DME1098 XEOTICID XEO03746 MOACRIVE Inhibition DME1098 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1098 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03747 XEO_CLAS Peptide DME1098 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO03747 GENEFORM Protein DME1098 XEOTICID XEO03747 MOACRIVE Inhibition DME1098 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1098 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03748 XEO_CLAS Peptide DME1098 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO03748 GENEFORM Protein DME1098 XEOTICID XEO03748 MOACRIVE Inhibition DME1098 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1098 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03749 XEO_CLAS Peptide DME1098 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO03749 GENEFORM Protein DME1098 XEOTICID XEO03749 MOACRIVE Inhibition DME1098 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1098 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03750 XEO_CLAS Peptide DME1098 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO03750 GENEFORM Protein DME1098 XEOTICID XEO03750 MOACRIVE Inhibition DME1098 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1098 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03751 XEO_CLAS Peptide DME1098 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO03751 GENEFORM Protein DME1098 XEOTICID XEO03751 MOACRIVE Inhibition DME1098 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1098 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03752 XEO_CLAS Peptide DME1098 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO03752 GENEFORM Protein DME1098 XEOTICID XEO03752 MOACRIVE Inhibition DME1098 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1098 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03753 XEO_CLAS Peptide DME1098 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 ug/ml) DME1098 XEOTICID XEO03753 GENEFORM Protein DME1098 XEOTICID XEO03753 MOACRIVE Inhibition DME1098 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1098 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03754 XEO_CLAS Peptide DME1098 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO03754 GENEFORM Protein DME1098 XEOTICID XEO03754 MOACRIVE Inhibition DME1098 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1098 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03755 XEO_CLAS Peptide DME1098 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO03755 GENEFORM Protein DME1098 XEOTICID XEO03755 MOACRIVE Inhibition DME1098 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1098 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03756 XEO_CLAS Peptide DME1098 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO03756 GENEFORM Protein DME1098 XEOTICID XEO03756 MOACRIVE Inhibition DME1098 XEOTICID XEO03757 XEO_NAME L6 peptide DME1098 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03757 XEO_CLAS Peptide DME1098 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15.17 microM) DME1098 XEOTICID XEO03757 GENEFORM Protein DME1098 XEOTICID XEO03757 MOACRIVE Inhibition DME1098 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1098 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03758 XEO_CLAS Peptide DME1098 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 80 ug/ml) DME1098 XEOTICID XEO03758 GENEFORM Protein DME1098 XEOTICID XEO03758 MOACRIVE Inhibition DME1098 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1098 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03759 XEO_CLAS Peptide DME1098 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.3 ug/ml) DME1098 XEOTICID XEO03759 GENEFORM Protein DME1098 XEOTICID XEO03759 MOACRIVE Inhibition DME1098 XEOTICID XEO03760 XEO_NAME L7 peptide DME1098 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03760 XEO_CLAS Peptide DME1098 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16.02 microM) DME1098 XEOTICID XEO03760 GENEFORM Protein DME1098 XEOTICID XEO03760 MOACRIVE Inhibition DME1098 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1098 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03761 XEO_CLAS Peptide DME1098 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 ug/ml) DME1098 XEOTICID XEO03761 GENEFORM Protein DME1098 XEOTICID XEO03761 MOACRIVE Inhibition DME1098 XEOTICID XEO03763 XEO_NAME L8 peptide DME1098 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03763 XEO_CLAS Peptide DME1098 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.71 microM) DME1098 XEOTICID XEO03763 GENEFORM Protein DME1098 XEOTICID XEO03763 MOACRIVE Inhibition DME1098 XEOTICID XEO03765 XEO_NAME L9 peptide DME1098 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03765 XEO_CLAS Peptide DME1098 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.78 microM) DME1098 XEOTICID XEO03765 GENEFORM Protein DME1098 XEOTICID XEO03765 MOACRIVE Inhibition DME1098 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1098 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03775 XEO_CLAS Peptide DME1098 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 17.3 microM) DME1098 XEOTICID XEO03775 GENEFORM Protein DME1098 XEOTICID XEO03775 MOACRIVE Inhibition DME1098 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1098 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03776 XEO_CLAS Peptide DME1098 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03776 GENEFORM Protein DME1098 XEOTICID XEO03776 MOACRIVE Inhibition DME1098 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1098 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03781 XEO_CLAS Peptide DME1098 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.47 microM) DME1098 XEOTICID XEO03781 GENEFORM Protein DME1098 XEOTICID XEO03781 MOACRIVE Inhibition DME1098 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1098 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03782 XEO_CLAS Peptide DME1098 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.47 microM) DME1098 XEOTICID XEO03782 GENEFORM Protein DME1098 XEOTICID XEO03782 MOACRIVE Inhibition DME1098 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1098 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03783 XEO_CLAS Peptide DME1098 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.68 microM) DME1098 XEOTICID XEO03783 GENEFORM Protein DME1098 XEOTICID XEO03783 MOACRIVE Inhibition DME1098 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1098 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03784 XEO_CLAS Peptide DME1098 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.45 microM) DME1098 XEOTICID XEO03784 GENEFORM Protein DME1098 XEOTICID XEO03784 MOACRIVE Inhibition DME1098 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1098 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03785 XEO_CLAS Peptide DME1098 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.73 microM) DME1098 XEOTICID XEO03785 GENEFORM Protein DME1098 XEOTICID XEO03785 MOACRIVE Inhibition DME1098 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1098 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03786 XEO_CLAS Peptide DME1098 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.45 microM) DME1098 XEOTICID XEO03786 GENEFORM Protein DME1098 XEOTICID XEO03786 MOACRIVE Inhibition DME1098 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1098 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03787 XEO_CLAS Peptide DME1098 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.38 microM) DME1098 XEOTICID XEO03787 GENEFORM Protein DME1098 XEOTICID XEO03787 MOACRIVE Inhibition DME1098 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1098 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03788 XEO_CLAS Peptide DME1098 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.46 microM) DME1098 XEOTICID XEO03788 GENEFORM Protein DME1098 XEOTICID XEO03788 MOACRIVE Inhibition DME1098 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1098 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03789 XEO_CLAS Peptide DME1098 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 13.05 microM) DME1098 XEOTICID XEO03789 GENEFORM Protein DME1098 XEOTICID XEO03789 MOACRIVE Inhibition DME1098 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1098 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03790 XEO_CLAS Peptide DME1098 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.82 microM) DME1098 XEOTICID XEO03790 GENEFORM Protein DME1098 XEOTICID XEO03790 MOACRIVE Inhibition DME1098 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1098 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03791 XEO_CLAS Peptide DME1098 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.80 microM) DME1098 XEOTICID XEO03791 GENEFORM Protein DME1098 XEOTICID XEO03791 MOACRIVE Inhibition DME1098 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1098 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03792 XEO_CLAS Peptide DME1098 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.26 microM) DME1098 XEOTICID XEO03792 GENEFORM Protein DME1098 XEOTICID XEO03792 MOACRIVE Inhibition DME1098 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1098 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03793 XEO_CLAS Peptide DME1098 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 microM) DME1098 XEOTICID XEO03793 GENEFORM Protein DME1098 XEOTICID XEO03793 MOACRIVE Inhibition DME1098 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1098 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03797 XEO_CLAS Peptide DME1098 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.4 microM) DME1098 XEOTICID XEO03797 GENEFORM Protein DME1098 XEOTICID XEO03797 MOACRIVE Inhibition DME1098 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1098 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03798 XEO_CLAS Peptide DME1098 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03798 GENEFORM Protein DME1098 XEOTICID XEO03798 MOACRIVE Inhibition DME1098 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1098 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03799 XEO_CLAS Peptide DME1098 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03799 GENEFORM Protein DME1098 XEOTICID XEO03799 MOACRIVE Inhibition DME1098 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1098 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03810 XEO_CLAS Peptide DME1098 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03810 GENEFORM Protein DME1098 XEOTICID XEO03810 MOACRIVE Inhibition DME1098 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1098 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03846 XEO_CLAS Peptide DME1098 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03846 GENEFORM Protein DME1098 XEOTICID XEO03846 MOACRIVE Inhibition DME1098 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1098 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03847 XEO_CLAS Peptide DME1098 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03847 GENEFORM Protein DME1098 XEOTICID XEO03847 MOACRIVE Inhibition DME1098 XEOTICID XEO03850 XEO_NAME Lemon DME1098 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1098 XEOTICID XEO03850 XEO_CLAS Food Additive DME1098 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03850 GENEFORM Protein DME1098 XEOTICID XEO03850 MOACRIVE Inhibition DME1098 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1098 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03853 XEO_CLAS Peptide DME1098 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO03853 GENEFORM Protein DME1098 XEOTICID XEO03853 MOACRIVE Inhibition DME1098 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1098 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03857 XEO_CLAS Peptide DME1098 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 38.49 microM) DME1098 XEOTICID XEO03857 GENEFORM Protein DME1098 XEOTICID XEO03857 MOACRIVE Inhibition DME1098 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1098 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03860 XEO_CLAS Peptide DME1098 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 24 microM) DME1098 XEOTICID XEO03860 GENEFORM Protein DME1098 XEOTICID XEO03860 MOACRIVE Inhibition DME1098 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1098 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03861 XEO_CLAS Peptide DME1098 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 35 microM) DME1098 XEOTICID XEO03861 GENEFORM Protein DME1098 XEOTICID XEO03861 MOACRIVE Inhibition DME1098 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1098 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03862 XEO_CLAS Peptide DME1098 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 70 microM) DME1098 XEOTICID XEO03862 GENEFORM Protein DME1098 XEOTICID XEO03862 MOACRIVE Inhibition DME1098 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1098 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03863 XEO_CLAS Peptide DME1098 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 35 microM) DME1098 XEOTICID XEO03863 GENEFORM Protein DME1098 XEOTICID XEO03863 MOACRIVE Inhibition DME1098 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1098 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03864 XEO_CLAS Peptide DME1098 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO03864 GENEFORM Protein DME1098 XEOTICID XEO03864 MOACRIVE Inhibition DME1098 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1098 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03865 XEO_CLAS Peptide DME1098 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO03865 GENEFORM Protein DME1098 XEOTICID XEO03865 MOACRIVE Inhibition DME1098 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1098 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03866 XEO_CLAS Peptide DME1098 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 microM) DME1098 XEOTICID XEO03866 GENEFORM Protein DME1098 XEOTICID XEO03866 MOACRIVE Inhibition DME1098 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1098 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03867 XEO_CLAS Peptide DME1098 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40 microM) DME1098 XEOTICID XEO03867 GENEFORM Protein DME1098 XEOTICID XEO03867 MOACRIVE Inhibition DME1098 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1098 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03868 XEO_CLAS Peptide DME1098 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 51 microM) DME1098 XEOTICID XEO03868 GENEFORM Protein DME1098 XEOTICID XEO03868 MOACRIVE Inhibition DME1098 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1098 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03869 XEO_CLAS Peptide DME1098 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 35 microM) DME1098 XEOTICID XEO03869 GENEFORM Protein DME1098 XEOTICID XEO03869 MOACRIVE Inhibition DME1098 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1098 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03870 XEO_CLAS Peptide DME1098 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 61 microM) DME1098 XEOTICID XEO03870 GENEFORM Protein DME1098 XEOTICID XEO03870 MOACRIVE Inhibition DME1098 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1098 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03871 XEO_CLAS Peptide DME1098 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 microM) DME1098 XEOTICID XEO03871 GENEFORM Protein DME1098 XEOTICID XEO03871 MOACRIVE Inhibition DME1098 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1098 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03872 XEO_CLAS Peptide DME1098 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 28 microM) DME1098 XEOTICID XEO03872 GENEFORM Protein DME1098 XEOTICID XEO03872 MOACRIVE Inhibition DME1098 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1098 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03873 XEO_CLAS Peptide DME1098 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 22.5 microM) DME1098 XEOTICID XEO03873 GENEFORM Protein DME1098 XEOTICID XEO03873 MOACRIVE Inhibition DME1098 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1098 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03874 XEO_CLAS Peptide DME1098 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 11.25 microM) DME1098 XEOTICID XEO03874 GENEFORM Protein DME1098 XEOTICID XEO03874 MOACRIVE Inhibition DME1098 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1098 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03875 XEO_CLAS Peptide DME1098 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 microM) DME1098 XEOTICID XEO03875 GENEFORM Protein DME1098 XEOTICID XEO03875 MOACRIVE Inhibition DME1098 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1098 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03876 XEO_CLAS Peptide DME1098 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.75 microM) DME1098 XEOTICID XEO03876 GENEFORM Protein DME1098 XEOTICID XEO03876 MOACRIVE Inhibition DME1098 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1098 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03877 XEO_CLAS Peptide DME1098 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 microM) DME1098 XEOTICID XEO03877 GENEFORM Protein DME1098 XEOTICID XEO03877 MOACRIVE Inhibition DME1098 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1098 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03878 XEO_CLAS Peptide DME1098 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 microM) DME1098 XEOTICID XEO03878 GENEFORM Protein DME1098 XEOTICID XEO03878 MOACRIVE Inhibition DME1098 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1098 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03879 XEO_CLAS Peptide DME1098 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 252 microM) DME1098 XEOTICID XEO03879 GENEFORM Protein DME1098 XEOTICID XEO03879 MOACRIVE Inhibition DME1098 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1098 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03880 XEO_CLAS Peptide DME1098 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 174 microM) DME1098 XEOTICID XEO03880 GENEFORM Protein DME1098 XEOTICID XEO03880 MOACRIVE Inhibition DME1098 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1098 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03883 XEO_CLAS Peptide DME1098 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 74 microM) DME1098 XEOTICID XEO03883 GENEFORM Protein DME1098 XEOTICID XEO03883 MOACRIVE Inhibition DME1098 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1098 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03884 XEO_CLAS Peptide DME1098 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 31 microM) DME1098 XEOTICID XEO03884 GENEFORM Protein DME1098 XEOTICID XEO03884 MOACRIVE Inhibition DME1098 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1098 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03885 XEO_CLAS Peptide DME1098 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO03885 GENEFORM Protein DME1098 XEOTICID XEO03885 MOACRIVE Inhibition DME1098 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1098 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03886 XEO_CLAS Peptide DME1098 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 391 microM) DME1098 XEOTICID XEO03886 GENEFORM Protein DME1098 XEOTICID XEO03886 MOACRIVE Inhibition DME1098 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1098 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03887 XEO_CLAS Peptide DME1098 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 151 microM) DME1098 XEOTICID XEO03887 GENEFORM Protein DME1098 XEOTICID XEO03887 MOACRIVE Inhibition DME1098 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1098 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03888 XEO_CLAS Peptide DME1098 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 134 microM) DME1098 XEOTICID XEO03888 GENEFORM Protein DME1098 XEOTICID XEO03888 MOACRIVE Inhibition DME1098 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1098 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03889 XEO_CLAS Peptide DME1098 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 88 microM) DME1098 XEOTICID XEO03889 GENEFORM Protein DME1098 XEOTICID XEO03889 MOACRIVE Inhibition DME1098 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1098 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03890 XEO_CLAS Peptide DME1098 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 31 microM) DME1098 XEOTICID XEO03890 GENEFORM Protein DME1098 XEOTICID XEO03890 MOACRIVE Inhibition DME1098 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1098 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03891 XEO_CLAS Peptide DME1098 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 microM) DME1098 XEOTICID XEO03891 GENEFORM Protein DME1098 XEOTICID XEO03891 MOACRIVE Inhibition DME1098 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1098 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03892 XEO_CLAS Peptide DME1098 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 37 microM) DME1098 XEOTICID XEO03892 GENEFORM Protein DME1098 XEOTICID XEO03892 MOACRIVE Inhibition DME1098 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1098 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03893 XEO_CLAS Peptide DME1098 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 19 microM) DME1098 XEOTICID XEO03893 GENEFORM Protein DME1098 XEOTICID XEO03893 MOACRIVE Inhibition DME1098 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1098 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03894 XEO_CLAS Peptide DME1098 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO03894 GENEFORM Protein DME1098 XEOTICID XEO03894 MOACRIVE Inhibition DME1098 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1098 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03895 XEO_CLAS Peptide DME1098 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO03895 GENEFORM Protein DME1098 XEOTICID XEO03895 MOACRIVE Inhibition DME1098 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1098 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03896 XEO_CLAS Peptide DME1098 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 microM) DME1098 XEOTICID XEO03896 GENEFORM Protein DME1098 XEOTICID XEO03896 MOACRIVE Inhibition DME1098 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1098 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03897 XEO_CLAS Peptide DME1098 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 63 microM) DME1098 XEOTICID XEO03897 GENEFORM Protein DME1098 XEOTICID XEO03897 MOACRIVE Inhibition DME1098 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1098 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03898 XEO_CLAS Peptide DME1098 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 219 microM) DME1098 XEOTICID XEO03898 GENEFORM Protein DME1098 XEOTICID XEO03898 MOACRIVE Inhibition DME1098 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1098 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03901 XEO_CLAS Peptide DME1098 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 35 microM) DME1098 XEOTICID XEO03901 GENEFORM Protein DME1098 XEOTICID XEO03901 MOACRIVE Inhibition DME1098 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1098 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03902 XEO_CLAS Peptide DME1098 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 70 microM) DME1098 XEOTICID XEO03902 GENEFORM Protein DME1098 XEOTICID XEO03902 MOACRIVE Inhibition DME1098 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1098 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03904 XEO_CLAS Peptide DME1098 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO03904 GENEFORM Protein DME1098 XEOTICID XEO03904 MOACRIVE Inhibition DME1098 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1098 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03905 XEO_CLAS Peptide DME1098 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO03905 GENEFORM Protein DME1098 XEOTICID XEO03905 MOACRIVE Inhibition DME1098 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1098 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03908 XEO_CLAS Peptide DME1098 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03908 GENEFORM Protein DME1098 XEOTICID XEO03908 MOACRIVE Inhibition DME1098 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1098 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03915 XEO_CLAS Peptide DME1098 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03915 GENEFORM Protein DME1098 XEOTICID XEO03915 MOACRIVE Inhibition DME1098 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1098 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03916 XEO_CLAS Peptide DME1098 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.8 ug/ml) DME1098 XEOTICID XEO03916 GENEFORM Protein DME1098 XEOTICID XEO03916 MOACRIVE Inhibition DME1098 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1098 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03917 XEO_CLAS Peptide DME1098 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 13.1 ug/ml) DME1098 XEOTICID XEO03917 GENEFORM Protein DME1098 XEOTICID XEO03917 MOACRIVE Inhibition DME1098 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1098 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03918 XEO_CLAS Peptide DME1098 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.5 ug/ml) DME1098 XEOTICID XEO03918 GENEFORM Protein DME1098 XEOTICID XEO03918 MOACRIVE Inhibition DME1098 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1098 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03919 XEO_CLAS Peptide DME1098 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 80 ug/ml) DME1098 XEOTICID XEO03919 GENEFORM Protein DME1098 XEOTICID XEO03919 MOACRIVE Inhibition DME1098 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1098 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03922 XEO_CLAS Peptide DME1098 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 9 microM) DME1098 XEOTICID XEO03922 GENEFORM Protein DME1098 XEOTICID XEO03922 MOACRIVE Inhibition DME1098 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1098 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03923 XEO_CLAS Peptide DME1098 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 80 microM) DME1098 XEOTICID XEO03923 GENEFORM Protein DME1098 XEOTICID XEO03923 MOACRIVE Inhibition DME1098 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1098 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03924 XEO_CLAS Peptide DME1098 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO03924 GENEFORM Protein DME1098 XEOTICID XEO03924 MOACRIVE Inhibition DME1098 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1098 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03927 XEO_CLAS Peptide DME1098 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 80 microM) DME1098 XEOTICID XEO03927 GENEFORM Protein DME1098 XEOTICID XEO03927 MOACRIVE Inhibition DME1098 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1098 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03928 XEO_CLAS Peptide DME1098 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 microM) DME1098 XEOTICID XEO03928 GENEFORM Protein DME1098 XEOTICID XEO03928 MOACRIVE Inhibition DME1098 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1098 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03929 XEO_CLAS Peptide DME1098 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 microM) DME1098 XEOTICID XEO03929 GENEFORM Protein DME1098 XEOTICID XEO03929 MOACRIVE Inhibition DME1098 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1098 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03930 XEO_CLAS Peptide DME1098 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 microM) DME1098 XEOTICID XEO03930 GENEFORM Protein DME1098 XEOTICID XEO03930 MOACRIVE Inhibition DME1098 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1098 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03931 XEO_CLAS Peptide DME1098 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 microM) DME1098 XEOTICID XEO03931 GENEFORM Protein DME1098 XEOTICID XEO03931 MOACRIVE Inhibition DME1098 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1098 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03933 XEO_CLAS Peptide DME1098 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.5 microM) DME1098 XEOTICID XEO03933 GENEFORM Protein DME1098 XEOTICID XEO03933 MOACRIVE Inhibition DME1098 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1098 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03934 XEO_CLAS Peptide DME1098 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.7 microM) DME1098 XEOTICID XEO03934 GENEFORM Protein DME1098 XEOTICID XEO03934 MOACRIVE Inhibition DME1098 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1098 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03935 XEO_CLAS Peptide DME1098 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.7 microM) DME1098 XEOTICID XEO03935 GENEFORM Protein DME1098 XEOTICID XEO03935 MOACRIVE Inhibition DME1098 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1098 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03936 XEO_CLAS Peptide DME1098 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.0 microM) DME1098 XEOTICID XEO03936 GENEFORM Protein DME1098 XEOTICID XEO03936 MOACRIVE Inhibition DME1098 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1098 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03937 XEO_CLAS Peptide DME1098 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.1 microM) DME1098 XEOTICID XEO03937 GENEFORM Protein DME1098 XEOTICID XEO03937 MOACRIVE Inhibition DME1098 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1098 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03938 XEO_CLAS Peptide DME1098 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.7 microM) DME1098 XEOTICID XEO03938 GENEFORM Protein DME1098 XEOTICID XEO03938 MOACRIVE Inhibition DME1098 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1098 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03939 XEO_CLAS Peptide DME1098 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.7 microM) DME1098 XEOTICID XEO03939 GENEFORM Protein DME1098 XEOTICID XEO03939 MOACRIVE Inhibition DME1098 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1098 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03940 XEO_CLAS Peptide DME1098 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.5 microM) DME1098 XEOTICID XEO03940 GENEFORM Protein DME1098 XEOTICID XEO03940 MOACRIVE Inhibition DME1098 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1098 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03941 XEO_CLAS Peptide DME1098 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.4 microM) DME1098 XEOTICID XEO03941 GENEFORM Protein DME1098 XEOTICID XEO03941 MOACRIVE Inhibition DME1098 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1098 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03943 XEO_CLAS Peptide DME1098 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.4 microM) DME1098 XEOTICID XEO03943 GENEFORM Protein DME1098 XEOTICID XEO03943 MOACRIVE Inhibition DME1098 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1098 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03944 XEO_CLAS Peptide DME1098 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.7 microM) DME1098 XEOTICID XEO03944 GENEFORM Protein DME1098 XEOTICID XEO03944 MOACRIVE Inhibition DME1098 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1098 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03945 XEO_CLAS Peptide DME1098 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.2 microM) DME1098 XEOTICID XEO03945 GENEFORM Protein DME1098 XEOTICID XEO03945 MOACRIVE Inhibition DME1098 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1098 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03947 XEO_CLAS Peptide DME1098 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.0 microM) DME1098 XEOTICID XEO03947 GENEFORM Protein DME1098 XEOTICID XEO03947 MOACRIVE Inhibition DME1098 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1098 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03948 XEO_CLAS Peptide DME1098 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 23.3 microM) DME1098 XEOTICID XEO03948 GENEFORM Protein DME1098 XEOTICID XEO03948 MOACRIVE Inhibition DME1098 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1098 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03950 XEO_CLAS Peptide DME1098 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4.4 microM) DME1098 XEOTICID XEO03950 GENEFORM Protein DME1098 XEOTICID XEO03950 MOACRIVE Inhibition DME1098 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1098 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03951 XEO_CLAS Peptide DME1098 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8.8 microM) DME1098 XEOTICID XEO03951 GENEFORM Protein DME1098 XEOTICID XEO03951 MOACRIVE Inhibition DME1098 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1098 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03952 XEO_CLAS Peptide DME1098 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.2 microM) DME1098 XEOTICID XEO03952 GENEFORM Protein DME1098 XEOTICID XEO03952 MOACRIVE Inhibition DME1098 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1098 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03953 XEO_CLAS Peptide DME1098 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 microM) DME1098 XEOTICID XEO03953 GENEFORM Protein DME1098 XEOTICID XEO03953 MOACRIVE Inhibition DME1098 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1098 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03958 XEO_CLAS Peptide DME1098 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03958 GENEFORM Protein DME1098 XEOTICID XEO03958 MOACRIVE Inhibition DME1098 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1098 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03965 XEO_CLAS Peptide DME1098 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 128 microM) DME1098 XEOTICID XEO03965 GENEFORM Protein DME1098 XEOTICID XEO03965 MOACRIVE Inhibition DME1098 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1098 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03966 XEO_CLAS Peptide DME1098 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 microM) DME1098 XEOTICID XEO03966 GENEFORM Protein DME1098 XEOTICID XEO03966 MOACRIVE Inhibition DME1098 XEOTICID XEO03971 XEO_NAME Lumbrican DME1098 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03971 XEO_CLAS Peptide DME1098 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03971 GENEFORM Protein DME1098 XEOTICID XEO03971 MOACRIVE Inhibition DME1098 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1098 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03972 XEO_CLAS Peptide DME1098 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO03972 GENEFORM Protein DME1098 XEOTICID XEO03972 MOACRIVE Inhibition DME1098 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1098 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03980 XEO_CLAS Peptide DME1098 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 32 microM) DME1098 XEOTICID XEO03980 GENEFORM Protein DME1098 XEOTICID XEO03980 MOACRIVE Inhibition DME1098 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1098 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03985 XEO_CLAS Peptide DME1098 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 ug/ml) DME1098 XEOTICID XEO03985 GENEFORM Protein DME1098 XEOTICID XEO03985 MOACRIVE Inhibition DME1098 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1098 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03991 XEO_CLAS Peptide DME1098 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03991 GENEFORM Protein DME1098 XEOTICID XEO03991 MOACRIVE Inhibition DME1098 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1098 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03992 XEO_CLAS Peptide DME1098 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03992 GENEFORM Protein DME1098 XEOTICID XEO03992 MOACRIVE Inhibition DME1098 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1098 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03993 XEO_CLAS Peptide DME1098 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03993 GENEFORM Protein DME1098 XEOTICID XEO03993 MOACRIVE Inhibition DME1098 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1098 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03994 XEO_CLAS Peptide DME1098 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO03994 GENEFORM Protein DME1098 XEOTICID XEO03994 MOACRIVE Inhibition DME1098 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1098 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03996 XEO_CLAS Peptide DME1098 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 65 microM) DME1098 XEOTICID XEO03996 GENEFORM Protein DME1098 XEOTICID XEO03996 MOACRIVE Inhibition DME1098 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1098 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03997 XEO_CLAS Peptide DME1098 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 7.5 microM) DME1098 XEOTICID XEO03997 GENEFORM Protein DME1098 XEOTICID XEO03997 MOACRIVE Inhibition DME1098 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1098 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03998 XEO_CLAS Peptide DME1098 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15.5 microM) DME1098 XEOTICID XEO03998 GENEFORM Protein DME1098 XEOTICID XEO03998 MOACRIVE Inhibition DME1098 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1098 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO03999 XEO_CLAS Peptide DME1098 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25.8 microM) DME1098 XEOTICID XEO03999 GENEFORM Protein DME1098 XEOTICID XEO03999 MOACRIVE Inhibition DME1098 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1098 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04000 XEO_CLAS Peptide DME1098 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO04000 GENEFORM Protein DME1098 XEOTICID XEO04000 MOACRIVE Inhibition DME1098 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1098 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04001 XEO_CLAS Peptide DME1098 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO04001 GENEFORM Protein DME1098 XEOTICID XEO04001 MOACRIVE Inhibition DME1098 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1098 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04002 XEO_CLAS Peptide DME1098 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 7.5 ug/ml) DME1098 XEOTICID XEO04002 GENEFORM Protein DME1098 XEOTICID XEO04002 MOACRIVE Inhibition DME1098 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1098 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04003 XEO_CLAS Peptide DME1098 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 ug/ml) DME1098 XEOTICID XEO04003 GENEFORM Protein DME1098 XEOTICID XEO04003 MOACRIVE Inhibition DME1098 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1098 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04004 XEO_CLAS Peptide DME1098 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.0 ug/ml) DME1098 XEOTICID XEO04004 GENEFORM Protein DME1098 XEOTICID XEO04004 MOACRIVE Inhibition DME1098 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1098 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04005 XEO_CLAS Peptide DME1098 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.0 ug/ml) DME1098 XEOTICID XEO04005 GENEFORM Protein DME1098 XEOTICID XEO04005 MOACRIVE Inhibition DME1098 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1098 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04007 XEO_CLAS Peptide DME1098 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 19.5 ug/ml) DME1098 XEOTICID XEO04007 GENEFORM Protein DME1098 XEOTICID XEO04007 MOACRIVE Inhibition DME1098 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1098 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04011 XEO_CLAS Peptide DME1098 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 19.5 ug/ml) DME1098 XEOTICID XEO04011 GENEFORM Protein DME1098 XEOTICID XEO04011 MOACRIVE Inhibition DME1098 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1098 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04012 XEO_CLAS Peptide DME1098 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.9 ug/ml) DME1098 XEOTICID XEO04012 GENEFORM Protein DME1098 XEOTICID XEO04012 MOACRIVE Inhibition DME1098 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1098 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04013 XEO_CLAS Peptide DME1098 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.7 ug/ml) DME1098 XEOTICID XEO04013 GENEFORM Protein DME1098 XEOTICID XEO04013 MOACRIVE Inhibition DME1098 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1098 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04018 XEO_CLAS Peptide DME1098 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 9 ug/ml) DME1098 XEOTICID XEO04018 GENEFORM Protein DME1098 XEOTICID XEO04018 MOACRIVE Inhibition DME1098 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1098 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04026 XEO_CLAS Peptide DME1098 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO04026 GENEFORM Protein DME1098 XEOTICID XEO04026 MOACRIVE Inhibition DME1098 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1098 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04027 XEO_CLAS Peptide DME1098 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO04027 GENEFORM Protein DME1098 XEOTICID XEO04027 MOACRIVE Inhibition DME1098 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1098 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04028 XEO_CLAS Peptide DME1098 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 ug/ml) DME1098 XEOTICID XEO04028 GENEFORM Protein DME1098 XEOTICID XEO04028 MOACRIVE Inhibition DME1098 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1098 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04038 XEO_CLAS Peptide DME1098 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04038 GENEFORM Protein DME1098 XEOTICID XEO04038 MOACRIVE Inhibition DME1098 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1098 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04039 XEO_CLAS Peptide DME1098 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 microM) DME1098 XEOTICID XEO04039 GENEFORM Protein DME1098 XEOTICID XEO04039 MOACRIVE Inhibition DME1098 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1098 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04051 XEO_CLAS Peptide DME1098 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1098 XEOTICID XEO04051 GENEFORM Protein DME1098 XEOTICID XEO04051 MOACRIVE Inhibition DME1098 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1098 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04052 XEO_CLAS Peptide DME1098 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04052 GENEFORM Protein DME1098 XEOTICID XEO04052 MOACRIVE Inhibition DME1098 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1098 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04053 XEO_CLAS Peptide DME1098 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.08-0.16 microM) DME1098 XEOTICID XEO04053 GENEFORM Protein DME1098 XEOTICID XEO04053 MOACRIVE Inhibition DME1098 XEOTICID XEO04055 XEO_NAME Melectin DME1098 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04055 XEO_CLAS Peptide DME1098 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.0 microM) DME1098 XEOTICID XEO04055 GENEFORM Protein DME1098 XEOTICID XEO04055 MOACRIVE Inhibition DME1098 XEOTICID XEO04057 XEO_NAME Melittin DME1098 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04057 XEO_CLAS Peptide DME1098 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.8 microM) DME1098 XEOTICID XEO04057 GENEFORM Protein DME1098 XEOTICID XEO04057 MOACRIVE Inhibition DME1098 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1098 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04061 XEO_CLAS Peptide DME1098 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.9 microM) DME1098 XEOTICID XEO04061 GENEFORM Protein DME1098 XEOTICID XEO04061 MOACRIVE Inhibition DME1098 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1098 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04062 XEO_CLAS Peptide DME1098 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.5 microM) DME1098 XEOTICID XEO04062 GENEFORM Protein DME1098 XEOTICID XEO04062 MOACRIVE Inhibition DME1098 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1098 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04063 XEO_CLAS Peptide DME1098 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 7.8 microM) DME1098 XEOTICID XEO04063 GENEFORM Protein DME1098 XEOTICID XEO04063 MOACRIVE Inhibition DME1098 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1098 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04064 XEO_CLAS Peptide DME1098 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 46.7 microM) DME1098 XEOTICID XEO04064 GENEFORM Protein DME1098 XEOTICID XEO04064 MOACRIVE Inhibition DME1098 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1098 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04066 XEO_CLAS Peptide DME1098 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16.3 microM) DME1098 XEOTICID XEO04066 GENEFORM Protein DME1098 XEOTICID XEO04066 MOACRIVE Inhibition DME1098 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1098 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04067 XEO_CLAS Peptide DME1098 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.6 microM) DME1098 XEOTICID XEO04067 GENEFORM Protein DME1098 XEOTICID XEO04067 MOACRIVE Inhibition DME1098 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1098 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04068 XEO_CLAS Peptide DME1098 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.6 microM) DME1098 XEOTICID XEO04068 GENEFORM Protein DME1098 XEOTICID XEO04068 MOACRIVE Inhibition DME1098 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1098 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04086 GENEFORM Protein DME1098 XEOTICID XEO04086 MOACRIVE Inhibition DME1098 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1098 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04087 GENEFORM Protein DME1098 XEOTICID XEO04087 MOACRIVE Inhibition DME1098 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1098 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04089 GENEFORM Protein DME1098 XEOTICID XEO04089 MOACRIVE Inhibition DME1098 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1098 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04094 GENEFORM Protein DME1098 XEOTICID XEO04094 MOACRIVE Inhibition DME1098 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1098 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04096 GENEFORM Protein DME1098 XEOTICID XEO04096 MOACRIVE Inhibition DME1098 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1098 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04098 GENEFORM Protein DME1098 XEOTICID XEO04098 MOACRIVE Inhibition DME1098 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1098 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04111 XEO_CLAS Peptide DME1098 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04111 GENEFORM Protein DME1098 XEOTICID XEO04111 MOACRIVE Inhibition DME1098 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1098 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04112 XEO_CLAS Peptide DME1098 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.02 microM) DME1098 XEOTICID XEO04112 GENEFORM Protein DME1098 XEOTICID XEO04112 MOACRIVE Inhibition DME1098 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1098 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04113 XEO_CLAS Peptide DME1098 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.02 ug/ml) DME1098 XEOTICID XEO04113 GENEFORM Protein DME1098 XEOTICID XEO04113 MOACRIVE Inhibition DME1098 XEOTICID XEO04114 XEO_NAME Microcin L DME1098 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04114 XEO_CLAS Peptide DME1098 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04114 GENEFORM Protein DME1098 XEOTICID XEO04114 MOACRIVE Inhibition DME1098 XEOTICID XEO04117 XEO_NAME Misgurin DME1098 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04117 XEO_CLAS Peptide DME1098 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04117 GENEFORM Protein DME1098 XEOTICID XEO04117 MOACRIVE Inhibition DME1098 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1098 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04118 XEO_CLAS Peptide DME1098 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 300 microM) DME1098 XEOTICID XEO04118 GENEFORM Protein DME1098 XEOTICID XEO04118 MOACRIVE Inhibition DME1098 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1098 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04119 XEO_CLAS Peptide DME1098 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-20 microM) DME1098 XEOTICID XEO04119 GENEFORM Protein DME1098 XEOTICID XEO04119 MOACRIVE Inhibition DME1098 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1098 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04120 XEO_CLAS Peptide DME1098 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC < 10 microM) DME1098 XEOTICID XEO04120 GENEFORM Protein DME1098 XEOTICID XEO04120 MOACRIVE Inhibition DME1098 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1098 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04121 XEO_CLAS Peptide DME1098 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.2-6.4 microM) DME1098 XEOTICID XEO04121 GENEFORM Protein DME1098 XEOTICID XEO04121 MOACRIVE Inhibition DME1098 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1098 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04122 XEO_CLAS Peptide DME1098 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.14-6.29 microM) DME1098 XEOTICID XEO04122 GENEFORM Protein DME1098 XEOTICID XEO04122 MOACRIVE Inhibition DME1098 XEOTICID XEO04123 XEO_NAME Modified defensin DME1098 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04123 XEO_CLAS Peptide DME1098 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO04123 GENEFORM Protein DME1098 XEOTICID XEO04123 MOACRIVE Inhibition DME1098 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1098 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04128 XEO_CLAS Peptide DME1098 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.31 microM) DME1098 XEOTICID XEO04128 GENEFORM Protein DME1098 XEOTICID XEO04128 MOACRIVE Inhibition DME1098 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1098 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04129 XEO_CLAS Peptide DME1098 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO04129 GENEFORM Protein DME1098 XEOTICID XEO04129 MOACRIVE Inhibition DME1098 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1098 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04130 XEO_CLAS Peptide DME1098 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO04130 GENEFORM Protein DME1098 XEOTICID XEO04130 MOACRIVE Inhibition DME1098 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1098 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04131 XEO_CLAS Peptide DME1098 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 microM) DME1098 XEOTICID XEO04131 GENEFORM Protein DME1098 XEOTICID XEO04131 MOACRIVE Inhibition DME1098 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1098 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04132 XEO_CLAS Peptide DME1098 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 microM) DME1098 XEOTICID XEO04132 GENEFORM Protein DME1098 XEOTICID XEO04132 MOACRIVE Inhibition DME1098 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1098 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04133 XEO_CLAS Peptide DME1098 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO04133 GENEFORM Protein DME1098 XEOTICID XEO04133 MOACRIVE Inhibition DME1098 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1098 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04134 XEO_CLAS Peptide DME1098 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO04134 GENEFORM Protein DME1098 XEOTICID XEO04134 MOACRIVE Inhibition DME1098 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1098 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04135 XEO_CLAS Peptide DME1098 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 microM) DME1098 XEOTICID XEO04135 GENEFORM Protein DME1098 XEOTICID XEO04135 MOACRIVE Inhibition DME1098 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1098 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04137 XEO_CLAS Peptide DME1098 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.6 microM) DME1098 XEOTICID XEO04137 GENEFORM Protein DME1098 XEOTICID XEO04137 MOACRIVE Inhibition DME1098 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1098 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04138 XEO_CLAS Peptide DME1098 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 microM) DME1098 XEOTICID XEO04138 GENEFORM Protein DME1098 XEOTICID XEO04138 MOACRIVE Inhibition DME1098 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1098 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04139 XEO_CLAS Peptide DME1098 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 microM) DME1098 XEOTICID XEO04139 GENEFORM Protein DME1098 XEOTICID XEO04139 MOACRIVE Inhibition DME1098 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1098 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04140 XEO_CLAS Peptide DME1098 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 70 microM) DME1098 XEOTICID XEO04140 GENEFORM Protein DME1098 XEOTICID XEO04140 MOACRIVE Inhibition DME1098 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1098 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04141 XEO_CLAS Peptide DME1098 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 microM) DME1098 XEOTICID XEO04141 GENEFORM Protein DME1098 XEOTICID XEO04141 MOACRIVE Inhibition DME1098 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1098 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04142 XEO_CLAS Peptide DME1098 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8-16 microM) DME1098 XEOTICID XEO04142 GENEFORM Protein DME1098 XEOTICID XEO04142 MOACRIVE Inhibition DME1098 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1098 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04146 XEO_CLAS Peptide DME1098 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04146 GENEFORM Protein DME1098 XEOTICID XEO04146 MOACRIVE Inhibition DME1098 XEOTICID XEO04149 XEO_NAME Mucroporin DME1098 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04149 XEO_CLAS Peptide DME1098 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 ug/ml) DME1098 XEOTICID XEO04149 GENEFORM Protein DME1098 XEOTICID XEO04149 MOACRIVE Inhibition DME1098 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1098 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04158 XEO_CLAS Peptide DME1098 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO04158 GENEFORM Protein DME1098 XEOTICID XEO04158 MOACRIVE Inhibition DME1098 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1098 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04159 XEO_CLAS Peptide DME1098 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 microM) DME1098 XEOTICID XEO04159 GENEFORM Protein DME1098 XEOTICID XEO04159 MOACRIVE Inhibition DME1098 XEOTICID XEO04167 XEO_NAME Myticin-B DME1098 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04167 XEO_CLAS Peptide DME1098 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04167 GENEFORM Protein DME1098 XEOTICID XEO04167 MOACRIVE Inhibition DME1098 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1098 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04168 XEO_CLAS Peptide DME1098 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.7-12.5 microM) DME1098 XEOTICID XEO04168 GENEFORM Protein DME1098 XEOTICID XEO04168 MOACRIVE Inhibition DME1098 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1098 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04169 XEO_CLAS Peptide DME1098 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04169 GENEFORM Protein DME1098 XEOTICID XEO04169 MOACRIVE Inhibition DME1098 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1098 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04170 XEO_CLAS Peptide DME1098 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04170 GENEFORM Protein DME1098 XEOTICID XEO04170 MOACRIVE Inhibition DME1098 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1098 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04171 XEO_CLAS Peptide DME1098 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04171 GENEFORM Protein DME1098 XEOTICID XEO04171 MOACRIVE Inhibition DME1098 XEOTICID XEO04172 XEO_NAME Myxinidin DME1098 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04172 XEO_CLAS Peptide DME1098 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04172 GENEFORM Protein DME1098 XEOTICID XEO04172 MOACRIVE Inhibition DME1098 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1098 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04177 XEO_CLAS Peptide DME1098 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.7 microM) DME1098 XEOTICID XEO04177 GENEFORM Protein DME1098 XEOTICID XEO04177 MOACRIVE Inhibition DME1098 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1098 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04178 XEO_CLAS Peptide DME1098 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.7 microM) DME1098 XEOTICID XEO04178 GENEFORM Protein DME1098 XEOTICID XEO04178 MOACRIVE Inhibition DME1098 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1098 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04179 XEO_CLAS Peptide DME1098 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.5 microM) DME1098 XEOTICID XEO04179 GENEFORM Protein DME1098 XEOTICID XEO04179 MOACRIVE Inhibition DME1098 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1098 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04180 XEO_CLAS Peptide DME1098 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 23 microM) DME1098 XEOTICID XEO04180 GENEFORM Protein DME1098 XEOTICID XEO04180 MOACRIVE Inhibition DME1098 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1098 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04181 XEO_CLAS Peptide DME1098 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.2 microM) DME1098 XEOTICID XEO04181 GENEFORM Protein DME1098 XEOTICID XEO04181 MOACRIVE Inhibition DME1098 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1098 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04182 XEO_CLAS Peptide DME1098 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4.4 microM) DME1098 XEOTICID XEO04182 GENEFORM Protein DME1098 XEOTICID XEO04182 MOACRIVE Inhibition DME1098 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1098 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04183 XEO_CLAS Peptide DME1098 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.6 microM) DME1098 XEOTICID XEO04183 GENEFORM Protein DME1098 XEOTICID XEO04183 MOACRIVE Inhibition DME1098 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1098 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04184 XEO_CLAS Peptide DME1098 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 microM) DME1098 XEOTICID XEO04184 GENEFORM Protein DME1098 XEOTICID XEO04184 MOACRIVE Inhibition DME1098 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1098 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04185 XEO_CLAS Peptide DME1098 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04185 GENEFORM Protein DME1098 XEOTICID XEO04185 MOACRIVE Inhibition DME1098 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1098 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04186 XEO_CLAS Peptide DME1098 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04186 GENEFORM Protein DME1098 XEOTICID XEO04186 MOACRIVE Inhibition DME1098 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1098 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04187 XEO_CLAS Peptide DME1098 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04187 GENEFORM Protein DME1098 XEOTICID XEO04187 MOACRIVE Inhibition DME1098 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1098 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04188 XEO_CLAS Peptide DME1098 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04188 GENEFORM Protein DME1098 XEOTICID XEO04188 MOACRIVE Inhibition DME1098 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1098 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04206 XEO_CLAS Peptide DME1098 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25 microM) DME1098 XEOTICID XEO04206 GENEFORM Protein DME1098 XEOTICID XEO04206 MOACRIVE Inhibition DME1098 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1098 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04214 XEO_CLAS Peptide DME1098 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25 microM) DME1098 XEOTICID XEO04214 GENEFORM Protein DME1098 XEOTICID XEO04214 MOACRIVE Inhibition DME1098 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1098 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04216 XEO_CLAS Peptide DME1098 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO04216 GENEFORM Protein DME1098 XEOTICID XEO04216 MOACRIVE Inhibition DME1098 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1098 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04218 XEO_CLAS Peptide DME1098 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.125 microM) DME1098 XEOTICID XEO04218 GENEFORM Protein DME1098 XEOTICID XEO04218 MOACRIVE Inhibition DME1098 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1098 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04219 XEO_CLAS Peptide DME1098 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO04219 GENEFORM Protein DME1098 XEOTICID XEO04219 MOACRIVE Inhibition DME1098 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1098 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04220 XEO_CLAS Peptide DME1098 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.125 microM) DME1098 XEOTICID XEO04220 GENEFORM Protein DME1098 XEOTICID XEO04220 MOACRIVE Inhibition DME1098 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1098 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04221 XEO_CLAS Peptide DME1098 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO04221 GENEFORM Protein DME1098 XEOTICID XEO04221 MOACRIVE Inhibition DME1098 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1098 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04222 XEO_CLAS Peptide DME1098 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25 microM) DME1098 XEOTICID XEO04222 GENEFORM Protein DME1098 XEOTICID XEO04222 MOACRIVE Inhibition DME1098 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1098 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04233 XEO_CLAS Peptide DME1098 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04233 GENEFORM Protein DME1098 XEOTICID XEO04233 MOACRIVE Inhibition DME1098 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1098 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04234 XEO_CLAS Peptide DME1098 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04234 GENEFORM Protein DME1098 XEOTICID XEO04234 MOACRIVE Inhibition DME1098 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1098 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04241 XEO_CLAS Peptide DME1098 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04241 GENEFORM Protein DME1098 XEOTICID XEO04241 MOACRIVE Inhibition DME1098 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1098 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04242 XEO_CLAS Peptide DME1098 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04242 GENEFORM Protein DME1098 XEOTICID XEO04242 MOACRIVE Inhibition DME1098 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1098 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04245 XEO_CLAS Natural Product DME1098 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04245 GENEFORM Protein DME1098 XEOTICID XEO04245 MOACRIVE Inhibition DME1098 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1098 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04246 XEO_CLAS Natural Product DME1098 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04246 GENEFORM Protein DME1098 XEOTICID XEO04246 MOACRIVE Inhibition DME1098 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1098 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04249 XEO_CLAS Peptide DME1098 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 500 ug/ml) DME1098 XEOTICID XEO04249 GENEFORM Protein DME1098 XEOTICID XEO04249 MOACRIVE Inhibition DME1098 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1098 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04251 XEO_CLAS Peptide DME1098 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04251 GENEFORM Protein DME1098 XEOTICID XEO04251 MOACRIVE Inhibition DME1098 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1098 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04253 XEO_CLAS Peptide DME1098 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04253 GENEFORM Protein DME1098 XEOTICID XEO04253 MOACRIVE Inhibition DME1098 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1098 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04254 XEO_CLAS Peptide DME1098 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04254 GENEFORM Protein DME1098 XEOTICID XEO04254 MOACRIVE Inhibition DME1098 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1098 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04255 XEO_CLAS Peptide DME1098 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04255 GENEFORM Protein DME1098 XEOTICID XEO04255 MOACRIVE Inhibition DME1098 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1098 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04256 XEO_CLAS Peptide DME1098 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04256 GENEFORM Protein DME1098 XEOTICID XEO04256 MOACRIVE Inhibition DME1098 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1098 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04257 XEO_CLAS Peptide DME1098 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04257 GENEFORM Protein DME1098 XEOTICID XEO04257 MOACRIVE Inhibition DME1098 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1098 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04258 XEO_CLAS Peptide DME1098 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04258 GENEFORM Protein DME1098 XEOTICID XEO04258 MOACRIVE Inhibition DME1098 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1098 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04259 XEO_CLAS Peptide DME1098 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04259 GENEFORM Protein DME1098 XEOTICID XEO04259 MOACRIVE Inhibition DME1098 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1098 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04260 XEO_CLAS Peptide DME1098 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04260 GENEFORM Protein DME1098 XEOTICID XEO04260 MOACRIVE Inhibition DME1098 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1098 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04261 XEO_CLAS Peptide DME1098 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04261 GENEFORM Protein DME1098 XEOTICID XEO04261 MOACRIVE Inhibition DME1098 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1098 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04262 XEO_CLAS Peptide DME1098 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04262 GENEFORM Protein DME1098 XEOTICID XEO04262 MOACRIVE Inhibition DME1098 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1098 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04263 XEO_CLAS Peptide DME1098 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04263 GENEFORM Protein DME1098 XEOTICID XEO04263 MOACRIVE Inhibition DME1098 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1098 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04264 XEO_CLAS Peptide DME1098 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04264 GENEFORM Protein DME1098 XEOTICID XEO04264 MOACRIVE Inhibition DME1098 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1098 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04265 XEO_CLAS Peptide DME1098 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04265 GENEFORM Protein DME1098 XEOTICID XEO04265 MOACRIVE Inhibition DME1098 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1098 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04266 XEO_CLAS Peptide DME1098 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04266 GENEFORM Protein DME1098 XEOTICID XEO04266 MOACRIVE Inhibition DME1098 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1098 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04267 XEO_CLAS Peptide DME1098 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04267 GENEFORM Protein DME1098 XEOTICID XEO04267 MOACRIVE Inhibition DME1098 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1098 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04268 XEO_CLAS Peptide DME1098 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04268 GENEFORM Protein DME1098 XEOTICID XEO04268 MOACRIVE Inhibition DME1098 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1098 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04269 XEO_CLAS Peptide DME1098 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04269 GENEFORM Protein DME1098 XEOTICID XEO04269 MOACRIVE Inhibition DME1098 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1098 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04270 XEO_CLAS Peptide DME1098 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04270 GENEFORM Protein DME1098 XEOTICID XEO04270 MOACRIVE Inhibition DME1098 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1098 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04271 XEO_CLAS Peptide DME1098 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04271 GENEFORM Protein DME1098 XEOTICID XEO04271 MOACRIVE Inhibition DME1098 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1098 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04272 XEO_CLAS Peptide DME1098 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04272 GENEFORM Protein DME1098 XEOTICID XEO04272 MOACRIVE Inhibition DME1098 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1098 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04277 XEO_CLAS Peptide DME1098 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 110.00 ug/ml) DME1098 XEOTICID XEO04277 GENEFORM Protein DME1098 XEOTICID XEO04277 MOACRIVE Inhibition DME1098 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1098 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04280 XEO_CLAS Peptide DME1098 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 37.50 ug/ml) DME1098 XEOTICID XEO04280 GENEFORM Protein DME1098 XEOTICID XEO04280 MOACRIVE Inhibition DME1098 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1098 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04281 XEO_CLAS Peptide DME1098 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25.00 ug/ml) DME1098 XEOTICID XEO04281 GENEFORM Protein DME1098 XEOTICID XEO04281 MOACRIVE Inhibition DME1098 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1098 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04282 XEO_CLAS Peptide DME1098 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.2 ug/ml) DME1098 XEOTICID XEO04282 GENEFORM Protein DME1098 XEOTICID XEO04282 MOACRIVE Inhibition DME1098 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1098 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04283 XEO_CLAS Peptide DME1098 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.3 ug/ml) DME1098 XEOTICID XEO04283 GENEFORM Protein DME1098 XEOTICID XEO04283 MOACRIVE Inhibition DME1098 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1098 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04284 XEO_CLAS Peptide DME1098 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10.8 ug/ml) DME1098 XEOTICID XEO04284 GENEFORM Protein DME1098 XEOTICID XEO04284 MOACRIVE Inhibition DME1098 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1098 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04285 XEO_CLAS Peptide DME1098 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 11.5 ug/ml) DME1098 XEOTICID XEO04285 GENEFORM Protein DME1098 XEOTICID XEO04285 MOACRIVE Inhibition DME1098 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1098 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04286 XEO_CLAS Peptide DME1098 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8.6 ug/ml) DME1098 XEOTICID XEO04286 GENEFORM Protein DME1098 XEOTICID XEO04286 MOACRIVE Inhibition DME1098 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1098 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04287 XEO_CLAS Peptide DME1098 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10.2 ug/ml) DME1098 XEOTICID XEO04287 GENEFORM Protein DME1098 XEOTICID XEO04287 MOACRIVE Inhibition DME1098 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1098 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04288 XEO_CLAS Peptide DME1098 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4.4 ug/ml) DME1098 XEOTICID XEO04288 GENEFORM Protein DME1098 XEOTICID XEO04288 MOACRIVE Inhibition DME1098 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1098 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04289 XEO_CLAS Peptide DME1098 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.2 ug/ml) DME1098 XEOTICID XEO04289 GENEFORM Protein DME1098 XEOTICID XEO04289 MOACRIVE Inhibition DME1098 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1098 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04290 XEO_CLAS Peptide DME1098 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 11.3 ug/ml) DME1098 XEOTICID XEO04290 GENEFORM Protein DME1098 XEOTICID XEO04290 MOACRIVE Inhibition DME1098 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1098 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04291 XEO_CLAS Peptide DME1098 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 7.2 ug/ml) DME1098 XEOTICID XEO04291 GENEFORM Protein DME1098 XEOTICID XEO04291 MOACRIVE Inhibition DME1098 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1098 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04292 XEO_CLAS Peptide DME1098 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.1 ug/ml) DME1098 XEOTICID XEO04292 GENEFORM Protein DME1098 XEOTICID XEO04292 MOACRIVE Inhibition DME1098 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1098 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04293 XEO_CLAS Peptide DME1098 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO04293 GENEFORM Protein DME1098 XEOTICID XEO04293 MOACRIVE Inhibition DME1098 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1098 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04294 XEO_CLAS Peptide DME1098 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO04294 GENEFORM Protein DME1098 XEOTICID XEO04294 MOACRIVE Inhibition DME1098 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1098 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04295 XEO_CLAS Peptide DME1098 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO04295 GENEFORM Protein DME1098 XEOTICID XEO04295 MOACRIVE Inhibition DME1098 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1098 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04296 XEO_CLAS Peptide DME1098 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 28 microM) DME1098 XEOTICID XEO04296 GENEFORM Protein DME1098 XEOTICID XEO04296 MOACRIVE Inhibition DME1098 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1098 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04297 XEO_CLAS Peptide DME1098 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 14 microM) DME1098 XEOTICID XEO04297 GENEFORM Protein DME1098 XEOTICID XEO04297 MOACRIVE Inhibition DME1098 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1098 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04298 XEO_CLAS Peptide DME1098 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO04298 GENEFORM Protein DME1098 XEOTICID XEO04298 MOACRIVE Inhibition DME1098 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1098 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04299 XEO_CLAS Peptide DME1098 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO04299 GENEFORM Protein DME1098 XEOTICID XEO04299 MOACRIVE Inhibition DME1098 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1098 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04300 XEO_CLAS Peptide DME1098 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO04300 GENEFORM Protein DME1098 XEOTICID XEO04300 MOACRIVE Inhibition DME1098 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1098 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04301 XEO_CLAS Peptide DME1098 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 microM) DME1098 XEOTICID XEO04301 GENEFORM Protein DME1098 XEOTICID XEO04301 MOACRIVE Inhibition DME1098 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1098 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04302 XEO_CLAS Peptide DME1098 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 microM) DME1098 XEOTICID XEO04302 GENEFORM Protein DME1098 XEOTICID XEO04302 MOACRIVE Inhibition DME1098 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1098 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04303 XEO_CLAS Peptide DME1098 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 microM) DME1098 XEOTICID XEO04303 GENEFORM Protein DME1098 XEOTICID XEO04303 MOACRIVE Inhibition DME1098 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1098 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04304 XEO_CLAS Peptide DME1098 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO04304 GENEFORM Protein DME1098 XEOTICID XEO04304 MOACRIVE Inhibition DME1098 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1098 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04305 XEO_CLAS Peptide DME1098 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 70 microM) DME1098 XEOTICID XEO04305 GENEFORM Protein DME1098 XEOTICID XEO04305 MOACRIVE Inhibition DME1098 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1098 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04306 XEO_CLAS Peptide DME1098 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO04306 GENEFORM Protein DME1098 XEOTICID XEO04306 MOACRIVE Inhibition DME1098 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1098 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04307 XEO_CLAS Peptide DME1098 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 ug/ml) DME1098 XEOTICID XEO04307 GENEFORM Protein DME1098 XEOTICID XEO04307 MOACRIVE Inhibition DME1098 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1098 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04308 XEO_CLAS Peptide DME1098 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 9.37 ug/ml) DME1098 XEOTICID XEO04308 GENEFORM Protein DME1098 XEOTICID XEO04308 MOACRIVE Inhibition DME1098 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1098 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04309 XEO_CLAS Peptide DME1098 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 microM) DME1098 XEOTICID XEO04309 GENEFORM Protein DME1098 XEOTICID XEO04309 MOACRIVE Inhibition DME1098 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1098 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04310 XEO_CLAS Peptide DME1098 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO04310 GENEFORM Protein DME1098 XEOTICID XEO04310 MOACRIVE Inhibition DME1098 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1098 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04311 XEO_CLAS Peptide DME1098 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO04311 GENEFORM Protein DME1098 XEOTICID XEO04311 MOACRIVE Inhibition DME1098 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1098 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04312 XEO_CLAS Peptide DME1098 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4.68 ug/ml) DME1098 XEOTICID XEO04312 GENEFORM Protein DME1098 XEOTICID XEO04312 MOACRIVE Inhibition DME1098 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1098 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04313 XEO_CLAS Peptide DME1098 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4.68 ug/ml) DME1098 XEOTICID XEO04313 GENEFORM Protein DME1098 XEOTICID XEO04313 MOACRIVE Inhibition DME1098 XEOTICID XEO04331 XEO_NAME Norspermidine DME1098 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1098 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04331 GENEFORM Protein DME1098 XEOTICID XEO04331 MOACRIVE Inhibition DME1098 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1098 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04335 XEO_CLAS Peptide DME1098 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 32 ug/ml) DME1098 XEOTICID XEO04335 GENEFORM Protein DME1098 XEOTICID XEO04335 MOACRIVE Inhibition DME1098 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1098 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04336 XEO_CLAS Peptide DME1098 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 32 ug/ml) DME1098 XEOTICID XEO04336 GENEFORM Protein DME1098 XEOTICID XEO04336 MOACRIVE Inhibition DME1098 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1098 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04338 XEO_CLAS Peptide DME1098 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 ug/ml) DME1098 XEOTICID XEO04338 GENEFORM Protein DME1098 XEOTICID XEO04338 MOACRIVE Inhibition DME1098 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1098 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04339 XEO_CLAS Peptide DME1098 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 ug/ml) DME1098 XEOTICID XEO04339 GENEFORM Protein DME1098 XEOTICID XEO04339 MOACRIVE Inhibition DME1098 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1098 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04340 XEO_CLAS Peptide DME1098 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO04340 GENEFORM Protein DME1098 XEOTICID XEO04340 MOACRIVE Inhibition DME1098 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1098 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04344 XEO_CLAS Peptide DME1098 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04344 GENEFORM Protein DME1098 XEOTICID XEO04344 MOACRIVE Inhibition DME1098 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1098 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04345 XEO_CLAS Peptide DME1098 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04345 GENEFORM Protein DME1098 XEOTICID XEO04345 MOACRIVE Inhibition DME1098 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1098 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04346 XEO_CLAS Peptide DME1098 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04346 GENEFORM Protein DME1098 XEOTICID XEO04346 MOACRIVE Inhibition DME1098 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1098 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04347 XEO_CLAS Peptide DME1098 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 microM) DME1098 XEOTICID XEO04347 GENEFORM Protein DME1098 XEOTICID XEO04347 MOACRIVE Inhibition DME1098 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1098 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04348 XEO_CLAS Peptide DME1098 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40 microM) DME1098 XEOTICID XEO04348 GENEFORM Protein DME1098 XEOTICID XEO04348 MOACRIVE Inhibition DME1098 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1098 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04349 XEO_CLAS Peptide DME1098 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO04349 GENEFORM Protein DME1098 XEOTICID XEO04349 MOACRIVE Inhibition DME1098 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1098 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04354 XEO_CLAS Peptide DME1098 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 35.2 ug/ml) DME1098 XEOTICID XEO04354 GENEFORM Protein DME1098 XEOTICID XEO04354 MOACRIVE Inhibition DME1098 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1098 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04355 XEO_CLAS Peptide DME1098 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.21 ug/ml) DME1098 XEOTICID XEO04355 GENEFORM Protein DME1098 XEOTICID XEO04355 MOACRIVE Inhibition DME1098 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1098 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04356 XEO_CLAS Peptide DME1098 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8.21 ug/ml) DME1098 XEOTICID XEO04356 GENEFORM Protein DME1098 XEOTICID XEO04356 MOACRIVE Inhibition DME1098 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1098 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04357 XEO_CLAS Peptide DME1098 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16.32 ug/ml) DME1098 XEOTICID XEO04357 GENEFORM Protein DME1098 XEOTICID XEO04357 MOACRIVE Inhibition DME1098 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1098 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04358 XEO_CLAS Peptide DME1098 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 9.37 ug/ml) DME1098 XEOTICID XEO04358 GENEFORM Protein DME1098 XEOTICID XEO04358 MOACRIVE Inhibition DME1098 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1098 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04359 XEO_CLAS Peptide DME1098 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4.20 ug/ml) DME1098 XEOTICID XEO04359 GENEFORM Protein DME1098 XEOTICID XEO04359 MOACRIVE Inhibition DME1098 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1098 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04360 XEO_CLAS Peptide DME1098 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 ug/ml) DME1098 XEOTICID XEO04360 GENEFORM Protein DME1098 XEOTICID XEO04360 MOACRIVE Inhibition DME1098 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1098 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04361 XEO_CLAS Peptide DME1098 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 7.5 ug/ml) DME1098 XEOTICID XEO04361 GENEFORM Protein DME1098 XEOTICID XEO04361 MOACRIVE Inhibition DME1098 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1098 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04362 XEO_CLAS Peptide DME1098 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.6 ug/ml) DME1098 XEOTICID XEO04362 GENEFORM Protein DME1098 XEOTICID XEO04362 MOACRIVE Inhibition DME1098 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1098 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04363 XEO_CLAS Peptide DME1098 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8.2 ug/ml) DME1098 XEOTICID XEO04363 GENEFORM Protein DME1098 XEOTICID XEO04363 MOACRIVE Inhibition DME1098 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1098 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04364 XEO_CLAS Peptide DME1098 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO04364 GENEFORM Protein DME1098 XEOTICID XEO04364 MOACRIVE Inhibition DME1098 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1098 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04365 XEO_CLAS Peptide DME1098 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4.68 ug/ml) DME1098 XEOTICID XEO04365 GENEFORM Protein DME1098 XEOTICID XEO04365 MOACRIVE Inhibition DME1098 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1098 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04366 XEO_CLAS Peptide DME1098 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 23.60 ug/ml) DME1098 XEOTICID XEO04366 GENEFORM Protein DME1098 XEOTICID XEO04366 MOACRIVE Inhibition DME1098 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1098 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04367 XEO_CLAS Peptide DME1098 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 35.60 ug/ml) DME1098 XEOTICID XEO04367 GENEFORM Protein DME1098 XEOTICID XEO04367 MOACRIVE Inhibition DME1098 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1098 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04368 XEO_CLAS Peptide DME1098 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40.2 ug/ml) DME1098 XEOTICID XEO04368 GENEFORM Protein DME1098 XEOTICID XEO04368 MOACRIVE Inhibition DME1098 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1098 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04369 XEO_CLAS Peptide DME1098 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40.2 ug/ml) DME1098 XEOTICID XEO04369 GENEFORM Protein DME1098 XEOTICID XEO04369 MOACRIVE Inhibition DME1098 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1098 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04370 XEO_CLAS Peptide DME1098 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4.68 ug/ml) DME1098 XEOTICID XEO04370 GENEFORM Protein DME1098 XEOTICID XEO04370 MOACRIVE Inhibition DME1098 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1098 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04371 XEO_CLAS Peptide DME1098 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 9.37 ug/ml) DME1098 XEOTICID XEO04371 GENEFORM Protein DME1098 XEOTICID XEO04371 MOACRIVE Inhibition DME1098 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1098 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04373 XEO_CLAS Peptide DME1098 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 ug/ml) DME1098 XEOTICID XEO04373 GENEFORM Protein DME1098 XEOTICID XEO04373 MOACRIVE Inhibition DME1098 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1098 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04374 XEO_CLAS Peptide DME1098 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.50 ug/ml) DME1098 XEOTICID XEO04374 GENEFORM Protein DME1098 XEOTICID XEO04374 MOACRIVE Inhibition DME1098 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1098 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04375 XEO_CLAS Peptide DME1098 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25 ug/ml) DME1098 XEOTICID XEO04375 GENEFORM Protein DME1098 XEOTICID XEO04375 MOACRIVE Inhibition DME1098 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1098 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04377 XEO_CLAS Peptide DME1098 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 42.50 ug/ml) DME1098 XEOTICID XEO04377 GENEFORM Protein DME1098 XEOTICID XEO04377 MOACRIVE Inhibition DME1098 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1098 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04378 XEO_CLAS Peptide DME1098 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 17.50 ug/ml) DME1098 XEOTICID XEO04378 GENEFORM Protein DME1098 XEOTICID XEO04378 MOACRIVE Inhibition DME1098 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1098 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04379 XEO_CLAS Peptide DME1098 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 ug/ml) DME1098 XEOTICID XEO04379 GENEFORM Protein DME1098 XEOTICID XEO04379 MOACRIVE Inhibition DME1098 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1098 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04380 XEO_CLAS Peptide DME1098 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 36.00 ug/ml) DME1098 XEOTICID XEO04380 GENEFORM Protein DME1098 XEOTICID XEO04380 MOACRIVE Inhibition DME1098 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1098 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04381 XEO_CLAS Peptide DME1098 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.60 ug/ml) DME1098 XEOTICID XEO04381 GENEFORM Protein DME1098 XEOTICID XEO04381 MOACRIVE Inhibition DME1098 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1098 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04382 XEO_CLAS Peptide DME1098 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 ug/ml) DME1098 XEOTICID XEO04382 GENEFORM Protein DME1098 XEOTICID XEO04382 MOACRIVE Inhibition DME1098 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1098 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04383 XEO_CLAS Peptide DME1098 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO04383 GENEFORM Protein DME1098 XEOTICID XEO04383 MOACRIVE Inhibition DME1098 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1098 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04384 XEO_CLAS Peptide DME1098 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO04384 GENEFORM Protein DME1098 XEOTICID XEO04384 MOACRIVE Inhibition DME1098 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1098 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04385 XEO_CLAS Peptide DME1098 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.25 ug/ml) DME1098 XEOTICID XEO04385 GENEFORM Protein DME1098 XEOTICID XEO04385 MOACRIVE Inhibition DME1098 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1098 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04395 XEO_CLAS Peptide DME1098 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1098 XEOTICID XEO04395 GENEFORM Protein DME1098 XEOTICID XEO04395 MOACRIVE Inhibition DME1098 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1098 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04396 XEO_CLAS Peptide DME1098 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1098 XEOTICID XEO04396 GENEFORM Protein DME1098 XEOTICID XEO04396 MOACRIVE Inhibition DME1098 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1098 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04397 XEO_CLAS Peptide DME1098 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1098 XEOTICID XEO04397 GENEFORM Protein DME1098 XEOTICID XEO04397 MOACRIVE Inhibition DME1098 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1098 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04398 XEO_CLAS Peptide DME1098 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 microM) DME1098 XEOTICID XEO04398 GENEFORM Protein DME1098 XEOTICID XEO04398 MOACRIVE Inhibition DME1098 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1098 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04399 XEO_CLAS Peptide DME1098 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO04399 GENEFORM Protein DME1098 XEOTICID XEO04399 MOACRIVE Inhibition DME1098 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1098 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04400 XEO_CLAS Peptide DME1098 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 ug/ml) DME1098 XEOTICID XEO04400 GENEFORM Protein DME1098 XEOTICID XEO04400 MOACRIVE Inhibition DME1098 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1098 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04401 XEO_CLAS Peptide DME1098 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.6 ug/ml) DME1098 XEOTICID XEO04401 GENEFORM Protein DME1098 XEOTICID XEO04401 MOACRIVE Inhibition DME1098 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1098 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04402 XEO_CLAS Peptide DME1098 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 ug/ml) DME1098 XEOTICID XEO04402 GENEFORM Protein DME1098 XEOTICID XEO04402 MOACRIVE Inhibition DME1098 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1098 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04403 XEO_CLAS Peptide DME1098 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.6 ug/ml) DME1098 XEOTICID XEO04403 GENEFORM Protein DME1098 XEOTICID XEO04403 MOACRIVE Inhibition DME1098 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1098 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04404 XEO_CLAS Peptide DME1098 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.6 ug/ml) DME1098 XEOTICID XEO04404 GENEFORM Protein DME1098 XEOTICID XEO04404 MOACRIVE Inhibition DME1098 XEOTICID XEO04410 XEO_NAME Insect osmin DME1098 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04410 XEO_CLAS Peptide DME1098 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.125-1.56 microM) DME1098 XEOTICID XEO04410 GENEFORM Protein DME1098 XEOTICID XEO04410 MOACRIVE Inhibition DME1098 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1098 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04412 XEO_CLAS Peptide DME1098 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04412 GENEFORM Protein DME1098 XEOTICID XEO04412 MOACRIVE Inhibition DME1098 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1098 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04414 XEO_CLAS Peptide DME1098 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04414 GENEFORM Protein DME1098 XEOTICID XEO04414 MOACRIVE Inhibition DME1098 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1098 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04415 XEO_CLAS Peptide DME1098 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04415 GENEFORM Protein DME1098 XEOTICID XEO04415 MOACRIVE Inhibition DME1098 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1098 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04421 XEO_CLAS Peptide DME1098 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 microM) DME1098 XEOTICID XEO04421 GENEFORM Protein DME1098 XEOTICID XEO04421 MOACRIVE Inhibition DME1098 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1098 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04426 XEO_CLAS Peptide DME1098 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO04426 GENEFORM Protein DME1098 XEOTICID XEO04426 MOACRIVE Inhibition DME1098 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1098 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04428 XEO_CLAS Peptide DME1098 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.3 ug/ml) DME1098 XEOTICID XEO04428 GENEFORM Protein DME1098 XEOTICID XEO04428 MOACRIVE Inhibition DME1098 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1098 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04430 XEO_CLAS Peptide DME1098 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25 microM) DME1098 XEOTICID XEO04430 GENEFORM Protein DME1098 XEOTICID XEO04430 MOACRIVE Inhibition DME1098 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1098 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04433 XEO_CLAS Peptide DME1098 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 160 microM) DME1098 XEOTICID XEO04433 GENEFORM Protein DME1098 XEOTICID XEO04433 MOACRIVE Inhibition DME1098 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1098 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04435 XEO_CLAS Peptide DME1098 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 160 microM) DME1098 XEOTICID XEO04435 GENEFORM Protein DME1098 XEOTICID XEO04435 MOACRIVE Inhibition DME1098 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1098 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1098 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04438 GENEFORM Protein DME1098 XEOTICID XEO04438 MOACRIVE Inhibition DME1098 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1098 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04439 XEO_CLAS Peptide DME1098 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04439 GENEFORM Protein DME1098 XEOTICID XEO04439 MOACRIVE Inhibition DME1098 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1098 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04440 XEO_CLAS Peptide DME1098 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 microM) DME1098 XEOTICID XEO04440 GENEFORM Protein DME1098 XEOTICID XEO04440 MOACRIVE Inhibition DME1098 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1098 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04441 XEO_CLAS Peptide DME1098 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 28 microM) DME1098 XEOTICID XEO04441 GENEFORM Protein DME1098 XEOTICID XEO04441 MOACRIVE Inhibition DME1098 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1098 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04442 XEO_CLAS Peptide DME1098 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 28 microM) DME1098 XEOTICID XEO04442 GENEFORM Protein DME1098 XEOTICID XEO04442 MOACRIVE Inhibition DME1098 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1098 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04443 XEO_CLAS Peptide DME1098 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04443 GENEFORM Protein DME1098 XEOTICID XEO04443 MOACRIVE Inhibition DME1098 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1098 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04444 XEO_CLAS Peptide DME1098 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 13 microM) DME1098 XEOTICID XEO04444 GENEFORM Protein DME1098 XEOTICID XEO04444 MOACRIVE Inhibition DME1098 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1098 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04445 XEO_CLAS Peptide DME1098 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04445 GENEFORM Protein DME1098 XEOTICID XEO04445 MOACRIVE Inhibition DME1098 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1098 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04446 XEO_CLAS Peptide DME1098 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 78 microM) DME1098 XEOTICID XEO04446 GENEFORM Protein DME1098 XEOTICID XEO04446 MOACRIVE Inhibition DME1098 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1098 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04447 XEO_CLAS Peptide DME1098 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 120 microM) DME1098 XEOTICID XEO04447 GENEFORM Protein DME1098 XEOTICID XEO04447 MOACRIVE Inhibition DME1098 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1098 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04448 XEO_CLAS Peptide DME1098 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 microM) DME1098 XEOTICID XEO04448 GENEFORM Protein DME1098 XEOTICID XEO04448 MOACRIVE Inhibition DME1098 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1098 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04449 XEO_CLAS Peptide DME1098 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.3 microM) DME1098 XEOTICID XEO04449 GENEFORM Protein DME1098 XEOTICID XEO04449 MOACRIVE Inhibition DME1098 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1098 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04450 XEO_CLAS Peptide DME1098 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.3 microM) DME1098 XEOTICID XEO04450 GENEFORM Protein DME1098 XEOTICID XEO04450 MOACRIVE Inhibition DME1098 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1098 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04451 XEO_CLAS Peptide DME1098 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO04451 GENEFORM Protein DME1098 XEOTICID XEO04451 MOACRIVE Inhibition DME1098 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1098 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04452 XEO_CLAS Peptide DME1098 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.1 microM) DME1098 XEOTICID XEO04452 GENEFORM Protein DME1098 XEOTICID XEO04452 MOACRIVE Inhibition DME1098 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1098 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04453 XEO_CLAS Peptide DME1098 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO04453 GENEFORM Protein DME1098 XEOTICID XEO04453 MOACRIVE Inhibition DME1098 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1098 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04455 XEO_CLAS Peptide DME1098 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 microM) DME1098 XEOTICID XEO04455 GENEFORM Protein DME1098 XEOTICID XEO04455 MOACRIVE Inhibition DME1098 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1098 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04457 XEO_CLAS Peptide DME1098 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.3 microM) DME1098 XEOTICID XEO04457 GENEFORM Protein DME1098 XEOTICID XEO04457 MOACRIVE Inhibition DME1098 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1098 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04458 XEO_CLAS Peptide DME1098 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1 microM) DME1098 XEOTICID XEO04458 GENEFORM Protein DME1098 XEOTICID XEO04458 MOACRIVE Inhibition DME1098 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1098 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04459 XEO_CLAS Peptide DME1098 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1 microM) DME1098 XEOTICID XEO04459 GENEFORM Protein DME1098 XEOTICID XEO04459 MOACRIVE Inhibition DME1098 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1098 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04461 XEO_CLAS Peptide DME1098 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20.8 microM) DME1098 XEOTICID XEO04461 GENEFORM Protein DME1098 XEOTICID XEO04461 MOACRIVE Inhibition DME1098 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1098 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04462 XEO_CLAS Peptide DME1098 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 19.1 microM) DME1098 XEOTICID XEO04462 GENEFORM Protein DME1098 XEOTICID XEO04462 MOACRIVE Inhibition DME1098 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1098 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04463 XEO_CLAS Peptide DME1098 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04463 GENEFORM Protein DME1098 XEOTICID XEO04463 MOACRIVE Inhibition DME1098 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1098 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04464 XEO_CLAS Peptide DME1098 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.5 microM) DME1098 XEOTICID XEO04464 GENEFORM Protein DME1098 XEOTICID XEO04464 MOACRIVE Inhibition DME1098 XEOTICID XEO04466 XEO_NAME Panusin DME1098 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04466 XEO_CLAS Peptide DME1098 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04466 GENEFORM Protein DME1098 XEOTICID XEO04466 MOACRIVE Inhibition DME1098 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1098 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04467 XEO_CLAS Peptide DME1098 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4.8 microM) DME1098 XEOTICID XEO04467 GENEFORM Protein DME1098 XEOTICID XEO04467 MOACRIVE Inhibition DME1098 XEOTICID XEO04468 XEO_NAME Papillosin DME1098 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04468 XEO_CLAS Peptide DME1098 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04468 GENEFORM Protein DME1098 XEOTICID XEO04468 MOACRIVE Inhibition DME1098 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1098 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04471 XEO_CLAS Peptide DME1098 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.1 microM) DME1098 XEOTICID XEO04471 GENEFORM Protein DME1098 XEOTICID XEO04471 MOACRIVE Inhibition DME1098 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1098 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04480 XEO_CLAS Peptide DME1098 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 ug/ml) DME1098 XEOTICID XEO04480 GENEFORM Protein DME1098 XEOTICID XEO04480 MOACRIVE Inhibition DME1098 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1098 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1098 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04482 GENEFORM Protein DME1098 XEOTICID XEO04482 MOACRIVE Inhibition DME1098 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1098 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04484 XEO_CLAS Peptide DME1098 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 microM) DME1098 XEOTICID XEO04484 GENEFORM Protein DME1098 XEOTICID XEO04484 MOACRIVE Inhibition DME1098 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1098 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04485 XEO_CLAS Peptide DME1098 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO04485 GENEFORM Protein DME1098 XEOTICID XEO04485 MOACRIVE Inhibition DME1098 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1098 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04486 XEO_CLAS Peptide DME1098 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 microM) DME1098 XEOTICID XEO04486 GENEFORM Protein DME1098 XEOTICID XEO04486 MOACRIVE Inhibition DME1098 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1098 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04487 XEO_CLAS Peptide DME1098 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO04487 GENEFORM Protein DME1098 XEOTICID XEO04487 MOACRIVE Inhibition DME1098 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1098 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04488 XEO_CLAS Peptide DME1098 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 9 microM) DME1098 XEOTICID XEO04488 GENEFORM Protein DME1098 XEOTICID XEO04488 MOACRIVE Inhibition DME1098 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1098 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04489 XEO_CLAS Peptide DME1098 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 13 microM) DME1098 XEOTICID XEO04489 GENEFORM Protein DME1098 XEOTICID XEO04489 MOACRIVE Inhibition DME1098 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1098 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04490 XEO_CLAS Peptide DME1098 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 47.5 microM) DME1098 XEOTICID XEO04490 GENEFORM Protein DME1098 XEOTICID XEO04490 MOACRIVE Inhibition DME1098 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1098 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04491 XEO_CLAS Peptide DME1098 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO04491 GENEFORM Protein DME1098 XEOTICID XEO04491 MOACRIVE Inhibition DME1098 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1098 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04492 XEO_CLAS Peptide DME1098 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 35 microM) DME1098 XEOTICID XEO04492 GENEFORM Protein DME1098 XEOTICID XEO04492 MOACRIVE Inhibition DME1098 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1098 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04493 XEO_CLAS Peptide DME1098 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 microM) DME1098 XEOTICID XEO04493 GENEFORM Protein DME1098 XEOTICID XEO04493 MOACRIVE Inhibition DME1098 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1098 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04494 XEO_CLAS Peptide DME1098 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO04494 GENEFORM Protein DME1098 XEOTICID XEO04494 MOACRIVE Inhibition DME1098 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1098 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04495 XEO_CLAS Peptide DME1098 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO04495 GENEFORM Protein DME1098 XEOTICID XEO04495 MOACRIVE Inhibition DME1098 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1098 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04496 XEO_CLAS Peptide DME1098 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 67.5 microM) DME1098 XEOTICID XEO04496 GENEFORM Protein DME1098 XEOTICID XEO04496 MOACRIVE Inhibition DME1098 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1098 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04497 XEO_CLAS Peptide DME1098 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO04497 GENEFORM Protein DME1098 XEOTICID XEO04497 MOACRIVE Inhibition DME1098 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1098 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04498 XEO_CLAS Peptide DME1098 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO04498 GENEFORM Protein DME1098 XEOTICID XEO04498 MOACRIVE Inhibition DME1098 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1098 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04499 XEO_CLAS Peptide DME1098 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 43 microM) DME1098 XEOTICID XEO04499 GENEFORM Protein DME1098 XEOTICID XEO04499 MOACRIVE Inhibition DME1098 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1098 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04500 XEO_CLAS Peptide DME1098 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO04500 GENEFORM Protein DME1098 XEOTICID XEO04500 MOACRIVE Inhibition DME1098 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1098 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04504 XEO_CLAS Peptide DME1098 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04504 GENEFORM Protein DME1098 XEOTICID XEO04504 MOACRIVE Inhibition DME1098 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1098 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04505 XEO_CLAS Peptide DME1098 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04505 GENEFORM Protein DME1098 XEOTICID XEO04505 MOACRIVE Inhibition DME1098 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1098 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04506 XEO_CLAS Peptide DME1098 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 40 microM) DME1098 XEOTICID XEO04506 GENEFORM Protein DME1098 XEOTICID XEO04506 MOACRIVE Inhibition DME1098 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1098 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04507 XEO_CLAS Peptide DME1098 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10-20 microM) DME1098 XEOTICID XEO04507 GENEFORM Protein DME1098 XEOTICID XEO04507 MOACRIVE Inhibition DME1098 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1098 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04508 XEO_CLAS Peptide DME1098 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04508 GENEFORM Protein DME1098 XEOTICID XEO04508 MOACRIVE Inhibition DME1098 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1098 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04509 XEO_CLAS Peptide DME1098 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04509 GENEFORM Protein DME1098 XEOTICID XEO04509 MOACRIVE Inhibition DME1098 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1098 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04510 XEO_CLAS Peptide DME1098 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 22-33 microM) DME1098 XEOTICID XEO04510 GENEFORM Protein DME1098 XEOTICID XEO04510 MOACRIVE Inhibition DME1098 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1098 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04525 XEO_CLAS Peptide DME1098 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 32.0 microM) DME1098 XEOTICID XEO04525 GENEFORM Protein DME1098 XEOTICID XEO04525 MOACRIVE Inhibition DME1098 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1098 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04526 XEO_CLAS Peptide DME1098 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.0 microM) DME1098 XEOTICID XEO04526 GENEFORM Protein DME1098 XEOTICID XEO04526 MOACRIVE Inhibition DME1098 XEOTICID XEO04527 XEO_NAME Pepcon DME1098 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04527 XEO_CLAS Peptide DME1098 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO04527 GENEFORM Protein DME1098 XEOTICID XEO04527 MOACRIVE Inhibition DME1098 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1098 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04532 XEO_CLAS Peptide DME1098 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04532 GENEFORM Protein DME1098 XEOTICID XEO04532 MOACRIVE Inhibition DME1098 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1098 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04540 XEO_CLAS Peptide DME1098 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 18.1 ug/ml) DME1098 XEOTICID XEO04540 GENEFORM Protein DME1098 XEOTICID XEO04540 MOACRIVE Inhibition DME1098 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1098 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04541 XEO_CLAS Peptide DME1098 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.5 ug/ml) DME1098 XEOTICID XEO04541 GENEFORM Protein DME1098 XEOTICID XEO04541 MOACRIVE Inhibition DME1098 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1098 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04542 XEO_CLAS Peptide DME1098 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04542 GENEFORM Protein DME1098 XEOTICID XEO04542 MOACRIVE Inhibition DME1098 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1098 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04543 XEO_CLAS Peptide DME1098 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04543 GENEFORM Protein DME1098 XEOTICID XEO04543 MOACRIVE Inhibition DME1098 XEOTICID XEO04546 XEO_NAME Perinerin DME1098 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04546 XEO_CLAS Peptide DME1098 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04546 GENEFORM Protein DME1098 XEOTICID XEO04546 MOACRIVE Inhibition DME1098 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1098 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04548 XEO_CLAS Peptide DME1098 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 72000 ug/ml) DME1098 XEOTICID XEO04548 GENEFORM Protein DME1098 XEOTICID XEO04548 MOACRIVE Inhibition DME1098 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1098 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04549 XEO_CLAS Peptide DME1098 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 62-125 ug/ml) DME1098 XEOTICID XEO04549 GENEFORM Protein DME1098 XEOTICID XEO04549 MOACRIVE Inhibition DME1098 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1098 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04550 XEO_CLAS Peptide DME1098 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO04550 GENEFORM Protein DME1098 XEOTICID XEO04550 MOACRIVE Inhibition DME1098 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1098 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04551 XEO_CLAS Peptide DME1098 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 23.6 ug/ml) DME1098 XEOTICID XEO04551 GENEFORM Protein DME1098 XEOTICID XEO04551 MOACRIVE Inhibition DME1098 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1098 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04552 XEO_CLAS Peptide DME1098 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04552 GENEFORM Protein DME1098 XEOTICID XEO04552 MOACRIVE Inhibition DME1098 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1098 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04553 XEO_CLAS Peptide DME1098 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04553 GENEFORM Protein DME1098 XEOTICID XEO04553 MOACRIVE Inhibition DME1098 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1098 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04554 XEO_CLAS Peptide DME1098 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04554 GENEFORM Protein DME1098 XEOTICID XEO04554 MOACRIVE Inhibition DME1098 XEOTICID XEO04563 XEO_NAME Phosphate DME1098 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1098 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04563 GENEFORM Protein DME1098 XEOTICID XEO04563 MOACRIVE Inhibition DME1098 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1098 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04565 XEO_CLAS Peptide DME1098 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.5 microM) DME1098 XEOTICID XEO04565 GENEFORM Protein DME1098 XEOTICID XEO04565 MOACRIVE Inhibition DME1098 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1098 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04566 XEO_CLAS Peptide DME1098 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.7 microM) DME1098 XEOTICID XEO04566 GENEFORM Protein DME1098 XEOTICID XEO04566 MOACRIVE Inhibition DME1098 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1098 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04569 XEO_CLAS Peptide DME1098 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 7.9 microM) DME1098 XEOTICID XEO04569 GENEFORM Protein DME1098 XEOTICID XEO04569 MOACRIVE Inhibition DME1098 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1098 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04570 XEO_CLAS Peptide DME1098 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04570 GENEFORM Protein DME1098 XEOTICID XEO04570 MOACRIVE Inhibition DME1098 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1098 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04571 XEO_CLAS Peptide DME1098 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04571 GENEFORM Protein DME1098 XEOTICID XEO04571 MOACRIVE Inhibition DME1098 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1098 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04572 XEO_CLAS Peptide DME1098 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04572 GENEFORM Protein DME1098 XEOTICID XEO04572 MOACRIVE Inhibition DME1098 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1098 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04573 XEO_CLAS Peptide DME1098 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 microM) DME1098 XEOTICID XEO04573 GENEFORM Protein DME1098 XEOTICID XEO04573 MOACRIVE Inhibition DME1098 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1098 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04574 XEO_CLAS Peptide DME1098 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 128 ug/ml) DME1098 XEOTICID XEO04574 GENEFORM Protein DME1098 XEOTICID XEO04574 MOACRIVE Inhibition DME1098 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1098 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04575 XEO_CLAS Peptide DME1098 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO04575 GENEFORM Protein DME1098 XEOTICID XEO04575 MOACRIVE Inhibition DME1098 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1098 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04578 GENEFORM Protein DME1098 XEOTICID XEO04578 MOACRIVE Inhibition DME1098 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1098 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04579 GENEFORM Protein DME1098 XEOTICID XEO04579 MOACRIVE Inhibition DME1098 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1098 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04580 GENEFORM Protein DME1098 XEOTICID XEO04580 MOACRIVE Inhibition DME1098 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1098 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04583 GENEFORM Protein DME1098 XEOTICID XEO04583 MOACRIVE Inhibition DME1098 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1098 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04588 GENEFORM Protein DME1098 XEOTICID XEO04588 MOACRIVE Inhibition DME1098 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1098 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04589 GENEFORM Protein DME1098 XEOTICID XEO04589 MOACRIVE Inhibition DME1098 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1098 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04590 GENEFORM Protein DME1098 XEOTICID XEO04590 MOACRIVE Inhibition DME1098 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1098 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04591 GENEFORM Protein DME1098 XEOTICID XEO04591 MOACRIVE Inhibition DME1098 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1098 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04592 GENEFORM Protein DME1098 XEOTICID XEO04592 MOACRIVE Inhibition DME1098 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1098 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04593 GENEFORM Protein DME1098 XEOTICID XEO04593 MOACRIVE Inhibition DME1098 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1098 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04594 GENEFORM Protein DME1098 XEOTICID XEO04594 MOACRIVE Inhibition DME1098 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1098 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04595 GENEFORM Protein DME1098 XEOTICID XEO04595 MOACRIVE Inhibition DME1098 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1098 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04596 GENEFORM Protein DME1098 XEOTICID XEO04596 MOACRIVE Inhibition DME1098 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1098 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04597 GENEFORM Protein DME1098 XEOTICID XEO04597 MOACRIVE Inhibition DME1098 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1098 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04598 GENEFORM Protein DME1098 XEOTICID XEO04598 MOACRIVE Inhibition DME1098 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1098 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04599 GENEFORM Protein DME1098 XEOTICID XEO04599 MOACRIVE Inhibition DME1098 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1098 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04601 XEO_CLAS Peptide DME1098 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 18.75 ug/ml) DME1098 XEOTICID XEO04601 GENEFORM Protein DME1098 XEOTICID XEO04601 MOACRIVE Inhibition DME1098 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1098 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04602 XEO_CLAS Peptide DME1098 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 37.5 ug/ml) DME1098 XEOTICID XEO04602 GENEFORM Protein DME1098 XEOTICID XEO04602 MOACRIVE Inhibition DME1098 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1098 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04604 XEO_CLAS Peptide DME1098 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC < 25 microM) DME1098 XEOTICID XEO04604 GENEFORM Protein DME1098 XEOTICID XEO04604 MOACRIVE Inhibition DME1098 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1098 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04605 XEO_CLAS Peptide DME1098 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC < 6.25 microM) DME1098 XEOTICID XEO04605 GENEFORM Protein DME1098 XEOTICID XEO04605 MOACRIVE Inhibition DME1098 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1098 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04606 XEO_CLAS Peptide DME1098 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO04606 GENEFORM Protein DME1098 XEOTICID XEO04606 MOACRIVE Inhibition DME1098 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1098 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1098 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04607 GENEFORM Protein DME1098 XEOTICID XEO04607 MOACRIVE Inhibition DME1098 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1098 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04612 XEO_CLAS Peptide DME1098 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5-10 microM) DME1098 XEOTICID XEO04612 GENEFORM Protein DME1098 XEOTICID XEO04612 MOACRIVE Inhibition DME1098 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1098 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04613 XEO_CLAS Peptide DME1098 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5-10 microM) DME1098 XEOTICID XEO04613 GENEFORM Protein DME1098 XEOTICID XEO04613 MOACRIVE Inhibition DME1098 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1098 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04625 XEO_CLAS Peptide DME1098 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO04625 GENEFORM Protein DME1098 XEOTICID XEO04625 MOACRIVE Inhibition DME1098 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1098 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04626 XEO_CLAS Peptide DME1098 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO04626 GENEFORM Protein DME1098 XEOTICID XEO04626 MOACRIVE Inhibition DME1098 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1098 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04627 XEO_CLAS Peptide DME1098 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.5 microM) DME1098 XEOTICID XEO04627 GENEFORM Protein DME1098 XEOTICID XEO04627 MOACRIVE Inhibition DME1098 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1098 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04630 XEO_CLAS Peptide DME1098 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 60 ug/ml) DME1098 XEOTICID XEO04630 GENEFORM Protein DME1098 XEOTICID XEO04630 MOACRIVE Inhibition DME1098 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1098 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04631 XEO_CLAS Peptide DME1098 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 60 ug/ml) DME1098 XEOTICID XEO04631 GENEFORM Protein DME1098 XEOTICID XEO04631 MOACRIVE Inhibition DME1098 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1098 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04633 XEO_CLAS Peptide DME1098 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 ug/ml) DME1098 XEOTICID XEO04633 GENEFORM Protein DME1098 XEOTICID XEO04633 MOACRIVE Inhibition DME1098 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1098 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04634 XEO_CLAS Peptide DME1098 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 ug/ml) DME1098 XEOTICID XEO04634 GENEFORM Protein DME1098 XEOTICID XEO04634 MOACRIVE Inhibition DME1098 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1098 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04635 XEO_CLAS Peptide DME1098 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 ug/ml) DME1098 XEOTICID XEO04635 GENEFORM Protein DME1098 XEOTICID XEO04635 MOACRIVE Inhibition DME1098 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1098 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04636 XEO_CLAS Peptide DME1098 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 ug/ml) DME1098 XEOTICID XEO04636 GENEFORM Protein DME1098 XEOTICID XEO04636 MOACRIVE Inhibition DME1098 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1098 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04637 XEO_CLAS Peptide DME1098 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 ug/ml) DME1098 XEOTICID XEO04637 GENEFORM Protein DME1098 XEOTICID XEO04637 MOACRIVE Inhibition DME1098 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1098 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04638 XEO_CLAS Peptide DME1098 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 ug/ml) DME1098 XEOTICID XEO04638 GENEFORM Protein DME1098 XEOTICID XEO04638 MOACRIVE Inhibition DME1098 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1098 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04639 XEO_CLAS Peptide DME1098 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 ug/ml) DME1098 XEOTICID XEO04639 GENEFORM Protein DME1098 XEOTICID XEO04639 MOACRIVE Inhibition DME1098 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1098 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04640 XEO_CLAS Peptide DME1098 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.2-3.3 microM) DME1098 XEOTICID XEO04640 GENEFORM Protein DME1098 XEOTICID XEO04640 MOACRIVE Inhibition DME1098 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1098 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04642 XEO_CLAS Peptide DME1098 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 ug/ml) DME1098 XEOTICID XEO04642 GENEFORM Protein DME1098 XEOTICID XEO04642 MOACRIVE Inhibition DME1098 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1098 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04643 XEO_CLAS Peptide DME1098 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO04643 GENEFORM Protein DME1098 XEOTICID XEO04643 MOACRIVE Inhibition DME1098 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1098 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04644 XEO_CLAS Peptide DME1098 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO04644 GENEFORM Protein DME1098 XEOTICID XEO04644 MOACRIVE Inhibition DME1098 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1098 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04645 XEO_CLAS Peptide DME1098 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 ug/ml) DME1098 XEOTICID XEO04645 GENEFORM Protein DME1098 XEOTICID XEO04645 MOACRIVE Inhibition DME1098 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1098 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04646 XEO_CLAS Peptide DME1098 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1 ug/ml) DME1098 XEOTICID XEO04646 GENEFORM Protein DME1098 XEOTICID XEO04646 MOACRIVE Inhibition DME1098 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1098 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04647 XEO_CLAS Peptide DME1098 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO04647 GENEFORM Protein DME1098 XEOTICID XEO04647 MOACRIVE Inhibition DME1098 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1098 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04648 XEO_CLAS Peptide DME1098 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 ug/ml) DME1098 XEOTICID XEO04648 GENEFORM Protein DME1098 XEOTICID XEO04648 MOACRIVE Inhibition DME1098 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1098 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04649 XEO_CLAS Peptide DME1098 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 64 ug/ml) DME1098 XEOTICID XEO04649 GENEFORM Protein DME1098 XEOTICID XEO04649 MOACRIVE Inhibition DME1098 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1098 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04650 XEO_CLAS Peptide DME1098 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 ug/ml) DME1098 XEOTICID XEO04650 GENEFORM Protein DME1098 XEOTICID XEO04650 MOACRIVE Inhibition DME1098 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1098 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04651 XEO_CLAS Peptide DME1098 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 ug/ml) DME1098 XEOTICID XEO04651 GENEFORM Protein DME1098 XEOTICID XEO04651 MOACRIVE Inhibition DME1098 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1098 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04652 XEO_CLAS Peptide DME1098 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO04652 GENEFORM Protein DME1098 XEOTICID XEO04652 MOACRIVE Inhibition DME1098 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1098 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04653 XEO_CLAS Peptide DME1098 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 64 ug/ml) DME1098 XEOTICID XEO04653 GENEFORM Protein DME1098 XEOTICID XEO04653 MOACRIVE Inhibition DME1098 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1098 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04654 XEO_CLAS Peptide DME1098 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 ug/ml) DME1098 XEOTICID XEO04654 GENEFORM Protein DME1098 XEOTICID XEO04654 MOACRIVE Inhibition DME1098 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1098 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04655 XEO_CLAS Peptide DME1098 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO04655 GENEFORM Protein DME1098 XEOTICID XEO04655 MOACRIVE Inhibition DME1098 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1098 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04657 XEO_CLAS Peptide DME1098 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 300 microM) DME1098 XEOTICID XEO04657 GENEFORM Protein DME1098 XEOTICID XEO04657 MOACRIVE Inhibition DME1098 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1098 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04660 XEO_CLAS Peptide DME1098 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO04660 GENEFORM Protein DME1098 XEOTICID XEO04660 MOACRIVE Inhibition DME1098 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1098 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04661 XEO_CLAS Peptide DME1098 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 microM) DME1098 XEOTICID XEO04661 GENEFORM Protein DME1098 XEOTICID XEO04661 MOACRIVE Inhibition DME1098 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1098 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04662 XEO_CLAS Peptide DME1098 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 microM) DME1098 XEOTICID XEO04662 GENEFORM Protein DME1098 XEOTICID XEO04662 MOACRIVE Inhibition DME1098 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1098 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04663 XEO_CLAS Peptide DME1098 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 microM) DME1098 XEOTICID XEO04663 GENEFORM Protein DME1098 XEOTICID XEO04663 MOACRIVE Inhibition DME1098 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1098 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04664 XEO_CLAS Peptide DME1098 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5.5 microM) DME1098 XEOTICID XEO04664 GENEFORM Protein DME1098 XEOTICID XEO04664 MOACRIVE Inhibition DME1098 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1098 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04665 XEO_CLAS Peptide DME1098 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 microM) DME1098 XEOTICID XEO04665 GENEFORM Protein DME1098 XEOTICID XEO04665 MOACRIVE Inhibition DME1098 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1098 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04666 XEO_CLAS Peptide DME1098 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO04666 GENEFORM Protein DME1098 XEOTICID XEO04666 MOACRIVE Inhibition DME1098 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1098 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04667 XEO_CLAS Peptide DME1098 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6.25 microM) DME1098 XEOTICID XEO04667 GENEFORM Protein DME1098 XEOTICID XEO04667 MOACRIVE Inhibition DME1098 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1098 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04668 XEO_CLAS Peptide DME1098 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 microM) DME1098 XEOTICID XEO04668 GENEFORM Protein DME1098 XEOTICID XEO04668 MOACRIVE Inhibition DME1098 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1098 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04669 XEO_CLAS Peptide DME1098 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO04669 GENEFORM Protein DME1098 XEOTICID XEO04669 MOACRIVE Inhibition DME1098 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1098 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04670 XEO_CLAS Peptide DME1098 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 21 microM) DME1098 XEOTICID XEO04670 GENEFORM Protein DME1098 XEOTICID XEO04670 MOACRIVE Inhibition DME1098 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1098 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04671 XEO_CLAS Peptide DME1098 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 62 microM) DME1098 XEOTICID XEO04671 GENEFORM Protein DME1098 XEOTICID XEO04671 MOACRIVE Inhibition DME1098 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1098 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04672 XEO_CLAS Peptide DME1098 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO04672 GENEFORM Protein DME1098 XEOTICID XEO04672 MOACRIVE Inhibition DME1098 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1098 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04673 XEO_CLAS Peptide DME1098 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO04673 GENEFORM Protein DME1098 XEOTICID XEO04673 MOACRIVE Inhibition DME1098 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1098 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04674 XEO_CLAS Peptide DME1098 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 75 microM) DME1098 XEOTICID XEO04674 GENEFORM Protein DME1098 XEOTICID XEO04674 MOACRIVE Inhibition DME1098 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1098 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04675 XEO_CLAS Peptide DME1098 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 microM) DME1098 XEOTICID XEO04675 GENEFORM Protein DME1098 XEOTICID XEO04675 MOACRIVE Inhibition DME1098 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1098 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04676 XEO_CLAS Peptide DME1098 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 microM) DME1098 XEOTICID XEO04676 GENEFORM Protein DME1098 XEOTICID XEO04676 MOACRIVE Inhibition DME1098 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1098 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04677 XEO_CLAS Peptide DME1098 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO04677 GENEFORM Protein DME1098 XEOTICID XEO04677 MOACRIVE Inhibition DME1098 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1098 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04680 XEO_CLAS Peptide DME1098 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 microM) DME1098 XEOTICID XEO04680 GENEFORM Protein DME1098 XEOTICID XEO04680 MOACRIVE Inhibition DME1098 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1098 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04682 XEO_CLAS Peptide DME1098 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 microM) DME1098 XEOTICID XEO04682 GENEFORM Protein DME1098 XEOTICID XEO04682 MOACRIVE Inhibition DME1098 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1098 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04683 XEO_CLAS Peptide DME1098 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 microM) DME1098 XEOTICID XEO04683 GENEFORM Protein DME1098 XEOTICID XEO04683 MOACRIVE Inhibition DME1098 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1098 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04684 XEO_CLAS Peptide DME1098 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 38 microM) DME1098 XEOTICID XEO04684 GENEFORM Protein DME1098 XEOTICID XEO04684 MOACRIVE Inhibition DME1098 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1098 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04690 XEO_CLAS Peptide DME1098 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.5 ug/ml) DME1098 XEOTICID XEO04690 GENEFORM Protein DME1098 XEOTICID XEO04690 MOACRIVE Inhibition DME1098 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1098 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04695 XEO_CLAS Peptide DME1098 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04695 GENEFORM Protein DME1098 XEOTICID XEO04695 MOACRIVE Inhibition DME1098 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1098 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04696 XEO_CLAS Peptide DME1098 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04696 GENEFORM Protein DME1098 XEOTICID XEO04696 MOACRIVE Inhibition DME1098 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1098 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04712 XEO_CLAS Peptide DME1098 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16.7 microM) DME1098 XEOTICID XEO04712 GENEFORM Protein DME1098 XEOTICID XEO04712 MOACRIVE Inhibition DME1098 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1098 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04713 XEO_CLAS Peptide DME1098 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16.7 microM) DME1098 XEOTICID XEO04713 GENEFORM Protein DME1098 XEOTICID XEO04713 MOACRIVE Inhibition DME1098 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1098 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04714 XEO_CLAS Peptide DME1098 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 23.3 microM) DME1098 XEOTICID XEO04714 GENEFORM Protein DME1098 XEOTICID XEO04714 MOACRIVE Inhibition DME1098 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1098 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04716 XEO_CLAS Peptide DME1098 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 microM) DME1098 XEOTICID XEO04716 GENEFORM Protein DME1098 XEOTICID XEO04716 MOACRIVE Inhibition DME1098 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1098 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04717 XEO_CLAS Peptide DME1098 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 50 microM) DME1098 XEOTICID XEO04717 GENEFORM Protein DME1098 XEOTICID XEO04717 MOACRIVE Inhibition DME1098 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1098 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04725 XEO_CLAS Peptide DME1098 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04725 GENEFORM Protein DME1098 XEOTICID XEO04725 MOACRIVE Inhibition DME1098 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1098 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04726 XEO_CLAS Peptide DME1098 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04726 GENEFORM Protein DME1098 XEOTICID XEO04726 MOACRIVE Inhibition DME1098 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1098 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04731 XEO_CLAS Peptide DME1098 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 ug/ml) DME1098 XEOTICID XEO04731 GENEFORM Protein DME1098 XEOTICID XEO04731 MOACRIVE Inhibition DME1098 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1098 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04732 XEO_CLAS Peptide DME1098 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 25 ug/ml) DME1098 XEOTICID XEO04732 GENEFORM Protein DME1098 XEOTICID XEO04732 MOACRIVE Inhibition DME1098 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1098 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04733 XEO_CLAS Peptide DME1098 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04733 GENEFORM Protein DME1098 XEOTICID XEO04733 MOACRIVE Inhibition DME1098 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1098 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04734 XEO_CLAS Peptide DME1098 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04734 GENEFORM Protein DME1098 XEOTICID XEO04734 MOACRIVE Inhibition DME1098 XEOTICID XEO04737 XEO_NAME Protonectin DME1098 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04737 XEO_CLAS Peptide DME1098 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 ug/ml) DME1098 XEOTICID XEO04737 GENEFORM Protein DME1098 XEOTICID XEO04737 MOACRIVE Inhibition DME1098 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1098 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04739 XEO_CLAS Peptide DME1098 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04739 GENEFORM Protein DME1098 XEOTICID XEO04739 MOACRIVE Inhibition DME1098 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1098 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04740 XEO_CLAS Peptide DME1098 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04740 GENEFORM Protein DME1098 XEOTICID XEO04740 MOACRIVE Inhibition DME1098 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1098 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04741 XEO_CLAS Peptide DME1098 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04741 GENEFORM Protein DME1098 XEOTICID XEO04741 MOACRIVE Inhibition DME1098 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1098 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04742 XEO_CLAS Peptide DME1098 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04742 GENEFORM Protein DME1098 XEOTICID XEO04742 MOACRIVE Inhibition DME1098 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1098 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04762 XEO_CLAS Peptide DME1098 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.8 microM) DME1098 XEOTICID XEO04762 GENEFORM Protein DME1098 XEOTICID XEO04762 MOACRIVE Inhibition DME1098 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1098 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04766 XEO_CLAS Peptide DME1098 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.1 microM) DME1098 XEOTICID XEO04766 GENEFORM Protein DME1098 XEOTICID XEO04766 MOACRIVE Inhibition DME1098 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1098 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04767 XEO_CLAS Peptide DME1098 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.1 ug/ml) DME1098 XEOTICID XEO04767 GENEFORM Protein DME1098 XEOTICID XEO04767 MOACRIVE Inhibition DME1098 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1098 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04779 XEO_CLAS Peptide DME1098 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04779 GENEFORM Protein DME1098 XEOTICID XEO04779 MOACRIVE Inhibition DME1098 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1098 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04780 XEO_CLAS Peptide DME1098 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04780 GENEFORM Protein DME1098 XEOTICID XEO04780 MOACRIVE Inhibition DME1098 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1098 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04781 XEO_CLAS Peptide DME1098 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04781 GENEFORM Protein DME1098 XEOTICID XEO04781 MOACRIVE Inhibition DME1098 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1098 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04782 XEO_CLAS Peptide DME1098 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 ug/ml) DME1098 XEOTICID XEO04782 GENEFORM Protein DME1098 XEOTICID XEO04782 MOACRIVE Inhibition DME1098 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1098 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04783 XEO_CLAS Peptide DME1098 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO04783 GENEFORM Protein DME1098 XEOTICID XEO04783 MOACRIVE Inhibition DME1098 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1098 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04784 XEO_CLAS Peptide DME1098 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO04784 GENEFORM Protein DME1098 XEOTICID XEO04784 MOACRIVE Inhibition DME1098 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1098 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04785 XEO_CLAS Peptide DME1098 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO04785 GENEFORM Protein DME1098 XEOTICID XEO04785 MOACRIVE Inhibition DME1098 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1098 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04786 XEO_CLAS Peptide DME1098 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 ug/ml) DME1098 XEOTICID XEO04786 GENEFORM Protein DME1098 XEOTICID XEO04786 MOACRIVE Inhibition DME1098 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1098 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04787 XEO_CLAS Peptide DME1098 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04787 GENEFORM Protein DME1098 XEOTICID XEO04787 MOACRIVE Inhibition DME1098 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1098 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04793 XEO_CLAS Peptide DME1098 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04793 GENEFORM Protein DME1098 XEOTICID XEO04793 MOACRIVE Inhibition DME1098 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1098 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04798 XEO_CLAS Peptide DME1098 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 microM) DME1098 XEOTICID XEO04798 GENEFORM Protein DME1098 XEOTICID XEO04798 MOACRIVE Inhibition DME1098 XEOTICID XEO04799 XEO_NAME Ranalexin DME1098 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04799 XEO_CLAS Peptide DME1098 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 32 ug/ml) DME1098 XEOTICID XEO04799 GENEFORM Protein DME1098 XEOTICID XEO04799 MOACRIVE Inhibition DME1098 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1098 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04800 XEO_CLAS Peptide DME1098 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 microM) DME1098 XEOTICID XEO04800 GENEFORM Protein DME1098 XEOTICID XEO04800 MOACRIVE Inhibition DME1098 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1098 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04801 XEO_CLAS Peptide DME1098 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 9 microM) DME1098 XEOTICID XEO04801 GENEFORM Protein DME1098 XEOTICID XEO04801 MOACRIVE Inhibition DME1098 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1098 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04802 XEO_CLAS Peptide DME1098 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12 microM) DME1098 XEOTICID XEO04802 GENEFORM Protein DME1098 XEOTICID XEO04802 MOACRIVE Inhibition DME1098 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1098 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04803 XEO_CLAS Peptide DME1098 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO04803 GENEFORM Protein DME1098 XEOTICID XEO04803 MOACRIVE Inhibition DME1098 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1098 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04804 XEO_CLAS Peptide DME1098 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO04804 GENEFORM Protein DME1098 XEOTICID XEO04804 MOACRIVE Inhibition DME1098 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1098 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04805 XEO_CLAS Peptide DME1098 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.5 microM) DME1098 XEOTICID XEO04805 GENEFORM Protein DME1098 XEOTICID XEO04805 MOACRIVE Inhibition DME1098 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1098 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04806 XEO_CLAS Peptide DME1098 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.5 microM) DME1098 XEOTICID XEO04806 GENEFORM Protein DME1098 XEOTICID XEO04806 MOACRIVE Inhibition DME1098 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1098 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04807 XEO_CLAS Peptide DME1098 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04807 GENEFORM Protein DME1098 XEOTICID XEO04807 MOACRIVE Inhibition DME1098 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1098 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04809 XEO_CLAS Peptide DME1098 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 microM) DME1098 XEOTICID XEO04809 GENEFORM Protein DME1098 XEOTICID XEO04809 MOACRIVE Inhibition DME1098 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1098 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04811 XEO_CLAS Peptide DME1098 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO04811 GENEFORM Protein DME1098 XEOTICID XEO04811 MOACRIVE Inhibition DME1098 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1098 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04812 XEO_CLAS Peptide DME1098 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO04812 GENEFORM Protein DME1098 XEOTICID XEO04812 MOACRIVE Inhibition DME1098 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1098 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04813 XEO_CLAS Peptide DME1098 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 microM) DME1098 XEOTICID XEO04813 GENEFORM Protein DME1098 XEOTICID XEO04813 MOACRIVE Inhibition DME1098 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1098 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04814 XEO_CLAS Peptide DME1098 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 19 microM) DME1098 XEOTICID XEO04814 GENEFORM Protein DME1098 XEOTICID XEO04814 MOACRIVE Inhibition DME1098 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1098 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04815 XEO_CLAS Peptide DME1098 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 microM) DME1098 XEOTICID XEO04815 GENEFORM Protein DME1098 XEOTICID XEO04815 MOACRIVE Inhibition DME1098 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1098 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04816 XEO_CLAS Peptide DME1098 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 microM) DME1098 XEOTICID XEO04816 GENEFORM Protein DME1098 XEOTICID XEO04816 MOACRIVE Inhibition DME1098 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1098 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04817 XEO_CLAS Peptide DME1098 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 13 microM) DME1098 XEOTICID XEO04817 GENEFORM Protein DME1098 XEOTICID XEO04817 MOACRIVE Inhibition DME1098 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1098 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04818 XEO_CLAS Peptide DME1098 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO04818 GENEFORM Protein DME1098 XEOTICID XEO04818 MOACRIVE Inhibition DME1098 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1098 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04819 XEO_CLAS Peptide DME1098 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO04819 GENEFORM Protein DME1098 XEOTICID XEO04819 MOACRIVE Inhibition DME1098 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1098 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04820 XEO_CLAS Peptide DME1098 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3 microM) DME1098 XEOTICID XEO04820 GENEFORM Protein DME1098 XEOTICID XEO04820 MOACRIVE Inhibition DME1098 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1098 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04821 XEO_CLAS Peptide DME1098 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 microM) DME1098 XEOTICID XEO04821 GENEFORM Protein DME1098 XEOTICID XEO04821 MOACRIVE Inhibition DME1098 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1098 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04822 XEO_CLAS Peptide DME1098 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO04822 GENEFORM Protein DME1098 XEOTICID XEO04822 MOACRIVE Inhibition DME1098 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1098 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04823 XEO_CLAS Peptide DME1098 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 23 microM) DME1098 XEOTICID XEO04823 GENEFORM Protein DME1098 XEOTICID XEO04823 MOACRIVE Inhibition DME1098 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1098 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04824 XEO_CLAS Peptide DME1098 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04824 GENEFORM Protein DME1098 XEOTICID XEO04824 MOACRIVE Inhibition DME1098 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1098 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04825 XEO_CLAS Peptide DME1098 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04825 GENEFORM Protein DME1098 XEOTICID XEO04825 MOACRIVE Inhibition DME1098 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1098 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04826 XEO_CLAS Peptide DME1098 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO04826 GENEFORM Protein DME1098 XEOTICID XEO04826 MOACRIVE Inhibition DME1098 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1098 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04827 XEO_CLAS Peptide DME1098 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO04827 GENEFORM Protein DME1098 XEOTICID XEO04827 MOACRIVE Inhibition DME1098 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1098 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04835 XEO_CLAS Peptide DME1098 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04835 GENEFORM Protein DME1098 XEOTICID XEO04835 MOACRIVE Inhibition DME1098 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1098 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04836 XEO_CLAS Peptide DME1098 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04836 GENEFORM Protein DME1098 XEOTICID XEO04836 MOACRIVE Inhibition DME1098 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1098 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04837 XEO_CLAS Peptide DME1098 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 microM) DME1098 XEOTICID XEO04837 GENEFORM Protein DME1098 XEOTICID XEO04837 MOACRIVE Inhibition DME1098 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1098 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04839 XEO_CLAS Peptide DME1098 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04839 GENEFORM Protein DME1098 XEOTICID XEO04839 MOACRIVE Inhibition DME1098 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1098 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04840 XEO_CLAS Peptide DME1098 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 35-20 microM) DME1098 XEOTICID XEO04840 GENEFORM Protein DME1098 XEOTICID XEO04840 MOACRIVE Inhibition DME1098 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1098 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04847 XEO_CLAS Peptide DME1098 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04847 GENEFORM Protein DME1098 XEOTICID XEO04847 MOACRIVE Inhibition DME1098 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1098 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04848 XEO_CLAS Peptide DME1098 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04848 GENEFORM Protein DME1098 XEOTICID XEO04848 MOACRIVE Inhibition DME1098 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1098 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04849 XEO_CLAS Peptide DME1098 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04849 GENEFORM Protein DME1098 XEOTICID XEO04849 MOACRIVE Inhibition DME1098 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1098 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04850 XEO_CLAS Peptide DME1098 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04850 GENEFORM Protein DME1098 XEOTICID XEO04850 MOACRIVE Inhibition DME1098 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1098 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04851 XEO_CLAS Peptide DME1098 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1 ug/ml) DME1098 XEOTICID XEO04851 GENEFORM Protein DME1098 XEOTICID XEO04851 MOACRIVE Inhibition DME1098 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1098 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04857 XEO_CLAS Peptide DME1098 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 microM) DME1098 XEOTICID XEO04857 GENEFORM Protein DME1098 XEOTICID XEO04857 MOACRIVE Inhibition DME1098 XEOTICID XEO04863 XEO_NAME RTD peptide DME1098 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04863 XEO_CLAS Peptide DME1098 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.0 microM) DME1098 XEOTICID XEO04863 GENEFORM Protein DME1098 XEOTICID XEO04863 MOACRIVE Inhibition DME1098 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1098 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04865 XEO_CLAS Peptide DME1098 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 ug/ml) DME1098 XEOTICID XEO04865 GENEFORM Protein DME1098 XEOTICID XEO04865 MOACRIVE Inhibition DME1098 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1098 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04866 XEO_CLAS Peptide DME1098 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12.5 ug/ml) DME1098 XEOTICID XEO04866 GENEFORM Protein DME1098 XEOTICID XEO04866 MOACRIVE Inhibition DME1098 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1098 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04868 XEO_CLAS Peptide DME1098 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25.00 ug/ml) DME1098 XEOTICID XEO04868 GENEFORM Protein DME1098 XEOTICID XEO04868 MOACRIVE Inhibition DME1098 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1098 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04869 XEO_CLAS Peptide DME1098 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25.00 ug/ml) DME1098 XEOTICID XEO04869 GENEFORM Protein DME1098 XEOTICID XEO04869 MOACRIVE Inhibition DME1098 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1098 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04870 XEO_CLAS Peptide DME1098 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25.00 ug/ml) DME1098 XEOTICID XEO04870 GENEFORM Protein DME1098 XEOTICID XEO04870 MOACRIVE Inhibition DME1098 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1098 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04877 XEO_CLAS Peptide DME1098 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04877 GENEFORM Protein DME1098 XEOTICID XEO04877 MOACRIVE Inhibition DME1098 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1098 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04880 XEO_CLAS Peptide DME1098 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.5 ug/ml) DME1098 XEOTICID XEO04880 GENEFORM Protein DME1098 XEOTICID XEO04880 MOACRIVE Inhibition DME1098 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1098 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04886 XEO_CLAS Peptide DME1098 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.6 ug/ml) DME1098 XEOTICID XEO04886 GENEFORM Protein DME1098 XEOTICID XEO04886 MOACRIVE Inhibition DME1098 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1098 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04891 XEO_CLAS Peptide DME1098 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04891 GENEFORM Protein DME1098 XEOTICID XEO04891 MOACRIVE Inhibition DME1098 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1098 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04895 XEO_CLAS Peptide DME1098 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04895 GENEFORM Protein DME1098 XEOTICID XEO04895 MOACRIVE Inhibition DME1098 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1098 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04901 XEO_CLAS Peptide DME1098 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 microM) DME1098 XEOTICID XEO04901 GENEFORM Protein DME1098 XEOTICID XEO04901 MOACRIVE Inhibition DME1098 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1098 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04904 XEO_CLAS Peptide DME1098 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 78 ug/ml) DME1098 XEOTICID XEO04904 GENEFORM Protein DME1098 XEOTICID XEO04904 MOACRIVE Inhibition DME1098 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1098 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04905 XEO_CLAS Peptide DME1098 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04905 GENEFORM Protein DME1098 XEOTICID XEO04905 MOACRIVE Inhibition DME1098 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1098 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04906 XEO_CLAS Peptide DME1098 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04906 GENEFORM Protein DME1098 XEOTICID XEO04906 MOACRIVE Inhibition DME1098 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1098 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04907 XEO_CLAS Peptide DME1098 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04907 GENEFORM Protein DME1098 XEOTICID XEO04907 MOACRIVE Inhibition DME1098 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1098 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04908 XEO_CLAS Peptide DME1098 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04908 GENEFORM Protein DME1098 XEOTICID XEO04908 MOACRIVE Inhibition DME1098 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1098 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04909 XEO_CLAS Peptide DME1098 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04909 GENEFORM Protein DME1098 XEOTICID XEO04909 MOACRIVE Inhibition DME1098 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1098 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04915 XEO_CLAS Peptide DME1098 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 100 ug/ml) DME1098 XEOTICID XEO04915 GENEFORM Protein DME1098 XEOTICID XEO04915 MOACRIVE Inhibition DME1098 XEOTICID XEO04916 XEO_NAME Scopoletin DME1098 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1098 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04916 GENEFORM Protein DME1098 XEOTICID XEO04916 MOACRIVE Inhibition DME1098 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1098 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04926 XEO_CLAS Peptide DME1098 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04926 GENEFORM Protein DME1098 XEOTICID XEO04926 MOACRIVE Inhibition DME1098 XEOTICID XEO04931 XEO_NAME Shepherin I DME1098 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04931 XEO_CLAS Peptide DME1098 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04931 GENEFORM Protein DME1098 XEOTICID XEO04931 MOACRIVE Inhibition DME1098 XEOTICID XEO04932 XEO_NAME shepherin II DME1098 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04932 XEO_CLAS Peptide DME1098 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04932 GENEFORM Protein DME1098 XEOTICID XEO04932 MOACRIVE Inhibition DME1098 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1098 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04938 XEO_CLAS Peptide DME1098 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC <= 100 microM) DME1098 XEOTICID XEO04938 GENEFORM Protein DME1098 XEOTICID XEO04938 MOACRIVE Inhibition DME1098 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1098 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04947 XEO_CLAS Natural Product DME1098 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04947 GENEFORM Protein DME1098 XEOTICID XEO04947 MOACRIVE Inhibition DME1098 XEOTICID XEO04948 XEO_NAME Sinensetin DME1098 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1098 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1098 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04948 GENEFORM Protein DME1098 XEOTICID XEO04948 MOACRIVE Inhibition DME1098 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1098 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04950 XEO_CLAS Peptide DME1098 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 ug/ml) DME1098 XEOTICID XEO04950 GENEFORM Protein DME1098 XEOTICID XEO04950 MOACRIVE Inhibition DME1098 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1098 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04955 XEO_CLAS Peptide DME1098 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.07 microM) DME1098 XEOTICID XEO04955 GENEFORM Protein DME1098 XEOTICID XEO04955 MOACRIVE Inhibition DME1098 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1098 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04956 XEO_CLAS Peptide DME1098 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16.0 microM) DME1098 XEOTICID XEO04956 GENEFORM Protein DME1098 XEOTICID XEO04956 MOACRIVE Inhibition DME1098 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1098 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04957 XEO_CLAS Peptide DME1098 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.23 microM) DME1098 XEOTICID XEO04957 GENEFORM Protein DME1098 XEOTICID XEO04957 MOACRIVE Inhibition DME1098 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1098 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04958 XEO_CLAS Peptide DME1098 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 ug/ml) DME1098 XEOTICID XEO04958 GENEFORM Protein DME1098 XEOTICID XEO04958 MOACRIVE Inhibition DME1098 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1098 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04959 XEO_CLAS Peptide DME1098 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04959 GENEFORM Protein DME1098 XEOTICID XEO04959 MOACRIVE Inhibition DME1098 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1098 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04967 XEO_CLAS Peptide DME1098 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 28 microM) DME1098 XEOTICID XEO04967 GENEFORM Protein DME1098 XEOTICID XEO04967 MOACRIVE Inhibition DME1098 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1098 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04969 XEO_CLAS Peptide DME1098 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50-100 ug/ml) DME1098 XEOTICID XEO04969 GENEFORM Protein DME1098 XEOTICID XEO04969 MOACRIVE Inhibition DME1098 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1098 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04970 XEO_CLAS Peptide DME1098 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04970 GENEFORM Protein DME1098 XEOTICID XEO04970 MOACRIVE Inhibition DME1098 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1098 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04971 XEO_CLAS Peptide DME1098 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.8-1.5 microM) DME1098 XEOTICID XEO04971 GENEFORM Protein DME1098 XEOTICID XEO04971 MOACRIVE Inhibition DME1098 XEOTICID XEO04974 XEO_NAME Spinigerin DME1098 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04974 XEO_CLAS Peptide DME1098 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3-6 microM) DME1098 XEOTICID XEO04974 GENEFORM Protein DME1098 XEOTICID XEO04974 MOACRIVE Inhibition DME1098 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1098 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1098 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04975 GENEFORM Protein DME1098 XEOTICID XEO04975 MOACRIVE Inhibition DME1098 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1098 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1098 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04976 GENEFORM Protein DME1098 XEOTICID XEO04976 MOACRIVE Inhibition DME1098 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1098 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1098 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04977 GENEFORM Protein DME1098 XEOTICID XEO04977 MOACRIVE Inhibition DME1098 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1098 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1098 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04978 GENEFORM Protein DME1098 XEOTICID XEO04978 MOACRIVE Inhibition DME1098 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1098 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1098 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04979 GENEFORM Protein DME1098 XEOTICID XEO04979 MOACRIVE Inhibition DME1098 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1098 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04981 XEO_CLAS Peptide DME1098 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10.1 microM) DME1098 XEOTICID XEO04981 GENEFORM Protein DME1098 XEOTICID XEO04981 MOACRIVE Inhibition DME1098 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1098 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04982 XEO_CLAS Peptide DME1098 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40.5 microM) DME1098 XEOTICID XEO04982 GENEFORM Protein DME1098 XEOTICID XEO04982 MOACRIVE Inhibition DME1098 XEOTICID XEO04994 XEO_NAME Stilbene DME1098 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1098 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1098 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO04994 GENEFORM Protein DME1098 XEOTICID XEO04994 MOACRIVE Inhibition DME1098 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1098 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04995 XEO_CLAS Peptide DME1098 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC < 0.19 microM) DME1098 XEOTICID XEO04995 GENEFORM Protein DME1098 XEOTICID XEO04995 MOACRIVE Inhibition DME1098 XEOTICID XEO04998 XEO_NAME Styelin A DME1098 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04998 XEO_CLAS Peptide DME1098 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.7 ug/ml) DME1098 XEOTICID XEO04998 GENEFORM Protein DME1098 XEOTICID XEO04998 MOACRIVE Inhibition DME1098 XEOTICID XEO04999 XEO_NAME Styelin B DME1098 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO04999 XEO_CLAS Peptide DME1098 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.7 ug/ml) DME1098 XEOTICID XEO04999 GENEFORM Protein DME1098 XEOTICID XEO04999 MOACRIVE Inhibition DME1098 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1098 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05000 XEO_CLAS Peptide DME1098 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO05000 GENEFORM Protein DME1098 XEOTICID XEO05000 MOACRIVE Inhibition DME1098 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1098 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05001 XEO_CLAS Peptide DME1098 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.5 ug/ml) DME1098 XEOTICID XEO05001 GENEFORM Protein DME1098 XEOTICID XEO05001 MOACRIVE Inhibition DME1098 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1098 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05002 XEO_CLAS Peptide DME1098 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO05002 GENEFORM Protein DME1098 XEOTICID XEO05002 MOACRIVE Inhibition DME1098 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1098 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05003 XEO_CLAS Peptide DME1098 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO05003 GENEFORM Protein DME1098 XEOTICID XEO05003 MOACRIVE Inhibition DME1098 XEOTICID XEO05006 XEO_NAME Substance P DME1098 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05006 XEO_CLAS Peptide DME1098 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05006 GENEFORM Protein DME1098 XEOTICID XEO05006 MOACRIVE Inhibition DME1098 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1098 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05007 XEO_CLAS Peptide DME1098 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05007 GENEFORM Protein DME1098 XEOTICID XEO05007 MOACRIVE Inhibition DME1098 XEOTICID XEO05008 XEO_NAME Subtilosin DME1098 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05008 XEO_CLAS Peptide DME1098 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05008 GENEFORM Protein DME1098 XEOTICID XEO05008 MOACRIVE Inhibition DME1098 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1098 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05013 XEO_CLAS Peptide DME1098 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO05013 GENEFORM Protein DME1098 XEOTICID XEO05013 MOACRIVE Inhibition DME1098 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1098 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05014 XEO_CLAS Peptide DME1098 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO05014 GENEFORM Protein DME1098 XEOTICID XEO05014 MOACRIVE Inhibition DME1098 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1098 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05015 XEO_CLAS Peptide DME1098 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO05015 GENEFORM Protein DME1098 XEOTICID XEO05015 MOACRIVE Inhibition DME1098 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1098 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05016 XEO_CLAS Peptide DME1098 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO05016 GENEFORM Protein DME1098 XEOTICID XEO05016 MOACRIVE Inhibition DME1098 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1098 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05017 XEO_CLAS Peptide DME1098 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 20 ug/ml) DME1098 XEOTICID XEO05017 GENEFORM Protein DME1098 XEOTICID XEO05017 MOACRIVE Inhibition DME1098 XEOTICID XEO05018 XEO_NAME Syringic acid DME1098 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1098 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05018 GENEFORM Protein DME1098 XEOTICID XEO05018 MOACRIVE Inhibition DME1098 XEOTICID XEO05020 XEO_NAME Tachycitin DME1098 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05020 XEO_CLAS Peptide DME1098 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05020 GENEFORM Protein DME1098 XEOTICID XEO05020 MOACRIVE Inhibition DME1098 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1098 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05023 XEO_CLAS Peptide DME1098 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05023 GENEFORM Protein DME1098 XEOTICID XEO05023 MOACRIVE Inhibition DME1098 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1098 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05024 XEO_CLAS Peptide DME1098 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05024 GENEFORM Protein DME1098 XEOTICID XEO05024 MOACRIVE Inhibition DME1098 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1098 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05027 XEO_CLAS Peptide DME1098 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05027 GENEFORM Protein DME1098 XEOTICID XEO05027 MOACRIVE Inhibition DME1098 XEOTICID XEO05031 XEO_NAME Tannic acid DME1098 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1098 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05031 GENEFORM Protein DME1098 XEOTICID XEO05031 MOACRIVE Inhibition DME1098 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1098 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05033 XEO_CLAS Peptide DME1098 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05033 GENEFORM Protein DME1098 XEOTICID XEO05033 MOACRIVE Inhibition DME1098 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1098 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05042 XEO_CLAS Peptide DME1098 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO05042 GENEFORM Protein DME1098 XEOTICID XEO05042 MOACRIVE Inhibition DME1098 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1098 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05043 XEO_CLAS Peptide DME1098 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO05043 GENEFORM Protein DME1098 XEOTICID XEO05043 MOACRIVE Inhibition DME1098 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1098 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05044 XEO_CLAS Peptide DME1098 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 128 microM) DME1098 XEOTICID XEO05044 GENEFORM Protein DME1098 XEOTICID XEO05044 MOACRIVE Inhibition DME1098 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1098 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05045 XEO_CLAS Peptide DME1098 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 128 microM) DME1098 XEOTICID XEO05045 GENEFORM Protein DME1098 XEOTICID XEO05045 MOACRIVE Inhibition DME1098 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1098 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05046 XEO_CLAS Peptide DME1098 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 microM) DME1098 XEOTICID XEO05046 GENEFORM Protein DME1098 XEOTICID XEO05046 MOACRIVE Inhibition DME1098 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1098 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05047 XEO_CLAS Peptide DME1098 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 60 microM) DME1098 XEOTICID XEO05047 GENEFORM Protein DME1098 XEOTICID XEO05047 MOACRIVE Inhibition DME1098 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1098 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05051 XEO_CLAS Peptide DME1098 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05051 GENEFORM Protein DME1098 XEOTICID XEO05051 MOACRIVE Inhibition DME1098 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1098 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05055 XEO_CLAS Peptide DME1098 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 70 microM) DME1098 XEOTICID XEO05055 GENEFORM Protein DME1098 XEOTICID XEO05055 MOACRIVE Inhibition DME1098 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1098 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05056 XEO_CLAS Peptide DME1098 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05056 GENEFORM Protein DME1098 XEOTICID XEO05056 MOACRIVE Inhibition DME1098 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1098 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05059 XEO_CLAS Peptide DME1098 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05059 GENEFORM Protein DME1098 XEOTICID XEO05059 MOACRIVE Inhibition DME1098 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1098 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05061 XEO_CLAS Peptide DME1098 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO05061 GENEFORM Protein DME1098 XEOTICID XEO05061 MOACRIVE Inhibition DME1098 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1098 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05062 XEO_CLAS Peptide DME1098 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05062 GENEFORM Protein DME1098 XEOTICID XEO05062 MOACRIVE Inhibition DME1098 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1098 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05063 XEO_CLAS Peptide DME1098 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO05063 GENEFORM Protein DME1098 XEOTICID XEO05063 MOACRIVE Inhibition DME1098 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1098 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05064 XEO_CLAS Peptide DME1098 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 231 microM) DME1098 XEOTICID XEO05064 GENEFORM Protein DME1098 XEOTICID XEO05064 MOACRIVE Inhibition DME1098 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1098 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05065 XEO_CLAS Peptide DME1098 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 161 ug/ml) DME1098 XEOTICID XEO05065 GENEFORM Protein DME1098 XEOTICID XEO05065 MOACRIVE Inhibition DME1098 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1098 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05069 XEO_CLAS Peptide DME1098 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO05069 GENEFORM Protein DME1098 XEOTICID XEO05069 MOACRIVE Inhibition DME1098 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1098 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05070 XEO_CLAS Peptide DME1098 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 37.5 microM) DME1098 XEOTICID XEO05070 GENEFORM Protein DME1098 XEOTICID XEO05070 MOACRIVE Inhibition DME1098 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1098 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05071 XEO_CLAS Peptide DME1098 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 150 microM) DME1098 XEOTICID XEO05071 GENEFORM Protein DME1098 XEOTICID XEO05071 MOACRIVE Inhibition DME1098 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1098 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05072 XEO_CLAS Peptide DME1098 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO05072 GENEFORM Protein DME1098 XEOTICID XEO05072 MOACRIVE Inhibition DME1098 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1098 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05073 XEO_CLAS Peptide DME1098 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40 microM) DME1098 XEOTICID XEO05073 GENEFORM Protein DME1098 XEOTICID XEO05073 MOACRIVE Inhibition DME1098 XEOTICID XEO05076 XEO_NAME Temporin-A DME1098 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05076 XEO_CLAS Peptide DME1098 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 11.9 microM) DME1098 XEOTICID XEO05076 GENEFORM Protein DME1098 XEOTICID XEO05076 MOACRIVE Inhibition DME1098 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1098 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05077 XEO_CLAS Peptide DME1098 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.25 ug/ml) DME1098 XEOTICID XEO05077 GENEFORM Protein DME1098 XEOTICID XEO05077 MOACRIVE Inhibition DME1098 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1098 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05078 XEO_CLAS Peptide DME1098 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.25 ug/ml) DME1098 XEOTICID XEO05078 GENEFORM Protein DME1098 XEOTICID XEO05078 MOACRIVE Inhibition DME1098 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1098 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05079 XEO_CLAS Peptide DME1098 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.5 ug/ml) DME1098 XEOTICID XEO05079 GENEFORM Protein DME1098 XEOTICID XEO05079 MOACRIVE Inhibition DME1098 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1098 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05080 XEO_CLAS Peptide DME1098 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 ug/ml) DME1098 XEOTICID XEO05080 GENEFORM Protein DME1098 XEOTICID XEO05080 MOACRIVE Inhibition DME1098 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1098 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05081 XEO_CLAS Peptide DME1098 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 5 ug/ml) DME1098 XEOTICID XEO05081 GENEFORM Protein DME1098 XEOTICID XEO05081 MOACRIVE Inhibition DME1098 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1098 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05082 XEO_CLAS Peptide DME1098 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 7.5 ug/ml) DME1098 XEOTICID XEO05082 GENEFORM Protein DME1098 XEOTICID XEO05082 MOACRIVE Inhibition DME1098 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1098 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05083 XEO_CLAS Peptide DME1098 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 ug/ml) DME1098 XEOTICID XEO05083 GENEFORM Protein DME1098 XEOTICID XEO05083 MOACRIVE Inhibition DME1098 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1098 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05084 XEO_CLAS Peptide DME1098 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 ug/ml) DME1098 XEOTICID XEO05084 GENEFORM Protein DME1098 XEOTICID XEO05084 MOACRIVE Inhibition DME1098 XEOTICID XEO05085 XEO_NAME Temporin-B DME1098 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05085 XEO_CLAS Peptide DME1098 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 21.0 ug/ml) DME1098 XEOTICID XEO05085 GENEFORM Protein DME1098 XEOTICID XEO05085 MOACRIVE Inhibition DME1098 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1098 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05086 XEO_CLAS Peptide DME1098 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC > 100 microM) DME1098 XEOTICID XEO05086 GENEFORM Protein DME1098 XEOTICID XEO05086 MOACRIVE Inhibition DME1098 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1098 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05087 XEO_CLAS Peptide DME1098 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO05087 GENEFORM Protein DME1098 XEOTICID XEO05087 MOACRIVE Inhibition DME1098 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1098 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05097 XEO_CLAS Peptide DME1098 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16.0 microM) DME1098 XEOTICID XEO05097 GENEFORM Protein DME1098 XEOTICID XEO05097 MOACRIVE Inhibition DME1098 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1098 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05099 XEO_CLAS Peptide DME1098 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.0 microM) DME1098 XEOTICID XEO05099 GENEFORM Protein DME1098 XEOTICID XEO05099 MOACRIVE Inhibition DME1098 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1098 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05100 XEO_CLAS Peptide DME1098 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05100 GENEFORM Protein DME1098 XEOTICID XEO05100 MOACRIVE Inhibition DME1098 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1098 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05101 XEO_CLAS Peptide DME1098 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 24.2 ug/ml) DME1098 XEOTICID XEO05101 GENEFORM Protein DME1098 XEOTICID XEO05101 MOACRIVE Inhibition DME1098 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1098 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05102 XEO_CLAS Peptide DME1098 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 34.5 ug/ml) DME1098 XEOTICID XEO05102 GENEFORM Protein DME1098 XEOTICID XEO05102 MOACRIVE Inhibition DME1098 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1098 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05105 XEO_CLAS Peptide DME1098 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO05105 GENEFORM Protein DME1098 XEOTICID XEO05105 MOACRIVE Inhibition DME1098 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1098 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05106 XEO_CLAS Peptide DME1098 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25-200 microM) DME1098 XEOTICID XEO05106 GENEFORM Protein DME1098 XEOTICID XEO05106 MOACRIVE Inhibition DME1098 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1098 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05108 XEO_CLAS Peptide DME1098 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40 microM) DME1098 XEOTICID XEO05108 GENEFORM Protein DME1098 XEOTICID XEO05108 MOACRIVE Inhibition DME1098 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1098 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1098 XEOTICID XEO05111 XEO_CLAS Natural Product DME1098 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05111 GENEFORM Protein DME1098 XEOTICID XEO05111 MOACRIVE Inhibition DME1098 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1098 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05119 XEO_CLAS Peptide DME1098 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05119 GENEFORM Protein DME1098 XEOTICID XEO05119 MOACRIVE Inhibition DME1098 XEOTICID XEO05120 XEO_NAME Thanatin DME1098 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05120 XEO_CLAS Peptide DME1098 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1098 XEOTICID XEO05120 GENEFORM Protein DME1098 XEOTICID XEO05120 MOACRIVE Inhibition DME1098 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1098 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05121 XEO_CLAS Peptide DME1098 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 62.5 ug/ml) DME1098 XEOTICID XEO05121 GENEFORM Protein DME1098 XEOTICID XEO05121 MOACRIVE Inhibition DME1098 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1098 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05125 XEO_CLAS Peptide DME1098 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05125 GENEFORM Protein DME1098 XEOTICID XEO05125 MOACRIVE Inhibition DME1098 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1098 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05130 XEO_CLAS Peptide DME1098 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05130 GENEFORM Protein DME1098 XEOTICID XEO05130 MOACRIVE Inhibition DME1098 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1098 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05144 XEO_CLAS Peptide DME1098 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40 ug/ml) DME1098 XEOTICID XEO05144 GENEFORM Protein DME1098 XEOTICID XEO05144 MOACRIVE Inhibition DME1098 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1098 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05145 XEO_CLAS Peptide DME1098 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 ug/ml) DME1098 XEOTICID XEO05145 GENEFORM Protein DME1098 XEOTICID XEO05145 MOACRIVE Inhibition DME1098 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1098 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05146 XEO_CLAS Peptide DME1098 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 40 ug/ml) DME1098 XEOTICID XEO05146 GENEFORM Protein DME1098 XEOTICID XEO05146 MOACRIVE Inhibition DME1098 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1098 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05147 XEO_CLAS Peptide DME1098 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 60 ug/ml) DME1098 XEOTICID XEO05147 GENEFORM Protein DME1098 XEOTICID XEO05147 MOACRIVE Inhibition DME1098 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1098 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05158 XEO_CLAS Peptide DME1098 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05158 GENEFORM Protein DME1098 XEOTICID XEO05158 MOACRIVE Inhibition DME1098 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1098 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05161 XEO_CLAS Peptide DME1098 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 32 ug/ml) DME1098 XEOTICID XEO05161 GENEFORM Protein DME1098 XEOTICID XEO05161 MOACRIVE Inhibition DME1098 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1098 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05162 XEO_CLAS Peptide DME1098 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 32 ug/ml) DME1098 XEOTICID XEO05162 GENEFORM Protein DME1098 XEOTICID XEO05162 MOACRIVE Inhibition DME1098 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1098 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05163 XEO_CLAS Peptide DME1098 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 12-25 ug/ml) DME1098 XEOTICID XEO05163 GENEFORM Protein DME1098 XEOTICID XEO05163 MOACRIVE Inhibition DME1098 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1098 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05170 XEO_CLAS Peptide DME1098 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 3.0 microM) DME1098 XEOTICID XEO05170 GENEFORM Protein DME1098 XEOTICID XEO05170 MOACRIVE Inhibition DME1098 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1098 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05171 XEO_CLAS Peptide DME1098 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 50 microM) DME1098 XEOTICID XEO05171 GENEFORM Protein DME1098 XEOTICID XEO05171 MOACRIVE Inhibition DME1098 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1098 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05179 XEO_CLAS Peptide DME1098 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05179 GENEFORM Protein DME1098 XEOTICID XEO05179 MOACRIVE Inhibition DME1098 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1098 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05180 XEO_CLAS Peptide DME1098 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 160 microM) DME1098 XEOTICID XEO05180 GENEFORM Protein DME1098 XEOTICID XEO05180 MOACRIVE Inhibition DME1098 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1098 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05182 XEO_CLAS Peptide DME1098 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 microM) DME1098 XEOTICID XEO05182 GENEFORM Protein DME1098 XEOTICID XEO05182 MOACRIVE Inhibition DME1098 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1098 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05183 XEO_CLAS Peptide DME1098 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 microM) DME1098 XEOTICID XEO05183 GENEFORM Protein DME1098 XEOTICID XEO05183 MOACRIVE Inhibition DME1098 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1098 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05184 XEO_CLAS Peptide DME1098 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 microM) DME1098 XEOTICID XEO05184 GENEFORM Protein DME1098 XEOTICID XEO05184 MOACRIVE Inhibition DME1098 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1098 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05185 XEO_CLAS Peptide DME1098 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 microM) DME1098 XEOTICID XEO05185 GENEFORM Protein DME1098 XEOTICID XEO05185 MOACRIVE Inhibition DME1098 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1098 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05186 XEO_CLAS Peptide DME1098 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 microM) DME1098 XEOTICID XEO05186 GENEFORM Protein DME1098 XEOTICID XEO05186 MOACRIVE Inhibition DME1098 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1098 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05187 XEO_CLAS Peptide DME1098 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16 microM) DME1098 XEOTICID XEO05187 GENEFORM Protein DME1098 XEOTICID XEO05187 MOACRIVE Inhibition DME1098 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1098 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05188 XEO_CLAS Peptide DME1098 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 64 microM) DME1098 XEOTICID XEO05188 GENEFORM Protein DME1098 XEOTICID XEO05188 MOACRIVE Inhibition DME1098 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1098 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05190 XEO_CLAS Peptide DME1098 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05190 GENEFORM Protein DME1098 XEOTICID XEO05190 MOACRIVE Inhibition DME1098 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1098 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05193 XEO_CLAS Peptide DME1098 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO05193 GENEFORM Protein DME1098 XEOTICID XEO05193 MOACRIVE Inhibition DME1098 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1098 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05197 XEO_CLAS Peptide DME1098 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05197 GENEFORM Protein DME1098 XEOTICID XEO05197 MOACRIVE Inhibition DME1098 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1098 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05205 XEO_CLAS Peptide DME1098 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05205 GENEFORM Protein DME1098 XEOTICID XEO05205 MOACRIVE Inhibition DME1098 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1098 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05206 XEO_CLAS Peptide DME1098 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 10 microM) DME1098 XEOTICID XEO05206 GENEFORM Protein DME1098 XEOTICID XEO05206 MOACRIVE Inhibition DME1098 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1098 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05207 XEO_CLAS Peptide DME1098 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 25 microM) DME1098 XEOTICID XEO05207 GENEFORM Protein DME1098 XEOTICID XEO05207 MOACRIVE Inhibition DME1098 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1098 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05208 XEO_CLAS Peptide DME1098 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 microM) DME1098 XEOTICID XEO05208 GENEFORM Protein DME1098 XEOTICID XEO05208 MOACRIVE Inhibition DME1098 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1098 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05209 XEO_CLAS Peptide DME1098 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 15 microM) DME1098 XEOTICID XEO05209 GENEFORM Protein DME1098 XEOTICID XEO05209 MOACRIVE Inhibition DME1098 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1098 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05212 XEO_CLAS Peptide DME1098 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.5 ug/ml) DME1098 XEOTICID XEO05212 GENEFORM Protein DME1098 XEOTICID XEO05212 MOACRIVE Inhibition DME1098 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1098 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05220 XEO_CLAS Peptide DME1098 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.6-1.2 microM) DME1098 XEOTICID XEO05220 GENEFORM Protein DME1098 XEOTICID XEO05220 MOACRIVE Inhibition DME1098 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1098 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05230 XEO_CLAS Peptide DME1098 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 7.90 microM) DME1098 XEOTICID XEO05230 GENEFORM Protein DME1098 XEOTICID XEO05230 MOACRIVE Inhibition DME1098 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1098 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05231 XEO_CLAS Peptide DME1098 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2.40 microM) DME1098 XEOTICID XEO05231 GENEFORM Protein DME1098 XEOTICID XEO05231 MOACRIVE Inhibition DME1098 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1098 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05232 XEO_CLAS Peptide DME1098 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05232 GENEFORM Protein DME1098 XEOTICID XEO05232 MOACRIVE Inhibition DME1098 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1098 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05233 XEO_CLAS Peptide DME1098 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 ug/ml) DME1098 XEOTICID XEO05233 GENEFORM Protein DME1098 XEOTICID XEO05233 MOACRIVE Inhibition DME1098 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1098 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05234 XEO_CLAS Peptide DME1098 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 ug/ml) DME1098 XEOTICID XEO05234 GENEFORM Protein DME1098 XEOTICID XEO05234 MOACRIVE Inhibition DME1098 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1098 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05235 XEO_CLAS Peptide DME1098 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 30 ug/ml) DME1098 XEOTICID XEO05235 GENEFORM Protein DME1098 XEOTICID XEO05235 MOACRIVE Inhibition DME1098 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1098 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05237 XEO_CLAS Peptide DME1098 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 microM) DME1098 XEOTICID XEO05237 GENEFORM Protein DME1098 XEOTICID XEO05237 MOACRIVE Inhibition DME1098 XEOTICID XEO05245 XEO_NAME Viresin DME1098 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05245 XEO_CLAS Peptide DME1098 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05245 GENEFORM Protein DME1098 XEOTICID XEO05245 MOACRIVE Inhibition DME1098 XEOTICID XEO05248 XEO_NAME Vitamin C DME1098 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1098 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1098 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05248 GENEFORM Protein DME1098 XEOTICID XEO05248 MOACRIVE Inhibition DME1098 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1098 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05264 XEO_CLAS Peptide DME1098 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 4 ug/ml) DME1098 XEOTICID XEO05264 GENEFORM Protein DME1098 XEOTICID XEO05264 MOACRIVE Inhibition DME1098 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1098 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05267 XEO_CLAS Peptide DME1098 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 2 ug/ml) DME1098 XEOTICID XEO05267 GENEFORM Protein DME1098 XEOTICID XEO05267 MOACRIVE Inhibition DME1098 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1098 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05268 XEO_CLAS Peptide DME1098 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 1.6 ug/ml) DME1098 XEOTICID XEO05268 GENEFORM Protein DME1098 XEOTICID XEO05268 MOACRIVE Inhibition DME1098 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1098 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05269 XEO_CLAS Peptide DME1098 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 6 ug/ml) DME1098 XEOTICID XEO05269 GENEFORM Protein DME1098 XEOTICID XEO05269 MOACRIVE Inhibition DME1098 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1098 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05273 XEO_CLAS Peptide DME1098 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05273 GENEFORM Protein DME1098 XEOTICID XEO05273 MOACRIVE Inhibition DME1098 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1098 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05274 XEO_CLAS Peptide DME1098 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05274 GENEFORM Protein DME1098 XEOTICID XEO05274 MOACRIVE Inhibition DME1098 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1098 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05287 XEO_CLAS Peptide DME1098 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli DME1098 XEOTICID XEO05287 GENEFORM Protein DME1098 XEOTICID XEO05287 MOACRIVE Inhibition DME1098 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1098 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05303 XEO_CLAS Peptide DME1098 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 16-31 ug/ml) DME1098 XEOTICID XEO05303 GENEFORM Protein DME1098 XEOTICID XEO05303 MOACRIVE Inhibition DME1098 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1098 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05306 XEO_CLAS Peptide DME1098 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 8 ug/ml) DME1098 XEOTICID XEO05306 GENEFORM Protein DME1098 XEOTICID XEO05306 MOACRIVE Inhibition DME1098 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1098 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1098 XEOTICID XEO05308 XEO_CLAS Peptide DME1098 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Escherichia coli (MIC = 0.4 ug/ml) DME1098 XEOTICID XEO05308 GENEFORM Protein DME1098 XEOTICID XEO05308 MOACRIVE Inhibition DME1100 DME___ID DME1100 DME1100 DME_NAME Arylamine N-acetyltransferase (NAT) DME1100 SPESNAME Shigella flexneri DME1100 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1100 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1100 XEOTICID XEO02304 XEO_CLAS Peptide DME1100 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Shigella flexneri (MIC = 0.1 ug/ml) DME1100 XEOTICID XEO02304 GENEFORM Protein DME1100 XEOTICID XEO02304 MOACRIVE Inhibition DME1100 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1100 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1100 XEOTICID XEO02305 XEO_CLAS Peptide DME1100 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Shigella flexneri (MIC = 0.1 ug/ml) DME1100 XEOTICID XEO02305 GENEFORM Protein DME1100 XEOTICID XEO02305 MOACRIVE Inhibition DME1100 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1100 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1100 XEOTICID XEO02306 XEO_CLAS Peptide DME1100 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Shigella flexneri (MIC = 0.1 ug/ml) DME1100 XEOTICID XEO02306 GENEFORM Protein DME1100 XEOTICID XEO02306 MOACRIVE Inhibition DME1100 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1100 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1100 XEOTICID XEO02332 XEO_CLAS Peptide DME1100 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Shigella flexneri (MIC = 0.98 ug/ml) DME1100 XEOTICID XEO02332 GENEFORM Protein DME1100 XEOTICID XEO02332 MOACRIVE Inhibition DME1100 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1100 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1100 XEOTICID XEO04111 XEO_CLAS Peptide DME1100 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Shigella flexneri DME1100 XEOTICID XEO04111 GENEFORM Protein DME1100 XEOTICID XEO04111 MOACRIVE Inhibition DME1100 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1100 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1100 XEOTICID XEO04113 XEO_CLAS Peptide DME1100 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Shigella flexneri DME1100 XEOTICID XEO04113 GENEFORM Protein DME1100 XEOTICID XEO04113 MOACRIVE Inhibition DME1100 XEOTICID XEO04114 XEO_NAME Microcin L DME1100 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1100 XEOTICID XEO04114 XEO_CLAS Peptide DME1100 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Shigella flexneri DME1100 XEOTICID XEO04114 GENEFORM Protein DME1100 XEOTICID XEO04114 MOACRIVE Inhibition DME1100 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1100 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1100 XEOTICID XEO04612 XEO_CLAS Peptide DME1100 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Shigella flexneri (MIC = 2.5-5 microM) DME1100 XEOTICID XEO04612 GENEFORM Protein DME1100 XEOTICID XEO04612 MOACRIVE Inhibition DME1100 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1100 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1100 XEOTICID XEO04613 XEO_CLAS Peptide DME1100 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Shigella flexneri (MIC = 2.5-5 microM) DME1100 XEOTICID XEO04613 GENEFORM Protein DME1100 XEOTICID XEO04613 MOACRIVE Inhibition DME1100 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1100 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1100 XEOTICID XEO05005 XEO_CLAS Peptide DME1100 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Shigella flexneri DME1100 XEOTICID XEO05005 GENEFORM Protein DME1100 XEOTICID XEO05005 MOACRIVE Inhibition DME1100 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1100 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1100 XEOTICID XEO05139 XEO_CLAS Peptide DME1100 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Shigella flexneri DME1100 XEOTICID XEO05139 GENEFORM Protein DME1100 XEOTICID XEO05139 MOACRIVE Inhibition DME1100 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1100 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1100 XEOTICID XEO05308 XEO_CLAS Peptide DME1100 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Shigella flexneri (MIC = 2.0 ug/ml) DME1100 XEOTICID XEO05308 GENEFORM Protein DME1100 XEOTICID XEO05308 MOACRIVE Inhibition DME1102 DME___ID DME1102 DME1102 DME_NAME Arylamine N-acetyltransferase (NAT) DME1102 SPESNAME Morganella morganii DME1102 XEOTICID XEO00122 XEO_NAME Amikacin DME1102 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1102 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1102 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Morganella morganii DME1102 XEOTICID XEO00122 GENEFORM Protein DME1102 XEOTICID XEO00122 MOACRIVE Inhibition DME1102 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1102 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1102 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1102 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Morganella morganii DME1102 XEOTICID XEO00237 GENEFORM Protein DME1102 XEOTICID XEO00237 MOACRIVE Inhibition DME1102 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1102 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1102 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1102 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Morganella morganii DME1102 XEOTICID XEO00349 GENEFORM Protein DME1102 XEOTICID XEO00349 MOACRIVE Inhibition DME1102 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1102 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1102 XEOTICID XEO02376 XEO_CLAS Peptide DME1102 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Morganella morganii DME1102 XEOTICID XEO02376 GENEFORM Protein DME1102 XEOTICID XEO02376 MOACRIVE Inhibition DME1102 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1102 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1102 XEOTICID XEO02378 XEO_CLAS Peptide DME1102 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Morganella morganii (MIC = 0.38 ug/ml) DME1102 XEOTICID XEO02378 GENEFORM Protein DME1102 XEOTICID XEO02378 MOACRIVE Inhibition DME1102 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1102 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1102 XEOTICID XEO03253 XEO_CLAS Peptide DME1102 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Morganella morganii DME1102 XEOTICID XEO03253 GENEFORM Protein DME1102 XEOTICID XEO03253 MOACRIVE Inhibition DME1103 DME___ID DME1103 DME1103 DME_NAME Arylamine N-acetyltransferase (NAT) DME1103 SPESNAME Citrobacter freundii DME1103 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME1103 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME1103 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME1103 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Citrobacter freundii DME1103 XEOTICID XEO00613 GENEFORM Protein DME1103 XEOTICID XEO00613 MOACRIVE Inhibition DME1103 XEOTICID XEO00683 XEO_NAME Curcumin DME1103 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1103 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1103 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Citrobacter freundii DME1103 XEOTICID XEO00683 GENEFORM Protein DME1103 XEOTICID XEO00683 MOACRIVE Inhibition DME1103 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1103 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1103 XEOTICID XEO02319 XEO_CLAS Peptide DME1103 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Citrobacter freundii DME1103 XEOTICID XEO02319 GENEFORM Protein DME1103 XEOTICID XEO02319 MOACRIVE Inhibition DME1103 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1103 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1103 XEOTICID XEO02378 XEO_CLAS Peptide DME1103 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Citrobacter freundii (MIC = 0.76 ug/ml) DME1103 XEOTICID XEO02378 GENEFORM Protein DME1103 XEOTICID XEO02378 MOACRIVE Inhibition DME1103 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1103 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1103 XEOTICID XEO03253 XEO_CLAS Peptide DME1103 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Citrobacter freundii (MIC = 1.6 ug/ml) DME1103 XEOTICID XEO03253 GENEFORM Protein DME1103 XEOTICID XEO03253 MOACRIVE Inhibition DME1103 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1103 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1103 XEOTICID XEO03609 XEO_CLAS Peptide DME1103 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Citrobacter freundii DME1103 XEOTICID XEO03609 GENEFORM Protein DME1103 XEOTICID XEO03609 MOACRIVE Inhibition DME1103 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1103 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1103 XEOTICID XEO03853 XEO_CLAS Peptide DME1103 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Citrobacter freundii (MIC = 75 microM) DME1103 XEOTICID XEO03853 GENEFORM Protein DME1103 XEOTICID XEO03853 MOACRIVE Inhibition DME1103 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1103 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1103 XEOTICID XEO03985 XEO_CLAS Peptide DME1103 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Citrobacter freundii (MIC = 30 ug/ml) DME1103 XEOTICID XEO03985 GENEFORM Protein DME1103 XEOTICID XEO03985 MOACRIVE Inhibition DME1103 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1103 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1103 XEOTICID XEO04426 XEO_CLAS Peptide DME1103 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Citrobacter freundii (MIC = 2 microM) DME1103 XEOTICID XEO04426 GENEFORM Protein DME1103 XEOTICID XEO04426 MOACRIVE Inhibition DME1103 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1103 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1103 XEOTICID XEO04606 XEO_CLAS Peptide DME1103 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Citrobacter freundii (MIC = 2 microM) DME1103 XEOTICID XEO04606 GENEFORM Protein DME1103 XEOTICID XEO04606 MOACRIVE Inhibition DME1104 DME___ID DME1104 DME1104 DME_NAME Arylamine N-acetyltransferase (NAT) DME1104 SPESNAME Serratia marcescens DME1104 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1104 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1104 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1104 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO00574 GENEFORM Protein DME1104 XEOTICID XEO00574 MOACRIVE Inhibition DME1104 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME1104 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME1104 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME1104 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO00613 GENEFORM Protein DME1104 XEOTICID XEO00613 MOACRIVE Inhibition DME1104 XEOTICID XEO00683 XEO_NAME Curcumin DME1104 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1104 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1104 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO00683 GENEFORM Protein DME1104 XEOTICID XEO00683 MOACRIVE Inhibition DME1104 XEOTICID XEO01419 XEO_NAME Oxyquinoline DME1104 XEOTICID XEO01419 XEO_TYPE Health or Environmental Toxicant(s) DME1104 XEOTICID XEO01419 XEO_CLAS Acute Toxic Substance DME1104 XEOTICID XEO01419 DESCRIPT Oxyquinoline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO01419 GENEFORM Protein DME1104 XEOTICID XEO01419 MOACRIVE Inhibition DME1104 XEOTICID XEO02091 XEO_NAME 7-chloroquinolin-4-ol DME1104 XEOTICID XEO02091 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1104 XEOTICID XEO02091 XEO_CLAS Chemical Compound DME1104 XEOTICID XEO02091 DESCRIPT 7-chloroquinolin-4-ol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO02091 GENEFORM Protein DME1104 XEOTICID XEO02091 MOACRIVE Inhibition DME1104 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1104 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02117 XEO_CLAS Peptide DME1104 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO02117 GENEFORM Protein DME1104 XEOTICID XEO02117 MOACRIVE Inhibition DME1104 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1104 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02118 XEO_CLAS Peptide DME1104 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO02118 GENEFORM Protein DME1104 XEOTICID XEO02118 MOACRIVE Inhibition DME1104 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1104 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02119 XEO_CLAS Peptide DME1104 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO02119 GENEFORM Protein DME1104 XEOTICID XEO02119 MOACRIVE Inhibition DME1104 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1104 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02120 XEO_CLAS Peptide DME1104 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO02120 GENEFORM Protein DME1104 XEOTICID XEO02120 MOACRIVE Inhibition DME1104 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1104 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02121 XEO_CLAS Peptide DME1104 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO02121 GENEFORM Protein DME1104 XEOTICID XEO02121 MOACRIVE Inhibition DME1104 XEOTICID XEO02226 XEO_NAME Andropin DME1104 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02226 XEO_CLAS Peptide DME1104 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC > 127 microM) DME1104 XEOTICID XEO02226 GENEFORM Protein DME1104 XEOTICID XEO02226 MOACRIVE Inhibition DME1104 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1104 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02298 XEO_CLAS Peptide DME1104 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC = 32 ug/ml) DME1104 XEOTICID XEO02298 GENEFORM Protein DME1104 XEOTICID XEO02298 MOACRIVE Inhibition DME1104 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1104 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02333 XEO_CLAS Peptide DME1104 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC > 200 microM) DME1104 XEOTICID XEO02333 GENEFORM Protein DME1104 XEOTICID XEO02333 MOACRIVE Inhibition DME1104 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1104 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02466 XEO_CLAS Peptide DME1104 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC = 1.5 microM) DME1104 XEOTICID XEO02466 GENEFORM Protein DME1104 XEOTICID XEO02466 MOACRIVE Inhibition DME1104 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1104 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02491 XEO_CLAS Peptide DME1104 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC = 68.2 microM) DME1104 XEOTICID XEO02491 GENEFORM Protein DME1104 XEOTICID XEO02491 MOACRIVE Inhibition DME1104 XEOTICID XEO02654 XEO_NAME Butane-1,4-diamine DME1104 XEOTICID XEO02654 XEO_TYPE Pharmaceutical Agent(s) DME1104 XEOTICID XEO02654 XEO_CLAS Drug in Phase 2 Clinical Trial DME1104 XEOTICID XEO02654 DESCRIPT Butane-1,4-diamine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO02654 GENEFORM Protein DME1104 XEOTICID XEO02654 MOACRIVE Inhibition DME1104 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1104 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02731 XEO_CLAS Peptide DME1104 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC = 4 microM) DME1104 XEOTICID XEO02731 GENEFORM Protein DME1104 XEOTICID XEO02731 MOACRIVE Inhibition DME1104 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1104 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02739 XEO_CLAS Peptide DME1104 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC = 2 microM) DME1104 XEOTICID XEO02739 GENEFORM Protein DME1104 XEOTICID XEO02739 MOACRIVE Inhibition DME1104 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1104 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02740 XEO_CLAS Peptide DME1104 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC = 2 ug/ml) DME1104 XEOTICID XEO02740 GENEFORM Protein DME1104 XEOTICID XEO02740 MOACRIVE Inhibition DME1104 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1104 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02768 XEO_CLAS Peptide DME1104 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO02768 GENEFORM Protein DME1104 XEOTICID XEO02768 MOACRIVE Inhibition DME1104 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1104 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02769 XEO_CLAS Peptide DME1104 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC = 2.2 microM) DME1104 XEOTICID XEO02769 GENEFORM Protein DME1104 XEOTICID XEO02769 MOACRIVE Inhibition DME1104 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1104 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO02772 XEO_CLAS Peptide DME1104 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO02772 GENEFORM Protein DME1104 XEOTICID XEO02772 MOACRIVE Inhibition DME1104 XEOTICID XEO02912 XEO_NAME Coral associated bacteria 23 DME1104 XEOTICID XEO02912 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1104 XEOTICID XEO02912 XEO_CLAS Bacterial Extract DME1104 XEOTICID XEO02912 DESCRIPT Coral associated bacteria 23 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO02912 GENEFORM Protein DME1104 XEOTICID XEO02912 MOACRIVE Inhibition DME1104 XEOTICID XEO02913 XEO_NAME Coral associated bacteria 41 DME1104 XEOTICID XEO02913 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1104 XEOTICID XEO02913 XEO_CLAS Bacterial Extract DME1104 XEOTICID XEO02913 DESCRIPT Coral associated bacteria 41 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO02913 GENEFORM Protein DME1104 XEOTICID XEO02913 MOACRIVE Inhibition DME1104 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1104 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO03073 XEO_CLAS Peptide DME1104 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC > 256 ug/ml) DME1104 XEOTICID XEO03073 GENEFORM Protein DME1104 XEOTICID XEO03073 MOACRIVE Inhibition DME1104 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1104 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO03116 XEO_CLAS Peptide DME1104 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC > 40 microM) DME1104 XEOTICID XEO03116 GENEFORM Protein DME1104 XEOTICID XEO03116 MOACRIVE Inhibition DME1104 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1104 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO03225 XEO_CLAS Peptide DME1104 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC = 93 microM) DME1104 XEOTICID XEO03225 GENEFORM Protein DME1104 XEOTICID XEO03225 MOACRIVE Inhibition DME1104 XEOTICID XEO03340 XEO_NAME Ethane-1,2-diamine DME1104 XEOTICID XEO03340 XEO_TYPE Pharmaceutical Agent(s) DME1104 XEOTICID XEO03340 XEO_CLAS Investigative Agent DME1104 XEOTICID XEO03340 DESCRIPT Ethane-1,2-diamine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO03340 GENEFORM Protein DME1104 XEOTICID XEO03340 MOACRIVE Inhibition DME1104 XEOTICID XEO03354 XEO_NAME Piper betle ethyl acetate extract DME1104 XEOTICID XEO03354 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1104 XEOTICID XEO03354 XEO_CLAS Plant Extract DME1104 XEOTICID XEO03354 DESCRIPT Piper betle ethyl acetate extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO03354 GENEFORM Protein DME1104 XEOTICID XEO03354 MOACRIVE Inhibition DME1104 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1104 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO03437 XEO_CLAS Peptide DME1104 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC > 200 ug/ml) DME1104 XEOTICID XEO03437 GENEFORM Protein DME1104 XEOTICID XEO03437 MOACRIVE Inhibition DME1104 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1104 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO03438 XEO_CLAS Peptide DME1104 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC > 200 ug/ml) DME1104 XEOTICID XEO03438 GENEFORM Protein DME1104 XEOTICID XEO03438 MOACRIVE Inhibition DME1104 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1104 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO03439 XEO_CLAS Peptide DME1104 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC > 200 ug/ml) DME1104 XEOTICID XEO03439 GENEFORM Protein DME1104 XEOTICID XEO03439 MOACRIVE Inhibition DME1104 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1104 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO03441 XEO_CLAS Peptide DME1104 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC > 200 ug/ml) DME1104 XEOTICID XEO03441 GENEFORM Protein DME1104 XEOTICID XEO03441 MOACRIVE Inhibition DME1104 XEOTICID XEO03519 XEO_NAME Hadrurin DME1104 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO03519 XEO_CLAS Peptide DME1104 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO03519 GENEFORM Protein DME1104 XEOTICID XEO03519 MOACRIVE Inhibition DME1104 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1104 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1104 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1104 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO03552 GENEFORM Protein DME1104 XEOTICID XEO03552 MOACRIVE Inhibition DME1104 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1104 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO03609 XEO_CLAS Peptide DME1104 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO03609 GENEFORM Protein DME1104 XEOTICID XEO03609 MOACRIVE Inhibition DME1104 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1104 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO03985 XEO_CLAS Peptide DME1104 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC = 100 ug/ml) DME1104 XEOTICID XEO03985 GENEFORM Protein DME1104 XEOTICID XEO03985 MOACRIVE Inhibition DME1104 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1104 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04039 XEO_CLAS Peptide DME1104 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC = 4 microM) DME1104 XEOTICID XEO04039 GENEFORM Protein DME1104 XEOTICID XEO04039 MOACRIVE Inhibition DME1104 XEOTICID XEO04081 XEO_NAME Aphrocallistes bocagei methanol extract DME1104 XEOTICID XEO04081 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1104 XEOTICID XEO04081 XEO_CLAS Sponge Extract DME1104 XEOTICID XEO04081 DESCRIPT Aphrocallistes bocagei methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04081 GENEFORM Protein DME1104 XEOTICID XEO04081 MOACRIVE Inhibition DME1104 XEOTICID XEO04082 XEO_NAME Clathria atrasanguinea methanol extract DME1104 XEOTICID XEO04082 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1104 XEOTICID XEO04082 XEO_CLAS Sponge Extract DME1104 XEOTICID XEO04082 DESCRIPT Clathria atrasanguinea methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04082 GENEFORM Protein DME1104 XEOTICID XEO04082 MOACRIVE Inhibition DME1104 XEOTICID XEO04083 XEO_NAME Haliclona megastoma methanol extract DME1104 XEOTICID XEO04083 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1104 XEOTICID XEO04083 XEO_CLAS Sponge Extract DME1104 XEOTICID XEO04083 DESCRIPT Haliclona megastoma methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04083 GENEFORM Protein DME1104 XEOTICID XEO04083 MOACRIVE Inhibition DME1104 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1104 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1104 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1104 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04086 GENEFORM Protein DME1104 XEOTICID XEO04086 MOACRIVE Inhibition DME1104 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1104 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1104 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1104 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04089 GENEFORM Protein DME1104 XEOTICID XEO04089 MOACRIVE Inhibition DME1104 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1104 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04158 XEO_CLAS Peptide DME1104 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC = 2 microM) DME1104 XEOTICID XEO04158 GENEFORM Protein DME1104 XEOTICID XEO04158 MOACRIVE Inhibition DME1104 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1104 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04159 XEO_CLAS Peptide DME1104 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC = 2 microM) DME1104 XEOTICID XEO04159 GENEFORM Protein DME1104 XEOTICID XEO04159 MOACRIVE Inhibition DME1104 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1104 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04185 XEO_CLAS Peptide DME1104 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04185 GENEFORM Protein DME1104 XEOTICID XEO04185 MOACRIVE Inhibition DME1104 XEOTICID XEO04208 XEO_NAME N1-(7-chloroquinolin-4-yl)ethane-1,2-diamine DME1104 XEOTICID XEO04208 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1104 XEOTICID XEO04208 XEO_CLAS Chemical Compound DME1104 XEOTICID XEO04208 DESCRIPT N1-(7-chloroquinolin-4-yl)ethane-1,2-diamine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04208 GENEFORM Protein DME1104 XEOTICID XEO04208 MOACRIVE Inhibition DME1104 XEOTICID XEO04352 XEO_NAME 1,8-Diaminooctane DME1104 XEOTICID XEO04352 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1104 XEOTICID XEO04352 XEO_CLAS Chemical Compound DME1104 XEOTICID XEO04352 DESCRIPT 1,8-Diaminooctane inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04352 GENEFORM Protein DME1104 XEOTICID XEO04352 MOACRIVE Inhibition DME1104 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1104 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04399 XEO_CLAS Peptide DME1104 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC = 50 microM) DME1104 XEOTICID XEO04399 GENEFORM Protein DME1104 XEOTICID XEO04399 MOACRIVE Inhibition DME1104 XEOTICID XEO04557 XEO_NAME 2,4-Di-tert-butylphenol DME1104 XEOTICID XEO04557 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1104 XEOTICID XEO04557 XEO_CLAS Natural Product DME1104 XEOTICID XEO04557 DESCRIPT 2,4-Di-tert-butylphenol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04557 GENEFORM Protein DME1104 XEOTICID XEO04557 MOACRIVE Inhibition DME1104 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1104 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04612 XEO_CLAS Peptide DME1104 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC > 20 microM) DME1104 XEOTICID XEO04612 GENEFORM Protein DME1104 XEOTICID XEO04612 MOACRIVE Inhibition DME1104 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1104 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04613 XEO_CLAS Peptide DME1104 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC > 20 microM) DME1104 XEOTICID XEO04613 GENEFORM Protein DME1104 XEOTICID XEO04613 MOACRIVE Inhibition DME1104 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1104 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04640 XEO_CLAS Peptide DME1104 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens (MIC > 35.0 microM) DME1104 XEOTICID XEO04640 GENEFORM Protein DME1104 XEOTICID XEO04640 MOACRIVE Inhibition DME1104 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1104 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04695 XEO_CLAS Peptide DME1104 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04695 GENEFORM Protein DME1104 XEOTICID XEO04695 MOACRIVE Inhibition DME1104 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1104 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04696 XEO_CLAS Peptide DME1104 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04696 GENEFORM Protein DME1104 XEOTICID XEO04696 MOACRIVE Inhibition DME1104 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1104 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04699 XEO_CLAS Peptide DME1104 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04699 GENEFORM Protein DME1104 XEOTICID XEO04699 MOACRIVE Inhibition DME1104 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1104 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04700 XEO_CLAS Peptide DME1104 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04700 GENEFORM Protein DME1104 XEOTICID XEO04700 MOACRIVE Inhibition DME1104 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1104 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04701 XEO_CLAS Peptide DME1104 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04701 GENEFORM Protein DME1104 XEOTICID XEO04701 MOACRIVE Inhibition DME1104 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1104 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04702 XEO_CLAS Peptide DME1104 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04702 GENEFORM Protein DME1104 XEOTICID XEO04702 MOACRIVE Inhibition DME1104 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1104 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04703 XEO_CLAS Peptide DME1104 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04703 GENEFORM Protein DME1104 XEOTICID XEO04703 MOACRIVE Inhibition DME1104 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1104 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1104 XEOTICID XEO04704 XEO_CLAS Peptide DME1104 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO04704 GENEFORM Protein DME1104 XEOTICID XEO04704 MOACRIVE Inhibition DME1104 XEOTICID XEO05199 XEO_NAME Undecanoic acid DME1104 XEOTICID XEO05199 XEO_TYPE Pharmaceutical Agent(s) DME1104 XEOTICID XEO05199 XEO_CLAS Investigative Agent DME1104 XEOTICID XEO05199 DESCRIPT Undecanoic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Serratia marcescens DME1104 XEOTICID XEO05199 GENEFORM Protein DME1104 XEOTICID XEO05199 MOACRIVE Inhibition DME1106 DME___ID DME1106 DME1106 DME_NAME Arylamine N-acetyltransferase (NAT) DME1106 SPESNAME Klebsiella pneumoniae DME1106 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1106 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1106 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1106 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO00546 GENEFORM Protein DME1106 XEOTICID XEO00546 MOACRIVE Inhibition DME1106 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1106 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1106 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1106 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO00574 GENEFORM Protein DME1106 XEOTICID XEO00574 MOACRIVE Inhibition DME1106 XEOTICID XEO01266 XEO_NAME Cyanidin DME1106 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME1106 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME1106 XEOTICID XEO01266 DESCRIPT Cyanidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO01266 GENEFORM Protein DME1106 XEOTICID XEO01266 MOACRIVE Inhibition DME1106 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1106 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO01816 XEO_CLAS Peptide DME1106 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 6.25 microM) DME1106 XEOTICID XEO01816 GENEFORM Protein DME1106 XEOTICID XEO01816 MOACRIVE Inhibition DME1106 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1106 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO01827 XEO_CLAS Peptide DME1106 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC > 50 microM) DME1106 XEOTICID XEO01827 GENEFORM Protein DME1106 XEOTICID XEO01827 MOACRIVE Inhibition DME1106 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1106 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02115 XEO_CLAS Peptide DME1106 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO02115 GENEFORM Protein DME1106 XEOTICID XEO02115 MOACRIVE Inhibition DME1106 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1106 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02230 XEO_CLAS Peptide DME1106 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1106 XEOTICID XEO02230 GENEFORM Protein DME1106 XEOTICID XEO02230 MOACRIVE Inhibition DME1106 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1106 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02280 XEO_CLAS Peptide DME1106 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO02280 GENEFORM Protein DME1106 XEOTICID XEO02280 MOACRIVE Inhibition DME1106 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1106 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02325 XEO_CLAS Peptide DME1106 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 13 microM) DME1106 XEOTICID XEO02325 GENEFORM Protein DME1106 XEOTICID XEO02325 MOACRIVE Inhibition DME1106 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1106 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02370 XEO_CLAS Peptide DME1106 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO02370 GENEFORM Protein DME1106 XEOTICID XEO02370 MOACRIVE Inhibition DME1106 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1106 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02371 XEO_CLAS Peptide DME1106 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 12 ug/ml) DME1106 XEOTICID XEO02371 GENEFORM Protein DME1106 XEOTICID XEO02371 MOACRIVE Inhibition DME1106 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1106 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02378 XEO_CLAS Peptide DME1106 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 0.76 ug/ml) DME1106 XEOTICID XEO02378 GENEFORM Protein DME1106 XEOTICID XEO02378 MOACRIVE Inhibition DME1106 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1106 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02416 XEO_CLAS Peptide DME1106 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO02416 GENEFORM Protein DME1106 XEOTICID XEO02416 MOACRIVE Inhibition DME1106 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1106 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02451 XEO_CLAS Peptide DME1106 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO02451 GENEFORM Protein DME1106 XEOTICID XEO02451 MOACRIVE Inhibition DME1106 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1106 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02473 XEO_CLAS Peptide DME1106 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO02473 GENEFORM Protein DME1106 XEOTICID XEO02473 MOACRIVE Inhibition DME1106 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1106 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02491 XEO_CLAS Peptide DME1106 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 2.8 microM) DME1106 XEOTICID XEO02491 GENEFORM Protein DME1106 XEOTICID XEO02491 MOACRIVE Inhibition DME1106 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1106 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02496 XEO_CLAS Peptide DME1106 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 50 microM) DME1106 XEOTICID XEO02496 GENEFORM Protein DME1106 XEOTICID XEO02496 MOACRIVE Inhibition DME1106 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1106 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02497 XEO_CLAS Peptide DME1106 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC > 50 microM) DME1106 XEOTICID XEO02497 GENEFORM Protein DME1106 XEOTICID XEO02497 MOACRIVE Inhibition DME1106 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1106 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02512 XEO_CLAS Peptide DME1106 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 150 microM) DME1106 XEOTICID XEO02512 GENEFORM Protein DME1106 XEOTICID XEO02512 MOACRIVE Inhibition DME1106 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1106 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02566 XEO_CLAS Peptide DME1106 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC > 100 microM) DME1106 XEOTICID XEO02566 GENEFORM Protein DME1106 XEOTICID XEO02566 MOACRIVE Inhibition DME1106 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1106 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02637 XEO_CLAS Peptide DME1106 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 6 microM) DME1106 XEOTICID XEO02637 GENEFORM Protein DME1106 XEOTICID XEO02637 MOACRIVE Inhibition DME1106 XEOTICID XEO02656 XEO_NAME Himatanthus drasticus butanolic extract DME1106 XEOTICID XEO02656 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1106 XEOTICID XEO02656 XEO_CLAS Plant Extract DME1106 XEOTICID XEO02656 DESCRIPT Himatanthus drasticus butanolic extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO02656 GENEFORM Protein DME1106 XEOTICID XEO02656 MOACRIVE Inhibition DME1106 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1106 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02688 XEO_CLAS Peptide DME1106 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 25 microM) DME1106 XEOTICID XEO02688 GENEFORM Protein DME1106 XEOTICID XEO02688 MOACRIVE Inhibition DME1106 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1106 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02708 XEO_CLAS Peptide DME1106 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 20 ug/ml) DME1106 XEOTICID XEO02708 GENEFORM Protein DME1106 XEOTICID XEO02708 MOACRIVE Inhibition DME1106 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1106 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02732 XEO_CLAS Peptide DME1106 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 1.25 microM) DME1106 XEOTICID XEO02732 GENEFORM Protein DME1106 XEOTICID XEO02732 MOACRIVE Inhibition DME1106 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1106 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02734 XEO_CLAS Peptide DME1106 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 0.40 microM) DME1106 XEOTICID XEO02734 GENEFORM Protein DME1106 XEOTICID XEO02734 MOACRIVE Inhibition DME1106 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1106 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02736 XEO_CLAS Peptide DME1106 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 0.66 microM) DME1106 XEOTICID XEO02736 GENEFORM Protein DME1106 XEOTICID XEO02736 MOACRIVE Inhibition DME1106 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1106 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02738 XEO_CLAS Peptide DME1106 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 1 microM) DME1106 XEOTICID XEO02738 GENEFORM Protein DME1106 XEOTICID XEO02738 MOACRIVE Inhibition DME1106 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1106 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02743 XEO_CLAS Peptide DME1106 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 4.7 ug/ml) DME1106 XEOTICID XEO02743 GENEFORM Protein DME1106 XEOTICID XEO02743 MOACRIVE Inhibition DME1106 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1106 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02749 XEO_CLAS Peptide DME1106 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 20 mug/ml) DME1106 XEOTICID XEO02749 GENEFORM Protein DME1106 XEOTICID XEO02749 MOACRIVE Inhibition DME1106 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1106 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02767 XEO_CLAS Peptide DME1106 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO02767 GENEFORM Protein DME1106 XEOTICID XEO02767 MOACRIVE Inhibition DME1106 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1106 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02768 XEO_CLAS Peptide DME1106 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 1-2.5 ug/ml) DME1106 XEOTICID XEO02768 GENEFORM Protein DME1106 XEOTICID XEO02768 MOACRIVE Inhibition DME1106 XEOTICID XEO02780 XEO_NAME Cefixime DME1106 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1106 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1106 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO02780 GENEFORM Protein DME1106 XEOTICID XEO02780 MOACRIVE Inhibition DME1106 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1106 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO02942 XEO_CLAS Peptide DME1106 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO02942 GENEFORM Protein DME1106 XEOTICID XEO02942 MOACRIVE Inhibition DME1106 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1106 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03029 XEO_CLAS Peptide DME1106 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 0.145 microM) DME1106 XEOTICID XEO03029 GENEFORM Protein DME1106 XEOTICID XEO03029 MOACRIVE Inhibition DME1106 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1106 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03030 XEO_CLAS Peptide DME1106 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 0.643 microM) DME1106 XEOTICID XEO03030 GENEFORM Protein DME1106 XEOTICID XEO03030 MOACRIVE Inhibition DME1106 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1106 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03031 XEO_CLAS Peptide DME1106 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 0.01 microM) DME1106 XEOTICID XEO03031 GENEFORM Protein DME1106 XEOTICID XEO03031 MOACRIVE Inhibition DME1106 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1106 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03032 XEO_CLAS Peptide DME1106 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC < 0.005 microM) DME1106 XEOTICID XEO03032 GENEFORM Protein DME1106 XEOTICID XEO03032 MOACRIVE Inhibition DME1106 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1106 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03033 XEO_CLAS Peptide DME1106 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC > 0.692 microM) DME1106 XEOTICID XEO03033 GENEFORM Protein DME1106 XEOTICID XEO03033 MOACRIVE Inhibition DME1106 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1106 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03034 XEO_CLAS Peptide DME1106 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 0.004 microM) DME1106 XEOTICID XEO03034 GENEFORM Protein DME1106 XEOTICID XEO03034 MOACRIVE Inhibition DME1106 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1106 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03035 XEO_CLAS Peptide DME1106 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 0.458 microM) DME1106 XEOTICID XEO03035 GENEFORM Protein DME1106 XEOTICID XEO03035 MOACRIVE Inhibition DME1106 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1106 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03051 XEO_CLAS Peptide DME1106 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1106 XEOTICID XEO03051 GENEFORM Protein DME1106 XEOTICID XEO03051 MOACRIVE Inhibition DME1106 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1106 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03052 XEO_CLAS Peptide DME1106 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1106 XEOTICID XEO03052 GENEFORM Protein DME1106 XEOTICID XEO03052 MOACRIVE Inhibition DME1106 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1106 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03053 XEO_CLAS Peptide DME1106 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1106 XEOTICID XEO03053 GENEFORM Protein DME1106 XEOTICID XEO03053 MOACRIVE Inhibition DME1106 XEOTICID XEO03089 XEO_NAME Decoralin DME1106 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03089 XEO_CLAS Peptide DME1106 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 80 microM) DME1106 XEOTICID XEO03089 GENEFORM Protein DME1106 XEOTICID XEO03089 MOACRIVE Inhibition DME1106 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1106 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03112 XEO_CLAS Peptide DME1106 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC > 50 ug/ml) DME1106 XEOTICID XEO03112 GENEFORM Protein DME1106 XEOTICID XEO03112 MOACRIVE Inhibition DME1106 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1106 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03137 XEO_CLAS Peptide DME1106 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03137 GENEFORM Protein DME1106 XEOTICID XEO03137 MOACRIVE Inhibition DME1106 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1106 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03162 XEO_CLAS Peptide DME1106 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 0.8 microM) DME1106 XEOTICID XEO03162 GENEFORM Protein DME1106 XEOTICID XEO03162 MOACRIVE Inhibition DME1106 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1106 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03224 XEO_CLAS Peptide DME1106 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1106 XEOTICID XEO03224 GENEFORM Protein DME1106 XEOTICID XEO03224 MOACRIVE Inhibition DME1106 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1106 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03235 XEO_CLAS Peptide DME1106 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 60 ug/ml) DME1106 XEOTICID XEO03235 GENEFORM Protein DME1106 XEOTICID XEO03235 MOACRIVE Inhibition DME1106 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1106 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03237 XEO_CLAS Peptide DME1106 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC > 100 ug/ml) DME1106 XEOTICID XEO03237 GENEFORM Protein DME1106 XEOTICID XEO03237 MOACRIVE Inhibition DME1106 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1106 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03238 XEO_CLAS Peptide DME1106 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1106 XEOTICID XEO03238 GENEFORM Protein DME1106 XEOTICID XEO03238 MOACRIVE Inhibition DME1106 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1106 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03239 XEO_CLAS Peptide DME1106 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1106 XEOTICID XEO03239 GENEFORM Protein DME1106 XEOTICID XEO03239 MOACRIVE Inhibition DME1106 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1106 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03250 XEO_CLAS Peptide DME1106 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03250 GENEFORM Protein DME1106 XEOTICID XEO03250 MOACRIVE Inhibition DME1106 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1106 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03251 XEO_CLAS Peptide DME1106 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03251 GENEFORM Protein DME1106 XEOTICID XEO03251 MOACRIVE Inhibition DME1106 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1106 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03253 XEO_CLAS Peptide DME1106 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 3.2 ug/ml) DME1106 XEOTICID XEO03253 GENEFORM Protein DME1106 XEOTICID XEO03253 MOACRIVE Inhibition DME1106 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1106 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1106 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1106 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03348 GENEFORM Protein DME1106 XEOTICID XEO03348 MOACRIVE Inhibition DME1106 XEOTICID XEO03387 XEO_NAME Ferric chloride DME1106 XEOTICID XEO03387 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1106 XEOTICID XEO03387 XEO_CLAS Chemical Compound DME1106 XEOTICID XEO03387 DESCRIPT Ferric chloride inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03387 GENEFORM Protein DME1106 XEOTICID XEO03387 MOACRIVE Inhibition DME1106 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1106 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03436 XEO_CLAS Peptide DME1106 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1106 XEOTICID XEO03436 GENEFORM Protein DME1106 XEOTICID XEO03436 MOACRIVE Inhibition DME1106 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1106 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03437 XEO_CLAS Peptide DME1106 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1106 XEOTICID XEO03437 GENEFORM Protein DME1106 XEOTICID XEO03437 MOACRIVE Inhibition DME1106 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1106 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03438 XEO_CLAS Peptide DME1106 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1106 XEOTICID XEO03438 GENEFORM Protein DME1106 XEOTICID XEO03438 MOACRIVE Inhibition DME1106 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1106 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03439 XEO_CLAS Peptide DME1106 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1106 XEOTICID XEO03439 GENEFORM Protein DME1106 XEOTICID XEO03439 MOACRIVE Inhibition DME1106 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1106 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03440 XEO_CLAS Peptide DME1106 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1106 XEOTICID XEO03440 GENEFORM Protein DME1106 XEOTICID XEO03440 MOACRIVE Inhibition DME1106 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1106 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03441 XEO_CLAS Peptide DME1106 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1106 XEOTICID XEO03441 GENEFORM Protein DME1106 XEOTICID XEO03441 MOACRIVE Inhibition DME1106 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1106 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03497 XEO_CLAS Peptide DME1106 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1106 XEOTICID XEO03497 GENEFORM Protein DME1106 XEOTICID XEO03497 MOACRIVE Inhibition DME1106 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1106 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03498 XEO_CLAS Peptide DME1106 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1106 XEOTICID XEO03498 GENEFORM Protein DME1106 XEOTICID XEO03498 MOACRIVE Inhibition DME1106 XEOTICID XEO03519 XEO_NAME Hadrurin DME1106 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03519 XEO_CLAS Peptide DME1106 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03519 GENEFORM Protein DME1106 XEOTICID XEO03519 MOACRIVE Inhibition DME1106 XEOTICID XEO03522 XEO_NAME Halocyntin DME1106 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03522 XEO_CLAS Peptide DME1106 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03522 GENEFORM Protein DME1106 XEOTICID XEO03522 MOACRIVE Inhibition DME1106 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1106 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03540 XEO_CLAS Peptide DME1106 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1106 XEOTICID XEO03540 GENEFORM Protein DME1106 XEOTICID XEO03540 MOACRIVE Inhibition DME1106 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1106 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03549 XEO_CLAS Peptide DME1106 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03549 GENEFORM Protein DME1106 XEOTICID XEO03549 MOACRIVE Inhibition DME1106 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1106 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1106 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1106 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03552 GENEFORM Protein DME1106 XEOTICID XEO03552 MOACRIVE Inhibition DME1106 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1106 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03556 XEO_CLAS Peptide DME1106 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1106 XEOTICID XEO03556 GENEFORM Protein DME1106 XEOTICID XEO03556 MOACRIVE Inhibition DME1106 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1106 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03557 XEO_CLAS Peptide DME1106 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1106 XEOTICID XEO03557 GENEFORM Protein DME1106 XEOTICID XEO03557 MOACRIVE Inhibition DME1106 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1106 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03591 XEO_CLAS Peptide DME1106 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1106 XEOTICID XEO03591 GENEFORM Protein DME1106 XEOTICID XEO03591 MOACRIVE Inhibition DME1106 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1106 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03593 XEO_CLAS Peptide DME1106 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1106 XEOTICID XEO03593 GENEFORM Protein DME1106 XEOTICID XEO03593 MOACRIVE Inhibition DME1106 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1106 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03609 XEO_CLAS Peptide DME1106 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03609 GENEFORM Protein DME1106 XEOTICID XEO03609 MOACRIVE Inhibition DME1106 XEOTICID XEO03611 XEO_NAME Himatanthus drasticus hydroalcoholic extract DME1106 XEOTICID XEO03611 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1106 XEOTICID XEO03611 XEO_CLAS Plant Extract DME1106 XEOTICID XEO03611 DESCRIPT Himatanthus drasticus hydroalcoholic extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03611 GENEFORM Protein DME1106 XEOTICID XEO03611 MOACRIVE Inhibition DME1106 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1106 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03622 XEO_CLAS Peptide DME1106 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 20-40 microM) DME1106 XEOTICID XEO03622 GENEFORM Protein DME1106 XEOTICID XEO03622 MOACRIVE Inhibition DME1106 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1106 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03630 XEO_CLAS Peptide DME1106 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03630 GENEFORM Protein DME1106 XEOTICID XEO03630 MOACRIVE Inhibition DME1106 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1106 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03631 XEO_CLAS Peptide DME1106 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03631 GENEFORM Protein DME1106 XEOTICID XEO03631 MOACRIVE Inhibition DME1106 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1106 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03632 XEO_CLAS Peptide DME1106 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03632 GENEFORM Protein DME1106 XEOTICID XEO03632 MOACRIVE Inhibition DME1106 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1106 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03633 XEO_CLAS Peptide DME1106 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03633 GENEFORM Protein DME1106 XEOTICID XEO03633 MOACRIVE Inhibition DME1106 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1106 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03634 XEO_CLAS Peptide DME1106 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03634 GENEFORM Protein DME1106 XEOTICID XEO03634 MOACRIVE Inhibition DME1106 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1106 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03635 XEO_CLAS Peptide DME1106 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03635 GENEFORM Protein DME1106 XEOTICID XEO03635 MOACRIVE Inhibition DME1106 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1106 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03636 XEO_CLAS Peptide DME1106 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03636 GENEFORM Protein DME1106 XEOTICID XEO03636 MOACRIVE Inhibition DME1106 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1106 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03637 XEO_CLAS Peptide DME1106 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03637 GENEFORM Protein DME1106 XEOTICID XEO03637 MOACRIVE Inhibition DME1106 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1106 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03638 XEO_CLAS Peptide DME1106 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03638 GENEFORM Protein DME1106 XEOTICID XEO03638 MOACRIVE Inhibition DME1106 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1106 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03639 XEO_CLAS Peptide DME1106 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03639 GENEFORM Protein DME1106 XEOTICID XEO03639 MOACRIVE Inhibition DME1106 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1106 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03640 XEO_CLAS Peptide DME1106 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03640 GENEFORM Protein DME1106 XEOTICID XEO03640 MOACRIVE Inhibition DME1106 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1106 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03672 XEO_CLAS Peptide DME1106 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1106 XEOTICID XEO03672 GENEFORM Protein DME1106 XEOTICID XEO03672 MOACRIVE Inhibition DME1106 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1106 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03673 XEO_CLAS Peptide DME1106 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1106 XEOTICID XEO03673 GENEFORM Protein DME1106 XEOTICID XEO03673 MOACRIVE Inhibition DME1106 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1106 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03674 XEO_CLAS Peptide DME1106 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO03674 GENEFORM Protein DME1106 XEOTICID XEO03674 MOACRIVE Inhibition DME1106 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1106 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03675 XEO_CLAS Peptide DME1106 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 15 microM) DME1106 XEOTICID XEO03675 GENEFORM Protein DME1106 XEOTICID XEO03675 MOACRIVE Inhibition DME1106 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1106 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03678 XEO_CLAS Peptide DME1106 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1106 XEOTICID XEO03678 GENEFORM Protein DME1106 XEOTICID XEO03678 MOACRIVE Inhibition DME1106 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1106 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03681 XEO_CLAS Peptide DME1106 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 1.2-2.5 microM) DME1106 XEOTICID XEO03681 GENEFORM Protein DME1106 XEOTICID XEO03681 MOACRIVE Inhibition DME1106 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1106 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03697 XEO_CLAS Peptide DME1106 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 25 microM) DME1106 XEOTICID XEO03697 GENEFORM Protein DME1106 XEOTICID XEO03697 MOACRIVE Inhibition DME1106 XEOTICID XEO03724 XEO_NAME L10 peptide DME1106 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03724 XEO_CLAS Peptide DME1106 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 3.35 microM) DME1106 XEOTICID XEO03724 GENEFORM Protein DME1106 XEOTICID XEO03724 MOACRIVE Inhibition DME1106 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1106 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03744 XEO_CLAS Peptide DME1106 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1106 XEOTICID XEO03744 GENEFORM Protein DME1106 XEOTICID XEO03744 MOACRIVE Inhibition DME1106 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1106 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03746 XEO_CLAS Peptide DME1106 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1106 XEOTICID XEO03746 GENEFORM Protein DME1106 XEOTICID XEO03746 MOACRIVE Inhibition DME1106 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1106 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03747 XEO_CLAS Peptide DME1106 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1106 XEOTICID XEO03747 GENEFORM Protein DME1106 XEOTICID XEO03747 MOACRIVE Inhibition DME1106 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1106 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03748 XEO_CLAS Peptide DME1106 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1106 XEOTICID XEO03748 GENEFORM Protein DME1106 XEOTICID XEO03748 MOACRIVE Inhibition DME1106 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1106 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03749 XEO_CLAS Peptide DME1106 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1106 XEOTICID XEO03749 GENEFORM Protein DME1106 XEOTICID XEO03749 MOACRIVE Inhibition DME1106 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1106 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03750 XEO_CLAS Peptide DME1106 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1106 XEOTICID XEO03750 GENEFORM Protein DME1106 XEOTICID XEO03750 MOACRIVE Inhibition DME1106 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1106 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03751 XEO_CLAS Peptide DME1106 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1106 XEOTICID XEO03751 GENEFORM Protein DME1106 XEOTICID XEO03751 MOACRIVE Inhibition DME1106 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1106 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03752 XEO_CLAS Peptide DME1106 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1106 XEOTICID XEO03752 GENEFORM Protein DME1106 XEOTICID XEO03752 MOACRIVE Inhibition DME1106 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1106 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03753 XEO_CLAS Peptide DME1106 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1106 XEOTICID XEO03753 GENEFORM Protein DME1106 XEOTICID XEO03753 MOACRIVE Inhibition DME1106 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1106 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03754 XEO_CLAS Peptide DME1106 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1106 XEOTICID XEO03754 GENEFORM Protein DME1106 XEOTICID XEO03754 MOACRIVE Inhibition DME1106 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1106 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03755 XEO_CLAS Peptide DME1106 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1106 XEOTICID XEO03755 GENEFORM Protein DME1106 XEOTICID XEO03755 MOACRIVE Inhibition DME1106 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1106 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03756 XEO_CLAS Peptide DME1106 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1106 XEOTICID XEO03756 GENEFORM Protein DME1106 XEOTICID XEO03756 MOACRIVE Inhibition DME1106 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1106 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03759 XEO_CLAS Peptide DME1106 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1106 XEOTICID XEO03759 GENEFORM Protein DME1106 XEOTICID XEO03759 MOACRIVE Inhibition DME1106 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1106 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03761 XEO_CLAS Peptide DME1106 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1106 XEOTICID XEO03761 GENEFORM Protein DME1106 XEOTICID XEO03761 MOACRIVE Inhibition DME1106 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1106 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO03985 XEO_CLAS Peptide DME1106 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1106 XEOTICID XEO03985 GENEFORM Protein DME1106 XEOTICID XEO03985 MOACRIVE Inhibition DME1106 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1106 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04001 XEO_CLAS Peptide DME1106 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 12.5 microM) DME1106 XEOTICID XEO04001 GENEFORM Protein DME1106 XEOTICID XEO04001 MOACRIVE Inhibition DME1106 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1106 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04007 XEO_CLAS Peptide DME1106 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1106 XEOTICID XEO04007 GENEFORM Protein DME1106 XEOTICID XEO04007 MOACRIVE Inhibition DME1106 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1106 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04011 XEO_CLAS Peptide DME1106 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1106 XEOTICID XEO04011 GENEFORM Protein DME1106 XEOTICID XEO04011 MOACRIVE Inhibition DME1106 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1106 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04012 XEO_CLAS Peptide DME1106 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1106 XEOTICID XEO04012 GENEFORM Protein DME1106 XEOTICID XEO04012 MOACRIVE Inhibition DME1106 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1106 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04013 XEO_CLAS Peptide DME1106 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1106 XEOTICID XEO04013 GENEFORM Protein DME1106 XEOTICID XEO04013 MOACRIVE Inhibition DME1106 XEOTICID XEO04014 XEO_NAME Maximin-5 DME1106 XEOTICID XEO04014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04014 XEO_CLAS Peptide DME1106 XEOTICID XEO04014 DESCRIPT Maximin-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 3.6 ug/ml) DME1106 XEOTICID XEO04014 GENEFORM Protein DME1106 XEOTICID XEO04014 MOACRIVE Inhibition DME1106 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1106 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1106 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1106 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04087 GENEFORM Protein DME1106 XEOTICID XEO04087 MOACRIVE Inhibition DME1106 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1106 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04111 XEO_CLAS Peptide DME1106 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04111 GENEFORM Protein DME1106 XEOTICID XEO04111 MOACRIVE Inhibition DME1106 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1106 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04241 XEO_CLAS Peptide DME1106 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04241 GENEFORM Protein DME1106 XEOTICID XEO04241 MOACRIVE Inhibition DME1106 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1106 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04242 XEO_CLAS Peptide DME1106 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04242 GENEFORM Protein DME1106 XEOTICID XEO04242 MOACRIVE Inhibition DME1106 XEOTICID XEO04331 XEO_NAME Norspermidine DME1106 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1106 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1106 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04331 GENEFORM Protein DME1106 XEOTICID XEO04331 MOACRIVE Inhibition DME1106 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1106 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04348 XEO_CLAS Peptide DME1106 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 80 microM) DME1106 XEOTICID XEO04348 GENEFORM Protein DME1106 XEOTICID XEO04348 MOACRIVE Inhibition DME1106 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1106 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04349 XEO_CLAS Peptide DME1106 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 100 microM) DME1106 XEOTICID XEO04349 GENEFORM Protein DME1106 XEOTICID XEO04349 MOACRIVE Inhibition DME1106 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1106 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04399 XEO_CLAS Peptide DME1106 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 6.3 microM) DME1106 XEOTICID XEO04399 GENEFORM Protein DME1106 XEOTICID XEO04399 MOACRIVE Inhibition DME1106 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1106 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04426 XEO_CLAS Peptide DME1106 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 2 microM) DME1106 XEOTICID XEO04426 GENEFORM Protein DME1106 XEOTICID XEO04426 MOACRIVE Inhibition DME1106 XEOTICID XEO04468 XEO_NAME Papillosin DME1106 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04468 XEO_CLAS Peptide DME1106 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04468 GENEFORM Protein DME1106 XEOTICID XEO04468 MOACRIVE Inhibition DME1106 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1106 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04471 XEO_CLAS Peptide DME1106 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 1.6 microM) DME1106 XEOTICID XEO04471 GENEFORM Protein DME1106 XEOTICID XEO04471 MOACRIVE Inhibition DME1106 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1106 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04506 XEO_CLAS Peptide DME1106 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC > 20 microM) DME1106 XEOTICID XEO04506 GENEFORM Protein DME1106 XEOTICID XEO04506 MOACRIVE Inhibition DME1106 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1106 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04507 XEO_CLAS Peptide DME1106 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC > 40 microM) DME1106 XEOTICID XEO04507 GENEFORM Protein DME1106 XEOTICID XEO04507 MOACRIVE Inhibition DME1106 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1106 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04510 XEO_CLAS Peptide DME1106 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC > 50 microM) DME1106 XEOTICID XEO04510 GENEFORM Protein DME1106 XEOTICID XEO04510 MOACRIVE Inhibition DME1106 XEOTICID XEO04531 XEO_NAME Mollusca/molluscs/mollusks peptide 2 DME1106 XEOTICID XEO04531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04531 XEO_CLAS Peptide DME1106 XEOTICID XEO04531 DESCRIPT Mollusca/molluscs/mollusks peptide 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04531 GENEFORM Protein DME1106 XEOTICID XEO04531 MOACRIVE Inhibition DME1106 XEOTICID XEO04533 XEO_NAME Mollusca/molluscs/mollusks peptide 3 DME1106 XEOTICID XEO04533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04533 XEO_CLAS Peptide DME1106 XEOTICID XEO04533 DESCRIPT Mollusca/molluscs/mollusks peptide 3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04533 GENEFORM Protein DME1106 XEOTICID XEO04533 MOACRIVE Inhibition DME1106 XEOTICID XEO04534 XEO_NAME Mollusca/molluscs/mollusks peptide 4 DME1106 XEOTICID XEO04534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04534 XEO_CLAS Peptide DME1106 XEOTICID XEO04534 DESCRIPT Mollusca/molluscs/mollusks peptide 4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04534 GENEFORM Protein DME1106 XEOTICID XEO04534 MOACRIVE Inhibition DME1106 XEOTICID XEO04535 XEO_NAME Mollusca/molluscs/mollusks peptide 5 DME1106 XEOTICID XEO04535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04535 XEO_CLAS Peptide DME1106 XEOTICID XEO04535 DESCRIPT Mollusca/molluscs/mollusks peptide 5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04535 GENEFORM Protein DME1106 XEOTICID XEO04535 MOACRIVE Inhibition DME1106 XEOTICID XEO04536 XEO_NAME Mollusca/molluscs/mollusks peptide 6 DME1106 XEOTICID XEO04536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04536 XEO_CLAS Peptide DME1106 XEOTICID XEO04536 DESCRIPT Mollusca/molluscs/mollusks peptide 6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04536 GENEFORM Protein DME1106 XEOTICID XEO04536 MOACRIVE Inhibition DME1106 XEOTICID XEO04537 XEO_NAME Mollusca/molluscs/mollusks peptide 7 DME1106 XEOTICID XEO04537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04537 XEO_CLAS Peptide DME1106 XEOTICID XEO04537 DESCRIPT Mollusca/molluscs/mollusks peptide 7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04537 GENEFORM Protein DME1106 XEOTICID XEO04537 MOACRIVE Inhibition DME1106 XEOTICID XEO04538 XEO_NAME Mollusca/molluscs/mollusks peptide 8 DME1106 XEOTICID XEO04538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04538 XEO_CLAS Peptide DME1106 XEOTICID XEO04538 DESCRIPT Mollusca/molluscs/mollusks peptide 8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04538 GENEFORM Protein DME1106 XEOTICID XEO04538 MOACRIVE Inhibition DME1106 XEOTICID XEO04539 XEO_NAME Mollusca/molluscs/mollusks peptide 9 DME1106 XEOTICID XEO04539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04539 XEO_CLAS Peptide DME1106 XEOTICID XEO04539 DESCRIPT Mollusca/molluscs/mollusks peptide 9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04539 GENEFORM Protein DME1106 XEOTICID XEO04539 MOACRIVE Inhibition DME1106 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1106 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04548 XEO_CLAS Peptide DME1106 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 32000 ug/ml) DME1106 XEOTICID XEO04548 GENEFORM Protein DME1106 XEOTICID XEO04548 MOACRIVE Inhibition DME1106 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1106 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04549 XEO_CLAS Peptide DME1106 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 250-500 ug/ml) DME1106 XEOTICID XEO04549 GENEFORM Protein DME1106 XEOTICID XEO04549 MOACRIVE Inhibition DME1106 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1106 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04571 XEO_CLAS Peptide DME1106 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04571 GENEFORM Protein DME1106 XEOTICID XEO04571 MOACRIVE Inhibition DME1106 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1106 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04572 XEO_CLAS Peptide DME1106 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04572 GENEFORM Protein DME1106 XEOTICID XEO04572 MOACRIVE Inhibition DME1106 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1106 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04606 XEO_CLAS Peptide DME1106 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 2 microM) DME1106 XEOTICID XEO04606 GENEFORM Protein DME1106 XEOTICID XEO04606 MOACRIVE Inhibition DME1106 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1106 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04612 XEO_CLAS Peptide DME1106 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1106 XEOTICID XEO04612 GENEFORM Protein DME1106 XEOTICID XEO04612 MOACRIVE Inhibition DME1106 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1106 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04613 XEO_CLAS Peptide DME1106 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1106 XEOTICID XEO04613 GENEFORM Protein DME1106 XEOTICID XEO04613 MOACRIVE Inhibition DME1106 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1106 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04695 XEO_CLAS Peptide DME1106 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04695 GENEFORM Protein DME1106 XEOTICID XEO04695 MOACRIVE Inhibition DME1106 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1106 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04696 XEO_CLAS Peptide DME1106 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04696 GENEFORM Protein DME1106 XEOTICID XEO04696 MOACRIVE Inhibition DME1106 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1106 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04697 XEO_CLAS Peptide DME1106 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04697 GENEFORM Protein DME1106 XEOTICID XEO04697 MOACRIVE Inhibition DME1106 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1106 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04698 XEO_CLAS Peptide DME1106 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04698 GENEFORM Protein DME1106 XEOTICID XEO04698 MOACRIVE Inhibition DME1106 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1106 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04699 XEO_CLAS Peptide DME1106 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04699 GENEFORM Protein DME1106 XEOTICID XEO04699 MOACRIVE Inhibition DME1106 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1106 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04700 XEO_CLAS Peptide DME1106 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04700 GENEFORM Protein DME1106 XEOTICID XEO04700 MOACRIVE Inhibition DME1106 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1106 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04701 XEO_CLAS Peptide DME1106 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04701 GENEFORM Protein DME1106 XEOTICID XEO04701 MOACRIVE Inhibition DME1106 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1106 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04702 XEO_CLAS Peptide DME1106 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04702 GENEFORM Protein DME1106 XEOTICID XEO04702 MOACRIVE Inhibition DME1106 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1106 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04703 XEO_CLAS Peptide DME1106 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04703 GENEFORM Protein DME1106 XEOTICID XEO04703 MOACRIVE Inhibition DME1106 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1106 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04762 XEO_CLAS Peptide DME1106 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC > 25 microM) DME1106 XEOTICID XEO04762 GENEFORM Protein DME1106 XEOTICID XEO04762 MOACRIVE Inhibition DME1106 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1106 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04809 XEO_CLAS Peptide DME1106 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 10 microM) DME1106 XEOTICID XEO04809 GENEFORM Protein DME1106 XEOTICID XEO04809 MOACRIVE Inhibition DME1106 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1106 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04891 XEO_CLAS Peptide DME1106 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04891 GENEFORM Protein DME1106 XEOTICID XEO04891 MOACRIVE Inhibition DME1106 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1106 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04905 XEO_CLAS Peptide DME1106 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04905 GENEFORM Protein DME1106 XEOTICID XEO04905 MOACRIVE Inhibition DME1106 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1106 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04906 XEO_CLAS Peptide DME1106 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO04906 GENEFORM Protein DME1106 XEOTICID XEO04906 MOACRIVE Inhibition DME1106 XEOTICID XEO04917 XEO_NAME Scorpine DME1106 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04917 XEO_CLAS Peptide DME1106 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 10 microM) DME1106 XEOTICID XEO04917 GENEFORM Protein DME1106 XEOTICID XEO04917 MOACRIVE Inhibition DME1106 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1106 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04971 XEO_CLAS Peptide DME1106 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1106 XEOTICID XEO04971 GENEFORM Protein DME1106 XEOTICID XEO04971 MOACRIVE Inhibition DME1106 XEOTICID XEO04974 XEO_NAME Spinigerin DME1106 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04974 XEO_CLAS Peptide DME1106 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1106 XEOTICID XEO04974 GENEFORM Protein DME1106 XEOTICID XEO04974 MOACRIVE Inhibition DME1106 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1106 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO04995 XEO_CLAS Peptide DME1106 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 0.78-1.56 microM) DME1106 XEOTICID XEO04995 GENEFORM Protein DME1106 XEOTICID XEO04995 MOACRIVE Inhibition DME1106 XEOTICID XEO05020 XEO_NAME Tachycitin DME1106 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO05020 XEO_CLAS Peptide DME1106 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae DME1106 XEOTICID XEO05020 GENEFORM Protein DME1106 XEOTICID XEO05020 MOACRIVE Inhibition DME1106 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1106 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO05073 XEO_CLAS Peptide DME1106 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 80 microM) DME1106 XEOTICID XEO05073 GENEFORM Protein DME1106 XEOTICID XEO05073 MOACRIVE Inhibition DME1106 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1106 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO05075 XEO_CLAS Peptide DME1106 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 80 microM) DME1106 XEOTICID XEO05075 GENEFORM Protein DME1106 XEOTICID XEO05075 MOACRIVE Inhibition DME1106 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1106 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO05101 XEO_CLAS Peptide DME1106 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 31.2 ug/ml) DME1106 XEOTICID XEO05101 GENEFORM Protein DME1106 XEOTICID XEO05101 MOACRIVE Inhibition DME1106 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1106 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO05102 XEO_CLAS Peptide DME1106 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 35.1 ug/ml) DME1106 XEOTICID XEO05102 GENEFORM Protein DME1106 XEOTICID XEO05102 MOACRIVE Inhibition DME1106 XEOTICID XEO05120 XEO_NAME Thanatin DME1106 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO05120 XEO_CLAS Peptide DME1106 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 0.6-1.2 microM) DME1106 XEOTICID XEO05120 GENEFORM Protein DME1106 XEOTICID XEO05120 MOACRIVE Inhibition DME1106 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1106 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO05163 XEO_CLAS Peptide DME1106 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 12-25 ug/ml) DME1106 XEOTICID XEO05163 GENEFORM Protein DME1106 XEOTICID XEO05163 MOACRIVE Inhibition DME1106 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1106 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1106 XEOTICID XEO05220 XEO_CLAS Peptide DME1106 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1106 XEOTICID XEO05220 GENEFORM Protein DME1106 XEOTICID XEO05220 MOACRIVE Inhibition DME1108 DME___ID DME1108 DME1108 DME_NAME Arylamine N-acetyltransferase (NAT) DME1108 SPESNAME Klebsiella oxytoca DME1108 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1108 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO01812 XEO_CLAS Peptide DME1108 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca (MIC = 4.0 microM) DME1108 XEOTICID XEO01812 GENEFORM Protein DME1108 XEOTICID XEO01812 MOACRIVE Inhibition DME1108 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1108 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO01813 XEO_CLAS Peptide DME1108 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca (MIC = 4.1 microM) DME1108 XEOTICID XEO01813 GENEFORM Protein DME1108 XEOTICID XEO01813 MOACRIVE Inhibition DME1108 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1108 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO01814 XEO_CLAS Peptide DME1108 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca (MIC = 2.4 microM) DME1108 XEOTICID XEO01814 GENEFORM Protein DME1108 XEOTICID XEO01814 MOACRIVE Inhibition DME1108 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1108 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO01815 XEO_CLAS Peptide DME1108 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca (MIC = 6.1 microM) DME1108 XEOTICID XEO01815 GENEFORM Protein DME1108 XEOTICID XEO01815 MOACRIVE Inhibition DME1108 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1108 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO02284 XEO_CLAS Peptide DME1108 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca (MIC = 50.5 microM) DME1108 XEOTICID XEO02284 GENEFORM Protein DME1108 XEOTICID XEO02284 MOACRIVE Inhibition DME1108 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1108 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO02285 XEO_CLAS Peptide DME1108 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca (MIC = 50.5 microM) DME1108 XEOTICID XEO02285 GENEFORM Protein DME1108 XEOTICID XEO02285 MOACRIVE Inhibition DME1108 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1108 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO02286 XEO_CLAS Peptide DME1108 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca (MIC = 50.5 microM) DME1108 XEOTICID XEO02286 GENEFORM Protein DME1108 XEOTICID XEO02286 MOACRIVE Inhibition DME1108 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1108 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO02287 XEO_CLAS Peptide DME1108 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca (MIC = 50.5 microM) DME1108 XEOTICID XEO02287 GENEFORM Protein DME1108 XEOTICID XEO02287 MOACRIVE Inhibition DME1108 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1108 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO03039 XEO_CLAS Peptide DME1108 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca (MIC = 5.80 microM) DME1108 XEOTICID XEO03039 GENEFORM Protein DME1108 XEOTICID XEO03039 MOACRIVE Inhibition DME1108 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1108 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO03609 XEO_CLAS Peptide DME1108 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca DME1108 XEOTICID XEO03609 GENEFORM Protein DME1108 XEOTICID XEO03609 MOACRIVE Inhibition DME1108 XEOTICID XEO03693 XEO_NAME Kalata-B1 DME1108 XEOTICID XEO03693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO03693 XEO_CLAS Peptide DME1108 XEOTICID XEO03693 DESCRIPT Kalata-B1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca (MIC = 54.8 microM) DME1108 XEOTICID XEO03693 GENEFORM Protein DME1108 XEOTICID XEO03693 MOACRIVE Inhibition DME1108 XEOTICID XEO04114 XEO_NAME Microcin L DME1108 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO04114 XEO_CLAS Peptide DME1108 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca DME1108 XEOTICID XEO04114 GENEFORM Protein DME1108 XEOTICID XEO04114 MOACRIVE Inhibition DME1108 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1108 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO04259 XEO_CLAS Peptide DME1108 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca DME1108 XEOTICID XEO04259 GENEFORM Protein DME1108 XEOTICID XEO04259 MOACRIVE Inhibition DME1108 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1108 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO04261 XEO_CLAS Peptide DME1108 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca DME1108 XEOTICID XEO04261 GENEFORM Protein DME1108 XEOTICID XEO04261 MOACRIVE Inhibition DME1108 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1108 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO04265 XEO_CLAS Peptide DME1108 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca DME1108 XEOTICID XEO04265 GENEFORM Protein DME1108 XEOTICID XEO04265 MOACRIVE Inhibition DME1108 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1108 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO04268 XEO_CLAS Peptide DME1108 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca DME1108 XEOTICID XEO04268 GENEFORM Protein DME1108 XEOTICID XEO04268 MOACRIVE Inhibition DME1108 XEOTICID XEO04863 XEO_NAME RTD peptide DME1108 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO04863 XEO_CLAS Peptide DME1108 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca (MIC = 2.0 microM) DME1108 XEOTICID XEO04863 GENEFORM Protein DME1108 XEOTICID XEO04863 MOACRIVE Inhibition DME1108 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1108 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1108 XEOTICID XEO05170 XEO_CLAS Peptide DME1108 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Klebsiella oxytoca (MIC = 2.1 microM) DME1108 XEOTICID XEO05170 GENEFORM Protein DME1108 XEOTICID XEO05170 MOACRIVE Inhibition DME1110 DME___ID DME1110 DME1110 DME_NAME Arylamine N-acetyltransferase (NAT) DME1110 SPESNAME Pseudomonas aeruginosa DME1110 XEOTICID XEO00001 XEO_NAME Dimethyl sulfoxide DME1110 XEOTICID XEO00001 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00001 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00001 DESCRIPT Dimethyl sulfoxide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00001 GENEFORM Protein DME1110 XEOTICID XEO00001 MOACRIVE Inhibition DME1110 XEOTICID XEO00037 XEO_NAME Fluorouracil DME1110 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00037 DESCRIPT Fluorouracil inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00037 GENEFORM Protein DME1110 XEOTICID XEO00037 MOACRIVE Inhibition DME1110 XEOTICID XEO00096 XEO_NAME Ampicillin DME1110 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00096 GENEFORM Protein DME1110 XEOTICID XEO00096 MOACRIVE Inhibition DME1110 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1110 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00117 GENEFORM Protein DME1110 XEOTICID XEO00117 MOACRIVE Inhibition DME1110 XEOTICID XEO00164 XEO_NAME Azithromycin DME1110 XEOTICID XEO00164 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00164 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00164 DESCRIPT Azithromycin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00164 GENEFORM Protein DME1110 XEOTICID XEO00164 MOACRIVE Inhibition DME1110 XEOTICID XEO00199 XEO_NAME Doxycycline DME1110 XEOTICID XEO00199 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00199 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00199 DESCRIPT Doxycycline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00199 GENEFORM Protein DME1110 XEOTICID XEO00199 MOACRIVE Inhibition DME1110 XEOTICID XEO00218 XEO_NAME Caffeine DME1110 XEOTICID XEO00218 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00218 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00218 DESCRIPT Caffeine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00218 GENEFORM Protein DME1110 XEOTICID XEO00218 MOACRIVE Inhibition DME1110 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1110 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00237 GENEFORM Protein DME1110 XEOTICID XEO00237 MOACRIVE Inhibition DME1110 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1110 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00349 GENEFORM Protein DME1110 XEOTICID XEO00349 MOACRIVE Inhibition DME1110 XEOTICID XEO00375 XEO_NAME Piperacillin DME1110 XEOTICID XEO00375 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00375 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00375 DESCRIPT Piperacillin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00375 GENEFORM Protein DME1110 XEOTICID XEO00375 MOACRIVE Inhibition DME1110 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME1110 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00388 GENEFORM Protein DME1110 XEOTICID XEO00388 MOACRIVE Inhibition DME1110 XEOTICID XEO00396 XEO_NAME Gentamicin DME1110 XEOTICID XEO00396 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00396 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00396 DESCRIPT Gentamicin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00396 GENEFORM Protein DME1110 XEOTICID XEO00396 MOACRIVE Inhibition DME1110 XEOTICID XEO00405 XEO_NAME Niclosamide DME1110 XEOTICID XEO00405 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00405 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00405 DESCRIPT Niclosamide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00405 GENEFORM Protein DME1110 XEOTICID XEO00405 MOACRIVE Inhibition DME1110 XEOTICID XEO00416 XEO_NAME Menthol DME1110 XEOTICID XEO00416 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00416 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00416 DESCRIPT Menthol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00416 GENEFORM Protein DME1110 XEOTICID XEO00416 MOACRIVE Inhibition DME1110 XEOTICID XEO00444 XEO_NAME Zinc chloride DME1110 XEOTICID XEO00444 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00444 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00444 DESCRIPT Zinc chloride inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00444 GENEFORM Protein DME1110 XEOTICID XEO00444 MOACRIVE Inhibition DME1110 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1110 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00460 GENEFORM Protein DME1110 XEOTICID XEO00460 MOACRIVE Inhibition DME1110 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1110 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00511 GENEFORM Protein DME1110 XEOTICID XEO00511 MOACRIVE Inhibition DME1110 XEOTICID XEO00538 XEO_NAME Quercetin DME1110 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1110 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00538 GENEFORM Protein DME1110 XEOTICID XEO00538 MOACRIVE Inhibition DME1110 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1110 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1110 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00546 GENEFORM Protein DME1110 XEOTICID XEO00546 MOACRIVE Inhibition DME1110 XEOTICID XEO00568 XEO_NAME Resveratrol DME1110 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1110 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00568 GENEFORM Protein DME1110 XEOTICID XEO00568 MOACRIVE Inhibition DME1110 XEOTICID XEO00573 XEO_NAME Naringenin DME1110 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1110 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00573 GENEFORM Protein DME1110 XEOTICID XEO00573 MOACRIVE Inhibition DME1110 XEOTICID XEO00619 XEO_NAME Delphinidin DME1110 XEOTICID XEO00619 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00619 XEO_CLAS Drug in Phase 2 Clinical Trial DME1110 XEOTICID XEO00619 DESCRIPT Delphinidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00619 GENEFORM Protein DME1110 XEOTICID XEO00619 MOACRIVE Inhibition DME1110 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1110 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1110 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00646 GENEFORM Protein DME1110 XEOTICID XEO00646 MOACRIVE Inhibition DME1110 XEOTICID XEO00683 XEO_NAME Curcumin DME1110 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1110 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00683 GENEFORM Protein DME1110 XEOTICID XEO00683 MOACRIVE Inhibition DME1110 XEOTICID XEO00692 XEO_NAME Emodin DME1110 XEOTICID XEO00692 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00692 XEO_CLAS Preclinical/Patented Drug DME1110 XEOTICID XEO00692 DESCRIPT Emodin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00692 GENEFORM Protein DME1110 XEOTICID XEO00692 MOACRIVE Inhibition DME1110 XEOTICID XEO00702 XEO_NAME Baicalin DME1110 XEOTICID XEO00702 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00702 XEO_CLAS Preclinical/Patented Drug DME1110 XEOTICID XEO00702 DESCRIPT Baicalin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00702 GENEFORM Protein DME1110 XEOTICID XEO00702 MOACRIVE Inhibition DME1110 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1110 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1110 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00730 GENEFORM Protein DME1110 XEOTICID XEO00730 MOACRIVE Inhibition DME1110 XEOTICID XEO00858 XEO_NAME Flavonoids DME1110 XEOTICID XEO00858 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO00858 XEO_CLAS Natural Mixture DME1110 XEOTICID XEO00858 DESCRIPT Flavonoids inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00858 GENEFORM Protein DME1110 XEOTICID XEO00858 MOACRIVE Inhibition DME1110 XEOTICID XEO00879 XEO_NAME Coumarin DME1110 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1110 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1110 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00879 GENEFORM Protein DME1110 XEOTICID XEO00879 MOACRIVE Inhibition DME1110 XEOTICID XEO00880 XEO_NAME Isatin DME1110 XEOTICID XEO00880 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO00880 XEO_CLAS Natural Product DME1110 XEOTICID XEO00880 DESCRIPT Isatin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00880 GENEFORM Protein DME1110 XEOTICID XEO00880 MOACRIVE Inhibition DME1110 XEOTICID XEO00885 XEO_NAME Eugenol DME1110 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1110 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO00885 GENEFORM Protein DME1110 XEOTICID XEO00885 MOACRIVE Inhibition DME1110 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1110 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1110 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1110 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01032 GENEFORM Protein DME1110 XEOTICID XEO01032 MOACRIVE Inhibition DME1110 XEOTICID XEO01212 XEO_NAME Baicalein DME1110 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO01212 XEO_CLAS Natural Product DME1110 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01212 GENEFORM Protein DME1110 XEOTICID XEO01212 MOACRIVE Inhibition DME1110 XEOTICID XEO01221 XEO_NAME Betulin DME1110 XEOTICID XEO01221 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO01221 XEO_CLAS Natural Product DME1110 XEOTICID XEO01221 DESCRIPT Betulin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01221 GENEFORM Protein DME1110 XEOTICID XEO01221 MOACRIVE Inhibition DME1110 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1110 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1110 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1110 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01232 GENEFORM Protein DME1110 XEOTICID XEO01232 MOACRIVE Inhibition DME1110 XEOTICID XEO01237 XEO_NAME Carvacrol DME1110 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1110 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01237 GENEFORM Protein DME1110 XEOTICID XEO01237 MOACRIVE Inhibition DME1110 XEOTICID XEO01239 XEO_NAME Catechin DME1110 XEOTICID XEO01239 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO01239 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO01239 DESCRIPT Catechin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01239 GENEFORM Protein DME1110 XEOTICID XEO01239 MOACRIVE Inhibition DME1110 XEOTICID XEO01252 XEO_NAME Cinnamic acid DME1110 XEOTICID XEO01252 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO01252 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO01252 DESCRIPT Cinnamic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01252 GENEFORM Protein DME1110 XEOTICID XEO01252 MOACRIVE Inhibition DME1110 XEOTICID XEO01266 XEO_NAME Cyanidin DME1110 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME1110 XEOTICID XEO01266 DESCRIPT Cyanidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01266 GENEFORM Protein DME1110 XEOTICID XEO01266 MOACRIVE Inhibition DME1110 XEOTICID XEO01291 XEO_NAME Esculetin DME1110 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1110 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01291 GENEFORM Protein DME1110 XEOTICID XEO01291 MOACRIVE Inhibition DME1110 XEOTICID XEO01357 XEO_NAME Kojic acid DME1110 XEOTICID XEO01357 XEO_TYPE Health or Environmental Toxicant(s) DME1110 XEOTICID XEO01357 XEO_CLAS Health Hazard/Toxicant DME1110 XEOTICID XEO01357 DESCRIPT Kojic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01357 GENEFORM Protein DME1110 XEOTICID XEO01357 MOACRIVE Inhibition DME1110 XEOTICID XEO01412 XEO_NAME Oleic acid DME1110 XEOTICID XEO01412 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO01412 XEO_CLAS Preclinical/Patented Drug DME1110 XEOTICID XEO01412 DESCRIPT Oleic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01412 GENEFORM Protein DME1110 XEOTICID XEO01412 MOACRIVE Inhibition DME1110 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1110 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1110 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01420 GENEFORM Protein DME1110 XEOTICID XEO01420 MOACRIVE Inhibition DME1110 XEOTICID XEO01424 XEO_NAME Pelargonidin DME1110 XEOTICID XEO01424 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO01424 XEO_CLAS Natural Product DME1110 XEOTICID XEO01424 DESCRIPT Pelargonidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01424 GENEFORM Protein DME1110 XEOTICID XEO01424 MOACRIVE Inhibition DME1110 XEOTICID XEO01442 XEO_NAME Puag-haad DME1110 XEOTICID XEO01442 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO01442 XEO_CLAS Natural Product DME1110 XEOTICID XEO01442 DESCRIPT Puag-haad inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01442 GENEFORM Protein DME1110 XEOTICID XEO01442 MOACRIVE Inhibition DME1110 XEOTICID XEO01455 XEO_NAME Rhein DME1110 XEOTICID XEO01455 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO01455 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO01455 DESCRIPT Rhein inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01455 GENEFORM Protein DME1110 XEOTICID XEO01455 MOACRIVE Inhibition DME1110 XEOTICID XEO01460 XEO_NAME Rosmarinic acid DME1110 XEOTICID XEO01460 XEO_TYPE Health or Environmental Toxicant(s) DME1110 XEOTICID XEO01460 XEO_CLAS Acute Toxic Substance DME1110 XEOTICID XEO01460 DESCRIPT Rosmarinic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01460 GENEFORM Protein DME1110 XEOTICID XEO01460 MOACRIVE Inhibition DME1110 XEOTICID XEO01463 XEO_NAME Rutin DME1110 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO01463 XEO_CLAS Natural Product DME1110 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01463 GENEFORM Protein DME1110 XEOTICID XEO01463 MOACRIVE Inhibition DME1110 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1110 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1110 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01496 GENEFORM Protein DME1110 XEOTICID XEO01496 MOACRIVE Inhibition DME1110 XEOTICID XEO01528 XEO_NAME Chrysophanic acid DME1110 XEOTICID XEO01528 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO01528 XEO_CLAS Natural Product DME1110 XEOTICID XEO01528 DESCRIPT Chrysophanic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01528 GENEFORM Protein DME1110 XEOTICID XEO01528 MOACRIVE Inhibition DME1110 XEOTICID XEO01531 XEO_NAME Clove oil DME1110 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO01531 XEO_CLAS Natural Product DME1110 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01531 GENEFORM Protein DME1110 XEOTICID XEO01531 MOACRIVE Inhibition DME1110 XEOTICID XEO01571 XEO_NAME Peppermint oil DME1110 XEOTICID XEO01571 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO01571 XEO_CLAS Natural Product DME1110 XEOTICID XEO01571 DESCRIPT Peppermint oil inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01571 GENEFORM Protein DME1110 XEOTICID XEO01571 MOACRIVE Inhibition DME1110 XEOTICID XEO01587 XEO_NAME Shikonin DME1110 XEOTICID XEO01587 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO01587 XEO_CLAS Natural Product DME1110 XEOTICID XEO01587 DESCRIPT Shikonin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01587 GENEFORM Protein DME1110 XEOTICID XEO01587 MOACRIVE Inhibition DME1110 XEOTICID XEO01804 XEO_NAME (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one DME1110 XEOTICID XEO01804 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01804 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01804 DESCRIPT (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01804 GENEFORM Protein DME1110 XEOTICID XEO01804 MOACRIVE Inhibition DME1110 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1110 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01810 XEO_CLAS Peptide DME1110 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.0 microM) DME1110 XEOTICID XEO01810 GENEFORM Protein DME1110 XEOTICID XEO01810 MOACRIVE Inhibition DME1110 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1110 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01811 XEO_CLAS Peptide DME1110 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 microM) DME1110 XEOTICID XEO01811 GENEFORM Protein DME1110 XEOTICID XEO01811 MOACRIVE Inhibition DME1110 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1110 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01812 XEO_CLAS Peptide DME1110 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.2 microM) DME1110 XEOTICID XEO01812 GENEFORM Protein DME1110 XEOTICID XEO01812 MOACRIVE Inhibition DME1110 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1110 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01813 XEO_CLAS Peptide DME1110 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.0 microM) DME1110 XEOTICID XEO01813 GENEFORM Protein DME1110 XEOTICID XEO01813 MOACRIVE Inhibition DME1110 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1110 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01814 XEO_CLAS Peptide DME1110 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.9 microM) DME1110 XEOTICID XEO01814 GENEFORM Protein DME1110 XEOTICID XEO01814 MOACRIVE Inhibition DME1110 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1110 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01815 XEO_CLAS Peptide DME1110 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8.0 microM) DME1110 XEOTICID XEO01815 GENEFORM Protein DME1110 XEOTICID XEO01815 MOACRIVE Inhibition DME1110 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1110 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01816 XEO_CLAS Peptide DME1110 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1110 XEOTICID XEO01816 GENEFORM Protein DME1110 XEOTICID XEO01816 MOACRIVE Inhibition DME1110 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1110 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01817 XEO_CLAS Peptide DME1110 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.0 microM) DME1110 XEOTICID XEO01817 GENEFORM Protein DME1110 XEOTICID XEO01817 MOACRIVE Inhibition DME1110 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1110 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01818 XEO_CLAS Peptide DME1110 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.0 microM) DME1110 XEOTICID XEO01818 GENEFORM Protein DME1110 XEOTICID XEO01818 MOACRIVE Inhibition DME1110 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1110 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01819 XEO_CLAS Peptide DME1110 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) DME1110 XEOTICID XEO01819 GENEFORM Protein DME1110 XEOTICID XEO01819 MOACRIVE Inhibition DME1110 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1110 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01820 XEO_CLAS Peptide DME1110 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) DME1110 XEOTICID XEO01820 GENEFORM Protein DME1110 XEOTICID XEO01820 MOACRIVE Inhibition DME1110 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1110 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01821 XEO_CLAS Peptide DME1110 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) DME1110 XEOTICID XEO01821 GENEFORM Protein DME1110 XEOTICID XEO01821 MOACRIVE Inhibition DME1110 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1110 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01822 XEO_CLAS Peptide DME1110 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 microM) DME1110 XEOTICID XEO01822 GENEFORM Protein DME1110 XEOTICID XEO01822 MOACRIVE Inhibition DME1110 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1110 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01823 XEO_CLAS Peptide DME1110 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.125 microM) DME1110 XEOTICID XEO01823 GENEFORM Protein DME1110 XEOTICID XEO01823 MOACRIVE Inhibition DME1110 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1110 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO01825 XEO_CLAS Peptide DME1110 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1110 XEOTICID XEO01825 GENEFORM Protein DME1110 XEOTICID XEO01825 MOACRIVE Inhibition DME1110 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1110 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01829 GENEFORM Protein DME1110 XEOTICID XEO01829 MOACRIVE Inhibition DME1110 XEOTICID XEO01831 XEO_NAME 3',5'-Dinitroacetophenone DME1110 XEOTICID XEO01831 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01831 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01831 DESCRIPT 3',5'-Dinitroacetophenone inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01831 GENEFORM Protein DME1110 XEOTICID XEO01831 MOACRIVE Inhibition DME1110 XEOTICID XEO01832 XEO_NAME 1-(4-amino-2-hydroxyphenyl)ethan-1-one DME1110 XEOTICID XEO01832 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01832 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01832 DESCRIPT 1-(4-amino-2-hydroxyphenyl)ethan-1-one inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01832 GENEFORM Protein DME1110 XEOTICID XEO01832 MOACRIVE Inhibition DME1110 XEOTICID XEO01837 XEO_NAME 2-Amino-5-acetylpyridine DME1110 XEOTICID XEO01837 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01837 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01837 DESCRIPT 2-Amino-5-acetylpyridine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01837 GENEFORM Protein DME1110 XEOTICID XEO01837 MOACRIVE Inhibition DME1110 XEOTICID XEO01838 XEO_NAME 1-(pyrazin-2-yl)ethan-1-one DME1110 XEOTICID XEO01838 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01838 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01838 DESCRIPT 1-(pyrazin-2-yl)ethan-1-one inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01838 GENEFORM Protein DME1110 XEOTICID XEO01838 MOACRIVE Inhibition DME1110 XEOTICID XEO01839 XEO_NAME 4-Acetylpyridine DME1110 XEOTICID XEO01839 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01839 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01839 DESCRIPT 4-Acetylpyridine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01839 GENEFORM Protein DME1110 XEOTICID XEO01839 MOACRIVE Inhibition DME1110 XEOTICID XEO01860 XEO_NAME Aseanostatin P5 DME1110 XEOTICID XEO01860 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO01860 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO01860 DESCRIPT Aseanostatin P5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01860 GENEFORM Protein DME1110 XEOTICID XEO01860 MOACRIVE Inhibition DME1110 XEOTICID XEO01869 XEO_NAME Isopentadecylic acid DME1110 XEOTICID XEO01869 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO01869 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO01869 DESCRIPT Isopentadecylic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01869 GENEFORM Protein DME1110 XEOTICID XEO01869 MOACRIVE Inhibition DME1110 XEOTICID XEO01872 XEO_NAME AL-1 DME1110 XEOTICID XEO01872 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO01872 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO01872 DESCRIPT AL-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01872 GENEFORM Protein DME1110 XEOTICID XEO01872 MOACRIVE Inhibition DME1110 XEOTICID XEO01879 XEO_NAME 1-methanesulfonyl-4-methylbenzene DME1110 XEOTICID XEO01879 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01879 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01879 DESCRIPT 1-methanesulfonyl-4-methylbenzene inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01879 GENEFORM Protein DME1110 XEOTICID XEO01879 MOACRIVE Inhibition DME1110 XEOTICID XEO01937 XEO_NAME 2-bromodecanoic acid DME1110 XEOTICID XEO01937 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01937 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01937 DESCRIPT 2-bromodecanoic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01937 GENEFORM Protein DME1110 XEOTICID XEO01937 MOACRIVE Inhibition DME1110 XEOTICID XEO01938 XEO_NAME 2-bromohexanoic acid DME1110 XEOTICID XEO01938 XEO_TYPE Health or Environmental Toxicant(s) DME1110 XEOTICID XEO01938 XEO_CLAS Health Hazard/Toxicant DME1110 XEOTICID XEO01938 DESCRIPT 2-bromohexanoic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01938 GENEFORM Protein DME1110 XEOTICID XEO01938 MOACRIVE Inhibition DME1110 XEOTICID XEO01939 XEO_NAME 2-bromooctanoic acid DME1110 XEOTICID XEO01939 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01939 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01939 DESCRIPT 2-bromooctanoic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01939 GENEFORM Protein DME1110 XEOTICID XEO01939 MOACRIVE Inhibition DME1110 XEOTICID XEO01952 XEO_NAME 2-oxindole DME1110 XEOTICID XEO01952 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01952 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01952 DESCRIPT 2-oxindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01952 GENEFORM Protein DME1110 XEOTICID XEO01952 MOACRIVE Inhibition DME1110 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1110 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01961 GENEFORM Protein DME1110 XEOTICID XEO01961 MOACRIVE Inhibition DME1110 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1110 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01966 GENEFORM Protein DME1110 XEOTICID XEO01966 MOACRIVE Inhibition DME1110 XEOTICID XEO01975 XEO_NAME 3,5-dimethylaniline DME1110 XEOTICID XEO01975 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01975 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01975 DESCRIPT 3,5-dimethylaniline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01975 GENEFORM Protein DME1110 XEOTICID XEO01975 MOACRIVE Inhibition DME1110 XEOTICID XEO01976 XEO_NAME Allicin DME1110 XEOTICID XEO01976 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO01976 XEO_CLAS Drug in Phase 1 Clinical Trial DME1110 XEOTICID XEO01976 DESCRIPT Allicin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01976 GENEFORM Protein DME1110 XEOTICID XEO01976 MOACRIVE Inhibition DME1110 XEOTICID XEO01987 XEO_NAME 3-fluoroaniline DME1110 XEOTICID XEO01987 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01987 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01987 DESCRIPT 3-fluoroaniline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01987 GENEFORM Protein DME1110 XEOTICID XEO01987 MOACRIVE Inhibition DME1110 XEOTICID XEO01994 XEO_NAME 3-Indoleacetonitrile DME1110 XEOTICID XEO01994 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO01994 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO01994 DESCRIPT 3-Indoleacetonitrile inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO01994 GENEFORM Protein DME1110 XEOTICID XEO01994 MOACRIVE Inhibition DME1110 XEOTICID XEO02026 XEO_NAME 4-bromoaniline DME1110 XEOTICID XEO02026 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02026 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02026 DESCRIPT 4-bromoaniline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02026 GENEFORM Protein DME1110 XEOTICID XEO02026 MOACRIVE Inhibition DME1110 XEOTICID XEO02029 XEO_NAME 4-chloro-7-(trifluoromethyl)quinoline DME1110 XEOTICID XEO02029 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02029 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02029 DESCRIPT 4-chloro-7-(trifluoromethyl)quinoline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02029 GENEFORM Protein DME1110 XEOTICID XEO02029 MOACRIVE Inhibition DME1110 XEOTICID XEO02030 XEO_NAME 4-chloroaniline DME1110 XEOTICID XEO02030 XEO_TYPE Health or Environmental Toxicant(s) DME1110 XEOTICID XEO02030 XEO_CLAS Health Hazard/Toxicant DME1110 XEOTICID XEO02030 DESCRIPT 4-chloroaniline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02030 GENEFORM Protein DME1110 XEOTICID XEO02030 MOACRIVE Inhibition DME1110 XEOTICID XEO02036 XEO_NAME 4-fluoroindole DME1110 XEOTICID XEO02036 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02036 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02036 DESCRIPT 4-fluoroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02036 GENEFORM Protein DME1110 XEOTICID XEO02036 MOACRIVE Inhibition DME1110 XEOTICID XEO02040 XEO_NAME Furaneol DME1110 XEOTICID XEO02040 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02040 XEO_CLAS Food Additive DME1110 XEOTICID XEO02040 DESCRIPT Furaneol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02040 GENEFORM Protein DME1110 XEOTICID XEO02040 MOACRIVE Inhibition DME1110 XEOTICID XEO02042 XEO_NAME 4-methanesulfonylaniline DME1110 XEOTICID XEO02042 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02042 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02042 DESCRIPT 4-methanesulfonylaniline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02042 GENEFORM Protein DME1110 XEOTICID XEO02042 MOACRIVE Inhibition DME1110 XEOTICID XEO02065 XEO_NAME 5-Bromoindole DME1110 XEOTICID XEO02065 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02065 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02065 DESCRIPT 5-Bromoindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02065 GENEFORM Protein DME1110 XEOTICID XEO02065 MOACRIVE Inhibition DME1110 XEOTICID XEO02068 XEO_NAME 5-Chloro-1-(2-chloroacetyl)indoline-2,3-dione DME1110 XEOTICID XEO02068 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02068 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02068 DESCRIPT 5-Chloro-1-(2-chloroacetyl)indoline-2,3-dione inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02068 GENEFORM Protein DME1110 XEOTICID XEO02068 MOACRIVE Inhibition DME1110 XEOTICID XEO02069 XEO_NAME 5-Chloroindole DME1110 XEOTICID XEO02069 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO02069 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO02069 DESCRIPT 5-Chloroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02069 GENEFORM Protein DME1110 XEOTICID XEO02069 MOACRIVE Inhibition DME1110 XEOTICID XEO02072 XEO_NAME 5-fluoroindole DME1110 XEOTICID XEO02072 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO02072 XEO_CLAS Preclinical/Patented Drug DME1110 XEOTICID XEO02072 DESCRIPT 5-fluoroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02072 GENEFORM Protein DME1110 XEOTICID XEO02072 MOACRIVE Inhibition DME1110 XEOTICID XEO02081 XEO_NAME 6-Chloroindole DME1110 XEOTICID XEO02081 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02081 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02081 DESCRIPT 6-Chloroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02081 GENEFORM Protein DME1110 XEOTICID XEO02081 MOACRIVE Inhibition DME1110 XEOTICID XEO02082 XEO_NAME 6-Chlorooxindole DME1110 XEOTICID XEO02082 XEO_TYPE Health or Environmental Toxicant(s) DME1110 XEOTICID XEO02082 XEO_CLAS Environmental Pollutant DME1110 XEOTICID XEO02082 DESCRIPT 6-Chlorooxindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02082 GENEFORM Protein DME1110 XEOTICID XEO02082 MOACRIVE Inhibition DME1110 XEOTICID XEO02083 XEO_NAME 6-fluoroindole DME1110 XEOTICID XEO02083 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02083 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02083 DESCRIPT 6-fluoroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02083 GENEFORM Protein DME1110 XEOTICID XEO02083 MOACRIVE Inhibition DME1110 XEOTICID XEO02084 XEO_NAME 6-Gingerol DME1110 XEOTICID XEO02084 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO02084 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO02084 DESCRIPT 6-Gingerol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02084 GENEFORM Protein DME1110 XEOTICID XEO02084 MOACRIVE Inhibition DME1110 XEOTICID XEO02089 XEO_NAME 7-bromoindole DME1110 XEOTICID XEO02089 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02089 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02089 DESCRIPT 7-bromoindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02089 GENEFORM Protein DME1110 XEOTICID XEO02089 MOACRIVE Inhibition DME1110 XEOTICID XEO02090 XEO_NAME 7-chloroindole DME1110 XEOTICID XEO02090 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02090 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02090 DESCRIPT 7-chloroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02090 GENEFORM Protein DME1110 XEOTICID XEO02090 MOACRIVE Inhibition DME1110 XEOTICID XEO02092 XEO_NAME 7-fluoroindole DME1110 XEOTICID XEO02092 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02092 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02092 DESCRIPT 7-fluoroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02092 GENEFORM Protein DME1110 XEOTICID XEO02092 MOACRIVE Inhibition DME1110 XEOTICID XEO02093 XEO_NAME 7-Fluoroisatin DME1110 XEOTICID XEO02093 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02093 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02093 DESCRIPT 7-Fluoroisatin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02093 GENEFORM Protein DME1110 XEOTICID XEO02093 MOACRIVE Inhibition DME1110 XEOTICID XEO02094 XEO_NAME 7-formylindole DME1110 XEOTICID XEO02094 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02094 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02094 DESCRIPT 7-formylindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02094 GENEFORM Protein DME1110 XEOTICID XEO02094 MOACRIVE Inhibition DME1110 XEOTICID XEO02095 XEO_NAME 7-hydroxyindole DME1110 XEOTICID XEO02095 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02095 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02095 DESCRIPT 7-hydroxyindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02095 GENEFORM Protein DME1110 XEOTICID XEO02095 MOACRIVE Inhibition DME1110 XEOTICID XEO02096 XEO_NAME 7-methoxyindole DME1110 XEOTICID XEO02096 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02096 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02096 DESCRIPT 7-methoxyindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02096 GENEFORM Protein DME1110 XEOTICID XEO02096 MOACRIVE Inhibition DME1110 XEOTICID XEO02097 XEO_NAME 7-methylindole DME1110 XEOTICID XEO02097 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02097 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02097 DESCRIPT 7-methylindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02097 GENEFORM Protein DME1110 XEOTICID XEO02097 MOACRIVE Inhibition DME1110 XEOTICID XEO02098 XEO_NAME 7-nitroindole DME1110 XEOTICID XEO02098 XEO_TYPE Health or Environmental Toxicant(s) DME1110 XEOTICID XEO02098 XEO_CLAS Health Hazard/Toxicant DME1110 XEOTICID XEO02098 DESCRIPT 7-nitroindole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02098 GENEFORM Protein DME1110 XEOTICID XEO02098 MOACRIVE Inhibition DME1110 XEOTICID XEO02100 XEO_NAME 8-fluoroquinoline DME1110 XEOTICID XEO02100 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO02100 XEO_CLAS Preclinical/Patented Drug DME1110 XEOTICID XEO02100 DESCRIPT 8-fluoroquinoline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02100 GENEFORM Protein DME1110 XEOTICID XEO02100 MOACRIVE Inhibition DME1110 XEOTICID XEO02103 XEO_NAME CP-P derivative A10 DME1110 XEOTICID XEO02103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02103 XEO_CLAS Peptide DME1110 XEOTICID XEO02103 DESCRIPT CP-P derivative A10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1110 XEOTICID XEO02103 GENEFORM Protein DME1110 XEOTICID XEO02103 MOACRIVE Inhibition DME1110 XEOTICID XEO02104 XEO_NAME V13KL peptide derivative A12L DME1110 XEOTICID XEO02104 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02104 XEO_CLAS Peptide DME1110 XEOTICID XEO02104 DESCRIPT V13KL peptide derivative A12L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 24.8 ug/ml) DME1110 XEOTICID XEO02104 GENEFORM Protein DME1110 XEOTICID XEO02104 MOACRIVE Inhibition DME1110 XEOTICID XEO02105 XEO_NAME V13KL peptide derivative A12L/A20L DME1110 XEOTICID XEO02105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02105 XEO_CLAS Peptide DME1110 XEOTICID XEO02105 DESCRIPT V13KL peptide derivative A12L/A20L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 125 ug/ml) DME1110 XEOTICID XEO02105 GENEFORM Protein DME1110 XEOTICID XEO02105 MOACRIVE Inhibition DME1110 XEOTICID XEO02106 XEO_NAME V13KL peptide derivative A12L/A23L DME1110 XEOTICID XEO02106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02106 XEO_CLAS Peptide DME1110 XEOTICID XEO02106 DESCRIPT V13KL peptide derivative A12L/A23L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 31.2 ug/ml) DME1110 XEOTICID XEO02106 GENEFORM Protein DME1110 XEOTICID XEO02106 MOACRIVE Inhibition DME1110 XEOTICID XEO02107 XEO_NAME CP-P derivative A13 DME1110 XEOTICID XEO02107 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02107 XEO_CLAS Peptide DME1110 XEOTICID XEO02107 DESCRIPT CP-P derivative A13 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1110 XEOTICID XEO02107 GENEFORM Protein DME1110 XEOTICID XEO02107 MOACRIVE Inhibition DME1110 XEOTICID XEO02108 XEO_NAME V13KL peptide derivative A20L DME1110 XEOTICID XEO02108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02108 XEO_CLAS Peptide DME1110 XEOTICID XEO02108 DESCRIPT V13KL peptide derivative A20L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 15.6 ug/ml) DME1110 XEOTICID XEO02108 GENEFORM Protein DME1110 XEOTICID XEO02108 MOACRIVE Inhibition DME1110 XEOTICID XEO02109 XEO_NAME V13KL peptide derivative A23L DME1110 XEOTICID XEO02109 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02109 XEO_CLAS Peptide DME1110 XEOTICID XEO02109 DESCRIPT V13KL peptide derivative A23L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 35.1 ug/ml) DME1110 XEOTICID XEO02109 GENEFORM Protein DME1110 XEOTICID XEO02109 MOACRIVE Inhibition DME1110 XEOTICID XEO02110 XEO_NAME CP-P derivative A9 DME1110 XEOTICID XEO02110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02110 XEO_CLAS Peptide DME1110 XEOTICID XEO02110 DESCRIPT CP-P derivative A9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1110 XEOTICID XEO02110 GENEFORM Protein DME1110 XEOTICID XEO02110 MOACRIVE Inhibition DME1110 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1110 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02122 XEO_CLAS Peptide DME1110 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1110 XEOTICID XEO02122 GENEFORM Protein DME1110 XEOTICID XEO02122 MOACRIVE Inhibition DME1110 XEOTICID XEO02123 XEO_NAME Aceroside VIII DME1110 XEOTICID XEO02123 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02123 XEO_CLAS Natural Product DME1110 XEOTICID XEO02123 DESCRIPT Aceroside VIII inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02123 GENEFORM Protein DME1110 XEOTICID XEO02123 MOACRIVE Inhibition DME1110 XEOTICID XEO02134 XEO_NAME Acylase DME1110 XEOTICID XEO02134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02134 XEO_CLAS Peptide DME1110 XEOTICID XEO02134 DESCRIPT Acylase inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02134 GENEFORM Protein DME1110 XEOTICID XEO02134 MOACRIVE Inhibition DME1110 XEOTICID XEO02139 XEO_NAME Clidemia dentata aerial part extract DME1110 XEOTICID XEO02139 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02139 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02139 DESCRIPT Clidemia dentata aerial part extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02139 GENEFORM Protein DME1110 XEOTICID XEO02139 MOACRIVE Inhibition DME1110 XEOTICID XEO02143 XEO_NAME Ossaea brenesii aerial part extract DME1110 XEOTICID XEO02143 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02143 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02143 DESCRIPT Ossaea brenesii aerial part extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02143 GENEFORM Protein DME1110 XEOTICID XEO02143 MOACRIVE Inhibition DME1110 XEOTICID XEO02144 XEO_NAME Piper bisasperatum aerial part extract DME1110 XEOTICID XEO02144 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02144 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02144 DESCRIPT Piper bisasperatum aerial part extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02144 GENEFORM Protein DME1110 XEOTICID XEO02144 MOACRIVE Inhibition DME1110 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1110 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02147 XEO_CLAS Peptide DME1110 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 257 ug/ml) DME1110 XEOTICID XEO02147 GENEFORM Protein DME1110 XEOTICID XEO02147 MOACRIVE Inhibition DME1110 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1110 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02149 XEO_CLAS Peptide DME1110 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 47.35 microM) DME1110 XEOTICID XEO02149 GENEFORM Protein DME1110 XEOTICID XEO02149 MOACRIVE Inhibition DME1110 XEOTICID XEO02150 XEO_NAME AI-hemocidins 3 DME1110 XEOTICID XEO02150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02150 XEO_CLAS Peptide DME1110 XEOTICID XEO02150 DESCRIPT AI-hemocidins 3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 95.37 microM) DME1110 XEOTICID XEO02150 GENEFORM Protein DME1110 XEOTICID XEO02150 MOACRIVE Inhibition DME1110 XEOTICID XEO02152 XEO_NAME Ajoene DME1110 XEOTICID XEO02152 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02152 XEO_CLAS Natural Product DME1110 XEOTICID XEO02152 DESCRIPT Ajoene inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02152 GENEFORM Protein DME1110 XEOTICID XEO02152 MOACRIVE Inhibition DME1110 XEOTICID XEO02188 XEO_NAME Aminocyclopropane DME1110 XEOTICID XEO02188 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02188 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02188 DESCRIPT Aminocyclopropane inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02188 GENEFORM Protein DME1110 XEOTICID XEO02188 MOACRIVE Inhibition DME1110 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1110 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02200 XEO_CLAS Peptide DME1110 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1110 XEOTICID XEO02200 GENEFORM Protein DME1110 XEOTICID XEO02200 MOACRIVE Inhibition DME1110 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1110 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02201 XEO_CLAS Peptide DME1110 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 ug/ml) DME1110 XEOTICID XEO02201 GENEFORM Protein DME1110 XEOTICID XEO02201 MOACRIVE Inhibition DME1110 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1110 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02202 XEO_CLAS Peptide DME1110 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10 microM) DME1110 XEOTICID XEO02202 GENEFORM Protein DME1110 XEOTICID XEO02202 MOACRIVE Inhibition DME1110 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1110 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02203 XEO_CLAS Peptide DME1110 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10 microM) DME1110 XEOTICID XEO02203 GENEFORM Protein DME1110 XEOTICID XEO02203 MOACRIVE Inhibition DME1110 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1110 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02207 XEO_CLAS Peptide DME1110 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.13 ug/ml) DME1110 XEOTICID XEO02207 GENEFORM Protein DME1110 XEOTICID XEO02207 MOACRIVE Inhibition DME1110 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1110 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02208 XEO_CLAS Peptide DME1110 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1110 XEOTICID XEO02208 GENEFORM Protein DME1110 XEOTICID XEO02208 MOACRIVE Inhibition DME1110 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1110 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02209 XEO_CLAS Peptide DME1110 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.13 ug/ml) DME1110 XEOTICID XEO02209 GENEFORM Protein DME1110 XEOTICID XEO02209 MOACRIVE Inhibition DME1110 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1110 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02210 XEO_CLAS Peptide DME1110 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1110 XEOTICID XEO02210 GENEFORM Protein DME1110 XEOTICID XEO02210 MOACRIVE Inhibition DME1110 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1110 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02211 XEO_CLAS Peptide DME1110 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1110 XEOTICID XEO02211 GENEFORM Protein DME1110 XEOTICID XEO02211 MOACRIVE Inhibition DME1110 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1110 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02212 XEO_CLAS Peptide DME1110 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1110 XEOTICID XEO02212 GENEFORM Protein DME1110 XEOTICID XEO02212 MOACRIVE Inhibition DME1110 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1110 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02213 XEO_CLAS Peptide DME1110 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.13 ug/ml) DME1110 XEOTICID XEO02213 GENEFORM Protein DME1110 XEOTICID XEO02213 MOACRIVE Inhibition DME1110 XEOTICID XEO02226 XEO_NAME Andropin DME1110 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02226 XEO_CLAS Peptide DME1110 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 300 microM) DME1110 XEOTICID XEO02226 GENEFORM Protein DME1110 XEOTICID XEO02226 MOACRIVE Inhibition DME1110 XEOTICID XEO02228 XEO_NAME Aniline DME1110 XEOTICID XEO02228 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02228 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02228 DESCRIPT Aniline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02228 GENEFORM Protein DME1110 XEOTICID XEO02228 MOACRIVE Inhibition DME1110 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1110 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02230 XEO_CLAS Peptide DME1110 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1-2.5 microM) DME1110 XEOTICID XEO02230 GENEFORM Protein DME1110 XEOTICID XEO02230 MOACRIVE Inhibition DME1110 XEOTICID XEO02235 XEO_NAME Anthranilate DME1110 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02235 XEO_CLAS Natural Product DME1110 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02235 GENEFORM Protein DME1110 XEOTICID XEO02235 MOACRIVE Inhibition DME1110 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1110 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02242 XEO_CLAS Peptide DME1110 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 microM) DME1110 XEOTICID XEO02242 GENEFORM Protein DME1110 XEOTICID XEO02242 MOACRIVE Inhibition DME1110 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1110 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02243 XEO_CLAS Peptide DME1110 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 microM) DME1110 XEOTICID XEO02243 GENEFORM Protein DME1110 XEOTICID XEO02243 MOACRIVE Inhibition DME1110 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1110 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02244 XEO_CLAS Peptide DME1110 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) DME1110 XEOTICID XEO02244 GENEFORM Protein DME1110 XEOTICID XEO02244 MOACRIVE Inhibition DME1110 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1110 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02247 XEO_CLAS Peptide DME1110 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02247 GENEFORM Protein DME1110 XEOTICID XEO02247 MOACRIVE Inhibition DME1110 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1110 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02248 XEO_CLAS Peptide DME1110 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 200 microM) DME1110 XEOTICID XEO02248 GENEFORM Protein DME1110 XEOTICID XEO02248 MOACRIVE Inhibition DME1110 XEOTICID XEO02249 XEO_NAME Anticancerous peptide Cr-ACP1 DME1110 XEOTICID XEO02249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02249 XEO_CLAS Peptide DME1110 XEOTICID XEO02249 DESCRIPT Anticancerous peptide Cr-ACP1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 30 microM) DME1110 XEOTICID XEO02249 GENEFORM Protein DME1110 XEOTICID XEO02249 MOACRIVE Inhibition DME1110 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1110 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02253 XEO_CLAS Peptide DME1110 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02253 GENEFORM Protein DME1110 XEOTICID XEO02253 MOACRIVE Inhibition DME1110 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1110 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02261 XEO_CLAS Peptide DME1110 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 79 ug/ml) DME1110 XEOTICID XEO02261 GENEFORM Protein DME1110 XEOTICID XEO02261 MOACRIVE Inhibition DME1110 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1110 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02268 XEO_CLAS Peptide DME1110 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 169 ug/ml) DME1110 XEOTICID XEO02268 GENEFORM Protein DME1110 XEOTICID XEO02268 MOACRIVE Inhibition DME1110 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1110 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02271 XEO_CLAS Peptide DME1110 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 259 ug/ml) DME1110 XEOTICID XEO02271 GENEFORM Protein DME1110 XEOTICID XEO02271 MOACRIVE Inhibition DME1110 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1110 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02275 XEO_CLAS Peptide DME1110 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 60 microM) DME1110 XEOTICID XEO02275 GENEFORM Protein DME1110 XEOTICID XEO02275 MOACRIVE Inhibition DME1110 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1110 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02280 XEO_CLAS Peptide DME1110 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02280 GENEFORM Protein DME1110 XEOTICID XEO02280 MOACRIVE Inhibition DME1110 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1110 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02281 XEO_CLAS Peptide DME1110 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02281 GENEFORM Protein DME1110 XEOTICID XEO02281 MOACRIVE Inhibition DME1110 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1110 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02283 XEO_CLAS Peptide DME1110 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1110 XEOTICID XEO02283 GENEFORM Protein DME1110 XEOTICID XEO02283 MOACRIVE Inhibition DME1110 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1110 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02290 XEO_CLAS Peptide DME1110 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.5 ug/ml) DME1110 XEOTICID XEO02290 GENEFORM Protein DME1110 XEOTICID XEO02290 MOACRIVE Inhibition DME1110 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1110 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02294 XEO_CLAS Peptide DME1110 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 250-500 ug/ml) DME1110 XEOTICID XEO02294 GENEFORM Protein DME1110 XEOTICID XEO02294 MOACRIVE Inhibition DME1110 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1110 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02297 XEO_CLAS Peptide DME1110 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC < 25 ug/ml) DME1110 XEOTICID XEO02297 GENEFORM Protein DME1110 XEOTICID XEO02297 MOACRIVE Inhibition DME1110 XEOTICID XEO02301 XEO_NAME Fungus ribonuclease DME1110 XEOTICID XEO02301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02301 XEO_CLAS Peptide DME1110 XEOTICID XEO02301 DESCRIPT Fungus ribonuclease inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02301 GENEFORM Protein DME1110 XEOTICID XEO02301 MOACRIVE Inhibition DME1110 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1110 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02325 XEO_CLAS Peptide DME1110 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 13 microM) DME1110 XEOTICID XEO02325 GENEFORM Protein DME1110 XEOTICID XEO02325 MOACRIVE Inhibition DME1110 XEOTICID XEO02329 XEO_NAME Asperdiol DME1110 XEOTICID XEO02329 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02329 XEO_CLAS Natural Product DME1110 XEOTICID XEO02329 DESCRIPT Asperdiol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02329 GENEFORM Protein DME1110 XEOTICID XEO02329 MOACRIVE Inhibition DME1110 XEOTICID XEO02330 XEO_NAME Asperdiol acetate DME1110 XEOTICID XEO02330 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02330 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO02330 DESCRIPT Asperdiol acetate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02330 GENEFORM Protein DME1110 XEOTICID XEO02330 MOACRIVE Inhibition DME1110 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1110 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02333 XEO_CLAS Peptide DME1110 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 200 microM) DME1110 XEOTICID XEO02333 GENEFORM Protein DME1110 XEOTICID XEO02333 MOACRIVE Inhibition DME1110 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1110 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02352 XEO_CLAS Peptide DME1110 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 23 ug/ml) DME1110 XEOTICID XEO02352 GENEFORM Protein DME1110 XEOTICID XEO02352 MOACRIVE Inhibition DME1110 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1110 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02353 XEO_CLAS Peptide DME1110 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 11 ug/ml) DME1110 XEOTICID XEO02353 GENEFORM Protein DME1110 XEOTICID XEO02353 MOACRIVE Inhibition DME1110 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1110 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02354 XEO_CLAS Peptide DME1110 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1110 XEOTICID XEO02354 GENEFORM Protein DME1110 XEOTICID XEO02354 MOACRIVE Inhibition DME1110 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1110 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02355 XEO_CLAS Peptide DME1110 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1110 XEOTICID XEO02355 GENEFORM Protein DME1110 XEOTICID XEO02355 MOACRIVE Inhibition DME1110 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1110 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02356 XEO_CLAS Peptide DME1110 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO02356 GENEFORM Protein DME1110 XEOTICID XEO02356 MOACRIVE Inhibition DME1110 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1110 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02357 XEO_CLAS Peptide DME1110 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO02357 GENEFORM Protein DME1110 XEOTICID XEO02357 MOACRIVE Inhibition DME1110 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1110 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02358 XEO_CLAS Peptide DME1110 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO02358 GENEFORM Protein DME1110 XEOTICID XEO02358 MOACRIVE Inhibition DME1110 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1110 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02360 XEO_CLAS Peptide DME1110 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO02360 GENEFORM Protein DME1110 XEOTICID XEO02360 MOACRIVE Inhibition DME1110 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1110 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02361 XEO_CLAS Peptide DME1110 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 250 ug/ml) DME1110 XEOTICID XEO02361 GENEFORM Protein DME1110 XEOTICID XEO02361 MOACRIVE Inhibition DME1110 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1110 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02365 XEO_CLAS Peptide DME1110 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 64 ug/ml) DME1110 XEOTICID XEO02365 GENEFORM Protein DME1110 XEOTICID XEO02365 MOACRIVE Inhibition DME1110 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1110 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02366 XEO_CLAS Peptide DME1110 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO02366 GENEFORM Protein DME1110 XEOTICID XEO02366 MOACRIVE Inhibition DME1110 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1110 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02367 XEO_CLAS Peptide DME1110 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO02367 GENEFORM Protein DME1110 XEOTICID XEO02367 MOACRIVE Inhibition DME1110 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1110 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02368 XEO_CLAS Peptide DME1110 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO02368 GENEFORM Protein DME1110 XEOTICID XEO02368 MOACRIVE Inhibition DME1110 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1110 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02369 XEO_CLAS Peptide DME1110 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1110 XEOTICID XEO02369 GENEFORM Protein DME1110 XEOTICID XEO02369 MOACRIVE Inhibition DME1110 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1110 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02371 XEO_CLAS Peptide DME1110 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1110 XEOTICID XEO02371 GENEFORM Protein DME1110 XEOTICID XEO02371 MOACRIVE Inhibition DME1110 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1110 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02378 XEO_CLAS Peptide DME1110 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.38 ug/ml) DME1110 XEOTICID XEO02378 GENEFORM Protein DME1110 XEOTICID XEO02378 MOACRIVE Inhibition DME1110 XEOTICID XEO02386 XEO_NAME Bactridin-1 DME1110 XEOTICID XEO02386 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02386 XEO_CLAS Peptide DME1110 XEOTICID XEO02386 DESCRIPT Bactridin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 77 microM) DME1110 XEOTICID XEO02386 GENEFORM Protein DME1110 XEOTICID XEO02386 MOACRIVE Inhibition DME1110 XEOTICID XEO02387 XEO_NAME Bactridin-2 DME1110 XEOTICID XEO02387 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02387 XEO_CLAS Peptide DME1110 XEOTICID XEO02387 DESCRIPT Bactridin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 54 microM) DME1110 XEOTICID XEO02387 GENEFORM Protein DME1110 XEOTICID XEO02387 MOACRIVE Inhibition DME1110 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1110 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02388 XEO_CLAS Peptide DME1110 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1110 XEOTICID XEO02388 GENEFORM Protein DME1110 XEOTICID XEO02388 MOACRIVE Inhibition DME1110 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1110 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02389 XEO_CLAS Peptide DME1110 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1110 XEOTICID XEO02389 GENEFORM Protein DME1110 XEOTICID XEO02389 MOACRIVE Inhibition DME1110 XEOTICID XEO02393 XEO_NAME Azadirachta indica bark extract DME1110 XEOTICID XEO02393 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02393 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02393 DESCRIPT Azadirachta indica bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02393 GENEFORM Protein DME1110 XEOTICID XEO02393 MOACRIVE Inhibition DME1110 XEOTICID XEO02394 XEO_NAME Cabralea canjerana bark extract DME1110 XEOTICID XEO02394 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02394 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02394 DESCRIPT Cabralea canjerana bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02394 GENEFORM Protein DME1110 XEOTICID XEO02394 MOACRIVE Inhibition DME1110 XEOTICID XEO02395 XEO_NAME Carapa guianensis bark extract DME1110 XEOTICID XEO02395 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02395 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02395 DESCRIPT Carapa guianensis bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02395 GENEFORM Protein DME1110 XEOTICID XEO02395 MOACRIVE Inhibition DME1110 XEOTICID XEO02396 XEO_NAME Cedrela fissilis bark extract DME1110 XEOTICID XEO02396 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02396 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02396 DESCRIPT Cedrela fissilis bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02396 GENEFORM Protein DME1110 XEOTICID XEO02396 MOACRIVE Inhibition DME1110 XEOTICID XEO02397 XEO_NAME Cedrela odorata bark extract DME1110 XEOTICID XEO02397 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02397 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02397 DESCRIPT Cedrela odorata bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02397 GENEFORM Protein DME1110 XEOTICID XEO02397 MOACRIVE Inhibition DME1110 XEOTICID XEO02398 XEO_NAME Cedrela salvadorensis bark extract DME1110 XEOTICID XEO02398 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02398 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02398 DESCRIPT Cedrela salvadorensis bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02398 GENEFORM Protein DME1110 XEOTICID XEO02398 MOACRIVE Inhibition DME1110 XEOTICID XEO02399 XEO_NAME Cedrela tonduzii bark extract DME1110 XEOTICID XEO02399 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02399 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02399 DESCRIPT Cedrela tonduzii bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02399 GENEFORM Protein DME1110 XEOTICID XEO02399 MOACRIVE Inhibition DME1110 XEOTICID XEO02400 XEO_NAME Chukrasia tabularis bark extract DME1110 XEOTICID XEO02400 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02400 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02400 DESCRIPT Chukrasia tabularis bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02400 GENEFORM Protein DME1110 XEOTICID XEO02400 MOACRIVE Inhibition DME1110 XEOTICID XEO02401 XEO_NAME Cupania glabra bark extract DME1110 XEOTICID XEO02401 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02401 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02401 DESCRIPT Cupania glabra bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02401 GENEFORM Protein DME1110 XEOTICID XEO02401 MOACRIVE Inhibition DME1110 XEOTICID XEO02402 XEO_NAME Dalbergia trichocarpa bark extract DME1110 XEOTICID XEO02402 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02402 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02402 DESCRIPT Dalbergia trichocarpa bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02402 GENEFORM Protein DME1110 XEOTICID XEO02402 MOACRIVE Inhibition DME1110 XEOTICID XEO02403 XEO_NAME Guarea glabra bark extract DME1110 XEOTICID XEO02403 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02403 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02403 DESCRIPT Guarea glabra bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02403 GENEFORM Protein DME1110 XEOTICID XEO02403 MOACRIVE Inhibition DME1110 XEOTICID XEO02404 XEO_NAME Guarea grandifolia bark extract DME1110 XEOTICID XEO02404 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02404 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02404 DESCRIPT Guarea grandifolia bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02404 GENEFORM Protein DME1110 XEOTICID XEO02404 MOACRIVE Inhibition DME1110 XEOTICID XEO02405 XEO_NAME Guarea guidonia bark extract DME1110 XEOTICID XEO02405 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02405 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02405 DESCRIPT Guarea guidonia bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02405 GENEFORM Protein DME1110 XEOTICID XEO02405 MOACRIVE Inhibition DME1110 XEOTICID XEO02406 XEO_NAME Guarea pterorhachis bark extract DME1110 XEOTICID XEO02406 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02406 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02406 DESCRIPT Guarea pterorhachis bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02406 GENEFORM Protein DME1110 XEOTICID XEO02406 MOACRIVE Inhibition DME1110 XEOTICID XEO02407 XEO_NAME Guarea pyriformis bark extract DME1110 XEOTICID XEO02407 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02407 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02407 DESCRIPT Guarea pyriformis bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02407 GENEFORM Protein DME1110 XEOTICID XEO02407 MOACRIVE Inhibition DME1110 XEOTICID XEO02408 XEO_NAME Ruptiliocarpon caracolito bark extract DME1110 XEOTICID XEO02408 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02408 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02408 DESCRIPT Ruptiliocarpon caracolito bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02408 GENEFORM Protein DME1110 XEOTICID XEO02408 MOACRIVE Inhibition DME1110 XEOTICID XEO02409 XEO_NAME Simarouba glauca bark extract DME1110 XEOTICID XEO02409 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02409 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02409 DESCRIPT Simarouba glauca bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02409 GENEFORM Protein DME1110 XEOTICID XEO02409 MOACRIVE Inhibition DME1110 XEOTICID XEO02410 XEO_NAME Swietenia macrophylla bark extract DME1110 XEOTICID XEO02410 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02410 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02410 DESCRIPT Swietenia macrophylla bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02410 GENEFORM Protein DME1110 XEOTICID XEO02410 MOACRIVE Inhibition DME1110 XEOTICID XEO02411 XEO_NAME Swietenia mahogani bark extract DME1110 XEOTICID XEO02411 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02411 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02411 DESCRIPT Swietenia mahogani bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02411 GENEFORM Protein DME1110 XEOTICID XEO02411 MOACRIVE Inhibition DME1110 XEOTICID XEO02413 XEO_NAME Trichilia martiana bark extract DME1110 XEOTICID XEO02413 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02413 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02413 DESCRIPT Trichilia martiana bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02413 GENEFORM Protein DME1110 XEOTICID XEO02413 MOACRIVE Inhibition DME1110 XEOTICID XEO02414 XEO_NAME Trichilia pleeana bark extract DME1110 XEOTICID XEO02414 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02414 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02414 DESCRIPT Trichilia pleeana bark extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02414 GENEFORM Protein DME1110 XEOTICID XEO02414 MOACRIVE Inhibition DME1110 XEOTICID XEO02425 XEO_NAME Benzocaine DME1110 XEOTICID XEO02425 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO02425 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO02425 DESCRIPT Benzocaine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02425 GENEFORM Protein DME1110 XEOTICID XEO02425 MOACRIVE Inhibition DME1110 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1110 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02437 XEO_CLAS Peptide DME1110 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02437 GENEFORM Protein DME1110 XEOTICID XEO02437 MOACRIVE Inhibition DME1110 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1110 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02438 XEO_CLAS Peptide DME1110 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02438 GENEFORM Protein DME1110 XEOTICID XEO02438 MOACRIVE Inhibition DME1110 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1110 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02440 XEO_CLAS Peptide DME1110 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02440 GENEFORM Protein DME1110 XEOTICID XEO02440 MOACRIVE Inhibition DME1110 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1110 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02443 XEO_CLAS Peptide DME1110 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02443 GENEFORM Protein DME1110 XEOTICID XEO02443 MOACRIVE Inhibition DME1110 XEOTICID XEO02462 XEO_NAME bLF peptide DME1110 XEOTICID XEO02462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02462 XEO_CLAS Peptide DME1110 XEOTICID XEO02462 DESCRIPT bLF peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02462 GENEFORM Protein DME1110 XEOTICID XEO02462 MOACRIVE Inhibition DME1110 XEOTICID XEO02464 XEO_NAME BMAP-27 DME1110 XEOTICID XEO02464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02464 XEO_CLAS Peptide DME1110 XEOTICID XEO02464 DESCRIPT BMAP-27 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02464 GENEFORM Protein DME1110 XEOTICID XEO02464 MOACRIVE Inhibition DME1110 XEOTICID XEO02465 XEO_NAME BMAP-28 DME1110 XEOTICID XEO02465 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02465 XEO_CLAS Peptide DME1110 XEOTICID XEO02465 DESCRIPT BMAP-28 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02465 GENEFORM Protein DME1110 XEOTICID XEO02465 MOACRIVE Inhibition DME1110 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1110 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02466 XEO_CLAS Peptide DME1110 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC <= 18 microM) DME1110 XEOTICID XEO02466 GENEFORM Protein DME1110 XEOTICID XEO02466 MOACRIVE Inhibition DME1110 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1110 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02473 XEO_CLAS Peptide DME1110 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02473 GENEFORM Protein DME1110 XEOTICID XEO02473 MOACRIVE Inhibition DME1110 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1110 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02474 XEO_CLAS Peptide DME1110 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.3 microM) DME1110 XEOTICID XEO02474 GENEFORM Protein DME1110 XEOTICID XEO02474 MOACRIVE Inhibition DME1110 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1110 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02475 XEO_CLAS Peptide DME1110 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 9.2 microM) DME1110 XEOTICID XEO02475 GENEFORM Protein DME1110 XEOTICID XEO02475 MOACRIVE Inhibition DME1110 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1110 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02491 XEO_CLAS Peptide DME1110 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.7 microM) DME1110 XEOTICID XEO02491 GENEFORM Protein DME1110 XEOTICID XEO02491 MOACRIVE Inhibition DME1110 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1110 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02492 XEO_CLAS Peptide DME1110 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1110 XEOTICID XEO02492 GENEFORM Protein DME1110 XEOTICID XEO02492 MOACRIVE Inhibition DME1110 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1110 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02493 XEO_CLAS Peptide DME1110 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1110 XEOTICID XEO02493 GENEFORM Protein DME1110 XEOTICID XEO02493 MOACRIVE Inhibition DME1110 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1110 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02494 XEO_CLAS Peptide DME1110 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1110 XEOTICID XEO02494 GENEFORM Protein DME1110 XEOTICID XEO02494 MOACRIVE Inhibition DME1110 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1110 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02496 XEO_CLAS Peptide DME1110 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 microM) DME1110 XEOTICID XEO02496 GENEFORM Protein DME1110 XEOTICID XEO02496 MOACRIVE Inhibition DME1110 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1110 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02497 XEO_CLAS Peptide DME1110 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 microM) DME1110 XEOTICID XEO02497 GENEFORM Protein DME1110 XEOTICID XEO02497 MOACRIVE Inhibition DME1110 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1110 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02511 XEO_CLAS Peptide DME1110 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 75 microM) DME1110 XEOTICID XEO02511 GENEFORM Protein DME1110 XEOTICID XEO02511 MOACRIVE Inhibition DME1110 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1110 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02512 XEO_CLAS Peptide DME1110 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 75 microM) DME1110 XEOTICID XEO02512 GENEFORM Protein DME1110 XEOTICID XEO02512 MOACRIVE Inhibition DME1110 XEOTICID XEO02521 XEO_NAME Brevinin-1E DME1110 XEOTICID XEO02521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02521 XEO_CLAS Peptide DME1110 XEOTICID XEO02521 DESCRIPT Brevinin-1E inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 30.6 microM) DME1110 XEOTICID XEO02521 GENEFORM Protein DME1110 XEOTICID XEO02521 MOACRIVE Inhibition DME1110 XEOTICID XEO02554 XEO_NAME Brevinin-1RTa DME1110 XEOTICID XEO02554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02554 XEO_CLAS Peptide DME1110 XEOTICID XEO02554 DESCRIPT Brevinin-1RTa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02554 GENEFORM Protein DME1110 XEOTICID XEO02554 MOACRIVE Inhibition DME1110 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1110 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02566 XEO_CLAS Peptide DME1110 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 microM) DME1110 XEOTICID XEO02566 GENEFORM Protein DME1110 XEOTICID XEO02566 MOACRIVE Inhibition DME1110 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1110 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02575 XEO_CLAS Peptide DME1110 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 microM) DME1110 XEOTICID XEO02575 GENEFORM Protein DME1110 XEOTICID XEO02575 MOACRIVE Inhibition DME1110 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1110 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02576 XEO_CLAS Peptide DME1110 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 44 microM) DME1110 XEOTICID XEO02576 GENEFORM Protein DME1110 XEOTICID XEO02576 MOACRIVE Inhibition DME1110 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1110 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02584 XEO_CLAS Peptide DME1110 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 30 microM) DME1110 XEOTICID XEO02584 GENEFORM Protein DME1110 XEOTICID XEO02584 MOACRIVE Inhibition DME1110 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1110 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02598 XEO_CLAS Peptide DME1110 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 65 microM) DME1110 XEOTICID XEO02598 GENEFORM Protein DME1110 XEOTICID XEO02598 MOACRIVE Inhibition DME1110 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1110 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02599 XEO_CLAS Peptide DME1110 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 30 microM) DME1110 XEOTICID XEO02599 GENEFORM Protein DME1110 XEOTICID XEO02599 MOACRIVE Inhibition DME1110 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1110 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02630 XEO_CLAS Peptide DME1110 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1110 XEOTICID XEO02630 GENEFORM Protein DME1110 XEOTICID XEO02630 MOACRIVE Inhibition DME1110 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1110 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02631 XEO_CLAS Peptide DME1110 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1110 XEOTICID XEO02631 GENEFORM Protein DME1110 XEOTICID XEO02631 MOACRIVE Inhibition DME1110 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1110 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02637 XEO_CLAS Peptide DME1110 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 microM) DME1110 XEOTICID XEO02637 GENEFORM Protein DME1110 XEOTICID XEO02637 MOACRIVE Inhibition DME1110 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1110 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02639 XEO_CLAS Peptide DME1110 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5 microM) DME1110 XEOTICID XEO02639 GENEFORM Protein DME1110 XEOTICID XEO02639 MOACRIVE Inhibition DME1110 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1110 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02663 XEO_CLAS Peptide DME1110 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1110 XEOTICID XEO02663 GENEFORM Protein DME1110 XEOTICID XEO02663 MOACRIVE Inhibition DME1110 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1110 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02664 XEO_CLAS Peptide DME1110 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25-12.5 microM) DME1110 XEOTICID XEO02664 GENEFORM Protein DME1110 XEOTICID XEO02664 MOACRIVE Inhibition DME1110 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1110 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02672 XEO_CLAS Peptide DME1110 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1110 XEOTICID XEO02672 GENEFORM Protein DME1110 XEOTICID XEO02672 MOACRIVE Inhibition DME1110 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1110 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02673 XEO_CLAS Peptide DME1110 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1110 XEOTICID XEO02673 GENEFORM Protein DME1110 XEOTICID XEO02673 MOACRIVE Inhibition DME1110 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1110 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02674 XEO_CLAS Peptide DME1110 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1110 XEOTICID XEO02674 GENEFORM Protein DME1110 XEOTICID XEO02674 MOACRIVE Inhibition DME1110 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1110 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02676 XEO_CLAS Peptide DME1110 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1110 XEOTICID XEO02676 GENEFORM Protein DME1110 XEOTICID XEO02676 MOACRIVE Inhibition DME1110 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1110 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02677 XEO_CLAS Peptide DME1110 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1110 XEOTICID XEO02677 GENEFORM Protein DME1110 XEOTICID XEO02677 MOACRIVE Inhibition DME1110 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1110 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02679 XEO_CLAS Peptide DME1110 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1110 XEOTICID XEO02679 GENEFORM Protein DME1110 XEOTICID XEO02679 MOACRIVE Inhibition DME1110 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1110 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02680 XEO_CLAS Peptide DME1110 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1110 XEOTICID XEO02680 GENEFORM Protein DME1110 XEOTICID XEO02680 MOACRIVE Inhibition DME1110 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1110 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02683 XEO_CLAS Peptide DME1110 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1110 XEOTICID XEO02683 GENEFORM Protein DME1110 XEOTICID XEO02683 MOACRIVE Inhibition DME1110 XEOTICID XEO02685 XEO_NAME Cadmium Ion DME1110 XEOTICID XEO02685 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02685 XEO_CLAS Nanoparticle DME1110 XEOTICID XEO02685 DESCRIPT Cadmium Ion inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02685 GENEFORM Protein DME1110 XEOTICID XEO02685 MOACRIVE Inhibition DME1110 XEOTICID XEO02703 XEO_NAME Calcitermin DME1110 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02703 XEO_CLAS Peptide DME1110 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02703 GENEFORM Protein DME1110 XEOTICID XEO02703 MOACRIVE Inhibition DME1110 XEOTICID XEO02705 XEO_NAME CAMA peptide DME1110 XEOTICID XEO02705 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02705 XEO_CLAS Peptide DME1110 XEOTICID XEO02705 DESCRIPT CAMA peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02705 GENEFORM Protein DME1110 XEOTICID XEO02705 MOACRIVE Inhibition DME1110 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1110 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02709 XEO_CLAS Peptide DME1110 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.05 microM) DME1110 XEOTICID XEO02709 GENEFORM Protein DME1110 XEOTICID XEO02709 MOACRIVE Inhibition DME1110 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1110 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1110 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02713 GENEFORM Protein DME1110 XEOTICID XEO02713 MOACRIVE Inhibition DME1110 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1110 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02714 GENEFORM Protein DME1110 XEOTICID XEO02714 MOACRIVE Inhibition DME1110 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1110 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02731 XEO_CLAS Peptide DME1110 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.63 microM) DME1110 XEOTICID XEO02731 GENEFORM Protein DME1110 XEOTICID XEO02731 MOACRIVE Inhibition DME1110 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1110 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02732 XEO_CLAS Peptide DME1110 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.25 microM) DME1110 XEOTICID XEO02732 GENEFORM Protein DME1110 XEOTICID XEO02732 MOACRIVE Inhibition DME1110 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1110 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02734 XEO_CLAS Peptide DME1110 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.18 microM) DME1110 XEOTICID XEO02734 GENEFORM Protein DME1110 XEOTICID XEO02734 MOACRIVE Inhibition DME1110 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1110 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02735 XEO_CLAS Peptide DME1110 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1110 XEOTICID XEO02735 GENEFORM Protein DME1110 XEOTICID XEO02735 MOACRIVE Inhibition DME1110 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1110 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02736 XEO_CLAS Peptide DME1110 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.66 microM) DME1110 XEOTICID XEO02736 GENEFORM Protein DME1110 XEOTICID XEO02736 MOACRIVE Inhibition DME1110 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1110 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02739 XEO_CLAS Peptide DME1110 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 microM) DME1110 XEOTICID XEO02739 GENEFORM Protein DME1110 XEOTICID XEO02739 MOACRIVE Inhibition DME1110 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1110 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02740 XEO_CLAS Peptide DME1110 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1110 XEOTICID XEO02740 GENEFORM Protein DME1110 XEOTICID XEO02740 MOACRIVE Inhibition DME1110 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1110 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02743 XEO_CLAS Peptide DME1110 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.2 ug/ml) DME1110 XEOTICID XEO02743 GENEFORM Protein DME1110 XEOTICID XEO02743 MOACRIVE Inhibition DME1110 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1110 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02744 XEO_CLAS Peptide DME1110 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.7 ug/ml) DME1110 XEOTICID XEO02744 GENEFORM Protein DME1110 XEOTICID XEO02744 MOACRIVE Inhibition DME1110 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1110 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02745 XEO_CLAS Peptide DME1110 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02745 GENEFORM Protein DME1110 XEOTICID XEO02745 MOACRIVE Inhibition DME1110 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1110 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02746 XEO_CLAS Peptide DME1110 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02746 GENEFORM Protein DME1110 XEOTICID XEO02746 MOACRIVE Inhibition DME1110 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1110 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02756 XEO_CLAS Peptide DME1110 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 15 microM) DME1110 XEOTICID XEO02756 GENEFORM Protein DME1110 XEOTICID XEO02756 MOACRIVE Inhibition DME1110 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1110 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02757 XEO_CLAS Peptide DME1110 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 microM) DME1110 XEOTICID XEO02757 GENEFORM Protein DME1110 XEOTICID XEO02757 MOACRIVE Inhibition DME1110 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1110 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02758 XEO_CLAS Peptide DME1110 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 15 microM) DME1110 XEOTICID XEO02758 GENEFORM Protein DME1110 XEOTICID XEO02758 MOACRIVE Inhibition DME1110 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1110 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02759 XEO_CLAS Peptide DME1110 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 microM) DME1110 XEOTICID XEO02759 GENEFORM Protein DME1110 XEOTICID XEO02759 MOACRIVE Inhibition DME1110 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1110 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02760 XEO_CLAS Peptide DME1110 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) DME1110 XEOTICID XEO02760 GENEFORM Protein DME1110 XEOTICID XEO02760 MOACRIVE Inhibition DME1110 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1110 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02761 XEO_CLAS Peptide DME1110 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 microM) DME1110 XEOTICID XEO02761 GENEFORM Protein DME1110 XEOTICID XEO02761 MOACRIVE Inhibition DME1110 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1110 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02762 XEO_CLAS Peptide DME1110 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 microM) DME1110 XEOTICID XEO02762 GENEFORM Protein DME1110 XEOTICID XEO02762 MOACRIVE Inhibition DME1110 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1110 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02763 XEO_CLAS Peptide DME1110 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.9 microM) DME1110 XEOTICID XEO02763 GENEFORM Protein DME1110 XEOTICID XEO02763 MOACRIVE Inhibition DME1110 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1110 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02764 XEO_CLAS Peptide DME1110 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 microM) DME1110 XEOTICID XEO02764 GENEFORM Protein DME1110 XEOTICID XEO02764 MOACRIVE Inhibition DME1110 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1110 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02765 XEO_CLAS Peptide DME1110 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.7 microM) DME1110 XEOTICID XEO02765 GENEFORM Protein DME1110 XEOTICID XEO02765 MOACRIVE Inhibition DME1110 XEOTICID XEO02766 XEO_NAME Cecropin-B DME1110 XEOTICID XEO02766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02766 XEO_CLAS Peptide DME1110 XEOTICID XEO02766 DESCRIPT Cecropin-B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02766 GENEFORM Protein DME1110 XEOTICID XEO02766 MOACRIVE Inhibition DME1110 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1110 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02767 XEO_CLAS Peptide DME1110 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02767 GENEFORM Protein DME1110 XEOTICID XEO02767 MOACRIVE Inhibition DME1110 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1110 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02768 XEO_CLAS Peptide DME1110 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10-25 ug/ml) DME1110 XEOTICID XEO02768 GENEFORM Protein DME1110 XEOTICID XEO02768 MOACRIVE Inhibition DME1110 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1110 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02769 XEO_CLAS Peptide DME1110 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.9 microM) DME1110 XEOTICID XEO02769 GENEFORM Protein DME1110 XEOTICID XEO02769 MOACRIVE Inhibition DME1110 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1110 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02770 XEO_CLAS Peptide DME1110 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.9 microM) DME1110 XEOTICID XEO02770 GENEFORM Protein DME1110 XEOTICID XEO02770 MOACRIVE Inhibition DME1110 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1110 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02771 XEO_CLAS Peptide DME1110 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 81 microM) DME1110 XEOTICID XEO02771 GENEFORM Protein DME1110 XEOTICID XEO02771 MOACRIVE Inhibition DME1110 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1110 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02772 XEO_CLAS Peptide DME1110 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02772 GENEFORM Protein DME1110 XEOTICID XEO02772 MOACRIVE Inhibition DME1110 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1110 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02774 XEO_CLAS Peptide DME1110 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5.9 microM) DME1110 XEOTICID XEO02774 GENEFORM Protein DME1110 XEOTICID XEO02774 MOACRIVE Inhibition DME1110 XEOTICID XEO02798 XEO_NAME Enterobacter asburiae cell-free lysate DME1110 XEOTICID XEO02798 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02798 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO02798 DESCRIPT Enterobacter asburiae cell-free lysate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02798 GENEFORM Protein DME1110 XEOTICID XEO02798 MOACRIVE Inhibition DME1110 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1110 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02799 XEO_CLAS Peptide DME1110 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1110 XEOTICID XEO02799 GENEFORM Protein DME1110 XEOTICID XEO02799 MOACRIVE Inhibition DME1110 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1110 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02800 XEO_CLAS Peptide DME1110 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1110 XEOTICID XEO02800 GENEFORM Protein DME1110 XEOTICID XEO02800 MOACRIVE Inhibition DME1110 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1110 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02802 XEO_CLAS Peptide DME1110 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 50 microM) DME1110 XEOTICID XEO02802 GENEFORM Protein DME1110 XEOTICID XEO02802 MOACRIVE Inhibition DME1110 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1110 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02820 XEO_CLAS Peptide DME1110 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO02820 GENEFORM Protein DME1110 XEOTICID XEO02820 MOACRIVE Inhibition DME1110 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1110 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02824 XEO_CLAS Peptide DME1110 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 9 microM) DME1110 XEOTICID XEO02824 GENEFORM Protein DME1110 XEOTICID XEO02824 MOACRIVE Inhibition DME1110 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1110 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02834 GENEFORM Protein DME1110 XEOTICID XEO02834 MOACRIVE Inhibition DME1110 XEOTICID XEO02836 XEO_NAME Chromate DME1110 XEOTICID XEO02836 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02836 XEO_CLAS Nanoparticle DME1110 XEOTICID XEO02836 DESCRIPT Chromate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02836 GENEFORM Protein DME1110 XEOTICID XEO02836 MOACRIVE Inhibition DME1110 XEOTICID XEO02847 XEO_NAME Cinnamon oil DME1110 XEOTICID XEO02847 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02847 XEO_CLAS Natural Product DME1110 XEOTICID XEO02847 DESCRIPT Cinnamon oil inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02847 GENEFORM Protein DME1110 XEOTICID XEO02847 MOACRIVE Inhibition DME1110 XEOTICID XEO02852 XEO_NAME Cis-2-dodecenoic acid DME1110 XEOTICID XEO02852 XEO_TYPE Health or Environmental Toxicant(s) DME1110 XEOTICID XEO02852 XEO_CLAS Environmental Pollutant DME1110 XEOTICID XEO02852 DESCRIPT Cis-2-dodecenoic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02852 GENEFORM Protein DME1110 XEOTICID XEO02852 MOACRIVE Inhibition DME1110 XEOTICID XEO02864 XEO_NAME Cathelicidin cjaRL-37 DME1110 XEOTICID XEO02864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02864 XEO_CLAS Peptide DME1110 XEOTICID XEO02864 DESCRIPT Cathelicidin cjaRL-37 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) DME1110 XEOTICID XEO02864 GENEFORM Protein DME1110 XEOTICID XEO02864 MOACRIVE Inhibition DME1110 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1110 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02875 XEO_CLAS Peptide DME1110 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.7 microM) DME1110 XEOTICID XEO02875 GENEFORM Protein DME1110 XEOTICID XEO02875 MOACRIVE Inhibition DME1110 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1110 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02876 XEO_CLAS Peptide DME1110 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) DME1110 XEOTICID XEO02876 GENEFORM Protein DME1110 XEOTICID XEO02876 MOACRIVE Inhibition DME1110 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1110 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02877 XEO_CLAS Peptide DME1110 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) DME1110 XEOTICID XEO02877 GENEFORM Protein DME1110 XEOTICID XEO02877 MOACRIVE Inhibition DME1110 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1110 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02878 XEO_CLAS Peptide DME1110 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.9 microM) DME1110 XEOTICID XEO02878 GENEFORM Protein DME1110 XEOTICID XEO02878 MOACRIVE Inhibition DME1110 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1110 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02885 XEO_CLAS Peptide DME1110 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO02885 GENEFORM Protein DME1110 XEOTICID XEO02885 MOACRIVE Inhibition DME1110 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1110 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02886 XEO_CLAS Peptide DME1110 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1110 XEOTICID XEO02886 GENEFORM Protein DME1110 XEOTICID XEO02886 MOACRIVE Inhibition DME1110 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1110 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02887 XEO_CLAS Peptide DME1110 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1110 XEOTICID XEO02887 GENEFORM Protein DME1110 XEOTICID XEO02887 MOACRIVE Inhibition DME1110 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1110 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02888 XEO_CLAS Peptide DME1110 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1110 XEOTICID XEO02888 GENEFORM Protein DME1110 XEOTICID XEO02888 MOACRIVE Inhibition DME1110 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1110 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02889 XEO_CLAS Peptide DME1110 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 19 ug/ml) DME1110 XEOTICID XEO02889 GENEFORM Protein DME1110 XEOTICID XEO02889 MOACRIVE Inhibition DME1110 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1110 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02890 XEO_CLAS Peptide DME1110 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1110 XEOTICID XEO02890 GENEFORM Protein DME1110 XEOTICID XEO02890 MOACRIVE Inhibition DME1110 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1110 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02891 XEO_CLAS Peptide DME1110 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO02891 GENEFORM Protein DME1110 XEOTICID XEO02891 MOACRIVE Inhibition DME1110 XEOTICID XEO02898 XEO_NAME Cobalt Ion DME1110 XEOTICID XEO02898 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO02898 XEO_CLAS Nanoparticle DME1110 XEOTICID XEO02898 DESCRIPT Cobalt Ion inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02898 GENEFORM Protein DME1110 XEOTICID XEO02898 MOACRIVE Inhibition DME1110 XEOTICID XEO02903 XEO_NAME Colistin DME1110 XEOTICID XEO02903 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO02903 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO02903 DESCRIPT Colistin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02903 GENEFORM Protein DME1110 XEOTICID XEO02903 MOACRIVE Inhibition DME1110 XEOTICID XEO02914 XEO_NAME Coral associated bacteria extract DME1110 XEOTICID XEO02914 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02914 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO02914 DESCRIPT Coral associated bacteria extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02914 GENEFORM Protein DME1110 XEOTICID XEO02914 MOACRIVE Inhibition DME1110 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1110 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02931 XEO_CLAS Peptide DME1110 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1110 XEOTICID XEO02931 GENEFORM Protein DME1110 XEOTICID XEO02931 MOACRIVE Inhibition DME1110 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1110 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02933 XEO_CLAS Peptide DME1110 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO02933 GENEFORM Protein DME1110 XEOTICID XEO02933 MOACRIVE Inhibition DME1110 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1110 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02934 XEO_CLAS Peptide DME1110 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO02934 GENEFORM Protein DME1110 XEOTICID XEO02934 MOACRIVE Inhibition DME1110 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1110 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02935 XEO_CLAS Peptide DME1110 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1110 XEOTICID XEO02935 GENEFORM Protein DME1110 XEOTICID XEO02935 MOACRIVE Inhibition DME1110 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1110 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02936 XEO_CLAS Peptide DME1110 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO02936 GENEFORM Protein DME1110 XEOTICID XEO02936 MOACRIVE Inhibition DME1110 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1110 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02937 XEO_CLAS Peptide DME1110 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1110 XEOTICID XEO02937 GENEFORM Protein DME1110 XEOTICID XEO02937 MOACRIVE Inhibition DME1110 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1110 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02938 XEO_CLAS Peptide DME1110 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1110 XEOTICID XEO02938 GENEFORM Protein DME1110 XEOTICID XEO02938 MOACRIVE Inhibition DME1110 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1110 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02939 XEO_CLAS Peptide DME1110 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1110 XEOTICID XEO02939 GENEFORM Protein DME1110 XEOTICID XEO02939 MOACRIVE Inhibition DME1110 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1110 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02940 XEO_CLAS Peptide DME1110 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1110 XEOTICID XEO02940 GENEFORM Protein DME1110 XEOTICID XEO02940 MOACRIVE Inhibition DME1110 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1110 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02941 XEO_CLAS Peptide DME1110 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1110 XEOTICID XEO02941 GENEFORM Protein DME1110 XEOTICID XEO02941 MOACRIVE Inhibition DME1110 XEOTICID XEO02943 XEO_NAME CP-P peptide DME1110 XEOTICID XEO02943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02943 XEO_CLAS Peptide DME1110 XEOTICID XEO02943 DESCRIPT CP-P peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1110 XEOTICID XEO02943 GENEFORM Protein DME1110 XEOTICID XEO02943 MOACRIVE Inhibition DME1110 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1110 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02947 XEO_CLAS Peptide DME1110 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO02947 GENEFORM Protein DME1110 XEOTICID XEO02947 MOACRIVE Inhibition DME1110 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1110 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02948 XEO_CLAS Peptide DME1110 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1110 XEOTICID XEO02948 GENEFORM Protein DME1110 XEOTICID XEO02948 MOACRIVE Inhibition DME1110 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1110 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02949 XEO_CLAS Peptide DME1110 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO02949 GENEFORM Protein DME1110 XEOTICID XEO02949 MOACRIVE Inhibition DME1110 XEOTICID XEO02953 XEO_NAME Crocin DME1110 XEOTICID XEO02953 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02953 XEO_CLAS Natural Product DME1110 XEOTICID XEO02953 DESCRIPT Crocin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02953 GENEFORM Protein DME1110 XEOTICID XEO02953 MOACRIVE Inhibition DME1110 XEOTICID XEO02957 XEO_NAME Equisetum hyemale crude extract DME1110 XEOTICID XEO02957 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02957 XEO_CLAS Plant Extract DME1110 XEOTICID XEO02957 DESCRIPT Equisetum hyemale crude extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02957 GENEFORM Protein DME1110 XEOTICID XEO02957 MOACRIVE Inhibition DME1110 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1110 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02969 XEO_CLAS Peptide DME1110 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 microM) DME1110 XEOTICID XEO02969 GENEFORM Protein DME1110 XEOTICID XEO02969 MOACRIVE Inhibition DME1110 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1110 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO02971 XEO_CLAS Peptide DME1110 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 128 microM) DME1110 XEOTICID XEO02971 GENEFORM Protein DME1110 XEOTICID XEO02971 MOACRIVE Inhibition DME1110 XEOTICID XEO02974 XEO_NAME Bacillus sp. culture extract DME1110 XEOTICID XEO02974 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02974 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO02974 DESCRIPT Bacillus sp. culture extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02974 GENEFORM Protein DME1110 XEOTICID XEO02974 MOACRIVE Inhibition DME1110 XEOTICID XEO02976 XEO_NAME Paenibacillus strain culture extract DME1110 XEOTICID XEO02976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02976 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO02976 DESCRIPT Paenibacillus strain culture extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02976 GENEFORM Protein DME1110 XEOTICID XEO02976 MOACRIVE Inhibition DME1110 XEOTICID XEO02986 XEO_NAME Bacillus aquimaris culture supernatant DME1110 XEOTICID XEO02986 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02986 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO02986 DESCRIPT Bacillus aquimaris culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02986 GENEFORM Protein DME1110 XEOTICID XEO02986 MOACRIVE Inhibition DME1110 XEOTICID XEO02987 XEO_NAME Bacillus arsenicus culture supernatant DME1110 XEOTICID XEO02987 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02987 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO02987 DESCRIPT Bacillus arsenicus culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02987 GENEFORM Protein DME1110 XEOTICID XEO02987 MOACRIVE Inhibition DME1110 XEOTICID XEO02988 XEO_NAME Bacillus cereus culture supernatant DME1110 XEOTICID XEO02988 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02988 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO02988 DESCRIPT Bacillus cereus culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02988 GENEFORM Protein DME1110 XEOTICID XEO02988 MOACRIVE Inhibition DME1110 XEOTICID XEO02989 XEO_NAME Bacillus indicus culture supernatant DME1110 XEOTICID XEO02989 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO02989 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO02989 DESCRIPT Bacillus indicus culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO02989 GENEFORM Protein DME1110 XEOTICID XEO02989 MOACRIVE Inhibition DME1110 XEOTICID XEO03000 XEO_NAME Bacillus niabensis culture supernatant DME1110 XEOTICID XEO03000 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03000 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO03000 DESCRIPT Bacillus niabensis culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03000 GENEFORM Protein DME1110 XEOTICID XEO03000 MOACRIVE Inhibition DME1110 XEOTICID XEO03001 XEO_NAME Bacillus pumilus culture supernatant DME1110 XEOTICID XEO03001 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03001 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO03001 DESCRIPT Bacillus pumilus culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03001 GENEFORM Protein DME1110 XEOTICID XEO03001 MOACRIVE Inhibition DME1110 XEOTICID XEO03002 XEO_NAME Ferrimonas balearica culture supernatant DME1110 XEOTICID XEO03002 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03002 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO03002 DESCRIPT Ferrimonas balearica culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03002 GENEFORM Protein DME1110 XEOTICID XEO03002 MOACRIVE Inhibition DME1110 XEOTICID XEO03003 XEO_NAME Halobacillus trueperi S6-09 culture supernatant DME1110 XEOTICID XEO03003 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03003 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO03003 DESCRIPT Halobacillus trueperi S6-09 culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03003 GENEFORM Protein DME1110 XEOTICID XEO03003 MOACRIVE Inhibition DME1110 XEOTICID XEO03004 XEO_NAME Halobacillus trueperi S6-16 culture supernatant DME1110 XEOTICID XEO03004 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03004 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO03004 DESCRIPT Halobacillus trueperi S6-16 culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03004 GENEFORM Protein DME1110 XEOTICID XEO03004 MOACRIVE Inhibition DME1110 XEOTICID XEO03007 XEO_NAME Marinobacter hydrocarbonoclasticus culture supernatant DME1110 XEOTICID XEO03007 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03007 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO03007 DESCRIPT Marinobacter hydrocarbonoclasticus culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03007 GENEFORM Protein DME1110 XEOTICID XEO03007 MOACRIVE Inhibition DME1110 XEOTICID XEO03008 XEO_NAME Staphylococcus pasteuri culture supernatant DME1110 XEOTICID XEO03008 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03008 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO03008 DESCRIPT Staphylococcus pasteuri culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03008 GENEFORM Protein DME1110 XEOTICID XEO03008 MOACRIVE Inhibition DME1110 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1110 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03021 XEO_CLAS Peptide DME1110 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.31-0.63 microM) DME1110 XEOTICID XEO03021 GENEFORM Protein DME1110 XEOTICID XEO03021 MOACRIVE Inhibition DME1110 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1110 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03029 XEO_CLAS Peptide DME1110 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 0.619 microM) DME1110 XEOTICID XEO03029 GENEFORM Protein DME1110 XEOTICID XEO03029 MOACRIVE Inhibition DME1110 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1110 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03030 XEO_CLAS Peptide DME1110 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 0.643 microM) DME1110 XEOTICID XEO03030 GENEFORM Protein DME1110 XEOTICID XEO03030 MOACRIVE Inhibition DME1110 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1110 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03031 XEO_CLAS Peptide DME1110 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.005 microM) DME1110 XEOTICID XEO03031 GENEFORM Protein DME1110 XEOTICID XEO03031 MOACRIVE Inhibition DME1110 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1110 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03032 XEO_CLAS Peptide DME1110 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.005 microM) DME1110 XEOTICID XEO03032 GENEFORM Protein DME1110 XEOTICID XEO03032 MOACRIVE Inhibition DME1110 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1110 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03033 XEO_CLAS Peptide DME1110 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.005 microM) DME1110 XEOTICID XEO03033 GENEFORM Protein DME1110 XEOTICID XEO03033 MOACRIVE Inhibition DME1110 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1110 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03034 XEO_CLAS Peptide DME1110 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.004 microM) DME1110 XEOTICID XEO03034 GENEFORM Protein DME1110 XEOTICID XEO03034 MOACRIVE Inhibition DME1110 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1110 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03035 XEO_CLAS Peptide DME1110 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.004 microM) DME1110 XEOTICID XEO03035 GENEFORM Protein DME1110 XEOTICID XEO03035 MOACRIVE Inhibition DME1110 XEOTICID XEO03036 XEO_NAME Cyclic protegrin-1-mimetic L27-11 DME1110 XEOTICID XEO03036 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03036 XEO_CLAS Peptide DME1110 XEOTICID XEO03036 DESCRIPT Cyclic protegrin-1-mimetic L27-11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03036 GENEFORM Protein DME1110 XEOTICID XEO03036 MOACRIVE Inhibition DME1110 XEOTICID XEO03037 XEO_NAME Cyclo(Trp-Ser) DME1110 XEOTICID XEO03037 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03037 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO03037 DESCRIPT Cyclo(Trp-Ser) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03037 GENEFORM Protein DME1110 XEOTICID XEO03037 MOACRIVE Inhibition DME1110 XEOTICID XEO03038 XEO_NAME Cyclobutanamine DME1110 XEOTICID XEO03038 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO03038 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO03038 DESCRIPT Cyclobutanamine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03038 GENEFORM Protein DME1110 XEOTICID XEO03038 MOACRIVE Inhibition DME1110 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1110 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03039 XEO_CLAS Peptide DME1110 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 13.5 microM) DME1110 XEOTICID XEO03039 GENEFORM Protein DME1110 XEOTICID XEO03039 MOACRIVE Inhibition DME1110 XEOTICID XEO03040 XEO_NAME Cynarin DME1110 XEOTICID XEO03040 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO03040 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO03040 DESCRIPT Cynarin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03040 GENEFORM Protein DME1110 XEOTICID XEO03040 MOACRIVE Inhibition DME1110 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1110 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03043 XEO_CLAS Peptide DME1110 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) DME1110 XEOTICID XEO03043 GENEFORM Protein DME1110 XEOTICID XEO03043 MOACRIVE Inhibition DME1110 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1110 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03049 XEO_CLAS Peptide DME1110 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) DME1110 XEOTICID XEO03049 GENEFORM Protein DME1110 XEOTICID XEO03049 MOACRIVE Inhibition DME1110 XEOTICID XEO03050 XEO_NAME CP-P derivative D11 DME1110 XEOTICID XEO03050 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03050 XEO_CLAS Peptide DME1110 XEOTICID XEO03050 DESCRIPT CP-P derivative D11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1110 XEOTICID XEO03050 GENEFORM Protein DME1110 XEOTICID XEO03050 MOACRIVE Inhibition DME1110 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1110 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03051 XEO_CLAS Peptide DME1110 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 200 ug/ml) DME1110 XEOTICID XEO03051 GENEFORM Protein DME1110 XEOTICID XEO03051 MOACRIVE Inhibition DME1110 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1110 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03052 XEO_CLAS Peptide DME1110 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1110 XEOTICID XEO03052 GENEFORM Protein DME1110 XEOTICID XEO03052 MOACRIVE Inhibition DME1110 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1110 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03053 XEO_CLAS Peptide DME1110 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 125 ug/ml) DME1110 XEOTICID XEO03053 GENEFORM Protein DME1110 XEOTICID XEO03053 MOACRIVE Inhibition DME1110 XEOTICID XEO03054 XEO_NAME CP-P derivative D18 DME1110 XEOTICID XEO03054 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03054 XEO_CLAS Peptide DME1110 XEOTICID XEO03054 DESCRIPT CP-P derivative D18 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1110 XEOTICID XEO03054 GENEFORM Protein DME1110 XEOTICID XEO03054 MOACRIVE Inhibition DME1110 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1110 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03055 XEO_CLAS Peptide DME1110 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) DME1110 XEOTICID XEO03055 GENEFORM Protein DME1110 XEOTICID XEO03055 MOACRIVE Inhibition DME1110 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1110 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03059 XEO_CLAS Peptide DME1110 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12 microM) DME1110 XEOTICID XEO03059 GENEFORM Protein DME1110 XEOTICID XEO03059 MOACRIVE Inhibition DME1110 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1110 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03060 XEO_CLAS Peptide DME1110 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) DME1110 XEOTICID XEO03060 GENEFORM Protein DME1110 XEOTICID XEO03060 MOACRIVE Inhibition DME1110 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1110 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03062 XEO_CLAS Peptide DME1110 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 microM) DME1110 XEOTICID XEO03062 GENEFORM Protein DME1110 XEOTICID XEO03062 MOACRIVE Inhibition DME1110 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1110 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03064 XEO_CLAS Peptide DME1110 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 microM) DME1110 XEOTICID XEO03064 GENEFORM Protein DME1110 XEOTICID XEO03064 MOACRIVE Inhibition DME1110 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1110 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03066 XEO_CLAS Peptide DME1110 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 microM) DME1110 XEOTICID XEO03066 GENEFORM Protein DME1110 XEOTICID XEO03066 MOACRIVE Inhibition DME1110 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1110 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03068 XEO_CLAS Peptide DME1110 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 microM) DME1110 XEOTICID XEO03068 GENEFORM Protein DME1110 XEOTICID XEO03068 MOACRIVE Inhibition DME1110 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1110 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03073 XEO_CLAS Peptide DME1110 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16-32 ug/ml) DME1110 XEOTICID XEO03073 GENEFORM Protein DME1110 XEOTICID XEO03073 MOACRIVE Inhibition DME1110 XEOTICID XEO03096 XEO_NAME Frog defensin DME1110 XEOTICID XEO03096 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03096 XEO_CLAS Peptide DME1110 XEOTICID XEO03096 DESCRIPT Frog defensin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03096 GENEFORM Protein DME1110 XEOTICID XEO03096 MOACRIVE Inhibition DME1110 XEOTICID XEO03098 XEO_NAME Insect defensin DME1110 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03098 XEO_CLAS Peptide DME1110 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 50 ug/ml) DME1110 XEOTICID XEO03098 GENEFORM Protein DME1110 XEOTICID XEO03098 MOACRIVE Inhibition DME1110 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1110 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03116 XEO_CLAS Peptide DME1110 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 40 microM) DME1110 XEOTICID XEO03116 GENEFORM Protein DME1110 XEOTICID XEO03116 MOACRIVE Inhibition DME1110 XEOTICID XEO03123 XEO_NAME Defensin-like protein fabatin-2 DME1110 XEOTICID XEO03123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03123 XEO_CLAS Peptide DME1110 XEOTICID XEO03123 DESCRIPT Defensin-like protein fabatin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03123 GENEFORM Protein DME1110 XEOTICID XEO03123 MOACRIVE Inhibition DME1110 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1110 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03126 XEO_CLAS Peptide DME1110 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 9.3 microM) DME1110 XEOTICID XEO03126 GENEFORM Protein DME1110 XEOTICID XEO03126 MOACRIVE Inhibition DME1110 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1110 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03127 XEO_CLAS Peptide DME1110 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03127 GENEFORM Protein DME1110 XEOTICID XEO03127 MOACRIVE Inhibition DME1110 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1110 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03128 XEO_CLAS Peptide DME1110 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 256 ug/ml) DME1110 XEOTICID XEO03128 GENEFORM Protein DME1110 XEOTICID XEO03128 MOACRIVE Inhibition DME1110 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1110 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03129 XEO_CLAS Peptide DME1110 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 256 ug/ml) DME1110 XEOTICID XEO03129 GENEFORM Protein DME1110 XEOTICID XEO03129 MOACRIVE Inhibition DME1110 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1110 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03130 XEO_CLAS Peptide DME1110 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 256 ug/ml) DME1110 XEOTICID XEO03130 GENEFORM Protein DME1110 XEOTICID XEO03130 MOACRIVE Inhibition DME1110 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1110 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03131 XEO_CLAS Peptide DME1110 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 256 ug/ml) DME1110 XEOTICID XEO03131 GENEFORM Protein DME1110 XEOTICID XEO03131 MOACRIVE Inhibition DME1110 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1110 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03132 XEO_CLAS Peptide DME1110 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 128 ug/ml) DME1110 XEOTICID XEO03132 GENEFORM Protein DME1110 XEOTICID XEO03132 MOACRIVE Inhibition DME1110 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1110 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03137 XEO_CLAS Peptide DME1110 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03137 GENEFORM Protein DME1110 XEOTICID XEO03137 MOACRIVE Inhibition DME1110 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1110 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03145 XEO_CLAS Peptide DME1110 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.4 microM) DME1110 XEOTICID XEO03145 GENEFORM Protein DME1110 XEOTICID XEO03145 MOACRIVE Inhibition DME1110 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1110 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03146 XEO_CLAS Peptide DME1110 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 40 microM) DME1110 XEOTICID XEO03146 GENEFORM Protein DME1110 XEOTICID XEO03146 MOACRIVE Inhibition DME1110 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1110 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03147 XEO_CLAS Peptide DME1110 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 38 microM) DME1110 XEOTICID XEO03147 GENEFORM Protein DME1110 XEOTICID XEO03147 MOACRIVE Inhibition DME1110 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1110 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03148 XEO_CLAS Peptide DME1110 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5.4 microM) DME1110 XEOTICID XEO03148 GENEFORM Protein DME1110 XEOTICID XEO03148 MOACRIVE Inhibition DME1110 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1110 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03149 XEO_CLAS Peptide DME1110 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 22 microM) DME1110 XEOTICID XEO03149 GENEFORM Protein DME1110 XEOTICID XEO03149 MOACRIVE Inhibition DME1110 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1110 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03152 XEO_CLAS Peptide DME1110 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.6 microM) DME1110 XEOTICID XEO03152 GENEFORM Protein DME1110 XEOTICID XEO03152 MOACRIVE Inhibition DME1110 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1110 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03156 XEO_CLAS Peptide DME1110 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.3 microM) DME1110 XEOTICID XEO03156 GENEFORM Protein DME1110 XEOTICID XEO03156 MOACRIVE Inhibition DME1110 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1110 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03157 XEO_CLAS Peptide DME1110 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 11.6 microM) DME1110 XEOTICID XEO03157 GENEFORM Protein DME1110 XEOTICID XEO03157 MOACRIVE Inhibition DME1110 XEOTICID XEO03164 XEO_NAME Dermatoxin DME1110 XEOTICID XEO03164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03164 XEO_CLAS Peptide DME1110 XEOTICID XEO03164 DESCRIPT Dermatoxin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03164 GENEFORM Protein DME1110 XEOTICID XEO03164 MOACRIVE Inhibition DME1110 XEOTICID XEO03179 XEO_NAME Dibenzyl disulphide DME1110 XEOTICID XEO03179 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO03179 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO03179 DESCRIPT Dibenzyl disulphide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03179 GENEFORM Protein DME1110 XEOTICID XEO03179 MOACRIVE Inhibition DME1110 XEOTICID XEO03184 XEO_NAME Diclofenac sodium DME1110 XEOTICID XEO03184 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO03184 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO03184 DESCRIPT Diclofenac sodium inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03184 GENEFORM Protein DME1110 XEOTICID XEO03184 MOACRIVE Inhibition DME1110 XEOTICID XEO03191 XEO_NAME Diphenyl disulphide DME1110 XEOTICID XEO03191 XEO_TYPE Health or Environmental Toxicant(s) DME1110 XEOTICID XEO03191 XEO_CLAS Environmental Pollutant DME1110 XEOTICID XEO03191 DESCRIPT Diphenyl disulphide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03191 GENEFORM Protein DME1110 XEOTICID XEO03191 MOACRIVE Inhibition DME1110 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1110 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03197 XEO_CLAS Peptide DME1110 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 28.0 microM) DME1110 XEOTICID XEO03197 GENEFORM Protein DME1110 XEOTICID XEO03197 MOACRIVE Inhibition DME1110 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1110 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03202 XEO_CLAS Peptide DME1110 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 7.92 microM) DME1110 XEOTICID XEO03202 GENEFORM Protein DME1110 XEOTICID XEO03202 MOACRIVE Inhibition DME1110 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1110 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03203 XEO_CLAS Peptide DME1110 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.71 microM) DME1110 XEOTICID XEO03203 GENEFORM Protein DME1110 XEOTICID XEO03203 MOACRIVE Inhibition DME1110 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1110 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03204 XEO_CLAS Peptide DME1110 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.83 microM) DME1110 XEOTICID XEO03204 GENEFORM Protein DME1110 XEOTICID XEO03204 MOACRIVE Inhibition DME1110 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1110 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03205 XEO_CLAS Peptide DME1110 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.22 microM) DME1110 XEOTICID XEO03205 GENEFORM Protein DME1110 XEOTICID XEO03205 MOACRIVE Inhibition DME1110 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1110 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03206 XEO_CLAS Peptide DME1110 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.35 microM) DME1110 XEOTICID XEO03206 GENEFORM Protein DME1110 XEOTICID XEO03206 MOACRIVE Inhibition DME1110 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1110 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03207 XEO_CLAS Peptide DME1110 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.42 microM) DME1110 XEOTICID XEO03207 GENEFORM Protein DME1110 XEOTICID XEO03207 MOACRIVE Inhibition DME1110 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1110 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03208 XEO_CLAS Peptide DME1110 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.69 microM) DME1110 XEOTICID XEO03208 GENEFORM Protein DME1110 XEOTICID XEO03208 MOACRIVE Inhibition DME1110 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1110 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03209 XEO_CLAS Peptide DME1110 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.23 microM) DME1110 XEOTICID XEO03209 GENEFORM Protein DME1110 XEOTICID XEO03209 MOACRIVE Inhibition DME1110 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1110 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03210 XEO_CLAS Peptide DME1110 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 22.62 microM) DME1110 XEOTICID XEO03210 GENEFORM Protein DME1110 XEOTICID XEO03210 MOACRIVE Inhibition DME1110 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1110 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03211 XEO_CLAS Peptide DME1110 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 22.62 microM) DME1110 XEOTICID XEO03211 GENEFORM Protein DME1110 XEOTICID XEO03211 MOACRIVE Inhibition DME1110 XEOTICID XEO03218 XEO_NAME Dorema oil DME1110 XEOTICID XEO03218 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03218 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03218 DESCRIPT Dorema oil inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03218 GENEFORM Protein DME1110 XEOTICID XEO03218 MOACRIVE Inhibition DME1110 XEOTICID XEO03219 XEO_NAME Doripenem DME1110 XEOTICID XEO03219 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO03219 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO03219 DESCRIPT Doripenem inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03219 GENEFORM Protein DME1110 XEOTICID XEO03219 MOACRIVE Inhibition DME1110 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1110 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03223 XEO_CLAS Peptide DME1110 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.2 microM) DME1110 XEOTICID XEO03223 GENEFORM Protein DME1110 XEOTICID XEO03223 MOACRIVE Inhibition DME1110 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1110 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03224 XEO_CLAS Peptide DME1110 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1-2.5 microM) DME1110 XEOTICID XEO03224 GENEFORM Protein DME1110 XEOTICID XEO03224 MOACRIVE Inhibition DME1110 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1110 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03225 XEO_CLAS Peptide DME1110 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.2 microM) DME1110 XEOTICID XEO03225 GENEFORM Protein DME1110 XEOTICID XEO03225 MOACRIVE Inhibition DME1110 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1110 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03251 XEO_CLAS Peptide DME1110 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03251 GENEFORM Protein DME1110 XEOTICID XEO03251 MOACRIVE Inhibition DME1110 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1110 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03253 XEO_CLAS Peptide DME1110 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03253 GENEFORM Protein DME1110 XEOTICID XEO03253 MOACRIVE Inhibition DME1110 XEOTICID XEO03263 XEO_NAME Ephedrine DME1110 XEOTICID XEO03263 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03263 XEO_CLAS Natural Product DME1110 XEOTICID XEO03263 DESCRIPT Ephedrine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03263 GENEFORM Protein DME1110 XEOTICID XEO03263 MOACRIVE Inhibition DME1110 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1110 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03277 XEO_CLAS Peptide DME1110 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.7 microM) DME1110 XEOTICID XEO03277 GENEFORM Protein DME1110 XEOTICID XEO03277 MOACRIVE Inhibition DME1110 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1110 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03299 XEO_CLAS Peptide DME1110 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.5 microM) DME1110 XEOTICID XEO03299 GENEFORM Protein DME1110 XEOTICID XEO03299 MOACRIVE Inhibition DME1110 XEOTICID XEO03323 XEO_NAME Esculin DME1110 XEOTICID XEO03323 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO03323 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO03323 DESCRIPT Esculin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03323 GENEFORM Protein DME1110 XEOTICID XEO03323 MOACRIVE Inhibition DME1110 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1110 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03348 GENEFORM Protein DME1110 XEOTICID XEO03348 MOACRIVE Inhibition DME1110 XEOTICID XEO03349 XEO_NAME Burdock leaf ethanolic extract DME1110 XEOTICID XEO03349 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03349 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03349 DESCRIPT Burdock leaf ethanolic extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03349 GENEFORM Protein DME1110 XEOTICID XEO03349 MOACRIVE Inhibition DME1110 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1110 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03362 XEO_CLAS Peptide DME1110 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 20 ug/ml) DME1110 XEOTICID XEO03362 GENEFORM Protein DME1110 XEOTICID XEO03362 MOACRIVE Inhibition DME1110 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1110 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03363 XEO_CLAS Peptide DME1110 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 30 microM) DME1110 XEOTICID XEO03363 GENEFORM Protein DME1110 XEOTICID XEO03363 MOACRIVE Inhibition DME1110 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1110 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03364 XEO_CLAS Peptide DME1110 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 30 microM) DME1110 XEOTICID XEO03364 GENEFORM Protein DME1110 XEOTICID XEO03364 MOACRIVE Inhibition DME1110 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1110 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03366 XEO_CLAS Peptide DME1110 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 30 microM) DME1110 XEOTICID XEO03366 GENEFORM Protein DME1110 XEOTICID XEO03366 MOACRIVE Inhibition DME1110 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1110 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03367 XEO_CLAS Peptide DME1110 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 30 microM) DME1110 XEOTICID XEO03367 GENEFORM Protein DME1110 XEOTICID XEO03367 MOACRIVE Inhibition DME1110 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1110 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03368 XEO_CLAS Peptide DME1110 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 30 microM) DME1110 XEOTICID XEO03368 GENEFORM Protein DME1110 XEOTICID XEO03368 MOACRIVE Inhibition DME1110 XEOTICID XEO03371 XEO_NAME Herba patriniae extract DME1110 XEOTICID XEO03371 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03371 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03371 DESCRIPT Herba patriniae extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03371 GENEFORM Protein DME1110 XEOTICID XEO03371 MOACRIVE Inhibition DME1110 XEOTICID XEO03377 XEO_NAME CP-P derivative F2 DME1110 XEOTICID XEO03377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03377 XEO_CLAS Peptide DME1110 XEOTICID XEO03377 DESCRIPT CP-P derivative F2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1110 XEOTICID XEO03377 GENEFORM Protein DME1110 XEOTICID XEO03377 MOACRIVE Inhibition DME1110 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1110 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03379 XEO_CLAS Peptide DME1110 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1110 XEOTICID XEO03379 GENEFORM Protein DME1110 XEOTICID XEO03379 MOACRIVE Inhibition DME1110 XEOTICID XEO03388 XEO_NAME Ferrous DME1110 XEOTICID XEO03388 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO03388 XEO_CLAS Nanoparticle DME1110 XEOTICID XEO03388 DESCRIPT Ferrous inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03388 GENEFORM Protein DME1110 XEOTICID XEO03388 MOACRIVE Inhibition DME1110 XEOTICID XEO03389 XEO_NAME Ferula oil DME1110 XEOTICID XEO03389 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03389 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03389 DESCRIPT Ferula oil inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03389 GENEFORM Protein DME1110 XEOTICID XEO03389 MOACRIVE Inhibition DME1110 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1110 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03396 XEO_CLAS Peptide DME1110 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03396 GENEFORM Protein DME1110 XEOTICID XEO03396 MOACRIVE Inhibition DME1110 XEOTICID XEO03403 XEO_NAME Fraxin DME1110 XEOTICID XEO03403 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03403 XEO_CLAS Natural Product DME1110 XEOTICID XEO03403 DESCRIPT Fraxin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03403 GENEFORM Protein DME1110 XEOTICID XEO03403 MOACRIVE Inhibition DME1110 XEOTICID XEO03408 XEO_NAME Lagerstroemia speciosa fruit extract DME1110 XEOTICID XEO03408 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03408 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03408 DESCRIPT Lagerstroemia speciosa fruit extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03408 GENEFORM Protein DME1110 XEOTICID XEO03408 MOACRIVE Inhibition DME1110 XEOTICID XEO03409 XEO_NAME Ruptiliocarpon caracolito fruit extract DME1110 XEOTICID XEO03409 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03409 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03409 DESCRIPT Ruptiliocarpon caracolito fruit extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03409 GENEFORM Protein DME1110 XEOTICID XEO03409 MOACRIVE Inhibition DME1110 XEOTICID XEO03410 XEO_NAME Terminalia chebula fruit extract DME1110 XEOTICID XEO03410 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03410 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03410 DESCRIPT Terminalia chebula fruit extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03410 GENEFORM Protein DME1110 XEOTICID XEO03410 MOACRIVE Inhibition DME1110 XEOTICID XEO03411 XEO_NAME Trichilia martiana fruit extract DME1110 XEOTICID XEO03411 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03411 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03411 DESCRIPT Trichilia martiana fruit extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03411 GENEFORM Protein DME1110 XEOTICID XEO03411 MOACRIVE Inhibition DME1110 XEOTICID XEO03413 XEO_NAME Furanone DME1110 XEOTICID XEO03413 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO03413 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO03413 DESCRIPT Furanone inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03413 GENEFORM Protein DME1110 XEOTICID XEO03413 MOACRIVE Inhibition DME1110 XEOTICID XEO03415 XEO_NAME Furanone C-30 DME1110 XEOTICID XEO03415 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO03415 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO03415 DESCRIPT Furanone C-30 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03415 GENEFORM Protein DME1110 XEOTICID XEO03415 MOACRIVE Inhibition DME1110 XEOTICID XEO03422 XEO_NAME Furvina DME1110 XEOTICID XEO03422 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO03422 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO03422 DESCRIPT Furvina inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03422 GENEFORM Protein DME1110 XEOTICID XEO03422 MOACRIVE Inhibition DME1110 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1110 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03424 XEO_CLAS Peptide DME1110 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03424 GENEFORM Protein DME1110 XEOTICID XEO03424 MOACRIVE Inhibition DME1110 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1110 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03428 XEO_CLAS Peptide DME1110 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 125 ug/ml) DME1110 XEOTICID XEO03428 GENEFORM Protein DME1110 XEOTICID XEO03428 MOACRIVE Inhibition DME1110 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1110 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03430 XEO_CLAS Peptide DME1110 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 63 ug/ml) DME1110 XEOTICID XEO03430 GENEFORM Protein DME1110 XEOTICID XEO03430 MOACRIVE Inhibition DME1110 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1110 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03434 XEO_CLAS Peptide DME1110 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 31 ug/ml) DME1110 XEOTICID XEO03434 GENEFORM Protein DME1110 XEOTICID XEO03434 MOACRIVE Inhibition DME1110 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1110 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03436 XEO_CLAS Peptide DME1110 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1110 XEOTICID XEO03436 GENEFORM Protein DME1110 XEOTICID XEO03436 MOACRIVE Inhibition DME1110 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1110 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03437 XEO_CLAS Peptide DME1110 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1110 XEOTICID XEO03437 GENEFORM Protein DME1110 XEOTICID XEO03437 MOACRIVE Inhibition DME1110 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1110 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03438 XEO_CLAS Peptide DME1110 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1110 XEOTICID XEO03438 GENEFORM Protein DME1110 XEOTICID XEO03438 MOACRIVE Inhibition DME1110 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1110 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03439 XEO_CLAS Peptide DME1110 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1110 XEOTICID XEO03439 GENEFORM Protein DME1110 XEOTICID XEO03439 MOACRIVE Inhibition DME1110 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1110 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03440 XEO_CLAS Peptide DME1110 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1110 XEOTICID XEO03440 GENEFORM Protein DME1110 XEOTICID XEO03440 MOACRIVE Inhibition DME1110 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1110 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03441 XEO_CLAS Peptide DME1110 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1110 XEOTICID XEO03441 GENEFORM Protein DME1110 XEOTICID XEO03441 MOACRIVE Inhibition DME1110 XEOTICID XEO03469 XEO_NAME Gallium cation DME1110 XEOTICID XEO03469 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO03469 XEO_CLAS Nanoparticle DME1110 XEOTICID XEO03469 DESCRIPT Gallium cation inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03469 GENEFORM Protein DME1110 XEOTICID XEO03469 MOACRIVE Inhibition DME1110 XEOTICID XEO03472 XEO_NAME Garlic extract DME1110 XEOTICID XEO03472 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03472 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03472 DESCRIPT Garlic extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03472 GENEFORM Protein DME1110 XEOTICID XEO03472 MOACRIVE Inhibition DME1110 XEOTICID XEO03482 XEO_NAME Ginger extract DME1110 XEOTICID XEO03482 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03482 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03482 DESCRIPT Ginger extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03482 GENEFORM Protein DME1110 XEOTICID XEO03482 MOACRIVE Inhibition DME1110 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1110 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03497 XEO_CLAS Peptide DME1110 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.6-3.15 microM) DME1110 XEOTICID XEO03497 GENEFORM Protein DME1110 XEOTICID XEO03497 MOACRIVE Inhibition DME1110 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1110 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03498 XEO_CLAS Peptide DME1110 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.6-3.15 microM) DME1110 XEOTICID XEO03498 GENEFORM Protein DME1110 XEOTICID XEO03498 MOACRIVE Inhibition DME1110 XEOTICID XEO03508 XEO_NAME Gratisin analogue DME1110 XEOTICID XEO03508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03508 XEO_CLAS Peptide DME1110 XEOTICID XEO03508 DESCRIPT Gratisin analogue inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03508 GENEFORM Protein DME1110 XEOTICID XEO03508 MOACRIVE Inhibition DME1110 XEOTICID XEO03517 XEO_NAME Histone H5 peptide derivative H5(61-90) DME1110 XEOTICID XEO03517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03517 XEO_CLAS Peptide DME1110 XEOTICID XEO03517 DESCRIPT Histone H5 peptide derivative H5(61-90) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO03517 GENEFORM Protein DME1110 XEOTICID XEO03517 MOACRIVE Inhibition DME1110 XEOTICID XEO03519 XEO_NAME Hadrurin DME1110 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03519 XEO_CLAS Peptide DME1110 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03519 GENEFORM Protein DME1110 XEOTICID XEO03519 MOACRIVE Inhibition DME1110 XEOTICID XEO03520 XEO_NAME Halocidin subunit A DME1110 XEOTICID XEO03520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03520 XEO_CLAS Peptide DME1110 XEOTICID XEO03520 DESCRIPT Halocidin subunit A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03520 GENEFORM Protein DME1110 XEOTICID XEO03520 MOACRIVE Inhibition DME1110 XEOTICID XEO03521 XEO_NAME Halocidin subunit B DME1110 XEOTICID XEO03521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03521 XEO_CLAS Peptide DME1110 XEOTICID XEO03521 DESCRIPT Halocidin subunit B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03521 GENEFORM Protein DME1110 XEOTICID XEO03521 MOACRIVE Inhibition DME1110 XEOTICID XEO03522 XEO_NAME Halocyntin DME1110 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03522 XEO_CLAS Peptide DME1110 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03522 GENEFORM Protein DME1110 XEOTICID XEO03522 MOACRIVE Inhibition DME1110 XEOTICID XEO03523 XEO_NAME Hamamelitannin DME1110 XEOTICID XEO03523 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO03523 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO03523 DESCRIPT Hamamelitannin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03523 GENEFORM Protein DME1110 XEOTICID XEO03523 MOACRIVE Inhibition DME1110 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1110 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03540 XEO_CLAS Peptide DME1110 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO03540 GENEFORM Protein DME1110 XEOTICID XEO03540 MOACRIVE Inhibition DME1110 XEOTICID XEO03545 XEO_NAME Heptadecanoic acid DME1110 XEOTICID XEO03545 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO03545 XEO_CLAS Food Additive DME1110 XEOTICID XEO03545 DESCRIPT Heptadecanoic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03545 GENEFORM Protein DME1110 XEOTICID XEO03545 MOACRIVE Inhibition DME1110 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1110 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03549 XEO_CLAS Peptide DME1110 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03549 GENEFORM Protein DME1110 XEOTICID XEO03549 MOACRIVE Inhibition DME1110 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1110 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03556 XEO_CLAS Peptide DME1110 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO03556 GENEFORM Protein DME1110 XEOTICID XEO03556 MOACRIVE Inhibition DME1110 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1110 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03557 XEO_CLAS Peptide DME1110 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO03557 GENEFORM Protein DME1110 XEOTICID XEO03557 MOACRIVE Inhibition DME1110 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1110 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03558 XEO_CLAS Peptide DME1110 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 microM) DME1110 XEOTICID XEO03558 GENEFORM Protein DME1110 XEOTICID XEO03558 MOACRIVE Inhibition DME1110 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1110 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03559 XEO_CLAS Peptide DME1110 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 microM) DME1110 XEOTICID XEO03559 GENEFORM Protein DME1110 XEOTICID XEO03559 MOACRIVE Inhibition DME1110 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1110 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03560 XEO_CLAS Peptide DME1110 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 microM) DME1110 XEOTICID XEO03560 GENEFORM Protein DME1110 XEOTICID XEO03560 MOACRIVE Inhibition DME1110 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1110 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03573 XEO_CLAS Peptide DME1110 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 37.5 ug/ml) DME1110 XEOTICID XEO03573 GENEFORM Protein DME1110 XEOTICID XEO03573 MOACRIVE Inhibition DME1110 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1110 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03579 XEO_CLAS Peptide DME1110 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03579 GENEFORM Protein DME1110 XEOTICID XEO03579 MOACRIVE Inhibition DME1110 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1110 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03585 XEO_CLAS Peptide DME1110 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 125 ug/ml) DME1110 XEOTICID XEO03585 GENEFORM Protein DME1110 XEOTICID XEO03585 MOACRIVE Inhibition DME1110 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1110 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03588 XEO_CLAS Peptide DME1110 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 62 ug/ml) DME1110 XEOTICID XEO03588 GENEFORM Protein DME1110 XEOTICID XEO03588 MOACRIVE Inhibition DME1110 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1110 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03591 XEO_CLAS Peptide DME1110 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 37.5 ug/ml) DME1110 XEOTICID XEO03591 GENEFORM Protein DME1110 XEOTICID XEO03591 MOACRIVE Inhibition DME1110 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1110 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03593 XEO_CLAS Peptide DME1110 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 18.75 ug/ml) DME1110 XEOTICID XEO03593 GENEFORM Protein DME1110 XEOTICID XEO03593 MOACRIVE Inhibition DME1110 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1110 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03594 XEO_CLAS Peptide DME1110 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.1 ug/ml) DME1110 XEOTICID XEO03594 GENEFORM Protein DME1110 XEOTICID XEO03594 MOACRIVE Inhibition DME1110 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1110 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03609 XEO_CLAS Peptide DME1110 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03609 GENEFORM Protein DME1110 XEOTICID XEO03609 MOACRIVE Inhibition DME1110 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1110 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03615 XEO_CLAS Peptide DME1110 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 48.8-64.0 ug/ml) DME1110 XEOTICID XEO03615 GENEFORM Protein DME1110 XEOTICID XEO03615 MOACRIVE Inhibition DME1110 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1110 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03616 XEO_CLAS Peptide DME1110 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 microM) DME1110 XEOTICID XEO03616 GENEFORM Protein DME1110 XEOTICID XEO03616 MOACRIVE Inhibition DME1110 XEOTICID XEO03620 XEO_NAME Hyperoside DME1110 XEOTICID XEO03620 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03620 XEO_CLAS Natural Product DME1110 XEOTICID XEO03620 DESCRIPT Hyperoside inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03620 GENEFORM Protein DME1110 XEOTICID XEO03620 MOACRIVE Inhibition DME1110 XEOTICID XEO03642 XEO_NAME Indirubin DME1110 XEOTICID XEO03642 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03642 XEO_CLAS Natural Product DME1110 XEOTICID XEO03642 DESCRIPT Indirubin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03642 GENEFORM Protein DME1110 XEOTICID XEO03642 MOACRIVE Inhibition DME1110 XEOTICID XEO03644 XEO_NAME Indole DME1110 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1110 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1110 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03644 GENEFORM Protein DME1110 XEOTICID XEO03644 MOACRIVE Inhibition DME1110 XEOTICID XEO03645 XEO_NAME Indole-3-acetaldehyde DME1110 XEOTICID XEO03645 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO03645 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO03645 DESCRIPT Indole-3-acetaldehyde inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03645 GENEFORM Protein DME1110 XEOTICID XEO03645 MOACRIVE Inhibition DME1110 XEOTICID XEO03647 XEO_NAME Indole-3-carboxyaldehyde DME1110 XEOTICID XEO03647 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO03647 XEO_CLAS Food Additive DME1110 XEOTICID XEO03647 DESCRIPT Indole-3-carboxyaldehyde inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03647 GENEFORM Protein DME1110 XEOTICID XEO03647 MOACRIVE Inhibition DME1110 XEOTICID XEO03648 XEO_NAME Indole-7-carboxylic acid DME1110 XEOTICID XEO03648 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO03648 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO03648 DESCRIPT Indole-7-carboxylic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03648 GENEFORM Protein DME1110 XEOTICID XEO03648 MOACRIVE Inhibition DME1110 XEOTICID XEO03649 XEO_NAME Indolicidin DME1110 XEOTICID XEO03649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03649 XEO_CLAS Peptide DME1110 XEOTICID XEO03649 DESCRIPT Indolicidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03649 GENEFORM Protein DME1110 XEOTICID XEO03649 MOACRIVE Inhibition DME1110 XEOTICID XEO03671 XEO_NAME Plant JCpep7 DME1110 XEOTICID XEO03671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03671 XEO_CLAS Peptide DME1110 XEOTICID XEO03671 DESCRIPT Plant JCpep7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1110 XEOTICID XEO03671 GENEFORM Protein DME1110 XEOTICID XEO03671 MOACRIVE Inhibition DME1110 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1110 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03672 XEO_CLAS Peptide DME1110 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10 ug/ml) DME1110 XEOTICID XEO03672 GENEFORM Protein DME1110 XEOTICID XEO03672 MOACRIVE Inhibition DME1110 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1110 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03673 XEO_CLAS Peptide DME1110 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 15 ug/ml) DME1110 XEOTICID XEO03673 GENEFORM Protein DME1110 XEOTICID XEO03673 MOACRIVE Inhibition DME1110 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1110 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03674 XEO_CLAS Peptide DME1110 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 30 ug/ml) DME1110 XEOTICID XEO03674 GENEFORM Protein DME1110 XEOTICID XEO03674 MOACRIVE Inhibition DME1110 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1110 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03675 XEO_CLAS Peptide DME1110 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 23 microM) DME1110 XEOTICID XEO03675 GENEFORM Protein DME1110 XEOTICID XEO03675 MOACRIVE Inhibition DME1110 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1110 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03678 XEO_CLAS Peptide DME1110 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1110 XEOTICID XEO03678 GENEFORM Protein DME1110 XEOTICID XEO03678 MOACRIVE Inhibition DME1110 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1110 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03679 XEO_CLAS Peptide DME1110 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1110 XEOTICID XEO03679 GENEFORM Protein DME1110 XEOTICID XEO03679 MOACRIVE Inhibition DME1110 XEOTICID XEO03680 XEO_NAME CP-P derivative K17 DME1110 XEOTICID XEO03680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03680 XEO_CLAS Peptide DME1110 XEOTICID XEO03680 DESCRIPT CP-P derivative K17 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1110 XEOTICID XEO03680 GENEFORM Protein DME1110 XEOTICID XEO03680 MOACRIVE Inhibition DME1110 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1110 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03681 XEO_CLAS Peptide DME1110 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 20-40 microM) DME1110 XEOTICID XEO03681 GENEFORM Protein DME1110 XEOTICID XEO03681 MOACRIVE Inhibition DME1110 XEOTICID XEO03683 XEO_NAME CP-P derivative K6 DME1110 XEOTICID XEO03683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03683 XEO_CLAS Peptide DME1110 XEOTICID XEO03683 DESCRIPT CP-P derivative K6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1110 XEOTICID XEO03683 GENEFORM Protein DME1110 XEOTICID XEO03683 MOACRIVE Inhibition DME1110 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1110 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03684 XEO_CLAS Peptide DME1110 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 31 ug/ml) DME1110 XEOTICID XEO03684 GENEFORM Protein DME1110 XEOTICID XEO03684 MOACRIVE Inhibition DME1110 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1110 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03697 XEO_CLAS Peptide DME1110 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 microM) DME1110 XEOTICID XEO03697 GENEFORM Protein DME1110 XEOTICID XEO03697 MOACRIVE Inhibition DME1110 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1110 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03709 XEO_CLAS Peptide DME1110 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1110 XEOTICID XEO03709 GENEFORM Protein DME1110 XEOTICID XEO03709 MOACRIVE Inhibition DME1110 XEOTICID XEO03710 XEO_NAME knightine DME1110 XEOTICID XEO03710 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03710 XEO_CLAS Natural Product DME1110 XEOTICID XEO03710 DESCRIPT knightine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03710 GENEFORM Protein DME1110 XEOTICID XEO03710 MOACRIVE Inhibition DME1110 XEOTICID XEO03725 XEO_NAME CP-P derivative L10 DME1110 XEOTICID XEO03725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03725 XEO_CLAS Peptide DME1110 XEOTICID XEO03725 DESCRIPT CP-P derivative L10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1110 XEOTICID XEO03725 GENEFORM Protein DME1110 XEOTICID XEO03725 MOACRIVE Inhibition DME1110 XEOTICID XEO03739 XEO_NAME LlKmWn model peptide L4K3W4 DME1110 XEOTICID XEO03739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03739 XEO_CLAS Peptide DME1110 XEOTICID XEO03739 DESCRIPT LlKmWn model peptide L4K3W4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1110 XEOTICID XEO03739 GENEFORM Protein DME1110 XEOTICID XEO03739 MOACRIVE Inhibition DME1110 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1110 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03744 XEO_CLAS Peptide DME1110 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1110 XEOTICID XEO03744 GENEFORM Protein DME1110 XEOTICID XEO03744 MOACRIVE Inhibition DME1110 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1110 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03746 XEO_CLAS Peptide DME1110 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO03746 GENEFORM Protein DME1110 XEOTICID XEO03746 MOACRIVE Inhibition DME1110 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1110 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03747 XEO_CLAS Peptide DME1110 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1110 XEOTICID XEO03747 GENEFORM Protein DME1110 XEOTICID XEO03747 MOACRIVE Inhibition DME1110 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1110 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03748 XEO_CLAS Peptide DME1110 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO03748 GENEFORM Protein DME1110 XEOTICID XEO03748 MOACRIVE Inhibition DME1110 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1110 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03749 XEO_CLAS Peptide DME1110 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO03749 GENEFORM Protein DME1110 XEOTICID XEO03749 MOACRIVE Inhibition DME1110 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1110 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03750 XEO_CLAS Peptide DME1110 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO03750 GENEFORM Protein DME1110 XEOTICID XEO03750 MOACRIVE Inhibition DME1110 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1110 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03751 XEO_CLAS Peptide DME1110 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1110 XEOTICID XEO03751 GENEFORM Protein DME1110 XEOTICID XEO03751 MOACRIVE Inhibition DME1110 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1110 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03752 XEO_CLAS Peptide DME1110 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO03752 GENEFORM Protein DME1110 XEOTICID XEO03752 MOACRIVE Inhibition DME1110 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1110 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03753 XEO_CLAS Peptide DME1110 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1110 XEOTICID XEO03753 GENEFORM Protein DME1110 XEOTICID XEO03753 MOACRIVE Inhibition DME1110 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1110 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03754 XEO_CLAS Peptide DME1110 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO03754 GENEFORM Protein DME1110 XEOTICID XEO03754 MOACRIVE Inhibition DME1110 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1110 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03755 XEO_CLAS Peptide DME1110 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO03755 GENEFORM Protein DME1110 XEOTICID XEO03755 MOACRIVE Inhibition DME1110 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1110 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03756 XEO_CLAS Peptide DME1110 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1110 XEOTICID XEO03756 GENEFORM Protein DME1110 XEOTICID XEO03756 MOACRIVE Inhibition DME1110 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1110 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03759 XEO_CLAS Peptide DME1110 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1110 XEOTICID XEO03759 GENEFORM Protein DME1110 XEOTICID XEO03759 MOACRIVE Inhibition DME1110 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1110 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03781 XEO_CLAS Peptide DME1110 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.20 microM) DME1110 XEOTICID XEO03781 GENEFORM Protein DME1110 XEOTICID XEO03781 MOACRIVE Inhibition DME1110 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1110 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03782 XEO_CLAS Peptide DME1110 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 9.16 microM) DME1110 XEOTICID XEO03782 GENEFORM Protein DME1110 XEOTICID XEO03782 MOACRIVE Inhibition DME1110 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1110 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03783 XEO_CLAS Peptide DME1110 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.14 microM) DME1110 XEOTICID XEO03783 GENEFORM Protein DME1110 XEOTICID XEO03783 MOACRIVE Inhibition DME1110 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1110 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03784 XEO_CLAS Peptide DME1110 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.45 microM) DME1110 XEOTICID XEO03784 GENEFORM Protein DME1110 XEOTICID XEO03784 MOACRIVE Inhibition DME1110 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1110 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03785 XEO_CLAS Peptide DME1110 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.23 microM) DME1110 XEOTICID XEO03785 GENEFORM Protein DME1110 XEOTICID XEO03785 MOACRIVE Inhibition DME1110 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1110 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03786 XEO_CLAS Peptide DME1110 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.14 microM) DME1110 XEOTICID XEO03786 GENEFORM Protein DME1110 XEOTICID XEO03786 MOACRIVE Inhibition DME1110 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1110 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03787 XEO_CLAS Peptide DME1110 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.69 microM) DME1110 XEOTICID XEO03787 GENEFORM Protein DME1110 XEOTICID XEO03787 MOACRIVE Inhibition DME1110 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1110 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03788 XEO_CLAS Peptide DME1110 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.98 microM) DME1110 XEOTICID XEO03788 GENEFORM Protein DME1110 XEOTICID XEO03788 MOACRIVE Inhibition DME1110 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1110 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03790 XEO_CLAS Peptide DME1110 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.18 microM) DME1110 XEOTICID XEO03790 GENEFORM Protein DME1110 XEOTICID XEO03790 MOACRIVE Inhibition DME1110 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1110 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03791 XEO_CLAS Peptide DME1110 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.86 microM) DME1110 XEOTICID XEO03791 GENEFORM Protein DME1110 XEOTICID XEO03791 MOACRIVE Inhibition DME1110 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1110 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03792 XEO_CLAS Peptide DME1110 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.13 microM) DME1110 XEOTICID XEO03792 GENEFORM Protein DME1110 XEOTICID XEO03792 MOACRIVE Inhibition DME1110 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1110 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03793 XEO_CLAS Peptide DME1110 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 microM) DME1110 XEOTICID XEO03793 GENEFORM Protein DME1110 XEOTICID XEO03793 MOACRIVE Inhibition DME1110 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1110 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03797 XEO_CLAS Peptide DME1110 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.2 microM) DME1110 XEOTICID XEO03797 GENEFORM Protein DME1110 XEOTICID XEO03797 MOACRIVE Inhibition DME1110 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1110 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03810 XEO_CLAS Peptide DME1110 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03810 GENEFORM Protein DME1110 XEOTICID XEO03810 MOACRIVE Inhibition DME1110 XEOTICID XEO03815 XEO_NAME Blakea gracilis leaf extract DME1110 XEOTICID XEO03815 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03815 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03815 DESCRIPT Blakea gracilis leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03815 GENEFORM Protein DME1110 XEOTICID XEO03815 MOACRIVE Inhibition DME1110 XEOTICID XEO03816 XEO_NAME Carapa guianensis leaf extract DME1110 XEOTICID XEO03816 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03816 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03816 DESCRIPT Carapa guianensis leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03816 GENEFORM Protein DME1110 XEOTICID XEO03816 MOACRIVE Inhibition DME1110 XEOTICID XEO03817 XEO_NAME Cedrela fissilis leaf extract DME1110 XEOTICID XEO03817 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03817 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03817 DESCRIPT Cedrela fissilis leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03817 GENEFORM Protein DME1110 XEOTICID XEO03817 MOACRIVE Inhibition DME1110 XEOTICID XEO03818 XEO_NAME Cedrela tonduzii leaf extract DME1110 XEOTICID XEO03818 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03818 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03818 DESCRIPT Cedrela tonduzii leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03818 GENEFORM Protein DME1110 XEOTICID XEO03818 MOACRIVE Inhibition DME1110 XEOTICID XEO03819 XEO_NAME Chukrasia tabularis leaf extract DME1110 XEOTICID XEO03819 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03819 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03819 DESCRIPT Chukrasia tabularis leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03819 GENEFORM Protein DME1110 XEOTICID XEO03819 MOACRIVE Inhibition DME1110 XEOTICID XEO03822 XEO_NAME Conostegia rhodopetala leaf extract DME1110 XEOTICID XEO03822 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03822 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03822 DESCRIPT Conostegia rhodopetala leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03822 GENEFORM Protein DME1110 XEOTICID XEO03822 MOACRIVE Inhibition DME1110 XEOTICID XEO03823 XEO_NAME Cupania glabra leaf extract DME1110 XEOTICID XEO03823 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03823 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03823 DESCRIPT Cupania glabra leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03823 GENEFORM Protein DME1110 XEOTICID XEO03823 MOACRIVE Inhibition DME1110 XEOTICID XEO03824 XEO_NAME Guarea bullata leaf extract DME1110 XEOTICID XEO03824 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03824 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03824 DESCRIPT Guarea bullata leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03824 GENEFORM Protein DME1110 XEOTICID XEO03824 MOACRIVE Inhibition DME1110 XEOTICID XEO03825 XEO_NAME Guarea glabra leaf extract DME1110 XEOTICID XEO03825 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03825 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03825 DESCRIPT Guarea glabra leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03825 GENEFORM Protein DME1110 XEOTICID XEO03825 MOACRIVE Inhibition DME1110 XEOTICID XEO03826 XEO_NAME Guarea grandifolia leaf extract DME1110 XEOTICID XEO03826 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03826 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03826 DESCRIPT Guarea grandifolia leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03826 GENEFORM Protein DME1110 XEOTICID XEO03826 MOACRIVE Inhibition DME1110 XEOTICID XEO03827 XEO_NAME Guarea guidonia leaf extract DME1110 XEOTICID XEO03827 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03827 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03827 DESCRIPT Guarea guidonia leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03827 GENEFORM Protein DME1110 XEOTICID XEO03827 MOACRIVE Inhibition DME1110 XEOTICID XEO03828 XEO_NAME Guarea pterorhachis leaf extract DME1110 XEOTICID XEO03828 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03828 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03828 DESCRIPT Guarea pterorhachis leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03828 GENEFORM Protein DME1110 XEOTICID XEO03828 MOACRIVE Inhibition DME1110 XEOTICID XEO03829 XEO_NAME Leandra melanodesma leaf extract DME1110 XEOTICID XEO03829 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03829 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03829 DESCRIPT Leandra melanodesma leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03829 GENEFORM Protein DME1110 XEOTICID XEO03829 MOACRIVE Inhibition DME1110 XEOTICID XEO03830 XEO_NAME Mangifera indica leaf extract DME1110 XEOTICID XEO03830 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03830 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03830 DESCRIPT Mangifera indica leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03830 GENEFORM Protein DME1110 XEOTICID XEO03830 MOACRIVE Inhibition DME1110 XEOTICID XEO03831 XEO_NAME Miconia longifolia leaf extract DME1110 XEOTICID XEO03831 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03831 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03831 DESCRIPT Miconia longifolia leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03831 GENEFORM Protein DME1110 XEOTICID XEO03831 MOACRIVE Inhibition DME1110 XEOTICID XEO03832 XEO_NAME Miconia pittieri leaf extract DME1110 XEOTICID XEO03832 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03832 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03832 DESCRIPT Miconia pittieri leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03832 GENEFORM Protein DME1110 XEOTICID XEO03832 MOACRIVE Inhibition DME1110 XEOTICID XEO03833 XEO_NAME Piper decurrens leaf extract DME1110 XEOTICID XEO03833 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03833 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03833 DESCRIPT Piper decurrens leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03833 GENEFORM Protein DME1110 XEOTICID XEO03833 MOACRIVE Inhibition DME1110 XEOTICID XEO03834 XEO_NAME Piper pseudolindenii leaf extract DME1110 XEOTICID XEO03834 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03834 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03834 DESCRIPT Piper pseudolindenii leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03834 GENEFORM Protein DME1110 XEOTICID XEO03834 MOACRIVE Inhibition DME1110 XEOTICID XEO03835 XEO_NAME Piper reticulatum leaf extract DME1110 XEOTICID XEO03835 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03835 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03835 DESCRIPT Piper reticulatum leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03835 GENEFORM Protein DME1110 XEOTICID XEO03835 MOACRIVE Inhibition DME1110 XEOTICID XEO03836 XEO_NAME Piper urostachyum leaf extract DME1110 XEOTICID XEO03836 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03836 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03836 DESCRIPT Piper urostachyum leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03836 GENEFORM Protein DME1110 XEOTICID XEO03836 MOACRIVE Inhibition DME1110 XEOTICID XEO03838 XEO_NAME Ruptiliocarpon caracolito leaf extract DME1110 XEOTICID XEO03838 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03838 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03838 DESCRIPT Ruptiliocarpon caracolito leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03838 GENEFORM Protein DME1110 XEOTICID XEO03838 MOACRIVE Inhibition DME1110 XEOTICID XEO03839 XEO_NAME Simarouba amara leaf extract DME1110 XEOTICID XEO03839 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03839 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03839 DESCRIPT Simarouba amara leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03839 GENEFORM Protein DME1110 XEOTICID XEO03839 MOACRIVE Inhibition DME1110 XEOTICID XEO03840 XEO_NAME Simarouba glauca leaf extract DME1110 XEOTICID XEO03840 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03840 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03840 DESCRIPT Simarouba glauca leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03840 GENEFORM Protein DME1110 XEOTICID XEO03840 MOACRIVE Inhibition DME1110 XEOTICID XEO03841 XEO_NAME Swietenia macrophylla leaf extract DME1110 XEOTICID XEO03841 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03841 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03841 DESCRIPT Swietenia macrophylla leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03841 GENEFORM Protein DME1110 XEOTICID XEO03841 MOACRIVE Inhibition DME1110 XEOTICID XEO03842 XEO_NAME Swietenia mahogani leaf extract DME1110 XEOTICID XEO03842 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03842 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03842 DESCRIPT Swietenia mahogani leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03842 GENEFORM Protein DME1110 XEOTICID XEO03842 MOACRIVE Inhibition DME1110 XEOTICID XEO03843 XEO_NAME Trichilia martiana leaf extract DME1110 XEOTICID XEO03843 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03843 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03843 DESCRIPT Trichilia martiana leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03843 GENEFORM Protein DME1110 XEOTICID XEO03843 MOACRIVE Inhibition DME1110 XEOTICID XEO03844 XEO_NAME Trichilia pleeana leaf extract DME1110 XEOTICID XEO03844 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03844 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03844 DESCRIPT Trichilia pleeana leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03844 GENEFORM Protein DME1110 XEOTICID XEO03844 MOACRIVE Inhibition DME1110 XEOTICID XEO03845 XEO_NAME Trichilia septentrionalis leaf extract DME1110 XEOTICID XEO03845 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03845 XEO_CLAS Plant Extract DME1110 XEOTICID XEO03845 DESCRIPT Trichilia septentrionalis leaf extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03845 GENEFORM Protein DME1110 XEOTICID XEO03845 MOACRIVE Inhibition DME1110 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1110 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03853 XEO_CLAS Peptide DME1110 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 microM) DME1110 XEOTICID XEO03853 GENEFORM Protein DME1110 XEOTICID XEO03853 MOACRIVE Inhibition DME1110 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1110 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03904 XEO_CLAS Peptide DME1110 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO03904 GENEFORM Protein DME1110 XEOTICID XEO03904 MOACRIVE Inhibition DME1110 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1110 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03905 XEO_CLAS Peptide DME1110 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO03905 GENEFORM Protein DME1110 XEOTICID XEO03905 MOACRIVE Inhibition DME1110 XEOTICID XEO03911 XEO_NAME Lipoic acid DME1110 XEOTICID XEO03911 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO03911 XEO_CLAS Drug in Phase 2 Clinical Trial DME1110 XEOTICID XEO03911 DESCRIPT Lipoic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03911 GENEFORM Protein DME1110 XEOTICID XEO03911 MOACRIVE Inhibition DME1110 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1110 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03928 XEO_CLAS Peptide DME1110 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 microM) DME1110 XEOTICID XEO03928 GENEFORM Protein DME1110 XEOTICID XEO03928 MOACRIVE Inhibition DME1110 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1110 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03933 XEO_CLAS Peptide DME1110 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 22.7 microM) DME1110 XEOTICID XEO03933 GENEFORM Protein DME1110 XEOTICID XEO03933 MOACRIVE Inhibition DME1110 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1110 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03934 XEO_CLAS Peptide DME1110 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 26.9 microM) DME1110 XEOTICID XEO03934 GENEFORM Protein DME1110 XEOTICID XEO03934 MOACRIVE Inhibition DME1110 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1110 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03935 XEO_CLAS Peptide DME1110 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 19.0 microM) DME1110 XEOTICID XEO03935 GENEFORM Protein DME1110 XEOTICID XEO03935 MOACRIVE Inhibition DME1110 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1110 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03936 XEO_CLAS Peptide DME1110 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 microM) DME1110 XEOTICID XEO03936 GENEFORM Protein DME1110 XEOTICID XEO03936 MOACRIVE Inhibition DME1110 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1110 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03937 XEO_CLAS Peptide DME1110 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 23.3 microM) DME1110 XEOTICID XEO03937 GENEFORM Protein DME1110 XEOTICID XEO03937 MOACRIVE Inhibition DME1110 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1110 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03938 XEO_CLAS Peptide DME1110 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 22.5 microM) DME1110 XEOTICID XEO03938 GENEFORM Protein DME1110 XEOTICID XEO03938 MOACRIVE Inhibition DME1110 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1110 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03939 XEO_CLAS Peptide DME1110 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 26.1 microM) DME1110 XEOTICID XEO03939 GENEFORM Protein DME1110 XEOTICID XEO03939 MOACRIVE Inhibition DME1110 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1110 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03940 XEO_CLAS Peptide DME1110 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 microM) DME1110 XEOTICID XEO03940 GENEFORM Protein DME1110 XEOTICID XEO03940 MOACRIVE Inhibition DME1110 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1110 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03941 XEO_CLAS Peptide DME1110 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 23.1 microM) DME1110 XEOTICID XEO03941 GENEFORM Protein DME1110 XEOTICID XEO03941 MOACRIVE Inhibition DME1110 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1110 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03943 XEO_CLAS Peptide DME1110 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 27.1 microM) DME1110 XEOTICID XEO03943 GENEFORM Protein DME1110 XEOTICID XEO03943 MOACRIVE Inhibition DME1110 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1110 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03944 XEO_CLAS Peptide DME1110 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 26.1 microM) DME1110 XEOTICID XEO03944 GENEFORM Protein DME1110 XEOTICID XEO03944 MOACRIVE Inhibition DME1110 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1110 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03945 XEO_CLAS Peptide DME1110 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 microM) DME1110 XEOTICID XEO03945 GENEFORM Protein DME1110 XEOTICID XEO03945 MOACRIVE Inhibition DME1110 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1110 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03947 XEO_CLAS Peptide DME1110 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 22.5 microM) DME1110 XEOTICID XEO03947 GENEFORM Protein DME1110 XEOTICID XEO03947 MOACRIVE Inhibition DME1110 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1110 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03948 XEO_CLAS Peptide DME1110 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 75 microM) DME1110 XEOTICID XEO03948 GENEFORM Protein DME1110 XEOTICID XEO03948 MOACRIVE Inhibition DME1110 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1110 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03950 XEO_CLAS Peptide DME1110 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 78.7 microM) DME1110 XEOTICID XEO03950 GENEFORM Protein DME1110 XEOTICID XEO03950 MOACRIVE Inhibition DME1110 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1110 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03951 XEO_CLAS Peptide DME1110 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 86.7 microM) DME1110 XEOTICID XEO03951 GENEFORM Protein DME1110 XEOTICID XEO03951 MOACRIVE Inhibition DME1110 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1110 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03952 XEO_CLAS Peptide DME1110 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 76.3 microM) DME1110 XEOTICID XEO03952 GENEFORM Protein DME1110 XEOTICID XEO03952 MOACRIVE Inhibition DME1110 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1110 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03958 XEO_CLAS Peptide DME1110 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03958 GENEFORM Protein DME1110 XEOTICID XEO03958 MOACRIVE Inhibition DME1110 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1110 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1110 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03968 GENEFORM Protein DME1110 XEOTICID XEO03968 MOACRIVE Inhibition DME1110 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1110 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO03985 XEO_CLAS Peptide DME1110 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1110 XEOTICID XEO03985 GENEFORM Protein DME1110 XEOTICID XEO03985 MOACRIVE Inhibition DME1110 XEOTICID XEO03988 XEO_NAME Malabaricone C DME1110 XEOTICID XEO03988 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO03988 XEO_CLAS Natural Product DME1110 XEOTICID XEO03988 DESCRIPT Malabaricone C inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO03988 GENEFORM Protein DME1110 XEOTICID XEO03988 MOACRIVE Inhibition DME1110 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1110 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04000 XEO_CLAS Peptide DME1110 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO04000 GENEFORM Protein DME1110 XEOTICID XEO04000 MOACRIVE Inhibition DME1110 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1110 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04001 XEO_CLAS Peptide DME1110 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 microM) DME1110 XEOTICID XEO04001 GENEFORM Protein DME1110 XEOTICID XEO04001 MOACRIVE Inhibition DME1110 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1110 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04039 XEO_CLAS Peptide DME1110 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.5 microM) DME1110 XEOTICID XEO04039 GENEFORM Protein DME1110 XEOTICID XEO04039 MOACRIVE Inhibition DME1110 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1110 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04051 XEO_CLAS Peptide DME1110 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.31-0.63 microM) DME1110 XEOTICID XEO04051 GENEFORM Protein DME1110 XEOTICID XEO04051 MOACRIVE Inhibition DME1110 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1110 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04052 XEO_CLAS Peptide DME1110 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04052 GENEFORM Protein DME1110 XEOTICID XEO04052 MOACRIVE Inhibition DME1110 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1110 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04053 XEO_CLAS Peptide DME1110 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.16-0.31 microM) DME1110 XEOTICID XEO04053 GENEFORM Protein DME1110 XEOTICID XEO04053 MOACRIVE Inhibition DME1110 XEOTICID XEO04055 XEO_NAME Melectin DME1110 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04055 XEO_CLAS Peptide DME1110 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 18.5 microM) DME1110 XEOTICID XEO04055 GENEFORM Protein DME1110 XEOTICID XEO04055 MOACRIVE Inhibition DME1110 XEOTICID XEO04057 XEO_NAME Melittin DME1110 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04057 XEO_CLAS Peptide DME1110 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 microM) DME1110 XEOTICID XEO04057 GENEFORM Protein DME1110 XEOTICID XEO04057 MOACRIVE Inhibition DME1110 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1110 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04061 XEO_CLAS Peptide DME1110 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 17.3 microM) DME1110 XEOTICID XEO04061 GENEFORM Protein DME1110 XEOTICID XEO04061 MOACRIVE Inhibition DME1110 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1110 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04062 XEO_CLAS Peptide DME1110 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 77 microM) DME1110 XEOTICID XEO04062 GENEFORM Protein DME1110 XEOTICID XEO04062 MOACRIVE Inhibition DME1110 XEOTICID XEO04073 XEO_NAME meta-toluidine DME1110 XEOTICID XEO04073 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO04073 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO04073 DESCRIPT meta-toluidine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04073 GENEFORM Protein DME1110 XEOTICID XEO04073 MOACRIVE Inhibition DME1110 XEOTICID XEO04076 XEO_NAME methanesulfonylbenzene DME1110 XEOTICID XEO04076 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO04076 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO04076 DESCRIPT methanesulfonylbenzene inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04076 GENEFORM Protein DME1110 XEOTICID XEO04076 MOACRIVE Inhibition DME1110 XEOTICID XEO04078 XEO_NAME Actinomycetes NIO 10058 methanol extract DME1110 XEOTICID XEO04078 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04078 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO04078 DESCRIPT Actinomycetes NIO 10058 methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04078 GENEFORM Protein DME1110 XEOTICID XEO04078 MOACRIVE Inhibition DME1110 XEOTICID XEO04079 XEO_NAME Actinomycetes NIO 10068 methanol extract DME1110 XEOTICID XEO04079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04079 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO04079 DESCRIPT Actinomycetes NIO 10068 methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04079 GENEFORM Protein DME1110 XEOTICID XEO04079 MOACRIVE Inhibition DME1110 XEOTICID XEO04080 XEO_NAME Actinomycetes NIO 10090 methanol extract DME1110 XEOTICID XEO04080 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04080 XEO_CLAS Bacterial Extract DME1110 XEOTICID XEO04080 DESCRIPT Actinomycetes NIO 10090 methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04080 GENEFORM Protein DME1110 XEOTICID XEO04080 MOACRIVE Inhibition DME1110 XEOTICID XEO04084 XEO_NAME Kalanchoe blossfeldiana leaf methanol extract DME1110 XEOTICID XEO04084 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04084 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04084 DESCRIPT Kalanchoe blossfeldiana leaf methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04084 GENEFORM Protein DME1110 XEOTICID XEO04084 MOACRIVE Inhibition DME1110 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1110 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04087 GENEFORM Protein DME1110 XEOTICID XEO04087 MOACRIVE Inhibition DME1110 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1110 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04089 GENEFORM Protein DME1110 XEOTICID XEO04089 MOACRIVE Inhibition DME1110 XEOTICID XEO04106 XEO_NAME Methyl gallate DME1110 XEOTICID XEO04106 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO04106 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO04106 DESCRIPT Methyl gallate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04106 GENEFORM Protein DME1110 XEOTICID XEO04106 MOACRIVE Inhibition DME1110 XEOTICID XEO04107 XEO_NAME Methyl indole-7-carboxylate DME1110 XEOTICID XEO04107 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO04107 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO04107 DESCRIPT Methyl indole-7-carboxylate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04107 GENEFORM Protein DME1110 XEOTICID XEO04107 MOACRIVE Inhibition DME1110 XEOTICID XEO04109 XEO_NAME Micafungin DME1110 XEOTICID XEO04109 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO04109 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO04109 DESCRIPT Micafungin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04109 GENEFORM Protein DME1110 XEOTICID XEO04109 MOACRIVE Inhibition DME1110 XEOTICID XEO04114 XEO_NAME Microcin L DME1110 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04114 XEO_CLAS Peptide DME1110 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04114 GENEFORM Protein DME1110 XEOTICID XEO04114 MOACRIVE Inhibition DME1110 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1110 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04121 XEO_CLAS Peptide DME1110 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04121 GENEFORM Protein DME1110 XEOTICID XEO04121 MOACRIVE Inhibition DME1110 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1110 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04122 XEO_CLAS Peptide DME1110 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5.02-10.05 microM) DME1110 XEOTICID XEO04122 GENEFORM Protein DME1110 XEOTICID XEO04122 MOACRIVE Inhibition DME1110 XEOTICID XEO04123 XEO_NAME Modified defensin DME1110 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04123 XEO_CLAS Peptide DME1110 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1110 XEOTICID XEO04123 GENEFORM Protein DME1110 XEOTICID XEO04123 MOACRIVE Inhibition DME1110 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1110 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04128 XEO_CLAS Peptide DME1110 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.81 microM) DME1110 XEOTICID XEO04128 GENEFORM Protein DME1110 XEOTICID XEO04128 MOACRIVE Inhibition DME1110 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1110 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04142 XEO_CLAS Peptide DME1110 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8-16 microM) DME1110 XEOTICID XEO04142 GENEFORM Protein DME1110 XEOTICID XEO04142 MOACRIVE Inhibition DME1110 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1110 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04146 XEO_CLAS Peptide DME1110 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04146 GENEFORM Protein DME1110 XEOTICID XEO04146 MOACRIVE Inhibition DME1110 XEOTICID XEO04149 XEO_NAME Mucroporin DME1110 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04149 XEO_CLAS Peptide DME1110 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 ug/ml) DME1110 XEOTICID XEO04149 GENEFORM Protein DME1110 XEOTICID XEO04149 MOACRIVE Inhibition DME1110 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1110 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04158 XEO_CLAS Peptide DME1110 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 microM) DME1110 XEOTICID XEO04158 GENEFORM Protein DME1110 XEOTICID XEO04158 MOACRIVE Inhibition DME1110 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1110 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04159 XEO_CLAS Peptide DME1110 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 microM) DME1110 XEOTICID XEO04159 GENEFORM Protein DME1110 XEOTICID XEO04159 MOACRIVE Inhibition DME1110 XEOTICID XEO04162 XEO_NAME Myristic acid DME1110 XEOTICID XEO04162 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO04162 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO04162 DESCRIPT Myristic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04162 GENEFORM Protein DME1110 XEOTICID XEO04162 MOACRIVE Inhibition DME1110 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1110 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04168 XEO_CLAS Peptide DME1110 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 25.0 microM) DME1110 XEOTICID XEO04168 GENEFORM Protein DME1110 XEOTICID XEO04168 MOACRIVE Inhibition DME1110 XEOTICID XEO04172 XEO_NAME Myxinidin DME1110 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04172 XEO_CLAS Peptide DME1110 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04172 GENEFORM Protein DME1110 XEOTICID XEO04172 MOACRIVE Inhibition DME1110 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1110 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04177 XEO_CLAS Peptide DME1110 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.1 microM) DME1110 XEOTICID XEO04177 GENEFORM Protein DME1110 XEOTICID XEO04177 MOACRIVE Inhibition DME1110 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1110 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04178 XEO_CLAS Peptide DME1110 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.7 microM) DME1110 XEOTICID XEO04178 GENEFORM Protein DME1110 XEOTICID XEO04178 MOACRIVE Inhibition DME1110 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1110 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04179 XEO_CLAS Peptide DME1110 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 40 microM) DME1110 XEOTICID XEO04179 GENEFORM Protein DME1110 XEOTICID XEO04179 MOACRIVE Inhibition DME1110 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1110 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04180 XEO_CLAS Peptide DME1110 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 45 microM) DME1110 XEOTICID XEO04180 GENEFORM Protein DME1110 XEOTICID XEO04180 MOACRIVE Inhibition DME1110 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1110 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04181 XEO_CLAS Peptide DME1110 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 35 microM) DME1110 XEOTICID XEO04181 GENEFORM Protein DME1110 XEOTICID XEO04181 MOACRIVE Inhibition DME1110 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1110 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04182 XEO_CLAS Peptide DME1110 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 35 microM) DME1110 XEOTICID XEO04182 GENEFORM Protein DME1110 XEOTICID XEO04182 MOACRIVE Inhibition DME1110 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1110 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04183 XEO_CLAS Peptide DME1110 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 18 microM) DME1110 XEOTICID XEO04183 GENEFORM Protein DME1110 XEOTICID XEO04183 MOACRIVE Inhibition DME1110 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1110 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04184 XEO_CLAS Peptide DME1110 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.9 microM) DME1110 XEOTICID XEO04184 GENEFORM Protein DME1110 XEOTICID XEO04184 MOACRIVE Inhibition DME1110 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1110 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04185 XEO_CLAS Peptide DME1110 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04185 GENEFORM Protein DME1110 XEOTICID XEO04185 MOACRIVE Inhibition DME1110 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1110 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04206 XEO_CLAS Peptide DME1110 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1110 XEOTICID XEO04206 GENEFORM Protein DME1110 XEOTICID XEO04206 MOACRIVE Inhibition DME1110 XEOTICID XEO04213 XEO_NAME CP-P derivative N18 DME1110 XEOTICID XEO04213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04213 XEO_CLAS Peptide DME1110 XEOTICID XEO04213 DESCRIPT CP-P derivative N18 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1110 XEOTICID XEO04213 GENEFORM Protein DME1110 XEOTICID XEO04213 MOACRIVE Inhibition DME1110 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1110 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04214 XEO_CLAS Peptide DME1110 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1110 XEOTICID XEO04214 GENEFORM Protein DME1110 XEOTICID XEO04214 MOACRIVE Inhibition DME1110 XEOTICID XEO04215 XEO_NAME CP-P derivative N20 DME1110 XEOTICID XEO04215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04215 XEO_CLAS Peptide DME1110 XEOTICID XEO04215 DESCRIPT CP-P derivative N20 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1110 XEOTICID XEO04215 GENEFORM Protein DME1110 XEOTICID XEO04215 MOACRIVE Inhibition DME1110 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1110 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04216 XEO_CLAS Peptide DME1110 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1110 XEOTICID XEO04216 GENEFORM Protein DME1110 XEOTICID XEO04216 MOACRIVE Inhibition DME1110 XEOTICID XEO04217 XEO_NAME CP-P derivative N3 DME1110 XEOTICID XEO04217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04217 XEO_CLAS Peptide DME1110 XEOTICID XEO04217 DESCRIPT CP-P derivative N3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1110 XEOTICID XEO04217 GENEFORM Protein DME1110 XEOTICID XEO04217 MOACRIVE Inhibition DME1110 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1110 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04218 XEO_CLAS Peptide DME1110 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.125 microM) DME1110 XEOTICID XEO04218 GENEFORM Protein DME1110 XEOTICID XEO04218 MOACRIVE Inhibition DME1110 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1110 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04219 XEO_CLAS Peptide DME1110 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1110 XEOTICID XEO04219 GENEFORM Protein DME1110 XEOTICID XEO04219 MOACRIVE Inhibition DME1110 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1110 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04220 XEO_CLAS Peptide DME1110 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1110 XEOTICID XEO04220 GENEFORM Protein DME1110 XEOTICID XEO04220 MOACRIVE Inhibition DME1110 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1110 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04221 XEO_CLAS Peptide DME1110 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.125 microM) DME1110 XEOTICID XEO04221 GENEFORM Protein DME1110 XEOTICID XEO04221 MOACRIVE Inhibition DME1110 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1110 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04222 XEO_CLAS Peptide DME1110 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.125 microM) DME1110 XEOTICID XEO04222 GENEFORM Protein DME1110 XEOTICID XEO04222 MOACRIVE Inhibition DME1110 XEOTICID XEO04223 XEO_NAME CP-P derivative N7 DME1110 XEOTICID XEO04223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04223 XEO_CLAS Peptide DME1110 XEOTICID XEO04223 DESCRIPT CP-P derivative N7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1110 XEOTICID XEO04223 GENEFORM Protein DME1110 XEOTICID XEO04223 MOACRIVE Inhibition DME1110 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1110 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04241 XEO_CLAS Peptide DME1110 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04241 GENEFORM Protein DME1110 XEOTICID XEO04241 MOACRIVE Inhibition DME1110 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1110 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04242 XEO_CLAS Peptide DME1110 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04242 GENEFORM Protein DME1110 XEOTICID XEO04242 MOACRIVE Inhibition DME1110 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1110 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04249 XEO_CLAS Peptide DME1110 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 500 ug/ml) DME1110 XEOTICID XEO04249 GENEFORM Protein DME1110 XEOTICID XEO04249 MOACRIVE Inhibition DME1110 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1110 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04256 XEO_CLAS Peptide DME1110 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04256 GENEFORM Protein DME1110 XEOTICID XEO04256 MOACRIVE Inhibition DME1110 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1110 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04259 XEO_CLAS Peptide DME1110 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04259 GENEFORM Protein DME1110 XEOTICID XEO04259 MOACRIVE Inhibition DME1110 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1110 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04261 XEO_CLAS Peptide DME1110 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04261 GENEFORM Protein DME1110 XEOTICID XEO04261 MOACRIVE Inhibition DME1110 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1110 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04265 XEO_CLAS Peptide DME1110 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04265 GENEFORM Protein DME1110 XEOTICID XEO04265 MOACRIVE Inhibition DME1110 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1110 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04268 XEO_CLAS Peptide DME1110 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04268 GENEFORM Protein DME1110 XEOTICID XEO04268 MOACRIVE Inhibition DME1110 XEOTICID XEO04276 XEO_NAME Nigroain-B1 DME1110 XEOTICID XEO04276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04276 XEO_CLAS Peptide DME1110 XEOTICID XEO04276 DESCRIPT Nigroain-B1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25.00 ug/ml) DME1110 XEOTICID XEO04276 GENEFORM Protein DME1110 XEOTICID XEO04276 MOACRIVE Inhibition DME1110 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1110 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04277 XEO_CLAS Peptide DME1110 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 55.00 ug/ml) DME1110 XEOTICID XEO04277 GENEFORM Protein DME1110 XEOTICID XEO04277 MOACRIVE Inhibition DME1110 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1110 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04281 XEO_CLAS Peptide DME1110 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25.00 ug/ml) DME1110 XEOTICID XEO04281 GENEFORM Protein DME1110 XEOTICID XEO04281 MOACRIVE Inhibition DME1110 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1110 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04309 XEO_CLAS Peptide DME1110 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 7 microM) DME1110 XEOTICID XEO04309 GENEFORM Protein DME1110 XEOTICID XEO04309 MOACRIVE Inhibition DME1110 XEOTICID XEO04325 XEO_NAME Nodakenetin DME1110 XEOTICID XEO04325 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04325 XEO_CLAS Natural Product DME1110 XEOTICID XEO04325 DESCRIPT Nodakenetin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04325 GENEFORM Protein DME1110 XEOTICID XEO04325 MOACRIVE Inhibition DME1110 XEOTICID XEO04331 XEO_NAME Norspermidine DME1110 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04331 GENEFORM Protein DME1110 XEOTICID XEO04331 MOACRIVE Inhibition DME1110 XEOTICID XEO04333 XEO_NAME Novispirin G-10 DME1110 XEOTICID XEO04333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04333 XEO_CLAS Peptide DME1110 XEOTICID XEO04333 DESCRIPT Novispirin G-10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.11-12.7 ug/ml) DME1110 XEOTICID XEO04333 GENEFORM Protein DME1110 XEOTICID XEO04333 MOACRIVE Inhibition DME1110 XEOTICID XEO04334 XEO_NAME Novispirin T-7 DME1110 XEOTICID XEO04334 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04334 XEO_CLAS Peptide DME1110 XEOTICID XEO04334 DESCRIPT Novispirin T-7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.26-27.8 ug/ml) DME1110 XEOTICID XEO04334 GENEFORM Protein DME1110 XEOTICID XEO04334 MOACRIVE Inhibition DME1110 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1110 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04335 XEO_CLAS Peptide DME1110 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1110 XEOTICID XEO04335 GENEFORM Protein DME1110 XEOTICID XEO04335 MOACRIVE Inhibition DME1110 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1110 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04336 XEO_CLAS Peptide DME1110 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1110 XEOTICID XEO04336 GENEFORM Protein DME1110 XEOTICID XEO04336 MOACRIVE Inhibition DME1110 XEOTICID XEO04337 XEO_NAME NRC-16 peptide DME1110 XEOTICID XEO04337 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04337 XEO_CLAS Peptide DME1110 XEOTICID XEO04337 DESCRIPT NRC-16 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04337 GENEFORM Protein DME1110 XEOTICID XEO04337 MOACRIVE Inhibition DME1110 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1110 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04338 XEO_CLAS Peptide DME1110 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1110 XEOTICID XEO04338 GENEFORM Protein DME1110 XEOTICID XEO04338 MOACRIVE Inhibition DME1110 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1110 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04339 XEO_CLAS Peptide DME1110 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1110 XEOTICID XEO04339 GENEFORM Protein DME1110 XEOTICID XEO04339 MOACRIVE Inhibition DME1110 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1110 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04340 XEO_CLAS Peptide DME1110 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1110 XEOTICID XEO04340 GENEFORM Protein DME1110 XEOTICID XEO04340 MOACRIVE Inhibition DME1110 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1110 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04348 XEO_CLAS Peptide DME1110 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 80 microM) DME1110 XEOTICID XEO04348 GENEFORM Protein DME1110 XEOTICID XEO04348 MOACRIVE Inhibition DME1110 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1110 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04349 XEO_CLAS Peptide DME1110 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 microM) DME1110 XEOTICID XEO04349 GENEFORM Protein DME1110 XEOTICID XEO04349 MOACRIVE Inhibition DME1110 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1110 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04364 XEO_CLAS Peptide DME1110 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 microM) DME1110 XEOTICID XEO04364 GENEFORM Protein DME1110 XEOTICID XEO04364 MOACRIVE Inhibition DME1110 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1110 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04384 XEO_CLAS Peptide DME1110 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1110 XEOTICID XEO04384 GENEFORM Protein DME1110 XEOTICID XEO04384 MOACRIVE Inhibition DME1110 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1110 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04385 XEO_CLAS Peptide DME1110 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5 ug/ml) DME1110 XEOTICID XEO04385 GENEFORM Protein DME1110 XEOTICID XEO04385 MOACRIVE Inhibition DME1110 XEOTICID XEO04386 XEO_NAME Syzygium aromaticum oil DME1110 XEOTICID XEO04386 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04386 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04386 DESCRIPT Syzygium aromaticum oil inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04386 GENEFORM Protein DME1110 XEOTICID XEO04386 MOACRIVE Inhibition DME1110 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1110 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04399 XEO_CLAS Peptide DME1110 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1110 XEOTICID XEO04399 GENEFORM Protein DME1110 XEOTICID XEO04399 MOACRIVE Inhibition DME1110 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1110 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04400 XEO_CLAS Peptide DME1110 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1110 XEOTICID XEO04400 GENEFORM Protein DME1110 XEOTICID XEO04400 MOACRIVE Inhibition DME1110 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1110 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04401 XEO_CLAS Peptide DME1110 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1110 XEOTICID XEO04401 GENEFORM Protein DME1110 XEOTICID XEO04401 MOACRIVE Inhibition DME1110 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1110 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04402 XEO_CLAS Peptide DME1110 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1110 XEOTICID XEO04402 GENEFORM Protein DME1110 XEOTICID XEO04402 MOACRIVE Inhibition DME1110 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1110 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04403 XEO_CLAS Peptide DME1110 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1110 XEOTICID XEO04403 GENEFORM Protein DME1110 XEOTICID XEO04403 MOACRIVE Inhibition DME1110 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1110 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04404 XEO_CLAS Peptide DME1110 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1110 XEOTICID XEO04404 GENEFORM Protein DME1110 XEOTICID XEO04404 MOACRIVE Inhibition DME1110 XEOTICID XEO04416 XEO_NAME Ovispirin-1 DME1110 XEOTICID XEO04416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04416 XEO_CLAS Peptide DME1110 XEOTICID XEO04416 DESCRIPT Ovispirin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.7-5.6 ug/ml) DME1110 XEOTICID XEO04416 GENEFORM Protein DME1110 XEOTICID XEO04416 MOACRIVE Inhibition DME1110 XEOTICID XEO04417 XEO_NAME Ovispirin-2 DME1110 XEOTICID XEO04417 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04417 XEO_CLAS Peptide DME1110 XEOTICID XEO04417 DESCRIPT Ovispirin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.03-16 ug/ml) DME1110 XEOTICID XEO04417 GENEFORM Protein DME1110 XEOTICID XEO04417 MOACRIVE Inhibition DME1110 XEOTICID XEO04418 XEO_NAME Ovispirin-3 DME1110 XEOTICID XEO04418 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04418 XEO_CLAS Peptide DME1110 XEOTICID XEO04418 DESCRIPT Ovispirin-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1-8 ug/ml) DME1110 XEOTICID XEO04418 GENEFORM Protein DME1110 XEOTICID XEO04418 MOACRIVE Inhibition DME1110 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1110 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04426 XEO_CLAS Peptide DME1110 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 microM) DME1110 XEOTICID XEO04426 GENEFORM Protein DME1110 XEOTICID XEO04426 MOACRIVE Inhibition DME1110 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1110 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04430 XEO_CLAS Peptide DME1110 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1110 XEOTICID XEO04430 GENEFORM Protein DME1110 XEOTICID XEO04430 MOACRIVE Inhibition DME1110 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1110 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04438 GENEFORM Protein DME1110 XEOTICID XEO04438 MOACRIVE Inhibition DME1110 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1110 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04444 XEO_CLAS Peptide DME1110 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 33 microM) DME1110 XEOTICID XEO04444 GENEFORM Protein DME1110 XEOTICID XEO04444 MOACRIVE Inhibition DME1110 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1110 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04461 XEO_CLAS Peptide DME1110 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 20.8 microM) DME1110 XEOTICID XEO04461 GENEFORM Protein DME1110 XEOTICID XEO04461 MOACRIVE Inhibition DME1110 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1110 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04462 XEO_CLAS Peptide DME1110 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 38.2 microM) DME1110 XEOTICID XEO04462 GENEFORM Protein DME1110 XEOTICID XEO04462 MOACRIVE Inhibition DME1110 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1110 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04463 XEO_CLAS Peptide DME1110 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04463 GENEFORM Protein DME1110 XEOTICID XEO04463 MOACRIVE Inhibition DME1110 XEOTICID XEO04468 XEO_NAME Papillosin DME1110 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04468 XEO_CLAS Peptide DME1110 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04468 GENEFORM Protein DME1110 XEOTICID XEO04468 MOACRIVE Inhibition DME1110 XEOTICID XEO04469 XEO_NAME para-anisidine DME1110 XEOTICID XEO04469 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO04469 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO04469 DESCRIPT para-anisidine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04469 GENEFORM Protein DME1110 XEOTICID XEO04469 MOACRIVE Inhibition DME1110 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1110 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04471 XEO_CLAS Peptide DME1110 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6.3 microM) DME1110 XEOTICID XEO04471 GENEFORM Protein DME1110 XEOTICID XEO04471 MOACRIVE Inhibition DME1110 XEOTICID XEO04473 XEO_NAME para-ethylaniline DME1110 XEOTICID XEO04473 XEO_TYPE Health or Environmental Toxicant(s) DME1110 XEOTICID XEO04473 XEO_CLAS Acute Toxic Substance DME1110 XEOTICID XEO04473 DESCRIPT para-ethylaniline inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04473 GENEFORM Protein DME1110 XEOTICID XEO04473 MOACRIVE Inhibition DME1110 XEOTICID XEO04475 XEO_NAME para-toluidine DME1110 XEOTICID XEO04475 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO04475 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO04475 DESCRIPT para-toluidine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04475 GENEFORM Protein DME1110 XEOTICID XEO04475 MOACRIVE Inhibition DME1110 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1110 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04482 GENEFORM Protein DME1110 XEOTICID XEO04482 MOACRIVE Inhibition DME1110 XEOTICID XEO04503 XEO_NAME Defensin-like AMP pelovaterin DME1110 XEOTICID XEO04503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04503 XEO_CLAS Peptide DME1110 XEOTICID XEO04503 DESCRIPT Defensin-like AMP pelovaterin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04503 GENEFORM Protein DME1110 XEOTICID XEO04503 MOACRIVE Inhibition DME1110 XEOTICID XEO04512 XEO_NAME Penicillenol A1 DME1110 XEOTICID XEO04512 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04512 XEO_CLAS Natural Product DME1110 XEOTICID XEO04512 DESCRIPT Penicillenol A1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04512 GENEFORM Protein DME1110 XEOTICID XEO04512 MOACRIVE Inhibition DME1110 XEOTICID XEO04513 XEO_NAME Penicillenol A2 DME1110 XEOTICID XEO04513 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04513 XEO_CLAS Natural Product DME1110 XEOTICID XEO04513 DESCRIPT Penicillenol A2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04513 GENEFORM Protein DME1110 XEOTICID XEO04513 MOACRIVE Inhibition DME1110 XEOTICID XEO04514 XEO_NAME Penicillenol B1 DME1110 XEOTICID XEO04514 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04514 XEO_CLAS Natural Product DME1110 XEOTICID XEO04514 DESCRIPT Penicillenol B1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04514 GENEFORM Protein DME1110 XEOTICID XEO04514 MOACRIVE Inhibition DME1110 XEOTICID XEO04515 XEO_NAME Penicillenol B2 DME1110 XEOTICID XEO04515 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04515 XEO_CLAS Natural Product DME1110 XEOTICID XEO04515 DESCRIPT Penicillenol B2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04515 GENEFORM Protein DME1110 XEOTICID XEO04515 MOACRIVE Inhibition DME1110 XEOTICID XEO04516 XEO_NAME Penicillenol C1 DME1110 XEOTICID XEO04516 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04516 XEO_CLAS Natural Product DME1110 XEOTICID XEO04516 DESCRIPT Penicillenol C1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04516 GENEFORM Protein DME1110 XEOTICID XEO04516 MOACRIVE Inhibition DME1110 XEOTICID XEO04517 XEO_NAME Penicillenol C2 DME1110 XEOTICID XEO04517 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04517 XEO_CLAS Natural Product DME1110 XEOTICID XEO04517 DESCRIPT Penicillenol C2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04517 GENEFORM Protein DME1110 XEOTICID XEO04517 MOACRIVE Inhibition DME1110 XEOTICID XEO04518 XEO_NAME Penicillic acid DME1110 XEOTICID XEO04518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04518 XEO_CLAS Natural Product DME1110 XEOTICID XEO04518 DESCRIPT Penicillic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04518 GENEFORM Protein DME1110 XEOTICID XEO04518 MOACRIVE Inhibition DME1110 XEOTICID XEO04522 XEO_NAME Pentagalloylglucose DME1110 XEOTICID XEO04522 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO04522 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO04522 DESCRIPT Pentagalloylglucose inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04522 GENEFORM Protein DME1110 XEOTICID XEO04522 MOACRIVE Inhibition DME1110 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1110 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04526 XEO_CLAS Peptide DME1110 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.0 microM) DME1110 XEOTICID XEO04526 GENEFORM Protein DME1110 XEOTICID XEO04526 MOACRIVE Inhibition DME1110 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1110 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04532 XEO_CLAS Peptide DME1110 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04532 GENEFORM Protein DME1110 XEOTICID XEO04532 MOACRIVE Inhibition DME1110 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1110 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04540 XEO_CLAS Peptide DME1110 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 90.8 ug/ml) DME1110 XEOTICID XEO04540 GENEFORM Protein DME1110 XEOTICID XEO04540 MOACRIVE Inhibition DME1110 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1110 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04541 XEO_CLAS Peptide DME1110 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 21.3 ug/ml) DME1110 XEOTICID XEO04541 GENEFORM Protein DME1110 XEOTICID XEO04541 MOACRIVE Inhibition DME1110 XEOTICID XEO04544 XEO_NAME Histone H5 derivative(71-90) DME1110 XEOTICID XEO04544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04544 XEO_CLAS Peptide DME1110 XEOTICID XEO04544 DESCRIPT Histone H5 derivative(71-90) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 26.7 ug/ml) DME1110 XEOTICID XEO04544 GENEFORM Protein DME1110 XEOTICID XEO04544 MOACRIVE Inhibition DME1110 XEOTICID XEO04546 XEO_NAME Perinerin DME1110 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04546 XEO_CLAS Peptide DME1110 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04546 GENEFORM Protein DME1110 XEOTICID XEO04546 MOACRIVE Inhibition DME1110 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1110 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04549 XEO_CLAS Peptide DME1110 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 250-500 ug/ml) DME1110 XEOTICID XEO04549 GENEFORM Protein DME1110 XEOTICID XEO04549 MOACRIVE Inhibition DME1110 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1110 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04571 XEO_CLAS Peptide DME1110 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04571 GENEFORM Protein DME1110 XEOTICID XEO04571 MOACRIVE Inhibition DME1110 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1110 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04572 XEO_CLAS Peptide DME1110 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04572 GENEFORM Protein DME1110 XEOTICID XEO04572 MOACRIVE Inhibition DME1110 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1110 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04573 XEO_CLAS Peptide DME1110 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 microM) DME1110 XEOTICID XEO04573 GENEFORM Protein DME1110 XEOTICID XEO04573 MOACRIVE Inhibition DME1110 XEOTICID XEO04581 XEO_NAME Carex arenicola extract DME1110 XEOTICID XEO04581 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04581 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04581 DESCRIPT Carex arenicola extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04581 GENEFORM Protein DME1110 XEOTICID XEO04581 MOACRIVE Inhibition DME1110 XEOTICID XEO04582 XEO_NAME Carex boottiana extract DME1110 XEOTICID XEO04582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04582 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04582 DESCRIPT Carex boottiana extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04582 GENEFORM Protein DME1110 XEOTICID XEO04582 MOACRIVE Inhibition DME1110 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1110 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04583 GENEFORM Protein DME1110 XEOTICID XEO04583 MOACRIVE Inhibition DME1110 XEOTICID XEO04584 XEO_NAME Carex humilis extract DME1110 XEOTICID XEO04584 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04584 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04584 DESCRIPT Carex humilis extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04584 GENEFORM Protein DME1110 XEOTICID XEO04584 MOACRIVE Inhibition DME1110 XEOTICID XEO04585 XEO_NAME Carex lanceolata extract DME1110 XEOTICID XEO04585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04585 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04585 DESCRIPT Carex lanceolata extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04585 GENEFORM Protein DME1110 XEOTICID XEO04585 MOACRIVE Inhibition DME1110 XEOTICID XEO04586 XEO_NAME Carex pumila extract DME1110 XEOTICID XEO04586 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04586 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04586 DESCRIPT Carex pumila extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04586 GENEFORM Protein DME1110 XEOTICID XEO04586 MOACRIVE Inhibition DME1110 XEOTICID XEO04587 XEO_NAME Carex scabrifolia extract DME1110 XEOTICID XEO04587 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04587 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04587 DESCRIPT Carex scabrifolia extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04587 GENEFORM Protein DME1110 XEOTICID XEO04587 MOACRIVE Inhibition DME1110 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1110 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04588 GENEFORM Protein DME1110 XEOTICID XEO04588 MOACRIVE Inhibition DME1110 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1110 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04601 XEO_CLAS Peptide DME1110 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 37.5 ug/ml) DME1110 XEOTICID XEO04601 GENEFORM Protein DME1110 XEOTICID XEO04601 MOACRIVE Inhibition DME1110 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1110 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04602 XEO_CLAS Peptide DME1110 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 18.75 ug/ml) DME1110 XEOTICID XEO04602 GENEFORM Protein DME1110 XEOTICID XEO04602 MOACRIVE Inhibition DME1110 XEOTICID XEO04603 XEO_NAME Picolinic acid DME1110 XEOTICID XEO04603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04603 XEO_CLAS Amino Acid DME1110 XEOTICID XEO04603 DESCRIPT Picolinic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04603 GENEFORM Protein DME1110 XEOTICID XEO04603 MOACRIVE Inhibition DME1110 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1110 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04605 XEO_CLAS Peptide DME1110 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC < 25 microM) DME1110 XEOTICID XEO04605 GENEFORM Protein DME1110 XEOTICID XEO04605 MOACRIVE Inhibition DME1110 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1110 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04606 XEO_CLAS Peptide DME1110 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 microM) DME1110 XEOTICID XEO04606 GENEFORM Protein DME1110 XEOTICID XEO04606 MOACRIVE Inhibition DME1110 XEOTICID XEO04609 XEO_NAME Pinguisenol DME1110 XEOTICID XEO04609 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO04609 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO04609 DESCRIPT Pinguisenol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04609 GENEFORM Protein DME1110 XEOTICID XEO04609 MOACRIVE Inhibition DME1110 XEOTICID XEO04611 XEO_NAME Piperacillin-Tazobactam DME1110 XEOTICID XEO04611 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO04611 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO04611 DESCRIPT Piperacillin-Tazobactam inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04611 GENEFORM Protein DME1110 XEOTICID XEO04611 MOACRIVE Inhibition DME1110 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1110 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04613 XEO_CLAS Peptide DME1110 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5-10 microM) DME1110 XEOTICID XEO04613 GENEFORM Protein DME1110 XEOTICID XEO04613 MOACRIVE Inhibition DME1110 XEOTICID XEO04628 XEO_NAME Platinum (IV) ion DME1110 XEOTICID XEO04628 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO04628 XEO_CLAS Nanoparticle DME1110 XEOTICID XEO04628 DESCRIPT Platinum (IV) ion inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04628 GENEFORM Protein DME1110 XEOTICID XEO04628 MOACRIVE Inhibition DME1110 XEOTICID XEO04629 XEO_NAME Platyphylloside DME1110 XEOTICID XEO04629 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04629 XEO_CLAS Natural Product DME1110 XEOTICID XEO04629 DESCRIPT Platyphylloside inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04629 GENEFORM Protein DME1110 XEOTICID XEO04629 MOACRIVE Inhibition DME1110 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1110 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04640 XEO_CLAS Peptide DME1110 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 35.0 microM) DME1110 XEOTICID XEO04640 GENEFORM Protein DME1110 XEOTICID XEO04640 MOACRIVE Inhibition DME1110 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1110 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04642 XEO_CLAS Peptide DME1110 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1110 XEOTICID XEO04642 GENEFORM Protein DME1110 XEOTICID XEO04642 MOACRIVE Inhibition DME1110 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1110 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04643 XEO_CLAS Peptide DME1110 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1110 XEOTICID XEO04643 GENEFORM Protein DME1110 XEOTICID XEO04643 MOACRIVE Inhibition DME1110 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1110 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04644 XEO_CLAS Peptide DME1110 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1110 XEOTICID XEO04644 GENEFORM Protein DME1110 XEOTICID XEO04644 MOACRIVE Inhibition DME1110 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1110 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04645 XEO_CLAS Peptide DME1110 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1110 XEOTICID XEO04645 GENEFORM Protein DME1110 XEOTICID XEO04645 MOACRIVE Inhibition DME1110 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1110 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04646 XEO_CLAS Peptide DME1110 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1110 XEOTICID XEO04646 GENEFORM Protein DME1110 XEOTICID XEO04646 MOACRIVE Inhibition DME1110 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1110 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04647 XEO_CLAS Peptide DME1110 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1110 XEOTICID XEO04647 GENEFORM Protein DME1110 XEOTICID XEO04647 MOACRIVE Inhibition DME1110 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1110 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04648 XEO_CLAS Peptide DME1110 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1110 XEOTICID XEO04648 GENEFORM Protein DME1110 XEOTICID XEO04648 MOACRIVE Inhibition DME1110 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1110 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04649 XEO_CLAS Peptide DME1110 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1110 XEOTICID XEO04649 GENEFORM Protein DME1110 XEOTICID XEO04649 MOACRIVE Inhibition DME1110 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1110 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04650 XEO_CLAS Peptide DME1110 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1110 XEOTICID XEO04650 GENEFORM Protein DME1110 XEOTICID XEO04650 MOACRIVE Inhibition DME1110 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1110 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04651 XEO_CLAS Peptide DME1110 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1110 XEOTICID XEO04651 GENEFORM Protein DME1110 XEOTICID XEO04651 MOACRIVE Inhibition DME1110 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1110 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04652 XEO_CLAS Peptide DME1110 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO04652 GENEFORM Protein DME1110 XEOTICID XEO04652 MOACRIVE Inhibition DME1110 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1110 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04653 XEO_CLAS Peptide DME1110 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 64 ug/ml) DME1110 XEOTICID XEO04653 GENEFORM Protein DME1110 XEOTICID XEO04653 MOACRIVE Inhibition DME1110 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1110 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04654 XEO_CLAS Peptide DME1110 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1110 XEOTICID XEO04654 GENEFORM Protein DME1110 XEOTICID XEO04654 MOACRIVE Inhibition DME1110 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1110 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04655 XEO_CLAS Peptide DME1110 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1110 XEOTICID XEO04655 GENEFORM Protein DME1110 XEOTICID XEO04655 MOACRIVE Inhibition DME1110 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1110 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04660 XEO_CLAS Peptide DME1110 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1110 XEOTICID XEO04660 GENEFORM Protein DME1110 XEOTICID XEO04660 MOACRIVE Inhibition DME1110 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1110 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04661 XEO_CLAS Peptide DME1110 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3 microM) DME1110 XEOTICID XEO04661 GENEFORM Protein DME1110 XEOTICID XEO04661 MOACRIVE Inhibition DME1110 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1110 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04680 XEO_CLAS Peptide DME1110 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.5-1 microM) DME1110 XEOTICID XEO04680 GENEFORM Protein DME1110 XEOTICID XEO04680 MOACRIVE Inhibition DME1110 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1110 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04682 XEO_CLAS Peptide DME1110 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5 microM) DME1110 XEOTICID XEO04682 GENEFORM Protein DME1110 XEOTICID XEO04682 MOACRIVE Inhibition DME1110 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1110 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04683 XEO_CLAS Peptide DME1110 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 38 microM) DME1110 XEOTICID XEO04683 GENEFORM Protein DME1110 XEOTICID XEO04683 MOACRIVE Inhibition DME1110 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1110 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04684 XEO_CLAS Peptide DME1110 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 310 microM) DME1110 XEOTICID XEO04684 GENEFORM Protein DME1110 XEOTICID XEO04684 MOACRIVE Inhibition DME1110 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1110 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04690 XEO_CLAS Peptide DME1110 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1110 XEOTICID XEO04690 GENEFORM Protein DME1110 XEOTICID XEO04690 MOACRIVE Inhibition DME1110 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1110 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04695 XEO_CLAS Peptide DME1110 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04695 GENEFORM Protein DME1110 XEOTICID XEO04695 MOACRIVE Inhibition DME1110 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1110 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04696 XEO_CLAS Peptide DME1110 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04696 GENEFORM Protein DME1110 XEOTICID XEO04696 MOACRIVE Inhibition DME1110 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1110 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04697 XEO_CLAS Peptide DME1110 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04697 GENEFORM Protein DME1110 XEOTICID XEO04697 MOACRIVE Inhibition DME1110 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1110 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04698 XEO_CLAS Peptide DME1110 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04698 GENEFORM Protein DME1110 XEOTICID XEO04698 MOACRIVE Inhibition DME1110 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1110 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04699 XEO_CLAS Peptide DME1110 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04699 GENEFORM Protein DME1110 XEOTICID XEO04699 MOACRIVE Inhibition DME1110 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1110 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04700 XEO_CLAS Peptide DME1110 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04700 GENEFORM Protein DME1110 XEOTICID XEO04700 MOACRIVE Inhibition DME1110 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1110 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04701 XEO_CLAS Peptide DME1110 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04701 GENEFORM Protein DME1110 XEOTICID XEO04701 MOACRIVE Inhibition DME1110 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1110 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04702 XEO_CLAS Peptide DME1110 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04702 GENEFORM Protein DME1110 XEOTICID XEO04702 MOACRIVE Inhibition DME1110 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1110 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04703 XEO_CLAS Peptide DME1110 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04703 GENEFORM Protein DME1110 XEOTICID XEO04703 MOACRIVE Inhibition DME1110 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1110 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04704 XEO_CLAS Peptide DME1110 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04704 GENEFORM Protein DME1110 XEOTICID XEO04704 MOACRIVE Inhibition DME1110 XEOTICID XEO04719 XEO_NAME Pro-Gly DME1110 XEOTICID XEO04719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04719 XEO_CLAS Peptide DME1110 XEOTICID XEO04719 DESCRIPT Pro-Gly inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04719 GENEFORM Protein DME1110 XEOTICID XEO04719 MOACRIVE Inhibition DME1110 XEOTICID XEO04736 XEO_NAME Protocatechuic acid DME1110 XEOTICID XEO04736 XEO_TYPE Health or Environmental Toxicant(s) DME1110 XEOTICID XEO04736 XEO_CLAS Environmental Pollutant DME1110 XEOTICID XEO04736 DESCRIPT Protocatechuic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04736 GENEFORM Protein DME1110 XEOTICID XEO04736 MOACRIVE Inhibition DME1110 XEOTICID XEO04737 XEO_NAME Protonectin DME1110 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04737 XEO_CLAS Peptide DME1110 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.7 ug/ml) DME1110 XEOTICID XEO04737 GENEFORM Protein DME1110 XEOTICID XEO04737 MOACRIVE Inhibition DME1110 XEOTICID XEO04757 XEO_NAME Psoralen DME1110 XEOTICID XEO04757 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04757 XEO_CLAS Natural Product DME1110 XEOTICID XEO04757 DESCRIPT Psoralen inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04757 GENEFORM Protein DME1110 XEOTICID XEO04757 MOACRIVE Inhibition DME1110 XEOTICID XEO04758 XEO_NAME Anti-lipopolysaccharide factor PtALF5 DME1110 XEOTICID XEO04758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04758 XEO_CLAS Peptide DME1110 XEOTICID XEO04758 DESCRIPT Anti-lipopolysaccharide factor PtALF5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 15.54-31.08 microM) DME1110 XEOTICID XEO04758 GENEFORM Protein DME1110 XEOTICID XEO04758 MOACRIVE Inhibition DME1110 XEOTICID XEO04759 XEO_NAME Anti-lipopolysaccharide factor PtALF6 DME1110 XEOTICID XEO04759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04759 XEO_CLAS Peptide DME1110 XEOTICID XEO04759 DESCRIPT Anti-lipopolysaccharide factor PtALF6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 9.32-18.64 microM) DME1110 XEOTICID XEO04759 GENEFORM Protein DME1110 XEOTICID XEO04759 MOACRIVE Inhibition DME1110 XEOTICID XEO04760 XEO_NAME Anti-lipopolysaccharide factor PtALF7 DME1110 XEOTICID XEO04760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04760 XEO_CLAS Peptide DME1110 XEOTICID XEO04760 DESCRIPT Anti-lipopolysaccharide factor PtALF7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 1.02-2.04 microM) DME1110 XEOTICID XEO04760 GENEFORM Protein DME1110 XEOTICID XEO04760 MOACRIVE Inhibition DME1110 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1110 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04762 XEO_CLAS Peptide DME1110 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1110 XEOTICID XEO04762 GENEFORM Protein DME1110 XEOTICID XEO04762 MOACRIVE Inhibition DME1110 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1110 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04782 XEO_CLAS Peptide DME1110 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 12 ug/ml) DME1110 XEOTICID XEO04782 GENEFORM Protein DME1110 XEOTICID XEO04782 MOACRIVE Inhibition DME1110 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1110 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04783 XEO_CLAS Peptide DME1110 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO04783 GENEFORM Protein DME1110 XEOTICID XEO04783 MOACRIVE Inhibition DME1110 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1110 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04784 XEO_CLAS Peptide DME1110 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO04784 GENEFORM Protein DME1110 XEOTICID XEO04784 MOACRIVE Inhibition DME1110 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1110 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04785 XEO_CLAS Peptide DME1110 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO04785 GENEFORM Protein DME1110 XEOTICID XEO04785 MOACRIVE Inhibition DME1110 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1110 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04786 XEO_CLAS Peptide DME1110 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 63 ug/ml) DME1110 XEOTICID XEO04786 GENEFORM Protein DME1110 XEOTICID XEO04786 MOACRIVE Inhibition DME1110 XEOTICID XEO04799 XEO_NAME Ranalexin DME1110 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04799 XEO_CLAS Peptide DME1110 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 128 ug/ml) DME1110 XEOTICID XEO04799 GENEFORM Protein DME1110 XEOTICID XEO04799 MOACRIVE Inhibition DME1110 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1110 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04809 XEO_CLAS Peptide DME1110 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5 microM) DME1110 XEOTICID XEO04809 GENEFORM Protein DME1110 XEOTICID XEO04809 MOACRIVE Inhibition DME1110 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1110 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04827 XEO_CLAS Peptide DME1110 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 microM) DME1110 XEOTICID XEO04827 GENEFORM Protein DME1110 XEOTICID XEO04827 MOACRIVE Inhibition DME1110 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1110 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04837 XEO_CLAS Peptide DME1110 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10 microM) DME1110 XEOTICID XEO04837 GENEFORM Protein DME1110 XEOTICID XEO04837 MOACRIVE Inhibition DME1110 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1110 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04839 XEO_CLAS Peptide DME1110 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04839 GENEFORM Protein DME1110 XEOTICID XEO04839 MOACRIVE Inhibition DME1110 XEOTICID XEO04852 XEO_NAME Rhipicephalus microplus egg-wax DME1110 XEOTICID XEO04852 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04852 XEO_CLAS Parasite Extract DME1110 XEOTICID XEO04852 DESCRIPT Rhipicephalus microplus egg-wax inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04852 GENEFORM Protein DME1110 XEOTICID XEO04852 MOACRIVE Inhibition DME1110 XEOTICID XEO04863 XEO_NAME RTD peptide DME1110 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04863 XEO_CLAS Peptide DME1110 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2.0 microM) DME1110 XEOTICID XEO04863 GENEFORM Protein DME1110 XEOTICID XEO04863 MOACRIVE Inhibition DME1110 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1110 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04865 XEO_CLAS Peptide DME1110 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 ug/ml) DME1110 XEOTICID XEO04865 GENEFORM Protein DME1110 XEOTICID XEO04865 MOACRIVE Inhibition DME1110 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1110 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04866 XEO_CLAS Peptide DME1110 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1110 XEOTICID XEO04866 GENEFORM Protein DME1110 XEOTICID XEO04866 MOACRIVE Inhibition DME1110 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1110 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04877 XEO_CLAS Peptide DME1110 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04877 GENEFORM Protein DME1110 XEOTICID XEO04877 MOACRIVE Inhibition DME1110 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1110 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04880 XEO_CLAS Peptide DME1110 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10.1 ug/ml) DME1110 XEOTICID XEO04880 GENEFORM Protein DME1110 XEOTICID XEO04880 MOACRIVE Inhibition DME1110 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1110 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04886 XEO_CLAS Peptide DME1110 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10.1 ug/ml) DME1110 XEOTICID XEO04886 GENEFORM Protein DME1110 XEOTICID XEO04886 MOACRIVE Inhibition DME1110 XEOTICID XEO04888 XEO_NAME CP-P derivative S16 DME1110 XEOTICID XEO04888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04888 XEO_CLAS Peptide DME1110 XEOTICID XEO04888 DESCRIPT CP-P derivative S16 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.125 ug/ml) DME1110 XEOTICID XEO04888 GENEFORM Protein DME1110 XEOTICID XEO04888 MOACRIVE Inhibition DME1110 XEOTICID XEO04890 XEO_NAME CP-P derivative S9 DME1110 XEOTICID XEO04890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04890 XEO_CLAS Peptide DME1110 XEOTICID XEO04890 DESCRIPT CP-P derivative S9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1110 XEOTICID XEO04890 GENEFORM Protein DME1110 XEOTICID XEO04890 MOACRIVE Inhibition DME1110 XEOTICID XEO04912 XEO_NAME Scandium carbonate DME1110 XEOTICID XEO04912 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO04912 XEO_CLAS Nanoparticle DME1110 XEOTICID XEO04912 DESCRIPT Scandium carbonate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04912 GENEFORM Protein DME1110 XEOTICID XEO04912 MOACRIVE Inhibition DME1110 XEOTICID XEO04925 XEO_NAME Selenium nanoparticles DME1110 XEOTICID XEO04925 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04925 XEO_CLAS Natural Product DME1110 XEOTICID XEO04925 DESCRIPT Selenium nanoparticles inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04925 GENEFORM Protein DME1110 XEOTICID XEO04925 MOACRIVE Inhibition DME1110 XEOTICID XEO04940 XEO_NAME Silver Ion DME1110 XEOTICID XEO04940 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO04940 XEO_CLAS Nanoparticle DME1110 XEOTICID XEO04940 DESCRIPT Silver Ion inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04940 GENEFORM Protein DME1110 XEOTICID XEO04940 MOACRIVE Inhibition DME1110 XEOTICID XEO04941 XEO_NAME Silver nanoparticle DME1110 XEOTICID XEO04941 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO04941 XEO_CLAS Nanoparticle DME1110 XEOTICID XEO04941 DESCRIPT Silver nanoparticle inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04941 GENEFORM Protein DME1110 XEOTICID XEO04941 MOACRIVE Inhibition DME1110 XEOTICID XEO04954 XEO_NAME SMAP-29 DME1110 XEOTICID XEO04954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04954 XEO_CLAS Peptide DME1110 XEOTICID XEO04954 DESCRIPT SMAP-29 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04954 GENEFORM Protein DME1110 XEOTICID XEO04954 MOACRIVE Inhibition DME1110 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1110 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04955 XEO_CLAS Peptide DME1110 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.08 microM) DME1110 XEOTICID XEO04955 GENEFORM Protein DME1110 XEOTICID XEO04955 MOACRIVE Inhibition DME1110 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1110 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04956 XEO_CLAS Peptide DME1110 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16.0 microM) DME1110 XEOTICID XEO04956 GENEFORM Protein DME1110 XEOTICID XEO04956 MOACRIVE Inhibition DME1110 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1110 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04957 XEO_CLAS Peptide DME1110 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.77 microM) DME1110 XEOTICID XEO04957 GENEFORM Protein DME1110 XEOTICID XEO04957 MOACRIVE Inhibition DME1110 XEOTICID XEO04962 XEO_NAME Sodium ascorbate DME1110 XEOTICID XEO04962 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO04962 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO04962 DESCRIPT Sodium ascorbate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04962 GENEFORM Protein DME1110 XEOTICID XEO04962 MOACRIVE Inhibition DME1110 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1110 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04971 XEO_CLAS Peptide DME1110 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6-12 microM) DME1110 XEOTICID XEO04971 GENEFORM Protein DME1110 XEOTICID XEO04971 MOACRIVE Inhibition DME1110 XEOTICID XEO04973 XEO_NAME 3-(Phenylsulfinyl)-L-alanine DME1110 XEOTICID XEO04973 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO04973 XEO_CLAS Chemical Compound DME1110 XEOTICID XEO04973 DESCRIPT 3-(Phenylsulfinyl)-L-alanine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04973 GENEFORM Protein DME1110 XEOTICID XEO04973 MOACRIVE Inhibition DME1110 XEOTICID XEO04974 XEO_NAME Spinigerin DME1110 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04974 XEO_CLAS Peptide DME1110 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 50-100 microM) DME1110 XEOTICID XEO04974 GENEFORM Protein DME1110 XEOTICID XEO04974 MOACRIVE Inhibition DME1110 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1110 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1110 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04975 GENEFORM Protein DME1110 XEOTICID XEO04975 MOACRIVE Inhibition DME1110 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1110 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1110 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04976 GENEFORM Protein DME1110 XEOTICID XEO04976 MOACRIVE Inhibition DME1110 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1110 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1110 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04977 GENEFORM Protein DME1110 XEOTICID XEO04977 MOACRIVE Inhibition DME1110 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1110 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1110 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04978 GENEFORM Protein DME1110 XEOTICID XEO04978 MOACRIVE Inhibition DME1110 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1110 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1110 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04979 GENEFORM Protein DME1110 XEOTICID XEO04979 MOACRIVE Inhibition DME1110 XEOTICID XEO04988 XEO_NAME Guarea bullata stem extract DME1110 XEOTICID XEO04988 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04988 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04988 DESCRIPT Guarea bullata stem extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04988 GENEFORM Protein DME1110 XEOTICID XEO04988 MOACRIVE Inhibition DME1110 XEOTICID XEO04989 XEO_NAME Guarea grandifolia stem extract DME1110 XEOTICID XEO04989 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04989 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04989 DESCRIPT Guarea grandifolia stem extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04989 GENEFORM Protein DME1110 XEOTICID XEO04989 MOACRIVE Inhibition DME1110 XEOTICID XEO04990 XEO_NAME Leandra melanodesma stem extract DME1110 XEOTICID XEO04990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04990 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04990 DESCRIPT Leandra melanodesma stem extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04990 GENEFORM Protein DME1110 XEOTICID XEO04990 MOACRIVE Inhibition DME1110 XEOTICID XEO04991 XEO_NAME Miconia pittieri stem extract DME1110 XEOTICID XEO04991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04991 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04991 DESCRIPT Miconia pittieri stem extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04991 GENEFORM Protein DME1110 XEOTICID XEO04991 MOACRIVE Inhibition DME1110 XEOTICID XEO04992 XEO_NAME Piper urostachyum stem extract DME1110 XEOTICID XEO04992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04992 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04992 DESCRIPT Piper urostachyum stem extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04992 GENEFORM Protein DME1110 XEOTICID XEO04992 MOACRIVE Inhibition DME1110 XEOTICID XEO04993 XEO_NAME Trichilia pittieri stem extract DME1110 XEOTICID XEO04993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO04993 XEO_CLAS Plant Extract DME1110 XEOTICID XEO04993 DESCRIPT Trichilia pittieri stem extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04993 GENEFORM Protein DME1110 XEOTICID XEO04993 MOACRIVE Inhibition DME1110 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1110 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04995 XEO_CLAS Peptide DME1110 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 0.39-0.78 microM) DME1110 XEOTICID XEO04995 GENEFORM Protein DME1110 XEOTICID XEO04995 MOACRIVE Inhibition DME1110 XEOTICID XEO04996 XEO_NAME Streptomycin DME1110 XEOTICID XEO04996 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO04996 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO04996 DESCRIPT Streptomycin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO04996 GENEFORM Protein DME1110 XEOTICID XEO04996 MOACRIVE Inhibition DME1110 XEOTICID XEO04998 XEO_NAME Styelin A DME1110 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04998 XEO_CLAS Peptide DME1110 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1110 XEOTICID XEO04998 GENEFORM Protein DME1110 XEOTICID XEO04998 MOACRIVE Inhibition DME1110 XEOTICID XEO04999 XEO_NAME Styelin B DME1110 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO04999 XEO_CLAS Peptide DME1110 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.5 ug/ml) DME1110 XEOTICID XEO04999 GENEFORM Protein DME1110 XEOTICID XEO04999 MOACRIVE Inhibition DME1110 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1110 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05000 XEO_CLAS Peptide DME1110 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO05000 GENEFORM Protein DME1110 XEOTICID XEO05000 MOACRIVE Inhibition DME1110 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1110 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05001 XEO_CLAS Peptide DME1110 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1110 XEOTICID XEO05001 GENEFORM Protein DME1110 XEOTICID XEO05001 MOACRIVE Inhibition DME1110 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1110 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05002 XEO_CLAS Peptide DME1110 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1110 XEOTICID XEO05002 GENEFORM Protein DME1110 XEOTICID XEO05002 MOACRIVE Inhibition DME1110 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1110 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05003 XEO_CLAS Peptide DME1110 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 31 ug/ml) DME1110 XEOTICID XEO05003 GENEFORM Protein DME1110 XEOTICID XEO05003 MOACRIVE Inhibition DME1110 XEOTICID XEO05006 XEO_NAME Substance P DME1110 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05006 XEO_CLAS Peptide DME1110 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05006 GENEFORM Protein DME1110 XEOTICID XEO05006 MOACRIVE Inhibition DME1110 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1110 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05007 XEO_CLAS Peptide DME1110 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05007 GENEFORM Protein DME1110 XEOTICID XEO05007 MOACRIVE Inhibition DME1110 XEOTICID XEO05021 XEO_NAME Tachyplesin III DME1110 XEOTICID XEO05021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05021 XEO_CLAS Peptide DME1110 XEOTICID XEO05021 DESCRIPT Tachyplesin III inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05021 GENEFORM Protein DME1110 XEOTICID XEO05021 MOACRIVE Inhibition DME1110 XEOTICID XEO05031 XEO_NAME Tannic acid DME1110 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05031 GENEFORM Protein DME1110 XEOTICID XEO05031 MOACRIVE Inhibition DME1110 XEOTICID XEO05037 XEO_NAME Tellurite DME1110 XEOTICID XEO05037 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO05037 XEO_CLAS Nanoparticle DME1110 XEOTICID XEO05037 DESCRIPT Tellurite inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05037 GENEFORM Protein DME1110 XEOTICID XEO05037 MOACRIVE Inhibition DME1110 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1110 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05063 XEO_CLAS Peptide DME1110 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 31 microM) DME1110 XEOTICID XEO05063 GENEFORM Protein DME1110 XEOTICID XEO05063 MOACRIVE Inhibition DME1110 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1110 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05065 XEO_CLAS Peptide DME1110 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 161 ug/ml) DME1110 XEOTICID XEO05065 GENEFORM Protein DME1110 XEOTICID XEO05065 MOACRIVE Inhibition DME1110 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1110 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05073 XEO_CLAS Peptide DME1110 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 160 microM) DME1110 XEOTICID XEO05073 GENEFORM Protein DME1110 XEOTICID XEO05073 MOACRIVE Inhibition DME1110 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1110 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05075 XEO_CLAS Peptide DME1110 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 160 microM) DME1110 XEOTICID XEO05075 GENEFORM Protein DME1110 XEOTICID XEO05075 MOACRIVE Inhibition DME1110 XEOTICID XEO05076 XEO_NAME Temporin-A DME1110 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05076 XEO_CLAS Peptide DME1110 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 360 microM) DME1110 XEOTICID XEO05076 GENEFORM Protein DME1110 XEOTICID XEO05076 MOACRIVE Inhibition DME1110 XEOTICID XEO05085 XEO_NAME Temporin-B DME1110 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05085 XEO_CLAS Peptide DME1110 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 360 microM) DME1110 XEOTICID XEO05085 GENEFORM Protein DME1110 XEOTICID XEO05085 MOACRIVE Inhibition DME1110 XEOTICID XEO05103 XEO_NAME Temporin-RN1 DME1110 XEOTICID XEO05103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05103 XEO_CLAS Peptide DME1110 XEOTICID XEO05103 DESCRIPT Temporin-RN1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 4.7 ug/ml) DME1110 XEOTICID XEO05103 GENEFORM Protein DME1110 XEOTICID XEO05103 MOACRIVE Inhibition DME1110 XEOTICID XEO05104 XEO_NAME Temporin-RN3 DME1110 XEOTICID XEO05104 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05104 XEO_CLAS Peptide DME1110 XEOTICID XEO05104 DESCRIPT Temporin-RN3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 3.75 ug/ml) DME1110 XEOTICID XEO05104 GENEFORM Protein DME1110 XEOTICID XEO05104 MOACRIVE Inhibition DME1110 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1110 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05139 XEO_CLAS Peptide DME1110 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05139 GENEFORM Protein DME1110 XEOTICID XEO05139 MOACRIVE Inhibition DME1110 XEOTICID XEO05156 XEO_NAME Tobramycin DME1110 XEOTICID XEO05156 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO05156 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO05156 DESCRIPT Tobramycin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05156 GENEFORM Protein DME1110 XEOTICID XEO05156 MOACRIVE Inhibition DME1110 XEOTICID XEO05160 XEO_NAME Toremifene DME1110 XEOTICID XEO05160 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO05160 XEO_CLAS Approved/Marketed Drug DME1110 XEOTICID XEO05160 DESCRIPT Toremifene inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05160 GENEFORM Protein DME1110 XEOTICID XEO05160 MOACRIVE Inhibition DME1110 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1110 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05161 XEO_CLAS Peptide DME1110 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1110 XEOTICID XEO05161 GENEFORM Protein DME1110 XEOTICID XEO05161 MOACRIVE Inhibition DME1110 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1110 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05162 XEO_CLAS Peptide DME1110 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1110 XEOTICID XEO05162 GENEFORM Protein DME1110 XEOTICID XEO05162 MOACRIVE Inhibition DME1110 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1110 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05163 XEO_CLAS Peptide DME1110 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 25-50 ug/ml) DME1110 XEOTICID XEO05163 GENEFORM Protein DME1110 XEOTICID XEO05163 MOACRIVE Inhibition DME1110 XEOTICID XEO05167 XEO_NAME Tricaine DME1110 XEOTICID XEO05167 XEO_TYPE Pharmaceutical Agent(s) DME1110 XEOTICID XEO05167 XEO_CLAS Investigative Agent DME1110 XEOTICID XEO05167 DESCRIPT Tricaine inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05167 GENEFORM Protein DME1110 XEOTICID XEO05167 MOACRIVE Inhibition DME1110 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1110 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05170 XEO_CLAS Peptide DME1110 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 5.0 microM) DME1110 XEOTICID XEO05170 GENEFORM Protein DME1110 XEOTICID XEO05170 MOACRIVE Inhibition DME1110 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1110 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05179 XEO_CLAS Peptide DME1110 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05179 GENEFORM Protein DME1110 XEOTICID XEO05179 MOACRIVE Inhibition DME1110 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1110 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05182 XEO_CLAS Peptide DME1110 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) DME1110 XEOTICID XEO05182 GENEFORM Protein DME1110 XEOTICID XEO05182 MOACRIVE Inhibition DME1110 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1110 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05183 XEO_CLAS Peptide DME1110 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) DME1110 XEOTICID XEO05183 GENEFORM Protein DME1110 XEOTICID XEO05183 MOACRIVE Inhibition DME1110 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1110 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05184 XEO_CLAS Peptide DME1110 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) DME1110 XEOTICID XEO05184 GENEFORM Protein DME1110 XEOTICID XEO05184 MOACRIVE Inhibition DME1110 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1110 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05185 XEO_CLAS Peptide DME1110 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 100 microM) DME1110 XEOTICID XEO05185 GENEFORM Protein DME1110 XEOTICID XEO05185 MOACRIVE Inhibition DME1110 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1110 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05186 XEO_CLAS Peptide DME1110 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) DME1110 XEOTICID XEO05186 GENEFORM Protein DME1110 XEOTICID XEO05186 MOACRIVE Inhibition DME1110 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1110 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05187 XEO_CLAS Peptide DME1110 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) DME1110 XEOTICID XEO05187 GENEFORM Protein DME1110 XEOTICID XEO05187 MOACRIVE Inhibition DME1110 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1110 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05188 XEO_CLAS Peptide DME1110 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 100 microM) DME1110 XEOTICID XEO05188 GENEFORM Protein DME1110 XEOTICID XEO05188 MOACRIVE Inhibition DME1110 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1110 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05193 XEO_CLAS Peptide DME1110 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO05193 GENEFORM Protein DME1110 XEOTICID XEO05193 MOACRIVE Inhibition DME1110 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1110 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05206 XEO_CLAS Peptide DME1110 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10 microM) DME1110 XEOTICID XEO05206 GENEFORM Protein DME1110 XEOTICID XEO05206 MOACRIVE Inhibition DME1110 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1110 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05207 XEO_CLAS Peptide DME1110 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 40 microM) DME1110 XEOTICID XEO05207 GENEFORM Protein DME1110 XEOTICID XEO05207 MOACRIVE Inhibition DME1110 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1110 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05208 XEO_CLAS Peptide DME1110 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 microM) DME1110 XEOTICID XEO05208 GENEFORM Protein DME1110 XEOTICID XEO05208 MOACRIVE Inhibition DME1110 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1110 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05209 XEO_CLAS Peptide DME1110 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 2 microM) DME1110 XEOTICID XEO05209 GENEFORM Protein DME1110 XEOTICID XEO05209 MOACRIVE Inhibition DME1110 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1110 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05212 XEO_CLAS Peptide DME1110 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 10.1 ug/ml) DME1110 XEOTICID XEO05212 GENEFORM Protein DME1110 XEOTICID XEO05212 MOACRIVE Inhibition DME1110 XEOTICID XEO05227 XEO_NAME Vanillylacetone DME1110 XEOTICID XEO05227 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05227 XEO_CLAS Natural Product DME1110 XEOTICID XEO05227 DESCRIPT Vanillylacetone inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05227 GENEFORM Protein DME1110 XEOTICID XEO05227 MOACRIVE Inhibition DME1110 XEOTICID XEO05250 XEO_NAME Vitexin DME1110 XEOTICID XEO05250 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05250 XEO_CLAS Natural Product DME1110 XEOTICID XEO05250 DESCRIPT Vitexin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05250 GENEFORM Protein DME1110 XEOTICID XEO05250 MOACRIVE Inhibition DME1110 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1110 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05264 XEO_CLAS Peptide DME1110 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1110 XEOTICID XEO05264 GENEFORM Protein DME1110 XEOTICID XEO05264 MOACRIVE Inhibition DME1110 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1110 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05267 XEO_CLAS Peptide DME1110 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1110 XEOTICID XEO05267 GENEFORM Protein DME1110 XEOTICID XEO05267 MOACRIVE Inhibition DME1110 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1110 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05268 XEO_CLAS Peptide DME1110 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1110 XEOTICID XEO05268 GENEFORM Protein DME1110 XEOTICID XEO05268 MOACRIVE Inhibition DME1110 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1110 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05269 XEO_CLAS Peptide DME1110 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC > 50 ug/ml) DME1110 XEOTICID XEO05269 GENEFORM Protein DME1110 XEOTICID XEO05269 MOACRIVE Inhibition DME1110 XEOTICID XEO05276 XEO_NAME Agaricus blazei water extract DME1110 XEOTICID XEO05276 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05276 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05276 DESCRIPT Agaricus blazei water extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05276 GENEFORM Protein DME1110 XEOTICID XEO05276 MOACRIVE Inhibition DME1110 XEOTICID XEO05286 XEO_NAME Peperomia vinasiana extract DME1110 XEOTICID XEO05286 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05286 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05286 DESCRIPT Peperomia vinasiana extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05286 GENEFORM Protein DME1110 XEOTICID XEO05286 MOACRIVE Inhibition DME1110 XEOTICID XEO05288 XEO_NAME Azadirachta indica wood extract DME1110 XEOTICID XEO05288 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05288 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05288 DESCRIPT Azadirachta indica wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05288 GENEFORM Protein DME1110 XEOTICID XEO05288 MOACRIVE Inhibition DME1110 XEOTICID XEO05289 XEO_NAME Carapa guianensis wood extract DME1110 XEOTICID XEO05289 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05289 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05289 DESCRIPT Carapa guianensis wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05289 GENEFORM Protein DME1110 XEOTICID XEO05289 MOACRIVE Inhibition DME1110 XEOTICID XEO05290 XEO_NAME Cedrela odorata wood extract DME1110 XEOTICID XEO05290 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05290 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05290 DESCRIPT Cedrela odorata wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05290 GENEFORM Protein DME1110 XEOTICID XEO05290 MOACRIVE Inhibition DME1110 XEOTICID XEO05291 XEO_NAME Cedrela tonduzii wood extract DME1110 XEOTICID XEO05291 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05291 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05291 DESCRIPT Cedrela tonduzii wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05291 GENEFORM Protein DME1110 XEOTICID XEO05291 MOACRIVE Inhibition DME1110 XEOTICID XEO05292 XEO_NAME Chukrasia tabularis wood extract DME1110 XEOTICID XEO05292 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05292 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05292 DESCRIPT Chukrasia tabularis wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05292 GENEFORM Protein DME1110 XEOTICID XEO05292 MOACRIVE Inhibition DME1110 XEOTICID XEO05293 XEO_NAME Cupania glabra wood extract DME1110 XEOTICID XEO05293 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05293 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05293 DESCRIPT Cupania glabra wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05293 GENEFORM Protein DME1110 XEOTICID XEO05293 MOACRIVE Inhibition DME1110 XEOTICID XEO05294 XEO_NAME Ruptiliocarpon caracolito wood extract DME1110 XEOTICID XEO05294 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05294 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05294 DESCRIPT Ruptiliocarpon caracolito wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05294 GENEFORM Protein DME1110 XEOTICID XEO05294 MOACRIVE Inhibition DME1110 XEOTICID XEO05295 XEO_NAME Swietenia macrophylla wood extract DME1110 XEOTICID XEO05295 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05295 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05295 DESCRIPT Swietenia macrophylla wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05295 GENEFORM Protein DME1110 XEOTICID XEO05295 MOACRIVE Inhibition DME1110 XEOTICID XEO05296 XEO_NAME Swietenia mahogani wood extract DME1110 XEOTICID XEO05296 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05296 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05296 DESCRIPT Swietenia mahogani wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05296 GENEFORM Protein DME1110 XEOTICID XEO05296 MOACRIVE Inhibition DME1110 XEOTICID XEO05297 XEO_NAME Toona ciliata wood extract DME1110 XEOTICID XEO05297 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05297 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05297 DESCRIPT Toona ciliata wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05297 GENEFORM Protein DME1110 XEOTICID XEO05297 MOACRIVE Inhibition DME1110 XEOTICID XEO05298 XEO_NAME Trichilia glabra wood extract DME1110 XEOTICID XEO05298 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05298 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05298 DESCRIPT Trichilia glabra wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05298 GENEFORM Protein DME1110 XEOTICID XEO05298 MOACRIVE Inhibition DME1110 XEOTICID XEO05299 XEO_NAME Trichilia pleeana wood extract DME1110 XEOTICID XEO05299 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05299 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05299 DESCRIPT Trichilia pleeana wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05299 GENEFORM Protein DME1110 XEOTICID XEO05299 MOACRIVE Inhibition DME1110 XEOTICID XEO05300 XEO_NAME Trichilia septentrionalis wood extract DME1110 XEOTICID XEO05300 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05300 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05300 DESCRIPT Trichilia septentrionalis wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05300 GENEFORM Protein DME1110 XEOTICID XEO05300 MOACRIVE Inhibition DME1110 XEOTICID XEO05301 XEO_NAME Trichilia trifolia wood extract DME1110 XEOTICID XEO05301 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1110 XEOTICID XEO05301 XEO_CLAS Plant Extract DME1110 XEOTICID XEO05301 DESCRIPT Trichilia trifolia wood extract inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05301 GENEFORM Protein DME1110 XEOTICID XEO05301 MOACRIVE Inhibition DME1110 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1110 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1110 XEOTICID XEO05303 XEO_CLAS Peptide DME1110 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa (MIC = 125-250 ug/ml) DME1110 XEOTICID XEO05303 GENEFORM Protein DME1110 XEOTICID XEO05303 MOACRIVE Inhibition DME1110 XEOTICID XEO05311 XEO_NAME Zeaxanthin DME1110 XEOTICID XEO05311 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO05311 XEO_CLAS Food Additive DME1110 XEOTICID XEO05311 DESCRIPT Zeaxanthin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05311 GENEFORM Protein DME1110 XEOTICID XEO05311 MOACRIVE Inhibition DME1110 XEOTICID XEO05315 XEO_NAME Zinc Nitrate DME1110 XEOTICID XEO05315 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1110 XEOTICID XEO05315 XEO_CLAS Nanoparticle DME1110 XEOTICID XEO05315 DESCRIPT Zinc Nitrate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Pseudomonas aeruginosa DME1110 XEOTICID XEO05315 GENEFORM Protein DME1110 XEOTICID XEO05315 MOACRIVE Inhibition DME1111 DME___ID DME1111 DME1111 DME_NAME Arylamine N-acetyltransferase (NAT) DME1111 SPESNAME Salmonella enterica DME1111 XEOTICID XEO01237 XEO_NAME Carvacrol DME1111 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1111 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1111 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO01237 GENEFORM Protein DME1111 XEOTICID XEO01237 MOACRIVE Inhibition DME1111 XEOTICID XEO01802 XEO_NAME (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone DME1111 XEOTICID XEO01802 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1111 XEOTICID XEO01802 XEO_CLAS Chemical Compound DME1111 XEOTICID XEO01802 DESCRIPT (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO01802 GENEFORM Protein DME1111 XEOTICID XEO01802 MOACRIVE Inhibition DME1111 XEOTICID XEO01944 XEO_NAME 2-Hexylmaleic anhydride DME1111 XEOTICID XEO01944 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1111 XEOTICID XEO01944 XEO_CLAS Chemical Compound DME1111 XEOTICID XEO01944 DESCRIPT 2-Hexylmaleic anhydride inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO01944 GENEFORM Protein DME1111 XEOTICID XEO01944 MOACRIVE Inhibition DME1111 XEOTICID XEO01990 XEO_NAME 3-hexyl-4-bromo-5-methylene-2(5H)-furanone DME1111 XEOTICID XEO01990 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1111 XEOTICID XEO01990 XEO_CLAS Chemical Compound DME1111 XEOTICID XEO01990 DESCRIPT 3-hexyl-4-bromo-5-methylene-2(5H)-furanone inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO01990 GENEFORM Protein DME1111 XEOTICID XEO01990 MOACRIVE Inhibition DME1111 XEOTICID XEO02235 XEO_NAME Anthranilate DME1111 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1111 XEOTICID XEO02235 XEO_CLAS Natural Product DME1111 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO02235 GENEFORM Protein DME1111 XEOTICID XEO02235 MOACRIVE Inhibition DME1111 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1111 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO02284 XEO_CLAS Peptide DME1111 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 25.0 microM) DME1111 XEOTICID XEO02284 GENEFORM Protein DME1111 XEOTICID XEO02284 MOACRIVE Inhibition DME1111 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1111 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO02285 XEO_CLAS Peptide DME1111 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 25.0 microM) DME1111 XEOTICID XEO02285 GENEFORM Protein DME1111 XEOTICID XEO02285 MOACRIVE Inhibition DME1111 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1111 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO02286 XEO_CLAS Peptide DME1111 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 25.0 microM) DME1111 XEOTICID XEO02286 GENEFORM Protein DME1111 XEOTICID XEO02286 MOACRIVE Inhibition DME1111 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1111 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO02287 XEO_CLAS Peptide DME1111 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 25.0 microM) DME1111 XEOTICID XEO02287 GENEFORM Protein DME1111 XEOTICID XEO02287 MOACRIVE Inhibition DME1111 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1111 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO02317 XEO_CLAS Peptide DME1111 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 300 microM) DME1111 XEOTICID XEO02317 GENEFORM Protein DME1111 XEOTICID XEO02317 MOACRIVE Inhibition DME1111 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1111 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO02491 XEO_CLAS Peptide DME1111 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 2.3 microM) DME1111 XEOTICID XEO02491 GENEFORM Protein DME1111 XEOTICID XEO02491 MOACRIVE Inhibition DME1111 XEOTICID XEO02641 XEO_NAME Bromohexylmaleic anhydride DME1111 XEOTICID XEO02641 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1111 XEOTICID XEO02641 XEO_CLAS Chemical Compound DME1111 XEOTICID XEO02641 DESCRIPT Bromohexylmaleic anhydride inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO02641 GENEFORM Protein DME1111 XEOTICID XEO02641 MOACRIVE Inhibition DME1111 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1111 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1111 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1111 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO02990 GENEFORM Protein DME1111 XEOTICID XEO02990 MOACRIVE Inhibition DME1111 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1111 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO03029 XEO_CLAS Peptide DME1111 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 0.005 microM) DME1111 XEOTICID XEO03029 GENEFORM Protein DME1111 XEOTICID XEO03029 MOACRIVE Inhibition DME1111 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1111 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO03030 XEO_CLAS Peptide DME1111 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 0.005 microM) DME1111 XEOTICID XEO03030 GENEFORM Protein DME1111 XEOTICID XEO03030 MOACRIVE Inhibition DME1111 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1111 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO03031 XEO_CLAS Peptide DME1111 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 0.3 microM) DME1111 XEOTICID XEO03031 GENEFORM Protein DME1111 XEOTICID XEO03031 MOACRIVE Inhibition DME1111 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1111 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO03032 XEO_CLAS Peptide DME1111 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 0.005 microM) DME1111 XEOTICID XEO03032 GENEFORM Protein DME1111 XEOTICID XEO03032 MOACRIVE Inhibition DME1111 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1111 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO03033 XEO_CLAS Peptide DME1111 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 0.005 microM) DME1111 XEOTICID XEO03033 GENEFORM Protein DME1111 XEOTICID XEO03033 MOACRIVE Inhibition DME1111 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1111 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO03034 XEO_CLAS Peptide DME1111 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 0.528 microM) DME1111 XEOTICID XEO03034 GENEFORM Protein DME1111 XEOTICID XEO03034 MOACRIVE Inhibition DME1111 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1111 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO03035 XEO_CLAS Peptide DME1111 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 0.004 microM) DME1111 XEOTICID XEO03035 GENEFORM Protein DME1111 XEOTICID XEO03035 MOACRIVE Inhibition DME1111 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1111 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO03250 XEO_CLAS Peptide DME1111 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO03250 GENEFORM Protein DME1111 XEOTICID XEO03250 MOACRIVE Inhibition DME1111 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1111 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1111 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1111 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO03968 GENEFORM Protein DME1111 XEOTICID XEO03968 MOACRIVE Inhibition DME1111 XEOTICID XEO04114 XEO_NAME Microcin L DME1111 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04114 XEO_CLAS Peptide DME1111 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO04114 GENEFORM Protein DME1111 XEOTICID XEO04114 MOACRIVE Inhibition DME1111 XEOTICID XEO04172 XEO_NAME Myxinidin DME1111 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04172 XEO_CLAS Peptide DME1111 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO04172 GENEFORM Protein DME1111 XEOTICID XEO04172 MOACRIVE Inhibition DME1111 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1111 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04335 XEO_CLAS Peptide DME1111 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 16 ug/ml) DME1111 XEOTICID XEO04335 GENEFORM Protein DME1111 XEOTICID XEO04335 MOACRIVE Inhibition DME1111 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1111 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04336 XEO_CLAS Peptide DME1111 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 16 ug/ml) DME1111 XEOTICID XEO04336 GENEFORM Protein DME1111 XEOTICID XEO04336 MOACRIVE Inhibition DME1111 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1111 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04338 XEO_CLAS Peptide DME1111 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 0.5 ug/ml) DME1111 XEOTICID XEO04338 GENEFORM Protein DME1111 XEOTICID XEO04338 MOACRIVE Inhibition DME1111 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1111 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04339 XEO_CLAS Peptide DME1111 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 64 ug/ml) DME1111 XEOTICID XEO04339 GENEFORM Protein DME1111 XEOTICID XEO04339 MOACRIVE Inhibition DME1111 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1111 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04340 XEO_CLAS Peptide DME1111 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 2 ug/ml) DME1111 XEOTICID XEO04340 GENEFORM Protein DME1111 XEOTICID XEO04340 MOACRIVE Inhibition DME1111 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1111 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04642 XEO_CLAS Peptide DME1111 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 4 ug/ml) DME1111 XEOTICID XEO04642 GENEFORM Protein DME1111 XEOTICID XEO04642 MOACRIVE Inhibition DME1111 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1111 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04643 XEO_CLAS Peptide DME1111 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 2 ug/ml) DME1111 XEOTICID XEO04643 GENEFORM Protein DME1111 XEOTICID XEO04643 MOACRIVE Inhibition DME1111 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1111 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04644 XEO_CLAS Peptide DME1111 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 2 ug/ml) DME1111 XEOTICID XEO04644 GENEFORM Protein DME1111 XEOTICID XEO04644 MOACRIVE Inhibition DME1111 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1111 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04645 XEO_CLAS Peptide DME1111 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 32 ug/ml) DME1111 XEOTICID XEO04645 GENEFORM Protein DME1111 XEOTICID XEO04645 MOACRIVE Inhibition DME1111 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1111 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04646 XEO_CLAS Peptide DME1111 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 1 ug/ml) DME1111 XEOTICID XEO04646 GENEFORM Protein DME1111 XEOTICID XEO04646 MOACRIVE Inhibition DME1111 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1111 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04647 XEO_CLAS Peptide DME1111 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 4 ug/ml) DME1111 XEOTICID XEO04647 GENEFORM Protein DME1111 XEOTICID XEO04647 MOACRIVE Inhibition DME1111 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1111 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04648 XEO_CLAS Peptide DME1111 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 16 ug/ml) DME1111 XEOTICID XEO04648 GENEFORM Protein DME1111 XEOTICID XEO04648 MOACRIVE Inhibition DME1111 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1111 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04649 XEO_CLAS Peptide DME1111 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC > 64 ug/ml) DME1111 XEOTICID XEO04649 GENEFORM Protein DME1111 XEOTICID XEO04649 MOACRIVE Inhibition DME1111 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1111 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04650 XEO_CLAS Peptide DME1111 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 16 ug/ml) DME1111 XEOTICID XEO04650 GENEFORM Protein DME1111 XEOTICID XEO04650 MOACRIVE Inhibition DME1111 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1111 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04651 XEO_CLAS Peptide DME1111 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 64 ug/ml) DME1111 XEOTICID XEO04651 GENEFORM Protein DME1111 XEOTICID XEO04651 MOACRIVE Inhibition DME1111 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1111 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04652 XEO_CLAS Peptide DME1111 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 4 ug/ml) DME1111 XEOTICID XEO04652 GENEFORM Protein DME1111 XEOTICID XEO04652 MOACRIVE Inhibition DME1111 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1111 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04655 XEO_CLAS Peptide DME1111 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 2 ug/ml) DME1111 XEOTICID XEO04655 GENEFORM Protein DME1111 XEOTICID XEO04655 MOACRIVE Inhibition DME1111 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1111 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04695 XEO_CLAS Peptide DME1111 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO04695 GENEFORM Protein DME1111 XEOTICID XEO04695 MOACRIVE Inhibition DME1111 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1111 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04696 XEO_CLAS Peptide DME1111 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO04696 GENEFORM Protein DME1111 XEOTICID XEO04696 MOACRIVE Inhibition DME1111 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1111 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04699 XEO_CLAS Peptide DME1111 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO04699 GENEFORM Protein DME1111 XEOTICID XEO04699 MOACRIVE Inhibition DME1111 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1111 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04700 XEO_CLAS Peptide DME1111 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO04700 GENEFORM Protein DME1111 XEOTICID XEO04700 MOACRIVE Inhibition DME1111 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1111 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04701 XEO_CLAS Peptide DME1111 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO04701 GENEFORM Protein DME1111 XEOTICID XEO04701 MOACRIVE Inhibition DME1111 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1111 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04702 XEO_CLAS Peptide DME1111 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO04702 GENEFORM Protein DME1111 XEOTICID XEO04702 MOACRIVE Inhibition DME1111 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1111 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO04703 XEO_CLAS Peptide DME1111 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO04703 GENEFORM Protein DME1111 XEOTICID XEO04703 MOACRIVE Inhibition DME1111 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1111 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO05171 XEO_CLAS Peptide DME1111 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica DME1111 XEOTICID XEO05171 GENEFORM Protein DME1111 XEOTICID XEO05171 MOACRIVE Inhibition DME1111 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1111 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1111 XEOTICID XEO05308 XEO_CLAS Peptide DME1111 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Arylamine N-acetyltransferase (NAT) from Salmonella enterica (MIC = 0.9 ug/ml) DME1111 XEOTICID XEO05308 GENEFORM Protein DME1111 XEOTICID XEO05308 MOACRIVE Inhibition DME1113 DME___ID DME1113 DME1113 DME_NAME Thymidylate synthase (thyA) DME1113 SPESNAME Lactobacillus casei DME1113 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1113 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1113 XEOTICID XEO03771 XEO_CLAS Peptide DME1113 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Thymidylate synthase (thyA) from Lactobacillus casei DME1113 XEOTICID XEO03771 GENEFORM Protein DME1113 XEOTICID XEO03771 MOACRIVE Inhibition DME1113 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1113 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1113 XEOTICID XEO03775 XEO_CLAS Peptide DME1113 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Thymidylate synthase (thyA) from Lactobacillus casei (MIC = 2.27 microM) DME1113 XEOTICID XEO03775 GENEFORM Protein DME1113 XEOTICID XEO03775 MOACRIVE Inhibition DME1113 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1113 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1113 XEOTICID XEO03803 XEO_CLAS Peptide DME1113 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Thymidylate synthase (thyA) from Lactobacillus casei DME1113 XEOTICID XEO03803 GENEFORM Protein DME1113 XEOTICID XEO03803 MOACRIVE Inhibition DME1113 XEOTICID XEO03967 XEO_NAME Bacteriocin LSEI_2163 DME1113 XEOTICID XEO03967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1113 XEOTICID XEO03967 XEO_CLAS Peptide DME1113 XEOTICID XEO03967 DESCRIPT Bacteriocin LSEI_2163 inhibits the drug-metabolizing activity of Thymidylate synthase (thyA) from Lactobacillus casei DME1113 XEOTICID XEO03967 GENEFORM Protein DME1113 XEOTICID XEO03967 MOACRIVE Inhibition DME1113 XEOTICID XEO04332 XEO_NAME Nosiheptide DME1113 XEOTICID XEO04332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1113 XEOTICID XEO04332 XEO_CLAS Peptide DME1113 XEOTICID XEO04332 DESCRIPT Nosiheptide inhibits the drug-metabolizing activity of Thymidylate synthase (thyA) from Lactobacillus casei (MIC = 0.003 ug/ml) DME1113 XEOTICID XEO04332 GENEFORM Protein DME1113 XEOTICID XEO04332 MOACRIVE Inhibition DME1113 XEOTICID XEO04521 XEO_NAME Penocin A DME1113 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1113 XEOTICID XEO04521 XEO_CLAS Peptide DME1113 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Thymidylate synthase (thyA) from Lactobacillus casei DME1113 XEOTICID XEO04521 GENEFORM Protein DME1113 XEOTICID XEO04521 MOACRIVE Inhibition DME1113 XEOTICID XEO04616 XEO_NAME Plantaricin E DME1113 XEOTICID XEO04616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1113 XEOTICID XEO04616 XEO_CLAS Peptide DME1113 XEOTICID XEO04616 DESCRIPT Plantaricin E inhibits the drug-metabolizing activity of Thymidylate synthase (thyA) from Lactobacillus casei (MIC = 0.02 microM) DME1113 XEOTICID XEO04616 GENEFORM Protein DME1113 XEOTICID XEO04616 MOACRIVE Inhibition DME1113 XEOTICID XEO04617 XEO_NAME Plantaricin F DME1113 XEOTICID XEO04617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1113 XEOTICID XEO04617 XEO_CLAS Peptide DME1113 XEOTICID XEO04617 DESCRIPT Plantaricin F inhibits the drug-metabolizing activity of Thymidylate synthase (thyA) from Lactobacillus casei (MIC = 0.02 microM) DME1113 XEOTICID XEO04617 GENEFORM Protein DME1113 XEOTICID XEO04617 MOACRIVE Inhibition DME1113 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1113 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1113 XEOTICID XEO05004 XEO_CLAS Peptide DME1113 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Thymidylate synthase (thyA) from Lactobacillus casei DME1113 XEOTICID XEO05004 GENEFORM Protein DME1113 XEOTICID XEO05004 MOACRIVE Inhibition DME1113 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1113 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1113 XEOTICID XEO05005 XEO_CLAS Peptide DME1113 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Thymidylate synthase (thyA) from Lactobacillus casei DME1113 XEOTICID XEO05005 GENEFORM Protein DME1113 XEOTICID XEO05005 MOACRIVE Inhibition DME1113 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1113 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1113 XEOTICID XEO05283 XEO_CLAS Peptide DME1113 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Thymidylate synthase (thyA) from Lactobacillus casei DME1113 XEOTICID XEO05283 GENEFORM Protein DME1113 XEOTICID XEO05283 MOACRIVE Inhibition DME1115 DME___ID DME1115 DME1115 DME_NAME S-adenosylhomocysteine nucleosidase (mtnN) DME1115 SPESNAME Klebsiella pneumoniae DME1115 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1115 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1115 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1115 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO00546 GENEFORM Protein DME1115 XEOTICID XEO00546 MOACRIVE Inhibition DME1115 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1115 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1115 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1115 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO00574 GENEFORM Protein DME1115 XEOTICID XEO00574 MOACRIVE Inhibition DME1115 XEOTICID XEO01266 XEO_NAME Cyanidin DME1115 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME1115 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME1115 XEOTICID XEO01266 DESCRIPT Cyanidin inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO01266 GENEFORM Protein DME1115 XEOTICID XEO01266 MOACRIVE Inhibition DME1115 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1115 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO01816 XEO_CLAS Peptide DME1115 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 6.25 microM) DME1115 XEOTICID XEO01816 GENEFORM Protein DME1115 XEOTICID XEO01816 MOACRIVE Inhibition DME1115 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1115 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO01827 XEO_CLAS Peptide DME1115 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC > 50 microM) DME1115 XEOTICID XEO01827 GENEFORM Protein DME1115 XEOTICID XEO01827 MOACRIVE Inhibition DME1115 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1115 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02115 XEO_CLAS Peptide DME1115 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO02115 GENEFORM Protein DME1115 XEOTICID XEO02115 MOACRIVE Inhibition DME1115 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1115 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02230 XEO_CLAS Peptide DME1115 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1115 XEOTICID XEO02230 GENEFORM Protein DME1115 XEOTICID XEO02230 MOACRIVE Inhibition DME1115 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1115 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02280 XEO_CLAS Peptide DME1115 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO02280 GENEFORM Protein DME1115 XEOTICID XEO02280 MOACRIVE Inhibition DME1115 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1115 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02325 XEO_CLAS Peptide DME1115 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 13 microM) DME1115 XEOTICID XEO02325 GENEFORM Protein DME1115 XEOTICID XEO02325 MOACRIVE Inhibition DME1115 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1115 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02370 XEO_CLAS Peptide DME1115 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO02370 GENEFORM Protein DME1115 XEOTICID XEO02370 MOACRIVE Inhibition DME1115 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1115 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02371 XEO_CLAS Peptide DME1115 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 12 ug/ml) DME1115 XEOTICID XEO02371 GENEFORM Protein DME1115 XEOTICID XEO02371 MOACRIVE Inhibition DME1115 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1115 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02378 XEO_CLAS Peptide DME1115 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 0.76 ug/ml) DME1115 XEOTICID XEO02378 GENEFORM Protein DME1115 XEOTICID XEO02378 MOACRIVE Inhibition DME1115 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1115 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02416 XEO_CLAS Peptide DME1115 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO02416 GENEFORM Protein DME1115 XEOTICID XEO02416 MOACRIVE Inhibition DME1115 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1115 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02451 XEO_CLAS Peptide DME1115 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO02451 GENEFORM Protein DME1115 XEOTICID XEO02451 MOACRIVE Inhibition DME1115 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1115 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02473 XEO_CLAS Peptide DME1115 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO02473 GENEFORM Protein DME1115 XEOTICID XEO02473 MOACRIVE Inhibition DME1115 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1115 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02491 XEO_CLAS Peptide DME1115 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 2.8 microM) DME1115 XEOTICID XEO02491 GENEFORM Protein DME1115 XEOTICID XEO02491 MOACRIVE Inhibition DME1115 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1115 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02496 XEO_CLAS Peptide DME1115 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 50 microM) DME1115 XEOTICID XEO02496 GENEFORM Protein DME1115 XEOTICID XEO02496 MOACRIVE Inhibition DME1115 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1115 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02497 XEO_CLAS Peptide DME1115 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC > 50 microM) DME1115 XEOTICID XEO02497 GENEFORM Protein DME1115 XEOTICID XEO02497 MOACRIVE Inhibition DME1115 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1115 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02512 XEO_CLAS Peptide DME1115 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 150 microM) DME1115 XEOTICID XEO02512 GENEFORM Protein DME1115 XEOTICID XEO02512 MOACRIVE Inhibition DME1115 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1115 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02566 XEO_CLAS Peptide DME1115 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC > 100 microM) DME1115 XEOTICID XEO02566 GENEFORM Protein DME1115 XEOTICID XEO02566 MOACRIVE Inhibition DME1115 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1115 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02637 XEO_CLAS Peptide DME1115 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 6 microM) DME1115 XEOTICID XEO02637 GENEFORM Protein DME1115 XEOTICID XEO02637 MOACRIVE Inhibition DME1115 XEOTICID XEO02656 XEO_NAME Himatanthus drasticus butanolic extract DME1115 XEOTICID XEO02656 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1115 XEOTICID XEO02656 XEO_CLAS Plant Extract DME1115 XEOTICID XEO02656 DESCRIPT Himatanthus drasticus butanolic extract inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO02656 GENEFORM Protein DME1115 XEOTICID XEO02656 MOACRIVE Inhibition DME1115 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1115 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02688 XEO_CLAS Peptide DME1115 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 25 microM) DME1115 XEOTICID XEO02688 GENEFORM Protein DME1115 XEOTICID XEO02688 MOACRIVE Inhibition DME1115 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1115 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02708 XEO_CLAS Peptide DME1115 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 20 ug/ml) DME1115 XEOTICID XEO02708 GENEFORM Protein DME1115 XEOTICID XEO02708 MOACRIVE Inhibition DME1115 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1115 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02732 XEO_CLAS Peptide DME1115 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 1.25 microM) DME1115 XEOTICID XEO02732 GENEFORM Protein DME1115 XEOTICID XEO02732 MOACRIVE Inhibition DME1115 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1115 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02734 XEO_CLAS Peptide DME1115 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 0.40 microM) DME1115 XEOTICID XEO02734 GENEFORM Protein DME1115 XEOTICID XEO02734 MOACRIVE Inhibition DME1115 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1115 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02736 XEO_CLAS Peptide DME1115 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 0.66 microM) DME1115 XEOTICID XEO02736 GENEFORM Protein DME1115 XEOTICID XEO02736 MOACRIVE Inhibition DME1115 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1115 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02738 XEO_CLAS Peptide DME1115 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 1 microM) DME1115 XEOTICID XEO02738 GENEFORM Protein DME1115 XEOTICID XEO02738 MOACRIVE Inhibition DME1115 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1115 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02743 XEO_CLAS Peptide DME1115 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 4.7 ug/ml) DME1115 XEOTICID XEO02743 GENEFORM Protein DME1115 XEOTICID XEO02743 MOACRIVE Inhibition DME1115 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1115 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02749 XEO_CLAS Peptide DME1115 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 20 mug/ml) DME1115 XEOTICID XEO02749 GENEFORM Protein DME1115 XEOTICID XEO02749 MOACRIVE Inhibition DME1115 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1115 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02767 XEO_CLAS Peptide DME1115 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO02767 GENEFORM Protein DME1115 XEOTICID XEO02767 MOACRIVE Inhibition DME1115 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1115 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02768 XEO_CLAS Peptide DME1115 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 1-2.5 ug/ml) DME1115 XEOTICID XEO02768 GENEFORM Protein DME1115 XEOTICID XEO02768 MOACRIVE Inhibition DME1115 XEOTICID XEO02780 XEO_NAME Cefixime DME1115 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1115 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1115 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO02780 GENEFORM Protein DME1115 XEOTICID XEO02780 MOACRIVE Inhibition DME1115 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1115 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO02942 XEO_CLAS Peptide DME1115 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO02942 GENEFORM Protein DME1115 XEOTICID XEO02942 MOACRIVE Inhibition DME1115 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1115 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03029 XEO_CLAS Peptide DME1115 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 0.145 microM) DME1115 XEOTICID XEO03029 GENEFORM Protein DME1115 XEOTICID XEO03029 MOACRIVE Inhibition DME1115 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1115 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03030 XEO_CLAS Peptide DME1115 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 0.643 microM) DME1115 XEOTICID XEO03030 GENEFORM Protein DME1115 XEOTICID XEO03030 MOACRIVE Inhibition DME1115 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1115 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03031 XEO_CLAS Peptide DME1115 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 0.01 microM) DME1115 XEOTICID XEO03031 GENEFORM Protein DME1115 XEOTICID XEO03031 MOACRIVE Inhibition DME1115 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1115 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03032 XEO_CLAS Peptide DME1115 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC < 0.005 microM) DME1115 XEOTICID XEO03032 GENEFORM Protein DME1115 XEOTICID XEO03032 MOACRIVE Inhibition DME1115 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1115 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03033 XEO_CLAS Peptide DME1115 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC > 0.692 microM) DME1115 XEOTICID XEO03033 GENEFORM Protein DME1115 XEOTICID XEO03033 MOACRIVE Inhibition DME1115 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1115 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03034 XEO_CLAS Peptide DME1115 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 0.004 microM) DME1115 XEOTICID XEO03034 GENEFORM Protein DME1115 XEOTICID XEO03034 MOACRIVE Inhibition DME1115 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1115 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03035 XEO_CLAS Peptide DME1115 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 0.458 microM) DME1115 XEOTICID XEO03035 GENEFORM Protein DME1115 XEOTICID XEO03035 MOACRIVE Inhibition DME1115 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1115 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03051 XEO_CLAS Peptide DME1115 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1115 XEOTICID XEO03051 GENEFORM Protein DME1115 XEOTICID XEO03051 MOACRIVE Inhibition DME1115 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1115 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03052 XEO_CLAS Peptide DME1115 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1115 XEOTICID XEO03052 GENEFORM Protein DME1115 XEOTICID XEO03052 MOACRIVE Inhibition DME1115 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1115 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03053 XEO_CLAS Peptide DME1115 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1115 XEOTICID XEO03053 GENEFORM Protein DME1115 XEOTICID XEO03053 MOACRIVE Inhibition DME1115 XEOTICID XEO03089 XEO_NAME Decoralin DME1115 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03089 XEO_CLAS Peptide DME1115 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 80 microM) DME1115 XEOTICID XEO03089 GENEFORM Protein DME1115 XEOTICID XEO03089 MOACRIVE Inhibition DME1115 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1115 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03112 XEO_CLAS Peptide DME1115 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC > 50 ug/ml) DME1115 XEOTICID XEO03112 GENEFORM Protein DME1115 XEOTICID XEO03112 MOACRIVE Inhibition DME1115 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1115 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03137 XEO_CLAS Peptide DME1115 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03137 GENEFORM Protein DME1115 XEOTICID XEO03137 MOACRIVE Inhibition DME1115 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1115 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03162 XEO_CLAS Peptide DME1115 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 0.8 microM) DME1115 XEOTICID XEO03162 GENEFORM Protein DME1115 XEOTICID XEO03162 MOACRIVE Inhibition DME1115 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1115 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03224 XEO_CLAS Peptide DME1115 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1115 XEOTICID XEO03224 GENEFORM Protein DME1115 XEOTICID XEO03224 MOACRIVE Inhibition DME1115 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1115 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03235 XEO_CLAS Peptide DME1115 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 60 ug/ml) DME1115 XEOTICID XEO03235 GENEFORM Protein DME1115 XEOTICID XEO03235 MOACRIVE Inhibition DME1115 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1115 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03237 XEO_CLAS Peptide DME1115 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC > 100 ug/ml) DME1115 XEOTICID XEO03237 GENEFORM Protein DME1115 XEOTICID XEO03237 MOACRIVE Inhibition DME1115 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1115 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03238 XEO_CLAS Peptide DME1115 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1115 XEOTICID XEO03238 GENEFORM Protein DME1115 XEOTICID XEO03238 MOACRIVE Inhibition DME1115 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1115 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03239 XEO_CLAS Peptide DME1115 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1115 XEOTICID XEO03239 GENEFORM Protein DME1115 XEOTICID XEO03239 MOACRIVE Inhibition DME1115 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1115 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03250 XEO_CLAS Peptide DME1115 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03250 GENEFORM Protein DME1115 XEOTICID XEO03250 MOACRIVE Inhibition DME1115 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1115 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03251 XEO_CLAS Peptide DME1115 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03251 GENEFORM Protein DME1115 XEOTICID XEO03251 MOACRIVE Inhibition DME1115 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1115 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03253 XEO_CLAS Peptide DME1115 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 3.2 ug/ml) DME1115 XEOTICID XEO03253 GENEFORM Protein DME1115 XEOTICID XEO03253 MOACRIVE Inhibition DME1115 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1115 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1115 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1115 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03348 GENEFORM Protein DME1115 XEOTICID XEO03348 MOACRIVE Inhibition DME1115 XEOTICID XEO03387 XEO_NAME Ferric chloride DME1115 XEOTICID XEO03387 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1115 XEOTICID XEO03387 XEO_CLAS Chemical Compound DME1115 XEOTICID XEO03387 DESCRIPT Ferric chloride inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03387 GENEFORM Protein DME1115 XEOTICID XEO03387 MOACRIVE Inhibition DME1115 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1115 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03436 XEO_CLAS Peptide DME1115 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1115 XEOTICID XEO03436 GENEFORM Protein DME1115 XEOTICID XEO03436 MOACRIVE Inhibition DME1115 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1115 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03437 XEO_CLAS Peptide DME1115 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1115 XEOTICID XEO03437 GENEFORM Protein DME1115 XEOTICID XEO03437 MOACRIVE Inhibition DME1115 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1115 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03438 XEO_CLAS Peptide DME1115 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1115 XEOTICID XEO03438 GENEFORM Protein DME1115 XEOTICID XEO03438 MOACRIVE Inhibition DME1115 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1115 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03439 XEO_CLAS Peptide DME1115 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1115 XEOTICID XEO03439 GENEFORM Protein DME1115 XEOTICID XEO03439 MOACRIVE Inhibition DME1115 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1115 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03440 XEO_CLAS Peptide DME1115 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1115 XEOTICID XEO03440 GENEFORM Protein DME1115 XEOTICID XEO03440 MOACRIVE Inhibition DME1115 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1115 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03441 XEO_CLAS Peptide DME1115 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1115 XEOTICID XEO03441 GENEFORM Protein DME1115 XEOTICID XEO03441 MOACRIVE Inhibition DME1115 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1115 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03497 XEO_CLAS Peptide DME1115 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1115 XEOTICID XEO03497 GENEFORM Protein DME1115 XEOTICID XEO03497 MOACRIVE Inhibition DME1115 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1115 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03498 XEO_CLAS Peptide DME1115 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1115 XEOTICID XEO03498 GENEFORM Protein DME1115 XEOTICID XEO03498 MOACRIVE Inhibition DME1115 XEOTICID XEO03519 XEO_NAME Hadrurin DME1115 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03519 XEO_CLAS Peptide DME1115 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03519 GENEFORM Protein DME1115 XEOTICID XEO03519 MOACRIVE Inhibition DME1115 XEOTICID XEO03522 XEO_NAME Halocyntin DME1115 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03522 XEO_CLAS Peptide DME1115 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03522 GENEFORM Protein DME1115 XEOTICID XEO03522 MOACRIVE Inhibition DME1115 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1115 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03540 XEO_CLAS Peptide DME1115 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1115 XEOTICID XEO03540 GENEFORM Protein DME1115 XEOTICID XEO03540 MOACRIVE Inhibition DME1115 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1115 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03549 XEO_CLAS Peptide DME1115 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03549 GENEFORM Protein DME1115 XEOTICID XEO03549 MOACRIVE Inhibition DME1115 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1115 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1115 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1115 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03552 GENEFORM Protein DME1115 XEOTICID XEO03552 MOACRIVE Inhibition DME1115 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1115 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03556 XEO_CLAS Peptide DME1115 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1115 XEOTICID XEO03556 GENEFORM Protein DME1115 XEOTICID XEO03556 MOACRIVE Inhibition DME1115 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1115 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03557 XEO_CLAS Peptide DME1115 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1115 XEOTICID XEO03557 GENEFORM Protein DME1115 XEOTICID XEO03557 MOACRIVE Inhibition DME1115 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1115 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03591 XEO_CLAS Peptide DME1115 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1115 XEOTICID XEO03591 GENEFORM Protein DME1115 XEOTICID XEO03591 MOACRIVE Inhibition DME1115 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1115 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03593 XEO_CLAS Peptide DME1115 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1115 XEOTICID XEO03593 GENEFORM Protein DME1115 XEOTICID XEO03593 MOACRIVE Inhibition DME1115 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1115 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03609 XEO_CLAS Peptide DME1115 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03609 GENEFORM Protein DME1115 XEOTICID XEO03609 MOACRIVE Inhibition DME1115 XEOTICID XEO03611 XEO_NAME Himatanthus drasticus hydroalcoholic extract DME1115 XEOTICID XEO03611 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1115 XEOTICID XEO03611 XEO_CLAS Plant Extract DME1115 XEOTICID XEO03611 DESCRIPT Himatanthus drasticus hydroalcoholic extract inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03611 GENEFORM Protein DME1115 XEOTICID XEO03611 MOACRIVE Inhibition DME1115 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1115 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03622 XEO_CLAS Peptide DME1115 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 20-40 microM) DME1115 XEOTICID XEO03622 GENEFORM Protein DME1115 XEOTICID XEO03622 MOACRIVE Inhibition DME1115 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1115 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03630 XEO_CLAS Peptide DME1115 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03630 GENEFORM Protein DME1115 XEOTICID XEO03630 MOACRIVE Inhibition DME1115 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1115 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03631 XEO_CLAS Peptide DME1115 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03631 GENEFORM Protein DME1115 XEOTICID XEO03631 MOACRIVE Inhibition DME1115 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1115 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03632 XEO_CLAS Peptide DME1115 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03632 GENEFORM Protein DME1115 XEOTICID XEO03632 MOACRIVE Inhibition DME1115 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1115 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03633 XEO_CLAS Peptide DME1115 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03633 GENEFORM Protein DME1115 XEOTICID XEO03633 MOACRIVE Inhibition DME1115 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1115 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03634 XEO_CLAS Peptide DME1115 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03634 GENEFORM Protein DME1115 XEOTICID XEO03634 MOACRIVE Inhibition DME1115 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1115 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03635 XEO_CLAS Peptide DME1115 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03635 GENEFORM Protein DME1115 XEOTICID XEO03635 MOACRIVE Inhibition DME1115 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1115 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03636 XEO_CLAS Peptide DME1115 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03636 GENEFORM Protein DME1115 XEOTICID XEO03636 MOACRIVE Inhibition DME1115 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1115 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03637 XEO_CLAS Peptide DME1115 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03637 GENEFORM Protein DME1115 XEOTICID XEO03637 MOACRIVE Inhibition DME1115 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1115 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03638 XEO_CLAS Peptide DME1115 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03638 GENEFORM Protein DME1115 XEOTICID XEO03638 MOACRIVE Inhibition DME1115 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1115 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03639 XEO_CLAS Peptide DME1115 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03639 GENEFORM Protein DME1115 XEOTICID XEO03639 MOACRIVE Inhibition DME1115 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1115 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03640 XEO_CLAS Peptide DME1115 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03640 GENEFORM Protein DME1115 XEOTICID XEO03640 MOACRIVE Inhibition DME1115 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1115 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03672 XEO_CLAS Peptide DME1115 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1115 XEOTICID XEO03672 GENEFORM Protein DME1115 XEOTICID XEO03672 MOACRIVE Inhibition DME1115 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1115 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03673 XEO_CLAS Peptide DME1115 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1115 XEOTICID XEO03673 GENEFORM Protein DME1115 XEOTICID XEO03673 MOACRIVE Inhibition DME1115 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1115 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03674 XEO_CLAS Peptide DME1115 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO03674 GENEFORM Protein DME1115 XEOTICID XEO03674 MOACRIVE Inhibition DME1115 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1115 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03675 XEO_CLAS Peptide DME1115 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 15 microM) DME1115 XEOTICID XEO03675 GENEFORM Protein DME1115 XEOTICID XEO03675 MOACRIVE Inhibition DME1115 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1115 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03678 XEO_CLAS Peptide DME1115 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1115 XEOTICID XEO03678 GENEFORM Protein DME1115 XEOTICID XEO03678 MOACRIVE Inhibition DME1115 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1115 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03681 XEO_CLAS Peptide DME1115 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 1.2-2.5 microM) DME1115 XEOTICID XEO03681 GENEFORM Protein DME1115 XEOTICID XEO03681 MOACRIVE Inhibition DME1115 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1115 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03697 XEO_CLAS Peptide DME1115 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 25 microM) DME1115 XEOTICID XEO03697 GENEFORM Protein DME1115 XEOTICID XEO03697 MOACRIVE Inhibition DME1115 XEOTICID XEO03724 XEO_NAME L10 peptide DME1115 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03724 XEO_CLAS Peptide DME1115 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 3.35 microM) DME1115 XEOTICID XEO03724 GENEFORM Protein DME1115 XEOTICID XEO03724 MOACRIVE Inhibition DME1115 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1115 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03744 XEO_CLAS Peptide DME1115 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1115 XEOTICID XEO03744 GENEFORM Protein DME1115 XEOTICID XEO03744 MOACRIVE Inhibition DME1115 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1115 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03746 XEO_CLAS Peptide DME1115 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1115 XEOTICID XEO03746 GENEFORM Protein DME1115 XEOTICID XEO03746 MOACRIVE Inhibition DME1115 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1115 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03747 XEO_CLAS Peptide DME1115 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1115 XEOTICID XEO03747 GENEFORM Protein DME1115 XEOTICID XEO03747 MOACRIVE Inhibition DME1115 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1115 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03748 XEO_CLAS Peptide DME1115 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1115 XEOTICID XEO03748 GENEFORM Protein DME1115 XEOTICID XEO03748 MOACRIVE Inhibition DME1115 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1115 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03749 XEO_CLAS Peptide DME1115 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1115 XEOTICID XEO03749 GENEFORM Protein DME1115 XEOTICID XEO03749 MOACRIVE Inhibition DME1115 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1115 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03750 XEO_CLAS Peptide DME1115 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1115 XEOTICID XEO03750 GENEFORM Protein DME1115 XEOTICID XEO03750 MOACRIVE Inhibition DME1115 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1115 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03751 XEO_CLAS Peptide DME1115 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1115 XEOTICID XEO03751 GENEFORM Protein DME1115 XEOTICID XEO03751 MOACRIVE Inhibition DME1115 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1115 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03752 XEO_CLAS Peptide DME1115 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1115 XEOTICID XEO03752 GENEFORM Protein DME1115 XEOTICID XEO03752 MOACRIVE Inhibition DME1115 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1115 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03753 XEO_CLAS Peptide DME1115 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1115 XEOTICID XEO03753 GENEFORM Protein DME1115 XEOTICID XEO03753 MOACRIVE Inhibition DME1115 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1115 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03754 XEO_CLAS Peptide DME1115 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1115 XEOTICID XEO03754 GENEFORM Protein DME1115 XEOTICID XEO03754 MOACRIVE Inhibition DME1115 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1115 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03755 XEO_CLAS Peptide DME1115 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1115 XEOTICID XEO03755 GENEFORM Protein DME1115 XEOTICID XEO03755 MOACRIVE Inhibition DME1115 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1115 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03756 XEO_CLAS Peptide DME1115 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1115 XEOTICID XEO03756 GENEFORM Protein DME1115 XEOTICID XEO03756 MOACRIVE Inhibition DME1115 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1115 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03759 XEO_CLAS Peptide DME1115 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1115 XEOTICID XEO03759 GENEFORM Protein DME1115 XEOTICID XEO03759 MOACRIVE Inhibition DME1115 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1115 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03761 XEO_CLAS Peptide DME1115 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1115 XEOTICID XEO03761 GENEFORM Protein DME1115 XEOTICID XEO03761 MOACRIVE Inhibition DME1115 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1115 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO03985 XEO_CLAS Peptide DME1115 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1115 XEOTICID XEO03985 GENEFORM Protein DME1115 XEOTICID XEO03985 MOACRIVE Inhibition DME1115 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1115 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04001 XEO_CLAS Peptide DME1115 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 12.5 microM) DME1115 XEOTICID XEO04001 GENEFORM Protein DME1115 XEOTICID XEO04001 MOACRIVE Inhibition DME1115 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1115 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04007 XEO_CLAS Peptide DME1115 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1115 XEOTICID XEO04007 GENEFORM Protein DME1115 XEOTICID XEO04007 MOACRIVE Inhibition DME1115 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1115 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04011 XEO_CLAS Peptide DME1115 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1115 XEOTICID XEO04011 GENEFORM Protein DME1115 XEOTICID XEO04011 MOACRIVE Inhibition DME1115 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1115 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04012 XEO_CLAS Peptide DME1115 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1115 XEOTICID XEO04012 GENEFORM Protein DME1115 XEOTICID XEO04012 MOACRIVE Inhibition DME1115 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1115 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04013 XEO_CLAS Peptide DME1115 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1115 XEOTICID XEO04013 GENEFORM Protein DME1115 XEOTICID XEO04013 MOACRIVE Inhibition DME1115 XEOTICID XEO04014 XEO_NAME Maximin-5 DME1115 XEOTICID XEO04014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04014 XEO_CLAS Peptide DME1115 XEOTICID XEO04014 DESCRIPT Maximin-5 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 3.6 ug/ml) DME1115 XEOTICID XEO04014 GENEFORM Protein DME1115 XEOTICID XEO04014 MOACRIVE Inhibition DME1115 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1115 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1115 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1115 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04087 GENEFORM Protein DME1115 XEOTICID XEO04087 MOACRIVE Inhibition DME1115 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1115 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04111 XEO_CLAS Peptide DME1115 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04111 GENEFORM Protein DME1115 XEOTICID XEO04111 MOACRIVE Inhibition DME1115 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1115 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04241 XEO_CLAS Peptide DME1115 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04241 GENEFORM Protein DME1115 XEOTICID XEO04241 MOACRIVE Inhibition DME1115 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1115 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04242 XEO_CLAS Peptide DME1115 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04242 GENEFORM Protein DME1115 XEOTICID XEO04242 MOACRIVE Inhibition DME1115 XEOTICID XEO04331 XEO_NAME Norspermidine DME1115 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1115 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1115 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04331 GENEFORM Protein DME1115 XEOTICID XEO04331 MOACRIVE Inhibition DME1115 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1115 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04348 XEO_CLAS Peptide DME1115 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 80 microM) DME1115 XEOTICID XEO04348 GENEFORM Protein DME1115 XEOTICID XEO04348 MOACRIVE Inhibition DME1115 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1115 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04349 XEO_CLAS Peptide DME1115 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 100 microM) DME1115 XEOTICID XEO04349 GENEFORM Protein DME1115 XEOTICID XEO04349 MOACRIVE Inhibition DME1115 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1115 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04399 XEO_CLAS Peptide DME1115 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 6.3 microM) DME1115 XEOTICID XEO04399 GENEFORM Protein DME1115 XEOTICID XEO04399 MOACRIVE Inhibition DME1115 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1115 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04426 XEO_CLAS Peptide DME1115 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 2 microM) DME1115 XEOTICID XEO04426 GENEFORM Protein DME1115 XEOTICID XEO04426 MOACRIVE Inhibition DME1115 XEOTICID XEO04468 XEO_NAME Papillosin DME1115 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04468 XEO_CLAS Peptide DME1115 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04468 GENEFORM Protein DME1115 XEOTICID XEO04468 MOACRIVE Inhibition DME1115 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1115 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04471 XEO_CLAS Peptide DME1115 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 1.6 microM) DME1115 XEOTICID XEO04471 GENEFORM Protein DME1115 XEOTICID XEO04471 MOACRIVE Inhibition DME1115 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1115 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04506 XEO_CLAS Peptide DME1115 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC > 20 microM) DME1115 XEOTICID XEO04506 GENEFORM Protein DME1115 XEOTICID XEO04506 MOACRIVE Inhibition DME1115 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1115 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04507 XEO_CLAS Peptide DME1115 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC > 40 microM) DME1115 XEOTICID XEO04507 GENEFORM Protein DME1115 XEOTICID XEO04507 MOACRIVE Inhibition DME1115 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1115 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04510 XEO_CLAS Peptide DME1115 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC > 50 microM) DME1115 XEOTICID XEO04510 GENEFORM Protein DME1115 XEOTICID XEO04510 MOACRIVE Inhibition DME1115 XEOTICID XEO04531 XEO_NAME Mollusca/molluscs/mollusks peptide 2 DME1115 XEOTICID XEO04531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04531 XEO_CLAS Peptide DME1115 XEOTICID XEO04531 DESCRIPT Mollusca/molluscs/mollusks peptide 2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04531 GENEFORM Protein DME1115 XEOTICID XEO04531 MOACRIVE Inhibition DME1115 XEOTICID XEO04533 XEO_NAME Mollusca/molluscs/mollusks peptide 3 DME1115 XEOTICID XEO04533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04533 XEO_CLAS Peptide DME1115 XEOTICID XEO04533 DESCRIPT Mollusca/molluscs/mollusks peptide 3 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04533 GENEFORM Protein DME1115 XEOTICID XEO04533 MOACRIVE Inhibition DME1115 XEOTICID XEO04534 XEO_NAME Mollusca/molluscs/mollusks peptide 4 DME1115 XEOTICID XEO04534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04534 XEO_CLAS Peptide DME1115 XEOTICID XEO04534 DESCRIPT Mollusca/molluscs/mollusks peptide 4 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04534 GENEFORM Protein DME1115 XEOTICID XEO04534 MOACRIVE Inhibition DME1115 XEOTICID XEO04535 XEO_NAME Mollusca/molluscs/mollusks peptide 5 DME1115 XEOTICID XEO04535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04535 XEO_CLAS Peptide DME1115 XEOTICID XEO04535 DESCRIPT Mollusca/molluscs/mollusks peptide 5 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04535 GENEFORM Protein DME1115 XEOTICID XEO04535 MOACRIVE Inhibition DME1115 XEOTICID XEO04536 XEO_NAME Mollusca/molluscs/mollusks peptide 6 DME1115 XEOTICID XEO04536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04536 XEO_CLAS Peptide DME1115 XEOTICID XEO04536 DESCRIPT Mollusca/molluscs/mollusks peptide 6 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04536 GENEFORM Protein DME1115 XEOTICID XEO04536 MOACRIVE Inhibition DME1115 XEOTICID XEO04537 XEO_NAME Mollusca/molluscs/mollusks peptide 7 DME1115 XEOTICID XEO04537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04537 XEO_CLAS Peptide DME1115 XEOTICID XEO04537 DESCRIPT Mollusca/molluscs/mollusks peptide 7 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04537 GENEFORM Protein DME1115 XEOTICID XEO04537 MOACRIVE Inhibition DME1115 XEOTICID XEO04538 XEO_NAME Mollusca/molluscs/mollusks peptide 8 DME1115 XEOTICID XEO04538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04538 XEO_CLAS Peptide DME1115 XEOTICID XEO04538 DESCRIPT Mollusca/molluscs/mollusks peptide 8 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04538 GENEFORM Protein DME1115 XEOTICID XEO04538 MOACRIVE Inhibition DME1115 XEOTICID XEO04539 XEO_NAME Mollusca/molluscs/mollusks peptide 9 DME1115 XEOTICID XEO04539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04539 XEO_CLAS Peptide DME1115 XEOTICID XEO04539 DESCRIPT Mollusca/molluscs/mollusks peptide 9 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04539 GENEFORM Protein DME1115 XEOTICID XEO04539 MOACRIVE Inhibition DME1115 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1115 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04548 XEO_CLAS Peptide DME1115 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 32000 ug/ml) DME1115 XEOTICID XEO04548 GENEFORM Protein DME1115 XEOTICID XEO04548 MOACRIVE Inhibition DME1115 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1115 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04549 XEO_CLAS Peptide DME1115 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 250-500 ug/ml) DME1115 XEOTICID XEO04549 GENEFORM Protein DME1115 XEOTICID XEO04549 MOACRIVE Inhibition DME1115 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1115 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04571 XEO_CLAS Peptide DME1115 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04571 GENEFORM Protein DME1115 XEOTICID XEO04571 MOACRIVE Inhibition DME1115 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1115 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04572 XEO_CLAS Peptide DME1115 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04572 GENEFORM Protein DME1115 XEOTICID XEO04572 MOACRIVE Inhibition DME1115 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1115 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04606 XEO_CLAS Peptide DME1115 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 2 microM) DME1115 XEOTICID XEO04606 GENEFORM Protein DME1115 XEOTICID XEO04606 MOACRIVE Inhibition DME1115 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1115 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04612 XEO_CLAS Peptide DME1115 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1115 XEOTICID XEO04612 GENEFORM Protein DME1115 XEOTICID XEO04612 MOACRIVE Inhibition DME1115 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1115 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04613 XEO_CLAS Peptide DME1115 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1115 XEOTICID XEO04613 GENEFORM Protein DME1115 XEOTICID XEO04613 MOACRIVE Inhibition DME1115 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1115 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04695 XEO_CLAS Peptide DME1115 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04695 GENEFORM Protein DME1115 XEOTICID XEO04695 MOACRIVE Inhibition DME1115 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1115 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04696 XEO_CLAS Peptide DME1115 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04696 GENEFORM Protein DME1115 XEOTICID XEO04696 MOACRIVE Inhibition DME1115 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1115 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04697 XEO_CLAS Peptide DME1115 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04697 GENEFORM Protein DME1115 XEOTICID XEO04697 MOACRIVE Inhibition DME1115 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1115 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04698 XEO_CLAS Peptide DME1115 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04698 GENEFORM Protein DME1115 XEOTICID XEO04698 MOACRIVE Inhibition DME1115 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1115 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04699 XEO_CLAS Peptide DME1115 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04699 GENEFORM Protein DME1115 XEOTICID XEO04699 MOACRIVE Inhibition DME1115 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1115 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04700 XEO_CLAS Peptide DME1115 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04700 GENEFORM Protein DME1115 XEOTICID XEO04700 MOACRIVE Inhibition DME1115 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1115 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04701 XEO_CLAS Peptide DME1115 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04701 GENEFORM Protein DME1115 XEOTICID XEO04701 MOACRIVE Inhibition DME1115 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1115 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04702 XEO_CLAS Peptide DME1115 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04702 GENEFORM Protein DME1115 XEOTICID XEO04702 MOACRIVE Inhibition DME1115 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1115 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04703 XEO_CLAS Peptide DME1115 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04703 GENEFORM Protein DME1115 XEOTICID XEO04703 MOACRIVE Inhibition DME1115 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1115 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04762 XEO_CLAS Peptide DME1115 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC > 25 microM) DME1115 XEOTICID XEO04762 GENEFORM Protein DME1115 XEOTICID XEO04762 MOACRIVE Inhibition DME1115 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1115 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04809 XEO_CLAS Peptide DME1115 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 10 microM) DME1115 XEOTICID XEO04809 GENEFORM Protein DME1115 XEOTICID XEO04809 MOACRIVE Inhibition DME1115 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1115 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04891 XEO_CLAS Peptide DME1115 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04891 GENEFORM Protein DME1115 XEOTICID XEO04891 MOACRIVE Inhibition DME1115 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1115 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04905 XEO_CLAS Peptide DME1115 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04905 GENEFORM Protein DME1115 XEOTICID XEO04905 MOACRIVE Inhibition DME1115 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1115 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04906 XEO_CLAS Peptide DME1115 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO04906 GENEFORM Protein DME1115 XEOTICID XEO04906 MOACRIVE Inhibition DME1115 XEOTICID XEO04917 XEO_NAME Scorpine DME1115 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04917 XEO_CLAS Peptide DME1115 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 10 microM) DME1115 XEOTICID XEO04917 GENEFORM Protein DME1115 XEOTICID XEO04917 MOACRIVE Inhibition DME1115 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1115 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04971 XEO_CLAS Peptide DME1115 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1115 XEOTICID XEO04971 GENEFORM Protein DME1115 XEOTICID XEO04971 MOACRIVE Inhibition DME1115 XEOTICID XEO04974 XEO_NAME Spinigerin DME1115 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04974 XEO_CLAS Peptide DME1115 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1115 XEOTICID XEO04974 GENEFORM Protein DME1115 XEOTICID XEO04974 MOACRIVE Inhibition DME1115 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1115 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO04995 XEO_CLAS Peptide DME1115 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 0.78-1.56 microM) DME1115 XEOTICID XEO04995 GENEFORM Protein DME1115 XEOTICID XEO04995 MOACRIVE Inhibition DME1115 XEOTICID XEO05020 XEO_NAME Tachycitin DME1115 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO05020 XEO_CLAS Peptide DME1115 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae DME1115 XEOTICID XEO05020 GENEFORM Protein DME1115 XEOTICID XEO05020 MOACRIVE Inhibition DME1115 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1115 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO05073 XEO_CLAS Peptide DME1115 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 80 microM) DME1115 XEOTICID XEO05073 GENEFORM Protein DME1115 XEOTICID XEO05073 MOACRIVE Inhibition DME1115 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1115 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO05075 XEO_CLAS Peptide DME1115 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 80 microM) DME1115 XEOTICID XEO05075 GENEFORM Protein DME1115 XEOTICID XEO05075 MOACRIVE Inhibition DME1115 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1115 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO05101 XEO_CLAS Peptide DME1115 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 31.2 ug/ml) DME1115 XEOTICID XEO05101 GENEFORM Protein DME1115 XEOTICID XEO05101 MOACRIVE Inhibition DME1115 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1115 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO05102 XEO_CLAS Peptide DME1115 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 35.1 ug/ml) DME1115 XEOTICID XEO05102 GENEFORM Protein DME1115 XEOTICID XEO05102 MOACRIVE Inhibition DME1115 XEOTICID XEO05120 XEO_NAME Thanatin DME1115 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO05120 XEO_CLAS Peptide DME1115 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 0.6-1.2 microM) DME1115 XEOTICID XEO05120 GENEFORM Protein DME1115 XEOTICID XEO05120 MOACRIVE Inhibition DME1115 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1115 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO05163 XEO_CLAS Peptide DME1115 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 12-25 ug/ml) DME1115 XEOTICID XEO05163 GENEFORM Protein DME1115 XEOTICID XEO05163 MOACRIVE Inhibition DME1115 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1115 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1115 XEOTICID XEO05220 XEO_CLAS Peptide DME1115 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of S-adenosylhomocysteine nucleosidase (mtnN) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1115 XEOTICID XEO05220 GENEFORM Protein DME1115 XEOTICID XEO05220 MOACRIVE Inhibition DME1118 DME___ID DME1118 DME1118 DME_NAME Glutamate decarboxylase (gadB) DME1118 SPESNAME Lactobacillus johnsonii DME1118 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1118 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1118 XEOTICID XEO03771 XEO_CLAS Peptide DME1118 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus johnsonii DME1118 XEOTICID XEO03771 GENEFORM Protein DME1118 XEOTICID XEO03771 MOACRIVE Inhibition DME1121 DME___ID DME1121 DME1121 DME_NAME Glutamate racemase (MurI) DME1121 SPESNAME Escherichia coli DME1121 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1121 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00117 GENEFORM Protein DME1121 XEOTICID XEO00117 MOACRIVE Inhibition DME1121 XEOTICID XEO00122 XEO_NAME Amikacin DME1121 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00122 GENEFORM Protein DME1121 XEOTICID XEO00122 MOACRIVE Inhibition DME1121 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1121 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00136 GENEFORM Protein DME1121 XEOTICID XEO00136 MOACRIVE Inhibition DME1121 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1121 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00237 GENEFORM Protein DME1121 XEOTICID XEO00237 MOACRIVE Inhibition DME1121 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1121 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00349 GENEFORM Protein DME1121 XEOTICID XEO00349 MOACRIVE Inhibition DME1121 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1121 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00425 GENEFORM Protein DME1121 XEOTICID XEO00425 MOACRIVE Inhibition DME1121 XEOTICID XEO00439 XEO_NAME Daidzein DME1121 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00439 GENEFORM Protein DME1121 XEOTICID XEO00439 MOACRIVE Inhibition DME1121 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1121 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00460 GENEFORM Protein DME1121 XEOTICID XEO00460 MOACRIVE Inhibition DME1121 XEOTICID XEO00487 XEO_NAME Thymol DME1121 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00487 GENEFORM Protein DME1121 XEOTICID XEO00487 MOACRIVE Inhibition DME1121 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1121 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00511 GENEFORM Protein DME1121 XEOTICID XEO00511 MOACRIVE Inhibition DME1121 XEOTICID XEO00537 XEO_NAME Luteolin DME1121 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1121 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00537 GENEFORM Protein DME1121 XEOTICID XEO00537 MOACRIVE Inhibition DME1121 XEOTICID XEO00538 XEO_NAME Quercetin DME1121 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1121 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00538 GENEFORM Protein DME1121 XEOTICID XEO00538 MOACRIVE Inhibition DME1121 XEOTICID XEO00547 XEO_NAME Vitamin E DME1121 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1121 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00547 GENEFORM Protein DME1121 XEOTICID XEO00547 MOACRIVE Inhibition DME1121 XEOTICID XEO00557 XEO_NAME Genistein DME1121 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1121 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00557 GENEFORM Protein DME1121 XEOTICID XEO00557 MOACRIVE Inhibition DME1121 XEOTICID XEO00566 XEO_NAME Guaiacol DME1121 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1121 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00566 GENEFORM Protein DME1121 XEOTICID XEO00566 MOACRIVE Inhibition DME1121 XEOTICID XEO00568 XEO_NAME Resveratrol DME1121 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1121 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00568 GENEFORM Protein DME1121 XEOTICID XEO00568 MOACRIVE Inhibition DME1121 XEOTICID XEO00573 XEO_NAME Naringenin DME1121 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1121 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00573 GENEFORM Protein DME1121 XEOTICID XEO00573 MOACRIVE Inhibition DME1121 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1121 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1121 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00574 GENEFORM Protein DME1121 XEOTICID XEO00574 MOACRIVE Inhibition DME1121 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1121 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1121 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00611 GENEFORM Protein DME1121 XEOTICID XEO00611 MOACRIVE Inhibition DME1121 XEOTICID XEO00621 XEO_NAME Chitosan DME1121 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1121 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00621 GENEFORM Protein DME1121 XEOTICID XEO00621 MOACRIVE Inhibition DME1121 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1121 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1121 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00646 GENEFORM Protein DME1121 XEOTICID XEO00646 MOACRIVE Inhibition DME1121 XEOTICID XEO00683 XEO_NAME Curcumin DME1121 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1121 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00683 GENEFORM Protein DME1121 XEOTICID XEO00683 MOACRIVE Inhibition DME1121 XEOTICID XEO00727 XEO_NAME Vanillin DME1121 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1121 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00727 GENEFORM Protein DME1121 XEOTICID XEO00727 MOACRIVE Inhibition DME1121 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1121 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1121 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00730 GENEFORM Protein DME1121 XEOTICID XEO00730 MOACRIVE Inhibition DME1121 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1121 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO00782 XEO_CLAS Natural Product DME1121 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00782 GENEFORM Protein DME1121 XEOTICID XEO00782 MOACRIVE Inhibition DME1121 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1121 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1121 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00866 GENEFORM Protein DME1121 XEOTICID XEO00866 MOACRIVE Inhibition DME1121 XEOTICID XEO00878 XEO_NAME Chrysin DME1121 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO00878 XEO_CLAS Natural Product DME1121 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00878 GENEFORM Protein DME1121 XEOTICID XEO00878 MOACRIVE Inhibition DME1121 XEOTICID XEO00879 XEO_NAME Coumarin DME1121 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1121 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1121 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00879 GENEFORM Protein DME1121 XEOTICID XEO00879 MOACRIVE Inhibition DME1121 XEOTICID XEO00883 XEO_NAME Phloretin DME1121 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO00883 XEO_CLAS Natural Product DME1121 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00883 GENEFORM Protein DME1121 XEOTICID XEO00883 MOACRIVE Inhibition DME1121 XEOTICID XEO00885 XEO_NAME Eugenol DME1121 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1121 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO00885 GENEFORM Protein DME1121 XEOTICID XEO00885 MOACRIVE Inhibition DME1121 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1121 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1121 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1121 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01032 GENEFORM Protein DME1121 XEOTICID XEO01032 MOACRIVE Inhibition DME1121 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1121 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01174 XEO_CLAS Natural Product DME1121 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01174 GENEFORM Protein DME1121 XEOTICID XEO01174 MOACRIVE Inhibition DME1121 XEOTICID XEO01203 XEO_NAME Apigenin DME1121 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01203 XEO_CLAS Natural Product DME1121 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01203 GENEFORM Protein DME1121 XEOTICID XEO01203 MOACRIVE Inhibition DME1121 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1121 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1121 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1121 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01232 GENEFORM Protein DME1121 XEOTICID XEO01232 MOACRIVE Inhibition DME1121 XEOTICID XEO01237 XEO_NAME Carvacrol DME1121 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1121 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01237 GENEFORM Protein DME1121 XEOTICID XEO01237 MOACRIVE Inhibition DME1121 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1121 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1121 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01287 GENEFORM Protein DME1121 XEOTICID XEO01287 MOACRIVE Inhibition DME1121 XEOTICID XEO01291 XEO_NAME Esculetin DME1121 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1121 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01291 GENEFORM Protein DME1121 XEOTICID XEO01291 MOACRIVE Inhibition DME1121 XEOTICID XEO01304 XEO_NAME Flavone DME1121 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01304 XEO_CLAS Natural Product DME1121 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01304 GENEFORM Protein DME1121 XEOTICID XEO01304 MOACRIVE Inhibition DME1121 XEOTICID XEO01309 XEO_NAME Gallic acid DME1121 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01309 XEO_CLAS Natural Product DME1121 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01309 GENEFORM Protein DME1121 XEOTICID XEO01309 MOACRIVE Inhibition DME1121 XEOTICID XEO01340 XEO_NAME Imperatorin DME1121 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01340 XEO_CLAS Natural Product DME1121 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01340 GENEFORM Protein DME1121 XEOTICID XEO01340 MOACRIVE Inhibition DME1121 XEOTICID XEO01353 XEO_NAME Kaempferol DME1121 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1121 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1121 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01353 GENEFORM Protein DME1121 XEOTICID XEO01353 MOACRIVE Inhibition DME1121 XEOTICID XEO01366 XEO_NAME Linalool DME1121 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01366 XEO_CLAS Natural Product DME1121 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01366 GENEFORM Protein DME1121 XEOTICID XEO01366 MOACRIVE Inhibition DME1121 XEOTICID XEO01391 XEO_NAME Naringin DME1121 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01391 XEO_CLAS Natural Product DME1121 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01391 GENEFORM Protein DME1121 XEOTICID XEO01391 MOACRIVE Inhibition DME1121 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1121 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1121 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01420 GENEFORM Protein DME1121 XEOTICID XEO01420 MOACRIVE Inhibition DME1121 XEOTICID XEO01463 XEO_NAME Rutin DME1121 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01463 XEO_CLAS Natural Product DME1121 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01463 GENEFORM Protein DME1121 XEOTICID XEO01463 MOACRIVE Inhibition DME1121 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1121 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1121 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01496 GENEFORM Protein DME1121 XEOTICID XEO01496 MOACRIVE Inhibition DME1121 XEOTICID XEO01512 XEO_NAME Zinc DME1121 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1121 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1121 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01512 GENEFORM Protein DME1121 XEOTICID XEO01512 MOACRIVE Inhibition DME1121 XEOTICID XEO01527 XEO_NAME Bergamottin DME1121 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01527 XEO_CLAS Natural Product DME1121 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01527 GENEFORM Protein DME1121 XEOTICID XEO01527 MOACRIVE Inhibition DME1121 XEOTICID XEO01531 XEO_NAME Clove oil DME1121 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01531 XEO_CLAS Natural Product DME1121 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01531 GENEFORM Protein DME1121 XEOTICID XEO01531 MOACRIVE Inhibition DME1121 XEOTICID XEO01559 XEO_NAME Limonene DME1121 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01559 XEO_CLAS Natural Product DME1121 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01559 GENEFORM Protein DME1121 XEOTICID XEO01559 MOACRIVE Inhibition DME1121 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1121 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01563 XEO_CLAS Natural Product DME1121 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01563 GENEFORM Protein DME1121 XEOTICID XEO01563 MOACRIVE Inhibition DME1121 XEOTICID XEO01566 XEO_NAME Nobiletin DME1121 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01566 XEO_CLAS Natural Product DME1121 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01566 GENEFORM Protein DME1121 XEOTICID XEO01566 MOACRIVE Inhibition DME1121 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1121 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01778 XEO_CLAS Natural Product DME1121 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01778 GENEFORM Protein DME1121 XEOTICID XEO01778 MOACRIVE Inhibition DME1121 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1121 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01779 XEO_CLAS Peptide DME1121 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 128 microM) DME1121 XEOTICID XEO01779 GENEFORM Protein DME1121 XEOTICID XEO01779 MOACRIVE Inhibition DME1121 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1121 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01810 XEO_CLAS Peptide DME1121 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.0 microM) DME1121 XEOTICID XEO01810 GENEFORM Protein DME1121 XEOTICID XEO01810 MOACRIVE Inhibition DME1121 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1121 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01811 XEO_CLAS Peptide DME1121 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 microM) DME1121 XEOTICID XEO01811 GENEFORM Protein DME1121 XEOTICID XEO01811 MOACRIVE Inhibition DME1121 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1121 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01812 XEO_CLAS Peptide DME1121 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10.4 microM) DME1121 XEOTICID XEO01812 GENEFORM Protein DME1121 XEOTICID XEO01812 MOACRIVE Inhibition DME1121 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1121 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01813 XEO_CLAS Peptide DME1121 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.1 microM) DME1121 XEOTICID XEO01813 GENEFORM Protein DME1121 XEOTICID XEO01813 MOACRIVE Inhibition DME1121 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1121 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01814 XEO_CLAS Peptide DME1121 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.5 microM) DME1121 XEOTICID XEO01814 GENEFORM Protein DME1121 XEOTICID XEO01814 MOACRIVE Inhibition DME1121 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1121 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01815 XEO_CLAS Peptide DME1121 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 9.8 microM) DME1121 XEOTICID XEO01815 GENEFORM Protein DME1121 XEOTICID XEO01815 MOACRIVE Inhibition DME1121 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1121 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01816 XEO_CLAS Peptide DME1121 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO01816 GENEFORM Protein DME1121 XEOTICID XEO01816 MOACRIVE Inhibition DME1121 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1121 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01817 XEO_CLAS Peptide DME1121 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.0 microM) DME1121 XEOTICID XEO01817 GENEFORM Protein DME1121 XEOTICID XEO01817 MOACRIVE Inhibition DME1121 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1121 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01818 XEO_CLAS Peptide DME1121 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4.0 microM) DME1121 XEOTICID XEO01818 GENEFORM Protein DME1121 XEOTICID XEO01818 MOACRIVE Inhibition DME1121 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1121 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01819 XEO_CLAS Peptide DME1121 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO01819 GENEFORM Protein DME1121 XEOTICID XEO01819 MOACRIVE Inhibition DME1121 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1121 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01820 XEO_CLAS Peptide DME1121 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO01820 GENEFORM Protein DME1121 XEOTICID XEO01820 MOACRIVE Inhibition DME1121 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1121 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01821 XEO_CLAS Peptide DME1121 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO01821 GENEFORM Protein DME1121 XEOTICID XEO01821 MOACRIVE Inhibition DME1121 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1121 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01822 XEO_CLAS Peptide DME1121 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 microM) DME1121 XEOTICID XEO01822 GENEFORM Protein DME1121 XEOTICID XEO01822 MOACRIVE Inhibition DME1121 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1121 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01823 XEO_CLAS Peptide DME1121 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO01823 GENEFORM Protein DME1121 XEOTICID XEO01823 MOACRIVE Inhibition DME1121 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1121 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01824 XEO_CLAS Peptide DME1121 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO01824 GENEFORM Protein DME1121 XEOTICID XEO01824 MOACRIVE Inhibition DME1121 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1121 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01825 XEO_CLAS Peptide DME1121 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25.0 microM) DME1121 XEOTICID XEO01825 GENEFORM Protein DME1121 XEOTICID XEO01825 MOACRIVE Inhibition DME1121 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1121 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01827 XEO_CLAS Peptide DME1121 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.12-6.25 microM) DME1121 XEOTICID XEO01827 GENEFORM Protein DME1121 XEOTICID XEO01827 MOACRIVE Inhibition DME1121 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1121 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1121 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1121 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01829 GENEFORM Protein DME1121 XEOTICID XEO01829 MOACRIVE Inhibition DME1121 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1121 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01927 XEO_CLAS Peptide DME1121 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 ug/ml) DME1121 XEOTICID XEO01927 GENEFORM Protein DME1121 XEOTICID XEO01927 MOACRIVE Inhibition DME1121 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1121 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01945 XEO_CLAS Peptide DME1121 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.1 microM) DME1121 XEOTICID XEO01945 GENEFORM Protein DME1121 XEOTICID XEO01945 MOACRIVE Inhibition DME1121 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1121 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01946 XEO_CLAS Peptide DME1121 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.2 microM) DME1121 XEOTICID XEO01946 GENEFORM Protein DME1121 XEOTICID XEO01946 MOACRIVE Inhibition DME1121 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1121 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO01947 XEO_CLAS Natural Product DME1121 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01947 GENEFORM Protein DME1121 XEOTICID XEO01947 MOACRIVE Inhibition DME1121 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1121 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1121 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1121 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01950 GENEFORM Protein DME1121 XEOTICID XEO01950 MOACRIVE Inhibition DME1121 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1121 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1121 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1121 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01961 GENEFORM Protein DME1121 XEOTICID XEO01961 MOACRIVE Inhibition DME1121 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1121 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1121 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1121 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO01966 GENEFORM Protein DME1121 XEOTICID XEO01966 MOACRIVE Inhibition DME1121 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1121 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01996 XEO_CLAS Peptide DME1121 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.7 microM) DME1121 XEOTICID XEO01996 GENEFORM Protein DME1121 XEOTICID XEO01996 MOACRIVE Inhibition DME1121 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1121 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01997 XEO_CLAS Peptide DME1121 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.9 microM) DME1121 XEOTICID XEO01997 GENEFORM Protein DME1121 XEOTICID XEO01997 MOACRIVE Inhibition DME1121 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1121 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01998 XEO_CLAS Peptide DME1121 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO01998 GENEFORM Protein DME1121 XEOTICID XEO01998 MOACRIVE Inhibition DME1121 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1121 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO01999 XEO_CLAS Peptide DME1121 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.5 microM) DME1121 XEOTICID XEO01999 GENEFORM Protein DME1121 XEOTICID XEO01999 MOACRIVE Inhibition DME1121 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1121 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02013 XEO_CLAS Peptide DME1121 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02013 GENEFORM Protein DME1121 XEOTICID XEO02013 MOACRIVE Inhibition DME1121 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1121 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02032 XEO_CLAS Natural Product DME1121 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02032 GENEFORM Protein DME1121 XEOTICID XEO02032 MOACRIVE Inhibition DME1121 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1121 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02033 XEO_CLAS Natural Product DME1121 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02033 GENEFORM Protein DME1121 XEOTICID XEO02033 MOACRIVE Inhibition DME1121 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1121 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02079 XEO_CLAS Natural Product DME1121 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02079 GENEFORM Protein DME1121 XEOTICID XEO02079 MOACRIVE Inhibition DME1121 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1121 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1121 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02085 GENEFORM Protein DME1121 XEOTICID XEO02085 MOACRIVE Inhibition DME1121 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1121 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02111 XEO_CLAS Peptide DME1121 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2-4 ug/ml) DME1121 XEOTICID XEO02111 GENEFORM Protein DME1121 XEOTICID XEO02111 MOACRIVE Inhibition DME1121 XEOTICID XEO02113 XEO_NAME Abaecin DME1121 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02113 XEO_CLAS Peptide DME1121 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02113 GENEFORM Protein DME1121 XEOTICID XEO02113 MOACRIVE Inhibition DME1121 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1121 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02114 XEO_CLAS Peptide DME1121 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-25 ug/ml) DME1121 XEOTICID XEO02114 GENEFORM Protein DME1121 XEOTICID XEO02114 MOACRIVE Inhibition DME1121 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1121 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02115 XEO_CLAS Peptide DME1121 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02115 GENEFORM Protein DME1121 XEOTICID XEO02115 MOACRIVE Inhibition DME1121 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1121 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02117 XEO_CLAS Peptide DME1121 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02117 GENEFORM Protein DME1121 XEOTICID XEO02117 MOACRIVE Inhibition DME1121 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1121 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02118 XEO_CLAS Peptide DME1121 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02118 GENEFORM Protein DME1121 XEOTICID XEO02118 MOACRIVE Inhibition DME1121 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1121 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02119 XEO_CLAS Peptide DME1121 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02119 GENEFORM Protein DME1121 XEOTICID XEO02119 MOACRIVE Inhibition DME1121 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1121 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02120 XEO_CLAS Peptide DME1121 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02120 GENEFORM Protein DME1121 XEOTICID XEO02120 MOACRIVE Inhibition DME1121 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1121 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02121 XEO_CLAS Peptide DME1121 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02121 GENEFORM Protein DME1121 XEOTICID XEO02121 MOACRIVE Inhibition DME1121 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1121 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02122 XEO_CLAS Peptide DME1121 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 ug/ml) DME1121 XEOTICID XEO02122 GENEFORM Protein DME1121 XEOTICID XEO02122 MOACRIVE Inhibition DME1121 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1121 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02130 XEO_CLAS Peptide DME1121 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.7 microM) DME1121 XEOTICID XEO02130 GENEFORM Protein DME1121 XEOTICID XEO02130 MOACRIVE Inhibition DME1121 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1121 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02131 XEO_CLAS Peptide DME1121 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.3 microM) DME1121 XEOTICID XEO02131 GENEFORM Protein DME1121 XEOTICID XEO02131 MOACRIVE Inhibition DME1121 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1121 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02132 XEO_CLAS Peptide DME1121 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.5 microM) DME1121 XEOTICID XEO02132 GENEFORM Protein DME1121 XEOTICID XEO02132 MOACRIVE Inhibition DME1121 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1121 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02136 XEO_CLAS Peptide DME1121 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 ug/ml) DME1121 XEOTICID XEO02136 GENEFORM Protein DME1121 XEOTICID XEO02136 MOACRIVE Inhibition DME1121 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1121 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02147 XEO_CLAS Peptide DME1121 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 382 ug/ml) DME1121 XEOTICID XEO02147 GENEFORM Protein DME1121 XEOTICID XEO02147 MOACRIVE Inhibition DME1121 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1121 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02149 XEO_CLAS Peptide DME1121 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 47.35 microM) DME1121 XEOTICID XEO02149 GENEFORM Protein DME1121 XEOTICID XEO02149 MOACRIVE Inhibition DME1121 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1121 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02164 XEO_CLAS Peptide DME1121 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02164 GENEFORM Protein DME1121 XEOTICID XEO02164 MOACRIVE Inhibition DME1121 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1121 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02165 XEO_CLAS Peptide DME1121 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02165 GENEFORM Protein DME1121 XEOTICID XEO02165 MOACRIVE Inhibition DME1121 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1121 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02166 XEO_CLAS Peptide DME1121 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02166 GENEFORM Protein DME1121 XEOTICID XEO02166 MOACRIVE Inhibition DME1121 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1121 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02167 XEO_CLAS Peptide DME1121 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02167 GENEFORM Protein DME1121 XEOTICID XEO02167 MOACRIVE Inhibition DME1121 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1121 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02168 XEO_CLAS Peptide DME1121 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02168 GENEFORM Protein DME1121 XEOTICID XEO02168 MOACRIVE Inhibition DME1121 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1121 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02169 XEO_CLAS Peptide DME1121 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02169 GENEFORM Protein DME1121 XEOTICID XEO02169 MOACRIVE Inhibition DME1121 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1121 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02170 XEO_CLAS Peptide DME1121 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.4 microM) DME1121 XEOTICID XEO02170 GENEFORM Protein DME1121 XEOTICID XEO02170 MOACRIVE Inhibition DME1121 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1121 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02175 XEO_CLAS Natural Product DME1121 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02175 GENEFORM Protein DME1121 XEOTICID XEO02175 MOACRIVE Inhibition DME1121 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1121 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02177 XEO_CLAS Peptide DME1121 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO02177 GENEFORM Protein DME1121 XEOTICID XEO02177 MOACRIVE Inhibition DME1121 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1121 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02178 XEO_CLAS Peptide DME1121 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO02178 GENEFORM Protein DME1121 XEOTICID XEO02178 MOACRIVE Inhibition DME1121 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1121 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02179 XEO_CLAS Peptide DME1121 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO02179 GENEFORM Protein DME1121 XEOTICID XEO02179 MOACRIVE Inhibition DME1121 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1121 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02180 XEO_CLAS Peptide DME1121 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 214 microM) DME1121 XEOTICID XEO02180 GENEFORM Protein DME1121 XEOTICID XEO02180 MOACRIVE Inhibition DME1121 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1121 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02181 XEO_CLAS Peptide DME1121 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 217 microM) DME1121 XEOTICID XEO02181 GENEFORM Protein DME1121 XEOTICID XEO02181 MOACRIVE Inhibition DME1121 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1121 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02183 XEO_CLAS Peptide DME1121 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 38.4 microM) DME1121 XEOTICID XEO02183 GENEFORM Protein DME1121 XEOTICID XEO02183 MOACRIVE Inhibition DME1121 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1121 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02185 XEO_CLAS Peptide DME1121 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 microM) DME1121 XEOTICID XEO02185 GENEFORM Protein DME1121 XEOTICID XEO02185 MOACRIVE Inhibition DME1121 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1121 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02187 GENEFORM Protein DME1121 XEOTICID XEO02187 MOACRIVE Inhibition DME1121 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1121 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02191 XEO_CLAS Peptide DME1121 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02191 GENEFORM Protein DME1121 XEOTICID XEO02191 MOACRIVE Inhibition DME1121 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1121 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02192 XEO_CLAS Peptide DME1121 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.50 ug/ml) DME1121 XEOTICID XEO02192 GENEFORM Protein DME1121 XEOTICID XEO02192 MOACRIVE Inhibition DME1121 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1121 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02193 XEO_CLAS Peptide DME1121 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02193 GENEFORM Protein DME1121 XEOTICID XEO02193 MOACRIVE Inhibition DME1121 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1121 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02194 XEO_CLAS Peptide DME1121 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02194 GENEFORM Protein DME1121 XEOTICID XEO02194 MOACRIVE Inhibition DME1121 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1121 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02195 XEO_CLAS Peptide DME1121 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.00 ug/ml) DME1121 XEOTICID XEO02195 GENEFORM Protein DME1121 XEOTICID XEO02195 MOACRIVE Inhibition DME1121 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1121 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02197 XEO_CLAS Peptide DME1121 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02197 GENEFORM Protein DME1121 XEOTICID XEO02197 MOACRIVE Inhibition DME1121 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1121 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02200 XEO_CLAS Peptide DME1121 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 ug/ml) DME1121 XEOTICID XEO02200 GENEFORM Protein DME1121 XEOTICID XEO02200 MOACRIVE Inhibition DME1121 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1121 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02201 XEO_CLAS Peptide DME1121 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 ug/ml) DME1121 XEOTICID XEO02201 GENEFORM Protein DME1121 XEOTICID XEO02201 MOACRIVE Inhibition DME1121 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1121 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02202 XEO_CLAS Peptide DME1121 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO02202 GENEFORM Protein DME1121 XEOTICID XEO02202 MOACRIVE Inhibition DME1121 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1121 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02203 XEO_CLAS Peptide DME1121 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 microM) DME1121 XEOTICID XEO02203 GENEFORM Protein DME1121 XEOTICID XEO02203 MOACRIVE Inhibition DME1121 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1121 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02207 XEO_CLAS Peptide DME1121 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.78 ug/ml) DME1121 XEOTICID XEO02207 GENEFORM Protein DME1121 XEOTICID XEO02207 MOACRIVE Inhibition DME1121 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1121 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02208 XEO_CLAS Peptide DME1121 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.13 ug/ml) DME1121 XEOTICID XEO02208 GENEFORM Protein DME1121 XEOTICID XEO02208 MOACRIVE Inhibition DME1121 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1121 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02209 XEO_CLAS Peptide DME1121 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.56 ug/ml) DME1121 XEOTICID XEO02209 GENEFORM Protein DME1121 XEOTICID XEO02209 MOACRIVE Inhibition DME1121 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1121 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02210 XEO_CLAS Peptide DME1121 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 ug/ml) DME1121 XEOTICID XEO02210 GENEFORM Protein DME1121 XEOTICID XEO02210 MOACRIVE Inhibition DME1121 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1121 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02211 XEO_CLAS Peptide DME1121 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25 ug/ml) DME1121 XEOTICID XEO02211 GENEFORM Protein DME1121 XEOTICID XEO02211 MOACRIVE Inhibition DME1121 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1121 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02212 XEO_CLAS Peptide DME1121 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.13 ug/ml) DME1121 XEOTICID XEO02212 GENEFORM Protein DME1121 XEOTICID XEO02212 MOACRIVE Inhibition DME1121 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1121 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02213 XEO_CLAS Peptide DME1121 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.13 ug/ml) DME1121 XEOTICID XEO02213 GENEFORM Protein DME1121 XEOTICID XEO02213 MOACRIVE Inhibition DME1121 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1121 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02214 XEO_CLAS Peptide DME1121 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02214 GENEFORM Protein DME1121 XEOTICID XEO02214 MOACRIVE Inhibition DME1121 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1121 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02215 XEO_CLAS Peptide DME1121 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 ug/ml) DME1121 XEOTICID XEO02215 GENEFORM Protein DME1121 XEOTICID XEO02215 MOACRIVE Inhibition DME1121 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1121 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02216 XEO_CLAS Peptide DME1121 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 126 ug/ml) DME1121 XEOTICID XEO02216 GENEFORM Protein DME1121 XEOTICID XEO02216 MOACRIVE Inhibition DME1121 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1121 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02217 XEO_CLAS Peptide DME1121 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 200 ug/ml) DME1121 XEOTICID XEO02217 GENEFORM Protein DME1121 XEOTICID XEO02217 MOACRIVE Inhibition DME1121 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1121 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02218 XEO_CLAS Peptide DME1121 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 200 ug/ml) DME1121 XEOTICID XEO02218 GENEFORM Protein DME1121 XEOTICID XEO02218 MOACRIVE Inhibition DME1121 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1121 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02219 XEO_CLAS Peptide DME1121 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 200 ug/ml) DME1121 XEOTICID XEO02219 GENEFORM Protein DME1121 XEOTICID XEO02219 MOACRIVE Inhibition DME1121 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1121 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02220 XEO_CLAS Peptide DME1121 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 23.5 ug/ml) DME1121 XEOTICID XEO02220 GENEFORM Protein DME1121 XEOTICID XEO02220 MOACRIVE Inhibition DME1121 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1121 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02221 XEO_CLAS Peptide DME1121 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20.2 ug/ml) DME1121 XEOTICID XEO02221 GENEFORM Protein DME1121 XEOTICID XEO02221 MOACRIVE Inhibition DME1121 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1121 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02222 XEO_CLAS Peptide DME1121 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30.5 ug/ml) DME1121 XEOTICID XEO02222 GENEFORM Protein DME1121 XEOTICID XEO02222 MOACRIVE Inhibition DME1121 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1121 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02223 XEO_CLAS Peptide DME1121 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.2 ug/ml) DME1121 XEOTICID XEO02223 GENEFORM Protein DME1121 XEOTICID XEO02223 MOACRIVE Inhibition DME1121 XEOTICID XEO02224 XEO_NAME Androctonin DME1121 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02224 XEO_CLAS Peptide DME1121 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02224 GENEFORM Protein DME1121 XEOTICID XEO02224 MOACRIVE Inhibition DME1121 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1121 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02225 XEO_CLAS Peptide DME1121 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02225 GENEFORM Protein DME1121 XEOTICID XEO02225 MOACRIVE Inhibition DME1121 XEOTICID XEO02226 XEO_NAME Andropin DME1121 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02226 XEO_CLAS Peptide DME1121 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 140 microM) DME1121 XEOTICID XEO02226 GENEFORM Protein DME1121 XEOTICID XEO02226 MOACRIVE Inhibition DME1121 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1121 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02230 XEO_CLAS Peptide DME1121 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.05-0.1 microM) DME1121 XEOTICID XEO02230 GENEFORM Protein DME1121 XEOTICID XEO02230 MOACRIVE Inhibition DME1121 XEOTICID XEO02232 XEO_NAME Anoplin DME1121 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02232 XEO_CLAS Peptide DME1121 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 13 ug/ml) DME1121 XEOTICID XEO02232 GENEFORM Protein DME1121 XEOTICID XEO02232 MOACRIVE Inhibition DME1121 XEOTICID XEO02233 XEO_NAME Antapin DME1121 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02233 XEO_CLAS Peptide DME1121 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02233 GENEFORM Protein DME1121 XEOTICID XEO02233 MOACRIVE Inhibition DME1121 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1121 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02236 XEO_CLAS Peptide DME1121 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02236 GENEFORM Protein DME1121 XEOTICID XEO02236 MOACRIVE Inhibition DME1121 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1121 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02239 XEO_CLAS Peptide DME1121 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 250 microM) DME1121 XEOTICID XEO02239 GENEFORM Protein DME1121 XEOTICID XEO02239 MOACRIVE Inhibition DME1121 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1121 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02240 XEO_CLAS Peptide DME1121 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 microM) DME1121 XEOTICID XEO02240 GENEFORM Protein DME1121 XEOTICID XEO02240 MOACRIVE Inhibition DME1121 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1121 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02241 XEO_CLAS Peptide DME1121 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02241 GENEFORM Protein DME1121 XEOTICID XEO02241 MOACRIVE Inhibition DME1121 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1121 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02242 XEO_CLAS Peptide DME1121 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO02242 GENEFORM Protein DME1121 XEOTICID XEO02242 MOACRIVE Inhibition DME1121 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1121 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02243 XEO_CLAS Peptide DME1121 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 microM) DME1121 XEOTICID XEO02243 GENEFORM Protein DME1121 XEOTICID XEO02243 MOACRIVE Inhibition DME1121 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1121 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02244 XEO_CLAS Peptide DME1121 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1 microM) DME1121 XEOTICID XEO02244 GENEFORM Protein DME1121 XEOTICID XEO02244 MOACRIVE Inhibition DME1121 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1121 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02245 XEO_CLAS Peptide DME1121 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02245 GENEFORM Protein DME1121 XEOTICID XEO02245 MOACRIVE Inhibition DME1121 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1121 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02246 XEO_CLAS Peptide DME1121 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 microM) DME1121 XEOTICID XEO02246 GENEFORM Protein DME1121 XEOTICID XEO02246 MOACRIVE Inhibition DME1121 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1121 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02247 XEO_CLAS Peptide DME1121 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02247 GENEFORM Protein DME1121 XEOTICID XEO02247 MOACRIVE Inhibition DME1121 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1121 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02248 XEO_CLAS Peptide DME1121 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.3 microM) DME1121 XEOTICID XEO02248 GENEFORM Protein DME1121 XEOTICID XEO02248 MOACRIVE Inhibition DME1121 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1121 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02253 XEO_CLAS Peptide DME1121 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02253 GENEFORM Protein DME1121 XEOTICID XEO02253 MOACRIVE Inhibition DME1121 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1121 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02258 XEO_CLAS Peptide DME1121 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 150 microM) DME1121 XEOTICID XEO02258 GENEFORM Protein DME1121 XEOTICID XEO02258 MOACRIVE Inhibition DME1121 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1121 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02261 XEO_CLAS Peptide DME1121 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 82 ug/ml) DME1121 XEOTICID XEO02261 GENEFORM Protein DME1121 XEOTICID XEO02261 MOACRIVE Inhibition DME1121 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1121 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02263 XEO_CLAS Peptide DME1121 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO02263 GENEFORM Protein DME1121 XEOTICID XEO02263 MOACRIVE Inhibition DME1121 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1121 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02266 XEO_CLAS Peptide DME1121 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 120 microM) DME1121 XEOTICID XEO02266 GENEFORM Protein DME1121 XEOTICID XEO02266 MOACRIVE Inhibition DME1121 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1121 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02268 XEO_CLAS Peptide DME1121 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 170 ug/ml) DME1121 XEOTICID XEO02268 GENEFORM Protein DME1121 XEOTICID XEO02268 MOACRIVE Inhibition DME1121 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1121 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02270 XEO_CLAS Peptide DME1121 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 microM) DME1121 XEOTICID XEO02270 GENEFORM Protein DME1121 XEOTICID XEO02270 MOACRIVE Inhibition DME1121 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1121 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02271 XEO_CLAS Peptide DME1121 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 302 ug/ml) DME1121 XEOTICID XEO02271 GENEFORM Protein DME1121 XEOTICID XEO02271 MOACRIVE Inhibition DME1121 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1121 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02273 XEO_CLAS Peptide DME1121 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 18 microM) DME1121 XEOTICID XEO02273 GENEFORM Protein DME1121 XEOTICID XEO02273 MOACRIVE Inhibition DME1121 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1121 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02274 XEO_CLAS Peptide DME1121 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO02274 GENEFORM Protein DME1121 XEOTICID XEO02274 MOACRIVE Inhibition DME1121 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1121 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02275 XEO_CLAS Peptide DME1121 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 microM) DME1121 XEOTICID XEO02275 GENEFORM Protein DME1121 XEOTICID XEO02275 MOACRIVE Inhibition DME1121 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1121 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02276 XEO_CLAS Peptide DME1121 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 microM) DME1121 XEOTICID XEO02276 GENEFORM Protein DME1121 XEOTICID XEO02276 MOACRIVE Inhibition DME1121 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1121 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02280 XEO_CLAS Peptide DME1121 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02280 GENEFORM Protein DME1121 XEOTICID XEO02280 MOACRIVE Inhibition DME1121 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1121 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02281 XEO_CLAS Peptide DME1121 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02281 GENEFORM Protein DME1121 XEOTICID XEO02281 MOACRIVE Inhibition DME1121 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1121 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02283 XEO_CLAS Peptide DME1121 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 ug/ml) DME1121 XEOTICID XEO02283 GENEFORM Protein DME1121 XEOTICID XEO02283 MOACRIVE Inhibition DME1121 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1121 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02284 XEO_CLAS Peptide DME1121 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50.4 microM) DME1121 XEOTICID XEO02284 GENEFORM Protein DME1121 XEOTICID XEO02284 MOACRIVE Inhibition DME1121 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1121 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02285 XEO_CLAS Peptide DME1121 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50.4 microM) DME1121 XEOTICID XEO02285 GENEFORM Protein DME1121 XEOTICID XEO02285 MOACRIVE Inhibition DME1121 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1121 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02286 XEO_CLAS Peptide DME1121 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50.4 microM) DME1121 XEOTICID XEO02286 GENEFORM Protein DME1121 XEOTICID XEO02286 MOACRIVE Inhibition DME1121 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1121 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02287 XEO_CLAS Peptide DME1121 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50.4 microM) DME1121 XEOTICID XEO02287 GENEFORM Protein DME1121 XEOTICID XEO02287 MOACRIVE Inhibition DME1121 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1121 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02288 XEO_CLAS Peptide DME1121 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.2 ug/ml) DME1121 XEOTICID XEO02288 GENEFORM Protein DME1121 XEOTICID XEO02288 MOACRIVE Inhibition DME1121 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1121 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02289 XEO_CLAS Peptide DME1121 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 ug/ml) DME1121 XEOTICID XEO02289 GENEFORM Protein DME1121 XEOTICID XEO02289 MOACRIVE Inhibition DME1121 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1121 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02290 XEO_CLAS Peptide DME1121 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO02290 GENEFORM Protein DME1121 XEOTICID XEO02290 MOACRIVE Inhibition DME1121 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1121 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02291 XEO_CLAS Peptide DME1121 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02291 GENEFORM Protein DME1121 XEOTICID XEO02291 MOACRIVE Inhibition DME1121 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1121 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02293 XEO_CLAS Peptide DME1121 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 microM) DME1121 XEOTICID XEO02293 GENEFORM Protein DME1121 XEOTICID XEO02293 MOACRIVE Inhibition DME1121 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1121 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02294 XEO_CLAS Peptide DME1121 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 62-250 ug/ml) DME1121 XEOTICID XEO02294 GENEFORM Protein DME1121 XEOTICID XEO02294 MOACRIVE Inhibition DME1121 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1121 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02295 XEO_CLAS Peptide DME1121 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 ug/ml) DME1121 XEOTICID XEO02295 GENEFORM Protein DME1121 XEOTICID XEO02295 MOACRIVE Inhibition DME1121 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1121 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02296 XEO_CLAS Peptide DME1121 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02296 GENEFORM Protein DME1121 XEOTICID XEO02296 MOACRIVE Inhibition DME1121 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1121 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02297 XEO_CLAS Peptide DME1121 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC < 50 ug/ml) DME1121 XEOTICID XEO02297 GENEFORM Protein DME1121 XEOTICID XEO02297 MOACRIVE Inhibition DME1121 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1121 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02298 XEO_CLAS Peptide DME1121 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO02298 GENEFORM Protein DME1121 XEOTICID XEO02298 MOACRIVE Inhibition DME1121 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1121 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02303 XEO_CLAS Peptide DME1121 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02303 GENEFORM Protein DME1121 XEOTICID XEO02303 MOACRIVE Inhibition DME1121 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1121 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02304 XEO_CLAS Peptide DME1121 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.1 ug/ml) DME1121 XEOTICID XEO02304 GENEFORM Protein DME1121 XEOTICID XEO02304 MOACRIVE Inhibition DME1121 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1121 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02305 XEO_CLAS Peptide DME1121 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC <= 1 ug/ml) DME1121 XEOTICID XEO02305 GENEFORM Protein DME1121 XEOTICID XEO02305 MOACRIVE Inhibition DME1121 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1121 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02306 XEO_CLAS Peptide DME1121 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.2 ug/ml) DME1121 XEOTICID XEO02306 GENEFORM Protein DME1121 XEOTICID XEO02306 MOACRIVE Inhibition DME1121 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1121 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02309 XEO_CLAS Peptide DME1121 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02309 GENEFORM Protein DME1121 XEOTICID XEO02309 MOACRIVE Inhibition DME1121 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1121 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02310 XEO_CLAS Peptide DME1121 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02310 GENEFORM Protein DME1121 XEOTICID XEO02310 MOACRIVE Inhibition DME1121 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1121 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02315 XEO_CLAS Peptide DME1121 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO02315 GENEFORM Protein DME1121 XEOTICID XEO02315 MOACRIVE Inhibition DME1121 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1121 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02316 XEO_CLAS Peptide DME1121 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 50 microM) DME1121 XEOTICID XEO02316 GENEFORM Protein DME1121 XEOTICID XEO02316 MOACRIVE Inhibition DME1121 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1121 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02317 XEO_CLAS Peptide DME1121 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 300 microM) DME1121 XEOTICID XEO02317 GENEFORM Protein DME1121 XEOTICID XEO02317 MOACRIVE Inhibition DME1121 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1121 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02318 XEO_CLAS Peptide DME1121 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02318 GENEFORM Protein DME1121 XEOTICID XEO02318 MOACRIVE Inhibition DME1121 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1121 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02319 XEO_CLAS Peptide DME1121 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02319 GENEFORM Protein DME1121 XEOTICID XEO02319 MOACRIVE Inhibition DME1121 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1121 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02320 XEO_CLAS Peptide DME1121 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02320 GENEFORM Protein DME1121 XEOTICID XEO02320 MOACRIVE Inhibition DME1121 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1121 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02321 XEO_CLAS Peptide DME1121 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO02321 GENEFORM Protein DME1121 XEOTICID XEO02321 MOACRIVE Inhibition DME1121 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1121 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02322 XEO_CLAS Peptide DME1121 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02322 GENEFORM Protein DME1121 XEOTICID XEO02322 MOACRIVE Inhibition DME1121 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1121 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02323 XEO_CLAS Peptide DME1121 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO02323 GENEFORM Protein DME1121 XEOTICID XEO02323 MOACRIVE Inhibition DME1121 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1121 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02324 XEO_CLAS Peptide DME1121 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02324 GENEFORM Protein DME1121 XEOTICID XEO02324 MOACRIVE Inhibition DME1121 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1121 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02325 XEO_CLAS Peptide DME1121 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO02325 GENEFORM Protein DME1121 XEOTICID XEO02325 MOACRIVE Inhibition DME1121 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1121 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02326 XEO_CLAS Peptide DME1121 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02326 GENEFORM Protein DME1121 XEOTICID XEO02326 MOACRIVE Inhibition DME1121 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1121 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02327 XEO_CLAS Peptide DME1121 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO02327 GENEFORM Protein DME1121 XEOTICID XEO02327 MOACRIVE Inhibition DME1121 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1121 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02328 XEO_CLAS Peptide DME1121 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO02328 GENEFORM Protein DME1121 XEOTICID XEO02328 MOACRIVE Inhibition DME1121 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1121 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02332 XEO_CLAS Peptide DME1121 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.9 ug/ml) DME1121 XEOTICID XEO02332 GENEFORM Protein DME1121 XEOTICID XEO02332 MOACRIVE Inhibition DME1121 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1121 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02333 XEO_CLAS Peptide DME1121 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 200 microM) DME1121 XEOTICID XEO02333 GENEFORM Protein DME1121 XEOTICID XEO02333 MOACRIVE Inhibition DME1121 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1121 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02336 XEO_CLAS Peptide DME1121 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 microM) DME1121 XEOTICID XEO02336 GENEFORM Protein DME1121 XEOTICID XEO02336 MOACRIVE Inhibition DME1121 XEOTICID XEO02346 XEO_NAME Aurelin DME1121 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02346 XEO_CLAS Peptide DME1121 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 7.66 ug/ml) DME1121 XEOTICID XEO02346 GENEFORM Protein DME1121 XEOTICID XEO02346 MOACRIVE Inhibition DME1121 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1121 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02352 XEO_CLAS Peptide DME1121 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 11 ug/ml) DME1121 XEOTICID XEO02352 GENEFORM Protein DME1121 XEOTICID XEO02352 MOACRIVE Inhibition DME1121 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1121 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02353 XEO_CLAS Peptide DME1121 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 ug/ml) DME1121 XEOTICID XEO02353 GENEFORM Protein DME1121 XEOTICID XEO02353 MOACRIVE Inhibition DME1121 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1121 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02354 XEO_CLAS Peptide DME1121 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 ug/ml) DME1121 XEOTICID XEO02354 GENEFORM Protein DME1121 XEOTICID XEO02354 MOACRIVE Inhibition DME1121 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1121 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02355 XEO_CLAS Peptide DME1121 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 17 ug/ml) DME1121 XEOTICID XEO02355 GENEFORM Protein DME1121 XEOTICID XEO02355 MOACRIVE Inhibition DME1121 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1121 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02356 XEO_CLAS Peptide DME1121 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO02356 GENEFORM Protein DME1121 XEOTICID XEO02356 MOACRIVE Inhibition DME1121 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1121 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02357 XEO_CLAS Peptide DME1121 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO02357 GENEFORM Protein DME1121 XEOTICID XEO02357 MOACRIVE Inhibition DME1121 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1121 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02358 XEO_CLAS Peptide DME1121 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO02358 GENEFORM Protein DME1121 XEOTICID XEO02358 MOACRIVE Inhibition DME1121 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1121 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02360 XEO_CLAS Peptide DME1121 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02360 GENEFORM Protein DME1121 XEOTICID XEO02360 MOACRIVE Inhibition DME1121 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1121 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02361 XEO_CLAS Peptide DME1121 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 ug/ml) DME1121 XEOTICID XEO02361 GENEFORM Protein DME1121 XEOTICID XEO02361 MOACRIVE Inhibition DME1121 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1121 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02365 XEO_CLAS Peptide DME1121 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 32 ug/ml) DME1121 XEOTICID XEO02365 GENEFORM Protein DME1121 XEOTICID XEO02365 MOACRIVE Inhibition DME1121 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1121 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02366 XEO_CLAS Peptide DME1121 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO02366 GENEFORM Protein DME1121 XEOTICID XEO02366 MOACRIVE Inhibition DME1121 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1121 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02367 XEO_CLAS Peptide DME1121 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02367 GENEFORM Protein DME1121 XEOTICID XEO02367 MOACRIVE Inhibition DME1121 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1121 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02368 XEO_CLAS Peptide DME1121 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02368 GENEFORM Protein DME1121 XEOTICID XEO02368 MOACRIVE Inhibition DME1121 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1121 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02369 XEO_CLAS Peptide DME1121 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02369 GENEFORM Protein DME1121 XEOTICID XEO02369 MOACRIVE Inhibition DME1121 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1121 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02370 XEO_CLAS Peptide DME1121 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02370 GENEFORM Protein DME1121 XEOTICID XEO02370 MOACRIVE Inhibition DME1121 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1121 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02371 XEO_CLAS Peptide DME1121 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 ug/ml) DME1121 XEOTICID XEO02371 GENEFORM Protein DME1121 XEOTICID XEO02371 MOACRIVE Inhibition DME1121 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1121 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02374 XEO_CLAS Peptide DME1121 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02374 GENEFORM Protein DME1121 XEOTICID XEO02374 MOACRIVE Inhibition DME1121 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1121 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02376 XEO_CLAS Peptide DME1121 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02376 GENEFORM Protein DME1121 XEOTICID XEO02376 MOACRIVE Inhibition DME1121 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1121 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02378 XEO_CLAS Peptide DME1121 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.19 ug/ml) DME1121 XEOTICID XEO02378 GENEFORM Protein DME1121 XEOTICID XEO02378 MOACRIVE Inhibition DME1121 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1121 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02388 XEO_CLAS Peptide DME1121 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO02388 GENEFORM Protein DME1121 XEOTICID XEO02388 MOACRIVE Inhibition DME1121 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1121 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02389 XEO_CLAS Peptide DME1121 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02389 GENEFORM Protein DME1121 XEOTICID XEO02389 MOACRIVE Inhibition DME1121 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1121 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02415 XEO_CLAS Peptide DME1121 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02415 GENEFORM Protein DME1121 XEOTICID XEO02415 MOACRIVE Inhibition DME1121 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1121 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02416 XEO_CLAS Peptide DME1121 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 11 microM) DME1121 XEOTICID XEO02416 GENEFORM Protein DME1121 XEOTICID XEO02416 MOACRIVE Inhibition DME1121 XEOTICID XEO02419 XEO_NAME Bay oil DME1121 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1121 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02419 GENEFORM Protein DME1121 XEOTICID XEO02419 MOACRIVE Inhibition DME1121 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1121 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02435 XEO_CLAS Peptide DME1121 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02435 GENEFORM Protein DME1121 XEOTICID XEO02435 MOACRIVE Inhibition DME1121 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1121 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02436 XEO_CLAS Peptide DME1121 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02436 GENEFORM Protein DME1121 XEOTICID XEO02436 MOACRIVE Inhibition DME1121 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1121 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02437 XEO_CLAS Peptide DME1121 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02437 GENEFORM Protein DME1121 XEOTICID XEO02437 MOACRIVE Inhibition DME1121 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1121 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02438 XEO_CLAS Peptide DME1121 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02438 GENEFORM Protein DME1121 XEOTICID XEO02438 MOACRIVE Inhibition DME1121 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1121 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02439 XEO_CLAS Peptide DME1121 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02439 GENEFORM Protein DME1121 XEOTICID XEO02439 MOACRIVE Inhibition DME1121 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1121 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02440 XEO_CLAS Peptide DME1121 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02440 GENEFORM Protein DME1121 XEOTICID XEO02440 MOACRIVE Inhibition DME1121 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1121 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02441 XEO_CLAS Peptide DME1121 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02441 GENEFORM Protein DME1121 XEOTICID XEO02441 MOACRIVE Inhibition DME1121 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1121 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02442 XEO_CLAS Peptide DME1121 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO02442 GENEFORM Protein DME1121 XEOTICID XEO02442 MOACRIVE Inhibition DME1121 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1121 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02443 XEO_CLAS Peptide DME1121 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02443 GENEFORM Protein DME1121 XEOTICID XEO02443 MOACRIVE Inhibition DME1121 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1121 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02444 XEO_CLAS Peptide DME1121 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02444 GENEFORM Protein DME1121 XEOTICID XEO02444 MOACRIVE Inhibition DME1121 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1121 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1121 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02447 GENEFORM Protein DME1121 XEOTICID XEO02447 MOACRIVE Inhibition DME1121 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1121 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02452 XEO_CLAS Peptide DME1121 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 76800 ug/ml) DME1121 XEOTICID XEO02452 GENEFORM Protein DME1121 XEOTICID XEO02452 MOACRIVE Inhibition DME1121 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1121 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02453 XEO_CLAS Peptide DME1121 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02453 GENEFORM Protein DME1121 XEOTICID XEO02453 MOACRIVE Inhibition DME1121 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1121 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02463 XEO_CLAS Peptide DME1121 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 11.25 microM) DME1121 XEOTICID XEO02463 GENEFORM Protein DME1121 XEOTICID XEO02463 MOACRIVE Inhibition DME1121 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1121 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02466 XEO_CLAS Peptide DME1121 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.5 microM) DME1121 XEOTICID XEO02466 GENEFORM Protein DME1121 XEOTICID XEO02466 MOACRIVE Inhibition DME1121 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1121 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02467 XEO_CLAS Peptide DME1121 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8.4 microM) DME1121 XEOTICID XEO02467 GENEFORM Protein DME1121 XEOTICID XEO02467 MOACRIVE Inhibition DME1121 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1121 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02468 XEO_CLAS Peptide DME1121 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.7 microM) DME1121 XEOTICID XEO02468 GENEFORM Protein DME1121 XEOTICID XEO02468 MOACRIVE Inhibition DME1121 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1121 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02469 XEO_CLAS Peptide DME1121 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO02469 GENEFORM Protein DME1121 XEOTICID XEO02469 MOACRIVE Inhibition DME1121 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1121 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02470 XEO_CLAS Peptide DME1121 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.8 microM) DME1121 XEOTICID XEO02470 GENEFORM Protein DME1121 XEOTICID XEO02470 MOACRIVE Inhibition DME1121 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1121 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02471 XEO_CLAS Peptide DME1121 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4.8 microM) DME1121 XEOTICID XEO02471 GENEFORM Protein DME1121 XEOTICID XEO02471 MOACRIVE Inhibition DME1121 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1121 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02472 XEO_CLAS Peptide DME1121 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.0 microM) DME1121 XEOTICID XEO02472 GENEFORM Protein DME1121 XEOTICID XEO02472 MOACRIVE Inhibition DME1121 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1121 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02473 XEO_CLAS Peptide DME1121 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02473 GENEFORM Protein DME1121 XEOTICID XEO02473 MOACRIVE Inhibition DME1121 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1121 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02474 XEO_CLAS Peptide DME1121 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.5 microM) DME1121 XEOTICID XEO02474 GENEFORM Protein DME1121 XEOTICID XEO02474 MOACRIVE Inhibition DME1121 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1121 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02475 XEO_CLAS Peptide DME1121 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.5 microM) DME1121 XEOTICID XEO02475 GENEFORM Protein DME1121 XEOTICID XEO02475 MOACRIVE Inhibition DME1121 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1121 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02477 XEO_CLAS Peptide DME1121 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-300 ug/ml) DME1121 XEOTICID XEO02477 GENEFORM Protein DME1121 XEOTICID XEO02477 MOACRIVE Inhibition DME1121 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1121 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02478 XEO_CLAS Peptide DME1121 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-300 ug/ml) DME1121 XEOTICID XEO02478 GENEFORM Protein DME1121 XEOTICID XEO02478 MOACRIVE Inhibition DME1121 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1121 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02479 XEO_CLAS Peptide DME1121 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-300 ug/ml) DME1121 XEOTICID XEO02479 GENEFORM Protein DME1121 XEOTICID XEO02479 MOACRIVE Inhibition DME1121 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1121 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02480 XEO_CLAS Peptide DME1121 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-300 ug/ml) DME1121 XEOTICID XEO02480 GENEFORM Protein DME1121 XEOTICID XEO02480 MOACRIVE Inhibition DME1121 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1121 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02481 XEO_CLAS Peptide DME1121 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-300 ug/ml) DME1121 XEOTICID XEO02481 GENEFORM Protein DME1121 XEOTICID XEO02481 MOACRIVE Inhibition DME1121 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1121 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02482 XEO_CLAS Peptide DME1121 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-300 ug/ml) DME1121 XEOTICID XEO02482 GENEFORM Protein DME1121 XEOTICID XEO02482 MOACRIVE Inhibition DME1121 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1121 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02483 XEO_CLAS Peptide DME1121 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-300 ug/ml) DME1121 XEOTICID XEO02483 GENEFORM Protein DME1121 XEOTICID XEO02483 MOACRIVE Inhibition DME1121 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1121 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02484 XEO_CLAS Peptide DME1121 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-300 ug/ml) DME1121 XEOTICID XEO02484 GENEFORM Protein DME1121 XEOTICID XEO02484 MOACRIVE Inhibition DME1121 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1121 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02485 XEO_CLAS Peptide DME1121 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-300 ug/ml) DME1121 XEOTICID XEO02485 GENEFORM Protein DME1121 XEOTICID XEO02485 MOACRIVE Inhibition DME1121 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1121 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02486 XEO_CLAS Peptide DME1121 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-300 ug/ml) DME1121 XEOTICID XEO02486 GENEFORM Protein DME1121 XEOTICID XEO02486 MOACRIVE Inhibition DME1121 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1121 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02487 XEO_CLAS Peptide DME1121 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02487 GENEFORM Protein DME1121 XEOTICID XEO02487 MOACRIVE Inhibition DME1121 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1121 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02488 XEO_CLAS Peptide DME1121 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-300 ug/ml) DME1121 XEOTICID XEO02488 GENEFORM Protein DME1121 XEOTICID XEO02488 MOACRIVE Inhibition DME1121 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1121 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02489 XEO_CLAS Peptide DME1121 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-301 ug/ml) DME1121 XEOTICID XEO02489 GENEFORM Protein DME1121 XEOTICID XEO02489 MOACRIVE Inhibition DME1121 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1121 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02491 XEO_CLAS Peptide DME1121 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.3 microM) DME1121 XEOTICID XEO02491 GENEFORM Protein DME1121 XEOTICID XEO02491 MOACRIVE Inhibition DME1121 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1121 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02492 XEO_CLAS Peptide DME1121 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 ug/ml) DME1121 XEOTICID XEO02492 GENEFORM Protein DME1121 XEOTICID XEO02492 MOACRIVE Inhibition DME1121 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1121 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02493 XEO_CLAS Peptide DME1121 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 ug/ml) DME1121 XEOTICID XEO02493 GENEFORM Protein DME1121 XEOTICID XEO02493 MOACRIVE Inhibition DME1121 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1121 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02494 XEO_CLAS Peptide DME1121 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 ug/ml) DME1121 XEOTICID XEO02494 GENEFORM Protein DME1121 XEOTICID XEO02494 MOACRIVE Inhibition DME1121 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1121 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02495 XEO_CLAS Peptide DME1121 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 34 ug/ml) DME1121 XEOTICID XEO02495 GENEFORM Protein DME1121 XEOTICID XEO02495 MOACRIVE Inhibition DME1121 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1121 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02496 XEO_CLAS Peptide DME1121 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 13 microM) DME1121 XEOTICID XEO02496 GENEFORM Protein DME1121 XEOTICID XEO02496 MOACRIVE Inhibition DME1121 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1121 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02497 XEO_CLAS Peptide DME1121 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO02497 GENEFORM Protein DME1121 XEOTICID XEO02497 MOACRIVE Inhibition DME1121 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1121 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02499 XEO_CLAS Peptide DME1121 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO02499 GENEFORM Protein DME1121 XEOTICID XEO02499 MOACRIVE Inhibition DME1121 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1121 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02501 XEO_CLAS Peptide DME1121 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 7 microM) DME1121 XEOTICID XEO02501 GENEFORM Protein DME1121 XEOTICID XEO02501 MOACRIVE Inhibition DME1121 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1121 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02502 XEO_CLAS Peptide DME1121 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 microM) DME1121 XEOTICID XEO02502 GENEFORM Protein DME1121 XEOTICID XEO02502 MOACRIVE Inhibition DME1121 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1121 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02503 XEO_CLAS Peptide DME1121 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 19 microM) DME1121 XEOTICID XEO02503 GENEFORM Protein DME1121 XEOTICID XEO02503 MOACRIVE Inhibition DME1121 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1121 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02504 XEO_CLAS Peptide DME1121 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02504 GENEFORM Protein DME1121 XEOTICID XEO02504 MOACRIVE Inhibition DME1121 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1121 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02505 XEO_CLAS Peptide DME1121 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO02505 GENEFORM Protein DME1121 XEOTICID XEO02505 MOACRIVE Inhibition DME1121 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1121 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02507 XEO_CLAS Peptide DME1121 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO02507 GENEFORM Protein DME1121 XEOTICID XEO02507 MOACRIVE Inhibition DME1121 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1121 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02508 XEO_CLAS Peptide DME1121 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 150 microM) DME1121 XEOTICID XEO02508 GENEFORM Protein DME1121 XEOTICID XEO02508 MOACRIVE Inhibition DME1121 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1121 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02509 XEO_CLAS Peptide DME1121 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 150 microM) DME1121 XEOTICID XEO02509 GENEFORM Protein DME1121 XEOTICID XEO02509 MOACRIVE Inhibition DME1121 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1121 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02510 XEO_CLAS Peptide DME1121 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 150 microM) DME1121 XEOTICID XEO02510 GENEFORM Protein DME1121 XEOTICID XEO02510 MOACRIVE Inhibition DME1121 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1121 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02511 XEO_CLAS Peptide DME1121 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 150 microM) DME1121 XEOTICID XEO02511 GENEFORM Protein DME1121 XEOTICID XEO02511 MOACRIVE Inhibition DME1121 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1121 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02512 XEO_CLAS Peptide DME1121 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 75 microM) DME1121 XEOTICID XEO02512 GENEFORM Protein DME1121 XEOTICID XEO02512 MOACRIVE Inhibition DME1121 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1121 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02513 XEO_CLAS Peptide DME1121 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO02513 GENEFORM Protein DME1121 XEOTICID XEO02513 MOACRIVE Inhibition DME1121 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1121 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02514 XEO_CLAS Peptide DME1121 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO02514 GENEFORM Protein DME1121 XEOTICID XEO02514 MOACRIVE Inhibition DME1121 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1121 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02515 XEO_CLAS Peptide DME1121 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 80 microM) DME1121 XEOTICID XEO02515 GENEFORM Protein DME1121 XEOTICID XEO02515 MOACRIVE Inhibition DME1121 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1121 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02516 XEO_CLAS Peptide DME1121 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 32 microM) DME1121 XEOTICID XEO02516 GENEFORM Protein DME1121 XEOTICID XEO02516 MOACRIVE Inhibition DME1121 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1121 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02517 XEO_CLAS Peptide DME1121 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 microM) DME1121 XEOTICID XEO02517 GENEFORM Protein DME1121 XEOTICID XEO02517 MOACRIVE Inhibition DME1121 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1121 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02518 XEO_CLAS Peptide DME1121 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC < 15 microM) DME1121 XEOTICID XEO02518 GENEFORM Protein DME1121 XEOTICID XEO02518 MOACRIVE Inhibition DME1121 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1121 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02519 XEO_CLAS Peptide DME1121 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC < 15 microM) DME1121 XEOTICID XEO02519 GENEFORM Protein DME1121 XEOTICID XEO02519 MOACRIVE Inhibition DME1121 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1121 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02520 XEO_CLAS Peptide DME1121 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC < 15 microM) DME1121 XEOTICID XEO02520 GENEFORM Protein DME1121 XEOTICID XEO02520 MOACRIVE Inhibition DME1121 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1121 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02523 XEO_CLAS Peptide DME1121 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO02523 GENEFORM Protein DME1121 XEOTICID XEO02523 MOACRIVE Inhibition DME1121 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1121 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02524 XEO_CLAS Peptide DME1121 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 150 microM) DME1121 XEOTICID XEO02524 GENEFORM Protein DME1121 XEOTICID XEO02524 MOACRIVE Inhibition DME1121 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1121 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02525 XEO_CLAS Peptide DME1121 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 24 microM) DME1121 XEOTICID XEO02525 GENEFORM Protein DME1121 XEOTICID XEO02525 MOACRIVE Inhibition DME1121 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1121 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02526 XEO_CLAS Peptide DME1121 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 48 microM) DME1121 XEOTICID XEO02526 GENEFORM Protein DME1121 XEOTICID XEO02526 MOACRIVE Inhibition DME1121 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1121 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02527 XEO_CLAS Peptide DME1121 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 119 microM) DME1121 XEOTICID XEO02527 GENEFORM Protein DME1121 XEOTICID XEO02527 MOACRIVE Inhibition DME1121 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1121 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02528 XEO_CLAS Peptide DME1121 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 128 ug/ml) DME1121 XEOTICID XEO02528 GENEFORM Protein DME1121 XEOTICID XEO02528 MOACRIVE Inhibition DME1121 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1121 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02529 XEO_CLAS Peptide DME1121 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 128 ug/ml) DME1121 XEOTICID XEO02529 GENEFORM Protein DME1121 XEOTICID XEO02529 MOACRIVE Inhibition DME1121 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1121 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02530 XEO_CLAS Peptide DME1121 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02530 GENEFORM Protein DME1121 XEOTICID XEO02530 MOACRIVE Inhibition DME1121 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1121 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02531 XEO_CLAS Peptide DME1121 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 microM) DME1121 XEOTICID XEO02531 GENEFORM Protein DME1121 XEOTICID XEO02531 MOACRIVE Inhibition DME1121 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1121 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02533 XEO_CLAS Peptide DME1121 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.2 ug/ml) DME1121 XEOTICID XEO02533 GENEFORM Protein DME1121 XEOTICID XEO02533 MOACRIVE Inhibition DME1121 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1121 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02534 XEO_CLAS Peptide DME1121 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.6 ug/ml) DME1121 XEOTICID XEO02534 GENEFORM Protein DME1121 XEOTICID XEO02534 MOACRIVE Inhibition DME1121 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1121 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02535 XEO_CLAS Peptide DME1121 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.3 ug/ml) DME1121 XEOTICID XEO02535 GENEFORM Protein DME1121 XEOTICID XEO02535 MOACRIVE Inhibition DME1121 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1121 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02536 XEO_CLAS Peptide DME1121 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.4 ug/ml) DME1121 XEOTICID XEO02536 GENEFORM Protein DME1121 XEOTICID XEO02536 MOACRIVE Inhibition DME1121 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1121 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02537 XEO_CLAS Peptide DME1121 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.2 ug/ml) DME1121 XEOTICID XEO02537 GENEFORM Protein DME1121 XEOTICID XEO02537 MOACRIVE Inhibition DME1121 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1121 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02538 XEO_CLAS Peptide DME1121 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 9.1 ug/ml) DME1121 XEOTICID XEO02538 GENEFORM Protein DME1121 XEOTICID XEO02538 MOACRIVE Inhibition DME1121 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1121 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02539 XEO_CLAS Peptide DME1121 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8.6 ug/ml) DME1121 XEOTICID XEO02539 GENEFORM Protein DME1121 XEOTICID XEO02539 MOACRIVE Inhibition DME1121 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1121 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02540 XEO_CLAS Peptide DME1121 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15.2 ug/ml) DME1121 XEOTICID XEO02540 GENEFORM Protein DME1121 XEOTICID XEO02540 MOACRIVE Inhibition DME1121 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1121 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02541 XEO_CLAS Peptide DME1121 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 11.1 ug/ml) DME1121 XEOTICID XEO02541 GENEFORM Protein DME1121 XEOTICID XEO02541 MOACRIVE Inhibition DME1121 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1121 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02542 XEO_CLAS Peptide DME1121 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.7 ug/ml) DME1121 XEOTICID XEO02542 GENEFORM Protein DME1121 XEOTICID XEO02542 MOACRIVE Inhibition DME1121 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1121 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02543 XEO_CLAS Peptide DME1121 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 13.1 ug/ml) DME1121 XEOTICID XEO02543 GENEFORM Protein DME1121 XEOTICID XEO02543 MOACRIVE Inhibition DME1121 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1121 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02544 XEO_CLAS Peptide DME1121 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 9.8 ug/ml) DME1121 XEOTICID XEO02544 GENEFORM Protein DME1121 XEOTICID XEO02544 MOACRIVE Inhibition DME1121 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1121 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02545 XEO_CLAS Peptide DME1121 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 14 microM) DME1121 XEOTICID XEO02545 GENEFORM Protein DME1121 XEOTICID XEO02545 MOACRIVE Inhibition DME1121 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1121 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02546 XEO_CLAS Peptide DME1121 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 14 microM) DME1121 XEOTICID XEO02546 GENEFORM Protein DME1121 XEOTICID XEO02546 MOACRIVE Inhibition DME1121 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1121 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02547 XEO_CLAS Peptide DME1121 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 microM) DME1121 XEOTICID XEO02547 GENEFORM Protein DME1121 XEOTICID XEO02547 MOACRIVE Inhibition DME1121 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1121 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02548 XEO_CLAS Peptide DME1121 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 78 microM) DME1121 XEOTICID XEO02548 GENEFORM Protein DME1121 XEOTICID XEO02548 MOACRIVE Inhibition DME1121 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1121 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02549 XEO_CLAS Peptide DME1121 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02549 GENEFORM Protein DME1121 XEOTICID XEO02549 MOACRIVE Inhibition DME1121 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1121 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02552 XEO_CLAS Peptide DME1121 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 24 microM) DME1121 XEOTICID XEO02552 GENEFORM Protein DME1121 XEOTICID XEO02552 MOACRIVE Inhibition DME1121 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1121 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02553 XEO_CLAS Peptide DME1121 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02553 GENEFORM Protein DME1121 XEOTICID XEO02553 MOACRIVE Inhibition DME1121 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1121 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02556 XEO_CLAS Peptide DME1121 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 55 microM) DME1121 XEOTICID XEO02556 GENEFORM Protein DME1121 XEOTICID XEO02556 MOACRIVE Inhibition DME1121 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1121 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02557 XEO_CLAS Peptide DME1121 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 17 microM) DME1121 XEOTICID XEO02557 GENEFORM Protein DME1121 XEOTICID XEO02557 MOACRIVE Inhibition DME1121 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1121 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02558 XEO_CLAS Peptide DME1121 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 14 microM) DME1121 XEOTICID XEO02558 GENEFORM Protein DME1121 XEOTICID XEO02558 MOACRIVE Inhibition DME1121 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1121 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02559 XEO_CLAS Peptide DME1121 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02559 GENEFORM Protein DME1121 XEOTICID XEO02559 MOACRIVE Inhibition DME1121 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1121 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02560 XEO_CLAS Peptide DME1121 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 13 microM) DME1121 XEOTICID XEO02560 GENEFORM Protein DME1121 XEOTICID XEO02560 MOACRIVE Inhibition DME1121 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1121 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02561 XEO_CLAS Peptide DME1121 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO02561 GENEFORM Protein DME1121 XEOTICID XEO02561 MOACRIVE Inhibition DME1121 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1121 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02562 XEO_CLAS Peptide DME1121 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 13 microM) DME1121 XEOTICID XEO02562 GENEFORM Protein DME1121 XEOTICID XEO02562 MOACRIVE Inhibition DME1121 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1121 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02563 XEO_CLAS Peptide DME1121 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 45 microM) DME1121 XEOTICID XEO02563 GENEFORM Protein DME1121 XEOTICID XEO02563 MOACRIVE Inhibition DME1121 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1121 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02564 XEO_CLAS Peptide DME1121 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 ug/ml) DME1121 XEOTICID XEO02564 GENEFORM Protein DME1121 XEOTICID XEO02564 MOACRIVE Inhibition DME1121 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1121 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02565 XEO_CLAS Peptide DME1121 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 microM) DME1121 XEOTICID XEO02565 GENEFORM Protein DME1121 XEOTICID XEO02565 MOACRIVE Inhibition DME1121 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1121 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02566 XEO_CLAS Peptide DME1121 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO02566 GENEFORM Protein DME1121 XEOTICID XEO02566 MOACRIVE Inhibition DME1121 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1121 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02568 XEO_CLAS Peptide DME1121 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO02568 GENEFORM Protein DME1121 XEOTICID XEO02568 MOACRIVE Inhibition DME1121 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1121 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02569 XEO_CLAS Peptide DME1121 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO02569 GENEFORM Protein DME1121 XEOTICID XEO02569 MOACRIVE Inhibition DME1121 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1121 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02570 XEO_CLAS Peptide DME1121 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO02570 GENEFORM Protein DME1121 XEOTICID XEO02570 MOACRIVE Inhibition DME1121 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1121 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02571 XEO_CLAS Peptide DME1121 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO02571 GENEFORM Protein DME1121 XEOTICID XEO02571 MOACRIVE Inhibition DME1121 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1121 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02572 XEO_CLAS Peptide DME1121 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02572 GENEFORM Protein DME1121 XEOTICID XEO02572 MOACRIVE Inhibition DME1121 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1121 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02573 XEO_CLAS Peptide DME1121 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02573 GENEFORM Protein DME1121 XEOTICID XEO02573 MOACRIVE Inhibition DME1121 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1121 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02574 XEO_CLAS Peptide DME1121 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 microM) DME1121 XEOTICID XEO02574 GENEFORM Protein DME1121 XEOTICID XEO02574 MOACRIVE Inhibition DME1121 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1121 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02575 XEO_CLAS Peptide DME1121 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 microM) DME1121 XEOTICID XEO02575 GENEFORM Protein DME1121 XEOTICID XEO02575 MOACRIVE Inhibition DME1121 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1121 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02576 XEO_CLAS Peptide DME1121 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 33 microM) DME1121 XEOTICID XEO02576 GENEFORM Protein DME1121 XEOTICID XEO02576 MOACRIVE Inhibition DME1121 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1121 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02577 XEO_CLAS Peptide DME1121 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO02577 GENEFORM Protein DME1121 XEOTICID XEO02577 MOACRIVE Inhibition DME1121 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1121 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02578 XEO_CLAS Peptide DME1121 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02578 GENEFORM Protein DME1121 XEOTICID XEO02578 MOACRIVE Inhibition DME1121 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1121 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02579 XEO_CLAS Peptide DME1121 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02579 GENEFORM Protein DME1121 XEOTICID XEO02579 MOACRIVE Inhibition DME1121 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1121 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02580 XEO_CLAS Peptide DME1121 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC < 15 microM) DME1121 XEOTICID XEO02580 GENEFORM Protein DME1121 XEOTICID XEO02580 MOACRIVE Inhibition DME1121 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1121 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02581 XEO_CLAS Peptide DME1121 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 microM) DME1121 XEOTICID XEO02581 GENEFORM Protein DME1121 XEOTICID XEO02581 MOACRIVE Inhibition DME1121 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1121 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02582 XEO_CLAS Peptide DME1121 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 microM) DME1121 XEOTICID XEO02582 GENEFORM Protein DME1121 XEOTICID XEO02582 MOACRIVE Inhibition DME1121 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1121 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02583 XEO_CLAS Peptide DME1121 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 microM) DME1121 XEOTICID XEO02583 GENEFORM Protein DME1121 XEOTICID XEO02583 MOACRIVE Inhibition DME1121 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1121 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02584 XEO_CLAS Peptide DME1121 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 microM) DME1121 XEOTICID XEO02584 GENEFORM Protein DME1121 XEOTICID XEO02584 MOACRIVE Inhibition DME1121 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1121 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02585 XEO_CLAS Peptide DME1121 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO02585 GENEFORM Protein DME1121 XEOTICID XEO02585 MOACRIVE Inhibition DME1121 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1121 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02586 XEO_CLAS Peptide DME1121 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO02586 GENEFORM Protein DME1121 XEOTICID XEO02586 MOACRIVE Inhibition DME1121 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1121 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02587 XEO_CLAS Peptide DME1121 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02587 GENEFORM Protein DME1121 XEOTICID XEO02587 MOACRIVE Inhibition DME1121 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1121 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02589 XEO_CLAS Peptide DME1121 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8.2 ug/ml) DME1121 XEOTICID XEO02589 GENEFORM Protein DME1121 XEOTICID XEO02589 MOACRIVE Inhibition DME1121 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1121 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02590 XEO_CLAS Peptide DME1121 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 19.6 ug/ml) DME1121 XEOTICID XEO02590 GENEFORM Protein DME1121 XEOTICID XEO02590 MOACRIVE Inhibition DME1121 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1121 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02591 XEO_CLAS Peptide DME1121 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO02591 GENEFORM Protein DME1121 XEOTICID XEO02591 MOACRIVE Inhibition DME1121 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1121 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02593 XEO_CLAS Peptide DME1121 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 36 microM) DME1121 XEOTICID XEO02593 GENEFORM Protein DME1121 XEOTICID XEO02593 MOACRIVE Inhibition DME1121 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1121 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02594 XEO_CLAS Peptide DME1121 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02594 GENEFORM Protein DME1121 XEOTICID XEO02594 MOACRIVE Inhibition DME1121 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1121 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02595 XEO_CLAS Peptide DME1121 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO02595 GENEFORM Protein DME1121 XEOTICID XEO02595 MOACRIVE Inhibition DME1121 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1121 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02596 XEO_CLAS Peptide DME1121 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO02596 GENEFORM Protein DME1121 XEOTICID XEO02596 MOACRIVE Inhibition DME1121 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1121 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02597 XEO_CLAS Peptide DME1121 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO02597 GENEFORM Protein DME1121 XEOTICID XEO02597 MOACRIVE Inhibition DME1121 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1121 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02598 XEO_CLAS Peptide DME1121 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 32.5 microM) DME1121 XEOTICID XEO02598 GENEFORM Protein DME1121 XEOTICID XEO02598 MOACRIVE Inhibition DME1121 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1121 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02599 XEO_CLAS Peptide DME1121 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 microM) DME1121 XEOTICID XEO02599 GENEFORM Protein DME1121 XEOTICID XEO02599 MOACRIVE Inhibition DME1121 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1121 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02601 XEO_CLAS Peptide DME1121 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.1 ug/ml) DME1121 XEOTICID XEO02601 GENEFORM Protein DME1121 XEOTICID XEO02601 MOACRIVE Inhibition DME1121 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1121 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02602 XEO_CLAS Peptide DME1121 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 13.2 ug/ml) DME1121 XEOTICID XEO02602 GENEFORM Protein DME1121 XEOTICID XEO02602 MOACRIVE Inhibition DME1121 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1121 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02603 XEO_CLAS Peptide DME1121 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.3 ug/ml) DME1121 XEOTICID XEO02603 GENEFORM Protein DME1121 XEOTICID XEO02603 MOACRIVE Inhibition DME1121 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1121 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02604 XEO_CLAS Peptide DME1121 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO02604 GENEFORM Protein DME1121 XEOTICID XEO02604 MOACRIVE Inhibition DME1121 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1121 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02605 XEO_CLAS Peptide DME1121 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30.6 ug/ml) DME1121 XEOTICID XEO02605 GENEFORM Protein DME1121 XEOTICID XEO02605 MOACRIVE Inhibition DME1121 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1121 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02606 XEO_CLAS Peptide DME1121 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 11.2 ug/ml) DME1121 XEOTICID XEO02606 GENEFORM Protein DME1121 XEOTICID XEO02606 MOACRIVE Inhibition DME1121 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1121 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02607 XEO_CLAS Peptide DME1121 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.8 ug/ml) DME1121 XEOTICID XEO02607 GENEFORM Protein DME1121 XEOTICID XEO02607 MOACRIVE Inhibition DME1121 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1121 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02608 XEO_CLAS Peptide DME1121 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 7.9 ug/ml) DME1121 XEOTICID XEO02608 GENEFORM Protein DME1121 XEOTICID XEO02608 MOACRIVE Inhibition DME1121 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1121 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02609 XEO_CLAS Peptide DME1121 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15.8 ug/ml) DME1121 XEOTICID XEO02609 GENEFORM Protein DME1121 XEOTICID XEO02609 MOACRIVE Inhibition DME1121 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1121 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02610 XEO_CLAS Peptide DME1121 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.1 ug/ml) DME1121 XEOTICID XEO02610 GENEFORM Protein DME1121 XEOTICID XEO02610 MOACRIVE Inhibition DME1121 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1121 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02611 XEO_CLAS Peptide DME1121 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20.6 ug/ml) DME1121 XEOTICID XEO02611 GENEFORM Protein DME1121 XEOTICID XEO02611 MOACRIVE Inhibition DME1121 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1121 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02612 XEO_CLAS Peptide DME1121 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 11.8 ug/ml) DME1121 XEOTICID XEO02612 GENEFORM Protein DME1121 XEOTICID XEO02612 MOACRIVE Inhibition DME1121 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1121 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02613 XEO_CLAS Peptide DME1121 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 13.2 ug/ml) DME1121 XEOTICID XEO02613 GENEFORM Protein DME1121 XEOTICID XEO02613 MOACRIVE Inhibition DME1121 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1121 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02614 XEO_CLAS Peptide DME1121 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.8 ug/ml) DME1121 XEOTICID XEO02614 GENEFORM Protein DME1121 XEOTICID XEO02614 MOACRIVE Inhibition DME1121 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1121 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02615 XEO_CLAS Peptide DME1121 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8.6 ug/ml) DME1121 XEOTICID XEO02615 GENEFORM Protein DME1121 XEOTICID XEO02615 MOACRIVE Inhibition DME1121 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1121 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02616 XEO_CLAS Peptide DME1121 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20.4 ug/ml) DME1121 XEOTICID XEO02616 GENEFORM Protein DME1121 XEOTICID XEO02616 MOACRIVE Inhibition DME1121 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1121 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02617 XEO_CLAS Peptide DME1121 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4.7 ug/ml) DME1121 XEOTICID XEO02617 GENEFORM Protein DME1121 XEOTICID XEO02617 MOACRIVE Inhibition DME1121 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1121 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02618 XEO_CLAS Peptide DME1121 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.6 ug/ml) DME1121 XEOTICID XEO02618 GENEFORM Protein DME1121 XEOTICID XEO02618 MOACRIVE Inhibition DME1121 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1121 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02619 XEO_CLAS Peptide DME1121 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10.5 ug/ml) DME1121 XEOTICID XEO02619 GENEFORM Protein DME1121 XEOTICID XEO02619 MOACRIVE Inhibition DME1121 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1121 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02620 XEO_CLAS Peptide DME1121 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO02620 GENEFORM Protein DME1121 XEOTICID XEO02620 MOACRIVE Inhibition DME1121 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1121 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02621 XEO_CLAS Peptide DME1121 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO02621 GENEFORM Protein DME1121 XEOTICID XEO02621 MOACRIVE Inhibition DME1121 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1121 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02622 XEO_CLAS Peptide DME1121 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO02622 GENEFORM Protein DME1121 XEOTICID XEO02622 MOACRIVE Inhibition DME1121 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1121 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02623 XEO_CLAS Peptide DME1121 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO02623 GENEFORM Protein DME1121 XEOTICID XEO02623 MOACRIVE Inhibition DME1121 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1121 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02624 XEO_CLAS Peptide DME1121 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 18 microM) DME1121 XEOTICID XEO02624 GENEFORM Protein DME1121 XEOTICID XEO02624 MOACRIVE Inhibition DME1121 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1121 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02625 XEO_CLAS Peptide DME1121 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 9 microM) DME1121 XEOTICID XEO02625 GENEFORM Protein DME1121 XEOTICID XEO02625 MOACRIVE Inhibition DME1121 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1121 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02626 XEO_CLAS Peptide DME1121 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 18 microM) DME1121 XEOTICID XEO02626 GENEFORM Protein DME1121 XEOTICID XEO02626 MOACRIVE Inhibition DME1121 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1121 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02627 XEO_CLAS Peptide DME1121 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02627 GENEFORM Protein DME1121 XEOTICID XEO02627 MOACRIVE Inhibition DME1121 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1121 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02628 XEO_CLAS Peptide DME1121 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 18 microM) DME1121 XEOTICID XEO02628 GENEFORM Protein DME1121 XEOTICID XEO02628 MOACRIVE Inhibition DME1121 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1121 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02629 XEO_CLAS Peptide DME1121 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 13 microM) DME1121 XEOTICID XEO02629 GENEFORM Protein DME1121 XEOTICID XEO02629 MOACRIVE Inhibition DME1121 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1121 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02630 XEO_CLAS Peptide DME1121 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 ug/ml) DME1121 XEOTICID XEO02630 GENEFORM Protein DME1121 XEOTICID XEO02630 MOACRIVE Inhibition DME1121 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1121 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02631 XEO_CLAS Peptide DME1121 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 ug/ml) DME1121 XEOTICID XEO02631 GENEFORM Protein DME1121 XEOTICID XEO02631 MOACRIVE Inhibition DME1121 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1121 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02634 XEO_CLAS Peptide DME1121 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO02634 GENEFORM Protein DME1121 XEOTICID XEO02634 MOACRIVE Inhibition DME1121 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1121 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02635 XEO_CLAS Peptide DME1121 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40 ug/ml) DME1121 XEOTICID XEO02635 GENEFORM Protein DME1121 XEOTICID XEO02635 MOACRIVE Inhibition DME1121 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1121 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02636 XEO_CLAS Peptide DME1121 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO02636 GENEFORM Protein DME1121 XEOTICID XEO02636 MOACRIVE Inhibition DME1121 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1121 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02637 XEO_CLAS Peptide DME1121 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO02637 GENEFORM Protein DME1121 XEOTICID XEO02637 MOACRIVE Inhibition DME1121 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1121 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02638 XEO_CLAS Peptide DME1121 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 microM) DME1121 XEOTICID XEO02638 GENEFORM Protein DME1121 XEOTICID XEO02638 MOACRIVE Inhibition DME1121 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1121 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02639 XEO_CLAS Peptide DME1121 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 microM) DME1121 XEOTICID XEO02639 GENEFORM Protein DME1121 XEOTICID XEO02639 MOACRIVE Inhibition DME1121 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1121 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02644 XEO_CLAS Peptide DME1121 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02644 GENEFORM Protein DME1121 XEOTICID XEO02644 MOACRIVE Inhibition DME1121 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1121 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02645 XEO_CLAS Peptide DME1121 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02645 GENEFORM Protein DME1121 XEOTICID XEO02645 MOACRIVE Inhibition DME1121 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1121 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02646 XEO_CLAS Peptide DME1121 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02646 GENEFORM Protein DME1121 XEOTICID XEO02646 MOACRIVE Inhibition DME1121 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1121 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02647 XEO_CLAS Peptide DME1121 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02647 GENEFORM Protein DME1121 XEOTICID XEO02647 MOACRIVE Inhibition DME1121 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1121 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02649 XEO_CLAS Peptide DME1121 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO02649 GENEFORM Protein DME1121 XEOTICID XEO02649 MOACRIVE Inhibition DME1121 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1121 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02650 XEO_CLAS Peptide DME1121 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO02650 GENEFORM Protein DME1121 XEOTICID XEO02650 MOACRIVE Inhibition DME1121 XEOTICID XEO02658 XEO_NAME Buthinin DME1121 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02658 XEO_CLAS Peptide DME1121 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02658 GENEFORM Protein DME1121 XEOTICID XEO02658 MOACRIVE Inhibition DME1121 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1121 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02663 XEO_CLAS Peptide DME1121 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25 microM) DME1121 XEOTICID XEO02663 GENEFORM Protein DME1121 XEOTICID XEO02663 MOACRIVE Inhibition DME1121 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1121 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02664 XEO_CLAS Peptide DME1121 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25 microM) DME1121 XEOTICID XEO02664 GENEFORM Protein DME1121 XEOTICID XEO02664 MOACRIVE Inhibition DME1121 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1121 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02672 XEO_CLAS Peptide DME1121 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25 microM) DME1121 XEOTICID XEO02672 GENEFORM Protein DME1121 XEOTICID XEO02672 MOACRIVE Inhibition DME1121 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1121 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02673 XEO_CLAS Peptide DME1121 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25-12.5 microM) DME1121 XEOTICID XEO02673 GENEFORM Protein DME1121 XEOTICID XEO02673 MOACRIVE Inhibition DME1121 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1121 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02674 XEO_CLAS Peptide DME1121 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.125-6.25 microM) DME1121 XEOTICID XEO02674 GENEFORM Protein DME1121 XEOTICID XEO02674 MOACRIVE Inhibition DME1121 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1121 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02676 XEO_CLAS Peptide DME1121 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO02676 GENEFORM Protein DME1121 XEOTICID XEO02676 MOACRIVE Inhibition DME1121 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1121 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02677 XEO_CLAS Peptide DME1121 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25-12.5 microM) DME1121 XEOTICID XEO02677 GENEFORM Protein DME1121 XEOTICID XEO02677 MOACRIVE Inhibition DME1121 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1121 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02679 XEO_CLAS Peptide DME1121 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25-12.5 microM) DME1121 XEOTICID XEO02679 GENEFORM Protein DME1121 XEOTICID XEO02679 MOACRIVE Inhibition DME1121 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1121 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02680 XEO_CLAS Peptide DME1121 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25 microM) DME1121 XEOTICID XEO02680 GENEFORM Protein DME1121 XEOTICID XEO02680 MOACRIVE Inhibition DME1121 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1121 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02683 XEO_CLAS Peptide DME1121 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO02683 GENEFORM Protein DME1121 XEOTICID XEO02683 MOACRIVE Inhibition DME1121 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1121 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02688 XEO_CLAS Peptide DME1121 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO02688 GENEFORM Protein DME1121 XEOTICID XEO02688 MOACRIVE Inhibition DME1121 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1121 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02693 XEO_CLAS Peptide DME1121 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 ug/ml) DME1121 XEOTICID XEO02693 GENEFORM Protein DME1121 XEOTICID XEO02693 MOACRIVE Inhibition DME1121 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1121 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02699 XEO_CLAS Peptide DME1121 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 ug/ml) DME1121 XEOTICID XEO02699 GENEFORM Protein DME1121 XEOTICID XEO02699 MOACRIVE Inhibition DME1121 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1121 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02700 XEO_CLAS Peptide DME1121 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 ug/ml) DME1121 XEOTICID XEO02700 GENEFORM Protein DME1121 XEOTICID XEO02700 MOACRIVE Inhibition DME1121 XEOTICID XEO02703 XEO_NAME Calcitermin DME1121 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02703 XEO_CLAS Peptide DME1121 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02703 GENEFORM Protein DME1121 XEOTICID XEO02703 MOACRIVE Inhibition DME1121 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1121 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02708 XEO_CLAS Peptide DME1121 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO02708 GENEFORM Protein DME1121 XEOTICID XEO02708 MOACRIVE Inhibition DME1121 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1121 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02709 XEO_CLAS Peptide DME1121 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.05 microM) DME1121 XEOTICID XEO02709 GENEFORM Protein DME1121 XEOTICID XEO02709 MOACRIVE Inhibition DME1121 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1121 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1121 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02713 GENEFORM Protein DME1121 XEOTICID XEO02713 MOACRIVE Inhibition DME1121 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1121 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1121 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02714 GENEFORM Protein DME1121 XEOTICID XEO02714 MOACRIVE Inhibition DME1121 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1121 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02726 XEO_CLAS Peptide DME1121 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02726 GENEFORM Protein DME1121 XEOTICID XEO02726 MOACRIVE Inhibition DME1121 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1121 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02731 XEO_CLAS Peptide DME1121 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1 microM) DME1121 XEOTICID XEO02731 GENEFORM Protein DME1121 XEOTICID XEO02731 MOACRIVE Inhibition DME1121 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1121 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02732 XEO_CLAS Peptide DME1121 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.25 microM) DME1121 XEOTICID XEO02732 GENEFORM Protein DME1121 XEOTICID XEO02732 MOACRIVE Inhibition DME1121 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1121 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02733 XEO_CLAS Peptide DME1121 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8-25 ug/ml) DME1121 XEOTICID XEO02733 GENEFORM Protein DME1121 XEOTICID XEO02733 MOACRIVE Inhibition DME1121 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1121 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02735 XEO_CLAS Peptide DME1121 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1 ug/ml) DME1121 XEOTICID XEO02735 GENEFORM Protein DME1121 XEOTICID XEO02735 MOACRIVE Inhibition DME1121 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1121 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02737 XEO_CLAS Peptide DME1121 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02737 GENEFORM Protein DME1121 XEOTICID XEO02737 MOACRIVE Inhibition DME1121 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1121 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02738 XEO_CLAS Peptide DME1121 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO02738 GENEFORM Protein DME1121 XEOTICID XEO02738 MOACRIVE Inhibition DME1121 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1121 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02739 XEO_CLAS Peptide DME1121 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 microM) DME1121 XEOTICID XEO02739 GENEFORM Protein DME1121 XEOTICID XEO02739 MOACRIVE Inhibition DME1121 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1121 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02740 XEO_CLAS Peptide DME1121 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.25 ug/ml) DME1121 XEOTICID XEO02740 GENEFORM Protein DME1121 XEOTICID XEO02740 MOACRIVE Inhibition DME1121 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1121 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02741 XEO_CLAS Peptide DME1121 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 ug/ml) DME1121 XEOTICID XEO02741 GENEFORM Protein DME1121 XEOTICID XEO02741 MOACRIVE Inhibition DME1121 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1121 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02743 XEO_CLAS Peptide DME1121 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.6 ug/ml) DME1121 XEOTICID XEO02743 GENEFORM Protein DME1121 XEOTICID XEO02743 MOACRIVE Inhibition DME1121 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1121 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02744 XEO_CLAS Peptide DME1121 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 18.7 ug/ml) DME1121 XEOTICID XEO02744 GENEFORM Protein DME1121 XEOTICID XEO02744 MOACRIVE Inhibition DME1121 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1121 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02745 XEO_CLAS Peptide DME1121 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02745 GENEFORM Protein DME1121 XEOTICID XEO02745 MOACRIVE Inhibition DME1121 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1121 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02746 XEO_CLAS Peptide DME1121 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02746 GENEFORM Protein DME1121 XEOTICID XEO02746 MOACRIVE Inhibition DME1121 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1121 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02748 XEO_CLAS Peptide DME1121 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02748 GENEFORM Protein DME1121 XEOTICID XEO02748 MOACRIVE Inhibition DME1121 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1121 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02749 XEO_CLAS Peptide DME1121 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20-25 mug/ml) DME1121 XEOTICID XEO02749 GENEFORM Protein DME1121 XEOTICID XEO02749 MOACRIVE Inhibition DME1121 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1121 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02750 XEO_CLAS Peptide DME1121 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02750 GENEFORM Protein DME1121 XEOTICID XEO02750 MOACRIVE Inhibition DME1121 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1121 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02752 XEO_CLAS Peptide DME1121 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02752 GENEFORM Protein DME1121 XEOTICID XEO02752 MOACRIVE Inhibition DME1121 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1121 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02753 XEO_CLAS Peptide DME1121 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02753 GENEFORM Protein DME1121 XEOTICID XEO02753 MOACRIVE Inhibition DME1121 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1121 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02754 XEO_CLAS Peptide DME1121 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 microM) DME1121 XEOTICID XEO02754 GENEFORM Protein DME1121 XEOTICID XEO02754 MOACRIVE Inhibition DME1121 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1121 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02756 XEO_CLAS Peptide DME1121 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 microM) DME1121 XEOTICID XEO02756 GENEFORM Protein DME1121 XEOTICID XEO02756 MOACRIVE Inhibition DME1121 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1121 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02757 XEO_CLAS Peptide DME1121 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1 microM) DME1121 XEOTICID XEO02757 GENEFORM Protein DME1121 XEOTICID XEO02757 MOACRIVE Inhibition DME1121 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1121 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02758 XEO_CLAS Peptide DME1121 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO02758 GENEFORM Protein DME1121 XEOTICID XEO02758 MOACRIVE Inhibition DME1121 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1121 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02759 XEO_CLAS Peptide DME1121 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.6 microM) DME1121 XEOTICID XEO02759 GENEFORM Protein DME1121 XEOTICID XEO02759 MOACRIVE Inhibition DME1121 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1121 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02760 XEO_CLAS Peptide DME1121 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 microM) DME1121 XEOTICID XEO02760 GENEFORM Protein DME1121 XEOTICID XEO02760 MOACRIVE Inhibition DME1121 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1121 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02761 XEO_CLAS Peptide DME1121 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO02761 GENEFORM Protein DME1121 XEOTICID XEO02761 MOACRIVE Inhibition DME1121 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1121 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02762 XEO_CLAS Peptide DME1121 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 microM) DME1121 XEOTICID XEO02762 GENEFORM Protein DME1121 XEOTICID XEO02762 MOACRIVE Inhibition DME1121 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1121 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02763 XEO_CLAS Peptide DME1121 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.4 microM) DME1121 XEOTICID XEO02763 GENEFORM Protein DME1121 XEOTICID XEO02763 MOACRIVE Inhibition DME1121 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1121 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02764 XEO_CLAS Peptide DME1121 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 microM) DME1121 XEOTICID XEO02764 GENEFORM Protein DME1121 XEOTICID XEO02764 MOACRIVE Inhibition DME1121 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1121 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02765 XEO_CLAS Peptide DME1121 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.3 microM) DME1121 XEOTICID XEO02765 GENEFORM Protein DME1121 XEOTICID XEO02765 MOACRIVE Inhibition DME1121 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1121 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02767 XEO_CLAS Peptide DME1121 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02767 GENEFORM Protein DME1121 XEOTICID XEO02767 MOACRIVE Inhibition DME1121 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1121 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02768 XEO_CLAS Peptide DME1121 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1121 XEOTICID XEO02768 GENEFORM Protein DME1121 XEOTICID XEO02768 MOACRIVE Inhibition DME1121 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1121 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02769 XEO_CLAS Peptide DME1121 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.32 microM) DME1121 XEOTICID XEO02769 GENEFORM Protein DME1121 XEOTICID XEO02769 MOACRIVE Inhibition DME1121 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1121 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02770 XEO_CLAS Peptide DME1121 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.30 microM) DME1121 XEOTICID XEO02770 GENEFORM Protein DME1121 XEOTICID XEO02770 MOACRIVE Inhibition DME1121 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1121 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02771 XEO_CLAS Peptide DME1121 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.21 microM) DME1121 XEOTICID XEO02771 GENEFORM Protein DME1121 XEOTICID XEO02771 MOACRIVE Inhibition DME1121 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1121 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02772 XEO_CLAS Peptide DME1121 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02772 GENEFORM Protein DME1121 XEOTICID XEO02772 MOACRIVE Inhibition DME1121 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1121 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02773 XEO_CLAS Peptide DME1121 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.9-8.6 microM) DME1121 XEOTICID XEO02773 GENEFORM Protein DME1121 XEOTICID XEO02773 MOACRIVE Inhibition DME1121 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1121 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02774 XEO_CLAS Peptide DME1121 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.3 microM) DME1121 XEOTICID XEO02774 GENEFORM Protein DME1121 XEOTICID XEO02774 MOACRIVE Inhibition DME1121 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1121 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02789 GENEFORM Protein DME1121 XEOTICID XEO02789 MOACRIVE Inhibition DME1121 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1121 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02790 GENEFORM Protein DME1121 XEOTICID XEO02790 MOACRIVE Inhibition DME1121 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1121 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02791 GENEFORM Protein DME1121 XEOTICID XEO02791 MOACRIVE Inhibition DME1121 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1121 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02792 GENEFORM Protein DME1121 XEOTICID XEO02792 MOACRIVE Inhibition DME1121 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1121 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02793 GENEFORM Protein DME1121 XEOTICID XEO02793 MOACRIVE Inhibition DME1121 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1121 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02794 GENEFORM Protein DME1121 XEOTICID XEO02794 MOACRIVE Inhibition DME1121 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1121 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02795 GENEFORM Protein DME1121 XEOTICID XEO02795 MOACRIVE Inhibition DME1121 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1121 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02796 GENEFORM Protein DME1121 XEOTICID XEO02796 MOACRIVE Inhibition DME1121 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1121 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02797 GENEFORM Protein DME1121 XEOTICID XEO02797 MOACRIVE Inhibition DME1121 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1121 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02799 XEO_CLAS Peptide DME1121 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02799 GENEFORM Protein DME1121 XEOTICID XEO02799 MOACRIVE Inhibition DME1121 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1121 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02800 XEO_CLAS Peptide DME1121 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02800 GENEFORM Protein DME1121 XEOTICID XEO02800 MOACRIVE Inhibition DME1121 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1121 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02802 XEO_CLAS Peptide DME1121 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 13.6 microM) DME1121 XEOTICID XEO02802 GENEFORM Protein DME1121 XEOTICID XEO02802 MOACRIVE Inhibition DME1121 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1121 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02807 XEO_CLAS Peptide DME1121 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.2 microM) DME1121 XEOTICID XEO02807 GENEFORM Protein DME1121 XEOTICID XEO02807 MOACRIVE Inhibition DME1121 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1121 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02813 XEO_CLAS Peptide DME1121 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 80 microM) DME1121 XEOTICID XEO02813 GENEFORM Protein DME1121 XEOTICID XEO02813 MOACRIVE Inhibition DME1121 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1121 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02814 XEO_CLAS Peptide DME1121 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 80 microM) DME1121 XEOTICID XEO02814 GENEFORM Protein DME1121 XEOTICID XEO02814 MOACRIVE Inhibition DME1121 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1121 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02815 XEO_CLAS Peptide DME1121 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8.5 microM) DME1121 XEOTICID XEO02815 GENEFORM Protein DME1121 XEOTICID XEO02815 MOACRIVE Inhibition DME1121 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1121 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02816 XEO_CLAS Peptide DME1121 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 80 microM) DME1121 XEOTICID XEO02816 GENEFORM Protein DME1121 XEOTICID XEO02816 MOACRIVE Inhibition DME1121 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1121 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02817 XEO_CLAS Peptide DME1121 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 80 microM) DME1121 XEOTICID XEO02817 GENEFORM Protein DME1121 XEOTICID XEO02817 MOACRIVE Inhibition DME1121 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1121 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02818 XEO_CLAS Peptide DME1121 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.4 microM) DME1121 XEOTICID XEO02818 GENEFORM Protein DME1121 XEOTICID XEO02818 MOACRIVE Inhibition DME1121 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1121 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02819 XEO_CLAS Peptide DME1121 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.6 microM) DME1121 XEOTICID XEO02819 GENEFORM Protein DME1121 XEOTICID XEO02819 MOACRIVE Inhibition DME1121 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1121 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02820 XEO_CLAS Peptide DME1121 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO02820 GENEFORM Protein DME1121 XEOTICID XEO02820 MOACRIVE Inhibition DME1121 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1121 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02821 XEO_CLAS Peptide DME1121 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02821 GENEFORM Protein DME1121 XEOTICID XEO02821 MOACRIVE Inhibition DME1121 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1121 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02824 XEO_CLAS Peptide DME1121 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 35 microM) DME1121 XEOTICID XEO02824 GENEFORM Protein DME1121 XEOTICID XEO02824 MOACRIVE Inhibition DME1121 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1121 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02826 XEO_CLAS Peptide DME1121 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.7 ug/ml) DME1121 XEOTICID XEO02826 GENEFORM Protein DME1121 XEOTICID XEO02826 MOACRIVE Inhibition DME1121 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1121 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02834 GENEFORM Protein DME1121 XEOTICID XEO02834 MOACRIVE Inhibition DME1121 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1121 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02839 XEO_CLAS Peptide DME1121 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.25 microM) DME1121 XEOTICID XEO02839 GENEFORM Protein DME1121 XEOTICID XEO02839 MOACRIVE Inhibition DME1121 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1121 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02841 XEO_CLAS Peptide DME1121 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.25 microM) DME1121 XEOTICID XEO02841 GENEFORM Protein DME1121 XEOTICID XEO02841 MOACRIVE Inhibition DME1121 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1121 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02842 XEO_CLAS Peptide DME1121 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.25 microM) DME1121 XEOTICID XEO02842 GENEFORM Protein DME1121 XEOTICID XEO02842 MOACRIVE Inhibition DME1121 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1121 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02843 XEO_CLAS Peptide DME1121 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02843 GENEFORM Protein DME1121 XEOTICID XEO02843 MOACRIVE Inhibition DME1121 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1121 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02849 GENEFORM Protein DME1121 XEOTICID XEO02849 MOACRIVE Inhibition DME1121 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1121 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02857 XEO_CLAS Peptide DME1121 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 53 microM) DME1121 XEOTICID XEO02857 GENEFORM Protein DME1121 XEOTICID XEO02857 MOACRIVE Inhibition DME1121 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1121 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02858 XEO_CLAS Peptide DME1121 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 53 microM) DME1121 XEOTICID XEO02858 GENEFORM Protein DME1121 XEOTICID XEO02858 MOACRIVE Inhibition DME1121 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1121 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02860 XEO_CLAS Peptide DME1121 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 ug/ml) DME1121 XEOTICID XEO02860 GENEFORM Protein DME1121 XEOTICID XEO02860 MOACRIVE Inhibition DME1121 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1121 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02867 XEO_CLAS Peptide DME1121 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02867 GENEFORM Protein DME1121 XEOTICID XEO02867 MOACRIVE Inhibition DME1121 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1121 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02868 XEO_CLAS Peptide DME1121 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02868 GENEFORM Protein DME1121 XEOTICID XEO02868 MOACRIVE Inhibition DME1121 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1121 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02869 XEO_CLAS Peptide DME1121 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02869 GENEFORM Protein DME1121 XEOTICID XEO02869 MOACRIVE Inhibition DME1121 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1121 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02870 XEO_CLAS Peptide DME1121 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02870 GENEFORM Protein DME1121 XEOTICID XEO02870 MOACRIVE Inhibition DME1121 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1121 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02871 XEO_CLAS Peptide DME1121 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02871 GENEFORM Protein DME1121 XEOTICID XEO02871 MOACRIVE Inhibition DME1121 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1121 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02872 XEO_CLAS Peptide DME1121 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 308 microM) DME1121 XEOTICID XEO02872 GENEFORM Protein DME1121 XEOTICID XEO02872 MOACRIVE Inhibition DME1121 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1121 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02875 XEO_CLAS Peptide DME1121 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.1 microM) DME1121 XEOTICID XEO02875 GENEFORM Protein DME1121 XEOTICID XEO02875 MOACRIVE Inhibition DME1121 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1121 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02876 XEO_CLAS Peptide DME1121 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO02876 GENEFORM Protein DME1121 XEOTICID XEO02876 MOACRIVE Inhibition DME1121 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1121 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02877 XEO_CLAS Peptide DME1121 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO02877 GENEFORM Protein DME1121 XEOTICID XEO02877 MOACRIVE Inhibition DME1121 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1121 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02878 XEO_CLAS Peptide DME1121 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.3 microM) DME1121 XEOTICID XEO02878 GENEFORM Protein DME1121 XEOTICID XEO02878 MOACRIVE Inhibition DME1121 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1121 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02885 XEO_CLAS Peptide DME1121 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02885 GENEFORM Protein DME1121 XEOTICID XEO02885 MOACRIVE Inhibition DME1121 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1121 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02886 XEO_CLAS Peptide DME1121 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02886 GENEFORM Protein DME1121 XEOTICID XEO02886 MOACRIVE Inhibition DME1121 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1121 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02887 XEO_CLAS Peptide DME1121 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1 ug/ml) DME1121 XEOTICID XEO02887 GENEFORM Protein DME1121 XEOTICID XEO02887 MOACRIVE Inhibition DME1121 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1121 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02888 XEO_CLAS Peptide DME1121 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 ug/ml) DME1121 XEOTICID XEO02888 GENEFORM Protein DME1121 XEOTICID XEO02888 MOACRIVE Inhibition DME1121 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1121 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02889 XEO_CLAS Peptide DME1121 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 ug/ml) DME1121 XEOTICID XEO02889 GENEFORM Protein DME1121 XEOTICID XEO02889 MOACRIVE Inhibition DME1121 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1121 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02890 XEO_CLAS Peptide DME1121 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02890 GENEFORM Protein DME1121 XEOTICID XEO02890 MOACRIVE Inhibition DME1121 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1121 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02891 XEO_CLAS Peptide DME1121 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02891 GENEFORM Protein DME1121 XEOTICID XEO02891 MOACRIVE Inhibition DME1121 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1121 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02895 XEO_CLAS Peptide DME1121 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO02895 GENEFORM Protein DME1121 XEOTICID XEO02895 MOACRIVE Inhibition DME1121 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1121 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02896 XEO_CLAS Peptide DME1121 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO02896 GENEFORM Protein DME1121 XEOTICID XEO02896 MOACRIVE Inhibition DME1121 XEOTICID XEO02899 XEO_NAME Coladonin DME1121 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1121 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1121 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02899 GENEFORM Protein DME1121 XEOTICID XEO02899 MOACRIVE Inhibition DME1121 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1121 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02900 XEO_CLAS Peptide DME1121 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02900 GENEFORM Protein DME1121 XEOTICID XEO02900 MOACRIVE Inhibition DME1121 XEOTICID XEO02901 XEO_NAME Colicin-V DME1121 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02901 XEO_CLAS Peptide DME1121 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02901 GENEFORM Protein DME1121 XEOTICID XEO02901 MOACRIVE Inhibition DME1121 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1121 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02904 GENEFORM Protein DME1121 XEOTICID XEO02904 MOACRIVE Inhibition DME1121 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1121 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02908 XEO_CLAS Peptide DME1121 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 50 microM) DME1121 XEOTICID XEO02908 GENEFORM Protein DME1121 XEOTICID XEO02908 MOACRIVE Inhibition DME1121 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1121 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02923 XEO_CLAS Peptide DME1121 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02923 GENEFORM Protein DME1121 XEOTICID XEO02923 MOACRIVE Inhibition DME1121 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1121 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02924 XEO_CLAS Peptide DME1121 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 32 microM) DME1121 XEOTICID XEO02924 GENEFORM Protein DME1121 XEOTICID XEO02924 MOACRIVE Inhibition DME1121 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1121 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1121 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02927 GENEFORM Protein DME1121 XEOTICID XEO02927 MOACRIVE Inhibition DME1121 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1121 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02931 XEO_CLAS Peptide DME1121 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 ug/ml) DME1121 XEOTICID XEO02931 GENEFORM Protein DME1121 XEOTICID XEO02931 MOACRIVE Inhibition DME1121 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1121 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02933 XEO_CLAS Peptide DME1121 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO02933 GENEFORM Protein DME1121 XEOTICID XEO02933 MOACRIVE Inhibition DME1121 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1121 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02934 XEO_CLAS Peptide DME1121 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02934 GENEFORM Protein DME1121 XEOTICID XEO02934 MOACRIVE Inhibition DME1121 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1121 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02935 XEO_CLAS Peptide DME1121 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02935 GENEFORM Protein DME1121 XEOTICID XEO02935 MOACRIVE Inhibition DME1121 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1121 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02936 XEO_CLAS Peptide DME1121 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO02936 GENEFORM Protein DME1121 XEOTICID XEO02936 MOACRIVE Inhibition DME1121 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1121 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02937 XEO_CLAS Peptide DME1121 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02937 GENEFORM Protein DME1121 XEOTICID XEO02937 MOACRIVE Inhibition DME1121 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1121 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02938 XEO_CLAS Peptide DME1121 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 32 ug/ml) DME1121 XEOTICID XEO02938 GENEFORM Protein DME1121 XEOTICID XEO02938 MOACRIVE Inhibition DME1121 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1121 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02939 XEO_CLAS Peptide DME1121 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 11 ug/ml) DME1121 XEOTICID XEO02939 GENEFORM Protein DME1121 XEOTICID XEO02939 MOACRIVE Inhibition DME1121 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1121 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02940 XEO_CLAS Peptide DME1121 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1 ug/ml) DME1121 XEOTICID XEO02940 GENEFORM Protein DME1121 XEOTICID XEO02940 MOACRIVE Inhibition DME1121 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1121 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02941 XEO_CLAS Peptide DME1121 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02941 GENEFORM Protein DME1121 XEOTICID XEO02941 MOACRIVE Inhibition DME1121 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1121 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02944 XEO_CLAS Peptide DME1121 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 microM) DME1121 XEOTICID XEO02944 GENEFORM Protein DME1121 XEOTICID XEO02944 MOACRIVE Inhibition DME1121 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1121 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02945 XEO_CLAS Peptide DME1121 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 microM) DME1121 XEOTICID XEO02945 GENEFORM Protein DME1121 XEOTICID XEO02945 MOACRIVE Inhibition DME1121 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1121 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02946 XEO_CLAS Peptide DME1121 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 microM) DME1121 XEOTICID XEO02946 GENEFORM Protein DME1121 XEOTICID XEO02946 MOACRIVE Inhibition DME1121 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1121 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02947 XEO_CLAS Peptide DME1121 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02947 GENEFORM Protein DME1121 XEOTICID XEO02947 MOACRIVE Inhibition DME1121 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1121 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02948 XEO_CLAS Peptide DME1121 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO02948 GENEFORM Protein DME1121 XEOTICID XEO02948 MOACRIVE Inhibition DME1121 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1121 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02949 XEO_CLAS Peptide DME1121 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO02949 GENEFORM Protein DME1121 XEOTICID XEO02949 MOACRIVE Inhibition DME1121 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1121 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02954 XEO_CLAS Peptide DME1121 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02954 GENEFORM Protein DME1121 XEOTICID XEO02954 MOACRIVE Inhibition DME1121 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1121 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02958 XEO_CLAS Peptide DME1121 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02958 GENEFORM Protein DME1121 XEOTICID XEO02958 MOACRIVE Inhibition DME1121 XEOTICID XEO02962 XEO_NAME Cryptonin DME1121 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02962 XEO_CLAS Peptide DME1121 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.12 ug/ml) DME1121 XEOTICID XEO02962 GENEFORM Protein DME1121 XEOTICID XEO02962 MOACRIVE Inhibition DME1121 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1121 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02965 XEO_CLAS Peptide DME1121 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 ug/ml) DME1121 XEOTICID XEO02965 GENEFORM Protein DME1121 XEOTICID XEO02965 MOACRIVE Inhibition DME1121 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1121 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02969 XEO_CLAS Peptide DME1121 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 microM) DME1121 XEOTICID XEO02969 GENEFORM Protein DME1121 XEOTICID XEO02969 MOACRIVE Inhibition DME1121 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1121 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02971 XEO_CLAS Peptide DME1121 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 microM) DME1121 XEOTICID XEO02971 GENEFORM Protein DME1121 XEOTICID XEO02971 MOACRIVE Inhibition DME1121 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1121 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO02972 XEO_CLAS Peptide DME1121 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.4 microM) DME1121 XEOTICID XEO02972 GENEFORM Protein DME1121 XEOTICID XEO02972 MOACRIVE Inhibition DME1121 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1121 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02990 GENEFORM Protein DME1121 XEOTICID XEO02990 MOACRIVE Inhibition DME1121 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1121 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02991 GENEFORM Protein DME1121 XEOTICID XEO02991 MOACRIVE Inhibition DME1121 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1121 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02992 GENEFORM Protein DME1121 XEOTICID XEO02992 MOACRIVE Inhibition DME1121 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1121 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02993 GENEFORM Protein DME1121 XEOTICID XEO02993 MOACRIVE Inhibition DME1121 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1121 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02994 GENEFORM Protein DME1121 XEOTICID XEO02994 MOACRIVE Inhibition DME1121 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1121 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02995 GENEFORM Protein DME1121 XEOTICID XEO02995 MOACRIVE Inhibition DME1121 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1121 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02996 GENEFORM Protein DME1121 XEOTICID XEO02996 MOACRIVE Inhibition DME1121 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1121 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02997 GENEFORM Protein DME1121 XEOTICID XEO02997 MOACRIVE Inhibition DME1121 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1121 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02998 GENEFORM Protein DME1121 XEOTICID XEO02998 MOACRIVE Inhibition DME1121 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1121 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1121 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO02999 GENEFORM Protein DME1121 XEOTICID XEO02999 MOACRIVE Inhibition DME1121 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1121 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03021 XEO_CLAS Peptide DME1121 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.31-0.63 microM) DME1121 XEOTICID XEO03021 GENEFORM Protein DME1121 XEOTICID XEO03021 MOACRIVE Inhibition DME1121 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1121 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03029 XEO_CLAS Peptide DME1121 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.005 microM) DME1121 XEOTICID XEO03029 GENEFORM Protein DME1121 XEOTICID XEO03029 MOACRIVE Inhibition DME1121 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1121 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03030 XEO_CLAS Peptide DME1121 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.005 microM) DME1121 XEOTICID XEO03030 GENEFORM Protein DME1121 XEOTICID XEO03030 MOACRIVE Inhibition DME1121 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1121 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03031 XEO_CLAS Peptide DME1121 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.3 microM) DME1121 XEOTICID XEO03031 GENEFORM Protein DME1121 XEOTICID XEO03031 MOACRIVE Inhibition DME1121 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1121 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03032 XEO_CLAS Peptide DME1121 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.01 microM) DME1121 XEOTICID XEO03032 GENEFORM Protein DME1121 XEOTICID XEO03032 MOACRIVE Inhibition DME1121 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1121 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03033 XEO_CLAS Peptide DME1121 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.173 microM) DME1121 XEOTICID XEO03033 GENEFORM Protein DME1121 XEOTICID XEO03033 MOACRIVE Inhibition DME1121 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1121 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03034 XEO_CLAS Peptide DME1121 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.518 microM) DME1121 XEOTICID XEO03034 GENEFORM Protein DME1121 XEOTICID XEO03034 MOACRIVE Inhibition DME1121 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1121 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03035 XEO_CLAS Peptide DME1121 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.114 microM) DME1121 XEOTICID XEO03035 GENEFORM Protein DME1121 XEOTICID XEO03035 MOACRIVE Inhibition DME1121 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1121 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03039 XEO_CLAS Peptide DME1121 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.55 microM) DME1121 XEOTICID XEO03039 GENEFORM Protein DME1121 XEOTICID XEO03039 MOACRIVE Inhibition DME1121 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1121 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03043 XEO_CLAS Peptide DME1121 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 microM) DME1121 XEOTICID XEO03043 GENEFORM Protein DME1121 XEOTICID XEO03043 MOACRIVE Inhibition DME1121 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1121 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03044 XEO_CLAS Peptide DME1121 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03044 GENEFORM Protein DME1121 XEOTICID XEO03044 MOACRIVE Inhibition DME1121 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1121 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03045 XEO_CLAS Peptide DME1121 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03045 GENEFORM Protein DME1121 XEOTICID XEO03045 MOACRIVE Inhibition DME1121 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1121 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03046 XEO_CLAS Peptide DME1121 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03046 GENEFORM Protein DME1121 XEOTICID XEO03046 MOACRIVE Inhibition DME1121 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1121 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03049 XEO_CLAS Peptide DME1121 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 microM) DME1121 XEOTICID XEO03049 GENEFORM Protein DME1121 XEOTICID XEO03049 MOACRIVE Inhibition DME1121 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1121 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03055 XEO_CLAS Peptide DME1121 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 microM) DME1121 XEOTICID XEO03055 GENEFORM Protein DME1121 XEOTICID XEO03055 MOACRIVE Inhibition DME1121 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1121 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03059 XEO_CLAS Peptide DME1121 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO03059 GENEFORM Protein DME1121 XEOTICID XEO03059 MOACRIVE Inhibition DME1121 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1121 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03060 XEO_CLAS Peptide DME1121 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO03060 GENEFORM Protein DME1121 XEOTICID XEO03060 MOACRIVE Inhibition DME1121 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1121 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03062 XEO_CLAS Peptide DME1121 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO03062 GENEFORM Protein DME1121 XEOTICID XEO03062 MOACRIVE Inhibition DME1121 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1121 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03064 XEO_CLAS Peptide DME1121 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO03064 GENEFORM Protein DME1121 XEOTICID XEO03064 MOACRIVE Inhibition DME1121 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1121 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03066 XEO_CLAS Peptide DME1121 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO03066 GENEFORM Protein DME1121 XEOTICID XEO03066 MOACRIVE Inhibition DME1121 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1121 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03068 XEO_CLAS Peptide DME1121 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO03068 GENEFORM Protein DME1121 XEOTICID XEO03068 MOACRIVE Inhibition DME1121 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1121 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03073 XEO_CLAS Peptide DME1121 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8-16 ug/ml) DME1121 XEOTICID XEO03073 GENEFORM Protein DME1121 XEOTICID XEO03073 MOACRIVE Inhibition DME1121 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1121 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03081 XEO_CLAS Peptide DME1121 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 microM) DME1121 XEOTICID XEO03081 GENEFORM Protein DME1121 XEOTICID XEO03081 MOACRIVE Inhibition DME1121 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1121 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03082 XEO_CLAS Peptide DME1121 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03082 GENEFORM Protein DME1121 XEOTICID XEO03082 MOACRIVE Inhibition DME1121 XEOTICID XEO03089 XEO_NAME Decoralin DME1121 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03089 XEO_CLAS Peptide DME1121 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 160 microM) DME1121 XEOTICID XEO03089 GENEFORM Protein DME1121 XEOTICID XEO03089 MOACRIVE Inhibition DME1121 XEOTICID XEO03098 XEO_NAME Insect defensin DME1121 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03098 XEO_CLAS Peptide DME1121 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 ug/ml) DME1121 XEOTICID XEO03098 GENEFORM Protein DME1121 XEOTICID XEO03098 MOACRIVE Inhibition DME1121 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1121 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03100 XEO_CLAS Peptide DME1121 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03100 GENEFORM Protein DME1121 XEOTICID XEO03100 MOACRIVE Inhibition DME1121 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1121 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03103 XEO_CLAS Peptide DME1121 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03103 GENEFORM Protein DME1121 XEOTICID XEO03103 MOACRIVE Inhibition DME1121 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1121 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03105 XEO_CLAS Peptide DME1121 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03105 GENEFORM Protein DME1121 XEOTICID XEO03105 MOACRIVE Inhibition DME1121 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1121 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03110 XEO_CLAS Peptide DME1121 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.2 microM) DME1121 XEOTICID XEO03110 GENEFORM Protein DME1121 XEOTICID XEO03110 MOACRIVE Inhibition DME1121 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1121 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03111 XEO_CLAS Peptide DME1121 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03111 GENEFORM Protein DME1121 XEOTICID XEO03111 MOACRIVE Inhibition DME1121 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1121 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03112 XEO_CLAS Peptide DME1121 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 50 ug/ml) DME1121 XEOTICID XEO03112 GENEFORM Protein DME1121 XEOTICID XEO03112 MOACRIVE Inhibition DME1121 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1121 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03115 XEO_CLAS Peptide DME1121 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03115 GENEFORM Protein DME1121 XEOTICID XEO03115 MOACRIVE Inhibition DME1121 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1121 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03116 XEO_CLAS Peptide DME1121 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 40 microM) DME1121 XEOTICID XEO03116 GENEFORM Protein DME1121 XEOTICID XEO03116 MOACRIVE Inhibition DME1121 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1121 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03118 XEO_CLAS Peptide DME1121 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03118 GENEFORM Protein DME1121 XEOTICID XEO03118 MOACRIVE Inhibition DME1121 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1121 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03119 XEO_CLAS Peptide DME1121 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03119 GENEFORM Protein DME1121 XEOTICID XEO03119 MOACRIVE Inhibition DME1121 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1121 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03121 XEO_CLAS Peptide DME1121 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03121 GENEFORM Protein DME1121 XEOTICID XEO03121 MOACRIVE Inhibition DME1121 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1121 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03122 XEO_CLAS Peptide DME1121 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64000 ug/ml) DME1121 XEOTICID XEO03122 GENEFORM Protein DME1121 XEOTICID XEO03122 MOACRIVE Inhibition DME1121 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1121 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03124 XEO_CLAS Peptide DME1121 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03124 GENEFORM Protein DME1121 XEOTICID XEO03124 MOACRIVE Inhibition DME1121 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1121 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03125 XEO_CLAS Peptide DME1121 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03125 GENEFORM Protein DME1121 XEOTICID XEO03125 MOACRIVE Inhibition DME1121 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1121 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03126 XEO_CLAS Peptide DME1121 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.86 microM) DME1121 XEOTICID XEO03126 GENEFORM Protein DME1121 XEOTICID XEO03126 MOACRIVE Inhibition DME1121 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1121 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03127 XEO_CLAS Peptide DME1121 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03127 GENEFORM Protein DME1121 XEOTICID XEO03127 MOACRIVE Inhibition DME1121 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1121 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03128 XEO_CLAS Peptide DME1121 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 256 ug/ml) DME1121 XEOTICID XEO03128 GENEFORM Protein DME1121 XEOTICID XEO03128 MOACRIVE Inhibition DME1121 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1121 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03129 XEO_CLAS Peptide DME1121 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 256 ug/ml) DME1121 XEOTICID XEO03129 GENEFORM Protein DME1121 XEOTICID XEO03129 MOACRIVE Inhibition DME1121 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1121 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03130 XEO_CLAS Peptide DME1121 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 256 ug/ml) DME1121 XEOTICID XEO03130 GENEFORM Protein DME1121 XEOTICID XEO03130 MOACRIVE Inhibition DME1121 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1121 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03131 XEO_CLAS Peptide DME1121 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 256 ug/ml) DME1121 XEOTICID XEO03131 GENEFORM Protein DME1121 XEOTICID XEO03131 MOACRIVE Inhibition DME1121 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1121 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03132 XEO_CLAS Peptide DME1121 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 256 ug/ml) DME1121 XEOTICID XEO03132 GENEFORM Protein DME1121 XEOTICID XEO03132 MOACRIVE Inhibition DME1121 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1121 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03137 XEO_CLAS Peptide DME1121 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03137 GENEFORM Protein DME1121 XEOTICID XEO03137 MOACRIVE Inhibition DME1121 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1121 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03143 XEO_CLAS Peptide DME1121 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.6 microM) DME1121 XEOTICID XEO03143 GENEFORM Protein DME1121 XEOTICID XEO03143 MOACRIVE Inhibition DME1121 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1121 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03145 XEO_CLAS Peptide DME1121 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.6 microM) DME1121 XEOTICID XEO03145 GENEFORM Protein DME1121 XEOTICID XEO03145 MOACRIVE Inhibition DME1121 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1121 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03146 XEO_CLAS Peptide DME1121 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.5 microM) DME1121 XEOTICID XEO03146 GENEFORM Protein DME1121 XEOTICID XEO03146 MOACRIVE Inhibition DME1121 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1121 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03147 XEO_CLAS Peptide DME1121 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 9.7 microM) DME1121 XEOTICID XEO03147 GENEFORM Protein DME1121 XEOTICID XEO03147 MOACRIVE Inhibition DME1121 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1121 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03148 XEO_CLAS Peptide DME1121 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.3 microM) DME1121 XEOTICID XEO03148 GENEFORM Protein DME1121 XEOTICID XEO03148 MOACRIVE Inhibition DME1121 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1121 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03149 XEO_CLAS Peptide DME1121 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.6 microM) DME1121 XEOTICID XEO03149 GENEFORM Protein DME1121 XEOTICID XEO03149 MOACRIVE Inhibition DME1121 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1121 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03150 XEO_CLAS Peptide DME1121 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 9-3 microM) DME1121 XEOTICID XEO03150 GENEFORM Protein DME1121 XEOTICID XEO03150 MOACRIVE Inhibition DME1121 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1121 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03151 XEO_CLAS Peptide DME1121 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 ug/ml) DME1121 XEOTICID XEO03151 GENEFORM Protein DME1121 XEOTICID XEO03151 MOACRIVE Inhibition DME1121 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1121 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03152 XEO_CLAS Peptide DME1121 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO03152 GENEFORM Protein DME1121 XEOTICID XEO03152 MOACRIVE Inhibition DME1121 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1121 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03155 XEO_CLAS Peptide DME1121 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.4 microM) DME1121 XEOTICID XEO03155 GENEFORM Protein DME1121 XEOTICID XEO03155 MOACRIVE Inhibition DME1121 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1121 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03156 XEO_CLAS Peptide DME1121 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.3 microM) DME1121 XEOTICID XEO03156 GENEFORM Protein DME1121 XEOTICID XEO03156 MOACRIVE Inhibition DME1121 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1121 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03157 XEO_CLAS Peptide DME1121 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.3 microM) DME1121 XEOTICID XEO03157 GENEFORM Protein DME1121 XEOTICID XEO03157 MOACRIVE Inhibition DME1121 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1121 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03158 XEO_CLAS Peptide DME1121 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 ug/ml) DME1121 XEOTICID XEO03158 GENEFORM Protein DME1121 XEOTICID XEO03158 MOACRIVE Inhibition DME1121 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1121 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03159 XEO_CLAS Peptide DME1121 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03159 GENEFORM Protein DME1121 XEOTICID XEO03159 MOACRIVE Inhibition DME1121 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1121 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03161 XEO_CLAS Peptide DME1121 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 microM) DME1121 XEOTICID XEO03161 GENEFORM Protein DME1121 XEOTICID XEO03161 MOACRIVE Inhibition DME1121 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1121 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03162 XEO_CLAS Peptide DME1121 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.5 microM) DME1121 XEOTICID XEO03162 GENEFORM Protein DME1121 XEOTICID XEO03162 MOACRIVE Inhibition DME1121 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1121 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03169 XEO_CLAS Peptide DME1121 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO03169 GENEFORM Protein DME1121 XEOTICID XEO03169 MOACRIVE Inhibition DME1121 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1121 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03193 XEO_CLAS Peptide DME1121 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25 ug/ml) DME1121 XEOTICID XEO03193 GENEFORM Protein DME1121 XEOTICID XEO03193 MOACRIVE Inhibition DME1121 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1121 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03194 XEO_CLAS Peptide DME1121 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03194 GENEFORM Protein DME1121 XEOTICID XEO03194 MOACRIVE Inhibition DME1121 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1121 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03195 XEO_CLAS Peptide DME1121 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03195 GENEFORM Protein DME1121 XEOTICID XEO03195 MOACRIVE Inhibition DME1121 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1121 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03197 XEO_CLAS Peptide DME1121 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 14.5 microM) DME1121 XEOTICID XEO03197 GENEFORM Protein DME1121 XEOTICID XEO03197 MOACRIVE Inhibition DME1121 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1121 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03202 XEO_CLAS Peptide DME1121 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.51 microM) DME1121 XEOTICID XEO03202 GENEFORM Protein DME1121 XEOTICID XEO03202 MOACRIVE Inhibition DME1121 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1121 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03203 XEO_CLAS Peptide DME1121 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.62 microM) DME1121 XEOTICID XEO03203 GENEFORM Protein DME1121 XEOTICID XEO03203 MOACRIVE Inhibition DME1121 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1121 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03204 XEO_CLAS Peptide DME1121 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.38 microM) DME1121 XEOTICID XEO03204 GENEFORM Protein DME1121 XEOTICID XEO03204 MOACRIVE Inhibition DME1121 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1121 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03205 XEO_CLAS Peptide DME1121 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.29 microM) DME1121 XEOTICID XEO03205 GENEFORM Protein DME1121 XEOTICID XEO03205 MOACRIVE Inhibition DME1121 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1121 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03206 XEO_CLAS Peptide DME1121 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.40 microM) DME1121 XEOTICID XEO03206 GENEFORM Protein DME1121 XEOTICID XEO03206 MOACRIVE Inhibition DME1121 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1121 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03207 XEO_CLAS Peptide DME1121 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.58 microM) DME1121 XEOTICID XEO03207 GENEFORM Protein DME1121 XEOTICID XEO03207 MOACRIVE Inhibition DME1121 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1121 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03208 XEO_CLAS Peptide DME1121 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.76 microM) DME1121 XEOTICID XEO03208 GENEFORM Protein DME1121 XEOTICID XEO03208 MOACRIVE Inhibition DME1121 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1121 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03209 XEO_CLAS Peptide DME1121 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.49 microM) DME1121 XEOTICID XEO03209 GENEFORM Protein DME1121 XEOTICID XEO03209 MOACRIVE Inhibition DME1121 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1121 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03210 XEO_CLAS Peptide DME1121 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 7.07 microM) DME1121 XEOTICID XEO03210 GENEFORM Protein DME1121 XEOTICID XEO03210 MOACRIVE Inhibition DME1121 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1121 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03211 XEO_CLAS Peptide DME1121 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.40 microM) DME1121 XEOTICID XEO03211 GENEFORM Protein DME1121 XEOTICID XEO03211 MOACRIVE Inhibition DME1121 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1121 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03215 XEO_CLAS Peptide DME1121 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20.0 ug/ml) DME1121 XEOTICID XEO03215 GENEFORM Protein DME1121 XEOTICID XEO03215 MOACRIVE Inhibition DME1121 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1121 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03216 XEO_CLAS Peptide DME1121 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO03216 GENEFORM Protein DME1121 XEOTICID XEO03216 MOACRIVE Inhibition DME1121 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1121 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03217 XEO_CLAS Peptide DME1121 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO03217 GENEFORM Protein DME1121 XEOTICID XEO03217 MOACRIVE Inhibition DME1121 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1121 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03223 XEO_CLAS Peptide DME1121 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.8 microM) DME1121 XEOTICID XEO03223 GENEFORM Protein DME1121 XEOTICID XEO03223 MOACRIVE Inhibition DME1121 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1121 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03224 XEO_CLAS Peptide DME1121 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.1-0.25 microM) DME1121 XEOTICID XEO03224 GENEFORM Protein DME1121 XEOTICID XEO03224 MOACRIVE Inhibition DME1121 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1121 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03225 XEO_CLAS Peptide DME1121 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.3 microM) DME1121 XEOTICID XEO03225 GENEFORM Protein DME1121 XEOTICID XEO03225 MOACRIVE Inhibition DME1121 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1121 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03227 XEO_CLAS Peptide DME1121 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.3 microM) DME1121 XEOTICID XEO03227 GENEFORM Protein DME1121 XEOTICID XEO03227 MOACRIVE Inhibition DME1121 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1121 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03231 XEO_CLAS Peptide DME1121 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03231 GENEFORM Protein DME1121 XEOTICID XEO03231 MOACRIVE Inhibition DME1121 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1121 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03232 XEO_CLAS Peptide DME1121 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03232 GENEFORM Protein DME1121 XEOTICID XEO03232 MOACRIVE Inhibition DME1121 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1121 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03234 XEO_CLAS Peptide DME1121 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO03234 GENEFORM Protein DME1121 XEOTICID XEO03234 MOACRIVE Inhibition DME1121 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1121 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03235 XEO_CLAS Peptide DME1121 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 60 ug/ml) DME1121 XEOTICID XEO03235 GENEFORM Protein DME1121 XEOTICID XEO03235 MOACRIVE Inhibition DME1121 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1121 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03236 XEO_CLAS Peptide DME1121 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO03236 GENEFORM Protein DME1121 XEOTICID XEO03236 MOACRIVE Inhibition DME1121 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1121 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03237 XEO_CLAS Peptide DME1121 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 ug/ml) DME1121 XEOTICID XEO03237 GENEFORM Protein DME1121 XEOTICID XEO03237 MOACRIVE Inhibition DME1121 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1121 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03238 XEO_CLAS Peptide DME1121 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 ug/ml) DME1121 XEOTICID XEO03238 GENEFORM Protein DME1121 XEOTICID XEO03238 MOACRIVE Inhibition DME1121 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1121 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03239 XEO_CLAS Peptide DME1121 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 60 ug/ml) DME1121 XEOTICID XEO03239 GENEFORM Protein DME1121 XEOTICID XEO03239 MOACRIVE Inhibition DME1121 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1121 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03241 XEO_CLAS Peptide DME1121 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 128 microM) DME1121 XEOTICID XEO03241 GENEFORM Protein DME1121 XEOTICID XEO03241 MOACRIVE Inhibition DME1121 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1121 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03250 XEO_CLAS Peptide DME1121 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03250 GENEFORM Protein DME1121 XEOTICID XEO03250 MOACRIVE Inhibition DME1121 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1121 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03251 XEO_CLAS Peptide DME1121 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03251 GENEFORM Protein DME1121 XEOTICID XEO03251 MOACRIVE Inhibition DME1121 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1121 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03253 XEO_CLAS Peptide DME1121 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.1 ug/ml) DME1121 XEOTICID XEO03253 GENEFORM Protein DME1121 XEOTICID XEO03253 MOACRIVE Inhibition DME1121 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1121 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03274 XEO_CLAS Peptide DME1121 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.2 microM) DME1121 XEOTICID XEO03274 GENEFORM Protein DME1121 XEOTICID XEO03274 MOACRIVE Inhibition DME1121 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1121 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03275 XEO_CLAS Peptide DME1121 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO03275 GENEFORM Protein DME1121 XEOTICID XEO03275 MOACRIVE Inhibition DME1121 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1121 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03276 XEO_CLAS Peptide DME1121 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO03276 GENEFORM Protein DME1121 XEOTICID XEO03276 MOACRIVE Inhibition DME1121 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1121 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03277 XEO_CLAS Peptide DME1121 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.2 microM) DME1121 XEOTICID XEO03277 GENEFORM Protein DME1121 XEOTICID XEO03277 MOACRIVE Inhibition DME1121 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1121 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03278 XEO_CLAS Peptide DME1121 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO03278 GENEFORM Protein DME1121 XEOTICID XEO03278 MOACRIVE Inhibition DME1121 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1121 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03279 XEO_CLAS Peptide DME1121 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO03279 GENEFORM Protein DME1121 XEOTICID XEO03279 MOACRIVE Inhibition DME1121 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1121 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03280 XEO_CLAS Peptide DME1121 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 microM) DME1121 XEOTICID XEO03280 GENEFORM Protein DME1121 XEOTICID XEO03280 MOACRIVE Inhibition DME1121 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1121 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03281 XEO_CLAS Peptide DME1121 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.3 microM) DME1121 XEOTICID XEO03281 GENEFORM Protein DME1121 XEOTICID XEO03281 MOACRIVE Inhibition DME1121 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1121 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03282 XEO_CLAS Peptide DME1121 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.1 microM) DME1121 XEOTICID XEO03282 GENEFORM Protein DME1121 XEOTICID XEO03282 MOACRIVE Inhibition DME1121 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1121 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03283 XEO_CLAS Peptide DME1121 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 microM) DME1121 XEOTICID XEO03283 GENEFORM Protein DME1121 XEOTICID XEO03283 MOACRIVE Inhibition DME1121 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1121 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03284 XEO_CLAS Peptide DME1121 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.2 ug/ml) DME1121 XEOTICID XEO03284 GENEFORM Protein DME1121 XEOTICID XEO03284 MOACRIVE Inhibition DME1121 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1121 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03285 XEO_CLAS Peptide DME1121 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.5 ug/ml) DME1121 XEOTICID XEO03285 GENEFORM Protein DME1121 XEOTICID XEO03285 MOACRIVE Inhibition DME1121 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1121 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03286 XEO_CLAS Peptide DME1121 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.4 ug/ml) DME1121 XEOTICID XEO03286 GENEFORM Protein DME1121 XEOTICID XEO03286 MOACRIVE Inhibition DME1121 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1121 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03287 XEO_CLAS Peptide DME1121 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.6 ug/ml) DME1121 XEOTICID XEO03287 GENEFORM Protein DME1121 XEOTICID XEO03287 MOACRIVE Inhibition DME1121 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1121 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03288 XEO_CLAS Peptide DME1121 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.4 ug/ml) DME1121 XEOTICID XEO03288 GENEFORM Protein DME1121 XEOTICID XEO03288 MOACRIVE Inhibition DME1121 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1121 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03289 XEO_CLAS Peptide DME1121 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8.8 ug/ml) DME1121 XEOTICID XEO03289 GENEFORM Protein DME1121 XEOTICID XEO03289 MOACRIVE Inhibition DME1121 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1121 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03290 XEO_CLAS Peptide DME1121 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.5 ug/ml) DME1121 XEOTICID XEO03290 GENEFORM Protein DME1121 XEOTICID XEO03290 MOACRIVE Inhibition DME1121 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1121 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03291 XEO_CLAS Peptide DME1121 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8.6 ug/ml) DME1121 XEOTICID XEO03291 GENEFORM Protein DME1121 XEOTICID XEO03291 MOACRIVE Inhibition DME1121 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1121 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03292 XEO_CLAS Peptide DME1121 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4.1 ug/ml) DME1121 XEOTICID XEO03292 GENEFORM Protein DME1121 XEOTICID XEO03292 MOACRIVE Inhibition DME1121 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1121 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03293 XEO_CLAS Peptide DME1121 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1 microM) DME1121 XEOTICID XEO03293 GENEFORM Protein DME1121 XEOTICID XEO03293 MOACRIVE Inhibition DME1121 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1121 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03294 XEO_CLAS Peptide DME1121 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1 microM) DME1121 XEOTICID XEO03294 GENEFORM Protein DME1121 XEOTICID XEO03294 MOACRIVE Inhibition DME1121 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1121 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03295 XEO_CLAS Peptide DME1121 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.7 microM) DME1121 XEOTICID XEO03295 GENEFORM Protein DME1121 XEOTICID XEO03295 MOACRIVE Inhibition DME1121 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1121 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03296 XEO_CLAS Peptide DME1121 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03296 GENEFORM Protein DME1121 XEOTICID XEO03296 MOACRIVE Inhibition DME1121 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1121 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03297 XEO_CLAS Peptide DME1121 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03297 GENEFORM Protein DME1121 XEOTICID XEO03297 MOACRIVE Inhibition DME1121 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1121 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03298 XEO_CLAS Peptide DME1121 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.2 microM) DME1121 XEOTICID XEO03298 GENEFORM Protein DME1121 XEOTICID XEO03298 MOACRIVE Inhibition DME1121 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1121 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03299 XEO_CLAS Peptide DME1121 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.4 microM) DME1121 XEOTICID XEO03299 GENEFORM Protein DME1121 XEOTICID XEO03299 MOACRIVE Inhibition DME1121 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1121 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03300 XEO_CLAS Peptide DME1121 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 ug/ml) DME1121 XEOTICID XEO03300 GENEFORM Protein DME1121 XEOTICID XEO03300 MOACRIVE Inhibition DME1121 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1121 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03301 XEO_CLAS Peptide DME1121 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 ug/ml) DME1121 XEOTICID XEO03301 GENEFORM Protein DME1121 XEOTICID XEO03301 MOACRIVE Inhibition DME1121 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1121 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03302 XEO_CLAS Peptide DME1121 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1 microM) DME1121 XEOTICID XEO03302 GENEFORM Protein DME1121 XEOTICID XEO03302 MOACRIVE Inhibition DME1121 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1121 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03303 XEO_CLAS Peptide DME1121 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 microM) DME1121 XEOTICID XEO03303 GENEFORM Protein DME1121 XEOTICID XEO03303 MOACRIVE Inhibition DME1121 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1121 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03304 XEO_CLAS Peptide DME1121 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO03304 GENEFORM Protein DME1121 XEOTICID XEO03304 MOACRIVE Inhibition DME1121 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1121 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03305 XEO_CLAS Peptide DME1121 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 microM) DME1121 XEOTICID XEO03305 GENEFORM Protein DME1121 XEOTICID XEO03305 MOACRIVE Inhibition DME1121 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1121 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03306 XEO_CLAS Peptide DME1121 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO03306 GENEFORM Protein DME1121 XEOTICID XEO03306 MOACRIVE Inhibition DME1121 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1121 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03307 XEO_CLAS Peptide DME1121 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 34 ug/ml) DME1121 XEOTICID XEO03307 GENEFORM Protein DME1121 XEOTICID XEO03307 MOACRIVE Inhibition DME1121 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1121 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03308 XEO_CLAS Peptide DME1121 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO03308 GENEFORM Protein DME1121 XEOTICID XEO03308 MOACRIVE Inhibition DME1121 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1121 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03310 XEO_CLAS Peptide DME1121 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8.5 ug/ml) DME1121 XEOTICID XEO03310 GENEFORM Protein DME1121 XEOTICID XEO03310 MOACRIVE Inhibition DME1121 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1121 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03311 XEO_CLAS Peptide DME1121 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10.8 ug/ml) DME1121 XEOTICID XEO03311 GENEFORM Protein DME1121 XEOTICID XEO03311 MOACRIVE Inhibition DME1121 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1121 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03312 XEO_CLAS Peptide DME1121 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10.8 ug/ml) DME1121 XEOTICID XEO03312 GENEFORM Protein DME1121 XEOTICID XEO03312 MOACRIVE Inhibition DME1121 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1121 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03313 XEO_CLAS Peptide DME1121 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8.1 ug/ml) DME1121 XEOTICID XEO03313 GENEFORM Protein DME1121 XEOTICID XEO03313 MOACRIVE Inhibition DME1121 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1121 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03314 XEO_CLAS Peptide DME1121 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 7.9 ug/ml) DME1121 XEOTICID XEO03314 GENEFORM Protein DME1121 XEOTICID XEO03314 MOACRIVE Inhibition DME1121 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1121 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03315 XEO_CLAS Peptide DME1121 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.6 ug/ml) DME1121 XEOTICID XEO03315 GENEFORM Protein DME1121 XEOTICID XEO03315 MOACRIVE Inhibition DME1121 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1121 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03316 XEO_CLAS Peptide DME1121 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15.8 ug/ml) DME1121 XEOTICID XEO03316 GENEFORM Protein DME1121 XEOTICID XEO03316 MOACRIVE Inhibition DME1121 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1121 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03317 XEO_CLAS Peptide DME1121 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO03317 GENEFORM Protein DME1121 XEOTICID XEO03317 MOACRIVE Inhibition DME1121 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1121 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03318 XEO_CLAS Peptide DME1121 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1 microM) DME1121 XEOTICID XEO03318 GENEFORM Protein DME1121 XEOTICID XEO03318 MOACRIVE Inhibition DME1121 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1121 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03319 XEO_CLAS Peptide DME1121 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03319 GENEFORM Protein DME1121 XEOTICID XEO03319 MOACRIVE Inhibition DME1121 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1121 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03320 XEO_CLAS Peptide DME1121 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.1 microM) DME1121 XEOTICID XEO03320 GENEFORM Protein DME1121 XEOTICID XEO03320 MOACRIVE Inhibition DME1121 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1121 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03321 XEO_CLAS Peptide DME1121 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.8 microM) DME1121 XEOTICID XEO03321 GENEFORM Protein DME1121 XEOTICID XEO03321 MOACRIVE Inhibition DME1121 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1121 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1121 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03348 GENEFORM Protein DME1121 XEOTICID XEO03348 MOACRIVE Inhibition DME1121 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1121 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03362 XEO_CLAS Peptide DME1121 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO03362 GENEFORM Protein DME1121 XEOTICID XEO03362 MOACRIVE Inhibition DME1121 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1121 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03363 XEO_CLAS Peptide DME1121 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 microM) DME1121 XEOTICID XEO03363 GENEFORM Protein DME1121 XEOTICID XEO03363 MOACRIVE Inhibition DME1121 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1121 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03364 XEO_CLAS Peptide DME1121 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 microM) DME1121 XEOTICID XEO03364 GENEFORM Protein DME1121 XEOTICID XEO03364 MOACRIVE Inhibition DME1121 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1121 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03365 XEO_CLAS Peptide DME1121 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03365 GENEFORM Protein DME1121 XEOTICID XEO03365 MOACRIVE Inhibition DME1121 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1121 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03366 XEO_CLAS Peptide DME1121 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO03366 GENEFORM Protein DME1121 XEOTICID XEO03366 MOACRIVE Inhibition DME1121 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1121 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03367 XEO_CLAS Peptide DME1121 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 microM) DME1121 XEOTICID XEO03367 GENEFORM Protein DME1121 XEOTICID XEO03367 MOACRIVE Inhibition DME1121 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1121 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03368 XEO_CLAS Peptide DME1121 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 microM) DME1121 XEOTICID XEO03368 GENEFORM Protein DME1121 XEOTICID XEO03368 MOACRIVE Inhibition DME1121 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1121 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03379 XEO_CLAS Peptide DME1121 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.6 ug/ml) DME1121 XEOTICID XEO03379 GENEFORM Protein DME1121 XEOTICID XEO03379 MOACRIVE Inhibition DME1121 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1121 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03396 XEO_CLAS Peptide DME1121 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03396 GENEFORM Protein DME1121 XEOTICID XEO03396 MOACRIVE Inhibition DME1121 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1121 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03398 XEO_CLAS Peptide DME1121 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03398 GENEFORM Protein DME1121 XEOTICID XEO03398 MOACRIVE Inhibition DME1121 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1121 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03399 XEO_CLAS Peptide DME1121 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03399 GENEFORM Protein DME1121 XEOTICID XEO03399 MOACRIVE Inhibition DME1121 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1121 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03406 XEO_CLAS Peptide DME1121 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 ug/ml) DME1121 XEOTICID XEO03406 GENEFORM Protein DME1121 XEOTICID XEO03406 MOACRIVE Inhibition DME1121 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1121 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03424 XEO_CLAS Peptide DME1121 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03424 GENEFORM Protein DME1121 XEOTICID XEO03424 MOACRIVE Inhibition DME1121 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1121 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03426 XEO_CLAS Peptide DME1121 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO03426 GENEFORM Protein DME1121 XEOTICID XEO03426 MOACRIVE Inhibition DME1121 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1121 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03427 XEO_CLAS Peptide DME1121 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 microM) DME1121 XEOTICID XEO03427 GENEFORM Protein DME1121 XEOTICID XEO03427 MOACRIVE Inhibition DME1121 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1121 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03428 XEO_CLAS Peptide DME1121 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 ug/ml) DME1121 XEOTICID XEO03428 GENEFORM Protein DME1121 XEOTICID XEO03428 MOACRIVE Inhibition DME1121 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1121 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03430 XEO_CLAS Peptide DME1121 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 ug/ml) DME1121 XEOTICID XEO03430 GENEFORM Protein DME1121 XEOTICID XEO03430 MOACRIVE Inhibition DME1121 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1121 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03434 XEO_CLAS Peptide DME1121 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO03434 GENEFORM Protein DME1121 XEOTICID XEO03434 MOACRIVE Inhibition DME1121 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1121 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03442 XEO_CLAS Peptide DME1121 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 18.75 ug/ml) DME1121 XEOTICID XEO03442 GENEFORM Protein DME1121 XEOTICID XEO03442 MOACRIVE Inhibition DME1121 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1121 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03444 XEO_CLAS Peptide DME1121 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 37.50 ug/ml) DME1121 XEOTICID XEO03444 GENEFORM Protein DME1121 XEOTICID XEO03444 MOACRIVE Inhibition DME1121 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1121 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03459 XEO_CLAS Peptide DME1121 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03459 GENEFORM Protein DME1121 XEOTICID XEO03459 MOACRIVE Inhibition DME1121 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1121 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03460 XEO_CLAS Peptide DME1121 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03460 GENEFORM Protein DME1121 XEOTICID XEO03460 MOACRIVE Inhibition DME1121 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1121 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03461 XEO_CLAS Peptide DME1121 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.05 microM) DME1121 XEOTICID XEO03461 GENEFORM Protein DME1121 XEOTICID XEO03461 MOACRIVE Inhibition DME1121 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1121 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03462 XEO_CLAS Peptide DME1121 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03462 GENEFORM Protein DME1121 XEOTICID XEO03462 MOACRIVE Inhibition DME1121 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1121 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03463 XEO_CLAS Peptide DME1121 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03463 GENEFORM Protein DME1121 XEOTICID XEO03463 MOACRIVE Inhibition DME1121 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1121 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03467 XEO_CLAS Peptide DME1121 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03467 GENEFORM Protein DME1121 XEOTICID XEO03467 MOACRIVE Inhibition DME1121 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1121 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03468 XEO_CLAS Peptide DME1121 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03468 GENEFORM Protein DME1121 XEOTICID XEO03468 MOACRIVE Inhibition DME1121 XEOTICID XEO03471 XEO_NAME Gambicin DME1121 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03471 XEO_CLAS Peptide DME1121 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25-12.5 microM) DME1121 XEOTICID XEO03471 GENEFORM Protein DME1121 XEOTICID XEO03471 MOACRIVE Inhibition DME1121 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1121 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03485 XEO_CLAS Peptide DME1121 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4.07 ug/ml) DME1121 XEOTICID XEO03485 GENEFORM Protein DME1121 XEOTICID XEO03485 MOACRIVE Inhibition DME1121 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1121 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03486 XEO_CLAS Peptide DME1121 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.80 ug/ml) DME1121 XEOTICID XEO03486 GENEFORM Protein DME1121 XEOTICID XEO03486 MOACRIVE Inhibition DME1121 XEOTICID XEO03488 XEO_NAME GLK-19 DME1121 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03488 XEO_CLAS Peptide DME1121 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO03488 GENEFORM Protein DME1121 XEOTICID XEO03488 MOACRIVE Inhibition DME1121 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1121 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03497 XEO_CLAS Peptide DME1121 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.4-0.8 microM) DME1121 XEOTICID XEO03497 GENEFORM Protein DME1121 XEOTICID XEO03497 MOACRIVE Inhibition DME1121 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1121 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03498 XEO_CLAS Peptide DME1121 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.4-0.8 microM) DME1121 XEOTICID XEO03498 GENEFORM Protein DME1121 XEOTICID XEO03498 MOACRIVE Inhibition DME1121 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1121 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03500 XEO_CLAS Peptide DME1121 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-30 ug/ml) DME1121 XEOTICID XEO03500 GENEFORM Protein DME1121 XEOTICID XEO03500 MOACRIVE Inhibition DME1121 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1121 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03504 XEO_CLAS Peptide DME1121 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 ug/ml) DME1121 XEOTICID XEO03504 GENEFORM Protein DME1121 XEOTICID XEO03504 MOACRIVE Inhibition DME1121 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1121 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03505 XEO_CLAS Peptide DME1121 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 ug/ml) DME1121 XEOTICID XEO03505 GENEFORM Protein DME1121 XEOTICID XEO03505 MOACRIVE Inhibition DME1121 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1121 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03506 XEO_CLAS Peptide DME1121 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 ug/ml) DME1121 XEOTICID XEO03506 GENEFORM Protein DME1121 XEOTICID XEO03506 MOACRIVE Inhibition DME1121 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1121 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03513 XEO_CLAS Peptide DME1121 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO03513 GENEFORM Protein DME1121 XEOTICID XEO03513 MOACRIVE Inhibition DME1121 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1121 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03514 XEO_CLAS Peptide DME1121 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03514 GENEFORM Protein DME1121 XEOTICID XEO03514 MOACRIVE Inhibition DME1121 XEOTICID XEO03519 XEO_NAME Hadrurin DME1121 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03519 XEO_CLAS Peptide DME1121 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03519 GENEFORM Protein DME1121 XEOTICID XEO03519 MOACRIVE Inhibition DME1121 XEOTICID XEO03522 XEO_NAME Halocyntin DME1121 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03522 XEO_CLAS Peptide DME1121 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03522 GENEFORM Protein DME1121 XEOTICID XEO03522 MOACRIVE Inhibition DME1121 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1121 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03524 XEO_CLAS Peptide DME1121 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03524 GENEFORM Protein DME1121 XEOTICID XEO03524 MOACRIVE Inhibition DME1121 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1121 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03525 XEO_CLAS Peptide DME1121 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03525 GENEFORM Protein DME1121 XEOTICID XEO03525 MOACRIVE Inhibition DME1121 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1121 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03530 XEO_CLAS Peptide DME1121 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03530 GENEFORM Protein DME1121 XEOTICID XEO03530 MOACRIVE Inhibition DME1121 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1121 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03535 XEO_CLAS Peptide DME1121 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.4 microM) DME1121 XEOTICID XEO03535 GENEFORM Protein DME1121 XEOTICID XEO03535 MOACRIVE Inhibition DME1121 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1121 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03536 XEO_CLAS Peptide DME1121 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 80 microM) DME1121 XEOTICID XEO03536 GENEFORM Protein DME1121 XEOTICID XEO03536 MOACRIVE Inhibition DME1121 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1121 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03537 XEO_CLAS Peptide DME1121 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 ug/ml) DME1121 XEOTICID XEO03537 GENEFORM Protein DME1121 XEOTICID XEO03537 MOACRIVE Inhibition DME1121 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1121 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03538 XEO_CLAS Peptide DME1121 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 ug/ml) DME1121 XEOTICID XEO03538 GENEFORM Protein DME1121 XEOTICID XEO03538 MOACRIVE Inhibition DME1121 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1121 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03540 XEO_CLAS Peptide DME1121 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO03540 GENEFORM Protein DME1121 XEOTICID XEO03540 MOACRIVE Inhibition DME1121 XEOTICID XEO03542 XEO_NAME Hepcidin DME1121 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03542 XEO_CLAS Peptide DME1121 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 24 microM) DME1121 XEOTICID XEO03542 GENEFORM Protein DME1121 XEOTICID XEO03542 MOACRIVE Inhibition DME1121 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1121 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03544 XEO_CLAS Peptide DME1121 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03544 GENEFORM Protein DME1121 XEOTICID XEO03544 MOACRIVE Inhibition DME1121 XEOTICID XEO03548 XEO_NAME Hesperidin DME1121 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03548 GENEFORM Protein DME1121 XEOTICID XEO03548 MOACRIVE Inhibition DME1121 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1121 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1121 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03552 GENEFORM Protein DME1121 XEOTICID XEO03552 MOACRIVE Inhibition DME1121 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1121 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03556 XEO_CLAS Peptide DME1121 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO03556 GENEFORM Protein DME1121 XEOTICID XEO03556 MOACRIVE Inhibition DME1121 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1121 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03557 XEO_CLAS Peptide DME1121 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO03557 GENEFORM Protein DME1121 XEOTICID XEO03557 MOACRIVE Inhibition DME1121 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1121 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03558 XEO_CLAS Peptide DME1121 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 microM) DME1121 XEOTICID XEO03558 GENEFORM Protein DME1121 XEOTICID XEO03558 MOACRIVE Inhibition DME1121 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1121 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03559 XEO_CLAS Peptide DME1121 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 microM) DME1121 XEOTICID XEO03559 GENEFORM Protein DME1121 XEOTICID XEO03559 MOACRIVE Inhibition DME1121 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1121 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03560 XEO_CLAS Peptide DME1121 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 microM) DME1121 XEOTICID XEO03560 GENEFORM Protein DME1121 XEOTICID XEO03560 MOACRIVE Inhibition DME1121 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1121 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03561 XEO_CLAS Peptide DME1121 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03561 GENEFORM Protein DME1121 XEOTICID XEO03561 MOACRIVE Inhibition DME1121 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1121 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03567 XEO_CLAS Peptide DME1121 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03567 GENEFORM Protein DME1121 XEOTICID XEO03567 MOACRIVE Inhibition DME1121 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1121 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03569 XEO_CLAS Peptide DME1121 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 300 microM) DME1121 XEOTICID XEO03569 GENEFORM Protein DME1121 XEOTICID XEO03569 MOACRIVE Inhibition DME1121 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1121 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03570 XEO_CLAS Peptide DME1121 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03570 GENEFORM Protein DME1121 XEOTICID XEO03570 MOACRIVE Inhibition DME1121 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1121 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03572 XEO_CLAS Peptide DME1121 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1121 XEOTICID XEO03572 GENEFORM Protein DME1121 XEOTICID XEO03572 MOACRIVE Inhibition DME1121 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1121 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03573 XEO_CLAS Peptide DME1121 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 28.1 ug/ml) DME1121 XEOTICID XEO03573 GENEFORM Protein DME1121 XEOTICID XEO03573 MOACRIVE Inhibition DME1121 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1121 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03574 XEO_CLAS Peptide DME1121 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 500 microM) DME1121 XEOTICID XEO03574 GENEFORM Protein DME1121 XEOTICID XEO03574 MOACRIVE Inhibition DME1121 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1121 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03575 XEO_CLAS Peptide DME1121 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 18 microM) DME1121 XEOTICID XEO03575 GENEFORM Protein DME1121 XEOTICID XEO03575 MOACRIVE Inhibition DME1121 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1121 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03576 XEO_CLAS Peptide DME1121 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 750 microM) DME1121 XEOTICID XEO03576 GENEFORM Protein DME1121 XEOTICID XEO03576 MOACRIVE Inhibition DME1121 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1121 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03578 XEO_CLAS Peptide DME1121 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1121 XEOTICID XEO03578 GENEFORM Protein DME1121 XEOTICID XEO03578 MOACRIVE Inhibition DME1121 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1121 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03579 XEO_CLAS Peptide DME1121 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03579 GENEFORM Protein DME1121 XEOTICID XEO03579 MOACRIVE Inhibition DME1121 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1121 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03580 XEO_CLAS Peptide DME1121 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03580 GENEFORM Protein DME1121 XEOTICID XEO03580 MOACRIVE Inhibition DME1121 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1121 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03585 XEO_CLAS Peptide DME1121 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 125 ug/ml) DME1121 XEOTICID XEO03585 GENEFORM Protein DME1121 XEOTICID XEO03585 MOACRIVE Inhibition DME1121 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1121 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03588 XEO_CLAS Peptide DME1121 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 62 ug/ml) DME1121 XEOTICID XEO03588 GENEFORM Protein DME1121 XEOTICID XEO03588 MOACRIVE Inhibition DME1121 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1121 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03589 XEO_CLAS Peptide DME1121 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03589 GENEFORM Protein DME1121 XEOTICID XEO03589 MOACRIVE Inhibition DME1121 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1121 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03590 XEO_CLAS Peptide DME1121 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03590 GENEFORM Protein DME1121 XEOTICID XEO03590 MOACRIVE Inhibition DME1121 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1121 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03591 XEO_CLAS Peptide DME1121 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 37.5 ug/ml) DME1121 XEOTICID XEO03591 GENEFORM Protein DME1121 XEOTICID XEO03591 MOACRIVE Inhibition DME1121 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1121 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03593 XEO_CLAS Peptide DME1121 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 9.4 ug/ml) DME1121 XEOTICID XEO03593 GENEFORM Protein DME1121 XEOTICID XEO03593 MOACRIVE Inhibition DME1121 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1121 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03594 XEO_CLAS Peptide DME1121 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 ug/ml) DME1121 XEOTICID XEO03594 GENEFORM Protein DME1121 XEOTICID XEO03594 MOACRIVE Inhibition DME1121 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1121 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03595 XEO_CLAS Peptide DME1121 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03595 GENEFORM Protein DME1121 XEOTICID XEO03595 MOACRIVE Inhibition DME1121 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1121 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03596 XEO_CLAS Peptide DME1121 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03596 GENEFORM Protein DME1121 XEOTICID XEO03596 MOACRIVE Inhibition DME1121 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1121 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03598 XEO_CLAS Peptide DME1121 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03598 GENEFORM Protein DME1121 XEOTICID XEO03598 MOACRIVE Inhibition DME1121 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1121 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03599 XEO_CLAS Peptide DME1121 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03599 GENEFORM Protein DME1121 XEOTICID XEO03599 MOACRIVE Inhibition DME1121 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1121 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03600 XEO_CLAS Peptide DME1121 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03600 GENEFORM Protein DME1121 XEOTICID XEO03600 MOACRIVE Inhibition DME1121 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1121 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03606 XEO_CLAS Peptide DME1121 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03606 GENEFORM Protein DME1121 XEOTICID XEO03606 MOACRIVE Inhibition DME1121 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1121 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03607 XEO_CLAS Peptide DME1121 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03607 GENEFORM Protein DME1121 XEOTICID XEO03607 MOACRIVE Inhibition DME1121 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1121 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03609 XEO_CLAS Peptide DME1121 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03609 GENEFORM Protein DME1121 XEOTICID XEO03609 MOACRIVE Inhibition DME1121 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1121 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03615 XEO_CLAS Peptide DME1121 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1121 XEOTICID XEO03615 GENEFORM Protein DME1121 XEOTICID XEO03615 MOACRIVE Inhibition DME1121 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1121 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03616 XEO_CLAS Peptide DME1121 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 32 microM) DME1121 XEOTICID XEO03616 GENEFORM Protein DME1121 XEOTICID XEO03616 MOACRIVE Inhibition DME1121 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1121 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03617 XEO_CLAS Peptide DME1121 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40 microM) DME1121 XEOTICID XEO03617 GENEFORM Protein DME1121 XEOTICID XEO03617 MOACRIVE Inhibition DME1121 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1121 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03618 XEO_CLAS Peptide DME1121 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5-1 microM) DME1121 XEOTICID XEO03618 GENEFORM Protein DME1121 XEOTICID XEO03618 MOACRIVE Inhibition DME1121 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1121 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03622 XEO_CLAS Peptide DME1121 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20-40 microM) DME1121 XEOTICID XEO03622 GENEFORM Protein DME1121 XEOTICID XEO03622 MOACRIVE Inhibition DME1121 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1121 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03627 XEO_CLAS Peptide DME1121 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.4-0.8 microM) DME1121 XEOTICID XEO03627 GENEFORM Protein DME1121 XEOTICID XEO03627 MOACRIVE Inhibition DME1121 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1121 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03630 XEO_CLAS Peptide DME1121 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03630 GENEFORM Protein DME1121 XEOTICID XEO03630 MOACRIVE Inhibition DME1121 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1121 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03631 XEO_CLAS Peptide DME1121 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03631 GENEFORM Protein DME1121 XEOTICID XEO03631 MOACRIVE Inhibition DME1121 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1121 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03632 XEO_CLAS Peptide DME1121 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03632 GENEFORM Protein DME1121 XEOTICID XEO03632 MOACRIVE Inhibition DME1121 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1121 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03633 XEO_CLAS Peptide DME1121 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03633 GENEFORM Protein DME1121 XEOTICID XEO03633 MOACRIVE Inhibition DME1121 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1121 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03634 XEO_CLAS Peptide DME1121 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03634 GENEFORM Protein DME1121 XEOTICID XEO03634 MOACRIVE Inhibition DME1121 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1121 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03635 XEO_CLAS Peptide DME1121 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03635 GENEFORM Protein DME1121 XEOTICID XEO03635 MOACRIVE Inhibition DME1121 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1121 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03636 XEO_CLAS Peptide DME1121 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03636 GENEFORM Protein DME1121 XEOTICID XEO03636 MOACRIVE Inhibition DME1121 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1121 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03637 XEO_CLAS Peptide DME1121 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03637 GENEFORM Protein DME1121 XEOTICID XEO03637 MOACRIVE Inhibition DME1121 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1121 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03638 XEO_CLAS Peptide DME1121 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03638 GENEFORM Protein DME1121 XEOTICID XEO03638 MOACRIVE Inhibition DME1121 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1121 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03639 XEO_CLAS Peptide DME1121 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03639 GENEFORM Protein DME1121 XEOTICID XEO03639 MOACRIVE Inhibition DME1121 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1121 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03640 XEO_CLAS Peptide DME1121 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03640 GENEFORM Protein DME1121 XEOTICID XEO03640 MOACRIVE Inhibition DME1121 XEOTICID XEO03644 XEO_NAME Indole DME1121 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1121 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1121 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03644 GENEFORM Protein DME1121 XEOTICID XEO03644 MOACRIVE Inhibition DME1121 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1121 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03650 XEO_CLAS Peptide DME1121 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03650 GENEFORM Protein DME1121 XEOTICID XEO03650 MOACRIVE Inhibition DME1121 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1121 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO03655 XEO_CLAS Natural Product DME1121 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03655 GENEFORM Protein DME1121 XEOTICID XEO03655 MOACRIVE Inhibition DME1121 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1121 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03666 XEO_CLAS Peptide DME1121 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 ug/ml) DME1121 XEOTICID XEO03666 GENEFORM Protein DME1121 XEOTICID XEO03666 MOACRIVE Inhibition DME1121 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1121 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03667 XEO_CLAS Peptide DME1121 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 ug/ml) DME1121 XEOTICID XEO03667 GENEFORM Protein DME1121 XEOTICID XEO03667 MOACRIVE Inhibition DME1121 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1121 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03668 XEO_CLAS Peptide DME1121 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 microM) DME1121 XEOTICID XEO03668 GENEFORM Protein DME1121 XEOTICID XEO03668 MOACRIVE Inhibition DME1121 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1121 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03669 XEO_CLAS Peptide DME1121 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO03669 GENEFORM Protein DME1121 XEOTICID XEO03669 MOACRIVE Inhibition DME1121 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1121 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03670 XEO_CLAS Peptide DME1121 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 microM) DME1121 XEOTICID XEO03670 GENEFORM Protein DME1121 XEOTICID XEO03670 MOACRIVE Inhibition DME1121 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1121 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03672 XEO_CLAS Peptide DME1121 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.5 ug/ml) DME1121 XEOTICID XEO03672 GENEFORM Protein DME1121 XEOTICID XEO03672 MOACRIVE Inhibition DME1121 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1121 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03673 XEO_CLAS Peptide DME1121 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 ug/ml) DME1121 XEOTICID XEO03673 GENEFORM Protein DME1121 XEOTICID XEO03673 MOACRIVE Inhibition DME1121 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1121 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03674 XEO_CLAS Peptide DME1121 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 ug/ml) DME1121 XEOTICID XEO03674 GENEFORM Protein DME1121 XEOTICID XEO03674 MOACRIVE Inhibition DME1121 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1121 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03675 XEO_CLAS Peptide DME1121 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO03675 GENEFORM Protein DME1121 XEOTICID XEO03675 MOACRIVE Inhibition DME1121 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1121 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03678 XEO_CLAS Peptide DME1121 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 ug/ml) DME1121 XEOTICID XEO03678 GENEFORM Protein DME1121 XEOTICID XEO03678 MOACRIVE Inhibition DME1121 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1121 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03679 XEO_CLAS Peptide DME1121 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 ug/ml) DME1121 XEOTICID XEO03679 GENEFORM Protein DME1121 XEOTICID XEO03679 MOACRIVE Inhibition DME1121 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1121 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03681 XEO_CLAS Peptide DME1121 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.3-0.6 microM) DME1121 XEOTICID XEO03681 GENEFORM Protein DME1121 XEOTICID XEO03681 MOACRIVE Inhibition DME1121 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1121 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03684 XEO_CLAS Peptide DME1121 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 ug/ml) DME1121 XEOTICID XEO03684 GENEFORM Protein DME1121 XEOTICID XEO03684 MOACRIVE Inhibition DME1121 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1121 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03694 XEO_CLAS Peptide DME1121 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03694 GENEFORM Protein DME1121 XEOTICID XEO03694 MOACRIVE Inhibition DME1121 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1121 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03697 XEO_CLAS Peptide DME1121 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25 microM) DME1121 XEOTICID XEO03697 GENEFORM Protein DME1121 XEOTICID XEO03697 MOACRIVE Inhibition DME1121 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1121 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03698 XEO_CLAS Peptide DME1121 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03698 GENEFORM Protein DME1121 XEOTICID XEO03698 MOACRIVE Inhibition DME1121 XEOTICID XEO03703 XEO_NAME Kasstasin DME1121 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03703 XEO_CLAS Peptide DME1121 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 110 microM) DME1121 XEOTICID XEO03703 GENEFORM Protein DME1121 XEOTICID XEO03703 MOACRIVE Inhibition DME1121 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1121 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03706 XEO_CLAS Peptide DME1121 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03706 GENEFORM Protein DME1121 XEOTICID XEO03706 MOACRIVE Inhibition DME1121 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1121 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03707 XEO_CLAS Peptide DME1121 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03707 GENEFORM Protein DME1121 XEOTICID XEO03707 MOACRIVE Inhibition DME1121 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1121 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03709 XEO_CLAS Peptide DME1121 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 ug/ml) DME1121 XEOTICID XEO03709 GENEFORM Protein DME1121 XEOTICID XEO03709 MOACRIVE Inhibition DME1121 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1121 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03712 XEO_CLAS Peptide DME1121 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03712 GENEFORM Protein DME1121 XEOTICID XEO03712 MOACRIVE Inhibition DME1121 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1121 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03713 XEO_CLAS Peptide DME1121 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 64 microM) DME1121 XEOTICID XEO03713 GENEFORM Protein DME1121 XEOTICID XEO03713 MOACRIVE Inhibition DME1121 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1121 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03714 XEO_CLAS Peptide DME1121 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03714 GENEFORM Protein DME1121 XEOTICID XEO03714 MOACRIVE Inhibition DME1121 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1121 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03715 XEO_CLAS Peptide DME1121 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 microM) DME1121 XEOTICID XEO03715 GENEFORM Protein DME1121 XEOTICID XEO03715 MOACRIVE Inhibition DME1121 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1121 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03719 XEO_CLAS Peptide DME1121 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 microM) DME1121 XEOTICID XEO03719 GENEFORM Protein DME1121 XEOTICID XEO03719 MOACRIVE Inhibition DME1121 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1121 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03720 XEO_CLAS Peptide DME1121 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 microM) DME1121 XEOTICID XEO03720 GENEFORM Protein DME1121 XEOTICID XEO03720 MOACRIVE Inhibition DME1121 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1121 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03723 XEO_CLAS Peptide DME1121 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 62.36 microM) DME1121 XEOTICID XEO03723 GENEFORM Protein DME1121 XEOTICID XEO03723 MOACRIVE Inhibition DME1121 XEOTICID XEO03724 XEO_NAME L10 peptide DME1121 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03724 XEO_CLAS Peptide DME1121 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.8 microM) DME1121 XEOTICID XEO03724 GENEFORM Protein DME1121 XEOTICID XEO03724 MOACRIVE Inhibition DME1121 XEOTICID XEO03726 XEO_NAME L2 peptide DME1121 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03726 XEO_CLAS Peptide DME1121 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 129.66 microM) DME1121 XEOTICID XEO03726 GENEFORM Protein DME1121 XEOTICID XEO03726 MOACRIVE Inhibition DME1121 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1121 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03727 XEO_CLAS Peptide DME1121 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 80 ug/ml) DME1121 XEOTICID XEO03727 GENEFORM Protein DME1121 XEOTICID XEO03727 MOACRIVE Inhibition DME1121 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1121 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03728 XEO_CLAS Peptide DME1121 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40 ug/ml) DME1121 XEOTICID XEO03728 GENEFORM Protein DME1121 XEOTICID XEO03728 MOACRIVE Inhibition DME1121 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1121 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03729 XEO_CLAS Peptide DME1121 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 80 ug/ml) DME1121 XEOTICID XEO03729 GENEFORM Protein DME1121 XEOTICID XEO03729 MOACRIVE Inhibition DME1121 XEOTICID XEO03730 XEO_NAME L3 peptide DME1121 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03730 XEO_CLAS Peptide DME1121 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64.11 microM) DME1121 XEOTICID XEO03730 GENEFORM Protein DME1121 XEOTICID XEO03730 MOACRIVE Inhibition DME1121 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1121 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03731 XEO_CLAS Peptide DME1121 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40 ug/ml) DME1121 XEOTICID XEO03731 GENEFORM Protein DME1121 XEOTICID XEO03731 MOACRIVE Inhibition DME1121 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1121 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03733 XEO_CLAS Peptide DME1121 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40 ug/ml) DME1121 XEOTICID XEO03733 GENEFORM Protein DME1121 XEOTICID XEO03733 MOACRIVE Inhibition DME1121 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1121 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03734 XEO_CLAS Peptide DME1121 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO03734 GENEFORM Protein DME1121 XEOTICID XEO03734 MOACRIVE Inhibition DME1121 XEOTICID XEO03735 XEO_NAME L4 peptide DME1121 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03735 XEO_CLAS Peptide DME1121 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 31.61 microM) DME1121 XEOTICID XEO03735 GENEFORM Protein DME1121 XEOTICID XEO03735 MOACRIVE Inhibition DME1121 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1121 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03738 XEO_CLAS Peptide DME1121 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 ug/ml) DME1121 XEOTICID XEO03738 GENEFORM Protein DME1121 XEOTICID XEO03738 MOACRIVE Inhibition DME1121 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1121 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03741 XEO_CLAS Peptide DME1121 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40 ug/ml) DME1121 XEOTICID XEO03741 GENEFORM Protein DME1121 XEOTICID XEO03741 MOACRIVE Inhibition DME1121 XEOTICID XEO03742 XEO_NAME L5 peptide DME1121 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03742 XEO_CLAS Peptide DME1121 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 7.79 microM) DME1121 XEOTICID XEO03742 GENEFORM Protein DME1121 XEOTICID XEO03742 MOACRIVE Inhibition DME1121 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1121 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03743 XEO_CLAS Peptide DME1121 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 ug/ml) DME1121 XEOTICID XEO03743 GENEFORM Protein DME1121 XEOTICID XEO03743 MOACRIVE Inhibition DME1121 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1121 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03744 XEO_CLAS Peptide DME1121 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 ug/ml) DME1121 XEOTICID XEO03744 GENEFORM Protein DME1121 XEOTICID XEO03744 MOACRIVE Inhibition DME1121 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1121 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03745 XEO_CLAS Peptide DME1121 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 ug/ml) DME1121 XEOTICID XEO03745 GENEFORM Protein DME1121 XEOTICID XEO03745 MOACRIVE Inhibition DME1121 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1121 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03746 XEO_CLAS Peptide DME1121 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO03746 GENEFORM Protein DME1121 XEOTICID XEO03746 MOACRIVE Inhibition DME1121 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1121 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03747 XEO_CLAS Peptide DME1121 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO03747 GENEFORM Protein DME1121 XEOTICID XEO03747 MOACRIVE Inhibition DME1121 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1121 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03748 XEO_CLAS Peptide DME1121 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO03748 GENEFORM Protein DME1121 XEOTICID XEO03748 MOACRIVE Inhibition DME1121 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1121 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03749 XEO_CLAS Peptide DME1121 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO03749 GENEFORM Protein DME1121 XEOTICID XEO03749 MOACRIVE Inhibition DME1121 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1121 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03750 XEO_CLAS Peptide DME1121 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO03750 GENEFORM Protein DME1121 XEOTICID XEO03750 MOACRIVE Inhibition DME1121 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1121 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03751 XEO_CLAS Peptide DME1121 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO03751 GENEFORM Protein DME1121 XEOTICID XEO03751 MOACRIVE Inhibition DME1121 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1121 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03752 XEO_CLAS Peptide DME1121 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO03752 GENEFORM Protein DME1121 XEOTICID XEO03752 MOACRIVE Inhibition DME1121 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1121 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03753 XEO_CLAS Peptide DME1121 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 ug/ml) DME1121 XEOTICID XEO03753 GENEFORM Protein DME1121 XEOTICID XEO03753 MOACRIVE Inhibition DME1121 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1121 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03754 XEO_CLAS Peptide DME1121 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO03754 GENEFORM Protein DME1121 XEOTICID XEO03754 MOACRIVE Inhibition DME1121 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1121 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03755 XEO_CLAS Peptide DME1121 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO03755 GENEFORM Protein DME1121 XEOTICID XEO03755 MOACRIVE Inhibition DME1121 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1121 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03756 XEO_CLAS Peptide DME1121 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO03756 GENEFORM Protein DME1121 XEOTICID XEO03756 MOACRIVE Inhibition DME1121 XEOTICID XEO03757 XEO_NAME L6 peptide DME1121 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03757 XEO_CLAS Peptide DME1121 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15.17 microM) DME1121 XEOTICID XEO03757 GENEFORM Protein DME1121 XEOTICID XEO03757 MOACRIVE Inhibition DME1121 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1121 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03758 XEO_CLAS Peptide DME1121 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 80 ug/ml) DME1121 XEOTICID XEO03758 GENEFORM Protein DME1121 XEOTICID XEO03758 MOACRIVE Inhibition DME1121 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1121 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03759 XEO_CLAS Peptide DME1121 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.3 ug/ml) DME1121 XEOTICID XEO03759 GENEFORM Protein DME1121 XEOTICID XEO03759 MOACRIVE Inhibition DME1121 XEOTICID XEO03760 XEO_NAME L7 peptide DME1121 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03760 XEO_CLAS Peptide DME1121 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16.02 microM) DME1121 XEOTICID XEO03760 GENEFORM Protein DME1121 XEOTICID XEO03760 MOACRIVE Inhibition DME1121 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1121 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03761 XEO_CLAS Peptide DME1121 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 ug/ml) DME1121 XEOTICID XEO03761 GENEFORM Protein DME1121 XEOTICID XEO03761 MOACRIVE Inhibition DME1121 XEOTICID XEO03763 XEO_NAME L8 peptide DME1121 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03763 XEO_CLAS Peptide DME1121 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.71 microM) DME1121 XEOTICID XEO03763 GENEFORM Protein DME1121 XEOTICID XEO03763 MOACRIVE Inhibition DME1121 XEOTICID XEO03765 XEO_NAME L9 peptide DME1121 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03765 XEO_CLAS Peptide DME1121 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.78 microM) DME1121 XEOTICID XEO03765 GENEFORM Protein DME1121 XEOTICID XEO03765 MOACRIVE Inhibition DME1121 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1121 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03775 XEO_CLAS Peptide DME1121 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 17.3 microM) DME1121 XEOTICID XEO03775 GENEFORM Protein DME1121 XEOTICID XEO03775 MOACRIVE Inhibition DME1121 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1121 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03776 XEO_CLAS Peptide DME1121 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03776 GENEFORM Protein DME1121 XEOTICID XEO03776 MOACRIVE Inhibition DME1121 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1121 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03781 XEO_CLAS Peptide DME1121 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.47 microM) DME1121 XEOTICID XEO03781 GENEFORM Protein DME1121 XEOTICID XEO03781 MOACRIVE Inhibition DME1121 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1121 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03782 XEO_CLAS Peptide DME1121 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.47 microM) DME1121 XEOTICID XEO03782 GENEFORM Protein DME1121 XEOTICID XEO03782 MOACRIVE Inhibition DME1121 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1121 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03783 XEO_CLAS Peptide DME1121 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.68 microM) DME1121 XEOTICID XEO03783 GENEFORM Protein DME1121 XEOTICID XEO03783 MOACRIVE Inhibition DME1121 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1121 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03784 XEO_CLAS Peptide DME1121 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.45 microM) DME1121 XEOTICID XEO03784 GENEFORM Protein DME1121 XEOTICID XEO03784 MOACRIVE Inhibition DME1121 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1121 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03785 XEO_CLAS Peptide DME1121 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.73 microM) DME1121 XEOTICID XEO03785 GENEFORM Protein DME1121 XEOTICID XEO03785 MOACRIVE Inhibition DME1121 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1121 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03786 XEO_CLAS Peptide DME1121 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.45 microM) DME1121 XEOTICID XEO03786 GENEFORM Protein DME1121 XEOTICID XEO03786 MOACRIVE Inhibition DME1121 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1121 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03787 XEO_CLAS Peptide DME1121 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.38 microM) DME1121 XEOTICID XEO03787 GENEFORM Protein DME1121 XEOTICID XEO03787 MOACRIVE Inhibition DME1121 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1121 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03788 XEO_CLAS Peptide DME1121 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.46 microM) DME1121 XEOTICID XEO03788 GENEFORM Protein DME1121 XEOTICID XEO03788 MOACRIVE Inhibition DME1121 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1121 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03789 XEO_CLAS Peptide DME1121 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 13.05 microM) DME1121 XEOTICID XEO03789 GENEFORM Protein DME1121 XEOTICID XEO03789 MOACRIVE Inhibition DME1121 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1121 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03790 XEO_CLAS Peptide DME1121 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.82 microM) DME1121 XEOTICID XEO03790 GENEFORM Protein DME1121 XEOTICID XEO03790 MOACRIVE Inhibition DME1121 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1121 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03791 XEO_CLAS Peptide DME1121 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.80 microM) DME1121 XEOTICID XEO03791 GENEFORM Protein DME1121 XEOTICID XEO03791 MOACRIVE Inhibition DME1121 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1121 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03792 XEO_CLAS Peptide DME1121 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.26 microM) DME1121 XEOTICID XEO03792 GENEFORM Protein DME1121 XEOTICID XEO03792 MOACRIVE Inhibition DME1121 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1121 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03793 XEO_CLAS Peptide DME1121 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 microM) DME1121 XEOTICID XEO03793 GENEFORM Protein DME1121 XEOTICID XEO03793 MOACRIVE Inhibition DME1121 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1121 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03797 XEO_CLAS Peptide DME1121 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.4 microM) DME1121 XEOTICID XEO03797 GENEFORM Protein DME1121 XEOTICID XEO03797 MOACRIVE Inhibition DME1121 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1121 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03798 XEO_CLAS Peptide DME1121 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03798 GENEFORM Protein DME1121 XEOTICID XEO03798 MOACRIVE Inhibition DME1121 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1121 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03799 XEO_CLAS Peptide DME1121 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03799 GENEFORM Protein DME1121 XEOTICID XEO03799 MOACRIVE Inhibition DME1121 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1121 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03810 XEO_CLAS Peptide DME1121 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03810 GENEFORM Protein DME1121 XEOTICID XEO03810 MOACRIVE Inhibition DME1121 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1121 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03846 XEO_CLAS Peptide DME1121 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03846 GENEFORM Protein DME1121 XEOTICID XEO03846 MOACRIVE Inhibition DME1121 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1121 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03847 XEO_CLAS Peptide DME1121 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03847 GENEFORM Protein DME1121 XEOTICID XEO03847 MOACRIVE Inhibition DME1121 XEOTICID XEO03850 XEO_NAME Lemon DME1121 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1121 XEOTICID XEO03850 XEO_CLAS Food Additive DME1121 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03850 GENEFORM Protein DME1121 XEOTICID XEO03850 MOACRIVE Inhibition DME1121 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1121 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03853 XEO_CLAS Peptide DME1121 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO03853 GENEFORM Protein DME1121 XEOTICID XEO03853 MOACRIVE Inhibition DME1121 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1121 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03857 XEO_CLAS Peptide DME1121 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 38.49 microM) DME1121 XEOTICID XEO03857 GENEFORM Protein DME1121 XEOTICID XEO03857 MOACRIVE Inhibition DME1121 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1121 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03860 XEO_CLAS Peptide DME1121 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 24 microM) DME1121 XEOTICID XEO03860 GENEFORM Protein DME1121 XEOTICID XEO03860 MOACRIVE Inhibition DME1121 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1121 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03861 XEO_CLAS Peptide DME1121 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 35 microM) DME1121 XEOTICID XEO03861 GENEFORM Protein DME1121 XEOTICID XEO03861 MOACRIVE Inhibition DME1121 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1121 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03862 XEO_CLAS Peptide DME1121 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 70 microM) DME1121 XEOTICID XEO03862 GENEFORM Protein DME1121 XEOTICID XEO03862 MOACRIVE Inhibition DME1121 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1121 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03863 XEO_CLAS Peptide DME1121 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 35 microM) DME1121 XEOTICID XEO03863 GENEFORM Protein DME1121 XEOTICID XEO03863 MOACRIVE Inhibition DME1121 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1121 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03864 XEO_CLAS Peptide DME1121 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO03864 GENEFORM Protein DME1121 XEOTICID XEO03864 MOACRIVE Inhibition DME1121 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1121 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03865 XEO_CLAS Peptide DME1121 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO03865 GENEFORM Protein DME1121 XEOTICID XEO03865 MOACRIVE Inhibition DME1121 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1121 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03866 XEO_CLAS Peptide DME1121 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 microM) DME1121 XEOTICID XEO03866 GENEFORM Protein DME1121 XEOTICID XEO03866 MOACRIVE Inhibition DME1121 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1121 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03867 XEO_CLAS Peptide DME1121 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40 microM) DME1121 XEOTICID XEO03867 GENEFORM Protein DME1121 XEOTICID XEO03867 MOACRIVE Inhibition DME1121 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1121 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03868 XEO_CLAS Peptide DME1121 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 51 microM) DME1121 XEOTICID XEO03868 GENEFORM Protein DME1121 XEOTICID XEO03868 MOACRIVE Inhibition DME1121 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1121 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03869 XEO_CLAS Peptide DME1121 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 35 microM) DME1121 XEOTICID XEO03869 GENEFORM Protein DME1121 XEOTICID XEO03869 MOACRIVE Inhibition DME1121 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1121 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03870 XEO_CLAS Peptide DME1121 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 61 microM) DME1121 XEOTICID XEO03870 GENEFORM Protein DME1121 XEOTICID XEO03870 MOACRIVE Inhibition DME1121 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1121 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03871 XEO_CLAS Peptide DME1121 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 microM) DME1121 XEOTICID XEO03871 GENEFORM Protein DME1121 XEOTICID XEO03871 MOACRIVE Inhibition DME1121 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1121 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03872 XEO_CLAS Peptide DME1121 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 28 microM) DME1121 XEOTICID XEO03872 GENEFORM Protein DME1121 XEOTICID XEO03872 MOACRIVE Inhibition DME1121 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1121 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03873 XEO_CLAS Peptide DME1121 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 22.5 microM) DME1121 XEOTICID XEO03873 GENEFORM Protein DME1121 XEOTICID XEO03873 MOACRIVE Inhibition DME1121 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1121 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03874 XEO_CLAS Peptide DME1121 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 11.25 microM) DME1121 XEOTICID XEO03874 GENEFORM Protein DME1121 XEOTICID XEO03874 MOACRIVE Inhibition DME1121 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1121 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03875 XEO_CLAS Peptide DME1121 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 microM) DME1121 XEOTICID XEO03875 GENEFORM Protein DME1121 XEOTICID XEO03875 MOACRIVE Inhibition DME1121 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1121 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03876 XEO_CLAS Peptide DME1121 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.75 microM) DME1121 XEOTICID XEO03876 GENEFORM Protein DME1121 XEOTICID XEO03876 MOACRIVE Inhibition DME1121 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1121 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03877 XEO_CLAS Peptide DME1121 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 microM) DME1121 XEOTICID XEO03877 GENEFORM Protein DME1121 XEOTICID XEO03877 MOACRIVE Inhibition DME1121 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1121 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03878 XEO_CLAS Peptide DME1121 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 microM) DME1121 XEOTICID XEO03878 GENEFORM Protein DME1121 XEOTICID XEO03878 MOACRIVE Inhibition DME1121 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1121 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03879 XEO_CLAS Peptide DME1121 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 252 microM) DME1121 XEOTICID XEO03879 GENEFORM Protein DME1121 XEOTICID XEO03879 MOACRIVE Inhibition DME1121 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1121 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03880 XEO_CLAS Peptide DME1121 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 174 microM) DME1121 XEOTICID XEO03880 GENEFORM Protein DME1121 XEOTICID XEO03880 MOACRIVE Inhibition DME1121 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1121 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03883 XEO_CLAS Peptide DME1121 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 74 microM) DME1121 XEOTICID XEO03883 GENEFORM Protein DME1121 XEOTICID XEO03883 MOACRIVE Inhibition DME1121 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1121 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03884 XEO_CLAS Peptide DME1121 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 31 microM) DME1121 XEOTICID XEO03884 GENEFORM Protein DME1121 XEOTICID XEO03884 MOACRIVE Inhibition DME1121 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1121 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03885 XEO_CLAS Peptide DME1121 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO03885 GENEFORM Protein DME1121 XEOTICID XEO03885 MOACRIVE Inhibition DME1121 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1121 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03886 XEO_CLAS Peptide DME1121 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 391 microM) DME1121 XEOTICID XEO03886 GENEFORM Protein DME1121 XEOTICID XEO03886 MOACRIVE Inhibition DME1121 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1121 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03887 XEO_CLAS Peptide DME1121 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 151 microM) DME1121 XEOTICID XEO03887 GENEFORM Protein DME1121 XEOTICID XEO03887 MOACRIVE Inhibition DME1121 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1121 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03888 XEO_CLAS Peptide DME1121 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 134 microM) DME1121 XEOTICID XEO03888 GENEFORM Protein DME1121 XEOTICID XEO03888 MOACRIVE Inhibition DME1121 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1121 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03889 XEO_CLAS Peptide DME1121 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 88 microM) DME1121 XEOTICID XEO03889 GENEFORM Protein DME1121 XEOTICID XEO03889 MOACRIVE Inhibition DME1121 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1121 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03890 XEO_CLAS Peptide DME1121 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 31 microM) DME1121 XEOTICID XEO03890 GENEFORM Protein DME1121 XEOTICID XEO03890 MOACRIVE Inhibition DME1121 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1121 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03891 XEO_CLAS Peptide DME1121 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 microM) DME1121 XEOTICID XEO03891 GENEFORM Protein DME1121 XEOTICID XEO03891 MOACRIVE Inhibition DME1121 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1121 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03892 XEO_CLAS Peptide DME1121 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 37 microM) DME1121 XEOTICID XEO03892 GENEFORM Protein DME1121 XEOTICID XEO03892 MOACRIVE Inhibition DME1121 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1121 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03893 XEO_CLAS Peptide DME1121 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 19 microM) DME1121 XEOTICID XEO03893 GENEFORM Protein DME1121 XEOTICID XEO03893 MOACRIVE Inhibition DME1121 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1121 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03894 XEO_CLAS Peptide DME1121 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO03894 GENEFORM Protein DME1121 XEOTICID XEO03894 MOACRIVE Inhibition DME1121 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1121 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03895 XEO_CLAS Peptide DME1121 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO03895 GENEFORM Protein DME1121 XEOTICID XEO03895 MOACRIVE Inhibition DME1121 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1121 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03896 XEO_CLAS Peptide DME1121 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 microM) DME1121 XEOTICID XEO03896 GENEFORM Protein DME1121 XEOTICID XEO03896 MOACRIVE Inhibition DME1121 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1121 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03897 XEO_CLAS Peptide DME1121 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 63 microM) DME1121 XEOTICID XEO03897 GENEFORM Protein DME1121 XEOTICID XEO03897 MOACRIVE Inhibition DME1121 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1121 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03898 XEO_CLAS Peptide DME1121 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 219 microM) DME1121 XEOTICID XEO03898 GENEFORM Protein DME1121 XEOTICID XEO03898 MOACRIVE Inhibition DME1121 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1121 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03901 XEO_CLAS Peptide DME1121 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 35 microM) DME1121 XEOTICID XEO03901 GENEFORM Protein DME1121 XEOTICID XEO03901 MOACRIVE Inhibition DME1121 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1121 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03902 XEO_CLAS Peptide DME1121 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 70 microM) DME1121 XEOTICID XEO03902 GENEFORM Protein DME1121 XEOTICID XEO03902 MOACRIVE Inhibition DME1121 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1121 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03904 XEO_CLAS Peptide DME1121 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO03904 GENEFORM Protein DME1121 XEOTICID XEO03904 MOACRIVE Inhibition DME1121 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1121 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03905 XEO_CLAS Peptide DME1121 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO03905 GENEFORM Protein DME1121 XEOTICID XEO03905 MOACRIVE Inhibition DME1121 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1121 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03908 XEO_CLAS Peptide DME1121 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03908 GENEFORM Protein DME1121 XEOTICID XEO03908 MOACRIVE Inhibition DME1121 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1121 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03915 XEO_CLAS Peptide DME1121 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03915 GENEFORM Protein DME1121 XEOTICID XEO03915 MOACRIVE Inhibition DME1121 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1121 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03916 XEO_CLAS Peptide DME1121 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.8 ug/ml) DME1121 XEOTICID XEO03916 GENEFORM Protein DME1121 XEOTICID XEO03916 MOACRIVE Inhibition DME1121 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1121 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03917 XEO_CLAS Peptide DME1121 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 13.1 ug/ml) DME1121 XEOTICID XEO03917 GENEFORM Protein DME1121 XEOTICID XEO03917 MOACRIVE Inhibition DME1121 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1121 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03918 XEO_CLAS Peptide DME1121 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.5 ug/ml) DME1121 XEOTICID XEO03918 GENEFORM Protein DME1121 XEOTICID XEO03918 MOACRIVE Inhibition DME1121 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1121 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03919 XEO_CLAS Peptide DME1121 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 80 ug/ml) DME1121 XEOTICID XEO03919 GENEFORM Protein DME1121 XEOTICID XEO03919 MOACRIVE Inhibition DME1121 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1121 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03922 XEO_CLAS Peptide DME1121 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 9 microM) DME1121 XEOTICID XEO03922 GENEFORM Protein DME1121 XEOTICID XEO03922 MOACRIVE Inhibition DME1121 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1121 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03923 XEO_CLAS Peptide DME1121 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 80 microM) DME1121 XEOTICID XEO03923 GENEFORM Protein DME1121 XEOTICID XEO03923 MOACRIVE Inhibition DME1121 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1121 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03924 XEO_CLAS Peptide DME1121 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO03924 GENEFORM Protein DME1121 XEOTICID XEO03924 MOACRIVE Inhibition DME1121 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1121 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03927 XEO_CLAS Peptide DME1121 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 80 microM) DME1121 XEOTICID XEO03927 GENEFORM Protein DME1121 XEOTICID XEO03927 MOACRIVE Inhibition DME1121 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1121 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03928 XEO_CLAS Peptide DME1121 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 microM) DME1121 XEOTICID XEO03928 GENEFORM Protein DME1121 XEOTICID XEO03928 MOACRIVE Inhibition DME1121 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1121 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03929 XEO_CLAS Peptide DME1121 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 microM) DME1121 XEOTICID XEO03929 GENEFORM Protein DME1121 XEOTICID XEO03929 MOACRIVE Inhibition DME1121 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1121 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03930 XEO_CLAS Peptide DME1121 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 microM) DME1121 XEOTICID XEO03930 GENEFORM Protein DME1121 XEOTICID XEO03930 MOACRIVE Inhibition DME1121 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1121 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03931 XEO_CLAS Peptide DME1121 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 microM) DME1121 XEOTICID XEO03931 GENEFORM Protein DME1121 XEOTICID XEO03931 MOACRIVE Inhibition DME1121 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1121 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03933 XEO_CLAS Peptide DME1121 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.5 microM) DME1121 XEOTICID XEO03933 GENEFORM Protein DME1121 XEOTICID XEO03933 MOACRIVE Inhibition DME1121 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1121 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03934 XEO_CLAS Peptide DME1121 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.7 microM) DME1121 XEOTICID XEO03934 GENEFORM Protein DME1121 XEOTICID XEO03934 MOACRIVE Inhibition DME1121 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1121 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03935 XEO_CLAS Peptide DME1121 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.7 microM) DME1121 XEOTICID XEO03935 GENEFORM Protein DME1121 XEOTICID XEO03935 MOACRIVE Inhibition DME1121 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1121 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03936 XEO_CLAS Peptide DME1121 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.0 microM) DME1121 XEOTICID XEO03936 GENEFORM Protein DME1121 XEOTICID XEO03936 MOACRIVE Inhibition DME1121 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1121 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03937 XEO_CLAS Peptide DME1121 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.1 microM) DME1121 XEOTICID XEO03937 GENEFORM Protein DME1121 XEOTICID XEO03937 MOACRIVE Inhibition DME1121 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1121 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03938 XEO_CLAS Peptide DME1121 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.7 microM) DME1121 XEOTICID XEO03938 GENEFORM Protein DME1121 XEOTICID XEO03938 MOACRIVE Inhibition DME1121 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1121 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03939 XEO_CLAS Peptide DME1121 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.7 microM) DME1121 XEOTICID XEO03939 GENEFORM Protein DME1121 XEOTICID XEO03939 MOACRIVE Inhibition DME1121 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1121 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03940 XEO_CLAS Peptide DME1121 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.5 microM) DME1121 XEOTICID XEO03940 GENEFORM Protein DME1121 XEOTICID XEO03940 MOACRIVE Inhibition DME1121 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1121 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03941 XEO_CLAS Peptide DME1121 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.4 microM) DME1121 XEOTICID XEO03941 GENEFORM Protein DME1121 XEOTICID XEO03941 MOACRIVE Inhibition DME1121 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1121 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03943 XEO_CLAS Peptide DME1121 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.4 microM) DME1121 XEOTICID XEO03943 GENEFORM Protein DME1121 XEOTICID XEO03943 MOACRIVE Inhibition DME1121 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1121 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03944 XEO_CLAS Peptide DME1121 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.7 microM) DME1121 XEOTICID XEO03944 GENEFORM Protein DME1121 XEOTICID XEO03944 MOACRIVE Inhibition DME1121 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1121 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03945 XEO_CLAS Peptide DME1121 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.2 microM) DME1121 XEOTICID XEO03945 GENEFORM Protein DME1121 XEOTICID XEO03945 MOACRIVE Inhibition DME1121 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1121 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03947 XEO_CLAS Peptide DME1121 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.0 microM) DME1121 XEOTICID XEO03947 GENEFORM Protein DME1121 XEOTICID XEO03947 MOACRIVE Inhibition DME1121 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1121 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03948 XEO_CLAS Peptide DME1121 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 23.3 microM) DME1121 XEOTICID XEO03948 GENEFORM Protein DME1121 XEOTICID XEO03948 MOACRIVE Inhibition DME1121 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1121 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03950 XEO_CLAS Peptide DME1121 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4.4 microM) DME1121 XEOTICID XEO03950 GENEFORM Protein DME1121 XEOTICID XEO03950 MOACRIVE Inhibition DME1121 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1121 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03951 XEO_CLAS Peptide DME1121 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8.8 microM) DME1121 XEOTICID XEO03951 GENEFORM Protein DME1121 XEOTICID XEO03951 MOACRIVE Inhibition DME1121 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1121 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03952 XEO_CLAS Peptide DME1121 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.2 microM) DME1121 XEOTICID XEO03952 GENEFORM Protein DME1121 XEOTICID XEO03952 MOACRIVE Inhibition DME1121 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1121 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03953 XEO_CLAS Peptide DME1121 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 microM) DME1121 XEOTICID XEO03953 GENEFORM Protein DME1121 XEOTICID XEO03953 MOACRIVE Inhibition DME1121 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1121 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03958 XEO_CLAS Peptide DME1121 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03958 GENEFORM Protein DME1121 XEOTICID XEO03958 MOACRIVE Inhibition DME1121 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1121 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03965 XEO_CLAS Peptide DME1121 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 128 microM) DME1121 XEOTICID XEO03965 GENEFORM Protein DME1121 XEOTICID XEO03965 MOACRIVE Inhibition DME1121 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1121 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03966 XEO_CLAS Peptide DME1121 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 microM) DME1121 XEOTICID XEO03966 GENEFORM Protein DME1121 XEOTICID XEO03966 MOACRIVE Inhibition DME1121 XEOTICID XEO03971 XEO_NAME Lumbrican DME1121 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03971 XEO_CLAS Peptide DME1121 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03971 GENEFORM Protein DME1121 XEOTICID XEO03971 MOACRIVE Inhibition DME1121 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1121 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03972 XEO_CLAS Peptide DME1121 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO03972 GENEFORM Protein DME1121 XEOTICID XEO03972 MOACRIVE Inhibition DME1121 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1121 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03980 XEO_CLAS Peptide DME1121 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 32 microM) DME1121 XEOTICID XEO03980 GENEFORM Protein DME1121 XEOTICID XEO03980 MOACRIVE Inhibition DME1121 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1121 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03985 XEO_CLAS Peptide DME1121 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 ug/ml) DME1121 XEOTICID XEO03985 GENEFORM Protein DME1121 XEOTICID XEO03985 MOACRIVE Inhibition DME1121 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1121 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03991 XEO_CLAS Peptide DME1121 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03991 GENEFORM Protein DME1121 XEOTICID XEO03991 MOACRIVE Inhibition DME1121 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1121 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03992 XEO_CLAS Peptide DME1121 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03992 GENEFORM Protein DME1121 XEOTICID XEO03992 MOACRIVE Inhibition DME1121 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1121 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03993 XEO_CLAS Peptide DME1121 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03993 GENEFORM Protein DME1121 XEOTICID XEO03993 MOACRIVE Inhibition DME1121 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1121 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03994 XEO_CLAS Peptide DME1121 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO03994 GENEFORM Protein DME1121 XEOTICID XEO03994 MOACRIVE Inhibition DME1121 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1121 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03996 XEO_CLAS Peptide DME1121 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 65 microM) DME1121 XEOTICID XEO03996 GENEFORM Protein DME1121 XEOTICID XEO03996 MOACRIVE Inhibition DME1121 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1121 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03997 XEO_CLAS Peptide DME1121 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 7.5 microM) DME1121 XEOTICID XEO03997 GENEFORM Protein DME1121 XEOTICID XEO03997 MOACRIVE Inhibition DME1121 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1121 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03998 XEO_CLAS Peptide DME1121 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15.5 microM) DME1121 XEOTICID XEO03998 GENEFORM Protein DME1121 XEOTICID XEO03998 MOACRIVE Inhibition DME1121 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1121 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO03999 XEO_CLAS Peptide DME1121 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25.8 microM) DME1121 XEOTICID XEO03999 GENEFORM Protein DME1121 XEOTICID XEO03999 MOACRIVE Inhibition DME1121 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1121 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04000 XEO_CLAS Peptide DME1121 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO04000 GENEFORM Protein DME1121 XEOTICID XEO04000 MOACRIVE Inhibition DME1121 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1121 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04001 XEO_CLAS Peptide DME1121 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO04001 GENEFORM Protein DME1121 XEOTICID XEO04001 MOACRIVE Inhibition DME1121 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1121 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04002 XEO_CLAS Peptide DME1121 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 7.5 ug/ml) DME1121 XEOTICID XEO04002 GENEFORM Protein DME1121 XEOTICID XEO04002 MOACRIVE Inhibition DME1121 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1121 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04003 XEO_CLAS Peptide DME1121 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 ug/ml) DME1121 XEOTICID XEO04003 GENEFORM Protein DME1121 XEOTICID XEO04003 MOACRIVE Inhibition DME1121 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1121 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04004 XEO_CLAS Peptide DME1121 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.0 ug/ml) DME1121 XEOTICID XEO04004 GENEFORM Protein DME1121 XEOTICID XEO04004 MOACRIVE Inhibition DME1121 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1121 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04005 XEO_CLAS Peptide DME1121 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.0 ug/ml) DME1121 XEOTICID XEO04005 GENEFORM Protein DME1121 XEOTICID XEO04005 MOACRIVE Inhibition DME1121 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1121 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04007 XEO_CLAS Peptide DME1121 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 19.5 ug/ml) DME1121 XEOTICID XEO04007 GENEFORM Protein DME1121 XEOTICID XEO04007 MOACRIVE Inhibition DME1121 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1121 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04011 XEO_CLAS Peptide DME1121 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 19.5 ug/ml) DME1121 XEOTICID XEO04011 GENEFORM Protein DME1121 XEOTICID XEO04011 MOACRIVE Inhibition DME1121 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1121 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04012 XEO_CLAS Peptide DME1121 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.9 ug/ml) DME1121 XEOTICID XEO04012 GENEFORM Protein DME1121 XEOTICID XEO04012 MOACRIVE Inhibition DME1121 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1121 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04013 XEO_CLAS Peptide DME1121 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.7 ug/ml) DME1121 XEOTICID XEO04013 GENEFORM Protein DME1121 XEOTICID XEO04013 MOACRIVE Inhibition DME1121 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1121 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04018 XEO_CLAS Peptide DME1121 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 9 ug/ml) DME1121 XEOTICID XEO04018 GENEFORM Protein DME1121 XEOTICID XEO04018 MOACRIVE Inhibition DME1121 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1121 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04026 XEO_CLAS Peptide DME1121 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO04026 GENEFORM Protein DME1121 XEOTICID XEO04026 MOACRIVE Inhibition DME1121 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1121 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04027 XEO_CLAS Peptide DME1121 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO04027 GENEFORM Protein DME1121 XEOTICID XEO04027 MOACRIVE Inhibition DME1121 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1121 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04028 XEO_CLAS Peptide DME1121 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 ug/ml) DME1121 XEOTICID XEO04028 GENEFORM Protein DME1121 XEOTICID XEO04028 MOACRIVE Inhibition DME1121 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1121 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04038 XEO_CLAS Peptide DME1121 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04038 GENEFORM Protein DME1121 XEOTICID XEO04038 MOACRIVE Inhibition DME1121 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1121 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04039 XEO_CLAS Peptide DME1121 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 microM) DME1121 XEOTICID XEO04039 GENEFORM Protein DME1121 XEOTICID XEO04039 MOACRIVE Inhibition DME1121 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1121 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04051 XEO_CLAS Peptide DME1121 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.31-0.63 microM) DME1121 XEOTICID XEO04051 GENEFORM Protein DME1121 XEOTICID XEO04051 MOACRIVE Inhibition DME1121 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1121 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04052 XEO_CLAS Peptide DME1121 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04052 GENEFORM Protein DME1121 XEOTICID XEO04052 MOACRIVE Inhibition DME1121 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1121 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04053 XEO_CLAS Peptide DME1121 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.08-0.16 microM) DME1121 XEOTICID XEO04053 GENEFORM Protein DME1121 XEOTICID XEO04053 MOACRIVE Inhibition DME1121 XEOTICID XEO04055 XEO_NAME Melectin DME1121 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04055 XEO_CLAS Peptide DME1121 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.0 microM) DME1121 XEOTICID XEO04055 GENEFORM Protein DME1121 XEOTICID XEO04055 MOACRIVE Inhibition DME1121 XEOTICID XEO04057 XEO_NAME Melittin DME1121 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04057 XEO_CLAS Peptide DME1121 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.8 microM) DME1121 XEOTICID XEO04057 GENEFORM Protein DME1121 XEOTICID XEO04057 MOACRIVE Inhibition DME1121 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1121 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04061 XEO_CLAS Peptide DME1121 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.9 microM) DME1121 XEOTICID XEO04061 GENEFORM Protein DME1121 XEOTICID XEO04061 MOACRIVE Inhibition DME1121 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1121 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04062 XEO_CLAS Peptide DME1121 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.5 microM) DME1121 XEOTICID XEO04062 GENEFORM Protein DME1121 XEOTICID XEO04062 MOACRIVE Inhibition DME1121 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1121 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04063 XEO_CLAS Peptide DME1121 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 7.8 microM) DME1121 XEOTICID XEO04063 GENEFORM Protein DME1121 XEOTICID XEO04063 MOACRIVE Inhibition DME1121 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1121 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04064 XEO_CLAS Peptide DME1121 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 46.7 microM) DME1121 XEOTICID XEO04064 GENEFORM Protein DME1121 XEOTICID XEO04064 MOACRIVE Inhibition DME1121 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1121 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04066 XEO_CLAS Peptide DME1121 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16.3 microM) DME1121 XEOTICID XEO04066 GENEFORM Protein DME1121 XEOTICID XEO04066 MOACRIVE Inhibition DME1121 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1121 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04067 XEO_CLAS Peptide DME1121 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.6 microM) DME1121 XEOTICID XEO04067 GENEFORM Protein DME1121 XEOTICID XEO04067 MOACRIVE Inhibition DME1121 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1121 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04068 XEO_CLAS Peptide DME1121 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.6 microM) DME1121 XEOTICID XEO04068 GENEFORM Protein DME1121 XEOTICID XEO04068 MOACRIVE Inhibition DME1121 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1121 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04086 GENEFORM Protein DME1121 XEOTICID XEO04086 MOACRIVE Inhibition DME1121 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1121 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04087 GENEFORM Protein DME1121 XEOTICID XEO04087 MOACRIVE Inhibition DME1121 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1121 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04089 GENEFORM Protein DME1121 XEOTICID XEO04089 MOACRIVE Inhibition DME1121 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1121 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04094 GENEFORM Protein DME1121 XEOTICID XEO04094 MOACRIVE Inhibition DME1121 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1121 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04096 GENEFORM Protein DME1121 XEOTICID XEO04096 MOACRIVE Inhibition DME1121 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1121 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04098 GENEFORM Protein DME1121 XEOTICID XEO04098 MOACRIVE Inhibition DME1121 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1121 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04111 XEO_CLAS Peptide DME1121 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04111 GENEFORM Protein DME1121 XEOTICID XEO04111 MOACRIVE Inhibition DME1121 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1121 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04112 XEO_CLAS Peptide DME1121 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.02 microM) DME1121 XEOTICID XEO04112 GENEFORM Protein DME1121 XEOTICID XEO04112 MOACRIVE Inhibition DME1121 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1121 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04113 XEO_CLAS Peptide DME1121 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.02 ug/ml) DME1121 XEOTICID XEO04113 GENEFORM Protein DME1121 XEOTICID XEO04113 MOACRIVE Inhibition DME1121 XEOTICID XEO04114 XEO_NAME Microcin L DME1121 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04114 XEO_CLAS Peptide DME1121 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04114 GENEFORM Protein DME1121 XEOTICID XEO04114 MOACRIVE Inhibition DME1121 XEOTICID XEO04117 XEO_NAME Misgurin DME1121 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04117 XEO_CLAS Peptide DME1121 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04117 GENEFORM Protein DME1121 XEOTICID XEO04117 MOACRIVE Inhibition DME1121 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1121 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04118 XEO_CLAS Peptide DME1121 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 300 microM) DME1121 XEOTICID XEO04118 GENEFORM Protein DME1121 XEOTICID XEO04118 MOACRIVE Inhibition DME1121 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1121 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04119 XEO_CLAS Peptide DME1121 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-20 microM) DME1121 XEOTICID XEO04119 GENEFORM Protein DME1121 XEOTICID XEO04119 MOACRIVE Inhibition DME1121 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1121 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04120 XEO_CLAS Peptide DME1121 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC < 10 microM) DME1121 XEOTICID XEO04120 GENEFORM Protein DME1121 XEOTICID XEO04120 MOACRIVE Inhibition DME1121 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1121 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04121 XEO_CLAS Peptide DME1121 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.2-6.4 microM) DME1121 XEOTICID XEO04121 GENEFORM Protein DME1121 XEOTICID XEO04121 MOACRIVE Inhibition DME1121 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1121 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04122 XEO_CLAS Peptide DME1121 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.14-6.29 microM) DME1121 XEOTICID XEO04122 GENEFORM Protein DME1121 XEOTICID XEO04122 MOACRIVE Inhibition DME1121 XEOTICID XEO04123 XEO_NAME Modified defensin DME1121 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04123 XEO_CLAS Peptide DME1121 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO04123 GENEFORM Protein DME1121 XEOTICID XEO04123 MOACRIVE Inhibition DME1121 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1121 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04128 XEO_CLAS Peptide DME1121 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.31 microM) DME1121 XEOTICID XEO04128 GENEFORM Protein DME1121 XEOTICID XEO04128 MOACRIVE Inhibition DME1121 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1121 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04129 XEO_CLAS Peptide DME1121 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO04129 GENEFORM Protein DME1121 XEOTICID XEO04129 MOACRIVE Inhibition DME1121 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1121 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04130 XEO_CLAS Peptide DME1121 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO04130 GENEFORM Protein DME1121 XEOTICID XEO04130 MOACRIVE Inhibition DME1121 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1121 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04131 XEO_CLAS Peptide DME1121 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 microM) DME1121 XEOTICID XEO04131 GENEFORM Protein DME1121 XEOTICID XEO04131 MOACRIVE Inhibition DME1121 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1121 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04132 XEO_CLAS Peptide DME1121 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 microM) DME1121 XEOTICID XEO04132 GENEFORM Protein DME1121 XEOTICID XEO04132 MOACRIVE Inhibition DME1121 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1121 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04133 XEO_CLAS Peptide DME1121 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO04133 GENEFORM Protein DME1121 XEOTICID XEO04133 MOACRIVE Inhibition DME1121 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1121 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04134 XEO_CLAS Peptide DME1121 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO04134 GENEFORM Protein DME1121 XEOTICID XEO04134 MOACRIVE Inhibition DME1121 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1121 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04135 XEO_CLAS Peptide DME1121 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 microM) DME1121 XEOTICID XEO04135 GENEFORM Protein DME1121 XEOTICID XEO04135 MOACRIVE Inhibition DME1121 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1121 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04137 XEO_CLAS Peptide DME1121 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.6 microM) DME1121 XEOTICID XEO04137 GENEFORM Protein DME1121 XEOTICID XEO04137 MOACRIVE Inhibition DME1121 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1121 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04138 XEO_CLAS Peptide DME1121 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 microM) DME1121 XEOTICID XEO04138 GENEFORM Protein DME1121 XEOTICID XEO04138 MOACRIVE Inhibition DME1121 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1121 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04139 XEO_CLAS Peptide DME1121 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 microM) DME1121 XEOTICID XEO04139 GENEFORM Protein DME1121 XEOTICID XEO04139 MOACRIVE Inhibition DME1121 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1121 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04140 XEO_CLAS Peptide DME1121 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 70 microM) DME1121 XEOTICID XEO04140 GENEFORM Protein DME1121 XEOTICID XEO04140 MOACRIVE Inhibition DME1121 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1121 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04141 XEO_CLAS Peptide DME1121 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 microM) DME1121 XEOTICID XEO04141 GENEFORM Protein DME1121 XEOTICID XEO04141 MOACRIVE Inhibition DME1121 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1121 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04142 XEO_CLAS Peptide DME1121 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8-16 microM) DME1121 XEOTICID XEO04142 GENEFORM Protein DME1121 XEOTICID XEO04142 MOACRIVE Inhibition DME1121 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1121 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04146 XEO_CLAS Peptide DME1121 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04146 GENEFORM Protein DME1121 XEOTICID XEO04146 MOACRIVE Inhibition DME1121 XEOTICID XEO04149 XEO_NAME Mucroporin DME1121 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04149 XEO_CLAS Peptide DME1121 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 ug/ml) DME1121 XEOTICID XEO04149 GENEFORM Protein DME1121 XEOTICID XEO04149 MOACRIVE Inhibition DME1121 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1121 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04158 XEO_CLAS Peptide DME1121 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO04158 GENEFORM Protein DME1121 XEOTICID XEO04158 MOACRIVE Inhibition DME1121 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1121 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04159 XEO_CLAS Peptide DME1121 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 microM) DME1121 XEOTICID XEO04159 GENEFORM Protein DME1121 XEOTICID XEO04159 MOACRIVE Inhibition DME1121 XEOTICID XEO04167 XEO_NAME Myticin-B DME1121 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04167 XEO_CLAS Peptide DME1121 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04167 GENEFORM Protein DME1121 XEOTICID XEO04167 MOACRIVE Inhibition DME1121 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1121 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04168 XEO_CLAS Peptide DME1121 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.7-12.5 microM) DME1121 XEOTICID XEO04168 GENEFORM Protein DME1121 XEOTICID XEO04168 MOACRIVE Inhibition DME1121 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1121 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04169 XEO_CLAS Peptide DME1121 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04169 GENEFORM Protein DME1121 XEOTICID XEO04169 MOACRIVE Inhibition DME1121 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1121 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04170 XEO_CLAS Peptide DME1121 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04170 GENEFORM Protein DME1121 XEOTICID XEO04170 MOACRIVE Inhibition DME1121 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1121 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04171 XEO_CLAS Peptide DME1121 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04171 GENEFORM Protein DME1121 XEOTICID XEO04171 MOACRIVE Inhibition DME1121 XEOTICID XEO04172 XEO_NAME Myxinidin DME1121 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04172 XEO_CLAS Peptide DME1121 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04172 GENEFORM Protein DME1121 XEOTICID XEO04172 MOACRIVE Inhibition DME1121 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1121 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04177 XEO_CLAS Peptide DME1121 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.7 microM) DME1121 XEOTICID XEO04177 GENEFORM Protein DME1121 XEOTICID XEO04177 MOACRIVE Inhibition DME1121 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1121 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04178 XEO_CLAS Peptide DME1121 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.7 microM) DME1121 XEOTICID XEO04178 GENEFORM Protein DME1121 XEOTICID XEO04178 MOACRIVE Inhibition DME1121 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1121 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04179 XEO_CLAS Peptide DME1121 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.5 microM) DME1121 XEOTICID XEO04179 GENEFORM Protein DME1121 XEOTICID XEO04179 MOACRIVE Inhibition DME1121 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1121 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04180 XEO_CLAS Peptide DME1121 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 23 microM) DME1121 XEOTICID XEO04180 GENEFORM Protein DME1121 XEOTICID XEO04180 MOACRIVE Inhibition DME1121 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1121 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04181 XEO_CLAS Peptide DME1121 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.2 microM) DME1121 XEOTICID XEO04181 GENEFORM Protein DME1121 XEOTICID XEO04181 MOACRIVE Inhibition DME1121 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1121 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04182 XEO_CLAS Peptide DME1121 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4.4 microM) DME1121 XEOTICID XEO04182 GENEFORM Protein DME1121 XEOTICID XEO04182 MOACRIVE Inhibition DME1121 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1121 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04183 XEO_CLAS Peptide DME1121 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.6 microM) DME1121 XEOTICID XEO04183 GENEFORM Protein DME1121 XEOTICID XEO04183 MOACRIVE Inhibition DME1121 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1121 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04184 XEO_CLAS Peptide DME1121 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 microM) DME1121 XEOTICID XEO04184 GENEFORM Protein DME1121 XEOTICID XEO04184 MOACRIVE Inhibition DME1121 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1121 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04185 XEO_CLAS Peptide DME1121 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04185 GENEFORM Protein DME1121 XEOTICID XEO04185 MOACRIVE Inhibition DME1121 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1121 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04186 XEO_CLAS Peptide DME1121 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04186 GENEFORM Protein DME1121 XEOTICID XEO04186 MOACRIVE Inhibition DME1121 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1121 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04187 XEO_CLAS Peptide DME1121 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04187 GENEFORM Protein DME1121 XEOTICID XEO04187 MOACRIVE Inhibition DME1121 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1121 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04188 XEO_CLAS Peptide DME1121 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04188 GENEFORM Protein DME1121 XEOTICID XEO04188 MOACRIVE Inhibition DME1121 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1121 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04206 XEO_CLAS Peptide DME1121 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25 microM) DME1121 XEOTICID XEO04206 GENEFORM Protein DME1121 XEOTICID XEO04206 MOACRIVE Inhibition DME1121 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1121 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04214 XEO_CLAS Peptide DME1121 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25 microM) DME1121 XEOTICID XEO04214 GENEFORM Protein DME1121 XEOTICID XEO04214 MOACRIVE Inhibition DME1121 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1121 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04216 XEO_CLAS Peptide DME1121 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO04216 GENEFORM Protein DME1121 XEOTICID XEO04216 MOACRIVE Inhibition DME1121 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1121 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04218 XEO_CLAS Peptide DME1121 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.125 microM) DME1121 XEOTICID XEO04218 GENEFORM Protein DME1121 XEOTICID XEO04218 MOACRIVE Inhibition DME1121 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1121 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04219 XEO_CLAS Peptide DME1121 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO04219 GENEFORM Protein DME1121 XEOTICID XEO04219 MOACRIVE Inhibition DME1121 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1121 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04220 XEO_CLAS Peptide DME1121 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.125 microM) DME1121 XEOTICID XEO04220 GENEFORM Protein DME1121 XEOTICID XEO04220 MOACRIVE Inhibition DME1121 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1121 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04221 XEO_CLAS Peptide DME1121 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO04221 GENEFORM Protein DME1121 XEOTICID XEO04221 MOACRIVE Inhibition DME1121 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1121 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04222 XEO_CLAS Peptide DME1121 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25 microM) DME1121 XEOTICID XEO04222 GENEFORM Protein DME1121 XEOTICID XEO04222 MOACRIVE Inhibition DME1121 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1121 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04233 XEO_CLAS Peptide DME1121 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04233 GENEFORM Protein DME1121 XEOTICID XEO04233 MOACRIVE Inhibition DME1121 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1121 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04234 XEO_CLAS Peptide DME1121 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04234 GENEFORM Protein DME1121 XEOTICID XEO04234 MOACRIVE Inhibition DME1121 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1121 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04241 XEO_CLAS Peptide DME1121 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04241 GENEFORM Protein DME1121 XEOTICID XEO04241 MOACRIVE Inhibition DME1121 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1121 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04242 XEO_CLAS Peptide DME1121 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04242 GENEFORM Protein DME1121 XEOTICID XEO04242 MOACRIVE Inhibition DME1121 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1121 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04245 XEO_CLAS Natural Product DME1121 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04245 GENEFORM Protein DME1121 XEOTICID XEO04245 MOACRIVE Inhibition DME1121 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1121 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04246 XEO_CLAS Natural Product DME1121 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04246 GENEFORM Protein DME1121 XEOTICID XEO04246 MOACRIVE Inhibition DME1121 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1121 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04249 XEO_CLAS Peptide DME1121 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 500 ug/ml) DME1121 XEOTICID XEO04249 GENEFORM Protein DME1121 XEOTICID XEO04249 MOACRIVE Inhibition DME1121 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1121 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04251 XEO_CLAS Peptide DME1121 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04251 GENEFORM Protein DME1121 XEOTICID XEO04251 MOACRIVE Inhibition DME1121 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1121 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04253 XEO_CLAS Peptide DME1121 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04253 GENEFORM Protein DME1121 XEOTICID XEO04253 MOACRIVE Inhibition DME1121 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1121 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04254 XEO_CLAS Peptide DME1121 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04254 GENEFORM Protein DME1121 XEOTICID XEO04254 MOACRIVE Inhibition DME1121 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1121 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04255 XEO_CLAS Peptide DME1121 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04255 GENEFORM Protein DME1121 XEOTICID XEO04255 MOACRIVE Inhibition DME1121 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1121 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04256 XEO_CLAS Peptide DME1121 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04256 GENEFORM Protein DME1121 XEOTICID XEO04256 MOACRIVE Inhibition DME1121 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1121 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04257 XEO_CLAS Peptide DME1121 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04257 GENEFORM Protein DME1121 XEOTICID XEO04257 MOACRIVE Inhibition DME1121 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1121 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04258 XEO_CLAS Peptide DME1121 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04258 GENEFORM Protein DME1121 XEOTICID XEO04258 MOACRIVE Inhibition DME1121 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1121 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04259 XEO_CLAS Peptide DME1121 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04259 GENEFORM Protein DME1121 XEOTICID XEO04259 MOACRIVE Inhibition DME1121 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1121 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04260 XEO_CLAS Peptide DME1121 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04260 GENEFORM Protein DME1121 XEOTICID XEO04260 MOACRIVE Inhibition DME1121 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1121 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04261 XEO_CLAS Peptide DME1121 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04261 GENEFORM Protein DME1121 XEOTICID XEO04261 MOACRIVE Inhibition DME1121 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1121 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04262 XEO_CLAS Peptide DME1121 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04262 GENEFORM Protein DME1121 XEOTICID XEO04262 MOACRIVE Inhibition DME1121 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1121 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04263 XEO_CLAS Peptide DME1121 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04263 GENEFORM Protein DME1121 XEOTICID XEO04263 MOACRIVE Inhibition DME1121 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1121 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04264 XEO_CLAS Peptide DME1121 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04264 GENEFORM Protein DME1121 XEOTICID XEO04264 MOACRIVE Inhibition DME1121 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1121 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04265 XEO_CLAS Peptide DME1121 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04265 GENEFORM Protein DME1121 XEOTICID XEO04265 MOACRIVE Inhibition DME1121 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1121 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04266 XEO_CLAS Peptide DME1121 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04266 GENEFORM Protein DME1121 XEOTICID XEO04266 MOACRIVE Inhibition DME1121 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1121 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04267 XEO_CLAS Peptide DME1121 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04267 GENEFORM Protein DME1121 XEOTICID XEO04267 MOACRIVE Inhibition DME1121 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1121 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04268 XEO_CLAS Peptide DME1121 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04268 GENEFORM Protein DME1121 XEOTICID XEO04268 MOACRIVE Inhibition DME1121 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1121 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04269 XEO_CLAS Peptide DME1121 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04269 GENEFORM Protein DME1121 XEOTICID XEO04269 MOACRIVE Inhibition DME1121 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1121 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04270 XEO_CLAS Peptide DME1121 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04270 GENEFORM Protein DME1121 XEOTICID XEO04270 MOACRIVE Inhibition DME1121 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1121 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04271 XEO_CLAS Peptide DME1121 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04271 GENEFORM Protein DME1121 XEOTICID XEO04271 MOACRIVE Inhibition DME1121 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1121 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04272 XEO_CLAS Peptide DME1121 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04272 GENEFORM Protein DME1121 XEOTICID XEO04272 MOACRIVE Inhibition DME1121 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1121 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04277 XEO_CLAS Peptide DME1121 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 110.00 ug/ml) DME1121 XEOTICID XEO04277 GENEFORM Protein DME1121 XEOTICID XEO04277 MOACRIVE Inhibition DME1121 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1121 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04280 XEO_CLAS Peptide DME1121 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 37.50 ug/ml) DME1121 XEOTICID XEO04280 GENEFORM Protein DME1121 XEOTICID XEO04280 MOACRIVE Inhibition DME1121 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1121 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04281 XEO_CLAS Peptide DME1121 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25.00 ug/ml) DME1121 XEOTICID XEO04281 GENEFORM Protein DME1121 XEOTICID XEO04281 MOACRIVE Inhibition DME1121 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1121 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04282 XEO_CLAS Peptide DME1121 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.2 ug/ml) DME1121 XEOTICID XEO04282 GENEFORM Protein DME1121 XEOTICID XEO04282 MOACRIVE Inhibition DME1121 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1121 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04283 XEO_CLAS Peptide DME1121 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.3 ug/ml) DME1121 XEOTICID XEO04283 GENEFORM Protein DME1121 XEOTICID XEO04283 MOACRIVE Inhibition DME1121 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1121 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04284 XEO_CLAS Peptide DME1121 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10.8 ug/ml) DME1121 XEOTICID XEO04284 GENEFORM Protein DME1121 XEOTICID XEO04284 MOACRIVE Inhibition DME1121 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1121 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04285 XEO_CLAS Peptide DME1121 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 11.5 ug/ml) DME1121 XEOTICID XEO04285 GENEFORM Protein DME1121 XEOTICID XEO04285 MOACRIVE Inhibition DME1121 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1121 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04286 XEO_CLAS Peptide DME1121 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8.6 ug/ml) DME1121 XEOTICID XEO04286 GENEFORM Protein DME1121 XEOTICID XEO04286 MOACRIVE Inhibition DME1121 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1121 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04287 XEO_CLAS Peptide DME1121 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10.2 ug/ml) DME1121 XEOTICID XEO04287 GENEFORM Protein DME1121 XEOTICID XEO04287 MOACRIVE Inhibition DME1121 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1121 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04288 XEO_CLAS Peptide DME1121 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4.4 ug/ml) DME1121 XEOTICID XEO04288 GENEFORM Protein DME1121 XEOTICID XEO04288 MOACRIVE Inhibition DME1121 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1121 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04289 XEO_CLAS Peptide DME1121 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.2 ug/ml) DME1121 XEOTICID XEO04289 GENEFORM Protein DME1121 XEOTICID XEO04289 MOACRIVE Inhibition DME1121 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1121 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04290 XEO_CLAS Peptide DME1121 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 11.3 ug/ml) DME1121 XEOTICID XEO04290 GENEFORM Protein DME1121 XEOTICID XEO04290 MOACRIVE Inhibition DME1121 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1121 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04291 XEO_CLAS Peptide DME1121 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 7.2 ug/ml) DME1121 XEOTICID XEO04291 GENEFORM Protein DME1121 XEOTICID XEO04291 MOACRIVE Inhibition DME1121 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1121 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04292 XEO_CLAS Peptide DME1121 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.1 ug/ml) DME1121 XEOTICID XEO04292 GENEFORM Protein DME1121 XEOTICID XEO04292 MOACRIVE Inhibition DME1121 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1121 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04293 XEO_CLAS Peptide DME1121 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO04293 GENEFORM Protein DME1121 XEOTICID XEO04293 MOACRIVE Inhibition DME1121 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1121 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04294 XEO_CLAS Peptide DME1121 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO04294 GENEFORM Protein DME1121 XEOTICID XEO04294 MOACRIVE Inhibition DME1121 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1121 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04295 XEO_CLAS Peptide DME1121 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO04295 GENEFORM Protein DME1121 XEOTICID XEO04295 MOACRIVE Inhibition DME1121 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1121 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04296 XEO_CLAS Peptide DME1121 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 28 microM) DME1121 XEOTICID XEO04296 GENEFORM Protein DME1121 XEOTICID XEO04296 MOACRIVE Inhibition DME1121 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1121 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04297 XEO_CLAS Peptide DME1121 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 14 microM) DME1121 XEOTICID XEO04297 GENEFORM Protein DME1121 XEOTICID XEO04297 MOACRIVE Inhibition DME1121 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1121 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04298 XEO_CLAS Peptide DME1121 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO04298 GENEFORM Protein DME1121 XEOTICID XEO04298 MOACRIVE Inhibition DME1121 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1121 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04299 XEO_CLAS Peptide DME1121 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO04299 GENEFORM Protein DME1121 XEOTICID XEO04299 MOACRIVE Inhibition DME1121 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1121 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04300 XEO_CLAS Peptide DME1121 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO04300 GENEFORM Protein DME1121 XEOTICID XEO04300 MOACRIVE Inhibition DME1121 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1121 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04301 XEO_CLAS Peptide DME1121 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 microM) DME1121 XEOTICID XEO04301 GENEFORM Protein DME1121 XEOTICID XEO04301 MOACRIVE Inhibition DME1121 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1121 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04302 XEO_CLAS Peptide DME1121 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 microM) DME1121 XEOTICID XEO04302 GENEFORM Protein DME1121 XEOTICID XEO04302 MOACRIVE Inhibition DME1121 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1121 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04303 XEO_CLAS Peptide DME1121 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 microM) DME1121 XEOTICID XEO04303 GENEFORM Protein DME1121 XEOTICID XEO04303 MOACRIVE Inhibition DME1121 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1121 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04304 XEO_CLAS Peptide DME1121 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO04304 GENEFORM Protein DME1121 XEOTICID XEO04304 MOACRIVE Inhibition DME1121 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1121 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04305 XEO_CLAS Peptide DME1121 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 70 microM) DME1121 XEOTICID XEO04305 GENEFORM Protein DME1121 XEOTICID XEO04305 MOACRIVE Inhibition DME1121 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1121 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04306 XEO_CLAS Peptide DME1121 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO04306 GENEFORM Protein DME1121 XEOTICID XEO04306 MOACRIVE Inhibition DME1121 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1121 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04307 XEO_CLAS Peptide DME1121 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 ug/ml) DME1121 XEOTICID XEO04307 GENEFORM Protein DME1121 XEOTICID XEO04307 MOACRIVE Inhibition DME1121 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1121 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04308 XEO_CLAS Peptide DME1121 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 9.37 ug/ml) DME1121 XEOTICID XEO04308 GENEFORM Protein DME1121 XEOTICID XEO04308 MOACRIVE Inhibition DME1121 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1121 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04309 XEO_CLAS Peptide DME1121 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 microM) DME1121 XEOTICID XEO04309 GENEFORM Protein DME1121 XEOTICID XEO04309 MOACRIVE Inhibition DME1121 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1121 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04310 XEO_CLAS Peptide DME1121 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO04310 GENEFORM Protein DME1121 XEOTICID XEO04310 MOACRIVE Inhibition DME1121 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1121 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04311 XEO_CLAS Peptide DME1121 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO04311 GENEFORM Protein DME1121 XEOTICID XEO04311 MOACRIVE Inhibition DME1121 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1121 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04312 XEO_CLAS Peptide DME1121 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4.68 ug/ml) DME1121 XEOTICID XEO04312 GENEFORM Protein DME1121 XEOTICID XEO04312 MOACRIVE Inhibition DME1121 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1121 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04313 XEO_CLAS Peptide DME1121 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4.68 ug/ml) DME1121 XEOTICID XEO04313 GENEFORM Protein DME1121 XEOTICID XEO04313 MOACRIVE Inhibition DME1121 XEOTICID XEO04331 XEO_NAME Norspermidine DME1121 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1121 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04331 GENEFORM Protein DME1121 XEOTICID XEO04331 MOACRIVE Inhibition DME1121 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1121 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04335 XEO_CLAS Peptide DME1121 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 32 ug/ml) DME1121 XEOTICID XEO04335 GENEFORM Protein DME1121 XEOTICID XEO04335 MOACRIVE Inhibition DME1121 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1121 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04336 XEO_CLAS Peptide DME1121 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 32 ug/ml) DME1121 XEOTICID XEO04336 GENEFORM Protein DME1121 XEOTICID XEO04336 MOACRIVE Inhibition DME1121 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1121 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04338 XEO_CLAS Peptide DME1121 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 ug/ml) DME1121 XEOTICID XEO04338 GENEFORM Protein DME1121 XEOTICID XEO04338 MOACRIVE Inhibition DME1121 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1121 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04339 XEO_CLAS Peptide DME1121 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 ug/ml) DME1121 XEOTICID XEO04339 GENEFORM Protein DME1121 XEOTICID XEO04339 MOACRIVE Inhibition DME1121 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1121 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04340 XEO_CLAS Peptide DME1121 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO04340 GENEFORM Protein DME1121 XEOTICID XEO04340 MOACRIVE Inhibition DME1121 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1121 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04344 XEO_CLAS Peptide DME1121 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04344 GENEFORM Protein DME1121 XEOTICID XEO04344 MOACRIVE Inhibition DME1121 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1121 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04345 XEO_CLAS Peptide DME1121 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04345 GENEFORM Protein DME1121 XEOTICID XEO04345 MOACRIVE Inhibition DME1121 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1121 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04346 XEO_CLAS Peptide DME1121 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04346 GENEFORM Protein DME1121 XEOTICID XEO04346 MOACRIVE Inhibition DME1121 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1121 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04347 XEO_CLAS Peptide DME1121 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 microM) DME1121 XEOTICID XEO04347 GENEFORM Protein DME1121 XEOTICID XEO04347 MOACRIVE Inhibition DME1121 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1121 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04348 XEO_CLAS Peptide DME1121 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40 microM) DME1121 XEOTICID XEO04348 GENEFORM Protein DME1121 XEOTICID XEO04348 MOACRIVE Inhibition DME1121 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1121 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04349 XEO_CLAS Peptide DME1121 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO04349 GENEFORM Protein DME1121 XEOTICID XEO04349 MOACRIVE Inhibition DME1121 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1121 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04354 XEO_CLAS Peptide DME1121 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 35.2 ug/ml) DME1121 XEOTICID XEO04354 GENEFORM Protein DME1121 XEOTICID XEO04354 MOACRIVE Inhibition DME1121 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1121 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04355 XEO_CLAS Peptide DME1121 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.21 ug/ml) DME1121 XEOTICID XEO04355 GENEFORM Protein DME1121 XEOTICID XEO04355 MOACRIVE Inhibition DME1121 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1121 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04356 XEO_CLAS Peptide DME1121 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8.21 ug/ml) DME1121 XEOTICID XEO04356 GENEFORM Protein DME1121 XEOTICID XEO04356 MOACRIVE Inhibition DME1121 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1121 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04357 XEO_CLAS Peptide DME1121 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16.32 ug/ml) DME1121 XEOTICID XEO04357 GENEFORM Protein DME1121 XEOTICID XEO04357 MOACRIVE Inhibition DME1121 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1121 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04358 XEO_CLAS Peptide DME1121 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 9.37 ug/ml) DME1121 XEOTICID XEO04358 GENEFORM Protein DME1121 XEOTICID XEO04358 MOACRIVE Inhibition DME1121 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1121 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04359 XEO_CLAS Peptide DME1121 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4.20 ug/ml) DME1121 XEOTICID XEO04359 GENEFORM Protein DME1121 XEOTICID XEO04359 MOACRIVE Inhibition DME1121 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1121 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04360 XEO_CLAS Peptide DME1121 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 ug/ml) DME1121 XEOTICID XEO04360 GENEFORM Protein DME1121 XEOTICID XEO04360 MOACRIVE Inhibition DME1121 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1121 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04361 XEO_CLAS Peptide DME1121 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 7.5 ug/ml) DME1121 XEOTICID XEO04361 GENEFORM Protein DME1121 XEOTICID XEO04361 MOACRIVE Inhibition DME1121 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1121 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04362 XEO_CLAS Peptide DME1121 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.6 ug/ml) DME1121 XEOTICID XEO04362 GENEFORM Protein DME1121 XEOTICID XEO04362 MOACRIVE Inhibition DME1121 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1121 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04363 XEO_CLAS Peptide DME1121 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8.2 ug/ml) DME1121 XEOTICID XEO04363 GENEFORM Protein DME1121 XEOTICID XEO04363 MOACRIVE Inhibition DME1121 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1121 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04364 XEO_CLAS Peptide DME1121 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO04364 GENEFORM Protein DME1121 XEOTICID XEO04364 MOACRIVE Inhibition DME1121 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1121 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04365 XEO_CLAS Peptide DME1121 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4.68 ug/ml) DME1121 XEOTICID XEO04365 GENEFORM Protein DME1121 XEOTICID XEO04365 MOACRIVE Inhibition DME1121 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1121 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04366 XEO_CLAS Peptide DME1121 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 23.60 ug/ml) DME1121 XEOTICID XEO04366 GENEFORM Protein DME1121 XEOTICID XEO04366 MOACRIVE Inhibition DME1121 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1121 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04367 XEO_CLAS Peptide DME1121 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 35.60 ug/ml) DME1121 XEOTICID XEO04367 GENEFORM Protein DME1121 XEOTICID XEO04367 MOACRIVE Inhibition DME1121 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1121 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04368 XEO_CLAS Peptide DME1121 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40.2 ug/ml) DME1121 XEOTICID XEO04368 GENEFORM Protein DME1121 XEOTICID XEO04368 MOACRIVE Inhibition DME1121 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1121 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04369 XEO_CLAS Peptide DME1121 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40.2 ug/ml) DME1121 XEOTICID XEO04369 GENEFORM Protein DME1121 XEOTICID XEO04369 MOACRIVE Inhibition DME1121 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1121 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04370 XEO_CLAS Peptide DME1121 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4.68 ug/ml) DME1121 XEOTICID XEO04370 GENEFORM Protein DME1121 XEOTICID XEO04370 MOACRIVE Inhibition DME1121 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1121 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04371 XEO_CLAS Peptide DME1121 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 9.37 ug/ml) DME1121 XEOTICID XEO04371 GENEFORM Protein DME1121 XEOTICID XEO04371 MOACRIVE Inhibition DME1121 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1121 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04373 XEO_CLAS Peptide DME1121 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 ug/ml) DME1121 XEOTICID XEO04373 GENEFORM Protein DME1121 XEOTICID XEO04373 MOACRIVE Inhibition DME1121 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1121 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04374 XEO_CLAS Peptide DME1121 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.50 ug/ml) DME1121 XEOTICID XEO04374 GENEFORM Protein DME1121 XEOTICID XEO04374 MOACRIVE Inhibition DME1121 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1121 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04375 XEO_CLAS Peptide DME1121 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25 ug/ml) DME1121 XEOTICID XEO04375 GENEFORM Protein DME1121 XEOTICID XEO04375 MOACRIVE Inhibition DME1121 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1121 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04377 XEO_CLAS Peptide DME1121 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 42.50 ug/ml) DME1121 XEOTICID XEO04377 GENEFORM Protein DME1121 XEOTICID XEO04377 MOACRIVE Inhibition DME1121 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1121 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04378 XEO_CLAS Peptide DME1121 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 17.50 ug/ml) DME1121 XEOTICID XEO04378 GENEFORM Protein DME1121 XEOTICID XEO04378 MOACRIVE Inhibition DME1121 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1121 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04379 XEO_CLAS Peptide DME1121 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 ug/ml) DME1121 XEOTICID XEO04379 GENEFORM Protein DME1121 XEOTICID XEO04379 MOACRIVE Inhibition DME1121 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1121 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04380 XEO_CLAS Peptide DME1121 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 36.00 ug/ml) DME1121 XEOTICID XEO04380 GENEFORM Protein DME1121 XEOTICID XEO04380 MOACRIVE Inhibition DME1121 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1121 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04381 XEO_CLAS Peptide DME1121 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.60 ug/ml) DME1121 XEOTICID XEO04381 GENEFORM Protein DME1121 XEOTICID XEO04381 MOACRIVE Inhibition DME1121 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1121 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04382 XEO_CLAS Peptide DME1121 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 ug/ml) DME1121 XEOTICID XEO04382 GENEFORM Protein DME1121 XEOTICID XEO04382 MOACRIVE Inhibition DME1121 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1121 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04383 XEO_CLAS Peptide DME1121 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO04383 GENEFORM Protein DME1121 XEOTICID XEO04383 MOACRIVE Inhibition DME1121 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1121 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04384 XEO_CLAS Peptide DME1121 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO04384 GENEFORM Protein DME1121 XEOTICID XEO04384 MOACRIVE Inhibition DME1121 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1121 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04385 XEO_CLAS Peptide DME1121 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.25 ug/ml) DME1121 XEOTICID XEO04385 GENEFORM Protein DME1121 XEOTICID XEO04385 MOACRIVE Inhibition DME1121 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1121 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04395 XEO_CLAS Peptide DME1121 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.4-0.8 microM) DME1121 XEOTICID XEO04395 GENEFORM Protein DME1121 XEOTICID XEO04395 MOACRIVE Inhibition DME1121 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1121 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04396 XEO_CLAS Peptide DME1121 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.25-0.5 microM) DME1121 XEOTICID XEO04396 GENEFORM Protein DME1121 XEOTICID XEO04396 MOACRIVE Inhibition DME1121 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1121 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04397 XEO_CLAS Peptide DME1121 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.25-0.5 microM) DME1121 XEOTICID XEO04397 GENEFORM Protein DME1121 XEOTICID XEO04397 MOACRIVE Inhibition DME1121 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1121 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04398 XEO_CLAS Peptide DME1121 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 microM) DME1121 XEOTICID XEO04398 GENEFORM Protein DME1121 XEOTICID XEO04398 MOACRIVE Inhibition DME1121 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1121 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04399 XEO_CLAS Peptide DME1121 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO04399 GENEFORM Protein DME1121 XEOTICID XEO04399 MOACRIVE Inhibition DME1121 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1121 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04400 XEO_CLAS Peptide DME1121 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 ug/ml) DME1121 XEOTICID XEO04400 GENEFORM Protein DME1121 XEOTICID XEO04400 MOACRIVE Inhibition DME1121 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1121 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04401 XEO_CLAS Peptide DME1121 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.6 ug/ml) DME1121 XEOTICID XEO04401 GENEFORM Protein DME1121 XEOTICID XEO04401 MOACRIVE Inhibition DME1121 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1121 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04402 XEO_CLAS Peptide DME1121 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 ug/ml) DME1121 XEOTICID XEO04402 GENEFORM Protein DME1121 XEOTICID XEO04402 MOACRIVE Inhibition DME1121 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1121 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04403 XEO_CLAS Peptide DME1121 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.6 ug/ml) DME1121 XEOTICID XEO04403 GENEFORM Protein DME1121 XEOTICID XEO04403 MOACRIVE Inhibition DME1121 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1121 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04404 XEO_CLAS Peptide DME1121 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.6 ug/ml) DME1121 XEOTICID XEO04404 GENEFORM Protein DME1121 XEOTICID XEO04404 MOACRIVE Inhibition DME1121 XEOTICID XEO04410 XEO_NAME Insect osmin DME1121 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04410 XEO_CLAS Peptide DME1121 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.125-1.56 microM) DME1121 XEOTICID XEO04410 GENEFORM Protein DME1121 XEOTICID XEO04410 MOACRIVE Inhibition DME1121 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1121 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04412 XEO_CLAS Peptide DME1121 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04412 GENEFORM Protein DME1121 XEOTICID XEO04412 MOACRIVE Inhibition DME1121 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1121 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04414 XEO_CLAS Peptide DME1121 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04414 GENEFORM Protein DME1121 XEOTICID XEO04414 MOACRIVE Inhibition DME1121 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1121 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04415 XEO_CLAS Peptide DME1121 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04415 GENEFORM Protein DME1121 XEOTICID XEO04415 MOACRIVE Inhibition DME1121 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1121 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04421 XEO_CLAS Peptide DME1121 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 microM) DME1121 XEOTICID XEO04421 GENEFORM Protein DME1121 XEOTICID XEO04421 MOACRIVE Inhibition DME1121 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1121 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04426 XEO_CLAS Peptide DME1121 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO04426 GENEFORM Protein DME1121 XEOTICID XEO04426 MOACRIVE Inhibition DME1121 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1121 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04428 XEO_CLAS Peptide DME1121 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.3 ug/ml) DME1121 XEOTICID XEO04428 GENEFORM Protein DME1121 XEOTICID XEO04428 MOACRIVE Inhibition DME1121 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1121 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04430 XEO_CLAS Peptide DME1121 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25 microM) DME1121 XEOTICID XEO04430 GENEFORM Protein DME1121 XEOTICID XEO04430 MOACRIVE Inhibition DME1121 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1121 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04433 XEO_CLAS Peptide DME1121 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 160 microM) DME1121 XEOTICID XEO04433 GENEFORM Protein DME1121 XEOTICID XEO04433 MOACRIVE Inhibition DME1121 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1121 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04435 XEO_CLAS Peptide DME1121 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 160 microM) DME1121 XEOTICID XEO04435 GENEFORM Protein DME1121 XEOTICID XEO04435 MOACRIVE Inhibition DME1121 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1121 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1121 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04438 GENEFORM Protein DME1121 XEOTICID XEO04438 MOACRIVE Inhibition DME1121 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1121 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04439 XEO_CLAS Peptide DME1121 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04439 GENEFORM Protein DME1121 XEOTICID XEO04439 MOACRIVE Inhibition DME1121 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1121 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04440 XEO_CLAS Peptide DME1121 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 microM) DME1121 XEOTICID XEO04440 GENEFORM Protein DME1121 XEOTICID XEO04440 MOACRIVE Inhibition DME1121 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1121 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04441 XEO_CLAS Peptide DME1121 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 28 microM) DME1121 XEOTICID XEO04441 GENEFORM Protein DME1121 XEOTICID XEO04441 MOACRIVE Inhibition DME1121 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1121 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04442 XEO_CLAS Peptide DME1121 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 28 microM) DME1121 XEOTICID XEO04442 GENEFORM Protein DME1121 XEOTICID XEO04442 MOACRIVE Inhibition DME1121 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1121 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04443 XEO_CLAS Peptide DME1121 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04443 GENEFORM Protein DME1121 XEOTICID XEO04443 MOACRIVE Inhibition DME1121 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1121 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04444 XEO_CLAS Peptide DME1121 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 13 microM) DME1121 XEOTICID XEO04444 GENEFORM Protein DME1121 XEOTICID XEO04444 MOACRIVE Inhibition DME1121 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1121 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04445 XEO_CLAS Peptide DME1121 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04445 GENEFORM Protein DME1121 XEOTICID XEO04445 MOACRIVE Inhibition DME1121 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1121 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04446 XEO_CLAS Peptide DME1121 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 78 microM) DME1121 XEOTICID XEO04446 GENEFORM Protein DME1121 XEOTICID XEO04446 MOACRIVE Inhibition DME1121 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1121 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04447 XEO_CLAS Peptide DME1121 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 120 microM) DME1121 XEOTICID XEO04447 GENEFORM Protein DME1121 XEOTICID XEO04447 MOACRIVE Inhibition DME1121 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1121 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04448 XEO_CLAS Peptide DME1121 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 microM) DME1121 XEOTICID XEO04448 GENEFORM Protein DME1121 XEOTICID XEO04448 MOACRIVE Inhibition DME1121 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1121 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04449 XEO_CLAS Peptide DME1121 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.3 microM) DME1121 XEOTICID XEO04449 GENEFORM Protein DME1121 XEOTICID XEO04449 MOACRIVE Inhibition DME1121 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1121 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04450 XEO_CLAS Peptide DME1121 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.3 microM) DME1121 XEOTICID XEO04450 GENEFORM Protein DME1121 XEOTICID XEO04450 MOACRIVE Inhibition DME1121 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1121 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04451 XEO_CLAS Peptide DME1121 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO04451 GENEFORM Protein DME1121 XEOTICID XEO04451 MOACRIVE Inhibition DME1121 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1121 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04452 XEO_CLAS Peptide DME1121 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.1 microM) DME1121 XEOTICID XEO04452 GENEFORM Protein DME1121 XEOTICID XEO04452 MOACRIVE Inhibition DME1121 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1121 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04453 XEO_CLAS Peptide DME1121 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO04453 GENEFORM Protein DME1121 XEOTICID XEO04453 MOACRIVE Inhibition DME1121 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1121 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04455 XEO_CLAS Peptide DME1121 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 microM) DME1121 XEOTICID XEO04455 GENEFORM Protein DME1121 XEOTICID XEO04455 MOACRIVE Inhibition DME1121 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1121 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04457 XEO_CLAS Peptide DME1121 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.3 microM) DME1121 XEOTICID XEO04457 GENEFORM Protein DME1121 XEOTICID XEO04457 MOACRIVE Inhibition DME1121 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1121 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04458 XEO_CLAS Peptide DME1121 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1 microM) DME1121 XEOTICID XEO04458 GENEFORM Protein DME1121 XEOTICID XEO04458 MOACRIVE Inhibition DME1121 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1121 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04459 XEO_CLAS Peptide DME1121 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1 microM) DME1121 XEOTICID XEO04459 GENEFORM Protein DME1121 XEOTICID XEO04459 MOACRIVE Inhibition DME1121 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1121 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04461 XEO_CLAS Peptide DME1121 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20.8 microM) DME1121 XEOTICID XEO04461 GENEFORM Protein DME1121 XEOTICID XEO04461 MOACRIVE Inhibition DME1121 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1121 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04462 XEO_CLAS Peptide DME1121 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 19.1 microM) DME1121 XEOTICID XEO04462 GENEFORM Protein DME1121 XEOTICID XEO04462 MOACRIVE Inhibition DME1121 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1121 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04463 XEO_CLAS Peptide DME1121 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04463 GENEFORM Protein DME1121 XEOTICID XEO04463 MOACRIVE Inhibition DME1121 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1121 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04464 XEO_CLAS Peptide DME1121 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.5 microM) DME1121 XEOTICID XEO04464 GENEFORM Protein DME1121 XEOTICID XEO04464 MOACRIVE Inhibition DME1121 XEOTICID XEO04466 XEO_NAME Panusin DME1121 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04466 XEO_CLAS Peptide DME1121 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04466 GENEFORM Protein DME1121 XEOTICID XEO04466 MOACRIVE Inhibition DME1121 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1121 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04467 XEO_CLAS Peptide DME1121 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4.8 microM) DME1121 XEOTICID XEO04467 GENEFORM Protein DME1121 XEOTICID XEO04467 MOACRIVE Inhibition DME1121 XEOTICID XEO04468 XEO_NAME Papillosin DME1121 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04468 XEO_CLAS Peptide DME1121 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04468 GENEFORM Protein DME1121 XEOTICID XEO04468 MOACRIVE Inhibition DME1121 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1121 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04471 XEO_CLAS Peptide DME1121 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.1 microM) DME1121 XEOTICID XEO04471 GENEFORM Protein DME1121 XEOTICID XEO04471 MOACRIVE Inhibition DME1121 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1121 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04480 XEO_CLAS Peptide DME1121 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 ug/ml) DME1121 XEOTICID XEO04480 GENEFORM Protein DME1121 XEOTICID XEO04480 MOACRIVE Inhibition DME1121 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1121 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1121 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04482 GENEFORM Protein DME1121 XEOTICID XEO04482 MOACRIVE Inhibition DME1121 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1121 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04484 XEO_CLAS Peptide DME1121 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 microM) DME1121 XEOTICID XEO04484 GENEFORM Protein DME1121 XEOTICID XEO04484 MOACRIVE Inhibition DME1121 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1121 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04485 XEO_CLAS Peptide DME1121 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO04485 GENEFORM Protein DME1121 XEOTICID XEO04485 MOACRIVE Inhibition DME1121 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1121 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04486 XEO_CLAS Peptide DME1121 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 microM) DME1121 XEOTICID XEO04486 GENEFORM Protein DME1121 XEOTICID XEO04486 MOACRIVE Inhibition DME1121 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1121 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04487 XEO_CLAS Peptide DME1121 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO04487 GENEFORM Protein DME1121 XEOTICID XEO04487 MOACRIVE Inhibition DME1121 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1121 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04488 XEO_CLAS Peptide DME1121 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 9 microM) DME1121 XEOTICID XEO04488 GENEFORM Protein DME1121 XEOTICID XEO04488 MOACRIVE Inhibition DME1121 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1121 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04489 XEO_CLAS Peptide DME1121 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 13 microM) DME1121 XEOTICID XEO04489 GENEFORM Protein DME1121 XEOTICID XEO04489 MOACRIVE Inhibition DME1121 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1121 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04490 XEO_CLAS Peptide DME1121 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 47.5 microM) DME1121 XEOTICID XEO04490 GENEFORM Protein DME1121 XEOTICID XEO04490 MOACRIVE Inhibition DME1121 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1121 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04491 XEO_CLAS Peptide DME1121 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO04491 GENEFORM Protein DME1121 XEOTICID XEO04491 MOACRIVE Inhibition DME1121 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1121 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04492 XEO_CLAS Peptide DME1121 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 35 microM) DME1121 XEOTICID XEO04492 GENEFORM Protein DME1121 XEOTICID XEO04492 MOACRIVE Inhibition DME1121 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1121 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04493 XEO_CLAS Peptide DME1121 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 microM) DME1121 XEOTICID XEO04493 GENEFORM Protein DME1121 XEOTICID XEO04493 MOACRIVE Inhibition DME1121 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1121 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04494 XEO_CLAS Peptide DME1121 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO04494 GENEFORM Protein DME1121 XEOTICID XEO04494 MOACRIVE Inhibition DME1121 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1121 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04495 XEO_CLAS Peptide DME1121 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO04495 GENEFORM Protein DME1121 XEOTICID XEO04495 MOACRIVE Inhibition DME1121 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1121 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04496 XEO_CLAS Peptide DME1121 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 67.5 microM) DME1121 XEOTICID XEO04496 GENEFORM Protein DME1121 XEOTICID XEO04496 MOACRIVE Inhibition DME1121 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1121 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04497 XEO_CLAS Peptide DME1121 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO04497 GENEFORM Protein DME1121 XEOTICID XEO04497 MOACRIVE Inhibition DME1121 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1121 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04498 XEO_CLAS Peptide DME1121 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO04498 GENEFORM Protein DME1121 XEOTICID XEO04498 MOACRIVE Inhibition DME1121 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1121 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04499 XEO_CLAS Peptide DME1121 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 43 microM) DME1121 XEOTICID XEO04499 GENEFORM Protein DME1121 XEOTICID XEO04499 MOACRIVE Inhibition DME1121 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1121 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04500 XEO_CLAS Peptide DME1121 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO04500 GENEFORM Protein DME1121 XEOTICID XEO04500 MOACRIVE Inhibition DME1121 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1121 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04504 XEO_CLAS Peptide DME1121 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04504 GENEFORM Protein DME1121 XEOTICID XEO04504 MOACRIVE Inhibition DME1121 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1121 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04505 XEO_CLAS Peptide DME1121 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04505 GENEFORM Protein DME1121 XEOTICID XEO04505 MOACRIVE Inhibition DME1121 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1121 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04506 XEO_CLAS Peptide DME1121 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 40 microM) DME1121 XEOTICID XEO04506 GENEFORM Protein DME1121 XEOTICID XEO04506 MOACRIVE Inhibition DME1121 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1121 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04507 XEO_CLAS Peptide DME1121 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10-20 microM) DME1121 XEOTICID XEO04507 GENEFORM Protein DME1121 XEOTICID XEO04507 MOACRIVE Inhibition DME1121 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1121 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04508 XEO_CLAS Peptide DME1121 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04508 GENEFORM Protein DME1121 XEOTICID XEO04508 MOACRIVE Inhibition DME1121 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1121 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04509 XEO_CLAS Peptide DME1121 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04509 GENEFORM Protein DME1121 XEOTICID XEO04509 MOACRIVE Inhibition DME1121 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1121 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04510 XEO_CLAS Peptide DME1121 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 22-33 microM) DME1121 XEOTICID XEO04510 GENEFORM Protein DME1121 XEOTICID XEO04510 MOACRIVE Inhibition DME1121 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1121 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04525 XEO_CLAS Peptide DME1121 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 32.0 microM) DME1121 XEOTICID XEO04525 GENEFORM Protein DME1121 XEOTICID XEO04525 MOACRIVE Inhibition DME1121 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1121 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04526 XEO_CLAS Peptide DME1121 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.0 microM) DME1121 XEOTICID XEO04526 GENEFORM Protein DME1121 XEOTICID XEO04526 MOACRIVE Inhibition DME1121 XEOTICID XEO04527 XEO_NAME Pepcon DME1121 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04527 XEO_CLAS Peptide DME1121 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO04527 GENEFORM Protein DME1121 XEOTICID XEO04527 MOACRIVE Inhibition DME1121 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1121 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04532 XEO_CLAS Peptide DME1121 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04532 GENEFORM Protein DME1121 XEOTICID XEO04532 MOACRIVE Inhibition DME1121 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1121 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04540 XEO_CLAS Peptide DME1121 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 18.1 ug/ml) DME1121 XEOTICID XEO04540 GENEFORM Protein DME1121 XEOTICID XEO04540 MOACRIVE Inhibition DME1121 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1121 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04541 XEO_CLAS Peptide DME1121 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.5 ug/ml) DME1121 XEOTICID XEO04541 GENEFORM Protein DME1121 XEOTICID XEO04541 MOACRIVE Inhibition DME1121 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1121 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04542 XEO_CLAS Peptide DME1121 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04542 GENEFORM Protein DME1121 XEOTICID XEO04542 MOACRIVE Inhibition DME1121 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1121 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04543 XEO_CLAS Peptide DME1121 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04543 GENEFORM Protein DME1121 XEOTICID XEO04543 MOACRIVE Inhibition DME1121 XEOTICID XEO04546 XEO_NAME Perinerin DME1121 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04546 XEO_CLAS Peptide DME1121 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04546 GENEFORM Protein DME1121 XEOTICID XEO04546 MOACRIVE Inhibition DME1121 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1121 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04548 XEO_CLAS Peptide DME1121 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 72000 ug/ml) DME1121 XEOTICID XEO04548 GENEFORM Protein DME1121 XEOTICID XEO04548 MOACRIVE Inhibition DME1121 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1121 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04549 XEO_CLAS Peptide DME1121 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 62-125 ug/ml) DME1121 XEOTICID XEO04549 GENEFORM Protein DME1121 XEOTICID XEO04549 MOACRIVE Inhibition DME1121 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1121 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04550 XEO_CLAS Peptide DME1121 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO04550 GENEFORM Protein DME1121 XEOTICID XEO04550 MOACRIVE Inhibition DME1121 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1121 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04551 XEO_CLAS Peptide DME1121 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 23.6 ug/ml) DME1121 XEOTICID XEO04551 GENEFORM Protein DME1121 XEOTICID XEO04551 MOACRIVE Inhibition DME1121 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1121 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04552 XEO_CLAS Peptide DME1121 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04552 GENEFORM Protein DME1121 XEOTICID XEO04552 MOACRIVE Inhibition DME1121 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1121 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04553 XEO_CLAS Peptide DME1121 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04553 GENEFORM Protein DME1121 XEOTICID XEO04553 MOACRIVE Inhibition DME1121 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1121 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04554 XEO_CLAS Peptide DME1121 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04554 GENEFORM Protein DME1121 XEOTICID XEO04554 MOACRIVE Inhibition DME1121 XEOTICID XEO04563 XEO_NAME Phosphate DME1121 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1121 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04563 GENEFORM Protein DME1121 XEOTICID XEO04563 MOACRIVE Inhibition DME1121 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1121 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04565 XEO_CLAS Peptide DME1121 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.5 microM) DME1121 XEOTICID XEO04565 GENEFORM Protein DME1121 XEOTICID XEO04565 MOACRIVE Inhibition DME1121 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1121 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04566 XEO_CLAS Peptide DME1121 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.7 microM) DME1121 XEOTICID XEO04566 GENEFORM Protein DME1121 XEOTICID XEO04566 MOACRIVE Inhibition DME1121 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1121 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04569 XEO_CLAS Peptide DME1121 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 7.9 microM) DME1121 XEOTICID XEO04569 GENEFORM Protein DME1121 XEOTICID XEO04569 MOACRIVE Inhibition DME1121 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1121 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04570 XEO_CLAS Peptide DME1121 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04570 GENEFORM Protein DME1121 XEOTICID XEO04570 MOACRIVE Inhibition DME1121 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1121 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04571 XEO_CLAS Peptide DME1121 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04571 GENEFORM Protein DME1121 XEOTICID XEO04571 MOACRIVE Inhibition DME1121 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1121 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04572 XEO_CLAS Peptide DME1121 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04572 GENEFORM Protein DME1121 XEOTICID XEO04572 MOACRIVE Inhibition DME1121 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1121 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04573 XEO_CLAS Peptide DME1121 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 microM) DME1121 XEOTICID XEO04573 GENEFORM Protein DME1121 XEOTICID XEO04573 MOACRIVE Inhibition DME1121 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1121 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04574 XEO_CLAS Peptide DME1121 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 128 ug/ml) DME1121 XEOTICID XEO04574 GENEFORM Protein DME1121 XEOTICID XEO04574 MOACRIVE Inhibition DME1121 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1121 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04575 XEO_CLAS Peptide DME1121 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO04575 GENEFORM Protein DME1121 XEOTICID XEO04575 MOACRIVE Inhibition DME1121 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1121 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04578 GENEFORM Protein DME1121 XEOTICID XEO04578 MOACRIVE Inhibition DME1121 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1121 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04579 GENEFORM Protein DME1121 XEOTICID XEO04579 MOACRIVE Inhibition DME1121 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1121 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04580 GENEFORM Protein DME1121 XEOTICID XEO04580 MOACRIVE Inhibition DME1121 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1121 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04583 GENEFORM Protein DME1121 XEOTICID XEO04583 MOACRIVE Inhibition DME1121 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1121 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04588 GENEFORM Protein DME1121 XEOTICID XEO04588 MOACRIVE Inhibition DME1121 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1121 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04589 GENEFORM Protein DME1121 XEOTICID XEO04589 MOACRIVE Inhibition DME1121 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1121 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04590 GENEFORM Protein DME1121 XEOTICID XEO04590 MOACRIVE Inhibition DME1121 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1121 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04591 GENEFORM Protein DME1121 XEOTICID XEO04591 MOACRIVE Inhibition DME1121 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1121 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04592 GENEFORM Protein DME1121 XEOTICID XEO04592 MOACRIVE Inhibition DME1121 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1121 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04593 GENEFORM Protein DME1121 XEOTICID XEO04593 MOACRIVE Inhibition DME1121 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1121 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04594 GENEFORM Protein DME1121 XEOTICID XEO04594 MOACRIVE Inhibition DME1121 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1121 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04595 GENEFORM Protein DME1121 XEOTICID XEO04595 MOACRIVE Inhibition DME1121 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1121 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04596 GENEFORM Protein DME1121 XEOTICID XEO04596 MOACRIVE Inhibition DME1121 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1121 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04597 GENEFORM Protein DME1121 XEOTICID XEO04597 MOACRIVE Inhibition DME1121 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1121 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04598 GENEFORM Protein DME1121 XEOTICID XEO04598 MOACRIVE Inhibition DME1121 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1121 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04599 GENEFORM Protein DME1121 XEOTICID XEO04599 MOACRIVE Inhibition DME1121 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1121 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04601 XEO_CLAS Peptide DME1121 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 18.75 ug/ml) DME1121 XEOTICID XEO04601 GENEFORM Protein DME1121 XEOTICID XEO04601 MOACRIVE Inhibition DME1121 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1121 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04602 XEO_CLAS Peptide DME1121 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 37.5 ug/ml) DME1121 XEOTICID XEO04602 GENEFORM Protein DME1121 XEOTICID XEO04602 MOACRIVE Inhibition DME1121 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1121 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04604 XEO_CLAS Peptide DME1121 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC < 25 microM) DME1121 XEOTICID XEO04604 GENEFORM Protein DME1121 XEOTICID XEO04604 MOACRIVE Inhibition DME1121 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1121 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04605 XEO_CLAS Peptide DME1121 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC < 6.25 microM) DME1121 XEOTICID XEO04605 GENEFORM Protein DME1121 XEOTICID XEO04605 MOACRIVE Inhibition DME1121 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1121 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04606 XEO_CLAS Peptide DME1121 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO04606 GENEFORM Protein DME1121 XEOTICID XEO04606 MOACRIVE Inhibition DME1121 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1121 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1121 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04607 GENEFORM Protein DME1121 XEOTICID XEO04607 MOACRIVE Inhibition DME1121 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1121 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04612 XEO_CLAS Peptide DME1121 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5-10 microM) DME1121 XEOTICID XEO04612 GENEFORM Protein DME1121 XEOTICID XEO04612 MOACRIVE Inhibition DME1121 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1121 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04613 XEO_CLAS Peptide DME1121 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5-10 microM) DME1121 XEOTICID XEO04613 GENEFORM Protein DME1121 XEOTICID XEO04613 MOACRIVE Inhibition DME1121 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1121 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04625 XEO_CLAS Peptide DME1121 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO04625 GENEFORM Protein DME1121 XEOTICID XEO04625 MOACRIVE Inhibition DME1121 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1121 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04626 XEO_CLAS Peptide DME1121 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO04626 GENEFORM Protein DME1121 XEOTICID XEO04626 MOACRIVE Inhibition DME1121 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1121 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04627 XEO_CLAS Peptide DME1121 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.5 microM) DME1121 XEOTICID XEO04627 GENEFORM Protein DME1121 XEOTICID XEO04627 MOACRIVE Inhibition DME1121 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1121 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04630 XEO_CLAS Peptide DME1121 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 60 ug/ml) DME1121 XEOTICID XEO04630 GENEFORM Protein DME1121 XEOTICID XEO04630 MOACRIVE Inhibition DME1121 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1121 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04631 XEO_CLAS Peptide DME1121 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 60 ug/ml) DME1121 XEOTICID XEO04631 GENEFORM Protein DME1121 XEOTICID XEO04631 MOACRIVE Inhibition DME1121 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1121 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04633 XEO_CLAS Peptide DME1121 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 ug/ml) DME1121 XEOTICID XEO04633 GENEFORM Protein DME1121 XEOTICID XEO04633 MOACRIVE Inhibition DME1121 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1121 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04634 XEO_CLAS Peptide DME1121 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 ug/ml) DME1121 XEOTICID XEO04634 GENEFORM Protein DME1121 XEOTICID XEO04634 MOACRIVE Inhibition DME1121 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1121 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04635 XEO_CLAS Peptide DME1121 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 ug/ml) DME1121 XEOTICID XEO04635 GENEFORM Protein DME1121 XEOTICID XEO04635 MOACRIVE Inhibition DME1121 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1121 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04636 XEO_CLAS Peptide DME1121 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 ug/ml) DME1121 XEOTICID XEO04636 GENEFORM Protein DME1121 XEOTICID XEO04636 MOACRIVE Inhibition DME1121 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1121 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04637 XEO_CLAS Peptide DME1121 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 ug/ml) DME1121 XEOTICID XEO04637 GENEFORM Protein DME1121 XEOTICID XEO04637 MOACRIVE Inhibition DME1121 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1121 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04638 XEO_CLAS Peptide DME1121 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 ug/ml) DME1121 XEOTICID XEO04638 GENEFORM Protein DME1121 XEOTICID XEO04638 MOACRIVE Inhibition DME1121 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1121 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04639 XEO_CLAS Peptide DME1121 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 ug/ml) DME1121 XEOTICID XEO04639 GENEFORM Protein DME1121 XEOTICID XEO04639 MOACRIVE Inhibition DME1121 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1121 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04640 XEO_CLAS Peptide DME1121 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.2-3.3 microM) DME1121 XEOTICID XEO04640 GENEFORM Protein DME1121 XEOTICID XEO04640 MOACRIVE Inhibition DME1121 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1121 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04642 XEO_CLAS Peptide DME1121 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 ug/ml) DME1121 XEOTICID XEO04642 GENEFORM Protein DME1121 XEOTICID XEO04642 MOACRIVE Inhibition DME1121 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1121 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04643 XEO_CLAS Peptide DME1121 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO04643 GENEFORM Protein DME1121 XEOTICID XEO04643 MOACRIVE Inhibition DME1121 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1121 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04644 XEO_CLAS Peptide DME1121 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO04644 GENEFORM Protein DME1121 XEOTICID XEO04644 MOACRIVE Inhibition DME1121 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1121 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04645 XEO_CLAS Peptide DME1121 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 ug/ml) DME1121 XEOTICID XEO04645 GENEFORM Protein DME1121 XEOTICID XEO04645 MOACRIVE Inhibition DME1121 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1121 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04646 XEO_CLAS Peptide DME1121 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1 ug/ml) DME1121 XEOTICID XEO04646 GENEFORM Protein DME1121 XEOTICID XEO04646 MOACRIVE Inhibition DME1121 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1121 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04647 XEO_CLAS Peptide DME1121 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO04647 GENEFORM Protein DME1121 XEOTICID XEO04647 MOACRIVE Inhibition DME1121 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1121 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04648 XEO_CLAS Peptide DME1121 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 ug/ml) DME1121 XEOTICID XEO04648 GENEFORM Protein DME1121 XEOTICID XEO04648 MOACRIVE Inhibition DME1121 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1121 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04649 XEO_CLAS Peptide DME1121 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 64 ug/ml) DME1121 XEOTICID XEO04649 GENEFORM Protein DME1121 XEOTICID XEO04649 MOACRIVE Inhibition DME1121 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1121 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04650 XEO_CLAS Peptide DME1121 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 ug/ml) DME1121 XEOTICID XEO04650 GENEFORM Protein DME1121 XEOTICID XEO04650 MOACRIVE Inhibition DME1121 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1121 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04651 XEO_CLAS Peptide DME1121 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 ug/ml) DME1121 XEOTICID XEO04651 GENEFORM Protein DME1121 XEOTICID XEO04651 MOACRIVE Inhibition DME1121 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1121 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04652 XEO_CLAS Peptide DME1121 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO04652 GENEFORM Protein DME1121 XEOTICID XEO04652 MOACRIVE Inhibition DME1121 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1121 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04653 XEO_CLAS Peptide DME1121 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 64 ug/ml) DME1121 XEOTICID XEO04653 GENEFORM Protein DME1121 XEOTICID XEO04653 MOACRIVE Inhibition DME1121 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1121 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04654 XEO_CLAS Peptide DME1121 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 ug/ml) DME1121 XEOTICID XEO04654 GENEFORM Protein DME1121 XEOTICID XEO04654 MOACRIVE Inhibition DME1121 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1121 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04655 XEO_CLAS Peptide DME1121 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO04655 GENEFORM Protein DME1121 XEOTICID XEO04655 MOACRIVE Inhibition DME1121 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1121 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04657 XEO_CLAS Peptide DME1121 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 300 microM) DME1121 XEOTICID XEO04657 GENEFORM Protein DME1121 XEOTICID XEO04657 MOACRIVE Inhibition DME1121 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1121 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04660 XEO_CLAS Peptide DME1121 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO04660 GENEFORM Protein DME1121 XEOTICID XEO04660 MOACRIVE Inhibition DME1121 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1121 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04661 XEO_CLAS Peptide DME1121 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 microM) DME1121 XEOTICID XEO04661 GENEFORM Protein DME1121 XEOTICID XEO04661 MOACRIVE Inhibition DME1121 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1121 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04662 XEO_CLAS Peptide DME1121 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 microM) DME1121 XEOTICID XEO04662 GENEFORM Protein DME1121 XEOTICID XEO04662 MOACRIVE Inhibition DME1121 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1121 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04663 XEO_CLAS Peptide DME1121 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 microM) DME1121 XEOTICID XEO04663 GENEFORM Protein DME1121 XEOTICID XEO04663 MOACRIVE Inhibition DME1121 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1121 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04664 XEO_CLAS Peptide DME1121 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5.5 microM) DME1121 XEOTICID XEO04664 GENEFORM Protein DME1121 XEOTICID XEO04664 MOACRIVE Inhibition DME1121 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1121 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04665 XEO_CLAS Peptide DME1121 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 microM) DME1121 XEOTICID XEO04665 GENEFORM Protein DME1121 XEOTICID XEO04665 MOACRIVE Inhibition DME1121 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1121 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04666 XEO_CLAS Peptide DME1121 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO04666 GENEFORM Protein DME1121 XEOTICID XEO04666 MOACRIVE Inhibition DME1121 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1121 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04667 XEO_CLAS Peptide DME1121 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6.25 microM) DME1121 XEOTICID XEO04667 GENEFORM Protein DME1121 XEOTICID XEO04667 MOACRIVE Inhibition DME1121 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1121 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04668 XEO_CLAS Peptide DME1121 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 microM) DME1121 XEOTICID XEO04668 GENEFORM Protein DME1121 XEOTICID XEO04668 MOACRIVE Inhibition DME1121 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1121 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04669 XEO_CLAS Peptide DME1121 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO04669 GENEFORM Protein DME1121 XEOTICID XEO04669 MOACRIVE Inhibition DME1121 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1121 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04670 XEO_CLAS Peptide DME1121 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 21 microM) DME1121 XEOTICID XEO04670 GENEFORM Protein DME1121 XEOTICID XEO04670 MOACRIVE Inhibition DME1121 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1121 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04671 XEO_CLAS Peptide DME1121 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 62 microM) DME1121 XEOTICID XEO04671 GENEFORM Protein DME1121 XEOTICID XEO04671 MOACRIVE Inhibition DME1121 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1121 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04672 XEO_CLAS Peptide DME1121 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO04672 GENEFORM Protein DME1121 XEOTICID XEO04672 MOACRIVE Inhibition DME1121 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1121 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04673 XEO_CLAS Peptide DME1121 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO04673 GENEFORM Protein DME1121 XEOTICID XEO04673 MOACRIVE Inhibition DME1121 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1121 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04674 XEO_CLAS Peptide DME1121 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 75 microM) DME1121 XEOTICID XEO04674 GENEFORM Protein DME1121 XEOTICID XEO04674 MOACRIVE Inhibition DME1121 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1121 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04675 XEO_CLAS Peptide DME1121 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 microM) DME1121 XEOTICID XEO04675 GENEFORM Protein DME1121 XEOTICID XEO04675 MOACRIVE Inhibition DME1121 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1121 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04676 XEO_CLAS Peptide DME1121 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 microM) DME1121 XEOTICID XEO04676 GENEFORM Protein DME1121 XEOTICID XEO04676 MOACRIVE Inhibition DME1121 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1121 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04677 XEO_CLAS Peptide DME1121 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO04677 GENEFORM Protein DME1121 XEOTICID XEO04677 MOACRIVE Inhibition DME1121 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1121 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04680 XEO_CLAS Peptide DME1121 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 microM) DME1121 XEOTICID XEO04680 GENEFORM Protein DME1121 XEOTICID XEO04680 MOACRIVE Inhibition DME1121 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1121 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04682 XEO_CLAS Peptide DME1121 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 microM) DME1121 XEOTICID XEO04682 GENEFORM Protein DME1121 XEOTICID XEO04682 MOACRIVE Inhibition DME1121 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1121 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04683 XEO_CLAS Peptide DME1121 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 microM) DME1121 XEOTICID XEO04683 GENEFORM Protein DME1121 XEOTICID XEO04683 MOACRIVE Inhibition DME1121 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1121 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04684 XEO_CLAS Peptide DME1121 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 38 microM) DME1121 XEOTICID XEO04684 GENEFORM Protein DME1121 XEOTICID XEO04684 MOACRIVE Inhibition DME1121 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1121 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04690 XEO_CLAS Peptide DME1121 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.5 ug/ml) DME1121 XEOTICID XEO04690 GENEFORM Protein DME1121 XEOTICID XEO04690 MOACRIVE Inhibition DME1121 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1121 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04695 XEO_CLAS Peptide DME1121 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04695 GENEFORM Protein DME1121 XEOTICID XEO04695 MOACRIVE Inhibition DME1121 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1121 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04696 XEO_CLAS Peptide DME1121 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04696 GENEFORM Protein DME1121 XEOTICID XEO04696 MOACRIVE Inhibition DME1121 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1121 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04712 XEO_CLAS Peptide DME1121 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16.7 microM) DME1121 XEOTICID XEO04712 GENEFORM Protein DME1121 XEOTICID XEO04712 MOACRIVE Inhibition DME1121 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1121 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04713 XEO_CLAS Peptide DME1121 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16.7 microM) DME1121 XEOTICID XEO04713 GENEFORM Protein DME1121 XEOTICID XEO04713 MOACRIVE Inhibition DME1121 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1121 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04714 XEO_CLAS Peptide DME1121 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 23.3 microM) DME1121 XEOTICID XEO04714 GENEFORM Protein DME1121 XEOTICID XEO04714 MOACRIVE Inhibition DME1121 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1121 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04716 XEO_CLAS Peptide DME1121 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 microM) DME1121 XEOTICID XEO04716 GENEFORM Protein DME1121 XEOTICID XEO04716 MOACRIVE Inhibition DME1121 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1121 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04717 XEO_CLAS Peptide DME1121 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 50 microM) DME1121 XEOTICID XEO04717 GENEFORM Protein DME1121 XEOTICID XEO04717 MOACRIVE Inhibition DME1121 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1121 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04725 XEO_CLAS Peptide DME1121 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04725 GENEFORM Protein DME1121 XEOTICID XEO04725 MOACRIVE Inhibition DME1121 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1121 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04726 XEO_CLAS Peptide DME1121 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04726 GENEFORM Protein DME1121 XEOTICID XEO04726 MOACRIVE Inhibition DME1121 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1121 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04731 XEO_CLAS Peptide DME1121 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 ug/ml) DME1121 XEOTICID XEO04731 GENEFORM Protein DME1121 XEOTICID XEO04731 MOACRIVE Inhibition DME1121 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1121 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04732 XEO_CLAS Peptide DME1121 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 25 ug/ml) DME1121 XEOTICID XEO04732 GENEFORM Protein DME1121 XEOTICID XEO04732 MOACRIVE Inhibition DME1121 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1121 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04733 XEO_CLAS Peptide DME1121 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04733 GENEFORM Protein DME1121 XEOTICID XEO04733 MOACRIVE Inhibition DME1121 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1121 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04734 XEO_CLAS Peptide DME1121 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04734 GENEFORM Protein DME1121 XEOTICID XEO04734 MOACRIVE Inhibition DME1121 XEOTICID XEO04737 XEO_NAME Protonectin DME1121 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04737 XEO_CLAS Peptide DME1121 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 ug/ml) DME1121 XEOTICID XEO04737 GENEFORM Protein DME1121 XEOTICID XEO04737 MOACRIVE Inhibition DME1121 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1121 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04739 XEO_CLAS Peptide DME1121 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04739 GENEFORM Protein DME1121 XEOTICID XEO04739 MOACRIVE Inhibition DME1121 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1121 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04740 XEO_CLAS Peptide DME1121 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04740 GENEFORM Protein DME1121 XEOTICID XEO04740 MOACRIVE Inhibition DME1121 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1121 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04741 XEO_CLAS Peptide DME1121 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04741 GENEFORM Protein DME1121 XEOTICID XEO04741 MOACRIVE Inhibition DME1121 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1121 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04742 XEO_CLAS Peptide DME1121 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04742 GENEFORM Protein DME1121 XEOTICID XEO04742 MOACRIVE Inhibition DME1121 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1121 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04762 XEO_CLAS Peptide DME1121 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.8 microM) DME1121 XEOTICID XEO04762 GENEFORM Protein DME1121 XEOTICID XEO04762 MOACRIVE Inhibition DME1121 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1121 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04766 XEO_CLAS Peptide DME1121 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.1 microM) DME1121 XEOTICID XEO04766 GENEFORM Protein DME1121 XEOTICID XEO04766 MOACRIVE Inhibition DME1121 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1121 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04767 XEO_CLAS Peptide DME1121 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.1 ug/ml) DME1121 XEOTICID XEO04767 GENEFORM Protein DME1121 XEOTICID XEO04767 MOACRIVE Inhibition DME1121 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1121 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04779 XEO_CLAS Peptide DME1121 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04779 GENEFORM Protein DME1121 XEOTICID XEO04779 MOACRIVE Inhibition DME1121 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1121 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04780 XEO_CLAS Peptide DME1121 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04780 GENEFORM Protein DME1121 XEOTICID XEO04780 MOACRIVE Inhibition DME1121 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1121 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04781 XEO_CLAS Peptide DME1121 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04781 GENEFORM Protein DME1121 XEOTICID XEO04781 MOACRIVE Inhibition DME1121 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1121 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04782 XEO_CLAS Peptide DME1121 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 ug/ml) DME1121 XEOTICID XEO04782 GENEFORM Protein DME1121 XEOTICID XEO04782 MOACRIVE Inhibition DME1121 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1121 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04783 XEO_CLAS Peptide DME1121 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO04783 GENEFORM Protein DME1121 XEOTICID XEO04783 MOACRIVE Inhibition DME1121 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1121 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04784 XEO_CLAS Peptide DME1121 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO04784 GENEFORM Protein DME1121 XEOTICID XEO04784 MOACRIVE Inhibition DME1121 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1121 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04785 XEO_CLAS Peptide DME1121 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO04785 GENEFORM Protein DME1121 XEOTICID XEO04785 MOACRIVE Inhibition DME1121 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1121 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04786 XEO_CLAS Peptide DME1121 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 ug/ml) DME1121 XEOTICID XEO04786 GENEFORM Protein DME1121 XEOTICID XEO04786 MOACRIVE Inhibition DME1121 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1121 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04787 XEO_CLAS Peptide DME1121 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04787 GENEFORM Protein DME1121 XEOTICID XEO04787 MOACRIVE Inhibition DME1121 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1121 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04793 XEO_CLAS Peptide DME1121 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04793 GENEFORM Protein DME1121 XEOTICID XEO04793 MOACRIVE Inhibition DME1121 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1121 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04798 XEO_CLAS Peptide DME1121 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 microM) DME1121 XEOTICID XEO04798 GENEFORM Protein DME1121 XEOTICID XEO04798 MOACRIVE Inhibition DME1121 XEOTICID XEO04799 XEO_NAME Ranalexin DME1121 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04799 XEO_CLAS Peptide DME1121 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 32 ug/ml) DME1121 XEOTICID XEO04799 GENEFORM Protein DME1121 XEOTICID XEO04799 MOACRIVE Inhibition DME1121 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1121 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04800 XEO_CLAS Peptide DME1121 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 microM) DME1121 XEOTICID XEO04800 GENEFORM Protein DME1121 XEOTICID XEO04800 MOACRIVE Inhibition DME1121 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1121 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04801 XEO_CLAS Peptide DME1121 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 9 microM) DME1121 XEOTICID XEO04801 GENEFORM Protein DME1121 XEOTICID XEO04801 MOACRIVE Inhibition DME1121 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1121 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04802 XEO_CLAS Peptide DME1121 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12 microM) DME1121 XEOTICID XEO04802 GENEFORM Protein DME1121 XEOTICID XEO04802 MOACRIVE Inhibition DME1121 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1121 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04803 XEO_CLAS Peptide DME1121 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO04803 GENEFORM Protein DME1121 XEOTICID XEO04803 MOACRIVE Inhibition DME1121 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1121 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04804 XEO_CLAS Peptide DME1121 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO04804 GENEFORM Protein DME1121 XEOTICID XEO04804 MOACRIVE Inhibition DME1121 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1121 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04805 XEO_CLAS Peptide DME1121 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.5 microM) DME1121 XEOTICID XEO04805 GENEFORM Protein DME1121 XEOTICID XEO04805 MOACRIVE Inhibition DME1121 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1121 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04806 XEO_CLAS Peptide DME1121 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.5 microM) DME1121 XEOTICID XEO04806 GENEFORM Protein DME1121 XEOTICID XEO04806 MOACRIVE Inhibition DME1121 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1121 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04807 XEO_CLAS Peptide DME1121 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04807 GENEFORM Protein DME1121 XEOTICID XEO04807 MOACRIVE Inhibition DME1121 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1121 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04809 XEO_CLAS Peptide DME1121 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 microM) DME1121 XEOTICID XEO04809 GENEFORM Protein DME1121 XEOTICID XEO04809 MOACRIVE Inhibition DME1121 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1121 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04811 XEO_CLAS Peptide DME1121 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO04811 GENEFORM Protein DME1121 XEOTICID XEO04811 MOACRIVE Inhibition DME1121 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1121 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04812 XEO_CLAS Peptide DME1121 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO04812 GENEFORM Protein DME1121 XEOTICID XEO04812 MOACRIVE Inhibition DME1121 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1121 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04813 XEO_CLAS Peptide DME1121 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 microM) DME1121 XEOTICID XEO04813 GENEFORM Protein DME1121 XEOTICID XEO04813 MOACRIVE Inhibition DME1121 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1121 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04814 XEO_CLAS Peptide DME1121 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 19 microM) DME1121 XEOTICID XEO04814 GENEFORM Protein DME1121 XEOTICID XEO04814 MOACRIVE Inhibition DME1121 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1121 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04815 XEO_CLAS Peptide DME1121 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 microM) DME1121 XEOTICID XEO04815 GENEFORM Protein DME1121 XEOTICID XEO04815 MOACRIVE Inhibition DME1121 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1121 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04816 XEO_CLAS Peptide DME1121 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 microM) DME1121 XEOTICID XEO04816 GENEFORM Protein DME1121 XEOTICID XEO04816 MOACRIVE Inhibition DME1121 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1121 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04817 XEO_CLAS Peptide DME1121 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 13 microM) DME1121 XEOTICID XEO04817 GENEFORM Protein DME1121 XEOTICID XEO04817 MOACRIVE Inhibition DME1121 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1121 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04818 XEO_CLAS Peptide DME1121 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO04818 GENEFORM Protein DME1121 XEOTICID XEO04818 MOACRIVE Inhibition DME1121 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1121 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04819 XEO_CLAS Peptide DME1121 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO04819 GENEFORM Protein DME1121 XEOTICID XEO04819 MOACRIVE Inhibition DME1121 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1121 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04820 XEO_CLAS Peptide DME1121 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3 microM) DME1121 XEOTICID XEO04820 GENEFORM Protein DME1121 XEOTICID XEO04820 MOACRIVE Inhibition DME1121 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1121 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04821 XEO_CLAS Peptide DME1121 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 microM) DME1121 XEOTICID XEO04821 GENEFORM Protein DME1121 XEOTICID XEO04821 MOACRIVE Inhibition DME1121 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1121 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04822 XEO_CLAS Peptide DME1121 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO04822 GENEFORM Protein DME1121 XEOTICID XEO04822 MOACRIVE Inhibition DME1121 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1121 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04823 XEO_CLAS Peptide DME1121 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 23 microM) DME1121 XEOTICID XEO04823 GENEFORM Protein DME1121 XEOTICID XEO04823 MOACRIVE Inhibition DME1121 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1121 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04824 XEO_CLAS Peptide DME1121 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04824 GENEFORM Protein DME1121 XEOTICID XEO04824 MOACRIVE Inhibition DME1121 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1121 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04825 XEO_CLAS Peptide DME1121 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04825 GENEFORM Protein DME1121 XEOTICID XEO04825 MOACRIVE Inhibition DME1121 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1121 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04826 XEO_CLAS Peptide DME1121 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO04826 GENEFORM Protein DME1121 XEOTICID XEO04826 MOACRIVE Inhibition DME1121 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1121 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04827 XEO_CLAS Peptide DME1121 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO04827 GENEFORM Protein DME1121 XEOTICID XEO04827 MOACRIVE Inhibition DME1121 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1121 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04835 XEO_CLAS Peptide DME1121 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04835 GENEFORM Protein DME1121 XEOTICID XEO04835 MOACRIVE Inhibition DME1121 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1121 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04836 XEO_CLAS Peptide DME1121 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04836 GENEFORM Protein DME1121 XEOTICID XEO04836 MOACRIVE Inhibition DME1121 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1121 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04837 XEO_CLAS Peptide DME1121 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 microM) DME1121 XEOTICID XEO04837 GENEFORM Protein DME1121 XEOTICID XEO04837 MOACRIVE Inhibition DME1121 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1121 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04839 XEO_CLAS Peptide DME1121 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04839 GENEFORM Protein DME1121 XEOTICID XEO04839 MOACRIVE Inhibition DME1121 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1121 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04840 XEO_CLAS Peptide DME1121 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 35-20 microM) DME1121 XEOTICID XEO04840 GENEFORM Protein DME1121 XEOTICID XEO04840 MOACRIVE Inhibition DME1121 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1121 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04847 XEO_CLAS Peptide DME1121 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04847 GENEFORM Protein DME1121 XEOTICID XEO04847 MOACRIVE Inhibition DME1121 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1121 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04848 XEO_CLAS Peptide DME1121 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04848 GENEFORM Protein DME1121 XEOTICID XEO04848 MOACRIVE Inhibition DME1121 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1121 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04849 XEO_CLAS Peptide DME1121 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04849 GENEFORM Protein DME1121 XEOTICID XEO04849 MOACRIVE Inhibition DME1121 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1121 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04850 XEO_CLAS Peptide DME1121 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04850 GENEFORM Protein DME1121 XEOTICID XEO04850 MOACRIVE Inhibition DME1121 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1121 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04851 XEO_CLAS Peptide DME1121 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1 ug/ml) DME1121 XEOTICID XEO04851 GENEFORM Protein DME1121 XEOTICID XEO04851 MOACRIVE Inhibition DME1121 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1121 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04857 XEO_CLAS Peptide DME1121 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 microM) DME1121 XEOTICID XEO04857 GENEFORM Protein DME1121 XEOTICID XEO04857 MOACRIVE Inhibition DME1121 XEOTICID XEO04863 XEO_NAME RTD peptide DME1121 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04863 XEO_CLAS Peptide DME1121 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.0 microM) DME1121 XEOTICID XEO04863 GENEFORM Protein DME1121 XEOTICID XEO04863 MOACRIVE Inhibition DME1121 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1121 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04865 XEO_CLAS Peptide DME1121 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 ug/ml) DME1121 XEOTICID XEO04865 GENEFORM Protein DME1121 XEOTICID XEO04865 MOACRIVE Inhibition DME1121 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1121 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04866 XEO_CLAS Peptide DME1121 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12.5 ug/ml) DME1121 XEOTICID XEO04866 GENEFORM Protein DME1121 XEOTICID XEO04866 MOACRIVE Inhibition DME1121 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1121 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04868 XEO_CLAS Peptide DME1121 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25.00 ug/ml) DME1121 XEOTICID XEO04868 GENEFORM Protein DME1121 XEOTICID XEO04868 MOACRIVE Inhibition DME1121 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1121 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04869 XEO_CLAS Peptide DME1121 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25.00 ug/ml) DME1121 XEOTICID XEO04869 GENEFORM Protein DME1121 XEOTICID XEO04869 MOACRIVE Inhibition DME1121 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1121 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04870 XEO_CLAS Peptide DME1121 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25.00 ug/ml) DME1121 XEOTICID XEO04870 GENEFORM Protein DME1121 XEOTICID XEO04870 MOACRIVE Inhibition DME1121 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1121 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04877 XEO_CLAS Peptide DME1121 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04877 GENEFORM Protein DME1121 XEOTICID XEO04877 MOACRIVE Inhibition DME1121 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1121 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04880 XEO_CLAS Peptide DME1121 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.5 ug/ml) DME1121 XEOTICID XEO04880 GENEFORM Protein DME1121 XEOTICID XEO04880 MOACRIVE Inhibition DME1121 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1121 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04886 XEO_CLAS Peptide DME1121 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.6 ug/ml) DME1121 XEOTICID XEO04886 GENEFORM Protein DME1121 XEOTICID XEO04886 MOACRIVE Inhibition DME1121 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1121 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04891 XEO_CLAS Peptide DME1121 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04891 GENEFORM Protein DME1121 XEOTICID XEO04891 MOACRIVE Inhibition DME1121 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1121 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04895 XEO_CLAS Peptide DME1121 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04895 GENEFORM Protein DME1121 XEOTICID XEO04895 MOACRIVE Inhibition DME1121 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1121 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04901 XEO_CLAS Peptide DME1121 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 microM) DME1121 XEOTICID XEO04901 GENEFORM Protein DME1121 XEOTICID XEO04901 MOACRIVE Inhibition DME1121 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1121 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04904 XEO_CLAS Peptide DME1121 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 78 ug/ml) DME1121 XEOTICID XEO04904 GENEFORM Protein DME1121 XEOTICID XEO04904 MOACRIVE Inhibition DME1121 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1121 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04905 XEO_CLAS Peptide DME1121 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04905 GENEFORM Protein DME1121 XEOTICID XEO04905 MOACRIVE Inhibition DME1121 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1121 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04906 XEO_CLAS Peptide DME1121 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04906 GENEFORM Protein DME1121 XEOTICID XEO04906 MOACRIVE Inhibition DME1121 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1121 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04907 XEO_CLAS Peptide DME1121 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04907 GENEFORM Protein DME1121 XEOTICID XEO04907 MOACRIVE Inhibition DME1121 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1121 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04908 XEO_CLAS Peptide DME1121 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04908 GENEFORM Protein DME1121 XEOTICID XEO04908 MOACRIVE Inhibition DME1121 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1121 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04909 XEO_CLAS Peptide DME1121 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04909 GENEFORM Protein DME1121 XEOTICID XEO04909 MOACRIVE Inhibition DME1121 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1121 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04915 XEO_CLAS Peptide DME1121 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 100 ug/ml) DME1121 XEOTICID XEO04915 GENEFORM Protein DME1121 XEOTICID XEO04915 MOACRIVE Inhibition DME1121 XEOTICID XEO04916 XEO_NAME Scopoletin DME1121 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1121 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04916 GENEFORM Protein DME1121 XEOTICID XEO04916 MOACRIVE Inhibition DME1121 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1121 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04926 XEO_CLAS Peptide DME1121 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04926 GENEFORM Protein DME1121 XEOTICID XEO04926 MOACRIVE Inhibition DME1121 XEOTICID XEO04931 XEO_NAME Shepherin I DME1121 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04931 XEO_CLAS Peptide DME1121 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04931 GENEFORM Protein DME1121 XEOTICID XEO04931 MOACRIVE Inhibition DME1121 XEOTICID XEO04932 XEO_NAME shepherin II DME1121 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04932 XEO_CLAS Peptide DME1121 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04932 GENEFORM Protein DME1121 XEOTICID XEO04932 MOACRIVE Inhibition DME1121 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1121 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04938 XEO_CLAS Peptide DME1121 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC <= 100 microM) DME1121 XEOTICID XEO04938 GENEFORM Protein DME1121 XEOTICID XEO04938 MOACRIVE Inhibition DME1121 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1121 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04947 XEO_CLAS Natural Product DME1121 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04947 GENEFORM Protein DME1121 XEOTICID XEO04947 MOACRIVE Inhibition DME1121 XEOTICID XEO04948 XEO_NAME Sinensetin DME1121 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1121 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1121 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04948 GENEFORM Protein DME1121 XEOTICID XEO04948 MOACRIVE Inhibition DME1121 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1121 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04950 XEO_CLAS Peptide DME1121 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 ug/ml) DME1121 XEOTICID XEO04950 GENEFORM Protein DME1121 XEOTICID XEO04950 MOACRIVE Inhibition DME1121 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1121 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04955 XEO_CLAS Peptide DME1121 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.07 microM) DME1121 XEOTICID XEO04955 GENEFORM Protein DME1121 XEOTICID XEO04955 MOACRIVE Inhibition DME1121 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1121 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04956 XEO_CLAS Peptide DME1121 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16.0 microM) DME1121 XEOTICID XEO04956 GENEFORM Protein DME1121 XEOTICID XEO04956 MOACRIVE Inhibition DME1121 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1121 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04957 XEO_CLAS Peptide DME1121 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.23 microM) DME1121 XEOTICID XEO04957 GENEFORM Protein DME1121 XEOTICID XEO04957 MOACRIVE Inhibition DME1121 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1121 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04958 XEO_CLAS Peptide DME1121 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 ug/ml) DME1121 XEOTICID XEO04958 GENEFORM Protein DME1121 XEOTICID XEO04958 MOACRIVE Inhibition DME1121 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1121 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04959 XEO_CLAS Peptide DME1121 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04959 GENEFORM Protein DME1121 XEOTICID XEO04959 MOACRIVE Inhibition DME1121 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1121 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04967 XEO_CLAS Peptide DME1121 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 28 microM) DME1121 XEOTICID XEO04967 GENEFORM Protein DME1121 XEOTICID XEO04967 MOACRIVE Inhibition DME1121 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1121 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04969 XEO_CLAS Peptide DME1121 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50-100 ug/ml) DME1121 XEOTICID XEO04969 GENEFORM Protein DME1121 XEOTICID XEO04969 MOACRIVE Inhibition DME1121 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1121 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04970 XEO_CLAS Peptide DME1121 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04970 GENEFORM Protein DME1121 XEOTICID XEO04970 MOACRIVE Inhibition DME1121 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1121 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04971 XEO_CLAS Peptide DME1121 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.8-1.5 microM) DME1121 XEOTICID XEO04971 GENEFORM Protein DME1121 XEOTICID XEO04971 MOACRIVE Inhibition DME1121 XEOTICID XEO04974 XEO_NAME Spinigerin DME1121 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04974 XEO_CLAS Peptide DME1121 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3-6 microM) DME1121 XEOTICID XEO04974 GENEFORM Protein DME1121 XEOTICID XEO04974 MOACRIVE Inhibition DME1121 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1121 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1121 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04975 GENEFORM Protein DME1121 XEOTICID XEO04975 MOACRIVE Inhibition DME1121 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1121 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1121 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04976 GENEFORM Protein DME1121 XEOTICID XEO04976 MOACRIVE Inhibition DME1121 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1121 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1121 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04977 GENEFORM Protein DME1121 XEOTICID XEO04977 MOACRIVE Inhibition DME1121 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1121 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1121 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04978 GENEFORM Protein DME1121 XEOTICID XEO04978 MOACRIVE Inhibition DME1121 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1121 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1121 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04979 GENEFORM Protein DME1121 XEOTICID XEO04979 MOACRIVE Inhibition DME1121 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1121 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04981 XEO_CLAS Peptide DME1121 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10.1 microM) DME1121 XEOTICID XEO04981 GENEFORM Protein DME1121 XEOTICID XEO04981 MOACRIVE Inhibition DME1121 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1121 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04982 XEO_CLAS Peptide DME1121 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40.5 microM) DME1121 XEOTICID XEO04982 GENEFORM Protein DME1121 XEOTICID XEO04982 MOACRIVE Inhibition DME1121 XEOTICID XEO04994 XEO_NAME Stilbene DME1121 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1121 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1121 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO04994 GENEFORM Protein DME1121 XEOTICID XEO04994 MOACRIVE Inhibition DME1121 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1121 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04995 XEO_CLAS Peptide DME1121 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC < 0.19 microM) DME1121 XEOTICID XEO04995 GENEFORM Protein DME1121 XEOTICID XEO04995 MOACRIVE Inhibition DME1121 XEOTICID XEO04998 XEO_NAME Styelin A DME1121 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04998 XEO_CLAS Peptide DME1121 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.7 ug/ml) DME1121 XEOTICID XEO04998 GENEFORM Protein DME1121 XEOTICID XEO04998 MOACRIVE Inhibition DME1121 XEOTICID XEO04999 XEO_NAME Styelin B DME1121 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO04999 XEO_CLAS Peptide DME1121 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.7 ug/ml) DME1121 XEOTICID XEO04999 GENEFORM Protein DME1121 XEOTICID XEO04999 MOACRIVE Inhibition DME1121 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1121 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05000 XEO_CLAS Peptide DME1121 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO05000 GENEFORM Protein DME1121 XEOTICID XEO05000 MOACRIVE Inhibition DME1121 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1121 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05001 XEO_CLAS Peptide DME1121 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.5 ug/ml) DME1121 XEOTICID XEO05001 GENEFORM Protein DME1121 XEOTICID XEO05001 MOACRIVE Inhibition DME1121 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1121 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05002 XEO_CLAS Peptide DME1121 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO05002 GENEFORM Protein DME1121 XEOTICID XEO05002 MOACRIVE Inhibition DME1121 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1121 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05003 XEO_CLAS Peptide DME1121 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO05003 GENEFORM Protein DME1121 XEOTICID XEO05003 MOACRIVE Inhibition DME1121 XEOTICID XEO05006 XEO_NAME Substance P DME1121 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05006 XEO_CLAS Peptide DME1121 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05006 GENEFORM Protein DME1121 XEOTICID XEO05006 MOACRIVE Inhibition DME1121 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1121 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05007 XEO_CLAS Peptide DME1121 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05007 GENEFORM Protein DME1121 XEOTICID XEO05007 MOACRIVE Inhibition DME1121 XEOTICID XEO05008 XEO_NAME Subtilosin DME1121 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05008 XEO_CLAS Peptide DME1121 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05008 GENEFORM Protein DME1121 XEOTICID XEO05008 MOACRIVE Inhibition DME1121 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1121 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05013 XEO_CLAS Peptide DME1121 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO05013 GENEFORM Protein DME1121 XEOTICID XEO05013 MOACRIVE Inhibition DME1121 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1121 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05014 XEO_CLAS Peptide DME1121 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO05014 GENEFORM Protein DME1121 XEOTICID XEO05014 MOACRIVE Inhibition DME1121 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1121 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05015 XEO_CLAS Peptide DME1121 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO05015 GENEFORM Protein DME1121 XEOTICID XEO05015 MOACRIVE Inhibition DME1121 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1121 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05016 XEO_CLAS Peptide DME1121 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO05016 GENEFORM Protein DME1121 XEOTICID XEO05016 MOACRIVE Inhibition DME1121 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1121 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05017 XEO_CLAS Peptide DME1121 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 20 ug/ml) DME1121 XEOTICID XEO05017 GENEFORM Protein DME1121 XEOTICID XEO05017 MOACRIVE Inhibition DME1121 XEOTICID XEO05018 XEO_NAME Syringic acid DME1121 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1121 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05018 GENEFORM Protein DME1121 XEOTICID XEO05018 MOACRIVE Inhibition DME1121 XEOTICID XEO05020 XEO_NAME Tachycitin DME1121 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05020 XEO_CLAS Peptide DME1121 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05020 GENEFORM Protein DME1121 XEOTICID XEO05020 MOACRIVE Inhibition DME1121 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1121 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05023 XEO_CLAS Peptide DME1121 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05023 GENEFORM Protein DME1121 XEOTICID XEO05023 MOACRIVE Inhibition DME1121 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1121 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05024 XEO_CLAS Peptide DME1121 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05024 GENEFORM Protein DME1121 XEOTICID XEO05024 MOACRIVE Inhibition DME1121 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1121 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05027 XEO_CLAS Peptide DME1121 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05027 GENEFORM Protein DME1121 XEOTICID XEO05027 MOACRIVE Inhibition DME1121 XEOTICID XEO05031 XEO_NAME Tannic acid DME1121 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1121 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05031 GENEFORM Protein DME1121 XEOTICID XEO05031 MOACRIVE Inhibition DME1121 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1121 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05033 XEO_CLAS Peptide DME1121 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05033 GENEFORM Protein DME1121 XEOTICID XEO05033 MOACRIVE Inhibition DME1121 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1121 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05042 XEO_CLAS Peptide DME1121 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO05042 GENEFORM Protein DME1121 XEOTICID XEO05042 MOACRIVE Inhibition DME1121 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1121 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05043 XEO_CLAS Peptide DME1121 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO05043 GENEFORM Protein DME1121 XEOTICID XEO05043 MOACRIVE Inhibition DME1121 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1121 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05044 XEO_CLAS Peptide DME1121 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 128 microM) DME1121 XEOTICID XEO05044 GENEFORM Protein DME1121 XEOTICID XEO05044 MOACRIVE Inhibition DME1121 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1121 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05045 XEO_CLAS Peptide DME1121 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 128 microM) DME1121 XEOTICID XEO05045 GENEFORM Protein DME1121 XEOTICID XEO05045 MOACRIVE Inhibition DME1121 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1121 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05046 XEO_CLAS Peptide DME1121 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 microM) DME1121 XEOTICID XEO05046 GENEFORM Protein DME1121 XEOTICID XEO05046 MOACRIVE Inhibition DME1121 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1121 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05047 XEO_CLAS Peptide DME1121 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 60 microM) DME1121 XEOTICID XEO05047 GENEFORM Protein DME1121 XEOTICID XEO05047 MOACRIVE Inhibition DME1121 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1121 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05051 XEO_CLAS Peptide DME1121 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05051 GENEFORM Protein DME1121 XEOTICID XEO05051 MOACRIVE Inhibition DME1121 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1121 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05055 XEO_CLAS Peptide DME1121 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 70 microM) DME1121 XEOTICID XEO05055 GENEFORM Protein DME1121 XEOTICID XEO05055 MOACRIVE Inhibition DME1121 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1121 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05056 XEO_CLAS Peptide DME1121 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05056 GENEFORM Protein DME1121 XEOTICID XEO05056 MOACRIVE Inhibition DME1121 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1121 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05059 XEO_CLAS Peptide DME1121 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05059 GENEFORM Protein DME1121 XEOTICID XEO05059 MOACRIVE Inhibition DME1121 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1121 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05061 XEO_CLAS Peptide DME1121 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO05061 GENEFORM Protein DME1121 XEOTICID XEO05061 MOACRIVE Inhibition DME1121 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1121 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05062 XEO_CLAS Peptide DME1121 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05062 GENEFORM Protein DME1121 XEOTICID XEO05062 MOACRIVE Inhibition DME1121 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1121 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05063 XEO_CLAS Peptide DME1121 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO05063 GENEFORM Protein DME1121 XEOTICID XEO05063 MOACRIVE Inhibition DME1121 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1121 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05064 XEO_CLAS Peptide DME1121 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 231 microM) DME1121 XEOTICID XEO05064 GENEFORM Protein DME1121 XEOTICID XEO05064 MOACRIVE Inhibition DME1121 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1121 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05065 XEO_CLAS Peptide DME1121 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 161 ug/ml) DME1121 XEOTICID XEO05065 GENEFORM Protein DME1121 XEOTICID XEO05065 MOACRIVE Inhibition DME1121 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1121 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05069 XEO_CLAS Peptide DME1121 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO05069 GENEFORM Protein DME1121 XEOTICID XEO05069 MOACRIVE Inhibition DME1121 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1121 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05070 XEO_CLAS Peptide DME1121 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 37.5 microM) DME1121 XEOTICID XEO05070 GENEFORM Protein DME1121 XEOTICID XEO05070 MOACRIVE Inhibition DME1121 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1121 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05071 XEO_CLAS Peptide DME1121 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 150 microM) DME1121 XEOTICID XEO05071 GENEFORM Protein DME1121 XEOTICID XEO05071 MOACRIVE Inhibition DME1121 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1121 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05072 XEO_CLAS Peptide DME1121 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO05072 GENEFORM Protein DME1121 XEOTICID XEO05072 MOACRIVE Inhibition DME1121 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1121 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05073 XEO_CLAS Peptide DME1121 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40 microM) DME1121 XEOTICID XEO05073 GENEFORM Protein DME1121 XEOTICID XEO05073 MOACRIVE Inhibition DME1121 XEOTICID XEO05076 XEO_NAME Temporin-A DME1121 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05076 XEO_CLAS Peptide DME1121 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 11.9 microM) DME1121 XEOTICID XEO05076 GENEFORM Protein DME1121 XEOTICID XEO05076 MOACRIVE Inhibition DME1121 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1121 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05077 XEO_CLAS Peptide DME1121 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.25 ug/ml) DME1121 XEOTICID XEO05077 GENEFORM Protein DME1121 XEOTICID XEO05077 MOACRIVE Inhibition DME1121 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1121 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05078 XEO_CLAS Peptide DME1121 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.25 ug/ml) DME1121 XEOTICID XEO05078 GENEFORM Protein DME1121 XEOTICID XEO05078 MOACRIVE Inhibition DME1121 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1121 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05079 XEO_CLAS Peptide DME1121 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.5 ug/ml) DME1121 XEOTICID XEO05079 GENEFORM Protein DME1121 XEOTICID XEO05079 MOACRIVE Inhibition DME1121 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1121 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05080 XEO_CLAS Peptide DME1121 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 ug/ml) DME1121 XEOTICID XEO05080 GENEFORM Protein DME1121 XEOTICID XEO05080 MOACRIVE Inhibition DME1121 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1121 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05081 XEO_CLAS Peptide DME1121 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 5 ug/ml) DME1121 XEOTICID XEO05081 GENEFORM Protein DME1121 XEOTICID XEO05081 MOACRIVE Inhibition DME1121 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1121 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05082 XEO_CLAS Peptide DME1121 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 7.5 ug/ml) DME1121 XEOTICID XEO05082 GENEFORM Protein DME1121 XEOTICID XEO05082 MOACRIVE Inhibition DME1121 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1121 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05083 XEO_CLAS Peptide DME1121 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 ug/ml) DME1121 XEOTICID XEO05083 GENEFORM Protein DME1121 XEOTICID XEO05083 MOACRIVE Inhibition DME1121 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1121 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05084 XEO_CLAS Peptide DME1121 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 ug/ml) DME1121 XEOTICID XEO05084 GENEFORM Protein DME1121 XEOTICID XEO05084 MOACRIVE Inhibition DME1121 XEOTICID XEO05085 XEO_NAME Temporin-B DME1121 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05085 XEO_CLAS Peptide DME1121 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 21.0 ug/ml) DME1121 XEOTICID XEO05085 GENEFORM Protein DME1121 XEOTICID XEO05085 MOACRIVE Inhibition DME1121 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1121 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05086 XEO_CLAS Peptide DME1121 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC > 100 microM) DME1121 XEOTICID XEO05086 GENEFORM Protein DME1121 XEOTICID XEO05086 MOACRIVE Inhibition DME1121 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1121 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05087 XEO_CLAS Peptide DME1121 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO05087 GENEFORM Protein DME1121 XEOTICID XEO05087 MOACRIVE Inhibition DME1121 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1121 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05097 XEO_CLAS Peptide DME1121 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16.0 microM) DME1121 XEOTICID XEO05097 GENEFORM Protein DME1121 XEOTICID XEO05097 MOACRIVE Inhibition DME1121 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1121 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05099 XEO_CLAS Peptide DME1121 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.0 microM) DME1121 XEOTICID XEO05099 GENEFORM Protein DME1121 XEOTICID XEO05099 MOACRIVE Inhibition DME1121 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1121 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05100 XEO_CLAS Peptide DME1121 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05100 GENEFORM Protein DME1121 XEOTICID XEO05100 MOACRIVE Inhibition DME1121 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1121 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05101 XEO_CLAS Peptide DME1121 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 24.2 ug/ml) DME1121 XEOTICID XEO05101 GENEFORM Protein DME1121 XEOTICID XEO05101 MOACRIVE Inhibition DME1121 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1121 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05102 XEO_CLAS Peptide DME1121 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 34.5 ug/ml) DME1121 XEOTICID XEO05102 GENEFORM Protein DME1121 XEOTICID XEO05102 MOACRIVE Inhibition DME1121 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1121 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05105 XEO_CLAS Peptide DME1121 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO05105 GENEFORM Protein DME1121 XEOTICID XEO05105 MOACRIVE Inhibition DME1121 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1121 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05106 XEO_CLAS Peptide DME1121 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25-200 microM) DME1121 XEOTICID XEO05106 GENEFORM Protein DME1121 XEOTICID XEO05106 MOACRIVE Inhibition DME1121 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1121 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05108 XEO_CLAS Peptide DME1121 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40 microM) DME1121 XEOTICID XEO05108 GENEFORM Protein DME1121 XEOTICID XEO05108 MOACRIVE Inhibition DME1121 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1121 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1121 XEOTICID XEO05111 XEO_CLAS Natural Product DME1121 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05111 GENEFORM Protein DME1121 XEOTICID XEO05111 MOACRIVE Inhibition DME1121 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1121 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05119 XEO_CLAS Peptide DME1121 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05119 GENEFORM Protein DME1121 XEOTICID XEO05119 MOACRIVE Inhibition DME1121 XEOTICID XEO05120 XEO_NAME Thanatin DME1121 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05120 XEO_CLAS Peptide DME1121 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.3-0.6 microM) DME1121 XEOTICID XEO05120 GENEFORM Protein DME1121 XEOTICID XEO05120 MOACRIVE Inhibition DME1121 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1121 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05121 XEO_CLAS Peptide DME1121 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 62.5 ug/ml) DME1121 XEOTICID XEO05121 GENEFORM Protein DME1121 XEOTICID XEO05121 MOACRIVE Inhibition DME1121 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1121 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05125 XEO_CLAS Peptide DME1121 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05125 GENEFORM Protein DME1121 XEOTICID XEO05125 MOACRIVE Inhibition DME1121 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1121 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05130 XEO_CLAS Peptide DME1121 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05130 GENEFORM Protein DME1121 XEOTICID XEO05130 MOACRIVE Inhibition DME1121 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1121 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05144 XEO_CLAS Peptide DME1121 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40 ug/ml) DME1121 XEOTICID XEO05144 GENEFORM Protein DME1121 XEOTICID XEO05144 MOACRIVE Inhibition DME1121 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1121 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05145 XEO_CLAS Peptide DME1121 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 ug/ml) DME1121 XEOTICID XEO05145 GENEFORM Protein DME1121 XEOTICID XEO05145 MOACRIVE Inhibition DME1121 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1121 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05146 XEO_CLAS Peptide DME1121 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 40 ug/ml) DME1121 XEOTICID XEO05146 GENEFORM Protein DME1121 XEOTICID XEO05146 MOACRIVE Inhibition DME1121 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1121 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05147 XEO_CLAS Peptide DME1121 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 60 ug/ml) DME1121 XEOTICID XEO05147 GENEFORM Protein DME1121 XEOTICID XEO05147 MOACRIVE Inhibition DME1121 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1121 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05158 XEO_CLAS Peptide DME1121 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05158 GENEFORM Protein DME1121 XEOTICID XEO05158 MOACRIVE Inhibition DME1121 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1121 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05161 XEO_CLAS Peptide DME1121 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 32 ug/ml) DME1121 XEOTICID XEO05161 GENEFORM Protein DME1121 XEOTICID XEO05161 MOACRIVE Inhibition DME1121 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1121 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05162 XEO_CLAS Peptide DME1121 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 32 ug/ml) DME1121 XEOTICID XEO05162 GENEFORM Protein DME1121 XEOTICID XEO05162 MOACRIVE Inhibition DME1121 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1121 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05163 XEO_CLAS Peptide DME1121 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 12-25 ug/ml) DME1121 XEOTICID XEO05163 GENEFORM Protein DME1121 XEOTICID XEO05163 MOACRIVE Inhibition DME1121 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1121 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05170 XEO_CLAS Peptide DME1121 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 3.0 microM) DME1121 XEOTICID XEO05170 GENEFORM Protein DME1121 XEOTICID XEO05170 MOACRIVE Inhibition DME1121 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1121 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05171 XEO_CLAS Peptide DME1121 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 50 microM) DME1121 XEOTICID XEO05171 GENEFORM Protein DME1121 XEOTICID XEO05171 MOACRIVE Inhibition DME1121 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1121 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05179 XEO_CLAS Peptide DME1121 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05179 GENEFORM Protein DME1121 XEOTICID XEO05179 MOACRIVE Inhibition DME1121 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1121 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05180 XEO_CLAS Peptide DME1121 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 160 microM) DME1121 XEOTICID XEO05180 GENEFORM Protein DME1121 XEOTICID XEO05180 MOACRIVE Inhibition DME1121 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1121 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05182 XEO_CLAS Peptide DME1121 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 microM) DME1121 XEOTICID XEO05182 GENEFORM Protein DME1121 XEOTICID XEO05182 MOACRIVE Inhibition DME1121 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1121 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05183 XEO_CLAS Peptide DME1121 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 microM) DME1121 XEOTICID XEO05183 GENEFORM Protein DME1121 XEOTICID XEO05183 MOACRIVE Inhibition DME1121 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1121 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05184 XEO_CLAS Peptide DME1121 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 microM) DME1121 XEOTICID XEO05184 GENEFORM Protein DME1121 XEOTICID XEO05184 MOACRIVE Inhibition DME1121 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1121 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05185 XEO_CLAS Peptide DME1121 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 microM) DME1121 XEOTICID XEO05185 GENEFORM Protein DME1121 XEOTICID XEO05185 MOACRIVE Inhibition DME1121 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1121 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05186 XEO_CLAS Peptide DME1121 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 microM) DME1121 XEOTICID XEO05186 GENEFORM Protein DME1121 XEOTICID XEO05186 MOACRIVE Inhibition DME1121 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1121 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05187 XEO_CLAS Peptide DME1121 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16 microM) DME1121 XEOTICID XEO05187 GENEFORM Protein DME1121 XEOTICID XEO05187 MOACRIVE Inhibition DME1121 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1121 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05188 XEO_CLAS Peptide DME1121 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 64 microM) DME1121 XEOTICID XEO05188 GENEFORM Protein DME1121 XEOTICID XEO05188 MOACRIVE Inhibition DME1121 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1121 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05190 XEO_CLAS Peptide DME1121 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05190 GENEFORM Protein DME1121 XEOTICID XEO05190 MOACRIVE Inhibition DME1121 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1121 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05193 XEO_CLAS Peptide DME1121 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO05193 GENEFORM Protein DME1121 XEOTICID XEO05193 MOACRIVE Inhibition DME1121 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1121 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05197 XEO_CLAS Peptide DME1121 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05197 GENEFORM Protein DME1121 XEOTICID XEO05197 MOACRIVE Inhibition DME1121 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1121 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05205 XEO_CLAS Peptide DME1121 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05205 GENEFORM Protein DME1121 XEOTICID XEO05205 MOACRIVE Inhibition DME1121 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1121 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05206 XEO_CLAS Peptide DME1121 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 10 microM) DME1121 XEOTICID XEO05206 GENEFORM Protein DME1121 XEOTICID XEO05206 MOACRIVE Inhibition DME1121 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1121 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05207 XEO_CLAS Peptide DME1121 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 25 microM) DME1121 XEOTICID XEO05207 GENEFORM Protein DME1121 XEOTICID XEO05207 MOACRIVE Inhibition DME1121 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1121 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05208 XEO_CLAS Peptide DME1121 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 microM) DME1121 XEOTICID XEO05208 GENEFORM Protein DME1121 XEOTICID XEO05208 MOACRIVE Inhibition DME1121 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1121 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05209 XEO_CLAS Peptide DME1121 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 15 microM) DME1121 XEOTICID XEO05209 GENEFORM Protein DME1121 XEOTICID XEO05209 MOACRIVE Inhibition DME1121 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1121 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05212 XEO_CLAS Peptide DME1121 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.5 ug/ml) DME1121 XEOTICID XEO05212 GENEFORM Protein DME1121 XEOTICID XEO05212 MOACRIVE Inhibition DME1121 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1121 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05220 XEO_CLAS Peptide DME1121 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.6-1.2 microM) DME1121 XEOTICID XEO05220 GENEFORM Protein DME1121 XEOTICID XEO05220 MOACRIVE Inhibition DME1121 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1121 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05230 XEO_CLAS Peptide DME1121 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 7.90 microM) DME1121 XEOTICID XEO05230 GENEFORM Protein DME1121 XEOTICID XEO05230 MOACRIVE Inhibition DME1121 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1121 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05231 XEO_CLAS Peptide DME1121 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2.40 microM) DME1121 XEOTICID XEO05231 GENEFORM Protein DME1121 XEOTICID XEO05231 MOACRIVE Inhibition DME1121 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1121 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05232 XEO_CLAS Peptide DME1121 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05232 GENEFORM Protein DME1121 XEOTICID XEO05232 MOACRIVE Inhibition DME1121 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1121 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05233 XEO_CLAS Peptide DME1121 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 ug/ml) DME1121 XEOTICID XEO05233 GENEFORM Protein DME1121 XEOTICID XEO05233 MOACRIVE Inhibition DME1121 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1121 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05234 XEO_CLAS Peptide DME1121 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 ug/ml) DME1121 XEOTICID XEO05234 GENEFORM Protein DME1121 XEOTICID XEO05234 MOACRIVE Inhibition DME1121 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1121 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05235 XEO_CLAS Peptide DME1121 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 30 ug/ml) DME1121 XEOTICID XEO05235 GENEFORM Protein DME1121 XEOTICID XEO05235 MOACRIVE Inhibition DME1121 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1121 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05237 XEO_CLAS Peptide DME1121 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 microM) DME1121 XEOTICID XEO05237 GENEFORM Protein DME1121 XEOTICID XEO05237 MOACRIVE Inhibition DME1121 XEOTICID XEO05245 XEO_NAME Viresin DME1121 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05245 XEO_CLAS Peptide DME1121 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05245 GENEFORM Protein DME1121 XEOTICID XEO05245 MOACRIVE Inhibition DME1121 XEOTICID XEO05248 XEO_NAME Vitamin C DME1121 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1121 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1121 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05248 GENEFORM Protein DME1121 XEOTICID XEO05248 MOACRIVE Inhibition DME1121 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1121 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05264 XEO_CLAS Peptide DME1121 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 4 ug/ml) DME1121 XEOTICID XEO05264 GENEFORM Protein DME1121 XEOTICID XEO05264 MOACRIVE Inhibition DME1121 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1121 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05267 XEO_CLAS Peptide DME1121 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 2 ug/ml) DME1121 XEOTICID XEO05267 GENEFORM Protein DME1121 XEOTICID XEO05267 MOACRIVE Inhibition DME1121 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1121 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05268 XEO_CLAS Peptide DME1121 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 1.6 ug/ml) DME1121 XEOTICID XEO05268 GENEFORM Protein DME1121 XEOTICID XEO05268 MOACRIVE Inhibition DME1121 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1121 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05269 XEO_CLAS Peptide DME1121 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 6 ug/ml) DME1121 XEOTICID XEO05269 GENEFORM Protein DME1121 XEOTICID XEO05269 MOACRIVE Inhibition DME1121 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1121 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05273 XEO_CLAS Peptide DME1121 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05273 GENEFORM Protein DME1121 XEOTICID XEO05273 MOACRIVE Inhibition DME1121 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1121 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05274 XEO_CLAS Peptide DME1121 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05274 GENEFORM Protein DME1121 XEOTICID XEO05274 MOACRIVE Inhibition DME1121 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1121 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05287 XEO_CLAS Peptide DME1121 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli DME1121 XEOTICID XEO05287 GENEFORM Protein DME1121 XEOTICID XEO05287 MOACRIVE Inhibition DME1121 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1121 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05303 XEO_CLAS Peptide DME1121 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 16-31 ug/ml) DME1121 XEOTICID XEO05303 GENEFORM Protein DME1121 XEOTICID XEO05303 MOACRIVE Inhibition DME1121 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1121 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05306 XEO_CLAS Peptide DME1121 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 8 ug/ml) DME1121 XEOTICID XEO05306 GENEFORM Protein DME1121 XEOTICID XEO05306 MOACRIVE Inhibition DME1121 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1121 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1121 XEOTICID XEO05308 XEO_CLAS Peptide DME1121 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Escherichia coli (MIC = 0.4 ug/ml) DME1121 XEOTICID XEO05308 GENEFORM Protein DME1121 XEOTICID XEO05308 MOACRIVE Inhibition DME1123 DME___ID DME1123 DME1123 DME_NAME Glutamate racemase (MurI) DME1123 SPESNAME Lactobacillus fermentum DME1123 XEOTICID XEO02126 XEO_NAME Acidocin A DME1123 XEOTICID XEO02126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1123 XEOTICID XEO02126 XEO_CLAS Peptide DME1123 XEOTICID XEO02126 DESCRIPT Acidocin A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Lactobacillus fermentum DME1123 XEOTICID XEO02126 GENEFORM Protein DME1123 XEOTICID XEO02126 MOACRIVE Inhibition DME1123 XEOTICID XEO02127 XEO_NAME Acidocin B DME1123 XEOTICID XEO02127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1123 XEOTICID XEO02127 XEO_CLAS Peptide DME1123 XEOTICID XEO02127 DESCRIPT Acidocin B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Lactobacillus fermentum DME1123 XEOTICID XEO02127 GENEFORM Protein DME1123 XEOTICID XEO02127 MOACRIVE Inhibition DME1123 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1123 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1123 XEOTICID XEO02958 XEO_CLAS Peptide DME1123 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Lactobacillus fermentum DME1123 XEOTICID XEO02958 GENEFORM Protein DME1123 XEOTICID XEO02958 MOACRIVE Inhibition DME1123 XEOTICID XEO05136 XEO_NAME Thuricin CDalpha DME1123 XEOTICID XEO05136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1123 XEOTICID XEO05136 XEO_CLAS Peptide DME1123 XEOTICID XEO05136 DESCRIPT Thuricin CDalpha inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Lactobacillus fermentum DME1123 XEOTICID XEO05136 GENEFORM Protein DME1123 XEOTICID XEO05136 MOACRIVE Inhibition DME1123 XEOTICID XEO05137 XEO_NAME Thuricin CDdbeta DME1123 XEOTICID XEO05137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1123 XEOTICID XEO05137 XEO_CLAS Peptide DME1123 XEOTICID XEO05137 DESCRIPT Thuricin CDdbeta inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Lactobacillus fermentum DME1123 XEOTICID XEO05137 GENEFORM Protein DME1123 XEOTICID XEO05137 MOACRIVE Inhibition DME1124 DME___ID DME1124 DME1124 DME_NAME Glutamate racemase (MurI) DME1124 SPESNAME Bacillus subtilis DME1124 XEOTICID XEO00044 XEO_NAME Glipizide DME1124 XEOTICID XEO00044 XEO_TYPE Pharmaceutical Agent(s) DME1124 XEOTICID XEO00044 XEO_CLAS Approved/Marketed Drug DME1124 XEOTICID XEO00044 DESCRIPT Glipizide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO00044 GENEFORM Protein DME1124 XEOTICID XEO00044 MOACRIVE Inhibition DME1124 XEOTICID XEO00070 XEO_NAME Esomeprazole DME1124 XEOTICID XEO00070 XEO_TYPE Pharmaceutical Agent(s) DME1124 XEOTICID XEO00070 XEO_CLAS Approved/Marketed Drug DME1124 XEOTICID XEO00070 DESCRIPT Esomeprazole inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO00070 GENEFORM Protein DME1124 XEOTICID XEO00070 MOACRIVE Inhibition DME1124 XEOTICID XEO00096 XEO_NAME Ampicillin DME1124 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME1124 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME1124 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO00096 GENEFORM Protein DME1124 XEOTICID XEO00096 MOACRIVE Inhibition DME1124 XEOTICID XEO00246 XEO_NAME Amoxicillin DME1124 XEOTICID XEO00246 XEO_TYPE Pharmaceutical Agent(s) DME1124 XEOTICID XEO00246 XEO_CLAS Approved/Marketed Drug DME1124 XEOTICID XEO00246 DESCRIPT Amoxicillin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO00246 GENEFORM Protein DME1124 XEOTICID XEO00246 MOACRIVE Inhibition DME1124 XEOTICID XEO00338 XEO_NAME Amlodipine DME1124 XEOTICID XEO00338 XEO_TYPE Pharmaceutical Agent(s) DME1124 XEOTICID XEO00338 XEO_CLAS Approved/Marketed Drug DME1124 XEOTICID XEO00338 DESCRIPT Amlodipine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO00338 GENEFORM Protein DME1124 XEOTICID XEO00338 MOACRIVE Inhibition DME1124 XEOTICID XEO00356 XEO_NAME Enalapril DME1124 XEOTICID XEO00356 XEO_TYPE Pharmaceutical Agent(s) DME1124 XEOTICID XEO00356 XEO_CLAS Approved/Marketed Drug DME1124 XEOTICID XEO00356 DESCRIPT Enalapril inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO00356 GENEFORM Protein DME1124 XEOTICID XEO00356 MOACRIVE Inhibition DME1124 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1124 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO01810 XEO_CLAS Peptide DME1124 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2.0 microM) DME1124 XEOTICID XEO01810 GENEFORM Protein DME1124 XEOTICID XEO01810 MOACRIVE Inhibition DME1124 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1124 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO01817 XEO_CLAS Peptide DME1124 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 4.0 microM) DME1124 XEOTICID XEO01817 GENEFORM Protein DME1124 XEOTICID XEO01817 MOACRIVE Inhibition DME1124 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1124 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO01818 XEO_CLAS Peptide DME1124 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 4.0 microM) DME1124 XEOTICID XEO01818 GENEFORM Protein DME1124 XEOTICID XEO01818 MOACRIVE Inhibition DME1124 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1124 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO01823 XEO_CLAS Peptide DME1124 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.56 microM) DME1124 XEOTICID XEO01823 GENEFORM Protein DME1124 XEOTICID XEO01823 MOACRIVE Inhibition DME1124 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1124 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO01825 XEO_CLAS Peptide DME1124 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.56 microM) DME1124 XEOTICID XEO01825 GENEFORM Protein DME1124 XEOTICID XEO01825 MOACRIVE Inhibition DME1124 XEOTICID XEO01972 XEO_NAME 3,4-Dichloro-2-(1,3-dichloropropan-2-yloxy)-2H-furan-5-one DME1124 XEOTICID XEO01972 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1124 XEOTICID XEO01972 XEO_CLAS Chemical Compound DME1124 XEOTICID XEO01972 DESCRIPT 3,4-Dichloro-2-(1,3-dichloropropan-2-yloxy)-2H-furan-5-one inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO01972 GENEFORM Protein DME1124 XEOTICID XEO01972 MOACRIVE Inhibition DME1124 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1124 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02013 XEO_CLAS Peptide DME1124 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02013 GENEFORM Protein DME1124 XEOTICID XEO02013 MOACRIVE Inhibition DME1124 XEOTICID XEO02102 XEO_NAME A. dichotoma defensin DME1124 XEOTICID XEO02102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02102 XEO_CLAS Peptide DME1124 XEOTICID XEO02102 DESCRIPT A. dichotoma defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02102 GENEFORM Protein DME1124 XEOTICID XEO02102 MOACRIVE Inhibition DME1124 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1124 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02115 XEO_CLAS Peptide DME1124 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02115 GENEFORM Protein DME1124 XEOTICID XEO02115 MOACRIVE Inhibition DME1124 XEOTICID XEO02146 XEO_NAME Antimicrobial protein Ah-AMP1 DME1124 XEOTICID XEO02146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02146 XEO_CLAS Peptide DME1124 XEOTICID XEO02146 DESCRIPT Antimicrobial protein Ah-AMP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02146 GENEFORM Protein DME1124 XEOTICID XEO02146 MOACRIVE Inhibition DME1124 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1124 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02147 XEO_CLAS Peptide DME1124 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 237 ug/ml) DME1124 XEOTICID XEO02147 GENEFORM Protein DME1124 XEOTICID XEO02147 MOACRIVE Inhibition DME1124 XEOTICID XEO02151 XEO_NAME AI-hemocidins 4 DME1124 XEOTICID XEO02151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02151 XEO_CLAS Peptide DME1124 XEOTICID XEO02151 DESCRIPT AI-hemocidins 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 69.55 microM) DME1124 XEOTICID XEO02151 GENEFORM Protein DME1124 XEOTICID XEO02151 MOACRIVE Inhibition DME1124 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1124 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02200 XEO_CLAS Peptide DME1124 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 100 ug/ml) DME1124 XEOTICID XEO02200 GENEFORM Protein DME1124 XEOTICID XEO02200 MOACRIVE Inhibition DME1124 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1124 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02201 XEO_CLAS Peptide DME1124 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 25 ug/ml) DME1124 XEOTICID XEO02201 GENEFORM Protein DME1124 XEOTICID XEO02201 MOACRIVE Inhibition DME1124 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1124 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02202 XEO_CLAS Peptide DME1124 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 20 microM) DME1124 XEOTICID XEO02202 GENEFORM Protein DME1124 XEOTICID XEO02202 MOACRIVE Inhibition DME1124 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1124 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02203 XEO_CLAS Peptide DME1124 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 20 microM) DME1124 XEOTICID XEO02203 GENEFORM Protein DME1124 XEOTICID XEO02203 MOACRIVE Inhibition DME1124 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1124 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02207 XEO_CLAS Peptide DME1124 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1124 XEOTICID XEO02207 GENEFORM Protein DME1124 XEOTICID XEO02207 MOACRIVE Inhibition DME1124 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1124 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02208 XEO_CLAS Peptide DME1124 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1124 XEOTICID XEO02208 GENEFORM Protein DME1124 XEOTICID XEO02208 MOACRIVE Inhibition DME1124 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1124 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02209 XEO_CLAS Peptide DME1124 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1124 XEOTICID XEO02209 GENEFORM Protein DME1124 XEOTICID XEO02209 MOACRIVE Inhibition DME1124 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1124 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02210 XEO_CLAS Peptide DME1124 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1124 XEOTICID XEO02210 GENEFORM Protein DME1124 XEOTICID XEO02210 MOACRIVE Inhibition DME1124 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1124 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02211 XEO_CLAS Peptide DME1124 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 3.13 ug/ml) DME1124 XEOTICID XEO02211 GENEFORM Protein DME1124 XEOTICID XEO02211 MOACRIVE Inhibition DME1124 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1124 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02212 XEO_CLAS Peptide DME1124 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1124 XEOTICID XEO02212 GENEFORM Protein DME1124 XEOTICID XEO02212 MOACRIVE Inhibition DME1124 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1124 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02213 XEO_CLAS Peptide DME1124 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1124 XEOTICID XEO02213 GENEFORM Protein DME1124 XEOTICID XEO02213 MOACRIVE Inhibition DME1124 XEOTICID XEO02224 XEO_NAME Androctonin DME1124 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02224 XEO_CLAS Peptide DME1124 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02224 GENEFORM Protein DME1124 XEOTICID XEO02224 MOACRIVE Inhibition DME1124 XEOTICID XEO02226 XEO_NAME Andropin DME1124 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02226 XEO_CLAS Peptide DME1124 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 17 microM) DME1124 XEOTICID XEO02226 GENEFORM Protein DME1124 XEOTICID XEO02226 MOACRIVE Inhibition DME1124 XEOTICID XEO02235 XEO_NAME Anthranilate DME1124 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1124 XEOTICID XEO02235 XEO_CLAS Natural Product DME1124 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02235 GENEFORM Protein DME1124 XEOTICID XEO02235 MOACRIVE Inhibition DME1124 XEOTICID XEO02237 XEO_NAME Antibacterial napin DME1124 XEOTICID XEO02237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02237 XEO_CLAS Peptide DME1124 XEOTICID XEO02237 DESCRIPT Antibacterial napin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 236 microM) DME1124 XEOTICID XEO02237 GENEFORM Protein DME1124 XEOTICID XEO02237 MOACRIVE Inhibition DME1124 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1124 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02241 XEO_CLAS Peptide DME1124 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02241 GENEFORM Protein DME1124 XEOTICID XEO02241 MOACRIVE Inhibition DME1124 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1124 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02248 XEO_CLAS Peptide DME1124 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 15 microM) DME1124 XEOTICID XEO02248 GENEFORM Protein DME1124 XEOTICID XEO02248 MOACRIVE Inhibition DME1124 XEOTICID XEO02249 XEO_NAME Anticancerous peptide Cr-ACP1 DME1124 XEOTICID XEO02249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02249 XEO_CLAS Peptide DME1124 XEOTICID XEO02249 DESCRIPT Anticancerous peptide Cr-ACP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 30 microM) DME1124 XEOTICID XEO02249 GENEFORM Protein DME1124 XEOTICID XEO02249 MOACRIVE Inhibition DME1124 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1124 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02261 XEO_CLAS Peptide DME1124 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 76 ug/ml) DME1124 XEOTICID XEO02261 GENEFORM Protein DME1124 XEOTICID XEO02261 MOACRIVE Inhibition DME1124 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1124 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02268 XEO_CLAS Peptide DME1124 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 150 ug/ml) DME1124 XEOTICID XEO02268 GENEFORM Protein DME1124 XEOTICID XEO02268 MOACRIVE Inhibition DME1124 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1124 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02271 XEO_CLAS Peptide DME1124 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 257 ug/ml) DME1124 XEOTICID XEO02271 GENEFORM Protein DME1124 XEOTICID XEO02271 MOACRIVE Inhibition DME1124 XEOTICID XEO02278 XEO_NAME Antimicrobial peptide Ar-AMP DME1124 XEOTICID XEO02278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02278 XEO_CLAS Peptide DME1124 XEOTICID XEO02278 DESCRIPT Antimicrobial peptide Ar-AMP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02278 GENEFORM Protein DME1124 XEOTICID XEO02278 MOACRIVE Inhibition DME1124 XEOTICID XEO02282 XEO_NAME Antimicrobial peptide GP-19 DME1124 XEOTICID XEO02282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02282 XEO_CLAS Peptide DME1124 XEOTICID XEO02282 DESCRIPT Antimicrobial peptide GP-19 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02282 GENEFORM Protein DME1124 XEOTICID XEO02282 MOACRIVE Inhibition DME1124 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1124 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02283 XEO_CLAS Peptide DME1124 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 3.13 ug/ml) DME1124 XEOTICID XEO02283 GENEFORM Protein DME1124 XEOTICID XEO02283 MOACRIVE Inhibition DME1124 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1124 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02288 XEO_CLAS Peptide DME1124 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12.3 ug/ml) DME1124 XEOTICID XEO02288 GENEFORM Protein DME1124 XEOTICID XEO02288 MOACRIVE Inhibition DME1124 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1124 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02289 XEO_CLAS Peptide DME1124 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12 ug/ml) DME1124 XEOTICID XEO02289 GENEFORM Protein DME1124 XEOTICID XEO02289 MOACRIVE Inhibition DME1124 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1124 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02298 XEO_CLAS Peptide DME1124 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 32 ug/ml) DME1124 XEOTICID XEO02298 GENEFORM Protein DME1124 XEOTICID XEO02298 MOACRIVE Inhibition DME1124 XEOTICID XEO02300 XEO_NAME Antimicrobial protein BL-A60 DME1124 XEOTICID XEO02300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02300 XEO_CLAS Peptide DME1124 XEOTICID XEO02300 DESCRIPT Antimicrobial protein BL-A60 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 5 microM) DME1124 XEOTICID XEO02300 GENEFORM Protein DME1124 XEOTICID XEO02300 MOACRIVE Inhibition DME1124 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1124 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02316 XEO_CLAS Peptide DME1124 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.25-12.5 microM) DME1124 XEOTICID XEO02316 GENEFORM Protein DME1124 XEOTICID XEO02316 MOACRIVE Inhibition DME1124 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1124 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02320 XEO_CLAS Peptide DME1124 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02320 GENEFORM Protein DME1124 XEOTICID XEO02320 MOACRIVE Inhibition DME1124 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1124 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02332 XEO_CLAS Peptide DME1124 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.95 ug/ml) DME1124 XEOTICID XEO02332 GENEFORM Protein DME1124 XEOTICID XEO02332 MOACRIVE Inhibition DME1124 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1124 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02452 XEO_CLAS Peptide DME1124 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 76800 ug/ml) DME1124 XEOTICID XEO02452 GENEFORM Protein DME1124 XEOTICID XEO02452 MOACRIVE Inhibition DME1124 XEOTICID XEO02476 XEO_NAME Bacteriocin HJ50 DME1124 XEOTICID XEO02476 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02476 XEO_CLAS Peptide DME1124 XEOTICID XEO02476 DESCRIPT Bacteriocin HJ50 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02476 GENEFORM Protein DME1124 XEOTICID XEO02476 MOACRIVE Inhibition DME1124 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1124 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02491 XEO_CLAS Peptide DME1124 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 24.4 microM) DME1124 XEOTICID XEO02491 GENEFORM Protein DME1124 XEOTICID XEO02491 MOACRIVE Inhibition DME1124 XEOTICID XEO02532 XEO_NAME Brevinin-1LT1 DME1124 XEOTICID XEO02532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02532 XEO_CLAS Peptide DME1124 XEOTICID XEO02532 DESCRIPT Brevinin-1LT1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.25 microM) DME1124 XEOTICID XEO02532 GENEFORM Protein DME1124 XEOTICID XEO02532 MOACRIVE Inhibition DME1124 XEOTICID XEO02588 XEO_NAME Brevinin-2GHa DME1124 XEOTICID XEO02588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02588 XEO_CLAS Peptide DME1124 XEOTICID XEO02588 DESCRIPT Brevinin-2GHa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 64 ug/ml) DME1124 XEOTICID XEO02588 GENEFORM Protein DME1124 XEOTICID XEO02588 MOACRIVE Inhibition DME1124 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1124 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02589 XEO_CLAS Peptide DME1124 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 64 ug/ml) DME1124 XEOTICID XEO02589 GENEFORM Protein DME1124 XEOTICID XEO02589 MOACRIVE Inhibition DME1124 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1124 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02590 XEO_CLAS Peptide DME1124 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 64 ug/ml) DME1124 XEOTICID XEO02590 GENEFORM Protein DME1124 XEOTICID XEO02590 MOACRIVE Inhibition DME1124 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1124 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02595 XEO_CLAS Peptide DME1124 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12.5 microM) DME1124 XEOTICID XEO02595 GENEFORM Protein DME1124 XEOTICID XEO02595 MOACRIVE Inhibition DME1124 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1124 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02596 XEO_CLAS Peptide DME1124 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 25 microM) DME1124 XEOTICID XEO02596 GENEFORM Protein DME1124 XEOTICID XEO02596 MOACRIVE Inhibition DME1124 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1124 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02630 XEO_CLAS Peptide DME1124 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1124 XEOTICID XEO02630 GENEFORM Protein DME1124 XEOTICID XEO02630 MOACRIVE Inhibition DME1124 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1124 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02631 XEO_CLAS Peptide DME1124 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1124 XEOTICID XEO02631 GENEFORM Protein DME1124 XEOTICID XEO02631 MOACRIVE Inhibition DME1124 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1124 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02649 XEO_CLAS Peptide DME1124 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 4 ug/ml) DME1124 XEOTICID XEO02649 GENEFORM Protein DME1124 XEOTICID XEO02649 MOACRIVE Inhibition DME1124 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1124 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02650 XEO_CLAS Peptide DME1124 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2 ug/ml) DME1124 XEOTICID XEO02650 GENEFORM Protein DME1124 XEOTICID XEO02650 MOACRIVE Inhibition DME1124 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1124 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02663 XEO_CLAS Peptide DME1124 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.78 microM) DME1124 XEOTICID XEO02663 GENEFORM Protein DME1124 XEOTICID XEO02663 MOACRIVE Inhibition DME1124 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1124 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02664 XEO_CLAS Peptide DME1124 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.56 microM) DME1124 XEOTICID XEO02664 GENEFORM Protein DME1124 XEOTICID XEO02664 MOACRIVE Inhibition DME1124 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1124 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02672 XEO_CLAS Peptide DME1124 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.56 microM) DME1124 XEOTICID XEO02672 GENEFORM Protein DME1124 XEOTICID XEO02672 MOACRIVE Inhibition DME1124 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1124 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02673 XEO_CLAS Peptide DME1124 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.78-1.56 microM) DME1124 XEOTICID XEO02673 GENEFORM Protein DME1124 XEOTICID XEO02673 MOACRIVE Inhibition DME1124 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1124 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02674 XEO_CLAS Peptide DME1124 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.56 microM) DME1124 XEOTICID XEO02674 GENEFORM Protein DME1124 XEOTICID XEO02674 MOACRIVE Inhibition DME1124 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1124 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02676 XEO_CLAS Peptide DME1124 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.78 microM) DME1124 XEOTICID XEO02676 GENEFORM Protein DME1124 XEOTICID XEO02676 MOACRIVE Inhibition DME1124 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1124 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02677 XEO_CLAS Peptide DME1124 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.78 microM) DME1124 XEOTICID XEO02677 GENEFORM Protein DME1124 XEOTICID XEO02677 MOACRIVE Inhibition DME1124 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1124 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02679 XEO_CLAS Peptide DME1124 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.56 microM) DME1124 XEOTICID XEO02679 GENEFORM Protein DME1124 XEOTICID XEO02679 MOACRIVE Inhibition DME1124 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1124 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02680 XEO_CLAS Peptide DME1124 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.56 microM) DME1124 XEOTICID XEO02680 GENEFORM Protein DME1124 XEOTICID XEO02680 MOACRIVE Inhibition DME1124 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1124 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02683 XEO_CLAS Peptide DME1124 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.56 microM) DME1124 XEOTICID XEO02683 GENEFORM Protein DME1124 XEOTICID XEO02683 MOACRIVE Inhibition DME1124 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1124 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02735 XEO_CLAS Peptide DME1124 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC < 2 ug/ml) DME1124 XEOTICID XEO02735 GENEFORM Protein DME1124 XEOTICID XEO02735 MOACRIVE Inhibition DME1124 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1124 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02741 XEO_CLAS Peptide DME1124 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 100 ug/ml) DME1124 XEOTICID XEO02741 GENEFORM Protein DME1124 XEOTICID XEO02741 MOACRIVE Inhibition DME1124 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1124 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02743 XEO_CLAS Peptide DME1124 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 9.4 ug/ml) DME1124 XEOTICID XEO02743 GENEFORM Protein DME1124 XEOTICID XEO02743 MOACRIVE Inhibition DME1124 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1124 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02744 XEO_CLAS Peptide DME1124 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 75 ug/ml) DME1124 XEOTICID XEO02744 GENEFORM Protein DME1124 XEOTICID XEO02744 MOACRIVE Inhibition DME1124 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1124 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02756 XEO_CLAS Peptide DME1124 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.4 microM) DME1124 XEOTICID XEO02756 GENEFORM Protein DME1124 XEOTICID XEO02756 MOACRIVE Inhibition DME1124 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1124 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02757 XEO_CLAS Peptide DME1124 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.5 microM) DME1124 XEOTICID XEO02757 GENEFORM Protein DME1124 XEOTICID XEO02757 MOACRIVE Inhibition DME1124 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1124 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02758 XEO_CLAS Peptide DME1124 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 3 microM) DME1124 XEOTICID XEO02758 GENEFORM Protein DME1124 XEOTICID XEO02758 MOACRIVE Inhibition DME1124 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1124 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02759 XEO_CLAS Peptide DME1124 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.6 microM) DME1124 XEOTICID XEO02759 GENEFORM Protein DME1124 XEOTICID XEO02759 MOACRIVE Inhibition DME1124 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1124 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02760 XEO_CLAS Peptide DME1124 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.3 microM) DME1124 XEOTICID XEO02760 GENEFORM Protein DME1124 XEOTICID XEO02760 MOACRIVE Inhibition DME1124 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1124 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02761 XEO_CLAS Peptide DME1124 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1 microM) DME1124 XEOTICID XEO02761 GENEFORM Protein DME1124 XEOTICID XEO02761 MOACRIVE Inhibition DME1124 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1124 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02762 XEO_CLAS Peptide DME1124 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.3 microM) DME1124 XEOTICID XEO02762 GENEFORM Protein DME1124 XEOTICID XEO02762 MOACRIVE Inhibition DME1124 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1124 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02763 XEO_CLAS Peptide DME1124 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.3 microM) DME1124 XEOTICID XEO02763 GENEFORM Protein DME1124 XEOTICID XEO02763 MOACRIVE Inhibition DME1124 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1124 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02764 XEO_CLAS Peptide DME1124 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.7 microM) DME1124 XEOTICID XEO02764 GENEFORM Protein DME1124 XEOTICID XEO02764 MOACRIVE Inhibition DME1124 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1124 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02765 XEO_CLAS Peptide DME1124 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.4 microM) DME1124 XEOTICID XEO02765 GENEFORM Protein DME1124 XEOTICID XEO02765 MOACRIVE Inhibition DME1124 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1124 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02767 XEO_CLAS Peptide DME1124 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02767 GENEFORM Protein DME1124 XEOTICID XEO02767 MOACRIVE Inhibition DME1124 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1124 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02768 XEO_CLAS Peptide DME1124 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02768 GENEFORM Protein DME1124 XEOTICID XEO02768 MOACRIVE Inhibition DME1124 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1124 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02769 XEO_CLAS Peptide DME1124 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 18 microM) DME1124 XEOTICID XEO02769 GENEFORM Protein DME1124 XEOTICID XEO02769 MOACRIVE Inhibition DME1124 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1124 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02770 XEO_CLAS Peptide DME1124 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 17 microM) DME1124 XEOTICID XEO02770 GENEFORM Protein DME1124 XEOTICID XEO02770 MOACRIVE Inhibition DME1124 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1124 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02771 XEO_CLAS Peptide DME1124 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 81 microM) DME1124 XEOTICID XEO02771 GENEFORM Protein DME1124 XEOTICID XEO02771 MOACRIVE Inhibition DME1124 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1124 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02772 XEO_CLAS Peptide DME1124 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02772 GENEFORM Protein DME1124 XEOTICID XEO02772 MOACRIVE Inhibition DME1124 XEOTICID XEO02780 XEO_NAME Cefixime DME1124 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1124 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1124 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02780 GENEFORM Protein DME1124 XEOTICID XEO02780 MOACRIVE Inhibition DME1124 XEOTICID XEO02801 XEO_NAME Cephalexin DME1124 XEOTICID XEO02801 XEO_TYPE Pharmaceutical Agent(s) DME1124 XEOTICID XEO02801 XEO_CLAS Approved/Marketed Drug DME1124 XEOTICID XEO02801 DESCRIPT Cephalexin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02801 GENEFORM Protein DME1124 XEOTICID XEO02801 MOACRIVE Inhibition DME1124 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1124 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02802 XEO_CLAS Peptide DME1124 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 5.9 microM) DME1124 XEOTICID XEO02802 GENEFORM Protein DME1124 XEOTICID XEO02802 MOACRIVE Inhibition DME1124 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1124 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02807 XEO_CLAS Peptide DME1124 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.4 ug/mL) DME1124 XEOTICID XEO02807 GENEFORM Protein DME1124 XEOTICID XEO02807 MOACRIVE Inhibition DME1124 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1124 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02821 XEO_CLAS Peptide DME1124 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02821 GENEFORM Protein DME1124 XEOTICID XEO02821 MOACRIVE Inhibition DME1124 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1124 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02839 XEO_CLAS Peptide DME1124 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.25 microM) DME1124 XEOTICID XEO02839 GENEFORM Protein DME1124 XEOTICID XEO02839 MOACRIVE Inhibition DME1124 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1124 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02841 XEO_CLAS Peptide DME1124 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.25 microM) DME1124 XEOTICID XEO02841 GENEFORM Protein DME1124 XEOTICID XEO02841 MOACRIVE Inhibition DME1124 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1124 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02842 XEO_CLAS Peptide DME1124 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.25 microM) DME1124 XEOTICID XEO02842 GENEFORM Protein DME1124 XEOTICID XEO02842 MOACRIVE Inhibition DME1124 XEOTICID XEO02962 XEO_NAME Cryptonin DME1124 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02962 XEO_CLAS Peptide DME1124 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 3.12 ug/ml) DME1124 XEOTICID XEO02962 GENEFORM Protein DME1124 XEOTICID XEO02962 MOACRIVE Inhibition DME1124 XEOTICID XEO02966 XEO_NAME C. ternatea-antimicrobial peptide Ct-AMP1 DME1124 XEOTICID XEO02966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO02966 XEO_CLAS Peptide DME1124 XEOTICID XEO02966 DESCRIPT C. ternatea-antimicrobial peptide Ct-AMP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02966 GENEFORM Protein DME1124 XEOTICID XEO02966 MOACRIVE Inhibition DME1124 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1124 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1124 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1124 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO02990 GENEFORM Protein DME1124 XEOTICID XEO02990 MOACRIVE Inhibition DME1124 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1124 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03051 XEO_CLAS Peptide DME1124 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 25 ug/ml) DME1124 XEOTICID XEO03051 GENEFORM Protein DME1124 XEOTICID XEO03051 MOACRIVE Inhibition DME1124 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1124 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03052 XEO_CLAS Peptide DME1124 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2.5 ug/ml) DME1124 XEOTICID XEO03052 GENEFORM Protein DME1124 XEOTICID XEO03052 MOACRIVE Inhibition DME1124 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1124 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03053 XEO_CLAS Peptide DME1124 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 25 ug/ml) DME1124 XEOTICID XEO03053 GENEFORM Protein DME1124 XEOTICID XEO03053 MOACRIVE Inhibition DME1124 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1124 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03060 XEO_CLAS Peptide DME1124 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1 microM) DME1124 XEOTICID XEO03060 GENEFORM Protein DME1124 XEOTICID XEO03060 MOACRIVE Inhibition DME1124 XEOTICID XEO03089 XEO_NAME Decoralin DME1124 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03089 XEO_CLAS Peptide DME1124 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 40 microM) DME1124 XEOTICID XEO03089 GENEFORM Protein DME1124 XEOTICID XEO03089 MOACRIVE Inhibition DME1124 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1124 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03100 XEO_CLAS Peptide DME1124 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03100 GENEFORM Protein DME1124 XEOTICID XEO03100 MOACRIVE Inhibition DME1124 XEOTICID XEO03101 XEO_NAME Defensin varisin A1 DME1124 XEOTICID XEO03101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03101 XEO_CLAS Peptide DME1124 XEOTICID XEO03101 DESCRIPT Defensin varisin A1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03101 GENEFORM Protein DME1124 XEOTICID XEO03101 MOACRIVE Inhibition DME1124 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1124 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03103 XEO_CLAS Peptide DME1124 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03103 GENEFORM Protein DME1124 XEOTICID XEO03103 MOACRIVE Inhibition DME1124 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1124 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03105 XEO_CLAS Peptide DME1124 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03105 GENEFORM Protein DME1124 XEOTICID XEO03105 MOACRIVE Inhibition DME1124 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1124 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03112 XEO_CLAS Peptide DME1124 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 50 ug/ml) DME1124 XEOTICID XEO03112 GENEFORM Protein DME1124 XEOTICID XEO03112 MOACRIVE Inhibition DME1124 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1124 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03116 XEO_CLAS Peptide DME1124 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 40 microM) DME1124 XEOTICID XEO03116 GENEFORM Protein DME1124 XEOTICID XEO03116 MOACRIVE Inhibition DME1124 XEOTICID XEO03117 XEO_NAME Insect defensin B DME1124 XEOTICID XEO03117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03117 XEO_CLAS Peptide DME1124 XEOTICID XEO03117 DESCRIPT Insect defensin B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 20-40 microM) DME1124 XEOTICID XEO03117 GENEFORM Protein DME1124 XEOTICID XEO03117 MOACRIVE Inhibition DME1124 XEOTICID XEO03120 XEO_NAME Defensin-like protein Dm-AMP1 DME1124 XEOTICID XEO03120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03120 XEO_CLAS Peptide DME1124 XEOTICID XEO03120 DESCRIPT Defensin-like protein Dm-AMP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03120 GENEFORM Protein DME1124 XEOTICID XEO03120 MOACRIVE Inhibition DME1124 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1124 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03121 XEO_CLAS Peptide DME1124 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03121 GENEFORM Protein DME1124 XEOTICID XEO03121 MOACRIVE Inhibition DME1124 XEOTICID XEO03123 XEO_NAME Defensin-like protein fabatin-2 DME1124 XEOTICID XEO03123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03123 XEO_CLAS Peptide DME1124 XEOTICID XEO03123 DESCRIPT Defensin-like protein fabatin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03123 GENEFORM Protein DME1124 XEOTICID XEO03123 MOACRIVE Inhibition DME1124 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1124 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03124 XEO_CLAS Peptide DME1124 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03124 GENEFORM Protein DME1124 XEOTICID XEO03124 MOACRIVE Inhibition DME1124 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1124 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03215 XEO_CLAS Peptide DME1124 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2.5 ug/ml) DME1124 XEOTICID XEO03215 GENEFORM Protein DME1124 XEOTICID XEO03215 MOACRIVE Inhibition DME1124 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1124 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03216 XEO_CLAS Peptide DME1124 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2 ug/ml) DME1124 XEOTICID XEO03216 GENEFORM Protein DME1124 XEOTICID XEO03216 MOACRIVE Inhibition DME1124 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1124 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03217 XEO_CLAS Peptide DME1124 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2 ug/ml) DME1124 XEOTICID XEO03217 GENEFORM Protein DME1124 XEOTICID XEO03217 MOACRIVE Inhibition DME1124 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1124 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03223 XEO_CLAS Peptide DME1124 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 3.2 microM) DME1124 XEOTICID XEO03223 GENEFORM Protein DME1124 XEOTICID XEO03223 MOACRIVE Inhibition DME1124 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1124 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03225 XEO_CLAS Peptide DME1124 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 16 microM) DME1124 XEOTICID XEO03225 GENEFORM Protein DME1124 XEOTICID XEO03225 MOACRIVE Inhibition DME1124 XEOTICID XEO03233 XEO_NAME Dybowskin-1 DME1124 XEOTICID XEO03233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03233 XEO_CLAS Peptide DME1124 XEOTICID XEO03233 DESCRIPT Dybowskin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 50 ug/ml) DME1124 XEOTICID XEO03233 GENEFORM Protein DME1124 XEOTICID XEO03233 MOACRIVE Inhibition DME1124 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1124 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03235 XEO_CLAS Peptide DME1124 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 25 ug/ml) DME1124 XEOTICID XEO03235 GENEFORM Protein DME1124 XEOTICID XEO03235 MOACRIVE Inhibition DME1124 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1124 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03237 XEO_CLAS Peptide DME1124 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 60 ug/ml) DME1124 XEOTICID XEO03237 GENEFORM Protein DME1124 XEOTICID XEO03237 MOACRIVE Inhibition DME1124 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1124 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03238 XEO_CLAS Peptide DME1124 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1124 XEOTICID XEO03238 GENEFORM Protein DME1124 XEOTICID XEO03238 MOACRIVE Inhibition DME1124 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1124 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03239 XEO_CLAS Peptide DME1124 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 50 ug/ml) DME1124 XEOTICID XEO03239 GENEFORM Protein DME1124 XEOTICID XEO03239 MOACRIVE Inhibition DME1124 XEOTICID XEO03240 XEO_NAME Dybowskin-6 DME1124 XEOTICID XEO03240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03240 XEO_CLAS Peptide DME1124 XEOTICID XEO03240 DESCRIPT Dybowskin-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 50 ug/ml) DME1124 XEOTICID XEO03240 GENEFORM Protein DME1124 XEOTICID XEO03240 MOACRIVE Inhibition DME1124 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1124 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03250 XEO_CLAS Peptide DME1124 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03250 GENEFORM Protein DME1124 XEOTICID XEO03250 MOACRIVE Inhibition DME1124 XEOTICID XEO03252 XEO_NAME Enterocin B DME1124 XEOTICID XEO03252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03252 XEO_CLAS Peptide DME1124 XEOTICID XEO03252 DESCRIPT Enterocin B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 44.5 microM) DME1124 XEOTICID XEO03252 GENEFORM Protein DME1124 XEOTICID XEO03252 MOACRIVE Inhibition DME1124 XEOTICID XEO03254 XEO_NAME Enterocin EJ97 DME1124 XEOTICID XEO03254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03254 XEO_CLAS Peptide DME1124 XEOTICID XEO03254 DESCRIPT Enterocin EJ97 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12 ug/ml) DME1124 XEOTICID XEO03254 GENEFORM Protein DME1124 XEOTICID XEO03254 MOACRIVE Inhibition DME1124 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1124 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03258 XEO_CLAS Peptide DME1124 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03258 GENEFORM Protein DME1124 XEOTICID XEO03258 MOACRIVE Inhibition DME1124 XEOTICID XEO03260 XEO_NAME Enterocin X beta DME1124 XEOTICID XEO03260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03260 XEO_CLAS Peptide DME1124 XEOTICID XEO03260 DESCRIPT Enterocin X beta inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 3.25 microM) DME1124 XEOTICID XEO03260 GENEFORM Protein DME1124 XEOTICID XEO03260 MOACRIVE Inhibition DME1124 XEOTICID XEO03270 XEO_NAME Ericin S DME1124 XEOTICID XEO03270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03270 XEO_CLAS Peptide DME1124 XEOTICID XEO03270 DESCRIPT Ericin S inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03270 GENEFORM Protein DME1124 XEOTICID XEO03270 MOACRIVE Inhibition DME1124 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1124 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03281 XEO_CLAS Peptide DME1124 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 25 microM) DME1124 XEOTICID XEO03281 GENEFORM Protein DME1124 XEOTICID XEO03281 MOACRIVE Inhibition DME1124 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1124 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03282 XEO_CLAS Peptide DME1124 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12.5 microM) DME1124 XEOTICID XEO03282 GENEFORM Protein DME1124 XEOTICID XEO03282 MOACRIVE Inhibition DME1124 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1124 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03306 XEO_CLAS Peptide DME1124 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.3 microM) DME1124 XEOTICID XEO03306 GENEFORM Protein DME1124 XEOTICID XEO03306 MOACRIVE Inhibition DME1124 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1124 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03362 XEO_CLAS Peptide DME1124 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 40 ug/ml) DME1124 XEOTICID XEO03362 GENEFORM Protein DME1124 XEOTICID XEO03362 MOACRIVE Inhibition DME1124 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1124 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03363 XEO_CLAS Peptide DME1124 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 30 microM) DME1124 XEOTICID XEO03363 GENEFORM Protein DME1124 XEOTICID XEO03363 MOACRIVE Inhibition DME1124 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1124 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03364 XEO_CLAS Peptide DME1124 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 30 microM) DME1124 XEOTICID XEO03364 GENEFORM Protein DME1124 XEOTICID XEO03364 MOACRIVE Inhibition DME1124 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1124 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03366 XEO_CLAS Peptide DME1124 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 60 microM) DME1124 XEOTICID XEO03366 GENEFORM Protein DME1124 XEOTICID XEO03366 MOACRIVE Inhibition DME1124 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1124 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03367 XEO_CLAS Peptide DME1124 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 30 microM) DME1124 XEOTICID XEO03367 GENEFORM Protein DME1124 XEOTICID XEO03367 MOACRIVE Inhibition DME1124 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1124 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03368 XEO_CLAS Peptide DME1124 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 7.5 microM) DME1124 XEOTICID XEO03368 GENEFORM Protein DME1124 XEOTICID XEO03368 MOACRIVE Inhibition DME1124 XEOTICID XEO03431 XEO_NAME Thanatin truncated isoform G18C(1-18) DME1124 XEOTICID XEO03431 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03431 XEO_CLAS Peptide DME1124 XEOTICID XEO03431 DESCRIPT Thanatin truncated isoform G18C(1-18) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 5-10 microM) DME1124 XEOTICID XEO03431 GENEFORM Protein DME1124 XEOTICID XEO03431 MOACRIVE Inhibition DME1124 XEOTICID XEO03435 XEO_NAME Thanatin truncated isoform G20R(1-20) DME1124 XEOTICID XEO03435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03435 XEO_CLAS Peptide DME1124 XEOTICID XEO03435 DESCRIPT Thanatin truncated isoform G20R(1-20) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 20-40 microM) DME1124 XEOTICID XEO03435 GENEFORM Protein DME1124 XEOTICID XEO03435 MOACRIVE Inhibition DME1124 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1124 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03436 XEO_CLAS Peptide DME1124 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 50 ug/ml) DME1124 XEOTICID XEO03436 GENEFORM Protein DME1124 XEOTICID XEO03436 MOACRIVE Inhibition DME1124 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1124 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03437 XEO_CLAS Peptide DME1124 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 10 ug/ml) DME1124 XEOTICID XEO03437 GENEFORM Protein DME1124 XEOTICID XEO03437 MOACRIVE Inhibition DME1124 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1124 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03438 XEO_CLAS Peptide DME1124 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 10 ug/ml) DME1124 XEOTICID XEO03438 GENEFORM Protein DME1124 XEOTICID XEO03438 MOACRIVE Inhibition DME1124 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1124 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03439 XEO_CLAS Peptide DME1124 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 10 ug/ml) DME1124 XEOTICID XEO03439 GENEFORM Protein DME1124 XEOTICID XEO03439 MOACRIVE Inhibition DME1124 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1124 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03440 XEO_CLAS Peptide DME1124 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 10 ug/ml) DME1124 XEOTICID XEO03440 GENEFORM Protein DME1124 XEOTICID XEO03440 MOACRIVE Inhibition DME1124 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1124 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03441 XEO_CLAS Peptide DME1124 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 10 ug/ml) DME1124 XEOTICID XEO03441 GENEFORM Protein DME1124 XEOTICID XEO03441 MOACRIVE Inhibition DME1124 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1124 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03442 XEO_CLAS Peptide DME1124 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 4.69 ug/ml) DME1124 XEOTICID XEO03442 GENEFORM Protein DME1124 XEOTICID XEO03442 MOACRIVE Inhibition DME1124 XEOTICID XEO03443 XEO_NAME Gaegurin-RN4 DME1124 XEOTICID XEO03443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03443 XEO_CLAS Peptide DME1124 XEOTICID XEO03443 DESCRIPT Gaegurin-RN4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2.34 ug/ml) DME1124 XEOTICID XEO03443 GENEFORM Protein DME1124 XEOTICID XEO03443 MOACRIVE Inhibition DME1124 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1124 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03444 XEO_CLAS Peptide DME1124 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 4.69 ug/ml) DME1124 XEOTICID XEO03444 GENEFORM Protein DME1124 XEOTICID XEO03444 MOACRIVE Inhibition DME1124 XEOTICID XEO03478 XEO_NAME Geobacillin I DME1124 XEOTICID XEO03478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03478 XEO_CLAS Peptide DME1124 XEOTICID XEO03478 DESCRIPT Geobacillin I inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03478 GENEFORM Protein DME1124 XEOTICID XEO03478 MOACRIVE Inhibition DME1124 XEOTICID XEO03479 XEO_NAME Geobacillin II DME1124 XEOTICID XEO03479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03479 XEO_CLAS Peptide DME1124 XEOTICID XEO03479 DESCRIPT Geobacillin II inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03479 GENEFORM Protein DME1124 XEOTICID XEO03479 MOACRIVE Inhibition DME1124 XEOTICID XEO03501 XEO_NAME Gramicidin [Scr2]-GS analogue DME1124 XEOTICID XEO03501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03501 XEO_CLAS Peptide DME1124 XEOTICID XEO03501 DESCRIPT Gramicidin [Scr2]-GS analogue inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.3 ug/ml) DME1124 XEOTICID XEO03501 GENEFORM Protein DME1124 XEOTICID XEO03501 MOACRIVE Inhibition DME1124 XEOTICID XEO03503 XEO_NAME Gramicidin S DME1124 XEOTICID XEO03503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03503 XEO_CLAS Peptide DME1124 XEOTICID XEO03503 DESCRIPT Gramicidin S inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.6 ug/ml) DME1124 XEOTICID XEO03503 GENEFORM Protein DME1124 XEOTICID XEO03503 MOACRIVE Inhibition DME1124 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1124 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03504 XEO_CLAS Peptide DME1124 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 25 ug/ml) DME1124 XEOTICID XEO03504 GENEFORM Protein DME1124 XEOTICID XEO03504 MOACRIVE Inhibition DME1124 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1124 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03505 XEO_CLAS Peptide DME1124 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1124 XEOTICID XEO03505 GENEFORM Protein DME1124 XEOTICID XEO03505 MOACRIVE Inhibition DME1124 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1124 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03506 XEO_CLAS Peptide DME1124 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1124 XEOTICID XEO03506 GENEFORM Protein DME1124 XEOTICID XEO03506 MOACRIVE Inhibition DME1124 XEOTICID XEO03510 XEO_NAME Crab GRPSp peptide DME1124 XEOTICID XEO03510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03510 XEO_CLAS Peptide DME1124 XEOTICID XEO03510 DESCRIPT Crab GRPSp peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 50 microM) DME1124 XEOTICID XEO03510 GENEFORM Protein DME1124 XEOTICID XEO03510 MOACRIVE Inhibition DME1124 XEOTICID XEO03512 XEO_NAME Guentherin AMP-3 DME1124 XEOTICID XEO03512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03512 XEO_CLAS Peptide DME1124 XEOTICID XEO03512 DESCRIPT Guentherin AMP-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 64 ug/ml) DME1124 XEOTICID XEO03512 GENEFORM Protein DME1124 XEOTICID XEO03512 MOACRIVE Inhibition DME1124 XEOTICID XEO03542 XEO_NAME Hepcidin DME1124 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03542 XEO_CLAS Peptide DME1124 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6 microM) DME1124 XEOTICID XEO03542 GENEFORM Protein DME1124 XEOTICID XEO03542 MOACRIVE Inhibition DME1124 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1124 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03544 XEO_CLAS Peptide DME1124 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03544 GENEFORM Protein DME1124 XEOTICID XEO03544 MOACRIVE Inhibition DME1124 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1124 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03549 XEO_CLAS Peptide DME1124 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03549 GENEFORM Protein DME1124 XEOTICID XEO03549 MOACRIVE Inhibition DME1124 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1124 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03561 XEO_CLAS Peptide DME1124 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03561 GENEFORM Protein DME1124 XEOTICID XEO03561 MOACRIVE Inhibition DME1124 XEOTICID XEO03566 XEO_NAME Histone H2A DME1124 XEOTICID XEO03566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03566 XEO_CLAS Peptide DME1124 XEOTICID XEO03566 DESCRIPT Histone H2A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.6-1.2 microM) DME1124 XEOTICID XEO03566 GENEFORM Protein DME1124 XEOTICID XEO03566 MOACRIVE Inhibition DME1124 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1124 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03606 XEO_CLAS Peptide DME1124 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03606 GENEFORM Protein DME1124 XEOTICID XEO03606 MOACRIVE Inhibition DME1124 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1124 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03607 XEO_CLAS Peptide DME1124 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03607 GENEFORM Protein DME1124 XEOTICID XEO03607 MOACRIVE Inhibition DME1124 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1124 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03616 XEO_CLAS Peptide DME1124 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 8 microM) DME1124 XEOTICID XEO03616 GENEFORM Protein DME1124 XEOTICID XEO03616 MOACRIVE Inhibition DME1124 XEOTICID XEO03623 XEO_NAME Basic peptide AMP1 IB-AMP1 DME1124 XEOTICID XEO03623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03623 XEO_CLAS Peptide DME1124 XEOTICID XEO03623 DESCRIPT Basic peptide AMP1 IB-AMP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03623 GENEFORM Protein DME1124 XEOTICID XEO03623 MOACRIVE Inhibition DME1124 XEOTICID XEO03624 XEO_NAME Basic peptide AMP4 IB-AMP4 DME1124 XEOTICID XEO03624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03624 XEO_CLAS Peptide DME1124 XEOTICID XEO03624 DESCRIPT Basic peptide AMP4 IB-AMP4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03624 GENEFORM Protein DME1124 XEOTICID XEO03624 MOACRIVE Inhibition DME1124 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1124 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03627 XEO_CLAS Peptide DME1124 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.8-1.6 microM) DME1124 XEOTICID XEO03627 GENEFORM Protein DME1124 XEOTICID XEO03627 MOACRIVE Inhibition DME1124 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1124 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03630 XEO_CLAS Peptide DME1124 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03630 GENEFORM Protein DME1124 XEOTICID XEO03630 MOACRIVE Inhibition DME1124 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1124 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03631 XEO_CLAS Peptide DME1124 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03631 GENEFORM Protein DME1124 XEOTICID XEO03631 MOACRIVE Inhibition DME1124 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1124 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03632 XEO_CLAS Peptide DME1124 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03632 GENEFORM Protein DME1124 XEOTICID XEO03632 MOACRIVE Inhibition DME1124 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1124 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03633 XEO_CLAS Peptide DME1124 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03633 GENEFORM Protein DME1124 XEOTICID XEO03633 MOACRIVE Inhibition DME1124 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1124 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03634 XEO_CLAS Peptide DME1124 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03634 GENEFORM Protein DME1124 XEOTICID XEO03634 MOACRIVE Inhibition DME1124 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1124 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03635 XEO_CLAS Peptide DME1124 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03635 GENEFORM Protein DME1124 XEOTICID XEO03635 MOACRIVE Inhibition DME1124 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1124 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03636 XEO_CLAS Peptide DME1124 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03636 GENEFORM Protein DME1124 XEOTICID XEO03636 MOACRIVE Inhibition DME1124 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1124 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03637 XEO_CLAS Peptide DME1124 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03637 GENEFORM Protein DME1124 XEOTICID XEO03637 MOACRIVE Inhibition DME1124 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1124 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03638 XEO_CLAS Peptide DME1124 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03638 GENEFORM Protein DME1124 XEOTICID XEO03638 MOACRIVE Inhibition DME1124 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1124 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03639 XEO_CLAS Peptide DME1124 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03639 GENEFORM Protein DME1124 XEOTICID XEO03639 MOACRIVE Inhibition DME1124 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1124 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03640 XEO_CLAS Peptide DME1124 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03640 GENEFORM Protein DME1124 XEOTICID XEO03640 MOACRIVE Inhibition DME1124 XEOTICID XEO03664 XEO_NAME Ixodes ricinus defensin def1 DME1124 XEOTICID XEO03664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03664 XEO_CLAS Peptide DME1124 XEOTICID XEO03664 DESCRIPT Ixodes ricinus defensin def1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.5 microM) DME1124 XEOTICID XEO03664 GENEFORM Protein DME1124 XEOTICID XEO03664 MOACRIVE Inhibition DME1124 XEOTICID XEO03665 XEO_NAME Ixodes ricinus defensin def2 DME1124 XEOTICID XEO03665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03665 XEO_CLAS Peptide DME1124 XEOTICID XEO03665 DESCRIPT Ixodes ricinus defensin def2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.75 microM) DME1124 XEOTICID XEO03665 GENEFORM Protein DME1124 XEOTICID XEO03665 MOACRIVE Inhibition DME1124 XEOTICID XEO03671 XEO_NAME Plant JCpep7 DME1124 XEOTICID XEO03671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03671 XEO_CLAS Peptide DME1124 XEOTICID XEO03671 DESCRIPT Plant JCpep7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 24 ug/ml) DME1124 XEOTICID XEO03671 GENEFORM Protein DME1124 XEOTICID XEO03671 MOACRIVE Inhibition DME1124 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1124 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03672 XEO_CLAS Peptide DME1124 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 10 ug/ml) DME1124 XEOTICID XEO03672 GENEFORM Protein DME1124 XEOTICID XEO03672 MOACRIVE Inhibition DME1124 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1124 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03673 XEO_CLAS Peptide DME1124 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 30 ug/ml) DME1124 XEOTICID XEO03673 GENEFORM Protein DME1124 XEOTICID XEO03673 MOACRIVE Inhibition DME1124 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1124 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03678 XEO_CLAS Peptide DME1124 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2 ug/ml) DME1124 XEOTICID XEO03678 GENEFORM Protein DME1124 XEOTICID XEO03678 MOACRIVE Inhibition DME1124 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1124 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03681 XEO_CLAS Peptide DME1124 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 20-40 microM) DME1124 XEOTICID XEO03681 GENEFORM Protein DME1124 XEOTICID XEO03681 MOACRIVE Inhibition DME1124 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1124 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03709 XEO_CLAS Peptide DME1124 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1124 XEOTICID XEO03709 GENEFORM Protein DME1124 XEOTICID XEO03709 MOACRIVE Inhibition DME1124 XEOTICID XEO03737 XEO_NAME LlKmWn model peptide L4K2W4 DME1124 XEOTICID XEO03737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03737 XEO_CLAS Peptide DME1124 XEOTICID XEO03737 DESCRIPT LlKmWn model peptide L4K2W4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 25 ug/ml) DME1124 XEOTICID XEO03737 GENEFORM Protein DME1124 XEOTICID XEO03737 MOACRIVE Inhibition DME1124 XEOTICID XEO03739 XEO_NAME LlKmWn model peptide L4K3W4 DME1124 XEOTICID XEO03739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03739 XEO_CLAS Peptide DME1124 XEOTICID XEO03739 DESCRIPT LlKmWn model peptide L4K3W4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 50 ug/ml) DME1124 XEOTICID XEO03739 GENEFORM Protein DME1124 XEOTICID XEO03739 MOACRIVE Inhibition DME1124 XEOTICID XEO03740 XEO_NAME LlKmWn model peptide L4K3W5 DME1124 XEOTICID XEO03740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03740 XEO_CLAS Peptide DME1124 XEOTICID XEO03740 DESCRIPT LlKmWn model peptide L4K3W5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 50 ug/ml) DME1124 XEOTICID XEO03740 GENEFORM Protein DME1124 XEOTICID XEO03740 MOACRIVE Inhibition DME1124 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1124 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03744 XEO_CLAS Peptide DME1124 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1124 XEOTICID XEO03744 GENEFORM Protein DME1124 XEOTICID XEO03744 MOACRIVE Inhibition DME1124 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1124 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03746 XEO_CLAS Peptide DME1124 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2 ug/ml) DME1124 XEOTICID XEO03746 GENEFORM Protein DME1124 XEOTICID XEO03746 MOACRIVE Inhibition DME1124 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1124 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03747 XEO_CLAS Peptide DME1124 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1 ug/ml) DME1124 XEOTICID XEO03747 GENEFORM Protein DME1124 XEOTICID XEO03747 MOACRIVE Inhibition DME1124 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1124 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03748 XEO_CLAS Peptide DME1124 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2 ug/ml) DME1124 XEOTICID XEO03748 GENEFORM Protein DME1124 XEOTICID XEO03748 MOACRIVE Inhibition DME1124 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1124 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03749 XEO_CLAS Peptide DME1124 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2 ug/ml) DME1124 XEOTICID XEO03749 GENEFORM Protein DME1124 XEOTICID XEO03749 MOACRIVE Inhibition DME1124 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1124 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03750 XEO_CLAS Peptide DME1124 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2 ug/ml) DME1124 XEOTICID XEO03750 GENEFORM Protein DME1124 XEOTICID XEO03750 MOACRIVE Inhibition DME1124 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1124 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03751 XEO_CLAS Peptide DME1124 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2 ug/ml) DME1124 XEOTICID XEO03751 GENEFORM Protein DME1124 XEOTICID XEO03751 MOACRIVE Inhibition DME1124 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1124 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03752 XEO_CLAS Peptide DME1124 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2 ug/ml) DME1124 XEOTICID XEO03752 GENEFORM Protein DME1124 XEOTICID XEO03752 MOACRIVE Inhibition DME1124 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1124 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03753 XEO_CLAS Peptide DME1124 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.3 ug/ml) DME1124 XEOTICID XEO03753 GENEFORM Protein DME1124 XEOTICID XEO03753 MOACRIVE Inhibition DME1124 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1124 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03754 XEO_CLAS Peptide DME1124 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2 ug/ml) DME1124 XEOTICID XEO03754 GENEFORM Protein DME1124 XEOTICID XEO03754 MOACRIVE Inhibition DME1124 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1124 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03755 XEO_CLAS Peptide DME1124 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 4 ug/ml) DME1124 XEOTICID XEO03755 GENEFORM Protein DME1124 XEOTICID XEO03755 MOACRIVE Inhibition DME1124 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1124 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03756 XEO_CLAS Peptide DME1124 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2 ug/ml) DME1124 XEOTICID XEO03756 GENEFORM Protein DME1124 XEOTICID XEO03756 MOACRIVE Inhibition DME1124 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1124 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03759 XEO_CLAS Peptide DME1124 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.6 ug/ml) DME1124 XEOTICID XEO03759 GENEFORM Protein DME1124 XEOTICID XEO03759 MOACRIVE Inhibition DME1124 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1124 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03761 XEO_CLAS Peptide DME1124 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.6 ug/ml) DME1124 XEOTICID XEO03761 GENEFORM Protein DME1124 XEOTICID XEO03761 MOACRIVE Inhibition DME1124 XEOTICID XEO03762 XEO_NAME LlKmWn model peptide L7K5W7 DME1124 XEOTICID XEO03762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03762 XEO_CLAS Peptide DME1124 XEOTICID XEO03762 DESCRIPT LlKmWn model peptide L7K5W7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 3.1 ug/ml) DME1124 XEOTICID XEO03762 GENEFORM Protein DME1124 XEOTICID XEO03762 MOACRIVE Inhibition DME1124 XEOTICID XEO03764 XEO_NAME LlKmWn model peptide L8K4W7 DME1124 XEOTICID XEO03764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03764 XEO_CLAS Peptide DME1124 XEOTICID XEO03764 DESCRIPT LlKmWn model peptide L8K4W7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.3 ug/ml) DME1124 XEOTICID XEO03764 GENEFORM Protein DME1124 XEOTICID XEO03764 MOACRIVE Inhibition DME1124 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1124 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03771 XEO_CLAS Peptide DME1124 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03771 GENEFORM Protein DME1124 XEOTICID XEO03771 MOACRIVE Inhibition DME1124 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1124 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03793 XEO_CLAS Peptide DME1124 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 32 microM) DME1124 XEOTICID XEO03793 GENEFORM Protein DME1124 XEOTICID XEO03793 MOACRIVE Inhibition DME1124 XEOTICID XEO03804 XEO_NAME Lantibiotic lichenicidin VK21 A1 DME1124 XEOTICID XEO03804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03804 XEO_CLAS Peptide DME1124 XEOTICID XEO03804 DESCRIPT Lantibiotic lichenicidin VK21 A1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03804 GENEFORM Protein DME1124 XEOTICID XEO03804 MOACRIVE Inhibition DME1124 XEOTICID XEO03805 XEO_NAME Lantibiotic lichenicidin VK21 A2 DME1124 XEOTICID XEO03805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03805 XEO_CLAS Peptide DME1124 XEOTICID XEO03805 DESCRIPT Lantibiotic lichenicidin VK21 A2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03805 GENEFORM Protein DME1124 XEOTICID XEO03805 MOACRIVE Inhibition DME1124 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1124 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03810 XEO_CLAS Peptide DME1124 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03810 GENEFORM Protein DME1124 XEOTICID XEO03810 MOACRIVE Inhibition DME1124 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1124 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03928 XEO_CLAS Peptide DME1124 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 16 microM) DME1124 XEOTICID XEO03928 GENEFORM Protein DME1124 XEOTICID XEO03928 MOACRIVE Inhibition DME1124 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1124 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03933 XEO_CLAS Peptide DME1124 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.3 microM) DME1124 XEOTICID XEO03933 GENEFORM Protein DME1124 XEOTICID XEO03933 MOACRIVE Inhibition DME1124 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1124 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03934 XEO_CLAS Peptide DME1124 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.6 microM) DME1124 XEOTICID XEO03934 GENEFORM Protein DME1124 XEOTICID XEO03934 MOACRIVE Inhibition DME1124 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1124 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03935 XEO_CLAS Peptide DME1124 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.7 microM) DME1124 XEOTICID XEO03935 GENEFORM Protein DME1124 XEOTICID XEO03935 MOACRIVE Inhibition DME1124 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1124 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03936 XEO_CLAS Peptide DME1124 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.9 microM) DME1124 XEOTICID XEO03936 GENEFORM Protein DME1124 XEOTICID XEO03936 MOACRIVE Inhibition DME1124 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1124 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03937 XEO_CLAS Peptide DME1124 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.7 microM) DME1124 XEOTICID XEO03937 GENEFORM Protein DME1124 XEOTICID XEO03937 MOACRIVE Inhibition DME1124 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1124 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03938 XEO_CLAS Peptide DME1124 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.7 microM) DME1124 XEOTICID XEO03938 GENEFORM Protein DME1124 XEOTICID XEO03938 MOACRIVE Inhibition DME1124 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1124 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03939 XEO_CLAS Peptide DME1124 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.7 microM) DME1124 XEOTICID XEO03939 GENEFORM Protein DME1124 XEOTICID XEO03939 MOACRIVE Inhibition DME1124 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1124 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03940 XEO_CLAS Peptide DME1124 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.7 microM) DME1124 XEOTICID XEO03940 GENEFORM Protein DME1124 XEOTICID XEO03940 MOACRIVE Inhibition DME1124 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1124 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03941 XEO_CLAS Peptide DME1124 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.7 microM) DME1124 XEOTICID XEO03941 GENEFORM Protein DME1124 XEOTICID XEO03941 MOACRIVE Inhibition DME1124 XEOTICID XEO03942 XEO_NAME Lasioglossin LL-III derivative 10 DME1124 XEOTICID XEO03942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03942 XEO_CLAS Peptide DME1124 XEOTICID XEO03942 DESCRIPT Lasioglossin LL-III derivative 10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 100 microM) DME1124 XEOTICID XEO03942 GENEFORM Protein DME1124 XEOTICID XEO03942 MOACRIVE Inhibition DME1124 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1124 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03943 XEO_CLAS Peptide DME1124 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.6 microM) DME1124 XEOTICID XEO03943 GENEFORM Protein DME1124 XEOTICID XEO03943 MOACRIVE Inhibition DME1124 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1124 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03944 XEO_CLAS Peptide DME1124 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.7 microM) DME1124 XEOTICID XEO03944 GENEFORM Protein DME1124 XEOTICID XEO03944 MOACRIVE Inhibition DME1124 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1124 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03945 XEO_CLAS Peptide DME1124 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.8 microM) DME1124 XEOTICID XEO03945 GENEFORM Protein DME1124 XEOTICID XEO03945 MOACRIVE Inhibition DME1124 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1124 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03947 XEO_CLAS Peptide DME1124 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.5 microM) DME1124 XEOTICID XEO03947 GENEFORM Protein DME1124 XEOTICID XEO03947 MOACRIVE Inhibition DME1124 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1124 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03948 XEO_CLAS Peptide DME1124 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 4.7 microM) DME1124 XEOTICID XEO03948 GENEFORM Protein DME1124 XEOTICID XEO03948 MOACRIVE Inhibition DME1124 XEOTICID XEO03949 XEO_NAME Lasioglossin LL-III derivative 8 DME1124 XEOTICID XEO03949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03949 XEO_CLAS Peptide DME1124 XEOTICID XEO03949 DESCRIPT Lasioglossin LL-III derivative 8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 40 microM) DME1124 XEOTICID XEO03949 GENEFORM Protein DME1124 XEOTICID XEO03949 MOACRIVE Inhibition DME1124 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1124 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1124 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1124 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03968 GENEFORM Protein DME1124 XEOTICID XEO03968 MOACRIVE Inhibition DME1124 XEOTICID XEO03971 XEO_NAME Lumbrican DME1124 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03971 XEO_CLAS Peptide DME1124 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03971 GENEFORM Protein DME1124 XEOTICID XEO03971 MOACRIVE Inhibition DME1124 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1124 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03972 XEO_CLAS Peptide DME1124 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 8 ug/ml) DME1124 XEOTICID XEO03972 GENEFORM Protein DME1124 XEOTICID XEO03972 MOACRIVE Inhibition DME1124 XEOTICID XEO03973 XEO_NAME Lunatusin DME1124 XEOTICID XEO03973 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03973 XEO_CLAS Peptide DME1124 XEOTICID XEO03973 DESCRIPT Lunatusin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO03973 GENEFORM Protein DME1124 XEOTICID XEO03973 MOACRIVE Inhibition DME1124 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1124 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03996 XEO_CLAS Peptide DME1124 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 9 microM) DME1124 XEOTICID XEO03996 GENEFORM Protein DME1124 XEOTICID XEO03996 MOACRIVE Inhibition DME1124 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1124 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03997 XEO_CLAS Peptide DME1124 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 11.8 microM) DME1124 XEOTICID XEO03997 GENEFORM Protein DME1124 XEOTICID XEO03997 MOACRIVE Inhibition DME1124 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1124 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03998 XEO_CLAS Peptide DME1124 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 70 microM) DME1124 XEOTICID XEO03998 GENEFORM Protein DME1124 XEOTICID XEO03998 MOACRIVE Inhibition DME1124 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1124 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO03999 XEO_CLAS Peptide DME1124 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 7.3 microM) DME1124 XEOTICID XEO03999 GENEFORM Protein DME1124 XEOTICID XEO03999 MOACRIVE Inhibition DME1124 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1124 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04000 XEO_CLAS Peptide DME1124 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 4 ug/ml) DME1124 XEOTICID XEO04000 GENEFORM Protein DME1124 XEOTICID XEO04000 MOACRIVE Inhibition DME1124 XEOTICID XEO04055 XEO_NAME Melectin DME1124 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04055 XEO_CLAS Peptide DME1124 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.8 microM) DME1124 XEOTICID XEO04055 GENEFORM Protein DME1124 XEOTICID XEO04055 MOACRIVE Inhibition DME1124 XEOTICID XEO04057 XEO_NAME Melittin DME1124 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04057 XEO_CLAS Peptide DME1124 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.2 microM) DME1124 XEOTICID XEO04057 GENEFORM Protein DME1124 XEOTICID XEO04057 MOACRIVE Inhibition DME1124 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1124 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04121 XEO_CLAS Peptide DME1124 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.6-3.2 microM) DME1124 XEOTICID XEO04121 GENEFORM Protein DME1124 XEOTICID XEO04121 MOACRIVE Inhibition DME1124 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1124 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04122 XEO_CLAS Peptide DME1124 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.57-3.14 microM) DME1124 XEOTICID XEO04122 GENEFORM Protein DME1124 XEOTICID XEO04122 MOACRIVE Inhibition DME1124 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1124 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04128 XEO_CLAS Peptide DME1124 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.19 microM) DME1124 XEOTICID XEO04128 GENEFORM Protein DME1124 XEOTICID XEO04128 MOACRIVE Inhibition DME1124 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1124 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04137 XEO_CLAS Peptide DME1124 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04137 GENEFORM Protein DME1124 XEOTICID XEO04137 MOACRIVE Inhibition DME1124 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1124 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04138 XEO_CLAS Peptide DME1124 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 15 microM) DME1124 XEOTICID XEO04138 GENEFORM Protein DME1124 XEOTICID XEO04138 MOACRIVE Inhibition DME1124 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1124 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04139 XEO_CLAS Peptide DME1124 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 25 microM) DME1124 XEOTICID XEO04139 GENEFORM Protein DME1124 XEOTICID XEO04139 MOACRIVE Inhibition DME1124 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1124 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04140 XEO_CLAS Peptide DME1124 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 35 microM) DME1124 XEOTICID XEO04140 GENEFORM Protein DME1124 XEOTICID XEO04140 MOACRIVE Inhibition DME1124 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1124 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04141 XEO_CLAS Peptide DME1124 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 40 microM) DME1124 XEOTICID XEO04141 GENEFORM Protein DME1124 XEOTICID XEO04141 MOACRIVE Inhibition DME1124 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1124 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04142 XEO_CLAS Peptide DME1124 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.5 microM) DME1124 XEOTICID XEO04142 GENEFORM Protein DME1124 XEOTICID XEO04142 MOACRIVE Inhibition DME1124 XEOTICID XEO04147 XEO_NAME Mucobromic acid DME1124 XEOTICID XEO04147 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1124 XEOTICID XEO04147 XEO_CLAS Chemical Compound DME1124 XEOTICID XEO04147 DESCRIPT Mucobromic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04147 GENEFORM Protein DME1124 XEOTICID XEO04147 MOACRIVE Inhibition DME1124 XEOTICID XEO04148 XEO_NAME Mucochloric acid DME1124 XEOTICID XEO04148 XEO_TYPE Health or Environmental Toxicant(s) DME1124 XEOTICID XEO04148 XEO_CLAS Health Hazard/Toxicant DME1124 XEOTICID XEO04148 DESCRIPT Mucochloric acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04148 GENEFORM Protein DME1124 XEOTICID XEO04148 MOACRIVE Inhibition DME1124 XEOTICID XEO04149 XEO_NAME Mucroporin DME1124 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04149 XEO_CLAS Peptide DME1124 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 50 ug/ml) DME1124 XEOTICID XEO04149 GENEFORM Protein DME1124 XEOTICID XEO04149 MOACRIVE Inhibition DME1124 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1124 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04168 XEO_CLAS Peptide DME1124 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.2-2.5 microM) DME1124 XEOTICID XEO04168 GENEFORM Protein DME1124 XEOTICID XEO04168 MOACRIVE Inhibition DME1124 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1124 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04177 XEO_CLAS Peptide DME1124 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.0 microM) DME1124 XEOTICID XEO04177 GENEFORM Protein DME1124 XEOTICID XEO04177 MOACRIVE Inhibition DME1124 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1124 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04178 XEO_CLAS Peptide DME1124 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.4 microM) DME1124 XEOTICID XEO04178 GENEFORM Protein DME1124 XEOTICID XEO04178 MOACRIVE Inhibition DME1124 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1124 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04179 XEO_CLAS Peptide DME1124 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.2 microM) DME1124 XEOTICID XEO04179 GENEFORM Protein DME1124 XEOTICID XEO04179 MOACRIVE Inhibition DME1124 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1124 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04180 XEO_CLAS Peptide DME1124 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2.9 microM) DME1124 XEOTICID XEO04180 GENEFORM Protein DME1124 XEOTICID XEO04180 MOACRIVE Inhibition DME1124 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1124 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04181 XEO_CLAS Peptide DME1124 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.1 microM) DME1124 XEOTICID XEO04181 GENEFORM Protein DME1124 XEOTICID XEO04181 MOACRIVE Inhibition DME1124 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1124 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04182 XEO_CLAS Peptide DME1124 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.1 microM) DME1124 XEOTICID XEO04182 GENEFORM Protein DME1124 XEOTICID XEO04182 MOACRIVE Inhibition DME1124 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1124 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04183 XEO_CLAS Peptide DME1124 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.6 microM) DME1124 XEOTICID XEO04183 GENEFORM Protein DME1124 XEOTICID XEO04183 MOACRIVE Inhibition DME1124 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1124 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04184 XEO_CLAS Peptide DME1124 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.9 microM) DME1124 XEOTICID XEO04184 GENEFORM Protein DME1124 XEOTICID XEO04184 MOACRIVE Inhibition DME1124 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1124 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04185 XEO_CLAS Peptide DME1124 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04185 GENEFORM Protein DME1124 XEOTICID XEO04185 MOACRIVE Inhibition DME1124 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1124 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04206 XEO_CLAS Peptide DME1124 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.78 microM) DME1124 XEOTICID XEO04206 GENEFORM Protein DME1124 XEOTICID XEO04206 MOACRIVE Inhibition DME1124 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1124 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04214 XEO_CLAS Peptide DME1124 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.78 microM) DME1124 XEOTICID XEO04214 GENEFORM Protein DME1124 XEOTICID XEO04214 MOACRIVE Inhibition DME1124 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1124 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04216 XEO_CLAS Peptide DME1124 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.78 microM) DME1124 XEOTICID XEO04216 GENEFORM Protein DME1124 XEOTICID XEO04216 MOACRIVE Inhibition DME1124 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1124 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04218 XEO_CLAS Peptide DME1124 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.78 microM) DME1124 XEOTICID XEO04218 GENEFORM Protein DME1124 XEOTICID XEO04218 MOACRIVE Inhibition DME1124 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1124 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04219 XEO_CLAS Peptide DME1124 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.78 microM) DME1124 XEOTICID XEO04219 GENEFORM Protein DME1124 XEOTICID XEO04219 MOACRIVE Inhibition DME1124 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1124 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04220 XEO_CLAS Peptide DME1124 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.78 microM) DME1124 XEOTICID XEO04220 GENEFORM Protein DME1124 XEOTICID XEO04220 MOACRIVE Inhibition DME1124 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1124 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04221 XEO_CLAS Peptide DME1124 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.78 microM) DME1124 XEOTICID XEO04221 GENEFORM Protein DME1124 XEOTICID XEO04221 MOACRIVE Inhibition DME1124 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1124 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04222 XEO_CLAS Peptide DME1124 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.78 microM) DME1124 XEOTICID XEO04222 GENEFORM Protein DME1124 XEOTICID XEO04222 MOACRIVE Inhibition DME1124 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1124 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04233 XEO_CLAS Peptide DME1124 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04233 GENEFORM Protein DME1124 XEOTICID XEO04233 MOACRIVE Inhibition DME1124 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1124 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04234 XEO_CLAS Peptide DME1124 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04234 GENEFORM Protein DME1124 XEOTICID XEO04234 MOACRIVE Inhibition DME1124 XEOTICID XEO04235 XEO_NAME Napin-like polypeptide DME1124 XEOTICID XEO04235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04235 XEO_CLAS Peptide DME1124 XEOTICID XEO04235 DESCRIPT Napin-like polypeptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04235 GENEFORM Protein DME1124 XEOTICID XEO04235 MOACRIVE Inhibition DME1124 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1124 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04277 XEO_CLAS Peptide DME1124 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 110.00 ug/ml) DME1124 XEOTICID XEO04277 GENEFORM Protein DME1124 XEOTICID XEO04277 MOACRIVE Inhibition DME1124 XEOTICID XEO04278 XEO_NAME Nigroain-D3 DME1124 XEOTICID XEO04278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04278 XEO_CLAS Peptide DME1124 XEOTICID XEO04278 DESCRIPT Nigroain-D3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 55 ug/ml) DME1124 XEOTICID XEO04278 GENEFORM Protein DME1124 XEOTICID XEO04278 MOACRIVE Inhibition DME1124 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1124 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04280 XEO_CLAS Peptide DME1124 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 21.88 ug/ml) DME1124 XEOTICID XEO04280 GENEFORM Protein DME1124 XEOTICID XEO04280 MOACRIVE Inhibition DME1124 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1124 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04281 XEO_CLAS Peptide DME1124 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 9.38 ug/ml) DME1124 XEOTICID XEO04281 GENEFORM Protein DME1124 XEOTICID XEO04281 MOACRIVE Inhibition DME1124 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1124 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04298 XEO_CLAS Peptide DME1124 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12.5 microM) DME1124 XEOTICID XEO04298 GENEFORM Protein DME1124 XEOTICID XEO04298 MOACRIVE Inhibition DME1124 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1124 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04299 XEO_CLAS Peptide DME1124 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12.5 microM) DME1124 XEOTICID XEO04299 GENEFORM Protein DME1124 XEOTICID XEO04299 MOACRIVE Inhibition DME1124 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1124 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04307 XEO_CLAS Peptide DME1124 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 100 ug/ml) DME1124 XEOTICID XEO04307 GENEFORM Protein DME1124 XEOTICID XEO04307 MOACRIVE Inhibition DME1124 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1124 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04308 XEO_CLAS Peptide DME1124 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 37.50 ug/ml) DME1124 XEOTICID XEO04308 GENEFORM Protein DME1124 XEOTICID XEO04308 MOACRIVE Inhibition DME1124 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1124 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04312 XEO_CLAS Peptide DME1124 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 18.75 ug/ml) DME1124 XEOTICID XEO04312 GENEFORM Protein DME1124 XEOTICID XEO04312 MOACRIVE Inhibition DME1124 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1124 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04313 XEO_CLAS Peptide DME1124 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 18.75 ug/ml) DME1124 XEOTICID XEO04313 GENEFORM Protein DME1124 XEOTICID XEO04313 MOACRIVE Inhibition DME1124 XEOTICID XEO04331 XEO_NAME Norspermidine DME1124 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1124 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1124 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04331 GENEFORM Protein DME1124 XEOTICID XEO04331 MOACRIVE Inhibition DME1124 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1124 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04355 XEO_CLAS Peptide DME1124 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.85 ug/ml) DME1124 XEOTICID XEO04355 GENEFORM Protein DME1124 XEOTICID XEO04355 MOACRIVE Inhibition DME1124 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1124 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04356 XEO_CLAS Peptide DME1124 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 16.42 ug/ml) DME1124 XEOTICID XEO04356 GENEFORM Protein DME1124 XEOTICID XEO04356 MOACRIVE Inhibition DME1124 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1124 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04357 XEO_CLAS Peptide DME1124 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 8.16 ug/ml) DME1124 XEOTICID XEO04357 GENEFORM Protein DME1124 XEOTICID XEO04357 MOACRIVE Inhibition DME1124 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1124 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04358 XEO_CLAS Peptide DME1124 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 4.68 ug/ml) DME1124 XEOTICID XEO04358 GENEFORM Protein DME1124 XEOTICID XEO04358 MOACRIVE Inhibition DME1124 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1124 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04359 XEO_CLAS Peptide DME1124 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 8.40 ug/ml) DME1124 XEOTICID XEO04359 GENEFORM Protein DME1124 XEOTICID XEO04359 MOACRIVE Inhibition DME1124 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1124 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04365 XEO_CLAS Peptide DME1124 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 37.5 ug/ml) DME1124 XEOTICID XEO04365 GENEFORM Protein DME1124 XEOTICID XEO04365 MOACRIVE Inhibition DME1124 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1124 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04366 XEO_CLAS Peptide DME1124 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 5.90 ug/ml) DME1124 XEOTICID XEO04366 GENEFORM Protein DME1124 XEOTICID XEO04366 MOACRIVE Inhibition DME1124 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1124 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04367 XEO_CLAS Peptide DME1124 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 35.60 ug/ml) DME1124 XEOTICID XEO04367 GENEFORM Protein DME1124 XEOTICID XEO04367 MOACRIVE Inhibition DME1124 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1124 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04370 XEO_CLAS Peptide DME1124 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.10 ug/ml) DME1124 XEOTICID XEO04370 GENEFORM Protein DME1124 XEOTICID XEO04370 MOACRIVE Inhibition DME1124 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1124 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04371 XEO_CLAS Peptide DME1124 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 75 ug/ml) DME1124 XEOTICID XEO04371 GENEFORM Protein DME1124 XEOTICID XEO04371 MOACRIVE Inhibition DME1124 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1124 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04374 XEO_CLAS Peptide DME1124 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.75 ug/ml) DME1124 XEOTICID XEO04374 GENEFORM Protein DME1124 XEOTICID XEO04374 MOACRIVE Inhibition DME1124 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1124 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04375 XEO_CLAS Peptide DME1124 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1124 XEOTICID XEO04375 GENEFORM Protein DME1124 XEOTICID XEO04375 MOACRIVE Inhibition DME1124 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1124 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04377 XEO_CLAS Peptide DME1124 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 85.00 ug/ml) DME1124 XEOTICID XEO04377 GENEFORM Protein DME1124 XEOTICID XEO04377 MOACRIVE Inhibition DME1124 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1124 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04378 XEO_CLAS Peptide DME1124 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 17.50 ug/ml) DME1124 XEOTICID XEO04378 GENEFORM Protein DME1124 XEOTICID XEO04378 MOACRIVE Inhibition DME1124 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1124 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04379 XEO_CLAS Peptide DME1124 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 9.37 ug/ml) DME1124 XEOTICID XEO04379 GENEFORM Protein DME1124 XEOTICID XEO04379 MOACRIVE Inhibition DME1124 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1124 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04380 XEO_CLAS Peptide DME1124 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 18.00 ug/ml) DME1124 XEOTICID XEO04380 GENEFORM Protein DME1124 XEOTICID XEO04380 MOACRIVE Inhibition DME1124 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1124 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04381 XEO_CLAS Peptide DME1124 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.30 ug/ml) DME1124 XEOTICID XEO04381 GENEFORM Protein DME1124 XEOTICID XEO04381 MOACRIVE Inhibition DME1124 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1124 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04383 XEO_CLAS Peptide DME1124 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 128 ug/ml) DME1124 XEOTICID XEO04383 GENEFORM Protein DME1124 XEOTICID XEO04383 MOACRIVE Inhibition DME1124 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1124 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04396 XEO_CLAS Peptide DME1124 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.25-0.5 microM) DME1124 XEOTICID XEO04396 GENEFORM Protein DME1124 XEOTICID XEO04396 MOACRIVE Inhibition DME1124 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1124 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04397 XEO_CLAS Peptide DME1124 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.25-0.5 microM) DME1124 XEOTICID XEO04397 GENEFORM Protein DME1124 XEOTICID XEO04397 MOACRIVE Inhibition DME1124 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1124 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04399 XEO_CLAS Peptide DME1124 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12.5 microM) DME1124 XEOTICID XEO04399 GENEFORM Protein DME1124 XEOTICID XEO04399 MOACRIVE Inhibition DME1124 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1124 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04421 XEO_CLAS Peptide DME1124 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.5 microM) DME1124 XEOTICID XEO04421 GENEFORM Protein DME1124 XEOTICID XEO04421 MOACRIVE Inhibition DME1124 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1124 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04430 XEO_CLAS Peptide DME1124 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.78 microM) DME1124 XEOTICID XEO04430 GENEFORM Protein DME1124 XEOTICID XEO04430 MOACRIVE Inhibition DME1124 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1124 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04448 XEO_CLAS Peptide DME1124 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12.5 microM) DME1124 XEOTICID XEO04448 GENEFORM Protein DME1124 XEOTICID XEO04448 MOACRIVE Inhibition DME1124 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1124 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04455 XEO_CLAS Peptide DME1124 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12.5 microM) DME1124 XEOTICID XEO04455 GENEFORM Protein DME1124 XEOTICID XEO04455 MOACRIVE Inhibition DME1124 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1124 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04461 XEO_CLAS Peptide DME1124 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 5.2 microM) DME1124 XEOTICID XEO04461 GENEFORM Protein DME1124 XEOTICID XEO04461 MOACRIVE Inhibition DME1124 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1124 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04462 XEO_CLAS Peptide DME1124 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 4.8 microM) DME1124 XEOTICID XEO04462 GENEFORM Protein DME1124 XEOTICID XEO04462 MOACRIVE Inhibition DME1124 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1124 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04471 XEO_CLAS Peptide DME1124 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.3 microM) DME1124 XEOTICID XEO04471 GENEFORM Protein DME1124 XEOTICID XEO04471 MOACRIVE Inhibition DME1124 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1124 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04484 XEO_CLAS Peptide DME1124 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 45 microM) DME1124 XEOTICID XEO04484 GENEFORM Protein DME1124 XEOTICID XEO04484 MOACRIVE Inhibition DME1124 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1124 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04485 XEO_CLAS Peptide DME1124 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 10 microM) DME1124 XEOTICID XEO04485 GENEFORM Protein DME1124 XEOTICID XEO04485 MOACRIVE Inhibition DME1124 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1124 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04486 XEO_CLAS Peptide DME1124 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 15 microM) DME1124 XEOTICID XEO04486 GENEFORM Protein DME1124 XEOTICID XEO04486 MOACRIVE Inhibition DME1124 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1124 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04487 XEO_CLAS Peptide DME1124 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 20 microM) DME1124 XEOTICID XEO04487 GENEFORM Protein DME1124 XEOTICID XEO04487 MOACRIVE Inhibition DME1124 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1124 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04488 XEO_CLAS Peptide DME1124 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 5 microM) DME1124 XEOTICID XEO04488 GENEFORM Protein DME1124 XEOTICID XEO04488 MOACRIVE Inhibition DME1124 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1124 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04489 XEO_CLAS Peptide DME1124 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 8.5 microM) DME1124 XEOTICID XEO04489 GENEFORM Protein DME1124 XEOTICID XEO04489 MOACRIVE Inhibition DME1124 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1124 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04490 XEO_CLAS Peptide DME1124 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 17.5 microM) DME1124 XEOTICID XEO04490 GENEFORM Protein DME1124 XEOTICID XEO04490 MOACRIVE Inhibition DME1124 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1124 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04491 XEO_CLAS Peptide DME1124 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 17 microM) DME1124 XEOTICID XEO04491 GENEFORM Protein DME1124 XEOTICID XEO04491 MOACRIVE Inhibition DME1124 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1124 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04492 XEO_CLAS Peptide DME1124 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 40 microM) DME1124 XEOTICID XEO04492 GENEFORM Protein DME1124 XEOTICID XEO04492 MOACRIVE Inhibition DME1124 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1124 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04493 XEO_CLAS Peptide DME1124 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 87.5 microM) DME1124 XEOTICID XEO04493 GENEFORM Protein DME1124 XEOTICID XEO04493 MOACRIVE Inhibition DME1124 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1124 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04494 XEO_CLAS Peptide DME1124 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 100 microM) DME1124 XEOTICID XEO04494 GENEFORM Protein DME1124 XEOTICID XEO04494 MOACRIVE Inhibition DME1124 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1124 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04495 XEO_CLAS Peptide DME1124 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 22.5 microM) DME1124 XEOTICID XEO04495 GENEFORM Protein DME1124 XEOTICID XEO04495 MOACRIVE Inhibition DME1124 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1124 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04496 XEO_CLAS Peptide DME1124 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 25 microM) DME1124 XEOTICID XEO04496 GENEFORM Protein DME1124 XEOTICID XEO04496 MOACRIVE Inhibition DME1124 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1124 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04497 XEO_CLAS Peptide DME1124 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 17.5 microM) DME1124 XEOTICID XEO04497 GENEFORM Protein DME1124 XEOTICID XEO04497 MOACRIVE Inhibition DME1124 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1124 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04498 XEO_CLAS Peptide DME1124 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 22.5 microM) DME1124 XEOTICID XEO04498 GENEFORM Protein DME1124 XEOTICID XEO04498 MOACRIVE Inhibition DME1124 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1124 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04499 XEO_CLAS Peptide DME1124 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 15.5 microM) DME1124 XEOTICID XEO04499 GENEFORM Protein DME1124 XEOTICID XEO04499 MOACRIVE Inhibition DME1124 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1124 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04500 XEO_CLAS Peptide DME1124 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 100 microM) DME1124 XEOTICID XEO04500 GENEFORM Protein DME1124 XEOTICID XEO04500 MOACRIVE Inhibition DME1124 XEOTICID XEO04518 XEO_NAME Penicillic acid DME1124 XEOTICID XEO04518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1124 XEOTICID XEO04518 XEO_CLAS Natural Product DME1124 XEOTICID XEO04518 DESCRIPT Penicillic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04518 GENEFORM Protein DME1124 XEOTICID XEO04518 MOACRIVE Inhibition DME1124 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1124 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04525 XEO_CLAS Peptide DME1124 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 8.0 microM) DME1124 XEOTICID XEO04525 GENEFORM Protein DME1124 XEOTICID XEO04525 MOACRIVE Inhibition DME1124 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1124 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04526 XEO_CLAS Peptide DME1124 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2.0 microM) DME1124 XEOTICID XEO04526 GENEFORM Protein DME1124 XEOTICID XEO04526 MOACRIVE Inhibition DME1124 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1124 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04540 XEO_CLAS Peptide DME1124 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 48.8 ug/ml) DME1124 XEOTICID XEO04540 GENEFORM Protein DME1124 XEOTICID XEO04540 MOACRIVE Inhibition DME1124 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1124 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04541 XEO_CLAS Peptide DME1124 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 5 ug/ml) DME1124 XEOTICID XEO04541 GENEFORM Protein DME1124 XEOTICID XEO04541 MOACRIVE Inhibition DME1124 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1124 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04542 XEO_CLAS Peptide DME1124 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04542 GENEFORM Protein DME1124 XEOTICID XEO04542 MOACRIVE Inhibition DME1124 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1124 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04551 XEO_CLAS Peptide DME1124 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 14.4 ug/ml) DME1124 XEOTICID XEO04551 GENEFORM Protein DME1124 XEOTICID XEO04551 MOACRIVE Inhibition DME1124 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1124 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04604 XEO_CLAS Peptide DME1124 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC < 50 microM) DME1124 XEOTICID XEO04604 GENEFORM Protein DME1124 XEOTICID XEO04604 MOACRIVE Inhibition DME1124 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1124 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04605 XEO_CLAS Peptide DME1124 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC < 50 microM) DME1124 XEOTICID XEO04605 GENEFORM Protein DME1124 XEOTICID XEO04605 MOACRIVE Inhibition DME1124 XEOTICID XEO04624 XEO_NAME Plantazolicin DME1124 XEOTICID XEO04624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04624 XEO_CLAS Peptide DME1124 XEOTICID XEO04624 DESCRIPT Plantazolicin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04624 GENEFORM Protein DME1124 XEOTICID XEO04624 MOACRIVE Inhibition DME1124 XEOTICID XEO04632 XEO_NAME Pleurain-B1 DME1124 XEOTICID XEO04632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04632 XEO_CLAS Peptide DME1124 XEOTICID XEO04632 DESCRIPT Pleurain-B1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 3.1 ug/ml) DME1124 XEOTICID XEO04632 GENEFORM Protein DME1124 XEOTICID XEO04632 MOACRIVE Inhibition DME1124 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1124 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04633 XEO_CLAS Peptide DME1124 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 3.1 ug/ml) DME1124 XEOTICID XEO04633 GENEFORM Protein DME1124 XEOTICID XEO04633 MOACRIVE Inhibition DME1124 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1124 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04634 XEO_CLAS Peptide DME1124 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 50 ug/ml) DME1124 XEOTICID XEO04634 GENEFORM Protein DME1124 XEOTICID XEO04634 MOACRIVE Inhibition DME1124 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1124 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04636 XEO_CLAS Peptide DME1124 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 100 ug/ml) DME1124 XEOTICID XEO04636 GENEFORM Protein DME1124 XEOTICID XEO04636 MOACRIVE Inhibition DME1124 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1124 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04637 XEO_CLAS Peptide DME1124 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 50 ug/ml) DME1124 XEOTICID XEO04637 GENEFORM Protein DME1124 XEOTICID XEO04637 MOACRIVE Inhibition DME1124 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1124 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04639 XEO_CLAS Peptide DME1124 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 100 ug/ml) DME1124 XEOTICID XEO04639 GENEFORM Protein DME1124 XEOTICID XEO04639 MOACRIVE Inhibition DME1124 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1124 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04640 XEO_CLAS Peptide DME1124 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.1-2.2 microM) DME1124 XEOTICID XEO04640 GENEFORM Protein DME1124 XEOTICID XEO04640 MOACRIVE Inhibition DME1124 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1124 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04664 XEO_CLAS Peptide DME1124 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 27.2 microM) DME1124 XEOTICID XEO04664 GENEFORM Protein DME1124 XEOTICID XEO04664 MOACRIVE Inhibition DME1124 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1124 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04665 XEO_CLAS Peptide DME1124 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 35 microM) DME1124 XEOTICID XEO04665 GENEFORM Protein DME1124 XEOTICID XEO04665 MOACRIVE Inhibition DME1124 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1124 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04666 XEO_CLAS Peptide DME1124 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 100 microM) DME1124 XEOTICID XEO04666 GENEFORM Protein DME1124 XEOTICID XEO04666 MOACRIVE Inhibition DME1124 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1124 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04667 XEO_CLAS Peptide DME1124 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 10 microM) DME1124 XEOTICID XEO04667 GENEFORM Protein DME1124 XEOTICID XEO04667 MOACRIVE Inhibition DME1124 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1124 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04668 XEO_CLAS Peptide DME1124 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 60 microM) DME1124 XEOTICID XEO04668 GENEFORM Protein DME1124 XEOTICID XEO04668 MOACRIVE Inhibition DME1124 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1124 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04669 XEO_CLAS Peptide DME1124 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 30 microM) DME1124 XEOTICID XEO04669 GENEFORM Protein DME1124 XEOTICID XEO04669 MOACRIVE Inhibition DME1124 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1124 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04670 XEO_CLAS Peptide DME1124 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 46 microM) DME1124 XEOTICID XEO04670 GENEFORM Protein DME1124 XEOTICID XEO04670 MOACRIVE Inhibition DME1124 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1124 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04671 XEO_CLAS Peptide DME1124 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 125 microM) DME1124 XEOTICID XEO04671 GENEFORM Protein DME1124 XEOTICID XEO04671 MOACRIVE Inhibition DME1124 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1124 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04672 XEO_CLAS Peptide DME1124 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 75 microM) DME1124 XEOTICID XEO04672 GENEFORM Protein DME1124 XEOTICID XEO04672 MOACRIVE Inhibition DME1124 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1124 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04673 XEO_CLAS Peptide DME1124 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 100 microM) DME1124 XEOTICID XEO04673 GENEFORM Protein DME1124 XEOTICID XEO04673 MOACRIVE Inhibition DME1124 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1124 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04674 XEO_CLAS Peptide DME1124 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 70 microM) DME1124 XEOTICID XEO04674 GENEFORM Protein DME1124 XEOTICID XEO04674 MOACRIVE Inhibition DME1124 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1124 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04675 XEO_CLAS Peptide DME1124 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 100 microM) DME1124 XEOTICID XEO04675 GENEFORM Protein DME1124 XEOTICID XEO04675 MOACRIVE Inhibition DME1124 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1124 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04676 XEO_CLAS Peptide DME1124 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 100 microM) DME1124 XEOTICID XEO04676 GENEFORM Protein DME1124 XEOTICID XEO04676 MOACRIVE Inhibition DME1124 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1124 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04677 XEO_CLAS Peptide DME1124 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 100 microM) DME1124 XEOTICID XEO04677 GENEFORM Protein DME1124 XEOTICID XEO04677 MOACRIVE Inhibition DME1124 XEOTICID XEO04678 XEO_NAME Plant defensin Pn-AMP1 DME1124 XEOTICID XEO04678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04678 XEO_CLAS Peptide DME1124 XEOTICID XEO04678 DESCRIPT Plant defensin Pn-AMP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04678 GENEFORM Protein DME1124 XEOTICID XEO04678 MOACRIVE Inhibition DME1124 XEOTICID XEO04679 XEO_NAME Plant defensin Pn-AMP2 DME1124 XEOTICID XEO04679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04679 XEO_CLAS Peptide DME1124 XEOTICID XEO04679 DESCRIPT Plant defensin Pn-AMP2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04679 GENEFORM Protein DME1124 XEOTICID XEO04679 MOACRIVE Inhibition DME1124 XEOTICID XEO04681 XEO_NAME Polybia chemotactic peptide polybia-CP DME1124 XEOTICID XEO04681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04681 XEO_CLAS Peptide DME1124 XEOTICID XEO04681 DESCRIPT Polybia chemotactic peptide polybia-CP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 15 ug/ml) DME1124 XEOTICID XEO04681 GENEFORM Protein DME1124 XEOTICID XEO04681 MOACRIVE Inhibition DME1124 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1124 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04695 XEO_CLAS Peptide DME1124 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04695 GENEFORM Protein DME1124 XEOTICID XEO04695 MOACRIVE Inhibition DME1124 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1124 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04697 XEO_CLAS Peptide DME1124 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04697 GENEFORM Protein DME1124 XEOTICID XEO04697 MOACRIVE Inhibition DME1124 XEOTICID XEO04707 XEO_NAME Pore-forming peptide ameobapore A DME1124 XEOTICID XEO04707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04707 XEO_CLAS Peptide DME1124 XEOTICID XEO04707 DESCRIPT Pore-forming peptide ameobapore A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 27 microM) DME1124 XEOTICID XEO04707 GENEFORM Protein DME1124 XEOTICID XEO04707 MOACRIVE Inhibition DME1124 XEOTICID XEO04711 XEO_NAME Insect PP102 peptide DME1124 XEOTICID XEO04711 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04711 XEO_CLAS Peptide DME1124 XEOTICID XEO04711 DESCRIPT Insect PP102 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 25 microM) DME1124 XEOTICID XEO04711 GENEFORM Protein DME1124 XEOTICID XEO04711 MOACRIVE Inhibition DME1124 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1124 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04712 XEO_CLAS Peptide DME1124 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 23.3 microM) DME1124 XEOTICID XEO04712 GENEFORM Protein DME1124 XEOTICID XEO04712 MOACRIVE Inhibition DME1124 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1124 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04713 XEO_CLAS Peptide DME1124 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 13.3 microM) DME1124 XEOTICID XEO04713 GENEFORM Protein DME1124 XEOTICID XEO04713 MOACRIVE Inhibition DME1124 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1124 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04714 XEO_CLAS Peptide DME1124 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 16.7 microM) DME1124 XEOTICID XEO04714 GENEFORM Protein DME1124 XEOTICID XEO04714 MOACRIVE Inhibition DME1124 XEOTICID XEO04737 XEO_NAME Protonectin DME1124 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04737 XEO_CLAS Peptide DME1124 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 3.1 ug/ml) DME1124 XEOTICID XEO04737 GENEFORM Protein DME1124 XEOTICID XEO04737 MOACRIVE Inhibition DME1124 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1124 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04762 XEO_CLAS Peptide DME1124 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 3.1 microM) DME1124 XEOTICID XEO04762 GENEFORM Protein DME1124 XEOTICID XEO04762 MOACRIVE Inhibition DME1124 XEOTICID XEO04790 XEO_NAME Ranacyclin-B-AL1 DME1124 XEOTICID XEO04790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04790 XEO_CLAS Peptide DME1124 XEOTICID XEO04790 DESCRIPT Ranacyclin-B-AL1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 26 microM) DME1124 XEOTICID XEO04790 GENEFORM Protein DME1124 XEOTICID XEO04790 MOACRIVE Inhibition DME1124 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1124 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04793 XEO_CLAS Peptide DME1124 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 46.2 microM) DME1124 XEOTICID XEO04793 GENEFORM Protein DME1124 XEOTICID XEO04793 MOACRIVE Inhibition DME1124 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1124 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04865 XEO_CLAS Peptide DME1124 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1124 XEOTICID XEO04865 GENEFORM Protein DME1124 XEOTICID XEO04865 MOACRIVE Inhibition DME1124 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1124 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04866 XEO_CLAS Peptide DME1124 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1124 XEOTICID XEO04866 GENEFORM Protein DME1124 XEOTICID XEO04866 MOACRIVE Inhibition DME1124 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1124 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04868 XEO_CLAS Peptide DME1124 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 9.38 ug/ml) DME1124 XEOTICID XEO04868 GENEFORM Protein DME1124 XEOTICID XEO04868 MOACRIVE Inhibition DME1124 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1124 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04869 XEO_CLAS Peptide DME1124 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 18.75 ug/ml) DME1124 XEOTICID XEO04869 GENEFORM Protein DME1124 XEOTICID XEO04869 MOACRIVE Inhibition DME1124 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1124 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04870 XEO_CLAS Peptide DME1124 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 18.75 ug/ml) DME1124 XEOTICID XEO04870 GENEFORM Protein DME1124 XEOTICID XEO04870 MOACRIVE Inhibition DME1124 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1124 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04880 XEO_CLAS Peptide DME1124 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2.0 ug/ml) DME1124 XEOTICID XEO04880 GENEFORM Protein DME1124 XEOTICID XEO04880 MOACRIVE Inhibition DME1124 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1124 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04886 XEO_CLAS Peptide DME1124 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.3 ug/ml) DME1124 XEOTICID XEO04886 GENEFORM Protein DME1124 XEOTICID XEO04886 MOACRIVE Inhibition DME1124 XEOTICID XEO04892 XEO_NAME Seabream beta defensin saBD DME1124 XEOTICID XEO04892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04892 XEO_CLAS Peptide DME1124 XEOTICID XEO04892 DESCRIPT Seabream beta defensin saBD inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04892 GENEFORM Protein DME1124 XEOTICID XEO04892 MOACRIVE Inhibition DME1124 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1124 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04901 XEO_CLAS Peptide DME1124 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2 microM) DME1124 XEOTICID XEO04901 GENEFORM Protein DME1124 XEOTICID XEO04901 MOACRIVE Inhibition DME1124 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1124 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04904 XEO_CLAS Peptide DME1124 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 20.0 ug/ml) DME1124 XEOTICID XEO04904 GENEFORM Protein DME1124 XEOTICID XEO04904 MOACRIVE Inhibition DME1124 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1124 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04909 XEO_CLAS Peptide DME1124 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04909 GENEFORM Protein DME1124 XEOTICID XEO04909 MOACRIVE Inhibition DME1124 XEOTICID XEO04917 XEO_NAME Scorpine DME1124 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04917 XEO_CLAS Peptide DME1124 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 1.0 microM) DME1124 XEOTICID XEO04917 GENEFORM Protein DME1124 XEOTICID XEO04917 MOACRIVE Inhibition DME1124 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1124 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04956 XEO_CLAS Peptide DME1124 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 8.0 microM) DME1124 XEOTICID XEO04956 GENEFORM Protein DME1124 XEOTICID XEO04956 MOACRIVE Inhibition DME1124 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1124 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04971 XEO_CLAS Peptide DME1124 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.8-1.5 microM) DME1124 XEOTICID XEO04971 GENEFORM Protein DME1124 XEOTICID XEO04971 MOACRIVE Inhibition DME1124 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1124 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1124 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1124 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04975 GENEFORM Protein DME1124 XEOTICID XEO04975 MOACRIVE Inhibition DME1124 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1124 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1124 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1124 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04976 GENEFORM Protein DME1124 XEOTICID XEO04976 MOACRIVE Inhibition DME1124 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1124 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1124 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1124 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04977 GENEFORM Protein DME1124 XEOTICID XEO04977 MOACRIVE Inhibition DME1124 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1124 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1124 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1124 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04978 GENEFORM Protein DME1124 XEOTICID XEO04978 MOACRIVE Inhibition DME1124 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1124 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1124 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1124 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO04979 GENEFORM Protein DME1124 XEOTICID XEO04979 MOACRIVE Inhibition DME1124 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1124 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO04995 XEO_CLAS Peptide DME1124 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 6.25-12.5 microM) DME1124 XEOTICID XEO04995 GENEFORM Protein DME1124 XEOTICID XEO04995 MOACRIVE Inhibition DME1124 XEOTICID XEO05089 XEO_NAME Temporin-GH DME1124 XEOTICID XEO05089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05089 XEO_CLAS Peptide DME1124 XEOTICID XEO05089 DESCRIPT Temporin-GH inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC > 64 ug/ml) DME1124 XEOTICID XEO05089 GENEFORM Protein DME1124 XEOTICID XEO05089 MOACRIVE Inhibition DME1124 XEOTICID XEO05092 XEO_NAME Temporin-LT1 DME1124 XEOTICID XEO05092 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05092 XEO_CLAS Peptide DME1124 XEOTICID XEO05092 DESCRIPT Temporin-LT1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 25 microM) DME1124 XEOTICID XEO05092 GENEFORM Protein DME1124 XEOTICID XEO05092 MOACRIVE Inhibition DME1124 XEOTICID XEO05093 XEO_NAME Temporin-LT2 DME1124 XEOTICID XEO05093 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05093 XEO_CLAS Peptide DME1124 XEOTICID XEO05093 DESCRIPT Temporin-LT2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 50 microM) DME1124 XEOTICID XEO05093 GENEFORM Protein DME1124 XEOTICID XEO05093 MOACRIVE Inhibition DME1124 XEOTICID XEO05094 XEO_NAME Temporin-LTa DME1124 XEOTICID XEO05094 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05094 XEO_CLAS Peptide DME1124 XEOTICID XEO05094 DESCRIPT Temporin-LTa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 10 ug/ml) DME1124 XEOTICID XEO05094 GENEFORM Protein DME1124 XEOTICID XEO05094 MOACRIVE Inhibition DME1124 XEOTICID XEO05095 XEO_NAME Temporin-LTb DME1124 XEOTICID XEO05095 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05095 XEO_CLAS Peptide DME1124 XEOTICID XEO05095 DESCRIPT Temporin-LTb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 25 ug/ml) DME1124 XEOTICID XEO05095 GENEFORM Protein DME1124 XEOTICID XEO05095 MOACRIVE Inhibition DME1124 XEOTICID XEO05096 XEO_NAME Temporin-LTc DME1124 XEOTICID XEO05096 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05096 XEO_CLAS Peptide DME1124 XEOTICID XEO05096 DESCRIPT Temporin-LTc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 50 ug/ml) DME1124 XEOTICID XEO05096 GENEFORM Protein DME1124 XEOTICID XEO05096 MOACRIVE Inhibition DME1124 XEOTICID XEO05120 XEO_NAME Thanatin DME1124 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05120 XEO_CLAS Peptide DME1124 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2.5-5 microM) DME1124 XEOTICID XEO05120 GENEFORM Protein DME1124 XEOTICID XEO05120 MOACRIVE Inhibition DME1124 XEOTICID XEO05129 XEO_NAME Thiocillin GE37468 DME1124 XEOTICID XEO05129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05129 XEO_CLAS Peptide DME1124 XEOTICID XEO05129 DESCRIPT Thiocillin GE37468 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.047 ug/ml) DME1124 XEOTICID XEO05129 GENEFORM Protein DME1124 XEOTICID XEO05129 MOACRIVE Inhibition DME1124 XEOTICID XEO05138 XEO_NAME Thuricin-17 DME1124 XEOTICID XEO05138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05138 XEO_CLAS Peptide DME1124 XEOTICID XEO05138 DESCRIPT Thuricin-17 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO05138 GENEFORM Protein DME1124 XEOTICID XEO05138 MOACRIVE Inhibition DME1124 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1124 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05139 XEO_CLAS Peptide DME1124 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO05139 GENEFORM Protein DME1124 XEOTICID XEO05139 MOACRIVE Inhibition DME1124 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1124 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05144 XEO_CLAS Peptide DME1124 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 30 ug/ml) DME1124 XEOTICID XEO05144 GENEFORM Protein DME1124 XEOTICID XEO05144 MOACRIVE Inhibition DME1124 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1124 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05145 XEO_CLAS Peptide DME1124 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 20 ug/ml) DME1124 XEOTICID XEO05145 GENEFORM Protein DME1124 XEOTICID XEO05145 MOACRIVE Inhibition DME1124 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1124 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05146 XEO_CLAS Peptide DME1124 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 30 ug/ml) DME1124 XEOTICID XEO05146 GENEFORM Protein DME1124 XEOTICID XEO05146 MOACRIVE Inhibition DME1124 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1124 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05161 XEO_CLAS Peptide DME1124 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 16 ug/ml) DME1124 XEOTICID XEO05161 GENEFORM Protein DME1124 XEOTICID XEO05161 MOACRIVE Inhibition DME1124 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1124 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05162 XEO_CLAS Peptide DME1124 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 16 ug/ml) DME1124 XEOTICID XEO05162 GENEFORM Protein DME1124 XEOTICID XEO05162 MOACRIVE Inhibition DME1124 XEOTICID XEO05169 XEO_NAME Tricyclic peptide MS-271 DME1124 XEOTICID XEO05169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05169 XEO_CLAS Peptide DME1124 XEOTICID XEO05169 DESCRIPT Tricyclic peptide MS-271 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis DME1124 XEOTICID XEO05169 GENEFORM Protein DME1124 XEOTICID XEO05169 MOACRIVE Inhibition DME1124 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1124 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05193 XEO_CLAS Peptide DME1124 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 8 ug/ml) DME1124 XEOTICID XEO05193 GENEFORM Protein DME1124 XEOTICID XEO05193 MOACRIVE Inhibition DME1124 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1124 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05212 XEO_CLAS Peptide DME1124 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 2.0 ug/ml) DME1124 XEOTICID XEO05212 GENEFORM Protein DME1124 XEOTICID XEO05212 MOACRIVE Inhibition DME1124 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1124 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05220 XEO_CLAS Peptide DME1124 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 20-40 microM) DME1124 XEOTICID XEO05220 GENEFORM Protein DME1124 XEOTICID XEO05220 MOACRIVE Inhibition DME1124 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1124 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1124 XEOTICID XEO05308 XEO_CLAS Peptide DME1124 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus subtilis (MIC = 0.7 ug/ml) DME1124 XEOTICID XEO05308 GENEFORM Protein DME1124 XEOTICID XEO05308 MOACRIVE Inhibition DME1125 DME___ID DME1125 DME1125 DME_NAME Glutamate racemase (MurI) DME1125 SPESNAME Bacillus pumilus DME1125 XEOTICID XEO00044 XEO_NAME Glipizide DME1125 XEOTICID XEO00044 XEO_TYPE Pharmaceutical Agent(s) DME1125 XEOTICID XEO00044 XEO_CLAS Approved/Marketed Drug DME1125 XEOTICID XEO00044 DESCRIPT Glipizide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO00044 GENEFORM Protein DME1125 XEOTICID XEO00044 MOACRIVE Inhibition DME1125 XEOTICID XEO00070 XEO_NAME Esomeprazole DME1125 XEOTICID XEO00070 XEO_TYPE Pharmaceutical Agent(s) DME1125 XEOTICID XEO00070 XEO_CLAS Approved/Marketed Drug DME1125 XEOTICID XEO00070 DESCRIPT Esomeprazole inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO00070 GENEFORM Protein DME1125 XEOTICID XEO00070 MOACRIVE Inhibition DME1125 XEOTICID XEO00096 XEO_NAME Ampicillin DME1125 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME1125 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME1125 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO00096 GENEFORM Protein DME1125 XEOTICID XEO00096 MOACRIVE Inhibition DME1125 XEOTICID XEO00246 XEO_NAME Amoxicillin DME1125 XEOTICID XEO00246 XEO_TYPE Pharmaceutical Agent(s) DME1125 XEOTICID XEO00246 XEO_CLAS Approved/Marketed Drug DME1125 XEOTICID XEO00246 DESCRIPT Amoxicillin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO00246 GENEFORM Protein DME1125 XEOTICID XEO00246 MOACRIVE Inhibition DME1125 XEOTICID XEO00338 XEO_NAME Amlodipine DME1125 XEOTICID XEO00338 XEO_TYPE Pharmaceutical Agent(s) DME1125 XEOTICID XEO00338 XEO_CLAS Approved/Marketed Drug DME1125 XEOTICID XEO00338 DESCRIPT Amlodipine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO00338 GENEFORM Protein DME1125 XEOTICID XEO00338 MOACRIVE Inhibition DME1125 XEOTICID XEO00356 XEO_NAME Enalapril DME1125 XEOTICID XEO00356 XEO_TYPE Pharmaceutical Agent(s) DME1125 XEOTICID XEO00356 XEO_CLAS Approved/Marketed Drug DME1125 XEOTICID XEO00356 DESCRIPT Enalapril inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO00356 GENEFORM Protein DME1125 XEOTICID XEO00356 MOACRIVE Inhibition DME1125 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1125 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO01810 XEO_CLAS Peptide DME1125 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2.0 microM) DME1125 XEOTICID XEO01810 GENEFORM Protein DME1125 XEOTICID XEO01810 MOACRIVE Inhibition DME1125 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1125 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO01817 XEO_CLAS Peptide DME1125 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 4.0 microM) DME1125 XEOTICID XEO01817 GENEFORM Protein DME1125 XEOTICID XEO01817 MOACRIVE Inhibition DME1125 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1125 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO01818 XEO_CLAS Peptide DME1125 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 4.0 microM) DME1125 XEOTICID XEO01818 GENEFORM Protein DME1125 XEOTICID XEO01818 MOACRIVE Inhibition DME1125 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1125 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO01823 XEO_CLAS Peptide DME1125 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.56 microM) DME1125 XEOTICID XEO01823 GENEFORM Protein DME1125 XEOTICID XEO01823 MOACRIVE Inhibition DME1125 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1125 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO01825 XEO_CLAS Peptide DME1125 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.56 microM) DME1125 XEOTICID XEO01825 GENEFORM Protein DME1125 XEOTICID XEO01825 MOACRIVE Inhibition DME1125 XEOTICID XEO01972 XEO_NAME 3,4-Dichloro-2-(1,3-dichloropropan-2-yloxy)-2H-furan-5-one DME1125 XEOTICID XEO01972 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1125 XEOTICID XEO01972 XEO_CLAS Chemical Compound DME1125 XEOTICID XEO01972 DESCRIPT 3,4-Dichloro-2-(1,3-dichloropropan-2-yloxy)-2H-furan-5-one inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO01972 GENEFORM Protein DME1125 XEOTICID XEO01972 MOACRIVE Inhibition DME1125 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1125 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02013 XEO_CLAS Peptide DME1125 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02013 GENEFORM Protein DME1125 XEOTICID XEO02013 MOACRIVE Inhibition DME1125 XEOTICID XEO02102 XEO_NAME A. dichotoma defensin DME1125 XEOTICID XEO02102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02102 XEO_CLAS Peptide DME1125 XEOTICID XEO02102 DESCRIPT A. dichotoma defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02102 GENEFORM Protein DME1125 XEOTICID XEO02102 MOACRIVE Inhibition DME1125 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1125 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02115 XEO_CLAS Peptide DME1125 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02115 GENEFORM Protein DME1125 XEOTICID XEO02115 MOACRIVE Inhibition DME1125 XEOTICID XEO02146 XEO_NAME Antimicrobial protein Ah-AMP1 DME1125 XEOTICID XEO02146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02146 XEO_CLAS Peptide DME1125 XEOTICID XEO02146 DESCRIPT Antimicrobial protein Ah-AMP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02146 GENEFORM Protein DME1125 XEOTICID XEO02146 MOACRIVE Inhibition DME1125 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1125 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02147 XEO_CLAS Peptide DME1125 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 237 ug/ml) DME1125 XEOTICID XEO02147 GENEFORM Protein DME1125 XEOTICID XEO02147 MOACRIVE Inhibition DME1125 XEOTICID XEO02151 XEO_NAME AI-hemocidins 4 DME1125 XEOTICID XEO02151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02151 XEO_CLAS Peptide DME1125 XEOTICID XEO02151 DESCRIPT AI-hemocidins 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 69.55 microM) DME1125 XEOTICID XEO02151 GENEFORM Protein DME1125 XEOTICID XEO02151 MOACRIVE Inhibition DME1125 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1125 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02200 XEO_CLAS Peptide DME1125 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 100 ug/ml) DME1125 XEOTICID XEO02200 GENEFORM Protein DME1125 XEOTICID XEO02200 MOACRIVE Inhibition DME1125 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1125 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02201 XEO_CLAS Peptide DME1125 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 25 ug/ml) DME1125 XEOTICID XEO02201 GENEFORM Protein DME1125 XEOTICID XEO02201 MOACRIVE Inhibition DME1125 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1125 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02202 XEO_CLAS Peptide DME1125 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 20 microM) DME1125 XEOTICID XEO02202 GENEFORM Protein DME1125 XEOTICID XEO02202 MOACRIVE Inhibition DME1125 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1125 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02203 XEO_CLAS Peptide DME1125 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 20 microM) DME1125 XEOTICID XEO02203 GENEFORM Protein DME1125 XEOTICID XEO02203 MOACRIVE Inhibition DME1125 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1125 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02207 XEO_CLAS Peptide DME1125 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.56 ug/ml) DME1125 XEOTICID XEO02207 GENEFORM Protein DME1125 XEOTICID XEO02207 MOACRIVE Inhibition DME1125 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1125 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02208 XEO_CLAS Peptide DME1125 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.56 ug/ml) DME1125 XEOTICID XEO02208 GENEFORM Protein DME1125 XEOTICID XEO02208 MOACRIVE Inhibition DME1125 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1125 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02209 XEO_CLAS Peptide DME1125 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.56 ug/ml) DME1125 XEOTICID XEO02209 GENEFORM Protein DME1125 XEOTICID XEO02209 MOACRIVE Inhibition DME1125 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1125 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02210 XEO_CLAS Peptide DME1125 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.25 ug/ml) DME1125 XEOTICID XEO02210 GENEFORM Protein DME1125 XEOTICID XEO02210 MOACRIVE Inhibition DME1125 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1125 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02211 XEO_CLAS Peptide DME1125 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 3.13 ug/ml) DME1125 XEOTICID XEO02211 GENEFORM Protein DME1125 XEOTICID XEO02211 MOACRIVE Inhibition DME1125 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1125 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02212 XEO_CLAS Peptide DME1125 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.56 ug/ml) DME1125 XEOTICID XEO02212 GENEFORM Protein DME1125 XEOTICID XEO02212 MOACRIVE Inhibition DME1125 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1125 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02213 XEO_CLAS Peptide DME1125 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.56 ug/ml) DME1125 XEOTICID XEO02213 GENEFORM Protein DME1125 XEOTICID XEO02213 MOACRIVE Inhibition DME1125 XEOTICID XEO02224 XEO_NAME Androctonin DME1125 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02224 XEO_CLAS Peptide DME1125 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02224 GENEFORM Protein DME1125 XEOTICID XEO02224 MOACRIVE Inhibition DME1125 XEOTICID XEO02226 XEO_NAME Andropin DME1125 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02226 XEO_CLAS Peptide DME1125 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 17 microM) DME1125 XEOTICID XEO02226 GENEFORM Protein DME1125 XEOTICID XEO02226 MOACRIVE Inhibition DME1125 XEOTICID XEO02235 XEO_NAME Anthranilate DME1125 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1125 XEOTICID XEO02235 XEO_CLAS Natural Product DME1125 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02235 GENEFORM Protein DME1125 XEOTICID XEO02235 MOACRIVE Inhibition DME1125 XEOTICID XEO02237 XEO_NAME Antibacterial napin DME1125 XEOTICID XEO02237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02237 XEO_CLAS Peptide DME1125 XEOTICID XEO02237 DESCRIPT Antibacterial napin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 236 microM) DME1125 XEOTICID XEO02237 GENEFORM Protein DME1125 XEOTICID XEO02237 MOACRIVE Inhibition DME1125 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1125 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02241 XEO_CLAS Peptide DME1125 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02241 GENEFORM Protein DME1125 XEOTICID XEO02241 MOACRIVE Inhibition DME1125 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1125 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02248 XEO_CLAS Peptide DME1125 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 15 microM) DME1125 XEOTICID XEO02248 GENEFORM Protein DME1125 XEOTICID XEO02248 MOACRIVE Inhibition DME1125 XEOTICID XEO02249 XEO_NAME Anticancerous peptide Cr-ACP1 DME1125 XEOTICID XEO02249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02249 XEO_CLAS Peptide DME1125 XEOTICID XEO02249 DESCRIPT Anticancerous peptide Cr-ACP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 30 microM) DME1125 XEOTICID XEO02249 GENEFORM Protein DME1125 XEOTICID XEO02249 MOACRIVE Inhibition DME1125 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1125 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02261 XEO_CLAS Peptide DME1125 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 76 ug/ml) DME1125 XEOTICID XEO02261 GENEFORM Protein DME1125 XEOTICID XEO02261 MOACRIVE Inhibition DME1125 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1125 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02268 XEO_CLAS Peptide DME1125 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 150 ug/ml) DME1125 XEOTICID XEO02268 GENEFORM Protein DME1125 XEOTICID XEO02268 MOACRIVE Inhibition DME1125 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1125 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02271 XEO_CLAS Peptide DME1125 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 257 ug/ml) DME1125 XEOTICID XEO02271 GENEFORM Protein DME1125 XEOTICID XEO02271 MOACRIVE Inhibition DME1125 XEOTICID XEO02278 XEO_NAME Antimicrobial peptide Ar-AMP DME1125 XEOTICID XEO02278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02278 XEO_CLAS Peptide DME1125 XEOTICID XEO02278 DESCRIPT Antimicrobial peptide Ar-AMP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02278 GENEFORM Protein DME1125 XEOTICID XEO02278 MOACRIVE Inhibition DME1125 XEOTICID XEO02282 XEO_NAME Antimicrobial peptide GP-19 DME1125 XEOTICID XEO02282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02282 XEO_CLAS Peptide DME1125 XEOTICID XEO02282 DESCRIPT Antimicrobial peptide GP-19 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02282 GENEFORM Protein DME1125 XEOTICID XEO02282 MOACRIVE Inhibition DME1125 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1125 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02283 XEO_CLAS Peptide DME1125 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 3.13 ug/ml) DME1125 XEOTICID XEO02283 GENEFORM Protein DME1125 XEOTICID XEO02283 MOACRIVE Inhibition DME1125 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1125 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02288 XEO_CLAS Peptide DME1125 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12.3 ug/ml) DME1125 XEOTICID XEO02288 GENEFORM Protein DME1125 XEOTICID XEO02288 MOACRIVE Inhibition DME1125 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1125 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02289 XEO_CLAS Peptide DME1125 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12 ug/ml) DME1125 XEOTICID XEO02289 GENEFORM Protein DME1125 XEOTICID XEO02289 MOACRIVE Inhibition DME1125 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1125 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02298 XEO_CLAS Peptide DME1125 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 32 ug/ml) DME1125 XEOTICID XEO02298 GENEFORM Protein DME1125 XEOTICID XEO02298 MOACRIVE Inhibition DME1125 XEOTICID XEO02300 XEO_NAME Antimicrobial protein BL-A60 DME1125 XEOTICID XEO02300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02300 XEO_CLAS Peptide DME1125 XEOTICID XEO02300 DESCRIPT Antimicrobial protein BL-A60 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 5 microM) DME1125 XEOTICID XEO02300 GENEFORM Protein DME1125 XEOTICID XEO02300 MOACRIVE Inhibition DME1125 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1125 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02316 XEO_CLAS Peptide DME1125 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.25-12.5 microM) DME1125 XEOTICID XEO02316 GENEFORM Protein DME1125 XEOTICID XEO02316 MOACRIVE Inhibition DME1125 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1125 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02320 XEO_CLAS Peptide DME1125 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02320 GENEFORM Protein DME1125 XEOTICID XEO02320 MOACRIVE Inhibition DME1125 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1125 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02332 XEO_CLAS Peptide DME1125 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.95 ug/ml) DME1125 XEOTICID XEO02332 GENEFORM Protein DME1125 XEOTICID XEO02332 MOACRIVE Inhibition DME1125 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1125 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02452 XEO_CLAS Peptide DME1125 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 76800 ug/ml) DME1125 XEOTICID XEO02452 GENEFORM Protein DME1125 XEOTICID XEO02452 MOACRIVE Inhibition DME1125 XEOTICID XEO02476 XEO_NAME Bacteriocin HJ50 DME1125 XEOTICID XEO02476 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02476 XEO_CLAS Peptide DME1125 XEOTICID XEO02476 DESCRIPT Bacteriocin HJ50 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02476 GENEFORM Protein DME1125 XEOTICID XEO02476 MOACRIVE Inhibition DME1125 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1125 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02491 XEO_CLAS Peptide DME1125 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 24.4 microM) DME1125 XEOTICID XEO02491 GENEFORM Protein DME1125 XEOTICID XEO02491 MOACRIVE Inhibition DME1125 XEOTICID XEO02532 XEO_NAME Brevinin-1LT1 DME1125 XEOTICID XEO02532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02532 XEO_CLAS Peptide DME1125 XEOTICID XEO02532 DESCRIPT Brevinin-1LT1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.25 microM) DME1125 XEOTICID XEO02532 GENEFORM Protein DME1125 XEOTICID XEO02532 MOACRIVE Inhibition DME1125 XEOTICID XEO02588 XEO_NAME Brevinin-2GHa DME1125 XEOTICID XEO02588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02588 XEO_CLAS Peptide DME1125 XEOTICID XEO02588 DESCRIPT Brevinin-2GHa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 64 ug/ml) DME1125 XEOTICID XEO02588 GENEFORM Protein DME1125 XEOTICID XEO02588 MOACRIVE Inhibition DME1125 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1125 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02589 XEO_CLAS Peptide DME1125 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 64 ug/ml) DME1125 XEOTICID XEO02589 GENEFORM Protein DME1125 XEOTICID XEO02589 MOACRIVE Inhibition DME1125 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1125 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02590 XEO_CLAS Peptide DME1125 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 64 ug/ml) DME1125 XEOTICID XEO02590 GENEFORM Protein DME1125 XEOTICID XEO02590 MOACRIVE Inhibition DME1125 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1125 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02595 XEO_CLAS Peptide DME1125 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12.5 microM) DME1125 XEOTICID XEO02595 GENEFORM Protein DME1125 XEOTICID XEO02595 MOACRIVE Inhibition DME1125 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1125 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02596 XEO_CLAS Peptide DME1125 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 25 microM) DME1125 XEOTICID XEO02596 GENEFORM Protein DME1125 XEOTICID XEO02596 MOACRIVE Inhibition DME1125 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1125 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02630 XEO_CLAS Peptide DME1125 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12.5 ug/ml) DME1125 XEOTICID XEO02630 GENEFORM Protein DME1125 XEOTICID XEO02630 MOACRIVE Inhibition DME1125 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1125 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02631 XEO_CLAS Peptide DME1125 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12.5 ug/ml) DME1125 XEOTICID XEO02631 GENEFORM Protein DME1125 XEOTICID XEO02631 MOACRIVE Inhibition DME1125 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1125 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02649 XEO_CLAS Peptide DME1125 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 4 ug/ml) DME1125 XEOTICID XEO02649 GENEFORM Protein DME1125 XEOTICID XEO02649 MOACRIVE Inhibition DME1125 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1125 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02650 XEO_CLAS Peptide DME1125 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2 ug/ml) DME1125 XEOTICID XEO02650 GENEFORM Protein DME1125 XEOTICID XEO02650 MOACRIVE Inhibition DME1125 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1125 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02663 XEO_CLAS Peptide DME1125 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.78 microM) DME1125 XEOTICID XEO02663 GENEFORM Protein DME1125 XEOTICID XEO02663 MOACRIVE Inhibition DME1125 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1125 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02664 XEO_CLAS Peptide DME1125 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.56 microM) DME1125 XEOTICID XEO02664 GENEFORM Protein DME1125 XEOTICID XEO02664 MOACRIVE Inhibition DME1125 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1125 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02672 XEO_CLAS Peptide DME1125 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.56 microM) DME1125 XEOTICID XEO02672 GENEFORM Protein DME1125 XEOTICID XEO02672 MOACRIVE Inhibition DME1125 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1125 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02673 XEO_CLAS Peptide DME1125 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.78-1.56 microM) DME1125 XEOTICID XEO02673 GENEFORM Protein DME1125 XEOTICID XEO02673 MOACRIVE Inhibition DME1125 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1125 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02674 XEO_CLAS Peptide DME1125 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.56 microM) DME1125 XEOTICID XEO02674 GENEFORM Protein DME1125 XEOTICID XEO02674 MOACRIVE Inhibition DME1125 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1125 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02676 XEO_CLAS Peptide DME1125 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.78 microM) DME1125 XEOTICID XEO02676 GENEFORM Protein DME1125 XEOTICID XEO02676 MOACRIVE Inhibition DME1125 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1125 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02677 XEO_CLAS Peptide DME1125 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.78 microM) DME1125 XEOTICID XEO02677 GENEFORM Protein DME1125 XEOTICID XEO02677 MOACRIVE Inhibition DME1125 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1125 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02679 XEO_CLAS Peptide DME1125 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.56 microM) DME1125 XEOTICID XEO02679 GENEFORM Protein DME1125 XEOTICID XEO02679 MOACRIVE Inhibition DME1125 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1125 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02680 XEO_CLAS Peptide DME1125 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.56 microM) DME1125 XEOTICID XEO02680 GENEFORM Protein DME1125 XEOTICID XEO02680 MOACRIVE Inhibition DME1125 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1125 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02683 XEO_CLAS Peptide DME1125 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.56 microM) DME1125 XEOTICID XEO02683 GENEFORM Protein DME1125 XEOTICID XEO02683 MOACRIVE Inhibition DME1125 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1125 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02735 XEO_CLAS Peptide DME1125 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC < 2 ug/ml) DME1125 XEOTICID XEO02735 GENEFORM Protein DME1125 XEOTICID XEO02735 MOACRIVE Inhibition DME1125 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1125 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02741 XEO_CLAS Peptide DME1125 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 100 ug/ml) DME1125 XEOTICID XEO02741 GENEFORM Protein DME1125 XEOTICID XEO02741 MOACRIVE Inhibition DME1125 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1125 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02743 XEO_CLAS Peptide DME1125 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 9.4 ug/ml) DME1125 XEOTICID XEO02743 GENEFORM Protein DME1125 XEOTICID XEO02743 MOACRIVE Inhibition DME1125 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1125 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02744 XEO_CLAS Peptide DME1125 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 75 ug/ml) DME1125 XEOTICID XEO02744 GENEFORM Protein DME1125 XEOTICID XEO02744 MOACRIVE Inhibition DME1125 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1125 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02756 XEO_CLAS Peptide DME1125 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.4 microM) DME1125 XEOTICID XEO02756 GENEFORM Protein DME1125 XEOTICID XEO02756 MOACRIVE Inhibition DME1125 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1125 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02757 XEO_CLAS Peptide DME1125 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.5 microM) DME1125 XEOTICID XEO02757 GENEFORM Protein DME1125 XEOTICID XEO02757 MOACRIVE Inhibition DME1125 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1125 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02758 XEO_CLAS Peptide DME1125 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 3 microM) DME1125 XEOTICID XEO02758 GENEFORM Protein DME1125 XEOTICID XEO02758 MOACRIVE Inhibition DME1125 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1125 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02759 XEO_CLAS Peptide DME1125 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.6 microM) DME1125 XEOTICID XEO02759 GENEFORM Protein DME1125 XEOTICID XEO02759 MOACRIVE Inhibition DME1125 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1125 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02760 XEO_CLAS Peptide DME1125 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.3 microM) DME1125 XEOTICID XEO02760 GENEFORM Protein DME1125 XEOTICID XEO02760 MOACRIVE Inhibition DME1125 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1125 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02761 XEO_CLAS Peptide DME1125 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1 microM) DME1125 XEOTICID XEO02761 GENEFORM Protein DME1125 XEOTICID XEO02761 MOACRIVE Inhibition DME1125 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1125 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02762 XEO_CLAS Peptide DME1125 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.3 microM) DME1125 XEOTICID XEO02762 GENEFORM Protein DME1125 XEOTICID XEO02762 MOACRIVE Inhibition DME1125 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1125 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02763 XEO_CLAS Peptide DME1125 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.3 microM) DME1125 XEOTICID XEO02763 GENEFORM Protein DME1125 XEOTICID XEO02763 MOACRIVE Inhibition DME1125 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1125 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02764 XEO_CLAS Peptide DME1125 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.7 microM) DME1125 XEOTICID XEO02764 GENEFORM Protein DME1125 XEOTICID XEO02764 MOACRIVE Inhibition DME1125 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1125 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02765 XEO_CLAS Peptide DME1125 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.4 microM) DME1125 XEOTICID XEO02765 GENEFORM Protein DME1125 XEOTICID XEO02765 MOACRIVE Inhibition DME1125 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1125 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02767 XEO_CLAS Peptide DME1125 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02767 GENEFORM Protein DME1125 XEOTICID XEO02767 MOACRIVE Inhibition DME1125 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1125 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02768 XEO_CLAS Peptide DME1125 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02768 GENEFORM Protein DME1125 XEOTICID XEO02768 MOACRIVE Inhibition DME1125 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1125 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02769 XEO_CLAS Peptide DME1125 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 18 microM) DME1125 XEOTICID XEO02769 GENEFORM Protein DME1125 XEOTICID XEO02769 MOACRIVE Inhibition DME1125 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1125 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02770 XEO_CLAS Peptide DME1125 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 17 microM) DME1125 XEOTICID XEO02770 GENEFORM Protein DME1125 XEOTICID XEO02770 MOACRIVE Inhibition DME1125 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1125 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02771 XEO_CLAS Peptide DME1125 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 81 microM) DME1125 XEOTICID XEO02771 GENEFORM Protein DME1125 XEOTICID XEO02771 MOACRIVE Inhibition DME1125 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1125 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02772 XEO_CLAS Peptide DME1125 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02772 GENEFORM Protein DME1125 XEOTICID XEO02772 MOACRIVE Inhibition DME1125 XEOTICID XEO02780 XEO_NAME Cefixime DME1125 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1125 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1125 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02780 GENEFORM Protein DME1125 XEOTICID XEO02780 MOACRIVE Inhibition DME1125 XEOTICID XEO02801 XEO_NAME Cephalexin DME1125 XEOTICID XEO02801 XEO_TYPE Pharmaceutical Agent(s) DME1125 XEOTICID XEO02801 XEO_CLAS Approved/Marketed Drug DME1125 XEOTICID XEO02801 DESCRIPT Cephalexin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02801 GENEFORM Protein DME1125 XEOTICID XEO02801 MOACRIVE Inhibition DME1125 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1125 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02802 XEO_CLAS Peptide DME1125 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 5.9 microM) DME1125 XEOTICID XEO02802 GENEFORM Protein DME1125 XEOTICID XEO02802 MOACRIVE Inhibition DME1125 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1125 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02807 XEO_CLAS Peptide DME1125 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.4 ug/mL) DME1125 XEOTICID XEO02807 GENEFORM Protein DME1125 XEOTICID XEO02807 MOACRIVE Inhibition DME1125 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1125 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02821 XEO_CLAS Peptide DME1125 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02821 GENEFORM Protein DME1125 XEOTICID XEO02821 MOACRIVE Inhibition DME1125 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1125 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02839 XEO_CLAS Peptide DME1125 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.25 microM) DME1125 XEOTICID XEO02839 GENEFORM Protein DME1125 XEOTICID XEO02839 MOACRIVE Inhibition DME1125 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1125 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02841 XEO_CLAS Peptide DME1125 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.25 microM) DME1125 XEOTICID XEO02841 GENEFORM Protein DME1125 XEOTICID XEO02841 MOACRIVE Inhibition DME1125 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1125 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02842 XEO_CLAS Peptide DME1125 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.25 microM) DME1125 XEOTICID XEO02842 GENEFORM Protein DME1125 XEOTICID XEO02842 MOACRIVE Inhibition DME1125 XEOTICID XEO02962 XEO_NAME Cryptonin DME1125 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02962 XEO_CLAS Peptide DME1125 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 3.12 ug/ml) DME1125 XEOTICID XEO02962 GENEFORM Protein DME1125 XEOTICID XEO02962 MOACRIVE Inhibition DME1125 XEOTICID XEO02966 XEO_NAME C. ternatea-antimicrobial peptide Ct-AMP1 DME1125 XEOTICID XEO02966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO02966 XEO_CLAS Peptide DME1125 XEOTICID XEO02966 DESCRIPT C. ternatea-antimicrobial peptide Ct-AMP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02966 GENEFORM Protein DME1125 XEOTICID XEO02966 MOACRIVE Inhibition DME1125 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1125 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1125 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1125 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO02990 GENEFORM Protein DME1125 XEOTICID XEO02990 MOACRIVE Inhibition DME1125 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1125 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03051 XEO_CLAS Peptide DME1125 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 25 ug/ml) DME1125 XEOTICID XEO03051 GENEFORM Protein DME1125 XEOTICID XEO03051 MOACRIVE Inhibition DME1125 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1125 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03052 XEO_CLAS Peptide DME1125 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2.5 ug/ml) DME1125 XEOTICID XEO03052 GENEFORM Protein DME1125 XEOTICID XEO03052 MOACRIVE Inhibition DME1125 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1125 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03053 XEO_CLAS Peptide DME1125 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 25 ug/ml) DME1125 XEOTICID XEO03053 GENEFORM Protein DME1125 XEOTICID XEO03053 MOACRIVE Inhibition DME1125 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1125 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03060 XEO_CLAS Peptide DME1125 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1 microM) DME1125 XEOTICID XEO03060 GENEFORM Protein DME1125 XEOTICID XEO03060 MOACRIVE Inhibition DME1125 XEOTICID XEO03089 XEO_NAME Decoralin DME1125 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03089 XEO_CLAS Peptide DME1125 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 40 microM) DME1125 XEOTICID XEO03089 GENEFORM Protein DME1125 XEOTICID XEO03089 MOACRIVE Inhibition DME1125 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1125 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03100 XEO_CLAS Peptide DME1125 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03100 GENEFORM Protein DME1125 XEOTICID XEO03100 MOACRIVE Inhibition DME1125 XEOTICID XEO03101 XEO_NAME Defensin varisin A1 DME1125 XEOTICID XEO03101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03101 XEO_CLAS Peptide DME1125 XEOTICID XEO03101 DESCRIPT Defensin varisin A1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03101 GENEFORM Protein DME1125 XEOTICID XEO03101 MOACRIVE Inhibition DME1125 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1125 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03103 XEO_CLAS Peptide DME1125 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03103 GENEFORM Protein DME1125 XEOTICID XEO03103 MOACRIVE Inhibition DME1125 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1125 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03105 XEO_CLAS Peptide DME1125 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03105 GENEFORM Protein DME1125 XEOTICID XEO03105 MOACRIVE Inhibition DME1125 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1125 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03112 XEO_CLAS Peptide DME1125 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 50 ug/ml) DME1125 XEOTICID XEO03112 GENEFORM Protein DME1125 XEOTICID XEO03112 MOACRIVE Inhibition DME1125 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1125 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03116 XEO_CLAS Peptide DME1125 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 40 microM) DME1125 XEOTICID XEO03116 GENEFORM Protein DME1125 XEOTICID XEO03116 MOACRIVE Inhibition DME1125 XEOTICID XEO03117 XEO_NAME Insect defensin B DME1125 XEOTICID XEO03117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03117 XEO_CLAS Peptide DME1125 XEOTICID XEO03117 DESCRIPT Insect defensin B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 20-40 microM) DME1125 XEOTICID XEO03117 GENEFORM Protein DME1125 XEOTICID XEO03117 MOACRIVE Inhibition DME1125 XEOTICID XEO03120 XEO_NAME Defensin-like protein Dm-AMP1 DME1125 XEOTICID XEO03120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03120 XEO_CLAS Peptide DME1125 XEOTICID XEO03120 DESCRIPT Defensin-like protein Dm-AMP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03120 GENEFORM Protein DME1125 XEOTICID XEO03120 MOACRIVE Inhibition DME1125 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1125 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03121 XEO_CLAS Peptide DME1125 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03121 GENEFORM Protein DME1125 XEOTICID XEO03121 MOACRIVE Inhibition DME1125 XEOTICID XEO03123 XEO_NAME Defensin-like protein fabatin-2 DME1125 XEOTICID XEO03123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03123 XEO_CLAS Peptide DME1125 XEOTICID XEO03123 DESCRIPT Defensin-like protein fabatin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03123 GENEFORM Protein DME1125 XEOTICID XEO03123 MOACRIVE Inhibition DME1125 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1125 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03124 XEO_CLAS Peptide DME1125 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03124 GENEFORM Protein DME1125 XEOTICID XEO03124 MOACRIVE Inhibition DME1125 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1125 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03215 XEO_CLAS Peptide DME1125 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2.5 ug/ml) DME1125 XEOTICID XEO03215 GENEFORM Protein DME1125 XEOTICID XEO03215 MOACRIVE Inhibition DME1125 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1125 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03216 XEO_CLAS Peptide DME1125 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2 ug/ml) DME1125 XEOTICID XEO03216 GENEFORM Protein DME1125 XEOTICID XEO03216 MOACRIVE Inhibition DME1125 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1125 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03217 XEO_CLAS Peptide DME1125 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2 ug/ml) DME1125 XEOTICID XEO03217 GENEFORM Protein DME1125 XEOTICID XEO03217 MOACRIVE Inhibition DME1125 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1125 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03223 XEO_CLAS Peptide DME1125 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 3.2 microM) DME1125 XEOTICID XEO03223 GENEFORM Protein DME1125 XEOTICID XEO03223 MOACRIVE Inhibition DME1125 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1125 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03225 XEO_CLAS Peptide DME1125 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 16 microM) DME1125 XEOTICID XEO03225 GENEFORM Protein DME1125 XEOTICID XEO03225 MOACRIVE Inhibition DME1125 XEOTICID XEO03233 XEO_NAME Dybowskin-1 DME1125 XEOTICID XEO03233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03233 XEO_CLAS Peptide DME1125 XEOTICID XEO03233 DESCRIPT Dybowskin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 50 ug/ml) DME1125 XEOTICID XEO03233 GENEFORM Protein DME1125 XEOTICID XEO03233 MOACRIVE Inhibition DME1125 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1125 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03235 XEO_CLAS Peptide DME1125 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 25 ug/ml) DME1125 XEOTICID XEO03235 GENEFORM Protein DME1125 XEOTICID XEO03235 MOACRIVE Inhibition DME1125 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1125 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03237 XEO_CLAS Peptide DME1125 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 60 ug/ml) DME1125 XEOTICID XEO03237 GENEFORM Protein DME1125 XEOTICID XEO03237 MOACRIVE Inhibition DME1125 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1125 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03238 XEO_CLAS Peptide DME1125 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.25 ug/ml) DME1125 XEOTICID XEO03238 GENEFORM Protein DME1125 XEOTICID XEO03238 MOACRIVE Inhibition DME1125 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1125 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03239 XEO_CLAS Peptide DME1125 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 50 ug/ml) DME1125 XEOTICID XEO03239 GENEFORM Protein DME1125 XEOTICID XEO03239 MOACRIVE Inhibition DME1125 XEOTICID XEO03240 XEO_NAME Dybowskin-6 DME1125 XEOTICID XEO03240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03240 XEO_CLAS Peptide DME1125 XEOTICID XEO03240 DESCRIPT Dybowskin-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 50 ug/ml) DME1125 XEOTICID XEO03240 GENEFORM Protein DME1125 XEOTICID XEO03240 MOACRIVE Inhibition DME1125 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1125 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03250 XEO_CLAS Peptide DME1125 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03250 GENEFORM Protein DME1125 XEOTICID XEO03250 MOACRIVE Inhibition DME1125 XEOTICID XEO03252 XEO_NAME Enterocin B DME1125 XEOTICID XEO03252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03252 XEO_CLAS Peptide DME1125 XEOTICID XEO03252 DESCRIPT Enterocin B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 44.5 microM) DME1125 XEOTICID XEO03252 GENEFORM Protein DME1125 XEOTICID XEO03252 MOACRIVE Inhibition DME1125 XEOTICID XEO03254 XEO_NAME Enterocin EJ97 DME1125 XEOTICID XEO03254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03254 XEO_CLAS Peptide DME1125 XEOTICID XEO03254 DESCRIPT Enterocin EJ97 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12 ug/ml) DME1125 XEOTICID XEO03254 GENEFORM Protein DME1125 XEOTICID XEO03254 MOACRIVE Inhibition DME1125 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1125 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03258 XEO_CLAS Peptide DME1125 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03258 GENEFORM Protein DME1125 XEOTICID XEO03258 MOACRIVE Inhibition DME1125 XEOTICID XEO03260 XEO_NAME Enterocin X beta DME1125 XEOTICID XEO03260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03260 XEO_CLAS Peptide DME1125 XEOTICID XEO03260 DESCRIPT Enterocin X beta inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 3.25 microM) DME1125 XEOTICID XEO03260 GENEFORM Protein DME1125 XEOTICID XEO03260 MOACRIVE Inhibition DME1125 XEOTICID XEO03270 XEO_NAME Ericin S DME1125 XEOTICID XEO03270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03270 XEO_CLAS Peptide DME1125 XEOTICID XEO03270 DESCRIPT Ericin S inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03270 GENEFORM Protein DME1125 XEOTICID XEO03270 MOACRIVE Inhibition DME1125 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1125 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03281 XEO_CLAS Peptide DME1125 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 25 microM) DME1125 XEOTICID XEO03281 GENEFORM Protein DME1125 XEOTICID XEO03281 MOACRIVE Inhibition DME1125 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1125 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03282 XEO_CLAS Peptide DME1125 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12.5 microM) DME1125 XEOTICID XEO03282 GENEFORM Protein DME1125 XEOTICID XEO03282 MOACRIVE Inhibition DME1125 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1125 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03306 XEO_CLAS Peptide DME1125 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.3 microM) DME1125 XEOTICID XEO03306 GENEFORM Protein DME1125 XEOTICID XEO03306 MOACRIVE Inhibition DME1125 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1125 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03362 XEO_CLAS Peptide DME1125 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 40 ug/ml) DME1125 XEOTICID XEO03362 GENEFORM Protein DME1125 XEOTICID XEO03362 MOACRIVE Inhibition DME1125 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1125 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03363 XEO_CLAS Peptide DME1125 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 30 microM) DME1125 XEOTICID XEO03363 GENEFORM Protein DME1125 XEOTICID XEO03363 MOACRIVE Inhibition DME1125 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1125 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03364 XEO_CLAS Peptide DME1125 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 30 microM) DME1125 XEOTICID XEO03364 GENEFORM Protein DME1125 XEOTICID XEO03364 MOACRIVE Inhibition DME1125 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1125 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03366 XEO_CLAS Peptide DME1125 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 60 microM) DME1125 XEOTICID XEO03366 GENEFORM Protein DME1125 XEOTICID XEO03366 MOACRIVE Inhibition DME1125 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1125 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03367 XEO_CLAS Peptide DME1125 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 30 microM) DME1125 XEOTICID XEO03367 GENEFORM Protein DME1125 XEOTICID XEO03367 MOACRIVE Inhibition DME1125 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1125 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03368 XEO_CLAS Peptide DME1125 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 7.5 microM) DME1125 XEOTICID XEO03368 GENEFORM Protein DME1125 XEOTICID XEO03368 MOACRIVE Inhibition DME1125 XEOTICID XEO03431 XEO_NAME Thanatin truncated isoform G18C(1-18) DME1125 XEOTICID XEO03431 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03431 XEO_CLAS Peptide DME1125 XEOTICID XEO03431 DESCRIPT Thanatin truncated isoform G18C(1-18) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 5-10 microM) DME1125 XEOTICID XEO03431 GENEFORM Protein DME1125 XEOTICID XEO03431 MOACRIVE Inhibition DME1125 XEOTICID XEO03435 XEO_NAME Thanatin truncated isoform G20R(1-20) DME1125 XEOTICID XEO03435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03435 XEO_CLAS Peptide DME1125 XEOTICID XEO03435 DESCRIPT Thanatin truncated isoform G20R(1-20) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 20-40 microM) DME1125 XEOTICID XEO03435 GENEFORM Protein DME1125 XEOTICID XEO03435 MOACRIVE Inhibition DME1125 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1125 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03436 XEO_CLAS Peptide DME1125 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 50 ug/ml) DME1125 XEOTICID XEO03436 GENEFORM Protein DME1125 XEOTICID XEO03436 MOACRIVE Inhibition DME1125 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1125 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03437 XEO_CLAS Peptide DME1125 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 10 ug/ml) DME1125 XEOTICID XEO03437 GENEFORM Protein DME1125 XEOTICID XEO03437 MOACRIVE Inhibition DME1125 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1125 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03438 XEO_CLAS Peptide DME1125 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 10 ug/ml) DME1125 XEOTICID XEO03438 GENEFORM Protein DME1125 XEOTICID XEO03438 MOACRIVE Inhibition DME1125 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1125 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03439 XEO_CLAS Peptide DME1125 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 10 ug/ml) DME1125 XEOTICID XEO03439 GENEFORM Protein DME1125 XEOTICID XEO03439 MOACRIVE Inhibition DME1125 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1125 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03440 XEO_CLAS Peptide DME1125 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 10 ug/ml) DME1125 XEOTICID XEO03440 GENEFORM Protein DME1125 XEOTICID XEO03440 MOACRIVE Inhibition DME1125 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1125 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03441 XEO_CLAS Peptide DME1125 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 10 ug/ml) DME1125 XEOTICID XEO03441 GENEFORM Protein DME1125 XEOTICID XEO03441 MOACRIVE Inhibition DME1125 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1125 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03442 XEO_CLAS Peptide DME1125 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 4.69 ug/ml) DME1125 XEOTICID XEO03442 GENEFORM Protein DME1125 XEOTICID XEO03442 MOACRIVE Inhibition DME1125 XEOTICID XEO03443 XEO_NAME Gaegurin-RN4 DME1125 XEOTICID XEO03443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03443 XEO_CLAS Peptide DME1125 XEOTICID XEO03443 DESCRIPT Gaegurin-RN4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2.34 ug/ml) DME1125 XEOTICID XEO03443 GENEFORM Protein DME1125 XEOTICID XEO03443 MOACRIVE Inhibition DME1125 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1125 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03444 XEO_CLAS Peptide DME1125 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 4.69 ug/ml) DME1125 XEOTICID XEO03444 GENEFORM Protein DME1125 XEOTICID XEO03444 MOACRIVE Inhibition DME1125 XEOTICID XEO03478 XEO_NAME Geobacillin I DME1125 XEOTICID XEO03478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03478 XEO_CLAS Peptide DME1125 XEOTICID XEO03478 DESCRIPT Geobacillin I inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03478 GENEFORM Protein DME1125 XEOTICID XEO03478 MOACRIVE Inhibition DME1125 XEOTICID XEO03479 XEO_NAME Geobacillin II DME1125 XEOTICID XEO03479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03479 XEO_CLAS Peptide DME1125 XEOTICID XEO03479 DESCRIPT Geobacillin II inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03479 GENEFORM Protein DME1125 XEOTICID XEO03479 MOACRIVE Inhibition DME1125 XEOTICID XEO03501 XEO_NAME Gramicidin [Scr2]-GS analogue DME1125 XEOTICID XEO03501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03501 XEO_CLAS Peptide DME1125 XEOTICID XEO03501 DESCRIPT Gramicidin [Scr2]-GS analogue inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.3 ug/ml) DME1125 XEOTICID XEO03501 GENEFORM Protein DME1125 XEOTICID XEO03501 MOACRIVE Inhibition DME1125 XEOTICID XEO03503 XEO_NAME Gramicidin S DME1125 XEOTICID XEO03503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03503 XEO_CLAS Peptide DME1125 XEOTICID XEO03503 DESCRIPT Gramicidin S inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.6 ug/ml) DME1125 XEOTICID XEO03503 GENEFORM Protein DME1125 XEOTICID XEO03503 MOACRIVE Inhibition DME1125 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1125 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03504 XEO_CLAS Peptide DME1125 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 25 ug/ml) DME1125 XEOTICID XEO03504 GENEFORM Protein DME1125 XEOTICID XEO03504 MOACRIVE Inhibition DME1125 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1125 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03505 XEO_CLAS Peptide DME1125 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.25 ug/ml) DME1125 XEOTICID XEO03505 GENEFORM Protein DME1125 XEOTICID XEO03505 MOACRIVE Inhibition DME1125 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1125 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03506 XEO_CLAS Peptide DME1125 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.25 ug/ml) DME1125 XEOTICID XEO03506 GENEFORM Protein DME1125 XEOTICID XEO03506 MOACRIVE Inhibition DME1125 XEOTICID XEO03510 XEO_NAME Crab GRPSp peptide DME1125 XEOTICID XEO03510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03510 XEO_CLAS Peptide DME1125 XEOTICID XEO03510 DESCRIPT Crab GRPSp peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 50 microM) DME1125 XEOTICID XEO03510 GENEFORM Protein DME1125 XEOTICID XEO03510 MOACRIVE Inhibition DME1125 XEOTICID XEO03512 XEO_NAME Guentherin AMP-3 DME1125 XEOTICID XEO03512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03512 XEO_CLAS Peptide DME1125 XEOTICID XEO03512 DESCRIPT Guentherin AMP-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 64 ug/ml) DME1125 XEOTICID XEO03512 GENEFORM Protein DME1125 XEOTICID XEO03512 MOACRIVE Inhibition DME1125 XEOTICID XEO03542 XEO_NAME Hepcidin DME1125 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03542 XEO_CLAS Peptide DME1125 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6 microM) DME1125 XEOTICID XEO03542 GENEFORM Protein DME1125 XEOTICID XEO03542 MOACRIVE Inhibition DME1125 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1125 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03544 XEO_CLAS Peptide DME1125 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03544 GENEFORM Protein DME1125 XEOTICID XEO03544 MOACRIVE Inhibition DME1125 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1125 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03549 XEO_CLAS Peptide DME1125 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03549 GENEFORM Protein DME1125 XEOTICID XEO03549 MOACRIVE Inhibition DME1125 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1125 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03561 XEO_CLAS Peptide DME1125 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03561 GENEFORM Protein DME1125 XEOTICID XEO03561 MOACRIVE Inhibition DME1125 XEOTICID XEO03566 XEO_NAME Histone H2A DME1125 XEOTICID XEO03566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03566 XEO_CLAS Peptide DME1125 XEOTICID XEO03566 DESCRIPT Histone H2A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.6-1.2 microM) DME1125 XEOTICID XEO03566 GENEFORM Protein DME1125 XEOTICID XEO03566 MOACRIVE Inhibition DME1125 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1125 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03606 XEO_CLAS Peptide DME1125 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03606 GENEFORM Protein DME1125 XEOTICID XEO03606 MOACRIVE Inhibition DME1125 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1125 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03607 XEO_CLAS Peptide DME1125 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03607 GENEFORM Protein DME1125 XEOTICID XEO03607 MOACRIVE Inhibition DME1125 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1125 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03616 XEO_CLAS Peptide DME1125 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 8 microM) DME1125 XEOTICID XEO03616 GENEFORM Protein DME1125 XEOTICID XEO03616 MOACRIVE Inhibition DME1125 XEOTICID XEO03623 XEO_NAME Basic peptide AMP1 IB-AMP1 DME1125 XEOTICID XEO03623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03623 XEO_CLAS Peptide DME1125 XEOTICID XEO03623 DESCRIPT Basic peptide AMP1 IB-AMP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03623 GENEFORM Protein DME1125 XEOTICID XEO03623 MOACRIVE Inhibition DME1125 XEOTICID XEO03624 XEO_NAME Basic peptide AMP4 IB-AMP4 DME1125 XEOTICID XEO03624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03624 XEO_CLAS Peptide DME1125 XEOTICID XEO03624 DESCRIPT Basic peptide AMP4 IB-AMP4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03624 GENEFORM Protein DME1125 XEOTICID XEO03624 MOACRIVE Inhibition DME1125 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1125 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03627 XEO_CLAS Peptide DME1125 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.8-1.6 microM) DME1125 XEOTICID XEO03627 GENEFORM Protein DME1125 XEOTICID XEO03627 MOACRIVE Inhibition DME1125 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1125 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03630 XEO_CLAS Peptide DME1125 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03630 GENEFORM Protein DME1125 XEOTICID XEO03630 MOACRIVE Inhibition DME1125 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1125 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03631 XEO_CLAS Peptide DME1125 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03631 GENEFORM Protein DME1125 XEOTICID XEO03631 MOACRIVE Inhibition DME1125 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1125 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03632 XEO_CLAS Peptide DME1125 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03632 GENEFORM Protein DME1125 XEOTICID XEO03632 MOACRIVE Inhibition DME1125 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1125 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03633 XEO_CLAS Peptide DME1125 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03633 GENEFORM Protein DME1125 XEOTICID XEO03633 MOACRIVE Inhibition DME1125 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1125 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03634 XEO_CLAS Peptide DME1125 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03634 GENEFORM Protein DME1125 XEOTICID XEO03634 MOACRIVE Inhibition DME1125 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1125 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03635 XEO_CLAS Peptide DME1125 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03635 GENEFORM Protein DME1125 XEOTICID XEO03635 MOACRIVE Inhibition DME1125 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1125 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03636 XEO_CLAS Peptide DME1125 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03636 GENEFORM Protein DME1125 XEOTICID XEO03636 MOACRIVE Inhibition DME1125 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1125 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03637 XEO_CLAS Peptide DME1125 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03637 GENEFORM Protein DME1125 XEOTICID XEO03637 MOACRIVE Inhibition DME1125 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1125 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03638 XEO_CLAS Peptide DME1125 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03638 GENEFORM Protein DME1125 XEOTICID XEO03638 MOACRIVE Inhibition DME1125 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1125 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03639 XEO_CLAS Peptide DME1125 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03639 GENEFORM Protein DME1125 XEOTICID XEO03639 MOACRIVE Inhibition DME1125 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1125 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03640 XEO_CLAS Peptide DME1125 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03640 GENEFORM Protein DME1125 XEOTICID XEO03640 MOACRIVE Inhibition DME1125 XEOTICID XEO03664 XEO_NAME Ixodes ricinus defensin def1 DME1125 XEOTICID XEO03664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03664 XEO_CLAS Peptide DME1125 XEOTICID XEO03664 DESCRIPT Ixodes ricinus defensin def1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.5 microM) DME1125 XEOTICID XEO03664 GENEFORM Protein DME1125 XEOTICID XEO03664 MOACRIVE Inhibition DME1125 XEOTICID XEO03665 XEO_NAME Ixodes ricinus defensin def2 DME1125 XEOTICID XEO03665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03665 XEO_CLAS Peptide DME1125 XEOTICID XEO03665 DESCRIPT Ixodes ricinus defensin def2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.75 microM) DME1125 XEOTICID XEO03665 GENEFORM Protein DME1125 XEOTICID XEO03665 MOACRIVE Inhibition DME1125 XEOTICID XEO03671 XEO_NAME Plant JCpep7 DME1125 XEOTICID XEO03671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03671 XEO_CLAS Peptide DME1125 XEOTICID XEO03671 DESCRIPT Plant JCpep7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 24 ug/ml) DME1125 XEOTICID XEO03671 GENEFORM Protein DME1125 XEOTICID XEO03671 MOACRIVE Inhibition DME1125 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1125 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03672 XEO_CLAS Peptide DME1125 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 10 ug/ml) DME1125 XEOTICID XEO03672 GENEFORM Protein DME1125 XEOTICID XEO03672 MOACRIVE Inhibition DME1125 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1125 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03673 XEO_CLAS Peptide DME1125 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 30 ug/ml) DME1125 XEOTICID XEO03673 GENEFORM Protein DME1125 XEOTICID XEO03673 MOACRIVE Inhibition DME1125 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1125 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03678 XEO_CLAS Peptide DME1125 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2 ug/ml) DME1125 XEOTICID XEO03678 GENEFORM Protein DME1125 XEOTICID XEO03678 MOACRIVE Inhibition DME1125 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1125 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03681 XEO_CLAS Peptide DME1125 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 20-40 microM) DME1125 XEOTICID XEO03681 GENEFORM Protein DME1125 XEOTICID XEO03681 MOACRIVE Inhibition DME1125 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1125 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03709 XEO_CLAS Peptide DME1125 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.25 ug/ml) DME1125 XEOTICID XEO03709 GENEFORM Protein DME1125 XEOTICID XEO03709 MOACRIVE Inhibition DME1125 XEOTICID XEO03737 XEO_NAME LlKmWn model peptide L4K2W4 DME1125 XEOTICID XEO03737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03737 XEO_CLAS Peptide DME1125 XEOTICID XEO03737 DESCRIPT LlKmWn model peptide L4K2W4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 25 ug/ml) DME1125 XEOTICID XEO03737 GENEFORM Protein DME1125 XEOTICID XEO03737 MOACRIVE Inhibition DME1125 XEOTICID XEO03739 XEO_NAME LlKmWn model peptide L4K3W4 DME1125 XEOTICID XEO03739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03739 XEO_CLAS Peptide DME1125 XEOTICID XEO03739 DESCRIPT LlKmWn model peptide L4K3W4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 50 ug/ml) DME1125 XEOTICID XEO03739 GENEFORM Protein DME1125 XEOTICID XEO03739 MOACRIVE Inhibition DME1125 XEOTICID XEO03740 XEO_NAME LlKmWn model peptide L4K3W5 DME1125 XEOTICID XEO03740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03740 XEO_CLAS Peptide DME1125 XEOTICID XEO03740 DESCRIPT LlKmWn model peptide L4K3W5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 50 ug/ml) DME1125 XEOTICID XEO03740 GENEFORM Protein DME1125 XEOTICID XEO03740 MOACRIVE Inhibition DME1125 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1125 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03744 XEO_CLAS Peptide DME1125 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12.5 ug/ml) DME1125 XEOTICID XEO03744 GENEFORM Protein DME1125 XEOTICID XEO03744 MOACRIVE Inhibition DME1125 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1125 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03746 XEO_CLAS Peptide DME1125 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2 ug/ml) DME1125 XEOTICID XEO03746 GENEFORM Protein DME1125 XEOTICID XEO03746 MOACRIVE Inhibition DME1125 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1125 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03747 XEO_CLAS Peptide DME1125 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1 ug/ml) DME1125 XEOTICID XEO03747 GENEFORM Protein DME1125 XEOTICID XEO03747 MOACRIVE Inhibition DME1125 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1125 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03748 XEO_CLAS Peptide DME1125 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2 ug/ml) DME1125 XEOTICID XEO03748 GENEFORM Protein DME1125 XEOTICID XEO03748 MOACRIVE Inhibition DME1125 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1125 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03749 XEO_CLAS Peptide DME1125 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2 ug/ml) DME1125 XEOTICID XEO03749 GENEFORM Protein DME1125 XEOTICID XEO03749 MOACRIVE Inhibition DME1125 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1125 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03750 XEO_CLAS Peptide DME1125 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2 ug/ml) DME1125 XEOTICID XEO03750 GENEFORM Protein DME1125 XEOTICID XEO03750 MOACRIVE Inhibition DME1125 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1125 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03751 XEO_CLAS Peptide DME1125 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2 ug/ml) DME1125 XEOTICID XEO03751 GENEFORM Protein DME1125 XEOTICID XEO03751 MOACRIVE Inhibition DME1125 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1125 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03752 XEO_CLAS Peptide DME1125 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2 ug/ml) DME1125 XEOTICID XEO03752 GENEFORM Protein DME1125 XEOTICID XEO03752 MOACRIVE Inhibition DME1125 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1125 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03753 XEO_CLAS Peptide DME1125 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.3 ug/ml) DME1125 XEOTICID XEO03753 GENEFORM Protein DME1125 XEOTICID XEO03753 MOACRIVE Inhibition DME1125 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1125 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03754 XEO_CLAS Peptide DME1125 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2 ug/ml) DME1125 XEOTICID XEO03754 GENEFORM Protein DME1125 XEOTICID XEO03754 MOACRIVE Inhibition DME1125 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1125 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03755 XEO_CLAS Peptide DME1125 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 4 ug/ml) DME1125 XEOTICID XEO03755 GENEFORM Protein DME1125 XEOTICID XEO03755 MOACRIVE Inhibition DME1125 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1125 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03756 XEO_CLAS Peptide DME1125 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2 ug/ml) DME1125 XEOTICID XEO03756 GENEFORM Protein DME1125 XEOTICID XEO03756 MOACRIVE Inhibition DME1125 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1125 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03759 XEO_CLAS Peptide DME1125 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.6 ug/ml) DME1125 XEOTICID XEO03759 GENEFORM Protein DME1125 XEOTICID XEO03759 MOACRIVE Inhibition DME1125 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1125 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03761 XEO_CLAS Peptide DME1125 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.6 ug/ml) DME1125 XEOTICID XEO03761 GENEFORM Protein DME1125 XEOTICID XEO03761 MOACRIVE Inhibition DME1125 XEOTICID XEO03762 XEO_NAME LlKmWn model peptide L7K5W7 DME1125 XEOTICID XEO03762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03762 XEO_CLAS Peptide DME1125 XEOTICID XEO03762 DESCRIPT LlKmWn model peptide L7K5W7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 3.1 ug/ml) DME1125 XEOTICID XEO03762 GENEFORM Protein DME1125 XEOTICID XEO03762 MOACRIVE Inhibition DME1125 XEOTICID XEO03764 XEO_NAME LlKmWn model peptide L8K4W7 DME1125 XEOTICID XEO03764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03764 XEO_CLAS Peptide DME1125 XEOTICID XEO03764 DESCRIPT LlKmWn model peptide L8K4W7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.3 ug/ml) DME1125 XEOTICID XEO03764 GENEFORM Protein DME1125 XEOTICID XEO03764 MOACRIVE Inhibition DME1125 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1125 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03771 XEO_CLAS Peptide DME1125 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03771 GENEFORM Protein DME1125 XEOTICID XEO03771 MOACRIVE Inhibition DME1125 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1125 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03793 XEO_CLAS Peptide DME1125 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 32 microM) DME1125 XEOTICID XEO03793 GENEFORM Protein DME1125 XEOTICID XEO03793 MOACRIVE Inhibition DME1125 XEOTICID XEO03804 XEO_NAME Lantibiotic lichenicidin VK21 A1 DME1125 XEOTICID XEO03804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03804 XEO_CLAS Peptide DME1125 XEOTICID XEO03804 DESCRIPT Lantibiotic lichenicidin VK21 A1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03804 GENEFORM Protein DME1125 XEOTICID XEO03804 MOACRIVE Inhibition DME1125 XEOTICID XEO03805 XEO_NAME Lantibiotic lichenicidin VK21 A2 DME1125 XEOTICID XEO03805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03805 XEO_CLAS Peptide DME1125 XEOTICID XEO03805 DESCRIPT Lantibiotic lichenicidin VK21 A2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03805 GENEFORM Protein DME1125 XEOTICID XEO03805 MOACRIVE Inhibition DME1125 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1125 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03810 XEO_CLAS Peptide DME1125 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03810 GENEFORM Protein DME1125 XEOTICID XEO03810 MOACRIVE Inhibition DME1125 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1125 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03928 XEO_CLAS Peptide DME1125 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 16 microM) DME1125 XEOTICID XEO03928 GENEFORM Protein DME1125 XEOTICID XEO03928 MOACRIVE Inhibition DME1125 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1125 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03933 XEO_CLAS Peptide DME1125 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.3 microM) DME1125 XEOTICID XEO03933 GENEFORM Protein DME1125 XEOTICID XEO03933 MOACRIVE Inhibition DME1125 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1125 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03934 XEO_CLAS Peptide DME1125 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.6 microM) DME1125 XEOTICID XEO03934 GENEFORM Protein DME1125 XEOTICID XEO03934 MOACRIVE Inhibition DME1125 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1125 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03935 XEO_CLAS Peptide DME1125 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.7 microM) DME1125 XEOTICID XEO03935 GENEFORM Protein DME1125 XEOTICID XEO03935 MOACRIVE Inhibition DME1125 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1125 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03936 XEO_CLAS Peptide DME1125 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.9 microM) DME1125 XEOTICID XEO03936 GENEFORM Protein DME1125 XEOTICID XEO03936 MOACRIVE Inhibition DME1125 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1125 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03937 XEO_CLAS Peptide DME1125 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.7 microM) DME1125 XEOTICID XEO03937 GENEFORM Protein DME1125 XEOTICID XEO03937 MOACRIVE Inhibition DME1125 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1125 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03938 XEO_CLAS Peptide DME1125 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.7 microM) DME1125 XEOTICID XEO03938 GENEFORM Protein DME1125 XEOTICID XEO03938 MOACRIVE Inhibition DME1125 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1125 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03939 XEO_CLAS Peptide DME1125 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.7 microM) DME1125 XEOTICID XEO03939 GENEFORM Protein DME1125 XEOTICID XEO03939 MOACRIVE Inhibition DME1125 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1125 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03940 XEO_CLAS Peptide DME1125 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.7 microM) DME1125 XEOTICID XEO03940 GENEFORM Protein DME1125 XEOTICID XEO03940 MOACRIVE Inhibition DME1125 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1125 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03941 XEO_CLAS Peptide DME1125 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.7 microM) DME1125 XEOTICID XEO03941 GENEFORM Protein DME1125 XEOTICID XEO03941 MOACRIVE Inhibition DME1125 XEOTICID XEO03942 XEO_NAME Lasioglossin LL-III derivative 10 DME1125 XEOTICID XEO03942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03942 XEO_CLAS Peptide DME1125 XEOTICID XEO03942 DESCRIPT Lasioglossin LL-III derivative 10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 100 microM) DME1125 XEOTICID XEO03942 GENEFORM Protein DME1125 XEOTICID XEO03942 MOACRIVE Inhibition DME1125 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1125 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03943 XEO_CLAS Peptide DME1125 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.6 microM) DME1125 XEOTICID XEO03943 GENEFORM Protein DME1125 XEOTICID XEO03943 MOACRIVE Inhibition DME1125 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1125 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03944 XEO_CLAS Peptide DME1125 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.7 microM) DME1125 XEOTICID XEO03944 GENEFORM Protein DME1125 XEOTICID XEO03944 MOACRIVE Inhibition DME1125 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1125 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03945 XEO_CLAS Peptide DME1125 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.8 microM) DME1125 XEOTICID XEO03945 GENEFORM Protein DME1125 XEOTICID XEO03945 MOACRIVE Inhibition DME1125 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1125 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03947 XEO_CLAS Peptide DME1125 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.5 microM) DME1125 XEOTICID XEO03947 GENEFORM Protein DME1125 XEOTICID XEO03947 MOACRIVE Inhibition DME1125 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1125 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03948 XEO_CLAS Peptide DME1125 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 4.7 microM) DME1125 XEOTICID XEO03948 GENEFORM Protein DME1125 XEOTICID XEO03948 MOACRIVE Inhibition DME1125 XEOTICID XEO03949 XEO_NAME Lasioglossin LL-III derivative 8 DME1125 XEOTICID XEO03949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03949 XEO_CLAS Peptide DME1125 XEOTICID XEO03949 DESCRIPT Lasioglossin LL-III derivative 8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 40 microM) DME1125 XEOTICID XEO03949 GENEFORM Protein DME1125 XEOTICID XEO03949 MOACRIVE Inhibition DME1125 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1125 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1125 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1125 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03968 GENEFORM Protein DME1125 XEOTICID XEO03968 MOACRIVE Inhibition DME1125 XEOTICID XEO03971 XEO_NAME Lumbrican DME1125 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03971 XEO_CLAS Peptide DME1125 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03971 GENEFORM Protein DME1125 XEOTICID XEO03971 MOACRIVE Inhibition DME1125 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1125 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03972 XEO_CLAS Peptide DME1125 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 8 ug/ml) DME1125 XEOTICID XEO03972 GENEFORM Protein DME1125 XEOTICID XEO03972 MOACRIVE Inhibition DME1125 XEOTICID XEO03973 XEO_NAME Lunatusin DME1125 XEOTICID XEO03973 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03973 XEO_CLAS Peptide DME1125 XEOTICID XEO03973 DESCRIPT Lunatusin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO03973 GENEFORM Protein DME1125 XEOTICID XEO03973 MOACRIVE Inhibition DME1125 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1125 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03996 XEO_CLAS Peptide DME1125 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 9 microM) DME1125 XEOTICID XEO03996 GENEFORM Protein DME1125 XEOTICID XEO03996 MOACRIVE Inhibition DME1125 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1125 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03997 XEO_CLAS Peptide DME1125 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 11.8 microM) DME1125 XEOTICID XEO03997 GENEFORM Protein DME1125 XEOTICID XEO03997 MOACRIVE Inhibition DME1125 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1125 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03998 XEO_CLAS Peptide DME1125 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 70 microM) DME1125 XEOTICID XEO03998 GENEFORM Protein DME1125 XEOTICID XEO03998 MOACRIVE Inhibition DME1125 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1125 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO03999 XEO_CLAS Peptide DME1125 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 7.3 microM) DME1125 XEOTICID XEO03999 GENEFORM Protein DME1125 XEOTICID XEO03999 MOACRIVE Inhibition DME1125 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1125 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04000 XEO_CLAS Peptide DME1125 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 4 ug/ml) DME1125 XEOTICID XEO04000 GENEFORM Protein DME1125 XEOTICID XEO04000 MOACRIVE Inhibition DME1125 XEOTICID XEO04055 XEO_NAME Melectin DME1125 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04055 XEO_CLAS Peptide DME1125 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.8 microM) DME1125 XEOTICID XEO04055 GENEFORM Protein DME1125 XEOTICID XEO04055 MOACRIVE Inhibition DME1125 XEOTICID XEO04057 XEO_NAME Melittin DME1125 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04057 XEO_CLAS Peptide DME1125 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.2 microM) DME1125 XEOTICID XEO04057 GENEFORM Protein DME1125 XEOTICID XEO04057 MOACRIVE Inhibition DME1125 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1125 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04121 XEO_CLAS Peptide DME1125 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.6-3.2 microM) DME1125 XEOTICID XEO04121 GENEFORM Protein DME1125 XEOTICID XEO04121 MOACRIVE Inhibition DME1125 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1125 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04122 XEO_CLAS Peptide DME1125 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.57-3.14 microM) DME1125 XEOTICID XEO04122 GENEFORM Protein DME1125 XEOTICID XEO04122 MOACRIVE Inhibition DME1125 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1125 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04128 XEO_CLAS Peptide DME1125 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.19 microM) DME1125 XEOTICID XEO04128 GENEFORM Protein DME1125 XEOTICID XEO04128 MOACRIVE Inhibition DME1125 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1125 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04137 XEO_CLAS Peptide DME1125 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04137 GENEFORM Protein DME1125 XEOTICID XEO04137 MOACRIVE Inhibition DME1125 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1125 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04138 XEO_CLAS Peptide DME1125 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 15 microM) DME1125 XEOTICID XEO04138 GENEFORM Protein DME1125 XEOTICID XEO04138 MOACRIVE Inhibition DME1125 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1125 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04139 XEO_CLAS Peptide DME1125 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 25 microM) DME1125 XEOTICID XEO04139 GENEFORM Protein DME1125 XEOTICID XEO04139 MOACRIVE Inhibition DME1125 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1125 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04140 XEO_CLAS Peptide DME1125 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 35 microM) DME1125 XEOTICID XEO04140 GENEFORM Protein DME1125 XEOTICID XEO04140 MOACRIVE Inhibition DME1125 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1125 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04141 XEO_CLAS Peptide DME1125 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 40 microM) DME1125 XEOTICID XEO04141 GENEFORM Protein DME1125 XEOTICID XEO04141 MOACRIVE Inhibition DME1125 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1125 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04142 XEO_CLAS Peptide DME1125 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.5 microM) DME1125 XEOTICID XEO04142 GENEFORM Protein DME1125 XEOTICID XEO04142 MOACRIVE Inhibition DME1125 XEOTICID XEO04147 XEO_NAME Mucobromic acid DME1125 XEOTICID XEO04147 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1125 XEOTICID XEO04147 XEO_CLAS Chemical Compound DME1125 XEOTICID XEO04147 DESCRIPT Mucobromic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04147 GENEFORM Protein DME1125 XEOTICID XEO04147 MOACRIVE Inhibition DME1125 XEOTICID XEO04148 XEO_NAME Mucochloric acid DME1125 XEOTICID XEO04148 XEO_TYPE Health or Environmental Toxicant(s) DME1125 XEOTICID XEO04148 XEO_CLAS Health Hazard/Toxicant DME1125 XEOTICID XEO04148 DESCRIPT Mucochloric acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04148 GENEFORM Protein DME1125 XEOTICID XEO04148 MOACRIVE Inhibition DME1125 XEOTICID XEO04149 XEO_NAME Mucroporin DME1125 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04149 XEO_CLAS Peptide DME1125 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 50 ug/ml) DME1125 XEOTICID XEO04149 GENEFORM Protein DME1125 XEOTICID XEO04149 MOACRIVE Inhibition DME1125 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1125 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04168 XEO_CLAS Peptide DME1125 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.2-2.5 microM) DME1125 XEOTICID XEO04168 GENEFORM Protein DME1125 XEOTICID XEO04168 MOACRIVE Inhibition DME1125 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1125 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04177 XEO_CLAS Peptide DME1125 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.0 microM) DME1125 XEOTICID XEO04177 GENEFORM Protein DME1125 XEOTICID XEO04177 MOACRIVE Inhibition DME1125 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1125 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04178 XEO_CLAS Peptide DME1125 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.4 microM) DME1125 XEOTICID XEO04178 GENEFORM Protein DME1125 XEOTICID XEO04178 MOACRIVE Inhibition DME1125 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1125 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04179 XEO_CLAS Peptide DME1125 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.2 microM) DME1125 XEOTICID XEO04179 GENEFORM Protein DME1125 XEOTICID XEO04179 MOACRIVE Inhibition DME1125 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1125 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04180 XEO_CLAS Peptide DME1125 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2.9 microM) DME1125 XEOTICID XEO04180 GENEFORM Protein DME1125 XEOTICID XEO04180 MOACRIVE Inhibition DME1125 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1125 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04181 XEO_CLAS Peptide DME1125 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.1 microM) DME1125 XEOTICID XEO04181 GENEFORM Protein DME1125 XEOTICID XEO04181 MOACRIVE Inhibition DME1125 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1125 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04182 XEO_CLAS Peptide DME1125 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.1 microM) DME1125 XEOTICID XEO04182 GENEFORM Protein DME1125 XEOTICID XEO04182 MOACRIVE Inhibition DME1125 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1125 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04183 XEO_CLAS Peptide DME1125 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.6 microM) DME1125 XEOTICID XEO04183 GENEFORM Protein DME1125 XEOTICID XEO04183 MOACRIVE Inhibition DME1125 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1125 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04184 XEO_CLAS Peptide DME1125 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.9 microM) DME1125 XEOTICID XEO04184 GENEFORM Protein DME1125 XEOTICID XEO04184 MOACRIVE Inhibition DME1125 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1125 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04185 XEO_CLAS Peptide DME1125 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04185 GENEFORM Protein DME1125 XEOTICID XEO04185 MOACRIVE Inhibition DME1125 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1125 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04206 XEO_CLAS Peptide DME1125 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.78 microM) DME1125 XEOTICID XEO04206 GENEFORM Protein DME1125 XEOTICID XEO04206 MOACRIVE Inhibition DME1125 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1125 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04214 XEO_CLAS Peptide DME1125 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.78 microM) DME1125 XEOTICID XEO04214 GENEFORM Protein DME1125 XEOTICID XEO04214 MOACRIVE Inhibition DME1125 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1125 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04216 XEO_CLAS Peptide DME1125 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.78 microM) DME1125 XEOTICID XEO04216 GENEFORM Protein DME1125 XEOTICID XEO04216 MOACRIVE Inhibition DME1125 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1125 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04218 XEO_CLAS Peptide DME1125 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.78 microM) DME1125 XEOTICID XEO04218 GENEFORM Protein DME1125 XEOTICID XEO04218 MOACRIVE Inhibition DME1125 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1125 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04219 XEO_CLAS Peptide DME1125 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.78 microM) DME1125 XEOTICID XEO04219 GENEFORM Protein DME1125 XEOTICID XEO04219 MOACRIVE Inhibition DME1125 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1125 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04220 XEO_CLAS Peptide DME1125 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.78 microM) DME1125 XEOTICID XEO04220 GENEFORM Protein DME1125 XEOTICID XEO04220 MOACRIVE Inhibition DME1125 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1125 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04221 XEO_CLAS Peptide DME1125 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.78 microM) DME1125 XEOTICID XEO04221 GENEFORM Protein DME1125 XEOTICID XEO04221 MOACRIVE Inhibition DME1125 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1125 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04222 XEO_CLAS Peptide DME1125 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.78 microM) DME1125 XEOTICID XEO04222 GENEFORM Protein DME1125 XEOTICID XEO04222 MOACRIVE Inhibition DME1125 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1125 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04233 XEO_CLAS Peptide DME1125 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04233 GENEFORM Protein DME1125 XEOTICID XEO04233 MOACRIVE Inhibition DME1125 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1125 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04234 XEO_CLAS Peptide DME1125 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04234 GENEFORM Protein DME1125 XEOTICID XEO04234 MOACRIVE Inhibition DME1125 XEOTICID XEO04235 XEO_NAME Napin-like polypeptide DME1125 XEOTICID XEO04235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04235 XEO_CLAS Peptide DME1125 XEOTICID XEO04235 DESCRIPT Napin-like polypeptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04235 GENEFORM Protein DME1125 XEOTICID XEO04235 MOACRIVE Inhibition DME1125 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1125 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04277 XEO_CLAS Peptide DME1125 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 110.00 ug/ml) DME1125 XEOTICID XEO04277 GENEFORM Protein DME1125 XEOTICID XEO04277 MOACRIVE Inhibition DME1125 XEOTICID XEO04278 XEO_NAME Nigroain-D3 DME1125 XEOTICID XEO04278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04278 XEO_CLAS Peptide DME1125 XEOTICID XEO04278 DESCRIPT Nigroain-D3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 55 ug/ml) DME1125 XEOTICID XEO04278 GENEFORM Protein DME1125 XEOTICID XEO04278 MOACRIVE Inhibition DME1125 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1125 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04280 XEO_CLAS Peptide DME1125 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 21.88 ug/ml) DME1125 XEOTICID XEO04280 GENEFORM Protein DME1125 XEOTICID XEO04280 MOACRIVE Inhibition DME1125 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1125 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04281 XEO_CLAS Peptide DME1125 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 9.38 ug/ml) DME1125 XEOTICID XEO04281 GENEFORM Protein DME1125 XEOTICID XEO04281 MOACRIVE Inhibition DME1125 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1125 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04298 XEO_CLAS Peptide DME1125 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12.5 microM) DME1125 XEOTICID XEO04298 GENEFORM Protein DME1125 XEOTICID XEO04298 MOACRIVE Inhibition DME1125 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1125 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04299 XEO_CLAS Peptide DME1125 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12.5 microM) DME1125 XEOTICID XEO04299 GENEFORM Protein DME1125 XEOTICID XEO04299 MOACRIVE Inhibition DME1125 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1125 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04307 XEO_CLAS Peptide DME1125 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 100 ug/ml) DME1125 XEOTICID XEO04307 GENEFORM Protein DME1125 XEOTICID XEO04307 MOACRIVE Inhibition DME1125 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1125 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04308 XEO_CLAS Peptide DME1125 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 37.50 ug/ml) DME1125 XEOTICID XEO04308 GENEFORM Protein DME1125 XEOTICID XEO04308 MOACRIVE Inhibition DME1125 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1125 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04312 XEO_CLAS Peptide DME1125 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 18.75 ug/ml) DME1125 XEOTICID XEO04312 GENEFORM Protein DME1125 XEOTICID XEO04312 MOACRIVE Inhibition DME1125 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1125 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04313 XEO_CLAS Peptide DME1125 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 18.75 ug/ml) DME1125 XEOTICID XEO04313 GENEFORM Protein DME1125 XEOTICID XEO04313 MOACRIVE Inhibition DME1125 XEOTICID XEO04331 XEO_NAME Norspermidine DME1125 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1125 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1125 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04331 GENEFORM Protein DME1125 XEOTICID XEO04331 MOACRIVE Inhibition DME1125 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1125 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04355 XEO_CLAS Peptide DME1125 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.85 ug/ml) DME1125 XEOTICID XEO04355 GENEFORM Protein DME1125 XEOTICID XEO04355 MOACRIVE Inhibition DME1125 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1125 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04356 XEO_CLAS Peptide DME1125 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 16.42 ug/ml) DME1125 XEOTICID XEO04356 GENEFORM Protein DME1125 XEOTICID XEO04356 MOACRIVE Inhibition DME1125 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1125 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04357 XEO_CLAS Peptide DME1125 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 8.16 ug/ml) DME1125 XEOTICID XEO04357 GENEFORM Protein DME1125 XEOTICID XEO04357 MOACRIVE Inhibition DME1125 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1125 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04358 XEO_CLAS Peptide DME1125 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 4.68 ug/ml) DME1125 XEOTICID XEO04358 GENEFORM Protein DME1125 XEOTICID XEO04358 MOACRIVE Inhibition DME1125 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1125 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04359 XEO_CLAS Peptide DME1125 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 8.40 ug/ml) DME1125 XEOTICID XEO04359 GENEFORM Protein DME1125 XEOTICID XEO04359 MOACRIVE Inhibition DME1125 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1125 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04365 XEO_CLAS Peptide DME1125 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 37.5 ug/ml) DME1125 XEOTICID XEO04365 GENEFORM Protein DME1125 XEOTICID XEO04365 MOACRIVE Inhibition DME1125 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1125 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04366 XEO_CLAS Peptide DME1125 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 5.90 ug/ml) DME1125 XEOTICID XEO04366 GENEFORM Protein DME1125 XEOTICID XEO04366 MOACRIVE Inhibition DME1125 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1125 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04367 XEO_CLAS Peptide DME1125 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 35.60 ug/ml) DME1125 XEOTICID XEO04367 GENEFORM Protein DME1125 XEOTICID XEO04367 MOACRIVE Inhibition DME1125 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1125 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04370 XEO_CLAS Peptide DME1125 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.10 ug/ml) DME1125 XEOTICID XEO04370 GENEFORM Protein DME1125 XEOTICID XEO04370 MOACRIVE Inhibition DME1125 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1125 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04371 XEO_CLAS Peptide DME1125 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 75 ug/ml) DME1125 XEOTICID XEO04371 GENEFORM Protein DME1125 XEOTICID XEO04371 MOACRIVE Inhibition DME1125 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1125 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04374 XEO_CLAS Peptide DME1125 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.75 ug/ml) DME1125 XEOTICID XEO04374 GENEFORM Protein DME1125 XEOTICID XEO04374 MOACRIVE Inhibition DME1125 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1125 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04375 XEO_CLAS Peptide DME1125 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12.5 ug/ml) DME1125 XEOTICID XEO04375 GENEFORM Protein DME1125 XEOTICID XEO04375 MOACRIVE Inhibition DME1125 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1125 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04377 XEO_CLAS Peptide DME1125 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 85.00 ug/ml) DME1125 XEOTICID XEO04377 GENEFORM Protein DME1125 XEOTICID XEO04377 MOACRIVE Inhibition DME1125 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1125 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04378 XEO_CLAS Peptide DME1125 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 17.50 ug/ml) DME1125 XEOTICID XEO04378 GENEFORM Protein DME1125 XEOTICID XEO04378 MOACRIVE Inhibition DME1125 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1125 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04379 XEO_CLAS Peptide DME1125 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 9.37 ug/ml) DME1125 XEOTICID XEO04379 GENEFORM Protein DME1125 XEOTICID XEO04379 MOACRIVE Inhibition DME1125 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1125 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04380 XEO_CLAS Peptide DME1125 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 18.00 ug/ml) DME1125 XEOTICID XEO04380 GENEFORM Protein DME1125 XEOTICID XEO04380 MOACRIVE Inhibition DME1125 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1125 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04381 XEO_CLAS Peptide DME1125 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.30 ug/ml) DME1125 XEOTICID XEO04381 GENEFORM Protein DME1125 XEOTICID XEO04381 MOACRIVE Inhibition DME1125 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1125 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04383 XEO_CLAS Peptide DME1125 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 128 ug/ml) DME1125 XEOTICID XEO04383 GENEFORM Protein DME1125 XEOTICID XEO04383 MOACRIVE Inhibition DME1125 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1125 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04396 XEO_CLAS Peptide DME1125 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.25-0.5 microM) DME1125 XEOTICID XEO04396 GENEFORM Protein DME1125 XEOTICID XEO04396 MOACRIVE Inhibition DME1125 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1125 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04397 XEO_CLAS Peptide DME1125 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.25-0.5 microM) DME1125 XEOTICID XEO04397 GENEFORM Protein DME1125 XEOTICID XEO04397 MOACRIVE Inhibition DME1125 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1125 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04399 XEO_CLAS Peptide DME1125 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12.5 microM) DME1125 XEOTICID XEO04399 GENEFORM Protein DME1125 XEOTICID XEO04399 MOACRIVE Inhibition DME1125 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1125 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04421 XEO_CLAS Peptide DME1125 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.5 microM) DME1125 XEOTICID XEO04421 GENEFORM Protein DME1125 XEOTICID XEO04421 MOACRIVE Inhibition DME1125 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1125 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04430 XEO_CLAS Peptide DME1125 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.78 microM) DME1125 XEOTICID XEO04430 GENEFORM Protein DME1125 XEOTICID XEO04430 MOACRIVE Inhibition DME1125 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1125 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04448 XEO_CLAS Peptide DME1125 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12.5 microM) DME1125 XEOTICID XEO04448 GENEFORM Protein DME1125 XEOTICID XEO04448 MOACRIVE Inhibition DME1125 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1125 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04455 XEO_CLAS Peptide DME1125 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12.5 microM) DME1125 XEOTICID XEO04455 GENEFORM Protein DME1125 XEOTICID XEO04455 MOACRIVE Inhibition DME1125 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1125 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04461 XEO_CLAS Peptide DME1125 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 5.2 microM) DME1125 XEOTICID XEO04461 GENEFORM Protein DME1125 XEOTICID XEO04461 MOACRIVE Inhibition DME1125 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1125 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04462 XEO_CLAS Peptide DME1125 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 4.8 microM) DME1125 XEOTICID XEO04462 GENEFORM Protein DME1125 XEOTICID XEO04462 MOACRIVE Inhibition DME1125 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1125 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04471 XEO_CLAS Peptide DME1125 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.3 microM) DME1125 XEOTICID XEO04471 GENEFORM Protein DME1125 XEOTICID XEO04471 MOACRIVE Inhibition DME1125 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1125 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04484 XEO_CLAS Peptide DME1125 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 45 microM) DME1125 XEOTICID XEO04484 GENEFORM Protein DME1125 XEOTICID XEO04484 MOACRIVE Inhibition DME1125 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1125 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04485 XEO_CLAS Peptide DME1125 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 10 microM) DME1125 XEOTICID XEO04485 GENEFORM Protein DME1125 XEOTICID XEO04485 MOACRIVE Inhibition DME1125 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1125 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04486 XEO_CLAS Peptide DME1125 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 15 microM) DME1125 XEOTICID XEO04486 GENEFORM Protein DME1125 XEOTICID XEO04486 MOACRIVE Inhibition DME1125 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1125 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04487 XEO_CLAS Peptide DME1125 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 20 microM) DME1125 XEOTICID XEO04487 GENEFORM Protein DME1125 XEOTICID XEO04487 MOACRIVE Inhibition DME1125 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1125 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04488 XEO_CLAS Peptide DME1125 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 5 microM) DME1125 XEOTICID XEO04488 GENEFORM Protein DME1125 XEOTICID XEO04488 MOACRIVE Inhibition DME1125 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1125 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04489 XEO_CLAS Peptide DME1125 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 8.5 microM) DME1125 XEOTICID XEO04489 GENEFORM Protein DME1125 XEOTICID XEO04489 MOACRIVE Inhibition DME1125 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1125 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04490 XEO_CLAS Peptide DME1125 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 17.5 microM) DME1125 XEOTICID XEO04490 GENEFORM Protein DME1125 XEOTICID XEO04490 MOACRIVE Inhibition DME1125 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1125 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04491 XEO_CLAS Peptide DME1125 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 17 microM) DME1125 XEOTICID XEO04491 GENEFORM Protein DME1125 XEOTICID XEO04491 MOACRIVE Inhibition DME1125 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1125 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04492 XEO_CLAS Peptide DME1125 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 40 microM) DME1125 XEOTICID XEO04492 GENEFORM Protein DME1125 XEOTICID XEO04492 MOACRIVE Inhibition DME1125 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1125 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04493 XEO_CLAS Peptide DME1125 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 87.5 microM) DME1125 XEOTICID XEO04493 GENEFORM Protein DME1125 XEOTICID XEO04493 MOACRIVE Inhibition DME1125 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1125 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04494 XEO_CLAS Peptide DME1125 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 100 microM) DME1125 XEOTICID XEO04494 GENEFORM Protein DME1125 XEOTICID XEO04494 MOACRIVE Inhibition DME1125 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1125 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04495 XEO_CLAS Peptide DME1125 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 22.5 microM) DME1125 XEOTICID XEO04495 GENEFORM Protein DME1125 XEOTICID XEO04495 MOACRIVE Inhibition DME1125 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1125 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04496 XEO_CLAS Peptide DME1125 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 25 microM) DME1125 XEOTICID XEO04496 GENEFORM Protein DME1125 XEOTICID XEO04496 MOACRIVE Inhibition DME1125 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1125 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04497 XEO_CLAS Peptide DME1125 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 17.5 microM) DME1125 XEOTICID XEO04497 GENEFORM Protein DME1125 XEOTICID XEO04497 MOACRIVE Inhibition DME1125 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1125 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04498 XEO_CLAS Peptide DME1125 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 22.5 microM) DME1125 XEOTICID XEO04498 GENEFORM Protein DME1125 XEOTICID XEO04498 MOACRIVE Inhibition DME1125 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1125 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04499 XEO_CLAS Peptide DME1125 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 15.5 microM) DME1125 XEOTICID XEO04499 GENEFORM Protein DME1125 XEOTICID XEO04499 MOACRIVE Inhibition DME1125 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1125 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04500 XEO_CLAS Peptide DME1125 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 100 microM) DME1125 XEOTICID XEO04500 GENEFORM Protein DME1125 XEOTICID XEO04500 MOACRIVE Inhibition DME1125 XEOTICID XEO04518 XEO_NAME Penicillic acid DME1125 XEOTICID XEO04518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1125 XEOTICID XEO04518 XEO_CLAS Natural Product DME1125 XEOTICID XEO04518 DESCRIPT Penicillic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04518 GENEFORM Protein DME1125 XEOTICID XEO04518 MOACRIVE Inhibition DME1125 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1125 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04525 XEO_CLAS Peptide DME1125 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 8.0 microM) DME1125 XEOTICID XEO04525 GENEFORM Protein DME1125 XEOTICID XEO04525 MOACRIVE Inhibition DME1125 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1125 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04526 XEO_CLAS Peptide DME1125 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2.0 microM) DME1125 XEOTICID XEO04526 GENEFORM Protein DME1125 XEOTICID XEO04526 MOACRIVE Inhibition DME1125 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1125 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04540 XEO_CLAS Peptide DME1125 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 48.8 ug/ml) DME1125 XEOTICID XEO04540 GENEFORM Protein DME1125 XEOTICID XEO04540 MOACRIVE Inhibition DME1125 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1125 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04541 XEO_CLAS Peptide DME1125 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 5 ug/ml) DME1125 XEOTICID XEO04541 GENEFORM Protein DME1125 XEOTICID XEO04541 MOACRIVE Inhibition DME1125 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1125 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04542 XEO_CLAS Peptide DME1125 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04542 GENEFORM Protein DME1125 XEOTICID XEO04542 MOACRIVE Inhibition DME1125 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1125 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04551 XEO_CLAS Peptide DME1125 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 14.4 ug/ml) DME1125 XEOTICID XEO04551 GENEFORM Protein DME1125 XEOTICID XEO04551 MOACRIVE Inhibition DME1125 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1125 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04604 XEO_CLAS Peptide DME1125 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC < 50 microM) DME1125 XEOTICID XEO04604 GENEFORM Protein DME1125 XEOTICID XEO04604 MOACRIVE Inhibition DME1125 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1125 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04605 XEO_CLAS Peptide DME1125 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC < 50 microM) DME1125 XEOTICID XEO04605 GENEFORM Protein DME1125 XEOTICID XEO04605 MOACRIVE Inhibition DME1125 XEOTICID XEO04624 XEO_NAME Plantazolicin DME1125 XEOTICID XEO04624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04624 XEO_CLAS Peptide DME1125 XEOTICID XEO04624 DESCRIPT Plantazolicin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04624 GENEFORM Protein DME1125 XEOTICID XEO04624 MOACRIVE Inhibition DME1125 XEOTICID XEO04632 XEO_NAME Pleurain-B1 DME1125 XEOTICID XEO04632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04632 XEO_CLAS Peptide DME1125 XEOTICID XEO04632 DESCRIPT Pleurain-B1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 3.1 ug/ml) DME1125 XEOTICID XEO04632 GENEFORM Protein DME1125 XEOTICID XEO04632 MOACRIVE Inhibition DME1125 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1125 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04633 XEO_CLAS Peptide DME1125 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 3.1 ug/ml) DME1125 XEOTICID XEO04633 GENEFORM Protein DME1125 XEOTICID XEO04633 MOACRIVE Inhibition DME1125 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1125 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04634 XEO_CLAS Peptide DME1125 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 50 ug/ml) DME1125 XEOTICID XEO04634 GENEFORM Protein DME1125 XEOTICID XEO04634 MOACRIVE Inhibition DME1125 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1125 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04636 XEO_CLAS Peptide DME1125 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 100 ug/ml) DME1125 XEOTICID XEO04636 GENEFORM Protein DME1125 XEOTICID XEO04636 MOACRIVE Inhibition DME1125 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1125 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04637 XEO_CLAS Peptide DME1125 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 50 ug/ml) DME1125 XEOTICID XEO04637 GENEFORM Protein DME1125 XEOTICID XEO04637 MOACRIVE Inhibition DME1125 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1125 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04639 XEO_CLAS Peptide DME1125 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 100 ug/ml) DME1125 XEOTICID XEO04639 GENEFORM Protein DME1125 XEOTICID XEO04639 MOACRIVE Inhibition DME1125 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1125 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04640 XEO_CLAS Peptide DME1125 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.1-2.2 microM) DME1125 XEOTICID XEO04640 GENEFORM Protein DME1125 XEOTICID XEO04640 MOACRIVE Inhibition DME1125 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1125 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04664 XEO_CLAS Peptide DME1125 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 27.2 microM) DME1125 XEOTICID XEO04664 GENEFORM Protein DME1125 XEOTICID XEO04664 MOACRIVE Inhibition DME1125 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1125 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04665 XEO_CLAS Peptide DME1125 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 35 microM) DME1125 XEOTICID XEO04665 GENEFORM Protein DME1125 XEOTICID XEO04665 MOACRIVE Inhibition DME1125 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1125 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04666 XEO_CLAS Peptide DME1125 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 100 microM) DME1125 XEOTICID XEO04666 GENEFORM Protein DME1125 XEOTICID XEO04666 MOACRIVE Inhibition DME1125 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1125 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04667 XEO_CLAS Peptide DME1125 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 10 microM) DME1125 XEOTICID XEO04667 GENEFORM Protein DME1125 XEOTICID XEO04667 MOACRIVE Inhibition DME1125 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1125 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04668 XEO_CLAS Peptide DME1125 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 60 microM) DME1125 XEOTICID XEO04668 GENEFORM Protein DME1125 XEOTICID XEO04668 MOACRIVE Inhibition DME1125 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1125 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04669 XEO_CLAS Peptide DME1125 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 30 microM) DME1125 XEOTICID XEO04669 GENEFORM Protein DME1125 XEOTICID XEO04669 MOACRIVE Inhibition DME1125 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1125 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04670 XEO_CLAS Peptide DME1125 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 46 microM) DME1125 XEOTICID XEO04670 GENEFORM Protein DME1125 XEOTICID XEO04670 MOACRIVE Inhibition DME1125 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1125 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04671 XEO_CLAS Peptide DME1125 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 125 microM) DME1125 XEOTICID XEO04671 GENEFORM Protein DME1125 XEOTICID XEO04671 MOACRIVE Inhibition DME1125 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1125 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04672 XEO_CLAS Peptide DME1125 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 75 microM) DME1125 XEOTICID XEO04672 GENEFORM Protein DME1125 XEOTICID XEO04672 MOACRIVE Inhibition DME1125 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1125 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04673 XEO_CLAS Peptide DME1125 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 100 microM) DME1125 XEOTICID XEO04673 GENEFORM Protein DME1125 XEOTICID XEO04673 MOACRIVE Inhibition DME1125 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1125 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04674 XEO_CLAS Peptide DME1125 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 70 microM) DME1125 XEOTICID XEO04674 GENEFORM Protein DME1125 XEOTICID XEO04674 MOACRIVE Inhibition DME1125 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1125 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04675 XEO_CLAS Peptide DME1125 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 100 microM) DME1125 XEOTICID XEO04675 GENEFORM Protein DME1125 XEOTICID XEO04675 MOACRIVE Inhibition DME1125 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1125 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04676 XEO_CLAS Peptide DME1125 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 100 microM) DME1125 XEOTICID XEO04676 GENEFORM Protein DME1125 XEOTICID XEO04676 MOACRIVE Inhibition DME1125 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1125 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04677 XEO_CLAS Peptide DME1125 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 100 microM) DME1125 XEOTICID XEO04677 GENEFORM Protein DME1125 XEOTICID XEO04677 MOACRIVE Inhibition DME1125 XEOTICID XEO04678 XEO_NAME Plant defensin Pn-AMP1 DME1125 XEOTICID XEO04678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04678 XEO_CLAS Peptide DME1125 XEOTICID XEO04678 DESCRIPT Plant defensin Pn-AMP1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04678 GENEFORM Protein DME1125 XEOTICID XEO04678 MOACRIVE Inhibition DME1125 XEOTICID XEO04679 XEO_NAME Plant defensin Pn-AMP2 DME1125 XEOTICID XEO04679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04679 XEO_CLAS Peptide DME1125 XEOTICID XEO04679 DESCRIPT Plant defensin Pn-AMP2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04679 GENEFORM Protein DME1125 XEOTICID XEO04679 MOACRIVE Inhibition DME1125 XEOTICID XEO04681 XEO_NAME Polybia chemotactic peptide polybia-CP DME1125 XEOTICID XEO04681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04681 XEO_CLAS Peptide DME1125 XEOTICID XEO04681 DESCRIPT Polybia chemotactic peptide polybia-CP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 15 ug/ml) DME1125 XEOTICID XEO04681 GENEFORM Protein DME1125 XEOTICID XEO04681 MOACRIVE Inhibition DME1125 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1125 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04695 XEO_CLAS Peptide DME1125 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04695 GENEFORM Protein DME1125 XEOTICID XEO04695 MOACRIVE Inhibition DME1125 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1125 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04697 XEO_CLAS Peptide DME1125 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04697 GENEFORM Protein DME1125 XEOTICID XEO04697 MOACRIVE Inhibition DME1125 XEOTICID XEO04707 XEO_NAME Pore-forming peptide ameobapore A DME1125 XEOTICID XEO04707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04707 XEO_CLAS Peptide DME1125 XEOTICID XEO04707 DESCRIPT Pore-forming peptide ameobapore A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 27 microM) DME1125 XEOTICID XEO04707 GENEFORM Protein DME1125 XEOTICID XEO04707 MOACRIVE Inhibition DME1125 XEOTICID XEO04711 XEO_NAME Insect PP102 peptide DME1125 XEOTICID XEO04711 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04711 XEO_CLAS Peptide DME1125 XEOTICID XEO04711 DESCRIPT Insect PP102 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 25 microM) DME1125 XEOTICID XEO04711 GENEFORM Protein DME1125 XEOTICID XEO04711 MOACRIVE Inhibition DME1125 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1125 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04712 XEO_CLAS Peptide DME1125 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 23.3 microM) DME1125 XEOTICID XEO04712 GENEFORM Protein DME1125 XEOTICID XEO04712 MOACRIVE Inhibition DME1125 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1125 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04713 XEO_CLAS Peptide DME1125 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 13.3 microM) DME1125 XEOTICID XEO04713 GENEFORM Protein DME1125 XEOTICID XEO04713 MOACRIVE Inhibition DME1125 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1125 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04714 XEO_CLAS Peptide DME1125 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 16.7 microM) DME1125 XEOTICID XEO04714 GENEFORM Protein DME1125 XEOTICID XEO04714 MOACRIVE Inhibition DME1125 XEOTICID XEO04737 XEO_NAME Protonectin DME1125 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04737 XEO_CLAS Peptide DME1125 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 3.1 ug/ml) DME1125 XEOTICID XEO04737 GENEFORM Protein DME1125 XEOTICID XEO04737 MOACRIVE Inhibition DME1125 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1125 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04762 XEO_CLAS Peptide DME1125 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 3.1 microM) DME1125 XEOTICID XEO04762 GENEFORM Protein DME1125 XEOTICID XEO04762 MOACRIVE Inhibition DME1125 XEOTICID XEO04790 XEO_NAME Ranacyclin-B-AL1 DME1125 XEOTICID XEO04790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04790 XEO_CLAS Peptide DME1125 XEOTICID XEO04790 DESCRIPT Ranacyclin-B-AL1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 26 microM) DME1125 XEOTICID XEO04790 GENEFORM Protein DME1125 XEOTICID XEO04790 MOACRIVE Inhibition DME1125 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1125 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04793 XEO_CLAS Peptide DME1125 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 46.2 microM) DME1125 XEOTICID XEO04793 GENEFORM Protein DME1125 XEOTICID XEO04793 MOACRIVE Inhibition DME1125 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1125 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04865 XEO_CLAS Peptide DME1125 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 12.5 ug/ml) DME1125 XEOTICID XEO04865 GENEFORM Protein DME1125 XEOTICID XEO04865 MOACRIVE Inhibition DME1125 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1125 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04866 XEO_CLAS Peptide DME1125 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.25 ug/ml) DME1125 XEOTICID XEO04866 GENEFORM Protein DME1125 XEOTICID XEO04866 MOACRIVE Inhibition DME1125 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1125 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04868 XEO_CLAS Peptide DME1125 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 9.38 ug/ml) DME1125 XEOTICID XEO04868 GENEFORM Protein DME1125 XEOTICID XEO04868 MOACRIVE Inhibition DME1125 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1125 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04869 XEO_CLAS Peptide DME1125 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 18.75 ug/ml) DME1125 XEOTICID XEO04869 GENEFORM Protein DME1125 XEOTICID XEO04869 MOACRIVE Inhibition DME1125 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1125 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04870 XEO_CLAS Peptide DME1125 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 18.75 ug/ml) DME1125 XEOTICID XEO04870 GENEFORM Protein DME1125 XEOTICID XEO04870 MOACRIVE Inhibition DME1125 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1125 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04880 XEO_CLAS Peptide DME1125 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2.0 ug/ml) DME1125 XEOTICID XEO04880 GENEFORM Protein DME1125 XEOTICID XEO04880 MOACRIVE Inhibition DME1125 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1125 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04886 XEO_CLAS Peptide DME1125 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.3 ug/ml) DME1125 XEOTICID XEO04886 GENEFORM Protein DME1125 XEOTICID XEO04886 MOACRIVE Inhibition DME1125 XEOTICID XEO04892 XEO_NAME Seabream beta defensin saBD DME1125 XEOTICID XEO04892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04892 XEO_CLAS Peptide DME1125 XEOTICID XEO04892 DESCRIPT Seabream beta defensin saBD inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04892 GENEFORM Protein DME1125 XEOTICID XEO04892 MOACRIVE Inhibition DME1125 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1125 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04901 XEO_CLAS Peptide DME1125 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2 microM) DME1125 XEOTICID XEO04901 GENEFORM Protein DME1125 XEOTICID XEO04901 MOACRIVE Inhibition DME1125 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1125 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04904 XEO_CLAS Peptide DME1125 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 20.0 ug/ml) DME1125 XEOTICID XEO04904 GENEFORM Protein DME1125 XEOTICID XEO04904 MOACRIVE Inhibition DME1125 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1125 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04909 XEO_CLAS Peptide DME1125 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04909 GENEFORM Protein DME1125 XEOTICID XEO04909 MOACRIVE Inhibition DME1125 XEOTICID XEO04917 XEO_NAME Scorpine DME1125 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04917 XEO_CLAS Peptide DME1125 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 1.0 microM) DME1125 XEOTICID XEO04917 GENEFORM Protein DME1125 XEOTICID XEO04917 MOACRIVE Inhibition DME1125 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1125 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04956 XEO_CLAS Peptide DME1125 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 8.0 microM) DME1125 XEOTICID XEO04956 GENEFORM Protein DME1125 XEOTICID XEO04956 MOACRIVE Inhibition DME1125 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1125 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04971 XEO_CLAS Peptide DME1125 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.8-1.5 microM) DME1125 XEOTICID XEO04971 GENEFORM Protein DME1125 XEOTICID XEO04971 MOACRIVE Inhibition DME1125 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1125 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1125 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1125 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04975 GENEFORM Protein DME1125 XEOTICID XEO04975 MOACRIVE Inhibition DME1125 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1125 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1125 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1125 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04976 GENEFORM Protein DME1125 XEOTICID XEO04976 MOACRIVE Inhibition DME1125 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1125 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1125 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1125 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04977 GENEFORM Protein DME1125 XEOTICID XEO04977 MOACRIVE Inhibition DME1125 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1125 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1125 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1125 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04978 GENEFORM Protein DME1125 XEOTICID XEO04978 MOACRIVE Inhibition DME1125 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1125 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1125 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1125 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO04979 GENEFORM Protein DME1125 XEOTICID XEO04979 MOACRIVE Inhibition DME1125 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1125 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO04995 XEO_CLAS Peptide DME1125 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 6.25-12.5 microM) DME1125 XEOTICID XEO04995 GENEFORM Protein DME1125 XEOTICID XEO04995 MOACRIVE Inhibition DME1125 XEOTICID XEO05089 XEO_NAME Temporin-GH DME1125 XEOTICID XEO05089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05089 XEO_CLAS Peptide DME1125 XEOTICID XEO05089 DESCRIPT Temporin-GH inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC > 64 ug/ml) DME1125 XEOTICID XEO05089 GENEFORM Protein DME1125 XEOTICID XEO05089 MOACRIVE Inhibition DME1125 XEOTICID XEO05092 XEO_NAME Temporin-LT1 DME1125 XEOTICID XEO05092 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05092 XEO_CLAS Peptide DME1125 XEOTICID XEO05092 DESCRIPT Temporin-LT1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 25 microM) DME1125 XEOTICID XEO05092 GENEFORM Protein DME1125 XEOTICID XEO05092 MOACRIVE Inhibition DME1125 XEOTICID XEO05093 XEO_NAME Temporin-LT2 DME1125 XEOTICID XEO05093 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05093 XEO_CLAS Peptide DME1125 XEOTICID XEO05093 DESCRIPT Temporin-LT2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 50 microM) DME1125 XEOTICID XEO05093 GENEFORM Protein DME1125 XEOTICID XEO05093 MOACRIVE Inhibition DME1125 XEOTICID XEO05094 XEO_NAME Temporin-LTa DME1125 XEOTICID XEO05094 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05094 XEO_CLAS Peptide DME1125 XEOTICID XEO05094 DESCRIPT Temporin-LTa inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 10 ug/ml) DME1125 XEOTICID XEO05094 GENEFORM Protein DME1125 XEOTICID XEO05094 MOACRIVE Inhibition DME1125 XEOTICID XEO05095 XEO_NAME Temporin-LTb DME1125 XEOTICID XEO05095 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05095 XEO_CLAS Peptide DME1125 XEOTICID XEO05095 DESCRIPT Temporin-LTb inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 25 ug/ml) DME1125 XEOTICID XEO05095 GENEFORM Protein DME1125 XEOTICID XEO05095 MOACRIVE Inhibition DME1125 XEOTICID XEO05096 XEO_NAME Temporin-LTc DME1125 XEOTICID XEO05096 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05096 XEO_CLAS Peptide DME1125 XEOTICID XEO05096 DESCRIPT Temporin-LTc inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 50 ug/ml) DME1125 XEOTICID XEO05096 GENEFORM Protein DME1125 XEOTICID XEO05096 MOACRIVE Inhibition DME1125 XEOTICID XEO05120 XEO_NAME Thanatin DME1125 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05120 XEO_CLAS Peptide DME1125 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2.5-5 microM) DME1125 XEOTICID XEO05120 GENEFORM Protein DME1125 XEOTICID XEO05120 MOACRIVE Inhibition DME1125 XEOTICID XEO05129 XEO_NAME Thiocillin GE37468 DME1125 XEOTICID XEO05129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05129 XEO_CLAS Peptide DME1125 XEOTICID XEO05129 DESCRIPT Thiocillin GE37468 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.047 ug/ml) DME1125 XEOTICID XEO05129 GENEFORM Protein DME1125 XEOTICID XEO05129 MOACRIVE Inhibition DME1125 XEOTICID XEO05138 XEO_NAME Thuricin-17 DME1125 XEOTICID XEO05138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05138 XEO_CLAS Peptide DME1125 XEOTICID XEO05138 DESCRIPT Thuricin-17 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO05138 GENEFORM Protein DME1125 XEOTICID XEO05138 MOACRIVE Inhibition DME1125 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1125 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05139 XEO_CLAS Peptide DME1125 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO05139 GENEFORM Protein DME1125 XEOTICID XEO05139 MOACRIVE Inhibition DME1125 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1125 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05144 XEO_CLAS Peptide DME1125 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 30 ug/ml) DME1125 XEOTICID XEO05144 GENEFORM Protein DME1125 XEOTICID XEO05144 MOACRIVE Inhibition DME1125 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1125 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05145 XEO_CLAS Peptide DME1125 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 20 ug/ml) DME1125 XEOTICID XEO05145 GENEFORM Protein DME1125 XEOTICID XEO05145 MOACRIVE Inhibition DME1125 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1125 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05146 XEO_CLAS Peptide DME1125 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 30 ug/ml) DME1125 XEOTICID XEO05146 GENEFORM Protein DME1125 XEOTICID XEO05146 MOACRIVE Inhibition DME1125 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1125 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05161 XEO_CLAS Peptide DME1125 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 16 ug/ml) DME1125 XEOTICID XEO05161 GENEFORM Protein DME1125 XEOTICID XEO05161 MOACRIVE Inhibition DME1125 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1125 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05162 XEO_CLAS Peptide DME1125 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 16 ug/ml) DME1125 XEOTICID XEO05162 GENEFORM Protein DME1125 XEOTICID XEO05162 MOACRIVE Inhibition DME1125 XEOTICID XEO05169 XEO_NAME Tricyclic peptide MS-271 DME1125 XEOTICID XEO05169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05169 XEO_CLAS Peptide DME1125 XEOTICID XEO05169 DESCRIPT Tricyclic peptide MS-271 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus DME1125 XEOTICID XEO05169 GENEFORM Protein DME1125 XEOTICID XEO05169 MOACRIVE Inhibition DME1125 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1125 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05193 XEO_CLAS Peptide DME1125 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 8 ug/ml) DME1125 XEOTICID XEO05193 GENEFORM Protein DME1125 XEOTICID XEO05193 MOACRIVE Inhibition DME1125 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1125 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05212 XEO_CLAS Peptide DME1125 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 2.0 ug/ml) DME1125 XEOTICID XEO05212 GENEFORM Protein DME1125 XEOTICID XEO05212 MOACRIVE Inhibition DME1125 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1125 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05220 XEO_CLAS Peptide DME1125 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 20-40 microM) DME1125 XEOTICID XEO05220 GENEFORM Protein DME1125 XEOTICID XEO05220 MOACRIVE Inhibition DME1125 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1125 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1125 XEOTICID XEO05308 XEO_CLAS Peptide DME1125 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus pumilus (MIC = 0.7 ug/ml) DME1125 XEOTICID XEO05308 GENEFORM Protein DME1125 XEOTICID XEO05308 MOACRIVE Inhibition DME1126 DME___ID DME1126 DME1126 DME_NAME Glutamate racemase (MurI) DME1126 SPESNAME Bacillus anthracis DME1126 XEOTICID XEO02206 XEO_NAME Amythiamicin A/B DME1126 XEOTICID XEO02206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1126 XEOTICID XEO02206 XEO_CLAS Peptide DME1126 XEOTICID XEO02206 DESCRIPT Amythiamicin A/B inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus anthracis (MIC = 0.1 ug/ml) DME1126 XEOTICID XEO02206 GENEFORM Protein DME1126 XEOTICID XEO02206 MOACRIVE Inhibition DME1126 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1126 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1126 XEOTICID XEO02298 XEO_CLAS Peptide DME1126 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus anthracis (MIC = 128 ug/ml) DME1126 XEOTICID XEO02298 GENEFORM Protein DME1126 XEOTICID XEO02298 MOACRIVE Inhibition DME1126 XEOTICID XEO03056 XEO_NAME Rational design peptide D22 DME1126 XEOTICID XEO03056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1126 XEOTICID XEO03056 XEO_CLAS Peptide DME1126 XEOTICID XEO03056 DESCRIPT Rational design peptide D22 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus anthracis (MIC = 64 ug/ml) DME1126 XEOTICID XEO03056 GENEFORM Protein DME1126 XEOTICID XEO03056 MOACRIVE Inhibition DME1126 XEOTICID XEO03057 XEO_NAME Rational design peptide D28 DME1126 XEOTICID XEO03057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1126 XEOTICID XEO03057 XEO_CLAS Peptide DME1126 XEOTICID XEO03057 DESCRIPT Rational design peptide D28 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus anthracis (MIC = 16 ug/ml) DME1126 XEOTICID XEO03057 GENEFORM Protein DME1126 XEOTICID XEO03057 MOACRIVE Inhibition DME1126 XEOTICID XEO03065 XEO_NAME Rational design peptide D51 DME1126 XEOTICID XEO03065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1126 XEOTICID XEO03065 XEO_CLAS Peptide DME1126 XEOTICID XEO03065 DESCRIPT Rational design peptide D51 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus anthracis (MIC = 16 ug/ml) DME1126 XEOTICID XEO03065 GENEFORM Protein DME1126 XEOTICID XEO03065 MOACRIVE Inhibition DME1126 XEOTICID XEO03478 XEO_NAME Geobacillin I DME1126 XEOTICID XEO03478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1126 XEOTICID XEO03478 XEO_CLAS Peptide DME1126 XEOTICID XEO03478 DESCRIPT Geobacillin I inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus anthracis DME1126 XEOTICID XEO03478 GENEFORM Protein DME1126 XEOTICID XEO03478 MOACRIVE Inhibition DME1126 XEOTICID XEO04394 XEO_NAME Omwaprin-a DME1126 XEOTICID XEO04394 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1126 XEOTICID XEO04394 XEO_CLAS Peptide DME1126 XEOTICID XEO04394 DESCRIPT Omwaprin-a inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus anthracis DME1126 XEOTICID XEO04394 GENEFORM Protein DME1126 XEOTICID XEO04394 MOACRIVE Inhibition DME1126 XEOTICID XEO04624 XEO_NAME Plantazolicin DME1126 XEOTICID XEO04624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1126 XEOTICID XEO04624 XEO_CLAS Peptide DME1126 XEOTICID XEO04624 DESCRIPT Plantazolicin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Bacillus anthracis (MIC = 2-4 ug/ml) DME1126 XEOTICID XEO04624 GENEFORM Protein DME1126 XEOTICID XEO04624 MOACRIVE Inhibition DME1134 DME___ID DME1134 DME1134 DME_NAME Cellobiose 2-epimerase (CE) DME1134 SPESNAME Ruminococcus albus DME1134 XEOTICID XEO02661 XEO_NAME Butyrivibriocin AR10 DME1134 XEOTICID XEO02661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1134 XEOTICID XEO02661 XEO_CLAS Peptide DME1134 XEOTICID XEO02661 DESCRIPT Butyrivibriocin AR10 inhibits the drug-metabolizing activity of Cellobiose 2-epimerase (CE) from Ruminococcus albus DME1134 XEOTICID XEO02661 GENEFORM Protein DME1134 XEOTICID XEO02661 MOACRIVE Inhibition DME1137 DME___ID DME1137 DME1137 DME_NAME Maltose phosphorylase (malP) DME1137 SPESNAME Lactobacillus acidophilus DME1137 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1137 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1137 XEOTICID XEO03771 XEO_CLAS Peptide DME1137 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Maltose phosphorylase (malP) from Lactobacillus acidophilus DME1137 XEOTICID XEO03771 GENEFORM Protein DME1137 XEOTICID XEO03771 MOACRIVE Inhibition DME1137 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1137 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1137 XEOTICID XEO03803 XEO_CLAS Peptide DME1137 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Maltose phosphorylase (malP) from Lactobacillus acidophilus DME1137 XEOTICID XEO03803 GENEFORM Protein DME1137 XEOTICID XEO03803 MOACRIVE Inhibition DME1137 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1137 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1137 XEOTICID XEO04249 XEO_CLAS Peptide DME1137 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Maltose phosphorylase (malP) from Lactobacillus acidophilus (MIC > 500 ug/ml) DME1137 XEOTICID XEO04249 GENEFORM Protein DME1137 XEOTICID XEO04249 MOACRIVE Inhibition DME1137 XEOTICID XEO04320 XEO_NAME Nisin U DME1137 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1137 XEOTICID XEO04320 XEO_CLAS Peptide DME1137 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of Maltose phosphorylase (malP) from Lactobacillus acidophilus DME1137 XEOTICID XEO04320 GENEFORM Protein DME1137 XEOTICID XEO04320 MOACRIVE Inhibition DME1137 XEOTICID XEO05228 XEO_NAME Variacin DME1137 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1137 XEOTICID XEO05228 XEO_CLAS Peptide DME1137 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Maltose phosphorylase (malP) from Lactobacillus acidophilus DME1137 XEOTICID XEO05228 GENEFORM Protein DME1137 XEOTICID XEO05228 MOACRIVE Inhibition DME1140 DME___ID DME1140 DME1140 DME_NAME Beta-galactosidase (bgaB) DME1140 SPESNAME Bifidobacterium adolescentis DME1140 XEOTICID XEO03113 XEO_NAME Royalisin defensin-1 DME1140 XEOTICID XEO03113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1140 XEOTICID XEO03113 XEO_CLAS Peptide DME1140 XEOTICID XEO03113 DESCRIPT Royalisin defensin-1 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Bifidobacterium adolescentis DME1140 XEOTICID XEO03113 GENEFORM Protein DME1140 XEOTICID XEO03113 MOACRIVE Inhibition DME1141 DME___ID DME1141 DME1141 DME_NAME Aminoglycoside acetyltransferase (aac) DME1141 SPESNAME Providencia stuartii DME1141 XEOTICID XEO00122 XEO_NAME Amikacin DME1141 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1141 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1141 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Aminoglycoside acetyltransferase (aac) from Providencia stuartii DME1141 XEOTICID XEO00122 GENEFORM Protein DME1141 XEOTICID XEO00122 MOACRIVE Inhibition DME1141 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1141 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1141 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1141 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Aminoglycoside acetyltransferase (aac) from Providencia stuartii DME1141 XEOTICID XEO00237 GENEFORM Protein DME1141 XEOTICID XEO00237 MOACRIVE Inhibition DME1141 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1141 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1141 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1141 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Aminoglycoside acetyltransferase (aac) from Providencia stuartii DME1141 XEOTICID XEO00349 GENEFORM Protein DME1141 XEOTICID XEO00349 MOACRIVE Inhibition DME1141 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1141 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1141 XEOTICID XEO03575 XEO_CLAS Peptide DME1141 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Aminoglycoside acetyltransferase (aac) from Providencia stuartii (MIC = 110 microM) DME1141 XEOTICID XEO03575 GENEFORM Protein DME1141 XEOTICID XEO03575 MOACRIVE Inhibition DME1142 DME___ID DME1142 DME1142 DME_NAME Aminoglycoside O-phosphotransferase (aphA6) DME1142 SPESNAME Providencia stuartii DME1142 XEOTICID XEO00122 XEO_NAME Amikacin DME1142 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1142 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1142 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Providencia stuartii DME1142 XEOTICID XEO00122 GENEFORM Protein DME1142 XEOTICID XEO00122 MOACRIVE Inhibition DME1142 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1142 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1142 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1142 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Providencia stuartii DME1142 XEOTICID XEO00237 GENEFORM Protein DME1142 XEOTICID XEO00237 MOACRIVE Inhibition DME1142 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1142 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1142 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1142 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Providencia stuartii DME1142 XEOTICID XEO00349 GENEFORM Protein DME1142 XEOTICID XEO00349 MOACRIVE Inhibition DME1142 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1142 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1142 XEOTICID XEO03575 XEO_CLAS Peptide DME1142 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Aminoglycoside O-phosphotransferase (aphA6) from Providencia stuartii (MIC = 110 microM) DME1142 XEOTICID XEO03575 GENEFORM Protein DME1142 XEOTICID XEO03575 MOACRIVE Inhibition DME1143 DME___ID DME1143 DME1143 DME_NAME Hyaluronidase (hyl) DME1143 SPESNAME Bacillus megaterium DME1143 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1143 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1143 XEOTICID XEO05230 XEO_CLAS Peptide DME1143 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Hyaluronidase (hyl) from Bacillus megaterium (MIC = 2 microM) DME1143 XEOTICID XEO05230 GENEFORM Protein DME1143 XEOTICID XEO05230 MOACRIVE Inhibition DME1143 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1143 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1143 XEOTICID XEO05231 XEO_CLAS Peptide DME1143 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Hyaluronidase (hyl) from Bacillus megaterium (MIC = 0.60 microM) DME1143 XEOTICID XEO05231 GENEFORM Protein DME1143 XEOTICID XEO05231 MOACRIVE Inhibition DME1143 XEOTICID XEO05260 XEO_NAME V. philippinarum beta defensin VpBD DME1143 XEOTICID XEO05260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1143 XEOTICID XEO05260 XEO_CLAS Peptide DME1143 XEOTICID XEO05260 DESCRIPT V. philippinarum beta defensin VpBD inhibits the drug-metabolizing activity of Hyaluronidase (hyl) from Bacillus megaterium (MIC = 13.13-26.26 microM) DME1143 XEOTICID XEO05260 GENEFORM Protein DME1143 XEOTICID XEO05260 MOACRIVE Inhibition DME1149 DME___ID DME1149 DME1149 DME_NAME CDP-alcohol phosphatidyltransferase (pgsA) DME1149 SPESNAME Streptococcus mitis DME1149 XEOTICID XEO01559 XEO_NAME Limonene DME1149 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1149 XEOTICID XEO01559 XEO_CLAS Natural Product DME1149 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of CDP-alcohol phosphatidyltransferase (pgsA) from Streptococcus mitis DME1149 XEOTICID XEO01559 GENEFORM Protein DME1149 XEOTICID XEO01559 MOACRIVE Inhibition DME1149 XEOTICID XEO04155 XEO_NAME Mutacin-1140 DME1149 XEOTICID XEO04155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1149 XEOTICID XEO04155 XEO_CLAS Peptide DME1149 XEOTICID XEO04155 DESCRIPT Mutacin-1140 inhibits the drug-metabolizing activity of CDP-alcohol phosphatidyltransferase (pgsA) from Streptococcus mitis DME1149 XEOTICID XEO04155 GENEFORM Protein DME1149 XEOTICID XEO04155 MOACRIVE Inhibition DME1149 XEOTICID XEO04320 XEO_NAME Nisin U DME1149 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1149 XEOTICID XEO04320 XEO_CLAS Peptide DME1149 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of CDP-alcohol phosphatidyltransferase (pgsA) from Streptococcus mitis DME1149 XEOTICID XEO04320 GENEFORM Protein DME1149 XEOTICID XEO04320 MOACRIVE Inhibition DME1153 DME___ID DME1153 DME1153 DME_NAME Histidine decarboxylase (hdcA) DME1153 SPESNAME Lactobacillus reuteri DME1153 XEOTICID XEO03473 XEO_NAME Garvicin ML DME1153 XEOTICID XEO03473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1153 XEOTICID XEO03473 XEO_CLAS Peptide DME1153 XEOTICID XEO03473 DESCRIPT Garvicin ML inhibits the drug-metabolizing activity of Histidine decarboxylase (hdcA) from Lactobacillus reuteri DME1153 XEOTICID XEO03473 GENEFORM Protein DME1153 XEOTICID XEO03473 MOACRIVE Inhibition DME1153 XEOTICID XEO04319 XEO_NAME Nisin F DME1153 XEOTICID XEO04319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1153 XEOTICID XEO04319 XEO_CLAS Peptide DME1153 XEOTICID XEO04319 DESCRIPT Nisin F inhibits the drug-metabolizing activity of Histidine decarboxylase (hdcA) from Lactobacillus reuteri DME1153 XEOTICID XEO04319 GENEFORM Protein DME1153 XEOTICID XEO04319 MOACRIVE Inhibition DME1154 DME___ID DME1154 DME1154 DME_NAME ATP-dependent 6-phosphofructokinase (pfkA) DME1154 SPESNAME Lactobacillus delbrueckii DME1154 XEOTICID XEO02126 XEO_NAME Acidocin A DME1154 XEOTICID XEO02126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1154 XEOTICID XEO02126 XEO_CLAS Peptide DME1154 XEOTICID XEO02126 DESCRIPT Acidocin A inhibits the drug-metabolizing activity of ATP-dependent 6-phosphofructokinase (pfkA) from Lactobacillus delbrueckii DME1154 XEOTICID XEO02126 GENEFORM Protein DME1154 XEOTICID XEO02126 MOACRIVE Inhibition DME1154 XEOTICID XEO02127 XEO_NAME Acidocin B DME1154 XEOTICID XEO02127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1154 XEOTICID XEO02127 XEO_CLAS Peptide DME1154 XEOTICID XEO02127 DESCRIPT Acidocin B inhibits the drug-metabolizing activity of ATP-dependent 6-phosphofructokinase (pfkA) from Lactobacillus delbrueckii DME1154 XEOTICID XEO02127 GENEFORM Protein DME1154 XEOTICID XEO02127 MOACRIVE Inhibition DME1154 XEOTICID XEO02377 XEO_NAME Bacteriocin hiracin-JM79 DME1154 XEOTICID XEO02377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1154 XEOTICID XEO02377 XEO_CLAS Peptide DME1154 XEOTICID XEO02377 DESCRIPT Bacteriocin hiracin-JM79 inhibits the drug-metabolizing activity of ATP-dependent 6-phosphofructokinase (pfkA) from Lactobacillus delbrueckii DME1154 XEOTICID XEO02377 GENEFORM Protein DME1154 XEOTICID XEO02377 MOACRIVE Inhibition DME1154 XEOTICID XEO04730 XEO_NAME Protease-activated antimicrobial peptide DME1154 XEOTICID XEO04730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1154 XEOTICID XEO04730 XEO_CLAS Peptide DME1154 XEOTICID XEO04730 DESCRIPT Protease-activated antimicrobial peptide inhibits the drug-metabolizing activity of ATP-dependent 6-phosphofructokinase (pfkA) from Lactobacillus delbrueckii (MIC = 0.0005 microM) DME1154 XEOTICID XEO04730 GENEFORM Protein DME1154 XEOTICID XEO04730 MOACRIVE Inhibition DME1154 XEOTICID XEO05228 XEO_NAME Variacin DME1154 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1154 XEOTICID XEO05228 XEO_CLAS Peptide DME1154 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of ATP-dependent 6-phosphofructokinase (pfkA) from Lactobacillus delbrueckii DME1154 XEOTICID XEO05228 GENEFORM Protein DME1154 XEOTICID XEO05228 MOACRIVE Inhibition DME1162 DME___ID DME1162 DME1162 DME_NAME Beta-fructofuranosidase (BFRU) DME1162 SPESNAME Bifidobacterium longum DME1162 XEOTICID XEO03113 XEO_NAME Royalisin defensin-1 DME1162 XEOTICID XEO03113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1162 XEOTICID XEO03113 XEO_CLAS Peptide DME1162 XEOTICID XEO03113 DESCRIPT Royalisin defensin-1 inhibits the drug-metabolizing activity of Beta-fructofuranosidase (BFRU) from Bifidobacterium longum DME1162 XEOTICID XEO03113 GENEFORM Protein DME1162 XEOTICID XEO03113 MOACRIVE Inhibition DME1164 DME___ID DME1164 DME1164 DME_NAME Xylose isomerase (xylA) DME1164 SPESNAME Bifidobacterium adolescentis DME1164 XEOTICID XEO03113 XEO_NAME Royalisin defensin-1 DME1164 XEOTICID XEO03113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1164 XEOTICID XEO03113 XEO_CLAS Peptide DME1164 XEOTICID XEO03113 DESCRIPT Royalisin defensin-1 inhibits the drug-metabolizing activity of Xylose isomerase (xylA) from Bifidobacterium adolescentis DME1164 XEOTICID XEO03113 GENEFORM Protein DME1164 XEOTICID XEO03113 MOACRIVE Inhibition DME1167 DME___ID DME1167 DME1167 DME_NAME Dextransucrase 1 (dsrF1) DME1167 SPESNAME Leuconostoc mesenteroides DME1167 XEOTICID XEO02382 XEO_NAME Bacteriocin plantarican ASM1 DME1167 XEOTICID XEO02382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO02382 XEO_CLAS Peptide DME1167 XEOTICID XEO02382 DESCRIPT Bacteriocin plantarican ASM1 inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides DME1167 XEOTICID XEO02382 GENEFORM Protein DME1167 XEOTICID XEO02382 MOACRIVE Inhibition DME1167 XEOTICID XEO02476 XEO_NAME Bacteriocin HJ50 DME1167 XEOTICID XEO02476 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO02476 XEO_CLAS Peptide DME1167 XEOTICID XEO02476 DESCRIPT Bacteriocin HJ50 inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides DME1167 XEOTICID XEO02476 GENEFORM Protein DME1167 XEOTICID XEO02476 MOACRIVE Inhibition DME1167 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1167 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO02721 XEO_CLAS Peptide DME1167 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides DME1167 XEOTICID XEO02721 GENEFORM Protein DME1167 XEOTICID XEO02721 MOACRIVE Inhibition DME1167 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1167 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO03250 XEO_CLAS Peptide DME1167 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides DME1167 XEOTICID XEO03250 GENEFORM Protein DME1167 XEOTICID XEO03250 MOACRIVE Inhibition DME1167 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1167 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO03258 XEO_CLAS Peptide DME1167 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides DME1167 XEOTICID XEO03258 GENEFORM Protein DME1167 XEOTICID XEO03258 MOACRIVE Inhibition DME1167 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1167 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO03406 XEO_CLAS Peptide DME1167 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides (MIC = 25 ug/ml) DME1167 XEOTICID XEO03406 GENEFORM Protein DME1167 XEOTICID XEO03406 MOACRIVE Inhibition DME1167 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1167 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO03771 XEO_CLAS Peptide DME1167 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides DME1167 XEOTICID XEO03771 GENEFORM Protein DME1167 XEOTICID XEO03771 MOACRIVE Inhibition DME1167 XEOTICID XEO03806 XEO_NAME Lantibiotic paenibacillin DME1167 XEOTICID XEO03806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO03806 XEO_CLAS Peptide DME1167 XEOTICID XEO03806 DESCRIPT Lantibiotic paenibacillin inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides DME1167 XEOTICID XEO03806 GENEFORM Protein DME1167 XEOTICID XEO03806 MOACRIVE Inhibition DME1167 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1167 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO03854 XEO_CLAS Peptide DME1167 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides (MIC = 2.60 microM) DME1167 XEOTICID XEO03854 GENEFORM Protein DME1167 XEOTICID XEO03854 MOACRIVE Inhibition DME1167 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1167 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO03855 XEO_CLAS Peptide DME1167 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides (MIC = 4.10 microM) DME1167 XEOTICID XEO03855 GENEFORM Protein DME1167 XEOTICID XEO03855 MOACRIVE Inhibition DME1167 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1167 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO03857 XEO_CLAS Peptide DME1167 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides (MIC = 0.3 microM) DME1167 XEOTICID XEO03857 GENEFORM Protein DME1167 XEOTICID XEO03857 MOACRIVE Inhibition DME1167 XEOTICID XEO04150 XEO_NAME Mundticin ATO6 DME1167 XEOTICID XEO04150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO04150 XEO_CLAS Peptide DME1167 XEOTICID XEO04150 DESCRIPT Mundticin ATO6 inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides DME1167 XEOTICID XEO04150 GENEFORM Protein DME1167 XEOTICID XEO04150 MOACRIVE Inhibition DME1167 XEOTICID XEO04521 XEO_NAME Penocin A DME1167 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO04521 XEO_CLAS Peptide DME1167 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides DME1167 XEOTICID XEO04521 GENEFORM Protein DME1167 XEOTICID XEO04521 MOACRIVE Inhibition DME1167 XEOTICID XEO04622 XEO_NAME Plantaricin W alpha DME1167 XEOTICID XEO04622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO04622 XEO_CLAS Peptide DME1167 XEOTICID XEO04622 DESCRIPT Plantaricin W alpha inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides DME1167 XEOTICID XEO04622 GENEFORM Protein DME1167 XEOTICID XEO04622 MOACRIVE Inhibition DME1167 XEOTICID XEO04623 XEO_NAME Plantaricin W beta DME1167 XEOTICID XEO04623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO04623 XEO_CLAS Peptide DME1167 XEOTICID XEO04623 DESCRIPT Plantaricin W beta inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides DME1167 XEOTICID XEO04623 GENEFORM Protein DME1167 XEOTICID XEO04623 MOACRIVE Inhibition DME1167 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1167 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO05004 XEO_CLAS Peptide DME1167 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides DME1167 XEOTICID XEO05004 GENEFORM Protein DME1167 XEOTICID XEO05004 MOACRIVE Inhibition DME1167 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1167 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO05005 XEO_CLAS Peptide DME1167 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides DME1167 XEOTICID XEO05005 GENEFORM Protein DME1167 XEOTICID XEO05005 MOACRIVE Inhibition DME1167 XEOTICID XEO05228 XEO_NAME Variacin DME1167 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1167 XEOTICID XEO05228 XEO_CLAS Peptide DME1167 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Dextransucrase 1 (dsrF1) from Leuconostoc mesenteroides DME1167 XEOTICID XEO05228 GENEFORM Protein DME1167 XEOTICID XEO05228 MOACRIVE Inhibition DME1168 DME___ID DME1168 DME1168 DME_NAME Dextransucrase 2 (dsrF2) DME1168 SPESNAME Leuconostoc mesenteroides DME1168 XEOTICID XEO02382 XEO_NAME Bacteriocin plantarican ASM1 DME1168 XEOTICID XEO02382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO02382 XEO_CLAS Peptide DME1168 XEOTICID XEO02382 DESCRIPT Bacteriocin plantarican ASM1 inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides DME1168 XEOTICID XEO02382 GENEFORM Protein DME1168 XEOTICID XEO02382 MOACRIVE Inhibition DME1168 XEOTICID XEO02476 XEO_NAME Bacteriocin HJ50 DME1168 XEOTICID XEO02476 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO02476 XEO_CLAS Peptide DME1168 XEOTICID XEO02476 DESCRIPT Bacteriocin HJ50 inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides DME1168 XEOTICID XEO02476 GENEFORM Protein DME1168 XEOTICID XEO02476 MOACRIVE Inhibition DME1168 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1168 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO02721 XEO_CLAS Peptide DME1168 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides DME1168 XEOTICID XEO02721 GENEFORM Protein DME1168 XEOTICID XEO02721 MOACRIVE Inhibition DME1168 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1168 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO03250 XEO_CLAS Peptide DME1168 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides DME1168 XEOTICID XEO03250 GENEFORM Protein DME1168 XEOTICID XEO03250 MOACRIVE Inhibition DME1168 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1168 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO03258 XEO_CLAS Peptide DME1168 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides DME1168 XEOTICID XEO03258 GENEFORM Protein DME1168 XEOTICID XEO03258 MOACRIVE Inhibition DME1168 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1168 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO03406 XEO_CLAS Peptide DME1168 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides (MIC = 25 ug/ml) DME1168 XEOTICID XEO03406 GENEFORM Protein DME1168 XEOTICID XEO03406 MOACRIVE Inhibition DME1168 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1168 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO03771 XEO_CLAS Peptide DME1168 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides DME1168 XEOTICID XEO03771 GENEFORM Protein DME1168 XEOTICID XEO03771 MOACRIVE Inhibition DME1168 XEOTICID XEO03806 XEO_NAME Lantibiotic paenibacillin DME1168 XEOTICID XEO03806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO03806 XEO_CLAS Peptide DME1168 XEOTICID XEO03806 DESCRIPT Lantibiotic paenibacillin inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides DME1168 XEOTICID XEO03806 GENEFORM Protein DME1168 XEOTICID XEO03806 MOACRIVE Inhibition DME1168 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1168 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO03854 XEO_CLAS Peptide DME1168 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides (MIC = 2.60 microM) DME1168 XEOTICID XEO03854 GENEFORM Protein DME1168 XEOTICID XEO03854 MOACRIVE Inhibition DME1168 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1168 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO03855 XEO_CLAS Peptide DME1168 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides (MIC = 4.10 microM) DME1168 XEOTICID XEO03855 GENEFORM Protein DME1168 XEOTICID XEO03855 MOACRIVE Inhibition DME1168 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1168 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO03857 XEO_CLAS Peptide DME1168 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides (MIC = 0.3 microM) DME1168 XEOTICID XEO03857 GENEFORM Protein DME1168 XEOTICID XEO03857 MOACRIVE Inhibition DME1168 XEOTICID XEO04150 XEO_NAME Mundticin ATO6 DME1168 XEOTICID XEO04150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO04150 XEO_CLAS Peptide DME1168 XEOTICID XEO04150 DESCRIPT Mundticin ATO6 inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides DME1168 XEOTICID XEO04150 GENEFORM Protein DME1168 XEOTICID XEO04150 MOACRIVE Inhibition DME1168 XEOTICID XEO04521 XEO_NAME Penocin A DME1168 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO04521 XEO_CLAS Peptide DME1168 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides DME1168 XEOTICID XEO04521 GENEFORM Protein DME1168 XEOTICID XEO04521 MOACRIVE Inhibition DME1168 XEOTICID XEO04622 XEO_NAME Plantaricin W alpha DME1168 XEOTICID XEO04622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO04622 XEO_CLAS Peptide DME1168 XEOTICID XEO04622 DESCRIPT Plantaricin W alpha inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides DME1168 XEOTICID XEO04622 GENEFORM Protein DME1168 XEOTICID XEO04622 MOACRIVE Inhibition DME1168 XEOTICID XEO04623 XEO_NAME Plantaricin W beta DME1168 XEOTICID XEO04623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO04623 XEO_CLAS Peptide DME1168 XEOTICID XEO04623 DESCRIPT Plantaricin W beta inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides DME1168 XEOTICID XEO04623 GENEFORM Protein DME1168 XEOTICID XEO04623 MOACRIVE Inhibition DME1168 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1168 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO05004 XEO_CLAS Peptide DME1168 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides DME1168 XEOTICID XEO05004 GENEFORM Protein DME1168 XEOTICID XEO05004 MOACRIVE Inhibition DME1168 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1168 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO05005 XEO_CLAS Peptide DME1168 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides DME1168 XEOTICID XEO05005 GENEFORM Protein DME1168 XEOTICID XEO05005 MOACRIVE Inhibition DME1168 XEOTICID XEO05228 XEO_NAME Variacin DME1168 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1168 XEOTICID XEO05228 XEO_CLAS Peptide DME1168 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Dextransucrase 2 (dsrF2) from Leuconostoc mesenteroides DME1168 XEOTICID XEO05228 GENEFORM Protein DME1168 XEOTICID XEO05228 MOACRIVE Inhibition DME1169 DME___ID DME1169 DME1169 DME_NAME Dextransucrase 3 (dsrF3) DME1169 SPESNAME Leuconostoc mesenteroides DME1169 XEOTICID XEO02382 XEO_NAME Bacteriocin plantarican ASM1 DME1169 XEOTICID XEO02382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO02382 XEO_CLAS Peptide DME1169 XEOTICID XEO02382 DESCRIPT Bacteriocin plantarican ASM1 inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides DME1169 XEOTICID XEO02382 GENEFORM Protein DME1169 XEOTICID XEO02382 MOACRIVE Inhibition DME1169 XEOTICID XEO02476 XEO_NAME Bacteriocin HJ50 DME1169 XEOTICID XEO02476 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO02476 XEO_CLAS Peptide DME1169 XEOTICID XEO02476 DESCRIPT Bacteriocin HJ50 inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides DME1169 XEOTICID XEO02476 GENEFORM Protein DME1169 XEOTICID XEO02476 MOACRIVE Inhibition DME1169 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1169 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO02721 XEO_CLAS Peptide DME1169 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides DME1169 XEOTICID XEO02721 GENEFORM Protein DME1169 XEOTICID XEO02721 MOACRIVE Inhibition DME1169 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1169 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO03250 XEO_CLAS Peptide DME1169 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides DME1169 XEOTICID XEO03250 GENEFORM Protein DME1169 XEOTICID XEO03250 MOACRIVE Inhibition DME1169 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1169 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO03258 XEO_CLAS Peptide DME1169 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides DME1169 XEOTICID XEO03258 GENEFORM Protein DME1169 XEOTICID XEO03258 MOACRIVE Inhibition DME1169 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1169 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO03406 XEO_CLAS Peptide DME1169 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides (MIC = 25 ug/ml) DME1169 XEOTICID XEO03406 GENEFORM Protein DME1169 XEOTICID XEO03406 MOACRIVE Inhibition DME1169 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1169 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO03771 XEO_CLAS Peptide DME1169 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides DME1169 XEOTICID XEO03771 GENEFORM Protein DME1169 XEOTICID XEO03771 MOACRIVE Inhibition DME1169 XEOTICID XEO03806 XEO_NAME Lantibiotic paenibacillin DME1169 XEOTICID XEO03806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO03806 XEO_CLAS Peptide DME1169 XEOTICID XEO03806 DESCRIPT Lantibiotic paenibacillin inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides DME1169 XEOTICID XEO03806 GENEFORM Protein DME1169 XEOTICID XEO03806 MOACRIVE Inhibition DME1169 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1169 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO03854 XEO_CLAS Peptide DME1169 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides (MIC = 2.60 microM) DME1169 XEOTICID XEO03854 GENEFORM Protein DME1169 XEOTICID XEO03854 MOACRIVE Inhibition DME1169 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1169 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO03855 XEO_CLAS Peptide DME1169 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides (MIC = 4.10 microM) DME1169 XEOTICID XEO03855 GENEFORM Protein DME1169 XEOTICID XEO03855 MOACRIVE Inhibition DME1169 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1169 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO03857 XEO_CLAS Peptide DME1169 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides (MIC = 0.3 microM) DME1169 XEOTICID XEO03857 GENEFORM Protein DME1169 XEOTICID XEO03857 MOACRIVE Inhibition DME1169 XEOTICID XEO04150 XEO_NAME Mundticin ATO6 DME1169 XEOTICID XEO04150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO04150 XEO_CLAS Peptide DME1169 XEOTICID XEO04150 DESCRIPT Mundticin ATO6 inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides DME1169 XEOTICID XEO04150 GENEFORM Protein DME1169 XEOTICID XEO04150 MOACRIVE Inhibition DME1169 XEOTICID XEO04521 XEO_NAME Penocin A DME1169 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO04521 XEO_CLAS Peptide DME1169 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides DME1169 XEOTICID XEO04521 GENEFORM Protein DME1169 XEOTICID XEO04521 MOACRIVE Inhibition DME1169 XEOTICID XEO04622 XEO_NAME Plantaricin W alpha DME1169 XEOTICID XEO04622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO04622 XEO_CLAS Peptide DME1169 XEOTICID XEO04622 DESCRIPT Plantaricin W alpha inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides DME1169 XEOTICID XEO04622 GENEFORM Protein DME1169 XEOTICID XEO04622 MOACRIVE Inhibition DME1169 XEOTICID XEO04623 XEO_NAME Plantaricin W beta DME1169 XEOTICID XEO04623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO04623 XEO_CLAS Peptide DME1169 XEOTICID XEO04623 DESCRIPT Plantaricin W beta inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides DME1169 XEOTICID XEO04623 GENEFORM Protein DME1169 XEOTICID XEO04623 MOACRIVE Inhibition DME1169 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1169 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO05004 XEO_CLAS Peptide DME1169 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides DME1169 XEOTICID XEO05004 GENEFORM Protein DME1169 XEOTICID XEO05004 MOACRIVE Inhibition DME1169 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1169 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO05005 XEO_CLAS Peptide DME1169 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides DME1169 XEOTICID XEO05005 GENEFORM Protein DME1169 XEOTICID XEO05005 MOACRIVE Inhibition DME1169 XEOTICID XEO05228 XEO_NAME Variacin DME1169 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1169 XEOTICID XEO05228 XEO_CLAS Peptide DME1169 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Dextransucrase 3 (dsrF3) from Leuconostoc mesenteroides DME1169 XEOTICID XEO05228 GENEFORM Protein DME1169 XEOTICID XEO05228 MOACRIVE Inhibition DME1170 DME___ID DME1170 DME1170 DME_NAME Dextransucrase 4 (dsrF4) DME1170 SPESNAME Leuconostoc mesenteroides DME1170 XEOTICID XEO02382 XEO_NAME Bacteriocin plantarican ASM1 DME1170 XEOTICID XEO02382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO02382 XEO_CLAS Peptide DME1170 XEOTICID XEO02382 DESCRIPT Bacteriocin plantarican ASM1 inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides DME1170 XEOTICID XEO02382 GENEFORM Protein DME1170 XEOTICID XEO02382 MOACRIVE Inhibition DME1170 XEOTICID XEO02476 XEO_NAME Bacteriocin HJ50 DME1170 XEOTICID XEO02476 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO02476 XEO_CLAS Peptide DME1170 XEOTICID XEO02476 DESCRIPT Bacteriocin HJ50 inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides DME1170 XEOTICID XEO02476 GENEFORM Protein DME1170 XEOTICID XEO02476 MOACRIVE Inhibition DME1170 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1170 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO02721 XEO_CLAS Peptide DME1170 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides DME1170 XEOTICID XEO02721 GENEFORM Protein DME1170 XEOTICID XEO02721 MOACRIVE Inhibition DME1170 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1170 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO03250 XEO_CLAS Peptide DME1170 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides DME1170 XEOTICID XEO03250 GENEFORM Protein DME1170 XEOTICID XEO03250 MOACRIVE Inhibition DME1170 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1170 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO03258 XEO_CLAS Peptide DME1170 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides DME1170 XEOTICID XEO03258 GENEFORM Protein DME1170 XEOTICID XEO03258 MOACRIVE Inhibition DME1170 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1170 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO03406 XEO_CLAS Peptide DME1170 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides (MIC = 25 ug/ml) DME1170 XEOTICID XEO03406 GENEFORM Protein DME1170 XEOTICID XEO03406 MOACRIVE Inhibition DME1170 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1170 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO03771 XEO_CLAS Peptide DME1170 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides DME1170 XEOTICID XEO03771 GENEFORM Protein DME1170 XEOTICID XEO03771 MOACRIVE Inhibition DME1170 XEOTICID XEO03806 XEO_NAME Lantibiotic paenibacillin DME1170 XEOTICID XEO03806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO03806 XEO_CLAS Peptide DME1170 XEOTICID XEO03806 DESCRIPT Lantibiotic paenibacillin inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides DME1170 XEOTICID XEO03806 GENEFORM Protein DME1170 XEOTICID XEO03806 MOACRIVE Inhibition DME1170 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1170 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO03854 XEO_CLAS Peptide DME1170 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides (MIC = 2.60 microM) DME1170 XEOTICID XEO03854 GENEFORM Protein DME1170 XEOTICID XEO03854 MOACRIVE Inhibition DME1170 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1170 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO03855 XEO_CLAS Peptide DME1170 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides (MIC = 4.10 microM) DME1170 XEOTICID XEO03855 GENEFORM Protein DME1170 XEOTICID XEO03855 MOACRIVE Inhibition DME1170 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1170 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO03857 XEO_CLAS Peptide DME1170 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides (MIC = 0.3 microM) DME1170 XEOTICID XEO03857 GENEFORM Protein DME1170 XEOTICID XEO03857 MOACRIVE Inhibition DME1170 XEOTICID XEO04150 XEO_NAME Mundticin ATO6 DME1170 XEOTICID XEO04150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO04150 XEO_CLAS Peptide DME1170 XEOTICID XEO04150 DESCRIPT Mundticin ATO6 inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides DME1170 XEOTICID XEO04150 GENEFORM Protein DME1170 XEOTICID XEO04150 MOACRIVE Inhibition DME1170 XEOTICID XEO04521 XEO_NAME Penocin A DME1170 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO04521 XEO_CLAS Peptide DME1170 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides DME1170 XEOTICID XEO04521 GENEFORM Protein DME1170 XEOTICID XEO04521 MOACRIVE Inhibition DME1170 XEOTICID XEO04622 XEO_NAME Plantaricin W alpha DME1170 XEOTICID XEO04622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO04622 XEO_CLAS Peptide DME1170 XEOTICID XEO04622 DESCRIPT Plantaricin W alpha inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides DME1170 XEOTICID XEO04622 GENEFORM Protein DME1170 XEOTICID XEO04622 MOACRIVE Inhibition DME1170 XEOTICID XEO04623 XEO_NAME Plantaricin W beta DME1170 XEOTICID XEO04623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO04623 XEO_CLAS Peptide DME1170 XEOTICID XEO04623 DESCRIPT Plantaricin W beta inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides DME1170 XEOTICID XEO04623 GENEFORM Protein DME1170 XEOTICID XEO04623 MOACRIVE Inhibition DME1170 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1170 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO05004 XEO_CLAS Peptide DME1170 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides DME1170 XEOTICID XEO05004 GENEFORM Protein DME1170 XEOTICID XEO05004 MOACRIVE Inhibition DME1170 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1170 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO05005 XEO_CLAS Peptide DME1170 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides DME1170 XEOTICID XEO05005 GENEFORM Protein DME1170 XEOTICID XEO05005 MOACRIVE Inhibition DME1170 XEOTICID XEO05228 XEO_NAME Variacin DME1170 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1170 XEOTICID XEO05228 XEO_CLAS Peptide DME1170 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Dextransucrase 4 (dsrF4) from Leuconostoc mesenteroides DME1170 XEOTICID XEO05228 GENEFORM Protein DME1170 XEOTICID XEO05228 MOACRIVE Inhibition DME1172 DME___ID DME1172 DME1172 DME_NAME Aminoglycoside N-acetyltransferase (aacC2) DME1172 SPESNAME Acinetobacter baumannii DME1172 XEOTICID XEO01366 XEO_NAME Linalool DME1172 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1172 XEOTICID XEO01366 XEO_CLAS Natural Product DME1172 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii DME1172 XEOTICID XEO01366 GENEFORM Protein DME1172 XEOTICID XEO01366 MOACRIVE Inhibition DME1172 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1172 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1172 XEOTICID XEO01816 XEO_CLAS Peptide DME1172 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii (MIC = 3 microM) DME1172 XEOTICID XEO01816 GENEFORM Protein DME1172 XEOTICID XEO01816 MOACRIVE Inhibition DME1172 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1172 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1172 XEOTICID XEO01824 XEO_CLAS Peptide DME1172 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii (MIC = 50 microM) DME1172 XEOTICID XEO01824 GENEFORM Protein DME1172 XEOTICID XEO01824 MOACRIVE Inhibition DME1172 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1172 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1172 XEOTICID XEO02731 XEO_CLAS Peptide DME1172 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii DME1172 XEOTICID XEO02731 GENEFORM Protein DME1172 XEOTICID XEO02731 MOACRIVE Inhibition DME1172 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1172 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1172 XEOTICID XEO02900 XEO_CLAS Peptide DME1172 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii DME1172 XEOTICID XEO02900 GENEFORM Protein DME1172 XEOTICID XEO02900 MOACRIVE Inhibition DME1172 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1172 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1172 XEOTICID XEO02942 XEO_CLAS Peptide DME1172 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii DME1172 XEOTICID XEO02942 GENEFORM Protein DME1172 XEOTICID XEO02942 MOACRIVE Inhibition DME1172 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1172 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1172 XEOTICID XEO03540 XEO_CLAS Peptide DME1172 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii (MIC = 8-16 ug/ml) DME1172 XEOTICID XEO03540 GENEFORM Protein DME1172 XEOTICID XEO03540 MOACRIVE Inhibition DME1172 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1172 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1172 XEOTICID XEO03556 XEO_CLAS Peptide DME1172 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii (MIC = 8-16 ug/ml) DME1172 XEOTICID XEO03556 GENEFORM Protein DME1172 XEOTICID XEO03556 MOACRIVE Inhibition DME1172 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1172 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1172 XEOTICID XEO03557 XEO_CLAS Peptide DME1172 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii (MIC = 8-16 ug/ml) DME1172 XEOTICID XEO03557 GENEFORM Protein DME1172 XEOTICID XEO03557 MOACRIVE Inhibition DME1172 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1172 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1172 XEOTICID XEO03609 XEO_CLAS Peptide DME1172 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii DME1172 XEOTICID XEO03609 GENEFORM Protein DME1172 XEOTICID XEO03609 MOACRIVE Inhibition DME1172 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1172 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1172 XEOTICID XEO03678 XEO_CLAS Peptide DME1172 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii (MIC = 0.8 ug/ml) DME1172 XEOTICID XEO03678 GENEFORM Protein DME1172 XEOTICID XEO03678 MOACRIVE Inhibition DME1172 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1172 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1172 XEOTICID XEO04001 XEO_CLAS Peptide DME1172 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii (MIC = 2.7 microM) DME1172 XEOTICID XEO04001 GENEFORM Protein DME1172 XEOTICID XEO04001 MOACRIVE Inhibition DME1172 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1172 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1172 XEOTICID XEO04241 XEO_CLAS Peptide DME1172 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii DME1172 XEOTICID XEO04241 GENEFORM Protein DME1172 XEOTICID XEO04241 MOACRIVE Inhibition DME1172 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1172 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1172 XEOTICID XEO04242 XEO_CLAS Peptide DME1172 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii DME1172 XEOTICID XEO04242 GENEFORM Protein DME1172 XEOTICID XEO04242 MOACRIVE Inhibition DME1172 XEOTICID XEO04331 XEO_NAME Norspermidine DME1172 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1172 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1172 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii DME1172 XEOTICID XEO04331 GENEFORM Protein DME1172 XEOTICID XEO04331 MOACRIVE Inhibition DME1172 XEOTICID XEO04686 XEO_NAME Polyethyleneimine DME1172 XEOTICID XEO04686 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1172 XEOTICID XEO04686 XEO_CLAS Chemical Compound DME1172 XEOTICID XEO04686 DESCRIPT Polyethyleneimine inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii DME1172 XEOTICID XEO04686 GENEFORM Protein DME1172 XEOTICID XEO04686 MOACRIVE Inhibition DME1172 XEOTICID XEO04888 XEO_NAME CP-P derivative S16 DME1172 XEOTICID XEO04888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1172 XEOTICID XEO04888 XEO_CLAS Peptide DME1172 XEOTICID XEO04888 DESCRIPT CP-P derivative S16 inhibits the drug-metabolizing activity of Aminoglycoside N-acetyltransferase (aacC2) from Acinetobacter baumannii (MIC = 3.125 ug/ml) DME1172 XEOTICID XEO04888 GENEFORM Protein DME1172 XEOTICID XEO04888 MOACRIVE Inhibition DME1175 DME___ID DME1175 DME1175 DME_NAME Beta-glucosidase (bglA) DME1175 SPESNAME Bacillus subtilis DME1175 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1175 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1175 XEOTICID XEO05230 XEO_CLAS Peptide DME1175 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Bacillus subtilis (MIC = 2 microM) DME1175 XEOTICID XEO05230 GENEFORM Protein DME1175 XEOTICID XEO05230 MOACRIVE Inhibition DME1175 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1175 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1175 XEOTICID XEO05231 XEO_CLAS Peptide DME1175 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Bacillus subtilis (MIC = 0.60 microM) DME1175 XEOTICID XEO05231 GENEFORM Protein DME1175 XEOTICID XEO05231 MOACRIVE Inhibition DME1175 XEOTICID XEO05260 XEO_NAME V. philippinarum beta defensin VpBD DME1175 XEOTICID XEO05260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1175 XEOTICID XEO05260 XEO_CLAS Peptide DME1175 XEOTICID XEO05260 DESCRIPT V. philippinarum beta defensin VpBD inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Bacillus subtilis (MIC = 13.13-26.26 microM) DME1175 XEOTICID XEO05260 GENEFORM Protein DME1175 XEOTICID XEO05260 MOACRIVE Inhibition DME1177 DME___ID DME1177 DME1177 DME_NAME Inositol dehydrogenase (idh) DME1177 SPESNAME Lactobacillus casei DME1177 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1177 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1177 XEOTICID XEO03771 XEO_CLAS Peptide DME1177 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei DME1177 XEOTICID XEO03771 GENEFORM Protein DME1177 XEOTICID XEO03771 MOACRIVE Inhibition DME1177 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1177 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1177 XEOTICID XEO03775 XEO_CLAS Peptide DME1177 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei (MIC = 2.27 microM) DME1177 XEOTICID XEO03775 GENEFORM Protein DME1177 XEOTICID XEO03775 MOACRIVE Inhibition DME1177 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1177 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1177 XEOTICID XEO03803 XEO_CLAS Peptide DME1177 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei DME1177 XEOTICID XEO03803 GENEFORM Protein DME1177 XEOTICID XEO03803 MOACRIVE Inhibition DME1177 XEOTICID XEO03967 XEO_NAME Bacteriocin LSEI_2163 DME1177 XEOTICID XEO03967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1177 XEOTICID XEO03967 XEO_CLAS Peptide DME1177 XEOTICID XEO03967 DESCRIPT Bacteriocin LSEI_2163 inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei DME1177 XEOTICID XEO03967 GENEFORM Protein DME1177 XEOTICID XEO03967 MOACRIVE Inhibition DME1177 XEOTICID XEO04332 XEO_NAME Nosiheptide DME1177 XEOTICID XEO04332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1177 XEOTICID XEO04332 XEO_CLAS Peptide DME1177 XEOTICID XEO04332 DESCRIPT Nosiheptide inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei (MIC = 0.003 ug/ml) DME1177 XEOTICID XEO04332 GENEFORM Protein DME1177 XEOTICID XEO04332 MOACRIVE Inhibition DME1177 XEOTICID XEO04521 XEO_NAME Penocin A DME1177 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1177 XEOTICID XEO04521 XEO_CLAS Peptide DME1177 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei DME1177 XEOTICID XEO04521 GENEFORM Protein DME1177 XEOTICID XEO04521 MOACRIVE Inhibition DME1177 XEOTICID XEO04616 XEO_NAME Plantaricin E DME1177 XEOTICID XEO04616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1177 XEOTICID XEO04616 XEO_CLAS Peptide DME1177 XEOTICID XEO04616 DESCRIPT Plantaricin E inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei (MIC = 0.02 microM) DME1177 XEOTICID XEO04616 GENEFORM Protein DME1177 XEOTICID XEO04616 MOACRIVE Inhibition DME1177 XEOTICID XEO04617 XEO_NAME Plantaricin F DME1177 XEOTICID XEO04617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1177 XEOTICID XEO04617 XEO_CLAS Peptide DME1177 XEOTICID XEO04617 DESCRIPT Plantaricin F inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei (MIC = 0.02 microM) DME1177 XEOTICID XEO04617 GENEFORM Protein DME1177 XEOTICID XEO04617 MOACRIVE Inhibition DME1177 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1177 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1177 XEOTICID XEO05004 XEO_CLAS Peptide DME1177 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei DME1177 XEOTICID XEO05004 GENEFORM Protein DME1177 XEOTICID XEO05004 MOACRIVE Inhibition DME1177 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1177 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1177 XEOTICID XEO05005 XEO_CLAS Peptide DME1177 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei DME1177 XEOTICID XEO05005 GENEFORM Protein DME1177 XEOTICID XEO05005 MOACRIVE Inhibition DME1177 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1177 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1177 XEOTICID XEO05283 XEO_CLAS Peptide DME1177 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei DME1177 XEOTICID XEO05283 GENEFORM Protein DME1177 XEOTICID XEO05283 MOACRIVE Inhibition DME1178 DME___ID DME1178 DME1178 DME_NAME Inositol dehydrogenase (idh) DME1178 SPESNAME Lactobacillus casei DME1178 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1178 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1178 XEOTICID XEO03771 XEO_CLAS Peptide DME1178 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei DME1178 XEOTICID XEO03771 GENEFORM Protein DME1178 XEOTICID XEO03771 MOACRIVE Inhibition DME1178 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1178 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1178 XEOTICID XEO03775 XEO_CLAS Peptide DME1178 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei (MIC = 2.27 microM) DME1178 XEOTICID XEO03775 GENEFORM Protein DME1178 XEOTICID XEO03775 MOACRIVE Inhibition DME1178 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1178 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1178 XEOTICID XEO03803 XEO_CLAS Peptide DME1178 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei DME1178 XEOTICID XEO03803 GENEFORM Protein DME1178 XEOTICID XEO03803 MOACRIVE Inhibition DME1178 XEOTICID XEO03967 XEO_NAME Bacteriocin LSEI_2163 DME1178 XEOTICID XEO03967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1178 XEOTICID XEO03967 XEO_CLAS Peptide DME1178 XEOTICID XEO03967 DESCRIPT Bacteriocin LSEI_2163 inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei DME1178 XEOTICID XEO03967 GENEFORM Protein DME1178 XEOTICID XEO03967 MOACRIVE Inhibition DME1178 XEOTICID XEO04332 XEO_NAME Nosiheptide DME1178 XEOTICID XEO04332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1178 XEOTICID XEO04332 XEO_CLAS Peptide DME1178 XEOTICID XEO04332 DESCRIPT Nosiheptide inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei (MIC = 0.003 ug/ml) DME1178 XEOTICID XEO04332 GENEFORM Protein DME1178 XEOTICID XEO04332 MOACRIVE Inhibition DME1178 XEOTICID XEO04521 XEO_NAME Penocin A DME1178 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1178 XEOTICID XEO04521 XEO_CLAS Peptide DME1178 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei DME1178 XEOTICID XEO04521 GENEFORM Protein DME1178 XEOTICID XEO04521 MOACRIVE Inhibition DME1178 XEOTICID XEO04616 XEO_NAME Plantaricin E DME1178 XEOTICID XEO04616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1178 XEOTICID XEO04616 XEO_CLAS Peptide DME1178 XEOTICID XEO04616 DESCRIPT Plantaricin E inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei (MIC = 0.02 microM) DME1178 XEOTICID XEO04616 GENEFORM Protein DME1178 XEOTICID XEO04616 MOACRIVE Inhibition DME1178 XEOTICID XEO04617 XEO_NAME Plantaricin F DME1178 XEOTICID XEO04617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1178 XEOTICID XEO04617 XEO_CLAS Peptide DME1178 XEOTICID XEO04617 DESCRIPT Plantaricin F inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei (MIC = 0.02 microM) DME1178 XEOTICID XEO04617 GENEFORM Protein DME1178 XEOTICID XEO04617 MOACRIVE Inhibition DME1178 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1178 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1178 XEOTICID XEO05004 XEO_CLAS Peptide DME1178 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei DME1178 XEOTICID XEO05004 GENEFORM Protein DME1178 XEOTICID XEO05004 MOACRIVE Inhibition DME1178 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1178 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1178 XEOTICID XEO05005 XEO_CLAS Peptide DME1178 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei DME1178 XEOTICID XEO05005 GENEFORM Protein DME1178 XEOTICID XEO05005 MOACRIVE Inhibition DME1178 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1178 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1178 XEOTICID XEO05283 XEO_CLAS Peptide DME1178 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Inositol dehydrogenase (idh) from Lactobacillus casei DME1178 XEOTICID XEO05283 GENEFORM Protein DME1178 XEOTICID XEO05283 MOACRIVE Inhibition DME1184 DME___ID DME1184 DME1184 DME_NAME VanB ligase (vanB) DME1184 SPESNAME Enterococcus faecium DME1184 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1184 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1184 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1184 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO01961 GENEFORM Protein DME1184 XEOTICID XEO01961 MOACRIVE Inhibition DME1184 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1184 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1184 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1184 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO01966 GENEFORM Protein DME1184 XEOTICID XEO01966 MOACRIVE Inhibition DME1184 XEOTICID XEO02373 XEO_NAME Bacteriocin 32 DME1184 XEOTICID XEO02373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO02373 XEO_CLAS Peptide DME1184 XEOTICID XEO02373 DESCRIPT Bacteriocin 32 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO02373 GENEFORM Protein DME1184 XEOTICID XEO02373 MOACRIVE Inhibition DME1184 XEOTICID XEO02377 XEO_NAME Bacteriocin hiracin-JM79 DME1184 XEOTICID XEO02377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO02377 XEO_CLAS Peptide DME1184 XEOTICID XEO02377 DESCRIPT Bacteriocin hiracin-JM79 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO02377 GENEFORM Protein DME1184 XEOTICID XEO02377 MOACRIVE Inhibition DME1184 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1184 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO02440 XEO_CLAS Peptide DME1184 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO02440 GENEFORM Protein DME1184 XEOTICID XEO02440 MOACRIVE Inhibition DME1184 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1184 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO02524 XEO_CLAS Peptide DME1184 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium (MIC = 19 microM) DME1184 XEOTICID XEO02524 GENEFORM Protein DME1184 XEOTICID XEO02524 MOACRIVE Inhibition DME1184 XEOTICID XEO02567 XEO_NAME Brevinin-1V DME1184 XEOTICID XEO02567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO02567 XEO_CLAS Peptide DME1184 XEOTICID XEO02567 DESCRIPT Brevinin-1V inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium (MIC = 19 microM) DME1184 XEOTICID XEO02567 GENEFORM Protein DME1184 XEOTICID XEO02567 MOACRIVE Inhibition DME1184 XEOTICID XEO02718 XEO_NAME Carnobacteriocin CbnB2 DME1184 XEOTICID XEO02718 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO02718 XEO_CLAS Peptide DME1184 XEOTICID XEO02718 DESCRIPT Carnobacteriocin CbnB2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO02718 GENEFORM Protein DME1184 XEOTICID XEO02718 MOACRIVE Inhibition DME1184 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1184 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO02743 XEO_CLAS Peptide DME1184 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium (MIC = 150 ug/ml) DME1184 XEOTICID XEO02743 GENEFORM Protein DME1184 XEOTICID XEO02743 MOACRIVE Inhibition DME1184 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1184 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO03073 XEO_CLAS Peptide DME1184 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium (MIC = 4 ug/ml) DME1184 XEOTICID XEO03073 GENEFORM Protein DME1184 XEOTICID XEO03073 MOACRIVE Inhibition DME1184 XEOTICID XEO03255 XEO_NAME Enterocin L50A DME1184 XEOTICID XEO03255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO03255 XEO_CLAS Peptide DME1184 XEOTICID XEO03255 DESCRIPT Enterocin L50A inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO03255 GENEFORM Protein DME1184 XEOTICID XEO03255 MOACRIVE Inhibition DME1184 XEOTICID XEO03256 XEO_NAME Enterocin L50B DME1184 XEOTICID XEO03256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO03256 XEO_CLAS Peptide DME1184 XEOTICID XEO03256 DESCRIPT Enterocin L50B inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO03256 GENEFORM Protein DME1184 XEOTICID XEO03256 MOACRIVE Inhibition DME1184 XEOTICID XEO03257 XEO_NAME Enterocin P DME1184 XEOTICID XEO03257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO03257 XEO_CLAS Peptide DME1184 XEOTICID XEO03257 DESCRIPT Enterocin P inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium (MIC = 0.002 ug/ml) DME1184 XEOTICID XEO03257 GENEFORM Protein DME1184 XEOTICID XEO03257 MOACRIVE Inhibition DME1184 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME1184 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO03259 XEO_CLAS Peptide DME1184 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium (MIC = 0.0508 microM) DME1184 XEOTICID XEO03259 GENEFORM Protein DME1184 XEOTICID XEO03259 MOACRIVE Inhibition DME1184 XEOTICID XEO03473 XEO_NAME Garvicin ML DME1184 XEOTICID XEO03473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO03473 XEO_CLAS Peptide DME1184 XEOTICID XEO03473 DESCRIPT Garvicin ML inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO03473 GENEFORM Protein DME1184 XEOTICID XEO03473 MOACRIVE Inhibition DME1184 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1184 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO03540 XEO_CLAS Peptide DME1184 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium (MIC = 4-8 ug/ml) DME1184 XEOTICID XEO03540 GENEFORM Protein DME1184 XEOTICID XEO03540 MOACRIVE Inhibition DME1184 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1184 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO03556 XEO_CLAS Peptide DME1184 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium (MIC = 4-8 ug/ml) DME1184 XEOTICID XEO03556 GENEFORM Protein DME1184 XEOTICID XEO03556 MOACRIVE Inhibition DME1184 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1184 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO03557 XEO_CLAS Peptide DME1184 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium (MIC = 4-8 ug/ml) DME1184 XEOTICID XEO03557 GENEFORM Protein DME1184 XEOTICID XEO03557 MOACRIVE Inhibition DME1184 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1184 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO03771 XEO_CLAS Peptide DME1184 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO03771 GENEFORM Protein DME1184 XEOTICID XEO03771 MOACRIVE Inhibition DME1184 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1184 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO03775 XEO_CLAS Peptide DME1184 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium (MIC = 0.71 microM) DME1184 XEOTICID XEO03775 GENEFORM Protein DME1184 XEOTICID XEO03775 MOACRIVE Inhibition DME1184 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1184 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO03857 XEO_CLAS Peptide DME1184 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium (MIC = 0.038 microM) DME1184 XEOTICID XEO03857 GENEFORM Protein DME1184 XEOTICID XEO03857 MOACRIVE Inhibition DME1184 XEOTICID XEO04151 XEO_NAME Mundticin KS DME1184 XEOTICID XEO04151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO04151 XEO_CLAS Peptide DME1184 XEOTICID XEO04151 DESCRIPT Mundticin KS inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO04151 GENEFORM Protein DME1184 XEOTICID XEO04151 MOACRIVE Inhibition DME1184 XEOTICID XEO04521 XEO_NAME Penocin A DME1184 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO04521 XEO_CLAS Peptide DME1184 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO04521 GENEFORM Protein DME1184 XEOTICID XEO04521 MOACRIVE Inhibition DME1184 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1184 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO04640 XEO_CLAS Peptide DME1184 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO04640 GENEFORM Protein DME1184 XEOTICID XEO04640 MOACRIVE Inhibition DME1184 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1184 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO04877 XEO_CLAS Peptide DME1184 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO04877 GENEFORM Protein DME1184 XEOTICID XEO04877 MOACRIVE Inhibition DME1184 XEOTICID XEO05169 XEO_NAME Tricyclic peptide MS-271 DME1184 XEOTICID XEO05169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO05169 XEO_CLAS Peptide DME1184 XEOTICID XEO05169 DESCRIPT Tricyclic peptide MS-271 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO05169 GENEFORM Protein DME1184 XEOTICID XEO05169 MOACRIVE Inhibition DME1184 XEOTICID XEO05228 XEO_NAME Variacin DME1184 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1184 XEOTICID XEO05228 XEO_CLAS Peptide DME1184 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecium DME1184 XEOTICID XEO05228 GENEFORM Protein DME1184 XEOTICID XEO05228 MOACRIVE Inhibition DME1185 DME___ID DME1185 DME1185 DME_NAME VanC2 ligase (vanC) DME1185 SPESNAME Enterococcus gallinarum DME1185 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1185 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1185 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1185 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of VanC2 ligase (vanC) from Enterococcus gallinarum DME1185 XEOTICID XEO01961 GENEFORM Protein DME1185 XEOTICID XEO01961 MOACRIVE Inhibition DME1185 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1185 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1185 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1185 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of VanC2 ligase (vanC) from Enterococcus gallinarum DME1185 XEOTICID XEO01966 GENEFORM Protein DME1185 XEOTICID XEO01966 MOACRIVE Inhibition DME1191 DME___ID DME1191 DME1191 DME_NAME Ampc beta-lactamase (ampC) DME1191 SPESNAME Burkholderia cenocepacia DME1191 XEOTICID XEO00164 XEO_NAME Azithromycin DME1191 XEOTICID XEO00164 XEO_TYPE Pharmaceutical Agent(s) DME1191 XEOTICID XEO00164 XEO_CLAS Approved/Marketed Drug DME1191 XEOTICID XEO00164 DESCRIPT Azithromycin inhibits the drug-metabolizing activity of Ampc beta-lactamase (ampC) from Burkholderia cenocepacia DME1191 XEOTICID XEO00164 GENEFORM Protein DME1191 XEOTICID XEO00164 MOACRIVE Inhibition DME1191 XEOTICID XEO00568 XEO_NAME Resveratrol DME1191 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1191 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1191 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Ampc beta-lactamase (ampC) from Burkholderia cenocepacia DME1191 XEOTICID XEO00568 GENEFORM Protein DME1191 XEOTICID XEO00568 MOACRIVE Inhibition DME1191 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME1191 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME1191 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME1191 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of Ampc beta-lactamase (ampC) from Burkholderia cenocepacia DME1191 XEOTICID XEO00613 GENEFORM Protein DME1191 XEOTICID XEO00613 MOACRIVE Inhibition DME1191 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME1191 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1191 XEOTICID XEO01253 XEO_CLAS Natural Product DME1191 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde inhibits the drug-metabolizing activity of Ampc beta-lactamase (ampC) from Burkholderia cenocepacia DME1191 XEOTICID XEO01253 GENEFORM Protein DME1191 XEOTICID XEO01253 MOACRIVE Inhibition DME1191 XEOTICID XEO01291 XEO_NAME Esculetin DME1191 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1191 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1191 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Ampc beta-lactamase (ampC) from Burkholderia cenocepacia DME1191 XEOTICID XEO01291 GENEFORM Protein DME1191 XEOTICID XEO01291 MOACRIVE Inhibition DME1191 XEOTICID XEO01298 XEO_NAME Farnesol DME1191 XEOTICID XEO01298 XEO_TYPE Pharmaceutical Agent(s) DME1191 XEOTICID XEO01298 XEO_CLAS Investigative Agent DME1191 XEOTICID XEO01298 DESCRIPT Farnesol inhibits the drug-metabolizing activity of Ampc beta-lactamase (ampC) from Burkholderia cenocepacia DME1191 XEOTICID XEO01298 GENEFORM Protein DME1191 XEOTICID XEO01298 MOACRIVE Inhibition DME1191 XEOTICID XEO01450 XEO_NAME Quinone DME1191 XEOTICID XEO01450 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1191 XEOTICID XEO01450 XEO_CLAS Natural Product DME1191 XEOTICID XEO01450 DESCRIPT Quinone inhibits the drug-metabolizing activity of Ampc beta-lactamase (ampC) from Burkholderia cenocepacia DME1191 XEOTICID XEO01450 GENEFORM Protein DME1191 XEOTICID XEO01450 MOACRIVE Inhibition DME1191 XEOTICID XEO02786 XEO_NAME Ceftazidime hydrate DME1191 XEOTICID XEO02786 XEO_TYPE Pharmaceutical Agent(s) DME1191 XEOTICID XEO02786 XEO_CLAS Approved/Marketed Drug DME1191 XEOTICID XEO02786 DESCRIPT Ceftazidime hydrate inhibits the drug-metabolizing activity of Ampc beta-lactamase (ampC) from Burkholderia cenocepacia DME1191 XEOTICID XEO02786 GENEFORM Protein DME1191 XEOTICID XEO02786 MOACRIVE Inhibition DME1191 XEOTICID XEO03324 XEO_NAME Esculin hydrate DME1191 XEOTICID XEO03324 XEO_TYPE Pharmaceutical Agent(s) DME1191 XEOTICID XEO03324 XEO_CLAS Investigative Agent DME1191 XEOTICID XEO03324 DESCRIPT Esculin hydrate inhibits the drug-metabolizing activity of Ampc beta-lactamase (ampC) from Burkholderia cenocepacia DME1191 XEOTICID XEO03324 GENEFORM Protein DME1191 XEOTICID XEO03324 MOACRIVE Inhibition DME1191 XEOTICID XEO03523 XEO_NAME Hamamelitannin DME1191 XEOTICID XEO03523 XEO_TYPE Pharmaceutical Agent(s) DME1191 XEOTICID XEO03523 XEO_CLAS Investigative Agent DME1191 XEOTICID XEO03523 DESCRIPT Hamamelitannin inhibits the drug-metabolizing activity of Ampc beta-lactamase (ampC) from Burkholderia cenocepacia DME1191 XEOTICID XEO03523 GENEFORM Protein DME1191 XEOTICID XEO03523 MOACRIVE Inhibition DME1191 XEOTICID XEO03644 XEO_NAME Indole DME1191 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1191 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1191 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Ampc beta-lactamase (ampC) from Burkholderia cenocepacia DME1191 XEOTICID XEO03644 GENEFORM Protein DME1191 XEOTICID XEO03644 MOACRIVE Inhibition DME1191 XEOTICID XEO03812 XEO_NAME L-Canavanine DME1191 XEOTICID XEO03812 XEO_TYPE Pharmaceutical Agent(s) DME1191 XEOTICID XEO03812 XEO_CLAS Investigative Agent DME1191 XEOTICID XEO03812 DESCRIPT L-Canavanine inhibits the drug-metabolizing activity of Ampc beta-lactamase (ampC) from Burkholderia cenocepacia DME1191 XEOTICID XEO03812 GENEFORM Protein DME1191 XEOTICID XEO03812 MOACRIVE Inhibition DME1191 XEOTICID XEO05156 XEO_NAME Tobramycin DME1191 XEOTICID XEO05156 XEO_TYPE Pharmaceutical Agent(s) DME1191 XEOTICID XEO05156 XEO_CLAS Approved/Marketed Drug DME1191 XEOTICID XEO05156 DESCRIPT Tobramycin inhibits the drug-metabolizing activity of Ampc beta-lactamase (ampC) from Burkholderia cenocepacia DME1191 XEOTICID XEO05156 GENEFORM Protein DME1191 XEOTICID XEO05156 MOACRIVE Inhibition DME1192 DME___ID DME1192 DME1192 DME_NAME AmpC beta-lactamase (ampC) DME1192 SPESNAME Burkholderia multivorans DME1192 XEOTICID XEO00568 XEO_NAME Resveratrol DME1192 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1192 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1192 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of AmpC beta-lactamase (ampC) from Burkholderia multivorans DME1192 XEOTICID XEO00568 GENEFORM Protein DME1192 XEOTICID XEO00568 MOACRIVE Inhibition DME1192 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME1192 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME1192 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME1192 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of AmpC beta-lactamase (ampC) from Burkholderia multivorans DME1192 XEOTICID XEO00613 GENEFORM Protein DME1192 XEOTICID XEO00613 MOACRIVE Inhibition DME1192 XEOTICID XEO00683 XEO_NAME Curcumin DME1192 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1192 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1192 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of AmpC beta-lactamase (ampC) from Burkholderia multivorans DME1192 XEOTICID XEO00683 GENEFORM Protein DME1192 XEOTICID XEO00683 MOACRIVE Inhibition DME1192 XEOTICID XEO01212 XEO_NAME Baicalein DME1192 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1192 XEOTICID XEO01212 XEO_CLAS Natural Product DME1192 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of AmpC beta-lactamase (ampC) from Burkholderia multivorans DME1192 XEOTICID XEO01212 GENEFORM Protein DME1192 XEOTICID XEO01212 MOACRIVE Inhibition DME1192 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME1192 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1192 XEOTICID XEO01253 XEO_CLAS Natural Product DME1192 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde inhibits the drug-metabolizing activity of AmpC beta-lactamase (ampC) from Burkholderia multivorans DME1192 XEOTICID XEO01253 GENEFORM Protein DME1192 XEOTICID XEO01253 MOACRIVE Inhibition DME1192 XEOTICID XEO01291 XEO_NAME Esculetin DME1192 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1192 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1192 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of AmpC beta-lactamase (ampC) from Burkholderia multivorans DME1192 XEOTICID XEO01291 GENEFORM Protein DME1192 XEOTICID XEO01291 MOACRIVE Inhibition DME1192 XEOTICID XEO01298 XEO_NAME Farnesol DME1192 XEOTICID XEO01298 XEO_TYPE Pharmaceutical Agent(s) DME1192 XEOTICID XEO01298 XEO_CLAS Investigative Agent DME1192 XEOTICID XEO01298 DESCRIPT Farnesol inhibits the drug-metabolizing activity of AmpC beta-lactamase (ampC) from Burkholderia multivorans DME1192 XEOTICID XEO01298 GENEFORM Protein DME1192 XEOTICID XEO01298 MOACRIVE Inhibition DME1192 XEOTICID XEO01933 XEO_NAME 6-Fluoroanthranilic acid DME1192 XEOTICID XEO01933 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1192 XEOTICID XEO01933 XEO_CLAS Chemical Compound DME1192 XEOTICID XEO01933 DESCRIPT 6-Fluoroanthranilic acid inhibits the drug-metabolizing activity of AmpC beta-lactamase (ampC) from Burkholderia multivorans DME1192 XEOTICID XEO01933 GENEFORM Protein DME1192 XEOTICID XEO01933 MOACRIVE Inhibition DME1192 XEOTICID XEO02786 XEO_NAME Ceftazidime hydrate DME1192 XEOTICID XEO02786 XEO_TYPE Pharmaceutical Agent(s) DME1192 XEOTICID XEO02786 XEO_CLAS Approved/Marketed Drug DME1192 XEOTICID XEO02786 DESCRIPT Ceftazidime hydrate inhibits the drug-metabolizing activity of AmpC beta-lactamase (ampC) from Burkholderia multivorans DME1192 XEOTICID XEO02786 GENEFORM Protein DME1192 XEOTICID XEO02786 MOACRIVE Inhibition DME1192 XEOTICID XEO03324 XEO_NAME Esculin hydrate DME1192 XEOTICID XEO03324 XEO_TYPE Pharmaceutical Agent(s) DME1192 XEOTICID XEO03324 XEO_CLAS Investigative Agent DME1192 XEOTICID XEO03324 DESCRIPT Esculin hydrate inhibits the drug-metabolizing activity of AmpC beta-lactamase (ampC) from Burkholderia multivorans DME1192 XEOTICID XEO03324 GENEFORM Protein DME1192 XEOTICID XEO03324 MOACRIVE Inhibition DME1192 XEOTICID XEO03812 XEO_NAME L-Canavanine DME1192 XEOTICID XEO03812 XEO_TYPE Pharmaceutical Agent(s) DME1192 XEOTICID XEO03812 XEO_CLAS Investigative Agent DME1192 XEOTICID XEO03812 DESCRIPT L-Canavanine inhibits the drug-metabolizing activity of AmpC beta-lactamase (ampC) from Burkholderia multivorans DME1192 XEOTICID XEO03812 GENEFORM Protein DME1192 XEOTICID XEO03812 MOACRIVE Inhibition DME1198 DME___ID DME1198 DME1198 DME_NAME Lactate racemase (Lsa784) DME1198 SPESNAME Lactobacillus sakei DME1198 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1198 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1198 XEOTICID XEO03775 XEO_CLAS Peptide DME1198 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Lactate racemase (Lsa784) from Lactobacillus sakei (MIC = 0.015 microM) DME1198 XEOTICID XEO03775 GENEFORM Protein DME1198 XEOTICID XEO03775 MOACRIVE Inhibition DME1198 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1198 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1198 XEOTICID XEO03803 XEO_CLAS Peptide DME1198 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Lactate racemase (Lsa784) from Lactobacillus sakei DME1198 XEOTICID XEO03803 GENEFORM Protein DME1198 XEOTICID XEO03803 MOACRIVE Inhibition DME1198 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1198 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1198 XEOTICID XEO03854 XEO_CLAS Peptide DME1198 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of Lactate racemase (Lsa784) from Lactobacillus sakei (MIC = 1.30 microM) DME1198 XEOTICID XEO03854 GENEFORM Protein DME1198 XEOTICID XEO03854 MOACRIVE Inhibition DME1198 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1198 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1198 XEOTICID XEO03855 XEO_CLAS Peptide DME1198 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of Lactate racemase (Lsa784) from Lactobacillus sakei (MIC = 1.04 microM) DME1198 XEOTICID XEO03855 GENEFORM Protein DME1198 XEOTICID XEO03855 MOACRIVE Inhibition DME1198 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1198 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1198 XEOTICID XEO03857 XEO_CLAS Peptide DME1198 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Lactate racemase (Lsa784) from Lactobacillus sakei (MIC = 0.038 microM) DME1198 XEOTICID XEO03857 GENEFORM Protein DME1198 XEOTICID XEO03857 MOACRIVE Inhibition DME1198 XEOTICID XEO04501 XEO_NAME Pediocin PA-1 DME1198 XEOTICID XEO04501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1198 XEOTICID XEO04501 XEO_CLAS Peptide DME1198 XEOTICID XEO04501 DESCRIPT Pediocin PA-1 inhibits the drug-metabolizing activity of Lactate racemase (Lsa784) from Lactobacillus sakei DME1198 XEOTICID XEO04501 GENEFORM Protein DME1198 XEOTICID XEO04501 MOACRIVE Inhibition DME1198 XEOTICID XEO04616 XEO_NAME Plantaricin E DME1198 XEOTICID XEO04616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1198 XEOTICID XEO04616 XEO_CLAS Peptide DME1198 XEOTICID XEO04616 DESCRIPT Plantaricin E inhibits the drug-metabolizing activity of Lactate racemase (Lsa784) from Lactobacillus sakei (MIC = 0.004 microM) DME1198 XEOTICID XEO04616 GENEFORM Protein DME1198 XEOTICID XEO04616 MOACRIVE Inhibition DME1198 XEOTICID XEO04617 XEO_NAME Plantaricin F DME1198 XEOTICID XEO04617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1198 XEOTICID XEO04617 XEO_CLAS Peptide DME1198 XEOTICID XEO04617 DESCRIPT Plantaricin F inhibits the drug-metabolizing activity of Lactate racemase (Lsa784) from Lactobacillus sakei (MIC = 0.004 microM) DME1198 XEOTICID XEO04617 GENEFORM Protein DME1198 XEOTICID XEO04617 MOACRIVE Inhibition DME1199 DME___ID DME1199 DME1199 DME_NAME L,D-carboxypeptidase A (ldcA) DME1199 SPESNAME Neisseria gonorrhoeae DME1199 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1199 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1199 XEOTICID XEO02732 XEO_CLAS Peptide DME1199 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Neisseria gonorrhoeae (MIC = 0.06 microM) DME1199 XEOTICID XEO02732 GENEFORM Protein DME1199 XEOTICID XEO02732 MOACRIVE Inhibition DME1199 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1199 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1199 XEOTICID XEO02749 XEO_CLAS Peptide DME1199 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Neisseria gonorrhoeae (MIC = 50 mug/ml) DME1199 XEOTICID XEO02749 GENEFORM Protein DME1199 XEOTICID XEO02749 MOACRIVE Inhibition DME1199 XEOTICID XEO03522 XEO_NAME Halocyntin DME1199 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1199 XEOTICID XEO03522 XEO_CLAS Peptide DME1199 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Neisseria gonorrhoeae DME1199 XEOTICID XEO03522 GENEFORM Protein DME1199 XEOTICID XEO03522 MOACRIVE Inhibition DME1199 XEOTICID XEO04156 XEO_NAME Mutacin II mutacin H-29B DME1199 XEOTICID XEO04156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1199 XEOTICID XEO04156 XEO_CLAS Peptide DME1199 XEOTICID XEO04156 DESCRIPT Mutacin II mutacin H-29B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Neisseria gonorrhoeae DME1199 XEOTICID XEO04156 GENEFORM Protein DME1199 XEOTICID XEO04156 MOACRIVE Inhibition DME1199 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1199 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1199 XEOTICID XEO04613 XEO_CLAS Peptide DME1199 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Neisseria gonorrhoeae (MIC > 20 microM) DME1199 XEOTICID XEO04613 GENEFORM Protein DME1199 XEOTICID XEO04613 MOACRIVE Inhibition DME1200 DME___ID DME1200 DME1200 DME_NAME L,D-carboxypeptidase A (ldcA) DME1200 SPESNAME Escherichia coli DME1200 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1200 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00117 GENEFORM Protein DME1200 XEOTICID XEO00117 MOACRIVE Inhibition DME1200 XEOTICID XEO00122 XEO_NAME Amikacin DME1200 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00122 GENEFORM Protein DME1200 XEOTICID XEO00122 MOACRIVE Inhibition DME1200 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1200 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00136 GENEFORM Protein DME1200 XEOTICID XEO00136 MOACRIVE Inhibition DME1200 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1200 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00237 GENEFORM Protein DME1200 XEOTICID XEO00237 MOACRIVE Inhibition DME1200 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1200 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00349 GENEFORM Protein DME1200 XEOTICID XEO00349 MOACRIVE Inhibition DME1200 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1200 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00425 GENEFORM Protein DME1200 XEOTICID XEO00425 MOACRIVE Inhibition DME1200 XEOTICID XEO00439 XEO_NAME Daidzein DME1200 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00439 GENEFORM Protein DME1200 XEOTICID XEO00439 MOACRIVE Inhibition DME1200 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1200 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00460 GENEFORM Protein DME1200 XEOTICID XEO00460 MOACRIVE Inhibition DME1200 XEOTICID XEO00487 XEO_NAME Thymol DME1200 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00487 GENEFORM Protein DME1200 XEOTICID XEO00487 MOACRIVE Inhibition DME1200 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1200 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00511 GENEFORM Protein DME1200 XEOTICID XEO00511 MOACRIVE Inhibition DME1200 XEOTICID XEO00537 XEO_NAME Luteolin DME1200 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1200 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00537 GENEFORM Protein DME1200 XEOTICID XEO00537 MOACRIVE Inhibition DME1200 XEOTICID XEO00538 XEO_NAME Quercetin DME1200 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1200 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00538 GENEFORM Protein DME1200 XEOTICID XEO00538 MOACRIVE Inhibition DME1200 XEOTICID XEO00547 XEO_NAME Vitamin E DME1200 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1200 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00547 GENEFORM Protein DME1200 XEOTICID XEO00547 MOACRIVE Inhibition DME1200 XEOTICID XEO00557 XEO_NAME Genistein DME1200 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1200 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00557 GENEFORM Protein DME1200 XEOTICID XEO00557 MOACRIVE Inhibition DME1200 XEOTICID XEO00566 XEO_NAME Guaiacol DME1200 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1200 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00566 GENEFORM Protein DME1200 XEOTICID XEO00566 MOACRIVE Inhibition DME1200 XEOTICID XEO00568 XEO_NAME Resveratrol DME1200 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1200 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00568 GENEFORM Protein DME1200 XEOTICID XEO00568 MOACRIVE Inhibition DME1200 XEOTICID XEO00573 XEO_NAME Naringenin DME1200 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1200 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00573 GENEFORM Protein DME1200 XEOTICID XEO00573 MOACRIVE Inhibition DME1200 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1200 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1200 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00574 GENEFORM Protein DME1200 XEOTICID XEO00574 MOACRIVE Inhibition DME1200 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1200 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1200 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00611 GENEFORM Protein DME1200 XEOTICID XEO00611 MOACRIVE Inhibition DME1200 XEOTICID XEO00621 XEO_NAME Chitosan DME1200 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1200 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00621 GENEFORM Protein DME1200 XEOTICID XEO00621 MOACRIVE Inhibition DME1200 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1200 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1200 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00646 GENEFORM Protein DME1200 XEOTICID XEO00646 MOACRIVE Inhibition DME1200 XEOTICID XEO00683 XEO_NAME Curcumin DME1200 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1200 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00683 GENEFORM Protein DME1200 XEOTICID XEO00683 MOACRIVE Inhibition DME1200 XEOTICID XEO00727 XEO_NAME Vanillin DME1200 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1200 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00727 GENEFORM Protein DME1200 XEOTICID XEO00727 MOACRIVE Inhibition DME1200 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1200 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1200 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00730 GENEFORM Protein DME1200 XEOTICID XEO00730 MOACRIVE Inhibition DME1200 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1200 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO00782 XEO_CLAS Natural Product DME1200 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00782 GENEFORM Protein DME1200 XEOTICID XEO00782 MOACRIVE Inhibition DME1200 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1200 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1200 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00866 GENEFORM Protein DME1200 XEOTICID XEO00866 MOACRIVE Inhibition DME1200 XEOTICID XEO00878 XEO_NAME Chrysin DME1200 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO00878 XEO_CLAS Natural Product DME1200 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00878 GENEFORM Protein DME1200 XEOTICID XEO00878 MOACRIVE Inhibition DME1200 XEOTICID XEO00879 XEO_NAME Coumarin DME1200 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1200 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1200 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00879 GENEFORM Protein DME1200 XEOTICID XEO00879 MOACRIVE Inhibition DME1200 XEOTICID XEO00883 XEO_NAME Phloretin DME1200 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO00883 XEO_CLAS Natural Product DME1200 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00883 GENEFORM Protein DME1200 XEOTICID XEO00883 MOACRIVE Inhibition DME1200 XEOTICID XEO00885 XEO_NAME Eugenol DME1200 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1200 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO00885 GENEFORM Protein DME1200 XEOTICID XEO00885 MOACRIVE Inhibition DME1200 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1200 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1200 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1200 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01032 GENEFORM Protein DME1200 XEOTICID XEO01032 MOACRIVE Inhibition DME1200 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1200 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01174 XEO_CLAS Natural Product DME1200 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01174 GENEFORM Protein DME1200 XEOTICID XEO01174 MOACRIVE Inhibition DME1200 XEOTICID XEO01203 XEO_NAME Apigenin DME1200 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01203 XEO_CLAS Natural Product DME1200 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01203 GENEFORM Protein DME1200 XEOTICID XEO01203 MOACRIVE Inhibition DME1200 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1200 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1200 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1200 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01232 GENEFORM Protein DME1200 XEOTICID XEO01232 MOACRIVE Inhibition DME1200 XEOTICID XEO01237 XEO_NAME Carvacrol DME1200 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1200 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01237 GENEFORM Protein DME1200 XEOTICID XEO01237 MOACRIVE Inhibition DME1200 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1200 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1200 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01287 GENEFORM Protein DME1200 XEOTICID XEO01287 MOACRIVE Inhibition DME1200 XEOTICID XEO01291 XEO_NAME Esculetin DME1200 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1200 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01291 GENEFORM Protein DME1200 XEOTICID XEO01291 MOACRIVE Inhibition DME1200 XEOTICID XEO01304 XEO_NAME Flavone DME1200 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01304 XEO_CLAS Natural Product DME1200 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01304 GENEFORM Protein DME1200 XEOTICID XEO01304 MOACRIVE Inhibition DME1200 XEOTICID XEO01309 XEO_NAME Gallic acid DME1200 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01309 XEO_CLAS Natural Product DME1200 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01309 GENEFORM Protein DME1200 XEOTICID XEO01309 MOACRIVE Inhibition DME1200 XEOTICID XEO01340 XEO_NAME Imperatorin DME1200 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01340 XEO_CLAS Natural Product DME1200 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01340 GENEFORM Protein DME1200 XEOTICID XEO01340 MOACRIVE Inhibition DME1200 XEOTICID XEO01353 XEO_NAME Kaempferol DME1200 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1200 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1200 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01353 GENEFORM Protein DME1200 XEOTICID XEO01353 MOACRIVE Inhibition DME1200 XEOTICID XEO01366 XEO_NAME Linalool DME1200 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01366 XEO_CLAS Natural Product DME1200 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01366 GENEFORM Protein DME1200 XEOTICID XEO01366 MOACRIVE Inhibition DME1200 XEOTICID XEO01391 XEO_NAME Naringin DME1200 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01391 XEO_CLAS Natural Product DME1200 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01391 GENEFORM Protein DME1200 XEOTICID XEO01391 MOACRIVE Inhibition DME1200 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1200 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1200 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01420 GENEFORM Protein DME1200 XEOTICID XEO01420 MOACRIVE Inhibition DME1200 XEOTICID XEO01463 XEO_NAME Rutin DME1200 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01463 XEO_CLAS Natural Product DME1200 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01463 GENEFORM Protein DME1200 XEOTICID XEO01463 MOACRIVE Inhibition DME1200 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1200 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1200 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01496 GENEFORM Protein DME1200 XEOTICID XEO01496 MOACRIVE Inhibition DME1200 XEOTICID XEO01512 XEO_NAME Zinc DME1200 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1200 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1200 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01512 GENEFORM Protein DME1200 XEOTICID XEO01512 MOACRIVE Inhibition DME1200 XEOTICID XEO01527 XEO_NAME Bergamottin DME1200 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01527 XEO_CLAS Natural Product DME1200 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01527 GENEFORM Protein DME1200 XEOTICID XEO01527 MOACRIVE Inhibition DME1200 XEOTICID XEO01531 XEO_NAME Clove oil DME1200 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01531 XEO_CLAS Natural Product DME1200 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01531 GENEFORM Protein DME1200 XEOTICID XEO01531 MOACRIVE Inhibition DME1200 XEOTICID XEO01559 XEO_NAME Limonene DME1200 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01559 XEO_CLAS Natural Product DME1200 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01559 GENEFORM Protein DME1200 XEOTICID XEO01559 MOACRIVE Inhibition DME1200 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1200 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01563 XEO_CLAS Natural Product DME1200 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01563 GENEFORM Protein DME1200 XEOTICID XEO01563 MOACRIVE Inhibition DME1200 XEOTICID XEO01566 XEO_NAME Nobiletin DME1200 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01566 XEO_CLAS Natural Product DME1200 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01566 GENEFORM Protein DME1200 XEOTICID XEO01566 MOACRIVE Inhibition DME1200 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1200 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01778 XEO_CLAS Natural Product DME1200 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01778 GENEFORM Protein DME1200 XEOTICID XEO01778 MOACRIVE Inhibition DME1200 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1200 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01779 XEO_CLAS Peptide DME1200 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 128 microM) DME1200 XEOTICID XEO01779 GENEFORM Protein DME1200 XEOTICID XEO01779 MOACRIVE Inhibition DME1200 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1200 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01810 XEO_CLAS Peptide DME1200 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.0 microM) DME1200 XEOTICID XEO01810 GENEFORM Protein DME1200 XEOTICID XEO01810 MOACRIVE Inhibition DME1200 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1200 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01811 XEO_CLAS Peptide DME1200 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 microM) DME1200 XEOTICID XEO01811 GENEFORM Protein DME1200 XEOTICID XEO01811 MOACRIVE Inhibition DME1200 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1200 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01812 XEO_CLAS Peptide DME1200 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10.4 microM) DME1200 XEOTICID XEO01812 GENEFORM Protein DME1200 XEOTICID XEO01812 MOACRIVE Inhibition DME1200 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1200 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01813 XEO_CLAS Peptide DME1200 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.1 microM) DME1200 XEOTICID XEO01813 GENEFORM Protein DME1200 XEOTICID XEO01813 MOACRIVE Inhibition DME1200 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1200 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01814 XEO_CLAS Peptide DME1200 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.5 microM) DME1200 XEOTICID XEO01814 GENEFORM Protein DME1200 XEOTICID XEO01814 MOACRIVE Inhibition DME1200 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1200 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01815 XEO_CLAS Peptide DME1200 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 9.8 microM) DME1200 XEOTICID XEO01815 GENEFORM Protein DME1200 XEOTICID XEO01815 MOACRIVE Inhibition DME1200 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1200 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01816 XEO_CLAS Peptide DME1200 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO01816 GENEFORM Protein DME1200 XEOTICID XEO01816 MOACRIVE Inhibition DME1200 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1200 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01817 XEO_CLAS Peptide DME1200 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.0 microM) DME1200 XEOTICID XEO01817 GENEFORM Protein DME1200 XEOTICID XEO01817 MOACRIVE Inhibition DME1200 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1200 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01818 XEO_CLAS Peptide DME1200 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4.0 microM) DME1200 XEOTICID XEO01818 GENEFORM Protein DME1200 XEOTICID XEO01818 MOACRIVE Inhibition DME1200 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1200 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01819 XEO_CLAS Peptide DME1200 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO01819 GENEFORM Protein DME1200 XEOTICID XEO01819 MOACRIVE Inhibition DME1200 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1200 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01820 XEO_CLAS Peptide DME1200 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO01820 GENEFORM Protein DME1200 XEOTICID XEO01820 MOACRIVE Inhibition DME1200 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1200 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01821 XEO_CLAS Peptide DME1200 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO01821 GENEFORM Protein DME1200 XEOTICID XEO01821 MOACRIVE Inhibition DME1200 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1200 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01822 XEO_CLAS Peptide DME1200 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 microM) DME1200 XEOTICID XEO01822 GENEFORM Protein DME1200 XEOTICID XEO01822 MOACRIVE Inhibition DME1200 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1200 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01823 XEO_CLAS Peptide DME1200 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO01823 GENEFORM Protein DME1200 XEOTICID XEO01823 MOACRIVE Inhibition DME1200 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1200 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01824 XEO_CLAS Peptide DME1200 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO01824 GENEFORM Protein DME1200 XEOTICID XEO01824 MOACRIVE Inhibition DME1200 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1200 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01825 XEO_CLAS Peptide DME1200 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25.0 microM) DME1200 XEOTICID XEO01825 GENEFORM Protein DME1200 XEOTICID XEO01825 MOACRIVE Inhibition DME1200 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1200 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01827 XEO_CLAS Peptide DME1200 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.12-6.25 microM) DME1200 XEOTICID XEO01827 GENEFORM Protein DME1200 XEOTICID XEO01827 MOACRIVE Inhibition DME1200 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1200 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1200 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1200 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01829 GENEFORM Protein DME1200 XEOTICID XEO01829 MOACRIVE Inhibition DME1200 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1200 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01927 XEO_CLAS Peptide DME1200 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 ug/ml) DME1200 XEOTICID XEO01927 GENEFORM Protein DME1200 XEOTICID XEO01927 MOACRIVE Inhibition DME1200 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1200 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01945 XEO_CLAS Peptide DME1200 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.1 microM) DME1200 XEOTICID XEO01945 GENEFORM Protein DME1200 XEOTICID XEO01945 MOACRIVE Inhibition DME1200 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1200 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01946 XEO_CLAS Peptide DME1200 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.2 microM) DME1200 XEOTICID XEO01946 GENEFORM Protein DME1200 XEOTICID XEO01946 MOACRIVE Inhibition DME1200 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1200 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO01947 XEO_CLAS Natural Product DME1200 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01947 GENEFORM Protein DME1200 XEOTICID XEO01947 MOACRIVE Inhibition DME1200 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1200 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1200 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1200 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01950 GENEFORM Protein DME1200 XEOTICID XEO01950 MOACRIVE Inhibition DME1200 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1200 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1200 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1200 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01961 GENEFORM Protein DME1200 XEOTICID XEO01961 MOACRIVE Inhibition DME1200 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1200 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1200 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1200 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO01966 GENEFORM Protein DME1200 XEOTICID XEO01966 MOACRIVE Inhibition DME1200 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1200 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01996 XEO_CLAS Peptide DME1200 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.7 microM) DME1200 XEOTICID XEO01996 GENEFORM Protein DME1200 XEOTICID XEO01996 MOACRIVE Inhibition DME1200 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1200 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01997 XEO_CLAS Peptide DME1200 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.9 microM) DME1200 XEOTICID XEO01997 GENEFORM Protein DME1200 XEOTICID XEO01997 MOACRIVE Inhibition DME1200 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1200 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01998 XEO_CLAS Peptide DME1200 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO01998 GENEFORM Protein DME1200 XEOTICID XEO01998 MOACRIVE Inhibition DME1200 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1200 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO01999 XEO_CLAS Peptide DME1200 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.5 microM) DME1200 XEOTICID XEO01999 GENEFORM Protein DME1200 XEOTICID XEO01999 MOACRIVE Inhibition DME1200 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1200 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02013 XEO_CLAS Peptide DME1200 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02013 GENEFORM Protein DME1200 XEOTICID XEO02013 MOACRIVE Inhibition DME1200 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1200 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02032 XEO_CLAS Natural Product DME1200 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02032 GENEFORM Protein DME1200 XEOTICID XEO02032 MOACRIVE Inhibition DME1200 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1200 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02033 XEO_CLAS Natural Product DME1200 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02033 GENEFORM Protein DME1200 XEOTICID XEO02033 MOACRIVE Inhibition DME1200 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1200 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02079 XEO_CLAS Natural Product DME1200 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02079 GENEFORM Protein DME1200 XEOTICID XEO02079 MOACRIVE Inhibition DME1200 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1200 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1200 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02085 GENEFORM Protein DME1200 XEOTICID XEO02085 MOACRIVE Inhibition DME1200 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1200 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02111 XEO_CLAS Peptide DME1200 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2-4 ug/ml) DME1200 XEOTICID XEO02111 GENEFORM Protein DME1200 XEOTICID XEO02111 MOACRIVE Inhibition DME1200 XEOTICID XEO02113 XEO_NAME Abaecin DME1200 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02113 XEO_CLAS Peptide DME1200 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02113 GENEFORM Protein DME1200 XEOTICID XEO02113 MOACRIVE Inhibition DME1200 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1200 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02114 XEO_CLAS Peptide DME1200 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-25 ug/ml) DME1200 XEOTICID XEO02114 GENEFORM Protein DME1200 XEOTICID XEO02114 MOACRIVE Inhibition DME1200 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1200 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02115 XEO_CLAS Peptide DME1200 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02115 GENEFORM Protein DME1200 XEOTICID XEO02115 MOACRIVE Inhibition DME1200 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1200 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02117 XEO_CLAS Peptide DME1200 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02117 GENEFORM Protein DME1200 XEOTICID XEO02117 MOACRIVE Inhibition DME1200 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1200 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02118 XEO_CLAS Peptide DME1200 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02118 GENEFORM Protein DME1200 XEOTICID XEO02118 MOACRIVE Inhibition DME1200 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1200 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02119 XEO_CLAS Peptide DME1200 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02119 GENEFORM Protein DME1200 XEOTICID XEO02119 MOACRIVE Inhibition DME1200 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1200 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02120 XEO_CLAS Peptide DME1200 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02120 GENEFORM Protein DME1200 XEOTICID XEO02120 MOACRIVE Inhibition DME1200 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1200 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02121 XEO_CLAS Peptide DME1200 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02121 GENEFORM Protein DME1200 XEOTICID XEO02121 MOACRIVE Inhibition DME1200 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1200 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02122 XEO_CLAS Peptide DME1200 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 ug/ml) DME1200 XEOTICID XEO02122 GENEFORM Protein DME1200 XEOTICID XEO02122 MOACRIVE Inhibition DME1200 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1200 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02130 XEO_CLAS Peptide DME1200 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.7 microM) DME1200 XEOTICID XEO02130 GENEFORM Protein DME1200 XEOTICID XEO02130 MOACRIVE Inhibition DME1200 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1200 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02131 XEO_CLAS Peptide DME1200 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.3 microM) DME1200 XEOTICID XEO02131 GENEFORM Protein DME1200 XEOTICID XEO02131 MOACRIVE Inhibition DME1200 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1200 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02132 XEO_CLAS Peptide DME1200 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.5 microM) DME1200 XEOTICID XEO02132 GENEFORM Protein DME1200 XEOTICID XEO02132 MOACRIVE Inhibition DME1200 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1200 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02136 XEO_CLAS Peptide DME1200 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 ug/ml) DME1200 XEOTICID XEO02136 GENEFORM Protein DME1200 XEOTICID XEO02136 MOACRIVE Inhibition DME1200 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1200 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02147 XEO_CLAS Peptide DME1200 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 382 ug/ml) DME1200 XEOTICID XEO02147 GENEFORM Protein DME1200 XEOTICID XEO02147 MOACRIVE Inhibition DME1200 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1200 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02149 XEO_CLAS Peptide DME1200 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 47.35 microM) DME1200 XEOTICID XEO02149 GENEFORM Protein DME1200 XEOTICID XEO02149 MOACRIVE Inhibition DME1200 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1200 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02164 XEO_CLAS Peptide DME1200 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02164 GENEFORM Protein DME1200 XEOTICID XEO02164 MOACRIVE Inhibition DME1200 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1200 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02165 XEO_CLAS Peptide DME1200 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02165 GENEFORM Protein DME1200 XEOTICID XEO02165 MOACRIVE Inhibition DME1200 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1200 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02166 XEO_CLAS Peptide DME1200 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02166 GENEFORM Protein DME1200 XEOTICID XEO02166 MOACRIVE Inhibition DME1200 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1200 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02167 XEO_CLAS Peptide DME1200 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02167 GENEFORM Protein DME1200 XEOTICID XEO02167 MOACRIVE Inhibition DME1200 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1200 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02168 XEO_CLAS Peptide DME1200 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02168 GENEFORM Protein DME1200 XEOTICID XEO02168 MOACRIVE Inhibition DME1200 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1200 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02169 XEO_CLAS Peptide DME1200 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02169 GENEFORM Protein DME1200 XEOTICID XEO02169 MOACRIVE Inhibition DME1200 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1200 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02170 XEO_CLAS Peptide DME1200 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.4 microM) DME1200 XEOTICID XEO02170 GENEFORM Protein DME1200 XEOTICID XEO02170 MOACRIVE Inhibition DME1200 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1200 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02175 XEO_CLAS Natural Product DME1200 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02175 GENEFORM Protein DME1200 XEOTICID XEO02175 MOACRIVE Inhibition DME1200 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1200 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02177 XEO_CLAS Peptide DME1200 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO02177 GENEFORM Protein DME1200 XEOTICID XEO02177 MOACRIVE Inhibition DME1200 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1200 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02178 XEO_CLAS Peptide DME1200 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO02178 GENEFORM Protein DME1200 XEOTICID XEO02178 MOACRIVE Inhibition DME1200 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1200 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02179 XEO_CLAS Peptide DME1200 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO02179 GENEFORM Protein DME1200 XEOTICID XEO02179 MOACRIVE Inhibition DME1200 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1200 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02180 XEO_CLAS Peptide DME1200 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 214 microM) DME1200 XEOTICID XEO02180 GENEFORM Protein DME1200 XEOTICID XEO02180 MOACRIVE Inhibition DME1200 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1200 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02181 XEO_CLAS Peptide DME1200 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 217 microM) DME1200 XEOTICID XEO02181 GENEFORM Protein DME1200 XEOTICID XEO02181 MOACRIVE Inhibition DME1200 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1200 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02183 XEO_CLAS Peptide DME1200 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 38.4 microM) DME1200 XEOTICID XEO02183 GENEFORM Protein DME1200 XEOTICID XEO02183 MOACRIVE Inhibition DME1200 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1200 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02185 XEO_CLAS Peptide DME1200 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 microM) DME1200 XEOTICID XEO02185 GENEFORM Protein DME1200 XEOTICID XEO02185 MOACRIVE Inhibition DME1200 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1200 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02187 GENEFORM Protein DME1200 XEOTICID XEO02187 MOACRIVE Inhibition DME1200 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1200 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02191 XEO_CLAS Peptide DME1200 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02191 GENEFORM Protein DME1200 XEOTICID XEO02191 MOACRIVE Inhibition DME1200 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1200 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02192 XEO_CLAS Peptide DME1200 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.50 ug/ml) DME1200 XEOTICID XEO02192 GENEFORM Protein DME1200 XEOTICID XEO02192 MOACRIVE Inhibition DME1200 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1200 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02193 XEO_CLAS Peptide DME1200 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02193 GENEFORM Protein DME1200 XEOTICID XEO02193 MOACRIVE Inhibition DME1200 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1200 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02194 XEO_CLAS Peptide DME1200 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02194 GENEFORM Protein DME1200 XEOTICID XEO02194 MOACRIVE Inhibition DME1200 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1200 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02195 XEO_CLAS Peptide DME1200 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.00 ug/ml) DME1200 XEOTICID XEO02195 GENEFORM Protein DME1200 XEOTICID XEO02195 MOACRIVE Inhibition DME1200 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1200 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02197 XEO_CLAS Peptide DME1200 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02197 GENEFORM Protein DME1200 XEOTICID XEO02197 MOACRIVE Inhibition DME1200 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1200 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02200 XEO_CLAS Peptide DME1200 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 ug/ml) DME1200 XEOTICID XEO02200 GENEFORM Protein DME1200 XEOTICID XEO02200 MOACRIVE Inhibition DME1200 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1200 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02201 XEO_CLAS Peptide DME1200 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 ug/ml) DME1200 XEOTICID XEO02201 GENEFORM Protein DME1200 XEOTICID XEO02201 MOACRIVE Inhibition DME1200 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1200 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02202 XEO_CLAS Peptide DME1200 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO02202 GENEFORM Protein DME1200 XEOTICID XEO02202 MOACRIVE Inhibition DME1200 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1200 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02203 XEO_CLAS Peptide DME1200 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 microM) DME1200 XEOTICID XEO02203 GENEFORM Protein DME1200 XEOTICID XEO02203 MOACRIVE Inhibition DME1200 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1200 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02207 XEO_CLAS Peptide DME1200 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.78 ug/ml) DME1200 XEOTICID XEO02207 GENEFORM Protein DME1200 XEOTICID XEO02207 MOACRIVE Inhibition DME1200 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1200 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02208 XEO_CLAS Peptide DME1200 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.13 ug/ml) DME1200 XEOTICID XEO02208 GENEFORM Protein DME1200 XEOTICID XEO02208 MOACRIVE Inhibition DME1200 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1200 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02209 XEO_CLAS Peptide DME1200 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.56 ug/ml) DME1200 XEOTICID XEO02209 GENEFORM Protein DME1200 XEOTICID XEO02209 MOACRIVE Inhibition DME1200 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1200 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02210 XEO_CLAS Peptide DME1200 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 ug/ml) DME1200 XEOTICID XEO02210 GENEFORM Protein DME1200 XEOTICID XEO02210 MOACRIVE Inhibition DME1200 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1200 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02211 XEO_CLAS Peptide DME1200 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25 ug/ml) DME1200 XEOTICID XEO02211 GENEFORM Protein DME1200 XEOTICID XEO02211 MOACRIVE Inhibition DME1200 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1200 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02212 XEO_CLAS Peptide DME1200 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.13 ug/ml) DME1200 XEOTICID XEO02212 GENEFORM Protein DME1200 XEOTICID XEO02212 MOACRIVE Inhibition DME1200 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1200 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02213 XEO_CLAS Peptide DME1200 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.13 ug/ml) DME1200 XEOTICID XEO02213 GENEFORM Protein DME1200 XEOTICID XEO02213 MOACRIVE Inhibition DME1200 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1200 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02214 XEO_CLAS Peptide DME1200 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02214 GENEFORM Protein DME1200 XEOTICID XEO02214 MOACRIVE Inhibition DME1200 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1200 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02215 XEO_CLAS Peptide DME1200 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 ug/ml) DME1200 XEOTICID XEO02215 GENEFORM Protein DME1200 XEOTICID XEO02215 MOACRIVE Inhibition DME1200 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1200 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02216 XEO_CLAS Peptide DME1200 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 126 ug/ml) DME1200 XEOTICID XEO02216 GENEFORM Protein DME1200 XEOTICID XEO02216 MOACRIVE Inhibition DME1200 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1200 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02217 XEO_CLAS Peptide DME1200 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 200 ug/ml) DME1200 XEOTICID XEO02217 GENEFORM Protein DME1200 XEOTICID XEO02217 MOACRIVE Inhibition DME1200 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1200 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02218 XEO_CLAS Peptide DME1200 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 200 ug/ml) DME1200 XEOTICID XEO02218 GENEFORM Protein DME1200 XEOTICID XEO02218 MOACRIVE Inhibition DME1200 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1200 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02219 XEO_CLAS Peptide DME1200 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 200 ug/ml) DME1200 XEOTICID XEO02219 GENEFORM Protein DME1200 XEOTICID XEO02219 MOACRIVE Inhibition DME1200 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1200 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02220 XEO_CLAS Peptide DME1200 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 23.5 ug/ml) DME1200 XEOTICID XEO02220 GENEFORM Protein DME1200 XEOTICID XEO02220 MOACRIVE Inhibition DME1200 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1200 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02221 XEO_CLAS Peptide DME1200 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20.2 ug/ml) DME1200 XEOTICID XEO02221 GENEFORM Protein DME1200 XEOTICID XEO02221 MOACRIVE Inhibition DME1200 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1200 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02222 XEO_CLAS Peptide DME1200 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30.5 ug/ml) DME1200 XEOTICID XEO02222 GENEFORM Protein DME1200 XEOTICID XEO02222 MOACRIVE Inhibition DME1200 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1200 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02223 XEO_CLAS Peptide DME1200 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.2 ug/ml) DME1200 XEOTICID XEO02223 GENEFORM Protein DME1200 XEOTICID XEO02223 MOACRIVE Inhibition DME1200 XEOTICID XEO02224 XEO_NAME Androctonin DME1200 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02224 XEO_CLAS Peptide DME1200 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02224 GENEFORM Protein DME1200 XEOTICID XEO02224 MOACRIVE Inhibition DME1200 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1200 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02225 XEO_CLAS Peptide DME1200 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02225 GENEFORM Protein DME1200 XEOTICID XEO02225 MOACRIVE Inhibition DME1200 XEOTICID XEO02226 XEO_NAME Andropin DME1200 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02226 XEO_CLAS Peptide DME1200 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 140 microM) DME1200 XEOTICID XEO02226 GENEFORM Protein DME1200 XEOTICID XEO02226 MOACRIVE Inhibition DME1200 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1200 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02230 XEO_CLAS Peptide DME1200 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.05-0.1 microM) DME1200 XEOTICID XEO02230 GENEFORM Protein DME1200 XEOTICID XEO02230 MOACRIVE Inhibition DME1200 XEOTICID XEO02232 XEO_NAME Anoplin DME1200 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02232 XEO_CLAS Peptide DME1200 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 13 ug/ml) DME1200 XEOTICID XEO02232 GENEFORM Protein DME1200 XEOTICID XEO02232 MOACRIVE Inhibition DME1200 XEOTICID XEO02233 XEO_NAME Antapin DME1200 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02233 XEO_CLAS Peptide DME1200 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02233 GENEFORM Protein DME1200 XEOTICID XEO02233 MOACRIVE Inhibition DME1200 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1200 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02236 XEO_CLAS Peptide DME1200 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02236 GENEFORM Protein DME1200 XEOTICID XEO02236 MOACRIVE Inhibition DME1200 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1200 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02239 XEO_CLAS Peptide DME1200 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 250 microM) DME1200 XEOTICID XEO02239 GENEFORM Protein DME1200 XEOTICID XEO02239 MOACRIVE Inhibition DME1200 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1200 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02240 XEO_CLAS Peptide DME1200 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 microM) DME1200 XEOTICID XEO02240 GENEFORM Protein DME1200 XEOTICID XEO02240 MOACRIVE Inhibition DME1200 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1200 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02241 XEO_CLAS Peptide DME1200 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02241 GENEFORM Protein DME1200 XEOTICID XEO02241 MOACRIVE Inhibition DME1200 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1200 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02242 XEO_CLAS Peptide DME1200 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO02242 GENEFORM Protein DME1200 XEOTICID XEO02242 MOACRIVE Inhibition DME1200 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1200 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02243 XEO_CLAS Peptide DME1200 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 microM) DME1200 XEOTICID XEO02243 GENEFORM Protein DME1200 XEOTICID XEO02243 MOACRIVE Inhibition DME1200 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1200 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02244 XEO_CLAS Peptide DME1200 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1 microM) DME1200 XEOTICID XEO02244 GENEFORM Protein DME1200 XEOTICID XEO02244 MOACRIVE Inhibition DME1200 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1200 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02245 XEO_CLAS Peptide DME1200 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02245 GENEFORM Protein DME1200 XEOTICID XEO02245 MOACRIVE Inhibition DME1200 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1200 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02246 XEO_CLAS Peptide DME1200 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 microM) DME1200 XEOTICID XEO02246 GENEFORM Protein DME1200 XEOTICID XEO02246 MOACRIVE Inhibition DME1200 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1200 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02247 XEO_CLAS Peptide DME1200 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02247 GENEFORM Protein DME1200 XEOTICID XEO02247 MOACRIVE Inhibition DME1200 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1200 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02248 XEO_CLAS Peptide DME1200 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.3 microM) DME1200 XEOTICID XEO02248 GENEFORM Protein DME1200 XEOTICID XEO02248 MOACRIVE Inhibition DME1200 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1200 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02253 XEO_CLAS Peptide DME1200 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02253 GENEFORM Protein DME1200 XEOTICID XEO02253 MOACRIVE Inhibition DME1200 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1200 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02258 XEO_CLAS Peptide DME1200 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 150 microM) DME1200 XEOTICID XEO02258 GENEFORM Protein DME1200 XEOTICID XEO02258 MOACRIVE Inhibition DME1200 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1200 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02261 XEO_CLAS Peptide DME1200 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 82 ug/ml) DME1200 XEOTICID XEO02261 GENEFORM Protein DME1200 XEOTICID XEO02261 MOACRIVE Inhibition DME1200 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1200 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02263 XEO_CLAS Peptide DME1200 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO02263 GENEFORM Protein DME1200 XEOTICID XEO02263 MOACRIVE Inhibition DME1200 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1200 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02266 XEO_CLAS Peptide DME1200 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 120 microM) DME1200 XEOTICID XEO02266 GENEFORM Protein DME1200 XEOTICID XEO02266 MOACRIVE Inhibition DME1200 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1200 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02268 XEO_CLAS Peptide DME1200 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 170 ug/ml) DME1200 XEOTICID XEO02268 GENEFORM Protein DME1200 XEOTICID XEO02268 MOACRIVE Inhibition DME1200 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1200 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02270 XEO_CLAS Peptide DME1200 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 microM) DME1200 XEOTICID XEO02270 GENEFORM Protein DME1200 XEOTICID XEO02270 MOACRIVE Inhibition DME1200 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1200 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02271 XEO_CLAS Peptide DME1200 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 302 ug/ml) DME1200 XEOTICID XEO02271 GENEFORM Protein DME1200 XEOTICID XEO02271 MOACRIVE Inhibition DME1200 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1200 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02273 XEO_CLAS Peptide DME1200 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 18 microM) DME1200 XEOTICID XEO02273 GENEFORM Protein DME1200 XEOTICID XEO02273 MOACRIVE Inhibition DME1200 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1200 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02274 XEO_CLAS Peptide DME1200 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO02274 GENEFORM Protein DME1200 XEOTICID XEO02274 MOACRIVE Inhibition DME1200 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1200 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02275 XEO_CLAS Peptide DME1200 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 microM) DME1200 XEOTICID XEO02275 GENEFORM Protein DME1200 XEOTICID XEO02275 MOACRIVE Inhibition DME1200 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1200 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02276 XEO_CLAS Peptide DME1200 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 microM) DME1200 XEOTICID XEO02276 GENEFORM Protein DME1200 XEOTICID XEO02276 MOACRIVE Inhibition DME1200 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1200 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02280 XEO_CLAS Peptide DME1200 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02280 GENEFORM Protein DME1200 XEOTICID XEO02280 MOACRIVE Inhibition DME1200 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1200 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02281 XEO_CLAS Peptide DME1200 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02281 GENEFORM Protein DME1200 XEOTICID XEO02281 MOACRIVE Inhibition DME1200 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1200 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02283 XEO_CLAS Peptide DME1200 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 ug/ml) DME1200 XEOTICID XEO02283 GENEFORM Protein DME1200 XEOTICID XEO02283 MOACRIVE Inhibition DME1200 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1200 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02284 XEO_CLAS Peptide DME1200 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50.4 microM) DME1200 XEOTICID XEO02284 GENEFORM Protein DME1200 XEOTICID XEO02284 MOACRIVE Inhibition DME1200 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1200 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02285 XEO_CLAS Peptide DME1200 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50.4 microM) DME1200 XEOTICID XEO02285 GENEFORM Protein DME1200 XEOTICID XEO02285 MOACRIVE Inhibition DME1200 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1200 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02286 XEO_CLAS Peptide DME1200 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50.4 microM) DME1200 XEOTICID XEO02286 GENEFORM Protein DME1200 XEOTICID XEO02286 MOACRIVE Inhibition DME1200 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1200 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02287 XEO_CLAS Peptide DME1200 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50.4 microM) DME1200 XEOTICID XEO02287 GENEFORM Protein DME1200 XEOTICID XEO02287 MOACRIVE Inhibition DME1200 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1200 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02288 XEO_CLAS Peptide DME1200 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.2 ug/ml) DME1200 XEOTICID XEO02288 GENEFORM Protein DME1200 XEOTICID XEO02288 MOACRIVE Inhibition DME1200 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1200 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02289 XEO_CLAS Peptide DME1200 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 ug/ml) DME1200 XEOTICID XEO02289 GENEFORM Protein DME1200 XEOTICID XEO02289 MOACRIVE Inhibition DME1200 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1200 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02290 XEO_CLAS Peptide DME1200 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO02290 GENEFORM Protein DME1200 XEOTICID XEO02290 MOACRIVE Inhibition DME1200 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1200 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02291 XEO_CLAS Peptide DME1200 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02291 GENEFORM Protein DME1200 XEOTICID XEO02291 MOACRIVE Inhibition DME1200 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1200 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02293 XEO_CLAS Peptide DME1200 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 microM) DME1200 XEOTICID XEO02293 GENEFORM Protein DME1200 XEOTICID XEO02293 MOACRIVE Inhibition DME1200 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1200 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02294 XEO_CLAS Peptide DME1200 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 62-250 ug/ml) DME1200 XEOTICID XEO02294 GENEFORM Protein DME1200 XEOTICID XEO02294 MOACRIVE Inhibition DME1200 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1200 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02295 XEO_CLAS Peptide DME1200 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 ug/ml) DME1200 XEOTICID XEO02295 GENEFORM Protein DME1200 XEOTICID XEO02295 MOACRIVE Inhibition DME1200 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1200 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02296 XEO_CLAS Peptide DME1200 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02296 GENEFORM Protein DME1200 XEOTICID XEO02296 MOACRIVE Inhibition DME1200 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1200 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02297 XEO_CLAS Peptide DME1200 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC < 50 ug/ml) DME1200 XEOTICID XEO02297 GENEFORM Protein DME1200 XEOTICID XEO02297 MOACRIVE Inhibition DME1200 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1200 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02298 XEO_CLAS Peptide DME1200 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO02298 GENEFORM Protein DME1200 XEOTICID XEO02298 MOACRIVE Inhibition DME1200 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1200 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02303 XEO_CLAS Peptide DME1200 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02303 GENEFORM Protein DME1200 XEOTICID XEO02303 MOACRIVE Inhibition DME1200 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1200 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02304 XEO_CLAS Peptide DME1200 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.1 ug/ml) DME1200 XEOTICID XEO02304 GENEFORM Protein DME1200 XEOTICID XEO02304 MOACRIVE Inhibition DME1200 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1200 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02305 XEO_CLAS Peptide DME1200 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC <= 1 ug/ml) DME1200 XEOTICID XEO02305 GENEFORM Protein DME1200 XEOTICID XEO02305 MOACRIVE Inhibition DME1200 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1200 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02306 XEO_CLAS Peptide DME1200 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.2 ug/ml) DME1200 XEOTICID XEO02306 GENEFORM Protein DME1200 XEOTICID XEO02306 MOACRIVE Inhibition DME1200 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1200 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02309 XEO_CLAS Peptide DME1200 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02309 GENEFORM Protein DME1200 XEOTICID XEO02309 MOACRIVE Inhibition DME1200 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1200 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02310 XEO_CLAS Peptide DME1200 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02310 GENEFORM Protein DME1200 XEOTICID XEO02310 MOACRIVE Inhibition DME1200 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1200 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02315 XEO_CLAS Peptide DME1200 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO02315 GENEFORM Protein DME1200 XEOTICID XEO02315 MOACRIVE Inhibition DME1200 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1200 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02316 XEO_CLAS Peptide DME1200 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 50 microM) DME1200 XEOTICID XEO02316 GENEFORM Protein DME1200 XEOTICID XEO02316 MOACRIVE Inhibition DME1200 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1200 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02317 XEO_CLAS Peptide DME1200 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 300 microM) DME1200 XEOTICID XEO02317 GENEFORM Protein DME1200 XEOTICID XEO02317 MOACRIVE Inhibition DME1200 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1200 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02318 XEO_CLAS Peptide DME1200 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02318 GENEFORM Protein DME1200 XEOTICID XEO02318 MOACRIVE Inhibition DME1200 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1200 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02319 XEO_CLAS Peptide DME1200 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02319 GENEFORM Protein DME1200 XEOTICID XEO02319 MOACRIVE Inhibition DME1200 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1200 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02320 XEO_CLAS Peptide DME1200 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02320 GENEFORM Protein DME1200 XEOTICID XEO02320 MOACRIVE Inhibition DME1200 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1200 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02321 XEO_CLAS Peptide DME1200 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO02321 GENEFORM Protein DME1200 XEOTICID XEO02321 MOACRIVE Inhibition DME1200 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1200 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02322 XEO_CLAS Peptide DME1200 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02322 GENEFORM Protein DME1200 XEOTICID XEO02322 MOACRIVE Inhibition DME1200 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1200 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02323 XEO_CLAS Peptide DME1200 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO02323 GENEFORM Protein DME1200 XEOTICID XEO02323 MOACRIVE Inhibition DME1200 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1200 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02324 XEO_CLAS Peptide DME1200 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02324 GENEFORM Protein DME1200 XEOTICID XEO02324 MOACRIVE Inhibition DME1200 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1200 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02325 XEO_CLAS Peptide DME1200 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO02325 GENEFORM Protein DME1200 XEOTICID XEO02325 MOACRIVE Inhibition DME1200 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1200 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02326 XEO_CLAS Peptide DME1200 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02326 GENEFORM Protein DME1200 XEOTICID XEO02326 MOACRIVE Inhibition DME1200 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1200 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02327 XEO_CLAS Peptide DME1200 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO02327 GENEFORM Protein DME1200 XEOTICID XEO02327 MOACRIVE Inhibition DME1200 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1200 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02328 XEO_CLAS Peptide DME1200 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO02328 GENEFORM Protein DME1200 XEOTICID XEO02328 MOACRIVE Inhibition DME1200 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1200 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02332 XEO_CLAS Peptide DME1200 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.9 ug/ml) DME1200 XEOTICID XEO02332 GENEFORM Protein DME1200 XEOTICID XEO02332 MOACRIVE Inhibition DME1200 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1200 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02333 XEO_CLAS Peptide DME1200 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 200 microM) DME1200 XEOTICID XEO02333 GENEFORM Protein DME1200 XEOTICID XEO02333 MOACRIVE Inhibition DME1200 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1200 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02336 XEO_CLAS Peptide DME1200 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 microM) DME1200 XEOTICID XEO02336 GENEFORM Protein DME1200 XEOTICID XEO02336 MOACRIVE Inhibition DME1200 XEOTICID XEO02346 XEO_NAME Aurelin DME1200 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02346 XEO_CLAS Peptide DME1200 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 7.66 ug/ml) DME1200 XEOTICID XEO02346 GENEFORM Protein DME1200 XEOTICID XEO02346 MOACRIVE Inhibition DME1200 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1200 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02352 XEO_CLAS Peptide DME1200 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 11 ug/ml) DME1200 XEOTICID XEO02352 GENEFORM Protein DME1200 XEOTICID XEO02352 MOACRIVE Inhibition DME1200 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1200 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02353 XEO_CLAS Peptide DME1200 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 ug/ml) DME1200 XEOTICID XEO02353 GENEFORM Protein DME1200 XEOTICID XEO02353 MOACRIVE Inhibition DME1200 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1200 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02354 XEO_CLAS Peptide DME1200 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 ug/ml) DME1200 XEOTICID XEO02354 GENEFORM Protein DME1200 XEOTICID XEO02354 MOACRIVE Inhibition DME1200 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1200 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02355 XEO_CLAS Peptide DME1200 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 17 ug/ml) DME1200 XEOTICID XEO02355 GENEFORM Protein DME1200 XEOTICID XEO02355 MOACRIVE Inhibition DME1200 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1200 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02356 XEO_CLAS Peptide DME1200 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO02356 GENEFORM Protein DME1200 XEOTICID XEO02356 MOACRIVE Inhibition DME1200 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1200 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02357 XEO_CLAS Peptide DME1200 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO02357 GENEFORM Protein DME1200 XEOTICID XEO02357 MOACRIVE Inhibition DME1200 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1200 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02358 XEO_CLAS Peptide DME1200 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO02358 GENEFORM Protein DME1200 XEOTICID XEO02358 MOACRIVE Inhibition DME1200 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1200 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02360 XEO_CLAS Peptide DME1200 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02360 GENEFORM Protein DME1200 XEOTICID XEO02360 MOACRIVE Inhibition DME1200 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1200 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02361 XEO_CLAS Peptide DME1200 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 ug/ml) DME1200 XEOTICID XEO02361 GENEFORM Protein DME1200 XEOTICID XEO02361 MOACRIVE Inhibition DME1200 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1200 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02365 XEO_CLAS Peptide DME1200 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 32 ug/ml) DME1200 XEOTICID XEO02365 GENEFORM Protein DME1200 XEOTICID XEO02365 MOACRIVE Inhibition DME1200 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1200 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02366 XEO_CLAS Peptide DME1200 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO02366 GENEFORM Protein DME1200 XEOTICID XEO02366 MOACRIVE Inhibition DME1200 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1200 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02367 XEO_CLAS Peptide DME1200 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02367 GENEFORM Protein DME1200 XEOTICID XEO02367 MOACRIVE Inhibition DME1200 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1200 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02368 XEO_CLAS Peptide DME1200 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02368 GENEFORM Protein DME1200 XEOTICID XEO02368 MOACRIVE Inhibition DME1200 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1200 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02369 XEO_CLAS Peptide DME1200 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02369 GENEFORM Protein DME1200 XEOTICID XEO02369 MOACRIVE Inhibition DME1200 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1200 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02370 XEO_CLAS Peptide DME1200 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02370 GENEFORM Protein DME1200 XEOTICID XEO02370 MOACRIVE Inhibition DME1200 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1200 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02371 XEO_CLAS Peptide DME1200 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 ug/ml) DME1200 XEOTICID XEO02371 GENEFORM Protein DME1200 XEOTICID XEO02371 MOACRIVE Inhibition DME1200 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1200 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02374 XEO_CLAS Peptide DME1200 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02374 GENEFORM Protein DME1200 XEOTICID XEO02374 MOACRIVE Inhibition DME1200 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1200 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02376 XEO_CLAS Peptide DME1200 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02376 GENEFORM Protein DME1200 XEOTICID XEO02376 MOACRIVE Inhibition DME1200 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1200 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02378 XEO_CLAS Peptide DME1200 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.19 ug/ml) DME1200 XEOTICID XEO02378 GENEFORM Protein DME1200 XEOTICID XEO02378 MOACRIVE Inhibition DME1200 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1200 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02388 XEO_CLAS Peptide DME1200 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO02388 GENEFORM Protein DME1200 XEOTICID XEO02388 MOACRIVE Inhibition DME1200 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1200 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02389 XEO_CLAS Peptide DME1200 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02389 GENEFORM Protein DME1200 XEOTICID XEO02389 MOACRIVE Inhibition DME1200 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1200 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02415 XEO_CLAS Peptide DME1200 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02415 GENEFORM Protein DME1200 XEOTICID XEO02415 MOACRIVE Inhibition DME1200 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1200 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02416 XEO_CLAS Peptide DME1200 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 11 microM) DME1200 XEOTICID XEO02416 GENEFORM Protein DME1200 XEOTICID XEO02416 MOACRIVE Inhibition DME1200 XEOTICID XEO02419 XEO_NAME Bay oil DME1200 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1200 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02419 GENEFORM Protein DME1200 XEOTICID XEO02419 MOACRIVE Inhibition DME1200 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1200 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02435 XEO_CLAS Peptide DME1200 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02435 GENEFORM Protein DME1200 XEOTICID XEO02435 MOACRIVE Inhibition DME1200 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1200 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02436 XEO_CLAS Peptide DME1200 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02436 GENEFORM Protein DME1200 XEOTICID XEO02436 MOACRIVE Inhibition DME1200 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1200 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02437 XEO_CLAS Peptide DME1200 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02437 GENEFORM Protein DME1200 XEOTICID XEO02437 MOACRIVE Inhibition DME1200 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1200 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02438 XEO_CLAS Peptide DME1200 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02438 GENEFORM Protein DME1200 XEOTICID XEO02438 MOACRIVE Inhibition DME1200 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1200 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02439 XEO_CLAS Peptide DME1200 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02439 GENEFORM Protein DME1200 XEOTICID XEO02439 MOACRIVE Inhibition DME1200 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1200 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02440 XEO_CLAS Peptide DME1200 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02440 GENEFORM Protein DME1200 XEOTICID XEO02440 MOACRIVE Inhibition DME1200 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1200 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02441 XEO_CLAS Peptide DME1200 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02441 GENEFORM Protein DME1200 XEOTICID XEO02441 MOACRIVE Inhibition DME1200 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1200 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02442 XEO_CLAS Peptide DME1200 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO02442 GENEFORM Protein DME1200 XEOTICID XEO02442 MOACRIVE Inhibition DME1200 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1200 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02443 XEO_CLAS Peptide DME1200 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02443 GENEFORM Protein DME1200 XEOTICID XEO02443 MOACRIVE Inhibition DME1200 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1200 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02444 XEO_CLAS Peptide DME1200 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02444 GENEFORM Protein DME1200 XEOTICID XEO02444 MOACRIVE Inhibition DME1200 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1200 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1200 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02447 GENEFORM Protein DME1200 XEOTICID XEO02447 MOACRIVE Inhibition DME1200 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1200 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02452 XEO_CLAS Peptide DME1200 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 76800 ug/ml) DME1200 XEOTICID XEO02452 GENEFORM Protein DME1200 XEOTICID XEO02452 MOACRIVE Inhibition DME1200 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1200 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02453 XEO_CLAS Peptide DME1200 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02453 GENEFORM Protein DME1200 XEOTICID XEO02453 MOACRIVE Inhibition DME1200 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1200 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02463 XEO_CLAS Peptide DME1200 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 11.25 microM) DME1200 XEOTICID XEO02463 GENEFORM Protein DME1200 XEOTICID XEO02463 MOACRIVE Inhibition DME1200 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1200 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02466 XEO_CLAS Peptide DME1200 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.5 microM) DME1200 XEOTICID XEO02466 GENEFORM Protein DME1200 XEOTICID XEO02466 MOACRIVE Inhibition DME1200 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1200 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02467 XEO_CLAS Peptide DME1200 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8.4 microM) DME1200 XEOTICID XEO02467 GENEFORM Protein DME1200 XEOTICID XEO02467 MOACRIVE Inhibition DME1200 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1200 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02468 XEO_CLAS Peptide DME1200 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.7 microM) DME1200 XEOTICID XEO02468 GENEFORM Protein DME1200 XEOTICID XEO02468 MOACRIVE Inhibition DME1200 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1200 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02469 XEO_CLAS Peptide DME1200 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO02469 GENEFORM Protein DME1200 XEOTICID XEO02469 MOACRIVE Inhibition DME1200 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1200 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02470 XEO_CLAS Peptide DME1200 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.8 microM) DME1200 XEOTICID XEO02470 GENEFORM Protein DME1200 XEOTICID XEO02470 MOACRIVE Inhibition DME1200 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1200 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02471 XEO_CLAS Peptide DME1200 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4.8 microM) DME1200 XEOTICID XEO02471 GENEFORM Protein DME1200 XEOTICID XEO02471 MOACRIVE Inhibition DME1200 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1200 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02472 XEO_CLAS Peptide DME1200 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.0 microM) DME1200 XEOTICID XEO02472 GENEFORM Protein DME1200 XEOTICID XEO02472 MOACRIVE Inhibition DME1200 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1200 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02473 XEO_CLAS Peptide DME1200 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02473 GENEFORM Protein DME1200 XEOTICID XEO02473 MOACRIVE Inhibition DME1200 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1200 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02474 XEO_CLAS Peptide DME1200 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.5 microM) DME1200 XEOTICID XEO02474 GENEFORM Protein DME1200 XEOTICID XEO02474 MOACRIVE Inhibition DME1200 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1200 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02475 XEO_CLAS Peptide DME1200 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.5 microM) DME1200 XEOTICID XEO02475 GENEFORM Protein DME1200 XEOTICID XEO02475 MOACRIVE Inhibition DME1200 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1200 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02477 XEO_CLAS Peptide DME1200 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-300 ug/ml) DME1200 XEOTICID XEO02477 GENEFORM Protein DME1200 XEOTICID XEO02477 MOACRIVE Inhibition DME1200 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1200 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02478 XEO_CLAS Peptide DME1200 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-300 ug/ml) DME1200 XEOTICID XEO02478 GENEFORM Protein DME1200 XEOTICID XEO02478 MOACRIVE Inhibition DME1200 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1200 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02479 XEO_CLAS Peptide DME1200 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-300 ug/ml) DME1200 XEOTICID XEO02479 GENEFORM Protein DME1200 XEOTICID XEO02479 MOACRIVE Inhibition DME1200 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1200 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02480 XEO_CLAS Peptide DME1200 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-300 ug/ml) DME1200 XEOTICID XEO02480 GENEFORM Protein DME1200 XEOTICID XEO02480 MOACRIVE Inhibition DME1200 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1200 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02481 XEO_CLAS Peptide DME1200 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-300 ug/ml) DME1200 XEOTICID XEO02481 GENEFORM Protein DME1200 XEOTICID XEO02481 MOACRIVE Inhibition DME1200 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1200 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02482 XEO_CLAS Peptide DME1200 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-300 ug/ml) DME1200 XEOTICID XEO02482 GENEFORM Protein DME1200 XEOTICID XEO02482 MOACRIVE Inhibition DME1200 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1200 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02483 XEO_CLAS Peptide DME1200 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-300 ug/ml) DME1200 XEOTICID XEO02483 GENEFORM Protein DME1200 XEOTICID XEO02483 MOACRIVE Inhibition DME1200 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1200 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02484 XEO_CLAS Peptide DME1200 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-300 ug/ml) DME1200 XEOTICID XEO02484 GENEFORM Protein DME1200 XEOTICID XEO02484 MOACRIVE Inhibition DME1200 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1200 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02485 XEO_CLAS Peptide DME1200 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-300 ug/ml) DME1200 XEOTICID XEO02485 GENEFORM Protein DME1200 XEOTICID XEO02485 MOACRIVE Inhibition DME1200 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1200 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02486 XEO_CLAS Peptide DME1200 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-300 ug/ml) DME1200 XEOTICID XEO02486 GENEFORM Protein DME1200 XEOTICID XEO02486 MOACRIVE Inhibition DME1200 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1200 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02487 XEO_CLAS Peptide DME1200 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02487 GENEFORM Protein DME1200 XEOTICID XEO02487 MOACRIVE Inhibition DME1200 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1200 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02488 XEO_CLAS Peptide DME1200 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-300 ug/ml) DME1200 XEOTICID XEO02488 GENEFORM Protein DME1200 XEOTICID XEO02488 MOACRIVE Inhibition DME1200 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1200 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02489 XEO_CLAS Peptide DME1200 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-301 ug/ml) DME1200 XEOTICID XEO02489 GENEFORM Protein DME1200 XEOTICID XEO02489 MOACRIVE Inhibition DME1200 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1200 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02491 XEO_CLAS Peptide DME1200 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.3 microM) DME1200 XEOTICID XEO02491 GENEFORM Protein DME1200 XEOTICID XEO02491 MOACRIVE Inhibition DME1200 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1200 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02492 XEO_CLAS Peptide DME1200 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 ug/ml) DME1200 XEOTICID XEO02492 GENEFORM Protein DME1200 XEOTICID XEO02492 MOACRIVE Inhibition DME1200 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1200 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02493 XEO_CLAS Peptide DME1200 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 ug/ml) DME1200 XEOTICID XEO02493 GENEFORM Protein DME1200 XEOTICID XEO02493 MOACRIVE Inhibition DME1200 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1200 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02494 XEO_CLAS Peptide DME1200 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 ug/ml) DME1200 XEOTICID XEO02494 GENEFORM Protein DME1200 XEOTICID XEO02494 MOACRIVE Inhibition DME1200 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1200 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02495 XEO_CLAS Peptide DME1200 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 34 ug/ml) DME1200 XEOTICID XEO02495 GENEFORM Protein DME1200 XEOTICID XEO02495 MOACRIVE Inhibition DME1200 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1200 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02496 XEO_CLAS Peptide DME1200 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 13 microM) DME1200 XEOTICID XEO02496 GENEFORM Protein DME1200 XEOTICID XEO02496 MOACRIVE Inhibition DME1200 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1200 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02497 XEO_CLAS Peptide DME1200 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO02497 GENEFORM Protein DME1200 XEOTICID XEO02497 MOACRIVE Inhibition DME1200 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1200 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02499 XEO_CLAS Peptide DME1200 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO02499 GENEFORM Protein DME1200 XEOTICID XEO02499 MOACRIVE Inhibition DME1200 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1200 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02501 XEO_CLAS Peptide DME1200 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 7 microM) DME1200 XEOTICID XEO02501 GENEFORM Protein DME1200 XEOTICID XEO02501 MOACRIVE Inhibition DME1200 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1200 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02502 XEO_CLAS Peptide DME1200 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 microM) DME1200 XEOTICID XEO02502 GENEFORM Protein DME1200 XEOTICID XEO02502 MOACRIVE Inhibition DME1200 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1200 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02503 XEO_CLAS Peptide DME1200 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 19 microM) DME1200 XEOTICID XEO02503 GENEFORM Protein DME1200 XEOTICID XEO02503 MOACRIVE Inhibition DME1200 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1200 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02504 XEO_CLAS Peptide DME1200 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02504 GENEFORM Protein DME1200 XEOTICID XEO02504 MOACRIVE Inhibition DME1200 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1200 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02505 XEO_CLAS Peptide DME1200 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO02505 GENEFORM Protein DME1200 XEOTICID XEO02505 MOACRIVE Inhibition DME1200 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1200 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02507 XEO_CLAS Peptide DME1200 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO02507 GENEFORM Protein DME1200 XEOTICID XEO02507 MOACRIVE Inhibition DME1200 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1200 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02508 XEO_CLAS Peptide DME1200 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 150 microM) DME1200 XEOTICID XEO02508 GENEFORM Protein DME1200 XEOTICID XEO02508 MOACRIVE Inhibition DME1200 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1200 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02509 XEO_CLAS Peptide DME1200 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 150 microM) DME1200 XEOTICID XEO02509 GENEFORM Protein DME1200 XEOTICID XEO02509 MOACRIVE Inhibition DME1200 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1200 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02510 XEO_CLAS Peptide DME1200 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 150 microM) DME1200 XEOTICID XEO02510 GENEFORM Protein DME1200 XEOTICID XEO02510 MOACRIVE Inhibition DME1200 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1200 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02511 XEO_CLAS Peptide DME1200 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 150 microM) DME1200 XEOTICID XEO02511 GENEFORM Protein DME1200 XEOTICID XEO02511 MOACRIVE Inhibition DME1200 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1200 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02512 XEO_CLAS Peptide DME1200 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 75 microM) DME1200 XEOTICID XEO02512 GENEFORM Protein DME1200 XEOTICID XEO02512 MOACRIVE Inhibition DME1200 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1200 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02513 XEO_CLAS Peptide DME1200 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO02513 GENEFORM Protein DME1200 XEOTICID XEO02513 MOACRIVE Inhibition DME1200 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1200 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02514 XEO_CLAS Peptide DME1200 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO02514 GENEFORM Protein DME1200 XEOTICID XEO02514 MOACRIVE Inhibition DME1200 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1200 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02515 XEO_CLAS Peptide DME1200 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 80 microM) DME1200 XEOTICID XEO02515 GENEFORM Protein DME1200 XEOTICID XEO02515 MOACRIVE Inhibition DME1200 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1200 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02516 XEO_CLAS Peptide DME1200 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 32 microM) DME1200 XEOTICID XEO02516 GENEFORM Protein DME1200 XEOTICID XEO02516 MOACRIVE Inhibition DME1200 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1200 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02517 XEO_CLAS Peptide DME1200 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 microM) DME1200 XEOTICID XEO02517 GENEFORM Protein DME1200 XEOTICID XEO02517 MOACRIVE Inhibition DME1200 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1200 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02518 XEO_CLAS Peptide DME1200 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC < 15 microM) DME1200 XEOTICID XEO02518 GENEFORM Protein DME1200 XEOTICID XEO02518 MOACRIVE Inhibition DME1200 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1200 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02519 XEO_CLAS Peptide DME1200 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC < 15 microM) DME1200 XEOTICID XEO02519 GENEFORM Protein DME1200 XEOTICID XEO02519 MOACRIVE Inhibition DME1200 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1200 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02520 XEO_CLAS Peptide DME1200 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC < 15 microM) DME1200 XEOTICID XEO02520 GENEFORM Protein DME1200 XEOTICID XEO02520 MOACRIVE Inhibition DME1200 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1200 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02523 XEO_CLAS Peptide DME1200 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO02523 GENEFORM Protein DME1200 XEOTICID XEO02523 MOACRIVE Inhibition DME1200 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1200 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02524 XEO_CLAS Peptide DME1200 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 150 microM) DME1200 XEOTICID XEO02524 GENEFORM Protein DME1200 XEOTICID XEO02524 MOACRIVE Inhibition DME1200 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1200 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02525 XEO_CLAS Peptide DME1200 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 24 microM) DME1200 XEOTICID XEO02525 GENEFORM Protein DME1200 XEOTICID XEO02525 MOACRIVE Inhibition DME1200 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1200 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02526 XEO_CLAS Peptide DME1200 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 48 microM) DME1200 XEOTICID XEO02526 GENEFORM Protein DME1200 XEOTICID XEO02526 MOACRIVE Inhibition DME1200 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1200 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02527 XEO_CLAS Peptide DME1200 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 119 microM) DME1200 XEOTICID XEO02527 GENEFORM Protein DME1200 XEOTICID XEO02527 MOACRIVE Inhibition DME1200 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1200 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02528 XEO_CLAS Peptide DME1200 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 128 ug/ml) DME1200 XEOTICID XEO02528 GENEFORM Protein DME1200 XEOTICID XEO02528 MOACRIVE Inhibition DME1200 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1200 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02529 XEO_CLAS Peptide DME1200 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 128 ug/ml) DME1200 XEOTICID XEO02529 GENEFORM Protein DME1200 XEOTICID XEO02529 MOACRIVE Inhibition DME1200 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1200 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02530 XEO_CLAS Peptide DME1200 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02530 GENEFORM Protein DME1200 XEOTICID XEO02530 MOACRIVE Inhibition DME1200 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1200 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02531 XEO_CLAS Peptide DME1200 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 microM) DME1200 XEOTICID XEO02531 GENEFORM Protein DME1200 XEOTICID XEO02531 MOACRIVE Inhibition DME1200 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1200 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02533 XEO_CLAS Peptide DME1200 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.2 ug/ml) DME1200 XEOTICID XEO02533 GENEFORM Protein DME1200 XEOTICID XEO02533 MOACRIVE Inhibition DME1200 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1200 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02534 XEO_CLAS Peptide DME1200 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.6 ug/ml) DME1200 XEOTICID XEO02534 GENEFORM Protein DME1200 XEOTICID XEO02534 MOACRIVE Inhibition DME1200 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1200 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02535 XEO_CLAS Peptide DME1200 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.3 ug/ml) DME1200 XEOTICID XEO02535 GENEFORM Protein DME1200 XEOTICID XEO02535 MOACRIVE Inhibition DME1200 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1200 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02536 XEO_CLAS Peptide DME1200 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.4 ug/ml) DME1200 XEOTICID XEO02536 GENEFORM Protein DME1200 XEOTICID XEO02536 MOACRIVE Inhibition DME1200 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1200 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02537 XEO_CLAS Peptide DME1200 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.2 ug/ml) DME1200 XEOTICID XEO02537 GENEFORM Protein DME1200 XEOTICID XEO02537 MOACRIVE Inhibition DME1200 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1200 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02538 XEO_CLAS Peptide DME1200 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 9.1 ug/ml) DME1200 XEOTICID XEO02538 GENEFORM Protein DME1200 XEOTICID XEO02538 MOACRIVE Inhibition DME1200 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1200 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02539 XEO_CLAS Peptide DME1200 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8.6 ug/ml) DME1200 XEOTICID XEO02539 GENEFORM Protein DME1200 XEOTICID XEO02539 MOACRIVE Inhibition DME1200 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1200 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02540 XEO_CLAS Peptide DME1200 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15.2 ug/ml) DME1200 XEOTICID XEO02540 GENEFORM Protein DME1200 XEOTICID XEO02540 MOACRIVE Inhibition DME1200 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1200 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02541 XEO_CLAS Peptide DME1200 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 11.1 ug/ml) DME1200 XEOTICID XEO02541 GENEFORM Protein DME1200 XEOTICID XEO02541 MOACRIVE Inhibition DME1200 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1200 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02542 XEO_CLAS Peptide DME1200 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.7 ug/ml) DME1200 XEOTICID XEO02542 GENEFORM Protein DME1200 XEOTICID XEO02542 MOACRIVE Inhibition DME1200 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1200 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02543 XEO_CLAS Peptide DME1200 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 13.1 ug/ml) DME1200 XEOTICID XEO02543 GENEFORM Protein DME1200 XEOTICID XEO02543 MOACRIVE Inhibition DME1200 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1200 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02544 XEO_CLAS Peptide DME1200 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 9.8 ug/ml) DME1200 XEOTICID XEO02544 GENEFORM Protein DME1200 XEOTICID XEO02544 MOACRIVE Inhibition DME1200 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1200 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02545 XEO_CLAS Peptide DME1200 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 14 microM) DME1200 XEOTICID XEO02545 GENEFORM Protein DME1200 XEOTICID XEO02545 MOACRIVE Inhibition DME1200 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1200 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02546 XEO_CLAS Peptide DME1200 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 14 microM) DME1200 XEOTICID XEO02546 GENEFORM Protein DME1200 XEOTICID XEO02546 MOACRIVE Inhibition DME1200 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1200 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02547 XEO_CLAS Peptide DME1200 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 microM) DME1200 XEOTICID XEO02547 GENEFORM Protein DME1200 XEOTICID XEO02547 MOACRIVE Inhibition DME1200 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1200 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02548 XEO_CLAS Peptide DME1200 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 78 microM) DME1200 XEOTICID XEO02548 GENEFORM Protein DME1200 XEOTICID XEO02548 MOACRIVE Inhibition DME1200 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1200 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02549 XEO_CLAS Peptide DME1200 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02549 GENEFORM Protein DME1200 XEOTICID XEO02549 MOACRIVE Inhibition DME1200 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1200 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02552 XEO_CLAS Peptide DME1200 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 24 microM) DME1200 XEOTICID XEO02552 GENEFORM Protein DME1200 XEOTICID XEO02552 MOACRIVE Inhibition DME1200 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1200 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02553 XEO_CLAS Peptide DME1200 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02553 GENEFORM Protein DME1200 XEOTICID XEO02553 MOACRIVE Inhibition DME1200 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1200 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02556 XEO_CLAS Peptide DME1200 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 55 microM) DME1200 XEOTICID XEO02556 GENEFORM Protein DME1200 XEOTICID XEO02556 MOACRIVE Inhibition DME1200 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1200 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02557 XEO_CLAS Peptide DME1200 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 17 microM) DME1200 XEOTICID XEO02557 GENEFORM Protein DME1200 XEOTICID XEO02557 MOACRIVE Inhibition DME1200 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1200 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02558 XEO_CLAS Peptide DME1200 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 14 microM) DME1200 XEOTICID XEO02558 GENEFORM Protein DME1200 XEOTICID XEO02558 MOACRIVE Inhibition DME1200 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1200 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02559 XEO_CLAS Peptide DME1200 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02559 GENEFORM Protein DME1200 XEOTICID XEO02559 MOACRIVE Inhibition DME1200 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1200 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02560 XEO_CLAS Peptide DME1200 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 13 microM) DME1200 XEOTICID XEO02560 GENEFORM Protein DME1200 XEOTICID XEO02560 MOACRIVE Inhibition DME1200 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1200 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02561 XEO_CLAS Peptide DME1200 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO02561 GENEFORM Protein DME1200 XEOTICID XEO02561 MOACRIVE Inhibition DME1200 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1200 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02562 XEO_CLAS Peptide DME1200 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 13 microM) DME1200 XEOTICID XEO02562 GENEFORM Protein DME1200 XEOTICID XEO02562 MOACRIVE Inhibition DME1200 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1200 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02563 XEO_CLAS Peptide DME1200 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 45 microM) DME1200 XEOTICID XEO02563 GENEFORM Protein DME1200 XEOTICID XEO02563 MOACRIVE Inhibition DME1200 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1200 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02564 XEO_CLAS Peptide DME1200 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 ug/ml) DME1200 XEOTICID XEO02564 GENEFORM Protein DME1200 XEOTICID XEO02564 MOACRIVE Inhibition DME1200 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1200 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02565 XEO_CLAS Peptide DME1200 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 microM) DME1200 XEOTICID XEO02565 GENEFORM Protein DME1200 XEOTICID XEO02565 MOACRIVE Inhibition DME1200 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1200 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02566 XEO_CLAS Peptide DME1200 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO02566 GENEFORM Protein DME1200 XEOTICID XEO02566 MOACRIVE Inhibition DME1200 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1200 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02568 XEO_CLAS Peptide DME1200 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO02568 GENEFORM Protein DME1200 XEOTICID XEO02568 MOACRIVE Inhibition DME1200 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1200 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02569 XEO_CLAS Peptide DME1200 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO02569 GENEFORM Protein DME1200 XEOTICID XEO02569 MOACRIVE Inhibition DME1200 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1200 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02570 XEO_CLAS Peptide DME1200 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO02570 GENEFORM Protein DME1200 XEOTICID XEO02570 MOACRIVE Inhibition DME1200 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1200 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02571 XEO_CLAS Peptide DME1200 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO02571 GENEFORM Protein DME1200 XEOTICID XEO02571 MOACRIVE Inhibition DME1200 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1200 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02572 XEO_CLAS Peptide DME1200 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02572 GENEFORM Protein DME1200 XEOTICID XEO02572 MOACRIVE Inhibition DME1200 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1200 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02573 XEO_CLAS Peptide DME1200 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02573 GENEFORM Protein DME1200 XEOTICID XEO02573 MOACRIVE Inhibition DME1200 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1200 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02574 XEO_CLAS Peptide DME1200 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 microM) DME1200 XEOTICID XEO02574 GENEFORM Protein DME1200 XEOTICID XEO02574 MOACRIVE Inhibition DME1200 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1200 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02575 XEO_CLAS Peptide DME1200 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 microM) DME1200 XEOTICID XEO02575 GENEFORM Protein DME1200 XEOTICID XEO02575 MOACRIVE Inhibition DME1200 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1200 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02576 XEO_CLAS Peptide DME1200 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 33 microM) DME1200 XEOTICID XEO02576 GENEFORM Protein DME1200 XEOTICID XEO02576 MOACRIVE Inhibition DME1200 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1200 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02577 XEO_CLAS Peptide DME1200 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO02577 GENEFORM Protein DME1200 XEOTICID XEO02577 MOACRIVE Inhibition DME1200 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1200 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02578 XEO_CLAS Peptide DME1200 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02578 GENEFORM Protein DME1200 XEOTICID XEO02578 MOACRIVE Inhibition DME1200 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1200 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02579 XEO_CLAS Peptide DME1200 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02579 GENEFORM Protein DME1200 XEOTICID XEO02579 MOACRIVE Inhibition DME1200 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1200 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02580 XEO_CLAS Peptide DME1200 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC < 15 microM) DME1200 XEOTICID XEO02580 GENEFORM Protein DME1200 XEOTICID XEO02580 MOACRIVE Inhibition DME1200 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1200 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02581 XEO_CLAS Peptide DME1200 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 microM) DME1200 XEOTICID XEO02581 GENEFORM Protein DME1200 XEOTICID XEO02581 MOACRIVE Inhibition DME1200 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1200 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02582 XEO_CLAS Peptide DME1200 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 microM) DME1200 XEOTICID XEO02582 GENEFORM Protein DME1200 XEOTICID XEO02582 MOACRIVE Inhibition DME1200 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1200 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02583 XEO_CLAS Peptide DME1200 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 microM) DME1200 XEOTICID XEO02583 GENEFORM Protein DME1200 XEOTICID XEO02583 MOACRIVE Inhibition DME1200 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1200 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02584 XEO_CLAS Peptide DME1200 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 microM) DME1200 XEOTICID XEO02584 GENEFORM Protein DME1200 XEOTICID XEO02584 MOACRIVE Inhibition DME1200 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1200 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02585 XEO_CLAS Peptide DME1200 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO02585 GENEFORM Protein DME1200 XEOTICID XEO02585 MOACRIVE Inhibition DME1200 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1200 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02586 XEO_CLAS Peptide DME1200 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO02586 GENEFORM Protein DME1200 XEOTICID XEO02586 MOACRIVE Inhibition DME1200 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1200 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02587 XEO_CLAS Peptide DME1200 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02587 GENEFORM Protein DME1200 XEOTICID XEO02587 MOACRIVE Inhibition DME1200 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1200 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02589 XEO_CLAS Peptide DME1200 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8.2 ug/ml) DME1200 XEOTICID XEO02589 GENEFORM Protein DME1200 XEOTICID XEO02589 MOACRIVE Inhibition DME1200 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1200 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02590 XEO_CLAS Peptide DME1200 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 19.6 ug/ml) DME1200 XEOTICID XEO02590 GENEFORM Protein DME1200 XEOTICID XEO02590 MOACRIVE Inhibition DME1200 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1200 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02591 XEO_CLAS Peptide DME1200 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO02591 GENEFORM Protein DME1200 XEOTICID XEO02591 MOACRIVE Inhibition DME1200 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1200 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02593 XEO_CLAS Peptide DME1200 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 36 microM) DME1200 XEOTICID XEO02593 GENEFORM Protein DME1200 XEOTICID XEO02593 MOACRIVE Inhibition DME1200 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1200 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02594 XEO_CLAS Peptide DME1200 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02594 GENEFORM Protein DME1200 XEOTICID XEO02594 MOACRIVE Inhibition DME1200 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1200 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02595 XEO_CLAS Peptide DME1200 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO02595 GENEFORM Protein DME1200 XEOTICID XEO02595 MOACRIVE Inhibition DME1200 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1200 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02596 XEO_CLAS Peptide DME1200 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO02596 GENEFORM Protein DME1200 XEOTICID XEO02596 MOACRIVE Inhibition DME1200 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1200 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02597 XEO_CLAS Peptide DME1200 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO02597 GENEFORM Protein DME1200 XEOTICID XEO02597 MOACRIVE Inhibition DME1200 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1200 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02598 XEO_CLAS Peptide DME1200 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 32.5 microM) DME1200 XEOTICID XEO02598 GENEFORM Protein DME1200 XEOTICID XEO02598 MOACRIVE Inhibition DME1200 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1200 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02599 XEO_CLAS Peptide DME1200 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 microM) DME1200 XEOTICID XEO02599 GENEFORM Protein DME1200 XEOTICID XEO02599 MOACRIVE Inhibition DME1200 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1200 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02601 XEO_CLAS Peptide DME1200 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.1 ug/ml) DME1200 XEOTICID XEO02601 GENEFORM Protein DME1200 XEOTICID XEO02601 MOACRIVE Inhibition DME1200 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1200 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02602 XEO_CLAS Peptide DME1200 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 13.2 ug/ml) DME1200 XEOTICID XEO02602 GENEFORM Protein DME1200 XEOTICID XEO02602 MOACRIVE Inhibition DME1200 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1200 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02603 XEO_CLAS Peptide DME1200 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.3 ug/ml) DME1200 XEOTICID XEO02603 GENEFORM Protein DME1200 XEOTICID XEO02603 MOACRIVE Inhibition DME1200 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1200 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02604 XEO_CLAS Peptide DME1200 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO02604 GENEFORM Protein DME1200 XEOTICID XEO02604 MOACRIVE Inhibition DME1200 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1200 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02605 XEO_CLAS Peptide DME1200 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30.6 ug/ml) DME1200 XEOTICID XEO02605 GENEFORM Protein DME1200 XEOTICID XEO02605 MOACRIVE Inhibition DME1200 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1200 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02606 XEO_CLAS Peptide DME1200 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 11.2 ug/ml) DME1200 XEOTICID XEO02606 GENEFORM Protein DME1200 XEOTICID XEO02606 MOACRIVE Inhibition DME1200 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1200 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02607 XEO_CLAS Peptide DME1200 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.8 ug/ml) DME1200 XEOTICID XEO02607 GENEFORM Protein DME1200 XEOTICID XEO02607 MOACRIVE Inhibition DME1200 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1200 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02608 XEO_CLAS Peptide DME1200 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 7.9 ug/ml) DME1200 XEOTICID XEO02608 GENEFORM Protein DME1200 XEOTICID XEO02608 MOACRIVE Inhibition DME1200 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1200 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02609 XEO_CLAS Peptide DME1200 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15.8 ug/ml) DME1200 XEOTICID XEO02609 GENEFORM Protein DME1200 XEOTICID XEO02609 MOACRIVE Inhibition DME1200 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1200 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02610 XEO_CLAS Peptide DME1200 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.1 ug/ml) DME1200 XEOTICID XEO02610 GENEFORM Protein DME1200 XEOTICID XEO02610 MOACRIVE Inhibition DME1200 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1200 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02611 XEO_CLAS Peptide DME1200 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20.6 ug/ml) DME1200 XEOTICID XEO02611 GENEFORM Protein DME1200 XEOTICID XEO02611 MOACRIVE Inhibition DME1200 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1200 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02612 XEO_CLAS Peptide DME1200 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 11.8 ug/ml) DME1200 XEOTICID XEO02612 GENEFORM Protein DME1200 XEOTICID XEO02612 MOACRIVE Inhibition DME1200 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1200 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02613 XEO_CLAS Peptide DME1200 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 13.2 ug/ml) DME1200 XEOTICID XEO02613 GENEFORM Protein DME1200 XEOTICID XEO02613 MOACRIVE Inhibition DME1200 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1200 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02614 XEO_CLAS Peptide DME1200 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.8 ug/ml) DME1200 XEOTICID XEO02614 GENEFORM Protein DME1200 XEOTICID XEO02614 MOACRIVE Inhibition DME1200 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1200 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02615 XEO_CLAS Peptide DME1200 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8.6 ug/ml) DME1200 XEOTICID XEO02615 GENEFORM Protein DME1200 XEOTICID XEO02615 MOACRIVE Inhibition DME1200 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1200 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02616 XEO_CLAS Peptide DME1200 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20.4 ug/ml) DME1200 XEOTICID XEO02616 GENEFORM Protein DME1200 XEOTICID XEO02616 MOACRIVE Inhibition DME1200 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1200 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02617 XEO_CLAS Peptide DME1200 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4.7 ug/ml) DME1200 XEOTICID XEO02617 GENEFORM Protein DME1200 XEOTICID XEO02617 MOACRIVE Inhibition DME1200 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1200 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02618 XEO_CLAS Peptide DME1200 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.6 ug/ml) DME1200 XEOTICID XEO02618 GENEFORM Protein DME1200 XEOTICID XEO02618 MOACRIVE Inhibition DME1200 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1200 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02619 XEO_CLAS Peptide DME1200 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10.5 ug/ml) DME1200 XEOTICID XEO02619 GENEFORM Protein DME1200 XEOTICID XEO02619 MOACRIVE Inhibition DME1200 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1200 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02620 XEO_CLAS Peptide DME1200 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO02620 GENEFORM Protein DME1200 XEOTICID XEO02620 MOACRIVE Inhibition DME1200 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1200 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02621 XEO_CLAS Peptide DME1200 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO02621 GENEFORM Protein DME1200 XEOTICID XEO02621 MOACRIVE Inhibition DME1200 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1200 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02622 XEO_CLAS Peptide DME1200 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO02622 GENEFORM Protein DME1200 XEOTICID XEO02622 MOACRIVE Inhibition DME1200 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1200 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02623 XEO_CLAS Peptide DME1200 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO02623 GENEFORM Protein DME1200 XEOTICID XEO02623 MOACRIVE Inhibition DME1200 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1200 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02624 XEO_CLAS Peptide DME1200 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 18 microM) DME1200 XEOTICID XEO02624 GENEFORM Protein DME1200 XEOTICID XEO02624 MOACRIVE Inhibition DME1200 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1200 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02625 XEO_CLAS Peptide DME1200 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 9 microM) DME1200 XEOTICID XEO02625 GENEFORM Protein DME1200 XEOTICID XEO02625 MOACRIVE Inhibition DME1200 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1200 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02626 XEO_CLAS Peptide DME1200 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 18 microM) DME1200 XEOTICID XEO02626 GENEFORM Protein DME1200 XEOTICID XEO02626 MOACRIVE Inhibition DME1200 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1200 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02627 XEO_CLAS Peptide DME1200 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02627 GENEFORM Protein DME1200 XEOTICID XEO02627 MOACRIVE Inhibition DME1200 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1200 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02628 XEO_CLAS Peptide DME1200 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 18 microM) DME1200 XEOTICID XEO02628 GENEFORM Protein DME1200 XEOTICID XEO02628 MOACRIVE Inhibition DME1200 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1200 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02629 XEO_CLAS Peptide DME1200 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 13 microM) DME1200 XEOTICID XEO02629 GENEFORM Protein DME1200 XEOTICID XEO02629 MOACRIVE Inhibition DME1200 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1200 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02630 XEO_CLAS Peptide DME1200 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 ug/ml) DME1200 XEOTICID XEO02630 GENEFORM Protein DME1200 XEOTICID XEO02630 MOACRIVE Inhibition DME1200 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1200 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02631 XEO_CLAS Peptide DME1200 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 ug/ml) DME1200 XEOTICID XEO02631 GENEFORM Protein DME1200 XEOTICID XEO02631 MOACRIVE Inhibition DME1200 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1200 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02634 XEO_CLAS Peptide DME1200 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO02634 GENEFORM Protein DME1200 XEOTICID XEO02634 MOACRIVE Inhibition DME1200 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1200 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02635 XEO_CLAS Peptide DME1200 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40 ug/ml) DME1200 XEOTICID XEO02635 GENEFORM Protein DME1200 XEOTICID XEO02635 MOACRIVE Inhibition DME1200 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1200 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02636 XEO_CLAS Peptide DME1200 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO02636 GENEFORM Protein DME1200 XEOTICID XEO02636 MOACRIVE Inhibition DME1200 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1200 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02637 XEO_CLAS Peptide DME1200 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO02637 GENEFORM Protein DME1200 XEOTICID XEO02637 MOACRIVE Inhibition DME1200 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1200 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02638 XEO_CLAS Peptide DME1200 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 microM) DME1200 XEOTICID XEO02638 GENEFORM Protein DME1200 XEOTICID XEO02638 MOACRIVE Inhibition DME1200 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1200 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02639 XEO_CLAS Peptide DME1200 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 microM) DME1200 XEOTICID XEO02639 GENEFORM Protein DME1200 XEOTICID XEO02639 MOACRIVE Inhibition DME1200 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1200 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02644 XEO_CLAS Peptide DME1200 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02644 GENEFORM Protein DME1200 XEOTICID XEO02644 MOACRIVE Inhibition DME1200 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1200 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02645 XEO_CLAS Peptide DME1200 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02645 GENEFORM Protein DME1200 XEOTICID XEO02645 MOACRIVE Inhibition DME1200 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1200 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02646 XEO_CLAS Peptide DME1200 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02646 GENEFORM Protein DME1200 XEOTICID XEO02646 MOACRIVE Inhibition DME1200 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1200 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02647 XEO_CLAS Peptide DME1200 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02647 GENEFORM Protein DME1200 XEOTICID XEO02647 MOACRIVE Inhibition DME1200 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1200 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02649 XEO_CLAS Peptide DME1200 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO02649 GENEFORM Protein DME1200 XEOTICID XEO02649 MOACRIVE Inhibition DME1200 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1200 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02650 XEO_CLAS Peptide DME1200 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO02650 GENEFORM Protein DME1200 XEOTICID XEO02650 MOACRIVE Inhibition DME1200 XEOTICID XEO02658 XEO_NAME Buthinin DME1200 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02658 XEO_CLAS Peptide DME1200 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02658 GENEFORM Protein DME1200 XEOTICID XEO02658 MOACRIVE Inhibition DME1200 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1200 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02663 XEO_CLAS Peptide DME1200 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25 microM) DME1200 XEOTICID XEO02663 GENEFORM Protein DME1200 XEOTICID XEO02663 MOACRIVE Inhibition DME1200 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1200 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02664 XEO_CLAS Peptide DME1200 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25 microM) DME1200 XEOTICID XEO02664 GENEFORM Protein DME1200 XEOTICID XEO02664 MOACRIVE Inhibition DME1200 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1200 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02672 XEO_CLAS Peptide DME1200 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25 microM) DME1200 XEOTICID XEO02672 GENEFORM Protein DME1200 XEOTICID XEO02672 MOACRIVE Inhibition DME1200 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1200 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02673 XEO_CLAS Peptide DME1200 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1200 XEOTICID XEO02673 GENEFORM Protein DME1200 XEOTICID XEO02673 MOACRIVE Inhibition DME1200 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1200 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02674 XEO_CLAS Peptide DME1200 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.125-6.25 microM) DME1200 XEOTICID XEO02674 GENEFORM Protein DME1200 XEOTICID XEO02674 MOACRIVE Inhibition DME1200 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1200 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02676 XEO_CLAS Peptide DME1200 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO02676 GENEFORM Protein DME1200 XEOTICID XEO02676 MOACRIVE Inhibition DME1200 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1200 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02677 XEO_CLAS Peptide DME1200 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1200 XEOTICID XEO02677 GENEFORM Protein DME1200 XEOTICID XEO02677 MOACRIVE Inhibition DME1200 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1200 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02679 XEO_CLAS Peptide DME1200 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1200 XEOTICID XEO02679 GENEFORM Protein DME1200 XEOTICID XEO02679 MOACRIVE Inhibition DME1200 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1200 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02680 XEO_CLAS Peptide DME1200 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25 microM) DME1200 XEOTICID XEO02680 GENEFORM Protein DME1200 XEOTICID XEO02680 MOACRIVE Inhibition DME1200 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1200 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02683 XEO_CLAS Peptide DME1200 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO02683 GENEFORM Protein DME1200 XEOTICID XEO02683 MOACRIVE Inhibition DME1200 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1200 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02688 XEO_CLAS Peptide DME1200 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO02688 GENEFORM Protein DME1200 XEOTICID XEO02688 MOACRIVE Inhibition DME1200 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1200 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02693 XEO_CLAS Peptide DME1200 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 ug/ml) DME1200 XEOTICID XEO02693 GENEFORM Protein DME1200 XEOTICID XEO02693 MOACRIVE Inhibition DME1200 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1200 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02699 XEO_CLAS Peptide DME1200 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 ug/ml) DME1200 XEOTICID XEO02699 GENEFORM Protein DME1200 XEOTICID XEO02699 MOACRIVE Inhibition DME1200 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1200 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02700 XEO_CLAS Peptide DME1200 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 ug/ml) DME1200 XEOTICID XEO02700 GENEFORM Protein DME1200 XEOTICID XEO02700 MOACRIVE Inhibition DME1200 XEOTICID XEO02703 XEO_NAME Calcitermin DME1200 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02703 XEO_CLAS Peptide DME1200 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02703 GENEFORM Protein DME1200 XEOTICID XEO02703 MOACRIVE Inhibition DME1200 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1200 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02708 XEO_CLAS Peptide DME1200 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO02708 GENEFORM Protein DME1200 XEOTICID XEO02708 MOACRIVE Inhibition DME1200 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1200 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02709 XEO_CLAS Peptide DME1200 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.05 microM) DME1200 XEOTICID XEO02709 GENEFORM Protein DME1200 XEOTICID XEO02709 MOACRIVE Inhibition DME1200 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1200 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1200 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02713 GENEFORM Protein DME1200 XEOTICID XEO02713 MOACRIVE Inhibition DME1200 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1200 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1200 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02714 GENEFORM Protein DME1200 XEOTICID XEO02714 MOACRIVE Inhibition DME1200 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1200 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02726 XEO_CLAS Peptide DME1200 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02726 GENEFORM Protein DME1200 XEOTICID XEO02726 MOACRIVE Inhibition DME1200 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1200 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02731 XEO_CLAS Peptide DME1200 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1 microM) DME1200 XEOTICID XEO02731 GENEFORM Protein DME1200 XEOTICID XEO02731 MOACRIVE Inhibition DME1200 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1200 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02732 XEO_CLAS Peptide DME1200 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.25 microM) DME1200 XEOTICID XEO02732 GENEFORM Protein DME1200 XEOTICID XEO02732 MOACRIVE Inhibition DME1200 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1200 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02733 XEO_CLAS Peptide DME1200 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8-25 ug/ml) DME1200 XEOTICID XEO02733 GENEFORM Protein DME1200 XEOTICID XEO02733 MOACRIVE Inhibition DME1200 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1200 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02735 XEO_CLAS Peptide DME1200 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1 ug/ml) DME1200 XEOTICID XEO02735 GENEFORM Protein DME1200 XEOTICID XEO02735 MOACRIVE Inhibition DME1200 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1200 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02737 XEO_CLAS Peptide DME1200 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02737 GENEFORM Protein DME1200 XEOTICID XEO02737 MOACRIVE Inhibition DME1200 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1200 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02738 XEO_CLAS Peptide DME1200 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO02738 GENEFORM Protein DME1200 XEOTICID XEO02738 MOACRIVE Inhibition DME1200 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1200 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02739 XEO_CLAS Peptide DME1200 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 microM) DME1200 XEOTICID XEO02739 GENEFORM Protein DME1200 XEOTICID XEO02739 MOACRIVE Inhibition DME1200 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1200 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02740 XEO_CLAS Peptide DME1200 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.25 ug/ml) DME1200 XEOTICID XEO02740 GENEFORM Protein DME1200 XEOTICID XEO02740 MOACRIVE Inhibition DME1200 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1200 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02741 XEO_CLAS Peptide DME1200 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 ug/ml) DME1200 XEOTICID XEO02741 GENEFORM Protein DME1200 XEOTICID XEO02741 MOACRIVE Inhibition DME1200 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1200 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02743 XEO_CLAS Peptide DME1200 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.6 ug/ml) DME1200 XEOTICID XEO02743 GENEFORM Protein DME1200 XEOTICID XEO02743 MOACRIVE Inhibition DME1200 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1200 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02744 XEO_CLAS Peptide DME1200 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 18.7 ug/ml) DME1200 XEOTICID XEO02744 GENEFORM Protein DME1200 XEOTICID XEO02744 MOACRIVE Inhibition DME1200 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1200 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02745 XEO_CLAS Peptide DME1200 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02745 GENEFORM Protein DME1200 XEOTICID XEO02745 MOACRIVE Inhibition DME1200 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1200 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02746 XEO_CLAS Peptide DME1200 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02746 GENEFORM Protein DME1200 XEOTICID XEO02746 MOACRIVE Inhibition DME1200 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1200 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02748 XEO_CLAS Peptide DME1200 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02748 GENEFORM Protein DME1200 XEOTICID XEO02748 MOACRIVE Inhibition DME1200 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1200 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02749 XEO_CLAS Peptide DME1200 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20-25 mug/ml) DME1200 XEOTICID XEO02749 GENEFORM Protein DME1200 XEOTICID XEO02749 MOACRIVE Inhibition DME1200 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1200 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02750 XEO_CLAS Peptide DME1200 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02750 GENEFORM Protein DME1200 XEOTICID XEO02750 MOACRIVE Inhibition DME1200 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1200 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02752 XEO_CLAS Peptide DME1200 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02752 GENEFORM Protein DME1200 XEOTICID XEO02752 MOACRIVE Inhibition DME1200 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1200 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02753 XEO_CLAS Peptide DME1200 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02753 GENEFORM Protein DME1200 XEOTICID XEO02753 MOACRIVE Inhibition DME1200 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1200 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02754 XEO_CLAS Peptide DME1200 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 microM) DME1200 XEOTICID XEO02754 GENEFORM Protein DME1200 XEOTICID XEO02754 MOACRIVE Inhibition DME1200 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1200 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02756 XEO_CLAS Peptide DME1200 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 microM) DME1200 XEOTICID XEO02756 GENEFORM Protein DME1200 XEOTICID XEO02756 MOACRIVE Inhibition DME1200 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1200 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02757 XEO_CLAS Peptide DME1200 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1 microM) DME1200 XEOTICID XEO02757 GENEFORM Protein DME1200 XEOTICID XEO02757 MOACRIVE Inhibition DME1200 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1200 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02758 XEO_CLAS Peptide DME1200 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO02758 GENEFORM Protein DME1200 XEOTICID XEO02758 MOACRIVE Inhibition DME1200 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1200 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02759 XEO_CLAS Peptide DME1200 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.6 microM) DME1200 XEOTICID XEO02759 GENEFORM Protein DME1200 XEOTICID XEO02759 MOACRIVE Inhibition DME1200 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1200 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02760 XEO_CLAS Peptide DME1200 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 microM) DME1200 XEOTICID XEO02760 GENEFORM Protein DME1200 XEOTICID XEO02760 MOACRIVE Inhibition DME1200 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1200 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02761 XEO_CLAS Peptide DME1200 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO02761 GENEFORM Protein DME1200 XEOTICID XEO02761 MOACRIVE Inhibition DME1200 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1200 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02762 XEO_CLAS Peptide DME1200 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 microM) DME1200 XEOTICID XEO02762 GENEFORM Protein DME1200 XEOTICID XEO02762 MOACRIVE Inhibition DME1200 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1200 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02763 XEO_CLAS Peptide DME1200 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.4 microM) DME1200 XEOTICID XEO02763 GENEFORM Protein DME1200 XEOTICID XEO02763 MOACRIVE Inhibition DME1200 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1200 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02764 XEO_CLAS Peptide DME1200 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 microM) DME1200 XEOTICID XEO02764 GENEFORM Protein DME1200 XEOTICID XEO02764 MOACRIVE Inhibition DME1200 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1200 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02765 XEO_CLAS Peptide DME1200 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.3 microM) DME1200 XEOTICID XEO02765 GENEFORM Protein DME1200 XEOTICID XEO02765 MOACRIVE Inhibition DME1200 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1200 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02767 XEO_CLAS Peptide DME1200 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02767 GENEFORM Protein DME1200 XEOTICID XEO02767 MOACRIVE Inhibition DME1200 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1200 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02768 XEO_CLAS Peptide DME1200 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1200 XEOTICID XEO02768 GENEFORM Protein DME1200 XEOTICID XEO02768 MOACRIVE Inhibition DME1200 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1200 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02769 XEO_CLAS Peptide DME1200 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.32 microM) DME1200 XEOTICID XEO02769 GENEFORM Protein DME1200 XEOTICID XEO02769 MOACRIVE Inhibition DME1200 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1200 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02770 XEO_CLAS Peptide DME1200 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.30 microM) DME1200 XEOTICID XEO02770 GENEFORM Protein DME1200 XEOTICID XEO02770 MOACRIVE Inhibition DME1200 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1200 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02771 XEO_CLAS Peptide DME1200 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.21 microM) DME1200 XEOTICID XEO02771 GENEFORM Protein DME1200 XEOTICID XEO02771 MOACRIVE Inhibition DME1200 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1200 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02772 XEO_CLAS Peptide DME1200 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02772 GENEFORM Protein DME1200 XEOTICID XEO02772 MOACRIVE Inhibition DME1200 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1200 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02773 XEO_CLAS Peptide DME1200 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.9-8.6 microM) DME1200 XEOTICID XEO02773 GENEFORM Protein DME1200 XEOTICID XEO02773 MOACRIVE Inhibition DME1200 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1200 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02774 XEO_CLAS Peptide DME1200 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.3 microM) DME1200 XEOTICID XEO02774 GENEFORM Protein DME1200 XEOTICID XEO02774 MOACRIVE Inhibition DME1200 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1200 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02789 GENEFORM Protein DME1200 XEOTICID XEO02789 MOACRIVE Inhibition DME1200 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1200 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02790 GENEFORM Protein DME1200 XEOTICID XEO02790 MOACRIVE Inhibition DME1200 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1200 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02791 GENEFORM Protein DME1200 XEOTICID XEO02791 MOACRIVE Inhibition DME1200 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1200 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02792 GENEFORM Protein DME1200 XEOTICID XEO02792 MOACRIVE Inhibition DME1200 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1200 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02793 GENEFORM Protein DME1200 XEOTICID XEO02793 MOACRIVE Inhibition DME1200 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1200 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02794 GENEFORM Protein DME1200 XEOTICID XEO02794 MOACRIVE Inhibition DME1200 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1200 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02795 GENEFORM Protein DME1200 XEOTICID XEO02795 MOACRIVE Inhibition DME1200 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1200 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02796 GENEFORM Protein DME1200 XEOTICID XEO02796 MOACRIVE Inhibition DME1200 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1200 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02797 GENEFORM Protein DME1200 XEOTICID XEO02797 MOACRIVE Inhibition DME1200 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1200 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02799 XEO_CLAS Peptide DME1200 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02799 GENEFORM Protein DME1200 XEOTICID XEO02799 MOACRIVE Inhibition DME1200 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1200 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02800 XEO_CLAS Peptide DME1200 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02800 GENEFORM Protein DME1200 XEOTICID XEO02800 MOACRIVE Inhibition DME1200 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1200 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02802 XEO_CLAS Peptide DME1200 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 13.6 microM) DME1200 XEOTICID XEO02802 GENEFORM Protein DME1200 XEOTICID XEO02802 MOACRIVE Inhibition DME1200 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1200 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02807 XEO_CLAS Peptide DME1200 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.2 microM) DME1200 XEOTICID XEO02807 GENEFORM Protein DME1200 XEOTICID XEO02807 MOACRIVE Inhibition DME1200 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1200 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02813 XEO_CLAS Peptide DME1200 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 80 microM) DME1200 XEOTICID XEO02813 GENEFORM Protein DME1200 XEOTICID XEO02813 MOACRIVE Inhibition DME1200 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1200 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02814 XEO_CLAS Peptide DME1200 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 80 microM) DME1200 XEOTICID XEO02814 GENEFORM Protein DME1200 XEOTICID XEO02814 MOACRIVE Inhibition DME1200 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1200 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02815 XEO_CLAS Peptide DME1200 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8.5 microM) DME1200 XEOTICID XEO02815 GENEFORM Protein DME1200 XEOTICID XEO02815 MOACRIVE Inhibition DME1200 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1200 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02816 XEO_CLAS Peptide DME1200 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 80 microM) DME1200 XEOTICID XEO02816 GENEFORM Protein DME1200 XEOTICID XEO02816 MOACRIVE Inhibition DME1200 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1200 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02817 XEO_CLAS Peptide DME1200 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 80 microM) DME1200 XEOTICID XEO02817 GENEFORM Protein DME1200 XEOTICID XEO02817 MOACRIVE Inhibition DME1200 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1200 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02818 XEO_CLAS Peptide DME1200 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.4 microM) DME1200 XEOTICID XEO02818 GENEFORM Protein DME1200 XEOTICID XEO02818 MOACRIVE Inhibition DME1200 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1200 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02819 XEO_CLAS Peptide DME1200 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.6 microM) DME1200 XEOTICID XEO02819 GENEFORM Protein DME1200 XEOTICID XEO02819 MOACRIVE Inhibition DME1200 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1200 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02820 XEO_CLAS Peptide DME1200 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO02820 GENEFORM Protein DME1200 XEOTICID XEO02820 MOACRIVE Inhibition DME1200 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1200 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02821 XEO_CLAS Peptide DME1200 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02821 GENEFORM Protein DME1200 XEOTICID XEO02821 MOACRIVE Inhibition DME1200 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1200 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02824 XEO_CLAS Peptide DME1200 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 35 microM) DME1200 XEOTICID XEO02824 GENEFORM Protein DME1200 XEOTICID XEO02824 MOACRIVE Inhibition DME1200 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1200 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02826 XEO_CLAS Peptide DME1200 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.7 ug/ml) DME1200 XEOTICID XEO02826 GENEFORM Protein DME1200 XEOTICID XEO02826 MOACRIVE Inhibition DME1200 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1200 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02834 GENEFORM Protein DME1200 XEOTICID XEO02834 MOACRIVE Inhibition DME1200 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1200 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02839 XEO_CLAS Peptide DME1200 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.25 microM) DME1200 XEOTICID XEO02839 GENEFORM Protein DME1200 XEOTICID XEO02839 MOACRIVE Inhibition DME1200 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1200 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02841 XEO_CLAS Peptide DME1200 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.25 microM) DME1200 XEOTICID XEO02841 GENEFORM Protein DME1200 XEOTICID XEO02841 MOACRIVE Inhibition DME1200 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1200 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02842 XEO_CLAS Peptide DME1200 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.25 microM) DME1200 XEOTICID XEO02842 GENEFORM Protein DME1200 XEOTICID XEO02842 MOACRIVE Inhibition DME1200 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1200 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02843 XEO_CLAS Peptide DME1200 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02843 GENEFORM Protein DME1200 XEOTICID XEO02843 MOACRIVE Inhibition DME1200 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1200 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02849 GENEFORM Protein DME1200 XEOTICID XEO02849 MOACRIVE Inhibition DME1200 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1200 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02857 XEO_CLAS Peptide DME1200 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 53 microM) DME1200 XEOTICID XEO02857 GENEFORM Protein DME1200 XEOTICID XEO02857 MOACRIVE Inhibition DME1200 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1200 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02858 XEO_CLAS Peptide DME1200 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 53 microM) DME1200 XEOTICID XEO02858 GENEFORM Protein DME1200 XEOTICID XEO02858 MOACRIVE Inhibition DME1200 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1200 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02860 XEO_CLAS Peptide DME1200 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 ug/ml) DME1200 XEOTICID XEO02860 GENEFORM Protein DME1200 XEOTICID XEO02860 MOACRIVE Inhibition DME1200 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1200 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02867 XEO_CLAS Peptide DME1200 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02867 GENEFORM Protein DME1200 XEOTICID XEO02867 MOACRIVE Inhibition DME1200 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1200 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02868 XEO_CLAS Peptide DME1200 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02868 GENEFORM Protein DME1200 XEOTICID XEO02868 MOACRIVE Inhibition DME1200 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1200 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02869 XEO_CLAS Peptide DME1200 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02869 GENEFORM Protein DME1200 XEOTICID XEO02869 MOACRIVE Inhibition DME1200 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1200 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02870 XEO_CLAS Peptide DME1200 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02870 GENEFORM Protein DME1200 XEOTICID XEO02870 MOACRIVE Inhibition DME1200 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1200 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02871 XEO_CLAS Peptide DME1200 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02871 GENEFORM Protein DME1200 XEOTICID XEO02871 MOACRIVE Inhibition DME1200 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1200 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02872 XEO_CLAS Peptide DME1200 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 308 microM) DME1200 XEOTICID XEO02872 GENEFORM Protein DME1200 XEOTICID XEO02872 MOACRIVE Inhibition DME1200 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1200 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02875 XEO_CLAS Peptide DME1200 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.1 microM) DME1200 XEOTICID XEO02875 GENEFORM Protein DME1200 XEOTICID XEO02875 MOACRIVE Inhibition DME1200 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1200 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02876 XEO_CLAS Peptide DME1200 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO02876 GENEFORM Protein DME1200 XEOTICID XEO02876 MOACRIVE Inhibition DME1200 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1200 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02877 XEO_CLAS Peptide DME1200 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO02877 GENEFORM Protein DME1200 XEOTICID XEO02877 MOACRIVE Inhibition DME1200 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1200 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02878 XEO_CLAS Peptide DME1200 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.3 microM) DME1200 XEOTICID XEO02878 GENEFORM Protein DME1200 XEOTICID XEO02878 MOACRIVE Inhibition DME1200 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1200 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02885 XEO_CLAS Peptide DME1200 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02885 GENEFORM Protein DME1200 XEOTICID XEO02885 MOACRIVE Inhibition DME1200 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1200 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02886 XEO_CLAS Peptide DME1200 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02886 GENEFORM Protein DME1200 XEOTICID XEO02886 MOACRIVE Inhibition DME1200 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1200 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02887 XEO_CLAS Peptide DME1200 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1 ug/ml) DME1200 XEOTICID XEO02887 GENEFORM Protein DME1200 XEOTICID XEO02887 MOACRIVE Inhibition DME1200 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1200 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02888 XEO_CLAS Peptide DME1200 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 ug/ml) DME1200 XEOTICID XEO02888 GENEFORM Protein DME1200 XEOTICID XEO02888 MOACRIVE Inhibition DME1200 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1200 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02889 XEO_CLAS Peptide DME1200 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 ug/ml) DME1200 XEOTICID XEO02889 GENEFORM Protein DME1200 XEOTICID XEO02889 MOACRIVE Inhibition DME1200 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1200 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02890 XEO_CLAS Peptide DME1200 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02890 GENEFORM Protein DME1200 XEOTICID XEO02890 MOACRIVE Inhibition DME1200 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1200 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02891 XEO_CLAS Peptide DME1200 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02891 GENEFORM Protein DME1200 XEOTICID XEO02891 MOACRIVE Inhibition DME1200 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1200 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02895 XEO_CLAS Peptide DME1200 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO02895 GENEFORM Protein DME1200 XEOTICID XEO02895 MOACRIVE Inhibition DME1200 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1200 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02896 XEO_CLAS Peptide DME1200 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO02896 GENEFORM Protein DME1200 XEOTICID XEO02896 MOACRIVE Inhibition DME1200 XEOTICID XEO02899 XEO_NAME Coladonin DME1200 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1200 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1200 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02899 GENEFORM Protein DME1200 XEOTICID XEO02899 MOACRIVE Inhibition DME1200 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1200 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02900 XEO_CLAS Peptide DME1200 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02900 GENEFORM Protein DME1200 XEOTICID XEO02900 MOACRIVE Inhibition DME1200 XEOTICID XEO02901 XEO_NAME Colicin-V DME1200 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02901 XEO_CLAS Peptide DME1200 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02901 GENEFORM Protein DME1200 XEOTICID XEO02901 MOACRIVE Inhibition DME1200 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1200 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02904 GENEFORM Protein DME1200 XEOTICID XEO02904 MOACRIVE Inhibition DME1200 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1200 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02908 XEO_CLAS Peptide DME1200 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 50 microM) DME1200 XEOTICID XEO02908 GENEFORM Protein DME1200 XEOTICID XEO02908 MOACRIVE Inhibition DME1200 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1200 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02923 XEO_CLAS Peptide DME1200 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02923 GENEFORM Protein DME1200 XEOTICID XEO02923 MOACRIVE Inhibition DME1200 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1200 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02924 XEO_CLAS Peptide DME1200 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 32 microM) DME1200 XEOTICID XEO02924 GENEFORM Protein DME1200 XEOTICID XEO02924 MOACRIVE Inhibition DME1200 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1200 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1200 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02927 GENEFORM Protein DME1200 XEOTICID XEO02927 MOACRIVE Inhibition DME1200 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1200 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02931 XEO_CLAS Peptide DME1200 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 ug/ml) DME1200 XEOTICID XEO02931 GENEFORM Protein DME1200 XEOTICID XEO02931 MOACRIVE Inhibition DME1200 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1200 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02933 XEO_CLAS Peptide DME1200 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO02933 GENEFORM Protein DME1200 XEOTICID XEO02933 MOACRIVE Inhibition DME1200 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1200 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02934 XEO_CLAS Peptide DME1200 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02934 GENEFORM Protein DME1200 XEOTICID XEO02934 MOACRIVE Inhibition DME1200 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1200 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02935 XEO_CLAS Peptide DME1200 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02935 GENEFORM Protein DME1200 XEOTICID XEO02935 MOACRIVE Inhibition DME1200 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1200 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02936 XEO_CLAS Peptide DME1200 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO02936 GENEFORM Protein DME1200 XEOTICID XEO02936 MOACRIVE Inhibition DME1200 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1200 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02937 XEO_CLAS Peptide DME1200 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02937 GENEFORM Protein DME1200 XEOTICID XEO02937 MOACRIVE Inhibition DME1200 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1200 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02938 XEO_CLAS Peptide DME1200 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 32 ug/ml) DME1200 XEOTICID XEO02938 GENEFORM Protein DME1200 XEOTICID XEO02938 MOACRIVE Inhibition DME1200 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1200 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02939 XEO_CLAS Peptide DME1200 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 11 ug/ml) DME1200 XEOTICID XEO02939 GENEFORM Protein DME1200 XEOTICID XEO02939 MOACRIVE Inhibition DME1200 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1200 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02940 XEO_CLAS Peptide DME1200 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1 ug/ml) DME1200 XEOTICID XEO02940 GENEFORM Protein DME1200 XEOTICID XEO02940 MOACRIVE Inhibition DME1200 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1200 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02941 XEO_CLAS Peptide DME1200 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02941 GENEFORM Protein DME1200 XEOTICID XEO02941 MOACRIVE Inhibition DME1200 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1200 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02944 XEO_CLAS Peptide DME1200 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 microM) DME1200 XEOTICID XEO02944 GENEFORM Protein DME1200 XEOTICID XEO02944 MOACRIVE Inhibition DME1200 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1200 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02945 XEO_CLAS Peptide DME1200 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 microM) DME1200 XEOTICID XEO02945 GENEFORM Protein DME1200 XEOTICID XEO02945 MOACRIVE Inhibition DME1200 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1200 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02946 XEO_CLAS Peptide DME1200 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 microM) DME1200 XEOTICID XEO02946 GENEFORM Protein DME1200 XEOTICID XEO02946 MOACRIVE Inhibition DME1200 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1200 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02947 XEO_CLAS Peptide DME1200 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02947 GENEFORM Protein DME1200 XEOTICID XEO02947 MOACRIVE Inhibition DME1200 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1200 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02948 XEO_CLAS Peptide DME1200 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO02948 GENEFORM Protein DME1200 XEOTICID XEO02948 MOACRIVE Inhibition DME1200 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1200 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02949 XEO_CLAS Peptide DME1200 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO02949 GENEFORM Protein DME1200 XEOTICID XEO02949 MOACRIVE Inhibition DME1200 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1200 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02954 XEO_CLAS Peptide DME1200 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02954 GENEFORM Protein DME1200 XEOTICID XEO02954 MOACRIVE Inhibition DME1200 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1200 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02958 XEO_CLAS Peptide DME1200 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02958 GENEFORM Protein DME1200 XEOTICID XEO02958 MOACRIVE Inhibition DME1200 XEOTICID XEO02962 XEO_NAME Cryptonin DME1200 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02962 XEO_CLAS Peptide DME1200 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.12 ug/ml) DME1200 XEOTICID XEO02962 GENEFORM Protein DME1200 XEOTICID XEO02962 MOACRIVE Inhibition DME1200 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1200 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02965 XEO_CLAS Peptide DME1200 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 ug/ml) DME1200 XEOTICID XEO02965 GENEFORM Protein DME1200 XEOTICID XEO02965 MOACRIVE Inhibition DME1200 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1200 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02969 XEO_CLAS Peptide DME1200 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 microM) DME1200 XEOTICID XEO02969 GENEFORM Protein DME1200 XEOTICID XEO02969 MOACRIVE Inhibition DME1200 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1200 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02971 XEO_CLAS Peptide DME1200 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 microM) DME1200 XEOTICID XEO02971 GENEFORM Protein DME1200 XEOTICID XEO02971 MOACRIVE Inhibition DME1200 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1200 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO02972 XEO_CLAS Peptide DME1200 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.4 microM) DME1200 XEOTICID XEO02972 GENEFORM Protein DME1200 XEOTICID XEO02972 MOACRIVE Inhibition DME1200 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1200 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02990 GENEFORM Protein DME1200 XEOTICID XEO02990 MOACRIVE Inhibition DME1200 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1200 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02991 GENEFORM Protein DME1200 XEOTICID XEO02991 MOACRIVE Inhibition DME1200 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1200 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02992 GENEFORM Protein DME1200 XEOTICID XEO02992 MOACRIVE Inhibition DME1200 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1200 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02993 GENEFORM Protein DME1200 XEOTICID XEO02993 MOACRIVE Inhibition DME1200 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1200 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02994 GENEFORM Protein DME1200 XEOTICID XEO02994 MOACRIVE Inhibition DME1200 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1200 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02995 GENEFORM Protein DME1200 XEOTICID XEO02995 MOACRIVE Inhibition DME1200 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1200 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02996 GENEFORM Protein DME1200 XEOTICID XEO02996 MOACRIVE Inhibition DME1200 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1200 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02997 GENEFORM Protein DME1200 XEOTICID XEO02997 MOACRIVE Inhibition DME1200 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1200 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02998 GENEFORM Protein DME1200 XEOTICID XEO02998 MOACRIVE Inhibition DME1200 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1200 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1200 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO02999 GENEFORM Protein DME1200 XEOTICID XEO02999 MOACRIVE Inhibition DME1200 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1200 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03021 XEO_CLAS Peptide DME1200 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1200 XEOTICID XEO03021 GENEFORM Protein DME1200 XEOTICID XEO03021 MOACRIVE Inhibition DME1200 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1200 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03029 XEO_CLAS Peptide DME1200 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.005 microM) DME1200 XEOTICID XEO03029 GENEFORM Protein DME1200 XEOTICID XEO03029 MOACRIVE Inhibition DME1200 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1200 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03030 XEO_CLAS Peptide DME1200 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.005 microM) DME1200 XEOTICID XEO03030 GENEFORM Protein DME1200 XEOTICID XEO03030 MOACRIVE Inhibition DME1200 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1200 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03031 XEO_CLAS Peptide DME1200 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.3 microM) DME1200 XEOTICID XEO03031 GENEFORM Protein DME1200 XEOTICID XEO03031 MOACRIVE Inhibition DME1200 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1200 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03032 XEO_CLAS Peptide DME1200 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.01 microM) DME1200 XEOTICID XEO03032 GENEFORM Protein DME1200 XEOTICID XEO03032 MOACRIVE Inhibition DME1200 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1200 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03033 XEO_CLAS Peptide DME1200 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.173 microM) DME1200 XEOTICID XEO03033 GENEFORM Protein DME1200 XEOTICID XEO03033 MOACRIVE Inhibition DME1200 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1200 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03034 XEO_CLAS Peptide DME1200 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.518 microM) DME1200 XEOTICID XEO03034 GENEFORM Protein DME1200 XEOTICID XEO03034 MOACRIVE Inhibition DME1200 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1200 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03035 XEO_CLAS Peptide DME1200 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.114 microM) DME1200 XEOTICID XEO03035 GENEFORM Protein DME1200 XEOTICID XEO03035 MOACRIVE Inhibition DME1200 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1200 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03039 XEO_CLAS Peptide DME1200 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.55 microM) DME1200 XEOTICID XEO03039 GENEFORM Protein DME1200 XEOTICID XEO03039 MOACRIVE Inhibition DME1200 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1200 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03043 XEO_CLAS Peptide DME1200 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 microM) DME1200 XEOTICID XEO03043 GENEFORM Protein DME1200 XEOTICID XEO03043 MOACRIVE Inhibition DME1200 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1200 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03044 XEO_CLAS Peptide DME1200 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03044 GENEFORM Protein DME1200 XEOTICID XEO03044 MOACRIVE Inhibition DME1200 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1200 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03045 XEO_CLAS Peptide DME1200 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03045 GENEFORM Protein DME1200 XEOTICID XEO03045 MOACRIVE Inhibition DME1200 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1200 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03046 XEO_CLAS Peptide DME1200 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03046 GENEFORM Protein DME1200 XEOTICID XEO03046 MOACRIVE Inhibition DME1200 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1200 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03049 XEO_CLAS Peptide DME1200 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 microM) DME1200 XEOTICID XEO03049 GENEFORM Protein DME1200 XEOTICID XEO03049 MOACRIVE Inhibition DME1200 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1200 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03055 XEO_CLAS Peptide DME1200 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 microM) DME1200 XEOTICID XEO03055 GENEFORM Protein DME1200 XEOTICID XEO03055 MOACRIVE Inhibition DME1200 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1200 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03059 XEO_CLAS Peptide DME1200 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO03059 GENEFORM Protein DME1200 XEOTICID XEO03059 MOACRIVE Inhibition DME1200 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1200 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03060 XEO_CLAS Peptide DME1200 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO03060 GENEFORM Protein DME1200 XEOTICID XEO03060 MOACRIVE Inhibition DME1200 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1200 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03062 XEO_CLAS Peptide DME1200 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO03062 GENEFORM Protein DME1200 XEOTICID XEO03062 MOACRIVE Inhibition DME1200 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1200 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03064 XEO_CLAS Peptide DME1200 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO03064 GENEFORM Protein DME1200 XEOTICID XEO03064 MOACRIVE Inhibition DME1200 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1200 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03066 XEO_CLAS Peptide DME1200 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO03066 GENEFORM Protein DME1200 XEOTICID XEO03066 MOACRIVE Inhibition DME1200 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1200 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03068 XEO_CLAS Peptide DME1200 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO03068 GENEFORM Protein DME1200 XEOTICID XEO03068 MOACRIVE Inhibition DME1200 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1200 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03073 XEO_CLAS Peptide DME1200 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8-16 ug/ml) DME1200 XEOTICID XEO03073 GENEFORM Protein DME1200 XEOTICID XEO03073 MOACRIVE Inhibition DME1200 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1200 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03081 XEO_CLAS Peptide DME1200 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 microM) DME1200 XEOTICID XEO03081 GENEFORM Protein DME1200 XEOTICID XEO03081 MOACRIVE Inhibition DME1200 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1200 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03082 XEO_CLAS Peptide DME1200 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03082 GENEFORM Protein DME1200 XEOTICID XEO03082 MOACRIVE Inhibition DME1200 XEOTICID XEO03089 XEO_NAME Decoralin DME1200 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03089 XEO_CLAS Peptide DME1200 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 160 microM) DME1200 XEOTICID XEO03089 GENEFORM Protein DME1200 XEOTICID XEO03089 MOACRIVE Inhibition DME1200 XEOTICID XEO03098 XEO_NAME Insect defensin DME1200 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03098 XEO_CLAS Peptide DME1200 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 ug/ml) DME1200 XEOTICID XEO03098 GENEFORM Protein DME1200 XEOTICID XEO03098 MOACRIVE Inhibition DME1200 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1200 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03100 XEO_CLAS Peptide DME1200 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03100 GENEFORM Protein DME1200 XEOTICID XEO03100 MOACRIVE Inhibition DME1200 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1200 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03103 XEO_CLAS Peptide DME1200 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03103 GENEFORM Protein DME1200 XEOTICID XEO03103 MOACRIVE Inhibition DME1200 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1200 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03105 XEO_CLAS Peptide DME1200 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03105 GENEFORM Protein DME1200 XEOTICID XEO03105 MOACRIVE Inhibition DME1200 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1200 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03110 XEO_CLAS Peptide DME1200 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.2 microM) DME1200 XEOTICID XEO03110 GENEFORM Protein DME1200 XEOTICID XEO03110 MOACRIVE Inhibition DME1200 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1200 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03111 XEO_CLAS Peptide DME1200 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03111 GENEFORM Protein DME1200 XEOTICID XEO03111 MOACRIVE Inhibition DME1200 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1200 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03112 XEO_CLAS Peptide DME1200 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 50 ug/ml) DME1200 XEOTICID XEO03112 GENEFORM Protein DME1200 XEOTICID XEO03112 MOACRIVE Inhibition DME1200 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1200 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03115 XEO_CLAS Peptide DME1200 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03115 GENEFORM Protein DME1200 XEOTICID XEO03115 MOACRIVE Inhibition DME1200 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1200 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03116 XEO_CLAS Peptide DME1200 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 40 microM) DME1200 XEOTICID XEO03116 GENEFORM Protein DME1200 XEOTICID XEO03116 MOACRIVE Inhibition DME1200 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1200 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03118 XEO_CLAS Peptide DME1200 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03118 GENEFORM Protein DME1200 XEOTICID XEO03118 MOACRIVE Inhibition DME1200 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1200 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03119 XEO_CLAS Peptide DME1200 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03119 GENEFORM Protein DME1200 XEOTICID XEO03119 MOACRIVE Inhibition DME1200 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1200 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03121 XEO_CLAS Peptide DME1200 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03121 GENEFORM Protein DME1200 XEOTICID XEO03121 MOACRIVE Inhibition DME1200 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1200 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03122 XEO_CLAS Peptide DME1200 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64000 ug/ml) DME1200 XEOTICID XEO03122 GENEFORM Protein DME1200 XEOTICID XEO03122 MOACRIVE Inhibition DME1200 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1200 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03124 XEO_CLAS Peptide DME1200 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03124 GENEFORM Protein DME1200 XEOTICID XEO03124 MOACRIVE Inhibition DME1200 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1200 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03125 XEO_CLAS Peptide DME1200 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03125 GENEFORM Protein DME1200 XEOTICID XEO03125 MOACRIVE Inhibition DME1200 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1200 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03126 XEO_CLAS Peptide DME1200 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.86 microM) DME1200 XEOTICID XEO03126 GENEFORM Protein DME1200 XEOTICID XEO03126 MOACRIVE Inhibition DME1200 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1200 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03127 XEO_CLAS Peptide DME1200 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03127 GENEFORM Protein DME1200 XEOTICID XEO03127 MOACRIVE Inhibition DME1200 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1200 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03128 XEO_CLAS Peptide DME1200 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 256 ug/ml) DME1200 XEOTICID XEO03128 GENEFORM Protein DME1200 XEOTICID XEO03128 MOACRIVE Inhibition DME1200 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1200 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03129 XEO_CLAS Peptide DME1200 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 256 ug/ml) DME1200 XEOTICID XEO03129 GENEFORM Protein DME1200 XEOTICID XEO03129 MOACRIVE Inhibition DME1200 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1200 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03130 XEO_CLAS Peptide DME1200 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 256 ug/ml) DME1200 XEOTICID XEO03130 GENEFORM Protein DME1200 XEOTICID XEO03130 MOACRIVE Inhibition DME1200 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1200 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03131 XEO_CLAS Peptide DME1200 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 256 ug/ml) DME1200 XEOTICID XEO03131 GENEFORM Protein DME1200 XEOTICID XEO03131 MOACRIVE Inhibition DME1200 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1200 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03132 XEO_CLAS Peptide DME1200 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 256 ug/ml) DME1200 XEOTICID XEO03132 GENEFORM Protein DME1200 XEOTICID XEO03132 MOACRIVE Inhibition DME1200 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1200 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03137 XEO_CLAS Peptide DME1200 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03137 GENEFORM Protein DME1200 XEOTICID XEO03137 MOACRIVE Inhibition DME1200 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1200 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03143 XEO_CLAS Peptide DME1200 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.6 microM) DME1200 XEOTICID XEO03143 GENEFORM Protein DME1200 XEOTICID XEO03143 MOACRIVE Inhibition DME1200 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1200 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03145 XEO_CLAS Peptide DME1200 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.6 microM) DME1200 XEOTICID XEO03145 GENEFORM Protein DME1200 XEOTICID XEO03145 MOACRIVE Inhibition DME1200 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1200 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03146 XEO_CLAS Peptide DME1200 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.5 microM) DME1200 XEOTICID XEO03146 GENEFORM Protein DME1200 XEOTICID XEO03146 MOACRIVE Inhibition DME1200 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1200 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03147 XEO_CLAS Peptide DME1200 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 9.7 microM) DME1200 XEOTICID XEO03147 GENEFORM Protein DME1200 XEOTICID XEO03147 MOACRIVE Inhibition DME1200 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1200 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03148 XEO_CLAS Peptide DME1200 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.3 microM) DME1200 XEOTICID XEO03148 GENEFORM Protein DME1200 XEOTICID XEO03148 MOACRIVE Inhibition DME1200 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1200 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03149 XEO_CLAS Peptide DME1200 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.6 microM) DME1200 XEOTICID XEO03149 GENEFORM Protein DME1200 XEOTICID XEO03149 MOACRIVE Inhibition DME1200 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1200 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03150 XEO_CLAS Peptide DME1200 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 9-3 microM) DME1200 XEOTICID XEO03150 GENEFORM Protein DME1200 XEOTICID XEO03150 MOACRIVE Inhibition DME1200 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1200 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03151 XEO_CLAS Peptide DME1200 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 ug/ml) DME1200 XEOTICID XEO03151 GENEFORM Protein DME1200 XEOTICID XEO03151 MOACRIVE Inhibition DME1200 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1200 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03152 XEO_CLAS Peptide DME1200 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO03152 GENEFORM Protein DME1200 XEOTICID XEO03152 MOACRIVE Inhibition DME1200 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1200 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03155 XEO_CLAS Peptide DME1200 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.4 microM) DME1200 XEOTICID XEO03155 GENEFORM Protein DME1200 XEOTICID XEO03155 MOACRIVE Inhibition DME1200 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1200 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03156 XEO_CLAS Peptide DME1200 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.3 microM) DME1200 XEOTICID XEO03156 GENEFORM Protein DME1200 XEOTICID XEO03156 MOACRIVE Inhibition DME1200 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1200 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03157 XEO_CLAS Peptide DME1200 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.3 microM) DME1200 XEOTICID XEO03157 GENEFORM Protein DME1200 XEOTICID XEO03157 MOACRIVE Inhibition DME1200 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1200 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03158 XEO_CLAS Peptide DME1200 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 ug/ml) DME1200 XEOTICID XEO03158 GENEFORM Protein DME1200 XEOTICID XEO03158 MOACRIVE Inhibition DME1200 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1200 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03159 XEO_CLAS Peptide DME1200 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03159 GENEFORM Protein DME1200 XEOTICID XEO03159 MOACRIVE Inhibition DME1200 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1200 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03161 XEO_CLAS Peptide DME1200 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 microM) DME1200 XEOTICID XEO03161 GENEFORM Protein DME1200 XEOTICID XEO03161 MOACRIVE Inhibition DME1200 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1200 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03162 XEO_CLAS Peptide DME1200 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.5 microM) DME1200 XEOTICID XEO03162 GENEFORM Protein DME1200 XEOTICID XEO03162 MOACRIVE Inhibition DME1200 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1200 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03169 XEO_CLAS Peptide DME1200 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO03169 GENEFORM Protein DME1200 XEOTICID XEO03169 MOACRIVE Inhibition DME1200 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1200 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03193 XEO_CLAS Peptide DME1200 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25 ug/ml) DME1200 XEOTICID XEO03193 GENEFORM Protein DME1200 XEOTICID XEO03193 MOACRIVE Inhibition DME1200 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1200 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03194 XEO_CLAS Peptide DME1200 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03194 GENEFORM Protein DME1200 XEOTICID XEO03194 MOACRIVE Inhibition DME1200 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1200 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03195 XEO_CLAS Peptide DME1200 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03195 GENEFORM Protein DME1200 XEOTICID XEO03195 MOACRIVE Inhibition DME1200 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1200 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03197 XEO_CLAS Peptide DME1200 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 14.5 microM) DME1200 XEOTICID XEO03197 GENEFORM Protein DME1200 XEOTICID XEO03197 MOACRIVE Inhibition DME1200 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1200 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03202 XEO_CLAS Peptide DME1200 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.51 microM) DME1200 XEOTICID XEO03202 GENEFORM Protein DME1200 XEOTICID XEO03202 MOACRIVE Inhibition DME1200 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1200 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03203 XEO_CLAS Peptide DME1200 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.62 microM) DME1200 XEOTICID XEO03203 GENEFORM Protein DME1200 XEOTICID XEO03203 MOACRIVE Inhibition DME1200 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1200 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03204 XEO_CLAS Peptide DME1200 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.38 microM) DME1200 XEOTICID XEO03204 GENEFORM Protein DME1200 XEOTICID XEO03204 MOACRIVE Inhibition DME1200 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1200 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03205 XEO_CLAS Peptide DME1200 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.29 microM) DME1200 XEOTICID XEO03205 GENEFORM Protein DME1200 XEOTICID XEO03205 MOACRIVE Inhibition DME1200 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1200 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03206 XEO_CLAS Peptide DME1200 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.40 microM) DME1200 XEOTICID XEO03206 GENEFORM Protein DME1200 XEOTICID XEO03206 MOACRIVE Inhibition DME1200 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1200 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03207 XEO_CLAS Peptide DME1200 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.58 microM) DME1200 XEOTICID XEO03207 GENEFORM Protein DME1200 XEOTICID XEO03207 MOACRIVE Inhibition DME1200 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1200 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03208 XEO_CLAS Peptide DME1200 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.76 microM) DME1200 XEOTICID XEO03208 GENEFORM Protein DME1200 XEOTICID XEO03208 MOACRIVE Inhibition DME1200 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1200 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03209 XEO_CLAS Peptide DME1200 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.49 microM) DME1200 XEOTICID XEO03209 GENEFORM Protein DME1200 XEOTICID XEO03209 MOACRIVE Inhibition DME1200 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1200 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03210 XEO_CLAS Peptide DME1200 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 7.07 microM) DME1200 XEOTICID XEO03210 GENEFORM Protein DME1200 XEOTICID XEO03210 MOACRIVE Inhibition DME1200 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1200 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03211 XEO_CLAS Peptide DME1200 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.40 microM) DME1200 XEOTICID XEO03211 GENEFORM Protein DME1200 XEOTICID XEO03211 MOACRIVE Inhibition DME1200 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1200 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03215 XEO_CLAS Peptide DME1200 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20.0 ug/ml) DME1200 XEOTICID XEO03215 GENEFORM Protein DME1200 XEOTICID XEO03215 MOACRIVE Inhibition DME1200 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1200 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03216 XEO_CLAS Peptide DME1200 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO03216 GENEFORM Protein DME1200 XEOTICID XEO03216 MOACRIVE Inhibition DME1200 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1200 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03217 XEO_CLAS Peptide DME1200 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO03217 GENEFORM Protein DME1200 XEOTICID XEO03217 MOACRIVE Inhibition DME1200 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1200 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03223 XEO_CLAS Peptide DME1200 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.8 microM) DME1200 XEOTICID XEO03223 GENEFORM Protein DME1200 XEOTICID XEO03223 MOACRIVE Inhibition DME1200 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1200 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03224 XEO_CLAS Peptide DME1200 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.1-0.25 microM) DME1200 XEOTICID XEO03224 GENEFORM Protein DME1200 XEOTICID XEO03224 MOACRIVE Inhibition DME1200 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1200 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03225 XEO_CLAS Peptide DME1200 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.3 microM) DME1200 XEOTICID XEO03225 GENEFORM Protein DME1200 XEOTICID XEO03225 MOACRIVE Inhibition DME1200 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1200 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03227 XEO_CLAS Peptide DME1200 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.3 microM) DME1200 XEOTICID XEO03227 GENEFORM Protein DME1200 XEOTICID XEO03227 MOACRIVE Inhibition DME1200 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1200 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03231 XEO_CLAS Peptide DME1200 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03231 GENEFORM Protein DME1200 XEOTICID XEO03231 MOACRIVE Inhibition DME1200 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1200 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03232 XEO_CLAS Peptide DME1200 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03232 GENEFORM Protein DME1200 XEOTICID XEO03232 MOACRIVE Inhibition DME1200 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1200 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03234 XEO_CLAS Peptide DME1200 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO03234 GENEFORM Protein DME1200 XEOTICID XEO03234 MOACRIVE Inhibition DME1200 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1200 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03235 XEO_CLAS Peptide DME1200 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 60 ug/ml) DME1200 XEOTICID XEO03235 GENEFORM Protein DME1200 XEOTICID XEO03235 MOACRIVE Inhibition DME1200 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1200 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03236 XEO_CLAS Peptide DME1200 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO03236 GENEFORM Protein DME1200 XEOTICID XEO03236 MOACRIVE Inhibition DME1200 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1200 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03237 XEO_CLAS Peptide DME1200 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 ug/ml) DME1200 XEOTICID XEO03237 GENEFORM Protein DME1200 XEOTICID XEO03237 MOACRIVE Inhibition DME1200 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1200 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03238 XEO_CLAS Peptide DME1200 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 ug/ml) DME1200 XEOTICID XEO03238 GENEFORM Protein DME1200 XEOTICID XEO03238 MOACRIVE Inhibition DME1200 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1200 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03239 XEO_CLAS Peptide DME1200 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 60 ug/ml) DME1200 XEOTICID XEO03239 GENEFORM Protein DME1200 XEOTICID XEO03239 MOACRIVE Inhibition DME1200 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1200 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03241 XEO_CLAS Peptide DME1200 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 128 microM) DME1200 XEOTICID XEO03241 GENEFORM Protein DME1200 XEOTICID XEO03241 MOACRIVE Inhibition DME1200 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1200 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03250 XEO_CLAS Peptide DME1200 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03250 GENEFORM Protein DME1200 XEOTICID XEO03250 MOACRIVE Inhibition DME1200 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1200 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03251 XEO_CLAS Peptide DME1200 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03251 GENEFORM Protein DME1200 XEOTICID XEO03251 MOACRIVE Inhibition DME1200 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1200 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03253 XEO_CLAS Peptide DME1200 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.1 ug/ml) DME1200 XEOTICID XEO03253 GENEFORM Protein DME1200 XEOTICID XEO03253 MOACRIVE Inhibition DME1200 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1200 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03274 XEO_CLAS Peptide DME1200 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.2 microM) DME1200 XEOTICID XEO03274 GENEFORM Protein DME1200 XEOTICID XEO03274 MOACRIVE Inhibition DME1200 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1200 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03275 XEO_CLAS Peptide DME1200 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO03275 GENEFORM Protein DME1200 XEOTICID XEO03275 MOACRIVE Inhibition DME1200 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1200 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03276 XEO_CLAS Peptide DME1200 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO03276 GENEFORM Protein DME1200 XEOTICID XEO03276 MOACRIVE Inhibition DME1200 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1200 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03277 XEO_CLAS Peptide DME1200 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.2 microM) DME1200 XEOTICID XEO03277 GENEFORM Protein DME1200 XEOTICID XEO03277 MOACRIVE Inhibition DME1200 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1200 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03278 XEO_CLAS Peptide DME1200 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO03278 GENEFORM Protein DME1200 XEOTICID XEO03278 MOACRIVE Inhibition DME1200 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1200 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03279 XEO_CLAS Peptide DME1200 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO03279 GENEFORM Protein DME1200 XEOTICID XEO03279 MOACRIVE Inhibition DME1200 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1200 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03280 XEO_CLAS Peptide DME1200 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 microM) DME1200 XEOTICID XEO03280 GENEFORM Protein DME1200 XEOTICID XEO03280 MOACRIVE Inhibition DME1200 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1200 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03281 XEO_CLAS Peptide DME1200 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.3 microM) DME1200 XEOTICID XEO03281 GENEFORM Protein DME1200 XEOTICID XEO03281 MOACRIVE Inhibition DME1200 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1200 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03282 XEO_CLAS Peptide DME1200 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.1 microM) DME1200 XEOTICID XEO03282 GENEFORM Protein DME1200 XEOTICID XEO03282 MOACRIVE Inhibition DME1200 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1200 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03283 XEO_CLAS Peptide DME1200 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 microM) DME1200 XEOTICID XEO03283 GENEFORM Protein DME1200 XEOTICID XEO03283 MOACRIVE Inhibition DME1200 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1200 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03284 XEO_CLAS Peptide DME1200 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.2 ug/ml) DME1200 XEOTICID XEO03284 GENEFORM Protein DME1200 XEOTICID XEO03284 MOACRIVE Inhibition DME1200 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1200 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03285 XEO_CLAS Peptide DME1200 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.5 ug/ml) DME1200 XEOTICID XEO03285 GENEFORM Protein DME1200 XEOTICID XEO03285 MOACRIVE Inhibition DME1200 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1200 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03286 XEO_CLAS Peptide DME1200 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.4 ug/ml) DME1200 XEOTICID XEO03286 GENEFORM Protein DME1200 XEOTICID XEO03286 MOACRIVE Inhibition DME1200 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1200 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03287 XEO_CLAS Peptide DME1200 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.6 ug/ml) DME1200 XEOTICID XEO03287 GENEFORM Protein DME1200 XEOTICID XEO03287 MOACRIVE Inhibition DME1200 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1200 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03288 XEO_CLAS Peptide DME1200 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.4 ug/ml) DME1200 XEOTICID XEO03288 GENEFORM Protein DME1200 XEOTICID XEO03288 MOACRIVE Inhibition DME1200 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1200 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03289 XEO_CLAS Peptide DME1200 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8.8 ug/ml) DME1200 XEOTICID XEO03289 GENEFORM Protein DME1200 XEOTICID XEO03289 MOACRIVE Inhibition DME1200 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1200 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03290 XEO_CLAS Peptide DME1200 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.5 ug/ml) DME1200 XEOTICID XEO03290 GENEFORM Protein DME1200 XEOTICID XEO03290 MOACRIVE Inhibition DME1200 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1200 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03291 XEO_CLAS Peptide DME1200 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8.6 ug/ml) DME1200 XEOTICID XEO03291 GENEFORM Protein DME1200 XEOTICID XEO03291 MOACRIVE Inhibition DME1200 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1200 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03292 XEO_CLAS Peptide DME1200 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4.1 ug/ml) DME1200 XEOTICID XEO03292 GENEFORM Protein DME1200 XEOTICID XEO03292 MOACRIVE Inhibition DME1200 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1200 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03293 XEO_CLAS Peptide DME1200 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1 microM) DME1200 XEOTICID XEO03293 GENEFORM Protein DME1200 XEOTICID XEO03293 MOACRIVE Inhibition DME1200 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1200 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03294 XEO_CLAS Peptide DME1200 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1 microM) DME1200 XEOTICID XEO03294 GENEFORM Protein DME1200 XEOTICID XEO03294 MOACRIVE Inhibition DME1200 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1200 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03295 XEO_CLAS Peptide DME1200 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.7 microM) DME1200 XEOTICID XEO03295 GENEFORM Protein DME1200 XEOTICID XEO03295 MOACRIVE Inhibition DME1200 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1200 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03296 XEO_CLAS Peptide DME1200 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03296 GENEFORM Protein DME1200 XEOTICID XEO03296 MOACRIVE Inhibition DME1200 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1200 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03297 XEO_CLAS Peptide DME1200 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03297 GENEFORM Protein DME1200 XEOTICID XEO03297 MOACRIVE Inhibition DME1200 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1200 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03298 XEO_CLAS Peptide DME1200 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.2 microM) DME1200 XEOTICID XEO03298 GENEFORM Protein DME1200 XEOTICID XEO03298 MOACRIVE Inhibition DME1200 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1200 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03299 XEO_CLAS Peptide DME1200 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.4 microM) DME1200 XEOTICID XEO03299 GENEFORM Protein DME1200 XEOTICID XEO03299 MOACRIVE Inhibition DME1200 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1200 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03300 XEO_CLAS Peptide DME1200 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 ug/ml) DME1200 XEOTICID XEO03300 GENEFORM Protein DME1200 XEOTICID XEO03300 MOACRIVE Inhibition DME1200 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1200 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03301 XEO_CLAS Peptide DME1200 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 ug/ml) DME1200 XEOTICID XEO03301 GENEFORM Protein DME1200 XEOTICID XEO03301 MOACRIVE Inhibition DME1200 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1200 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03302 XEO_CLAS Peptide DME1200 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1 microM) DME1200 XEOTICID XEO03302 GENEFORM Protein DME1200 XEOTICID XEO03302 MOACRIVE Inhibition DME1200 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1200 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03303 XEO_CLAS Peptide DME1200 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 microM) DME1200 XEOTICID XEO03303 GENEFORM Protein DME1200 XEOTICID XEO03303 MOACRIVE Inhibition DME1200 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1200 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03304 XEO_CLAS Peptide DME1200 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO03304 GENEFORM Protein DME1200 XEOTICID XEO03304 MOACRIVE Inhibition DME1200 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1200 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03305 XEO_CLAS Peptide DME1200 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 microM) DME1200 XEOTICID XEO03305 GENEFORM Protein DME1200 XEOTICID XEO03305 MOACRIVE Inhibition DME1200 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1200 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03306 XEO_CLAS Peptide DME1200 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO03306 GENEFORM Protein DME1200 XEOTICID XEO03306 MOACRIVE Inhibition DME1200 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1200 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03307 XEO_CLAS Peptide DME1200 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 34 ug/ml) DME1200 XEOTICID XEO03307 GENEFORM Protein DME1200 XEOTICID XEO03307 MOACRIVE Inhibition DME1200 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1200 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03308 XEO_CLAS Peptide DME1200 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO03308 GENEFORM Protein DME1200 XEOTICID XEO03308 MOACRIVE Inhibition DME1200 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1200 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03310 XEO_CLAS Peptide DME1200 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8.5 ug/ml) DME1200 XEOTICID XEO03310 GENEFORM Protein DME1200 XEOTICID XEO03310 MOACRIVE Inhibition DME1200 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1200 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03311 XEO_CLAS Peptide DME1200 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10.8 ug/ml) DME1200 XEOTICID XEO03311 GENEFORM Protein DME1200 XEOTICID XEO03311 MOACRIVE Inhibition DME1200 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1200 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03312 XEO_CLAS Peptide DME1200 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10.8 ug/ml) DME1200 XEOTICID XEO03312 GENEFORM Protein DME1200 XEOTICID XEO03312 MOACRIVE Inhibition DME1200 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1200 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03313 XEO_CLAS Peptide DME1200 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8.1 ug/ml) DME1200 XEOTICID XEO03313 GENEFORM Protein DME1200 XEOTICID XEO03313 MOACRIVE Inhibition DME1200 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1200 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03314 XEO_CLAS Peptide DME1200 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 7.9 ug/ml) DME1200 XEOTICID XEO03314 GENEFORM Protein DME1200 XEOTICID XEO03314 MOACRIVE Inhibition DME1200 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1200 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03315 XEO_CLAS Peptide DME1200 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.6 ug/ml) DME1200 XEOTICID XEO03315 GENEFORM Protein DME1200 XEOTICID XEO03315 MOACRIVE Inhibition DME1200 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1200 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03316 XEO_CLAS Peptide DME1200 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15.8 ug/ml) DME1200 XEOTICID XEO03316 GENEFORM Protein DME1200 XEOTICID XEO03316 MOACRIVE Inhibition DME1200 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1200 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03317 XEO_CLAS Peptide DME1200 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO03317 GENEFORM Protein DME1200 XEOTICID XEO03317 MOACRIVE Inhibition DME1200 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1200 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03318 XEO_CLAS Peptide DME1200 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1 microM) DME1200 XEOTICID XEO03318 GENEFORM Protein DME1200 XEOTICID XEO03318 MOACRIVE Inhibition DME1200 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1200 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03319 XEO_CLAS Peptide DME1200 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03319 GENEFORM Protein DME1200 XEOTICID XEO03319 MOACRIVE Inhibition DME1200 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1200 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03320 XEO_CLAS Peptide DME1200 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.1 microM) DME1200 XEOTICID XEO03320 GENEFORM Protein DME1200 XEOTICID XEO03320 MOACRIVE Inhibition DME1200 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1200 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03321 XEO_CLAS Peptide DME1200 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.8 microM) DME1200 XEOTICID XEO03321 GENEFORM Protein DME1200 XEOTICID XEO03321 MOACRIVE Inhibition DME1200 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1200 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1200 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03348 GENEFORM Protein DME1200 XEOTICID XEO03348 MOACRIVE Inhibition DME1200 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1200 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03362 XEO_CLAS Peptide DME1200 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO03362 GENEFORM Protein DME1200 XEOTICID XEO03362 MOACRIVE Inhibition DME1200 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1200 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03363 XEO_CLAS Peptide DME1200 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 microM) DME1200 XEOTICID XEO03363 GENEFORM Protein DME1200 XEOTICID XEO03363 MOACRIVE Inhibition DME1200 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1200 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03364 XEO_CLAS Peptide DME1200 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 microM) DME1200 XEOTICID XEO03364 GENEFORM Protein DME1200 XEOTICID XEO03364 MOACRIVE Inhibition DME1200 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1200 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03365 XEO_CLAS Peptide DME1200 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03365 GENEFORM Protein DME1200 XEOTICID XEO03365 MOACRIVE Inhibition DME1200 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1200 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03366 XEO_CLAS Peptide DME1200 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO03366 GENEFORM Protein DME1200 XEOTICID XEO03366 MOACRIVE Inhibition DME1200 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1200 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03367 XEO_CLAS Peptide DME1200 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 microM) DME1200 XEOTICID XEO03367 GENEFORM Protein DME1200 XEOTICID XEO03367 MOACRIVE Inhibition DME1200 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1200 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03368 XEO_CLAS Peptide DME1200 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 microM) DME1200 XEOTICID XEO03368 GENEFORM Protein DME1200 XEOTICID XEO03368 MOACRIVE Inhibition DME1200 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1200 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03379 XEO_CLAS Peptide DME1200 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.6 ug/ml) DME1200 XEOTICID XEO03379 GENEFORM Protein DME1200 XEOTICID XEO03379 MOACRIVE Inhibition DME1200 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1200 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03396 XEO_CLAS Peptide DME1200 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03396 GENEFORM Protein DME1200 XEOTICID XEO03396 MOACRIVE Inhibition DME1200 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1200 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03398 XEO_CLAS Peptide DME1200 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03398 GENEFORM Protein DME1200 XEOTICID XEO03398 MOACRIVE Inhibition DME1200 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1200 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03399 XEO_CLAS Peptide DME1200 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03399 GENEFORM Protein DME1200 XEOTICID XEO03399 MOACRIVE Inhibition DME1200 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1200 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03406 XEO_CLAS Peptide DME1200 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 ug/ml) DME1200 XEOTICID XEO03406 GENEFORM Protein DME1200 XEOTICID XEO03406 MOACRIVE Inhibition DME1200 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1200 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03424 XEO_CLAS Peptide DME1200 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03424 GENEFORM Protein DME1200 XEOTICID XEO03424 MOACRIVE Inhibition DME1200 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1200 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03426 XEO_CLAS Peptide DME1200 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO03426 GENEFORM Protein DME1200 XEOTICID XEO03426 MOACRIVE Inhibition DME1200 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1200 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03427 XEO_CLAS Peptide DME1200 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 microM) DME1200 XEOTICID XEO03427 GENEFORM Protein DME1200 XEOTICID XEO03427 MOACRIVE Inhibition DME1200 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1200 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03428 XEO_CLAS Peptide DME1200 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 ug/ml) DME1200 XEOTICID XEO03428 GENEFORM Protein DME1200 XEOTICID XEO03428 MOACRIVE Inhibition DME1200 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1200 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03430 XEO_CLAS Peptide DME1200 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 ug/ml) DME1200 XEOTICID XEO03430 GENEFORM Protein DME1200 XEOTICID XEO03430 MOACRIVE Inhibition DME1200 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1200 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03434 XEO_CLAS Peptide DME1200 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO03434 GENEFORM Protein DME1200 XEOTICID XEO03434 MOACRIVE Inhibition DME1200 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1200 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03442 XEO_CLAS Peptide DME1200 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 18.75 ug/ml) DME1200 XEOTICID XEO03442 GENEFORM Protein DME1200 XEOTICID XEO03442 MOACRIVE Inhibition DME1200 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1200 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03444 XEO_CLAS Peptide DME1200 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 37.50 ug/ml) DME1200 XEOTICID XEO03444 GENEFORM Protein DME1200 XEOTICID XEO03444 MOACRIVE Inhibition DME1200 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1200 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03459 XEO_CLAS Peptide DME1200 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03459 GENEFORM Protein DME1200 XEOTICID XEO03459 MOACRIVE Inhibition DME1200 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1200 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03460 XEO_CLAS Peptide DME1200 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03460 GENEFORM Protein DME1200 XEOTICID XEO03460 MOACRIVE Inhibition DME1200 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1200 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03461 XEO_CLAS Peptide DME1200 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.05 microM) DME1200 XEOTICID XEO03461 GENEFORM Protein DME1200 XEOTICID XEO03461 MOACRIVE Inhibition DME1200 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1200 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03462 XEO_CLAS Peptide DME1200 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03462 GENEFORM Protein DME1200 XEOTICID XEO03462 MOACRIVE Inhibition DME1200 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1200 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03463 XEO_CLAS Peptide DME1200 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03463 GENEFORM Protein DME1200 XEOTICID XEO03463 MOACRIVE Inhibition DME1200 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1200 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03467 XEO_CLAS Peptide DME1200 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03467 GENEFORM Protein DME1200 XEOTICID XEO03467 MOACRIVE Inhibition DME1200 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1200 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03468 XEO_CLAS Peptide DME1200 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03468 GENEFORM Protein DME1200 XEOTICID XEO03468 MOACRIVE Inhibition DME1200 XEOTICID XEO03471 XEO_NAME Gambicin DME1200 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03471 XEO_CLAS Peptide DME1200 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1200 XEOTICID XEO03471 GENEFORM Protein DME1200 XEOTICID XEO03471 MOACRIVE Inhibition DME1200 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1200 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03485 XEO_CLAS Peptide DME1200 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4.07 ug/ml) DME1200 XEOTICID XEO03485 GENEFORM Protein DME1200 XEOTICID XEO03485 MOACRIVE Inhibition DME1200 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1200 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03486 XEO_CLAS Peptide DME1200 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.80 ug/ml) DME1200 XEOTICID XEO03486 GENEFORM Protein DME1200 XEOTICID XEO03486 MOACRIVE Inhibition DME1200 XEOTICID XEO03488 XEO_NAME GLK-19 DME1200 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03488 XEO_CLAS Peptide DME1200 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO03488 GENEFORM Protein DME1200 XEOTICID XEO03488 MOACRIVE Inhibition DME1200 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1200 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03497 XEO_CLAS Peptide DME1200 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1200 XEOTICID XEO03497 GENEFORM Protein DME1200 XEOTICID XEO03497 MOACRIVE Inhibition DME1200 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1200 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03498 XEO_CLAS Peptide DME1200 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1200 XEOTICID XEO03498 GENEFORM Protein DME1200 XEOTICID XEO03498 MOACRIVE Inhibition DME1200 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1200 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03500 XEO_CLAS Peptide DME1200 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-30 ug/ml) DME1200 XEOTICID XEO03500 GENEFORM Protein DME1200 XEOTICID XEO03500 MOACRIVE Inhibition DME1200 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1200 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03504 XEO_CLAS Peptide DME1200 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 ug/ml) DME1200 XEOTICID XEO03504 GENEFORM Protein DME1200 XEOTICID XEO03504 MOACRIVE Inhibition DME1200 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1200 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03505 XEO_CLAS Peptide DME1200 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 ug/ml) DME1200 XEOTICID XEO03505 GENEFORM Protein DME1200 XEOTICID XEO03505 MOACRIVE Inhibition DME1200 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1200 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03506 XEO_CLAS Peptide DME1200 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 ug/ml) DME1200 XEOTICID XEO03506 GENEFORM Protein DME1200 XEOTICID XEO03506 MOACRIVE Inhibition DME1200 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1200 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03513 XEO_CLAS Peptide DME1200 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO03513 GENEFORM Protein DME1200 XEOTICID XEO03513 MOACRIVE Inhibition DME1200 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1200 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03514 XEO_CLAS Peptide DME1200 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03514 GENEFORM Protein DME1200 XEOTICID XEO03514 MOACRIVE Inhibition DME1200 XEOTICID XEO03519 XEO_NAME Hadrurin DME1200 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03519 XEO_CLAS Peptide DME1200 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03519 GENEFORM Protein DME1200 XEOTICID XEO03519 MOACRIVE Inhibition DME1200 XEOTICID XEO03522 XEO_NAME Halocyntin DME1200 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03522 XEO_CLAS Peptide DME1200 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03522 GENEFORM Protein DME1200 XEOTICID XEO03522 MOACRIVE Inhibition DME1200 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1200 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03524 XEO_CLAS Peptide DME1200 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03524 GENEFORM Protein DME1200 XEOTICID XEO03524 MOACRIVE Inhibition DME1200 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1200 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03525 XEO_CLAS Peptide DME1200 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03525 GENEFORM Protein DME1200 XEOTICID XEO03525 MOACRIVE Inhibition DME1200 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1200 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03530 XEO_CLAS Peptide DME1200 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03530 GENEFORM Protein DME1200 XEOTICID XEO03530 MOACRIVE Inhibition DME1200 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1200 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03535 XEO_CLAS Peptide DME1200 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.4 microM) DME1200 XEOTICID XEO03535 GENEFORM Protein DME1200 XEOTICID XEO03535 MOACRIVE Inhibition DME1200 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1200 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03536 XEO_CLAS Peptide DME1200 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 80 microM) DME1200 XEOTICID XEO03536 GENEFORM Protein DME1200 XEOTICID XEO03536 MOACRIVE Inhibition DME1200 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1200 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03537 XEO_CLAS Peptide DME1200 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 ug/ml) DME1200 XEOTICID XEO03537 GENEFORM Protein DME1200 XEOTICID XEO03537 MOACRIVE Inhibition DME1200 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1200 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03538 XEO_CLAS Peptide DME1200 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 ug/ml) DME1200 XEOTICID XEO03538 GENEFORM Protein DME1200 XEOTICID XEO03538 MOACRIVE Inhibition DME1200 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1200 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03540 XEO_CLAS Peptide DME1200 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO03540 GENEFORM Protein DME1200 XEOTICID XEO03540 MOACRIVE Inhibition DME1200 XEOTICID XEO03542 XEO_NAME Hepcidin DME1200 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03542 XEO_CLAS Peptide DME1200 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 24 microM) DME1200 XEOTICID XEO03542 GENEFORM Protein DME1200 XEOTICID XEO03542 MOACRIVE Inhibition DME1200 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1200 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03544 XEO_CLAS Peptide DME1200 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03544 GENEFORM Protein DME1200 XEOTICID XEO03544 MOACRIVE Inhibition DME1200 XEOTICID XEO03548 XEO_NAME Hesperidin DME1200 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03548 GENEFORM Protein DME1200 XEOTICID XEO03548 MOACRIVE Inhibition DME1200 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1200 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1200 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03552 GENEFORM Protein DME1200 XEOTICID XEO03552 MOACRIVE Inhibition DME1200 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1200 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03556 XEO_CLAS Peptide DME1200 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO03556 GENEFORM Protein DME1200 XEOTICID XEO03556 MOACRIVE Inhibition DME1200 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1200 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03557 XEO_CLAS Peptide DME1200 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO03557 GENEFORM Protein DME1200 XEOTICID XEO03557 MOACRIVE Inhibition DME1200 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1200 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03558 XEO_CLAS Peptide DME1200 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 microM) DME1200 XEOTICID XEO03558 GENEFORM Protein DME1200 XEOTICID XEO03558 MOACRIVE Inhibition DME1200 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1200 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03559 XEO_CLAS Peptide DME1200 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 microM) DME1200 XEOTICID XEO03559 GENEFORM Protein DME1200 XEOTICID XEO03559 MOACRIVE Inhibition DME1200 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1200 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03560 XEO_CLAS Peptide DME1200 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 microM) DME1200 XEOTICID XEO03560 GENEFORM Protein DME1200 XEOTICID XEO03560 MOACRIVE Inhibition DME1200 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1200 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03561 XEO_CLAS Peptide DME1200 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03561 GENEFORM Protein DME1200 XEOTICID XEO03561 MOACRIVE Inhibition DME1200 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1200 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03567 XEO_CLAS Peptide DME1200 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03567 GENEFORM Protein DME1200 XEOTICID XEO03567 MOACRIVE Inhibition DME1200 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1200 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03569 XEO_CLAS Peptide DME1200 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 300 microM) DME1200 XEOTICID XEO03569 GENEFORM Protein DME1200 XEOTICID XEO03569 MOACRIVE Inhibition DME1200 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1200 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03570 XEO_CLAS Peptide DME1200 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03570 GENEFORM Protein DME1200 XEOTICID XEO03570 MOACRIVE Inhibition DME1200 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1200 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03572 XEO_CLAS Peptide DME1200 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1200 XEOTICID XEO03572 GENEFORM Protein DME1200 XEOTICID XEO03572 MOACRIVE Inhibition DME1200 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1200 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03573 XEO_CLAS Peptide DME1200 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 28.1 ug/ml) DME1200 XEOTICID XEO03573 GENEFORM Protein DME1200 XEOTICID XEO03573 MOACRIVE Inhibition DME1200 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1200 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03574 XEO_CLAS Peptide DME1200 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 500 microM) DME1200 XEOTICID XEO03574 GENEFORM Protein DME1200 XEOTICID XEO03574 MOACRIVE Inhibition DME1200 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1200 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03575 XEO_CLAS Peptide DME1200 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 18 microM) DME1200 XEOTICID XEO03575 GENEFORM Protein DME1200 XEOTICID XEO03575 MOACRIVE Inhibition DME1200 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1200 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03576 XEO_CLAS Peptide DME1200 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 750 microM) DME1200 XEOTICID XEO03576 GENEFORM Protein DME1200 XEOTICID XEO03576 MOACRIVE Inhibition DME1200 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1200 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03578 XEO_CLAS Peptide DME1200 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1200 XEOTICID XEO03578 GENEFORM Protein DME1200 XEOTICID XEO03578 MOACRIVE Inhibition DME1200 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1200 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03579 XEO_CLAS Peptide DME1200 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03579 GENEFORM Protein DME1200 XEOTICID XEO03579 MOACRIVE Inhibition DME1200 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1200 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03580 XEO_CLAS Peptide DME1200 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03580 GENEFORM Protein DME1200 XEOTICID XEO03580 MOACRIVE Inhibition DME1200 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1200 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03585 XEO_CLAS Peptide DME1200 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 125 ug/ml) DME1200 XEOTICID XEO03585 GENEFORM Protein DME1200 XEOTICID XEO03585 MOACRIVE Inhibition DME1200 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1200 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03588 XEO_CLAS Peptide DME1200 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 62 ug/ml) DME1200 XEOTICID XEO03588 GENEFORM Protein DME1200 XEOTICID XEO03588 MOACRIVE Inhibition DME1200 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1200 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03589 XEO_CLAS Peptide DME1200 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03589 GENEFORM Protein DME1200 XEOTICID XEO03589 MOACRIVE Inhibition DME1200 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1200 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03590 XEO_CLAS Peptide DME1200 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03590 GENEFORM Protein DME1200 XEOTICID XEO03590 MOACRIVE Inhibition DME1200 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1200 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03591 XEO_CLAS Peptide DME1200 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 37.5 ug/ml) DME1200 XEOTICID XEO03591 GENEFORM Protein DME1200 XEOTICID XEO03591 MOACRIVE Inhibition DME1200 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1200 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03593 XEO_CLAS Peptide DME1200 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 9.4 ug/ml) DME1200 XEOTICID XEO03593 GENEFORM Protein DME1200 XEOTICID XEO03593 MOACRIVE Inhibition DME1200 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1200 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03594 XEO_CLAS Peptide DME1200 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 ug/ml) DME1200 XEOTICID XEO03594 GENEFORM Protein DME1200 XEOTICID XEO03594 MOACRIVE Inhibition DME1200 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1200 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03595 XEO_CLAS Peptide DME1200 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03595 GENEFORM Protein DME1200 XEOTICID XEO03595 MOACRIVE Inhibition DME1200 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1200 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03596 XEO_CLAS Peptide DME1200 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03596 GENEFORM Protein DME1200 XEOTICID XEO03596 MOACRIVE Inhibition DME1200 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1200 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03598 XEO_CLAS Peptide DME1200 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03598 GENEFORM Protein DME1200 XEOTICID XEO03598 MOACRIVE Inhibition DME1200 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1200 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03599 XEO_CLAS Peptide DME1200 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03599 GENEFORM Protein DME1200 XEOTICID XEO03599 MOACRIVE Inhibition DME1200 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1200 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03600 XEO_CLAS Peptide DME1200 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03600 GENEFORM Protein DME1200 XEOTICID XEO03600 MOACRIVE Inhibition DME1200 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1200 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03606 XEO_CLAS Peptide DME1200 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03606 GENEFORM Protein DME1200 XEOTICID XEO03606 MOACRIVE Inhibition DME1200 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1200 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03607 XEO_CLAS Peptide DME1200 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03607 GENEFORM Protein DME1200 XEOTICID XEO03607 MOACRIVE Inhibition DME1200 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1200 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03609 XEO_CLAS Peptide DME1200 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03609 GENEFORM Protein DME1200 XEOTICID XEO03609 MOACRIVE Inhibition DME1200 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1200 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03615 XEO_CLAS Peptide DME1200 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1200 XEOTICID XEO03615 GENEFORM Protein DME1200 XEOTICID XEO03615 MOACRIVE Inhibition DME1200 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1200 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03616 XEO_CLAS Peptide DME1200 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 32 microM) DME1200 XEOTICID XEO03616 GENEFORM Protein DME1200 XEOTICID XEO03616 MOACRIVE Inhibition DME1200 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1200 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03617 XEO_CLAS Peptide DME1200 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40 microM) DME1200 XEOTICID XEO03617 GENEFORM Protein DME1200 XEOTICID XEO03617 MOACRIVE Inhibition DME1200 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1200 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03618 XEO_CLAS Peptide DME1200 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5-1 microM) DME1200 XEOTICID XEO03618 GENEFORM Protein DME1200 XEOTICID XEO03618 MOACRIVE Inhibition DME1200 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1200 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03622 XEO_CLAS Peptide DME1200 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20-40 microM) DME1200 XEOTICID XEO03622 GENEFORM Protein DME1200 XEOTICID XEO03622 MOACRIVE Inhibition DME1200 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1200 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03627 XEO_CLAS Peptide DME1200 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1200 XEOTICID XEO03627 GENEFORM Protein DME1200 XEOTICID XEO03627 MOACRIVE Inhibition DME1200 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1200 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03630 XEO_CLAS Peptide DME1200 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03630 GENEFORM Protein DME1200 XEOTICID XEO03630 MOACRIVE Inhibition DME1200 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1200 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03631 XEO_CLAS Peptide DME1200 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03631 GENEFORM Protein DME1200 XEOTICID XEO03631 MOACRIVE Inhibition DME1200 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1200 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03632 XEO_CLAS Peptide DME1200 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03632 GENEFORM Protein DME1200 XEOTICID XEO03632 MOACRIVE Inhibition DME1200 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1200 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03633 XEO_CLAS Peptide DME1200 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03633 GENEFORM Protein DME1200 XEOTICID XEO03633 MOACRIVE Inhibition DME1200 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1200 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03634 XEO_CLAS Peptide DME1200 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03634 GENEFORM Protein DME1200 XEOTICID XEO03634 MOACRIVE Inhibition DME1200 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1200 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03635 XEO_CLAS Peptide DME1200 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03635 GENEFORM Protein DME1200 XEOTICID XEO03635 MOACRIVE Inhibition DME1200 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1200 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03636 XEO_CLAS Peptide DME1200 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03636 GENEFORM Protein DME1200 XEOTICID XEO03636 MOACRIVE Inhibition DME1200 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1200 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03637 XEO_CLAS Peptide DME1200 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03637 GENEFORM Protein DME1200 XEOTICID XEO03637 MOACRIVE Inhibition DME1200 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1200 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03638 XEO_CLAS Peptide DME1200 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03638 GENEFORM Protein DME1200 XEOTICID XEO03638 MOACRIVE Inhibition DME1200 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1200 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03639 XEO_CLAS Peptide DME1200 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03639 GENEFORM Protein DME1200 XEOTICID XEO03639 MOACRIVE Inhibition DME1200 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1200 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03640 XEO_CLAS Peptide DME1200 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03640 GENEFORM Protein DME1200 XEOTICID XEO03640 MOACRIVE Inhibition DME1200 XEOTICID XEO03644 XEO_NAME Indole DME1200 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1200 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1200 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03644 GENEFORM Protein DME1200 XEOTICID XEO03644 MOACRIVE Inhibition DME1200 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1200 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03650 XEO_CLAS Peptide DME1200 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03650 GENEFORM Protein DME1200 XEOTICID XEO03650 MOACRIVE Inhibition DME1200 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1200 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO03655 XEO_CLAS Natural Product DME1200 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03655 GENEFORM Protein DME1200 XEOTICID XEO03655 MOACRIVE Inhibition DME1200 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1200 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03666 XEO_CLAS Peptide DME1200 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 ug/ml) DME1200 XEOTICID XEO03666 GENEFORM Protein DME1200 XEOTICID XEO03666 MOACRIVE Inhibition DME1200 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1200 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03667 XEO_CLAS Peptide DME1200 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 ug/ml) DME1200 XEOTICID XEO03667 GENEFORM Protein DME1200 XEOTICID XEO03667 MOACRIVE Inhibition DME1200 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1200 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03668 XEO_CLAS Peptide DME1200 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 microM) DME1200 XEOTICID XEO03668 GENEFORM Protein DME1200 XEOTICID XEO03668 MOACRIVE Inhibition DME1200 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1200 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03669 XEO_CLAS Peptide DME1200 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO03669 GENEFORM Protein DME1200 XEOTICID XEO03669 MOACRIVE Inhibition DME1200 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1200 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03670 XEO_CLAS Peptide DME1200 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 microM) DME1200 XEOTICID XEO03670 GENEFORM Protein DME1200 XEOTICID XEO03670 MOACRIVE Inhibition DME1200 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1200 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03672 XEO_CLAS Peptide DME1200 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.5 ug/ml) DME1200 XEOTICID XEO03672 GENEFORM Protein DME1200 XEOTICID XEO03672 MOACRIVE Inhibition DME1200 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1200 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03673 XEO_CLAS Peptide DME1200 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 ug/ml) DME1200 XEOTICID XEO03673 GENEFORM Protein DME1200 XEOTICID XEO03673 MOACRIVE Inhibition DME1200 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1200 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03674 XEO_CLAS Peptide DME1200 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 ug/ml) DME1200 XEOTICID XEO03674 GENEFORM Protein DME1200 XEOTICID XEO03674 MOACRIVE Inhibition DME1200 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1200 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03675 XEO_CLAS Peptide DME1200 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO03675 GENEFORM Protein DME1200 XEOTICID XEO03675 MOACRIVE Inhibition DME1200 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1200 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03678 XEO_CLAS Peptide DME1200 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 ug/ml) DME1200 XEOTICID XEO03678 GENEFORM Protein DME1200 XEOTICID XEO03678 MOACRIVE Inhibition DME1200 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1200 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03679 XEO_CLAS Peptide DME1200 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 ug/ml) DME1200 XEOTICID XEO03679 GENEFORM Protein DME1200 XEOTICID XEO03679 MOACRIVE Inhibition DME1200 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1200 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03681 XEO_CLAS Peptide DME1200 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1200 XEOTICID XEO03681 GENEFORM Protein DME1200 XEOTICID XEO03681 MOACRIVE Inhibition DME1200 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1200 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03684 XEO_CLAS Peptide DME1200 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 ug/ml) DME1200 XEOTICID XEO03684 GENEFORM Protein DME1200 XEOTICID XEO03684 MOACRIVE Inhibition DME1200 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1200 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03694 XEO_CLAS Peptide DME1200 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03694 GENEFORM Protein DME1200 XEOTICID XEO03694 MOACRIVE Inhibition DME1200 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1200 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03697 XEO_CLAS Peptide DME1200 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25 microM) DME1200 XEOTICID XEO03697 GENEFORM Protein DME1200 XEOTICID XEO03697 MOACRIVE Inhibition DME1200 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1200 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03698 XEO_CLAS Peptide DME1200 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03698 GENEFORM Protein DME1200 XEOTICID XEO03698 MOACRIVE Inhibition DME1200 XEOTICID XEO03703 XEO_NAME Kasstasin DME1200 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03703 XEO_CLAS Peptide DME1200 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 110 microM) DME1200 XEOTICID XEO03703 GENEFORM Protein DME1200 XEOTICID XEO03703 MOACRIVE Inhibition DME1200 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1200 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03706 XEO_CLAS Peptide DME1200 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03706 GENEFORM Protein DME1200 XEOTICID XEO03706 MOACRIVE Inhibition DME1200 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1200 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03707 XEO_CLAS Peptide DME1200 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03707 GENEFORM Protein DME1200 XEOTICID XEO03707 MOACRIVE Inhibition DME1200 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1200 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03709 XEO_CLAS Peptide DME1200 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 ug/ml) DME1200 XEOTICID XEO03709 GENEFORM Protein DME1200 XEOTICID XEO03709 MOACRIVE Inhibition DME1200 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1200 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03712 XEO_CLAS Peptide DME1200 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03712 GENEFORM Protein DME1200 XEOTICID XEO03712 MOACRIVE Inhibition DME1200 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1200 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03713 XEO_CLAS Peptide DME1200 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 64 microM) DME1200 XEOTICID XEO03713 GENEFORM Protein DME1200 XEOTICID XEO03713 MOACRIVE Inhibition DME1200 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1200 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03714 XEO_CLAS Peptide DME1200 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03714 GENEFORM Protein DME1200 XEOTICID XEO03714 MOACRIVE Inhibition DME1200 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1200 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03715 XEO_CLAS Peptide DME1200 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 microM) DME1200 XEOTICID XEO03715 GENEFORM Protein DME1200 XEOTICID XEO03715 MOACRIVE Inhibition DME1200 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1200 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03719 XEO_CLAS Peptide DME1200 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 microM) DME1200 XEOTICID XEO03719 GENEFORM Protein DME1200 XEOTICID XEO03719 MOACRIVE Inhibition DME1200 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1200 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03720 XEO_CLAS Peptide DME1200 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 microM) DME1200 XEOTICID XEO03720 GENEFORM Protein DME1200 XEOTICID XEO03720 MOACRIVE Inhibition DME1200 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1200 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03723 XEO_CLAS Peptide DME1200 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 62.36 microM) DME1200 XEOTICID XEO03723 GENEFORM Protein DME1200 XEOTICID XEO03723 MOACRIVE Inhibition DME1200 XEOTICID XEO03724 XEO_NAME L10 peptide DME1200 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03724 XEO_CLAS Peptide DME1200 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.8 microM) DME1200 XEOTICID XEO03724 GENEFORM Protein DME1200 XEOTICID XEO03724 MOACRIVE Inhibition DME1200 XEOTICID XEO03726 XEO_NAME L2 peptide DME1200 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03726 XEO_CLAS Peptide DME1200 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 129.66 microM) DME1200 XEOTICID XEO03726 GENEFORM Protein DME1200 XEOTICID XEO03726 MOACRIVE Inhibition DME1200 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1200 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03727 XEO_CLAS Peptide DME1200 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 80 ug/ml) DME1200 XEOTICID XEO03727 GENEFORM Protein DME1200 XEOTICID XEO03727 MOACRIVE Inhibition DME1200 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1200 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03728 XEO_CLAS Peptide DME1200 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40 ug/ml) DME1200 XEOTICID XEO03728 GENEFORM Protein DME1200 XEOTICID XEO03728 MOACRIVE Inhibition DME1200 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1200 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03729 XEO_CLAS Peptide DME1200 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 80 ug/ml) DME1200 XEOTICID XEO03729 GENEFORM Protein DME1200 XEOTICID XEO03729 MOACRIVE Inhibition DME1200 XEOTICID XEO03730 XEO_NAME L3 peptide DME1200 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03730 XEO_CLAS Peptide DME1200 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64.11 microM) DME1200 XEOTICID XEO03730 GENEFORM Protein DME1200 XEOTICID XEO03730 MOACRIVE Inhibition DME1200 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1200 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03731 XEO_CLAS Peptide DME1200 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40 ug/ml) DME1200 XEOTICID XEO03731 GENEFORM Protein DME1200 XEOTICID XEO03731 MOACRIVE Inhibition DME1200 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1200 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03733 XEO_CLAS Peptide DME1200 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40 ug/ml) DME1200 XEOTICID XEO03733 GENEFORM Protein DME1200 XEOTICID XEO03733 MOACRIVE Inhibition DME1200 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1200 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03734 XEO_CLAS Peptide DME1200 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO03734 GENEFORM Protein DME1200 XEOTICID XEO03734 MOACRIVE Inhibition DME1200 XEOTICID XEO03735 XEO_NAME L4 peptide DME1200 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03735 XEO_CLAS Peptide DME1200 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 31.61 microM) DME1200 XEOTICID XEO03735 GENEFORM Protein DME1200 XEOTICID XEO03735 MOACRIVE Inhibition DME1200 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1200 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03738 XEO_CLAS Peptide DME1200 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 ug/ml) DME1200 XEOTICID XEO03738 GENEFORM Protein DME1200 XEOTICID XEO03738 MOACRIVE Inhibition DME1200 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1200 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03741 XEO_CLAS Peptide DME1200 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40 ug/ml) DME1200 XEOTICID XEO03741 GENEFORM Protein DME1200 XEOTICID XEO03741 MOACRIVE Inhibition DME1200 XEOTICID XEO03742 XEO_NAME L5 peptide DME1200 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03742 XEO_CLAS Peptide DME1200 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 7.79 microM) DME1200 XEOTICID XEO03742 GENEFORM Protein DME1200 XEOTICID XEO03742 MOACRIVE Inhibition DME1200 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1200 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03743 XEO_CLAS Peptide DME1200 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 ug/ml) DME1200 XEOTICID XEO03743 GENEFORM Protein DME1200 XEOTICID XEO03743 MOACRIVE Inhibition DME1200 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1200 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03744 XEO_CLAS Peptide DME1200 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 ug/ml) DME1200 XEOTICID XEO03744 GENEFORM Protein DME1200 XEOTICID XEO03744 MOACRIVE Inhibition DME1200 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1200 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03745 XEO_CLAS Peptide DME1200 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 ug/ml) DME1200 XEOTICID XEO03745 GENEFORM Protein DME1200 XEOTICID XEO03745 MOACRIVE Inhibition DME1200 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1200 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03746 XEO_CLAS Peptide DME1200 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO03746 GENEFORM Protein DME1200 XEOTICID XEO03746 MOACRIVE Inhibition DME1200 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1200 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03747 XEO_CLAS Peptide DME1200 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO03747 GENEFORM Protein DME1200 XEOTICID XEO03747 MOACRIVE Inhibition DME1200 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1200 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03748 XEO_CLAS Peptide DME1200 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO03748 GENEFORM Protein DME1200 XEOTICID XEO03748 MOACRIVE Inhibition DME1200 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1200 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03749 XEO_CLAS Peptide DME1200 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO03749 GENEFORM Protein DME1200 XEOTICID XEO03749 MOACRIVE Inhibition DME1200 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1200 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03750 XEO_CLAS Peptide DME1200 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO03750 GENEFORM Protein DME1200 XEOTICID XEO03750 MOACRIVE Inhibition DME1200 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1200 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03751 XEO_CLAS Peptide DME1200 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO03751 GENEFORM Protein DME1200 XEOTICID XEO03751 MOACRIVE Inhibition DME1200 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1200 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03752 XEO_CLAS Peptide DME1200 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO03752 GENEFORM Protein DME1200 XEOTICID XEO03752 MOACRIVE Inhibition DME1200 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1200 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03753 XEO_CLAS Peptide DME1200 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 ug/ml) DME1200 XEOTICID XEO03753 GENEFORM Protein DME1200 XEOTICID XEO03753 MOACRIVE Inhibition DME1200 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1200 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03754 XEO_CLAS Peptide DME1200 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO03754 GENEFORM Protein DME1200 XEOTICID XEO03754 MOACRIVE Inhibition DME1200 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1200 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03755 XEO_CLAS Peptide DME1200 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO03755 GENEFORM Protein DME1200 XEOTICID XEO03755 MOACRIVE Inhibition DME1200 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1200 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03756 XEO_CLAS Peptide DME1200 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO03756 GENEFORM Protein DME1200 XEOTICID XEO03756 MOACRIVE Inhibition DME1200 XEOTICID XEO03757 XEO_NAME L6 peptide DME1200 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03757 XEO_CLAS Peptide DME1200 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15.17 microM) DME1200 XEOTICID XEO03757 GENEFORM Protein DME1200 XEOTICID XEO03757 MOACRIVE Inhibition DME1200 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1200 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03758 XEO_CLAS Peptide DME1200 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 80 ug/ml) DME1200 XEOTICID XEO03758 GENEFORM Protein DME1200 XEOTICID XEO03758 MOACRIVE Inhibition DME1200 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1200 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03759 XEO_CLAS Peptide DME1200 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.3 ug/ml) DME1200 XEOTICID XEO03759 GENEFORM Protein DME1200 XEOTICID XEO03759 MOACRIVE Inhibition DME1200 XEOTICID XEO03760 XEO_NAME L7 peptide DME1200 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03760 XEO_CLAS Peptide DME1200 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16.02 microM) DME1200 XEOTICID XEO03760 GENEFORM Protein DME1200 XEOTICID XEO03760 MOACRIVE Inhibition DME1200 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1200 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03761 XEO_CLAS Peptide DME1200 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 ug/ml) DME1200 XEOTICID XEO03761 GENEFORM Protein DME1200 XEOTICID XEO03761 MOACRIVE Inhibition DME1200 XEOTICID XEO03763 XEO_NAME L8 peptide DME1200 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03763 XEO_CLAS Peptide DME1200 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.71 microM) DME1200 XEOTICID XEO03763 GENEFORM Protein DME1200 XEOTICID XEO03763 MOACRIVE Inhibition DME1200 XEOTICID XEO03765 XEO_NAME L9 peptide DME1200 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03765 XEO_CLAS Peptide DME1200 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.78 microM) DME1200 XEOTICID XEO03765 GENEFORM Protein DME1200 XEOTICID XEO03765 MOACRIVE Inhibition DME1200 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1200 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03775 XEO_CLAS Peptide DME1200 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 17.3 microM) DME1200 XEOTICID XEO03775 GENEFORM Protein DME1200 XEOTICID XEO03775 MOACRIVE Inhibition DME1200 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1200 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03776 XEO_CLAS Peptide DME1200 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03776 GENEFORM Protein DME1200 XEOTICID XEO03776 MOACRIVE Inhibition DME1200 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1200 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03781 XEO_CLAS Peptide DME1200 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.47 microM) DME1200 XEOTICID XEO03781 GENEFORM Protein DME1200 XEOTICID XEO03781 MOACRIVE Inhibition DME1200 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1200 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03782 XEO_CLAS Peptide DME1200 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.47 microM) DME1200 XEOTICID XEO03782 GENEFORM Protein DME1200 XEOTICID XEO03782 MOACRIVE Inhibition DME1200 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1200 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03783 XEO_CLAS Peptide DME1200 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.68 microM) DME1200 XEOTICID XEO03783 GENEFORM Protein DME1200 XEOTICID XEO03783 MOACRIVE Inhibition DME1200 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1200 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03784 XEO_CLAS Peptide DME1200 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.45 microM) DME1200 XEOTICID XEO03784 GENEFORM Protein DME1200 XEOTICID XEO03784 MOACRIVE Inhibition DME1200 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1200 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03785 XEO_CLAS Peptide DME1200 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.73 microM) DME1200 XEOTICID XEO03785 GENEFORM Protein DME1200 XEOTICID XEO03785 MOACRIVE Inhibition DME1200 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1200 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03786 XEO_CLAS Peptide DME1200 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.45 microM) DME1200 XEOTICID XEO03786 GENEFORM Protein DME1200 XEOTICID XEO03786 MOACRIVE Inhibition DME1200 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1200 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03787 XEO_CLAS Peptide DME1200 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.38 microM) DME1200 XEOTICID XEO03787 GENEFORM Protein DME1200 XEOTICID XEO03787 MOACRIVE Inhibition DME1200 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1200 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03788 XEO_CLAS Peptide DME1200 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.46 microM) DME1200 XEOTICID XEO03788 GENEFORM Protein DME1200 XEOTICID XEO03788 MOACRIVE Inhibition DME1200 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1200 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03789 XEO_CLAS Peptide DME1200 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 13.05 microM) DME1200 XEOTICID XEO03789 GENEFORM Protein DME1200 XEOTICID XEO03789 MOACRIVE Inhibition DME1200 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1200 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03790 XEO_CLAS Peptide DME1200 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.82 microM) DME1200 XEOTICID XEO03790 GENEFORM Protein DME1200 XEOTICID XEO03790 MOACRIVE Inhibition DME1200 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1200 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03791 XEO_CLAS Peptide DME1200 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.80 microM) DME1200 XEOTICID XEO03791 GENEFORM Protein DME1200 XEOTICID XEO03791 MOACRIVE Inhibition DME1200 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1200 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03792 XEO_CLAS Peptide DME1200 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.26 microM) DME1200 XEOTICID XEO03792 GENEFORM Protein DME1200 XEOTICID XEO03792 MOACRIVE Inhibition DME1200 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1200 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03793 XEO_CLAS Peptide DME1200 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 microM) DME1200 XEOTICID XEO03793 GENEFORM Protein DME1200 XEOTICID XEO03793 MOACRIVE Inhibition DME1200 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1200 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03797 XEO_CLAS Peptide DME1200 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.4 microM) DME1200 XEOTICID XEO03797 GENEFORM Protein DME1200 XEOTICID XEO03797 MOACRIVE Inhibition DME1200 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1200 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03798 XEO_CLAS Peptide DME1200 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03798 GENEFORM Protein DME1200 XEOTICID XEO03798 MOACRIVE Inhibition DME1200 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1200 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03799 XEO_CLAS Peptide DME1200 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03799 GENEFORM Protein DME1200 XEOTICID XEO03799 MOACRIVE Inhibition DME1200 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1200 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03810 XEO_CLAS Peptide DME1200 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03810 GENEFORM Protein DME1200 XEOTICID XEO03810 MOACRIVE Inhibition DME1200 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1200 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03846 XEO_CLAS Peptide DME1200 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03846 GENEFORM Protein DME1200 XEOTICID XEO03846 MOACRIVE Inhibition DME1200 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1200 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03847 XEO_CLAS Peptide DME1200 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03847 GENEFORM Protein DME1200 XEOTICID XEO03847 MOACRIVE Inhibition DME1200 XEOTICID XEO03850 XEO_NAME Lemon DME1200 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1200 XEOTICID XEO03850 XEO_CLAS Food Additive DME1200 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03850 GENEFORM Protein DME1200 XEOTICID XEO03850 MOACRIVE Inhibition DME1200 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1200 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03853 XEO_CLAS Peptide DME1200 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO03853 GENEFORM Protein DME1200 XEOTICID XEO03853 MOACRIVE Inhibition DME1200 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1200 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03857 XEO_CLAS Peptide DME1200 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 38.49 microM) DME1200 XEOTICID XEO03857 GENEFORM Protein DME1200 XEOTICID XEO03857 MOACRIVE Inhibition DME1200 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1200 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03860 XEO_CLAS Peptide DME1200 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 24 microM) DME1200 XEOTICID XEO03860 GENEFORM Protein DME1200 XEOTICID XEO03860 MOACRIVE Inhibition DME1200 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1200 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03861 XEO_CLAS Peptide DME1200 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 35 microM) DME1200 XEOTICID XEO03861 GENEFORM Protein DME1200 XEOTICID XEO03861 MOACRIVE Inhibition DME1200 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1200 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03862 XEO_CLAS Peptide DME1200 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 70 microM) DME1200 XEOTICID XEO03862 GENEFORM Protein DME1200 XEOTICID XEO03862 MOACRIVE Inhibition DME1200 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1200 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03863 XEO_CLAS Peptide DME1200 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 35 microM) DME1200 XEOTICID XEO03863 GENEFORM Protein DME1200 XEOTICID XEO03863 MOACRIVE Inhibition DME1200 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1200 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03864 XEO_CLAS Peptide DME1200 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO03864 GENEFORM Protein DME1200 XEOTICID XEO03864 MOACRIVE Inhibition DME1200 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1200 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03865 XEO_CLAS Peptide DME1200 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO03865 GENEFORM Protein DME1200 XEOTICID XEO03865 MOACRIVE Inhibition DME1200 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1200 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03866 XEO_CLAS Peptide DME1200 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 microM) DME1200 XEOTICID XEO03866 GENEFORM Protein DME1200 XEOTICID XEO03866 MOACRIVE Inhibition DME1200 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1200 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03867 XEO_CLAS Peptide DME1200 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40 microM) DME1200 XEOTICID XEO03867 GENEFORM Protein DME1200 XEOTICID XEO03867 MOACRIVE Inhibition DME1200 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1200 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03868 XEO_CLAS Peptide DME1200 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 51 microM) DME1200 XEOTICID XEO03868 GENEFORM Protein DME1200 XEOTICID XEO03868 MOACRIVE Inhibition DME1200 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1200 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03869 XEO_CLAS Peptide DME1200 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 35 microM) DME1200 XEOTICID XEO03869 GENEFORM Protein DME1200 XEOTICID XEO03869 MOACRIVE Inhibition DME1200 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1200 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03870 XEO_CLAS Peptide DME1200 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 61 microM) DME1200 XEOTICID XEO03870 GENEFORM Protein DME1200 XEOTICID XEO03870 MOACRIVE Inhibition DME1200 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1200 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03871 XEO_CLAS Peptide DME1200 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 microM) DME1200 XEOTICID XEO03871 GENEFORM Protein DME1200 XEOTICID XEO03871 MOACRIVE Inhibition DME1200 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1200 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03872 XEO_CLAS Peptide DME1200 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 28 microM) DME1200 XEOTICID XEO03872 GENEFORM Protein DME1200 XEOTICID XEO03872 MOACRIVE Inhibition DME1200 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1200 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03873 XEO_CLAS Peptide DME1200 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 22.5 microM) DME1200 XEOTICID XEO03873 GENEFORM Protein DME1200 XEOTICID XEO03873 MOACRIVE Inhibition DME1200 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1200 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03874 XEO_CLAS Peptide DME1200 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 11.25 microM) DME1200 XEOTICID XEO03874 GENEFORM Protein DME1200 XEOTICID XEO03874 MOACRIVE Inhibition DME1200 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1200 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03875 XEO_CLAS Peptide DME1200 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 microM) DME1200 XEOTICID XEO03875 GENEFORM Protein DME1200 XEOTICID XEO03875 MOACRIVE Inhibition DME1200 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1200 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03876 XEO_CLAS Peptide DME1200 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.75 microM) DME1200 XEOTICID XEO03876 GENEFORM Protein DME1200 XEOTICID XEO03876 MOACRIVE Inhibition DME1200 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1200 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03877 XEO_CLAS Peptide DME1200 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 microM) DME1200 XEOTICID XEO03877 GENEFORM Protein DME1200 XEOTICID XEO03877 MOACRIVE Inhibition DME1200 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1200 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03878 XEO_CLAS Peptide DME1200 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 microM) DME1200 XEOTICID XEO03878 GENEFORM Protein DME1200 XEOTICID XEO03878 MOACRIVE Inhibition DME1200 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1200 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03879 XEO_CLAS Peptide DME1200 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 252 microM) DME1200 XEOTICID XEO03879 GENEFORM Protein DME1200 XEOTICID XEO03879 MOACRIVE Inhibition DME1200 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1200 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03880 XEO_CLAS Peptide DME1200 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 174 microM) DME1200 XEOTICID XEO03880 GENEFORM Protein DME1200 XEOTICID XEO03880 MOACRIVE Inhibition DME1200 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1200 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03883 XEO_CLAS Peptide DME1200 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 74 microM) DME1200 XEOTICID XEO03883 GENEFORM Protein DME1200 XEOTICID XEO03883 MOACRIVE Inhibition DME1200 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1200 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03884 XEO_CLAS Peptide DME1200 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 31 microM) DME1200 XEOTICID XEO03884 GENEFORM Protein DME1200 XEOTICID XEO03884 MOACRIVE Inhibition DME1200 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1200 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03885 XEO_CLAS Peptide DME1200 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO03885 GENEFORM Protein DME1200 XEOTICID XEO03885 MOACRIVE Inhibition DME1200 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1200 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03886 XEO_CLAS Peptide DME1200 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 391 microM) DME1200 XEOTICID XEO03886 GENEFORM Protein DME1200 XEOTICID XEO03886 MOACRIVE Inhibition DME1200 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1200 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03887 XEO_CLAS Peptide DME1200 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 151 microM) DME1200 XEOTICID XEO03887 GENEFORM Protein DME1200 XEOTICID XEO03887 MOACRIVE Inhibition DME1200 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1200 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03888 XEO_CLAS Peptide DME1200 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 134 microM) DME1200 XEOTICID XEO03888 GENEFORM Protein DME1200 XEOTICID XEO03888 MOACRIVE Inhibition DME1200 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1200 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03889 XEO_CLAS Peptide DME1200 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 88 microM) DME1200 XEOTICID XEO03889 GENEFORM Protein DME1200 XEOTICID XEO03889 MOACRIVE Inhibition DME1200 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1200 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03890 XEO_CLAS Peptide DME1200 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 31 microM) DME1200 XEOTICID XEO03890 GENEFORM Protein DME1200 XEOTICID XEO03890 MOACRIVE Inhibition DME1200 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1200 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03891 XEO_CLAS Peptide DME1200 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 microM) DME1200 XEOTICID XEO03891 GENEFORM Protein DME1200 XEOTICID XEO03891 MOACRIVE Inhibition DME1200 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1200 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03892 XEO_CLAS Peptide DME1200 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 37 microM) DME1200 XEOTICID XEO03892 GENEFORM Protein DME1200 XEOTICID XEO03892 MOACRIVE Inhibition DME1200 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1200 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03893 XEO_CLAS Peptide DME1200 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 19 microM) DME1200 XEOTICID XEO03893 GENEFORM Protein DME1200 XEOTICID XEO03893 MOACRIVE Inhibition DME1200 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1200 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03894 XEO_CLAS Peptide DME1200 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO03894 GENEFORM Protein DME1200 XEOTICID XEO03894 MOACRIVE Inhibition DME1200 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1200 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03895 XEO_CLAS Peptide DME1200 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO03895 GENEFORM Protein DME1200 XEOTICID XEO03895 MOACRIVE Inhibition DME1200 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1200 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03896 XEO_CLAS Peptide DME1200 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 microM) DME1200 XEOTICID XEO03896 GENEFORM Protein DME1200 XEOTICID XEO03896 MOACRIVE Inhibition DME1200 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1200 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03897 XEO_CLAS Peptide DME1200 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 63 microM) DME1200 XEOTICID XEO03897 GENEFORM Protein DME1200 XEOTICID XEO03897 MOACRIVE Inhibition DME1200 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1200 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03898 XEO_CLAS Peptide DME1200 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 219 microM) DME1200 XEOTICID XEO03898 GENEFORM Protein DME1200 XEOTICID XEO03898 MOACRIVE Inhibition DME1200 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1200 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03901 XEO_CLAS Peptide DME1200 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 35 microM) DME1200 XEOTICID XEO03901 GENEFORM Protein DME1200 XEOTICID XEO03901 MOACRIVE Inhibition DME1200 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1200 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03902 XEO_CLAS Peptide DME1200 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 70 microM) DME1200 XEOTICID XEO03902 GENEFORM Protein DME1200 XEOTICID XEO03902 MOACRIVE Inhibition DME1200 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1200 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03904 XEO_CLAS Peptide DME1200 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO03904 GENEFORM Protein DME1200 XEOTICID XEO03904 MOACRIVE Inhibition DME1200 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1200 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03905 XEO_CLAS Peptide DME1200 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO03905 GENEFORM Protein DME1200 XEOTICID XEO03905 MOACRIVE Inhibition DME1200 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1200 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03908 XEO_CLAS Peptide DME1200 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03908 GENEFORM Protein DME1200 XEOTICID XEO03908 MOACRIVE Inhibition DME1200 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1200 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03915 XEO_CLAS Peptide DME1200 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03915 GENEFORM Protein DME1200 XEOTICID XEO03915 MOACRIVE Inhibition DME1200 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1200 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03916 XEO_CLAS Peptide DME1200 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.8 ug/ml) DME1200 XEOTICID XEO03916 GENEFORM Protein DME1200 XEOTICID XEO03916 MOACRIVE Inhibition DME1200 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1200 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03917 XEO_CLAS Peptide DME1200 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 13.1 ug/ml) DME1200 XEOTICID XEO03917 GENEFORM Protein DME1200 XEOTICID XEO03917 MOACRIVE Inhibition DME1200 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1200 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03918 XEO_CLAS Peptide DME1200 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.5 ug/ml) DME1200 XEOTICID XEO03918 GENEFORM Protein DME1200 XEOTICID XEO03918 MOACRIVE Inhibition DME1200 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1200 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03919 XEO_CLAS Peptide DME1200 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 80 ug/ml) DME1200 XEOTICID XEO03919 GENEFORM Protein DME1200 XEOTICID XEO03919 MOACRIVE Inhibition DME1200 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1200 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03922 XEO_CLAS Peptide DME1200 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 9 microM) DME1200 XEOTICID XEO03922 GENEFORM Protein DME1200 XEOTICID XEO03922 MOACRIVE Inhibition DME1200 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1200 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03923 XEO_CLAS Peptide DME1200 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 80 microM) DME1200 XEOTICID XEO03923 GENEFORM Protein DME1200 XEOTICID XEO03923 MOACRIVE Inhibition DME1200 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1200 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03924 XEO_CLAS Peptide DME1200 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO03924 GENEFORM Protein DME1200 XEOTICID XEO03924 MOACRIVE Inhibition DME1200 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1200 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03927 XEO_CLAS Peptide DME1200 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 80 microM) DME1200 XEOTICID XEO03927 GENEFORM Protein DME1200 XEOTICID XEO03927 MOACRIVE Inhibition DME1200 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1200 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03928 XEO_CLAS Peptide DME1200 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 microM) DME1200 XEOTICID XEO03928 GENEFORM Protein DME1200 XEOTICID XEO03928 MOACRIVE Inhibition DME1200 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1200 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03929 XEO_CLAS Peptide DME1200 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 microM) DME1200 XEOTICID XEO03929 GENEFORM Protein DME1200 XEOTICID XEO03929 MOACRIVE Inhibition DME1200 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1200 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03930 XEO_CLAS Peptide DME1200 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 microM) DME1200 XEOTICID XEO03930 GENEFORM Protein DME1200 XEOTICID XEO03930 MOACRIVE Inhibition DME1200 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1200 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03931 XEO_CLAS Peptide DME1200 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 microM) DME1200 XEOTICID XEO03931 GENEFORM Protein DME1200 XEOTICID XEO03931 MOACRIVE Inhibition DME1200 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1200 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03933 XEO_CLAS Peptide DME1200 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.5 microM) DME1200 XEOTICID XEO03933 GENEFORM Protein DME1200 XEOTICID XEO03933 MOACRIVE Inhibition DME1200 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1200 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03934 XEO_CLAS Peptide DME1200 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.7 microM) DME1200 XEOTICID XEO03934 GENEFORM Protein DME1200 XEOTICID XEO03934 MOACRIVE Inhibition DME1200 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1200 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03935 XEO_CLAS Peptide DME1200 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.7 microM) DME1200 XEOTICID XEO03935 GENEFORM Protein DME1200 XEOTICID XEO03935 MOACRIVE Inhibition DME1200 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1200 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03936 XEO_CLAS Peptide DME1200 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.0 microM) DME1200 XEOTICID XEO03936 GENEFORM Protein DME1200 XEOTICID XEO03936 MOACRIVE Inhibition DME1200 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1200 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03937 XEO_CLAS Peptide DME1200 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.1 microM) DME1200 XEOTICID XEO03937 GENEFORM Protein DME1200 XEOTICID XEO03937 MOACRIVE Inhibition DME1200 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1200 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03938 XEO_CLAS Peptide DME1200 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.7 microM) DME1200 XEOTICID XEO03938 GENEFORM Protein DME1200 XEOTICID XEO03938 MOACRIVE Inhibition DME1200 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1200 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03939 XEO_CLAS Peptide DME1200 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.7 microM) DME1200 XEOTICID XEO03939 GENEFORM Protein DME1200 XEOTICID XEO03939 MOACRIVE Inhibition DME1200 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1200 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03940 XEO_CLAS Peptide DME1200 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.5 microM) DME1200 XEOTICID XEO03940 GENEFORM Protein DME1200 XEOTICID XEO03940 MOACRIVE Inhibition DME1200 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1200 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03941 XEO_CLAS Peptide DME1200 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.4 microM) DME1200 XEOTICID XEO03941 GENEFORM Protein DME1200 XEOTICID XEO03941 MOACRIVE Inhibition DME1200 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1200 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03943 XEO_CLAS Peptide DME1200 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.4 microM) DME1200 XEOTICID XEO03943 GENEFORM Protein DME1200 XEOTICID XEO03943 MOACRIVE Inhibition DME1200 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1200 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03944 XEO_CLAS Peptide DME1200 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.7 microM) DME1200 XEOTICID XEO03944 GENEFORM Protein DME1200 XEOTICID XEO03944 MOACRIVE Inhibition DME1200 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1200 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03945 XEO_CLAS Peptide DME1200 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.2 microM) DME1200 XEOTICID XEO03945 GENEFORM Protein DME1200 XEOTICID XEO03945 MOACRIVE Inhibition DME1200 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1200 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03947 XEO_CLAS Peptide DME1200 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.0 microM) DME1200 XEOTICID XEO03947 GENEFORM Protein DME1200 XEOTICID XEO03947 MOACRIVE Inhibition DME1200 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1200 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03948 XEO_CLAS Peptide DME1200 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 23.3 microM) DME1200 XEOTICID XEO03948 GENEFORM Protein DME1200 XEOTICID XEO03948 MOACRIVE Inhibition DME1200 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1200 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03950 XEO_CLAS Peptide DME1200 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4.4 microM) DME1200 XEOTICID XEO03950 GENEFORM Protein DME1200 XEOTICID XEO03950 MOACRIVE Inhibition DME1200 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1200 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03951 XEO_CLAS Peptide DME1200 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8.8 microM) DME1200 XEOTICID XEO03951 GENEFORM Protein DME1200 XEOTICID XEO03951 MOACRIVE Inhibition DME1200 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1200 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03952 XEO_CLAS Peptide DME1200 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.2 microM) DME1200 XEOTICID XEO03952 GENEFORM Protein DME1200 XEOTICID XEO03952 MOACRIVE Inhibition DME1200 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1200 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03953 XEO_CLAS Peptide DME1200 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 microM) DME1200 XEOTICID XEO03953 GENEFORM Protein DME1200 XEOTICID XEO03953 MOACRIVE Inhibition DME1200 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1200 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03958 XEO_CLAS Peptide DME1200 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03958 GENEFORM Protein DME1200 XEOTICID XEO03958 MOACRIVE Inhibition DME1200 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1200 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03965 XEO_CLAS Peptide DME1200 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 128 microM) DME1200 XEOTICID XEO03965 GENEFORM Protein DME1200 XEOTICID XEO03965 MOACRIVE Inhibition DME1200 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1200 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03966 XEO_CLAS Peptide DME1200 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 microM) DME1200 XEOTICID XEO03966 GENEFORM Protein DME1200 XEOTICID XEO03966 MOACRIVE Inhibition DME1200 XEOTICID XEO03971 XEO_NAME Lumbrican DME1200 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03971 XEO_CLAS Peptide DME1200 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03971 GENEFORM Protein DME1200 XEOTICID XEO03971 MOACRIVE Inhibition DME1200 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1200 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03972 XEO_CLAS Peptide DME1200 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO03972 GENEFORM Protein DME1200 XEOTICID XEO03972 MOACRIVE Inhibition DME1200 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1200 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03980 XEO_CLAS Peptide DME1200 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 32 microM) DME1200 XEOTICID XEO03980 GENEFORM Protein DME1200 XEOTICID XEO03980 MOACRIVE Inhibition DME1200 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1200 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03985 XEO_CLAS Peptide DME1200 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 ug/ml) DME1200 XEOTICID XEO03985 GENEFORM Protein DME1200 XEOTICID XEO03985 MOACRIVE Inhibition DME1200 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1200 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03991 XEO_CLAS Peptide DME1200 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03991 GENEFORM Protein DME1200 XEOTICID XEO03991 MOACRIVE Inhibition DME1200 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1200 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03992 XEO_CLAS Peptide DME1200 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03992 GENEFORM Protein DME1200 XEOTICID XEO03992 MOACRIVE Inhibition DME1200 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1200 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03993 XEO_CLAS Peptide DME1200 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03993 GENEFORM Protein DME1200 XEOTICID XEO03993 MOACRIVE Inhibition DME1200 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1200 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03994 XEO_CLAS Peptide DME1200 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO03994 GENEFORM Protein DME1200 XEOTICID XEO03994 MOACRIVE Inhibition DME1200 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1200 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03996 XEO_CLAS Peptide DME1200 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 65 microM) DME1200 XEOTICID XEO03996 GENEFORM Protein DME1200 XEOTICID XEO03996 MOACRIVE Inhibition DME1200 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1200 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03997 XEO_CLAS Peptide DME1200 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 7.5 microM) DME1200 XEOTICID XEO03997 GENEFORM Protein DME1200 XEOTICID XEO03997 MOACRIVE Inhibition DME1200 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1200 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03998 XEO_CLAS Peptide DME1200 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15.5 microM) DME1200 XEOTICID XEO03998 GENEFORM Protein DME1200 XEOTICID XEO03998 MOACRIVE Inhibition DME1200 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1200 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO03999 XEO_CLAS Peptide DME1200 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25.8 microM) DME1200 XEOTICID XEO03999 GENEFORM Protein DME1200 XEOTICID XEO03999 MOACRIVE Inhibition DME1200 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1200 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04000 XEO_CLAS Peptide DME1200 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO04000 GENEFORM Protein DME1200 XEOTICID XEO04000 MOACRIVE Inhibition DME1200 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1200 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04001 XEO_CLAS Peptide DME1200 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO04001 GENEFORM Protein DME1200 XEOTICID XEO04001 MOACRIVE Inhibition DME1200 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1200 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04002 XEO_CLAS Peptide DME1200 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 7.5 ug/ml) DME1200 XEOTICID XEO04002 GENEFORM Protein DME1200 XEOTICID XEO04002 MOACRIVE Inhibition DME1200 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1200 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04003 XEO_CLAS Peptide DME1200 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 ug/ml) DME1200 XEOTICID XEO04003 GENEFORM Protein DME1200 XEOTICID XEO04003 MOACRIVE Inhibition DME1200 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1200 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04004 XEO_CLAS Peptide DME1200 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.0 ug/ml) DME1200 XEOTICID XEO04004 GENEFORM Protein DME1200 XEOTICID XEO04004 MOACRIVE Inhibition DME1200 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1200 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04005 XEO_CLAS Peptide DME1200 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.0 ug/ml) DME1200 XEOTICID XEO04005 GENEFORM Protein DME1200 XEOTICID XEO04005 MOACRIVE Inhibition DME1200 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1200 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04007 XEO_CLAS Peptide DME1200 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 19.5 ug/ml) DME1200 XEOTICID XEO04007 GENEFORM Protein DME1200 XEOTICID XEO04007 MOACRIVE Inhibition DME1200 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1200 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04011 XEO_CLAS Peptide DME1200 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 19.5 ug/ml) DME1200 XEOTICID XEO04011 GENEFORM Protein DME1200 XEOTICID XEO04011 MOACRIVE Inhibition DME1200 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1200 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04012 XEO_CLAS Peptide DME1200 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.9 ug/ml) DME1200 XEOTICID XEO04012 GENEFORM Protein DME1200 XEOTICID XEO04012 MOACRIVE Inhibition DME1200 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1200 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04013 XEO_CLAS Peptide DME1200 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.7 ug/ml) DME1200 XEOTICID XEO04013 GENEFORM Protein DME1200 XEOTICID XEO04013 MOACRIVE Inhibition DME1200 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1200 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04018 XEO_CLAS Peptide DME1200 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 9 ug/ml) DME1200 XEOTICID XEO04018 GENEFORM Protein DME1200 XEOTICID XEO04018 MOACRIVE Inhibition DME1200 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1200 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04026 XEO_CLAS Peptide DME1200 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO04026 GENEFORM Protein DME1200 XEOTICID XEO04026 MOACRIVE Inhibition DME1200 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1200 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04027 XEO_CLAS Peptide DME1200 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO04027 GENEFORM Protein DME1200 XEOTICID XEO04027 MOACRIVE Inhibition DME1200 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1200 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04028 XEO_CLAS Peptide DME1200 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 ug/ml) DME1200 XEOTICID XEO04028 GENEFORM Protein DME1200 XEOTICID XEO04028 MOACRIVE Inhibition DME1200 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1200 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04038 XEO_CLAS Peptide DME1200 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04038 GENEFORM Protein DME1200 XEOTICID XEO04038 MOACRIVE Inhibition DME1200 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1200 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04039 XEO_CLAS Peptide DME1200 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 microM) DME1200 XEOTICID XEO04039 GENEFORM Protein DME1200 XEOTICID XEO04039 MOACRIVE Inhibition DME1200 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1200 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04051 XEO_CLAS Peptide DME1200 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1200 XEOTICID XEO04051 GENEFORM Protein DME1200 XEOTICID XEO04051 MOACRIVE Inhibition DME1200 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1200 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04052 XEO_CLAS Peptide DME1200 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04052 GENEFORM Protein DME1200 XEOTICID XEO04052 MOACRIVE Inhibition DME1200 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1200 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04053 XEO_CLAS Peptide DME1200 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.08-0.16 microM) DME1200 XEOTICID XEO04053 GENEFORM Protein DME1200 XEOTICID XEO04053 MOACRIVE Inhibition DME1200 XEOTICID XEO04055 XEO_NAME Melectin DME1200 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04055 XEO_CLAS Peptide DME1200 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.0 microM) DME1200 XEOTICID XEO04055 GENEFORM Protein DME1200 XEOTICID XEO04055 MOACRIVE Inhibition DME1200 XEOTICID XEO04057 XEO_NAME Melittin DME1200 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04057 XEO_CLAS Peptide DME1200 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.8 microM) DME1200 XEOTICID XEO04057 GENEFORM Protein DME1200 XEOTICID XEO04057 MOACRIVE Inhibition DME1200 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1200 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04061 XEO_CLAS Peptide DME1200 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.9 microM) DME1200 XEOTICID XEO04061 GENEFORM Protein DME1200 XEOTICID XEO04061 MOACRIVE Inhibition DME1200 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1200 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04062 XEO_CLAS Peptide DME1200 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.5 microM) DME1200 XEOTICID XEO04062 GENEFORM Protein DME1200 XEOTICID XEO04062 MOACRIVE Inhibition DME1200 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1200 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04063 XEO_CLAS Peptide DME1200 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 7.8 microM) DME1200 XEOTICID XEO04063 GENEFORM Protein DME1200 XEOTICID XEO04063 MOACRIVE Inhibition DME1200 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1200 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04064 XEO_CLAS Peptide DME1200 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 46.7 microM) DME1200 XEOTICID XEO04064 GENEFORM Protein DME1200 XEOTICID XEO04064 MOACRIVE Inhibition DME1200 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1200 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04066 XEO_CLAS Peptide DME1200 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16.3 microM) DME1200 XEOTICID XEO04066 GENEFORM Protein DME1200 XEOTICID XEO04066 MOACRIVE Inhibition DME1200 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1200 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04067 XEO_CLAS Peptide DME1200 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.6 microM) DME1200 XEOTICID XEO04067 GENEFORM Protein DME1200 XEOTICID XEO04067 MOACRIVE Inhibition DME1200 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1200 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04068 XEO_CLAS Peptide DME1200 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.6 microM) DME1200 XEOTICID XEO04068 GENEFORM Protein DME1200 XEOTICID XEO04068 MOACRIVE Inhibition DME1200 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1200 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04086 GENEFORM Protein DME1200 XEOTICID XEO04086 MOACRIVE Inhibition DME1200 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1200 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04087 GENEFORM Protein DME1200 XEOTICID XEO04087 MOACRIVE Inhibition DME1200 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1200 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04089 GENEFORM Protein DME1200 XEOTICID XEO04089 MOACRIVE Inhibition DME1200 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1200 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04094 GENEFORM Protein DME1200 XEOTICID XEO04094 MOACRIVE Inhibition DME1200 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1200 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04096 GENEFORM Protein DME1200 XEOTICID XEO04096 MOACRIVE Inhibition DME1200 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1200 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04098 GENEFORM Protein DME1200 XEOTICID XEO04098 MOACRIVE Inhibition DME1200 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1200 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04111 XEO_CLAS Peptide DME1200 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04111 GENEFORM Protein DME1200 XEOTICID XEO04111 MOACRIVE Inhibition DME1200 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1200 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04112 XEO_CLAS Peptide DME1200 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.02 microM) DME1200 XEOTICID XEO04112 GENEFORM Protein DME1200 XEOTICID XEO04112 MOACRIVE Inhibition DME1200 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1200 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04113 XEO_CLAS Peptide DME1200 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.02 ug/ml) DME1200 XEOTICID XEO04113 GENEFORM Protein DME1200 XEOTICID XEO04113 MOACRIVE Inhibition DME1200 XEOTICID XEO04114 XEO_NAME Microcin L DME1200 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04114 XEO_CLAS Peptide DME1200 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04114 GENEFORM Protein DME1200 XEOTICID XEO04114 MOACRIVE Inhibition DME1200 XEOTICID XEO04117 XEO_NAME Misgurin DME1200 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04117 XEO_CLAS Peptide DME1200 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04117 GENEFORM Protein DME1200 XEOTICID XEO04117 MOACRIVE Inhibition DME1200 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1200 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04118 XEO_CLAS Peptide DME1200 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 300 microM) DME1200 XEOTICID XEO04118 GENEFORM Protein DME1200 XEOTICID XEO04118 MOACRIVE Inhibition DME1200 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1200 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04119 XEO_CLAS Peptide DME1200 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-20 microM) DME1200 XEOTICID XEO04119 GENEFORM Protein DME1200 XEOTICID XEO04119 MOACRIVE Inhibition DME1200 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1200 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04120 XEO_CLAS Peptide DME1200 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC < 10 microM) DME1200 XEOTICID XEO04120 GENEFORM Protein DME1200 XEOTICID XEO04120 MOACRIVE Inhibition DME1200 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1200 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04121 XEO_CLAS Peptide DME1200 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.2-6.4 microM) DME1200 XEOTICID XEO04121 GENEFORM Protein DME1200 XEOTICID XEO04121 MOACRIVE Inhibition DME1200 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1200 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04122 XEO_CLAS Peptide DME1200 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.14-6.29 microM) DME1200 XEOTICID XEO04122 GENEFORM Protein DME1200 XEOTICID XEO04122 MOACRIVE Inhibition DME1200 XEOTICID XEO04123 XEO_NAME Modified defensin DME1200 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04123 XEO_CLAS Peptide DME1200 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO04123 GENEFORM Protein DME1200 XEOTICID XEO04123 MOACRIVE Inhibition DME1200 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1200 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04128 XEO_CLAS Peptide DME1200 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.31 microM) DME1200 XEOTICID XEO04128 GENEFORM Protein DME1200 XEOTICID XEO04128 MOACRIVE Inhibition DME1200 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1200 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04129 XEO_CLAS Peptide DME1200 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO04129 GENEFORM Protein DME1200 XEOTICID XEO04129 MOACRIVE Inhibition DME1200 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1200 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04130 XEO_CLAS Peptide DME1200 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO04130 GENEFORM Protein DME1200 XEOTICID XEO04130 MOACRIVE Inhibition DME1200 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1200 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04131 XEO_CLAS Peptide DME1200 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 microM) DME1200 XEOTICID XEO04131 GENEFORM Protein DME1200 XEOTICID XEO04131 MOACRIVE Inhibition DME1200 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1200 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04132 XEO_CLAS Peptide DME1200 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 microM) DME1200 XEOTICID XEO04132 GENEFORM Protein DME1200 XEOTICID XEO04132 MOACRIVE Inhibition DME1200 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1200 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04133 XEO_CLAS Peptide DME1200 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO04133 GENEFORM Protein DME1200 XEOTICID XEO04133 MOACRIVE Inhibition DME1200 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1200 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04134 XEO_CLAS Peptide DME1200 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO04134 GENEFORM Protein DME1200 XEOTICID XEO04134 MOACRIVE Inhibition DME1200 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1200 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04135 XEO_CLAS Peptide DME1200 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 microM) DME1200 XEOTICID XEO04135 GENEFORM Protein DME1200 XEOTICID XEO04135 MOACRIVE Inhibition DME1200 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1200 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04137 XEO_CLAS Peptide DME1200 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.6 microM) DME1200 XEOTICID XEO04137 GENEFORM Protein DME1200 XEOTICID XEO04137 MOACRIVE Inhibition DME1200 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1200 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04138 XEO_CLAS Peptide DME1200 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 microM) DME1200 XEOTICID XEO04138 GENEFORM Protein DME1200 XEOTICID XEO04138 MOACRIVE Inhibition DME1200 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1200 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04139 XEO_CLAS Peptide DME1200 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 microM) DME1200 XEOTICID XEO04139 GENEFORM Protein DME1200 XEOTICID XEO04139 MOACRIVE Inhibition DME1200 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1200 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04140 XEO_CLAS Peptide DME1200 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 70 microM) DME1200 XEOTICID XEO04140 GENEFORM Protein DME1200 XEOTICID XEO04140 MOACRIVE Inhibition DME1200 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1200 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04141 XEO_CLAS Peptide DME1200 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 microM) DME1200 XEOTICID XEO04141 GENEFORM Protein DME1200 XEOTICID XEO04141 MOACRIVE Inhibition DME1200 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1200 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04142 XEO_CLAS Peptide DME1200 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8-16 microM) DME1200 XEOTICID XEO04142 GENEFORM Protein DME1200 XEOTICID XEO04142 MOACRIVE Inhibition DME1200 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1200 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04146 XEO_CLAS Peptide DME1200 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04146 GENEFORM Protein DME1200 XEOTICID XEO04146 MOACRIVE Inhibition DME1200 XEOTICID XEO04149 XEO_NAME Mucroporin DME1200 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04149 XEO_CLAS Peptide DME1200 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 ug/ml) DME1200 XEOTICID XEO04149 GENEFORM Protein DME1200 XEOTICID XEO04149 MOACRIVE Inhibition DME1200 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1200 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04158 XEO_CLAS Peptide DME1200 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO04158 GENEFORM Protein DME1200 XEOTICID XEO04158 MOACRIVE Inhibition DME1200 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1200 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04159 XEO_CLAS Peptide DME1200 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 microM) DME1200 XEOTICID XEO04159 GENEFORM Protein DME1200 XEOTICID XEO04159 MOACRIVE Inhibition DME1200 XEOTICID XEO04167 XEO_NAME Myticin-B DME1200 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04167 XEO_CLAS Peptide DME1200 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04167 GENEFORM Protein DME1200 XEOTICID XEO04167 MOACRIVE Inhibition DME1200 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1200 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04168 XEO_CLAS Peptide DME1200 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.7-12.5 microM) DME1200 XEOTICID XEO04168 GENEFORM Protein DME1200 XEOTICID XEO04168 MOACRIVE Inhibition DME1200 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1200 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04169 XEO_CLAS Peptide DME1200 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04169 GENEFORM Protein DME1200 XEOTICID XEO04169 MOACRIVE Inhibition DME1200 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1200 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04170 XEO_CLAS Peptide DME1200 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04170 GENEFORM Protein DME1200 XEOTICID XEO04170 MOACRIVE Inhibition DME1200 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1200 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04171 XEO_CLAS Peptide DME1200 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04171 GENEFORM Protein DME1200 XEOTICID XEO04171 MOACRIVE Inhibition DME1200 XEOTICID XEO04172 XEO_NAME Myxinidin DME1200 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04172 XEO_CLAS Peptide DME1200 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04172 GENEFORM Protein DME1200 XEOTICID XEO04172 MOACRIVE Inhibition DME1200 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1200 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04177 XEO_CLAS Peptide DME1200 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.7 microM) DME1200 XEOTICID XEO04177 GENEFORM Protein DME1200 XEOTICID XEO04177 MOACRIVE Inhibition DME1200 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1200 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04178 XEO_CLAS Peptide DME1200 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.7 microM) DME1200 XEOTICID XEO04178 GENEFORM Protein DME1200 XEOTICID XEO04178 MOACRIVE Inhibition DME1200 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1200 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04179 XEO_CLAS Peptide DME1200 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.5 microM) DME1200 XEOTICID XEO04179 GENEFORM Protein DME1200 XEOTICID XEO04179 MOACRIVE Inhibition DME1200 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1200 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04180 XEO_CLAS Peptide DME1200 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 23 microM) DME1200 XEOTICID XEO04180 GENEFORM Protein DME1200 XEOTICID XEO04180 MOACRIVE Inhibition DME1200 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1200 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04181 XEO_CLAS Peptide DME1200 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.2 microM) DME1200 XEOTICID XEO04181 GENEFORM Protein DME1200 XEOTICID XEO04181 MOACRIVE Inhibition DME1200 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1200 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04182 XEO_CLAS Peptide DME1200 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4.4 microM) DME1200 XEOTICID XEO04182 GENEFORM Protein DME1200 XEOTICID XEO04182 MOACRIVE Inhibition DME1200 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1200 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04183 XEO_CLAS Peptide DME1200 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.6 microM) DME1200 XEOTICID XEO04183 GENEFORM Protein DME1200 XEOTICID XEO04183 MOACRIVE Inhibition DME1200 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1200 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04184 XEO_CLAS Peptide DME1200 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 microM) DME1200 XEOTICID XEO04184 GENEFORM Protein DME1200 XEOTICID XEO04184 MOACRIVE Inhibition DME1200 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1200 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04185 XEO_CLAS Peptide DME1200 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04185 GENEFORM Protein DME1200 XEOTICID XEO04185 MOACRIVE Inhibition DME1200 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1200 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04186 XEO_CLAS Peptide DME1200 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04186 GENEFORM Protein DME1200 XEOTICID XEO04186 MOACRIVE Inhibition DME1200 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1200 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04187 XEO_CLAS Peptide DME1200 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04187 GENEFORM Protein DME1200 XEOTICID XEO04187 MOACRIVE Inhibition DME1200 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1200 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04188 XEO_CLAS Peptide DME1200 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04188 GENEFORM Protein DME1200 XEOTICID XEO04188 MOACRIVE Inhibition DME1200 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1200 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04206 XEO_CLAS Peptide DME1200 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25 microM) DME1200 XEOTICID XEO04206 GENEFORM Protein DME1200 XEOTICID XEO04206 MOACRIVE Inhibition DME1200 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1200 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04214 XEO_CLAS Peptide DME1200 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25 microM) DME1200 XEOTICID XEO04214 GENEFORM Protein DME1200 XEOTICID XEO04214 MOACRIVE Inhibition DME1200 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1200 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04216 XEO_CLAS Peptide DME1200 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO04216 GENEFORM Protein DME1200 XEOTICID XEO04216 MOACRIVE Inhibition DME1200 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1200 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04218 XEO_CLAS Peptide DME1200 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.125 microM) DME1200 XEOTICID XEO04218 GENEFORM Protein DME1200 XEOTICID XEO04218 MOACRIVE Inhibition DME1200 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1200 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04219 XEO_CLAS Peptide DME1200 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO04219 GENEFORM Protein DME1200 XEOTICID XEO04219 MOACRIVE Inhibition DME1200 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1200 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04220 XEO_CLAS Peptide DME1200 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.125 microM) DME1200 XEOTICID XEO04220 GENEFORM Protein DME1200 XEOTICID XEO04220 MOACRIVE Inhibition DME1200 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1200 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04221 XEO_CLAS Peptide DME1200 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO04221 GENEFORM Protein DME1200 XEOTICID XEO04221 MOACRIVE Inhibition DME1200 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1200 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04222 XEO_CLAS Peptide DME1200 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25 microM) DME1200 XEOTICID XEO04222 GENEFORM Protein DME1200 XEOTICID XEO04222 MOACRIVE Inhibition DME1200 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1200 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04233 XEO_CLAS Peptide DME1200 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04233 GENEFORM Protein DME1200 XEOTICID XEO04233 MOACRIVE Inhibition DME1200 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1200 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04234 XEO_CLAS Peptide DME1200 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04234 GENEFORM Protein DME1200 XEOTICID XEO04234 MOACRIVE Inhibition DME1200 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1200 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04241 XEO_CLAS Peptide DME1200 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04241 GENEFORM Protein DME1200 XEOTICID XEO04241 MOACRIVE Inhibition DME1200 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1200 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04242 XEO_CLAS Peptide DME1200 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04242 GENEFORM Protein DME1200 XEOTICID XEO04242 MOACRIVE Inhibition DME1200 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1200 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04245 XEO_CLAS Natural Product DME1200 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04245 GENEFORM Protein DME1200 XEOTICID XEO04245 MOACRIVE Inhibition DME1200 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1200 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04246 XEO_CLAS Natural Product DME1200 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04246 GENEFORM Protein DME1200 XEOTICID XEO04246 MOACRIVE Inhibition DME1200 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1200 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04249 XEO_CLAS Peptide DME1200 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 500 ug/ml) DME1200 XEOTICID XEO04249 GENEFORM Protein DME1200 XEOTICID XEO04249 MOACRIVE Inhibition DME1200 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1200 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04251 XEO_CLAS Peptide DME1200 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04251 GENEFORM Protein DME1200 XEOTICID XEO04251 MOACRIVE Inhibition DME1200 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1200 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04253 XEO_CLAS Peptide DME1200 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04253 GENEFORM Protein DME1200 XEOTICID XEO04253 MOACRIVE Inhibition DME1200 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1200 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04254 XEO_CLAS Peptide DME1200 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04254 GENEFORM Protein DME1200 XEOTICID XEO04254 MOACRIVE Inhibition DME1200 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1200 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04255 XEO_CLAS Peptide DME1200 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04255 GENEFORM Protein DME1200 XEOTICID XEO04255 MOACRIVE Inhibition DME1200 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1200 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04256 XEO_CLAS Peptide DME1200 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04256 GENEFORM Protein DME1200 XEOTICID XEO04256 MOACRIVE Inhibition DME1200 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1200 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04257 XEO_CLAS Peptide DME1200 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04257 GENEFORM Protein DME1200 XEOTICID XEO04257 MOACRIVE Inhibition DME1200 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1200 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04258 XEO_CLAS Peptide DME1200 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04258 GENEFORM Protein DME1200 XEOTICID XEO04258 MOACRIVE Inhibition DME1200 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1200 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04259 XEO_CLAS Peptide DME1200 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04259 GENEFORM Protein DME1200 XEOTICID XEO04259 MOACRIVE Inhibition DME1200 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1200 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04260 XEO_CLAS Peptide DME1200 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04260 GENEFORM Protein DME1200 XEOTICID XEO04260 MOACRIVE Inhibition DME1200 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1200 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04261 XEO_CLAS Peptide DME1200 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04261 GENEFORM Protein DME1200 XEOTICID XEO04261 MOACRIVE Inhibition DME1200 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1200 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04262 XEO_CLAS Peptide DME1200 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04262 GENEFORM Protein DME1200 XEOTICID XEO04262 MOACRIVE Inhibition DME1200 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1200 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04263 XEO_CLAS Peptide DME1200 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04263 GENEFORM Protein DME1200 XEOTICID XEO04263 MOACRIVE Inhibition DME1200 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1200 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04264 XEO_CLAS Peptide DME1200 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04264 GENEFORM Protein DME1200 XEOTICID XEO04264 MOACRIVE Inhibition DME1200 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1200 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04265 XEO_CLAS Peptide DME1200 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04265 GENEFORM Protein DME1200 XEOTICID XEO04265 MOACRIVE Inhibition DME1200 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1200 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04266 XEO_CLAS Peptide DME1200 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04266 GENEFORM Protein DME1200 XEOTICID XEO04266 MOACRIVE Inhibition DME1200 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1200 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04267 XEO_CLAS Peptide DME1200 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04267 GENEFORM Protein DME1200 XEOTICID XEO04267 MOACRIVE Inhibition DME1200 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1200 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04268 XEO_CLAS Peptide DME1200 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04268 GENEFORM Protein DME1200 XEOTICID XEO04268 MOACRIVE Inhibition DME1200 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1200 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04269 XEO_CLAS Peptide DME1200 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04269 GENEFORM Protein DME1200 XEOTICID XEO04269 MOACRIVE Inhibition DME1200 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1200 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04270 XEO_CLAS Peptide DME1200 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04270 GENEFORM Protein DME1200 XEOTICID XEO04270 MOACRIVE Inhibition DME1200 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1200 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04271 XEO_CLAS Peptide DME1200 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04271 GENEFORM Protein DME1200 XEOTICID XEO04271 MOACRIVE Inhibition DME1200 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1200 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04272 XEO_CLAS Peptide DME1200 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04272 GENEFORM Protein DME1200 XEOTICID XEO04272 MOACRIVE Inhibition DME1200 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1200 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04277 XEO_CLAS Peptide DME1200 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 110.00 ug/ml) DME1200 XEOTICID XEO04277 GENEFORM Protein DME1200 XEOTICID XEO04277 MOACRIVE Inhibition DME1200 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1200 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04280 XEO_CLAS Peptide DME1200 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 37.50 ug/ml) DME1200 XEOTICID XEO04280 GENEFORM Protein DME1200 XEOTICID XEO04280 MOACRIVE Inhibition DME1200 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1200 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04281 XEO_CLAS Peptide DME1200 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25.00 ug/ml) DME1200 XEOTICID XEO04281 GENEFORM Protein DME1200 XEOTICID XEO04281 MOACRIVE Inhibition DME1200 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1200 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04282 XEO_CLAS Peptide DME1200 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.2 ug/ml) DME1200 XEOTICID XEO04282 GENEFORM Protein DME1200 XEOTICID XEO04282 MOACRIVE Inhibition DME1200 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1200 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04283 XEO_CLAS Peptide DME1200 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.3 ug/ml) DME1200 XEOTICID XEO04283 GENEFORM Protein DME1200 XEOTICID XEO04283 MOACRIVE Inhibition DME1200 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1200 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04284 XEO_CLAS Peptide DME1200 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10.8 ug/ml) DME1200 XEOTICID XEO04284 GENEFORM Protein DME1200 XEOTICID XEO04284 MOACRIVE Inhibition DME1200 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1200 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04285 XEO_CLAS Peptide DME1200 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 11.5 ug/ml) DME1200 XEOTICID XEO04285 GENEFORM Protein DME1200 XEOTICID XEO04285 MOACRIVE Inhibition DME1200 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1200 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04286 XEO_CLAS Peptide DME1200 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8.6 ug/ml) DME1200 XEOTICID XEO04286 GENEFORM Protein DME1200 XEOTICID XEO04286 MOACRIVE Inhibition DME1200 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1200 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04287 XEO_CLAS Peptide DME1200 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10.2 ug/ml) DME1200 XEOTICID XEO04287 GENEFORM Protein DME1200 XEOTICID XEO04287 MOACRIVE Inhibition DME1200 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1200 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04288 XEO_CLAS Peptide DME1200 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4.4 ug/ml) DME1200 XEOTICID XEO04288 GENEFORM Protein DME1200 XEOTICID XEO04288 MOACRIVE Inhibition DME1200 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1200 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04289 XEO_CLAS Peptide DME1200 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.2 ug/ml) DME1200 XEOTICID XEO04289 GENEFORM Protein DME1200 XEOTICID XEO04289 MOACRIVE Inhibition DME1200 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1200 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04290 XEO_CLAS Peptide DME1200 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 11.3 ug/ml) DME1200 XEOTICID XEO04290 GENEFORM Protein DME1200 XEOTICID XEO04290 MOACRIVE Inhibition DME1200 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1200 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04291 XEO_CLAS Peptide DME1200 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 7.2 ug/ml) DME1200 XEOTICID XEO04291 GENEFORM Protein DME1200 XEOTICID XEO04291 MOACRIVE Inhibition DME1200 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1200 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04292 XEO_CLAS Peptide DME1200 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.1 ug/ml) DME1200 XEOTICID XEO04292 GENEFORM Protein DME1200 XEOTICID XEO04292 MOACRIVE Inhibition DME1200 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1200 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04293 XEO_CLAS Peptide DME1200 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO04293 GENEFORM Protein DME1200 XEOTICID XEO04293 MOACRIVE Inhibition DME1200 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1200 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04294 XEO_CLAS Peptide DME1200 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO04294 GENEFORM Protein DME1200 XEOTICID XEO04294 MOACRIVE Inhibition DME1200 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1200 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04295 XEO_CLAS Peptide DME1200 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO04295 GENEFORM Protein DME1200 XEOTICID XEO04295 MOACRIVE Inhibition DME1200 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1200 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04296 XEO_CLAS Peptide DME1200 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 28 microM) DME1200 XEOTICID XEO04296 GENEFORM Protein DME1200 XEOTICID XEO04296 MOACRIVE Inhibition DME1200 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1200 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04297 XEO_CLAS Peptide DME1200 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 14 microM) DME1200 XEOTICID XEO04297 GENEFORM Protein DME1200 XEOTICID XEO04297 MOACRIVE Inhibition DME1200 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1200 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04298 XEO_CLAS Peptide DME1200 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO04298 GENEFORM Protein DME1200 XEOTICID XEO04298 MOACRIVE Inhibition DME1200 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1200 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04299 XEO_CLAS Peptide DME1200 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO04299 GENEFORM Protein DME1200 XEOTICID XEO04299 MOACRIVE Inhibition DME1200 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1200 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04300 XEO_CLAS Peptide DME1200 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO04300 GENEFORM Protein DME1200 XEOTICID XEO04300 MOACRIVE Inhibition DME1200 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1200 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04301 XEO_CLAS Peptide DME1200 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 microM) DME1200 XEOTICID XEO04301 GENEFORM Protein DME1200 XEOTICID XEO04301 MOACRIVE Inhibition DME1200 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1200 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04302 XEO_CLAS Peptide DME1200 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 microM) DME1200 XEOTICID XEO04302 GENEFORM Protein DME1200 XEOTICID XEO04302 MOACRIVE Inhibition DME1200 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1200 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04303 XEO_CLAS Peptide DME1200 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 microM) DME1200 XEOTICID XEO04303 GENEFORM Protein DME1200 XEOTICID XEO04303 MOACRIVE Inhibition DME1200 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1200 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04304 XEO_CLAS Peptide DME1200 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO04304 GENEFORM Protein DME1200 XEOTICID XEO04304 MOACRIVE Inhibition DME1200 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1200 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04305 XEO_CLAS Peptide DME1200 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 70 microM) DME1200 XEOTICID XEO04305 GENEFORM Protein DME1200 XEOTICID XEO04305 MOACRIVE Inhibition DME1200 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1200 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04306 XEO_CLAS Peptide DME1200 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO04306 GENEFORM Protein DME1200 XEOTICID XEO04306 MOACRIVE Inhibition DME1200 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1200 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04307 XEO_CLAS Peptide DME1200 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 ug/ml) DME1200 XEOTICID XEO04307 GENEFORM Protein DME1200 XEOTICID XEO04307 MOACRIVE Inhibition DME1200 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1200 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04308 XEO_CLAS Peptide DME1200 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 9.37 ug/ml) DME1200 XEOTICID XEO04308 GENEFORM Protein DME1200 XEOTICID XEO04308 MOACRIVE Inhibition DME1200 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1200 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04309 XEO_CLAS Peptide DME1200 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 microM) DME1200 XEOTICID XEO04309 GENEFORM Protein DME1200 XEOTICID XEO04309 MOACRIVE Inhibition DME1200 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1200 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04310 XEO_CLAS Peptide DME1200 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO04310 GENEFORM Protein DME1200 XEOTICID XEO04310 MOACRIVE Inhibition DME1200 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1200 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04311 XEO_CLAS Peptide DME1200 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO04311 GENEFORM Protein DME1200 XEOTICID XEO04311 MOACRIVE Inhibition DME1200 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1200 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04312 XEO_CLAS Peptide DME1200 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4.68 ug/ml) DME1200 XEOTICID XEO04312 GENEFORM Protein DME1200 XEOTICID XEO04312 MOACRIVE Inhibition DME1200 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1200 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04313 XEO_CLAS Peptide DME1200 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4.68 ug/ml) DME1200 XEOTICID XEO04313 GENEFORM Protein DME1200 XEOTICID XEO04313 MOACRIVE Inhibition DME1200 XEOTICID XEO04331 XEO_NAME Norspermidine DME1200 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1200 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04331 GENEFORM Protein DME1200 XEOTICID XEO04331 MOACRIVE Inhibition DME1200 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1200 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04335 XEO_CLAS Peptide DME1200 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 32 ug/ml) DME1200 XEOTICID XEO04335 GENEFORM Protein DME1200 XEOTICID XEO04335 MOACRIVE Inhibition DME1200 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1200 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04336 XEO_CLAS Peptide DME1200 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 32 ug/ml) DME1200 XEOTICID XEO04336 GENEFORM Protein DME1200 XEOTICID XEO04336 MOACRIVE Inhibition DME1200 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1200 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04338 XEO_CLAS Peptide DME1200 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 ug/ml) DME1200 XEOTICID XEO04338 GENEFORM Protein DME1200 XEOTICID XEO04338 MOACRIVE Inhibition DME1200 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1200 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04339 XEO_CLAS Peptide DME1200 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 ug/ml) DME1200 XEOTICID XEO04339 GENEFORM Protein DME1200 XEOTICID XEO04339 MOACRIVE Inhibition DME1200 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1200 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04340 XEO_CLAS Peptide DME1200 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO04340 GENEFORM Protein DME1200 XEOTICID XEO04340 MOACRIVE Inhibition DME1200 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1200 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04344 XEO_CLAS Peptide DME1200 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04344 GENEFORM Protein DME1200 XEOTICID XEO04344 MOACRIVE Inhibition DME1200 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1200 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04345 XEO_CLAS Peptide DME1200 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04345 GENEFORM Protein DME1200 XEOTICID XEO04345 MOACRIVE Inhibition DME1200 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1200 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04346 XEO_CLAS Peptide DME1200 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04346 GENEFORM Protein DME1200 XEOTICID XEO04346 MOACRIVE Inhibition DME1200 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1200 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04347 XEO_CLAS Peptide DME1200 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 microM) DME1200 XEOTICID XEO04347 GENEFORM Protein DME1200 XEOTICID XEO04347 MOACRIVE Inhibition DME1200 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1200 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04348 XEO_CLAS Peptide DME1200 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40 microM) DME1200 XEOTICID XEO04348 GENEFORM Protein DME1200 XEOTICID XEO04348 MOACRIVE Inhibition DME1200 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1200 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04349 XEO_CLAS Peptide DME1200 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO04349 GENEFORM Protein DME1200 XEOTICID XEO04349 MOACRIVE Inhibition DME1200 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1200 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04354 XEO_CLAS Peptide DME1200 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 35.2 ug/ml) DME1200 XEOTICID XEO04354 GENEFORM Protein DME1200 XEOTICID XEO04354 MOACRIVE Inhibition DME1200 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1200 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04355 XEO_CLAS Peptide DME1200 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.21 ug/ml) DME1200 XEOTICID XEO04355 GENEFORM Protein DME1200 XEOTICID XEO04355 MOACRIVE Inhibition DME1200 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1200 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04356 XEO_CLAS Peptide DME1200 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8.21 ug/ml) DME1200 XEOTICID XEO04356 GENEFORM Protein DME1200 XEOTICID XEO04356 MOACRIVE Inhibition DME1200 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1200 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04357 XEO_CLAS Peptide DME1200 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16.32 ug/ml) DME1200 XEOTICID XEO04357 GENEFORM Protein DME1200 XEOTICID XEO04357 MOACRIVE Inhibition DME1200 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1200 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04358 XEO_CLAS Peptide DME1200 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 9.37 ug/ml) DME1200 XEOTICID XEO04358 GENEFORM Protein DME1200 XEOTICID XEO04358 MOACRIVE Inhibition DME1200 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1200 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04359 XEO_CLAS Peptide DME1200 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4.20 ug/ml) DME1200 XEOTICID XEO04359 GENEFORM Protein DME1200 XEOTICID XEO04359 MOACRIVE Inhibition DME1200 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1200 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04360 XEO_CLAS Peptide DME1200 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 ug/ml) DME1200 XEOTICID XEO04360 GENEFORM Protein DME1200 XEOTICID XEO04360 MOACRIVE Inhibition DME1200 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1200 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04361 XEO_CLAS Peptide DME1200 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 7.5 ug/ml) DME1200 XEOTICID XEO04361 GENEFORM Protein DME1200 XEOTICID XEO04361 MOACRIVE Inhibition DME1200 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1200 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04362 XEO_CLAS Peptide DME1200 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.6 ug/ml) DME1200 XEOTICID XEO04362 GENEFORM Protein DME1200 XEOTICID XEO04362 MOACRIVE Inhibition DME1200 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1200 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04363 XEO_CLAS Peptide DME1200 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8.2 ug/ml) DME1200 XEOTICID XEO04363 GENEFORM Protein DME1200 XEOTICID XEO04363 MOACRIVE Inhibition DME1200 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1200 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04364 XEO_CLAS Peptide DME1200 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO04364 GENEFORM Protein DME1200 XEOTICID XEO04364 MOACRIVE Inhibition DME1200 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1200 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04365 XEO_CLAS Peptide DME1200 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4.68 ug/ml) DME1200 XEOTICID XEO04365 GENEFORM Protein DME1200 XEOTICID XEO04365 MOACRIVE Inhibition DME1200 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1200 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04366 XEO_CLAS Peptide DME1200 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 23.60 ug/ml) DME1200 XEOTICID XEO04366 GENEFORM Protein DME1200 XEOTICID XEO04366 MOACRIVE Inhibition DME1200 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1200 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04367 XEO_CLAS Peptide DME1200 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 35.60 ug/ml) DME1200 XEOTICID XEO04367 GENEFORM Protein DME1200 XEOTICID XEO04367 MOACRIVE Inhibition DME1200 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1200 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04368 XEO_CLAS Peptide DME1200 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40.2 ug/ml) DME1200 XEOTICID XEO04368 GENEFORM Protein DME1200 XEOTICID XEO04368 MOACRIVE Inhibition DME1200 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1200 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04369 XEO_CLAS Peptide DME1200 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40.2 ug/ml) DME1200 XEOTICID XEO04369 GENEFORM Protein DME1200 XEOTICID XEO04369 MOACRIVE Inhibition DME1200 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1200 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04370 XEO_CLAS Peptide DME1200 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4.68 ug/ml) DME1200 XEOTICID XEO04370 GENEFORM Protein DME1200 XEOTICID XEO04370 MOACRIVE Inhibition DME1200 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1200 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04371 XEO_CLAS Peptide DME1200 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 9.37 ug/ml) DME1200 XEOTICID XEO04371 GENEFORM Protein DME1200 XEOTICID XEO04371 MOACRIVE Inhibition DME1200 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1200 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04373 XEO_CLAS Peptide DME1200 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 ug/ml) DME1200 XEOTICID XEO04373 GENEFORM Protein DME1200 XEOTICID XEO04373 MOACRIVE Inhibition DME1200 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1200 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04374 XEO_CLAS Peptide DME1200 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.50 ug/ml) DME1200 XEOTICID XEO04374 GENEFORM Protein DME1200 XEOTICID XEO04374 MOACRIVE Inhibition DME1200 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1200 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04375 XEO_CLAS Peptide DME1200 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25 ug/ml) DME1200 XEOTICID XEO04375 GENEFORM Protein DME1200 XEOTICID XEO04375 MOACRIVE Inhibition DME1200 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1200 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04377 XEO_CLAS Peptide DME1200 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 42.50 ug/ml) DME1200 XEOTICID XEO04377 GENEFORM Protein DME1200 XEOTICID XEO04377 MOACRIVE Inhibition DME1200 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1200 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04378 XEO_CLAS Peptide DME1200 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 17.50 ug/ml) DME1200 XEOTICID XEO04378 GENEFORM Protein DME1200 XEOTICID XEO04378 MOACRIVE Inhibition DME1200 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1200 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04379 XEO_CLAS Peptide DME1200 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 ug/ml) DME1200 XEOTICID XEO04379 GENEFORM Protein DME1200 XEOTICID XEO04379 MOACRIVE Inhibition DME1200 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1200 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04380 XEO_CLAS Peptide DME1200 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 36.00 ug/ml) DME1200 XEOTICID XEO04380 GENEFORM Protein DME1200 XEOTICID XEO04380 MOACRIVE Inhibition DME1200 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1200 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04381 XEO_CLAS Peptide DME1200 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.60 ug/ml) DME1200 XEOTICID XEO04381 GENEFORM Protein DME1200 XEOTICID XEO04381 MOACRIVE Inhibition DME1200 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1200 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04382 XEO_CLAS Peptide DME1200 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 ug/ml) DME1200 XEOTICID XEO04382 GENEFORM Protein DME1200 XEOTICID XEO04382 MOACRIVE Inhibition DME1200 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1200 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04383 XEO_CLAS Peptide DME1200 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO04383 GENEFORM Protein DME1200 XEOTICID XEO04383 MOACRIVE Inhibition DME1200 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1200 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04384 XEO_CLAS Peptide DME1200 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO04384 GENEFORM Protein DME1200 XEOTICID XEO04384 MOACRIVE Inhibition DME1200 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1200 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04385 XEO_CLAS Peptide DME1200 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.25 ug/ml) DME1200 XEOTICID XEO04385 GENEFORM Protein DME1200 XEOTICID XEO04385 MOACRIVE Inhibition DME1200 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1200 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04395 XEO_CLAS Peptide DME1200 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1200 XEOTICID XEO04395 GENEFORM Protein DME1200 XEOTICID XEO04395 MOACRIVE Inhibition DME1200 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1200 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04396 XEO_CLAS Peptide DME1200 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1200 XEOTICID XEO04396 GENEFORM Protein DME1200 XEOTICID XEO04396 MOACRIVE Inhibition DME1200 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1200 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04397 XEO_CLAS Peptide DME1200 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1200 XEOTICID XEO04397 GENEFORM Protein DME1200 XEOTICID XEO04397 MOACRIVE Inhibition DME1200 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1200 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04398 XEO_CLAS Peptide DME1200 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 microM) DME1200 XEOTICID XEO04398 GENEFORM Protein DME1200 XEOTICID XEO04398 MOACRIVE Inhibition DME1200 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1200 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04399 XEO_CLAS Peptide DME1200 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO04399 GENEFORM Protein DME1200 XEOTICID XEO04399 MOACRIVE Inhibition DME1200 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1200 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04400 XEO_CLAS Peptide DME1200 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 ug/ml) DME1200 XEOTICID XEO04400 GENEFORM Protein DME1200 XEOTICID XEO04400 MOACRIVE Inhibition DME1200 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1200 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04401 XEO_CLAS Peptide DME1200 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.6 ug/ml) DME1200 XEOTICID XEO04401 GENEFORM Protein DME1200 XEOTICID XEO04401 MOACRIVE Inhibition DME1200 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1200 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04402 XEO_CLAS Peptide DME1200 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 ug/ml) DME1200 XEOTICID XEO04402 GENEFORM Protein DME1200 XEOTICID XEO04402 MOACRIVE Inhibition DME1200 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1200 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04403 XEO_CLAS Peptide DME1200 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.6 ug/ml) DME1200 XEOTICID XEO04403 GENEFORM Protein DME1200 XEOTICID XEO04403 MOACRIVE Inhibition DME1200 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1200 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04404 XEO_CLAS Peptide DME1200 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.6 ug/ml) DME1200 XEOTICID XEO04404 GENEFORM Protein DME1200 XEOTICID XEO04404 MOACRIVE Inhibition DME1200 XEOTICID XEO04410 XEO_NAME Insect osmin DME1200 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04410 XEO_CLAS Peptide DME1200 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.125-1.56 microM) DME1200 XEOTICID XEO04410 GENEFORM Protein DME1200 XEOTICID XEO04410 MOACRIVE Inhibition DME1200 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1200 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04412 XEO_CLAS Peptide DME1200 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04412 GENEFORM Protein DME1200 XEOTICID XEO04412 MOACRIVE Inhibition DME1200 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1200 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04414 XEO_CLAS Peptide DME1200 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04414 GENEFORM Protein DME1200 XEOTICID XEO04414 MOACRIVE Inhibition DME1200 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1200 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04415 XEO_CLAS Peptide DME1200 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04415 GENEFORM Protein DME1200 XEOTICID XEO04415 MOACRIVE Inhibition DME1200 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1200 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04421 XEO_CLAS Peptide DME1200 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 microM) DME1200 XEOTICID XEO04421 GENEFORM Protein DME1200 XEOTICID XEO04421 MOACRIVE Inhibition DME1200 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1200 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04426 XEO_CLAS Peptide DME1200 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO04426 GENEFORM Protein DME1200 XEOTICID XEO04426 MOACRIVE Inhibition DME1200 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1200 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04428 XEO_CLAS Peptide DME1200 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.3 ug/ml) DME1200 XEOTICID XEO04428 GENEFORM Protein DME1200 XEOTICID XEO04428 MOACRIVE Inhibition DME1200 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1200 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04430 XEO_CLAS Peptide DME1200 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25 microM) DME1200 XEOTICID XEO04430 GENEFORM Protein DME1200 XEOTICID XEO04430 MOACRIVE Inhibition DME1200 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1200 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04433 XEO_CLAS Peptide DME1200 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 160 microM) DME1200 XEOTICID XEO04433 GENEFORM Protein DME1200 XEOTICID XEO04433 MOACRIVE Inhibition DME1200 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1200 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04435 XEO_CLAS Peptide DME1200 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 160 microM) DME1200 XEOTICID XEO04435 GENEFORM Protein DME1200 XEOTICID XEO04435 MOACRIVE Inhibition DME1200 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1200 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1200 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04438 GENEFORM Protein DME1200 XEOTICID XEO04438 MOACRIVE Inhibition DME1200 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1200 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04439 XEO_CLAS Peptide DME1200 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04439 GENEFORM Protein DME1200 XEOTICID XEO04439 MOACRIVE Inhibition DME1200 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1200 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04440 XEO_CLAS Peptide DME1200 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 microM) DME1200 XEOTICID XEO04440 GENEFORM Protein DME1200 XEOTICID XEO04440 MOACRIVE Inhibition DME1200 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1200 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04441 XEO_CLAS Peptide DME1200 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 28 microM) DME1200 XEOTICID XEO04441 GENEFORM Protein DME1200 XEOTICID XEO04441 MOACRIVE Inhibition DME1200 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1200 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04442 XEO_CLAS Peptide DME1200 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 28 microM) DME1200 XEOTICID XEO04442 GENEFORM Protein DME1200 XEOTICID XEO04442 MOACRIVE Inhibition DME1200 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1200 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04443 XEO_CLAS Peptide DME1200 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04443 GENEFORM Protein DME1200 XEOTICID XEO04443 MOACRIVE Inhibition DME1200 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1200 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04444 XEO_CLAS Peptide DME1200 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 13 microM) DME1200 XEOTICID XEO04444 GENEFORM Protein DME1200 XEOTICID XEO04444 MOACRIVE Inhibition DME1200 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1200 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04445 XEO_CLAS Peptide DME1200 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04445 GENEFORM Protein DME1200 XEOTICID XEO04445 MOACRIVE Inhibition DME1200 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1200 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04446 XEO_CLAS Peptide DME1200 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 78 microM) DME1200 XEOTICID XEO04446 GENEFORM Protein DME1200 XEOTICID XEO04446 MOACRIVE Inhibition DME1200 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1200 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04447 XEO_CLAS Peptide DME1200 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 120 microM) DME1200 XEOTICID XEO04447 GENEFORM Protein DME1200 XEOTICID XEO04447 MOACRIVE Inhibition DME1200 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1200 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04448 XEO_CLAS Peptide DME1200 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 microM) DME1200 XEOTICID XEO04448 GENEFORM Protein DME1200 XEOTICID XEO04448 MOACRIVE Inhibition DME1200 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1200 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04449 XEO_CLAS Peptide DME1200 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.3 microM) DME1200 XEOTICID XEO04449 GENEFORM Protein DME1200 XEOTICID XEO04449 MOACRIVE Inhibition DME1200 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1200 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04450 XEO_CLAS Peptide DME1200 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.3 microM) DME1200 XEOTICID XEO04450 GENEFORM Protein DME1200 XEOTICID XEO04450 MOACRIVE Inhibition DME1200 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1200 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04451 XEO_CLAS Peptide DME1200 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO04451 GENEFORM Protein DME1200 XEOTICID XEO04451 MOACRIVE Inhibition DME1200 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1200 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04452 XEO_CLAS Peptide DME1200 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.1 microM) DME1200 XEOTICID XEO04452 GENEFORM Protein DME1200 XEOTICID XEO04452 MOACRIVE Inhibition DME1200 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1200 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04453 XEO_CLAS Peptide DME1200 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO04453 GENEFORM Protein DME1200 XEOTICID XEO04453 MOACRIVE Inhibition DME1200 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1200 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04455 XEO_CLAS Peptide DME1200 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 microM) DME1200 XEOTICID XEO04455 GENEFORM Protein DME1200 XEOTICID XEO04455 MOACRIVE Inhibition DME1200 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1200 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04457 XEO_CLAS Peptide DME1200 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.3 microM) DME1200 XEOTICID XEO04457 GENEFORM Protein DME1200 XEOTICID XEO04457 MOACRIVE Inhibition DME1200 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1200 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04458 XEO_CLAS Peptide DME1200 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1 microM) DME1200 XEOTICID XEO04458 GENEFORM Protein DME1200 XEOTICID XEO04458 MOACRIVE Inhibition DME1200 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1200 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04459 XEO_CLAS Peptide DME1200 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1 microM) DME1200 XEOTICID XEO04459 GENEFORM Protein DME1200 XEOTICID XEO04459 MOACRIVE Inhibition DME1200 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1200 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04461 XEO_CLAS Peptide DME1200 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20.8 microM) DME1200 XEOTICID XEO04461 GENEFORM Protein DME1200 XEOTICID XEO04461 MOACRIVE Inhibition DME1200 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1200 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04462 XEO_CLAS Peptide DME1200 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 19.1 microM) DME1200 XEOTICID XEO04462 GENEFORM Protein DME1200 XEOTICID XEO04462 MOACRIVE Inhibition DME1200 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1200 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04463 XEO_CLAS Peptide DME1200 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04463 GENEFORM Protein DME1200 XEOTICID XEO04463 MOACRIVE Inhibition DME1200 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1200 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04464 XEO_CLAS Peptide DME1200 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.5 microM) DME1200 XEOTICID XEO04464 GENEFORM Protein DME1200 XEOTICID XEO04464 MOACRIVE Inhibition DME1200 XEOTICID XEO04466 XEO_NAME Panusin DME1200 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04466 XEO_CLAS Peptide DME1200 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04466 GENEFORM Protein DME1200 XEOTICID XEO04466 MOACRIVE Inhibition DME1200 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1200 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04467 XEO_CLAS Peptide DME1200 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4.8 microM) DME1200 XEOTICID XEO04467 GENEFORM Protein DME1200 XEOTICID XEO04467 MOACRIVE Inhibition DME1200 XEOTICID XEO04468 XEO_NAME Papillosin DME1200 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04468 XEO_CLAS Peptide DME1200 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04468 GENEFORM Protein DME1200 XEOTICID XEO04468 MOACRIVE Inhibition DME1200 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1200 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04471 XEO_CLAS Peptide DME1200 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.1 microM) DME1200 XEOTICID XEO04471 GENEFORM Protein DME1200 XEOTICID XEO04471 MOACRIVE Inhibition DME1200 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1200 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04480 XEO_CLAS Peptide DME1200 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 ug/ml) DME1200 XEOTICID XEO04480 GENEFORM Protein DME1200 XEOTICID XEO04480 MOACRIVE Inhibition DME1200 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1200 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1200 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04482 GENEFORM Protein DME1200 XEOTICID XEO04482 MOACRIVE Inhibition DME1200 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1200 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04484 XEO_CLAS Peptide DME1200 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 microM) DME1200 XEOTICID XEO04484 GENEFORM Protein DME1200 XEOTICID XEO04484 MOACRIVE Inhibition DME1200 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1200 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04485 XEO_CLAS Peptide DME1200 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO04485 GENEFORM Protein DME1200 XEOTICID XEO04485 MOACRIVE Inhibition DME1200 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1200 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04486 XEO_CLAS Peptide DME1200 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 microM) DME1200 XEOTICID XEO04486 GENEFORM Protein DME1200 XEOTICID XEO04486 MOACRIVE Inhibition DME1200 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1200 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04487 XEO_CLAS Peptide DME1200 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO04487 GENEFORM Protein DME1200 XEOTICID XEO04487 MOACRIVE Inhibition DME1200 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1200 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04488 XEO_CLAS Peptide DME1200 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 9 microM) DME1200 XEOTICID XEO04488 GENEFORM Protein DME1200 XEOTICID XEO04488 MOACRIVE Inhibition DME1200 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1200 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04489 XEO_CLAS Peptide DME1200 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 13 microM) DME1200 XEOTICID XEO04489 GENEFORM Protein DME1200 XEOTICID XEO04489 MOACRIVE Inhibition DME1200 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1200 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04490 XEO_CLAS Peptide DME1200 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 47.5 microM) DME1200 XEOTICID XEO04490 GENEFORM Protein DME1200 XEOTICID XEO04490 MOACRIVE Inhibition DME1200 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1200 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04491 XEO_CLAS Peptide DME1200 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO04491 GENEFORM Protein DME1200 XEOTICID XEO04491 MOACRIVE Inhibition DME1200 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1200 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04492 XEO_CLAS Peptide DME1200 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 35 microM) DME1200 XEOTICID XEO04492 GENEFORM Protein DME1200 XEOTICID XEO04492 MOACRIVE Inhibition DME1200 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1200 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04493 XEO_CLAS Peptide DME1200 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 microM) DME1200 XEOTICID XEO04493 GENEFORM Protein DME1200 XEOTICID XEO04493 MOACRIVE Inhibition DME1200 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1200 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04494 XEO_CLAS Peptide DME1200 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO04494 GENEFORM Protein DME1200 XEOTICID XEO04494 MOACRIVE Inhibition DME1200 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1200 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04495 XEO_CLAS Peptide DME1200 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO04495 GENEFORM Protein DME1200 XEOTICID XEO04495 MOACRIVE Inhibition DME1200 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1200 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04496 XEO_CLAS Peptide DME1200 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 67.5 microM) DME1200 XEOTICID XEO04496 GENEFORM Protein DME1200 XEOTICID XEO04496 MOACRIVE Inhibition DME1200 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1200 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04497 XEO_CLAS Peptide DME1200 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO04497 GENEFORM Protein DME1200 XEOTICID XEO04497 MOACRIVE Inhibition DME1200 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1200 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04498 XEO_CLAS Peptide DME1200 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO04498 GENEFORM Protein DME1200 XEOTICID XEO04498 MOACRIVE Inhibition DME1200 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1200 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04499 XEO_CLAS Peptide DME1200 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 43 microM) DME1200 XEOTICID XEO04499 GENEFORM Protein DME1200 XEOTICID XEO04499 MOACRIVE Inhibition DME1200 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1200 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04500 XEO_CLAS Peptide DME1200 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO04500 GENEFORM Protein DME1200 XEOTICID XEO04500 MOACRIVE Inhibition DME1200 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1200 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04504 XEO_CLAS Peptide DME1200 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04504 GENEFORM Protein DME1200 XEOTICID XEO04504 MOACRIVE Inhibition DME1200 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1200 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04505 XEO_CLAS Peptide DME1200 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04505 GENEFORM Protein DME1200 XEOTICID XEO04505 MOACRIVE Inhibition DME1200 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1200 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04506 XEO_CLAS Peptide DME1200 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 40 microM) DME1200 XEOTICID XEO04506 GENEFORM Protein DME1200 XEOTICID XEO04506 MOACRIVE Inhibition DME1200 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1200 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04507 XEO_CLAS Peptide DME1200 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10-20 microM) DME1200 XEOTICID XEO04507 GENEFORM Protein DME1200 XEOTICID XEO04507 MOACRIVE Inhibition DME1200 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1200 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04508 XEO_CLAS Peptide DME1200 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04508 GENEFORM Protein DME1200 XEOTICID XEO04508 MOACRIVE Inhibition DME1200 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1200 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04509 XEO_CLAS Peptide DME1200 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04509 GENEFORM Protein DME1200 XEOTICID XEO04509 MOACRIVE Inhibition DME1200 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1200 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04510 XEO_CLAS Peptide DME1200 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 22-33 microM) DME1200 XEOTICID XEO04510 GENEFORM Protein DME1200 XEOTICID XEO04510 MOACRIVE Inhibition DME1200 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1200 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04525 XEO_CLAS Peptide DME1200 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 32.0 microM) DME1200 XEOTICID XEO04525 GENEFORM Protein DME1200 XEOTICID XEO04525 MOACRIVE Inhibition DME1200 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1200 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04526 XEO_CLAS Peptide DME1200 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.0 microM) DME1200 XEOTICID XEO04526 GENEFORM Protein DME1200 XEOTICID XEO04526 MOACRIVE Inhibition DME1200 XEOTICID XEO04527 XEO_NAME Pepcon DME1200 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04527 XEO_CLAS Peptide DME1200 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO04527 GENEFORM Protein DME1200 XEOTICID XEO04527 MOACRIVE Inhibition DME1200 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1200 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04532 XEO_CLAS Peptide DME1200 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04532 GENEFORM Protein DME1200 XEOTICID XEO04532 MOACRIVE Inhibition DME1200 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1200 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04540 XEO_CLAS Peptide DME1200 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 18.1 ug/ml) DME1200 XEOTICID XEO04540 GENEFORM Protein DME1200 XEOTICID XEO04540 MOACRIVE Inhibition DME1200 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1200 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04541 XEO_CLAS Peptide DME1200 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.5 ug/ml) DME1200 XEOTICID XEO04541 GENEFORM Protein DME1200 XEOTICID XEO04541 MOACRIVE Inhibition DME1200 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1200 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04542 XEO_CLAS Peptide DME1200 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04542 GENEFORM Protein DME1200 XEOTICID XEO04542 MOACRIVE Inhibition DME1200 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1200 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04543 XEO_CLAS Peptide DME1200 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04543 GENEFORM Protein DME1200 XEOTICID XEO04543 MOACRIVE Inhibition DME1200 XEOTICID XEO04546 XEO_NAME Perinerin DME1200 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04546 XEO_CLAS Peptide DME1200 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04546 GENEFORM Protein DME1200 XEOTICID XEO04546 MOACRIVE Inhibition DME1200 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1200 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04548 XEO_CLAS Peptide DME1200 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 72000 ug/ml) DME1200 XEOTICID XEO04548 GENEFORM Protein DME1200 XEOTICID XEO04548 MOACRIVE Inhibition DME1200 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1200 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04549 XEO_CLAS Peptide DME1200 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 62-125 ug/ml) DME1200 XEOTICID XEO04549 GENEFORM Protein DME1200 XEOTICID XEO04549 MOACRIVE Inhibition DME1200 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1200 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04550 XEO_CLAS Peptide DME1200 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO04550 GENEFORM Protein DME1200 XEOTICID XEO04550 MOACRIVE Inhibition DME1200 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1200 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04551 XEO_CLAS Peptide DME1200 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 23.6 ug/ml) DME1200 XEOTICID XEO04551 GENEFORM Protein DME1200 XEOTICID XEO04551 MOACRIVE Inhibition DME1200 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1200 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04552 XEO_CLAS Peptide DME1200 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04552 GENEFORM Protein DME1200 XEOTICID XEO04552 MOACRIVE Inhibition DME1200 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1200 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04553 XEO_CLAS Peptide DME1200 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04553 GENEFORM Protein DME1200 XEOTICID XEO04553 MOACRIVE Inhibition DME1200 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1200 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04554 XEO_CLAS Peptide DME1200 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04554 GENEFORM Protein DME1200 XEOTICID XEO04554 MOACRIVE Inhibition DME1200 XEOTICID XEO04563 XEO_NAME Phosphate DME1200 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1200 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04563 GENEFORM Protein DME1200 XEOTICID XEO04563 MOACRIVE Inhibition DME1200 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1200 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04565 XEO_CLAS Peptide DME1200 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.5 microM) DME1200 XEOTICID XEO04565 GENEFORM Protein DME1200 XEOTICID XEO04565 MOACRIVE Inhibition DME1200 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1200 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04566 XEO_CLAS Peptide DME1200 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.7 microM) DME1200 XEOTICID XEO04566 GENEFORM Protein DME1200 XEOTICID XEO04566 MOACRIVE Inhibition DME1200 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1200 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04569 XEO_CLAS Peptide DME1200 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 7.9 microM) DME1200 XEOTICID XEO04569 GENEFORM Protein DME1200 XEOTICID XEO04569 MOACRIVE Inhibition DME1200 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1200 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04570 XEO_CLAS Peptide DME1200 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04570 GENEFORM Protein DME1200 XEOTICID XEO04570 MOACRIVE Inhibition DME1200 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1200 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04571 XEO_CLAS Peptide DME1200 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04571 GENEFORM Protein DME1200 XEOTICID XEO04571 MOACRIVE Inhibition DME1200 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1200 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04572 XEO_CLAS Peptide DME1200 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04572 GENEFORM Protein DME1200 XEOTICID XEO04572 MOACRIVE Inhibition DME1200 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1200 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04573 XEO_CLAS Peptide DME1200 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 microM) DME1200 XEOTICID XEO04573 GENEFORM Protein DME1200 XEOTICID XEO04573 MOACRIVE Inhibition DME1200 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1200 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04574 XEO_CLAS Peptide DME1200 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 128 ug/ml) DME1200 XEOTICID XEO04574 GENEFORM Protein DME1200 XEOTICID XEO04574 MOACRIVE Inhibition DME1200 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1200 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04575 XEO_CLAS Peptide DME1200 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO04575 GENEFORM Protein DME1200 XEOTICID XEO04575 MOACRIVE Inhibition DME1200 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1200 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04578 GENEFORM Protein DME1200 XEOTICID XEO04578 MOACRIVE Inhibition DME1200 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1200 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04579 GENEFORM Protein DME1200 XEOTICID XEO04579 MOACRIVE Inhibition DME1200 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1200 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04580 GENEFORM Protein DME1200 XEOTICID XEO04580 MOACRIVE Inhibition DME1200 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1200 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04583 GENEFORM Protein DME1200 XEOTICID XEO04583 MOACRIVE Inhibition DME1200 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1200 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04588 GENEFORM Protein DME1200 XEOTICID XEO04588 MOACRIVE Inhibition DME1200 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1200 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04589 GENEFORM Protein DME1200 XEOTICID XEO04589 MOACRIVE Inhibition DME1200 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1200 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04590 GENEFORM Protein DME1200 XEOTICID XEO04590 MOACRIVE Inhibition DME1200 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1200 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04591 GENEFORM Protein DME1200 XEOTICID XEO04591 MOACRIVE Inhibition DME1200 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1200 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04592 GENEFORM Protein DME1200 XEOTICID XEO04592 MOACRIVE Inhibition DME1200 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1200 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04593 GENEFORM Protein DME1200 XEOTICID XEO04593 MOACRIVE Inhibition DME1200 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1200 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04594 GENEFORM Protein DME1200 XEOTICID XEO04594 MOACRIVE Inhibition DME1200 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1200 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04595 GENEFORM Protein DME1200 XEOTICID XEO04595 MOACRIVE Inhibition DME1200 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1200 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04596 GENEFORM Protein DME1200 XEOTICID XEO04596 MOACRIVE Inhibition DME1200 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1200 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04597 GENEFORM Protein DME1200 XEOTICID XEO04597 MOACRIVE Inhibition DME1200 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1200 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04598 GENEFORM Protein DME1200 XEOTICID XEO04598 MOACRIVE Inhibition DME1200 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1200 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04599 GENEFORM Protein DME1200 XEOTICID XEO04599 MOACRIVE Inhibition DME1200 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1200 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04601 XEO_CLAS Peptide DME1200 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 18.75 ug/ml) DME1200 XEOTICID XEO04601 GENEFORM Protein DME1200 XEOTICID XEO04601 MOACRIVE Inhibition DME1200 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1200 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04602 XEO_CLAS Peptide DME1200 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 37.5 ug/ml) DME1200 XEOTICID XEO04602 GENEFORM Protein DME1200 XEOTICID XEO04602 MOACRIVE Inhibition DME1200 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1200 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04604 XEO_CLAS Peptide DME1200 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC < 25 microM) DME1200 XEOTICID XEO04604 GENEFORM Protein DME1200 XEOTICID XEO04604 MOACRIVE Inhibition DME1200 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1200 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04605 XEO_CLAS Peptide DME1200 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC < 6.25 microM) DME1200 XEOTICID XEO04605 GENEFORM Protein DME1200 XEOTICID XEO04605 MOACRIVE Inhibition DME1200 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1200 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04606 XEO_CLAS Peptide DME1200 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO04606 GENEFORM Protein DME1200 XEOTICID XEO04606 MOACRIVE Inhibition DME1200 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1200 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1200 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04607 GENEFORM Protein DME1200 XEOTICID XEO04607 MOACRIVE Inhibition DME1200 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1200 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04612 XEO_CLAS Peptide DME1200 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5-10 microM) DME1200 XEOTICID XEO04612 GENEFORM Protein DME1200 XEOTICID XEO04612 MOACRIVE Inhibition DME1200 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1200 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04613 XEO_CLAS Peptide DME1200 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5-10 microM) DME1200 XEOTICID XEO04613 GENEFORM Protein DME1200 XEOTICID XEO04613 MOACRIVE Inhibition DME1200 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1200 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04625 XEO_CLAS Peptide DME1200 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO04625 GENEFORM Protein DME1200 XEOTICID XEO04625 MOACRIVE Inhibition DME1200 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1200 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04626 XEO_CLAS Peptide DME1200 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO04626 GENEFORM Protein DME1200 XEOTICID XEO04626 MOACRIVE Inhibition DME1200 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1200 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04627 XEO_CLAS Peptide DME1200 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.5 microM) DME1200 XEOTICID XEO04627 GENEFORM Protein DME1200 XEOTICID XEO04627 MOACRIVE Inhibition DME1200 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1200 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04630 XEO_CLAS Peptide DME1200 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 60 ug/ml) DME1200 XEOTICID XEO04630 GENEFORM Protein DME1200 XEOTICID XEO04630 MOACRIVE Inhibition DME1200 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1200 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04631 XEO_CLAS Peptide DME1200 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 60 ug/ml) DME1200 XEOTICID XEO04631 GENEFORM Protein DME1200 XEOTICID XEO04631 MOACRIVE Inhibition DME1200 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1200 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04633 XEO_CLAS Peptide DME1200 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 ug/ml) DME1200 XEOTICID XEO04633 GENEFORM Protein DME1200 XEOTICID XEO04633 MOACRIVE Inhibition DME1200 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1200 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04634 XEO_CLAS Peptide DME1200 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 ug/ml) DME1200 XEOTICID XEO04634 GENEFORM Protein DME1200 XEOTICID XEO04634 MOACRIVE Inhibition DME1200 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1200 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04635 XEO_CLAS Peptide DME1200 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 ug/ml) DME1200 XEOTICID XEO04635 GENEFORM Protein DME1200 XEOTICID XEO04635 MOACRIVE Inhibition DME1200 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1200 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04636 XEO_CLAS Peptide DME1200 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 ug/ml) DME1200 XEOTICID XEO04636 GENEFORM Protein DME1200 XEOTICID XEO04636 MOACRIVE Inhibition DME1200 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1200 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04637 XEO_CLAS Peptide DME1200 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 ug/ml) DME1200 XEOTICID XEO04637 GENEFORM Protein DME1200 XEOTICID XEO04637 MOACRIVE Inhibition DME1200 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1200 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04638 XEO_CLAS Peptide DME1200 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 ug/ml) DME1200 XEOTICID XEO04638 GENEFORM Protein DME1200 XEOTICID XEO04638 MOACRIVE Inhibition DME1200 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1200 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04639 XEO_CLAS Peptide DME1200 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 ug/ml) DME1200 XEOTICID XEO04639 GENEFORM Protein DME1200 XEOTICID XEO04639 MOACRIVE Inhibition DME1200 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1200 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04640 XEO_CLAS Peptide DME1200 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.2-3.3 microM) DME1200 XEOTICID XEO04640 GENEFORM Protein DME1200 XEOTICID XEO04640 MOACRIVE Inhibition DME1200 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1200 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04642 XEO_CLAS Peptide DME1200 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 ug/ml) DME1200 XEOTICID XEO04642 GENEFORM Protein DME1200 XEOTICID XEO04642 MOACRIVE Inhibition DME1200 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1200 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04643 XEO_CLAS Peptide DME1200 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO04643 GENEFORM Protein DME1200 XEOTICID XEO04643 MOACRIVE Inhibition DME1200 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1200 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04644 XEO_CLAS Peptide DME1200 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO04644 GENEFORM Protein DME1200 XEOTICID XEO04644 MOACRIVE Inhibition DME1200 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1200 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04645 XEO_CLAS Peptide DME1200 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 ug/ml) DME1200 XEOTICID XEO04645 GENEFORM Protein DME1200 XEOTICID XEO04645 MOACRIVE Inhibition DME1200 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1200 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04646 XEO_CLAS Peptide DME1200 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1 ug/ml) DME1200 XEOTICID XEO04646 GENEFORM Protein DME1200 XEOTICID XEO04646 MOACRIVE Inhibition DME1200 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1200 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04647 XEO_CLAS Peptide DME1200 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO04647 GENEFORM Protein DME1200 XEOTICID XEO04647 MOACRIVE Inhibition DME1200 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1200 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04648 XEO_CLAS Peptide DME1200 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 ug/ml) DME1200 XEOTICID XEO04648 GENEFORM Protein DME1200 XEOTICID XEO04648 MOACRIVE Inhibition DME1200 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1200 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04649 XEO_CLAS Peptide DME1200 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 64 ug/ml) DME1200 XEOTICID XEO04649 GENEFORM Protein DME1200 XEOTICID XEO04649 MOACRIVE Inhibition DME1200 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1200 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04650 XEO_CLAS Peptide DME1200 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 ug/ml) DME1200 XEOTICID XEO04650 GENEFORM Protein DME1200 XEOTICID XEO04650 MOACRIVE Inhibition DME1200 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1200 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04651 XEO_CLAS Peptide DME1200 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 ug/ml) DME1200 XEOTICID XEO04651 GENEFORM Protein DME1200 XEOTICID XEO04651 MOACRIVE Inhibition DME1200 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1200 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04652 XEO_CLAS Peptide DME1200 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO04652 GENEFORM Protein DME1200 XEOTICID XEO04652 MOACRIVE Inhibition DME1200 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1200 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04653 XEO_CLAS Peptide DME1200 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 64 ug/ml) DME1200 XEOTICID XEO04653 GENEFORM Protein DME1200 XEOTICID XEO04653 MOACRIVE Inhibition DME1200 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1200 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04654 XEO_CLAS Peptide DME1200 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 ug/ml) DME1200 XEOTICID XEO04654 GENEFORM Protein DME1200 XEOTICID XEO04654 MOACRIVE Inhibition DME1200 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1200 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04655 XEO_CLAS Peptide DME1200 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO04655 GENEFORM Protein DME1200 XEOTICID XEO04655 MOACRIVE Inhibition DME1200 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1200 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04657 XEO_CLAS Peptide DME1200 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 300 microM) DME1200 XEOTICID XEO04657 GENEFORM Protein DME1200 XEOTICID XEO04657 MOACRIVE Inhibition DME1200 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1200 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04660 XEO_CLAS Peptide DME1200 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO04660 GENEFORM Protein DME1200 XEOTICID XEO04660 MOACRIVE Inhibition DME1200 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1200 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04661 XEO_CLAS Peptide DME1200 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 microM) DME1200 XEOTICID XEO04661 GENEFORM Protein DME1200 XEOTICID XEO04661 MOACRIVE Inhibition DME1200 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1200 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04662 XEO_CLAS Peptide DME1200 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 microM) DME1200 XEOTICID XEO04662 GENEFORM Protein DME1200 XEOTICID XEO04662 MOACRIVE Inhibition DME1200 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1200 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04663 XEO_CLAS Peptide DME1200 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 microM) DME1200 XEOTICID XEO04663 GENEFORM Protein DME1200 XEOTICID XEO04663 MOACRIVE Inhibition DME1200 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1200 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04664 XEO_CLAS Peptide DME1200 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5.5 microM) DME1200 XEOTICID XEO04664 GENEFORM Protein DME1200 XEOTICID XEO04664 MOACRIVE Inhibition DME1200 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1200 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04665 XEO_CLAS Peptide DME1200 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 microM) DME1200 XEOTICID XEO04665 GENEFORM Protein DME1200 XEOTICID XEO04665 MOACRIVE Inhibition DME1200 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1200 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04666 XEO_CLAS Peptide DME1200 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO04666 GENEFORM Protein DME1200 XEOTICID XEO04666 MOACRIVE Inhibition DME1200 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1200 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04667 XEO_CLAS Peptide DME1200 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6.25 microM) DME1200 XEOTICID XEO04667 GENEFORM Protein DME1200 XEOTICID XEO04667 MOACRIVE Inhibition DME1200 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1200 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04668 XEO_CLAS Peptide DME1200 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 microM) DME1200 XEOTICID XEO04668 GENEFORM Protein DME1200 XEOTICID XEO04668 MOACRIVE Inhibition DME1200 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1200 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04669 XEO_CLAS Peptide DME1200 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO04669 GENEFORM Protein DME1200 XEOTICID XEO04669 MOACRIVE Inhibition DME1200 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1200 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04670 XEO_CLAS Peptide DME1200 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 21 microM) DME1200 XEOTICID XEO04670 GENEFORM Protein DME1200 XEOTICID XEO04670 MOACRIVE Inhibition DME1200 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1200 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04671 XEO_CLAS Peptide DME1200 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 62 microM) DME1200 XEOTICID XEO04671 GENEFORM Protein DME1200 XEOTICID XEO04671 MOACRIVE Inhibition DME1200 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1200 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04672 XEO_CLAS Peptide DME1200 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO04672 GENEFORM Protein DME1200 XEOTICID XEO04672 MOACRIVE Inhibition DME1200 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1200 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04673 XEO_CLAS Peptide DME1200 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO04673 GENEFORM Protein DME1200 XEOTICID XEO04673 MOACRIVE Inhibition DME1200 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1200 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04674 XEO_CLAS Peptide DME1200 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 75 microM) DME1200 XEOTICID XEO04674 GENEFORM Protein DME1200 XEOTICID XEO04674 MOACRIVE Inhibition DME1200 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1200 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04675 XEO_CLAS Peptide DME1200 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 microM) DME1200 XEOTICID XEO04675 GENEFORM Protein DME1200 XEOTICID XEO04675 MOACRIVE Inhibition DME1200 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1200 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04676 XEO_CLAS Peptide DME1200 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 microM) DME1200 XEOTICID XEO04676 GENEFORM Protein DME1200 XEOTICID XEO04676 MOACRIVE Inhibition DME1200 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1200 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04677 XEO_CLAS Peptide DME1200 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO04677 GENEFORM Protein DME1200 XEOTICID XEO04677 MOACRIVE Inhibition DME1200 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1200 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04680 XEO_CLAS Peptide DME1200 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 microM) DME1200 XEOTICID XEO04680 GENEFORM Protein DME1200 XEOTICID XEO04680 MOACRIVE Inhibition DME1200 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1200 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04682 XEO_CLAS Peptide DME1200 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 microM) DME1200 XEOTICID XEO04682 GENEFORM Protein DME1200 XEOTICID XEO04682 MOACRIVE Inhibition DME1200 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1200 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04683 XEO_CLAS Peptide DME1200 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 microM) DME1200 XEOTICID XEO04683 GENEFORM Protein DME1200 XEOTICID XEO04683 MOACRIVE Inhibition DME1200 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1200 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04684 XEO_CLAS Peptide DME1200 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 38 microM) DME1200 XEOTICID XEO04684 GENEFORM Protein DME1200 XEOTICID XEO04684 MOACRIVE Inhibition DME1200 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1200 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04690 XEO_CLAS Peptide DME1200 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.5 ug/ml) DME1200 XEOTICID XEO04690 GENEFORM Protein DME1200 XEOTICID XEO04690 MOACRIVE Inhibition DME1200 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1200 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04695 XEO_CLAS Peptide DME1200 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04695 GENEFORM Protein DME1200 XEOTICID XEO04695 MOACRIVE Inhibition DME1200 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1200 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04696 XEO_CLAS Peptide DME1200 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04696 GENEFORM Protein DME1200 XEOTICID XEO04696 MOACRIVE Inhibition DME1200 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1200 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04712 XEO_CLAS Peptide DME1200 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16.7 microM) DME1200 XEOTICID XEO04712 GENEFORM Protein DME1200 XEOTICID XEO04712 MOACRIVE Inhibition DME1200 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1200 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04713 XEO_CLAS Peptide DME1200 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16.7 microM) DME1200 XEOTICID XEO04713 GENEFORM Protein DME1200 XEOTICID XEO04713 MOACRIVE Inhibition DME1200 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1200 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04714 XEO_CLAS Peptide DME1200 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 23.3 microM) DME1200 XEOTICID XEO04714 GENEFORM Protein DME1200 XEOTICID XEO04714 MOACRIVE Inhibition DME1200 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1200 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04716 XEO_CLAS Peptide DME1200 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 microM) DME1200 XEOTICID XEO04716 GENEFORM Protein DME1200 XEOTICID XEO04716 MOACRIVE Inhibition DME1200 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1200 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04717 XEO_CLAS Peptide DME1200 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 50 microM) DME1200 XEOTICID XEO04717 GENEFORM Protein DME1200 XEOTICID XEO04717 MOACRIVE Inhibition DME1200 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1200 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04725 XEO_CLAS Peptide DME1200 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04725 GENEFORM Protein DME1200 XEOTICID XEO04725 MOACRIVE Inhibition DME1200 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1200 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04726 XEO_CLAS Peptide DME1200 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04726 GENEFORM Protein DME1200 XEOTICID XEO04726 MOACRIVE Inhibition DME1200 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1200 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04731 XEO_CLAS Peptide DME1200 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 ug/ml) DME1200 XEOTICID XEO04731 GENEFORM Protein DME1200 XEOTICID XEO04731 MOACRIVE Inhibition DME1200 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1200 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04732 XEO_CLAS Peptide DME1200 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 25 ug/ml) DME1200 XEOTICID XEO04732 GENEFORM Protein DME1200 XEOTICID XEO04732 MOACRIVE Inhibition DME1200 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1200 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04733 XEO_CLAS Peptide DME1200 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04733 GENEFORM Protein DME1200 XEOTICID XEO04733 MOACRIVE Inhibition DME1200 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1200 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04734 XEO_CLAS Peptide DME1200 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04734 GENEFORM Protein DME1200 XEOTICID XEO04734 MOACRIVE Inhibition DME1200 XEOTICID XEO04737 XEO_NAME Protonectin DME1200 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04737 XEO_CLAS Peptide DME1200 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 ug/ml) DME1200 XEOTICID XEO04737 GENEFORM Protein DME1200 XEOTICID XEO04737 MOACRIVE Inhibition DME1200 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1200 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04739 XEO_CLAS Peptide DME1200 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04739 GENEFORM Protein DME1200 XEOTICID XEO04739 MOACRIVE Inhibition DME1200 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1200 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04740 XEO_CLAS Peptide DME1200 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04740 GENEFORM Protein DME1200 XEOTICID XEO04740 MOACRIVE Inhibition DME1200 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1200 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04741 XEO_CLAS Peptide DME1200 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04741 GENEFORM Protein DME1200 XEOTICID XEO04741 MOACRIVE Inhibition DME1200 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1200 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04742 XEO_CLAS Peptide DME1200 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04742 GENEFORM Protein DME1200 XEOTICID XEO04742 MOACRIVE Inhibition DME1200 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1200 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04762 XEO_CLAS Peptide DME1200 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.8 microM) DME1200 XEOTICID XEO04762 GENEFORM Protein DME1200 XEOTICID XEO04762 MOACRIVE Inhibition DME1200 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1200 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04766 XEO_CLAS Peptide DME1200 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.1 microM) DME1200 XEOTICID XEO04766 GENEFORM Protein DME1200 XEOTICID XEO04766 MOACRIVE Inhibition DME1200 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1200 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04767 XEO_CLAS Peptide DME1200 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.1 ug/ml) DME1200 XEOTICID XEO04767 GENEFORM Protein DME1200 XEOTICID XEO04767 MOACRIVE Inhibition DME1200 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1200 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04779 XEO_CLAS Peptide DME1200 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04779 GENEFORM Protein DME1200 XEOTICID XEO04779 MOACRIVE Inhibition DME1200 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1200 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04780 XEO_CLAS Peptide DME1200 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04780 GENEFORM Protein DME1200 XEOTICID XEO04780 MOACRIVE Inhibition DME1200 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1200 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04781 XEO_CLAS Peptide DME1200 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04781 GENEFORM Protein DME1200 XEOTICID XEO04781 MOACRIVE Inhibition DME1200 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1200 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04782 XEO_CLAS Peptide DME1200 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 ug/ml) DME1200 XEOTICID XEO04782 GENEFORM Protein DME1200 XEOTICID XEO04782 MOACRIVE Inhibition DME1200 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1200 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04783 XEO_CLAS Peptide DME1200 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO04783 GENEFORM Protein DME1200 XEOTICID XEO04783 MOACRIVE Inhibition DME1200 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1200 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04784 XEO_CLAS Peptide DME1200 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO04784 GENEFORM Protein DME1200 XEOTICID XEO04784 MOACRIVE Inhibition DME1200 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1200 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04785 XEO_CLAS Peptide DME1200 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO04785 GENEFORM Protein DME1200 XEOTICID XEO04785 MOACRIVE Inhibition DME1200 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1200 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04786 XEO_CLAS Peptide DME1200 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 ug/ml) DME1200 XEOTICID XEO04786 GENEFORM Protein DME1200 XEOTICID XEO04786 MOACRIVE Inhibition DME1200 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1200 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04787 XEO_CLAS Peptide DME1200 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04787 GENEFORM Protein DME1200 XEOTICID XEO04787 MOACRIVE Inhibition DME1200 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1200 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04793 XEO_CLAS Peptide DME1200 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04793 GENEFORM Protein DME1200 XEOTICID XEO04793 MOACRIVE Inhibition DME1200 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1200 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04798 XEO_CLAS Peptide DME1200 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 microM) DME1200 XEOTICID XEO04798 GENEFORM Protein DME1200 XEOTICID XEO04798 MOACRIVE Inhibition DME1200 XEOTICID XEO04799 XEO_NAME Ranalexin DME1200 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04799 XEO_CLAS Peptide DME1200 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 32 ug/ml) DME1200 XEOTICID XEO04799 GENEFORM Protein DME1200 XEOTICID XEO04799 MOACRIVE Inhibition DME1200 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1200 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04800 XEO_CLAS Peptide DME1200 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 microM) DME1200 XEOTICID XEO04800 GENEFORM Protein DME1200 XEOTICID XEO04800 MOACRIVE Inhibition DME1200 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1200 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04801 XEO_CLAS Peptide DME1200 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 9 microM) DME1200 XEOTICID XEO04801 GENEFORM Protein DME1200 XEOTICID XEO04801 MOACRIVE Inhibition DME1200 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1200 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04802 XEO_CLAS Peptide DME1200 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12 microM) DME1200 XEOTICID XEO04802 GENEFORM Protein DME1200 XEOTICID XEO04802 MOACRIVE Inhibition DME1200 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1200 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04803 XEO_CLAS Peptide DME1200 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO04803 GENEFORM Protein DME1200 XEOTICID XEO04803 MOACRIVE Inhibition DME1200 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1200 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04804 XEO_CLAS Peptide DME1200 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO04804 GENEFORM Protein DME1200 XEOTICID XEO04804 MOACRIVE Inhibition DME1200 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1200 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04805 XEO_CLAS Peptide DME1200 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.5 microM) DME1200 XEOTICID XEO04805 GENEFORM Protein DME1200 XEOTICID XEO04805 MOACRIVE Inhibition DME1200 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1200 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04806 XEO_CLAS Peptide DME1200 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.5 microM) DME1200 XEOTICID XEO04806 GENEFORM Protein DME1200 XEOTICID XEO04806 MOACRIVE Inhibition DME1200 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1200 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04807 XEO_CLAS Peptide DME1200 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04807 GENEFORM Protein DME1200 XEOTICID XEO04807 MOACRIVE Inhibition DME1200 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1200 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04809 XEO_CLAS Peptide DME1200 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 microM) DME1200 XEOTICID XEO04809 GENEFORM Protein DME1200 XEOTICID XEO04809 MOACRIVE Inhibition DME1200 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1200 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04811 XEO_CLAS Peptide DME1200 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO04811 GENEFORM Protein DME1200 XEOTICID XEO04811 MOACRIVE Inhibition DME1200 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1200 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04812 XEO_CLAS Peptide DME1200 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO04812 GENEFORM Protein DME1200 XEOTICID XEO04812 MOACRIVE Inhibition DME1200 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1200 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04813 XEO_CLAS Peptide DME1200 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 microM) DME1200 XEOTICID XEO04813 GENEFORM Protein DME1200 XEOTICID XEO04813 MOACRIVE Inhibition DME1200 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1200 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04814 XEO_CLAS Peptide DME1200 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 19 microM) DME1200 XEOTICID XEO04814 GENEFORM Protein DME1200 XEOTICID XEO04814 MOACRIVE Inhibition DME1200 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1200 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04815 XEO_CLAS Peptide DME1200 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 microM) DME1200 XEOTICID XEO04815 GENEFORM Protein DME1200 XEOTICID XEO04815 MOACRIVE Inhibition DME1200 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1200 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04816 XEO_CLAS Peptide DME1200 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 microM) DME1200 XEOTICID XEO04816 GENEFORM Protein DME1200 XEOTICID XEO04816 MOACRIVE Inhibition DME1200 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1200 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04817 XEO_CLAS Peptide DME1200 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 13 microM) DME1200 XEOTICID XEO04817 GENEFORM Protein DME1200 XEOTICID XEO04817 MOACRIVE Inhibition DME1200 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1200 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04818 XEO_CLAS Peptide DME1200 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO04818 GENEFORM Protein DME1200 XEOTICID XEO04818 MOACRIVE Inhibition DME1200 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1200 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04819 XEO_CLAS Peptide DME1200 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO04819 GENEFORM Protein DME1200 XEOTICID XEO04819 MOACRIVE Inhibition DME1200 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1200 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04820 XEO_CLAS Peptide DME1200 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3 microM) DME1200 XEOTICID XEO04820 GENEFORM Protein DME1200 XEOTICID XEO04820 MOACRIVE Inhibition DME1200 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1200 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04821 XEO_CLAS Peptide DME1200 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 microM) DME1200 XEOTICID XEO04821 GENEFORM Protein DME1200 XEOTICID XEO04821 MOACRIVE Inhibition DME1200 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1200 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04822 XEO_CLAS Peptide DME1200 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO04822 GENEFORM Protein DME1200 XEOTICID XEO04822 MOACRIVE Inhibition DME1200 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1200 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04823 XEO_CLAS Peptide DME1200 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 23 microM) DME1200 XEOTICID XEO04823 GENEFORM Protein DME1200 XEOTICID XEO04823 MOACRIVE Inhibition DME1200 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1200 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04824 XEO_CLAS Peptide DME1200 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04824 GENEFORM Protein DME1200 XEOTICID XEO04824 MOACRIVE Inhibition DME1200 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1200 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04825 XEO_CLAS Peptide DME1200 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04825 GENEFORM Protein DME1200 XEOTICID XEO04825 MOACRIVE Inhibition DME1200 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1200 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04826 XEO_CLAS Peptide DME1200 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO04826 GENEFORM Protein DME1200 XEOTICID XEO04826 MOACRIVE Inhibition DME1200 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1200 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04827 XEO_CLAS Peptide DME1200 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO04827 GENEFORM Protein DME1200 XEOTICID XEO04827 MOACRIVE Inhibition DME1200 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1200 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04835 XEO_CLAS Peptide DME1200 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04835 GENEFORM Protein DME1200 XEOTICID XEO04835 MOACRIVE Inhibition DME1200 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1200 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04836 XEO_CLAS Peptide DME1200 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04836 GENEFORM Protein DME1200 XEOTICID XEO04836 MOACRIVE Inhibition DME1200 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1200 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04837 XEO_CLAS Peptide DME1200 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 microM) DME1200 XEOTICID XEO04837 GENEFORM Protein DME1200 XEOTICID XEO04837 MOACRIVE Inhibition DME1200 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1200 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04839 XEO_CLAS Peptide DME1200 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04839 GENEFORM Protein DME1200 XEOTICID XEO04839 MOACRIVE Inhibition DME1200 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1200 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04840 XEO_CLAS Peptide DME1200 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 35-20 microM) DME1200 XEOTICID XEO04840 GENEFORM Protein DME1200 XEOTICID XEO04840 MOACRIVE Inhibition DME1200 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1200 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04847 XEO_CLAS Peptide DME1200 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04847 GENEFORM Protein DME1200 XEOTICID XEO04847 MOACRIVE Inhibition DME1200 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1200 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04848 XEO_CLAS Peptide DME1200 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04848 GENEFORM Protein DME1200 XEOTICID XEO04848 MOACRIVE Inhibition DME1200 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1200 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04849 XEO_CLAS Peptide DME1200 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04849 GENEFORM Protein DME1200 XEOTICID XEO04849 MOACRIVE Inhibition DME1200 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1200 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04850 XEO_CLAS Peptide DME1200 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04850 GENEFORM Protein DME1200 XEOTICID XEO04850 MOACRIVE Inhibition DME1200 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1200 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04851 XEO_CLAS Peptide DME1200 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1 ug/ml) DME1200 XEOTICID XEO04851 GENEFORM Protein DME1200 XEOTICID XEO04851 MOACRIVE Inhibition DME1200 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1200 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04857 XEO_CLAS Peptide DME1200 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 microM) DME1200 XEOTICID XEO04857 GENEFORM Protein DME1200 XEOTICID XEO04857 MOACRIVE Inhibition DME1200 XEOTICID XEO04863 XEO_NAME RTD peptide DME1200 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04863 XEO_CLAS Peptide DME1200 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.0 microM) DME1200 XEOTICID XEO04863 GENEFORM Protein DME1200 XEOTICID XEO04863 MOACRIVE Inhibition DME1200 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1200 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04865 XEO_CLAS Peptide DME1200 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 ug/ml) DME1200 XEOTICID XEO04865 GENEFORM Protein DME1200 XEOTICID XEO04865 MOACRIVE Inhibition DME1200 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1200 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04866 XEO_CLAS Peptide DME1200 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12.5 ug/ml) DME1200 XEOTICID XEO04866 GENEFORM Protein DME1200 XEOTICID XEO04866 MOACRIVE Inhibition DME1200 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1200 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04868 XEO_CLAS Peptide DME1200 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25.00 ug/ml) DME1200 XEOTICID XEO04868 GENEFORM Protein DME1200 XEOTICID XEO04868 MOACRIVE Inhibition DME1200 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1200 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04869 XEO_CLAS Peptide DME1200 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25.00 ug/ml) DME1200 XEOTICID XEO04869 GENEFORM Protein DME1200 XEOTICID XEO04869 MOACRIVE Inhibition DME1200 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1200 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04870 XEO_CLAS Peptide DME1200 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25.00 ug/ml) DME1200 XEOTICID XEO04870 GENEFORM Protein DME1200 XEOTICID XEO04870 MOACRIVE Inhibition DME1200 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1200 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04877 XEO_CLAS Peptide DME1200 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04877 GENEFORM Protein DME1200 XEOTICID XEO04877 MOACRIVE Inhibition DME1200 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1200 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04880 XEO_CLAS Peptide DME1200 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.5 ug/ml) DME1200 XEOTICID XEO04880 GENEFORM Protein DME1200 XEOTICID XEO04880 MOACRIVE Inhibition DME1200 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1200 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04886 XEO_CLAS Peptide DME1200 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.6 ug/ml) DME1200 XEOTICID XEO04886 GENEFORM Protein DME1200 XEOTICID XEO04886 MOACRIVE Inhibition DME1200 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1200 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04891 XEO_CLAS Peptide DME1200 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04891 GENEFORM Protein DME1200 XEOTICID XEO04891 MOACRIVE Inhibition DME1200 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1200 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04895 XEO_CLAS Peptide DME1200 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04895 GENEFORM Protein DME1200 XEOTICID XEO04895 MOACRIVE Inhibition DME1200 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1200 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04901 XEO_CLAS Peptide DME1200 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 microM) DME1200 XEOTICID XEO04901 GENEFORM Protein DME1200 XEOTICID XEO04901 MOACRIVE Inhibition DME1200 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1200 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04904 XEO_CLAS Peptide DME1200 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 78 ug/ml) DME1200 XEOTICID XEO04904 GENEFORM Protein DME1200 XEOTICID XEO04904 MOACRIVE Inhibition DME1200 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1200 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04905 XEO_CLAS Peptide DME1200 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04905 GENEFORM Protein DME1200 XEOTICID XEO04905 MOACRIVE Inhibition DME1200 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1200 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04906 XEO_CLAS Peptide DME1200 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04906 GENEFORM Protein DME1200 XEOTICID XEO04906 MOACRIVE Inhibition DME1200 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1200 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04907 XEO_CLAS Peptide DME1200 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04907 GENEFORM Protein DME1200 XEOTICID XEO04907 MOACRIVE Inhibition DME1200 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1200 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04908 XEO_CLAS Peptide DME1200 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04908 GENEFORM Protein DME1200 XEOTICID XEO04908 MOACRIVE Inhibition DME1200 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1200 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04909 XEO_CLAS Peptide DME1200 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04909 GENEFORM Protein DME1200 XEOTICID XEO04909 MOACRIVE Inhibition DME1200 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1200 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04915 XEO_CLAS Peptide DME1200 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 100 ug/ml) DME1200 XEOTICID XEO04915 GENEFORM Protein DME1200 XEOTICID XEO04915 MOACRIVE Inhibition DME1200 XEOTICID XEO04916 XEO_NAME Scopoletin DME1200 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1200 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04916 GENEFORM Protein DME1200 XEOTICID XEO04916 MOACRIVE Inhibition DME1200 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1200 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04926 XEO_CLAS Peptide DME1200 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04926 GENEFORM Protein DME1200 XEOTICID XEO04926 MOACRIVE Inhibition DME1200 XEOTICID XEO04931 XEO_NAME Shepherin I DME1200 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04931 XEO_CLAS Peptide DME1200 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04931 GENEFORM Protein DME1200 XEOTICID XEO04931 MOACRIVE Inhibition DME1200 XEOTICID XEO04932 XEO_NAME shepherin II DME1200 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04932 XEO_CLAS Peptide DME1200 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04932 GENEFORM Protein DME1200 XEOTICID XEO04932 MOACRIVE Inhibition DME1200 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1200 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04938 XEO_CLAS Peptide DME1200 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC <= 100 microM) DME1200 XEOTICID XEO04938 GENEFORM Protein DME1200 XEOTICID XEO04938 MOACRIVE Inhibition DME1200 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1200 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04947 XEO_CLAS Natural Product DME1200 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04947 GENEFORM Protein DME1200 XEOTICID XEO04947 MOACRIVE Inhibition DME1200 XEOTICID XEO04948 XEO_NAME Sinensetin DME1200 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1200 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1200 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04948 GENEFORM Protein DME1200 XEOTICID XEO04948 MOACRIVE Inhibition DME1200 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1200 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04950 XEO_CLAS Peptide DME1200 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 ug/ml) DME1200 XEOTICID XEO04950 GENEFORM Protein DME1200 XEOTICID XEO04950 MOACRIVE Inhibition DME1200 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1200 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04955 XEO_CLAS Peptide DME1200 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.07 microM) DME1200 XEOTICID XEO04955 GENEFORM Protein DME1200 XEOTICID XEO04955 MOACRIVE Inhibition DME1200 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1200 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04956 XEO_CLAS Peptide DME1200 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16.0 microM) DME1200 XEOTICID XEO04956 GENEFORM Protein DME1200 XEOTICID XEO04956 MOACRIVE Inhibition DME1200 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1200 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04957 XEO_CLAS Peptide DME1200 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.23 microM) DME1200 XEOTICID XEO04957 GENEFORM Protein DME1200 XEOTICID XEO04957 MOACRIVE Inhibition DME1200 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1200 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04958 XEO_CLAS Peptide DME1200 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 ug/ml) DME1200 XEOTICID XEO04958 GENEFORM Protein DME1200 XEOTICID XEO04958 MOACRIVE Inhibition DME1200 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1200 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04959 XEO_CLAS Peptide DME1200 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04959 GENEFORM Protein DME1200 XEOTICID XEO04959 MOACRIVE Inhibition DME1200 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1200 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04967 XEO_CLAS Peptide DME1200 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 28 microM) DME1200 XEOTICID XEO04967 GENEFORM Protein DME1200 XEOTICID XEO04967 MOACRIVE Inhibition DME1200 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1200 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04969 XEO_CLAS Peptide DME1200 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50-100 ug/ml) DME1200 XEOTICID XEO04969 GENEFORM Protein DME1200 XEOTICID XEO04969 MOACRIVE Inhibition DME1200 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1200 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04970 XEO_CLAS Peptide DME1200 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04970 GENEFORM Protein DME1200 XEOTICID XEO04970 MOACRIVE Inhibition DME1200 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1200 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04971 XEO_CLAS Peptide DME1200 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.8-1.5 microM) DME1200 XEOTICID XEO04971 GENEFORM Protein DME1200 XEOTICID XEO04971 MOACRIVE Inhibition DME1200 XEOTICID XEO04974 XEO_NAME Spinigerin DME1200 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04974 XEO_CLAS Peptide DME1200 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3-6 microM) DME1200 XEOTICID XEO04974 GENEFORM Protein DME1200 XEOTICID XEO04974 MOACRIVE Inhibition DME1200 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1200 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1200 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04975 GENEFORM Protein DME1200 XEOTICID XEO04975 MOACRIVE Inhibition DME1200 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1200 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1200 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04976 GENEFORM Protein DME1200 XEOTICID XEO04976 MOACRIVE Inhibition DME1200 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1200 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1200 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04977 GENEFORM Protein DME1200 XEOTICID XEO04977 MOACRIVE Inhibition DME1200 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1200 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1200 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04978 GENEFORM Protein DME1200 XEOTICID XEO04978 MOACRIVE Inhibition DME1200 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1200 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1200 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04979 GENEFORM Protein DME1200 XEOTICID XEO04979 MOACRIVE Inhibition DME1200 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1200 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04981 XEO_CLAS Peptide DME1200 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10.1 microM) DME1200 XEOTICID XEO04981 GENEFORM Protein DME1200 XEOTICID XEO04981 MOACRIVE Inhibition DME1200 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1200 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04982 XEO_CLAS Peptide DME1200 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40.5 microM) DME1200 XEOTICID XEO04982 GENEFORM Protein DME1200 XEOTICID XEO04982 MOACRIVE Inhibition DME1200 XEOTICID XEO04994 XEO_NAME Stilbene DME1200 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1200 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1200 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO04994 GENEFORM Protein DME1200 XEOTICID XEO04994 MOACRIVE Inhibition DME1200 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1200 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04995 XEO_CLAS Peptide DME1200 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC < 0.19 microM) DME1200 XEOTICID XEO04995 GENEFORM Protein DME1200 XEOTICID XEO04995 MOACRIVE Inhibition DME1200 XEOTICID XEO04998 XEO_NAME Styelin A DME1200 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04998 XEO_CLAS Peptide DME1200 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.7 ug/ml) DME1200 XEOTICID XEO04998 GENEFORM Protein DME1200 XEOTICID XEO04998 MOACRIVE Inhibition DME1200 XEOTICID XEO04999 XEO_NAME Styelin B DME1200 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO04999 XEO_CLAS Peptide DME1200 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.7 ug/ml) DME1200 XEOTICID XEO04999 GENEFORM Protein DME1200 XEOTICID XEO04999 MOACRIVE Inhibition DME1200 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1200 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05000 XEO_CLAS Peptide DME1200 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO05000 GENEFORM Protein DME1200 XEOTICID XEO05000 MOACRIVE Inhibition DME1200 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1200 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05001 XEO_CLAS Peptide DME1200 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.5 ug/ml) DME1200 XEOTICID XEO05001 GENEFORM Protein DME1200 XEOTICID XEO05001 MOACRIVE Inhibition DME1200 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1200 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05002 XEO_CLAS Peptide DME1200 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO05002 GENEFORM Protein DME1200 XEOTICID XEO05002 MOACRIVE Inhibition DME1200 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1200 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05003 XEO_CLAS Peptide DME1200 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO05003 GENEFORM Protein DME1200 XEOTICID XEO05003 MOACRIVE Inhibition DME1200 XEOTICID XEO05006 XEO_NAME Substance P DME1200 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05006 XEO_CLAS Peptide DME1200 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05006 GENEFORM Protein DME1200 XEOTICID XEO05006 MOACRIVE Inhibition DME1200 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1200 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05007 XEO_CLAS Peptide DME1200 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05007 GENEFORM Protein DME1200 XEOTICID XEO05007 MOACRIVE Inhibition DME1200 XEOTICID XEO05008 XEO_NAME Subtilosin DME1200 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05008 XEO_CLAS Peptide DME1200 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05008 GENEFORM Protein DME1200 XEOTICID XEO05008 MOACRIVE Inhibition DME1200 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1200 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05013 XEO_CLAS Peptide DME1200 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO05013 GENEFORM Protein DME1200 XEOTICID XEO05013 MOACRIVE Inhibition DME1200 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1200 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05014 XEO_CLAS Peptide DME1200 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO05014 GENEFORM Protein DME1200 XEOTICID XEO05014 MOACRIVE Inhibition DME1200 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1200 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05015 XEO_CLAS Peptide DME1200 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO05015 GENEFORM Protein DME1200 XEOTICID XEO05015 MOACRIVE Inhibition DME1200 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1200 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05016 XEO_CLAS Peptide DME1200 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO05016 GENEFORM Protein DME1200 XEOTICID XEO05016 MOACRIVE Inhibition DME1200 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1200 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05017 XEO_CLAS Peptide DME1200 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 20 ug/ml) DME1200 XEOTICID XEO05017 GENEFORM Protein DME1200 XEOTICID XEO05017 MOACRIVE Inhibition DME1200 XEOTICID XEO05018 XEO_NAME Syringic acid DME1200 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1200 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05018 GENEFORM Protein DME1200 XEOTICID XEO05018 MOACRIVE Inhibition DME1200 XEOTICID XEO05020 XEO_NAME Tachycitin DME1200 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05020 XEO_CLAS Peptide DME1200 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05020 GENEFORM Protein DME1200 XEOTICID XEO05020 MOACRIVE Inhibition DME1200 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1200 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05023 XEO_CLAS Peptide DME1200 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05023 GENEFORM Protein DME1200 XEOTICID XEO05023 MOACRIVE Inhibition DME1200 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1200 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05024 XEO_CLAS Peptide DME1200 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05024 GENEFORM Protein DME1200 XEOTICID XEO05024 MOACRIVE Inhibition DME1200 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1200 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05027 XEO_CLAS Peptide DME1200 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05027 GENEFORM Protein DME1200 XEOTICID XEO05027 MOACRIVE Inhibition DME1200 XEOTICID XEO05031 XEO_NAME Tannic acid DME1200 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1200 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05031 GENEFORM Protein DME1200 XEOTICID XEO05031 MOACRIVE Inhibition DME1200 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1200 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05033 XEO_CLAS Peptide DME1200 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05033 GENEFORM Protein DME1200 XEOTICID XEO05033 MOACRIVE Inhibition DME1200 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1200 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05042 XEO_CLAS Peptide DME1200 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO05042 GENEFORM Protein DME1200 XEOTICID XEO05042 MOACRIVE Inhibition DME1200 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1200 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05043 XEO_CLAS Peptide DME1200 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO05043 GENEFORM Protein DME1200 XEOTICID XEO05043 MOACRIVE Inhibition DME1200 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1200 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05044 XEO_CLAS Peptide DME1200 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 128 microM) DME1200 XEOTICID XEO05044 GENEFORM Protein DME1200 XEOTICID XEO05044 MOACRIVE Inhibition DME1200 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1200 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05045 XEO_CLAS Peptide DME1200 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 128 microM) DME1200 XEOTICID XEO05045 GENEFORM Protein DME1200 XEOTICID XEO05045 MOACRIVE Inhibition DME1200 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1200 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05046 XEO_CLAS Peptide DME1200 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 microM) DME1200 XEOTICID XEO05046 GENEFORM Protein DME1200 XEOTICID XEO05046 MOACRIVE Inhibition DME1200 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1200 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05047 XEO_CLAS Peptide DME1200 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 60 microM) DME1200 XEOTICID XEO05047 GENEFORM Protein DME1200 XEOTICID XEO05047 MOACRIVE Inhibition DME1200 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1200 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05051 XEO_CLAS Peptide DME1200 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05051 GENEFORM Protein DME1200 XEOTICID XEO05051 MOACRIVE Inhibition DME1200 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1200 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05055 XEO_CLAS Peptide DME1200 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 70 microM) DME1200 XEOTICID XEO05055 GENEFORM Protein DME1200 XEOTICID XEO05055 MOACRIVE Inhibition DME1200 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1200 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05056 XEO_CLAS Peptide DME1200 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05056 GENEFORM Protein DME1200 XEOTICID XEO05056 MOACRIVE Inhibition DME1200 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1200 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05059 XEO_CLAS Peptide DME1200 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05059 GENEFORM Protein DME1200 XEOTICID XEO05059 MOACRIVE Inhibition DME1200 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1200 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05061 XEO_CLAS Peptide DME1200 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO05061 GENEFORM Protein DME1200 XEOTICID XEO05061 MOACRIVE Inhibition DME1200 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1200 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05062 XEO_CLAS Peptide DME1200 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05062 GENEFORM Protein DME1200 XEOTICID XEO05062 MOACRIVE Inhibition DME1200 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1200 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05063 XEO_CLAS Peptide DME1200 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO05063 GENEFORM Protein DME1200 XEOTICID XEO05063 MOACRIVE Inhibition DME1200 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1200 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05064 XEO_CLAS Peptide DME1200 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 231 microM) DME1200 XEOTICID XEO05064 GENEFORM Protein DME1200 XEOTICID XEO05064 MOACRIVE Inhibition DME1200 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1200 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05065 XEO_CLAS Peptide DME1200 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 161 ug/ml) DME1200 XEOTICID XEO05065 GENEFORM Protein DME1200 XEOTICID XEO05065 MOACRIVE Inhibition DME1200 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1200 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05069 XEO_CLAS Peptide DME1200 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO05069 GENEFORM Protein DME1200 XEOTICID XEO05069 MOACRIVE Inhibition DME1200 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1200 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05070 XEO_CLAS Peptide DME1200 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 37.5 microM) DME1200 XEOTICID XEO05070 GENEFORM Protein DME1200 XEOTICID XEO05070 MOACRIVE Inhibition DME1200 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1200 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05071 XEO_CLAS Peptide DME1200 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 150 microM) DME1200 XEOTICID XEO05071 GENEFORM Protein DME1200 XEOTICID XEO05071 MOACRIVE Inhibition DME1200 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1200 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05072 XEO_CLAS Peptide DME1200 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO05072 GENEFORM Protein DME1200 XEOTICID XEO05072 MOACRIVE Inhibition DME1200 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1200 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05073 XEO_CLAS Peptide DME1200 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40 microM) DME1200 XEOTICID XEO05073 GENEFORM Protein DME1200 XEOTICID XEO05073 MOACRIVE Inhibition DME1200 XEOTICID XEO05076 XEO_NAME Temporin-A DME1200 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05076 XEO_CLAS Peptide DME1200 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 11.9 microM) DME1200 XEOTICID XEO05076 GENEFORM Protein DME1200 XEOTICID XEO05076 MOACRIVE Inhibition DME1200 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1200 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05077 XEO_CLAS Peptide DME1200 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.25 ug/ml) DME1200 XEOTICID XEO05077 GENEFORM Protein DME1200 XEOTICID XEO05077 MOACRIVE Inhibition DME1200 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1200 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05078 XEO_CLAS Peptide DME1200 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.25 ug/ml) DME1200 XEOTICID XEO05078 GENEFORM Protein DME1200 XEOTICID XEO05078 MOACRIVE Inhibition DME1200 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1200 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05079 XEO_CLAS Peptide DME1200 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.5 ug/ml) DME1200 XEOTICID XEO05079 GENEFORM Protein DME1200 XEOTICID XEO05079 MOACRIVE Inhibition DME1200 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1200 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05080 XEO_CLAS Peptide DME1200 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 ug/ml) DME1200 XEOTICID XEO05080 GENEFORM Protein DME1200 XEOTICID XEO05080 MOACRIVE Inhibition DME1200 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1200 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05081 XEO_CLAS Peptide DME1200 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 5 ug/ml) DME1200 XEOTICID XEO05081 GENEFORM Protein DME1200 XEOTICID XEO05081 MOACRIVE Inhibition DME1200 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1200 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05082 XEO_CLAS Peptide DME1200 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 7.5 ug/ml) DME1200 XEOTICID XEO05082 GENEFORM Protein DME1200 XEOTICID XEO05082 MOACRIVE Inhibition DME1200 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1200 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05083 XEO_CLAS Peptide DME1200 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 ug/ml) DME1200 XEOTICID XEO05083 GENEFORM Protein DME1200 XEOTICID XEO05083 MOACRIVE Inhibition DME1200 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1200 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05084 XEO_CLAS Peptide DME1200 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 ug/ml) DME1200 XEOTICID XEO05084 GENEFORM Protein DME1200 XEOTICID XEO05084 MOACRIVE Inhibition DME1200 XEOTICID XEO05085 XEO_NAME Temporin-B DME1200 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05085 XEO_CLAS Peptide DME1200 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 21.0 ug/ml) DME1200 XEOTICID XEO05085 GENEFORM Protein DME1200 XEOTICID XEO05085 MOACRIVE Inhibition DME1200 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1200 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05086 XEO_CLAS Peptide DME1200 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC > 100 microM) DME1200 XEOTICID XEO05086 GENEFORM Protein DME1200 XEOTICID XEO05086 MOACRIVE Inhibition DME1200 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1200 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05087 XEO_CLAS Peptide DME1200 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO05087 GENEFORM Protein DME1200 XEOTICID XEO05087 MOACRIVE Inhibition DME1200 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1200 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05097 XEO_CLAS Peptide DME1200 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16.0 microM) DME1200 XEOTICID XEO05097 GENEFORM Protein DME1200 XEOTICID XEO05097 MOACRIVE Inhibition DME1200 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1200 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05099 XEO_CLAS Peptide DME1200 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.0 microM) DME1200 XEOTICID XEO05099 GENEFORM Protein DME1200 XEOTICID XEO05099 MOACRIVE Inhibition DME1200 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1200 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05100 XEO_CLAS Peptide DME1200 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05100 GENEFORM Protein DME1200 XEOTICID XEO05100 MOACRIVE Inhibition DME1200 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1200 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05101 XEO_CLAS Peptide DME1200 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 24.2 ug/ml) DME1200 XEOTICID XEO05101 GENEFORM Protein DME1200 XEOTICID XEO05101 MOACRIVE Inhibition DME1200 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1200 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05102 XEO_CLAS Peptide DME1200 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 34.5 ug/ml) DME1200 XEOTICID XEO05102 GENEFORM Protein DME1200 XEOTICID XEO05102 MOACRIVE Inhibition DME1200 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1200 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05105 XEO_CLAS Peptide DME1200 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO05105 GENEFORM Protein DME1200 XEOTICID XEO05105 MOACRIVE Inhibition DME1200 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1200 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05106 XEO_CLAS Peptide DME1200 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25-200 microM) DME1200 XEOTICID XEO05106 GENEFORM Protein DME1200 XEOTICID XEO05106 MOACRIVE Inhibition DME1200 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1200 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05108 XEO_CLAS Peptide DME1200 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40 microM) DME1200 XEOTICID XEO05108 GENEFORM Protein DME1200 XEOTICID XEO05108 MOACRIVE Inhibition DME1200 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1200 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1200 XEOTICID XEO05111 XEO_CLAS Natural Product DME1200 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05111 GENEFORM Protein DME1200 XEOTICID XEO05111 MOACRIVE Inhibition DME1200 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1200 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05119 XEO_CLAS Peptide DME1200 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05119 GENEFORM Protein DME1200 XEOTICID XEO05119 MOACRIVE Inhibition DME1200 XEOTICID XEO05120 XEO_NAME Thanatin DME1200 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05120 XEO_CLAS Peptide DME1200 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1200 XEOTICID XEO05120 GENEFORM Protein DME1200 XEOTICID XEO05120 MOACRIVE Inhibition DME1200 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1200 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05121 XEO_CLAS Peptide DME1200 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 62.5 ug/ml) DME1200 XEOTICID XEO05121 GENEFORM Protein DME1200 XEOTICID XEO05121 MOACRIVE Inhibition DME1200 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1200 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05125 XEO_CLAS Peptide DME1200 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05125 GENEFORM Protein DME1200 XEOTICID XEO05125 MOACRIVE Inhibition DME1200 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1200 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05130 XEO_CLAS Peptide DME1200 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05130 GENEFORM Protein DME1200 XEOTICID XEO05130 MOACRIVE Inhibition DME1200 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1200 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05144 XEO_CLAS Peptide DME1200 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40 ug/ml) DME1200 XEOTICID XEO05144 GENEFORM Protein DME1200 XEOTICID XEO05144 MOACRIVE Inhibition DME1200 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1200 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05145 XEO_CLAS Peptide DME1200 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 ug/ml) DME1200 XEOTICID XEO05145 GENEFORM Protein DME1200 XEOTICID XEO05145 MOACRIVE Inhibition DME1200 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1200 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05146 XEO_CLAS Peptide DME1200 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 40 ug/ml) DME1200 XEOTICID XEO05146 GENEFORM Protein DME1200 XEOTICID XEO05146 MOACRIVE Inhibition DME1200 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1200 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05147 XEO_CLAS Peptide DME1200 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 60 ug/ml) DME1200 XEOTICID XEO05147 GENEFORM Protein DME1200 XEOTICID XEO05147 MOACRIVE Inhibition DME1200 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1200 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05158 XEO_CLAS Peptide DME1200 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05158 GENEFORM Protein DME1200 XEOTICID XEO05158 MOACRIVE Inhibition DME1200 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1200 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05161 XEO_CLAS Peptide DME1200 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 32 ug/ml) DME1200 XEOTICID XEO05161 GENEFORM Protein DME1200 XEOTICID XEO05161 MOACRIVE Inhibition DME1200 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1200 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05162 XEO_CLAS Peptide DME1200 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 32 ug/ml) DME1200 XEOTICID XEO05162 GENEFORM Protein DME1200 XEOTICID XEO05162 MOACRIVE Inhibition DME1200 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1200 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05163 XEO_CLAS Peptide DME1200 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 12-25 ug/ml) DME1200 XEOTICID XEO05163 GENEFORM Protein DME1200 XEOTICID XEO05163 MOACRIVE Inhibition DME1200 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1200 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05170 XEO_CLAS Peptide DME1200 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 3.0 microM) DME1200 XEOTICID XEO05170 GENEFORM Protein DME1200 XEOTICID XEO05170 MOACRIVE Inhibition DME1200 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1200 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05171 XEO_CLAS Peptide DME1200 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 50 microM) DME1200 XEOTICID XEO05171 GENEFORM Protein DME1200 XEOTICID XEO05171 MOACRIVE Inhibition DME1200 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1200 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05179 XEO_CLAS Peptide DME1200 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05179 GENEFORM Protein DME1200 XEOTICID XEO05179 MOACRIVE Inhibition DME1200 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1200 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05180 XEO_CLAS Peptide DME1200 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 160 microM) DME1200 XEOTICID XEO05180 GENEFORM Protein DME1200 XEOTICID XEO05180 MOACRIVE Inhibition DME1200 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1200 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05182 XEO_CLAS Peptide DME1200 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 microM) DME1200 XEOTICID XEO05182 GENEFORM Protein DME1200 XEOTICID XEO05182 MOACRIVE Inhibition DME1200 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1200 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05183 XEO_CLAS Peptide DME1200 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 microM) DME1200 XEOTICID XEO05183 GENEFORM Protein DME1200 XEOTICID XEO05183 MOACRIVE Inhibition DME1200 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1200 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05184 XEO_CLAS Peptide DME1200 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 microM) DME1200 XEOTICID XEO05184 GENEFORM Protein DME1200 XEOTICID XEO05184 MOACRIVE Inhibition DME1200 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1200 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05185 XEO_CLAS Peptide DME1200 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 microM) DME1200 XEOTICID XEO05185 GENEFORM Protein DME1200 XEOTICID XEO05185 MOACRIVE Inhibition DME1200 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1200 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05186 XEO_CLAS Peptide DME1200 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 microM) DME1200 XEOTICID XEO05186 GENEFORM Protein DME1200 XEOTICID XEO05186 MOACRIVE Inhibition DME1200 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1200 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05187 XEO_CLAS Peptide DME1200 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16 microM) DME1200 XEOTICID XEO05187 GENEFORM Protein DME1200 XEOTICID XEO05187 MOACRIVE Inhibition DME1200 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1200 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05188 XEO_CLAS Peptide DME1200 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 64 microM) DME1200 XEOTICID XEO05188 GENEFORM Protein DME1200 XEOTICID XEO05188 MOACRIVE Inhibition DME1200 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1200 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05190 XEO_CLAS Peptide DME1200 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05190 GENEFORM Protein DME1200 XEOTICID XEO05190 MOACRIVE Inhibition DME1200 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1200 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05193 XEO_CLAS Peptide DME1200 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO05193 GENEFORM Protein DME1200 XEOTICID XEO05193 MOACRIVE Inhibition DME1200 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1200 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05197 XEO_CLAS Peptide DME1200 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05197 GENEFORM Protein DME1200 XEOTICID XEO05197 MOACRIVE Inhibition DME1200 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1200 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05205 XEO_CLAS Peptide DME1200 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05205 GENEFORM Protein DME1200 XEOTICID XEO05205 MOACRIVE Inhibition DME1200 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1200 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05206 XEO_CLAS Peptide DME1200 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 10 microM) DME1200 XEOTICID XEO05206 GENEFORM Protein DME1200 XEOTICID XEO05206 MOACRIVE Inhibition DME1200 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1200 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05207 XEO_CLAS Peptide DME1200 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 25 microM) DME1200 XEOTICID XEO05207 GENEFORM Protein DME1200 XEOTICID XEO05207 MOACRIVE Inhibition DME1200 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1200 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05208 XEO_CLAS Peptide DME1200 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 microM) DME1200 XEOTICID XEO05208 GENEFORM Protein DME1200 XEOTICID XEO05208 MOACRIVE Inhibition DME1200 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1200 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05209 XEO_CLAS Peptide DME1200 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 15 microM) DME1200 XEOTICID XEO05209 GENEFORM Protein DME1200 XEOTICID XEO05209 MOACRIVE Inhibition DME1200 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1200 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05212 XEO_CLAS Peptide DME1200 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.5 ug/ml) DME1200 XEOTICID XEO05212 GENEFORM Protein DME1200 XEOTICID XEO05212 MOACRIVE Inhibition DME1200 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1200 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05220 XEO_CLAS Peptide DME1200 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.6-1.2 microM) DME1200 XEOTICID XEO05220 GENEFORM Protein DME1200 XEOTICID XEO05220 MOACRIVE Inhibition DME1200 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1200 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05230 XEO_CLAS Peptide DME1200 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 7.90 microM) DME1200 XEOTICID XEO05230 GENEFORM Protein DME1200 XEOTICID XEO05230 MOACRIVE Inhibition DME1200 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1200 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05231 XEO_CLAS Peptide DME1200 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2.40 microM) DME1200 XEOTICID XEO05231 GENEFORM Protein DME1200 XEOTICID XEO05231 MOACRIVE Inhibition DME1200 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1200 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05232 XEO_CLAS Peptide DME1200 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05232 GENEFORM Protein DME1200 XEOTICID XEO05232 MOACRIVE Inhibition DME1200 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1200 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05233 XEO_CLAS Peptide DME1200 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 ug/ml) DME1200 XEOTICID XEO05233 GENEFORM Protein DME1200 XEOTICID XEO05233 MOACRIVE Inhibition DME1200 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1200 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05234 XEO_CLAS Peptide DME1200 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 ug/ml) DME1200 XEOTICID XEO05234 GENEFORM Protein DME1200 XEOTICID XEO05234 MOACRIVE Inhibition DME1200 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1200 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05235 XEO_CLAS Peptide DME1200 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 30 ug/ml) DME1200 XEOTICID XEO05235 GENEFORM Protein DME1200 XEOTICID XEO05235 MOACRIVE Inhibition DME1200 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1200 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05237 XEO_CLAS Peptide DME1200 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 microM) DME1200 XEOTICID XEO05237 GENEFORM Protein DME1200 XEOTICID XEO05237 MOACRIVE Inhibition DME1200 XEOTICID XEO05245 XEO_NAME Viresin DME1200 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05245 XEO_CLAS Peptide DME1200 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05245 GENEFORM Protein DME1200 XEOTICID XEO05245 MOACRIVE Inhibition DME1200 XEOTICID XEO05248 XEO_NAME Vitamin C DME1200 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1200 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1200 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05248 GENEFORM Protein DME1200 XEOTICID XEO05248 MOACRIVE Inhibition DME1200 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1200 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05264 XEO_CLAS Peptide DME1200 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 4 ug/ml) DME1200 XEOTICID XEO05264 GENEFORM Protein DME1200 XEOTICID XEO05264 MOACRIVE Inhibition DME1200 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1200 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05267 XEO_CLAS Peptide DME1200 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 2 ug/ml) DME1200 XEOTICID XEO05267 GENEFORM Protein DME1200 XEOTICID XEO05267 MOACRIVE Inhibition DME1200 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1200 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05268 XEO_CLAS Peptide DME1200 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 1.6 ug/ml) DME1200 XEOTICID XEO05268 GENEFORM Protein DME1200 XEOTICID XEO05268 MOACRIVE Inhibition DME1200 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1200 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05269 XEO_CLAS Peptide DME1200 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 6 ug/ml) DME1200 XEOTICID XEO05269 GENEFORM Protein DME1200 XEOTICID XEO05269 MOACRIVE Inhibition DME1200 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1200 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05273 XEO_CLAS Peptide DME1200 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05273 GENEFORM Protein DME1200 XEOTICID XEO05273 MOACRIVE Inhibition DME1200 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1200 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05274 XEO_CLAS Peptide DME1200 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05274 GENEFORM Protein DME1200 XEOTICID XEO05274 MOACRIVE Inhibition DME1200 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1200 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05287 XEO_CLAS Peptide DME1200 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli DME1200 XEOTICID XEO05287 GENEFORM Protein DME1200 XEOTICID XEO05287 MOACRIVE Inhibition DME1200 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1200 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05303 XEO_CLAS Peptide DME1200 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 16-31 ug/ml) DME1200 XEOTICID XEO05303 GENEFORM Protein DME1200 XEOTICID XEO05303 MOACRIVE Inhibition DME1200 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1200 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05306 XEO_CLAS Peptide DME1200 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 8 ug/ml) DME1200 XEOTICID XEO05306 GENEFORM Protein DME1200 XEOTICID XEO05306 MOACRIVE Inhibition DME1200 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1200 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1200 XEOTICID XEO05308 XEO_CLAS Peptide DME1200 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of L,D-carboxypeptidase A (ldcA) from Escherichia coli (MIC = 0.4 ug/ml) DME1200 XEOTICID XEO05308 GENEFORM Protein DME1200 XEOTICID XEO05308 MOACRIVE Inhibition DME1207 DME___ID DME1207 DME1207 DME_NAME Beta-glucosidase (bglA) DME1207 SPESNAME Lactobacillus rhamnosus DME1207 XEOTICID XEO03967 XEO_NAME Bacteriocin LSEI_2163 DME1207 XEOTICID XEO03967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1207 XEOTICID XEO03967 XEO_CLAS Peptide DME1207 XEOTICID XEO03967 DESCRIPT Bacteriocin LSEI_2163 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Lactobacillus rhamnosus DME1207 XEOTICID XEO03967 GENEFORM Protein DME1207 XEOTICID XEO03967 MOACRIVE Inhibition DME1208 DME___ID DME1208 DME1208 DME_NAME Beta-glucuronidase (uidA) DME1208 SPESNAME Clostridium perfringens DME1208 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1208 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1208 XEOTICID XEO02378 XEO_CLAS Peptide DME1208 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Clostridium perfringens (MIC = 0.7 ug/ml) DME1208 XEOTICID XEO02378 GENEFORM Protein DME1208 XEOTICID XEO02378 MOACRIVE Inhibition DME1208 XEOTICID XEO02720 XEO_NAME Carnobacteriocin-A DME1208 XEOTICID XEO02720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1208 XEOTICID XEO02720 XEO_CLAS Peptide DME1208 XEOTICID XEO02720 DESCRIPT Carnobacteriocin-A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Clostridium perfringens DME1208 XEOTICID XEO02720 GENEFORM Protein DME1208 XEOTICID XEO02720 MOACRIVE Inhibition DME1208 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1208 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1208 XEOTICID XEO03540 XEO_CLAS Peptide DME1208 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Clostridium perfringens DME1208 XEOTICID XEO03540 GENEFORM Protein DME1208 XEOTICID XEO03540 MOACRIVE Inhibition DME1208 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1208 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1208 XEOTICID XEO03556 XEO_CLAS Peptide DME1208 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Clostridium perfringens (MIC = 4-32 ug/ml) DME1208 XEOTICID XEO03556 GENEFORM Protein DME1208 XEOTICID XEO03556 MOACRIVE Inhibition DME1208 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1208 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1208 XEOTICID XEO03557 XEO_CLAS Peptide DME1208 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Clostridium perfringens (MIC = 4-32 ug/ml) DME1208 XEOTICID XEO03557 GENEFORM Protein DME1208 XEOTICID XEO03557 MOACRIVE Inhibition DME1211 DME___ID DME1211 DME1211 DME_NAME Beta-glucuronidase (uidA) DME1211 SPESNAME Lactobacillus rhamnosus DME1211 XEOTICID XEO03967 XEO_NAME Bacteriocin LSEI_2163 DME1211 XEOTICID XEO03967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1211 XEOTICID XEO03967 XEO_CLAS Peptide DME1211 XEOTICID XEO03967 DESCRIPT Bacteriocin LSEI_2163 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Lactobacillus rhamnosus DME1211 XEOTICID XEO03967 GENEFORM Protein DME1211 XEOTICID XEO03967 MOACRIVE Inhibition DME1214 DME___ID DME1214 DME1214 DME_NAME Beta-lactamase (blaB) DME1214 SPESNAME Bacillus megaterium DME1214 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1214 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1214 XEOTICID XEO05230 XEO_CLAS Peptide DME1214 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus megaterium (MIC = 2 microM) DME1214 XEOTICID XEO05230 GENEFORM Protein DME1214 XEOTICID XEO05230 MOACRIVE Inhibition DME1214 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1214 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1214 XEOTICID XEO05231 XEO_CLAS Peptide DME1214 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus megaterium (MIC = 0.60 microM) DME1214 XEOTICID XEO05231 GENEFORM Protein DME1214 XEOTICID XEO05231 MOACRIVE Inhibition DME1214 XEOTICID XEO05260 XEO_NAME V. philippinarum beta defensin VpBD DME1214 XEOTICID XEO05260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1214 XEOTICID XEO05260 XEO_CLAS Peptide DME1214 XEOTICID XEO05260 DESCRIPT V. philippinarum beta defensin VpBD inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus megaterium (MIC = 13.13-26.26 microM) DME1214 XEOTICID XEO05260 GENEFORM Protein DME1214 XEOTICID XEO05260 MOACRIVE Inhibition DME1223 DME___ID DME1223 DME1223 DME_NAME Beta-lactamase (blaB) DME1223 SPESNAME Escherichia coli DME1223 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1223 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00117 GENEFORM Protein DME1223 XEOTICID XEO00117 MOACRIVE Inhibition DME1223 XEOTICID XEO00122 XEO_NAME Amikacin DME1223 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00122 GENEFORM Protein DME1223 XEOTICID XEO00122 MOACRIVE Inhibition DME1223 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1223 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00136 GENEFORM Protein DME1223 XEOTICID XEO00136 MOACRIVE Inhibition DME1223 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1223 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00237 GENEFORM Protein DME1223 XEOTICID XEO00237 MOACRIVE Inhibition DME1223 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1223 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00349 GENEFORM Protein DME1223 XEOTICID XEO00349 MOACRIVE Inhibition DME1223 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1223 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00425 GENEFORM Protein DME1223 XEOTICID XEO00425 MOACRIVE Inhibition DME1223 XEOTICID XEO00439 XEO_NAME Daidzein DME1223 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00439 GENEFORM Protein DME1223 XEOTICID XEO00439 MOACRIVE Inhibition DME1223 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1223 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00460 GENEFORM Protein DME1223 XEOTICID XEO00460 MOACRIVE Inhibition DME1223 XEOTICID XEO00487 XEO_NAME Thymol DME1223 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00487 GENEFORM Protein DME1223 XEOTICID XEO00487 MOACRIVE Inhibition DME1223 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1223 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00511 GENEFORM Protein DME1223 XEOTICID XEO00511 MOACRIVE Inhibition DME1223 XEOTICID XEO00537 XEO_NAME Luteolin DME1223 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1223 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00537 GENEFORM Protein DME1223 XEOTICID XEO00537 MOACRIVE Inhibition DME1223 XEOTICID XEO00538 XEO_NAME Quercetin DME1223 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1223 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00538 GENEFORM Protein DME1223 XEOTICID XEO00538 MOACRIVE Inhibition DME1223 XEOTICID XEO00547 XEO_NAME Vitamin E DME1223 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1223 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00547 GENEFORM Protein DME1223 XEOTICID XEO00547 MOACRIVE Inhibition DME1223 XEOTICID XEO00557 XEO_NAME Genistein DME1223 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1223 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00557 GENEFORM Protein DME1223 XEOTICID XEO00557 MOACRIVE Inhibition DME1223 XEOTICID XEO00566 XEO_NAME Guaiacol DME1223 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1223 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00566 GENEFORM Protein DME1223 XEOTICID XEO00566 MOACRIVE Inhibition DME1223 XEOTICID XEO00568 XEO_NAME Resveratrol DME1223 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1223 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00568 GENEFORM Protein DME1223 XEOTICID XEO00568 MOACRIVE Inhibition DME1223 XEOTICID XEO00573 XEO_NAME Naringenin DME1223 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1223 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00573 GENEFORM Protein DME1223 XEOTICID XEO00573 MOACRIVE Inhibition DME1223 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1223 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1223 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00574 GENEFORM Protein DME1223 XEOTICID XEO00574 MOACRIVE Inhibition DME1223 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1223 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1223 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00611 GENEFORM Protein DME1223 XEOTICID XEO00611 MOACRIVE Inhibition DME1223 XEOTICID XEO00621 XEO_NAME Chitosan DME1223 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1223 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00621 GENEFORM Protein DME1223 XEOTICID XEO00621 MOACRIVE Inhibition DME1223 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1223 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1223 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00646 GENEFORM Protein DME1223 XEOTICID XEO00646 MOACRIVE Inhibition DME1223 XEOTICID XEO00683 XEO_NAME Curcumin DME1223 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1223 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00683 GENEFORM Protein DME1223 XEOTICID XEO00683 MOACRIVE Inhibition DME1223 XEOTICID XEO00727 XEO_NAME Vanillin DME1223 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1223 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00727 GENEFORM Protein DME1223 XEOTICID XEO00727 MOACRIVE Inhibition DME1223 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1223 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1223 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00730 GENEFORM Protein DME1223 XEOTICID XEO00730 MOACRIVE Inhibition DME1223 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1223 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO00782 XEO_CLAS Natural Product DME1223 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00782 GENEFORM Protein DME1223 XEOTICID XEO00782 MOACRIVE Inhibition DME1223 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1223 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1223 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00866 GENEFORM Protein DME1223 XEOTICID XEO00866 MOACRIVE Inhibition DME1223 XEOTICID XEO00878 XEO_NAME Chrysin DME1223 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO00878 XEO_CLAS Natural Product DME1223 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00878 GENEFORM Protein DME1223 XEOTICID XEO00878 MOACRIVE Inhibition DME1223 XEOTICID XEO00879 XEO_NAME Coumarin DME1223 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1223 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1223 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00879 GENEFORM Protein DME1223 XEOTICID XEO00879 MOACRIVE Inhibition DME1223 XEOTICID XEO00883 XEO_NAME Phloretin DME1223 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO00883 XEO_CLAS Natural Product DME1223 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00883 GENEFORM Protein DME1223 XEOTICID XEO00883 MOACRIVE Inhibition DME1223 XEOTICID XEO00885 XEO_NAME Eugenol DME1223 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1223 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO00885 GENEFORM Protein DME1223 XEOTICID XEO00885 MOACRIVE Inhibition DME1223 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1223 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1223 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1223 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01032 GENEFORM Protein DME1223 XEOTICID XEO01032 MOACRIVE Inhibition DME1223 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1223 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01174 XEO_CLAS Natural Product DME1223 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01174 GENEFORM Protein DME1223 XEOTICID XEO01174 MOACRIVE Inhibition DME1223 XEOTICID XEO01203 XEO_NAME Apigenin DME1223 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01203 XEO_CLAS Natural Product DME1223 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01203 GENEFORM Protein DME1223 XEOTICID XEO01203 MOACRIVE Inhibition DME1223 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1223 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1223 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1223 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01232 GENEFORM Protein DME1223 XEOTICID XEO01232 MOACRIVE Inhibition DME1223 XEOTICID XEO01237 XEO_NAME Carvacrol DME1223 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1223 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01237 GENEFORM Protein DME1223 XEOTICID XEO01237 MOACRIVE Inhibition DME1223 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1223 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1223 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01287 GENEFORM Protein DME1223 XEOTICID XEO01287 MOACRIVE Inhibition DME1223 XEOTICID XEO01291 XEO_NAME Esculetin DME1223 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1223 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01291 GENEFORM Protein DME1223 XEOTICID XEO01291 MOACRIVE Inhibition DME1223 XEOTICID XEO01304 XEO_NAME Flavone DME1223 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01304 XEO_CLAS Natural Product DME1223 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01304 GENEFORM Protein DME1223 XEOTICID XEO01304 MOACRIVE Inhibition DME1223 XEOTICID XEO01309 XEO_NAME Gallic acid DME1223 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01309 XEO_CLAS Natural Product DME1223 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01309 GENEFORM Protein DME1223 XEOTICID XEO01309 MOACRIVE Inhibition DME1223 XEOTICID XEO01340 XEO_NAME Imperatorin DME1223 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01340 XEO_CLAS Natural Product DME1223 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01340 GENEFORM Protein DME1223 XEOTICID XEO01340 MOACRIVE Inhibition DME1223 XEOTICID XEO01353 XEO_NAME Kaempferol DME1223 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1223 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1223 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01353 GENEFORM Protein DME1223 XEOTICID XEO01353 MOACRIVE Inhibition DME1223 XEOTICID XEO01366 XEO_NAME Linalool DME1223 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01366 XEO_CLAS Natural Product DME1223 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01366 GENEFORM Protein DME1223 XEOTICID XEO01366 MOACRIVE Inhibition DME1223 XEOTICID XEO01391 XEO_NAME Naringin DME1223 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01391 XEO_CLAS Natural Product DME1223 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01391 GENEFORM Protein DME1223 XEOTICID XEO01391 MOACRIVE Inhibition DME1223 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1223 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1223 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01420 GENEFORM Protein DME1223 XEOTICID XEO01420 MOACRIVE Inhibition DME1223 XEOTICID XEO01463 XEO_NAME Rutin DME1223 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01463 XEO_CLAS Natural Product DME1223 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01463 GENEFORM Protein DME1223 XEOTICID XEO01463 MOACRIVE Inhibition DME1223 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1223 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1223 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01496 GENEFORM Protein DME1223 XEOTICID XEO01496 MOACRIVE Inhibition DME1223 XEOTICID XEO01512 XEO_NAME Zinc DME1223 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1223 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1223 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01512 GENEFORM Protein DME1223 XEOTICID XEO01512 MOACRIVE Inhibition DME1223 XEOTICID XEO01527 XEO_NAME Bergamottin DME1223 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01527 XEO_CLAS Natural Product DME1223 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01527 GENEFORM Protein DME1223 XEOTICID XEO01527 MOACRIVE Inhibition DME1223 XEOTICID XEO01531 XEO_NAME Clove oil DME1223 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01531 XEO_CLAS Natural Product DME1223 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01531 GENEFORM Protein DME1223 XEOTICID XEO01531 MOACRIVE Inhibition DME1223 XEOTICID XEO01559 XEO_NAME Limonene DME1223 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01559 XEO_CLAS Natural Product DME1223 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01559 GENEFORM Protein DME1223 XEOTICID XEO01559 MOACRIVE Inhibition DME1223 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1223 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01563 XEO_CLAS Natural Product DME1223 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01563 GENEFORM Protein DME1223 XEOTICID XEO01563 MOACRIVE Inhibition DME1223 XEOTICID XEO01566 XEO_NAME Nobiletin DME1223 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01566 XEO_CLAS Natural Product DME1223 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01566 GENEFORM Protein DME1223 XEOTICID XEO01566 MOACRIVE Inhibition DME1223 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1223 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01778 XEO_CLAS Natural Product DME1223 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01778 GENEFORM Protein DME1223 XEOTICID XEO01778 MOACRIVE Inhibition DME1223 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1223 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01779 XEO_CLAS Peptide DME1223 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 128 microM) DME1223 XEOTICID XEO01779 GENEFORM Protein DME1223 XEOTICID XEO01779 MOACRIVE Inhibition DME1223 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1223 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01810 XEO_CLAS Peptide DME1223 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.0 microM) DME1223 XEOTICID XEO01810 GENEFORM Protein DME1223 XEOTICID XEO01810 MOACRIVE Inhibition DME1223 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1223 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01811 XEO_CLAS Peptide DME1223 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 microM) DME1223 XEOTICID XEO01811 GENEFORM Protein DME1223 XEOTICID XEO01811 MOACRIVE Inhibition DME1223 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1223 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01812 XEO_CLAS Peptide DME1223 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10.4 microM) DME1223 XEOTICID XEO01812 GENEFORM Protein DME1223 XEOTICID XEO01812 MOACRIVE Inhibition DME1223 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1223 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01813 XEO_CLAS Peptide DME1223 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.1 microM) DME1223 XEOTICID XEO01813 GENEFORM Protein DME1223 XEOTICID XEO01813 MOACRIVE Inhibition DME1223 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1223 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01814 XEO_CLAS Peptide DME1223 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.5 microM) DME1223 XEOTICID XEO01814 GENEFORM Protein DME1223 XEOTICID XEO01814 MOACRIVE Inhibition DME1223 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1223 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01815 XEO_CLAS Peptide DME1223 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 9.8 microM) DME1223 XEOTICID XEO01815 GENEFORM Protein DME1223 XEOTICID XEO01815 MOACRIVE Inhibition DME1223 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1223 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01816 XEO_CLAS Peptide DME1223 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO01816 GENEFORM Protein DME1223 XEOTICID XEO01816 MOACRIVE Inhibition DME1223 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1223 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01817 XEO_CLAS Peptide DME1223 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.0 microM) DME1223 XEOTICID XEO01817 GENEFORM Protein DME1223 XEOTICID XEO01817 MOACRIVE Inhibition DME1223 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1223 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01818 XEO_CLAS Peptide DME1223 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4.0 microM) DME1223 XEOTICID XEO01818 GENEFORM Protein DME1223 XEOTICID XEO01818 MOACRIVE Inhibition DME1223 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1223 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01819 XEO_CLAS Peptide DME1223 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO01819 GENEFORM Protein DME1223 XEOTICID XEO01819 MOACRIVE Inhibition DME1223 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1223 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01820 XEO_CLAS Peptide DME1223 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO01820 GENEFORM Protein DME1223 XEOTICID XEO01820 MOACRIVE Inhibition DME1223 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1223 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01821 XEO_CLAS Peptide DME1223 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO01821 GENEFORM Protein DME1223 XEOTICID XEO01821 MOACRIVE Inhibition DME1223 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1223 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01822 XEO_CLAS Peptide DME1223 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 microM) DME1223 XEOTICID XEO01822 GENEFORM Protein DME1223 XEOTICID XEO01822 MOACRIVE Inhibition DME1223 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1223 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01823 XEO_CLAS Peptide DME1223 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO01823 GENEFORM Protein DME1223 XEOTICID XEO01823 MOACRIVE Inhibition DME1223 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1223 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01824 XEO_CLAS Peptide DME1223 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO01824 GENEFORM Protein DME1223 XEOTICID XEO01824 MOACRIVE Inhibition DME1223 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1223 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01825 XEO_CLAS Peptide DME1223 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25.0 microM) DME1223 XEOTICID XEO01825 GENEFORM Protein DME1223 XEOTICID XEO01825 MOACRIVE Inhibition DME1223 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1223 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01827 XEO_CLAS Peptide DME1223 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.12-6.25 microM) DME1223 XEOTICID XEO01827 GENEFORM Protein DME1223 XEOTICID XEO01827 MOACRIVE Inhibition DME1223 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1223 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1223 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1223 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01829 GENEFORM Protein DME1223 XEOTICID XEO01829 MOACRIVE Inhibition DME1223 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1223 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01927 XEO_CLAS Peptide DME1223 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 ug/ml) DME1223 XEOTICID XEO01927 GENEFORM Protein DME1223 XEOTICID XEO01927 MOACRIVE Inhibition DME1223 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1223 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01945 XEO_CLAS Peptide DME1223 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.1 microM) DME1223 XEOTICID XEO01945 GENEFORM Protein DME1223 XEOTICID XEO01945 MOACRIVE Inhibition DME1223 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1223 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01946 XEO_CLAS Peptide DME1223 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.2 microM) DME1223 XEOTICID XEO01946 GENEFORM Protein DME1223 XEOTICID XEO01946 MOACRIVE Inhibition DME1223 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1223 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO01947 XEO_CLAS Natural Product DME1223 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01947 GENEFORM Protein DME1223 XEOTICID XEO01947 MOACRIVE Inhibition DME1223 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1223 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1223 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1223 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01950 GENEFORM Protein DME1223 XEOTICID XEO01950 MOACRIVE Inhibition DME1223 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1223 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1223 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1223 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01961 GENEFORM Protein DME1223 XEOTICID XEO01961 MOACRIVE Inhibition DME1223 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1223 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1223 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1223 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO01966 GENEFORM Protein DME1223 XEOTICID XEO01966 MOACRIVE Inhibition DME1223 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1223 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01996 XEO_CLAS Peptide DME1223 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.7 microM) DME1223 XEOTICID XEO01996 GENEFORM Protein DME1223 XEOTICID XEO01996 MOACRIVE Inhibition DME1223 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1223 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01997 XEO_CLAS Peptide DME1223 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.9 microM) DME1223 XEOTICID XEO01997 GENEFORM Protein DME1223 XEOTICID XEO01997 MOACRIVE Inhibition DME1223 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1223 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01998 XEO_CLAS Peptide DME1223 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO01998 GENEFORM Protein DME1223 XEOTICID XEO01998 MOACRIVE Inhibition DME1223 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1223 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO01999 XEO_CLAS Peptide DME1223 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.5 microM) DME1223 XEOTICID XEO01999 GENEFORM Protein DME1223 XEOTICID XEO01999 MOACRIVE Inhibition DME1223 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1223 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02013 XEO_CLAS Peptide DME1223 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02013 GENEFORM Protein DME1223 XEOTICID XEO02013 MOACRIVE Inhibition DME1223 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1223 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02032 XEO_CLAS Natural Product DME1223 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02032 GENEFORM Protein DME1223 XEOTICID XEO02032 MOACRIVE Inhibition DME1223 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1223 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02033 XEO_CLAS Natural Product DME1223 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02033 GENEFORM Protein DME1223 XEOTICID XEO02033 MOACRIVE Inhibition DME1223 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1223 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02079 XEO_CLAS Natural Product DME1223 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02079 GENEFORM Protein DME1223 XEOTICID XEO02079 MOACRIVE Inhibition DME1223 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1223 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1223 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02085 GENEFORM Protein DME1223 XEOTICID XEO02085 MOACRIVE Inhibition DME1223 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1223 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02111 XEO_CLAS Peptide DME1223 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2-4 ug/ml) DME1223 XEOTICID XEO02111 GENEFORM Protein DME1223 XEOTICID XEO02111 MOACRIVE Inhibition DME1223 XEOTICID XEO02113 XEO_NAME Abaecin DME1223 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02113 XEO_CLAS Peptide DME1223 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02113 GENEFORM Protein DME1223 XEOTICID XEO02113 MOACRIVE Inhibition DME1223 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1223 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02114 XEO_CLAS Peptide DME1223 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-25 ug/ml) DME1223 XEOTICID XEO02114 GENEFORM Protein DME1223 XEOTICID XEO02114 MOACRIVE Inhibition DME1223 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1223 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02115 XEO_CLAS Peptide DME1223 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02115 GENEFORM Protein DME1223 XEOTICID XEO02115 MOACRIVE Inhibition DME1223 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1223 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02117 XEO_CLAS Peptide DME1223 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02117 GENEFORM Protein DME1223 XEOTICID XEO02117 MOACRIVE Inhibition DME1223 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1223 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02118 XEO_CLAS Peptide DME1223 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02118 GENEFORM Protein DME1223 XEOTICID XEO02118 MOACRIVE Inhibition DME1223 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1223 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02119 XEO_CLAS Peptide DME1223 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02119 GENEFORM Protein DME1223 XEOTICID XEO02119 MOACRIVE Inhibition DME1223 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1223 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02120 XEO_CLAS Peptide DME1223 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02120 GENEFORM Protein DME1223 XEOTICID XEO02120 MOACRIVE Inhibition DME1223 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1223 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02121 XEO_CLAS Peptide DME1223 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02121 GENEFORM Protein DME1223 XEOTICID XEO02121 MOACRIVE Inhibition DME1223 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1223 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02122 XEO_CLAS Peptide DME1223 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 ug/ml) DME1223 XEOTICID XEO02122 GENEFORM Protein DME1223 XEOTICID XEO02122 MOACRIVE Inhibition DME1223 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1223 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02130 XEO_CLAS Peptide DME1223 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.7 microM) DME1223 XEOTICID XEO02130 GENEFORM Protein DME1223 XEOTICID XEO02130 MOACRIVE Inhibition DME1223 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1223 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02131 XEO_CLAS Peptide DME1223 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.3 microM) DME1223 XEOTICID XEO02131 GENEFORM Protein DME1223 XEOTICID XEO02131 MOACRIVE Inhibition DME1223 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1223 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02132 XEO_CLAS Peptide DME1223 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.5 microM) DME1223 XEOTICID XEO02132 GENEFORM Protein DME1223 XEOTICID XEO02132 MOACRIVE Inhibition DME1223 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1223 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02136 XEO_CLAS Peptide DME1223 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 ug/ml) DME1223 XEOTICID XEO02136 GENEFORM Protein DME1223 XEOTICID XEO02136 MOACRIVE Inhibition DME1223 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1223 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02147 XEO_CLAS Peptide DME1223 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 382 ug/ml) DME1223 XEOTICID XEO02147 GENEFORM Protein DME1223 XEOTICID XEO02147 MOACRIVE Inhibition DME1223 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1223 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02149 XEO_CLAS Peptide DME1223 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 47.35 microM) DME1223 XEOTICID XEO02149 GENEFORM Protein DME1223 XEOTICID XEO02149 MOACRIVE Inhibition DME1223 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1223 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02164 XEO_CLAS Peptide DME1223 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02164 GENEFORM Protein DME1223 XEOTICID XEO02164 MOACRIVE Inhibition DME1223 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1223 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02165 XEO_CLAS Peptide DME1223 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02165 GENEFORM Protein DME1223 XEOTICID XEO02165 MOACRIVE Inhibition DME1223 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1223 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02166 XEO_CLAS Peptide DME1223 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02166 GENEFORM Protein DME1223 XEOTICID XEO02166 MOACRIVE Inhibition DME1223 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1223 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02167 XEO_CLAS Peptide DME1223 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02167 GENEFORM Protein DME1223 XEOTICID XEO02167 MOACRIVE Inhibition DME1223 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1223 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02168 XEO_CLAS Peptide DME1223 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02168 GENEFORM Protein DME1223 XEOTICID XEO02168 MOACRIVE Inhibition DME1223 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1223 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02169 XEO_CLAS Peptide DME1223 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02169 GENEFORM Protein DME1223 XEOTICID XEO02169 MOACRIVE Inhibition DME1223 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1223 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02170 XEO_CLAS Peptide DME1223 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.4 microM) DME1223 XEOTICID XEO02170 GENEFORM Protein DME1223 XEOTICID XEO02170 MOACRIVE Inhibition DME1223 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1223 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02175 XEO_CLAS Natural Product DME1223 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02175 GENEFORM Protein DME1223 XEOTICID XEO02175 MOACRIVE Inhibition DME1223 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1223 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02177 XEO_CLAS Peptide DME1223 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO02177 GENEFORM Protein DME1223 XEOTICID XEO02177 MOACRIVE Inhibition DME1223 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1223 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02178 XEO_CLAS Peptide DME1223 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO02178 GENEFORM Protein DME1223 XEOTICID XEO02178 MOACRIVE Inhibition DME1223 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1223 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02179 XEO_CLAS Peptide DME1223 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO02179 GENEFORM Protein DME1223 XEOTICID XEO02179 MOACRIVE Inhibition DME1223 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1223 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02180 XEO_CLAS Peptide DME1223 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 214 microM) DME1223 XEOTICID XEO02180 GENEFORM Protein DME1223 XEOTICID XEO02180 MOACRIVE Inhibition DME1223 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1223 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02181 XEO_CLAS Peptide DME1223 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 217 microM) DME1223 XEOTICID XEO02181 GENEFORM Protein DME1223 XEOTICID XEO02181 MOACRIVE Inhibition DME1223 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1223 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02183 XEO_CLAS Peptide DME1223 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 38.4 microM) DME1223 XEOTICID XEO02183 GENEFORM Protein DME1223 XEOTICID XEO02183 MOACRIVE Inhibition DME1223 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1223 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02185 XEO_CLAS Peptide DME1223 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 microM) DME1223 XEOTICID XEO02185 GENEFORM Protein DME1223 XEOTICID XEO02185 MOACRIVE Inhibition DME1223 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1223 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02187 GENEFORM Protein DME1223 XEOTICID XEO02187 MOACRIVE Inhibition DME1223 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1223 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02191 XEO_CLAS Peptide DME1223 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02191 GENEFORM Protein DME1223 XEOTICID XEO02191 MOACRIVE Inhibition DME1223 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1223 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02192 XEO_CLAS Peptide DME1223 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.50 ug/ml) DME1223 XEOTICID XEO02192 GENEFORM Protein DME1223 XEOTICID XEO02192 MOACRIVE Inhibition DME1223 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1223 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02193 XEO_CLAS Peptide DME1223 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02193 GENEFORM Protein DME1223 XEOTICID XEO02193 MOACRIVE Inhibition DME1223 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1223 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02194 XEO_CLAS Peptide DME1223 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02194 GENEFORM Protein DME1223 XEOTICID XEO02194 MOACRIVE Inhibition DME1223 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1223 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02195 XEO_CLAS Peptide DME1223 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.00 ug/ml) DME1223 XEOTICID XEO02195 GENEFORM Protein DME1223 XEOTICID XEO02195 MOACRIVE Inhibition DME1223 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1223 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02197 XEO_CLAS Peptide DME1223 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02197 GENEFORM Protein DME1223 XEOTICID XEO02197 MOACRIVE Inhibition DME1223 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1223 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02200 XEO_CLAS Peptide DME1223 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 ug/ml) DME1223 XEOTICID XEO02200 GENEFORM Protein DME1223 XEOTICID XEO02200 MOACRIVE Inhibition DME1223 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1223 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02201 XEO_CLAS Peptide DME1223 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 ug/ml) DME1223 XEOTICID XEO02201 GENEFORM Protein DME1223 XEOTICID XEO02201 MOACRIVE Inhibition DME1223 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1223 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02202 XEO_CLAS Peptide DME1223 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO02202 GENEFORM Protein DME1223 XEOTICID XEO02202 MOACRIVE Inhibition DME1223 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1223 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02203 XEO_CLAS Peptide DME1223 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 microM) DME1223 XEOTICID XEO02203 GENEFORM Protein DME1223 XEOTICID XEO02203 MOACRIVE Inhibition DME1223 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1223 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02207 XEO_CLAS Peptide DME1223 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.78 ug/ml) DME1223 XEOTICID XEO02207 GENEFORM Protein DME1223 XEOTICID XEO02207 MOACRIVE Inhibition DME1223 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1223 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02208 XEO_CLAS Peptide DME1223 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.13 ug/ml) DME1223 XEOTICID XEO02208 GENEFORM Protein DME1223 XEOTICID XEO02208 MOACRIVE Inhibition DME1223 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1223 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02209 XEO_CLAS Peptide DME1223 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.56 ug/ml) DME1223 XEOTICID XEO02209 GENEFORM Protein DME1223 XEOTICID XEO02209 MOACRIVE Inhibition DME1223 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1223 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02210 XEO_CLAS Peptide DME1223 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 ug/ml) DME1223 XEOTICID XEO02210 GENEFORM Protein DME1223 XEOTICID XEO02210 MOACRIVE Inhibition DME1223 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1223 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02211 XEO_CLAS Peptide DME1223 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25 ug/ml) DME1223 XEOTICID XEO02211 GENEFORM Protein DME1223 XEOTICID XEO02211 MOACRIVE Inhibition DME1223 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1223 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02212 XEO_CLAS Peptide DME1223 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.13 ug/ml) DME1223 XEOTICID XEO02212 GENEFORM Protein DME1223 XEOTICID XEO02212 MOACRIVE Inhibition DME1223 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1223 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02213 XEO_CLAS Peptide DME1223 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.13 ug/ml) DME1223 XEOTICID XEO02213 GENEFORM Protein DME1223 XEOTICID XEO02213 MOACRIVE Inhibition DME1223 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1223 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02214 XEO_CLAS Peptide DME1223 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02214 GENEFORM Protein DME1223 XEOTICID XEO02214 MOACRIVE Inhibition DME1223 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1223 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02215 XEO_CLAS Peptide DME1223 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 ug/ml) DME1223 XEOTICID XEO02215 GENEFORM Protein DME1223 XEOTICID XEO02215 MOACRIVE Inhibition DME1223 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1223 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02216 XEO_CLAS Peptide DME1223 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 126 ug/ml) DME1223 XEOTICID XEO02216 GENEFORM Protein DME1223 XEOTICID XEO02216 MOACRIVE Inhibition DME1223 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1223 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02217 XEO_CLAS Peptide DME1223 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 200 ug/ml) DME1223 XEOTICID XEO02217 GENEFORM Protein DME1223 XEOTICID XEO02217 MOACRIVE Inhibition DME1223 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1223 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02218 XEO_CLAS Peptide DME1223 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 200 ug/ml) DME1223 XEOTICID XEO02218 GENEFORM Protein DME1223 XEOTICID XEO02218 MOACRIVE Inhibition DME1223 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1223 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02219 XEO_CLAS Peptide DME1223 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 200 ug/ml) DME1223 XEOTICID XEO02219 GENEFORM Protein DME1223 XEOTICID XEO02219 MOACRIVE Inhibition DME1223 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1223 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02220 XEO_CLAS Peptide DME1223 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 23.5 ug/ml) DME1223 XEOTICID XEO02220 GENEFORM Protein DME1223 XEOTICID XEO02220 MOACRIVE Inhibition DME1223 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1223 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02221 XEO_CLAS Peptide DME1223 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20.2 ug/ml) DME1223 XEOTICID XEO02221 GENEFORM Protein DME1223 XEOTICID XEO02221 MOACRIVE Inhibition DME1223 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1223 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02222 XEO_CLAS Peptide DME1223 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30.5 ug/ml) DME1223 XEOTICID XEO02222 GENEFORM Protein DME1223 XEOTICID XEO02222 MOACRIVE Inhibition DME1223 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1223 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02223 XEO_CLAS Peptide DME1223 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.2 ug/ml) DME1223 XEOTICID XEO02223 GENEFORM Protein DME1223 XEOTICID XEO02223 MOACRIVE Inhibition DME1223 XEOTICID XEO02224 XEO_NAME Androctonin DME1223 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02224 XEO_CLAS Peptide DME1223 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02224 GENEFORM Protein DME1223 XEOTICID XEO02224 MOACRIVE Inhibition DME1223 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1223 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02225 XEO_CLAS Peptide DME1223 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02225 GENEFORM Protein DME1223 XEOTICID XEO02225 MOACRIVE Inhibition DME1223 XEOTICID XEO02226 XEO_NAME Andropin DME1223 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02226 XEO_CLAS Peptide DME1223 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 140 microM) DME1223 XEOTICID XEO02226 GENEFORM Protein DME1223 XEOTICID XEO02226 MOACRIVE Inhibition DME1223 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1223 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02230 XEO_CLAS Peptide DME1223 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.05-0.1 microM) DME1223 XEOTICID XEO02230 GENEFORM Protein DME1223 XEOTICID XEO02230 MOACRIVE Inhibition DME1223 XEOTICID XEO02232 XEO_NAME Anoplin DME1223 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02232 XEO_CLAS Peptide DME1223 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 13 ug/ml) DME1223 XEOTICID XEO02232 GENEFORM Protein DME1223 XEOTICID XEO02232 MOACRIVE Inhibition DME1223 XEOTICID XEO02233 XEO_NAME Antapin DME1223 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02233 XEO_CLAS Peptide DME1223 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02233 GENEFORM Protein DME1223 XEOTICID XEO02233 MOACRIVE Inhibition DME1223 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1223 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02236 XEO_CLAS Peptide DME1223 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02236 GENEFORM Protein DME1223 XEOTICID XEO02236 MOACRIVE Inhibition DME1223 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1223 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02239 XEO_CLAS Peptide DME1223 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 250 microM) DME1223 XEOTICID XEO02239 GENEFORM Protein DME1223 XEOTICID XEO02239 MOACRIVE Inhibition DME1223 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1223 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02240 XEO_CLAS Peptide DME1223 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 microM) DME1223 XEOTICID XEO02240 GENEFORM Protein DME1223 XEOTICID XEO02240 MOACRIVE Inhibition DME1223 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1223 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02241 XEO_CLAS Peptide DME1223 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02241 GENEFORM Protein DME1223 XEOTICID XEO02241 MOACRIVE Inhibition DME1223 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1223 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02242 XEO_CLAS Peptide DME1223 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO02242 GENEFORM Protein DME1223 XEOTICID XEO02242 MOACRIVE Inhibition DME1223 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1223 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02243 XEO_CLAS Peptide DME1223 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 microM) DME1223 XEOTICID XEO02243 GENEFORM Protein DME1223 XEOTICID XEO02243 MOACRIVE Inhibition DME1223 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1223 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02244 XEO_CLAS Peptide DME1223 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1 microM) DME1223 XEOTICID XEO02244 GENEFORM Protein DME1223 XEOTICID XEO02244 MOACRIVE Inhibition DME1223 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1223 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02245 XEO_CLAS Peptide DME1223 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02245 GENEFORM Protein DME1223 XEOTICID XEO02245 MOACRIVE Inhibition DME1223 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1223 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02246 XEO_CLAS Peptide DME1223 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 microM) DME1223 XEOTICID XEO02246 GENEFORM Protein DME1223 XEOTICID XEO02246 MOACRIVE Inhibition DME1223 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1223 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02247 XEO_CLAS Peptide DME1223 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02247 GENEFORM Protein DME1223 XEOTICID XEO02247 MOACRIVE Inhibition DME1223 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1223 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02248 XEO_CLAS Peptide DME1223 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.3 microM) DME1223 XEOTICID XEO02248 GENEFORM Protein DME1223 XEOTICID XEO02248 MOACRIVE Inhibition DME1223 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1223 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02253 XEO_CLAS Peptide DME1223 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02253 GENEFORM Protein DME1223 XEOTICID XEO02253 MOACRIVE Inhibition DME1223 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1223 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02258 XEO_CLAS Peptide DME1223 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 150 microM) DME1223 XEOTICID XEO02258 GENEFORM Protein DME1223 XEOTICID XEO02258 MOACRIVE Inhibition DME1223 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1223 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02261 XEO_CLAS Peptide DME1223 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 82 ug/ml) DME1223 XEOTICID XEO02261 GENEFORM Protein DME1223 XEOTICID XEO02261 MOACRIVE Inhibition DME1223 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1223 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02263 XEO_CLAS Peptide DME1223 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO02263 GENEFORM Protein DME1223 XEOTICID XEO02263 MOACRIVE Inhibition DME1223 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1223 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02266 XEO_CLAS Peptide DME1223 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 120 microM) DME1223 XEOTICID XEO02266 GENEFORM Protein DME1223 XEOTICID XEO02266 MOACRIVE Inhibition DME1223 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1223 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02268 XEO_CLAS Peptide DME1223 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 170 ug/ml) DME1223 XEOTICID XEO02268 GENEFORM Protein DME1223 XEOTICID XEO02268 MOACRIVE Inhibition DME1223 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1223 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02270 XEO_CLAS Peptide DME1223 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 microM) DME1223 XEOTICID XEO02270 GENEFORM Protein DME1223 XEOTICID XEO02270 MOACRIVE Inhibition DME1223 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1223 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02271 XEO_CLAS Peptide DME1223 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 302 ug/ml) DME1223 XEOTICID XEO02271 GENEFORM Protein DME1223 XEOTICID XEO02271 MOACRIVE Inhibition DME1223 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1223 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02273 XEO_CLAS Peptide DME1223 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 18 microM) DME1223 XEOTICID XEO02273 GENEFORM Protein DME1223 XEOTICID XEO02273 MOACRIVE Inhibition DME1223 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1223 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02274 XEO_CLAS Peptide DME1223 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO02274 GENEFORM Protein DME1223 XEOTICID XEO02274 MOACRIVE Inhibition DME1223 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1223 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02275 XEO_CLAS Peptide DME1223 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 microM) DME1223 XEOTICID XEO02275 GENEFORM Protein DME1223 XEOTICID XEO02275 MOACRIVE Inhibition DME1223 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1223 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02276 XEO_CLAS Peptide DME1223 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 microM) DME1223 XEOTICID XEO02276 GENEFORM Protein DME1223 XEOTICID XEO02276 MOACRIVE Inhibition DME1223 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1223 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02280 XEO_CLAS Peptide DME1223 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02280 GENEFORM Protein DME1223 XEOTICID XEO02280 MOACRIVE Inhibition DME1223 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1223 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02281 XEO_CLAS Peptide DME1223 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02281 GENEFORM Protein DME1223 XEOTICID XEO02281 MOACRIVE Inhibition DME1223 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1223 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02283 XEO_CLAS Peptide DME1223 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 ug/ml) DME1223 XEOTICID XEO02283 GENEFORM Protein DME1223 XEOTICID XEO02283 MOACRIVE Inhibition DME1223 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1223 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02284 XEO_CLAS Peptide DME1223 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50.4 microM) DME1223 XEOTICID XEO02284 GENEFORM Protein DME1223 XEOTICID XEO02284 MOACRIVE Inhibition DME1223 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1223 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02285 XEO_CLAS Peptide DME1223 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50.4 microM) DME1223 XEOTICID XEO02285 GENEFORM Protein DME1223 XEOTICID XEO02285 MOACRIVE Inhibition DME1223 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1223 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02286 XEO_CLAS Peptide DME1223 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50.4 microM) DME1223 XEOTICID XEO02286 GENEFORM Protein DME1223 XEOTICID XEO02286 MOACRIVE Inhibition DME1223 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1223 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02287 XEO_CLAS Peptide DME1223 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50.4 microM) DME1223 XEOTICID XEO02287 GENEFORM Protein DME1223 XEOTICID XEO02287 MOACRIVE Inhibition DME1223 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1223 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02288 XEO_CLAS Peptide DME1223 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.2 ug/ml) DME1223 XEOTICID XEO02288 GENEFORM Protein DME1223 XEOTICID XEO02288 MOACRIVE Inhibition DME1223 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1223 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02289 XEO_CLAS Peptide DME1223 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 ug/ml) DME1223 XEOTICID XEO02289 GENEFORM Protein DME1223 XEOTICID XEO02289 MOACRIVE Inhibition DME1223 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1223 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02290 XEO_CLAS Peptide DME1223 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO02290 GENEFORM Protein DME1223 XEOTICID XEO02290 MOACRIVE Inhibition DME1223 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1223 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02291 XEO_CLAS Peptide DME1223 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02291 GENEFORM Protein DME1223 XEOTICID XEO02291 MOACRIVE Inhibition DME1223 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1223 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02293 XEO_CLAS Peptide DME1223 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 microM) DME1223 XEOTICID XEO02293 GENEFORM Protein DME1223 XEOTICID XEO02293 MOACRIVE Inhibition DME1223 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1223 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02294 XEO_CLAS Peptide DME1223 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 62-250 ug/ml) DME1223 XEOTICID XEO02294 GENEFORM Protein DME1223 XEOTICID XEO02294 MOACRIVE Inhibition DME1223 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1223 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02295 XEO_CLAS Peptide DME1223 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 ug/ml) DME1223 XEOTICID XEO02295 GENEFORM Protein DME1223 XEOTICID XEO02295 MOACRIVE Inhibition DME1223 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1223 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02296 XEO_CLAS Peptide DME1223 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02296 GENEFORM Protein DME1223 XEOTICID XEO02296 MOACRIVE Inhibition DME1223 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1223 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02297 XEO_CLAS Peptide DME1223 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC < 50 ug/ml) DME1223 XEOTICID XEO02297 GENEFORM Protein DME1223 XEOTICID XEO02297 MOACRIVE Inhibition DME1223 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1223 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02298 XEO_CLAS Peptide DME1223 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO02298 GENEFORM Protein DME1223 XEOTICID XEO02298 MOACRIVE Inhibition DME1223 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1223 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02303 XEO_CLAS Peptide DME1223 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02303 GENEFORM Protein DME1223 XEOTICID XEO02303 MOACRIVE Inhibition DME1223 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1223 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02304 XEO_CLAS Peptide DME1223 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.1 ug/ml) DME1223 XEOTICID XEO02304 GENEFORM Protein DME1223 XEOTICID XEO02304 MOACRIVE Inhibition DME1223 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1223 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02305 XEO_CLAS Peptide DME1223 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC <= 1 ug/ml) DME1223 XEOTICID XEO02305 GENEFORM Protein DME1223 XEOTICID XEO02305 MOACRIVE Inhibition DME1223 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1223 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02306 XEO_CLAS Peptide DME1223 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.2 ug/ml) DME1223 XEOTICID XEO02306 GENEFORM Protein DME1223 XEOTICID XEO02306 MOACRIVE Inhibition DME1223 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1223 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02309 XEO_CLAS Peptide DME1223 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02309 GENEFORM Protein DME1223 XEOTICID XEO02309 MOACRIVE Inhibition DME1223 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1223 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02310 XEO_CLAS Peptide DME1223 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02310 GENEFORM Protein DME1223 XEOTICID XEO02310 MOACRIVE Inhibition DME1223 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1223 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02315 XEO_CLAS Peptide DME1223 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO02315 GENEFORM Protein DME1223 XEOTICID XEO02315 MOACRIVE Inhibition DME1223 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1223 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02316 XEO_CLAS Peptide DME1223 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 50 microM) DME1223 XEOTICID XEO02316 GENEFORM Protein DME1223 XEOTICID XEO02316 MOACRIVE Inhibition DME1223 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1223 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02317 XEO_CLAS Peptide DME1223 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 300 microM) DME1223 XEOTICID XEO02317 GENEFORM Protein DME1223 XEOTICID XEO02317 MOACRIVE Inhibition DME1223 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1223 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02318 XEO_CLAS Peptide DME1223 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02318 GENEFORM Protein DME1223 XEOTICID XEO02318 MOACRIVE Inhibition DME1223 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1223 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02319 XEO_CLAS Peptide DME1223 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02319 GENEFORM Protein DME1223 XEOTICID XEO02319 MOACRIVE Inhibition DME1223 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1223 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02320 XEO_CLAS Peptide DME1223 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02320 GENEFORM Protein DME1223 XEOTICID XEO02320 MOACRIVE Inhibition DME1223 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1223 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02321 XEO_CLAS Peptide DME1223 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO02321 GENEFORM Protein DME1223 XEOTICID XEO02321 MOACRIVE Inhibition DME1223 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1223 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02322 XEO_CLAS Peptide DME1223 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02322 GENEFORM Protein DME1223 XEOTICID XEO02322 MOACRIVE Inhibition DME1223 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1223 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02323 XEO_CLAS Peptide DME1223 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO02323 GENEFORM Protein DME1223 XEOTICID XEO02323 MOACRIVE Inhibition DME1223 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1223 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02324 XEO_CLAS Peptide DME1223 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02324 GENEFORM Protein DME1223 XEOTICID XEO02324 MOACRIVE Inhibition DME1223 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1223 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02325 XEO_CLAS Peptide DME1223 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO02325 GENEFORM Protein DME1223 XEOTICID XEO02325 MOACRIVE Inhibition DME1223 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1223 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02326 XEO_CLAS Peptide DME1223 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02326 GENEFORM Protein DME1223 XEOTICID XEO02326 MOACRIVE Inhibition DME1223 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1223 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02327 XEO_CLAS Peptide DME1223 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO02327 GENEFORM Protein DME1223 XEOTICID XEO02327 MOACRIVE Inhibition DME1223 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1223 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02328 XEO_CLAS Peptide DME1223 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO02328 GENEFORM Protein DME1223 XEOTICID XEO02328 MOACRIVE Inhibition DME1223 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1223 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02332 XEO_CLAS Peptide DME1223 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.9 ug/ml) DME1223 XEOTICID XEO02332 GENEFORM Protein DME1223 XEOTICID XEO02332 MOACRIVE Inhibition DME1223 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1223 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02333 XEO_CLAS Peptide DME1223 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 200 microM) DME1223 XEOTICID XEO02333 GENEFORM Protein DME1223 XEOTICID XEO02333 MOACRIVE Inhibition DME1223 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1223 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02336 XEO_CLAS Peptide DME1223 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 microM) DME1223 XEOTICID XEO02336 GENEFORM Protein DME1223 XEOTICID XEO02336 MOACRIVE Inhibition DME1223 XEOTICID XEO02346 XEO_NAME Aurelin DME1223 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02346 XEO_CLAS Peptide DME1223 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 7.66 ug/ml) DME1223 XEOTICID XEO02346 GENEFORM Protein DME1223 XEOTICID XEO02346 MOACRIVE Inhibition DME1223 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1223 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02352 XEO_CLAS Peptide DME1223 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 11 ug/ml) DME1223 XEOTICID XEO02352 GENEFORM Protein DME1223 XEOTICID XEO02352 MOACRIVE Inhibition DME1223 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1223 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02353 XEO_CLAS Peptide DME1223 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 ug/ml) DME1223 XEOTICID XEO02353 GENEFORM Protein DME1223 XEOTICID XEO02353 MOACRIVE Inhibition DME1223 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1223 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02354 XEO_CLAS Peptide DME1223 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 ug/ml) DME1223 XEOTICID XEO02354 GENEFORM Protein DME1223 XEOTICID XEO02354 MOACRIVE Inhibition DME1223 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1223 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02355 XEO_CLAS Peptide DME1223 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 17 ug/ml) DME1223 XEOTICID XEO02355 GENEFORM Protein DME1223 XEOTICID XEO02355 MOACRIVE Inhibition DME1223 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1223 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02356 XEO_CLAS Peptide DME1223 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO02356 GENEFORM Protein DME1223 XEOTICID XEO02356 MOACRIVE Inhibition DME1223 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1223 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02357 XEO_CLAS Peptide DME1223 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO02357 GENEFORM Protein DME1223 XEOTICID XEO02357 MOACRIVE Inhibition DME1223 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1223 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02358 XEO_CLAS Peptide DME1223 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO02358 GENEFORM Protein DME1223 XEOTICID XEO02358 MOACRIVE Inhibition DME1223 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1223 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02360 XEO_CLAS Peptide DME1223 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02360 GENEFORM Protein DME1223 XEOTICID XEO02360 MOACRIVE Inhibition DME1223 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1223 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02361 XEO_CLAS Peptide DME1223 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 ug/ml) DME1223 XEOTICID XEO02361 GENEFORM Protein DME1223 XEOTICID XEO02361 MOACRIVE Inhibition DME1223 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1223 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02365 XEO_CLAS Peptide DME1223 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 32 ug/ml) DME1223 XEOTICID XEO02365 GENEFORM Protein DME1223 XEOTICID XEO02365 MOACRIVE Inhibition DME1223 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1223 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02366 XEO_CLAS Peptide DME1223 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO02366 GENEFORM Protein DME1223 XEOTICID XEO02366 MOACRIVE Inhibition DME1223 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1223 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02367 XEO_CLAS Peptide DME1223 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02367 GENEFORM Protein DME1223 XEOTICID XEO02367 MOACRIVE Inhibition DME1223 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1223 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02368 XEO_CLAS Peptide DME1223 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02368 GENEFORM Protein DME1223 XEOTICID XEO02368 MOACRIVE Inhibition DME1223 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1223 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02369 XEO_CLAS Peptide DME1223 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02369 GENEFORM Protein DME1223 XEOTICID XEO02369 MOACRIVE Inhibition DME1223 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1223 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02370 XEO_CLAS Peptide DME1223 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02370 GENEFORM Protein DME1223 XEOTICID XEO02370 MOACRIVE Inhibition DME1223 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1223 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02371 XEO_CLAS Peptide DME1223 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 ug/ml) DME1223 XEOTICID XEO02371 GENEFORM Protein DME1223 XEOTICID XEO02371 MOACRIVE Inhibition DME1223 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1223 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02374 XEO_CLAS Peptide DME1223 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02374 GENEFORM Protein DME1223 XEOTICID XEO02374 MOACRIVE Inhibition DME1223 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1223 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02376 XEO_CLAS Peptide DME1223 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02376 GENEFORM Protein DME1223 XEOTICID XEO02376 MOACRIVE Inhibition DME1223 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1223 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02378 XEO_CLAS Peptide DME1223 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.19 ug/ml) DME1223 XEOTICID XEO02378 GENEFORM Protein DME1223 XEOTICID XEO02378 MOACRIVE Inhibition DME1223 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1223 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02388 XEO_CLAS Peptide DME1223 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO02388 GENEFORM Protein DME1223 XEOTICID XEO02388 MOACRIVE Inhibition DME1223 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1223 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02389 XEO_CLAS Peptide DME1223 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02389 GENEFORM Protein DME1223 XEOTICID XEO02389 MOACRIVE Inhibition DME1223 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1223 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02415 XEO_CLAS Peptide DME1223 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02415 GENEFORM Protein DME1223 XEOTICID XEO02415 MOACRIVE Inhibition DME1223 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1223 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02416 XEO_CLAS Peptide DME1223 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 11 microM) DME1223 XEOTICID XEO02416 GENEFORM Protein DME1223 XEOTICID XEO02416 MOACRIVE Inhibition DME1223 XEOTICID XEO02419 XEO_NAME Bay oil DME1223 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1223 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02419 GENEFORM Protein DME1223 XEOTICID XEO02419 MOACRIVE Inhibition DME1223 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1223 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02435 XEO_CLAS Peptide DME1223 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02435 GENEFORM Protein DME1223 XEOTICID XEO02435 MOACRIVE Inhibition DME1223 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1223 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02436 XEO_CLAS Peptide DME1223 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02436 GENEFORM Protein DME1223 XEOTICID XEO02436 MOACRIVE Inhibition DME1223 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1223 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02437 XEO_CLAS Peptide DME1223 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02437 GENEFORM Protein DME1223 XEOTICID XEO02437 MOACRIVE Inhibition DME1223 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1223 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02438 XEO_CLAS Peptide DME1223 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02438 GENEFORM Protein DME1223 XEOTICID XEO02438 MOACRIVE Inhibition DME1223 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1223 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02439 XEO_CLAS Peptide DME1223 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02439 GENEFORM Protein DME1223 XEOTICID XEO02439 MOACRIVE Inhibition DME1223 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1223 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02440 XEO_CLAS Peptide DME1223 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02440 GENEFORM Protein DME1223 XEOTICID XEO02440 MOACRIVE Inhibition DME1223 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1223 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02441 XEO_CLAS Peptide DME1223 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02441 GENEFORM Protein DME1223 XEOTICID XEO02441 MOACRIVE Inhibition DME1223 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1223 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02442 XEO_CLAS Peptide DME1223 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO02442 GENEFORM Protein DME1223 XEOTICID XEO02442 MOACRIVE Inhibition DME1223 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1223 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02443 XEO_CLAS Peptide DME1223 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02443 GENEFORM Protein DME1223 XEOTICID XEO02443 MOACRIVE Inhibition DME1223 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1223 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02444 XEO_CLAS Peptide DME1223 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02444 GENEFORM Protein DME1223 XEOTICID XEO02444 MOACRIVE Inhibition DME1223 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1223 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1223 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02447 GENEFORM Protein DME1223 XEOTICID XEO02447 MOACRIVE Inhibition DME1223 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1223 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02452 XEO_CLAS Peptide DME1223 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 76800 ug/ml) DME1223 XEOTICID XEO02452 GENEFORM Protein DME1223 XEOTICID XEO02452 MOACRIVE Inhibition DME1223 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1223 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02453 XEO_CLAS Peptide DME1223 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02453 GENEFORM Protein DME1223 XEOTICID XEO02453 MOACRIVE Inhibition DME1223 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1223 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02463 XEO_CLAS Peptide DME1223 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 11.25 microM) DME1223 XEOTICID XEO02463 GENEFORM Protein DME1223 XEOTICID XEO02463 MOACRIVE Inhibition DME1223 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1223 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02466 XEO_CLAS Peptide DME1223 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.5 microM) DME1223 XEOTICID XEO02466 GENEFORM Protein DME1223 XEOTICID XEO02466 MOACRIVE Inhibition DME1223 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1223 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02467 XEO_CLAS Peptide DME1223 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8.4 microM) DME1223 XEOTICID XEO02467 GENEFORM Protein DME1223 XEOTICID XEO02467 MOACRIVE Inhibition DME1223 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1223 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02468 XEO_CLAS Peptide DME1223 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.7 microM) DME1223 XEOTICID XEO02468 GENEFORM Protein DME1223 XEOTICID XEO02468 MOACRIVE Inhibition DME1223 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1223 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02469 XEO_CLAS Peptide DME1223 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO02469 GENEFORM Protein DME1223 XEOTICID XEO02469 MOACRIVE Inhibition DME1223 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1223 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02470 XEO_CLAS Peptide DME1223 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.8 microM) DME1223 XEOTICID XEO02470 GENEFORM Protein DME1223 XEOTICID XEO02470 MOACRIVE Inhibition DME1223 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1223 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02471 XEO_CLAS Peptide DME1223 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4.8 microM) DME1223 XEOTICID XEO02471 GENEFORM Protein DME1223 XEOTICID XEO02471 MOACRIVE Inhibition DME1223 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1223 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02472 XEO_CLAS Peptide DME1223 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.0 microM) DME1223 XEOTICID XEO02472 GENEFORM Protein DME1223 XEOTICID XEO02472 MOACRIVE Inhibition DME1223 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1223 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02473 XEO_CLAS Peptide DME1223 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02473 GENEFORM Protein DME1223 XEOTICID XEO02473 MOACRIVE Inhibition DME1223 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1223 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02474 XEO_CLAS Peptide DME1223 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.5 microM) DME1223 XEOTICID XEO02474 GENEFORM Protein DME1223 XEOTICID XEO02474 MOACRIVE Inhibition DME1223 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1223 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02475 XEO_CLAS Peptide DME1223 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.5 microM) DME1223 XEOTICID XEO02475 GENEFORM Protein DME1223 XEOTICID XEO02475 MOACRIVE Inhibition DME1223 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1223 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02477 XEO_CLAS Peptide DME1223 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-300 ug/ml) DME1223 XEOTICID XEO02477 GENEFORM Protein DME1223 XEOTICID XEO02477 MOACRIVE Inhibition DME1223 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1223 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02478 XEO_CLAS Peptide DME1223 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-300 ug/ml) DME1223 XEOTICID XEO02478 GENEFORM Protein DME1223 XEOTICID XEO02478 MOACRIVE Inhibition DME1223 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1223 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02479 XEO_CLAS Peptide DME1223 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-300 ug/ml) DME1223 XEOTICID XEO02479 GENEFORM Protein DME1223 XEOTICID XEO02479 MOACRIVE Inhibition DME1223 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1223 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02480 XEO_CLAS Peptide DME1223 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-300 ug/ml) DME1223 XEOTICID XEO02480 GENEFORM Protein DME1223 XEOTICID XEO02480 MOACRIVE Inhibition DME1223 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1223 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02481 XEO_CLAS Peptide DME1223 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-300 ug/ml) DME1223 XEOTICID XEO02481 GENEFORM Protein DME1223 XEOTICID XEO02481 MOACRIVE Inhibition DME1223 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1223 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02482 XEO_CLAS Peptide DME1223 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-300 ug/ml) DME1223 XEOTICID XEO02482 GENEFORM Protein DME1223 XEOTICID XEO02482 MOACRIVE Inhibition DME1223 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1223 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02483 XEO_CLAS Peptide DME1223 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-300 ug/ml) DME1223 XEOTICID XEO02483 GENEFORM Protein DME1223 XEOTICID XEO02483 MOACRIVE Inhibition DME1223 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1223 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02484 XEO_CLAS Peptide DME1223 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-300 ug/ml) DME1223 XEOTICID XEO02484 GENEFORM Protein DME1223 XEOTICID XEO02484 MOACRIVE Inhibition DME1223 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1223 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02485 XEO_CLAS Peptide DME1223 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-300 ug/ml) DME1223 XEOTICID XEO02485 GENEFORM Protein DME1223 XEOTICID XEO02485 MOACRIVE Inhibition DME1223 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1223 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02486 XEO_CLAS Peptide DME1223 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-300 ug/ml) DME1223 XEOTICID XEO02486 GENEFORM Protein DME1223 XEOTICID XEO02486 MOACRIVE Inhibition DME1223 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1223 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02487 XEO_CLAS Peptide DME1223 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02487 GENEFORM Protein DME1223 XEOTICID XEO02487 MOACRIVE Inhibition DME1223 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1223 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02488 XEO_CLAS Peptide DME1223 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-300 ug/ml) DME1223 XEOTICID XEO02488 GENEFORM Protein DME1223 XEOTICID XEO02488 MOACRIVE Inhibition DME1223 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1223 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02489 XEO_CLAS Peptide DME1223 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-301 ug/ml) DME1223 XEOTICID XEO02489 GENEFORM Protein DME1223 XEOTICID XEO02489 MOACRIVE Inhibition DME1223 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1223 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02491 XEO_CLAS Peptide DME1223 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.3 microM) DME1223 XEOTICID XEO02491 GENEFORM Protein DME1223 XEOTICID XEO02491 MOACRIVE Inhibition DME1223 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1223 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02492 XEO_CLAS Peptide DME1223 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 ug/ml) DME1223 XEOTICID XEO02492 GENEFORM Protein DME1223 XEOTICID XEO02492 MOACRIVE Inhibition DME1223 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1223 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02493 XEO_CLAS Peptide DME1223 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 ug/ml) DME1223 XEOTICID XEO02493 GENEFORM Protein DME1223 XEOTICID XEO02493 MOACRIVE Inhibition DME1223 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1223 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02494 XEO_CLAS Peptide DME1223 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 ug/ml) DME1223 XEOTICID XEO02494 GENEFORM Protein DME1223 XEOTICID XEO02494 MOACRIVE Inhibition DME1223 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1223 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02495 XEO_CLAS Peptide DME1223 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 34 ug/ml) DME1223 XEOTICID XEO02495 GENEFORM Protein DME1223 XEOTICID XEO02495 MOACRIVE Inhibition DME1223 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1223 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02496 XEO_CLAS Peptide DME1223 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 13 microM) DME1223 XEOTICID XEO02496 GENEFORM Protein DME1223 XEOTICID XEO02496 MOACRIVE Inhibition DME1223 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1223 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02497 XEO_CLAS Peptide DME1223 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO02497 GENEFORM Protein DME1223 XEOTICID XEO02497 MOACRIVE Inhibition DME1223 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1223 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02499 XEO_CLAS Peptide DME1223 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO02499 GENEFORM Protein DME1223 XEOTICID XEO02499 MOACRIVE Inhibition DME1223 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1223 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02501 XEO_CLAS Peptide DME1223 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 7 microM) DME1223 XEOTICID XEO02501 GENEFORM Protein DME1223 XEOTICID XEO02501 MOACRIVE Inhibition DME1223 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1223 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02502 XEO_CLAS Peptide DME1223 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 microM) DME1223 XEOTICID XEO02502 GENEFORM Protein DME1223 XEOTICID XEO02502 MOACRIVE Inhibition DME1223 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1223 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02503 XEO_CLAS Peptide DME1223 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 19 microM) DME1223 XEOTICID XEO02503 GENEFORM Protein DME1223 XEOTICID XEO02503 MOACRIVE Inhibition DME1223 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1223 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02504 XEO_CLAS Peptide DME1223 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02504 GENEFORM Protein DME1223 XEOTICID XEO02504 MOACRIVE Inhibition DME1223 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1223 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02505 XEO_CLAS Peptide DME1223 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO02505 GENEFORM Protein DME1223 XEOTICID XEO02505 MOACRIVE Inhibition DME1223 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1223 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02507 XEO_CLAS Peptide DME1223 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO02507 GENEFORM Protein DME1223 XEOTICID XEO02507 MOACRIVE Inhibition DME1223 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1223 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02508 XEO_CLAS Peptide DME1223 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 150 microM) DME1223 XEOTICID XEO02508 GENEFORM Protein DME1223 XEOTICID XEO02508 MOACRIVE Inhibition DME1223 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1223 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02509 XEO_CLAS Peptide DME1223 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 150 microM) DME1223 XEOTICID XEO02509 GENEFORM Protein DME1223 XEOTICID XEO02509 MOACRIVE Inhibition DME1223 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1223 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02510 XEO_CLAS Peptide DME1223 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 150 microM) DME1223 XEOTICID XEO02510 GENEFORM Protein DME1223 XEOTICID XEO02510 MOACRIVE Inhibition DME1223 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1223 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02511 XEO_CLAS Peptide DME1223 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 150 microM) DME1223 XEOTICID XEO02511 GENEFORM Protein DME1223 XEOTICID XEO02511 MOACRIVE Inhibition DME1223 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1223 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02512 XEO_CLAS Peptide DME1223 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 75 microM) DME1223 XEOTICID XEO02512 GENEFORM Protein DME1223 XEOTICID XEO02512 MOACRIVE Inhibition DME1223 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1223 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02513 XEO_CLAS Peptide DME1223 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO02513 GENEFORM Protein DME1223 XEOTICID XEO02513 MOACRIVE Inhibition DME1223 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1223 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02514 XEO_CLAS Peptide DME1223 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO02514 GENEFORM Protein DME1223 XEOTICID XEO02514 MOACRIVE Inhibition DME1223 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1223 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02515 XEO_CLAS Peptide DME1223 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 80 microM) DME1223 XEOTICID XEO02515 GENEFORM Protein DME1223 XEOTICID XEO02515 MOACRIVE Inhibition DME1223 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1223 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02516 XEO_CLAS Peptide DME1223 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 32 microM) DME1223 XEOTICID XEO02516 GENEFORM Protein DME1223 XEOTICID XEO02516 MOACRIVE Inhibition DME1223 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1223 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02517 XEO_CLAS Peptide DME1223 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 microM) DME1223 XEOTICID XEO02517 GENEFORM Protein DME1223 XEOTICID XEO02517 MOACRIVE Inhibition DME1223 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1223 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02518 XEO_CLAS Peptide DME1223 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC < 15 microM) DME1223 XEOTICID XEO02518 GENEFORM Protein DME1223 XEOTICID XEO02518 MOACRIVE Inhibition DME1223 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1223 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02519 XEO_CLAS Peptide DME1223 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC < 15 microM) DME1223 XEOTICID XEO02519 GENEFORM Protein DME1223 XEOTICID XEO02519 MOACRIVE Inhibition DME1223 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1223 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02520 XEO_CLAS Peptide DME1223 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC < 15 microM) DME1223 XEOTICID XEO02520 GENEFORM Protein DME1223 XEOTICID XEO02520 MOACRIVE Inhibition DME1223 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1223 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02523 XEO_CLAS Peptide DME1223 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO02523 GENEFORM Protein DME1223 XEOTICID XEO02523 MOACRIVE Inhibition DME1223 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1223 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02524 XEO_CLAS Peptide DME1223 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 150 microM) DME1223 XEOTICID XEO02524 GENEFORM Protein DME1223 XEOTICID XEO02524 MOACRIVE Inhibition DME1223 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1223 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02525 XEO_CLAS Peptide DME1223 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 24 microM) DME1223 XEOTICID XEO02525 GENEFORM Protein DME1223 XEOTICID XEO02525 MOACRIVE Inhibition DME1223 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1223 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02526 XEO_CLAS Peptide DME1223 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 48 microM) DME1223 XEOTICID XEO02526 GENEFORM Protein DME1223 XEOTICID XEO02526 MOACRIVE Inhibition DME1223 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1223 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02527 XEO_CLAS Peptide DME1223 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 119 microM) DME1223 XEOTICID XEO02527 GENEFORM Protein DME1223 XEOTICID XEO02527 MOACRIVE Inhibition DME1223 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1223 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02528 XEO_CLAS Peptide DME1223 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 128 ug/ml) DME1223 XEOTICID XEO02528 GENEFORM Protein DME1223 XEOTICID XEO02528 MOACRIVE Inhibition DME1223 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1223 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02529 XEO_CLAS Peptide DME1223 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 128 ug/ml) DME1223 XEOTICID XEO02529 GENEFORM Protein DME1223 XEOTICID XEO02529 MOACRIVE Inhibition DME1223 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1223 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02530 XEO_CLAS Peptide DME1223 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02530 GENEFORM Protein DME1223 XEOTICID XEO02530 MOACRIVE Inhibition DME1223 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1223 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02531 XEO_CLAS Peptide DME1223 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 microM) DME1223 XEOTICID XEO02531 GENEFORM Protein DME1223 XEOTICID XEO02531 MOACRIVE Inhibition DME1223 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1223 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02533 XEO_CLAS Peptide DME1223 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.2 ug/ml) DME1223 XEOTICID XEO02533 GENEFORM Protein DME1223 XEOTICID XEO02533 MOACRIVE Inhibition DME1223 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1223 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02534 XEO_CLAS Peptide DME1223 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.6 ug/ml) DME1223 XEOTICID XEO02534 GENEFORM Protein DME1223 XEOTICID XEO02534 MOACRIVE Inhibition DME1223 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1223 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02535 XEO_CLAS Peptide DME1223 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.3 ug/ml) DME1223 XEOTICID XEO02535 GENEFORM Protein DME1223 XEOTICID XEO02535 MOACRIVE Inhibition DME1223 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1223 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02536 XEO_CLAS Peptide DME1223 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.4 ug/ml) DME1223 XEOTICID XEO02536 GENEFORM Protein DME1223 XEOTICID XEO02536 MOACRIVE Inhibition DME1223 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1223 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02537 XEO_CLAS Peptide DME1223 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.2 ug/ml) DME1223 XEOTICID XEO02537 GENEFORM Protein DME1223 XEOTICID XEO02537 MOACRIVE Inhibition DME1223 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1223 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02538 XEO_CLAS Peptide DME1223 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 9.1 ug/ml) DME1223 XEOTICID XEO02538 GENEFORM Protein DME1223 XEOTICID XEO02538 MOACRIVE Inhibition DME1223 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1223 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02539 XEO_CLAS Peptide DME1223 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8.6 ug/ml) DME1223 XEOTICID XEO02539 GENEFORM Protein DME1223 XEOTICID XEO02539 MOACRIVE Inhibition DME1223 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1223 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02540 XEO_CLAS Peptide DME1223 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15.2 ug/ml) DME1223 XEOTICID XEO02540 GENEFORM Protein DME1223 XEOTICID XEO02540 MOACRIVE Inhibition DME1223 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1223 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02541 XEO_CLAS Peptide DME1223 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 11.1 ug/ml) DME1223 XEOTICID XEO02541 GENEFORM Protein DME1223 XEOTICID XEO02541 MOACRIVE Inhibition DME1223 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1223 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02542 XEO_CLAS Peptide DME1223 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.7 ug/ml) DME1223 XEOTICID XEO02542 GENEFORM Protein DME1223 XEOTICID XEO02542 MOACRIVE Inhibition DME1223 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1223 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02543 XEO_CLAS Peptide DME1223 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 13.1 ug/ml) DME1223 XEOTICID XEO02543 GENEFORM Protein DME1223 XEOTICID XEO02543 MOACRIVE Inhibition DME1223 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1223 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02544 XEO_CLAS Peptide DME1223 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 9.8 ug/ml) DME1223 XEOTICID XEO02544 GENEFORM Protein DME1223 XEOTICID XEO02544 MOACRIVE Inhibition DME1223 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1223 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02545 XEO_CLAS Peptide DME1223 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 14 microM) DME1223 XEOTICID XEO02545 GENEFORM Protein DME1223 XEOTICID XEO02545 MOACRIVE Inhibition DME1223 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1223 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02546 XEO_CLAS Peptide DME1223 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 14 microM) DME1223 XEOTICID XEO02546 GENEFORM Protein DME1223 XEOTICID XEO02546 MOACRIVE Inhibition DME1223 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1223 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02547 XEO_CLAS Peptide DME1223 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 microM) DME1223 XEOTICID XEO02547 GENEFORM Protein DME1223 XEOTICID XEO02547 MOACRIVE Inhibition DME1223 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1223 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02548 XEO_CLAS Peptide DME1223 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 78 microM) DME1223 XEOTICID XEO02548 GENEFORM Protein DME1223 XEOTICID XEO02548 MOACRIVE Inhibition DME1223 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1223 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02549 XEO_CLAS Peptide DME1223 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02549 GENEFORM Protein DME1223 XEOTICID XEO02549 MOACRIVE Inhibition DME1223 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1223 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02552 XEO_CLAS Peptide DME1223 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 24 microM) DME1223 XEOTICID XEO02552 GENEFORM Protein DME1223 XEOTICID XEO02552 MOACRIVE Inhibition DME1223 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1223 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02553 XEO_CLAS Peptide DME1223 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02553 GENEFORM Protein DME1223 XEOTICID XEO02553 MOACRIVE Inhibition DME1223 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1223 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02556 XEO_CLAS Peptide DME1223 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 55 microM) DME1223 XEOTICID XEO02556 GENEFORM Protein DME1223 XEOTICID XEO02556 MOACRIVE Inhibition DME1223 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1223 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02557 XEO_CLAS Peptide DME1223 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 17 microM) DME1223 XEOTICID XEO02557 GENEFORM Protein DME1223 XEOTICID XEO02557 MOACRIVE Inhibition DME1223 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1223 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02558 XEO_CLAS Peptide DME1223 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 14 microM) DME1223 XEOTICID XEO02558 GENEFORM Protein DME1223 XEOTICID XEO02558 MOACRIVE Inhibition DME1223 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1223 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02559 XEO_CLAS Peptide DME1223 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02559 GENEFORM Protein DME1223 XEOTICID XEO02559 MOACRIVE Inhibition DME1223 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1223 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02560 XEO_CLAS Peptide DME1223 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 13 microM) DME1223 XEOTICID XEO02560 GENEFORM Protein DME1223 XEOTICID XEO02560 MOACRIVE Inhibition DME1223 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1223 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02561 XEO_CLAS Peptide DME1223 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO02561 GENEFORM Protein DME1223 XEOTICID XEO02561 MOACRIVE Inhibition DME1223 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1223 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02562 XEO_CLAS Peptide DME1223 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 13 microM) DME1223 XEOTICID XEO02562 GENEFORM Protein DME1223 XEOTICID XEO02562 MOACRIVE Inhibition DME1223 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1223 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02563 XEO_CLAS Peptide DME1223 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 45 microM) DME1223 XEOTICID XEO02563 GENEFORM Protein DME1223 XEOTICID XEO02563 MOACRIVE Inhibition DME1223 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1223 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02564 XEO_CLAS Peptide DME1223 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 ug/ml) DME1223 XEOTICID XEO02564 GENEFORM Protein DME1223 XEOTICID XEO02564 MOACRIVE Inhibition DME1223 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1223 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02565 XEO_CLAS Peptide DME1223 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 microM) DME1223 XEOTICID XEO02565 GENEFORM Protein DME1223 XEOTICID XEO02565 MOACRIVE Inhibition DME1223 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1223 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02566 XEO_CLAS Peptide DME1223 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO02566 GENEFORM Protein DME1223 XEOTICID XEO02566 MOACRIVE Inhibition DME1223 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1223 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02568 XEO_CLAS Peptide DME1223 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO02568 GENEFORM Protein DME1223 XEOTICID XEO02568 MOACRIVE Inhibition DME1223 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1223 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02569 XEO_CLAS Peptide DME1223 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO02569 GENEFORM Protein DME1223 XEOTICID XEO02569 MOACRIVE Inhibition DME1223 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1223 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02570 XEO_CLAS Peptide DME1223 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO02570 GENEFORM Protein DME1223 XEOTICID XEO02570 MOACRIVE Inhibition DME1223 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1223 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02571 XEO_CLAS Peptide DME1223 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO02571 GENEFORM Protein DME1223 XEOTICID XEO02571 MOACRIVE Inhibition DME1223 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1223 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02572 XEO_CLAS Peptide DME1223 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02572 GENEFORM Protein DME1223 XEOTICID XEO02572 MOACRIVE Inhibition DME1223 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1223 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02573 XEO_CLAS Peptide DME1223 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02573 GENEFORM Protein DME1223 XEOTICID XEO02573 MOACRIVE Inhibition DME1223 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1223 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02574 XEO_CLAS Peptide DME1223 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 microM) DME1223 XEOTICID XEO02574 GENEFORM Protein DME1223 XEOTICID XEO02574 MOACRIVE Inhibition DME1223 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1223 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02575 XEO_CLAS Peptide DME1223 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 microM) DME1223 XEOTICID XEO02575 GENEFORM Protein DME1223 XEOTICID XEO02575 MOACRIVE Inhibition DME1223 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1223 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02576 XEO_CLAS Peptide DME1223 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 33 microM) DME1223 XEOTICID XEO02576 GENEFORM Protein DME1223 XEOTICID XEO02576 MOACRIVE Inhibition DME1223 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1223 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02577 XEO_CLAS Peptide DME1223 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO02577 GENEFORM Protein DME1223 XEOTICID XEO02577 MOACRIVE Inhibition DME1223 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1223 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02578 XEO_CLAS Peptide DME1223 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02578 GENEFORM Protein DME1223 XEOTICID XEO02578 MOACRIVE Inhibition DME1223 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1223 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02579 XEO_CLAS Peptide DME1223 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02579 GENEFORM Protein DME1223 XEOTICID XEO02579 MOACRIVE Inhibition DME1223 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1223 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02580 XEO_CLAS Peptide DME1223 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC < 15 microM) DME1223 XEOTICID XEO02580 GENEFORM Protein DME1223 XEOTICID XEO02580 MOACRIVE Inhibition DME1223 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1223 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02581 XEO_CLAS Peptide DME1223 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 microM) DME1223 XEOTICID XEO02581 GENEFORM Protein DME1223 XEOTICID XEO02581 MOACRIVE Inhibition DME1223 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1223 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02582 XEO_CLAS Peptide DME1223 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 microM) DME1223 XEOTICID XEO02582 GENEFORM Protein DME1223 XEOTICID XEO02582 MOACRIVE Inhibition DME1223 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1223 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02583 XEO_CLAS Peptide DME1223 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 microM) DME1223 XEOTICID XEO02583 GENEFORM Protein DME1223 XEOTICID XEO02583 MOACRIVE Inhibition DME1223 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1223 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02584 XEO_CLAS Peptide DME1223 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 microM) DME1223 XEOTICID XEO02584 GENEFORM Protein DME1223 XEOTICID XEO02584 MOACRIVE Inhibition DME1223 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1223 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02585 XEO_CLAS Peptide DME1223 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO02585 GENEFORM Protein DME1223 XEOTICID XEO02585 MOACRIVE Inhibition DME1223 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1223 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02586 XEO_CLAS Peptide DME1223 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO02586 GENEFORM Protein DME1223 XEOTICID XEO02586 MOACRIVE Inhibition DME1223 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1223 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02587 XEO_CLAS Peptide DME1223 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02587 GENEFORM Protein DME1223 XEOTICID XEO02587 MOACRIVE Inhibition DME1223 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1223 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02589 XEO_CLAS Peptide DME1223 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8.2 ug/ml) DME1223 XEOTICID XEO02589 GENEFORM Protein DME1223 XEOTICID XEO02589 MOACRIVE Inhibition DME1223 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1223 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02590 XEO_CLAS Peptide DME1223 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 19.6 ug/ml) DME1223 XEOTICID XEO02590 GENEFORM Protein DME1223 XEOTICID XEO02590 MOACRIVE Inhibition DME1223 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1223 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02591 XEO_CLAS Peptide DME1223 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO02591 GENEFORM Protein DME1223 XEOTICID XEO02591 MOACRIVE Inhibition DME1223 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1223 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02593 XEO_CLAS Peptide DME1223 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 36 microM) DME1223 XEOTICID XEO02593 GENEFORM Protein DME1223 XEOTICID XEO02593 MOACRIVE Inhibition DME1223 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1223 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02594 XEO_CLAS Peptide DME1223 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02594 GENEFORM Protein DME1223 XEOTICID XEO02594 MOACRIVE Inhibition DME1223 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1223 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02595 XEO_CLAS Peptide DME1223 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO02595 GENEFORM Protein DME1223 XEOTICID XEO02595 MOACRIVE Inhibition DME1223 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1223 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02596 XEO_CLAS Peptide DME1223 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO02596 GENEFORM Protein DME1223 XEOTICID XEO02596 MOACRIVE Inhibition DME1223 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1223 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02597 XEO_CLAS Peptide DME1223 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO02597 GENEFORM Protein DME1223 XEOTICID XEO02597 MOACRIVE Inhibition DME1223 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1223 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02598 XEO_CLAS Peptide DME1223 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 32.5 microM) DME1223 XEOTICID XEO02598 GENEFORM Protein DME1223 XEOTICID XEO02598 MOACRIVE Inhibition DME1223 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1223 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02599 XEO_CLAS Peptide DME1223 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 microM) DME1223 XEOTICID XEO02599 GENEFORM Protein DME1223 XEOTICID XEO02599 MOACRIVE Inhibition DME1223 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1223 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02601 XEO_CLAS Peptide DME1223 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.1 ug/ml) DME1223 XEOTICID XEO02601 GENEFORM Protein DME1223 XEOTICID XEO02601 MOACRIVE Inhibition DME1223 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1223 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02602 XEO_CLAS Peptide DME1223 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 13.2 ug/ml) DME1223 XEOTICID XEO02602 GENEFORM Protein DME1223 XEOTICID XEO02602 MOACRIVE Inhibition DME1223 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1223 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02603 XEO_CLAS Peptide DME1223 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.3 ug/ml) DME1223 XEOTICID XEO02603 GENEFORM Protein DME1223 XEOTICID XEO02603 MOACRIVE Inhibition DME1223 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1223 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02604 XEO_CLAS Peptide DME1223 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO02604 GENEFORM Protein DME1223 XEOTICID XEO02604 MOACRIVE Inhibition DME1223 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1223 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02605 XEO_CLAS Peptide DME1223 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30.6 ug/ml) DME1223 XEOTICID XEO02605 GENEFORM Protein DME1223 XEOTICID XEO02605 MOACRIVE Inhibition DME1223 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1223 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02606 XEO_CLAS Peptide DME1223 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 11.2 ug/ml) DME1223 XEOTICID XEO02606 GENEFORM Protein DME1223 XEOTICID XEO02606 MOACRIVE Inhibition DME1223 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1223 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02607 XEO_CLAS Peptide DME1223 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.8 ug/ml) DME1223 XEOTICID XEO02607 GENEFORM Protein DME1223 XEOTICID XEO02607 MOACRIVE Inhibition DME1223 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1223 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02608 XEO_CLAS Peptide DME1223 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 7.9 ug/ml) DME1223 XEOTICID XEO02608 GENEFORM Protein DME1223 XEOTICID XEO02608 MOACRIVE Inhibition DME1223 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1223 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02609 XEO_CLAS Peptide DME1223 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15.8 ug/ml) DME1223 XEOTICID XEO02609 GENEFORM Protein DME1223 XEOTICID XEO02609 MOACRIVE Inhibition DME1223 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1223 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02610 XEO_CLAS Peptide DME1223 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.1 ug/ml) DME1223 XEOTICID XEO02610 GENEFORM Protein DME1223 XEOTICID XEO02610 MOACRIVE Inhibition DME1223 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1223 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02611 XEO_CLAS Peptide DME1223 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20.6 ug/ml) DME1223 XEOTICID XEO02611 GENEFORM Protein DME1223 XEOTICID XEO02611 MOACRIVE Inhibition DME1223 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1223 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02612 XEO_CLAS Peptide DME1223 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 11.8 ug/ml) DME1223 XEOTICID XEO02612 GENEFORM Protein DME1223 XEOTICID XEO02612 MOACRIVE Inhibition DME1223 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1223 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02613 XEO_CLAS Peptide DME1223 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 13.2 ug/ml) DME1223 XEOTICID XEO02613 GENEFORM Protein DME1223 XEOTICID XEO02613 MOACRIVE Inhibition DME1223 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1223 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02614 XEO_CLAS Peptide DME1223 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.8 ug/ml) DME1223 XEOTICID XEO02614 GENEFORM Protein DME1223 XEOTICID XEO02614 MOACRIVE Inhibition DME1223 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1223 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02615 XEO_CLAS Peptide DME1223 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8.6 ug/ml) DME1223 XEOTICID XEO02615 GENEFORM Protein DME1223 XEOTICID XEO02615 MOACRIVE Inhibition DME1223 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1223 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02616 XEO_CLAS Peptide DME1223 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20.4 ug/ml) DME1223 XEOTICID XEO02616 GENEFORM Protein DME1223 XEOTICID XEO02616 MOACRIVE Inhibition DME1223 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1223 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02617 XEO_CLAS Peptide DME1223 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4.7 ug/ml) DME1223 XEOTICID XEO02617 GENEFORM Protein DME1223 XEOTICID XEO02617 MOACRIVE Inhibition DME1223 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1223 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02618 XEO_CLAS Peptide DME1223 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.6 ug/ml) DME1223 XEOTICID XEO02618 GENEFORM Protein DME1223 XEOTICID XEO02618 MOACRIVE Inhibition DME1223 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1223 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02619 XEO_CLAS Peptide DME1223 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10.5 ug/ml) DME1223 XEOTICID XEO02619 GENEFORM Protein DME1223 XEOTICID XEO02619 MOACRIVE Inhibition DME1223 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1223 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02620 XEO_CLAS Peptide DME1223 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO02620 GENEFORM Protein DME1223 XEOTICID XEO02620 MOACRIVE Inhibition DME1223 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1223 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02621 XEO_CLAS Peptide DME1223 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO02621 GENEFORM Protein DME1223 XEOTICID XEO02621 MOACRIVE Inhibition DME1223 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1223 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02622 XEO_CLAS Peptide DME1223 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO02622 GENEFORM Protein DME1223 XEOTICID XEO02622 MOACRIVE Inhibition DME1223 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1223 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02623 XEO_CLAS Peptide DME1223 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO02623 GENEFORM Protein DME1223 XEOTICID XEO02623 MOACRIVE Inhibition DME1223 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1223 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02624 XEO_CLAS Peptide DME1223 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 18 microM) DME1223 XEOTICID XEO02624 GENEFORM Protein DME1223 XEOTICID XEO02624 MOACRIVE Inhibition DME1223 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1223 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02625 XEO_CLAS Peptide DME1223 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 9 microM) DME1223 XEOTICID XEO02625 GENEFORM Protein DME1223 XEOTICID XEO02625 MOACRIVE Inhibition DME1223 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1223 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02626 XEO_CLAS Peptide DME1223 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 18 microM) DME1223 XEOTICID XEO02626 GENEFORM Protein DME1223 XEOTICID XEO02626 MOACRIVE Inhibition DME1223 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1223 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02627 XEO_CLAS Peptide DME1223 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02627 GENEFORM Protein DME1223 XEOTICID XEO02627 MOACRIVE Inhibition DME1223 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1223 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02628 XEO_CLAS Peptide DME1223 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 18 microM) DME1223 XEOTICID XEO02628 GENEFORM Protein DME1223 XEOTICID XEO02628 MOACRIVE Inhibition DME1223 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1223 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02629 XEO_CLAS Peptide DME1223 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 13 microM) DME1223 XEOTICID XEO02629 GENEFORM Protein DME1223 XEOTICID XEO02629 MOACRIVE Inhibition DME1223 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1223 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02630 XEO_CLAS Peptide DME1223 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 ug/ml) DME1223 XEOTICID XEO02630 GENEFORM Protein DME1223 XEOTICID XEO02630 MOACRIVE Inhibition DME1223 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1223 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02631 XEO_CLAS Peptide DME1223 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 ug/ml) DME1223 XEOTICID XEO02631 GENEFORM Protein DME1223 XEOTICID XEO02631 MOACRIVE Inhibition DME1223 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1223 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02634 XEO_CLAS Peptide DME1223 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO02634 GENEFORM Protein DME1223 XEOTICID XEO02634 MOACRIVE Inhibition DME1223 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1223 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02635 XEO_CLAS Peptide DME1223 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40 ug/ml) DME1223 XEOTICID XEO02635 GENEFORM Protein DME1223 XEOTICID XEO02635 MOACRIVE Inhibition DME1223 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1223 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02636 XEO_CLAS Peptide DME1223 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO02636 GENEFORM Protein DME1223 XEOTICID XEO02636 MOACRIVE Inhibition DME1223 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1223 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02637 XEO_CLAS Peptide DME1223 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO02637 GENEFORM Protein DME1223 XEOTICID XEO02637 MOACRIVE Inhibition DME1223 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1223 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02638 XEO_CLAS Peptide DME1223 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 microM) DME1223 XEOTICID XEO02638 GENEFORM Protein DME1223 XEOTICID XEO02638 MOACRIVE Inhibition DME1223 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1223 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02639 XEO_CLAS Peptide DME1223 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 microM) DME1223 XEOTICID XEO02639 GENEFORM Protein DME1223 XEOTICID XEO02639 MOACRIVE Inhibition DME1223 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1223 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02644 XEO_CLAS Peptide DME1223 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02644 GENEFORM Protein DME1223 XEOTICID XEO02644 MOACRIVE Inhibition DME1223 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1223 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02645 XEO_CLAS Peptide DME1223 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02645 GENEFORM Protein DME1223 XEOTICID XEO02645 MOACRIVE Inhibition DME1223 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1223 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02646 XEO_CLAS Peptide DME1223 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02646 GENEFORM Protein DME1223 XEOTICID XEO02646 MOACRIVE Inhibition DME1223 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1223 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02647 XEO_CLAS Peptide DME1223 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02647 GENEFORM Protein DME1223 XEOTICID XEO02647 MOACRIVE Inhibition DME1223 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1223 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02649 XEO_CLAS Peptide DME1223 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO02649 GENEFORM Protein DME1223 XEOTICID XEO02649 MOACRIVE Inhibition DME1223 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1223 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02650 XEO_CLAS Peptide DME1223 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO02650 GENEFORM Protein DME1223 XEOTICID XEO02650 MOACRIVE Inhibition DME1223 XEOTICID XEO02658 XEO_NAME Buthinin DME1223 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02658 XEO_CLAS Peptide DME1223 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02658 GENEFORM Protein DME1223 XEOTICID XEO02658 MOACRIVE Inhibition DME1223 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1223 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02663 XEO_CLAS Peptide DME1223 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25 microM) DME1223 XEOTICID XEO02663 GENEFORM Protein DME1223 XEOTICID XEO02663 MOACRIVE Inhibition DME1223 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1223 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02664 XEO_CLAS Peptide DME1223 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25 microM) DME1223 XEOTICID XEO02664 GENEFORM Protein DME1223 XEOTICID XEO02664 MOACRIVE Inhibition DME1223 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1223 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02672 XEO_CLAS Peptide DME1223 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25 microM) DME1223 XEOTICID XEO02672 GENEFORM Protein DME1223 XEOTICID XEO02672 MOACRIVE Inhibition DME1223 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1223 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02673 XEO_CLAS Peptide DME1223 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25-12.5 microM) DME1223 XEOTICID XEO02673 GENEFORM Protein DME1223 XEOTICID XEO02673 MOACRIVE Inhibition DME1223 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1223 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02674 XEO_CLAS Peptide DME1223 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.125-6.25 microM) DME1223 XEOTICID XEO02674 GENEFORM Protein DME1223 XEOTICID XEO02674 MOACRIVE Inhibition DME1223 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1223 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02676 XEO_CLAS Peptide DME1223 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO02676 GENEFORM Protein DME1223 XEOTICID XEO02676 MOACRIVE Inhibition DME1223 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1223 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02677 XEO_CLAS Peptide DME1223 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25-12.5 microM) DME1223 XEOTICID XEO02677 GENEFORM Protein DME1223 XEOTICID XEO02677 MOACRIVE Inhibition DME1223 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1223 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02679 XEO_CLAS Peptide DME1223 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25-12.5 microM) DME1223 XEOTICID XEO02679 GENEFORM Protein DME1223 XEOTICID XEO02679 MOACRIVE Inhibition DME1223 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1223 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02680 XEO_CLAS Peptide DME1223 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25 microM) DME1223 XEOTICID XEO02680 GENEFORM Protein DME1223 XEOTICID XEO02680 MOACRIVE Inhibition DME1223 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1223 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02683 XEO_CLAS Peptide DME1223 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO02683 GENEFORM Protein DME1223 XEOTICID XEO02683 MOACRIVE Inhibition DME1223 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1223 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02688 XEO_CLAS Peptide DME1223 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO02688 GENEFORM Protein DME1223 XEOTICID XEO02688 MOACRIVE Inhibition DME1223 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1223 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02693 XEO_CLAS Peptide DME1223 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 ug/ml) DME1223 XEOTICID XEO02693 GENEFORM Protein DME1223 XEOTICID XEO02693 MOACRIVE Inhibition DME1223 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1223 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02699 XEO_CLAS Peptide DME1223 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 ug/ml) DME1223 XEOTICID XEO02699 GENEFORM Protein DME1223 XEOTICID XEO02699 MOACRIVE Inhibition DME1223 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1223 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02700 XEO_CLAS Peptide DME1223 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 ug/ml) DME1223 XEOTICID XEO02700 GENEFORM Protein DME1223 XEOTICID XEO02700 MOACRIVE Inhibition DME1223 XEOTICID XEO02703 XEO_NAME Calcitermin DME1223 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02703 XEO_CLAS Peptide DME1223 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02703 GENEFORM Protein DME1223 XEOTICID XEO02703 MOACRIVE Inhibition DME1223 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1223 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02708 XEO_CLAS Peptide DME1223 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO02708 GENEFORM Protein DME1223 XEOTICID XEO02708 MOACRIVE Inhibition DME1223 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1223 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02709 XEO_CLAS Peptide DME1223 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.05 microM) DME1223 XEOTICID XEO02709 GENEFORM Protein DME1223 XEOTICID XEO02709 MOACRIVE Inhibition DME1223 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1223 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1223 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02713 GENEFORM Protein DME1223 XEOTICID XEO02713 MOACRIVE Inhibition DME1223 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1223 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1223 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02714 GENEFORM Protein DME1223 XEOTICID XEO02714 MOACRIVE Inhibition DME1223 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1223 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02726 XEO_CLAS Peptide DME1223 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02726 GENEFORM Protein DME1223 XEOTICID XEO02726 MOACRIVE Inhibition DME1223 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1223 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02731 XEO_CLAS Peptide DME1223 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1 microM) DME1223 XEOTICID XEO02731 GENEFORM Protein DME1223 XEOTICID XEO02731 MOACRIVE Inhibition DME1223 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1223 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02732 XEO_CLAS Peptide DME1223 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.25 microM) DME1223 XEOTICID XEO02732 GENEFORM Protein DME1223 XEOTICID XEO02732 MOACRIVE Inhibition DME1223 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1223 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02733 XEO_CLAS Peptide DME1223 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8-25 ug/ml) DME1223 XEOTICID XEO02733 GENEFORM Protein DME1223 XEOTICID XEO02733 MOACRIVE Inhibition DME1223 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1223 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02735 XEO_CLAS Peptide DME1223 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1 ug/ml) DME1223 XEOTICID XEO02735 GENEFORM Protein DME1223 XEOTICID XEO02735 MOACRIVE Inhibition DME1223 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1223 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02737 XEO_CLAS Peptide DME1223 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02737 GENEFORM Protein DME1223 XEOTICID XEO02737 MOACRIVE Inhibition DME1223 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1223 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02738 XEO_CLAS Peptide DME1223 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO02738 GENEFORM Protein DME1223 XEOTICID XEO02738 MOACRIVE Inhibition DME1223 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1223 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02739 XEO_CLAS Peptide DME1223 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 microM) DME1223 XEOTICID XEO02739 GENEFORM Protein DME1223 XEOTICID XEO02739 MOACRIVE Inhibition DME1223 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1223 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02740 XEO_CLAS Peptide DME1223 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.25 ug/ml) DME1223 XEOTICID XEO02740 GENEFORM Protein DME1223 XEOTICID XEO02740 MOACRIVE Inhibition DME1223 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1223 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02741 XEO_CLAS Peptide DME1223 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 ug/ml) DME1223 XEOTICID XEO02741 GENEFORM Protein DME1223 XEOTICID XEO02741 MOACRIVE Inhibition DME1223 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1223 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02743 XEO_CLAS Peptide DME1223 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.6 ug/ml) DME1223 XEOTICID XEO02743 GENEFORM Protein DME1223 XEOTICID XEO02743 MOACRIVE Inhibition DME1223 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1223 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02744 XEO_CLAS Peptide DME1223 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 18.7 ug/ml) DME1223 XEOTICID XEO02744 GENEFORM Protein DME1223 XEOTICID XEO02744 MOACRIVE Inhibition DME1223 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1223 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02745 XEO_CLAS Peptide DME1223 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02745 GENEFORM Protein DME1223 XEOTICID XEO02745 MOACRIVE Inhibition DME1223 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1223 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02746 XEO_CLAS Peptide DME1223 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02746 GENEFORM Protein DME1223 XEOTICID XEO02746 MOACRIVE Inhibition DME1223 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1223 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02748 XEO_CLAS Peptide DME1223 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02748 GENEFORM Protein DME1223 XEOTICID XEO02748 MOACRIVE Inhibition DME1223 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1223 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02749 XEO_CLAS Peptide DME1223 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20-25 mug/ml) DME1223 XEOTICID XEO02749 GENEFORM Protein DME1223 XEOTICID XEO02749 MOACRIVE Inhibition DME1223 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1223 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02750 XEO_CLAS Peptide DME1223 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02750 GENEFORM Protein DME1223 XEOTICID XEO02750 MOACRIVE Inhibition DME1223 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1223 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02752 XEO_CLAS Peptide DME1223 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02752 GENEFORM Protein DME1223 XEOTICID XEO02752 MOACRIVE Inhibition DME1223 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1223 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02753 XEO_CLAS Peptide DME1223 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02753 GENEFORM Protein DME1223 XEOTICID XEO02753 MOACRIVE Inhibition DME1223 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1223 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02754 XEO_CLAS Peptide DME1223 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 microM) DME1223 XEOTICID XEO02754 GENEFORM Protein DME1223 XEOTICID XEO02754 MOACRIVE Inhibition DME1223 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1223 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02756 XEO_CLAS Peptide DME1223 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 microM) DME1223 XEOTICID XEO02756 GENEFORM Protein DME1223 XEOTICID XEO02756 MOACRIVE Inhibition DME1223 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1223 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02757 XEO_CLAS Peptide DME1223 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1 microM) DME1223 XEOTICID XEO02757 GENEFORM Protein DME1223 XEOTICID XEO02757 MOACRIVE Inhibition DME1223 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1223 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02758 XEO_CLAS Peptide DME1223 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO02758 GENEFORM Protein DME1223 XEOTICID XEO02758 MOACRIVE Inhibition DME1223 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1223 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02759 XEO_CLAS Peptide DME1223 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.6 microM) DME1223 XEOTICID XEO02759 GENEFORM Protein DME1223 XEOTICID XEO02759 MOACRIVE Inhibition DME1223 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1223 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02760 XEO_CLAS Peptide DME1223 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 microM) DME1223 XEOTICID XEO02760 GENEFORM Protein DME1223 XEOTICID XEO02760 MOACRIVE Inhibition DME1223 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1223 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02761 XEO_CLAS Peptide DME1223 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO02761 GENEFORM Protein DME1223 XEOTICID XEO02761 MOACRIVE Inhibition DME1223 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1223 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02762 XEO_CLAS Peptide DME1223 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 microM) DME1223 XEOTICID XEO02762 GENEFORM Protein DME1223 XEOTICID XEO02762 MOACRIVE Inhibition DME1223 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1223 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02763 XEO_CLAS Peptide DME1223 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.4 microM) DME1223 XEOTICID XEO02763 GENEFORM Protein DME1223 XEOTICID XEO02763 MOACRIVE Inhibition DME1223 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1223 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02764 XEO_CLAS Peptide DME1223 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 microM) DME1223 XEOTICID XEO02764 GENEFORM Protein DME1223 XEOTICID XEO02764 MOACRIVE Inhibition DME1223 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1223 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02765 XEO_CLAS Peptide DME1223 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.3 microM) DME1223 XEOTICID XEO02765 GENEFORM Protein DME1223 XEOTICID XEO02765 MOACRIVE Inhibition DME1223 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1223 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02767 XEO_CLAS Peptide DME1223 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02767 GENEFORM Protein DME1223 XEOTICID XEO02767 MOACRIVE Inhibition DME1223 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1223 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02768 XEO_CLAS Peptide DME1223 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1223 XEOTICID XEO02768 GENEFORM Protein DME1223 XEOTICID XEO02768 MOACRIVE Inhibition DME1223 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1223 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02769 XEO_CLAS Peptide DME1223 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.32 microM) DME1223 XEOTICID XEO02769 GENEFORM Protein DME1223 XEOTICID XEO02769 MOACRIVE Inhibition DME1223 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1223 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02770 XEO_CLAS Peptide DME1223 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.30 microM) DME1223 XEOTICID XEO02770 GENEFORM Protein DME1223 XEOTICID XEO02770 MOACRIVE Inhibition DME1223 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1223 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02771 XEO_CLAS Peptide DME1223 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.21 microM) DME1223 XEOTICID XEO02771 GENEFORM Protein DME1223 XEOTICID XEO02771 MOACRIVE Inhibition DME1223 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1223 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02772 XEO_CLAS Peptide DME1223 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02772 GENEFORM Protein DME1223 XEOTICID XEO02772 MOACRIVE Inhibition DME1223 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1223 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02773 XEO_CLAS Peptide DME1223 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.9-8.6 microM) DME1223 XEOTICID XEO02773 GENEFORM Protein DME1223 XEOTICID XEO02773 MOACRIVE Inhibition DME1223 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1223 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02774 XEO_CLAS Peptide DME1223 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.3 microM) DME1223 XEOTICID XEO02774 GENEFORM Protein DME1223 XEOTICID XEO02774 MOACRIVE Inhibition DME1223 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1223 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02789 GENEFORM Protein DME1223 XEOTICID XEO02789 MOACRIVE Inhibition DME1223 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1223 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02790 GENEFORM Protein DME1223 XEOTICID XEO02790 MOACRIVE Inhibition DME1223 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1223 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02791 GENEFORM Protein DME1223 XEOTICID XEO02791 MOACRIVE Inhibition DME1223 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1223 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02792 GENEFORM Protein DME1223 XEOTICID XEO02792 MOACRIVE Inhibition DME1223 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1223 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02793 GENEFORM Protein DME1223 XEOTICID XEO02793 MOACRIVE Inhibition DME1223 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1223 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02794 GENEFORM Protein DME1223 XEOTICID XEO02794 MOACRIVE Inhibition DME1223 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1223 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02795 GENEFORM Protein DME1223 XEOTICID XEO02795 MOACRIVE Inhibition DME1223 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1223 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02796 GENEFORM Protein DME1223 XEOTICID XEO02796 MOACRIVE Inhibition DME1223 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1223 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02797 GENEFORM Protein DME1223 XEOTICID XEO02797 MOACRIVE Inhibition DME1223 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1223 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02799 XEO_CLAS Peptide DME1223 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02799 GENEFORM Protein DME1223 XEOTICID XEO02799 MOACRIVE Inhibition DME1223 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1223 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02800 XEO_CLAS Peptide DME1223 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02800 GENEFORM Protein DME1223 XEOTICID XEO02800 MOACRIVE Inhibition DME1223 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1223 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02802 XEO_CLAS Peptide DME1223 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 13.6 microM) DME1223 XEOTICID XEO02802 GENEFORM Protein DME1223 XEOTICID XEO02802 MOACRIVE Inhibition DME1223 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1223 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02807 XEO_CLAS Peptide DME1223 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.2 microM) DME1223 XEOTICID XEO02807 GENEFORM Protein DME1223 XEOTICID XEO02807 MOACRIVE Inhibition DME1223 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1223 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02813 XEO_CLAS Peptide DME1223 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 80 microM) DME1223 XEOTICID XEO02813 GENEFORM Protein DME1223 XEOTICID XEO02813 MOACRIVE Inhibition DME1223 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1223 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02814 XEO_CLAS Peptide DME1223 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 80 microM) DME1223 XEOTICID XEO02814 GENEFORM Protein DME1223 XEOTICID XEO02814 MOACRIVE Inhibition DME1223 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1223 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02815 XEO_CLAS Peptide DME1223 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8.5 microM) DME1223 XEOTICID XEO02815 GENEFORM Protein DME1223 XEOTICID XEO02815 MOACRIVE Inhibition DME1223 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1223 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02816 XEO_CLAS Peptide DME1223 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 80 microM) DME1223 XEOTICID XEO02816 GENEFORM Protein DME1223 XEOTICID XEO02816 MOACRIVE Inhibition DME1223 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1223 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02817 XEO_CLAS Peptide DME1223 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 80 microM) DME1223 XEOTICID XEO02817 GENEFORM Protein DME1223 XEOTICID XEO02817 MOACRIVE Inhibition DME1223 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1223 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02818 XEO_CLAS Peptide DME1223 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.4 microM) DME1223 XEOTICID XEO02818 GENEFORM Protein DME1223 XEOTICID XEO02818 MOACRIVE Inhibition DME1223 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1223 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02819 XEO_CLAS Peptide DME1223 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.6 microM) DME1223 XEOTICID XEO02819 GENEFORM Protein DME1223 XEOTICID XEO02819 MOACRIVE Inhibition DME1223 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1223 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02820 XEO_CLAS Peptide DME1223 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO02820 GENEFORM Protein DME1223 XEOTICID XEO02820 MOACRIVE Inhibition DME1223 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1223 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02821 XEO_CLAS Peptide DME1223 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02821 GENEFORM Protein DME1223 XEOTICID XEO02821 MOACRIVE Inhibition DME1223 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1223 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02824 XEO_CLAS Peptide DME1223 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 35 microM) DME1223 XEOTICID XEO02824 GENEFORM Protein DME1223 XEOTICID XEO02824 MOACRIVE Inhibition DME1223 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1223 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02826 XEO_CLAS Peptide DME1223 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.7 ug/ml) DME1223 XEOTICID XEO02826 GENEFORM Protein DME1223 XEOTICID XEO02826 MOACRIVE Inhibition DME1223 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1223 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02834 GENEFORM Protein DME1223 XEOTICID XEO02834 MOACRIVE Inhibition DME1223 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1223 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02839 XEO_CLAS Peptide DME1223 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.25 microM) DME1223 XEOTICID XEO02839 GENEFORM Protein DME1223 XEOTICID XEO02839 MOACRIVE Inhibition DME1223 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1223 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02841 XEO_CLAS Peptide DME1223 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.25 microM) DME1223 XEOTICID XEO02841 GENEFORM Protein DME1223 XEOTICID XEO02841 MOACRIVE Inhibition DME1223 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1223 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02842 XEO_CLAS Peptide DME1223 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.25 microM) DME1223 XEOTICID XEO02842 GENEFORM Protein DME1223 XEOTICID XEO02842 MOACRIVE Inhibition DME1223 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1223 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02843 XEO_CLAS Peptide DME1223 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02843 GENEFORM Protein DME1223 XEOTICID XEO02843 MOACRIVE Inhibition DME1223 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1223 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02849 GENEFORM Protein DME1223 XEOTICID XEO02849 MOACRIVE Inhibition DME1223 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1223 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02857 XEO_CLAS Peptide DME1223 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 53 microM) DME1223 XEOTICID XEO02857 GENEFORM Protein DME1223 XEOTICID XEO02857 MOACRIVE Inhibition DME1223 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1223 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02858 XEO_CLAS Peptide DME1223 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 53 microM) DME1223 XEOTICID XEO02858 GENEFORM Protein DME1223 XEOTICID XEO02858 MOACRIVE Inhibition DME1223 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1223 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02860 XEO_CLAS Peptide DME1223 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 ug/ml) DME1223 XEOTICID XEO02860 GENEFORM Protein DME1223 XEOTICID XEO02860 MOACRIVE Inhibition DME1223 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1223 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02867 XEO_CLAS Peptide DME1223 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02867 GENEFORM Protein DME1223 XEOTICID XEO02867 MOACRIVE Inhibition DME1223 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1223 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02868 XEO_CLAS Peptide DME1223 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02868 GENEFORM Protein DME1223 XEOTICID XEO02868 MOACRIVE Inhibition DME1223 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1223 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02869 XEO_CLAS Peptide DME1223 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02869 GENEFORM Protein DME1223 XEOTICID XEO02869 MOACRIVE Inhibition DME1223 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1223 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02870 XEO_CLAS Peptide DME1223 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02870 GENEFORM Protein DME1223 XEOTICID XEO02870 MOACRIVE Inhibition DME1223 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1223 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02871 XEO_CLAS Peptide DME1223 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02871 GENEFORM Protein DME1223 XEOTICID XEO02871 MOACRIVE Inhibition DME1223 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1223 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02872 XEO_CLAS Peptide DME1223 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 308 microM) DME1223 XEOTICID XEO02872 GENEFORM Protein DME1223 XEOTICID XEO02872 MOACRIVE Inhibition DME1223 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1223 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02875 XEO_CLAS Peptide DME1223 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.1 microM) DME1223 XEOTICID XEO02875 GENEFORM Protein DME1223 XEOTICID XEO02875 MOACRIVE Inhibition DME1223 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1223 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02876 XEO_CLAS Peptide DME1223 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO02876 GENEFORM Protein DME1223 XEOTICID XEO02876 MOACRIVE Inhibition DME1223 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1223 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02877 XEO_CLAS Peptide DME1223 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO02877 GENEFORM Protein DME1223 XEOTICID XEO02877 MOACRIVE Inhibition DME1223 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1223 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02878 XEO_CLAS Peptide DME1223 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.3 microM) DME1223 XEOTICID XEO02878 GENEFORM Protein DME1223 XEOTICID XEO02878 MOACRIVE Inhibition DME1223 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1223 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02885 XEO_CLAS Peptide DME1223 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02885 GENEFORM Protein DME1223 XEOTICID XEO02885 MOACRIVE Inhibition DME1223 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1223 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02886 XEO_CLAS Peptide DME1223 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02886 GENEFORM Protein DME1223 XEOTICID XEO02886 MOACRIVE Inhibition DME1223 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1223 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02887 XEO_CLAS Peptide DME1223 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1 ug/ml) DME1223 XEOTICID XEO02887 GENEFORM Protein DME1223 XEOTICID XEO02887 MOACRIVE Inhibition DME1223 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1223 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02888 XEO_CLAS Peptide DME1223 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 ug/ml) DME1223 XEOTICID XEO02888 GENEFORM Protein DME1223 XEOTICID XEO02888 MOACRIVE Inhibition DME1223 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1223 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02889 XEO_CLAS Peptide DME1223 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 ug/ml) DME1223 XEOTICID XEO02889 GENEFORM Protein DME1223 XEOTICID XEO02889 MOACRIVE Inhibition DME1223 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1223 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02890 XEO_CLAS Peptide DME1223 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02890 GENEFORM Protein DME1223 XEOTICID XEO02890 MOACRIVE Inhibition DME1223 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1223 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02891 XEO_CLAS Peptide DME1223 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02891 GENEFORM Protein DME1223 XEOTICID XEO02891 MOACRIVE Inhibition DME1223 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1223 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02895 XEO_CLAS Peptide DME1223 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO02895 GENEFORM Protein DME1223 XEOTICID XEO02895 MOACRIVE Inhibition DME1223 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1223 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02896 XEO_CLAS Peptide DME1223 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO02896 GENEFORM Protein DME1223 XEOTICID XEO02896 MOACRIVE Inhibition DME1223 XEOTICID XEO02899 XEO_NAME Coladonin DME1223 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1223 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1223 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02899 GENEFORM Protein DME1223 XEOTICID XEO02899 MOACRIVE Inhibition DME1223 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1223 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02900 XEO_CLAS Peptide DME1223 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02900 GENEFORM Protein DME1223 XEOTICID XEO02900 MOACRIVE Inhibition DME1223 XEOTICID XEO02901 XEO_NAME Colicin-V DME1223 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02901 XEO_CLAS Peptide DME1223 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02901 GENEFORM Protein DME1223 XEOTICID XEO02901 MOACRIVE Inhibition DME1223 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1223 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02904 GENEFORM Protein DME1223 XEOTICID XEO02904 MOACRIVE Inhibition DME1223 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1223 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02908 XEO_CLAS Peptide DME1223 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 50 microM) DME1223 XEOTICID XEO02908 GENEFORM Protein DME1223 XEOTICID XEO02908 MOACRIVE Inhibition DME1223 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1223 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02923 XEO_CLAS Peptide DME1223 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02923 GENEFORM Protein DME1223 XEOTICID XEO02923 MOACRIVE Inhibition DME1223 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1223 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02924 XEO_CLAS Peptide DME1223 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 32 microM) DME1223 XEOTICID XEO02924 GENEFORM Protein DME1223 XEOTICID XEO02924 MOACRIVE Inhibition DME1223 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1223 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1223 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02927 GENEFORM Protein DME1223 XEOTICID XEO02927 MOACRIVE Inhibition DME1223 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1223 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02931 XEO_CLAS Peptide DME1223 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 ug/ml) DME1223 XEOTICID XEO02931 GENEFORM Protein DME1223 XEOTICID XEO02931 MOACRIVE Inhibition DME1223 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1223 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02933 XEO_CLAS Peptide DME1223 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO02933 GENEFORM Protein DME1223 XEOTICID XEO02933 MOACRIVE Inhibition DME1223 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1223 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02934 XEO_CLAS Peptide DME1223 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02934 GENEFORM Protein DME1223 XEOTICID XEO02934 MOACRIVE Inhibition DME1223 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1223 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02935 XEO_CLAS Peptide DME1223 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02935 GENEFORM Protein DME1223 XEOTICID XEO02935 MOACRIVE Inhibition DME1223 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1223 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02936 XEO_CLAS Peptide DME1223 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO02936 GENEFORM Protein DME1223 XEOTICID XEO02936 MOACRIVE Inhibition DME1223 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1223 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02937 XEO_CLAS Peptide DME1223 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02937 GENEFORM Protein DME1223 XEOTICID XEO02937 MOACRIVE Inhibition DME1223 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1223 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02938 XEO_CLAS Peptide DME1223 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 32 ug/ml) DME1223 XEOTICID XEO02938 GENEFORM Protein DME1223 XEOTICID XEO02938 MOACRIVE Inhibition DME1223 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1223 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02939 XEO_CLAS Peptide DME1223 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 11 ug/ml) DME1223 XEOTICID XEO02939 GENEFORM Protein DME1223 XEOTICID XEO02939 MOACRIVE Inhibition DME1223 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1223 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02940 XEO_CLAS Peptide DME1223 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1 ug/ml) DME1223 XEOTICID XEO02940 GENEFORM Protein DME1223 XEOTICID XEO02940 MOACRIVE Inhibition DME1223 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1223 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02941 XEO_CLAS Peptide DME1223 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02941 GENEFORM Protein DME1223 XEOTICID XEO02941 MOACRIVE Inhibition DME1223 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1223 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02944 XEO_CLAS Peptide DME1223 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 microM) DME1223 XEOTICID XEO02944 GENEFORM Protein DME1223 XEOTICID XEO02944 MOACRIVE Inhibition DME1223 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1223 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02945 XEO_CLAS Peptide DME1223 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 microM) DME1223 XEOTICID XEO02945 GENEFORM Protein DME1223 XEOTICID XEO02945 MOACRIVE Inhibition DME1223 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1223 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02946 XEO_CLAS Peptide DME1223 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 microM) DME1223 XEOTICID XEO02946 GENEFORM Protein DME1223 XEOTICID XEO02946 MOACRIVE Inhibition DME1223 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1223 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02947 XEO_CLAS Peptide DME1223 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02947 GENEFORM Protein DME1223 XEOTICID XEO02947 MOACRIVE Inhibition DME1223 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1223 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02948 XEO_CLAS Peptide DME1223 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO02948 GENEFORM Protein DME1223 XEOTICID XEO02948 MOACRIVE Inhibition DME1223 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1223 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02949 XEO_CLAS Peptide DME1223 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO02949 GENEFORM Protein DME1223 XEOTICID XEO02949 MOACRIVE Inhibition DME1223 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1223 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02954 XEO_CLAS Peptide DME1223 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02954 GENEFORM Protein DME1223 XEOTICID XEO02954 MOACRIVE Inhibition DME1223 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1223 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02958 XEO_CLAS Peptide DME1223 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02958 GENEFORM Protein DME1223 XEOTICID XEO02958 MOACRIVE Inhibition DME1223 XEOTICID XEO02962 XEO_NAME Cryptonin DME1223 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02962 XEO_CLAS Peptide DME1223 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.12 ug/ml) DME1223 XEOTICID XEO02962 GENEFORM Protein DME1223 XEOTICID XEO02962 MOACRIVE Inhibition DME1223 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1223 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02965 XEO_CLAS Peptide DME1223 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 ug/ml) DME1223 XEOTICID XEO02965 GENEFORM Protein DME1223 XEOTICID XEO02965 MOACRIVE Inhibition DME1223 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1223 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02969 XEO_CLAS Peptide DME1223 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 microM) DME1223 XEOTICID XEO02969 GENEFORM Protein DME1223 XEOTICID XEO02969 MOACRIVE Inhibition DME1223 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1223 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02971 XEO_CLAS Peptide DME1223 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 microM) DME1223 XEOTICID XEO02971 GENEFORM Protein DME1223 XEOTICID XEO02971 MOACRIVE Inhibition DME1223 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1223 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO02972 XEO_CLAS Peptide DME1223 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.4 microM) DME1223 XEOTICID XEO02972 GENEFORM Protein DME1223 XEOTICID XEO02972 MOACRIVE Inhibition DME1223 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1223 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02990 GENEFORM Protein DME1223 XEOTICID XEO02990 MOACRIVE Inhibition DME1223 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1223 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02991 GENEFORM Protein DME1223 XEOTICID XEO02991 MOACRIVE Inhibition DME1223 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1223 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02992 GENEFORM Protein DME1223 XEOTICID XEO02992 MOACRIVE Inhibition DME1223 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1223 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02993 GENEFORM Protein DME1223 XEOTICID XEO02993 MOACRIVE Inhibition DME1223 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1223 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02994 GENEFORM Protein DME1223 XEOTICID XEO02994 MOACRIVE Inhibition DME1223 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1223 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02995 GENEFORM Protein DME1223 XEOTICID XEO02995 MOACRIVE Inhibition DME1223 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1223 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02996 GENEFORM Protein DME1223 XEOTICID XEO02996 MOACRIVE Inhibition DME1223 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1223 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02997 GENEFORM Protein DME1223 XEOTICID XEO02997 MOACRIVE Inhibition DME1223 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1223 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02998 GENEFORM Protein DME1223 XEOTICID XEO02998 MOACRIVE Inhibition DME1223 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1223 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1223 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO02999 GENEFORM Protein DME1223 XEOTICID XEO02999 MOACRIVE Inhibition DME1223 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1223 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03021 XEO_CLAS Peptide DME1223 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.31-0.63 microM) DME1223 XEOTICID XEO03021 GENEFORM Protein DME1223 XEOTICID XEO03021 MOACRIVE Inhibition DME1223 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1223 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03029 XEO_CLAS Peptide DME1223 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.005 microM) DME1223 XEOTICID XEO03029 GENEFORM Protein DME1223 XEOTICID XEO03029 MOACRIVE Inhibition DME1223 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1223 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03030 XEO_CLAS Peptide DME1223 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.005 microM) DME1223 XEOTICID XEO03030 GENEFORM Protein DME1223 XEOTICID XEO03030 MOACRIVE Inhibition DME1223 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1223 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03031 XEO_CLAS Peptide DME1223 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.3 microM) DME1223 XEOTICID XEO03031 GENEFORM Protein DME1223 XEOTICID XEO03031 MOACRIVE Inhibition DME1223 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1223 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03032 XEO_CLAS Peptide DME1223 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.01 microM) DME1223 XEOTICID XEO03032 GENEFORM Protein DME1223 XEOTICID XEO03032 MOACRIVE Inhibition DME1223 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1223 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03033 XEO_CLAS Peptide DME1223 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.173 microM) DME1223 XEOTICID XEO03033 GENEFORM Protein DME1223 XEOTICID XEO03033 MOACRIVE Inhibition DME1223 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1223 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03034 XEO_CLAS Peptide DME1223 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.518 microM) DME1223 XEOTICID XEO03034 GENEFORM Protein DME1223 XEOTICID XEO03034 MOACRIVE Inhibition DME1223 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1223 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03035 XEO_CLAS Peptide DME1223 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.114 microM) DME1223 XEOTICID XEO03035 GENEFORM Protein DME1223 XEOTICID XEO03035 MOACRIVE Inhibition DME1223 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1223 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03039 XEO_CLAS Peptide DME1223 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.55 microM) DME1223 XEOTICID XEO03039 GENEFORM Protein DME1223 XEOTICID XEO03039 MOACRIVE Inhibition DME1223 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1223 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03043 XEO_CLAS Peptide DME1223 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 microM) DME1223 XEOTICID XEO03043 GENEFORM Protein DME1223 XEOTICID XEO03043 MOACRIVE Inhibition DME1223 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1223 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03044 XEO_CLAS Peptide DME1223 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03044 GENEFORM Protein DME1223 XEOTICID XEO03044 MOACRIVE Inhibition DME1223 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1223 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03045 XEO_CLAS Peptide DME1223 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03045 GENEFORM Protein DME1223 XEOTICID XEO03045 MOACRIVE Inhibition DME1223 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1223 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03046 XEO_CLAS Peptide DME1223 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03046 GENEFORM Protein DME1223 XEOTICID XEO03046 MOACRIVE Inhibition DME1223 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1223 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03049 XEO_CLAS Peptide DME1223 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 microM) DME1223 XEOTICID XEO03049 GENEFORM Protein DME1223 XEOTICID XEO03049 MOACRIVE Inhibition DME1223 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1223 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03055 XEO_CLAS Peptide DME1223 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 microM) DME1223 XEOTICID XEO03055 GENEFORM Protein DME1223 XEOTICID XEO03055 MOACRIVE Inhibition DME1223 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1223 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03059 XEO_CLAS Peptide DME1223 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO03059 GENEFORM Protein DME1223 XEOTICID XEO03059 MOACRIVE Inhibition DME1223 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1223 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03060 XEO_CLAS Peptide DME1223 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO03060 GENEFORM Protein DME1223 XEOTICID XEO03060 MOACRIVE Inhibition DME1223 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1223 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03062 XEO_CLAS Peptide DME1223 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO03062 GENEFORM Protein DME1223 XEOTICID XEO03062 MOACRIVE Inhibition DME1223 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1223 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03064 XEO_CLAS Peptide DME1223 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO03064 GENEFORM Protein DME1223 XEOTICID XEO03064 MOACRIVE Inhibition DME1223 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1223 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03066 XEO_CLAS Peptide DME1223 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO03066 GENEFORM Protein DME1223 XEOTICID XEO03066 MOACRIVE Inhibition DME1223 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1223 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03068 XEO_CLAS Peptide DME1223 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO03068 GENEFORM Protein DME1223 XEOTICID XEO03068 MOACRIVE Inhibition DME1223 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1223 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03073 XEO_CLAS Peptide DME1223 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8-16 ug/ml) DME1223 XEOTICID XEO03073 GENEFORM Protein DME1223 XEOTICID XEO03073 MOACRIVE Inhibition DME1223 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1223 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03081 XEO_CLAS Peptide DME1223 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 microM) DME1223 XEOTICID XEO03081 GENEFORM Protein DME1223 XEOTICID XEO03081 MOACRIVE Inhibition DME1223 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1223 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03082 XEO_CLAS Peptide DME1223 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03082 GENEFORM Protein DME1223 XEOTICID XEO03082 MOACRIVE Inhibition DME1223 XEOTICID XEO03089 XEO_NAME Decoralin DME1223 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03089 XEO_CLAS Peptide DME1223 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 160 microM) DME1223 XEOTICID XEO03089 GENEFORM Protein DME1223 XEOTICID XEO03089 MOACRIVE Inhibition DME1223 XEOTICID XEO03098 XEO_NAME Insect defensin DME1223 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03098 XEO_CLAS Peptide DME1223 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 ug/ml) DME1223 XEOTICID XEO03098 GENEFORM Protein DME1223 XEOTICID XEO03098 MOACRIVE Inhibition DME1223 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1223 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03100 XEO_CLAS Peptide DME1223 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03100 GENEFORM Protein DME1223 XEOTICID XEO03100 MOACRIVE Inhibition DME1223 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1223 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03103 XEO_CLAS Peptide DME1223 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03103 GENEFORM Protein DME1223 XEOTICID XEO03103 MOACRIVE Inhibition DME1223 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1223 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03105 XEO_CLAS Peptide DME1223 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03105 GENEFORM Protein DME1223 XEOTICID XEO03105 MOACRIVE Inhibition DME1223 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1223 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03110 XEO_CLAS Peptide DME1223 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.2 microM) DME1223 XEOTICID XEO03110 GENEFORM Protein DME1223 XEOTICID XEO03110 MOACRIVE Inhibition DME1223 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1223 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03111 XEO_CLAS Peptide DME1223 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03111 GENEFORM Protein DME1223 XEOTICID XEO03111 MOACRIVE Inhibition DME1223 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1223 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03112 XEO_CLAS Peptide DME1223 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 50 ug/ml) DME1223 XEOTICID XEO03112 GENEFORM Protein DME1223 XEOTICID XEO03112 MOACRIVE Inhibition DME1223 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1223 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03115 XEO_CLAS Peptide DME1223 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03115 GENEFORM Protein DME1223 XEOTICID XEO03115 MOACRIVE Inhibition DME1223 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1223 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03116 XEO_CLAS Peptide DME1223 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 40 microM) DME1223 XEOTICID XEO03116 GENEFORM Protein DME1223 XEOTICID XEO03116 MOACRIVE Inhibition DME1223 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1223 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03118 XEO_CLAS Peptide DME1223 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03118 GENEFORM Protein DME1223 XEOTICID XEO03118 MOACRIVE Inhibition DME1223 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1223 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03119 XEO_CLAS Peptide DME1223 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03119 GENEFORM Protein DME1223 XEOTICID XEO03119 MOACRIVE Inhibition DME1223 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1223 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03121 XEO_CLAS Peptide DME1223 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03121 GENEFORM Protein DME1223 XEOTICID XEO03121 MOACRIVE Inhibition DME1223 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1223 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03122 XEO_CLAS Peptide DME1223 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64000 ug/ml) DME1223 XEOTICID XEO03122 GENEFORM Protein DME1223 XEOTICID XEO03122 MOACRIVE Inhibition DME1223 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1223 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03124 XEO_CLAS Peptide DME1223 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03124 GENEFORM Protein DME1223 XEOTICID XEO03124 MOACRIVE Inhibition DME1223 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1223 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03125 XEO_CLAS Peptide DME1223 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03125 GENEFORM Protein DME1223 XEOTICID XEO03125 MOACRIVE Inhibition DME1223 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1223 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03126 XEO_CLAS Peptide DME1223 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.86 microM) DME1223 XEOTICID XEO03126 GENEFORM Protein DME1223 XEOTICID XEO03126 MOACRIVE Inhibition DME1223 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1223 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03127 XEO_CLAS Peptide DME1223 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03127 GENEFORM Protein DME1223 XEOTICID XEO03127 MOACRIVE Inhibition DME1223 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1223 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03128 XEO_CLAS Peptide DME1223 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 256 ug/ml) DME1223 XEOTICID XEO03128 GENEFORM Protein DME1223 XEOTICID XEO03128 MOACRIVE Inhibition DME1223 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1223 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03129 XEO_CLAS Peptide DME1223 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 256 ug/ml) DME1223 XEOTICID XEO03129 GENEFORM Protein DME1223 XEOTICID XEO03129 MOACRIVE Inhibition DME1223 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1223 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03130 XEO_CLAS Peptide DME1223 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 256 ug/ml) DME1223 XEOTICID XEO03130 GENEFORM Protein DME1223 XEOTICID XEO03130 MOACRIVE Inhibition DME1223 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1223 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03131 XEO_CLAS Peptide DME1223 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 256 ug/ml) DME1223 XEOTICID XEO03131 GENEFORM Protein DME1223 XEOTICID XEO03131 MOACRIVE Inhibition DME1223 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1223 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03132 XEO_CLAS Peptide DME1223 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 256 ug/ml) DME1223 XEOTICID XEO03132 GENEFORM Protein DME1223 XEOTICID XEO03132 MOACRIVE Inhibition DME1223 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1223 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03137 XEO_CLAS Peptide DME1223 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03137 GENEFORM Protein DME1223 XEOTICID XEO03137 MOACRIVE Inhibition DME1223 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1223 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03143 XEO_CLAS Peptide DME1223 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.6 microM) DME1223 XEOTICID XEO03143 GENEFORM Protein DME1223 XEOTICID XEO03143 MOACRIVE Inhibition DME1223 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1223 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03145 XEO_CLAS Peptide DME1223 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.6 microM) DME1223 XEOTICID XEO03145 GENEFORM Protein DME1223 XEOTICID XEO03145 MOACRIVE Inhibition DME1223 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1223 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03146 XEO_CLAS Peptide DME1223 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.5 microM) DME1223 XEOTICID XEO03146 GENEFORM Protein DME1223 XEOTICID XEO03146 MOACRIVE Inhibition DME1223 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1223 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03147 XEO_CLAS Peptide DME1223 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 9.7 microM) DME1223 XEOTICID XEO03147 GENEFORM Protein DME1223 XEOTICID XEO03147 MOACRIVE Inhibition DME1223 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1223 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03148 XEO_CLAS Peptide DME1223 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.3 microM) DME1223 XEOTICID XEO03148 GENEFORM Protein DME1223 XEOTICID XEO03148 MOACRIVE Inhibition DME1223 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1223 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03149 XEO_CLAS Peptide DME1223 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.6 microM) DME1223 XEOTICID XEO03149 GENEFORM Protein DME1223 XEOTICID XEO03149 MOACRIVE Inhibition DME1223 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1223 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03150 XEO_CLAS Peptide DME1223 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 9-3 microM) DME1223 XEOTICID XEO03150 GENEFORM Protein DME1223 XEOTICID XEO03150 MOACRIVE Inhibition DME1223 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1223 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03151 XEO_CLAS Peptide DME1223 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 ug/ml) DME1223 XEOTICID XEO03151 GENEFORM Protein DME1223 XEOTICID XEO03151 MOACRIVE Inhibition DME1223 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1223 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03152 XEO_CLAS Peptide DME1223 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO03152 GENEFORM Protein DME1223 XEOTICID XEO03152 MOACRIVE Inhibition DME1223 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1223 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03155 XEO_CLAS Peptide DME1223 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.4 microM) DME1223 XEOTICID XEO03155 GENEFORM Protein DME1223 XEOTICID XEO03155 MOACRIVE Inhibition DME1223 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1223 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03156 XEO_CLAS Peptide DME1223 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.3 microM) DME1223 XEOTICID XEO03156 GENEFORM Protein DME1223 XEOTICID XEO03156 MOACRIVE Inhibition DME1223 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1223 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03157 XEO_CLAS Peptide DME1223 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.3 microM) DME1223 XEOTICID XEO03157 GENEFORM Protein DME1223 XEOTICID XEO03157 MOACRIVE Inhibition DME1223 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1223 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03158 XEO_CLAS Peptide DME1223 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 ug/ml) DME1223 XEOTICID XEO03158 GENEFORM Protein DME1223 XEOTICID XEO03158 MOACRIVE Inhibition DME1223 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1223 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03159 XEO_CLAS Peptide DME1223 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03159 GENEFORM Protein DME1223 XEOTICID XEO03159 MOACRIVE Inhibition DME1223 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1223 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03161 XEO_CLAS Peptide DME1223 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 microM) DME1223 XEOTICID XEO03161 GENEFORM Protein DME1223 XEOTICID XEO03161 MOACRIVE Inhibition DME1223 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1223 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03162 XEO_CLAS Peptide DME1223 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.5 microM) DME1223 XEOTICID XEO03162 GENEFORM Protein DME1223 XEOTICID XEO03162 MOACRIVE Inhibition DME1223 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1223 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03169 XEO_CLAS Peptide DME1223 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO03169 GENEFORM Protein DME1223 XEOTICID XEO03169 MOACRIVE Inhibition DME1223 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1223 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03193 XEO_CLAS Peptide DME1223 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25 ug/ml) DME1223 XEOTICID XEO03193 GENEFORM Protein DME1223 XEOTICID XEO03193 MOACRIVE Inhibition DME1223 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1223 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03194 XEO_CLAS Peptide DME1223 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03194 GENEFORM Protein DME1223 XEOTICID XEO03194 MOACRIVE Inhibition DME1223 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1223 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03195 XEO_CLAS Peptide DME1223 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03195 GENEFORM Protein DME1223 XEOTICID XEO03195 MOACRIVE Inhibition DME1223 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1223 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03197 XEO_CLAS Peptide DME1223 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 14.5 microM) DME1223 XEOTICID XEO03197 GENEFORM Protein DME1223 XEOTICID XEO03197 MOACRIVE Inhibition DME1223 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1223 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03202 XEO_CLAS Peptide DME1223 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.51 microM) DME1223 XEOTICID XEO03202 GENEFORM Protein DME1223 XEOTICID XEO03202 MOACRIVE Inhibition DME1223 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1223 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03203 XEO_CLAS Peptide DME1223 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.62 microM) DME1223 XEOTICID XEO03203 GENEFORM Protein DME1223 XEOTICID XEO03203 MOACRIVE Inhibition DME1223 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1223 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03204 XEO_CLAS Peptide DME1223 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.38 microM) DME1223 XEOTICID XEO03204 GENEFORM Protein DME1223 XEOTICID XEO03204 MOACRIVE Inhibition DME1223 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1223 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03205 XEO_CLAS Peptide DME1223 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.29 microM) DME1223 XEOTICID XEO03205 GENEFORM Protein DME1223 XEOTICID XEO03205 MOACRIVE Inhibition DME1223 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1223 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03206 XEO_CLAS Peptide DME1223 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.40 microM) DME1223 XEOTICID XEO03206 GENEFORM Protein DME1223 XEOTICID XEO03206 MOACRIVE Inhibition DME1223 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1223 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03207 XEO_CLAS Peptide DME1223 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.58 microM) DME1223 XEOTICID XEO03207 GENEFORM Protein DME1223 XEOTICID XEO03207 MOACRIVE Inhibition DME1223 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1223 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03208 XEO_CLAS Peptide DME1223 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.76 microM) DME1223 XEOTICID XEO03208 GENEFORM Protein DME1223 XEOTICID XEO03208 MOACRIVE Inhibition DME1223 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1223 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03209 XEO_CLAS Peptide DME1223 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.49 microM) DME1223 XEOTICID XEO03209 GENEFORM Protein DME1223 XEOTICID XEO03209 MOACRIVE Inhibition DME1223 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1223 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03210 XEO_CLAS Peptide DME1223 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 7.07 microM) DME1223 XEOTICID XEO03210 GENEFORM Protein DME1223 XEOTICID XEO03210 MOACRIVE Inhibition DME1223 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1223 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03211 XEO_CLAS Peptide DME1223 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.40 microM) DME1223 XEOTICID XEO03211 GENEFORM Protein DME1223 XEOTICID XEO03211 MOACRIVE Inhibition DME1223 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1223 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03215 XEO_CLAS Peptide DME1223 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20.0 ug/ml) DME1223 XEOTICID XEO03215 GENEFORM Protein DME1223 XEOTICID XEO03215 MOACRIVE Inhibition DME1223 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1223 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03216 XEO_CLAS Peptide DME1223 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO03216 GENEFORM Protein DME1223 XEOTICID XEO03216 MOACRIVE Inhibition DME1223 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1223 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03217 XEO_CLAS Peptide DME1223 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO03217 GENEFORM Protein DME1223 XEOTICID XEO03217 MOACRIVE Inhibition DME1223 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1223 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03223 XEO_CLAS Peptide DME1223 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.8 microM) DME1223 XEOTICID XEO03223 GENEFORM Protein DME1223 XEOTICID XEO03223 MOACRIVE Inhibition DME1223 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1223 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03224 XEO_CLAS Peptide DME1223 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.1-0.25 microM) DME1223 XEOTICID XEO03224 GENEFORM Protein DME1223 XEOTICID XEO03224 MOACRIVE Inhibition DME1223 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1223 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03225 XEO_CLAS Peptide DME1223 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.3 microM) DME1223 XEOTICID XEO03225 GENEFORM Protein DME1223 XEOTICID XEO03225 MOACRIVE Inhibition DME1223 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1223 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03227 XEO_CLAS Peptide DME1223 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.3 microM) DME1223 XEOTICID XEO03227 GENEFORM Protein DME1223 XEOTICID XEO03227 MOACRIVE Inhibition DME1223 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1223 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03231 XEO_CLAS Peptide DME1223 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03231 GENEFORM Protein DME1223 XEOTICID XEO03231 MOACRIVE Inhibition DME1223 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1223 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03232 XEO_CLAS Peptide DME1223 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03232 GENEFORM Protein DME1223 XEOTICID XEO03232 MOACRIVE Inhibition DME1223 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1223 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03234 XEO_CLAS Peptide DME1223 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO03234 GENEFORM Protein DME1223 XEOTICID XEO03234 MOACRIVE Inhibition DME1223 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1223 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03235 XEO_CLAS Peptide DME1223 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 60 ug/ml) DME1223 XEOTICID XEO03235 GENEFORM Protein DME1223 XEOTICID XEO03235 MOACRIVE Inhibition DME1223 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1223 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03236 XEO_CLAS Peptide DME1223 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO03236 GENEFORM Protein DME1223 XEOTICID XEO03236 MOACRIVE Inhibition DME1223 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1223 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03237 XEO_CLAS Peptide DME1223 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 ug/ml) DME1223 XEOTICID XEO03237 GENEFORM Protein DME1223 XEOTICID XEO03237 MOACRIVE Inhibition DME1223 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1223 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03238 XEO_CLAS Peptide DME1223 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 ug/ml) DME1223 XEOTICID XEO03238 GENEFORM Protein DME1223 XEOTICID XEO03238 MOACRIVE Inhibition DME1223 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1223 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03239 XEO_CLAS Peptide DME1223 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 60 ug/ml) DME1223 XEOTICID XEO03239 GENEFORM Protein DME1223 XEOTICID XEO03239 MOACRIVE Inhibition DME1223 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1223 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03241 XEO_CLAS Peptide DME1223 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 128 microM) DME1223 XEOTICID XEO03241 GENEFORM Protein DME1223 XEOTICID XEO03241 MOACRIVE Inhibition DME1223 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1223 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03250 XEO_CLAS Peptide DME1223 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03250 GENEFORM Protein DME1223 XEOTICID XEO03250 MOACRIVE Inhibition DME1223 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1223 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03251 XEO_CLAS Peptide DME1223 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03251 GENEFORM Protein DME1223 XEOTICID XEO03251 MOACRIVE Inhibition DME1223 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1223 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03253 XEO_CLAS Peptide DME1223 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.1 ug/ml) DME1223 XEOTICID XEO03253 GENEFORM Protein DME1223 XEOTICID XEO03253 MOACRIVE Inhibition DME1223 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1223 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03274 XEO_CLAS Peptide DME1223 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.2 microM) DME1223 XEOTICID XEO03274 GENEFORM Protein DME1223 XEOTICID XEO03274 MOACRIVE Inhibition DME1223 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1223 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03275 XEO_CLAS Peptide DME1223 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO03275 GENEFORM Protein DME1223 XEOTICID XEO03275 MOACRIVE Inhibition DME1223 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1223 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03276 XEO_CLAS Peptide DME1223 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO03276 GENEFORM Protein DME1223 XEOTICID XEO03276 MOACRIVE Inhibition DME1223 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1223 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03277 XEO_CLAS Peptide DME1223 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.2 microM) DME1223 XEOTICID XEO03277 GENEFORM Protein DME1223 XEOTICID XEO03277 MOACRIVE Inhibition DME1223 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1223 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03278 XEO_CLAS Peptide DME1223 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO03278 GENEFORM Protein DME1223 XEOTICID XEO03278 MOACRIVE Inhibition DME1223 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1223 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03279 XEO_CLAS Peptide DME1223 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO03279 GENEFORM Protein DME1223 XEOTICID XEO03279 MOACRIVE Inhibition DME1223 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1223 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03280 XEO_CLAS Peptide DME1223 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 microM) DME1223 XEOTICID XEO03280 GENEFORM Protein DME1223 XEOTICID XEO03280 MOACRIVE Inhibition DME1223 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1223 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03281 XEO_CLAS Peptide DME1223 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.3 microM) DME1223 XEOTICID XEO03281 GENEFORM Protein DME1223 XEOTICID XEO03281 MOACRIVE Inhibition DME1223 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1223 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03282 XEO_CLAS Peptide DME1223 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.1 microM) DME1223 XEOTICID XEO03282 GENEFORM Protein DME1223 XEOTICID XEO03282 MOACRIVE Inhibition DME1223 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1223 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03283 XEO_CLAS Peptide DME1223 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 microM) DME1223 XEOTICID XEO03283 GENEFORM Protein DME1223 XEOTICID XEO03283 MOACRIVE Inhibition DME1223 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1223 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03284 XEO_CLAS Peptide DME1223 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.2 ug/ml) DME1223 XEOTICID XEO03284 GENEFORM Protein DME1223 XEOTICID XEO03284 MOACRIVE Inhibition DME1223 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1223 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03285 XEO_CLAS Peptide DME1223 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.5 ug/ml) DME1223 XEOTICID XEO03285 GENEFORM Protein DME1223 XEOTICID XEO03285 MOACRIVE Inhibition DME1223 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1223 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03286 XEO_CLAS Peptide DME1223 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.4 ug/ml) DME1223 XEOTICID XEO03286 GENEFORM Protein DME1223 XEOTICID XEO03286 MOACRIVE Inhibition DME1223 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1223 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03287 XEO_CLAS Peptide DME1223 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.6 ug/ml) DME1223 XEOTICID XEO03287 GENEFORM Protein DME1223 XEOTICID XEO03287 MOACRIVE Inhibition DME1223 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1223 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03288 XEO_CLAS Peptide DME1223 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.4 ug/ml) DME1223 XEOTICID XEO03288 GENEFORM Protein DME1223 XEOTICID XEO03288 MOACRIVE Inhibition DME1223 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1223 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03289 XEO_CLAS Peptide DME1223 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8.8 ug/ml) DME1223 XEOTICID XEO03289 GENEFORM Protein DME1223 XEOTICID XEO03289 MOACRIVE Inhibition DME1223 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1223 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03290 XEO_CLAS Peptide DME1223 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.5 ug/ml) DME1223 XEOTICID XEO03290 GENEFORM Protein DME1223 XEOTICID XEO03290 MOACRIVE Inhibition DME1223 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1223 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03291 XEO_CLAS Peptide DME1223 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8.6 ug/ml) DME1223 XEOTICID XEO03291 GENEFORM Protein DME1223 XEOTICID XEO03291 MOACRIVE Inhibition DME1223 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1223 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03292 XEO_CLAS Peptide DME1223 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4.1 ug/ml) DME1223 XEOTICID XEO03292 GENEFORM Protein DME1223 XEOTICID XEO03292 MOACRIVE Inhibition DME1223 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1223 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03293 XEO_CLAS Peptide DME1223 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1 microM) DME1223 XEOTICID XEO03293 GENEFORM Protein DME1223 XEOTICID XEO03293 MOACRIVE Inhibition DME1223 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1223 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03294 XEO_CLAS Peptide DME1223 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1 microM) DME1223 XEOTICID XEO03294 GENEFORM Protein DME1223 XEOTICID XEO03294 MOACRIVE Inhibition DME1223 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1223 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03295 XEO_CLAS Peptide DME1223 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.7 microM) DME1223 XEOTICID XEO03295 GENEFORM Protein DME1223 XEOTICID XEO03295 MOACRIVE Inhibition DME1223 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1223 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03296 XEO_CLAS Peptide DME1223 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03296 GENEFORM Protein DME1223 XEOTICID XEO03296 MOACRIVE Inhibition DME1223 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1223 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03297 XEO_CLAS Peptide DME1223 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03297 GENEFORM Protein DME1223 XEOTICID XEO03297 MOACRIVE Inhibition DME1223 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1223 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03298 XEO_CLAS Peptide DME1223 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.2 microM) DME1223 XEOTICID XEO03298 GENEFORM Protein DME1223 XEOTICID XEO03298 MOACRIVE Inhibition DME1223 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1223 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03299 XEO_CLAS Peptide DME1223 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.4 microM) DME1223 XEOTICID XEO03299 GENEFORM Protein DME1223 XEOTICID XEO03299 MOACRIVE Inhibition DME1223 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1223 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03300 XEO_CLAS Peptide DME1223 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 ug/ml) DME1223 XEOTICID XEO03300 GENEFORM Protein DME1223 XEOTICID XEO03300 MOACRIVE Inhibition DME1223 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1223 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03301 XEO_CLAS Peptide DME1223 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 ug/ml) DME1223 XEOTICID XEO03301 GENEFORM Protein DME1223 XEOTICID XEO03301 MOACRIVE Inhibition DME1223 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1223 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03302 XEO_CLAS Peptide DME1223 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1 microM) DME1223 XEOTICID XEO03302 GENEFORM Protein DME1223 XEOTICID XEO03302 MOACRIVE Inhibition DME1223 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1223 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03303 XEO_CLAS Peptide DME1223 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 microM) DME1223 XEOTICID XEO03303 GENEFORM Protein DME1223 XEOTICID XEO03303 MOACRIVE Inhibition DME1223 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1223 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03304 XEO_CLAS Peptide DME1223 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO03304 GENEFORM Protein DME1223 XEOTICID XEO03304 MOACRIVE Inhibition DME1223 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1223 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03305 XEO_CLAS Peptide DME1223 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 microM) DME1223 XEOTICID XEO03305 GENEFORM Protein DME1223 XEOTICID XEO03305 MOACRIVE Inhibition DME1223 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1223 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03306 XEO_CLAS Peptide DME1223 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO03306 GENEFORM Protein DME1223 XEOTICID XEO03306 MOACRIVE Inhibition DME1223 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1223 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03307 XEO_CLAS Peptide DME1223 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 34 ug/ml) DME1223 XEOTICID XEO03307 GENEFORM Protein DME1223 XEOTICID XEO03307 MOACRIVE Inhibition DME1223 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1223 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03308 XEO_CLAS Peptide DME1223 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO03308 GENEFORM Protein DME1223 XEOTICID XEO03308 MOACRIVE Inhibition DME1223 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1223 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03310 XEO_CLAS Peptide DME1223 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8.5 ug/ml) DME1223 XEOTICID XEO03310 GENEFORM Protein DME1223 XEOTICID XEO03310 MOACRIVE Inhibition DME1223 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1223 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03311 XEO_CLAS Peptide DME1223 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10.8 ug/ml) DME1223 XEOTICID XEO03311 GENEFORM Protein DME1223 XEOTICID XEO03311 MOACRIVE Inhibition DME1223 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1223 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03312 XEO_CLAS Peptide DME1223 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10.8 ug/ml) DME1223 XEOTICID XEO03312 GENEFORM Protein DME1223 XEOTICID XEO03312 MOACRIVE Inhibition DME1223 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1223 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03313 XEO_CLAS Peptide DME1223 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8.1 ug/ml) DME1223 XEOTICID XEO03313 GENEFORM Protein DME1223 XEOTICID XEO03313 MOACRIVE Inhibition DME1223 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1223 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03314 XEO_CLAS Peptide DME1223 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 7.9 ug/ml) DME1223 XEOTICID XEO03314 GENEFORM Protein DME1223 XEOTICID XEO03314 MOACRIVE Inhibition DME1223 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1223 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03315 XEO_CLAS Peptide DME1223 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.6 ug/ml) DME1223 XEOTICID XEO03315 GENEFORM Protein DME1223 XEOTICID XEO03315 MOACRIVE Inhibition DME1223 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1223 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03316 XEO_CLAS Peptide DME1223 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15.8 ug/ml) DME1223 XEOTICID XEO03316 GENEFORM Protein DME1223 XEOTICID XEO03316 MOACRIVE Inhibition DME1223 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1223 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03317 XEO_CLAS Peptide DME1223 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO03317 GENEFORM Protein DME1223 XEOTICID XEO03317 MOACRIVE Inhibition DME1223 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1223 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03318 XEO_CLAS Peptide DME1223 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1 microM) DME1223 XEOTICID XEO03318 GENEFORM Protein DME1223 XEOTICID XEO03318 MOACRIVE Inhibition DME1223 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1223 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03319 XEO_CLAS Peptide DME1223 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03319 GENEFORM Protein DME1223 XEOTICID XEO03319 MOACRIVE Inhibition DME1223 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1223 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03320 XEO_CLAS Peptide DME1223 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.1 microM) DME1223 XEOTICID XEO03320 GENEFORM Protein DME1223 XEOTICID XEO03320 MOACRIVE Inhibition DME1223 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1223 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03321 XEO_CLAS Peptide DME1223 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.8 microM) DME1223 XEOTICID XEO03321 GENEFORM Protein DME1223 XEOTICID XEO03321 MOACRIVE Inhibition DME1223 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1223 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1223 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03348 GENEFORM Protein DME1223 XEOTICID XEO03348 MOACRIVE Inhibition DME1223 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1223 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03362 XEO_CLAS Peptide DME1223 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO03362 GENEFORM Protein DME1223 XEOTICID XEO03362 MOACRIVE Inhibition DME1223 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1223 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03363 XEO_CLAS Peptide DME1223 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 microM) DME1223 XEOTICID XEO03363 GENEFORM Protein DME1223 XEOTICID XEO03363 MOACRIVE Inhibition DME1223 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1223 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03364 XEO_CLAS Peptide DME1223 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 microM) DME1223 XEOTICID XEO03364 GENEFORM Protein DME1223 XEOTICID XEO03364 MOACRIVE Inhibition DME1223 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1223 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03365 XEO_CLAS Peptide DME1223 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03365 GENEFORM Protein DME1223 XEOTICID XEO03365 MOACRIVE Inhibition DME1223 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1223 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03366 XEO_CLAS Peptide DME1223 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO03366 GENEFORM Protein DME1223 XEOTICID XEO03366 MOACRIVE Inhibition DME1223 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1223 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03367 XEO_CLAS Peptide DME1223 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 microM) DME1223 XEOTICID XEO03367 GENEFORM Protein DME1223 XEOTICID XEO03367 MOACRIVE Inhibition DME1223 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1223 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03368 XEO_CLAS Peptide DME1223 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 microM) DME1223 XEOTICID XEO03368 GENEFORM Protein DME1223 XEOTICID XEO03368 MOACRIVE Inhibition DME1223 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1223 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03379 XEO_CLAS Peptide DME1223 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.6 ug/ml) DME1223 XEOTICID XEO03379 GENEFORM Protein DME1223 XEOTICID XEO03379 MOACRIVE Inhibition DME1223 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1223 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03396 XEO_CLAS Peptide DME1223 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03396 GENEFORM Protein DME1223 XEOTICID XEO03396 MOACRIVE Inhibition DME1223 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1223 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03398 XEO_CLAS Peptide DME1223 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03398 GENEFORM Protein DME1223 XEOTICID XEO03398 MOACRIVE Inhibition DME1223 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1223 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03399 XEO_CLAS Peptide DME1223 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03399 GENEFORM Protein DME1223 XEOTICID XEO03399 MOACRIVE Inhibition DME1223 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1223 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03406 XEO_CLAS Peptide DME1223 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 ug/ml) DME1223 XEOTICID XEO03406 GENEFORM Protein DME1223 XEOTICID XEO03406 MOACRIVE Inhibition DME1223 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1223 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03424 XEO_CLAS Peptide DME1223 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03424 GENEFORM Protein DME1223 XEOTICID XEO03424 MOACRIVE Inhibition DME1223 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1223 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03426 XEO_CLAS Peptide DME1223 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO03426 GENEFORM Protein DME1223 XEOTICID XEO03426 MOACRIVE Inhibition DME1223 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1223 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03427 XEO_CLAS Peptide DME1223 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 microM) DME1223 XEOTICID XEO03427 GENEFORM Protein DME1223 XEOTICID XEO03427 MOACRIVE Inhibition DME1223 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1223 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03428 XEO_CLAS Peptide DME1223 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 ug/ml) DME1223 XEOTICID XEO03428 GENEFORM Protein DME1223 XEOTICID XEO03428 MOACRIVE Inhibition DME1223 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1223 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03430 XEO_CLAS Peptide DME1223 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 ug/ml) DME1223 XEOTICID XEO03430 GENEFORM Protein DME1223 XEOTICID XEO03430 MOACRIVE Inhibition DME1223 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1223 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03434 XEO_CLAS Peptide DME1223 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO03434 GENEFORM Protein DME1223 XEOTICID XEO03434 MOACRIVE Inhibition DME1223 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1223 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03442 XEO_CLAS Peptide DME1223 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 18.75 ug/ml) DME1223 XEOTICID XEO03442 GENEFORM Protein DME1223 XEOTICID XEO03442 MOACRIVE Inhibition DME1223 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1223 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03444 XEO_CLAS Peptide DME1223 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 37.50 ug/ml) DME1223 XEOTICID XEO03444 GENEFORM Protein DME1223 XEOTICID XEO03444 MOACRIVE Inhibition DME1223 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1223 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03459 XEO_CLAS Peptide DME1223 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03459 GENEFORM Protein DME1223 XEOTICID XEO03459 MOACRIVE Inhibition DME1223 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1223 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03460 XEO_CLAS Peptide DME1223 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03460 GENEFORM Protein DME1223 XEOTICID XEO03460 MOACRIVE Inhibition DME1223 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1223 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03461 XEO_CLAS Peptide DME1223 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.05 microM) DME1223 XEOTICID XEO03461 GENEFORM Protein DME1223 XEOTICID XEO03461 MOACRIVE Inhibition DME1223 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1223 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03462 XEO_CLAS Peptide DME1223 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03462 GENEFORM Protein DME1223 XEOTICID XEO03462 MOACRIVE Inhibition DME1223 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1223 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03463 XEO_CLAS Peptide DME1223 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03463 GENEFORM Protein DME1223 XEOTICID XEO03463 MOACRIVE Inhibition DME1223 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1223 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03467 XEO_CLAS Peptide DME1223 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03467 GENEFORM Protein DME1223 XEOTICID XEO03467 MOACRIVE Inhibition DME1223 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1223 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03468 XEO_CLAS Peptide DME1223 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03468 GENEFORM Protein DME1223 XEOTICID XEO03468 MOACRIVE Inhibition DME1223 XEOTICID XEO03471 XEO_NAME Gambicin DME1223 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03471 XEO_CLAS Peptide DME1223 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25-12.5 microM) DME1223 XEOTICID XEO03471 GENEFORM Protein DME1223 XEOTICID XEO03471 MOACRIVE Inhibition DME1223 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1223 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03485 XEO_CLAS Peptide DME1223 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4.07 ug/ml) DME1223 XEOTICID XEO03485 GENEFORM Protein DME1223 XEOTICID XEO03485 MOACRIVE Inhibition DME1223 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1223 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03486 XEO_CLAS Peptide DME1223 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.80 ug/ml) DME1223 XEOTICID XEO03486 GENEFORM Protein DME1223 XEOTICID XEO03486 MOACRIVE Inhibition DME1223 XEOTICID XEO03488 XEO_NAME GLK-19 DME1223 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03488 XEO_CLAS Peptide DME1223 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO03488 GENEFORM Protein DME1223 XEOTICID XEO03488 MOACRIVE Inhibition DME1223 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1223 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03497 XEO_CLAS Peptide DME1223 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.4-0.8 microM) DME1223 XEOTICID XEO03497 GENEFORM Protein DME1223 XEOTICID XEO03497 MOACRIVE Inhibition DME1223 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1223 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03498 XEO_CLAS Peptide DME1223 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.4-0.8 microM) DME1223 XEOTICID XEO03498 GENEFORM Protein DME1223 XEOTICID XEO03498 MOACRIVE Inhibition DME1223 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1223 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03500 XEO_CLAS Peptide DME1223 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-30 ug/ml) DME1223 XEOTICID XEO03500 GENEFORM Protein DME1223 XEOTICID XEO03500 MOACRIVE Inhibition DME1223 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1223 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03504 XEO_CLAS Peptide DME1223 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 ug/ml) DME1223 XEOTICID XEO03504 GENEFORM Protein DME1223 XEOTICID XEO03504 MOACRIVE Inhibition DME1223 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1223 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03505 XEO_CLAS Peptide DME1223 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 ug/ml) DME1223 XEOTICID XEO03505 GENEFORM Protein DME1223 XEOTICID XEO03505 MOACRIVE Inhibition DME1223 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1223 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03506 XEO_CLAS Peptide DME1223 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 ug/ml) DME1223 XEOTICID XEO03506 GENEFORM Protein DME1223 XEOTICID XEO03506 MOACRIVE Inhibition DME1223 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1223 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03513 XEO_CLAS Peptide DME1223 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO03513 GENEFORM Protein DME1223 XEOTICID XEO03513 MOACRIVE Inhibition DME1223 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1223 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03514 XEO_CLAS Peptide DME1223 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03514 GENEFORM Protein DME1223 XEOTICID XEO03514 MOACRIVE Inhibition DME1223 XEOTICID XEO03519 XEO_NAME Hadrurin DME1223 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03519 XEO_CLAS Peptide DME1223 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03519 GENEFORM Protein DME1223 XEOTICID XEO03519 MOACRIVE Inhibition DME1223 XEOTICID XEO03522 XEO_NAME Halocyntin DME1223 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03522 XEO_CLAS Peptide DME1223 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03522 GENEFORM Protein DME1223 XEOTICID XEO03522 MOACRIVE Inhibition DME1223 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1223 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03524 XEO_CLAS Peptide DME1223 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03524 GENEFORM Protein DME1223 XEOTICID XEO03524 MOACRIVE Inhibition DME1223 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1223 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03525 XEO_CLAS Peptide DME1223 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03525 GENEFORM Protein DME1223 XEOTICID XEO03525 MOACRIVE Inhibition DME1223 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1223 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03530 XEO_CLAS Peptide DME1223 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03530 GENEFORM Protein DME1223 XEOTICID XEO03530 MOACRIVE Inhibition DME1223 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1223 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03535 XEO_CLAS Peptide DME1223 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.4 microM) DME1223 XEOTICID XEO03535 GENEFORM Protein DME1223 XEOTICID XEO03535 MOACRIVE Inhibition DME1223 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1223 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03536 XEO_CLAS Peptide DME1223 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 80 microM) DME1223 XEOTICID XEO03536 GENEFORM Protein DME1223 XEOTICID XEO03536 MOACRIVE Inhibition DME1223 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1223 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03537 XEO_CLAS Peptide DME1223 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 ug/ml) DME1223 XEOTICID XEO03537 GENEFORM Protein DME1223 XEOTICID XEO03537 MOACRIVE Inhibition DME1223 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1223 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03538 XEO_CLAS Peptide DME1223 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 ug/ml) DME1223 XEOTICID XEO03538 GENEFORM Protein DME1223 XEOTICID XEO03538 MOACRIVE Inhibition DME1223 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1223 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03540 XEO_CLAS Peptide DME1223 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO03540 GENEFORM Protein DME1223 XEOTICID XEO03540 MOACRIVE Inhibition DME1223 XEOTICID XEO03542 XEO_NAME Hepcidin DME1223 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03542 XEO_CLAS Peptide DME1223 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 24 microM) DME1223 XEOTICID XEO03542 GENEFORM Protein DME1223 XEOTICID XEO03542 MOACRIVE Inhibition DME1223 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1223 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03544 XEO_CLAS Peptide DME1223 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03544 GENEFORM Protein DME1223 XEOTICID XEO03544 MOACRIVE Inhibition DME1223 XEOTICID XEO03548 XEO_NAME Hesperidin DME1223 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03548 GENEFORM Protein DME1223 XEOTICID XEO03548 MOACRIVE Inhibition DME1223 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1223 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1223 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03552 GENEFORM Protein DME1223 XEOTICID XEO03552 MOACRIVE Inhibition DME1223 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1223 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03556 XEO_CLAS Peptide DME1223 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO03556 GENEFORM Protein DME1223 XEOTICID XEO03556 MOACRIVE Inhibition DME1223 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1223 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03557 XEO_CLAS Peptide DME1223 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO03557 GENEFORM Protein DME1223 XEOTICID XEO03557 MOACRIVE Inhibition DME1223 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1223 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03558 XEO_CLAS Peptide DME1223 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 microM) DME1223 XEOTICID XEO03558 GENEFORM Protein DME1223 XEOTICID XEO03558 MOACRIVE Inhibition DME1223 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1223 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03559 XEO_CLAS Peptide DME1223 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 microM) DME1223 XEOTICID XEO03559 GENEFORM Protein DME1223 XEOTICID XEO03559 MOACRIVE Inhibition DME1223 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1223 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03560 XEO_CLAS Peptide DME1223 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 microM) DME1223 XEOTICID XEO03560 GENEFORM Protein DME1223 XEOTICID XEO03560 MOACRIVE Inhibition DME1223 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1223 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03561 XEO_CLAS Peptide DME1223 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03561 GENEFORM Protein DME1223 XEOTICID XEO03561 MOACRIVE Inhibition DME1223 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1223 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03567 XEO_CLAS Peptide DME1223 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03567 GENEFORM Protein DME1223 XEOTICID XEO03567 MOACRIVE Inhibition DME1223 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1223 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03569 XEO_CLAS Peptide DME1223 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 300 microM) DME1223 XEOTICID XEO03569 GENEFORM Protein DME1223 XEOTICID XEO03569 MOACRIVE Inhibition DME1223 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1223 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03570 XEO_CLAS Peptide DME1223 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03570 GENEFORM Protein DME1223 XEOTICID XEO03570 MOACRIVE Inhibition DME1223 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1223 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03572 XEO_CLAS Peptide DME1223 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1223 XEOTICID XEO03572 GENEFORM Protein DME1223 XEOTICID XEO03572 MOACRIVE Inhibition DME1223 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1223 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03573 XEO_CLAS Peptide DME1223 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 28.1 ug/ml) DME1223 XEOTICID XEO03573 GENEFORM Protein DME1223 XEOTICID XEO03573 MOACRIVE Inhibition DME1223 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1223 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03574 XEO_CLAS Peptide DME1223 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 500 microM) DME1223 XEOTICID XEO03574 GENEFORM Protein DME1223 XEOTICID XEO03574 MOACRIVE Inhibition DME1223 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1223 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03575 XEO_CLAS Peptide DME1223 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 18 microM) DME1223 XEOTICID XEO03575 GENEFORM Protein DME1223 XEOTICID XEO03575 MOACRIVE Inhibition DME1223 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1223 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03576 XEO_CLAS Peptide DME1223 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 750 microM) DME1223 XEOTICID XEO03576 GENEFORM Protein DME1223 XEOTICID XEO03576 MOACRIVE Inhibition DME1223 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1223 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03578 XEO_CLAS Peptide DME1223 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1223 XEOTICID XEO03578 GENEFORM Protein DME1223 XEOTICID XEO03578 MOACRIVE Inhibition DME1223 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1223 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03579 XEO_CLAS Peptide DME1223 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03579 GENEFORM Protein DME1223 XEOTICID XEO03579 MOACRIVE Inhibition DME1223 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1223 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03580 XEO_CLAS Peptide DME1223 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03580 GENEFORM Protein DME1223 XEOTICID XEO03580 MOACRIVE Inhibition DME1223 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1223 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03585 XEO_CLAS Peptide DME1223 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 125 ug/ml) DME1223 XEOTICID XEO03585 GENEFORM Protein DME1223 XEOTICID XEO03585 MOACRIVE Inhibition DME1223 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1223 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03588 XEO_CLAS Peptide DME1223 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 62 ug/ml) DME1223 XEOTICID XEO03588 GENEFORM Protein DME1223 XEOTICID XEO03588 MOACRIVE Inhibition DME1223 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1223 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03589 XEO_CLAS Peptide DME1223 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03589 GENEFORM Protein DME1223 XEOTICID XEO03589 MOACRIVE Inhibition DME1223 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1223 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03590 XEO_CLAS Peptide DME1223 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03590 GENEFORM Protein DME1223 XEOTICID XEO03590 MOACRIVE Inhibition DME1223 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1223 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03591 XEO_CLAS Peptide DME1223 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 37.5 ug/ml) DME1223 XEOTICID XEO03591 GENEFORM Protein DME1223 XEOTICID XEO03591 MOACRIVE Inhibition DME1223 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1223 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03593 XEO_CLAS Peptide DME1223 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 9.4 ug/ml) DME1223 XEOTICID XEO03593 GENEFORM Protein DME1223 XEOTICID XEO03593 MOACRIVE Inhibition DME1223 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1223 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03594 XEO_CLAS Peptide DME1223 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 ug/ml) DME1223 XEOTICID XEO03594 GENEFORM Protein DME1223 XEOTICID XEO03594 MOACRIVE Inhibition DME1223 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1223 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03595 XEO_CLAS Peptide DME1223 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03595 GENEFORM Protein DME1223 XEOTICID XEO03595 MOACRIVE Inhibition DME1223 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1223 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03596 XEO_CLAS Peptide DME1223 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03596 GENEFORM Protein DME1223 XEOTICID XEO03596 MOACRIVE Inhibition DME1223 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1223 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03598 XEO_CLAS Peptide DME1223 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03598 GENEFORM Protein DME1223 XEOTICID XEO03598 MOACRIVE Inhibition DME1223 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1223 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03599 XEO_CLAS Peptide DME1223 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03599 GENEFORM Protein DME1223 XEOTICID XEO03599 MOACRIVE Inhibition DME1223 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1223 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03600 XEO_CLAS Peptide DME1223 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03600 GENEFORM Protein DME1223 XEOTICID XEO03600 MOACRIVE Inhibition DME1223 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1223 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03606 XEO_CLAS Peptide DME1223 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03606 GENEFORM Protein DME1223 XEOTICID XEO03606 MOACRIVE Inhibition DME1223 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1223 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03607 XEO_CLAS Peptide DME1223 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03607 GENEFORM Protein DME1223 XEOTICID XEO03607 MOACRIVE Inhibition DME1223 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1223 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03609 XEO_CLAS Peptide DME1223 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03609 GENEFORM Protein DME1223 XEOTICID XEO03609 MOACRIVE Inhibition DME1223 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1223 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03615 XEO_CLAS Peptide DME1223 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1223 XEOTICID XEO03615 GENEFORM Protein DME1223 XEOTICID XEO03615 MOACRIVE Inhibition DME1223 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1223 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03616 XEO_CLAS Peptide DME1223 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 32 microM) DME1223 XEOTICID XEO03616 GENEFORM Protein DME1223 XEOTICID XEO03616 MOACRIVE Inhibition DME1223 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1223 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03617 XEO_CLAS Peptide DME1223 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40 microM) DME1223 XEOTICID XEO03617 GENEFORM Protein DME1223 XEOTICID XEO03617 MOACRIVE Inhibition DME1223 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1223 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03618 XEO_CLAS Peptide DME1223 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5-1 microM) DME1223 XEOTICID XEO03618 GENEFORM Protein DME1223 XEOTICID XEO03618 MOACRIVE Inhibition DME1223 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1223 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03622 XEO_CLAS Peptide DME1223 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20-40 microM) DME1223 XEOTICID XEO03622 GENEFORM Protein DME1223 XEOTICID XEO03622 MOACRIVE Inhibition DME1223 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1223 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03627 XEO_CLAS Peptide DME1223 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.4-0.8 microM) DME1223 XEOTICID XEO03627 GENEFORM Protein DME1223 XEOTICID XEO03627 MOACRIVE Inhibition DME1223 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1223 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03630 XEO_CLAS Peptide DME1223 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03630 GENEFORM Protein DME1223 XEOTICID XEO03630 MOACRIVE Inhibition DME1223 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1223 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03631 XEO_CLAS Peptide DME1223 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03631 GENEFORM Protein DME1223 XEOTICID XEO03631 MOACRIVE Inhibition DME1223 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1223 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03632 XEO_CLAS Peptide DME1223 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03632 GENEFORM Protein DME1223 XEOTICID XEO03632 MOACRIVE Inhibition DME1223 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1223 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03633 XEO_CLAS Peptide DME1223 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03633 GENEFORM Protein DME1223 XEOTICID XEO03633 MOACRIVE Inhibition DME1223 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1223 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03634 XEO_CLAS Peptide DME1223 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03634 GENEFORM Protein DME1223 XEOTICID XEO03634 MOACRIVE Inhibition DME1223 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1223 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03635 XEO_CLAS Peptide DME1223 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03635 GENEFORM Protein DME1223 XEOTICID XEO03635 MOACRIVE Inhibition DME1223 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1223 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03636 XEO_CLAS Peptide DME1223 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03636 GENEFORM Protein DME1223 XEOTICID XEO03636 MOACRIVE Inhibition DME1223 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1223 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03637 XEO_CLAS Peptide DME1223 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03637 GENEFORM Protein DME1223 XEOTICID XEO03637 MOACRIVE Inhibition DME1223 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1223 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03638 XEO_CLAS Peptide DME1223 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03638 GENEFORM Protein DME1223 XEOTICID XEO03638 MOACRIVE Inhibition DME1223 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1223 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03639 XEO_CLAS Peptide DME1223 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03639 GENEFORM Protein DME1223 XEOTICID XEO03639 MOACRIVE Inhibition DME1223 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1223 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03640 XEO_CLAS Peptide DME1223 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03640 GENEFORM Protein DME1223 XEOTICID XEO03640 MOACRIVE Inhibition DME1223 XEOTICID XEO03644 XEO_NAME Indole DME1223 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1223 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1223 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03644 GENEFORM Protein DME1223 XEOTICID XEO03644 MOACRIVE Inhibition DME1223 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1223 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03650 XEO_CLAS Peptide DME1223 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03650 GENEFORM Protein DME1223 XEOTICID XEO03650 MOACRIVE Inhibition DME1223 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1223 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO03655 XEO_CLAS Natural Product DME1223 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03655 GENEFORM Protein DME1223 XEOTICID XEO03655 MOACRIVE Inhibition DME1223 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1223 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03666 XEO_CLAS Peptide DME1223 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 ug/ml) DME1223 XEOTICID XEO03666 GENEFORM Protein DME1223 XEOTICID XEO03666 MOACRIVE Inhibition DME1223 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1223 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03667 XEO_CLAS Peptide DME1223 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 ug/ml) DME1223 XEOTICID XEO03667 GENEFORM Protein DME1223 XEOTICID XEO03667 MOACRIVE Inhibition DME1223 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1223 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03668 XEO_CLAS Peptide DME1223 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 microM) DME1223 XEOTICID XEO03668 GENEFORM Protein DME1223 XEOTICID XEO03668 MOACRIVE Inhibition DME1223 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1223 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03669 XEO_CLAS Peptide DME1223 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO03669 GENEFORM Protein DME1223 XEOTICID XEO03669 MOACRIVE Inhibition DME1223 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1223 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03670 XEO_CLAS Peptide DME1223 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 microM) DME1223 XEOTICID XEO03670 GENEFORM Protein DME1223 XEOTICID XEO03670 MOACRIVE Inhibition DME1223 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1223 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03672 XEO_CLAS Peptide DME1223 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.5 ug/ml) DME1223 XEOTICID XEO03672 GENEFORM Protein DME1223 XEOTICID XEO03672 MOACRIVE Inhibition DME1223 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1223 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03673 XEO_CLAS Peptide DME1223 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 ug/ml) DME1223 XEOTICID XEO03673 GENEFORM Protein DME1223 XEOTICID XEO03673 MOACRIVE Inhibition DME1223 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1223 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03674 XEO_CLAS Peptide DME1223 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 ug/ml) DME1223 XEOTICID XEO03674 GENEFORM Protein DME1223 XEOTICID XEO03674 MOACRIVE Inhibition DME1223 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1223 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03675 XEO_CLAS Peptide DME1223 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO03675 GENEFORM Protein DME1223 XEOTICID XEO03675 MOACRIVE Inhibition DME1223 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1223 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03678 XEO_CLAS Peptide DME1223 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 ug/ml) DME1223 XEOTICID XEO03678 GENEFORM Protein DME1223 XEOTICID XEO03678 MOACRIVE Inhibition DME1223 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1223 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03679 XEO_CLAS Peptide DME1223 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 ug/ml) DME1223 XEOTICID XEO03679 GENEFORM Protein DME1223 XEOTICID XEO03679 MOACRIVE Inhibition DME1223 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1223 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03681 XEO_CLAS Peptide DME1223 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.3-0.6 microM) DME1223 XEOTICID XEO03681 GENEFORM Protein DME1223 XEOTICID XEO03681 MOACRIVE Inhibition DME1223 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1223 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03684 XEO_CLAS Peptide DME1223 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 ug/ml) DME1223 XEOTICID XEO03684 GENEFORM Protein DME1223 XEOTICID XEO03684 MOACRIVE Inhibition DME1223 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1223 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03694 XEO_CLAS Peptide DME1223 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03694 GENEFORM Protein DME1223 XEOTICID XEO03694 MOACRIVE Inhibition DME1223 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1223 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03697 XEO_CLAS Peptide DME1223 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25 microM) DME1223 XEOTICID XEO03697 GENEFORM Protein DME1223 XEOTICID XEO03697 MOACRIVE Inhibition DME1223 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1223 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03698 XEO_CLAS Peptide DME1223 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03698 GENEFORM Protein DME1223 XEOTICID XEO03698 MOACRIVE Inhibition DME1223 XEOTICID XEO03703 XEO_NAME Kasstasin DME1223 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03703 XEO_CLAS Peptide DME1223 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 110 microM) DME1223 XEOTICID XEO03703 GENEFORM Protein DME1223 XEOTICID XEO03703 MOACRIVE Inhibition DME1223 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1223 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03706 XEO_CLAS Peptide DME1223 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03706 GENEFORM Protein DME1223 XEOTICID XEO03706 MOACRIVE Inhibition DME1223 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1223 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03707 XEO_CLAS Peptide DME1223 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03707 GENEFORM Protein DME1223 XEOTICID XEO03707 MOACRIVE Inhibition DME1223 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1223 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03709 XEO_CLAS Peptide DME1223 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 ug/ml) DME1223 XEOTICID XEO03709 GENEFORM Protein DME1223 XEOTICID XEO03709 MOACRIVE Inhibition DME1223 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1223 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03712 XEO_CLAS Peptide DME1223 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03712 GENEFORM Protein DME1223 XEOTICID XEO03712 MOACRIVE Inhibition DME1223 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1223 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03713 XEO_CLAS Peptide DME1223 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 64 microM) DME1223 XEOTICID XEO03713 GENEFORM Protein DME1223 XEOTICID XEO03713 MOACRIVE Inhibition DME1223 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1223 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03714 XEO_CLAS Peptide DME1223 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03714 GENEFORM Protein DME1223 XEOTICID XEO03714 MOACRIVE Inhibition DME1223 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1223 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03715 XEO_CLAS Peptide DME1223 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 microM) DME1223 XEOTICID XEO03715 GENEFORM Protein DME1223 XEOTICID XEO03715 MOACRIVE Inhibition DME1223 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1223 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03719 XEO_CLAS Peptide DME1223 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 microM) DME1223 XEOTICID XEO03719 GENEFORM Protein DME1223 XEOTICID XEO03719 MOACRIVE Inhibition DME1223 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1223 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03720 XEO_CLAS Peptide DME1223 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 microM) DME1223 XEOTICID XEO03720 GENEFORM Protein DME1223 XEOTICID XEO03720 MOACRIVE Inhibition DME1223 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1223 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03723 XEO_CLAS Peptide DME1223 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 62.36 microM) DME1223 XEOTICID XEO03723 GENEFORM Protein DME1223 XEOTICID XEO03723 MOACRIVE Inhibition DME1223 XEOTICID XEO03724 XEO_NAME L10 peptide DME1223 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03724 XEO_CLAS Peptide DME1223 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.8 microM) DME1223 XEOTICID XEO03724 GENEFORM Protein DME1223 XEOTICID XEO03724 MOACRIVE Inhibition DME1223 XEOTICID XEO03726 XEO_NAME L2 peptide DME1223 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03726 XEO_CLAS Peptide DME1223 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 129.66 microM) DME1223 XEOTICID XEO03726 GENEFORM Protein DME1223 XEOTICID XEO03726 MOACRIVE Inhibition DME1223 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1223 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03727 XEO_CLAS Peptide DME1223 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 80 ug/ml) DME1223 XEOTICID XEO03727 GENEFORM Protein DME1223 XEOTICID XEO03727 MOACRIVE Inhibition DME1223 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1223 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03728 XEO_CLAS Peptide DME1223 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40 ug/ml) DME1223 XEOTICID XEO03728 GENEFORM Protein DME1223 XEOTICID XEO03728 MOACRIVE Inhibition DME1223 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1223 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03729 XEO_CLAS Peptide DME1223 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 80 ug/ml) DME1223 XEOTICID XEO03729 GENEFORM Protein DME1223 XEOTICID XEO03729 MOACRIVE Inhibition DME1223 XEOTICID XEO03730 XEO_NAME L3 peptide DME1223 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03730 XEO_CLAS Peptide DME1223 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64.11 microM) DME1223 XEOTICID XEO03730 GENEFORM Protein DME1223 XEOTICID XEO03730 MOACRIVE Inhibition DME1223 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1223 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03731 XEO_CLAS Peptide DME1223 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40 ug/ml) DME1223 XEOTICID XEO03731 GENEFORM Protein DME1223 XEOTICID XEO03731 MOACRIVE Inhibition DME1223 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1223 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03733 XEO_CLAS Peptide DME1223 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40 ug/ml) DME1223 XEOTICID XEO03733 GENEFORM Protein DME1223 XEOTICID XEO03733 MOACRIVE Inhibition DME1223 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1223 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03734 XEO_CLAS Peptide DME1223 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO03734 GENEFORM Protein DME1223 XEOTICID XEO03734 MOACRIVE Inhibition DME1223 XEOTICID XEO03735 XEO_NAME L4 peptide DME1223 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03735 XEO_CLAS Peptide DME1223 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 31.61 microM) DME1223 XEOTICID XEO03735 GENEFORM Protein DME1223 XEOTICID XEO03735 MOACRIVE Inhibition DME1223 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1223 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03738 XEO_CLAS Peptide DME1223 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 ug/ml) DME1223 XEOTICID XEO03738 GENEFORM Protein DME1223 XEOTICID XEO03738 MOACRIVE Inhibition DME1223 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1223 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03741 XEO_CLAS Peptide DME1223 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40 ug/ml) DME1223 XEOTICID XEO03741 GENEFORM Protein DME1223 XEOTICID XEO03741 MOACRIVE Inhibition DME1223 XEOTICID XEO03742 XEO_NAME L5 peptide DME1223 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03742 XEO_CLAS Peptide DME1223 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 7.79 microM) DME1223 XEOTICID XEO03742 GENEFORM Protein DME1223 XEOTICID XEO03742 MOACRIVE Inhibition DME1223 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1223 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03743 XEO_CLAS Peptide DME1223 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 ug/ml) DME1223 XEOTICID XEO03743 GENEFORM Protein DME1223 XEOTICID XEO03743 MOACRIVE Inhibition DME1223 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1223 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03744 XEO_CLAS Peptide DME1223 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 ug/ml) DME1223 XEOTICID XEO03744 GENEFORM Protein DME1223 XEOTICID XEO03744 MOACRIVE Inhibition DME1223 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1223 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03745 XEO_CLAS Peptide DME1223 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 ug/ml) DME1223 XEOTICID XEO03745 GENEFORM Protein DME1223 XEOTICID XEO03745 MOACRIVE Inhibition DME1223 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1223 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03746 XEO_CLAS Peptide DME1223 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO03746 GENEFORM Protein DME1223 XEOTICID XEO03746 MOACRIVE Inhibition DME1223 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1223 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03747 XEO_CLAS Peptide DME1223 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO03747 GENEFORM Protein DME1223 XEOTICID XEO03747 MOACRIVE Inhibition DME1223 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1223 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03748 XEO_CLAS Peptide DME1223 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO03748 GENEFORM Protein DME1223 XEOTICID XEO03748 MOACRIVE Inhibition DME1223 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1223 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03749 XEO_CLAS Peptide DME1223 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO03749 GENEFORM Protein DME1223 XEOTICID XEO03749 MOACRIVE Inhibition DME1223 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1223 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03750 XEO_CLAS Peptide DME1223 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO03750 GENEFORM Protein DME1223 XEOTICID XEO03750 MOACRIVE Inhibition DME1223 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1223 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03751 XEO_CLAS Peptide DME1223 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO03751 GENEFORM Protein DME1223 XEOTICID XEO03751 MOACRIVE Inhibition DME1223 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1223 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03752 XEO_CLAS Peptide DME1223 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO03752 GENEFORM Protein DME1223 XEOTICID XEO03752 MOACRIVE Inhibition DME1223 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1223 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03753 XEO_CLAS Peptide DME1223 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 ug/ml) DME1223 XEOTICID XEO03753 GENEFORM Protein DME1223 XEOTICID XEO03753 MOACRIVE Inhibition DME1223 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1223 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03754 XEO_CLAS Peptide DME1223 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO03754 GENEFORM Protein DME1223 XEOTICID XEO03754 MOACRIVE Inhibition DME1223 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1223 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03755 XEO_CLAS Peptide DME1223 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO03755 GENEFORM Protein DME1223 XEOTICID XEO03755 MOACRIVE Inhibition DME1223 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1223 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03756 XEO_CLAS Peptide DME1223 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO03756 GENEFORM Protein DME1223 XEOTICID XEO03756 MOACRIVE Inhibition DME1223 XEOTICID XEO03757 XEO_NAME L6 peptide DME1223 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03757 XEO_CLAS Peptide DME1223 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15.17 microM) DME1223 XEOTICID XEO03757 GENEFORM Protein DME1223 XEOTICID XEO03757 MOACRIVE Inhibition DME1223 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1223 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03758 XEO_CLAS Peptide DME1223 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 80 ug/ml) DME1223 XEOTICID XEO03758 GENEFORM Protein DME1223 XEOTICID XEO03758 MOACRIVE Inhibition DME1223 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1223 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03759 XEO_CLAS Peptide DME1223 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.3 ug/ml) DME1223 XEOTICID XEO03759 GENEFORM Protein DME1223 XEOTICID XEO03759 MOACRIVE Inhibition DME1223 XEOTICID XEO03760 XEO_NAME L7 peptide DME1223 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03760 XEO_CLAS Peptide DME1223 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16.02 microM) DME1223 XEOTICID XEO03760 GENEFORM Protein DME1223 XEOTICID XEO03760 MOACRIVE Inhibition DME1223 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1223 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03761 XEO_CLAS Peptide DME1223 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 ug/ml) DME1223 XEOTICID XEO03761 GENEFORM Protein DME1223 XEOTICID XEO03761 MOACRIVE Inhibition DME1223 XEOTICID XEO03763 XEO_NAME L8 peptide DME1223 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03763 XEO_CLAS Peptide DME1223 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.71 microM) DME1223 XEOTICID XEO03763 GENEFORM Protein DME1223 XEOTICID XEO03763 MOACRIVE Inhibition DME1223 XEOTICID XEO03765 XEO_NAME L9 peptide DME1223 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03765 XEO_CLAS Peptide DME1223 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.78 microM) DME1223 XEOTICID XEO03765 GENEFORM Protein DME1223 XEOTICID XEO03765 MOACRIVE Inhibition DME1223 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1223 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03775 XEO_CLAS Peptide DME1223 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 17.3 microM) DME1223 XEOTICID XEO03775 GENEFORM Protein DME1223 XEOTICID XEO03775 MOACRIVE Inhibition DME1223 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1223 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03776 XEO_CLAS Peptide DME1223 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03776 GENEFORM Protein DME1223 XEOTICID XEO03776 MOACRIVE Inhibition DME1223 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1223 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03781 XEO_CLAS Peptide DME1223 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.47 microM) DME1223 XEOTICID XEO03781 GENEFORM Protein DME1223 XEOTICID XEO03781 MOACRIVE Inhibition DME1223 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1223 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03782 XEO_CLAS Peptide DME1223 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.47 microM) DME1223 XEOTICID XEO03782 GENEFORM Protein DME1223 XEOTICID XEO03782 MOACRIVE Inhibition DME1223 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1223 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03783 XEO_CLAS Peptide DME1223 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.68 microM) DME1223 XEOTICID XEO03783 GENEFORM Protein DME1223 XEOTICID XEO03783 MOACRIVE Inhibition DME1223 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1223 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03784 XEO_CLAS Peptide DME1223 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.45 microM) DME1223 XEOTICID XEO03784 GENEFORM Protein DME1223 XEOTICID XEO03784 MOACRIVE Inhibition DME1223 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1223 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03785 XEO_CLAS Peptide DME1223 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.73 microM) DME1223 XEOTICID XEO03785 GENEFORM Protein DME1223 XEOTICID XEO03785 MOACRIVE Inhibition DME1223 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1223 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03786 XEO_CLAS Peptide DME1223 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.45 microM) DME1223 XEOTICID XEO03786 GENEFORM Protein DME1223 XEOTICID XEO03786 MOACRIVE Inhibition DME1223 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1223 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03787 XEO_CLAS Peptide DME1223 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.38 microM) DME1223 XEOTICID XEO03787 GENEFORM Protein DME1223 XEOTICID XEO03787 MOACRIVE Inhibition DME1223 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1223 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03788 XEO_CLAS Peptide DME1223 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.46 microM) DME1223 XEOTICID XEO03788 GENEFORM Protein DME1223 XEOTICID XEO03788 MOACRIVE Inhibition DME1223 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1223 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03789 XEO_CLAS Peptide DME1223 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 13.05 microM) DME1223 XEOTICID XEO03789 GENEFORM Protein DME1223 XEOTICID XEO03789 MOACRIVE Inhibition DME1223 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1223 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03790 XEO_CLAS Peptide DME1223 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.82 microM) DME1223 XEOTICID XEO03790 GENEFORM Protein DME1223 XEOTICID XEO03790 MOACRIVE Inhibition DME1223 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1223 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03791 XEO_CLAS Peptide DME1223 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.80 microM) DME1223 XEOTICID XEO03791 GENEFORM Protein DME1223 XEOTICID XEO03791 MOACRIVE Inhibition DME1223 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1223 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03792 XEO_CLAS Peptide DME1223 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.26 microM) DME1223 XEOTICID XEO03792 GENEFORM Protein DME1223 XEOTICID XEO03792 MOACRIVE Inhibition DME1223 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1223 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03793 XEO_CLAS Peptide DME1223 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 microM) DME1223 XEOTICID XEO03793 GENEFORM Protein DME1223 XEOTICID XEO03793 MOACRIVE Inhibition DME1223 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1223 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03797 XEO_CLAS Peptide DME1223 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.4 microM) DME1223 XEOTICID XEO03797 GENEFORM Protein DME1223 XEOTICID XEO03797 MOACRIVE Inhibition DME1223 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1223 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03798 XEO_CLAS Peptide DME1223 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03798 GENEFORM Protein DME1223 XEOTICID XEO03798 MOACRIVE Inhibition DME1223 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1223 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03799 XEO_CLAS Peptide DME1223 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03799 GENEFORM Protein DME1223 XEOTICID XEO03799 MOACRIVE Inhibition DME1223 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1223 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03810 XEO_CLAS Peptide DME1223 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03810 GENEFORM Protein DME1223 XEOTICID XEO03810 MOACRIVE Inhibition DME1223 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1223 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03846 XEO_CLAS Peptide DME1223 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03846 GENEFORM Protein DME1223 XEOTICID XEO03846 MOACRIVE Inhibition DME1223 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1223 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03847 XEO_CLAS Peptide DME1223 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03847 GENEFORM Protein DME1223 XEOTICID XEO03847 MOACRIVE Inhibition DME1223 XEOTICID XEO03850 XEO_NAME Lemon DME1223 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1223 XEOTICID XEO03850 XEO_CLAS Food Additive DME1223 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03850 GENEFORM Protein DME1223 XEOTICID XEO03850 MOACRIVE Inhibition DME1223 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1223 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03853 XEO_CLAS Peptide DME1223 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO03853 GENEFORM Protein DME1223 XEOTICID XEO03853 MOACRIVE Inhibition DME1223 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1223 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03857 XEO_CLAS Peptide DME1223 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 38.49 microM) DME1223 XEOTICID XEO03857 GENEFORM Protein DME1223 XEOTICID XEO03857 MOACRIVE Inhibition DME1223 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1223 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03860 XEO_CLAS Peptide DME1223 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 24 microM) DME1223 XEOTICID XEO03860 GENEFORM Protein DME1223 XEOTICID XEO03860 MOACRIVE Inhibition DME1223 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1223 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03861 XEO_CLAS Peptide DME1223 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 35 microM) DME1223 XEOTICID XEO03861 GENEFORM Protein DME1223 XEOTICID XEO03861 MOACRIVE Inhibition DME1223 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1223 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03862 XEO_CLAS Peptide DME1223 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 70 microM) DME1223 XEOTICID XEO03862 GENEFORM Protein DME1223 XEOTICID XEO03862 MOACRIVE Inhibition DME1223 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1223 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03863 XEO_CLAS Peptide DME1223 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 35 microM) DME1223 XEOTICID XEO03863 GENEFORM Protein DME1223 XEOTICID XEO03863 MOACRIVE Inhibition DME1223 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1223 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03864 XEO_CLAS Peptide DME1223 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO03864 GENEFORM Protein DME1223 XEOTICID XEO03864 MOACRIVE Inhibition DME1223 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1223 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03865 XEO_CLAS Peptide DME1223 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO03865 GENEFORM Protein DME1223 XEOTICID XEO03865 MOACRIVE Inhibition DME1223 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1223 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03866 XEO_CLAS Peptide DME1223 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 microM) DME1223 XEOTICID XEO03866 GENEFORM Protein DME1223 XEOTICID XEO03866 MOACRIVE Inhibition DME1223 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1223 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03867 XEO_CLAS Peptide DME1223 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40 microM) DME1223 XEOTICID XEO03867 GENEFORM Protein DME1223 XEOTICID XEO03867 MOACRIVE Inhibition DME1223 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1223 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03868 XEO_CLAS Peptide DME1223 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 51 microM) DME1223 XEOTICID XEO03868 GENEFORM Protein DME1223 XEOTICID XEO03868 MOACRIVE Inhibition DME1223 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1223 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03869 XEO_CLAS Peptide DME1223 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 35 microM) DME1223 XEOTICID XEO03869 GENEFORM Protein DME1223 XEOTICID XEO03869 MOACRIVE Inhibition DME1223 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1223 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03870 XEO_CLAS Peptide DME1223 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 61 microM) DME1223 XEOTICID XEO03870 GENEFORM Protein DME1223 XEOTICID XEO03870 MOACRIVE Inhibition DME1223 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1223 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03871 XEO_CLAS Peptide DME1223 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 microM) DME1223 XEOTICID XEO03871 GENEFORM Protein DME1223 XEOTICID XEO03871 MOACRIVE Inhibition DME1223 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1223 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03872 XEO_CLAS Peptide DME1223 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 28 microM) DME1223 XEOTICID XEO03872 GENEFORM Protein DME1223 XEOTICID XEO03872 MOACRIVE Inhibition DME1223 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1223 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03873 XEO_CLAS Peptide DME1223 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 22.5 microM) DME1223 XEOTICID XEO03873 GENEFORM Protein DME1223 XEOTICID XEO03873 MOACRIVE Inhibition DME1223 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1223 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03874 XEO_CLAS Peptide DME1223 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 11.25 microM) DME1223 XEOTICID XEO03874 GENEFORM Protein DME1223 XEOTICID XEO03874 MOACRIVE Inhibition DME1223 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1223 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03875 XEO_CLAS Peptide DME1223 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 microM) DME1223 XEOTICID XEO03875 GENEFORM Protein DME1223 XEOTICID XEO03875 MOACRIVE Inhibition DME1223 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1223 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03876 XEO_CLAS Peptide DME1223 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.75 microM) DME1223 XEOTICID XEO03876 GENEFORM Protein DME1223 XEOTICID XEO03876 MOACRIVE Inhibition DME1223 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1223 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03877 XEO_CLAS Peptide DME1223 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 microM) DME1223 XEOTICID XEO03877 GENEFORM Protein DME1223 XEOTICID XEO03877 MOACRIVE Inhibition DME1223 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1223 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03878 XEO_CLAS Peptide DME1223 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 microM) DME1223 XEOTICID XEO03878 GENEFORM Protein DME1223 XEOTICID XEO03878 MOACRIVE Inhibition DME1223 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1223 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03879 XEO_CLAS Peptide DME1223 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 252 microM) DME1223 XEOTICID XEO03879 GENEFORM Protein DME1223 XEOTICID XEO03879 MOACRIVE Inhibition DME1223 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1223 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03880 XEO_CLAS Peptide DME1223 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 174 microM) DME1223 XEOTICID XEO03880 GENEFORM Protein DME1223 XEOTICID XEO03880 MOACRIVE Inhibition DME1223 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1223 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03883 XEO_CLAS Peptide DME1223 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 74 microM) DME1223 XEOTICID XEO03883 GENEFORM Protein DME1223 XEOTICID XEO03883 MOACRIVE Inhibition DME1223 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1223 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03884 XEO_CLAS Peptide DME1223 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 31 microM) DME1223 XEOTICID XEO03884 GENEFORM Protein DME1223 XEOTICID XEO03884 MOACRIVE Inhibition DME1223 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1223 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03885 XEO_CLAS Peptide DME1223 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO03885 GENEFORM Protein DME1223 XEOTICID XEO03885 MOACRIVE Inhibition DME1223 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1223 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03886 XEO_CLAS Peptide DME1223 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 391 microM) DME1223 XEOTICID XEO03886 GENEFORM Protein DME1223 XEOTICID XEO03886 MOACRIVE Inhibition DME1223 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1223 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03887 XEO_CLAS Peptide DME1223 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 151 microM) DME1223 XEOTICID XEO03887 GENEFORM Protein DME1223 XEOTICID XEO03887 MOACRIVE Inhibition DME1223 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1223 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03888 XEO_CLAS Peptide DME1223 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 134 microM) DME1223 XEOTICID XEO03888 GENEFORM Protein DME1223 XEOTICID XEO03888 MOACRIVE Inhibition DME1223 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1223 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03889 XEO_CLAS Peptide DME1223 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 88 microM) DME1223 XEOTICID XEO03889 GENEFORM Protein DME1223 XEOTICID XEO03889 MOACRIVE Inhibition DME1223 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1223 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03890 XEO_CLAS Peptide DME1223 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 31 microM) DME1223 XEOTICID XEO03890 GENEFORM Protein DME1223 XEOTICID XEO03890 MOACRIVE Inhibition DME1223 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1223 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03891 XEO_CLAS Peptide DME1223 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 microM) DME1223 XEOTICID XEO03891 GENEFORM Protein DME1223 XEOTICID XEO03891 MOACRIVE Inhibition DME1223 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1223 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03892 XEO_CLAS Peptide DME1223 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 37 microM) DME1223 XEOTICID XEO03892 GENEFORM Protein DME1223 XEOTICID XEO03892 MOACRIVE Inhibition DME1223 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1223 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03893 XEO_CLAS Peptide DME1223 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 19 microM) DME1223 XEOTICID XEO03893 GENEFORM Protein DME1223 XEOTICID XEO03893 MOACRIVE Inhibition DME1223 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1223 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03894 XEO_CLAS Peptide DME1223 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO03894 GENEFORM Protein DME1223 XEOTICID XEO03894 MOACRIVE Inhibition DME1223 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1223 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03895 XEO_CLAS Peptide DME1223 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO03895 GENEFORM Protein DME1223 XEOTICID XEO03895 MOACRIVE Inhibition DME1223 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1223 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03896 XEO_CLAS Peptide DME1223 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 microM) DME1223 XEOTICID XEO03896 GENEFORM Protein DME1223 XEOTICID XEO03896 MOACRIVE Inhibition DME1223 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1223 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03897 XEO_CLAS Peptide DME1223 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 63 microM) DME1223 XEOTICID XEO03897 GENEFORM Protein DME1223 XEOTICID XEO03897 MOACRIVE Inhibition DME1223 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1223 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03898 XEO_CLAS Peptide DME1223 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 219 microM) DME1223 XEOTICID XEO03898 GENEFORM Protein DME1223 XEOTICID XEO03898 MOACRIVE Inhibition DME1223 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1223 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03901 XEO_CLAS Peptide DME1223 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 35 microM) DME1223 XEOTICID XEO03901 GENEFORM Protein DME1223 XEOTICID XEO03901 MOACRIVE Inhibition DME1223 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1223 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03902 XEO_CLAS Peptide DME1223 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 70 microM) DME1223 XEOTICID XEO03902 GENEFORM Protein DME1223 XEOTICID XEO03902 MOACRIVE Inhibition DME1223 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1223 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03904 XEO_CLAS Peptide DME1223 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO03904 GENEFORM Protein DME1223 XEOTICID XEO03904 MOACRIVE Inhibition DME1223 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1223 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03905 XEO_CLAS Peptide DME1223 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO03905 GENEFORM Protein DME1223 XEOTICID XEO03905 MOACRIVE Inhibition DME1223 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1223 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03908 XEO_CLAS Peptide DME1223 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03908 GENEFORM Protein DME1223 XEOTICID XEO03908 MOACRIVE Inhibition DME1223 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1223 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03915 XEO_CLAS Peptide DME1223 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03915 GENEFORM Protein DME1223 XEOTICID XEO03915 MOACRIVE Inhibition DME1223 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1223 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03916 XEO_CLAS Peptide DME1223 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.8 ug/ml) DME1223 XEOTICID XEO03916 GENEFORM Protein DME1223 XEOTICID XEO03916 MOACRIVE Inhibition DME1223 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1223 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03917 XEO_CLAS Peptide DME1223 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 13.1 ug/ml) DME1223 XEOTICID XEO03917 GENEFORM Protein DME1223 XEOTICID XEO03917 MOACRIVE Inhibition DME1223 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1223 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03918 XEO_CLAS Peptide DME1223 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.5 ug/ml) DME1223 XEOTICID XEO03918 GENEFORM Protein DME1223 XEOTICID XEO03918 MOACRIVE Inhibition DME1223 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1223 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03919 XEO_CLAS Peptide DME1223 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 80 ug/ml) DME1223 XEOTICID XEO03919 GENEFORM Protein DME1223 XEOTICID XEO03919 MOACRIVE Inhibition DME1223 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1223 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03922 XEO_CLAS Peptide DME1223 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 9 microM) DME1223 XEOTICID XEO03922 GENEFORM Protein DME1223 XEOTICID XEO03922 MOACRIVE Inhibition DME1223 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1223 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03923 XEO_CLAS Peptide DME1223 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 80 microM) DME1223 XEOTICID XEO03923 GENEFORM Protein DME1223 XEOTICID XEO03923 MOACRIVE Inhibition DME1223 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1223 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03924 XEO_CLAS Peptide DME1223 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO03924 GENEFORM Protein DME1223 XEOTICID XEO03924 MOACRIVE Inhibition DME1223 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1223 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03927 XEO_CLAS Peptide DME1223 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 80 microM) DME1223 XEOTICID XEO03927 GENEFORM Protein DME1223 XEOTICID XEO03927 MOACRIVE Inhibition DME1223 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1223 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03928 XEO_CLAS Peptide DME1223 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 microM) DME1223 XEOTICID XEO03928 GENEFORM Protein DME1223 XEOTICID XEO03928 MOACRIVE Inhibition DME1223 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1223 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03929 XEO_CLAS Peptide DME1223 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 microM) DME1223 XEOTICID XEO03929 GENEFORM Protein DME1223 XEOTICID XEO03929 MOACRIVE Inhibition DME1223 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1223 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03930 XEO_CLAS Peptide DME1223 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 microM) DME1223 XEOTICID XEO03930 GENEFORM Protein DME1223 XEOTICID XEO03930 MOACRIVE Inhibition DME1223 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1223 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03931 XEO_CLAS Peptide DME1223 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 microM) DME1223 XEOTICID XEO03931 GENEFORM Protein DME1223 XEOTICID XEO03931 MOACRIVE Inhibition DME1223 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1223 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03933 XEO_CLAS Peptide DME1223 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.5 microM) DME1223 XEOTICID XEO03933 GENEFORM Protein DME1223 XEOTICID XEO03933 MOACRIVE Inhibition DME1223 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1223 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03934 XEO_CLAS Peptide DME1223 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.7 microM) DME1223 XEOTICID XEO03934 GENEFORM Protein DME1223 XEOTICID XEO03934 MOACRIVE Inhibition DME1223 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1223 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03935 XEO_CLAS Peptide DME1223 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.7 microM) DME1223 XEOTICID XEO03935 GENEFORM Protein DME1223 XEOTICID XEO03935 MOACRIVE Inhibition DME1223 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1223 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03936 XEO_CLAS Peptide DME1223 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.0 microM) DME1223 XEOTICID XEO03936 GENEFORM Protein DME1223 XEOTICID XEO03936 MOACRIVE Inhibition DME1223 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1223 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03937 XEO_CLAS Peptide DME1223 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.1 microM) DME1223 XEOTICID XEO03937 GENEFORM Protein DME1223 XEOTICID XEO03937 MOACRIVE Inhibition DME1223 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1223 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03938 XEO_CLAS Peptide DME1223 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.7 microM) DME1223 XEOTICID XEO03938 GENEFORM Protein DME1223 XEOTICID XEO03938 MOACRIVE Inhibition DME1223 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1223 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03939 XEO_CLAS Peptide DME1223 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.7 microM) DME1223 XEOTICID XEO03939 GENEFORM Protein DME1223 XEOTICID XEO03939 MOACRIVE Inhibition DME1223 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1223 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03940 XEO_CLAS Peptide DME1223 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.5 microM) DME1223 XEOTICID XEO03940 GENEFORM Protein DME1223 XEOTICID XEO03940 MOACRIVE Inhibition DME1223 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1223 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03941 XEO_CLAS Peptide DME1223 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.4 microM) DME1223 XEOTICID XEO03941 GENEFORM Protein DME1223 XEOTICID XEO03941 MOACRIVE Inhibition DME1223 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1223 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03943 XEO_CLAS Peptide DME1223 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.4 microM) DME1223 XEOTICID XEO03943 GENEFORM Protein DME1223 XEOTICID XEO03943 MOACRIVE Inhibition DME1223 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1223 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03944 XEO_CLAS Peptide DME1223 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.7 microM) DME1223 XEOTICID XEO03944 GENEFORM Protein DME1223 XEOTICID XEO03944 MOACRIVE Inhibition DME1223 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1223 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03945 XEO_CLAS Peptide DME1223 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.2 microM) DME1223 XEOTICID XEO03945 GENEFORM Protein DME1223 XEOTICID XEO03945 MOACRIVE Inhibition DME1223 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1223 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03947 XEO_CLAS Peptide DME1223 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.0 microM) DME1223 XEOTICID XEO03947 GENEFORM Protein DME1223 XEOTICID XEO03947 MOACRIVE Inhibition DME1223 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1223 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03948 XEO_CLAS Peptide DME1223 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 23.3 microM) DME1223 XEOTICID XEO03948 GENEFORM Protein DME1223 XEOTICID XEO03948 MOACRIVE Inhibition DME1223 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1223 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03950 XEO_CLAS Peptide DME1223 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4.4 microM) DME1223 XEOTICID XEO03950 GENEFORM Protein DME1223 XEOTICID XEO03950 MOACRIVE Inhibition DME1223 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1223 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03951 XEO_CLAS Peptide DME1223 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8.8 microM) DME1223 XEOTICID XEO03951 GENEFORM Protein DME1223 XEOTICID XEO03951 MOACRIVE Inhibition DME1223 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1223 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03952 XEO_CLAS Peptide DME1223 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.2 microM) DME1223 XEOTICID XEO03952 GENEFORM Protein DME1223 XEOTICID XEO03952 MOACRIVE Inhibition DME1223 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1223 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03953 XEO_CLAS Peptide DME1223 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 microM) DME1223 XEOTICID XEO03953 GENEFORM Protein DME1223 XEOTICID XEO03953 MOACRIVE Inhibition DME1223 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1223 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03958 XEO_CLAS Peptide DME1223 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03958 GENEFORM Protein DME1223 XEOTICID XEO03958 MOACRIVE Inhibition DME1223 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1223 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03965 XEO_CLAS Peptide DME1223 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 128 microM) DME1223 XEOTICID XEO03965 GENEFORM Protein DME1223 XEOTICID XEO03965 MOACRIVE Inhibition DME1223 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1223 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03966 XEO_CLAS Peptide DME1223 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 microM) DME1223 XEOTICID XEO03966 GENEFORM Protein DME1223 XEOTICID XEO03966 MOACRIVE Inhibition DME1223 XEOTICID XEO03971 XEO_NAME Lumbrican DME1223 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03971 XEO_CLAS Peptide DME1223 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03971 GENEFORM Protein DME1223 XEOTICID XEO03971 MOACRIVE Inhibition DME1223 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1223 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03972 XEO_CLAS Peptide DME1223 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO03972 GENEFORM Protein DME1223 XEOTICID XEO03972 MOACRIVE Inhibition DME1223 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1223 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03980 XEO_CLAS Peptide DME1223 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 32 microM) DME1223 XEOTICID XEO03980 GENEFORM Protein DME1223 XEOTICID XEO03980 MOACRIVE Inhibition DME1223 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1223 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03985 XEO_CLAS Peptide DME1223 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 ug/ml) DME1223 XEOTICID XEO03985 GENEFORM Protein DME1223 XEOTICID XEO03985 MOACRIVE Inhibition DME1223 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1223 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03991 XEO_CLAS Peptide DME1223 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03991 GENEFORM Protein DME1223 XEOTICID XEO03991 MOACRIVE Inhibition DME1223 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1223 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03992 XEO_CLAS Peptide DME1223 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03992 GENEFORM Protein DME1223 XEOTICID XEO03992 MOACRIVE Inhibition DME1223 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1223 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03993 XEO_CLAS Peptide DME1223 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03993 GENEFORM Protein DME1223 XEOTICID XEO03993 MOACRIVE Inhibition DME1223 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1223 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03994 XEO_CLAS Peptide DME1223 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO03994 GENEFORM Protein DME1223 XEOTICID XEO03994 MOACRIVE Inhibition DME1223 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1223 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03996 XEO_CLAS Peptide DME1223 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 65 microM) DME1223 XEOTICID XEO03996 GENEFORM Protein DME1223 XEOTICID XEO03996 MOACRIVE Inhibition DME1223 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1223 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03997 XEO_CLAS Peptide DME1223 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 7.5 microM) DME1223 XEOTICID XEO03997 GENEFORM Protein DME1223 XEOTICID XEO03997 MOACRIVE Inhibition DME1223 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1223 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03998 XEO_CLAS Peptide DME1223 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15.5 microM) DME1223 XEOTICID XEO03998 GENEFORM Protein DME1223 XEOTICID XEO03998 MOACRIVE Inhibition DME1223 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1223 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO03999 XEO_CLAS Peptide DME1223 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25.8 microM) DME1223 XEOTICID XEO03999 GENEFORM Protein DME1223 XEOTICID XEO03999 MOACRIVE Inhibition DME1223 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1223 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04000 XEO_CLAS Peptide DME1223 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO04000 GENEFORM Protein DME1223 XEOTICID XEO04000 MOACRIVE Inhibition DME1223 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1223 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04001 XEO_CLAS Peptide DME1223 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO04001 GENEFORM Protein DME1223 XEOTICID XEO04001 MOACRIVE Inhibition DME1223 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1223 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04002 XEO_CLAS Peptide DME1223 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 7.5 ug/ml) DME1223 XEOTICID XEO04002 GENEFORM Protein DME1223 XEOTICID XEO04002 MOACRIVE Inhibition DME1223 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1223 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04003 XEO_CLAS Peptide DME1223 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 ug/ml) DME1223 XEOTICID XEO04003 GENEFORM Protein DME1223 XEOTICID XEO04003 MOACRIVE Inhibition DME1223 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1223 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04004 XEO_CLAS Peptide DME1223 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.0 ug/ml) DME1223 XEOTICID XEO04004 GENEFORM Protein DME1223 XEOTICID XEO04004 MOACRIVE Inhibition DME1223 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1223 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04005 XEO_CLAS Peptide DME1223 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.0 ug/ml) DME1223 XEOTICID XEO04005 GENEFORM Protein DME1223 XEOTICID XEO04005 MOACRIVE Inhibition DME1223 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1223 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04007 XEO_CLAS Peptide DME1223 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 19.5 ug/ml) DME1223 XEOTICID XEO04007 GENEFORM Protein DME1223 XEOTICID XEO04007 MOACRIVE Inhibition DME1223 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1223 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04011 XEO_CLAS Peptide DME1223 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 19.5 ug/ml) DME1223 XEOTICID XEO04011 GENEFORM Protein DME1223 XEOTICID XEO04011 MOACRIVE Inhibition DME1223 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1223 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04012 XEO_CLAS Peptide DME1223 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.9 ug/ml) DME1223 XEOTICID XEO04012 GENEFORM Protein DME1223 XEOTICID XEO04012 MOACRIVE Inhibition DME1223 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1223 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04013 XEO_CLAS Peptide DME1223 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.7 ug/ml) DME1223 XEOTICID XEO04013 GENEFORM Protein DME1223 XEOTICID XEO04013 MOACRIVE Inhibition DME1223 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1223 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04018 XEO_CLAS Peptide DME1223 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 9 ug/ml) DME1223 XEOTICID XEO04018 GENEFORM Protein DME1223 XEOTICID XEO04018 MOACRIVE Inhibition DME1223 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1223 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04026 XEO_CLAS Peptide DME1223 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO04026 GENEFORM Protein DME1223 XEOTICID XEO04026 MOACRIVE Inhibition DME1223 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1223 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04027 XEO_CLAS Peptide DME1223 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO04027 GENEFORM Protein DME1223 XEOTICID XEO04027 MOACRIVE Inhibition DME1223 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1223 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04028 XEO_CLAS Peptide DME1223 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 ug/ml) DME1223 XEOTICID XEO04028 GENEFORM Protein DME1223 XEOTICID XEO04028 MOACRIVE Inhibition DME1223 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1223 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04038 XEO_CLAS Peptide DME1223 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04038 GENEFORM Protein DME1223 XEOTICID XEO04038 MOACRIVE Inhibition DME1223 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1223 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04039 XEO_CLAS Peptide DME1223 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 microM) DME1223 XEOTICID XEO04039 GENEFORM Protein DME1223 XEOTICID XEO04039 MOACRIVE Inhibition DME1223 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1223 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04051 XEO_CLAS Peptide DME1223 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.31-0.63 microM) DME1223 XEOTICID XEO04051 GENEFORM Protein DME1223 XEOTICID XEO04051 MOACRIVE Inhibition DME1223 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1223 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04052 XEO_CLAS Peptide DME1223 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04052 GENEFORM Protein DME1223 XEOTICID XEO04052 MOACRIVE Inhibition DME1223 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1223 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04053 XEO_CLAS Peptide DME1223 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.08-0.16 microM) DME1223 XEOTICID XEO04053 GENEFORM Protein DME1223 XEOTICID XEO04053 MOACRIVE Inhibition DME1223 XEOTICID XEO04055 XEO_NAME Melectin DME1223 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04055 XEO_CLAS Peptide DME1223 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.0 microM) DME1223 XEOTICID XEO04055 GENEFORM Protein DME1223 XEOTICID XEO04055 MOACRIVE Inhibition DME1223 XEOTICID XEO04057 XEO_NAME Melittin DME1223 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04057 XEO_CLAS Peptide DME1223 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.8 microM) DME1223 XEOTICID XEO04057 GENEFORM Protein DME1223 XEOTICID XEO04057 MOACRIVE Inhibition DME1223 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1223 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04061 XEO_CLAS Peptide DME1223 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.9 microM) DME1223 XEOTICID XEO04061 GENEFORM Protein DME1223 XEOTICID XEO04061 MOACRIVE Inhibition DME1223 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1223 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04062 XEO_CLAS Peptide DME1223 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.5 microM) DME1223 XEOTICID XEO04062 GENEFORM Protein DME1223 XEOTICID XEO04062 MOACRIVE Inhibition DME1223 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1223 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04063 XEO_CLAS Peptide DME1223 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 7.8 microM) DME1223 XEOTICID XEO04063 GENEFORM Protein DME1223 XEOTICID XEO04063 MOACRIVE Inhibition DME1223 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1223 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04064 XEO_CLAS Peptide DME1223 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 46.7 microM) DME1223 XEOTICID XEO04064 GENEFORM Protein DME1223 XEOTICID XEO04064 MOACRIVE Inhibition DME1223 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1223 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04066 XEO_CLAS Peptide DME1223 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16.3 microM) DME1223 XEOTICID XEO04066 GENEFORM Protein DME1223 XEOTICID XEO04066 MOACRIVE Inhibition DME1223 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1223 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04067 XEO_CLAS Peptide DME1223 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.6 microM) DME1223 XEOTICID XEO04067 GENEFORM Protein DME1223 XEOTICID XEO04067 MOACRIVE Inhibition DME1223 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1223 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04068 XEO_CLAS Peptide DME1223 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.6 microM) DME1223 XEOTICID XEO04068 GENEFORM Protein DME1223 XEOTICID XEO04068 MOACRIVE Inhibition DME1223 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1223 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04086 GENEFORM Protein DME1223 XEOTICID XEO04086 MOACRIVE Inhibition DME1223 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1223 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04087 GENEFORM Protein DME1223 XEOTICID XEO04087 MOACRIVE Inhibition DME1223 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1223 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04089 GENEFORM Protein DME1223 XEOTICID XEO04089 MOACRIVE Inhibition DME1223 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1223 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04094 GENEFORM Protein DME1223 XEOTICID XEO04094 MOACRIVE Inhibition DME1223 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1223 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04096 GENEFORM Protein DME1223 XEOTICID XEO04096 MOACRIVE Inhibition DME1223 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1223 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04098 GENEFORM Protein DME1223 XEOTICID XEO04098 MOACRIVE Inhibition DME1223 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1223 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04111 XEO_CLAS Peptide DME1223 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04111 GENEFORM Protein DME1223 XEOTICID XEO04111 MOACRIVE Inhibition DME1223 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1223 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04112 XEO_CLAS Peptide DME1223 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.02 microM) DME1223 XEOTICID XEO04112 GENEFORM Protein DME1223 XEOTICID XEO04112 MOACRIVE Inhibition DME1223 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1223 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04113 XEO_CLAS Peptide DME1223 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.02 ug/ml) DME1223 XEOTICID XEO04113 GENEFORM Protein DME1223 XEOTICID XEO04113 MOACRIVE Inhibition DME1223 XEOTICID XEO04114 XEO_NAME Microcin L DME1223 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04114 XEO_CLAS Peptide DME1223 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04114 GENEFORM Protein DME1223 XEOTICID XEO04114 MOACRIVE Inhibition DME1223 XEOTICID XEO04117 XEO_NAME Misgurin DME1223 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04117 XEO_CLAS Peptide DME1223 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04117 GENEFORM Protein DME1223 XEOTICID XEO04117 MOACRIVE Inhibition DME1223 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1223 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04118 XEO_CLAS Peptide DME1223 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 300 microM) DME1223 XEOTICID XEO04118 GENEFORM Protein DME1223 XEOTICID XEO04118 MOACRIVE Inhibition DME1223 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1223 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04119 XEO_CLAS Peptide DME1223 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-20 microM) DME1223 XEOTICID XEO04119 GENEFORM Protein DME1223 XEOTICID XEO04119 MOACRIVE Inhibition DME1223 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1223 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04120 XEO_CLAS Peptide DME1223 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC < 10 microM) DME1223 XEOTICID XEO04120 GENEFORM Protein DME1223 XEOTICID XEO04120 MOACRIVE Inhibition DME1223 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1223 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04121 XEO_CLAS Peptide DME1223 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.2-6.4 microM) DME1223 XEOTICID XEO04121 GENEFORM Protein DME1223 XEOTICID XEO04121 MOACRIVE Inhibition DME1223 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1223 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04122 XEO_CLAS Peptide DME1223 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.14-6.29 microM) DME1223 XEOTICID XEO04122 GENEFORM Protein DME1223 XEOTICID XEO04122 MOACRIVE Inhibition DME1223 XEOTICID XEO04123 XEO_NAME Modified defensin DME1223 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04123 XEO_CLAS Peptide DME1223 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO04123 GENEFORM Protein DME1223 XEOTICID XEO04123 MOACRIVE Inhibition DME1223 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1223 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04128 XEO_CLAS Peptide DME1223 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.31 microM) DME1223 XEOTICID XEO04128 GENEFORM Protein DME1223 XEOTICID XEO04128 MOACRIVE Inhibition DME1223 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1223 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04129 XEO_CLAS Peptide DME1223 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO04129 GENEFORM Protein DME1223 XEOTICID XEO04129 MOACRIVE Inhibition DME1223 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1223 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04130 XEO_CLAS Peptide DME1223 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO04130 GENEFORM Protein DME1223 XEOTICID XEO04130 MOACRIVE Inhibition DME1223 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1223 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04131 XEO_CLAS Peptide DME1223 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 microM) DME1223 XEOTICID XEO04131 GENEFORM Protein DME1223 XEOTICID XEO04131 MOACRIVE Inhibition DME1223 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1223 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04132 XEO_CLAS Peptide DME1223 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 microM) DME1223 XEOTICID XEO04132 GENEFORM Protein DME1223 XEOTICID XEO04132 MOACRIVE Inhibition DME1223 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1223 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04133 XEO_CLAS Peptide DME1223 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO04133 GENEFORM Protein DME1223 XEOTICID XEO04133 MOACRIVE Inhibition DME1223 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1223 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04134 XEO_CLAS Peptide DME1223 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO04134 GENEFORM Protein DME1223 XEOTICID XEO04134 MOACRIVE Inhibition DME1223 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1223 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04135 XEO_CLAS Peptide DME1223 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 microM) DME1223 XEOTICID XEO04135 GENEFORM Protein DME1223 XEOTICID XEO04135 MOACRIVE Inhibition DME1223 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1223 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04137 XEO_CLAS Peptide DME1223 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.6 microM) DME1223 XEOTICID XEO04137 GENEFORM Protein DME1223 XEOTICID XEO04137 MOACRIVE Inhibition DME1223 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1223 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04138 XEO_CLAS Peptide DME1223 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 microM) DME1223 XEOTICID XEO04138 GENEFORM Protein DME1223 XEOTICID XEO04138 MOACRIVE Inhibition DME1223 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1223 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04139 XEO_CLAS Peptide DME1223 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 microM) DME1223 XEOTICID XEO04139 GENEFORM Protein DME1223 XEOTICID XEO04139 MOACRIVE Inhibition DME1223 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1223 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04140 XEO_CLAS Peptide DME1223 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 70 microM) DME1223 XEOTICID XEO04140 GENEFORM Protein DME1223 XEOTICID XEO04140 MOACRIVE Inhibition DME1223 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1223 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04141 XEO_CLAS Peptide DME1223 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 microM) DME1223 XEOTICID XEO04141 GENEFORM Protein DME1223 XEOTICID XEO04141 MOACRIVE Inhibition DME1223 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1223 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04142 XEO_CLAS Peptide DME1223 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8-16 microM) DME1223 XEOTICID XEO04142 GENEFORM Protein DME1223 XEOTICID XEO04142 MOACRIVE Inhibition DME1223 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1223 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04146 XEO_CLAS Peptide DME1223 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04146 GENEFORM Protein DME1223 XEOTICID XEO04146 MOACRIVE Inhibition DME1223 XEOTICID XEO04149 XEO_NAME Mucroporin DME1223 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04149 XEO_CLAS Peptide DME1223 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 ug/ml) DME1223 XEOTICID XEO04149 GENEFORM Protein DME1223 XEOTICID XEO04149 MOACRIVE Inhibition DME1223 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1223 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04158 XEO_CLAS Peptide DME1223 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO04158 GENEFORM Protein DME1223 XEOTICID XEO04158 MOACRIVE Inhibition DME1223 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1223 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04159 XEO_CLAS Peptide DME1223 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 microM) DME1223 XEOTICID XEO04159 GENEFORM Protein DME1223 XEOTICID XEO04159 MOACRIVE Inhibition DME1223 XEOTICID XEO04167 XEO_NAME Myticin-B DME1223 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04167 XEO_CLAS Peptide DME1223 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04167 GENEFORM Protein DME1223 XEOTICID XEO04167 MOACRIVE Inhibition DME1223 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1223 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04168 XEO_CLAS Peptide DME1223 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.7-12.5 microM) DME1223 XEOTICID XEO04168 GENEFORM Protein DME1223 XEOTICID XEO04168 MOACRIVE Inhibition DME1223 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1223 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04169 XEO_CLAS Peptide DME1223 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04169 GENEFORM Protein DME1223 XEOTICID XEO04169 MOACRIVE Inhibition DME1223 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1223 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04170 XEO_CLAS Peptide DME1223 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04170 GENEFORM Protein DME1223 XEOTICID XEO04170 MOACRIVE Inhibition DME1223 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1223 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04171 XEO_CLAS Peptide DME1223 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04171 GENEFORM Protein DME1223 XEOTICID XEO04171 MOACRIVE Inhibition DME1223 XEOTICID XEO04172 XEO_NAME Myxinidin DME1223 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04172 XEO_CLAS Peptide DME1223 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04172 GENEFORM Protein DME1223 XEOTICID XEO04172 MOACRIVE Inhibition DME1223 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1223 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04177 XEO_CLAS Peptide DME1223 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.7 microM) DME1223 XEOTICID XEO04177 GENEFORM Protein DME1223 XEOTICID XEO04177 MOACRIVE Inhibition DME1223 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1223 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04178 XEO_CLAS Peptide DME1223 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.7 microM) DME1223 XEOTICID XEO04178 GENEFORM Protein DME1223 XEOTICID XEO04178 MOACRIVE Inhibition DME1223 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1223 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04179 XEO_CLAS Peptide DME1223 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.5 microM) DME1223 XEOTICID XEO04179 GENEFORM Protein DME1223 XEOTICID XEO04179 MOACRIVE Inhibition DME1223 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1223 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04180 XEO_CLAS Peptide DME1223 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 23 microM) DME1223 XEOTICID XEO04180 GENEFORM Protein DME1223 XEOTICID XEO04180 MOACRIVE Inhibition DME1223 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1223 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04181 XEO_CLAS Peptide DME1223 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.2 microM) DME1223 XEOTICID XEO04181 GENEFORM Protein DME1223 XEOTICID XEO04181 MOACRIVE Inhibition DME1223 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1223 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04182 XEO_CLAS Peptide DME1223 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4.4 microM) DME1223 XEOTICID XEO04182 GENEFORM Protein DME1223 XEOTICID XEO04182 MOACRIVE Inhibition DME1223 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1223 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04183 XEO_CLAS Peptide DME1223 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.6 microM) DME1223 XEOTICID XEO04183 GENEFORM Protein DME1223 XEOTICID XEO04183 MOACRIVE Inhibition DME1223 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1223 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04184 XEO_CLAS Peptide DME1223 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 microM) DME1223 XEOTICID XEO04184 GENEFORM Protein DME1223 XEOTICID XEO04184 MOACRIVE Inhibition DME1223 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1223 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04185 XEO_CLAS Peptide DME1223 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04185 GENEFORM Protein DME1223 XEOTICID XEO04185 MOACRIVE Inhibition DME1223 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1223 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04186 XEO_CLAS Peptide DME1223 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04186 GENEFORM Protein DME1223 XEOTICID XEO04186 MOACRIVE Inhibition DME1223 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1223 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04187 XEO_CLAS Peptide DME1223 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04187 GENEFORM Protein DME1223 XEOTICID XEO04187 MOACRIVE Inhibition DME1223 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1223 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04188 XEO_CLAS Peptide DME1223 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04188 GENEFORM Protein DME1223 XEOTICID XEO04188 MOACRIVE Inhibition DME1223 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1223 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04206 XEO_CLAS Peptide DME1223 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25 microM) DME1223 XEOTICID XEO04206 GENEFORM Protein DME1223 XEOTICID XEO04206 MOACRIVE Inhibition DME1223 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1223 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04214 XEO_CLAS Peptide DME1223 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25 microM) DME1223 XEOTICID XEO04214 GENEFORM Protein DME1223 XEOTICID XEO04214 MOACRIVE Inhibition DME1223 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1223 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04216 XEO_CLAS Peptide DME1223 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO04216 GENEFORM Protein DME1223 XEOTICID XEO04216 MOACRIVE Inhibition DME1223 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1223 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04218 XEO_CLAS Peptide DME1223 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.125 microM) DME1223 XEOTICID XEO04218 GENEFORM Protein DME1223 XEOTICID XEO04218 MOACRIVE Inhibition DME1223 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1223 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04219 XEO_CLAS Peptide DME1223 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO04219 GENEFORM Protein DME1223 XEOTICID XEO04219 MOACRIVE Inhibition DME1223 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1223 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04220 XEO_CLAS Peptide DME1223 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.125 microM) DME1223 XEOTICID XEO04220 GENEFORM Protein DME1223 XEOTICID XEO04220 MOACRIVE Inhibition DME1223 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1223 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04221 XEO_CLAS Peptide DME1223 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO04221 GENEFORM Protein DME1223 XEOTICID XEO04221 MOACRIVE Inhibition DME1223 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1223 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04222 XEO_CLAS Peptide DME1223 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25 microM) DME1223 XEOTICID XEO04222 GENEFORM Protein DME1223 XEOTICID XEO04222 MOACRIVE Inhibition DME1223 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1223 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04233 XEO_CLAS Peptide DME1223 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04233 GENEFORM Protein DME1223 XEOTICID XEO04233 MOACRIVE Inhibition DME1223 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1223 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04234 XEO_CLAS Peptide DME1223 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04234 GENEFORM Protein DME1223 XEOTICID XEO04234 MOACRIVE Inhibition DME1223 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1223 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04241 XEO_CLAS Peptide DME1223 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04241 GENEFORM Protein DME1223 XEOTICID XEO04241 MOACRIVE Inhibition DME1223 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1223 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04242 XEO_CLAS Peptide DME1223 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04242 GENEFORM Protein DME1223 XEOTICID XEO04242 MOACRIVE Inhibition DME1223 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1223 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04245 XEO_CLAS Natural Product DME1223 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04245 GENEFORM Protein DME1223 XEOTICID XEO04245 MOACRIVE Inhibition DME1223 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1223 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04246 XEO_CLAS Natural Product DME1223 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04246 GENEFORM Protein DME1223 XEOTICID XEO04246 MOACRIVE Inhibition DME1223 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1223 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04249 XEO_CLAS Peptide DME1223 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 500 ug/ml) DME1223 XEOTICID XEO04249 GENEFORM Protein DME1223 XEOTICID XEO04249 MOACRIVE Inhibition DME1223 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1223 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04251 XEO_CLAS Peptide DME1223 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04251 GENEFORM Protein DME1223 XEOTICID XEO04251 MOACRIVE Inhibition DME1223 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1223 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04253 XEO_CLAS Peptide DME1223 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04253 GENEFORM Protein DME1223 XEOTICID XEO04253 MOACRIVE Inhibition DME1223 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1223 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04254 XEO_CLAS Peptide DME1223 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04254 GENEFORM Protein DME1223 XEOTICID XEO04254 MOACRIVE Inhibition DME1223 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1223 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04255 XEO_CLAS Peptide DME1223 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04255 GENEFORM Protein DME1223 XEOTICID XEO04255 MOACRIVE Inhibition DME1223 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1223 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04256 XEO_CLAS Peptide DME1223 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04256 GENEFORM Protein DME1223 XEOTICID XEO04256 MOACRIVE Inhibition DME1223 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1223 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04257 XEO_CLAS Peptide DME1223 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04257 GENEFORM Protein DME1223 XEOTICID XEO04257 MOACRIVE Inhibition DME1223 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1223 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04258 XEO_CLAS Peptide DME1223 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04258 GENEFORM Protein DME1223 XEOTICID XEO04258 MOACRIVE Inhibition DME1223 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1223 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04259 XEO_CLAS Peptide DME1223 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04259 GENEFORM Protein DME1223 XEOTICID XEO04259 MOACRIVE Inhibition DME1223 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1223 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04260 XEO_CLAS Peptide DME1223 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04260 GENEFORM Protein DME1223 XEOTICID XEO04260 MOACRIVE Inhibition DME1223 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1223 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04261 XEO_CLAS Peptide DME1223 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04261 GENEFORM Protein DME1223 XEOTICID XEO04261 MOACRIVE Inhibition DME1223 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1223 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04262 XEO_CLAS Peptide DME1223 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04262 GENEFORM Protein DME1223 XEOTICID XEO04262 MOACRIVE Inhibition DME1223 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1223 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04263 XEO_CLAS Peptide DME1223 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04263 GENEFORM Protein DME1223 XEOTICID XEO04263 MOACRIVE Inhibition DME1223 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1223 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04264 XEO_CLAS Peptide DME1223 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04264 GENEFORM Protein DME1223 XEOTICID XEO04264 MOACRIVE Inhibition DME1223 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1223 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04265 XEO_CLAS Peptide DME1223 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04265 GENEFORM Protein DME1223 XEOTICID XEO04265 MOACRIVE Inhibition DME1223 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1223 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04266 XEO_CLAS Peptide DME1223 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04266 GENEFORM Protein DME1223 XEOTICID XEO04266 MOACRIVE Inhibition DME1223 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1223 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04267 XEO_CLAS Peptide DME1223 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04267 GENEFORM Protein DME1223 XEOTICID XEO04267 MOACRIVE Inhibition DME1223 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1223 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04268 XEO_CLAS Peptide DME1223 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04268 GENEFORM Protein DME1223 XEOTICID XEO04268 MOACRIVE Inhibition DME1223 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1223 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04269 XEO_CLAS Peptide DME1223 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04269 GENEFORM Protein DME1223 XEOTICID XEO04269 MOACRIVE Inhibition DME1223 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1223 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04270 XEO_CLAS Peptide DME1223 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04270 GENEFORM Protein DME1223 XEOTICID XEO04270 MOACRIVE Inhibition DME1223 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1223 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04271 XEO_CLAS Peptide DME1223 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04271 GENEFORM Protein DME1223 XEOTICID XEO04271 MOACRIVE Inhibition DME1223 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1223 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04272 XEO_CLAS Peptide DME1223 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04272 GENEFORM Protein DME1223 XEOTICID XEO04272 MOACRIVE Inhibition DME1223 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1223 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04277 XEO_CLAS Peptide DME1223 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 110.00 ug/ml) DME1223 XEOTICID XEO04277 GENEFORM Protein DME1223 XEOTICID XEO04277 MOACRIVE Inhibition DME1223 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1223 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04280 XEO_CLAS Peptide DME1223 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 37.50 ug/ml) DME1223 XEOTICID XEO04280 GENEFORM Protein DME1223 XEOTICID XEO04280 MOACRIVE Inhibition DME1223 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1223 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04281 XEO_CLAS Peptide DME1223 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25.00 ug/ml) DME1223 XEOTICID XEO04281 GENEFORM Protein DME1223 XEOTICID XEO04281 MOACRIVE Inhibition DME1223 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1223 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04282 XEO_CLAS Peptide DME1223 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.2 ug/ml) DME1223 XEOTICID XEO04282 GENEFORM Protein DME1223 XEOTICID XEO04282 MOACRIVE Inhibition DME1223 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1223 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04283 XEO_CLAS Peptide DME1223 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.3 ug/ml) DME1223 XEOTICID XEO04283 GENEFORM Protein DME1223 XEOTICID XEO04283 MOACRIVE Inhibition DME1223 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1223 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04284 XEO_CLAS Peptide DME1223 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10.8 ug/ml) DME1223 XEOTICID XEO04284 GENEFORM Protein DME1223 XEOTICID XEO04284 MOACRIVE Inhibition DME1223 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1223 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04285 XEO_CLAS Peptide DME1223 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 11.5 ug/ml) DME1223 XEOTICID XEO04285 GENEFORM Protein DME1223 XEOTICID XEO04285 MOACRIVE Inhibition DME1223 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1223 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04286 XEO_CLAS Peptide DME1223 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8.6 ug/ml) DME1223 XEOTICID XEO04286 GENEFORM Protein DME1223 XEOTICID XEO04286 MOACRIVE Inhibition DME1223 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1223 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04287 XEO_CLAS Peptide DME1223 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10.2 ug/ml) DME1223 XEOTICID XEO04287 GENEFORM Protein DME1223 XEOTICID XEO04287 MOACRIVE Inhibition DME1223 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1223 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04288 XEO_CLAS Peptide DME1223 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4.4 ug/ml) DME1223 XEOTICID XEO04288 GENEFORM Protein DME1223 XEOTICID XEO04288 MOACRIVE Inhibition DME1223 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1223 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04289 XEO_CLAS Peptide DME1223 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.2 ug/ml) DME1223 XEOTICID XEO04289 GENEFORM Protein DME1223 XEOTICID XEO04289 MOACRIVE Inhibition DME1223 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1223 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04290 XEO_CLAS Peptide DME1223 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 11.3 ug/ml) DME1223 XEOTICID XEO04290 GENEFORM Protein DME1223 XEOTICID XEO04290 MOACRIVE Inhibition DME1223 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1223 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04291 XEO_CLAS Peptide DME1223 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 7.2 ug/ml) DME1223 XEOTICID XEO04291 GENEFORM Protein DME1223 XEOTICID XEO04291 MOACRIVE Inhibition DME1223 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1223 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04292 XEO_CLAS Peptide DME1223 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.1 ug/ml) DME1223 XEOTICID XEO04292 GENEFORM Protein DME1223 XEOTICID XEO04292 MOACRIVE Inhibition DME1223 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1223 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04293 XEO_CLAS Peptide DME1223 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO04293 GENEFORM Protein DME1223 XEOTICID XEO04293 MOACRIVE Inhibition DME1223 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1223 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04294 XEO_CLAS Peptide DME1223 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO04294 GENEFORM Protein DME1223 XEOTICID XEO04294 MOACRIVE Inhibition DME1223 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1223 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04295 XEO_CLAS Peptide DME1223 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO04295 GENEFORM Protein DME1223 XEOTICID XEO04295 MOACRIVE Inhibition DME1223 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1223 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04296 XEO_CLAS Peptide DME1223 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 28 microM) DME1223 XEOTICID XEO04296 GENEFORM Protein DME1223 XEOTICID XEO04296 MOACRIVE Inhibition DME1223 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1223 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04297 XEO_CLAS Peptide DME1223 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 14 microM) DME1223 XEOTICID XEO04297 GENEFORM Protein DME1223 XEOTICID XEO04297 MOACRIVE Inhibition DME1223 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1223 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04298 XEO_CLAS Peptide DME1223 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO04298 GENEFORM Protein DME1223 XEOTICID XEO04298 MOACRIVE Inhibition DME1223 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1223 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04299 XEO_CLAS Peptide DME1223 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO04299 GENEFORM Protein DME1223 XEOTICID XEO04299 MOACRIVE Inhibition DME1223 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1223 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04300 XEO_CLAS Peptide DME1223 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO04300 GENEFORM Protein DME1223 XEOTICID XEO04300 MOACRIVE Inhibition DME1223 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1223 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04301 XEO_CLAS Peptide DME1223 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 microM) DME1223 XEOTICID XEO04301 GENEFORM Protein DME1223 XEOTICID XEO04301 MOACRIVE Inhibition DME1223 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1223 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04302 XEO_CLAS Peptide DME1223 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 microM) DME1223 XEOTICID XEO04302 GENEFORM Protein DME1223 XEOTICID XEO04302 MOACRIVE Inhibition DME1223 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1223 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04303 XEO_CLAS Peptide DME1223 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 microM) DME1223 XEOTICID XEO04303 GENEFORM Protein DME1223 XEOTICID XEO04303 MOACRIVE Inhibition DME1223 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1223 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04304 XEO_CLAS Peptide DME1223 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO04304 GENEFORM Protein DME1223 XEOTICID XEO04304 MOACRIVE Inhibition DME1223 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1223 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04305 XEO_CLAS Peptide DME1223 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 70 microM) DME1223 XEOTICID XEO04305 GENEFORM Protein DME1223 XEOTICID XEO04305 MOACRIVE Inhibition DME1223 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1223 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04306 XEO_CLAS Peptide DME1223 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO04306 GENEFORM Protein DME1223 XEOTICID XEO04306 MOACRIVE Inhibition DME1223 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1223 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04307 XEO_CLAS Peptide DME1223 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 ug/ml) DME1223 XEOTICID XEO04307 GENEFORM Protein DME1223 XEOTICID XEO04307 MOACRIVE Inhibition DME1223 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1223 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04308 XEO_CLAS Peptide DME1223 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 9.37 ug/ml) DME1223 XEOTICID XEO04308 GENEFORM Protein DME1223 XEOTICID XEO04308 MOACRIVE Inhibition DME1223 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1223 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04309 XEO_CLAS Peptide DME1223 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 microM) DME1223 XEOTICID XEO04309 GENEFORM Protein DME1223 XEOTICID XEO04309 MOACRIVE Inhibition DME1223 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1223 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04310 XEO_CLAS Peptide DME1223 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO04310 GENEFORM Protein DME1223 XEOTICID XEO04310 MOACRIVE Inhibition DME1223 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1223 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04311 XEO_CLAS Peptide DME1223 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO04311 GENEFORM Protein DME1223 XEOTICID XEO04311 MOACRIVE Inhibition DME1223 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1223 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04312 XEO_CLAS Peptide DME1223 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4.68 ug/ml) DME1223 XEOTICID XEO04312 GENEFORM Protein DME1223 XEOTICID XEO04312 MOACRIVE Inhibition DME1223 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1223 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04313 XEO_CLAS Peptide DME1223 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4.68 ug/ml) DME1223 XEOTICID XEO04313 GENEFORM Protein DME1223 XEOTICID XEO04313 MOACRIVE Inhibition DME1223 XEOTICID XEO04331 XEO_NAME Norspermidine DME1223 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1223 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04331 GENEFORM Protein DME1223 XEOTICID XEO04331 MOACRIVE Inhibition DME1223 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1223 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04335 XEO_CLAS Peptide DME1223 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 32 ug/ml) DME1223 XEOTICID XEO04335 GENEFORM Protein DME1223 XEOTICID XEO04335 MOACRIVE Inhibition DME1223 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1223 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04336 XEO_CLAS Peptide DME1223 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 32 ug/ml) DME1223 XEOTICID XEO04336 GENEFORM Protein DME1223 XEOTICID XEO04336 MOACRIVE Inhibition DME1223 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1223 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04338 XEO_CLAS Peptide DME1223 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 ug/ml) DME1223 XEOTICID XEO04338 GENEFORM Protein DME1223 XEOTICID XEO04338 MOACRIVE Inhibition DME1223 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1223 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04339 XEO_CLAS Peptide DME1223 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 ug/ml) DME1223 XEOTICID XEO04339 GENEFORM Protein DME1223 XEOTICID XEO04339 MOACRIVE Inhibition DME1223 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1223 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04340 XEO_CLAS Peptide DME1223 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO04340 GENEFORM Protein DME1223 XEOTICID XEO04340 MOACRIVE Inhibition DME1223 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1223 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04344 XEO_CLAS Peptide DME1223 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04344 GENEFORM Protein DME1223 XEOTICID XEO04344 MOACRIVE Inhibition DME1223 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1223 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04345 XEO_CLAS Peptide DME1223 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04345 GENEFORM Protein DME1223 XEOTICID XEO04345 MOACRIVE Inhibition DME1223 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1223 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04346 XEO_CLAS Peptide DME1223 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04346 GENEFORM Protein DME1223 XEOTICID XEO04346 MOACRIVE Inhibition DME1223 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1223 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04347 XEO_CLAS Peptide DME1223 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 microM) DME1223 XEOTICID XEO04347 GENEFORM Protein DME1223 XEOTICID XEO04347 MOACRIVE Inhibition DME1223 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1223 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04348 XEO_CLAS Peptide DME1223 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40 microM) DME1223 XEOTICID XEO04348 GENEFORM Protein DME1223 XEOTICID XEO04348 MOACRIVE Inhibition DME1223 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1223 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04349 XEO_CLAS Peptide DME1223 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO04349 GENEFORM Protein DME1223 XEOTICID XEO04349 MOACRIVE Inhibition DME1223 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1223 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04354 XEO_CLAS Peptide DME1223 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 35.2 ug/ml) DME1223 XEOTICID XEO04354 GENEFORM Protein DME1223 XEOTICID XEO04354 MOACRIVE Inhibition DME1223 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1223 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04355 XEO_CLAS Peptide DME1223 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.21 ug/ml) DME1223 XEOTICID XEO04355 GENEFORM Protein DME1223 XEOTICID XEO04355 MOACRIVE Inhibition DME1223 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1223 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04356 XEO_CLAS Peptide DME1223 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8.21 ug/ml) DME1223 XEOTICID XEO04356 GENEFORM Protein DME1223 XEOTICID XEO04356 MOACRIVE Inhibition DME1223 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1223 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04357 XEO_CLAS Peptide DME1223 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16.32 ug/ml) DME1223 XEOTICID XEO04357 GENEFORM Protein DME1223 XEOTICID XEO04357 MOACRIVE Inhibition DME1223 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1223 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04358 XEO_CLAS Peptide DME1223 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 9.37 ug/ml) DME1223 XEOTICID XEO04358 GENEFORM Protein DME1223 XEOTICID XEO04358 MOACRIVE Inhibition DME1223 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1223 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04359 XEO_CLAS Peptide DME1223 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4.20 ug/ml) DME1223 XEOTICID XEO04359 GENEFORM Protein DME1223 XEOTICID XEO04359 MOACRIVE Inhibition DME1223 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1223 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04360 XEO_CLAS Peptide DME1223 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 ug/ml) DME1223 XEOTICID XEO04360 GENEFORM Protein DME1223 XEOTICID XEO04360 MOACRIVE Inhibition DME1223 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1223 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04361 XEO_CLAS Peptide DME1223 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 7.5 ug/ml) DME1223 XEOTICID XEO04361 GENEFORM Protein DME1223 XEOTICID XEO04361 MOACRIVE Inhibition DME1223 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1223 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04362 XEO_CLAS Peptide DME1223 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.6 ug/ml) DME1223 XEOTICID XEO04362 GENEFORM Protein DME1223 XEOTICID XEO04362 MOACRIVE Inhibition DME1223 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1223 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04363 XEO_CLAS Peptide DME1223 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8.2 ug/ml) DME1223 XEOTICID XEO04363 GENEFORM Protein DME1223 XEOTICID XEO04363 MOACRIVE Inhibition DME1223 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1223 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04364 XEO_CLAS Peptide DME1223 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO04364 GENEFORM Protein DME1223 XEOTICID XEO04364 MOACRIVE Inhibition DME1223 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1223 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04365 XEO_CLAS Peptide DME1223 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4.68 ug/ml) DME1223 XEOTICID XEO04365 GENEFORM Protein DME1223 XEOTICID XEO04365 MOACRIVE Inhibition DME1223 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1223 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04366 XEO_CLAS Peptide DME1223 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 23.60 ug/ml) DME1223 XEOTICID XEO04366 GENEFORM Protein DME1223 XEOTICID XEO04366 MOACRIVE Inhibition DME1223 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1223 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04367 XEO_CLAS Peptide DME1223 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 35.60 ug/ml) DME1223 XEOTICID XEO04367 GENEFORM Protein DME1223 XEOTICID XEO04367 MOACRIVE Inhibition DME1223 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1223 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04368 XEO_CLAS Peptide DME1223 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40.2 ug/ml) DME1223 XEOTICID XEO04368 GENEFORM Protein DME1223 XEOTICID XEO04368 MOACRIVE Inhibition DME1223 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1223 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04369 XEO_CLAS Peptide DME1223 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40.2 ug/ml) DME1223 XEOTICID XEO04369 GENEFORM Protein DME1223 XEOTICID XEO04369 MOACRIVE Inhibition DME1223 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1223 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04370 XEO_CLAS Peptide DME1223 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4.68 ug/ml) DME1223 XEOTICID XEO04370 GENEFORM Protein DME1223 XEOTICID XEO04370 MOACRIVE Inhibition DME1223 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1223 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04371 XEO_CLAS Peptide DME1223 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 9.37 ug/ml) DME1223 XEOTICID XEO04371 GENEFORM Protein DME1223 XEOTICID XEO04371 MOACRIVE Inhibition DME1223 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1223 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04373 XEO_CLAS Peptide DME1223 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 ug/ml) DME1223 XEOTICID XEO04373 GENEFORM Protein DME1223 XEOTICID XEO04373 MOACRIVE Inhibition DME1223 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1223 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04374 XEO_CLAS Peptide DME1223 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.50 ug/ml) DME1223 XEOTICID XEO04374 GENEFORM Protein DME1223 XEOTICID XEO04374 MOACRIVE Inhibition DME1223 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1223 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04375 XEO_CLAS Peptide DME1223 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25 ug/ml) DME1223 XEOTICID XEO04375 GENEFORM Protein DME1223 XEOTICID XEO04375 MOACRIVE Inhibition DME1223 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1223 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04377 XEO_CLAS Peptide DME1223 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 42.50 ug/ml) DME1223 XEOTICID XEO04377 GENEFORM Protein DME1223 XEOTICID XEO04377 MOACRIVE Inhibition DME1223 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1223 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04378 XEO_CLAS Peptide DME1223 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 17.50 ug/ml) DME1223 XEOTICID XEO04378 GENEFORM Protein DME1223 XEOTICID XEO04378 MOACRIVE Inhibition DME1223 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1223 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04379 XEO_CLAS Peptide DME1223 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 ug/ml) DME1223 XEOTICID XEO04379 GENEFORM Protein DME1223 XEOTICID XEO04379 MOACRIVE Inhibition DME1223 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1223 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04380 XEO_CLAS Peptide DME1223 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 36.00 ug/ml) DME1223 XEOTICID XEO04380 GENEFORM Protein DME1223 XEOTICID XEO04380 MOACRIVE Inhibition DME1223 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1223 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04381 XEO_CLAS Peptide DME1223 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.60 ug/ml) DME1223 XEOTICID XEO04381 GENEFORM Protein DME1223 XEOTICID XEO04381 MOACRIVE Inhibition DME1223 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1223 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04382 XEO_CLAS Peptide DME1223 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 ug/ml) DME1223 XEOTICID XEO04382 GENEFORM Protein DME1223 XEOTICID XEO04382 MOACRIVE Inhibition DME1223 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1223 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04383 XEO_CLAS Peptide DME1223 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO04383 GENEFORM Protein DME1223 XEOTICID XEO04383 MOACRIVE Inhibition DME1223 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1223 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04384 XEO_CLAS Peptide DME1223 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO04384 GENEFORM Protein DME1223 XEOTICID XEO04384 MOACRIVE Inhibition DME1223 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1223 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04385 XEO_CLAS Peptide DME1223 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.25 ug/ml) DME1223 XEOTICID XEO04385 GENEFORM Protein DME1223 XEOTICID XEO04385 MOACRIVE Inhibition DME1223 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1223 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04395 XEO_CLAS Peptide DME1223 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.4-0.8 microM) DME1223 XEOTICID XEO04395 GENEFORM Protein DME1223 XEOTICID XEO04395 MOACRIVE Inhibition DME1223 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1223 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04396 XEO_CLAS Peptide DME1223 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.25-0.5 microM) DME1223 XEOTICID XEO04396 GENEFORM Protein DME1223 XEOTICID XEO04396 MOACRIVE Inhibition DME1223 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1223 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04397 XEO_CLAS Peptide DME1223 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.25-0.5 microM) DME1223 XEOTICID XEO04397 GENEFORM Protein DME1223 XEOTICID XEO04397 MOACRIVE Inhibition DME1223 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1223 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04398 XEO_CLAS Peptide DME1223 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 microM) DME1223 XEOTICID XEO04398 GENEFORM Protein DME1223 XEOTICID XEO04398 MOACRIVE Inhibition DME1223 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1223 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04399 XEO_CLAS Peptide DME1223 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO04399 GENEFORM Protein DME1223 XEOTICID XEO04399 MOACRIVE Inhibition DME1223 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1223 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04400 XEO_CLAS Peptide DME1223 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 ug/ml) DME1223 XEOTICID XEO04400 GENEFORM Protein DME1223 XEOTICID XEO04400 MOACRIVE Inhibition DME1223 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1223 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04401 XEO_CLAS Peptide DME1223 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.6 ug/ml) DME1223 XEOTICID XEO04401 GENEFORM Protein DME1223 XEOTICID XEO04401 MOACRIVE Inhibition DME1223 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1223 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04402 XEO_CLAS Peptide DME1223 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 ug/ml) DME1223 XEOTICID XEO04402 GENEFORM Protein DME1223 XEOTICID XEO04402 MOACRIVE Inhibition DME1223 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1223 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04403 XEO_CLAS Peptide DME1223 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.6 ug/ml) DME1223 XEOTICID XEO04403 GENEFORM Protein DME1223 XEOTICID XEO04403 MOACRIVE Inhibition DME1223 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1223 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04404 XEO_CLAS Peptide DME1223 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.6 ug/ml) DME1223 XEOTICID XEO04404 GENEFORM Protein DME1223 XEOTICID XEO04404 MOACRIVE Inhibition DME1223 XEOTICID XEO04410 XEO_NAME Insect osmin DME1223 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04410 XEO_CLAS Peptide DME1223 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.125-1.56 microM) DME1223 XEOTICID XEO04410 GENEFORM Protein DME1223 XEOTICID XEO04410 MOACRIVE Inhibition DME1223 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1223 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04412 XEO_CLAS Peptide DME1223 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04412 GENEFORM Protein DME1223 XEOTICID XEO04412 MOACRIVE Inhibition DME1223 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1223 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04414 XEO_CLAS Peptide DME1223 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04414 GENEFORM Protein DME1223 XEOTICID XEO04414 MOACRIVE Inhibition DME1223 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1223 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04415 XEO_CLAS Peptide DME1223 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04415 GENEFORM Protein DME1223 XEOTICID XEO04415 MOACRIVE Inhibition DME1223 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1223 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04421 XEO_CLAS Peptide DME1223 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 microM) DME1223 XEOTICID XEO04421 GENEFORM Protein DME1223 XEOTICID XEO04421 MOACRIVE Inhibition DME1223 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1223 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04426 XEO_CLAS Peptide DME1223 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO04426 GENEFORM Protein DME1223 XEOTICID XEO04426 MOACRIVE Inhibition DME1223 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1223 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04428 XEO_CLAS Peptide DME1223 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.3 ug/ml) DME1223 XEOTICID XEO04428 GENEFORM Protein DME1223 XEOTICID XEO04428 MOACRIVE Inhibition DME1223 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1223 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04430 XEO_CLAS Peptide DME1223 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25 microM) DME1223 XEOTICID XEO04430 GENEFORM Protein DME1223 XEOTICID XEO04430 MOACRIVE Inhibition DME1223 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1223 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04433 XEO_CLAS Peptide DME1223 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 160 microM) DME1223 XEOTICID XEO04433 GENEFORM Protein DME1223 XEOTICID XEO04433 MOACRIVE Inhibition DME1223 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1223 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04435 XEO_CLAS Peptide DME1223 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 160 microM) DME1223 XEOTICID XEO04435 GENEFORM Protein DME1223 XEOTICID XEO04435 MOACRIVE Inhibition DME1223 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1223 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1223 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04438 GENEFORM Protein DME1223 XEOTICID XEO04438 MOACRIVE Inhibition DME1223 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1223 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04439 XEO_CLAS Peptide DME1223 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04439 GENEFORM Protein DME1223 XEOTICID XEO04439 MOACRIVE Inhibition DME1223 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1223 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04440 XEO_CLAS Peptide DME1223 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 microM) DME1223 XEOTICID XEO04440 GENEFORM Protein DME1223 XEOTICID XEO04440 MOACRIVE Inhibition DME1223 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1223 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04441 XEO_CLAS Peptide DME1223 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 28 microM) DME1223 XEOTICID XEO04441 GENEFORM Protein DME1223 XEOTICID XEO04441 MOACRIVE Inhibition DME1223 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1223 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04442 XEO_CLAS Peptide DME1223 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 28 microM) DME1223 XEOTICID XEO04442 GENEFORM Protein DME1223 XEOTICID XEO04442 MOACRIVE Inhibition DME1223 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1223 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04443 XEO_CLAS Peptide DME1223 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04443 GENEFORM Protein DME1223 XEOTICID XEO04443 MOACRIVE Inhibition DME1223 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1223 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04444 XEO_CLAS Peptide DME1223 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 13 microM) DME1223 XEOTICID XEO04444 GENEFORM Protein DME1223 XEOTICID XEO04444 MOACRIVE Inhibition DME1223 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1223 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04445 XEO_CLAS Peptide DME1223 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04445 GENEFORM Protein DME1223 XEOTICID XEO04445 MOACRIVE Inhibition DME1223 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1223 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04446 XEO_CLAS Peptide DME1223 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 78 microM) DME1223 XEOTICID XEO04446 GENEFORM Protein DME1223 XEOTICID XEO04446 MOACRIVE Inhibition DME1223 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1223 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04447 XEO_CLAS Peptide DME1223 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 120 microM) DME1223 XEOTICID XEO04447 GENEFORM Protein DME1223 XEOTICID XEO04447 MOACRIVE Inhibition DME1223 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1223 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04448 XEO_CLAS Peptide DME1223 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 microM) DME1223 XEOTICID XEO04448 GENEFORM Protein DME1223 XEOTICID XEO04448 MOACRIVE Inhibition DME1223 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1223 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04449 XEO_CLAS Peptide DME1223 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.3 microM) DME1223 XEOTICID XEO04449 GENEFORM Protein DME1223 XEOTICID XEO04449 MOACRIVE Inhibition DME1223 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1223 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04450 XEO_CLAS Peptide DME1223 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.3 microM) DME1223 XEOTICID XEO04450 GENEFORM Protein DME1223 XEOTICID XEO04450 MOACRIVE Inhibition DME1223 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1223 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04451 XEO_CLAS Peptide DME1223 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO04451 GENEFORM Protein DME1223 XEOTICID XEO04451 MOACRIVE Inhibition DME1223 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1223 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04452 XEO_CLAS Peptide DME1223 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.1 microM) DME1223 XEOTICID XEO04452 GENEFORM Protein DME1223 XEOTICID XEO04452 MOACRIVE Inhibition DME1223 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1223 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04453 XEO_CLAS Peptide DME1223 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO04453 GENEFORM Protein DME1223 XEOTICID XEO04453 MOACRIVE Inhibition DME1223 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1223 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04455 XEO_CLAS Peptide DME1223 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 microM) DME1223 XEOTICID XEO04455 GENEFORM Protein DME1223 XEOTICID XEO04455 MOACRIVE Inhibition DME1223 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1223 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04457 XEO_CLAS Peptide DME1223 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.3 microM) DME1223 XEOTICID XEO04457 GENEFORM Protein DME1223 XEOTICID XEO04457 MOACRIVE Inhibition DME1223 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1223 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04458 XEO_CLAS Peptide DME1223 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1 microM) DME1223 XEOTICID XEO04458 GENEFORM Protein DME1223 XEOTICID XEO04458 MOACRIVE Inhibition DME1223 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1223 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04459 XEO_CLAS Peptide DME1223 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1 microM) DME1223 XEOTICID XEO04459 GENEFORM Protein DME1223 XEOTICID XEO04459 MOACRIVE Inhibition DME1223 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1223 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04461 XEO_CLAS Peptide DME1223 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20.8 microM) DME1223 XEOTICID XEO04461 GENEFORM Protein DME1223 XEOTICID XEO04461 MOACRIVE Inhibition DME1223 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1223 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04462 XEO_CLAS Peptide DME1223 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 19.1 microM) DME1223 XEOTICID XEO04462 GENEFORM Protein DME1223 XEOTICID XEO04462 MOACRIVE Inhibition DME1223 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1223 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04463 XEO_CLAS Peptide DME1223 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04463 GENEFORM Protein DME1223 XEOTICID XEO04463 MOACRIVE Inhibition DME1223 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1223 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04464 XEO_CLAS Peptide DME1223 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.5 microM) DME1223 XEOTICID XEO04464 GENEFORM Protein DME1223 XEOTICID XEO04464 MOACRIVE Inhibition DME1223 XEOTICID XEO04466 XEO_NAME Panusin DME1223 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04466 XEO_CLAS Peptide DME1223 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04466 GENEFORM Protein DME1223 XEOTICID XEO04466 MOACRIVE Inhibition DME1223 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1223 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04467 XEO_CLAS Peptide DME1223 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4.8 microM) DME1223 XEOTICID XEO04467 GENEFORM Protein DME1223 XEOTICID XEO04467 MOACRIVE Inhibition DME1223 XEOTICID XEO04468 XEO_NAME Papillosin DME1223 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04468 XEO_CLAS Peptide DME1223 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04468 GENEFORM Protein DME1223 XEOTICID XEO04468 MOACRIVE Inhibition DME1223 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1223 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04471 XEO_CLAS Peptide DME1223 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.1 microM) DME1223 XEOTICID XEO04471 GENEFORM Protein DME1223 XEOTICID XEO04471 MOACRIVE Inhibition DME1223 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1223 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04480 XEO_CLAS Peptide DME1223 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 ug/ml) DME1223 XEOTICID XEO04480 GENEFORM Protein DME1223 XEOTICID XEO04480 MOACRIVE Inhibition DME1223 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1223 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1223 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04482 GENEFORM Protein DME1223 XEOTICID XEO04482 MOACRIVE Inhibition DME1223 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1223 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04484 XEO_CLAS Peptide DME1223 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 microM) DME1223 XEOTICID XEO04484 GENEFORM Protein DME1223 XEOTICID XEO04484 MOACRIVE Inhibition DME1223 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1223 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04485 XEO_CLAS Peptide DME1223 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO04485 GENEFORM Protein DME1223 XEOTICID XEO04485 MOACRIVE Inhibition DME1223 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1223 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04486 XEO_CLAS Peptide DME1223 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 microM) DME1223 XEOTICID XEO04486 GENEFORM Protein DME1223 XEOTICID XEO04486 MOACRIVE Inhibition DME1223 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1223 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04487 XEO_CLAS Peptide DME1223 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO04487 GENEFORM Protein DME1223 XEOTICID XEO04487 MOACRIVE Inhibition DME1223 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1223 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04488 XEO_CLAS Peptide DME1223 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 9 microM) DME1223 XEOTICID XEO04488 GENEFORM Protein DME1223 XEOTICID XEO04488 MOACRIVE Inhibition DME1223 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1223 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04489 XEO_CLAS Peptide DME1223 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 13 microM) DME1223 XEOTICID XEO04489 GENEFORM Protein DME1223 XEOTICID XEO04489 MOACRIVE Inhibition DME1223 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1223 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04490 XEO_CLAS Peptide DME1223 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 47.5 microM) DME1223 XEOTICID XEO04490 GENEFORM Protein DME1223 XEOTICID XEO04490 MOACRIVE Inhibition DME1223 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1223 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04491 XEO_CLAS Peptide DME1223 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO04491 GENEFORM Protein DME1223 XEOTICID XEO04491 MOACRIVE Inhibition DME1223 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1223 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04492 XEO_CLAS Peptide DME1223 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 35 microM) DME1223 XEOTICID XEO04492 GENEFORM Protein DME1223 XEOTICID XEO04492 MOACRIVE Inhibition DME1223 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1223 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04493 XEO_CLAS Peptide DME1223 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 microM) DME1223 XEOTICID XEO04493 GENEFORM Protein DME1223 XEOTICID XEO04493 MOACRIVE Inhibition DME1223 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1223 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04494 XEO_CLAS Peptide DME1223 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO04494 GENEFORM Protein DME1223 XEOTICID XEO04494 MOACRIVE Inhibition DME1223 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1223 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04495 XEO_CLAS Peptide DME1223 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO04495 GENEFORM Protein DME1223 XEOTICID XEO04495 MOACRIVE Inhibition DME1223 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1223 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04496 XEO_CLAS Peptide DME1223 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 67.5 microM) DME1223 XEOTICID XEO04496 GENEFORM Protein DME1223 XEOTICID XEO04496 MOACRIVE Inhibition DME1223 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1223 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04497 XEO_CLAS Peptide DME1223 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO04497 GENEFORM Protein DME1223 XEOTICID XEO04497 MOACRIVE Inhibition DME1223 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1223 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04498 XEO_CLAS Peptide DME1223 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO04498 GENEFORM Protein DME1223 XEOTICID XEO04498 MOACRIVE Inhibition DME1223 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1223 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04499 XEO_CLAS Peptide DME1223 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 43 microM) DME1223 XEOTICID XEO04499 GENEFORM Protein DME1223 XEOTICID XEO04499 MOACRIVE Inhibition DME1223 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1223 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04500 XEO_CLAS Peptide DME1223 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO04500 GENEFORM Protein DME1223 XEOTICID XEO04500 MOACRIVE Inhibition DME1223 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1223 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04504 XEO_CLAS Peptide DME1223 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04504 GENEFORM Protein DME1223 XEOTICID XEO04504 MOACRIVE Inhibition DME1223 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1223 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04505 XEO_CLAS Peptide DME1223 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04505 GENEFORM Protein DME1223 XEOTICID XEO04505 MOACRIVE Inhibition DME1223 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1223 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04506 XEO_CLAS Peptide DME1223 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 40 microM) DME1223 XEOTICID XEO04506 GENEFORM Protein DME1223 XEOTICID XEO04506 MOACRIVE Inhibition DME1223 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1223 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04507 XEO_CLAS Peptide DME1223 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10-20 microM) DME1223 XEOTICID XEO04507 GENEFORM Protein DME1223 XEOTICID XEO04507 MOACRIVE Inhibition DME1223 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1223 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04508 XEO_CLAS Peptide DME1223 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04508 GENEFORM Protein DME1223 XEOTICID XEO04508 MOACRIVE Inhibition DME1223 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1223 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04509 XEO_CLAS Peptide DME1223 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04509 GENEFORM Protein DME1223 XEOTICID XEO04509 MOACRIVE Inhibition DME1223 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1223 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04510 XEO_CLAS Peptide DME1223 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 22-33 microM) DME1223 XEOTICID XEO04510 GENEFORM Protein DME1223 XEOTICID XEO04510 MOACRIVE Inhibition DME1223 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1223 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04525 XEO_CLAS Peptide DME1223 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 32.0 microM) DME1223 XEOTICID XEO04525 GENEFORM Protein DME1223 XEOTICID XEO04525 MOACRIVE Inhibition DME1223 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1223 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04526 XEO_CLAS Peptide DME1223 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.0 microM) DME1223 XEOTICID XEO04526 GENEFORM Protein DME1223 XEOTICID XEO04526 MOACRIVE Inhibition DME1223 XEOTICID XEO04527 XEO_NAME Pepcon DME1223 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04527 XEO_CLAS Peptide DME1223 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO04527 GENEFORM Protein DME1223 XEOTICID XEO04527 MOACRIVE Inhibition DME1223 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1223 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04532 XEO_CLAS Peptide DME1223 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04532 GENEFORM Protein DME1223 XEOTICID XEO04532 MOACRIVE Inhibition DME1223 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1223 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04540 XEO_CLAS Peptide DME1223 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 18.1 ug/ml) DME1223 XEOTICID XEO04540 GENEFORM Protein DME1223 XEOTICID XEO04540 MOACRIVE Inhibition DME1223 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1223 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04541 XEO_CLAS Peptide DME1223 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.5 ug/ml) DME1223 XEOTICID XEO04541 GENEFORM Protein DME1223 XEOTICID XEO04541 MOACRIVE Inhibition DME1223 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1223 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04542 XEO_CLAS Peptide DME1223 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04542 GENEFORM Protein DME1223 XEOTICID XEO04542 MOACRIVE Inhibition DME1223 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1223 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04543 XEO_CLAS Peptide DME1223 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04543 GENEFORM Protein DME1223 XEOTICID XEO04543 MOACRIVE Inhibition DME1223 XEOTICID XEO04546 XEO_NAME Perinerin DME1223 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04546 XEO_CLAS Peptide DME1223 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04546 GENEFORM Protein DME1223 XEOTICID XEO04546 MOACRIVE Inhibition DME1223 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1223 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04548 XEO_CLAS Peptide DME1223 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 72000 ug/ml) DME1223 XEOTICID XEO04548 GENEFORM Protein DME1223 XEOTICID XEO04548 MOACRIVE Inhibition DME1223 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1223 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04549 XEO_CLAS Peptide DME1223 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 62-125 ug/ml) DME1223 XEOTICID XEO04549 GENEFORM Protein DME1223 XEOTICID XEO04549 MOACRIVE Inhibition DME1223 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1223 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04550 XEO_CLAS Peptide DME1223 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO04550 GENEFORM Protein DME1223 XEOTICID XEO04550 MOACRIVE Inhibition DME1223 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1223 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04551 XEO_CLAS Peptide DME1223 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 23.6 ug/ml) DME1223 XEOTICID XEO04551 GENEFORM Protein DME1223 XEOTICID XEO04551 MOACRIVE Inhibition DME1223 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1223 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04552 XEO_CLAS Peptide DME1223 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04552 GENEFORM Protein DME1223 XEOTICID XEO04552 MOACRIVE Inhibition DME1223 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1223 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04553 XEO_CLAS Peptide DME1223 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04553 GENEFORM Protein DME1223 XEOTICID XEO04553 MOACRIVE Inhibition DME1223 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1223 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04554 XEO_CLAS Peptide DME1223 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04554 GENEFORM Protein DME1223 XEOTICID XEO04554 MOACRIVE Inhibition DME1223 XEOTICID XEO04563 XEO_NAME Phosphate DME1223 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1223 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04563 GENEFORM Protein DME1223 XEOTICID XEO04563 MOACRIVE Inhibition DME1223 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1223 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04565 XEO_CLAS Peptide DME1223 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.5 microM) DME1223 XEOTICID XEO04565 GENEFORM Protein DME1223 XEOTICID XEO04565 MOACRIVE Inhibition DME1223 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1223 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04566 XEO_CLAS Peptide DME1223 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.7 microM) DME1223 XEOTICID XEO04566 GENEFORM Protein DME1223 XEOTICID XEO04566 MOACRIVE Inhibition DME1223 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1223 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04569 XEO_CLAS Peptide DME1223 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 7.9 microM) DME1223 XEOTICID XEO04569 GENEFORM Protein DME1223 XEOTICID XEO04569 MOACRIVE Inhibition DME1223 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1223 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04570 XEO_CLAS Peptide DME1223 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04570 GENEFORM Protein DME1223 XEOTICID XEO04570 MOACRIVE Inhibition DME1223 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1223 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04571 XEO_CLAS Peptide DME1223 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04571 GENEFORM Protein DME1223 XEOTICID XEO04571 MOACRIVE Inhibition DME1223 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1223 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04572 XEO_CLAS Peptide DME1223 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04572 GENEFORM Protein DME1223 XEOTICID XEO04572 MOACRIVE Inhibition DME1223 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1223 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04573 XEO_CLAS Peptide DME1223 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 microM) DME1223 XEOTICID XEO04573 GENEFORM Protein DME1223 XEOTICID XEO04573 MOACRIVE Inhibition DME1223 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1223 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04574 XEO_CLAS Peptide DME1223 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 128 ug/ml) DME1223 XEOTICID XEO04574 GENEFORM Protein DME1223 XEOTICID XEO04574 MOACRIVE Inhibition DME1223 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1223 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04575 XEO_CLAS Peptide DME1223 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO04575 GENEFORM Protein DME1223 XEOTICID XEO04575 MOACRIVE Inhibition DME1223 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1223 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04578 GENEFORM Protein DME1223 XEOTICID XEO04578 MOACRIVE Inhibition DME1223 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1223 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04579 GENEFORM Protein DME1223 XEOTICID XEO04579 MOACRIVE Inhibition DME1223 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1223 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04580 GENEFORM Protein DME1223 XEOTICID XEO04580 MOACRIVE Inhibition DME1223 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1223 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04583 GENEFORM Protein DME1223 XEOTICID XEO04583 MOACRIVE Inhibition DME1223 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1223 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04588 GENEFORM Protein DME1223 XEOTICID XEO04588 MOACRIVE Inhibition DME1223 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1223 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04589 GENEFORM Protein DME1223 XEOTICID XEO04589 MOACRIVE Inhibition DME1223 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1223 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04590 GENEFORM Protein DME1223 XEOTICID XEO04590 MOACRIVE Inhibition DME1223 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1223 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04591 GENEFORM Protein DME1223 XEOTICID XEO04591 MOACRIVE Inhibition DME1223 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1223 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04592 GENEFORM Protein DME1223 XEOTICID XEO04592 MOACRIVE Inhibition DME1223 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1223 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04593 GENEFORM Protein DME1223 XEOTICID XEO04593 MOACRIVE Inhibition DME1223 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1223 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04594 GENEFORM Protein DME1223 XEOTICID XEO04594 MOACRIVE Inhibition DME1223 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1223 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04595 GENEFORM Protein DME1223 XEOTICID XEO04595 MOACRIVE Inhibition DME1223 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1223 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04596 GENEFORM Protein DME1223 XEOTICID XEO04596 MOACRIVE Inhibition DME1223 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1223 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04597 GENEFORM Protein DME1223 XEOTICID XEO04597 MOACRIVE Inhibition DME1223 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1223 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04598 GENEFORM Protein DME1223 XEOTICID XEO04598 MOACRIVE Inhibition DME1223 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1223 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04599 GENEFORM Protein DME1223 XEOTICID XEO04599 MOACRIVE Inhibition DME1223 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1223 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04601 XEO_CLAS Peptide DME1223 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 18.75 ug/ml) DME1223 XEOTICID XEO04601 GENEFORM Protein DME1223 XEOTICID XEO04601 MOACRIVE Inhibition DME1223 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1223 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04602 XEO_CLAS Peptide DME1223 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 37.5 ug/ml) DME1223 XEOTICID XEO04602 GENEFORM Protein DME1223 XEOTICID XEO04602 MOACRIVE Inhibition DME1223 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1223 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04604 XEO_CLAS Peptide DME1223 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC < 25 microM) DME1223 XEOTICID XEO04604 GENEFORM Protein DME1223 XEOTICID XEO04604 MOACRIVE Inhibition DME1223 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1223 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04605 XEO_CLAS Peptide DME1223 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC < 6.25 microM) DME1223 XEOTICID XEO04605 GENEFORM Protein DME1223 XEOTICID XEO04605 MOACRIVE Inhibition DME1223 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1223 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04606 XEO_CLAS Peptide DME1223 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO04606 GENEFORM Protein DME1223 XEOTICID XEO04606 MOACRIVE Inhibition DME1223 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1223 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1223 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04607 GENEFORM Protein DME1223 XEOTICID XEO04607 MOACRIVE Inhibition DME1223 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1223 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04612 XEO_CLAS Peptide DME1223 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5-10 microM) DME1223 XEOTICID XEO04612 GENEFORM Protein DME1223 XEOTICID XEO04612 MOACRIVE Inhibition DME1223 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1223 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04613 XEO_CLAS Peptide DME1223 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5-10 microM) DME1223 XEOTICID XEO04613 GENEFORM Protein DME1223 XEOTICID XEO04613 MOACRIVE Inhibition DME1223 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1223 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04625 XEO_CLAS Peptide DME1223 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO04625 GENEFORM Protein DME1223 XEOTICID XEO04625 MOACRIVE Inhibition DME1223 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1223 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04626 XEO_CLAS Peptide DME1223 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO04626 GENEFORM Protein DME1223 XEOTICID XEO04626 MOACRIVE Inhibition DME1223 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1223 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04627 XEO_CLAS Peptide DME1223 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.5 microM) DME1223 XEOTICID XEO04627 GENEFORM Protein DME1223 XEOTICID XEO04627 MOACRIVE Inhibition DME1223 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1223 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04630 XEO_CLAS Peptide DME1223 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 60 ug/ml) DME1223 XEOTICID XEO04630 GENEFORM Protein DME1223 XEOTICID XEO04630 MOACRIVE Inhibition DME1223 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1223 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04631 XEO_CLAS Peptide DME1223 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 60 ug/ml) DME1223 XEOTICID XEO04631 GENEFORM Protein DME1223 XEOTICID XEO04631 MOACRIVE Inhibition DME1223 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1223 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04633 XEO_CLAS Peptide DME1223 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 ug/ml) DME1223 XEOTICID XEO04633 GENEFORM Protein DME1223 XEOTICID XEO04633 MOACRIVE Inhibition DME1223 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1223 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04634 XEO_CLAS Peptide DME1223 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 ug/ml) DME1223 XEOTICID XEO04634 GENEFORM Protein DME1223 XEOTICID XEO04634 MOACRIVE Inhibition DME1223 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1223 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04635 XEO_CLAS Peptide DME1223 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 ug/ml) DME1223 XEOTICID XEO04635 GENEFORM Protein DME1223 XEOTICID XEO04635 MOACRIVE Inhibition DME1223 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1223 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04636 XEO_CLAS Peptide DME1223 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 ug/ml) DME1223 XEOTICID XEO04636 GENEFORM Protein DME1223 XEOTICID XEO04636 MOACRIVE Inhibition DME1223 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1223 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04637 XEO_CLAS Peptide DME1223 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 ug/ml) DME1223 XEOTICID XEO04637 GENEFORM Protein DME1223 XEOTICID XEO04637 MOACRIVE Inhibition DME1223 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1223 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04638 XEO_CLAS Peptide DME1223 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 ug/ml) DME1223 XEOTICID XEO04638 GENEFORM Protein DME1223 XEOTICID XEO04638 MOACRIVE Inhibition DME1223 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1223 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04639 XEO_CLAS Peptide DME1223 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 ug/ml) DME1223 XEOTICID XEO04639 GENEFORM Protein DME1223 XEOTICID XEO04639 MOACRIVE Inhibition DME1223 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1223 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04640 XEO_CLAS Peptide DME1223 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.2-3.3 microM) DME1223 XEOTICID XEO04640 GENEFORM Protein DME1223 XEOTICID XEO04640 MOACRIVE Inhibition DME1223 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1223 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04642 XEO_CLAS Peptide DME1223 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 ug/ml) DME1223 XEOTICID XEO04642 GENEFORM Protein DME1223 XEOTICID XEO04642 MOACRIVE Inhibition DME1223 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1223 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04643 XEO_CLAS Peptide DME1223 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO04643 GENEFORM Protein DME1223 XEOTICID XEO04643 MOACRIVE Inhibition DME1223 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1223 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04644 XEO_CLAS Peptide DME1223 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO04644 GENEFORM Protein DME1223 XEOTICID XEO04644 MOACRIVE Inhibition DME1223 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1223 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04645 XEO_CLAS Peptide DME1223 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 ug/ml) DME1223 XEOTICID XEO04645 GENEFORM Protein DME1223 XEOTICID XEO04645 MOACRIVE Inhibition DME1223 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1223 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04646 XEO_CLAS Peptide DME1223 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1 ug/ml) DME1223 XEOTICID XEO04646 GENEFORM Protein DME1223 XEOTICID XEO04646 MOACRIVE Inhibition DME1223 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1223 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04647 XEO_CLAS Peptide DME1223 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO04647 GENEFORM Protein DME1223 XEOTICID XEO04647 MOACRIVE Inhibition DME1223 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1223 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04648 XEO_CLAS Peptide DME1223 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 ug/ml) DME1223 XEOTICID XEO04648 GENEFORM Protein DME1223 XEOTICID XEO04648 MOACRIVE Inhibition DME1223 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1223 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04649 XEO_CLAS Peptide DME1223 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 64 ug/ml) DME1223 XEOTICID XEO04649 GENEFORM Protein DME1223 XEOTICID XEO04649 MOACRIVE Inhibition DME1223 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1223 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04650 XEO_CLAS Peptide DME1223 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 ug/ml) DME1223 XEOTICID XEO04650 GENEFORM Protein DME1223 XEOTICID XEO04650 MOACRIVE Inhibition DME1223 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1223 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04651 XEO_CLAS Peptide DME1223 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 ug/ml) DME1223 XEOTICID XEO04651 GENEFORM Protein DME1223 XEOTICID XEO04651 MOACRIVE Inhibition DME1223 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1223 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04652 XEO_CLAS Peptide DME1223 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO04652 GENEFORM Protein DME1223 XEOTICID XEO04652 MOACRIVE Inhibition DME1223 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1223 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04653 XEO_CLAS Peptide DME1223 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 64 ug/ml) DME1223 XEOTICID XEO04653 GENEFORM Protein DME1223 XEOTICID XEO04653 MOACRIVE Inhibition DME1223 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1223 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04654 XEO_CLAS Peptide DME1223 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 ug/ml) DME1223 XEOTICID XEO04654 GENEFORM Protein DME1223 XEOTICID XEO04654 MOACRIVE Inhibition DME1223 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1223 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04655 XEO_CLAS Peptide DME1223 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO04655 GENEFORM Protein DME1223 XEOTICID XEO04655 MOACRIVE Inhibition DME1223 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1223 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04657 XEO_CLAS Peptide DME1223 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 300 microM) DME1223 XEOTICID XEO04657 GENEFORM Protein DME1223 XEOTICID XEO04657 MOACRIVE Inhibition DME1223 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1223 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04660 XEO_CLAS Peptide DME1223 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO04660 GENEFORM Protein DME1223 XEOTICID XEO04660 MOACRIVE Inhibition DME1223 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1223 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04661 XEO_CLAS Peptide DME1223 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 microM) DME1223 XEOTICID XEO04661 GENEFORM Protein DME1223 XEOTICID XEO04661 MOACRIVE Inhibition DME1223 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1223 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04662 XEO_CLAS Peptide DME1223 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 microM) DME1223 XEOTICID XEO04662 GENEFORM Protein DME1223 XEOTICID XEO04662 MOACRIVE Inhibition DME1223 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1223 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04663 XEO_CLAS Peptide DME1223 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 microM) DME1223 XEOTICID XEO04663 GENEFORM Protein DME1223 XEOTICID XEO04663 MOACRIVE Inhibition DME1223 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1223 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04664 XEO_CLAS Peptide DME1223 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5.5 microM) DME1223 XEOTICID XEO04664 GENEFORM Protein DME1223 XEOTICID XEO04664 MOACRIVE Inhibition DME1223 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1223 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04665 XEO_CLAS Peptide DME1223 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 microM) DME1223 XEOTICID XEO04665 GENEFORM Protein DME1223 XEOTICID XEO04665 MOACRIVE Inhibition DME1223 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1223 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04666 XEO_CLAS Peptide DME1223 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO04666 GENEFORM Protein DME1223 XEOTICID XEO04666 MOACRIVE Inhibition DME1223 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1223 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04667 XEO_CLAS Peptide DME1223 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6.25 microM) DME1223 XEOTICID XEO04667 GENEFORM Protein DME1223 XEOTICID XEO04667 MOACRIVE Inhibition DME1223 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1223 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04668 XEO_CLAS Peptide DME1223 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 microM) DME1223 XEOTICID XEO04668 GENEFORM Protein DME1223 XEOTICID XEO04668 MOACRIVE Inhibition DME1223 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1223 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04669 XEO_CLAS Peptide DME1223 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO04669 GENEFORM Protein DME1223 XEOTICID XEO04669 MOACRIVE Inhibition DME1223 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1223 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04670 XEO_CLAS Peptide DME1223 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 21 microM) DME1223 XEOTICID XEO04670 GENEFORM Protein DME1223 XEOTICID XEO04670 MOACRIVE Inhibition DME1223 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1223 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04671 XEO_CLAS Peptide DME1223 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 62 microM) DME1223 XEOTICID XEO04671 GENEFORM Protein DME1223 XEOTICID XEO04671 MOACRIVE Inhibition DME1223 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1223 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04672 XEO_CLAS Peptide DME1223 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO04672 GENEFORM Protein DME1223 XEOTICID XEO04672 MOACRIVE Inhibition DME1223 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1223 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04673 XEO_CLAS Peptide DME1223 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO04673 GENEFORM Protein DME1223 XEOTICID XEO04673 MOACRIVE Inhibition DME1223 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1223 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04674 XEO_CLAS Peptide DME1223 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 75 microM) DME1223 XEOTICID XEO04674 GENEFORM Protein DME1223 XEOTICID XEO04674 MOACRIVE Inhibition DME1223 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1223 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04675 XEO_CLAS Peptide DME1223 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 microM) DME1223 XEOTICID XEO04675 GENEFORM Protein DME1223 XEOTICID XEO04675 MOACRIVE Inhibition DME1223 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1223 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04676 XEO_CLAS Peptide DME1223 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 microM) DME1223 XEOTICID XEO04676 GENEFORM Protein DME1223 XEOTICID XEO04676 MOACRIVE Inhibition DME1223 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1223 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04677 XEO_CLAS Peptide DME1223 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO04677 GENEFORM Protein DME1223 XEOTICID XEO04677 MOACRIVE Inhibition DME1223 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1223 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04680 XEO_CLAS Peptide DME1223 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 microM) DME1223 XEOTICID XEO04680 GENEFORM Protein DME1223 XEOTICID XEO04680 MOACRIVE Inhibition DME1223 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1223 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04682 XEO_CLAS Peptide DME1223 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 microM) DME1223 XEOTICID XEO04682 GENEFORM Protein DME1223 XEOTICID XEO04682 MOACRIVE Inhibition DME1223 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1223 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04683 XEO_CLAS Peptide DME1223 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 microM) DME1223 XEOTICID XEO04683 GENEFORM Protein DME1223 XEOTICID XEO04683 MOACRIVE Inhibition DME1223 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1223 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04684 XEO_CLAS Peptide DME1223 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 38 microM) DME1223 XEOTICID XEO04684 GENEFORM Protein DME1223 XEOTICID XEO04684 MOACRIVE Inhibition DME1223 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1223 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04690 XEO_CLAS Peptide DME1223 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.5 ug/ml) DME1223 XEOTICID XEO04690 GENEFORM Protein DME1223 XEOTICID XEO04690 MOACRIVE Inhibition DME1223 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1223 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04695 XEO_CLAS Peptide DME1223 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04695 GENEFORM Protein DME1223 XEOTICID XEO04695 MOACRIVE Inhibition DME1223 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1223 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04696 XEO_CLAS Peptide DME1223 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04696 GENEFORM Protein DME1223 XEOTICID XEO04696 MOACRIVE Inhibition DME1223 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1223 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04712 XEO_CLAS Peptide DME1223 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16.7 microM) DME1223 XEOTICID XEO04712 GENEFORM Protein DME1223 XEOTICID XEO04712 MOACRIVE Inhibition DME1223 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1223 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04713 XEO_CLAS Peptide DME1223 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16.7 microM) DME1223 XEOTICID XEO04713 GENEFORM Protein DME1223 XEOTICID XEO04713 MOACRIVE Inhibition DME1223 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1223 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04714 XEO_CLAS Peptide DME1223 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 23.3 microM) DME1223 XEOTICID XEO04714 GENEFORM Protein DME1223 XEOTICID XEO04714 MOACRIVE Inhibition DME1223 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1223 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04716 XEO_CLAS Peptide DME1223 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 microM) DME1223 XEOTICID XEO04716 GENEFORM Protein DME1223 XEOTICID XEO04716 MOACRIVE Inhibition DME1223 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1223 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04717 XEO_CLAS Peptide DME1223 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 50 microM) DME1223 XEOTICID XEO04717 GENEFORM Protein DME1223 XEOTICID XEO04717 MOACRIVE Inhibition DME1223 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1223 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04725 XEO_CLAS Peptide DME1223 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04725 GENEFORM Protein DME1223 XEOTICID XEO04725 MOACRIVE Inhibition DME1223 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1223 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04726 XEO_CLAS Peptide DME1223 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04726 GENEFORM Protein DME1223 XEOTICID XEO04726 MOACRIVE Inhibition DME1223 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1223 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04731 XEO_CLAS Peptide DME1223 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 ug/ml) DME1223 XEOTICID XEO04731 GENEFORM Protein DME1223 XEOTICID XEO04731 MOACRIVE Inhibition DME1223 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1223 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04732 XEO_CLAS Peptide DME1223 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 25 ug/ml) DME1223 XEOTICID XEO04732 GENEFORM Protein DME1223 XEOTICID XEO04732 MOACRIVE Inhibition DME1223 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1223 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04733 XEO_CLAS Peptide DME1223 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04733 GENEFORM Protein DME1223 XEOTICID XEO04733 MOACRIVE Inhibition DME1223 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1223 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04734 XEO_CLAS Peptide DME1223 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04734 GENEFORM Protein DME1223 XEOTICID XEO04734 MOACRIVE Inhibition DME1223 XEOTICID XEO04737 XEO_NAME Protonectin DME1223 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04737 XEO_CLAS Peptide DME1223 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 ug/ml) DME1223 XEOTICID XEO04737 GENEFORM Protein DME1223 XEOTICID XEO04737 MOACRIVE Inhibition DME1223 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1223 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04739 XEO_CLAS Peptide DME1223 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04739 GENEFORM Protein DME1223 XEOTICID XEO04739 MOACRIVE Inhibition DME1223 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1223 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04740 XEO_CLAS Peptide DME1223 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04740 GENEFORM Protein DME1223 XEOTICID XEO04740 MOACRIVE Inhibition DME1223 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1223 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04741 XEO_CLAS Peptide DME1223 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04741 GENEFORM Protein DME1223 XEOTICID XEO04741 MOACRIVE Inhibition DME1223 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1223 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04742 XEO_CLAS Peptide DME1223 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04742 GENEFORM Protein DME1223 XEOTICID XEO04742 MOACRIVE Inhibition DME1223 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1223 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04762 XEO_CLAS Peptide DME1223 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.8 microM) DME1223 XEOTICID XEO04762 GENEFORM Protein DME1223 XEOTICID XEO04762 MOACRIVE Inhibition DME1223 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1223 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04766 XEO_CLAS Peptide DME1223 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.1 microM) DME1223 XEOTICID XEO04766 GENEFORM Protein DME1223 XEOTICID XEO04766 MOACRIVE Inhibition DME1223 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1223 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04767 XEO_CLAS Peptide DME1223 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.1 ug/ml) DME1223 XEOTICID XEO04767 GENEFORM Protein DME1223 XEOTICID XEO04767 MOACRIVE Inhibition DME1223 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1223 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04779 XEO_CLAS Peptide DME1223 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04779 GENEFORM Protein DME1223 XEOTICID XEO04779 MOACRIVE Inhibition DME1223 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1223 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04780 XEO_CLAS Peptide DME1223 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04780 GENEFORM Protein DME1223 XEOTICID XEO04780 MOACRIVE Inhibition DME1223 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1223 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04781 XEO_CLAS Peptide DME1223 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04781 GENEFORM Protein DME1223 XEOTICID XEO04781 MOACRIVE Inhibition DME1223 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1223 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04782 XEO_CLAS Peptide DME1223 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 ug/ml) DME1223 XEOTICID XEO04782 GENEFORM Protein DME1223 XEOTICID XEO04782 MOACRIVE Inhibition DME1223 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1223 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04783 XEO_CLAS Peptide DME1223 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO04783 GENEFORM Protein DME1223 XEOTICID XEO04783 MOACRIVE Inhibition DME1223 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1223 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04784 XEO_CLAS Peptide DME1223 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO04784 GENEFORM Protein DME1223 XEOTICID XEO04784 MOACRIVE Inhibition DME1223 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1223 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04785 XEO_CLAS Peptide DME1223 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO04785 GENEFORM Protein DME1223 XEOTICID XEO04785 MOACRIVE Inhibition DME1223 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1223 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04786 XEO_CLAS Peptide DME1223 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 ug/ml) DME1223 XEOTICID XEO04786 GENEFORM Protein DME1223 XEOTICID XEO04786 MOACRIVE Inhibition DME1223 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1223 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04787 XEO_CLAS Peptide DME1223 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04787 GENEFORM Protein DME1223 XEOTICID XEO04787 MOACRIVE Inhibition DME1223 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1223 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04793 XEO_CLAS Peptide DME1223 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04793 GENEFORM Protein DME1223 XEOTICID XEO04793 MOACRIVE Inhibition DME1223 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1223 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04798 XEO_CLAS Peptide DME1223 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 microM) DME1223 XEOTICID XEO04798 GENEFORM Protein DME1223 XEOTICID XEO04798 MOACRIVE Inhibition DME1223 XEOTICID XEO04799 XEO_NAME Ranalexin DME1223 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04799 XEO_CLAS Peptide DME1223 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 32 ug/ml) DME1223 XEOTICID XEO04799 GENEFORM Protein DME1223 XEOTICID XEO04799 MOACRIVE Inhibition DME1223 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1223 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04800 XEO_CLAS Peptide DME1223 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 microM) DME1223 XEOTICID XEO04800 GENEFORM Protein DME1223 XEOTICID XEO04800 MOACRIVE Inhibition DME1223 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1223 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04801 XEO_CLAS Peptide DME1223 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 9 microM) DME1223 XEOTICID XEO04801 GENEFORM Protein DME1223 XEOTICID XEO04801 MOACRIVE Inhibition DME1223 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1223 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04802 XEO_CLAS Peptide DME1223 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12 microM) DME1223 XEOTICID XEO04802 GENEFORM Protein DME1223 XEOTICID XEO04802 MOACRIVE Inhibition DME1223 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1223 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04803 XEO_CLAS Peptide DME1223 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO04803 GENEFORM Protein DME1223 XEOTICID XEO04803 MOACRIVE Inhibition DME1223 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1223 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04804 XEO_CLAS Peptide DME1223 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO04804 GENEFORM Protein DME1223 XEOTICID XEO04804 MOACRIVE Inhibition DME1223 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1223 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04805 XEO_CLAS Peptide DME1223 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.5 microM) DME1223 XEOTICID XEO04805 GENEFORM Protein DME1223 XEOTICID XEO04805 MOACRIVE Inhibition DME1223 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1223 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04806 XEO_CLAS Peptide DME1223 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.5 microM) DME1223 XEOTICID XEO04806 GENEFORM Protein DME1223 XEOTICID XEO04806 MOACRIVE Inhibition DME1223 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1223 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04807 XEO_CLAS Peptide DME1223 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04807 GENEFORM Protein DME1223 XEOTICID XEO04807 MOACRIVE Inhibition DME1223 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1223 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04809 XEO_CLAS Peptide DME1223 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 microM) DME1223 XEOTICID XEO04809 GENEFORM Protein DME1223 XEOTICID XEO04809 MOACRIVE Inhibition DME1223 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1223 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04811 XEO_CLAS Peptide DME1223 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO04811 GENEFORM Protein DME1223 XEOTICID XEO04811 MOACRIVE Inhibition DME1223 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1223 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04812 XEO_CLAS Peptide DME1223 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO04812 GENEFORM Protein DME1223 XEOTICID XEO04812 MOACRIVE Inhibition DME1223 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1223 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04813 XEO_CLAS Peptide DME1223 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 microM) DME1223 XEOTICID XEO04813 GENEFORM Protein DME1223 XEOTICID XEO04813 MOACRIVE Inhibition DME1223 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1223 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04814 XEO_CLAS Peptide DME1223 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 19 microM) DME1223 XEOTICID XEO04814 GENEFORM Protein DME1223 XEOTICID XEO04814 MOACRIVE Inhibition DME1223 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1223 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04815 XEO_CLAS Peptide DME1223 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 microM) DME1223 XEOTICID XEO04815 GENEFORM Protein DME1223 XEOTICID XEO04815 MOACRIVE Inhibition DME1223 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1223 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04816 XEO_CLAS Peptide DME1223 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 microM) DME1223 XEOTICID XEO04816 GENEFORM Protein DME1223 XEOTICID XEO04816 MOACRIVE Inhibition DME1223 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1223 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04817 XEO_CLAS Peptide DME1223 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 13 microM) DME1223 XEOTICID XEO04817 GENEFORM Protein DME1223 XEOTICID XEO04817 MOACRIVE Inhibition DME1223 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1223 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04818 XEO_CLAS Peptide DME1223 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO04818 GENEFORM Protein DME1223 XEOTICID XEO04818 MOACRIVE Inhibition DME1223 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1223 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04819 XEO_CLAS Peptide DME1223 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO04819 GENEFORM Protein DME1223 XEOTICID XEO04819 MOACRIVE Inhibition DME1223 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1223 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04820 XEO_CLAS Peptide DME1223 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3 microM) DME1223 XEOTICID XEO04820 GENEFORM Protein DME1223 XEOTICID XEO04820 MOACRIVE Inhibition DME1223 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1223 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04821 XEO_CLAS Peptide DME1223 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 microM) DME1223 XEOTICID XEO04821 GENEFORM Protein DME1223 XEOTICID XEO04821 MOACRIVE Inhibition DME1223 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1223 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04822 XEO_CLAS Peptide DME1223 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO04822 GENEFORM Protein DME1223 XEOTICID XEO04822 MOACRIVE Inhibition DME1223 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1223 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04823 XEO_CLAS Peptide DME1223 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 23 microM) DME1223 XEOTICID XEO04823 GENEFORM Protein DME1223 XEOTICID XEO04823 MOACRIVE Inhibition DME1223 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1223 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04824 XEO_CLAS Peptide DME1223 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04824 GENEFORM Protein DME1223 XEOTICID XEO04824 MOACRIVE Inhibition DME1223 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1223 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04825 XEO_CLAS Peptide DME1223 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04825 GENEFORM Protein DME1223 XEOTICID XEO04825 MOACRIVE Inhibition DME1223 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1223 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04826 XEO_CLAS Peptide DME1223 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO04826 GENEFORM Protein DME1223 XEOTICID XEO04826 MOACRIVE Inhibition DME1223 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1223 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04827 XEO_CLAS Peptide DME1223 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO04827 GENEFORM Protein DME1223 XEOTICID XEO04827 MOACRIVE Inhibition DME1223 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1223 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04835 XEO_CLAS Peptide DME1223 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04835 GENEFORM Protein DME1223 XEOTICID XEO04835 MOACRIVE Inhibition DME1223 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1223 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04836 XEO_CLAS Peptide DME1223 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04836 GENEFORM Protein DME1223 XEOTICID XEO04836 MOACRIVE Inhibition DME1223 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1223 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04837 XEO_CLAS Peptide DME1223 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 microM) DME1223 XEOTICID XEO04837 GENEFORM Protein DME1223 XEOTICID XEO04837 MOACRIVE Inhibition DME1223 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1223 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04839 XEO_CLAS Peptide DME1223 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04839 GENEFORM Protein DME1223 XEOTICID XEO04839 MOACRIVE Inhibition DME1223 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1223 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04840 XEO_CLAS Peptide DME1223 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 35-20 microM) DME1223 XEOTICID XEO04840 GENEFORM Protein DME1223 XEOTICID XEO04840 MOACRIVE Inhibition DME1223 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1223 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04847 XEO_CLAS Peptide DME1223 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04847 GENEFORM Protein DME1223 XEOTICID XEO04847 MOACRIVE Inhibition DME1223 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1223 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04848 XEO_CLAS Peptide DME1223 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04848 GENEFORM Protein DME1223 XEOTICID XEO04848 MOACRIVE Inhibition DME1223 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1223 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04849 XEO_CLAS Peptide DME1223 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04849 GENEFORM Protein DME1223 XEOTICID XEO04849 MOACRIVE Inhibition DME1223 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1223 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04850 XEO_CLAS Peptide DME1223 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04850 GENEFORM Protein DME1223 XEOTICID XEO04850 MOACRIVE Inhibition DME1223 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1223 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04851 XEO_CLAS Peptide DME1223 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1 ug/ml) DME1223 XEOTICID XEO04851 GENEFORM Protein DME1223 XEOTICID XEO04851 MOACRIVE Inhibition DME1223 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1223 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04857 XEO_CLAS Peptide DME1223 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 microM) DME1223 XEOTICID XEO04857 GENEFORM Protein DME1223 XEOTICID XEO04857 MOACRIVE Inhibition DME1223 XEOTICID XEO04863 XEO_NAME RTD peptide DME1223 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04863 XEO_CLAS Peptide DME1223 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.0 microM) DME1223 XEOTICID XEO04863 GENEFORM Protein DME1223 XEOTICID XEO04863 MOACRIVE Inhibition DME1223 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1223 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04865 XEO_CLAS Peptide DME1223 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 ug/ml) DME1223 XEOTICID XEO04865 GENEFORM Protein DME1223 XEOTICID XEO04865 MOACRIVE Inhibition DME1223 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1223 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04866 XEO_CLAS Peptide DME1223 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12.5 ug/ml) DME1223 XEOTICID XEO04866 GENEFORM Protein DME1223 XEOTICID XEO04866 MOACRIVE Inhibition DME1223 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1223 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04868 XEO_CLAS Peptide DME1223 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25.00 ug/ml) DME1223 XEOTICID XEO04868 GENEFORM Protein DME1223 XEOTICID XEO04868 MOACRIVE Inhibition DME1223 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1223 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04869 XEO_CLAS Peptide DME1223 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25.00 ug/ml) DME1223 XEOTICID XEO04869 GENEFORM Protein DME1223 XEOTICID XEO04869 MOACRIVE Inhibition DME1223 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1223 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04870 XEO_CLAS Peptide DME1223 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25.00 ug/ml) DME1223 XEOTICID XEO04870 GENEFORM Protein DME1223 XEOTICID XEO04870 MOACRIVE Inhibition DME1223 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1223 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04877 XEO_CLAS Peptide DME1223 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04877 GENEFORM Protein DME1223 XEOTICID XEO04877 MOACRIVE Inhibition DME1223 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1223 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04880 XEO_CLAS Peptide DME1223 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.5 ug/ml) DME1223 XEOTICID XEO04880 GENEFORM Protein DME1223 XEOTICID XEO04880 MOACRIVE Inhibition DME1223 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1223 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04886 XEO_CLAS Peptide DME1223 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.6 ug/ml) DME1223 XEOTICID XEO04886 GENEFORM Protein DME1223 XEOTICID XEO04886 MOACRIVE Inhibition DME1223 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1223 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04891 XEO_CLAS Peptide DME1223 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04891 GENEFORM Protein DME1223 XEOTICID XEO04891 MOACRIVE Inhibition DME1223 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1223 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04895 XEO_CLAS Peptide DME1223 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04895 GENEFORM Protein DME1223 XEOTICID XEO04895 MOACRIVE Inhibition DME1223 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1223 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04901 XEO_CLAS Peptide DME1223 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 microM) DME1223 XEOTICID XEO04901 GENEFORM Protein DME1223 XEOTICID XEO04901 MOACRIVE Inhibition DME1223 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1223 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04904 XEO_CLAS Peptide DME1223 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 78 ug/ml) DME1223 XEOTICID XEO04904 GENEFORM Protein DME1223 XEOTICID XEO04904 MOACRIVE Inhibition DME1223 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1223 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04905 XEO_CLAS Peptide DME1223 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04905 GENEFORM Protein DME1223 XEOTICID XEO04905 MOACRIVE Inhibition DME1223 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1223 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04906 XEO_CLAS Peptide DME1223 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04906 GENEFORM Protein DME1223 XEOTICID XEO04906 MOACRIVE Inhibition DME1223 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1223 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04907 XEO_CLAS Peptide DME1223 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04907 GENEFORM Protein DME1223 XEOTICID XEO04907 MOACRIVE Inhibition DME1223 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1223 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04908 XEO_CLAS Peptide DME1223 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04908 GENEFORM Protein DME1223 XEOTICID XEO04908 MOACRIVE Inhibition DME1223 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1223 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04909 XEO_CLAS Peptide DME1223 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04909 GENEFORM Protein DME1223 XEOTICID XEO04909 MOACRIVE Inhibition DME1223 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1223 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04915 XEO_CLAS Peptide DME1223 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 100 ug/ml) DME1223 XEOTICID XEO04915 GENEFORM Protein DME1223 XEOTICID XEO04915 MOACRIVE Inhibition DME1223 XEOTICID XEO04916 XEO_NAME Scopoletin DME1223 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1223 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04916 GENEFORM Protein DME1223 XEOTICID XEO04916 MOACRIVE Inhibition DME1223 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1223 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04926 XEO_CLAS Peptide DME1223 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04926 GENEFORM Protein DME1223 XEOTICID XEO04926 MOACRIVE Inhibition DME1223 XEOTICID XEO04931 XEO_NAME Shepherin I DME1223 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04931 XEO_CLAS Peptide DME1223 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04931 GENEFORM Protein DME1223 XEOTICID XEO04931 MOACRIVE Inhibition DME1223 XEOTICID XEO04932 XEO_NAME shepherin II DME1223 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04932 XEO_CLAS Peptide DME1223 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04932 GENEFORM Protein DME1223 XEOTICID XEO04932 MOACRIVE Inhibition DME1223 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1223 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04938 XEO_CLAS Peptide DME1223 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC <= 100 microM) DME1223 XEOTICID XEO04938 GENEFORM Protein DME1223 XEOTICID XEO04938 MOACRIVE Inhibition DME1223 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1223 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04947 XEO_CLAS Natural Product DME1223 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04947 GENEFORM Protein DME1223 XEOTICID XEO04947 MOACRIVE Inhibition DME1223 XEOTICID XEO04948 XEO_NAME Sinensetin DME1223 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1223 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1223 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04948 GENEFORM Protein DME1223 XEOTICID XEO04948 MOACRIVE Inhibition DME1223 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1223 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04950 XEO_CLAS Peptide DME1223 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 ug/ml) DME1223 XEOTICID XEO04950 GENEFORM Protein DME1223 XEOTICID XEO04950 MOACRIVE Inhibition DME1223 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1223 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04955 XEO_CLAS Peptide DME1223 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.07 microM) DME1223 XEOTICID XEO04955 GENEFORM Protein DME1223 XEOTICID XEO04955 MOACRIVE Inhibition DME1223 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1223 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04956 XEO_CLAS Peptide DME1223 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16.0 microM) DME1223 XEOTICID XEO04956 GENEFORM Protein DME1223 XEOTICID XEO04956 MOACRIVE Inhibition DME1223 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1223 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04957 XEO_CLAS Peptide DME1223 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.23 microM) DME1223 XEOTICID XEO04957 GENEFORM Protein DME1223 XEOTICID XEO04957 MOACRIVE Inhibition DME1223 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1223 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04958 XEO_CLAS Peptide DME1223 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 ug/ml) DME1223 XEOTICID XEO04958 GENEFORM Protein DME1223 XEOTICID XEO04958 MOACRIVE Inhibition DME1223 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1223 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04959 XEO_CLAS Peptide DME1223 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04959 GENEFORM Protein DME1223 XEOTICID XEO04959 MOACRIVE Inhibition DME1223 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1223 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04967 XEO_CLAS Peptide DME1223 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 28 microM) DME1223 XEOTICID XEO04967 GENEFORM Protein DME1223 XEOTICID XEO04967 MOACRIVE Inhibition DME1223 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1223 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04969 XEO_CLAS Peptide DME1223 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50-100 ug/ml) DME1223 XEOTICID XEO04969 GENEFORM Protein DME1223 XEOTICID XEO04969 MOACRIVE Inhibition DME1223 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1223 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04970 XEO_CLAS Peptide DME1223 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04970 GENEFORM Protein DME1223 XEOTICID XEO04970 MOACRIVE Inhibition DME1223 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1223 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04971 XEO_CLAS Peptide DME1223 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.8-1.5 microM) DME1223 XEOTICID XEO04971 GENEFORM Protein DME1223 XEOTICID XEO04971 MOACRIVE Inhibition DME1223 XEOTICID XEO04974 XEO_NAME Spinigerin DME1223 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04974 XEO_CLAS Peptide DME1223 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3-6 microM) DME1223 XEOTICID XEO04974 GENEFORM Protein DME1223 XEOTICID XEO04974 MOACRIVE Inhibition DME1223 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1223 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1223 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04975 GENEFORM Protein DME1223 XEOTICID XEO04975 MOACRIVE Inhibition DME1223 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1223 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1223 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04976 GENEFORM Protein DME1223 XEOTICID XEO04976 MOACRIVE Inhibition DME1223 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1223 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1223 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04977 GENEFORM Protein DME1223 XEOTICID XEO04977 MOACRIVE Inhibition DME1223 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1223 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1223 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04978 GENEFORM Protein DME1223 XEOTICID XEO04978 MOACRIVE Inhibition DME1223 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1223 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1223 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04979 GENEFORM Protein DME1223 XEOTICID XEO04979 MOACRIVE Inhibition DME1223 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1223 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04981 XEO_CLAS Peptide DME1223 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10.1 microM) DME1223 XEOTICID XEO04981 GENEFORM Protein DME1223 XEOTICID XEO04981 MOACRIVE Inhibition DME1223 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1223 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04982 XEO_CLAS Peptide DME1223 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40.5 microM) DME1223 XEOTICID XEO04982 GENEFORM Protein DME1223 XEOTICID XEO04982 MOACRIVE Inhibition DME1223 XEOTICID XEO04994 XEO_NAME Stilbene DME1223 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1223 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1223 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO04994 GENEFORM Protein DME1223 XEOTICID XEO04994 MOACRIVE Inhibition DME1223 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1223 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04995 XEO_CLAS Peptide DME1223 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC < 0.19 microM) DME1223 XEOTICID XEO04995 GENEFORM Protein DME1223 XEOTICID XEO04995 MOACRIVE Inhibition DME1223 XEOTICID XEO04998 XEO_NAME Styelin A DME1223 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04998 XEO_CLAS Peptide DME1223 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.7 ug/ml) DME1223 XEOTICID XEO04998 GENEFORM Protein DME1223 XEOTICID XEO04998 MOACRIVE Inhibition DME1223 XEOTICID XEO04999 XEO_NAME Styelin B DME1223 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO04999 XEO_CLAS Peptide DME1223 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.7 ug/ml) DME1223 XEOTICID XEO04999 GENEFORM Protein DME1223 XEOTICID XEO04999 MOACRIVE Inhibition DME1223 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1223 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05000 XEO_CLAS Peptide DME1223 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO05000 GENEFORM Protein DME1223 XEOTICID XEO05000 MOACRIVE Inhibition DME1223 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1223 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05001 XEO_CLAS Peptide DME1223 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.5 ug/ml) DME1223 XEOTICID XEO05001 GENEFORM Protein DME1223 XEOTICID XEO05001 MOACRIVE Inhibition DME1223 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1223 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05002 XEO_CLAS Peptide DME1223 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO05002 GENEFORM Protein DME1223 XEOTICID XEO05002 MOACRIVE Inhibition DME1223 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1223 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05003 XEO_CLAS Peptide DME1223 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO05003 GENEFORM Protein DME1223 XEOTICID XEO05003 MOACRIVE Inhibition DME1223 XEOTICID XEO05006 XEO_NAME Substance P DME1223 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05006 XEO_CLAS Peptide DME1223 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05006 GENEFORM Protein DME1223 XEOTICID XEO05006 MOACRIVE Inhibition DME1223 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1223 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05007 XEO_CLAS Peptide DME1223 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05007 GENEFORM Protein DME1223 XEOTICID XEO05007 MOACRIVE Inhibition DME1223 XEOTICID XEO05008 XEO_NAME Subtilosin DME1223 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05008 XEO_CLAS Peptide DME1223 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05008 GENEFORM Protein DME1223 XEOTICID XEO05008 MOACRIVE Inhibition DME1223 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1223 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05013 XEO_CLAS Peptide DME1223 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO05013 GENEFORM Protein DME1223 XEOTICID XEO05013 MOACRIVE Inhibition DME1223 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1223 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05014 XEO_CLAS Peptide DME1223 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO05014 GENEFORM Protein DME1223 XEOTICID XEO05014 MOACRIVE Inhibition DME1223 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1223 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05015 XEO_CLAS Peptide DME1223 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO05015 GENEFORM Protein DME1223 XEOTICID XEO05015 MOACRIVE Inhibition DME1223 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1223 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05016 XEO_CLAS Peptide DME1223 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO05016 GENEFORM Protein DME1223 XEOTICID XEO05016 MOACRIVE Inhibition DME1223 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1223 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05017 XEO_CLAS Peptide DME1223 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 20 ug/ml) DME1223 XEOTICID XEO05017 GENEFORM Protein DME1223 XEOTICID XEO05017 MOACRIVE Inhibition DME1223 XEOTICID XEO05018 XEO_NAME Syringic acid DME1223 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1223 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05018 GENEFORM Protein DME1223 XEOTICID XEO05018 MOACRIVE Inhibition DME1223 XEOTICID XEO05020 XEO_NAME Tachycitin DME1223 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05020 XEO_CLAS Peptide DME1223 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05020 GENEFORM Protein DME1223 XEOTICID XEO05020 MOACRIVE Inhibition DME1223 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1223 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05023 XEO_CLAS Peptide DME1223 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05023 GENEFORM Protein DME1223 XEOTICID XEO05023 MOACRIVE Inhibition DME1223 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1223 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05024 XEO_CLAS Peptide DME1223 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05024 GENEFORM Protein DME1223 XEOTICID XEO05024 MOACRIVE Inhibition DME1223 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1223 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05027 XEO_CLAS Peptide DME1223 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05027 GENEFORM Protein DME1223 XEOTICID XEO05027 MOACRIVE Inhibition DME1223 XEOTICID XEO05031 XEO_NAME Tannic acid DME1223 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1223 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05031 GENEFORM Protein DME1223 XEOTICID XEO05031 MOACRIVE Inhibition DME1223 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1223 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05033 XEO_CLAS Peptide DME1223 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05033 GENEFORM Protein DME1223 XEOTICID XEO05033 MOACRIVE Inhibition DME1223 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1223 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05042 XEO_CLAS Peptide DME1223 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO05042 GENEFORM Protein DME1223 XEOTICID XEO05042 MOACRIVE Inhibition DME1223 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1223 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05043 XEO_CLAS Peptide DME1223 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO05043 GENEFORM Protein DME1223 XEOTICID XEO05043 MOACRIVE Inhibition DME1223 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1223 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05044 XEO_CLAS Peptide DME1223 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 128 microM) DME1223 XEOTICID XEO05044 GENEFORM Protein DME1223 XEOTICID XEO05044 MOACRIVE Inhibition DME1223 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1223 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05045 XEO_CLAS Peptide DME1223 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 128 microM) DME1223 XEOTICID XEO05045 GENEFORM Protein DME1223 XEOTICID XEO05045 MOACRIVE Inhibition DME1223 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1223 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05046 XEO_CLAS Peptide DME1223 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 microM) DME1223 XEOTICID XEO05046 GENEFORM Protein DME1223 XEOTICID XEO05046 MOACRIVE Inhibition DME1223 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1223 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05047 XEO_CLAS Peptide DME1223 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 60 microM) DME1223 XEOTICID XEO05047 GENEFORM Protein DME1223 XEOTICID XEO05047 MOACRIVE Inhibition DME1223 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1223 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05051 XEO_CLAS Peptide DME1223 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05051 GENEFORM Protein DME1223 XEOTICID XEO05051 MOACRIVE Inhibition DME1223 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1223 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05055 XEO_CLAS Peptide DME1223 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 70 microM) DME1223 XEOTICID XEO05055 GENEFORM Protein DME1223 XEOTICID XEO05055 MOACRIVE Inhibition DME1223 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1223 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05056 XEO_CLAS Peptide DME1223 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05056 GENEFORM Protein DME1223 XEOTICID XEO05056 MOACRIVE Inhibition DME1223 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1223 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05059 XEO_CLAS Peptide DME1223 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05059 GENEFORM Protein DME1223 XEOTICID XEO05059 MOACRIVE Inhibition DME1223 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1223 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05061 XEO_CLAS Peptide DME1223 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO05061 GENEFORM Protein DME1223 XEOTICID XEO05061 MOACRIVE Inhibition DME1223 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1223 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05062 XEO_CLAS Peptide DME1223 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05062 GENEFORM Protein DME1223 XEOTICID XEO05062 MOACRIVE Inhibition DME1223 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1223 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05063 XEO_CLAS Peptide DME1223 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO05063 GENEFORM Protein DME1223 XEOTICID XEO05063 MOACRIVE Inhibition DME1223 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1223 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05064 XEO_CLAS Peptide DME1223 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 231 microM) DME1223 XEOTICID XEO05064 GENEFORM Protein DME1223 XEOTICID XEO05064 MOACRIVE Inhibition DME1223 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1223 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05065 XEO_CLAS Peptide DME1223 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 161 ug/ml) DME1223 XEOTICID XEO05065 GENEFORM Protein DME1223 XEOTICID XEO05065 MOACRIVE Inhibition DME1223 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1223 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05069 XEO_CLAS Peptide DME1223 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO05069 GENEFORM Protein DME1223 XEOTICID XEO05069 MOACRIVE Inhibition DME1223 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1223 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05070 XEO_CLAS Peptide DME1223 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 37.5 microM) DME1223 XEOTICID XEO05070 GENEFORM Protein DME1223 XEOTICID XEO05070 MOACRIVE Inhibition DME1223 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1223 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05071 XEO_CLAS Peptide DME1223 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 150 microM) DME1223 XEOTICID XEO05071 GENEFORM Protein DME1223 XEOTICID XEO05071 MOACRIVE Inhibition DME1223 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1223 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05072 XEO_CLAS Peptide DME1223 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO05072 GENEFORM Protein DME1223 XEOTICID XEO05072 MOACRIVE Inhibition DME1223 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1223 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05073 XEO_CLAS Peptide DME1223 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40 microM) DME1223 XEOTICID XEO05073 GENEFORM Protein DME1223 XEOTICID XEO05073 MOACRIVE Inhibition DME1223 XEOTICID XEO05076 XEO_NAME Temporin-A DME1223 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05076 XEO_CLAS Peptide DME1223 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 11.9 microM) DME1223 XEOTICID XEO05076 GENEFORM Protein DME1223 XEOTICID XEO05076 MOACRIVE Inhibition DME1223 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1223 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05077 XEO_CLAS Peptide DME1223 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.25 ug/ml) DME1223 XEOTICID XEO05077 GENEFORM Protein DME1223 XEOTICID XEO05077 MOACRIVE Inhibition DME1223 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1223 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05078 XEO_CLAS Peptide DME1223 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.25 ug/ml) DME1223 XEOTICID XEO05078 GENEFORM Protein DME1223 XEOTICID XEO05078 MOACRIVE Inhibition DME1223 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1223 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05079 XEO_CLAS Peptide DME1223 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.5 ug/ml) DME1223 XEOTICID XEO05079 GENEFORM Protein DME1223 XEOTICID XEO05079 MOACRIVE Inhibition DME1223 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1223 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05080 XEO_CLAS Peptide DME1223 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 ug/ml) DME1223 XEOTICID XEO05080 GENEFORM Protein DME1223 XEOTICID XEO05080 MOACRIVE Inhibition DME1223 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1223 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05081 XEO_CLAS Peptide DME1223 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 5 ug/ml) DME1223 XEOTICID XEO05081 GENEFORM Protein DME1223 XEOTICID XEO05081 MOACRIVE Inhibition DME1223 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1223 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05082 XEO_CLAS Peptide DME1223 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 7.5 ug/ml) DME1223 XEOTICID XEO05082 GENEFORM Protein DME1223 XEOTICID XEO05082 MOACRIVE Inhibition DME1223 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1223 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05083 XEO_CLAS Peptide DME1223 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 ug/ml) DME1223 XEOTICID XEO05083 GENEFORM Protein DME1223 XEOTICID XEO05083 MOACRIVE Inhibition DME1223 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1223 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05084 XEO_CLAS Peptide DME1223 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 ug/ml) DME1223 XEOTICID XEO05084 GENEFORM Protein DME1223 XEOTICID XEO05084 MOACRIVE Inhibition DME1223 XEOTICID XEO05085 XEO_NAME Temporin-B DME1223 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05085 XEO_CLAS Peptide DME1223 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 21.0 ug/ml) DME1223 XEOTICID XEO05085 GENEFORM Protein DME1223 XEOTICID XEO05085 MOACRIVE Inhibition DME1223 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1223 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05086 XEO_CLAS Peptide DME1223 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC > 100 microM) DME1223 XEOTICID XEO05086 GENEFORM Protein DME1223 XEOTICID XEO05086 MOACRIVE Inhibition DME1223 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1223 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05087 XEO_CLAS Peptide DME1223 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO05087 GENEFORM Protein DME1223 XEOTICID XEO05087 MOACRIVE Inhibition DME1223 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1223 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05097 XEO_CLAS Peptide DME1223 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16.0 microM) DME1223 XEOTICID XEO05097 GENEFORM Protein DME1223 XEOTICID XEO05097 MOACRIVE Inhibition DME1223 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1223 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05099 XEO_CLAS Peptide DME1223 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.0 microM) DME1223 XEOTICID XEO05099 GENEFORM Protein DME1223 XEOTICID XEO05099 MOACRIVE Inhibition DME1223 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1223 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05100 XEO_CLAS Peptide DME1223 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05100 GENEFORM Protein DME1223 XEOTICID XEO05100 MOACRIVE Inhibition DME1223 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1223 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05101 XEO_CLAS Peptide DME1223 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 24.2 ug/ml) DME1223 XEOTICID XEO05101 GENEFORM Protein DME1223 XEOTICID XEO05101 MOACRIVE Inhibition DME1223 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1223 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05102 XEO_CLAS Peptide DME1223 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 34.5 ug/ml) DME1223 XEOTICID XEO05102 GENEFORM Protein DME1223 XEOTICID XEO05102 MOACRIVE Inhibition DME1223 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1223 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05105 XEO_CLAS Peptide DME1223 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO05105 GENEFORM Protein DME1223 XEOTICID XEO05105 MOACRIVE Inhibition DME1223 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1223 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05106 XEO_CLAS Peptide DME1223 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25-200 microM) DME1223 XEOTICID XEO05106 GENEFORM Protein DME1223 XEOTICID XEO05106 MOACRIVE Inhibition DME1223 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1223 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05108 XEO_CLAS Peptide DME1223 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40 microM) DME1223 XEOTICID XEO05108 GENEFORM Protein DME1223 XEOTICID XEO05108 MOACRIVE Inhibition DME1223 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1223 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1223 XEOTICID XEO05111 XEO_CLAS Natural Product DME1223 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05111 GENEFORM Protein DME1223 XEOTICID XEO05111 MOACRIVE Inhibition DME1223 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1223 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05119 XEO_CLAS Peptide DME1223 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05119 GENEFORM Protein DME1223 XEOTICID XEO05119 MOACRIVE Inhibition DME1223 XEOTICID XEO05120 XEO_NAME Thanatin DME1223 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05120 XEO_CLAS Peptide DME1223 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.3-0.6 microM) DME1223 XEOTICID XEO05120 GENEFORM Protein DME1223 XEOTICID XEO05120 MOACRIVE Inhibition DME1223 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1223 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05121 XEO_CLAS Peptide DME1223 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 62.5 ug/ml) DME1223 XEOTICID XEO05121 GENEFORM Protein DME1223 XEOTICID XEO05121 MOACRIVE Inhibition DME1223 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1223 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05125 XEO_CLAS Peptide DME1223 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05125 GENEFORM Protein DME1223 XEOTICID XEO05125 MOACRIVE Inhibition DME1223 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1223 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05130 XEO_CLAS Peptide DME1223 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05130 GENEFORM Protein DME1223 XEOTICID XEO05130 MOACRIVE Inhibition DME1223 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1223 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05144 XEO_CLAS Peptide DME1223 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40 ug/ml) DME1223 XEOTICID XEO05144 GENEFORM Protein DME1223 XEOTICID XEO05144 MOACRIVE Inhibition DME1223 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1223 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05145 XEO_CLAS Peptide DME1223 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 ug/ml) DME1223 XEOTICID XEO05145 GENEFORM Protein DME1223 XEOTICID XEO05145 MOACRIVE Inhibition DME1223 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1223 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05146 XEO_CLAS Peptide DME1223 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 40 ug/ml) DME1223 XEOTICID XEO05146 GENEFORM Protein DME1223 XEOTICID XEO05146 MOACRIVE Inhibition DME1223 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1223 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05147 XEO_CLAS Peptide DME1223 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 60 ug/ml) DME1223 XEOTICID XEO05147 GENEFORM Protein DME1223 XEOTICID XEO05147 MOACRIVE Inhibition DME1223 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1223 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05158 XEO_CLAS Peptide DME1223 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05158 GENEFORM Protein DME1223 XEOTICID XEO05158 MOACRIVE Inhibition DME1223 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1223 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05161 XEO_CLAS Peptide DME1223 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 32 ug/ml) DME1223 XEOTICID XEO05161 GENEFORM Protein DME1223 XEOTICID XEO05161 MOACRIVE Inhibition DME1223 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1223 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05162 XEO_CLAS Peptide DME1223 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 32 ug/ml) DME1223 XEOTICID XEO05162 GENEFORM Protein DME1223 XEOTICID XEO05162 MOACRIVE Inhibition DME1223 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1223 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05163 XEO_CLAS Peptide DME1223 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 12-25 ug/ml) DME1223 XEOTICID XEO05163 GENEFORM Protein DME1223 XEOTICID XEO05163 MOACRIVE Inhibition DME1223 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1223 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05170 XEO_CLAS Peptide DME1223 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 3.0 microM) DME1223 XEOTICID XEO05170 GENEFORM Protein DME1223 XEOTICID XEO05170 MOACRIVE Inhibition DME1223 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1223 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05171 XEO_CLAS Peptide DME1223 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 50 microM) DME1223 XEOTICID XEO05171 GENEFORM Protein DME1223 XEOTICID XEO05171 MOACRIVE Inhibition DME1223 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1223 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05179 XEO_CLAS Peptide DME1223 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05179 GENEFORM Protein DME1223 XEOTICID XEO05179 MOACRIVE Inhibition DME1223 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1223 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05180 XEO_CLAS Peptide DME1223 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 160 microM) DME1223 XEOTICID XEO05180 GENEFORM Protein DME1223 XEOTICID XEO05180 MOACRIVE Inhibition DME1223 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1223 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05182 XEO_CLAS Peptide DME1223 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 microM) DME1223 XEOTICID XEO05182 GENEFORM Protein DME1223 XEOTICID XEO05182 MOACRIVE Inhibition DME1223 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1223 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05183 XEO_CLAS Peptide DME1223 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 microM) DME1223 XEOTICID XEO05183 GENEFORM Protein DME1223 XEOTICID XEO05183 MOACRIVE Inhibition DME1223 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1223 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05184 XEO_CLAS Peptide DME1223 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 microM) DME1223 XEOTICID XEO05184 GENEFORM Protein DME1223 XEOTICID XEO05184 MOACRIVE Inhibition DME1223 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1223 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05185 XEO_CLAS Peptide DME1223 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 microM) DME1223 XEOTICID XEO05185 GENEFORM Protein DME1223 XEOTICID XEO05185 MOACRIVE Inhibition DME1223 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1223 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05186 XEO_CLAS Peptide DME1223 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 microM) DME1223 XEOTICID XEO05186 GENEFORM Protein DME1223 XEOTICID XEO05186 MOACRIVE Inhibition DME1223 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1223 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05187 XEO_CLAS Peptide DME1223 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16 microM) DME1223 XEOTICID XEO05187 GENEFORM Protein DME1223 XEOTICID XEO05187 MOACRIVE Inhibition DME1223 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1223 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05188 XEO_CLAS Peptide DME1223 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 64 microM) DME1223 XEOTICID XEO05188 GENEFORM Protein DME1223 XEOTICID XEO05188 MOACRIVE Inhibition DME1223 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1223 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05190 XEO_CLAS Peptide DME1223 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05190 GENEFORM Protein DME1223 XEOTICID XEO05190 MOACRIVE Inhibition DME1223 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1223 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05193 XEO_CLAS Peptide DME1223 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO05193 GENEFORM Protein DME1223 XEOTICID XEO05193 MOACRIVE Inhibition DME1223 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1223 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05197 XEO_CLAS Peptide DME1223 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05197 GENEFORM Protein DME1223 XEOTICID XEO05197 MOACRIVE Inhibition DME1223 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1223 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05205 XEO_CLAS Peptide DME1223 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05205 GENEFORM Protein DME1223 XEOTICID XEO05205 MOACRIVE Inhibition DME1223 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1223 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05206 XEO_CLAS Peptide DME1223 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 10 microM) DME1223 XEOTICID XEO05206 GENEFORM Protein DME1223 XEOTICID XEO05206 MOACRIVE Inhibition DME1223 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1223 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05207 XEO_CLAS Peptide DME1223 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 25 microM) DME1223 XEOTICID XEO05207 GENEFORM Protein DME1223 XEOTICID XEO05207 MOACRIVE Inhibition DME1223 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1223 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05208 XEO_CLAS Peptide DME1223 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 microM) DME1223 XEOTICID XEO05208 GENEFORM Protein DME1223 XEOTICID XEO05208 MOACRIVE Inhibition DME1223 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1223 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05209 XEO_CLAS Peptide DME1223 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 15 microM) DME1223 XEOTICID XEO05209 GENEFORM Protein DME1223 XEOTICID XEO05209 MOACRIVE Inhibition DME1223 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1223 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05212 XEO_CLAS Peptide DME1223 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.5 ug/ml) DME1223 XEOTICID XEO05212 GENEFORM Protein DME1223 XEOTICID XEO05212 MOACRIVE Inhibition DME1223 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1223 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05220 XEO_CLAS Peptide DME1223 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.6-1.2 microM) DME1223 XEOTICID XEO05220 GENEFORM Protein DME1223 XEOTICID XEO05220 MOACRIVE Inhibition DME1223 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1223 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05230 XEO_CLAS Peptide DME1223 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 7.90 microM) DME1223 XEOTICID XEO05230 GENEFORM Protein DME1223 XEOTICID XEO05230 MOACRIVE Inhibition DME1223 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1223 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05231 XEO_CLAS Peptide DME1223 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2.40 microM) DME1223 XEOTICID XEO05231 GENEFORM Protein DME1223 XEOTICID XEO05231 MOACRIVE Inhibition DME1223 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1223 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05232 XEO_CLAS Peptide DME1223 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05232 GENEFORM Protein DME1223 XEOTICID XEO05232 MOACRIVE Inhibition DME1223 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1223 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05233 XEO_CLAS Peptide DME1223 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 ug/ml) DME1223 XEOTICID XEO05233 GENEFORM Protein DME1223 XEOTICID XEO05233 MOACRIVE Inhibition DME1223 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1223 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05234 XEO_CLAS Peptide DME1223 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 ug/ml) DME1223 XEOTICID XEO05234 GENEFORM Protein DME1223 XEOTICID XEO05234 MOACRIVE Inhibition DME1223 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1223 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05235 XEO_CLAS Peptide DME1223 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 30 ug/ml) DME1223 XEOTICID XEO05235 GENEFORM Protein DME1223 XEOTICID XEO05235 MOACRIVE Inhibition DME1223 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1223 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05237 XEO_CLAS Peptide DME1223 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 microM) DME1223 XEOTICID XEO05237 GENEFORM Protein DME1223 XEOTICID XEO05237 MOACRIVE Inhibition DME1223 XEOTICID XEO05245 XEO_NAME Viresin DME1223 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05245 XEO_CLAS Peptide DME1223 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05245 GENEFORM Protein DME1223 XEOTICID XEO05245 MOACRIVE Inhibition DME1223 XEOTICID XEO05248 XEO_NAME Vitamin C DME1223 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1223 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1223 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05248 GENEFORM Protein DME1223 XEOTICID XEO05248 MOACRIVE Inhibition DME1223 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1223 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05264 XEO_CLAS Peptide DME1223 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 4 ug/ml) DME1223 XEOTICID XEO05264 GENEFORM Protein DME1223 XEOTICID XEO05264 MOACRIVE Inhibition DME1223 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1223 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05267 XEO_CLAS Peptide DME1223 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 2 ug/ml) DME1223 XEOTICID XEO05267 GENEFORM Protein DME1223 XEOTICID XEO05267 MOACRIVE Inhibition DME1223 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1223 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05268 XEO_CLAS Peptide DME1223 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 1.6 ug/ml) DME1223 XEOTICID XEO05268 GENEFORM Protein DME1223 XEOTICID XEO05268 MOACRIVE Inhibition DME1223 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1223 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05269 XEO_CLAS Peptide DME1223 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 6 ug/ml) DME1223 XEOTICID XEO05269 GENEFORM Protein DME1223 XEOTICID XEO05269 MOACRIVE Inhibition DME1223 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1223 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05273 XEO_CLAS Peptide DME1223 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05273 GENEFORM Protein DME1223 XEOTICID XEO05273 MOACRIVE Inhibition DME1223 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1223 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05274 XEO_CLAS Peptide DME1223 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05274 GENEFORM Protein DME1223 XEOTICID XEO05274 MOACRIVE Inhibition DME1223 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1223 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05287 XEO_CLAS Peptide DME1223 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli DME1223 XEOTICID XEO05287 GENEFORM Protein DME1223 XEOTICID XEO05287 MOACRIVE Inhibition DME1223 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1223 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05303 XEO_CLAS Peptide DME1223 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 16-31 ug/ml) DME1223 XEOTICID XEO05303 GENEFORM Protein DME1223 XEOTICID XEO05303 MOACRIVE Inhibition DME1223 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1223 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05306 XEO_CLAS Peptide DME1223 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 8 ug/ml) DME1223 XEOTICID XEO05306 GENEFORM Protein DME1223 XEOTICID XEO05306 MOACRIVE Inhibition DME1223 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1223 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1223 XEOTICID XEO05308 XEO_CLAS Peptide DME1223 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Escherichia coli (MIC = 0.4 ug/ml) DME1223 XEOTICID XEO05308 GENEFORM Protein DME1223 XEOTICID XEO05308 MOACRIVE Inhibition DME1226 DME___ID DME1226 DME1226 DME_NAME Beta-lactamase (blaB) DME1226 SPESNAME Klebsiella oxytoca DME1226 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1226 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO01812 XEO_CLAS Peptide DME1226 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca (MIC = 4.0 microM) DME1226 XEOTICID XEO01812 GENEFORM Protein DME1226 XEOTICID XEO01812 MOACRIVE Inhibition DME1226 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1226 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO01813 XEO_CLAS Peptide DME1226 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca (MIC = 4.1 microM) DME1226 XEOTICID XEO01813 GENEFORM Protein DME1226 XEOTICID XEO01813 MOACRIVE Inhibition DME1226 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1226 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO01814 XEO_CLAS Peptide DME1226 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca (MIC = 2.4 microM) DME1226 XEOTICID XEO01814 GENEFORM Protein DME1226 XEOTICID XEO01814 MOACRIVE Inhibition DME1226 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1226 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO01815 XEO_CLAS Peptide DME1226 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca (MIC = 6.1 microM) DME1226 XEOTICID XEO01815 GENEFORM Protein DME1226 XEOTICID XEO01815 MOACRIVE Inhibition DME1226 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1226 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO02284 XEO_CLAS Peptide DME1226 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca (MIC = 50.5 microM) DME1226 XEOTICID XEO02284 GENEFORM Protein DME1226 XEOTICID XEO02284 MOACRIVE Inhibition DME1226 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1226 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO02285 XEO_CLAS Peptide DME1226 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca (MIC = 50.5 microM) DME1226 XEOTICID XEO02285 GENEFORM Protein DME1226 XEOTICID XEO02285 MOACRIVE Inhibition DME1226 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1226 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO02286 XEO_CLAS Peptide DME1226 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca (MIC = 50.5 microM) DME1226 XEOTICID XEO02286 GENEFORM Protein DME1226 XEOTICID XEO02286 MOACRIVE Inhibition DME1226 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1226 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO02287 XEO_CLAS Peptide DME1226 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca (MIC = 50.5 microM) DME1226 XEOTICID XEO02287 GENEFORM Protein DME1226 XEOTICID XEO02287 MOACRIVE Inhibition DME1226 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1226 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO03039 XEO_CLAS Peptide DME1226 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca (MIC = 5.80 microM) DME1226 XEOTICID XEO03039 GENEFORM Protein DME1226 XEOTICID XEO03039 MOACRIVE Inhibition DME1226 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1226 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO03609 XEO_CLAS Peptide DME1226 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca DME1226 XEOTICID XEO03609 GENEFORM Protein DME1226 XEOTICID XEO03609 MOACRIVE Inhibition DME1226 XEOTICID XEO03693 XEO_NAME Kalata-B1 DME1226 XEOTICID XEO03693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO03693 XEO_CLAS Peptide DME1226 XEOTICID XEO03693 DESCRIPT Kalata-B1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca (MIC = 54.8 microM) DME1226 XEOTICID XEO03693 GENEFORM Protein DME1226 XEOTICID XEO03693 MOACRIVE Inhibition DME1226 XEOTICID XEO04114 XEO_NAME Microcin L DME1226 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO04114 XEO_CLAS Peptide DME1226 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca DME1226 XEOTICID XEO04114 GENEFORM Protein DME1226 XEOTICID XEO04114 MOACRIVE Inhibition DME1226 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1226 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO04259 XEO_CLAS Peptide DME1226 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca DME1226 XEOTICID XEO04259 GENEFORM Protein DME1226 XEOTICID XEO04259 MOACRIVE Inhibition DME1226 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1226 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO04261 XEO_CLAS Peptide DME1226 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca DME1226 XEOTICID XEO04261 GENEFORM Protein DME1226 XEOTICID XEO04261 MOACRIVE Inhibition DME1226 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1226 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO04265 XEO_CLAS Peptide DME1226 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca DME1226 XEOTICID XEO04265 GENEFORM Protein DME1226 XEOTICID XEO04265 MOACRIVE Inhibition DME1226 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1226 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO04268 XEO_CLAS Peptide DME1226 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca DME1226 XEOTICID XEO04268 GENEFORM Protein DME1226 XEOTICID XEO04268 MOACRIVE Inhibition DME1226 XEOTICID XEO04863 XEO_NAME RTD peptide DME1226 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO04863 XEO_CLAS Peptide DME1226 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca (MIC = 2.0 microM) DME1226 XEOTICID XEO04863 GENEFORM Protein DME1226 XEOTICID XEO04863 MOACRIVE Inhibition DME1226 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1226 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1226 XEOTICID XEO05170 XEO_CLAS Peptide DME1226 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella oxytoca (MIC = 2.1 microM) DME1226 XEOTICID XEO05170 GENEFORM Protein DME1226 XEOTICID XEO05170 MOACRIVE Inhibition DME1231 DME___ID DME1231 DME1231 DME_NAME Beta-lactamase (blaB) DME1231 SPESNAME Serratia marcescens DME1231 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1231 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1231 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1231 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO00574 GENEFORM Protein DME1231 XEOTICID XEO00574 MOACRIVE Inhibition DME1231 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME1231 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME1231 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME1231 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO00613 GENEFORM Protein DME1231 XEOTICID XEO00613 MOACRIVE Inhibition DME1231 XEOTICID XEO00683 XEO_NAME Curcumin DME1231 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1231 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1231 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO00683 GENEFORM Protein DME1231 XEOTICID XEO00683 MOACRIVE Inhibition DME1231 XEOTICID XEO01419 XEO_NAME Oxyquinoline DME1231 XEOTICID XEO01419 XEO_TYPE Health or Environmental Toxicant(s) DME1231 XEOTICID XEO01419 XEO_CLAS Acute Toxic Substance DME1231 XEOTICID XEO01419 DESCRIPT Oxyquinoline inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO01419 GENEFORM Protein DME1231 XEOTICID XEO01419 MOACRIVE Inhibition DME1231 XEOTICID XEO02091 XEO_NAME 7-chloroquinolin-4-ol DME1231 XEOTICID XEO02091 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1231 XEOTICID XEO02091 XEO_CLAS Chemical Compound DME1231 XEOTICID XEO02091 DESCRIPT 7-chloroquinolin-4-ol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO02091 GENEFORM Protein DME1231 XEOTICID XEO02091 MOACRIVE Inhibition DME1231 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1231 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02117 XEO_CLAS Peptide DME1231 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO02117 GENEFORM Protein DME1231 XEOTICID XEO02117 MOACRIVE Inhibition DME1231 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1231 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02118 XEO_CLAS Peptide DME1231 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO02118 GENEFORM Protein DME1231 XEOTICID XEO02118 MOACRIVE Inhibition DME1231 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1231 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02119 XEO_CLAS Peptide DME1231 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO02119 GENEFORM Protein DME1231 XEOTICID XEO02119 MOACRIVE Inhibition DME1231 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1231 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02120 XEO_CLAS Peptide DME1231 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO02120 GENEFORM Protein DME1231 XEOTICID XEO02120 MOACRIVE Inhibition DME1231 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1231 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02121 XEO_CLAS Peptide DME1231 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO02121 GENEFORM Protein DME1231 XEOTICID XEO02121 MOACRIVE Inhibition DME1231 XEOTICID XEO02226 XEO_NAME Andropin DME1231 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02226 XEO_CLAS Peptide DME1231 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC > 127 microM) DME1231 XEOTICID XEO02226 GENEFORM Protein DME1231 XEOTICID XEO02226 MOACRIVE Inhibition DME1231 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1231 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02298 XEO_CLAS Peptide DME1231 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC = 32 ug/ml) DME1231 XEOTICID XEO02298 GENEFORM Protein DME1231 XEOTICID XEO02298 MOACRIVE Inhibition DME1231 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1231 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02333 XEO_CLAS Peptide DME1231 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC > 200 microM) DME1231 XEOTICID XEO02333 GENEFORM Protein DME1231 XEOTICID XEO02333 MOACRIVE Inhibition DME1231 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1231 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02466 XEO_CLAS Peptide DME1231 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC = 1.5 microM) DME1231 XEOTICID XEO02466 GENEFORM Protein DME1231 XEOTICID XEO02466 MOACRIVE Inhibition DME1231 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1231 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02491 XEO_CLAS Peptide DME1231 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC = 68.2 microM) DME1231 XEOTICID XEO02491 GENEFORM Protein DME1231 XEOTICID XEO02491 MOACRIVE Inhibition DME1231 XEOTICID XEO02654 XEO_NAME Butane-1,4-diamine DME1231 XEOTICID XEO02654 XEO_TYPE Pharmaceutical Agent(s) DME1231 XEOTICID XEO02654 XEO_CLAS Drug in Phase 2 Clinical Trial DME1231 XEOTICID XEO02654 DESCRIPT Butane-1,4-diamine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO02654 GENEFORM Protein DME1231 XEOTICID XEO02654 MOACRIVE Inhibition DME1231 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1231 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02731 XEO_CLAS Peptide DME1231 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC = 4 microM) DME1231 XEOTICID XEO02731 GENEFORM Protein DME1231 XEOTICID XEO02731 MOACRIVE Inhibition DME1231 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1231 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02739 XEO_CLAS Peptide DME1231 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC = 2 microM) DME1231 XEOTICID XEO02739 GENEFORM Protein DME1231 XEOTICID XEO02739 MOACRIVE Inhibition DME1231 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1231 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02740 XEO_CLAS Peptide DME1231 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC = 2 ug/ml) DME1231 XEOTICID XEO02740 GENEFORM Protein DME1231 XEOTICID XEO02740 MOACRIVE Inhibition DME1231 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1231 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02768 XEO_CLAS Peptide DME1231 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO02768 GENEFORM Protein DME1231 XEOTICID XEO02768 MOACRIVE Inhibition DME1231 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1231 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02769 XEO_CLAS Peptide DME1231 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC = 2.2 microM) DME1231 XEOTICID XEO02769 GENEFORM Protein DME1231 XEOTICID XEO02769 MOACRIVE Inhibition DME1231 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1231 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO02772 XEO_CLAS Peptide DME1231 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO02772 GENEFORM Protein DME1231 XEOTICID XEO02772 MOACRIVE Inhibition DME1231 XEOTICID XEO02912 XEO_NAME Coral associated bacteria 23 DME1231 XEOTICID XEO02912 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1231 XEOTICID XEO02912 XEO_CLAS Bacterial Extract DME1231 XEOTICID XEO02912 DESCRIPT Coral associated bacteria 23 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO02912 GENEFORM Protein DME1231 XEOTICID XEO02912 MOACRIVE Inhibition DME1231 XEOTICID XEO02913 XEO_NAME Coral associated bacteria 41 DME1231 XEOTICID XEO02913 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1231 XEOTICID XEO02913 XEO_CLAS Bacterial Extract DME1231 XEOTICID XEO02913 DESCRIPT Coral associated bacteria 41 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO02913 GENEFORM Protein DME1231 XEOTICID XEO02913 MOACRIVE Inhibition DME1231 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1231 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO03073 XEO_CLAS Peptide DME1231 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC > 256 ug/ml) DME1231 XEOTICID XEO03073 GENEFORM Protein DME1231 XEOTICID XEO03073 MOACRIVE Inhibition DME1231 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1231 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO03116 XEO_CLAS Peptide DME1231 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC > 40 microM) DME1231 XEOTICID XEO03116 GENEFORM Protein DME1231 XEOTICID XEO03116 MOACRIVE Inhibition DME1231 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1231 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO03225 XEO_CLAS Peptide DME1231 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC = 93 microM) DME1231 XEOTICID XEO03225 GENEFORM Protein DME1231 XEOTICID XEO03225 MOACRIVE Inhibition DME1231 XEOTICID XEO03340 XEO_NAME Ethane-1,2-diamine DME1231 XEOTICID XEO03340 XEO_TYPE Pharmaceutical Agent(s) DME1231 XEOTICID XEO03340 XEO_CLAS Investigative Agent DME1231 XEOTICID XEO03340 DESCRIPT Ethane-1,2-diamine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO03340 GENEFORM Protein DME1231 XEOTICID XEO03340 MOACRIVE Inhibition DME1231 XEOTICID XEO03354 XEO_NAME Piper betle ethyl acetate extract DME1231 XEOTICID XEO03354 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1231 XEOTICID XEO03354 XEO_CLAS Plant Extract DME1231 XEOTICID XEO03354 DESCRIPT Piper betle ethyl acetate extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO03354 GENEFORM Protein DME1231 XEOTICID XEO03354 MOACRIVE Inhibition DME1231 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1231 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO03437 XEO_CLAS Peptide DME1231 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC > 200 ug/ml) DME1231 XEOTICID XEO03437 GENEFORM Protein DME1231 XEOTICID XEO03437 MOACRIVE Inhibition DME1231 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1231 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO03438 XEO_CLAS Peptide DME1231 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC > 200 ug/ml) DME1231 XEOTICID XEO03438 GENEFORM Protein DME1231 XEOTICID XEO03438 MOACRIVE Inhibition DME1231 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1231 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO03439 XEO_CLAS Peptide DME1231 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC > 200 ug/ml) DME1231 XEOTICID XEO03439 GENEFORM Protein DME1231 XEOTICID XEO03439 MOACRIVE Inhibition DME1231 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1231 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO03441 XEO_CLAS Peptide DME1231 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC > 200 ug/ml) DME1231 XEOTICID XEO03441 GENEFORM Protein DME1231 XEOTICID XEO03441 MOACRIVE Inhibition DME1231 XEOTICID XEO03519 XEO_NAME Hadrurin DME1231 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO03519 XEO_CLAS Peptide DME1231 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO03519 GENEFORM Protein DME1231 XEOTICID XEO03519 MOACRIVE Inhibition DME1231 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1231 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1231 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1231 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO03552 GENEFORM Protein DME1231 XEOTICID XEO03552 MOACRIVE Inhibition DME1231 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1231 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO03609 XEO_CLAS Peptide DME1231 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO03609 GENEFORM Protein DME1231 XEOTICID XEO03609 MOACRIVE Inhibition DME1231 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1231 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO03985 XEO_CLAS Peptide DME1231 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC = 100 ug/ml) DME1231 XEOTICID XEO03985 GENEFORM Protein DME1231 XEOTICID XEO03985 MOACRIVE Inhibition DME1231 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1231 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04039 XEO_CLAS Peptide DME1231 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC = 4 microM) DME1231 XEOTICID XEO04039 GENEFORM Protein DME1231 XEOTICID XEO04039 MOACRIVE Inhibition DME1231 XEOTICID XEO04081 XEO_NAME Aphrocallistes bocagei methanol extract DME1231 XEOTICID XEO04081 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1231 XEOTICID XEO04081 XEO_CLAS Sponge Extract DME1231 XEOTICID XEO04081 DESCRIPT Aphrocallistes bocagei methanol extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04081 GENEFORM Protein DME1231 XEOTICID XEO04081 MOACRIVE Inhibition DME1231 XEOTICID XEO04082 XEO_NAME Clathria atrasanguinea methanol extract DME1231 XEOTICID XEO04082 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1231 XEOTICID XEO04082 XEO_CLAS Sponge Extract DME1231 XEOTICID XEO04082 DESCRIPT Clathria atrasanguinea methanol extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04082 GENEFORM Protein DME1231 XEOTICID XEO04082 MOACRIVE Inhibition DME1231 XEOTICID XEO04083 XEO_NAME Haliclona megastoma methanol extract DME1231 XEOTICID XEO04083 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1231 XEOTICID XEO04083 XEO_CLAS Sponge Extract DME1231 XEOTICID XEO04083 DESCRIPT Haliclona megastoma methanol extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04083 GENEFORM Protein DME1231 XEOTICID XEO04083 MOACRIVE Inhibition DME1231 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1231 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1231 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1231 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04086 GENEFORM Protein DME1231 XEOTICID XEO04086 MOACRIVE Inhibition DME1231 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1231 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1231 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1231 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04089 GENEFORM Protein DME1231 XEOTICID XEO04089 MOACRIVE Inhibition DME1231 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1231 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04158 XEO_CLAS Peptide DME1231 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC = 2 microM) DME1231 XEOTICID XEO04158 GENEFORM Protein DME1231 XEOTICID XEO04158 MOACRIVE Inhibition DME1231 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1231 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04159 XEO_CLAS Peptide DME1231 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC = 2 microM) DME1231 XEOTICID XEO04159 GENEFORM Protein DME1231 XEOTICID XEO04159 MOACRIVE Inhibition DME1231 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1231 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04185 XEO_CLAS Peptide DME1231 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04185 GENEFORM Protein DME1231 XEOTICID XEO04185 MOACRIVE Inhibition DME1231 XEOTICID XEO04208 XEO_NAME N1-(7-chloroquinolin-4-yl)ethane-1,2-diamine DME1231 XEOTICID XEO04208 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1231 XEOTICID XEO04208 XEO_CLAS Chemical Compound DME1231 XEOTICID XEO04208 DESCRIPT N1-(7-chloroquinolin-4-yl)ethane-1,2-diamine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04208 GENEFORM Protein DME1231 XEOTICID XEO04208 MOACRIVE Inhibition DME1231 XEOTICID XEO04352 XEO_NAME 1,8-Diaminooctane DME1231 XEOTICID XEO04352 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1231 XEOTICID XEO04352 XEO_CLAS Chemical Compound DME1231 XEOTICID XEO04352 DESCRIPT 1,8-Diaminooctane inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04352 GENEFORM Protein DME1231 XEOTICID XEO04352 MOACRIVE Inhibition DME1231 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1231 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04399 XEO_CLAS Peptide DME1231 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC = 50 microM) DME1231 XEOTICID XEO04399 GENEFORM Protein DME1231 XEOTICID XEO04399 MOACRIVE Inhibition DME1231 XEOTICID XEO04557 XEO_NAME 2,4-Di-tert-butylphenol DME1231 XEOTICID XEO04557 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1231 XEOTICID XEO04557 XEO_CLAS Natural Product DME1231 XEOTICID XEO04557 DESCRIPT 2,4-Di-tert-butylphenol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04557 GENEFORM Protein DME1231 XEOTICID XEO04557 MOACRIVE Inhibition DME1231 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1231 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04612 XEO_CLAS Peptide DME1231 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC > 20 microM) DME1231 XEOTICID XEO04612 GENEFORM Protein DME1231 XEOTICID XEO04612 MOACRIVE Inhibition DME1231 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1231 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04613 XEO_CLAS Peptide DME1231 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC > 20 microM) DME1231 XEOTICID XEO04613 GENEFORM Protein DME1231 XEOTICID XEO04613 MOACRIVE Inhibition DME1231 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1231 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04640 XEO_CLAS Peptide DME1231 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens (MIC > 35.0 microM) DME1231 XEOTICID XEO04640 GENEFORM Protein DME1231 XEOTICID XEO04640 MOACRIVE Inhibition DME1231 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1231 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04695 XEO_CLAS Peptide DME1231 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04695 GENEFORM Protein DME1231 XEOTICID XEO04695 MOACRIVE Inhibition DME1231 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1231 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04696 XEO_CLAS Peptide DME1231 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04696 GENEFORM Protein DME1231 XEOTICID XEO04696 MOACRIVE Inhibition DME1231 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1231 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04699 XEO_CLAS Peptide DME1231 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04699 GENEFORM Protein DME1231 XEOTICID XEO04699 MOACRIVE Inhibition DME1231 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1231 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04700 XEO_CLAS Peptide DME1231 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04700 GENEFORM Protein DME1231 XEOTICID XEO04700 MOACRIVE Inhibition DME1231 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1231 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04701 XEO_CLAS Peptide DME1231 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04701 GENEFORM Protein DME1231 XEOTICID XEO04701 MOACRIVE Inhibition DME1231 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1231 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04702 XEO_CLAS Peptide DME1231 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04702 GENEFORM Protein DME1231 XEOTICID XEO04702 MOACRIVE Inhibition DME1231 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1231 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04703 XEO_CLAS Peptide DME1231 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04703 GENEFORM Protein DME1231 XEOTICID XEO04703 MOACRIVE Inhibition DME1231 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1231 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1231 XEOTICID XEO04704 XEO_CLAS Peptide DME1231 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO04704 GENEFORM Protein DME1231 XEOTICID XEO04704 MOACRIVE Inhibition DME1231 XEOTICID XEO05199 XEO_NAME Undecanoic acid DME1231 XEOTICID XEO05199 XEO_TYPE Pharmaceutical Agent(s) DME1231 XEOTICID XEO05199 XEO_CLAS Investigative Agent DME1231 XEOTICID XEO05199 DESCRIPT Undecanoic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Serratia marcescens DME1231 XEOTICID XEO05199 GENEFORM Protein DME1231 XEOTICID XEO05199 MOACRIVE Inhibition DME1234 DME___ID DME1234 DME1234 DME_NAME Cytochrome P450 124 (cyp124) DME1234 SPESNAME Mycobacterium tuberculosis DME1234 XEOTICID XEO03807 XEO_NAME Lariatins A DME1234 XEOTICID XEO03807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1234 XEOTICID XEO03807 XEO_CLAS Peptide DME1234 XEOTICID XEO03807 DESCRIPT Lariatins A inhibits the drug-metabolizing activity of Cytochrome P450 124 (cyp124) from Mycobacterium tuberculosis DME1234 XEOTICID XEO03807 GENEFORM Protein DME1234 XEOTICID XEO03807 MOACRIVE Inhibition DME1234 XEOTICID XEO03808 XEO_NAME Lariatins B DME1234 XEOTICID XEO03808 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1234 XEOTICID XEO03808 XEO_CLAS Peptide DME1234 XEOTICID XEO03808 DESCRIPT Lariatins B inhibits the drug-metabolizing activity of Cytochrome P450 124 (cyp124) from Mycobacterium tuberculosis DME1234 XEOTICID XEO03808 GENEFORM Protein DME1234 XEOTICID XEO03808 MOACRIVE Inhibition DME1235 DME___ID DME1235 DME1235 DME_NAME Cytochrome P450 51B1 (cyp51) DME1235 SPESNAME Mycobacterium tuberculosis DME1235 XEOTICID XEO03807 XEO_NAME Lariatins A DME1235 XEOTICID XEO03807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1235 XEOTICID XEO03807 XEO_CLAS Peptide DME1235 XEOTICID XEO03807 DESCRIPT Lariatins A inhibits the drug-metabolizing activity of Cytochrome P450 51B1 (cyp51) from Mycobacterium tuberculosis DME1235 XEOTICID XEO03807 GENEFORM Protein DME1235 XEOTICID XEO03807 MOACRIVE Inhibition DME1235 XEOTICID XEO03808 XEO_NAME Lariatins B DME1235 XEOTICID XEO03808 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1235 XEOTICID XEO03808 XEO_CLAS Peptide DME1235 XEOTICID XEO03808 DESCRIPT Lariatins B inhibits the drug-metabolizing activity of Cytochrome P450 51B1 (cyp51) from Mycobacterium tuberculosis DME1235 XEOTICID XEO03808 GENEFORM Protein DME1235 XEOTICID XEO03808 MOACRIVE Inhibition DME1236 DME___ID DME1236 DME1236 DME_NAME Cytochrome P450 BM3 (cypBM3) DME1236 SPESNAME Bacillus megaterium DME1236 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1236 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO01823 XEO_CLAS Peptide DME1236 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1.56 microM) DME1236 XEOTICID XEO01823 GENEFORM Protein DME1236 XEOTICID XEO01823 MOACRIVE Inhibition DME1236 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1236 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO01824 XEO_CLAS Peptide DME1236 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3.125 microM) DME1236 XEOTICID XEO01824 GENEFORM Protein DME1236 XEOTICID XEO01824 MOACRIVE Inhibition DME1236 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1236 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO01825 XEO_CLAS Peptide DME1236 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3.125 microM) DME1236 XEOTICID XEO01825 GENEFORM Protein DME1236 XEOTICID XEO01825 MOACRIVE Inhibition DME1236 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1236 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO01827 XEO_CLAS Peptide DME1236 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3.12-6.25 microM) DME1236 XEOTICID XEO01827 GENEFORM Protein DME1236 XEOTICID XEO01827 MOACRIVE Inhibition DME1236 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1236 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02230 XEO_CLAS Peptide DME1236 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.5-1 microM) DME1236 XEOTICID XEO02230 GENEFORM Protein DME1236 XEOTICID XEO02230 MOACRIVE Inhibition DME1236 XEOTICID XEO02237 XEO_NAME Antibacterial napin DME1236 XEOTICID XEO02237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02237 XEO_CLAS Peptide DME1236 XEOTICID XEO02237 DESCRIPT Antibacterial napin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 215 microM) DME1236 XEOTICID XEO02237 GENEFORM Protein DME1236 XEOTICID XEO02237 MOACRIVE Inhibition DME1236 XEOTICID XEO02238 XEO_NAME Antibacterial peptide 3910 DME1236 XEOTICID XEO02238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02238 XEO_CLAS Peptide DME1236 XEOTICID XEO02238 DESCRIPT Antibacterial peptide 3910 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO02238 GENEFORM Protein DME1236 XEOTICID XEO02238 MOACRIVE Inhibition DME1236 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1236 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02242 XEO_CLAS Peptide DME1236 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2 microM) DME1236 XEOTICID XEO02242 GENEFORM Protein DME1236 XEOTICID XEO02242 MOACRIVE Inhibition DME1236 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1236 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02243 XEO_CLAS Peptide DME1236 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3 microM) DME1236 XEOTICID XEO02243 GENEFORM Protein DME1236 XEOTICID XEO02243 MOACRIVE Inhibition DME1236 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1236 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02244 XEO_CLAS Peptide DME1236 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 4 microM) DME1236 XEOTICID XEO02244 GENEFORM Protein DME1236 XEOTICID XEO02244 MOACRIVE Inhibition DME1236 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1236 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02248 XEO_CLAS Peptide DME1236 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.3 microM) DME1236 XEOTICID XEO02248 GENEFORM Protein DME1236 XEOTICID XEO02248 MOACRIVE Inhibition DME1236 XEOTICID XEO02259 XEO_NAME Antimicrobial peptide AC-AMP1 DME1236 XEOTICID XEO02259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02259 XEO_CLAS Peptide DME1236 XEOTICID XEO02259 DESCRIPT Antimicrobial peptide AC-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO02259 GENEFORM Protein DME1236 XEOTICID XEO02259 MOACRIVE Inhibition DME1236 XEOTICID XEO02262 XEO_NAME Antimicrobial peptide MJ-AMP1 DME1236 XEOTICID XEO02262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02262 XEO_CLAS Peptide DME1236 XEOTICID XEO02262 DESCRIPT Antimicrobial peptide MJ-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 6 ug/ml) DME1236 XEOTICID XEO02262 GENEFORM Protein DME1236 XEOTICID XEO02262 MOACRIVE Inhibition DME1236 XEOTICID XEO02267 XEO_NAME Antimicrobial peptide AC-AMP2 DME1236 XEOTICID XEO02267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02267 XEO_CLAS Peptide DME1236 XEOTICID XEO02267 DESCRIPT Antimicrobial peptide AC-AMP2 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO02267 GENEFORM Protein DME1236 XEOTICID XEO02267 MOACRIVE Inhibition DME1236 XEOTICID XEO02269 XEO_NAME Antimicrobial peptide MJ-AMP2 DME1236 XEOTICID XEO02269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02269 XEO_CLAS Peptide DME1236 XEOTICID XEO02269 DESCRIPT Antimicrobial peptide MJ-AMP2 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2 ug/ml) DME1236 XEOTICID XEO02269 GENEFORM Protein DME1236 XEOTICID XEO02269 MOACRIVE Inhibition DME1236 XEOTICID XEO02282 XEO_NAME Antimicrobial peptide GP-19 DME1236 XEOTICID XEO02282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02282 XEO_CLAS Peptide DME1236 XEOTICID XEO02282 DESCRIPT Antimicrobial peptide GP-19 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO02282 GENEFORM Protein DME1236 XEOTICID XEO02282 MOACRIVE Inhibition DME1236 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1236 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02293 XEO_CLAS Peptide DME1236 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.8 microM) DME1236 XEOTICID XEO02293 GENEFORM Protein DME1236 XEOTICID XEO02293 MOACRIVE Inhibition DME1236 XEOTICID XEO02299 XEO_NAME Antimicrobial protein Ace-AMP1 DME1236 XEOTICID XEO02299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02299 XEO_CLAS Peptide DME1236 XEOTICID XEO02299 DESCRIPT Antimicrobial protein Ace-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO02299 GENEFORM Protein DME1236 XEOTICID XEO02299 MOACRIVE Inhibition DME1236 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1236 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02304 XEO_CLAS Peptide DME1236 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 150 ug/ml) DME1236 XEOTICID XEO02304 GENEFORM Protein DME1236 XEOTICID XEO02304 MOACRIVE Inhibition DME1236 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1236 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02305 XEO_CLAS Peptide DME1236 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 100 ug/ml) DME1236 XEOTICID XEO02305 GENEFORM Protein DME1236 XEOTICID XEO02305 MOACRIVE Inhibition DME1236 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1236 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02306 XEO_CLAS Peptide DME1236 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 100 ug/ml) DME1236 XEOTICID XEO02306 GENEFORM Protein DME1236 XEOTICID XEO02306 MOACRIVE Inhibition DME1236 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1236 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02319 XEO_CLAS Peptide DME1236 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.5-1.25 microM) DME1236 XEOTICID XEO02319 GENEFORM Protein DME1236 XEOTICID XEO02319 MOACRIVE Inhibition DME1236 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1236 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02333 XEO_CLAS Peptide DME1236 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC > 200 microM) DME1236 XEOTICID XEO02333 GENEFORM Protein DME1236 XEOTICID XEO02333 MOACRIVE Inhibition DME1236 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1236 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02466 XEO_CLAS Peptide DME1236 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3 microM) DME1236 XEOTICID XEO02466 GENEFORM Protein DME1236 XEOTICID XEO02466 MOACRIVE Inhibition DME1236 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1236 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02468 XEO_CLAS Peptide DME1236 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3.3 microM) DME1236 XEOTICID XEO02468 GENEFORM Protein DME1236 XEOTICID XEO02468 MOACRIVE Inhibition DME1236 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1236 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02474 XEO_CLAS Peptide DME1236 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.3 microM) DME1236 XEOTICID XEO02474 GENEFORM Protein DME1236 XEOTICID XEO02474 MOACRIVE Inhibition DME1236 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1236 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02475 XEO_CLAS Peptide DME1236 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.3 microM) DME1236 XEOTICID XEO02475 GENEFORM Protein DME1236 XEOTICID XEO02475 MOACRIVE Inhibition DME1236 XEOTICID XEO02476 XEO_NAME Bacteriocin HJ50 DME1236 XEOTICID XEO02476 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02476 XEO_CLAS Peptide DME1236 XEOTICID XEO02476 DESCRIPT Bacteriocin HJ50 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO02476 GENEFORM Protein DME1236 XEOTICID XEO02476 MOACRIVE Inhibition DME1236 XEOTICID XEO02521 XEO_NAME Brevinin-1E DME1236 XEOTICID XEO02521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02521 XEO_CLAS Peptide DME1236 XEOTICID XEO02521 DESCRIPT Brevinin-1E inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.4 microM) DME1236 XEOTICID XEO02521 GENEFORM Protein DME1236 XEOTICID XEO02521 MOACRIVE Inhibition DME1236 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1236 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02584 XEO_CLAS Peptide DME1236 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.2 microM) DME1236 XEOTICID XEO02584 GENEFORM Protein DME1236 XEOTICID XEO02584 MOACRIVE Inhibition DME1236 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1236 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02663 XEO_CLAS Peptide DME1236 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1.56 microM) DME1236 XEOTICID XEO02663 GENEFORM Protein DME1236 XEOTICID XEO02663 MOACRIVE Inhibition DME1236 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1236 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02664 XEO_CLAS Peptide DME1236 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3.125 microM) DME1236 XEOTICID XEO02664 GENEFORM Protein DME1236 XEOTICID XEO02664 MOACRIVE Inhibition DME1236 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1236 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02672 XEO_CLAS Peptide DME1236 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1.56 microM) DME1236 XEOTICID XEO02672 GENEFORM Protein DME1236 XEOTICID XEO02672 MOACRIVE Inhibition DME1236 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1236 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02673 XEO_CLAS Peptide DME1236 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3.125 microM) DME1236 XEOTICID XEO02673 GENEFORM Protein DME1236 XEOTICID XEO02673 MOACRIVE Inhibition DME1236 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1236 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02674 XEO_CLAS Peptide DME1236 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3.125 microM) DME1236 XEOTICID XEO02674 GENEFORM Protein DME1236 XEOTICID XEO02674 MOACRIVE Inhibition DME1236 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1236 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02676 XEO_CLAS Peptide DME1236 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1.56 microM) DME1236 XEOTICID XEO02676 GENEFORM Protein DME1236 XEOTICID XEO02676 MOACRIVE Inhibition DME1236 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1236 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02677 XEO_CLAS Peptide DME1236 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3.125 microM) DME1236 XEOTICID XEO02677 GENEFORM Protein DME1236 XEOTICID XEO02677 MOACRIVE Inhibition DME1236 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1236 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02679 XEO_CLAS Peptide DME1236 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3.125 microM) DME1236 XEOTICID XEO02679 GENEFORM Protein DME1236 XEOTICID XEO02679 MOACRIVE Inhibition DME1236 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1236 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02680 XEO_CLAS Peptide DME1236 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3.125 microM) DME1236 XEOTICID XEO02680 GENEFORM Protein DME1236 XEOTICID XEO02680 MOACRIVE Inhibition DME1236 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1236 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02683 XEO_CLAS Peptide DME1236 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3.125 microM) DME1236 XEOTICID XEO02683 GENEFORM Protein DME1236 XEOTICID XEO02683 MOACRIVE Inhibition DME1236 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1236 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02731 XEO_CLAS Peptide DME1236 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 4 microM) DME1236 XEOTICID XEO02731 GENEFORM Protein DME1236 XEOTICID XEO02731 MOACRIVE Inhibition DME1236 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1236 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02739 XEO_CLAS Peptide DME1236 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2 microM) DME1236 XEOTICID XEO02739 GENEFORM Protein DME1236 XEOTICID XEO02739 MOACRIVE Inhibition DME1236 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1236 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02740 XEO_CLAS Peptide DME1236 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2 ug/ml) DME1236 XEOTICID XEO02740 GENEFORM Protein DME1236 XEOTICID XEO02740 MOACRIVE Inhibition DME1236 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1236 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02756 XEO_CLAS Peptide DME1236 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.8 microM) DME1236 XEOTICID XEO02756 GENEFORM Protein DME1236 XEOTICID XEO02756 MOACRIVE Inhibition DME1236 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1236 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02757 XEO_CLAS Peptide DME1236 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.7 microM) DME1236 XEOTICID XEO02757 GENEFORM Protein DME1236 XEOTICID XEO02757 MOACRIVE Inhibition DME1236 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1236 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02758 XEO_CLAS Peptide DME1236 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.9 microM) DME1236 XEOTICID XEO02758 GENEFORM Protein DME1236 XEOTICID XEO02758 MOACRIVE Inhibition DME1236 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1236 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02759 XEO_CLAS Peptide DME1236 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.5 microM) DME1236 XEOTICID XEO02759 GENEFORM Protein DME1236 XEOTICID XEO02759 MOACRIVE Inhibition DME1236 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1236 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02760 XEO_CLAS Peptide DME1236 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.5 microM) DME1236 XEOTICID XEO02760 GENEFORM Protein DME1236 XEOTICID XEO02760 MOACRIVE Inhibition DME1236 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1236 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02761 XEO_CLAS Peptide DME1236 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.5 microM) DME1236 XEOTICID XEO02761 GENEFORM Protein DME1236 XEOTICID XEO02761 MOACRIVE Inhibition DME1236 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1236 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02762 XEO_CLAS Peptide DME1236 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.5 microM) DME1236 XEOTICID XEO02762 GENEFORM Protein DME1236 XEOTICID XEO02762 MOACRIVE Inhibition DME1236 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1236 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02763 XEO_CLAS Peptide DME1236 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.2 microM) DME1236 XEOTICID XEO02763 GENEFORM Protein DME1236 XEOTICID XEO02763 MOACRIVE Inhibition DME1236 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1236 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02765 XEO_CLAS Peptide DME1236 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.4 microM) DME1236 XEOTICID XEO02765 GENEFORM Protein DME1236 XEOTICID XEO02765 MOACRIVE Inhibition DME1236 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1236 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02768 XEO_CLAS Peptide DME1236 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1-2.5 ug/ml) DME1236 XEOTICID XEO02768 GENEFORM Protein DME1236 XEOTICID XEO02768 MOACRIVE Inhibition DME1236 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1236 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02769 XEO_CLAS Peptide DME1236 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.44 microM) DME1236 XEOTICID XEO02769 GENEFORM Protein DME1236 XEOTICID XEO02769 MOACRIVE Inhibition DME1236 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1236 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02770 XEO_CLAS Peptide DME1236 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.64 microM) DME1236 XEOTICID XEO02770 GENEFORM Protein DME1236 XEOTICID XEO02770 MOACRIVE Inhibition DME1236 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1236 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02771 XEO_CLAS Peptide DME1236 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 24 microM) DME1236 XEOTICID XEO02771 GENEFORM Protein DME1236 XEOTICID XEO02771 MOACRIVE Inhibition DME1236 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1236 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02772 XEO_CLAS Peptide DME1236 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO02772 GENEFORM Protein DME1236 XEOTICID XEO02772 MOACRIVE Inhibition DME1236 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1236 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO02774 XEO_CLAS Peptide DME1236 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1.8 microM) DME1236 XEOTICID XEO02774 GENEFORM Protein DME1236 XEOTICID XEO02774 MOACRIVE Inhibition DME1236 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1236 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03081 XEO_CLAS Peptide DME1236 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.69 microM) DME1236 XEOTICID XEO03081 GENEFORM Protein DME1236 XEOTICID XEO03081 MOACRIVE Inhibition DME1236 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1236 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03100 XEO_CLAS Peptide DME1236 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO03100 GENEFORM Protein DME1236 XEOTICID XEO03100 MOACRIVE Inhibition DME1236 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1236 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03110 XEO_CLAS Peptide DME1236 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.8 microM) DME1236 XEOTICID XEO03110 GENEFORM Protein DME1236 XEOTICID XEO03110 MOACRIVE Inhibition DME1236 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1236 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03116 XEO_CLAS Peptide DME1236 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1.2-2.5 microM) DME1236 XEOTICID XEO03116 GENEFORM Protein DME1236 XEOTICID XEO03116 MOACRIVE Inhibition DME1236 XEOTICID XEO03117 XEO_NAME Insect defensin B DME1236 XEOTICID XEO03117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03117 XEO_CLAS Peptide DME1236 XEOTICID XEO03117 DESCRIPT Insect defensin B inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1.2-2.5 microM) DME1236 XEOTICID XEO03117 GENEFORM Protein DME1236 XEOTICID XEO03117 MOACRIVE Inhibition DME1236 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1236 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03119 XEO_CLAS Peptide DME1236 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO03119 GENEFORM Protein DME1236 XEOTICID XEO03119 MOACRIVE Inhibition DME1236 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1236 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03137 XEO_CLAS Peptide DME1236 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO03137 GENEFORM Protein DME1236 XEOTICID XEO03137 MOACRIVE Inhibition DME1236 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1236 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03162 XEO_CLAS Peptide DME1236 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.8 microM) DME1236 XEOTICID XEO03162 GENEFORM Protein DME1236 XEOTICID XEO03162 MOACRIVE Inhibition DME1236 XEOTICID XEO03164 XEO_NAME Dermatoxin DME1236 XEOTICID XEO03164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03164 XEO_CLAS Peptide DME1236 XEOTICID XEO03164 DESCRIPT Dermatoxin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO03164 GENEFORM Protein DME1236 XEOTICID XEO03164 MOACRIVE Inhibition DME1236 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1236 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03224 XEO_CLAS Peptide DME1236 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1-2.5 microM) DME1236 XEOTICID XEO03224 GENEFORM Protein DME1236 XEOTICID XEO03224 MOACRIVE Inhibition DME1236 XEOTICID XEO03243 XEO_NAME Hevein-like antimicrobial peptide Ee-CBPb DME1236 XEOTICID XEO03243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03243 XEO_CLAS Peptide DME1236 XEOTICID XEO03243 DESCRIPT Hevein-like antimicrobial peptide Ee-CBPb inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO03243 GENEFORM Protein DME1236 XEOTICID XEO03243 MOACRIVE Inhibition DME1236 XEOTICID XEO03249 XEO_NAME Enkelytin DME1236 XEOTICID XEO03249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03249 XEO_CLAS Peptide DME1236 XEOTICID XEO03249 DESCRIPT Enkelytin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.2-0.4 microM) DME1236 XEOTICID XEO03249 GENEFORM Protein DME1236 XEOTICID XEO03249 MOACRIVE Inhibition DME1236 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1236 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03251 XEO_CLAS Peptide DME1236 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO03251 GENEFORM Protein DME1236 XEOTICID XEO03251 MOACRIVE Inhibition DME1236 XEOTICID XEO03254 XEO_NAME Enterocin EJ97 DME1236 XEOTICID XEO03254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03254 XEO_CLAS Peptide DME1236 XEOTICID XEO03254 DESCRIPT Enterocin EJ97 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 4 ug/ml) DME1236 XEOTICID XEO03254 GENEFORM Protein DME1236 XEOTICID XEO03254 MOACRIVE Inhibition DME1236 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1236 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03274 XEO_CLAS Peptide DME1236 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.1 microM) DME1236 XEOTICID XEO03274 GENEFORM Protein DME1236 XEOTICID XEO03274 MOACRIVE Inhibition DME1236 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1236 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03277 XEO_CLAS Peptide DME1236 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.1 microM) DME1236 XEOTICID XEO03277 GENEFORM Protein DME1236 XEOTICID XEO03277 MOACRIVE Inhibition DME1236 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1236 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03299 XEO_CLAS Peptide DME1236 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.2 microM) DME1236 XEOTICID XEO03299 GENEFORM Protein DME1236 XEOTICID XEO03299 MOACRIVE Inhibition DME1236 XEOTICID XEO03431 XEO_NAME Thanatin truncated isoform G18C(1-18) DME1236 XEOTICID XEO03431 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03431 XEO_CLAS Peptide DME1236 XEOTICID XEO03431 DESCRIPT Thanatin truncated isoform G18C(1-18) inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 5-10 microM) DME1236 XEOTICID XEO03431 GENEFORM Protein DME1236 XEOTICID XEO03431 MOACRIVE Inhibition DME1236 XEOTICID XEO03432 XEO_NAME Thanatin truncated isoform G19Q(1-19) DME1236 XEOTICID XEO03432 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03432 XEO_CLAS Peptide DME1236 XEOTICID XEO03432 DESCRIPT Thanatin truncated isoform G19Q(1-19) inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 5-10 microM) DME1236 XEOTICID XEO03432 GENEFORM Protein DME1236 XEOTICID XEO03432 MOACRIVE Inhibition DME1236 XEOTICID XEO03435 XEO_NAME Thanatin truncated isoform G20R(1-20) DME1236 XEOTICID XEO03435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03435 XEO_CLAS Peptide DME1236 XEOTICID XEO03435 DESCRIPT Thanatin truncated isoform G20R(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2.5-5 microM) DME1236 XEOTICID XEO03435 GENEFORM Protein DME1236 XEOTICID XEO03435 MOACRIVE Inhibition DME1236 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1236 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03497 XEO_CLAS Peptide DME1236 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.2-0.4 microM) DME1236 XEOTICID XEO03497 GENEFORM Protein DME1236 XEOTICID XEO03497 MOACRIVE Inhibition DME1236 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1236 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03498 XEO_CLAS Peptide DME1236 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.2-0.4 microM) DME1236 XEOTICID XEO03498 GENEFORM Protein DME1236 XEOTICID XEO03498 MOACRIVE Inhibition DME1236 XEOTICID XEO03522 XEO_NAME Halocyntin DME1236 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03522 XEO_CLAS Peptide DME1236 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO03522 GENEFORM Protein DME1236 XEOTICID XEO03522 MOACRIVE Inhibition DME1236 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1236 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03561 XEO_CLAS Peptide DME1236 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO03561 GENEFORM Protein DME1236 XEOTICID XEO03561 MOACRIVE Inhibition DME1236 XEOTICID XEO03605 XEO_NAME Human recombinant Ser-Thr-Ala-CGA1-78 DME1236 XEOTICID XEO03605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03605 XEO_CLAS Peptide DME1236 XEOTICID XEO03605 DESCRIPT Human recombinant Ser-Thr-Ala-CGA1-78 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 30 microM) DME1236 XEOTICID XEO03605 GENEFORM Protein DME1236 XEOTICID XEO03605 MOACRIVE Inhibition DME1236 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1236 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03618 XEO_CLAS Peptide DME1236 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.5-1 microM) DME1236 XEOTICID XEO03618 GENEFORM Protein DME1236 XEOTICID XEO03618 MOACRIVE Inhibition DME1236 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1236 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03622 XEO_CLAS Peptide DME1236 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 10-20 microM) DME1236 XEOTICID XEO03622 GENEFORM Protein DME1236 XEOTICID XEO03622 MOACRIVE Inhibition DME1236 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1236 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03681 XEO_CLAS Peptide DME1236 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2.5-5 microM) DME1236 XEOTICID XEO03681 GENEFORM Protein DME1236 XEOTICID XEO03681 MOACRIVE Inhibition DME1236 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1236 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03712 XEO_CLAS Peptide DME1236 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO03712 GENEFORM Protein DME1236 XEOTICID XEO03712 MOACRIVE Inhibition DME1236 XEOTICID XEO03804 XEO_NAME Lantibiotic lichenicidin VK21 A1 DME1236 XEOTICID XEO03804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03804 XEO_CLAS Peptide DME1236 XEOTICID XEO03804 DESCRIPT Lantibiotic lichenicidin VK21 A1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO03804 GENEFORM Protein DME1236 XEOTICID XEO03804 MOACRIVE Inhibition DME1236 XEOTICID XEO03805 XEO_NAME Lantibiotic lichenicidin VK21 A2 DME1236 XEOTICID XEO03805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03805 XEO_CLAS Peptide DME1236 XEOTICID XEO03805 DESCRIPT Lantibiotic lichenicidin VK21 A2 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO03805 GENEFORM Protein DME1236 XEOTICID XEO03805 MOACRIVE Inhibition DME1236 XEOTICID XEO03973 XEO_NAME Lunatusin DME1236 XEOTICID XEO03973 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO03973 XEO_CLAS Peptide DME1236 XEOTICID XEO03973 DESCRIPT Lunatusin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO03973 GENEFORM Protein DME1236 XEOTICID XEO03973 MOACRIVE Inhibition DME1236 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1236 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04039 XEO_CLAS Peptide DME1236 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2 microM) DME1236 XEOTICID XEO04039 GENEFORM Protein DME1236 XEOTICID XEO04039 MOACRIVE Inhibition DME1236 XEOTICID XEO04057 XEO_NAME Melittin DME1236 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04057 XEO_CLAS Peptide DME1236 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.6 microM) DME1236 XEOTICID XEO04057 GENEFORM Protein DME1236 XEOTICID XEO04057 MOACRIVE Inhibition DME1236 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1236 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04128 XEO_CLAS Peptide DME1236 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.09 microM) DME1236 XEOTICID XEO04128 GENEFORM Protein DME1236 XEOTICID XEO04128 MOACRIVE Inhibition DME1236 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1236 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04158 XEO_CLAS Peptide DME1236 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2 microM) DME1236 XEOTICID XEO04158 GENEFORM Protein DME1236 XEOTICID XEO04158 MOACRIVE Inhibition DME1236 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1236 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04159 XEO_CLAS Peptide DME1236 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2 microM) DME1236 XEOTICID XEO04159 GENEFORM Protein DME1236 XEOTICID XEO04159 MOACRIVE Inhibition DME1236 XEOTICID XEO04166 XEO_NAME Myticin-A DME1236 XEOTICID XEO04166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04166 XEO_CLAS Peptide DME1236 XEOTICID XEO04166 DESCRIPT Myticin-A inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO04166 GENEFORM Protein DME1236 XEOTICID XEO04166 MOACRIVE Inhibition DME1236 XEOTICID XEO04167 XEO_NAME Myticin-B DME1236 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04167 XEO_CLAS Peptide DME1236 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO04167 GENEFORM Protein DME1236 XEOTICID XEO04167 MOACRIVE Inhibition DME1236 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1236 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04168 XEO_CLAS Peptide DME1236 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2.5-5.0 microM) DME1236 XEOTICID XEO04168 GENEFORM Protein DME1236 XEOTICID XEO04168 MOACRIVE Inhibition DME1236 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1236 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04169 XEO_CLAS Peptide DME1236 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO04169 GENEFORM Protein DME1236 XEOTICID XEO04169 MOACRIVE Inhibition DME1236 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1236 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04206 XEO_CLAS Peptide DME1236 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1.56 microM) DME1236 XEOTICID XEO04206 GENEFORM Protein DME1236 XEOTICID XEO04206 MOACRIVE Inhibition DME1236 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1236 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04214 XEO_CLAS Peptide DME1236 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.78 microM) DME1236 XEOTICID XEO04214 GENEFORM Protein DME1236 XEOTICID XEO04214 MOACRIVE Inhibition DME1236 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1236 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04216 XEO_CLAS Peptide DME1236 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1.56 microM) DME1236 XEOTICID XEO04216 GENEFORM Protein DME1236 XEOTICID XEO04216 MOACRIVE Inhibition DME1236 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1236 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04218 XEO_CLAS Peptide DME1236 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.78 microM) DME1236 XEOTICID XEO04218 GENEFORM Protein DME1236 XEOTICID XEO04218 MOACRIVE Inhibition DME1236 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1236 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04219 XEO_CLAS Peptide DME1236 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1.56 microM) DME1236 XEOTICID XEO04219 GENEFORM Protein DME1236 XEOTICID XEO04219 MOACRIVE Inhibition DME1236 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1236 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04220 XEO_CLAS Peptide DME1236 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.78 microM) DME1236 XEOTICID XEO04220 GENEFORM Protein DME1236 XEOTICID XEO04220 MOACRIVE Inhibition DME1236 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1236 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04221 XEO_CLAS Peptide DME1236 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1.56 microM) DME1236 XEOTICID XEO04221 GENEFORM Protein DME1236 XEOTICID XEO04221 MOACRIVE Inhibition DME1236 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1236 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04222 XEO_CLAS Peptide DME1236 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1.56 microM) DME1236 XEOTICID XEO04222 GENEFORM Protein DME1236 XEOTICID XEO04222 MOACRIVE Inhibition DME1236 XEOTICID XEO04235 XEO_NAME Napin-like polypeptide DME1236 XEOTICID XEO04235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04235 XEO_CLAS Peptide DME1236 XEOTICID XEO04235 DESCRIPT Napin-like polypeptide inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO04235 GENEFORM Protein DME1236 XEOTICID XEO04235 MOACRIVE Inhibition DME1236 XEOTICID XEO04394 XEO_NAME Omwaprin-a DME1236 XEOTICID XEO04394 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04394 XEO_CLAS Peptide DME1236 XEOTICID XEO04394 DESCRIPT Omwaprin-a inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO04394 GENEFORM Protein DME1236 XEOTICID XEO04394 MOACRIVE Inhibition DME1236 XEOTICID XEO04424 XEO_NAME P. americana Pa-AMP-1 DME1236 XEOTICID XEO04424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04424 XEO_CLAS Peptide DME1236 XEOTICID XEO04424 DESCRIPT P. americana Pa-AMP-1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO04424 GENEFORM Protein DME1236 XEOTICID XEO04424 MOACRIVE Inhibition DME1236 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1236 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04426 XEO_CLAS Peptide DME1236 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2 microM) DME1236 XEOTICID XEO04426 GENEFORM Protein DME1236 XEOTICID XEO04426 MOACRIVE Inhibition DME1236 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1236 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04430 XEO_CLAS Peptide DME1236 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.78 microM) DME1236 XEOTICID XEO04430 GENEFORM Protein DME1236 XEOTICID XEO04430 MOACRIVE Inhibition DME1236 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1236 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04463 XEO_CLAS Peptide DME1236 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO04463 GENEFORM Protein DME1236 XEOTICID XEO04463 MOACRIVE Inhibition DME1236 XEOTICID XEO04468 XEO_NAME Papillosin DME1236 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04468 XEO_CLAS Peptide DME1236 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO04468 GENEFORM Protein DME1236 XEOTICID XEO04468 MOACRIVE Inhibition DME1236 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1236 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04506 XEO_CLAS Peptide DME1236 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2.5-5 microM) DME1236 XEOTICID XEO04506 GENEFORM Protein DME1236 XEOTICID XEO04506 MOACRIVE Inhibition DME1236 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1236 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04507 XEO_CLAS Peptide DME1236 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2.5-5 microM) DME1236 XEOTICID XEO04507 GENEFORM Protein DME1236 XEOTICID XEO04507 MOACRIVE Inhibition DME1236 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1236 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04510 XEO_CLAS Peptide DME1236 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC > 50 microM) DME1236 XEOTICID XEO04510 GENEFORM Protein DME1236 XEOTICID XEO04510 MOACRIVE Inhibition DME1236 XEOTICID XEO04511 XEO_NAME Penaeidin-4d DME1236 XEOTICID XEO04511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04511 XEO_CLAS Peptide DME1236 XEOTICID XEO04511 DESCRIPT Penaeidin-4d inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC > 50 microM) DME1236 XEOTICID XEO04511 GENEFORM Protein DME1236 XEOTICID XEO04511 MOACRIVE Inhibition DME1236 XEOTICID XEO04545 XEO_NAME Peptide leucine arginine DME1236 XEOTICID XEO04545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04545 XEO_CLAS Peptide DME1236 XEOTICID XEO04545 DESCRIPT Peptide leucine arginine inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 20 microM) DME1236 XEOTICID XEO04545 GENEFORM Protein DME1236 XEOTICID XEO04545 MOACRIVE Inhibition DME1236 XEOTICID XEO04546 XEO_NAME Perinerin DME1236 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04546 XEO_CLAS Peptide DME1236 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO04546 GENEFORM Protein DME1236 XEOTICID XEO04546 MOACRIVE Inhibition DME1236 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1236 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04575 XEO_CLAS Peptide DME1236 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3.12 microM) DME1236 XEOTICID XEO04575 GENEFORM Protein DME1236 XEOTICID XEO04575 MOACRIVE Inhibition DME1236 XEOTICID XEO04624 XEO_NAME Plantazolicin DME1236 XEOTICID XEO04624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04624 XEO_CLAS Peptide DME1236 XEOTICID XEO04624 DESCRIPT Plantazolicin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO04624 GENEFORM Protein DME1236 XEOTICID XEO04624 MOACRIVE Inhibition DME1236 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1236 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04625 XEO_CLAS Peptide DME1236 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 12.5 microM) DME1236 XEOTICID XEO04625 GENEFORM Protein DME1236 XEOTICID XEO04625 MOACRIVE Inhibition DME1236 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1236 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04626 XEO_CLAS Peptide DME1236 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 12.5 microM) DME1236 XEOTICID XEO04626 GENEFORM Protein DME1236 XEOTICID XEO04626 MOACRIVE Inhibition DME1236 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1236 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04627 XEO_CLAS Peptide DME1236 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 50.25 microM) DME1236 XEOTICID XEO04627 GENEFORM Protein DME1236 XEOTICID XEO04627 MOACRIVE Inhibition DME1236 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1236 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04661 XEO_CLAS Peptide DME1236 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3 microM) DME1236 XEOTICID XEO04661 GENEFORM Protein DME1236 XEOTICID XEO04661 MOACRIVE Inhibition DME1236 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1236 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04662 XEO_CLAS Peptide DME1236 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1 microM) DME1236 XEOTICID XEO04662 GENEFORM Protein DME1236 XEOTICID XEO04662 MOACRIVE Inhibition DME1236 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1236 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04663 XEO_CLAS Peptide DME1236 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1 microM) DME1236 XEOTICID XEO04663 GENEFORM Protein DME1236 XEOTICID XEO04663 MOACRIVE Inhibition DME1236 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1236 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04695 XEO_CLAS Peptide DME1236 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO04695 GENEFORM Protein DME1236 XEOTICID XEO04695 MOACRIVE Inhibition DME1236 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1236 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04697 XEO_CLAS Peptide DME1236 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO04697 GENEFORM Protein DME1236 XEOTICID XEO04697 MOACRIVE Inhibition DME1236 XEOTICID XEO04707 XEO_NAME Pore-forming peptide ameobapore A DME1236 XEOTICID XEO04707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04707 XEO_CLAS Peptide DME1236 XEOTICID XEO04707 DESCRIPT Pore-forming peptide ameobapore A inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 13 microM) DME1236 XEOTICID XEO04707 GENEFORM Protein DME1236 XEOTICID XEO04707 MOACRIVE Inhibition DME1236 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1236 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04762 XEO_CLAS Peptide DME1236 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.1 microM) DME1236 XEOTICID XEO04762 GENEFORM Protein DME1236 XEOTICID XEO04762 MOACRIVE Inhibition DME1236 XEOTICID XEO04770 XEO_NAME Pyrrhocoricin DME1236 XEOTICID XEO04770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04770 XEO_CLAS Peptide DME1236 XEOTICID XEO04770 DESCRIPT Pyrrhocoricin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC > 80 microM) DME1236 XEOTICID XEO04770 GENEFORM Protein DME1236 XEOTICID XEO04770 MOACRIVE Inhibition DME1236 XEOTICID XEO04797 XEO_NAME Ranacyclin-E DME1236 XEOTICID XEO04797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04797 XEO_CLAS Peptide DME1236 XEOTICID XEO04797 DESCRIPT Ranacyclin-E inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3 microM) DME1236 XEOTICID XEO04797 GENEFORM Protein DME1236 XEOTICID XEO04797 MOACRIVE Inhibition DME1236 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1236 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04798 XEO_CLAS Peptide DME1236 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 3 microM) DME1236 XEOTICID XEO04798 GENEFORM Protein DME1236 XEOTICID XEO04798 MOACRIVE Inhibition DME1236 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1236 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04840 XEO_CLAS Peptide DME1236 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC > 20 microM) DME1236 XEOTICID XEO04840 GENEFORM Protein DME1236 XEOTICID XEO04840 MOACRIVE Inhibition DME1236 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1236 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04905 XEO_CLAS Peptide DME1236 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO04905 GENEFORM Protein DME1236 XEOTICID XEO04905 MOACRIVE Inhibition DME1236 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1236 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04906 XEO_CLAS Peptide DME1236 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO04906 GENEFORM Protein DME1236 XEOTICID XEO04906 MOACRIVE Inhibition DME1236 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1236 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04971 XEO_CLAS Peptide DME1236 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.4-0.8 microM) DME1236 XEOTICID XEO04971 GENEFORM Protein DME1236 XEOTICID XEO04971 MOACRIVE Inhibition DME1236 XEOTICID XEO04974 XEO_NAME Spinigerin DME1236 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04974 XEO_CLAS Peptide DME1236 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.8-1.5 microM) DME1236 XEOTICID XEO04974 GENEFORM Protein DME1236 XEOTICID XEO04974 MOACRIVE Inhibition DME1236 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1236 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO04995 XEO_CLAS Peptide DME1236 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.78-1.56 microM) DME1236 XEOTICID XEO04995 GENEFORM Protein DME1236 XEOTICID XEO04995 MOACRIVE Inhibition DME1236 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1236 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05004 XEO_CLAS Peptide DME1236 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO05004 GENEFORM Protein DME1236 XEOTICID XEO05004 MOACRIVE Inhibition DME1236 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1236 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05005 XEO_CLAS Peptide DME1236 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO05005 GENEFORM Protein DME1236 XEOTICID XEO05005 MOACRIVE Inhibition DME1236 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1236 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05063 XEO_CLAS Peptide DME1236 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2 microM) DME1236 XEOTICID XEO05063 GENEFORM Protein DME1236 XEOTICID XEO05063 MOACRIVE Inhibition DME1236 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1236 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05064 XEO_CLAS Peptide DME1236 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 46 microM) DME1236 XEOTICID XEO05064 GENEFORM Protein DME1236 XEOTICID XEO05064 MOACRIVE Inhibition DME1236 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1236 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05065 XEO_CLAS Peptide DME1236 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 4 ug/ml) DME1236 XEOTICID XEO05065 GENEFORM Protein DME1236 XEOTICID XEO05065 MOACRIVE Inhibition DME1236 XEOTICID XEO05076 XEO_NAME Temporin-A DME1236 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05076 XEO_CLAS Peptide DME1236 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 1.2 microM) DME1236 XEOTICID XEO05076 GENEFORM Protein DME1236 XEOTICID XEO05076 MOACRIVE Inhibition DME1236 XEOTICID XEO05085 XEO_NAME Temporin-B DME1236 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05085 XEO_CLAS Peptide DME1236 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2.8 ug/ml) DME1236 XEOTICID XEO05085 GENEFORM Protein DME1236 XEOTICID XEO05085 MOACRIVE Inhibition DME1236 XEOTICID XEO05088 XEO_NAME Temporin-D DME1236 XEOTICID XEO05088 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05088 XEO_CLAS Peptide DME1236 XEOTICID XEO05088 DESCRIPT Temporin-D inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO05088 GENEFORM Protein DME1236 XEOTICID XEO05088 MOACRIVE Inhibition DME1236 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1236 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05105 XEO_CLAS Peptide DME1236 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2 microM) DME1236 XEOTICID XEO05105 GENEFORM Protein DME1236 XEOTICID XEO05105 MOACRIVE Inhibition DME1236 XEOTICID XEO05110 XEO_NAME Termicin DME1236 XEOTICID XEO05110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05110 XEO_CLAS Peptide DME1236 XEOTICID XEO05110 DESCRIPT Termicin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO05110 GENEFORM Protein DME1236 XEOTICID XEO05110 MOACRIVE Inhibition DME1236 XEOTICID XEO05120 XEO_NAME Thanatin DME1236 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05120 XEO_CLAS Peptide DME1236 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 2.5-5 microM) DME1236 XEOTICID XEO05120 GENEFORM Protein DME1236 XEOTICID XEO05120 MOACRIVE Inhibition DME1236 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1236 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05125 XEO_CLAS Peptide DME1236 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO05125 GENEFORM Protein DME1236 XEOTICID XEO05125 MOACRIVE Inhibition DME1236 XEOTICID XEO05138 XEO_NAME Thuricin-17 DME1236 XEOTICID XEO05138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05138 XEO_CLAS Peptide DME1236 XEOTICID XEO05138 DESCRIPT Thuricin-17 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium DME1236 XEOTICID XEO05138 GENEFORM Protein DME1236 XEOTICID XEO05138 MOACRIVE Inhibition DME1236 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1236 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05220 XEO_CLAS Peptide DME1236 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 5-10 microM) DME1236 XEOTICID XEO05220 GENEFORM Protein DME1236 XEOTICID XEO05220 MOACRIVE Inhibition DME1236 XEOTICID XEO05229 XEO_NAME Vasostatin-1 DME1236 XEOTICID XEO05229 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05229 XEO_CLAS Peptide DME1236 XEOTICID XEO05229 DESCRIPT Vasostatin-1 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.2 microM) DME1236 XEOTICID XEO05229 GENEFORM Protein DME1236 XEOTICID XEO05229 MOACRIVE Inhibition DME1236 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1236 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05230 XEO_CLAS Peptide DME1236 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.25 microM) DME1236 XEOTICID XEO05230 GENEFORM Protein DME1236 XEOTICID XEO05230 MOACRIVE Inhibition DME1236 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1236 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05231 XEO_CLAS Peptide DME1236 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 0.25 microM) DME1236 XEOTICID XEO05231 GENEFORM Protein DME1236 XEOTICID XEO05231 MOACRIVE Inhibition DME1236 XEOTICID XEO05304 XEO_NAME Thanatin truncated isoform Y12M(10-21) DME1236 XEOTICID XEO05304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1236 XEOTICID XEO05304 XEO_CLAS Peptide DME1236 XEOTICID XEO05304 DESCRIPT Thanatin truncated isoform Y12M(10-21) inhibits the drug-metabolizing activity of Cytochrome P450 BM3 (cypBM3) from Bacillus megaterium (MIC = 20-40 microM) DME1236 XEOTICID XEO05304 GENEFORM Protein DME1236 XEOTICID XEO05304 MOACRIVE Inhibition DME1239 DME___ID DME1239 DME1239 DME_NAME Folylpolyglutamate synthetase (fpgS) DME1239 SPESNAME Lactobacillus casei DME1239 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1239 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1239 XEOTICID XEO03771 XEO_CLAS Peptide DME1239 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Folylpolyglutamate synthetase (fpgS) from Lactobacillus casei DME1239 XEOTICID XEO03771 GENEFORM Protein DME1239 XEOTICID XEO03771 MOACRIVE Inhibition DME1239 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1239 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1239 XEOTICID XEO03775 XEO_CLAS Peptide DME1239 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Folylpolyglutamate synthetase (fpgS) from Lactobacillus casei (MIC = 2.27 microM) DME1239 XEOTICID XEO03775 GENEFORM Protein DME1239 XEOTICID XEO03775 MOACRIVE Inhibition DME1239 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1239 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1239 XEOTICID XEO03803 XEO_CLAS Peptide DME1239 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Folylpolyglutamate synthetase (fpgS) from Lactobacillus casei DME1239 XEOTICID XEO03803 GENEFORM Protein DME1239 XEOTICID XEO03803 MOACRIVE Inhibition DME1239 XEOTICID XEO03967 XEO_NAME Bacteriocin LSEI_2163 DME1239 XEOTICID XEO03967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1239 XEOTICID XEO03967 XEO_CLAS Peptide DME1239 XEOTICID XEO03967 DESCRIPT Bacteriocin LSEI_2163 inhibits the drug-metabolizing activity of Folylpolyglutamate synthetase (fpgS) from Lactobacillus casei DME1239 XEOTICID XEO03967 GENEFORM Protein DME1239 XEOTICID XEO03967 MOACRIVE Inhibition DME1239 XEOTICID XEO04332 XEO_NAME Nosiheptide DME1239 XEOTICID XEO04332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1239 XEOTICID XEO04332 XEO_CLAS Peptide DME1239 XEOTICID XEO04332 DESCRIPT Nosiheptide inhibits the drug-metabolizing activity of Folylpolyglutamate synthetase (fpgS) from Lactobacillus casei (MIC = 0.003 ug/ml) DME1239 XEOTICID XEO04332 GENEFORM Protein DME1239 XEOTICID XEO04332 MOACRIVE Inhibition DME1239 XEOTICID XEO04521 XEO_NAME Penocin A DME1239 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1239 XEOTICID XEO04521 XEO_CLAS Peptide DME1239 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Folylpolyglutamate synthetase (fpgS) from Lactobacillus casei DME1239 XEOTICID XEO04521 GENEFORM Protein DME1239 XEOTICID XEO04521 MOACRIVE Inhibition DME1239 XEOTICID XEO04616 XEO_NAME Plantaricin E DME1239 XEOTICID XEO04616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1239 XEOTICID XEO04616 XEO_CLAS Peptide DME1239 XEOTICID XEO04616 DESCRIPT Plantaricin E inhibits the drug-metabolizing activity of Folylpolyglutamate synthetase (fpgS) from Lactobacillus casei (MIC = 0.02 microM) DME1239 XEOTICID XEO04616 GENEFORM Protein DME1239 XEOTICID XEO04616 MOACRIVE Inhibition DME1239 XEOTICID XEO04617 XEO_NAME Plantaricin F DME1239 XEOTICID XEO04617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1239 XEOTICID XEO04617 XEO_CLAS Peptide DME1239 XEOTICID XEO04617 DESCRIPT Plantaricin F inhibits the drug-metabolizing activity of Folylpolyglutamate synthetase (fpgS) from Lactobacillus casei (MIC = 0.02 microM) DME1239 XEOTICID XEO04617 GENEFORM Protein DME1239 XEOTICID XEO04617 MOACRIVE Inhibition DME1239 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1239 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1239 XEOTICID XEO05004 XEO_CLAS Peptide DME1239 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Folylpolyglutamate synthetase (fpgS) from Lactobacillus casei DME1239 XEOTICID XEO05004 GENEFORM Protein DME1239 XEOTICID XEO05004 MOACRIVE Inhibition DME1239 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1239 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1239 XEOTICID XEO05005 XEO_CLAS Peptide DME1239 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Folylpolyglutamate synthetase (fpgS) from Lactobacillus casei DME1239 XEOTICID XEO05005 GENEFORM Protein DME1239 XEOTICID XEO05005 MOACRIVE Inhibition DME1239 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1239 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1239 XEOTICID XEO05283 XEO_CLAS Peptide DME1239 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Folylpolyglutamate synthetase (fpgS) from Lactobacillus casei DME1239 XEOTICID XEO05283 GENEFORM Protein DME1239 XEOTICID XEO05283 MOACRIVE Inhibition DME1242 DME___ID DME1242 DME1242 DME_NAME NADPH-dependent oxidoreductase (nfrA) DME1242 SPESNAME Staphylococcus aureus DME1242 XEOTICID XEO00096 XEO_NAME Ampicillin DME1242 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00096 GENEFORM Protein DME1242 XEOTICID XEO00096 MOACRIVE Inhibition DME1242 XEOTICID XEO00110 XEO_NAME Acetylcysteine DME1242 XEOTICID XEO00110 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00110 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO00110 DESCRIPT Acetylcysteine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00110 GENEFORM Protein DME1242 XEOTICID XEO00110 MOACRIVE Inhibition DME1242 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1242 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00117 GENEFORM Protein DME1242 XEOTICID XEO00117 MOACRIVE Inhibition DME1242 XEOTICID XEO00120 XEO_NAME Cefazolin DME1242 XEOTICID XEO00120 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00120 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO00120 DESCRIPT Cefazolin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00120 GENEFORM Protein DME1242 XEOTICID XEO00120 MOACRIVE Inhibition DME1242 XEOTICID XEO00164 XEO_NAME Azithromycin DME1242 XEOTICID XEO00164 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00164 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO00164 DESCRIPT Azithromycin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00164 GENEFORM Protein DME1242 XEOTICID XEO00164 MOACRIVE Inhibition DME1242 XEOTICID XEO00223 XEO_NAME Rifampin DME1242 XEOTICID XEO00223 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00223 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO00223 DESCRIPT Rifampin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00223 GENEFORM Protein DME1242 XEOTICID XEO00223 MOACRIVE Inhibition DME1242 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1242 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00349 GENEFORM Protein DME1242 XEOTICID XEO00349 MOACRIVE Inhibition DME1242 XEOTICID XEO00396 XEO_NAME Gentamicin DME1242 XEOTICID XEO00396 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00396 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO00396 DESCRIPT Gentamicin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00396 GENEFORM Protein DME1242 XEOTICID XEO00396 MOACRIVE Inhibition DME1242 XEOTICID XEO00441 XEO_NAME Silybin DME1242 XEOTICID XEO00441 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00441 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO00441 DESCRIPT Silybin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00441 GENEFORM Protein DME1242 XEOTICID XEO00441 MOACRIVE Inhibition DME1242 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1242 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00460 GENEFORM Protein DME1242 XEOTICID XEO00460 MOACRIVE Inhibition DME1242 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1242 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00511 GENEFORM Protein DME1242 XEOTICID XEO00511 MOACRIVE Inhibition DME1242 XEOTICID XEO00547 XEO_NAME Vitamin E DME1242 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1242 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00547 GENEFORM Protein DME1242 XEOTICID XEO00547 MOACRIVE Inhibition DME1242 XEOTICID XEO00568 XEO_NAME Resveratrol DME1242 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1242 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00568 GENEFORM Protein DME1242 XEOTICID XEO00568 MOACRIVE Inhibition DME1242 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME1242 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME1242 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00613 GENEFORM Protein DME1242 XEOTICID XEO00613 MOACRIVE Inhibition DME1242 XEOTICID XEO00621 XEO_NAME Chitosan DME1242 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1242 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00621 GENEFORM Protein DME1242 XEOTICID XEO00621 MOACRIVE Inhibition DME1242 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1242 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1242 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00730 GENEFORM Protein DME1242 XEOTICID XEO00730 MOACRIVE Inhibition DME1242 XEOTICID XEO00852 XEO_NAME Allyl isothiocyanate DME1242 XEOTICID XEO00852 XEO_TYPE Health or Environmental Toxicant(s) DME1242 XEOTICID XEO00852 XEO_CLAS Acute Toxic Substance DME1242 XEOTICID XEO00852 DESCRIPT Allyl isothiocyanate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00852 GENEFORM Protein DME1242 XEOTICID XEO00852 MOACRIVE Inhibition DME1242 XEOTICID XEO00856 XEO_NAME Hesperetin DME1242 XEOTICID XEO00856 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO00856 XEO_CLAS Natural Product DME1242 XEOTICID XEO00856 DESCRIPT Hesperetin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00856 GENEFORM Protein DME1242 XEOTICID XEO00856 MOACRIVE Inhibition DME1242 XEOTICID XEO00865 XEO_NAME Sanguinarine DME1242 XEOTICID XEO00865 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO00865 XEO_CLAS Natural Product DME1242 XEOTICID XEO00865 DESCRIPT Sanguinarine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00865 GENEFORM Protein DME1242 XEOTICID XEO00865 MOACRIVE Inhibition DME1242 XEOTICID XEO00879 XEO_NAME Coumarin DME1242 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1242 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1242 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00879 GENEFORM Protein DME1242 XEOTICID XEO00879 MOACRIVE Inhibition DME1242 XEOTICID XEO00883 XEO_NAME Phloretin DME1242 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO00883 XEO_CLAS Natural Product DME1242 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00883 GENEFORM Protein DME1242 XEOTICID XEO00883 MOACRIVE Inhibition DME1242 XEOTICID XEO00885 XEO_NAME Eugenol DME1242 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1242 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO00885 GENEFORM Protein DME1242 XEOTICID XEO00885 MOACRIVE Inhibition DME1242 XEOTICID XEO01000 XEO_NAME Carbon tetrachloride DME1242 XEOTICID XEO01000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01000 XEO_CLAS Peptide DME1242 XEOTICID XEO01000 DESCRIPT Carbon tetrachloride inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01000 GENEFORM Protein DME1242 XEOTICID XEO01000 MOACRIVE Inhibition DME1242 XEOTICID XEO01016 XEO_NAME N-hexane DME1242 XEOTICID XEO01016 XEO_TYPE Health or Environmental Toxicant(s) DME1242 XEOTICID XEO01016 XEO_CLAS Health Hazard/Toxicant DME1242 XEOTICID XEO01016 DESCRIPT N-hexane inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01016 GENEFORM Protein DME1242 XEOTICID XEO01016 MOACRIVE Inhibition DME1242 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1242 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1242 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1242 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01032 GENEFORM Protein DME1242 XEOTICID XEO01032 MOACRIVE Inhibition DME1242 XEOTICID XEO01212 XEO_NAME Baicalein DME1242 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO01212 XEO_CLAS Natural Product DME1242 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01212 GENEFORM Protein DME1242 XEOTICID XEO01212 MOACRIVE Inhibition DME1242 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1242 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1242 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1242 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01232 GENEFORM Protein DME1242 XEOTICID XEO01232 MOACRIVE Inhibition DME1242 XEOTICID XEO01237 XEO_NAME Carvacrol DME1242 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1242 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01237 GENEFORM Protein DME1242 XEOTICID XEO01237 MOACRIVE Inhibition DME1242 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME1242 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO01253 XEO_CLAS Natural Product DME1242 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01253 GENEFORM Protein DME1242 XEOTICID XEO01253 MOACRIVE Inhibition DME1242 XEOTICID XEO01286 XEO_NAME Egtazic acid DME1242 XEOTICID XEO01286 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO01286 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO01286 DESCRIPT Egtazic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01286 GENEFORM Protein DME1242 XEOTICID XEO01286 MOACRIVE Inhibition DME1242 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1242 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1242 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01287 GENEFORM Protein DME1242 XEOTICID XEO01287 MOACRIVE Inhibition DME1242 XEOTICID XEO01298 XEO_NAME Farnesol DME1242 XEOTICID XEO01298 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO01298 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO01298 DESCRIPT Farnesol inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01298 GENEFORM Protein DME1242 XEOTICID XEO01298 MOACRIVE Inhibition DME1242 XEOTICID XEO01309 XEO_NAME Gallic acid DME1242 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO01309 XEO_CLAS Natural Product DME1242 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01309 GENEFORM Protein DME1242 XEOTICID XEO01309 MOACRIVE Inhibition DME1242 XEOTICID XEO01353 XEO_NAME Kaempferol DME1242 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1242 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1242 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01353 GENEFORM Protein DME1242 XEOTICID XEO01353 MOACRIVE Inhibition DME1242 XEOTICID XEO01384 XEO_NAME Myricetin DME1242 XEOTICID XEO01384 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO01384 XEO_CLAS Preclinical/Patented Drug DME1242 XEOTICID XEO01384 DESCRIPT Myricetin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01384 GENEFORM Protein DME1242 XEOTICID XEO01384 MOACRIVE Inhibition DME1242 XEOTICID XEO01408 XEO_NAME Octyl gallate DME1242 XEOTICID XEO01408 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO01408 XEO_CLAS Natural Product DME1242 XEOTICID XEO01408 DESCRIPT Octyl gallate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01408 GENEFORM Protein DME1242 XEOTICID XEO01408 MOACRIVE Inhibition DME1242 XEOTICID XEO01411 XEO_NAME Oleanolic acid DME1242 XEOTICID XEO01411 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO01411 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO01411 DESCRIPT Oleanolic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01411 GENEFORM Protein DME1242 XEOTICID XEO01411 MOACRIVE Inhibition DME1242 XEOTICID XEO01429 XEO_NAME Phlorhizin DME1242 XEOTICID XEO01429 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO01429 XEO_CLAS Natural Product DME1242 XEOTICID XEO01429 DESCRIPT Phlorhizin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01429 GENEFORM Protein DME1242 XEOTICID XEO01429 MOACRIVE Inhibition DME1242 XEOTICID XEO01442 XEO_NAME Puag-haad DME1242 XEOTICID XEO01442 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO01442 XEO_CLAS Natural Product DME1242 XEOTICID XEO01442 DESCRIPT Puag-haad inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01442 GENEFORM Protein DME1242 XEOTICID XEO01442 MOACRIVE Inhibition DME1242 XEOTICID XEO01453 XEO_NAME Resorcinol DME1242 XEOTICID XEO01453 XEO_TYPE Health or Environmental Toxicant(s) DME1242 XEOTICID XEO01453 XEO_CLAS Environmental Pollutant DME1242 XEOTICID XEO01453 DESCRIPT Resorcinol inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01453 GENEFORM Protein DME1242 XEOTICID XEO01453 MOACRIVE Inhibition DME1242 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1242 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1242 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01496 GENEFORM Protein DME1242 XEOTICID XEO01496 MOACRIVE Inhibition DME1242 XEOTICID XEO01557 XEO_NAME Lemongrass oil DME1242 XEOTICID XEO01557 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO01557 XEO_CLAS Natural Product DME1242 XEOTICID XEO01557 DESCRIPT Lemongrass oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01557 GENEFORM Protein DME1242 XEOTICID XEO01557 MOACRIVE Inhibition DME1242 XEOTICID XEO01571 XEO_NAME Peppermint oil DME1242 XEOTICID XEO01571 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO01571 XEO_CLAS Natural Product DME1242 XEOTICID XEO01571 DESCRIPT Peppermint oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01571 GENEFORM Protein DME1242 XEOTICID XEO01571 MOACRIVE Inhibition DME1242 XEOTICID XEO01745 XEO_NAME (2S)-2-amino-3-(1,3-thiazol-4-yl)propanoic acid DME1242 XEOTICID XEO01745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01745 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01745 DESCRIPT (2S)-2-amino-3-(1,3-thiazol-4-yl)propanoic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01745 GENEFORM Protein DME1242 XEOTICID XEO01745 MOACRIVE Inhibition DME1242 XEOTICID XEO01747 XEO_NAME (2S)-2-amino-4-bromopent-4-enoic acid DME1242 XEOTICID XEO01747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01747 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01747 DESCRIPT (2S)-2-amino-4-bromopent-4-enoic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01747 GENEFORM Protein DME1242 XEOTICID XEO01747 MOACRIVE Inhibition DME1242 XEOTICID XEO01785 XEO_NAME (R)-2,3-Diaminopropanoic acid DME1242 XEOTICID XEO01785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01785 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01785 DESCRIPT (R)-2,3-Diaminopropanoic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01785 GENEFORM Protein DME1242 XEOTICID XEO01785 MOACRIVE Inhibition DME1242 XEOTICID XEO01786 XEO_NAME (R)-2-amino-3-cyclohexylpropanoic acid DME1242 XEOTICID XEO01786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01786 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01786 DESCRIPT (R)-2-amino-3-cyclohexylpropanoic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01786 GENEFORM Protein DME1242 XEOTICID XEO01786 MOACRIVE Inhibition DME1242 XEOTICID XEO01787 XEO_NAME (R)-2-amino-3-cyclopentylpropanoic acid DME1242 XEOTICID XEO01787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01787 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01787 DESCRIPT (R)-2-amino-3-cyclopentylpropanoic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01787 GENEFORM Protein DME1242 XEOTICID XEO01787 MOACRIVE Inhibition DME1242 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1242 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01810 XEO_CLAS Peptide DME1242 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.0 microM) DME1242 XEOTICID XEO01810 GENEFORM Protein DME1242 XEOTICID XEO01810 MOACRIVE Inhibition DME1242 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1242 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01811 XEO_CLAS Peptide DME1242 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 64 microM) DME1242 XEOTICID XEO01811 GENEFORM Protein DME1242 XEOTICID XEO01811 MOACRIVE Inhibition DME1242 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1242 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01812 XEO_CLAS Peptide DME1242 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.3 microM) DME1242 XEOTICID XEO01812 GENEFORM Protein DME1242 XEOTICID XEO01812 MOACRIVE Inhibition DME1242 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1242 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01813 XEO_CLAS Peptide DME1242 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.7 microM) DME1242 XEOTICID XEO01813 GENEFORM Protein DME1242 XEOTICID XEO01813 MOACRIVE Inhibition DME1242 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1242 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01814 XEO_CLAS Peptide DME1242 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.7 microM) DME1242 XEOTICID XEO01814 GENEFORM Protein DME1242 XEOTICID XEO01814 MOACRIVE Inhibition DME1242 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1242 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01815 XEO_CLAS Peptide DME1242 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.3 microM) DME1242 XEOTICID XEO01815 GENEFORM Protein DME1242 XEOTICID XEO01815 MOACRIVE Inhibition DME1242 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1242 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01816 XEO_CLAS Peptide DME1242 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 microM) DME1242 XEOTICID XEO01816 GENEFORM Protein DME1242 XEOTICID XEO01816 MOACRIVE Inhibition DME1242 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1242 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01817 XEO_CLAS Peptide DME1242 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.0 microM) DME1242 XEOTICID XEO01817 GENEFORM Protein DME1242 XEOTICID XEO01817 MOACRIVE Inhibition DME1242 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1242 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01818 XEO_CLAS Peptide DME1242 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.0 microM) DME1242 XEOTICID XEO01818 GENEFORM Protein DME1242 XEOTICID XEO01818 MOACRIVE Inhibition DME1242 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1242 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01819 XEO_CLAS Peptide DME1242 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO01819 GENEFORM Protein DME1242 XEOTICID XEO01819 MOACRIVE Inhibition DME1242 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1242 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01820 XEO_CLAS Peptide DME1242 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 microM) DME1242 XEOTICID XEO01820 GENEFORM Protein DME1242 XEOTICID XEO01820 MOACRIVE Inhibition DME1242 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1242 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01821 XEO_CLAS Peptide DME1242 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO01821 GENEFORM Protein DME1242 XEOTICID XEO01821 MOACRIVE Inhibition DME1242 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1242 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01822 XEO_CLAS Peptide DME1242 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 microM) DME1242 XEOTICID XEO01822 GENEFORM Protein DME1242 XEOTICID XEO01822 MOACRIVE Inhibition DME1242 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1242 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01823 XEO_CLAS Peptide DME1242 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.125 microM) DME1242 XEOTICID XEO01823 GENEFORM Protein DME1242 XEOTICID XEO01823 MOACRIVE Inhibition DME1242 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1242 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01825 XEO_CLAS Peptide DME1242 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 microM) DME1242 XEOTICID XEO01825 GENEFORM Protein DME1242 XEOTICID XEO01825 MOACRIVE Inhibition DME1242 XEOTICID XEO01918 XEO_NAME 2,3,4,5,6-Pentafluoro-L-phenylalanine DME1242 XEOTICID XEO01918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01918 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01918 DESCRIPT 2,3,4,5,6-Pentafluoro-L-phenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01918 GENEFORM Protein DME1242 XEOTICID XEO01918 MOACRIVE Inhibition DME1242 XEOTICID XEO01919 XEO_NAME 2,3-Dehydrosilybin DME1242 XEOTICID XEO01919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO01919 XEO_CLAS Natural Product DME1242 XEOTICID XEO01919 DESCRIPT 2,3-Dehydrosilybin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01919 GENEFORM Protein DME1242 XEOTICID XEO01919 MOACRIVE Inhibition DME1242 XEOTICID XEO01920 XEO_NAME 2,3-dihydroxybenzoic acid DME1242 XEOTICID XEO01920 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO01920 XEO_CLAS Natural Product DME1242 XEOTICID XEO01920 DESCRIPT 2,3-dihydroxybenzoic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01920 GENEFORM Protein DME1242 XEOTICID XEO01920 MOACRIVE Inhibition DME1242 XEOTICID XEO01921 XEO_NAME 2,4,5-Trifluorophenylalanine DME1242 XEOTICID XEO01921 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01921 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01921 DESCRIPT 2,4,5-Trifluorophenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01921 GENEFORM Protein DME1242 XEOTICID XEO01921 MOACRIVE Inhibition DME1242 XEOTICID XEO01922 XEO_NAME 2,4-Difluorophenylalanine DME1242 XEOTICID XEO01922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01922 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01922 DESCRIPT 2,4-Difluorophenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01922 GENEFORM Protein DME1242 XEOTICID XEO01922 MOACRIVE Inhibition DME1242 XEOTICID XEO01923 XEO_NAME 2,4-Dimethylphenylalanine DME1242 XEOTICID XEO01923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01923 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01923 DESCRIPT 2,4-Dimethylphenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01923 GENEFORM Protein DME1242 XEOTICID XEO01923 MOACRIVE Inhibition DME1242 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1242 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01927 XEO_CLAS Peptide DME1242 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5 ug/ml) DME1242 XEOTICID XEO01927 GENEFORM Protein DME1242 XEOTICID XEO01927 MOACRIVE Inhibition DME1242 XEOTICID XEO01928 XEO_NAME 2-amino-3-(3-chlorophenyl)propanoic acid DME1242 XEOTICID XEO01928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01928 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01928 DESCRIPT 2-amino-3-(3-chlorophenyl)propanoic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01928 GENEFORM Protein DME1242 XEOTICID XEO01928 MOACRIVE Inhibition DME1242 XEOTICID XEO01929 XEO_NAME 2-amino-3-(3-nitrophenyl)propanoic acid DME1242 XEOTICID XEO01929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01929 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01929 DESCRIPT 2-amino-3-(3-nitrophenyl)propanoic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01929 GENEFORM Protein DME1242 XEOTICID XEO01929 MOACRIVE Inhibition DME1242 XEOTICID XEO01932 XEO_NAME 2-amino-5-methoxy-5-oxopentanoic acid DME1242 XEOTICID XEO01932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01932 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01932 DESCRIPT 2-amino-5-methoxy-5-oxopentanoic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01932 GENEFORM Protein DME1242 XEOTICID XEO01932 MOACRIVE Inhibition DME1242 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1242 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01945 XEO_CLAS Peptide DME1242 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 32 microM) DME1242 XEOTICID XEO01945 GENEFORM Protein DME1242 XEOTICID XEO01945 MOACRIVE Inhibition DME1242 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1242 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01946 XEO_CLAS Peptide DME1242 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 26 microM) DME1242 XEOTICID XEO01946 GENEFORM Protein DME1242 XEOTICID XEO01946 MOACRIVE Inhibition DME1242 XEOTICID XEO01949 XEO_NAME 2-Methoxy-D-Phenylalanine DME1242 XEOTICID XEO01949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01949 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01949 DESCRIPT 2-Methoxy-D-Phenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01949 GENEFORM Protein DME1242 XEOTICID XEO01949 MOACRIVE Inhibition DME1242 XEOTICID XEO01953 XEO_NAME 3-(1-Naphthyl)-D-Alanine DME1242 XEOTICID XEO01953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01953 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01953 DESCRIPT 3-(1-Naphthyl)-D-Alanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01953 GENEFORM Protein DME1242 XEOTICID XEO01953 MOACRIVE Inhibition DME1242 XEOTICID XEO01954 XEO_NAME 3-(2-Furyl)-D-alanine DME1242 XEOTICID XEO01954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01954 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01954 DESCRIPT 3-(2-Furyl)-D-alanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01954 GENEFORM Protein DME1242 XEOTICID XEO01954 MOACRIVE Inhibition DME1242 XEOTICID XEO01956 XEO_NAME 3-(2-Naphthyl)alanine DME1242 XEOTICID XEO01956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01956 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01956 DESCRIPT 3-(2-Naphthyl)alanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01956 GENEFORM Protein DME1242 XEOTICID XEO01956 MOACRIVE Inhibition DME1242 XEOTICID XEO01957 XEO_NAME 3-(2-Naphthyl)-D-alanine DME1242 XEOTICID XEO01957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01957 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01957 DESCRIPT 3-(2-Naphthyl)-D-alanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01957 GENEFORM Protein DME1242 XEOTICID XEO01957 MOACRIVE Inhibition DME1242 XEOTICID XEO01959 XEO_NAME 3-(2-Thienyl)alanine DME1242 XEOTICID XEO01959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01959 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01959 DESCRIPT 3-(2-Thienyl)alanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01959 GENEFORM Protein DME1242 XEOTICID XEO01959 MOACRIVE Inhibition DME1242 XEOTICID XEO01960 XEO_NAME 3-(2-Thienyl)-D-alanine DME1242 XEOTICID XEO01960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01960 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01960 DESCRIPT 3-(2-Thienyl)-D-alanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01960 GENEFORM Protein DME1242 XEOTICID XEO01960 MOACRIVE Inhibition DME1242 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1242 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1242 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1242 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01961 GENEFORM Protein DME1242 XEOTICID XEO01961 MOACRIVE Inhibition DME1242 XEOTICID XEO01962 XEO_NAME 3-(3-Pyridinyl)alanine DME1242 XEOTICID XEO01962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01962 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01962 DESCRIPT 3-(3-Pyridinyl)alanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01962 GENEFORM Protein DME1242 XEOTICID XEO01962 MOACRIVE Inhibition DME1242 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1242 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1242 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1242 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01966 GENEFORM Protein DME1242 XEOTICID XEO01966 MOACRIVE Inhibition DME1242 XEOTICID XEO01967 XEO_NAME 3-(Trifluoromethyl)phenylalanine DME1242 XEOTICID XEO01967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01967 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01967 DESCRIPT 3-(Trifluoromethyl)phenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01967 GENEFORM Protein DME1242 XEOTICID XEO01967 MOACRIVE Inhibition DME1242 XEOTICID XEO01973 XEO_NAME 3,5-Diiodotyrosine DME1242 XEOTICID XEO01973 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01973 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01973 DESCRIPT 3,5-Diiodotyrosine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01973 GENEFORM Protein DME1242 XEOTICID XEO01973 MOACRIVE Inhibition DME1242 XEOTICID XEO01986 XEO_NAME 3-Chlorotyrosine DME1242 XEOTICID XEO01986 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO01986 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO01986 DESCRIPT 3-Chlorotyrosine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01986 GENEFORM Protein DME1242 XEOTICID XEO01986 MOACRIVE Inhibition DME1242 XEOTICID XEO01992 XEO_NAME 3-Hydroxyphenylalanine DME1242 XEOTICID XEO01992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01992 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01992 DESCRIPT 3-Hydroxyphenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01992 GENEFORM Protein DME1242 XEOTICID XEO01992 MOACRIVE Inhibition DME1242 XEOTICID XEO01993 XEO_NAME 3-Hydroxytyrosine DME1242 XEOTICID XEO01993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01993 XEO_CLAS Amino Acid DME1242 XEOTICID XEO01993 DESCRIPT 3-Hydroxytyrosine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01993 GENEFORM Protein DME1242 XEOTICID XEO01993 MOACRIVE Inhibition DME1242 XEOTICID XEO01995 XEO_NAME 3-Iodotyrosine DME1242 XEOTICID XEO01995 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO01995 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO01995 DESCRIPT 3-Iodotyrosine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO01995 GENEFORM Protein DME1242 XEOTICID XEO01995 MOACRIVE Inhibition DME1242 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1242 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01996 XEO_CLAS Peptide DME1242 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.7 microM) DME1242 XEOTICID XEO01996 GENEFORM Protein DME1242 XEOTICID XEO01996 MOACRIVE Inhibition DME1242 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1242 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01997 XEO_CLAS Peptide DME1242 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.6 microM) DME1242 XEOTICID XEO01997 GENEFORM Protein DME1242 XEOTICID XEO01997 MOACRIVE Inhibition DME1242 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1242 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01998 XEO_CLAS Peptide DME1242 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11 microM) DME1242 XEOTICID XEO01998 GENEFORM Protein DME1242 XEOTICID XEO01998 MOACRIVE Inhibition DME1242 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1242 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO01999 XEO_CLAS Peptide DME1242 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.6 microM) DME1242 XEOTICID XEO01999 GENEFORM Protein DME1242 XEOTICID XEO01999 MOACRIVE Inhibition DME1242 XEOTICID XEO02000 XEO_NAME 3-Methoxy-D-Phenylalanine DME1242 XEOTICID XEO02000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02000 XEO_CLAS Amino Acid DME1242 XEOTICID XEO02000 DESCRIPT 3-Methoxy-D-Phenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02000 GENEFORM Protein DME1242 XEOTICID XEO02000 MOACRIVE Inhibition DME1242 XEOTICID XEO02001 XEO_NAME 3-Methyl-D-phenylalanine DME1242 XEOTICID XEO02001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02001 XEO_CLAS Amino Acid DME1242 XEOTICID XEO02001 DESCRIPT 3-Methyl-D-phenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02001 GENEFORM Protein DME1242 XEOTICID XEO02001 MOACRIVE Inhibition DME1242 XEOTICID XEO02002 XEO_NAME 3-Nitro-D-tyrosine DME1242 XEOTICID XEO02002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02002 XEO_CLAS Amino Acid DME1242 XEOTICID XEO02002 DESCRIPT 3-Nitro-D-tyrosine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02002 GENEFORM Protein DME1242 XEOTICID XEO02002 MOACRIVE Inhibition DME1242 XEOTICID XEO02003 XEO_NAME 3-Nitrophenylalanine DME1242 XEOTICID XEO02003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02003 XEO_CLAS Amino Acid DME1242 XEOTICID XEO02003 DESCRIPT 3-Nitrophenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02003 GENEFORM Protein DME1242 XEOTICID XEO02003 MOACRIVE Inhibition DME1242 XEOTICID XEO02015 XEO_NAME 4-Amino-D-phenylalanine DME1242 XEOTICID XEO02015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02015 XEO_CLAS Amino Acid DME1242 XEOTICID XEO02015 DESCRIPT 4-Amino-D-phenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02015 GENEFORM Protein DME1242 XEOTICID XEO02015 MOACRIVE Inhibition DME1242 XEOTICID XEO02016 XEO_NAME 4-Benzoylphenylalanine DME1242 XEOTICID XEO02016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02016 XEO_CLAS Amino Acid DME1242 XEOTICID XEO02016 DESCRIPT 4-Benzoylphenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02016 GENEFORM Protein DME1242 XEOTICID XEO02016 MOACRIVE Inhibition DME1242 XEOTICID XEO02027 XEO_NAME 4-Bromo-D-phenylalanine DME1242 XEOTICID XEO02027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02027 XEO_CLAS Amino Acid DME1242 XEOTICID XEO02027 DESCRIPT 4-Bromo-D-phenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02027 GENEFORM Protein DME1242 XEOTICID XEO02027 MOACRIVE Inhibition DME1242 XEOTICID XEO02041 XEO_NAME 4-Iodo-d-phenylalanine DME1242 XEOTICID XEO02041 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02041 XEO_CLAS Amino Acid DME1242 XEOTICID XEO02041 DESCRIPT 4-Iodo-d-phenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02041 GENEFORM Protein DME1242 XEOTICID XEO02041 MOACRIVE Inhibition DME1242 XEOTICID XEO02046 XEO_NAME 4-Methylphenylalanine DME1242 XEOTICID XEO02046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02046 XEO_CLAS Amino Acid DME1242 XEOTICID XEO02046 DESCRIPT 4-Methylphenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02046 GENEFORM Protein DME1242 XEOTICID XEO02046 MOACRIVE Inhibition DME1242 XEOTICID XEO02102 XEO_NAME A. dichotoma defensin DME1242 XEOTICID XEO02102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02102 XEO_CLAS Peptide DME1242 XEOTICID XEO02102 DESCRIPT A. dichotoma defensin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02102 GENEFORM Protein DME1242 XEOTICID XEO02102 MOACRIVE Inhibition DME1242 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1242 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02115 XEO_CLAS Peptide DME1242 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02115 GENEFORM Protein DME1242 XEOTICID XEO02115 MOACRIVE Inhibition DME1242 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1242 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02122 XEO_CLAS Peptide DME1242 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 20 ug/ml) DME1242 XEOTICID XEO02122 GENEFORM Protein DME1242 XEOTICID XEO02122 MOACRIVE Inhibition DME1242 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1242 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02147 XEO_CLAS Peptide DME1242 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 191 ug/ml) DME1242 XEOTICID XEO02147 GENEFORM Protein DME1242 XEOTICID XEO02147 MOACRIVE Inhibition DME1242 XEOTICID XEO02154 XEO_NAME Ala4-uperin 3.6 DME1242 XEOTICID XEO02154 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02154 XEO_CLAS Peptide DME1242 XEOTICID XEO02154 DESCRIPT Ala4-uperin 3.6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO02154 GENEFORM Protein DME1242 XEOTICID XEO02154 MOACRIVE Inhibition DME1242 XEOTICID XEO02174 XEO_NAME Alpha-melanocyte-stimulating hormone DME1242 XEOTICID XEO02174 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02174 XEO_CLAS Peptide DME1242 XEOTICID XEO02174 DESCRIPT Alpha-melanocyte-stimulating hormone inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02174 GENEFORM Protein DME1242 XEOTICID XEO02174 MOACRIVE Inhibition DME1242 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1242 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02180 XEO_CLAS Peptide DME1242 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 214 microM) DME1242 XEOTICID XEO02180 GENEFORM Protein DME1242 XEOTICID XEO02180 MOACRIVE Inhibition DME1242 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1242 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02181 XEO_CLAS Peptide DME1242 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 434 microM) DME1242 XEOTICID XEO02181 GENEFORM Protein DME1242 XEOTICID XEO02181 MOACRIVE Inhibition DME1242 XEOTICID XEO02182 XEO_NAME Alyteserin-2a DME1242 XEOTICID XEO02182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02182 XEO_CLAS Peptide DME1242 XEOTICID XEO02182 DESCRIPT Alyteserin-2a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 microM) DME1242 XEOTICID XEO02182 GENEFORM Protein DME1242 XEOTICID XEO02182 MOACRIVE Inhibition DME1242 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1242 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02183 XEO_CLAS Peptide DME1242 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9.5 microM) DME1242 XEOTICID XEO02183 GENEFORM Protein DME1242 XEOTICID XEO02183 MOACRIVE Inhibition DME1242 XEOTICID XEO02184 XEO_NAME Alyteserin-2Mb DME1242 XEOTICID XEO02184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02184 XEO_CLAS Peptide DME1242 XEOTICID XEO02184 DESCRIPT Alyteserin-2Mb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 19.3 microM) DME1242 XEOTICID XEO02184 GENEFORM Protein DME1242 XEOTICID XEO02184 MOACRIVE Inhibition DME1242 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1242 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02185 XEO_CLAS Peptide DME1242 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7.5 microM) DME1242 XEOTICID XEO02185 GENEFORM Protein DME1242 XEOTICID XEO02185 MOACRIVE Inhibition DME1242 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1242 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02191 XEO_CLAS Peptide DME1242 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02191 GENEFORM Protein DME1242 XEOTICID XEO02191 MOACRIVE Inhibition DME1242 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1242 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02192 XEO_CLAS Peptide DME1242 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5.50 ug/ml) DME1242 XEOTICID XEO02192 GENEFORM Protein DME1242 XEOTICID XEO02192 MOACRIVE Inhibition DME1242 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1242 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02193 XEO_CLAS Peptide DME1242 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02193 GENEFORM Protein DME1242 XEOTICID XEO02193 MOACRIVE Inhibition DME1242 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1242 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02194 XEO_CLAS Peptide DME1242 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02194 GENEFORM Protein DME1242 XEOTICID XEO02194 MOACRIVE Inhibition DME1242 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1242 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02195 XEO_CLAS Peptide DME1242 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.00 ug/ml) DME1242 XEOTICID XEO02195 GENEFORM Protein DME1242 XEOTICID XEO02195 MOACRIVE Inhibition DME1242 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1242 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02197 XEO_CLAS Peptide DME1242 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02197 GENEFORM Protein DME1242 XEOTICID XEO02197 MOACRIVE Inhibition DME1242 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1242 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02200 XEO_CLAS Peptide DME1242 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 ug/ml) DME1242 XEOTICID XEO02200 GENEFORM Protein DME1242 XEOTICID XEO02200 MOACRIVE Inhibition DME1242 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1242 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02201 XEO_CLAS Peptide DME1242 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 ug/ml) DME1242 XEOTICID XEO02201 GENEFORM Protein DME1242 XEOTICID XEO02201 MOACRIVE Inhibition DME1242 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1242 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02202 XEO_CLAS Peptide DME1242 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10 microM) DME1242 XEOTICID XEO02202 GENEFORM Protein DME1242 XEOTICID XEO02202 MOACRIVE Inhibition DME1242 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1242 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02203 XEO_CLAS Peptide DME1242 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10 microM) DME1242 XEOTICID XEO02203 GENEFORM Protein DME1242 XEOTICID XEO02203 MOACRIVE Inhibition DME1242 XEOTICID XEO02206 XEO_NAME Amythiamicin A/B DME1242 XEOTICID XEO02206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02206 XEO_CLAS Peptide DME1242 XEOTICID XEO02206 DESCRIPT Amythiamicin A/B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.1 ug/ml) DME1242 XEOTICID XEO02206 GENEFORM Protein DME1242 XEOTICID XEO02206 MOACRIVE Inhibition DME1242 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1242 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02207 XEO_CLAS Peptide DME1242 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.13 ug/ml) DME1242 XEOTICID XEO02207 GENEFORM Protein DME1242 XEOTICID XEO02207 MOACRIVE Inhibition DME1242 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1242 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02208 XEO_CLAS Peptide DME1242 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 ug/ml) DME1242 XEOTICID XEO02208 GENEFORM Protein DME1242 XEOTICID XEO02208 MOACRIVE Inhibition DME1242 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1242 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02209 XEO_CLAS Peptide DME1242 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.56 ug/ml) DME1242 XEOTICID XEO02209 GENEFORM Protein DME1242 XEOTICID XEO02209 MOACRIVE Inhibition DME1242 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1242 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02210 XEO_CLAS Peptide DME1242 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 12.5 ug/ml) DME1242 XEOTICID XEO02210 GENEFORM Protein DME1242 XEOTICID XEO02210 MOACRIVE Inhibition DME1242 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1242 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02211 XEO_CLAS Peptide DME1242 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 12.5 ug/ml) DME1242 XEOTICID XEO02211 GENEFORM Protein DME1242 XEOTICID XEO02211 MOACRIVE Inhibition DME1242 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1242 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02212 XEO_CLAS Peptide DME1242 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.13 ug/ml) DME1242 XEOTICID XEO02212 GENEFORM Protein DME1242 XEOTICID XEO02212 MOACRIVE Inhibition DME1242 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1242 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02213 XEO_CLAS Peptide DME1242 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.13 ug/ml) DME1242 XEOTICID XEO02213 GENEFORM Protein DME1242 XEOTICID XEO02213 MOACRIVE Inhibition DME1242 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1242 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02215 XEO_CLAS Peptide DME1242 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 120 ug/ml) DME1242 XEOTICID XEO02215 GENEFORM Protein DME1242 XEOTICID XEO02215 MOACRIVE Inhibition DME1242 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1242 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02216 XEO_CLAS Peptide DME1242 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO02216 GENEFORM Protein DME1242 XEOTICID XEO02216 MOACRIVE Inhibition DME1242 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1242 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02217 XEO_CLAS Peptide DME1242 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 200 ug/ml) DME1242 XEOTICID XEO02217 GENEFORM Protein DME1242 XEOTICID XEO02217 MOACRIVE Inhibition DME1242 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1242 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02218 XEO_CLAS Peptide DME1242 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 200 ug/ml) DME1242 XEOTICID XEO02218 GENEFORM Protein DME1242 XEOTICID XEO02218 MOACRIVE Inhibition DME1242 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1242 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02219 XEO_CLAS Peptide DME1242 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 200 ug/ml) DME1242 XEOTICID XEO02219 GENEFORM Protein DME1242 XEOTICID XEO02219 MOACRIVE Inhibition DME1242 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1242 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02220 XEO_CLAS Peptide DME1242 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 47 ug/ml) DME1242 XEOTICID XEO02220 GENEFORM Protein DME1242 XEOTICID XEO02220 MOACRIVE Inhibition DME1242 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1242 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02221 XEO_CLAS Peptide DME1242 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10.1 ug/ml) DME1242 XEOTICID XEO02221 GENEFORM Protein DME1242 XEOTICID XEO02221 MOACRIVE Inhibition DME1242 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1242 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02222 XEO_CLAS Peptide DME1242 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15.3 ug/ml) DME1242 XEOTICID XEO02222 GENEFORM Protein DME1242 XEOTICID XEO02222 MOACRIVE Inhibition DME1242 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1242 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02223 XEO_CLAS Peptide DME1242 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.6 ug/ml) DME1242 XEOTICID XEO02223 GENEFORM Protein DME1242 XEOTICID XEO02223 MOACRIVE Inhibition DME1242 XEOTICID XEO02224 XEO_NAME Androctonin DME1242 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02224 XEO_CLAS Peptide DME1242 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02224 GENEFORM Protein DME1242 XEOTICID XEO02224 MOACRIVE Inhibition DME1242 XEOTICID XEO02227 XEO_NAME Angelica root oil DME1242 XEOTICID XEO02227 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02227 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02227 DESCRIPT Angelica root oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02227 GENEFORM Protein DME1242 XEOTICID XEO02227 MOACRIVE Inhibition DME1242 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1242 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02230 XEO_CLAS Peptide DME1242 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50-100 microM) DME1242 XEOTICID XEO02230 GENEFORM Protein DME1242 XEOTICID XEO02230 MOACRIVE Inhibition DME1242 XEOTICID XEO02231 XEO_NAME Anopheles gambiae defensin DME1242 XEOTICID XEO02231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02231 XEO_CLAS Peptide DME1242 XEOTICID XEO02231 DESCRIPT Anopheles gambiae defensin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02231 GENEFORM Protein DME1242 XEOTICID XEO02231 MOACRIVE Inhibition DME1242 XEOTICID XEO02232 XEO_NAME Anoplin DME1242 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02232 XEO_CLAS Peptide DME1242 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 26 ug/ml) DME1242 XEOTICID XEO02232 GENEFORM Protein DME1242 XEOTICID XEO02232 MOACRIVE Inhibition DME1242 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1242 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02242 XEO_CLAS Peptide DME1242 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 microM) DME1242 XEOTICID XEO02242 GENEFORM Protein DME1242 XEOTICID XEO02242 MOACRIVE Inhibition DME1242 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1242 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02243 XEO_CLAS Peptide DME1242 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO02243 GENEFORM Protein DME1242 XEOTICID XEO02243 MOACRIVE Inhibition DME1242 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1242 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02244 XEO_CLAS Peptide DME1242 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 32 microM) DME1242 XEOTICID XEO02244 GENEFORM Protein DME1242 XEOTICID XEO02244 MOACRIVE Inhibition DME1242 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1242 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02246 XEO_CLAS Peptide DME1242 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 32 microM) DME1242 XEOTICID XEO02246 GENEFORM Protein DME1242 XEOTICID XEO02246 MOACRIVE Inhibition DME1242 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1242 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02247 XEO_CLAS Peptide DME1242 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02247 GENEFORM Protein DME1242 XEOTICID XEO02247 MOACRIVE Inhibition DME1242 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1242 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02248 XEO_CLAS Peptide DME1242 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 200 microM) DME1242 XEOTICID XEO02248 GENEFORM Protein DME1242 XEOTICID XEO02248 MOACRIVE Inhibition DME1242 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1242 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02253 XEO_CLAS Peptide DME1242 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02253 GENEFORM Protein DME1242 XEOTICID XEO02253 MOACRIVE Inhibition DME1242 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1242 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02258 XEO_CLAS Peptide DME1242 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 20 microM) DME1242 XEOTICID XEO02258 GENEFORM Protein DME1242 XEOTICID XEO02258 MOACRIVE Inhibition DME1242 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1242 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02261 XEO_CLAS Peptide DME1242 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 80 ug/ml) DME1242 XEOTICID XEO02261 GENEFORM Protein DME1242 XEOTICID XEO02261 MOACRIVE Inhibition DME1242 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1242 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02263 XEO_CLAS Peptide DME1242 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5 microM) DME1242 XEOTICID XEO02263 GENEFORM Protein DME1242 XEOTICID XEO02263 MOACRIVE Inhibition DME1242 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1242 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02266 XEO_CLAS Peptide DME1242 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 48 microM) DME1242 XEOTICID XEO02266 GENEFORM Protein DME1242 XEOTICID XEO02266 MOACRIVE Inhibition DME1242 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1242 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02268 XEO_CLAS Peptide DME1242 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 170 ug/ml) DME1242 XEOTICID XEO02268 GENEFORM Protein DME1242 XEOTICID XEO02268 MOACRIVE Inhibition DME1242 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1242 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02270 XEO_CLAS Peptide DME1242 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO02270 GENEFORM Protein DME1242 XEOTICID XEO02270 MOACRIVE Inhibition DME1242 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1242 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02271 XEO_CLAS Peptide DME1242 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 274 ug/ml) DME1242 XEOTICID XEO02271 GENEFORM Protein DME1242 XEOTICID XEO02271 MOACRIVE Inhibition DME1242 XEOTICID XEO02272 XEO_NAME Antimicrobial peptide XT-3 DME1242 XEOTICID XEO02272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02272 XEO_CLAS Peptide DME1242 XEOTICID XEO02272 DESCRIPT Antimicrobial peptide XT-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02272 GENEFORM Protein DME1242 XEOTICID XEO02272 MOACRIVE Inhibition DME1242 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1242 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02273 XEO_CLAS Peptide DME1242 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO02273 GENEFORM Protein DME1242 XEOTICID XEO02273 MOACRIVE Inhibition DME1242 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1242 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02274 XEO_CLAS Peptide DME1242 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO02274 GENEFORM Protein DME1242 XEOTICID XEO02274 MOACRIVE Inhibition DME1242 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1242 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02275 XEO_CLAS Peptide DME1242 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5 microM) DME1242 XEOTICID XEO02275 GENEFORM Protein DME1242 XEOTICID XEO02275 MOACRIVE Inhibition DME1242 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1242 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02276 XEO_CLAS Peptide DME1242 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5 microM) DME1242 XEOTICID XEO02276 GENEFORM Protein DME1242 XEOTICID XEO02276 MOACRIVE Inhibition DME1242 XEOTICID XEO02279 XEO_NAME Antimicrobial peptide ctriporin DME1242 XEOTICID XEO02279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02279 XEO_CLAS Peptide DME1242 XEOTICID XEO02279 DESCRIPT Antimicrobial peptide ctriporin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5 ug/ml) DME1242 XEOTICID XEO02279 GENEFORM Protein DME1242 XEOTICID XEO02279 MOACRIVE Inhibition DME1242 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1242 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02283 XEO_CLAS Peptide DME1242 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 ug/ml) DME1242 XEOTICID XEO02283 GENEFORM Protein DME1242 XEOTICID XEO02283 MOACRIVE Inhibition DME1242 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1242 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02284 XEO_CLAS Peptide DME1242 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 23.6 microM) DME1242 XEOTICID XEO02284 GENEFORM Protein DME1242 XEOTICID XEO02284 MOACRIVE Inhibition DME1242 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1242 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02285 XEO_CLAS Peptide DME1242 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 23.6 microM) DME1242 XEOTICID XEO02285 GENEFORM Protein DME1242 XEOTICID XEO02285 MOACRIVE Inhibition DME1242 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1242 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02286 XEO_CLAS Peptide DME1242 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 23.6 microM) DME1242 XEOTICID XEO02286 GENEFORM Protein DME1242 XEOTICID XEO02286 MOACRIVE Inhibition DME1242 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1242 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02287 XEO_CLAS Peptide DME1242 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 23.6 microM) DME1242 XEOTICID XEO02287 GENEFORM Protein DME1242 XEOTICID XEO02287 MOACRIVE Inhibition DME1242 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1242 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02288 XEO_CLAS Peptide DME1242 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10.4 ug/ml) DME1242 XEOTICID XEO02288 GENEFORM Protein DME1242 XEOTICID XEO02288 MOACRIVE Inhibition DME1242 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1242 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02289 XEO_CLAS Peptide DME1242 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO02289 GENEFORM Protein DME1242 XEOTICID XEO02289 MOACRIVE Inhibition DME1242 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1242 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02290 XEO_CLAS Peptide DME1242 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5 ug/ml) DME1242 XEOTICID XEO02290 GENEFORM Protein DME1242 XEOTICID XEO02290 MOACRIVE Inhibition DME1242 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1242 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02294 XEO_CLAS Peptide DME1242 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 250-500 ug/ml) DME1242 XEOTICID XEO02294 GENEFORM Protein DME1242 XEOTICID XEO02294 MOACRIVE Inhibition DME1242 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1242 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02295 XEO_CLAS Peptide DME1242 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.2 ug/ml) DME1242 XEOTICID XEO02295 GENEFORM Protein DME1242 XEOTICID XEO02295 MOACRIVE Inhibition DME1242 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1242 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02296 XEO_CLAS Peptide DME1242 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.5 ug/ml) DME1242 XEOTICID XEO02296 GENEFORM Protein DME1242 XEOTICID XEO02296 MOACRIVE Inhibition DME1242 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1242 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02297 XEO_CLAS Peptide DME1242 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC < 100 ug/ml) DME1242 XEOTICID XEO02297 GENEFORM Protein DME1242 XEOTICID XEO02297 MOACRIVE Inhibition DME1242 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1242 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02298 XEO_CLAS Peptide DME1242 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 64 ug/ml) DME1242 XEOTICID XEO02298 GENEFORM Protein DME1242 XEOTICID XEO02298 MOACRIVE Inhibition DME1242 XEOTICID XEO02301 XEO_NAME Fungus ribonuclease DME1242 XEOTICID XEO02301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02301 XEO_CLAS Peptide DME1242 XEOTICID XEO02301 DESCRIPT Fungus ribonuclease inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02301 GENEFORM Protein DME1242 XEOTICID XEO02301 MOACRIVE Inhibition DME1242 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1242 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02320 XEO_CLAS Peptide DME1242 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02320 GENEFORM Protein DME1242 XEOTICID XEO02320 MOACRIVE Inhibition DME1242 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1242 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02321 XEO_CLAS Peptide DME1242 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 50 microM) DME1242 XEOTICID XEO02321 GENEFORM Protein DME1242 XEOTICID XEO02321 MOACRIVE Inhibition DME1242 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1242 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02323 XEO_CLAS Peptide DME1242 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 50 microM) DME1242 XEOTICID XEO02323 GENEFORM Protein DME1242 XEOTICID XEO02323 MOACRIVE Inhibition DME1242 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1242 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02325 XEO_CLAS Peptide DME1242 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 microM) DME1242 XEOTICID XEO02325 GENEFORM Protein DME1242 XEOTICID XEO02325 MOACRIVE Inhibition DME1242 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1242 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02327 XEO_CLAS Peptide DME1242 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 microM) DME1242 XEOTICID XEO02327 GENEFORM Protein DME1242 XEOTICID XEO02327 MOACRIVE Inhibition DME1242 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1242 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02328 XEO_CLAS Peptide DME1242 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO02328 GENEFORM Protein DME1242 XEOTICID XEO02328 MOACRIVE Inhibition DME1242 XEOTICID XEO02329 XEO_NAME Asperdiol DME1242 XEOTICID XEO02329 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02329 XEO_CLAS Natural Product DME1242 XEOTICID XEO02329 DESCRIPT Asperdiol inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02329 GENEFORM Protein DME1242 XEOTICID XEO02329 MOACRIVE Inhibition DME1242 XEOTICID XEO02330 XEO_NAME Asperdiol acetate DME1242 XEOTICID XEO02330 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1242 XEOTICID XEO02330 XEO_CLAS Chemical Compound DME1242 XEOTICID XEO02330 DESCRIPT Asperdiol acetate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02330 GENEFORM Protein DME1242 XEOTICID XEO02330 MOACRIVE Inhibition DME1242 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1242 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02332 XEO_CLAS Peptide DME1242 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7.8 ug/ml) DME1242 XEOTICID XEO02332 GENEFORM Protein DME1242 XEOTICID XEO02332 MOACRIVE Inhibition DME1242 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1242 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02333 XEO_CLAS Peptide DME1242 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 200 microM) DME1242 XEOTICID XEO02333 GENEFORM Protein DME1242 XEOTICID XEO02333 MOACRIVE Inhibition DME1242 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1242 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02336 XEO_CLAS Peptide DME1242 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 microM) DME1242 XEOTICID XEO02336 GENEFORM Protein DME1242 XEOTICID XEO02336 MOACRIVE Inhibition DME1242 XEOTICID XEO02338 XEO_NAME Aurein-2.2 DME1242 XEOTICID XEO02338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02338 XEO_CLAS Peptide DME1242 XEOTICID XEO02338 DESCRIPT Aurein-2.2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO02338 GENEFORM Protein DME1242 XEOTICID XEO02338 MOACRIVE Inhibition DME1242 XEOTICID XEO02339 XEO_NAME Aurein-2.3 DME1242 XEOTICID XEO02339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02339 XEO_CLAS Peptide DME1242 XEOTICID XEO02339 DESCRIPT Aurein-2.3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 100 ug/ml) DME1242 XEOTICID XEO02339 GENEFORM Protein DME1242 XEOTICID XEO02339 MOACRIVE Inhibition DME1242 XEOTICID XEO02340 XEO_NAME Aurein-2.4 DME1242 XEOTICID XEO02340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02340 XEO_CLAS Peptide DME1242 XEOTICID XEO02340 DESCRIPT Aurein-2.4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO02340 GENEFORM Protein DME1242 XEOTICID XEO02340 MOACRIVE Inhibition DME1242 XEOTICID XEO02341 XEO_NAME Aurein-2.5 DME1242 XEOTICID XEO02341 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02341 XEO_CLAS Peptide DME1242 XEOTICID XEO02341 DESCRIPT Aurein-2.5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 ug/ml) DME1242 XEOTICID XEO02341 GENEFORM Protein DME1242 XEOTICID XEO02341 MOACRIVE Inhibition DME1242 XEOTICID XEO02342 XEO_NAME Aurein-2.6 DME1242 XEOTICID XEO02342 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02342 XEO_CLAS Peptide DME1242 XEOTICID XEO02342 DESCRIPT Aurein-2.6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 ug/ml) DME1242 XEOTICID XEO02342 GENEFORM Protein DME1242 XEOTICID XEO02342 MOACRIVE Inhibition DME1242 XEOTICID XEO02343 XEO_NAME Aurein-3.1 DME1242 XEOTICID XEO02343 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02343 XEO_CLAS Peptide DME1242 XEOTICID XEO02343 DESCRIPT Aurein-3.1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 ug/ml) DME1242 XEOTICID XEO02343 GENEFORM Protein DME1242 XEOTICID XEO02343 MOACRIVE Inhibition DME1242 XEOTICID XEO02344 XEO_NAME Aurein-3.2 DME1242 XEOTICID XEO02344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02344 XEO_CLAS Peptide DME1242 XEOTICID XEO02344 DESCRIPT Aurein-3.2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 ug/ml) DME1242 XEOTICID XEO02344 GENEFORM Protein DME1242 XEOTICID XEO02344 MOACRIVE Inhibition DME1242 XEOTICID XEO02345 XEO_NAME Aurein-3.3 DME1242 XEOTICID XEO02345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02345 XEO_CLAS Peptide DME1242 XEOTICID XEO02345 DESCRIPT Aurein-3.3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 100 ug/ml) DME1242 XEOTICID XEO02345 GENEFORM Protein DME1242 XEOTICID XEO02345 MOACRIVE Inhibition DME1242 XEOTICID XEO02347 XEO_NAME Aureocin A53 DME1242 XEOTICID XEO02347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02347 XEO_CLAS Peptide DME1242 XEOTICID XEO02347 DESCRIPT Aureocin A53 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02347 GENEFORM Protein DME1242 XEOTICID XEO02347 MOACRIVE Inhibition DME1242 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1242 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02352 XEO_CLAS Peptide DME1242 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 23 ug/ml) DME1242 XEOTICID XEO02352 GENEFORM Protein DME1242 XEOTICID XEO02352 MOACRIVE Inhibition DME1242 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1242 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02353 XEO_CLAS Peptide DME1242 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11 ug/ml) DME1242 XEOTICID XEO02353 GENEFORM Protein DME1242 XEOTICID XEO02353 MOACRIVE Inhibition DME1242 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1242 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02354 XEO_CLAS Peptide DME1242 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO02354 GENEFORM Protein DME1242 XEOTICID XEO02354 MOACRIVE Inhibition DME1242 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1242 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02355 XEO_CLAS Peptide DME1242 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 17 ug/ml) DME1242 XEOTICID XEO02355 GENEFORM Protein DME1242 XEOTICID XEO02355 MOACRIVE Inhibition DME1242 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1242 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02356 XEO_CLAS Peptide DME1242 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 32 ug/ml) DME1242 XEOTICID XEO02356 GENEFORM Protein DME1242 XEOTICID XEO02356 MOACRIVE Inhibition DME1242 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1242 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02357 XEO_CLAS Peptide DME1242 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO02357 GENEFORM Protein DME1242 XEOTICID XEO02357 MOACRIVE Inhibition DME1242 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1242 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02358 XEO_CLAS Peptide DME1242 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 ug/ml) DME1242 XEOTICID XEO02358 GENEFORM Protein DME1242 XEOTICID XEO02358 MOACRIVE Inhibition DME1242 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1242 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02360 XEO_CLAS Peptide DME1242 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO02360 GENEFORM Protein DME1242 XEOTICID XEO02360 MOACRIVE Inhibition DME1242 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1242 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02361 XEO_CLAS Peptide DME1242 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO02361 GENEFORM Protein DME1242 XEOTICID XEO02361 MOACRIVE Inhibition DME1242 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1242 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02365 XEO_CLAS Peptide DME1242 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 64 ug/ml) DME1242 XEOTICID XEO02365 GENEFORM Protein DME1242 XEOTICID XEO02365 MOACRIVE Inhibition DME1242 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1242 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02366 XEO_CLAS Peptide DME1242 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 32 ug/ml) DME1242 XEOTICID XEO02366 GENEFORM Protein DME1242 XEOTICID XEO02366 MOACRIVE Inhibition DME1242 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1242 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02367 XEO_CLAS Peptide DME1242 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 64 ug/ml) DME1242 XEOTICID XEO02367 GENEFORM Protein DME1242 XEOTICID XEO02367 MOACRIVE Inhibition DME1242 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1242 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02368 XEO_CLAS Peptide DME1242 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 64 ug/ml) DME1242 XEOTICID XEO02368 GENEFORM Protein DME1242 XEOTICID XEO02368 MOACRIVE Inhibition DME1242 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1242 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02369 XEO_CLAS Peptide DME1242 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 64 ug/ml) DME1242 XEOTICID XEO02369 GENEFORM Protein DME1242 XEOTICID XEO02369 MOACRIVE Inhibition DME1242 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1242 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02376 XEO_CLAS Peptide DME1242 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.2-0.8 ug/ml) DME1242 XEOTICID XEO02376 GENEFORM Protein DME1242 XEOTICID XEO02376 MOACRIVE Inhibition DME1242 XEOTICID XEO02377 XEO_NAME Bacteriocin hiracin-JM79 DME1242 XEOTICID XEO02377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02377 XEO_CLAS Peptide DME1242 XEOTICID XEO02377 DESCRIPT Bacteriocin hiracin-JM79 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02377 GENEFORM Protein DME1242 XEOTICID XEO02377 MOACRIVE Inhibition DME1242 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1242 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02378 XEO_CLAS Peptide DME1242 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.76 ug/ml) DME1242 XEOTICID XEO02378 GENEFORM Protein DME1242 XEOTICID XEO02378 MOACRIVE Inhibition DME1242 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1242 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02388 XEO_CLAS Peptide DME1242 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 ug/ml) DME1242 XEOTICID XEO02388 GENEFORM Protein DME1242 XEOTICID XEO02388 MOACRIVE Inhibition DME1242 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1242 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02389 XEO_CLAS Peptide DME1242 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO02389 GENEFORM Protein DME1242 XEOTICID XEO02389 MOACRIVE Inhibition DME1242 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1242 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02415 XEO_CLAS Peptide DME1242 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02415 GENEFORM Protein DME1242 XEOTICID XEO02415 MOACRIVE Inhibition DME1242 XEOTICID XEO02419 XEO_NAME Bay oil DME1242 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02419 GENEFORM Protein DME1242 XEOTICID XEO02419 MOACRIVE Inhibition DME1242 XEOTICID XEO02430 XEO_NAME Bergamot oil DME1242 XEOTICID XEO02430 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02430 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02430 DESCRIPT Bergamot oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02430 GENEFORM Protein DME1242 XEOTICID XEO02430 MOACRIVE Inhibition DME1242 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1242 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02437 XEO_CLAS Peptide DME1242 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02437 GENEFORM Protein DME1242 XEOTICID XEO02437 MOACRIVE Inhibition DME1242 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1242 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02441 XEO_CLAS Peptide DME1242 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02441 GENEFORM Protein DME1242 XEOTICID XEO02441 MOACRIVE Inhibition DME1242 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1242 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02443 XEO_CLAS Peptide DME1242 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02443 GENEFORM Protein DME1242 XEOTICID XEO02443 MOACRIVE Inhibition DME1242 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1242 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02451 XEO_CLAS Peptide DME1242 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02451 GENEFORM Protein DME1242 XEOTICID XEO02451 MOACRIVE Inhibition DME1242 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1242 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02452 XEO_CLAS Peptide DME1242 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9.6 ug/ml) DME1242 XEOTICID XEO02452 GENEFORM Protein DME1242 XEOTICID XEO02452 MOACRIVE Inhibition DME1242 XEOTICID XEO02455 XEO_NAME Biphenyl DME1242 XEOTICID XEO02455 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02455 XEO_CLAS Natural Product DME1242 XEOTICID XEO02455 DESCRIPT Biphenyl inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02455 GENEFORM Protein DME1242 XEOTICID XEO02455 MOACRIVE Inhibition DME1242 XEOTICID XEO02461 XEO_NAME Black pepper oil DME1242 XEOTICID XEO02461 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02461 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02461 DESCRIPT Black pepper oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02461 GENEFORM Protein DME1242 XEOTICID XEO02461 MOACRIVE Inhibition DME1242 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1242 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02463 XEO_CLAS Peptide DME1242 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11.25 microM) DME1242 XEOTICID XEO02463 GENEFORM Protein DME1242 XEOTICID XEO02463 MOACRIVE Inhibition DME1242 XEOTICID XEO02465 XEO_NAME BMAP-28 DME1242 XEOTICID XEO02465 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02465 XEO_CLAS Peptide DME1242 XEOTICID XEO02465 DESCRIPT BMAP-28 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02465 GENEFORM Protein DME1242 XEOTICID XEO02465 MOACRIVE Inhibition DME1242 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1242 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02466 XEO_CLAS Peptide DME1242 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO02466 GENEFORM Protein DME1242 XEOTICID XEO02466 MOACRIVE Inhibition DME1242 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1242 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02469 XEO_CLAS Peptide DME1242 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 14 microM) DME1242 XEOTICID XEO02469 GENEFORM Protein DME1242 XEOTICID XEO02469 MOACRIVE Inhibition DME1242 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1242 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02470 XEO_CLAS Peptide DME1242 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.1 microM) DME1242 XEOTICID XEO02470 GENEFORM Protein DME1242 XEOTICID XEO02470 MOACRIVE Inhibition DME1242 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1242 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02471 XEO_CLAS Peptide DME1242 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.3 microM) DME1242 XEOTICID XEO02471 GENEFORM Protein DME1242 XEOTICID XEO02471 MOACRIVE Inhibition DME1242 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1242 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02472 XEO_CLAS Peptide DME1242 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.0 microM) DME1242 XEOTICID XEO02472 GENEFORM Protein DME1242 XEOTICID XEO02472 MOACRIVE Inhibition DME1242 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1242 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02474 XEO_CLAS Peptide DME1242 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.4 microM) DME1242 XEOTICID XEO02474 GENEFORM Protein DME1242 XEOTICID XEO02474 MOACRIVE Inhibition DME1242 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1242 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02475 XEO_CLAS Peptide DME1242 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.7 microM) DME1242 XEOTICID XEO02475 GENEFORM Protein DME1242 XEOTICID XEO02475 MOACRIVE Inhibition DME1242 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1242 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02478 XEO_CLAS Peptide DME1242 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10-300 ug/ml) DME1242 XEOTICID XEO02478 GENEFORM Protein DME1242 XEOTICID XEO02478 MOACRIVE Inhibition DME1242 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1242 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02479 XEO_CLAS Peptide DME1242 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10-300 ug/ml) DME1242 XEOTICID XEO02479 GENEFORM Protein DME1242 XEOTICID XEO02479 MOACRIVE Inhibition DME1242 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1242 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02480 XEO_CLAS Peptide DME1242 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10-300 ug/ml) DME1242 XEOTICID XEO02480 GENEFORM Protein DME1242 XEOTICID XEO02480 MOACRIVE Inhibition DME1242 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1242 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02481 XEO_CLAS Peptide DME1242 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10-300 ug/ml) DME1242 XEOTICID XEO02481 GENEFORM Protein DME1242 XEOTICID XEO02481 MOACRIVE Inhibition DME1242 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1242 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02482 XEO_CLAS Peptide DME1242 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10-300 ug/ml) DME1242 XEOTICID XEO02482 GENEFORM Protein DME1242 XEOTICID XEO02482 MOACRIVE Inhibition DME1242 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1242 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02483 XEO_CLAS Peptide DME1242 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10-300 ug/ml) DME1242 XEOTICID XEO02483 GENEFORM Protein DME1242 XEOTICID XEO02483 MOACRIVE Inhibition DME1242 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1242 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02484 XEO_CLAS Peptide DME1242 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10-300 ug/ml) DME1242 XEOTICID XEO02484 GENEFORM Protein DME1242 XEOTICID XEO02484 MOACRIVE Inhibition DME1242 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1242 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02486 XEO_CLAS Peptide DME1242 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10-300 ug/ml) DME1242 XEOTICID XEO02486 GENEFORM Protein DME1242 XEOTICID XEO02486 MOACRIVE Inhibition DME1242 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1242 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02487 XEO_CLAS Peptide DME1242 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02487 GENEFORM Protein DME1242 XEOTICID XEO02487 MOACRIVE Inhibition DME1242 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1242 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02488 XEO_CLAS Peptide DME1242 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10-300 ug/ml) DME1242 XEOTICID XEO02488 GENEFORM Protein DME1242 XEOTICID XEO02488 MOACRIVE Inhibition DME1242 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1242 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02489 XEO_CLAS Peptide DME1242 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10-300 ug/ml) DME1242 XEOTICID XEO02489 GENEFORM Protein DME1242 XEOTICID XEO02489 MOACRIVE Inhibition DME1242 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1242 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02491 XEO_CLAS Peptide DME1242 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 70 microM) DME1242 XEOTICID XEO02491 GENEFORM Protein DME1242 XEOTICID XEO02491 MOACRIVE Inhibition DME1242 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1242 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02492 XEO_CLAS Peptide DME1242 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 100 ug/ml) DME1242 XEOTICID XEO02492 GENEFORM Protein DME1242 XEOTICID XEO02492 MOACRIVE Inhibition DME1242 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1242 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02493 XEO_CLAS Peptide DME1242 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO02493 GENEFORM Protein DME1242 XEOTICID XEO02493 MOACRIVE Inhibition DME1242 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1242 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02494 XEO_CLAS Peptide DME1242 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 ug/ml) DME1242 XEOTICID XEO02494 GENEFORM Protein DME1242 XEOTICID XEO02494 MOACRIVE Inhibition DME1242 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1242 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02495 XEO_CLAS Peptide DME1242 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO02495 GENEFORM Protein DME1242 XEOTICID XEO02495 MOACRIVE Inhibition DME1242 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1242 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02496 XEO_CLAS Peptide DME1242 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO02496 GENEFORM Protein DME1242 XEOTICID XEO02496 MOACRIVE Inhibition DME1242 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1242 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02497 XEO_CLAS Peptide DME1242 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO02497 GENEFORM Protein DME1242 XEOTICID XEO02497 MOACRIVE Inhibition DME1242 XEOTICID XEO02498 XEO_NAME Brevinin-1Ba DME1242 XEOTICID XEO02498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02498 XEO_CLAS Peptide DME1242 XEOTICID XEO02498 DESCRIPT Brevinin-1Ba inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO02498 GENEFORM Protein DME1242 XEOTICID XEO02498 MOACRIVE Inhibition DME1242 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1242 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02499 XEO_CLAS Peptide DME1242 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 microM) DME1242 XEOTICID XEO02499 GENEFORM Protein DME1242 XEOTICID XEO02499 MOACRIVE Inhibition DME1242 XEOTICID XEO02500 XEO_NAME Brevinin-1Bc DME1242 XEOTICID XEO02500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02500 XEO_CLAS Peptide DME1242 XEOTICID XEO02500 DESCRIPT Brevinin-1Bc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 13 microM) DME1242 XEOTICID XEO02500 GENEFORM Protein DME1242 XEOTICID XEO02500 MOACRIVE Inhibition DME1242 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1242 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02501 XEO_CLAS Peptide DME1242 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO02501 GENEFORM Protein DME1242 XEOTICID XEO02501 MOACRIVE Inhibition DME1242 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1242 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02502 XEO_CLAS Peptide DME1242 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO02502 GENEFORM Protein DME1242 XEOTICID XEO02502 MOACRIVE Inhibition DME1242 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1242 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02503 XEO_CLAS Peptide DME1242 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 microM) DME1242 XEOTICID XEO02503 GENEFORM Protein DME1242 XEOTICID XEO02503 MOACRIVE Inhibition DME1242 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1242 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02504 XEO_CLAS Peptide DME1242 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02504 GENEFORM Protein DME1242 XEOTICID XEO02504 MOACRIVE Inhibition DME1242 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1242 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02505 XEO_CLAS Peptide DME1242 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.5 microM) DME1242 XEOTICID XEO02505 GENEFORM Protein DME1242 XEOTICID XEO02505 MOACRIVE Inhibition DME1242 XEOTICID XEO02506 XEO_NAME Brevinin-1BYc DME1242 XEOTICID XEO02506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02506 XEO_CLAS Peptide DME1242 XEOTICID XEO02506 DESCRIPT Brevinin-1BYc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02506 GENEFORM Protein DME1242 XEOTICID XEO02506 MOACRIVE Inhibition DME1242 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1242 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02507 XEO_CLAS Peptide DME1242 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO02507 GENEFORM Protein DME1242 XEOTICID XEO02507 MOACRIVE Inhibition DME1242 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1242 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02509 XEO_CLAS Peptide DME1242 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9 microM) DME1242 XEOTICID XEO02509 GENEFORM Protein DME1242 XEOTICID XEO02509 MOACRIVE Inhibition DME1242 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1242 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02510 XEO_CLAS Peptide DME1242 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 19 microM) DME1242 XEOTICID XEO02510 GENEFORM Protein DME1242 XEOTICID XEO02510 MOACRIVE Inhibition DME1242 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1242 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02511 XEO_CLAS Peptide DME1242 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9 microM) DME1242 XEOTICID XEO02511 GENEFORM Protein DME1242 XEOTICID XEO02511 MOACRIVE Inhibition DME1242 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1242 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02512 XEO_CLAS Peptide DME1242 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9 microM) DME1242 XEOTICID XEO02512 GENEFORM Protein DME1242 XEOTICID XEO02512 MOACRIVE Inhibition DME1242 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1242 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02516 XEO_CLAS Peptide DME1242 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO02516 GENEFORM Protein DME1242 XEOTICID XEO02516 MOACRIVE Inhibition DME1242 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1242 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02517 XEO_CLAS Peptide DME1242 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7 microM) DME1242 XEOTICID XEO02517 GENEFORM Protein DME1242 XEOTICID XEO02517 MOACRIVE Inhibition DME1242 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1242 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02518 XEO_CLAS Peptide DME1242 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02518 GENEFORM Protein DME1242 XEOTICID XEO02518 MOACRIVE Inhibition DME1242 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1242 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02519 XEO_CLAS Peptide DME1242 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02519 GENEFORM Protein DME1242 XEOTICID XEO02519 MOACRIVE Inhibition DME1242 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1242 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02520 XEO_CLAS Peptide DME1242 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02520 GENEFORM Protein DME1242 XEOTICID XEO02520 MOACRIVE Inhibition DME1242 XEOTICID XEO02521 XEO_NAME Brevinin-1E DME1242 XEOTICID XEO02521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02521 XEO_CLAS Peptide DME1242 XEOTICID XEO02521 DESCRIPT Brevinin-1E inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.6 microM) DME1242 XEOTICID XEO02521 GENEFORM Protein DME1242 XEOTICID XEO02521 MOACRIVE Inhibition DME1242 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1242 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02523 XEO_CLAS Peptide DME1242 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO02523 GENEFORM Protein DME1242 XEOTICID XEO02523 MOACRIVE Inhibition DME1242 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1242 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02524 XEO_CLAS Peptide DME1242 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.2 microM) DME1242 XEOTICID XEO02524 GENEFORM Protein DME1242 XEOTICID XEO02524 MOACRIVE Inhibition DME1242 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1242 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02525 XEO_CLAS Peptide DME1242 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO02525 GENEFORM Protein DME1242 XEOTICID XEO02525 MOACRIVE Inhibition DME1242 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1242 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02526 XEO_CLAS Peptide DME1242 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO02526 GENEFORM Protein DME1242 XEOTICID XEO02526 MOACRIVE Inhibition DME1242 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1242 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02527 XEO_CLAS Peptide DME1242 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 microM) DME1242 XEOTICID XEO02527 GENEFORM Protein DME1242 XEOTICID XEO02527 MOACRIVE Inhibition DME1242 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1242 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02528 XEO_CLAS Peptide DME1242 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO02528 GENEFORM Protein DME1242 XEOTICID XEO02528 MOACRIVE Inhibition DME1242 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1242 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02529 XEO_CLAS Peptide DME1242 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO02529 GENEFORM Protein DME1242 XEOTICID XEO02529 MOACRIVE Inhibition DME1242 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1242 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02530 XEO_CLAS Peptide DME1242 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02530 GENEFORM Protein DME1242 XEOTICID XEO02530 MOACRIVE Inhibition DME1242 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1242 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02531 XEO_CLAS Peptide DME1242 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 microM) DME1242 XEOTICID XEO02531 GENEFORM Protein DME1242 XEOTICID XEO02531 MOACRIVE Inhibition DME1242 XEOTICID XEO02532 XEO_NAME Brevinin-1LT1 DME1242 XEOTICID XEO02532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02532 XEO_CLAS Peptide DME1242 XEOTICID XEO02532 DESCRIPT Brevinin-1LT1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 microM) DME1242 XEOTICID XEO02532 GENEFORM Protein DME1242 XEOTICID XEO02532 MOACRIVE Inhibition DME1242 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1242 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02533 XEO_CLAS Peptide DME1242 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.4 ug/ml) DME1242 XEOTICID XEO02533 GENEFORM Protein DME1242 XEOTICID XEO02533 MOACRIVE Inhibition DME1242 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1242 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02534 XEO_CLAS Peptide DME1242 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.6 ug/ml) DME1242 XEOTICID XEO02534 GENEFORM Protein DME1242 XEOTICID XEO02534 MOACRIVE Inhibition DME1242 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1242 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02535 XEO_CLAS Peptide DME1242 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10.6 ug/ml) DME1242 XEOTICID XEO02535 GENEFORM Protein DME1242 XEOTICID XEO02535 MOACRIVE Inhibition DME1242 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1242 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02536 XEO_CLAS Peptide DME1242 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.8 ug/ml) DME1242 XEOTICID XEO02536 GENEFORM Protein DME1242 XEOTICID XEO02536 MOACRIVE Inhibition DME1242 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1242 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02537 XEO_CLAS Peptide DME1242 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.4 ug/ml) DME1242 XEOTICID XEO02537 GENEFORM Protein DME1242 XEOTICID XEO02537 MOACRIVE Inhibition DME1242 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1242 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02538 XEO_CLAS Peptide DME1242 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 18.2 ug/ml) DME1242 XEOTICID XEO02538 GENEFORM Protein DME1242 XEOTICID XEO02538 MOACRIVE Inhibition DME1242 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1242 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02539 XEO_CLAS Peptide DME1242 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8.6 ug/ml) DME1242 XEOTICID XEO02539 GENEFORM Protein DME1242 XEOTICID XEO02539 MOACRIVE Inhibition DME1242 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1242 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02540 XEO_CLAS Peptide DME1242 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15.2 ug/ml) DME1242 XEOTICID XEO02540 GENEFORM Protein DME1242 XEOTICID XEO02540 MOACRIVE Inhibition DME1242 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1242 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02541 XEO_CLAS Peptide DME1242 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 22.2 ug/ml) DME1242 XEOTICID XEO02541 GENEFORM Protein DME1242 XEOTICID XEO02541 MOACRIVE Inhibition DME1242 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1242 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02542 XEO_CLAS Peptide DME1242 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11.4 ug/ml) DME1242 XEOTICID XEO02542 GENEFORM Protein DME1242 XEOTICID XEO02542 MOACRIVE Inhibition DME1242 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1242 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02543 XEO_CLAS Peptide DME1242 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 26.2 ug/ml) DME1242 XEOTICID XEO02543 GENEFORM Protein DME1242 XEOTICID XEO02543 MOACRIVE Inhibition DME1242 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1242 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02544 XEO_CLAS Peptide DME1242 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.9 ug/ml) DME1242 XEOTICID XEO02544 GENEFORM Protein DME1242 XEOTICID XEO02544 MOACRIVE Inhibition DME1242 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1242 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02545 XEO_CLAS Peptide DME1242 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7 microM) DME1242 XEOTICID XEO02545 GENEFORM Protein DME1242 XEOTICID XEO02545 MOACRIVE Inhibition DME1242 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1242 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02546 XEO_CLAS Peptide DME1242 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5 microM) DME1242 XEOTICID XEO02546 GENEFORM Protein DME1242 XEOTICID XEO02546 MOACRIVE Inhibition DME1242 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1242 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02547 XEO_CLAS Peptide DME1242 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7 microM) DME1242 XEOTICID XEO02547 GENEFORM Protein DME1242 XEOTICID XEO02547 MOACRIVE Inhibition DME1242 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1242 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02548 XEO_CLAS Peptide DME1242 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 27 microM) DME1242 XEOTICID XEO02548 GENEFORM Protein DME1242 XEOTICID XEO02548 MOACRIVE Inhibition DME1242 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1242 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02549 XEO_CLAS Peptide DME1242 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02549 GENEFORM Protein DME1242 XEOTICID XEO02549 MOACRIVE Inhibition DME1242 XEOTICID XEO02550 XEO_NAME Brevinin-1PLb DME1242 XEOTICID XEO02550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02550 XEO_CLAS Peptide DME1242 XEOTICID XEO02550 DESCRIPT Brevinin-1PLb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9 microM) DME1242 XEOTICID XEO02550 GENEFORM Protein DME1242 XEOTICID XEO02550 MOACRIVE Inhibition DME1242 XEOTICID XEO02551 XEO_NAME Brevinin-1PLc DME1242 XEOTICID XEO02551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02551 XEO_CLAS Peptide DME1242 XEOTICID XEO02551 DESCRIPT Brevinin-1PLc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 microM) DME1242 XEOTICID XEO02551 GENEFORM Protein DME1242 XEOTICID XEO02551 MOACRIVE Inhibition DME1242 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1242 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02552 XEO_CLAS Peptide DME1242 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO02552 GENEFORM Protein DME1242 XEOTICID XEO02552 MOACRIVE Inhibition DME1242 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1242 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02553 XEO_CLAS Peptide DME1242 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02553 GENEFORM Protein DME1242 XEOTICID XEO02553 MOACRIVE Inhibition DME1242 XEOTICID XEO02554 XEO_NAME Brevinin-1RTa DME1242 XEOTICID XEO02554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02554 XEO_CLAS Peptide DME1242 XEOTICID XEO02554 DESCRIPT Brevinin-1RTa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.3 ug/ml) DME1242 XEOTICID XEO02554 GENEFORM Protein DME1242 XEOTICID XEO02554 MOACRIVE Inhibition DME1242 XEOTICID XEO02555 XEO_NAME Brevinin-1RTb DME1242 XEOTICID XEO02555 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02555 XEO_CLAS Peptide DME1242 XEOTICID XEO02555 DESCRIPT Brevinin-1RTb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.1 ug/ml) DME1242 XEOTICID XEO02555 GENEFORM Protein DME1242 XEOTICID XEO02555 MOACRIVE Inhibition DME1242 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1242 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02560 XEO_CLAS Peptide DME1242 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO02560 GENEFORM Protein DME1242 XEOTICID XEO02560 MOACRIVE Inhibition DME1242 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1242 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02561 XEO_CLAS Peptide DME1242 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 13 microM) DME1242 XEOTICID XEO02561 GENEFORM Protein DME1242 XEOTICID XEO02561 MOACRIVE Inhibition DME1242 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1242 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02562 XEO_CLAS Peptide DME1242 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO02562 GENEFORM Protein DME1242 XEOTICID XEO02562 MOACRIVE Inhibition DME1242 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1242 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02563 XEO_CLAS Peptide DME1242 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7 microM) DME1242 XEOTICID XEO02563 GENEFORM Protein DME1242 XEOTICID XEO02563 MOACRIVE Inhibition DME1242 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1242 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02566 XEO_CLAS Peptide DME1242 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 microM) DME1242 XEOTICID XEO02566 GENEFORM Protein DME1242 XEOTICID XEO02566 MOACRIVE Inhibition DME1242 XEOTICID XEO02567 XEO_NAME Brevinin-1V DME1242 XEOTICID XEO02567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02567 XEO_CLAS Peptide DME1242 XEOTICID XEO02567 DESCRIPT Brevinin-1V inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 19 microM) DME1242 XEOTICID XEO02567 GENEFORM Protein DME1242 XEOTICID XEO02567 MOACRIVE Inhibition DME1242 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1242 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02572 XEO_CLAS Peptide DME1242 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02572 GENEFORM Protein DME1242 XEOTICID XEO02572 MOACRIVE Inhibition DME1242 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1242 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02573 XEO_CLAS Peptide DME1242 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02573 GENEFORM Protein DME1242 XEOTICID XEO02573 MOACRIVE Inhibition DME1242 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1242 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02574 XEO_CLAS Peptide DME1242 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO02574 GENEFORM Protein DME1242 XEOTICID XEO02574 MOACRIVE Inhibition DME1242 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1242 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02575 XEO_CLAS Peptide DME1242 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 microM) DME1242 XEOTICID XEO02575 GENEFORM Protein DME1242 XEOTICID XEO02575 MOACRIVE Inhibition DME1242 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1242 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02576 XEO_CLAS Peptide DME1242 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 17 microM) DME1242 XEOTICID XEO02576 GENEFORM Protein DME1242 XEOTICID XEO02576 MOACRIVE Inhibition DME1242 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1242 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02577 XEO_CLAS Peptide DME1242 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO02577 GENEFORM Protein DME1242 XEOTICID XEO02577 MOACRIVE Inhibition DME1242 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1242 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02578 XEO_CLAS Peptide DME1242 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02578 GENEFORM Protein DME1242 XEOTICID XEO02578 MOACRIVE Inhibition DME1242 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1242 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02579 XEO_CLAS Peptide DME1242 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02579 GENEFORM Protein DME1242 XEOTICID XEO02579 MOACRIVE Inhibition DME1242 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1242 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02580 XEO_CLAS Peptide DME1242 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC < 15 microM) DME1242 XEOTICID XEO02580 GENEFORM Protein DME1242 XEOTICID XEO02580 MOACRIVE Inhibition DME1242 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1242 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02581 XEO_CLAS Peptide DME1242 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 30 microM) DME1242 XEOTICID XEO02581 GENEFORM Protein DME1242 XEOTICID XEO02581 MOACRIVE Inhibition DME1242 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1242 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02582 XEO_CLAS Peptide DME1242 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 microM) DME1242 XEOTICID XEO02582 GENEFORM Protein DME1242 XEOTICID XEO02582 MOACRIVE Inhibition DME1242 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1242 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02583 XEO_CLAS Peptide DME1242 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 microM) DME1242 XEOTICID XEO02583 GENEFORM Protein DME1242 XEOTICID XEO02583 MOACRIVE Inhibition DME1242 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1242 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02584 XEO_CLAS Peptide DME1242 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.0 microM) DME1242 XEOTICID XEO02584 GENEFORM Protein DME1242 XEOTICID XEO02584 MOACRIVE Inhibition DME1242 XEOTICID XEO02588 XEO_NAME Brevinin-2GHa DME1242 XEOTICID XEO02588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02588 XEO_CLAS Peptide DME1242 XEOTICID XEO02588 DESCRIPT Brevinin-2GHa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 14.9 ug/ml) DME1242 XEOTICID XEO02588 GENEFORM Protein DME1242 XEOTICID XEO02588 MOACRIVE Inhibition DME1242 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1242 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02589 XEO_CLAS Peptide DME1242 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16.5 ug/ml) DME1242 XEOTICID XEO02589 GENEFORM Protein DME1242 XEOTICID XEO02589 MOACRIVE Inhibition DME1242 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1242 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02590 XEO_CLAS Peptide DME1242 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9.8 ug/ml) DME1242 XEOTICID XEO02590 GENEFORM Protein DME1242 XEOTICID XEO02590 MOACRIVE Inhibition DME1242 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1242 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02591 XEO_CLAS Peptide DME1242 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 microM) DME1242 XEOTICID XEO02591 GENEFORM Protein DME1242 XEOTICID XEO02591 MOACRIVE Inhibition DME1242 XEOTICID XEO02592 XEO_NAME Brevinin-2HS2 DME1242 XEOTICID XEO02592 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02592 XEO_CLAS Peptide DME1242 XEOTICID XEO02592 DESCRIPT Brevinin-2HS2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 19 microM) DME1242 XEOTICID XEO02592 GENEFORM Protein DME1242 XEOTICID XEO02592 MOACRIVE Inhibition DME1242 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1242 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02593 XEO_CLAS Peptide DME1242 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 18 microM) DME1242 XEOTICID XEO02593 GENEFORM Protein DME1242 XEOTICID XEO02593 MOACRIVE Inhibition DME1242 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1242 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02594 XEO_CLAS Peptide DME1242 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02594 GENEFORM Protein DME1242 XEOTICID XEO02594 MOACRIVE Inhibition DME1242 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1242 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02595 XEO_CLAS Peptide DME1242 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO02595 GENEFORM Protein DME1242 XEOTICID XEO02595 MOACRIVE Inhibition DME1242 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1242 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02596 XEO_CLAS Peptide DME1242 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.3 microM) DME1242 XEOTICID XEO02596 GENEFORM Protein DME1242 XEOTICID XEO02596 MOACRIVE Inhibition DME1242 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1242 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02597 XEO_CLAS Peptide DME1242 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 microM) DME1242 XEOTICID XEO02597 GENEFORM Protein DME1242 XEOTICID XEO02597 MOACRIVE Inhibition DME1242 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1242 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02598 XEO_CLAS Peptide DME1242 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO02598 GENEFORM Protein DME1242 XEOTICID XEO02598 MOACRIVE Inhibition DME1242 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1242 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02599 XEO_CLAS Peptide DME1242 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.8 microM) DME1242 XEOTICID XEO02599 GENEFORM Protein DME1242 XEOTICID XEO02599 MOACRIVE Inhibition DME1242 XEOTICID XEO02600 XEO_NAME Brevinin-2LTc DME1242 XEOTICID XEO02600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02600 XEO_CLAS Peptide DME1242 XEOTICID XEO02600 DESCRIPT Brevinin-2LTc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 60 microM) DME1242 XEOTICID XEO02600 GENEFORM Protein DME1242 XEOTICID XEO02600 MOACRIVE Inhibition DME1242 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1242 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02601 XEO_CLAS Peptide DME1242 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.1 ug/ml) DME1242 XEOTICID XEO02601 GENEFORM Protein DME1242 XEOTICID XEO02601 MOACRIVE Inhibition DME1242 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1242 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02602 XEO_CLAS Peptide DME1242 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.6 ug/ml) DME1242 XEOTICID XEO02602 GENEFORM Protein DME1242 XEOTICID XEO02602 MOACRIVE Inhibition DME1242 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1242 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02603 XEO_CLAS Peptide DME1242 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.3 ug/ml) DME1242 XEOTICID XEO02603 GENEFORM Protein DME1242 XEOTICID XEO02603 MOACRIVE Inhibition DME1242 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1242 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02604 XEO_CLAS Peptide DME1242 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10 ug/ml) DME1242 XEOTICID XEO02604 GENEFORM Protein DME1242 XEOTICID XEO02604 MOACRIVE Inhibition DME1242 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1242 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02605 XEO_CLAS Peptide DME1242 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 30.6 ug/ml) DME1242 XEOTICID XEO02605 GENEFORM Protein DME1242 XEOTICID XEO02605 MOACRIVE Inhibition DME1242 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1242 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02606 XEO_CLAS Peptide DME1242 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 22.4 ug/ml) DME1242 XEOTICID XEO02606 GENEFORM Protein DME1242 XEOTICID XEO02606 MOACRIVE Inhibition DME1242 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1242 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02607 XEO_CLAS Peptide DME1242 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11.6 ug/ml) DME1242 XEOTICID XEO02607 GENEFORM Protein DME1242 XEOTICID XEO02607 MOACRIVE Inhibition DME1242 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1242 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02608 XEO_CLAS Peptide DME1242 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.0 ug/ml) DME1242 XEOTICID XEO02608 GENEFORM Protein DME1242 XEOTICID XEO02608 MOACRIVE Inhibition DME1242 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1242 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02609 XEO_CLAS Peptide DME1242 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7.9 ug/ml) DME1242 XEOTICID XEO02609 GENEFORM Protein DME1242 XEOTICID XEO02609 MOACRIVE Inhibition DME1242 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1242 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02610 XEO_CLAS Peptide DME1242 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.1 ug/ml) DME1242 XEOTICID XEO02610 GENEFORM Protein DME1242 XEOTICID XEO02610 MOACRIVE Inhibition DME1242 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1242 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02611 XEO_CLAS Peptide DME1242 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 20.6 ug/ml) DME1242 XEOTICID XEO02611 GENEFORM Protein DME1242 XEOTICID XEO02611 MOACRIVE Inhibition DME1242 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1242 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02612 XEO_CLAS Peptide DME1242 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5.9 ug/ml) DME1242 XEOTICID XEO02612 GENEFORM Protein DME1242 XEOTICID XEO02612 MOACRIVE Inhibition DME1242 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1242 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02613 XEO_CLAS Peptide DME1242 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.6 ug/ml) DME1242 XEOTICID XEO02613 GENEFORM Protein DME1242 XEOTICID XEO02613 MOACRIVE Inhibition DME1242 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1242 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02614 XEO_CLAS Peptide DME1242 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5.8 ug/ml) DME1242 XEOTICID XEO02614 GENEFORM Protein DME1242 XEOTICID XEO02614 MOACRIVE Inhibition DME1242 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1242 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02615 XEO_CLAS Peptide DME1242 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8.6 ug/ml) DME1242 XEOTICID XEO02615 GENEFORM Protein DME1242 XEOTICID XEO02615 MOACRIVE Inhibition DME1242 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1242 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02616 XEO_CLAS Peptide DME1242 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10.2 ug/ml) DME1242 XEOTICID XEO02616 GENEFORM Protein DME1242 XEOTICID XEO02616 MOACRIVE Inhibition DME1242 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1242 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02617 XEO_CLAS Peptide DME1242 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9.4 ug/ml) DME1242 XEOTICID XEO02617 GENEFORM Protein DME1242 XEOTICID XEO02617 MOACRIVE Inhibition DME1242 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1242 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02618 XEO_CLAS Peptide DME1242 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.3 ug/ml) DME1242 XEOTICID XEO02618 GENEFORM Protein DME1242 XEOTICID XEO02618 MOACRIVE Inhibition DME1242 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1242 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02619 XEO_CLAS Peptide DME1242 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10.5 ug/ml) DME1242 XEOTICID XEO02619 GENEFORM Protein DME1242 XEOTICID XEO02619 MOACRIVE Inhibition DME1242 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1242 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02624 XEO_CLAS Peptide DME1242 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 18 microM) DME1242 XEOTICID XEO02624 GENEFORM Protein DME1242 XEOTICID XEO02624 MOACRIVE Inhibition DME1242 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1242 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02625 XEO_CLAS Peptide DME1242 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9 microM) DME1242 XEOTICID XEO02625 GENEFORM Protein DME1242 XEOTICID XEO02625 MOACRIVE Inhibition DME1242 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1242 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02626 XEO_CLAS Peptide DME1242 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 72 microM) DME1242 XEOTICID XEO02626 GENEFORM Protein DME1242 XEOTICID XEO02626 MOACRIVE Inhibition DME1242 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1242 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02627 XEO_CLAS Peptide DME1242 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02627 GENEFORM Protein DME1242 XEOTICID XEO02627 MOACRIVE Inhibition DME1242 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1242 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02628 XEO_CLAS Peptide DME1242 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 36 microM) DME1242 XEOTICID XEO02628 GENEFORM Protein DME1242 XEOTICID XEO02628 MOACRIVE Inhibition DME1242 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1242 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02629 XEO_CLAS Peptide DME1242 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 microM) DME1242 XEOTICID XEO02629 GENEFORM Protein DME1242 XEOTICID XEO02629 MOACRIVE Inhibition DME1242 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1242 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02630 XEO_CLAS Peptide DME1242 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.10 ug/ml) DME1242 XEOTICID XEO02630 GENEFORM Protein DME1242 XEOTICID XEO02630 MOACRIVE Inhibition DME1242 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1242 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02631 XEO_CLAS Peptide DME1242 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 ug/ml) DME1242 XEOTICID XEO02631 GENEFORM Protein DME1242 XEOTICID XEO02631 MOACRIVE Inhibition DME1242 XEOTICID XEO02632 XEO_NAME Brevinin-2RTa DME1242 XEOTICID XEO02632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02632 XEO_CLAS Peptide DME1242 XEOTICID XEO02632 DESCRIPT Brevinin-2RTa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 ug/ml) DME1242 XEOTICID XEO02632 GENEFORM Protein DME1242 XEOTICID XEO02632 MOACRIVE Inhibition DME1242 XEOTICID XEO02633 XEO_NAME Brevinin-2RTb DME1242 XEOTICID XEO02633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02633 XEO_CLAS Peptide DME1242 XEOTICID XEO02633 DESCRIPT Brevinin-2RTb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50.0 ug/ml) DME1242 XEOTICID XEO02633 GENEFORM Protein DME1242 XEOTICID XEO02633 MOACRIVE Inhibition DME1242 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1242 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02634 XEO_CLAS Peptide DME1242 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 50 microM) DME1242 XEOTICID XEO02634 GENEFORM Protein DME1242 XEOTICID XEO02634 MOACRIVE Inhibition DME1242 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1242 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02637 XEO_CLAS Peptide DME1242 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO02637 GENEFORM Protein DME1242 XEOTICID XEO02637 MOACRIVE Inhibition DME1242 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1242 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02639 XEO_CLAS Peptide DME1242 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 microM) DME1242 XEOTICID XEO02639 GENEFORM Protein DME1242 XEOTICID XEO02639 MOACRIVE Inhibition DME1242 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1242 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02644 XEO_CLAS Peptide DME1242 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02644 GENEFORM Protein DME1242 XEOTICID XEO02644 MOACRIVE Inhibition DME1242 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1242 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02645 XEO_CLAS Peptide DME1242 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02645 GENEFORM Protein DME1242 XEOTICID XEO02645 MOACRIVE Inhibition DME1242 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1242 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02646 XEO_CLAS Peptide DME1242 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02646 GENEFORM Protein DME1242 XEOTICID XEO02646 MOACRIVE Inhibition DME1242 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1242 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02647 XEO_CLAS Peptide DME1242 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02647 GENEFORM Protein DME1242 XEOTICID XEO02647 MOACRIVE Inhibition DME1242 XEOTICID XEO02648 XEO_NAME Buchu oil DME1242 XEOTICID XEO02648 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02648 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02648 DESCRIPT Buchu oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02648 GENEFORM Protein DME1242 XEOTICID XEO02648 MOACRIVE Inhibition DME1242 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1242 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02649 XEO_CLAS Peptide DME1242 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 ug/ml) DME1242 XEOTICID XEO02649 GENEFORM Protein DME1242 XEOTICID XEO02649 MOACRIVE Inhibition DME1242 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1242 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02650 XEO_CLAS Peptide DME1242 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 ug/ml) DME1242 XEOTICID XEO02650 GENEFORM Protein DME1242 XEOTICID XEO02650 MOACRIVE Inhibition DME1242 XEOTICID XEO02660 XEO_NAME Butyl gallate DME1242 XEOTICID XEO02660 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1242 XEOTICID XEO02660 XEO_CLAS Chemical Compound DME1242 XEOTICID XEO02660 DESCRIPT Butyl gallate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02660 GENEFORM Protein DME1242 XEOTICID XEO02660 MOACRIVE Inhibition DME1242 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1242 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02663 XEO_CLAS Peptide DME1242 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.125 microM) DME1242 XEOTICID XEO02663 GENEFORM Protein DME1242 XEOTICID XEO02663 MOACRIVE Inhibition DME1242 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1242 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02664 XEO_CLAS Peptide DME1242 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 microM) DME1242 XEOTICID XEO02664 GENEFORM Protein DME1242 XEOTICID XEO02664 MOACRIVE Inhibition DME1242 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1242 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02672 XEO_CLAS Peptide DME1242 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.125 microM) DME1242 XEOTICID XEO02672 GENEFORM Protein DME1242 XEOTICID XEO02672 MOACRIVE Inhibition DME1242 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1242 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02673 XEO_CLAS Peptide DME1242 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.125 microM) DME1242 XEOTICID XEO02673 GENEFORM Protein DME1242 XEOTICID XEO02673 MOACRIVE Inhibition DME1242 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1242 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02674 XEO_CLAS Peptide DME1242 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.125 microM) DME1242 XEOTICID XEO02674 GENEFORM Protein DME1242 XEOTICID XEO02674 MOACRIVE Inhibition DME1242 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1242 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02676 XEO_CLAS Peptide DME1242 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 microM) DME1242 XEOTICID XEO02676 GENEFORM Protein DME1242 XEOTICID XEO02676 MOACRIVE Inhibition DME1242 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1242 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02677 XEO_CLAS Peptide DME1242 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 microM) DME1242 XEOTICID XEO02677 GENEFORM Protein DME1242 XEOTICID XEO02677 MOACRIVE Inhibition DME1242 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1242 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02679 XEO_CLAS Peptide DME1242 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 microM) DME1242 XEOTICID XEO02679 GENEFORM Protein DME1242 XEOTICID XEO02679 MOACRIVE Inhibition DME1242 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1242 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02680 XEO_CLAS Peptide DME1242 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 microM) DME1242 XEOTICID XEO02680 GENEFORM Protein DME1242 XEOTICID XEO02680 MOACRIVE Inhibition DME1242 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1242 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02683 XEO_CLAS Peptide DME1242 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO02683 GENEFORM Protein DME1242 XEOTICID XEO02683 MOACRIVE Inhibition DME1242 XEOTICID XEO02684 XEO_NAME Cade oil DME1242 XEOTICID XEO02684 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02684 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02684 DESCRIPT Cade oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02684 GENEFORM Protein DME1242 XEOTICID XEO02684 MOACRIVE Inhibition DME1242 XEOTICID XEO02686 XEO_NAME Caerin-1.1 DME1242 XEOTICID XEO02686 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02686 XEO_CLAS Peptide DME1242 XEOTICID XEO02686 DESCRIPT Caerin-1.1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3-12 ug/ml) DME1242 XEOTICID XEO02686 GENEFORM Protein DME1242 XEOTICID XEO02686 MOACRIVE Inhibition DME1242 XEOTICID XEO02689 XEO_NAME Caerin-1.17 DME1242 XEOTICID XEO02689 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02689 XEO_CLAS Peptide DME1242 XEOTICID XEO02689 DESCRIPT Caerin-1.17 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 ug/ml) DME1242 XEOTICID XEO02689 GENEFORM Protein DME1242 XEOTICID XEO02689 MOACRIVE Inhibition DME1242 XEOTICID XEO02690 XEO_NAME Caerin-1.18 DME1242 XEOTICID XEO02690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02690 XEO_CLAS Peptide DME1242 XEOTICID XEO02690 DESCRIPT Caerin-1.18 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 ug/ml) DME1242 XEOTICID XEO02690 GENEFORM Protein DME1242 XEOTICID XEO02690 MOACRIVE Inhibition DME1242 XEOTICID XEO02691 XEO_NAME Caerin-1.19 DME1242 XEOTICID XEO02691 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02691 XEO_CLAS Peptide DME1242 XEOTICID XEO02691 DESCRIPT Caerin-1.19 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 ug/ml) DME1242 XEOTICID XEO02691 GENEFORM Protein DME1242 XEOTICID XEO02691 MOACRIVE Inhibition DME1242 XEOTICID XEO02692 XEO_NAME Caerin-1.3 DME1242 XEOTICID XEO02692 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02692 XEO_CLAS Peptide DME1242 XEOTICID XEO02692 DESCRIPT Caerin-1.3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6-12 ug/ml) DME1242 XEOTICID XEO02692 GENEFORM Protein DME1242 XEOTICID XEO02692 MOACRIVE Inhibition DME1242 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1242 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02693 XEO_CLAS Peptide DME1242 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 100 ug/ml) DME1242 XEOTICID XEO02693 GENEFORM Protein DME1242 XEOTICID XEO02693 MOACRIVE Inhibition DME1242 XEOTICID XEO02694 XEO_NAME Caerin-1.5 DME1242 XEOTICID XEO02694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02694 XEO_CLAS Peptide DME1242 XEOTICID XEO02694 DESCRIPT Caerin-1.5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO02694 GENEFORM Protein DME1242 XEOTICID XEO02694 MOACRIVE Inhibition DME1242 XEOTICID XEO02695 XEO_NAME Caerin-1.9 DME1242 XEOTICID XEO02695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02695 XEO_CLAS Peptide DME1242 XEOTICID XEO02695 DESCRIPT Caerin-1.9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 100 ug/ml) DME1242 XEOTICID XEO02695 GENEFORM Protein DME1242 XEOTICID XEO02695 MOACRIVE Inhibition DME1242 XEOTICID XEO02705 XEO_NAME CAMA peptide DME1242 XEOTICID XEO02705 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02705 XEO_CLAS Peptide DME1242 XEOTICID XEO02705 DESCRIPT CAMA peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02705 GENEFORM Protein DME1242 XEOTICID XEO02705 MOACRIVE Inhibition DME1242 XEOTICID XEO02707 XEO_NAME Cananga oil DME1242 XEOTICID XEO02707 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02707 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02707 DESCRIPT Cananga oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02707 GENEFORM Protein DME1242 XEOTICID XEO02707 MOACRIVE Inhibition DME1242 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1242 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02708 XEO_CLAS Peptide DME1242 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 100 ug/ml) DME1242 XEOTICID XEO02708 GENEFORM Protein DME1242 XEOTICID XEO02708 MOACRIVE Inhibition DME1242 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1242 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02709 XEO_CLAS Peptide DME1242 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.41 microM) DME1242 XEOTICID XEO02709 GENEFORM Protein DME1242 XEOTICID XEO02709 MOACRIVE Inhibition DME1242 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1242 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1242 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02713 GENEFORM Protein DME1242 XEOTICID XEO02713 MOACRIVE Inhibition DME1242 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1242 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02714 GENEFORM Protein DME1242 XEOTICID XEO02714 MOACRIVE Inhibition DME1242 XEOTICID XEO02715 XEO_NAME Cardamon oil DME1242 XEOTICID XEO02715 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02715 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02715 DESCRIPT Cardamon oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02715 GENEFORM Protein DME1242 XEOTICID XEO02715 MOACRIVE Inhibition DME1242 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1242 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02721 XEO_CLAS Peptide DME1242 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02721 GENEFORM Protein DME1242 XEOTICID XEO02721 MOACRIVE Inhibition DME1242 XEOTICID XEO02723 XEO_NAME Carrot seed oil DME1242 XEOTICID XEO02723 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02723 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02723 DESCRIPT Carrot seed oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02723 GENEFORM Protein DME1242 XEOTICID XEO02723 MOACRIVE Inhibition DME1242 XEOTICID XEO02725 XEO_NAME Cascarilla bark oil DME1242 XEOTICID XEO02725 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02725 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02725 DESCRIPT Cascarilla bark oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02725 GENEFORM Protein DME1242 XEOTICID XEO02725 MOACRIVE Inhibition DME1242 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1242 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02731 XEO_CLAS Peptide DME1242 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.25 microM) DME1242 XEOTICID XEO02731 GENEFORM Protein DME1242 XEOTICID XEO02731 MOACRIVE Inhibition DME1242 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1242 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02732 XEO_CLAS Peptide DME1242 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 microM) DME1242 XEOTICID XEO02732 GENEFORM Protein DME1242 XEOTICID XEO02732 MOACRIVE Inhibition DME1242 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1242 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02733 XEO_CLAS Peptide DME1242 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1-8 ug/ml) DME1242 XEOTICID XEO02733 GENEFORM Protein DME1242 XEOTICID XEO02733 MOACRIVE Inhibition DME1242 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1242 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02734 XEO_CLAS Peptide DME1242 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.40 microM) DME1242 XEOTICID XEO02734 GENEFORM Protein DME1242 XEOTICID XEO02734 MOACRIVE Inhibition DME1242 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1242 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02735 XEO_CLAS Peptide DME1242 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC < 2 ug/ml) DME1242 XEOTICID XEO02735 GENEFORM Protein DME1242 XEOTICID XEO02735 MOACRIVE Inhibition DME1242 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1242 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02736 XEO_CLAS Peptide DME1242 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.33 microM) DME1242 XEOTICID XEO02736 GENEFORM Protein DME1242 XEOTICID XEO02736 MOACRIVE Inhibition DME1242 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1242 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02738 XEO_CLAS Peptide DME1242 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 microM) DME1242 XEOTICID XEO02738 GENEFORM Protein DME1242 XEOTICID XEO02738 MOACRIVE Inhibition DME1242 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1242 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02739 XEO_CLAS Peptide DME1242 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 microM) DME1242 XEOTICID XEO02739 GENEFORM Protein DME1242 XEOTICID XEO02739 MOACRIVE Inhibition DME1242 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1242 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02740 XEO_CLAS Peptide DME1242 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO02740 GENEFORM Protein DME1242 XEOTICID XEO02740 MOACRIVE Inhibition DME1242 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1242 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02741 XEO_CLAS Peptide DME1242 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 ug/ml) DME1242 XEOTICID XEO02741 GENEFORM Protein DME1242 XEOTICID XEO02741 MOACRIVE Inhibition DME1242 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1242 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02743 XEO_CLAS Peptide DME1242 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.7 ug/ml) DME1242 XEOTICID XEO02743 GENEFORM Protein DME1242 XEOTICID XEO02743 MOACRIVE Inhibition DME1242 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1242 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02744 XEO_CLAS Peptide DME1242 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 75 ug/ml) DME1242 XEOTICID XEO02744 GENEFORM Protein DME1242 XEOTICID XEO02744 MOACRIVE Inhibition DME1242 XEOTICID XEO02747 XEO_NAME Cathelicidin-PY DME1242 XEOTICID XEO02747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02747 XEO_CLAS Peptide DME1242 XEOTICID XEO02747 DESCRIPT Cathelicidin-PY inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.74 microM) DME1242 XEOTICID XEO02747 GENEFORM Protein DME1242 XEOTICID XEO02747 MOACRIVE Inhibition DME1242 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1242 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02749 XEO_CLAS Peptide DME1242 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 100 ug/ml) DME1242 XEOTICID XEO02749 GENEFORM Protein DME1242 XEOTICID XEO02749 MOACRIVE Inhibition DME1242 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1242 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02750 XEO_CLAS Peptide DME1242 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02750 GENEFORM Protein DME1242 XEOTICID XEO02750 MOACRIVE Inhibition DME1242 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1242 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02752 XEO_CLAS Peptide DME1242 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02752 GENEFORM Protein DME1242 XEOTICID XEO02752 MOACRIVE Inhibition DME1242 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1242 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02753 XEO_CLAS Peptide DME1242 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02753 GENEFORM Protein DME1242 XEOTICID XEO02753 MOACRIVE Inhibition DME1242 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1242 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02756 XEO_CLAS Peptide DME1242 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 29 microM) DME1242 XEOTICID XEO02756 GENEFORM Protein DME1242 XEOTICID XEO02756 MOACRIVE Inhibition DME1242 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1242 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02757 XEO_CLAS Peptide DME1242 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO02757 GENEFORM Protein DME1242 XEOTICID XEO02757 MOACRIVE Inhibition DME1242 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1242 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02758 XEO_CLAS Peptide DME1242 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 200 microM) DME1242 XEOTICID XEO02758 GENEFORM Protein DME1242 XEOTICID XEO02758 MOACRIVE Inhibition DME1242 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1242 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02759 XEO_CLAS Peptide DME1242 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 microM) DME1242 XEOTICID XEO02759 GENEFORM Protein DME1242 XEOTICID XEO02759 MOACRIVE Inhibition DME1242 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1242 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02760 XEO_CLAS Peptide DME1242 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 microM) DME1242 XEOTICID XEO02760 GENEFORM Protein DME1242 XEOTICID XEO02760 MOACRIVE Inhibition DME1242 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1242 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02761 XEO_CLAS Peptide DME1242 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 51 microM) DME1242 XEOTICID XEO02761 GENEFORM Protein DME1242 XEOTICID XEO02761 MOACRIVE Inhibition DME1242 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1242 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02762 XEO_CLAS Peptide DME1242 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7 microM) DME1242 XEOTICID XEO02762 GENEFORM Protein DME1242 XEOTICID XEO02762 MOACRIVE Inhibition DME1242 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1242 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02763 XEO_CLAS Peptide DME1242 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO02763 GENEFORM Protein DME1242 XEOTICID XEO02763 MOACRIVE Inhibition DME1242 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1242 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02764 XEO_CLAS Peptide DME1242 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO02764 GENEFORM Protein DME1242 XEOTICID XEO02764 MOACRIVE Inhibition DME1242 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1242 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02765 XEO_CLAS Peptide DME1242 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 microM) DME1242 XEOTICID XEO02765 GENEFORM Protein DME1242 XEOTICID XEO02765 MOACRIVE Inhibition DME1242 XEOTICID XEO02766 XEO_NAME Cecropin-B DME1242 XEOTICID XEO02766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02766 XEO_CLAS Peptide DME1242 XEOTICID XEO02766 DESCRIPT Cecropin-B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02766 GENEFORM Protein DME1242 XEOTICID XEO02766 MOACRIVE Inhibition DME1242 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1242 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02767 XEO_CLAS Peptide DME1242 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02767 GENEFORM Protein DME1242 XEOTICID XEO02767 MOACRIVE Inhibition DME1242 XEOTICID XEO02775 XEO_NAME Cecropin-XJ DME1242 XEOTICID XEO02775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02775 XEO_CLAS Peptide DME1242 XEOTICID XEO02775 DESCRIPT Cecropin-XJ inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02775 GENEFORM Protein DME1242 XEOTICID XEO02775 MOACRIVE Inhibition DME1242 XEOTICID XEO02776 XEO_NAME Cedarwood oil DME1242 XEOTICID XEO02776 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02776 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02776 DESCRIPT Cedarwood oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02776 GENEFORM Protein DME1242 XEOTICID XEO02776 MOACRIVE Inhibition DME1242 XEOTICID XEO02778 XEO_NAME Cefalonium DME1242 XEOTICID XEO02778 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO02778 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO02778 DESCRIPT Cefalonium inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02778 GENEFORM Protein DME1242 XEOTICID XEO02778 MOACRIVE Inhibition DME1242 XEOTICID XEO02780 XEO_NAME Cefixime DME1242 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02780 GENEFORM Protein DME1242 XEOTICID XEO02780 MOACRIVE Inhibition DME1242 XEOTICID XEO02784 XEO_NAME Cefoxitin DME1242 XEOTICID XEO02784 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO02784 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO02784 DESCRIPT Cefoxitin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02784 GENEFORM Protein DME1242 XEOTICID XEO02784 MOACRIVE Inhibition DME1242 XEOTICID XEO02788 XEO_NAME Celery seed oil DME1242 XEOTICID XEO02788 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02788 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02788 DESCRIPT Celery seed oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02788 GENEFORM Protein DME1242 XEOTICID XEO02788 MOACRIVE Inhibition DME1242 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1242 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02802 XEO_CLAS Peptide DME1242 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 50 microM) DME1242 XEOTICID XEO02802 GENEFORM Protein DME1242 XEOTICID XEO02802 MOACRIVE Inhibition DME1242 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1242 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02813 XEO_CLAS Peptide DME1242 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 80 microM) DME1242 XEOTICID XEO02813 GENEFORM Protein DME1242 XEOTICID XEO02813 MOACRIVE Inhibition DME1242 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1242 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02814 XEO_CLAS Peptide DME1242 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 80 microM) DME1242 XEOTICID XEO02814 GENEFORM Protein DME1242 XEOTICID XEO02814 MOACRIVE Inhibition DME1242 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1242 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02815 XEO_CLAS Peptide DME1242 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 80 microM) DME1242 XEOTICID XEO02815 GENEFORM Protein DME1242 XEOTICID XEO02815 MOACRIVE Inhibition DME1242 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1242 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02816 XEO_CLAS Peptide DME1242 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 80 microM) DME1242 XEOTICID XEO02816 GENEFORM Protein DME1242 XEOTICID XEO02816 MOACRIVE Inhibition DME1242 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1242 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02817 XEO_CLAS Peptide DME1242 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 80 microM) DME1242 XEOTICID XEO02817 GENEFORM Protein DME1242 XEOTICID XEO02817 MOACRIVE Inhibition DME1242 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1242 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02818 XEO_CLAS Peptide DME1242 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 80 microM) DME1242 XEOTICID XEO02818 GENEFORM Protein DME1242 XEOTICID XEO02818 MOACRIVE Inhibition DME1242 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1242 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02819 XEO_CLAS Peptide DME1242 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 80 microM) DME1242 XEOTICID XEO02819 GENEFORM Protein DME1242 XEOTICID XEO02819 MOACRIVE Inhibition DME1242 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1242 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02820 XEO_CLAS Peptide DME1242 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO02820 GENEFORM Protein DME1242 XEOTICID XEO02820 MOACRIVE Inhibition DME1242 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1242 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02821 XEO_CLAS Peptide DME1242 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02821 GENEFORM Protein DME1242 XEOTICID XEO02821 MOACRIVE Inhibition DME1242 XEOTICID XEO02822 XEO_NAME Chaxapeptin DME1242 XEOTICID XEO02822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02822 XEO_CLAS Peptide DME1242 XEOTICID XEO02822 DESCRIPT Chaxapeptin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02822 GENEFORM Protein DME1242 XEOTICID XEO02822 MOACRIVE Inhibition DME1242 XEOTICID XEO02823 XEO_NAME Chelerythrine DME1242 XEOTICID XEO02823 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO02823 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO02823 DESCRIPT Chelerythrine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02823 GENEFORM Protein DME1242 XEOTICID XEO02823 MOACRIVE Inhibition DME1242 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1242 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02824 XEO_CLAS Peptide DME1242 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 17 microM) DME1242 XEOTICID XEO02824 GENEFORM Protein DME1242 XEOTICID XEO02824 MOACRIVE Inhibition DME1242 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1242 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02826 XEO_CLAS Peptide DME1242 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.7 ug/ml) DME1242 XEOTICID XEO02826 GENEFORM Protein DME1242 XEOTICID XEO02826 MOACRIVE Inhibition DME1242 XEOTICID XEO02831 XEO_NAME Chlorhexidine acetate DME1242 XEOTICID XEO02831 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO02831 XEO_CLAS Drug in Phase 1 Clinical Trial DME1242 XEOTICID XEO02831 DESCRIPT Chlorhexidine acetate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02831 GENEFORM Protein DME1242 XEOTICID XEO02831 MOACRIVE Inhibition DME1242 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1242 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02834 GENEFORM Protein DME1242 XEOTICID XEO02834 MOACRIVE Inhibition DME1242 XEOTICID XEO02850 XEO_NAME Circulin-A DME1242 XEOTICID XEO02850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02850 XEO_CLAS Peptide DME1242 XEOTICID XEO02850 DESCRIPT Circulin-A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.19 microM) DME1242 XEOTICID XEO02850 GENEFORM Protein DME1242 XEOTICID XEO02850 MOACRIVE Inhibition DME1242 XEOTICID XEO02851 XEO_NAME Circulin-B DME1242 XEOTICID XEO02851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02851 XEO_CLAS Peptide DME1242 XEOTICID XEO02851 DESCRIPT Circulin-B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02851 GENEFORM Protein DME1242 XEOTICID XEO02851 MOACRIVE Inhibition DME1242 XEOTICID XEO02855 XEO_NAME Citronella oil DME1242 XEOTICID XEO02855 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02855 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02855 DESCRIPT Citronella oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02855 GENEFORM Protein DME1242 XEOTICID XEO02855 MOACRIVE Inhibition DME1242 XEOTICID XEO02856 XEO_NAME Citropin 1.1 DME1242 XEOTICID XEO02856 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02856 XEO_CLAS Peptide DME1242 XEOTICID XEO02856 DESCRIPT Citropin 1.1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02856 GENEFORM Protein DME1242 XEOTICID XEO02856 MOACRIVE Inhibition DME1242 XEOTICID XEO02859 XEO_NAME Frog citropin-1.1 DME1242 XEOTICID XEO02859 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02859 XEO_CLAS Peptide DME1242 XEOTICID XEO02859 DESCRIPT Frog citropin-1.1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO02859 GENEFORM Protein DME1242 XEOTICID XEO02859 MOACRIVE Inhibition DME1242 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1242 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02860 XEO_CLAS Peptide DME1242 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO02860 GENEFORM Protein DME1242 XEOTICID XEO02860 MOACRIVE Inhibition DME1242 XEOTICID XEO02861 XEO_NAME Citropin-1.1 sm2 DME1242 XEOTICID XEO02861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02861 XEO_CLAS Peptide DME1242 XEOTICID XEO02861 DESCRIPT Citropin-1.1 sm2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 100 ug/ml) DME1242 XEOTICID XEO02861 GENEFORM Protein DME1242 XEOTICID XEO02861 MOACRIVE Inhibition DME1242 XEOTICID XEO02862 XEO_NAME Citropin-1.2 DME1242 XEOTICID XEO02862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02862 XEO_CLAS Peptide DME1242 XEOTICID XEO02862 DESCRIPT Citropin-1.2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO02862 GENEFORM Protein DME1242 XEOTICID XEO02862 MOACRIVE Inhibition DME1242 XEOTICID XEO02863 XEO_NAME Citropin-1.3 DME1242 XEOTICID XEO02863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02863 XEO_CLAS Peptide DME1242 XEOTICID XEO02863 DESCRIPT Citropin-1.3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO02863 GENEFORM Protein DME1242 XEOTICID XEO02863 MOACRIVE Inhibition DME1242 XEOTICID XEO02864 XEO_NAME Cathelicidin cjaRL-37 DME1242 XEOTICID XEO02864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02864 XEO_CLAS Peptide DME1242 XEOTICID XEO02864 DESCRIPT Cathelicidin cjaRL-37 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 microM) DME1242 XEOTICID XEO02864 GENEFORM Protein DME1242 XEOTICID XEO02864 MOACRIVE Inhibition DME1242 XEOTICID XEO02866 XEO_NAME Clary sage oil DME1242 XEOTICID XEO02866 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02866 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02866 DESCRIPT Clary sage oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02866 GENEFORM Protein DME1242 XEOTICID XEO02866 MOACRIVE Inhibition DME1242 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1242 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02872 XEO_CLAS Peptide DME1242 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 308 microM) DME1242 XEOTICID XEO02872 GENEFORM Protein DME1242 XEOTICID XEO02872 MOACRIVE Inhibition DME1242 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1242 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02875 XEO_CLAS Peptide DME1242 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02875 GENEFORM Protein DME1242 XEOTICID XEO02875 MOACRIVE Inhibition DME1242 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1242 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02876 XEO_CLAS Peptide DME1242 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02876 GENEFORM Protein DME1242 XEOTICID XEO02876 MOACRIVE Inhibition DME1242 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1242 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02877 XEO_CLAS Peptide DME1242 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02877 GENEFORM Protein DME1242 XEOTICID XEO02877 MOACRIVE Inhibition DME1242 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1242 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02878 XEO_CLAS Peptide DME1242 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02878 GENEFORM Protein DME1242 XEOTICID XEO02878 MOACRIVE Inhibition DME1242 XEOTICID XEO02881 XEO_NAME Clove leaf oil DME1242 XEOTICID XEO02881 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02881 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02881 DESCRIPT Clove leaf oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02881 GENEFORM Protein DME1242 XEOTICID XEO02881 MOACRIVE Inhibition DME1242 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1242 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02895 XEO_CLAS Peptide DME1242 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 50 microM) DME1242 XEOTICID XEO02895 GENEFORM Protein DME1242 XEOTICID XEO02895 MOACRIVE Inhibition DME1242 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1242 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02896 XEO_CLAS Peptide DME1242 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO02896 GENEFORM Protein DME1242 XEOTICID XEO02896 MOACRIVE Inhibition DME1242 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1242 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02908 XEO_CLAS Peptide DME1242 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25-50 microM) DME1242 XEOTICID XEO02908 GENEFORM Protein DME1242 XEOTICID XEO02908 MOACRIVE Inhibition DME1242 XEOTICID XEO02922 XEO_NAME Coriander herb oil DME1242 XEOTICID XEO02922 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02922 XEO_CLAS Plant Extract DME1242 XEOTICID XEO02922 DESCRIPT Coriander herb oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02922 GENEFORM Protein DME1242 XEOTICID XEO02922 MOACRIVE Inhibition DME1242 XEOTICID XEO02930 XEO_NAME Indolicidin derivative CP10A DME1242 XEOTICID XEO02930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02930 XEO_CLAS Peptide DME1242 XEOTICID XEO02930 DESCRIPT Indolicidin derivative CP10A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 ug/ml) DME1242 XEOTICID XEO02930 GENEFORM Protein DME1242 XEOTICID XEO02930 MOACRIVE Inhibition DME1242 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1242 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02931 XEO_CLAS Peptide DME1242 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO02931 GENEFORM Protein DME1242 XEOTICID XEO02931 MOACRIVE Inhibition DME1242 XEOTICID XEO02932 XEO_NAME CP11CN peptide DME1242 XEOTICID XEO02932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02932 XEO_CLAS Peptide DME1242 XEOTICID XEO02932 DESCRIPT CP11CN peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO02932 GENEFORM Protein DME1242 XEOTICID XEO02932 MOACRIVE Inhibition DME1242 XEOTICID XEO02952 XEO_NAME Crinicepsin-1 DME1242 XEOTICID XEO02952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02952 XEO_CLAS Peptide DME1242 XEOTICID XEO02952 DESCRIPT Crinicepsin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 125 ug/ml) DME1242 XEOTICID XEO02952 GENEFORM Protein DME1242 XEOTICID XEO02952 MOACRIVE Inhibition DME1242 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1242 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02954 XEO_CLAS Peptide DME1242 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02954 GENEFORM Protein DME1242 XEOTICID XEO02954 MOACRIVE Inhibition DME1242 XEOTICID XEO02962 XEO_NAME Cryptonin DME1242 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02962 XEO_CLAS Peptide DME1242 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO02962 GENEFORM Protein DME1242 XEOTICID XEO02962 MOACRIVE Inhibition DME1242 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1242 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02965 XEO_CLAS Peptide DME1242 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 ug/ml) DME1242 XEOTICID XEO02965 GENEFORM Protein DME1242 XEOTICID XEO02965 MOACRIVE Inhibition DME1242 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1242 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02971 XEO_CLAS Peptide DME1242 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 microM) DME1242 XEOTICID XEO02971 GENEFORM Protein DME1242 XEOTICID XEO02971 MOACRIVE Inhibition DME1242 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1242 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO02972 XEO_CLAS Peptide DME1242 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.7 microM) DME1242 XEOTICID XEO02972 GENEFORM Protein DME1242 XEOTICID XEO02972 MOACRIVE Inhibition DME1242 XEOTICID XEO02980 XEO_NAME Streptomyces sp. culture extract DME1242 XEOTICID XEO02980 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02980 XEO_CLAS Bacterial Extract DME1242 XEOTICID XEO02980 DESCRIPT Streptomyces sp. culture extract inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02980 GENEFORM Protein DME1242 XEOTICID XEO02980 MOACRIVE Inhibition DME1242 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1242 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1242 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO02990 GENEFORM Protein DME1242 XEOTICID XEO02990 MOACRIVE Inhibition DME1242 XEOTICID XEO03005 XEO_NAME Kribbella hippodromi culture supernatant DME1242 XEOTICID XEO03005 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03005 XEO_CLAS Bacterial Extract DME1242 XEOTICID XEO03005 DESCRIPT Kribbella hippodromi culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03005 GENEFORM Protein DME1242 XEOTICID XEO03005 MOACRIVE Inhibition DME1242 XEOTICID XEO03006 XEO_NAME Kribbella sp. culture supernatant DME1242 XEOTICID XEO03006 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03006 XEO_CLAS Bacterial Extract DME1242 XEOTICID XEO03006 DESCRIPT Kribbella sp. culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03006 GENEFORM Protein DME1242 XEOTICID XEO03006 MOACRIVE Inhibition DME1242 XEOTICID XEO03010 XEO_NAME Streptomyces akiyoshiensis culture supernatant DME1242 XEOTICID XEO03010 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03010 XEO_CLAS Bacterial Extract DME1242 XEOTICID XEO03010 DESCRIPT Streptomyces akiyoshiensis culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03010 GENEFORM Protein DME1242 XEOTICID XEO03010 MOACRIVE Inhibition DME1242 XEOTICID XEO03011 XEO_NAME Streptomyces anulatus culture supernatant DME1242 XEOTICID XEO03011 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03011 XEO_CLAS Bacterial Extract DME1242 XEOTICID XEO03011 DESCRIPT Streptomyces anulatus culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03011 GENEFORM Protein DME1242 XEOTICID XEO03011 MOACRIVE Inhibition DME1242 XEOTICID XEO03012 XEO_NAME Streptomyces griseoruber culture supernatant DME1242 XEOTICID XEO03012 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03012 XEO_CLAS Bacterial Extract DME1242 XEOTICID XEO03012 DESCRIPT Streptomyces griseoruber culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03012 GENEFORM Protein DME1242 XEOTICID XEO03012 MOACRIVE Inhibition DME1242 XEOTICID XEO03013 XEO_NAME Streptomyces hebeiensis culture supernatant DME1242 XEOTICID XEO03013 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03013 XEO_CLAS Bacterial Extract DME1242 XEOTICID XEO03013 DESCRIPT Streptomyces hebeiensis culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03013 GENEFORM Protein DME1242 XEOTICID XEO03013 MOACRIVE Inhibition DME1242 XEOTICID XEO03014 XEO_NAME Streptomyces laceyi culture supernatant DME1242 XEOTICID XEO03014 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03014 XEO_CLAS Bacterial Extract DME1242 XEOTICID XEO03014 DESCRIPT Streptomyces laceyi culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03014 GENEFORM Protein DME1242 XEOTICID XEO03014 MOACRIVE Inhibition DME1242 XEOTICID XEO03015 XEO_NAME Streptomyces lanatus culture supernatant DME1242 XEOTICID XEO03015 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03015 XEO_CLAS Bacterial Extract DME1242 XEOTICID XEO03015 DESCRIPT Streptomyces lanatus culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03015 GENEFORM Protein DME1242 XEOTICID XEO03015 MOACRIVE Inhibition DME1242 XEOTICID XEO03016 XEO_NAME Streptomyces sp. BFI 250 culture supernatant DME1242 XEOTICID XEO03016 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03016 XEO_CLAS Bacterial Extract DME1242 XEOTICID XEO03016 DESCRIPT Streptomyces sp. BFI 250 culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03016 GENEFORM Protein DME1242 XEOTICID XEO03016 MOACRIVE Inhibition DME1242 XEOTICID XEO03017 XEO_NAME Streptomyces sp. DA10202 culture supernatant DME1242 XEOTICID XEO03017 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03017 XEO_CLAS Bacterial Extract DME1242 XEOTICID XEO03017 DESCRIPT Streptomyces sp. DA10202 culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03017 GENEFORM Protein DME1242 XEOTICID XEO03017 MOACRIVE Inhibition DME1242 XEOTICID XEO03018 XEO_NAME Streptomyces sp. HB096culture supernatant DME1242 XEOTICID XEO03018 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03018 XEO_CLAS Bacterial Extract DME1242 XEOTICID XEO03018 DESCRIPT Streptomyces sp. HB096culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03018 GENEFORM Protein DME1242 XEOTICID XEO03018 MOACRIVE Inhibition DME1242 XEOTICID XEO03019 XEO_NAME Streptomyces turgidiscabies culture supernatant DME1242 XEOTICID XEO03019 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03019 XEO_CLAS Bacterial Extract DME1242 XEOTICID XEO03019 DESCRIPT Streptomyces turgidiscabies culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03019 GENEFORM Protein DME1242 XEOTICID XEO03019 MOACRIVE Inhibition DME1242 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1242 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03021 XEO_CLAS Peptide DME1242 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.31-0.63 microM) DME1242 XEOTICID XEO03021 GENEFORM Protein DME1242 XEOTICID XEO03021 MOACRIVE Inhibition DME1242 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1242 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03039 XEO_CLAS Peptide DME1242 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 39.0 microM) DME1242 XEOTICID XEO03039 GENEFORM Protein DME1242 XEOTICID XEO03039 MOACRIVE Inhibition DME1242 XEOTICID XEO03042 XEO_NAME Cypress oil DME1242 XEOTICID XEO03042 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03042 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03042 DESCRIPT Cypress oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03042 GENEFORM Protein DME1242 XEOTICID XEO03042 MOACRIVE Inhibition DME1242 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1242 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03043 XEO_CLAS Peptide DME1242 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO03043 GENEFORM Protein DME1242 XEOTICID XEO03043 MOACRIVE Inhibition DME1242 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1242 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03049 XEO_CLAS Peptide DME1242 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO03049 GENEFORM Protein DME1242 XEOTICID XEO03049 MOACRIVE Inhibition DME1242 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1242 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03055 XEO_CLAS Peptide DME1242 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO03055 GENEFORM Protein DME1242 XEOTICID XEO03055 MOACRIVE Inhibition DME1242 XEOTICID XEO03056 XEO_NAME Rational design peptide D22 DME1242 XEOTICID XEO03056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03056 XEO_CLAS Peptide DME1242 XEOTICID XEO03056 DESCRIPT Rational design peptide D22 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 64 ug/ml) DME1242 XEOTICID XEO03056 GENEFORM Protein DME1242 XEOTICID XEO03056 MOACRIVE Inhibition DME1242 XEOTICID XEO03057 XEO_NAME Rational design peptide D28 DME1242 XEOTICID XEO03057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03057 XEO_CLAS Peptide DME1242 XEOTICID XEO03057 DESCRIPT Rational design peptide D28 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO03057 GENEFORM Protein DME1242 XEOTICID XEO03057 MOACRIVE Inhibition DME1242 XEOTICID XEO03058 XEO_NAME D-2-aminoadipic acid DME1242 XEOTICID XEO03058 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03058 XEO_CLAS Amino Acid DME1242 XEOTICID XEO03058 DESCRIPT D-2-aminoadipic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03058 GENEFORM Protein DME1242 XEOTICID XEO03058 MOACRIVE Inhibition DME1242 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1242 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03059 XEO_CLAS Peptide DME1242 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 microM) DME1242 XEOTICID XEO03059 GENEFORM Protein DME1242 XEOTICID XEO03059 MOACRIVE Inhibition DME1242 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1242 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03060 XEO_CLAS Peptide DME1242 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO03060 GENEFORM Protein DME1242 XEOTICID XEO03060 MOACRIVE Inhibition DME1242 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1242 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03062 XEO_CLAS Peptide DME1242 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 microM) DME1242 XEOTICID XEO03062 GENEFORM Protein DME1242 XEOTICID XEO03062 MOACRIVE Inhibition DME1242 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1242 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03064 XEO_CLAS Peptide DME1242 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO03064 GENEFORM Protein DME1242 XEOTICID XEO03064 MOACRIVE Inhibition DME1242 XEOTICID XEO03065 XEO_NAME Rational design peptide D51 DME1242 XEOTICID XEO03065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03065 XEO_CLAS Peptide DME1242 XEOTICID XEO03065 DESCRIPT Rational design peptide D51 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO03065 GENEFORM Protein DME1242 XEOTICID XEO03065 MOACRIVE Inhibition DME1242 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1242 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03066 XEO_CLAS Peptide DME1242 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO03066 GENEFORM Protein DME1242 XEOTICID XEO03066 MOACRIVE Inhibition DME1242 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1242 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03068 XEO_CLAS Peptide DME1242 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO03068 GENEFORM Protein DME1242 XEOTICID XEO03068 MOACRIVE Inhibition DME1242 XEOTICID XEO03072 XEO_NAME Dalbavancin DME1242 XEOTICID XEO03072 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO03072 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO03072 DESCRIPT Dalbavancin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03072 GENEFORM Protein DME1242 XEOTICID XEO03072 MOACRIVE Inhibition DME1242 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1242 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03073 XEO_CLAS Peptide DME1242 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO03073 GENEFORM Protein DME1242 XEOTICID XEO03073 MOACRIVE Inhibition DME1242 XEOTICID XEO03075 XEO_NAME Daptomycin DME1242 XEOTICID XEO03075 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO03075 XEO_CLAS Drug Marketed but Withdrawn from Market DME1242 XEOTICID XEO03075 DESCRIPT Daptomycin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03075 GENEFORM Protein DME1242 XEOTICID XEO03075 MOACRIVE Inhibition DME1242 XEOTICID XEO03077 XEO_NAME D-Asparagine DME1242 XEOTICID XEO03077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03077 XEO_CLAS Amino Acid DME1242 XEOTICID XEO03077 DESCRIPT D-Asparagine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03077 GENEFORM Protein DME1242 XEOTICID XEO03077 MOACRIVE Inhibition DME1242 XEOTICID XEO03078 XEO_NAME D-Aspartic acid DME1242 XEOTICID XEO03078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03078 XEO_CLAS Amino Acid DME1242 XEOTICID XEO03078 DESCRIPT D-Aspartic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03078 GENEFORM Protein DME1242 XEOTICID XEO03078 MOACRIVE Inhibition DME1242 XEOTICID XEO03080 XEO_NAME Davana oil DME1242 XEOTICID XEO03080 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03080 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03080 DESCRIPT Davana oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03080 GENEFORM Protein DME1242 XEOTICID XEO03080 MOACRIVE Inhibition DME1242 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1242 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03082 XEO_CLAS Peptide DME1242 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03082 GENEFORM Protein DME1242 XEOTICID XEO03082 MOACRIVE Inhibition DME1242 XEOTICID XEO03083 XEO_NAME D-Citrulline DME1242 XEOTICID XEO03083 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO03083 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO03083 DESCRIPT D-Citrulline inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03083 GENEFORM Protein DME1242 XEOTICID XEO03083 MOACRIVE Inhibition DME1242 XEOTICID XEO03085 XEO_NAME D-Cystine DME1242 XEOTICID XEO03085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03085 XEO_CLAS Amino Acid DME1242 XEOTICID XEO03085 DESCRIPT D-Cystine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03085 GENEFORM Protein DME1242 XEOTICID XEO03085 MOACRIVE Inhibition DME1242 XEOTICID XEO03086 XEO_NAME DD13 peptide DME1242 XEOTICID XEO03086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03086 XEO_CLAS Peptide DME1242 XEOTICID XEO03086 DESCRIPT DD13 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03086 GENEFORM Protein DME1242 XEOTICID XEO03086 MOACRIVE Inhibition DME1242 XEOTICID XEO03089 XEO_NAME Decoralin DME1242 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03089 XEO_CLAS Peptide DME1242 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 40 microM) DME1242 XEOTICID XEO03089 GENEFORM Protein DME1242 XEOTICID XEO03089 MOACRIVE Inhibition DME1242 XEOTICID XEO03091 XEO_NAME Hybrid defensin Def-ABB DME1242 XEOTICID XEO03091 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03091 XEO_CLAS Peptide DME1242 XEOTICID XEO03091 DESCRIPT Hybrid defensin Def-ABB inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03091 GENEFORM Protein DME1242 XEOTICID XEO03091 MOACRIVE Inhibition DME1242 XEOTICID XEO03092 XEO_NAME Hybrid defensin Def-AcAA DME1242 XEOTICID XEO03092 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03092 XEO_CLAS Peptide DME1242 XEOTICID XEO03092 DESCRIPT Hybrid defensin Def-AcAA inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03092 GENEFORM Protein DME1242 XEOTICID XEO03092 MOACRIVE Inhibition DME1242 XEOTICID XEO03093 XEO_NAME Hybrid defensin Def-BAT DME1242 XEOTICID XEO03093 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03093 XEO_CLAS Peptide DME1242 XEOTICID XEO03093 DESCRIPT Hybrid defensin Def-BAT inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03093 GENEFORM Protein DME1242 XEOTICID XEO03093 MOACRIVE Inhibition DME1242 XEOTICID XEO03094 XEO_NAME Hybrid defensin Def-BBB DME1242 XEOTICID XEO03094 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03094 XEO_CLAS Peptide DME1242 XEOTICID XEO03094 DESCRIPT Hybrid defensin Def-BBB inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03094 GENEFORM Protein DME1242 XEOTICID XEO03094 MOACRIVE Inhibition DME1242 XEOTICID XEO03095 XEO_NAME Hybrid defensin Def-DAA DME1242 XEOTICID XEO03095 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03095 XEO_CLAS Peptide DME1242 XEOTICID XEO03095 DESCRIPT Hybrid defensin Def-DAA inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03095 GENEFORM Protein DME1242 XEOTICID XEO03095 MOACRIVE Inhibition DME1242 XEOTICID XEO03098 XEO_NAME Insect defensin DME1242 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03098 XEO_CLAS Peptide DME1242 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO03098 GENEFORM Protein DME1242 XEOTICID XEO03098 MOACRIVE Inhibition DME1242 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1242 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03100 XEO_CLAS Peptide DME1242 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03100 GENEFORM Protein DME1242 XEOTICID XEO03100 MOACRIVE Inhibition DME1242 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1242 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03110 XEO_CLAS Peptide DME1242 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.6 microM) DME1242 XEOTICID XEO03110 GENEFORM Protein DME1242 XEOTICID XEO03110 MOACRIVE Inhibition DME1242 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1242 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03111 XEO_CLAS Peptide DME1242 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03111 GENEFORM Protein DME1242 XEOTICID XEO03111 MOACRIVE Inhibition DME1242 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1242 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03112 XEO_CLAS Peptide DME1242 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 50 ug/ml) DME1242 XEOTICID XEO03112 GENEFORM Protein DME1242 XEOTICID XEO03112 MOACRIVE Inhibition DME1242 XEOTICID XEO03113 XEO_NAME Royalisin defensin-1 DME1242 XEOTICID XEO03113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03113 XEO_CLAS Peptide DME1242 XEOTICID XEO03113 DESCRIPT Royalisin defensin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03113 GENEFORM Protein DME1242 XEOTICID XEO03113 MOACRIVE Inhibition DME1242 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1242 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03116 XEO_CLAS Peptide DME1242 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.5-5 microM) DME1242 XEOTICID XEO03116 GENEFORM Protein DME1242 XEOTICID XEO03116 MOACRIVE Inhibition DME1242 XEOTICID XEO03117 XEO_NAME Insect defensin B DME1242 XEOTICID XEO03117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03117 XEO_CLAS Peptide DME1242 XEOTICID XEO03117 DESCRIPT Insect defensin B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.5-5 microM) DME1242 XEOTICID XEO03117 GENEFORM Protein DME1242 XEOTICID XEO03117 MOACRIVE Inhibition DME1242 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1242 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03122 XEO_CLAS Peptide DME1242 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 128000 ug/ml) DME1242 XEOTICID XEO03122 GENEFORM Protein DME1242 XEOTICID XEO03122 MOACRIVE Inhibition DME1242 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1242 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03124 XEO_CLAS Peptide DME1242 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03124 GENEFORM Protein DME1242 XEOTICID XEO03124 MOACRIVE Inhibition DME1242 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1242 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03125 XEO_CLAS Peptide DME1242 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03125 GENEFORM Protein DME1242 XEOTICID XEO03125 MOACRIVE Inhibition DME1242 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1242 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03126 XEO_CLAS Peptide DME1242 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.93 microM) DME1242 XEOTICID XEO03126 GENEFORM Protein DME1242 XEOTICID XEO03126 MOACRIVE Inhibition DME1242 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1242 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03127 XEO_CLAS Peptide DME1242 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03127 GENEFORM Protein DME1242 XEOTICID XEO03127 MOACRIVE Inhibition DME1242 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1242 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03128 XEO_CLAS Peptide DME1242 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 256 ug/ml) DME1242 XEOTICID XEO03128 GENEFORM Protein DME1242 XEOTICID XEO03128 MOACRIVE Inhibition DME1242 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1242 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03129 XEO_CLAS Peptide DME1242 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 256 ug/ml) DME1242 XEOTICID XEO03129 GENEFORM Protein DME1242 XEOTICID XEO03129 MOACRIVE Inhibition DME1242 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1242 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03130 XEO_CLAS Peptide DME1242 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 256 ug/ml) DME1242 XEOTICID XEO03130 GENEFORM Protein DME1242 XEOTICID XEO03130 MOACRIVE Inhibition DME1242 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1242 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03131 XEO_CLAS Peptide DME1242 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 256 ug/ml) DME1242 XEOTICID XEO03131 GENEFORM Protein DME1242 XEOTICID XEO03131 MOACRIVE Inhibition DME1242 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1242 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03132 XEO_CLAS Peptide DME1242 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 128 ug/ml) DME1242 XEOTICID XEO03132 GENEFORM Protein DME1242 XEOTICID XEO03132 MOACRIVE Inhibition DME1242 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1242 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03137 XEO_CLAS Peptide DME1242 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03137 GENEFORM Protein DME1242 XEOTICID XEO03137 MOACRIVE Inhibition DME1242 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1242 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03143 XEO_CLAS Peptide DME1242 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.9 microM) DME1242 XEOTICID XEO03143 GENEFORM Protein DME1242 XEOTICID XEO03143 MOACRIVE Inhibition DME1242 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1242 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03146 XEO_CLAS Peptide DME1242 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.3 microM) DME1242 XEOTICID XEO03146 GENEFORM Protein DME1242 XEOTICID XEO03146 MOACRIVE Inhibition DME1242 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1242 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03147 XEO_CLAS Peptide DME1242 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 38 microM) DME1242 XEOTICID XEO03147 GENEFORM Protein DME1242 XEOTICID XEO03147 MOACRIVE Inhibition DME1242 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1242 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03148 XEO_CLAS Peptide DME1242 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.7 microM) DME1242 XEOTICID XEO03148 GENEFORM Protein DME1242 XEOTICID XEO03148 MOACRIVE Inhibition DME1242 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1242 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03149 XEO_CLAS Peptide DME1242 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 22 microM) DME1242 XEOTICID XEO03149 GENEFORM Protein DME1242 XEOTICID XEO03149 MOACRIVE Inhibition DME1242 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1242 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03150 XEO_CLAS Peptide DME1242 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.5-1.5 microM) DME1242 XEOTICID XEO03150 GENEFORM Protein DME1242 XEOTICID XEO03150 MOACRIVE Inhibition DME1242 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1242 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03152 XEO_CLAS Peptide DME1242 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO03152 GENEFORM Protein DME1242 XEOTICID XEO03152 MOACRIVE Inhibition DME1242 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1242 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03155 XEO_CLAS Peptide DME1242 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.2 microM) DME1242 XEOTICID XEO03155 GENEFORM Protein DME1242 XEOTICID XEO03155 MOACRIVE Inhibition DME1242 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1242 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03156 XEO_CLAS Peptide DME1242 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.3 microM) DME1242 XEOTICID XEO03156 GENEFORM Protein DME1242 XEOTICID XEO03156 MOACRIVE Inhibition DME1242 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1242 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03157 XEO_CLAS Peptide DME1242 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.3 microM) DME1242 XEOTICID XEO03157 GENEFORM Protein DME1242 XEOTICID XEO03157 MOACRIVE Inhibition DME1242 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1242 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03159 XEO_CLAS Peptide DME1242 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03159 GENEFORM Protein DME1242 XEOTICID XEO03159 MOACRIVE Inhibition DME1242 XEOTICID XEO03160 XEO_NAME Dermaseptin DMS5 DME1242 XEOTICID XEO03160 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03160 XEO_CLAS Peptide DME1242 XEOTICID XEO03160 DESCRIPT Dermaseptin DMS5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.5 microM) DME1242 XEOTICID XEO03160 GENEFORM Protein DME1242 XEOTICID XEO03160 MOACRIVE Inhibition DME1242 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1242 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03162 XEO_CLAS Peptide DME1242 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.1 microM) DME1242 XEOTICID XEO03162 GENEFORM Protein DME1242 XEOTICID XEO03162 MOACRIVE Inhibition DME1242 XEOTICID XEO03164 XEO_NAME Dermatoxin DME1242 XEOTICID XEO03164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03164 XEO_CLAS Peptide DME1242 XEOTICID XEO03164 DESCRIPT Dermatoxin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03164 GENEFORM Protein DME1242 XEOTICID XEO03164 MOACRIVE Inhibition DME1242 XEOTICID XEO03168 XEO_NAME DFTamP1 peptide DME1242 XEOTICID XEO03168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03168 XEO_CLAS Peptide DME1242 XEOTICID XEO03168 DESCRIPT DFTamP1 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.12 microM) DME1242 XEOTICID XEO03168 GENEFORM Protein DME1242 XEOTICID XEO03168 MOACRIVE Inhibition DME1242 XEOTICID XEO03171 XEO_NAME D-glutamine DME1242 XEOTICID XEO03171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03171 XEO_CLAS Amino Acid DME1242 XEOTICID XEO03171 DESCRIPT D-glutamine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03171 GENEFORM Protein DME1242 XEOTICID XEO03171 MOACRIVE Inhibition DME1242 XEOTICID XEO03172 XEO_NAME D-Histidine DME1242 XEOTICID XEO03172 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO03172 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO03172 DESCRIPT D-Histidine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03172 GENEFORM Protein DME1242 XEOTICID XEO03172 MOACRIVE Inhibition DME1242 XEOTICID XEO03181 XEO_NAME Dichloromethane DME1242 XEOTICID XEO03181 XEO_TYPE Health or Environmental Toxicant(s) DME1242 XEOTICID XEO03181 XEO_CLAS Health Hazard/Toxicant DME1242 XEOTICID XEO03181 DESCRIPT Dichloromethane inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03181 GENEFORM Protein DME1242 XEOTICID XEO03181 MOACRIVE Inhibition DME1242 XEOTICID XEO03183 XEO_NAME Diphenylhexatriene DME1242 XEOTICID XEO03183 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03183 XEO_CLAS Natural Product DME1242 XEOTICID XEO03183 DESCRIPT Diphenylhexatriene inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03183 GENEFORM Protein DME1242 XEOTICID XEO03183 MOACRIVE Inhibition DME1242 XEOTICID XEO03187 XEO_NAME DiHydroxybenzofuran DME1242 XEOTICID XEO03187 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03187 XEO_CLAS Natural Product DME1242 XEOTICID XEO03187 DESCRIPT DiHydroxybenzofuran inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03187 GENEFORM Protein DME1242 XEOTICID XEO03187 MOACRIVE Inhibition DME1242 XEOTICID XEO03192 XEO_NAME Diphenyl methane DME1242 XEOTICID XEO03192 XEO_TYPE Health or Environmental Toxicant(s) DME1242 XEOTICID XEO03192 XEO_CLAS Environmental Pollutant DME1242 XEOTICID XEO03192 DESCRIPT Diphenyl methane inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03192 GENEFORM Protein DME1242 XEOTICID XEO03192 MOACRIVE Inhibition DME1242 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1242 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03197 XEO_CLAS Peptide DME1242 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 28.0 microM) DME1242 XEOTICID XEO03197 GENEFORM Protein DME1242 XEOTICID XEO03197 MOACRIVE Inhibition DME1242 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1242 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03215 XEO_CLAS Peptide DME1242 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 20.0 ug/ml) DME1242 XEOTICID XEO03215 GENEFORM Protein DME1242 XEOTICID XEO03215 MOACRIVE Inhibition DME1242 XEOTICID XEO03226 XEO_NAME Frog DRP-PBN1 DME1242 XEOTICID XEO03226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03226 XEO_CLAS Peptide DME1242 XEOTICID XEO03226 DESCRIPT Frog DRP-PBN1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 microM) DME1242 XEOTICID XEO03226 GENEFORM Protein DME1242 XEOTICID XEO03226 MOACRIVE Inhibition DME1242 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1242 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03227 XEO_CLAS Peptide DME1242 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8.9 microM) DME1242 XEOTICID XEO03227 GENEFORM Protein DME1242 XEOTICID XEO03227 MOACRIVE Inhibition DME1242 XEOTICID XEO03228 XEO_NAME D-tert-Leucine DME1242 XEOTICID XEO03228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03228 XEO_CLAS Amino Acid DME1242 XEOTICID XEO03228 DESCRIPT D-tert-Leucine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03228 GENEFORM Protein DME1242 XEOTICID XEO03228 MOACRIVE Inhibition DME1242 XEOTICID XEO03229 XEO_NAME D-Tryptophan DME1242 XEOTICID XEO03229 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO03229 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO03229 DESCRIPT D-Tryptophan inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03229 GENEFORM Protein DME1242 XEOTICID XEO03229 MOACRIVE Inhibition DME1242 XEOTICID XEO03230 XEO_NAME D-Tyrosine DME1242 XEOTICID XEO03230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03230 XEO_CLAS Amino Acid DME1242 XEOTICID XEO03230 DESCRIPT D-Tyrosine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03230 GENEFORM Protein DME1242 XEOTICID XEO03230 MOACRIVE Inhibition DME1242 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1242 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03231 XEO_CLAS Peptide DME1242 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03231 GENEFORM Protein DME1242 XEOTICID XEO03231 MOACRIVE Inhibition DME1242 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1242 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03232 XEO_CLAS Peptide DME1242 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03232 GENEFORM Protein DME1242 XEOTICID XEO03232 MOACRIVE Inhibition DME1242 XEOTICID XEO03233 XEO_NAME Dybowskin-1 DME1242 XEOTICID XEO03233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03233 XEO_CLAS Peptide DME1242 XEOTICID XEO03233 DESCRIPT Dybowskin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO03233 GENEFORM Protein DME1242 XEOTICID XEO03233 MOACRIVE Inhibition DME1242 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1242 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03234 XEO_CLAS Peptide DME1242 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO03234 GENEFORM Protein DME1242 XEOTICID XEO03234 MOACRIVE Inhibition DME1242 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1242 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03235 XEO_CLAS Peptide DME1242 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 ug/ml) DME1242 XEOTICID XEO03235 GENEFORM Protein DME1242 XEOTICID XEO03235 MOACRIVE Inhibition DME1242 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1242 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03236 XEO_CLAS Peptide DME1242 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO03236 GENEFORM Protein DME1242 XEOTICID XEO03236 MOACRIVE Inhibition DME1242 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1242 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03237 XEO_CLAS Peptide DME1242 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 ug/ml) DME1242 XEOTICID XEO03237 GENEFORM Protein DME1242 XEOTICID XEO03237 MOACRIVE Inhibition DME1242 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1242 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03238 XEO_CLAS Peptide DME1242 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.13 ug/ml) DME1242 XEOTICID XEO03238 GENEFORM Protein DME1242 XEOTICID XEO03238 MOACRIVE Inhibition DME1242 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1242 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03239 XEO_CLAS Peptide DME1242 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO03239 GENEFORM Protein DME1242 XEOTICID XEO03239 MOACRIVE Inhibition DME1242 XEOTICID XEO03240 XEO_NAME Dybowskin-6 DME1242 XEOTICID XEO03240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03240 XEO_CLAS Peptide DME1242 XEOTICID XEO03240 DESCRIPT Dybowskin-6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 ug/ml) DME1242 XEOTICID XEO03240 GENEFORM Protein DME1242 XEOTICID XEO03240 MOACRIVE Inhibition DME1242 XEOTICID XEO03246 XEO_NAME Elliptophenone A DME1242 XEOTICID XEO03246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03246 XEO_CLAS Natural Product DME1242 XEOTICID XEO03246 DESCRIPT Elliptophenone A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03246 GENEFORM Protein DME1242 XEOTICID XEO03246 MOACRIVE Inhibition DME1242 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1242 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03250 XEO_CLAS Peptide DME1242 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03250 GENEFORM Protein DME1242 XEOTICID XEO03250 MOACRIVE Inhibition DME1242 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1242 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03251 XEO_CLAS Peptide DME1242 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03251 GENEFORM Protein DME1242 XEOTICID XEO03251 MOACRIVE Inhibition DME1242 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1242 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03253 XEO_CLAS Peptide DME1242 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03253 GENEFORM Protein DME1242 XEOTICID XEO03253 MOACRIVE Inhibition DME1242 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1242 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03258 XEO_CLAS Peptide DME1242 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03258 GENEFORM Protein DME1242 XEOTICID XEO03258 MOACRIVE Inhibition DME1242 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1242 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03274 XEO_CLAS Peptide DME1242 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.4 microM) DME1242 XEOTICID XEO03274 GENEFORM Protein DME1242 XEOTICID XEO03274 MOACRIVE Inhibition DME1242 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1242 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03275 XEO_CLAS Peptide DME1242 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 13 microM) DME1242 XEOTICID XEO03275 GENEFORM Protein DME1242 XEOTICID XEO03275 MOACRIVE Inhibition DME1242 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1242 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03276 XEO_CLAS Peptide DME1242 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 60 microM) DME1242 XEOTICID XEO03276 GENEFORM Protein DME1242 XEOTICID XEO03276 MOACRIVE Inhibition DME1242 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1242 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03277 XEO_CLAS Peptide DME1242 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.4 microM) DME1242 XEOTICID XEO03277 GENEFORM Protein DME1242 XEOTICID XEO03277 MOACRIVE Inhibition DME1242 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1242 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03278 XEO_CLAS Peptide DME1242 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 microM) DME1242 XEOTICID XEO03278 GENEFORM Protein DME1242 XEOTICID XEO03278 MOACRIVE Inhibition DME1242 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1242 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03279 XEO_CLAS Peptide DME1242 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO03279 GENEFORM Protein DME1242 XEOTICID XEO03279 MOACRIVE Inhibition DME1242 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1242 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03280 XEO_CLAS Peptide DME1242 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 microM) DME1242 XEOTICID XEO03280 GENEFORM Protein DME1242 XEOTICID XEO03280 MOACRIVE Inhibition DME1242 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1242 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03281 XEO_CLAS Peptide DME1242 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 microM) DME1242 XEOTICID XEO03281 GENEFORM Protein DME1242 XEOTICID XEO03281 MOACRIVE Inhibition DME1242 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1242 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03282 XEO_CLAS Peptide DME1242 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO03282 GENEFORM Protein DME1242 XEOTICID XEO03282 MOACRIVE Inhibition DME1242 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1242 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03283 XEO_CLAS Peptide DME1242 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.6 microM) DME1242 XEOTICID XEO03283 GENEFORM Protein DME1242 XEOTICID XEO03283 MOACRIVE Inhibition DME1242 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1242 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03284 XEO_CLAS Peptide DME1242 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.2 ug/ml) DME1242 XEOTICID XEO03284 GENEFORM Protein DME1242 XEOTICID XEO03284 MOACRIVE Inhibition DME1242 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1242 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03285 XEO_CLAS Peptide DME1242 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.3 ug/ml) DME1242 XEOTICID XEO03285 GENEFORM Protein DME1242 XEOTICID XEO03285 MOACRIVE Inhibition DME1242 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1242 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03286 XEO_CLAS Peptide DME1242 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5.4 ug/ml) DME1242 XEOTICID XEO03286 GENEFORM Protein DME1242 XEOTICID XEO03286 MOACRIVE Inhibition DME1242 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1242 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03287 XEO_CLAS Peptide DME1242 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.8 ug/ml) DME1242 XEOTICID XEO03287 GENEFORM Protein DME1242 XEOTICID XEO03287 MOACRIVE Inhibition DME1242 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1242 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03288 XEO_CLAS Peptide DME1242 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.7 ug/ml) DME1242 XEOTICID XEO03288 GENEFORM Protein DME1242 XEOTICID XEO03288 MOACRIVE Inhibition DME1242 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1242 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03289 XEO_CLAS Peptide DME1242 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.4 ug/ml) DME1242 XEOTICID XEO03289 GENEFORM Protein DME1242 XEOTICID XEO03289 MOACRIVE Inhibition DME1242 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1242 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03290 XEO_CLAS Peptide DME1242 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11 ug/ml) DME1242 XEOTICID XEO03290 GENEFORM Protein DME1242 XEOTICID XEO03290 MOACRIVE Inhibition DME1242 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1242 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03291 XEO_CLAS Peptide DME1242 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8.6 ug/ml) DME1242 XEOTICID XEO03291 GENEFORM Protein DME1242 XEOTICID XEO03291 MOACRIVE Inhibition DME1242 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1242 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03292 XEO_CLAS Peptide DME1242 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.1 ug/ml) DME1242 XEOTICID XEO03292 GENEFORM Protein DME1242 XEOTICID XEO03292 MOACRIVE Inhibition DME1242 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1242 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03293 XEO_CLAS Peptide DME1242 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 microM) DME1242 XEOTICID XEO03293 GENEFORM Protein DME1242 XEOTICID XEO03293 MOACRIVE Inhibition DME1242 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1242 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03294 XEO_CLAS Peptide DME1242 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 microM) DME1242 XEOTICID XEO03294 GENEFORM Protein DME1242 XEOTICID XEO03294 MOACRIVE Inhibition DME1242 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1242 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03295 XEO_CLAS Peptide DME1242 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO03295 GENEFORM Protein DME1242 XEOTICID XEO03295 MOACRIVE Inhibition DME1242 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1242 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03298 XEO_CLAS Peptide DME1242 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.9 microM) DME1242 XEOTICID XEO03298 GENEFORM Protein DME1242 XEOTICID XEO03298 MOACRIVE Inhibition DME1242 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1242 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03299 XEO_CLAS Peptide DME1242 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.8 microM) DME1242 XEOTICID XEO03299 GENEFORM Protein DME1242 XEOTICID XEO03299 MOACRIVE Inhibition DME1242 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1242 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03300 XEO_CLAS Peptide DME1242 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.5 ug/ml) DME1242 XEOTICID XEO03300 GENEFORM Protein DME1242 XEOTICID XEO03300 MOACRIVE Inhibition DME1242 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1242 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03301 XEO_CLAS Peptide DME1242 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.25 ug/ml) DME1242 XEOTICID XEO03301 GENEFORM Protein DME1242 XEOTICID XEO03301 MOACRIVE Inhibition DME1242 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1242 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03302 XEO_CLAS Peptide DME1242 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 microM) DME1242 XEOTICID XEO03302 GENEFORM Protein DME1242 XEOTICID XEO03302 MOACRIVE Inhibition DME1242 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1242 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03304 XEO_CLAS Peptide DME1242 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 microM) DME1242 XEOTICID XEO03304 GENEFORM Protein DME1242 XEOTICID XEO03304 MOACRIVE Inhibition DME1242 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1242 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03305 XEO_CLAS Peptide DME1242 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 32 microM) DME1242 XEOTICID XEO03305 GENEFORM Protein DME1242 XEOTICID XEO03305 MOACRIVE Inhibition DME1242 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1242 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03306 XEO_CLAS Peptide DME1242 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 microM) DME1242 XEOTICID XEO03306 GENEFORM Protein DME1242 XEOTICID XEO03306 MOACRIVE Inhibition DME1242 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1242 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03307 XEO_CLAS Peptide DME1242 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO03307 GENEFORM Protein DME1242 XEOTICID XEO03307 MOACRIVE Inhibition DME1242 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1242 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03308 XEO_CLAS Peptide DME1242 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO03308 GENEFORM Protein DME1242 XEOTICID XEO03308 MOACRIVE Inhibition DME1242 XEOTICID XEO03309 XEO_NAME Esculentin-2LTa DME1242 XEOTICID XEO03309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03309 XEO_CLAS Peptide DME1242 XEOTICID XEO03309 DESCRIPT Esculentin-2LTa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.6 microM) DME1242 XEOTICID XEO03309 GENEFORM Protein DME1242 XEOTICID XEO03309 MOACRIVE Inhibition DME1242 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1242 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03310 XEO_CLAS Peptide DME1242 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.3 ug/ml) DME1242 XEOTICID XEO03310 GENEFORM Protein DME1242 XEOTICID XEO03310 MOACRIVE Inhibition DME1242 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1242 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03311 XEO_CLAS Peptide DME1242 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 21.6 ug/ml) DME1242 XEOTICID XEO03311 GENEFORM Protein DME1242 XEOTICID XEO03311 MOACRIVE Inhibition DME1242 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1242 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03312 XEO_CLAS Peptide DME1242 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 21.6 ug/ml) DME1242 XEOTICID XEO03312 GENEFORM Protein DME1242 XEOTICID XEO03312 MOACRIVE Inhibition DME1242 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1242 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03313 XEO_CLAS Peptide DME1242 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.1 ug/ml) DME1242 XEOTICID XEO03313 GENEFORM Protein DME1242 XEOTICID XEO03313 MOACRIVE Inhibition DME1242 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1242 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03314 XEO_CLAS Peptide DME1242 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7.9 ug/ml) DME1242 XEOTICID XEO03314 GENEFORM Protein DME1242 XEOTICID XEO03314 MOACRIVE Inhibition DME1242 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1242 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03315 XEO_CLAS Peptide DME1242 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.6 ug/ml) DME1242 XEOTICID XEO03315 GENEFORM Protein DME1242 XEOTICID XEO03315 MOACRIVE Inhibition DME1242 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1242 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03316 XEO_CLAS Peptide DME1242 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15.8 ug/ml) DME1242 XEOTICID XEO03316 GENEFORM Protein DME1242 XEOTICID XEO03316 MOACRIVE Inhibition DME1242 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1242 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03318 XEO_CLAS Peptide DME1242 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10 microM) DME1242 XEOTICID XEO03318 GENEFORM Protein DME1242 XEOTICID XEO03318 MOACRIVE Inhibition DME1242 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1242 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03319 XEO_CLAS Peptide DME1242 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03319 GENEFORM Protein DME1242 XEOTICID XEO03319 MOACRIVE Inhibition DME1242 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1242 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03320 XEO_CLAS Peptide DME1242 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.6 microM) DME1242 XEOTICID XEO03320 GENEFORM Protein DME1242 XEOTICID XEO03320 MOACRIVE Inhibition DME1242 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1242 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03321 XEO_CLAS Peptide DME1242 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.4 microM) DME1242 XEOTICID XEO03321 GENEFORM Protein DME1242 XEOTICID XEO03321 MOACRIVE Inhibition DME1242 XEOTICID XEO03326 XEO_NAME Essential oil DME1242 XEOTICID XEO03326 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03326 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03326 DESCRIPT Essential oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03326 GENEFORM Protein DME1242 XEOTICID XEO03326 MOACRIVE Inhibition DME1242 XEOTICID XEO03341 XEO_NAME Sanguisorba officinalis ethanol extract DME1242 XEOTICID XEO03341 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03341 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03341 DESCRIPT Sanguisorba officinalis ethanol extract inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03341 GENEFORM Protein DME1242 XEOTICID XEO03341 MOACRIVE Inhibition DME1242 XEOTICID XEO03342 XEO_NAME Artemisia princeps ethanol extract DME1242 XEOTICID XEO03342 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03342 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03342 DESCRIPT Artemisia princeps ethanol extract inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03342 GENEFORM Protein DME1242 XEOTICID XEO03342 MOACRIVE Inhibition DME1242 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1242 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03348 GENEFORM Protein DME1242 XEOTICID XEO03348 MOACRIVE Inhibition DME1242 XEOTICID XEO03352 XEO_NAME Ethyl acetate DME1242 XEOTICID XEO03352 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1242 XEOTICID XEO03352 XEO_CLAS Chemical Compound DME1242 XEOTICID XEO03352 DESCRIPT Ethyl acetate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03352 GENEFORM Protein DME1242 XEOTICID XEO03352 MOACRIVE Inhibition DME1242 XEOTICID XEO03357 XEO_NAME Ethyl gallate DME1242 XEOTICID XEO03357 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO03357 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO03357 DESCRIPT Ethyl gallate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03357 GENEFORM Protein DME1242 XEOTICID XEO03357 MOACRIVE Inhibition DME1242 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1242 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03362 XEO_CLAS Peptide DME1242 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5 ug/ml) DME1242 XEOTICID XEO03362 GENEFORM Protein DME1242 XEOTICID XEO03362 MOACRIVE Inhibition DME1242 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1242 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03363 XEO_CLAS Peptide DME1242 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 30 microM) DME1242 XEOTICID XEO03363 GENEFORM Protein DME1242 XEOTICID XEO03363 MOACRIVE Inhibition DME1242 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1242 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03364 XEO_CLAS Peptide DME1242 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 30 microM) DME1242 XEOTICID XEO03364 GENEFORM Protein DME1242 XEOTICID XEO03364 MOACRIVE Inhibition DME1242 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1242 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03366 XEO_CLAS Peptide DME1242 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO03366 GENEFORM Protein DME1242 XEOTICID XEO03366 MOACRIVE Inhibition DME1242 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1242 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03367 XEO_CLAS Peptide DME1242 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 60 microM) DME1242 XEOTICID XEO03367 GENEFORM Protein DME1242 XEOTICID XEO03367 MOACRIVE Inhibition DME1242 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1242 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03368 XEO_CLAS Peptide DME1242 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 60 microM) DME1242 XEOTICID XEO03368 GENEFORM Protein DME1242 XEOTICID XEO03368 MOACRIVE Inhibition DME1242 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1242 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03379 XEO_CLAS Peptide DME1242 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 ug/ml) DME1242 XEOTICID XEO03379 GENEFORM Protein DME1242 XEOTICID XEO03379 MOACRIVE Inhibition DME1242 XEOTICID XEO03385 XEO_NAME Fenclonine DME1242 XEOTICID XEO03385 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO03385 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO03385 DESCRIPT Fenclonine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03385 GENEFORM Protein DME1242 XEOTICID XEO03385 MOACRIVE Inhibition DME1242 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1242 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03396 XEO_CLAS Peptide DME1242 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03396 GENEFORM Protein DME1242 XEOTICID XEO03396 MOACRIVE Inhibition DME1242 XEOTICID XEO03402 XEO_NAME Frankincense oil DME1242 XEOTICID XEO03402 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03402 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03402 DESCRIPT Frankincense oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03402 GENEFORM Protein DME1242 XEOTICID XEO03402 MOACRIVE Inhibition DME1242 XEOTICID XEO03412 XEO_NAME FS8 peptide DME1242 XEOTICID XEO03412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03412 XEO_CLAS Peptide DME1242 XEOTICID XEO03412 DESCRIPT FS8 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03412 GENEFORM Protein DME1242 XEOTICID XEO03412 MOACRIVE Inhibition DME1242 XEOTICID XEO03423 XEO_NAME Fusidic acid DME1242 XEOTICID XEO03423 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO03423 XEO_CLAS Drug in Phase 3 Clinical Trial DME1242 XEOTICID XEO03423 DESCRIPT Fusidic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03423 GENEFORM Protein DME1242 XEOTICID XEO03423 MOACRIVE Inhibition DME1242 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1242 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03428 XEO_CLAS Peptide DME1242 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 63 ug/ml) DME1242 XEOTICID XEO03428 GENEFORM Protein DME1242 XEOTICID XEO03428 MOACRIVE Inhibition DME1242 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1242 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03430 XEO_CLAS Peptide DME1242 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 63 ug/ml) DME1242 XEOTICID XEO03430 GENEFORM Protein DME1242 XEOTICID XEO03430 MOACRIVE Inhibition DME1242 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1242 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03434 XEO_CLAS Peptide DME1242 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 31 ug/ml) DME1242 XEOTICID XEO03434 GENEFORM Protein DME1242 XEOTICID XEO03434 MOACRIVE Inhibition DME1242 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1242 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03442 XEO_CLAS Peptide DME1242 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.34 ug/ml) DME1242 XEOTICID XEO03442 GENEFORM Protein DME1242 XEOTICID XEO03442 MOACRIVE Inhibition DME1242 XEOTICID XEO03443 XEO_NAME Gaegurin-RN4 DME1242 XEOTICID XEO03443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03443 XEO_CLAS Peptide DME1242 XEOTICID XEO03443 DESCRIPT Gaegurin-RN4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.17 ug/ml) DME1242 XEOTICID XEO03443 GENEFORM Protein DME1242 XEOTICID XEO03443 MOACRIVE Inhibition DME1242 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1242 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03444 XEO_CLAS Peptide DME1242 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.75 ug/ml) DME1242 XEOTICID XEO03444 GENEFORM Protein DME1242 XEOTICID XEO03444 MOACRIVE Inhibition DME1242 XEOTICID XEO03454 XEO_NAME Galbanum oil DME1242 XEOTICID XEO03454 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03454 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03454 DESCRIPT Galbanum oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03454 GENEFORM Protein DME1242 XEOTICID XEO03454 MOACRIVE Inhibition DME1242 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1242 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03460 XEO_CLAS Peptide DME1242 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03460 GENEFORM Protein DME1242 XEOTICID XEO03460 MOACRIVE Inhibition DME1242 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1242 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03468 XEO_CLAS Peptide DME1242 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03468 GENEFORM Protein DME1242 XEOTICID XEO03468 MOACRIVE Inhibition DME1242 XEOTICID XEO03481 XEO_NAME Geranium oil DME1242 XEOTICID XEO03481 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03481 XEO_CLAS Natural Product DME1242 XEOTICID XEO03481 DESCRIPT Geranium oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03481 GENEFORM Protein DME1242 XEOTICID XEO03481 MOACRIVE Inhibition DME1242 XEOTICID XEO03483 XEO_NAME Ginger oil DME1242 XEOTICID XEO03483 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03483 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03483 DESCRIPT Ginger oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03483 GENEFORM Protein DME1242 XEOTICID XEO03483 MOACRIVE Inhibition DME1242 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1242 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03485 XEO_CLAS Peptide DME1242 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.07 ug/ml) DME1242 XEOTICID XEO03485 GENEFORM Protein DME1242 XEOTICID XEO03485 MOACRIVE Inhibition DME1242 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1242 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03486 XEO_CLAS Peptide DME1242 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.80 ug/ml) DME1242 XEOTICID XEO03486 GENEFORM Protein DME1242 XEOTICID XEO03486 MOACRIVE Inhibition DME1242 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1242 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03497 XEO_CLAS Peptide DME1242 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.6-3.15 microM) DME1242 XEOTICID XEO03497 GENEFORM Protein DME1242 XEOTICID XEO03497 MOACRIVE Inhibition DME1242 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1242 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03498 XEO_CLAS Peptide DME1242 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.6-3.15 microM) DME1242 XEOTICID XEO03498 GENEFORM Protein DME1242 XEOTICID XEO03498 MOACRIVE Inhibition DME1242 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1242 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03500 XEO_CLAS Peptide DME1242 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC < 10 ug/ml) DME1242 XEOTICID XEO03500 GENEFORM Protein DME1242 XEOTICID XEO03500 MOACRIVE Inhibition DME1242 XEOTICID XEO03501 XEO_NAME Gramicidin [Scr2]-GS analogue DME1242 XEOTICID XEO03501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03501 XEO_CLAS Peptide DME1242 XEOTICID XEO03501 DESCRIPT Gramicidin [Scr2]-GS analogue inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO03501 GENEFORM Protein DME1242 XEOTICID XEO03501 MOACRIVE Inhibition DME1242 XEOTICID XEO03503 XEO_NAME Gramicidin S DME1242 XEOTICID XEO03503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03503 XEO_CLAS Peptide DME1242 XEOTICID XEO03503 DESCRIPT Gramicidin S inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.3 ug/ml) DME1242 XEOTICID XEO03503 GENEFORM Protein DME1242 XEOTICID XEO03503 MOACRIVE Inhibition DME1242 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1242 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03504 XEO_CLAS Peptide DME1242 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 ug/ml) DME1242 XEOTICID XEO03504 GENEFORM Protein DME1242 XEOTICID XEO03504 MOACRIVE Inhibition DME1242 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1242 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03505 XEO_CLAS Peptide DME1242 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 ug/ml) DME1242 XEOTICID XEO03505 GENEFORM Protein DME1242 XEOTICID XEO03505 MOACRIVE Inhibition DME1242 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1242 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03506 XEO_CLAS Peptide DME1242 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 ug/ml) DME1242 XEOTICID XEO03506 GENEFORM Protein DME1242 XEOTICID XEO03506 MOACRIVE Inhibition DME1242 XEOTICID XEO03512 XEO_NAME Guentherin AMP-3 DME1242 XEOTICID XEO03512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03512 XEO_CLAS Peptide DME1242 XEOTICID XEO03512 DESCRIPT Guentherin AMP-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 35.5 ug/ml) DME1242 XEOTICID XEO03512 GENEFORM Protein DME1242 XEOTICID XEO03512 MOACRIVE Inhibition DME1242 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1242 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03513 XEO_CLAS Peptide DME1242 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO03513 GENEFORM Protein DME1242 XEOTICID XEO03513 MOACRIVE Inhibition DME1242 XEOTICID XEO03520 XEO_NAME Halocidin subunit A DME1242 XEOTICID XEO03520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03520 XEO_CLAS Peptide DME1242 XEOTICID XEO03520 DESCRIPT Halocidin subunit A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03520 GENEFORM Protein DME1242 XEOTICID XEO03520 MOACRIVE Inhibition DME1242 XEOTICID XEO03521 XEO_NAME Halocidin subunit B DME1242 XEOTICID XEO03521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03521 XEO_CLAS Peptide DME1242 XEOTICID XEO03521 DESCRIPT Halocidin subunit B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03521 GENEFORM Protein DME1242 XEOTICID XEO03521 MOACRIVE Inhibition DME1242 XEOTICID XEO03522 XEO_NAME Halocyntin DME1242 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03522 XEO_CLAS Peptide DME1242 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03522 GENEFORM Protein DME1242 XEOTICID XEO03522 MOACRIVE Inhibition DME1242 XEOTICID XEO03523 XEO_NAME Hamamelitannin DME1242 XEOTICID XEO03523 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO03523 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO03523 DESCRIPT Hamamelitannin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03523 GENEFORM Protein DME1242 XEOTICID XEO03523 MOACRIVE Inhibition DME1242 XEOTICID XEO03533 XEO_NAME HE4 peptide DME1242 XEOTICID XEO03533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03533 XEO_CLAS Peptide DME1242 XEOTICID XEO03533 DESCRIPT HE4 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03533 GENEFORM Protein DME1242 XEOTICID XEO03533 MOACRIVE Inhibition DME1242 XEOTICID XEO03534 XEO_NAME Marine annelid hedistin DME1242 XEOTICID XEO03534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03534 XEO_CLAS Peptide DME1242 XEOTICID XEO03534 DESCRIPT Marine annelid hedistin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03534 GENEFORM Protein DME1242 XEOTICID XEO03534 MOACRIVE Inhibition DME1242 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1242 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03537 XEO_CLAS Peptide DME1242 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO03537 GENEFORM Protein DME1242 XEOTICID XEO03537 MOACRIVE Inhibition DME1242 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1242 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03538 XEO_CLAS Peptide DME1242 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 100 ug/ml) DME1242 XEOTICID XEO03538 GENEFORM Protein DME1242 XEOTICID XEO03538 MOACRIVE Inhibition DME1242 XEOTICID XEO03539 XEO_NAME Helichrysum oil DME1242 XEOTICID XEO03539 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03539 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03539 DESCRIPT Helichrysum oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03539 GENEFORM Protein DME1242 XEOTICID XEO03539 MOACRIVE Inhibition DME1242 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1242 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03540 XEO_CLAS Peptide DME1242 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO03540 GENEFORM Protein DME1242 XEOTICID XEO03540 MOACRIVE Inhibition DME1242 XEOTICID XEO03542 XEO_NAME Hepcidin DME1242 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03542 XEO_CLAS Peptide DME1242 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO03542 GENEFORM Protein DME1242 XEOTICID XEO03542 MOACRIVE Inhibition DME1242 XEOTICID XEO03548 XEO_NAME Hesperidin DME1242 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03548 GENEFORM Protein DME1242 XEOTICID XEO03548 MOACRIVE Inhibition DME1242 XEOTICID XEO03555 XEO_NAME Hexyl gallate DME1242 XEOTICID XEO03555 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1242 XEOTICID XEO03555 XEO_CLAS Chemical Compound DME1242 XEOTICID XEO03555 DESCRIPT Hexyl gallate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03555 GENEFORM Protein DME1242 XEOTICID XEO03555 MOACRIVE Inhibition DME1242 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1242 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03556 XEO_CLAS Peptide DME1242 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO03556 GENEFORM Protein DME1242 XEOTICID XEO03556 MOACRIVE Inhibition DME1242 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1242 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03557 XEO_CLAS Peptide DME1242 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO03557 GENEFORM Protein DME1242 XEOTICID XEO03557 MOACRIVE Inhibition DME1242 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1242 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03558 XEO_CLAS Peptide DME1242 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 microM) DME1242 XEOTICID XEO03558 GENEFORM Protein DME1242 XEOTICID XEO03558 MOACRIVE Inhibition DME1242 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1242 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03559 XEO_CLAS Peptide DME1242 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 microM) DME1242 XEOTICID XEO03559 GENEFORM Protein DME1242 XEOTICID XEO03559 MOACRIVE Inhibition DME1242 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1242 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03560 XEO_CLAS Peptide DME1242 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 microM) DME1242 XEOTICID XEO03560 GENEFORM Protein DME1242 XEOTICID XEO03560 MOACRIVE Inhibition DME1242 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1242 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03569 XEO_CLAS Peptide DME1242 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 300 microM) DME1242 XEOTICID XEO03569 GENEFORM Protein DME1242 XEOTICID XEO03569 MOACRIVE Inhibition DME1242 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1242 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03572 XEO_CLAS Peptide DME1242 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5000-25000 ug/ml) DME1242 XEOTICID XEO03572 GENEFORM Protein DME1242 XEOTICID XEO03572 MOACRIVE Inhibition DME1242 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1242 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03573 XEO_CLAS Peptide DME1242 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 18.8 ug/ml) DME1242 XEOTICID XEO03573 GENEFORM Protein DME1242 XEOTICID XEO03573 MOACRIVE Inhibition DME1242 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1242 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03574 XEO_CLAS Peptide DME1242 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 500 microM) DME1242 XEOTICID XEO03574 GENEFORM Protein DME1242 XEOTICID XEO03574 MOACRIVE Inhibition DME1242 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1242 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03575 XEO_CLAS Peptide DME1242 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 14 microM) DME1242 XEOTICID XEO03575 GENEFORM Protein DME1242 XEOTICID XEO03575 MOACRIVE Inhibition DME1242 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1242 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03576 XEO_CLAS Peptide DME1242 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 250 microM) DME1242 XEOTICID XEO03576 GENEFORM Protein DME1242 XEOTICID XEO03576 MOACRIVE Inhibition DME1242 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1242 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03578 XEO_CLAS Peptide DME1242 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5000-25000 ug/ml) DME1242 XEOTICID XEO03578 GENEFORM Protein DME1242 XEOTICID XEO03578 MOACRIVE Inhibition DME1242 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1242 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03579 XEO_CLAS Peptide DME1242 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03579 GENEFORM Protein DME1242 XEOTICID XEO03579 MOACRIVE Inhibition DME1242 XEOTICID XEO03583 XEO_NAME Hominicin DME1242 XEOTICID XEO03583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03583 XEO_CLAS Peptide DME1242 XEOTICID XEO03583 DESCRIPT Hominicin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.06 ug/ml) DME1242 XEOTICID XEO03583 GENEFORM Protein DME1242 XEOTICID XEO03583 MOACRIVE Inhibition DME1242 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1242 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03585 XEO_CLAS Peptide DME1242 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 31.25 ug/ml) DME1242 XEOTICID XEO03585 GENEFORM Protein DME1242 XEOTICID XEO03585 MOACRIVE Inhibition DME1242 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1242 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03588 XEO_CLAS Peptide DME1242 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 62 ug/ml) DME1242 XEOTICID XEO03588 GENEFORM Protein DME1242 XEOTICID XEO03588 MOACRIVE Inhibition DME1242 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1242 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03591 XEO_CLAS Peptide DME1242 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO03591 GENEFORM Protein DME1242 XEOTICID XEO03591 MOACRIVE Inhibition DME1242 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1242 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03593 XEO_CLAS Peptide DME1242 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.7 ug/ml) DME1242 XEOTICID XEO03593 GENEFORM Protein DME1242 XEOTICID XEO03593 MOACRIVE Inhibition DME1242 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1242 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03595 XEO_CLAS Peptide DME1242 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03595 GENEFORM Protein DME1242 XEOTICID XEO03595 MOACRIVE Inhibition DME1242 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1242 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03596 XEO_CLAS Peptide DME1242 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03596 GENEFORM Protein DME1242 XEOTICID XEO03596 MOACRIVE Inhibition DME1242 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1242 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03598 XEO_CLAS Peptide DME1242 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03598 GENEFORM Protein DME1242 XEOTICID XEO03598 MOACRIVE Inhibition DME1242 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1242 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03599 XEO_CLAS Peptide DME1242 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03599 GENEFORM Protein DME1242 XEOTICID XEO03599 MOACRIVE Inhibition DME1242 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1242 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03606 XEO_CLAS Peptide DME1242 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03606 GENEFORM Protein DME1242 XEOTICID XEO03606 MOACRIVE Inhibition DME1242 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1242 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03607 XEO_CLAS Peptide DME1242 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03607 GENEFORM Protein DME1242 XEOTICID XEO03607 MOACRIVE Inhibition DME1242 XEOTICID XEO03608 XEO_NAME Hydnocarpin D DME1242 XEOTICID XEO03608 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03608 XEO_CLAS Natural Product DME1242 XEOTICID XEO03608 DESCRIPT Hydnocarpin D inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03608 GENEFORM Protein DME1242 XEOTICID XEO03608 MOACRIVE Inhibition DME1242 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1242 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03609 XEO_CLAS Peptide DME1242 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03609 GENEFORM Protein DME1242 XEOTICID XEO03609 MOACRIVE Inhibition DME1242 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1242 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03615 XEO_CLAS Peptide DME1242 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.1-8.0 ug/ml) DME1242 XEOTICID XEO03615 GENEFORM Protein DME1242 XEOTICID XEO03615 MOACRIVE Inhibition DME1242 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1242 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03616 XEO_CLAS Peptide DME1242 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 microM) DME1242 XEOTICID XEO03616 GENEFORM Protein DME1242 XEOTICID XEO03616 MOACRIVE Inhibition DME1242 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1242 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03617 XEO_CLAS Peptide DME1242 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 80 microM) DME1242 XEOTICID XEO03617 GENEFORM Protein DME1242 XEOTICID XEO03617 MOACRIVE Inhibition DME1242 XEOTICID XEO03621 XEO_NAME Hyssop oil DME1242 XEOTICID XEO03621 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03621 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03621 DESCRIPT Hyssop oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03621 GENEFORM Protein DME1242 XEOTICID XEO03621 MOACRIVE Inhibition DME1242 XEOTICID XEO03623 XEO_NAME Basic peptide AMP1 IB-AMP1 DME1242 XEOTICID XEO03623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03623 XEO_CLAS Peptide DME1242 XEOTICID XEO03623 DESCRIPT Basic peptide AMP1 IB-AMP1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03623 GENEFORM Protein DME1242 XEOTICID XEO03623 MOACRIVE Inhibition DME1242 XEOTICID XEO03624 XEO_NAME Basic peptide AMP4 IB-AMP4 DME1242 XEOTICID XEO03624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03624 XEO_CLAS Peptide DME1242 XEOTICID XEO03624 DESCRIPT Basic peptide AMP4 IB-AMP4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03624 GENEFORM Protein DME1242 XEOTICID XEO03624 MOACRIVE Inhibition DME1242 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1242 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03627 XEO_CLAS Peptide DME1242 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 13-25 microM) DME1242 XEOTICID XEO03627 GENEFORM Protein DME1242 XEOTICID XEO03627 MOACRIVE Inhibition DME1242 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1242 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03630 XEO_CLAS Peptide DME1242 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03630 GENEFORM Protein DME1242 XEOTICID XEO03630 MOACRIVE Inhibition DME1242 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1242 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03631 XEO_CLAS Peptide DME1242 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03631 GENEFORM Protein DME1242 XEOTICID XEO03631 MOACRIVE Inhibition DME1242 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1242 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03632 XEO_CLAS Peptide DME1242 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03632 GENEFORM Protein DME1242 XEOTICID XEO03632 MOACRIVE Inhibition DME1242 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1242 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03633 XEO_CLAS Peptide DME1242 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03633 GENEFORM Protein DME1242 XEOTICID XEO03633 MOACRIVE Inhibition DME1242 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1242 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03634 XEO_CLAS Peptide DME1242 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03634 GENEFORM Protein DME1242 XEOTICID XEO03634 MOACRIVE Inhibition DME1242 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1242 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03635 XEO_CLAS Peptide DME1242 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03635 GENEFORM Protein DME1242 XEOTICID XEO03635 MOACRIVE Inhibition DME1242 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1242 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03636 XEO_CLAS Peptide DME1242 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03636 GENEFORM Protein DME1242 XEOTICID XEO03636 MOACRIVE Inhibition DME1242 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1242 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03637 XEO_CLAS Peptide DME1242 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03637 GENEFORM Protein DME1242 XEOTICID XEO03637 MOACRIVE Inhibition DME1242 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1242 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03638 XEO_CLAS Peptide DME1242 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03638 GENEFORM Protein DME1242 XEOTICID XEO03638 MOACRIVE Inhibition DME1242 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1242 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03639 XEO_CLAS Peptide DME1242 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03639 GENEFORM Protein DME1242 XEOTICID XEO03639 MOACRIVE Inhibition DME1242 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1242 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03640 XEO_CLAS Peptide DME1242 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03640 GENEFORM Protein DME1242 XEOTICID XEO03640 MOACRIVE Inhibition DME1242 XEOTICID XEO03649 XEO_NAME Indolicidin DME1242 XEOTICID XEO03649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03649 XEO_CLAS Peptide DME1242 XEOTICID XEO03649 DESCRIPT Indolicidin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03649 GENEFORM Protein DME1242 XEOTICID XEO03649 MOACRIVE Inhibition DME1242 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1242 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03650 XEO_CLAS Peptide DME1242 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03650 GENEFORM Protein DME1242 XEOTICID XEO03650 MOACRIVE Inhibition DME1242 XEOTICID XEO03656 XEO_NAME Isohydnocarpin DME1242 XEOTICID XEO03656 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03656 XEO_CLAS Natural Product DME1242 XEOTICID XEO03656 DESCRIPT Isohydnocarpin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03656 GENEFORM Protein DME1242 XEOTICID XEO03656 MOACRIVE Inhibition DME1242 XEOTICID XEO03659 XEO_NAME Isosilybin A DME1242 XEOTICID XEO03659 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03659 XEO_CLAS Natural Product DME1242 XEOTICID XEO03659 DESCRIPT Isosilybin A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03659 GENEFORM Protein DME1242 XEOTICID XEO03659 MOACRIVE Inhibition DME1242 XEOTICID XEO03664 XEO_NAME Ixodes ricinus defensin def1 DME1242 XEOTICID XEO03664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03664 XEO_CLAS Peptide DME1242 XEOTICID XEO03664 DESCRIPT Ixodes ricinus defensin def1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 microM) DME1242 XEOTICID XEO03664 GENEFORM Protein DME1242 XEOTICID XEO03664 MOACRIVE Inhibition DME1242 XEOTICID XEO03665 XEO_NAME Ixodes ricinus defensin def2 DME1242 XEOTICID XEO03665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03665 XEO_CLAS Peptide DME1242 XEOTICID XEO03665 DESCRIPT Ixodes ricinus defensin def2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 microM) DME1242 XEOTICID XEO03665 GENEFORM Protein DME1242 XEOTICID XEO03665 MOACRIVE Inhibition DME1242 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1242 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03666 XEO_CLAS Peptide DME1242 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.7 ug/ml) DME1242 XEOTICID XEO03666 GENEFORM Protein DME1242 XEOTICID XEO03666 MOACRIVE Inhibition DME1242 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1242 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03667 XEO_CLAS Peptide DME1242 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.5 ug/ml) DME1242 XEOTICID XEO03667 GENEFORM Protein DME1242 XEOTICID XEO03667 MOACRIVE Inhibition DME1242 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1242 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03668 XEO_CLAS Peptide DME1242 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO03668 GENEFORM Protein DME1242 XEOTICID XEO03668 MOACRIVE Inhibition DME1242 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1242 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03669 XEO_CLAS Peptide DME1242 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO03669 GENEFORM Protein DME1242 XEOTICID XEO03669 MOACRIVE Inhibition DME1242 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1242 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03670 XEO_CLAS Peptide DME1242 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 20 microM) DME1242 XEOTICID XEO03670 GENEFORM Protein DME1242 XEOTICID XEO03670 MOACRIVE Inhibition DME1242 XEOTICID XEO03671 XEO_NAME Plant JCpep7 DME1242 XEOTICID XEO03671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03671 XEO_CLAS Peptide DME1242 XEOTICID XEO03671 DESCRIPT Plant JCpep7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 40 ug/ml) DME1242 XEOTICID XEO03671 GENEFORM Protein DME1242 XEOTICID XEO03671 MOACRIVE Inhibition DME1242 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1242 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03672 XEO_CLAS Peptide DME1242 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10 ug/ml) DME1242 XEOTICID XEO03672 GENEFORM Protein DME1242 XEOTICID XEO03672 MOACRIVE Inhibition DME1242 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1242 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03673 XEO_CLAS Peptide DME1242 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 ug/ml) DME1242 XEOTICID XEO03673 GENEFORM Protein DME1242 XEOTICID XEO03673 MOACRIVE Inhibition DME1242 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1242 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03674 XEO_CLAS Peptide DME1242 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 30 ug/ml) DME1242 XEOTICID XEO03674 GENEFORM Protein DME1242 XEOTICID XEO03674 MOACRIVE Inhibition DME1242 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1242 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03675 XEO_CLAS Peptide DME1242 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 17 microM) DME1242 XEOTICID XEO03675 GENEFORM Protein DME1242 XEOTICID XEO03675 MOACRIVE Inhibition DME1242 XEOTICID XEO03677 XEO_NAME Juniper berry oil DME1242 XEOTICID XEO03677 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03677 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03677 DESCRIPT Juniper berry oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03677 GENEFORM Protein DME1242 XEOTICID XEO03677 MOACRIVE Inhibition DME1242 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1242 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03678 XEO_CLAS Peptide DME1242 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.5 ug/ml) DME1242 XEOTICID XEO03678 GENEFORM Protein DME1242 XEOTICID XEO03678 MOACRIVE Inhibition DME1242 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1242 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03679 XEO_CLAS Peptide DME1242 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 ug/ml) DME1242 XEOTICID XEO03679 GENEFORM Protein DME1242 XEOTICID XEO03679 MOACRIVE Inhibition DME1242 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1242 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03684 XEO_CLAS Peptide DME1242 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 125 ug/ml) DME1242 XEOTICID XEO03684 GENEFORM Protein DME1242 XEOTICID XEO03684 MOACRIVE Inhibition DME1242 XEOTICID XEO03685 XEO_NAME Def-DAA defensin mutant K8I DME1242 XEOTICID XEO03685 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03685 XEO_CLAS Peptide DME1242 XEOTICID XEO03685 DESCRIPT Def-DAA defensin mutant K8I inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03685 GENEFORM Protein DME1242 XEOTICID XEO03685 MOACRIVE Inhibition DME1242 XEOTICID XEO03686 XEO_NAME Def-DAA defensin mutant K8I,W11V DME1242 XEOTICID XEO03686 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03686 XEO_CLAS Peptide DME1242 XEOTICID XEO03686 DESCRIPT Def-DAA defensin mutant K8I,W11V inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03686 GENEFORM Protein DME1242 XEOTICID XEO03686 MOACRIVE Inhibition DME1242 XEOTICID XEO03687 XEO_NAME Def-DAA defensin mutant K8I,W11V,T14A DME1242 XEOTICID XEO03687 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03687 XEO_CLAS Peptide DME1242 XEOTICID XEO03687 DESCRIPT Def-DAA defensin mutant K8I,W11V,T14A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03687 GENEFORM Protein DME1242 XEOTICID XEO03687 MOACRIVE Inhibition DME1242 XEOTICID XEO03688 XEO_NAME Def-DAA defensin mutant K8I,W9F DME1242 XEOTICID XEO03688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03688 XEO_CLAS Peptide DME1242 XEOTICID XEO03688 DESCRIPT Def-DAA defensin mutant K8I,W9F inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03688 GENEFORM Protein DME1242 XEOTICID XEO03688 MOACRIVE Inhibition DME1242 XEOTICID XEO03689 XEO_NAME Def-DAA defensin mutant K8I,W9F,T14A DME1242 XEOTICID XEO03689 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03689 XEO_CLAS Peptide DME1242 XEOTICID XEO03689 DESCRIPT Def-DAA defensin mutant K8I,W9F,T14A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03689 GENEFORM Protein DME1242 XEOTICID XEO03689 MOACRIVE Inhibition DME1242 XEOTICID XEO03690 XEO_NAME Def-DAA defensin mutant K8I,W9F,W11V DME1242 XEOTICID XEO03690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03690 XEO_CLAS Peptide DME1242 XEOTICID XEO03690 DESCRIPT Def-DAA defensin mutant K8I,W9F,W11V inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03690 GENEFORM Protein DME1242 XEOTICID XEO03690 MOACRIVE Inhibition DME1242 XEOTICID XEO03693 XEO_NAME Kalata-B1 DME1242 XEOTICID XEO03693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03693 XEO_CLAS Peptide DME1242 XEOTICID XEO03693 DESCRIPT Kalata-B1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.26 microM) DME1242 XEOTICID XEO03693 GENEFORM Protein DME1242 XEOTICID XEO03693 MOACRIVE Inhibition DME1242 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1242 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03697 XEO_CLAS Peptide DME1242 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 microM) DME1242 XEOTICID XEO03697 GENEFORM Protein DME1242 XEOTICID XEO03697 MOACRIVE Inhibition DME1242 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1242 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03698 XEO_CLAS Peptide DME1242 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 microM) DME1242 XEOTICID XEO03698 GENEFORM Protein DME1242 XEOTICID XEO03698 MOACRIVE Inhibition DME1242 XEOTICID XEO03699 XEO_NAME Kassinatuerin-2Mb DME1242 XEOTICID XEO03699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03699 XEO_CLAS Peptide DME1242 XEOTICID XEO03699 DESCRIPT Kassinatuerin-2Mb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03699 GENEFORM Protein DME1242 XEOTICID XEO03699 MOACRIVE Inhibition DME1242 XEOTICID XEO03700 XEO_NAME Kassinatuerin-2Mc DME1242 XEOTICID XEO03700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03700 XEO_CLAS Peptide DME1242 XEOTICID XEO03700 DESCRIPT Kassinatuerin-2Mc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03700 GENEFORM Protein DME1242 XEOTICID XEO03700 MOACRIVE Inhibition DME1242 XEOTICID XEO03701 XEO_NAME Kassinatuerin-2Md DME1242 XEOTICID XEO03701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03701 XEO_CLAS Peptide DME1242 XEOTICID XEO03701 DESCRIPT Kassinatuerin-2Md inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03701 GENEFORM Protein DME1242 XEOTICID XEO03701 MOACRIVE Inhibition DME1242 XEOTICID XEO03702 XEO_NAME Kassorin-S DME1242 XEOTICID XEO03702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03702 XEO_CLAS Peptide DME1242 XEOTICID XEO03702 DESCRIPT Kassorin-S inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 30 microM) DME1242 XEOTICID XEO03702 GENEFORM Protein DME1242 XEOTICID XEO03702 MOACRIVE Inhibition DME1242 XEOTICID XEO03703 XEO_NAME Kasstasin DME1242 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03703 XEO_CLAS Peptide DME1242 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 55 microM) DME1242 XEOTICID XEO03703 GENEFORM Protein DME1242 XEOTICID XEO03703 MOACRIVE Inhibition DME1242 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1242 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03709 XEO_CLAS Peptide DME1242 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.13 ug/ml) DME1242 XEOTICID XEO03709 GENEFORM Protein DME1242 XEOTICID XEO03709 MOACRIVE Inhibition DME1242 XEOTICID XEO03710 XEO_NAME knightine DME1242 XEOTICID XEO03710 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03710 XEO_CLAS Natural Product DME1242 XEOTICID XEO03710 DESCRIPT knightine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03710 GENEFORM Protein DME1242 XEOTICID XEO03710 MOACRIVE Inhibition DME1242 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1242 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03713 XEO_CLAS Peptide DME1242 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 microM) DME1242 XEOTICID XEO03713 GENEFORM Protein DME1242 XEOTICID XEO03713 MOACRIVE Inhibition DME1242 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1242 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03715 XEO_CLAS Peptide DME1242 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 microM) DME1242 XEOTICID XEO03715 GENEFORM Protein DME1242 XEOTICID XEO03715 MOACRIVE Inhibition DME1242 XEOTICID XEO03736 XEO_NAME L-4-Carbamoylphenylalanine DME1242 XEOTICID XEO03736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03736 XEO_CLAS Amino Acid DME1242 XEOTICID XEO03736 DESCRIPT L-4-Carbamoylphenylalanine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03736 GENEFORM Protein DME1242 XEOTICID XEO03736 MOACRIVE Inhibition DME1242 XEOTICID XEO03737 XEO_NAME LlKmWn model peptide L4K2W4 DME1242 XEOTICID XEO03737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03737 XEO_CLAS Peptide DME1242 XEOTICID XEO03737 DESCRIPT LlKmWn model peptide L4K2W4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO03737 GENEFORM Protein DME1242 XEOTICID XEO03737 MOACRIVE Inhibition DME1242 XEOTICID XEO03739 XEO_NAME LlKmWn model peptide L4K3W4 DME1242 XEOTICID XEO03739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03739 XEO_CLAS Peptide DME1242 XEOTICID XEO03739 DESCRIPT LlKmWn model peptide L4K3W4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO03739 GENEFORM Protein DME1242 XEOTICID XEO03739 MOACRIVE Inhibition DME1242 XEOTICID XEO03740 XEO_NAME LlKmWn model peptide L4K3W5 DME1242 XEOTICID XEO03740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03740 XEO_CLAS Peptide DME1242 XEOTICID XEO03740 DESCRIPT LlKmWn model peptide L4K3W5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO03740 GENEFORM Protein DME1242 XEOTICID XEO03740 MOACRIVE Inhibition DME1242 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1242 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03744 XEO_CLAS Peptide DME1242 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.1 ug/ml) DME1242 XEOTICID XEO03744 GENEFORM Protein DME1242 XEOTICID XEO03744 MOACRIVE Inhibition DME1242 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1242 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03746 XEO_CLAS Peptide DME1242 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO03746 GENEFORM Protein DME1242 XEOTICID XEO03746 MOACRIVE Inhibition DME1242 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1242 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03747 XEO_CLAS Peptide DME1242 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 ug/ml) DME1242 XEOTICID XEO03747 GENEFORM Protein DME1242 XEOTICID XEO03747 MOACRIVE Inhibition DME1242 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1242 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03748 XEO_CLAS Peptide DME1242 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO03748 GENEFORM Protein DME1242 XEOTICID XEO03748 MOACRIVE Inhibition DME1242 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1242 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03749 XEO_CLAS Peptide DME1242 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO03749 GENEFORM Protein DME1242 XEOTICID XEO03749 MOACRIVE Inhibition DME1242 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1242 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03750 XEO_CLAS Peptide DME1242 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO03750 GENEFORM Protein DME1242 XEOTICID XEO03750 MOACRIVE Inhibition DME1242 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1242 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03751 XEO_CLAS Peptide DME1242 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO03751 GENEFORM Protein DME1242 XEOTICID XEO03751 MOACRIVE Inhibition DME1242 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1242 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03752 XEO_CLAS Peptide DME1242 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO03752 GENEFORM Protein DME1242 XEOTICID XEO03752 MOACRIVE Inhibition DME1242 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1242 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03753 XEO_CLAS Peptide DME1242 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.3 ug/ml) DME1242 XEOTICID XEO03753 GENEFORM Protein DME1242 XEOTICID XEO03753 MOACRIVE Inhibition DME1242 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1242 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03754 XEO_CLAS Peptide DME1242 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO03754 GENEFORM Protein DME1242 XEOTICID XEO03754 MOACRIVE Inhibition DME1242 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1242 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03755 XEO_CLAS Peptide DME1242 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO03755 GENEFORM Protein DME1242 XEOTICID XEO03755 MOACRIVE Inhibition DME1242 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1242 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03756 XEO_CLAS Peptide DME1242 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO03756 GENEFORM Protein DME1242 XEOTICID XEO03756 MOACRIVE Inhibition DME1242 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1242 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03759 XEO_CLAS Peptide DME1242 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.6 ug/ml) DME1242 XEOTICID XEO03759 GENEFORM Protein DME1242 XEOTICID XEO03759 MOACRIVE Inhibition DME1242 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1242 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03761 XEO_CLAS Peptide DME1242 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.1 ug/ml) DME1242 XEOTICID XEO03761 GENEFORM Protein DME1242 XEOTICID XEO03761 MOACRIVE Inhibition DME1242 XEOTICID XEO03762 XEO_NAME LlKmWn model peptide L7K5W7 DME1242 XEOTICID XEO03762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03762 XEO_CLAS Peptide DME1242 XEOTICID XEO03762 DESCRIPT LlKmWn model peptide L7K5W7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 ug/ml) DME1242 XEOTICID XEO03762 GENEFORM Protein DME1242 XEOTICID XEO03762 MOACRIVE Inhibition DME1242 XEOTICID XEO03764 XEO_NAME LlKmWn model peptide L8K4W7 DME1242 XEOTICID XEO03764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03764 XEO_CLAS Peptide DME1242 XEOTICID XEO03764 DESCRIPT LlKmWn model peptide L8K4W7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO03764 GENEFORM Protein DME1242 XEOTICID XEO03764 MOACRIVE Inhibition DME1242 XEOTICID XEO03766 XEO_NAME Plant labaditin DME1242 XEOTICID XEO03766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03766 XEO_CLAS Peptide DME1242 XEOTICID XEO03766 DESCRIPT Plant labaditin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03766 GENEFORM Protein DME1242 XEOTICID XEO03766 MOACRIVE Inhibition DME1242 XEOTICID XEO03767 XEO_NAME Laccase DME1242 XEOTICID XEO03767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03767 XEO_CLAS Peptide DME1242 XEOTICID XEO03767 DESCRIPT Laccase inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03767 GENEFORM Protein DME1242 XEOTICID XEO03767 MOACRIVE Inhibition DME1242 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1242 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03775 XEO_CLAS Peptide DME1242 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 91.6 microM) DME1242 XEOTICID XEO03775 GENEFORM Protein DME1242 XEOTICID XEO03775 MOACRIVE Inhibition DME1242 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1242 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03776 XEO_CLAS Peptide DME1242 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO03776 GENEFORM Protein DME1242 XEOTICID XEO03776 MOACRIVE Inhibition DME1242 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1242 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03793 XEO_CLAS Peptide DME1242 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 ug/ml) DME1242 XEOTICID XEO03793 GENEFORM Protein DME1242 XEOTICID XEO03793 MOACRIVE Inhibition DME1242 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1242 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03797 XEO_CLAS Peptide DME1242 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.006 microM) DME1242 XEOTICID XEO03797 GENEFORM Protein DME1242 XEOTICID XEO03797 MOACRIVE Inhibition DME1242 XEOTICID XEO03804 XEO_NAME Lantibiotic lichenicidin VK21 A1 DME1242 XEOTICID XEO03804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03804 XEO_CLAS Peptide DME1242 XEOTICID XEO03804 DESCRIPT Lantibiotic lichenicidin VK21 A1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03804 GENEFORM Protein DME1242 XEOTICID XEO03804 MOACRIVE Inhibition DME1242 XEOTICID XEO03805 XEO_NAME Lantibiotic lichenicidin VK21 A2 DME1242 XEOTICID XEO03805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03805 XEO_CLAS Peptide DME1242 XEOTICID XEO03805 DESCRIPT Lantibiotic lichenicidin VK21 A2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03805 GENEFORM Protein DME1242 XEOTICID XEO03805 MOACRIVE Inhibition DME1242 XEOTICID XEO03806 XEO_NAME Lantibiotic paenibacillin DME1242 XEOTICID XEO03806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03806 XEO_CLAS Peptide DME1242 XEOTICID XEO03806 DESCRIPT Lantibiotic paenibacillin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03806 GENEFORM Protein DME1242 XEOTICID XEO03806 MOACRIVE Inhibition DME1242 XEOTICID XEO03809 XEO_NAME L-Aspartate DME1242 XEOTICID XEO03809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03809 XEO_CLAS Amino Acid DME1242 XEOTICID XEO03809 DESCRIPT L-Aspartate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03809 GENEFORM Protein DME1242 XEOTICID XEO03809 MOACRIVE Inhibition DME1242 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1242 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03810 XEO_CLAS Peptide DME1242 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03810 GENEFORM Protein DME1242 XEOTICID XEO03810 MOACRIVE Inhibition DME1242 XEOTICID XEO03811 XEO_NAME Lavender oil DME1242 XEOTICID XEO03811 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03811 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03811 DESCRIPT Lavender oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03811 GENEFORM Protein DME1242 XEOTICID XEO03811 MOACRIVE Inhibition DME1242 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1242 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03846 XEO_CLAS Peptide DME1242 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03846 GENEFORM Protein DME1242 XEOTICID XEO03846 MOACRIVE Inhibition DME1242 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1242 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03847 XEO_CLAS Peptide DME1242 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03847 GENEFORM Protein DME1242 XEOTICID XEO03847 MOACRIVE Inhibition DME1242 XEOTICID XEO03851 XEO_NAME Lemon oil DME1242 XEOTICID XEO03851 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03851 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03851 DESCRIPT Lemon oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03851 GENEFORM Protein DME1242 XEOTICID XEO03851 MOACRIVE Inhibition DME1242 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1242 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03860 XEO_CLAS Peptide DME1242 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 48 microM) DME1242 XEOTICID XEO03860 GENEFORM Protein DME1242 XEOTICID XEO03860 MOACRIVE Inhibition DME1242 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1242 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03861 XEO_CLAS Peptide DME1242 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO03861 GENEFORM Protein DME1242 XEOTICID XEO03861 MOACRIVE Inhibition DME1242 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1242 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03862 XEO_CLAS Peptide DME1242 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO03862 GENEFORM Protein DME1242 XEOTICID XEO03862 MOACRIVE Inhibition DME1242 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1242 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03863 XEO_CLAS Peptide DME1242 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO03863 GENEFORM Protein DME1242 XEOTICID XEO03863 MOACRIVE Inhibition DME1242 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1242 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03864 XEO_CLAS Peptide DME1242 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO03864 GENEFORM Protein DME1242 XEOTICID XEO03864 MOACRIVE Inhibition DME1242 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1242 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03865 XEO_CLAS Peptide DME1242 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO03865 GENEFORM Protein DME1242 XEOTICID XEO03865 MOACRIVE Inhibition DME1242 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1242 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03866 XEO_CLAS Peptide DME1242 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 77 microM) DME1242 XEOTICID XEO03866 GENEFORM Protein DME1242 XEOTICID XEO03866 MOACRIVE Inhibition DME1242 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1242 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03867 XEO_CLAS Peptide DME1242 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO03867 GENEFORM Protein DME1242 XEOTICID XEO03867 MOACRIVE Inhibition DME1242 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1242 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03868 XEO_CLAS Peptide DME1242 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 microM) DME1242 XEOTICID XEO03868 GENEFORM Protein DME1242 XEOTICID XEO03868 MOACRIVE Inhibition DME1242 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1242 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03869 XEO_CLAS Peptide DME1242 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO03869 GENEFORM Protein DME1242 XEOTICID XEO03869 MOACRIVE Inhibition DME1242 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1242 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03870 XEO_CLAS Peptide DME1242 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO03870 GENEFORM Protein DME1242 XEOTICID XEO03870 MOACRIVE Inhibition DME1242 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1242 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03871 XEO_CLAS Peptide DME1242 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 75 microM) DME1242 XEOTICID XEO03871 GENEFORM Protein DME1242 XEOTICID XEO03871 MOACRIVE Inhibition DME1242 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1242 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03872 XEO_CLAS Peptide DME1242 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO03872 GENEFORM Protein DME1242 XEOTICID XEO03872 MOACRIVE Inhibition DME1242 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1242 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03873 XEO_CLAS Peptide DME1242 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11.25 microM) DME1242 XEOTICID XEO03873 GENEFORM Protein DME1242 XEOTICID XEO03873 MOACRIVE Inhibition DME1242 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1242 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03874 XEO_CLAS Peptide DME1242 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11.25 microM) DME1242 XEOTICID XEO03874 GENEFORM Protein DME1242 XEOTICID XEO03874 MOACRIVE Inhibition DME1242 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1242 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03875 XEO_CLAS Peptide DME1242 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 microM) DME1242 XEOTICID XEO03875 GENEFORM Protein DME1242 XEOTICID XEO03875 MOACRIVE Inhibition DME1242 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1242 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03876 XEO_CLAS Peptide DME1242 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11.25 microM) DME1242 XEOTICID XEO03876 GENEFORM Protein DME1242 XEOTICID XEO03876 MOACRIVE Inhibition DME1242 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1242 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03877 XEO_CLAS Peptide DME1242 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7.5 microM) DME1242 XEOTICID XEO03877 GENEFORM Protein DME1242 XEOTICID XEO03877 MOACRIVE Inhibition DME1242 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1242 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03878 XEO_CLAS Peptide DME1242 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7.5 microM) DME1242 XEOTICID XEO03878 GENEFORM Protein DME1242 XEOTICID XEO03878 MOACRIVE Inhibition DME1242 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1242 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03879 XEO_CLAS Peptide DME1242 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 500 microM) DME1242 XEOTICID XEO03879 GENEFORM Protein DME1242 XEOTICID XEO03879 MOACRIVE Inhibition DME1242 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1242 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03880 XEO_CLAS Peptide DME1242 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 500 microM) DME1242 XEOTICID XEO03880 GENEFORM Protein DME1242 XEOTICID XEO03880 MOACRIVE Inhibition DME1242 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1242 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03883 XEO_CLAS Peptide DME1242 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 500 microM) DME1242 XEOTICID XEO03883 GENEFORM Protein DME1242 XEOTICID XEO03883 MOACRIVE Inhibition DME1242 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1242 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03884 XEO_CLAS Peptide DME1242 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 257 microM) DME1242 XEOTICID XEO03884 GENEFORM Protein DME1242 XEOTICID XEO03884 MOACRIVE Inhibition DME1242 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1242 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03885 XEO_CLAS Peptide DME1242 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 40 microM) DME1242 XEOTICID XEO03885 GENEFORM Protein DME1242 XEOTICID XEO03885 MOACRIVE Inhibition DME1242 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1242 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03890 XEO_CLAS Peptide DME1242 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 257 microM) DME1242 XEOTICID XEO03890 GENEFORM Protein DME1242 XEOTICID XEO03890 MOACRIVE Inhibition DME1242 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1242 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03891 XEO_CLAS Peptide DME1242 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 microM) DME1242 XEOTICID XEO03891 GENEFORM Protein DME1242 XEOTICID XEO03891 MOACRIVE Inhibition DME1242 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1242 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03892 XEO_CLAS Peptide DME1242 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 374 microM) DME1242 XEOTICID XEO03892 GENEFORM Protein DME1242 XEOTICID XEO03892 MOACRIVE Inhibition DME1242 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1242 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03893 XEO_CLAS Peptide DME1242 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 73 microM) DME1242 XEOTICID XEO03893 GENEFORM Protein DME1242 XEOTICID XEO03893 MOACRIVE Inhibition DME1242 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1242 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03894 XEO_CLAS Peptide DME1242 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 37 microM) DME1242 XEOTICID XEO03894 GENEFORM Protein DME1242 XEOTICID XEO03894 MOACRIVE Inhibition DME1242 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1242 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03895 XEO_CLAS Peptide DME1242 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 microM) DME1242 XEOTICID XEO03895 GENEFORM Protein DME1242 XEOTICID XEO03895 MOACRIVE Inhibition DME1242 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1242 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03898 XEO_CLAS Peptide DME1242 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 500 microM) DME1242 XEOTICID XEO03898 GENEFORM Protein DME1242 XEOTICID XEO03898 MOACRIVE Inhibition DME1242 XEOTICID XEO03900 XEO_NAME Lime dis 5-fold oil DME1242 XEOTICID XEO03900 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03900 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03900 DESCRIPT Lime dis 5-fold oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03900 GENEFORM Protein DME1242 XEOTICID XEO03900 MOACRIVE Inhibition DME1242 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1242 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03904 XEO_CLAS Peptide DME1242 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 ug/ml) DME1242 XEOTICID XEO03904 GENEFORM Protein DME1242 XEOTICID XEO03904 MOACRIVE Inhibition DME1242 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1242 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03905 XEO_CLAS Peptide DME1242 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO03905 GENEFORM Protein DME1242 XEOTICID XEO03905 MOACRIVE Inhibition DME1242 XEOTICID XEO03907 XEO_NAME Linezolid DME1242 XEOTICID XEO03907 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO03907 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO03907 DESCRIPT Linezolid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03907 GENEFORM Protein DME1242 XEOTICID XEO03907 MOACRIVE Inhibition DME1242 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1242 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03908 XEO_CLAS Peptide DME1242 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03908 GENEFORM Protein DME1242 XEOTICID XEO03908 MOACRIVE Inhibition DME1242 XEOTICID XEO03914 XEO_NAME Litsea oil DME1242 XEOTICID XEO03914 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03914 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03914 DESCRIPT Litsea oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03914 GENEFORM Protein DME1242 XEOTICID XEO03914 MOACRIVE Inhibition DME1242 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1242 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03916 XEO_CLAS Peptide DME1242 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11.6 ug/ml) DME1242 XEOTICID XEO03916 GENEFORM Protein DME1242 XEOTICID XEO03916 MOACRIVE Inhibition DME1242 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1242 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03917 XEO_CLAS Peptide DME1242 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 13.1 ug/ml) DME1242 XEOTICID XEO03917 GENEFORM Protein DME1242 XEOTICID XEO03917 MOACRIVE Inhibition DME1242 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1242 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03918 XEO_CLAS Peptide DME1242 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11 ug/ml) DME1242 XEOTICID XEO03918 GENEFORM Protein DME1242 XEOTICID XEO03918 MOACRIVE Inhibition DME1242 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1242 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03922 XEO_CLAS Peptide DME1242 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO03922 GENEFORM Protein DME1242 XEOTICID XEO03922 MOACRIVE Inhibition DME1242 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1242 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03923 XEO_CLAS Peptide DME1242 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.35-0.7 microM) DME1242 XEOTICID XEO03923 GENEFORM Protein DME1242 XEOTICID XEO03923 MOACRIVE Inhibition DME1242 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1242 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03924 XEO_CLAS Peptide DME1242 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 microM) DME1242 XEOTICID XEO03924 GENEFORM Protein DME1242 XEOTICID XEO03924 MOACRIVE Inhibition DME1242 XEOTICID XEO03926 XEO_NAME LL-37 pentamide DME1242 XEOTICID XEO03926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03926 XEO_CLAS Peptide DME1242 XEOTICID XEO03926 DESCRIPT LL-37 pentamide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03926 GENEFORM Protein DME1242 XEOTICID XEO03926 MOACRIVE Inhibition DME1242 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1242 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03928 XEO_CLAS Peptide DME1242 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 microM) DME1242 XEOTICID XEO03928 GENEFORM Protein DME1242 XEOTICID XEO03928 MOACRIVE Inhibition DME1242 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1242 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03933 XEO_CLAS Peptide DME1242 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 71.6 microM) DME1242 XEOTICID XEO03933 GENEFORM Protein DME1242 XEOTICID XEO03933 MOACRIVE Inhibition DME1242 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1242 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03934 XEO_CLAS Peptide DME1242 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7.2 microM) DME1242 XEOTICID XEO03934 GENEFORM Protein DME1242 XEOTICID XEO03934 MOACRIVE Inhibition DME1242 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1242 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03935 XEO_CLAS Peptide DME1242 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15.6 microM) DME1242 XEOTICID XEO03935 GENEFORM Protein DME1242 XEOTICID XEO03935 MOACRIVE Inhibition DME1242 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1242 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03937 XEO_CLAS Peptide DME1242 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 19.7 microM) DME1242 XEOTICID XEO03937 GENEFORM Protein DME1242 XEOTICID XEO03937 MOACRIVE Inhibition DME1242 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1242 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03938 XEO_CLAS Peptide DME1242 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.3 microM) DME1242 XEOTICID XEO03938 GENEFORM Protein DME1242 XEOTICID XEO03938 MOACRIVE Inhibition DME1242 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1242 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03939 XEO_CLAS Peptide DME1242 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15.6 microM) DME1242 XEOTICID XEO03939 GENEFORM Protein DME1242 XEOTICID XEO03939 MOACRIVE Inhibition DME1242 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1242 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03940 XEO_CLAS Peptide DME1242 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 80 microM) DME1242 XEOTICID XEO03940 GENEFORM Protein DME1242 XEOTICID XEO03940 MOACRIVE Inhibition DME1242 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1242 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03941 XEO_CLAS Peptide DME1242 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9.0 microM) DME1242 XEOTICID XEO03941 GENEFORM Protein DME1242 XEOTICID XEO03941 MOACRIVE Inhibition DME1242 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1242 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03943 XEO_CLAS Peptide DME1242 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.2 microM) DME1242 XEOTICID XEO03943 GENEFORM Protein DME1242 XEOTICID XEO03943 MOACRIVE Inhibition DME1242 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1242 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03944 XEO_CLAS Peptide DME1242 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9.6 microM) DME1242 XEOTICID XEO03944 GENEFORM Protein DME1242 XEOTICID XEO03944 MOACRIVE Inhibition DME1242 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1242 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03945 XEO_CLAS Peptide DME1242 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 32.5 microM) DME1242 XEOTICID XEO03945 GENEFORM Protein DME1242 XEOTICID XEO03945 MOACRIVE Inhibition DME1242 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1242 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03947 XEO_CLAS Peptide DME1242 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.1 microM) DME1242 XEOTICID XEO03947 GENEFORM Protein DME1242 XEOTICID XEO03947 MOACRIVE Inhibition DME1242 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1242 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03950 XEO_CLAS Peptide DME1242 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO03950 GENEFORM Protein DME1242 XEOTICID XEO03950 MOACRIVE Inhibition DME1242 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1242 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03951 XEO_CLAS Peptide DME1242 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 20.3 microM) DME1242 XEOTICID XEO03951 GENEFORM Protein DME1242 XEOTICID XEO03951 MOACRIVE Inhibition DME1242 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1242 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03952 XEO_CLAS Peptide DME1242 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 21.7 microM) DME1242 XEOTICID XEO03952 GENEFORM Protein DME1242 XEOTICID XEO03952 MOACRIVE Inhibition DME1242 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1242 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03953 XEO_CLAS Peptide DME1242 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 80 microM) DME1242 XEOTICID XEO03953 GENEFORM Protein DME1242 XEOTICID XEO03953 MOACRIVE Inhibition DME1242 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1242 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03958 XEO_CLAS Peptide DME1242 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03958 GENEFORM Protein DME1242 XEOTICID XEO03958 MOACRIVE Inhibition DME1242 XEOTICID XEO03961 XEO_NAME Lovage root oil DME1242 XEOTICID XEO03961 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03961 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03961 DESCRIPT Lovage root oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03961 GENEFORM Protein DME1242 XEOTICID XEO03961 MOACRIVE Inhibition DME1242 XEOTICID XEO03964 XEO_NAME L-pipecolic acid DME1242 XEOTICID XEO03964 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03964 XEO_CLAS Amino Acid DME1242 XEOTICID XEO03964 DESCRIPT L-pipecolic acid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03964 GENEFORM Protein DME1242 XEOTICID XEO03964 MOACRIVE Inhibition DME1242 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1242 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1242 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03968 GENEFORM Protein DME1242 XEOTICID XEO03968 MOACRIVE Inhibition DME1242 XEOTICID XEO03969 XEO_NAME L-Tyrosine DME1242 XEOTICID XEO03969 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO03969 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO03969 DESCRIPT L-Tyrosine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03969 GENEFORM Protein DME1242 XEOTICID XEO03969 MOACRIVE Inhibition DME1242 XEOTICID XEO03971 XEO_NAME Lumbrican DME1242 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03971 XEO_CLAS Peptide DME1242 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03971 GENEFORM Protein DME1242 XEOTICID XEO03971 MOACRIVE Inhibition DME1242 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1242 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03972 XEO_CLAS Peptide DME1242 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 ug/ml) DME1242 XEOTICID XEO03972 GENEFORM Protein DME1242 XEOTICID XEO03972 MOACRIVE Inhibition DME1242 XEOTICID XEO03981 XEO_NAME Maculatin-1.1 DME1242 XEOTICID XEO03981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03981 XEO_CLAS Peptide DME1242 XEOTICID XEO03981 DESCRIPT Maculatin-1.1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 ug/ml) DME1242 XEOTICID XEO03981 GENEFORM Protein DME1242 XEOTICID XEO03981 MOACRIVE Inhibition DME1242 XEOTICID XEO03982 XEO_NAME Maculatin-1.2 DME1242 XEOTICID XEO03982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03982 XEO_CLAS Peptide DME1242 XEOTICID XEO03982 DESCRIPT Maculatin-1.2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03982 GENEFORM Protein DME1242 XEOTICID XEO03982 MOACRIVE Inhibition DME1242 XEOTICID XEO03983 XEO_NAME Maculatin-1.4 DME1242 XEOTICID XEO03983 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03983 XEO_CLAS Peptide DME1242 XEOTICID XEO03983 DESCRIPT Maculatin-1.4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 ug/ml) DME1242 XEOTICID XEO03983 GENEFORM Protein DME1242 XEOTICID XEO03983 MOACRIVE Inhibition DME1242 XEOTICID XEO03984 XEO_NAME Maculatin-2.1 DME1242 XEOTICID XEO03984 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03984 XEO_CLAS Peptide DME1242 XEOTICID XEO03984 DESCRIPT Maculatin-2.1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 100 ug/ml) DME1242 XEOTICID XEO03984 GENEFORM Protein DME1242 XEOTICID XEO03984 MOACRIVE Inhibition DME1242 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1242 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03985 XEO_CLAS Peptide DME1242 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 ug/ml) DME1242 XEOTICID XEO03985 GENEFORM Protein DME1242 XEOTICID XEO03985 MOACRIVE Inhibition DME1242 XEOTICID XEO03986 XEO_NAME Magainin-I peptide DME1242 XEOTICID XEO03986 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03986 XEO_CLAS Peptide DME1242 XEOTICID XEO03986 DESCRIPT Magainin-I peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03986 GENEFORM Protein DME1242 XEOTICID XEO03986 MOACRIVE Inhibition DME1242 XEOTICID XEO03989 XEO_NAME Mandarin oil DME1242 XEOTICID XEO03989 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO03989 XEO_CLAS Plant Extract DME1242 XEOTICID XEO03989 DESCRIPT Mandarin oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03989 GENEFORM Protein DME1242 XEOTICID XEO03989 MOACRIVE Inhibition DME1242 XEOTICID XEO03990 XEO_NAME Manduca sexta moricin DME1242 XEOTICID XEO03990 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03990 XEO_CLAS Peptide DME1242 XEOTICID XEO03990 DESCRIPT Manduca sexta moricin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 ug/ml) DME1242 XEOTICID XEO03990 GENEFORM Protein DME1242 XEOTICID XEO03990 MOACRIVE Inhibition DME1242 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1242 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03991 XEO_CLAS Peptide DME1242 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03991 GENEFORM Protein DME1242 XEOTICID XEO03991 MOACRIVE Inhibition DME1242 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1242 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03992 XEO_CLAS Peptide DME1242 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03992 GENEFORM Protein DME1242 XEOTICID XEO03992 MOACRIVE Inhibition DME1242 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1242 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03993 XEO_CLAS Peptide DME1242 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03993 GENEFORM Protein DME1242 XEOTICID XEO03993 MOACRIVE Inhibition DME1242 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1242 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO03994 XEO_CLAS Peptide DME1242 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO03994 GENEFORM Protein DME1242 XEOTICID XEO03994 MOACRIVE Inhibition DME1242 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1242 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04000 XEO_CLAS Peptide DME1242 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 ug/ml) DME1242 XEOTICID XEO04000 GENEFORM Protein DME1242 XEOTICID XEO04000 MOACRIVE Inhibition DME1242 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1242 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04001 XEO_CLAS Peptide DME1242 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO04001 GENEFORM Protein DME1242 XEOTICID XEO04001 MOACRIVE Inhibition DME1242 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1242 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04002 XEO_CLAS Peptide DME1242 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.7 ug/ml) DME1242 XEOTICID XEO04002 GENEFORM Protein DME1242 XEOTICID XEO04002 MOACRIVE Inhibition DME1242 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1242 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04003 XEO_CLAS Peptide DME1242 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.7 ug/ml) DME1242 XEOTICID XEO04003 GENEFORM Protein DME1242 XEOTICID XEO04003 MOACRIVE Inhibition DME1242 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1242 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04004 XEO_CLAS Peptide DME1242 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.0 ug/ml) DME1242 XEOTICID XEO04004 GENEFORM Protein DME1242 XEOTICID XEO04004 MOACRIVE Inhibition DME1242 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1242 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04005 XEO_CLAS Peptide DME1242 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.5 ug/ml) DME1242 XEOTICID XEO04005 GENEFORM Protein DME1242 XEOTICID XEO04005 MOACRIVE Inhibition DME1242 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1242 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04007 XEO_CLAS Peptide DME1242 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 19.5 ug/ml) DME1242 XEOTICID XEO04007 GENEFORM Protein DME1242 XEOTICID XEO04007 MOACRIVE Inhibition DME1242 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1242 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04011 XEO_CLAS Peptide DME1242 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 19.5 ug/ml) DME1242 XEOTICID XEO04011 GENEFORM Protein DME1242 XEOTICID XEO04011 MOACRIVE Inhibition DME1242 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1242 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04012 XEO_CLAS Peptide DME1242 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.1 ug/ml) DME1242 XEOTICID XEO04012 GENEFORM Protein DME1242 XEOTICID XEO04012 MOACRIVE Inhibition DME1242 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1242 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04013 XEO_CLAS Peptide DME1242 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.7 ug/ml) DME1242 XEOTICID XEO04013 GENEFORM Protein DME1242 XEOTICID XEO04013 MOACRIVE Inhibition DME1242 XEOTICID XEO04014 XEO_NAME Maximin-5 DME1242 XEOTICID XEO04014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04014 XEO_CLAS Peptide DME1242 XEOTICID XEO04014 DESCRIPT Maximin-5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.6 ug/ml) DME1242 XEOTICID XEO04014 GENEFORM Protein DME1242 XEOTICID XEO04014 MOACRIVE Inhibition DME1242 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1242 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04018 XEO_CLAS Peptide DME1242 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.5 ug/ml) DME1242 XEOTICID XEO04018 GENEFORM Protein DME1242 XEOTICID XEO04018 MOACRIVE Inhibition DME1242 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1242 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04026 XEO_CLAS Peptide DME1242 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO04026 GENEFORM Protein DME1242 XEOTICID XEO04026 MOACRIVE Inhibition DME1242 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1242 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04027 XEO_CLAS Peptide DME1242 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10 ug/ml) DME1242 XEOTICID XEO04027 GENEFORM Protein DME1242 XEOTICID XEO04027 MOACRIVE Inhibition DME1242 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1242 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04028 XEO_CLAS Peptide DME1242 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 ug/ml) DME1242 XEOTICID XEO04028 GENEFORM Protein DME1242 XEOTICID XEO04028 MOACRIVE Inhibition DME1242 XEOTICID XEO04029 XEO_NAME Maximin-H5 DME1242 XEOTICID XEO04029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04029 XEO_CLAS Peptide DME1242 XEOTICID XEO04029 DESCRIPT Maximin-H5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04029 GENEFORM Protein DME1242 XEOTICID XEO04029 MOACRIVE Inhibition DME1242 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1242 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04039 XEO_CLAS Peptide DME1242 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 microM) DME1242 XEOTICID XEO04039 GENEFORM Protein DME1242 XEOTICID XEO04039 MOACRIVE Inhibition DME1242 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1242 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04051 XEO_CLAS Peptide DME1242 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.31-0.63 microM) DME1242 XEOTICID XEO04051 GENEFORM Protein DME1242 XEOTICID XEO04051 MOACRIVE Inhibition DME1242 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1242 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04052 XEO_CLAS Peptide DME1242 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04052 GENEFORM Protein DME1242 XEOTICID XEO04052 MOACRIVE Inhibition DME1242 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1242 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04053 XEO_CLAS Peptide DME1242 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.63-1.25 microM) DME1242 XEOTICID XEO04053 GENEFORM Protein DME1242 XEOTICID XEO04053 MOACRIVE Inhibition DME1242 XEOTICID XEO04055 XEO_NAME Melectin DME1242 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04055 XEO_CLAS Peptide DME1242 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.8 microM) DME1242 XEOTICID XEO04055 GENEFORM Protein DME1242 XEOTICID XEO04055 MOACRIVE Inhibition DME1242 XEOTICID XEO04056 XEO_NAME Melissa oil DME1242 XEOTICID XEO04056 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04056 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04056 DESCRIPT Melissa oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04056 GENEFORM Protein DME1242 XEOTICID XEO04056 MOACRIVE Inhibition DME1242 XEOTICID XEO04057 XEO_NAME Melittin DME1242 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04057 XEO_CLAS Peptide DME1242 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.2 microM) DME1242 XEOTICID XEO04057 GENEFORM Protein DME1242 XEOTICID XEO04057 MOACRIVE Inhibition DME1242 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1242 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04061 XEO_CLAS Peptide DME1242 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.5 microM) DME1242 XEOTICID XEO04061 GENEFORM Protein DME1242 XEOTICID XEO04061 MOACRIVE Inhibition DME1242 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1242 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04062 XEO_CLAS Peptide DME1242 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10.8 microM) DME1242 XEOTICID XEO04062 GENEFORM Protein DME1242 XEOTICID XEO04062 MOACRIVE Inhibition DME1242 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1242 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04063 XEO_CLAS Peptide DME1242 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 37 microM) DME1242 XEOTICID XEO04063 GENEFORM Protein DME1242 XEOTICID XEO04063 MOACRIVE Inhibition DME1242 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1242 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04066 XEO_CLAS Peptide DME1242 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 37 microM) DME1242 XEOTICID XEO04066 GENEFORM Protein DME1242 XEOTICID XEO04066 MOACRIVE Inhibition DME1242 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1242 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04067 XEO_CLAS Peptide DME1242 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 57 microM) DME1242 XEOTICID XEO04067 GENEFORM Protein DME1242 XEOTICID XEO04067 MOACRIVE Inhibition DME1242 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1242 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04068 XEO_CLAS Peptide DME1242 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 43 microM) DME1242 XEOTICID XEO04068 GENEFORM Protein DME1242 XEOTICID XEO04068 MOACRIVE Inhibition DME1242 XEOTICID XEO04077 XEO_NAME Methanol DME1242 XEOTICID XEO04077 XEO_TYPE Health or Environmental Toxicant(s) DME1242 XEOTICID XEO04077 XEO_CLAS Acute Toxic Substance DME1242 XEOTICID XEO04077 DESCRIPT Methanol inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04077 GENEFORM Protein DME1242 XEOTICID XEO04077 MOACRIVE Inhibition DME1242 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1242 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04087 GENEFORM Protein DME1242 XEOTICID XEO04087 MOACRIVE Inhibition DME1242 XEOTICID XEO04106 XEO_NAME Methyl gallate DME1242 XEOTICID XEO04106 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO04106 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO04106 DESCRIPT Methyl gallate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04106 GENEFORM Protein DME1242 XEOTICID XEO04106 MOACRIVE Inhibition DME1242 XEOTICID XEO04116 XEO_NAME Minocycline DME1242 XEOTICID XEO04116 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO04116 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO04116 DESCRIPT Minocycline inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04116 GENEFORM Protein DME1242 XEOTICID XEO04116 MOACRIVE Inhibition DME1242 XEOTICID XEO04117 XEO_NAME Misgurin DME1242 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04117 XEO_CLAS Peptide DME1242 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04117 GENEFORM Protein DME1242 XEOTICID XEO04117 MOACRIVE Inhibition DME1242 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1242 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04118 XEO_CLAS Peptide DME1242 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 300 microM) DME1242 XEOTICID XEO04118 GENEFORM Protein DME1242 XEOTICID XEO04118 MOACRIVE Inhibition DME1242 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1242 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04121 XEO_CLAS Peptide DME1242 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04121 GENEFORM Protein DME1242 XEOTICID XEO04121 MOACRIVE Inhibition DME1242 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1242 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04122 XEO_CLAS Peptide DME1242 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04122 GENEFORM Protein DME1242 XEOTICID XEO04122 MOACRIVE Inhibition DME1242 XEOTICID XEO04123 XEO_NAME Modified defensin DME1242 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04123 XEO_CLAS Peptide DME1242 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO04123 GENEFORM Protein DME1242 XEOTICID XEO04123 MOACRIVE Inhibition DME1242 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1242 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04128 XEO_CLAS Peptide DME1242 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.21 microM) DME1242 XEOTICID XEO04128 GENEFORM Protein DME1242 XEOTICID XEO04128 MOACRIVE Inhibition DME1242 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1242 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04137 XEO_CLAS Peptide DME1242 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.2 microM) DME1242 XEOTICID XEO04137 GENEFORM Protein DME1242 XEOTICID XEO04137 MOACRIVE Inhibition DME1242 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1242 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04142 XEO_CLAS Peptide DME1242 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2-4 microM) DME1242 XEOTICID XEO04142 GENEFORM Protein DME1242 XEOTICID XEO04142 MOACRIVE Inhibition DME1242 XEOTICID XEO04149 XEO_NAME Mucroporin DME1242 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04149 XEO_CLAS Peptide DME1242 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO04149 GENEFORM Protein DME1242 XEOTICID XEO04149 MOACRIVE Inhibition DME1242 XEOTICID XEO04154 XEO_NAME Mutacin I DME1242 XEOTICID XEO04154 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04154 XEO_CLAS Peptide DME1242 XEOTICID XEO04154 DESCRIPT Mutacin I inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04154 GENEFORM Protein DME1242 XEOTICID XEO04154 MOACRIVE Inhibition DME1242 XEOTICID XEO04156 XEO_NAME Mutacin II mutacin H-29B DME1242 XEOTICID XEO04156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04156 XEO_CLAS Peptide DME1242 XEOTICID XEO04156 DESCRIPT Mutacin II mutacin H-29B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04156 GENEFORM Protein DME1242 XEOTICID XEO04156 MOACRIVE Inhibition DME1242 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1242 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04158 XEO_CLAS Peptide DME1242 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO04158 GENEFORM Protein DME1242 XEOTICID XEO04158 MOACRIVE Inhibition DME1242 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1242 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04159 XEO_CLAS Peptide DME1242 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 microM) DME1242 XEOTICID XEO04159 GENEFORM Protein DME1242 XEOTICID XEO04159 MOACRIVE Inhibition DME1242 XEOTICID XEO04161 XEO_NAME Myricitrin DME1242 XEOTICID XEO04161 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04161 XEO_CLAS Natural Product DME1242 XEOTICID XEO04161 DESCRIPT Myricitrin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04161 GENEFORM Protein DME1242 XEOTICID XEO04161 MOACRIVE Inhibition DME1242 XEOTICID XEO04164 XEO_NAME Myrrh oil DME1242 XEOTICID XEO04164 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04164 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04164 DESCRIPT Myrrh oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04164 GENEFORM Protein DME1242 XEOTICID XEO04164 MOACRIVE Inhibition DME1242 XEOTICID XEO04165 XEO_NAME Myrtle oil DME1242 XEOTICID XEO04165 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04165 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04165 DESCRIPT Myrtle oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04165 GENEFORM Protein DME1242 XEOTICID XEO04165 MOACRIVE Inhibition DME1242 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1242 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04168 XEO_CLAS Peptide DME1242 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.5-5.0 microM) DME1242 XEOTICID XEO04168 GENEFORM Protein DME1242 XEOTICID XEO04168 MOACRIVE Inhibition DME1242 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1242 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04169 XEO_CLAS Peptide DME1242 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04169 GENEFORM Protein DME1242 XEOTICID XEO04169 MOACRIVE Inhibition DME1242 XEOTICID XEO04172 XEO_NAME Myxinidin DME1242 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04172 XEO_CLAS Peptide DME1242 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04172 GENEFORM Protein DME1242 XEOTICID XEO04172 MOACRIVE Inhibition DME1242 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1242 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04184 XEO_CLAS Peptide DME1242 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 30 microM) DME1242 XEOTICID XEO04184 GENEFORM Protein DME1242 XEOTICID XEO04184 MOACRIVE Inhibition DME1242 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1242 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04185 XEO_CLAS Peptide DME1242 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04185 GENEFORM Protein DME1242 XEOTICID XEO04185 MOACRIVE Inhibition DME1242 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1242 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04206 XEO_CLAS Peptide DME1242 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.125 microM) DME1242 XEOTICID XEO04206 GENEFORM Protein DME1242 XEOTICID XEO04206 MOACRIVE Inhibition DME1242 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1242 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04214 XEO_CLAS Peptide DME1242 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.125 microM) DME1242 XEOTICID XEO04214 GENEFORM Protein DME1242 XEOTICID XEO04214 MOACRIVE Inhibition DME1242 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1242 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04216 XEO_CLAS Peptide DME1242 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.125 microM) DME1242 XEOTICID XEO04216 GENEFORM Protein DME1242 XEOTICID XEO04216 MOACRIVE Inhibition DME1242 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1242 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04218 XEO_CLAS Peptide DME1242 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.56 microM) DME1242 XEOTICID XEO04218 GENEFORM Protein DME1242 XEOTICID XEO04218 MOACRIVE Inhibition DME1242 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1242 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04219 XEO_CLAS Peptide DME1242 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.125 microM) DME1242 XEOTICID XEO04219 GENEFORM Protein DME1242 XEOTICID XEO04219 MOACRIVE Inhibition DME1242 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1242 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04220 XEO_CLAS Peptide DME1242 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.125 microM) DME1242 XEOTICID XEO04220 GENEFORM Protein DME1242 XEOTICID XEO04220 MOACRIVE Inhibition DME1242 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1242 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04221 XEO_CLAS Peptide DME1242 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.125 microM) DME1242 XEOTICID XEO04221 GENEFORM Protein DME1242 XEOTICID XEO04221 MOACRIVE Inhibition DME1242 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1242 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04222 XEO_CLAS Peptide DME1242 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.125 microM) DME1242 XEOTICID XEO04222 GENEFORM Protein DME1242 XEOTICID XEO04222 MOACRIVE Inhibition DME1242 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1242 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04241 XEO_CLAS Peptide DME1242 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04241 GENEFORM Protein DME1242 XEOTICID XEO04241 MOACRIVE Inhibition DME1242 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1242 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04242 XEO_CLAS Peptide DME1242 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04242 GENEFORM Protein DME1242 XEOTICID XEO04242 MOACRIVE Inhibition DME1242 XEOTICID XEO04247 XEO_NAME Neroli oil DME1242 XEOTICID XEO04247 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04247 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04247 DESCRIPT Neroli oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04247 GENEFORM Protein DME1242 XEOTICID XEO04247 MOACRIVE Inhibition DME1242 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1242 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04249 XEO_CLAS Peptide DME1242 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 500 ug/ml) DME1242 XEOTICID XEO04249 GENEFORM Protein DME1242 XEOTICID XEO04249 MOACRIVE Inhibition DME1242 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1242 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04251 XEO_CLAS Peptide DME1242 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04251 GENEFORM Protein DME1242 XEOTICID XEO04251 MOACRIVE Inhibition DME1242 XEOTICID XEO04252 XEO_NAME Neutrophil antibiotic peptide NP-2 DME1242 XEOTICID XEO04252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04252 XEO_CLAS Peptide DME1242 XEOTICID XEO04252 DESCRIPT Neutrophil antibiotic peptide NP-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04252 GENEFORM Protein DME1242 XEOTICID XEO04252 MOACRIVE Inhibition DME1242 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1242 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04253 XEO_CLAS Peptide DME1242 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04253 GENEFORM Protein DME1242 XEOTICID XEO04253 MOACRIVE Inhibition DME1242 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1242 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04254 XEO_CLAS Peptide DME1242 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 ug/ml) DME1242 XEOTICID XEO04254 GENEFORM Protein DME1242 XEOTICID XEO04254 MOACRIVE Inhibition DME1242 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1242 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04255 XEO_CLAS Peptide DME1242 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04255 GENEFORM Protein DME1242 XEOTICID XEO04255 MOACRIVE Inhibition DME1242 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1242 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04256 XEO_CLAS Peptide DME1242 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04256 GENEFORM Protein DME1242 XEOTICID XEO04256 MOACRIVE Inhibition DME1242 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1242 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04257 XEO_CLAS Peptide DME1242 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04257 GENEFORM Protein DME1242 XEOTICID XEO04257 MOACRIVE Inhibition DME1242 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1242 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04258 XEO_CLAS Peptide DME1242 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04258 GENEFORM Protein DME1242 XEOTICID XEO04258 MOACRIVE Inhibition DME1242 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1242 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04259 XEO_CLAS Peptide DME1242 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04259 GENEFORM Protein DME1242 XEOTICID XEO04259 MOACRIVE Inhibition DME1242 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1242 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04260 XEO_CLAS Peptide DME1242 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04260 GENEFORM Protein DME1242 XEOTICID XEO04260 MOACRIVE Inhibition DME1242 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1242 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04261 XEO_CLAS Peptide DME1242 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04261 GENEFORM Protein DME1242 XEOTICID XEO04261 MOACRIVE Inhibition DME1242 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1242 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04262 XEO_CLAS Peptide DME1242 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04262 GENEFORM Protein DME1242 XEOTICID XEO04262 MOACRIVE Inhibition DME1242 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1242 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04263 XEO_CLAS Peptide DME1242 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04263 GENEFORM Protein DME1242 XEOTICID XEO04263 MOACRIVE Inhibition DME1242 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1242 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04264 XEO_CLAS Peptide DME1242 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04264 GENEFORM Protein DME1242 XEOTICID XEO04264 MOACRIVE Inhibition DME1242 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1242 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04265 XEO_CLAS Peptide DME1242 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04265 GENEFORM Protein DME1242 XEOTICID XEO04265 MOACRIVE Inhibition DME1242 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1242 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04266 XEO_CLAS Peptide DME1242 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04266 GENEFORM Protein DME1242 XEOTICID XEO04266 MOACRIVE Inhibition DME1242 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1242 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04267 XEO_CLAS Peptide DME1242 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04267 GENEFORM Protein DME1242 XEOTICID XEO04267 MOACRIVE Inhibition DME1242 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1242 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04268 XEO_CLAS Peptide DME1242 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04268 GENEFORM Protein DME1242 XEOTICID XEO04268 MOACRIVE Inhibition DME1242 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1242 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04269 XEO_CLAS Peptide DME1242 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04269 GENEFORM Protein DME1242 XEOTICID XEO04269 MOACRIVE Inhibition DME1242 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1242 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04270 XEO_CLAS Peptide DME1242 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04270 GENEFORM Protein DME1242 XEOTICID XEO04270 MOACRIVE Inhibition DME1242 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1242 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04271 XEO_CLAS Peptide DME1242 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04271 GENEFORM Protein DME1242 XEOTICID XEO04271 MOACRIVE Inhibition DME1242 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1242 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04272 XEO_CLAS Peptide DME1242 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04272 GENEFORM Protein DME1242 XEOTICID XEO04272 MOACRIVE Inhibition DME1242 XEOTICID XEO04274 XEO_NAME Niaouli oil DME1242 XEOTICID XEO04274 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04274 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04274 DESCRIPT Niaouli oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04274 GENEFORM Protein DME1242 XEOTICID XEO04274 MOACRIVE Inhibition DME1242 XEOTICID XEO04276 XEO_NAME Nigroain-B1 DME1242 XEOTICID XEO04276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04276 XEO_CLAS Peptide DME1242 XEOTICID XEO04276 DESCRIPT Nigroain-B1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.69 ug/ml) DME1242 XEOTICID XEO04276 GENEFORM Protein DME1242 XEOTICID XEO04276 MOACRIVE Inhibition DME1242 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1242 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04277 XEO_CLAS Peptide DME1242 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 27.50 ug/ml) DME1242 XEOTICID XEO04277 GENEFORM Protein DME1242 XEOTICID XEO04277 MOACRIVE Inhibition DME1242 XEOTICID XEO04279 XEO_NAME Nigroain-E1 DME1242 XEOTICID XEO04279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04279 XEO_CLAS Peptide DME1242 XEOTICID XEO04279 DESCRIPT Nigroain-E1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 18.75 ug/ml) DME1242 XEOTICID XEO04279 GENEFORM Protein DME1242 XEOTICID XEO04279 MOACRIVE Inhibition DME1242 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1242 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04280 XEO_CLAS Peptide DME1242 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9.38 ug/ml) DME1242 XEOTICID XEO04280 GENEFORM Protein DME1242 XEOTICID XEO04280 MOACRIVE Inhibition DME1242 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1242 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04281 XEO_CLAS Peptide DME1242 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11.25 ug/ml) DME1242 XEOTICID XEO04281 GENEFORM Protein DME1242 XEOTICID XEO04281 MOACRIVE Inhibition DME1242 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1242 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04282 XEO_CLAS Peptide DME1242 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10.4 ug/ml) DME1242 XEOTICID XEO04282 GENEFORM Protein DME1242 XEOTICID XEO04282 MOACRIVE Inhibition DME1242 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1242 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04283 XEO_CLAS Peptide DME1242 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.3 ug/ml) DME1242 XEOTICID XEO04283 GENEFORM Protein DME1242 XEOTICID XEO04283 MOACRIVE Inhibition DME1242 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1242 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04284 XEO_CLAS Peptide DME1242 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5.4 ug/ml) DME1242 XEOTICID XEO04284 GENEFORM Protein DME1242 XEOTICID XEO04284 MOACRIVE Inhibition DME1242 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1242 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04285 XEO_CLAS Peptide DME1242 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5.8 ug/ml) DME1242 XEOTICID XEO04285 GENEFORM Protein DME1242 XEOTICID XEO04285 MOACRIVE Inhibition DME1242 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1242 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04286 XEO_CLAS Peptide DME1242 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8.6 ug/ml) DME1242 XEOTICID XEO04286 GENEFORM Protein DME1242 XEOTICID XEO04286 MOACRIVE Inhibition DME1242 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1242 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04287 XEO_CLAS Peptide DME1242 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 20.4 ug/ml) DME1242 XEOTICID XEO04287 GENEFORM Protein DME1242 XEOTICID XEO04287 MOACRIVE Inhibition DME1242 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1242 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04288 XEO_CLAS Peptide DME1242 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8.8 ug/ml) DME1242 XEOTICID XEO04288 GENEFORM Protein DME1242 XEOTICID XEO04288 MOACRIVE Inhibition DME1242 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1242 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04289 XEO_CLAS Peptide DME1242 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.2 ug/ml) DME1242 XEOTICID XEO04289 GENEFORM Protein DME1242 XEOTICID XEO04289 MOACRIVE Inhibition DME1242 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1242 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04290 XEO_CLAS Peptide DME1242 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11.3 ug/ml) DME1242 XEOTICID XEO04290 GENEFORM Protein DME1242 XEOTICID XEO04290 MOACRIVE Inhibition DME1242 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1242 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04291 XEO_CLAS Peptide DME1242 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.6 ug/ml) DME1242 XEOTICID XEO04291 GENEFORM Protein DME1242 XEOTICID XEO04291 MOACRIVE Inhibition DME1242 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1242 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04292 XEO_CLAS Peptide DME1242 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5.1 ug/ml) DME1242 XEOTICID XEO04292 GENEFORM Protein DME1242 XEOTICID XEO04292 MOACRIVE Inhibition DME1242 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1242 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04294 XEO_CLAS Peptide DME1242 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO04294 GENEFORM Protein DME1242 XEOTICID XEO04294 MOACRIVE Inhibition DME1242 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1242 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04296 XEO_CLAS Peptide DME1242 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 56 microM) DME1242 XEOTICID XEO04296 GENEFORM Protein DME1242 XEOTICID XEO04296 MOACRIVE Inhibition DME1242 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1242 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04297 XEO_CLAS Peptide DME1242 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 28 microM) DME1242 XEOTICID XEO04297 GENEFORM Protein DME1242 XEOTICID XEO04297 MOACRIVE Inhibition DME1242 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1242 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04298 XEO_CLAS Peptide DME1242 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO04298 GENEFORM Protein DME1242 XEOTICID XEO04298 MOACRIVE Inhibition DME1242 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1242 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04299 XEO_CLAS Peptide DME1242 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO04299 GENEFORM Protein DME1242 XEOTICID XEO04299 MOACRIVE Inhibition DME1242 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1242 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04300 XEO_CLAS Peptide DME1242 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO04300 GENEFORM Protein DME1242 XEOTICID XEO04300 MOACRIVE Inhibition DME1242 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1242 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04301 XEO_CLAS Peptide DME1242 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 microM) DME1242 XEOTICID XEO04301 GENEFORM Protein DME1242 XEOTICID XEO04301 MOACRIVE Inhibition DME1242 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1242 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04302 XEO_CLAS Peptide DME1242 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 microM) DME1242 XEOTICID XEO04302 GENEFORM Protein DME1242 XEOTICID XEO04302 MOACRIVE Inhibition DME1242 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1242 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04303 XEO_CLAS Peptide DME1242 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 microM) DME1242 XEOTICID XEO04303 GENEFORM Protein DME1242 XEOTICID XEO04303 MOACRIVE Inhibition DME1242 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1242 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04307 XEO_CLAS Peptide DME1242 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 ug/ml) DME1242 XEOTICID XEO04307 GENEFORM Protein DME1242 XEOTICID XEO04307 MOACRIVE Inhibition DME1242 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1242 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04308 XEO_CLAS Peptide DME1242 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 18.75 ug/ml) DME1242 XEOTICID XEO04308 GENEFORM Protein DME1242 XEOTICID XEO04308 MOACRIVE Inhibition DME1242 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1242 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04309 XEO_CLAS Peptide DME1242 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO04309 GENEFORM Protein DME1242 XEOTICID XEO04309 MOACRIVE Inhibition DME1242 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1242 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04310 XEO_CLAS Peptide DME1242 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO04310 GENEFORM Protein DME1242 XEOTICID XEO04310 MOACRIVE Inhibition DME1242 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1242 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04311 XEO_CLAS Peptide DME1242 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO04311 GENEFORM Protein DME1242 XEOTICID XEO04311 MOACRIVE Inhibition DME1242 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1242 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04312 XEO_CLAS Peptide DME1242 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9.37 ug/ml) DME1242 XEOTICID XEO04312 GENEFORM Protein DME1242 XEOTICID XEO04312 MOACRIVE Inhibition DME1242 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1242 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04313 XEO_CLAS Peptide DME1242 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9.37 ug/ml) DME1242 XEOTICID XEO04313 GENEFORM Protein DME1242 XEOTICID XEO04313 MOACRIVE Inhibition DME1242 XEOTICID XEO04319 XEO_NAME Nisin F DME1242 XEOTICID XEO04319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04319 XEO_CLAS Peptide DME1242 XEOTICID XEO04319 DESCRIPT Nisin F inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04319 GENEFORM Protein DME1242 XEOTICID XEO04319 MOACRIVE Inhibition DME1242 XEOTICID XEO04322 XEO_NAME n-Methyl-D-valine DME1242 XEOTICID XEO04322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04322 XEO_CLAS Amino Acid DME1242 XEOTICID XEO04322 DESCRIPT n-Methyl-D-valine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04322 GENEFORM Protein DME1242 XEOTICID XEO04322 MOACRIVE Inhibition DME1242 XEOTICID XEO04327 XEO_NAME Non-specific lipid transfer peptide DME1242 XEOTICID XEO04327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04327 XEO_CLAS Peptide DME1242 XEOTICID XEO04327 DESCRIPT Non-specific lipid transfer peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04327 GENEFORM Protein DME1242 XEOTICID XEO04327 MOACRIVE Inhibition DME1242 XEOTICID XEO04329 XEO_NAME Norgestimate DME1242 XEOTICID XEO04329 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO04329 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO04329 DESCRIPT Norgestimate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04329 GENEFORM Protein DME1242 XEOTICID XEO04329 MOACRIVE Inhibition DME1242 XEOTICID XEO04331 XEO_NAME Norspermidine DME1242 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04331 GENEFORM Protein DME1242 XEOTICID XEO04331 MOACRIVE Inhibition DME1242 XEOTICID XEO04332 XEO_NAME Nosiheptide DME1242 XEOTICID XEO04332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04332 XEO_CLAS Peptide DME1242 XEOTICID XEO04332 DESCRIPT Nosiheptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.0009 ug/ml) DME1242 XEOTICID XEO04332 GENEFORM Protein DME1242 XEOTICID XEO04332 MOACRIVE Inhibition DME1242 XEOTICID XEO04333 XEO_NAME Novispirin G-10 DME1242 XEOTICID XEO04333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04333 XEO_CLAS Peptide DME1242 XEOTICID XEO04333 DESCRIPT Novispirin G-10 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.6 ug/ml) DME1242 XEOTICID XEO04333 GENEFORM Protein DME1242 XEOTICID XEO04333 MOACRIVE Inhibition DME1242 XEOTICID XEO04334 XEO_NAME Novispirin T-7 DME1242 XEOTICID XEO04334 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04334 XEO_CLAS Peptide DME1242 XEOTICID XEO04334 DESCRIPT Novispirin T-7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.3 ug/ml) DME1242 XEOTICID XEO04334 GENEFORM Protein DME1242 XEOTICID XEO04334 MOACRIVE Inhibition DME1242 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1242 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04335 XEO_CLAS Peptide DME1242 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 64 ug/ml) DME1242 XEOTICID XEO04335 GENEFORM Protein DME1242 XEOTICID XEO04335 MOACRIVE Inhibition DME1242 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1242 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04336 XEO_CLAS Peptide DME1242 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 64 ug/ml) DME1242 XEOTICID XEO04336 GENEFORM Protein DME1242 XEOTICID XEO04336 MOACRIVE Inhibition DME1242 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1242 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04338 XEO_CLAS Peptide DME1242 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 32 ug/ml) DME1242 XEOTICID XEO04338 GENEFORM Protein DME1242 XEOTICID XEO04338 MOACRIVE Inhibition DME1242 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1242 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04339 XEO_CLAS Peptide DME1242 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 64 ug/ml) DME1242 XEOTICID XEO04339 GENEFORM Protein DME1242 XEOTICID XEO04339 MOACRIVE Inhibition DME1242 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1242 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04340 XEO_CLAS Peptide DME1242 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO04340 GENEFORM Protein DME1242 XEOTICID XEO04340 MOACRIVE Inhibition DME1242 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1242 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04347 XEO_CLAS Peptide DME1242 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 64 microM) DME1242 XEOTICID XEO04347 GENEFORM Protein DME1242 XEOTICID XEO04347 MOACRIVE Inhibition DME1242 XEOTICID XEO04350 XEO_NAME Octadecyl gallate DME1242 XEOTICID XEO04350 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1242 XEOTICID XEO04350 XEO_CLAS Chemical Compound DME1242 XEOTICID XEO04350 DESCRIPT Octadecyl gallate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04350 GENEFORM Protein DME1242 XEOTICID XEO04350 MOACRIVE Inhibition DME1242 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1242 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04354 XEO_CLAS Peptide DME1242 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 35.2 ug/ml) DME1242 XEOTICID XEO04354 GENEFORM Protein DME1242 XEOTICID XEO04354 MOACRIVE Inhibition DME1242 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1242 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04355 XEO_CLAS Peptide DME1242 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5.83 ug/ml) DME1242 XEOTICID XEO04355 GENEFORM Protein DME1242 XEOTICID XEO04355 MOACRIVE Inhibition DME1242 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1242 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04356 XEO_CLAS Peptide DME1242 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.11 ug/ml) DME1242 XEOTICID XEO04356 GENEFORM Protein DME1242 XEOTICID XEO04356 MOACRIVE Inhibition DME1242 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1242 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04357 XEO_CLAS Peptide DME1242 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8.16 ug/ml) DME1242 XEOTICID XEO04357 GENEFORM Protein DME1242 XEOTICID XEO04357 MOACRIVE Inhibition DME1242 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1242 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04358 XEO_CLAS Peptide DME1242 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.68 ug/ml) DME1242 XEOTICID XEO04358 GENEFORM Protein DME1242 XEOTICID XEO04358 MOACRIVE Inhibition DME1242 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1242 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04359 XEO_CLAS Peptide DME1242 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.10 ug/ml) DME1242 XEOTICID XEO04359 GENEFORM Protein DME1242 XEOTICID XEO04359 MOACRIVE Inhibition DME1242 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1242 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04360 XEO_CLAS Peptide DME1242 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.5 ug/ml) DME1242 XEOTICID XEO04360 GENEFORM Protein DME1242 XEOTICID XEO04360 MOACRIVE Inhibition DME1242 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1242 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04361 XEO_CLAS Peptide DME1242 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.8 ug/ml) DME1242 XEOTICID XEO04361 GENEFORM Protein DME1242 XEOTICID XEO04361 MOACRIVE Inhibition DME1242 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1242 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04362 XEO_CLAS Peptide DME1242 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.3 ug/ml) DME1242 XEOTICID XEO04362 GENEFORM Protein DME1242 XEOTICID XEO04362 MOACRIVE Inhibition DME1242 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1242 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04363 XEO_CLAS Peptide DME1242 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.1 ug/ml) DME1242 XEOTICID XEO04363 GENEFORM Protein DME1242 XEOTICID XEO04363 MOACRIVE Inhibition DME1242 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1242 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04364 XEO_CLAS Peptide DME1242 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 microM) DME1242 XEOTICID XEO04364 GENEFORM Protein DME1242 XEOTICID XEO04364 MOACRIVE Inhibition DME1242 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1242 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04365 XEO_CLAS Peptide DME1242 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9.37 ug/ml) DME1242 XEOTICID XEO04365 GENEFORM Protein DME1242 XEOTICID XEO04365 MOACRIVE Inhibition DME1242 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1242 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04366 XEO_CLAS Peptide DME1242 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5.90 ug/ml) DME1242 XEOTICID XEO04366 GENEFORM Protein DME1242 XEOTICID XEO04366 MOACRIVE Inhibition DME1242 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1242 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04367 XEO_CLAS Peptide DME1242 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 17.80 ug/ml) DME1242 XEOTICID XEO04367 GENEFORM Protein DME1242 XEOTICID XEO04367 MOACRIVE Inhibition DME1242 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1242 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04368 XEO_CLAS Peptide DME1242 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 20.1 ug/ml) DME1242 XEOTICID XEO04368 GENEFORM Protein DME1242 XEOTICID XEO04368 MOACRIVE Inhibition DME1242 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1242 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04369 XEO_CLAS Peptide DME1242 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 20.1 ug/ml) DME1242 XEOTICID XEO04369 GENEFORM Protein DME1242 XEOTICID XEO04369 MOACRIVE Inhibition DME1242 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1242 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04370 XEO_CLAS Peptide DME1242 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.68 ug/ml) DME1242 XEOTICID XEO04370 GENEFORM Protein DME1242 XEOTICID XEO04370 MOACRIVE Inhibition DME1242 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1242 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04371 XEO_CLAS Peptide DME1242 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.68 ug/ml) DME1242 XEOTICID XEO04371 GENEFORM Protein DME1242 XEOTICID XEO04371 MOACRIVE Inhibition DME1242 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1242 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04373 XEO_CLAS Peptide DME1242 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9.375 ug/ml) DME1242 XEOTICID XEO04373 GENEFORM Protein DME1242 XEOTICID XEO04373 MOACRIVE Inhibition DME1242 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1242 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04374 XEO_CLAS Peptide DME1242 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.50 ug/ml) DME1242 XEOTICID XEO04374 GENEFORM Protein DME1242 XEOTICID XEO04374 MOACRIVE Inhibition DME1242 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1242 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04375 XEO_CLAS Peptide DME1242 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.12 ug/ml) DME1242 XEOTICID XEO04375 GENEFORM Protein DME1242 XEOTICID XEO04375 MOACRIVE Inhibition DME1242 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1242 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04377 XEO_CLAS Peptide DME1242 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 21.25 ug/ml) DME1242 XEOTICID XEO04377 GENEFORM Protein DME1242 XEOTICID XEO04377 MOACRIVE Inhibition DME1242 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1242 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04378 XEO_CLAS Peptide DME1242 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 35.00 ug/ml) DME1242 XEOTICID XEO04378 GENEFORM Protein DME1242 XEOTICID XEO04378 MOACRIVE Inhibition DME1242 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1242 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04379 XEO_CLAS Peptide DME1242 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 75.00 ug/ml) DME1242 XEOTICID XEO04379 GENEFORM Protein DME1242 XEOTICID XEO04379 MOACRIVE Inhibition DME1242 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1242 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04380 XEO_CLAS Peptide DME1242 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 18.00 ug/ml) DME1242 XEOTICID XEO04380 GENEFORM Protein DME1242 XEOTICID XEO04380 MOACRIVE Inhibition DME1242 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1242 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04381 XEO_CLAS Peptide DME1242 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.30 ug/ml) DME1242 XEOTICID XEO04381 GENEFORM Protein DME1242 XEOTICID XEO04381 MOACRIVE Inhibition DME1242 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1242 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04382 XEO_CLAS Peptide DME1242 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5 ug/ml) DME1242 XEOTICID XEO04382 GENEFORM Protein DME1242 XEOTICID XEO04382 MOACRIVE Inhibition DME1242 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1242 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04383 XEO_CLAS Peptide DME1242 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO04383 GENEFORM Protein DME1242 XEOTICID XEO04383 MOACRIVE Inhibition DME1242 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1242 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04385 XEO_CLAS Peptide DME1242 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.25 ug/ml) DME1242 XEOTICID XEO04385 GENEFORM Protein DME1242 XEOTICID XEO04385 MOACRIVE Inhibition DME1242 XEOTICID XEO04391 XEO_NAME Olive oil DME1242 XEOTICID XEO04391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04391 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04391 DESCRIPT Olive oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04391 GENEFORM Protein DME1242 XEOTICID XEO04391 MOACRIVE Inhibition DME1242 XEOTICID XEO04393 XEO_NAME O-Methyl-D-tyrosine DME1242 XEOTICID XEO04393 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04393 XEO_CLAS Amino Acid DME1242 XEOTICID XEO04393 DESCRIPT O-Methyl-D-tyrosine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04393 GENEFORM Protein DME1242 XEOTICID XEO04393 MOACRIVE Inhibition DME1242 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1242 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04399 XEO_CLAS Peptide DME1242 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 50 microM) DME1242 XEOTICID XEO04399 GENEFORM Protein DME1242 XEOTICID XEO04399 MOACRIVE Inhibition DME1242 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1242 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04400 XEO_CLAS Peptide DME1242 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 ug/ml) DME1242 XEOTICID XEO04400 GENEFORM Protein DME1242 XEOTICID XEO04400 MOACRIVE Inhibition DME1242 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1242 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04401 XEO_CLAS Peptide DME1242 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 ug/ml) DME1242 XEOTICID XEO04401 GENEFORM Protein DME1242 XEOTICID XEO04401 MOACRIVE Inhibition DME1242 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1242 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04402 XEO_CLAS Peptide DME1242 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 ug/ml) DME1242 XEOTICID XEO04402 GENEFORM Protein DME1242 XEOTICID XEO04402 MOACRIVE Inhibition DME1242 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1242 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04403 XEO_CLAS Peptide DME1242 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 ug/ml) DME1242 XEOTICID XEO04403 GENEFORM Protein DME1242 XEOTICID XEO04403 MOACRIVE Inhibition DME1242 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1242 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04404 XEO_CLAS Peptide DME1242 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 ug/ml) DME1242 XEOTICID XEO04404 GENEFORM Protein DME1242 XEOTICID XEO04404 MOACRIVE Inhibition DME1242 XEOTICID XEO04405 XEO_NAME Orancis-protonectin DME1242 XEOTICID XEO04405 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04405 XEO_CLAS Peptide DME1242 XEOTICID XEO04405 DESCRIPT Orancis-protonectin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO04405 GENEFORM Protein DME1242 XEOTICID XEO04405 MOACRIVE Inhibition DME1242 XEOTICID XEO04406 XEO_NAME Oregano oil DME1242 XEOTICID XEO04406 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04406 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04406 DESCRIPT Oregano oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04406 GENEFORM Protein DME1242 XEOTICID XEO04406 MOACRIVE Inhibition DME1242 XEOTICID XEO04407 XEO_NAME Origanum oil DME1242 XEOTICID XEO04407 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04407 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04407 DESCRIPT Origanum oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04407 GENEFORM Protein DME1242 XEOTICID XEO04407 MOACRIVE Inhibition DME1242 XEOTICID XEO04408 XEO_NAME Oryctes rhinoceros defensin DME1242 XEOTICID XEO04408 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04408 XEO_CLAS Peptide DME1242 XEOTICID XEO04408 DESCRIPT Oryctes rhinoceros defensin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04408 GENEFORM Protein DME1242 XEOTICID XEO04408 MOACRIVE Inhibition DME1242 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1242 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04412 XEO_CLAS Peptide DME1242 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.25 ug/ml) DME1242 XEOTICID XEO04412 GENEFORM Protein DME1242 XEOTICID XEO04412 MOACRIVE Inhibition DME1242 XEOTICID XEO04413 XEO_NAME Ostricacin-2 DME1242 XEOTICID XEO04413 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04413 XEO_CLAS Peptide DME1242 XEOTICID XEO04413 DESCRIPT Ostricacin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.25 ug/ml) DME1242 XEOTICID XEO04413 GENEFORM Protein DME1242 XEOTICID XEO04413 MOACRIVE Inhibition DME1242 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1242 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04414 XEO_CLAS Peptide DME1242 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.78 ug/ml) DME1242 XEOTICID XEO04414 GENEFORM Protein DME1242 XEOTICID XEO04414 MOACRIVE Inhibition DME1242 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1242 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04415 XEO_CLAS Peptide DME1242 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11.48 ug/ml) DME1242 XEOTICID XEO04415 GENEFORM Protein DME1242 XEOTICID XEO04415 MOACRIVE Inhibition DME1242 XEOTICID XEO04416 XEO_NAME Ovispirin-1 DME1242 XEOTICID XEO04416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04416 XEO_CLAS Peptide DME1242 XEOTICID XEO04416 DESCRIPT Ovispirin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.0 ug/ml) DME1242 XEOTICID XEO04416 GENEFORM Protein DME1242 XEOTICID XEO04416 MOACRIVE Inhibition DME1242 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1242 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04426 XEO_CLAS Peptide DME1242 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.5 microM) DME1242 XEOTICID XEO04426 GENEFORM Protein DME1242 XEOTICID XEO04426 MOACRIVE Inhibition DME1242 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1242 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04428 XEO_CLAS Peptide DME1242 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 ug/ml) DME1242 XEOTICID XEO04428 GENEFORM Protein DME1242 XEOTICID XEO04428 MOACRIVE Inhibition DME1242 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1242 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04430 XEO_CLAS Peptide DME1242 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.56 microM) DME1242 XEOTICID XEO04430 GENEFORM Protein DME1242 XEOTICID XEO04430 MOACRIVE Inhibition DME1242 XEOTICID XEO04436 XEO_NAME Palmarosa oil DME1242 XEOTICID XEO04436 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04436 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04436 DESCRIPT Palmarosa oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04436 GENEFORM Protein DME1242 XEOTICID XEO04436 MOACRIVE Inhibition DME1242 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1242 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04444 XEO_CLAS Peptide DME1242 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 20 microM) DME1242 XEOTICID XEO04444 GENEFORM Protein DME1242 XEOTICID XEO04444 MOACRIVE Inhibition DME1242 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1242 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04448 XEO_CLAS Peptide DME1242 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 100 microM) DME1242 XEOTICID XEO04448 GENEFORM Protein DME1242 XEOTICID XEO04448 MOACRIVE Inhibition DME1242 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1242 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04449 XEO_CLAS Peptide DME1242 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.3 microM) DME1242 XEOTICID XEO04449 GENEFORM Protein DME1242 XEOTICID XEO04449 MOACRIVE Inhibition DME1242 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1242 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04450 XEO_CLAS Peptide DME1242 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.6 microM) DME1242 XEOTICID XEO04450 GENEFORM Protein DME1242 XEOTICID XEO04450 MOACRIVE Inhibition DME1242 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1242 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04451 XEO_CLAS Peptide DME1242 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.1 microM) DME1242 XEOTICID XEO04451 GENEFORM Protein DME1242 XEOTICID XEO04451 MOACRIVE Inhibition DME1242 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1242 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04452 XEO_CLAS Peptide DME1242 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.3 microM) DME1242 XEOTICID XEO04452 GENEFORM Protein DME1242 XEOTICID XEO04452 MOACRIVE Inhibition DME1242 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1242 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04453 XEO_CLAS Peptide DME1242 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.1 microM) DME1242 XEOTICID XEO04453 GENEFORM Protein DME1242 XEOTICID XEO04453 MOACRIVE Inhibition DME1242 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1242 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04455 XEO_CLAS Peptide DME1242 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 microM) DME1242 XEOTICID XEO04455 GENEFORM Protein DME1242 XEOTICID XEO04455 MOACRIVE Inhibition DME1242 XEOTICID XEO04456 XEO_NAME Palustrin-2LTa DME1242 XEOTICID XEO04456 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04456 XEO_CLAS Peptide DME1242 XEOTICID XEO04456 DESCRIPT Palustrin-2LTa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.7 microM) DME1242 XEOTICID XEO04456 GENEFORM Protein DME1242 XEOTICID XEO04456 MOACRIVE Inhibition DME1242 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1242 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04457 XEO_CLAS Peptide DME1242 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.3 microM) DME1242 XEOTICID XEO04457 GENEFORM Protein DME1242 XEOTICID XEO04457 MOACRIVE Inhibition DME1242 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1242 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04461 XEO_CLAS Peptide DME1242 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.6 microM) DME1242 XEOTICID XEO04461 GENEFORM Protein DME1242 XEOTICID XEO04461 MOACRIVE Inhibition DME1242 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1242 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04462 XEO_CLAS Peptide DME1242 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.4 microM) DME1242 XEOTICID XEO04462 GENEFORM Protein DME1242 XEOTICID XEO04462 MOACRIVE Inhibition DME1242 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1242 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04463 XEO_CLAS Peptide DME1242 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04463 GENEFORM Protein DME1242 XEOTICID XEO04463 MOACRIVE Inhibition DME1242 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1242 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04467 XEO_CLAS Peptide DME1242 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.46 microM) DME1242 XEOTICID XEO04467 GENEFORM Protein DME1242 XEOTICID XEO04467 MOACRIVE Inhibition DME1242 XEOTICID XEO04468 XEO_NAME Papillosin DME1242 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04468 XEO_CLAS Peptide DME1242 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04468 GENEFORM Protein DME1242 XEOTICID XEO04468 MOACRIVE Inhibition DME1242 XEOTICID XEO04476 XEO_NAME Parsley seed oil DME1242 XEOTICID XEO04476 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04476 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04476 DESCRIPT Parsley seed oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04476 GENEFORM Protein DME1242 XEOTICID XEO04476 MOACRIVE Inhibition DME1242 XEOTICID XEO04477 XEO_NAME Patchouli oil DME1242 XEOTICID XEO04477 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04477 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04477 DESCRIPT Patchouli oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04477 GENEFORM Protein DME1242 XEOTICID XEO04477 MOACRIVE Inhibition DME1242 XEOTICID XEO04479 XEO_NAME Porcine beta-defensin pBD-1 DME1242 XEOTICID XEO04479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04479 XEO_CLAS Peptide DME1242 XEOTICID XEO04479 DESCRIPT Porcine beta-defensin pBD-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04479 GENEFORM Protein DME1242 XEOTICID XEO04479 MOACRIVE Inhibition DME1242 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1242 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04480 XEO_CLAS Peptide DME1242 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 80 ug/ml) DME1242 XEOTICID XEO04480 GENEFORM Protein DME1242 XEOTICID XEO04480 MOACRIVE Inhibition DME1242 XEOTICID XEO04483 XEO_NAME Beta-casein PDC213(213-224) DME1242 XEOTICID XEO04483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04483 XEO_CLAS Peptide DME1242 XEOTICID XEO04483 DESCRIPT Beta-casein PDC213(213-224) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04483 GENEFORM Protein DME1242 XEOTICID XEO04483 MOACRIVE Inhibition DME1242 XEOTICID XEO04503 XEO_NAME Defensin-like AMP pelovaterin DME1242 XEOTICID XEO04503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04503 XEO_CLAS Peptide DME1242 XEOTICID XEO04503 DESCRIPT Defensin-like AMP pelovaterin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04503 GENEFORM Protein DME1242 XEOTICID XEO04503 MOACRIVE Inhibition DME1242 XEOTICID XEO04512 XEO_NAME Penicillenol A1 DME1242 XEOTICID XEO04512 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04512 XEO_CLAS Natural Product DME1242 XEOTICID XEO04512 DESCRIPT Penicillenol A1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04512 GENEFORM Protein DME1242 XEOTICID XEO04512 MOACRIVE Inhibition DME1242 XEOTICID XEO04513 XEO_NAME Penicillenol A2 DME1242 XEOTICID XEO04513 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04513 XEO_CLAS Natural Product DME1242 XEOTICID XEO04513 DESCRIPT Penicillenol A2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04513 GENEFORM Protein DME1242 XEOTICID XEO04513 MOACRIVE Inhibition DME1242 XEOTICID XEO04514 XEO_NAME Penicillenol B1 DME1242 XEOTICID XEO04514 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04514 XEO_CLAS Natural Product DME1242 XEOTICID XEO04514 DESCRIPT Penicillenol B1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04514 GENEFORM Protein DME1242 XEOTICID XEO04514 MOACRIVE Inhibition DME1242 XEOTICID XEO04515 XEO_NAME Penicillenol B2 DME1242 XEOTICID XEO04515 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04515 XEO_CLAS Natural Product DME1242 XEOTICID XEO04515 DESCRIPT Penicillenol B2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04515 GENEFORM Protein DME1242 XEOTICID XEO04515 MOACRIVE Inhibition DME1242 XEOTICID XEO04516 XEO_NAME Penicillenol C1 DME1242 XEOTICID XEO04516 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04516 XEO_CLAS Natural Product DME1242 XEOTICID XEO04516 DESCRIPT Penicillenol C1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04516 GENEFORM Protein DME1242 XEOTICID XEO04516 MOACRIVE Inhibition DME1242 XEOTICID XEO04517 XEO_NAME Penicillenol C2 DME1242 XEOTICID XEO04517 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04517 XEO_CLAS Natural Product DME1242 XEOTICID XEO04517 DESCRIPT Penicillenol C2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04517 GENEFORM Protein DME1242 XEOTICID XEO04517 MOACRIVE Inhibition DME1242 XEOTICID XEO04522 XEO_NAME Pentagalloylglucose DME1242 XEOTICID XEO04522 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO04522 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO04522 DESCRIPT Pentagalloylglucose inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04522 GENEFORM Protein DME1242 XEOTICID XEO04522 MOACRIVE Inhibition DME1242 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1242 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04525 XEO_CLAS Peptide DME1242 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 64.0 microM) DME1242 XEOTICID XEO04525 GENEFORM Protein DME1242 XEOTICID XEO04525 MOACRIVE Inhibition DME1242 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1242 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04526 XEO_CLAS Peptide DME1242 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.0 microM) DME1242 XEOTICID XEO04526 GENEFORM Protein DME1242 XEOTICID XEO04526 MOACRIVE Inhibition DME1242 XEOTICID XEO04531 XEO_NAME Mollusca/molluscs/mollusks peptide 2 DME1242 XEOTICID XEO04531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04531 XEO_CLAS Peptide DME1242 XEOTICID XEO04531 DESCRIPT Mollusca/molluscs/mollusks peptide 2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04531 GENEFORM Protein DME1242 XEOTICID XEO04531 MOACRIVE Inhibition DME1242 XEOTICID XEO04533 XEO_NAME Mollusca/molluscs/mollusks peptide 3 DME1242 XEOTICID XEO04533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04533 XEO_CLAS Peptide DME1242 XEOTICID XEO04533 DESCRIPT Mollusca/molluscs/mollusks peptide 3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04533 GENEFORM Protein DME1242 XEOTICID XEO04533 MOACRIVE Inhibition DME1242 XEOTICID XEO04534 XEO_NAME Mollusca/molluscs/mollusks peptide 4 DME1242 XEOTICID XEO04534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04534 XEO_CLAS Peptide DME1242 XEOTICID XEO04534 DESCRIPT Mollusca/molluscs/mollusks peptide 4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04534 GENEFORM Protein DME1242 XEOTICID XEO04534 MOACRIVE Inhibition DME1242 XEOTICID XEO04535 XEO_NAME Mollusca/molluscs/mollusks peptide 5 DME1242 XEOTICID XEO04535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04535 XEO_CLAS Peptide DME1242 XEOTICID XEO04535 DESCRIPT Mollusca/molluscs/mollusks peptide 5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04535 GENEFORM Protein DME1242 XEOTICID XEO04535 MOACRIVE Inhibition DME1242 XEOTICID XEO04536 XEO_NAME Mollusca/molluscs/mollusks peptide 6 DME1242 XEOTICID XEO04536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04536 XEO_CLAS Peptide DME1242 XEOTICID XEO04536 DESCRIPT Mollusca/molluscs/mollusks peptide 6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04536 GENEFORM Protein DME1242 XEOTICID XEO04536 MOACRIVE Inhibition DME1242 XEOTICID XEO04537 XEO_NAME Mollusca/molluscs/mollusks peptide 7 DME1242 XEOTICID XEO04537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04537 XEO_CLAS Peptide DME1242 XEOTICID XEO04537 DESCRIPT Mollusca/molluscs/mollusks peptide 7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04537 GENEFORM Protein DME1242 XEOTICID XEO04537 MOACRIVE Inhibition DME1242 XEOTICID XEO04538 XEO_NAME Mollusca/molluscs/mollusks peptide 8 DME1242 XEOTICID XEO04538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04538 XEO_CLAS Peptide DME1242 XEOTICID XEO04538 DESCRIPT Mollusca/molluscs/mollusks peptide 8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04538 GENEFORM Protein DME1242 XEOTICID XEO04538 MOACRIVE Inhibition DME1242 XEOTICID XEO04539 XEO_NAME Mollusca/molluscs/mollusks peptide 9 DME1242 XEOTICID XEO04539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04539 XEO_CLAS Peptide DME1242 XEOTICID XEO04539 DESCRIPT Mollusca/molluscs/mollusks peptide 9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04539 GENEFORM Protein DME1242 XEOTICID XEO04539 MOACRIVE Inhibition DME1242 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1242 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04540 XEO_CLAS Peptide DME1242 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO04540 GENEFORM Protein DME1242 XEOTICID XEO04540 MOACRIVE Inhibition DME1242 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1242 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04541 XEO_CLAS Peptide DME1242 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.6 ug/ml) DME1242 XEOTICID XEO04541 GENEFORM Protein DME1242 XEOTICID XEO04541 MOACRIVE Inhibition DME1242 XEOTICID XEO04546 XEO_NAME Perinerin DME1242 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04546 XEO_CLAS Peptide DME1242 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04546 GENEFORM Protein DME1242 XEOTICID XEO04546 MOACRIVE Inhibition DME1242 XEOTICID XEO04547 XEO_NAME Petitgrain oil DME1242 XEOTICID XEO04547 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04547 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04547 DESCRIPT Petitgrain oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04547 GENEFORM Protein DME1242 XEOTICID XEO04547 MOACRIVE Inhibition DME1242 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1242 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04549 XEO_CLAS Peptide DME1242 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 125-500 ug/ml) DME1242 XEOTICID XEO04549 GENEFORM Protein DME1242 XEOTICID XEO04549 MOACRIVE Inhibition DME1242 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1242 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04551 XEO_CLAS Peptide DME1242 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 67.8 ug/ml) DME1242 XEOTICID XEO04551 GENEFORM Protein DME1242 XEOTICID XEO04551 MOACRIVE Inhibition DME1242 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1242 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04552 XEO_CLAS Peptide DME1242 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04552 GENEFORM Protein DME1242 XEOTICID XEO04552 MOACRIVE Inhibition DME1242 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1242 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04553 XEO_CLAS Peptide DME1242 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04553 GENEFORM Protein DME1242 XEOTICID XEO04553 MOACRIVE Inhibition DME1242 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1242 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04554 XEO_CLAS Peptide DME1242 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04554 GENEFORM Protein DME1242 XEOTICID XEO04554 MOACRIVE Inhibition DME1242 XEOTICID XEO04560 XEO_NAME Phlebotomus duboscqi defensin DME1242 XEOTICID XEO04560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04560 XEO_CLAS Peptide DME1242 XEOTICID XEO04560 DESCRIPT Phlebotomus duboscqi defensin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.78-1.56 microM) DME1242 XEOTICID XEO04560 GENEFORM Protein DME1242 XEOTICID XEO04560 MOACRIVE Inhibition DME1242 XEOTICID XEO04564 XEO_NAME Phosphorylserine DME1242 XEOTICID XEO04564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04564 XEO_CLAS Amino Acid DME1242 XEOTICID XEO04564 DESCRIPT Phosphorylserine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04564 GENEFORM Protein DME1242 XEOTICID XEO04564 MOACRIVE Inhibition DME1242 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1242 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04565 XEO_CLAS Peptide DME1242 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.6 microM) DME1242 XEOTICID XEO04565 GENEFORM Protein DME1242 XEOTICID XEO04565 MOACRIVE Inhibition DME1242 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1242 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04566 XEO_CLAS Peptide DME1242 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.7 microM) DME1242 XEOTICID XEO04566 GENEFORM Protein DME1242 XEOTICID XEO04566 MOACRIVE Inhibition DME1242 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1242 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04569 XEO_CLAS Peptide DME1242 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7.9 microM) DME1242 XEOTICID XEO04569 GENEFORM Protein DME1242 XEOTICID XEO04569 MOACRIVE Inhibition DME1242 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1242 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04573 XEO_CLAS Peptide DME1242 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.6 microM) DME1242 XEOTICID XEO04573 GENEFORM Protein DME1242 XEOTICID XEO04573 MOACRIVE Inhibition DME1242 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1242 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04601 XEO_CLAS Peptide DME1242 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9.38 ug/ml) DME1242 XEOTICID XEO04601 GENEFORM Protein DME1242 XEOTICID XEO04601 MOACRIVE Inhibition DME1242 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1242 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04602 XEO_CLAS Peptide DME1242 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9.38 ug/ml) DME1242 XEOTICID XEO04602 GENEFORM Protein DME1242 XEOTICID XEO04602 MOACRIVE Inhibition DME1242 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1242 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04605 XEO_CLAS Peptide DME1242 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC < 6.25 microM) DME1242 XEOTICID XEO04605 GENEFORM Protein DME1242 XEOTICID XEO04605 MOACRIVE Inhibition DME1242 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1242 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04607 GENEFORM Protein DME1242 XEOTICID XEO04607 MOACRIVE Inhibition DME1242 XEOTICID XEO04608 XEO_NAME Pine needle oil DME1242 XEOTICID XEO04608 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04608 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04608 DESCRIPT Pine needle oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04608 GENEFORM Protein DME1242 XEOTICID XEO04608 MOACRIVE Inhibition DME1242 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1242 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04612 XEO_CLAS Peptide DME1242 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.25-2.5 microM) DME1242 XEOTICID XEO04612 GENEFORM Protein DME1242 XEOTICID XEO04612 MOACRIVE Inhibition DME1242 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1242 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04613 XEO_CLAS Peptide DME1242 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.25-2.5 microM) DME1242 XEOTICID XEO04613 GENEFORM Protein DME1242 XEOTICID XEO04613 MOACRIVE Inhibition DME1242 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1242 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04625 XEO_CLAS Peptide DME1242 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO04625 GENEFORM Protein DME1242 XEOTICID XEO04625 MOACRIVE Inhibition DME1242 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1242 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04626 XEO_CLAS Peptide DME1242 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50.5 microM) DME1242 XEOTICID XEO04626 GENEFORM Protein DME1242 XEOTICID XEO04626 MOACRIVE Inhibition DME1242 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1242 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04627 XEO_CLAS Peptide DME1242 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.5 microM) DME1242 XEOTICID XEO04627 GENEFORM Protein DME1242 XEOTICID XEO04627 MOACRIVE Inhibition DME1242 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1242 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04630 XEO_CLAS Peptide DME1242 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 ug/ml) DME1242 XEOTICID XEO04630 GENEFORM Protein DME1242 XEOTICID XEO04630 MOACRIVE Inhibition DME1242 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1242 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04631 XEO_CLAS Peptide DME1242 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 ug/ml) DME1242 XEOTICID XEO04631 GENEFORM Protein DME1242 XEOTICID XEO04631 MOACRIVE Inhibition DME1242 XEOTICID XEO04632 XEO_NAME Pleurain-B1 DME1242 XEOTICID XEO04632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04632 XEO_CLAS Peptide DME1242 XEOTICID XEO04632 DESCRIPT Pleurain-B1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.1 ug/ml) DME1242 XEOTICID XEO04632 GENEFORM Protein DME1242 XEOTICID XEO04632 MOACRIVE Inhibition DME1242 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1242 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04633 XEO_CLAS Peptide DME1242 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.3 ug/ml) DME1242 XEOTICID XEO04633 GENEFORM Protein DME1242 XEOTICID XEO04633 MOACRIVE Inhibition DME1242 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1242 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04634 XEO_CLAS Peptide DME1242 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 ug/ml) DME1242 XEOTICID XEO04634 GENEFORM Protein DME1242 XEOTICID XEO04634 MOACRIVE Inhibition DME1242 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1242 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04635 XEO_CLAS Peptide DME1242 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6..3 ug/ml) DME1242 XEOTICID XEO04635 GENEFORM Protein DME1242 XEOTICID XEO04635 MOACRIVE Inhibition DME1242 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1242 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04636 XEO_CLAS Peptide DME1242 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 ug/ml) DME1242 XEOTICID XEO04636 GENEFORM Protein DME1242 XEOTICID XEO04636 MOACRIVE Inhibition DME1242 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1242 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04637 XEO_CLAS Peptide DME1242 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 ug/ml) DME1242 XEOTICID XEO04637 GENEFORM Protein DME1242 XEOTICID XEO04637 MOACRIVE Inhibition DME1242 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1242 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04638 XEO_CLAS Peptide DME1242 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 ug/ml) DME1242 XEOTICID XEO04638 GENEFORM Protein DME1242 XEOTICID XEO04638 MOACRIVE Inhibition DME1242 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1242 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04639 XEO_CLAS Peptide DME1242 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO04639 GENEFORM Protein DME1242 XEOTICID XEO04639 MOACRIVE Inhibition DME1242 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1242 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04640 XEO_CLAS Peptide DME1242 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 17.7-35.0 microM) DME1242 XEOTICID XEO04640 GENEFORM Protein DME1242 XEOTICID XEO04640 MOACRIVE Inhibition DME1242 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1242 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04642 XEO_CLAS Peptide DME1242 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 64 ug/ml) DME1242 XEOTICID XEO04642 GENEFORM Protein DME1242 XEOTICID XEO04642 MOACRIVE Inhibition DME1242 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1242 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04643 XEO_CLAS Peptide DME1242 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO04643 GENEFORM Protein DME1242 XEOTICID XEO04643 MOACRIVE Inhibition DME1242 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1242 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04644 XEO_CLAS Peptide DME1242 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 ug/ml) DME1242 XEOTICID XEO04644 GENEFORM Protein DME1242 XEOTICID XEO04644 MOACRIVE Inhibition DME1242 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1242 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04645 XEO_CLAS Peptide DME1242 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 64 ug/ml) DME1242 XEOTICID XEO04645 GENEFORM Protein DME1242 XEOTICID XEO04645 MOACRIVE Inhibition DME1242 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1242 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04646 XEO_CLAS Peptide DME1242 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO04646 GENEFORM Protein DME1242 XEOTICID XEO04646 MOACRIVE Inhibition DME1242 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1242 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04647 XEO_CLAS Peptide DME1242 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 ug/ml) DME1242 XEOTICID XEO04647 GENEFORM Protein DME1242 XEOTICID XEO04647 MOACRIVE Inhibition DME1242 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1242 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04648 XEO_CLAS Peptide DME1242 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO04648 GENEFORM Protein DME1242 XEOTICID XEO04648 MOACRIVE Inhibition DME1242 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1242 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04649 XEO_CLAS Peptide DME1242 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 64 ug/ml) DME1242 XEOTICID XEO04649 GENEFORM Protein DME1242 XEOTICID XEO04649 MOACRIVE Inhibition DME1242 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1242 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04650 XEO_CLAS Peptide DME1242 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO04650 GENEFORM Protein DME1242 XEOTICID XEO04650 MOACRIVE Inhibition DME1242 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1242 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04651 XEO_CLAS Peptide DME1242 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 32 ug/ml) DME1242 XEOTICID XEO04651 GENEFORM Protein DME1242 XEOTICID XEO04651 MOACRIVE Inhibition DME1242 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1242 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04652 XEO_CLAS Peptide DME1242 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 32 ug/ml) DME1242 XEOTICID XEO04652 GENEFORM Protein DME1242 XEOTICID XEO04652 MOACRIVE Inhibition DME1242 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1242 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04653 XEO_CLAS Peptide DME1242 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 64 ug/ml) DME1242 XEOTICID XEO04653 GENEFORM Protein DME1242 XEOTICID XEO04653 MOACRIVE Inhibition DME1242 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1242 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04654 XEO_CLAS Peptide DME1242 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 64 ug/ml) DME1242 XEOTICID XEO04654 GENEFORM Protein DME1242 XEOTICID XEO04654 MOACRIVE Inhibition DME1242 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1242 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04655 XEO_CLAS Peptide DME1242 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 64 ug/ml) DME1242 XEOTICID XEO04655 GENEFORM Protein DME1242 XEOTICID XEO04655 MOACRIVE Inhibition DME1242 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1242 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04657 XEO_CLAS Peptide DME1242 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 300 microM) DME1242 XEOTICID XEO04657 GENEFORM Protein DME1242 XEOTICID XEO04657 MOACRIVE Inhibition DME1242 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1242 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04660 XEO_CLAS Peptide DME1242 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 32 ug/ml) DME1242 XEOTICID XEO04660 GENEFORM Protein DME1242 XEOTICID XEO04660 MOACRIVE Inhibition DME1242 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1242 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04661 XEO_CLAS Peptide DME1242 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO04661 GENEFORM Protein DME1242 XEOTICID XEO04661 MOACRIVE Inhibition DME1242 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1242 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04662 XEO_CLAS Peptide DME1242 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 microM) DME1242 XEOTICID XEO04662 GENEFORM Protein DME1242 XEOTICID XEO04662 MOACRIVE Inhibition DME1242 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1242 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04663 XEO_CLAS Peptide DME1242 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO04663 GENEFORM Protein DME1242 XEOTICID XEO04663 MOACRIVE Inhibition DME1242 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1242 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04680 XEO_CLAS Peptide DME1242 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.5 microM) DME1242 XEOTICID XEO04680 GENEFORM Protein DME1242 XEOTICID XEO04680 MOACRIVE Inhibition DME1242 XEOTICID XEO04681 XEO_NAME Polybia chemotactic peptide polybia-CP DME1242 XEOTICID XEO04681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04681 XEO_CLAS Peptide DME1242 XEOTICID XEO04681 DESCRIPT Polybia chemotactic peptide polybia-CP inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 ug/ml) DME1242 XEOTICID XEO04681 GENEFORM Protein DME1242 XEOTICID XEO04681 MOACRIVE Inhibition DME1242 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1242 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04682 XEO_CLAS Peptide DME1242 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9 microM) DME1242 XEOTICID XEO04682 GENEFORM Protein DME1242 XEOTICID XEO04682 MOACRIVE Inhibition DME1242 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1242 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04683 XEO_CLAS Peptide DME1242 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO04683 GENEFORM Protein DME1242 XEOTICID XEO04683 MOACRIVE Inhibition DME1242 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1242 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04684 XEO_CLAS Peptide DME1242 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 19 microM) DME1242 XEOTICID XEO04684 GENEFORM Protein DME1242 XEOTICID XEO04684 MOACRIVE Inhibition DME1242 XEOTICID XEO04686 XEO_NAME Polyethyleneimine DME1242 XEOTICID XEO04686 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1242 XEOTICID XEO04686 XEO_CLAS Chemical Compound DME1242 XEOTICID XEO04686 DESCRIPT Polyethyleneimine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04686 GENEFORM Protein DME1242 XEOTICID XEO04686 MOACRIVE Inhibition DME1242 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1242 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04690 XEO_CLAS Peptide DME1242 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO04690 GENEFORM Protein DME1242 XEOTICID XEO04690 MOACRIVE Inhibition DME1242 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1242 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04695 XEO_CLAS Peptide DME1242 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04695 GENEFORM Protein DME1242 XEOTICID XEO04695 MOACRIVE Inhibition DME1242 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1242 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04696 XEO_CLAS Peptide DME1242 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04696 GENEFORM Protein DME1242 XEOTICID XEO04696 MOACRIVE Inhibition DME1242 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1242 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04698 XEO_CLAS Peptide DME1242 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04698 GENEFORM Protein DME1242 XEOTICID XEO04698 MOACRIVE Inhibition DME1242 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1242 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04699 XEO_CLAS Peptide DME1242 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04699 GENEFORM Protein DME1242 XEOTICID XEO04699 MOACRIVE Inhibition DME1242 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1242 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04700 XEO_CLAS Peptide DME1242 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04700 GENEFORM Protein DME1242 XEOTICID XEO04700 MOACRIVE Inhibition DME1242 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1242 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04701 XEO_CLAS Peptide DME1242 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04701 GENEFORM Protein DME1242 XEOTICID XEO04701 MOACRIVE Inhibition DME1242 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1242 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04702 XEO_CLAS Peptide DME1242 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04702 GENEFORM Protein DME1242 XEOTICID XEO04702 MOACRIVE Inhibition DME1242 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1242 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04703 XEO_CLAS Peptide DME1242 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04703 GENEFORM Protein DME1242 XEOTICID XEO04703 MOACRIVE Inhibition DME1242 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1242 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04704 XEO_CLAS Peptide DME1242 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04704 GENEFORM Protein DME1242 XEOTICID XEO04704 MOACRIVE Inhibition DME1242 XEOTICID XEO04707 XEO_NAME Pore-forming peptide ameobapore A DME1242 XEOTICID XEO04707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04707 XEO_CLAS Peptide DME1242 XEOTICID XEO04707 DESCRIPT Pore-forming peptide ameobapore A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 15 microM) DME1242 XEOTICID XEO04707 GENEFORM Protein DME1242 XEOTICID XEO04707 MOACRIVE Inhibition DME1242 XEOTICID XEO04710 XEO_NAME Povidone Iodine DME1242 XEOTICID XEO04710 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO04710 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO04710 DESCRIPT Povidone Iodine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04710 GENEFORM Protein DME1242 XEOTICID XEO04710 MOACRIVE Inhibition DME1242 XEOTICID XEO04711 XEO_NAME Insect PP102 peptide DME1242 XEOTICID XEO04711 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04711 XEO_CLAS Peptide DME1242 XEOTICID XEO04711 DESCRIPT Insect PP102 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 13.3 microM) DME1242 XEOTICID XEO04711 GENEFORM Protein DME1242 XEOTICID XEO04711 MOACRIVE Inhibition DME1242 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1242 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04712 XEO_CLAS Peptide DME1242 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 13 microM) DME1242 XEOTICID XEO04712 GENEFORM Protein DME1242 XEOTICID XEO04712 MOACRIVE Inhibition DME1242 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1242 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04713 XEO_CLAS Peptide DME1242 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 23.3 microM) DME1242 XEOTICID XEO04713 GENEFORM Protein DME1242 XEOTICID XEO04713 MOACRIVE Inhibition DME1242 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1242 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04714 XEO_CLAS Peptide DME1242 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 133.3 microM) DME1242 XEOTICID XEO04714 GENEFORM Protein DME1242 XEOTICID XEO04714 MOACRIVE Inhibition DME1242 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1242 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04716 XEO_CLAS Peptide DME1242 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.5 microM) DME1242 XEOTICID XEO04716 GENEFORM Protein DME1242 XEOTICID XEO04716 MOACRIVE Inhibition DME1242 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1242 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04717 XEO_CLAS Peptide DME1242 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 microM) DME1242 XEOTICID XEO04717 GENEFORM Protein DME1242 XEOTICID XEO04717 MOACRIVE Inhibition DME1242 XEOTICID XEO04721 XEO_NAME Prolificin A DME1242 XEOTICID XEO04721 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO04721 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO04721 DESCRIPT Prolificin A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04721 GENEFORM Protein DME1242 XEOTICID XEO04721 MOACRIVE Inhibition DME1242 XEOTICID XEO04727 XEO_NAME Propyl gallate DME1242 XEOTICID XEO04727 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1242 XEOTICID XEO04727 XEO_CLAS Food Additive DME1242 XEOTICID XEO04727 DESCRIPT Propyl gallate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04727 GENEFORM Protein DME1242 XEOTICID XEO04727 MOACRIVE Inhibition DME1242 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1242 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04731 XEO_CLAS Peptide DME1242 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 64 ug/ml) DME1242 XEOTICID XEO04731 GENEFORM Protein DME1242 XEOTICID XEO04731 MOACRIVE Inhibition DME1242 XEOTICID XEO04737 XEO_NAME Protonectin DME1242 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04737 XEO_CLAS Peptide DME1242 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 ug/ml) DME1242 XEOTICID XEO04737 GENEFORM Protein DME1242 XEOTICID XEO04737 MOACRIVE Inhibition DME1242 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1242 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04739 XEO_CLAS Peptide DME1242 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04739 GENEFORM Protein DME1242 XEOTICID XEO04739 MOACRIVE Inhibition DME1242 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1242 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04740 XEO_CLAS Peptide DME1242 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04740 GENEFORM Protein DME1242 XEOTICID XEO04740 MOACRIVE Inhibition DME1242 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1242 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04741 XEO_CLAS Peptide DME1242 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04741 GENEFORM Protein DME1242 XEOTICID XEO04741 MOACRIVE Inhibition DME1242 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1242 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04742 XEO_CLAS Peptide DME1242 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04742 GENEFORM Protein DME1242 XEOTICID XEO04742 MOACRIVE Inhibition DME1242 XEOTICID XEO04759 XEO_NAME Anti-lipopolysaccharide factor PtALF6 DME1242 XEOTICID XEO04759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04759 XEO_CLAS Peptide DME1242 XEOTICID XEO04759 DESCRIPT Anti-lipopolysaccharide factor PtALF6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 9.32-18.64 microM) DME1242 XEOTICID XEO04759 GENEFORM Protein DME1242 XEOTICID XEO04759 MOACRIVE Inhibition DME1242 XEOTICID XEO04760 XEO_NAME Anti-lipopolysaccharide factor PtALF7 DME1242 XEOTICID XEO04760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04760 XEO_CLAS Peptide DME1242 XEOTICID XEO04760 DESCRIPT Anti-lipopolysaccharide factor PtALF7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8.15-16.30 microM) DME1242 XEOTICID XEO04760 GENEFORM Protein DME1242 XEOTICID XEO04760 MOACRIVE Inhibition DME1242 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1242 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04762 XEO_CLAS Peptide DME1242 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 25 microM) DME1242 XEOTICID XEO04762 GENEFORM Protein DME1242 XEOTICID XEO04762 MOACRIVE Inhibition DME1242 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1242 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04767 XEO_CLAS Peptide DME1242 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.1 ug/ml) DME1242 XEOTICID XEO04767 GENEFORM Protein DME1242 XEOTICID XEO04767 MOACRIVE Inhibition DME1242 XEOTICID XEO04768 XEO_NAME Pyrimidinedione DME1242 XEOTICID XEO04768 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO04768 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO04768 DESCRIPT Pyrimidinedione inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04768 GENEFORM Protein DME1242 XEOTICID XEO04768 MOACRIVE Inhibition DME1242 XEOTICID XEO04773 XEO_NAME Quercetin Dihydrate DME1242 XEOTICID XEO04773 XEO_TYPE Health or Environmental Toxicant(s) DME1242 XEOTICID XEO04773 XEO_CLAS Acute Toxic Substance DME1242 XEOTICID XEO04773 DESCRIPT Quercetin Dihydrate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04773 GENEFORM Protein DME1242 XEOTICID XEO04773 MOACRIVE Inhibition DME1242 XEOTICID XEO04774 XEO_NAME Quercetin-3-O-glucuronide DME1242 XEOTICID XEO04774 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04774 XEO_CLAS Natural Product DME1242 XEOTICID XEO04774 DESCRIPT Quercetin-3-O-glucuronide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04774 GENEFORM Protein DME1242 XEOTICID XEO04774 MOACRIVE Inhibition DME1242 XEOTICID XEO04778 XEO_NAME Synercid DME1242 XEOTICID XEO04778 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO04778 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO04778 DESCRIPT Synercid inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04778 GENEFORM Protein DME1242 XEOTICID XEO04778 MOACRIVE Inhibition DME1242 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1242 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04782 XEO_CLAS Peptide DME1242 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 ug/ml) DME1242 XEOTICID XEO04782 GENEFORM Protein DME1242 XEOTICID XEO04782 MOACRIVE Inhibition DME1242 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1242 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04783 XEO_CLAS Peptide DME1242 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO04783 GENEFORM Protein DME1242 XEOTICID XEO04783 MOACRIVE Inhibition DME1242 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1242 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04784 XEO_CLAS Peptide DME1242 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO04784 GENEFORM Protein DME1242 XEOTICID XEO04784 MOACRIVE Inhibition DME1242 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1242 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04785 XEO_CLAS Peptide DME1242 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO04785 GENEFORM Protein DME1242 XEOTICID XEO04785 MOACRIVE Inhibition DME1242 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1242 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04786 XEO_CLAS Peptide DME1242 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 63 ug/ml) DME1242 XEOTICID XEO04786 GENEFORM Protein DME1242 XEOTICID XEO04786 MOACRIVE Inhibition DME1242 XEOTICID XEO04788 XEO_NAME Ranacyclin B3 DME1242 XEOTICID XEO04788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04788 XEO_CLAS Peptide DME1242 XEOTICID XEO04788 DESCRIPT Ranacyclin B3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11.7 microM) DME1242 XEOTICID XEO04788 GENEFORM Protein DME1242 XEOTICID XEO04788 MOACRIVE Inhibition DME1242 XEOTICID XEO04789 XEO_NAME Ranacyclin B5 DME1242 XEOTICID XEO04789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04789 XEO_CLAS Peptide DME1242 XEOTICID XEO04789 DESCRIPT Ranacyclin B5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5.8 microM) DME1242 XEOTICID XEO04789 GENEFORM Protein DME1242 XEOTICID XEO04789 MOACRIVE Inhibition DME1242 XEOTICID XEO04790 XEO_NAME Ranacyclin-B-AL1 DME1242 XEOTICID XEO04790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04790 XEO_CLAS Peptide DME1242 XEOTICID XEO04790 DESCRIPT Ranacyclin-B-AL1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 51 microM) DME1242 XEOTICID XEO04790 GENEFORM Protein DME1242 XEOTICID XEO04790 MOACRIVE Inhibition DME1242 XEOTICID XEO04791 XEO_NAME Ranacyclin-B-LK1 DME1242 XEOTICID XEO04791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04791 XEO_CLAS Peptide DME1242 XEOTICID XEO04791 DESCRIPT Ranacyclin-B-LK1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 23 microM) DME1242 XEOTICID XEO04791 GENEFORM Protein DME1242 XEOTICID XEO04791 MOACRIVE Inhibition DME1242 XEOTICID XEO04792 XEO_NAME Ranacyclin-B-LK2 DME1242 XEOTICID XEO04792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04792 XEO_CLAS Peptide DME1242 XEOTICID XEO04792 DESCRIPT Ranacyclin-B-LK2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11.8 microM) DME1242 XEOTICID XEO04792 GENEFORM Protein DME1242 XEOTICID XEO04792 MOACRIVE Inhibition DME1242 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1242 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04793 XEO_CLAS Peptide DME1242 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5.8 microM) DME1242 XEOTICID XEO04793 GENEFORM Protein DME1242 XEOTICID XEO04793 MOACRIVE Inhibition DME1242 XEOTICID XEO04794 XEO_NAME Ranacyclin-B-RN1 DME1242 XEOTICID XEO04794 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04794 XEO_CLAS Peptide DME1242 XEOTICID XEO04794 DESCRIPT Ranacyclin-B-RN1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO04794 GENEFORM Protein DME1242 XEOTICID XEO04794 MOACRIVE Inhibition DME1242 XEOTICID XEO04795 XEO_NAME Ranacyclin-B-RN2 DME1242 XEOTICID XEO04795 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04795 XEO_CLAS Peptide DME1242 XEOTICID XEO04795 DESCRIPT Ranacyclin-B-RN2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.7 microM) DME1242 XEOTICID XEO04795 GENEFORM Protein DME1242 XEOTICID XEO04795 MOACRIVE Inhibition DME1242 XEOTICID XEO04796 XEO_NAME Ranacyclin-B-RN6 DME1242 XEOTICID XEO04796 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04796 XEO_CLAS Peptide DME1242 XEOTICID XEO04796 DESCRIPT Ranacyclin-B-RN6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11.7 microM) DME1242 XEOTICID XEO04796 GENEFORM Protein DME1242 XEOTICID XEO04796 MOACRIVE Inhibition DME1242 XEOTICID XEO04799 XEO_NAME Ranalexin DME1242 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04799 XEO_CLAS Peptide DME1242 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 ug/ml) DME1242 XEOTICID XEO04799 GENEFORM Protein DME1242 XEOTICID XEO04799 MOACRIVE Inhibition DME1242 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1242 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04800 XEO_CLAS Peptide DME1242 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 17 microM) DME1242 XEOTICID XEO04800 GENEFORM Protein DME1242 XEOTICID XEO04800 MOACRIVE Inhibition DME1242 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1242 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04801 XEO_CLAS Peptide DME1242 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 18 microM) DME1242 XEOTICID XEO04801 GENEFORM Protein DME1242 XEOTICID XEO04801 MOACRIVE Inhibition DME1242 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1242 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04802 XEO_CLAS Peptide DME1242 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 microM) DME1242 XEOTICID XEO04802 GENEFORM Protein DME1242 XEOTICID XEO04802 MOACRIVE Inhibition DME1242 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1242 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04803 XEO_CLAS Peptide DME1242 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 50 microM) DME1242 XEOTICID XEO04803 GENEFORM Protein DME1242 XEOTICID XEO04803 MOACRIVE Inhibition DME1242 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1242 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04804 XEO_CLAS Peptide DME1242 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 microM) DME1242 XEOTICID XEO04804 GENEFORM Protein DME1242 XEOTICID XEO04804 MOACRIVE Inhibition DME1242 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1242 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04805 XEO_CLAS Peptide DME1242 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 55 microM) DME1242 XEOTICID XEO04805 GENEFORM Protein DME1242 XEOTICID XEO04805 MOACRIVE Inhibition DME1242 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1242 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04806 XEO_CLAS Peptide DME1242 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 60 microM) DME1242 XEOTICID XEO04806 GENEFORM Protein DME1242 XEOTICID XEO04806 MOACRIVE Inhibition DME1242 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1242 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04807 XEO_CLAS Peptide DME1242 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04807 GENEFORM Protein DME1242 XEOTICID XEO04807 MOACRIVE Inhibition DME1242 XEOTICID XEO04808 XEO_NAME Ranatuerin-2 DME1242 XEOTICID XEO04808 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04808 XEO_CLAS Peptide DME1242 XEOTICID XEO04808 DESCRIPT Ranatuerin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 60 microM) DME1242 XEOTICID XEO04808 GENEFORM Protein DME1242 XEOTICID XEO04808 MOACRIVE Inhibition DME1242 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1242 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04809 XEO_CLAS Peptide DME1242 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 20 microM) DME1242 XEOTICID XEO04809 GENEFORM Protein DME1242 XEOTICID XEO04809 MOACRIVE Inhibition DME1242 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1242 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04811 XEO_CLAS Peptide DME1242 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO04811 GENEFORM Protein DME1242 XEOTICID XEO04811 MOACRIVE Inhibition DME1242 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1242 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04812 XEO_CLAS Peptide DME1242 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 40 ug/ml) DME1242 XEOTICID XEO04812 GENEFORM Protein DME1242 XEOTICID XEO04812 MOACRIVE Inhibition DME1242 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1242 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04813 XEO_CLAS Peptide DME1242 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10 microM) DME1242 XEOTICID XEO04813 GENEFORM Protein DME1242 XEOTICID XEO04813 MOACRIVE Inhibition DME1242 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1242 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04814 XEO_CLAS Peptide DME1242 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 150 microM) DME1242 XEOTICID XEO04814 GENEFORM Protein DME1242 XEOTICID XEO04814 MOACRIVE Inhibition DME1242 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1242 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04815 XEO_CLAS Peptide DME1242 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11 microM) DME1242 XEOTICID XEO04815 GENEFORM Protein DME1242 XEOTICID XEO04815 MOACRIVE Inhibition DME1242 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1242 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04816 XEO_CLAS Peptide DME1242 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 microM) DME1242 XEOTICID XEO04816 GENEFORM Protein DME1242 XEOTICID XEO04816 MOACRIVE Inhibition DME1242 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1242 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04817 XEO_CLAS Peptide DME1242 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 microM) DME1242 XEOTICID XEO04817 GENEFORM Protein DME1242 XEOTICID XEO04817 MOACRIVE Inhibition DME1242 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1242 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04826 XEO_CLAS Peptide DME1242 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 microM) DME1242 XEOTICID XEO04826 GENEFORM Protein DME1242 XEOTICID XEO04826 MOACRIVE Inhibition DME1242 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1242 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04827 XEO_CLAS Peptide DME1242 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 microM) DME1242 XEOTICID XEO04827 GENEFORM Protein DME1242 XEOTICID XEO04827 MOACRIVE Inhibition DME1242 XEOTICID XEO04828 XEO_NAME Ranatuerin-3 DME1242 XEOTICID XEO04828 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04828 XEO_CLAS Peptide DME1242 XEOTICID XEO04828 DESCRIPT Ranatuerin-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 60 microM) DME1242 XEOTICID XEO04828 GENEFORM Protein DME1242 XEOTICID XEO04828 MOACRIVE Inhibition DME1242 XEOTICID XEO04829 XEO_NAME Ranatuerin-4 DME1242 XEOTICID XEO04829 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04829 XEO_CLAS Peptide DME1242 XEOTICID XEO04829 DESCRIPT Ranatuerin-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 55 microM) DME1242 XEOTICID XEO04829 GENEFORM Protein DME1242 XEOTICID XEO04829 MOACRIVE Inhibition DME1242 XEOTICID XEO04830 XEO_NAME Ranatuerin-5 DME1242 XEOTICID XEO04830 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04830 XEO_CLAS Peptide DME1242 XEOTICID XEO04830 DESCRIPT Ranatuerin-5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 200 microM) DME1242 XEOTICID XEO04830 GENEFORM Protein DME1242 XEOTICID XEO04830 MOACRIVE Inhibition DME1242 XEOTICID XEO04831 XEO_NAME Ranatuerin-6 DME1242 XEOTICID XEO04831 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04831 XEO_CLAS Peptide DME1242 XEOTICID XEO04831 DESCRIPT Ranatuerin-6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 100 microM) DME1242 XEOTICID XEO04831 GENEFORM Protein DME1242 XEOTICID XEO04831 MOACRIVE Inhibition DME1242 XEOTICID XEO04832 XEO_NAME Ranatuerin-7 DME1242 XEOTICID XEO04832 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04832 XEO_CLAS Peptide DME1242 XEOTICID XEO04832 DESCRIPT Ranatuerin-7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 200 microM) DME1242 XEOTICID XEO04832 GENEFORM Protein DME1242 XEOTICID XEO04832 MOACRIVE Inhibition DME1242 XEOTICID XEO04833 XEO_NAME Ranatuerin-8 DME1242 XEOTICID XEO04833 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04833 XEO_CLAS Peptide DME1242 XEOTICID XEO04833 DESCRIPT Ranatuerin-8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 130 microM) DME1242 XEOTICID XEO04833 GENEFORM Protein DME1242 XEOTICID XEO04833 MOACRIVE Inhibition DME1242 XEOTICID XEO04834 XEO_NAME Ranatuerin-9 DME1242 XEOTICID XEO04834 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04834 XEO_CLAS Peptide DME1242 XEOTICID XEO04834 DESCRIPT Ranatuerin-9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 130 microM) DME1242 XEOTICID XEO04834 GENEFORM Protein DME1242 XEOTICID XEO04834 MOACRIVE Inhibition DME1242 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1242 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04835 XEO_CLAS Peptide DME1242 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04835 GENEFORM Protein DME1242 XEOTICID XEO04835 MOACRIVE Inhibition DME1242 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1242 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04837 XEO_CLAS Peptide DME1242 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 20 microM) DME1242 XEOTICID XEO04837 GENEFORM Protein DME1242 XEOTICID XEO04837 MOACRIVE Inhibition DME1242 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1242 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04839 XEO_CLAS Peptide DME1242 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04839 GENEFORM Protein DME1242 XEOTICID XEO04839 MOACRIVE Inhibition DME1242 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1242 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04840 XEO_CLAS Peptide DME1242 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.25-2.5 microM) DME1242 XEOTICID XEO04840 GENEFORM Protein DME1242 XEOTICID XEO04840 MOACRIVE Inhibition DME1242 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1242 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04847 XEO_CLAS Peptide DME1242 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04847 GENEFORM Protein DME1242 XEOTICID XEO04847 MOACRIVE Inhibition DME1242 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1242 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04848 XEO_CLAS Peptide DME1242 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04848 GENEFORM Protein DME1242 XEOTICID XEO04848 MOACRIVE Inhibition DME1242 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1242 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04849 XEO_CLAS Peptide DME1242 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04849 GENEFORM Protein DME1242 XEOTICID XEO04849 MOACRIVE Inhibition DME1242 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1242 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04850 XEO_CLAS Peptide DME1242 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04850 GENEFORM Protein DME1242 XEOTICID XEO04850 MOACRIVE Inhibition DME1242 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1242 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04851 XEO_CLAS Peptide DME1242 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 ug/ml) DME1242 XEOTICID XEO04851 GENEFORM Protein DME1242 XEOTICID XEO04851 MOACRIVE Inhibition DME1242 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1242 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04857 XEO_CLAS Peptide DME1242 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 microM) DME1242 XEOTICID XEO04857 GENEFORM Protein DME1242 XEOTICID XEO04857 MOACRIVE Inhibition DME1242 XEOTICID XEO04859 XEO_NAME Rosewood oil DME1242 XEOTICID XEO04859 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04859 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04859 DESCRIPT Rosewood oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04859 GENEFORM Protein DME1242 XEOTICID XEO04859 MOACRIVE Inhibition DME1242 XEOTICID XEO04863 XEO_NAME RTD peptide DME1242 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04863 XEO_CLAS Peptide DME1242 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.1 microM) DME1242 XEOTICID XEO04863 GENEFORM Protein DME1242 XEOTICID XEO04863 MOACRIVE Inhibition DME1242 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1242 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04865 XEO_CLAS Peptide DME1242 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 ug/ml) DME1242 XEOTICID XEO04865 GENEFORM Protein DME1242 XEOTICID XEO04865 MOACRIVE Inhibition DME1242 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1242 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04866 XEO_CLAS Peptide DME1242 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.25 ug/ml) DME1242 XEOTICID XEO04866 GENEFORM Protein DME1242 XEOTICID XEO04866 MOACRIVE Inhibition DME1242 XEOTICID XEO04867 XEO_NAME Rugosin-C DME1242 XEOTICID XEO04867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04867 XEO_CLAS Peptide DME1242 XEOTICID XEO04867 DESCRIPT Rugosin-C inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04867 GENEFORM Protein DME1242 XEOTICID XEO04867 MOACRIVE Inhibition DME1242 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1242 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04868 XEO_CLAS Peptide DME1242 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.69 ug/ml) DME1242 XEOTICID XEO04868 GENEFORM Protein DME1242 XEOTICID XEO04868 MOACRIVE Inhibition DME1242 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1242 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04869 XEO_CLAS Peptide DME1242 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16.51 ug/ml) DME1242 XEOTICID XEO04869 GENEFORM Protein DME1242 XEOTICID XEO04869 MOACRIVE Inhibition DME1242 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1242 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04870 XEO_CLAS Peptide DME1242 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.50 ug/ml) DME1242 XEOTICID XEO04870 GENEFORM Protein DME1242 XEOTICID XEO04870 MOACRIVE Inhibition DME1242 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1242 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04877 XEO_CLAS Peptide DME1242 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04877 GENEFORM Protein DME1242 XEOTICID XEO04877 MOACRIVE Inhibition DME1242 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1242 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04880 XEO_CLAS Peptide DME1242 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5.0 ug/ml) DME1242 XEOTICID XEO04880 GENEFORM Protein DME1242 XEOTICID XEO04880 MOACRIVE Inhibition DME1242 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1242 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04886 XEO_CLAS Peptide DME1242 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.7 ug/ml) DME1242 XEOTICID XEO04886 GENEFORM Protein DME1242 XEOTICID XEO04886 MOACRIVE Inhibition DME1242 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1242 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04891 XEO_CLAS Peptide DME1242 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04891 GENEFORM Protein DME1242 XEOTICID XEO04891 MOACRIVE Inhibition DME1242 XEOTICID XEO04894 XEO_NAME Sage oil DME1242 XEOTICID XEO04894 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04894 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04894 DESCRIPT Sage oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04894 GENEFORM Protein DME1242 XEOTICID XEO04894 MOACRIVE Inhibition DME1242 XEOTICID XEO04902 XEO_NAME Sandalwood oil DME1242 XEOTICID XEO04902 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04902 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04902 DESCRIPT Sandalwood oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04902 GENEFORM Protein DME1242 XEOTICID XEO04902 MOACRIVE Inhibition DME1242 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1242 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04904 XEO_CLAS Peptide DME1242 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5.0 ug/ml) DME1242 XEOTICID XEO04904 GENEFORM Protein DME1242 XEOTICID XEO04904 MOACRIVE Inhibition DME1242 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1242 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04909 XEO_CLAS Peptide DME1242 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04909 GENEFORM Protein DME1242 XEOTICID XEO04909 MOACRIVE Inhibition DME1242 XEOTICID XEO04910 XEO_NAME Savory oil DME1242 XEOTICID XEO04910 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO04910 XEO_CLAS Plant Extract DME1242 XEOTICID XEO04910 DESCRIPT Savory oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04910 GENEFORM Protein DME1242 XEOTICID XEO04910 MOACRIVE Inhibition DME1242 XEOTICID XEO04913 XEO_NAME Scarabaecin, major form DME1242 XEOTICID XEO04913 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04913 XEO_CLAS Peptide DME1242 XEOTICID XEO04913 DESCRIPT Scarabaecin, major form inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04913 GENEFORM Protein DME1242 XEOTICID XEO04913 MOACRIVE Inhibition DME1242 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1242 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04915 XEO_CLAS Peptide DME1242 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 ug/ml) DME1242 XEOTICID XEO04915 GENEFORM Protein DME1242 XEOTICID XEO04915 MOACRIVE Inhibition DME1242 XEOTICID XEO04918 XEO_NAME Scorpine-like DME1242 XEOTICID XEO04918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04918 XEO_CLAS Peptide DME1242 XEOTICID XEO04918 DESCRIPT Scorpine-like inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04918 GENEFORM Protein DME1242 XEOTICID XEO04918 MOACRIVE Inhibition DME1242 XEOTICID XEO04927 XEO_NAME Senegalin DME1242 XEOTICID XEO04927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04927 XEO_CLAS Peptide DME1242 XEOTICID XEO04927 DESCRIPT Senegalin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 microM) DME1242 XEOTICID XEO04927 GENEFORM Protein DME1242 XEOTICID XEO04927 MOACRIVE Inhibition DME1242 XEOTICID XEO04934 XEO_NAME Sh-lantibiotic-alpha DME1242 XEOTICID XEO04934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04934 XEO_CLAS Peptide DME1242 XEOTICID XEO04934 DESCRIPT Sh-lantibiotic-alpha inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04934 GENEFORM Protein DME1242 XEOTICID XEO04934 MOACRIVE Inhibition DME1242 XEOTICID XEO04935 XEO_NAME Sh-lantibiotic-beta DME1242 XEOTICID XEO04935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04935 XEO_CLAS Peptide DME1242 XEOTICID XEO04935 DESCRIPT Sh-lantibiotic-beta inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04935 GENEFORM Protein DME1242 XEOTICID XEO04935 MOACRIVE Inhibition DME1242 XEOTICID XEO04937 XEO_NAME Signiferin-2.1 DME1242 XEOTICID XEO04937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04937 XEO_CLAS Peptide DME1242 XEOTICID XEO04937 DESCRIPT Signiferin-2.1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 microM) DME1242 XEOTICID XEO04937 GENEFORM Protein DME1242 XEOTICID XEO04937 MOACRIVE Inhibition DME1242 XEOTICID XEO04939 XEO_NAME Axenohl DME1242 XEOTICID XEO04939 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO04939 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO04939 DESCRIPT Axenohl inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04939 GENEFORM Protein DME1242 XEOTICID XEO04939 MOACRIVE Inhibition DME1242 XEOTICID XEO04941 XEO_NAME Silver nanoparticle DME1242 XEOTICID XEO04941 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1242 XEOTICID XEO04941 XEO_CLAS Nanoparticle DME1242 XEOTICID XEO04941 DESCRIPT Silver nanoparticle inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04941 GENEFORM Protein DME1242 XEOTICID XEO04941 MOACRIVE Inhibition DME1242 XEOTICID XEO04944 XEO_NAME Silver sulfadiazine DME1242 XEOTICID XEO04944 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO04944 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO04944 DESCRIPT Silver sulfadiazine inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04944 GENEFORM Protein DME1242 XEOTICID XEO04944 MOACRIVE Inhibition DME1242 XEOTICID XEO04945 XEO_NAME Silver sulphate DME1242 XEOTICID XEO04945 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1242 XEOTICID XEO04945 XEO_CLAS Chemical Compound DME1242 XEOTICID XEO04945 DESCRIPT Silver sulphate inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04945 GENEFORM Protein DME1242 XEOTICID XEO04945 MOACRIVE Inhibition DME1242 XEOTICID XEO04949 XEO_NAME Gly-rich SK84 peptide DME1242 XEOTICID XEO04949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04949 XEO_CLAS Peptide DME1242 XEOTICID XEO04949 DESCRIPT Gly-rich SK84 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 microM) DME1242 XEOTICID XEO04949 GENEFORM Protein DME1242 XEOTICID XEO04949 MOACRIVE Inhibition DME1242 XEOTICID XEO04954 XEO_NAME SMAP-29 DME1242 XEOTICID XEO04954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04954 XEO_CLAS Peptide DME1242 XEOTICID XEO04954 DESCRIPT SMAP-29 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04954 GENEFORM Protein DME1242 XEOTICID XEO04954 MOACRIVE Inhibition DME1242 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1242 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04955 XEO_CLAS Peptide DME1242 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.31 microM) DME1242 XEOTICID XEO04955 GENEFORM Protein DME1242 XEOTICID XEO04955 MOACRIVE Inhibition DME1242 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1242 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04956 XEO_CLAS Peptide DME1242 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.0 microM) DME1242 XEOTICID XEO04956 GENEFORM Protein DME1242 XEOTICID XEO04956 MOACRIVE Inhibition DME1242 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1242 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04957 XEO_CLAS Peptide DME1242 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 13.3 microM) DME1242 XEOTICID XEO04957 GENEFORM Protein DME1242 XEOTICID XEO04957 MOACRIVE Inhibition DME1242 XEOTICID XEO04965 XEO_NAME Plant defensin SolyC DME1242 XEOTICID XEO04965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04965 XEO_CLAS Peptide DME1242 XEOTICID XEO04965 DESCRIPT Plant defensin SolyC inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 40 ug/ml) DME1242 XEOTICID XEO04965 GENEFORM Protein DME1242 XEOTICID XEO04965 MOACRIVE Inhibition DME1242 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1242 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04971 XEO_CLAS Peptide DME1242 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.5-3.0 microM) DME1242 XEOTICID XEO04971 GENEFORM Protein DME1242 XEOTICID XEO04971 MOACRIVE Inhibition DME1242 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1242 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04981 XEO_CLAS Peptide DME1242 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 40.5 microM) DME1242 XEOTICID XEO04981 GENEFORM Protein DME1242 XEOTICID XEO04981 MOACRIVE Inhibition DME1242 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1242 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04982 XEO_CLAS Peptide DME1242 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 14.6 microM) DME1242 XEOTICID XEO04982 GENEFORM Protein DME1242 XEOTICID XEO04982 MOACRIVE Inhibition DME1242 XEOTICID XEO04985 XEO_NAME Staphylococcin C55 alpha DME1242 XEOTICID XEO04985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04985 XEO_CLAS Peptide DME1242 XEOTICID XEO04985 DESCRIPT Staphylococcin C55 alpha inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04985 GENEFORM Protein DME1242 XEOTICID XEO04985 MOACRIVE Inhibition DME1242 XEOTICID XEO04996 XEO_NAME Streptomycin DME1242 XEOTICID XEO04996 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO04996 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO04996 DESCRIPT Streptomycin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04996 GENEFORM Protein DME1242 XEOTICID XEO04996 MOACRIVE Inhibition DME1242 XEOTICID XEO04997 XEO_NAME Streptorubin B DME1242 XEOTICID XEO04997 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO04997 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO04997 DESCRIPT Streptorubin B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO04997 GENEFORM Protein DME1242 XEOTICID XEO04997 MOACRIVE Inhibition DME1242 XEOTICID XEO04998 XEO_NAME Styelin A DME1242 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04998 XEO_CLAS Peptide DME1242 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 ug/ml) DME1242 XEOTICID XEO04998 GENEFORM Protein DME1242 XEOTICID XEO04998 MOACRIVE Inhibition DME1242 XEOTICID XEO04999 XEO_NAME Styelin B DME1242 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO04999 XEO_CLAS Peptide DME1242 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 ug/ml) DME1242 XEOTICID XEO04999 GENEFORM Protein DME1242 XEOTICID XEO04999 MOACRIVE Inhibition DME1242 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1242 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05000 XEO_CLAS Peptide DME1242 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO05000 GENEFORM Protein DME1242 XEOTICID XEO05000 MOACRIVE Inhibition DME1242 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1242 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05001 XEO_CLAS Peptide DME1242 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO05001 GENEFORM Protein DME1242 XEOTICID XEO05001 MOACRIVE Inhibition DME1242 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1242 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05002 XEO_CLAS Peptide DME1242 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO05002 GENEFORM Protein DME1242 XEOTICID XEO05002 MOACRIVE Inhibition DME1242 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1242 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05003 XEO_CLAS Peptide DME1242 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO05003 GENEFORM Protein DME1242 XEOTICID XEO05003 MOACRIVE Inhibition DME1242 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1242 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05005 XEO_CLAS Peptide DME1242 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05005 GENEFORM Protein DME1242 XEOTICID XEO05005 MOACRIVE Inhibition DME1242 XEOTICID XEO05006 XEO_NAME Substance P DME1242 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05006 XEO_CLAS Peptide DME1242 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05006 GENEFORM Protein DME1242 XEOTICID XEO05006 MOACRIVE Inhibition DME1242 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1242 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05007 XEO_CLAS Peptide DME1242 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05007 GENEFORM Protein DME1242 XEOTICID XEO05007 MOACRIVE Inhibition DME1242 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1242 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05013 XEO_CLAS Peptide DME1242 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO05013 GENEFORM Protein DME1242 XEOTICID XEO05013 MOACRIVE Inhibition DME1242 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1242 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05014 XEO_CLAS Peptide DME1242 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO05014 GENEFORM Protein DME1242 XEOTICID XEO05014 MOACRIVE Inhibition DME1242 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1242 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05015 XEO_CLAS Peptide DME1242 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 ug/ml) DME1242 XEOTICID XEO05015 GENEFORM Protein DME1242 XEOTICID XEO05015 MOACRIVE Inhibition DME1242 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1242 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05016 XEO_CLAS Peptide DME1242 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO05016 GENEFORM Protein DME1242 XEOTICID XEO05016 MOACRIVE Inhibition DME1242 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1242 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05017 XEO_CLAS Peptide DME1242 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO05017 GENEFORM Protein DME1242 XEOTICID XEO05017 MOACRIVE Inhibition DME1242 XEOTICID XEO05020 XEO_NAME Tachycitin DME1242 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05020 XEO_CLAS Peptide DME1242 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05020 GENEFORM Protein DME1242 XEOTICID XEO05020 MOACRIVE Inhibition DME1242 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1242 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05023 XEO_CLAS Peptide DME1242 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05023 GENEFORM Protein DME1242 XEOTICID XEO05023 MOACRIVE Inhibition DME1242 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1242 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05024 XEO_CLAS Peptide DME1242 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05024 GENEFORM Protein DME1242 XEOTICID XEO05024 MOACRIVE Inhibition DME1242 XEOTICID XEO05025 XEO_NAME Tachystatin-B1 DME1242 XEOTICID XEO05025 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05025 XEO_CLAS Peptide DME1242 XEOTICID XEO05025 DESCRIPT Tachystatin-B1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05025 GENEFORM Protein DME1242 XEOTICID XEO05025 MOACRIVE Inhibition DME1242 XEOTICID XEO05026 XEO_NAME Tachystatin-B2 DME1242 XEOTICID XEO05026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05026 XEO_CLAS Peptide DME1242 XEOTICID XEO05026 DESCRIPT Tachystatin-B2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05026 GENEFORM Protein DME1242 XEOTICID XEO05026 MOACRIVE Inhibition DME1242 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1242 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05027 XEO_CLAS Peptide DME1242 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05027 GENEFORM Protein DME1242 XEOTICID XEO05027 MOACRIVE Inhibition DME1242 XEOTICID XEO05028 XEO_NAME Tagette oil DME1242 XEOTICID XEO05028 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO05028 XEO_CLAS Plant Extract DME1242 XEOTICID XEO05028 DESCRIPT Tagette oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05028 GENEFORM Protein DME1242 XEOTICID XEO05028 MOACRIVE Inhibition DME1242 XEOTICID XEO05030 XEO_NAME Tangerine oil DME1242 XEOTICID XEO05030 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO05030 XEO_CLAS Plant Extract DME1242 XEOTICID XEO05030 DESCRIPT Tangerine oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05030 GENEFORM Protein DME1242 XEOTICID XEO05030 MOACRIVE Inhibition DME1242 XEOTICID XEO05034 XEO_NAME Tea tree oil DME1242 XEOTICID XEO05034 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO05034 XEO_CLAS Plant Extract DME1242 XEOTICID XEO05034 DESCRIPT Tea tree oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05034 GENEFORM Protein DME1242 XEOTICID XEO05034 MOACRIVE Inhibition DME1242 XEOTICID XEO05038 XEO_NAME Temporin-1BYa DME1242 XEOTICID XEO05038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05038 XEO_CLAS Peptide DME1242 XEOTICID XEO05038 DESCRIPT Temporin-1BYa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05038 GENEFORM Protein DME1242 XEOTICID XEO05038 MOACRIVE Inhibition DME1242 XEOTICID XEO05039 XEO_NAME Temporin-1Cb DME1242 XEOTICID XEO05039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05039 XEO_CLAS Peptide DME1242 XEOTICID XEO05039 DESCRIPT Temporin-1Cb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 140 microM) DME1242 XEOTICID XEO05039 GENEFORM Protein DME1242 XEOTICID XEO05039 MOACRIVE Inhibition DME1242 XEOTICID XEO05040 XEO_NAME Temporin-1Cd DME1242 XEOTICID XEO05040 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05040 XEO_CLAS Peptide DME1242 XEOTICID XEO05040 DESCRIPT Temporin-1Cd inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 80 microM) DME1242 XEOTICID XEO05040 GENEFORM Protein DME1242 XEOTICID XEO05040 MOACRIVE Inhibition DME1242 XEOTICID XEO05041 XEO_NAME Temporin-1Ce DME1242 XEOTICID XEO05041 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05041 XEO_CLAS Peptide DME1242 XEOTICID XEO05041 DESCRIPT Temporin-1Ce inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 100 microM) DME1242 XEOTICID XEO05041 GENEFORM Protein DME1242 XEOTICID XEO05041 MOACRIVE Inhibition DME1242 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1242 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05042 XEO_CLAS Peptide DME1242 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 14.4 microM) DME1242 XEOTICID XEO05042 GENEFORM Protein DME1242 XEOTICID XEO05042 MOACRIVE Inhibition DME1242 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1242 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05043 XEO_CLAS Peptide DME1242 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 41 microM) DME1242 XEOTICID XEO05043 GENEFORM Protein DME1242 XEOTICID XEO05043 MOACRIVE Inhibition DME1242 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1242 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05044 XEO_CLAS Peptide DME1242 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 microM) DME1242 XEOTICID XEO05044 GENEFORM Protein DME1242 XEOTICID XEO05044 MOACRIVE Inhibition DME1242 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1242 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05045 XEO_CLAS Peptide DME1242 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 64 microM) DME1242 XEOTICID XEO05045 GENEFORM Protein DME1242 XEOTICID XEO05045 MOACRIVE Inhibition DME1242 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1242 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05046 XEO_CLAS Peptide DME1242 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 microM) DME1242 XEOTICID XEO05046 GENEFORM Protein DME1242 XEOTICID XEO05046 MOACRIVE Inhibition DME1242 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1242 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05047 XEO_CLAS Peptide DME1242 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 60 microM) DME1242 XEOTICID XEO05047 GENEFORM Protein DME1242 XEOTICID XEO05047 MOACRIVE Inhibition DME1242 XEOTICID XEO05048 XEO_NAME Temporin-1Gb DME1242 XEOTICID XEO05048 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05048 XEO_CLAS Peptide DME1242 XEOTICID XEO05048 DESCRIPT Temporin-1Gb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05048 GENEFORM Protein DME1242 XEOTICID XEO05048 MOACRIVE Inhibition DME1242 XEOTICID XEO05049 XEO_NAME Temporin-1Gc DME1242 XEOTICID XEO05049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05049 XEO_CLAS Peptide DME1242 XEOTICID XEO05049 DESCRIPT Temporin-1Gc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05049 GENEFORM Protein DME1242 XEOTICID XEO05049 MOACRIVE Inhibition DME1242 XEOTICID XEO05050 XEO_NAME Temporin-1Gd DME1242 XEOTICID XEO05050 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05050 XEO_CLAS Peptide DME1242 XEOTICID XEO05050 DESCRIPT Temporin-1Gd inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05050 GENEFORM Protein DME1242 XEOTICID XEO05050 MOACRIVE Inhibition DME1242 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1242 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05051 XEO_CLAS Peptide DME1242 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05051 GENEFORM Protein DME1242 XEOTICID XEO05051 MOACRIVE Inhibition DME1242 XEOTICID XEO05052 XEO_NAME Temporin-1La DME1242 XEOTICID XEO05052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05052 XEO_CLAS Peptide DME1242 XEOTICID XEO05052 DESCRIPT Temporin-1La inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 60 microM) DME1242 XEOTICID XEO05052 GENEFORM Protein DME1242 XEOTICID XEO05052 MOACRIVE Inhibition DME1242 XEOTICID XEO05053 XEO_NAME Temporin-1Lb DME1242 XEOTICID XEO05053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05053 XEO_CLAS Peptide DME1242 XEOTICID XEO05053 DESCRIPT Temporin-1Lb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 48 microM) DME1242 XEOTICID XEO05053 GENEFORM Protein DME1242 XEOTICID XEO05053 MOACRIVE Inhibition DME1242 XEOTICID XEO05054 XEO_NAME Temporin-1Lc DME1242 XEOTICID XEO05054 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05054 XEO_CLAS Peptide DME1242 XEOTICID XEO05054 DESCRIPT Temporin-1Lc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 125 microM) DME1242 XEOTICID XEO05054 GENEFORM Protein DME1242 XEOTICID XEO05054 MOACRIVE Inhibition DME1242 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1242 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05055 XEO_CLAS Peptide DME1242 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO05055 GENEFORM Protein DME1242 XEOTICID XEO05055 MOACRIVE Inhibition DME1242 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1242 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05056 XEO_CLAS Peptide DME1242 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05056 GENEFORM Protein DME1242 XEOTICID XEO05056 MOACRIVE Inhibition DME1242 XEOTICID XEO05057 XEO_NAME Temporin-1Oc DME1242 XEOTICID XEO05057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05057 XEO_CLAS Peptide DME1242 XEOTICID XEO05057 DESCRIPT Temporin-1Oc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 microM) DME1242 XEOTICID XEO05057 GENEFORM Protein DME1242 XEOTICID XEO05057 MOACRIVE Inhibition DME1242 XEOTICID XEO05058 XEO_NAME Temporin-1Od DME1242 XEOTICID XEO05058 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05058 XEO_CLAS Peptide DME1242 XEOTICID XEO05058 DESCRIPT Temporin-1Od inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05058 GENEFORM Protein DME1242 XEOTICID XEO05058 MOACRIVE Inhibition DME1242 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1242 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05059 XEO_CLAS Peptide DME1242 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 110 microM) DME1242 XEOTICID XEO05059 GENEFORM Protein DME1242 XEOTICID XEO05059 MOACRIVE Inhibition DME1242 XEOTICID XEO05060 XEO_NAME Temporin-1PLa DME1242 XEOTICID XEO05060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05060 XEO_CLAS Peptide DME1242 XEOTICID XEO05060 DESCRIPT Temporin-1PLa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 70 microM) DME1242 XEOTICID XEO05060 GENEFORM Protein DME1242 XEOTICID XEO05060 MOACRIVE Inhibition DME1242 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1242 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05061 XEO_CLAS Peptide DME1242 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO05061 GENEFORM Protein DME1242 XEOTICID XEO05061 MOACRIVE Inhibition DME1242 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1242 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05062 XEO_CLAS Peptide DME1242 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05062 GENEFORM Protein DME1242 XEOTICID XEO05062 MOACRIVE Inhibition DME1242 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1242 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05063 XEO_CLAS Peptide DME1242 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO05063 GENEFORM Protein DME1242 XEOTICID XEO05063 MOACRIVE Inhibition DME1242 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1242 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05064 XEO_CLAS Peptide DME1242 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 58 microM) DME1242 XEOTICID XEO05064 GENEFORM Protein DME1242 XEOTICID XEO05064 MOACRIVE Inhibition DME1242 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1242 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05065 XEO_CLAS Peptide DME1242 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10 ug/ml) DME1242 XEOTICID XEO05065 GENEFORM Protein DME1242 XEOTICID XEO05065 MOACRIVE Inhibition DME1242 XEOTICID XEO05066 XEO_NAME Temporin-1SKa DME1242 XEOTICID XEO05066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05066 XEO_CLAS Peptide DME1242 XEOTICID XEO05066 DESCRIPT Temporin-1SKa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 microM) DME1242 XEOTICID XEO05066 GENEFORM Protein DME1242 XEOTICID XEO05066 MOACRIVE Inhibition DME1242 XEOTICID XEO05067 XEO_NAME Temporin-1SPa DME1242 XEOTICID XEO05067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05067 XEO_CLAS Peptide DME1242 XEOTICID XEO05067 DESCRIPT Temporin-1SPa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05067 GENEFORM Protein DME1242 XEOTICID XEO05067 MOACRIVE Inhibition DME1242 XEOTICID XEO05068 XEO_NAME Temporin-1SPb DME1242 XEOTICID XEO05068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05068 XEO_CLAS Peptide DME1242 XEOTICID XEO05068 DESCRIPT Temporin-1SPb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6 microM) DME1242 XEOTICID XEO05068 GENEFORM Protein DME1242 XEOTICID XEO05068 MOACRIVE Inhibition DME1242 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1242 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05069 XEO_CLAS Peptide DME1242 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 microM) DME1242 XEOTICID XEO05069 GENEFORM Protein DME1242 XEOTICID XEO05069 MOACRIVE Inhibition DME1242 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1242 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05070 XEO_CLAS Peptide DME1242 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 150 microM) DME1242 XEOTICID XEO05070 GENEFORM Protein DME1242 XEOTICID XEO05070 MOACRIVE Inhibition DME1242 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1242 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05071 XEO_CLAS Peptide DME1242 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 37.5 microM) DME1242 XEOTICID XEO05071 GENEFORM Protein DME1242 XEOTICID XEO05071 MOACRIVE Inhibition DME1242 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1242 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05072 XEO_CLAS Peptide DME1242 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 microM) DME1242 XEOTICID XEO05072 GENEFORM Protein DME1242 XEOTICID XEO05072 MOACRIVE Inhibition DME1242 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1242 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05073 XEO_CLAS Peptide DME1242 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10 microM) DME1242 XEOTICID XEO05073 GENEFORM Protein DME1242 XEOTICID XEO05073 MOACRIVE Inhibition DME1242 XEOTICID XEO05074 XEO_NAME Temporin-1Vb DME1242 XEOTICID XEO05074 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05074 XEO_CLAS Peptide DME1242 XEOTICID XEO05074 DESCRIPT Temporin-1Vb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5 microM) DME1242 XEOTICID XEO05074 GENEFORM Protein DME1242 XEOTICID XEO05074 MOACRIVE Inhibition DME1242 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1242 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05075 XEO_CLAS Peptide DME1242 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5 microM) DME1242 XEOTICID XEO05075 GENEFORM Protein DME1242 XEOTICID XEO05075 MOACRIVE Inhibition DME1242 XEOTICID XEO05076 XEO_NAME Temporin-A DME1242 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05076 XEO_CLAS Peptide DME1242 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.3 microM) DME1242 XEOTICID XEO05076 GENEFORM Protein DME1242 XEOTICID XEO05076 MOACRIVE Inhibition DME1242 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1242 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05077 XEO_CLAS Peptide DME1242 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.25 ug/ml) DME1242 XEOTICID XEO05077 GENEFORM Protein DME1242 XEOTICID XEO05077 MOACRIVE Inhibition DME1242 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1242 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05078 XEO_CLAS Peptide DME1242 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.25 ug/ml) DME1242 XEOTICID XEO05078 GENEFORM Protein DME1242 XEOTICID XEO05078 MOACRIVE Inhibition DME1242 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1242 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05079 XEO_CLAS Peptide DME1242 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.5 ug/ml) DME1242 XEOTICID XEO05079 GENEFORM Protein DME1242 XEOTICID XEO05079 MOACRIVE Inhibition DME1242 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1242 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05080 XEO_CLAS Peptide DME1242 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.5 ug/ml) DME1242 XEOTICID XEO05080 GENEFORM Protein DME1242 XEOTICID XEO05080 MOACRIVE Inhibition DME1242 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1242 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05081 XEO_CLAS Peptide DME1242 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.5 ug/ml) DME1242 XEOTICID XEO05081 GENEFORM Protein DME1242 XEOTICID XEO05081 MOACRIVE Inhibition DME1242 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1242 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05082 XEO_CLAS Peptide DME1242 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7.5 ug/ml) DME1242 XEOTICID XEO05082 GENEFORM Protein DME1242 XEOTICID XEO05082 MOACRIVE Inhibition DME1242 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1242 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05083 XEO_CLAS Peptide DME1242 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 7.5 ug/ml) DME1242 XEOTICID XEO05083 GENEFORM Protein DME1242 XEOTICID XEO05083 MOACRIVE Inhibition DME1242 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1242 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05084 XEO_CLAS Peptide DME1242 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 ug/ml) DME1242 XEOTICID XEO05084 GENEFORM Protein DME1242 XEOTICID XEO05084 MOACRIVE Inhibition DME1242 XEOTICID XEO05085 XEO_NAME Temporin-B DME1242 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05085 XEO_CLAS Peptide DME1242 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 6.0 ug/ml) DME1242 XEOTICID XEO05085 GENEFORM Protein DME1242 XEOTICID XEO05085 MOACRIVE Inhibition DME1242 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1242 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05086 XEO_CLAS Peptide DME1242 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO05086 GENEFORM Protein DME1242 XEOTICID XEO05086 MOACRIVE Inhibition DME1242 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1242 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05087 XEO_CLAS Peptide DME1242 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 microM) DME1242 XEOTICID XEO05087 GENEFORM Protein DME1242 XEOTICID XEO05087 MOACRIVE Inhibition DME1242 XEOTICID XEO05089 XEO_NAME Temporin-GH DME1242 XEOTICID XEO05089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05089 XEO_CLAS Peptide DME1242 XEOTICID XEO05089 DESCRIPT Temporin-GH inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 44.3 ug/ml) DME1242 XEOTICID XEO05089 GENEFORM Protein DME1242 XEOTICID XEO05089 MOACRIVE Inhibition DME1242 XEOTICID XEO05090 XEO_NAME Temporin-HN1 DME1242 XEOTICID XEO05090 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05090 XEO_CLAS Peptide DME1242 XEOTICID XEO05090 DESCRIPT Temporin-HN1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 37.5 microM) DME1242 XEOTICID XEO05090 GENEFORM Protein DME1242 XEOTICID XEO05090 MOACRIVE Inhibition DME1242 XEOTICID XEO05091 XEO_NAME Temporin-HN2 DME1242 XEOTICID XEO05091 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05091 XEO_CLAS Peptide DME1242 XEOTICID XEO05091 DESCRIPT Temporin-HN2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.8 microM) DME1242 XEOTICID XEO05091 GENEFORM Protein DME1242 XEOTICID XEO05091 MOACRIVE Inhibition DME1242 XEOTICID XEO05092 XEO_NAME Temporin-LT1 DME1242 XEOTICID XEO05092 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05092 XEO_CLAS Peptide DME1242 XEOTICID XEO05092 DESCRIPT Temporin-LT1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO05092 GENEFORM Protein DME1242 XEOTICID XEO05092 MOACRIVE Inhibition DME1242 XEOTICID XEO05093 XEO_NAME Temporin-LT2 DME1242 XEOTICID XEO05093 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05093 XEO_CLAS Peptide DME1242 XEOTICID XEO05093 DESCRIPT Temporin-LT2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO05093 GENEFORM Protein DME1242 XEOTICID XEO05093 MOACRIVE Inhibition DME1242 XEOTICID XEO05094 XEO_NAME Temporin-LTa DME1242 XEOTICID XEO05094 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05094 XEO_CLAS Peptide DME1242 XEOTICID XEO05094 DESCRIPT Temporin-LTa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 20 ug/ml) DME1242 XEOTICID XEO05094 GENEFORM Protein DME1242 XEOTICID XEO05094 MOACRIVE Inhibition DME1242 XEOTICID XEO05095 XEO_NAME Temporin-LTb DME1242 XEOTICID XEO05095 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05095 XEO_CLAS Peptide DME1242 XEOTICID XEO05095 DESCRIPT Temporin-LTb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 ug/ml) DME1242 XEOTICID XEO05095 GENEFORM Protein DME1242 XEOTICID XEO05095 MOACRIVE Inhibition DME1242 XEOTICID XEO05096 XEO_NAME Temporin-LTc DME1242 XEOTICID XEO05096 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05096 XEO_CLAS Peptide DME1242 XEOTICID XEO05096 DESCRIPT Temporin-LTc inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 ug/ml) DME1242 XEOTICID XEO05096 GENEFORM Protein DME1242 XEOTICID XEO05096 MOACRIVE Inhibition DME1242 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1242 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05097 XEO_CLAS Peptide DME1242 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2.0 microM) DME1242 XEOTICID XEO05097 GENEFORM Protein DME1242 XEOTICID XEO05097 MOACRIVE Inhibition DME1242 XEOTICID XEO05098 XEO_NAME Temporin-PEa DME1242 XEOTICID XEO05098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05098 XEO_CLAS Peptide DME1242 XEOTICID XEO05098 DESCRIPT Temporin-PEa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.0 microM) DME1242 XEOTICID XEO05098 GENEFORM Protein DME1242 XEOTICID XEO05098 MOACRIVE Inhibition DME1242 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1242 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05099 XEO_CLAS Peptide DME1242 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.0 microM) DME1242 XEOTICID XEO05099 GENEFORM Protein DME1242 XEOTICID XEO05099 MOACRIVE Inhibition DME1242 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1242 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05100 XEO_CLAS Peptide DME1242 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05100 GENEFORM Protein DME1242 XEOTICID XEO05100 MOACRIVE Inhibition DME1242 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1242 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05101 XEO_CLAS Peptide DME1242 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 35.2 ug/ml) DME1242 XEOTICID XEO05101 GENEFORM Protein DME1242 XEOTICID XEO05101 MOACRIVE Inhibition DME1242 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1242 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05102 XEO_CLAS Peptide DME1242 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 42.1 ug/ml) DME1242 XEOTICID XEO05102 GENEFORM Protein DME1242 XEOTICID XEO05102 MOACRIVE Inhibition DME1242 XEOTICID XEO05103 XEO_NAME Temporin-RN1 DME1242 XEOTICID XEO05103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05103 XEO_CLAS Peptide DME1242 XEOTICID XEO05103 DESCRIPT Temporin-RN1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.69 ug/ml) DME1242 XEOTICID XEO05103 GENEFORM Protein DME1242 XEOTICID XEO05103 MOACRIVE Inhibition DME1242 XEOTICID XEO05104 XEO_NAME Temporin-RN3 DME1242 XEOTICID XEO05104 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05104 XEO_CLAS Peptide DME1242 XEOTICID XEO05104 DESCRIPT Temporin-RN3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3.75 ug/ml) DME1242 XEOTICID XEO05104 GENEFORM Protein DME1242 XEOTICID XEO05104 MOACRIVE Inhibition DME1242 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1242 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05105 XEO_CLAS Peptide DME1242 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 3 microM) DME1242 XEOTICID XEO05105 GENEFORM Protein DME1242 XEOTICID XEO05105 MOACRIVE Inhibition DME1242 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1242 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05106 XEO_CLAS Peptide DME1242 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12.5 microM) DME1242 XEOTICID XEO05106 GENEFORM Protein DME1242 XEOTICID XEO05106 MOACRIVE Inhibition DME1242 XEOTICID XEO05115 XEO_NAME Trp- and Arg-rich Tet213 DME1242 XEOTICID XEO05115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05115 XEO_CLAS Peptide DME1242 XEOTICID XEO05115 DESCRIPT Trp- and Arg-rich Tet213 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05115 GENEFORM Protein DME1242 XEOTICID XEO05115 MOACRIVE Inhibition DME1242 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1242 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05119 XEO_CLAS Peptide DME1242 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05119 GENEFORM Protein DME1242 XEOTICID XEO05119 MOACRIVE Inhibition DME1242 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1242 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05125 XEO_CLAS Peptide DME1242 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05125 GENEFORM Protein DME1242 XEOTICID XEO05125 MOACRIVE Inhibition DME1242 XEOTICID XEO05129 XEO_NAME Thiocillin GE37468 DME1242 XEOTICID XEO05129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05129 XEO_CLAS Peptide DME1242 XEOTICID XEO05129 DESCRIPT Thiocillin GE37468 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 0.047 ug/ml) DME1242 XEOTICID XEO05129 GENEFORM Protein DME1242 XEOTICID XEO05129 MOACRIVE Inhibition DME1242 XEOTICID XEO05138 XEO_NAME Thuricin-17 DME1242 XEOTICID XEO05138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05138 XEO_CLAS Peptide DME1242 XEOTICID XEO05138 DESCRIPT Thuricin-17 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05138 GENEFORM Protein DME1242 XEOTICID XEO05138 MOACRIVE Inhibition DME1242 XEOTICID XEO05141 XEO_NAME Thyme red oil DME1242 XEOTICID XEO05141 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO05141 XEO_CLAS Natural Product DME1242 XEOTICID XEO05141 DESCRIPT Thyme red oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05141 GENEFORM Protein DME1242 XEOTICID XEO05141 MOACRIVE Inhibition DME1242 XEOTICID XEO05143 XEO_NAME Tigecycline DME1242 XEOTICID XEO05143 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO05143 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO05143 DESCRIPT Tigecycline inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05143 GENEFORM Protein DME1242 XEOTICID XEO05143 MOACRIVE Inhibition DME1242 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1242 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05144 XEO_CLAS Peptide DME1242 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 30 ug/ml) DME1242 XEOTICID XEO05144 GENEFORM Protein DME1242 XEOTICID XEO05144 MOACRIVE Inhibition DME1242 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1242 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05145 XEO_CLAS Peptide DME1242 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 40 ug/ml) DME1242 XEOTICID XEO05145 GENEFORM Protein DME1242 XEOTICID XEO05145 MOACRIVE Inhibition DME1242 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1242 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05146 XEO_CLAS Peptide DME1242 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 30 ug/ml) DME1242 XEOTICID XEO05146 GENEFORM Protein DME1242 XEOTICID XEO05146 MOACRIVE Inhibition DME1242 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1242 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05147 XEO_CLAS Peptide DME1242 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 ug/ml) DME1242 XEOTICID XEO05147 GENEFORM Protein DME1242 XEOTICID XEO05147 MOACRIVE Inhibition DME1242 XEOTICID XEO05150 XEO_NAME Tiliroside DME1242 XEOTICID XEO05150 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO05150 XEO_CLAS Investigative Agent DME1242 XEOTICID XEO05150 DESCRIPT Tiliroside inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05150 GENEFORM Protein DME1242 XEOTICID XEO05150 MOACRIVE Inhibition DME1242 XEOTICID XEO05154 XEO_NAME TFPI-1 C-terminal peptide TO17 DME1242 XEOTICID XEO05154 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05154 XEO_CLAS Peptide DME1242 XEOTICID XEO05154 DESCRIPT TFPI-1 C-terminal peptide TO17 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4 microM) DME1242 XEOTICID XEO05154 GENEFORM Protein DME1242 XEOTICID XEO05154 MOACRIVE Inhibition DME1242 XEOTICID XEO05156 XEO_NAME Tobramycin DME1242 XEOTICID XEO05156 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO05156 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO05156 DESCRIPT Tobramycin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05156 GENEFORM Protein DME1242 XEOTICID XEO05156 MOACRIVE Inhibition DME1242 XEOTICID XEO05160 XEO_NAME Toremifene DME1242 XEOTICID XEO05160 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO05160 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO05160 DESCRIPT Toremifene inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05160 GENEFORM Protein DME1242 XEOTICID XEO05160 MOACRIVE Inhibition DME1242 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1242 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05161 XEO_CLAS Peptide DME1242 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 32 ug/ml) DME1242 XEOTICID XEO05161 GENEFORM Protein DME1242 XEOTICID XEO05161 MOACRIVE Inhibition DME1242 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1242 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05162 XEO_CLAS Peptide DME1242 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO05162 GENEFORM Protein DME1242 XEOTICID XEO05162 MOACRIVE Inhibition DME1242 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1242 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05163 XEO_CLAS Peptide DME1242 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25-50 ug/ml) DME1242 XEOTICID XEO05163 GENEFORM Protein DME1242 XEOTICID XEO05163 MOACRIVE Inhibition DME1242 XEOTICID XEO05169 XEO_NAME Tricyclic peptide MS-271 DME1242 XEOTICID XEO05169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05169 XEO_CLAS Peptide DME1242 XEOTICID XEO05169 DESCRIPT Tricyclic peptide MS-271 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05169 GENEFORM Protein DME1242 XEOTICID XEO05169 MOACRIVE Inhibition DME1242 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1242 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05170 XEO_CLAS Peptide DME1242 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1.0 microM) DME1242 XEOTICID XEO05170 GENEFORM Protein DME1242 XEOTICID XEO05170 MOACRIVE Inhibition DME1242 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1242 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05180 XEO_CLAS Peptide DME1242 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 120 microM) DME1242 XEOTICID XEO05180 GENEFORM Protein DME1242 XEOTICID XEO05180 MOACRIVE Inhibition DME1242 XEOTICID XEO05181 XEO_NAME T. serrulatus antimicrobial peptide TsAP-2 DME1242 XEOTICID XEO05181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05181 XEO_CLAS Peptide DME1242 XEOTICID XEO05181 DESCRIPT T. serrulatus antimicrobial peptide TsAP-2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5 microM) DME1242 XEOTICID XEO05181 GENEFORM Protein DME1242 XEOTICID XEO05181 MOACRIVE Inhibition DME1242 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1242 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05182 XEO_CLAS Peptide DME1242 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 64 microM) DME1242 XEOTICID XEO05182 GENEFORM Protein DME1242 XEOTICID XEO05182 MOACRIVE Inhibition DME1242 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1242 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05183 XEO_CLAS Peptide DME1242 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 100 microM) DME1242 XEOTICID XEO05183 GENEFORM Protein DME1242 XEOTICID XEO05183 MOACRIVE Inhibition DME1242 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1242 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05184 XEO_CLAS Peptide DME1242 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO05184 GENEFORM Protein DME1242 XEOTICID XEO05184 MOACRIVE Inhibition DME1242 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1242 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05185 XEO_CLAS Peptide DME1242 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 32 microM) DME1242 XEOTICID XEO05185 GENEFORM Protein DME1242 XEOTICID XEO05185 MOACRIVE Inhibition DME1242 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1242 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05186 XEO_CLAS Peptide DME1242 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 32 microM) DME1242 XEOTICID XEO05186 GENEFORM Protein DME1242 XEOTICID XEO05186 MOACRIVE Inhibition DME1242 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1242 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05187 XEO_CLAS Peptide DME1242 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 microM) DME1242 XEOTICID XEO05187 GENEFORM Protein DME1242 XEOTICID XEO05187 MOACRIVE Inhibition DME1242 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1242 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05188 XEO_CLAS Peptide DME1242 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC > 100 microM) DME1242 XEOTICID XEO05188 GENEFORM Protein DME1242 XEOTICID XEO05188 MOACRIVE Inhibition DME1242 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1242 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05190 XEO_CLAS Peptide DME1242 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05190 GENEFORM Protein DME1242 XEOTICID XEO05190 MOACRIVE Inhibition DME1242 XEOTICID XEO05191 XEO_NAME Turkey Heterophil Peptide 2 DME1242 XEOTICID XEO05191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05191 XEO_CLAS Peptide DME1242 XEOTICID XEO05191 DESCRIPT Turkey Heterophil Peptide 2 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05191 GENEFORM Protein DME1242 XEOTICID XEO05191 MOACRIVE Inhibition DME1242 XEOTICID XEO05192 XEO_NAME Turkey Heterophil Peptide 3 DME1242 XEOTICID XEO05192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05192 XEO_CLAS Peptide DME1242 XEOTICID XEO05192 DESCRIPT Turkey Heterophil Peptide 3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05192 GENEFORM Protein DME1242 XEOTICID XEO05192 MOACRIVE Inhibition DME1242 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1242 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05193 XEO_CLAS Peptide DME1242 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 16 ug/ml) DME1242 XEOTICID XEO05193 GENEFORM Protein DME1242 XEOTICID XEO05193 MOACRIVE Inhibition DME1242 XEOTICID XEO05201 XEO_NAME Uperin-3.5 DME1242 XEOTICID XEO05201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05201 XEO_CLAS Peptide DME1242 XEOTICID XEO05201 DESCRIPT Uperin-3.5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 ug/ml) DME1242 XEOTICID XEO05201 GENEFORM Protein DME1242 XEOTICID XEO05201 MOACRIVE Inhibition DME1242 XEOTICID XEO05202 XEO_NAME Uperin-3.6 DME1242 XEOTICID XEO05202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05202 XEO_CLAS Peptide DME1242 XEOTICID XEO05202 DESCRIPT Uperin-3.6 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 25 ug/ml) DME1242 XEOTICID XEO05202 GENEFORM Protein DME1242 XEOTICID XEO05202 MOACRIVE Inhibition DME1242 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1242 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05206 XEO_CLAS Peptide DME1242 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 15 microM) DME1242 XEOTICID XEO05206 GENEFORM Protein DME1242 XEOTICID XEO05206 MOACRIVE Inhibition DME1242 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1242 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05208 XEO_CLAS Peptide DME1242 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10 microM) DME1242 XEOTICID XEO05208 GENEFORM Protein DME1242 XEOTICID XEO05208 MOACRIVE Inhibition DME1242 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1242 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05209 XEO_CLAS Peptide DME1242 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 1 microM) DME1242 XEOTICID XEO05209 GENEFORM Protein DME1242 XEOTICID XEO05209 MOACRIVE Inhibition DME1242 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1242 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05212 XEO_CLAS Peptide DME1242 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10.1 ug/ml) DME1242 XEOTICID XEO05212 GENEFORM Protein DME1242 XEOTICID XEO05212 MOACRIVE Inhibition DME1242 XEOTICID XEO05223 XEO_NAME Valefian oil DME1242 XEOTICID XEO05223 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO05223 XEO_CLAS Plant Extract DME1242 XEOTICID XEO05223 DESCRIPT Valefian oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05223 GENEFORM Protein DME1242 XEOTICID XEO05223 MOACRIVE Inhibition DME1242 XEOTICID XEO05224 XEO_NAME Vancomycin DME1242 XEOTICID XEO05224 XEO_TYPE Pharmaceutical Agent(s) DME1242 XEOTICID XEO05224 XEO_CLAS Approved/Marketed Drug DME1242 XEOTICID XEO05224 DESCRIPT Vancomycin inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05224 GENEFORM Protein DME1242 XEOTICID XEO05224 MOACRIVE Inhibition DME1242 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1242 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05233 XEO_CLAS Peptide DME1242 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5 ug/ml) DME1242 XEOTICID XEO05233 GENEFORM Protein DME1242 XEOTICID XEO05233 MOACRIVE Inhibition DME1242 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1242 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05234 XEO_CLAS Peptide DME1242 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 5 ug/ml) DME1242 XEOTICID XEO05234 GENEFORM Protein DME1242 XEOTICID XEO05234 MOACRIVE Inhibition DME1242 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1242 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05235 XEO_CLAS Peptide DME1242 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 10 ug/ml) DME1242 XEOTICID XEO05235 GENEFORM Protein DME1242 XEOTICID XEO05235 MOACRIVE Inhibition DME1242 XEOTICID XEO05236 XEO_NAME Vetiver Haiti oil DME1242 XEOTICID XEO05236 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO05236 XEO_CLAS Plant Extract DME1242 XEOTICID XEO05236 DESCRIPT Vetiver Haiti oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05236 GENEFORM Protein DME1242 XEOTICID XEO05236 MOACRIVE Inhibition DME1242 XEOTICID XEO05251 XEO_NAME Histone derived VK10 peptide DME1242 XEOTICID XEO05251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05251 XEO_CLAS Peptide DME1242 XEOTICID XEO05251 DESCRIPT Histone derived VK10 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05251 GENEFORM Protein DME1242 XEOTICID XEO05251 MOACRIVE Inhibition DME1242 XEOTICID XEO05252 XEO_NAME Histone derived VK11 peptide DME1242 XEOTICID XEO05252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05252 XEO_CLAS Peptide DME1242 XEOTICID XEO05252 DESCRIPT Histone derived VK11 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05252 GENEFORM Protein DME1242 XEOTICID XEO05252 MOACRIVE Inhibition DME1242 XEOTICID XEO05253 XEO_NAME Histone derived VK12 peptide DME1242 XEOTICID XEO05253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05253 XEO_CLAS Peptide DME1242 XEOTICID XEO05253 DESCRIPT Histone derived VK12 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05253 GENEFORM Protein DME1242 XEOTICID XEO05253 MOACRIVE Inhibition DME1242 XEOTICID XEO05254 XEO_NAME Histone derived VK13 peptide DME1242 XEOTICID XEO05254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05254 XEO_CLAS Peptide DME1242 XEOTICID XEO05254 DESCRIPT Histone derived VK13 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05254 GENEFORM Protein DME1242 XEOTICID XEO05254 MOACRIVE Inhibition DME1242 XEOTICID XEO05255 XEO_NAME Histone derived VK14 peptide DME1242 XEOTICID XEO05255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05255 XEO_CLAS Peptide DME1242 XEOTICID XEO05255 DESCRIPT Histone derived VK14 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05255 GENEFORM Protein DME1242 XEOTICID XEO05255 MOACRIVE Inhibition DME1242 XEOTICID XEO05256 XEO_NAME Histone derived VK25 peptide DME1242 XEOTICID XEO05256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05256 XEO_CLAS Peptide DME1242 XEOTICID XEO05256 DESCRIPT Histone derived VK25 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05256 GENEFORM Protein DME1242 XEOTICID XEO05256 MOACRIVE Inhibition DME1242 XEOTICID XEO05257 XEO_NAME Histone derived VK6 peptide DME1242 XEOTICID XEO05257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05257 XEO_CLAS Peptide DME1242 XEOTICID XEO05257 DESCRIPT Histone derived VK6 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05257 GENEFORM Protein DME1242 XEOTICID XEO05257 MOACRIVE Inhibition DME1242 XEOTICID XEO05258 XEO_NAME Histone derived VK7 peptide DME1242 XEOTICID XEO05258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05258 XEO_CLAS Peptide DME1242 XEOTICID XEO05258 DESCRIPT Histone derived VK7 peptide inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05258 GENEFORM Protein DME1242 XEOTICID XEO05258 MOACRIVE Inhibition DME1242 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1242 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05264 XEO_CLAS Peptide DME1242 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 8 ug/ml) DME1242 XEOTICID XEO05264 GENEFORM Protein DME1242 XEOTICID XEO05264 MOACRIVE Inhibition DME1242 XEOTICID XEO05265 XEO_NAME Def-DAA defensin mutant W11V DME1242 XEOTICID XEO05265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05265 XEO_CLAS Peptide DME1242 XEOTICID XEO05265 DESCRIPT Def-DAA defensin mutant W11V inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05265 GENEFORM Protein DME1242 XEOTICID XEO05265 MOACRIVE Inhibition DME1242 XEOTICID XEO05266 XEO_NAME Def-DAA defensin mutant W11V,T14A DME1242 XEOTICID XEO05266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05266 XEO_CLAS Peptide DME1242 XEOTICID XEO05266 DESCRIPT Def-DAA defensin mutant W11V,T14A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05266 GENEFORM Protein DME1242 XEOTICID XEO05266 MOACRIVE Inhibition DME1242 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1242 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05267 XEO_CLAS Peptide DME1242 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 2 ug/ml) DME1242 XEOTICID XEO05267 GENEFORM Protein DME1242 XEOTICID XEO05267 MOACRIVE Inhibition DME1242 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1242 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05268 XEO_CLAS Peptide DME1242 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 12 ug/ml) DME1242 XEOTICID XEO05268 GENEFORM Protein DME1242 XEOTICID XEO05268 MOACRIVE Inhibition DME1242 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1242 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05269 XEO_CLAS Peptide DME1242 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 50 ug/ml) DME1242 XEOTICID XEO05269 GENEFORM Protein DME1242 XEOTICID XEO05269 MOACRIVE Inhibition DME1242 XEOTICID XEO05270 XEO_NAME Def-DAA defensin mutant W9F DME1242 XEOTICID XEO05270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05270 XEO_CLAS Peptide DME1242 XEOTICID XEO05270 DESCRIPT Def-DAA defensin mutant W9F inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05270 GENEFORM Protein DME1242 XEOTICID XEO05270 MOACRIVE Inhibition DME1242 XEOTICID XEO05271 XEO_NAME Def-DAA defensin mutant W9F,T14A DME1242 XEOTICID XEO05271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05271 XEO_CLAS Peptide DME1242 XEOTICID XEO05271 DESCRIPT Def-DAA defensin mutant W9F,T14A inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05271 GENEFORM Protein DME1242 XEOTICID XEO05271 MOACRIVE Inhibition DME1242 XEOTICID XEO05272 XEO_NAME Def-DAA defensin mutant W9F,W11V DME1242 XEOTICID XEO05272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05272 XEO_CLAS Peptide DME1242 XEOTICID XEO05272 DESCRIPT Def-DAA defensin mutant W9F,W11V inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05272 GENEFORM Protein DME1242 XEOTICID XEO05272 MOACRIVE Inhibition DME1242 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1242 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05273 XEO_CLAS Peptide DME1242 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05273 GENEFORM Protein DME1242 XEOTICID XEO05273 MOACRIVE Inhibition DME1242 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1242 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05274 XEO_CLAS Peptide DME1242 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05274 GENEFORM Protein DME1242 XEOTICID XEO05274 MOACRIVE Inhibition DME1242 XEOTICID XEO05282 XEO_NAME WB piscidin 5 DME1242 XEOTICID XEO05282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05282 XEO_CLAS Peptide DME1242 XEOTICID XEO05282 DESCRIPT WB piscidin 5 inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 4.52 microM) DME1242 XEOTICID XEO05282 GENEFORM Protein DME1242 XEOTICID XEO05282 MOACRIVE Inhibition DME1242 XEOTICID XEO05302 XEO_NAME Wormwood oil DME1242 XEOTICID XEO05302 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO05302 XEO_CLAS Plant Extract DME1242 XEOTICID XEO05302 DESCRIPT Wormwood oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05302 GENEFORM Protein DME1242 XEOTICID XEO05302 MOACRIVE Inhibition DME1242 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1242 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05303 XEO_CLAS Peptide DME1242 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 250-500 ug/ml) DME1242 XEOTICID XEO05303 GENEFORM Protein DME1242 XEOTICID XEO05303 MOACRIVE Inhibition DME1242 XEOTICID XEO05305 XEO_NAME Yarrow oil DME1242 XEOTICID XEO05305 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1242 XEOTICID XEO05305 XEO_CLAS Plant Extract DME1242 XEOTICID XEO05305 DESCRIPT Yarrow oil inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus DME1242 XEOTICID XEO05305 GENEFORM Protein DME1242 XEOTICID XEO05305 MOACRIVE Inhibition DME1242 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1242 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1242 XEOTICID XEO05308 XEO_CLAS Peptide DME1242 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of NADPH-dependent oxidoreductase (nfrA) from Staphylococcus aureus (MIC = 11.0 ug/ml) DME1242 XEOTICID XEO05308 GENEFORM Protein DME1242 XEOTICID XEO05308 MOACRIVE Inhibition DME1243 DME___ID DME1243 DME1243 DME_NAME NADPH-dependent nitroreductase (nfrA1) DME1243 SPESNAME Bacillus subtilis DME1243 XEOTICID XEO00044 XEO_NAME Glipizide DME1243 XEOTICID XEO00044 XEO_TYPE Pharmaceutical Agent(s) DME1243 XEOTICID XEO00044 XEO_CLAS Approved/Marketed Drug DME1243 XEOTICID XEO00044 DESCRIPT Glipizide inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO00044 GENEFORM Protein DME1243 XEOTICID XEO00044 MOACRIVE Inhibition DME1243 XEOTICID XEO00070 XEO_NAME Esomeprazole DME1243 XEOTICID XEO00070 XEO_TYPE Pharmaceutical Agent(s) DME1243 XEOTICID XEO00070 XEO_CLAS Approved/Marketed Drug DME1243 XEOTICID XEO00070 DESCRIPT Esomeprazole inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO00070 GENEFORM Protein DME1243 XEOTICID XEO00070 MOACRIVE Inhibition DME1243 XEOTICID XEO00096 XEO_NAME Ampicillin DME1243 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME1243 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME1243 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO00096 GENEFORM Protein DME1243 XEOTICID XEO00096 MOACRIVE Inhibition DME1243 XEOTICID XEO00246 XEO_NAME Amoxicillin DME1243 XEOTICID XEO00246 XEO_TYPE Pharmaceutical Agent(s) DME1243 XEOTICID XEO00246 XEO_CLAS Approved/Marketed Drug DME1243 XEOTICID XEO00246 DESCRIPT Amoxicillin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO00246 GENEFORM Protein DME1243 XEOTICID XEO00246 MOACRIVE Inhibition DME1243 XEOTICID XEO00338 XEO_NAME Amlodipine DME1243 XEOTICID XEO00338 XEO_TYPE Pharmaceutical Agent(s) DME1243 XEOTICID XEO00338 XEO_CLAS Approved/Marketed Drug DME1243 XEOTICID XEO00338 DESCRIPT Amlodipine inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO00338 GENEFORM Protein DME1243 XEOTICID XEO00338 MOACRIVE Inhibition DME1243 XEOTICID XEO00356 XEO_NAME Enalapril DME1243 XEOTICID XEO00356 XEO_TYPE Pharmaceutical Agent(s) DME1243 XEOTICID XEO00356 XEO_CLAS Approved/Marketed Drug DME1243 XEOTICID XEO00356 DESCRIPT Enalapril inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO00356 GENEFORM Protein DME1243 XEOTICID XEO00356 MOACRIVE Inhibition DME1243 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1243 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO01810 XEO_CLAS Peptide DME1243 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2.0 microM) DME1243 XEOTICID XEO01810 GENEFORM Protein DME1243 XEOTICID XEO01810 MOACRIVE Inhibition DME1243 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1243 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO01817 XEO_CLAS Peptide DME1243 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 4.0 microM) DME1243 XEOTICID XEO01817 GENEFORM Protein DME1243 XEOTICID XEO01817 MOACRIVE Inhibition DME1243 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1243 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO01818 XEO_CLAS Peptide DME1243 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 4.0 microM) DME1243 XEOTICID XEO01818 GENEFORM Protein DME1243 XEOTICID XEO01818 MOACRIVE Inhibition DME1243 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1243 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO01823 XEO_CLAS Peptide DME1243 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.56 microM) DME1243 XEOTICID XEO01823 GENEFORM Protein DME1243 XEOTICID XEO01823 MOACRIVE Inhibition DME1243 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1243 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO01825 XEO_CLAS Peptide DME1243 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.56 microM) DME1243 XEOTICID XEO01825 GENEFORM Protein DME1243 XEOTICID XEO01825 MOACRIVE Inhibition DME1243 XEOTICID XEO01972 XEO_NAME 3,4-Dichloro-2-(1,3-dichloropropan-2-yloxy)-2H-furan-5-one DME1243 XEOTICID XEO01972 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1243 XEOTICID XEO01972 XEO_CLAS Chemical Compound DME1243 XEOTICID XEO01972 DESCRIPT 3,4-Dichloro-2-(1,3-dichloropropan-2-yloxy)-2H-furan-5-one inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO01972 GENEFORM Protein DME1243 XEOTICID XEO01972 MOACRIVE Inhibition DME1243 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1243 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02013 XEO_CLAS Peptide DME1243 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02013 GENEFORM Protein DME1243 XEOTICID XEO02013 MOACRIVE Inhibition DME1243 XEOTICID XEO02102 XEO_NAME A. dichotoma defensin DME1243 XEOTICID XEO02102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02102 XEO_CLAS Peptide DME1243 XEOTICID XEO02102 DESCRIPT A. dichotoma defensin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02102 GENEFORM Protein DME1243 XEOTICID XEO02102 MOACRIVE Inhibition DME1243 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1243 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02115 XEO_CLAS Peptide DME1243 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02115 GENEFORM Protein DME1243 XEOTICID XEO02115 MOACRIVE Inhibition DME1243 XEOTICID XEO02146 XEO_NAME Antimicrobial protein Ah-AMP1 DME1243 XEOTICID XEO02146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02146 XEO_CLAS Peptide DME1243 XEOTICID XEO02146 DESCRIPT Antimicrobial protein Ah-AMP1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02146 GENEFORM Protein DME1243 XEOTICID XEO02146 MOACRIVE Inhibition DME1243 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1243 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02147 XEO_CLAS Peptide DME1243 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 237 ug/ml) DME1243 XEOTICID XEO02147 GENEFORM Protein DME1243 XEOTICID XEO02147 MOACRIVE Inhibition DME1243 XEOTICID XEO02151 XEO_NAME AI-hemocidins 4 DME1243 XEOTICID XEO02151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02151 XEO_CLAS Peptide DME1243 XEOTICID XEO02151 DESCRIPT AI-hemocidins 4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 69.55 microM) DME1243 XEOTICID XEO02151 GENEFORM Protein DME1243 XEOTICID XEO02151 MOACRIVE Inhibition DME1243 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1243 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02200 XEO_CLAS Peptide DME1243 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 100 ug/ml) DME1243 XEOTICID XEO02200 GENEFORM Protein DME1243 XEOTICID XEO02200 MOACRIVE Inhibition DME1243 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1243 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02201 XEO_CLAS Peptide DME1243 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 25 ug/ml) DME1243 XEOTICID XEO02201 GENEFORM Protein DME1243 XEOTICID XEO02201 MOACRIVE Inhibition DME1243 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1243 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02202 XEO_CLAS Peptide DME1243 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 20 microM) DME1243 XEOTICID XEO02202 GENEFORM Protein DME1243 XEOTICID XEO02202 MOACRIVE Inhibition DME1243 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1243 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02203 XEO_CLAS Peptide DME1243 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 20 microM) DME1243 XEOTICID XEO02203 GENEFORM Protein DME1243 XEOTICID XEO02203 MOACRIVE Inhibition DME1243 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1243 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02207 XEO_CLAS Peptide DME1243 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1243 XEOTICID XEO02207 GENEFORM Protein DME1243 XEOTICID XEO02207 MOACRIVE Inhibition DME1243 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1243 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02208 XEO_CLAS Peptide DME1243 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1243 XEOTICID XEO02208 GENEFORM Protein DME1243 XEOTICID XEO02208 MOACRIVE Inhibition DME1243 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1243 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02209 XEO_CLAS Peptide DME1243 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1243 XEOTICID XEO02209 GENEFORM Protein DME1243 XEOTICID XEO02209 MOACRIVE Inhibition DME1243 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1243 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02210 XEO_CLAS Peptide DME1243 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1243 XEOTICID XEO02210 GENEFORM Protein DME1243 XEOTICID XEO02210 MOACRIVE Inhibition DME1243 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1243 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02211 XEO_CLAS Peptide DME1243 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 3.13 ug/ml) DME1243 XEOTICID XEO02211 GENEFORM Protein DME1243 XEOTICID XEO02211 MOACRIVE Inhibition DME1243 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1243 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02212 XEO_CLAS Peptide DME1243 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1243 XEOTICID XEO02212 GENEFORM Protein DME1243 XEOTICID XEO02212 MOACRIVE Inhibition DME1243 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1243 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02213 XEO_CLAS Peptide DME1243 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1243 XEOTICID XEO02213 GENEFORM Protein DME1243 XEOTICID XEO02213 MOACRIVE Inhibition DME1243 XEOTICID XEO02224 XEO_NAME Androctonin DME1243 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02224 XEO_CLAS Peptide DME1243 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02224 GENEFORM Protein DME1243 XEOTICID XEO02224 MOACRIVE Inhibition DME1243 XEOTICID XEO02226 XEO_NAME Andropin DME1243 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02226 XEO_CLAS Peptide DME1243 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 17 microM) DME1243 XEOTICID XEO02226 GENEFORM Protein DME1243 XEOTICID XEO02226 MOACRIVE Inhibition DME1243 XEOTICID XEO02235 XEO_NAME Anthranilate DME1243 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1243 XEOTICID XEO02235 XEO_CLAS Natural Product DME1243 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02235 GENEFORM Protein DME1243 XEOTICID XEO02235 MOACRIVE Inhibition DME1243 XEOTICID XEO02237 XEO_NAME Antibacterial napin DME1243 XEOTICID XEO02237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02237 XEO_CLAS Peptide DME1243 XEOTICID XEO02237 DESCRIPT Antibacterial napin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 236 microM) DME1243 XEOTICID XEO02237 GENEFORM Protein DME1243 XEOTICID XEO02237 MOACRIVE Inhibition DME1243 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1243 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02241 XEO_CLAS Peptide DME1243 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02241 GENEFORM Protein DME1243 XEOTICID XEO02241 MOACRIVE Inhibition DME1243 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1243 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02248 XEO_CLAS Peptide DME1243 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 15 microM) DME1243 XEOTICID XEO02248 GENEFORM Protein DME1243 XEOTICID XEO02248 MOACRIVE Inhibition DME1243 XEOTICID XEO02249 XEO_NAME Anticancerous peptide Cr-ACP1 DME1243 XEOTICID XEO02249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02249 XEO_CLAS Peptide DME1243 XEOTICID XEO02249 DESCRIPT Anticancerous peptide Cr-ACP1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 30 microM) DME1243 XEOTICID XEO02249 GENEFORM Protein DME1243 XEOTICID XEO02249 MOACRIVE Inhibition DME1243 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1243 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02261 XEO_CLAS Peptide DME1243 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 76 ug/ml) DME1243 XEOTICID XEO02261 GENEFORM Protein DME1243 XEOTICID XEO02261 MOACRIVE Inhibition DME1243 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1243 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02268 XEO_CLAS Peptide DME1243 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 150 ug/ml) DME1243 XEOTICID XEO02268 GENEFORM Protein DME1243 XEOTICID XEO02268 MOACRIVE Inhibition DME1243 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1243 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02271 XEO_CLAS Peptide DME1243 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 257 ug/ml) DME1243 XEOTICID XEO02271 GENEFORM Protein DME1243 XEOTICID XEO02271 MOACRIVE Inhibition DME1243 XEOTICID XEO02278 XEO_NAME Antimicrobial peptide Ar-AMP DME1243 XEOTICID XEO02278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02278 XEO_CLAS Peptide DME1243 XEOTICID XEO02278 DESCRIPT Antimicrobial peptide Ar-AMP inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02278 GENEFORM Protein DME1243 XEOTICID XEO02278 MOACRIVE Inhibition DME1243 XEOTICID XEO02282 XEO_NAME Antimicrobial peptide GP-19 DME1243 XEOTICID XEO02282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02282 XEO_CLAS Peptide DME1243 XEOTICID XEO02282 DESCRIPT Antimicrobial peptide GP-19 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02282 GENEFORM Protein DME1243 XEOTICID XEO02282 MOACRIVE Inhibition DME1243 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1243 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02283 XEO_CLAS Peptide DME1243 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 3.13 ug/ml) DME1243 XEOTICID XEO02283 GENEFORM Protein DME1243 XEOTICID XEO02283 MOACRIVE Inhibition DME1243 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1243 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02288 XEO_CLAS Peptide DME1243 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12.3 ug/ml) DME1243 XEOTICID XEO02288 GENEFORM Protein DME1243 XEOTICID XEO02288 MOACRIVE Inhibition DME1243 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1243 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02289 XEO_CLAS Peptide DME1243 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12 ug/ml) DME1243 XEOTICID XEO02289 GENEFORM Protein DME1243 XEOTICID XEO02289 MOACRIVE Inhibition DME1243 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1243 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02298 XEO_CLAS Peptide DME1243 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 32 ug/ml) DME1243 XEOTICID XEO02298 GENEFORM Protein DME1243 XEOTICID XEO02298 MOACRIVE Inhibition DME1243 XEOTICID XEO02300 XEO_NAME Antimicrobial protein BL-A60 DME1243 XEOTICID XEO02300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02300 XEO_CLAS Peptide DME1243 XEOTICID XEO02300 DESCRIPT Antimicrobial protein BL-A60 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 5 microM) DME1243 XEOTICID XEO02300 GENEFORM Protein DME1243 XEOTICID XEO02300 MOACRIVE Inhibition DME1243 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1243 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02316 XEO_CLAS Peptide DME1243 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.25-12.5 microM) DME1243 XEOTICID XEO02316 GENEFORM Protein DME1243 XEOTICID XEO02316 MOACRIVE Inhibition DME1243 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1243 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02320 XEO_CLAS Peptide DME1243 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02320 GENEFORM Protein DME1243 XEOTICID XEO02320 MOACRIVE Inhibition DME1243 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1243 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02332 XEO_CLAS Peptide DME1243 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.95 ug/ml) DME1243 XEOTICID XEO02332 GENEFORM Protein DME1243 XEOTICID XEO02332 MOACRIVE Inhibition DME1243 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1243 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02452 XEO_CLAS Peptide DME1243 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 76800 ug/ml) DME1243 XEOTICID XEO02452 GENEFORM Protein DME1243 XEOTICID XEO02452 MOACRIVE Inhibition DME1243 XEOTICID XEO02476 XEO_NAME Bacteriocin HJ50 DME1243 XEOTICID XEO02476 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02476 XEO_CLAS Peptide DME1243 XEOTICID XEO02476 DESCRIPT Bacteriocin HJ50 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02476 GENEFORM Protein DME1243 XEOTICID XEO02476 MOACRIVE Inhibition DME1243 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1243 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02491 XEO_CLAS Peptide DME1243 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 24.4 microM) DME1243 XEOTICID XEO02491 GENEFORM Protein DME1243 XEOTICID XEO02491 MOACRIVE Inhibition DME1243 XEOTICID XEO02532 XEO_NAME Brevinin-1LT1 DME1243 XEOTICID XEO02532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02532 XEO_CLAS Peptide DME1243 XEOTICID XEO02532 DESCRIPT Brevinin-1LT1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.25 microM) DME1243 XEOTICID XEO02532 GENEFORM Protein DME1243 XEOTICID XEO02532 MOACRIVE Inhibition DME1243 XEOTICID XEO02588 XEO_NAME Brevinin-2GHa DME1243 XEOTICID XEO02588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02588 XEO_CLAS Peptide DME1243 XEOTICID XEO02588 DESCRIPT Brevinin-2GHa inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 64 ug/ml) DME1243 XEOTICID XEO02588 GENEFORM Protein DME1243 XEOTICID XEO02588 MOACRIVE Inhibition DME1243 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1243 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02589 XEO_CLAS Peptide DME1243 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 64 ug/ml) DME1243 XEOTICID XEO02589 GENEFORM Protein DME1243 XEOTICID XEO02589 MOACRIVE Inhibition DME1243 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1243 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02590 XEO_CLAS Peptide DME1243 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 64 ug/ml) DME1243 XEOTICID XEO02590 GENEFORM Protein DME1243 XEOTICID XEO02590 MOACRIVE Inhibition DME1243 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1243 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02595 XEO_CLAS Peptide DME1243 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12.5 microM) DME1243 XEOTICID XEO02595 GENEFORM Protein DME1243 XEOTICID XEO02595 MOACRIVE Inhibition DME1243 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1243 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02596 XEO_CLAS Peptide DME1243 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 25 microM) DME1243 XEOTICID XEO02596 GENEFORM Protein DME1243 XEOTICID XEO02596 MOACRIVE Inhibition DME1243 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1243 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02630 XEO_CLAS Peptide DME1243 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1243 XEOTICID XEO02630 GENEFORM Protein DME1243 XEOTICID XEO02630 MOACRIVE Inhibition DME1243 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1243 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02631 XEO_CLAS Peptide DME1243 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1243 XEOTICID XEO02631 GENEFORM Protein DME1243 XEOTICID XEO02631 MOACRIVE Inhibition DME1243 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1243 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02649 XEO_CLAS Peptide DME1243 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 4 ug/ml) DME1243 XEOTICID XEO02649 GENEFORM Protein DME1243 XEOTICID XEO02649 MOACRIVE Inhibition DME1243 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1243 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02650 XEO_CLAS Peptide DME1243 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2 ug/ml) DME1243 XEOTICID XEO02650 GENEFORM Protein DME1243 XEOTICID XEO02650 MOACRIVE Inhibition DME1243 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1243 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02663 XEO_CLAS Peptide DME1243 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.78 microM) DME1243 XEOTICID XEO02663 GENEFORM Protein DME1243 XEOTICID XEO02663 MOACRIVE Inhibition DME1243 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1243 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02664 XEO_CLAS Peptide DME1243 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.56 microM) DME1243 XEOTICID XEO02664 GENEFORM Protein DME1243 XEOTICID XEO02664 MOACRIVE Inhibition DME1243 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1243 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02672 XEO_CLAS Peptide DME1243 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.56 microM) DME1243 XEOTICID XEO02672 GENEFORM Protein DME1243 XEOTICID XEO02672 MOACRIVE Inhibition DME1243 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1243 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02673 XEO_CLAS Peptide DME1243 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.78-1.56 microM) DME1243 XEOTICID XEO02673 GENEFORM Protein DME1243 XEOTICID XEO02673 MOACRIVE Inhibition DME1243 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1243 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02674 XEO_CLAS Peptide DME1243 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.56 microM) DME1243 XEOTICID XEO02674 GENEFORM Protein DME1243 XEOTICID XEO02674 MOACRIVE Inhibition DME1243 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1243 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02676 XEO_CLAS Peptide DME1243 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.78 microM) DME1243 XEOTICID XEO02676 GENEFORM Protein DME1243 XEOTICID XEO02676 MOACRIVE Inhibition DME1243 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1243 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02677 XEO_CLAS Peptide DME1243 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.78 microM) DME1243 XEOTICID XEO02677 GENEFORM Protein DME1243 XEOTICID XEO02677 MOACRIVE Inhibition DME1243 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1243 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02679 XEO_CLAS Peptide DME1243 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.56 microM) DME1243 XEOTICID XEO02679 GENEFORM Protein DME1243 XEOTICID XEO02679 MOACRIVE Inhibition DME1243 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1243 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02680 XEO_CLAS Peptide DME1243 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.56 microM) DME1243 XEOTICID XEO02680 GENEFORM Protein DME1243 XEOTICID XEO02680 MOACRIVE Inhibition DME1243 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1243 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02683 XEO_CLAS Peptide DME1243 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.56 microM) DME1243 XEOTICID XEO02683 GENEFORM Protein DME1243 XEOTICID XEO02683 MOACRIVE Inhibition DME1243 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1243 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02735 XEO_CLAS Peptide DME1243 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC < 2 ug/ml) DME1243 XEOTICID XEO02735 GENEFORM Protein DME1243 XEOTICID XEO02735 MOACRIVE Inhibition DME1243 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1243 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02741 XEO_CLAS Peptide DME1243 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 100 ug/ml) DME1243 XEOTICID XEO02741 GENEFORM Protein DME1243 XEOTICID XEO02741 MOACRIVE Inhibition DME1243 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1243 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02743 XEO_CLAS Peptide DME1243 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 9.4 ug/ml) DME1243 XEOTICID XEO02743 GENEFORM Protein DME1243 XEOTICID XEO02743 MOACRIVE Inhibition DME1243 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1243 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02744 XEO_CLAS Peptide DME1243 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 75 ug/ml) DME1243 XEOTICID XEO02744 GENEFORM Protein DME1243 XEOTICID XEO02744 MOACRIVE Inhibition DME1243 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1243 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02756 XEO_CLAS Peptide DME1243 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.4 microM) DME1243 XEOTICID XEO02756 GENEFORM Protein DME1243 XEOTICID XEO02756 MOACRIVE Inhibition DME1243 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1243 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02757 XEO_CLAS Peptide DME1243 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.5 microM) DME1243 XEOTICID XEO02757 GENEFORM Protein DME1243 XEOTICID XEO02757 MOACRIVE Inhibition DME1243 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1243 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02758 XEO_CLAS Peptide DME1243 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 3 microM) DME1243 XEOTICID XEO02758 GENEFORM Protein DME1243 XEOTICID XEO02758 MOACRIVE Inhibition DME1243 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1243 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02759 XEO_CLAS Peptide DME1243 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.6 microM) DME1243 XEOTICID XEO02759 GENEFORM Protein DME1243 XEOTICID XEO02759 MOACRIVE Inhibition DME1243 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1243 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02760 XEO_CLAS Peptide DME1243 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.3 microM) DME1243 XEOTICID XEO02760 GENEFORM Protein DME1243 XEOTICID XEO02760 MOACRIVE Inhibition DME1243 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1243 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02761 XEO_CLAS Peptide DME1243 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1 microM) DME1243 XEOTICID XEO02761 GENEFORM Protein DME1243 XEOTICID XEO02761 MOACRIVE Inhibition DME1243 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1243 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02762 XEO_CLAS Peptide DME1243 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.3 microM) DME1243 XEOTICID XEO02762 GENEFORM Protein DME1243 XEOTICID XEO02762 MOACRIVE Inhibition DME1243 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1243 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02763 XEO_CLAS Peptide DME1243 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.3 microM) DME1243 XEOTICID XEO02763 GENEFORM Protein DME1243 XEOTICID XEO02763 MOACRIVE Inhibition DME1243 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1243 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02764 XEO_CLAS Peptide DME1243 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.7 microM) DME1243 XEOTICID XEO02764 GENEFORM Protein DME1243 XEOTICID XEO02764 MOACRIVE Inhibition DME1243 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1243 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02765 XEO_CLAS Peptide DME1243 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.4 microM) DME1243 XEOTICID XEO02765 GENEFORM Protein DME1243 XEOTICID XEO02765 MOACRIVE Inhibition DME1243 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1243 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02767 XEO_CLAS Peptide DME1243 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02767 GENEFORM Protein DME1243 XEOTICID XEO02767 MOACRIVE Inhibition DME1243 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1243 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02768 XEO_CLAS Peptide DME1243 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02768 GENEFORM Protein DME1243 XEOTICID XEO02768 MOACRIVE Inhibition DME1243 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1243 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02769 XEO_CLAS Peptide DME1243 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 18 microM) DME1243 XEOTICID XEO02769 GENEFORM Protein DME1243 XEOTICID XEO02769 MOACRIVE Inhibition DME1243 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1243 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02770 XEO_CLAS Peptide DME1243 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 17 microM) DME1243 XEOTICID XEO02770 GENEFORM Protein DME1243 XEOTICID XEO02770 MOACRIVE Inhibition DME1243 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1243 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02771 XEO_CLAS Peptide DME1243 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 81 microM) DME1243 XEOTICID XEO02771 GENEFORM Protein DME1243 XEOTICID XEO02771 MOACRIVE Inhibition DME1243 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1243 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02772 XEO_CLAS Peptide DME1243 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02772 GENEFORM Protein DME1243 XEOTICID XEO02772 MOACRIVE Inhibition DME1243 XEOTICID XEO02780 XEO_NAME Cefixime DME1243 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1243 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1243 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02780 GENEFORM Protein DME1243 XEOTICID XEO02780 MOACRIVE Inhibition DME1243 XEOTICID XEO02801 XEO_NAME Cephalexin DME1243 XEOTICID XEO02801 XEO_TYPE Pharmaceutical Agent(s) DME1243 XEOTICID XEO02801 XEO_CLAS Approved/Marketed Drug DME1243 XEOTICID XEO02801 DESCRIPT Cephalexin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02801 GENEFORM Protein DME1243 XEOTICID XEO02801 MOACRIVE Inhibition DME1243 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1243 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02802 XEO_CLAS Peptide DME1243 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 5.9 microM) DME1243 XEOTICID XEO02802 GENEFORM Protein DME1243 XEOTICID XEO02802 MOACRIVE Inhibition DME1243 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1243 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02807 XEO_CLAS Peptide DME1243 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.4 ug/mL) DME1243 XEOTICID XEO02807 GENEFORM Protein DME1243 XEOTICID XEO02807 MOACRIVE Inhibition DME1243 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1243 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02821 XEO_CLAS Peptide DME1243 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02821 GENEFORM Protein DME1243 XEOTICID XEO02821 MOACRIVE Inhibition DME1243 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1243 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02839 XEO_CLAS Peptide DME1243 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.25 microM) DME1243 XEOTICID XEO02839 GENEFORM Protein DME1243 XEOTICID XEO02839 MOACRIVE Inhibition DME1243 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1243 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02841 XEO_CLAS Peptide DME1243 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.25 microM) DME1243 XEOTICID XEO02841 GENEFORM Protein DME1243 XEOTICID XEO02841 MOACRIVE Inhibition DME1243 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1243 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02842 XEO_CLAS Peptide DME1243 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.25 microM) DME1243 XEOTICID XEO02842 GENEFORM Protein DME1243 XEOTICID XEO02842 MOACRIVE Inhibition DME1243 XEOTICID XEO02962 XEO_NAME Cryptonin DME1243 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02962 XEO_CLAS Peptide DME1243 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 3.12 ug/ml) DME1243 XEOTICID XEO02962 GENEFORM Protein DME1243 XEOTICID XEO02962 MOACRIVE Inhibition DME1243 XEOTICID XEO02966 XEO_NAME C. ternatea-antimicrobial peptide Ct-AMP1 DME1243 XEOTICID XEO02966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO02966 XEO_CLAS Peptide DME1243 XEOTICID XEO02966 DESCRIPT C. ternatea-antimicrobial peptide Ct-AMP1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02966 GENEFORM Protein DME1243 XEOTICID XEO02966 MOACRIVE Inhibition DME1243 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1243 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1243 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1243 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO02990 GENEFORM Protein DME1243 XEOTICID XEO02990 MOACRIVE Inhibition DME1243 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1243 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03051 XEO_CLAS Peptide DME1243 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 25 ug/ml) DME1243 XEOTICID XEO03051 GENEFORM Protein DME1243 XEOTICID XEO03051 MOACRIVE Inhibition DME1243 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1243 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03052 XEO_CLAS Peptide DME1243 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2.5 ug/ml) DME1243 XEOTICID XEO03052 GENEFORM Protein DME1243 XEOTICID XEO03052 MOACRIVE Inhibition DME1243 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1243 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03053 XEO_CLAS Peptide DME1243 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 25 ug/ml) DME1243 XEOTICID XEO03053 GENEFORM Protein DME1243 XEOTICID XEO03053 MOACRIVE Inhibition DME1243 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1243 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03060 XEO_CLAS Peptide DME1243 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1 microM) DME1243 XEOTICID XEO03060 GENEFORM Protein DME1243 XEOTICID XEO03060 MOACRIVE Inhibition DME1243 XEOTICID XEO03089 XEO_NAME Decoralin DME1243 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03089 XEO_CLAS Peptide DME1243 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 40 microM) DME1243 XEOTICID XEO03089 GENEFORM Protein DME1243 XEOTICID XEO03089 MOACRIVE Inhibition DME1243 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1243 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03100 XEO_CLAS Peptide DME1243 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03100 GENEFORM Protein DME1243 XEOTICID XEO03100 MOACRIVE Inhibition DME1243 XEOTICID XEO03101 XEO_NAME Defensin varisin A1 DME1243 XEOTICID XEO03101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03101 XEO_CLAS Peptide DME1243 XEOTICID XEO03101 DESCRIPT Defensin varisin A1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03101 GENEFORM Protein DME1243 XEOTICID XEO03101 MOACRIVE Inhibition DME1243 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1243 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03103 XEO_CLAS Peptide DME1243 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03103 GENEFORM Protein DME1243 XEOTICID XEO03103 MOACRIVE Inhibition DME1243 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1243 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03105 XEO_CLAS Peptide DME1243 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03105 GENEFORM Protein DME1243 XEOTICID XEO03105 MOACRIVE Inhibition DME1243 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1243 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03112 XEO_CLAS Peptide DME1243 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 50 ug/ml) DME1243 XEOTICID XEO03112 GENEFORM Protein DME1243 XEOTICID XEO03112 MOACRIVE Inhibition DME1243 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1243 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03116 XEO_CLAS Peptide DME1243 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 40 microM) DME1243 XEOTICID XEO03116 GENEFORM Protein DME1243 XEOTICID XEO03116 MOACRIVE Inhibition DME1243 XEOTICID XEO03117 XEO_NAME Insect defensin B DME1243 XEOTICID XEO03117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03117 XEO_CLAS Peptide DME1243 XEOTICID XEO03117 DESCRIPT Insect defensin B inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 20-40 microM) DME1243 XEOTICID XEO03117 GENEFORM Protein DME1243 XEOTICID XEO03117 MOACRIVE Inhibition DME1243 XEOTICID XEO03120 XEO_NAME Defensin-like protein Dm-AMP1 DME1243 XEOTICID XEO03120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03120 XEO_CLAS Peptide DME1243 XEOTICID XEO03120 DESCRIPT Defensin-like protein Dm-AMP1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03120 GENEFORM Protein DME1243 XEOTICID XEO03120 MOACRIVE Inhibition DME1243 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1243 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03121 XEO_CLAS Peptide DME1243 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03121 GENEFORM Protein DME1243 XEOTICID XEO03121 MOACRIVE Inhibition DME1243 XEOTICID XEO03123 XEO_NAME Defensin-like protein fabatin-2 DME1243 XEOTICID XEO03123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03123 XEO_CLAS Peptide DME1243 XEOTICID XEO03123 DESCRIPT Defensin-like protein fabatin-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03123 GENEFORM Protein DME1243 XEOTICID XEO03123 MOACRIVE Inhibition DME1243 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1243 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03124 XEO_CLAS Peptide DME1243 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03124 GENEFORM Protein DME1243 XEOTICID XEO03124 MOACRIVE Inhibition DME1243 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1243 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03215 XEO_CLAS Peptide DME1243 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2.5 ug/ml) DME1243 XEOTICID XEO03215 GENEFORM Protein DME1243 XEOTICID XEO03215 MOACRIVE Inhibition DME1243 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1243 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03216 XEO_CLAS Peptide DME1243 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2 ug/ml) DME1243 XEOTICID XEO03216 GENEFORM Protein DME1243 XEOTICID XEO03216 MOACRIVE Inhibition DME1243 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1243 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03217 XEO_CLAS Peptide DME1243 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2 ug/ml) DME1243 XEOTICID XEO03217 GENEFORM Protein DME1243 XEOTICID XEO03217 MOACRIVE Inhibition DME1243 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1243 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03223 XEO_CLAS Peptide DME1243 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 3.2 microM) DME1243 XEOTICID XEO03223 GENEFORM Protein DME1243 XEOTICID XEO03223 MOACRIVE Inhibition DME1243 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1243 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03225 XEO_CLAS Peptide DME1243 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 16 microM) DME1243 XEOTICID XEO03225 GENEFORM Protein DME1243 XEOTICID XEO03225 MOACRIVE Inhibition DME1243 XEOTICID XEO03233 XEO_NAME Dybowskin-1 DME1243 XEOTICID XEO03233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03233 XEO_CLAS Peptide DME1243 XEOTICID XEO03233 DESCRIPT Dybowskin-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 50 ug/ml) DME1243 XEOTICID XEO03233 GENEFORM Protein DME1243 XEOTICID XEO03233 MOACRIVE Inhibition DME1243 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1243 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03235 XEO_CLAS Peptide DME1243 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 25 ug/ml) DME1243 XEOTICID XEO03235 GENEFORM Protein DME1243 XEOTICID XEO03235 MOACRIVE Inhibition DME1243 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1243 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03237 XEO_CLAS Peptide DME1243 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 60 ug/ml) DME1243 XEOTICID XEO03237 GENEFORM Protein DME1243 XEOTICID XEO03237 MOACRIVE Inhibition DME1243 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1243 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03238 XEO_CLAS Peptide DME1243 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1243 XEOTICID XEO03238 GENEFORM Protein DME1243 XEOTICID XEO03238 MOACRIVE Inhibition DME1243 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1243 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03239 XEO_CLAS Peptide DME1243 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 50 ug/ml) DME1243 XEOTICID XEO03239 GENEFORM Protein DME1243 XEOTICID XEO03239 MOACRIVE Inhibition DME1243 XEOTICID XEO03240 XEO_NAME Dybowskin-6 DME1243 XEOTICID XEO03240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03240 XEO_CLAS Peptide DME1243 XEOTICID XEO03240 DESCRIPT Dybowskin-6 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 50 ug/ml) DME1243 XEOTICID XEO03240 GENEFORM Protein DME1243 XEOTICID XEO03240 MOACRIVE Inhibition DME1243 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1243 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03250 XEO_CLAS Peptide DME1243 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03250 GENEFORM Protein DME1243 XEOTICID XEO03250 MOACRIVE Inhibition DME1243 XEOTICID XEO03252 XEO_NAME Enterocin B DME1243 XEOTICID XEO03252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03252 XEO_CLAS Peptide DME1243 XEOTICID XEO03252 DESCRIPT Enterocin B inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 44.5 microM) DME1243 XEOTICID XEO03252 GENEFORM Protein DME1243 XEOTICID XEO03252 MOACRIVE Inhibition DME1243 XEOTICID XEO03254 XEO_NAME Enterocin EJ97 DME1243 XEOTICID XEO03254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03254 XEO_CLAS Peptide DME1243 XEOTICID XEO03254 DESCRIPT Enterocin EJ97 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12 ug/ml) DME1243 XEOTICID XEO03254 GENEFORM Protein DME1243 XEOTICID XEO03254 MOACRIVE Inhibition DME1243 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1243 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03258 XEO_CLAS Peptide DME1243 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03258 GENEFORM Protein DME1243 XEOTICID XEO03258 MOACRIVE Inhibition DME1243 XEOTICID XEO03260 XEO_NAME Enterocin X beta DME1243 XEOTICID XEO03260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03260 XEO_CLAS Peptide DME1243 XEOTICID XEO03260 DESCRIPT Enterocin X beta inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 3.25 microM) DME1243 XEOTICID XEO03260 GENEFORM Protein DME1243 XEOTICID XEO03260 MOACRIVE Inhibition DME1243 XEOTICID XEO03270 XEO_NAME Ericin S DME1243 XEOTICID XEO03270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03270 XEO_CLAS Peptide DME1243 XEOTICID XEO03270 DESCRIPT Ericin S inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03270 GENEFORM Protein DME1243 XEOTICID XEO03270 MOACRIVE Inhibition DME1243 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1243 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03281 XEO_CLAS Peptide DME1243 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 25 microM) DME1243 XEOTICID XEO03281 GENEFORM Protein DME1243 XEOTICID XEO03281 MOACRIVE Inhibition DME1243 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1243 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03282 XEO_CLAS Peptide DME1243 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12.5 microM) DME1243 XEOTICID XEO03282 GENEFORM Protein DME1243 XEOTICID XEO03282 MOACRIVE Inhibition DME1243 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1243 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03306 XEO_CLAS Peptide DME1243 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.3 microM) DME1243 XEOTICID XEO03306 GENEFORM Protein DME1243 XEOTICID XEO03306 MOACRIVE Inhibition DME1243 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1243 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03362 XEO_CLAS Peptide DME1243 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 40 ug/ml) DME1243 XEOTICID XEO03362 GENEFORM Protein DME1243 XEOTICID XEO03362 MOACRIVE Inhibition DME1243 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1243 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03363 XEO_CLAS Peptide DME1243 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 30 microM) DME1243 XEOTICID XEO03363 GENEFORM Protein DME1243 XEOTICID XEO03363 MOACRIVE Inhibition DME1243 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1243 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03364 XEO_CLAS Peptide DME1243 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 30 microM) DME1243 XEOTICID XEO03364 GENEFORM Protein DME1243 XEOTICID XEO03364 MOACRIVE Inhibition DME1243 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1243 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03366 XEO_CLAS Peptide DME1243 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 60 microM) DME1243 XEOTICID XEO03366 GENEFORM Protein DME1243 XEOTICID XEO03366 MOACRIVE Inhibition DME1243 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1243 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03367 XEO_CLAS Peptide DME1243 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 30 microM) DME1243 XEOTICID XEO03367 GENEFORM Protein DME1243 XEOTICID XEO03367 MOACRIVE Inhibition DME1243 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1243 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03368 XEO_CLAS Peptide DME1243 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 7.5 microM) DME1243 XEOTICID XEO03368 GENEFORM Protein DME1243 XEOTICID XEO03368 MOACRIVE Inhibition DME1243 XEOTICID XEO03431 XEO_NAME Thanatin truncated isoform G18C(1-18) DME1243 XEOTICID XEO03431 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03431 XEO_CLAS Peptide DME1243 XEOTICID XEO03431 DESCRIPT Thanatin truncated isoform G18C(1-18) inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 5-10 microM) DME1243 XEOTICID XEO03431 GENEFORM Protein DME1243 XEOTICID XEO03431 MOACRIVE Inhibition DME1243 XEOTICID XEO03435 XEO_NAME Thanatin truncated isoform G20R(1-20) DME1243 XEOTICID XEO03435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03435 XEO_CLAS Peptide DME1243 XEOTICID XEO03435 DESCRIPT Thanatin truncated isoform G20R(1-20) inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 20-40 microM) DME1243 XEOTICID XEO03435 GENEFORM Protein DME1243 XEOTICID XEO03435 MOACRIVE Inhibition DME1243 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1243 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03436 XEO_CLAS Peptide DME1243 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 50 ug/ml) DME1243 XEOTICID XEO03436 GENEFORM Protein DME1243 XEOTICID XEO03436 MOACRIVE Inhibition DME1243 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1243 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03437 XEO_CLAS Peptide DME1243 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 10 ug/ml) DME1243 XEOTICID XEO03437 GENEFORM Protein DME1243 XEOTICID XEO03437 MOACRIVE Inhibition DME1243 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1243 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03438 XEO_CLAS Peptide DME1243 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 10 ug/ml) DME1243 XEOTICID XEO03438 GENEFORM Protein DME1243 XEOTICID XEO03438 MOACRIVE Inhibition DME1243 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1243 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03439 XEO_CLAS Peptide DME1243 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 10 ug/ml) DME1243 XEOTICID XEO03439 GENEFORM Protein DME1243 XEOTICID XEO03439 MOACRIVE Inhibition DME1243 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1243 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03440 XEO_CLAS Peptide DME1243 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 10 ug/ml) DME1243 XEOTICID XEO03440 GENEFORM Protein DME1243 XEOTICID XEO03440 MOACRIVE Inhibition DME1243 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1243 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03441 XEO_CLAS Peptide DME1243 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 10 ug/ml) DME1243 XEOTICID XEO03441 GENEFORM Protein DME1243 XEOTICID XEO03441 MOACRIVE Inhibition DME1243 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1243 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03442 XEO_CLAS Peptide DME1243 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 4.69 ug/ml) DME1243 XEOTICID XEO03442 GENEFORM Protein DME1243 XEOTICID XEO03442 MOACRIVE Inhibition DME1243 XEOTICID XEO03443 XEO_NAME Gaegurin-RN4 DME1243 XEOTICID XEO03443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03443 XEO_CLAS Peptide DME1243 XEOTICID XEO03443 DESCRIPT Gaegurin-RN4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2.34 ug/ml) DME1243 XEOTICID XEO03443 GENEFORM Protein DME1243 XEOTICID XEO03443 MOACRIVE Inhibition DME1243 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1243 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03444 XEO_CLAS Peptide DME1243 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 4.69 ug/ml) DME1243 XEOTICID XEO03444 GENEFORM Protein DME1243 XEOTICID XEO03444 MOACRIVE Inhibition DME1243 XEOTICID XEO03478 XEO_NAME Geobacillin I DME1243 XEOTICID XEO03478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03478 XEO_CLAS Peptide DME1243 XEOTICID XEO03478 DESCRIPT Geobacillin I inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03478 GENEFORM Protein DME1243 XEOTICID XEO03478 MOACRIVE Inhibition DME1243 XEOTICID XEO03479 XEO_NAME Geobacillin II DME1243 XEOTICID XEO03479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03479 XEO_CLAS Peptide DME1243 XEOTICID XEO03479 DESCRIPT Geobacillin II inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03479 GENEFORM Protein DME1243 XEOTICID XEO03479 MOACRIVE Inhibition DME1243 XEOTICID XEO03501 XEO_NAME Gramicidin [Scr2]-GS analogue DME1243 XEOTICID XEO03501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03501 XEO_CLAS Peptide DME1243 XEOTICID XEO03501 DESCRIPT Gramicidin [Scr2]-GS analogue inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.3 ug/ml) DME1243 XEOTICID XEO03501 GENEFORM Protein DME1243 XEOTICID XEO03501 MOACRIVE Inhibition DME1243 XEOTICID XEO03503 XEO_NAME Gramicidin S DME1243 XEOTICID XEO03503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03503 XEO_CLAS Peptide DME1243 XEOTICID XEO03503 DESCRIPT Gramicidin S inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.6 ug/ml) DME1243 XEOTICID XEO03503 GENEFORM Protein DME1243 XEOTICID XEO03503 MOACRIVE Inhibition DME1243 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1243 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03504 XEO_CLAS Peptide DME1243 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 25 ug/ml) DME1243 XEOTICID XEO03504 GENEFORM Protein DME1243 XEOTICID XEO03504 MOACRIVE Inhibition DME1243 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1243 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03505 XEO_CLAS Peptide DME1243 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1243 XEOTICID XEO03505 GENEFORM Protein DME1243 XEOTICID XEO03505 MOACRIVE Inhibition DME1243 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1243 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03506 XEO_CLAS Peptide DME1243 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1243 XEOTICID XEO03506 GENEFORM Protein DME1243 XEOTICID XEO03506 MOACRIVE Inhibition DME1243 XEOTICID XEO03510 XEO_NAME Crab GRPSp peptide DME1243 XEOTICID XEO03510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03510 XEO_CLAS Peptide DME1243 XEOTICID XEO03510 DESCRIPT Crab GRPSp peptide inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 50 microM) DME1243 XEOTICID XEO03510 GENEFORM Protein DME1243 XEOTICID XEO03510 MOACRIVE Inhibition DME1243 XEOTICID XEO03512 XEO_NAME Guentherin AMP-3 DME1243 XEOTICID XEO03512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03512 XEO_CLAS Peptide DME1243 XEOTICID XEO03512 DESCRIPT Guentherin AMP-3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 64 ug/ml) DME1243 XEOTICID XEO03512 GENEFORM Protein DME1243 XEOTICID XEO03512 MOACRIVE Inhibition DME1243 XEOTICID XEO03542 XEO_NAME Hepcidin DME1243 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03542 XEO_CLAS Peptide DME1243 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6 microM) DME1243 XEOTICID XEO03542 GENEFORM Protein DME1243 XEOTICID XEO03542 MOACRIVE Inhibition DME1243 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1243 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03544 XEO_CLAS Peptide DME1243 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03544 GENEFORM Protein DME1243 XEOTICID XEO03544 MOACRIVE Inhibition DME1243 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1243 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03549 XEO_CLAS Peptide DME1243 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03549 GENEFORM Protein DME1243 XEOTICID XEO03549 MOACRIVE Inhibition DME1243 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1243 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03561 XEO_CLAS Peptide DME1243 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03561 GENEFORM Protein DME1243 XEOTICID XEO03561 MOACRIVE Inhibition DME1243 XEOTICID XEO03566 XEO_NAME Histone H2A DME1243 XEOTICID XEO03566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03566 XEO_CLAS Peptide DME1243 XEOTICID XEO03566 DESCRIPT Histone H2A inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.6-1.2 microM) DME1243 XEOTICID XEO03566 GENEFORM Protein DME1243 XEOTICID XEO03566 MOACRIVE Inhibition DME1243 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1243 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03606 XEO_CLAS Peptide DME1243 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03606 GENEFORM Protein DME1243 XEOTICID XEO03606 MOACRIVE Inhibition DME1243 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1243 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03607 XEO_CLAS Peptide DME1243 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03607 GENEFORM Protein DME1243 XEOTICID XEO03607 MOACRIVE Inhibition DME1243 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1243 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03616 XEO_CLAS Peptide DME1243 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 8 microM) DME1243 XEOTICID XEO03616 GENEFORM Protein DME1243 XEOTICID XEO03616 MOACRIVE Inhibition DME1243 XEOTICID XEO03623 XEO_NAME Basic peptide AMP1 IB-AMP1 DME1243 XEOTICID XEO03623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03623 XEO_CLAS Peptide DME1243 XEOTICID XEO03623 DESCRIPT Basic peptide AMP1 IB-AMP1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03623 GENEFORM Protein DME1243 XEOTICID XEO03623 MOACRIVE Inhibition DME1243 XEOTICID XEO03624 XEO_NAME Basic peptide AMP4 IB-AMP4 DME1243 XEOTICID XEO03624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03624 XEO_CLAS Peptide DME1243 XEOTICID XEO03624 DESCRIPT Basic peptide AMP4 IB-AMP4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03624 GENEFORM Protein DME1243 XEOTICID XEO03624 MOACRIVE Inhibition DME1243 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1243 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03627 XEO_CLAS Peptide DME1243 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.8-1.6 microM) DME1243 XEOTICID XEO03627 GENEFORM Protein DME1243 XEOTICID XEO03627 MOACRIVE Inhibition DME1243 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1243 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03630 XEO_CLAS Peptide DME1243 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03630 GENEFORM Protein DME1243 XEOTICID XEO03630 MOACRIVE Inhibition DME1243 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1243 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03631 XEO_CLAS Peptide DME1243 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03631 GENEFORM Protein DME1243 XEOTICID XEO03631 MOACRIVE Inhibition DME1243 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1243 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03632 XEO_CLAS Peptide DME1243 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03632 GENEFORM Protein DME1243 XEOTICID XEO03632 MOACRIVE Inhibition DME1243 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1243 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03633 XEO_CLAS Peptide DME1243 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03633 GENEFORM Protein DME1243 XEOTICID XEO03633 MOACRIVE Inhibition DME1243 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1243 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03634 XEO_CLAS Peptide DME1243 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03634 GENEFORM Protein DME1243 XEOTICID XEO03634 MOACRIVE Inhibition DME1243 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1243 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03635 XEO_CLAS Peptide DME1243 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03635 GENEFORM Protein DME1243 XEOTICID XEO03635 MOACRIVE Inhibition DME1243 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1243 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03636 XEO_CLAS Peptide DME1243 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03636 GENEFORM Protein DME1243 XEOTICID XEO03636 MOACRIVE Inhibition DME1243 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1243 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03637 XEO_CLAS Peptide DME1243 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03637 GENEFORM Protein DME1243 XEOTICID XEO03637 MOACRIVE Inhibition DME1243 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1243 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03638 XEO_CLAS Peptide DME1243 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03638 GENEFORM Protein DME1243 XEOTICID XEO03638 MOACRIVE Inhibition DME1243 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1243 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03639 XEO_CLAS Peptide DME1243 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03639 GENEFORM Protein DME1243 XEOTICID XEO03639 MOACRIVE Inhibition DME1243 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1243 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03640 XEO_CLAS Peptide DME1243 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03640 GENEFORM Protein DME1243 XEOTICID XEO03640 MOACRIVE Inhibition DME1243 XEOTICID XEO03664 XEO_NAME Ixodes ricinus defensin def1 DME1243 XEOTICID XEO03664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03664 XEO_CLAS Peptide DME1243 XEOTICID XEO03664 DESCRIPT Ixodes ricinus defensin def1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.5 microM) DME1243 XEOTICID XEO03664 GENEFORM Protein DME1243 XEOTICID XEO03664 MOACRIVE Inhibition DME1243 XEOTICID XEO03665 XEO_NAME Ixodes ricinus defensin def2 DME1243 XEOTICID XEO03665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03665 XEO_CLAS Peptide DME1243 XEOTICID XEO03665 DESCRIPT Ixodes ricinus defensin def2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.75 microM) DME1243 XEOTICID XEO03665 GENEFORM Protein DME1243 XEOTICID XEO03665 MOACRIVE Inhibition DME1243 XEOTICID XEO03671 XEO_NAME Plant JCpep7 DME1243 XEOTICID XEO03671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03671 XEO_CLAS Peptide DME1243 XEOTICID XEO03671 DESCRIPT Plant JCpep7 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 24 ug/ml) DME1243 XEOTICID XEO03671 GENEFORM Protein DME1243 XEOTICID XEO03671 MOACRIVE Inhibition DME1243 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1243 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03672 XEO_CLAS Peptide DME1243 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 10 ug/ml) DME1243 XEOTICID XEO03672 GENEFORM Protein DME1243 XEOTICID XEO03672 MOACRIVE Inhibition DME1243 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1243 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03673 XEO_CLAS Peptide DME1243 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 30 ug/ml) DME1243 XEOTICID XEO03673 GENEFORM Protein DME1243 XEOTICID XEO03673 MOACRIVE Inhibition DME1243 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1243 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03678 XEO_CLAS Peptide DME1243 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2 ug/ml) DME1243 XEOTICID XEO03678 GENEFORM Protein DME1243 XEOTICID XEO03678 MOACRIVE Inhibition DME1243 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1243 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03681 XEO_CLAS Peptide DME1243 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 20-40 microM) DME1243 XEOTICID XEO03681 GENEFORM Protein DME1243 XEOTICID XEO03681 MOACRIVE Inhibition DME1243 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1243 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03709 XEO_CLAS Peptide DME1243 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1243 XEOTICID XEO03709 GENEFORM Protein DME1243 XEOTICID XEO03709 MOACRIVE Inhibition DME1243 XEOTICID XEO03737 XEO_NAME LlKmWn model peptide L4K2W4 DME1243 XEOTICID XEO03737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03737 XEO_CLAS Peptide DME1243 XEOTICID XEO03737 DESCRIPT LlKmWn model peptide L4K2W4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 25 ug/ml) DME1243 XEOTICID XEO03737 GENEFORM Protein DME1243 XEOTICID XEO03737 MOACRIVE Inhibition DME1243 XEOTICID XEO03739 XEO_NAME LlKmWn model peptide L4K3W4 DME1243 XEOTICID XEO03739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03739 XEO_CLAS Peptide DME1243 XEOTICID XEO03739 DESCRIPT LlKmWn model peptide L4K3W4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 50 ug/ml) DME1243 XEOTICID XEO03739 GENEFORM Protein DME1243 XEOTICID XEO03739 MOACRIVE Inhibition DME1243 XEOTICID XEO03740 XEO_NAME LlKmWn model peptide L4K3W5 DME1243 XEOTICID XEO03740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03740 XEO_CLAS Peptide DME1243 XEOTICID XEO03740 DESCRIPT LlKmWn model peptide L4K3W5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 50 ug/ml) DME1243 XEOTICID XEO03740 GENEFORM Protein DME1243 XEOTICID XEO03740 MOACRIVE Inhibition DME1243 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1243 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03744 XEO_CLAS Peptide DME1243 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1243 XEOTICID XEO03744 GENEFORM Protein DME1243 XEOTICID XEO03744 MOACRIVE Inhibition DME1243 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1243 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03746 XEO_CLAS Peptide DME1243 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2 ug/ml) DME1243 XEOTICID XEO03746 GENEFORM Protein DME1243 XEOTICID XEO03746 MOACRIVE Inhibition DME1243 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1243 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03747 XEO_CLAS Peptide DME1243 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1 ug/ml) DME1243 XEOTICID XEO03747 GENEFORM Protein DME1243 XEOTICID XEO03747 MOACRIVE Inhibition DME1243 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1243 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03748 XEO_CLAS Peptide DME1243 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2 ug/ml) DME1243 XEOTICID XEO03748 GENEFORM Protein DME1243 XEOTICID XEO03748 MOACRIVE Inhibition DME1243 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1243 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03749 XEO_CLAS Peptide DME1243 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2 ug/ml) DME1243 XEOTICID XEO03749 GENEFORM Protein DME1243 XEOTICID XEO03749 MOACRIVE Inhibition DME1243 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1243 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03750 XEO_CLAS Peptide DME1243 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2 ug/ml) DME1243 XEOTICID XEO03750 GENEFORM Protein DME1243 XEOTICID XEO03750 MOACRIVE Inhibition DME1243 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1243 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03751 XEO_CLAS Peptide DME1243 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2 ug/ml) DME1243 XEOTICID XEO03751 GENEFORM Protein DME1243 XEOTICID XEO03751 MOACRIVE Inhibition DME1243 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1243 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03752 XEO_CLAS Peptide DME1243 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2 ug/ml) DME1243 XEOTICID XEO03752 GENEFORM Protein DME1243 XEOTICID XEO03752 MOACRIVE Inhibition DME1243 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1243 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03753 XEO_CLAS Peptide DME1243 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.3 ug/ml) DME1243 XEOTICID XEO03753 GENEFORM Protein DME1243 XEOTICID XEO03753 MOACRIVE Inhibition DME1243 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1243 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03754 XEO_CLAS Peptide DME1243 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2 ug/ml) DME1243 XEOTICID XEO03754 GENEFORM Protein DME1243 XEOTICID XEO03754 MOACRIVE Inhibition DME1243 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1243 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03755 XEO_CLAS Peptide DME1243 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 4 ug/ml) DME1243 XEOTICID XEO03755 GENEFORM Protein DME1243 XEOTICID XEO03755 MOACRIVE Inhibition DME1243 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1243 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03756 XEO_CLAS Peptide DME1243 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2 ug/ml) DME1243 XEOTICID XEO03756 GENEFORM Protein DME1243 XEOTICID XEO03756 MOACRIVE Inhibition DME1243 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1243 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03759 XEO_CLAS Peptide DME1243 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.6 ug/ml) DME1243 XEOTICID XEO03759 GENEFORM Protein DME1243 XEOTICID XEO03759 MOACRIVE Inhibition DME1243 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1243 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03761 XEO_CLAS Peptide DME1243 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.6 ug/ml) DME1243 XEOTICID XEO03761 GENEFORM Protein DME1243 XEOTICID XEO03761 MOACRIVE Inhibition DME1243 XEOTICID XEO03762 XEO_NAME LlKmWn model peptide L7K5W7 DME1243 XEOTICID XEO03762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03762 XEO_CLAS Peptide DME1243 XEOTICID XEO03762 DESCRIPT LlKmWn model peptide L7K5W7 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 3.1 ug/ml) DME1243 XEOTICID XEO03762 GENEFORM Protein DME1243 XEOTICID XEO03762 MOACRIVE Inhibition DME1243 XEOTICID XEO03764 XEO_NAME LlKmWn model peptide L8K4W7 DME1243 XEOTICID XEO03764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03764 XEO_CLAS Peptide DME1243 XEOTICID XEO03764 DESCRIPT LlKmWn model peptide L8K4W7 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.3 ug/ml) DME1243 XEOTICID XEO03764 GENEFORM Protein DME1243 XEOTICID XEO03764 MOACRIVE Inhibition DME1243 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1243 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03771 XEO_CLAS Peptide DME1243 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03771 GENEFORM Protein DME1243 XEOTICID XEO03771 MOACRIVE Inhibition DME1243 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1243 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03793 XEO_CLAS Peptide DME1243 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 32 microM) DME1243 XEOTICID XEO03793 GENEFORM Protein DME1243 XEOTICID XEO03793 MOACRIVE Inhibition DME1243 XEOTICID XEO03804 XEO_NAME Lantibiotic lichenicidin VK21 A1 DME1243 XEOTICID XEO03804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03804 XEO_CLAS Peptide DME1243 XEOTICID XEO03804 DESCRIPT Lantibiotic lichenicidin VK21 A1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03804 GENEFORM Protein DME1243 XEOTICID XEO03804 MOACRIVE Inhibition DME1243 XEOTICID XEO03805 XEO_NAME Lantibiotic lichenicidin VK21 A2 DME1243 XEOTICID XEO03805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03805 XEO_CLAS Peptide DME1243 XEOTICID XEO03805 DESCRIPT Lantibiotic lichenicidin VK21 A2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03805 GENEFORM Protein DME1243 XEOTICID XEO03805 MOACRIVE Inhibition DME1243 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1243 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03810 XEO_CLAS Peptide DME1243 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03810 GENEFORM Protein DME1243 XEOTICID XEO03810 MOACRIVE Inhibition DME1243 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1243 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03928 XEO_CLAS Peptide DME1243 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 16 microM) DME1243 XEOTICID XEO03928 GENEFORM Protein DME1243 XEOTICID XEO03928 MOACRIVE Inhibition DME1243 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1243 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03933 XEO_CLAS Peptide DME1243 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.3 microM) DME1243 XEOTICID XEO03933 GENEFORM Protein DME1243 XEOTICID XEO03933 MOACRIVE Inhibition DME1243 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1243 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03934 XEO_CLAS Peptide DME1243 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.6 microM) DME1243 XEOTICID XEO03934 GENEFORM Protein DME1243 XEOTICID XEO03934 MOACRIVE Inhibition DME1243 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1243 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03935 XEO_CLAS Peptide DME1243 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.7 microM) DME1243 XEOTICID XEO03935 GENEFORM Protein DME1243 XEOTICID XEO03935 MOACRIVE Inhibition DME1243 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1243 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03936 XEO_CLAS Peptide DME1243 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.9 microM) DME1243 XEOTICID XEO03936 GENEFORM Protein DME1243 XEOTICID XEO03936 MOACRIVE Inhibition DME1243 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1243 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03937 XEO_CLAS Peptide DME1243 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.7 microM) DME1243 XEOTICID XEO03937 GENEFORM Protein DME1243 XEOTICID XEO03937 MOACRIVE Inhibition DME1243 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1243 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03938 XEO_CLAS Peptide DME1243 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.7 microM) DME1243 XEOTICID XEO03938 GENEFORM Protein DME1243 XEOTICID XEO03938 MOACRIVE Inhibition DME1243 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1243 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03939 XEO_CLAS Peptide DME1243 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.7 microM) DME1243 XEOTICID XEO03939 GENEFORM Protein DME1243 XEOTICID XEO03939 MOACRIVE Inhibition DME1243 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1243 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03940 XEO_CLAS Peptide DME1243 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.7 microM) DME1243 XEOTICID XEO03940 GENEFORM Protein DME1243 XEOTICID XEO03940 MOACRIVE Inhibition DME1243 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1243 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03941 XEO_CLAS Peptide DME1243 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.7 microM) DME1243 XEOTICID XEO03941 GENEFORM Protein DME1243 XEOTICID XEO03941 MOACRIVE Inhibition DME1243 XEOTICID XEO03942 XEO_NAME Lasioglossin LL-III derivative 10 DME1243 XEOTICID XEO03942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03942 XEO_CLAS Peptide DME1243 XEOTICID XEO03942 DESCRIPT Lasioglossin LL-III derivative 10 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 100 microM) DME1243 XEOTICID XEO03942 GENEFORM Protein DME1243 XEOTICID XEO03942 MOACRIVE Inhibition DME1243 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1243 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03943 XEO_CLAS Peptide DME1243 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.6 microM) DME1243 XEOTICID XEO03943 GENEFORM Protein DME1243 XEOTICID XEO03943 MOACRIVE Inhibition DME1243 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1243 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03944 XEO_CLAS Peptide DME1243 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.7 microM) DME1243 XEOTICID XEO03944 GENEFORM Protein DME1243 XEOTICID XEO03944 MOACRIVE Inhibition DME1243 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1243 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03945 XEO_CLAS Peptide DME1243 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.8 microM) DME1243 XEOTICID XEO03945 GENEFORM Protein DME1243 XEOTICID XEO03945 MOACRIVE Inhibition DME1243 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1243 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03947 XEO_CLAS Peptide DME1243 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.5 microM) DME1243 XEOTICID XEO03947 GENEFORM Protein DME1243 XEOTICID XEO03947 MOACRIVE Inhibition DME1243 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1243 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03948 XEO_CLAS Peptide DME1243 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 4.7 microM) DME1243 XEOTICID XEO03948 GENEFORM Protein DME1243 XEOTICID XEO03948 MOACRIVE Inhibition DME1243 XEOTICID XEO03949 XEO_NAME Lasioglossin LL-III derivative 8 DME1243 XEOTICID XEO03949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03949 XEO_CLAS Peptide DME1243 XEOTICID XEO03949 DESCRIPT Lasioglossin LL-III derivative 8 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 40 microM) DME1243 XEOTICID XEO03949 GENEFORM Protein DME1243 XEOTICID XEO03949 MOACRIVE Inhibition DME1243 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1243 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1243 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1243 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03968 GENEFORM Protein DME1243 XEOTICID XEO03968 MOACRIVE Inhibition DME1243 XEOTICID XEO03971 XEO_NAME Lumbrican DME1243 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03971 XEO_CLAS Peptide DME1243 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03971 GENEFORM Protein DME1243 XEOTICID XEO03971 MOACRIVE Inhibition DME1243 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1243 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03972 XEO_CLAS Peptide DME1243 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 8 ug/ml) DME1243 XEOTICID XEO03972 GENEFORM Protein DME1243 XEOTICID XEO03972 MOACRIVE Inhibition DME1243 XEOTICID XEO03973 XEO_NAME Lunatusin DME1243 XEOTICID XEO03973 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03973 XEO_CLAS Peptide DME1243 XEOTICID XEO03973 DESCRIPT Lunatusin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO03973 GENEFORM Protein DME1243 XEOTICID XEO03973 MOACRIVE Inhibition DME1243 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1243 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03996 XEO_CLAS Peptide DME1243 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 9 microM) DME1243 XEOTICID XEO03996 GENEFORM Protein DME1243 XEOTICID XEO03996 MOACRIVE Inhibition DME1243 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1243 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03997 XEO_CLAS Peptide DME1243 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 11.8 microM) DME1243 XEOTICID XEO03997 GENEFORM Protein DME1243 XEOTICID XEO03997 MOACRIVE Inhibition DME1243 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1243 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03998 XEO_CLAS Peptide DME1243 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 70 microM) DME1243 XEOTICID XEO03998 GENEFORM Protein DME1243 XEOTICID XEO03998 MOACRIVE Inhibition DME1243 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1243 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO03999 XEO_CLAS Peptide DME1243 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 7.3 microM) DME1243 XEOTICID XEO03999 GENEFORM Protein DME1243 XEOTICID XEO03999 MOACRIVE Inhibition DME1243 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1243 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04000 XEO_CLAS Peptide DME1243 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 4 ug/ml) DME1243 XEOTICID XEO04000 GENEFORM Protein DME1243 XEOTICID XEO04000 MOACRIVE Inhibition DME1243 XEOTICID XEO04055 XEO_NAME Melectin DME1243 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04055 XEO_CLAS Peptide DME1243 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.8 microM) DME1243 XEOTICID XEO04055 GENEFORM Protein DME1243 XEOTICID XEO04055 MOACRIVE Inhibition DME1243 XEOTICID XEO04057 XEO_NAME Melittin DME1243 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04057 XEO_CLAS Peptide DME1243 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.2 microM) DME1243 XEOTICID XEO04057 GENEFORM Protein DME1243 XEOTICID XEO04057 MOACRIVE Inhibition DME1243 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1243 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04121 XEO_CLAS Peptide DME1243 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.6-3.2 microM) DME1243 XEOTICID XEO04121 GENEFORM Protein DME1243 XEOTICID XEO04121 MOACRIVE Inhibition DME1243 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1243 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04122 XEO_CLAS Peptide DME1243 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.57-3.14 microM) DME1243 XEOTICID XEO04122 GENEFORM Protein DME1243 XEOTICID XEO04122 MOACRIVE Inhibition DME1243 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1243 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04128 XEO_CLAS Peptide DME1243 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.19 microM) DME1243 XEOTICID XEO04128 GENEFORM Protein DME1243 XEOTICID XEO04128 MOACRIVE Inhibition DME1243 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1243 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04137 XEO_CLAS Peptide DME1243 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04137 GENEFORM Protein DME1243 XEOTICID XEO04137 MOACRIVE Inhibition DME1243 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1243 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04138 XEO_CLAS Peptide DME1243 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 15 microM) DME1243 XEOTICID XEO04138 GENEFORM Protein DME1243 XEOTICID XEO04138 MOACRIVE Inhibition DME1243 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1243 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04139 XEO_CLAS Peptide DME1243 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 25 microM) DME1243 XEOTICID XEO04139 GENEFORM Protein DME1243 XEOTICID XEO04139 MOACRIVE Inhibition DME1243 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1243 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04140 XEO_CLAS Peptide DME1243 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 35 microM) DME1243 XEOTICID XEO04140 GENEFORM Protein DME1243 XEOTICID XEO04140 MOACRIVE Inhibition DME1243 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1243 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04141 XEO_CLAS Peptide DME1243 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 40 microM) DME1243 XEOTICID XEO04141 GENEFORM Protein DME1243 XEOTICID XEO04141 MOACRIVE Inhibition DME1243 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1243 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04142 XEO_CLAS Peptide DME1243 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.5 microM) DME1243 XEOTICID XEO04142 GENEFORM Protein DME1243 XEOTICID XEO04142 MOACRIVE Inhibition DME1243 XEOTICID XEO04147 XEO_NAME Mucobromic acid DME1243 XEOTICID XEO04147 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1243 XEOTICID XEO04147 XEO_CLAS Chemical Compound DME1243 XEOTICID XEO04147 DESCRIPT Mucobromic acid inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04147 GENEFORM Protein DME1243 XEOTICID XEO04147 MOACRIVE Inhibition DME1243 XEOTICID XEO04148 XEO_NAME Mucochloric acid DME1243 XEOTICID XEO04148 XEO_TYPE Health or Environmental Toxicant(s) DME1243 XEOTICID XEO04148 XEO_CLAS Health Hazard/Toxicant DME1243 XEOTICID XEO04148 DESCRIPT Mucochloric acid inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04148 GENEFORM Protein DME1243 XEOTICID XEO04148 MOACRIVE Inhibition DME1243 XEOTICID XEO04149 XEO_NAME Mucroporin DME1243 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04149 XEO_CLAS Peptide DME1243 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 50 ug/ml) DME1243 XEOTICID XEO04149 GENEFORM Protein DME1243 XEOTICID XEO04149 MOACRIVE Inhibition DME1243 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1243 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04168 XEO_CLAS Peptide DME1243 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.2-2.5 microM) DME1243 XEOTICID XEO04168 GENEFORM Protein DME1243 XEOTICID XEO04168 MOACRIVE Inhibition DME1243 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1243 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04177 XEO_CLAS Peptide DME1243 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.0 microM) DME1243 XEOTICID XEO04177 GENEFORM Protein DME1243 XEOTICID XEO04177 MOACRIVE Inhibition DME1243 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1243 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04178 XEO_CLAS Peptide DME1243 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.4 microM) DME1243 XEOTICID XEO04178 GENEFORM Protein DME1243 XEOTICID XEO04178 MOACRIVE Inhibition DME1243 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1243 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04179 XEO_CLAS Peptide DME1243 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.2 microM) DME1243 XEOTICID XEO04179 GENEFORM Protein DME1243 XEOTICID XEO04179 MOACRIVE Inhibition DME1243 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1243 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04180 XEO_CLAS Peptide DME1243 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2.9 microM) DME1243 XEOTICID XEO04180 GENEFORM Protein DME1243 XEOTICID XEO04180 MOACRIVE Inhibition DME1243 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1243 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04181 XEO_CLAS Peptide DME1243 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.1 microM) DME1243 XEOTICID XEO04181 GENEFORM Protein DME1243 XEOTICID XEO04181 MOACRIVE Inhibition DME1243 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1243 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04182 XEO_CLAS Peptide DME1243 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.1 microM) DME1243 XEOTICID XEO04182 GENEFORM Protein DME1243 XEOTICID XEO04182 MOACRIVE Inhibition DME1243 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1243 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04183 XEO_CLAS Peptide DME1243 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.6 microM) DME1243 XEOTICID XEO04183 GENEFORM Protein DME1243 XEOTICID XEO04183 MOACRIVE Inhibition DME1243 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1243 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04184 XEO_CLAS Peptide DME1243 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.9 microM) DME1243 XEOTICID XEO04184 GENEFORM Protein DME1243 XEOTICID XEO04184 MOACRIVE Inhibition DME1243 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1243 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04185 XEO_CLAS Peptide DME1243 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04185 GENEFORM Protein DME1243 XEOTICID XEO04185 MOACRIVE Inhibition DME1243 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1243 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04206 XEO_CLAS Peptide DME1243 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.78 microM) DME1243 XEOTICID XEO04206 GENEFORM Protein DME1243 XEOTICID XEO04206 MOACRIVE Inhibition DME1243 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1243 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04214 XEO_CLAS Peptide DME1243 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.78 microM) DME1243 XEOTICID XEO04214 GENEFORM Protein DME1243 XEOTICID XEO04214 MOACRIVE Inhibition DME1243 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1243 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04216 XEO_CLAS Peptide DME1243 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.78 microM) DME1243 XEOTICID XEO04216 GENEFORM Protein DME1243 XEOTICID XEO04216 MOACRIVE Inhibition DME1243 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1243 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04218 XEO_CLAS Peptide DME1243 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.78 microM) DME1243 XEOTICID XEO04218 GENEFORM Protein DME1243 XEOTICID XEO04218 MOACRIVE Inhibition DME1243 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1243 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04219 XEO_CLAS Peptide DME1243 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.78 microM) DME1243 XEOTICID XEO04219 GENEFORM Protein DME1243 XEOTICID XEO04219 MOACRIVE Inhibition DME1243 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1243 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04220 XEO_CLAS Peptide DME1243 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.78 microM) DME1243 XEOTICID XEO04220 GENEFORM Protein DME1243 XEOTICID XEO04220 MOACRIVE Inhibition DME1243 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1243 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04221 XEO_CLAS Peptide DME1243 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.78 microM) DME1243 XEOTICID XEO04221 GENEFORM Protein DME1243 XEOTICID XEO04221 MOACRIVE Inhibition DME1243 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1243 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04222 XEO_CLAS Peptide DME1243 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.78 microM) DME1243 XEOTICID XEO04222 GENEFORM Protein DME1243 XEOTICID XEO04222 MOACRIVE Inhibition DME1243 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1243 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04233 XEO_CLAS Peptide DME1243 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04233 GENEFORM Protein DME1243 XEOTICID XEO04233 MOACRIVE Inhibition DME1243 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1243 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04234 XEO_CLAS Peptide DME1243 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04234 GENEFORM Protein DME1243 XEOTICID XEO04234 MOACRIVE Inhibition DME1243 XEOTICID XEO04235 XEO_NAME Napin-like polypeptide DME1243 XEOTICID XEO04235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04235 XEO_CLAS Peptide DME1243 XEOTICID XEO04235 DESCRIPT Napin-like polypeptide inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04235 GENEFORM Protein DME1243 XEOTICID XEO04235 MOACRIVE Inhibition DME1243 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1243 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04277 XEO_CLAS Peptide DME1243 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 110.00 ug/ml) DME1243 XEOTICID XEO04277 GENEFORM Protein DME1243 XEOTICID XEO04277 MOACRIVE Inhibition DME1243 XEOTICID XEO04278 XEO_NAME Nigroain-D3 DME1243 XEOTICID XEO04278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04278 XEO_CLAS Peptide DME1243 XEOTICID XEO04278 DESCRIPT Nigroain-D3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 55 ug/ml) DME1243 XEOTICID XEO04278 GENEFORM Protein DME1243 XEOTICID XEO04278 MOACRIVE Inhibition DME1243 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1243 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04280 XEO_CLAS Peptide DME1243 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 21.88 ug/ml) DME1243 XEOTICID XEO04280 GENEFORM Protein DME1243 XEOTICID XEO04280 MOACRIVE Inhibition DME1243 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1243 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04281 XEO_CLAS Peptide DME1243 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 9.38 ug/ml) DME1243 XEOTICID XEO04281 GENEFORM Protein DME1243 XEOTICID XEO04281 MOACRIVE Inhibition DME1243 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1243 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04298 XEO_CLAS Peptide DME1243 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12.5 microM) DME1243 XEOTICID XEO04298 GENEFORM Protein DME1243 XEOTICID XEO04298 MOACRIVE Inhibition DME1243 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1243 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04299 XEO_CLAS Peptide DME1243 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12.5 microM) DME1243 XEOTICID XEO04299 GENEFORM Protein DME1243 XEOTICID XEO04299 MOACRIVE Inhibition DME1243 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1243 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04307 XEO_CLAS Peptide DME1243 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 100 ug/ml) DME1243 XEOTICID XEO04307 GENEFORM Protein DME1243 XEOTICID XEO04307 MOACRIVE Inhibition DME1243 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1243 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04308 XEO_CLAS Peptide DME1243 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 37.50 ug/ml) DME1243 XEOTICID XEO04308 GENEFORM Protein DME1243 XEOTICID XEO04308 MOACRIVE Inhibition DME1243 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1243 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04312 XEO_CLAS Peptide DME1243 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 18.75 ug/ml) DME1243 XEOTICID XEO04312 GENEFORM Protein DME1243 XEOTICID XEO04312 MOACRIVE Inhibition DME1243 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1243 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04313 XEO_CLAS Peptide DME1243 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 18.75 ug/ml) DME1243 XEOTICID XEO04313 GENEFORM Protein DME1243 XEOTICID XEO04313 MOACRIVE Inhibition DME1243 XEOTICID XEO04331 XEO_NAME Norspermidine DME1243 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1243 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1243 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04331 GENEFORM Protein DME1243 XEOTICID XEO04331 MOACRIVE Inhibition DME1243 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1243 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04355 XEO_CLAS Peptide DME1243 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.85 ug/ml) DME1243 XEOTICID XEO04355 GENEFORM Protein DME1243 XEOTICID XEO04355 MOACRIVE Inhibition DME1243 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1243 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04356 XEO_CLAS Peptide DME1243 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 16.42 ug/ml) DME1243 XEOTICID XEO04356 GENEFORM Protein DME1243 XEOTICID XEO04356 MOACRIVE Inhibition DME1243 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1243 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04357 XEO_CLAS Peptide DME1243 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 8.16 ug/ml) DME1243 XEOTICID XEO04357 GENEFORM Protein DME1243 XEOTICID XEO04357 MOACRIVE Inhibition DME1243 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1243 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04358 XEO_CLAS Peptide DME1243 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 4.68 ug/ml) DME1243 XEOTICID XEO04358 GENEFORM Protein DME1243 XEOTICID XEO04358 MOACRIVE Inhibition DME1243 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1243 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04359 XEO_CLAS Peptide DME1243 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 8.40 ug/ml) DME1243 XEOTICID XEO04359 GENEFORM Protein DME1243 XEOTICID XEO04359 MOACRIVE Inhibition DME1243 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1243 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04365 XEO_CLAS Peptide DME1243 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 37.5 ug/ml) DME1243 XEOTICID XEO04365 GENEFORM Protein DME1243 XEOTICID XEO04365 MOACRIVE Inhibition DME1243 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1243 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04366 XEO_CLAS Peptide DME1243 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 5.90 ug/ml) DME1243 XEOTICID XEO04366 GENEFORM Protein DME1243 XEOTICID XEO04366 MOACRIVE Inhibition DME1243 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1243 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04367 XEO_CLAS Peptide DME1243 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 35.60 ug/ml) DME1243 XEOTICID XEO04367 GENEFORM Protein DME1243 XEOTICID XEO04367 MOACRIVE Inhibition DME1243 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1243 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04370 XEO_CLAS Peptide DME1243 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.10 ug/ml) DME1243 XEOTICID XEO04370 GENEFORM Protein DME1243 XEOTICID XEO04370 MOACRIVE Inhibition DME1243 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1243 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04371 XEO_CLAS Peptide DME1243 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 75 ug/ml) DME1243 XEOTICID XEO04371 GENEFORM Protein DME1243 XEOTICID XEO04371 MOACRIVE Inhibition DME1243 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1243 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04374 XEO_CLAS Peptide DME1243 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.75 ug/ml) DME1243 XEOTICID XEO04374 GENEFORM Protein DME1243 XEOTICID XEO04374 MOACRIVE Inhibition DME1243 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1243 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04375 XEO_CLAS Peptide DME1243 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1243 XEOTICID XEO04375 GENEFORM Protein DME1243 XEOTICID XEO04375 MOACRIVE Inhibition DME1243 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1243 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04377 XEO_CLAS Peptide DME1243 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 85.00 ug/ml) DME1243 XEOTICID XEO04377 GENEFORM Protein DME1243 XEOTICID XEO04377 MOACRIVE Inhibition DME1243 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1243 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04378 XEO_CLAS Peptide DME1243 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 17.50 ug/ml) DME1243 XEOTICID XEO04378 GENEFORM Protein DME1243 XEOTICID XEO04378 MOACRIVE Inhibition DME1243 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1243 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04379 XEO_CLAS Peptide DME1243 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 9.37 ug/ml) DME1243 XEOTICID XEO04379 GENEFORM Protein DME1243 XEOTICID XEO04379 MOACRIVE Inhibition DME1243 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1243 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04380 XEO_CLAS Peptide DME1243 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 18.00 ug/ml) DME1243 XEOTICID XEO04380 GENEFORM Protein DME1243 XEOTICID XEO04380 MOACRIVE Inhibition DME1243 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1243 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04381 XEO_CLAS Peptide DME1243 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.30 ug/ml) DME1243 XEOTICID XEO04381 GENEFORM Protein DME1243 XEOTICID XEO04381 MOACRIVE Inhibition DME1243 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1243 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04383 XEO_CLAS Peptide DME1243 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 128 ug/ml) DME1243 XEOTICID XEO04383 GENEFORM Protein DME1243 XEOTICID XEO04383 MOACRIVE Inhibition DME1243 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1243 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04396 XEO_CLAS Peptide DME1243 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.25-0.5 microM) DME1243 XEOTICID XEO04396 GENEFORM Protein DME1243 XEOTICID XEO04396 MOACRIVE Inhibition DME1243 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1243 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04397 XEO_CLAS Peptide DME1243 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.25-0.5 microM) DME1243 XEOTICID XEO04397 GENEFORM Protein DME1243 XEOTICID XEO04397 MOACRIVE Inhibition DME1243 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1243 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04399 XEO_CLAS Peptide DME1243 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12.5 microM) DME1243 XEOTICID XEO04399 GENEFORM Protein DME1243 XEOTICID XEO04399 MOACRIVE Inhibition DME1243 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1243 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04421 XEO_CLAS Peptide DME1243 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.5 microM) DME1243 XEOTICID XEO04421 GENEFORM Protein DME1243 XEOTICID XEO04421 MOACRIVE Inhibition DME1243 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1243 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04430 XEO_CLAS Peptide DME1243 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.78 microM) DME1243 XEOTICID XEO04430 GENEFORM Protein DME1243 XEOTICID XEO04430 MOACRIVE Inhibition DME1243 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1243 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04448 XEO_CLAS Peptide DME1243 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12.5 microM) DME1243 XEOTICID XEO04448 GENEFORM Protein DME1243 XEOTICID XEO04448 MOACRIVE Inhibition DME1243 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1243 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04455 XEO_CLAS Peptide DME1243 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12.5 microM) DME1243 XEOTICID XEO04455 GENEFORM Protein DME1243 XEOTICID XEO04455 MOACRIVE Inhibition DME1243 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1243 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04461 XEO_CLAS Peptide DME1243 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 5.2 microM) DME1243 XEOTICID XEO04461 GENEFORM Protein DME1243 XEOTICID XEO04461 MOACRIVE Inhibition DME1243 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1243 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04462 XEO_CLAS Peptide DME1243 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 4.8 microM) DME1243 XEOTICID XEO04462 GENEFORM Protein DME1243 XEOTICID XEO04462 MOACRIVE Inhibition DME1243 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1243 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04471 XEO_CLAS Peptide DME1243 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.3 microM) DME1243 XEOTICID XEO04471 GENEFORM Protein DME1243 XEOTICID XEO04471 MOACRIVE Inhibition DME1243 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1243 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04484 XEO_CLAS Peptide DME1243 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 45 microM) DME1243 XEOTICID XEO04484 GENEFORM Protein DME1243 XEOTICID XEO04484 MOACRIVE Inhibition DME1243 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1243 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04485 XEO_CLAS Peptide DME1243 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 10 microM) DME1243 XEOTICID XEO04485 GENEFORM Protein DME1243 XEOTICID XEO04485 MOACRIVE Inhibition DME1243 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1243 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04486 XEO_CLAS Peptide DME1243 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 15 microM) DME1243 XEOTICID XEO04486 GENEFORM Protein DME1243 XEOTICID XEO04486 MOACRIVE Inhibition DME1243 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1243 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04487 XEO_CLAS Peptide DME1243 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 20 microM) DME1243 XEOTICID XEO04487 GENEFORM Protein DME1243 XEOTICID XEO04487 MOACRIVE Inhibition DME1243 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1243 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04488 XEO_CLAS Peptide DME1243 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 5 microM) DME1243 XEOTICID XEO04488 GENEFORM Protein DME1243 XEOTICID XEO04488 MOACRIVE Inhibition DME1243 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1243 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04489 XEO_CLAS Peptide DME1243 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 8.5 microM) DME1243 XEOTICID XEO04489 GENEFORM Protein DME1243 XEOTICID XEO04489 MOACRIVE Inhibition DME1243 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1243 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04490 XEO_CLAS Peptide DME1243 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 17.5 microM) DME1243 XEOTICID XEO04490 GENEFORM Protein DME1243 XEOTICID XEO04490 MOACRIVE Inhibition DME1243 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1243 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04491 XEO_CLAS Peptide DME1243 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 17 microM) DME1243 XEOTICID XEO04491 GENEFORM Protein DME1243 XEOTICID XEO04491 MOACRIVE Inhibition DME1243 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1243 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04492 XEO_CLAS Peptide DME1243 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 40 microM) DME1243 XEOTICID XEO04492 GENEFORM Protein DME1243 XEOTICID XEO04492 MOACRIVE Inhibition DME1243 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1243 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04493 XEO_CLAS Peptide DME1243 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 87.5 microM) DME1243 XEOTICID XEO04493 GENEFORM Protein DME1243 XEOTICID XEO04493 MOACRIVE Inhibition DME1243 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1243 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04494 XEO_CLAS Peptide DME1243 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 100 microM) DME1243 XEOTICID XEO04494 GENEFORM Protein DME1243 XEOTICID XEO04494 MOACRIVE Inhibition DME1243 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1243 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04495 XEO_CLAS Peptide DME1243 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 22.5 microM) DME1243 XEOTICID XEO04495 GENEFORM Protein DME1243 XEOTICID XEO04495 MOACRIVE Inhibition DME1243 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1243 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04496 XEO_CLAS Peptide DME1243 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 25 microM) DME1243 XEOTICID XEO04496 GENEFORM Protein DME1243 XEOTICID XEO04496 MOACRIVE Inhibition DME1243 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1243 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04497 XEO_CLAS Peptide DME1243 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 17.5 microM) DME1243 XEOTICID XEO04497 GENEFORM Protein DME1243 XEOTICID XEO04497 MOACRIVE Inhibition DME1243 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1243 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04498 XEO_CLAS Peptide DME1243 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 22.5 microM) DME1243 XEOTICID XEO04498 GENEFORM Protein DME1243 XEOTICID XEO04498 MOACRIVE Inhibition DME1243 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1243 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04499 XEO_CLAS Peptide DME1243 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 15.5 microM) DME1243 XEOTICID XEO04499 GENEFORM Protein DME1243 XEOTICID XEO04499 MOACRIVE Inhibition DME1243 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1243 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04500 XEO_CLAS Peptide DME1243 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 100 microM) DME1243 XEOTICID XEO04500 GENEFORM Protein DME1243 XEOTICID XEO04500 MOACRIVE Inhibition DME1243 XEOTICID XEO04518 XEO_NAME Penicillic acid DME1243 XEOTICID XEO04518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1243 XEOTICID XEO04518 XEO_CLAS Natural Product DME1243 XEOTICID XEO04518 DESCRIPT Penicillic acid inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04518 GENEFORM Protein DME1243 XEOTICID XEO04518 MOACRIVE Inhibition DME1243 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1243 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04525 XEO_CLAS Peptide DME1243 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 8.0 microM) DME1243 XEOTICID XEO04525 GENEFORM Protein DME1243 XEOTICID XEO04525 MOACRIVE Inhibition DME1243 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1243 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04526 XEO_CLAS Peptide DME1243 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2.0 microM) DME1243 XEOTICID XEO04526 GENEFORM Protein DME1243 XEOTICID XEO04526 MOACRIVE Inhibition DME1243 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1243 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04540 XEO_CLAS Peptide DME1243 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 48.8 ug/ml) DME1243 XEOTICID XEO04540 GENEFORM Protein DME1243 XEOTICID XEO04540 MOACRIVE Inhibition DME1243 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1243 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04541 XEO_CLAS Peptide DME1243 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 5 ug/ml) DME1243 XEOTICID XEO04541 GENEFORM Protein DME1243 XEOTICID XEO04541 MOACRIVE Inhibition DME1243 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1243 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04542 XEO_CLAS Peptide DME1243 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04542 GENEFORM Protein DME1243 XEOTICID XEO04542 MOACRIVE Inhibition DME1243 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1243 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04551 XEO_CLAS Peptide DME1243 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 14.4 ug/ml) DME1243 XEOTICID XEO04551 GENEFORM Protein DME1243 XEOTICID XEO04551 MOACRIVE Inhibition DME1243 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1243 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04604 XEO_CLAS Peptide DME1243 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC < 50 microM) DME1243 XEOTICID XEO04604 GENEFORM Protein DME1243 XEOTICID XEO04604 MOACRIVE Inhibition DME1243 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1243 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04605 XEO_CLAS Peptide DME1243 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC < 50 microM) DME1243 XEOTICID XEO04605 GENEFORM Protein DME1243 XEOTICID XEO04605 MOACRIVE Inhibition DME1243 XEOTICID XEO04624 XEO_NAME Plantazolicin DME1243 XEOTICID XEO04624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04624 XEO_CLAS Peptide DME1243 XEOTICID XEO04624 DESCRIPT Plantazolicin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04624 GENEFORM Protein DME1243 XEOTICID XEO04624 MOACRIVE Inhibition DME1243 XEOTICID XEO04632 XEO_NAME Pleurain-B1 DME1243 XEOTICID XEO04632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04632 XEO_CLAS Peptide DME1243 XEOTICID XEO04632 DESCRIPT Pleurain-B1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 3.1 ug/ml) DME1243 XEOTICID XEO04632 GENEFORM Protein DME1243 XEOTICID XEO04632 MOACRIVE Inhibition DME1243 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1243 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04633 XEO_CLAS Peptide DME1243 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 3.1 ug/ml) DME1243 XEOTICID XEO04633 GENEFORM Protein DME1243 XEOTICID XEO04633 MOACRIVE Inhibition DME1243 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1243 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04634 XEO_CLAS Peptide DME1243 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 50 ug/ml) DME1243 XEOTICID XEO04634 GENEFORM Protein DME1243 XEOTICID XEO04634 MOACRIVE Inhibition DME1243 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1243 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04636 XEO_CLAS Peptide DME1243 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 100 ug/ml) DME1243 XEOTICID XEO04636 GENEFORM Protein DME1243 XEOTICID XEO04636 MOACRIVE Inhibition DME1243 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1243 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04637 XEO_CLAS Peptide DME1243 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 50 ug/ml) DME1243 XEOTICID XEO04637 GENEFORM Protein DME1243 XEOTICID XEO04637 MOACRIVE Inhibition DME1243 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1243 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04639 XEO_CLAS Peptide DME1243 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 100 ug/ml) DME1243 XEOTICID XEO04639 GENEFORM Protein DME1243 XEOTICID XEO04639 MOACRIVE Inhibition DME1243 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1243 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04640 XEO_CLAS Peptide DME1243 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.1-2.2 microM) DME1243 XEOTICID XEO04640 GENEFORM Protein DME1243 XEOTICID XEO04640 MOACRIVE Inhibition DME1243 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1243 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04664 XEO_CLAS Peptide DME1243 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 27.2 microM) DME1243 XEOTICID XEO04664 GENEFORM Protein DME1243 XEOTICID XEO04664 MOACRIVE Inhibition DME1243 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1243 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04665 XEO_CLAS Peptide DME1243 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 35 microM) DME1243 XEOTICID XEO04665 GENEFORM Protein DME1243 XEOTICID XEO04665 MOACRIVE Inhibition DME1243 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1243 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04666 XEO_CLAS Peptide DME1243 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 100 microM) DME1243 XEOTICID XEO04666 GENEFORM Protein DME1243 XEOTICID XEO04666 MOACRIVE Inhibition DME1243 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1243 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04667 XEO_CLAS Peptide DME1243 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 10 microM) DME1243 XEOTICID XEO04667 GENEFORM Protein DME1243 XEOTICID XEO04667 MOACRIVE Inhibition DME1243 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1243 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04668 XEO_CLAS Peptide DME1243 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 60 microM) DME1243 XEOTICID XEO04668 GENEFORM Protein DME1243 XEOTICID XEO04668 MOACRIVE Inhibition DME1243 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1243 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04669 XEO_CLAS Peptide DME1243 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 30 microM) DME1243 XEOTICID XEO04669 GENEFORM Protein DME1243 XEOTICID XEO04669 MOACRIVE Inhibition DME1243 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1243 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04670 XEO_CLAS Peptide DME1243 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 46 microM) DME1243 XEOTICID XEO04670 GENEFORM Protein DME1243 XEOTICID XEO04670 MOACRIVE Inhibition DME1243 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1243 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04671 XEO_CLAS Peptide DME1243 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 125 microM) DME1243 XEOTICID XEO04671 GENEFORM Protein DME1243 XEOTICID XEO04671 MOACRIVE Inhibition DME1243 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1243 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04672 XEO_CLAS Peptide DME1243 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 75 microM) DME1243 XEOTICID XEO04672 GENEFORM Protein DME1243 XEOTICID XEO04672 MOACRIVE Inhibition DME1243 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1243 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04673 XEO_CLAS Peptide DME1243 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 100 microM) DME1243 XEOTICID XEO04673 GENEFORM Protein DME1243 XEOTICID XEO04673 MOACRIVE Inhibition DME1243 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1243 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04674 XEO_CLAS Peptide DME1243 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 70 microM) DME1243 XEOTICID XEO04674 GENEFORM Protein DME1243 XEOTICID XEO04674 MOACRIVE Inhibition DME1243 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1243 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04675 XEO_CLAS Peptide DME1243 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 100 microM) DME1243 XEOTICID XEO04675 GENEFORM Protein DME1243 XEOTICID XEO04675 MOACRIVE Inhibition DME1243 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1243 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04676 XEO_CLAS Peptide DME1243 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 100 microM) DME1243 XEOTICID XEO04676 GENEFORM Protein DME1243 XEOTICID XEO04676 MOACRIVE Inhibition DME1243 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1243 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04677 XEO_CLAS Peptide DME1243 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 100 microM) DME1243 XEOTICID XEO04677 GENEFORM Protein DME1243 XEOTICID XEO04677 MOACRIVE Inhibition DME1243 XEOTICID XEO04678 XEO_NAME Plant defensin Pn-AMP1 DME1243 XEOTICID XEO04678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04678 XEO_CLAS Peptide DME1243 XEOTICID XEO04678 DESCRIPT Plant defensin Pn-AMP1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04678 GENEFORM Protein DME1243 XEOTICID XEO04678 MOACRIVE Inhibition DME1243 XEOTICID XEO04679 XEO_NAME Plant defensin Pn-AMP2 DME1243 XEOTICID XEO04679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04679 XEO_CLAS Peptide DME1243 XEOTICID XEO04679 DESCRIPT Plant defensin Pn-AMP2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04679 GENEFORM Protein DME1243 XEOTICID XEO04679 MOACRIVE Inhibition DME1243 XEOTICID XEO04681 XEO_NAME Polybia chemotactic peptide polybia-CP DME1243 XEOTICID XEO04681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04681 XEO_CLAS Peptide DME1243 XEOTICID XEO04681 DESCRIPT Polybia chemotactic peptide polybia-CP inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 15 ug/ml) DME1243 XEOTICID XEO04681 GENEFORM Protein DME1243 XEOTICID XEO04681 MOACRIVE Inhibition DME1243 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1243 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04695 XEO_CLAS Peptide DME1243 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04695 GENEFORM Protein DME1243 XEOTICID XEO04695 MOACRIVE Inhibition DME1243 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1243 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04697 XEO_CLAS Peptide DME1243 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04697 GENEFORM Protein DME1243 XEOTICID XEO04697 MOACRIVE Inhibition DME1243 XEOTICID XEO04707 XEO_NAME Pore-forming peptide ameobapore A DME1243 XEOTICID XEO04707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04707 XEO_CLAS Peptide DME1243 XEOTICID XEO04707 DESCRIPT Pore-forming peptide ameobapore A inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 27 microM) DME1243 XEOTICID XEO04707 GENEFORM Protein DME1243 XEOTICID XEO04707 MOACRIVE Inhibition DME1243 XEOTICID XEO04711 XEO_NAME Insect PP102 peptide DME1243 XEOTICID XEO04711 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04711 XEO_CLAS Peptide DME1243 XEOTICID XEO04711 DESCRIPT Insect PP102 peptide inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 25 microM) DME1243 XEOTICID XEO04711 GENEFORM Protein DME1243 XEOTICID XEO04711 MOACRIVE Inhibition DME1243 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1243 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04712 XEO_CLAS Peptide DME1243 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 23.3 microM) DME1243 XEOTICID XEO04712 GENEFORM Protein DME1243 XEOTICID XEO04712 MOACRIVE Inhibition DME1243 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1243 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04713 XEO_CLAS Peptide DME1243 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 13.3 microM) DME1243 XEOTICID XEO04713 GENEFORM Protein DME1243 XEOTICID XEO04713 MOACRIVE Inhibition DME1243 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1243 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04714 XEO_CLAS Peptide DME1243 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 16.7 microM) DME1243 XEOTICID XEO04714 GENEFORM Protein DME1243 XEOTICID XEO04714 MOACRIVE Inhibition DME1243 XEOTICID XEO04737 XEO_NAME Protonectin DME1243 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04737 XEO_CLAS Peptide DME1243 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 3.1 ug/ml) DME1243 XEOTICID XEO04737 GENEFORM Protein DME1243 XEOTICID XEO04737 MOACRIVE Inhibition DME1243 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1243 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04762 XEO_CLAS Peptide DME1243 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 3.1 microM) DME1243 XEOTICID XEO04762 GENEFORM Protein DME1243 XEOTICID XEO04762 MOACRIVE Inhibition DME1243 XEOTICID XEO04790 XEO_NAME Ranacyclin-B-AL1 DME1243 XEOTICID XEO04790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04790 XEO_CLAS Peptide DME1243 XEOTICID XEO04790 DESCRIPT Ranacyclin-B-AL1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 26 microM) DME1243 XEOTICID XEO04790 GENEFORM Protein DME1243 XEOTICID XEO04790 MOACRIVE Inhibition DME1243 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1243 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04793 XEO_CLAS Peptide DME1243 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 46.2 microM) DME1243 XEOTICID XEO04793 GENEFORM Protein DME1243 XEOTICID XEO04793 MOACRIVE Inhibition DME1243 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1243 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04865 XEO_CLAS Peptide DME1243 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1243 XEOTICID XEO04865 GENEFORM Protein DME1243 XEOTICID XEO04865 MOACRIVE Inhibition DME1243 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1243 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04866 XEO_CLAS Peptide DME1243 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1243 XEOTICID XEO04866 GENEFORM Protein DME1243 XEOTICID XEO04866 MOACRIVE Inhibition DME1243 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1243 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04868 XEO_CLAS Peptide DME1243 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 9.38 ug/ml) DME1243 XEOTICID XEO04868 GENEFORM Protein DME1243 XEOTICID XEO04868 MOACRIVE Inhibition DME1243 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1243 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04869 XEO_CLAS Peptide DME1243 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 18.75 ug/ml) DME1243 XEOTICID XEO04869 GENEFORM Protein DME1243 XEOTICID XEO04869 MOACRIVE Inhibition DME1243 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1243 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04870 XEO_CLAS Peptide DME1243 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 18.75 ug/ml) DME1243 XEOTICID XEO04870 GENEFORM Protein DME1243 XEOTICID XEO04870 MOACRIVE Inhibition DME1243 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1243 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04880 XEO_CLAS Peptide DME1243 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2.0 ug/ml) DME1243 XEOTICID XEO04880 GENEFORM Protein DME1243 XEOTICID XEO04880 MOACRIVE Inhibition DME1243 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1243 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04886 XEO_CLAS Peptide DME1243 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.3 ug/ml) DME1243 XEOTICID XEO04886 GENEFORM Protein DME1243 XEOTICID XEO04886 MOACRIVE Inhibition DME1243 XEOTICID XEO04892 XEO_NAME Seabream beta defensin saBD DME1243 XEOTICID XEO04892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04892 XEO_CLAS Peptide DME1243 XEOTICID XEO04892 DESCRIPT Seabream beta defensin saBD inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04892 GENEFORM Protein DME1243 XEOTICID XEO04892 MOACRIVE Inhibition DME1243 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1243 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04901 XEO_CLAS Peptide DME1243 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2 microM) DME1243 XEOTICID XEO04901 GENEFORM Protein DME1243 XEOTICID XEO04901 MOACRIVE Inhibition DME1243 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1243 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04904 XEO_CLAS Peptide DME1243 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 20.0 ug/ml) DME1243 XEOTICID XEO04904 GENEFORM Protein DME1243 XEOTICID XEO04904 MOACRIVE Inhibition DME1243 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1243 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04909 XEO_CLAS Peptide DME1243 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04909 GENEFORM Protein DME1243 XEOTICID XEO04909 MOACRIVE Inhibition DME1243 XEOTICID XEO04917 XEO_NAME Scorpine DME1243 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04917 XEO_CLAS Peptide DME1243 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 1.0 microM) DME1243 XEOTICID XEO04917 GENEFORM Protein DME1243 XEOTICID XEO04917 MOACRIVE Inhibition DME1243 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1243 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04956 XEO_CLAS Peptide DME1243 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 8.0 microM) DME1243 XEOTICID XEO04956 GENEFORM Protein DME1243 XEOTICID XEO04956 MOACRIVE Inhibition DME1243 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1243 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04971 XEO_CLAS Peptide DME1243 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.8-1.5 microM) DME1243 XEOTICID XEO04971 GENEFORM Protein DME1243 XEOTICID XEO04971 MOACRIVE Inhibition DME1243 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1243 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1243 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1243 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04975 GENEFORM Protein DME1243 XEOTICID XEO04975 MOACRIVE Inhibition DME1243 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1243 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1243 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1243 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04976 GENEFORM Protein DME1243 XEOTICID XEO04976 MOACRIVE Inhibition DME1243 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1243 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1243 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1243 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04977 GENEFORM Protein DME1243 XEOTICID XEO04977 MOACRIVE Inhibition DME1243 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1243 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1243 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1243 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04978 GENEFORM Protein DME1243 XEOTICID XEO04978 MOACRIVE Inhibition DME1243 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1243 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1243 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1243 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO04979 GENEFORM Protein DME1243 XEOTICID XEO04979 MOACRIVE Inhibition DME1243 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1243 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO04995 XEO_CLAS Peptide DME1243 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 6.25-12.5 microM) DME1243 XEOTICID XEO04995 GENEFORM Protein DME1243 XEOTICID XEO04995 MOACRIVE Inhibition DME1243 XEOTICID XEO05089 XEO_NAME Temporin-GH DME1243 XEOTICID XEO05089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05089 XEO_CLAS Peptide DME1243 XEOTICID XEO05089 DESCRIPT Temporin-GH inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC > 64 ug/ml) DME1243 XEOTICID XEO05089 GENEFORM Protein DME1243 XEOTICID XEO05089 MOACRIVE Inhibition DME1243 XEOTICID XEO05092 XEO_NAME Temporin-LT1 DME1243 XEOTICID XEO05092 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05092 XEO_CLAS Peptide DME1243 XEOTICID XEO05092 DESCRIPT Temporin-LT1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 25 microM) DME1243 XEOTICID XEO05092 GENEFORM Protein DME1243 XEOTICID XEO05092 MOACRIVE Inhibition DME1243 XEOTICID XEO05093 XEO_NAME Temporin-LT2 DME1243 XEOTICID XEO05093 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05093 XEO_CLAS Peptide DME1243 XEOTICID XEO05093 DESCRIPT Temporin-LT2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 50 microM) DME1243 XEOTICID XEO05093 GENEFORM Protein DME1243 XEOTICID XEO05093 MOACRIVE Inhibition DME1243 XEOTICID XEO05094 XEO_NAME Temporin-LTa DME1243 XEOTICID XEO05094 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05094 XEO_CLAS Peptide DME1243 XEOTICID XEO05094 DESCRIPT Temporin-LTa inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 10 ug/ml) DME1243 XEOTICID XEO05094 GENEFORM Protein DME1243 XEOTICID XEO05094 MOACRIVE Inhibition DME1243 XEOTICID XEO05095 XEO_NAME Temporin-LTb DME1243 XEOTICID XEO05095 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05095 XEO_CLAS Peptide DME1243 XEOTICID XEO05095 DESCRIPT Temporin-LTb inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 25 ug/ml) DME1243 XEOTICID XEO05095 GENEFORM Protein DME1243 XEOTICID XEO05095 MOACRIVE Inhibition DME1243 XEOTICID XEO05096 XEO_NAME Temporin-LTc DME1243 XEOTICID XEO05096 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05096 XEO_CLAS Peptide DME1243 XEOTICID XEO05096 DESCRIPT Temporin-LTc inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 50 ug/ml) DME1243 XEOTICID XEO05096 GENEFORM Protein DME1243 XEOTICID XEO05096 MOACRIVE Inhibition DME1243 XEOTICID XEO05120 XEO_NAME Thanatin DME1243 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05120 XEO_CLAS Peptide DME1243 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2.5-5 microM) DME1243 XEOTICID XEO05120 GENEFORM Protein DME1243 XEOTICID XEO05120 MOACRIVE Inhibition DME1243 XEOTICID XEO05129 XEO_NAME Thiocillin GE37468 DME1243 XEOTICID XEO05129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05129 XEO_CLAS Peptide DME1243 XEOTICID XEO05129 DESCRIPT Thiocillin GE37468 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.047 ug/ml) DME1243 XEOTICID XEO05129 GENEFORM Protein DME1243 XEOTICID XEO05129 MOACRIVE Inhibition DME1243 XEOTICID XEO05138 XEO_NAME Thuricin-17 DME1243 XEOTICID XEO05138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05138 XEO_CLAS Peptide DME1243 XEOTICID XEO05138 DESCRIPT Thuricin-17 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO05138 GENEFORM Protein DME1243 XEOTICID XEO05138 MOACRIVE Inhibition DME1243 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1243 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05139 XEO_CLAS Peptide DME1243 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO05139 GENEFORM Protein DME1243 XEOTICID XEO05139 MOACRIVE Inhibition DME1243 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1243 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05144 XEO_CLAS Peptide DME1243 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 30 ug/ml) DME1243 XEOTICID XEO05144 GENEFORM Protein DME1243 XEOTICID XEO05144 MOACRIVE Inhibition DME1243 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1243 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05145 XEO_CLAS Peptide DME1243 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 20 ug/ml) DME1243 XEOTICID XEO05145 GENEFORM Protein DME1243 XEOTICID XEO05145 MOACRIVE Inhibition DME1243 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1243 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05146 XEO_CLAS Peptide DME1243 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 30 ug/ml) DME1243 XEOTICID XEO05146 GENEFORM Protein DME1243 XEOTICID XEO05146 MOACRIVE Inhibition DME1243 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1243 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05161 XEO_CLAS Peptide DME1243 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 16 ug/ml) DME1243 XEOTICID XEO05161 GENEFORM Protein DME1243 XEOTICID XEO05161 MOACRIVE Inhibition DME1243 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1243 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05162 XEO_CLAS Peptide DME1243 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 16 ug/ml) DME1243 XEOTICID XEO05162 GENEFORM Protein DME1243 XEOTICID XEO05162 MOACRIVE Inhibition DME1243 XEOTICID XEO05169 XEO_NAME Tricyclic peptide MS-271 DME1243 XEOTICID XEO05169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05169 XEO_CLAS Peptide DME1243 XEOTICID XEO05169 DESCRIPT Tricyclic peptide MS-271 inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis DME1243 XEOTICID XEO05169 GENEFORM Protein DME1243 XEOTICID XEO05169 MOACRIVE Inhibition DME1243 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1243 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05193 XEO_CLAS Peptide DME1243 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 8 ug/ml) DME1243 XEOTICID XEO05193 GENEFORM Protein DME1243 XEOTICID XEO05193 MOACRIVE Inhibition DME1243 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1243 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05212 XEO_CLAS Peptide DME1243 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 2.0 ug/ml) DME1243 XEOTICID XEO05212 GENEFORM Protein DME1243 XEOTICID XEO05212 MOACRIVE Inhibition DME1243 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1243 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05220 XEO_CLAS Peptide DME1243 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 20-40 microM) DME1243 XEOTICID XEO05220 GENEFORM Protein DME1243 XEOTICID XEO05220 MOACRIVE Inhibition DME1243 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1243 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1243 XEOTICID XEO05308 XEO_CLAS Peptide DME1243 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of NADPH-dependent nitroreductase (nfrA1) from Bacillus subtilis (MIC = 0.7 ug/ml) DME1243 XEOTICID XEO05308 GENEFORM Protein DME1243 XEOTICID XEO05308 MOACRIVE Inhibition DME1245 DME___ID DME1245 DME1245 DME_NAME Nitroreductase (NTR) DME1245 SPESNAME Clostridium perfringens DME1245 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1245 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1245 XEOTICID XEO02378 XEO_CLAS Peptide DME1245 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Clostridium perfringens (MIC = 0.7 ug/ml) DME1245 XEOTICID XEO02378 GENEFORM Protein DME1245 XEOTICID XEO02378 MOACRIVE Inhibition DME1245 XEOTICID XEO02720 XEO_NAME Carnobacteriocin-A DME1245 XEOTICID XEO02720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1245 XEOTICID XEO02720 XEO_CLAS Peptide DME1245 XEOTICID XEO02720 DESCRIPT Carnobacteriocin-A inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Clostridium perfringens DME1245 XEOTICID XEO02720 GENEFORM Protein DME1245 XEOTICID XEO02720 MOACRIVE Inhibition DME1245 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1245 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1245 XEOTICID XEO03540 XEO_CLAS Peptide DME1245 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Clostridium perfringens DME1245 XEOTICID XEO03540 GENEFORM Protein DME1245 XEOTICID XEO03540 MOACRIVE Inhibition DME1245 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1245 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1245 XEOTICID XEO03556 XEO_CLAS Peptide DME1245 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Clostridium perfringens (MIC = 4-32 ug/ml) DME1245 XEOTICID XEO03556 GENEFORM Protein DME1245 XEOTICID XEO03556 MOACRIVE Inhibition DME1245 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1245 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1245 XEOTICID XEO03557 XEO_CLAS Peptide DME1245 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Clostridium perfringens (MIC = 4-32 ug/ml) DME1245 XEOTICID XEO03557 GENEFORM Protein DME1245 XEOTICID XEO03557 MOACRIVE Inhibition DME1247 DME___ID DME1247 DME1247 DME_NAME Nitroreductase (NTR) DME1247 SPESNAME Enterobacter cloacae DME1247 XEOTICID XEO02226 XEO_NAME Andropin DME1247 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02226 XEO_CLAS Peptide DME1247 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC > 300 microM) DME1247 XEOTICID XEO02226 GENEFORM Protein DME1247 XEOTICID XEO02226 MOACRIVE Inhibition DME1247 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1247 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02230 XEO_CLAS Peptide DME1247 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 0.5-1 microM) DME1247 XEOTICID XEO02230 GENEFORM Protein DME1247 XEOTICID XEO02230 MOACRIVE Inhibition DME1247 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1247 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02275 XEO_CLAS Peptide DME1247 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 35 microM) DME1247 XEOTICID XEO02275 GENEFORM Protein DME1247 XEOTICID XEO02275 MOACRIVE Inhibition DME1247 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1247 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02284 XEO_CLAS Peptide DME1247 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 47.9 microM) DME1247 XEOTICID XEO02284 GENEFORM Protein DME1247 XEOTICID XEO02284 MOACRIVE Inhibition DME1247 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1247 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02285 XEO_CLAS Peptide DME1247 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 47.9 microM) DME1247 XEOTICID XEO02285 GENEFORM Protein DME1247 XEOTICID XEO02285 MOACRIVE Inhibition DME1247 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1247 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02286 XEO_CLAS Peptide DME1247 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 47.9 microM) DME1247 XEOTICID XEO02286 GENEFORM Protein DME1247 XEOTICID XEO02286 MOACRIVE Inhibition DME1247 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1247 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02287 XEO_CLAS Peptide DME1247 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 47.9 microM) DME1247 XEOTICID XEO02287 GENEFORM Protein DME1247 XEOTICID XEO02287 MOACRIVE Inhibition DME1247 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1247 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02319 XEO_CLAS Peptide DME1247 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO02319 GENEFORM Protein DME1247 XEOTICID XEO02319 MOACRIVE Inhibition DME1247 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1247 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02325 XEO_CLAS Peptide DME1247 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 6 microM) DME1247 XEOTICID XEO02325 GENEFORM Protein DME1247 XEOTICID XEO02325 MOACRIVE Inhibition DME1247 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1247 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02333 XEO_CLAS Peptide DME1247 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC > 200 microM) DME1247 XEOTICID XEO02333 GENEFORM Protein DME1247 XEOTICID XEO02333 MOACRIVE Inhibition DME1247 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1247 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02371 XEO_CLAS Peptide DME1247 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 25 ug/ml) DME1247 XEOTICID XEO02371 GENEFORM Protein DME1247 XEOTICID XEO02371 MOACRIVE Inhibition DME1247 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1247 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02473 XEO_CLAS Peptide DME1247 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO02473 GENEFORM Protein DME1247 XEOTICID XEO02473 MOACRIVE Inhibition DME1247 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1247 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02496 XEO_CLAS Peptide DME1247 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 13 microM) DME1247 XEOTICID XEO02496 GENEFORM Protein DME1247 XEOTICID XEO02496 MOACRIVE Inhibition DME1247 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1247 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02497 XEO_CLAS Peptide DME1247 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 25 microM) DME1247 XEOTICID XEO02497 GENEFORM Protein DME1247 XEOTICID XEO02497 MOACRIVE Inhibition DME1247 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1247 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02566 XEO_CLAS Peptide DME1247 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 50 microM) DME1247 XEOTICID XEO02566 GENEFORM Protein DME1247 XEOTICID XEO02566 MOACRIVE Inhibition DME1247 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1247 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02637 XEO_CLAS Peptide DME1247 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 6 microM) DME1247 XEOTICID XEO02637 GENEFORM Protein DME1247 XEOTICID XEO02637 MOACRIVE Inhibition DME1247 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1247 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02688 XEO_CLAS Peptide DME1247 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 50 microM) DME1247 XEOTICID XEO02688 GENEFORM Protein DME1247 XEOTICID XEO02688 MOACRIVE Inhibition DME1247 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1247 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02745 XEO_CLAS Peptide DME1247 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO02745 GENEFORM Protein DME1247 XEOTICID XEO02745 MOACRIVE Inhibition DME1247 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1247 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02746 XEO_CLAS Peptide DME1247 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO02746 GENEFORM Protein DME1247 XEOTICID XEO02746 MOACRIVE Inhibition DME1247 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1247 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO02768 XEO_CLAS Peptide DME1247 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 50-100 ug/ml) DME1247 XEOTICID XEO02768 GENEFORM Protein DME1247 XEOTICID XEO02768 MOACRIVE Inhibition DME1247 XEOTICID XEO03114 XEO_NAME Defensin AaeDefA DME1247 XEOTICID XEO03114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03114 XEO_CLAS Peptide DME1247 XEOTICID XEO03114 DESCRIPT Defensin AaeDefA inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 1.2-2.4 microM) DME1247 XEOTICID XEO03114 GENEFORM Protein DME1247 XEOTICID XEO03114 MOACRIVE Inhibition DME1247 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1247 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03137 XEO_CLAS Peptide DME1247 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO03137 GENEFORM Protein DME1247 XEOTICID XEO03137 MOACRIVE Inhibition DME1247 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1247 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03162 XEO_CLAS Peptide DME1247 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 12.5 microM) DME1247 XEOTICID XEO03162 GENEFORM Protein DME1247 XEOTICID XEO03162 MOACRIVE Inhibition DME1247 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1247 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03223 XEO_CLAS Peptide DME1247 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 1.0 microM) DME1247 XEOTICID XEO03223 GENEFORM Protein DME1247 XEOTICID XEO03223 MOACRIVE Inhibition DME1247 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1247 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03224 XEO_CLAS Peptide DME1247 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 0.5-1 microM) DME1247 XEOTICID XEO03224 GENEFORM Protein DME1247 XEOTICID XEO03224 MOACRIVE Inhibition DME1247 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1247 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03225 XEO_CLAS Peptide DME1247 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 0.4 microM) DME1247 XEOTICID XEO03225 GENEFORM Protein DME1247 XEOTICID XEO03225 MOACRIVE Inhibition DME1247 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1247 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03250 XEO_CLAS Peptide DME1247 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO03250 GENEFORM Protein DME1247 XEOTICID XEO03250 MOACRIVE Inhibition DME1247 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1247 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03251 XEO_CLAS Peptide DME1247 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO03251 GENEFORM Protein DME1247 XEOTICID XEO03251 MOACRIVE Inhibition DME1247 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1247 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03497 XEO_CLAS Peptide DME1247 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 3.15-6.25 microM) DME1247 XEOTICID XEO03497 GENEFORM Protein DME1247 XEOTICID XEO03497 MOACRIVE Inhibition DME1247 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1247 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03498 XEO_CLAS Peptide DME1247 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 3.15-6.25 microM) DME1247 XEOTICID XEO03498 GENEFORM Protein DME1247 XEOTICID XEO03498 MOACRIVE Inhibition DME1247 XEOTICID XEO03519 XEO_NAME Hadrurin DME1247 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03519 XEO_CLAS Peptide DME1247 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO03519 GENEFORM Protein DME1247 XEOTICID XEO03519 MOACRIVE Inhibition DME1247 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1247 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03540 XEO_CLAS Peptide DME1247 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 8-16 ug/ml) DME1247 XEOTICID XEO03540 GENEFORM Protein DME1247 XEOTICID XEO03540 MOACRIVE Inhibition DME1247 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1247 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03556 XEO_CLAS Peptide DME1247 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 8-16 ug/ml) DME1247 XEOTICID XEO03556 GENEFORM Protein DME1247 XEOTICID XEO03556 MOACRIVE Inhibition DME1247 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1247 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03557 XEO_CLAS Peptide DME1247 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 8-16 ug/ml) DME1247 XEOTICID XEO03557 GENEFORM Protein DME1247 XEOTICID XEO03557 MOACRIVE Inhibition DME1247 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1247 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03561 XEO_CLAS Peptide DME1247 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO03561 GENEFORM Protein DME1247 XEOTICID XEO03561 MOACRIVE Inhibition DME1247 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1247 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03585 XEO_CLAS Peptide DME1247 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 62.5 ug/ml) DME1247 XEOTICID XEO03585 GENEFORM Protein DME1247 XEOTICID XEO03585 MOACRIVE Inhibition DME1247 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1247 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03609 XEO_CLAS Peptide DME1247 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO03609 GENEFORM Protein DME1247 XEOTICID XEO03609 MOACRIVE Inhibition DME1247 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1247 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03672 XEO_CLAS Peptide DME1247 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 10 ug/ml) DME1247 XEOTICID XEO03672 GENEFORM Protein DME1247 XEOTICID XEO03672 MOACRIVE Inhibition DME1247 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1247 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03673 XEO_CLAS Peptide DME1247 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 15 ug/ml) DME1247 XEOTICID XEO03673 GENEFORM Protein DME1247 XEOTICID XEO03673 MOACRIVE Inhibition DME1247 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1247 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03674 XEO_CLAS Peptide DME1247 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO03674 GENEFORM Protein DME1247 XEOTICID XEO03674 MOACRIVE Inhibition DME1247 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1247 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03675 XEO_CLAS Peptide DME1247 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 40 microM) DME1247 XEOTICID XEO03675 GENEFORM Protein DME1247 XEOTICID XEO03675 MOACRIVE Inhibition DME1247 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1247 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03681 XEO_CLAS Peptide DME1247 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 1.2-2.5 microM) DME1247 XEOTICID XEO03681 GENEFORM Protein DME1247 XEOTICID XEO03681 MOACRIVE Inhibition DME1247 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1247 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03697 XEO_CLAS Peptide DME1247 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 6.25 microM) DME1247 XEOTICID XEO03697 GENEFORM Protein DME1247 XEOTICID XEO03697 MOACRIVE Inhibition DME1247 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1247 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO03985 XEO_CLAS Peptide DME1247 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 50 ug/ml) DME1247 XEOTICID XEO03985 GENEFORM Protein DME1247 XEOTICID XEO03985 MOACRIVE Inhibition DME1247 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1247 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04348 XEO_CLAS Peptide DME1247 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 20 microM) DME1247 XEOTICID XEO04348 GENEFORM Protein DME1247 XEOTICID XEO04348 MOACRIVE Inhibition DME1247 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1247 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04349 XEO_CLAS Peptide DME1247 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 50 microM) DME1247 XEOTICID XEO04349 GENEFORM Protein DME1247 XEOTICID XEO04349 MOACRIVE Inhibition DME1247 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1247 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04612 XEO_CLAS Peptide DME1247 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 10-20 microM) DME1247 XEOTICID XEO04612 GENEFORM Protein DME1247 XEOTICID XEO04612 MOACRIVE Inhibition DME1247 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1247 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04613 XEO_CLAS Peptide DME1247 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 10-20 microM) DME1247 XEOTICID XEO04613 GENEFORM Protein DME1247 XEOTICID XEO04613 MOACRIVE Inhibition DME1247 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1247 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04627 XEO_CLAS Peptide DME1247 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 12.5 microM) DME1247 XEOTICID XEO04627 GENEFORM Protein DME1247 XEOTICID XEO04627 MOACRIVE Inhibition DME1247 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1247 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04695 XEO_CLAS Peptide DME1247 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO04695 GENEFORM Protein DME1247 XEOTICID XEO04695 MOACRIVE Inhibition DME1247 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1247 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04696 XEO_CLAS Peptide DME1247 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO04696 GENEFORM Protein DME1247 XEOTICID XEO04696 MOACRIVE Inhibition DME1247 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1247 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04699 XEO_CLAS Peptide DME1247 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO04699 GENEFORM Protein DME1247 XEOTICID XEO04699 MOACRIVE Inhibition DME1247 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1247 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04700 XEO_CLAS Peptide DME1247 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO04700 GENEFORM Protein DME1247 XEOTICID XEO04700 MOACRIVE Inhibition DME1247 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1247 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04701 XEO_CLAS Peptide DME1247 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO04701 GENEFORM Protein DME1247 XEOTICID XEO04701 MOACRIVE Inhibition DME1247 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1247 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04702 XEO_CLAS Peptide DME1247 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO04702 GENEFORM Protein DME1247 XEOTICID XEO04702 MOACRIVE Inhibition DME1247 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1247 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04703 XEO_CLAS Peptide DME1247 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO04703 GENEFORM Protein DME1247 XEOTICID XEO04703 MOACRIVE Inhibition DME1247 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1247 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04809 XEO_CLAS Peptide DME1247 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 5 microM) DME1247 XEOTICID XEO04809 GENEFORM Protein DME1247 XEOTICID XEO04809 MOACRIVE Inhibition DME1247 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1247 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04938 XEO_CLAS Peptide DME1247 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC <= 100 microM) DME1247 XEOTICID XEO04938 GENEFORM Protein DME1247 XEOTICID XEO04938 MOACRIVE Inhibition DME1247 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1247 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO04995 XEO_CLAS Peptide DME1247 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 3.12-6.25 microM) DME1247 XEOTICID XEO04995 GENEFORM Protein DME1247 XEOTICID XEO04995 MOACRIVE Inhibition DME1247 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1247 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO05073 XEO_CLAS Peptide DME1247 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 40 microM) DME1247 XEOTICID XEO05073 GENEFORM Protein DME1247 XEOTICID XEO05073 MOACRIVE Inhibition DME1247 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1247 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO05075 XEO_CLAS Peptide DME1247 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 40 microM) DME1247 XEOTICID XEO05075 GENEFORM Protein DME1247 XEOTICID XEO05075 MOACRIVE Inhibition DME1247 XEOTICID XEO05120 XEO_NAME Thanatin DME1247 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO05120 XEO_CLAS Peptide DME1247 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 1.2-2.5 microM) DME1247 XEOTICID XEO05120 GENEFORM Protein DME1247 XEOTICID XEO05120 MOACRIVE Inhibition DME1247 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1247 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO05139 XEO_CLAS Peptide DME1247 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae DME1247 XEOTICID XEO05139 GENEFORM Protein DME1247 XEOTICID XEO05139 MOACRIVE Inhibition DME1247 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1247 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO05220 XEO_CLAS Peptide DME1247 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 5-10 microM) DME1247 XEOTICID XEO05220 GENEFORM Protein DME1247 XEOTICID XEO05220 MOACRIVE Inhibition DME1247 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1247 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1247 XEOTICID XEO05308 XEO_CLAS Peptide DME1247 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterobacter cloacae (MIC = 12.0 ug/ml) DME1247 XEOTICID XEO05308 GENEFORM Protein DME1247 XEOTICID XEO05308 MOACRIVE Inhibition DME1257 DME___ID DME1257 DME1257 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1257 SPESNAME Bifidobacterium longum DME1257 XEOTICID XEO03113 XEO_NAME Royalisin defensin-1 DME1257 XEOTICID XEO03113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1257 XEOTICID XEO03113 XEO_CLAS Peptide DME1257 XEOTICID XEO03113 DESCRIPT Royalisin defensin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Bifidobacterium longum DME1257 XEOTICID XEO03113 GENEFORM Protein DME1257 XEOTICID XEO03113 MOACRIVE Inhibition DME1260 DME___ID DME1260 DME1260 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1260 SPESNAME Clostridium perfringens DME1260 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1260 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1260 XEOTICID XEO02378 XEO_CLAS Peptide DME1260 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Clostridium perfringens (MIC = 0.7 ug/ml) DME1260 XEOTICID XEO02378 GENEFORM Protein DME1260 XEOTICID XEO02378 MOACRIVE Inhibition DME1260 XEOTICID XEO02720 XEO_NAME Carnobacteriocin-A DME1260 XEOTICID XEO02720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1260 XEOTICID XEO02720 XEO_CLAS Peptide DME1260 XEOTICID XEO02720 DESCRIPT Carnobacteriocin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Clostridium perfringens DME1260 XEOTICID XEO02720 GENEFORM Protein DME1260 XEOTICID XEO02720 MOACRIVE Inhibition DME1260 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1260 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1260 XEOTICID XEO03540 XEO_CLAS Peptide DME1260 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Clostridium perfringens DME1260 XEOTICID XEO03540 GENEFORM Protein DME1260 XEOTICID XEO03540 MOACRIVE Inhibition DME1260 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1260 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1260 XEOTICID XEO03556 XEO_CLAS Peptide DME1260 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Clostridium perfringens (MIC = 4-32 ug/ml) DME1260 XEOTICID XEO03556 GENEFORM Protein DME1260 XEOTICID XEO03556 MOACRIVE Inhibition DME1260 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1260 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1260 XEOTICID XEO03557 XEO_CLAS Peptide DME1260 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Clostridium perfringens (MIC = 4-32 ug/ml) DME1260 XEOTICID XEO03557 GENEFORM Protein DME1260 XEOTICID XEO03557 MOACRIVE Inhibition DME1264 DME___ID DME1264 DME1264 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1264 SPESNAME Enterococcus malodoratus DME1264 XEOTICID XEO02379 XEO_NAME Bacteriocin lacticin 3147 A2 DME1264 XEOTICID XEO02379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1264 XEOTICID XEO02379 XEO_CLAS Peptide DME1264 XEOTICID XEO02379 DESCRIPT Bacteriocin lacticin 3147 A2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus malodoratus DME1264 XEOTICID XEO02379 GENEFORM Protein DME1264 XEOTICID XEO02379 MOACRIVE Inhibition DME1264 XEOTICID XEO02417 XEO_NAME Bavaricin-A DME1264 XEOTICID XEO02417 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1264 XEOTICID XEO02417 XEO_CLAS Peptide DME1264 XEOTICID XEO02417 DESCRIPT Bavaricin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus malodoratus DME1264 XEOTICID XEO02417 GENEFORM Protein DME1264 XEOTICID XEO02417 MOACRIVE Inhibition DME1264 XEOTICID XEO02719 XEO_NAME Carnobacteriocin BM1 DME1264 XEOTICID XEO02719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1264 XEOTICID XEO02719 XEO_CLAS Peptide DME1264 XEOTICID XEO02719 DESCRIPT Carnobacteriocin BM1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus malodoratus DME1264 XEOTICID XEO02719 GENEFORM Protein DME1264 XEOTICID XEO02719 MOACRIVE Inhibition DME1264 XEOTICID XEO02720 XEO_NAME Carnobacteriocin-A DME1264 XEOTICID XEO02720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1264 XEOTICID XEO02720 XEO_CLAS Peptide DME1264 XEOTICID XEO02720 DESCRIPT Carnobacteriocin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus malodoratus DME1264 XEOTICID XEO02720 GENEFORM Protein DME1264 XEOTICID XEO02720 MOACRIVE Inhibition DME1264 XEOTICID XEO03026 XEO_NAME Curvaticin FS47 DME1264 XEOTICID XEO03026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1264 XEOTICID XEO03026 XEO_CLAS Peptide DME1264 XEOTICID XEO03026 DESCRIPT Curvaticin FS47 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus malodoratus DME1264 XEOTICID XEO03026 GENEFORM Protein DME1264 XEOTICID XEO03026 MOACRIVE Inhibition DME1264 XEOTICID XEO03770 XEO_NAME Lacticin 3147 LtnA1 DME1264 XEOTICID XEO03770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1264 XEOTICID XEO03770 XEO_CLAS Peptide DME1264 XEOTICID XEO03770 DESCRIPT Lacticin 3147 LtnA1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus malodoratus DME1264 XEOTICID XEO03770 GENEFORM Protein DME1264 XEOTICID XEO03770 MOACRIVE Inhibition DME1264 XEOTICID XEO04318 XEO_NAME Nisin A DME1264 XEOTICID XEO04318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1264 XEOTICID XEO04318 XEO_CLAS Peptide DME1264 XEOTICID XEO04318 DESCRIPT Nisin A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus malodoratus DME1264 XEOTICID XEO04318 GENEFORM Protein DME1264 XEOTICID XEO04318 MOACRIVE Inhibition DME1264 XEOTICID XEO04321 XEO_NAME Nisin Z DME1264 XEOTICID XEO04321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1264 XEOTICID XEO04321 XEO_CLAS Peptide DME1264 XEOTICID XEO04321 DESCRIPT Nisin Z inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus malodoratus DME1264 XEOTICID XEO04321 GENEFORM Protein DME1264 XEOTICID XEO04321 MOACRIVE Inhibition DME1264 XEOTICID XEO04620 XEO_NAME Plantaricin S alpha DME1264 XEOTICID XEO04620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1264 XEOTICID XEO04620 XEO_CLAS Peptide DME1264 XEOTICID XEO04620 DESCRIPT Plantaricin S alpha inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus malodoratus DME1264 XEOTICID XEO04620 GENEFORM Protein DME1264 XEOTICID XEO04620 MOACRIVE Inhibition DME1264 XEOTICID XEO04621 XEO_NAME Plantaricin S beta DME1264 XEOTICID XEO04621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1264 XEOTICID XEO04621 XEO_CLAS Peptide DME1264 XEOTICID XEO04621 DESCRIPT Plantaricin S beta inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus malodoratus DME1264 XEOTICID XEO04621 GENEFORM Protein DME1264 XEOTICID XEO04621 MOACRIVE Inhibition DME1265 DME___ID DME1265 DME1265 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1265 SPESNAME Escherichia coli DME1265 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1265 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00117 GENEFORM Protein DME1265 XEOTICID XEO00117 MOACRIVE Inhibition DME1265 XEOTICID XEO00122 XEO_NAME Amikacin DME1265 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00122 GENEFORM Protein DME1265 XEOTICID XEO00122 MOACRIVE Inhibition DME1265 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1265 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00136 GENEFORM Protein DME1265 XEOTICID XEO00136 MOACRIVE Inhibition DME1265 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1265 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00237 GENEFORM Protein DME1265 XEOTICID XEO00237 MOACRIVE Inhibition DME1265 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1265 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00349 GENEFORM Protein DME1265 XEOTICID XEO00349 MOACRIVE Inhibition DME1265 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1265 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00425 GENEFORM Protein DME1265 XEOTICID XEO00425 MOACRIVE Inhibition DME1265 XEOTICID XEO00439 XEO_NAME Daidzein DME1265 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00439 GENEFORM Protein DME1265 XEOTICID XEO00439 MOACRIVE Inhibition DME1265 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1265 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00460 GENEFORM Protein DME1265 XEOTICID XEO00460 MOACRIVE Inhibition DME1265 XEOTICID XEO00487 XEO_NAME Thymol DME1265 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00487 GENEFORM Protein DME1265 XEOTICID XEO00487 MOACRIVE Inhibition DME1265 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1265 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00511 GENEFORM Protein DME1265 XEOTICID XEO00511 MOACRIVE Inhibition DME1265 XEOTICID XEO00537 XEO_NAME Luteolin DME1265 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1265 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00537 GENEFORM Protein DME1265 XEOTICID XEO00537 MOACRIVE Inhibition DME1265 XEOTICID XEO00538 XEO_NAME Quercetin DME1265 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1265 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00538 GENEFORM Protein DME1265 XEOTICID XEO00538 MOACRIVE Inhibition DME1265 XEOTICID XEO00547 XEO_NAME Vitamin E DME1265 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1265 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00547 GENEFORM Protein DME1265 XEOTICID XEO00547 MOACRIVE Inhibition DME1265 XEOTICID XEO00557 XEO_NAME Genistein DME1265 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1265 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00557 GENEFORM Protein DME1265 XEOTICID XEO00557 MOACRIVE Inhibition DME1265 XEOTICID XEO00566 XEO_NAME Guaiacol DME1265 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1265 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00566 GENEFORM Protein DME1265 XEOTICID XEO00566 MOACRIVE Inhibition DME1265 XEOTICID XEO00568 XEO_NAME Resveratrol DME1265 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1265 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00568 GENEFORM Protein DME1265 XEOTICID XEO00568 MOACRIVE Inhibition DME1265 XEOTICID XEO00573 XEO_NAME Naringenin DME1265 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1265 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00573 GENEFORM Protein DME1265 XEOTICID XEO00573 MOACRIVE Inhibition DME1265 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1265 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1265 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00574 GENEFORM Protein DME1265 XEOTICID XEO00574 MOACRIVE Inhibition DME1265 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1265 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1265 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00611 GENEFORM Protein DME1265 XEOTICID XEO00611 MOACRIVE Inhibition DME1265 XEOTICID XEO00621 XEO_NAME Chitosan DME1265 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1265 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00621 GENEFORM Protein DME1265 XEOTICID XEO00621 MOACRIVE Inhibition DME1265 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1265 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1265 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00646 GENEFORM Protein DME1265 XEOTICID XEO00646 MOACRIVE Inhibition DME1265 XEOTICID XEO00683 XEO_NAME Curcumin DME1265 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1265 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00683 GENEFORM Protein DME1265 XEOTICID XEO00683 MOACRIVE Inhibition DME1265 XEOTICID XEO00727 XEO_NAME Vanillin DME1265 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1265 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00727 GENEFORM Protein DME1265 XEOTICID XEO00727 MOACRIVE Inhibition DME1265 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1265 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1265 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00730 GENEFORM Protein DME1265 XEOTICID XEO00730 MOACRIVE Inhibition DME1265 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1265 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO00782 XEO_CLAS Natural Product DME1265 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00782 GENEFORM Protein DME1265 XEOTICID XEO00782 MOACRIVE Inhibition DME1265 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1265 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1265 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00866 GENEFORM Protein DME1265 XEOTICID XEO00866 MOACRIVE Inhibition DME1265 XEOTICID XEO00878 XEO_NAME Chrysin DME1265 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO00878 XEO_CLAS Natural Product DME1265 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00878 GENEFORM Protein DME1265 XEOTICID XEO00878 MOACRIVE Inhibition DME1265 XEOTICID XEO00879 XEO_NAME Coumarin DME1265 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1265 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1265 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00879 GENEFORM Protein DME1265 XEOTICID XEO00879 MOACRIVE Inhibition DME1265 XEOTICID XEO00883 XEO_NAME Phloretin DME1265 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO00883 XEO_CLAS Natural Product DME1265 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00883 GENEFORM Protein DME1265 XEOTICID XEO00883 MOACRIVE Inhibition DME1265 XEOTICID XEO00885 XEO_NAME Eugenol DME1265 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1265 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO00885 GENEFORM Protein DME1265 XEOTICID XEO00885 MOACRIVE Inhibition DME1265 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1265 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1265 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1265 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01032 GENEFORM Protein DME1265 XEOTICID XEO01032 MOACRIVE Inhibition DME1265 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1265 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01174 XEO_CLAS Natural Product DME1265 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01174 GENEFORM Protein DME1265 XEOTICID XEO01174 MOACRIVE Inhibition DME1265 XEOTICID XEO01203 XEO_NAME Apigenin DME1265 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01203 XEO_CLAS Natural Product DME1265 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01203 GENEFORM Protein DME1265 XEOTICID XEO01203 MOACRIVE Inhibition DME1265 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1265 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1265 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1265 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01232 GENEFORM Protein DME1265 XEOTICID XEO01232 MOACRIVE Inhibition DME1265 XEOTICID XEO01237 XEO_NAME Carvacrol DME1265 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1265 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01237 GENEFORM Protein DME1265 XEOTICID XEO01237 MOACRIVE Inhibition DME1265 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1265 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1265 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01287 GENEFORM Protein DME1265 XEOTICID XEO01287 MOACRIVE Inhibition DME1265 XEOTICID XEO01291 XEO_NAME Esculetin DME1265 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1265 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01291 GENEFORM Protein DME1265 XEOTICID XEO01291 MOACRIVE Inhibition DME1265 XEOTICID XEO01304 XEO_NAME Flavone DME1265 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01304 XEO_CLAS Natural Product DME1265 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01304 GENEFORM Protein DME1265 XEOTICID XEO01304 MOACRIVE Inhibition DME1265 XEOTICID XEO01309 XEO_NAME Gallic acid DME1265 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01309 XEO_CLAS Natural Product DME1265 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01309 GENEFORM Protein DME1265 XEOTICID XEO01309 MOACRIVE Inhibition DME1265 XEOTICID XEO01340 XEO_NAME Imperatorin DME1265 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01340 XEO_CLAS Natural Product DME1265 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01340 GENEFORM Protein DME1265 XEOTICID XEO01340 MOACRIVE Inhibition DME1265 XEOTICID XEO01353 XEO_NAME Kaempferol DME1265 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1265 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1265 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01353 GENEFORM Protein DME1265 XEOTICID XEO01353 MOACRIVE Inhibition DME1265 XEOTICID XEO01366 XEO_NAME Linalool DME1265 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01366 XEO_CLAS Natural Product DME1265 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01366 GENEFORM Protein DME1265 XEOTICID XEO01366 MOACRIVE Inhibition DME1265 XEOTICID XEO01391 XEO_NAME Naringin DME1265 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01391 XEO_CLAS Natural Product DME1265 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01391 GENEFORM Protein DME1265 XEOTICID XEO01391 MOACRIVE Inhibition DME1265 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1265 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1265 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01420 GENEFORM Protein DME1265 XEOTICID XEO01420 MOACRIVE Inhibition DME1265 XEOTICID XEO01463 XEO_NAME Rutin DME1265 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01463 XEO_CLAS Natural Product DME1265 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01463 GENEFORM Protein DME1265 XEOTICID XEO01463 MOACRIVE Inhibition DME1265 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1265 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1265 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01496 GENEFORM Protein DME1265 XEOTICID XEO01496 MOACRIVE Inhibition DME1265 XEOTICID XEO01512 XEO_NAME Zinc DME1265 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1265 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1265 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01512 GENEFORM Protein DME1265 XEOTICID XEO01512 MOACRIVE Inhibition DME1265 XEOTICID XEO01527 XEO_NAME Bergamottin DME1265 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01527 XEO_CLAS Natural Product DME1265 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01527 GENEFORM Protein DME1265 XEOTICID XEO01527 MOACRIVE Inhibition DME1265 XEOTICID XEO01531 XEO_NAME Clove oil DME1265 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01531 XEO_CLAS Natural Product DME1265 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01531 GENEFORM Protein DME1265 XEOTICID XEO01531 MOACRIVE Inhibition DME1265 XEOTICID XEO01559 XEO_NAME Limonene DME1265 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01559 XEO_CLAS Natural Product DME1265 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01559 GENEFORM Protein DME1265 XEOTICID XEO01559 MOACRIVE Inhibition DME1265 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1265 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01563 XEO_CLAS Natural Product DME1265 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01563 GENEFORM Protein DME1265 XEOTICID XEO01563 MOACRIVE Inhibition DME1265 XEOTICID XEO01566 XEO_NAME Nobiletin DME1265 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01566 XEO_CLAS Natural Product DME1265 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01566 GENEFORM Protein DME1265 XEOTICID XEO01566 MOACRIVE Inhibition DME1265 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1265 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01778 XEO_CLAS Natural Product DME1265 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01778 GENEFORM Protein DME1265 XEOTICID XEO01778 MOACRIVE Inhibition DME1265 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1265 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01779 XEO_CLAS Peptide DME1265 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 128 microM) DME1265 XEOTICID XEO01779 GENEFORM Protein DME1265 XEOTICID XEO01779 MOACRIVE Inhibition DME1265 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1265 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01810 XEO_CLAS Peptide DME1265 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.0 microM) DME1265 XEOTICID XEO01810 GENEFORM Protein DME1265 XEOTICID XEO01810 MOACRIVE Inhibition DME1265 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1265 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01811 XEO_CLAS Peptide DME1265 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 microM) DME1265 XEOTICID XEO01811 GENEFORM Protein DME1265 XEOTICID XEO01811 MOACRIVE Inhibition DME1265 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1265 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01812 XEO_CLAS Peptide DME1265 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10.4 microM) DME1265 XEOTICID XEO01812 GENEFORM Protein DME1265 XEOTICID XEO01812 MOACRIVE Inhibition DME1265 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1265 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01813 XEO_CLAS Peptide DME1265 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.1 microM) DME1265 XEOTICID XEO01813 GENEFORM Protein DME1265 XEOTICID XEO01813 MOACRIVE Inhibition DME1265 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1265 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01814 XEO_CLAS Peptide DME1265 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.5 microM) DME1265 XEOTICID XEO01814 GENEFORM Protein DME1265 XEOTICID XEO01814 MOACRIVE Inhibition DME1265 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1265 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01815 XEO_CLAS Peptide DME1265 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 9.8 microM) DME1265 XEOTICID XEO01815 GENEFORM Protein DME1265 XEOTICID XEO01815 MOACRIVE Inhibition DME1265 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1265 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01816 XEO_CLAS Peptide DME1265 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO01816 GENEFORM Protein DME1265 XEOTICID XEO01816 MOACRIVE Inhibition DME1265 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1265 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01817 XEO_CLAS Peptide DME1265 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.0 microM) DME1265 XEOTICID XEO01817 GENEFORM Protein DME1265 XEOTICID XEO01817 MOACRIVE Inhibition DME1265 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1265 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01818 XEO_CLAS Peptide DME1265 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4.0 microM) DME1265 XEOTICID XEO01818 GENEFORM Protein DME1265 XEOTICID XEO01818 MOACRIVE Inhibition DME1265 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1265 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01819 XEO_CLAS Peptide DME1265 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO01819 GENEFORM Protein DME1265 XEOTICID XEO01819 MOACRIVE Inhibition DME1265 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1265 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01820 XEO_CLAS Peptide DME1265 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO01820 GENEFORM Protein DME1265 XEOTICID XEO01820 MOACRIVE Inhibition DME1265 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1265 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01821 XEO_CLAS Peptide DME1265 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO01821 GENEFORM Protein DME1265 XEOTICID XEO01821 MOACRIVE Inhibition DME1265 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1265 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01822 XEO_CLAS Peptide DME1265 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 microM) DME1265 XEOTICID XEO01822 GENEFORM Protein DME1265 XEOTICID XEO01822 MOACRIVE Inhibition DME1265 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1265 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01823 XEO_CLAS Peptide DME1265 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO01823 GENEFORM Protein DME1265 XEOTICID XEO01823 MOACRIVE Inhibition DME1265 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1265 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01824 XEO_CLAS Peptide DME1265 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO01824 GENEFORM Protein DME1265 XEOTICID XEO01824 MOACRIVE Inhibition DME1265 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1265 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01825 XEO_CLAS Peptide DME1265 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25.0 microM) DME1265 XEOTICID XEO01825 GENEFORM Protein DME1265 XEOTICID XEO01825 MOACRIVE Inhibition DME1265 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1265 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01827 XEO_CLAS Peptide DME1265 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.12-6.25 microM) DME1265 XEOTICID XEO01827 GENEFORM Protein DME1265 XEOTICID XEO01827 MOACRIVE Inhibition DME1265 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1265 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1265 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1265 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01829 GENEFORM Protein DME1265 XEOTICID XEO01829 MOACRIVE Inhibition DME1265 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1265 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01927 XEO_CLAS Peptide DME1265 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 ug/ml) DME1265 XEOTICID XEO01927 GENEFORM Protein DME1265 XEOTICID XEO01927 MOACRIVE Inhibition DME1265 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1265 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01945 XEO_CLAS Peptide DME1265 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.1 microM) DME1265 XEOTICID XEO01945 GENEFORM Protein DME1265 XEOTICID XEO01945 MOACRIVE Inhibition DME1265 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1265 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01946 XEO_CLAS Peptide DME1265 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.2 microM) DME1265 XEOTICID XEO01946 GENEFORM Protein DME1265 XEOTICID XEO01946 MOACRIVE Inhibition DME1265 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1265 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO01947 XEO_CLAS Natural Product DME1265 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01947 GENEFORM Protein DME1265 XEOTICID XEO01947 MOACRIVE Inhibition DME1265 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1265 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1265 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1265 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01950 GENEFORM Protein DME1265 XEOTICID XEO01950 MOACRIVE Inhibition DME1265 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1265 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1265 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1265 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01961 GENEFORM Protein DME1265 XEOTICID XEO01961 MOACRIVE Inhibition DME1265 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1265 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1265 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1265 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO01966 GENEFORM Protein DME1265 XEOTICID XEO01966 MOACRIVE Inhibition DME1265 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1265 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01996 XEO_CLAS Peptide DME1265 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.7 microM) DME1265 XEOTICID XEO01996 GENEFORM Protein DME1265 XEOTICID XEO01996 MOACRIVE Inhibition DME1265 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1265 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01997 XEO_CLAS Peptide DME1265 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.9 microM) DME1265 XEOTICID XEO01997 GENEFORM Protein DME1265 XEOTICID XEO01997 MOACRIVE Inhibition DME1265 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1265 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01998 XEO_CLAS Peptide DME1265 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO01998 GENEFORM Protein DME1265 XEOTICID XEO01998 MOACRIVE Inhibition DME1265 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1265 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO01999 XEO_CLAS Peptide DME1265 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.5 microM) DME1265 XEOTICID XEO01999 GENEFORM Protein DME1265 XEOTICID XEO01999 MOACRIVE Inhibition DME1265 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1265 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02013 XEO_CLAS Peptide DME1265 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02013 GENEFORM Protein DME1265 XEOTICID XEO02013 MOACRIVE Inhibition DME1265 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1265 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02032 XEO_CLAS Natural Product DME1265 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02032 GENEFORM Protein DME1265 XEOTICID XEO02032 MOACRIVE Inhibition DME1265 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1265 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02033 XEO_CLAS Natural Product DME1265 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02033 GENEFORM Protein DME1265 XEOTICID XEO02033 MOACRIVE Inhibition DME1265 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1265 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02079 XEO_CLAS Natural Product DME1265 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02079 GENEFORM Protein DME1265 XEOTICID XEO02079 MOACRIVE Inhibition DME1265 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1265 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1265 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02085 GENEFORM Protein DME1265 XEOTICID XEO02085 MOACRIVE Inhibition DME1265 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1265 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02111 XEO_CLAS Peptide DME1265 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2-4 ug/ml) DME1265 XEOTICID XEO02111 GENEFORM Protein DME1265 XEOTICID XEO02111 MOACRIVE Inhibition DME1265 XEOTICID XEO02113 XEO_NAME Abaecin DME1265 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02113 XEO_CLAS Peptide DME1265 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02113 GENEFORM Protein DME1265 XEOTICID XEO02113 MOACRIVE Inhibition DME1265 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1265 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02114 XEO_CLAS Peptide DME1265 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-25 ug/ml) DME1265 XEOTICID XEO02114 GENEFORM Protein DME1265 XEOTICID XEO02114 MOACRIVE Inhibition DME1265 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1265 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02115 XEO_CLAS Peptide DME1265 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02115 GENEFORM Protein DME1265 XEOTICID XEO02115 MOACRIVE Inhibition DME1265 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1265 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02117 XEO_CLAS Peptide DME1265 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02117 GENEFORM Protein DME1265 XEOTICID XEO02117 MOACRIVE Inhibition DME1265 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1265 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02118 XEO_CLAS Peptide DME1265 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02118 GENEFORM Protein DME1265 XEOTICID XEO02118 MOACRIVE Inhibition DME1265 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1265 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02119 XEO_CLAS Peptide DME1265 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02119 GENEFORM Protein DME1265 XEOTICID XEO02119 MOACRIVE Inhibition DME1265 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1265 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02120 XEO_CLAS Peptide DME1265 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02120 GENEFORM Protein DME1265 XEOTICID XEO02120 MOACRIVE Inhibition DME1265 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1265 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02121 XEO_CLAS Peptide DME1265 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02121 GENEFORM Protein DME1265 XEOTICID XEO02121 MOACRIVE Inhibition DME1265 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1265 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02122 XEO_CLAS Peptide DME1265 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 ug/ml) DME1265 XEOTICID XEO02122 GENEFORM Protein DME1265 XEOTICID XEO02122 MOACRIVE Inhibition DME1265 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1265 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02130 XEO_CLAS Peptide DME1265 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.7 microM) DME1265 XEOTICID XEO02130 GENEFORM Protein DME1265 XEOTICID XEO02130 MOACRIVE Inhibition DME1265 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1265 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02131 XEO_CLAS Peptide DME1265 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.3 microM) DME1265 XEOTICID XEO02131 GENEFORM Protein DME1265 XEOTICID XEO02131 MOACRIVE Inhibition DME1265 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1265 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02132 XEO_CLAS Peptide DME1265 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.5 microM) DME1265 XEOTICID XEO02132 GENEFORM Protein DME1265 XEOTICID XEO02132 MOACRIVE Inhibition DME1265 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1265 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02136 XEO_CLAS Peptide DME1265 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 ug/ml) DME1265 XEOTICID XEO02136 GENEFORM Protein DME1265 XEOTICID XEO02136 MOACRIVE Inhibition DME1265 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1265 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02147 XEO_CLAS Peptide DME1265 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 382 ug/ml) DME1265 XEOTICID XEO02147 GENEFORM Protein DME1265 XEOTICID XEO02147 MOACRIVE Inhibition DME1265 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1265 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02149 XEO_CLAS Peptide DME1265 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 47.35 microM) DME1265 XEOTICID XEO02149 GENEFORM Protein DME1265 XEOTICID XEO02149 MOACRIVE Inhibition DME1265 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1265 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02164 XEO_CLAS Peptide DME1265 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02164 GENEFORM Protein DME1265 XEOTICID XEO02164 MOACRIVE Inhibition DME1265 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1265 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02165 XEO_CLAS Peptide DME1265 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02165 GENEFORM Protein DME1265 XEOTICID XEO02165 MOACRIVE Inhibition DME1265 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1265 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02166 XEO_CLAS Peptide DME1265 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02166 GENEFORM Protein DME1265 XEOTICID XEO02166 MOACRIVE Inhibition DME1265 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1265 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02167 XEO_CLAS Peptide DME1265 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02167 GENEFORM Protein DME1265 XEOTICID XEO02167 MOACRIVE Inhibition DME1265 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1265 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02168 XEO_CLAS Peptide DME1265 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02168 GENEFORM Protein DME1265 XEOTICID XEO02168 MOACRIVE Inhibition DME1265 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1265 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02169 XEO_CLAS Peptide DME1265 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02169 GENEFORM Protein DME1265 XEOTICID XEO02169 MOACRIVE Inhibition DME1265 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1265 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02170 XEO_CLAS Peptide DME1265 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.4 microM) DME1265 XEOTICID XEO02170 GENEFORM Protein DME1265 XEOTICID XEO02170 MOACRIVE Inhibition DME1265 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1265 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02175 XEO_CLAS Natural Product DME1265 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02175 GENEFORM Protein DME1265 XEOTICID XEO02175 MOACRIVE Inhibition DME1265 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1265 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02177 XEO_CLAS Peptide DME1265 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO02177 GENEFORM Protein DME1265 XEOTICID XEO02177 MOACRIVE Inhibition DME1265 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1265 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02178 XEO_CLAS Peptide DME1265 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO02178 GENEFORM Protein DME1265 XEOTICID XEO02178 MOACRIVE Inhibition DME1265 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1265 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02179 XEO_CLAS Peptide DME1265 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO02179 GENEFORM Protein DME1265 XEOTICID XEO02179 MOACRIVE Inhibition DME1265 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1265 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02180 XEO_CLAS Peptide DME1265 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 214 microM) DME1265 XEOTICID XEO02180 GENEFORM Protein DME1265 XEOTICID XEO02180 MOACRIVE Inhibition DME1265 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1265 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02181 XEO_CLAS Peptide DME1265 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 217 microM) DME1265 XEOTICID XEO02181 GENEFORM Protein DME1265 XEOTICID XEO02181 MOACRIVE Inhibition DME1265 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1265 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02183 XEO_CLAS Peptide DME1265 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 38.4 microM) DME1265 XEOTICID XEO02183 GENEFORM Protein DME1265 XEOTICID XEO02183 MOACRIVE Inhibition DME1265 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1265 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02185 XEO_CLAS Peptide DME1265 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 microM) DME1265 XEOTICID XEO02185 GENEFORM Protein DME1265 XEOTICID XEO02185 MOACRIVE Inhibition DME1265 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1265 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02187 GENEFORM Protein DME1265 XEOTICID XEO02187 MOACRIVE Inhibition DME1265 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1265 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02191 XEO_CLAS Peptide DME1265 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02191 GENEFORM Protein DME1265 XEOTICID XEO02191 MOACRIVE Inhibition DME1265 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1265 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02192 XEO_CLAS Peptide DME1265 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.50 ug/ml) DME1265 XEOTICID XEO02192 GENEFORM Protein DME1265 XEOTICID XEO02192 MOACRIVE Inhibition DME1265 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1265 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02193 XEO_CLAS Peptide DME1265 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02193 GENEFORM Protein DME1265 XEOTICID XEO02193 MOACRIVE Inhibition DME1265 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1265 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02194 XEO_CLAS Peptide DME1265 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02194 GENEFORM Protein DME1265 XEOTICID XEO02194 MOACRIVE Inhibition DME1265 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1265 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02195 XEO_CLAS Peptide DME1265 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.00 ug/ml) DME1265 XEOTICID XEO02195 GENEFORM Protein DME1265 XEOTICID XEO02195 MOACRIVE Inhibition DME1265 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1265 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02197 XEO_CLAS Peptide DME1265 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02197 GENEFORM Protein DME1265 XEOTICID XEO02197 MOACRIVE Inhibition DME1265 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1265 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02200 XEO_CLAS Peptide DME1265 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 ug/ml) DME1265 XEOTICID XEO02200 GENEFORM Protein DME1265 XEOTICID XEO02200 MOACRIVE Inhibition DME1265 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1265 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02201 XEO_CLAS Peptide DME1265 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 ug/ml) DME1265 XEOTICID XEO02201 GENEFORM Protein DME1265 XEOTICID XEO02201 MOACRIVE Inhibition DME1265 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1265 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02202 XEO_CLAS Peptide DME1265 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO02202 GENEFORM Protein DME1265 XEOTICID XEO02202 MOACRIVE Inhibition DME1265 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1265 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02203 XEO_CLAS Peptide DME1265 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 microM) DME1265 XEOTICID XEO02203 GENEFORM Protein DME1265 XEOTICID XEO02203 MOACRIVE Inhibition DME1265 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1265 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02207 XEO_CLAS Peptide DME1265 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.78 ug/ml) DME1265 XEOTICID XEO02207 GENEFORM Protein DME1265 XEOTICID XEO02207 MOACRIVE Inhibition DME1265 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1265 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02208 XEO_CLAS Peptide DME1265 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.13 ug/ml) DME1265 XEOTICID XEO02208 GENEFORM Protein DME1265 XEOTICID XEO02208 MOACRIVE Inhibition DME1265 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1265 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02209 XEO_CLAS Peptide DME1265 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.56 ug/ml) DME1265 XEOTICID XEO02209 GENEFORM Protein DME1265 XEOTICID XEO02209 MOACRIVE Inhibition DME1265 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1265 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02210 XEO_CLAS Peptide DME1265 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 ug/ml) DME1265 XEOTICID XEO02210 GENEFORM Protein DME1265 XEOTICID XEO02210 MOACRIVE Inhibition DME1265 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1265 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02211 XEO_CLAS Peptide DME1265 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25 ug/ml) DME1265 XEOTICID XEO02211 GENEFORM Protein DME1265 XEOTICID XEO02211 MOACRIVE Inhibition DME1265 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1265 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02212 XEO_CLAS Peptide DME1265 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.13 ug/ml) DME1265 XEOTICID XEO02212 GENEFORM Protein DME1265 XEOTICID XEO02212 MOACRIVE Inhibition DME1265 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1265 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02213 XEO_CLAS Peptide DME1265 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.13 ug/ml) DME1265 XEOTICID XEO02213 GENEFORM Protein DME1265 XEOTICID XEO02213 MOACRIVE Inhibition DME1265 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1265 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02214 XEO_CLAS Peptide DME1265 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02214 GENEFORM Protein DME1265 XEOTICID XEO02214 MOACRIVE Inhibition DME1265 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1265 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02215 XEO_CLAS Peptide DME1265 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 ug/ml) DME1265 XEOTICID XEO02215 GENEFORM Protein DME1265 XEOTICID XEO02215 MOACRIVE Inhibition DME1265 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1265 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02216 XEO_CLAS Peptide DME1265 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 126 ug/ml) DME1265 XEOTICID XEO02216 GENEFORM Protein DME1265 XEOTICID XEO02216 MOACRIVE Inhibition DME1265 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1265 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02217 XEO_CLAS Peptide DME1265 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 200 ug/ml) DME1265 XEOTICID XEO02217 GENEFORM Protein DME1265 XEOTICID XEO02217 MOACRIVE Inhibition DME1265 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1265 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02218 XEO_CLAS Peptide DME1265 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 200 ug/ml) DME1265 XEOTICID XEO02218 GENEFORM Protein DME1265 XEOTICID XEO02218 MOACRIVE Inhibition DME1265 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1265 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02219 XEO_CLAS Peptide DME1265 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 200 ug/ml) DME1265 XEOTICID XEO02219 GENEFORM Protein DME1265 XEOTICID XEO02219 MOACRIVE Inhibition DME1265 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1265 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02220 XEO_CLAS Peptide DME1265 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 23.5 ug/ml) DME1265 XEOTICID XEO02220 GENEFORM Protein DME1265 XEOTICID XEO02220 MOACRIVE Inhibition DME1265 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1265 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02221 XEO_CLAS Peptide DME1265 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20.2 ug/ml) DME1265 XEOTICID XEO02221 GENEFORM Protein DME1265 XEOTICID XEO02221 MOACRIVE Inhibition DME1265 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1265 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02222 XEO_CLAS Peptide DME1265 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30.5 ug/ml) DME1265 XEOTICID XEO02222 GENEFORM Protein DME1265 XEOTICID XEO02222 MOACRIVE Inhibition DME1265 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1265 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02223 XEO_CLAS Peptide DME1265 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.2 ug/ml) DME1265 XEOTICID XEO02223 GENEFORM Protein DME1265 XEOTICID XEO02223 MOACRIVE Inhibition DME1265 XEOTICID XEO02224 XEO_NAME Androctonin DME1265 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02224 XEO_CLAS Peptide DME1265 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02224 GENEFORM Protein DME1265 XEOTICID XEO02224 MOACRIVE Inhibition DME1265 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1265 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02225 XEO_CLAS Peptide DME1265 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02225 GENEFORM Protein DME1265 XEOTICID XEO02225 MOACRIVE Inhibition DME1265 XEOTICID XEO02226 XEO_NAME Andropin DME1265 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02226 XEO_CLAS Peptide DME1265 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 140 microM) DME1265 XEOTICID XEO02226 GENEFORM Protein DME1265 XEOTICID XEO02226 MOACRIVE Inhibition DME1265 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1265 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02230 XEO_CLAS Peptide DME1265 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.05-0.1 microM) DME1265 XEOTICID XEO02230 GENEFORM Protein DME1265 XEOTICID XEO02230 MOACRIVE Inhibition DME1265 XEOTICID XEO02232 XEO_NAME Anoplin DME1265 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02232 XEO_CLAS Peptide DME1265 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 13 ug/ml) DME1265 XEOTICID XEO02232 GENEFORM Protein DME1265 XEOTICID XEO02232 MOACRIVE Inhibition DME1265 XEOTICID XEO02233 XEO_NAME Antapin DME1265 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02233 XEO_CLAS Peptide DME1265 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02233 GENEFORM Protein DME1265 XEOTICID XEO02233 MOACRIVE Inhibition DME1265 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1265 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02236 XEO_CLAS Peptide DME1265 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02236 GENEFORM Protein DME1265 XEOTICID XEO02236 MOACRIVE Inhibition DME1265 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1265 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02239 XEO_CLAS Peptide DME1265 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 250 microM) DME1265 XEOTICID XEO02239 GENEFORM Protein DME1265 XEOTICID XEO02239 MOACRIVE Inhibition DME1265 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1265 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02240 XEO_CLAS Peptide DME1265 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 microM) DME1265 XEOTICID XEO02240 GENEFORM Protein DME1265 XEOTICID XEO02240 MOACRIVE Inhibition DME1265 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1265 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02241 XEO_CLAS Peptide DME1265 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02241 GENEFORM Protein DME1265 XEOTICID XEO02241 MOACRIVE Inhibition DME1265 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1265 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02242 XEO_CLAS Peptide DME1265 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO02242 GENEFORM Protein DME1265 XEOTICID XEO02242 MOACRIVE Inhibition DME1265 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1265 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02243 XEO_CLAS Peptide DME1265 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 microM) DME1265 XEOTICID XEO02243 GENEFORM Protein DME1265 XEOTICID XEO02243 MOACRIVE Inhibition DME1265 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1265 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02244 XEO_CLAS Peptide DME1265 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1 microM) DME1265 XEOTICID XEO02244 GENEFORM Protein DME1265 XEOTICID XEO02244 MOACRIVE Inhibition DME1265 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1265 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02245 XEO_CLAS Peptide DME1265 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02245 GENEFORM Protein DME1265 XEOTICID XEO02245 MOACRIVE Inhibition DME1265 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1265 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02246 XEO_CLAS Peptide DME1265 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 microM) DME1265 XEOTICID XEO02246 GENEFORM Protein DME1265 XEOTICID XEO02246 MOACRIVE Inhibition DME1265 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1265 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02247 XEO_CLAS Peptide DME1265 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02247 GENEFORM Protein DME1265 XEOTICID XEO02247 MOACRIVE Inhibition DME1265 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1265 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02248 XEO_CLAS Peptide DME1265 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.3 microM) DME1265 XEOTICID XEO02248 GENEFORM Protein DME1265 XEOTICID XEO02248 MOACRIVE Inhibition DME1265 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1265 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02253 XEO_CLAS Peptide DME1265 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02253 GENEFORM Protein DME1265 XEOTICID XEO02253 MOACRIVE Inhibition DME1265 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1265 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02258 XEO_CLAS Peptide DME1265 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 150 microM) DME1265 XEOTICID XEO02258 GENEFORM Protein DME1265 XEOTICID XEO02258 MOACRIVE Inhibition DME1265 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1265 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02261 XEO_CLAS Peptide DME1265 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 82 ug/ml) DME1265 XEOTICID XEO02261 GENEFORM Protein DME1265 XEOTICID XEO02261 MOACRIVE Inhibition DME1265 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1265 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02263 XEO_CLAS Peptide DME1265 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO02263 GENEFORM Protein DME1265 XEOTICID XEO02263 MOACRIVE Inhibition DME1265 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1265 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02266 XEO_CLAS Peptide DME1265 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 120 microM) DME1265 XEOTICID XEO02266 GENEFORM Protein DME1265 XEOTICID XEO02266 MOACRIVE Inhibition DME1265 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1265 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02268 XEO_CLAS Peptide DME1265 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 170 ug/ml) DME1265 XEOTICID XEO02268 GENEFORM Protein DME1265 XEOTICID XEO02268 MOACRIVE Inhibition DME1265 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1265 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02270 XEO_CLAS Peptide DME1265 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 microM) DME1265 XEOTICID XEO02270 GENEFORM Protein DME1265 XEOTICID XEO02270 MOACRIVE Inhibition DME1265 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1265 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02271 XEO_CLAS Peptide DME1265 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 302 ug/ml) DME1265 XEOTICID XEO02271 GENEFORM Protein DME1265 XEOTICID XEO02271 MOACRIVE Inhibition DME1265 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1265 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02273 XEO_CLAS Peptide DME1265 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 18 microM) DME1265 XEOTICID XEO02273 GENEFORM Protein DME1265 XEOTICID XEO02273 MOACRIVE Inhibition DME1265 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1265 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02274 XEO_CLAS Peptide DME1265 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO02274 GENEFORM Protein DME1265 XEOTICID XEO02274 MOACRIVE Inhibition DME1265 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1265 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02275 XEO_CLAS Peptide DME1265 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 microM) DME1265 XEOTICID XEO02275 GENEFORM Protein DME1265 XEOTICID XEO02275 MOACRIVE Inhibition DME1265 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1265 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02276 XEO_CLAS Peptide DME1265 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 microM) DME1265 XEOTICID XEO02276 GENEFORM Protein DME1265 XEOTICID XEO02276 MOACRIVE Inhibition DME1265 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1265 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02280 XEO_CLAS Peptide DME1265 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02280 GENEFORM Protein DME1265 XEOTICID XEO02280 MOACRIVE Inhibition DME1265 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1265 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02281 XEO_CLAS Peptide DME1265 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02281 GENEFORM Protein DME1265 XEOTICID XEO02281 MOACRIVE Inhibition DME1265 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1265 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02283 XEO_CLAS Peptide DME1265 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 ug/ml) DME1265 XEOTICID XEO02283 GENEFORM Protein DME1265 XEOTICID XEO02283 MOACRIVE Inhibition DME1265 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1265 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02284 XEO_CLAS Peptide DME1265 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50.4 microM) DME1265 XEOTICID XEO02284 GENEFORM Protein DME1265 XEOTICID XEO02284 MOACRIVE Inhibition DME1265 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1265 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02285 XEO_CLAS Peptide DME1265 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50.4 microM) DME1265 XEOTICID XEO02285 GENEFORM Protein DME1265 XEOTICID XEO02285 MOACRIVE Inhibition DME1265 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1265 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02286 XEO_CLAS Peptide DME1265 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50.4 microM) DME1265 XEOTICID XEO02286 GENEFORM Protein DME1265 XEOTICID XEO02286 MOACRIVE Inhibition DME1265 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1265 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02287 XEO_CLAS Peptide DME1265 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50.4 microM) DME1265 XEOTICID XEO02287 GENEFORM Protein DME1265 XEOTICID XEO02287 MOACRIVE Inhibition DME1265 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1265 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02288 XEO_CLAS Peptide DME1265 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.2 ug/ml) DME1265 XEOTICID XEO02288 GENEFORM Protein DME1265 XEOTICID XEO02288 MOACRIVE Inhibition DME1265 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1265 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02289 XEO_CLAS Peptide DME1265 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 ug/ml) DME1265 XEOTICID XEO02289 GENEFORM Protein DME1265 XEOTICID XEO02289 MOACRIVE Inhibition DME1265 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1265 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02290 XEO_CLAS Peptide DME1265 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO02290 GENEFORM Protein DME1265 XEOTICID XEO02290 MOACRIVE Inhibition DME1265 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1265 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02291 XEO_CLAS Peptide DME1265 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02291 GENEFORM Protein DME1265 XEOTICID XEO02291 MOACRIVE Inhibition DME1265 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1265 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02293 XEO_CLAS Peptide DME1265 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 microM) DME1265 XEOTICID XEO02293 GENEFORM Protein DME1265 XEOTICID XEO02293 MOACRIVE Inhibition DME1265 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1265 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02294 XEO_CLAS Peptide DME1265 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 62-250 ug/ml) DME1265 XEOTICID XEO02294 GENEFORM Protein DME1265 XEOTICID XEO02294 MOACRIVE Inhibition DME1265 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1265 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02295 XEO_CLAS Peptide DME1265 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 ug/ml) DME1265 XEOTICID XEO02295 GENEFORM Protein DME1265 XEOTICID XEO02295 MOACRIVE Inhibition DME1265 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1265 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02296 XEO_CLAS Peptide DME1265 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02296 GENEFORM Protein DME1265 XEOTICID XEO02296 MOACRIVE Inhibition DME1265 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1265 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02297 XEO_CLAS Peptide DME1265 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC < 50 ug/ml) DME1265 XEOTICID XEO02297 GENEFORM Protein DME1265 XEOTICID XEO02297 MOACRIVE Inhibition DME1265 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1265 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02298 XEO_CLAS Peptide DME1265 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO02298 GENEFORM Protein DME1265 XEOTICID XEO02298 MOACRIVE Inhibition DME1265 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1265 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02303 XEO_CLAS Peptide DME1265 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02303 GENEFORM Protein DME1265 XEOTICID XEO02303 MOACRIVE Inhibition DME1265 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1265 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02304 XEO_CLAS Peptide DME1265 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.1 ug/ml) DME1265 XEOTICID XEO02304 GENEFORM Protein DME1265 XEOTICID XEO02304 MOACRIVE Inhibition DME1265 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1265 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02305 XEO_CLAS Peptide DME1265 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC <= 1 ug/ml) DME1265 XEOTICID XEO02305 GENEFORM Protein DME1265 XEOTICID XEO02305 MOACRIVE Inhibition DME1265 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1265 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02306 XEO_CLAS Peptide DME1265 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.2 ug/ml) DME1265 XEOTICID XEO02306 GENEFORM Protein DME1265 XEOTICID XEO02306 MOACRIVE Inhibition DME1265 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1265 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02309 XEO_CLAS Peptide DME1265 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02309 GENEFORM Protein DME1265 XEOTICID XEO02309 MOACRIVE Inhibition DME1265 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1265 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02310 XEO_CLAS Peptide DME1265 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02310 GENEFORM Protein DME1265 XEOTICID XEO02310 MOACRIVE Inhibition DME1265 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1265 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02315 XEO_CLAS Peptide DME1265 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO02315 GENEFORM Protein DME1265 XEOTICID XEO02315 MOACRIVE Inhibition DME1265 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1265 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02316 XEO_CLAS Peptide DME1265 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 50 microM) DME1265 XEOTICID XEO02316 GENEFORM Protein DME1265 XEOTICID XEO02316 MOACRIVE Inhibition DME1265 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1265 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02317 XEO_CLAS Peptide DME1265 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 300 microM) DME1265 XEOTICID XEO02317 GENEFORM Protein DME1265 XEOTICID XEO02317 MOACRIVE Inhibition DME1265 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1265 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02318 XEO_CLAS Peptide DME1265 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02318 GENEFORM Protein DME1265 XEOTICID XEO02318 MOACRIVE Inhibition DME1265 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1265 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02319 XEO_CLAS Peptide DME1265 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02319 GENEFORM Protein DME1265 XEOTICID XEO02319 MOACRIVE Inhibition DME1265 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1265 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02320 XEO_CLAS Peptide DME1265 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02320 GENEFORM Protein DME1265 XEOTICID XEO02320 MOACRIVE Inhibition DME1265 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1265 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02321 XEO_CLAS Peptide DME1265 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO02321 GENEFORM Protein DME1265 XEOTICID XEO02321 MOACRIVE Inhibition DME1265 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1265 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02322 XEO_CLAS Peptide DME1265 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02322 GENEFORM Protein DME1265 XEOTICID XEO02322 MOACRIVE Inhibition DME1265 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1265 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02323 XEO_CLAS Peptide DME1265 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO02323 GENEFORM Protein DME1265 XEOTICID XEO02323 MOACRIVE Inhibition DME1265 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1265 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02324 XEO_CLAS Peptide DME1265 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02324 GENEFORM Protein DME1265 XEOTICID XEO02324 MOACRIVE Inhibition DME1265 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1265 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02325 XEO_CLAS Peptide DME1265 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO02325 GENEFORM Protein DME1265 XEOTICID XEO02325 MOACRIVE Inhibition DME1265 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1265 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02326 XEO_CLAS Peptide DME1265 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02326 GENEFORM Protein DME1265 XEOTICID XEO02326 MOACRIVE Inhibition DME1265 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1265 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02327 XEO_CLAS Peptide DME1265 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO02327 GENEFORM Protein DME1265 XEOTICID XEO02327 MOACRIVE Inhibition DME1265 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1265 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02328 XEO_CLAS Peptide DME1265 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO02328 GENEFORM Protein DME1265 XEOTICID XEO02328 MOACRIVE Inhibition DME1265 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1265 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02332 XEO_CLAS Peptide DME1265 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.9 ug/ml) DME1265 XEOTICID XEO02332 GENEFORM Protein DME1265 XEOTICID XEO02332 MOACRIVE Inhibition DME1265 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1265 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02333 XEO_CLAS Peptide DME1265 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 200 microM) DME1265 XEOTICID XEO02333 GENEFORM Protein DME1265 XEOTICID XEO02333 MOACRIVE Inhibition DME1265 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1265 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02336 XEO_CLAS Peptide DME1265 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 microM) DME1265 XEOTICID XEO02336 GENEFORM Protein DME1265 XEOTICID XEO02336 MOACRIVE Inhibition DME1265 XEOTICID XEO02346 XEO_NAME Aurelin DME1265 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02346 XEO_CLAS Peptide DME1265 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 7.66 ug/ml) DME1265 XEOTICID XEO02346 GENEFORM Protein DME1265 XEOTICID XEO02346 MOACRIVE Inhibition DME1265 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1265 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02352 XEO_CLAS Peptide DME1265 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 11 ug/ml) DME1265 XEOTICID XEO02352 GENEFORM Protein DME1265 XEOTICID XEO02352 MOACRIVE Inhibition DME1265 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1265 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02353 XEO_CLAS Peptide DME1265 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 ug/ml) DME1265 XEOTICID XEO02353 GENEFORM Protein DME1265 XEOTICID XEO02353 MOACRIVE Inhibition DME1265 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1265 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02354 XEO_CLAS Peptide DME1265 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 ug/ml) DME1265 XEOTICID XEO02354 GENEFORM Protein DME1265 XEOTICID XEO02354 MOACRIVE Inhibition DME1265 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1265 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02355 XEO_CLAS Peptide DME1265 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 17 ug/ml) DME1265 XEOTICID XEO02355 GENEFORM Protein DME1265 XEOTICID XEO02355 MOACRIVE Inhibition DME1265 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1265 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02356 XEO_CLAS Peptide DME1265 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO02356 GENEFORM Protein DME1265 XEOTICID XEO02356 MOACRIVE Inhibition DME1265 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1265 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02357 XEO_CLAS Peptide DME1265 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO02357 GENEFORM Protein DME1265 XEOTICID XEO02357 MOACRIVE Inhibition DME1265 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1265 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02358 XEO_CLAS Peptide DME1265 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO02358 GENEFORM Protein DME1265 XEOTICID XEO02358 MOACRIVE Inhibition DME1265 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1265 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02360 XEO_CLAS Peptide DME1265 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02360 GENEFORM Protein DME1265 XEOTICID XEO02360 MOACRIVE Inhibition DME1265 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1265 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02361 XEO_CLAS Peptide DME1265 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 ug/ml) DME1265 XEOTICID XEO02361 GENEFORM Protein DME1265 XEOTICID XEO02361 MOACRIVE Inhibition DME1265 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1265 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02365 XEO_CLAS Peptide DME1265 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 32 ug/ml) DME1265 XEOTICID XEO02365 GENEFORM Protein DME1265 XEOTICID XEO02365 MOACRIVE Inhibition DME1265 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1265 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02366 XEO_CLAS Peptide DME1265 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO02366 GENEFORM Protein DME1265 XEOTICID XEO02366 MOACRIVE Inhibition DME1265 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1265 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02367 XEO_CLAS Peptide DME1265 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02367 GENEFORM Protein DME1265 XEOTICID XEO02367 MOACRIVE Inhibition DME1265 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1265 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02368 XEO_CLAS Peptide DME1265 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02368 GENEFORM Protein DME1265 XEOTICID XEO02368 MOACRIVE Inhibition DME1265 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1265 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02369 XEO_CLAS Peptide DME1265 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02369 GENEFORM Protein DME1265 XEOTICID XEO02369 MOACRIVE Inhibition DME1265 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1265 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02370 XEO_CLAS Peptide DME1265 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02370 GENEFORM Protein DME1265 XEOTICID XEO02370 MOACRIVE Inhibition DME1265 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1265 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02371 XEO_CLAS Peptide DME1265 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 ug/ml) DME1265 XEOTICID XEO02371 GENEFORM Protein DME1265 XEOTICID XEO02371 MOACRIVE Inhibition DME1265 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1265 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02374 XEO_CLAS Peptide DME1265 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02374 GENEFORM Protein DME1265 XEOTICID XEO02374 MOACRIVE Inhibition DME1265 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1265 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02376 XEO_CLAS Peptide DME1265 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02376 GENEFORM Protein DME1265 XEOTICID XEO02376 MOACRIVE Inhibition DME1265 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1265 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02378 XEO_CLAS Peptide DME1265 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.19 ug/ml) DME1265 XEOTICID XEO02378 GENEFORM Protein DME1265 XEOTICID XEO02378 MOACRIVE Inhibition DME1265 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1265 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02388 XEO_CLAS Peptide DME1265 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO02388 GENEFORM Protein DME1265 XEOTICID XEO02388 MOACRIVE Inhibition DME1265 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1265 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02389 XEO_CLAS Peptide DME1265 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02389 GENEFORM Protein DME1265 XEOTICID XEO02389 MOACRIVE Inhibition DME1265 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1265 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02415 XEO_CLAS Peptide DME1265 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02415 GENEFORM Protein DME1265 XEOTICID XEO02415 MOACRIVE Inhibition DME1265 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1265 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02416 XEO_CLAS Peptide DME1265 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 11 microM) DME1265 XEOTICID XEO02416 GENEFORM Protein DME1265 XEOTICID XEO02416 MOACRIVE Inhibition DME1265 XEOTICID XEO02419 XEO_NAME Bay oil DME1265 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1265 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02419 GENEFORM Protein DME1265 XEOTICID XEO02419 MOACRIVE Inhibition DME1265 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1265 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02435 XEO_CLAS Peptide DME1265 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02435 GENEFORM Protein DME1265 XEOTICID XEO02435 MOACRIVE Inhibition DME1265 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1265 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02436 XEO_CLAS Peptide DME1265 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02436 GENEFORM Protein DME1265 XEOTICID XEO02436 MOACRIVE Inhibition DME1265 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1265 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02437 XEO_CLAS Peptide DME1265 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02437 GENEFORM Protein DME1265 XEOTICID XEO02437 MOACRIVE Inhibition DME1265 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1265 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02438 XEO_CLAS Peptide DME1265 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02438 GENEFORM Protein DME1265 XEOTICID XEO02438 MOACRIVE Inhibition DME1265 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1265 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02439 XEO_CLAS Peptide DME1265 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02439 GENEFORM Protein DME1265 XEOTICID XEO02439 MOACRIVE Inhibition DME1265 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1265 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02440 XEO_CLAS Peptide DME1265 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02440 GENEFORM Protein DME1265 XEOTICID XEO02440 MOACRIVE Inhibition DME1265 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1265 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02441 XEO_CLAS Peptide DME1265 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02441 GENEFORM Protein DME1265 XEOTICID XEO02441 MOACRIVE Inhibition DME1265 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1265 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02442 XEO_CLAS Peptide DME1265 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO02442 GENEFORM Protein DME1265 XEOTICID XEO02442 MOACRIVE Inhibition DME1265 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1265 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02443 XEO_CLAS Peptide DME1265 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02443 GENEFORM Protein DME1265 XEOTICID XEO02443 MOACRIVE Inhibition DME1265 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1265 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02444 XEO_CLAS Peptide DME1265 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02444 GENEFORM Protein DME1265 XEOTICID XEO02444 MOACRIVE Inhibition DME1265 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1265 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1265 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02447 GENEFORM Protein DME1265 XEOTICID XEO02447 MOACRIVE Inhibition DME1265 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1265 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02452 XEO_CLAS Peptide DME1265 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 76800 ug/ml) DME1265 XEOTICID XEO02452 GENEFORM Protein DME1265 XEOTICID XEO02452 MOACRIVE Inhibition DME1265 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1265 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02453 XEO_CLAS Peptide DME1265 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02453 GENEFORM Protein DME1265 XEOTICID XEO02453 MOACRIVE Inhibition DME1265 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1265 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02463 XEO_CLAS Peptide DME1265 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 11.25 microM) DME1265 XEOTICID XEO02463 GENEFORM Protein DME1265 XEOTICID XEO02463 MOACRIVE Inhibition DME1265 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1265 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02466 XEO_CLAS Peptide DME1265 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.5 microM) DME1265 XEOTICID XEO02466 GENEFORM Protein DME1265 XEOTICID XEO02466 MOACRIVE Inhibition DME1265 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1265 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02467 XEO_CLAS Peptide DME1265 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8.4 microM) DME1265 XEOTICID XEO02467 GENEFORM Protein DME1265 XEOTICID XEO02467 MOACRIVE Inhibition DME1265 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1265 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02468 XEO_CLAS Peptide DME1265 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.7 microM) DME1265 XEOTICID XEO02468 GENEFORM Protein DME1265 XEOTICID XEO02468 MOACRIVE Inhibition DME1265 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1265 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02469 XEO_CLAS Peptide DME1265 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO02469 GENEFORM Protein DME1265 XEOTICID XEO02469 MOACRIVE Inhibition DME1265 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1265 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02470 XEO_CLAS Peptide DME1265 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.8 microM) DME1265 XEOTICID XEO02470 GENEFORM Protein DME1265 XEOTICID XEO02470 MOACRIVE Inhibition DME1265 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1265 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02471 XEO_CLAS Peptide DME1265 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4.8 microM) DME1265 XEOTICID XEO02471 GENEFORM Protein DME1265 XEOTICID XEO02471 MOACRIVE Inhibition DME1265 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1265 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02472 XEO_CLAS Peptide DME1265 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.0 microM) DME1265 XEOTICID XEO02472 GENEFORM Protein DME1265 XEOTICID XEO02472 MOACRIVE Inhibition DME1265 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1265 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02473 XEO_CLAS Peptide DME1265 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02473 GENEFORM Protein DME1265 XEOTICID XEO02473 MOACRIVE Inhibition DME1265 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1265 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02474 XEO_CLAS Peptide DME1265 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.5 microM) DME1265 XEOTICID XEO02474 GENEFORM Protein DME1265 XEOTICID XEO02474 MOACRIVE Inhibition DME1265 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1265 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02475 XEO_CLAS Peptide DME1265 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.5 microM) DME1265 XEOTICID XEO02475 GENEFORM Protein DME1265 XEOTICID XEO02475 MOACRIVE Inhibition DME1265 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1265 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02477 XEO_CLAS Peptide DME1265 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-300 ug/ml) DME1265 XEOTICID XEO02477 GENEFORM Protein DME1265 XEOTICID XEO02477 MOACRIVE Inhibition DME1265 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1265 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02478 XEO_CLAS Peptide DME1265 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-300 ug/ml) DME1265 XEOTICID XEO02478 GENEFORM Protein DME1265 XEOTICID XEO02478 MOACRIVE Inhibition DME1265 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1265 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02479 XEO_CLAS Peptide DME1265 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-300 ug/ml) DME1265 XEOTICID XEO02479 GENEFORM Protein DME1265 XEOTICID XEO02479 MOACRIVE Inhibition DME1265 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1265 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02480 XEO_CLAS Peptide DME1265 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-300 ug/ml) DME1265 XEOTICID XEO02480 GENEFORM Protein DME1265 XEOTICID XEO02480 MOACRIVE Inhibition DME1265 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1265 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02481 XEO_CLAS Peptide DME1265 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-300 ug/ml) DME1265 XEOTICID XEO02481 GENEFORM Protein DME1265 XEOTICID XEO02481 MOACRIVE Inhibition DME1265 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1265 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02482 XEO_CLAS Peptide DME1265 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-300 ug/ml) DME1265 XEOTICID XEO02482 GENEFORM Protein DME1265 XEOTICID XEO02482 MOACRIVE Inhibition DME1265 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1265 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02483 XEO_CLAS Peptide DME1265 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-300 ug/ml) DME1265 XEOTICID XEO02483 GENEFORM Protein DME1265 XEOTICID XEO02483 MOACRIVE Inhibition DME1265 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1265 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02484 XEO_CLAS Peptide DME1265 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-300 ug/ml) DME1265 XEOTICID XEO02484 GENEFORM Protein DME1265 XEOTICID XEO02484 MOACRIVE Inhibition DME1265 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1265 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02485 XEO_CLAS Peptide DME1265 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-300 ug/ml) DME1265 XEOTICID XEO02485 GENEFORM Protein DME1265 XEOTICID XEO02485 MOACRIVE Inhibition DME1265 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1265 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02486 XEO_CLAS Peptide DME1265 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-300 ug/ml) DME1265 XEOTICID XEO02486 GENEFORM Protein DME1265 XEOTICID XEO02486 MOACRIVE Inhibition DME1265 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1265 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02487 XEO_CLAS Peptide DME1265 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02487 GENEFORM Protein DME1265 XEOTICID XEO02487 MOACRIVE Inhibition DME1265 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1265 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02488 XEO_CLAS Peptide DME1265 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-300 ug/ml) DME1265 XEOTICID XEO02488 GENEFORM Protein DME1265 XEOTICID XEO02488 MOACRIVE Inhibition DME1265 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1265 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02489 XEO_CLAS Peptide DME1265 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-301 ug/ml) DME1265 XEOTICID XEO02489 GENEFORM Protein DME1265 XEOTICID XEO02489 MOACRIVE Inhibition DME1265 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1265 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02491 XEO_CLAS Peptide DME1265 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.3 microM) DME1265 XEOTICID XEO02491 GENEFORM Protein DME1265 XEOTICID XEO02491 MOACRIVE Inhibition DME1265 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1265 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02492 XEO_CLAS Peptide DME1265 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 ug/ml) DME1265 XEOTICID XEO02492 GENEFORM Protein DME1265 XEOTICID XEO02492 MOACRIVE Inhibition DME1265 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1265 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02493 XEO_CLAS Peptide DME1265 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 ug/ml) DME1265 XEOTICID XEO02493 GENEFORM Protein DME1265 XEOTICID XEO02493 MOACRIVE Inhibition DME1265 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1265 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02494 XEO_CLAS Peptide DME1265 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 ug/ml) DME1265 XEOTICID XEO02494 GENEFORM Protein DME1265 XEOTICID XEO02494 MOACRIVE Inhibition DME1265 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1265 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02495 XEO_CLAS Peptide DME1265 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 34 ug/ml) DME1265 XEOTICID XEO02495 GENEFORM Protein DME1265 XEOTICID XEO02495 MOACRIVE Inhibition DME1265 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1265 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02496 XEO_CLAS Peptide DME1265 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 13 microM) DME1265 XEOTICID XEO02496 GENEFORM Protein DME1265 XEOTICID XEO02496 MOACRIVE Inhibition DME1265 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1265 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02497 XEO_CLAS Peptide DME1265 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO02497 GENEFORM Protein DME1265 XEOTICID XEO02497 MOACRIVE Inhibition DME1265 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1265 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02499 XEO_CLAS Peptide DME1265 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO02499 GENEFORM Protein DME1265 XEOTICID XEO02499 MOACRIVE Inhibition DME1265 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1265 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02501 XEO_CLAS Peptide DME1265 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 7 microM) DME1265 XEOTICID XEO02501 GENEFORM Protein DME1265 XEOTICID XEO02501 MOACRIVE Inhibition DME1265 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1265 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02502 XEO_CLAS Peptide DME1265 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 microM) DME1265 XEOTICID XEO02502 GENEFORM Protein DME1265 XEOTICID XEO02502 MOACRIVE Inhibition DME1265 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1265 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02503 XEO_CLAS Peptide DME1265 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 19 microM) DME1265 XEOTICID XEO02503 GENEFORM Protein DME1265 XEOTICID XEO02503 MOACRIVE Inhibition DME1265 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1265 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02504 XEO_CLAS Peptide DME1265 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02504 GENEFORM Protein DME1265 XEOTICID XEO02504 MOACRIVE Inhibition DME1265 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1265 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02505 XEO_CLAS Peptide DME1265 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO02505 GENEFORM Protein DME1265 XEOTICID XEO02505 MOACRIVE Inhibition DME1265 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1265 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02507 XEO_CLAS Peptide DME1265 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO02507 GENEFORM Protein DME1265 XEOTICID XEO02507 MOACRIVE Inhibition DME1265 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1265 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02508 XEO_CLAS Peptide DME1265 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 150 microM) DME1265 XEOTICID XEO02508 GENEFORM Protein DME1265 XEOTICID XEO02508 MOACRIVE Inhibition DME1265 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1265 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02509 XEO_CLAS Peptide DME1265 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 150 microM) DME1265 XEOTICID XEO02509 GENEFORM Protein DME1265 XEOTICID XEO02509 MOACRIVE Inhibition DME1265 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1265 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02510 XEO_CLAS Peptide DME1265 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 150 microM) DME1265 XEOTICID XEO02510 GENEFORM Protein DME1265 XEOTICID XEO02510 MOACRIVE Inhibition DME1265 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1265 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02511 XEO_CLAS Peptide DME1265 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 150 microM) DME1265 XEOTICID XEO02511 GENEFORM Protein DME1265 XEOTICID XEO02511 MOACRIVE Inhibition DME1265 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1265 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02512 XEO_CLAS Peptide DME1265 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 75 microM) DME1265 XEOTICID XEO02512 GENEFORM Protein DME1265 XEOTICID XEO02512 MOACRIVE Inhibition DME1265 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1265 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02513 XEO_CLAS Peptide DME1265 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO02513 GENEFORM Protein DME1265 XEOTICID XEO02513 MOACRIVE Inhibition DME1265 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1265 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02514 XEO_CLAS Peptide DME1265 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO02514 GENEFORM Protein DME1265 XEOTICID XEO02514 MOACRIVE Inhibition DME1265 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1265 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02515 XEO_CLAS Peptide DME1265 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 80 microM) DME1265 XEOTICID XEO02515 GENEFORM Protein DME1265 XEOTICID XEO02515 MOACRIVE Inhibition DME1265 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1265 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02516 XEO_CLAS Peptide DME1265 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 32 microM) DME1265 XEOTICID XEO02516 GENEFORM Protein DME1265 XEOTICID XEO02516 MOACRIVE Inhibition DME1265 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1265 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02517 XEO_CLAS Peptide DME1265 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 microM) DME1265 XEOTICID XEO02517 GENEFORM Protein DME1265 XEOTICID XEO02517 MOACRIVE Inhibition DME1265 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1265 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02518 XEO_CLAS Peptide DME1265 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC < 15 microM) DME1265 XEOTICID XEO02518 GENEFORM Protein DME1265 XEOTICID XEO02518 MOACRIVE Inhibition DME1265 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1265 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02519 XEO_CLAS Peptide DME1265 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC < 15 microM) DME1265 XEOTICID XEO02519 GENEFORM Protein DME1265 XEOTICID XEO02519 MOACRIVE Inhibition DME1265 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1265 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02520 XEO_CLAS Peptide DME1265 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC < 15 microM) DME1265 XEOTICID XEO02520 GENEFORM Protein DME1265 XEOTICID XEO02520 MOACRIVE Inhibition DME1265 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1265 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02523 XEO_CLAS Peptide DME1265 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO02523 GENEFORM Protein DME1265 XEOTICID XEO02523 MOACRIVE Inhibition DME1265 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1265 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02524 XEO_CLAS Peptide DME1265 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 150 microM) DME1265 XEOTICID XEO02524 GENEFORM Protein DME1265 XEOTICID XEO02524 MOACRIVE Inhibition DME1265 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1265 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02525 XEO_CLAS Peptide DME1265 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 24 microM) DME1265 XEOTICID XEO02525 GENEFORM Protein DME1265 XEOTICID XEO02525 MOACRIVE Inhibition DME1265 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1265 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02526 XEO_CLAS Peptide DME1265 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 48 microM) DME1265 XEOTICID XEO02526 GENEFORM Protein DME1265 XEOTICID XEO02526 MOACRIVE Inhibition DME1265 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1265 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02527 XEO_CLAS Peptide DME1265 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 119 microM) DME1265 XEOTICID XEO02527 GENEFORM Protein DME1265 XEOTICID XEO02527 MOACRIVE Inhibition DME1265 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1265 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02528 XEO_CLAS Peptide DME1265 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 128 ug/ml) DME1265 XEOTICID XEO02528 GENEFORM Protein DME1265 XEOTICID XEO02528 MOACRIVE Inhibition DME1265 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1265 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02529 XEO_CLAS Peptide DME1265 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 128 ug/ml) DME1265 XEOTICID XEO02529 GENEFORM Protein DME1265 XEOTICID XEO02529 MOACRIVE Inhibition DME1265 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1265 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02530 XEO_CLAS Peptide DME1265 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02530 GENEFORM Protein DME1265 XEOTICID XEO02530 MOACRIVE Inhibition DME1265 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1265 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02531 XEO_CLAS Peptide DME1265 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 microM) DME1265 XEOTICID XEO02531 GENEFORM Protein DME1265 XEOTICID XEO02531 MOACRIVE Inhibition DME1265 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1265 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02533 XEO_CLAS Peptide DME1265 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.2 ug/ml) DME1265 XEOTICID XEO02533 GENEFORM Protein DME1265 XEOTICID XEO02533 MOACRIVE Inhibition DME1265 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1265 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02534 XEO_CLAS Peptide DME1265 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.6 ug/ml) DME1265 XEOTICID XEO02534 GENEFORM Protein DME1265 XEOTICID XEO02534 MOACRIVE Inhibition DME1265 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1265 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02535 XEO_CLAS Peptide DME1265 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.3 ug/ml) DME1265 XEOTICID XEO02535 GENEFORM Protein DME1265 XEOTICID XEO02535 MOACRIVE Inhibition DME1265 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1265 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02536 XEO_CLAS Peptide DME1265 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.4 ug/ml) DME1265 XEOTICID XEO02536 GENEFORM Protein DME1265 XEOTICID XEO02536 MOACRIVE Inhibition DME1265 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1265 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02537 XEO_CLAS Peptide DME1265 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.2 ug/ml) DME1265 XEOTICID XEO02537 GENEFORM Protein DME1265 XEOTICID XEO02537 MOACRIVE Inhibition DME1265 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1265 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02538 XEO_CLAS Peptide DME1265 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 9.1 ug/ml) DME1265 XEOTICID XEO02538 GENEFORM Protein DME1265 XEOTICID XEO02538 MOACRIVE Inhibition DME1265 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1265 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02539 XEO_CLAS Peptide DME1265 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8.6 ug/ml) DME1265 XEOTICID XEO02539 GENEFORM Protein DME1265 XEOTICID XEO02539 MOACRIVE Inhibition DME1265 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1265 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02540 XEO_CLAS Peptide DME1265 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15.2 ug/ml) DME1265 XEOTICID XEO02540 GENEFORM Protein DME1265 XEOTICID XEO02540 MOACRIVE Inhibition DME1265 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1265 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02541 XEO_CLAS Peptide DME1265 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 11.1 ug/ml) DME1265 XEOTICID XEO02541 GENEFORM Protein DME1265 XEOTICID XEO02541 MOACRIVE Inhibition DME1265 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1265 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02542 XEO_CLAS Peptide DME1265 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.7 ug/ml) DME1265 XEOTICID XEO02542 GENEFORM Protein DME1265 XEOTICID XEO02542 MOACRIVE Inhibition DME1265 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1265 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02543 XEO_CLAS Peptide DME1265 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 13.1 ug/ml) DME1265 XEOTICID XEO02543 GENEFORM Protein DME1265 XEOTICID XEO02543 MOACRIVE Inhibition DME1265 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1265 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02544 XEO_CLAS Peptide DME1265 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 9.8 ug/ml) DME1265 XEOTICID XEO02544 GENEFORM Protein DME1265 XEOTICID XEO02544 MOACRIVE Inhibition DME1265 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1265 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02545 XEO_CLAS Peptide DME1265 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 14 microM) DME1265 XEOTICID XEO02545 GENEFORM Protein DME1265 XEOTICID XEO02545 MOACRIVE Inhibition DME1265 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1265 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02546 XEO_CLAS Peptide DME1265 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 14 microM) DME1265 XEOTICID XEO02546 GENEFORM Protein DME1265 XEOTICID XEO02546 MOACRIVE Inhibition DME1265 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1265 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02547 XEO_CLAS Peptide DME1265 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 microM) DME1265 XEOTICID XEO02547 GENEFORM Protein DME1265 XEOTICID XEO02547 MOACRIVE Inhibition DME1265 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1265 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02548 XEO_CLAS Peptide DME1265 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 78 microM) DME1265 XEOTICID XEO02548 GENEFORM Protein DME1265 XEOTICID XEO02548 MOACRIVE Inhibition DME1265 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1265 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02549 XEO_CLAS Peptide DME1265 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02549 GENEFORM Protein DME1265 XEOTICID XEO02549 MOACRIVE Inhibition DME1265 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1265 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02552 XEO_CLAS Peptide DME1265 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 24 microM) DME1265 XEOTICID XEO02552 GENEFORM Protein DME1265 XEOTICID XEO02552 MOACRIVE Inhibition DME1265 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1265 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02553 XEO_CLAS Peptide DME1265 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02553 GENEFORM Protein DME1265 XEOTICID XEO02553 MOACRIVE Inhibition DME1265 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1265 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02556 XEO_CLAS Peptide DME1265 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 55 microM) DME1265 XEOTICID XEO02556 GENEFORM Protein DME1265 XEOTICID XEO02556 MOACRIVE Inhibition DME1265 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1265 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02557 XEO_CLAS Peptide DME1265 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 17 microM) DME1265 XEOTICID XEO02557 GENEFORM Protein DME1265 XEOTICID XEO02557 MOACRIVE Inhibition DME1265 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1265 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02558 XEO_CLAS Peptide DME1265 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 14 microM) DME1265 XEOTICID XEO02558 GENEFORM Protein DME1265 XEOTICID XEO02558 MOACRIVE Inhibition DME1265 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1265 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02559 XEO_CLAS Peptide DME1265 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02559 GENEFORM Protein DME1265 XEOTICID XEO02559 MOACRIVE Inhibition DME1265 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1265 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02560 XEO_CLAS Peptide DME1265 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 13 microM) DME1265 XEOTICID XEO02560 GENEFORM Protein DME1265 XEOTICID XEO02560 MOACRIVE Inhibition DME1265 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1265 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02561 XEO_CLAS Peptide DME1265 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO02561 GENEFORM Protein DME1265 XEOTICID XEO02561 MOACRIVE Inhibition DME1265 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1265 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02562 XEO_CLAS Peptide DME1265 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 13 microM) DME1265 XEOTICID XEO02562 GENEFORM Protein DME1265 XEOTICID XEO02562 MOACRIVE Inhibition DME1265 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1265 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02563 XEO_CLAS Peptide DME1265 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 45 microM) DME1265 XEOTICID XEO02563 GENEFORM Protein DME1265 XEOTICID XEO02563 MOACRIVE Inhibition DME1265 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1265 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02564 XEO_CLAS Peptide DME1265 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 ug/ml) DME1265 XEOTICID XEO02564 GENEFORM Protein DME1265 XEOTICID XEO02564 MOACRIVE Inhibition DME1265 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1265 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02565 XEO_CLAS Peptide DME1265 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 microM) DME1265 XEOTICID XEO02565 GENEFORM Protein DME1265 XEOTICID XEO02565 MOACRIVE Inhibition DME1265 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1265 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02566 XEO_CLAS Peptide DME1265 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO02566 GENEFORM Protein DME1265 XEOTICID XEO02566 MOACRIVE Inhibition DME1265 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1265 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02568 XEO_CLAS Peptide DME1265 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO02568 GENEFORM Protein DME1265 XEOTICID XEO02568 MOACRIVE Inhibition DME1265 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1265 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02569 XEO_CLAS Peptide DME1265 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO02569 GENEFORM Protein DME1265 XEOTICID XEO02569 MOACRIVE Inhibition DME1265 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1265 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02570 XEO_CLAS Peptide DME1265 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO02570 GENEFORM Protein DME1265 XEOTICID XEO02570 MOACRIVE Inhibition DME1265 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1265 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02571 XEO_CLAS Peptide DME1265 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO02571 GENEFORM Protein DME1265 XEOTICID XEO02571 MOACRIVE Inhibition DME1265 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1265 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02572 XEO_CLAS Peptide DME1265 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02572 GENEFORM Protein DME1265 XEOTICID XEO02572 MOACRIVE Inhibition DME1265 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1265 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02573 XEO_CLAS Peptide DME1265 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02573 GENEFORM Protein DME1265 XEOTICID XEO02573 MOACRIVE Inhibition DME1265 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1265 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02574 XEO_CLAS Peptide DME1265 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 microM) DME1265 XEOTICID XEO02574 GENEFORM Protein DME1265 XEOTICID XEO02574 MOACRIVE Inhibition DME1265 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1265 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02575 XEO_CLAS Peptide DME1265 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 microM) DME1265 XEOTICID XEO02575 GENEFORM Protein DME1265 XEOTICID XEO02575 MOACRIVE Inhibition DME1265 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1265 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02576 XEO_CLAS Peptide DME1265 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 33 microM) DME1265 XEOTICID XEO02576 GENEFORM Protein DME1265 XEOTICID XEO02576 MOACRIVE Inhibition DME1265 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1265 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02577 XEO_CLAS Peptide DME1265 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO02577 GENEFORM Protein DME1265 XEOTICID XEO02577 MOACRIVE Inhibition DME1265 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1265 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02578 XEO_CLAS Peptide DME1265 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02578 GENEFORM Protein DME1265 XEOTICID XEO02578 MOACRIVE Inhibition DME1265 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1265 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02579 XEO_CLAS Peptide DME1265 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02579 GENEFORM Protein DME1265 XEOTICID XEO02579 MOACRIVE Inhibition DME1265 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1265 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02580 XEO_CLAS Peptide DME1265 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC < 15 microM) DME1265 XEOTICID XEO02580 GENEFORM Protein DME1265 XEOTICID XEO02580 MOACRIVE Inhibition DME1265 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1265 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02581 XEO_CLAS Peptide DME1265 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 microM) DME1265 XEOTICID XEO02581 GENEFORM Protein DME1265 XEOTICID XEO02581 MOACRIVE Inhibition DME1265 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1265 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02582 XEO_CLAS Peptide DME1265 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 microM) DME1265 XEOTICID XEO02582 GENEFORM Protein DME1265 XEOTICID XEO02582 MOACRIVE Inhibition DME1265 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1265 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02583 XEO_CLAS Peptide DME1265 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 microM) DME1265 XEOTICID XEO02583 GENEFORM Protein DME1265 XEOTICID XEO02583 MOACRIVE Inhibition DME1265 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1265 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02584 XEO_CLAS Peptide DME1265 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 microM) DME1265 XEOTICID XEO02584 GENEFORM Protein DME1265 XEOTICID XEO02584 MOACRIVE Inhibition DME1265 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1265 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02585 XEO_CLAS Peptide DME1265 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO02585 GENEFORM Protein DME1265 XEOTICID XEO02585 MOACRIVE Inhibition DME1265 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1265 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02586 XEO_CLAS Peptide DME1265 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO02586 GENEFORM Protein DME1265 XEOTICID XEO02586 MOACRIVE Inhibition DME1265 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1265 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02587 XEO_CLAS Peptide DME1265 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02587 GENEFORM Protein DME1265 XEOTICID XEO02587 MOACRIVE Inhibition DME1265 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1265 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02589 XEO_CLAS Peptide DME1265 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8.2 ug/ml) DME1265 XEOTICID XEO02589 GENEFORM Protein DME1265 XEOTICID XEO02589 MOACRIVE Inhibition DME1265 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1265 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02590 XEO_CLAS Peptide DME1265 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 19.6 ug/ml) DME1265 XEOTICID XEO02590 GENEFORM Protein DME1265 XEOTICID XEO02590 MOACRIVE Inhibition DME1265 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1265 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02591 XEO_CLAS Peptide DME1265 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO02591 GENEFORM Protein DME1265 XEOTICID XEO02591 MOACRIVE Inhibition DME1265 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1265 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02593 XEO_CLAS Peptide DME1265 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 36 microM) DME1265 XEOTICID XEO02593 GENEFORM Protein DME1265 XEOTICID XEO02593 MOACRIVE Inhibition DME1265 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1265 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02594 XEO_CLAS Peptide DME1265 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02594 GENEFORM Protein DME1265 XEOTICID XEO02594 MOACRIVE Inhibition DME1265 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1265 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02595 XEO_CLAS Peptide DME1265 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO02595 GENEFORM Protein DME1265 XEOTICID XEO02595 MOACRIVE Inhibition DME1265 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1265 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02596 XEO_CLAS Peptide DME1265 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO02596 GENEFORM Protein DME1265 XEOTICID XEO02596 MOACRIVE Inhibition DME1265 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1265 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02597 XEO_CLAS Peptide DME1265 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO02597 GENEFORM Protein DME1265 XEOTICID XEO02597 MOACRIVE Inhibition DME1265 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1265 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02598 XEO_CLAS Peptide DME1265 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 32.5 microM) DME1265 XEOTICID XEO02598 GENEFORM Protein DME1265 XEOTICID XEO02598 MOACRIVE Inhibition DME1265 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1265 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02599 XEO_CLAS Peptide DME1265 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 microM) DME1265 XEOTICID XEO02599 GENEFORM Protein DME1265 XEOTICID XEO02599 MOACRIVE Inhibition DME1265 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1265 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02601 XEO_CLAS Peptide DME1265 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.1 ug/ml) DME1265 XEOTICID XEO02601 GENEFORM Protein DME1265 XEOTICID XEO02601 MOACRIVE Inhibition DME1265 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1265 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02602 XEO_CLAS Peptide DME1265 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 13.2 ug/ml) DME1265 XEOTICID XEO02602 GENEFORM Protein DME1265 XEOTICID XEO02602 MOACRIVE Inhibition DME1265 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1265 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02603 XEO_CLAS Peptide DME1265 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.3 ug/ml) DME1265 XEOTICID XEO02603 GENEFORM Protein DME1265 XEOTICID XEO02603 MOACRIVE Inhibition DME1265 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1265 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02604 XEO_CLAS Peptide DME1265 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO02604 GENEFORM Protein DME1265 XEOTICID XEO02604 MOACRIVE Inhibition DME1265 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1265 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02605 XEO_CLAS Peptide DME1265 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30.6 ug/ml) DME1265 XEOTICID XEO02605 GENEFORM Protein DME1265 XEOTICID XEO02605 MOACRIVE Inhibition DME1265 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1265 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02606 XEO_CLAS Peptide DME1265 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 11.2 ug/ml) DME1265 XEOTICID XEO02606 GENEFORM Protein DME1265 XEOTICID XEO02606 MOACRIVE Inhibition DME1265 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1265 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02607 XEO_CLAS Peptide DME1265 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.8 ug/ml) DME1265 XEOTICID XEO02607 GENEFORM Protein DME1265 XEOTICID XEO02607 MOACRIVE Inhibition DME1265 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1265 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02608 XEO_CLAS Peptide DME1265 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 7.9 ug/ml) DME1265 XEOTICID XEO02608 GENEFORM Protein DME1265 XEOTICID XEO02608 MOACRIVE Inhibition DME1265 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1265 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02609 XEO_CLAS Peptide DME1265 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15.8 ug/ml) DME1265 XEOTICID XEO02609 GENEFORM Protein DME1265 XEOTICID XEO02609 MOACRIVE Inhibition DME1265 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1265 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02610 XEO_CLAS Peptide DME1265 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.1 ug/ml) DME1265 XEOTICID XEO02610 GENEFORM Protein DME1265 XEOTICID XEO02610 MOACRIVE Inhibition DME1265 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1265 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02611 XEO_CLAS Peptide DME1265 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20.6 ug/ml) DME1265 XEOTICID XEO02611 GENEFORM Protein DME1265 XEOTICID XEO02611 MOACRIVE Inhibition DME1265 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1265 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02612 XEO_CLAS Peptide DME1265 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 11.8 ug/ml) DME1265 XEOTICID XEO02612 GENEFORM Protein DME1265 XEOTICID XEO02612 MOACRIVE Inhibition DME1265 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1265 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02613 XEO_CLAS Peptide DME1265 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 13.2 ug/ml) DME1265 XEOTICID XEO02613 GENEFORM Protein DME1265 XEOTICID XEO02613 MOACRIVE Inhibition DME1265 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1265 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02614 XEO_CLAS Peptide DME1265 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.8 ug/ml) DME1265 XEOTICID XEO02614 GENEFORM Protein DME1265 XEOTICID XEO02614 MOACRIVE Inhibition DME1265 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1265 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02615 XEO_CLAS Peptide DME1265 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8.6 ug/ml) DME1265 XEOTICID XEO02615 GENEFORM Protein DME1265 XEOTICID XEO02615 MOACRIVE Inhibition DME1265 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1265 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02616 XEO_CLAS Peptide DME1265 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20.4 ug/ml) DME1265 XEOTICID XEO02616 GENEFORM Protein DME1265 XEOTICID XEO02616 MOACRIVE Inhibition DME1265 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1265 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02617 XEO_CLAS Peptide DME1265 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4.7 ug/ml) DME1265 XEOTICID XEO02617 GENEFORM Protein DME1265 XEOTICID XEO02617 MOACRIVE Inhibition DME1265 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1265 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02618 XEO_CLAS Peptide DME1265 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.6 ug/ml) DME1265 XEOTICID XEO02618 GENEFORM Protein DME1265 XEOTICID XEO02618 MOACRIVE Inhibition DME1265 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1265 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02619 XEO_CLAS Peptide DME1265 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10.5 ug/ml) DME1265 XEOTICID XEO02619 GENEFORM Protein DME1265 XEOTICID XEO02619 MOACRIVE Inhibition DME1265 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1265 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02620 XEO_CLAS Peptide DME1265 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO02620 GENEFORM Protein DME1265 XEOTICID XEO02620 MOACRIVE Inhibition DME1265 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1265 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02621 XEO_CLAS Peptide DME1265 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO02621 GENEFORM Protein DME1265 XEOTICID XEO02621 MOACRIVE Inhibition DME1265 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1265 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02622 XEO_CLAS Peptide DME1265 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO02622 GENEFORM Protein DME1265 XEOTICID XEO02622 MOACRIVE Inhibition DME1265 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1265 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02623 XEO_CLAS Peptide DME1265 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO02623 GENEFORM Protein DME1265 XEOTICID XEO02623 MOACRIVE Inhibition DME1265 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1265 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02624 XEO_CLAS Peptide DME1265 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 18 microM) DME1265 XEOTICID XEO02624 GENEFORM Protein DME1265 XEOTICID XEO02624 MOACRIVE Inhibition DME1265 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1265 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02625 XEO_CLAS Peptide DME1265 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 9 microM) DME1265 XEOTICID XEO02625 GENEFORM Protein DME1265 XEOTICID XEO02625 MOACRIVE Inhibition DME1265 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1265 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02626 XEO_CLAS Peptide DME1265 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 18 microM) DME1265 XEOTICID XEO02626 GENEFORM Protein DME1265 XEOTICID XEO02626 MOACRIVE Inhibition DME1265 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1265 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02627 XEO_CLAS Peptide DME1265 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02627 GENEFORM Protein DME1265 XEOTICID XEO02627 MOACRIVE Inhibition DME1265 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1265 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02628 XEO_CLAS Peptide DME1265 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 18 microM) DME1265 XEOTICID XEO02628 GENEFORM Protein DME1265 XEOTICID XEO02628 MOACRIVE Inhibition DME1265 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1265 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02629 XEO_CLAS Peptide DME1265 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 13 microM) DME1265 XEOTICID XEO02629 GENEFORM Protein DME1265 XEOTICID XEO02629 MOACRIVE Inhibition DME1265 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1265 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02630 XEO_CLAS Peptide DME1265 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 ug/ml) DME1265 XEOTICID XEO02630 GENEFORM Protein DME1265 XEOTICID XEO02630 MOACRIVE Inhibition DME1265 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1265 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02631 XEO_CLAS Peptide DME1265 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 ug/ml) DME1265 XEOTICID XEO02631 GENEFORM Protein DME1265 XEOTICID XEO02631 MOACRIVE Inhibition DME1265 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1265 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02634 XEO_CLAS Peptide DME1265 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO02634 GENEFORM Protein DME1265 XEOTICID XEO02634 MOACRIVE Inhibition DME1265 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1265 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02635 XEO_CLAS Peptide DME1265 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40 ug/ml) DME1265 XEOTICID XEO02635 GENEFORM Protein DME1265 XEOTICID XEO02635 MOACRIVE Inhibition DME1265 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1265 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02636 XEO_CLAS Peptide DME1265 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO02636 GENEFORM Protein DME1265 XEOTICID XEO02636 MOACRIVE Inhibition DME1265 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1265 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02637 XEO_CLAS Peptide DME1265 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO02637 GENEFORM Protein DME1265 XEOTICID XEO02637 MOACRIVE Inhibition DME1265 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1265 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02638 XEO_CLAS Peptide DME1265 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 microM) DME1265 XEOTICID XEO02638 GENEFORM Protein DME1265 XEOTICID XEO02638 MOACRIVE Inhibition DME1265 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1265 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02639 XEO_CLAS Peptide DME1265 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 microM) DME1265 XEOTICID XEO02639 GENEFORM Protein DME1265 XEOTICID XEO02639 MOACRIVE Inhibition DME1265 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1265 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02644 XEO_CLAS Peptide DME1265 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02644 GENEFORM Protein DME1265 XEOTICID XEO02644 MOACRIVE Inhibition DME1265 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1265 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02645 XEO_CLAS Peptide DME1265 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02645 GENEFORM Protein DME1265 XEOTICID XEO02645 MOACRIVE Inhibition DME1265 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1265 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02646 XEO_CLAS Peptide DME1265 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02646 GENEFORM Protein DME1265 XEOTICID XEO02646 MOACRIVE Inhibition DME1265 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1265 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02647 XEO_CLAS Peptide DME1265 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02647 GENEFORM Protein DME1265 XEOTICID XEO02647 MOACRIVE Inhibition DME1265 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1265 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02649 XEO_CLAS Peptide DME1265 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO02649 GENEFORM Protein DME1265 XEOTICID XEO02649 MOACRIVE Inhibition DME1265 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1265 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02650 XEO_CLAS Peptide DME1265 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO02650 GENEFORM Protein DME1265 XEOTICID XEO02650 MOACRIVE Inhibition DME1265 XEOTICID XEO02658 XEO_NAME Buthinin DME1265 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02658 XEO_CLAS Peptide DME1265 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02658 GENEFORM Protein DME1265 XEOTICID XEO02658 MOACRIVE Inhibition DME1265 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1265 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02663 XEO_CLAS Peptide DME1265 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25 microM) DME1265 XEOTICID XEO02663 GENEFORM Protein DME1265 XEOTICID XEO02663 MOACRIVE Inhibition DME1265 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1265 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02664 XEO_CLAS Peptide DME1265 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25 microM) DME1265 XEOTICID XEO02664 GENEFORM Protein DME1265 XEOTICID XEO02664 MOACRIVE Inhibition DME1265 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1265 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02672 XEO_CLAS Peptide DME1265 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25 microM) DME1265 XEOTICID XEO02672 GENEFORM Protein DME1265 XEOTICID XEO02672 MOACRIVE Inhibition DME1265 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1265 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02673 XEO_CLAS Peptide DME1265 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25-12.5 microM) DME1265 XEOTICID XEO02673 GENEFORM Protein DME1265 XEOTICID XEO02673 MOACRIVE Inhibition DME1265 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1265 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02674 XEO_CLAS Peptide DME1265 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.125-6.25 microM) DME1265 XEOTICID XEO02674 GENEFORM Protein DME1265 XEOTICID XEO02674 MOACRIVE Inhibition DME1265 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1265 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02676 XEO_CLAS Peptide DME1265 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO02676 GENEFORM Protein DME1265 XEOTICID XEO02676 MOACRIVE Inhibition DME1265 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1265 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02677 XEO_CLAS Peptide DME1265 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25-12.5 microM) DME1265 XEOTICID XEO02677 GENEFORM Protein DME1265 XEOTICID XEO02677 MOACRIVE Inhibition DME1265 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1265 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02679 XEO_CLAS Peptide DME1265 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25-12.5 microM) DME1265 XEOTICID XEO02679 GENEFORM Protein DME1265 XEOTICID XEO02679 MOACRIVE Inhibition DME1265 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1265 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02680 XEO_CLAS Peptide DME1265 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25 microM) DME1265 XEOTICID XEO02680 GENEFORM Protein DME1265 XEOTICID XEO02680 MOACRIVE Inhibition DME1265 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1265 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02683 XEO_CLAS Peptide DME1265 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO02683 GENEFORM Protein DME1265 XEOTICID XEO02683 MOACRIVE Inhibition DME1265 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1265 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02688 XEO_CLAS Peptide DME1265 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO02688 GENEFORM Protein DME1265 XEOTICID XEO02688 MOACRIVE Inhibition DME1265 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1265 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02693 XEO_CLAS Peptide DME1265 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 ug/ml) DME1265 XEOTICID XEO02693 GENEFORM Protein DME1265 XEOTICID XEO02693 MOACRIVE Inhibition DME1265 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1265 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02699 XEO_CLAS Peptide DME1265 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 ug/ml) DME1265 XEOTICID XEO02699 GENEFORM Protein DME1265 XEOTICID XEO02699 MOACRIVE Inhibition DME1265 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1265 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02700 XEO_CLAS Peptide DME1265 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 ug/ml) DME1265 XEOTICID XEO02700 GENEFORM Protein DME1265 XEOTICID XEO02700 MOACRIVE Inhibition DME1265 XEOTICID XEO02703 XEO_NAME Calcitermin DME1265 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02703 XEO_CLAS Peptide DME1265 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02703 GENEFORM Protein DME1265 XEOTICID XEO02703 MOACRIVE Inhibition DME1265 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1265 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02708 XEO_CLAS Peptide DME1265 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO02708 GENEFORM Protein DME1265 XEOTICID XEO02708 MOACRIVE Inhibition DME1265 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1265 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02709 XEO_CLAS Peptide DME1265 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.05 microM) DME1265 XEOTICID XEO02709 GENEFORM Protein DME1265 XEOTICID XEO02709 MOACRIVE Inhibition DME1265 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1265 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1265 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02713 GENEFORM Protein DME1265 XEOTICID XEO02713 MOACRIVE Inhibition DME1265 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1265 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1265 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02714 GENEFORM Protein DME1265 XEOTICID XEO02714 MOACRIVE Inhibition DME1265 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1265 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02726 XEO_CLAS Peptide DME1265 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02726 GENEFORM Protein DME1265 XEOTICID XEO02726 MOACRIVE Inhibition DME1265 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1265 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02731 XEO_CLAS Peptide DME1265 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1 microM) DME1265 XEOTICID XEO02731 GENEFORM Protein DME1265 XEOTICID XEO02731 MOACRIVE Inhibition DME1265 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1265 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02732 XEO_CLAS Peptide DME1265 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.25 microM) DME1265 XEOTICID XEO02732 GENEFORM Protein DME1265 XEOTICID XEO02732 MOACRIVE Inhibition DME1265 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1265 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02733 XEO_CLAS Peptide DME1265 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8-25 ug/ml) DME1265 XEOTICID XEO02733 GENEFORM Protein DME1265 XEOTICID XEO02733 MOACRIVE Inhibition DME1265 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1265 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02735 XEO_CLAS Peptide DME1265 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1 ug/ml) DME1265 XEOTICID XEO02735 GENEFORM Protein DME1265 XEOTICID XEO02735 MOACRIVE Inhibition DME1265 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1265 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02737 XEO_CLAS Peptide DME1265 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02737 GENEFORM Protein DME1265 XEOTICID XEO02737 MOACRIVE Inhibition DME1265 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1265 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02738 XEO_CLAS Peptide DME1265 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO02738 GENEFORM Protein DME1265 XEOTICID XEO02738 MOACRIVE Inhibition DME1265 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1265 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02739 XEO_CLAS Peptide DME1265 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 microM) DME1265 XEOTICID XEO02739 GENEFORM Protein DME1265 XEOTICID XEO02739 MOACRIVE Inhibition DME1265 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1265 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02740 XEO_CLAS Peptide DME1265 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.25 ug/ml) DME1265 XEOTICID XEO02740 GENEFORM Protein DME1265 XEOTICID XEO02740 MOACRIVE Inhibition DME1265 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1265 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02741 XEO_CLAS Peptide DME1265 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 ug/ml) DME1265 XEOTICID XEO02741 GENEFORM Protein DME1265 XEOTICID XEO02741 MOACRIVE Inhibition DME1265 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1265 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02743 XEO_CLAS Peptide DME1265 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.6 ug/ml) DME1265 XEOTICID XEO02743 GENEFORM Protein DME1265 XEOTICID XEO02743 MOACRIVE Inhibition DME1265 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1265 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02744 XEO_CLAS Peptide DME1265 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 18.7 ug/ml) DME1265 XEOTICID XEO02744 GENEFORM Protein DME1265 XEOTICID XEO02744 MOACRIVE Inhibition DME1265 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1265 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02745 XEO_CLAS Peptide DME1265 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02745 GENEFORM Protein DME1265 XEOTICID XEO02745 MOACRIVE Inhibition DME1265 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1265 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02746 XEO_CLAS Peptide DME1265 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02746 GENEFORM Protein DME1265 XEOTICID XEO02746 MOACRIVE Inhibition DME1265 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1265 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02748 XEO_CLAS Peptide DME1265 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02748 GENEFORM Protein DME1265 XEOTICID XEO02748 MOACRIVE Inhibition DME1265 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1265 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02749 XEO_CLAS Peptide DME1265 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20-25 mug/ml) DME1265 XEOTICID XEO02749 GENEFORM Protein DME1265 XEOTICID XEO02749 MOACRIVE Inhibition DME1265 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1265 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02750 XEO_CLAS Peptide DME1265 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02750 GENEFORM Protein DME1265 XEOTICID XEO02750 MOACRIVE Inhibition DME1265 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1265 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02752 XEO_CLAS Peptide DME1265 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02752 GENEFORM Protein DME1265 XEOTICID XEO02752 MOACRIVE Inhibition DME1265 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1265 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02753 XEO_CLAS Peptide DME1265 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02753 GENEFORM Protein DME1265 XEOTICID XEO02753 MOACRIVE Inhibition DME1265 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1265 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02754 XEO_CLAS Peptide DME1265 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 microM) DME1265 XEOTICID XEO02754 GENEFORM Protein DME1265 XEOTICID XEO02754 MOACRIVE Inhibition DME1265 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1265 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02756 XEO_CLAS Peptide DME1265 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 microM) DME1265 XEOTICID XEO02756 GENEFORM Protein DME1265 XEOTICID XEO02756 MOACRIVE Inhibition DME1265 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1265 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02757 XEO_CLAS Peptide DME1265 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1 microM) DME1265 XEOTICID XEO02757 GENEFORM Protein DME1265 XEOTICID XEO02757 MOACRIVE Inhibition DME1265 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1265 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02758 XEO_CLAS Peptide DME1265 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO02758 GENEFORM Protein DME1265 XEOTICID XEO02758 MOACRIVE Inhibition DME1265 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1265 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02759 XEO_CLAS Peptide DME1265 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.6 microM) DME1265 XEOTICID XEO02759 GENEFORM Protein DME1265 XEOTICID XEO02759 MOACRIVE Inhibition DME1265 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1265 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02760 XEO_CLAS Peptide DME1265 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 microM) DME1265 XEOTICID XEO02760 GENEFORM Protein DME1265 XEOTICID XEO02760 MOACRIVE Inhibition DME1265 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1265 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02761 XEO_CLAS Peptide DME1265 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO02761 GENEFORM Protein DME1265 XEOTICID XEO02761 MOACRIVE Inhibition DME1265 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1265 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02762 XEO_CLAS Peptide DME1265 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 microM) DME1265 XEOTICID XEO02762 GENEFORM Protein DME1265 XEOTICID XEO02762 MOACRIVE Inhibition DME1265 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1265 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02763 XEO_CLAS Peptide DME1265 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.4 microM) DME1265 XEOTICID XEO02763 GENEFORM Protein DME1265 XEOTICID XEO02763 MOACRIVE Inhibition DME1265 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1265 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02764 XEO_CLAS Peptide DME1265 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 microM) DME1265 XEOTICID XEO02764 GENEFORM Protein DME1265 XEOTICID XEO02764 MOACRIVE Inhibition DME1265 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1265 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02765 XEO_CLAS Peptide DME1265 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.3 microM) DME1265 XEOTICID XEO02765 GENEFORM Protein DME1265 XEOTICID XEO02765 MOACRIVE Inhibition DME1265 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1265 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02767 XEO_CLAS Peptide DME1265 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02767 GENEFORM Protein DME1265 XEOTICID XEO02767 MOACRIVE Inhibition DME1265 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1265 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02768 XEO_CLAS Peptide DME1265 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1265 XEOTICID XEO02768 GENEFORM Protein DME1265 XEOTICID XEO02768 MOACRIVE Inhibition DME1265 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1265 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02769 XEO_CLAS Peptide DME1265 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.32 microM) DME1265 XEOTICID XEO02769 GENEFORM Protein DME1265 XEOTICID XEO02769 MOACRIVE Inhibition DME1265 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1265 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02770 XEO_CLAS Peptide DME1265 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.30 microM) DME1265 XEOTICID XEO02770 GENEFORM Protein DME1265 XEOTICID XEO02770 MOACRIVE Inhibition DME1265 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1265 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02771 XEO_CLAS Peptide DME1265 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.21 microM) DME1265 XEOTICID XEO02771 GENEFORM Protein DME1265 XEOTICID XEO02771 MOACRIVE Inhibition DME1265 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1265 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02772 XEO_CLAS Peptide DME1265 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02772 GENEFORM Protein DME1265 XEOTICID XEO02772 MOACRIVE Inhibition DME1265 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1265 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02773 XEO_CLAS Peptide DME1265 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.9-8.6 microM) DME1265 XEOTICID XEO02773 GENEFORM Protein DME1265 XEOTICID XEO02773 MOACRIVE Inhibition DME1265 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1265 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02774 XEO_CLAS Peptide DME1265 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.3 microM) DME1265 XEOTICID XEO02774 GENEFORM Protein DME1265 XEOTICID XEO02774 MOACRIVE Inhibition DME1265 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1265 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02789 GENEFORM Protein DME1265 XEOTICID XEO02789 MOACRIVE Inhibition DME1265 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1265 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02790 GENEFORM Protein DME1265 XEOTICID XEO02790 MOACRIVE Inhibition DME1265 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1265 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02791 GENEFORM Protein DME1265 XEOTICID XEO02791 MOACRIVE Inhibition DME1265 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1265 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02792 GENEFORM Protein DME1265 XEOTICID XEO02792 MOACRIVE Inhibition DME1265 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1265 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02793 GENEFORM Protein DME1265 XEOTICID XEO02793 MOACRIVE Inhibition DME1265 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1265 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02794 GENEFORM Protein DME1265 XEOTICID XEO02794 MOACRIVE Inhibition DME1265 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1265 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02795 GENEFORM Protein DME1265 XEOTICID XEO02795 MOACRIVE Inhibition DME1265 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1265 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02796 GENEFORM Protein DME1265 XEOTICID XEO02796 MOACRIVE Inhibition DME1265 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1265 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02797 GENEFORM Protein DME1265 XEOTICID XEO02797 MOACRIVE Inhibition DME1265 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1265 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02799 XEO_CLAS Peptide DME1265 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02799 GENEFORM Protein DME1265 XEOTICID XEO02799 MOACRIVE Inhibition DME1265 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1265 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02800 XEO_CLAS Peptide DME1265 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02800 GENEFORM Protein DME1265 XEOTICID XEO02800 MOACRIVE Inhibition DME1265 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1265 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02802 XEO_CLAS Peptide DME1265 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 13.6 microM) DME1265 XEOTICID XEO02802 GENEFORM Protein DME1265 XEOTICID XEO02802 MOACRIVE Inhibition DME1265 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1265 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02807 XEO_CLAS Peptide DME1265 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.2 microM) DME1265 XEOTICID XEO02807 GENEFORM Protein DME1265 XEOTICID XEO02807 MOACRIVE Inhibition DME1265 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1265 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02813 XEO_CLAS Peptide DME1265 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 80 microM) DME1265 XEOTICID XEO02813 GENEFORM Protein DME1265 XEOTICID XEO02813 MOACRIVE Inhibition DME1265 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1265 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02814 XEO_CLAS Peptide DME1265 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 80 microM) DME1265 XEOTICID XEO02814 GENEFORM Protein DME1265 XEOTICID XEO02814 MOACRIVE Inhibition DME1265 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1265 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02815 XEO_CLAS Peptide DME1265 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8.5 microM) DME1265 XEOTICID XEO02815 GENEFORM Protein DME1265 XEOTICID XEO02815 MOACRIVE Inhibition DME1265 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1265 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02816 XEO_CLAS Peptide DME1265 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 80 microM) DME1265 XEOTICID XEO02816 GENEFORM Protein DME1265 XEOTICID XEO02816 MOACRIVE Inhibition DME1265 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1265 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02817 XEO_CLAS Peptide DME1265 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 80 microM) DME1265 XEOTICID XEO02817 GENEFORM Protein DME1265 XEOTICID XEO02817 MOACRIVE Inhibition DME1265 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1265 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02818 XEO_CLAS Peptide DME1265 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.4 microM) DME1265 XEOTICID XEO02818 GENEFORM Protein DME1265 XEOTICID XEO02818 MOACRIVE Inhibition DME1265 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1265 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02819 XEO_CLAS Peptide DME1265 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.6 microM) DME1265 XEOTICID XEO02819 GENEFORM Protein DME1265 XEOTICID XEO02819 MOACRIVE Inhibition DME1265 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1265 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02820 XEO_CLAS Peptide DME1265 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO02820 GENEFORM Protein DME1265 XEOTICID XEO02820 MOACRIVE Inhibition DME1265 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1265 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02821 XEO_CLAS Peptide DME1265 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02821 GENEFORM Protein DME1265 XEOTICID XEO02821 MOACRIVE Inhibition DME1265 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1265 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02824 XEO_CLAS Peptide DME1265 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 35 microM) DME1265 XEOTICID XEO02824 GENEFORM Protein DME1265 XEOTICID XEO02824 MOACRIVE Inhibition DME1265 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1265 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02826 XEO_CLAS Peptide DME1265 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.7 ug/ml) DME1265 XEOTICID XEO02826 GENEFORM Protein DME1265 XEOTICID XEO02826 MOACRIVE Inhibition DME1265 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1265 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02834 GENEFORM Protein DME1265 XEOTICID XEO02834 MOACRIVE Inhibition DME1265 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1265 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02839 XEO_CLAS Peptide DME1265 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.25 microM) DME1265 XEOTICID XEO02839 GENEFORM Protein DME1265 XEOTICID XEO02839 MOACRIVE Inhibition DME1265 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1265 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02841 XEO_CLAS Peptide DME1265 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.25 microM) DME1265 XEOTICID XEO02841 GENEFORM Protein DME1265 XEOTICID XEO02841 MOACRIVE Inhibition DME1265 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1265 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02842 XEO_CLAS Peptide DME1265 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.25 microM) DME1265 XEOTICID XEO02842 GENEFORM Protein DME1265 XEOTICID XEO02842 MOACRIVE Inhibition DME1265 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1265 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02843 XEO_CLAS Peptide DME1265 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02843 GENEFORM Protein DME1265 XEOTICID XEO02843 MOACRIVE Inhibition DME1265 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1265 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02849 GENEFORM Protein DME1265 XEOTICID XEO02849 MOACRIVE Inhibition DME1265 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1265 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02857 XEO_CLAS Peptide DME1265 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 53 microM) DME1265 XEOTICID XEO02857 GENEFORM Protein DME1265 XEOTICID XEO02857 MOACRIVE Inhibition DME1265 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1265 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02858 XEO_CLAS Peptide DME1265 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 53 microM) DME1265 XEOTICID XEO02858 GENEFORM Protein DME1265 XEOTICID XEO02858 MOACRIVE Inhibition DME1265 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1265 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02860 XEO_CLAS Peptide DME1265 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 ug/ml) DME1265 XEOTICID XEO02860 GENEFORM Protein DME1265 XEOTICID XEO02860 MOACRIVE Inhibition DME1265 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1265 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02867 XEO_CLAS Peptide DME1265 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02867 GENEFORM Protein DME1265 XEOTICID XEO02867 MOACRIVE Inhibition DME1265 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1265 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02868 XEO_CLAS Peptide DME1265 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02868 GENEFORM Protein DME1265 XEOTICID XEO02868 MOACRIVE Inhibition DME1265 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1265 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02869 XEO_CLAS Peptide DME1265 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02869 GENEFORM Protein DME1265 XEOTICID XEO02869 MOACRIVE Inhibition DME1265 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1265 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02870 XEO_CLAS Peptide DME1265 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02870 GENEFORM Protein DME1265 XEOTICID XEO02870 MOACRIVE Inhibition DME1265 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1265 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02871 XEO_CLAS Peptide DME1265 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02871 GENEFORM Protein DME1265 XEOTICID XEO02871 MOACRIVE Inhibition DME1265 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1265 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02872 XEO_CLAS Peptide DME1265 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 308 microM) DME1265 XEOTICID XEO02872 GENEFORM Protein DME1265 XEOTICID XEO02872 MOACRIVE Inhibition DME1265 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1265 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02875 XEO_CLAS Peptide DME1265 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.1 microM) DME1265 XEOTICID XEO02875 GENEFORM Protein DME1265 XEOTICID XEO02875 MOACRIVE Inhibition DME1265 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1265 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02876 XEO_CLAS Peptide DME1265 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO02876 GENEFORM Protein DME1265 XEOTICID XEO02876 MOACRIVE Inhibition DME1265 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1265 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02877 XEO_CLAS Peptide DME1265 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO02877 GENEFORM Protein DME1265 XEOTICID XEO02877 MOACRIVE Inhibition DME1265 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1265 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02878 XEO_CLAS Peptide DME1265 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.3 microM) DME1265 XEOTICID XEO02878 GENEFORM Protein DME1265 XEOTICID XEO02878 MOACRIVE Inhibition DME1265 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1265 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02885 XEO_CLAS Peptide DME1265 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02885 GENEFORM Protein DME1265 XEOTICID XEO02885 MOACRIVE Inhibition DME1265 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1265 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02886 XEO_CLAS Peptide DME1265 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02886 GENEFORM Protein DME1265 XEOTICID XEO02886 MOACRIVE Inhibition DME1265 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1265 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02887 XEO_CLAS Peptide DME1265 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1 ug/ml) DME1265 XEOTICID XEO02887 GENEFORM Protein DME1265 XEOTICID XEO02887 MOACRIVE Inhibition DME1265 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1265 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02888 XEO_CLAS Peptide DME1265 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 ug/ml) DME1265 XEOTICID XEO02888 GENEFORM Protein DME1265 XEOTICID XEO02888 MOACRIVE Inhibition DME1265 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1265 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02889 XEO_CLAS Peptide DME1265 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 ug/ml) DME1265 XEOTICID XEO02889 GENEFORM Protein DME1265 XEOTICID XEO02889 MOACRIVE Inhibition DME1265 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1265 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02890 XEO_CLAS Peptide DME1265 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02890 GENEFORM Protein DME1265 XEOTICID XEO02890 MOACRIVE Inhibition DME1265 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1265 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02891 XEO_CLAS Peptide DME1265 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02891 GENEFORM Protein DME1265 XEOTICID XEO02891 MOACRIVE Inhibition DME1265 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1265 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02895 XEO_CLAS Peptide DME1265 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO02895 GENEFORM Protein DME1265 XEOTICID XEO02895 MOACRIVE Inhibition DME1265 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1265 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02896 XEO_CLAS Peptide DME1265 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO02896 GENEFORM Protein DME1265 XEOTICID XEO02896 MOACRIVE Inhibition DME1265 XEOTICID XEO02899 XEO_NAME Coladonin DME1265 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1265 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1265 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02899 GENEFORM Protein DME1265 XEOTICID XEO02899 MOACRIVE Inhibition DME1265 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1265 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02900 XEO_CLAS Peptide DME1265 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02900 GENEFORM Protein DME1265 XEOTICID XEO02900 MOACRIVE Inhibition DME1265 XEOTICID XEO02901 XEO_NAME Colicin-V DME1265 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02901 XEO_CLAS Peptide DME1265 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02901 GENEFORM Protein DME1265 XEOTICID XEO02901 MOACRIVE Inhibition DME1265 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1265 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02904 GENEFORM Protein DME1265 XEOTICID XEO02904 MOACRIVE Inhibition DME1265 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1265 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02908 XEO_CLAS Peptide DME1265 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 50 microM) DME1265 XEOTICID XEO02908 GENEFORM Protein DME1265 XEOTICID XEO02908 MOACRIVE Inhibition DME1265 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1265 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02923 XEO_CLAS Peptide DME1265 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02923 GENEFORM Protein DME1265 XEOTICID XEO02923 MOACRIVE Inhibition DME1265 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1265 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02924 XEO_CLAS Peptide DME1265 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 32 microM) DME1265 XEOTICID XEO02924 GENEFORM Protein DME1265 XEOTICID XEO02924 MOACRIVE Inhibition DME1265 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1265 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1265 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02927 GENEFORM Protein DME1265 XEOTICID XEO02927 MOACRIVE Inhibition DME1265 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1265 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02931 XEO_CLAS Peptide DME1265 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 ug/ml) DME1265 XEOTICID XEO02931 GENEFORM Protein DME1265 XEOTICID XEO02931 MOACRIVE Inhibition DME1265 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1265 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02933 XEO_CLAS Peptide DME1265 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO02933 GENEFORM Protein DME1265 XEOTICID XEO02933 MOACRIVE Inhibition DME1265 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1265 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02934 XEO_CLAS Peptide DME1265 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02934 GENEFORM Protein DME1265 XEOTICID XEO02934 MOACRIVE Inhibition DME1265 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1265 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02935 XEO_CLAS Peptide DME1265 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02935 GENEFORM Protein DME1265 XEOTICID XEO02935 MOACRIVE Inhibition DME1265 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1265 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02936 XEO_CLAS Peptide DME1265 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO02936 GENEFORM Protein DME1265 XEOTICID XEO02936 MOACRIVE Inhibition DME1265 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1265 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02937 XEO_CLAS Peptide DME1265 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02937 GENEFORM Protein DME1265 XEOTICID XEO02937 MOACRIVE Inhibition DME1265 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1265 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02938 XEO_CLAS Peptide DME1265 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 32 ug/ml) DME1265 XEOTICID XEO02938 GENEFORM Protein DME1265 XEOTICID XEO02938 MOACRIVE Inhibition DME1265 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1265 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02939 XEO_CLAS Peptide DME1265 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 11 ug/ml) DME1265 XEOTICID XEO02939 GENEFORM Protein DME1265 XEOTICID XEO02939 MOACRIVE Inhibition DME1265 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1265 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02940 XEO_CLAS Peptide DME1265 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1 ug/ml) DME1265 XEOTICID XEO02940 GENEFORM Protein DME1265 XEOTICID XEO02940 MOACRIVE Inhibition DME1265 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1265 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02941 XEO_CLAS Peptide DME1265 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02941 GENEFORM Protein DME1265 XEOTICID XEO02941 MOACRIVE Inhibition DME1265 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1265 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02944 XEO_CLAS Peptide DME1265 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 microM) DME1265 XEOTICID XEO02944 GENEFORM Protein DME1265 XEOTICID XEO02944 MOACRIVE Inhibition DME1265 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1265 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02945 XEO_CLAS Peptide DME1265 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 microM) DME1265 XEOTICID XEO02945 GENEFORM Protein DME1265 XEOTICID XEO02945 MOACRIVE Inhibition DME1265 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1265 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02946 XEO_CLAS Peptide DME1265 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 microM) DME1265 XEOTICID XEO02946 GENEFORM Protein DME1265 XEOTICID XEO02946 MOACRIVE Inhibition DME1265 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1265 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02947 XEO_CLAS Peptide DME1265 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02947 GENEFORM Protein DME1265 XEOTICID XEO02947 MOACRIVE Inhibition DME1265 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1265 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02948 XEO_CLAS Peptide DME1265 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO02948 GENEFORM Protein DME1265 XEOTICID XEO02948 MOACRIVE Inhibition DME1265 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1265 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02949 XEO_CLAS Peptide DME1265 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO02949 GENEFORM Protein DME1265 XEOTICID XEO02949 MOACRIVE Inhibition DME1265 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1265 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02954 XEO_CLAS Peptide DME1265 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02954 GENEFORM Protein DME1265 XEOTICID XEO02954 MOACRIVE Inhibition DME1265 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1265 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02958 XEO_CLAS Peptide DME1265 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02958 GENEFORM Protein DME1265 XEOTICID XEO02958 MOACRIVE Inhibition DME1265 XEOTICID XEO02962 XEO_NAME Cryptonin DME1265 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02962 XEO_CLAS Peptide DME1265 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.12 ug/ml) DME1265 XEOTICID XEO02962 GENEFORM Protein DME1265 XEOTICID XEO02962 MOACRIVE Inhibition DME1265 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1265 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02965 XEO_CLAS Peptide DME1265 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 ug/ml) DME1265 XEOTICID XEO02965 GENEFORM Protein DME1265 XEOTICID XEO02965 MOACRIVE Inhibition DME1265 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1265 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02969 XEO_CLAS Peptide DME1265 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 microM) DME1265 XEOTICID XEO02969 GENEFORM Protein DME1265 XEOTICID XEO02969 MOACRIVE Inhibition DME1265 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1265 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02971 XEO_CLAS Peptide DME1265 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 microM) DME1265 XEOTICID XEO02971 GENEFORM Protein DME1265 XEOTICID XEO02971 MOACRIVE Inhibition DME1265 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1265 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO02972 XEO_CLAS Peptide DME1265 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.4 microM) DME1265 XEOTICID XEO02972 GENEFORM Protein DME1265 XEOTICID XEO02972 MOACRIVE Inhibition DME1265 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1265 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02990 GENEFORM Protein DME1265 XEOTICID XEO02990 MOACRIVE Inhibition DME1265 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1265 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02991 GENEFORM Protein DME1265 XEOTICID XEO02991 MOACRIVE Inhibition DME1265 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1265 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02992 GENEFORM Protein DME1265 XEOTICID XEO02992 MOACRIVE Inhibition DME1265 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1265 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02993 GENEFORM Protein DME1265 XEOTICID XEO02993 MOACRIVE Inhibition DME1265 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1265 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02994 GENEFORM Protein DME1265 XEOTICID XEO02994 MOACRIVE Inhibition DME1265 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1265 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02995 GENEFORM Protein DME1265 XEOTICID XEO02995 MOACRIVE Inhibition DME1265 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1265 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02996 GENEFORM Protein DME1265 XEOTICID XEO02996 MOACRIVE Inhibition DME1265 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1265 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02997 GENEFORM Protein DME1265 XEOTICID XEO02997 MOACRIVE Inhibition DME1265 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1265 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02998 GENEFORM Protein DME1265 XEOTICID XEO02998 MOACRIVE Inhibition DME1265 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1265 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1265 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO02999 GENEFORM Protein DME1265 XEOTICID XEO02999 MOACRIVE Inhibition DME1265 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1265 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03021 XEO_CLAS Peptide DME1265 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.31-0.63 microM) DME1265 XEOTICID XEO03021 GENEFORM Protein DME1265 XEOTICID XEO03021 MOACRIVE Inhibition DME1265 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1265 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03029 XEO_CLAS Peptide DME1265 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.005 microM) DME1265 XEOTICID XEO03029 GENEFORM Protein DME1265 XEOTICID XEO03029 MOACRIVE Inhibition DME1265 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1265 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03030 XEO_CLAS Peptide DME1265 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.005 microM) DME1265 XEOTICID XEO03030 GENEFORM Protein DME1265 XEOTICID XEO03030 MOACRIVE Inhibition DME1265 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1265 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03031 XEO_CLAS Peptide DME1265 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.3 microM) DME1265 XEOTICID XEO03031 GENEFORM Protein DME1265 XEOTICID XEO03031 MOACRIVE Inhibition DME1265 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1265 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03032 XEO_CLAS Peptide DME1265 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.01 microM) DME1265 XEOTICID XEO03032 GENEFORM Protein DME1265 XEOTICID XEO03032 MOACRIVE Inhibition DME1265 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1265 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03033 XEO_CLAS Peptide DME1265 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.173 microM) DME1265 XEOTICID XEO03033 GENEFORM Protein DME1265 XEOTICID XEO03033 MOACRIVE Inhibition DME1265 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1265 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03034 XEO_CLAS Peptide DME1265 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.518 microM) DME1265 XEOTICID XEO03034 GENEFORM Protein DME1265 XEOTICID XEO03034 MOACRIVE Inhibition DME1265 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1265 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03035 XEO_CLAS Peptide DME1265 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.114 microM) DME1265 XEOTICID XEO03035 GENEFORM Protein DME1265 XEOTICID XEO03035 MOACRIVE Inhibition DME1265 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1265 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03039 XEO_CLAS Peptide DME1265 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.55 microM) DME1265 XEOTICID XEO03039 GENEFORM Protein DME1265 XEOTICID XEO03039 MOACRIVE Inhibition DME1265 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1265 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03043 XEO_CLAS Peptide DME1265 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 microM) DME1265 XEOTICID XEO03043 GENEFORM Protein DME1265 XEOTICID XEO03043 MOACRIVE Inhibition DME1265 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1265 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03044 XEO_CLAS Peptide DME1265 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03044 GENEFORM Protein DME1265 XEOTICID XEO03044 MOACRIVE Inhibition DME1265 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1265 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03045 XEO_CLAS Peptide DME1265 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03045 GENEFORM Protein DME1265 XEOTICID XEO03045 MOACRIVE Inhibition DME1265 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1265 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03046 XEO_CLAS Peptide DME1265 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03046 GENEFORM Protein DME1265 XEOTICID XEO03046 MOACRIVE Inhibition DME1265 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1265 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03049 XEO_CLAS Peptide DME1265 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 microM) DME1265 XEOTICID XEO03049 GENEFORM Protein DME1265 XEOTICID XEO03049 MOACRIVE Inhibition DME1265 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1265 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03055 XEO_CLAS Peptide DME1265 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 microM) DME1265 XEOTICID XEO03055 GENEFORM Protein DME1265 XEOTICID XEO03055 MOACRIVE Inhibition DME1265 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1265 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03059 XEO_CLAS Peptide DME1265 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO03059 GENEFORM Protein DME1265 XEOTICID XEO03059 MOACRIVE Inhibition DME1265 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1265 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03060 XEO_CLAS Peptide DME1265 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO03060 GENEFORM Protein DME1265 XEOTICID XEO03060 MOACRIVE Inhibition DME1265 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1265 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03062 XEO_CLAS Peptide DME1265 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO03062 GENEFORM Protein DME1265 XEOTICID XEO03062 MOACRIVE Inhibition DME1265 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1265 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03064 XEO_CLAS Peptide DME1265 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO03064 GENEFORM Protein DME1265 XEOTICID XEO03064 MOACRIVE Inhibition DME1265 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1265 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03066 XEO_CLAS Peptide DME1265 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO03066 GENEFORM Protein DME1265 XEOTICID XEO03066 MOACRIVE Inhibition DME1265 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1265 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03068 XEO_CLAS Peptide DME1265 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO03068 GENEFORM Protein DME1265 XEOTICID XEO03068 MOACRIVE Inhibition DME1265 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1265 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03073 XEO_CLAS Peptide DME1265 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8-16 ug/ml) DME1265 XEOTICID XEO03073 GENEFORM Protein DME1265 XEOTICID XEO03073 MOACRIVE Inhibition DME1265 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1265 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03081 XEO_CLAS Peptide DME1265 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 microM) DME1265 XEOTICID XEO03081 GENEFORM Protein DME1265 XEOTICID XEO03081 MOACRIVE Inhibition DME1265 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1265 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03082 XEO_CLAS Peptide DME1265 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03082 GENEFORM Protein DME1265 XEOTICID XEO03082 MOACRIVE Inhibition DME1265 XEOTICID XEO03089 XEO_NAME Decoralin DME1265 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03089 XEO_CLAS Peptide DME1265 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 160 microM) DME1265 XEOTICID XEO03089 GENEFORM Protein DME1265 XEOTICID XEO03089 MOACRIVE Inhibition DME1265 XEOTICID XEO03098 XEO_NAME Insect defensin DME1265 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03098 XEO_CLAS Peptide DME1265 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 ug/ml) DME1265 XEOTICID XEO03098 GENEFORM Protein DME1265 XEOTICID XEO03098 MOACRIVE Inhibition DME1265 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1265 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03100 XEO_CLAS Peptide DME1265 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03100 GENEFORM Protein DME1265 XEOTICID XEO03100 MOACRIVE Inhibition DME1265 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1265 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03103 XEO_CLAS Peptide DME1265 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03103 GENEFORM Protein DME1265 XEOTICID XEO03103 MOACRIVE Inhibition DME1265 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1265 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03105 XEO_CLAS Peptide DME1265 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03105 GENEFORM Protein DME1265 XEOTICID XEO03105 MOACRIVE Inhibition DME1265 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1265 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03110 XEO_CLAS Peptide DME1265 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.2 microM) DME1265 XEOTICID XEO03110 GENEFORM Protein DME1265 XEOTICID XEO03110 MOACRIVE Inhibition DME1265 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1265 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03111 XEO_CLAS Peptide DME1265 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03111 GENEFORM Protein DME1265 XEOTICID XEO03111 MOACRIVE Inhibition DME1265 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1265 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03112 XEO_CLAS Peptide DME1265 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 50 ug/ml) DME1265 XEOTICID XEO03112 GENEFORM Protein DME1265 XEOTICID XEO03112 MOACRIVE Inhibition DME1265 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1265 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03115 XEO_CLAS Peptide DME1265 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03115 GENEFORM Protein DME1265 XEOTICID XEO03115 MOACRIVE Inhibition DME1265 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1265 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03116 XEO_CLAS Peptide DME1265 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 40 microM) DME1265 XEOTICID XEO03116 GENEFORM Protein DME1265 XEOTICID XEO03116 MOACRIVE Inhibition DME1265 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1265 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03118 XEO_CLAS Peptide DME1265 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03118 GENEFORM Protein DME1265 XEOTICID XEO03118 MOACRIVE Inhibition DME1265 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1265 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03119 XEO_CLAS Peptide DME1265 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03119 GENEFORM Protein DME1265 XEOTICID XEO03119 MOACRIVE Inhibition DME1265 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1265 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03121 XEO_CLAS Peptide DME1265 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03121 GENEFORM Protein DME1265 XEOTICID XEO03121 MOACRIVE Inhibition DME1265 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1265 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03122 XEO_CLAS Peptide DME1265 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64000 ug/ml) DME1265 XEOTICID XEO03122 GENEFORM Protein DME1265 XEOTICID XEO03122 MOACRIVE Inhibition DME1265 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1265 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03124 XEO_CLAS Peptide DME1265 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03124 GENEFORM Protein DME1265 XEOTICID XEO03124 MOACRIVE Inhibition DME1265 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1265 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03125 XEO_CLAS Peptide DME1265 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03125 GENEFORM Protein DME1265 XEOTICID XEO03125 MOACRIVE Inhibition DME1265 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1265 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03126 XEO_CLAS Peptide DME1265 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.86 microM) DME1265 XEOTICID XEO03126 GENEFORM Protein DME1265 XEOTICID XEO03126 MOACRIVE Inhibition DME1265 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1265 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03127 XEO_CLAS Peptide DME1265 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03127 GENEFORM Protein DME1265 XEOTICID XEO03127 MOACRIVE Inhibition DME1265 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1265 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03128 XEO_CLAS Peptide DME1265 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 256 ug/ml) DME1265 XEOTICID XEO03128 GENEFORM Protein DME1265 XEOTICID XEO03128 MOACRIVE Inhibition DME1265 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1265 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03129 XEO_CLAS Peptide DME1265 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 256 ug/ml) DME1265 XEOTICID XEO03129 GENEFORM Protein DME1265 XEOTICID XEO03129 MOACRIVE Inhibition DME1265 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1265 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03130 XEO_CLAS Peptide DME1265 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 256 ug/ml) DME1265 XEOTICID XEO03130 GENEFORM Protein DME1265 XEOTICID XEO03130 MOACRIVE Inhibition DME1265 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1265 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03131 XEO_CLAS Peptide DME1265 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 256 ug/ml) DME1265 XEOTICID XEO03131 GENEFORM Protein DME1265 XEOTICID XEO03131 MOACRIVE Inhibition DME1265 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1265 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03132 XEO_CLAS Peptide DME1265 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 256 ug/ml) DME1265 XEOTICID XEO03132 GENEFORM Protein DME1265 XEOTICID XEO03132 MOACRIVE Inhibition DME1265 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1265 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03137 XEO_CLAS Peptide DME1265 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03137 GENEFORM Protein DME1265 XEOTICID XEO03137 MOACRIVE Inhibition DME1265 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1265 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03143 XEO_CLAS Peptide DME1265 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.6 microM) DME1265 XEOTICID XEO03143 GENEFORM Protein DME1265 XEOTICID XEO03143 MOACRIVE Inhibition DME1265 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1265 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03145 XEO_CLAS Peptide DME1265 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.6 microM) DME1265 XEOTICID XEO03145 GENEFORM Protein DME1265 XEOTICID XEO03145 MOACRIVE Inhibition DME1265 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1265 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03146 XEO_CLAS Peptide DME1265 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.5 microM) DME1265 XEOTICID XEO03146 GENEFORM Protein DME1265 XEOTICID XEO03146 MOACRIVE Inhibition DME1265 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1265 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03147 XEO_CLAS Peptide DME1265 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 9.7 microM) DME1265 XEOTICID XEO03147 GENEFORM Protein DME1265 XEOTICID XEO03147 MOACRIVE Inhibition DME1265 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1265 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03148 XEO_CLAS Peptide DME1265 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.3 microM) DME1265 XEOTICID XEO03148 GENEFORM Protein DME1265 XEOTICID XEO03148 MOACRIVE Inhibition DME1265 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1265 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03149 XEO_CLAS Peptide DME1265 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.6 microM) DME1265 XEOTICID XEO03149 GENEFORM Protein DME1265 XEOTICID XEO03149 MOACRIVE Inhibition DME1265 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1265 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03150 XEO_CLAS Peptide DME1265 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 9-3 microM) DME1265 XEOTICID XEO03150 GENEFORM Protein DME1265 XEOTICID XEO03150 MOACRIVE Inhibition DME1265 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1265 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03151 XEO_CLAS Peptide DME1265 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 ug/ml) DME1265 XEOTICID XEO03151 GENEFORM Protein DME1265 XEOTICID XEO03151 MOACRIVE Inhibition DME1265 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1265 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03152 XEO_CLAS Peptide DME1265 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO03152 GENEFORM Protein DME1265 XEOTICID XEO03152 MOACRIVE Inhibition DME1265 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1265 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03155 XEO_CLAS Peptide DME1265 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.4 microM) DME1265 XEOTICID XEO03155 GENEFORM Protein DME1265 XEOTICID XEO03155 MOACRIVE Inhibition DME1265 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1265 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03156 XEO_CLAS Peptide DME1265 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.3 microM) DME1265 XEOTICID XEO03156 GENEFORM Protein DME1265 XEOTICID XEO03156 MOACRIVE Inhibition DME1265 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1265 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03157 XEO_CLAS Peptide DME1265 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.3 microM) DME1265 XEOTICID XEO03157 GENEFORM Protein DME1265 XEOTICID XEO03157 MOACRIVE Inhibition DME1265 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1265 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03158 XEO_CLAS Peptide DME1265 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 ug/ml) DME1265 XEOTICID XEO03158 GENEFORM Protein DME1265 XEOTICID XEO03158 MOACRIVE Inhibition DME1265 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1265 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03159 XEO_CLAS Peptide DME1265 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03159 GENEFORM Protein DME1265 XEOTICID XEO03159 MOACRIVE Inhibition DME1265 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1265 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03161 XEO_CLAS Peptide DME1265 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 microM) DME1265 XEOTICID XEO03161 GENEFORM Protein DME1265 XEOTICID XEO03161 MOACRIVE Inhibition DME1265 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1265 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03162 XEO_CLAS Peptide DME1265 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.5 microM) DME1265 XEOTICID XEO03162 GENEFORM Protein DME1265 XEOTICID XEO03162 MOACRIVE Inhibition DME1265 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1265 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03169 XEO_CLAS Peptide DME1265 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO03169 GENEFORM Protein DME1265 XEOTICID XEO03169 MOACRIVE Inhibition DME1265 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1265 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03193 XEO_CLAS Peptide DME1265 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25 ug/ml) DME1265 XEOTICID XEO03193 GENEFORM Protein DME1265 XEOTICID XEO03193 MOACRIVE Inhibition DME1265 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1265 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03194 XEO_CLAS Peptide DME1265 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03194 GENEFORM Protein DME1265 XEOTICID XEO03194 MOACRIVE Inhibition DME1265 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1265 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03195 XEO_CLAS Peptide DME1265 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03195 GENEFORM Protein DME1265 XEOTICID XEO03195 MOACRIVE Inhibition DME1265 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1265 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03197 XEO_CLAS Peptide DME1265 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 14.5 microM) DME1265 XEOTICID XEO03197 GENEFORM Protein DME1265 XEOTICID XEO03197 MOACRIVE Inhibition DME1265 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1265 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03202 XEO_CLAS Peptide DME1265 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.51 microM) DME1265 XEOTICID XEO03202 GENEFORM Protein DME1265 XEOTICID XEO03202 MOACRIVE Inhibition DME1265 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1265 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03203 XEO_CLAS Peptide DME1265 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.62 microM) DME1265 XEOTICID XEO03203 GENEFORM Protein DME1265 XEOTICID XEO03203 MOACRIVE Inhibition DME1265 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1265 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03204 XEO_CLAS Peptide DME1265 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.38 microM) DME1265 XEOTICID XEO03204 GENEFORM Protein DME1265 XEOTICID XEO03204 MOACRIVE Inhibition DME1265 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1265 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03205 XEO_CLAS Peptide DME1265 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.29 microM) DME1265 XEOTICID XEO03205 GENEFORM Protein DME1265 XEOTICID XEO03205 MOACRIVE Inhibition DME1265 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1265 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03206 XEO_CLAS Peptide DME1265 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.40 microM) DME1265 XEOTICID XEO03206 GENEFORM Protein DME1265 XEOTICID XEO03206 MOACRIVE Inhibition DME1265 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1265 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03207 XEO_CLAS Peptide DME1265 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.58 microM) DME1265 XEOTICID XEO03207 GENEFORM Protein DME1265 XEOTICID XEO03207 MOACRIVE Inhibition DME1265 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1265 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03208 XEO_CLAS Peptide DME1265 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.76 microM) DME1265 XEOTICID XEO03208 GENEFORM Protein DME1265 XEOTICID XEO03208 MOACRIVE Inhibition DME1265 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1265 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03209 XEO_CLAS Peptide DME1265 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.49 microM) DME1265 XEOTICID XEO03209 GENEFORM Protein DME1265 XEOTICID XEO03209 MOACRIVE Inhibition DME1265 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1265 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03210 XEO_CLAS Peptide DME1265 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 7.07 microM) DME1265 XEOTICID XEO03210 GENEFORM Protein DME1265 XEOTICID XEO03210 MOACRIVE Inhibition DME1265 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1265 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03211 XEO_CLAS Peptide DME1265 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.40 microM) DME1265 XEOTICID XEO03211 GENEFORM Protein DME1265 XEOTICID XEO03211 MOACRIVE Inhibition DME1265 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1265 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03215 XEO_CLAS Peptide DME1265 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20.0 ug/ml) DME1265 XEOTICID XEO03215 GENEFORM Protein DME1265 XEOTICID XEO03215 MOACRIVE Inhibition DME1265 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1265 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03216 XEO_CLAS Peptide DME1265 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO03216 GENEFORM Protein DME1265 XEOTICID XEO03216 MOACRIVE Inhibition DME1265 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1265 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03217 XEO_CLAS Peptide DME1265 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO03217 GENEFORM Protein DME1265 XEOTICID XEO03217 MOACRIVE Inhibition DME1265 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1265 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03223 XEO_CLAS Peptide DME1265 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.8 microM) DME1265 XEOTICID XEO03223 GENEFORM Protein DME1265 XEOTICID XEO03223 MOACRIVE Inhibition DME1265 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1265 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03224 XEO_CLAS Peptide DME1265 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.1-0.25 microM) DME1265 XEOTICID XEO03224 GENEFORM Protein DME1265 XEOTICID XEO03224 MOACRIVE Inhibition DME1265 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1265 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03225 XEO_CLAS Peptide DME1265 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.3 microM) DME1265 XEOTICID XEO03225 GENEFORM Protein DME1265 XEOTICID XEO03225 MOACRIVE Inhibition DME1265 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1265 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03227 XEO_CLAS Peptide DME1265 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.3 microM) DME1265 XEOTICID XEO03227 GENEFORM Protein DME1265 XEOTICID XEO03227 MOACRIVE Inhibition DME1265 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1265 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03231 XEO_CLAS Peptide DME1265 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03231 GENEFORM Protein DME1265 XEOTICID XEO03231 MOACRIVE Inhibition DME1265 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1265 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03232 XEO_CLAS Peptide DME1265 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03232 GENEFORM Protein DME1265 XEOTICID XEO03232 MOACRIVE Inhibition DME1265 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1265 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03234 XEO_CLAS Peptide DME1265 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO03234 GENEFORM Protein DME1265 XEOTICID XEO03234 MOACRIVE Inhibition DME1265 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1265 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03235 XEO_CLAS Peptide DME1265 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 60 ug/ml) DME1265 XEOTICID XEO03235 GENEFORM Protein DME1265 XEOTICID XEO03235 MOACRIVE Inhibition DME1265 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1265 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03236 XEO_CLAS Peptide DME1265 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO03236 GENEFORM Protein DME1265 XEOTICID XEO03236 MOACRIVE Inhibition DME1265 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1265 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03237 XEO_CLAS Peptide DME1265 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 ug/ml) DME1265 XEOTICID XEO03237 GENEFORM Protein DME1265 XEOTICID XEO03237 MOACRIVE Inhibition DME1265 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1265 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03238 XEO_CLAS Peptide DME1265 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 ug/ml) DME1265 XEOTICID XEO03238 GENEFORM Protein DME1265 XEOTICID XEO03238 MOACRIVE Inhibition DME1265 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1265 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03239 XEO_CLAS Peptide DME1265 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 60 ug/ml) DME1265 XEOTICID XEO03239 GENEFORM Protein DME1265 XEOTICID XEO03239 MOACRIVE Inhibition DME1265 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1265 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03241 XEO_CLAS Peptide DME1265 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 128 microM) DME1265 XEOTICID XEO03241 GENEFORM Protein DME1265 XEOTICID XEO03241 MOACRIVE Inhibition DME1265 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1265 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03250 XEO_CLAS Peptide DME1265 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03250 GENEFORM Protein DME1265 XEOTICID XEO03250 MOACRIVE Inhibition DME1265 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1265 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03251 XEO_CLAS Peptide DME1265 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03251 GENEFORM Protein DME1265 XEOTICID XEO03251 MOACRIVE Inhibition DME1265 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1265 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03253 XEO_CLAS Peptide DME1265 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.1 ug/ml) DME1265 XEOTICID XEO03253 GENEFORM Protein DME1265 XEOTICID XEO03253 MOACRIVE Inhibition DME1265 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1265 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03274 XEO_CLAS Peptide DME1265 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.2 microM) DME1265 XEOTICID XEO03274 GENEFORM Protein DME1265 XEOTICID XEO03274 MOACRIVE Inhibition DME1265 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1265 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03275 XEO_CLAS Peptide DME1265 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO03275 GENEFORM Protein DME1265 XEOTICID XEO03275 MOACRIVE Inhibition DME1265 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1265 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03276 XEO_CLAS Peptide DME1265 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO03276 GENEFORM Protein DME1265 XEOTICID XEO03276 MOACRIVE Inhibition DME1265 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1265 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03277 XEO_CLAS Peptide DME1265 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.2 microM) DME1265 XEOTICID XEO03277 GENEFORM Protein DME1265 XEOTICID XEO03277 MOACRIVE Inhibition DME1265 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1265 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03278 XEO_CLAS Peptide DME1265 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO03278 GENEFORM Protein DME1265 XEOTICID XEO03278 MOACRIVE Inhibition DME1265 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1265 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03279 XEO_CLAS Peptide DME1265 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO03279 GENEFORM Protein DME1265 XEOTICID XEO03279 MOACRIVE Inhibition DME1265 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1265 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03280 XEO_CLAS Peptide DME1265 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 microM) DME1265 XEOTICID XEO03280 GENEFORM Protein DME1265 XEOTICID XEO03280 MOACRIVE Inhibition DME1265 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1265 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03281 XEO_CLAS Peptide DME1265 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.3 microM) DME1265 XEOTICID XEO03281 GENEFORM Protein DME1265 XEOTICID XEO03281 MOACRIVE Inhibition DME1265 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1265 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03282 XEO_CLAS Peptide DME1265 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.1 microM) DME1265 XEOTICID XEO03282 GENEFORM Protein DME1265 XEOTICID XEO03282 MOACRIVE Inhibition DME1265 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1265 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03283 XEO_CLAS Peptide DME1265 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 microM) DME1265 XEOTICID XEO03283 GENEFORM Protein DME1265 XEOTICID XEO03283 MOACRIVE Inhibition DME1265 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1265 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03284 XEO_CLAS Peptide DME1265 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.2 ug/ml) DME1265 XEOTICID XEO03284 GENEFORM Protein DME1265 XEOTICID XEO03284 MOACRIVE Inhibition DME1265 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1265 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03285 XEO_CLAS Peptide DME1265 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.5 ug/ml) DME1265 XEOTICID XEO03285 GENEFORM Protein DME1265 XEOTICID XEO03285 MOACRIVE Inhibition DME1265 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1265 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03286 XEO_CLAS Peptide DME1265 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.4 ug/ml) DME1265 XEOTICID XEO03286 GENEFORM Protein DME1265 XEOTICID XEO03286 MOACRIVE Inhibition DME1265 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1265 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03287 XEO_CLAS Peptide DME1265 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.6 ug/ml) DME1265 XEOTICID XEO03287 GENEFORM Protein DME1265 XEOTICID XEO03287 MOACRIVE Inhibition DME1265 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1265 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03288 XEO_CLAS Peptide DME1265 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.4 ug/ml) DME1265 XEOTICID XEO03288 GENEFORM Protein DME1265 XEOTICID XEO03288 MOACRIVE Inhibition DME1265 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1265 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03289 XEO_CLAS Peptide DME1265 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8.8 ug/ml) DME1265 XEOTICID XEO03289 GENEFORM Protein DME1265 XEOTICID XEO03289 MOACRIVE Inhibition DME1265 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1265 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03290 XEO_CLAS Peptide DME1265 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.5 ug/ml) DME1265 XEOTICID XEO03290 GENEFORM Protein DME1265 XEOTICID XEO03290 MOACRIVE Inhibition DME1265 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1265 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03291 XEO_CLAS Peptide DME1265 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8.6 ug/ml) DME1265 XEOTICID XEO03291 GENEFORM Protein DME1265 XEOTICID XEO03291 MOACRIVE Inhibition DME1265 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1265 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03292 XEO_CLAS Peptide DME1265 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4.1 ug/ml) DME1265 XEOTICID XEO03292 GENEFORM Protein DME1265 XEOTICID XEO03292 MOACRIVE Inhibition DME1265 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1265 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03293 XEO_CLAS Peptide DME1265 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1 microM) DME1265 XEOTICID XEO03293 GENEFORM Protein DME1265 XEOTICID XEO03293 MOACRIVE Inhibition DME1265 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1265 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03294 XEO_CLAS Peptide DME1265 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1 microM) DME1265 XEOTICID XEO03294 GENEFORM Protein DME1265 XEOTICID XEO03294 MOACRIVE Inhibition DME1265 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1265 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03295 XEO_CLAS Peptide DME1265 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.7 microM) DME1265 XEOTICID XEO03295 GENEFORM Protein DME1265 XEOTICID XEO03295 MOACRIVE Inhibition DME1265 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1265 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03296 XEO_CLAS Peptide DME1265 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03296 GENEFORM Protein DME1265 XEOTICID XEO03296 MOACRIVE Inhibition DME1265 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1265 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03297 XEO_CLAS Peptide DME1265 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03297 GENEFORM Protein DME1265 XEOTICID XEO03297 MOACRIVE Inhibition DME1265 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1265 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03298 XEO_CLAS Peptide DME1265 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.2 microM) DME1265 XEOTICID XEO03298 GENEFORM Protein DME1265 XEOTICID XEO03298 MOACRIVE Inhibition DME1265 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1265 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03299 XEO_CLAS Peptide DME1265 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.4 microM) DME1265 XEOTICID XEO03299 GENEFORM Protein DME1265 XEOTICID XEO03299 MOACRIVE Inhibition DME1265 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1265 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03300 XEO_CLAS Peptide DME1265 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 ug/ml) DME1265 XEOTICID XEO03300 GENEFORM Protein DME1265 XEOTICID XEO03300 MOACRIVE Inhibition DME1265 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1265 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03301 XEO_CLAS Peptide DME1265 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 ug/ml) DME1265 XEOTICID XEO03301 GENEFORM Protein DME1265 XEOTICID XEO03301 MOACRIVE Inhibition DME1265 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1265 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03302 XEO_CLAS Peptide DME1265 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1 microM) DME1265 XEOTICID XEO03302 GENEFORM Protein DME1265 XEOTICID XEO03302 MOACRIVE Inhibition DME1265 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1265 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03303 XEO_CLAS Peptide DME1265 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 microM) DME1265 XEOTICID XEO03303 GENEFORM Protein DME1265 XEOTICID XEO03303 MOACRIVE Inhibition DME1265 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1265 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03304 XEO_CLAS Peptide DME1265 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO03304 GENEFORM Protein DME1265 XEOTICID XEO03304 MOACRIVE Inhibition DME1265 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1265 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03305 XEO_CLAS Peptide DME1265 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 microM) DME1265 XEOTICID XEO03305 GENEFORM Protein DME1265 XEOTICID XEO03305 MOACRIVE Inhibition DME1265 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1265 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03306 XEO_CLAS Peptide DME1265 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO03306 GENEFORM Protein DME1265 XEOTICID XEO03306 MOACRIVE Inhibition DME1265 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1265 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03307 XEO_CLAS Peptide DME1265 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 34 ug/ml) DME1265 XEOTICID XEO03307 GENEFORM Protein DME1265 XEOTICID XEO03307 MOACRIVE Inhibition DME1265 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1265 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03308 XEO_CLAS Peptide DME1265 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO03308 GENEFORM Protein DME1265 XEOTICID XEO03308 MOACRIVE Inhibition DME1265 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1265 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03310 XEO_CLAS Peptide DME1265 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8.5 ug/ml) DME1265 XEOTICID XEO03310 GENEFORM Protein DME1265 XEOTICID XEO03310 MOACRIVE Inhibition DME1265 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1265 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03311 XEO_CLAS Peptide DME1265 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10.8 ug/ml) DME1265 XEOTICID XEO03311 GENEFORM Protein DME1265 XEOTICID XEO03311 MOACRIVE Inhibition DME1265 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1265 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03312 XEO_CLAS Peptide DME1265 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10.8 ug/ml) DME1265 XEOTICID XEO03312 GENEFORM Protein DME1265 XEOTICID XEO03312 MOACRIVE Inhibition DME1265 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1265 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03313 XEO_CLAS Peptide DME1265 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8.1 ug/ml) DME1265 XEOTICID XEO03313 GENEFORM Protein DME1265 XEOTICID XEO03313 MOACRIVE Inhibition DME1265 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1265 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03314 XEO_CLAS Peptide DME1265 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 7.9 ug/ml) DME1265 XEOTICID XEO03314 GENEFORM Protein DME1265 XEOTICID XEO03314 MOACRIVE Inhibition DME1265 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1265 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03315 XEO_CLAS Peptide DME1265 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.6 ug/ml) DME1265 XEOTICID XEO03315 GENEFORM Protein DME1265 XEOTICID XEO03315 MOACRIVE Inhibition DME1265 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1265 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03316 XEO_CLAS Peptide DME1265 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15.8 ug/ml) DME1265 XEOTICID XEO03316 GENEFORM Protein DME1265 XEOTICID XEO03316 MOACRIVE Inhibition DME1265 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1265 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03317 XEO_CLAS Peptide DME1265 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO03317 GENEFORM Protein DME1265 XEOTICID XEO03317 MOACRIVE Inhibition DME1265 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1265 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03318 XEO_CLAS Peptide DME1265 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1 microM) DME1265 XEOTICID XEO03318 GENEFORM Protein DME1265 XEOTICID XEO03318 MOACRIVE Inhibition DME1265 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1265 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03319 XEO_CLAS Peptide DME1265 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03319 GENEFORM Protein DME1265 XEOTICID XEO03319 MOACRIVE Inhibition DME1265 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1265 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03320 XEO_CLAS Peptide DME1265 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.1 microM) DME1265 XEOTICID XEO03320 GENEFORM Protein DME1265 XEOTICID XEO03320 MOACRIVE Inhibition DME1265 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1265 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03321 XEO_CLAS Peptide DME1265 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.8 microM) DME1265 XEOTICID XEO03321 GENEFORM Protein DME1265 XEOTICID XEO03321 MOACRIVE Inhibition DME1265 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1265 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1265 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03348 GENEFORM Protein DME1265 XEOTICID XEO03348 MOACRIVE Inhibition DME1265 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1265 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03362 XEO_CLAS Peptide DME1265 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO03362 GENEFORM Protein DME1265 XEOTICID XEO03362 MOACRIVE Inhibition DME1265 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1265 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03363 XEO_CLAS Peptide DME1265 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 microM) DME1265 XEOTICID XEO03363 GENEFORM Protein DME1265 XEOTICID XEO03363 MOACRIVE Inhibition DME1265 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1265 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03364 XEO_CLAS Peptide DME1265 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 microM) DME1265 XEOTICID XEO03364 GENEFORM Protein DME1265 XEOTICID XEO03364 MOACRIVE Inhibition DME1265 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1265 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03365 XEO_CLAS Peptide DME1265 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03365 GENEFORM Protein DME1265 XEOTICID XEO03365 MOACRIVE Inhibition DME1265 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1265 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03366 XEO_CLAS Peptide DME1265 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO03366 GENEFORM Protein DME1265 XEOTICID XEO03366 MOACRIVE Inhibition DME1265 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1265 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03367 XEO_CLAS Peptide DME1265 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 microM) DME1265 XEOTICID XEO03367 GENEFORM Protein DME1265 XEOTICID XEO03367 MOACRIVE Inhibition DME1265 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1265 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03368 XEO_CLAS Peptide DME1265 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 microM) DME1265 XEOTICID XEO03368 GENEFORM Protein DME1265 XEOTICID XEO03368 MOACRIVE Inhibition DME1265 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1265 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03379 XEO_CLAS Peptide DME1265 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.6 ug/ml) DME1265 XEOTICID XEO03379 GENEFORM Protein DME1265 XEOTICID XEO03379 MOACRIVE Inhibition DME1265 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1265 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03396 XEO_CLAS Peptide DME1265 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03396 GENEFORM Protein DME1265 XEOTICID XEO03396 MOACRIVE Inhibition DME1265 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1265 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03398 XEO_CLAS Peptide DME1265 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03398 GENEFORM Protein DME1265 XEOTICID XEO03398 MOACRIVE Inhibition DME1265 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1265 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03399 XEO_CLAS Peptide DME1265 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03399 GENEFORM Protein DME1265 XEOTICID XEO03399 MOACRIVE Inhibition DME1265 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1265 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03406 XEO_CLAS Peptide DME1265 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 ug/ml) DME1265 XEOTICID XEO03406 GENEFORM Protein DME1265 XEOTICID XEO03406 MOACRIVE Inhibition DME1265 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1265 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03424 XEO_CLAS Peptide DME1265 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03424 GENEFORM Protein DME1265 XEOTICID XEO03424 MOACRIVE Inhibition DME1265 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1265 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03426 XEO_CLAS Peptide DME1265 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO03426 GENEFORM Protein DME1265 XEOTICID XEO03426 MOACRIVE Inhibition DME1265 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1265 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03427 XEO_CLAS Peptide DME1265 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 microM) DME1265 XEOTICID XEO03427 GENEFORM Protein DME1265 XEOTICID XEO03427 MOACRIVE Inhibition DME1265 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1265 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03428 XEO_CLAS Peptide DME1265 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 ug/ml) DME1265 XEOTICID XEO03428 GENEFORM Protein DME1265 XEOTICID XEO03428 MOACRIVE Inhibition DME1265 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1265 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03430 XEO_CLAS Peptide DME1265 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 ug/ml) DME1265 XEOTICID XEO03430 GENEFORM Protein DME1265 XEOTICID XEO03430 MOACRIVE Inhibition DME1265 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1265 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03434 XEO_CLAS Peptide DME1265 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO03434 GENEFORM Protein DME1265 XEOTICID XEO03434 MOACRIVE Inhibition DME1265 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1265 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03442 XEO_CLAS Peptide DME1265 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 18.75 ug/ml) DME1265 XEOTICID XEO03442 GENEFORM Protein DME1265 XEOTICID XEO03442 MOACRIVE Inhibition DME1265 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1265 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03444 XEO_CLAS Peptide DME1265 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 37.50 ug/ml) DME1265 XEOTICID XEO03444 GENEFORM Protein DME1265 XEOTICID XEO03444 MOACRIVE Inhibition DME1265 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1265 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03459 XEO_CLAS Peptide DME1265 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03459 GENEFORM Protein DME1265 XEOTICID XEO03459 MOACRIVE Inhibition DME1265 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1265 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03460 XEO_CLAS Peptide DME1265 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03460 GENEFORM Protein DME1265 XEOTICID XEO03460 MOACRIVE Inhibition DME1265 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1265 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03461 XEO_CLAS Peptide DME1265 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.05 microM) DME1265 XEOTICID XEO03461 GENEFORM Protein DME1265 XEOTICID XEO03461 MOACRIVE Inhibition DME1265 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1265 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03462 XEO_CLAS Peptide DME1265 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03462 GENEFORM Protein DME1265 XEOTICID XEO03462 MOACRIVE Inhibition DME1265 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1265 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03463 XEO_CLAS Peptide DME1265 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03463 GENEFORM Protein DME1265 XEOTICID XEO03463 MOACRIVE Inhibition DME1265 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1265 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03467 XEO_CLAS Peptide DME1265 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03467 GENEFORM Protein DME1265 XEOTICID XEO03467 MOACRIVE Inhibition DME1265 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1265 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03468 XEO_CLAS Peptide DME1265 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03468 GENEFORM Protein DME1265 XEOTICID XEO03468 MOACRIVE Inhibition DME1265 XEOTICID XEO03471 XEO_NAME Gambicin DME1265 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03471 XEO_CLAS Peptide DME1265 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25-12.5 microM) DME1265 XEOTICID XEO03471 GENEFORM Protein DME1265 XEOTICID XEO03471 MOACRIVE Inhibition DME1265 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1265 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03485 XEO_CLAS Peptide DME1265 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4.07 ug/ml) DME1265 XEOTICID XEO03485 GENEFORM Protein DME1265 XEOTICID XEO03485 MOACRIVE Inhibition DME1265 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1265 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03486 XEO_CLAS Peptide DME1265 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.80 ug/ml) DME1265 XEOTICID XEO03486 GENEFORM Protein DME1265 XEOTICID XEO03486 MOACRIVE Inhibition DME1265 XEOTICID XEO03488 XEO_NAME GLK-19 DME1265 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03488 XEO_CLAS Peptide DME1265 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO03488 GENEFORM Protein DME1265 XEOTICID XEO03488 MOACRIVE Inhibition DME1265 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1265 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03497 XEO_CLAS Peptide DME1265 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.4-0.8 microM) DME1265 XEOTICID XEO03497 GENEFORM Protein DME1265 XEOTICID XEO03497 MOACRIVE Inhibition DME1265 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1265 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03498 XEO_CLAS Peptide DME1265 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.4-0.8 microM) DME1265 XEOTICID XEO03498 GENEFORM Protein DME1265 XEOTICID XEO03498 MOACRIVE Inhibition DME1265 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1265 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03500 XEO_CLAS Peptide DME1265 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-30 ug/ml) DME1265 XEOTICID XEO03500 GENEFORM Protein DME1265 XEOTICID XEO03500 MOACRIVE Inhibition DME1265 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1265 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03504 XEO_CLAS Peptide DME1265 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 ug/ml) DME1265 XEOTICID XEO03504 GENEFORM Protein DME1265 XEOTICID XEO03504 MOACRIVE Inhibition DME1265 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1265 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03505 XEO_CLAS Peptide DME1265 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 ug/ml) DME1265 XEOTICID XEO03505 GENEFORM Protein DME1265 XEOTICID XEO03505 MOACRIVE Inhibition DME1265 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1265 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03506 XEO_CLAS Peptide DME1265 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 ug/ml) DME1265 XEOTICID XEO03506 GENEFORM Protein DME1265 XEOTICID XEO03506 MOACRIVE Inhibition DME1265 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1265 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03513 XEO_CLAS Peptide DME1265 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO03513 GENEFORM Protein DME1265 XEOTICID XEO03513 MOACRIVE Inhibition DME1265 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1265 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03514 XEO_CLAS Peptide DME1265 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03514 GENEFORM Protein DME1265 XEOTICID XEO03514 MOACRIVE Inhibition DME1265 XEOTICID XEO03519 XEO_NAME Hadrurin DME1265 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03519 XEO_CLAS Peptide DME1265 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03519 GENEFORM Protein DME1265 XEOTICID XEO03519 MOACRIVE Inhibition DME1265 XEOTICID XEO03522 XEO_NAME Halocyntin DME1265 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03522 XEO_CLAS Peptide DME1265 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03522 GENEFORM Protein DME1265 XEOTICID XEO03522 MOACRIVE Inhibition DME1265 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1265 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03524 XEO_CLAS Peptide DME1265 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03524 GENEFORM Protein DME1265 XEOTICID XEO03524 MOACRIVE Inhibition DME1265 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1265 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03525 XEO_CLAS Peptide DME1265 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03525 GENEFORM Protein DME1265 XEOTICID XEO03525 MOACRIVE Inhibition DME1265 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1265 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03530 XEO_CLAS Peptide DME1265 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03530 GENEFORM Protein DME1265 XEOTICID XEO03530 MOACRIVE Inhibition DME1265 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1265 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03535 XEO_CLAS Peptide DME1265 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.4 microM) DME1265 XEOTICID XEO03535 GENEFORM Protein DME1265 XEOTICID XEO03535 MOACRIVE Inhibition DME1265 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1265 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03536 XEO_CLAS Peptide DME1265 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 80 microM) DME1265 XEOTICID XEO03536 GENEFORM Protein DME1265 XEOTICID XEO03536 MOACRIVE Inhibition DME1265 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1265 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03537 XEO_CLAS Peptide DME1265 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 ug/ml) DME1265 XEOTICID XEO03537 GENEFORM Protein DME1265 XEOTICID XEO03537 MOACRIVE Inhibition DME1265 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1265 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03538 XEO_CLAS Peptide DME1265 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 ug/ml) DME1265 XEOTICID XEO03538 GENEFORM Protein DME1265 XEOTICID XEO03538 MOACRIVE Inhibition DME1265 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1265 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03540 XEO_CLAS Peptide DME1265 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO03540 GENEFORM Protein DME1265 XEOTICID XEO03540 MOACRIVE Inhibition DME1265 XEOTICID XEO03542 XEO_NAME Hepcidin DME1265 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03542 XEO_CLAS Peptide DME1265 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 24 microM) DME1265 XEOTICID XEO03542 GENEFORM Protein DME1265 XEOTICID XEO03542 MOACRIVE Inhibition DME1265 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1265 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03544 XEO_CLAS Peptide DME1265 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03544 GENEFORM Protein DME1265 XEOTICID XEO03544 MOACRIVE Inhibition DME1265 XEOTICID XEO03548 XEO_NAME Hesperidin DME1265 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03548 GENEFORM Protein DME1265 XEOTICID XEO03548 MOACRIVE Inhibition DME1265 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1265 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1265 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03552 GENEFORM Protein DME1265 XEOTICID XEO03552 MOACRIVE Inhibition DME1265 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1265 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03556 XEO_CLAS Peptide DME1265 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO03556 GENEFORM Protein DME1265 XEOTICID XEO03556 MOACRIVE Inhibition DME1265 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1265 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03557 XEO_CLAS Peptide DME1265 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO03557 GENEFORM Protein DME1265 XEOTICID XEO03557 MOACRIVE Inhibition DME1265 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1265 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03558 XEO_CLAS Peptide DME1265 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 microM) DME1265 XEOTICID XEO03558 GENEFORM Protein DME1265 XEOTICID XEO03558 MOACRIVE Inhibition DME1265 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1265 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03559 XEO_CLAS Peptide DME1265 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 microM) DME1265 XEOTICID XEO03559 GENEFORM Protein DME1265 XEOTICID XEO03559 MOACRIVE Inhibition DME1265 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1265 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03560 XEO_CLAS Peptide DME1265 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 microM) DME1265 XEOTICID XEO03560 GENEFORM Protein DME1265 XEOTICID XEO03560 MOACRIVE Inhibition DME1265 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1265 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03561 XEO_CLAS Peptide DME1265 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03561 GENEFORM Protein DME1265 XEOTICID XEO03561 MOACRIVE Inhibition DME1265 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1265 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03567 XEO_CLAS Peptide DME1265 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03567 GENEFORM Protein DME1265 XEOTICID XEO03567 MOACRIVE Inhibition DME1265 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1265 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03569 XEO_CLAS Peptide DME1265 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 300 microM) DME1265 XEOTICID XEO03569 GENEFORM Protein DME1265 XEOTICID XEO03569 MOACRIVE Inhibition DME1265 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1265 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03570 XEO_CLAS Peptide DME1265 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03570 GENEFORM Protein DME1265 XEOTICID XEO03570 MOACRIVE Inhibition DME1265 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1265 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03572 XEO_CLAS Peptide DME1265 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1265 XEOTICID XEO03572 GENEFORM Protein DME1265 XEOTICID XEO03572 MOACRIVE Inhibition DME1265 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1265 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03573 XEO_CLAS Peptide DME1265 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 28.1 ug/ml) DME1265 XEOTICID XEO03573 GENEFORM Protein DME1265 XEOTICID XEO03573 MOACRIVE Inhibition DME1265 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1265 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03574 XEO_CLAS Peptide DME1265 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 500 microM) DME1265 XEOTICID XEO03574 GENEFORM Protein DME1265 XEOTICID XEO03574 MOACRIVE Inhibition DME1265 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1265 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03575 XEO_CLAS Peptide DME1265 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 18 microM) DME1265 XEOTICID XEO03575 GENEFORM Protein DME1265 XEOTICID XEO03575 MOACRIVE Inhibition DME1265 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1265 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03576 XEO_CLAS Peptide DME1265 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 750 microM) DME1265 XEOTICID XEO03576 GENEFORM Protein DME1265 XEOTICID XEO03576 MOACRIVE Inhibition DME1265 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1265 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03578 XEO_CLAS Peptide DME1265 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1265 XEOTICID XEO03578 GENEFORM Protein DME1265 XEOTICID XEO03578 MOACRIVE Inhibition DME1265 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1265 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03579 XEO_CLAS Peptide DME1265 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03579 GENEFORM Protein DME1265 XEOTICID XEO03579 MOACRIVE Inhibition DME1265 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1265 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03580 XEO_CLAS Peptide DME1265 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03580 GENEFORM Protein DME1265 XEOTICID XEO03580 MOACRIVE Inhibition DME1265 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1265 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03585 XEO_CLAS Peptide DME1265 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 125 ug/ml) DME1265 XEOTICID XEO03585 GENEFORM Protein DME1265 XEOTICID XEO03585 MOACRIVE Inhibition DME1265 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1265 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03588 XEO_CLAS Peptide DME1265 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 62 ug/ml) DME1265 XEOTICID XEO03588 GENEFORM Protein DME1265 XEOTICID XEO03588 MOACRIVE Inhibition DME1265 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1265 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03589 XEO_CLAS Peptide DME1265 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03589 GENEFORM Protein DME1265 XEOTICID XEO03589 MOACRIVE Inhibition DME1265 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1265 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03590 XEO_CLAS Peptide DME1265 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03590 GENEFORM Protein DME1265 XEOTICID XEO03590 MOACRIVE Inhibition DME1265 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1265 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03591 XEO_CLAS Peptide DME1265 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 37.5 ug/ml) DME1265 XEOTICID XEO03591 GENEFORM Protein DME1265 XEOTICID XEO03591 MOACRIVE Inhibition DME1265 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1265 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03593 XEO_CLAS Peptide DME1265 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 9.4 ug/ml) DME1265 XEOTICID XEO03593 GENEFORM Protein DME1265 XEOTICID XEO03593 MOACRIVE Inhibition DME1265 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1265 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03594 XEO_CLAS Peptide DME1265 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 ug/ml) DME1265 XEOTICID XEO03594 GENEFORM Protein DME1265 XEOTICID XEO03594 MOACRIVE Inhibition DME1265 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1265 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03595 XEO_CLAS Peptide DME1265 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03595 GENEFORM Protein DME1265 XEOTICID XEO03595 MOACRIVE Inhibition DME1265 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1265 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03596 XEO_CLAS Peptide DME1265 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03596 GENEFORM Protein DME1265 XEOTICID XEO03596 MOACRIVE Inhibition DME1265 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1265 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03598 XEO_CLAS Peptide DME1265 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03598 GENEFORM Protein DME1265 XEOTICID XEO03598 MOACRIVE Inhibition DME1265 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1265 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03599 XEO_CLAS Peptide DME1265 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03599 GENEFORM Protein DME1265 XEOTICID XEO03599 MOACRIVE Inhibition DME1265 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1265 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03600 XEO_CLAS Peptide DME1265 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03600 GENEFORM Protein DME1265 XEOTICID XEO03600 MOACRIVE Inhibition DME1265 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1265 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03606 XEO_CLAS Peptide DME1265 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03606 GENEFORM Protein DME1265 XEOTICID XEO03606 MOACRIVE Inhibition DME1265 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1265 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03607 XEO_CLAS Peptide DME1265 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03607 GENEFORM Protein DME1265 XEOTICID XEO03607 MOACRIVE Inhibition DME1265 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1265 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03609 XEO_CLAS Peptide DME1265 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03609 GENEFORM Protein DME1265 XEOTICID XEO03609 MOACRIVE Inhibition DME1265 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1265 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03615 XEO_CLAS Peptide DME1265 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1265 XEOTICID XEO03615 GENEFORM Protein DME1265 XEOTICID XEO03615 MOACRIVE Inhibition DME1265 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1265 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03616 XEO_CLAS Peptide DME1265 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 32 microM) DME1265 XEOTICID XEO03616 GENEFORM Protein DME1265 XEOTICID XEO03616 MOACRIVE Inhibition DME1265 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1265 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03617 XEO_CLAS Peptide DME1265 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40 microM) DME1265 XEOTICID XEO03617 GENEFORM Protein DME1265 XEOTICID XEO03617 MOACRIVE Inhibition DME1265 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1265 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03618 XEO_CLAS Peptide DME1265 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5-1 microM) DME1265 XEOTICID XEO03618 GENEFORM Protein DME1265 XEOTICID XEO03618 MOACRIVE Inhibition DME1265 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1265 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03622 XEO_CLAS Peptide DME1265 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20-40 microM) DME1265 XEOTICID XEO03622 GENEFORM Protein DME1265 XEOTICID XEO03622 MOACRIVE Inhibition DME1265 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1265 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03627 XEO_CLAS Peptide DME1265 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.4-0.8 microM) DME1265 XEOTICID XEO03627 GENEFORM Protein DME1265 XEOTICID XEO03627 MOACRIVE Inhibition DME1265 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1265 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03630 XEO_CLAS Peptide DME1265 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03630 GENEFORM Protein DME1265 XEOTICID XEO03630 MOACRIVE Inhibition DME1265 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1265 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03631 XEO_CLAS Peptide DME1265 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03631 GENEFORM Protein DME1265 XEOTICID XEO03631 MOACRIVE Inhibition DME1265 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1265 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03632 XEO_CLAS Peptide DME1265 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03632 GENEFORM Protein DME1265 XEOTICID XEO03632 MOACRIVE Inhibition DME1265 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1265 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03633 XEO_CLAS Peptide DME1265 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03633 GENEFORM Protein DME1265 XEOTICID XEO03633 MOACRIVE Inhibition DME1265 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1265 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03634 XEO_CLAS Peptide DME1265 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03634 GENEFORM Protein DME1265 XEOTICID XEO03634 MOACRIVE Inhibition DME1265 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1265 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03635 XEO_CLAS Peptide DME1265 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03635 GENEFORM Protein DME1265 XEOTICID XEO03635 MOACRIVE Inhibition DME1265 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1265 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03636 XEO_CLAS Peptide DME1265 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03636 GENEFORM Protein DME1265 XEOTICID XEO03636 MOACRIVE Inhibition DME1265 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1265 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03637 XEO_CLAS Peptide DME1265 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03637 GENEFORM Protein DME1265 XEOTICID XEO03637 MOACRIVE Inhibition DME1265 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1265 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03638 XEO_CLAS Peptide DME1265 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03638 GENEFORM Protein DME1265 XEOTICID XEO03638 MOACRIVE Inhibition DME1265 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1265 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03639 XEO_CLAS Peptide DME1265 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03639 GENEFORM Protein DME1265 XEOTICID XEO03639 MOACRIVE Inhibition DME1265 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1265 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03640 XEO_CLAS Peptide DME1265 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03640 GENEFORM Protein DME1265 XEOTICID XEO03640 MOACRIVE Inhibition DME1265 XEOTICID XEO03644 XEO_NAME Indole DME1265 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1265 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1265 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03644 GENEFORM Protein DME1265 XEOTICID XEO03644 MOACRIVE Inhibition DME1265 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1265 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03650 XEO_CLAS Peptide DME1265 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03650 GENEFORM Protein DME1265 XEOTICID XEO03650 MOACRIVE Inhibition DME1265 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1265 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO03655 XEO_CLAS Natural Product DME1265 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03655 GENEFORM Protein DME1265 XEOTICID XEO03655 MOACRIVE Inhibition DME1265 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1265 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03666 XEO_CLAS Peptide DME1265 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 ug/ml) DME1265 XEOTICID XEO03666 GENEFORM Protein DME1265 XEOTICID XEO03666 MOACRIVE Inhibition DME1265 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1265 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03667 XEO_CLAS Peptide DME1265 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 ug/ml) DME1265 XEOTICID XEO03667 GENEFORM Protein DME1265 XEOTICID XEO03667 MOACRIVE Inhibition DME1265 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1265 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03668 XEO_CLAS Peptide DME1265 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 microM) DME1265 XEOTICID XEO03668 GENEFORM Protein DME1265 XEOTICID XEO03668 MOACRIVE Inhibition DME1265 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1265 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03669 XEO_CLAS Peptide DME1265 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO03669 GENEFORM Protein DME1265 XEOTICID XEO03669 MOACRIVE Inhibition DME1265 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1265 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03670 XEO_CLAS Peptide DME1265 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 microM) DME1265 XEOTICID XEO03670 GENEFORM Protein DME1265 XEOTICID XEO03670 MOACRIVE Inhibition DME1265 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1265 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03672 XEO_CLAS Peptide DME1265 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.5 ug/ml) DME1265 XEOTICID XEO03672 GENEFORM Protein DME1265 XEOTICID XEO03672 MOACRIVE Inhibition DME1265 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1265 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03673 XEO_CLAS Peptide DME1265 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 ug/ml) DME1265 XEOTICID XEO03673 GENEFORM Protein DME1265 XEOTICID XEO03673 MOACRIVE Inhibition DME1265 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1265 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03674 XEO_CLAS Peptide DME1265 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 ug/ml) DME1265 XEOTICID XEO03674 GENEFORM Protein DME1265 XEOTICID XEO03674 MOACRIVE Inhibition DME1265 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1265 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03675 XEO_CLAS Peptide DME1265 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO03675 GENEFORM Protein DME1265 XEOTICID XEO03675 MOACRIVE Inhibition DME1265 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1265 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03678 XEO_CLAS Peptide DME1265 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 ug/ml) DME1265 XEOTICID XEO03678 GENEFORM Protein DME1265 XEOTICID XEO03678 MOACRIVE Inhibition DME1265 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1265 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03679 XEO_CLAS Peptide DME1265 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 ug/ml) DME1265 XEOTICID XEO03679 GENEFORM Protein DME1265 XEOTICID XEO03679 MOACRIVE Inhibition DME1265 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1265 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03681 XEO_CLAS Peptide DME1265 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.3-0.6 microM) DME1265 XEOTICID XEO03681 GENEFORM Protein DME1265 XEOTICID XEO03681 MOACRIVE Inhibition DME1265 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1265 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03684 XEO_CLAS Peptide DME1265 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 ug/ml) DME1265 XEOTICID XEO03684 GENEFORM Protein DME1265 XEOTICID XEO03684 MOACRIVE Inhibition DME1265 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1265 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03694 XEO_CLAS Peptide DME1265 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03694 GENEFORM Protein DME1265 XEOTICID XEO03694 MOACRIVE Inhibition DME1265 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1265 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03697 XEO_CLAS Peptide DME1265 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25 microM) DME1265 XEOTICID XEO03697 GENEFORM Protein DME1265 XEOTICID XEO03697 MOACRIVE Inhibition DME1265 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1265 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03698 XEO_CLAS Peptide DME1265 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03698 GENEFORM Protein DME1265 XEOTICID XEO03698 MOACRIVE Inhibition DME1265 XEOTICID XEO03703 XEO_NAME Kasstasin DME1265 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03703 XEO_CLAS Peptide DME1265 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 110 microM) DME1265 XEOTICID XEO03703 GENEFORM Protein DME1265 XEOTICID XEO03703 MOACRIVE Inhibition DME1265 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1265 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03706 XEO_CLAS Peptide DME1265 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03706 GENEFORM Protein DME1265 XEOTICID XEO03706 MOACRIVE Inhibition DME1265 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1265 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03707 XEO_CLAS Peptide DME1265 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03707 GENEFORM Protein DME1265 XEOTICID XEO03707 MOACRIVE Inhibition DME1265 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1265 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03709 XEO_CLAS Peptide DME1265 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 ug/ml) DME1265 XEOTICID XEO03709 GENEFORM Protein DME1265 XEOTICID XEO03709 MOACRIVE Inhibition DME1265 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1265 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03712 XEO_CLAS Peptide DME1265 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03712 GENEFORM Protein DME1265 XEOTICID XEO03712 MOACRIVE Inhibition DME1265 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1265 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03713 XEO_CLAS Peptide DME1265 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 64 microM) DME1265 XEOTICID XEO03713 GENEFORM Protein DME1265 XEOTICID XEO03713 MOACRIVE Inhibition DME1265 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1265 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03714 XEO_CLAS Peptide DME1265 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03714 GENEFORM Protein DME1265 XEOTICID XEO03714 MOACRIVE Inhibition DME1265 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1265 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03715 XEO_CLAS Peptide DME1265 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 microM) DME1265 XEOTICID XEO03715 GENEFORM Protein DME1265 XEOTICID XEO03715 MOACRIVE Inhibition DME1265 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1265 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03719 XEO_CLAS Peptide DME1265 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 microM) DME1265 XEOTICID XEO03719 GENEFORM Protein DME1265 XEOTICID XEO03719 MOACRIVE Inhibition DME1265 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1265 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03720 XEO_CLAS Peptide DME1265 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 microM) DME1265 XEOTICID XEO03720 GENEFORM Protein DME1265 XEOTICID XEO03720 MOACRIVE Inhibition DME1265 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1265 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03723 XEO_CLAS Peptide DME1265 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 62.36 microM) DME1265 XEOTICID XEO03723 GENEFORM Protein DME1265 XEOTICID XEO03723 MOACRIVE Inhibition DME1265 XEOTICID XEO03724 XEO_NAME L10 peptide DME1265 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03724 XEO_CLAS Peptide DME1265 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.8 microM) DME1265 XEOTICID XEO03724 GENEFORM Protein DME1265 XEOTICID XEO03724 MOACRIVE Inhibition DME1265 XEOTICID XEO03726 XEO_NAME L2 peptide DME1265 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03726 XEO_CLAS Peptide DME1265 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 129.66 microM) DME1265 XEOTICID XEO03726 GENEFORM Protein DME1265 XEOTICID XEO03726 MOACRIVE Inhibition DME1265 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1265 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03727 XEO_CLAS Peptide DME1265 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 80 ug/ml) DME1265 XEOTICID XEO03727 GENEFORM Protein DME1265 XEOTICID XEO03727 MOACRIVE Inhibition DME1265 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1265 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03728 XEO_CLAS Peptide DME1265 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40 ug/ml) DME1265 XEOTICID XEO03728 GENEFORM Protein DME1265 XEOTICID XEO03728 MOACRIVE Inhibition DME1265 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1265 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03729 XEO_CLAS Peptide DME1265 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 80 ug/ml) DME1265 XEOTICID XEO03729 GENEFORM Protein DME1265 XEOTICID XEO03729 MOACRIVE Inhibition DME1265 XEOTICID XEO03730 XEO_NAME L3 peptide DME1265 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03730 XEO_CLAS Peptide DME1265 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64.11 microM) DME1265 XEOTICID XEO03730 GENEFORM Protein DME1265 XEOTICID XEO03730 MOACRIVE Inhibition DME1265 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1265 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03731 XEO_CLAS Peptide DME1265 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40 ug/ml) DME1265 XEOTICID XEO03731 GENEFORM Protein DME1265 XEOTICID XEO03731 MOACRIVE Inhibition DME1265 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1265 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03733 XEO_CLAS Peptide DME1265 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40 ug/ml) DME1265 XEOTICID XEO03733 GENEFORM Protein DME1265 XEOTICID XEO03733 MOACRIVE Inhibition DME1265 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1265 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03734 XEO_CLAS Peptide DME1265 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO03734 GENEFORM Protein DME1265 XEOTICID XEO03734 MOACRIVE Inhibition DME1265 XEOTICID XEO03735 XEO_NAME L4 peptide DME1265 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03735 XEO_CLAS Peptide DME1265 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 31.61 microM) DME1265 XEOTICID XEO03735 GENEFORM Protein DME1265 XEOTICID XEO03735 MOACRIVE Inhibition DME1265 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1265 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03738 XEO_CLAS Peptide DME1265 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 ug/ml) DME1265 XEOTICID XEO03738 GENEFORM Protein DME1265 XEOTICID XEO03738 MOACRIVE Inhibition DME1265 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1265 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03741 XEO_CLAS Peptide DME1265 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40 ug/ml) DME1265 XEOTICID XEO03741 GENEFORM Protein DME1265 XEOTICID XEO03741 MOACRIVE Inhibition DME1265 XEOTICID XEO03742 XEO_NAME L5 peptide DME1265 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03742 XEO_CLAS Peptide DME1265 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 7.79 microM) DME1265 XEOTICID XEO03742 GENEFORM Protein DME1265 XEOTICID XEO03742 MOACRIVE Inhibition DME1265 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1265 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03743 XEO_CLAS Peptide DME1265 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 ug/ml) DME1265 XEOTICID XEO03743 GENEFORM Protein DME1265 XEOTICID XEO03743 MOACRIVE Inhibition DME1265 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1265 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03744 XEO_CLAS Peptide DME1265 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 ug/ml) DME1265 XEOTICID XEO03744 GENEFORM Protein DME1265 XEOTICID XEO03744 MOACRIVE Inhibition DME1265 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1265 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03745 XEO_CLAS Peptide DME1265 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 ug/ml) DME1265 XEOTICID XEO03745 GENEFORM Protein DME1265 XEOTICID XEO03745 MOACRIVE Inhibition DME1265 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1265 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03746 XEO_CLAS Peptide DME1265 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO03746 GENEFORM Protein DME1265 XEOTICID XEO03746 MOACRIVE Inhibition DME1265 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1265 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03747 XEO_CLAS Peptide DME1265 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO03747 GENEFORM Protein DME1265 XEOTICID XEO03747 MOACRIVE Inhibition DME1265 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1265 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03748 XEO_CLAS Peptide DME1265 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO03748 GENEFORM Protein DME1265 XEOTICID XEO03748 MOACRIVE Inhibition DME1265 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1265 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03749 XEO_CLAS Peptide DME1265 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO03749 GENEFORM Protein DME1265 XEOTICID XEO03749 MOACRIVE Inhibition DME1265 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1265 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03750 XEO_CLAS Peptide DME1265 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO03750 GENEFORM Protein DME1265 XEOTICID XEO03750 MOACRIVE Inhibition DME1265 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1265 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03751 XEO_CLAS Peptide DME1265 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO03751 GENEFORM Protein DME1265 XEOTICID XEO03751 MOACRIVE Inhibition DME1265 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1265 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03752 XEO_CLAS Peptide DME1265 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO03752 GENEFORM Protein DME1265 XEOTICID XEO03752 MOACRIVE Inhibition DME1265 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1265 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03753 XEO_CLAS Peptide DME1265 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 ug/ml) DME1265 XEOTICID XEO03753 GENEFORM Protein DME1265 XEOTICID XEO03753 MOACRIVE Inhibition DME1265 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1265 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03754 XEO_CLAS Peptide DME1265 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO03754 GENEFORM Protein DME1265 XEOTICID XEO03754 MOACRIVE Inhibition DME1265 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1265 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03755 XEO_CLAS Peptide DME1265 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO03755 GENEFORM Protein DME1265 XEOTICID XEO03755 MOACRIVE Inhibition DME1265 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1265 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03756 XEO_CLAS Peptide DME1265 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO03756 GENEFORM Protein DME1265 XEOTICID XEO03756 MOACRIVE Inhibition DME1265 XEOTICID XEO03757 XEO_NAME L6 peptide DME1265 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03757 XEO_CLAS Peptide DME1265 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15.17 microM) DME1265 XEOTICID XEO03757 GENEFORM Protein DME1265 XEOTICID XEO03757 MOACRIVE Inhibition DME1265 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1265 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03758 XEO_CLAS Peptide DME1265 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 80 ug/ml) DME1265 XEOTICID XEO03758 GENEFORM Protein DME1265 XEOTICID XEO03758 MOACRIVE Inhibition DME1265 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1265 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03759 XEO_CLAS Peptide DME1265 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.3 ug/ml) DME1265 XEOTICID XEO03759 GENEFORM Protein DME1265 XEOTICID XEO03759 MOACRIVE Inhibition DME1265 XEOTICID XEO03760 XEO_NAME L7 peptide DME1265 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03760 XEO_CLAS Peptide DME1265 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16.02 microM) DME1265 XEOTICID XEO03760 GENEFORM Protein DME1265 XEOTICID XEO03760 MOACRIVE Inhibition DME1265 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1265 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03761 XEO_CLAS Peptide DME1265 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 ug/ml) DME1265 XEOTICID XEO03761 GENEFORM Protein DME1265 XEOTICID XEO03761 MOACRIVE Inhibition DME1265 XEOTICID XEO03763 XEO_NAME L8 peptide DME1265 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03763 XEO_CLAS Peptide DME1265 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.71 microM) DME1265 XEOTICID XEO03763 GENEFORM Protein DME1265 XEOTICID XEO03763 MOACRIVE Inhibition DME1265 XEOTICID XEO03765 XEO_NAME L9 peptide DME1265 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03765 XEO_CLAS Peptide DME1265 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.78 microM) DME1265 XEOTICID XEO03765 GENEFORM Protein DME1265 XEOTICID XEO03765 MOACRIVE Inhibition DME1265 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1265 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03775 XEO_CLAS Peptide DME1265 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 17.3 microM) DME1265 XEOTICID XEO03775 GENEFORM Protein DME1265 XEOTICID XEO03775 MOACRIVE Inhibition DME1265 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1265 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03776 XEO_CLAS Peptide DME1265 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03776 GENEFORM Protein DME1265 XEOTICID XEO03776 MOACRIVE Inhibition DME1265 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1265 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03781 XEO_CLAS Peptide DME1265 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.47 microM) DME1265 XEOTICID XEO03781 GENEFORM Protein DME1265 XEOTICID XEO03781 MOACRIVE Inhibition DME1265 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1265 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03782 XEO_CLAS Peptide DME1265 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.47 microM) DME1265 XEOTICID XEO03782 GENEFORM Protein DME1265 XEOTICID XEO03782 MOACRIVE Inhibition DME1265 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1265 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03783 XEO_CLAS Peptide DME1265 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.68 microM) DME1265 XEOTICID XEO03783 GENEFORM Protein DME1265 XEOTICID XEO03783 MOACRIVE Inhibition DME1265 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1265 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03784 XEO_CLAS Peptide DME1265 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.45 microM) DME1265 XEOTICID XEO03784 GENEFORM Protein DME1265 XEOTICID XEO03784 MOACRIVE Inhibition DME1265 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1265 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03785 XEO_CLAS Peptide DME1265 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.73 microM) DME1265 XEOTICID XEO03785 GENEFORM Protein DME1265 XEOTICID XEO03785 MOACRIVE Inhibition DME1265 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1265 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03786 XEO_CLAS Peptide DME1265 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.45 microM) DME1265 XEOTICID XEO03786 GENEFORM Protein DME1265 XEOTICID XEO03786 MOACRIVE Inhibition DME1265 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1265 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03787 XEO_CLAS Peptide DME1265 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.38 microM) DME1265 XEOTICID XEO03787 GENEFORM Protein DME1265 XEOTICID XEO03787 MOACRIVE Inhibition DME1265 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1265 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03788 XEO_CLAS Peptide DME1265 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.46 microM) DME1265 XEOTICID XEO03788 GENEFORM Protein DME1265 XEOTICID XEO03788 MOACRIVE Inhibition DME1265 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1265 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03789 XEO_CLAS Peptide DME1265 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 13.05 microM) DME1265 XEOTICID XEO03789 GENEFORM Protein DME1265 XEOTICID XEO03789 MOACRIVE Inhibition DME1265 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1265 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03790 XEO_CLAS Peptide DME1265 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.82 microM) DME1265 XEOTICID XEO03790 GENEFORM Protein DME1265 XEOTICID XEO03790 MOACRIVE Inhibition DME1265 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1265 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03791 XEO_CLAS Peptide DME1265 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.80 microM) DME1265 XEOTICID XEO03791 GENEFORM Protein DME1265 XEOTICID XEO03791 MOACRIVE Inhibition DME1265 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1265 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03792 XEO_CLAS Peptide DME1265 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.26 microM) DME1265 XEOTICID XEO03792 GENEFORM Protein DME1265 XEOTICID XEO03792 MOACRIVE Inhibition DME1265 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1265 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03793 XEO_CLAS Peptide DME1265 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 microM) DME1265 XEOTICID XEO03793 GENEFORM Protein DME1265 XEOTICID XEO03793 MOACRIVE Inhibition DME1265 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1265 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03797 XEO_CLAS Peptide DME1265 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.4 microM) DME1265 XEOTICID XEO03797 GENEFORM Protein DME1265 XEOTICID XEO03797 MOACRIVE Inhibition DME1265 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1265 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03798 XEO_CLAS Peptide DME1265 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03798 GENEFORM Protein DME1265 XEOTICID XEO03798 MOACRIVE Inhibition DME1265 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1265 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03799 XEO_CLAS Peptide DME1265 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03799 GENEFORM Protein DME1265 XEOTICID XEO03799 MOACRIVE Inhibition DME1265 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1265 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03810 XEO_CLAS Peptide DME1265 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03810 GENEFORM Protein DME1265 XEOTICID XEO03810 MOACRIVE Inhibition DME1265 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1265 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03846 XEO_CLAS Peptide DME1265 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03846 GENEFORM Protein DME1265 XEOTICID XEO03846 MOACRIVE Inhibition DME1265 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1265 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03847 XEO_CLAS Peptide DME1265 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03847 GENEFORM Protein DME1265 XEOTICID XEO03847 MOACRIVE Inhibition DME1265 XEOTICID XEO03850 XEO_NAME Lemon DME1265 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1265 XEOTICID XEO03850 XEO_CLAS Food Additive DME1265 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03850 GENEFORM Protein DME1265 XEOTICID XEO03850 MOACRIVE Inhibition DME1265 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1265 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03853 XEO_CLAS Peptide DME1265 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO03853 GENEFORM Protein DME1265 XEOTICID XEO03853 MOACRIVE Inhibition DME1265 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1265 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03857 XEO_CLAS Peptide DME1265 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 38.49 microM) DME1265 XEOTICID XEO03857 GENEFORM Protein DME1265 XEOTICID XEO03857 MOACRIVE Inhibition DME1265 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1265 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03860 XEO_CLAS Peptide DME1265 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 24 microM) DME1265 XEOTICID XEO03860 GENEFORM Protein DME1265 XEOTICID XEO03860 MOACRIVE Inhibition DME1265 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1265 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03861 XEO_CLAS Peptide DME1265 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 35 microM) DME1265 XEOTICID XEO03861 GENEFORM Protein DME1265 XEOTICID XEO03861 MOACRIVE Inhibition DME1265 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1265 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03862 XEO_CLAS Peptide DME1265 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 70 microM) DME1265 XEOTICID XEO03862 GENEFORM Protein DME1265 XEOTICID XEO03862 MOACRIVE Inhibition DME1265 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1265 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03863 XEO_CLAS Peptide DME1265 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 35 microM) DME1265 XEOTICID XEO03863 GENEFORM Protein DME1265 XEOTICID XEO03863 MOACRIVE Inhibition DME1265 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1265 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03864 XEO_CLAS Peptide DME1265 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO03864 GENEFORM Protein DME1265 XEOTICID XEO03864 MOACRIVE Inhibition DME1265 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1265 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03865 XEO_CLAS Peptide DME1265 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO03865 GENEFORM Protein DME1265 XEOTICID XEO03865 MOACRIVE Inhibition DME1265 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1265 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03866 XEO_CLAS Peptide DME1265 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 microM) DME1265 XEOTICID XEO03866 GENEFORM Protein DME1265 XEOTICID XEO03866 MOACRIVE Inhibition DME1265 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1265 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03867 XEO_CLAS Peptide DME1265 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40 microM) DME1265 XEOTICID XEO03867 GENEFORM Protein DME1265 XEOTICID XEO03867 MOACRIVE Inhibition DME1265 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1265 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03868 XEO_CLAS Peptide DME1265 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 51 microM) DME1265 XEOTICID XEO03868 GENEFORM Protein DME1265 XEOTICID XEO03868 MOACRIVE Inhibition DME1265 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1265 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03869 XEO_CLAS Peptide DME1265 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 35 microM) DME1265 XEOTICID XEO03869 GENEFORM Protein DME1265 XEOTICID XEO03869 MOACRIVE Inhibition DME1265 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1265 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03870 XEO_CLAS Peptide DME1265 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 61 microM) DME1265 XEOTICID XEO03870 GENEFORM Protein DME1265 XEOTICID XEO03870 MOACRIVE Inhibition DME1265 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1265 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03871 XEO_CLAS Peptide DME1265 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 microM) DME1265 XEOTICID XEO03871 GENEFORM Protein DME1265 XEOTICID XEO03871 MOACRIVE Inhibition DME1265 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1265 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03872 XEO_CLAS Peptide DME1265 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 28 microM) DME1265 XEOTICID XEO03872 GENEFORM Protein DME1265 XEOTICID XEO03872 MOACRIVE Inhibition DME1265 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1265 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03873 XEO_CLAS Peptide DME1265 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 22.5 microM) DME1265 XEOTICID XEO03873 GENEFORM Protein DME1265 XEOTICID XEO03873 MOACRIVE Inhibition DME1265 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1265 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03874 XEO_CLAS Peptide DME1265 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 11.25 microM) DME1265 XEOTICID XEO03874 GENEFORM Protein DME1265 XEOTICID XEO03874 MOACRIVE Inhibition DME1265 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1265 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03875 XEO_CLAS Peptide DME1265 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 microM) DME1265 XEOTICID XEO03875 GENEFORM Protein DME1265 XEOTICID XEO03875 MOACRIVE Inhibition DME1265 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1265 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03876 XEO_CLAS Peptide DME1265 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.75 microM) DME1265 XEOTICID XEO03876 GENEFORM Protein DME1265 XEOTICID XEO03876 MOACRIVE Inhibition DME1265 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1265 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03877 XEO_CLAS Peptide DME1265 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 microM) DME1265 XEOTICID XEO03877 GENEFORM Protein DME1265 XEOTICID XEO03877 MOACRIVE Inhibition DME1265 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1265 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03878 XEO_CLAS Peptide DME1265 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 microM) DME1265 XEOTICID XEO03878 GENEFORM Protein DME1265 XEOTICID XEO03878 MOACRIVE Inhibition DME1265 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1265 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03879 XEO_CLAS Peptide DME1265 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 252 microM) DME1265 XEOTICID XEO03879 GENEFORM Protein DME1265 XEOTICID XEO03879 MOACRIVE Inhibition DME1265 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1265 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03880 XEO_CLAS Peptide DME1265 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 174 microM) DME1265 XEOTICID XEO03880 GENEFORM Protein DME1265 XEOTICID XEO03880 MOACRIVE Inhibition DME1265 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1265 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03883 XEO_CLAS Peptide DME1265 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 74 microM) DME1265 XEOTICID XEO03883 GENEFORM Protein DME1265 XEOTICID XEO03883 MOACRIVE Inhibition DME1265 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1265 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03884 XEO_CLAS Peptide DME1265 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 31 microM) DME1265 XEOTICID XEO03884 GENEFORM Protein DME1265 XEOTICID XEO03884 MOACRIVE Inhibition DME1265 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1265 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03885 XEO_CLAS Peptide DME1265 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO03885 GENEFORM Protein DME1265 XEOTICID XEO03885 MOACRIVE Inhibition DME1265 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1265 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03886 XEO_CLAS Peptide DME1265 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 391 microM) DME1265 XEOTICID XEO03886 GENEFORM Protein DME1265 XEOTICID XEO03886 MOACRIVE Inhibition DME1265 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1265 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03887 XEO_CLAS Peptide DME1265 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 151 microM) DME1265 XEOTICID XEO03887 GENEFORM Protein DME1265 XEOTICID XEO03887 MOACRIVE Inhibition DME1265 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1265 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03888 XEO_CLAS Peptide DME1265 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 134 microM) DME1265 XEOTICID XEO03888 GENEFORM Protein DME1265 XEOTICID XEO03888 MOACRIVE Inhibition DME1265 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1265 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03889 XEO_CLAS Peptide DME1265 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 88 microM) DME1265 XEOTICID XEO03889 GENEFORM Protein DME1265 XEOTICID XEO03889 MOACRIVE Inhibition DME1265 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1265 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03890 XEO_CLAS Peptide DME1265 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 31 microM) DME1265 XEOTICID XEO03890 GENEFORM Protein DME1265 XEOTICID XEO03890 MOACRIVE Inhibition DME1265 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1265 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03891 XEO_CLAS Peptide DME1265 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 microM) DME1265 XEOTICID XEO03891 GENEFORM Protein DME1265 XEOTICID XEO03891 MOACRIVE Inhibition DME1265 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1265 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03892 XEO_CLAS Peptide DME1265 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 37 microM) DME1265 XEOTICID XEO03892 GENEFORM Protein DME1265 XEOTICID XEO03892 MOACRIVE Inhibition DME1265 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1265 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03893 XEO_CLAS Peptide DME1265 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 19 microM) DME1265 XEOTICID XEO03893 GENEFORM Protein DME1265 XEOTICID XEO03893 MOACRIVE Inhibition DME1265 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1265 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03894 XEO_CLAS Peptide DME1265 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO03894 GENEFORM Protein DME1265 XEOTICID XEO03894 MOACRIVE Inhibition DME1265 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1265 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03895 XEO_CLAS Peptide DME1265 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO03895 GENEFORM Protein DME1265 XEOTICID XEO03895 MOACRIVE Inhibition DME1265 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1265 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03896 XEO_CLAS Peptide DME1265 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 microM) DME1265 XEOTICID XEO03896 GENEFORM Protein DME1265 XEOTICID XEO03896 MOACRIVE Inhibition DME1265 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1265 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03897 XEO_CLAS Peptide DME1265 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 63 microM) DME1265 XEOTICID XEO03897 GENEFORM Protein DME1265 XEOTICID XEO03897 MOACRIVE Inhibition DME1265 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1265 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03898 XEO_CLAS Peptide DME1265 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 219 microM) DME1265 XEOTICID XEO03898 GENEFORM Protein DME1265 XEOTICID XEO03898 MOACRIVE Inhibition DME1265 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1265 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03901 XEO_CLAS Peptide DME1265 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 35 microM) DME1265 XEOTICID XEO03901 GENEFORM Protein DME1265 XEOTICID XEO03901 MOACRIVE Inhibition DME1265 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1265 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03902 XEO_CLAS Peptide DME1265 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 70 microM) DME1265 XEOTICID XEO03902 GENEFORM Protein DME1265 XEOTICID XEO03902 MOACRIVE Inhibition DME1265 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1265 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03904 XEO_CLAS Peptide DME1265 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO03904 GENEFORM Protein DME1265 XEOTICID XEO03904 MOACRIVE Inhibition DME1265 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1265 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03905 XEO_CLAS Peptide DME1265 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO03905 GENEFORM Protein DME1265 XEOTICID XEO03905 MOACRIVE Inhibition DME1265 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1265 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03908 XEO_CLAS Peptide DME1265 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03908 GENEFORM Protein DME1265 XEOTICID XEO03908 MOACRIVE Inhibition DME1265 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1265 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03915 XEO_CLAS Peptide DME1265 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03915 GENEFORM Protein DME1265 XEOTICID XEO03915 MOACRIVE Inhibition DME1265 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1265 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03916 XEO_CLAS Peptide DME1265 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.8 ug/ml) DME1265 XEOTICID XEO03916 GENEFORM Protein DME1265 XEOTICID XEO03916 MOACRIVE Inhibition DME1265 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1265 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03917 XEO_CLAS Peptide DME1265 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 13.1 ug/ml) DME1265 XEOTICID XEO03917 GENEFORM Protein DME1265 XEOTICID XEO03917 MOACRIVE Inhibition DME1265 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1265 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03918 XEO_CLAS Peptide DME1265 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.5 ug/ml) DME1265 XEOTICID XEO03918 GENEFORM Protein DME1265 XEOTICID XEO03918 MOACRIVE Inhibition DME1265 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1265 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03919 XEO_CLAS Peptide DME1265 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 80 ug/ml) DME1265 XEOTICID XEO03919 GENEFORM Protein DME1265 XEOTICID XEO03919 MOACRIVE Inhibition DME1265 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1265 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03922 XEO_CLAS Peptide DME1265 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 9 microM) DME1265 XEOTICID XEO03922 GENEFORM Protein DME1265 XEOTICID XEO03922 MOACRIVE Inhibition DME1265 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1265 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03923 XEO_CLAS Peptide DME1265 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 80 microM) DME1265 XEOTICID XEO03923 GENEFORM Protein DME1265 XEOTICID XEO03923 MOACRIVE Inhibition DME1265 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1265 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03924 XEO_CLAS Peptide DME1265 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO03924 GENEFORM Protein DME1265 XEOTICID XEO03924 MOACRIVE Inhibition DME1265 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1265 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03927 XEO_CLAS Peptide DME1265 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 80 microM) DME1265 XEOTICID XEO03927 GENEFORM Protein DME1265 XEOTICID XEO03927 MOACRIVE Inhibition DME1265 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1265 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03928 XEO_CLAS Peptide DME1265 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 microM) DME1265 XEOTICID XEO03928 GENEFORM Protein DME1265 XEOTICID XEO03928 MOACRIVE Inhibition DME1265 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1265 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03929 XEO_CLAS Peptide DME1265 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 microM) DME1265 XEOTICID XEO03929 GENEFORM Protein DME1265 XEOTICID XEO03929 MOACRIVE Inhibition DME1265 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1265 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03930 XEO_CLAS Peptide DME1265 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 microM) DME1265 XEOTICID XEO03930 GENEFORM Protein DME1265 XEOTICID XEO03930 MOACRIVE Inhibition DME1265 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1265 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03931 XEO_CLAS Peptide DME1265 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 microM) DME1265 XEOTICID XEO03931 GENEFORM Protein DME1265 XEOTICID XEO03931 MOACRIVE Inhibition DME1265 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1265 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03933 XEO_CLAS Peptide DME1265 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.5 microM) DME1265 XEOTICID XEO03933 GENEFORM Protein DME1265 XEOTICID XEO03933 MOACRIVE Inhibition DME1265 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1265 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03934 XEO_CLAS Peptide DME1265 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.7 microM) DME1265 XEOTICID XEO03934 GENEFORM Protein DME1265 XEOTICID XEO03934 MOACRIVE Inhibition DME1265 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1265 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03935 XEO_CLAS Peptide DME1265 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.7 microM) DME1265 XEOTICID XEO03935 GENEFORM Protein DME1265 XEOTICID XEO03935 MOACRIVE Inhibition DME1265 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1265 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03936 XEO_CLAS Peptide DME1265 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.0 microM) DME1265 XEOTICID XEO03936 GENEFORM Protein DME1265 XEOTICID XEO03936 MOACRIVE Inhibition DME1265 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1265 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03937 XEO_CLAS Peptide DME1265 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.1 microM) DME1265 XEOTICID XEO03937 GENEFORM Protein DME1265 XEOTICID XEO03937 MOACRIVE Inhibition DME1265 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1265 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03938 XEO_CLAS Peptide DME1265 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.7 microM) DME1265 XEOTICID XEO03938 GENEFORM Protein DME1265 XEOTICID XEO03938 MOACRIVE Inhibition DME1265 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1265 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03939 XEO_CLAS Peptide DME1265 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.7 microM) DME1265 XEOTICID XEO03939 GENEFORM Protein DME1265 XEOTICID XEO03939 MOACRIVE Inhibition DME1265 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1265 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03940 XEO_CLAS Peptide DME1265 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.5 microM) DME1265 XEOTICID XEO03940 GENEFORM Protein DME1265 XEOTICID XEO03940 MOACRIVE Inhibition DME1265 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1265 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03941 XEO_CLAS Peptide DME1265 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.4 microM) DME1265 XEOTICID XEO03941 GENEFORM Protein DME1265 XEOTICID XEO03941 MOACRIVE Inhibition DME1265 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1265 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03943 XEO_CLAS Peptide DME1265 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.4 microM) DME1265 XEOTICID XEO03943 GENEFORM Protein DME1265 XEOTICID XEO03943 MOACRIVE Inhibition DME1265 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1265 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03944 XEO_CLAS Peptide DME1265 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.7 microM) DME1265 XEOTICID XEO03944 GENEFORM Protein DME1265 XEOTICID XEO03944 MOACRIVE Inhibition DME1265 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1265 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03945 XEO_CLAS Peptide DME1265 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.2 microM) DME1265 XEOTICID XEO03945 GENEFORM Protein DME1265 XEOTICID XEO03945 MOACRIVE Inhibition DME1265 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1265 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03947 XEO_CLAS Peptide DME1265 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.0 microM) DME1265 XEOTICID XEO03947 GENEFORM Protein DME1265 XEOTICID XEO03947 MOACRIVE Inhibition DME1265 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1265 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03948 XEO_CLAS Peptide DME1265 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 23.3 microM) DME1265 XEOTICID XEO03948 GENEFORM Protein DME1265 XEOTICID XEO03948 MOACRIVE Inhibition DME1265 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1265 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03950 XEO_CLAS Peptide DME1265 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4.4 microM) DME1265 XEOTICID XEO03950 GENEFORM Protein DME1265 XEOTICID XEO03950 MOACRIVE Inhibition DME1265 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1265 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03951 XEO_CLAS Peptide DME1265 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8.8 microM) DME1265 XEOTICID XEO03951 GENEFORM Protein DME1265 XEOTICID XEO03951 MOACRIVE Inhibition DME1265 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1265 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03952 XEO_CLAS Peptide DME1265 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.2 microM) DME1265 XEOTICID XEO03952 GENEFORM Protein DME1265 XEOTICID XEO03952 MOACRIVE Inhibition DME1265 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1265 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03953 XEO_CLAS Peptide DME1265 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 microM) DME1265 XEOTICID XEO03953 GENEFORM Protein DME1265 XEOTICID XEO03953 MOACRIVE Inhibition DME1265 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1265 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03958 XEO_CLAS Peptide DME1265 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03958 GENEFORM Protein DME1265 XEOTICID XEO03958 MOACRIVE Inhibition DME1265 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1265 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03965 XEO_CLAS Peptide DME1265 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 128 microM) DME1265 XEOTICID XEO03965 GENEFORM Protein DME1265 XEOTICID XEO03965 MOACRIVE Inhibition DME1265 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1265 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03966 XEO_CLAS Peptide DME1265 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 microM) DME1265 XEOTICID XEO03966 GENEFORM Protein DME1265 XEOTICID XEO03966 MOACRIVE Inhibition DME1265 XEOTICID XEO03971 XEO_NAME Lumbrican DME1265 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03971 XEO_CLAS Peptide DME1265 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03971 GENEFORM Protein DME1265 XEOTICID XEO03971 MOACRIVE Inhibition DME1265 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1265 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03972 XEO_CLAS Peptide DME1265 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO03972 GENEFORM Protein DME1265 XEOTICID XEO03972 MOACRIVE Inhibition DME1265 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1265 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03980 XEO_CLAS Peptide DME1265 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 32 microM) DME1265 XEOTICID XEO03980 GENEFORM Protein DME1265 XEOTICID XEO03980 MOACRIVE Inhibition DME1265 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1265 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03985 XEO_CLAS Peptide DME1265 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 ug/ml) DME1265 XEOTICID XEO03985 GENEFORM Protein DME1265 XEOTICID XEO03985 MOACRIVE Inhibition DME1265 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1265 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03991 XEO_CLAS Peptide DME1265 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03991 GENEFORM Protein DME1265 XEOTICID XEO03991 MOACRIVE Inhibition DME1265 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1265 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03992 XEO_CLAS Peptide DME1265 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03992 GENEFORM Protein DME1265 XEOTICID XEO03992 MOACRIVE Inhibition DME1265 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1265 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03993 XEO_CLAS Peptide DME1265 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03993 GENEFORM Protein DME1265 XEOTICID XEO03993 MOACRIVE Inhibition DME1265 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1265 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03994 XEO_CLAS Peptide DME1265 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO03994 GENEFORM Protein DME1265 XEOTICID XEO03994 MOACRIVE Inhibition DME1265 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1265 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03996 XEO_CLAS Peptide DME1265 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 65 microM) DME1265 XEOTICID XEO03996 GENEFORM Protein DME1265 XEOTICID XEO03996 MOACRIVE Inhibition DME1265 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1265 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03997 XEO_CLAS Peptide DME1265 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 7.5 microM) DME1265 XEOTICID XEO03997 GENEFORM Protein DME1265 XEOTICID XEO03997 MOACRIVE Inhibition DME1265 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1265 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03998 XEO_CLAS Peptide DME1265 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15.5 microM) DME1265 XEOTICID XEO03998 GENEFORM Protein DME1265 XEOTICID XEO03998 MOACRIVE Inhibition DME1265 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1265 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO03999 XEO_CLAS Peptide DME1265 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25.8 microM) DME1265 XEOTICID XEO03999 GENEFORM Protein DME1265 XEOTICID XEO03999 MOACRIVE Inhibition DME1265 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1265 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04000 XEO_CLAS Peptide DME1265 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO04000 GENEFORM Protein DME1265 XEOTICID XEO04000 MOACRIVE Inhibition DME1265 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1265 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04001 XEO_CLAS Peptide DME1265 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO04001 GENEFORM Protein DME1265 XEOTICID XEO04001 MOACRIVE Inhibition DME1265 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1265 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04002 XEO_CLAS Peptide DME1265 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 7.5 ug/ml) DME1265 XEOTICID XEO04002 GENEFORM Protein DME1265 XEOTICID XEO04002 MOACRIVE Inhibition DME1265 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1265 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04003 XEO_CLAS Peptide DME1265 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 ug/ml) DME1265 XEOTICID XEO04003 GENEFORM Protein DME1265 XEOTICID XEO04003 MOACRIVE Inhibition DME1265 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1265 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04004 XEO_CLAS Peptide DME1265 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.0 ug/ml) DME1265 XEOTICID XEO04004 GENEFORM Protein DME1265 XEOTICID XEO04004 MOACRIVE Inhibition DME1265 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1265 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04005 XEO_CLAS Peptide DME1265 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.0 ug/ml) DME1265 XEOTICID XEO04005 GENEFORM Protein DME1265 XEOTICID XEO04005 MOACRIVE Inhibition DME1265 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1265 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04007 XEO_CLAS Peptide DME1265 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 19.5 ug/ml) DME1265 XEOTICID XEO04007 GENEFORM Protein DME1265 XEOTICID XEO04007 MOACRIVE Inhibition DME1265 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1265 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04011 XEO_CLAS Peptide DME1265 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 19.5 ug/ml) DME1265 XEOTICID XEO04011 GENEFORM Protein DME1265 XEOTICID XEO04011 MOACRIVE Inhibition DME1265 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1265 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04012 XEO_CLAS Peptide DME1265 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.9 ug/ml) DME1265 XEOTICID XEO04012 GENEFORM Protein DME1265 XEOTICID XEO04012 MOACRIVE Inhibition DME1265 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1265 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04013 XEO_CLAS Peptide DME1265 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.7 ug/ml) DME1265 XEOTICID XEO04013 GENEFORM Protein DME1265 XEOTICID XEO04013 MOACRIVE Inhibition DME1265 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1265 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04018 XEO_CLAS Peptide DME1265 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 9 ug/ml) DME1265 XEOTICID XEO04018 GENEFORM Protein DME1265 XEOTICID XEO04018 MOACRIVE Inhibition DME1265 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1265 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04026 XEO_CLAS Peptide DME1265 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO04026 GENEFORM Protein DME1265 XEOTICID XEO04026 MOACRIVE Inhibition DME1265 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1265 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04027 XEO_CLAS Peptide DME1265 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO04027 GENEFORM Protein DME1265 XEOTICID XEO04027 MOACRIVE Inhibition DME1265 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1265 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04028 XEO_CLAS Peptide DME1265 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 ug/ml) DME1265 XEOTICID XEO04028 GENEFORM Protein DME1265 XEOTICID XEO04028 MOACRIVE Inhibition DME1265 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1265 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04038 XEO_CLAS Peptide DME1265 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04038 GENEFORM Protein DME1265 XEOTICID XEO04038 MOACRIVE Inhibition DME1265 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1265 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04039 XEO_CLAS Peptide DME1265 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 microM) DME1265 XEOTICID XEO04039 GENEFORM Protein DME1265 XEOTICID XEO04039 MOACRIVE Inhibition DME1265 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1265 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04051 XEO_CLAS Peptide DME1265 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.31-0.63 microM) DME1265 XEOTICID XEO04051 GENEFORM Protein DME1265 XEOTICID XEO04051 MOACRIVE Inhibition DME1265 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1265 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04052 XEO_CLAS Peptide DME1265 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04052 GENEFORM Protein DME1265 XEOTICID XEO04052 MOACRIVE Inhibition DME1265 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1265 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04053 XEO_CLAS Peptide DME1265 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.08-0.16 microM) DME1265 XEOTICID XEO04053 GENEFORM Protein DME1265 XEOTICID XEO04053 MOACRIVE Inhibition DME1265 XEOTICID XEO04055 XEO_NAME Melectin DME1265 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04055 XEO_CLAS Peptide DME1265 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.0 microM) DME1265 XEOTICID XEO04055 GENEFORM Protein DME1265 XEOTICID XEO04055 MOACRIVE Inhibition DME1265 XEOTICID XEO04057 XEO_NAME Melittin DME1265 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04057 XEO_CLAS Peptide DME1265 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.8 microM) DME1265 XEOTICID XEO04057 GENEFORM Protein DME1265 XEOTICID XEO04057 MOACRIVE Inhibition DME1265 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1265 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04061 XEO_CLAS Peptide DME1265 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.9 microM) DME1265 XEOTICID XEO04061 GENEFORM Protein DME1265 XEOTICID XEO04061 MOACRIVE Inhibition DME1265 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1265 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04062 XEO_CLAS Peptide DME1265 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.5 microM) DME1265 XEOTICID XEO04062 GENEFORM Protein DME1265 XEOTICID XEO04062 MOACRIVE Inhibition DME1265 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1265 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04063 XEO_CLAS Peptide DME1265 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 7.8 microM) DME1265 XEOTICID XEO04063 GENEFORM Protein DME1265 XEOTICID XEO04063 MOACRIVE Inhibition DME1265 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1265 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04064 XEO_CLAS Peptide DME1265 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 46.7 microM) DME1265 XEOTICID XEO04064 GENEFORM Protein DME1265 XEOTICID XEO04064 MOACRIVE Inhibition DME1265 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1265 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04066 XEO_CLAS Peptide DME1265 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16.3 microM) DME1265 XEOTICID XEO04066 GENEFORM Protein DME1265 XEOTICID XEO04066 MOACRIVE Inhibition DME1265 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1265 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04067 XEO_CLAS Peptide DME1265 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.6 microM) DME1265 XEOTICID XEO04067 GENEFORM Protein DME1265 XEOTICID XEO04067 MOACRIVE Inhibition DME1265 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1265 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04068 XEO_CLAS Peptide DME1265 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.6 microM) DME1265 XEOTICID XEO04068 GENEFORM Protein DME1265 XEOTICID XEO04068 MOACRIVE Inhibition DME1265 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1265 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04086 GENEFORM Protein DME1265 XEOTICID XEO04086 MOACRIVE Inhibition DME1265 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1265 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04087 GENEFORM Protein DME1265 XEOTICID XEO04087 MOACRIVE Inhibition DME1265 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1265 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04089 GENEFORM Protein DME1265 XEOTICID XEO04089 MOACRIVE Inhibition DME1265 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1265 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04094 GENEFORM Protein DME1265 XEOTICID XEO04094 MOACRIVE Inhibition DME1265 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1265 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04096 GENEFORM Protein DME1265 XEOTICID XEO04096 MOACRIVE Inhibition DME1265 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1265 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04098 GENEFORM Protein DME1265 XEOTICID XEO04098 MOACRIVE Inhibition DME1265 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1265 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04111 XEO_CLAS Peptide DME1265 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04111 GENEFORM Protein DME1265 XEOTICID XEO04111 MOACRIVE Inhibition DME1265 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1265 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04112 XEO_CLAS Peptide DME1265 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.02 microM) DME1265 XEOTICID XEO04112 GENEFORM Protein DME1265 XEOTICID XEO04112 MOACRIVE Inhibition DME1265 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1265 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04113 XEO_CLAS Peptide DME1265 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.02 ug/ml) DME1265 XEOTICID XEO04113 GENEFORM Protein DME1265 XEOTICID XEO04113 MOACRIVE Inhibition DME1265 XEOTICID XEO04114 XEO_NAME Microcin L DME1265 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04114 XEO_CLAS Peptide DME1265 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04114 GENEFORM Protein DME1265 XEOTICID XEO04114 MOACRIVE Inhibition DME1265 XEOTICID XEO04117 XEO_NAME Misgurin DME1265 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04117 XEO_CLAS Peptide DME1265 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04117 GENEFORM Protein DME1265 XEOTICID XEO04117 MOACRIVE Inhibition DME1265 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1265 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04118 XEO_CLAS Peptide DME1265 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 300 microM) DME1265 XEOTICID XEO04118 GENEFORM Protein DME1265 XEOTICID XEO04118 MOACRIVE Inhibition DME1265 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1265 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04119 XEO_CLAS Peptide DME1265 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-20 microM) DME1265 XEOTICID XEO04119 GENEFORM Protein DME1265 XEOTICID XEO04119 MOACRIVE Inhibition DME1265 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1265 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04120 XEO_CLAS Peptide DME1265 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC < 10 microM) DME1265 XEOTICID XEO04120 GENEFORM Protein DME1265 XEOTICID XEO04120 MOACRIVE Inhibition DME1265 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1265 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04121 XEO_CLAS Peptide DME1265 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.2-6.4 microM) DME1265 XEOTICID XEO04121 GENEFORM Protein DME1265 XEOTICID XEO04121 MOACRIVE Inhibition DME1265 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1265 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04122 XEO_CLAS Peptide DME1265 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.14-6.29 microM) DME1265 XEOTICID XEO04122 GENEFORM Protein DME1265 XEOTICID XEO04122 MOACRIVE Inhibition DME1265 XEOTICID XEO04123 XEO_NAME Modified defensin DME1265 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04123 XEO_CLAS Peptide DME1265 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO04123 GENEFORM Protein DME1265 XEOTICID XEO04123 MOACRIVE Inhibition DME1265 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1265 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04128 XEO_CLAS Peptide DME1265 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.31 microM) DME1265 XEOTICID XEO04128 GENEFORM Protein DME1265 XEOTICID XEO04128 MOACRIVE Inhibition DME1265 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1265 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04129 XEO_CLAS Peptide DME1265 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO04129 GENEFORM Protein DME1265 XEOTICID XEO04129 MOACRIVE Inhibition DME1265 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1265 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04130 XEO_CLAS Peptide DME1265 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO04130 GENEFORM Protein DME1265 XEOTICID XEO04130 MOACRIVE Inhibition DME1265 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1265 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04131 XEO_CLAS Peptide DME1265 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 microM) DME1265 XEOTICID XEO04131 GENEFORM Protein DME1265 XEOTICID XEO04131 MOACRIVE Inhibition DME1265 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1265 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04132 XEO_CLAS Peptide DME1265 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 microM) DME1265 XEOTICID XEO04132 GENEFORM Protein DME1265 XEOTICID XEO04132 MOACRIVE Inhibition DME1265 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1265 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04133 XEO_CLAS Peptide DME1265 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO04133 GENEFORM Protein DME1265 XEOTICID XEO04133 MOACRIVE Inhibition DME1265 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1265 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04134 XEO_CLAS Peptide DME1265 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO04134 GENEFORM Protein DME1265 XEOTICID XEO04134 MOACRIVE Inhibition DME1265 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1265 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04135 XEO_CLAS Peptide DME1265 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 microM) DME1265 XEOTICID XEO04135 GENEFORM Protein DME1265 XEOTICID XEO04135 MOACRIVE Inhibition DME1265 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1265 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04137 XEO_CLAS Peptide DME1265 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.6 microM) DME1265 XEOTICID XEO04137 GENEFORM Protein DME1265 XEOTICID XEO04137 MOACRIVE Inhibition DME1265 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1265 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04138 XEO_CLAS Peptide DME1265 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 microM) DME1265 XEOTICID XEO04138 GENEFORM Protein DME1265 XEOTICID XEO04138 MOACRIVE Inhibition DME1265 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1265 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04139 XEO_CLAS Peptide DME1265 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 microM) DME1265 XEOTICID XEO04139 GENEFORM Protein DME1265 XEOTICID XEO04139 MOACRIVE Inhibition DME1265 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1265 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04140 XEO_CLAS Peptide DME1265 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 70 microM) DME1265 XEOTICID XEO04140 GENEFORM Protein DME1265 XEOTICID XEO04140 MOACRIVE Inhibition DME1265 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1265 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04141 XEO_CLAS Peptide DME1265 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 microM) DME1265 XEOTICID XEO04141 GENEFORM Protein DME1265 XEOTICID XEO04141 MOACRIVE Inhibition DME1265 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1265 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04142 XEO_CLAS Peptide DME1265 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8-16 microM) DME1265 XEOTICID XEO04142 GENEFORM Protein DME1265 XEOTICID XEO04142 MOACRIVE Inhibition DME1265 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1265 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04146 XEO_CLAS Peptide DME1265 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04146 GENEFORM Protein DME1265 XEOTICID XEO04146 MOACRIVE Inhibition DME1265 XEOTICID XEO04149 XEO_NAME Mucroporin DME1265 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04149 XEO_CLAS Peptide DME1265 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 ug/ml) DME1265 XEOTICID XEO04149 GENEFORM Protein DME1265 XEOTICID XEO04149 MOACRIVE Inhibition DME1265 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1265 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04158 XEO_CLAS Peptide DME1265 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO04158 GENEFORM Protein DME1265 XEOTICID XEO04158 MOACRIVE Inhibition DME1265 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1265 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04159 XEO_CLAS Peptide DME1265 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 microM) DME1265 XEOTICID XEO04159 GENEFORM Protein DME1265 XEOTICID XEO04159 MOACRIVE Inhibition DME1265 XEOTICID XEO04167 XEO_NAME Myticin-B DME1265 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04167 XEO_CLAS Peptide DME1265 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04167 GENEFORM Protein DME1265 XEOTICID XEO04167 MOACRIVE Inhibition DME1265 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1265 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04168 XEO_CLAS Peptide DME1265 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.7-12.5 microM) DME1265 XEOTICID XEO04168 GENEFORM Protein DME1265 XEOTICID XEO04168 MOACRIVE Inhibition DME1265 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1265 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04169 XEO_CLAS Peptide DME1265 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04169 GENEFORM Protein DME1265 XEOTICID XEO04169 MOACRIVE Inhibition DME1265 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1265 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04170 XEO_CLAS Peptide DME1265 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04170 GENEFORM Protein DME1265 XEOTICID XEO04170 MOACRIVE Inhibition DME1265 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1265 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04171 XEO_CLAS Peptide DME1265 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04171 GENEFORM Protein DME1265 XEOTICID XEO04171 MOACRIVE Inhibition DME1265 XEOTICID XEO04172 XEO_NAME Myxinidin DME1265 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04172 XEO_CLAS Peptide DME1265 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04172 GENEFORM Protein DME1265 XEOTICID XEO04172 MOACRIVE Inhibition DME1265 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1265 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04177 XEO_CLAS Peptide DME1265 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.7 microM) DME1265 XEOTICID XEO04177 GENEFORM Protein DME1265 XEOTICID XEO04177 MOACRIVE Inhibition DME1265 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1265 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04178 XEO_CLAS Peptide DME1265 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.7 microM) DME1265 XEOTICID XEO04178 GENEFORM Protein DME1265 XEOTICID XEO04178 MOACRIVE Inhibition DME1265 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1265 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04179 XEO_CLAS Peptide DME1265 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.5 microM) DME1265 XEOTICID XEO04179 GENEFORM Protein DME1265 XEOTICID XEO04179 MOACRIVE Inhibition DME1265 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1265 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04180 XEO_CLAS Peptide DME1265 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 23 microM) DME1265 XEOTICID XEO04180 GENEFORM Protein DME1265 XEOTICID XEO04180 MOACRIVE Inhibition DME1265 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1265 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04181 XEO_CLAS Peptide DME1265 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.2 microM) DME1265 XEOTICID XEO04181 GENEFORM Protein DME1265 XEOTICID XEO04181 MOACRIVE Inhibition DME1265 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1265 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04182 XEO_CLAS Peptide DME1265 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4.4 microM) DME1265 XEOTICID XEO04182 GENEFORM Protein DME1265 XEOTICID XEO04182 MOACRIVE Inhibition DME1265 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1265 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04183 XEO_CLAS Peptide DME1265 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.6 microM) DME1265 XEOTICID XEO04183 GENEFORM Protein DME1265 XEOTICID XEO04183 MOACRIVE Inhibition DME1265 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1265 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04184 XEO_CLAS Peptide DME1265 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 microM) DME1265 XEOTICID XEO04184 GENEFORM Protein DME1265 XEOTICID XEO04184 MOACRIVE Inhibition DME1265 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1265 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04185 XEO_CLAS Peptide DME1265 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04185 GENEFORM Protein DME1265 XEOTICID XEO04185 MOACRIVE Inhibition DME1265 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1265 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04186 XEO_CLAS Peptide DME1265 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04186 GENEFORM Protein DME1265 XEOTICID XEO04186 MOACRIVE Inhibition DME1265 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1265 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04187 XEO_CLAS Peptide DME1265 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04187 GENEFORM Protein DME1265 XEOTICID XEO04187 MOACRIVE Inhibition DME1265 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1265 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04188 XEO_CLAS Peptide DME1265 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04188 GENEFORM Protein DME1265 XEOTICID XEO04188 MOACRIVE Inhibition DME1265 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1265 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04206 XEO_CLAS Peptide DME1265 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25 microM) DME1265 XEOTICID XEO04206 GENEFORM Protein DME1265 XEOTICID XEO04206 MOACRIVE Inhibition DME1265 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1265 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04214 XEO_CLAS Peptide DME1265 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25 microM) DME1265 XEOTICID XEO04214 GENEFORM Protein DME1265 XEOTICID XEO04214 MOACRIVE Inhibition DME1265 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1265 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04216 XEO_CLAS Peptide DME1265 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO04216 GENEFORM Protein DME1265 XEOTICID XEO04216 MOACRIVE Inhibition DME1265 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1265 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04218 XEO_CLAS Peptide DME1265 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.125 microM) DME1265 XEOTICID XEO04218 GENEFORM Protein DME1265 XEOTICID XEO04218 MOACRIVE Inhibition DME1265 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1265 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04219 XEO_CLAS Peptide DME1265 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO04219 GENEFORM Protein DME1265 XEOTICID XEO04219 MOACRIVE Inhibition DME1265 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1265 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04220 XEO_CLAS Peptide DME1265 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.125 microM) DME1265 XEOTICID XEO04220 GENEFORM Protein DME1265 XEOTICID XEO04220 MOACRIVE Inhibition DME1265 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1265 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04221 XEO_CLAS Peptide DME1265 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO04221 GENEFORM Protein DME1265 XEOTICID XEO04221 MOACRIVE Inhibition DME1265 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1265 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04222 XEO_CLAS Peptide DME1265 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25 microM) DME1265 XEOTICID XEO04222 GENEFORM Protein DME1265 XEOTICID XEO04222 MOACRIVE Inhibition DME1265 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1265 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04233 XEO_CLAS Peptide DME1265 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04233 GENEFORM Protein DME1265 XEOTICID XEO04233 MOACRIVE Inhibition DME1265 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1265 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04234 XEO_CLAS Peptide DME1265 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04234 GENEFORM Protein DME1265 XEOTICID XEO04234 MOACRIVE Inhibition DME1265 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1265 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04241 XEO_CLAS Peptide DME1265 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04241 GENEFORM Protein DME1265 XEOTICID XEO04241 MOACRIVE Inhibition DME1265 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1265 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04242 XEO_CLAS Peptide DME1265 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04242 GENEFORM Protein DME1265 XEOTICID XEO04242 MOACRIVE Inhibition DME1265 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1265 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04245 XEO_CLAS Natural Product DME1265 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04245 GENEFORM Protein DME1265 XEOTICID XEO04245 MOACRIVE Inhibition DME1265 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1265 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04246 XEO_CLAS Natural Product DME1265 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04246 GENEFORM Protein DME1265 XEOTICID XEO04246 MOACRIVE Inhibition DME1265 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1265 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04249 XEO_CLAS Peptide DME1265 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 500 ug/ml) DME1265 XEOTICID XEO04249 GENEFORM Protein DME1265 XEOTICID XEO04249 MOACRIVE Inhibition DME1265 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1265 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04251 XEO_CLAS Peptide DME1265 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04251 GENEFORM Protein DME1265 XEOTICID XEO04251 MOACRIVE Inhibition DME1265 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1265 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04253 XEO_CLAS Peptide DME1265 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04253 GENEFORM Protein DME1265 XEOTICID XEO04253 MOACRIVE Inhibition DME1265 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1265 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04254 XEO_CLAS Peptide DME1265 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04254 GENEFORM Protein DME1265 XEOTICID XEO04254 MOACRIVE Inhibition DME1265 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1265 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04255 XEO_CLAS Peptide DME1265 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04255 GENEFORM Protein DME1265 XEOTICID XEO04255 MOACRIVE Inhibition DME1265 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1265 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04256 XEO_CLAS Peptide DME1265 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04256 GENEFORM Protein DME1265 XEOTICID XEO04256 MOACRIVE Inhibition DME1265 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1265 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04257 XEO_CLAS Peptide DME1265 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04257 GENEFORM Protein DME1265 XEOTICID XEO04257 MOACRIVE Inhibition DME1265 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1265 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04258 XEO_CLAS Peptide DME1265 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04258 GENEFORM Protein DME1265 XEOTICID XEO04258 MOACRIVE Inhibition DME1265 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1265 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04259 XEO_CLAS Peptide DME1265 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04259 GENEFORM Protein DME1265 XEOTICID XEO04259 MOACRIVE Inhibition DME1265 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1265 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04260 XEO_CLAS Peptide DME1265 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04260 GENEFORM Protein DME1265 XEOTICID XEO04260 MOACRIVE Inhibition DME1265 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1265 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04261 XEO_CLAS Peptide DME1265 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04261 GENEFORM Protein DME1265 XEOTICID XEO04261 MOACRIVE Inhibition DME1265 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1265 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04262 XEO_CLAS Peptide DME1265 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04262 GENEFORM Protein DME1265 XEOTICID XEO04262 MOACRIVE Inhibition DME1265 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1265 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04263 XEO_CLAS Peptide DME1265 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04263 GENEFORM Protein DME1265 XEOTICID XEO04263 MOACRIVE Inhibition DME1265 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1265 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04264 XEO_CLAS Peptide DME1265 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04264 GENEFORM Protein DME1265 XEOTICID XEO04264 MOACRIVE Inhibition DME1265 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1265 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04265 XEO_CLAS Peptide DME1265 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04265 GENEFORM Protein DME1265 XEOTICID XEO04265 MOACRIVE Inhibition DME1265 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1265 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04266 XEO_CLAS Peptide DME1265 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04266 GENEFORM Protein DME1265 XEOTICID XEO04266 MOACRIVE Inhibition DME1265 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1265 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04267 XEO_CLAS Peptide DME1265 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04267 GENEFORM Protein DME1265 XEOTICID XEO04267 MOACRIVE Inhibition DME1265 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1265 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04268 XEO_CLAS Peptide DME1265 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04268 GENEFORM Protein DME1265 XEOTICID XEO04268 MOACRIVE Inhibition DME1265 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1265 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04269 XEO_CLAS Peptide DME1265 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04269 GENEFORM Protein DME1265 XEOTICID XEO04269 MOACRIVE Inhibition DME1265 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1265 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04270 XEO_CLAS Peptide DME1265 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04270 GENEFORM Protein DME1265 XEOTICID XEO04270 MOACRIVE Inhibition DME1265 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1265 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04271 XEO_CLAS Peptide DME1265 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04271 GENEFORM Protein DME1265 XEOTICID XEO04271 MOACRIVE Inhibition DME1265 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1265 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04272 XEO_CLAS Peptide DME1265 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04272 GENEFORM Protein DME1265 XEOTICID XEO04272 MOACRIVE Inhibition DME1265 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1265 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04277 XEO_CLAS Peptide DME1265 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 110.00 ug/ml) DME1265 XEOTICID XEO04277 GENEFORM Protein DME1265 XEOTICID XEO04277 MOACRIVE Inhibition DME1265 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1265 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04280 XEO_CLAS Peptide DME1265 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 37.50 ug/ml) DME1265 XEOTICID XEO04280 GENEFORM Protein DME1265 XEOTICID XEO04280 MOACRIVE Inhibition DME1265 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1265 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04281 XEO_CLAS Peptide DME1265 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25.00 ug/ml) DME1265 XEOTICID XEO04281 GENEFORM Protein DME1265 XEOTICID XEO04281 MOACRIVE Inhibition DME1265 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1265 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04282 XEO_CLAS Peptide DME1265 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.2 ug/ml) DME1265 XEOTICID XEO04282 GENEFORM Protein DME1265 XEOTICID XEO04282 MOACRIVE Inhibition DME1265 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1265 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04283 XEO_CLAS Peptide DME1265 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.3 ug/ml) DME1265 XEOTICID XEO04283 GENEFORM Protein DME1265 XEOTICID XEO04283 MOACRIVE Inhibition DME1265 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1265 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04284 XEO_CLAS Peptide DME1265 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10.8 ug/ml) DME1265 XEOTICID XEO04284 GENEFORM Protein DME1265 XEOTICID XEO04284 MOACRIVE Inhibition DME1265 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1265 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04285 XEO_CLAS Peptide DME1265 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 11.5 ug/ml) DME1265 XEOTICID XEO04285 GENEFORM Protein DME1265 XEOTICID XEO04285 MOACRIVE Inhibition DME1265 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1265 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04286 XEO_CLAS Peptide DME1265 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8.6 ug/ml) DME1265 XEOTICID XEO04286 GENEFORM Protein DME1265 XEOTICID XEO04286 MOACRIVE Inhibition DME1265 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1265 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04287 XEO_CLAS Peptide DME1265 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10.2 ug/ml) DME1265 XEOTICID XEO04287 GENEFORM Protein DME1265 XEOTICID XEO04287 MOACRIVE Inhibition DME1265 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1265 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04288 XEO_CLAS Peptide DME1265 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4.4 ug/ml) DME1265 XEOTICID XEO04288 GENEFORM Protein DME1265 XEOTICID XEO04288 MOACRIVE Inhibition DME1265 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1265 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04289 XEO_CLAS Peptide DME1265 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.2 ug/ml) DME1265 XEOTICID XEO04289 GENEFORM Protein DME1265 XEOTICID XEO04289 MOACRIVE Inhibition DME1265 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1265 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04290 XEO_CLAS Peptide DME1265 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 11.3 ug/ml) DME1265 XEOTICID XEO04290 GENEFORM Protein DME1265 XEOTICID XEO04290 MOACRIVE Inhibition DME1265 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1265 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04291 XEO_CLAS Peptide DME1265 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 7.2 ug/ml) DME1265 XEOTICID XEO04291 GENEFORM Protein DME1265 XEOTICID XEO04291 MOACRIVE Inhibition DME1265 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1265 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04292 XEO_CLAS Peptide DME1265 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.1 ug/ml) DME1265 XEOTICID XEO04292 GENEFORM Protein DME1265 XEOTICID XEO04292 MOACRIVE Inhibition DME1265 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1265 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04293 XEO_CLAS Peptide DME1265 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO04293 GENEFORM Protein DME1265 XEOTICID XEO04293 MOACRIVE Inhibition DME1265 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1265 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04294 XEO_CLAS Peptide DME1265 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO04294 GENEFORM Protein DME1265 XEOTICID XEO04294 MOACRIVE Inhibition DME1265 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1265 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04295 XEO_CLAS Peptide DME1265 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO04295 GENEFORM Protein DME1265 XEOTICID XEO04295 MOACRIVE Inhibition DME1265 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1265 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04296 XEO_CLAS Peptide DME1265 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 28 microM) DME1265 XEOTICID XEO04296 GENEFORM Protein DME1265 XEOTICID XEO04296 MOACRIVE Inhibition DME1265 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1265 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04297 XEO_CLAS Peptide DME1265 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 14 microM) DME1265 XEOTICID XEO04297 GENEFORM Protein DME1265 XEOTICID XEO04297 MOACRIVE Inhibition DME1265 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1265 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04298 XEO_CLAS Peptide DME1265 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO04298 GENEFORM Protein DME1265 XEOTICID XEO04298 MOACRIVE Inhibition DME1265 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1265 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04299 XEO_CLAS Peptide DME1265 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO04299 GENEFORM Protein DME1265 XEOTICID XEO04299 MOACRIVE Inhibition DME1265 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1265 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04300 XEO_CLAS Peptide DME1265 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO04300 GENEFORM Protein DME1265 XEOTICID XEO04300 MOACRIVE Inhibition DME1265 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1265 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04301 XEO_CLAS Peptide DME1265 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 microM) DME1265 XEOTICID XEO04301 GENEFORM Protein DME1265 XEOTICID XEO04301 MOACRIVE Inhibition DME1265 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1265 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04302 XEO_CLAS Peptide DME1265 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 microM) DME1265 XEOTICID XEO04302 GENEFORM Protein DME1265 XEOTICID XEO04302 MOACRIVE Inhibition DME1265 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1265 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04303 XEO_CLAS Peptide DME1265 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 microM) DME1265 XEOTICID XEO04303 GENEFORM Protein DME1265 XEOTICID XEO04303 MOACRIVE Inhibition DME1265 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1265 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04304 XEO_CLAS Peptide DME1265 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO04304 GENEFORM Protein DME1265 XEOTICID XEO04304 MOACRIVE Inhibition DME1265 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1265 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04305 XEO_CLAS Peptide DME1265 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 70 microM) DME1265 XEOTICID XEO04305 GENEFORM Protein DME1265 XEOTICID XEO04305 MOACRIVE Inhibition DME1265 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1265 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04306 XEO_CLAS Peptide DME1265 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO04306 GENEFORM Protein DME1265 XEOTICID XEO04306 MOACRIVE Inhibition DME1265 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1265 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04307 XEO_CLAS Peptide DME1265 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 ug/ml) DME1265 XEOTICID XEO04307 GENEFORM Protein DME1265 XEOTICID XEO04307 MOACRIVE Inhibition DME1265 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1265 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04308 XEO_CLAS Peptide DME1265 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 9.37 ug/ml) DME1265 XEOTICID XEO04308 GENEFORM Protein DME1265 XEOTICID XEO04308 MOACRIVE Inhibition DME1265 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1265 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04309 XEO_CLAS Peptide DME1265 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 microM) DME1265 XEOTICID XEO04309 GENEFORM Protein DME1265 XEOTICID XEO04309 MOACRIVE Inhibition DME1265 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1265 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04310 XEO_CLAS Peptide DME1265 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO04310 GENEFORM Protein DME1265 XEOTICID XEO04310 MOACRIVE Inhibition DME1265 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1265 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04311 XEO_CLAS Peptide DME1265 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO04311 GENEFORM Protein DME1265 XEOTICID XEO04311 MOACRIVE Inhibition DME1265 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1265 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04312 XEO_CLAS Peptide DME1265 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4.68 ug/ml) DME1265 XEOTICID XEO04312 GENEFORM Protein DME1265 XEOTICID XEO04312 MOACRIVE Inhibition DME1265 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1265 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04313 XEO_CLAS Peptide DME1265 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4.68 ug/ml) DME1265 XEOTICID XEO04313 GENEFORM Protein DME1265 XEOTICID XEO04313 MOACRIVE Inhibition DME1265 XEOTICID XEO04331 XEO_NAME Norspermidine DME1265 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1265 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04331 GENEFORM Protein DME1265 XEOTICID XEO04331 MOACRIVE Inhibition DME1265 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1265 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04335 XEO_CLAS Peptide DME1265 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 32 ug/ml) DME1265 XEOTICID XEO04335 GENEFORM Protein DME1265 XEOTICID XEO04335 MOACRIVE Inhibition DME1265 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1265 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04336 XEO_CLAS Peptide DME1265 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 32 ug/ml) DME1265 XEOTICID XEO04336 GENEFORM Protein DME1265 XEOTICID XEO04336 MOACRIVE Inhibition DME1265 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1265 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04338 XEO_CLAS Peptide DME1265 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 ug/ml) DME1265 XEOTICID XEO04338 GENEFORM Protein DME1265 XEOTICID XEO04338 MOACRIVE Inhibition DME1265 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1265 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04339 XEO_CLAS Peptide DME1265 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 ug/ml) DME1265 XEOTICID XEO04339 GENEFORM Protein DME1265 XEOTICID XEO04339 MOACRIVE Inhibition DME1265 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1265 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04340 XEO_CLAS Peptide DME1265 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO04340 GENEFORM Protein DME1265 XEOTICID XEO04340 MOACRIVE Inhibition DME1265 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1265 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04344 XEO_CLAS Peptide DME1265 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04344 GENEFORM Protein DME1265 XEOTICID XEO04344 MOACRIVE Inhibition DME1265 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1265 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04345 XEO_CLAS Peptide DME1265 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04345 GENEFORM Protein DME1265 XEOTICID XEO04345 MOACRIVE Inhibition DME1265 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1265 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04346 XEO_CLAS Peptide DME1265 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04346 GENEFORM Protein DME1265 XEOTICID XEO04346 MOACRIVE Inhibition DME1265 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1265 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04347 XEO_CLAS Peptide DME1265 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 microM) DME1265 XEOTICID XEO04347 GENEFORM Protein DME1265 XEOTICID XEO04347 MOACRIVE Inhibition DME1265 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1265 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04348 XEO_CLAS Peptide DME1265 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40 microM) DME1265 XEOTICID XEO04348 GENEFORM Protein DME1265 XEOTICID XEO04348 MOACRIVE Inhibition DME1265 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1265 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04349 XEO_CLAS Peptide DME1265 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO04349 GENEFORM Protein DME1265 XEOTICID XEO04349 MOACRIVE Inhibition DME1265 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1265 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04354 XEO_CLAS Peptide DME1265 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 35.2 ug/ml) DME1265 XEOTICID XEO04354 GENEFORM Protein DME1265 XEOTICID XEO04354 MOACRIVE Inhibition DME1265 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1265 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04355 XEO_CLAS Peptide DME1265 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.21 ug/ml) DME1265 XEOTICID XEO04355 GENEFORM Protein DME1265 XEOTICID XEO04355 MOACRIVE Inhibition DME1265 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1265 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04356 XEO_CLAS Peptide DME1265 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8.21 ug/ml) DME1265 XEOTICID XEO04356 GENEFORM Protein DME1265 XEOTICID XEO04356 MOACRIVE Inhibition DME1265 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1265 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04357 XEO_CLAS Peptide DME1265 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16.32 ug/ml) DME1265 XEOTICID XEO04357 GENEFORM Protein DME1265 XEOTICID XEO04357 MOACRIVE Inhibition DME1265 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1265 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04358 XEO_CLAS Peptide DME1265 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 9.37 ug/ml) DME1265 XEOTICID XEO04358 GENEFORM Protein DME1265 XEOTICID XEO04358 MOACRIVE Inhibition DME1265 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1265 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04359 XEO_CLAS Peptide DME1265 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4.20 ug/ml) DME1265 XEOTICID XEO04359 GENEFORM Protein DME1265 XEOTICID XEO04359 MOACRIVE Inhibition DME1265 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1265 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04360 XEO_CLAS Peptide DME1265 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 ug/ml) DME1265 XEOTICID XEO04360 GENEFORM Protein DME1265 XEOTICID XEO04360 MOACRIVE Inhibition DME1265 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1265 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04361 XEO_CLAS Peptide DME1265 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 7.5 ug/ml) DME1265 XEOTICID XEO04361 GENEFORM Protein DME1265 XEOTICID XEO04361 MOACRIVE Inhibition DME1265 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1265 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04362 XEO_CLAS Peptide DME1265 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.6 ug/ml) DME1265 XEOTICID XEO04362 GENEFORM Protein DME1265 XEOTICID XEO04362 MOACRIVE Inhibition DME1265 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1265 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04363 XEO_CLAS Peptide DME1265 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8.2 ug/ml) DME1265 XEOTICID XEO04363 GENEFORM Protein DME1265 XEOTICID XEO04363 MOACRIVE Inhibition DME1265 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1265 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04364 XEO_CLAS Peptide DME1265 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO04364 GENEFORM Protein DME1265 XEOTICID XEO04364 MOACRIVE Inhibition DME1265 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1265 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04365 XEO_CLAS Peptide DME1265 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4.68 ug/ml) DME1265 XEOTICID XEO04365 GENEFORM Protein DME1265 XEOTICID XEO04365 MOACRIVE Inhibition DME1265 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1265 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04366 XEO_CLAS Peptide DME1265 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 23.60 ug/ml) DME1265 XEOTICID XEO04366 GENEFORM Protein DME1265 XEOTICID XEO04366 MOACRIVE Inhibition DME1265 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1265 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04367 XEO_CLAS Peptide DME1265 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 35.60 ug/ml) DME1265 XEOTICID XEO04367 GENEFORM Protein DME1265 XEOTICID XEO04367 MOACRIVE Inhibition DME1265 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1265 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04368 XEO_CLAS Peptide DME1265 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40.2 ug/ml) DME1265 XEOTICID XEO04368 GENEFORM Protein DME1265 XEOTICID XEO04368 MOACRIVE Inhibition DME1265 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1265 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04369 XEO_CLAS Peptide DME1265 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40.2 ug/ml) DME1265 XEOTICID XEO04369 GENEFORM Protein DME1265 XEOTICID XEO04369 MOACRIVE Inhibition DME1265 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1265 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04370 XEO_CLAS Peptide DME1265 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4.68 ug/ml) DME1265 XEOTICID XEO04370 GENEFORM Protein DME1265 XEOTICID XEO04370 MOACRIVE Inhibition DME1265 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1265 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04371 XEO_CLAS Peptide DME1265 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 9.37 ug/ml) DME1265 XEOTICID XEO04371 GENEFORM Protein DME1265 XEOTICID XEO04371 MOACRIVE Inhibition DME1265 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1265 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04373 XEO_CLAS Peptide DME1265 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 ug/ml) DME1265 XEOTICID XEO04373 GENEFORM Protein DME1265 XEOTICID XEO04373 MOACRIVE Inhibition DME1265 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1265 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04374 XEO_CLAS Peptide DME1265 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.50 ug/ml) DME1265 XEOTICID XEO04374 GENEFORM Protein DME1265 XEOTICID XEO04374 MOACRIVE Inhibition DME1265 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1265 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04375 XEO_CLAS Peptide DME1265 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25 ug/ml) DME1265 XEOTICID XEO04375 GENEFORM Protein DME1265 XEOTICID XEO04375 MOACRIVE Inhibition DME1265 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1265 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04377 XEO_CLAS Peptide DME1265 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 42.50 ug/ml) DME1265 XEOTICID XEO04377 GENEFORM Protein DME1265 XEOTICID XEO04377 MOACRIVE Inhibition DME1265 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1265 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04378 XEO_CLAS Peptide DME1265 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 17.50 ug/ml) DME1265 XEOTICID XEO04378 GENEFORM Protein DME1265 XEOTICID XEO04378 MOACRIVE Inhibition DME1265 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1265 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04379 XEO_CLAS Peptide DME1265 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 ug/ml) DME1265 XEOTICID XEO04379 GENEFORM Protein DME1265 XEOTICID XEO04379 MOACRIVE Inhibition DME1265 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1265 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04380 XEO_CLAS Peptide DME1265 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 36.00 ug/ml) DME1265 XEOTICID XEO04380 GENEFORM Protein DME1265 XEOTICID XEO04380 MOACRIVE Inhibition DME1265 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1265 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04381 XEO_CLAS Peptide DME1265 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.60 ug/ml) DME1265 XEOTICID XEO04381 GENEFORM Protein DME1265 XEOTICID XEO04381 MOACRIVE Inhibition DME1265 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1265 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04382 XEO_CLAS Peptide DME1265 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 ug/ml) DME1265 XEOTICID XEO04382 GENEFORM Protein DME1265 XEOTICID XEO04382 MOACRIVE Inhibition DME1265 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1265 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04383 XEO_CLAS Peptide DME1265 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO04383 GENEFORM Protein DME1265 XEOTICID XEO04383 MOACRIVE Inhibition DME1265 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1265 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04384 XEO_CLAS Peptide DME1265 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO04384 GENEFORM Protein DME1265 XEOTICID XEO04384 MOACRIVE Inhibition DME1265 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1265 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04385 XEO_CLAS Peptide DME1265 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.25 ug/ml) DME1265 XEOTICID XEO04385 GENEFORM Protein DME1265 XEOTICID XEO04385 MOACRIVE Inhibition DME1265 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1265 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04395 XEO_CLAS Peptide DME1265 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.4-0.8 microM) DME1265 XEOTICID XEO04395 GENEFORM Protein DME1265 XEOTICID XEO04395 MOACRIVE Inhibition DME1265 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1265 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04396 XEO_CLAS Peptide DME1265 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.25-0.5 microM) DME1265 XEOTICID XEO04396 GENEFORM Protein DME1265 XEOTICID XEO04396 MOACRIVE Inhibition DME1265 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1265 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04397 XEO_CLAS Peptide DME1265 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.25-0.5 microM) DME1265 XEOTICID XEO04397 GENEFORM Protein DME1265 XEOTICID XEO04397 MOACRIVE Inhibition DME1265 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1265 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04398 XEO_CLAS Peptide DME1265 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 microM) DME1265 XEOTICID XEO04398 GENEFORM Protein DME1265 XEOTICID XEO04398 MOACRIVE Inhibition DME1265 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1265 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04399 XEO_CLAS Peptide DME1265 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO04399 GENEFORM Protein DME1265 XEOTICID XEO04399 MOACRIVE Inhibition DME1265 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1265 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04400 XEO_CLAS Peptide DME1265 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 ug/ml) DME1265 XEOTICID XEO04400 GENEFORM Protein DME1265 XEOTICID XEO04400 MOACRIVE Inhibition DME1265 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1265 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04401 XEO_CLAS Peptide DME1265 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.6 ug/ml) DME1265 XEOTICID XEO04401 GENEFORM Protein DME1265 XEOTICID XEO04401 MOACRIVE Inhibition DME1265 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1265 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04402 XEO_CLAS Peptide DME1265 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 ug/ml) DME1265 XEOTICID XEO04402 GENEFORM Protein DME1265 XEOTICID XEO04402 MOACRIVE Inhibition DME1265 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1265 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04403 XEO_CLAS Peptide DME1265 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.6 ug/ml) DME1265 XEOTICID XEO04403 GENEFORM Protein DME1265 XEOTICID XEO04403 MOACRIVE Inhibition DME1265 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1265 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04404 XEO_CLAS Peptide DME1265 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.6 ug/ml) DME1265 XEOTICID XEO04404 GENEFORM Protein DME1265 XEOTICID XEO04404 MOACRIVE Inhibition DME1265 XEOTICID XEO04410 XEO_NAME Insect osmin DME1265 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04410 XEO_CLAS Peptide DME1265 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.125-1.56 microM) DME1265 XEOTICID XEO04410 GENEFORM Protein DME1265 XEOTICID XEO04410 MOACRIVE Inhibition DME1265 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1265 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04412 XEO_CLAS Peptide DME1265 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04412 GENEFORM Protein DME1265 XEOTICID XEO04412 MOACRIVE Inhibition DME1265 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1265 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04414 XEO_CLAS Peptide DME1265 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04414 GENEFORM Protein DME1265 XEOTICID XEO04414 MOACRIVE Inhibition DME1265 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1265 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04415 XEO_CLAS Peptide DME1265 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04415 GENEFORM Protein DME1265 XEOTICID XEO04415 MOACRIVE Inhibition DME1265 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1265 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04421 XEO_CLAS Peptide DME1265 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 microM) DME1265 XEOTICID XEO04421 GENEFORM Protein DME1265 XEOTICID XEO04421 MOACRIVE Inhibition DME1265 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1265 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04426 XEO_CLAS Peptide DME1265 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO04426 GENEFORM Protein DME1265 XEOTICID XEO04426 MOACRIVE Inhibition DME1265 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1265 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04428 XEO_CLAS Peptide DME1265 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.3 ug/ml) DME1265 XEOTICID XEO04428 GENEFORM Protein DME1265 XEOTICID XEO04428 MOACRIVE Inhibition DME1265 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1265 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04430 XEO_CLAS Peptide DME1265 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25 microM) DME1265 XEOTICID XEO04430 GENEFORM Protein DME1265 XEOTICID XEO04430 MOACRIVE Inhibition DME1265 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1265 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04433 XEO_CLAS Peptide DME1265 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 160 microM) DME1265 XEOTICID XEO04433 GENEFORM Protein DME1265 XEOTICID XEO04433 MOACRIVE Inhibition DME1265 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1265 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04435 XEO_CLAS Peptide DME1265 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 160 microM) DME1265 XEOTICID XEO04435 GENEFORM Protein DME1265 XEOTICID XEO04435 MOACRIVE Inhibition DME1265 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1265 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1265 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04438 GENEFORM Protein DME1265 XEOTICID XEO04438 MOACRIVE Inhibition DME1265 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1265 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04439 XEO_CLAS Peptide DME1265 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04439 GENEFORM Protein DME1265 XEOTICID XEO04439 MOACRIVE Inhibition DME1265 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1265 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04440 XEO_CLAS Peptide DME1265 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 microM) DME1265 XEOTICID XEO04440 GENEFORM Protein DME1265 XEOTICID XEO04440 MOACRIVE Inhibition DME1265 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1265 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04441 XEO_CLAS Peptide DME1265 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 28 microM) DME1265 XEOTICID XEO04441 GENEFORM Protein DME1265 XEOTICID XEO04441 MOACRIVE Inhibition DME1265 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1265 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04442 XEO_CLAS Peptide DME1265 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 28 microM) DME1265 XEOTICID XEO04442 GENEFORM Protein DME1265 XEOTICID XEO04442 MOACRIVE Inhibition DME1265 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1265 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04443 XEO_CLAS Peptide DME1265 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04443 GENEFORM Protein DME1265 XEOTICID XEO04443 MOACRIVE Inhibition DME1265 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1265 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04444 XEO_CLAS Peptide DME1265 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 13 microM) DME1265 XEOTICID XEO04444 GENEFORM Protein DME1265 XEOTICID XEO04444 MOACRIVE Inhibition DME1265 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1265 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04445 XEO_CLAS Peptide DME1265 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04445 GENEFORM Protein DME1265 XEOTICID XEO04445 MOACRIVE Inhibition DME1265 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1265 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04446 XEO_CLAS Peptide DME1265 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 78 microM) DME1265 XEOTICID XEO04446 GENEFORM Protein DME1265 XEOTICID XEO04446 MOACRIVE Inhibition DME1265 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1265 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04447 XEO_CLAS Peptide DME1265 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 120 microM) DME1265 XEOTICID XEO04447 GENEFORM Protein DME1265 XEOTICID XEO04447 MOACRIVE Inhibition DME1265 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1265 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04448 XEO_CLAS Peptide DME1265 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 microM) DME1265 XEOTICID XEO04448 GENEFORM Protein DME1265 XEOTICID XEO04448 MOACRIVE Inhibition DME1265 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1265 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04449 XEO_CLAS Peptide DME1265 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.3 microM) DME1265 XEOTICID XEO04449 GENEFORM Protein DME1265 XEOTICID XEO04449 MOACRIVE Inhibition DME1265 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1265 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04450 XEO_CLAS Peptide DME1265 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.3 microM) DME1265 XEOTICID XEO04450 GENEFORM Protein DME1265 XEOTICID XEO04450 MOACRIVE Inhibition DME1265 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1265 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04451 XEO_CLAS Peptide DME1265 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO04451 GENEFORM Protein DME1265 XEOTICID XEO04451 MOACRIVE Inhibition DME1265 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1265 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04452 XEO_CLAS Peptide DME1265 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.1 microM) DME1265 XEOTICID XEO04452 GENEFORM Protein DME1265 XEOTICID XEO04452 MOACRIVE Inhibition DME1265 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1265 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04453 XEO_CLAS Peptide DME1265 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO04453 GENEFORM Protein DME1265 XEOTICID XEO04453 MOACRIVE Inhibition DME1265 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1265 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04455 XEO_CLAS Peptide DME1265 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 microM) DME1265 XEOTICID XEO04455 GENEFORM Protein DME1265 XEOTICID XEO04455 MOACRIVE Inhibition DME1265 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1265 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04457 XEO_CLAS Peptide DME1265 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.3 microM) DME1265 XEOTICID XEO04457 GENEFORM Protein DME1265 XEOTICID XEO04457 MOACRIVE Inhibition DME1265 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1265 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04458 XEO_CLAS Peptide DME1265 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1 microM) DME1265 XEOTICID XEO04458 GENEFORM Protein DME1265 XEOTICID XEO04458 MOACRIVE Inhibition DME1265 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1265 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04459 XEO_CLAS Peptide DME1265 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1 microM) DME1265 XEOTICID XEO04459 GENEFORM Protein DME1265 XEOTICID XEO04459 MOACRIVE Inhibition DME1265 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1265 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04461 XEO_CLAS Peptide DME1265 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20.8 microM) DME1265 XEOTICID XEO04461 GENEFORM Protein DME1265 XEOTICID XEO04461 MOACRIVE Inhibition DME1265 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1265 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04462 XEO_CLAS Peptide DME1265 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 19.1 microM) DME1265 XEOTICID XEO04462 GENEFORM Protein DME1265 XEOTICID XEO04462 MOACRIVE Inhibition DME1265 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1265 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04463 XEO_CLAS Peptide DME1265 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04463 GENEFORM Protein DME1265 XEOTICID XEO04463 MOACRIVE Inhibition DME1265 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1265 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04464 XEO_CLAS Peptide DME1265 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.5 microM) DME1265 XEOTICID XEO04464 GENEFORM Protein DME1265 XEOTICID XEO04464 MOACRIVE Inhibition DME1265 XEOTICID XEO04466 XEO_NAME Panusin DME1265 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04466 XEO_CLAS Peptide DME1265 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04466 GENEFORM Protein DME1265 XEOTICID XEO04466 MOACRIVE Inhibition DME1265 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1265 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04467 XEO_CLAS Peptide DME1265 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4.8 microM) DME1265 XEOTICID XEO04467 GENEFORM Protein DME1265 XEOTICID XEO04467 MOACRIVE Inhibition DME1265 XEOTICID XEO04468 XEO_NAME Papillosin DME1265 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04468 XEO_CLAS Peptide DME1265 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04468 GENEFORM Protein DME1265 XEOTICID XEO04468 MOACRIVE Inhibition DME1265 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1265 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04471 XEO_CLAS Peptide DME1265 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.1 microM) DME1265 XEOTICID XEO04471 GENEFORM Protein DME1265 XEOTICID XEO04471 MOACRIVE Inhibition DME1265 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1265 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04480 XEO_CLAS Peptide DME1265 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 ug/ml) DME1265 XEOTICID XEO04480 GENEFORM Protein DME1265 XEOTICID XEO04480 MOACRIVE Inhibition DME1265 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1265 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1265 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04482 GENEFORM Protein DME1265 XEOTICID XEO04482 MOACRIVE Inhibition DME1265 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1265 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04484 XEO_CLAS Peptide DME1265 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 microM) DME1265 XEOTICID XEO04484 GENEFORM Protein DME1265 XEOTICID XEO04484 MOACRIVE Inhibition DME1265 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1265 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04485 XEO_CLAS Peptide DME1265 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO04485 GENEFORM Protein DME1265 XEOTICID XEO04485 MOACRIVE Inhibition DME1265 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1265 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04486 XEO_CLAS Peptide DME1265 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 microM) DME1265 XEOTICID XEO04486 GENEFORM Protein DME1265 XEOTICID XEO04486 MOACRIVE Inhibition DME1265 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1265 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04487 XEO_CLAS Peptide DME1265 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO04487 GENEFORM Protein DME1265 XEOTICID XEO04487 MOACRIVE Inhibition DME1265 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1265 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04488 XEO_CLAS Peptide DME1265 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 9 microM) DME1265 XEOTICID XEO04488 GENEFORM Protein DME1265 XEOTICID XEO04488 MOACRIVE Inhibition DME1265 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1265 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04489 XEO_CLAS Peptide DME1265 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 13 microM) DME1265 XEOTICID XEO04489 GENEFORM Protein DME1265 XEOTICID XEO04489 MOACRIVE Inhibition DME1265 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1265 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04490 XEO_CLAS Peptide DME1265 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 47.5 microM) DME1265 XEOTICID XEO04490 GENEFORM Protein DME1265 XEOTICID XEO04490 MOACRIVE Inhibition DME1265 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1265 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04491 XEO_CLAS Peptide DME1265 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO04491 GENEFORM Protein DME1265 XEOTICID XEO04491 MOACRIVE Inhibition DME1265 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1265 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04492 XEO_CLAS Peptide DME1265 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 35 microM) DME1265 XEOTICID XEO04492 GENEFORM Protein DME1265 XEOTICID XEO04492 MOACRIVE Inhibition DME1265 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1265 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04493 XEO_CLAS Peptide DME1265 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 microM) DME1265 XEOTICID XEO04493 GENEFORM Protein DME1265 XEOTICID XEO04493 MOACRIVE Inhibition DME1265 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1265 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04494 XEO_CLAS Peptide DME1265 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO04494 GENEFORM Protein DME1265 XEOTICID XEO04494 MOACRIVE Inhibition DME1265 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1265 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04495 XEO_CLAS Peptide DME1265 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO04495 GENEFORM Protein DME1265 XEOTICID XEO04495 MOACRIVE Inhibition DME1265 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1265 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04496 XEO_CLAS Peptide DME1265 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 67.5 microM) DME1265 XEOTICID XEO04496 GENEFORM Protein DME1265 XEOTICID XEO04496 MOACRIVE Inhibition DME1265 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1265 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04497 XEO_CLAS Peptide DME1265 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO04497 GENEFORM Protein DME1265 XEOTICID XEO04497 MOACRIVE Inhibition DME1265 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1265 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04498 XEO_CLAS Peptide DME1265 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO04498 GENEFORM Protein DME1265 XEOTICID XEO04498 MOACRIVE Inhibition DME1265 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1265 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04499 XEO_CLAS Peptide DME1265 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 43 microM) DME1265 XEOTICID XEO04499 GENEFORM Protein DME1265 XEOTICID XEO04499 MOACRIVE Inhibition DME1265 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1265 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04500 XEO_CLAS Peptide DME1265 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO04500 GENEFORM Protein DME1265 XEOTICID XEO04500 MOACRIVE Inhibition DME1265 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1265 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04504 XEO_CLAS Peptide DME1265 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04504 GENEFORM Protein DME1265 XEOTICID XEO04504 MOACRIVE Inhibition DME1265 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1265 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04505 XEO_CLAS Peptide DME1265 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04505 GENEFORM Protein DME1265 XEOTICID XEO04505 MOACRIVE Inhibition DME1265 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1265 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04506 XEO_CLAS Peptide DME1265 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 40 microM) DME1265 XEOTICID XEO04506 GENEFORM Protein DME1265 XEOTICID XEO04506 MOACRIVE Inhibition DME1265 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1265 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04507 XEO_CLAS Peptide DME1265 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10-20 microM) DME1265 XEOTICID XEO04507 GENEFORM Protein DME1265 XEOTICID XEO04507 MOACRIVE Inhibition DME1265 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1265 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04508 XEO_CLAS Peptide DME1265 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04508 GENEFORM Protein DME1265 XEOTICID XEO04508 MOACRIVE Inhibition DME1265 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1265 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04509 XEO_CLAS Peptide DME1265 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04509 GENEFORM Protein DME1265 XEOTICID XEO04509 MOACRIVE Inhibition DME1265 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1265 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04510 XEO_CLAS Peptide DME1265 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 22-33 microM) DME1265 XEOTICID XEO04510 GENEFORM Protein DME1265 XEOTICID XEO04510 MOACRIVE Inhibition DME1265 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1265 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04525 XEO_CLAS Peptide DME1265 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 32.0 microM) DME1265 XEOTICID XEO04525 GENEFORM Protein DME1265 XEOTICID XEO04525 MOACRIVE Inhibition DME1265 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1265 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04526 XEO_CLAS Peptide DME1265 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.0 microM) DME1265 XEOTICID XEO04526 GENEFORM Protein DME1265 XEOTICID XEO04526 MOACRIVE Inhibition DME1265 XEOTICID XEO04527 XEO_NAME Pepcon DME1265 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04527 XEO_CLAS Peptide DME1265 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO04527 GENEFORM Protein DME1265 XEOTICID XEO04527 MOACRIVE Inhibition DME1265 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1265 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04532 XEO_CLAS Peptide DME1265 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04532 GENEFORM Protein DME1265 XEOTICID XEO04532 MOACRIVE Inhibition DME1265 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1265 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04540 XEO_CLAS Peptide DME1265 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 18.1 ug/ml) DME1265 XEOTICID XEO04540 GENEFORM Protein DME1265 XEOTICID XEO04540 MOACRIVE Inhibition DME1265 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1265 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04541 XEO_CLAS Peptide DME1265 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.5 ug/ml) DME1265 XEOTICID XEO04541 GENEFORM Protein DME1265 XEOTICID XEO04541 MOACRIVE Inhibition DME1265 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1265 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04542 XEO_CLAS Peptide DME1265 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04542 GENEFORM Protein DME1265 XEOTICID XEO04542 MOACRIVE Inhibition DME1265 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1265 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04543 XEO_CLAS Peptide DME1265 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04543 GENEFORM Protein DME1265 XEOTICID XEO04543 MOACRIVE Inhibition DME1265 XEOTICID XEO04546 XEO_NAME Perinerin DME1265 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04546 XEO_CLAS Peptide DME1265 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04546 GENEFORM Protein DME1265 XEOTICID XEO04546 MOACRIVE Inhibition DME1265 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1265 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04548 XEO_CLAS Peptide DME1265 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 72000 ug/ml) DME1265 XEOTICID XEO04548 GENEFORM Protein DME1265 XEOTICID XEO04548 MOACRIVE Inhibition DME1265 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1265 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04549 XEO_CLAS Peptide DME1265 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 62-125 ug/ml) DME1265 XEOTICID XEO04549 GENEFORM Protein DME1265 XEOTICID XEO04549 MOACRIVE Inhibition DME1265 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1265 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04550 XEO_CLAS Peptide DME1265 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO04550 GENEFORM Protein DME1265 XEOTICID XEO04550 MOACRIVE Inhibition DME1265 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1265 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04551 XEO_CLAS Peptide DME1265 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 23.6 ug/ml) DME1265 XEOTICID XEO04551 GENEFORM Protein DME1265 XEOTICID XEO04551 MOACRIVE Inhibition DME1265 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1265 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04552 XEO_CLAS Peptide DME1265 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04552 GENEFORM Protein DME1265 XEOTICID XEO04552 MOACRIVE Inhibition DME1265 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1265 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04553 XEO_CLAS Peptide DME1265 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04553 GENEFORM Protein DME1265 XEOTICID XEO04553 MOACRIVE Inhibition DME1265 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1265 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04554 XEO_CLAS Peptide DME1265 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04554 GENEFORM Protein DME1265 XEOTICID XEO04554 MOACRIVE Inhibition DME1265 XEOTICID XEO04563 XEO_NAME Phosphate DME1265 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1265 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04563 GENEFORM Protein DME1265 XEOTICID XEO04563 MOACRIVE Inhibition DME1265 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1265 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04565 XEO_CLAS Peptide DME1265 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.5 microM) DME1265 XEOTICID XEO04565 GENEFORM Protein DME1265 XEOTICID XEO04565 MOACRIVE Inhibition DME1265 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1265 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04566 XEO_CLAS Peptide DME1265 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.7 microM) DME1265 XEOTICID XEO04566 GENEFORM Protein DME1265 XEOTICID XEO04566 MOACRIVE Inhibition DME1265 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1265 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04569 XEO_CLAS Peptide DME1265 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 7.9 microM) DME1265 XEOTICID XEO04569 GENEFORM Protein DME1265 XEOTICID XEO04569 MOACRIVE Inhibition DME1265 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1265 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04570 XEO_CLAS Peptide DME1265 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04570 GENEFORM Protein DME1265 XEOTICID XEO04570 MOACRIVE Inhibition DME1265 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1265 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04571 XEO_CLAS Peptide DME1265 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04571 GENEFORM Protein DME1265 XEOTICID XEO04571 MOACRIVE Inhibition DME1265 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1265 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04572 XEO_CLAS Peptide DME1265 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04572 GENEFORM Protein DME1265 XEOTICID XEO04572 MOACRIVE Inhibition DME1265 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1265 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04573 XEO_CLAS Peptide DME1265 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 microM) DME1265 XEOTICID XEO04573 GENEFORM Protein DME1265 XEOTICID XEO04573 MOACRIVE Inhibition DME1265 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1265 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04574 XEO_CLAS Peptide DME1265 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 128 ug/ml) DME1265 XEOTICID XEO04574 GENEFORM Protein DME1265 XEOTICID XEO04574 MOACRIVE Inhibition DME1265 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1265 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04575 XEO_CLAS Peptide DME1265 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO04575 GENEFORM Protein DME1265 XEOTICID XEO04575 MOACRIVE Inhibition DME1265 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1265 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04578 GENEFORM Protein DME1265 XEOTICID XEO04578 MOACRIVE Inhibition DME1265 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1265 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04579 GENEFORM Protein DME1265 XEOTICID XEO04579 MOACRIVE Inhibition DME1265 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1265 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04580 GENEFORM Protein DME1265 XEOTICID XEO04580 MOACRIVE Inhibition DME1265 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1265 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04583 GENEFORM Protein DME1265 XEOTICID XEO04583 MOACRIVE Inhibition DME1265 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1265 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04588 GENEFORM Protein DME1265 XEOTICID XEO04588 MOACRIVE Inhibition DME1265 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1265 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04589 GENEFORM Protein DME1265 XEOTICID XEO04589 MOACRIVE Inhibition DME1265 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1265 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04590 GENEFORM Protein DME1265 XEOTICID XEO04590 MOACRIVE Inhibition DME1265 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1265 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04591 GENEFORM Protein DME1265 XEOTICID XEO04591 MOACRIVE Inhibition DME1265 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1265 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04592 GENEFORM Protein DME1265 XEOTICID XEO04592 MOACRIVE Inhibition DME1265 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1265 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04593 GENEFORM Protein DME1265 XEOTICID XEO04593 MOACRIVE Inhibition DME1265 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1265 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04594 GENEFORM Protein DME1265 XEOTICID XEO04594 MOACRIVE Inhibition DME1265 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1265 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04595 GENEFORM Protein DME1265 XEOTICID XEO04595 MOACRIVE Inhibition DME1265 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1265 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04596 GENEFORM Protein DME1265 XEOTICID XEO04596 MOACRIVE Inhibition DME1265 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1265 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04597 GENEFORM Protein DME1265 XEOTICID XEO04597 MOACRIVE Inhibition DME1265 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1265 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04598 GENEFORM Protein DME1265 XEOTICID XEO04598 MOACRIVE Inhibition DME1265 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1265 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04599 GENEFORM Protein DME1265 XEOTICID XEO04599 MOACRIVE Inhibition DME1265 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1265 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04601 XEO_CLAS Peptide DME1265 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 18.75 ug/ml) DME1265 XEOTICID XEO04601 GENEFORM Protein DME1265 XEOTICID XEO04601 MOACRIVE Inhibition DME1265 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1265 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04602 XEO_CLAS Peptide DME1265 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 37.5 ug/ml) DME1265 XEOTICID XEO04602 GENEFORM Protein DME1265 XEOTICID XEO04602 MOACRIVE Inhibition DME1265 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1265 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04604 XEO_CLAS Peptide DME1265 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC < 25 microM) DME1265 XEOTICID XEO04604 GENEFORM Protein DME1265 XEOTICID XEO04604 MOACRIVE Inhibition DME1265 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1265 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04605 XEO_CLAS Peptide DME1265 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC < 6.25 microM) DME1265 XEOTICID XEO04605 GENEFORM Protein DME1265 XEOTICID XEO04605 MOACRIVE Inhibition DME1265 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1265 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04606 XEO_CLAS Peptide DME1265 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO04606 GENEFORM Protein DME1265 XEOTICID XEO04606 MOACRIVE Inhibition DME1265 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1265 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1265 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04607 GENEFORM Protein DME1265 XEOTICID XEO04607 MOACRIVE Inhibition DME1265 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1265 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04612 XEO_CLAS Peptide DME1265 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5-10 microM) DME1265 XEOTICID XEO04612 GENEFORM Protein DME1265 XEOTICID XEO04612 MOACRIVE Inhibition DME1265 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1265 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04613 XEO_CLAS Peptide DME1265 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5-10 microM) DME1265 XEOTICID XEO04613 GENEFORM Protein DME1265 XEOTICID XEO04613 MOACRIVE Inhibition DME1265 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1265 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04625 XEO_CLAS Peptide DME1265 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO04625 GENEFORM Protein DME1265 XEOTICID XEO04625 MOACRIVE Inhibition DME1265 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1265 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04626 XEO_CLAS Peptide DME1265 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO04626 GENEFORM Protein DME1265 XEOTICID XEO04626 MOACRIVE Inhibition DME1265 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1265 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04627 XEO_CLAS Peptide DME1265 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.5 microM) DME1265 XEOTICID XEO04627 GENEFORM Protein DME1265 XEOTICID XEO04627 MOACRIVE Inhibition DME1265 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1265 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04630 XEO_CLAS Peptide DME1265 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 60 ug/ml) DME1265 XEOTICID XEO04630 GENEFORM Protein DME1265 XEOTICID XEO04630 MOACRIVE Inhibition DME1265 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1265 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04631 XEO_CLAS Peptide DME1265 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 60 ug/ml) DME1265 XEOTICID XEO04631 GENEFORM Protein DME1265 XEOTICID XEO04631 MOACRIVE Inhibition DME1265 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1265 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04633 XEO_CLAS Peptide DME1265 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 ug/ml) DME1265 XEOTICID XEO04633 GENEFORM Protein DME1265 XEOTICID XEO04633 MOACRIVE Inhibition DME1265 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1265 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04634 XEO_CLAS Peptide DME1265 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 ug/ml) DME1265 XEOTICID XEO04634 GENEFORM Protein DME1265 XEOTICID XEO04634 MOACRIVE Inhibition DME1265 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1265 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04635 XEO_CLAS Peptide DME1265 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 ug/ml) DME1265 XEOTICID XEO04635 GENEFORM Protein DME1265 XEOTICID XEO04635 MOACRIVE Inhibition DME1265 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1265 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04636 XEO_CLAS Peptide DME1265 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 ug/ml) DME1265 XEOTICID XEO04636 GENEFORM Protein DME1265 XEOTICID XEO04636 MOACRIVE Inhibition DME1265 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1265 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04637 XEO_CLAS Peptide DME1265 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 ug/ml) DME1265 XEOTICID XEO04637 GENEFORM Protein DME1265 XEOTICID XEO04637 MOACRIVE Inhibition DME1265 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1265 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04638 XEO_CLAS Peptide DME1265 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 ug/ml) DME1265 XEOTICID XEO04638 GENEFORM Protein DME1265 XEOTICID XEO04638 MOACRIVE Inhibition DME1265 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1265 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04639 XEO_CLAS Peptide DME1265 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 ug/ml) DME1265 XEOTICID XEO04639 GENEFORM Protein DME1265 XEOTICID XEO04639 MOACRIVE Inhibition DME1265 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1265 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04640 XEO_CLAS Peptide DME1265 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.2-3.3 microM) DME1265 XEOTICID XEO04640 GENEFORM Protein DME1265 XEOTICID XEO04640 MOACRIVE Inhibition DME1265 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1265 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04642 XEO_CLAS Peptide DME1265 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 ug/ml) DME1265 XEOTICID XEO04642 GENEFORM Protein DME1265 XEOTICID XEO04642 MOACRIVE Inhibition DME1265 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1265 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04643 XEO_CLAS Peptide DME1265 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO04643 GENEFORM Protein DME1265 XEOTICID XEO04643 MOACRIVE Inhibition DME1265 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1265 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04644 XEO_CLAS Peptide DME1265 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO04644 GENEFORM Protein DME1265 XEOTICID XEO04644 MOACRIVE Inhibition DME1265 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1265 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04645 XEO_CLAS Peptide DME1265 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 ug/ml) DME1265 XEOTICID XEO04645 GENEFORM Protein DME1265 XEOTICID XEO04645 MOACRIVE Inhibition DME1265 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1265 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04646 XEO_CLAS Peptide DME1265 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1 ug/ml) DME1265 XEOTICID XEO04646 GENEFORM Protein DME1265 XEOTICID XEO04646 MOACRIVE Inhibition DME1265 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1265 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04647 XEO_CLAS Peptide DME1265 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO04647 GENEFORM Protein DME1265 XEOTICID XEO04647 MOACRIVE Inhibition DME1265 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1265 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04648 XEO_CLAS Peptide DME1265 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 ug/ml) DME1265 XEOTICID XEO04648 GENEFORM Protein DME1265 XEOTICID XEO04648 MOACRIVE Inhibition DME1265 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1265 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04649 XEO_CLAS Peptide DME1265 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 64 ug/ml) DME1265 XEOTICID XEO04649 GENEFORM Protein DME1265 XEOTICID XEO04649 MOACRIVE Inhibition DME1265 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1265 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04650 XEO_CLAS Peptide DME1265 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 ug/ml) DME1265 XEOTICID XEO04650 GENEFORM Protein DME1265 XEOTICID XEO04650 MOACRIVE Inhibition DME1265 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1265 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04651 XEO_CLAS Peptide DME1265 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 ug/ml) DME1265 XEOTICID XEO04651 GENEFORM Protein DME1265 XEOTICID XEO04651 MOACRIVE Inhibition DME1265 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1265 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04652 XEO_CLAS Peptide DME1265 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO04652 GENEFORM Protein DME1265 XEOTICID XEO04652 MOACRIVE Inhibition DME1265 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1265 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04653 XEO_CLAS Peptide DME1265 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 64 ug/ml) DME1265 XEOTICID XEO04653 GENEFORM Protein DME1265 XEOTICID XEO04653 MOACRIVE Inhibition DME1265 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1265 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04654 XEO_CLAS Peptide DME1265 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 ug/ml) DME1265 XEOTICID XEO04654 GENEFORM Protein DME1265 XEOTICID XEO04654 MOACRIVE Inhibition DME1265 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1265 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04655 XEO_CLAS Peptide DME1265 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO04655 GENEFORM Protein DME1265 XEOTICID XEO04655 MOACRIVE Inhibition DME1265 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1265 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04657 XEO_CLAS Peptide DME1265 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 300 microM) DME1265 XEOTICID XEO04657 GENEFORM Protein DME1265 XEOTICID XEO04657 MOACRIVE Inhibition DME1265 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1265 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04660 XEO_CLAS Peptide DME1265 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO04660 GENEFORM Protein DME1265 XEOTICID XEO04660 MOACRIVE Inhibition DME1265 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1265 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04661 XEO_CLAS Peptide DME1265 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 microM) DME1265 XEOTICID XEO04661 GENEFORM Protein DME1265 XEOTICID XEO04661 MOACRIVE Inhibition DME1265 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1265 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04662 XEO_CLAS Peptide DME1265 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 microM) DME1265 XEOTICID XEO04662 GENEFORM Protein DME1265 XEOTICID XEO04662 MOACRIVE Inhibition DME1265 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1265 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04663 XEO_CLAS Peptide DME1265 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 microM) DME1265 XEOTICID XEO04663 GENEFORM Protein DME1265 XEOTICID XEO04663 MOACRIVE Inhibition DME1265 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1265 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04664 XEO_CLAS Peptide DME1265 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5.5 microM) DME1265 XEOTICID XEO04664 GENEFORM Protein DME1265 XEOTICID XEO04664 MOACRIVE Inhibition DME1265 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1265 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04665 XEO_CLAS Peptide DME1265 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 microM) DME1265 XEOTICID XEO04665 GENEFORM Protein DME1265 XEOTICID XEO04665 MOACRIVE Inhibition DME1265 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1265 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04666 XEO_CLAS Peptide DME1265 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO04666 GENEFORM Protein DME1265 XEOTICID XEO04666 MOACRIVE Inhibition DME1265 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1265 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04667 XEO_CLAS Peptide DME1265 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6.25 microM) DME1265 XEOTICID XEO04667 GENEFORM Protein DME1265 XEOTICID XEO04667 MOACRIVE Inhibition DME1265 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1265 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04668 XEO_CLAS Peptide DME1265 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 microM) DME1265 XEOTICID XEO04668 GENEFORM Protein DME1265 XEOTICID XEO04668 MOACRIVE Inhibition DME1265 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1265 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04669 XEO_CLAS Peptide DME1265 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO04669 GENEFORM Protein DME1265 XEOTICID XEO04669 MOACRIVE Inhibition DME1265 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1265 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04670 XEO_CLAS Peptide DME1265 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 21 microM) DME1265 XEOTICID XEO04670 GENEFORM Protein DME1265 XEOTICID XEO04670 MOACRIVE Inhibition DME1265 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1265 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04671 XEO_CLAS Peptide DME1265 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 62 microM) DME1265 XEOTICID XEO04671 GENEFORM Protein DME1265 XEOTICID XEO04671 MOACRIVE Inhibition DME1265 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1265 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04672 XEO_CLAS Peptide DME1265 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO04672 GENEFORM Protein DME1265 XEOTICID XEO04672 MOACRIVE Inhibition DME1265 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1265 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04673 XEO_CLAS Peptide DME1265 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO04673 GENEFORM Protein DME1265 XEOTICID XEO04673 MOACRIVE Inhibition DME1265 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1265 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04674 XEO_CLAS Peptide DME1265 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 75 microM) DME1265 XEOTICID XEO04674 GENEFORM Protein DME1265 XEOTICID XEO04674 MOACRIVE Inhibition DME1265 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1265 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04675 XEO_CLAS Peptide DME1265 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 microM) DME1265 XEOTICID XEO04675 GENEFORM Protein DME1265 XEOTICID XEO04675 MOACRIVE Inhibition DME1265 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1265 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04676 XEO_CLAS Peptide DME1265 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 microM) DME1265 XEOTICID XEO04676 GENEFORM Protein DME1265 XEOTICID XEO04676 MOACRIVE Inhibition DME1265 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1265 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04677 XEO_CLAS Peptide DME1265 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO04677 GENEFORM Protein DME1265 XEOTICID XEO04677 MOACRIVE Inhibition DME1265 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1265 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04680 XEO_CLAS Peptide DME1265 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 microM) DME1265 XEOTICID XEO04680 GENEFORM Protein DME1265 XEOTICID XEO04680 MOACRIVE Inhibition DME1265 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1265 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04682 XEO_CLAS Peptide DME1265 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 microM) DME1265 XEOTICID XEO04682 GENEFORM Protein DME1265 XEOTICID XEO04682 MOACRIVE Inhibition DME1265 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1265 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04683 XEO_CLAS Peptide DME1265 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 microM) DME1265 XEOTICID XEO04683 GENEFORM Protein DME1265 XEOTICID XEO04683 MOACRIVE Inhibition DME1265 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1265 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04684 XEO_CLAS Peptide DME1265 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 38 microM) DME1265 XEOTICID XEO04684 GENEFORM Protein DME1265 XEOTICID XEO04684 MOACRIVE Inhibition DME1265 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1265 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04690 XEO_CLAS Peptide DME1265 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.5 ug/ml) DME1265 XEOTICID XEO04690 GENEFORM Protein DME1265 XEOTICID XEO04690 MOACRIVE Inhibition DME1265 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1265 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04695 XEO_CLAS Peptide DME1265 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04695 GENEFORM Protein DME1265 XEOTICID XEO04695 MOACRIVE Inhibition DME1265 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1265 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04696 XEO_CLAS Peptide DME1265 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04696 GENEFORM Protein DME1265 XEOTICID XEO04696 MOACRIVE Inhibition DME1265 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1265 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04712 XEO_CLAS Peptide DME1265 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16.7 microM) DME1265 XEOTICID XEO04712 GENEFORM Protein DME1265 XEOTICID XEO04712 MOACRIVE Inhibition DME1265 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1265 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04713 XEO_CLAS Peptide DME1265 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16.7 microM) DME1265 XEOTICID XEO04713 GENEFORM Protein DME1265 XEOTICID XEO04713 MOACRIVE Inhibition DME1265 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1265 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04714 XEO_CLAS Peptide DME1265 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 23.3 microM) DME1265 XEOTICID XEO04714 GENEFORM Protein DME1265 XEOTICID XEO04714 MOACRIVE Inhibition DME1265 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1265 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04716 XEO_CLAS Peptide DME1265 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 microM) DME1265 XEOTICID XEO04716 GENEFORM Protein DME1265 XEOTICID XEO04716 MOACRIVE Inhibition DME1265 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1265 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04717 XEO_CLAS Peptide DME1265 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 50 microM) DME1265 XEOTICID XEO04717 GENEFORM Protein DME1265 XEOTICID XEO04717 MOACRIVE Inhibition DME1265 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1265 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04725 XEO_CLAS Peptide DME1265 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04725 GENEFORM Protein DME1265 XEOTICID XEO04725 MOACRIVE Inhibition DME1265 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1265 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04726 XEO_CLAS Peptide DME1265 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04726 GENEFORM Protein DME1265 XEOTICID XEO04726 MOACRIVE Inhibition DME1265 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1265 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04731 XEO_CLAS Peptide DME1265 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 ug/ml) DME1265 XEOTICID XEO04731 GENEFORM Protein DME1265 XEOTICID XEO04731 MOACRIVE Inhibition DME1265 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1265 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04732 XEO_CLAS Peptide DME1265 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 25 ug/ml) DME1265 XEOTICID XEO04732 GENEFORM Protein DME1265 XEOTICID XEO04732 MOACRIVE Inhibition DME1265 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1265 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04733 XEO_CLAS Peptide DME1265 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04733 GENEFORM Protein DME1265 XEOTICID XEO04733 MOACRIVE Inhibition DME1265 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1265 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04734 XEO_CLAS Peptide DME1265 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04734 GENEFORM Protein DME1265 XEOTICID XEO04734 MOACRIVE Inhibition DME1265 XEOTICID XEO04737 XEO_NAME Protonectin DME1265 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04737 XEO_CLAS Peptide DME1265 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 ug/ml) DME1265 XEOTICID XEO04737 GENEFORM Protein DME1265 XEOTICID XEO04737 MOACRIVE Inhibition DME1265 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1265 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04739 XEO_CLAS Peptide DME1265 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04739 GENEFORM Protein DME1265 XEOTICID XEO04739 MOACRIVE Inhibition DME1265 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1265 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04740 XEO_CLAS Peptide DME1265 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04740 GENEFORM Protein DME1265 XEOTICID XEO04740 MOACRIVE Inhibition DME1265 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1265 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04741 XEO_CLAS Peptide DME1265 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04741 GENEFORM Protein DME1265 XEOTICID XEO04741 MOACRIVE Inhibition DME1265 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1265 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04742 XEO_CLAS Peptide DME1265 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04742 GENEFORM Protein DME1265 XEOTICID XEO04742 MOACRIVE Inhibition DME1265 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1265 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04762 XEO_CLAS Peptide DME1265 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.8 microM) DME1265 XEOTICID XEO04762 GENEFORM Protein DME1265 XEOTICID XEO04762 MOACRIVE Inhibition DME1265 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1265 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04766 XEO_CLAS Peptide DME1265 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.1 microM) DME1265 XEOTICID XEO04766 GENEFORM Protein DME1265 XEOTICID XEO04766 MOACRIVE Inhibition DME1265 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1265 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04767 XEO_CLAS Peptide DME1265 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.1 ug/ml) DME1265 XEOTICID XEO04767 GENEFORM Protein DME1265 XEOTICID XEO04767 MOACRIVE Inhibition DME1265 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1265 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04779 XEO_CLAS Peptide DME1265 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04779 GENEFORM Protein DME1265 XEOTICID XEO04779 MOACRIVE Inhibition DME1265 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1265 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04780 XEO_CLAS Peptide DME1265 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04780 GENEFORM Protein DME1265 XEOTICID XEO04780 MOACRIVE Inhibition DME1265 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1265 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04781 XEO_CLAS Peptide DME1265 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04781 GENEFORM Protein DME1265 XEOTICID XEO04781 MOACRIVE Inhibition DME1265 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1265 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04782 XEO_CLAS Peptide DME1265 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 ug/ml) DME1265 XEOTICID XEO04782 GENEFORM Protein DME1265 XEOTICID XEO04782 MOACRIVE Inhibition DME1265 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1265 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04783 XEO_CLAS Peptide DME1265 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO04783 GENEFORM Protein DME1265 XEOTICID XEO04783 MOACRIVE Inhibition DME1265 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1265 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04784 XEO_CLAS Peptide DME1265 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO04784 GENEFORM Protein DME1265 XEOTICID XEO04784 MOACRIVE Inhibition DME1265 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1265 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04785 XEO_CLAS Peptide DME1265 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO04785 GENEFORM Protein DME1265 XEOTICID XEO04785 MOACRIVE Inhibition DME1265 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1265 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04786 XEO_CLAS Peptide DME1265 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 ug/ml) DME1265 XEOTICID XEO04786 GENEFORM Protein DME1265 XEOTICID XEO04786 MOACRIVE Inhibition DME1265 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1265 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04787 XEO_CLAS Peptide DME1265 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04787 GENEFORM Protein DME1265 XEOTICID XEO04787 MOACRIVE Inhibition DME1265 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1265 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04793 XEO_CLAS Peptide DME1265 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04793 GENEFORM Protein DME1265 XEOTICID XEO04793 MOACRIVE Inhibition DME1265 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1265 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04798 XEO_CLAS Peptide DME1265 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 microM) DME1265 XEOTICID XEO04798 GENEFORM Protein DME1265 XEOTICID XEO04798 MOACRIVE Inhibition DME1265 XEOTICID XEO04799 XEO_NAME Ranalexin DME1265 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04799 XEO_CLAS Peptide DME1265 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 32 ug/ml) DME1265 XEOTICID XEO04799 GENEFORM Protein DME1265 XEOTICID XEO04799 MOACRIVE Inhibition DME1265 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1265 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04800 XEO_CLAS Peptide DME1265 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 microM) DME1265 XEOTICID XEO04800 GENEFORM Protein DME1265 XEOTICID XEO04800 MOACRIVE Inhibition DME1265 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1265 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04801 XEO_CLAS Peptide DME1265 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 9 microM) DME1265 XEOTICID XEO04801 GENEFORM Protein DME1265 XEOTICID XEO04801 MOACRIVE Inhibition DME1265 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1265 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04802 XEO_CLAS Peptide DME1265 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12 microM) DME1265 XEOTICID XEO04802 GENEFORM Protein DME1265 XEOTICID XEO04802 MOACRIVE Inhibition DME1265 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1265 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04803 XEO_CLAS Peptide DME1265 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO04803 GENEFORM Protein DME1265 XEOTICID XEO04803 MOACRIVE Inhibition DME1265 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1265 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04804 XEO_CLAS Peptide DME1265 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO04804 GENEFORM Protein DME1265 XEOTICID XEO04804 MOACRIVE Inhibition DME1265 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1265 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04805 XEO_CLAS Peptide DME1265 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.5 microM) DME1265 XEOTICID XEO04805 GENEFORM Protein DME1265 XEOTICID XEO04805 MOACRIVE Inhibition DME1265 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1265 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04806 XEO_CLAS Peptide DME1265 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.5 microM) DME1265 XEOTICID XEO04806 GENEFORM Protein DME1265 XEOTICID XEO04806 MOACRIVE Inhibition DME1265 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1265 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04807 XEO_CLAS Peptide DME1265 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04807 GENEFORM Protein DME1265 XEOTICID XEO04807 MOACRIVE Inhibition DME1265 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1265 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04809 XEO_CLAS Peptide DME1265 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 microM) DME1265 XEOTICID XEO04809 GENEFORM Protein DME1265 XEOTICID XEO04809 MOACRIVE Inhibition DME1265 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1265 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04811 XEO_CLAS Peptide DME1265 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO04811 GENEFORM Protein DME1265 XEOTICID XEO04811 MOACRIVE Inhibition DME1265 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1265 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04812 XEO_CLAS Peptide DME1265 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO04812 GENEFORM Protein DME1265 XEOTICID XEO04812 MOACRIVE Inhibition DME1265 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1265 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04813 XEO_CLAS Peptide DME1265 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 microM) DME1265 XEOTICID XEO04813 GENEFORM Protein DME1265 XEOTICID XEO04813 MOACRIVE Inhibition DME1265 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1265 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04814 XEO_CLAS Peptide DME1265 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 19 microM) DME1265 XEOTICID XEO04814 GENEFORM Protein DME1265 XEOTICID XEO04814 MOACRIVE Inhibition DME1265 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1265 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04815 XEO_CLAS Peptide DME1265 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 microM) DME1265 XEOTICID XEO04815 GENEFORM Protein DME1265 XEOTICID XEO04815 MOACRIVE Inhibition DME1265 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1265 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04816 XEO_CLAS Peptide DME1265 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 microM) DME1265 XEOTICID XEO04816 GENEFORM Protein DME1265 XEOTICID XEO04816 MOACRIVE Inhibition DME1265 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1265 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04817 XEO_CLAS Peptide DME1265 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 13 microM) DME1265 XEOTICID XEO04817 GENEFORM Protein DME1265 XEOTICID XEO04817 MOACRIVE Inhibition DME1265 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1265 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04818 XEO_CLAS Peptide DME1265 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO04818 GENEFORM Protein DME1265 XEOTICID XEO04818 MOACRIVE Inhibition DME1265 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1265 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04819 XEO_CLAS Peptide DME1265 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO04819 GENEFORM Protein DME1265 XEOTICID XEO04819 MOACRIVE Inhibition DME1265 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1265 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04820 XEO_CLAS Peptide DME1265 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3 microM) DME1265 XEOTICID XEO04820 GENEFORM Protein DME1265 XEOTICID XEO04820 MOACRIVE Inhibition DME1265 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1265 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04821 XEO_CLAS Peptide DME1265 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 microM) DME1265 XEOTICID XEO04821 GENEFORM Protein DME1265 XEOTICID XEO04821 MOACRIVE Inhibition DME1265 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1265 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04822 XEO_CLAS Peptide DME1265 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO04822 GENEFORM Protein DME1265 XEOTICID XEO04822 MOACRIVE Inhibition DME1265 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1265 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04823 XEO_CLAS Peptide DME1265 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 23 microM) DME1265 XEOTICID XEO04823 GENEFORM Protein DME1265 XEOTICID XEO04823 MOACRIVE Inhibition DME1265 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1265 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04824 XEO_CLAS Peptide DME1265 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04824 GENEFORM Protein DME1265 XEOTICID XEO04824 MOACRIVE Inhibition DME1265 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1265 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04825 XEO_CLAS Peptide DME1265 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04825 GENEFORM Protein DME1265 XEOTICID XEO04825 MOACRIVE Inhibition DME1265 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1265 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04826 XEO_CLAS Peptide DME1265 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO04826 GENEFORM Protein DME1265 XEOTICID XEO04826 MOACRIVE Inhibition DME1265 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1265 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04827 XEO_CLAS Peptide DME1265 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO04827 GENEFORM Protein DME1265 XEOTICID XEO04827 MOACRIVE Inhibition DME1265 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1265 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04835 XEO_CLAS Peptide DME1265 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04835 GENEFORM Protein DME1265 XEOTICID XEO04835 MOACRIVE Inhibition DME1265 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1265 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04836 XEO_CLAS Peptide DME1265 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04836 GENEFORM Protein DME1265 XEOTICID XEO04836 MOACRIVE Inhibition DME1265 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1265 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04837 XEO_CLAS Peptide DME1265 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 microM) DME1265 XEOTICID XEO04837 GENEFORM Protein DME1265 XEOTICID XEO04837 MOACRIVE Inhibition DME1265 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1265 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04839 XEO_CLAS Peptide DME1265 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04839 GENEFORM Protein DME1265 XEOTICID XEO04839 MOACRIVE Inhibition DME1265 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1265 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04840 XEO_CLAS Peptide DME1265 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 35-20 microM) DME1265 XEOTICID XEO04840 GENEFORM Protein DME1265 XEOTICID XEO04840 MOACRIVE Inhibition DME1265 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1265 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04847 XEO_CLAS Peptide DME1265 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04847 GENEFORM Protein DME1265 XEOTICID XEO04847 MOACRIVE Inhibition DME1265 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1265 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04848 XEO_CLAS Peptide DME1265 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04848 GENEFORM Protein DME1265 XEOTICID XEO04848 MOACRIVE Inhibition DME1265 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1265 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04849 XEO_CLAS Peptide DME1265 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04849 GENEFORM Protein DME1265 XEOTICID XEO04849 MOACRIVE Inhibition DME1265 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1265 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04850 XEO_CLAS Peptide DME1265 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04850 GENEFORM Protein DME1265 XEOTICID XEO04850 MOACRIVE Inhibition DME1265 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1265 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04851 XEO_CLAS Peptide DME1265 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1 ug/ml) DME1265 XEOTICID XEO04851 GENEFORM Protein DME1265 XEOTICID XEO04851 MOACRIVE Inhibition DME1265 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1265 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04857 XEO_CLAS Peptide DME1265 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 microM) DME1265 XEOTICID XEO04857 GENEFORM Protein DME1265 XEOTICID XEO04857 MOACRIVE Inhibition DME1265 XEOTICID XEO04863 XEO_NAME RTD peptide DME1265 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04863 XEO_CLAS Peptide DME1265 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.0 microM) DME1265 XEOTICID XEO04863 GENEFORM Protein DME1265 XEOTICID XEO04863 MOACRIVE Inhibition DME1265 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1265 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04865 XEO_CLAS Peptide DME1265 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 ug/ml) DME1265 XEOTICID XEO04865 GENEFORM Protein DME1265 XEOTICID XEO04865 MOACRIVE Inhibition DME1265 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1265 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04866 XEO_CLAS Peptide DME1265 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12.5 ug/ml) DME1265 XEOTICID XEO04866 GENEFORM Protein DME1265 XEOTICID XEO04866 MOACRIVE Inhibition DME1265 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1265 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04868 XEO_CLAS Peptide DME1265 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25.00 ug/ml) DME1265 XEOTICID XEO04868 GENEFORM Protein DME1265 XEOTICID XEO04868 MOACRIVE Inhibition DME1265 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1265 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04869 XEO_CLAS Peptide DME1265 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25.00 ug/ml) DME1265 XEOTICID XEO04869 GENEFORM Protein DME1265 XEOTICID XEO04869 MOACRIVE Inhibition DME1265 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1265 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04870 XEO_CLAS Peptide DME1265 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25.00 ug/ml) DME1265 XEOTICID XEO04870 GENEFORM Protein DME1265 XEOTICID XEO04870 MOACRIVE Inhibition DME1265 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1265 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04877 XEO_CLAS Peptide DME1265 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04877 GENEFORM Protein DME1265 XEOTICID XEO04877 MOACRIVE Inhibition DME1265 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1265 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04880 XEO_CLAS Peptide DME1265 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.5 ug/ml) DME1265 XEOTICID XEO04880 GENEFORM Protein DME1265 XEOTICID XEO04880 MOACRIVE Inhibition DME1265 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1265 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04886 XEO_CLAS Peptide DME1265 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.6 ug/ml) DME1265 XEOTICID XEO04886 GENEFORM Protein DME1265 XEOTICID XEO04886 MOACRIVE Inhibition DME1265 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1265 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04891 XEO_CLAS Peptide DME1265 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04891 GENEFORM Protein DME1265 XEOTICID XEO04891 MOACRIVE Inhibition DME1265 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1265 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04895 XEO_CLAS Peptide DME1265 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04895 GENEFORM Protein DME1265 XEOTICID XEO04895 MOACRIVE Inhibition DME1265 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1265 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04901 XEO_CLAS Peptide DME1265 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 microM) DME1265 XEOTICID XEO04901 GENEFORM Protein DME1265 XEOTICID XEO04901 MOACRIVE Inhibition DME1265 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1265 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04904 XEO_CLAS Peptide DME1265 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 78 ug/ml) DME1265 XEOTICID XEO04904 GENEFORM Protein DME1265 XEOTICID XEO04904 MOACRIVE Inhibition DME1265 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1265 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04905 XEO_CLAS Peptide DME1265 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04905 GENEFORM Protein DME1265 XEOTICID XEO04905 MOACRIVE Inhibition DME1265 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1265 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04906 XEO_CLAS Peptide DME1265 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04906 GENEFORM Protein DME1265 XEOTICID XEO04906 MOACRIVE Inhibition DME1265 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1265 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04907 XEO_CLAS Peptide DME1265 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04907 GENEFORM Protein DME1265 XEOTICID XEO04907 MOACRIVE Inhibition DME1265 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1265 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04908 XEO_CLAS Peptide DME1265 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04908 GENEFORM Protein DME1265 XEOTICID XEO04908 MOACRIVE Inhibition DME1265 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1265 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04909 XEO_CLAS Peptide DME1265 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04909 GENEFORM Protein DME1265 XEOTICID XEO04909 MOACRIVE Inhibition DME1265 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1265 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04915 XEO_CLAS Peptide DME1265 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 100 ug/ml) DME1265 XEOTICID XEO04915 GENEFORM Protein DME1265 XEOTICID XEO04915 MOACRIVE Inhibition DME1265 XEOTICID XEO04916 XEO_NAME Scopoletin DME1265 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1265 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04916 GENEFORM Protein DME1265 XEOTICID XEO04916 MOACRIVE Inhibition DME1265 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1265 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04926 XEO_CLAS Peptide DME1265 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04926 GENEFORM Protein DME1265 XEOTICID XEO04926 MOACRIVE Inhibition DME1265 XEOTICID XEO04931 XEO_NAME Shepherin I DME1265 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04931 XEO_CLAS Peptide DME1265 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04931 GENEFORM Protein DME1265 XEOTICID XEO04931 MOACRIVE Inhibition DME1265 XEOTICID XEO04932 XEO_NAME shepherin II DME1265 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04932 XEO_CLAS Peptide DME1265 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04932 GENEFORM Protein DME1265 XEOTICID XEO04932 MOACRIVE Inhibition DME1265 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1265 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04938 XEO_CLAS Peptide DME1265 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC <= 100 microM) DME1265 XEOTICID XEO04938 GENEFORM Protein DME1265 XEOTICID XEO04938 MOACRIVE Inhibition DME1265 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1265 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04947 XEO_CLAS Natural Product DME1265 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04947 GENEFORM Protein DME1265 XEOTICID XEO04947 MOACRIVE Inhibition DME1265 XEOTICID XEO04948 XEO_NAME Sinensetin DME1265 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1265 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1265 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04948 GENEFORM Protein DME1265 XEOTICID XEO04948 MOACRIVE Inhibition DME1265 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1265 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04950 XEO_CLAS Peptide DME1265 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 ug/ml) DME1265 XEOTICID XEO04950 GENEFORM Protein DME1265 XEOTICID XEO04950 MOACRIVE Inhibition DME1265 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1265 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04955 XEO_CLAS Peptide DME1265 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.07 microM) DME1265 XEOTICID XEO04955 GENEFORM Protein DME1265 XEOTICID XEO04955 MOACRIVE Inhibition DME1265 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1265 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04956 XEO_CLAS Peptide DME1265 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16.0 microM) DME1265 XEOTICID XEO04956 GENEFORM Protein DME1265 XEOTICID XEO04956 MOACRIVE Inhibition DME1265 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1265 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04957 XEO_CLAS Peptide DME1265 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.23 microM) DME1265 XEOTICID XEO04957 GENEFORM Protein DME1265 XEOTICID XEO04957 MOACRIVE Inhibition DME1265 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1265 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04958 XEO_CLAS Peptide DME1265 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 ug/ml) DME1265 XEOTICID XEO04958 GENEFORM Protein DME1265 XEOTICID XEO04958 MOACRIVE Inhibition DME1265 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1265 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04959 XEO_CLAS Peptide DME1265 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04959 GENEFORM Protein DME1265 XEOTICID XEO04959 MOACRIVE Inhibition DME1265 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1265 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04967 XEO_CLAS Peptide DME1265 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 28 microM) DME1265 XEOTICID XEO04967 GENEFORM Protein DME1265 XEOTICID XEO04967 MOACRIVE Inhibition DME1265 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1265 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04969 XEO_CLAS Peptide DME1265 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50-100 ug/ml) DME1265 XEOTICID XEO04969 GENEFORM Protein DME1265 XEOTICID XEO04969 MOACRIVE Inhibition DME1265 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1265 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04970 XEO_CLAS Peptide DME1265 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04970 GENEFORM Protein DME1265 XEOTICID XEO04970 MOACRIVE Inhibition DME1265 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1265 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04971 XEO_CLAS Peptide DME1265 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.8-1.5 microM) DME1265 XEOTICID XEO04971 GENEFORM Protein DME1265 XEOTICID XEO04971 MOACRIVE Inhibition DME1265 XEOTICID XEO04974 XEO_NAME Spinigerin DME1265 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04974 XEO_CLAS Peptide DME1265 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3-6 microM) DME1265 XEOTICID XEO04974 GENEFORM Protein DME1265 XEOTICID XEO04974 MOACRIVE Inhibition DME1265 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1265 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1265 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04975 GENEFORM Protein DME1265 XEOTICID XEO04975 MOACRIVE Inhibition DME1265 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1265 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1265 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04976 GENEFORM Protein DME1265 XEOTICID XEO04976 MOACRIVE Inhibition DME1265 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1265 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1265 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04977 GENEFORM Protein DME1265 XEOTICID XEO04977 MOACRIVE Inhibition DME1265 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1265 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1265 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04978 GENEFORM Protein DME1265 XEOTICID XEO04978 MOACRIVE Inhibition DME1265 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1265 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1265 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04979 GENEFORM Protein DME1265 XEOTICID XEO04979 MOACRIVE Inhibition DME1265 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1265 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04981 XEO_CLAS Peptide DME1265 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10.1 microM) DME1265 XEOTICID XEO04981 GENEFORM Protein DME1265 XEOTICID XEO04981 MOACRIVE Inhibition DME1265 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1265 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04982 XEO_CLAS Peptide DME1265 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40.5 microM) DME1265 XEOTICID XEO04982 GENEFORM Protein DME1265 XEOTICID XEO04982 MOACRIVE Inhibition DME1265 XEOTICID XEO04994 XEO_NAME Stilbene DME1265 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1265 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1265 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO04994 GENEFORM Protein DME1265 XEOTICID XEO04994 MOACRIVE Inhibition DME1265 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1265 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04995 XEO_CLAS Peptide DME1265 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC < 0.19 microM) DME1265 XEOTICID XEO04995 GENEFORM Protein DME1265 XEOTICID XEO04995 MOACRIVE Inhibition DME1265 XEOTICID XEO04998 XEO_NAME Styelin A DME1265 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04998 XEO_CLAS Peptide DME1265 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.7 ug/ml) DME1265 XEOTICID XEO04998 GENEFORM Protein DME1265 XEOTICID XEO04998 MOACRIVE Inhibition DME1265 XEOTICID XEO04999 XEO_NAME Styelin B DME1265 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO04999 XEO_CLAS Peptide DME1265 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.7 ug/ml) DME1265 XEOTICID XEO04999 GENEFORM Protein DME1265 XEOTICID XEO04999 MOACRIVE Inhibition DME1265 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1265 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05000 XEO_CLAS Peptide DME1265 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO05000 GENEFORM Protein DME1265 XEOTICID XEO05000 MOACRIVE Inhibition DME1265 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1265 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05001 XEO_CLAS Peptide DME1265 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.5 ug/ml) DME1265 XEOTICID XEO05001 GENEFORM Protein DME1265 XEOTICID XEO05001 MOACRIVE Inhibition DME1265 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1265 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05002 XEO_CLAS Peptide DME1265 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO05002 GENEFORM Protein DME1265 XEOTICID XEO05002 MOACRIVE Inhibition DME1265 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1265 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05003 XEO_CLAS Peptide DME1265 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO05003 GENEFORM Protein DME1265 XEOTICID XEO05003 MOACRIVE Inhibition DME1265 XEOTICID XEO05006 XEO_NAME Substance P DME1265 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05006 XEO_CLAS Peptide DME1265 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05006 GENEFORM Protein DME1265 XEOTICID XEO05006 MOACRIVE Inhibition DME1265 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1265 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05007 XEO_CLAS Peptide DME1265 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05007 GENEFORM Protein DME1265 XEOTICID XEO05007 MOACRIVE Inhibition DME1265 XEOTICID XEO05008 XEO_NAME Subtilosin DME1265 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05008 XEO_CLAS Peptide DME1265 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05008 GENEFORM Protein DME1265 XEOTICID XEO05008 MOACRIVE Inhibition DME1265 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1265 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05013 XEO_CLAS Peptide DME1265 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO05013 GENEFORM Protein DME1265 XEOTICID XEO05013 MOACRIVE Inhibition DME1265 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1265 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05014 XEO_CLAS Peptide DME1265 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO05014 GENEFORM Protein DME1265 XEOTICID XEO05014 MOACRIVE Inhibition DME1265 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1265 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05015 XEO_CLAS Peptide DME1265 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO05015 GENEFORM Protein DME1265 XEOTICID XEO05015 MOACRIVE Inhibition DME1265 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1265 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05016 XEO_CLAS Peptide DME1265 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO05016 GENEFORM Protein DME1265 XEOTICID XEO05016 MOACRIVE Inhibition DME1265 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1265 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05017 XEO_CLAS Peptide DME1265 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 20 ug/ml) DME1265 XEOTICID XEO05017 GENEFORM Protein DME1265 XEOTICID XEO05017 MOACRIVE Inhibition DME1265 XEOTICID XEO05018 XEO_NAME Syringic acid DME1265 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1265 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05018 GENEFORM Protein DME1265 XEOTICID XEO05018 MOACRIVE Inhibition DME1265 XEOTICID XEO05020 XEO_NAME Tachycitin DME1265 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05020 XEO_CLAS Peptide DME1265 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05020 GENEFORM Protein DME1265 XEOTICID XEO05020 MOACRIVE Inhibition DME1265 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1265 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05023 XEO_CLAS Peptide DME1265 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05023 GENEFORM Protein DME1265 XEOTICID XEO05023 MOACRIVE Inhibition DME1265 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1265 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05024 XEO_CLAS Peptide DME1265 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05024 GENEFORM Protein DME1265 XEOTICID XEO05024 MOACRIVE Inhibition DME1265 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1265 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05027 XEO_CLAS Peptide DME1265 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05027 GENEFORM Protein DME1265 XEOTICID XEO05027 MOACRIVE Inhibition DME1265 XEOTICID XEO05031 XEO_NAME Tannic acid DME1265 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1265 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05031 GENEFORM Protein DME1265 XEOTICID XEO05031 MOACRIVE Inhibition DME1265 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1265 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05033 XEO_CLAS Peptide DME1265 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05033 GENEFORM Protein DME1265 XEOTICID XEO05033 MOACRIVE Inhibition DME1265 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1265 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05042 XEO_CLAS Peptide DME1265 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO05042 GENEFORM Protein DME1265 XEOTICID XEO05042 MOACRIVE Inhibition DME1265 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1265 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05043 XEO_CLAS Peptide DME1265 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO05043 GENEFORM Protein DME1265 XEOTICID XEO05043 MOACRIVE Inhibition DME1265 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1265 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05044 XEO_CLAS Peptide DME1265 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 128 microM) DME1265 XEOTICID XEO05044 GENEFORM Protein DME1265 XEOTICID XEO05044 MOACRIVE Inhibition DME1265 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1265 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05045 XEO_CLAS Peptide DME1265 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 128 microM) DME1265 XEOTICID XEO05045 GENEFORM Protein DME1265 XEOTICID XEO05045 MOACRIVE Inhibition DME1265 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1265 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05046 XEO_CLAS Peptide DME1265 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 microM) DME1265 XEOTICID XEO05046 GENEFORM Protein DME1265 XEOTICID XEO05046 MOACRIVE Inhibition DME1265 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1265 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05047 XEO_CLAS Peptide DME1265 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 60 microM) DME1265 XEOTICID XEO05047 GENEFORM Protein DME1265 XEOTICID XEO05047 MOACRIVE Inhibition DME1265 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1265 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05051 XEO_CLAS Peptide DME1265 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05051 GENEFORM Protein DME1265 XEOTICID XEO05051 MOACRIVE Inhibition DME1265 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1265 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05055 XEO_CLAS Peptide DME1265 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 70 microM) DME1265 XEOTICID XEO05055 GENEFORM Protein DME1265 XEOTICID XEO05055 MOACRIVE Inhibition DME1265 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1265 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05056 XEO_CLAS Peptide DME1265 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05056 GENEFORM Protein DME1265 XEOTICID XEO05056 MOACRIVE Inhibition DME1265 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1265 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05059 XEO_CLAS Peptide DME1265 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05059 GENEFORM Protein DME1265 XEOTICID XEO05059 MOACRIVE Inhibition DME1265 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1265 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05061 XEO_CLAS Peptide DME1265 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO05061 GENEFORM Protein DME1265 XEOTICID XEO05061 MOACRIVE Inhibition DME1265 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1265 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05062 XEO_CLAS Peptide DME1265 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05062 GENEFORM Protein DME1265 XEOTICID XEO05062 MOACRIVE Inhibition DME1265 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1265 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05063 XEO_CLAS Peptide DME1265 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO05063 GENEFORM Protein DME1265 XEOTICID XEO05063 MOACRIVE Inhibition DME1265 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1265 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05064 XEO_CLAS Peptide DME1265 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 231 microM) DME1265 XEOTICID XEO05064 GENEFORM Protein DME1265 XEOTICID XEO05064 MOACRIVE Inhibition DME1265 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1265 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05065 XEO_CLAS Peptide DME1265 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 161 ug/ml) DME1265 XEOTICID XEO05065 GENEFORM Protein DME1265 XEOTICID XEO05065 MOACRIVE Inhibition DME1265 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1265 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05069 XEO_CLAS Peptide DME1265 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO05069 GENEFORM Protein DME1265 XEOTICID XEO05069 MOACRIVE Inhibition DME1265 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1265 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05070 XEO_CLAS Peptide DME1265 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 37.5 microM) DME1265 XEOTICID XEO05070 GENEFORM Protein DME1265 XEOTICID XEO05070 MOACRIVE Inhibition DME1265 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1265 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05071 XEO_CLAS Peptide DME1265 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 150 microM) DME1265 XEOTICID XEO05071 GENEFORM Protein DME1265 XEOTICID XEO05071 MOACRIVE Inhibition DME1265 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1265 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05072 XEO_CLAS Peptide DME1265 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO05072 GENEFORM Protein DME1265 XEOTICID XEO05072 MOACRIVE Inhibition DME1265 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1265 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05073 XEO_CLAS Peptide DME1265 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40 microM) DME1265 XEOTICID XEO05073 GENEFORM Protein DME1265 XEOTICID XEO05073 MOACRIVE Inhibition DME1265 XEOTICID XEO05076 XEO_NAME Temporin-A DME1265 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05076 XEO_CLAS Peptide DME1265 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 11.9 microM) DME1265 XEOTICID XEO05076 GENEFORM Protein DME1265 XEOTICID XEO05076 MOACRIVE Inhibition DME1265 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1265 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05077 XEO_CLAS Peptide DME1265 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.25 ug/ml) DME1265 XEOTICID XEO05077 GENEFORM Protein DME1265 XEOTICID XEO05077 MOACRIVE Inhibition DME1265 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1265 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05078 XEO_CLAS Peptide DME1265 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.25 ug/ml) DME1265 XEOTICID XEO05078 GENEFORM Protein DME1265 XEOTICID XEO05078 MOACRIVE Inhibition DME1265 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1265 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05079 XEO_CLAS Peptide DME1265 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.5 ug/ml) DME1265 XEOTICID XEO05079 GENEFORM Protein DME1265 XEOTICID XEO05079 MOACRIVE Inhibition DME1265 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1265 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05080 XEO_CLAS Peptide DME1265 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 ug/ml) DME1265 XEOTICID XEO05080 GENEFORM Protein DME1265 XEOTICID XEO05080 MOACRIVE Inhibition DME1265 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1265 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05081 XEO_CLAS Peptide DME1265 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 5 ug/ml) DME1265 XEOTICID XEO05081 GENEFORM Protein DME1265 XEOTICID XEO05081 MOACRIVE Inhibition DME1265 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1265 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05082 XEO_CLAS Peptide DME1265 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 7.5 ug/ml) DME1265 XEOTICID XEO05082 GENEFORM Protein DME1265 XEOTICID XEO05082 MOACRIVE Inhibition DME1265 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1265 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05083 XEO_CLAS Peptide DME1265 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 ug/ml) DME1265 XEOTICID XEO05083 GENEFORM Protein DME1265 XEOTICID XEO05083 MOACRIVE Inhibition DME1265 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1265 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05084 XEO_CLAS Peptide DME1265 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 ug/ml) DME1265 XEOTICID XEO05084 GENEFORM Protein DME1265 XEOTICID XEO05084 MOACRIVE Inhibition DME1265 XEOTICID XEO05085 XEO_NAME Temporin-B DME1265 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05085 XEO_CLAS Peptide DME1265 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 21.0 ug/ml) DME1265 XEOTICID XEO05085 GENEFORM Protein DME1265 XEOTICID XEO05085 MOACRIVE Inhibition DME1265 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1265 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05086 XEO_CLAS Peptide DME1265 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC > 100 microM) DME1265 XEOTICID XEO05086 GENEFORM Protein DME1265 XEOTICID XEO05086 MOACRIVE Inhibition DME1265 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1265 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05087 XEO_CLAS Peptide DME1265 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO05087 GENEFORM Protein DME1265 XEOTICID XEO05087 MOACRIVE Inhibition DME1265 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1265 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05097 XEO_CLAS Peptide DME1265 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16.0 microM) DME1265 XEOTICID XEO05097 GENEFORM Protein DME1265 XEOTICID XEO05097 MOACRIVE Inhibition DME1265 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1265 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05099 XEO_CLAS Peptide DME1265 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.0 microM) DME1265 XEOTICID XEO05099 GENEFORM Protein DME1265 XEOTICID XEO05099 MOACRIVE Inhibition DME1265 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1265 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05100 XEO_CLAS Peptide DME1265 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05100 GENEFORM Protein DME1265 XEOTICID XEO05100 MOACRIVE Inhibition DME1265 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1265 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05101 XEO_CLAS Peptide DME1265 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 24.2 ug/ml) DME1265 XEOTICID XEO05101 GENEFORM Protein DME1265 XEOTICID XEO05101 MOACRIVE Inhibition DME1265 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1265 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05102 XEO_CLAS Peptide DME1265 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 34.5 ug/ml) DME1265 XEOTICID XEO05102 GENEFORM Protein DME1265 XEOTICID XEO05102 MOACRIVE Inhibition DME1265 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1265 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05105 XEO_CLAS Peptide DME1265 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO05105 GENEFORM Protein DME1265 XEOTICID XEO05105 MOACRIVE Inhibition DME1265 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1265 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05106 XEO_CLAS Peptide DME1265 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25-200 microM) DME1265 XEOTICID XEO05106 GENEFORM Protein DME1265 XEOTICID XEO05106 MOACRIVE Inhibition DME1265 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1265 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05108 XEO_CLAS Peptide DME1265 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40 microM) DME1265 XEOTICID XEO05108 GENEFORM Protein DME1265 XEOTICID XEO05108 MOACRIVE Inhibition DME1265 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1265 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1265 XEOTICID XEO05111 XEO_CLAS Natural Product DME1265 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05111 GENEFORM Protein DME1265 XEOTICID XEO05111 MOACRIVE Inhibition DME1265 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1265 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05119 XEO_CLAS Peptide DME1265 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05119 GENEFORM Protein DME1265 XEOTICID XEO05119 MOACRIVE Inhibition DME1265 XEOTICID XEO05120 XEO_NAME Thanatin DME1265 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05120 XEO_CLAS Peptide DME1265 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.3-0.6 microM) DME1265 XEOTICID XEO05120 GENEFORM Protein DME1265 XEOTICID XEO05120 MOACRIVE Inhibition DME1265 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1265 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05121 XEO_CLAS Peptide DME1265 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 62.5 ug/ml) DME1265 XEOTICID XEO05121 GENEFORM Protein DME1265 XEOTICID XEO05121 MOACRIVE Inhibition DME1265 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1265 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05125 XEO_CLAS Peptide DME1265 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05125 GENEFORM Protein DME1265 XEOTICID XEO05125 MOACRIVE Inhibition DME1265 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1265 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05130 XEO_CLAS Peptide DME1265 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05130 GENEFORM Protein DME1265 XEOTICID XEO05130 MOACRIVE Inhibition DME1265 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1265 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05144 XEO_CLAS Peptide DME1265 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40 ug/ml) DME1265 XEOTICID XEO05144 GENEFORM Protein DME1265 XEOTICID XEO05144 MOACRIVE Inhibition DME1265 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1265 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05145 XEO_CLAS Peptide DME1265 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 ug/ml) DME1265 XEOTICID XEO05145 GENEFORM Protein DME1265 XEOTICID XEO05145 MOACRIVE Inhibition DME1265 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1265 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05146 XEO_CLAS Peptide DME1265 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 40 ug/ml) DME1265 XEOTICID XEO05146 GENEFORM Protein DME1265 XEOTICID XEO05146 MOACRIVE Inhibition DME1265 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1265 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05147 XEO_CLAS Peptide DME1265 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 60 ug/ml) DME1265 XEOTICID XEO05147 GENEFORM Protein DME1265 XEOTICID XEO05147 MOACRIVE Inhibition DME1265 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1265 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05158 XEO_CLAS Peptide DME1265 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05158 GENEFORM Protein DME1265 XEOTICID XEO05158 MOACRIVE Inhibition DME1265 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1265 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05161 XEO_CLAS Peptide DME1265 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 32 ug/ml) DME1265 XEOTICID XEO05161 GENEFORM Protein DME1265 XEOTICID XEO05161 MOACRIVE Inhibition DME1265 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1265 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05162 XEO_CLAS Peptide DME1265 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 32 ug/ml) DME1265 XEOTICID XEO05162 GENEFORM Protein DME1265 XEOTICID XEO05162 MOACRIVE Inhibition DME1265 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1265 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05163 XEO_CLAS Peptide DME1265 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 12-25 ug/ml) DME1265 XEOTICID XEO05163 GENEFORM Protein DME1265 XEOTICID XEO05163 MOACRIVE Inhibition DME1265 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1265 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05170 XEO_CLAS Peptide DME1265 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 3.0 microM) DME1265 XEOTICID XEO05170 GENEFORM Protein DME1265 XEOTICID XEO05170 MOACRIVE Inhibition DME1265 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1265 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05171 XEO_CLAS Peptide DME1265 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 50 microM) DME1265 XEOTICID XEO05171 GENEFORM Protein DME1265 XEOTICID XEO05171 MOACRIVE Inhibition DME1265 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1265 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05179 XEO_CLAS Peptide DME1265 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05179 GENEFORM Protein DME1265 XEOTICID XEO05179 MOACRIVE Inhibition DME1265 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1265 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05180 XEO_CLAS Peptide DME1265 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 160 microM) DME1265 XEOTICID XEO05180 GENEFORM Protein DME1265 XEOTICID XEO05180 MOACRIVE Inhibition DME1265 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1265 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05182 XEO_CLAS Peptide DME1265 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 microM) DME1265 XEOTICID XEO05182 GENEFORM Protein DME1265 XEOTICID XEO05182 MOACRIVE Inhibition DME1265 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1265 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05183 XEO_CLAS Peptide DME1265 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 microM) DME1265 XEOTICID XEO05183 GENEFORM Protein DME1265 XEOTICID XEO05183 MOACRIVE Inhibition DME1265 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1265 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05184 XEO_CLAS Peptide DME1265 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 microM) DME1265 XEOTICID XEO05184 GENEFORM Protein DME1265 XEOTICID XEO05184 MOACRIVE Inhibition DME1265 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1265 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05185 XEO_CLAS Peptide DME1265 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 microM) DME1265 XEOTICID XEO05185 GENEFORM Protein DME1265 XEOTICID XEO05185 MOACRIVE Inhibition DME1265 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1265 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05186 XEO_CLAS Peptide DME1265 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 microM) DME1265 XEOTICID XEO05186 GENEFORM Protein DME1265 XEOTICID XEO05186 MOACRIVE Inhibition DME1265 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1265 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05187 XEO_CLAS Peptide DME1265 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16 microM) DME1265 XEOTICID XEO05187 GENEFORM Protein DME1265 XEOTICID XEO05187 MOACRIVE Inhibition DME1265 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1265 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05188 XEO_CLAS Peptide DME1265 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 64 microM) DME1265 XEOTICID XEO05188 GENEFORM Protein DME1265 XEOTICID XEO05188 MOACRIVE Inhibition DME1265 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1265 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05190 XEO_CLAS Peptide DME1265 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05190 GENEFORM Protein DME1265 XEOTICID XEO05190 MOACRIVE Inhibition DME1265 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1265 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05193 XEO_CLAS Peptide DME1265 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO05193 GENEFORM Protein DME1265 XEOTICID XEO05193 MOACRIVE Inhibition DME1265 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1265 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05197 XEO_CLAS Peptide DME1265 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05197 GENEFORM Protein DME1265 XEOTICID XEO05197 MOACRIVE Inhibition DME1265 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1265 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05205 XEO_CLAS Peptide DME1265 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05205 GENEFORM Protein DME1265 XEOTICID XEO05205 MOACRIVE Inhibition DME1265 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1265 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05206 XEO_CLAS Peptide DME1265 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 10 microM) DME1265 XEOTICID XEO05206 GENEFORM Protein DME1265 XEOTICID XEO05206 MOACRIVE Inhibition DME1265 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1265 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05207 XEO_CLAS Peptide DME1265 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 25 microM) DME1265 XEOTICID XEO05207 GENEFORM Protein DME1265 XEOTICID XEO05207 MOACRIVE Inhibition DME1265 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1265 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05208 XEO_CLAS Peptide DME1265 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 microM) DME1265 XEOTICID XEO05208 GENEFORM Protein DME1265 XEOTICID XEO05208 MOACRIVE Inhibition DME1265 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1265 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05209 XEO_CLAS Peptide DME1265 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 15 microM) DME1265 XEOTICID XEO05209 GENEFORM Protein DME1265 XEOTICID XEO05209 MOACRIVE Inhibition DME1265 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1265 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05212 XEO_CLAS Peptide DME1265 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.5 ug/ml) DME1265 XEOTICID XEO05212 GENEFORM Protein DME1265 XEOTICID XEO05212 MOACRIVE Inhibition DME1265 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1265 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05220 XEO_CLAS Peptide DME1265 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.6-1.2 microM) DME1265 XEOTICID XEO05220 GENEFORM Protein DME1265 XEOTICID XEO05220 MOACRIVE Inhibition DME1265 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1265 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05230 XEO_CLAS Peptide DME1265 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 7.90 microM) DME1265 XEOTICID XEO05230 GENEFORM Protein DME1265 XEOTICID XEO05230 MOACRIVE Inhibition DME1265 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1265 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05231 XEO_CLAS Peptide DME1265 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2.40 microM) DME1265 XEOTICID XEO05231 GENEFORM Protein DME1265 XEOTICID XEO05231 MOACRIVE Inhibition DME1265 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1265 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05232 XEO_CLAS Peptide DME1265 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05232 GENEFORM Protein DME1265 XEOTICID XEO05232 MOACRIVE Inhibition DME1265 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1265 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05233 XEO_CLAS Peptide DME1265 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 ug/ml) DME1265 XEOTICID XEO05233 GENEFORM Protein DME1265 XEOTICID XEO05233 MOACRIVE Inhibition DME1265 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1265 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05234 XEO_CLAS Peptide DME1265 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 ug/ml) DME1265 XEOTICID XEO05234 GENEFORM Protein DME1265 XEOTICID XEO05234 MOACRIVE Inhibition DME1265 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1265 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05235 XEO_CLAS Peptide DME1265 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 30 ug/ml) DME1265 XEOTICID XEO05235 GENEFORM Protein DME1265 XEOTICID XEO05235 MOACRIVE Inhibition DME1265 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1265 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05237 XEO_CLAS Peptide DME1265 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 microM) DME1265 XEOTICID XEO05237 GENEFORM Protein DME1265 XEOTICID XEO05237 MOACRIVE Inhibition DME1265 XEOTICID XEO05245 XEO_NAME Viresin DME1265 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05245 XEO_CLAS Peptide DME1265 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05245 GENEFORM Protein DME1265 XEOTICID XEO05245 MOACRIVE Inhibition DME1265 XEOTICID XEO05248 XEO_NAME Vitamin C DME1265 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1265 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1265 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05248 GENEFORM Protein DME1265 XEOTICID XEO05248 MOACRIVE Inhibition DME1265 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1265 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05264 XEO_CLAS Peptide DME1265 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 4 ug/ml) DME1265 XEOTICID XEO05264 GENEFORM Protein DME1265 XEOTICID XEO05264 MOACRIVE Inhibition DME1265 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1265 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05267 XEO_CLAS Peptide DME1265 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 2 ug/ml) DME1265 XEOTICID XEO05267 GENEFORM Protein DME1265 XEOTICID XEO05267 MOACRIVE Inhibition DME1265 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1265 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05268 XEO_CLAS Peptide DME1265 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 1.6 ug/ml) DME1265 XEOTICID XEO05268 GENEFORM Protein DME1265 XEOTICID XEO05268 MOACRIVE Inhibition DME1265 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1265 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05269 XEO_CLAS Peptide DME1265 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 6 ug/ml) DME1265 XEOTICID XEO05269 GENEFORM Protein DME1265 XEOTICID XEO05269 MOACRIVE Inhibition DME1265 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1265 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05273 XEO_CLAS Peptide DME1265 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05273 GENEFORM Protein DME1265 XEOTICID XEO05273 MOACRIVE Inhibition DME1265 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1265 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05274 XEO_CLAS Peptide DME1265 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05274 GENEFORM Protein DME1265 XEOTICID XEO05274 MOACRIVE Inhibition DME1265 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1265 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05287 XEO_CLAS Peptide DME1265 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli DME1265 XEOTICID XEO05287 GENEFORM Protein DME1265 XEOTICID XEO05287 MOACRIVE Inhibition DME1265 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1265 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05303 XEO_CLAS Peptide DME1265 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 16-31 ug/ml) DME1265 XEOTICID XEO05303 GENEFORM Protein DME1265 XEOTICID XEO05303 MOACRIVE Inhibition DME1265 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1265 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05306 XEO_CLAS Peptide DME1265 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 8 ug/ml) DME1265 XEOTICID XEO05306 GENEFORM Protein DME1265 XEOTICID XEO05306 MOACRIVE Inhibition DME1265 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1265 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1265 XEOTICID XEO05308 XEO_CLAS Peptide DME1265 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Escherichia coli (MIC = 0.4 ug/ml) DME1265 XEOTICID XEO05308 GENEFORM Protein DME1265 XEOTICID XEO05308 MOACRIVE Inhibition DME1272 DME___ID DME1272 DME1272 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1272 SPESNAME Gardnerella vaginalis DME1272 XEOTICID XEO04156 XEO_NAME Mutacin II mutacin H-29B DME1272 XEOTICID XEO04156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1272 XEOTICID XEO04156 XEO_CLAS Peptide DME1272 XEOTICID XEO04156 DESCRIPT Mutacin II mutacin H-29B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Gardnerella vaginalis DME1272 XEOTICID XEO04156 GENEFORM Protein DME1272 XEOTICID XEO04156 MOACRIVE Inhibition DME1273 DME___ID DME1273 DME1273 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1273 SPESNAME Klebsiella oxytoca DME1273 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1273 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO01812 XEO_CLAS Peptide DME1273 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca (MIC = 4.0 microM) DME1273 XEOTICID XEO01812 GENEFORM Protein DME1273 XEOTICID XEO01812 MOACRIVE Inhibition DME1273 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1273 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO01813 XEO_CLAS Peptide DME1273 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca (MIC = 4.1 microM) DME1273 XEOTICID XEO01813 GENEFORM Protein DME1273 XEOTICID XEO01813 MOACRIVE Inhibition DME1273 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1273 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO01814 XEO_CLAS Peptide DME1273 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca (MIC = 2.4 microM) DME1273 XEOTICID XEO01814 GENEFORM Protein DME1273 XEOTICID XEO01814 MOACRIVE Inhibition DME1273 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1273 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO01815 XEO_CLAS Peptide DME1273 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca (MIC = 6.1 microM) DME1273 XEOTICID XEO01815 GENEFORM Protein DME1273 XEOTICID XEO01815 MOACRIVE Inhibition DME1273 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1273 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO02284 XEO_CLAS Peptide DME1273 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca (MIC = 50.5 microM) DME1273 XEOTICID XEO02284 GENEFORM Protein DME1273 XEOTICID XEO02284 MOACRIVE Inhibition DME1273 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1273 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO02285 XEO_CLAS Peptide DME1273 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca (MIC = 50.5 microM) DME1273 XEOTICID XEO02285 GENEFORM Protein DME1273 XEOTICID XEO02285 MOACRIVE Inhibition DME1273 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1273 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO02286 XEO_CLAS Peptide DME1273 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca (MIC = 50.5 microM) DME1273 XEOTICID XEO02286 GENEFORM Protein DME1273 XEOTICID XEO02286 MOACRIVE Inhibition DME1273 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1273 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO02287 XEO_CLAS Peptide DME1273 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca (MIC = 50.5 microM) DME1273 XEOTICID XEO02287 GENEFORM Protein DME1273 XEOTICID XEO02287 MOACRIVE Inhibition DME1273 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1273 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO03039 XEO_CLAS Peptide DME1273 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca (MIC = 5.80 microM) DME1273 XEOTICID XEO03039 GENEFORM Protein DME1273 XEOTICID XEO03039 MOACRIVE Inhibition DME1273 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1273 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO03609 XEO_CLAS Peptide DME1273 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca DME1273 XEOTICID XEO03609 GENEFORM Protein DME1273 XEOTICID XEO03609 MOACRIVE Inhibition DME1273 XEOTICID XEO03693 XEO_NAME Kalata-B1 DME1273 XEOTICID XEO03693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO03693 XEO_CLAS Peptide DME1273 XEOTICID XEO03693 DESCRIPT Kalata-B1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca (MIC = 54.8 microM) DME1273 XEOTICID XEO03693 GENEFORM Protein DME1273 XEOTICID XEO03693 MOACRIVE Inhibition DME1273 XEOTICID XEO04114 XEO_NAME Microcin L DME1273 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO04114 XEO_CLAS Peptide DME1273 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca DME1273 XEOTICID XEO04114 GENEFORM Protein DME1273 XEOTICID XEO04114 MOACRIVE Inhibition DME1273 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1273 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO04259 XEO_CLAS Peptide DME1273 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca DME1273 XEOTICID XEO04259 GENEFORM Protein DME1273 XEOTICID XEO04259 MOACRIVE Inhibition DME1273 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1273 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO04261 XEO_CLAS Peptide DME1273 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca DME1273 XEOTICID XEO04261 GENEFORM Protein DME1273 XEOTICID XEO04261 MOACRIVE Inhibition DME1273 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1273 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO04265 XEO_CLAS Peptide DME1273 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca DME1273 XEOTICID XEO04265 GENEFORM Protein DME1273 XEOTICID XEO04265 MOACRIVE Inhibition DME1273 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1273 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO04268 XEO_CLAS Peptide DME1273 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca DME1273 XEOTICID XEO04268 GENEFORM Protein DME1273 XEOTICID XEO04268 MOACRIVE Inhibition DME1273 XEOTICID XEO04863 XEO_NAME RTD peptide DME1273 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO04863 XEO_CLAS Peptide DME1273 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca (MIC = 2.0 microM) DME1273 XEOTICID XEO04863 GENEFORM Protein DME1273 XEOTICID XEO04863 MOACRIVE Inhibition DME1273 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1273 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1273 XEOTICID XEO05170 XEO_CLAS Peptide DME1273 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella oxytoca (MIC = 2.1 microM) DME1273 XEOTICID XEO05170 GENEFORM Protein DME1273 XEOTICID XEO05170 MOACRIVE Inhibition DME1274 DME___ID DME1274 DME1274 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1274 SPESNAME Klebsiella pneumoniae DME1274 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1274 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1274 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1274 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO00546 GENEFORM Protein DME1274 XEOTICID XEO00546 MOACRIVE Inhibition DME1274 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1274 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1274 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1274 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO00574 GENEFORM Protein DME1274 XEOTICID XEO00574 MOACRIVE Inhibition DME1274 XEOTICID XEO01266 XEO_NAME Cyanidin DME1274 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME1274 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME1274 XEOTICID XEO01266 DESCRIPT Cyanidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO01266 GENEFORM Protein DME1274 XEOTICID XEO01266 MOACRIVE Inhibition DME1274 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1274 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO01816 XEO_CLAS Peptide DME1274 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 6.25 microM) DME1274 XEOTICID XEO01816 GENEFORM Protein DME1274 XEOTICID XEO01816 MOACRIVE Inhibition DME1274 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1274 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO01827 XEO_CLAS Peptide DME1274 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC > 50 microM) DME1274 XEOTICID XEO01827 GENEFORM Protein DME1274 XEOTICID XEO01827 MOACRIVE Inhibition DME1274 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1274 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02115 XEO_CLAS Peptide DME1274 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO02115 GENEFORM Protein DME1274 XEOTICID XEO02115 MOACRIVE Inhibition DME1274 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1274 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02230 XEO_CLAS Peptide DME1274 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1274 XEOTICID XEO02230 GENEFORM Protein DME1274 XEOTICID XEO02230 MOACRIVE Inhibition DME1274 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1274 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02280 XEO_CLAS Peptide DME1274 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO02280 GENEFORM Protein DME1274 XEOTICID XEO02280 MOACRIVE Inhibition DME1274 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1274 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02325 XEO_CLAS Peptide DME1274 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 13 microM) DME1274 XEOTICID XEO02325 GENEFORM Protein DME1274 XEOTICID XEO02325 MOACRIVE Inhibition DME1274 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1274 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02370 XEO_CLAS Peptide DME1274 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO02370 GENEFORM Protein DME1274 XEOTICID XEO02370 MOACRIVE Inhibition DME1274 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1274 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02371 XEO_CLAS Peptide DME1274 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 12 ug/ml) DME1274 XEOTICID XEO02371 GENEFORM Protein DME1274 XEOTICID XEO02371 MOACRIVE Inhibition DME1274 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1274 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02378 XEO_CLAS Peptide DME1274 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 0.76 ug/ml) DME1274 XEOTICID XEO02378 GENEFORM Protein DME1274 XEOTICID XEO02378 MOACRIVE Inhibition DME1274 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1274 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02416 XEO_CLAS Peptide DME1274 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO02416 GENEFORM Protein DME1274 XEOTICID XEO02416 MOACRIVE Inhibition DME1274 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1274 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02451 XEO_CLAS Peptide DME1274 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO02451 GENEFORM Protein DME1274 XEOTICID XEO02451 MOACRIVE Inhibition DME1274 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1274 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02473 XEO_CLAS Peptide DME1274 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO02473 GENEFORM Protein DME1274 XEOTICID XEO02473 MOACRIVE Inhibition DME1274 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1274 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02491 XEO_CLAS Peptide DME1274 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 2.8 microM) DME1274 XEOTICID XEO02491 GENEFORM Protein DME1274 XEOTICID XEO02491 MOACRIVE Inhibition DME1274 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1274 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02496 XEO_CLAS Peptide DME1274 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 50 microM) DME1274 XEOTICID XEO02496 GENEFORM Protein DME1274 XEOTICID XEO02496 MOACRIVE Inhibition DME1274 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1274 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02497 XEO_CLAS Peptide DME1274 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC > 50 microM) DME1274 XEOTICID XEO02497 GENEFORM Protein DME1274 XEOTICID XEO02497 MOACRIVE Inhibition DME1274 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1274 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02512 XEO_CLAS Peptide DME1274 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 150 microM) DME1274 XEOTICID XEO02512 GENEFORM Protein DME1274 XEOTICID XEO02512 MOACRIVE Inhibition DME1274 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1274 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02566 XEO_CLAS Peptide DME1274 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC > 100 microM) DME1274 XEOTICID XEO02566 GENEFORM Protein DME1274 XEOTICID XEO02566 MOACRIVE Inhibition DME1274 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1274 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02637 XEO_CLAS Peptide DME1274 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 6 microM) DME1274 XEOTICID XEO02637 GENEFORM Protein DME1274 XEOTICID XEO02637 MOACRIVE Inhibition DME1274 XEOTICID XEO02656 XEO_NAME Himatanthus drasticus butanolic extract DME1274 XEOTICID XEO02656 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1274 XEOTICID XEO02656 XEO_CLAS Plant Extract DME1274 XEOTICID XEO02656 DESCRIPT Himatanthus drasticus butanolic extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO02656 GENEFORM Protein DME1274 XEOTICID XEO02656 MOACRIVE Inhibition DME1274 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1274 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02688 XEO_CLAS Peptide DME1274 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 25 microM) DME1274 XEOTICID XEO02688 GENEFORM Protein DME1274 XEOTICID XEO02688 MOACRIVE Inhibition DME1274 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1274 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02708 XEO_CLAS Peptide DME1274 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 20 ug/ml) DME1274 XEOTICID XEO02708 GENEFORM Protein DME1274 XEOTICID XEO02708 MOACRIVE Inhibition DME1274 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1274 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02732 XEO_CLAS Peptide DME1274 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 1.25 microM) DME1274 XEOTICID XEO02732 GENEFORM Protein DME1274 XEOTICID XEO02732 MOACRIVE Inhibition DME1274 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1274 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02734 XEO_CLAS Peptide DME1274 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 0.40 microM) DME1274 XEOTICID XEO02734 GENEFORM Protein DME1274 XEOTICID XEO02734 MOACRIVE Inhibition DME1274 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1274 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02736 XEO_CLAS Peptide DME1274 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 0.66 microM) DME1274 XEOTICID XEO02736 GENEFORM Protein DME1274 XEOTICID XEO02736 MOACRIVE Inhibition DME1274 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1274 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02738 XEO_CLAS Peptide DME1274 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 1 microM) DME1274 XEOTICID XEO02738 GENEFORM Protein DME1274 XEOTICID XEO02738 MOACRIVE Inhibition DME1274 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1274 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02743 XEO_CLAS Peptide DME1274 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 4.7 ug/ml) DME1274 XEOTICID XEO02743 GENEFORM Protein DME1274 XEOTICID XEO02743 MOACRIVE Inhibition DME1274 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1274 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02749 XEO_CLAS Peptide DME1274 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 20 mug/ml) DME1274 XEOTICID XEO02749 GENEFORM Protein DME1274 XEOTICID XEO02749 MOACRIVE Inhibition DME1274 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1274 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02767 XEO_CLAS Peptide DME1274 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO02767 GENEFORM Protein DME1274 XEOTICID XEO02767 MOACRIVE Inhibition DME1274 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1274 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02768 XEO_CLAS Peptide DME1274 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 1-2.5 ug/ml) DME1274 XEOTICID XEO02768 GENEFORM Protein DME1274 XEOTICID XEO02768 MOACRIVE Inhibition DME1274 XEOTICID XEO02780 XEO_NAME Cefixime DME1274 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1274 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1274 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO02780 GENEFORM Protein DME1274 XEOTICID XEO02780 MOACRIVE Inhibition DME1274 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1274 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO02942 XEO_CLAS Peptide DME1274 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO02942 GENEFORM Protein DME1274 XEOTICID XEO02942 MOACRIVE Inhibition DME1274 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1274 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03029 XEO_CLAS Peptide DME1274 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 0.145 microM) DME1274 XEOTICID XEO03029 GENEFORM Protein DME1274 XEOTICID XEO03029 MOACRIVE Inhibition DME1274 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1274 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03030 XEO_CLAS Peptide DME1274 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 0.643 microM) DME1274 XEOTICID XEO03030 GENEFORM Protein DME1274 XEOTICID XEO03030 MOACRIVE Inhibition DME1274 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1274 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03031 XEO_CLAS Peptide DME1274 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 0.01 microM) DME1274 XEOTICID XEO03031 GENEFORM Protein DME1274 XEOTICID XEO03031 MOACRIVE Inhibition DME1274 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1274 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03032 XEO_CLAS Peptide DME1274 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC < 0.005 microM) DME1274 XEOTICID XEO03032 GENEFORM Protein DME1274 XEOTICID XEO03032 MOACRIVE Inhibition DME1274 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1274 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03033 XEO_CLAS Peptide DME1274 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC > 0.692 microM) DME1274 XEOTICID XEO03033 GENEFORM Protein DME1274 XEOTICID XEO03033 MOACRIVE Inhibition DME1274 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1274 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03034 XEO_CLAS Peptide DME1274 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 0.004 microM) DME1274 XEOTICID XEO03034 GENEFORM Protein DME1274 XEOTICID XEO03034 MOACRIVE Inhibition DME1274 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1274 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03035 XEO_CLAS Peptide DME1274 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 0.458 microM) DME1274 XEOTICID XEO03035 GENEFORM Protein DME1274 XEOTICID XEO03035 MOACRIVE Inhibition DME1274 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1274 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03051 XEO_CLAS Peptide DME1274 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1274 XEOTICID XEO03051 GENEFORM Protein DME1274 XEOTICID XEO03051 MOACRIVE Inhibition DME1274 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1274 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03052 XEO_CLAS Peptide DME1274 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1274 XEOTICID XEO03052 GENEFORM Protein DME1274 XEOTICID XEO03052 MOACRIVE Inhibition DME1274 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1274 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03053 XEO_CLAS Peptide DME1274 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1274 XEOTICID XEO03053 GENEFORM Protein DME1274 XEOTICID XEO03053 MOACRIVE Inhibition DME1274 XEOTICID XEO03089 XEO_NAME Decoralin DME1274 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03089 XEO_CLAS Peptide DME1274 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 80 microM) DME1274 XEOTICID XEO03089 GENEFORM Protein DME1274 XEOTICID XEO03089 MOACRIVE Inhibition DME1274 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1274 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03112 XEO_CLAS Peptide DME1274 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC > 50 ug/ml) DME1274 XEOTICID XEO03112 GENEFORM Protein DME1274 XEOTICID XEO03112 MOACRIVE Inhibition DME1274 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1274 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03137 XEO_CLAS Peptide DME1274 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03137 GENEFORM Protein DME1274 XEOTICID XEO03137 MOACRIVE Inhibition DME1274 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1274 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03162 XEO_CLAS Peptide DME1274 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 0.8 microM) DME1274 XEOTICID XEO03162 GENEFORM Protein DME1274 XEOTICID XEO03162 MOACRIVE Inhibition DME1274 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1274 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03224 XEO_CLAS Peptide DME1274 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1274 XEOTICID XEO03224 GENEFORM Protein DME1274 XEOTICID XEO03224 MOACRIVE Inhibition DME1274 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1274 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03235 XEO_CLAS Peptide DME1274 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 60 ug/ml) DME1274 XEOTICID XEO03235 GENEFORM Protein DME1274 XEOTICID XEO03235 MOACRIVE Inhibition DME1274 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1274 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03237 XEO_CLAS Peptide DME1274 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC > 100 ug/ml) DME1274 XEOTICID XEO03237 GENEFORM Protein DME1274 XEOTICID XEO03237 MOACRIVE Inhibition DME1274 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1274 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03238 XEO_CLAS Peptide DME1274 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1274 XEOTICID XEO03238 GENEFORM Protein DME1274 XEOTICID XEO03238 MOACRIVE Inhibition DME1274 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1274 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03239 XEO_CLAS Peptide DME1274 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1274 XEOTICID XEO03239 GENEFORM Protein DME1274 XEOTICID XEO03239 MOACRIVE Inhibition DME1274 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1274 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03250 XEO_CLAS Peptide DME1274 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03250 GENEFORM Protein DME1274 XEOTICID XEO03250 MOACRIVE Inhibition DME1274 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1274 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03251 XEO_CLAS Peptide DME1274 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03251 GENEFORM Protein DME1274 XEOTICID XEO03251 MOACRIVE Inhibition DME1274 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1274 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03253 XEO_CLAS Peptide DME1274 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 3.2 ug/ml) DME1274 XEOTICID XEO03253 GENEFORM Protein DME1274 XEOTICID XEO03253 MOACRIVE Inhibition DME1274 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1274 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1274 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1274 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03348 GENEFORM Protein DME1274 XEOTICID XEO03348 MOACRIVE Inhibition DME1274 XEOTICID XEO03387 XEO_NAME Ferric chloride DME1274 XEOTICID XEO03387 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1274 XEOTICID XEO03387 XEO_CLAS Chemical Compound DME1274 XEOTICID XEO03387 DESCRIPT Ferric chloride inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03387 GENEFORM Protein DME1274 XEOTICID XEO03387 MOACRIVE Inhibition DME1274 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1274 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03436 XEO_CLAS Peptide DME1274 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1274 XEOTICID XEO03436 GENEFORM Protein DME1274 XEOTICID XEO03436 MOACRIVE Inhibition DME1274 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1274 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03437 XEO_CLAS Peptide DME1274 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1274 XEOTICID XEO03437 GENEFORM Protein DME1274 XEOTICID XEO03437 MOACRIVE Inhibition DME1274 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1274 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03438 XEO_CLAS Peptide DME1274 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1274 XEOTICID XEO03438 GENEFORM Protein DME1274 XEOTICID XEO03438 MOACRIVE Inhibition DME1274 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1274 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03439 XEO_CLAS Peptide DME1274 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1274 XEOTICID XEO03439 GENEFORM Protein DME1274 XEOTICID XEO03439 MOACRIVE Inhibition DME1274 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1274 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03440 XEO_CLAS Peptide DME1274 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1274 XEOTICID XEO03440 GENEFORM Protein DME1274 XEOTICID XEO03440 MOACRIVE Inhibition DME1274 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1274 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03441 XEO_CLAS Peptide DME1274 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1274 XEOTICID XEO03441 GENEFORM Protein DME1274 XEOTICID XEO03441 MOACRIVE Inhibition DME1274 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1274 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03497 XEO_CLAS Peptide DME1274 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1274 XEOTICID XEO03497 GENEFORM Protein DME1274 XEOTICID XEO03497 MOACRIVE Inhibition DME1274 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1274 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03498 XEO_CLAS Peptide DME1274 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1274 XEOTICID XEO03498 GENEFORM Protein DME1274 XEOTICID XEO03498 MOACRIVE Inhibition DME1274 XEOTICID XEO03519 XEO_NAME Hadrurin DME1274 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03519 XEO_CLAS Peptide DME1274 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03519 GENEFORM Protein DME1274 XEOTICID XEO03519 MOACRIVE Inhibition DME1274 XEOTICID XEO03522 XEO_NAME Halocyntin DME1274 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03522 XEO_CLAS Peptide DME1274 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03522 GENEFORM Protein DME1274 XEOTICID XEO03522 MOACRIVE Inhibition DME1274 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1274 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03540 XEO_CLAS Peptide DME1274 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1274 XEOTICID XEO03540 GENEFORM Protein DME1274 XEOTICID XEO03540 MOACRIVE Inhibition DME1274 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1274 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03549 XEO_CLAS Peptide DME1274 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03549 GENEFORM Protein DME1274 XEOTICID XEO03549 MOACRIVE Inhibition DME1274 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1274 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1274 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1274 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03552 GENEFORM Protein DME1274 XEOTICID XEO03552 MOACRIVE Inhibition DME1274 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1274 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03556 XEO_CLAS Peptide DME1274 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1274 XEOTICID XEO03556 GENEFORM Protein DME1274 XEOTICID XEO03556 MOACRIVE Inhibition DME1274 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1274 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03557 XEO_CLAS Peptide DME1274 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1274 XEOTICID XEO03557 GENEFORM Protein DME1274 XEOTICID XEO03557 MOACRIVE Inhibition DME1274 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1274 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03591 XEO_CLAS Peptide DME1274 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1274 XEOTICID XEO03591 GENEFORM Protein DME1274 XEOTICID XEO03591 MOACRIVE Inhibition DME1274 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1274 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03593 XEO_CLAS Peptide DME1274 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1274 XEOTICID XEO03593 GENEFORM Protein DME1274 XEOTICID XEO03593 MOACRIVE Inhibition DME1274 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1274 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03609 XEO_CLAS Peptide DME1274 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03609 GENEFORM Protein DME1274 XEOTICID XEO03609 MOACRIVE Inhibition DME1274 XEOTICID XEO03611 XEO_NAME Himatanthus drasticus hydroalcoholic extract DME1274 XEOTICID XEO03611 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1274 XEOTICID XEO03611 XEO_CLAS Plant Extract DME1274 XEOTICID XEO03611 DESCRIPT Himatanthus drasticus hydroalcoholic extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03611 GENEFORM Protein DME1274 XEOTICID XEO03611 MOACRIVE Inhibition DME1274 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1274 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03622 XEO_CLAS Peptide DME1274 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 20-40 microM) DME1274 XEOTICID XEO03622 GENEFORM Protein DME1274 XEOTICID XEO03622 MOACRIVE Inhibition DME1274 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1274 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03630 XEO_CLAS Peptide DME1274 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03630 GENEFORM Protein DME1274 XEOTICID XEO03630 MOACRIVE Inhibition DME1274 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1274 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03631 XEO_CLAS Peptide DME1274 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03631 GENEFORM Protein DME1274 XEOTICID XEO03631 MOACRIVE Inhibition DME1274 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1274 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03632 XEO_CLAS Peptide DME1274 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03632 GENEFORM Protein DME1274 XEOTICID XEO03632 MOACRIVE Inhibition DME1274 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1274 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03633 XEO_CLAS Peptide DME1274 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03633 GENEFORM Protein DME1274 XEOTICID XEO03633 MOACRIVE Inhibition DME1274 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1274 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03634 XEO_CLAS Peptide DME1274 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03634 GENEFORM Protein DME1274 XEOTICID XEO03634 MOACRIVE Inhibition DME1274 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1274 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03635 XEO_CLAS Peptide DME1274 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03635 GENEFORM Protein DME1274 XEOTICID XEO03635 MOACRIVE Inhibition DME1274 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1274 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03636 XEO_CLAS Peptide DME1274 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03636 GENEFORM Protein DME1274 XEOTICID XEO03636 MOACRIVE Inhibition DME1274 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1274 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03637 XEO_CLAS Peptide DME1274 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03637 GENEFORM Protein DME1274 XEOTICID XEO03637 MOACRIVE Inhibition DME1274 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1274 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03638 XEO_CLAS Peptide DME1274 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03638 GENEFORM Protein DME1274 XEOTICID XEO03638 MOACRIVE Inhibition DME1274 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1274 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03639 XEO_CLAS Peptide DME1274 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03639 GENEFORM Protein DME1274 XEOTICID XEO03639 MOACRIVE Inhibition DME1274 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1274 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03640 XEO_CLAS Peptide DME1274 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03640 GENEFORM Protein DME1274 XEOTICID XEO03640 MOACRIVE Inhibition DME1274 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1274 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03672 XEO_CLAS Peptide DME1274 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1274 XEOTICID XEO03672 GENEFORM Protein DME1274 XEOTICID XEO03672 MOACRIVE Inhibition DME1274 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1274 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03673 XEO_CLAS Peptide DME1274 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1274 XEOTICID XEO03673 GENEFORM Protein DME1274 XEOTICID XEO03673 MOACRIVE Inhibition DME1274 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1274 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03674 XEO_CLAS Peptide DME1274 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO03674 GENEFORM Protein DME1274 XEOTICID XEO03674 MOACRIVE Inhibition DME1274 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1274 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03675 XEO_CLAS Peptide DME1274 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 15 microM) DME1274 XEOTICID XEO03675 GENEFORM Protein DME1274 XEOTICID XEO03675 MOACRIVE Inhibition DME1274 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1274 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03678 XEO_CLAS Peptide DME1274 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1274 XEOTICID XEO03678 GENEFORM Protein DME1274 XEOTICID XEO03678 MOACRIVE Inhibition DME1274 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1274 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03681 XEO_CLAS Peptide DME1274 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 1.2-2.5 microM) DME1274 XEOTICID XEO03681 GENEFORM Protein DME1274 XEOTICID XEO03681 MOACRIVE Inhibition DME1274 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1274 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03697 XEO_CLAS Peptide DME1274 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 25 microM) DME1274 XEOTICID XEO03697 GENEFORM Protein DME1274 XEOTICID XEO03697 MOACRIVE Inhibition DME1274 XEOTICID XEO03724 XEO_NAME L10 peptide DME1274 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03724 XEO_CLAS Peptide DME1274 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 3.35 microM) DME1274 XEOTICID XEO03724 GENEFORM Protein DME1274 XEOTICID XEO03724 MOACRIVE Inhibition DME1274 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1274 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03744 XEO_CLAS Peptide DME1274 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1274 XEOTICID XEO03744 GENEFORM Protein DME1274 XEOTICID XEO03744 MOACRIVE Inhibition DME1274 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1274 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03746 XEO_CLAS Peptide DME1274 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1274 XEOTICID XEO03746 GENEFORM Protein DME1274 XEOTICID XEO03746 MOACRIVE Inhibition DME1274 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1274 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03747 XEO_CLAS Peptide DME1274 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1274 XEOTICID XEO03747 GENEFORM Protein DME1274 XEOTICID XEO03747 MOACRIVE Inhibition DME1274 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1274 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03748 XEO_CLAS Peptide DME1274 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1274 XEOTICID XEO03748 GENEFORM Protein DME1274 XEOTICID XEO03748 MOACRIVE Inhibition DME1274 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1274 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03749 XEO_CLAS Peptide DME1274 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1274 XEOTICID XEO03749 GENEFORM Protein DME1274 XEOTICID XEO03749 MOACRIVE Inhibition DME1274 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1274 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03750 XEO_CLAS Peptide DME1274 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1274 XEOTICID XEO03750 GENEFORM Protein DME1274 XEOTICID XEO03750 MOACRIVE Inhibition DME1274 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1274 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03751 XEO_CLAS Peptide DME1274 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1274 XEOTICID XEO03751 GENEFORM Protein DME1274 XEOTICID XEO03751 MOACRIVE Inhibition DME1274 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1274 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03752 XEO_CLAS Peptide DME1274 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1274 XEOTICID XEO03752 GENEFORM Protein DME1274 XEOTICID XEO03752 MOACRIVE Inhibition DME1274 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1274 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03753 XEO_CLAS Peptide DME1274 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1274 XEOTICID XEO03753 GENEFORM Protein DME1274 XEOTICID XEO03753 MOACRIVE Inhibition DME1274 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1274 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03754 XEO_CLAS Peptide DME1274 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1274 XEOTICID XEO03754 GENEFORM Protein DME1274 XEOTICID XEO03754 MOACRIVE Inhibition DME1274 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1274 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03755 XEO_CLAS Peptide DME1274 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1274 XEOTICID XEO03755 GENEFORM Protein DME1274 XEOTICID XEO03755 MOACRIVE Inhibition DME1274 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1274 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03756 XEO_CLAS Peptide DME1274 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1274 XEOTICID XEO03756 GENEFORM Protein DME1274 XEOTICID XEO03756 MOACRIVE Inhibition DME1274 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1274 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03759 XEO_CLAS Peptide DME1274 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1274 XEOTICID XEO03759 GENEFORM Protein DME1274 XEOTICID XEO03759 MOACRIVE Inhibition DME1274 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1274 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03761 XEO_CLAS Peptide DME1274 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1274 XEOTICID XEO03761 GENEFORM Protein DME1274 XEOTICID XEO03761 MOACRIVE Inhibition DME1274 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1274 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO03985 XEO_CLAS Peptide DME1274 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1274 XEOTICID XEO03985 GENEFORM Protein DME1274 XEOTICID XEO03985 MOACRIVE Inhibition DME1274 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1274 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04001 XEO_CLAS Peptide DME1274 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 12.5 microM) DME1274 XEOTICID XEO04001 GENEFORM Protein DME1274 XEOTICID XEO04001 MOACRIVE Inhibition DME1274 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1274 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04007 XEO_CLAS Peptide DME1274 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1274 XEOTICID XEO04007 GENEFORM Protein DME1274 XEOTICID XEO04007 MOACRIVE Inhibition DME1274 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1274 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04011 XEO_CLAS Peptide DME1274 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1274 XEOTICID XEO04011 GENEFORM Protein DME1274 XEOTICID XEO04011 MOACRIVE Inhibition DME1274 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1274 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04012 XEO_CLAS Peptide DME1274 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1274 XEOTICID XEO04012 GENEFORM Protein DME1274 XEOTICID XEO04012 MOACRIVE Inhibition DME1274 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1274 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04013 XEO_CLAS Peptide DME1274 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1274 XEOTICID XEO04013 GENEFORM Protein DME1274 XEOTICID XEO04013 MOACRIVE Inhibition DME1274 XEOTICID XEO04014 XEO_NAME Maximin-5 DME1274 XEOTICID XEO04014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04014 XEO_CLAS Peptide DME1274 XEOTICID XEO04014 DESCRIPT Maximin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 3.6 ug/ml) DME1274 XEOTICID XEO04014 GENEFORM Protein DME1274 XEOTICID XEO04014 MOACRIVE Inhibition DME1274 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1274 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1274 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1274 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04087 GENEFORM Protein DME1274 XEOTICID XEO04087 MOACRIVE Inhibition DME1274 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1274 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04111 XEO_CLAS Peptide DME1274 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04111 GENEFORM Protein DME1274 XEOTICID XEO04111 MOACRIVE Inhibition DME1274 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1274 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04241 XEO_CLAS Peptide DME1274 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04241 GENEFORM Protein DME1274 XEOTICID XEO04241 MOACRIVE Inhibition DME1274 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1274 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04242 XEO_CLAS Peptide DME1274 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04242 GENEFORM Protein DME1274 XEOTICID XEO04242 MOACRIVE Inhibition DME1274 XEOTICID XEO04331 XEO_NAME Norspermidine DME1274 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1274 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1274 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04331 GENEFORM Protein DME1274 XEOTICID XEO04331 MOACRIVE Inhibition DME1274 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1274 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04348 XEO_CLAS Peptide DME1274 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 80 microM) DME1274 XEOTICID XEO04348 GENEFORM Protein DME1274 XEOTICID XEO04348 MOACRIVE Inhibition DME1274 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1274 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04349 XEO_CLAS Peptide DME1274 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 100 microM) DME1274 XEOTICID XEO04349 GENEFORM Protein DME1274 XEOTICID XEO04349 MOACRIVE Inhibition DME1274 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1274 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04399 XEO_CLAS Peptide DME1274 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 6.3 microM) DME1274 XEOTICID XEO04399 GENEFORM Protein DME1274 XEOTICID XEO04399 MOACRIVE Inhibition DME1274 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1274 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04426 XEO_CLAS Peptide DME1274 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 2 microM) DME1274 XEOTICID XEO04426 GENEFORM Protein DME1274 XEOTICID XEO04426 MOACRIVE Inhibition DME1274 XEOTICID XEO04468 XEO_NAME Papillosin DME1274 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04468 XEO_CLAS Peptide DME1274 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04468 GENEFORM Protein DME1274 XEOTICID XEO04468 MOACRIVE Inhibition DME1274 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1274 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04471 XEO_CLAS Peptide DME1274 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 1.6 microM) DME1274 XEOTICID XEO04471 GENEFORM Protein DME1274 XEOTICID XEO04471 MOACRIVE Inhibition DME1274 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1274 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04506 XEO_CLAS Peptide DME1274 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC > 20 microM) DME1274 XEOTICID XEO04506 GENEFORM Protein DME1274 XEOTICID XEO04506 MOACRIVE Inhibition DME1274 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1274 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04507 XEO_CLAS Peptide DME1274 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC > 40 microM) DME1274 XEOTICID XEO04507 GENEFORM Protein DME1274 XEOTICID XEO04507 MOACRIVE Inhibition DME1274 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1274 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04510 XEO_CLAS Peptide DME1274 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC > 50 microM) DME1274 XEOTICID XEO04510 GENEFORM Protein DME1274 XEOTICID XEO04510 MOACRIVE Inhibition DME1274 XEOTICID XEO04531 XEO_NAME Mollusca/molluscs/mollusks peptide 2 DME1274 XEOTICID XEO04531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04531 XEO_CLAS Peptide DME1274 XEOTICID XEO04531 DESCRIPT Mollusca/molluscs/mollusks peptide 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04531 GENEFORM Protein DME1274 XEOTICID XEO04531 MOACRIVE Inhibition DME1274 XEOTICID XEO04533 XEO_NAME Mollusca/molluscs/mollusks peptide 3 DME1274 XEOTICID XEO04533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04533 XEO_CLAS Peptide DME1274 XEOTICID XEO04533 DESCRIPT Mollusca/molluscs/mollusks peptide 3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04533 GENEFORM Protein DME1274 XEOTICID XEO04533 MOACRIVE Inhibition DME1274 XEOTICID XEO04534 XEO_NAME Mollusca/molluscs/mollusks peptide 4 DME1274 XEOTICID XEO04534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04534 XEO_CLAS Peptide DME1274 XEOTICID XEO04534 DESCRIPT Mollusca/molluscs/mollusks peptide 4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04534 GENEFORM Protein DME1274 XEOTICID XEO04534 MOACRIVE Inhibition DME1274 XEOTICID XEO04535 XEO_NAME Mollusca/molluscs/mollusks peptide 5 DME1274 XEOTICID XEO04535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04535 XEO_CLAS Peptide DME1274 XEOTICID XEO04535 DESCRIPT Mollusca/molluscs/mollusks peptide 5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04535 GENEFORM Protein DME1274 XEOTICID XEO04535 MOACRIVE Inhibition DME1274 XEOTICID XEO04536 XEO_NAME Mollusca/molluscs/mollusks peptide 6 DME1274 XEOTICID XEO04536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04536 XEO_CLAS Peptide DME1274 XEOTICID XEO04536 DESCRIPT Mollusca/molluscs/mollusks peptide 6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04536 GENEFORM Protein DME1274 XEOTICID XEO04536 MOACRIVE Inhibition DME1274 XEOTICID XEO04537 XEO_NAME Mollusca/molluscs/mollusks peptide 7 DME1274 XEOTICID XEO04537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04537 XEO_CLAS Peptide DME1274 XEOTICID XEO04537 DESCRIPT Mollusca/molluscs/mollusks peptide 7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04537 GENEFORM Protein DME1274 XEOTICID XEO04537 MOACRIVE Inhibition DME1274 XEOTICID XEO04538 XEO_NAME Mollusca/molluscs/mollusks peptide 8 DME1274 XEOTICID XEO04538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04538 XEO_CLAS Peptide DME1274 XEOTICID XEO04538 DESCRIPT Mollusca/molluscs/mollusks peptide 8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04538 GENEFORM Protein DME1274 XEOTICID XEO04538 MOACRIVE Inhibition DME1274 XEOTICID XEO04539 XEO_NAME Mollusca/molluscs/mollusks peptide 9 DME1274 XEOTICID XEO04539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04539 XEO_CLAS Peptide DME1274 XEOTICID XEO04539 DESCRIPT Mollusca/molluscs/mollusks peptide 9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04539 GENEFORM Protein DME1274 XEOTICID XEO04539 MOACRIVE Inhibition DME1274 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1274 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04548 XEO_CLAS Peptide DME1274 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 32000 ug/ml) DME1274 XEOTICID XEO04548 GENEFORM Protein DME1274 XEOTICID XEO04548 MOACRIVE Inhibition DME1274 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1274 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04549 XEO_CLAS Peptide DME1274 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 250-500 ug/ml) DME1274 XEOTICID XEO04549 GENEFORM Protein DME1274 XEOTICID XEO04549 MOACRIVE Inhibition DME1274 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1274 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04571 XEO_CLAS Peptide DME1274 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04571 GENEFORM Protein DME1274 XEOTICID XEO04571 MOACRIVE Inhibition DME1274 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1274 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04572 XEO_CLAS Peptide DME1274 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04572 GENEFORM Protein DME1274 XEOTICID XEO04572 MOACRIVE Inhibition DME1274 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1274 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04606 XEO_CLAS Peptide DME1274 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 2 microM) DME1274 XEOTICID XEO04606 GENEFORM Protein DME1274 XEOTICID XEO04606 MOACRIVE Inhibition DME1274 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1274 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04612 XEO_CLAS Peptide DME1274 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1274 XEOTICID XEO04612 GENEFORM Protein DME1274 XEOTICID XEO04612 MOACRIVE Inhibition DME1274 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1274 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04613 XEO_CLAS Peptide DME1274 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1274 XEOTICID XEO04613 GENEFORM Protein DME1274 XEOTICID XEO04613 MOACRIVE Inhibition DME1274 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1274 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04695 XEO_CLAS Peptide DME1274 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04695 GENEFORM Protein DME1274 XEOTICID XEO04695 MOACRIVE Inhibition DME1274 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1274 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04696 XEO_CLAS Peptide DME1274 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04696 GENEFORM Protein DME1274 XEOTICID XEO04696 MOACRIVE Inhibition DME1274 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1274 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04697 XEO_CLAS Peptide DME1274 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04697 GENEFORM Protein DME1274 XEOTICID XEO04697 MOACRIVE Inhibition DME1274 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1274 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04698 XEO_CLAS Peptide DME1274 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04698 GENEFORM Protein DME1274 XEOTICID XEO04698 MOACRIVE Inhibition DME1274 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1274 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04699 XEO_CLAS Peptide DME1274 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04699 GENEFORM Protein DME1274 XEOTICID XEO04699 MOACRIVE Inhibition DME1274 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1274 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04700 XEO_CLAS Peptide DME1274 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04700 GENEFORM Protein DME1274 XEOTICID XEO04700 MOACRIVE Inhibition DME1274 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1274 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04701 XEO_CLAS Peptide DME1274 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04701 GENEFORM Protein DME1274 XEOTICID XEO04701 MOACRIVE Inhibition DME1274 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1274 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04702 XEO_CLAS Peptide DME1274 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04702 GENEFORM Protein DME1274 XEOTICID XEO04702 MOACRIVE Inhibition DME1274 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1274 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04703 XEO_CLAS Peptide DME1274 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04703 GENEFORM Protein DME1274 XEOTICID XEO04703 MOACRIVE Inhibition DME1274 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1274 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04762 XEO_CLAS Peptide DME1274 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC > 25 microM) DME1274 XEOTICID XEO04762 GENEFORM Protein DME1274 XEOTICID XEO04762 MOACRIVE Inhibition DME1274 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1274 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04809 XEO_CLAS Peptide DME1274 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 10 microM) DME1274 XEOTICID XEO04809 GENEFORM Protein DME1274 XEOTICID XEO04809 MOACRIVE Inhibition DME1274 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1274 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04891 XEO_CLAS Peptide DME1274 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04891 GENEFORM Protein DME1274 XEOTICID XEO04891 MOACRIVE Inhibition DME1274 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1274 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04905 XEO_CLAS Peptide DME1274 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04905 GENEFORM Protein DME1274 XEOTICID XEO04905 MOACRIVE Inhibition DME1274 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1274 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04906 XEO_CLAS Peptide DME1274 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO04906 GENEFORM Protein DME1274 XEOTICID XEO04906 MOACRIVE Inhibition DME1274 XEOTICID XEO04917 XEO_NAME Scorpine DME1274 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04917 XEO_CLAS Peptide DME1274 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 10 microM) DME1274 XEOTICID XEO04917 GENEFORM Protein DME1274 XEOTICID XEO04917 MOACRIVE Inhibition DME1274 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1274 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04971 XEO_CLAS Peptide DME1274 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1274 XEOTICID XEO04971 GENEFORM Protein DME1274 XEOTICID XEO04971 MOACRIVE Inhibition DME1274 XEOTICID XEO04974 XEO_NAME Spinigerin DME1274 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04974 XEO_CLAS Peptide DME1274 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1274 XEOTICID XEO04974 GENEFORM Protein DME1274 XEOTICID XEO04974 MOACRIVE Inhibition DME1274 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1274 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO04995 XEO_CLAS Peptide DME1274 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 0.78-1.56 microM) DME1274 XEOTICID XEO04995 GENEFORM Protein DME1274 XEOTICID XEO04995 MOACRIVE Inhibition DME1274 XEOTICID XEO05020 XEO_NAME Tachycitin DME1274 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO05020 XEO_CLAS Peptide DME1274 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae DME1274 XEOTICID XEO05020 GENEFORM Protein DME1274 XEOTICID XEO05020 MOACRIVE Inhibition DME1274 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1274 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO05073 XEO_CLAS Peptide DME1274 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 80 microM) DME1274 XEOTICID XEO05073 GENEFORM Protein DME1274 XEOTICID XEO05073 MOACRIVE Inhibition DME1274 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1274 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO05075 XEO_CLAS Peptide DME1274 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 80 microM) DME1274 XEOTICID XEO05075 GENEFORM Protein DME1274 XEOTICID XEO05075 MOACRIVE Inhibition DME1274 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1274 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO05101 XEO_CLAS Peptide DME1274 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 31.2 ug/ml) DME1274 XEOTICID XEO05101 GENEFORM Protein DME1274 XEOTICID XEO05101 MOACRIVE Inhibition DME1274 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1274 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO05102 XEO_CLAS Peptide DME1274 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 35.1 ug/ml) DME1274 XEOTICID XEO05102 GENEFORM Protein DME1274 XEOTICID XEO05102 MOACRIVE Inhibition DME1274 XEOTICID XEO05120 XEO_NAME Thanatin DME1274 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO05120 XEO_CLAS Peptide DME1274 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 0.6-1.2 microM) DME1274 XEOTICID XEO05120 GENEFORM Protein DME1274 XEOTICID XEO05120 MOACRIVE Inhibition DME1274 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1274 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO05163 XEO_CLAS Peptide DME1274 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 12-25 ug/ml) DME1274 XEOTICID XEO05163 GENEFORM Protein DME1274 XEOTICID XEO05163 MOACRIVE Inhibition DME1274 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1274 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1274 XEOTICID XEO05220 XEO_CLAS Peptide DME1274 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1274 XEOTICID XEO05220 GENEFORM Protein DME1274 XEOTICID XEO05220 MOACRIVE Inhibition DME1277 DME___ID DME1277 DME1277 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1277 SPESNAME Lactobacillus rhamnosus DME1277 XEOTICID XEO03967 XEO_NAME Bacteriocin LSEI_2163 DME1277 XEOTICID XEO03967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1277 XEOTICID XEO03967 XEO_CLAS Peptide DME1277 XEOTICID XEO03967 DESCRIPT Bacteriocin LSEI_2163 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactobacillus rhamnosus DME1277 XEOTICID XEO03967 GENEFORM Protein DME1277 XEOTICID XEO03967 MOACRIVE Inhibition DME1287 DME___ID DME1287 DME1287 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1287 SPESNAME Ralstonia solanacearum DME1287 XEOTICID XEO03104 XEO_NAME Defensin So-D1 DME1287 XEOTICID XEO03104 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1287 XEOTICID XEO03104 XEO_CLAS Peptide DME1287 XEOTICID XEO03104 DESCRIPT Defensin So-D1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Ralstonia solanacearum DME1287 XEOTICID XEO03104 GENEFORM Protein DME1287 XEOTICID XEO03104 MOACRIVE Inhibition DME1287 XEOTICID XEO03106 XEO_NAME Defensin So-D2 DME1287 XEOTICID XEO03106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1287 XEOTICID XEO03106 XEO_CLAS Peptide DME1287 XEOTICID XEO03106 DESCRIPT Defensin So-D2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Ralstonia solanacearum DME1287 XEOTICID XEO03106 GENEFORM Protein DME1287 XEOTICID XEO03106 MOACRIVE Inhibition DME1287 XEOTICID XEO03107 XEO_NAME Defensin So-D5 DME1287 XEOTICID XEO03107 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1287 XEOTICID XEO03107 XEO_CLAS Peptide DME1287 XEOTICID XEO03107 DESCRIPT Defensin So-D5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Ralstonia solanacearum DME1287 XEOTICID XEO03107 GENEFORM Protein DME1287 XEOTICID XEO03107 MOACRIVE Inhibition DME1287 XEOTICID XEO03108 XEO_NAME Defensin So-D6 DME1287 XEOTICID XEO03108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1287 XEOTICID XEO03108 XEO_CLAS Peptide DME1287 XEOTICID XEO03108 DESCRIPT Defensin So-D6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Ralstonia solanacearum DME1287 XEOTICID XEO03108 GENEFORM Protein DME1287 XEOTICID XEO03108 MOACRIVE Inhibition DME1287 XEOTICID XEO04960 XEO_NAME Snakin-1 StSN1 DME1287 XEOTICID XEO04960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1287 XEOTICID XEO04960 XEO_CLAS Peptide DME1287 XEOTICID XEO04960 DESCRIPT Snakin-1 StSN1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Ralstonia solanacearum DME1287 XEOTICID XEO04960 GENEFORM Protein DME1287 XEOTICID XEO04960 MOACRIVE Inhibition DME1287 XEOTICID XEO04961 XEO_NAME Snakin-2 StSN2 DME1287 XEOTICID XEO04961 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1287 XEOTICID XEO04961 XEO_CLAS Peptide DME1287 XEOTICID XEO04961 DESCRIPT Snakin-2 StSN2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Ralstonia solanacearum DME1287 XEOTICID XEO04961 GENEFORM Protein DME1287 XEOTICID XEO04961 MOACRIVE Inhibition DME1288 DME___ID DME1288 DME1288 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1288 SPESNAME Shewanella oneidensis DME1288 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1288 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1288 XEOTICID XEO05230 XEO_CLAS Peptide DME1288 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Shewanella oneidensis (MIC = 6.20 microM) DME1288 XEOTICID XEO05230 GENEFORM Protein DME1288 XEOTICID XEO05230 MOACRIVE Inhibition DME1288 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1288 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1288 XEOTICID XEO05231 XEO_CLAS Peptide DME1288 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Shewanella oneidensis (MIC = 1.50 microM) DME1288 XEOTICID XEO05231 GENEFORM Protein DME1288 XEOTICID XEO05231 MOACRIVE Inhibition DME1292 DME___ID DME1292 DME1292 DME_NAME VanB ligase (vanB) DME1292 SPESNAME Enterococcus faecalis DME1292 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1292 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1292 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1292 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO00546 GENEFORM Protein DME1292 XEOTICID XEO00546 MOACRIVE Inhibition DME1292 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1292 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO01812 XEO_CLAS Peptide DME1292 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 1.9 microM) DME1292 XEOTICID XEO01812 GENEFORM Protein DME1292 XEOTICID XEO01812 MOACRIVE Inhibition DME1292 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1292 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO01813 XEO_CLAS Peptide DME1292 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 1.4 microM) DME1292 XEOTICID XEO01813 GENEFORM Protein DME1292 XEOTICID XEO01813 MOACRIVE Inhibition DME1292 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1292 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO01814 XEO_CLAS Peptide DME1292 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 0.7 microM) DME1292 XEOTICID XEO01814 GENEFORM Protein DME1292 XEOTICID XEO01814 MOACRIVE Inhibition DME1292 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1292 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO01815 XEO_CLAS Peptide DME1292 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 1.0 microM) DME1292 XEOTICID XEO01815 GENEFORM Protein DME1292 XEOTICID XEO01815 MOACRIVE Inhibition DME1292 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1292 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1292 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1292 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO01961 GENEFORM Protein DME1292 XEOTICID XEO01961 MOACRIVE Inhibition DME1292 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1292 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1292 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1292 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO01966 GENEFORM Protein DME1292 XEOTICID XEO01966 MOACRIVE Inhibition DME1292 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1292 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02122 XEO_CLAS Peptide DME1292 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 50 ug/ml) DME1292 XEOTICID XEO02122 GENEFORM Protein DME1292 XEOTICID XEO02122 MOACRIVE Inhibition DME1292 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1292 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02247 XEO_CLAS Peptide DME1292 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02247 GENEFORM Protein DME1292 XEOTICID XEO02247 MOACRIVE Inhibition DME1292 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1292 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02319 XEO_CLAS Peptide DME1292 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02319 GENEFORM Protein DME1292 XEOTICID XEO02319 MOACRIVE Inhibition DME1292 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1292 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02325 XEO_CLAS Peptide DME1292 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 100 microM) DME1292 XEOTICID XEO02325 GENEFORM Protein DME1292 XEOTICID XEO02325 MOACRIVE Inhibition DME1292 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1292 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02355 XEO_CLAS Peptide DME1292 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 17 ug/ml) DME1292 XEOTICID XEO02355 GENEFORM Protein DME1292 XEOTICID XEO02355 MOACRIVE Inhibition DME1292 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1292 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02356 XEO_CLAS Peptide DME1292 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 32 ug/ml) DME1292 XEOTICID XEO02356 GENEFORM Protein DME1292 XEOTICID XEO02356 MOACRIVE Inhibition DME1292 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1292 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02357 XEO_CLAS Peptide DME1292 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 16 ug/ml) DME1292 XEOTICID XEO02357 GENEFORM Protein DME1292 XEOTICID XEO02357 MOACRIVE Inhibition DME1292 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1292 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02358 XEO_CLAS Peptide DME1292 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 8 ug/ml) DME1292 XEOTICID XEO02358 GENEFORM Protein DME1292 XEOTICID XEO02358 MOACRIVE Inhibition DME1292 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1292 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02360 XEO_CLAS Peptide DME1292 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 2 ug/ml) DME1292 XEOTICID XEO02360 GENEFORM Protein DME1292 XEOTICID XEO02360 MOACRIVE Inhibition DME1292 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1292 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02361 XEO_CLAS Peptide DME1292 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 32 ug/ml) DME1292 XEOTICID XEO02361 GENEFORM Protein DME1292 XEOTICID XEO02361 MOACRIVE Inhibition DME1292 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1292 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02365 XEO_CLAS Peptide DME1292 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 64 ug/ml) DME1292 XEOTICID XEO02365 GENEFORM Protein DME1292 XEOTICID XEO02365 MOACRIVE Inhibition DME1292 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1292 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02366 XEO_CLAS Peptide DME1292 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 32 ug/ml) DME1292 XEOTICID XEO02366 GENEFORM Protein DME1292 XEOTICID XEO02366 MOACRIVE Inhibition DME1292 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1292 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02367 XEO_CLAS Peptide DME1292 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 32 ug/ml) DME1292 XEOTICID XEO02367 GENEFORM Protein DME1292 XEOTICID XEO02367 MOACRIVE Inhibition DME1292 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1292 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02368 XEO_CLAS Peptide DME1292 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 64 ug/ml) DME1292 XEOTICID XEO02368 GENEFORM Protein DME1292 XEOTICID XEO02368 MOACRIVE Inhibition DME1292 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1292 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02369 XEO_CLAS Peptide DME1292 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 32 ug/ml) DME1292 XEOTICID XEO02369 GENEFORM Protein DME1292 XEOTICID XEO02369 MOACRIVE Inhibition DME1292 XEOTICID XEO02377 XEO_NAME Bacteriocin hiracin-JM79 DME1292 XEOTICID XEO02377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02377 XEO_CLAS Peptide DME1292 XEOTICID XEO02377 DESCRIPT Bacteriocin hiracin-JM79 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02377 GENEFORM Protein DME1292 XEOTICID XEO02377 MOACRIVE Inhibition DME1292 XEOTICID XEO02382 XEO_NAME Bacteriocin plantarican ASM1 DME1292 XEOTICID XEO02382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02382 XEO_CLAS Peptide DME1292 XEOTICID XEO02382 DESCRIPT Bacteriocin plantarican ASM1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02382 GENEFORM Protein DME1292 XEOTICID XEO02382 MOACRIVE Inhibition DME1292 XEOTICID XEO02386 XEO_NAME Bactridin-1 DME1292 XEOTICID XEO02386 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02386 XEO_CLAS Peptide DME1292 XEOTICID XEO02386 DESCRIPT Bactridin-1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 34 microM) DME1292 XEOTICID XEO02386 GENEFORM Protein DME1292 XEOTICID XEO02386 MOACRIVE Inhibition DME1292 XEOTICID XEO02387 XEO_NAME Bactridin-2 DME1292 XEOTICID XEO02387 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02387 XEO_CLAS Peptide DME1292 XEOTICID XEO02387 DESCRIPT Bactridin-2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 65 microM) DME1292 XEOTICID XEO02387 GENEFORM Protein DME1292 XEOTICID XEO02387 MOACRIVE Inhibition DME1292 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1292 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02388 XEO_CLAS Peptide DME1292 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 8 ug/ml) DME1292 XEOTICID XEO02388 GENEFORM Protein DME1292 XEOTICID XEO02388 MOACRIVE Inhibition DME1292 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1292 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02389 XEO_CLAS Peptide DME1292 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 2 ug/ml) DME1292 XEOTICID XEO02389 GENEFORM Protein DME1292 XEOTICID XEO02389 MOACRIVE Inhibition DME1292 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1292 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02463 XEO_CLAS Peptide DME1292 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 15 microM) DME1292 XEOTICID XEO02463 GENEFORM Protein DME1292 XEOTICID XEO02463 MOACRIVE Inhibition DME1292 XEOTICID XEO02465 XEO_NAME BMAP-28 DME1292 XEOTICID XEO02465 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02465 XEO_CLAS Peptide DME1292 XEOTICID XEO02465 DESCRIPT BMAP-28 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02465 GENEFORM Protein DME1292 XEOTICID XEO02465 MOACRIVE Inhibition DME1292 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1292 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02491 XEO_CLAS Peptide DME1292 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 57.1 microM) DME1292 XEOTICID XEO02491 GENEFORM Protein DME1292 XEOTICID XEO02491 MOACRIVE Inhibition DME1292 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1292 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02496 XEO_CLAS Peptide DME1292 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 13 microM) DME1292 XEOTICID XEO02496 GENEFORM Protein DME1292 XEOTICID XEO02496 MOACRIVE Inhibition DME1292 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1292 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02497 XEO_CLAS Peptide DME1292 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 6 microM) DME1292 XEOTICID XEO02497 GENEFORM Protein DME1292 XEOTICID XEO02497 MOACRIVE Inhibition DME1292 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1292 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02509 XEO_CLAS Peptide DME1292 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 19 microM) DME1292 XEOTICID XEO02509 GENEFORM Protein DME1292 XEOTICID XEO02509 MOACRIVE Inhibition DME1292 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1292 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02510 XEO_CLAS Peptide DME1292 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 75 microM) DME1292 XEOTICID XEO02510 GENEFORM Protein DME1292 XEOTICID XEO02510 MOACRIVE Inhibition DME1292 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1292 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02511 XEO_CLAS Peptide DME1292 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 9 microM) DME1292 XEOTICID XEO02511 GENEFORM Protein DME1292 XEOTICID XEO02511 MOACRIVE Inhibition DME1292 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1292 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02512 XEO_CLAS Peptide DME1292 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 9 microM) DME1292 XEOTICID XEO02512 GENEFORM Protein DME1292 XEOTICID XEO02512 MOACRIVE Inhibition DME1292 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1292 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02524 XEO_CLAS Peptide DME1292 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 19 microM) DME1292 XEOTICID XEO02524 GENEFORM Protein DME1292 XEOTICID XEO02524 MOACRIVE Inhibition DME1292 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1292 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02566 XEO_CLAS Peptide DME1292 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 50 microM) DME1292 XEOTICID XEO02566 GENEFORM Protein DME1292 XEOTICID XEO02566 MOACRIVE Inhibition DME1292 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1292 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02637 XEO_CLAS Peptide DME1292 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 25 microM) DME1292 XEOTICID XEO02637 GENEFORM Protein DME1292 XEOTICID XEO02637 MOACRIVE Inhibition DME1292 XEOTICID XEO02660 XEO_NAME Butyl gallate DME1292 XEOTICID XEO02660 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1292 XEOTICID XEO02660 XEO_CLAS Chemical Compound DME1292 XEOTICID XEO02660 DESCRIPT Butyl gallate inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02660 GENEFORM Protein DME1292 XEOTICID XEO02660 MOACRIVE Inhibition DME1292 XEOTICID XEO02718 XEO_NAME Carnobacteriocin CbnB2 DME1292 XEOTICID XEO02718 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02718 XEO_CLAS Peptide DME1292 XEOTICID XEO02718 DESCRIPT Carnobacteriocin CbnB2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02718 GENEFORM Protein DME1292 XEOTICID XEO02718 MOACRIVE Inhibition DME1292 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1292 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02721 XEO_CLAS Peptide DME1292 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02721 GENEFORM Protein DME1292 XEOTICID XEO02721 MOACRIVE Inhibition DME1292 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1292 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02820 XEO_CLAS Peptide DME1292 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 64 ug/ml) DME1292 XEOTICID XEO02820 GENEFORM Protein DME1292 XEOTICID XEO02820 MOACRIVE Inhibition DME1292 XEOTICID XEO02864 XEO_NAME Cathelicidin cjaRL-37 DME1292 XEOTICID XEO02864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02864 XEO_CLAS Peptide DME1292 XEOTICID XEO02864 DESCRIPT Cathelicidin cjaRL-37 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 32 microM) DME1292 XEOTICID XEO02864 GENEFORM Protein DME1292 XEOTICID XEO02864 MOACRIVE Inhibition DME1292 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1292 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02872 XEO_CLAS Peptide DME1292 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 300 microM) DME1292 XEOTICID XEO02872 GENEFORM Protein DME1292 XEOTICID XEO02872 MOACRIVE Inhibition DME1292 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1292 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02875 XEO_CLAS Peptide DME1292 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02875 GENEFORM Protein DME1292 XEOTICID XEO02875 MOACRIVE Inhibition DME1292 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1292 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02876 XEO_CLAS Peptide DME1292 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02876 GENEFORM Protein DME1292 XEOTICID XEO02876 MOACRIVE Inhibition DME1292 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1292 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02877 XEO_CLAS Peptide DME1292 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02877 GENEFORM Protein DME1292 XEOTICID XEO02877 MOACRIVE Inhibition DME1292 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1292 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02878 XEO_CLAS Peptide DME1292 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02878 GENEFORM Protein DME1292 XEOTICID XEO02878 MOACRIVE Inhibition DME1292 XEOTICID XEO02930 XEO_NAME Indolicidin derivative CP10A DME1292 XEOTICID XEO02930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02930 XEO_CLAS Peptide DME1292 XEOTICID XEO02930 DESCRIPT Indolicidin derivative CP10A inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 8 ug/ml) DME1292 XEOTICID XEO02930 GENEFORM Protein DME1292 XEOTICID XEO02930 MOACRIVE Inhibition DME1292 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1292 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02931 XEO_CLAS Peptide DME1292 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 64 ug/ml) DME1292 XEOTICID XEO02931 GENEFORM Protein DME1292 XEOTICID XEO02931 MOACRIVE Inhibition DME1292 XEOTICID XEO02932 XEO_NAME CP11CN peptide DME1292 XEOTICID XEO02932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02932 XEO_CLAS Peptide DME1292 XEOTICID XEO02932 DESCRIPT CP11CN peptide inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 64 ug/ml) DME1292 XEOTICID XEO02932 GENEFORM Protein DME1292 XEOTICID XEO02932 MOACRIVE Inhibition DME1292 XEOTICID XEO02955 XEO_NAME Cryptdin related sequence CRS4C-3c DME1292 XEOTICID XEO02955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02955 XEO_CLAS Peptide DME1292 XEOTICID XEO02955 DESCRIPT Cryptdin related sequence CRS4C-3c inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02955 GENEFORM Protein DME1292 XEOTICID XEO02955 MOACRIVE Inhibition DME1292 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1292 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02958 XEO_CLAS Peptide DME1292 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02958 GENEFORM Protein DME1292 XEOTICID XEO02958 MOACRIVE Inhibition DME1292 XEOTICID XEO02959 XEO_NAME Cryptdin related peptide CRS4C-1d DME1292 XEOTICID XEO02959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02959 XEO_CLAS Peptide DME1292 XEOTICID XEO02959 DESCRIPT Cryptdin related peptide CRS4C-1d inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02959 GENEFORM Protein DME1292 XEOTICID XEO02959 MOACRIVE Inhibition DME1292 XEOTICID XEO02960 XEO_NAME Cryptdin related peptide CRS4C-2 DME1292 XEOTICID XEO02960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02960 XEO_CLAS Peptide DME1292 XEOTICID XEO02960 DESCRIPT Cryptdin related peptide CRS4C-2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02960 GENEFORM Protein DME1292 XEOTICID XEO02960 MOACRIVE Inhibition DME1292 XEOTICID XEO02961 XEO_NAME Cryptdin related peptide CRS4C-2b DME1292 XEOTICID XEO02961 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO02961 XEO_CLAS Peptide DME1292 XEOTICID XEO02961 DESCRIPT Cryptdin related peptide CRS4C-2b inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO02961 GENEFORM Protein DME1292 XEOTICID XEO02961 MOACRIVE Inhibition DME1292 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1292 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03021 XEO_CLAS Peptide DME1292 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 1.25-2.50 microM) DME1292 XEOTICID XEO03021 GENEFORM Protein DME1292 XEOTICID XEO03021 MOACRIVE Inhibition DME1292 XEOTICID XEO03025 XEO_NAME Curvacin A DME1292 XEOTICID XEO03025 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03025 XEO_CLAS Peptide DME1292 XEOTICID XEO03025 DESCRIPT Curvacin A inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO03025 GENEFORM Protein DME1292 XEOTICID XEO03025 MOACRIVE Inhibition DME1292 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1292 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03073 XEO_CLAS Peptide DME1292 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 16 ug/ml) DME1292 XEOTICID XEO03073 GENEFORM Protein DME1292 XEOTICID XEO03073 MOACRIVE Inhibition DME1292 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1292 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03082 XEO_CLAS Peptide DME1292 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO03082 GENEFORM Protein DME1292 XEOTICID XEO03082 MOACRIVE Inhibition DME1292 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1292 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03137 XEO_CLAS Peptide DME1292 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO03137 GENEFORM Protein DME1292 XEOTICID XEO03137 MOACRIVE Inhibition DME1292 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1292 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03146 XEO_CLAS Peptide DME1292 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 10 microM) DME1292 XEOTICID XEO03146 GENEFORM Protein DME1292 XEOTICID XEO03146 MOACRIVE Inhibition DME1292 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1292 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03147 XEO_CLAS Peptide DME1292 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 38 microM) DME1292 XEOTICID XEO03147 GENEFORM Protein DME1292 XEOTICID XEO03147 MOACRIVE Inhibition DME1292 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1292 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03148 XEO_CLAS Peptide DME1292 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 22 microM) DME1292 XEOTICID XEO03148 GENEFORM Protein DME1292 XEOTICID XEO03148 MOACRIVE Inhibition DME1292 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1292 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03149 XEO_CLAS Peptide DME1292 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 11 microM) DME1292 XEOTICID XEO03149 GENEFORM Protein DME1292 XEOTICID XEO03149 MOACRIVE Inhibition DME1292 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1292 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03197 XEO_CLAS Peptide DME1292 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 14.5 microM) DME1292 XEOTICID XEO03197 GENEFORM Protein DME1292 XEOTICID XEO03197 MOACRIVE Inhibition DME1292 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1292 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03250 XEO_CLAS Peptide DME1292 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO03250 GENEFORM Protein DME1292 XEOTICID XEO03250 MOACRIVE Inhibition DME1292 XEOTICID XEO03252 XEO_NAME Enterocin B DME1292 XEOTICID XEO03252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03252 XEO_CLAS Peptide DME1292 XEOTICID XEO03252 DESCRIPT Enterocin B inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 0.0869 microM) DME1292 XEOTICID XEO03252 GENEFORM Protein DME1292 XEOTICID XEO03252 MOACRIVE Inhibition DME1292 XEOTICID XEO03254 XEO_NAME Enterocin EJ97 DME1292 XEOTICID XEO03254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03254 XEO_CLAS Peptide DME1292 XEOTICID XEO03254 DESCRIPT Enterocin EJ97 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 6 ug/ml) DME1292 XEOTICID XEO03254 GENEFORM Protein DME1292 XEOTICID XEO03254 MOACRIVE Inhibition DME1292 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1292 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03258 XEO_CLAS Peptide DME1292 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO03258 GENEFORM Protein DME1292 XEOTICID XEO03258 MOACRIVE Inhibition DME1292 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME1292 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03259 XEO_CLAS Peptide DME1292 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 0.0508 microM) DME1292 XEOTICID XEO03259 GENEFORM Protein DME1292 XEOTICID XEO03259 MOACRIVE Inhibition DME1292 XEOTICID XEO03260 XEO_NAME Enterocin X beta DME1292 XEOTICID XEO03260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03260 XEO_CLAS Peptide DME1292 XEOTICID XEO03260 DESCRIPT Enterocin X beta inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 0.813 microM) DME1292 XEOTICID XEO03260 GENEFORM Protein DME1292 XEOTICID XEO03260 MOACRIVE Inhibition DME1292 XEOTICID XEO03357 XEO_NAME Ethyl gallate DME1292 XEOTICID XEO03357 XEO_TYPE Pharmaceutical Agent(s) DME1292 XEOTICID XEO03357 XEO_CLAS Investigative Agent DME1292 XEOTICID XEO03357 DESCRIPT Ethyl gallate inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO03357 GENEFORM Protein DME1292 XEOTICID XEO03357 MOACRIVE Inhibition DME1292 XEOTICID XEO03381 XEO_NAME Fallaxidin 3.1 DME1292 XEOTICID XEO03381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03381 XEO_CLAS Peptide DME1292 XEOTICID XEO03381 DESCRIPT Fallaxidin 3.1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 100 microM) DME1292 XEOTICID XEO03381 GENEFORM Protein DME1292 XEOTICID XEO03381 MOACRIVE Inhibition DME1292 XEOTICID XEO03382 XEO_NAME Fallaxidin 3.2 DME1292 XEOTICID XEO03382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03382 XEO_CLAS Peptide DME1292 XEOTICID XEO03382 DESCRIPT Fallaxidin 3.2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 100 microM) DME1292 XEOTICID XEO03382 GENEFORM Protein DME1292 XEOTICID XEO03382 MOACRIVE Inhibition DME1292 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1292 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03428 XEO_CLAS Peptide DME1292 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 31 ug/ml) DME1292 XEOTICID XEO03428 GENEFORM Protein DME1292 XEOTICID XEO03428 MOACRIVE Inhibition DME1292 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1292 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03430 XEO_CLAS Peptide DME1292 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 31 ug/ml) DME1292 XEOTICID XEO03430 GENEFORM Protein DME1292 XEOTICID XEO03430 MOACRIVE Inhibition DME1292 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1292 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03434 XEO_CLAS Peptide DME1292 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 31 ug/ml) DME1292 XEOTICID XEO03434 GENEFORM Protein DME1292 XEOTICID XEO03434 MOACRIVE Inhibition DME1292 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1292 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03497 XEO_CLAS Peptide DME1292 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 6.2-12.5 microM) DME1292 XEOTICID XEO03497 GENEFORM Protein DME1292 XEOTICID XEO03497 MOACRIVE Inhibition DME1292 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1292 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03498 XEO_CLAS Peptide DME1292 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 6.2-12.5 microM) DME1292 XEOTICID XEO03498 GENEFORM Protein DME1292 XEOTICID XEO03498 MOACRIVE Inhibition DME1292 XEOTICID XEO03522 XEO_NAME Halocyntin DME1292 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03522 XEO_CLAS Peptide DME1292 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO03522 GENEFORM Protein DME1292 XEOTICID XEO03522 MOACRIVE Inhibition DME1292 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1292 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03540 XEO_CLAS Peptide DME1292 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 32 ug/ml) DME1292 XEOTICID XEO03540 GENEFORM Protein DME1292 XEOTICID XEO03540 MOACRIVE Inhibition DME1292 XEOTICID XEO03555 XEO_NAME Hexyl gallate DME1292 XEOTICID XEO03555 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1292 XEOTICID XEO03555 XEO_CLAS Chemical Compound DME1292 XEOTICID XEO03555 DESCRIPT Hexyl gallate inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO03555 GENEFORM Protein DME1292 XEOTICID XEO03555 MOACRIVE Inhibition DME1292 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1292 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03556 XEO_CLAS Peptide DME1292 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 32 ug/ml) DME1292 XEOTICID XEO03556 GENEFORM Protein DME1292 XEOTICID XEO03556 MOACRIVE Inhibition DME1292 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1292 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03557 XEO_CLAS Peptide DME1292 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 32 ug/ml) DME1292 XEOTICID XEO03557 GENEFORM Protein DME1292 XEOTICID XEO03557 MOACRIVE Inhibition DME1292 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1292 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03569 XEO_CLAS Peptide DME1292 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 300 microM) DME1292 XEOTICID XEO03569 GENEFORM Protein DME1292 XEOTICID XEO03569 MOACRIVE Inhibition DME1292 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1292 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03579 XEO_CLAS Peptide DME1292 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO03579 GENEFORM Protein DME1292 XEOTICID XEO03579 MOACRIVE Inhibition DME1292 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1292 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03588 XEO_CLAS Peptide DME1292 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 15 ug/ml) DME1292 XEOTICID XEO03588 GENEFORM Protein DME1292 XEOTICID XEO03588 MOACRIVE Inhibition DME1292 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1292 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03609 XEO_CLAS Peptide DME1292 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO03609 GENEFORM Protein DME1292 XEOTICID XEO03609 MOACRIVE Inhibition DME1292 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1292 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03616 XEO_CLAS Peptide DME1292 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 16 microM) DME1292 XEOTICID XEO03616 GENEFORM Protein DME1292 XEOTICID XEO03616 MOACRIVE Inhibition DME1292 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1292 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03675 XEO_CLAS Peptide DME1292 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 60 microM) DME1292 XEOTICID XEO03675 GENEFORM Protein DME1292 XEOTICID XEO03675 MOACRIVE Inhibition DME1292 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1292 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03684 XEO_CLAS Peptide DME1292 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 125 ug/ml) DME1292 XEOTICID XEO03684 GENEFORM Protein DME1292 XEOTICID XEO03684 MOACRIVE Inhibition DME1292 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1292 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03697 XEO_CLAS Peptide DME1292 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 12.5 microM) DME1292 XEOTICID XEO03697 GENEFORM Protein DME1292 XEOTICID XEO03697 MOACRIVE Inhibition DME1292 XEOTICID XEO03768 XEO_NAME Lactacin-F subunit LafA DME1292 XEOTICID XEO03768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03768 XEO_CLAS Peptide DME1292 XEOTICID XEO03768 DESCRIPT Lactacin-F subunit LafA inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO03768 GENEFORM Protein DME1292 XEOTICID XEO03768 MOACRIVE Inhibition DME1292 XEOTICID XEO03769 XEO_NAME Lactacin-F subunit LafX DME1292 XEOTICID XEO03769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03769 XEO_CLAS Peptide DME1292 XEOTICID XEO03769 DESCRIPT Lactacin-F subunit LafX inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO03769 GENEFORM Protein DME1292 XEOTICID XEO03769 MOACRIVE Inhibition DME1292 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1292 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03771 XEO_CLAS Peptide DME1292 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO03771 GENEFORM Protein DME1292 XEOTICID XEO03771 MOACRIVE Inhibition DME1292 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1292 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03793 XEO_CLAS Peptide DME1292 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 32 microM) DME1292 XEOTICID XEO03793 GENEFORM Protein DME1292 XEOTICID XEO03793 MOACRIVE Inhibition DME1292 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1292 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03854 XEO_CLAS Peptide DME1292 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 5.20 microM) DME1292 XEOTICID XEO03854 GENEFORM Protein DME1292 XEOTICID XEO03854 MOACRIVE Inhibition DME1292 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1292 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03855 XEO_CLAS Peptide DME1292 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 4.10 microM) DME1292 XEOTICID XEO03855 GENEFORM Protein DME1292 XEOTICID XEO03855 MOACRIVE Inhibition DME1292 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1292 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03873 XEO_CLAS Peptide DME1292 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 30 microM) DME1292 XEOTICID XEO03873 GENEFORM Protein DME1292 XEOTICID XEO03873 MOACRIVE Inhibition DME1292 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1292 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03874 XEO_CLAS Peptide DME1292 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 22.5 microM) DME1292 XEOTICID XEO03874 GENEFORM Protein DME1292 XEOTICID XEO03874 MOACRIVE Inhibition DME1292 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1292 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03875 XEO_CLAS Peptide DME1292 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 22.5 microM) DME1292 XEOTICID XEO03875 GENEFORM Protein DME1292 XEOTICID XEO03875 MOACRIVE Inhibition DME1292 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1292 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03876 XEO_CLAS Peptide DME1292 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 15 microM) DME1292 XEOTICID XEO03876 GENEFORM Protein DME1292 XEOTICID XEO03876 MOACRIVE Inhibition DME1292 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1292 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03877 XEO_CLAS Peptide DME1292 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 11.25 microM) DME1292 XEOTICID XEO03877 GENEFORM Protein DME1292 XEOTICID XEO03877 MOACRIVE Inhibition DME1292 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1292 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03878 XEO_CLAS Peptide DME1292 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 22.5 microM) DME1292 XEOTICID XEO03878 GENEFORM Protein DME1292 XEOTICID XEO03878 MOACRIVE Inhibition DME1292 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1292 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03904 XEO_CLAS Peptide DME1292 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 4 ug/ml) DME1292 XEOTICID XEO03904 GENEFORM Protein DME1292 XEOTICID XEO03904 MOACRIVE Inhibition DME1292 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1292 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03905 XEO_CLAS Peptide DME1292 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 16 ug/ml) DME1292 XEOTICID XEO03905 GENEFORM Protein DME1292 XEOTICID XEO03905 MOACRIVE Inhibition DME1292 XEOTICID XEO03986 XEO_NAME Magainin-I peptide DME1292 XEOTICID XEO03986 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO03986 XEO_CLAS Peptide DME1292 XEOTICID XEO03986 DESCRIPT Magainin-I peptide inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO03986 GENEFORM Protein DME1292 XEOTICID XEO03986 MOACRIVE Inhibition DME1292 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1292 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04001 XEO_CLAS Peptide DME1292 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 25 microM) DME1292 XEOTICID XEO04001 GENEFORM Protein DME1292 XEOTICID XEO04001 MOACRIVE Inhibition DME1292 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1292 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04051 XEO_CLAS Peptide DME1292 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 2.50-5.00 microM) DME1292 XEOTICID XEO04051 GENEFORM Protein DME1292 XEOTICID XEO04051 MOACRIVE Inhibition DME1292 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1292 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04052 XEO_CLAS Peptide DME1292 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04052 GENEFORM Protein DME1292 XEOTICID XEO04052 MOACRIVE Inhibition DME1292 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1292 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04053 XEO_CLAS Peptide DME1292 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 1.25-2.50 microM) DME1292 XEOTICID XEO04053 GENEFORM Protein DME1292 XEOTICID XEO04053 MOACRIVE Inhibition DME1292 XEOTICID XEO04106 XEO_NAME Methyl gallate DME1292 XEOTICID XEO04106 XEO_TYPE Pharmaceutical Agent(s) DME1292 XEOTICID XEO04106 XEO_CLAS Investigative Agent DME1292 XEOTICID XEO04106 DESCRIPT Methyl gallate inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04106 GENEFORM Protein DME1292 XEOTICID XEO04106 MOACRIVE Inhibition DME1292 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1292 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04118 XEO_CLAS Peptide DME1292 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 300 microM) DME1292 XEOTICID XEO04118 GENEFORM Protein DME1292 XEOTICID XEO04118 MOACRIVE Inhibition DME1292 XEOTICID XEO04150 XEO_NAME Mundticin ATO6 DME1292 XEOTICID XEO04150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04150 XEO_CLAS Peptide DME1292 XEOTICID XEO04150 DESCRIPT Mundticin ATO6 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04150 GENEFORM Protein DME1292 XEOTICID XEO04150 MOACRIVE Inhibition DME1292 XEOTICID XEO04151 XEO_NAME Mundticin KS DME1292 XEOTICID XEO04151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04151 XEO_CLAS Peptide DME1292 XEOTICID XEO04151 DESCRIPT Mundticin KS inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04151 GENEFORM Protein DME1292 XEOTICID XEO04151 MOACRIVE Inhibition DME1292 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1292 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04169 XEO_CLAS Peptide DME1292 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04169 GENEFORM Protein DME1292 XEOTICID XEO04169 MOACRIVE Inhibition DME1292 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1292 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04249 XEO_CLAS Peptide DME1292 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 500 ug/ml) DME1292 XEOTICID XEO04249 GENEFORM Protein DME1292 XEOTICID XEO04249 MOACRIVE Inhibition DME1292 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1292 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04259 XEO_CLAS Peptide DME1292 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04259 GENEFORM Protein DME1292 XEOTICID XEO04259 MOACRIVE Inhibition DME1292 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1292 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04261 XEO_CLAS Peptide DME1292 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04261 GENEFORM Protein DME1292 XEOTICID XEO04261 MOACRIVE Inhibition DME1292 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1292 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04265 XEO_CLAS Peptide DME1292 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04265 GENEFORM Protein DME1292 XEOTICID XEO04265 MOACRIVE Inhibition DME1292 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1292 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04268 XEO_CLAS Peptide DME1292 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04268 GENEFORM Protein DME1292 XEOTICID XEO04268 MOACRIVE Inhibition DME1292 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1292 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04399 XEO_CLAS Peptide DME1292 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 12.5 microM) DME1292 XEOTICID XEO04399 GENEFORM Protein DME1292 XEOTICID XEO04399 MOACRIVE Inhibition DME1292 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1292 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04444 XEO_CLAS Peptide DME1292 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 20 microM) DME1292 XEOTICID XEO04444 GENEFORM Protein DME1292 XEOTICID XEO04444 MOACRIVE Inhibition DME1292 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1292 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04461 XEO_CLAS Peptide DME1292 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 1.3 microM) DME1292 XEOTICID XEO04461 GENEFORM Protein DME1292 XEOTICID XEO04461 MOACRIVE Inhibition DME1292 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1292 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04462 XEO_CLAS Peptide DME1292 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 2.4 microM) DME1292 XEOTICID XEO04462 GENEFORM Protein DME1292 XEOTICID XEO04462 MOACRIVE Inhibition DME1292 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1292 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04463 XEO_CLAS Peptide DME1292 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04463 GENEFORM Protein DME1292 XEOTICID XEO04463 MOACRIVE Inhibition DME1292 XEOTICID XEO04468 XEO_NAME Papillosin DME1292 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04468 XEO_CLAS Peptide DME1292 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04468 GENEFORM Protein DME1292 XEOTICID XEO04468 MOACRIVE Inhibition DME1292 XEOTICID XEO04521 XEO_NAME Penocin A DME1292 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04521 XEO_CLAS Peptide DME1292 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04521 GENEFORM Protein DME1292 XEOTICID XEO04521 MOACRIVE Inhibition DME1292 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1292 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04569 XEO_CLAS Peptide DME1292 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 4.0 microM) DME1292 XEOTICID XEO04569 GENEFORM Protein DME1292 XEOTICID XEO04569 MOACRIVE Inhibition DME1292 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1292 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04612 XEO_CLAS Peptide DME1292 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 5-10 microM) DME1292 XEOTICID XEO04612 GENEFORM Protein DME1292 XEOTICID XEO04612 MOACRIVE Inhibition DME1292 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1292 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04613 XEO_CLAS Peptide DME1292 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 5-10 microM) DME1292 XEOTICID XEO04613 GENEFORM Protein DME1292 XEOTICID XEO04613 MOACRIVE Inhibition DME1292 XEOTICID XEO04622 XEO_NAME Plantaricin W alpha DME1292 XEOTICID XEO04622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04622 XEO_CLAS Peptide DME1292 XEOTICID XEO04622 DESCRIPT Plantaricin W alpha inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04622 GENEFORM Protein DME1292 XEOTICID XEO04622 MOACRIVE Inhibition DME1292 XEOTICID XEO04623 XEO_NAME Plantaricin W beta DME1292 XEOTICID XEO04623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04623 XEO_CLAS Peptide DME1292 XEOTICID XEO04623 DESCRIPT Plantaricin W beta inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04623 GENEFORM Protein DME1292 XEOTICID XEO04623 MOACRIVE Inhibition DME1292 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1292 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04657 XEO_CLAS Peptide DME1292 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 300 microM) DME1292 XEOTICID XEO04657 GENEFORM Protein DME1292 XEOTICID XEO04657 MOACRIVE Inhibition DME1292 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1292 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04660 XEO_CLAS Peptide DME1292 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 2 ug/ml) DME1292 XEOTICID XEO04660 GENEFORM Protein DME1292 XEOTICID XEO04660 MOACRIVE Inhibition DME1292 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1292 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04680 XEO_CLAS Peptide DME1292 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 1-2 microM) DME1292 XEOTICID XEO04680 GENEFORM Protein DME1292 XEOTICID XEO04680 MOACRIVE Inhibition DME1292 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1292 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04690 XEO_CLAS Peptide DME1292 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 1 ug/ml) DME1292 XEOTICID XEO04690 GENEFORM Protein DME1292 XEOTICID XEO04690 MOACRIVE Inhibition DME1292 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1292 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04695 XEO_CLAS Peptide DME1292 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04695 GENEFORM Protein DME1292 XEOTICID XEO04695 MOACRIVE Inhibition DME1292 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1292 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04696 XEO_CLAS Peptide DME1292 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04696 GENEFORM Protein DME1292 XEOTICID XEO04696 MOACRIVE Inhibition DME1292 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1292 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04699 XEO_CLAS Peptide DME1292 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04699 GENEFORM Protein DME1292 XEOTICID XEO04699 MOACRIVE Inhibition DME1292 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1292 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04700 XEO_CLAS Peptide DME1292 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04700 GENEFORM Protein DME1292 XEOTICID XEO04700 MOACRIVE Inhibition DME1292 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1292 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04701 XEO_CLAS Peptide DME1292 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04701 GENEFORM Protein DME1292 XEOTICID XEO04701 MOACRIVE Inhibition DME1292 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1292 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04702 XEO_CLAS Peptide DME1292 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04702 GENEFORM Protein DME1292 XEOTICID XEO04702 MOACRIVE Inhibition DME1292 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1292 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04703 XEO_CLAS Peptide DME1292 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04703 GENEFORM Protein DME1292 XEOTICID XEO04703 MOACRIVE Inhibition DME1292 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1292 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04704 XEO_CLAS Peptide DME1292 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04704 GENEFORM Protein DME1292 XEOTICID XEO04704 MOACRIVE Inhibition DME1292 XEOTICID XEO04727 XEO_NAME Propyl gallate DME1292 XEOTICID XEO04727 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1292 XEOTICID XEO04727 XEO_CLAS Food Additive DME1292 XEOTICID XEO04727 DESCRIPT Propyl gallate inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04727 GENEFORM Protein DME1292 XEOTICID XEO04727 MOACRIVE Inhibition DME1292 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1292 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04783 XEO_CLAS Peptide DME1292 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 8 ug/ml) DME1292 XEOTICID XEO04783 GENEFORM Protein DME1292 XEOTICID XEO04783 MOACRIVE Inhibition DME1292 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1292 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04784 XEO_CLAS Peptide DME1292 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 16 ug/ml) DME1292 XEOTICID XEO04784 GENEFORM Protein DME1292 XEOTICID XEO04784 MOACRIVE Inhibition DME1292 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1292 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04785 XEO_CLAS Peptide DME1292 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 8 ug/ml) DME1292 XEOTICID XEO04785 GENEFORM Protein DME1292 XEOTICID XEO04785 MOACRIVE Inhibition DME1292 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1292 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04786 XEO_CLAS Peptide DME1292 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 125 ug/ml) DME1292 XEOTICID XEO04786 GENEFORM Protein DME1292 XEOTICID XEO04786 MOACRIVE Inhibition DME1292 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1292 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04809 XEO_CLAS Peptide DME1292 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 40 microM) DME1292 XEOTICID XEO04809 GENEFORM Protein DME1292 XEOTICID XEO04809 MOACRIVE Inhibition DME1292 XEOTICID XEO04863 XEO_NAME RTD peptide DME1292 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04863 XEO_CLAS Peptide DME1292 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 1.2 microM) DME1292 XEOTICID XEO04863 GENEFORM Protein DME1292 XEOTICID XEO04863 MOACRIVE Inhibition DME1292 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1292 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04880 XEO_CLAS Peptide DME1292 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 12.7 ug/ml) DME1292 XEOTICID XEO04880 GENEFORM Protein DME1292 XEOTICID XEO04880 MOACRIVE Inhibition DME1292 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1292 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04886 XEO_CLAS Peptide DME1292 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 12.7 ug/ml) DME1292 XEOTICID XEO04886 GENEFORM Protein DME1292 XEOTICID XEO04886 MOACRIVE Inhibition DME1292 XEOTICID XEO04896 XEO_NAME Sakacin 5X DME1292 XEOTICID XEO04896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04896 XEO_CLAS Peptide DME1292 XEOTICID XEO04896 DESCRIPT Sakacin 5X inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04896 GENEFORM Protein DME1292 XEOTICID XEO04896 MOACRIVE Inhibition DME1292 XEOTICID XEO04898 XEO_NAME Sakacin P DME1292 XEOTICID XEO04898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04898 XEO_CLAS Peptide DME1292 XEOTICID XEO04898 DESCRIPT Sakacin P inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04898 GENEFORM Protein DME1292 XEOTICID XEO04898 MOACRIVE Inhibition DME1292 XEOTICID XEO04936 XEO_NAME Siamycin I DME1292 XEOTICID XEO04936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04936 XEO_CLAS Peptide DME1292 XEOTICID XEO04936 DESCRIPT Siamycin I inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO04936 GENEFORM Protein DME1292 XEOTICID XEO04936 MOACRIVE Inhibition DME1292 XEOTICID XEO04937 XEO_NAME Signiferin-2.1 DME1292 XEOTICID XEO04937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04937 XEO_CLAS Peptide DME1292 XEOTICID XEO04937 DESCRIPT Signiferin-2.1 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 100 microM) DME1292 XEOTICID XEO04937 GENEFORM Protein DME1292 XEOTICID XEO04937 MOACRIVE Inhibition DME1292 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1292 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04950 XEO_CLAS Peptide DME1292 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 10 ug/ml) DME1292 XEOTICID XEO04950 GENEFORM Protein DME1292 XEOTICID XEO04950 MOACRIVE Inhibition DME1292 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1292 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04995 XEO_CLAS Peptide DME1292 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 0.78-1.56 microM) DME1292 XEOTICID XEO04995 GENEFORM Protein DME1292 XEOTICID XEO04995 MOACRIVE Inhibition DME1292 XEOTICID XEO04998 XEO_NAME Styelin A DME1292 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04998 XEO_CLAS Peptide DME1292 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 2 ug/ml) DME1292 XEOTICID XEO04998 GENEFORM Protein DME1292 XEOTICID XEO04998 MOACRIVE Inhibition DME1292 XEOTICID XEO04999 XEO_NAME Styelin B DME1292 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO04999 XEO_CLAS Peptide DME1292 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 2 ug/ml) DME1292 XEOTICID XEO04999 GENEFORM Protein DME1292 XEOTICID XEO04999 MOACRIVE Inhibition DME1292 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1292 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05000 XEO_CLAS Peptide DME1292 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 4 ug/ml) DME1292 XEOTICID XEO05000 GENEFORM Protein DME1292 XEOTICID XEO05000 MOACRIVE Inhibition DME1292 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1292 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05001 XEO_CLAS Peptide DME1292 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 4 ug/ml) DME1292 XEOTICID XEO05001 GENEFORM Protein DME1292 XEOTICID XEO05001 MOACRIVE Inhibition DME1292 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1292 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05002 XEO_CLAS Peptide DME1292 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 2 ug/ml) DME1292 XEOTICID XEO05002 GENEFORM Protein DME1292 XEOTICID XEO05002 MOACRIVE Inhibition DME1292 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1292 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05003 XEO_CLAS Peptide DME1292 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 8 ug/ml) DME1292 XEOTICID XEO05003 GENEFORM Protein DME1292 XEOTICID XEO05003 MOACRIVE Inhibition DME1292 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1292 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05005 XEO_CLAS Peptide DME1292 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO05005 GENEFORM Protein DME1292 XEOTICID XEO05005 MOACRIVE Inhibition DME1292 XEOTICID XEO05006 XEO_NAME Substance P DME1292 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05006 XEO_CLAS Peptide DME1292 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO05006 GENEFORM Protein DME1292 XEOTICID XEO05006 MOACRIVE Inhibition DME1292 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1292 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05007 XEO_CLAS Peptide DME1292 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO05007 GENEFORM Protein DME1292 XEOTICID XEO05007 MOACRIVE Inhibition DME1292 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1292 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05063 XEO_CLAS Peptide DME1292 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 10 microM) DME1292 XEOTICID XEO05063 GENEFORM Protein DME1292 XEOTICID XEO05063 MOACRIVE Inhibition DME1292 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1292 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05064 XEO_CLAS Peptide DME1292 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 116 microM) DME1292 XEOTICID XEO05064 GENEFORM Protein DME1292 XEOTICID XEO05064 MOACRIVE Inhibition DME1292 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1292 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05065 XEO_CLAS Peptide DME1292 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC > 80 ug/ml) DME1292 XEOTICID XEO05065 GENEFORM Protein DME1292 XEOTICID XEO05065 MOACRIVE Inhibition DME1292 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1292 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05073 XEO_CLAS Peptide DME1292 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 40 microM) DME1292 XEOTICID XEO05073 GENEFORM Protein DME1292 XEOTICID XEO05073 MOACRIVE Inhibition DME1292 XEOTICID XEO05074 XEO_NAME Temporin-1Vb DME1292 XEOTICID XEO05074 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05074 XEO_CLAS Peptide DME1292 XEOTICID XEO05074 DESCRIPT Temporin-1Vb inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 20 microM) DME1292 XEOTICID XEO05074 GENEFORM Protein DME1292 XEOTICID XEO05074 MOACRIVE Inhibition DME1292 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1292 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05075 XEO_CLAS Peptide DME1292 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 40 microM) DME1292 XEOTICID XEO05075 GENEFORM Protein DME1292 XEOTICID XEO05075 MOACRIVE Inhibition DME1292 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1292 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05097 XEO_CLAS Peptide DME1292 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 8.0 microM) DME1292 XEOTICID XEO05097 GENEFORM Protein DME1292 XEOTICID XEO05097 MOACRIVE Inhibition DME1292 XEOTICID XEO05098 XEO_NAME Temporin-PEa DME1292 XEOTICID XEO05098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05098 XEO_CLAS Peptide DME1292 XEOTICID XEO05098 DESCRIPT Temporin-PEa inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 2.0 microM) DME1292 XEOTICID XEO05098 GENEFORM Protein DME1292 XEOTICID XEO05098 MOACRIVE Inhibition DME1292 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1292 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05099 XEO_CLAS Peptide DME1292 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 2.0 microM) DME1292 XEOTICID XEO05099 GENEFORM Protein DME1292 XEOTICID XEO05099 MOACRIVE Inhibition DME1292 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1292 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05170 XEO_CLAS Peptide DME1292 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 1.0 microM) DME1292 XEOTICID XEO05170 GENEFORM Protein DME1292 XEOTICID XEO05170 MOACRIVE Inhibition DME1292 XEOTICID XEO05196 XEO_NAME Ubericin-A DME1292 XEOTICID XEO05196 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05196 XEO_CLAS Peptide DME1292 XEOTICID XEO05196 DESCRIPT Ubericin-A inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO05196 GENEFORM Protein DME1292 XEOTICID XEO05196 MOACRIVE Inhibition DME1292 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1292 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05212 XEO_CLAS Peptide DME1292 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 50.8 ug/ml) DME1292 XEOTICID XEO05212 GENEFORM Protein DME1292 XEOTICID XEO05212 MOACRIVE Inhibition DME1292 XEOTICID XEO05224 XEO_NAME Vancomycin DME1292 XEOTICID XEO05224 XEO_TYPE Pharmaceutical Agent(s) DME1292 XEOTICID XEO05224 XEO_CLAS Approved/Marketed Drug DME1292 XEOTICID XEO05224 DESCRIPT Vancomycin inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO05224 GENEFORM Protein DME1292 XEOTICID XEO05224 MOACRIVE Inhibition DME1292 XEOTICID XEO05228 XEO_NAME Variacin DME1292 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05228 XEO_CLAS Peptide DME1292 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO05228 GENEFORM Protein DME1292 XEOTICID XEO05228 MOACRIVE Inhibition DME1292 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1292 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05264 XEO_CLAS Peptide DME1292 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 4 ug/ml) DME1292 XEOTICID XEO05264 GENEFORM Protein DME1292 XEOTICID XEO05264 MOACRIVE Inhibition DME1292 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1292 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05267 XEO_CLAS Peptide DME1292 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis (MIC = 2 ug/ml) DME1292 XEOTICID XEO05267 GENEFORM Protein DME1292 XEOTICID XEO05267 MOACRIVE Inhibition DME1292 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1292 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1292 XEOTICID XEO05283 XEO_CLAS Peptide DME1292 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of VanB ligase (vanB) from Enterococcus faecalis DME1292 XEOTICID XEO05283 GENEFORM Protein DME1292 XEOTICID XEO05283 MOACRIVE Inhibition DME1296 DME___ID DME1296 DME1296 DME_NAME Metallo-beta-lactamase (blaM) DME1296 SPESNAME Achromobacter xylosoxidans DME1296 XEOTICID XEO04478 XEO_NAME Patulin DME1296 XEOTICID XEO04478 XEO_TYPE Pharmaceutical Agent(s) DME1296 XEOTICID XEO04478 XEO_CLAS Investigative Agent DME1296 XEOTICID XEO04478 DESCRIPT Patulin inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Achromobacter xylosoxidans DME1296 XEOTICID XEO04478 GENEFORM Protein DME1296 XEOTICID XEO04478 MOACRIVE Inhibition DME1296 XEOTICID XEO04518 XEO_NAME Penicillic acid DME1296 XEOTICID XEO04518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1296 XEOTICID XEO04518 XEO_CLAS Natural Product DME1296 XEOTICID XEO04518 DESCRIPT Penicillic acid inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Achromobacter xylosoxidans DME1296 XEOTICID XEO04518 GENEFORM Protein DME1296 XEOTICID XEO04518 MOACRIVE Inhibition DME1298 DME___ID DME1298 DME1298 DME_NAME Beta-lactamase (blaB) DME1298 SPESNAME Shigella sonnei DME1298 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1298 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO02275 XEO_CLAS Peptide DME1298 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei (MIC = 35 microM) DME1298 XEOTICID XEO02275 GENEFORM Protein DME1298 XEOTICID XEO02275 MOACRIVE Inhibition DME1298 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1298 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO02416 XEO_CLAS Peptide DME1298 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei (MIC = 44 microM) DME1298 XEOTICID XEO02416 GENEFORM Protein DME1298 XEOTICID XEO02416 MOACRIVE Inhibition DME1298 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1298 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO03029 XEO_CLAS Peptide DME1298 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei (MIC = 0.005 microM) DME1298 XEOTICID XEO03029 GENEFORM Protein DME1298 XEOTICID XEO03029 MOACRIVE Inhibition DME1298 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1298 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO03030 XEO_CLAS Peptide DME1298 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei (MIC = 0.005 microM) DME1298 XEOTICID XEO03030 GENEFORM Protein DME1298 XEOTICID XEO03030 MOACRIVE Inhibition DME1298 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1298 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO03031 XEO_CLAS Peptide DME1298 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei (MIC = 0.005 microM) DME1298 XEOTICID XEO03031 GENEFORM Protein DME1298 XEOTICID XEO03031 MOACRIVE Inhibition DME1298 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1298 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO03032 XEO_CLAS Peptide DME1298 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei (MIC = 0.01 microM) DME1298 XEOTICID XEO03032 GENEFORM Protein DME1298 XEOTICID XEO03032 MOACRIVE Inhibition DME1298 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1298 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO03033 XEO_CLAS Peptide DME1298 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei (MIC = 0.692 microM) DME1298 XEOTICID XEO03033 GENEFORM Protein DME1298 XEOTICID XEO03033 MOACRIVE Inhibition DME1298 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1298 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO03034 XEO_CLAS Peptide DME1298 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei (MIC = 0.004 microM) DME1298 XEOTICID XEO03034 GENEFORM Protein DME1298 XEOTICID XEO03034 MOACRIVE Inhibition DME1298 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1298 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO03035 XEO_CLAS Peptide DME1298 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei (MIC = 0.007 microM) DME1298 XEOTICID XEO03035 GENEFORM Protein DME1298 XEOTICID XEO03035 MOACRIVE Inhibition DME1298 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1298 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO03193 XEO_CLAS Peptide DME1298 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei (MIC = 12.5 ug/ml) DME1298 XEOTICID XEO03193 GENEFORM Protein DME1298 XEOTICID XEO03193 MOACRIVE Inhibition DME1298 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1298 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO03251 XEO_CLAS Peptide DME1298 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei DME1298 XEOTICID XEO03251 GENEFORM Protein DME1298 XEOTICID XEO03251 MOACRIVE Inhibition DME1298 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1298 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO03540 XEO_CLAS Peptide DME1298 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei (MIC = 2-4 ug/ml) DME1298 XEOTICID XEO03540 GENEFORM Protein DME1298 XEOTICID XEO03540 MOACRIVE Inhibition DME1298 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1298 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO03556 XEO_CLAS Peptide DME1298 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei (MIC = 2-4 ug/ml) DME1298 XEOTICID XEO03556 GENEFORM Protein DME1298 XEOTICID XEO03556 MOACRIVE Inhibition DME1298 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1298 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO03557 XEO_CLAS Peptide DME1298 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei (MIC = 2-4 ug/ml) DME1298 XEOTICID XEO03557 GENEFORM Protein DME1298 XEOTICID XEO03557 MOACRIVE Inhibition DME1298 XEOTICID XEO04114 XEO_NAME Microcin L DME1298 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO04114 XEO_CLAS Peptide DME1298 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei DME1298 XEOTICID XEO04114 GENEFORM Protein DME1298 XEOTICID XEO04114 MOACRIVE Inhibition DME1298 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1298 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO04904 XEO_CLAS Peptide DME1298 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei (MIC > 78 ug/ml) DME1298 XEOTICID XEO04904 GENEFORM Protein DME1298 XEOTICID XEO04904 MOACRIVE Inhibition DME1298 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1298 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1298 XEOTICID XEO04909 XEO_CLAS Peptide DME1298 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Shigella sonnei DME1298 XEOTICID XEO04909 GENEFORM Protein DME1298 XEOTICID XEO04909 MOACRIVE Inhibition DME1302 DME___ID DME1302 DME1302 DME_NAME General stress protein 14 (ywrO) DME1302 SPESNAME Bacillus subtilis DME1302 XEOTICID XEO00044 XEO_NAME Glipizide DME1302 XEOTICID XEO00044 XEO_TYPE Pharmaceutical Agent(s) DME1302 XEOTICID XEO00044 XEO_CLAS Approved/Marketed Drug DME1302 XEOTICID XEO00044 DESCRIPT Glipizide inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO00044 GENEFORM Protein DME1302 XEOTICID XEO00044 MOACRIVE Inhibition DME1302 XEOTICID XEO00070 XEO_NAME Esomeprazole DME1302 XEOTICID XEO00070 XEO_TYPE Pharmaceutical Agent(s) DME1302 XEOTICID XEO00070 XEO_CLAS Approved/Marketed Drug DME1302 XEOTICID XEO00070 DESCRIPT Esomeprazole inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO00070 GENEFORM Protein DME1302 XEOTICID XEO00070 MOACRIVE Inhibition DME1302 XEOTICID XEO00096 XEO_NAME Ampicillin DME1302 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME1302 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME1302 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO00096 GENEFORM Protein DME1302 XEOTICID XEO00096 MOACRIVE Inhibition DME1302 XEOTICID XEO00246 XEO_NAME Amoxicillin DME1302 XEOTICID XEO00246 XEO_TYPE Pharmaceutical Agent(s) DME1302 XEOTICID XEO00246 XEO_CLAS Approved/Marketed Drug DME1302 XEOTICID XEO00246 DESCRIPT Amoxicillin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO00246 GENEFORM Protein DME1302 XEOTICID XEO00246 MOACRIVE Inhibition DME1302 XEOTICID XEO00338 XEO_NAME Amlodipine DME1302 XEOTICID XEO00338 XEO_TYPE Pharmaceutical Agent(s) DME1302 XEOTICID XEO00338 XEO_CLAS Approved/Marketed Drug DME1302 XEOTICID XEO00338 DESCRIPT Amlodipine inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO00338 GENEFORM Protein DME1302 XEOTICID XEO00338 MOACRIVE Inhibition DME1302 XEOTICID XEO00356 XEO_NAME Enalapril DME1302 XEOTICID XEO00356 XEO_TYPE Pharmaceutical Agent(s) DME1302 XEOTICID XEO00356 XEO_CLAS Approved/Marketed Drug DME1302 XEOTICID XEO00356 DESCRIPT Enalapril inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO00356 GENEFORM Protein DME1302 XEOTICID XEO00356 MOACRIVE Inhibition DME1302 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1302 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO01810 XEO_CLAS Peptide DME1302 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2.0 microM) DME1302 XEOTICID XEO01810 GENEFORM Protein DME1302 XEOTICID XEO01810 MOACRIVE Inhibition DME1302 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1302 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO01817 XEO_CLAS Peptide DME1302 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 4.0 microM) DME1302 XEOTICID XEO01817 GENEFORM Protein DME1302 XEOTICID XEO01817 MOACRIVE Inhibition DME1302 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1302 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO01818 XEO_CLAS Peptide DME1302 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 4.0 microM) DME1302 XEOTICID XEO01818 GENEFORM Protein DME1302 XEOTICID XEO01818 MOACRIVE Inhibition DME1302 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1302 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO01823 XEO_CLAS Peptide DME1302 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.56 microM) DME1302 XEOTICID XEO01823 GENEFORM Protein DME1302 XEOTICID XEO01823 MOACRIVE Inhibition DME1302 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1302 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO01825 XEO_CLAS Peptide DME1302 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.56 microM) DME1302 XEOTICID XEO01825 GENEFORM Protein DME1302 XEOTICID XEO01825 MOACRIVE Inhibition DME1302 XEOTICID XEO01972 XEO_NAME 3,4-Dichloro-2-(1,3-dichloropropan-2-yloxy)-2H-furan-5-one DME1302 XEOTICID XEO01972 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1302 XEOTICID XEO01972 XEO_CLAS Chemical Compound DME1302 XEOTICID XEO01972 DESCRIPT 3,4-Dichloro-2-(1,3-dichloropropan-2-yloxy)-2H-furan-5-one inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO01972 GENEFORM Protein DME1302 XEOTICID XEO01972 MOACRIVE Inhibition DME1302 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1302 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02013 XEO_CLAS Peptide DME1302 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02013 GENEFORM Protein DME1302 XEOTICID XEO02013 MOACRIVE Inhibition DME1302 XEOTICID XEO02102 XEO_NAME A. dichotoma defensin DME1302 XEOTICID XEO02102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02102 XEO_CLAS Peptide DME1302 XEOTICID XEO02102 DESCRIPT A. dichotoma defensin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02102 GENEFORM Protein DME1302 XEOTICID XEO02102 MOACRIVE Inhibition DME1302 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1302 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02115 XEO_CLAS Peptide DME1302 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02115 GENEFORM Protein DME1302 XEOTICID XEO02115 MOACRIVE Inhibition DME1302 XEOTICID XEO02146 XEO_NAME Antimicrobial protein Ah-AMP1 DME1302 XEOTICID XEO02146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02146 XEO_CLAS Peptide DME1302 XEOTICID XEO02146 DESCRIPT Antimicrobial protein Ah-AMP1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02146 GENEFORM Protein DME1302 XEOTICID XEO02146 MOACRIVE Inhibition DME1302 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1302 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02147 XEO_CLAS Peptide DME1302 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 237 ug/ml) DME1302 XEOTICID XEO02147 GENEFORM Protein DME1302 XEOTICID XEO02147 MOACRIVE Inhibition DME1302 XEOTICID XEO02151 XEO_NAME AI-hemocidins 4 DME1302 XEOTICID XEO02151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02151 XEO_CLAS Peptide DME1302 XEOTICID XEO02151 DESCRIPT AI-hemocidins 4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 69.55 microM) DME1302 XEOTICID XEO02151 GENEFORM Protein DME1302 XEOTICID XEO02151 MOACRIVE Inhibition DME1302 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1302 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02200 XEO_CLAS Peptide DME1302 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 100 ug/ml) DME1302 XEOTICID XEO02200 GENEFORM Protein DME1302 XEOTICID XEO02200 MOACRIVE Inhibition DME1302 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1302 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02201 XEO_CLAS Peptide DME1302 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 25 ug/ml) DME1302 XEOTICID XEO02201 GENEFORM Protein DME1302 XEOTICID XEO02201 MOACRIVE Inhibition DME1302 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1302 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02202 XEO_CLAS Peptide DME1302 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 20 microM) DME1302 XEOTICID XEO02202 GENEFORM Protein DME1302 XEOTICID XEO02202 MOACRIVE Inhibition DME1302 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1302 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02203 XEO_CLAS Peptide DME1302 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 20 microM) DME1302 XEOTICID XEO02203 GENEFORM Protein DME1302 XEOTICID XEO02203 MOACRIVE Inhibition DME1302 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1302 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02207 XEO_CLAS Peptide DME1302 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1302 XEOTICID XEO02207 GENEFORM Protein DME1302 XEOTICID XEO02207 MOACRIVE Inhibition DME1302 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1302 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02208 XEO_CLAS Peptide DME1302 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1302 XEOTICID XEO02208 GENEFORM Protein DME1302 XEOTICID XEO02208 MOACRIVE Inhibition DME1302 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1302 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02209 XEO_CLAS Peptide DME1302 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1302 XEOTICID XEO02209 GENEFORM Protein DME1302 XEOTICID XEO02209 MOACRIVE Inhibition DME1302 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1302 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02210 XEO_CLAS Peptide DME1302 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1302 XEOTICID XEO02210 GENEFORM Protein DME1302 XEOTICID XEO02210 MOACRIVE Inhibition DME1302 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1302 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02211 XEO_CLAS Peptide DME1302 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 3.13 ug/ml) DME1302 XEOTICID XEO02211 GENEFORM Protein DME1302 XEOTICID XEO02211 MOACRIVE Inhibition DME1302 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1302 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02212 XEO_CLAS Peptide DME1302 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1302 XEOTICID XEO02212 GENEFORM Protein DME1302 XEOTICID XEO02212 MOACRIVE Inhibition DME1302 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1302 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02213 XEO_CLAS Peptide DME1302 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.56 ug/ml) DME1302 XEOTICID XEO02213 GENEFORM Protein DME1302 XEOTICID XEO02213 MOACRIVE Inhibition DME1302 XEOTICID XEO02224 XEO_NAME Androctonin DME1302 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02224 XEO_CLAS Peptide DME1302 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02224 GENEFORM Protein DME1302 XEOTICID XEO02224 MOACRIVE Inhibition DME1302 XEOTICID XEO02226 XEO_NAME Andropin DME1302 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02226 XEO_CLAS Peptide DME1302 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 17 microM) DME1302 XEOTICID XEO02226 GENEFORM Protein DME1302 XEOTICID XEO02226 MOACRIVE Inhibition DME1302 XEOTICID XEO02235 XEO_NAME Anthranilate DME1302 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1302 XEOTICID XEO02235 XEO_CLAS Natural Product DME1302 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02235 GENEFORM Protein DME1302 XEOTICID XEO02235 MOACRIVE Inhibition DME1302 XEOTICID XEO02237 XEO_NAME Antibacterial napin DME1302 XEOTICID XEO02237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02237 XEO_CLAS Peptide DME1302 XEOTICID XEO02237 DESCRIPT Antibacterial napin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 236 microM) DME1302 XEOTICID XEO02237 GENEFORM Protein DME1302 XEOTICID XEO02237 MOACRIVE Inhibition DME1302 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1302 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02241 XEO_CLAS Peptide DME1302 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02241 GENEFORM Protein DME1302 XEOTICID XEO02241 MOACRIVE Inhibition DME1302 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1302 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02248 XEO_CLAS Peptide DME1302 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 15 microM) DME1302 XEOTICID XEO02248 GENEFORM Protein DME1302 XEOTICID XEO02248 MOACRIVE Inhibition DME1302 XEOTICID XEO02249 XEO_NAME Anticancerous peptide Cr-ACP1 DME1302 XEOTICID XEO02249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02249 XEO_CLAS Peptide DME1302 XEOTICID XEO02249 DESCRIPT Anticancerous peptide Cr-ACP1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 30 microM) DME1302 XEOTICID XEO02249 GENEFORM Protein DME1302 XEOTICID XEO02249 MOACRIVE Inhibition DME1302 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1302 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02261 XEO_CLAS Peptide DME1302 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 76 ug/ml) DME1302 XEOTICID XEO02261 GENEFORM Protein DME1302 XEOTICID XEO02261 MOACRIVE Inhibition DME1302 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1302 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02268 XEO_CLAS Peptide DME1302 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 150 ug/ml) DME1302 XEOTICID XEO02268 GENEFORM Protein DME1302 XEOTICID XEO02268 MOACRIVE Inhibition DME1302 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1302 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02271 XEO_CLAS Peptide DME1302 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 257 ug/ml) DME1302 XEOTICID XEO02271 GENEFORM Protein DME1302 XEOTICID XEO02271 MOACRIVE Inhibition DME1302 XEOTICID XEO02278 XEO_NAME Antimicrobial peptide Ar-AMP DME1302 XEOTICID XEO02278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02278 XEO_CLAS Peptide DME1302 XEOTICID XEO02278 DESCRIPT Antimicrobial peptide Ar-AMP inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02278 GENEFORM Protein DME1302 XEOTICID XEO02278 MOACRIVE Inhibition DME1302 XEOTICID XEO02282 XEO_NAME Antimicrobial peptide GP-19 DME1302 XEOTICID XEO02282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02282 XEO_CLAS Peptide DME1302 XEOTICID XEO02282 DESCRIPT Antimicrobial peptide GP-19 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02282 GENEFORM Protein DME1302 XEOTICID XEO02282 MOACRIVE Inhibition DME1302 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1302 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02283 XEO_CLAS Peptide DME1302 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 3.13 ug/ml) DME1302 XEOTICID XEO02283 GENEFORM Protein DME1302 XEOTICID XEO02283 MOACRIVE Inhibition DME1302 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1302 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02288 XEO_CLAS Peptide DME1302 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12.3 ug/ml) DME1302 XEOTICID XEO02288 GENEFORM Protein DME1302 XEOTICID XEO02288 MOACRIVE Inhibition DME1302 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1302 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02289 XEO_CLAS Peptide DME1302 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12 ug/ml) DME1302 XEOTICID XEO02289 GENEFORM Protein DME1302 XEOTICID XEO02289 MOACRIVE Inhibition DME1302 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1302 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02298 XEO_CLAS Peptide DME1302 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 32 ug/ml) DME1302 XEOTICID XEO02298 GENEFORM Protein DME1302 XEOTICID XEO02298 MOACRIVE Inhibition DME1302 XEOTICID XEO02300 XEO_NAME Antimicrobial protein BL-A60 DME1302 XEOTICID XEO02300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02300 XEO_CLAS Peptide DME1302 XEOTICID XEO02300 DESCRIPT Antimicrobial protein BL-A60 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 5 microM) DME1302 XEOTICID XEO02300 GENEFORM Protein DME1302 XEOTICID XEO02300 MOACRIVE Inhibition DME1302 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1302 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02316 XEO_CLAS Peptide DME1302 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.25-12.5 microM) DME1302 XEOTICID XEO02316 GENEFORM Protein DME1302 XEOTICID XEO02316 MOACRIVE Inhibition DME1302 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1302 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02320 XEO_CLAS Peptide DME1302 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02320 GENEFORM Protein DME1302 XEOTICID XEO02320 MOACRIVE Inhibition DME1302 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1302 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02332 XEO_CLAS Peptide DME1302 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.95 ug/ml) DME1302 XEOTICID XEO02332 GENEFORM Protein DME1302 XEOTICID XEO02332 MOACRIVE Inhibition DME1302 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1302 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02452 XEO_CLAS Peptide DME1302 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 76800 ug/ml) DME1302 XEOTICID XEO02452 GENEFORM Protein DME1302 XEOTICID XEO02452 MOACRIVE Inhibition DME1302 XEOTICID XEO02476 XEO_NAME Bacteriocin HJ50 DME1302 XEOTICID XEO02476 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02476 XEO_CLAS Peptide DME1302 XEOTICID XEO02476 DESCRIPT Bacteriocin HJ50 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02476 GENEFORM Protein DME1302 XEOTICID XEO02476 MOACRIVE Inhibition DME1302 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1302 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02491 XEO_CLAS Peptide DME1302 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 24.4 microM) DME1302 XEOTICID XEO02491 GENEFORM Protein DME1302 XEOTICID XEO02491 MOACRIVE Inhibition DME1302 XEOTICID XEO02532 XEO_NAME Brevinin-1LT1 DME1302 XEOTICID XEO02532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02532 XEO_CLAS Peptide DME1302 XEOTICID XEO02532 DESCRIPT Brevinin-1LT1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.25 microM) DME1302 XEOTICID XEO02532 GENEFORM Protein DME1302 XEOTICID XEO02532 MOACRIVE Inhibition DME1302 XEOTICID XEO02588 XEO_NAME Brevinin-2GHa DME1302 XEOTICID XEO02588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02588 XEO_CLAS Peptide DME1302 XEOTICID XEO02588 DESCRIPT Brevinin-2GHa inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 64 ug/ml) DME1302 XEOTICID XEO02588 GENEFORM Protein DME1302 XEOTICID XEO02588 MOACRIVE Inhibition DME1302 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1302 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02589 XEO_CLAS Peptide DME1302 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 64 ug/ml) DME1302 XEOTICID XEO02589 GENEFORM Protein DME1302 XEOTICID XEO02589 MOACRIVE Inhibition DME1302 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1302 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02590 XEO_CLAS Peptide DME1302 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 64 ug/ml) DME1302 XEOTICID XEO02590 GENEFORM Protein DME1302 XEOTICID XEO02590 MOACRIVE Inhibition DME1302 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1302 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02595 XEO_CLAS Peptide DME1302 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12.5 microM) DME1302 XEOTICID XEO02595 GENEFORM Protein DME1302 XEOTICID XEO02595 MOACRIVE Inhibition DME1302 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1302 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02596 XEO_CLAS Peptide DME1302 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 25 microM) DME1302 XEOTICID XEO02596 GENEFORM Protein DME1302 XEOTICID XEO02596 MOACRIVE Inhibition DME1302 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1302 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02630 XEO_CLAS Peptide DME1302 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1302 XEOTICID XEO02630 GENEFORM Protein DME1302 XEOTICID XEO02630 MOACRIVE Inhibition DME1302 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1302 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02631 XEO_CLAS Peptide DME1302 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1302 XEOTICID XEO02631 GENEFORM Protein DME1302 XEOTICID XEO02631 MOACRIVE Inhibition DME1302 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1302 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02649 XEO_CLAS Peptide DME1302 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 4 ug/ml) DME1302 XEOTICID XEO02649 GENEFORM Protein DME1302 XEOTICID XEO02649 MOACRIVE Inhibition DME1302 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1302 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02650 XEO_CLAS Peptide DME1302 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2 ug/ml) DME1302 XEOTICID XEO02650 GENEFORM Protein DME1302 XEOTICID XEO02650 MOACRIVE Inhibition DME1302 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1302 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02663 XEO_CLAS Peptide DME1302 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.78 microM) DME1302 XEOTICID XEO02663 GENEFORM Protein DME1302 XEOTICID XEO02663 MOACRIVE Inhibition DME1302 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1302 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02664 XEO_CLAS Peptide DME1302 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.56 microM) DME1302 XEOTICID XEO02664 GENEFORM Protein DME1302 XEOTICID XEO02664 MOACRIVE Inhibition DME1302 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1302 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02672 XEO_CLAS Peptide DME1302 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.56 microM) DME1302 XEOTICID XEO02672 GENEFORM Protein DME1302 XEOTICID XEO02672 MOACRIVE Inhibition DME1302 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1302 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02673 XEO_CLAS Peptide DME1302 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.78-1.56 microM) DME1302 XEOTICID XEO02673 GENEFORM Protein DME1302 XEOTICID XEO02673 MOACRIVE Inhibition DME1302 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1302 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02674 XEO_CLAS Peptide DME1302 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.56 microM) DME1302 XEOTICID XEO02674 GENEFORM Protein DME1302 XEOTICID XEO02674 MOACRIVE Inhibition DME1302 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1302 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02676 XEO_CLAS Peptide DME1302 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.78 microM) DME1302 XEOTICID XEO02676 GENEFORM Protein DME1302 XEOTICID XEO02676 MOACRIVE Inhibition DME1302 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1302 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02677 XEO_CLAS Peptide DME1302 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.78 microM) DME1302 XEOTICID XEO02677 GENEFORM Protein DME1302 XEOTICID XEO02677 MOACRIVE Inhibition DME1302 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1302 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02679 XEO_CLAS Peptide DME1302 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.56 microM) DME1302 XEOTICID XEO02679 GENEFORM Protein DME1302 XEOTICID XEO02679 MOACRIVE Inhibition DME1302 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1302 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02680 XEO_CLAS Peptide DME1302 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.56 microM) DME1302 XEOTICID XEO02680 GENEFORM Protein DME1302 XEOTICID XEO02680 MOACRIVE Inhibition DME1302 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1302 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02683 XEO_CLAS Peptide DME1302 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.56 microM) DME1302 XEOTICID XEO02683 GENEFORM Protein DME1302 XEOTICID XEO02683 MOACRIVE Inhibition DME1302 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1302 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02735 XEO_CLAS Peptide DME1302 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC < 2 ug/ml) DME1302 XEOTICID XEO02735 GENEFORM Protein DME1302 XEOTICID XEO02735 MOACRIVE Inhibition DME1302 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1302 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02741 XEO_CLAS Peptide DME1302 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 100 ug/ml) DME1302 XEOTICID XEO02741 GENEFORM Protein DME1302 XEOTICID XEO02741 MOACRIVE Inhibition DME1302 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1302 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02743 XEO_CLAS Peptide DME1302 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 9.4 ug/ml) DME1302 XEOTICID XEO02743 GENEFORM Protein DME1302 XEOTICID XEO02743 MOACRIVE Inhibition DME1302 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1302 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02744 XEO_CLAS Peptide DME1302 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 75 ug/ml) DME1302 XEOTICID XEO02744 GENEFORM Protein DME1302 XEOTICID XEO02744 MOACRIVE Inhibition DME1302 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1302 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02756 XEO_CLAS Peptide DME1302 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.4 microM) DME1302 XEOTICID XEO02756 GENEFORM Protein DME1302 XEOTICID XEO02756 MOACRIVE Inhibition DME1302 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1302 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02757 XEO_CLAS Peptide DME1302 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.5 microM) DME1302 XEOTICID XEO02757 GENEFORM Protein DME1302 XEOTICID XEO02757 MOACRIVE Inhibition DME1302 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1302 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02758 XEO_CLAS Peptide DME1302 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 3 microM) DME1302 XEOTICID XEO02758 GENEFORM Protein DME1302 XEOTICID XEO02758 MOACRIVE Inhibition DME1302 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1302 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02759 XEO_CLAS Peptide DME1302 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.6 microM) DME1302 XEOTICID XEO02759 GENEFORM Protein DME1302 XEOTICID XEO02759 MOACRIVE Inhibition DME1302 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1302 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02760 XEO_CLAS Peptide DME1302 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.3 microM) DME1302 XEOTICID XEO02760 GENEFORM Protein DME1302 XEOTICID XEO02760 MOACRIVE Inhibition DME1302 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1302 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02761 XEO_CLAS Peptide DME1302 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1 microM) DME1302 XEOTICID XEO02761 GENEFORM Protein DME1302 XEOTICID XEO02761 MOACRIVE Inhibition DME1302 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1302 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02762 XEO_CLAS Peptide DME1302 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.3 microM) DME1302 XEOTICID XEO02762 GENEFORM Protein DME1302 XEOTICID XEO02762 MOACRIVE Inhibition DME1302 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1302 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02763 XEO_CLAS Peptide DME1302 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.3 microM) DME1302 XEOTICID XEO02763 GENEFORM Protein DME1302 XEOTICID XEO02763 MOACRIVE Inhibition DME1302 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1302 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02764 XEO_CLAS Peptide DME1302 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.7 microM) DME1302 XEOTICID XEO02764 GENEFORM Protein DME1302 XEOTICID XEO02764 MOACRIVE Inhibition DME1302 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1302 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02765 XEO_CLAS Peptide DME1302 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.4 microM) DME1302 XEOTICID XEO02765 GENEFORM Protein DME1302 XEOTICID XEO02765 MOACRIVE Inhibition DME1302 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1302 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02767 XEO_CLAS Peptide DME1302 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02767 GENEFORM Protein DME1302 XEOTICID XEO02767 MOACRIVE Inhibition DME1302 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1302 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02768 XEO_CLAS Peptide DME1302 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02768 GENEFORM Protein DME1302 XEOTICID XEO02768 MOACRIVE Inhibition DME1302 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1302 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02769 XEO_CLAS Peptide DME1302 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 18 microM) DME1302 XEOTICID XEO02769 GENEFORM Protein DME1302 XEOTICID XEO02769 MOACRIVE Inhibition DME1302 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1302 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02770 XEO_CLAS Peptide DME1302 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 17 microM) DME1302 XEOTICID XEO02770 GENEFORM Protein DME1302 XEOTICID XEO02770 MOACRIVE Inhibition DME1302 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1302 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02771 XEO_CLAS Peptide DME1302 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 81 microM) DME1302 XEOTICID XEO02771 GENEFORM Protein DME1302 XEOTICID XEO02771 MOACRIVE Inhibition DME1302 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1302 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02772 XEO_CLAS Peptide DME1302 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02772 GENEFORM Protein DME1302 XEOTICID XEO02772 MOACRIVE Inhibition DME1302 XEOTICID XEO02780 XEO_NAME Cefixime DME1302 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1302 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1302 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02780 GENEFORM Protein DME1302 XEOTICID XEO02780 MOACRIVE Inhibition DME1302 XEOTICID XEO02801 XEO_NAME Cephalexin DME1302 XEOTICID XEO02801 XEO_TYPE Pharmaceutical Agent(s) DME1302 XEOTICID XEO02801 XEO_CLAS Approved/Marketed Drug DME1302 XEOTICID XEO02801 DESCRIPT Cephalexin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02801 GENEFORM Protein DME1302 XEOTICID XEO02801 MOACRIVE Inhibition DME1302 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1302 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02802 XEO_CLAS Peptide DME1302 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 5.9 microM) DME1302 XEOTICID XEO02802 GENEFORM Protein DME1302 XEOTICID XEO02802 MOACRIVE Inhibition DME1302 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1302 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02807 XEO_CLAS Peptide DME1302 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.4 ug/mL) DME1302 XEOTICID XEO02807 GENEFORM Protein DME1302 XEOTICID XEO02807 MOACRIVE Inhibition DME1302 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1302 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02821 XEO_CLAS Peptide DME1302 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02821 GENEFORM Protein DME1302 XEOTICID XEO02821 MOACRIVE Inhibition DME1302 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1302 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02839 XEO_CLAS Peptide DME1302 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.25 microM) DME1302 XEOTICID XEO02839 GENEFORM Protein DME1302 XEOTICID XEO02839 MOACRIVE Inhibition DME1302 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1302 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02841 XEO_CLAS Peptide DME1302 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.25 microM) DME1302 XEOTICID XEO02841 GENEFORM Protein DME1302 XEOTICID XEO02841 MOACRIVE Inhibition DME1302 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1302 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02842 XEO_CLAS Peptide DME1302 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.25 microM) DME1302 XEOTICID XEO02842 GENEFORM Protein DME1302 XEOTICID XEO02842 MOACRIVE Inhibition DME1302 XEOTICID XEO02962 XEO_NAME Cryptonin DME1302 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02962 XEO_CLAS Peptide DME1302 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 3.12 ug/ml) DME1302 XEOTICID XEO02962 GENEFORM Protein DME1302 XEOTICID XEO02962 MOACRIVE Inhibition DME1302 XEOTICID XEO02966 XEO_NAME C. ternatea-antimicrobial peptide Ct-AMP1 DME1302 XEOTICID XEO02966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO02966 XEO_CLAS Peptide DME1302 XEOTICID XEO02966 DESCRIPT C. ternatea-antimicrobial peptide Ct-AMP1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02966 GENEFORM Protein DME1302 XEOTICID XEO02966 MOACRIVE Inhibition DME1302 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1302 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1302 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1302 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO02990 GENEFORM Protein DME1302 XEOTICID XEO02990 MOACRIVE Inhibition DME1302 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1302 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03051 XEO_CLAS Peptide DME1302 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 25 ug/ml) DME1302 XEOTICID XEO03051 GENEFORM Protein DME1302 XEOTICID XEO03051 MOACRIVE Inhibition DME1302 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1302 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03052 XEO_CLAS Peptide DME1302 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2.5 ug/ml) DME1302 XEOTICID XEO03052 GENEFORM Protein DME1302 XEOTICID XEO03052 MOACRIVE Inhibition DME1302 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1302 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03053 XEO_CLAS Peptide DME1302 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 25 ug/ml) DME1302 XEOTICID XEO03053 GENEFORM Protein DME1302 XEOTICID XEO03053 MOACRIVE Inhibition DME1302 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1302 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03060 XEO_CLAS Peptide DME1302 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1 microM) DME1302 XEOTICID XEO03060 GENEFORM Protein DME1302 XEOTICID XEO03060 MOACRIVE Inhibition DME1302 XEOTICID XEO03089 XEO_NAME Decoralin DME1302 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03089 XEO_CLAS Peptide DME1302 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 40 microM) DME1302 XEOTICID XEO03089 GENEFORM Protein DME1302 XEOTICID XEO03089 MOACRIVE Inhibition DME1302 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1302 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03100 XEO_CLAS Peptide DME1302 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03100 GENEFORM Protein DME1302 XEOTICID XEO03100 MOACRIVE Inhibition DME1302 XEOTICID XEO03101 XEO_NAME Defensin varisin A1 DME1302 XEOTICID XEO03101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03101 XEO_CLAS Peptide DME1302 XEOTICID XEO03101 DESCRIPT Defensin varisin A1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03101 GENEFORM Protein DME1302 XEOTICID XEO03101 MOACRIVE Inhibition DME1302 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1302 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03103 XEO_CLAS Peptide DME1302 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03103 GENEFORM Protein DME1302 XEOTICID XEO03103 MOACRIVE Inhibition DME1302 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1302 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03105 XEO_CLAS Peptide DME1302 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03105 GENEFORM Protein DME1302 XEOTICID XEO03105 MOACRIVE Inhibition DME1302 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1302 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03112 XEO_CLAS Peptide DME1302 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 50 ug/ml) DME1302 XEOTICID XEO03112 GENEFORM Protein DME1302 XEOTICID XEO03112 MOACRIVE Inhibition DME1302 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1302 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03116 XEO_CLAS Peptide DME1302 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 40 microM) DME1302 XEOTICID XEO03116 GENEFORM Protein DME1302 XEOTICID XEO03116 MOACRIVE Inhibition DME1302 XEOTICID XEO03117 XEO_NAME Insect defensin B DME1302 XEOTICID XEO03117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03117 XEO_CLAS Peptide DME1302 XEOTICID XEO03117 DESCRIPT Insect defensin B inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 20-40 microM) DME1302 XEOTICID XEO03117 GENEFORM Protein DME1302 XEOTICID XEO03117 MOACRIVE Inhibition DME1302 XEOTICID XEO03120 XEO_NAME Defensin-like protein Dm-AMP1 DME1302 XEOTICID XEO03120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03120 XEO_CLAS Peptide DME1302 XEOTICID XEO03120 DESCRIPT Defensin-like protein Dm-AMP1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03120 GENEFORM Protein DME1302 XEOTICID XEO03120 MOACRIVE Inhibition DME1302 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1302 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03121 XEO_CLAS Peptide DME1302 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03121 GENEFORM Protein DME1302 XEOTICID XEO03121 MOACRIVE Inhibition DME1302 XEOTICID XEO03123 XEO_NAME Defensin-like protein fabatin-2 DME1302 XEOTICID XEO03123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03123 XEO_CLAS Peptide DME1302 XEOTICID XEO03123 DESCRIPT Defensin-like protein fabatin-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03123 GENEFORM Protein DME1302 XEOTICID XEO03123 MOACRIVE Inhibition DME1302 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1302 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03124 XEO_CLAS Peptide DME1302 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03124 GENEFORM Protein DME1302 XEOTICID XEO03124 MOACRIVE Inhibition DME1302 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1302 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03215 XEO_CLAS Peptide DME1302 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2.5 ug/ml) DME1302 XEOTICID XEO03215 GENEFORM Protein DME1302 XEOTICID XEO03215 MOACRIVE Inhibition DME1302 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1302 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03216 XEO_CLAS Peptide DME1302 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2 ug/ml) DME1302 XEOTICID XEO03216 GENEFORM Protein DME1302 XEOTICID XEO03216 MOACRIVE Inhibition DME1302 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1302 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03217 XEO_CLAS Peptide DME1302 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2 ug/ml) DME1302 XEOTICID XEO03217 GENEFORM Protein DME1302 XEOTICID XEO03217 MOACRIVE Inhibition DME1302 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1302 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03223 XEO_CLAS Peptide DME1302 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 3.2 microM) DME1302 XEOTICID XEO03223 GENEFORM Protein DME1302 XEOTICID XEO03223 MOACRIVE Inhibition DME1302 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1302 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03225 XEO_CLAS Peptide DME1302 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 16 microM) DME1302 XEOTICID XEO03225 GENEFORM Protein DME1302 XEOTICID XEO03225 MOACRIVE Inhibition DME1302 XEOTICID XEO03233 XEO_NAME Dybowskin-1 DME1302 XEOTICID XEO03233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03233 XEO_CLAS Peptide DME1302 XEOTICID XEO03233 DESCRIPT Dybowskin-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 50 ug/ml) DME1302 XEOTICID XEO03233 GENEFORM Protein DME1302 XEOTICID XEO03233 MOACRIVE Inhibition DME1302 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1302 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03235 XEO_CLAS Peptide DME1302 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 25 ug/ml) DME1302 XEOTICID XEO03235 GENEFORM Protein DME1302 XEOTICID XEO03235 MOACRIVE Inhibition DME1302 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1302 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03237 XEO_CLAS Peptide DME1302 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 60 ug/ml) DME1302 XEOTICID XEO03237 GENEFORM Protein DME1302 XEOTICID XEO03237 MOACRIVE Inhibition DME1302 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1302 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03238 XEO_CLAS Peptide DME1302 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1302 XEOTICID XEO03238 GENEFORM Protein DME1302 XEOTICID XEO03238 MOACRIVE Inhibition DME1302 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1302 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03239 XEO_CLAS Peptide DME1302 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 50 ug/ml) DME1302 XEOTICID XEO03239 GENEFORM Protein DME1302 XEOTICID XEO03239 MOACRIVE Inhibition DME1302 XEOTICID XEO03240 XEO_NAME Dybowskin-6 DME1302 XEOTICID XEO03240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03240 XEO_CLAS Peptide DME1302 XEOTICID XEO03240 DESCRIPT Dybowskin-6 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 50 ug/ml) DME1302 XEOTICID XEO03240 GENEFORM Protein DME1302 XEOTICID XEO03240 MOACRIVE Inhibition DME1302 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1302 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03250 XEO_CLAS Peptide DME1302 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03250 GENEFORM Protein DME1302 XEOTICID XEO03250 MOACRIVE Inhibition DME1302 XEOTICID XEO03252 XEO_NAME Enterocin B DME1302 XEOTICID XEO03252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03252 XEO_CLAS Peptide DME1302 XEOTICID XEO03252 DESCRIPT Enterocin B inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 44.5 microM) DME1302 XEOTICID XEO03252 GENEFORM Protein DME1302 XEOTICID XEO03252 MOACRIVE Inhibition DME1302 XEOTICID XEO03254 XEO_NAME Enterocin EJ97 DME1302 XEOTICID XEO03254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03254 XEO_CLAS Peptide DME1302 XEOTICID XEO03254 DESCRIPT Enterocin EJ97 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12 ug/ml) DME1302 XEOTICID XEO03254 GENEFORM Protein DME1302 XEOTICID XEO03254 MOACRIVE Inhibition DME1302 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1302 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03258 XEO_CLAS Peptide DME1302 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03258 GENEFORM Protein DME1302 XEOTICID XEO03258 MOACRIVE Inhibition DME1302 XEOTICID XEO03260 XEO_NAME Enterocin X beta DME1302 XEOTICID XEO03260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03260 XEO_CLAS Peptide DME1302 XEOTICID XEO03260 DESCRIPT Enterocin X beta inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 3.25 microM) DME1302 XEOTICID XEO03260 GENEFORM Protein DME1302 XEOTICID XEO03260 MOACRIVE Inhibition DME1302 XEOTICID XEO03270 XEO_NAME Ericin S DME1302 XEOTICID XEO03270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03270 XEO_CLAS Peptide DME1302 XEOTICID XEO03270 DESCRIPT Ericin S inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03270 GENEFORM Protein DME1302 XEOTICID XEO03270 MOACRIVE Inhibition DME1302 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1302 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03281 XEO_CLAS Peptide DME1302 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 25 microM) DME1302 XEOTICID XEO03281 GENEFORM Protein DME1302 XEOTICID XEO03281 MOACRIVE Inhibition DME1302 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1302 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03282 XEO_CLAS Peptide DME1302 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12.5 microM) DME1302 XEOTICID XEO03282 GENEFORM Protein DME1302 XEOTICID XEO03282 MOACRIVE Inhibition DME1302 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1302 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03306 XEO_CLAS Peptide DME1302 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.3 microM) DME1302 XEOTICID XEO03306 GENEFORM Protein DME1302 XEOTICID XEO03306 MOACRIVE Inhibition DME1302 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1302 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03362 XEO_CLAS Peptide DME1302 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 40 ug/ml) DME1302 XEOTICID XEO03362 GENEFORM Protein DME1302 XEOTICID XEO03362 MOACRIVE Inhibition DME1302 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1302 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03363 XEO_CLAS Peptide DME1302 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 30 microM) DME1302 XEOTICID XEO03363 GENEFORM Protein DME1302 XEOTICID XEO03363 MOACRIVE Inhibition DME1302 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1302 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03364 XEO_CLAS Peptide DME1302 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 30 microM) DME1302 XEOTICID XEO03364 GENEFORM Protein DME1302 XEOTICID XEO03364 MOACRIVE Inhibition DME1302 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1302 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03366 XEO_CLAS Peptide DME1302 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 60 microM) DME1302 XEOTICID XEO03366 GENEFORM Protein DME1302 XEOTICID XEO03366 MOACRIVE Inhibition DME1302 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1302 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03367 XEO_CLAS Peptide DME1302 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 30 microM) DME1302 XEOTICID XEO03367 GENEFORM Protein DME1302 XEOTICID XEO03367 MOACRIVE Inhibition DME1302 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1302 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03368 XEO_CLAS Peptide DME1302 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 7.5 microM) DME1302 XEOTICID XEO03368 GENEFORM Protein DME1302 XEOTICID XEO03368 MOACRIVE Inhibition DME1302 XEOTICID XEO03431 XEO_NAME Thanatin truncated isoform G18C(1-18) DME1302 XEOTICID XEO03431 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03431 XEO_CLAS Peptide DME1302 XEOTICID XEO03431 DESCRIPT Thanatin truncated isoform G18C(1-18) inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 5-10 microM) DME1302 XEOTICID XEO03431 GENEFORM Protein DME1302 XEOTICID XEO03431 MOACRIVE Inhibition DME1302 XEOTICID XEO03435 XEO_NAME Thanatin truncated isoform G20R(1-20) DME1302 XEOTICID XEO03435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03435 XEO_CLAS Peptide DME1302 XEOTICID XEO03435 DESCRIPT Thanatin truncated isoform G20R(1-20) inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 20-40 microM) DME1302 XEOTICID XEO03435 GENEFORM Protein DME1302 XEOTICID XEO03435 MOACRIVE Inhibition DME1302 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1302 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03436 XEO_CLAS Peptide DME1302 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 50 ug/ml) DME1302 XEOTICID XEO03436 GENEFORM Protein DME1302 XEOTICID XEO03436 MOACRIVE Inhibition DME1302 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1302 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03437 XEO_CLAS Peptide DME1302 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 10 ug/ml) DME1302 XEOTICID XEO03437 GENEFORM Protein DME1302 XEOTICID XEO03437 MOACRIVE Inhibition DME1302 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1302 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03438 XEO_CLAS Peptide DME1302 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 10 ug/ml) DME1302 XEOTICID XEO03438 GENEFORM Protein DME1302 XEOTICID XEO03438 MOACRIVE Inhibition DME1302 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1302 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03439 XEO_CLAS Peptide DME1302 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 10 ug/ml) DME1302 XEOTICID XEO03439 GENEFORM Protein DME1302 XEOTICID XEO03439 MOACRIVE Inhibition DME1302 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1302 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03440 XEO_CLAS Peptide DME1302 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 10 ug/ml) DME1302 XEOTICID XEO03440 GENEFORM Protein DME1302 XEOTICID XEO03440 MOACRIVE Inhibition DME1302 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1302 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03441 XEO_CLAS Peptide DME1302 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 10 ug/ml) DME1302 XEOTICID XEO03441 GENEFORM Protein DME1302 XEOTICID XEO03441 MOACRIVE Inhibition DME1302 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1302 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03442 XEO_CLAS Peptide DME1302 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 4.69 ug/ml) DME1302 XEOTICID XEO03442 GENEFORM Protein DME1302 XEOTICID XEO03442 MOACRIVE Inhibition DME1302 XEOTICID XEO03443 XEO_NAME Gaegurin-RN4 DME1302 XEOTICID XEO03443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03443 XEO_CLAS Peptide DME1302 XEOTICID XEO03443 DESCRIPT Gaegurin-RN4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2.34 ug/ml) DME1302 XEOTICID XEO03443 GENEFORM Protein DME1302 XEOTICID XEO03443 MOACRIVE Inhibition DME1302 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1302 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03444 XEO_CLAS Peptide DME1302 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 4.69 ug/ml) DME1302 XEOTICID XEO03444 GENEFORM Protein DME1302 XEOTICID XEO03444 MOACRIVE Inhibition DME1302 XEOTICID XEO03478 XEO_NAME Geobacillin I DME1302 XEOTICID XEO03478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03478 XEO_CLAS Peptide DME1302 XEOTICID XEO03478 DESCRIPT Geobacillin I inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03478 GENEFORM Protein DME1302 XEOTICID XEO03478 MOACRIVE Inhibition DME1302 XEOTICID XEO03479 XEO_NAME Geobacillin II DME1302 XEOTICID XEO03479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03479 XEO_CLAS Peptide DME1302 XEOTICID XEO03479 DESCRIPT Geobacillin II inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03479 GENEFORM Protein DME1302 XEOTICID XEO03479 MOACRIVE Inhibition DME1302 XEOTICID XEO03501 XEO_NAME Gramicidin [Scr2]-GS analogue DME1302 XEOTICID XEO03501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03501 XEO_CLAS Peptide DME1302 XEOTICID XEO03501 DESCRIPT Gramicidin [Scr2]-GS analogue inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.3 ug/ml) DME1302 XEOTICID XEO03501 GENEFORM Protein DME1302 XEOTICID XEO03501 MOACRIVE Inhibition DME1302 XEOTICID XEO03503 XEO_NAME Gramicidin S DME1302 XEOTICID XEO03503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03503 XEO_CLAS Peptide DME1302 XEOTICID XEO03503 DESCRIPT Gramicidin S inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.6 ug/ml) DME1302 XEOTICID XEO03503 GENEFORM Protein DME1302 XEOTICID XEO03503 MOACRIVE Inhibition DME1302 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1302 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03504 XEO_CLAS Peptide DME1302 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 25 ug/ml) DME1302 XEOTICID XEO03504 GENEFORM Protein DME1302 XEOTICID XEO03504 MOACRIVE Inhibition DME1302 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1302 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03505 XEO_CLAS Peptide DME1302 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1302 XEOTICID XEO03505 GENEFORM Protein DME1302 XEOTICID XEO03505 MOACRIVE Inhibition DME1302 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1302 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03506 XEO_CLAS Peptide DME1302 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1302 XEOTICID XEO03506 GENEFORM Protein DME1302 XEOTICID XEO03506 MOACRIVE Inhibition DME1302 XEOTICID XEO03510 XEO_NAME Crab GRPSp peptide DME1302 XEOTICID XEO03510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03510 XEO_CLAS Peptide DME1302 XEOTICID XEO03510 DESCRIPT Crab GRPSp peptide inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 50 microM) DME1302 XEOTICID XEO03510 GENEFORM Protein DME1302 XEOTICID XEO03510 MOACRIVE Inhibition DME1302 XEOTICID XEO03512 XEO_NAME Guentherin AMP-3 DME1302 XEOTICID XEO03512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03512 XEO_CLAS Peptide DME1302 XEOTICID XEO03512 DESCRIPT Guentherin AMP-3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 64 ug/ml) DME1302 XEOTICID XEO03512 GENEFORM Protein DME1302 XEOTICID XEO03512 MOACRIVE Inhibition DME1302 XEOTICID XEO03542 XEO_NAME Hepcidin DME1302 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03542 XEO_CLAS Peptide DME1302 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6 microM) DME1302 XEOTICID XEO03542 GENEFORM Protein DME1302 XEOTICID XEO03542 MOACRIVE Inhibition DME1302 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1302 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03544 XEO_CLAS Peptide DME1302 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03544 GENEFORM Protein DME1302 XEOTICID XEO03544 MOACRIVE Inhibition DME1302 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1302 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03549 XEO_CLAS Peptide DME1302 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03549 GENEFORM Protein DME1302 XEOTICID XEO03549 MOACRIVE Inhibition DME1302 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1302 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03561 XEO_CLAS Peptide DME1302 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03561 GENEFORM Protein DME1302 XEOTICID XEO03561 MOACRIVE Inhibition DME1302 XEOTICID XEO03566 XEO_NAME Histone H2A DME1302 XEOTICID XEO03566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03566 XEO_CLAS Peptide DME1302 XEOTICID XEO03566 DESCRIPT Histone H2A inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.6-1.2 microM) DME1302 XEOTICID XEO03566 GENEFORM Protein DME1302 XEOTICID XEO03566 MOACRIVE Inhibition DME1302 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1302 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03606 XEO_CLAS Peptide DME1302 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03606 GENEFORM Protein DME1302 XEOTICID XEO03606 MOACRIVE Inhibition DME1302 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1302 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03607 XEO_CLAS Peptide DME1302 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03607 GENEFORM Protein DME1302 XEOTICID XEO03607 MOACRIVE Inhibition DME1302 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1302 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03616 XEO_CLAS Peptide DME1302 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 8 microM) DME1302 XEOTICID XEO03616 GENEFORM Protein DME1302 XEOTICID XEO03616 MOACRIVE Inhibition DME1302 XEOTICID XEO03623 XEO_NAME Basic peptide AMP1 IB-AMP1 DME1302 XEOTICID XEO03623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03623 XEO_CLAS Peptide DME1302 XEOTICID XEO03623 DESCRIPT Basic peptide AMP1 IB-AMP1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03623 GENEFORM Protein DME1302 XEOTICID XEO03623 MOACRIVE Inhibition DME1302 XEOTICID XEO03624 XEO_NAME Basic peptide AMP4 IB-AMP4 DME1302 XEOTICID XEO03624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03624 XEO_CLAS Peptide DME1302 XEOTICID XEO03624 DESCRIPT Basic peptide AMP4 IB-AMP4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03624 GENEFORM Protein DME1302 XEOTICID XEO03624 MOACRIVE Inhibition DME1302 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1302 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03627 XEO_CLAS Peptide DME1302 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.8-1.6 microM) DME1302 XEOTICID XEO03627 GENEFORM Protein DME1302 XEOTICID XEO03627 MOACRIVE Inhibition DME1302 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1302 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03630 XEO_CLAS Peptide DME1302 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03630 GENEFORM Protein DME1302 XEOTICID XEO03630 MOACRIVE Inhibition DME1302 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1302 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03631 XEO_CLAS Peptide DME1302 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03631 GENEFORM Protein DME1302 XEOTICID XEO03631 MOACRIVE Inhibition DME1302 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1302 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03632 XEO_CLAS Peptide DME1302 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03632 GENEFORM Protein DME1302 XEOTICID XEO03632 MOACRIVE Inhibition DME1302 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1302 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03633 XEO_CLAS Peptide DME1302 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03633 GENEFORM Protein DME1302 XEOTICID XEO03633 MOACRIVE Inhibition DME1302 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1302 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03634 XEO_CLAS Peptide DME1302 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03634 GENEFORM Protein DME1302 XEOTICID XEO03634 MOACRIVE Inhibition DME1302 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1302 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03635 XEO_CLAS Peptide DME1302 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03635 GENEFORM Protein DME1302 XEOTICID XEO03635 MOACRIVE Inhibition DME1302 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1302 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03636 XEO_CLAS Peptide DME1302 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03636 GENEFORM Protein DME1302 XEOTICID XEO03636 MOACRIVE Inhibition DME1302 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1302 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03637 XEO_CLAS Peptide DME1302 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03637 GENEFORM Protein DME1302 XEOTICID XEO03637 MOACRIVE Inhibition DME1302 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1302 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03638 XEO_CLAS Peptide DME1302 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03638 GENEFORM Protein DME1302 XEOTICID XEO03638 MOACRIVE Inhibition DME1302 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1302 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03639 XEO_CLAS Peptide DME1302 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03639 GENEFORM Protein DME1302 XEOTICID XEO03639 MOACRIVE Inhibition DME1302 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1302 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03640 XEO_CLAS Peptide DME1302 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03640 GENEFORM Protein DME1302 XEOTICID XEO03640 MOACRIVE Inhibition DME1302 XEOTICID XEO03664 XEO_NAME Ixodes ricinus defensin def1 DME1302 XEOTICID XEO03664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03664 XEO_CLAS Peptide DME1302 XEOTICID XEO03664 DESCRIPT Ixodes ricinus defensin def1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.5 microM) DME1302 XEOTICID XEO03664 GENEFORM Protein DME1302 XEOTICID XEO03664 MOACRIVE Inhibition DME1302 XEOTICID XEO03665 XEO_NAME Ixodes ricinus defensin def2 DME1302 XEOTICID XEO03665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03665 XEO_CLAS Peptide DME1302 XEOTICID XEO03665 DESCRIPT Ixodes ricinus defensin def2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.75 microM) DME1302 XEOTICID XEO03665 GENEFORM Protein DME1302 XEOTICID XEO03665 MOACRIVE Inhibition DME1302 XEOTICID XEO03671 XEO_NAME Plant JCpep7 DME1302 XEOTICID XEO03671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03671 XEO_CLAS Peptide DME1302 XEOTICID XEO03671 DESCRIPT Plant JCpep7 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 24 ug/ml) DME1302 XEOTICID XEO03671 GENEFORM Protein DME1302 XEOTICID XEO03671 MOACRIVE Inhibition DME1302 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1302 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03672 XEO_CLAS Peptide DME1302 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 10 ug/ml) DME1302 XEOTICID XEO03672 GENEFORM Protein DME1302 XEOTICID XEO03672 MOACRIVE Inhibition DME1302 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1302 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03673 XEO_CLAS Peptide DME1302 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 30 ug/ml) DME1302 XEOTICID XEO03673 GENEFORM Protein DME1302 XEOTICID XEO03673 MOACRIVE Inhibition DME1302 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1302 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03678 XEO_CLAS Peptide DME1302 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2 ug/ml) DME1302 XEOTICID XEO03678 GENEFORM Protein DME1302 XEOTICID XEO03678 MOACRIVE Inhibition DME1302 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1302 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03681 XEO_CLAS Peptide DME1302 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 20-40 microM) DME1302 XEOTICID XEO03681 GENEFORM Protein DME1302 XEOTICID XEO03681 MOACRIVE Inhibition DME1302 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1302 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03709 XEO_CLAS Peptide DME1302 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1302 XEOTICID XEO03709 GENEFORM Protein DME1302 XEOTICID XEO03709 MOACRIVE Inhibition DME1302 XEOTICID XEO03737 XEO_NAME LlKmWn model peptide L4K2W4 DME1302 XEOTICID XEO03737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03737 XEO_CLAS Peptide DME1302 XEOTICID XEO03737 DESCRIPT LlKmWn model peptide L4K2W4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 25 ug/ml) DME1302 XEOTICID XEO03737 GENEFORM Protein DME1302 XEOTICID XEO03737 MOACRIVE Inhibition DME1302 XEOTICID XEO03739 XEO_NAME LlKmWn model peptide L4K3W4 DME1302 XEOTICID XEO03739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03739 XEO_CLAS Peptide DME1302 XEOTICID XEO03739 DESCRIPT LlKmWn model peptide L4K3W4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 50 ug/ml) DME1302 XEOTICID XEO03739 GENEFORM Protein DME1302 XEOTICID XEO03739 MOACRIVE Inhibition DME1302 XEOTICID XEO03740 XEO_NAME LlKmWn model peptide L4K3W5 DME1302 XEOTICID XEO03740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03740 XEO_CLAS Peptide DME1302 XEOTICID XEO03740 DESCRIPT LlKmWn model peptide L4K3W5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 50 ug/ml) DME1302 XEOTICID XEO03740 GENEFORM Protein DME1302 XEOTICID XEO03740 MOACRIVE Inhibition DME1302 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1302 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03744 XEO_CLAS Peptide DME1302 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1302 XEOTICID XEO03744 GENEFORM Protein DME1302 XEOTICID XEO03744 MOACRIVE Inhibition DME1302 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1302 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03746 XEO_CLAS Peptide DME1302 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2 ug/ml) DME1302 XEOTICID XEO03746 GENEFORM Protein DME1302 XEOTICID XEO03746 MOACRIVE Inhibition DME1302 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1302 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03747 XEO_CLAS Peptide DME1302 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1 ug/ml) DME1302 XEOTICID XEO03747 GENEFORM Protein DME1302 XEOTICID XEO03747 MOACRIVE Inhibition DME1302 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1302 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03748 XEO_CLAS Peptide DME1302 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2 ug/ml) DME1302 XEOTICID XEO03748 GENEFORM Protein DME1302 XEOTICID XEO03748 MOACRIVE Inhibition DME1302 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1302 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03749 XEO_CLAS Peptide DME1302 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2 ug/ml) DME1302 XEOTICID XEO03749 GENEFORM Protein DME1302 XEOTICID XEO03749 MOACRIVE Inhibition DME1302 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1302 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03750 XEO_CLAS Peptide DME1302 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2 ug/ml) DME1302 XEOTICID XEO03750 GENEFORM Protein DME1302 XEOTICID XEO03750 MOACRIVE Inhibition DME1302 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1302 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03751 XEO_CLAS Peptide DME1302 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2 ug/ml) DME1302 XEOTICID XEO03751 GENEFORM Protein DME1302 XEOTICID XEO03751 MOACRIVE Inhibition DME1302 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1302 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03752 XEO_CLAS Peptide DME1302 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2 ug/ml) DME1302 XEOTICID XEO03752 GENEFORM Protein DME1302 XEOTICID XEO03752 MOACRIVE Inhibition DME1302 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1302 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03753 XEO_CLAS Peptide DME1302 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.3 ug/ml) DME1302 XEOTICID XEO03753 GENEFORM Protein DME1302 XEOTICID XEO03753 MOACRIVE Inhibition DME1302 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1302 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03754 XEO_CLAS Peptide DME1302 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2 ug/ml) DME1302 XEOTICID XEO03754 GENEFORM Protein DME1302 XEOTICID XEO03754 MOACRIVE Inhibition DME1302 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1302 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03755 XEO_CLAS Peptide DME1302 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 4 ug/ml) DME1302 XEOTICID XEO03755 GENEFORM Protein DME1302 XEOTICID XEO03755 MOACRIVE Inhibition DME1302 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1302 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03756 XEO_CLAS Peptide DME1302 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2 ug/ml) DME1302 XEOTICID XEO03756 GENEFORM Protein DME1302 XEOTICID XEO03756 MOACRIVE Inhibition DME1302 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1302 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03759 XEO_CLAS Peptide DME1302 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.6 ug/ml) DME1302 XEOTICID XEO03759 GENEFORM Protein DME1302 XEOTICID XEO03759 MOACRIVE Inhibition DME1302 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1302 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03761 XEO_CLAS Peptide DME1302 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.6 ug/ml) DME1302 XEOTICID XEO03761 GENEFORM Protein DME1302 XEOTICID XEO03761 MOACRIVE Inhibition DME1302 XEOTICID XEO03762 XEO_NAME LlKmWn model peptide L7K5W7 DME1302 XEOTICID XEO03762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03762 XEO_CLAS Peptide DME1302 XEOTICID XEO03762 DESCRIPT LlKmWn model peptide L7K5W7 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 3.1 ug/ml) DME1302 XEOTICID XEO03762 GENEFORM Protein DME1302 XEOTICID XEO03762 MOACRIVE Inhibition DME1302 XEOTICID XEO03764 XEO_NAME LlKmWn model peptide L8K4W7 DME1302 XEOTICID XEO03764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03764 XEO_CLAS Peptide DME1302 XEOTICID XEO03764 DESCRIPT LlKmWn model peptide L8K4W7 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.3 ug/ml) DME1302 XEOTICID XEO03764 GENEFORM Protein DME1302 XEOTICID XEO03764 MOACRIVE Inhibition DME1302 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1302 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03771 XEO_CLAS Peptide DME1302 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03771 GENEFORM Protein DME1302 XEOTICID XEO03771 MOACRIVE Inhibition DME1302 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1302 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03793 XEO_CLAS Peptide DME1302 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 32 microM) DME1302 XEOTICID XEO03793 GENEFORM Protein DME1302 XEOTICID XEO03793 MOACRIVE Inhibition DME1302 XEOTICID XEO03804 XEO_NAME Lantibiotic lichenicidin VK21 A1 DME1302 XEOTICID XEO03804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03804 XEO_CLAS Peptide DME1302 XEOTICID XEO03804 DESCRIPT Lantibiotic lichenicidin VK21 A1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03804 GENEFORM Protein DME1302 XEOTICID XEO03804 MOACRIVE Inhibition DME1302 XEOTICID XEO03805 XEO_NAME Lantibiotic lichenicidin VK21 A2 DME1302 XEOTICID XEO03805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03805 XEO_CLAS Peptide DME1302 XEOTICID XEO03805 DESCRIPT Lantibiotic lichenicidin VK21 A2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03805 GENEFORM Protein DME1302 XEOTICID XEO03805 MOACRIVE Inhibition DME1302 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1302 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03810 XEO_CLAS Peptide DME1302 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03810 GENEFORM Protein DME1302 XEOTICID XEO03810 MOACRIVE Inhibition DME1302 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1302 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03928 XEO_CLAS Peptide DME1302 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 16 microM) DME1302 XEOTICID XEO03928 GENEFORM Protein DME1302 XEOTICID XEO03928 MOACRIVE Inhibition DME1302 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1302 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03933 XEO_CLAS Peptide DME1302 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.3 microM) DME1302 XEOTICID XEO03933 GENEFORM Protein DME1302 XEOTICID XEO03933 MOACRIVE Inhibition DME1302 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1302 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03934 XEO_CLAS Peptide DME1302 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.6 microM) DME1302 XEOTICID XEO03934 GENEFORM Protein DME1302 XEOTICID XEO03934 MOACRIVE Inhibition DME1302 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1302 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03935 XEO_CLAS Peptide DME1302 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.7 microM) DME1302 XEOTICID XEO03935 GENEFORM Protein DME1302 XEOTICID XEO03935 MOACRIVE Inhibition DME1302 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1302 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03936 XEO_CLAS Peptide DME1302 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.9 microM) DME1302 XEOTICID XEO03936 GENEFORM Protein DME1302 XEOTICID XEO03936 MOACRIVE Inhibition DME1302 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1302 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03937 XEO_CLAS Peptide DME1302 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.7 microM) DME1302 XEOTICID XEO03937 GENEFORM Protein DME1302 XEOTICID XEO03937 MOACRIVE Inhibition DME1302 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1302 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03938 XEO_CLAS Peptide DME1302 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.7 microM) DME1302 XEOTICID XEO03938 GENEFORM Protein DME1302 XEOTICID XEO03938 MOACRIVE Inhibition DME1302 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1302 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03939 XEO_CLAS Peptide DME1302 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.7 microM) DME1302 XEOTICID XEO03939 GENEFORM Protein DME1302 XEOTICID XEO03939 MOACRIVE Inhibition DME1302 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1302 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03940 XEO_CLAS Peptide DME1302 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.7 microM) DME1302 XEOTICID XEO03940 GENEFORM Protein DME1302 XEOTICID XEO03940 MOACRIVE Inhibition DME1302 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1302 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03941 XEO_CLAS Peptide DME1302 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.7 microM) DME1302 XEOTICID XEO03941 GENEFORM Protein DME1302 XEOTICID XEO03941 MOACRIVE Inhibition DME1302 XEOTICID XEO03942 XEO_NAME Lasioglossin LL-III derivative 10 DME1302 XEOTICID XEO03942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03942 XEO_CLAS Peptide DME1302 XEOTICID XEO03942 DESCRIPT Lasioglossin LL-III derivative 10 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 100 microM) DME1302 XEOTICID XEO03942 GENEFORM Protein DME1302 XEOTICID XEO03942 MOACRIVE Inhibition DME1302 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1302 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03943 XEO_CLAS Peptide DME1302 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.6 microM) DME1302 XEOTICID XEO03943 GENEFORM Protein DME1302 XEOTICID XEO03943 MOACRIVE Inhibition DME1302 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1302 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03944 XEO_CLAS Peptide DME1302 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.7 microM) DME1302 XEOTICID XEO03944 GENEFORM Protein DME1302 XEOTICID XEO03944 MOACRIVE Inhibition DME1302 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1302 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03945 XEO_CLAS Peptide DME1302 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.8 microM) DME1302 XEOTICID XEO03945 GENEFORM Protein DME1302 XEOTICID XEO03945 MOACRIVE Inhibition DME1302 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1302 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03947 XEO_CLAS Peptide DME1302 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.5 microM) DME1302 XEOTICID XEO03947 GENEFORM Protein DME1302 XEOTICID XEO03947 MOACRIVE Inhibition DME1302 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1302 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03948 XEO_CLAS Peptide DME1302 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 4.7 microM) DME1302 XEOTICID XEO03948 GENEFORM Protein DME1302 XEOTICID XEO03948 MOACRIVE Inhibition DME1302 XEOTICID XEO03949 XEO_NAME Lasioglossin LL-III derivative 8 DME1302 XEOTICID XEO03949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03949 XEO_CLAS Peptide DME1302 XEOTICID XEO03949 DESCRIPT Lasioglossin LL-III derivative 8 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 40 microM) DME1302 XEOTICID XEO03949 GENEFORM Protein DME1302 XEOTICID XEO03949 MOACRIVE Inhibition DME1302 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1302 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1302 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1302 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03968 GENEFORM Protein DME1302 XEOTICID XEO03968 MOACRIVE Inhibition DME1302 XEOTICID XEO03971 XEO_NAME Lumbrican DME1302 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03971 XEO_CLAS Peptide DME1302 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03971 GENEFORM Protein DME1302 XEOTICID XEO03971 MOACRIVE Inhibition DME1302 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1302 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03972 XEO_CLAS Peptide DME1302 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 8 ug/ml) DME1302 XEOTICID XEO03972 GENEFORM Protein DME1302 XEOTICID XEO03972 MOACRIVE Inhibition DME1302 XEOTICID XEO03973 XEO_NAME Lunatusin DME1302 XEOTICID XEO03973 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03973 XEO_CLAS Peptide DME1302 XEOTICID XEO03973 DESCRIPT Lunatusin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO03973 GENEFORM Protein DME1302 XEOTICID XEO03973 MOACRIVE Inhibition DME1302 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1302 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03996 XEO_CLAS Peptide DME1302 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 9 microM) DME1302 XEOTICID XEO03996 GENEFORM Protein DME1302 XEOTICID XEO03996 MOACRIVE Inhibition DME1302 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1302 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03997 XEO_CLAS Peptide DME1302 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 11.8 microM) DME1302 XEOTICID XEO03997 GENEFORM Protein DME1302 XEOTICID XEO03997 MOACRIVE Inhibition DME1302 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1302 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03998 XEO_CLAS Peptide DME1302 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 70 microM) DME1302 XEOTICID XEO03998 GENEFORM Protein DME1302 XEOTICID XEO03998 MOACRIVE Inhibition DME1302 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1302 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO03999 XEO_CLAS Peptide DME1302 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 7.3 microM) DME1302 XEOTICID XEO03999 GENEFORM Protein DME1302 XEOTICID XEO03999 MOACRIVE Inhibition DME1302 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1302 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04000 XEO_CLAS Peptide DME1302 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 4 ug/ml) DME1302 XEOTICID XEO04000 GENEFORM Protein DME1302 XEOTICID XEO04000 MOACRIVE Inhibition DME1302 XEOTICID XEO04055 XEO_NAME Melectin DME1302 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04055 XEO_CLAS Peptide DME1302 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.8 microM) DME1302 XEOTICID XEO04055 GENEFORM Protein DME1302 XEOTICID XEO04055 MOACRIVE Inhibition DME1302 XEOTICID XEO04057 XEO_NAME Melittin DME1302 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04057 XEO_CLAS Peptide DME1302 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.2 microM) DME1302 XEOTICID XEO04057 GENEFORM Protein DME1302 XEOTICID XEO04057 MOACRIVE Inhibition DME1302 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1302 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04121 XEO_CLAS Peptide DME1302 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.6-3.2 microM) DME1302 XEOTICID XEO04121 GENEFORM Protein DME1302 XEOTICID XEO04121 MOACRIVE Inhibition DME1302 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1302 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04122 XEO_CLAS Peptide DME1302 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.57-3.14 microM) DME1302 XEOTICID XEO04122 GENEFORM Protein DME1302 XEOTICID XEO04122 MOACRIVE Inhibition DME1302 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1302 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04128 XEO_CLAS Peptide DME1302 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.19 microM) DME1302 XEOTICID XEO04128 GENEFORM Protein DME1302 XEOTICID XEO04128 MOACRIVE Inhibition DME1302 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1302 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04137 XEO_CLAS Peptide DME1302 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04137 GENEFORM Protein DME1302 XEOTICID XEO04137 MOACRIVE Inhibition DME1302 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1302 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04138 XEO_CLAS Peptide DME1302 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 15 microM) DME1302 XEOTICID XEO04138 GENEFORM Protein DME1302 XEOTICID XEO04138 MOACRIVE Inhibition DME1302 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1302 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04139 XEO_CLAS Peptide DME1302 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 25 microM) DME1302 XEOTICID XEO04139 GENEFORM Protein DME1302 XEOTICID XEO04139 MOACRIVE Inhibition DME1302 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1302 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04140 XEO_CLAS Peptide DME1302 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 35 microM) DME1302 XEOTICID XEO04140 GENEFORM Protein DME1302 XEOTICID XEO04140 MOACRIVE Inhibition DME1302 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1302 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04141 XEO_CLAS Peptide DME1302 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 40 microM) DME1302 XEOTICID XEO04141 GENEFORM Protein DME1302 XEOTICID XEO04141 MOACRIVE Inhibition DME1302 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1302 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04142 XEO_CLAS Peptide DME1302 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.5 microM) DME1302 XEOTICID XEO04142 GENEFORM Protein DME1302 XEOTICID XEO04142 MOACRIVE Inhibition DME1302 XEOTICID XEO04147 XEO_NAME Mucobromic acid DME1302 XEOTICID XEO04147 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1302 XEOTICID XEO04147 XEO_CLAS Chemical Compound DME1302 XEOTICID XEO04147 DESCRIPT Mucobromic acid inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04147 GENEFORM Protein DME1302 XEOTICID XEO04147 MOACRIVE Inhibition DME1302 XEOTICID XEO04148 XEO_NAME Mucochloric acid DME1302 XEOTICID XEO04148 XEO_TYPE Health or Environmental Toxicant(s) DME1302 XEOTICID XEO04148 XEO_CLAS Health Hazard/Toxicant DME1302 XEOTICID XEO04148 DESCRIPT Mucochloric acid inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04148 GENEFORM Protein DME1302 XEOTICID XEO04148 MOACRIVE Inhibition DME1302 XEOTICID XEO04149 XEO_NAME Mucroporin DME1302 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04149 XEO_CLAS Peptide DME1302 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 50 ug/ml) DME1302 XEOTICID XEO04149 GENEFORM Protein DME1302 XEOTICID XEO04149 MOACRIVE Inhibition DME1302 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1302 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04168 XEO_CLAS Peptide DME1302 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.2-2.5 microM) DME1302 XEOTICID XEO04168 GENEFORM Protein DME1302 XEOTICID XEO04168 MOACRIVE Inhibition DME1302 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1302 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04177 XEO_CLAS Peptide DME1302 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.0 microM) DME1302 XEOTICID XEO04177 GENEFORM Protein DME1302 XEOTICID XEO04177 MOACRIVE Inhibition DME1302 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1302 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04178 XEO_CLAS Peptide DME1302 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.4 microM) DME1302 XEOTICID XEO04178 GENEFORM Protein DME1302 XEOTICID XEO04178 MOACRIVE Inhibition DME1302 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1302 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04179 XEO_CLAS Peptide DME1302 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.2 microM) DME1302 XEOTICID XEO04179 GENEFORM Protein DME1302 XEOTICID XEO04179 MOACRIVE Inhibition DME1302 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1302 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04180 XEO_CLAS Peptide DME1302 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2.9 microM) DME1302 XEOTICID XEO04180 GENEFORM Protein DME1302 XEOTICID XEO04180 MOACRIVE Inhibition DME1302 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1302 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04181 XEO_CLAS Peptide DME1302 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.1 microM) DME1302 XEOTICID XEO04181 GENEFORM Protein DME1302 XEOTICID XEO04181 MOACRIVE Inhibition DME1302 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1302 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04182 XEO_CLAS Peptide DME1302 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.1 microM) DME1302 XEOTICID XEO04182 GENEFORM Protein DME1302 XEOTICID XEO04182 MOACRIVE Inhibition DME1302 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1302 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04183 XEO_CLAS Peptide DME1302 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.6 microM) DME1302 XEOTICID XEO04183 GENEFORM Protein DME1302 XEOTICID XEO04183 MOACRIVE Inhibition DME1302 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1302 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04184 XEO_CLAS Peptide DME1302 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.9 microM) DME1302 XEOTICID XEO04184 GENEFORM Protein DME1302 XEOTICID XEO04184 MOACRIVE Inhibition DME1302 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1302 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04185 XEO_CLAS Peptide DME1302 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04185 GENEFORM Protein DME1302 XEOTICID XEO04185 MOACRIVE Inhibition DME1302 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1302 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04206 XEO_CLAS Peptide DME1302 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.78 microM) DME1302 XEOTICID XEO04206 GENEFORM Protein DME1302 XEOTICID XEO04206 MOACRIVE Inhibition DME1302 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1302 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04214 XEO_CLAS Peptide DME1302 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.78 microM) DME1302 XEOTICID XEO04214 GENEFORM Protein DME1302 XEOTICID XEO04214 MOACRIVE Inhibition DME1302 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1302 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04216 XEO_CLAS Peptide DME1302 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.78 microM) DME1302 XEOTICID XEO04216 GENEFORM Protein DME1302 XEOTICID XEO04216 MOACRIVE Inhibition DME1302 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1302 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04218 XEO_CLAS Peptide DME1302 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.78 microM) DME1302 XEOTICID XEO04218 GENEFORM Protein DME1302 XEOTICID XEO04218 MOACRIVE Inhibition DME1302 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1302 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04219 XEO_CLAS Peptide DME1302 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.78 microM) DME1302 XEOTICID XEO04219 GENEFORM Protein DME1302 XEOTICID XEO04219 MOACRIVE Inhibition DME1302 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1302 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04220 XEO_CLAS Peptide DME1302 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.78 microM) DME1302 XEOTICID XEO04220 GENEFORM Protein DME1302 XEOTICID XEO04220 MOACRIVE Inhibition DME1302 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1302 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04221 XEO_CLAS Peptide DME1302 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.78 microM) DME1302 XEOTICID XEO04221 GENEFORM Protein DME1302 XEOTICID XEO04221 MOACRIVE Inhibition DME1302 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1302 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04222 XEO_CLAS Peptide DME1302 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.78 microM) DME1302 XEOTICID XEO04222 GENEFORM Protein DME1302 XEOTICID XEO04222 MOACRIVE Inhibition DME1302 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1302 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04233 XEO_CLAS Peptide DME1302 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04233 GENEFORM Protein DME1302 XEOTICID XEO04233 MOACRIVE Inhibition DME1302 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1302 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04234 XEO_CLAS Peptide DME1302 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04234 GENEFORM Protein DME1302 XEOTICID XEO04234 MOACRIVE Inhibition DME1302 XEOTICID XEO04235 XEO_NAME Napin-like polypeptide DME1302 XEOTICID XEO04235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04235 XEO_CLAS Peptide DME1302 XEOTICID XEO04235 DESCRIPT Napin-like polypeptide inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04235 GENEFORM Protein DME1302 XEOTICID XEO04235 MOACRIVE Inhibition DME1302 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1302 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04277 XEO_CLAS Peptide DME1302 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 110.00 ug/ml) DME1302 XEOTICID XEO04277 GENEFORM Protein DME1302 XEOTICID XEO04277 MOACRIVE Inhibition DME1302 XEOTICID XEO04278 XEO_NAME Nigroain-D3 DME1302 XEOTICID XEO04278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04278 XEO_CLAS Peptide DME1302 XEOTICID XEO04278 DESCRIPT Nigroain-D3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 55 ug/ml) DME1302 XEOTICID XEO04278 GENEFORM Protein DME1302 XEOTICID XEO04278 MOACRIVE Inhibition DME1302 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1302 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04280 XEO_CLAS Peptide DME1302 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 21.88 ug/ml) DME1302 XEOTICID XEO04280 GENEFORM Protein DME1302 XEOTICID XEO04280 MOACRIVE Inhibition DME1302 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1302 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04281 XEO_CLAS Peptide DME1302 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 9.38 ug/ml) DME1302 XEOTICID XEO04281 GENEFORM Protein DME1302 XEOTICID XEO04281 MOACRIVE Inhibition DME1302 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1302 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04298 XEO_CLAS Peptide DME1302 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12.5 microM) DME1302 XEOTICID XEO04298 GENEFORM Protein DME1302 XEOTICID XEO04298 MOACRIVE Inhibition DME1302 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1302 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04299 XEO_CLAS Peptide DME1302 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12.5 microM) DME1302 XEOTICID XEO04299 GENEFORM Protein DME1302 XEOTICID XEO04299 MOACRIVE Inhibition DME1302 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1302 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04307 XEO_CLAS Peptide DME1302 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 100 ug/ml) DME1302 XEOTICID XEO04307 GENEFORM Protein DME1302 XEOTICID XEO04307 MOACRIVE Inhibition DME1302 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1302 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04308 XEO_CLAS Peptide DME1302 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 37.50 ug/ml) DME1302 XEOTICID XEO04308 GENEFORM Protein DME1302 XEOTICID XEO04308 MOACRIVE Inhibition DME1302 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1302 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04312 XEO_CLAS Peptide DME1302 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 18.75 ug/ml) DME1302 XEOTICID XEO04312 GENEFORM Protein DME1302 XEOTICID XEO04312 MOACRIVE Inhibition DME1302 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1302 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04313 XEO_CLAS Peptide DME1302 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 18.75 ug/ml) DME1302 XEOTICID XEO04313 GENEFORM Protein DME1302 XEOTICID XEO04313 MOACRIVE Inhibition DME1302 XEOTICID XEO04331 XEO_NAME Norspermidine DME1302 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1302 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1302 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04331 GENEFORM Protein DME1302 XEOTICID XEO04331 MOACRIVE Inhibition DME1302 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1302 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04355 XEO_CLAS Peptide DME1302 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.85 ug/ml) DME1302 XEOTICID XEO04355 GENEFORM Protein DME1302 XEOTICID XEO04355 MOACRIVE Inhibition DME1302 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1302 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04356 XEO_CLAS Peptide DME1302 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 16.42 ug/ml) DME1302 XEOTICID XEO04356 GENEFORM Protein DME1302 XEOTICID XEO04356 MOACRIVE Inhibition DME1302 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1302 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04357 XEO_CLAS Peptide DME1302 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 8.16 ug/ml) DME1302 XEOTICID XEO04357 GENEFORM Protein DME1302 XEOTICID XEO04357 MOACRIVE Inhibition DME1302 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1302 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04358 XEO_CLAS Peptide DME1302 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 4.68 ug/ml) DME1302 XEOTICID XEO04358 GENEFORM Protein DME1302 XEOTICID XEO04358 MOACRIVE Inhibition DME1302 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1302 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04359 XEO_CLAS Peptide DME1302 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 8.40 ug/ml) DME1302 XEOTICID XEO04359 GENEFORM Protein DME1302 XEOTICID XEO04359 MOACRIVE Inhibition DME1302 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1302 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04365 XEO_CLAS Peptide DME1302 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 37.5 ug/ml) DME1302 XEOTICID XEO04365 GENEFORM Protein DME1302 XEOTICID XEO04365 MOACRIVE Inhibition DME1302 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1302 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04366 XEO_CLAS Peptide DME1302 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 5.90 ug/ml) DME1302 XEOTICID XEO04366 GENEFORM Protein DME1302 XEOTICID XEO04366 MOACRIVE Inhibition DME1302 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1302 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04367 XEO_CLAS Peptide DME1302 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 35.60 ug/ml) DME1302 XEOTICID XEO04367 GENEFORM Protein DME1302 XEOTICID XEO04367 MOACRIVE Inhibition DME1302 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1302 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04370 XEO_CLAS Peptide DME1302 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.10 ug/ml) DME1302 XEOTICID XEO04370 GENEFORM Protein DME1302 XEOTICID XEO04370 MOACRIVE Inhibition DME1302 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1302 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04371 XEO_CLAS Peptide DME1302 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 75 ug/ml) DME1302 XEOTICID XEO04371 GENEFORM Protein DME1302 XEOTICID XEO04371 MOACRIVE Inhibition DME1302 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1302 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04374 XEO_CLAS Peptide DME1302 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.75 ug/ml) DME1302 XEOTICID XEO04374 GENEFORM Protein DME1302 XEOTICID XEO04374 MOACRIVE Inhibition DME1302 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1302 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04375 XEO_CLAS Peptide DME1302 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1302 XEOTICID XEO04375 GENEFORM Protein DME1302 XEOTICID XEO04375 MOACRIVE Inhibition DME1302 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1302 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04377 XEO_CLAS Peptide DME1302 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 85.00 ug/ml) DME1302 XEOTICID XEO04377 GENEFORM Protein DME1302 XEOTICID XEO04377 MOACRIVE Inhibition DME1302 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1302 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04378 XEO_CLAS Peptide DME1302 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 17.50 ug/ml) DME1302 XEOTICID XEO04378 GENEFORM Protein DME1302 XEOTICID XEO04378 MOACRIVE Inhibition DME1302 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1302 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04379 XEO_CLAS Peptide DME1302 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 9.37 ug/ml) DME1302 XEOTICID XEO04379 GENEFORM Protein DME1302 XEOTICID XEO04379 MOACRIVE Inhibition DME1302 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1302 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04380 XEO_CLAS Peptide DME1302 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 18.00 ug/ml) DME1302 XEOTICID XEO04380 GENEFORM Protein DME1302 XEOTICID XEO04380 MOACRIVE Inhibition DME1302 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1302 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04381 XEO_CLAS Peptide DME1302 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.30 ug/ml) DME1302 XEOTICID XEO04381 GENEFORM Protein DME1302 XEOTICID XEO04381 MOACRIVE Inhibition DME1302 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1302 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04383 XEO_CLAS Peptide DME1302 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 128 ug/ml) DME1302 XEOTICID XEO04383 GENEFORM Protein DME1302 XEOTICID XEO04383 MOACRIVE Inhibition DME1302 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1302 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04396 XEO_CLAS Peptide DME1302 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.25-0.5 microM) DME1302 XEOTICID XEO04396 GENEFORM Protein DME1302 XEOTICID XEO04396 MOACRIVE Inhibition DME1302 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1302 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04397 XEO_CLAS Peptide DME1302 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.25-0.5 microM) DME1302 XEOTICID XEO04397 GENEFORM Protein DME1302 XEOTICID XEO04397 MOACRIVE Inhibition DME1302 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1302 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04399 XEO_CLAS Peptide DME1302 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12.5 microM) DME1302 XEOTICID XEO04399 GENEFORM Protein DME1302 XEOTICID XEO04399 MOACRIVE Inhibition DME1302 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1302 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04421 XEO_CLAS Peptide DME1302 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.5 microM) DME1302 XEOTICID XEO04421 GENEFORM Protein DME1302 XEOTICID XEO04421 MOACRIVE Inhibition DME1302 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1302 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04430 XEO_CLAS Peptide DME1302 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.78 microM) DME1302 XEOTICID XEO04430 GENEFORM Protein DME1302 XEOTICID XEO04430 MOACRIVE Inhibition DME1302 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1302 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04448 XEO_CLAS Peptide DME1302 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12.5 microM) DME1302 XEOTICID XEO04448 GENEFORM Protein DME1302 XEOTICID XEO04448 MOACRIVE Inhibition DME1302 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1302 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04455 XEO_CLAS Peptide DME1302 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12.5 microM) DME1302 XEOTICID XEO04455 GENEFORM Protein DME1302 XEOTICID XEO04455 MOACRIVE Inhibition DME1302 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1302 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04461 XEO_CLAS Peptide DME1302 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 5.2 microM) DME1302 XEOTICID XEO04461 GENEFORM Protein DME1302 XEOTICID XEO04461 MOACRIVE Inhibition DME1302 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1302 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04462 XEO_CLAS Peptide DME1302 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 4.8 microM) DME1302 XEOTICID XEO04462 GENEFORM Protein DME1302 XEOTICID XEO04462 MOACRIVE Inhibition DME1302 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1302 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04471 XEO_CLAS Peptide DME1302 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.3 microM) DME1302 XEOTICID XEO04471 GENEFORM Protein DME1302 XEOTICID XEO04471 MOACRIVE Inhibition DME1302 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1302 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04484 XEO_CLAS Peptide DME1302 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 45 microM) DME1302 XEOTICID XEO04484 GENEFORM Protein DME1302 XEOTICID XEO04484 MOACRIVE Inhibition DME1302 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1302 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04485 XEO_CLAS Peptide DME1302 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 10 microM) DME1302 XEOTICID XEO04485 GENEFORM Protein DME1302 XEOTICID XEO04485 MOACRIVE Inhibition DME1302 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1302 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04486 XEO_CLAS Peptide DME1302 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 15 microM) DME1302 XEOTICID XEO04486 GENEFORM Protein DME1302 XEOTICID XEO04486 MOACRIVE Inhibition DME1302 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1302 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04487 XEO_CLAS Peptide DME1302 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 20 microM) DME1302 XEOTICID XEO04487 GENEFORM Protein DME1302 XEOTICID XEO04487 MOACRIVE Inhibition DME1302 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1302 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04488 XEO_CLAS Peptide DME1302 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 5 microM) DME1302 XEOTICID XEO04488 GENEFORM Protein DME1302 XEOTICID XEO04488 MOACRIVE Inhibition DME1302 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1302 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04489 XEO_CLAS Peptide DME1302 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 8.5 microM) DME1302 XEOTICID XEO04489 GENEFORM Protein DME1302 XEOTICID XEO04489 MOACRIVE Inhibition DME1302 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1302 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04490 XEO_CLAS Peptide DME1302 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 17.5 microM) DME1302 XEOTICID XEO04490 GENEFORM Protein DME1302 XEOTICID XEO04490 MOACRIVE Inhibition DME1302 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1302 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04491 XEO_CLAS Peptide DME1302 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 17 microM) DME1302 XEOTICID XEO04491 GENEFORM Protein DME1302 XEOTICID XEO04491 MOACRIVE Inhibition DME1302 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1302 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04492 XEO_CLAS Peptide DME1302 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 40 microM) DME1302 XEOTICID XEO04492 GENEFORM Protein DME1302 XEOTICID XEO04492 MOACRIVE Inhibition DME1302 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1302 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04493 XEO_CLAS Peptide DME1302 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 87.5 microM) DME1302 XEOTICID XEO04493 GENEFORM Protein DME1302 XEOTICID XEO04493 MOACRIVE Inhibition DME1302 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1302 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04494 XEO_CLAS Peptide DME1302 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 100 microM) DME1302 XEOTICID XEO04494 GENEFORM Protein DME1302 XEOTICID XEO04494 MOACRIVE Inhibition DME1302 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1302 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04495 XEO_CLAS Peptide DME1302 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 22.5 microM) DME1302 XEOTICID XEO04495 GENEFORM Protein DME1302 XEOTICID XEO04495 MOACRIVE Inhibition DME1302 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1302 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04496 XEO_CLAS Peptide DME1302 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 25 microM) DME1302 XEOTICID XEO04496 GENEFORM Protein DME1302 XEOTICID XEO04496 MOACRIVE Inhibition DME1302 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1302 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04497 XEO_CLAS Peptide DME1302 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 17.5 microM) DME1302 XEOTICID XEO04497 GENEFORM Protein DME1302 XEOTICID XEO04497 MOACRIVE Inhibition DME1302 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1302 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04498 XEO_CLAS Peptide DME1302 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 22.5 microM) DME1302 XEOTICID XEO04498 GENEFORM Protein DME1302 XEOTICID XEO04498 MOACRIVE Inhibition DME1302 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1302 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04499 XEO_CLAS Peptide DME1302 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 15.5 microM) DME1302 XEOTICID XEO04499 GENEFORM Protein DME1302 XEOTICID XEO04499 MOACRIVE Inhibition DME1302 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1302 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04500 XEO_CLAS Peptide DME1302 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 100 microM) DME1302 XEOTICID XEO04500 GENEFORM Protein DME1302 XEOTICID XEO04500 MOACRIVE Inhibition DME1302 XEOTICID XEO04518 XEO_NAME Penicillic acid DME1302 XEOTICID XEO04518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1302 XEOTICID XEO04518 XEO_CLAS Natural Product DME1302 XEOTICID XEO04518 DESCRIPT Penicillic acid inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04518 GENEFORM Protein DME1302 XEOTICID XEO04518 MOACRIVE Inhibition DME1302 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1302 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04525 XEO_CLAS Peptide DME1302 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 8.0 microM) DME1302 XEOTICID XEO04525 GENEFORM Protein DME1302 XEOTICID XEO04525 MOACRIVE Inhibition DME1302 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1302 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04526 XEO_CLAS Peptide DME1302 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2.0 microM) DME1302 XEOTICID XEO04526 GENEFORM Protein DME1302 XEOTICID XEO04526 MOACRIVE Inhibition DME1302 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1302 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04540 XEO_CLAS Peptide DME1302 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 48.8 ug/ml) DME1302 XEOTICID XEO04540 GENEFORM Protein DME1302 XEOTICID XEO04540 MOACRIVE Inhibition DME1302 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1302 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04541 XEO_CLAS Peptide DME1302 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 5 ug/ml) DME1302 XEOTICID XEO04541 GENEFORM Protein DME1302 XEOTICID XEO04541 MOACRIVE Inhibition DME1302 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1302 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04542 XEO_CLAS Peptide DME1302 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04542 GENEFORM Protein DME1302 XEOTICID XEO04542 MOACRIVE Inhibition DME1302 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1302 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04551 XEO_CLAS Peptide DME1302 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 14.4 ug/ml) DME1302 XEOTICID XEO04551 GENEFORM Protein DME1302 XEOTICID XEO04551 MOACRIVE Inhibition DME1302 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1302 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04604 XEO_CLAS Peptide DME1302 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC < 50 microM) DME1302 XEOTICID XEO04604 GENEFORM Protein DME1302 XEOTICID XEO04604 MOACRIVE Inhibition DME1302 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1302 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04605 XEO_CLAS Peptide DME1302 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC < 50 microM) DME1302 XEOTICID XEO04605 GENEFORM Protein DME1302 XEOTICID XEO04605 MOACRIVE Inhibition DME1302 XEOTICID XEO04624 XEO_NAME Plantazolicin DME1302 XEOTICID XEO04624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04624 XEO_CLAS Peptide DME1302 XEOTICID XEO04624 DESCRIPT Plantazolicin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04624 GENEFORM Protein DME1302 XEOTICID XEO04624 MOACRIVE Inhibition DME1302 XEOTICID XEO04632 XEO_NAME Pleurain-B1 DME1302 XEOTICID XEO04632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04632 XEO_CLAS Peptide DME1302 XEOTICID XEO04632 DESCRIPT Pleurain-B1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 3.1 ug/ml) DME1302 XEOTICID XEO04632 GENEFORM Protein DME1302 XEOTICID XEO04632 MOACRIVE Inhibition DME1302 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1302 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04633 XEO_CLAS Peptide DME1302 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 3.1 ug/ml) DME1302 XEOTICID XEO04633 GENEFORM Protein DME1302 XEOTICID XEO04633 MOACRIVE Inhibition DME1302 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1302 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04634 XEO_CLAS Peptide DME1302 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 50 ug/ml) DME1302 XEOTICID XEO04634 GENEFORM Protein DME1302 XEOTICID XEO04634 MOACRIVE Inhibition DME1302 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1302 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04636 XEO_CLAS Peptide DME1302 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 100 ug/ml) DME1302 XEOTICID XEO04636 GENEFORM Protein DME1302 XEOTICID XEO04636 MOACRIVE Inhibition DME1302 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1302 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04637 XEO_CLAS Peptide DME1302 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 50 ug/ml) DME1302 XEOTICID XEO04637 GENEFORM Protein DME1302 XEOTICID XEO04637 MOACRIVE Inhibition DME1302 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1302 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04639 XEO_CLAS Peptide DME1302 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 100 ug/ml) DME1302 XEOTICID XEO04639 GENEFORM Protein DME1302 XEOTICID XEO04639 MOACRIVE Inhibition DME1302 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1302 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04640 XEO_CLAS Peptide DME1302 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.1-2.2 microM) DME1302 XEOTICID XEO04640 GENEFORM Protein DME1302 XEOTICID XEO04640 MOACRIVE Inhibition DME1302 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1302 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04664 XEO_CLAS Peptide DME1302 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 27.2 microM) DME1302 XEOTICID XEO04664 GENEFORM Protein DME1302 XEOTICID XEO04664 MOACRIVE Inhibition DME1302 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1302 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04665 XEO_CLAS Peptide DME1302 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 35 microM) DME1302 XEOTICID XEO04665 GENEFORM Protein DME1302 XEOTICID XEO04665 MOACRIVE Inhibition DME1302 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1302 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04666 XEO_CLAS Peptide DME1302 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 100 microM) DME1302 XEOTICID XEO04666 GENEFORM Protein DME1302 XEOTICID XEO04666 MOACRIVE Inhibition DME1302 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1302 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04667 XEO_CLAS Peptide DME1302 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 10 microM) DME1302 XEOTICID XEO04667 GENEFORM Protein DME1302 XEOTICID XEO04667 MOACRIVE Inhibition DME1302 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1302 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04668 XEO_CLAS Peptide DME1302 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 60 microM) DME1302 XEOTICID XEO04668 GENEFORM Protein DME1302 XEOTICID XEO04668 MOACRIVE Inhibition DME1302 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1302 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04669 XEO_CLAS Peptide DME1302 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 30 microM) DME1302 XEOTICID XEO04669 GENEFORM Protein DME1302 XEOTICID XEO04669 MOACRIVE Inhibition DME1302 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1302 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04670 XEO_CLAS Peptide DME1302 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 46 microM) DME1302 XEOTICID XEO04670 GENEFORM Protein DME1302 XEOTICID XEO04670 MOACRIVE Inhibition DME1302 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1302 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04671 XEO_CLAS Peptide DME1302 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 125 microM) DME1302 XEOTICID XEO04671 GENEFORM Protein DME1302 XEOTICID XEO04671 MOACRIVE Inhibition DME1302 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1302 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04672 XEO_CLAS Peptide DME1302 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 75 microM) DME1302 XEOTICID XEO04672 GENEFORM Protein DME1302 XEOTICID XEO04672 MOACRIVE Inhibition DME1302 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1302 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04673 XEO_CLAS Peptide DME1302 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 100 microM) DME1302 XEOTICID XEO04673 GENEFORM Protein DME1302 XEOTICID XEO04673 MOACRIVE Inhibition DME1302 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1302 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04674 XEO_CLAS Peptide DME1302 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 70 microM) DME1302 XEOTICID XEO04674 GENEFORM Protein DME1302 XEOTICID XEO04674 MOACRIVE Inhibition DME1302 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1302 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04675 XEO_CLAS Peptide DME1302 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 100 microM) DME1302 XEOTICID XEO04675 GENEFORM Protein DME1302 XEOTICID XEO04675 MOACRIVE Inhibition DME1302 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1302 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04676 XEO_CLAS Peptide DME1302 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 100 microM) DME1302 XEOTICID XEO04676 GENEFORM Protein DME1302 XEOTICID XEO04676 MOACRIVE Inhibition DME1302 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1302 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04677 XEO_CLAS Peptide DME1302 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 100 microM) DME1302 XEOTICID XEO04677 GENEFORM Protein DME1302 XEOTICID XEO04677 MOACRIVE Inhibition DME1302 XEOTICID XEO04678 XEO_NAME Plant defensin Pn-AMP1 DME1302 XEOTICID XEO04678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04678 XEO_CLAS Peptide DME1302 XEOTICID XEO04678 DESCRIPT Plant defensin Pn-AMP1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04678 GENEFORM Protein DME1302 XEOTICID XEO04678 MOACRIVE Inhibition DME1302 XEOTICID XEO04679 XEO_NAME Plant defensin Pn-AMP2 DME1302 XEOTICID XEO04679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04679 XEO_CLAS Peptide DME1302 XEOTICID XEO04679 DESCRIPT Plant defensin Pn-AMP2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04679 GENEFORM Protein DME1302 XEOTICID XEO04679 MOACRIVE Inhibition DME1302 XEOTICID XEO04681 XEO_NAME Polybia chemotactic peptide polybia-CP DME1302 XEOTICID XEO04681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04681 XEO_CLAS Peptide DME1302 XEOTICID XEO04681 DESCRIPT Polybia chemotactic peptide polybia-CP inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 15 ug/ml) DME1302 XEOTICID XEO04681 GENEFORM Protein DME1302 XEOTICID XEO04681 MOACRIVE Inhibition DME1302 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1302 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04695 XEO_CLAS Peptide DME1302 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04695 GENEFORM Protein DME1302 XEOTICID XEO04695 MOACRIVE Inhibition DME1302 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1302 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04697 XEO_CLAS Peptide DME1302 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04697 GENEFORM Protein DME1302 XEOTICID XEO04697 MOACRIVE Inhibition DME1302 XEOTICID XEO04707 XEO_NAME Pore-forming peptide ameobapore A DME1302 XEOTICID XEO04707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04707 XEO_CLAS Peptide DME1302 XEOTICID XEO04707 DESCRIPT Pore-forming peptide ameobapore A inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 27 microM) DME1302 XEOTICID XEO04707 GENEFORM Protein DME1302 XEOTICID XEO04707 MOACRIVE Inhibition DME1302 XEOTICID XEO04711 XEO_NAME Insect PP102 peptide DME1302 XEOTICID XEO04711 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04711 XEO_CLAS Peptide DME1302 XEOTICID XEO04711 DESCRIPT Insect PP102 peptide inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 25 microM) DME1302 XEOTICID XEO04711 GENEFORM Protein DME1302 XEOTICID XEO04711 MOACRIVE Inhibition DME1302 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1302 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04712 XEO_CLAS Peptide DME1302 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 23.3 microM) DME1302 XEOTICID XEO04712 GENEFORM Protein DME1302 XEOTICID XEO04712 MOACRIVE Inhibition DME1302 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1302 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04713 XEO_CLAS Peptide DME1302 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 13.3 microM) DME1302 XEOTICID XEO04713 GENEFORM Protein DME1302 XEOTICID XEO04713 MOACRIVE Inhibition DME1302 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1302 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04714 XEO_CLAS Peptide DME1302 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 16.7 microM) DME1302 XEOTICID XEO04714 GENEFORM Protein DME1302 XEOTICID XEO04714 MOACRIVE Inhibition DME1302 XEOTICID XEO04737 XEO_NAME Protonectin DME1302 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04737 XEO_CLAS Peptide DME1302 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 3.1 ug/ml) DME1302 XEOTICID XEO04737 GENEFORM Protein DME1302 XEOTICID XEO04737 MOACRIVE Inhibition DME1302 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1302 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04762 XEO_CLAS Peptide DME1302 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 3.1 microM) DME1302 XEOTICID XEO04762 GENEFORM Protein DME1302 XEOTICID XEO04762 MOACRIVE Inhibition DME1302 XEOTICID XEO04790 XEO_NAME Ranacyclin-B-AL1 DME1302 XEOTICID XEO04790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04790 XEO_CLAS Peptide DME1302 XEOTICID XEO04790 DESCRIPT Ranacyclin-B-AL1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 26 microM) DME1302 XEOTICID XEO04790 GENEFORM Protein DME1302 XEOTICID XEO04790 MOACRIVE Inhibition DME1302 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1302 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04793 XEO_CLAS Peptide DME1302 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 46.2 microM) DME1302 XEOTICID XEO04793 GENEFORM Protein DME1302 XEOTICID XEO04793 MOACRIVE Inhibition DME1302 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1302 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04865 XEO_CLAS Peptide DME1302 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 12.5 ug/ml) DME1302 XEOTICID XEO04865 GENEFORM Protein DME1302 XEOTICID XEO04865 MOACRIVE Inhibition DME1302 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1302 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04866 XEO_CLAS Peptide DME1302 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.25 ug/ml) DME1302 XEOTICID XEO04866 GENEFORM Protein DME1302 XEOTICID XEO04866 MOACRIVE Inhibition DME1302 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1302 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04868 XEO_CLAS Peptide DME1302 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 9.38 ug/ml) DME1302 XEOTICID XEO04868 GENEFORM Protein DME1302 XEOTICID XEO04868 MOACRIVE Inhibition DME1302 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1302 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04869 XEO_CLAS Peptide DME1302 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 18.75 ug/ml) DME1302 XEOTICID XEO04869 GENEFORM Protein DME1302 XEOTICID XEO04869 MOACRIVE Inhibition DME1302 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1302 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04870 XEO_CLAS Peptide DME1302 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 18.75 ug/ml) DME1302 XEOTICID XEO04870 GENEFORM Protein DME1302 XEOTICID XEO04870 MOACRIVE Inhibition DME1302 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1302 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04880 XEO_CLAS Peptide DME1302 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2.0 ug/ml) DME1302 XEOTICID XEO04880 GENEFORM Protein DME1302 XEOTICID XEO04880 MOACRIVE Inhibition DME1302 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1302 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04886 XEO_CLAS Peptide DME1302 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.3 ug/ml) DME1302 XEOTICID XEO04886 GENEFORM Protein DME1302 XEOTICID XEO04886 MOACRIVE Inhibition DME1302 XEOTICID XEO04892 XEO_NAME Seabream beta defensin saBD DME1302 XEOTICID XEO04892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04892 XEO_CLAS Peptide DME1302 XEOTICID XEO04892 DESCRIPT Seabream beta defensin saBD inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04892 GENEFORM Protein DME1302 XEOTICID XEO04892 MOACRIVE Inhibition DME1302 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1302 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04901 XEO_CLAS Peptide DME1302 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2 microM) DME1302 XEOTICID XEO04901 GENEFORM Protein DME1302 XEOTICID XEO04901 MOACRIVE Inhibition DME1302 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1302 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04904 XEO_CLAS Peptide DME1302 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 20.0 ug/ml) DME1302 XEOTICID XEO04904 GENEFORM Protein DME1302 XEOTICID XEO04904 MOACRIVE Inhibition DME1302 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1302 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04909 XEO_CLAS Peptide DME1302 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04909 GENEFORM Protein DME1302 XEOTICID XEO04909 MOACRIVE Inhibition DME1302 XEOTICID XEO04917 XEO_NAME Scorpine DME1302 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04917 XEO_CLAS Peptide DME1302 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 1.0 microM) DME1302 XEOTICID XEO04917 GENEFORM Protein DME1302 XEOTICID XEO04917 MOACRIVE Inhibition DME1302 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1302 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04956 XEO_CLAS Peptide DME1302 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 8.0 microM) DME1302 XEOTICID XEO04956 GENEFORM Protein DME1302 XEOTICID XEO04956 MOACRIVE Inhibition DME1302 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1302 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04971 XEO_CLAS Peptide DME1302 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.8-1.5 microM) DME1302 XEOTICID XEO04971 GENEFORM Protein DME1302 XEOTICID XEO04971 MOACRIVE Inhibition DME1302 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1302 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1302 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1302 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04975 GENEFORM Protein DME1302 XEOTICID XEO04975 MOACRIVE Inhibition DME1302 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1302 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1302 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1302 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04976 GENEFORM Protein DME1302 XEOTICID XEO04976 MOACRIVE Inhibition DME1302 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1302 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1302 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1302 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04977 GENEFORM Protein DME1302 XEOTICID XEO04977 MOACRIVE Inhibition DME1302 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1302 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1302 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1302 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04978 GENEFORM Protein DME1302 XEOTICID XEO04978 MOACRIVE Inhibition DME1302 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1302 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1302 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1302 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO04979 GENEFORM Protein DME1302 XEOTICID XEO04979 MOACRIVE Inhibition DME1302 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1302 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO04995 XEO_CLAS Peptide DME1302 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 6.25-12.5 microM) DME1302 XEOTICID XEO04995 GENEFORM Protein DME1302 XEOTICID XEO04995 MOACRIVE Inhibition DME1302 XEOTICID XEO05089 XEO_NAME Temporin-GH DME1302 XEOTICID XEO05089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05089 XEO_CLAS Peptide DME1302 XEOTICID XEO05089 DESCRIPT Temporin-GH inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC > 64 ug/ml) DME1302 XEOTICID XEO05089 GENEFORM Protein DME1302 XEOTICID XEO05089 MOACRIVE Inhibition DME1302 XEOTICID XEO05092 XEO_NAME Temporin-LT1 DME1302 XEOTICID XEO05092 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05092 XEO_CLAS Peptide DME1302 XEOTICID XEO05092 DESCRIPT Temporin-LT1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 25 microM) DME1302 XEOTICID XEO05092 GENEFORM Protein DME1302 XEOTICID XEO05092 MOACRIVE Inhibition DME1302 XEOTICID XEO05093 XEO_NAME Temporin-LT2 DME1302 XEOTICID XEO05093 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05093 XEO_CLAS Peptide DME1302 XEOTICID XEO05093 DESCRIPT Temporin-LT2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 50 microM) DME1302 XEOTICID XEO05093 GENEFORM Protein DME1302 XEOTICID XEO05093 MOACRIVE Inhibition DME1302 XEOTICID XEO05094 XEO_NAME Temporin-LTa DME1302 XEOTICID XEO05094 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05094 XEO_CLAS Peptide DME1302 XEOTICID XEO05094 DESCRIPT Temporin-LTa inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 10 ug/ml) DME1302 XEOTICID XEO05094 GENEFORM Protein DME1302 XEOTICID XEO05094 MOACRIVE Inhibition DME1302 XEOTICID XEO05095 XEO_NAME Temporin-LTb DME1302 XEOTICID XEO05095 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05095 XEO_CLAS Peptide DME1302 XEOTICID XEO05095 DESCRIPT Temporin-LTb inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 25 ug/ml) DME1302 XEOTICID XEO05095 GENEFORM Protein DME1302 XEOTICID XEO05095 MOACRIVE Inhibition DME1302 XEOTICID XEO05096 XEO_NAME Temporin-LTc DME1302 XEOTICID XEO05096 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05096 XEO_CLAS Peptide DME1302 XEOTICID XEO05096 DESCRIPT Temporin-LTc inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 50 ug/ml) DME1302 XEOTICID XEO05096 GENEFORM Protein DME1302 XEOTICID XEO05096 MOACRIVE Inhibition DME1302 XEOTICID XEO05120 XEO_NAME Thanatin DME1302 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05120 XEO_CLAS Peptide DME1302 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2.5-5 microM) DME1302 XEOTICID XEO05120 GENEFORM Protein DME1302 XEOTICID XEO05120 MOACRIVE Inhibition DME1302 XEOTICID XEO05129 XEO_NAME Thiocillin GE37468 DME1302 XEOTICID XEO05129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05129 XEO_CLAS Peptide DME1302 XEOTICID XEO05129 DESCRIPT Thiocillin GE37468 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.047 ug/ml) DME1302 XEOTICID XEO05129 GENEFORM Protein DME1302 XEOTICID XEO05129 MOACRIVE Inhibition DME1302 XEOTICID XEO05138 XEO_NAME Thuricin-17 DME1302 XEOTICID XEO05138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05138 XEO_CLAS Peptide DME1302 XEOTICID XEO05138 DESCRIPT Thuricin-17 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO05138 GENEFORM Protein DME1302 XEOTICID XEO05138 MOACRIVE Inhibition DME1302 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1302 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05139 XEO_CLAS Peptide DME1302 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO05139 GENEFORM Protein DME1302 XEOTICID XEO05139 MOACRIVE Inhibition DME1302 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1302 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05144 XEO_CLAS Peptide DME1302 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 30 ug/ml) DME1302 XEOTICID XEO05144 GENEFORM Protein DME1302 XEOTICID XEO05144 MOACRIVE Inhibition DME1302 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1302 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05145 XEO_CLAS Peptide DME1302 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 20 ug/ml) DME1302 XEOTICID XEO05145 GENEFORM Protein DME1302 XEOTICID XEO05145 MOACRIVE Inhibition DME1302 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1302 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05146 XEO_CLAS Peptide DME1302 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 30 ug/ml) DME1302 XEOTICID XEO05146 GENEFORM Protein DME1302 XEOTICID XEO05146 MOACRIVE Inhibition DME1302 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1302 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05161 XEO_CLAS Peptide DME1302 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 16 ug/ml) DME1302 XEOTICID XEO05161 GENEFORM Protein DME1302 XEOTICID XEO05161 MOACRIVE Inhibition DME1302 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1302 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05162 XEO_CLAS Peptide DME1302 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 16 ug/ml) DME1302 XEOTICID XEO05162 GENEFORM Protein DME1302 XEOTICID XEO05162 MOACRIVE Inhibition DME1302 XEOTICID XEO05169 XEO_NAME Tricyclic peptide MS-271 DME1302 XEOTICID XEO05169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05169 XEO_CLAS Peptide DME1302 XEOTICID XEO05169 DESCRIPT Tricyclic peptide MS-271 inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis DME1302 XEOTICID XEO05169 GENEFORM Protein DME1302 XEOTICID XEO05169 MOACRIVE Inhibition DME1302 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1302 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05193 XEO_CLAS Peptide DME1302 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 8 ug/ml) DME1302 XEOTICID XEO05193 GENEFORM Protein DME1302 XEOTICID XEO05193 MOACRIVE Inhibition DME1302 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1302 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05212 XEO_CLAS Peptide DME1302 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 2.0 ug/ml) DME1302 XEOTICID XEO05212 GENEFORM Protein DME1302 XEOTICID XEO05212 MOACRIVE Inhibition DME1302 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1302 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05220 XEO_CLAS Peptide DME1302 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 20-40 microM) DME1302 XEOTICID XEO05220 GENEFORM Protein DME1302 XEOTICID XEO05220 MOACRIVE Inhibition DME1302 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1302 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1302 XEOTICID XEO05308 XEO_CLAS Peptide DME1302 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of General stress protein 14 (ywrO) from Bacillus subtilis (MIC = 0.7 ug/ml) DME1302 XEOTICID XEO05308 GENEFORM Protein DME1302 XEOTICID XEO05308 MOACRIVE Inhibition DME1303 DME___ID DME1303 DME1303 DME_NAME Glutamate decarboxylase (gadB) DME1303 SPESNAME Listeria monocytogenes DME1303 XEOTICID XEO00096 XEO_NAME Ampicillin DME1303 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO00096 GENEFORM Protein DME1303 XEOTICID XEO00096 MOACRIVE Inhibition DME1303 XEOTICID XEO00116 XEO_NAME Dicloxacillin DME1303 XEOTICID XEO00116 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO00116 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO00116 DESCRIPT Dicloxacillin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO00116 GENEFORM Protein DME1303 XEOTICID XEO00116 MOACRIVE Inhibition DME1303 XEOTICID XEO00124 XEO_NAME Cefaclor DME1303 XEOTICID XEO00124 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO00124 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO00124 DESCRIPT Cefaclor inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO00124 GENEFORM Protein DME1303 XEOTICID XEO00124 MOACRIVE Inhibition DME1303 XEOTICID XEO00246 XEO_NAME Amoxicillin DME1303 XEOTICID XEO00246 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO00246 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO00246 DESCRIPT Amoxicillin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO00246 GENEFORM Protein DME1303 XEOTICID XEO00246 MOACRIVE Inhibition DME1303 XEOTICID XEO00375 XEO_NAME Piperacillin DME1303 XEOTICID XEO00375 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO00375 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO00375 DESCRIPT Piperacillin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO00375 GENEFORM Protein DME1303 XEOTICID XEO00375 MOACRIVE Inhibition DME1303 XEOTICID XEO00437 XEO_NAME Penicillin G DME1303 XEOTICID XEO00437 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO00437 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO00437 DESCRIPT Penicillin G inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO00437 GENEFORM Protein DME1303 XEOTICID XEO00437 MOACRIVE Inhibition DME1303 XEOTICID XEO02126 XEO_NAME Acidocin A DME1303 XEOTICID XEO02126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02126 XEO_CLAS Peptide DME1303 XEOTICID XEO02126 DESCRIPT Acidocin A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02126 GENEFORM Protein DME1303 XEOTICID XEO02126 MOACRIVE Inhibition DME1303 XEOTICID XEO02127 XEO_NAME Acidocin B DME1303 XEOTICID XEO02127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02127 XEO_CLAS Peptide DME1303 XEOTICID XEO02127 DESCRIPT Acidocin B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02127 GENEFORM Protein DME1303 XEOTICID XEO02127 MOACRIVE Inhibition DME1303 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1303 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02164 XEO_CLAS Peptide DME1303 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02164 GENEFORM Protein DME1303 XEOTICID XEO02164 MOACRIVE Inhibition DME1303 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1303 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02165 XEO_CLAS Peptide DME1303 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02165 GENEFORM Protein DME1303 XEOTICID XEO02165 MOACRIVE Inhibition DME1303 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1303 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02166 XEO_CLAS Peptide DME1303 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02166 GENEFORM Protein DME1303 XEOTICID XEO02166 MOACRIVE Inhibition DME1303 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1303 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02167 XEO_CLAS Peptide DME1303 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02167 GENEFORM Protein DME1303 XEOTICID XEO02167 MOACRIVE Inhibition DME1303 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1303 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02168 XEO_CLAS Peptide DME1303 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02168 GENEFORM Protein DME1303 XEOTICID XEO02168 MOACRIVE Inhibition DME1303 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1303 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02169 XEO_CLAS Peptide DME1303 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02169 GENEFORM Protein DME1303 XEOTICID XEO02169 MOACRIVE Inhibition DME1303 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1303 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02170 XEO_CLAS Peptide DME1303 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 2.2 microM) DME1303 XEOTICID XEO02170 GENEFORM Protein DME1303 XEOTICID XEO02170 MOACRIVE Inhibition DME1303 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1303 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02207 XEO_CLAS Peptide DME1303 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.78 ug/ml) DME1303 XEOTICID XEO02207 GENEFORM Protein DME1303 XEOTICID XEO02207 MOACRIVE Inhibition DME1303 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1303 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02208 XEO_CLAS Peptide DME1303 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 1.56 ug/ml) DME1303 XEOTICID XEO02208 GENEFORM Protein DME1303 XEOTICID XEO02208 MOACRIVE Inhibition DME1303 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1303 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02209 XEO_CLAS Peptide DME1303 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.39 ug/ml) DME1303 XEOTICID XEO02209 GENEFORM Protein DME1303 XEOTICID XEO02209 MOACRIVE Inhibition DME1303 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1303 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02210 XEO_CLAS Peptide DME1303 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC > 12.5 ug/ml) DME1303 XEOTICID XEO02210 GENEFORM Protein DME1303 XEOTICID XEO02210 MOACRIVE Inhibition DME1303 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1303 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02211 XEO_CLAS Peptide DME1303 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC > 12.5 ug/ml) DME1303 XEOTICID XEO02211 GENEFORM Protein DME1303 XEOTICID XEO02211 MOACRIVE Inhibition DME1303 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1303 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02212 XEO_CLAS Peptide DME1303 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.78 ug/ml) DME1303 XEOTICID XEO02212 GENEFORM Protein DME1303 XEOTICID XEO02212 MOACRIVE Inhibition DME1303 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1303 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02213 XEO_CLAS Peptide DME1303 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.78 ug/ml) DME1303 XEOTICID XEO02213 GENEFORM Protein DME1303 XEOTICID XEO02213 MOACRIVE Inhibition DME1303 XEOTICID XEO02229 XEO_NAME Anionic antimicrobial peptide 2 DME1303 XEOTICID XEO02229 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02229 XEO_CLAS Peptide DME1303 XEOTICID XEO02229 DESCRIPT Anionic antimicrobial peptide 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 86.6 microM) DME1303 XEOTICID XEO02229 GENEFORM Protein DME1303 XEOTICID XEO02229 MOACRIVE Inhibition DME1303 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1303 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02230 XEO_CLAS Peptide DME1303 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 50-100 microM) DME1303 XEOTICID XEO02230 GENEFORM Protein DME1303 XEOTICID XEO02230 MOACRIVE Inhibition DME1303 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1303 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02283 XEO_CLAS Peptide DME1303 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 6.25 ug/ml) DME1303 XEOTICID XEO02283 GENEFORM Protein DME1303 XEOTICID XEO02283 MOACRIVE Inhibition DME1303 XEOTICID XEO02308 XEO_NAME Apolipophorin-3 DME1303 XEOTICID XEO02308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02308 XEO_CLAS Peptide DME1303 XEOTICID XEO02308 DESCRIPT Apolipophorin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 6.5 microM) DME1303 XEOTICID XEO02308 GENEFORM Protein DME1303 XEOTICID XEO02308 MOACRIVE Inhibition DME1303 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1303 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02317 XEO_CLAS Peptide DME1303 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.6 ug/ml) DME1303 XEOTICID XEO02317 GENEFORM Protein DME1303 XEOTICID XEO02317 MOACRIVE Inhibition DME1303 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1303 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02318 XEO_CLAS Peptide DME1303 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02318 GENEFORM Protein DME1303 XEOTICID XEO02318 MOACRIVE Inhibition DME1303 XEOTICID XEO02346 XEO_NAME Aurelin DME1303 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02346 XEO_CLAS Peptide DME1303 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 22.64 ug/ml) DME1303 XEOTICID XEO02346 GENEFORM Protein DME1303 XEOTICID XEO02346 MOACRIVE Inhibition DME1303 XEOTICID XEO02347 XEO_NAME Aureocin A53 DME1303 XEOTICID XEO02347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02347 XEO_CLAS Peptide DME1303 XEOTICID XEO02347 DESCRIPT Aureocin A53 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02347 GENEFORM Protein DME1303 XEOTICID XEO02347 MOACRIVE Inhibition DME1303 XEOTICID XEO02351 XEO_NAME Azlocillin DME1303 XEOTICID XEO02351 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO02351 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO02351 DESCRIPT Azlocillin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02351 GENEFORM Protein DME1303 XEOTICID XEO02351 MOACRIVE Inhibition DME1303 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1303 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02365 XEO_CLAS Peptide DME1303 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 2 ug/ml) DME1303 XEOTICID XEO02365 GENEFORM Protein DME1303 XEOTICID XEO02365 MOACRIVE Inhibition DME1303 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1303 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02367 XEO_CLAS Peptide DME1303 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.5 ug/ml) DME1303 XEOTICID XEO02367 GENEFORM Protein DME1303 XEOTICID XEO02367 MOACRIVE Inhibition DME1303 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1303 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02368 XEO_CLAS Peptide DME1303 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 1 ug/ml) DME1303 XEOTICID XEO02368 GENEFORM Protein DME1303 XEOTICID XEO02368 MOACRIVE Inhibition DME1303 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1303 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02369 XEO_CLAS Peptide DME1303 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC < 0.125 ug/ml) DME1303 XEOTICID XEO02369 GENEFORM Protein DME1303 XEOTICID XEO02369 MOACRIVE Inhibition DME1303 XEOTICID XEO02375 XEO_NAME Bacteriocin curvaticin DME1303 XEOTICID XEO02375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02375 XEO_CLAS Peptide DME1303 XEOTICID XEO02375 DESCRIPT Bacteriocin curvaticin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02375 GENEFORM Protein DME1303 XEOTICID XEO02375 MOACRIVE Inhibition DME1303 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1303 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02376 XEO_CLAS Peptide DME1303 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 2-8 ug/ml) DME1303 XEOTICID XEO02376 GENEFORM Protein DME1303 XEOTICID XEO02376 MOACRIVE Inhibition DME1303 XEOTICID XEO02377 XEO_NAME Bacteriocin hiracin-JM79 DME1303 XEOTICID XEO02377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02377 XEO_CLAS Peptide DME1303 XEOTICID XEO02377 DESCRIPT Bacteriocin hiracin-JM79 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02377 GENEFORM Protein DME1303 XEOTICID XEO02377 MOACRIVE Inhibition DME1303 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1303 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02378 XEO_CLAS Peptide DME1303 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.19 ug/ml) DME1303 XEOTICID XEO02378 GENEFORM Protein DME1303 XEOTICID XEO02378 MOACRIVE Inhibition DME1303 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1303 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02388 XEO_CLAS Peptide DME1303 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.5 ug/ml) DME1303 XEOTICID XEO02388 GENEFORM Protein DME1303 XEOTICID XEO02388 MOACRIVE Inhibition DME1303 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1303 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02389 XEO_CLAS Peptide DME1303 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.25 ug/ml) DME1303 XEOTICID XEO02389 GENEFORM Protein DME1303 XEOTICID XEO02389 MOACRIVE Inhibition DME1303 XEOTICID XEO02417 XEO_NAME Bavaricin-A DME1303 XEOTICID XEO02417 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02417 XEO_CLAS Peptide DME1303 XEOTICID XEO02417 DESCRIPT Bavaricin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02417 GENEFORM Protein DME1303 XEOTICID XEO02417 MOACRIVE Inhibition DME1303 XEOTICID XEO02418 XEO_NAME Bavaricin-MN DME1303 XEOTICID XEO02418 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02418 XEO_CLAS Peptide DME1303 XEOTICID XEO02418 DESCRIPT Bavaricin-MN inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02418 GENEFORM Protein DME1303 XEOTICID XEO02418 MOACRIVE Inhibition DME1303 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1303 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02436 XEO_CLAS Peptide DME1303 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02436 GENEFORM Protein DME1303 XEOTICID XEO02436 MOACRIVE Inhibition DME1303 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1303 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02491 XEO_CLAS Peptide DME1303 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 5.7 microM) DME1303 XEOTICID XEO02491 GENEFORM Protein DME1303 XEOTICID XEO02491 MOACRIVE Inhibition DME1303 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1303 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02708 XEO_CLAS Peptide DME1303 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 10 ug/ml) DME1303 XEOTICID XEO02708 GENEFORM Protein DME1303 XEOTICID XEO02708 MOACRIVE Inhibition DME1303 XEOTICID XEO02718 XEO_NAME Carnobacteriocin CbnB2 DME1303 XEOTICID XEO02718 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02718 XEO_CLAS Peptide DME1303 XEOTICID XEO02718 DESCRIPT Carnobacteriocin CbnB2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02718 GENEFORM Protein DME1303 XEOTICID XEO02718 MOACRIVE Inhibition DME1303 XEOTICID XEO02720 XEO_NAME Carnobacteriocin-A DME1303 XEOTICID XEO02720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02720 XEO_CLAS Peptide DME1303 XEOTICID XEO02720 DESCRIPT Carnobacteriocin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02720 GENEFORM Protein DME1303 XEOTICID XEO02720 MOACRIVE Inhibition DME1303 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1303 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02721 XEO_CLAS Peptide DME1303 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02721 GENEFORM Protein DME1303 XEOTICID XEO02721 MOACRIVE Inhibition DME1303 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1303 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02732 XEO_CLAS Peptide DME1303 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.5 microM) DME1303 XEOTICID XEO02732 GENEFORM Protein DME1303 XEOTICID XEO02732 MOACRIVE Inhibition DME1303 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1303 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02734 XEO_CLAS Peptide DME1303 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.80 microM) DME1303 XEOTICID XEO02734 GENEFORM Protein DME1303 XEOTICID XEO02734 MOACRIVE Inhibition DME1303 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1303 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02735 XEO_CLAS Peptide DME1303 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC < 2 ug/ml) DME1303 XEOTICID XEO02735 GENEFORM Protein DME1303 XEOTICID XEO02735 MOACRIVE Inhibition DME1303 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1303 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02738 XEO_CLAS Peptide DME1303 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 2 microM) DME1303 XEOTICID XEO02738 GENEFORM Protein DME1303 XEOTICID XEO02738 MOACRIVE Inhibition DME1303 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1303 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02773 XEO_CLAS Peptide DME1303 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02773 GENEFORM Protein DME1303 XEOTICID XEO02773 MOACRIVE Inhibition DME1303 XEOTICID XEO02778 XEO_NAME Cefalonium DME1303 XEOTICID XEO02778 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO02778 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO02778 DESCRIPT Cefalonium inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02778 GENEFORM Protein DME1303 XEOTICID XEO02778 MOACRIVE Inhibition DME1303 XEOTICID XEO02780 XEO_NAME Cefixime DME1303 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02780 GENEFORM Protein DME1303 XEOTICID XEO02780 MOACRIVE Inhibition DME1303 XEOTICID XEO02781 XEO_NAME Cefmetazole DME1303 XEOTICID XEO02781 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO02781 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO02781 DESCRIPT Cefmetazole inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02781 GENEFORM Protein DME1303 XEOTICID XEO02781 MOACRIVE Inhibition DME1303 XEOTICID XEO02782 XEO_NAME Cefotaxime DME1303 XEOTICID XEO02782 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO02782 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO02782 DESCRIPT Cefotaxime inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02782 GENEFORM Protein DME1303 XEOTICID XEO02782 MOACRIVE Inhibition DME1303 XEOTICID XEO02783 XEO_NAME Cefotiam DME1303 XEOTICID XEO02783 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO02783 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO02783 DESCRIPT Cefotiam inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02783 GENEFORM Protein DME1303 XEOTICID XEO02783 MOACRIVE Inhibition DME1303 XEOTICID XEO02784 XEO_NAME Cefoxitin DME1303 XEOTICID XEO02784 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO02784 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO02784 DESCRIPT Cefoxitin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02784 GENEFORM Protein DME1303 XEOTICID XEO02784 MOACRIVE Inhibition DME1303 XEOTICID XEO02787 XEO_NAME Cefuroxime DME1303 XEOTICID XEO02787 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO02787 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO02787 DESCRIPT Cefuroxime inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02787 GENEFORM Protein DME1303 XEOTICID XEO02787 MOACRIVE Inhibition DME1303 XEOTICID XEO02884 XEO_NAME Cloxacillin DME1303 XEOTICID XEO02884 XEO_TYPE Pharmaceutical Agent(s) DME1303 XEOTICID XEO02884 XEO_CLAS Approved/Marketed Drug DME1303 XEOTICID XEO02884 DESCRIPT Cloxacillin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02884 GENEFORM Protein DME1303 XEOTICID XEO02884 MOACRIVE Inhibition DME1303 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1303 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02895 XEO_CLAS Peptide DME1303 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 10 microM) DME1303 XEOTICID XEO02895 GENEFORM Protein DME1303 XEOTICID XEO02895 MOACRIVE Inhibition DME1303 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1303 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02896 XEO_CLAS Peptide DME1303 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 40 microM) DME1303 XEOTICID XEO02896 GENEFORM Protein DME1303 XEOTICID XEO02896 MOACRIVE Inhibition DME1303 XEOTICID XEO02930 XEO_NAME Indolicidin derivative CP10A DME1303 XEOTICID XEO02930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02930 XEO_CLAS Peptide DME1303 XEOTICID XEO02930 DESCRIPT Indolicidin derivative CP10A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 1 ug/ml) DME1303 XEOTICID XEO02930 GENEFORM Protein DME1303 XEOTICID XEO02930 MOACRIVE Inhibition DME1303 XEOTICID XEO02932 XEO_NAME CP11CN peptide DME1303 XEOTICID XEO02932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02932 XEO_CLAS Peptide DME1303 XEOTICID XEO02932 DESCRIPT CP11CN peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 16 ug/ml) DME1303 XEOTICID XEO02932 GENEFORM Protein DME1303 XEOTICID XEO02932 MOACRIVE Inhibition DME1303 XEOTICID XEO02955 XEO_NAME Cryptdin related sequence CRS4C-3c DME1303 XEOTICID XEO02955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02955 XEO_CLAS Peptide DME1303 XEOTICID XEO02955 DESCRIPT Cryptdin related sequence CRS4C-3c inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02955 GENEFORM Protein DME1303 XEOTICID XEO02955 MOACRIVE Inhibition DME1303 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1303 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02958 XEO_CLAS Peptide DME1303 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02958 GENEFORM Protein DME1303 XEOTICID XEO02958 MOACRIVE Inhibition DME1303 XEOTICID XEO02959 XEO_NAME Cryptdin related peptide CRS4C-1d DME1303 XEOTICID XEO02959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02959 XEO_CLAS Peptide DME1303 XEOTICID XEO02959 DESCRIPT Cryptdin related peptide CRS4C-1d inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02959 GENEFORM Protein DME1303 XEOTICID XEO02959 MOACRIVE Inhibition DME1303 XEOTICID XEO02960 XEO_NAME Cryptdin related peptide CRS4C-2 DME1303 XEOTICID XEO02960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02960 XEO_CLAS Peptide DME1303 XEOTICID XEO02960 DESCRIPT Cryptdin related peptide CRS4C-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02960 GENEFORM Protein DME1303 XEOTICID XEO02960 MOACRIVE Inhibition DME1303 XEOTICID XEO02961 XEO_NAME Cryptdin related peptide CRS4C-2b DME1303 XEOTICID XEO02961 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO02961 XEO_CLAS Peptide DME1303 XEOTICID XEO02961 DESCRIPT Cryptdin related peptide CRS4C-2b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02961 GENEFORM Protein DME1303 XEOTICID XEO02961 MOACRIVE Inhibition DME1303 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1303 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1303 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1303 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO02990 GENEFORM Protein DME1303 XEOTICID XEO02990 MOACRIVE Inhibition DME1303 XEOTICID XEO03025 XEO_NAME Curvacin A DME1303 XEOTICID XEO03025 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03025 XEO_CLAS Peptide DME1303 XEOTICID XEO03025 DESCRIPT Curvacin A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03025 GENEFORM Protein DME1303 XEOTICID XEO03025 MOACRIVE Inhibition DME1303 XEOTICID XEO03026 XEO_NAME Curvaticin FS47 DME1303 XEOTICID XEO03026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03026 XEO_CLAS Peptide DME1303 XEOTICID XEO03026 DESCRIPT Curvaticin FS47 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03026 GENEFORM Protein DME1303 XEOTICID XEO03026 MOACRIVE Inhibition DME1303 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1303 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03137 XEO_CLAS Peptide DME1303 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03137 GENEFORM Protein DME1303 XEOTICID XEO03137 MOACRIVE Inhibition DME1303 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1303 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03215 XEO_CLAS Peptide DME1303 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 40.0 ug/ml) DME1303 XEOTICID XEO03215 GENEFORM Protein DME1303 XEOTICID XEO03215 MOACRIVE Inhibition DME1303 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1303 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03250 XEO_CLAS Peptide DME1303 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03250 GENEFORM Protein DME1303 XEOTICID XEO03250 MOACRIVE Inhibition DME1303 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1303 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03253 XEO_CLAS Peptide DME1303 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.1 ug/ml) DME1303 XEOTICID XEO03253 GENEFORM Protein DME1303 XEOTICID XEO03253 MOACRIVE Inhibition DME1303 XEOTICID XEO03257 XEO_NAME Enterocin P DME1303 XEOTICID XEO03257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03257 XEO_CLAS Peptide DME1303 XEOTICID XEO03257 DESCRIPT Enterocin P inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.035 ug/ml) DME1303 XEOTICID XEO03257 GENEFORM Protein DME1303 XEOTICID XEO03257 MOACRIVE Inhibition DME1303 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1303 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03258 XEO_CLAS Peptide DME1303 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03258 GENEFORM Protein DME1303 XEOTICID XEO03258 MOACRIVE Inhibition DME1303 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1303 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03459 XEO_CLAS Peptide DME1303 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03459 GENEFORM Protein DME1303 XEOTICID XEO03459 MOACRIVE Inhibition DME1303 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1303 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03460 XEO_CLAS Peptide DME1303 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03460 GENEFORM Protein DME1303 XEOTICID XEO03460 MOACRIVE Inhibition DME1303 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1303 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03462 XEO_CLAS Peptide DME1303 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03462 GENEFORM Protein DME1303 XEOTICID XEO03462 MOACRIVE Inhibition DME1303 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1303 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03463 XEO_CLAS Peptide DME1303 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03463 GENEFORM Protein DME1303 XEOTICID XEO03463 MOACRIVE Inhibition DME1303 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1303 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03467 XEO_CLAS Peptide DME1303 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03467 GENEFORM Protein DME1303 XEOTICID XEO03467 MOACRIVE Inhibition DME1303 XEOTICID XEO03473 XEO_NAME Garvicin ML DME1303 XEOTICID XEO03473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03473 XEO_CLAS Peptide DME1303 XEOTICID XEO03473 DESCRIPT Garvicin ML inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03473 GENEFORM Protein DME1303 XEOTICID XEO03473 MOACRIVE Inhibition DME1303 XEOTICID XEO03474 XEO_NAME Garvieacin Q DME1303 XEOTICID XEO03474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03474 XEO_CLAS Peptide DME1303 XEOTICID XEO03474 DESCRIPT Garvieacin Q inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03474 GENEFORM Protein DME1303 XEOTICID XEO03474 MOACRIVE Inhibition DME1303 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1303 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03497 XEO_CLAS Peptide DME1303 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.8-1.6 microM) DME1303 XEOTICID XEO03497 GENEFORM Protein DME1303 XEOTICID XEO03497 MOACRIVE Inhibition DME1303 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1303 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03498 XEO_CLAS Peptide DME1303 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.8-1.6 microM) DME1303 XEOTICID XEO03498 GENEFORM Protein DME1303 XEOTICID XEO03498 MOACRIVE Inhibition DME1303 XEOTICID XEO03517 XEO_NAME Histone H5 peptide derivative H5(61-90) DME1303 XEOTICID XEO03517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03517 XEO_CLAS Peptide DME1303 XEOTICID XEO03517 DESCRIPT Histone H5 peptide derivative H5(61-90) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 106.7 ug/ml) DME1303 XEOTICID XEO03517 GENEFORM Protein DME1303 XEOTICID XEO03517 MOACRIVE Inhibition DME1303 XEOTICID XEO03772 XEO_NAME Bacteriocin lacticin S DME1303 XEOTICID XEO03772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03772 XEO_CLAS Peptide DME1303 XEOTICID XEO03772 DESCRIPT Bacteriocin lacticin S inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03772 GENEFORM Protein DME1303 XEOTICID XEO03772 MOACRIVE Inhibition DME1303 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1303 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03776 XEO_CLAS Peptide DME1303 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 2 microM) DME1303 XEOTICID XEO03776 GENEFORM Protein DME1303 XEOTICID XEO03776 MOACRIVE Inhibition DME1303 XEOTICID XEO03848 XEO_NAME Lebocin-like anionic peptide 1 DME1303 XEOTICID XEO03848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03848 XEO_CLAS Peptide DME1303 XEOTICID XEO03848 DESCRIPT Lebocin-like anionic peptide 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 90.9 microM) DME1303 XEOTICID XEO03848 GENEFORM Protein DME1303 XEOTICID XEO03848 MOACRIVE Inhibition DME1303 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1303 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03854 XEO_CLAS Peptide DME1303 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 1.30 microM) DME1303 XEOTICID XEO03854 GENEFORM Protein DME1303 XEOTICID XEO03854 MOACRIVE Inhibition DME1303 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1303 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03855 XEO_CLAS Peptide DME1303 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 1.03 microM) DME1303 XEOTICID XEO03855 GENEFORM Protein DME1303 XEOTICID XEO03855 MOACRIVE Inhibition DME1303 XEOTICID XEO03856 XEO_NAME Bacteriocin leucocin A DME1303 XEOTICID XEO03856 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03856 XEO_CLAS Peptide DME1303 XEOTICID XEO03856 DESCRIPT Bacteriocin leucocin A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03856 GENEFORM Protein DME1303 XEOTICID XEO03856 MOACRIVE Inhibition DME1303 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1303 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03904 XEO_CLAS Peptide DME1303 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.25 ug/ml) DME1303 XEOTICID XEO03904 GENEFORM Protein DME1303 XEOTICID XEO03904 MOACRIVE Inhibition DME1303 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1303 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03905 XEO_CLAS Peptide DME1303 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 0.5 ug/ml) DME1303 XEOTICID XEO03905 GENEFORM Protein DME1303 XEOTICID XEO03905 MOACRIVE Inhibition DME1303 XEOTICID XEO03913 XEO_NAME Listeriocin 743A DME1303 XEOTICID XEO03913 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03913 XEO_CLAS Peptide DME1303 XEOTICID XEO03913 DESCRIPT Listeriocin 743A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO03913 GENEFORM Protein DME1303 XEOTICID XEO03913 MOACRIVE Inhibition DME1303 XEOTICID XEO03990 XEO_NAME Manduca sexta moricin DME1303 XEOTICID XEO03990 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO03990 XEO_CLAS Peptide DME1303 XEOTICID XEO03990 DESCRIPT Manduca sexta moricin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 6.25 ug/ml) DME1303 XEOTICID XEO03990 GENEFORM Protein DME1303 XEOTICID XEO03990 MOACRIVE Inhibition DME1303 XEOTICID XEO04070 XEO_NAME Mesentericin Y105 DME1303 XEOTICID XEO04070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04070 XEO_CLAS Peptide DME1303 XEOTICID XEO04070 DESCRIPT Mesentericin Y105 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04070 GENEFORM Protein DME1303 XEOTICID XEO04070 MOACRIVE Inhibition DME1303 XEOTICID XEO04150 XEO_NAME Mundticin ATO6 DME1303 XEOTICID XEO04150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04150 XEO_CLAS Peptide DME1303 XEOTICID XEO04150 DESCRIPT Mundticin ATO6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04150 GENEFORM Protein DME1303 XEOTICID XEO04150 MOACRIVE Inhibition DME1303 XEOTICID XEO04151 XEO_NAME Mundticin KS DME1303 XEOTICID XEO04151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04151 XEO_CLAS Peptide DME1303 XEOTICID XEO04151 DESCRIPT Mundticin KS inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04151 GENEFORM Protein DME1303 XEOTICID XEO04151 MOACRIVE Inhibition DME1303 XEOTICID XEO04156 XEO_NAME Mutacin II mutacin H-29B DME1303 XEOTICID XEO04156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04156 XEO_CLAS Peptide DME1303 XEOTICID XEO04156 DESCRIPT Mutacin II mutacin H-29B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04156 GENEFORM Protein DME1303 XEOTICID XEO04156 MOACRIVE Inhibition DME1303 XEOTICID XEO04172 XEO_NAME Myxinidin DME1303 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04172 XEO_CLAS Peptide DME1303 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04172 GENEFORM Protein DME1303 XEOTICID XEO04172 MOACRIVE Inhibition DME1303 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1303 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04260 XEO_CLAS Peptide DME1303 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04260 GENEFORM Protein DME1303 XEOTICID XEO04260 MOACRIVE Inhibition DME1303 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1303 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04263 XEO_CLAS Peptide DME1303 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04263 GENEFORM Protein DME1303 XEOTICID XEO04263 MOACRIVE Inhibition DME1303 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1303 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04266 XEO_CLAS Peptide DME1303 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04266 GENEFORM Protein DME1303 XEOTICID XEO04266 MOACRIVE Inhibition DME1303 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1303 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04269 XEO_CLAS Peptide DME1303 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04269 GENEFORM Protein DME1303 XEOTICID XEO04269 MOACRIVE Inhibition DME1303 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1303 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04270 XEO_CLAS Peptide DME1303 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04270 GENEFORM Protein DME1303 XEOTICID XEO04270 MOACRIVE Inhibition DME1303 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1303 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04271 XEO_CLAS Peptide DME1303 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04271 GENEFORM Protein DME1303 XEOTICID XEO04271 MOACRIVE Inhibition DME1303 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1303 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04272 XEO_CLAS Peptide DME1303 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04272 GENEFORM Protein DME1303 XEOTICID XEO04272 MOACRIVE Inhibition DME1303 XEOTICID XEO04333 XEO_NAME Novispirin G-10 DME1303 XEOTICID XEO04333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04333 XEO_CLAS Peptide DME1303 XEOTICID XEO04333 DESCRIPT Novispirin G-10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 1.4 ug/ml) DME1303 XEOTICID XEO04333 GENEFORM Protein DME1303 XEOTICID XEO04333 MOACRIVE Inhibition DME1303 XEOTICID XEO04334 XEO_NAME Novispirin T-7 DME1303 XEOTICID XEO04334 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04334 XEO_CLAS Peptide DME1303 XEOTICID XEO04334 DESCRIPT Novispirin T-7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 2.4 ug/ml) DME1303 XEOTICID XEO04334 GENEFORM Protein DME1303 XEOTICID XEO04334 MOACRIVE Inhibition DME1303 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1303 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04399 XEO_CLAS Peptide DME1303 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 12.5 microM) DME1303 XEOTICID XEO04399 GENEFORM Protein DME1303 XEOTICID XEO04399 MOACRIVE Inhibition DME1303 XEOTICID XEO04416 XEO_NAME Ovispirin-1 DME1303 XEOTICID XEO04416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04416 XEO_CLAS Peptide DME1303 XEOTICID XEO04416 DESCRIPT Ovispirin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 1.5 ug/ml) DME1303 XEOTICID XEO04416 GENEFORM Protein DME1303 XEOTICID XEO04416 MOACRIVE Inhibition DME1303 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1303 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04471 XEO_CLAS Peptide DME1303 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 6.3 microM) DME1303 XEOTICID XEO04471 GENEFORM Protein DME1303 XEOTICID XEO04471 MOACRIVE Inhibition DME1303 XEOTICID XEO04481 XEO_NAME Porcine beta-defensin pBD-2 DME1303 XEOTICID XEO04481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04481 XEO_CLAS Peptide DME1303 XEOTICID XEO04481 DESCRIPT Porcine beta-defensin pBD-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04481 GENEFORM Protein DME1303 XEOTICID XEO04481 MOACRIVE Inhibition DME1303 XEOTICID XEO04501 XEO_NAME Pediocin PA-1 DME1303 XEOTICID XEO04501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04501 XEO_CLAS Peptide DME1303 XEOTICID XEO04501 DESCRIPT Pediocin PA-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04501 GENEFORM Protein DME1303 XEOTICID XEO04501 MOACRIVE Inhibition DME1303 XEOTICID XEO04521 XEO_NAME Penocin A DME1303 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04521 XEO_CLAS Peptide DME1303 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04521 GENEFORM Protein DME1303 XEOTICID XEO04521 MOACRIVE Inhibition DME1303 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1303 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04552 XEO_CLAS Peptide DME1303 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04552 GENEFORM Protein DME1303 XEOTICID XEO04552 MOACRIVE Inhibition DME1303 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1303 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04553 XEO_CLAS Peptide DME1303 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04553 GENEFORM Protein DME1303 XEOTICID XEO04553 MOACRIVE Inhibition DME1303 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1303 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04554 XEO_CLAS Peptide DME1303 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04554 GENEFORM Protein DME1303 XEOTICID XEO04554 MOACRIVE Inhibition DME1303 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1303 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04565 XEO_CLAS Peptide DME1303 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 1.6 microM) DME1303 XEOTICID XEO04565 GENEFORM Protein DME1303 XEOTICID XEO04565 MOACRIVE Inhibition DME1303 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1303 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04566 XEO_CLAS Peptide DME1303 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 1.5 microM) DME1303 XEOTICID XEO04566 GENEFORM Protein DME1303 XEOTICID XEO04566 MOACRIVE Inhibition DME1303 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1303 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04612 XEO_CLAS Peptide DME1303 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 2.5-5 microM) DME1303 XEOTICID XEO04612 GENEFORM Protein DME1303 XEOTICID XEO04612 MOACRIVE Inhibition DME1303 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1303 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04613 XEO_CLAS Peptide DME1303 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 2.5-5 microM) DME1303 XEOTICID XEO04613 GENEFORM Protein DME1303 XEOTICID XEO04613 MOACRIVE Inhibition DME1303 XEOTICID XEO04622 XEO_NAME Plantaricin W alpha DME1303 XEOTICID XEO04622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04622 XEO_CLAS Peptide DME1303 XEOTICID XEO04622 DESCRIPT Plantaricin W alpha inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04622 GENEFORM Protein DME1303 XEOTICID XEO04622 MOACRIVE Inhibition DME1303 XEOTICID XEO04623 XEO_NAME Plantaricin W beta DME1303 XEOTICID XEO04623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04623 XEO_CLAS Peptide DME1303 XEOTICID XEO04623 DESCRIPT Plantaricin W beta inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04623 GENEFORM Protein DME1303 XEOTICID XEO04623 MOACRIVE Inhibition DME1303 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1303 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04695 XEO_CLAS Peptide DME1303 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04695 GENEFORM Protein DME1303 XEOTICID XEO04695 MOACRIVE Inhibition DME1303 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1303 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04696 XEO_CLAS Peptide DME1303 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04696 GENEFORM Protein DME1303 XEOTICID XEO04696 MOACRIVE Inhibition DME1303 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1303 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04698 XEO_CLAS Peptide DME1303 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04698 GENEFORM Protein DME1303 XEOTICID XEO04698 MOACRIVE Inhibition DME1303 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1303 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04699 XEO_CLAS Peptide DME1303 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04699 GENEFORM Protein DME1303 XEOTICID XEO04699 MOACRIVE Inhibition DME1303 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1303 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04700 XEO_CLAS Peptide DME1303 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04700 GENEFORM Protein DME1303 XEOTICID XEO04700 MOACRIVE Inhibition DME1303 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1303 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04701 XEO_CLAS Peptide DME1303 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04701 GENEFORM Protein DME1303 XEOTICID XEO04701 MOACRIVE Inhibition DME1303 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1303 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04702 XEO_CLAS Peptide DME1303 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04702 GENEFORM Protein DME1303 XEOTICID XEO04702 MOACRIVE Inhibition DME1303 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1303 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04703 XEO_CLAS Peptide DME1303 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04703 GENEFORM Protein DME1303 XEOTICID XEO04703 MOACRIVE Inhibition DME1303 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1303 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04704 XEO_CLAS Peptide DME1303 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04704 GENEFORM Protein DME1303 XEOTICID XEO04704 MOACRIVE Inhibition DME1303 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1303 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04725 XEO_CLAS Peptide DME1303 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04725 GENEFORM Protein DME1303 XEOTICID XEO04725 MOACRIVE Inhibition DME1303 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1303 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04726 XEO_CLAS Peptide DME1303 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04726 GENEFORM Protein DME1303 XEOTICID XEO04726 MOACRIVE Inhibition DME1303 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1303 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04848 XEO_CLAS Peptide DME1303 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04848 GENEFORM Protein DME1303 XEOTICID XEO04848 MOACRIVE Inhibition DME1303 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1303 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04849 XEO_CLAS Peptide DME1303 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04849 GENEFORM Protein DME1303 XEOTICID XEO04849 MOACRIVE Inhibition DME1303 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1303 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04850 XEO_CLAS Peptide DME1303 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04850 GENEFORM Protein DME1303 XEOTICID XEO04850 MOACRIVE Inhibition DME1303 XEOTICID XEO04897 XEO_NAME Sakacin G DME1303 XEOTICID XEO04897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04897 XEO_CLAS Peptide DME1303 XEOTICID XEO04897 DESCRIPT Sakacin G inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04897 GENEFORM Protein DME1303 XEOTICID XEO04897 MOACRIVE Inhibition DME1303 XEOTICID XEO04898 XEO_NAME Sakacin P DME1303 XEOTICID XEO04898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04898 XEO_CLAS Peptide DME1303 XEOTICID XEO04898 DESCRIPT Sakacin P inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO04898 GENEFORM Protein DME1303 XEOTICID XEO04898 MOACRIVE Inhibition DME1303 XEOTICID XEO04960 XEO_NAME Snakin-1 StSN1 DME1303 XEOTICID XEO04960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04960 XEO_CLAS Peptide DME1303 XEOTICID XEO04960 DESCRIPT Snakin-1 StSN1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 10 ug/ml) DME1303 XEOTICID XEO04960 GENEFORM Protein DME1303 XEOTICID XEO04960 MOACRIVE Inhibition DME1303 XEOTICID XEO04965 XEO_NAME Plant defensin SolyC DME1303 XEOTICID XEO04965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04965 XEO_CLAS Peptide DME1303 XEOTICID XEO04965 DESCRIPT Plant defensin SolyC inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 40 ug/ml) DME1303 XEOTICID XEO04965 GENEFORM Protein DME1303 XEOTICID XEO04965 MOACRIVE Inhibition DME1303 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1303 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04971 XEO_CLAS Peptide DME1303 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 6-12 microM) DME1303 XEOTICID XEO04971 GENEFORM Protein DME1303 XEOTICID XEO04971 MOACRIVE Inhibition DME1303 XEOTICID XEO04998 XEO_NAME Styelin A DME1303 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04998 XEO_CLAS Peptide DME1303 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 2 ug/ml) DME1303 XEOTICID XEO04998 GENEFORM Protein DME1303 XEOTICID XEO04998 MOACRIVE Inhibition DME1303 XEOTICID XEO04999 XEO_NAME Styelin B DME1303 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO04999 XEO_CLAS Peptide DME1303 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes (MIC = 2 ug/ml) DME1303 XEOTICID XEO04999 GENEFORM Protein DME1303 XEOTICID XEO04999 MOACRIVE Inhibition DME1303 XEOTICID XEO05008 XEO_NAME Subtilosin DME1303 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO05008 XEO_CLAS Peptide DME1303 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO05008 GENEFORM Protein DME1303 XEOTICID XEO05008 MOACRIVE Inhibition DME1303 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1303 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO05033 XEO_CLAS Peptide DME1303 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO05033 GENEFORM Protein DME1303 XEOTICID XEO05033 MOACRIVE Inhibition DME1303 XEOTICID XEO05132 XEO_NAME Thermophilin 13 chain ThmA DME1303 XEOTICID XEO05132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO05132 XEO_CLAS Peptide DME1303 XEOTICID XEO05132 DESCRIPT Thermophilin 13 chain ThmA inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO05132 GENEFORM Protein DME1303 XEOTICID XEO05132 MOACRIVE Inhibition DME1303 XEOTICID XEO05133 XEO_NAME Thermophilin 13 chain ThmB DME1303 XEOTICID XEO05133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO05133 XEO_CLAS Peptide DME1303 XEOTICID XEO05133 DESCRIPT Thermophilin 13 chain ThmB inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO05133 GENEFORM Protein DME1303 XEOTICID XEO05133 MOACRIVE Inhibition DME1303 XEOTICID XEO05136 XEO_NAME Thuricin CDalpha DME1303 XEOTICID XEO05136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO05136 XEO_CLAS Peptide DME1303 XEOTICID XEO05136 DESCRIPT Thuricin CDalpha inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO05136 GENEFORM Protein DME1303 XEOTICID XEO05136 MOACRIVE Inhibition DME1303 XEOTICID XEO05137 XEO_NAME Thuricin CDdbeta DME1303 XEOTICID XEO05137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO05137 XEO_CLAS Peptide DME1303 XEOTICID XEO05137 DESCRIPT Thuricin CDdbeta inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO05137 GENEFORM Protein DME1303 XEOTICID XEO05137 MOACRIVE Inhibition DME1303 XEOTICID XEO05138 XEO_NAME Thuricin-17 DME1303 XEOTICID XEO05138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO05138 XEO_CLAS Peptide DME1303 XEOTICID XEO05138 DESCRIPT Thuricin-17 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO05138 GENEFORM Protein DME1303 XEOTICID XEO05138 MOACRIVE Inhibition DME1303 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1303 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO05139 XEO_CLAS Peptide DME1303 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO05139 GENEFORM Protein DME1303 XEOTICID XEO05139 MOACRIVE Inhibition DME1303 XEOTICID XEO05228 XEO_NAME Variacin DME1303 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO05228 XEO_CLAS Peptide DME1303 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO05228 GENEFORM Protein DME1303 XEOTICID XEO05228 MOACRIVE Inhibition DME1303 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1303 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1303 XEOTICID XEO05283 XEO_CLAS Peptide DME1303 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Listeria monocytogenes DME1303 XEOTICID XEO05283 GENEFORM Protein DME1303 XEOTICID XEO05283 MOACRIVE Inhibition DME1304 DME___ID DME1304 DME1304 DME_NAME Glutamate decarboxylase (gadB) DME1304 SPESNAME Escherichia coli DME1304 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1304 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00117 GENEFORM Protein DME1304 XEOTICID XEO00117 MOACRIVE Inhibition DME1304 XEOTICID XEO00122 XEO_NAME Amikacin DME1304 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00122 GENEFORM Protein DME1304 XEOTICID XEO00122 MOACRIVE Inhibition DME1304 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1304 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00136 GENEFORM Protein DME1304 XEOTICID XEO00136 MOACRIVE Inhibition DME1304 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1304 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00237 GENEFORM Protein DME1304 XEOTICID XEO00237 MOACRIVE Inhibition DME1304 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1304 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00349 GENEFORM Protein DME1304 XEOTICID XEO00349 MOACRIVE Inhibition DME1304 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1304 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00425 GENEFORM Protein DME1304 XEOTICID XEO00425 MOACRIVE Inhibition DME1304 XEOTICID XEO00439 XEO_NAME Daidzein DME1304 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00439 GENEFORM Protein DME1304 XEOTICID XEO00439 MOACRIVE Inhibition DME1304 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1304 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00460 GENEFORM Protein DME1304 XEOTICID XEO00460 MOACRIVE Inhibition DME1304 XEOTICID XEO00487 XEO_NAME Thymol DME1304 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00487 GENEFORM Protein DME1304 XEOTICID XEO00487 MOACRIVE Inhibition DME1304 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1304 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00511 GENEFORM Protein DME1304 XEOTICID XEO00511 MOACRIVE Inhibition DME1304 XEOTICID XEO00537 XEO_NAME Luteolin DME1304 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1304 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00537 GENEFORM Protein DME1304 XEOTICID XEO00537 MOACRIVE Inhibition DME1304 XEOTICID XEO00538 XEO_NAME Quercetin DME1304 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1304 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00538 GENEFORM Protein DME1304 XEOTICID XEO00538 MOACRIVE Inhibition DME1304 XEOTICID XEO00547 XEO_NAME Vitamin E DME1304 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1304 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00547 GENEFORM Protein DME1304 XEOTICID XEO00547 MOACRIVE Inhibition DME1304 XEOTICID XEO00557 XEO_NAME Genistein DME1304 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1304 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00557 GENEFORM Protein DME1304 XEOTICID XEO00557 MOACRIVE Inhibition DME1304 XEOTICID XEO00566 XEO_NAME Guaiacol DME1304 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1304 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00566 GENEFORM Protein DME1304 XEOTICID XEO00566 MOACRIVE Inhibition DME1304 XEOTICID XEO00568 XEO_NAME Resveratrol DME1304 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1304 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00568 GENEFORM Protein DME1304 XEOTICID XEO00568 MOACRIVE Inhibition DME1304 XEOTICID XEO00573 XEO_NAME Naringenin DME1304 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1304 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00573 GENEFORM Protein DME1304 XEOTICID XEO00573 MOACRIVE Inhibition DME1304 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1304 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1304 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00574 GENEFORM Protein DME1304 XEOTICID XEO00574 MOACRIVE Inhibition DME1304 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1304 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1304 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00611 GENEFORM Protein DME1304 XEOTICID XEO00611 MOACRIVE Inhibition DME1304 XEOTICID XEO00621 XEO_NAME Chitosan DME1304 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1304 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00621 GENEFORM Protein DME1304 XEOTICID XEO00621 MOACRIVE Inhibition DME1304 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1304 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1304 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00646 GENEFORM Protein DME1304 XEOTICID XEO00646 MOACRIVE Inhibition DME1304 XEOTICID XEO00683 XEO_NAME Curcumin DME1304 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1304 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00683 GENEFORM Protein DME1304 XEOTICID XEO00683 MOACRIVE Inhibition DME1304 XEOTICID XEO00727 XEO_NAME Vanillin DME1304 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1304 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00727 GENEFORM Protein DME1304 XEOTICID XEO00727 MOACRIVE Inhibition DME1304 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1304 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1304 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00730 GENEFORM Protein DME1304 XEOTICID XEO00730 MOACRIVE Inhibition DME1304 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1304 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO00782 XEO_CLAS Natural Product DME1304 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00782 GENEFORM Protein DME1304 XEOTICID XEO00782 MOACRIVE Inhibition DME1304 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1304 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1304 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00866 GENEFORM Protein DME1304 XEOTICID XEO00866 MOACRIVE Inhibition DME1304 XEOTICID XEO00878 XEO_NAME Chrysin DME1304 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO00878 XEO_CLAS Natural Product DME1304 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00878 GENEFORM Protein DME1304 XEOTICID XEO00878 MOACRIVE Inhibition DME1304 XEOTICID XEO00879 XEO_NAME Coumarin DME1304 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1304 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1304 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00879 GENEFORM Protein DME1304 XEOTICID XEO00879 MOACRIVE Inhibition DME1304 XEOTICID XEO00883 XEO_NAME Phloretin DME1304 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO00883 XEO_CLAS Natural Product DME1304 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00883 GENEFORM Protein DME1304 XEOTICID XEO00883 MOACRIVE Inhibition DME1304 XEOTICID XEO00885 XEO_NAME Eugenol DME1304 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1304 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO00885 GENEFORM Protein DME1304 XEOTICID XEO00885 MOACRIVE Inhibition DME1304 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1304 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1304 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1304 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01032 GENEFORM Protein DME1304 XEOTICID XEO01032 MOACRIVE Inhibition DME1304 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1304 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01174 XEO_CLAS Natural Product DME1304 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01174 GENEFORM Protein DME1304 XEOTICID XEO01174 MOACRIVE Inhibition DME1304 XEOTICID XEO01203 XEO_NAME Apigenin DME1304 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01203 XEO_CLAS Natural Product DME1304 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01203 GENEFORM Protein DME1304 XEOTICID XEO01203 MOACRIVE Inhibition DME1304 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1304 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1304 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1304 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01232 GENEFORM Protein DME1304 XEOTICID XEO01232 MOACRIVE Inhibition DME1304 XEOTICID XEO01237 XEO_NAME Carvacrol DME1304 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1304 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01237 GENEFORM Protein DME1304 XEOTICID XEO01237 MOACRIVE Inhibition DME1304 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1304 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1304 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01287 GENEFORM Protein DME1304 XEOTICID XEO01287 MOACRIVE Inhibition DME1304 XEOTICID XEO01291 XEO_NAME Esculetin DME1304 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1304 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01291 GENEFORM Protein DME1304 XEOTICID XEO01291 MOACRIVE Inhibition DME1304 XEOTICID XEO01304 XEO_NAME Flavone DME1304 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01304 XEO_CLAS Natural Product DME1304 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01304 GENEFORM Protein DME1304 XEOTICID XEO01304 MOACRIVE Inhibition DME1304 XEOTICID XEO01309 XEO_NAME Gallic acid DME1304 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01309 XEO_CLAS Natural Product DME1304 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01309 GENEFORM Protein DME1304 XEOTICID XEO01309 MOACRIVE Inhibition DME1304 XEOTICID XEO01340 XEO_NAME Imperatorin DME1304 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01340 XEO_CLAS Natural Product DME1304 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01340 GENEFORM Protein DME1304 XEOTICID XEO01340 MOACRIVE Inhibition DME1304 XEOTICID XEO01353 XEO_NAME Kaempferol DME1304 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1304 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1304 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01353 GENEFORM Protein DME1304 XEOTICID XEO01353 MOACRIVE Inhibition DME1304 XEOTICID XEO01366 XEO_NAME Linalool DME1304 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01366 XEO_CLAS Natural Product DME1304 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01366 GENEFORM Protein DME1304 XEOTICID XEO01366 MOACRIVE Inhibition DME1304 XEOTICID XEO01391 XEO_NAME Naringin DME1304 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01391 XEO_CLAS Natural Product DME1304 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01391 GENEFORM Protein DME1304 XEOTICID XEO01391 MOACRIVE Inhibition DME1304 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1304 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1304 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01420 GENEFORM Protein DME1304 XEOTICID XEO01420 MOACRIVE Inhibition DME1304 XEOTICID XEO01463 XEO_NAME Rutin DME1304 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01463 XEO_CLAS Natural Product DME1304 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01463 GENEFORM Protein DME1304 XEOTICID XEO01463 MOACRIVE Inhibition DME1304 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1304 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1304 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01496 GENEFORM Protein DME1304 XEOTICID XEO01496 MOACRIVE Inhibition DME1304 XEOTICID XEO01512 XEO_NAME Zinc DME1304 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1304 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1304 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01512 GENEFORM Protein DME1304 XEOTICID XEO01512 MOACRIVE Inhibition DME1304 XEOTICID XEO01527 XEO_NAME Bergamottin DME1304 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01527 XEO_CLAS Natural Product DME1304 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01527 GENEFORM Protein DME1304 XEOTICID XEO01527 MOACRIVE Inhibition DME1304 XEOTICID XEO01531 XEO_NAME Clove oil DME1304 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01531 XEO_CLAS Natural Product DME1304 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01531 GENEFORM Protein DME1304 XEOTICID XEO01531 MOACRIVE Inhibition DME1304 XEOTICID XEO01559 XEO_NAME Limonene DME1304 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01559 XEO_CLAS Natural Product DME1304 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01559 GENEFORM Protein DME1304 XEOTICID XEO01559 MOACRIVE Inhibition DME1304 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1304 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01563 XEO_CLAS Natural Product DME1304 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01563 GENEFORM Protein DME1304 XEOTICID XEO01563 MOACRIVE Inhibition DME1304 XEOTICID XEO01566 XEO_NAME Nobiletin DME1304 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01566 XEO_CLAS Natural Product DME1304 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01566 GENEFORM Protein DME1304 XEOTICID XEO01566 MOACRIVE Inhibition DME1304 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1304 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01778 XEO_CLAS Natural Product DME1304 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01778 GENEFORM Protein DME1304 XEOTICID XEO01778 MOACRIVE Inhibition DME1304 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1304 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01779 XEO_CLAS Peptide DME1304 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 128 microM) DME1304 XEOTICID XEO01779 GENEFORM Protein DME1304 XEOTICID XEO01779 MOACRIVE Inhibition DME1304 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1304 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01810 XEO_CLAS Peptide DME1304 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.0 microM) DME1304 XEOTICID XEO01810 GENEFORM Protein DME1304 XEOTICID XEO01810 MOACRIVE Inhibition DME1304 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1304 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01811 XEO_CLAS Peptide DME1304 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 microM) DME1304 XEOTICID XEO01811 GENEFORM Protein DME1304 XEOTICID XEO01811 MOACRIVE Inhibition DME1304 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1304 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01812 XEO_CLAS Peptide DME1304 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10.4 microM) DME1304 XEOTICID XEO01812 GENEFORM Protein DME1304 XEOTICID XEO01812 MOACRIVE Inhibition DME1304 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1304 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01813 XEO_CLAS Peptide DME1304 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.1 microM) DME1304 XEOTICID XEO01813 GENEFORM Protein DME1304 XEOTICID XEO01813 MOACRIVE Inhibition DME1304 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1304 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01814 XEO_CLAS Peptide DME1304 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.5 microM) DME1304 XEOTICID XEO01814 GENEFORM Protein DME1304 XEOTICID XEO01814 MOACRIVE Inhibition DME1304 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1304 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01815 XEO_CLAS Peptide DME1304 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 9.8 microM) DME1304 XEOTICID XEO01815 GENEFORM Protein DME1304 XEOTICID XEO01815 MOACRIVE Inhibition DME1304 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1304 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01816 XEO_CLAS Peptide DME1304 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO01816 GENEFORM Protein DME1304 XEOTICID XEO01816 MOACRIVE Inhibition DME1304 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1304 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01817 XEO_CLAS Peptide DME1304 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.0 microM) DME1304 XEOTICID XEO01817 GENEFORM Protein DME1304 XEOTICID XEO01817 MOACRIVE Inhibition DME1304 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1304 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01818 XEO_CLAS Peptide DME1304 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4.0 microM) DME1304 XEOTICID XEO01818 GENEFORM Protein DME1304 XEOTICID XEO01818 MOACRIVE Inhibition DME1304 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1304 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01819 XEO_CLAS Peptide DME1304 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO01819 GENEFORM Protein DME1304 XEOTICID XEO01819 MOACRIVE Inhibition DME1304 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1304 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01820 XEO_CLAS Peptide DME1304 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO01820 GENEFORM Protein DME1304 XEOTICID XEO01820 MOACRIVE Inhibition DME1304 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1304 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01821 XEO_CLAS Peptide DME1304 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO01821 GENEFORM Protein DME1304 XEOTICID XEO01821 MOACRIVE Inhibition DME1304 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1304 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01822 XEO_CLAS Peptide DME1304 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 microM) DME1304 XEOTICID XEO01822 GENEFORM Protein DME1304 XEOTICID XEO01822 MOACRIVE Inhibition DME1304 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1304 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01823 XEO_CLAS Peptide DME1304 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO01823 GENEFORM Protein DME1304 XEOTICID XEO01823 MOACRIVE Inhibition DME1304 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1304 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01824 XEO_CLAS Peptide DME1304 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO01824 GENEFORM Protein DME1304 XEOTICID XEO01824 MOACRIVE Inhibition DME1304 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1304 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01825 XEO_CLAS Peptide DME1304 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25.0 microM) DME1304 XEOTICID XEO01825 GENEFORM Protein DME1304 XEOTICID XEO01825 MOACRIVE Inhibition DME1304 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1304 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01827 XEO_CLAS Peptide DME1304 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.12-6.25 microM) DME1304 XEOTICID XEO01827 GENEFORM Protein DME1304 XEOTICID XEO01827 MOACRIVE Inhibition DME1304 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1304 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1304 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1304 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01829 GENEFORM Protein DME1304 XEOTICID XEO01829 MOACRIVE Inhibition DME1304 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1304 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01927 XEO_CLAS Peptide DME1304 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 ug/ml) DME1304 XEOTICID XEO01927 GENEFORM Protein DME1304 XEOTICID XEO01927 MOACRIVE Inhibition DME1304 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1304 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01945 XEO_CLAS Peptide DME1304 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.1 microM) DME1304 XEOTICID XEO01945 GENEFORM Protein DME1304 XEOTICID XEO01945 MOACRIVE Inhibition DME1304 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1304 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01946 XEO_CLAS Peptide DME1304 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.2 microM) DME1304 XEOTICID XEO01946 GENEFORM Protein DME1304 XEOTICID XEO01946 MOACRIVE Inhibition DME1304 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1304 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO01947 XEO_CLAS Natural Product DME1304 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01947 GENEFORM Protein DME1304 XEOTICID XEO01947 MOACRIVE Inhibition DME1304 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1304 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1304 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1304 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01950 GENEFORM Protein DME1304 XEOTICID XEO01950 MOACRIVE Inhibition DME1304 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1304 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1304 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1304 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01961 GENEFORM Protein DME1304 XEOTICID XEO01961 MOACRIVE Inhibition DME1304 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1304 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1304 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1304 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO01966 GENEFORM Protein DME1304 XEOTICID XEO01966 MOACRIVE Inhibition DME1304 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1304 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01996 XEO_CLAS Peptide DME1304 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.7 microM) DME1304 XEOTICID XEO01996 GENEFORM Protein DME1304 XEOTICID XEO01996 MOACRIVE Inhibition DME1304 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1304 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01997 XEO_CLAS Peptide DME1304 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.9 microM) DME1304 XEOTICID XEO01997 GENEFORM Protein DME1304 XEOTICID XEO01997 MOACRIVE Inhibition DME1304 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1304 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01998 XEO_CLAS Peptide DME1304 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO01998 GENEFORM Protein DME1304 XEOTICID XEO01998 MOACRIVE Inhibition DME1304 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1304 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO01999 XEO_CLAS Peptide DME1304 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.5 microM) DME1304 XEOTICID XEO01999 GENEFORM Protein DME1304 XEOTICID XEO01999 MOACRIVE Inhibition DME1304 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1304 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02013 XEO_CLAS Peptide DME1304 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02013 GENEFORM Protein DME1304 XEOTICID XEO02013 MOACRIVE Inhibition DME1304 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1304 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02032 XEO_CLAS Natural Product DME1304 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02032 GENEFORM Protein DME1304 XEOTICID XEO02032 MOACRIVE Inhibition DME1304 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1304 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02033 XEO_CLAS Natural Product DME1304 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02033 GENEFORM Protein DME1304 XEOTICID XEO02033 MOACRIVE Inhibition DME1304 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1304 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02079 XEO_CLAS Natural Product DME1304 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02079 GENEFORM Protein DME1304 XEOTICID XEO02079 MOACRIVE Inhibition DME1304 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1304 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1304 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02085 GENEFORM Protein DME1304 XEOTICID XEO02085 MOACRIVE Inhibition DME1304 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1304 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02111 XEO_CLAS Peptide DME1304 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2-4 ug/ml) DME1304 XEOTICID XEO02111 GENEFORM Protein DME1304 XEOTICID XEO02111 MOACRIVE Inhibition DME1304 XEOTICID XEO02113 XEO_NAME Abaecin DME1304 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02113 XEO_CLAS Peptide DME1304 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02113 GENEFORM Protein DME1304 XEOTICID XEO02113 MOACRIVE Inhibition DME1304 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1304 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02114 XEO_CLAS Peptide DME1304 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-25 ug/ml) DME1304 XEOTICID XEO02114 GENEFORM Protein DME1304 XEOTICID XEO02114 MOACRIVE Inhibition DME1304 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1304 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02115 XEO_CLAS Peptide DME1304 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02115 GENEFORM Protein DME1304 XEOTICID XEO02115 MOACRIVE Inhibition DME1304 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1304 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02117 XEO_CLAS Peptide DME1304 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02117 GENEFORM Protein DME1304 XEOTICID XEO02117 MOACRIVE Inhibition DME1304 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1304 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02118 XEO_CLAS Peptide DME1304 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02118 GENEFORM Protein DME1304 XEOTICID XEO02118 MOACRIVE Inhibition DME1304 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1304 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02119 XEO_CLAS Peptide DME1304 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02119 GENEFORM Protein DME1304 XEOTICID XEO02119 MOACRIVE Inhibition DME1304 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1304 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02120 XEO_CLAS Peptide DME1304 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02120 GENEFORM Protein DME1304 XEOTICID XEO02120 MOACRIVE Inhibition DME1304 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1304 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02121 XEO_CLAS Peptide DME1304 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02121 GENEFORM Protein DME1304 XEOTICID XEO02121 MOACRIVE Inhibition DME1304 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1304 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02122 XEO_CLAS Peptide DME1304 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 ug/ml) DME1304 XEOTICID XEO02122 GENEFORM Protein DME1304 XEOTICID XEO02122 MOACRIVE Inhibition DME1304 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1304 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02130 XEO_CLAS Peptide DME1304 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.7 microM) DME1304 XEOTICID XEO02130 GENEFORM Protein DME1304 XEOTICID XEO02130 MOACRIVE Inhibition DME1304 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1304 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02131 XEO_CLAS Peptide DME1304 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.3 microM) DME1304 XEOTICID XEO02131 GENEFORM Protein DME1304 XEOTICID XEO02131 MOACRIVE Inhibition DME1304 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1304 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02132 XEO_CLAS Peptide DME1304 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.5 microM) DME1304 XEOTICID XEO02132 GENEFORM Protein DME1304 XEOTICID XEO02132 MOACRIVE Inhibition DME1304 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1304 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02136 XEO_CLAS Peptide DME1304 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 ug/ml) DME1304 XEOTICID XEO02136 GENEFORM Protein DME1304 XEOTICID XEO02136 MOACRIVE Inhibition DME1304 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1304 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02147 XEO_CLAS Peptide DME1304 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 382 ug/ml) DME1304 XEOTICID XEO02147 GENEFORM Protein DME1304 XEOTICID XEO02147 MOACRIVE Inhibition DME1304 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1304 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02149 XEO_CLAS Peptide DME1304 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 47.35 microM) DME1304 XEOTICID XEO02149 GENEFORM Protein DME1304 XEOTICID XEO02149 MOACRIVE Inhibition DME1304 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1304 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02164 XEO_CLAS Peptide DME1304 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02164 GENEFORM Protein DME1304 XEOTICID XEO02164 MOACRIVE Inhibition DME1304 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1304 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02165 XEO_CLAS Peptide DME1304 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02165 GENEFORM Protein DME1304 XEOTICID XEO02165 MOACRIVE Inhibition DME1304 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1304 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02166 XEO_CLAS Peptide DME1304 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02166 GENEFORM Protein DME1304 XEOTICID XEO02166 MOACRIVE Inhibition DME1304 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1304 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02167 XEO_CLAS Peptide DME1304 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02167 GENEFORM Protein DME1304 XEOTICID XEO02167 MOACRIVE Inhibition DME1304 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1304 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02168 XEO_CLAS Peptide DME1304 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02168 GENEFORM Protein DME1304 XEOTICID XEO02168 MOACRIVE Inhibition DME1304 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1304 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02169 XEO_CLAS Peptide DME1304 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02169 GENEFORM Protein DME1304 XEOTICID XEO02169 MOACRIVE Inhibition DME1304 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1304 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02170 XEO_CLAS Peptide DME1304 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.4 microM) DME1304 XEOTICID XEO02170 GENEFORM Protein DME1304 XEOTICID XEO02170 MOACRIVE Inhibition DME1304 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1304 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02175 XEO_CLAS Natural Product DME1304 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02175 GENEFORM Protein DME1304 XEOTICID XEO02175 MOACRIVE Inhibition DME1304 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1304 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02177 XEO_CLAS Peptide DME1304 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO02177 GENEFORM Protein DME1304 XEOTICID XEO02177 MOACRIVE Inhibition DME1304 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1304 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02178 XEO_CLAS Peptide DME1304 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO02178 GENEFORM Protein DME1304 XEOTICID XEO02178 MOACRIVE Inhibition DME1304 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1304 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02179 XEO_CLAS Peptide DME1304 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO02179 GENEFORM Protein DME1304 XEOTICID XEO02179 MOACRIVE Inhibition DME1304 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1304 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02180 XEO_CLAS Peptide DME1304 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 214 microM) DME1304 XEOTICID XEO02180 GENEFORM Protein DME1304 XEOTICID XEO02180 MOACRIVE Inhibition DME1304 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1304 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02181 XEO_CLAS Peptide DME1304 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 217 microM) DME1304 XEOTICID XEO02181 GENEFORM Protein DME1304 XEOTICID XEO02181 MOACRIVE Inhibition DME1304 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1304 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02183 XEO_CLAS Peptide DME1304 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 38.4 microM) DME1304 XEOTICID XEO02183 GENEFORM Protein DME1304 XEOTICID XEO02183 MOACRIVE Inhibition DME1304 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1304 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02185 XEO_CLAS Peptide DME1304 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 microM) DME1304 XEOTICID XEO02185 GENEFORM Protein DME1304 XEOTICID XEO02185 MOACRIVE Inhibition DME1304 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1304 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02187 GENEFORM Protein DME1304 XEOTICID XEO02187 MOACRIVE Inhibition DME1304 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1304 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02191 XEO_CLAS Peptide DME1304 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02191 GENEFORM Protein DME1304 XEOTICID XEO02191 MOACRIVE Inhibition DME1304 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1304 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02192 XEO_CLAS Peptide DME1304 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.50 ug/ml) DME1304 XEOTICID XEO02192 GENEFORM Protein DME1304 XEOTICID XEO02192 MOACRIVE Inhibition DME1304 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1304 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02193 XEO_CLAS Peptide DME1304 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02193 GENEFORM Protein DME1304 XEOTICID XEO02193 MOACRIVE Inhibition DME1304 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1304 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02194 XEO_CLAS Peptide DME1304 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02194 GENEFORM Protein DME1304 XEOTICID XEO02194 MOACRIVE Inhibition DME1304 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1304 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02195 XEO_CLAS Peptide DME1304 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.00 ug/ml) DME1304 XEOTICID XEO02195 GENEFORM Protein DME1304 XEOTICID XEO02195 MOACRIVE Inhibition DME1304 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1304 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02197 XEO_CLAS Peptide DME1304 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02197 GENEFORM Protein DME1304 XEOTICID XEO02197 MOACRIVE Inhibition DME1304 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1304 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02200 XEO_CLAS Peptide DME1304 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 ug/ml) DME1304 XEOTICID XEO02200 GENEFORM Protein DME1304 XEOTICID XEO02200 MOACRIVE Inhibition DME1304 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1304 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02201 XEO_CLAS Peptide DME1304 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 ug/ml) DME1304 XEOTICID XEO02201 GENEFORM Protein DME1304 XEOTICID XEO02201 MOACRIVE Inhibition DME1304 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1304 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02202 XEO_CLAS Peptide DME1304 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO02202 GENEFORM Protein DME1304 XEOTICID XEO02202 MOACRIVE Inhibition DME1304 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1304 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02203 XEO_CLAS Peptide DME1304 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 microM) DME1304 XEOTICID XEO02203 GENEFORM Protein DME1304 XEOTICID XEO02203 MOACRIVE Inhibition DME1304 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1304 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02207 XEO_CLAS Peptide DME1304 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.78 ug/ml) DME1304 XEOTICID XEO02207 GENEFORM Protein DME1304 XEOTICID XEO02207 MOACRIVE Inhibition DME1304 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1304 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02208 XEO_CLAS Peptide DME1304 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.13 ug/ml) DME1304 XEOTICID XEO02208 GENEFORM Protein DME1304 XEOTICID XEO02208 MOACRIVE Inhibition DME1304 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1304 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02209 XEO_CLAS Peptide DME1304 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.56 ug/ml) DME1304 XEOTICID XEO02209 GENEFORM Protein DME1304 XEOTICID XEO02209 MOACRIVE Inhibition DME1304 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1304 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02210 XEO_CLAS Peptide DME1304 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 ug/ml) DME1304 XEOTICID XEO02210 GENEFORM Protein DME1304 XEOTICID XEO02210 MOACRIVE Inhibition DME1304 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1304 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02211 XEO_CLAS Peptide DME1304 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25 ug/ml) DME1304 XEOTICID XEO02211 GENEFORM Protein DME1304 XEOTICID XEO02211 MOACRIVE Inhibition DME1304 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1304 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02212 XEO_CLAS Peptide DME1304 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.13 ug/ml) DME1304 XEOTICID XEO02212 GENEFORM Protein DME1304 XEOTICID XEO02212 MOACRIVE Inhibition DME1304 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1304 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02213 XEO_CLAS Peptide DME1304 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.13 ug/ml) DME1304 XEOTICID XEO02213 GENEFORM Protein DME1304 XEOTICID XEO02213 MOACRIVE Inhibition DME1304 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1304 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02214 XEO_CLAS Peptide DME1304 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02214 GENEFORM Protein DME1304 XEOTICID XEO02214 MOACRIVE Inhibition DME1304 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1304 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02215 XEO_CLAS Peptide DME1304 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 ug/ml) DME1304 XEOTICID XEO02215 GENEFORM Protein DME1304 XEOTICID XEO02215 MOACRIVE Inhibition DME1304 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1304 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02216 XEO_CLAS Peptide DME1304 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 126 ug/ml) DME1304 XEOTICID XEO02216 GENEFORM Protein DME1304 XEOTICID XEO02216 MOACRIVE Inhibition DME1304 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1304 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02217 XEO_CLAS Peptide DME1304 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 200 ug/ml) DME1304 XEOTICID XEO02217 GENEFORM Protein DME1304 XEOTICID XEO02217 MOACRIVE Inhibition DME1304 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1304 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02218 XEO_CLAS Peptide DME1304 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 200 ug/ml) DME1304 XEOTICID XEO02218 GENEFORM Protein DME1304 XEOTICID XEO02218 MOACRIVE Inhibition DME1304 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1304 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02219 XEO_CLAS Peptide DME1304 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 200 ug/ml) DME1304 XEOTICID XEO02219 GENEFORM Protein DME1304 XEOTICID XEO02219 MOACRIVE Inhibition DME1304 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1304 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02220 XEO_CLAS Peptide DME1304 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 23.5 ug/ml) DME1304 XEOTICID XEO02220 GENEFORM Protein DME1304 XEOTICID XEO02220 MOACRIVE Inhibition DME1304 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1304 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02221 XEO_CLAS Peptide DME1304 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20.2 ug/ml) DME1304 XEOTICID XEO02221 GENEFORM Protein DME1304 XEOTICID XEO02221 MOACRIVE Inhibition DME1304 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1304 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02222 XEO_CLAS Peptide DME1304 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30.5 ug/ml) DME1304 XEOTICID XEO02222 GENEFORM Protein DME1304 XEOTICID XEO02222 MOACRIVE Inhibition DME1304 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1304 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02223 XEO_CLAS Peptide DME1304 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.2 ug/ml) DME1304 XEOTICID XEO02223 GENEFORM Protein DME1304 XEOTICID XEO02223 MOACRIVE Inhibition DME1304 XEOTICID XEO02224 XEO_NAME Androctonin DME1304 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02224 XEO_CLAS Peptide DME1304 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02224 GENEFORM Protein DME1304 XEOTICID XEO02224 MOACRIVE Inhibition DME1304 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1304 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02225 XEO_CLAS Peptide DME1304 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02225 GENEFORM Protein DME1304 XEOTICID XEO02225 MOACRIVE Inhibition DME1304 XEOTICID XEO02226 XEO_NAME Andropin DME1304 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02226 XEO_CLAS Peptide DME1304 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 140 microM) DME1304 XEOTICID XEO02226 GENEFORM Protein DME1304 XEOTICID XEO02226 MOACRIVE Inhibition DME1304 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1304 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02230 XEO_CLAS Peptide DME1304 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.05-0.1 microM) DME1304 XEOTICID XEO02230 GENEFORM Protein DME1304 XEOTICID XEO02230 MOACRIVE Inhibition DME1304 XEOTICID XEO02232 XEO_NAME Anoplin DME1304 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02232 XEO_CLAS Peptide DME1304 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 13 ug/ml) DME1304 XEOTICID XEO02232 GENEFORM Protein DME1304 XEOTICID XEO02232 MOACRIVE Inhibition DME1304 XEOTICID XEO02233 XEO_NAME Antapin DME1304 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02233 XEO_CLAS Peptide DME1304 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02233 GENEFORM Protein DME1304 XEOTICID XEO02233 MOACRIVE Inhibition DME1304 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1304 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02236 XEO_CLAS Peptide DME1304 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02236 GENEFORM Protein DME1304 XEOTICID XEO02236 MOACRIVE Inhibition DME1304 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1304 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02239 XEO_CLAS Peptide DME1304 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 250 microM) DME1304 XEOTICID XEO02239 GENEFORM Protein DME1304 XEOTICID XEO02239 MOACRIVE Inhibition DME1304 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1304 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02240 XEO_CLAS Peptide DME1304 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 microM) DME1304 XEOTICID XEO02240 GENEFORM Protein DME1304 XEOTICID XEO02240 MOACRIVE Inhibition DME1304 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1304 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02241 XEO_CLAS Peptide DME1304 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02241 GENEFORM Protein DME1304 XEOTICID XEO02241 MOACRIVE Inhibition DME1304 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1304 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02242 XEO_CLAS Peptide DME1304 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO02242 GENEFORM Protein DME1304 XEOTICID XEO02242 MOACRIVE Inhibition DME1304 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1304 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02243 XEO_CLAS Peptide DME1304 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 microM) DME1304 XEOTICID XEO02243 GENEFORM Protein DME1304 XEOTICID XEO02243 MOACRIVE Inhibition DME1304 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1304 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02244 XEO_CLAS Peptide DME1304 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1 microM) DME1304 XEOTICID XEO02244 GENEFORM Protein DME1304 XEOTICID XEO02244 MOACRIVE Inhibition DME1304 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1304 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02245 XEO_CLAS Peptide DME1304 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02245 GENEFORM Protein DME1304 XEOTICID XEO02245 MOACRIVE Inhibition DME1304 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1304 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02246 XEO_CLAS Peptide DME1304 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 microM) DME1304 XEOTICID XEO02246 GENEFORM Protein DME1304 XEOTICID XEO02246 MOACRIVE Inhibition DME1304 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1304 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02247 XEO_CLAS Peptide DME1304 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02247 GENEFORM Protein DME1304 XEOTICID XEO02247 MOACRIVE Inhibition DME1304 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1304 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02248 XEO_CLAS Peptide DME1304 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.3 microM) DME1304 XEOTICID XEO02248 GENEFORM Protein DME1304 XEOTICID XEO02248 MOACRIVE Inhibition DME1304 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1304 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02253 XEO_CLAS Peptide DME1304 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02253 GENEFORM Protein DME1304 XEOTICID XEO02253 MOACRIVE Inhibition DME1304 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1304 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02258 XEO_CLAS Peptide DME1304 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 150 microM) DME1304 XEOTICID XEO02258 GENEFORM Protein DME1304 XEOTICID XEO02258 MOACRIVE Inhibition DME1304 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1304 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02261 XEO_CLAS Peptide DME1304 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 82 ug/ml) DME1304 XEOTICID XEO02261 GENEFORM Protein DME1304 XEOTICID XEO02261 MOACRIVE Inhibition DME1304 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1304 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02263 XEO_CLAS Peptide DME1304 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO02263 GENEFORM Protein DME1304 XEOTICID XEO02263 MOACRIVE Inhibition DME1304 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1304 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02266 XEO_CLAS Peptide DME1304 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 120 microM) DME1304 XEOTICID XEO02266 GENEFORM Protein DME1304 XEOTICID XEO02266 MOACRIVE Inhibition DME1304 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1304 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02268 XEO_CLAS Peptide DME1304 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 170 ug/ml) DME1304 XEOTICID XEO02268 GENEFORM Protein DME1304 XEOTICID XEO02268 MOACRIVE Inhibition DME1304 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1304 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02270 XEO_CLAS Peptide DME1304 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 microM) DME1304 XEOTICID XEO02270 GENEFORM Protein DME1304 XEOTICID XEO02270 MOACRIVE Inhibition DME1304 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1304 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02271 XEO_CLAS Peptide DME1304 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 302 ug/ml) DME1304 XEOTICID XEO02271 GENEFORM Protein DME1304 XEOTICID XEO02271 MOACRIVE Inhibition DME1304 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1304 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02273 XEO_CLAS Peptide DME1304 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 18 microM) DME1304 XEOTICID XEO02273 GENEFORM Protein DME1304 XEOTICID XEO02273 MOACRIVE Inhibition DME1304 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1304 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02274 XEO_CLAS Peptide DME1304 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO02274 GENEFORM Protein DME1304 XEOTICID XEO02274 MOACRIVE Inhibition DME1304 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1304 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02275 XEO_CLAS Peptide DME1304 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 microM) DME1304 XEOTICID XEO02275 GENEFORM Protein DME1304 XEOTICID XEO02275 MOACRIVE Inhibition DME1304 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1304 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02276 XEO_CLAS Peptide DME1304 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 microM) DME1304 XEOTICID XEO02276 GENEFORM Protein DME1304 XEOTICID XEO02276 MOACRIVE Inhibition DME1304 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1304 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02280 XEO_CLAS Peptide DME1304 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02280 GENEFORM Protein DME1304 XEOTICID XEO02280 MOACRIVE Inhibition DME1304 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1304 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02281 XEO_CLAS Peptide DME1304 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02281 GENEFORM Protein DME1304 XEOTICID XEO02281 MOACRIVE Inhibition DME1304 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1304 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02283 XEO_CLAS Peptide DME1304 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 ug/ml) DME1304 XEOTICID XEO02283 GENEFORM Protein DME1304 XEOTICID XEO02283 MOACRIVE Inhibition DME1304 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1304 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02284 XEO_CLAS Peptide DME1304 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50.4 microM) DME1304 XEOTICID XEO02284 GENEFORM Protein DME1304 XEOTICID XEO02284 MOACRIVE Inhibition DME1304 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1304 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02285 XEO_CLAS Peptide DME1304 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50.4 microM) DME1304 XEOTICID XEO02285 GENEFORM Protein DME1304 XEOTICID XEO02285 MOACRIVE Inhibition DME1304 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1304 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02286 XEO_CLAS Peptide DME1304 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50.4 microM) DME1304 XEOTICID XEO02286 GENEFORM Protein DME1304 XEOTICID XEO02286 MOACRIVE Inhibition DME1304 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1304 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02287 XEO_CLAS Peptide DME1304 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50.4 microM) DME1304 XEOTICID XEO02287 GENEFORM Protein DME1304 XEOTICID XEO02287 MOACRIVE Inhibition DME1304 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1304 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02288 XEO_CLAS Peptide DME1304 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.2 ug/ml) DME1304 XEOTICID XEO02288 GENEFORM Protein DME1304 XEOTICID XEO02288 MOACRIVE Inhibition DME1304 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1304 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02289 XEO_CLAS Peptide DME1304 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 ug/ml) DME1304 XEOTICID XEO02289 GENEFORM Protein DME1304 XEOTICID XEO02289 MOACRIVE Inhibition DME1304 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1304 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02290 XEO_CLAS Peptide DME1304 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO02290 GENEFORM Protein DME1304 XEOTICID XEO02290 MOACRIVE Inhibition DME1304 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1304 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02291 XEO_CLAS Peptide DME1304 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02291 GENEFORM Protein DME1304 XEOTICID XEO02291 MOACRIVE Inhibition DME1304 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1304 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02293 XEO_CLAS Peptide DME1304 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 microM) DME1304 XEOTICID XEO02293 GENEFORM Protein DME1304 XEOTICID XEO02293 MOACRIVE Inhibition DME1304 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1304 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02294 XEO_CLAS Peptide DME1304 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 62-250 ug/ml) DME1304 XEOTICID XEO02294 GENEFORM Protein DME1304 XEOTICID XEO02294 MOACRIVE Inhibition DME1304 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1304 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02295 XEO_CLAS Peptide DME1304 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 ug/ml) DME1304 XEOTICID XEO02295 GENEFORM Protein DME1304 XEOTICID XEO02295 MOACRIVE Inhibition DME1304 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1304 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02296 XEO_CLAS Peptide DME1304 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02296 GENEFORM Protein DME1304 XEOTICID XEO02296 MOACRIVE Inhibition DME1304 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1304 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02297 XEO_CLAS Peptide DME1304 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC < 50 ug/ml) DME1304 XEOTICID XEO02297 GENEFORM Protein DME1304 XEOTICID XEO02297 MOACRIVE Inhibition DME1304 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1304 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02298 XEO_CLAS Peptide DME1304 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO02298 GENEFORM Protein DME1304 XEOTICID XEO02298 MOACRIVE Inhibition DME1304 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1304 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02303 XEO_CLAS Peptide DME1304 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02303 GENEFORM Protein DME1304 XEOTICID XEO02303 MOACRIVE Inhibition DME1304 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1304 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02304 XEO_CLAS Peptide DME1304 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.1 ug/ml) DME1304 XEOTICID XEO02304 GENEFORM Protein DME1304 XEOTICID XEO02304 MOACRIVE Inhibition DME1304 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1304 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02305 XEO_CLAS Peptide DME1304 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC <= 1 ug/ml) DME1304 XEOTICID XEO02305 GENEFORM Protein DME1304 XEOTICID XEO02305 MOACRIVE Inhibition DME1304 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1304 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02306 XEO_CLAS Peptide DME1304 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.2 ug/ml) DME1304 XEOTICID XEO02306 GENEFORM Protein DME1304 XEOTICID XEO02306 MOACRIVE Inhibition DME1304 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1304 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02309 XEO_CLAS Peptide DME1304 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02309 GENEFORM Protein DME1304 XEOTICID XEO02309 MOACRIVE Inhibition DME1304 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1304 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02310 XEO_CLAS Peptide DME1304 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02310 GENEFORM Protein DME1304 XEOTICID XEO02310 MOACRIVE Inhibition DME1304 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1304 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02315 XEO_CLAS Peptide DME1304 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO02315 GENEFORM Protein DME1304 XEOTICID XEO02315 MOACRIVE Inhibition DME1304 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1304 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02316 XEO_CLAS Peptide DME1304 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 50 microM) DME1304 XEOTICID XEO02316 GENEFORM Protein DME1304 XEOTICID XEO02316 MOACRIVE Inhibition DME1304 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1304 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02317 XEO_CLAS Peptide DME1304 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 300 microM) DME1304 XEOTICID XEO02317 GENEFORM Protein DME1304 XEOTICID XEO02317 MOACRIVE Inhibition DME1304 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1304 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02318 XEO_CLAS Peptide DME1304 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02318 GENEFORM Protein DME1304 XEOTICID XEO02318 MOACRIVE Inhibition DME1304 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1304 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02319 XEO_CLAS Peptide DME1304 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02319 GENEFORM Protein DME1304 XEOTICID XEO02319 MOACRIVE Inhibition DME1304 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1304 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02320 XEO_CLAS Peptide DME1304 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02320 GENEFORM Protein DME1304 XEOTICID XEO02320 MOACRIVE Inhibition DME1304 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1304 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02321 XEO_CLAS Peptide DME1304 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO02321 GENEFORM Protein DME1304 XEOTICID XEO02321 MOACRIVE Inhibition DME1304 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1304 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02322 XEO_CLAS Peptide DME1304 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02322 GENEFORM Protein DME1304 XEOTICID XEO02322 MOACRIVE Inhibition DME1304 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1304 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02323 XEO_CLAS Peptide DME1304 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO02323 GENEFORM Protein DME1304 XEOTICID XEO02323 MOACRIVE Inhibition DME1304 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1304 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02324 XEO_CLAS Peptide DME1304 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02324 GENEFORM Protein DME1304 XEOTICID XEO02324 MOACRIVE Inhibition DME1304 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1304 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02325 XEO_CLAS Peptide DME1304 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO02325 GENEFORM Protein DME1304 XEOTICID XEO02325 MOACRIVE Inhibition DME1304 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1304 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02326 XEO_CLAS Peptide DME1304 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02326 GENEFORM Protein DME1304 XEOTICID XEO02326 MOACRIVE Inhibition DME1304 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1304 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02327 XEO_CLAS Peptide DME1304 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO02327 GENEFORM Protein DME1304 XEOTICID XEO02327 MOACRIVE Inhibition DME1304 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1304 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02328 XEO_CLAS Peptide DME1304 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO02328 GENEFORM Protein DME1304 XEOTICID XEO02328 MOACRIVE Inhibition DME1304 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1304 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02332 XEO_CLAS Peptide DME1304 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.9 ug/ml) DME1304 XEOTICID XEO02332 GENEFORM Protein DME1304 XEOTICID XEO02332 MOACRIVE Inhibition DME1304 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1304 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02333 XEO_CLAS Peptide DME1304 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 200 microM) DME1304 XEOTICID XEO02333 GENEFORM Protein DME1304 XEOTICID XEO02333 MOACRIVE Inhibition DME1304 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1304 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02336 XEO_CLAS Peptide DME1304 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 microM) DME1304 XEOTICID XEO02336 GENEFORM Protein DME1304 XEOTICID XEO02336 MOACRIVE Inhibition DME1304 XEOTICID XEO02346 XEO_NAME Aurelin DME1304 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02346 XEO_CLAS Peptide DME1304 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 7.66 ug/ml) DME1304 XEOTICID XEO02346 GENEFORM Protein DME1304 XEOTICID XEO02346 MOACRIVE Inhibition DME1304 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1304 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02352 XEO_CLAS Peptide DME1304 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 11 ug/ml) DME1304 XEOTICID XEO02352 GENEFORM Protein DME1304 XEOTICID XEO02352 MOACRIVE Inhibition DME1304 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1304 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02353 XEO_CLAS Peptide DME1304 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 ug/ml) DME1304 XEOTICID XEO02353 GENEFORM Protein DME1304 XEOTICID XEO02353 MOACRIVE Inhibition DME1304 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1304 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02354 XEO_CLAS Peptide DME1304 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 ug/ml) DME1304 XEOTICID XEO02354 GENEFORM Protein DME1304 XEOTICID XEO02354 MOACRIVE Inhibition DME1304 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1304 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02355 XEO_CLAS Peptide DME1304 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 17 ug/ml) DME1304 XEOTICID XEO02355 GENEFORM Protein DME1304 XEOTICID XEO02355 MOACRIVE Inhibition DME1304 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1304 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02356 XEO_CLAS Peptide DME1304 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO02356 GENEFORM Protein DME1304 XEOTICID XEO02356 MOACRIVE Inhibition DME1304 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1304 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02357 XEO_CLAS Peptide DME1304 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO02357 GENEFORM Protein DME1304 XEOTICID XEO02357 MOACRIVE Inhibition DME1304 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1304 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02358 XEO_CLAS Peptide DME1304 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO02358 GENEFORM Protein DME1304 XEOTICID XEO02358 MOACRIVE Inhibition DME1304 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1304 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02360 XEO_CLAS Peptide DME1304 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02360 GENEFORM Protein DME1304 XEOTICID XEO02360 MOACRIVE Inhibition DME1304 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1304 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02361 XEO_CLAS Peptide DME1304 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 ug/ml) DME1304 XEOTICID XEO02361 GENEFORM Protein DME1304 XEOTICID XEO02361 MOACRIVE Inhibition DME1304 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1304 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02365 XEO_CLAS Peptide DME1304 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 32 ug/ml) DME1304 XEOTICID XEO02365 GENEFORM Protein DME1304 XEOTICID XEO02365 MOACRIVE Inhibition DME1304 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1304 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02366 XEO_CLAS Peptide DME1304 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO02366 GENEFORM Protein DME1304 XEOTICID XEO02366 MOACRIVE Inhibition DME1304 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1304 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02367 XEO_CLAS Peptide DME1304 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02367 GENEFORM Protein DME1304 XEOTICID XEO02367 MOACRIVE Inhibition DME1304 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1304 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02368 XEO_CLAS Peptide DME1304 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02368 GENEFORM Protein DME1304 XEOTICID XEO02368 MOACRIVE Inhibition DME1304 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1304 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02369 XEO_CLAS Peptide DME1304 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02369 GENEFORM Protein DME1304 XEOTICID XEO02369 MOACRIVE Inhibition DME1304 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1304 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02370 XEO_CLAS Peptide DME1304 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02370 GENEFORM Protein DME1304 XEOTICID XEO02370 MOACRIVE Inhibition DME1304 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1304 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02371 XEO_CLAS Peptide DME1304 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 ug/ml) DME1304 XEOTICID XEO02371 GENEFORM Protein DME1304 XEOTICID XEO02371 MOACRIVE Inhibition DME1304 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1304 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02374 XEO_CLAS Peptide DME1304 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02374 GENEFORM Protein DME1304 XEOTICID XEO02374 MOACRIVE Inhibition DME1304 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1304 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02376 XEO_CLAS Peptide DME1304 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02376 GENEFORM Protein DME1304 XEOTICID XEO02376 MOACRIVE Inhibition DME1304 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1304 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02378 XEO_CLAS Peptide DME1304 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.19 ug/ml) DME1304 XEOTICID XEO02378 GENEFORM Protein DME1304 XEOTICID XEO02378 MOACRIVE Inhibition DME1304 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1304 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02388 XEO_CLAS Peptide DME1304 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO02388 GENEFORM Protein DME1304 XEOTICID XEO02388 MOACRIVE Inhibition DME1304 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1304 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02389 XEO_CLAS Peptide DME1304 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02389 GENEFORM Protein DME1304 XEOTICID XEO02389 MOACRIVE Inhibition DME1304 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1304 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02415 XEO_CLAS Peptide DME1304 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02415 GENEFORM Protein DME1304 XEOTICID XEO02415 MOACRIVE Inhibition DME1304 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1304 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02416 XEO_CLAS Peptide DME1304 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 11 microM) DME1304 XEOTICID XEO02416 GENEFORM Protein DME1304 XEOTICID XEO02416 MOACRIVE Inhibition DME1304 XEOTICID XEO02419 XEO_NAME Bay oil DME1304 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1304 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02419 GENEFORM Protein DME1304 XEOTICID XEO02419 MOACRIVE Inhibition DME1304 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1304 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02435 XEO_CLAS Peptide DME1304 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02435 GENEFORM Protein DME1304 XEOTICID XEO02435 MOACRIVE Inhibition DME1304 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1304 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02436 XEO_CLAS Peptide DME1304 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02436 GENEFORM Protein DME1304 XEOTICID XEO02436 MOACRIVE Inhibition DME1304 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1304 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02437 XEO_CLAS Peptide DME1304 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02437 GENEFORM Protein DME1304 XEOTICID XEO02437 MOACRIVE Inhibition DME1304 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1304 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02438 XEO_CLAS Peptide DME1304 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02438 GENEFORM Protein DME1304 XEOTICID XEO02438 MOACRIVE Inhibition DME1304 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1304 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02439 XEO_CLAS Peptide DME1304 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02439 GENEFORM Protein DME1304 XEOTICID XEO02439 MOACRIVE Inhibition DME1304 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1304 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02440 XEO_CLAS Peptide DME1304 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02440 GENEFORM Protein DME1304 XEOTICID XEO02440 MOACRIVE Inhibition DME1304 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1304 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02441 XEO_CLAS Peptide DME1304 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02441 GENEFORM Protein DME1304 XEOTICID XEO02441 MOACRIVE Inhibition DME1304 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1304 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02442 XEO_CLAS Peptide DME1304 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO02442 GENEFORM Protein DME1304 XEOTICID XEO02442 MOACRIVE Inhibition DME1304 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1304 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02443 XEO_CLAS Peptide DME1304 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02443 GENEFORM Protein DME1304 XEOTICID XEO02443 MOACRIVE Inhibition DME1304 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1304 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02444 XEO_CLAS Peptide DME1304 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02444 GENEFORM Protein DME1304 XEOTICID XEO02444 MOACRIVE Inhibition DME1304 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1304 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1304 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02447 GENEFORM Protein DME1304 XEOTICID XEO02447 MOACRIVE Inhibition DME1304 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1304 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02452 XEO_CLAS Peptide DME1304 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 76800 ug/ml) DME1304 XEOTICID XEO02452 GENEFORM Protein DME1304 XEOTICID XEO02452 MOACRIVE Inhibition DME1304 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1304 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02453 XEO_CLAS Peptide DME1304 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02453 GENEFORM Protein DME1304 XEOTICID XEO02453 MOACRIVE Inhibition DME1304 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1304 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02463 XEO_CLAS Peptide DME1304 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 11.25 microM) DME1304 XEOTICID XEO02463 GENEFORM Protein DME1304 XEOTICID XEO02463 MOACRIVE Inhibition DME1304 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1304 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02466 XEO_CLAS Peptide DME1304 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.5 microM) DME1304 XEOTICID XEO02466 GENEFORM Protein DME1304 XEOTICID XEO02466 MOACRIVE Inhibition DME1304 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1304 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02467 XEO_CLAS Peptide DME1304 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8.4 microM) DME1304 XEOTICID XEO02467 GENEFORM Protein DME1304 XEOTICID XEO02467 MOACRIVE Inhibition DME1304 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1304 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02468 XEO_CLAS Peptide DME1304 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.7 microM) DME1304 XEOTICID XEO02468 GENEFORM Protein DME1304 XEOTICID XEO02468 MOACRIVE Inhibition DME1304 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1304 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02469 XEO_CLAS Peptide DME1304 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO02469 GENEFORM Protein DME1304 XEOTICID XEO02469 MOACRIVE Inhibition DME1304 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1304 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02470 XEO_CLAS Peptide DME1304 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.8 microM) DME1304 XEOTICID XEO02470 GENEFORM Protein DME1304 XEOTICID XEO02470 MOACRIVE Inhibition DME1304 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1304 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02471 XEO_CLAS Peptide DME1304 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4.8 microM) DME1304 XEOTICID XEO02471 GENEFORM Protein DME1304 XEOTICID XEO02471 MOACRIVE Inhibition DME1304 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1304 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02472 XEO_CLAS Peptide DME1304 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.0 microM) DME1304 XEOTICID XEO02472 GENEFORM Protein DME1304 XEOTICID XEO02472 MOACRIVE Inhibition DME1304 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1304 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02473 XEO_CLAS Peptide DME1304 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02473 GENEFORM Protein DME1304 XEOTICID XEO02473 MOACRIVE Inhibition DME1304 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1304 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02474 XEO_CLAS Peptide DME1304 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.5 microM) DME1304 XEOTICID XEO02474 GENEFORM Protein DME1304 XEOTICID XEO02474 MOACRIVE Inhibition DME1304 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1304 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02475 XEO_CLAS Peptide DME1304 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.5 microM) DME1304 XEOTICID XEO02475 GENEFORM Protein DME1304 XEOTICID XEO02475 MOACRIVE Inhibition DME1304 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1304 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02477 XEO_CLAS Peptide DME1304 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-300 ug/ml) DME1304 XEOTICID XEO02477 GENEFORM Protein DME1304 XEOTICID XEO02477 MOACRIVE Inhibition DME1304 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1304 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02478 XEO_CLAS Peptide DME1304 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-300 ug/ml) DME1304 XEOTICID XEO02478 GENEFORM Protein DME1304 XEOTICID XEO02478 MOACRIVE Inhibition DME1304 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1304 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02479 XEO_CLAS Peptide DME1304 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-300 ug/ml) DME1304 XEOTICID XEO02479 GENEFORM Protein DME1304 XEOTICID XEO02479 MOACRIVE Inhibition DME1304 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1304 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02480 XEO_CLAS Peptide DME1304 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-300 ug/ml) DME1304 XEOTICID XEO02480 GENEFORM Protein DME1304 XEOTICID XEO02480 MOACRIVE Inhibition DME1304 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1304 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02481 XEO_CLAS Peptide DME1304 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-300 ug/ml) DME1304 XEOTICID XEO02481 GENEFORM Protein DME1304 XEOTICID XEO02481 MOACRIVE Inhibition DME1304 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1304 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02482 XEO_CLAS Peptide DME1304 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-300 ug/ml) DME1304 XEOTICID XEO02482 GENEFORM Protein DME1304 XEOTICID XEO02482 MOACRIVE Inhibition DME1304 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1304 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02483 XEO_CLAS Peptide DME1304 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-300 ug/ml) DME1304 XEOTICID XEO02483 GENEFORM Protein DME1304 XEOTICID XEO02483 MOACRIVE Inhibition DME1304 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1304 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02484 XEO_CLAS Peptide DME1304 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-300 ug/ml) DME1304 XEOTICID XEO02484 GENEFORM Protein DME1304 XEOTICID XEO02484 MOACRIVE Inhibition DME1304 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1304 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02485 XEO_CLAS Peptide DME1304 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-300 ug/ml) DME1304 XEOTICID XEO02485 GENEFORM Protein DME1304 XEOTICID XEO02485 MOACRIVE Inhibition DME1304 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1304 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02486 XEO_CLAS Peptide DME1304 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-300 ug/ml) DME1304 XEOTICID XEO02486 GENEFORM Protein DME1304 XEOTICID XEO02486 MOACRIVE Inhibition DME1304 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1304 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02487 XEO_CLAS Peptide DME1304 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02487 GENEFORM Protein DME1304 XEOTICID XEO02487 MOACRIVE Inhibition DME1304 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1304 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02488 XEO_CLAS Peptide DME1304 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-300 ug/ml) DME1304 XEOTICID XEO02488 GENEFORM Protein DME1304 XEOTICID XEO02488 MOACRIVE Inhibition DME1304 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1304 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02489 XEO_CLAS Peptide DME1304 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-301 ug/ml) DME1304 XEOTICID XEO02489 GENEFORM Protein DME1304 XEOTICID XEO02489 MOACRIVE Inhibition DME1304 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1304 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02491 XEO_CLAS Peptide DME1304 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.3 microM) DME1304 XEOTICID XEO02491 GENEFORM Protein DME1304 XEOTICID XEO02491 MOACRIVE Inhibition DME1304 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1304 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02492 XEO_CLAS Peptide DME1304 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 ug/ml) DME1304 XEOTICID XEO02492 GENEFORM Protein DME1304 XEOTICID XEO02492 MOACRIVE Inhibition DME1304 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1304 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02493 XEO_CLAS Peptide DME1304 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 ug/ml) DME1304 XEOTICID XEO02493 GENEFORM Protein DME1304 XEOTICID XEO02493 MOACRIVE Inhibition DME1304 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1304 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02494 XEO_CLAS Peptide DME1304 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 ug/ml) DME1304 XEOTICID XEO02494 GENEFORM Protein DME1304 XEOTICID XEO02494 MOACRIVE Inhibition DME1304 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1304 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02495 XEO_CLAS Peptide DME1304 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 34 ug/ml) DME1304 XEOTICID XEO02495 GENEFORM Protein DME1304 XEOTICID XEO02495 MOACRIVE Inhibition DME1304 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1304 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02496 XEO_CLAS Peptide DME1304 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 13 microM) DME1304 XEOTICID XEO02496 GENEFORM Protein DME1304 XEOTICID XEO02496 MOACRIVE Inhibition DME1304 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1304 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02497 XEO_CLAS Peptide DME1304 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO02497 GENEFORM Protein DME1304 XEOTICID XEO02497 MOACRIVE Inhibition DME1304 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1304 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02499 XEO_CLAS Peptide DME1304 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO02499 GENEFORM Protein DME1304 XEOTICID XEO02499 MOACRIVE Inhibition DME1304 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1304 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02501 XEO_CLAS Peptide DME1304 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 7 microM) DME1304 XEOTICID XEO02501 GENEFORM Protein DME1304 XEOTICID XEO02501 MOACRIVE Inhibition DME1304 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1304 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02502 XEO_CLAS Peptide DME1304 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 microM) DME1304 XEOTICID XEO02502 GENEFORM Protein DME1304 XEOTICID XEO02502 MOACRIVE Inhibition DME1304 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1304 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02503 XEO_CLAS Peptide DME1304 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 19 microM) DME1304 XEOTICID XEO02503 GENEFORM Protein DME1304 XEOTICID XEO02503 MOACRIVE Inhibition DME1304 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1304 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02504 XEO_CLAS Peptide DME1304 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02504 GENEFORM Protein DME1304 XEOTICID XEO02504 MOACRIVE Inhibition DME1304 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1304 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02505 XEO_CLAS Peptide DME1304 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO02505 GENEFORM Protein DME1304 XEOTICID XEO02505 MOACRIVE Inhibition DME1304 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1304 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02507 XEO_CLAS Peptide DME1304 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO02507 GENEFORM Protein DME1304 XEOTICID XEO02507 MOACRIVE Inhibition DME1304 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1304 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02508 XEO_CLAS Peptide DME1304 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 150 microM) DME1304 XEOTICID XEO02508 GENEFORM Protein DME1304 XEOTICID XEO02508 MOACRIVE Inhibition DME1304 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1304 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02509 XEO_CLAS Peptide DME1304 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 150 microM) DME1304 XEOTICID XEO02509 GENEFORM Protein DME1304 XEOTICID XEO02509 MOACRIVE Inhibition DME1304 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1304 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02510 XEO_CLAS Peptide DME1304 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 150 microM) DME1304 XEOTICID XEO02510 GENEFORM Protein DME1304 XEOTICID XEO02510 MOACRIVE Inhibition DME1304 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1304 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02511 XEO_CLAS Peptide DME1304 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 150 microM) DME1304 XEOTICID XEO02511 GENEFORM Protein DME1304 XEOTICID XEO02511 MOACRIVE Inhibition DME1304 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1304 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02512 XEO_CLAS Peptide DME1304 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 75 microM) DME1304 XEOTICID XEO02512 GENEFORM Protein DME1304 XEOTICID XEO02512 MOACRIVE Inhibition DME1304 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1304 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02513 XEO_CLAS Peptide DME1304 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO02513 GENEFORM Protein DME1304 XEOTICID XEO02513 MOACRIVE Inhibition DME1304 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1304 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02514 XEO_CLAS Peptide DME1304 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO02514 GENEFORM Protein DME1304 XEOTICID XEO02514 MOACRIVE Inhibition DME1304 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1304 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02515 XEO_CLAS Peptide DME1304 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 80 microM) DME1304 XEOTICID XEO02515 GENEFORM Protein DME1304 XEOTICID XEO02515 MOACRIVE Inhibition DME1304 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1304 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02516 XEO_CLAS Peptide DME1304 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 32 microM) DME1304 XEOTICID XEO02516 GENEFORM Protein DME1304 XEOTICID XEO02516 MOACRIVE Inhibition DME1304 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1304 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02517 XEO_CLAS Peptide DME1304 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 microM) DME1304 XEOTICID XEO02517 GENEFORM Protein DME1304 XEOTICID XEO02517 MOACRIVE Inhibition DME1304 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1304 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02518 XEO_CLAS Peptide DME1304 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC < 15 microM) DME1304 XEOTICID XEO02518 GENEFORM Protein DME1304 XEOTICID XEO02518 MOACRIVE Inhibition DME1304 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1304 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02519 XEO_CLAS Peptide DME1304 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC < 15 microM) DME1304 XEOTICID XEO02519 GENEFORM Protein DME1304 XEOTICID XEO02519 MOACRIVE Inhibition DME1304 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1304 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02520 XEO_CLAS Peptide DME1304 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC < 15 microM) DME1304 XEOTICID XEO02520 GENEFORM Protein DME1304 XEOTICID XEO02520 MOACRIVE Inhibition DME1304 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1304 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02523 XEO_CLAS Peptide DME1304 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO02523 GENEFORM Protein DME1304 XEOTICID XEO02523 MOACRIVE Inhibition DME1304 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1304 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02524 XEO_CLAS Peptide DME1304 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 150 microM) DME1304 XEOTICID XEO02524 GENEFORM Protein DME1304 XEOTICID XEO02524 MOACRIVE Inhibition DME1304 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1304 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02525 XEO_CLAS Peptide DME1304 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 24 microM) DME1304 XEOTICID XEO02525 GENEFORM Protein DME1304 XEOTICID XEO02525 MOACRIVE Inhibition DME1304 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1304 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02526 XEO_CLAS Peptide DME1304 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 48 microM) DME1304 XEOTICID XEO02526 GENEFORM Protein DME1304 XEOTICID XEO02526 MOACRIVE Inhibition DME1304 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1304 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02527 XEO_CLAS Peptide DME1304 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 119 microM) DME1304 XEOTICID XEO02527 GENEFORM Protein DME1304 XEOTICID XEO02527 MOACRIVE Inhibition DME1304 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1304 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02528 XEO_CLAS Peptide DME1304 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 128 ug/ml) DME1304 XEOTICID XEO02528 GENEFORM Protein DME1304 XEOTICID XEO02528 MOACRIVE Inhibition DME1304 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1304 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02529 XEO_CLAS Peptide DME1304 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 128 ug/ml) DME1304 XEOTICID XEO02529 GENEFORM Protein DME1304 XEOTICID XEO02529 MOACRIVE Inhibition DME1304 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1304 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02530 XEO_CLAS Peptide DME1304 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02530 GENEFORM Protein DME1304 XEOTICID XEO02530 MOACRIVE Inhibition DME1304 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1304 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02531 XEO_CLAS Peptide DME1304 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 microM) DME1304 XEOTICID XEO02531 GENEFORM Protein DME1304 XEOTICID XEO02531 MOACRIVE Inhibition DME1304 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1304 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02533 XEO_CLAS Peptide DME1304 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.2 ug/ml) DME1304 XEOTICID XEO02533 GENEFORM Protein DME1304 XEOTICID XEO02533 MOACRIVE Inhibition DME1304 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1304 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02534 XEO_CLAS Peptide DME1304 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.6 ug/ml) DME1304 XEOTICID XEO02534 GENEFORM Protein DME1304 XEOTICID XEO02534 MOACRIVE Inhibition DME1304 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1304 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02535 XEO_CLAS Peptide DME1304 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.3 ug/ml) DME1304 XEOTICID XEO02535 GENEFORM Protein DME1304 XEOTICID XEO02535 MOACRIVE Inhibition DME1304 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1304 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02536 XEO_CLAS Peptide DME1304 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.4 ug/ml) DME1304 XEOTICID XEO02536 GENEFORM Protein DME1304 XEOTICID XEO02536 MOACRIVE Inhibition DME1304 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1304 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02537 XEO_CLAS Peptide DME1304 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.2 ug/ml) DME1304 XEOTICID XEO02537 GENEFORM Protein DME1304 XEOTICID XEO02537 MOACRIVE Inhibition DME1304 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1304 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02538 XEO_CLAS Peptide DME1304 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 9.1 ug/ml) DME1304 XEOTICID XEO02538 GENEFORM Protein DME1304 XEOTICID XEO02538 MOACRIVE Inhibition DME1304 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1304 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02539 XEO_CLAS Peptide DME1304 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8.6 ug/ml) DME1304 XEOTICID XEO02539 GENEFORM Protein DME1304 XEOTICID XEO02539 MOACRIVE Inhibition DME1304 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1304 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02540 XEO_CLAS Peptide DME1304 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15.2 ug/ml) DME1304 XEOTICID XEO02540 GENEFORM Protein DME1304 XEOTICID XEO02540 MOACRIVE Inhibition DME1304 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1304 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02541 XEO_CLAS Peptide DME1304 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 11.1 ug/ml) DME1304 XEOTICID XEO02541 GENEFORM Protein DME1304 XEOTICID XEO02541 MOACRIVE Inhibition DME1304 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1304 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02542 XEO_CLAS Peptide DME1304 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.7 ug/ml) DME1304 XEOTICID XEO02542 GENEFORM Protein DME1304 XEOTICID XEO02542 MOACRIVE Inhibition DME1304 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1304 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02543 XEO_CLAS Peptide DME1304 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 13.1 ug/ml) DME1304 XEOTICID XEO02543 GENEFORM Protein DME1304 XEOTICID XEO02543 MOACRIVE Inhibition DME1304 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1304 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02544 XEO_CLAS Peptide DME1304 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 9.8 ug/ml) DME1304 XEOTICID XEO02544 GENEFORM Protein DME1304 XEOTICID XEO02544 MOACRIVE Inhibition DME1304 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1304 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02545 XEO_CLAS Peptide DME1304 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 14 microM) DME1304 XEOTICID XEO02545 GENEFORM Protein DME1304 XEOTICID XEO02545 MOACRIVE Inhibition DME1304 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1304 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02546 XEO_CLAS Peptide DME1304 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 14 microM) DME1304 XEOTICID XEO02546 GENEFORM Protein DME1304 XEOTICID XEO02546 MOACRIVE Inhibition DME1304 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1304 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02547 XEO_CLAS Peptide DME1304 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 microM) DME1304 XEOTICID XEO02547 GENEFORM Protein DME1304 XEOTICID XEO02547 MOACRIVE Inhibition DME1304 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1304 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02548 XEO_CLAS Peptide DME1304 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 78 microM) DME1304 XEOTICID XEO02548 GENEFORM Protein DME1304 XEOTICID XEO02548 MOACRIVE Inhibition DME1304 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1304 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02549 XEO_CLAS Peptide DME1304 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02549 GENEFORM Protein DME1304 XEOTICID XEO02549 MOACRIVE Inhibition DME1304 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1304 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02552 XEO_CLAS Peptide DME1304 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 24 microM) DME1304 XEOTICID XEO02552 GENEFORM Protein DME1304 XEOTICID XEO02552 MOACRIVE Inhibition DME1304 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1304 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02553 XEO_CLAS Peptide DME1304 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02553 GENEFORM Protein DME1304 XEOTICID XEO02553 MOACRIVE Inhibition DME1304 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1304 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02556 XEO_CLAS Peptide DME1304 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 55 microM) DME1304 XEOTICID XEO02556 GENEFORM Protein DME1304 XEOTICID XEO02556 MOACRIVE Inhibition DME1304 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1304 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02557 XEO_CLAS Peptide DME1304 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 17 microM) DME1304 XEOTICID XEO02557 GENEFORM Protein DME1304 XEOTICID XEO02557 MOACRIVE Inhibition DME1304 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1304 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02558 XEO_CLAS Peptide DME1304 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 14 microM) DME1304 XEOTICID XEO02558 GENEFORM Protein DME1304 XEOTICID XEO02558 MOACRIVE Inhibition DME1304 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1304 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02559 XEO_CLAS Peptide DME1304 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02559 GENEFORM Protein DME1304 XEOTICID XEO02559 MOACRIVE Inhibition DME1304 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1304 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02560 XEO_CLAS Peptide DME1304 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 13 microM) DME1304 XEOTICID XEO02560 GENEFORM Protein DME1304 XEOTICID XEO02560 MOACRIVE Inhibition DME1304 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1304 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02561 XEO_CLAS Peptide DME1304 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO02561 GENEFORM Protein DME1304 XEOTICID XEO02561 MOACRIVE Inhibition DME1304 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1304 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02562 XEO_CLAS Peptide DME1304 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 13 microM) DME1304 XEOTICID XEO02562 GENEFORM Protein DME1304 XEOTICID XEO02562 MOACRIVE Inhibition DME1304 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1304 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02563 XEO_CLAS Peptide DME1304 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 45 microM) DME1304 XEOTICID XEO02563 GENEFORM Protein DME1304 XEOTICID XEO02563 MOACRIVE Inhibition DME1304 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1304 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02564 XEO_CLAS Peptide DME1304 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 ug/ml) DME1304 XEOTICID XEO02564 GENEFORM Protein DME1304 XEOTICID XEO02564 MOACRIVE Inhibition DME1304 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1304 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02565 XEO_CLAS Peptide DME1304 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 microM) DME1304 XEOTICID XEO02565 GENEFORM Protein DME1304 XEOTICID XEO02565 MOACRIVE Inhibition DME1304 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1304 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02566 XEO_CLAS Peptide DME1304 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO02566 GENEFORM Protein DME1304 XEOTICID XEO02566 MOACRIVE Inhibition DME1304 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1304 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02568 XEO_CLAS Peptide DME1304 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO02568 GENEFORM Protein DME1304 XEOTICID XEO02568 MOACRIVE Inhibition DME1304 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1304 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02569 XEO_CLAS Peptide DME1304 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO02569 GENEFORM Protein DME1304 XEOTICID XEO02569 MOACRIVE Inhibition DME1304 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1304 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02570 XEO_CLAS Peptide DME1304 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO02570 GENEFORM Protein DME1304 XEOTICID XEO02570 MOACRIVE Inhibition DME1304 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1304 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02571 XEO_CLAS Peptide DME1304 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO02571 GENEFORM Protein DME1304 XEOTICID XEO02571 MOACRIVE Inhibition DME1304 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1304 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02572 XEO_CLAS Peptide DME1304 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02572 GENEFORM Protein DME1304 XEOTICID XEO02572 MOACRIVE Inhibition DME1304 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1304 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02573 XEO_CLAS Peptide DME1304 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02573 GENEFORM Protein DME1304 XEOTICID XEO02573 MOACRIVE Inhibition DME1304 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1304 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02574 XEO_CLAS Peptide DME1304 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 microM) DME1304 XEOTICID XEO02574 GENEFORM Protein DME1304 XEOTICID XEO02574 MOACRIVE Inhibition DME1304 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1304 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02575 XEO_CLAS Peptide DME1304 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 microM) DME1304 XEOTICID XEO02575 GENEFORM Protein DME1304 XEOTICID XEO02575 MOACRIVE Inhibition DME1304 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1304 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02576 XEO_CLAS Peptide DME1304 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 33 microM) DME1304 XEOTICID XEO02576 GENEFORM Protein DME1304 XEOTICID XEO02576 MOACRIVE Inhibition DME1304 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1304 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02577 XEO_CLAS Peptide DME1304 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO02577 GENEFORM Protein DME1304 XEOTICID XEO02577 MOACRIVE Inhibition DME1304 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1304 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02578 XEO_CLAS Peptide DME1304 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02578 GENEFORM Protein DME1304 XEOTICID XEO02578 MOACRIVE Inhibition DME1304 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1304 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02579 XEO_CLAS Peptide DME1304 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02579 GENEFORM Protein DME1304 XEOTICID XEO02579 MOACRIVE Inhibition DME1304 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1304 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02580 XEO_CLAS Peptide DME1304 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC < 15 microM) DME1304 XEOTICID XEO02580 GENEFORM Protein DME1304 XEOTICID XEO02580 MOACRIVE Inhibition DME1304 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1304 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02581 XEO_CLAS Peptide DME1304 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 microM) DME1304 XEOTICID XEO02581 GENEFORM Protein DME1304 XEOTICID XEO02581 MOACRIVE Inhibition DME1304 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1304 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02582 XEO_CLAS Peptide DME1304 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 microM) DME1304 XEOTICID XEO02582 GENEFORM Protein DME1304 XEOTICID XEO02582 MOACRIVE Inhibition DME1304 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1304 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02583 XEO_CLAS Peptide DME1304 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 microM) DME1304 XEOTICID XEO02583 GENEFORM Protein DME1304 XEOTICID XEO02583 MOACRIVE Inhibition DME1304 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1304 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02584 XEO_CLAS Peptide DME1304 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 microM) DME1304 XEOTICID XEO02584 GENEFORM Protein DME1304 XEOTICID XEO02584 MOACRIVE Inhibition DME1304 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1304 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02585 XEO_CLAS Peptide DME1304 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO02585 GENEFORM Protein DME1304 XEOTICID XEO02585 MOACRIVE Inhibition DME1304 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1304 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02586 XEO_CLAS Peptide DME1304 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO02586 GENEFORM Protein DME1304 XEOTICID XEO02586 MOACRIVE Inhibition DME1304 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1304 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02587 XEO_CLAS Peptide DME1304 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02587 GENEFORM Protein DME1304 XEOTICID XEO02587 MOACRIVE Inhibition DME1304 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1304 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02589 XEO_CLAS Peptide DME1304 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8.2 ug/ml) DME1304 XEOTICID XEO02589 GENEFORM Protein DME1304 XEOTICID XEO02589 MOACRIVE Inhibition DME1304 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1304 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02590 XEO_CLAS Peptide DME1304 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 19.6 ug/ml) DME1304 XEOTICID XEO02590 GENEFORM Protein DME1304 XEOTICID XEO02590 MOACRIVE Inhibition DME1304 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1304 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02591 XEO_CLAS Peptide DME1304 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO02591 GENEFORM Protein DME1304 XEOTICID XEO02591 MOACRIVE Inhibition DME1304 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1304 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02593 XEO_CLAS Peptide DME1304 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 36 microM) DME1304 XEOTICID XEO02593 GENEFORM Protein DME1304 XEOTICID XEO02593 MOACRIVE Inhibition DME1304 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1304 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02594 XEO_CLAS Peptide DME1304 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02594 GENEFORM Protein DME1304 XEOTICID XEO02594 MOACRIVE Inhibition DME1304 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1304 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02595 XEO_CLAS Peptide DME1304 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO02595 GENEFORM Protein DME1304 XEOTICID XEO02595 MOACRIVE Inhibition DME1304 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1304 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02596 XEO_CLAS Peptide DME1304 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO02596 GENEFORM Protein DME1304 XEOTICID XEO02596 MOACRIVE Inhibition DME1304 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1304 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02597 XEO_CLAS Peptide DME1304 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO02597 GENEFORM Protein DME1304 XEOTICID XEO02597 MOACRIVE Inhibition DME1304 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1304 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02598 XEO_CLAS Peptide DME1304 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 32.5 microM) DME1304 XEOTICID XEO02598 GENEFORM Protein DME1304 XEOTICID XEO02598 MOACRIVE Inhibition DME1304 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1304 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02599 XEO_CLAS Peptide DME1304 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 microM) DME1304 XEOTICID XEO02599 GENEFORM Protein DME1304 XEOTICID XEO02599 MOACRIVE Inhibition DME1304 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1304 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02601 XEO_CLAS Peptide DME1304 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.1 ug/ml) DME1304 XEOTICID XEO02601 GENEFORM Protein DME1304 XEOTICID XEO02601 MOACRIVE Inhibition DME1304 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1304 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02602 XEO_CLAS Peptide DME1304 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 13.2 ug/ml) DME1304 XEOTICID XEO02602 GENEFORM Protein DME1304 XEOTICID XEO02602 MOACRIVE Inhibition DME1304 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1304 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02603 XEO_CLAS Peptide DME1304 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.3 ug/ml) DME1304 XEOTICID XEO02603 GENEFORM Protein DME1304 XEOTICID XEO02603 MOACRIVE Inhibition DME1304 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1304 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02604 XEO_CLAS Peptide DME1304 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO02604 GENEFORM Protein DME1304 XEOTICID XEO02604 MOACRIVE Inhibition DME1304 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1304 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02605 XEO_CLAS Peptide DME1304 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30.6 ug/ml) DME1304 XEOTICID XEO02605 GENEFORM Protein DME1304 XEOTICID XEO02605 MOACRIVE Inhibition DME1304 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1304 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02606 XEO_CLAS Peptide DME1304 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 11.2 ug/ml) DME1304 XEOTICID XEO02606 GENEFORM Protein DME1304 XEOTICID XEO02606 MOACRIVE Inhibition DME1304 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1304 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02607 XEO_CLAS Peptide DME1304 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.8 ug/ml) DME1304 XEOTICID XEO02607 GENEFORM Protein DME1304 XEOTICID XEO02607 MOACRIVE Inhibition DME1304 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1304 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02608 XEO_CLAS Peptide DME1304 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 7.9 ug/ml) DME1304 XEOTICID XEO02608 GENEFORM Protein DME1304 XEOTICID XEO02608 MOACRIVE Inhibition DME1304 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1304 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02609 XEO_CLAS Peptide DME1304 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15.8 ug/ml) DME1304 XEOTICID XEO02609 GENEFORM Protein DME1304 XEOTICID XEO02609 MOACRIVE Inhibition DME1304 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1304 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02610 XEO_CLAS Peptide DME1304 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.1 ug/ml) DME1304 XEOTICID XEO02610 GENEFORM Protein DME1304 XEOTICID XEO02610 MOACRIVE Inhibition DME1304 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1304 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02611 XEO_CLAS Peptide DME1304 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20.6 ug/ml) DME1304 XEOTICID XEO02611 GENEFORM Protein DME1304 XEOTICID XEO02611 MOACRIVE Inhibition DME1304 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1304 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02612 XEO_CLAS Peptide DME1304 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 11.8 ug/ml) DME1304 XEOTICID XEO02612 GENEFORM Protein DME1304 XEOTICID XEO02612 MOACRIVE Inhibition DME1304 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1304 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02613 XEO_CLAS Peptide DME1304 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 13.2 ug/ml) DME1304 XEOTICID XEO02613 GENEFORM Protein DME1304 XEOTICID XEO02613 MOACRIVE Inhibition DME1304 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1304 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02614 XEO_CLAS Peptide DME1304 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.8 ug/ml) DME1304 XEOTICID XEO02614 GENEFORM Protein DME1304 XEOTICID XEO02614 MOACRIVE Inhibition DME1304 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1304 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02615 XEO_CLAS Peptide DME1304 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8.6 ug/ml) DME1304 XEOTICID XEO02615 GENEFORM Protein DME1304 XEOTICID XEO02615 MOACRIVE Inhibition DME1304 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1304 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02616 XEO_CLAS Peptide DME1304 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20.4 ug/ml) DME1304 XEOTICID XEO02616 GENEFORM Protein DME1304 XEOTICID XEO02616 MOACRIVE Inhibition DME1304 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1304 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02617 XEO_CLAS Peptide DME1304 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4.7 ug/ml) DME1304 XEOTICID XEO02617 GENEFORM Protein DME1304 XEOTICID XEO02617 MOACRIVE Inhibition DME1304 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1304 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02618 XEO_CLAS Peptide DME1304 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.6 ug/ml) DME1304 XEOTICID XEO02618 GENEFORM Protein DME1304 XEOTICID XEO02618 MOACRIVE Inhibition DME1304 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1304 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02619 XEO_CLAS Peptide DME1304 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10.5 ug/ml) DME1304 XEOTICID XEO02619 GENEFORM Protein DME1304 XEOTICID XEO02619 MOACRIVE Inhibition DME1304 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1304 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02620 XEO_CLAS Peptide DME1304 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO02620 GENEFORM Protein DME1304 XEOTICID XEO02620 MOACRIVE Inhibition DME1304 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1304 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02621 XEO_CLAS Peptide DME1304 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO02621 GENEFORM Protein DME1304 XEOTICID XEO02621 MOACRIVE Inhibition DME1304 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1304 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02622 XEO_CLAS Peptide DME1304 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO02622 GENEFORM Protein DME1304 XEOTICID XEO02622 MOACRIVE Inhibition DME1304 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1304 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02623 XEO_CLAS Peptide DME1304 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO02623 GENEFORM Protein DME1304 XEOTICID XEO02623 MOACRIVE Inhibition DME1304 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1304 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02624 XEO_CLAS Peptide DME1304 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 18 microM) DME1304 XEOTICID XEO02624 GENEFORM Protein DME1304 XEOTICID XEO02624 MOACRIVE Inhibition DME1304 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1304 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02625 XEO_CLAS Peptide DME1304 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 9 microM) DME1304 XEOTICID XEO02625 GENEFORM Protein DME1304 XEOTICID XEO02625 MOACRIVE Inhibition DME1304 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1304 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02626 XEO_CLAS Peptide DME1304 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 18 microM) DME1304 XEOTICID XEO02626 GENEFORM Protein DME1304 XEOTICID XEO02626 MOACRIVE Inhibition DME1304 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1304 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02627 XEO_CLAS Peptide DME1304 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02627 GENEFORM Protein DME1304 XEOTICID XEO02627 MOACRIVE Inhibition DME1304 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1304 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02628 XEO_CLAS Peptide DME1304 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 18 microM) DME1304 XEOTICID XEO02628 GENEFORM Protein DME1304 XEOTICID XEO02628 MOACRIVE Inhibition DME1304 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1304 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02629 XEO_CLAS Peptide DME1304 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 13 microM) DME1304 XEOTICID XEO02629 GENEFORM Protein DME1304 XEOTICID XEO02629 MOACRIVE Inhibition DME1304 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1304 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02630 XEO_CLAS Peptide DME1304 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 ug/ml) DME1304 XEOTICID XEO02630 GENEFORM Protein DME1304 XEOTICID XEO02630 MOACRIVE Inhibition DME1304 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1304 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02631 XEO_CLAS Peptide DME1304 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 ug/ml) DME1304 XEOTICID XEO02631 GENEFORM Protein DME1304 XEOTICID XEO02631 MOACRIVE Inhibition DME1304 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1304 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02634 XEO_CLAS Peptide DME1304 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO02634 GENEFORM Protein DME1304 XEOTICID XEO02634 MOACRIVE Inhibition DME1304 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1304 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02635 XEO_CLAS Peptide DME1304 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40 ug/ml) DME1304 XEOTICID XEO02635 GENEFORM Protein DME1304 XEOTICID XEO02635 MOACRIVE Inhibition DME1304 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1304 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02636 XEO_CLAS Peptide DME1304 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO02636 GENEFORM Protein DME1304 XEOTICID XEO02636 MOACRIVE Inhibition DME1304 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1304 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02637 XEO_CLAS Peptide DME1304 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO02637 GENEFORM Protein DME1304 XEOTICID XEO02637 MOACRIVE Inhibition DME1304 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1304 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02638 XEO_CLAS Peptide DME1304 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 microM) DME1304 XEOTICID XEO02638 GENEFORM Protein DME1304 XEOTICID XEO02638 MOACRIVE Inhibition DME1304 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1304 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02639 XEO_CLAS Peptide DME1304 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 microM) DME1304 XEOTICID XEO02639 GENEFORM Protein DME1304 XEOTICID XEO02639 MOACRIVE Inhibition DME1304 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1304 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02644 XEO_CLAS Peptide DME1304 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02644 GENEFORM Protein DME1304 XEOTICID XEO02644 MOACRIVE Inhibition DME1304 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1304 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02645 XEO_CLAS Peptide DME1304 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02645 GENEFORM Protein DME1304 XEOTICID XEO02645 MOACRIVE Inhibition DME1304 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1304 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02646 XEO_CLAS Peptide DME1304 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02646 GENEFORM Protein DME1304 XEOTICID XEO02646 MOACRIVE Inhibition DME1304 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1304 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02647 XEO_CLAS Peptide DME1304 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02647 GENEFORM Protein DME1304 XEOTICID XEO02647 MOACRIVE Inhibition DME1304 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1304 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02649 XEO_CLAS Peptide DME1304 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO02649 GENEFORM Protein DME1304 XEOTICID XEO02649 MOACRIVE Inhibition DME1304 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1304 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02650 XEO_CLAS Peptide DME1304 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO02650 GENEFORM Protein DME1304 XEOTICID XEO02650 MOACRIVE Inhibition DME1304 XEOTICID XEO02658 XEO_NAME Buthinin DME1304 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02658 XEO_CLAS Peptide DME1304 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02658 GENEFORM Protein DME1304 XEOTICID XEO02658 MOACRIVE Inhibition DME1304 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1304 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02663 XEO_CLAS Peptide DME1304 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25 microM) DME1304 XEOTICID XEO02663 GENEFORM Protein DME1304 XEOTICID XEO02663 MOACRIVE Inhibition DME1304 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1304 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02664 XEO_CLAS Peptide DME1304 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25 microM) DME1304 XEOTICID XEO02664 GENEFORM Protein DME1304 XEOTICID XEO02664 MOACRIVE Inhibition DME1304 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1304 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02672 XEO_CLAS Peptide DME1304 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25 microM) DME1304 XEOTICID XEO02672 GENEFORM Protein DME1304 XEOTICID XEO02672 MOACRIVE Inhibition DME1304 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1304 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02673 XEO_CLAS Peptide DME1304 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25-12.5 microM) DME1304 XEOTICID XEO02673 GENEFORM Protein DME1304 XEOTICID XEO02673 MOACRIVE Inhibition DME1304 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1304 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02674 XEO_CLAS Peptide DME1304 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.125-6.25 microM) DME1304 XEOTICID XEO02674 GENEFORM Protein DME1304 XEOTICID XEO02674 MOACRIVE Inhibition DME1304 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1304 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02676 XEO_CLAS Peptide DME1304 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO02676 GENEFORM Protein DME1304 XEOTICID XEO02676 MOACRIVE Inhibition DME1304 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1304 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02677 XEO_CLAS Peptide DME1304 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25-12.5 microM) DME1304 XEOTICID XEO02677 GENEFORM Protein DME1304 XEOTICID XEO02677 MOACRIVE Inhibition DME1304 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1304 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02679 XEO_CLAS Peptide DME1304 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25-12.5 microM) DME1304 XEOTICID XEO02679 GENEFORM Protein DME1304 XEOTICID XEO02679 MOACRIVE Inhibition DME1304 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1304 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02680 XEO_CLAS Peptide DME1304 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25 microM) DME1304 XEOTICID XEO02680 GENEFORM Protein DME1304 XEOTICID XEO02680 MOACRIVE Inhibition DME1304 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1304 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02683 XEO_CLAS Peptide DME1304 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO02683 GENEFORM Protein DME1304 XEOTICID XEO02683 MOACRIVE Inhibition DME1304 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1304 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02688 XEO_CLAS Peptide DME1304 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO02688 GENEFORM Protein DME1304 XEOTICID XEO02688 MOACRIVE Inhibition DME1304 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1304 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02693 XEO_CLAS Peptide DME1304 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 ug/ml) DME1304 XEOTICID XEO02693 GENEFORM Protein DME1304 XEOTICID XEO02693 MOACRIVE Inhibition DME1304 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1304 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02699 XEO_CLAS Peptide DME1304 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 ug/ml) DME1304 XEOTICID XEO02699 GENEFORM Protein DME1304 XEOTICID XEO02699 MOACRIVE Inhibition DME1304 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1304 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02700 XEO_CLAS Peptide DME1304 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 ug/ml) DME1304 XEOTICID XEO02700 GENEFORM Protein DME1304 XEOTICID XEO02700 MOACRIVE Inhibition DME1304 XEOTICID XEO02703 XEO_NAME Calcitermin DME1304 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02703 XEO_CLAS Peptide DME1304 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02703 GENEFORM Protein DME1304 XEOTICID XEO02703 MOACRIVE Inhibition DME1304 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1304 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02708 XEO_CLAS Peptide DME1304 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO02708 GENEFORM Protein DME1304 XEOTICID XEO02708 MOACRIVE Inhibition DME1304 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1304 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02709 XEO_CLAS Peptide DME1304 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.05 microM) DME1304 XEOTICID XEO02709 GENEFORM Protein DME1304 XEOTICID XEO02709 MOACRIVE Inhibition DME1304 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1304 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1304 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02713 GENEFORM Protein DME1304 XEOTICID XEO02713 MOACRIVE Inhibition DME1304 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1304 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1304 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02714 GENEFORM Protein DME1304 XEOTICID XEO02714 MOACRIVE Inhibition DME1304 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1304 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02726 XEO_CLAS Peptide DME1304 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02726 GENEFORM Protein DME1304 XEOTICID XEO02726 MOACRIVE Inhibition DME1304 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1304 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02731 XEO_CLAS Peptide DME1304 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1 microM) DME1304 XEOTICID XEO02731 GENEFORM Protein DME1304 XEOTICID XEO02731 MOACRIVE Inhibition DME1304 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1304 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02732 XEO_CLAS Peptide DME1304 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.25 microM) DME1304 XEOTICID XEO02732 GENEFORM Protein DME1304 XEOTICID XEO02732 MOACRIVE Inhibition DME1304 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1304 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02733 XEO_CLAS Peptide DME1304 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8-25 ug/ml) DME1304 XEOTICID XEO02733 GENEFORM Protein DME1304 XEOTICID XEO02733 MOACRIVE Inhibition DME1304 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1304 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02735 XEO_CLAS Peptide DME1304 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1 ug/ml) DME1304 XEOTICID XEO02735 GENEFORM Protein DME1304 XEOTICID XEO02735 MOACRIVE Inhibition DME1304 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1304 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02737 XEO_CLAS Peptide DME1304 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02737 GENEFORM Protein DME1304 XEOTICID XEO02737 MOACRIVE Inhibition DME1304 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1304 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02738 XEO_CLAS Peptide DME1304 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO02738 GENEFORM Protein DME1304 XEOTICID XEO02738 MOACRIVE Inhibition DME1304 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1304 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02739 XEO_CLAS Peptide DME1304 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 microM) DME1304 XEOTICID XEO02739 GENEFORM Protein DME1304 XEOTICID XEO02739 MOACRIVE Inhibition DME1304 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1304 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02740 XEO_CLAS Peptide DME1304 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.25 ug/ml) DME1304 XEOTICID XEO02740 GENEFORM Protein DME1304 XEOTICID XEO02740 MOACRIVE Inhibition DME1304 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1304 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02741 XEO_CLAS Peptide DME1304 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 ug/ml) DME1304 XEOTICID XEO02741 GENEFORM Protein DME1304 XEOTICID XEO02741 MOACRIVE Inhibition DME1304 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1304 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02743 XEO_CLAS Peptide DME1304 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.6 ug/ml) DME1304 XEOTICID XEO02743 GENEFORM Protein DME1304 XEOTICID XEO02743 MOACRIVE Inhibition DME1304 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1304 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02744 XEO_CLAS Peptide DME1304 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 18.7 ug/ml) DME1304 XEOTICID XEO02744 GENEFORM Protein DME1304 XEOTICID XEO02744 MOACRIVE Inhibition DME1304 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1304 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02745 XEO_CLAS Peptide DME1304 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02745 GENEFORM Protein DME1304 XEOTICID XEO02745 MOACRIVE Inhibition DME1304 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1304 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02746 XEO_CLAS Peptide DME1304 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02746 GENEFORM Protein DME1304 XEOTICID XEO02746 MOACRIVE Inhibition DME1304 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1304 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02748 XEO_CLAS Peptide DME1304 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02748 GENEFORM Protein DME1304 XEOTICID XEO02748 MOACRIVE Inhibition DME1304 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1304 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02749 XEO_CLAS Peptide DME1304 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20-25 mug/ml) DME1304 XEOTICID XEO02749 GENEFORM Protein DME1304 XEOTICID XEO02749 MOACRIVE Inhibition DME1304 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1304 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02750 XEO_CLAS Peptide DME1304 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02750 GENEFORM Protein DME1304 XEOTICID XEO02750 MOACRIVE Inhibition DME1304 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1304 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02752 XEO_CLAS Peptide DME1304 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02752 GENEFORM Protein DME1304 XEOTICID XEO02752 MOACRIVE Inhibition DME1304 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1304 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02753 XEO_CLAS Peptide DME1304 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02753 GENEFORM Protein DME1304 XEOTICID XEO02753 MOACRIVE Inhibition DME1304 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1304 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02754 XEO_CLAS Peptide DME1304 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 microM) DME1304 XEOTICID XEO02754 GENEFORM Protein DME1304 XEOTICID XEO02754 MOACRIVE Inhibition DME1304 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1304 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02756 XEO_CLAS Peptide DME1304 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 microM) DME1304 XEOTICID XEO02756 GENEFORM Protein DME1304 XEOTICID XEO02756 MOACRIVE Inhibition DME1304 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1304 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02757 XEO_CLAS Peptide DME1304 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1 microM) DME1304 XEOTICID XEO02757 GENEFORM Protein DME1304 XEOTICID XEO02757 MOACRIVE Inhibition DME1304 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1304 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02758 XEO_CLAS Peptide DME1304 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO02758 GENEFORM Protein DME1304 XEOTICID XEO02758 MOACRIVE Inhibition DME1304 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1304 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02759 XEO_CLAS Peptide DME1304 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.6 microM) DME1304 XEOTICID XEO02759 GENEFORM Protein DME1304 XEOTICID XEO02759 MOACRIVE Inhibition DME1304 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1304 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02760 XEO_CLAS Peptide DME1304 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 microM) DME1304 XEOTICID XEO02760 GENEFORM Protein DME1304 XEOTICID XEO02760 MOACRIVE Inhibition DME1304 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1304 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02761 XEO_CLAS Peptide DME1304 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO02761 GENEFORM Protein DME1304 XEOTICID XEO02761 MOACRIVE Inhibition DME1304 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1304 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02762 XEO_CLAS Peptide DME1304 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 microM) DME1304 XEOTICID XEO02762 GENEFORM Protein DME1304 XEOTICID XEO02762 MOACRIVE Inhibition DME1304 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1304 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02763 XEO_CLAS Peptide DME1304 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.4 microM) DME1304 XEOTICID XEO02763 GENEFORM Protein DME1304 XEOTICID XEO02763 MOACRIVE Inhibition DME1304 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1304 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02764 XEO_CLAS Peptide DME1304 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 microM) DME1304 XEOTICID XEO02764 GENEFORM Protein DME1304 XEOTICID XEO02764 MOACRIVE Inhibition DME1304 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1304 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02765 XEO_CLAS Peptide DME1304 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.3 microM) DME1304 XEOTICID XEO02765 GENEFORM Protein DME1304 XEOTICID XEO02765 MOACRIVE Inhibition DME1304 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1304 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02767 XEO_CLAS Peptide DME1304 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02767 GENEFORM Protein DME1304 XEOTICID XEO02767 MOACRIVE Inhibition DME1304 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1304 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02768 XEO_CLAS Peptide DME1304 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1304 XEOTICID XEO02768 GENEFORM Protein DME1304 XEOTICID XEO02768 MOACRIVE Inhibition DME1304 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1304 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02769 XEO_CLAS Peptide DME1304 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.32 microM) DME1304 XEOTICID XEO02769 GENEFORM Protein DME1304 XEOTICID XEO02769 MOACRIVE Inhibition DME1304 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1304 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02770 XEO_CLAS Peptide DME1304 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.30 microM) DME1304 XEOTICID XEO02770 GENEFORM Protein DME1304 XEOTICID XEO02770 MOACRIVE Inhibition DME1304 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1304 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02771 XEO_CLAS Peptide DME1304 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.21 microM) DME1304 XEOTICID XEO02771 GENEFORM Protein DME1304 XEOTICID XEO02771 MOACRIVE Inhibition DME1304 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1304 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02772 XEO_CLAS Peptide DME1304 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02772 GENEFORM Protein DME1304 XEOTICID XEO02772 MOACRIVE Inhibition DME1304 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1304 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02773 XEO_CLAS Peptide DME1304 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.9-8.6 microM) DME1304 XEOTICID XEO02773 GENEFORM Protein DME1304 XEOTICID XEO02773 MOACRIVE Inhibition DME1304 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1304 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02774 XEO_CLAS Peptide DME1304 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.3 microM) DME1304 XEOTICID XEO02774 GENEFORM Protein DME1304 XEOTICID XEO02774 MOACRIVE Inhibition DME1304 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1304 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02789 GENEFORM Protein DME1304 XEOTICID XEO02789 MOACRIVE Inhibition DME1304 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1304 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02790 GENEFORM Protein DME1304 XEOTICID XEO02790 MOACRIVE Inhibition DME1304 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1304 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02791 GENEFORM Protein DME1304 XEOTICID XEO02791 MOACRIVE Inhibition DME1304 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1304 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02792 GENEFORM Protein DME1304 XEOTICID XEO02792 MOACRIVE Inhibition DME1304 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1304 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02793 GENEFORM Protein DME1304 XEOTICID XEO02793 MOACRIVE Inhibition DME1304 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1304 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02794 GENEFORM Protein DME1304 XEOTICID XEO02794 MOACRIVE Inhibition DME1304 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1304 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02795 GENEFORM Protein DME1304 XEOTICID XEO02795 MOACRIVE Inhibition DME1304 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1304 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02796 GENEFORM Protein DME1304 XEOTICID XEO02796 MOACRIVE Inhibition DME1304 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1304 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02797 GENEFORM Protein DME1304 XEOTICID XEO02797 MOACRIVE Inhibition DME1304 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1304 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02799 XEO_CLAS Peptide DME1304 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02799 GENEFORM Protein DME1304 XEOTICID XEO02799 MOACRIVE Inhibition DME1304 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1304 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02800 XEO_CLAS Peptide DME1304 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02800 GENEFORM Protein DME1304 XEOTICID XEO02800 MOACRIVE Inhibition DME1304 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1304 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02802 XEO_CLAS Peptide DME1304 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 13.6 microM) DME1304 XEOTICID XEO02802 GENEFORM Protein DME1304 XEOTICID XEO02802 MOACRIVE Inhibition DME1304 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1304 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02807 XEO_CLAS Peptide DME1304 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.2 microM) DME1304 XEOTICID XEO02807 GENEFORM Protein DME1304 XEOTICID XEO02807 MOACRIVE Inhibition DME1304 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1304 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02813 XEO_CLAS Peptide DME1304 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 80 microM) DME1304 XEOTICID XEO02813 GENEFORM Protein DME1304 XEOTICID XEO02813 MOACRIVE Inhibition DME1304 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1304 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02814 XEO_CLAS Peptide DME1304 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 80 microM) DME1304 XEOTICID XEO02814 GENEFORM Protein DME1304 XEOTICID XEO02814 MOACRIVE Inhibition DME1304 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1304 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02815 XEO_CLAS Peptide DME1304 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8.5 microM) DME1304 XEOTICID XEO02815 GENEFORM Protein DME1304 XEOTICID XEO02815 MOACRIVE Inhibition DME1304 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1304 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02816 XEO_CLAS Peptide DME1304 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 80 microM) DME1304 XEOTICID XEO02816 GENEFORM Protein DME1304 XEOTICID XEO02816 MOACRIVE Inhibition DME1304 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1304 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02817 XEO_CLAS Peptide DME1304 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 80 microM) DME1304 XEOTICID XEO02817 GENEFORM Protein DME1304 XEOTICID XEO02817 MOACRIVE Inhibition DME1304 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1304 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02818 XEO_CLAS Peptide DME1304 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.4 microM) DME1304 XEOTICID XEO02818 GENEFORM Protein DME1304 XEOTICID XEO02818 MOACRIVE Inhibition DME1304 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1304 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02819 XEO_CLAS Peptide DME1304 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.6 microM) DME1304 XEOTICID XEO02819 GENEFORM Protein DME1304 XEOTICID XEO02819 MOACRIVE Inhibition DME1304 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1304 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02820 XEO_CLAS Peptide DME1304 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO02820 GENEFORM Protein DME1304 XEOTICID XEO02820 MOACRIVE Inhibition DME1304 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1304 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02821 XEO_CLAS Peptide DME1304 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02821 GENEFORM Protein DME1304 XEOTICID XEO02821 MOACRIVE Inhibition DME1304 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1304 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02824 XEO_CLAS Peptide DME1304 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 35 microM) DME1304 XEOTICID XEO02824 GENEFORM Protein DME1304 XEOTICID XEO02824 MOACRIVE Inhibition DME1304 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1304 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02826 XEO_CLAS Peptide DME1304 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.7 ug/ml) DME1304 XEOTICID XEO02826 GENEFORM Protein DME1304 XEOTICID XEO02826 MOACRIVE Inhibition DME1304 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1304 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02834 GENEFORM Protein DME1304 XEOTICID XEO02834 MOACRIVE Inhibition DME1304 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1304 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02839 XEO_CLAS Peptide DME1304 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.25 microM) DME1304 XEOTICID XEO02839 GENEFORM Protein DME1304 XEOTICID XEO02839 MOACRIVE Inhibition DME1304 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1304 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02841 XEO_CLAS Peptide DME1304 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.25 microM) DME1304 XEOTICID XEO02841 GENEFORM Protein DME1304 XEOTICID XEO02841 MOACRIVE Inhibition DME1304 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1304 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02842 XEO_CLAS Peptide DME1304 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.25 microM) DME1304 XEOTICID XEO02842 GENEFORM Protein DME1304 XEOTICID XEO02842 MOACRIVE Inhibition DME1304 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1304 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02843 XEO_CLAS Peptide DME1304 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02843 GENEFORM Protein DME1304 XEOTICID XEO02843 MOACRIVE Inhibition DME1304 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1304 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02849 GENEFORM Protein DME1304 XEOTICID XEO02849 MOACRIVE Inhibition DME1304 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1304 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02857 XEO_CLAS Peptide DME1304 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 53 microM) DME1304 XEOTICID XEO02857 GENEFORM Protein DME1304 XEOTICID XEO02857 MOACRIVE Inhibition DME1304 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1304 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02858 XEO_CLAS Peptide DME1304 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 53 microM) DME1304 XEOTICID XEO02858 GENEFORM Protein DME1304 XEOTICID XEO02858 MOACRIVE Inhibition DME1304 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1304 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02860 XEO_CLAS Peptide DME1304 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 ug/ml) DME1304 XEOTICID XEO02860 GENEFORM Protein DME1304 XEOTICID XEO02860 MOACRIVE Inhibition DME1304 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1304 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02867 XEO_CLAS Peptide DME1304 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02867 GENEFORM Protein DME1304 XEOTICID XEO02867 MOACRIVE Inhibition DME1304 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1304 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02868 XEO_CLAS Peptide DME1304 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02868 GENEFORM Protein DME1304 XEOTICID XEO02868 MOACRIVE Inhibition DME1304 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1304 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02869 XEO_CLAS Peptide DME1304 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02869 GENEFORM Protein DME1304 XEOTICID XEO02869 MOACRIVE Inhibition DME1304 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1304 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02870 XEO_CLAS Peptide DME1304 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02870 GENEFORM Protein DME1304 XEOTICID XEO02870 MOACRIVE Inhibition DME1304 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1304 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02871 XEO_CLAS Peptide DME1304 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02871 GENEFORM Protein DME1304 XEOTICID XEO02871 MOACRIVE Inhibition DME1304 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1304 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02872 XEO_CLAS Peptide DME1304 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 308 microM) DME1304 XEOTICID XEO02872 GENEFORM Protein DME1304 XEOTICID XEO02872 MOACRIVE Inhibition DME1304 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1304 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02875 XEO_CLAS Peptide DME1304 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.1 microM) DME1304 XEOTICID XEO02875 GENEFORM Protein DME1304 XEOTICID XEO02875 MOACRIVE Inhibition DME1304 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1304 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02876 XEO_CLAS Peptide DME1304 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO02876 GENEFORM Protein DME1304 XEOTICID XEO02876 MOACRIVE Inhibition DME1304 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1304 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02877 XEO_CLAS Peptide DME1304 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO02877 GENEFORM Protein DME1304 XEOTICID XEO02877 MOACRIVE Inhibition DME1304 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1304 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02878 XEO_CLAS Peptide DME1304 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.3 microM) DME1304 XEOTICID XEO02878 GENEFORM Protein DME1304 XEOTICID XEO02878 MOACRIVE Inhibition DME1304 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1304 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02885 XEO_CLAS Peptide DME1304 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02885 GENEFORM Protein DME1304 XEOTICID XEO02885 MOACRIVE Inhibition DME1304 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1304 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02886 XEO_CLAS Peptide DME1304 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02886 GENEFORM Protein DME1304 XEOTICID XEO02886 MOACRIVE Inhibition DME1304 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1304 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02887 XEO_CLAS Peptide DME1304 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1 ug/ml) DME1304 XEOTICID XEO02887 GENEFORM Protein DME1304 XEOTICID XEO02887 MOACRIVE Inhibition DME1304 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1304 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02888 XEO_CLAS Peptide DME1304 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 ug/ml) DME1304 XEOTICID XEO02888 GENEFORM Protein DME1304 XEOTICID XEO02888 MOACRIVE Inhibition DME1304 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1304 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02889 XEO_CLAS Peptide DME1304 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 ug/ml) DME1304 XEOTICID XEO02889 GENEFORM Protein DME1304 XEOTICID XEO02889 MOACRIVE Inhibition DME1304 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1304 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02890 XEO_CLAS Peptide DME1304 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02890 GENEFORM Protein DME1304 XEOTICID XEO02890 MOACRIVE Inhibition DME1304 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1304 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02891 XEO_CLAS Peptide DME1304 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02891 GENEFORM Protein DME1304 XEOTICID XEO02891 MOACRIVE Inhibition DME1304 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1304 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02895 XEO_CLAS Peptide DME1304 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO02895 GENEFORM Protein DME1304 XEOTICID XEO02895 MOACRIVE Inhibition DME1304 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1304 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02896 XEO_CLAS Peptide DME1304 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO02896 GENEFORM Protein DME1304 XEOTICID XEO02896 MOACRIVE Inhibition DME1304 XEOTICID XEO02899 XEO_NAME Coladonin DME1304 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1304 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1304 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02899 GENEFORM Protein DME1304 XEOTICID XEO02899 MOACRIVE Inhibition DME1304 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1304 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02900 XEO_CLAS Peptide DME1304 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02900 GENEFORM Protein DME1304 XEOTICID XEO02900 MOACRIVE Inhibition DME1304 XEOTICID XEO02901 XEO_NAME Colicin-V DME1304 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02901 XEO_CLAS Peptide DME1304 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02901 GENEFORM Protein DME1304 XEOTICID XEO02901 MOACRIVE Inhibition DME1304 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1304 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02904 GENEFORM Protein DME1304 XEOTICID XEO02904 MOACRIVE Inhibition DME1304 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1304 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02908 XEO_CLAS Peptide DME1304 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 50 microM) DME1304 XEOTICID XEO02908 GENEFORM Protein DME1304 XEOTICID XEO02908 MOACRIVE Inhibition DME1304 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1304 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02923 XEO_CLAS Peptide DME1304 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02923 GENEFORM Protein DME1304 XEOTICID XEO02923 MOACRIVE Inhibition DME1304 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1304 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02924 XEO_CLAS Peptide DME1304 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 32 microM) DME1304 XEOTICID XEO02924 GENEFORM Protein DME1304 XEOTICID XEO02924 MOACRIVE Inhibition DME1304 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1304 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1304 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02927 GENEFORM Protein DME1304 XEOTICID XEO02927 MOACRIVE Inhibition DME1304 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1304 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02931 XEO_CLAS Peptide DME1304 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 ug/ml) DME1304 XEOTICID XEO02931 GENEFORM Protein DME1304 XEOTICID XEO02931 MOACRIVE Inhibition DME1304 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1304 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02933 XEO_CLAS Peptide DME1304 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO02933 GENEFORM Protein DME1304 XEOTICID XEO02933 MOACRIVE Inhibition DME1304 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1304 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02934 XEO_CLAS Peptide DME1304 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02934 GENEFORM Protein DME1304 XEOTICID XEO02934 MOACRIVE Inhibition DME1304 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1304 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02935 XEO_CLAS Peptide DME1304 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02935 GENEFORM Protein DME1304 XEOTICID XEO02935 MOACRIVE Inhibition DME1304 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1304 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02936 XEO_CLAS Peptide DME1304 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO02936 GENEFORM Protein DME1304 XEOTICID XEO02936 MOACRIVE Inhibition DME1304 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1304 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02937 XEO_CLAS Peptide DME1304 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02937 GENEFORM Protein DME1304 XEOTICID XEO02937 MOACRIVE Inhibition DME1304 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1304 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02938 XEO_CLAS Peptide DME1304 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 32 ug/ml) DME1304 XEOTICID XEO02938 GENEFORM Protein DME1304 XEOTICID XEO02938 MOACRIVE Inhibition DME1304 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1304 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02939 XEO_CLAS Peptide DME1304 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 11 ug/ml) DME1304 XEOTICID XEO02939 GENEFORM Protein DME1304 XEOTICID XEO02939 MOACRIVE Inhibition DME1304 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1304 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02940 XEO_CLAS Peptide DME1304 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1 ug/ml) DME1304 XEOTICID XEO02940 GENEFORM Protein DME1304 XEOTICID XEO02940 MOACRIVE Inhibition DME1304 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1304 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02941 XEO_CLAS Peptide DME1304 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02941 GENEFORM Protein DME1304 XEOTICID XEO02941 MOACRIVE Inhibition DME1304 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1304 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02944 XEO_CLAS Peptide DME1304 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 microM) DME1304 XEOTICID XEO02944 GENEFORM Protein DME1304 XEOTICID XEO02944 MOACRIVE Inhibition DME1304 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1304 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02945 XEO_CLAS Peptide DME1304 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 microM) DME1304 XEOTICID XEO02945 GENEFORM Protein DME1304 XEOTICID XEO02945 MOACRIVE Inhibition DME1304 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1304 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02946 XEO_CLAS Peptide DME1304 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 microM) DME1304 XEOTICID XEO02946 GENEFORM Protein DME1304 XEOTICID XEO02946 MOACRIVE Inhibition DME1304 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1304 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02947 XEO_CLAS Peptide DME1304 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02947 GENEFORM Protein DME1304 XEOTICID XEO02947 MOACRIVE Inhibition DME1304 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1304 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02948 XEO_CLAS Peptide DME1304 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO02948 GENEFORM Protein DME1304 XEOTICID XEO02948 MOACRIVE Inhibition DME1304 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1304 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02949 XEO_CLAS Peptide DME1304 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO02949 GENEFORM Protein DME1304 XEOTICID XEO02949 MOACRIVE Inhibition DME1304 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1304 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02954 XEO_CLAS Peptide DME1304 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02954 GENEFORM Protein DME1304 XEOTICID XEO02954 MOACRIVE Inhibition DME1304 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1304 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02958 XEO_CLAS Peptide DME1304 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02958 GENEFORM Protein DME1304 XEOTICID XEO02958 MOACRIVE Inhibition DME1304 XEOTICID XEO02962 XEO_NAME Cryptonin DME1304 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02962 XEO_CLAS Peptide DME1304 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.12 ug/ml) DME1304 XEOTICID XEO02962 GENEFORM Protein DME1304 XEOTICID XEO02962 MOACRIVE Inhibition DME1304 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1304 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02965 XEO_CLAS Peptide DME1304 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 ug/ml) DME1304 XEOTICID XEO02965 GENEFORM Protein DME1304 XEOTICID XEO02965 MOACRIVE Inhibition DME1304 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1304 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02969 XEO_CLAS Peptide DME1304 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 microM) DME1304 XEOTICID XEO02969 GENEFORM Protein DME1304 XEOTICID XEO02969 MOACRIVE Inhibition DME1304 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1304 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02971 XEO_CLAS Peptide DME1304 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 microM) DME1304 XEOTICID XEO02971 GENEFORM Protein DME1304 XEOTICID XEO02971 MOACRIVE Inhibition DME1304 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1304 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO02972 XEO_CLAS Peptide DME1304 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.4 microM) DME1304 XEOTICID XEO02972 GENEFORM Protein DME1304 XEOTICID XEO02972 MOACRIVE Inhibition DME1304 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1304 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02990 GENEFORM Protein DME1304 XEOTICID XEO02990 MOACRIVE Inhibition DME1304 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1304 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02991 GENEFORM Protein DME1304 XEOTICID XEO02991 MOACRIVE Inhibition DME1304 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1304 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02992 GENEFORM Protein DME1304 XEOTICID XEO02992 MOACRIVE Inhibition DME1304 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1304 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02993 GENEFORM Protein DME1304 XEOTICID XEO02993 MOACRIVE Inhibition DME1304 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1304 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02994 GENEFORM Protein DME1304 XEOTICID XEO02994 MOACRIVE Inhibition DME1304 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1304 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02995 GENEFORM Protein DME1304 XEOTICID XEO02995 MOACRIVE Inhibition DME1304 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1304 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02996 GENEFORM Protein DME1304 XEOTICID XEO02996 MOACRIVE Inhibition DME1304 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1304 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02997 GENEFORM Protein DME1304 XEOTICID XEO02997 MOACRIVE Inhibition DME1304 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1304 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02998 GENEFORM Protein DME1304 XEOTICID XEO02998 MOACRIVE Inhibition DME1304 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1304 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1304 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO02999 GENEFORM Protein DME1304 XEOTICID XEO02999 MOACRIVE Inhibition DME1304 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1304 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03021 XEO_CLAS Peptide DME1304 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.31-0.63 microM) DME1304 XEOTICID XEO03021 GENEFORM Protein DME1304 XEOTICID XEO03021 MOACRIVE Inhibition DME1304 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1304 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03029 XEO_CLAS Peptide DME1304 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.005 microM) DME1304 XEOTICID XEO03029 GENEFORM Protein DME1304 XEOTICID XEO03029 MOACRIVE Inhibition DME1304 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1304 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03030 XEO_CLAS Peptide DME1304 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.005 microM) DME1304 XEOTICID XEO03030 GENEFORM Protein DME1304 XEOTICID XEO03030 MOACRIVE Inhibition DME1304 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1304 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03031 XEO_CLAS Peptide DME1304 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.3 microM) DME1304 XEOTICID XEO03031 GENEFORM Protein DME1304 XEOTICID XEO03031 MOACRIVE Inhibition DME1304 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1304 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03032 XEO_CLAS Peptide DME1304 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.01 microM) DME1304 XEOTICID XEO03032 GENEFORM Protein DME1304 XEOTICID XEO03032 MOACRIVE Inhibition DME1304 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1304 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03033 XEO_CLAS Peptide DME1304 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.173 microM) DME1304 XEOTICID XEO03033 GENEFORM Protein DME1304 XEOTICID XEO03033 MOACRIVE Inhibition DME1304 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1304 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03034 XEO_CLAS Peptide DME1304 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.518 microM) DME1304 XEOTICID XEO03034 GENEFORM Protein DME1304 XEOTICID XEO03034 MOACRIVE Inhibition DME1304 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1304 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03035 XEO_CLAS Peptide DME1304 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.114 microM) DME1304 XEOTICID XEO03035 GENEFORM Protein DME1304 XEOTICID XEO03035 MOACRIVE Inhibition DME1304 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1304 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03039 XEO_CLAS Peptide DME1304 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.55 microM) DME1304 XEOTICID XEO03039 GENEFORM Protein DME1304 XEOTICID XEO03039 MOACRIVE Inhibition DME1304 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1304 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03043 XEO_CLAS Peptide DME1304 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 microM) DME1304 XEOTICID XEO03043 GENEFORM Protein DME1304 XEOTICID XEO03043 MOACRIVE Inhibition DME1304 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1304 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03044 XEO_CLAS Peptide DME1304 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03044 GENEFORM Protein DME1304 XEOTICID XEO03044 MOACRIVE Inhibition DME1304 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1304 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03045 XEO_CLAS Peptide DME1304 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03045 GENEFORM Protein DME1304 XEOTICID XEO03045 MOACRIVE Inhibition DME1304 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1304 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03046 XEO_CLAS Peptide DME1304 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03046 GENEFORM Protein DME1304 XEOTICID XEO03046 MOACRIVE Inhibition DME1304 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1304 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03049 XEO_CLAS Peptide DME1304 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 microM) DME1304 XEOTICID XEO03049 GENEFORM Protein DME1304 XEOTICID XEO03049 MOACRIVE Inhibition DME1304 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1304 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03055 XEO_CLAS Peptide DME1304 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 microM) DME1304 XEOTICID XEO03055 GENEFORM Protein DME1304 XEOTICID XEO03055 MOACRIVE Inhibition DME1304 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1304 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03059 XEO_CLAS Peptide DME1304 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO03059 GENEFORM Protein DME1304 XEOTICID XEO03059 MOACRIVE Inhibition DME1304 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1304 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03060 XEO_CLAS Peptide DME1304 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO03060 GENEFORM Protein DME1304 XEOTICID XEO03060 MOACRIVE Inhibition DME1304 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1304 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03062 XEO_CLAS Peptide DME1304 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO03062 GENEFORM Protein DME1304 XEOTICID XEO03062 MOACRIVE Inhibition DME1304 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1304 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03064 XEO_CLAS Peptide DME1304 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO03064 GENEFORM Protein DME1304 XEOTICID XEO03064 MOACRIVE Inhibition DME1304 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1304 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03066 XEO_CLAS Peptide DME1304 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO03066 GENEFORM Protein DME1304 XEOTICID XEO03066 MOACRIVE Inhibition DME1304 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1304 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03068 XEO_CLAS Peptide DME1304 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO03068 GENEFORM Protein DME1304 XEOTICID XEO03068 MOACRIVE Inhibition DME1304 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1304 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03073 XEO_CLAS Peptide DME1304 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8-16 ug/ml) DME1304 XEOTICID XEO03073 GENEFORM Protein DME1304 XEOTICID XEO03073 MOACRIVE Inhibition DME1304 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1304 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03081 XEO_CLAS Peptide DME1304 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 microM) DME1304 XEOTICID XEO03081 GENEFORM Protein DME1304 XEOTICID XEO03081 MOACRIVE Inhibition DME1304 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1304 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03082 XEO_CLAS Peptide DME1304 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03082 GENEFORM Protein DME1304 XEOTICID XEO03082 MOACRIVE Inhibition DME1304 XEOTICID XEO03089 XEO_NAME Decoralin DME1304 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03089 XEO_CLAS Peptide DME1304 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 160 microM) DME1304 XEOTICID XEO03089 GENEFORM Protein DME1304 XEOTICID XEO03089 MOACRIVE Inhibition DME1304 XEOTICID XEO03098 XEO_NAME Insect defensin DME1304 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03098 XEO_CLAS Peptide DME1304 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 ug/ml) DME1304 XEOTICID XEO03098 GENEFORM Protein DME1304 XEOTICID XEO03098 MOACRIVE Inhibition DME1304 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1304 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03100 XEO_CLAS Peptide DME1304 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03100 GENEFORM Protein DME1304 XEOTICID XEO03100 MOACRIVE Inhibition DME1304 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1304 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03103 XEO_CLAS Peptide DME1304 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03103 GENEFORM Protein DME1304 XEOTICID XEO03103 MOACRIVE Inhibition DME1304 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1304 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03105 XEO_CLAS Peptide DME1304 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03105 GENEFORM Protein DME1304 XEOTICID XEO03105 MOACRIVE Inhibition DME1304 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1304 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03110 XEO_CLAS Peptide DME1304 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.2 microM) DME1304 XEOTICID XEO03110 GENEFORM Protein DME1304 XEOTICID XEO03110 MOACRIVE Inhibition DME1304 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1304 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03111 XEO_CLAS Peptide DME1304 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03111 GENEFORM Protein DME1304 XEOTICID XEO03111 MOACRIVE Inhibition DME1304 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1304 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03112 XEO_CLAS Peptide DME1304 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 50 ug/ml) DME1304 XEOTICID XEO03112 GENEFORM Protein DME1304 XEOTICID XEO03112 MOACRIVE Inhibition DME1304 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1304 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03115 XEO_CLAS Peptide DME1304 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03115 GENEFORM Protein DME1304 XEOTICID XEO03115 MOACRIVE Inhibition DME1304 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1304 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03116 XEO_CLAS Peptide DME1304 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 40 microM) DME1304 XEOTICID XEO03116 GENEFORM Protein DME1304 XEOTICID XEO03116 MOACRIVE Inhibition DME1304 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1304 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03118 XEO_CLAS Peptide DME1304 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03118 GENEFORM Protein DME1304 XEOTICID XEO03118 MOACRIVE Inhibition DME1304 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1304 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03119 XEO_CLAS Peptide DME1304 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03119 GENEFORM Protein DME1304 XEOTICID XEO03119 MOACRIVE Inhibition DME1304 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1304 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03121 XEO_CLAS Peptide DME1304 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03121 GENEFORM Protein DME1304 XEOTICID XEO03121 MOACRIVE Inhibition DME1304 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1304 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03122 XEO_CLAS Peptide DME1304 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64000 ug/ml) DME1304 XEOTICID XEO03122 GENEFORM Protein DME1304 XEOTICID XEO03122 MOACRIVE Inhibition DME1304 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1304 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03124 XEO_CLAS Peptide DME1304 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03124 GENEFORM Protein DME1304 XEOTICID XEO03124 MOACRIVE Inhibition DME1304 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1304 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03125 XEO_CLAS Peptide DME1304 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03125 GENEFORM Protein DME1304 XEOTICID XEO03125 MOACRIVE Inhibition DME1304 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1304 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03126 XEO_CLAS Peptide DME1304 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.86 microM) DME1304 XEOTICID XEO03126 GENEFORM Protein DME1304 XEOTICID XEO03126 MOACRIVE Inhibition DME1304 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1304 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03127 XEO_CLAS Peptide DME1304 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03127 GENEFORM Protein DME1304 XEOTICID XEO03127 MOACRIVE Inhibition DME1304 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1304 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03128 XEO_CLAS Peptide DME1304 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 256 ug/ml) DME1304 XEOTICID XEO03128 GENEFORM Protein DME1304 XEOTICID XEO03128 MOACRIVE Inhibition DME1304 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1304 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03129 XEO_CLAS Peptide DME1304 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 256 ug/ml) DME1304 XEOTICID XEO03129 GENEFORM Protein DME1304 XEOTICID XEO03129 MOACRIVE Inhibition DME1304 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1304 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03130 XEO_CLAS Peptide DME1304 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 256 ug/ml) DME1304 XEOTICID XEO03130 GENEFORM Protein DME1304 XEOTICID XEO03130 MOACRIVE Inhibition DME1304 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1304 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03131 XEO_CLAS Peptide DME1304 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 256 ug/ml) DME1304 XEOTICID XEO03131 GENEFORM Protein DME1304 XEOTICID XEO03131 MOACRIVE Inhibition DME1304 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1304 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03132 XEO_CLAS Peptide DME1304 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 256 ug/ml) DME1304 XEOTICID XEO03132 GENEFORM Protein DME1304 XEOTICID XEO03132 MOACRIVE Inhibition DME1304 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1304 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03137 XEO_CLAS Peptide DME1304 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03137 GENEFORM Protein DME1304 XEOTICID XEO03137 MOACRIVE Inhibition DME1304 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1304 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03143 XEO_CLAS Peptide DME1304 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.6 microM) DME1304 XEOTICID XEO03143 GENEFORM Protein DME1304 XEOTICID XEO03143 MOACRIVE Inhibition DME1304 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1304 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03145 XEO_CLAS Peptide DME1304 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.6 microM) DME1304 XEOTICID XEO03145 GENEFORM Protein DME1304 XEOTICID XEO03145 MOACRIVE Inhibition DME1304 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1304 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03146 XEO_CLAS Peptide DME1304 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.5 microM) DME1304 XEOTICID XEO03146 GENEFORM Protein DME1304 XEOTICID XEO03146 MOACRIVE Inhibition DME1304 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1304 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03147 XEO_CLAS Peptide DME1304 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 9.7 microM) DME1304 XEOTICID XEO03147 GENEFORM Protein DME1304 XEOTICID XEO03147 MOACRIVE Inhibition DME1304 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1304 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03148 XEO_CLAS Peptide DME1304 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.3 microM) DME1304 XEOTICID XEO03148 GENEFORM Protein DME1304 XEOTICID XEO03148 MOACRIVE Inhibition DME1304 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1304 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03149 XEO_CLAS Peptide DME1304 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.6 microM) DME1304 XEOTICID XEO03149 GENEFORM Protein DME1304 XEOTICID XEO03149 MOACRIVE Inhibition DME1304 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1304 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03150 XEO_CLAS Peptide DME1304 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 9-3 microM) DME1304 XEOTICID XEO03150 GENEFORM Protein DME1304 XEOTICID XEO03150 MOACRIVE Inhibition DME1304 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1304 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03151 XEO_CLAS Peptide DME1304 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 ug/ml) DME1304 XEOTICID XEO03151 GENEFORM Protein DME1304 XEOTICID XEO03151 MOACRIVE Inhibition DME1304 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1304 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03152 XEO_CLAS Peptide DME1304 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO03152 GENEFORM Protein DME1304 XEOTICID XEO03152 MOACRIVE Inhibition DME1304 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1304 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03155 XEO_CLAS Peptide DME1304 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.4 microM) DME1304 XEOTICID XEO03155 GENEFORM Protein DME1304 XEOTICID XEO03155 MOACRIVE Inhibition DME1304 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1304 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03156 XEO_CLAS Peptide DME1304 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.3 microM) DME1304 XEOTICID XEO03156 GENEFORM Protein DME1304 XEOTICID XEO03156 MOACRIVE Inhibition DME1304 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1304 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03157 XEO_CLAS Peptide DME1304 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.3 microM) DME1304 XEOTICID XEO03157 GENEFORM Protein DME1304 XEOTICID XEO03157 MOACRIVE Inhibition DME1304 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1304 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03158 XEO_CLAS Peptide DME1304 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 ug/ml) DME1304 XEOTICID XEO03158 GENEFORM Protein DME1304 XEOTICID XEO03158 MOACRIVE Inhibition DME1304 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1304 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03159 XEO_CLAS Peptide DME1304 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03159 GENEFORM Protein DME1304 XEOTICID XEO03159 MOACRIVE Inhibition DME1304 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1304 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03161 XEO_CLAS Peptide DME1304 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 microM) DME1304 XEOTICID XEO03161 GENEFORM Protein DME1304 XEOTICID XEO03161 MOACRIVE Inhibition DME1304 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1304 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03162 XEO_CLAS Peptide DME1304 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.5 microM) DME1304 XEOTICID XEO03162 GENEFORM Protein DME1304 XEOTICID XEO03162 MOACRIVE Inhibition DME1304 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1304 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03169 XEO_CLAS Peptide DME1304 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO03169 GENEFORM Protein DME1304 XEOTICID XEO03169 MOACRIVE Inhibition DME1304 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1304 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03193 XEO_CLAS Peptide DME1304 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25 ug/ml) DME1304 XEOTICID XEO03193 GENEFORM Protein DME1304 XEOTICID XEO03193 MOACRIVE Inhibition DME1304 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1304 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03194 XEO_CLAS Peptide DME1304 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03194 GENEFORM Protein DME1304 XEOTICID XEO03194 MOACRIVE Inhibition DME1304 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1304 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03195 XEO_CLAS Peptide DME1304 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03195 GENEFORM Protein DME1304 XEOTICID XEO03195 MOACRIVE Inhibition DME1304 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1304 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03197 XEO_CLAS Peptide DME1304 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 14.5 microM) DME1304 XEOTICID XEO03197 GENEFORM Protein DME1304 XEOTICID XEO03197 MOACRIVE Inhibition DME1304 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1304 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03202 XEO_CLAS Peptide DME1304 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.51 microM) DME1304 XEOTICID XEO03202 GENEFORM Protein DME1304 XEOTICID XEO03202 MOACRIVE Inhibition DME1304 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1304 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03203 XEO_CLAS Peptide DME1304 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.62 microM) DME1304 XEOTICID XEO03203 GENEFORM Protein DME1304 XEOTICID XEO03203 MOACRIVE Inhibition DME1304 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1304 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03204 XEO_CLAS Peptide DME1304 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.38 microM) DME1304 XEOTICID XEO03204 GENEFORM Protein DME1304 XEOTICID XEO03204 MOACRIVE Inhibition DME1304 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1304 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03205 XEO_CLAS Peptide DME1304 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.29 microM) DME1304 XEOTICID XEO03205 GENEFORM Protein DME1304 XEOTICID XEO03205 MOACRIVE Inhibition DME1304 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1304 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03206 XEO_CLAS Peptide DME1304 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.40 microM) DME1304 XEOTICID XEO03206 GENEFORM Protein DME1304 XEOTICID XEO03206 MOACRIVE Inhibition DME1304 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1304 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03207 XEO_CLAS Peptide DME1304 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.58 microM) DME1304 XEOTICID XEO03207 GENEFORM Protein DME1304 XEOTICID XEO03207 MOACRIVE Inhibition DME1304 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1304 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03208 XEO_CLAS Peptide DME1304 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.76 microM) DME1304 XEOTICID XEO03208 GENEFORM Protein DME1304 XEOTICID XEO03208 MOACRIVE Inhibition DME1304 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1304 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03209 XEO_CLAS Peptide DME1304 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.49 microM) DME1304 XEOTICID XEO03209 GENEFORM Protein DME1304 XEOTICID XEO03209 MOACRIVE Inhibition DME1304 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1304 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03210 XEO_CLAS Peptide DME1304 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 7.07 microM) DME1304 XEOTICID XEO03210 GENEFORM Protein DME1304 XEOTICID XEO03210 MOACRIVE Inhibition DME1304 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1304 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03211 XEO_CLAS Peptide DME1304 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.40 microM) DME1304 XEOTICID XEO03211 GENEFORM Protein DME1304 XEOTICID XEO03211 MOACRIVE Inhibition DME1304 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1304 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03215 XEO_CLAS Peptide DME1304 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20.0 ug/ml) DME1304 XEOTICID XEO03215 GENEFORM Protein DME1304 XEOTICID XEO03215 MOACRIVE Inhibition DME1304 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1304 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03216 XEO_CLAS Peptide DME1304 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO03216 GENEFORM Protein DME1304 XEOTICID XEO03216 MOACRIVE Inhibition DME1304 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1304 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03217 XEO_CLAS Peptide DME1304 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO03217 GENEFORM Protein DME1304 XEOTICID XEO03217 MOACRIVE Inhibition DME1304 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1304 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03223 XEO_CLAS Peptide DME1304 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.8 microM) DME1304 XEOTICID XEO03223 GENEFORM Protein DME1304 XEOTICID XEO03223 MOACRIVE Inhibition DME1304 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1304 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03224 XEO_CLAS Peptide DME1304 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.1-0.25 microM) DME1304 XEOTICID XEO03224 GENEFORM Protein DME1304 XEOTICID XEO03224 MOACRIVE Inhibition DME1304 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1304 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03225 XEO_CLAS Peptide DME1304 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.3 microM) DME1304 XEOTICID XEO03225 GENEFORM Protein DME1304 XEOTICID XEO03225 MOACRIVE Inhibition DME1304 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1304 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03227 XEO_CLAS Peptide DME1304 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.3 microM) DME1304 XEOTICID XEO03227 GENEFORM Protein DME1304 XEOTICID XEO03227 MOACRIVE Inhibition DME1304 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1304 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03231 XEO_CLAS Peptide DME1304 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03231 GENEFORM Protein DME1304 XEOTICID XEO03231 MOACRIVE Inhibition DME1304 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1304 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03232 XEO_CLAS Peptide DME1304 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03232 GENEFORM Protein DME1304 XEOTICID XEO03232 MOACRIVE Inhibition DME1304 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1304 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03234 XEO_CLAS Peptide DME1304 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO03234 GENEFORM Protein DME1304 XEOTICID XEO03234 MOACRIVE Inhibition DME1304 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1304 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03235 XEO_CLAS Peptide DME1304 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 60 ug/ml) DME1304 XEOTICID XEO03235 GENEFORM Protein DME1304 XEOTICID XEO03235 MOACRIVE Inhibition DME1304 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1304 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03236 XEO_CLAS Peptide DME1304 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO03236 GENEFORM Protein DME1304 XEOTICID XEO03236 MOACRIVE Inhibition DME1304 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1304 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03237 XEO_CLAS Peptide DME1304 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 ug/ml) DME1304 XEOTICID XEO03237 GENEFORM Protein DME1304 XEOTICID XEO03237 MOACRIVE Inhibition DME1304 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1304 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03238 XEO_CLAS Peptide DME1304 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 ug/ml) DME1304 XEOTICID XEO03238 GENEFORM Protein DME1304 XEOTICID XEO03238 MOACRIVE Inhibition DME1304 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1304 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03239 XEO_CLAS Peptide DME1304 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 60 ug/ml) DME1304 XEOTICID XEO03239 GENEFORM Protein DME1304 XEOTICID XEO03239 MOACRIVE Inhibition DME1304 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1304 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03241 XEO_CLAS Peptide DME1304 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 128 microM) DME1304 XEOTICID XEO03241 GENEFORM Protein DME1304 XEOTICID XEO03241 MOACRIVE Inhibition DME1304 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1304 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03250 XEO_CLAS Peptide DME1304 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03250 GENEFORM Protein DME1304 XEOTICID XEO03250 MOACRIVE Inhibition DME1304 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1304 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03251 XEO_CLAS Peptide DME1304 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03251 GENEFORM Protein DME1304 XEOTICID XEO03251 MOACRIVE Inhibition DME1304 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1304 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03253 XEO_CLAS Peptide DME1304 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.1 ug/ml) DME1304 XEOTICID XEO03253 GENEFORM Protein DME1304 XEOTICID XEO03253 MOACRIVE Inhibition DME1304 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1304 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03274 XEO_CLAS Peptide DME1304 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.2 microM) DME1304 XEOTICID XEO03274 GENEFORM Protein DME1304 XEOTICID XEO03274 MOACRIVE Inhibition DME1304 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1304 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03275 XEO_CLAS Peptide DME1304 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO03275 GENEFORM Protein DME1304 XEOTICID XEO03275 MOACRIVE Inhibition DME1304 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1304 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03276 XEO_CLAS Peptide DME1304 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO03276 GENEFORM Protein DME1304 XEOTICID XEO03276 MOACRIVE Inhibition DME1304 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1304 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03277 XEO_CLAS Peptide DME1304 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.2 microM) DME1304 XEOTICID XEO03277 GENEFORM Protein DME1304 XEOTICID XEO03277 MOACRIVE Inhibition DME1304 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1304 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03278 XEO_CLAS Peptide DME1304 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO03278 GENEFORM Protein DME1304 XEOTICID XEO03278 MOACRIVE Inhibition DME1304 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1304 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03279 XEO_CLAS Peptide DME1304 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO03279 GENEFORM Protein DME1304 XEOTICID XEO03279 MOACRIVE Inhibition DME1304 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1304 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03280 XEO_CLAS Peptide DME1304 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 microM) DME1304 XEOTICID XEO03280 GENEFORM Protein DME1304 XEOTICID XEO03280 MOACRIVE Inhibition DME1304 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1304 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03281 XEO_CLAS Peptide DME1304 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.3 microM) DME1304 XEOTICID XEO03281 GENEFORM Protein DME1304 XEOTICID XEO03281 MOACRIVE Inhibition DME1304 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1304 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03282 XEO_CLAS Peptide DME1304 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.1 microM) DME1304 XEOTICID XEO03282 GENEFORM Protein DME1304 XEOTICID XEO03282 MOACRIVE Inhibition DME1304 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1304 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03283 XEO_CLAS Peptide DME1304 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 microM) DME1304 XEOTICID XEO03283 GENEFORM Protein DME1304 XEOTICID XEO03283 MOACRIVE Inhibition DME1304 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1304 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03284 XEO_CLAS Peptide DME1304 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.2 ug/ml) DME1304 XEOTICID XEO03284 GENEFORM Protein DME1304 XEOTICID XEO03284 MOACRIVE Inhibition DME1304 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1304 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03285 XEO_CLAS Peptide DME1304 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.5 ug/ml) DME1304 XEOTICID XEO03285 GENEFORM Protein DME1304 XEOTICID XEO03285 MOACRIVE Inhibition DME1304 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1304 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03286 XEO_CLAS Peptide DME1304 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.4 ug/ml) DME1304 XEOTICID XEO03286 GENEFORM Protein DME1304 XEOTICID XEO03286 MOACRIVE Inhibition DME1304 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1304 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03287 XEO_CLAS Peptide DME1304 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.6 ug/ml) DME1304 XEOTICID XEO03287 GENEFORM Protein DME1304 XEOTICID XEO03287 MOACRIVE Inhibition DME1304 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1304 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03288 XEO_CLAS Peptide DME1304 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.4 ug/ml) DME1304 XEOTICID XEO03288 GENEFORM Protein DME1304 XEOTICID XEO03288 MOACRIVE Inhibition DME1304 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1304 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03289 XEO_CLAS Peptide DME1304 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8.8 ug/ml) DME1304 XEOTICID XEO03289 GENEFORM Protein DME1304 XEOTICID XEO03289 MOACRIVE Inhibition DME1304 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1304 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03290 XEO_CLAS Peptide DME1304 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.5 ug/ml) DME1304 XEOTICID XEO03290 GENEFORM Protein DME1304 XEOTICID XEO03290 MOACRIVE Inhibition DME1304 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1304 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03291 XEO_CLAS Peptide DME1304 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8.6 ug/ml) DME1304 XEOTICID XEO03291 GENEFORM Protein DME1304 XEOTICID XEO03291 MOACRIVE Inhibition DME1304 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1304 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03292 XEO_CLAS Peptide DME1304 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4.1 ug/ml) DME1304 XEOTICID XEO03292 GENEFORM Protein DME1304 XEOTICID XEO03292 MOACRIVE Inhibition DME1304 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1304 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03293 XEO_CLAS Peptide DME1304 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1 microM) DME1304 XEOTICID XEO03293 GENEFORM Protein DME1304 XEOTICID XEO03293 MOACRIVE Inhibition DME1304 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1304 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03294 XEO_CLAS Peptide DME1304 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1 microM) DME1304 XEOTICID XEO03294 GENEFORM Protein DME1304 XEOTICID XEO03294 MOACRIVE Inhibition DME1304 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1304 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03295 XEO_CLAS Peptide DME1304 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.7 microM) DME1304 XEOTICID XEO03295 GENEFORM Protein DME1304 XEOTICID XEO03295 MOACRIVE Inhibition DME1304 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1304 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03296 XEO_CLAS Peptide DME1304 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03296 GENEFORM Protein DME1304 XEOTICID XEO03296 MOACRIVE Inhibition DME1304 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1304 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03297 XEO_CLAS Peptide DME1304 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03297 GENEFORM Protein DME1304 XEOTICID XEO03297 MOACRIVE Inhibition DME1304 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1304 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03298 XEO_CLAS Peptide DME1304 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.2 microM) DME1304 XEOTICID XEO03298 GENEFORM Protein DME1304 XEOTICID XEO03298 MOACRIVE Inhibition DME1304 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1304 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03299 XEO_CLAS Peptide DME1304 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.4 microM) DME1304 XEOTICID XEO03299 GENEFORM Protein DME1304 XEOTICID XEO03299 MOACRIVE Inhibition DME1304 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1304 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03300 XEO_CLAS Peptide DME1304 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 ug/ml) DME1304 XEOTICID XEO03300 GENEFORM Protein DME1304 XEOTICID XEO03300 MOACRIVE Inhibition DME1304 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1304 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03301 XEO_CLAS Peptide DME1304 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 ug/ml) DME1304 XEOTICID XEO03301 GENEFORM Protein DME1304 XEOTICID XEO03301 MOACRIVE Inhibition DME1304 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1304 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03302 XEO_CLAS Peptide DME1304 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1 microM) DME1304 XEOTICID XEO03302 GENEFORM Protein DME1304 XEOTICID XEO03302 MOACRIVE Inhibition DME1304 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1304 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03303 XEO_CLAS Peptide DME1304 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 microM) DME1304 XEOTICID XEO03303 GENEFORM Protein DME1304 XEOTICID XEO03303 MOACRIVE Inhibition DME1304 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1304 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03304 XEO_CLAS Peptide DME1304 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO03304 GENEFORM Protein DME1304 XEOTICID XEO03304 MOACRIVE Inhibition DME1304 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1304 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03305 XEO_CLAS Peptide DME1304 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 microM) DME1304 XEOTICID XEO03305 GENEFORM Protein DME1304 XEOTICID XEO03305 MOACRIVE Inhibition DME1304 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1304 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03306 XEO_CLAS Peptide DME1304 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO03306 GENEFORM Protein DME1304 XEOTICID XEO03306 MOACRIVE Inhibition DME1304 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1304 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03307 XEO_CLAS Peptide DME1304 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 34 ug/ml) DME1304 XEOTICID XEO03307 GENEFORM Protein DME1304 XEOTICID XEO03307 MOACRIVE Inhibition DME1304 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1304 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03308 XEO_CLAS Peptide DME1304 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO03308 GENEFORM Protein DME1304 XEOTICID XEO03308 MOACRIVE Inhibition DME1304 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1304 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03310 XEO_CLAS Peptide DME1304 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8.5 ug/ml) DME1304 XEOTICID XEO03310 GENEFORM Protein DME1304 XEOTICID XEO03310 MOACRIVE Inhibition DME1304 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1304 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03311 XEO_CLAS Peptide DME1304 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10.8 ug/ml) DME1304 XEOTICID XEO03311 GENEFORM Protein DME1304 XEOTICID XEO03311 MOACRIVE Inhibition DME1304 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1304 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03312 XEO_CLAS Peptide DME1304 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10.8 ug/ml) DME1304 XEOTICID XEO03312 GENEFORM Protein DME1304 XEOTICID XEO03312 MOACRIVE Inhibition DME1304 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1304 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03313 XEO_CLAS Peptide DME1304 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8.1 ug/ml) DME1304 XEOTICID XEO03313 GENEFORM Protein DME1304 XEOTICID XEO03313 MOACRIVE Inhibition DME1304 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1304 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03314 XEO_CLAS Peptide DME1304 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 7.9 ug/ml) DME1304 XEOTICID XEO03314 GENEFORM Protein DME1304 XEOTICID XEO03314 MOACRIVE Inhibition DME1304 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1304 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03315 XEO_CLAS Peptide DME1304 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.6 ug/ml) DME1304 XEOTICID XEO03315 GENEFORM Protein DME1304 XEOTICID XEO03315 MOACRIVE Inhibition DME1304 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1304 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03316 XEO_CLAS Peptide DME1304 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15.8 ug/ml) DME1304 XEOTICID XEO03316 GENEFORM Protein DME1304 XEOTICID XEO03316 MOACRIVE Inhibition DME1304 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1304 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03317 XEO_CLAS Peptide DME1304 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO03317 GENEFORM Protein DME1304 XEOTICID XEO03317 MOACRIVE Inhibition DME1304 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1304 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03318 XEO_CLAS Peptide DME1304 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1 microM) DME1304 XEOTICID XEO03318 GENEFORM Protein DME1304 XEOTICID XEO03318 MOACRIVE Inhibition DME1304 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1304 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03319 XEO_CLAS Peptide DME1304 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03319 GENEFORM Protein DME1304 XEOTICID XEO03319 MOACRIVE Inhibition DME1304 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1304 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03320 XEO_CLAS Peptide DME1304 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.1 microM) DME1304 XEOTICID XEO03320 GENEFORM Protein DME1304 XEOTICID XEO03320 MOACRIVE Inhibition DME1304 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1304 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03321 XEO_CLAS Peptide DME1304 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.8 microM) DME1304 XEOTICID XEO03321 GENEFORM Protein DME1304 XEOTICID XEO03321 MOACRIVE Inhibition DME1304 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1304 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1304 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03348 GENEFORM Protein DME1304 XEOTICID XEO03348 MOACRIVE Inhibition DME1304 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1304 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03362 XEO_CLAS Peptide DME1304 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO03362 GENEFORM Protein DME1304 XEOTICID XEO03362 MOACRIVE Inhibition DME1304 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1304 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03363 XEO_CLAS Peptide DME1304 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 microM) DME1304 XEOTICID XEO03363 GENEFORM Protein DME1304 XEOTICID XEO03363 MOACRIVE Inhibition DME1304 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1304 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03364 XEO_CLAS Peptide DME1304 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 microM) DME1304 XEOTICID XEO03364 GENEFORM Protein DME1304 XEOTICID XEO03364 MOACRIVE Inhibition DME1304 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1304 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03365 XEO_CLAS Peptide DME1304 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03365 GENEFORM Protein DME1304 XEOTICID XEO03365 MOACRIVE Inhibition DME1304 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1304 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03366 XEO_CLAS Peptide DME1304 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO03366 GENEFORM Protein DME1304 XEOTICID XEO03366 MOACRIVE Inhibition DME1304 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1304 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03367 XEO_CLAS Peptide DME1304 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 microM) DME1304 XEOTICID XEO03367 GENEFORM Protein DME1304 XEOTICID XEO03367 MOACRIVE Inhibition DME1304 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1304 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03368 XEO_CLAS Peptide DME1304 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 microM) DME1304 XEOTICID XEO03368 GENEFORM Protein DME1304 XEOTICID XEO03368 MOACRIVE Inhibition DME1304 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1304 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03379 XEO_CLAS Peptide DME1304 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.6 ug/ml) DME1304 XEOTICID XEO03379 GENEFORM Protein DME1304 XEOTICID XEO03379 MOACRIVE Inhibition DME1304 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1304 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03396 XEO_CLAS Peptide DME1304 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03396 GENEFORM Protein DME1304 XEOTICID XEO03396 MOACRIVE Inhibition DME1304 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1304 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03398 XEO_CLAS Peptide DME1304 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03398 GENEFORM Protein DME1304 XEOTICID XEO03398 MOACRIVE Inhibition DME1304 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1304 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03399 XEO_CLAS Peptide DME1304 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03399 GENEFORM Protein DME1304 XEOTICID XEO03399 MOACRIVE Inhibition DME1304 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1304 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03406 XEO_CLAS Peptide DME1304 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 ug/ml) DME1304 XEOTICID XEO03406 GENEFORM Protein DME1304 XEOTICID XEO03406 MOACRIVE Inhibition DME1304 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1304 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03424 XEO_CLAS Peptide DME1304 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03424 GENEFORM Protein DME1304 XEOTICID XEO03424 MOACRIVE Inhibition DME1304 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1304 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03426 XEO_CLAS Peptide DME1304 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO03426 GENEFORM Protein DME1304 XEOTICID XEO03426 MOACRIVE Inhibition DME1304 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1304 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03427 XEO_CLAS Peptide DME1304 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 microM) DME1304 XEOTICID XEO03427 GENEFORM Protein DME1304 XEOTICID XEO03427 MOACRIVE Inhibition DME1304 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1304 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03428 XEO_CLAS Peptide DME1304 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 ug/ml) DME1304 XEOTICID XEO03428 GENEFORM Protein DME1304 XEOTICID XEO03428 MOACRIVE Inhibition DME1304 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1304 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03430 XEO_CLAS Peptide DME1304 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 ug/ml) DME1304 XEOTICID XEO03430 GENEFORM Protein DME1304 XEOTICID XEO03430 MOACRIVE Inhibition DME1304 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1304 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03434 XEO_CLAS Peptide DME1304 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO03434 GENEFORM Protein DME1304 XEOTICID XEO03434 MOACRIVE Inhibition DME1304 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1304 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03442 XEO_CLAS Peptide DME1304 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 18.75 ug/ml) DME1304 XEOTICID XEO03442 GENEFORM Protein DME1304 XEOTICID XEO03442 MOACRIVE Inhibition DME1304 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1304 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03444 XEO_CLAS Peptide DME1304 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 37.50 ug/ml) DME1304 XEOTICID XEO03444 GENEFORM Protein DME1304 XEOTICID XEO03444 MOACRIVE Inhibition DME1304 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1304 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03459 XEO_CLAS Peptide DME1304 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03459 GENEFORM Protein DME1304 XEOTICID XEO03459 MOACRIVE Inhibition DME1304 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1304 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03460 XEO_CLAS Peptide DME1304 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03460 GENEFORM Protein DME1304 XEOTICID XEO03460 MOACRIVE Inhibition DME1304 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1304 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03461 XEO_CLAS Peptide DME1304 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.05 microM) DME1304 XEOTICID XEO03461 GENEFORM Protein DME1304 XEOTICID XEO03461 MOACRIVE Inhibition DME1304 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1304 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03462 XEO_CLAS Peptide DME1304 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03462 GENEFORM Protein DME1304 XEOTICID XEO03462 MOACRIVE Inhibition DME1304 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1304 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03463 XEO_CLAS Peptide DME1304 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03463 GENEFORM Protein DME1304 XEOTICID XEO03463 MOACRIVE Inhibition DME1304 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1304 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03467 XEO_CLAS Peptide DME1304 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03467 GENEFORM Protein DME1304 XEOTICID XEO03467 MOACRIVE Inhibition DME1304 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1304 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03468 XEO_CLAS Peptide DME1304 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03468 GENEFORM Protein DME1304 XEOTICID XEO03468 MOACRIVE Inhibition DME1304 XEOTICID XEO03471 XEO_NAME Gambicin DME1304 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03471 XEO_CLAS Peptide DME1304 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25-12.5 microM) DME1304 XEOTICID XEO03471 GENEFORM Protein DME1304 XEOTICID XEO03471 MOACRIVE Inhibition DME1304 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1304 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03485 XEO_CLAS Peptide DME1304 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4.07 ug/ml) DME1304 XEOTICID XEO03485 GENEFORM Protein DME1304 XEOTICID XEO03485 MOACRIVE Inhibition DME1304 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1304 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03486 XEO_CLAS Peptide DME1304 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.80 ug/ml) DME1304 XEOTICID XEO03486 GENEFORM Protein DME1304 XEOTICID XEO03486 MOACRIVE Inhibition DME1304 XEOTICID XEO03488 XEO_NAME GLK-19 DME1304 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03488 XEO_CLAS Peptide DME1304 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO03488 GENEFORM Protein DME1304 XEOTICID XEO03488 MOACRIVE Inhibition DME1304 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1304 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03497 XEO_CLAS Peptide DME1304 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.4-0.8 microM) DME1304 XEOTICID XEO03497 GENEFORM Protein DME1304 XEOTICID XEO03497 MOACRIVE Inhibition DME1304 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1304 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03498 XEO_CLAS Peptide DME1304 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.4-0.8 microM) DME1304 XEOTICID XEO03498 GENEFORM Protein DME1304 XEOTICID XEO03498 MOACRIVE Inhibition DME1304 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1304 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03500 XEO_CLAS Peptide DME1304 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-30 ug/ml) DME1304 XEOTICID XEO03500 GENEFORM Protein DME1304 XEOTICID XEO03500 MOACRIVE Inhibition DME1304 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1304 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03504 XEO_CLAS Peptide DME1304 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 ug/ml) DME1304 XEOTICID XEO03504 GENEFORM Protein DME1304 XEOTICID XEO03504 MOACRIVE Inhibition DME1304 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1304 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03505 XEO_CLAS Peptide DME1304 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 ug/ml) DME1304 XEOTICID XEO03505 GENEFORM Protein DME1304 XEOTICID XEO03505 MOACRIVE Inhibition DME1304 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1304 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03506 XEO_CLAS Peptide DME1304 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 ug/ml) DME1304 XEOTICID XEO03506 GENEFORM Protein DME1304 XEOTICID XEO03506 MOACRIVE Inhibition DME1304 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1304 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03513 XEO_CLAS Peptide DME1304 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO03513 GENEFORM Protein DME1304 XEOTICID XEO03513 MOACRIVE Inhibition DME1304 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1304 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03514 XEO_CLAS Peptide DME1304 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03514 GENEFORM Protein DME1304 XEOTICID XEO03514 MOACRIVE Inhibition DME1304 XEOTICID XEO03519 XEO_NAME Hadrurin DME1304 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03519 XEO_CLAS Peptide DME1304 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03519 GENEFORM Protein DME1304 XEOTICID XEO03519 MOACRIVE Inhibition DME1304 XEOTICID XEO03522 XEO_NAME Halocyntin DME1304 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03522 XEO_CLAS Peptide DME1304 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03522 GENEFORM Protein DME1304 XEOTICID XEO03522 MOACRIVE Inhibition DME1304 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1304 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03524 XEO_CLAS Peptide DME1304 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03524 GENEFORM Protein DME1304 XEOTICID XEO03524 MOACRIVE Inhibition DME1304 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1304 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03525 XEO_CLAS Peptide DME1304 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03525 GENEFORM Protein DME1304 XEOTICID XEO03525 MOACRIVE Inhibition DME1304 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1304 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03530 XEO_CLAS Peptide DME1304 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03530 GENEFORM Protein DME1304 XEOTICID XEO03530 MOACRIVE Inhibition DME1304 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1304 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03535 XEO_CLAS Peptide DME1304 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.4 microM) DME1304 XEOTICID XEO03535 GENEFORM Protein DME1304 XEOTICID XEO03535 MOACRIVE Inhibition DME1304 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1304 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03536 XEO_CLAS Peptide DME1304 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 80 microM) DME1304 XEOTICID XEO03536 GENEFORM Protein DME1304 XEOTICID XEO03536 MOACRIVE Inhibition DME1304 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1304 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03537 XEO_CLAS Peptide DME1304 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 ug/ml) DME1304 XEOTICID XEO03537 GENEFORM Protein DME1304 XEOTICID XEO03537 MOACRIVE Inhibition DME1304 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1304 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03538 XEO_CLAS Peptide DME1304 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 ug/ml) DME1304 XEOTICID XEO03538 GENEFORM Protein DME1304 XEOTICID XEO03538 MOACRIVE Inhibition DME1304 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1304 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03540 XEO_CLAS Peptide DME1304 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO03540 GENEFORM Protein DME1304 XEOTICID XEO03540 MOACRIVE Inhibition DME1304 XEOTICID XEO03542 XEO_NAME Hepcidin DME1304 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03542 XEO_CLAS Peptide DME1304 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 24 microM) DME1304 XEOTICID XEO03542 GENEFORM Protein DME1304 XEOTICID XEO03542 MOACRIVE Inhibition DME1304 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1304 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03544 XEO_CLAS Peptide DME1304 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03544 GENEFORM Protein DME1304 XEOTICID XEO03544 MOACRIVE Inhibition DME1304 XEOTICID XEO03548 XEO_NAME Hesperidin DME1304 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03548 GENEFORM Protein DME1304 XEOTICID XEO03548 MOACRIVE Inhibition DME1304 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1304 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1304 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03552 GENEFORM Protein DME1304 XEOTICID XEO03552 MOACRIVE Inhibition DME1304 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1304 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03556 XEO_CLAS Peptide DME1304 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO03556 GENEFORM Protein DME1304 XEOTICID XEO03556 MOACRIVE Inhibition DME1304 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1304 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03557 XEO_CLAS Peptide DME1304 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO03557 GENEFORM Protein DME1304 XEOTICID XEO03557 MOACRIVE Inhibition DME1304 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1304 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03558 XEO_CLAS Peptide DME1304 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 microM) DME1304 XEOTICID XEO03558 GENEFORM Protein DME1304 XEOTICID XEO03558 MOACRIVE Inhibition DME1304 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1304 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03559 XEO_CLAS Peptide DME1304 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 microM) DME1304 XEOTICID XEO03559 GENEFORM Protein DME1304 XEOTICID XEO03559 MOACRIVE Inhibition DME1304 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1304 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03560 XEO_CLAS Peptide DME1304 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 microM) DME1304 XEOTICID XEO03560 GENEFORM Protein DME1304 XEOTICID XEO03560 MOACRIVE Inhibition DME1304 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1304 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03561 XEO_CLAS Peptide DME1304 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03561 GENEFORM Protein DME1304 XEOTICID XEO03561 MOACRIVE Inhibition DME1304 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1304 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03567 XEO_CLAS Peptide DME1304 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03567 GENEFORM Protein DME1304 XEOTICID XEO03567 MOACRIVE Inhibition DME1304 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1304 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03569 XEO_CLAS Peptide DME1304 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 300 microM) DME1304 XEOTICID XEO03569 GENEFORM Protein DME1304 XEOTICID XEO03569 MOACRIVE Inhibition DME1304 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1304 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03570 XEO_CLAS Peptide DME1304 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03570 GENEFORM Protein DME1304 XEOTICID XEO03570 MOACRIVE Inhibition DME1304 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1304 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03572 XEO_CLAS Peptide DME1304 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1304 XEOTICID XEO03572 GENEFORM Protein DME1304 XEOTICID XEO03572 MOACRIVE Inhibition DME1304 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1304 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03573 XEO_CLAS Peptide DME1304 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 28.1 ug/ml) DME1304 XEOTICID XEO03573 GENEFORM Protein DME1304 XEOTICID XEO03573 MOACRIVE Inhibition DME1304 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1304 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03574 XEO_CLAS Peptide DME1304 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 500 microM) DME1304 XEOTICID XEO03574 GENEFORM Protein DME1304 XEOTICID XEO03574 MOACRIVE Inhibition DME1304 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1304 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03575 XEO_CLAS Peptide DME1304 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 18 microM) DME1304 XEOTICID XEO03575 GENEFORM Protein DME1304 XEOTICID XEO03575 MOACRIVE Inhibition DME1304 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1304 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03576 XEO_CLAS Peptide DME1304 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 750 microM) DME1304 XEOTICID XEO03576 GENEFORM Protein DME1304 XEOTICID XEO03576 MOACRIVE Inhibition DME1304 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1304 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03578 XEO_CLAS Peptide DME1304 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1304 XEOTICID XEO03578 GENEFORM Protein DME1304 XEOTICID XEO03578 MOACRIVE Inhibition DME1304 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1304 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03579 XEO_CLAS Peptide DME1304 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03579 GENEFORM Protein DME1304 XEOTICID XEO03579 MOACRIVE Inhibition DME1304 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1304 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03580 XEO_CLAS Peptide DME1304 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03580 GENEFORM Protein DME1304 XEOTICID XEO03580 MOACRIVE Inhibition DME1304 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1304 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03585 XEO_CLAS Peptide DME1304 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 125 ug/ml) DME1304 XEOTICID XEO03585 GENEFORM Protein DME1304 XEOTICID XEO03585 MOACRIVE Inhibition DME1304 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1304 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03588 XEO_CLAS Peptide DME1304 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 62 ug/ml) DME1304 XEOTICID XEO03588 GENEFORM Protein DME1304 XEOTICID XEO03588 MOACRIVE Inhibition DME1304 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1304 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03589 XEO_CLAS Peptide DME1304 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03589 GENEFORM Protein DME1304 XEOTICID XEO03589 MOACRIVE Inhibition DME1304 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1304 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03590 XEO_CLAS Peptide DME1304 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03590 GENEFORM Protein DME1304 XEOTICID XEO03590 MOACRIVE Inhibition DME1304 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1304 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03591 XEO_CLAS Peptide DME1304 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 37.5 ug/ml) DME1304 XEOTICID XEO03591 GENEFORM Protein DME1304 XEOTICID XEO03591 MOACRIVE Inhibition DME1304 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1304 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03593 XEO_CLAS Peptide DME1304 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 9.4 ug/ml) DME1304 XEOTICID XEO03593 GENEFORM Protein DME1304 XEOTICID XEO03593 MOACRIVE Inhibition DME1304 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1304 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03594 XEO_CLAS Peptide DME1304 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 ug/ml) DME1304 XEOTICID XEO03594 GENEFORM Protein DME1304 XEOTICID XEO03594 MOACRIVE Inhibition DME1304 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1304 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03595 XEO_CLAS Peptide DME1304 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03595 GENEFORM Protein DME1304 XEOTICID XEO03595 MOACRIVE Inhibition DME1304 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1304 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03596 XEO_CLAS Peptide DME1304 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03596 GENEFORM Protein DME1304 XEOTICID XEO03596 MOACRIVE Inhibition DME1304 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1304 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03598 XEO_CLAS Peptide DME1304 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03598 GENEFORM Protein DME1304 XEOTICID XEO03598 MOACRIVE Inhibition DME1304 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1304 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03599 XEO_CLAS Peptide DME1304 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03599 GENEFORM Protein DME1304 XEOTICID XEO03599 MOACRIVE Inhibition DME1304 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1304 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03600 XEO_CLAS Peptide DME1304 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03600 GENEFORM Protein DME1304 XEOTICID XEO03600 MOACRIVE Inhibition DME1304 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1304 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03606 XEO_CLAS Peptide DME1304 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03606 GENEFORM Protein DME1304 XEOTICID XEO03606 MOACRIVE Inhibition DME1304 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1304 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03607 XEO_CLAS Peptide DME1304 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03607 GENEFORM Protein DME1304 XEOTICID XEO03607 MOACRIVE Inhibition DME1304 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1304 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03609 XEO_CLAS Peptide DME1304 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03609 GENEFORM Protein DME1304 XEOTICID XEO03609 MOACRIVE Inhibition DME1304 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1304 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03615 XEO_CLAS Peptide DME1304 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1304 XEOTICID XEO03615 GENEFORM Protein DME1304 XEOTICID XEO03615 MOACRIVE Inhibition DME1304 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1304 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03616 XEO_CLAS Peptide DME1304 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 32 microM) DME1304 XEOTICID XEO03616 GENEFORM Protein DME1304 XEOTICID XEO03616 MOACRIVE Inhibition DME1304 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1304 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03617 XEO_CLAS Peptide DME1304 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40 microM) DME1304 XEOTICID XEO03617 GENEFORM Protein DME1304 XEOTICID XEO03617 MOACRIVE Inhibition DME1304 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1304 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03618 XEO_CLAS Peptide DME1304 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5-1 microM) DME1304 XEOTICID XEO03618 GENEFORM Protein DME1304 XEOTICID XEO03618 MOACRIVE Inhibition DME1304 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1304 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03622 XEO_CLAS Peptide DME1304 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20-40 microM) DME1304 XEOTICID XEO03622 GENEFORM Protein DME1304 XEOTICID XEO03622 MOACRIVE Inhibition DME1304 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1304 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03627 XEO_CLAS Peptide DME1304 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.4-0.8 microM) DME1304 XEOTICID XEO03627 GENEFORM Protein DME1304 XEOTICID XEO03627 MOACRIVE Inhibition DME1304 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1304 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03630 XEO_CLAS Peptide DME1304 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03630 GENEFORM Protein DME1304 XEOTICID XEO03630 MOACRIVE Inhibition DME1304 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1304 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03631 XEO_CLAS Peptide DME1304 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03631 GENEFORM Protein DME1304 XEOTICID XEO03631 MOACRIVE Inhibition DME1304 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1304 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03632 XEO_CLAS Peptide DME1304 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03632 GENEFORM Protein DME1304 XEOTICID XEO03632 MOACRIVE Inhibition DME1304 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1304 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03633 XEO_CLAS Peptide DME1304 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03633 GENEFORM Protein DME1304 XEOTICID XEO03633 MOACRIVE Inhibition DME1304 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1304 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03634 XEO_CLAS Peptide DME1304 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03634 GENEFORM Protein DME1304 XEOTICID XEO03634 MOACRIVE Inhibition DME1304 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1304 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03635 XEO_CLAS Peptide DME1304 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03635 GENEFORM Protein DME1304 XEOTICID XEO03635 MOACRIVE Inhibition DME1304 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1304 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03636 XEO_CLAS Peptide DME1304 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03636 GENEFORM Protein DME1304 XEOTICID XEO03636 MOACRIVE Inhibition DME1304 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1304 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03637 XEO_CLAS Peptide DME1304 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03637 GENEFORM Protein DME1304 XEOTICID XEO03637 MOACRIVE Inhibition DME1304 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1304 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03638 XEO_CLAS Peptide DME1304 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03638 GENEFORM Protein DME1304 XEOTICID XEO03638 MOACRIVE Inhibition DME1304 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1304 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03639 XEO_CLAS Peptide DME1304 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03639 GENEFORM Protein DME1304 XEOTICID XEO03639 MOACRIVE Inhibition DME1304 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1304 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03640 XEO_CLAS Peptide DME1304 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03640 GENEFORM Protein DME1304 XEOTICID XEO03640 MOACRIVE Inhibition DME1304 XEOTICID XEO03644 XEO_NAME Indole DME1304 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1304 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1304 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03644 GENEFORM Protein DME1304 XEOTICID XEO03644 MOACRIVE Inhibition DME1304 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1304 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03650 XEO_CLAS Peptide DME1304 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03650 GENEFORM Protein DME1304 XEOTICID XEO03650 MOACRIVE Inhibition DME1304 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1304 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO03655 XEO_CLAS Natural Product DME1304 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03655 GENEFORM Protein DME1304 XEOTICID XEO03655 MOACRIVE Inhibition DME1304 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1304 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03666 XEO_CLAS Peptide DME1304 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 ug/ml) DME1304 XEOTICID XEO03666 GENEFORM Protein DME1304 XEOTICID XEO03666 MOACRIVE Inhibition DME1304 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1304 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03667 XEO_CLAS Peptide DME1304 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 ug/ml) DME1304 XEOTICID XEO03667 GENEFORM Protein DME1304 XEOTICID XEO03667 MOACRIVE Inhibition DME1304 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1304 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03668 XEO_CLAS Peptide DME1304 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 microM) DME1304 XEOTICID XEO03668 GENEFORM Protein DME1304 XEOTICID XEO03668 MOACRIVE Inhibition DME1304 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1304 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03669 XEO_CLAS Peptide DME1304 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO03669 GENEFORM Protein DME1304 XEOTICID XEO03669 MOACRIVE Inhibition DME1304 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1304 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03670 XEO_CLAS Peptide DME1304 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 microM) DME1304 XEOTICID XEO03670 GENEFORM Protein DME1304 XEOTICID XEO03670 MOACRIVE Inhibition DME1304 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1304 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03672 XEO_CLAS Peptide DME1304 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.5 ug/ml) DME1304 XEOTICID XEO03672 GENEFORM Protein DME1304 XEOTICID XEO03672 MOACRIVE Inhibition DME1304 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1304 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03673 XEO_CLAS Peptide DME1304 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 ug/ml) DME1304 XEOTICID XEO03673 GENEFORM Protein DME1304 XEOTICID XEO03673 MOACRIVE Inhibition DME1304 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1304 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03674 XEO_CLAS Peptide DME1304 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 ug/ml) DME1304 XEOTICID XEO03674 GENEFORM Protein DME1304 XEOTICID XEO03674 MOACRIVE Inhibition DME1304 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1304 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03675 XEO_CLAS Peptide DME1304 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO03675 GENEFORM Protein DME1304 XEOTICID XEO03675 MOACRIVE Inhibition DME1304 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1304 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03678 XEO_CLAS Peptide DME1304 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 ug/ml) DME1304 XEOTICID XEO03678 GENEFORM Protein DME1304 XEOTICID XEO03678 MOACRIVE Inhibition DME1304 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1304 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03679 XEO_CLAS Peptide DME1304 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 ug/ml) DME1304 XEOTICID XEO03679 GENEFORM Protein DME1304 XEOTICID XEO03679 MOACRIVE Inhibition DME1304 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1304 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03681 XEO_CLAS Peptide DME1304 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.3-0.6 microM) DME1304 XEOTICID XEO03681 GENEFORM Protein DME1304 XEOTICID XEO03681 MOACRIVE Inhibition DME1304 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1304 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03684 XEO_CLAS Peptide DME1304 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 ug/ml) DME1304 XEOTICID XEO03684 GENEFORM Protein DME1304 XEOTICID XEO03684 MOACRIVE Inhibition DME1304 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1304 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03694 XEO_CLAS Peptide DME1304 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03694 GENEFORM Protein DME1304 XEOTICID XEO03694 MOACRIVE Inhibition DME1304 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1304 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03697 XEO_CLAS Peptide DME1304 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25 microM) DME1304 XEOTICID XEO03697 GENEFORM Protein DME1304 XEOTICID XEO03697 MOACRIVE Inhibition DME1304 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1304 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03698 XEO_CLAS Peptide DME1304 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03698 GENEFORM Protein DME1304 XEOTICID XEO03698 MOACRIVE Inhibition DME1304 XEOTICID XEO03703 XEO_NAME Kasstasin DME1304 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03703 XEO_CLAS Peptide DME1304 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 110 microM) DME1304 XEOTICID XEO03703 GENEFORM Protein DME1304 XEOTICID XEO03703 MOACRIVE Inhibition DME1304 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1304 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03706 XEO_CLAS Peptide DME1304 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03706 GENEFORM Protein DME1304 XEOTICID XEO03706 MOACRIVE Inhibition DME1304 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1304 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03707 XEO_CLAS Peptide DME1304 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03707 GENEFORM Protein DME1304 XEOTICID XEO03707 MOACRIVE Inhibition DME1304 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1304 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03709 XEO_CLAS Peptide DME1304 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 ug/ml) DME1304 XEOTICID XEO03709 GENEFORM Protein DME1304 XEOTICID XEO03709 MOACRIVE Inhibition DME1304 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1304 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03712 XEO_CLAS Peptide DME1304 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03712 GENEFORM Protein DME1304 XEOTICID XEO03712 MOACRIVE Inhibition DME1304 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1304 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03713 XEO_CLAS Peptide DME1304 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 64 microM) DME1304 XEOTICID XEO03713 GENEFORM Protein DME1304 XEOTICID XEO03713 MOACRIVE Inhibition DME1304 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1304 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03714 XEO_CLAS Peptide DME1304 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03714 GENEFORM Protein DME1304 XEOTICID XEO03714 MOACRIVE Inhibition DME1304 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1304 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03715 XEO_CLAS Peptide DME1304 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 microM) DME1304 XEOTICID XEO03715 GENEFORM Protein DME1304 XEOTICID XEO03715 MOACRIVE Inhibition DME1304 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1304 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03719 XEO_CLAS Peptide DME1304 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 microM) DME1304 XEOTICID XEO03719 GENEFORM Protein DME1304 XEOTICID XEO03719 MOACRIVE Inhibition DME1304 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1304 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03720 XEO_CLAS Peptide DME1304 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 microM) DME1304 XEOTICID XEO03720 GENEFORM Protein DME1304 XEOTICID XEO03720 MOACRIVE Inhibition DME1304 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1304 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03723 XEO_CLAS Peptide DME1304 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 62.36 microM) DME1304 XEOTICID XEO03723 GENEFORM Protein DME1304 XEOTICID XEO03723 MOACRIVE Inhibition DME1304 XEOTICID XEO03724 XEO_NAME L10 peptide DME1304 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03724 XEO_CLAS Peptide DME1304 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.8 microM) DME1304 XEOTICID XEO03724 GENEFORM Protein DME1304 XEOTICID XEO03724 MOACRIVE Inhibition DME1304 XEOTICID XEO03726 XEO_NAME L2 peptide DME1304 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03726 XEO_CLAS Peptide DME1304 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 129.66 microM) DME1304 XEOTICID XEO03726 GENEFORM Protein DME1304 XEOTICID XEO03726 MOACRIVE Inhibition DME1304 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1304 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03727 XEO_CLAS Peptide DME1304 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 80 ug/ml) DME1304 XEOTICID XEO03727 GENEFORM Protein DME1304 XEOTICID XEO03727 MOACRIVE Inhibition DME1304 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1304 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03728 XEO_CLAS Peptide DME1304 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40 ug/ml) DME1304 XEOTICID XEO03728 GENEFORM Protein DME1304 XEOTICID XEO03728 MOACRIVE Inhibition DME1304 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1304 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03729 XEO_CLAS Peptide DME1304 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 80 ug/ml) DME1304 XEOTICID XEO03729 GENEFORM Protein DME1304 XEOTICID XEO03729 MOACRIVE Inhibition DME1304 XEOTICID XEO03730 XEO_NAME L3 peptide DME1304 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03730 XEO_CLAS Peptide DME1304 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64.11 microM) DME1304 XEOTICID XEO03730 GENEFORM Protein DME1304 XEOTICID XEO03730 MOACRIVE Inhibition DME1304 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1304 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03731 XEO_CLAS Peptide DME1304 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40 ug/ml) DME1304 XEOTICID XEO03731 GENEFORM Protein DME1304 XEOTICID XEO03731 MOACRIVE Inhibition DME1304 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1304 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03733 XEO_CLAS Peptide DME1304 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40 ug/ml) DME1304 XEOTICID XEO03733 GENEFORM Protein DME1304 XEOTICID XEO03733 MOACRIVE Inhibition DME1304 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1304 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03734 XEO_CLAS Peptide DME1304 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO03734 GENEFORM Protein DME1304 XEOTICID XEO03734 MOACRIVE Inhibition DME1304 XEOTICID XEO03735 XEO_NAME L4 peptide DME1304 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03735 XEO_CLAS Peptide DME1304 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 31.61 microM) DME1304 XEOTICID XEO03735 GENEFORM Protein DME1304 XEOTICID XEO03735 MOACRIVE Inhibition DME1304 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1304 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03738 XEO_CLAS Peptide DME1304 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 ug/ml) DME1304 XEOTICID XEO03738 GENEFORM Protein DME1304 XEOTICID XEO03738 MOACRIVE Inhibition DME1304 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1304 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03741 XEO_CLAS Peptide DME1304 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40 ug/ml) DME1304 XEOTICID XEO03741 GENEFORM Protein DME1304 XEOTICID XEO03741 MOACRIVE Inhibition DME1304 XEOTICID XEO03742 XEO_NAME L5 peptide DME1304 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03742 XEO_CLAS Peptide DME1304 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 7.79 microM) DME1304 XEOTICID XEO03742 GENEFORM Protein DME1304 XEOTICID XEO03742 MOACRIVE Inhibition DME1304 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1304 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03743 XEO_CLAS Peptide DME1304 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 ug/ml) DME1304 XEOTICID XEO03743 GENEFORM Protein DME1304 XEOTICID XEO03743 MOACRIVE Inhibition DME1304 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1304 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03744 XEO_CLAS Peptide DME1304 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 ug/ml) DME1304 XEOTICID XEO03744 GENEFORM Protein DME1304 XEOTICID XEO03744 MOACRIVE Inhibition DME1304 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1304 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03745 XEO_CLAS Peptide DME1304 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 ug/ml) DME1304 XEOTICID XEO03745 GENEFORM Protein DME1304 XEOTICID XEO03745 MOACRIVE Inhibition DME1304 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1304 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03746 XEO_CLAS Peptide DME1304 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO03746 GENEFORM Protein DME1304 XEOTICID XEO03746 MOACRIVE Inhibition DME1304 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1304 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03747 XEO_CLAS Peptide DME1304 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO03747 GENEFORM Protein DME1304 XEOTICID XEO03747 MOACRIVE Inhibition DME1304 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1304 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03748 XEO_CLAS Peptide DME1304 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO03748 GENEFORM Protein DME1304 XEOTICID XEO03748 MOACRIVE Inhibition DME1304 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1304 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03749 XEO_CLAS Peptide DME1304 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO03749 GENEFORM Protein DME1304 XEOTICID XEO03749 MOACRIVE Inhibition DME1304 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1304 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03750 XEO_CLAS Peptide DME1304 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO03750 GENEFORM Protein DME1304 XEOTICID XEO03750 MOACRIVE Inhibition DME1304 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1304 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03751 XEO_CLAS Peptide DME1304 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO03751 GENEFORM Protein DME1304 XEOTICID XEO03751 MOACRIVE Inhibition DME1304 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1304 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03752 XEO_CLAS Peptide DME1304 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO03752 GENEFORM Protein DME1304 XEOTICID XEO03752 MOACRIVE Inhibition DME1304 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1304 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03753 XEO_CLAS Peptide DME1304 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 ug/ml) DME1304 XEOTICID XEO03753 GENEFORM Protein DME1304 XEOTICID XEO03753 MOACRIVE Inhibition DME1304 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1304 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03754 XEO_CLAS Peptide DME1304 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO03754 GENEFORM Protein DME1304 XEOTICID XEO03754 MOACRIVE Inhibition DME1304 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1304 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03755 XEO_CLAS Peptide DME1304 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO03755 GENEFORM Protein DME1304 XEOTICID XEO03755 MOACRIVE Inhibition DME1304 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1304 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03756 XEO_CLAS Peptide DME1304 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO03756 GENEFORM Protein DME1304 XEOTICID XEO03756 MOACRIVE Inhibition DME1304 XEOTICID XEO03757 XEO_NAME L6 peptide DME1304 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03757 XEO_CLAS Peptide DME1304 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15.17 microM) DME1304 XEOTICID XEO03757 GENEFORM Protein DME1304 XEOTICID XEO03757 MOACRIVE Inhibition DME1304 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1304 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03758 XEO_CLAS Peptide DME1304 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 80 ug/ml) DME1304 XEOTICID XEO03758 GENEFORM Protein DME1304 XEOTICID XEO03758 MOACRIVE Inhibition DME1304 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1304 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03759 XEO_CLAS Peptide DME1304 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.3 ug/ml) DME1304 XEOTICID XEO03759 GENEFORM Protein DME1304 XEOTICID XEO03759 MOACRIVE Inhibition DME1304 XEOTICID XEO03760 XEO_NAME L7 peptide DME1304 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03760 XEO_CLAS Peptide DME1304 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16.02 microM) DME1304 XEOTICID XEO03760 GENEFORM Protein DME1304 XEOTICID XEO03760 MOACRIVE Inhibition DME1304 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1304 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03761 XEO_CLAS Peptide DME1304 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 ug/ml) DME1304 XEOTICID XEO03761 GENEFORM Protein DME1304 XEOTICID XEO03761 MOACRIVE Inhibition DME1304 XEOTICID XEO03763 XEO_NAME L8 peptide DME1304 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03763 XEO_CLAS Peptide DME1304 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.71 microM) DME1304 XEOTICID XEO03763 GENEFORM Protein DME1304 XEOTICID XEO03763 MOACRIVE Inhibition DME1304 XEOTICID XEO03765 XEO_NAME L9 peptide DME1304 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03765 XEO_CLAS Peptide DME1304 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.78 microM) DME1304 XEOTICID XEO03765 GENEFORM Protein DME1304 XEOTICID XEO03765 MOACRIVE Inhibition DME1304 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1304 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03775 XEO_CLAS Peptide DME1304 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 17.3 microM) DME1304 XEOTICID XEO03775 GENEFORM Protein DME1304 XEOTICID XEO03775 MOACRIVE Inhibition DME1304 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1304 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03776 XEO_CLAS Peptide DME1304 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03776 GENEFORM Protein DME1304 XEOTICID XEO03776 MOACRIVE Inhibition DME1304 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1304 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03781 XEO_CLAS Peptide DME1304 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.47 microM) DME1304 XEOTICID XEO03781 GENEFORM Protein DME1304 XEOTICID XEO03781 MOACRIVE Inhibition DME1304 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1304 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03782 XEO_CLAS Peptide DME1304 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.47 microM) DME1304 XEOTICID XEO03782 GENEFORM Protein DME1304 XEOTICID XEO03782 MOACRIVE Inhibition DME1304 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1304 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03783 XEO_CLAS Peptide DME1304 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.68 microM) DME1304 XEOTICID XEO03783 GENEFORM Protein DME1304 XEOTICID XEO03783 MOACRIVE Inhibition DME1304 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1304 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03784 XEO_CLAS Peptide DME1304 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.45 microM) DME1304 XEOTICID XEO03784 GENEFORM Protein DME1304 XEOTICID XEO03784 MOACRIVE Inhibition DME1304 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1304 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03785 XEO_CLAS Peptide DME1304 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.73 microM) DME1304 XEOTICID XEO03785 GENEFORM Protein DME1304 XEOTICID XEO03785 MOACRIVE Inhibition DME1304 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1304 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03786 XEO_CLAS Peptide DME1304 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.45 microM) DME1304 XEOTICID XEO03786 GENEFORM Protein DME1304 XEOTICID XEO03786 MOACRIVE Inhibition DME1304 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1304 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03787 XEO_CLAS Peptide DME1304 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.38 microM) DME1304 XEOTICID XEO03787 GENEFORM Protein DME1304 XEOTICID XEO03787 MOACRIVE Inhibition DME1304 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1304 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03788 XEO_CLAS Peptide DME1304 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.46 microM) DME1304 XEOTICID XEO03788 GENEFORM Protein DME1304 XEOTICID XEO03788 MOACRIVE Inhibition DME1304 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1304 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03789 XEO_CLAS Peptide DME1304 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 13.05 microM) DME1304 XEOTICID XEO03789 GENEFORM Protein DME1304 XEOTICID XEO03789 MOACRIVE Inhibition DME1304 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1304 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03790 XEO_CLAS Peptide DME1304 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.82 microM) DME1304 XEOTICID XEO03790 GENEFORM Protein DME1304 XEOTICID XEO03790 MOACRIVE Inhibition DME1304 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1304 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03791 XEO_CLAS Peptide DME1304 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.80 microM) DME1304 XEOTICID XEO03791 GENEFORM Protein DME1304 XEOTICID XEO03791 MOACRIVE Inhibition DME1304 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1304 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03792 XEO_CLAS Peptide DME1304 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.26 microM) DME1304 XEOTICID XEO03792 GENEFORM Protein DME1304 XEOTICID XEO03792 MOACRIVE Inhibition DME1304 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1304 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03793 XEO_CLAS Peptide DME1304 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 microM) DME1304 XEOTICID XEO03793 GENEFORM Protein DME1304 XEOTICID XEO03793 MOACRIVE Inhibition DME1304 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1304 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03797 XEO_CLAS Peptide DME1304 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.4 microM) DME1304 XEOTICID XEO03797 GENEFORM Protein DME1304 XEOTICID XEO03797 MOACRIVE Inhibition DME1304 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1304 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03798 XEO_CLAS Peptide DME1304 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03798 GENEFORM Protein DME1304 XEOTICID XEO03798 MOACRIVE Inhibition DME1304 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1304 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03799 XEO_CLAS Peptide DME1304 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03799 GENEFORM Protein DME1304 XEOTICID XEO03799 MOACRIVE Inhibition DME1304 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1304 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03810 XEO_CLAS Peptide DME1304 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03810 GENEFORM Protein DME1304 XEOTICID XEO03810 MOACRIVE Inhibition DME1304 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1304 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03846 XEO_CLAS Peptide DME1304 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03846 GENEFORM Protein DME1304 XEOTICID XEO03846 MOACRIVE Inhibition DME1304 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1304 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03847 XEO_CLAS Peptide DME1304 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03847 GENEFORM Protein DME1304 XEOTICID XEO03847 MOACRIVE Inhibition DME1304 XEOTICID XEO03850 XEO_NAME Lemon DME1304 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1304 XEOTICID XEO03850 XEO_CLAS Food Additive DME1304 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03850 GENEFORM Protein DME1304 XEOTICID XEO03850 MOACRIVE Inhibition DME1304 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1304 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03853 XEO_CLAS Peptide DME1304 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO03853 GENEFORM Protein DME1304 XEOTICID XEO03853 MOACRIVE Inhibition DME1304 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1304 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03857 XEO_CLAS Peptide DME1304 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 38.49 microM) DME1304 XEOTICID XEO03857 GENEFORM Protein DME1304 XEOTICID XEO03857 MOACRIVE Inhibition DME1304 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1304 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03860 XEO_CLAS Peptide DME1304 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 24 microM) DME1304 XEOTICID XEO03860 GENEFORM Protein DME1304 XEOTICID XEO03860 MOACRIVE Inhibition DME1304 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1304 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03861 XEO_CLAS Peptide DME1304 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 35 microM) DME1304 XEOTICID XEO03861 GENEFORM Protein DME1304 XEOTICID XEO03861 MOACRIVE Inhibition DME1304 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1304 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03862 XEO_CLAS Peptide DME1304 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 70 microM) DME1304 XEOTICID XEO03862 GENEFORM Protein DME1304 XEOTICID XEO03862 MOACRIVE Inhibition DME1304 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1304 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03863 XEO_CLAS Peptide DME1304 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 35 microM) DME1304 XEOTICID XEO03863 GENEFORM Protein DME1304 XEOTICID XEO03863 MOACRIVE Inhibition DME1304 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1304 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03864 XEO_CLAS Peptide DME1304 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO03864 GENEFORM Protein DME1304 XEOTICID XEO03864 MOACRIVE Inhibition DME1304 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1304 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03865 XEO_CLAS Peptide DME1304 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO03865 GENEFORM Protein DME1304 XEOTICID XEO03865 MOACRIVE Inhibition DME1304 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1304 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03866 XEO_CLAS Peptide DME1304 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 microM) DME1304 XEOTICID XEO03866 GENEFORM Protein DME1304 XEOTICID XEO03866 MOACRIVE Inhibition DME1304 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1304 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03867 XEO_CLAS Peptide DME1304 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40 microM) DME1304 XEOTICID XEO03867 GENEFORM Protein DME1304 XEOTICID XEO03867 MOACRIVE Inhibition DME1304 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1304 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03868 XEO_CLAS Peptide DME1304 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 51 microM) DME1304 XEOTICID XEO03868 GENEFORM Protein DME1304 XEOTICID XEO03868 MOACRIVE Inhibition DME1304 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1304 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03869 XEO_CLAS Peptide DME1304 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 35 microM) DME1304 XEOTICID XEO03869 GENEFORM Protein DME1304 XEOTICID XEO03869 MOACRIVE Inhibition DME1304 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1304 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03870 XEO_CLAS Peptide DME1304 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 61 microM) DME1304 XEOTICID XEO03870 GENEFORM Protein DME1304 XEOTICID XEO03870 MOACRIVE Inhibition DME1304 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1304 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03871 XEO_CLAS Peptide DME1304 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 microM) DME1304 XEOTICID XEO03871 GENEFORM Protein DME1304 XEOTICID XEO03871 MOACRIVE Inhibition DME1304 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1304 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03872 XEO_CLAS Peptide DME1304 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 28 microM) DME1304 XEOTICID XEO03872 GENEFORM Protein DME1304 XEOTICID XEO03872 MOACRIVE Inhibition DME1304 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1304 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03873 XEO_CLAS Peptide DME1304 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 22.5 microM) DME1304 XEOTICID XEO03873 GENEFORM Protein DME1304 XEOTICID XEO03873 MOACRIVE Inhibition DME1304 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1304 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03874 XEO_CLAS Peptide DME1304 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 11.25 microM) DME1304 XEOTICID XEO03874 GENEFORM Protein DME1304 XEOTICID XEO03874 MOACRIVE Inhibition DME1304 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1304 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03875 XEO_CLAS Peptide DME1304 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 microM) DME1304 XEOTICID XEO03875 GENEFORM Protein DME1304 XEOTICID XEO03875 MOACRIVE Inhibition DME1304 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1304 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03876 XEO_CLAS Peptide DME1304 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.75 microM) DME1304 XEOTICID XEO03876 GENEFORM Protein DME1304 XEOTICID XEO03876 MOACRIVE Inhibition DME1304 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1304 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03877 XEO_CLAS Peptide DME1304 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 microM) DME1304 XEOTICID XEO03877 GENEFORM Protein DME1304 XEOTICID XEO03877 MOACRIVE Inhibition DME1304 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1304 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03878 XEO_CLAS Peptide DME1304 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 microM) DME1304 XEOTICID XEO03878 GENEFORM Protein DME1304 XEOTICID XEO03878 MOACRIVE Inhibition DME1304 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1304 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03879 XEO_CLAS Peptide DME1304 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 252 microM) DME1304 XEOTICID XEO03879 GENEFORM Protein DME1304 XEOTICID XEO03879 MOACRIVE Inhibition DME1304 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1304 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03880 XEO_CLAS Peptide DME1304 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 174 microM) DME1304 XEOTICID XEO03880 GENEFORM Protein DME1304 XEOTICID XEO03880 MOACRIVE Inhibition DME1304 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1304 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03883 XEO_CLAS Peptide DME1304 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 74 microM) DME1304 XEOTICID XEO03883 GENEFORM Protein DME1304 XEOTICID XEO03883 MOACRIVE Inhibition DME1304 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1304 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03884 XEO_CLAS Peptide DME1304 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 31 microM) DME1304 XEOTICID XEO03884 GENEFORM Protein DME1304 XEOTICID XEO03884 MOACRIVE Inhibition DME1304 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1304 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03885 XEO_CLAS Peptide DME1304 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO03885 GENEFORM Protein DME1304 XEOTICID XEO03885 MOACRIVE Inhibition DME1304 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1304 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03886 XEO_CLAS Peptide DME1304 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 391 microM) DME1304 XEOTICID XEO03886 GENEFORM Protein DME1304 XEOTICID XEO03886 MOACRIVE Inhibition DME1304 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1304 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03887 XEO_CLAS Peptide DME1304 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 151 microM) DME1304 XEOTICID XEO03887 GENEFORM Protein DME1304 XEOTICID XEO03887 MOACRIVE Inhibition DME1304 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1304 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03888 XEO_CLAS Peptide DME1304 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 134 microM) DME1304 XEOTICID XEO03888 GENEFORM Protein DME1304 XEOTICID XEO03888 MOACRIVE Inhibition DME1304 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1304 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03889 XEO_CLAS Peptide DME1304 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 88 microM) DME1304 XEOTICID XEO03889 GENEFORM Protein DME1304 XEOTICID XEO03889 MOACRIVE Inhibition DME1304 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1304 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03890 XEO_CLAS Peptide DME1304 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 31 microM) DME1304 XEOTICID XEO03890 GENEFORM Protein DME1304 XEOTICID XEO03890 MOACRIVE Inhibition DME1304 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1304 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03891 XEO_CLAS Peptide DME1304 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 microM) DME1304 XEOTICID XEO03891 GENEFORM Protein DME1304 XEOTICID XEO03891 MOACRIVE Inhibition DME1304 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1304 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03892 XEO_CLAS Peptide DME1304 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 37 microM) DME1304 XEOTICID XEO03892 GENEFORM Protein DME1304 XEOTICID XEO03892 MOACRIVE Inhibition DME1304 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1304 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03893 XEO_CLAS Peptide DME1304 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 19 microM) DME1304 XEOTICID XEO03893 GENEFORM Protein DME1304 XEOTICID XEO03893 MOACRIVE Inhibition DME1304 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1304 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03894 XEO_CLAS Peptide DME1304 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO03894 GENEFORM Protein DME1304 XEOTICID XEO03894 MOACRIVE Inhibition DME1304 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1304 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03895 XEO_CLAS Peptide DME1304 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO03895 GENEFORM Protein DME1304 XEOTICID XEO03895 MOACRIVE Inhibition DME1304 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1304 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03896 XEO_CLAS Peptide DME1304 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 microM) DME1304 XEOTICID XEO03896 GENEFORM Protein DME1304 XEOTICID XEO03896 MOACRIVE Inhibition DME1304 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1304 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03897 XEO_CLAS Peptide DME1304 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 63 microM) DME1304 XEOTICID XEO03897 GENEFORM Protein DME1304 XEOTICID XEO03897 MOACRIVE Inhibition DME1304 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1304 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03898 XEO_CLAS Peptide DME1304 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 219 microM) DME1304 XEOTICID XEO03898 GENEFORM Protein DME1304 XEOTICID XEO03898 MOACRIVE Inhibition DME1304 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1304 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03901 XEO_CLAS Peptide DME1304 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 35 microM) DME1304 XEOTICID XEO03901 GENEFORM Protein DME1304 XEOTICID XEO03901 MOACRIVE Inhibition DME1304 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1304 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03902 XEO_CLAS Peptide DME1304 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 70 microM) DME1304 XEOTICID XEO03902 GENEFORM Protein DME1304 XEOTICID XEO03902 MOACRIVE Inhibition DME1304 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1304 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03904 XEO_CLAS Peptide DME1304 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO03904 GENEFORM Protein DME1304 XEOTICID XEO03904 MOACRIVE Inhibition DME1304 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1304 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03905 XEO_CLAS Peptide DME1304 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO03905 GENEFORM Protein DME1304 XEOTICID XEO03905 MOACRIVE Inhibition DME1304 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1304 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03908 XEO_CLAS Peptide DME1304 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03908 GENEFORM Protein DME1304 XEOTICID XEO03908 MOACRIVE Inhibition DME1304 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1304 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03915 XEO_CLAS Peptide DME1304 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03915 GENEFORM Protein DME1304 XEOTICID XEO03915 MOACRIVE Inhibition DME1304 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1304 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03916 XEO_CLAS Peptide DME1304 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.8 ug/ml) DME1304 XEOTICID XEO03916 GENEFORM Protein DME1304 XEOTICID XEO03916 MOACRIVE Inhibition DME1304 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1304 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03917 XEO_CLAS Peptide DME1304 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 13.1 ug/ml) DME1304 XEOTICID XEO03917 GENEFORM Protein DME1304 XEOTICID XEO03917 MOACRIVE Inhibition DME1304 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1304 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03918 XEO_CLAS Peptide DME1304 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.5 ug/ml) DME1304 XEOTICID XEO03918 GENEFORM Protein DME1304 XEOTICID XEO03918 MOACRIVE Inhibition DME1304 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1304 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03919 XEO_CLAS Peptide DME1304 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 80 ug/ml) DME1304 XEOTICID XEO03919 GENEFORM Protein DME1304 XEOTICID XEO03919 MOACRIVE Inhibition DME1304 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1304 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03922 XEO_CLAS Peptide DME1304 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 9 microM) DME1304 XEOTICID XEO03922 GENEFORM Protein DME1304 XEOTICID XEO03922 MOACRIVE Inhibition DME1304 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1304 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03923 XEO_CLAS Peptide DME1304 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 80 microM) DME1304 XEOTICID XEO03923 GENEFORM Protein DME1304 XEOTICID XEO03923 MOACRIVE Inhibition DME1304 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1304 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03924 XEO_CLAS Peptide DME1304 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO03924 GENEFORM Protein DME1304 XEOTICID XEO03924 MOACRIVE Inhibition DME1304 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1304 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03927 XEO_CLAS Peptide DME1304 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 80 microM) DME1304 XEOTICID XEO03927 GENEFORM Protein DME1304 XEOTICID XEO03927 MOACRIVE Inhibition DME1304 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1304 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03928 XEO_CLAS Peptide DME1304 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 microM) DME1304 XEOTICID XEO03928 GENEFORM Protein DME1304 XEOTICID XEO03928 MOACRIVE Inhibition DME1304 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1304 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03929 XEO_CLAS Peptide DME1304 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 microM) DME1304 XEOTICID XEO03929 GENEFORM Protein DME1304 XEOTICID XEO03929 MOACRIVE Inhibition DME1304 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1304 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03930 XEO_CLAS Peptide DME1304 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 microM) DME1304 XEOTICID XEO03930 GENEFORM Protein DME1304 XEOTICID XEO03930 MOACRIVE Inhibition DME1304 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1304 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03931 XEO_CLAS Peptide DME1304 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 microM) DME1304 XEOTICID XEO03931 GENEFORM Protein DME1304 XEOTICID XEO03931 MOACRIVE Inhibition DME1304 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1304 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03933 XEO_CLAS Peptide DME1304 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.5 microM) DME1304 XEOTICID XEO03933 GENEFORM Protein DME1304 XEOTICID XEO03933 MOACRIVE Inhibition DME1304 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1304 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03934 XEO_CLAS Peptide DME1304 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.7 microM) DME1304 XEOTICID XEO03934 GENEFORM Protein DME1304 XEOTICID XEO03934 MOACRIVE Inhibition DME1304 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1304 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03935 XEO_CLAS Peptide DME1304 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.7 microM) DME1304 XEOTICID XEO03935 GENEFORM Protein DME1304 XEOTICID XEO03935 MOACRIVE Inhibition DME1304 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1304 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03936 XEO_CLAS Peptide DME1304 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.0 microM) DME1304 XEOTICID XEO03936 GENEFORM Protein DME1304 XEOTICID XEO03936 MOACRIVE Inhibition DME1304 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1304 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03937 XEO_CLAS Peptide DME1304 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.1 microM) DME1304 XEOTICID XEO03937 GENEFORM Protein DME1304 XEOTICID XEO03937 MOACRIVE Inhibition DME1304 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1304 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03938 XEO_CLAS Peptide DME1304 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.7 microM) DME1304 XEOTICID XEO03938 GENEFORM Protein DME1304 XEOTICID XEO03938 MOACRIVE Inhibition DME1304 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1304 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03939 XEO_CLAS Peptide DME1304 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.7 microM) DME1304 XEOTICID XEO03939 GENEFORM Protein DME1304 XEOTICID XEO03939 MOACRIVE Inhibition DME1304 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1304 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03940 XEO_CLAS Peptide DME1304 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.5 microM) DME1304 XEOTICID XEO03940 GENEFORM Protein DME1304 XEOTICID XEO03940 MOACRIVE Inhibition DME1304 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1304 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03941 XEO_CLAS Peptide DME1304 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.4 microM) DME1304 XEOTICID XEO03941 GENEFORM Protein DME1304 XEOTICID XEO03941 MOACRIVE Inhibition DME1304 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1304 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03943 XEO_CLAS Peptide DME1304 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.4 microM) DME1304 XEOTICID XEO03943 GENEFORM Protein DME1304 XEOTICID XEO03943 MOACRIVE Inhibition DME1304 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1304 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03944 XEO_CLAS Peptide DME1304 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.7 microM) DME1304 XEOTICID XEO03944 GENEFORM Protein DME1304 XEOTICID XEO03944 MOACRIVE Inhibition DME1304 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1304 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03945 XEO_CLAS Peptide DME1304 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.2 microM) DME1304 XEOTICID XEO03945 GENEFORM Protein DME1304 XEOTICID XEO03945 MOACRIVE Inhibition DME1304 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1304 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03947 XEO_CLAS Peptide DME1304 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.0 microM) DME1304 XEOTICID XEO03947 GENEFORM Protein DME1304 XEOTICID XEO03947 MOACRIVE Inhibition DME1304 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1304 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03948 XEO_CLAS Peptide DME1304 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 23.3 microM) DME1304 XEOTICID XEO03948 GENEFORM Protein DME1304 XEOTICID XEO03948 MOACRIVE Inhibition DME1304 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1304 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03950 XEO_CLAS Peptide DME1304 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4.4 microM) DME1304 XEOTICID XEO03950 GENEFORM Protein DME1304 XEOTICID XEO03950 MOACRIVE Inhibition DME1304 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1304 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03951 XEO_CLAS Peptide DME1304 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8.8 microM) DME1304 XEOTICID XEO03951 GENEFORM Protein DME1304 XEOTICID XEO03951 MOACRIVE Inhibition DME1304 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1304 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03952 XEO_CLAS Peptide DME1304 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.2 microM) DME1304 XEOTICID XEO03952 GENEFORM Protein DME1304 XEOTICID XEO03952 MOACRIVE Inhibition DME1304 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1304 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03953 XEO_CLAS Peptide DME1304 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 microM) DME1304 XEOTICID XEO03953 GENEFORM Protein DME1304 XEOTICID XEO03953 MOACRIVE Inhibition DME1304 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1304 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03958 XEO_CLAS Peptide DME1304 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03958 GENEFORM Protein DME1304 XEOTICID XEO03958 MOACRIVE Inhibition DME1304 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1304 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03965 XEO_CLAS Peptide DME1304 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 128 microM) DME1304 XEOTICID XEO03965 GENEFORM Protein DME1304 XEOTICID XEO03965 MOACRIVE Inhibition DME1304 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1304 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03966 XEO_CLAS Peptide DME1304 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 microM) DME1304 XEOTICID XEO03966 GENEFORM Protein DME1304 XEOTICID XEO03966 MOACRIVE Inhibition DME1304 XEOTICID XEO03971 XEO_NAME Lumbrican DME1304 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03971 XEO_CLAS Peptide DME1304 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03971 GENEFORM Protein DME1304 XEOTICID XEO03971 MOACRIVE Inhibition DME1304 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1304 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03972 XEO_CLAS Peptide DME1304 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO03972 GENEFORM Protein DME1304 XEOTICID XEO03972 MOACRIVE Inhibition DME1304 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1304 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03980 XEO_CLAS Peptide DME1304 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 32 microM) DME1304 XEOTICID XEO03980 GENEFORM Protein DME1304 XEOTICID XEO03980 MOACRIVE Inhibition DME1304 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1304 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03985 XEO_CLAS Peptide DME1304 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 ug/ml) DME1304 XEOTICID XEO03985 GENEFORM Protein DME1304 XEOTICID XEO03985 MOACRIVE Inhibition DME1304 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1304 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03991 XEO_CLAS Peptide DME1304 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03991 GENEFORM Protein DME1304 XEOTICID XEO03991 MOACRIVE Inhibition DME1304 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1304 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03992 XEO_CLAS Peptide DME1304 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03992 GENEFORM Protein DME1304 XEOTICID XEO03992 MOACRIVE Inhibition DME1304 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1304 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03993 XEO_CLAS Peptide DME1304 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03993 GENEFORM Protein DME1304 XEOTICID XEO03993 MOACRIVE Inhibition DME1304 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1304 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03994 XEO_CLAS Peptide DME1304 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO03994 GENEFORM Protein DME1304 XEOTICID XEO03994 MOACRIVE Inhibition DME1304 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1304 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03996 XEO_CLAS Peptide DME1304 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 65 microM) DME1304 XEOTICID XEO03996 GENEFORM Protein DME1304 XEOTICID XEO03996 MOACRIVE Inhibition DME1304 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1304 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03997 XEO_CLAS Peptide DME1304 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 7.5 microM) DME1304 XEOTICID XEO03997 GENEFORM Protein DME1304 XEOTICID XEO03997 MOACRIVE Inhibition DME1304 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1304 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03998 XEO_CLAS Peptide DME1304 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15.5 microM) DME1304 XEOTICID XEO03998 GENEFORM Protein DME1304 XEOTICID XEO03998 MOACRIVE Inhibition DME1304 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1304 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO03999 XEO_CLAS Peptide DME1304 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25.8 microM) DME1304 XEOTICID XEO03999 GENEFORM Protein DME1304 XEOTICID XEO03999 MOACRIVE Inhibition DME1304 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1304 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04000 XEO_CLAS Peptide DME1304 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO04000 GENEFORM Protein DME1304 XEOTICID XEO04000 MOACRIVE Inhibition DME1304 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1304 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04001 XEO_CLAS Peptide DME1304 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO04001 GENEFORM Protein DME1304 XEOTICID XEO04001 MOACRIVE Inhibition DME1304 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1304 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04002 XEO_CLAS Peptide DME1304 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 7.5 ug/ml) DME1304 XEOTICID XEO04002 GENEFORM Protein DME1304 XEOTICID XEO04002 MOACRIVE Inhibition DME1304 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1304 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04003 XEO_CLAS Peptide DME1304 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 ug/ml) DME1304 XEOTICID XEO04003 GENEFORM Protein DME1304 XEOTICID XEO04003 MOACRIVE Inhibition DME1304 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1304 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04004 XEO_CLAS Peptide DME1304 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.0 ug/ml) DME1304 XEOTICID XEO04004 GENEFORM Protein DME1304 XEOTICID XEO04004 MOACRIVE Inhibition DME1304 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1304 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04005 XEO_CLAS Peptide DME1304 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.0 ug/ml) DME1304 XEOTICID XEO04005 GENEFORM Protein DME1304 XEOTICID XEO04005 MOACRIVE Inhibition DME1304 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1304 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04007 XEO_CLAS Peptide DME1304 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 19.5 ug/ml) DME1304 XEOTICID XEO04007 GENEFORM Protein DME1304 XEOTICID XEO04007 MOACRIVE Inhibition DME1304 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1304 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04011 XEO_CLAS Peptide DME1304 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 19.5 ug/ml) DME1304 XEOTICID XEO04011 GENEFORM Protein DME1304 XEOTICID XEO04011 MOACRIVE Inhibition DME1304 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1304 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04012 XEO_CLAS Peptide DME1304 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.9 ug/ml) DME1304 XEOTICID XEO04012 GENEFORM Protein DME1304 XEOTICID XEO04012 MOACRIVE Inhibition DME1304 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1304 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04013 XEO_CLAS Peptide DME1304 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.7 ug/ml) DME1304 XEOTICID XEO04013 GENEFORM Protein DME1304 XEOTICID XEO04013 MOACRIVE Inhibition DME1304 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1304 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04018 XEO_CLAS Peptide DME1304 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 9 ug/ml) DME1304 XEOTICID XEO04018 GENEFORM Protein DME1304 XEOTICID XEO04018 MOACRIVE Inhibition DME1304 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1304 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04026 XEO_CLAS Peptide DME1304 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO04026 GENEFORM Protein DME1304 XEOTICID XEO04026 MOACRIVE Inhibition DME1304 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1304 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04027 XEO_CLAS Peptide DME1304 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO04027 GENEFORM Protein DME1304 XEOTICID XEO04027 MOACRIVE Inhibition DME1304 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1304 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04028 XEO_CLAS Peptide DME1304 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 ug/ml) DME1304 XEOTICID XEO04028 GENEFORM Protein DME1304 XEOTICID XEO04028 MOACRIVE Inhibition DME1304 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1304 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04038 XEO_CLAS Peptide DME1304 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04038 GENEFORM Protein DME1304 XEOTICID XEO04038 MOACRIVE Inhibition DME1304 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1304 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04039 XEO_CLAS Peptide DME1304 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 microM) DME1304 XEOTICID XEO04039 GENEFORM Protein DME1304 XEOTICID XEO04039 MOACRIVE Inhibition DME1304 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1304 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04051 XEO_CLAS Peptide DME1304 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.31-0.63 microM) DME1304 XEOTICID XEO04051 GENEFORM Protein DME1304 XEOTICID XEO04051 MOACRIVE Inhibition DME1304 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1304 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04052 XEO_CLAS Peptide DME1304 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04052 GENEFORM Protein DME1304 XEOTICID XEO04052 MOACRIVE Inhibition DME1304 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1304 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04053 XEO_CLAS Peptide DME1304 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.08-0.16 microM) DME1304 XEOTICID XEO04053 GENEFORM Protein DME1304 XEOTICID XEO04053 MOACRIVE Inhibition DME1304 XEOTICID XEO04055 XEO_NAME Melectin DME1304 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04055 XEO_CLAS Peptide DME1304 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.0 microM) DME1304 XEOTICID XEO04055 GENEFORM Protein DME1304 XEOTICID XEO04055 MOACRIVE Inhibition DME1304 XEOTICID XEO04057 XEO_NAME Melittin DME1304 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04057 XEO_CLAS Peptide DME1304 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.8 microM) DME1304 XEOTICID XEO04057 GENEFORM Protein DME1304 XEOTICID XEO04057 MOACRIVE Inhibition DME1304 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1304 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04061 XEO_CLAS Peptide DME1304 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.9 microM) DME1304 XEOTICID XEO04061 GENEFORM Protein DME1304 XEOTICID XEO04061 MOACRIVE Inhibition DME1304 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1304 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04062 XEO_CLAS Peptide DME1304 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.5 microM) DME1304 XEOTICID XEO04062 GENEFORM Protein DME1304 XEOTICID XEO04062 MOACRIVE Inhibition DME1304 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1304 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04063 XEO_CLAS Peptide DME1304 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 7.8 microM) DME1304 XEOTICID XEO04063 GENEFORM Protein DME1304 XEOTICID XEO04063 MOACRIVE Inhibition DME1304 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1304 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04064 XEO_CLAS Peptide DME1304 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 46.7 microM) DME1304 XEOTICID XEO04064 GENEFORM Protein DME1304 XEOTICID XEO04064 MOACRIVE Inhibition DME1304 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1304 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04066 XEO_CLAS Peptide DME1304 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16.3 microM) DME1304 XEOTICID XEO04066 GENEFORM Protein DME1304 XEOTICID XEO04066 MOACRIVE Inhibition DME1304 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1304 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04067 XEO_CLAS Peptide DME1304 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.6 microM) DME1304 XEOTICID XEO04067 GENEFORM Protein DME1304 XEOTICID XEO04067 MOACRIVE Inhibition DME1304 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1304 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04068 XEO_CLAS Peptide DME1304 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.6 microM) DME1304 XEOTICID XEO04068 GENEFORM Protein DME1304 XEOTICID XEO04068 MOACRIVE Inhibition DME1304 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1304 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04086 GENEFORM Protein DME1304 XEOTICID XEO04086 MOACRIVE Inhibition DME1304 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1304 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04087 GENEFORM Protein DME1304 XEOTICID XEO04087 MOACRIVE Inhibition DME1304 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1304 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04089 GENEFORM Protein DME1304 XEOTICID XEO04089 MOACRIVE Inhibition DME1304 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1304 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04094 GENEFORM Protein DME1304 XEOTICID XEO04094 MOACRIVE Inhibition DME1304 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1304 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04096 GENEFORM Protein DME1304 XEOTICID XEO04096 MOACRIVE Inhibition DME1304 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1304 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04098 GENEFORM Protein DME1304 XEOTICID XEO04098 MOACRIVE Inhibition DME1304 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1304 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04111 XEO_CLAS Peptide DME1304 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04111 GENEFORM Protein DME1304 XEOTICID XEO04111 MOACRIVE Inhibition DME1304 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1304 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04112 XEO_CLAS Peptide DME1304 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.02 microM) DME1304 XEOTICID XEO04112 GENEFORM Protein DME1304 XEOTICID XEO04112 MOACRIVE Inhibition DME1304 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1304 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04113 XEO_CLAS Peptide DME1304 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.02 ug/ml) DME1304 XEOTICID XEO04113 GENEFORM Protein DME1304 XEOTICID XEO04113 MOACRIVE Inhibition DME1304 XEOTICID XEO04114 XEO_NAME Microcin L DME1304 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04114 XEO_CLAS Peptide DME1304 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04114 GENEFORM Protein DME1304 XEOTICID XEO04114 MOACRIVE Inhibition DME1304 XEOTICID XEO04117 XEO_NAME Misgurin DME1304 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04117 XEO_CLAS Peptide DME1304 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04117 GENEFORM Protein DME1304 XEOTICID XEO04117 MOACRIVE Inhibition DME1304 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1304 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04118 XEO_CLAS Peptide DME1304 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 300 microM) DME1304 XEOTICID XEO04118 GENEFORM Protein DME1304 XEOTICID XEO04118 MOACRIVE Inhibition DME1304 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1304 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04119 XEO_CLAS Peptide DME1304 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-20 microM) DME1304 XEOTICID XEO04119 GENEFORM Protein DME1304 XEOTICID XEO04119 MOACRIVE Inhibition DME1304 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1304 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04120 XEO_CLAS Peptide DME1304 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC < 10 microM) DME1304 XEOTICID XEO04120 GENEFORM Protein DME1304 XEOTICID XEO04120 MOACRIVE Inhibition DME1304 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1304 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04121 XEO_CLAS Peptide DME1304 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.2-6.4 microM) DME1304 XEOTICID XEO04121 GENEFORM Protein DME1304 XEOTICID XEO04121 MOACRIVE Inhibition DME1304 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1304 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04122 XEO_CLAS Peptide DME1304 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.14-6.29 microM) DME1304 XEOTICID XEO04122 GENEFORM Protein DME1304 XEOTICID XEO04122 MOACRIVE Inhibition DME1304 XEOTICID XEO04123 XEO_NAME Modified defensin DME1304 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04123 XEO_CLAS Peptide DME1304 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO04123 GENEFORM Protein DME1304 XEOTICID XEO04123 MOACRIVE Inhibition DME1304 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1304 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04128 XEO_CLAS Peptide DME1304 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.31 microM) DME1304 XEOTICID XEO04128 GENEFORM Protein DME1304 XEOTICID XEO04128 MOACRIVE Inhibition DME1304 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1304 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04129 XEO_CLAS Peptide DME1304 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO04129 GENEFORM Protein DME1304 XEOTICID XEO04129 MOACRIVE Inhibition DME1304 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1304 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04130 XEO_CLAS Peptide DME1304 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO04130 GENEFORM Protein DME1304 XEOTICID XEO04130 MOACRIVE Inhibition DME1304 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1304 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04131 XEO_CLAS Peptide DME1304 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 microM) DME1304 XEOTICID XEO04131 GENEFORM Protein DME1304 XEOTICID XEO04131 MOACRIVE Inhibition DME1304 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1304 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04132 XEO_CLAS Peptide DME1304 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 microM) DME1304 XEOTICID XEO04132 GENEFORM Protein DME1304 XEOTICID XEO04132 MOACRIVE Inhibition DME1304 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1304 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04133 XEO_CLAS Peptide DME1304 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO04133 GENEFORM Protein DME1304 XEOTICID XEO04133 MOACRIVE Inhibition DME1304 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1304 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04134 XEO_CLAS Peptide DME1304 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO04134 GENEFORM Protein DME1304 XEOTICID XEO04134 MOACRIVE Inhibition DME1304 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1304 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04135 XEO_CLAS Peptide DME1304 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 microM) DME1304 XEOTICID XEO04135 GENEFORM Protein DME1304 XEOTICID XEO04135 MOACRIVE Inhibition DME1304 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1304 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04137 XEO_CLAS Peptide DME1304 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.6 microM) DME1304 XEOTICID XEO04137 GENEFORM Protein DME1304 XEOTICID XEO04137 MOACRIVE Inhibition DME1304 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1304 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04138 XEO_CLAS Peptide DME1304 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 microM) DME1304 XEOTICID XEO04138 GENEFORM Protein DME1304 XEOTICID XEO04138 MOACRIVE Inhibition DME1304 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1304 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04139 XEO_CLAS Peptide DME1304 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 microM) DME1304 XEOTICID XEO04139 GENEFORM Protein DME1304 XEOTICID XEO04139 MOACRIVE Inhibition DME1304 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1304 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04140 XEO_CLAS Peptide DME1304 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 70 microM) DME1304 XEOTICID XEO04140 GENEFORM Protein DME1304 XEOTICID XEO04140 MOACRIVE Inhibition DME1304 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1304 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04141 XEO_CLAS Peptide DME1304 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 microM) DME1304 XEOTICID XEO04141 GENEFORM Protein DME1304 XEOTICID XEO04141 MOACRIVE Inhibition DME1304 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1304 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04142 XEO_CLAS Peptide DME1304 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8-16 microM) DME1304 XEOTICID XEO04142 GENEFORM Protein DME1304 XEOTICID XEO04142 MOACRIVE Inhibition DME1304 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1304 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04146 XEO_CLAS Peptide DME1304 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04146 GENEFORM Protein DME1304 XEOTICID XEO04146 MOACRIVE Inhibition DME1304 XEOTICID XEO04149 XEO_NAME Mucroporin DME1304 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04149 XEO_CLAS Peptide DME1304 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 ug/ml) DME1304 XEOTICID XEO04149 GENEFORM Protein DME1304 XEOTICID XEO04149 MOACRIVE Inhibition DME1304 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1304 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04158 XEO_CLAS Peptide DME1304 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO04158 GENEFORM Protein DME1304 XEOTICID XEO04158 MOACRIVE Inhibition DME1304 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1304 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04159 XEO_CLAS Peptide DME1304 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 microM) DME1304 XEOTICID XEO04159 GENEFORM Protein DME1304 XEOTICID XEO04159 MOACRIVE Inhibition DME1304 XEOTICID XEO04167 XEO_NAME Myticin-B DME1304 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04167 XEO_CLAS Peptide DME1304 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04167 GENEFORM Protein DME1304 XEOTICID XEO04167 MOACRIVE Inhibition DME1304 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1304 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04168 XEO_CLAS Peptide DME1304 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.7-12.5 microM) DME1304 XEOTICID XEO04168 GENEFORM Protein DME1304 XEOTICID XEO04168 MOACRIVE Inhibition DME1304 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1304 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04169 XEO_CLAS Peptide DME1304 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04169 GENEFORM Protein DME1304 XEOTICID XEO04169 MOACRIVE Inhibition DME1304 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1304 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04170 XEO_CLAS Peptide DME1304 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04170 GENEFORM Protein DME1304 XEOTICID XEO04170 MOACRIVE Inhibition DME1304 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1304 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04171 XEO_CLAS Peptide DME1304 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04171 GENEFORM Protein DME1304 XEOTICID XEO04171 MOACRIVE Inhibition DME1304 XEOTICID XEO04172 XEO_NAME Myxinidin DME1304 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04172 XEO_CLAS Peptide DME1304 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04172 GENEFORM Protein DME1304 XEOTICID XEO04172 MOACRIVE Inhibition DME1304 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1304 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04177 XEO_CLAS Peptide DME1304 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.7 microM) DME1304 XEOTICID XEO04177 GENEFORM Protein DME1304 XEOTICID XEO04177 MOACRIVE Inhibition DME1304 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1304 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04178 XEO_CLAS Peptide DME1304 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.7 microM) DME1304 XEOTICID XEO04178 GENEFORM Protein DME1304 XEOTICID XEO04178 MOACRIVE Inhibition DME1304 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1304 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04179 XEO_CLAS Peptide DME1304 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.5 microM) DME1304 XEOTICID XEO04179 GENEFORM Protein DME1304 XEOTICID XEO04179 MOACRIVE Inhibition DME1304 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1304 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04180 XEO_CLAS Peptide DME1304 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 23 microM) DME1304 XEOTICID XEO04180 GENEFORM Protein DME1304 XEOTICID XEO04180 MOACRIVE Inhibition DME1304 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1304 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04181 XEO_CLAS Peptide DME1304 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.2 microM) DME1304 XEOTICID XEO04181 GENEFORM Protein DME1304 XEOTICID XEO04181 MOACRIVE Inhibition DME1304 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1304 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04182 XEO_CLAS Peptide DME1304 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4.4 microM) DME1304 XEOTICID XEO04182 GENEFORM Protein DME1304 XEOTICID XEO04182 MOACRIVE Inhibition DME1304 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1304 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04183 XEO_CLAS Peptide DME1304 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.6 microM) DME1304 XEOTICID XEO04183 GENEFORM Protein DME1304 XEOTICID XEO04183 MOACRIVE Inhibition DME1304 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1304 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04184 XEO_CLAS Peptide DME1304 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 microM) DME1304 XEOTICID XEO04184 GENEFORM Protein DME1304 XEOTICID XEO04184 MOACRIVE Inhibition DME1304 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1304 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04185 XEO_CLAS Peptide DME1304 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04185 GENEFORM Protein DME1304 XEOTICID XEO04185 MOACRIVE Inhibition DME1304 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1304 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04186 XEO_CLAS Peptide DME1304 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04186 GENEFORM Protein DME1304 XEOTICID XEO04186 MOACRIVE Inhibition DME1304 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1304 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04187 XEO_CLAS Peptide DME1304 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04187 GENEFORM Protein DME1304 XEOTICID XEO04187 MOACRIVE Inhibition DME1304 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1304 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04188 XEO_CLAS Peptide DME1304 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04188 GENEFORM Protein DME1304 XEOTICID XEO04188 MOACRIVE Inhibition DME1304 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1304 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04206 XEO_CLAS Peptide DME1304 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25 microM) DME1304 XEOTICID XEO04206 GENEFORM Protein DME1304 XEOTICID XEO04206 MOACRIVE Inhibition DME1304 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1304 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04214 XEO_CLAS Peptide DME1304 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25 microM) DME1304 XEOTICID XEO04214 GENEFORM Protein DME1304 XEOTICID XEO04214 MOACRIVE Inhibition DME1304 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1304 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04216 XEO_CLAS Peptide DME1304 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO04216 GENEFORM Protein DME1304 XEOTICID XEO04216 MOACRIVE Inhibition DME1304 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1304 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04218 XEO_CLAS Peptide DME1304 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.125 microM) DME1304 XEOTICID XEO04218 GENEFORM Protein DME1304 XEOTICID XEO04218 MOACRIVE Inhibition DME1304 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1304 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04219 XEO_CLAS Peptide DME1304 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO04219 GENEFORM Protein DME1304 XEOTICID XEO04219 MOACRIVE Inhibition DME1304 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1304 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04220 XEO_CLAS Peptide DME1304 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.125 microM) DME1304 XEOTICID XEO04220 GENEFORM Protein DME1304 XEOTICID XEO04220 MOACRIVE Inhibition DME1304 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1304 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04221 XEO_CLAS Peptide DME1304 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO04221 GENEFORM Protein DME1304 XEOTICID XEO04221 MOACRIVE Inhibition DME1304 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1304 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04222 XEO_CLAS Peptide DME1304 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25 microM) DME1304 XEOTICID XEO04222 GENEFORM Protein DME1304 XEOTICID XEO04222 MOACRIVE Inhibition DME1304 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1304 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04233 XEO_CLAS Peptide DME1304 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04233 GENEFORM Protein DME1304 XEOTICID XEO04233 MOACRIVE Inhibition DME1304 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1304 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04234 XEO_CLAS Peptide DME1304 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04234 GENEFORM Protein DME1304 XEOTICID XEO04234 MOACRIVE Inhibition DME1304 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1304 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04241 XEO_CLAS Peptide DME1304 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04241 GENEFORM Protein DME1304 XEOTICID XEO04241 MOACRIVE Inhibition DME1304 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1304 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04242 XEO_CLAS Peptide DME1304 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04242 GENEFORM Protein DME1304 XEOTICID XEO04242 MOACRIVE Inhibition DME1304 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1304 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04245 XEO_CLAS Natural Product DME1304 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04245 GENEFORM Protein DME1304 XEOTICID XEO04245 MOACRIVE Inhibition DME1304 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1304 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04246 XEO_CLAS Natural Product DME1304 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04246 GENEFORM Protein DME1304 XEOTICID XEO04246 MOACRIVE Inhibition DME1304 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1304 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04249 XEO_CLAS Peptide DME1304 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 500 ug/ml) DME1304 XEOTICID XEO04249 GENEFORM Protein DME1304 XEOTICID XEO04249 MOACRIVE Inhibition DME1304 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1304 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04251 XEO_CLAS Peptide DME1304 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04251 GENEFORM Protein DME1304 XEOTICID XEO04251 MOACRIVE Inhibition DME1304 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1304 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04253 XEO_CLAS Peptide DME1304 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04253 GENEFORM Protein DME1304 XEOTICID XEO04253 MOACRIVE Inhibition DME1304 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1304 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04254 XEO_CLAS Peptide DME1304 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04254 GENEFORM Protein DME1304 XEOTICID XEO04254 MOACRIVE Inhibition DME1304 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1304 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04255 XEO_CLAS Peptide DME1304 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04255 GENEFORM Protein DME1304 XEOTICID XEO04255 MOACRIVE Inhibition DME1304 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1304 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04256 XEO_CLAS Peptide DME1304 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04256 GENEFORM Protein DME1304 XEOTICID XEO04256 MOACRIVE Inhibition DME1304 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1304 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04257 XEO_CLAS Peptide DME1304 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04257 GENEFORM Protein DME1304 XEOTICID XEO04257 MOACRIVE Inhibition DME1304 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1304 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04258 XEO_CLAS Peptide DME1304 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04258 GENEFORM Protein DME1304 XEOTICID XEO04258 MOACRIVE Inhibition DME1304 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1304 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04259 XEO_CLAS Peptide DME1304 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04259 GENEFORM Protein DME1304 XEOTICID XEO04259 MOACRIVE Inhibition DME1304 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1304 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04260 XEO_CLAS Peptide DME1304 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04260 GENEFORM Protein DME1304 XEOTICID XEO04260 MOACRIVE Inhibition DME1304 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1304 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04261 XEO_CLAS Peptide DME1304 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04261 GENEFORM Protein DME1304 XEOTICID XEO04261 MOACRIVE Inhibition DME1304 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1304 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04262 XEO_CLAS Peptide DME1304 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04262 GENEFORM Protein DME1304 XEOTICID XEO04262 MOACRIVE Inhibition DME1304 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1304 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04263 XEO_CLAS Peptide DME1304 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04263 GENEFORM Protein DME1304 XEOTICID XEO04263 MOACRIVE Inhibition DME1304 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1304 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04264 XEO_CLAS Peptide DME1304 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04264 GENEFORM Protein DME1304 XEOTICID XEO04264 MOACRIVE Inhibition DME1304 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1304 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04265 XEO_CLAS Peptide DME1304 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04265 GENEFORM Protein DME1304 XEOTICID XEO04265 MOACRIVE Inhibition DME1304 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1304 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04266 XEO_CLAS Peptide DME1304 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04266 GENEFORM Protein DME1304 XEOTICID XEO04266 MOACRIVE Inhibition DME1304 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1304 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04267 XEO_CLAS Peptide DME1304 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04267 GENEFORM Protein DME1304 XEOTICID XEO04267 MOACRIVE Inhibition DME1304 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1304 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04268 XEO_CLAS Peptide DME1304 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04268 GENEFORM Protein DME1304 XEOTICID XEO04268 MOACRIVE Inhibition DME1304 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1304 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04269 XEO_CLAS Peptide DME1304 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04269 GENEFORM Protein DME1304 XEOTICID XEO04269 MOACRIVE Inhibition DME1304 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1304 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04270 XEO_CLAS Peptide DME1304 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04270 GENEFORM Protein DME1304 XEOTICID XEO04270 MOACRIVE Inhibition DME1304 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1304 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04271 XEO_CLAS Peptide DME1304 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04271 GENEFORM Protein DME1304 XEOTICID XEO04271 MOACRIVE Inhibition DME1304 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1304 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04272 XEO_CLAS Peptide DME1304 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04272 GENEFORM Protein DME1304 XEOTICID XEO04272 MOACRIVE Inhibition DME1304 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1304 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04277 XEO_CLAS Peptide DME1304 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 110.00 ug/ml) DME1304 XEOTICID XEO04277 GENEFORM Protein DME1304 XEOTICID XEO04277 MOACRIVE Inhibition DME1304 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1304 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04280 XEO_CLAS Peptide DME1304 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 37.50 ug/ml) DME1304 XEOTICID XEO04280 GENEFORM Protein DME1304 XEOTICID XEO04280 MOACRIVE Inhibition DME1304 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1304 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04281 XEO_CLAS Peptide DME1304 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25.00 ug/ml) DME1304 XEOTICID XEO04281 GENEFORM Protein DME1304 XEOTICID XEO04281 MOACRIVE Inhibition DME1304 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1304 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04282 XEO_CLAS Peptide DME1304 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.2 ug/ml) DME1304 XEOTICID XEO04282 GENEFORM Protein DME1304 XEOTICID XEO04282 MOACRIVE Inhibition DME1304 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1304 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04283 XEO_CLAS Peptide DME1304 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.3 ug/ml) DME1304 XEOTICID XEO04283 GENEFORM Protein DME1304 XEOTICID XEO04283 MOACRIVE Inhibition DME1304 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1304 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04284 XEO_CLAS Peptide DME1304 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10.8 ug/ml) DME1304 XEOTICID XEO04284 GENEFORM Protein DME1304 XEOTICID XEO04284 MOACRIVE Inhibition DME1304 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1304 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04285 XEO_CLAS Peptide DME1304 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 11.5 ug/ml) DME1304 XEOTICID XEO04285 GENEFORM Protein DME1304 XEOTICID XEO04285 MOACRIVE Inhibition DME1304 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1304 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04286 XEO_CLAS Peptide DME1304 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8.6 ug/ml) DME1304 XEOTICID XEO04286 GENEFORM Protein DME1304 XEOTICID XEO04286 MOACRIVE Inhibition DME1304 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1304 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04287 XEO_CLAS Peptide DME1304 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10.2 ug/ml) DME1304 XEOTICID XEO04287 GENEFORM Protein DME1304 XEOTICID XEO04287 MOACRIVE Inhibition DME1304 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1304 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04288 XEO_CLAS Peptide DME1304 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4.4 ug/ml) DME1304 XEOTICID XEO04288 GENEFORM Protein DME1304 XEOTICID XEO04288 MOACRIVE Inhibition DME1304 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1304 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04289 XEO_CLAS Peptide DME1304 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.2 ug/ml) DME1304 XEOTICID XEO04289 GENEFORM Protein DME1304 XEOTICID XEO04289 MOACRIVE Inhibition DME1304 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1304 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04290 XEO_CLAS Peptide DME1304 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 11.3 ug/ml) DME1304 XEOTICID XEO04290 GENEFORM Protein DME1304 XEOTICID XEO04290 MOACRIVE Inhibition DME1304 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1304 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04291 XEO_CLAS Peptide DME1304 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 7.2 ug/ml) DME1304 XEOTICID XEO04291 GENEFORM Protein DME1304 XEOTICID XEO04291 MOACRIVE Inhibition DME1304 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1304 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04292 XEO_CLAS Peptide DME1304 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.1 ug/ml) DME1304 XEOTICID XEO04292 GENEFORM Protein DME1304 XEOTICID XEO04292 MOACRIVE Inhibition DME1304 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1304 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04293 XEO_CLAS Peptide DME1304 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO04293 GENEFORM Protein DME1304 XEOTICID XEO04293 MOACRIVE Inhibition DME1304 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1304 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04294 XEO_CLAS Peptide DME1304 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO04294 GENEFORM Protein DME1304 XEOTICID XEO04294 MOACRIVE Inhibition DME1304 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1304 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04295 XEO_CLAS Peptide DME1304 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO04295 GENEFORM Protein DME1304 XEOTICID XEO04295 MOACRIVE Inhibition DME1304 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1304 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04296 XEO_CLAS Peptide DME1304 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 28 microM) DME1304 XEOTICID XEO04296 GENEFORM Protein DME1304 XEOTICID XEO04296 MOACRIVE Inhibition DME1304 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1304 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04297 XEO_CLAS Peptide DME1304 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 14 microM) DME1304 XEOTICID XEO04297 GENEFORM Protein DME1304 XEOTICID XEO04297 MOACRIVE Inhibition DME1304 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1304 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04298 XEO_CLAS Peptide DME1304 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO04298 GENEFORM Protein DME1304 XEOTICID XEO04298 MOACRIVE Inhibition DME1304 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1304 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04299 XEO_CLAS Peptide DME1304 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO04299 GENEFORM Protein DME1304 XEOTICID XEO04299 MOACRIVE Inhibition DME1304 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1304 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04300 XEO_CLAS Peptide DME1304 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO04300 GENEFORM Protein DME1304 XEOTICID XEO04300 MOACRIVE Inhibition DME1304 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1304 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04301 XEO_CLAS Peptide DME1304 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 microM) DME1304 XEOTICID XEO04301 GENEFORM Protein DME1304 XEOTICID XEO04301 MOACRIVE Inhibition DME1304 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1304 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04302 XEO_CLAS Peptide DME1304 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 microM) DME1304 XEOTICID XEO04302 GENEFORM Protein DME1304 XEOTICID XEO04302 MOACRIVE Inhibition DME1304 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1304 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04303 XEO_CLAS Peptide DME1304 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 microM) DME1304 XEOTICID XEO04303 GENEFORM Protein DME1304 XEOTICID XEO04303 MOACRIVE Inhibition DME1304 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1304 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04304 XEO_CLAS Peptide DME1304 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO04304 GENEFORM Protein DME1304 XEOTICID XEO04304 MOACRIVE Inhibition DME1304 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1304 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04305 XEO_CLAS Peptide DME1304 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 70 microM) DME1304 XEOTICID XEO04305 GENEFORM Protein DME1304 XEOTICID XEO04305 MOACRIVE Inhibition DME1304 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1304 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04306 XEO_CLAS Peptide DME1304 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO04306 GENEFORM Protein DME1304 XEOTICID XEO04306 MOACRIVE Inhibition DME1304 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1304 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04307 XEO_CLAS Peptide DME1304 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 ug/ml) DME1304 XEOTICID XEO04307 GENEFORM Protein DME1304 XEOTICID XEO04307 MOACRIVE Inhibition DME1304 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1304 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04308 XEO_CLAS Peptide DME1304 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 9.37 ug/ml) DME1304 XEOTICID XEO04308 GENEFORM Protein DME1304 XEOTICID XEO04308 MOACRIVE Inhibition DME1304 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1304 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04309 XEO_CLAS Peptide DME1304 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 microM) DME1304 XEOTICID XEO04309 GENEFORM Protein DME1304 XEOTICID XEO04309 MOACRIVE Inhibition DME1304 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1304 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04310 XEO_CLAS Peptide DME1304 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO04310 GENEFORM Protein DME1304 XEOTICID XEO04310 MOACRIVE Inhibition DME1304 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1304 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04311 XEO_CLAS Peptide DME1304 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO04311 GENEFORM Protein DME1304 XEOTICID XEO04311 MOACRIVE Inhibition DME1304 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1304 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04312 XEO_CLAS Peptide DME1304 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4.68 ug/ml) DME1304 XEOTICID XEO04312 GENEFORM Protein DME1304 XEOTICID XEO04312 MOACRIVE Inhibition DME1304 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1304 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04313 XEO_CLAS Peptide DME1304 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4.68 ug/ml) DME1304 XEOTICID XEO04313 GENEFORM Protein DME1304 XEOTICID XEO04313 MOACRIVE Inhibition DME1304 XEOTICID XEO04331 XEO_NAME Norspermidine DME1304 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1304 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04331 GENEFORM Protein DME1304 XEOTICID XEO04331 MOACRIVE Inhibition DME1304 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1304 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04335 XEO_CLAS Peptide DME1304 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 32 ug/ml) DME1304 XEOTICID XEO04335 GENEFORM Protein DME1304 XEOTICID XEO04335 MOACRIVE Inhibition DME1304 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1304 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04336 XEO_CLAS Peptide DME1304 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 32 ug/ml) DME1304 XEOTICID XEO04336 GENEFORM Protein DME1304 XEOTICID XEO04336 MOACRIVE Inhibition DME1304 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1304 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04338 XEO_CLAS Peptide DME1304 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 ug/ml) DME1304 XEOTICID XEO04338 GENEFORM Protein DME1304 XEOTICID XEO04338 MOACRIVE Inhibition DME1304 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1304 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04339 XEO_CLAS Peptide DME1304 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 ug/ml) DME1304 XEOTICID XEO04339 GENEFORM Protein DME1304 XEOTICID XEO04339 MOACRIVE Inhibition DME1304 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1304 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04340 XEO_CLAS Peptide DME1304 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO04340 GENEFORM Protein DME1304 XEOTICID XEO04340 MOACRIVE Inhibition DME1304 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1304 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04344 XEO_CLAS Peptide DME1304 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04344 GENEFORM Protein DME1304 XEOTICID XEO04344 MOACRIVE Inhibition DME1304 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1304 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04345 XEO_CLAS Peptide DME1304 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04345 GENEFORM Protein DME1304 XEOTICID XEO04345 MOACRIVE Inhibition DME1304 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1304 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04346 XEO_CLAS Peptide DME1304 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04346 GENEFORM Protein DME1304 XEOTICID XEO04346 MOACRIVE Inhibition DME1304 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1304 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04347 XEO_CLAS Peptide DME1304 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 microM) DME1304 XEOTICID XEO04347 GENEFORM Protein DME1304 XEOTICID XEO04347 MOACRIVE Inhibition DME1304 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1304 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04348 XEO_CLAS Peptide DME1304 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40 microM) DME1304 XEOTICID XEO04348 GENEFORM Protein DME1304 XEOTICID XEO04348 MOACRIVE Inhibition DME1304 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1304 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04349 XEO_CLAS Peptide DME1304 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO04349 GENEFORM Protein DME1304 XEOTICID XEO04349 MOACRIVE Inhibition DME1304 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1304 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04354 XEO_CLAS Peptide DME1304 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 35.2 ug/ml) DME1304 XEOTICID XEO04354 GENEFORM Protein DME1304 XEOTICID XEO04354 MOACRIVE Inhibition DME1304 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1304 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04355 XEO_CLAS Peptide DME1304 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.21 ug/ml) DME1304 XEOTICID XEO04355 GENEFORM Protein DME1304 XEOTICID XEO04355 MOACRIVE Inhibition DME1304 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1304 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04356 XEO_CLAS Peptide DME1304 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8.21 ug/ml) DME1304 XEOTICID XEO04356 GENEFORM Protein DME1304 XEOTICID XEO04356 MOACRIVE Inhibition DME1304 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1304 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04357 XEO_CLAS Peptide DME1304 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16.32 ug/ml) DME1304 XEOTICID XEO04357 GENEFORM Protein DME1304 XEOTICID XEO04357 MOACRIVE Inhibition DME1304 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1304 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04358 XEO_CLAS Peptide DME1304 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 9.37 ug/ml) DME1304 XEOTICID XEO04358 GENEFORM Protein DME1304 XEOTICID XEO04358 MOACRIVE Inhibition DME1304 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1304 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04359 XEO_CLAS Peptide DME1304 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4.20 ug/ml) DME1304 XEOTICID XEO04359 GENEFORM Protein DME1304 XEOTICID XEO04359 MOACRIVE Inhibition DME1304 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1304 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04360 XEO_CLAS Peptide DME1304 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 ug/ml) DME1304 XEOTICID XEO04360 GENEFORM Protein DME1304 XEOTICID XEO04360 MOACRIVE Inhibition DME1304 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1304 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04361 XEO_CLAS Peptide DME1304 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 7.5 ug/ml) DME1304 XEOTICID XEO04361 GENEFORM Protein DME1304 XEOTICID XEO04361 MOACRIVE Inhibition DME1304 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1304 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04362 XEO_CLAS Peptide DME1304 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.6 ug/ml) DME1304 XEOTICID XEO04362 GENEFORM Protein DME1304 XEOTICID XEO04362 MOACRIVE Inhibition DME1304 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1304 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04363 XEO_CLAS Peptide DME1304 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8.2 ug/ml) DME1304 XEOTICID XEO04363 GENEFORM Protein DME1304 XEOTICID XEO04363 MOACRIVE Inhibition DME1304 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1304 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04364 XEO_CLAS Peptide DME1304 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO04364 GENEFORM Protein DME1304 XEOTICID XEO04364 MOACRIVE Inhibition DME1304 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1304 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04365 XEO_CLAS Peptide DME1304 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4.68 ug/ml) DME1304 XEOTICID XEO04365 GENEFORM Protein DME1304 XEOTICID XEO04365 MOACRIVE Inhibition DME1304 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1304 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04366 XEO_CLAS Peptide DME1304 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 23.60 ug/ml) DME1304 XEOTICID XEO04366 GENEFORM Protein DME1304 XEOTICID XEO04366 MOACRIVE Inhibition DME1304 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1304 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04367 XEO_CLAS Peptide DME1304 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 35.60 ug/ml) DME1304 XEOTICID XEO04367 GENEFORM Protein DME1304 XEOTICID XEO04367 MOACRIVE Inhibition DME1304 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1304 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04368 XEO_CLAS Peptide DME1304 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40.2 ug/ml) DME1304 XEOTICID XEO04368 GENEFORM Protein DME1304 XEOTICID XEO04368 MOACRIVE Inhibition DME1304 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1304 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04369 XEO_CLAS Peptide DME1304 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40.2 ug/ml) DME1304 XEOTICID XEO04369 GENEFORM Protein DME1304 XEOTICID XEO04369 MOACRIVE Inhibition DME1304 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1304 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04370 XEO_CLAS Peptide DME1304 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4.68 ug/ml) DME1304 XEOTICID XEO04370 GENEFORM Protein DME1304 XEOTICID XEO04370 MOACRIVE Inhibition DME1304 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1304 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04371 XEO_CLAS Peptide DME1304 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 9.37 ug/ml) DME1304 XEOTICID XEO04371 GENEFORM Protein DME1304 XEOTICID XEO04371 MOACRIVE Inhibition DME1304 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1304 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04373 XEO_CLAS Peptide DME1304 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 ug/ml) DME1304 XEOTICID XEO04373 GENEFORM Protein DME1304 XEOTICID XEO04373 MOACRIVE Inhibition DME1304 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1304 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04374 XEO_CLAS Peptide DME1304 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.50 ug/ml) DME1304 XEOTICID XEO04374 GENEFORM Protein DME1304 XEOTICID XEO04374 MOACRIVE Inhibition DME1304 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1304 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04375 XEO_CLAS Peptide DME1304 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25 ug/ml) DME1304 XEOTICID XEO04375 GENEFORM Protein DME1304 XEOTICID XEO04375 MOACRIVE Inhibition DME1304 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1304 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04377 XEO_CLAS Peptide DME1304 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 42.50 ug/ml) DME1304 XEOTICID XEO04377 GENEFORM Protein DME1304 XEOTICID XEO04377 MOACRIVE Inhibition DME1304 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1304 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04378 XEO_CLAS Peptide DME1304 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 17.50 ug/ml) DME1304 XEOTICID XEO04378 GENEFORM Protein DME1304 XEOTICID XEO04378 MOACRIVE Inhibition DME1304 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1304 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04379 XEO_CLAS Peptide DME1304 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 ug/ml) DME1304 XEOTICID XEO04379 GENEFORM Protein DME1304 XEOTICID XEO04379 MOACRIVE Inhibition DME1304 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1304 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04380 XEO_CLAS Peptide DME1304 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 36.00 ug/ml) DME1304 XEOTICID XEO04380 GENEFORM Protein DME1304 XEOTICID XEO04380 MOACRIVE Inhibition DME1304 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1304 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04381 XEO_CLAS Peptide DME1304 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.60 ug/ml) DME1304 XEOTICID XEO04381 GENEFORM Protein DME1304 XEOTICID XEO04381 MOACRIVE Inhibition DME1304 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1304 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04382 XEO_CLAS Peptide DME1304 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 ug/ml) DME1304 XEOTICID XEO04382 GENEFORM Protein DME1304 XEOTICID XEO04382 MOACRIVE Inhibition DME1304 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1304 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04383 XEO_CLAS Peptide DME1304 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO04383 GENEFORM Protein DME1304 XEOTICID XEO04383 MOACRIVE Inhibition DME1304 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1304 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04384 XEO_CLAS Peptide DME1304 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO04384 GENEFORM Protein DME1304 XEOTICID XEO04384 MOACRIVE Inhibition DME1304 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1304 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04385 XEO_CLAS Peptide DME1304 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.25 ug/ml) DME1304 XEOTICID XEO04385 GENEFORM Protein DME1304 XEOTICID XEO04385 MOACRIVE Inhibition DME1304 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1304 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04395 XEO_CLAS Peptide DME1304 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.4-0.8 microM) DME1304 XEOTICID XEO04395 GENEFORM Protein DME1304 XEOTICID XEO04395 MOACRIVE Inhibition DME1304 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1304 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04396 XEO_CLAS Peptide DME1304 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.25-0.5 microM) DME1304 XEOTICID XEO04396 GENEFORM Protein DME1304 XEOTICID XEO04396 MOACRIVE Inhibition DME1304 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1304 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04397 XEO_CLAS Peptide DME1304 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.25-0.5 microM) DME1304 XEOTICID XEO04397 GENEFORM Protein DME1304 XEOTICID XEO04397 MOACRIVE Inhibition DME1304 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1304 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04398 XEO_CLAS Peptide DME1304 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 microM) DME1304 XEOTICID XEO04398 GENEFORM Protein DME1304 XEOTICID XEO04398 MOACRIVE Inhibition DME1304 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1304 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04399 XEO_CLAS Peptide DME1304 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO04399 GENEFORM Protein DME1304 XEOTICID XEO04399 MOACRIVE Inhibition DME1304 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1304 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04400 XEO_CLAS Peptide DME1304 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 ug/ml) DME1304 XEOTICID XEO04400 GENEFORM Protein DME1304 XEOTICID XEO04400 MOACRIVE Inhibition DME1304 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1304 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04401 XEO_CLAS Peptide DME1304 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.6 ug/ml) DME1304 XEOTICID XEO04401 GENEFORM Protein DME1304 XEOTICID XEO04401 MOACRIVE Inhibition DME1304 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1304 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04402 XEO_CLAS Peptide DME1304 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 ug/ml) DME1304 XEOTICID XEO04402 GENEFORM Protein DME1304 XEOTICID XEO04402 MOACRIVE Inhibition DME1304 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1304 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04403 XEO_CLAS Peptide DME1304 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.6 ug/ml) DME1304 XEOTICID XEO04403 GENEFORM Protein DME1304 XEOTICID XEO04403 MOACRIVE Inhibition DME1304 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1304 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04404 XEO_CLAS Peptide DME1304 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.6 ug/ml) DME1304 XEOTICID XEO04404 GENEFORM Protein DME1304 XEOTICID XEO04404 MOACRIVE Inhibition DME1304 XEOTICID XEO04410 XEO_NAME Insect osmin DME1304 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04410 XEO_CLAS Peptide DME1304 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.125-1.56 microM) DME1304 XEOTICID XEO04410 GENEFORM Protein DME1304 XEOTICID XEO04410 MOACRIVE Inhibition DME1304 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1304 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04412 XEO_CLAS Peptide DME1304 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04412 GENEFORM Protein DME1304 XEOTICID XEO04412 MOACRIVE Inhibition DME1304 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1304 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04414 XEO_CLAS Peptide DME1304 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04414 GENEFORM Protein DME1304 XEOTICID XEO04414 MOACRIVE Inhibition DME1304 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1304 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04415 XEO_CLAS Peptide DME1304 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04415 GENEFORM Protein DME1304 XEOTICID XEO04415 MOACRIVE Inhibition DME1304 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1304 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04421 XEO_CLAS Peptide DME1304 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 microM) DME1304 XEOTICID XEO04421 GENEFORM Protein DME1304 XEOTICID XEO04421 MOACRIVE Inhibition DME1304 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1304 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04426 XEO_CLAS Peptide DME1304 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO04426 GENEFORM Protein DME1304 XEOTICID XEO04426 MOACRIVE Inhibition DME1304 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1304 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04428 XEO_CLAS Peptide DME1304 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.3 ug/ml) DME1304 XEOTICID XEO04428 GENEFORM Protein DME1304 XEOTICID XEO04428 MOACRIVE Inhibition DME1304 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1304 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04430 XEO_CLAS Peptide DME1304 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25 microM) DME1304 XEOTICID XEO04430 GENEFORM Protein DME1304 XEOTICID XEO04430 MOACRIVE Inhibition DME1304 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1304 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04433 XEO_CLAS Peptide DME1304 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 160 microM) DME1304 XEOTICID XEO04433 GENEFORM Protein DME1304 XEOTICID XEO04433 MOACRIVE Inhibition DME1304 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1304 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04435 XEO_CLAS Peptide DME1304 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 160 microM) DME1304 XEOTICID XEO04435 GENEFORM Protein DME1304 XEOTICID XEO04435 MOACRIVE Inhibition DME1304 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1304 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1304 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04438 GENEFORM Protein DME1304 XEOTICID XEO04438 MOACRIVE Inhibition DME1304 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1304 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04439 XEO_CLAS Peptide DME1304 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04439 GENEFORM Protein DME1304 XEOTICID XEO04439 MOACRIVE Inhibition DME1304 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1304 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04440 XEO_CLAS Peptide DME1304 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 microM) DME1304 XEOTICID XEO04440 GENEFORM Protein DME1304 XEOTICID XEO04440 MOACRIVE Inhibition DME1304 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1304 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04441 XEO_CLAS Peptide DME1304 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 28 microM) DME1304 XEOTICID XEO04441 GENEFORM Protein DME1304 XEOTICID XEO04441 MOACRIVE Inhibition DME1304 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1304 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04442 XEO_CLAS Peptide DME1304 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 28 microM) DME1304 XEOTICID XEO04442 GENEFORM Protein DME1304 XEOTICID XEO04442 MOACRIVE Inhibition DME1304 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1304 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04443 XEO_CLAS Peptide DME1304 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04443 GENEFORM Protein DME1304 XEOTICID XEO04443 MOACRIVE Inhibition DME1304 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1304 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04444 XEO_CLAS Peptide DME1304 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 13 microM) DME1304 XEOTICID XEO04444 GENEFORM Protein DME1304 XEOTICID XEO04444 MOACRIVE Inhibition DME1304 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1304 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04445 XEO_CLAS Peptide DME1304 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04445 GENEFORM Protein DME1304 XEOTICID XEO04445 MOACRIVE Inhibition DME1304 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1304 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04446 XEO_CLAS Peptide DME1304 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 78 microM) DME1304 XEOTICID XEO04446 GENEFORM Protein DME1304 XEOTICID XEO04446 MOACRIVE Inhibition DME1304 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1304 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04447 XEO_CLAS Peptide DME1304 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 120 microM) DME1304 XEOTICID XEO04447 GENEFORM Protein DME1304 XEOTICID XEO04447 MOACRIVE Inhibition DME1304 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1304 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04448 XEO_CLAS Peptide DME1304 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 microM) DME1304 XEOTICID XEO04448 GENEFORM Protein DME1304 XEOTICID XEO04448 MOACRIVE Inhibition DME1304 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1304 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04449 XEO_CLAS Peptide DME1304 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.3 microM) DME1304 XEOTICID XEO04449 GENEFORM Protein DME1304 XEOTICID XEO04449 MOACRIVE Inhibition DME1304 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1304 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04450 XEO_CLAS Peptide DME1304 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.3 microM) DME1304 XEOTICID XEO04450 GENEFORM Protein DME1304 XEOTICID XEO04450 MOACRIVE Inhibition DME1304 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1304 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04451 XEO_CLAS Peptide DME1304 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO04451 GENEFORM Protein DME1304 XEOTICID XEO04451 MOACRIVE Inhibition DME1304 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1304 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04452 XEO_CLAS Peptide DME1304 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.1 microM) DME1304 XEOTICID XEO04452 GENEFORM Protein DME1304 XEOTICID XEO04452 MOACRIVE Inhibition DME1304 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1304 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04453 XEO_CLAS Peptide DME1304 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO04453 GENEFORM Protein DME1304 XEOTICID XEO04453 MOACRIVE Inhibition DME1304 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1304 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04455 XEO_CLAS Peptide DME1304 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 microM) DME1304 XEOTICID XEO04455 GENEFORM Protein DME1304 XEOTICID XEO04455 MOACRIVE Inhibition DME1304 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1304 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04457 XEO_CLAS Peptide DME1304 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.3 microM) DME1304 XEOTICID XEO04457 GENEFORM Protein DME1304 XEOTICID XEO04457 MOACRIVE Inhibition DME1304 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1304 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04458 XEO_CLAS Peptide DME1304 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1 microM) DME1304 XEOTICID XEO04458 GENEFORM Protein DME1304 XEOTICID XEO04458 MOACRIVE Inhibition DME1304 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1304 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04459 XEO_CLAS Peptide DME1304 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1 microM) DME1304 XEOTICID XEO04459 GENEFORM Protein DME1304 XEOTICID XEO04459 MOACRIVE Inhibition DME1304 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1304 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04461 XEO_CLAS Peptide DME1304 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20.8 microM) DME1304 XEOTICID XEO04461 GENEFORM Protein DME1304 XEOTICID XEO04461 MOACRIVE Inhibition DME1304 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1304 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04462 XEO_CLAS Peptide DME1304 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 19.1 microM) DME1304 XEOTICID XEO04462 GENEFORM Protein DME1304 XEOTICID XEO04462 MOACRIVE Inhibition DME1304 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1304 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04463 XEO_CLAS Peptide DME1304 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04463 GENEFORM Protein DME1304 XEOTICID XEO04463 MOACRIVE Inhibition DME1304 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1304 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04464 XEO_CLAS Peptide DME1304 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.5 microM) DME1304 XEOTICID XEO04464 GENEFORM Protein DME1304 XEOTICID XEO04464 MOACRIVE Inhibition DME1304 XEOTICID XEO04466 XEO_NAME Panusin DME1304 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04466 XEO_CLAS Peptide DME1304 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04466 GENEFORM Protein DME1304 XEOTICID XEO04466 MOACRIVE Inhibition DME1304 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1304 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04467 XEO_CLAS Peptide DME1304 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4.8 microM) DME1304 XEOTICID XEO04467 GENEFORM Protein DME1304 XEOTICID XEO04467 MOACRIVE Inhibition DME1304 XEOTICID XEO04468 XEO_NAME Papillosin DME1304 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04468 XEO_CLAS Peptide DME1304 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04468 GENEFORM Protein DME1304 XEOTICID XEO04468 MOACRIVE Inhibition DME1304 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1304 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04471 XEO_CLAS Peptide DME1304 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.1 microM) DME1304 XEOTICID XEO04471 GENEFORM Protein DME1304 XEOTICID XEO04471 MOACRIVE Inhibition DME1304 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1304 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04480 XEO_CLAS Peptide DME1304 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 ug/ml) DME1304 XEOTICID XEO04480 GENEFORM Protein DME1304 XEOTICID XEO04480 MOACRIVE Inhibition DME1304 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1304 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1304 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04482 GENEFORM Protein DME1304 XEOTICID XEO04482 MOACRIVE Inhibition DME1304 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1304 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04484 XEO_CLAS Peptide DME1304 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 microM) DME1304 XEOTICID XEO04484 GENEFORM Protein DME1304 XEOTICID XEO04484 MOACRIVE Inhibition DME1304 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1304 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04485 XEO_CLAS Peptide DME1304 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO04485 GENEFORM Protein DME1304 XEOTICID XEO04485 MOACRIVE Inhibition DME1304 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1304 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04486 XEO_CLAS Peptide DME1304 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 microM) DME1304 XEOTICID XEO04486 GENEFORM Protein DME1304 XEOTICID XEO04486 MOACRIVE Inhibition DME1304 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1304 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04487 XEO_CLAS Peptide DME1304 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO04487 GENEFORM Protein DME1304 XEOTICID XEO04487 MOACRIVE Inhibition DME1304 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1304 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04488 XEO_CLAS Peptide DME1304 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 9 microM) DME1304 XEOTICID XEO04488 GENEFORM Protein DME1304 XEOTICID XEO04488 MOACRIVE Inhibition DME1304 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1304 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04489 XEO_CLAS Peptide DME1304 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 13 microM) DME1304 XEOTICID XEO04489 GENEFORM Protein DME1304 XEOTICID XEO04489 MOACRIVE Inhibition DME1304 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1304 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04490 XEO_CLAS Peptide DME1304 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 47.5 microM) DME1304 XEOTICID XEO04490 GENEFORM Protein DME1304 XEOTICID XEO04490 MOACRIVE Inhibition DME1304 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1304 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04491 XEO_CLAS Peptide DME1304 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO04491 GENEFORM Protein DME1304 XEOTICID XEO04491 MOACRIVE Inhibition DME1304 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1304 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04492 XEO_CLAS Peptide DME1304 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 35 microM) DME1304 XEOTICID XEO04492 GENEFORM Protein DME1304 XEOTICID XEO04492 MOACRIVE Inhibition DME1304 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1304 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04493 XEO_CLAS Peptide DME1304 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 microM) DME1304 XEOTICID XEO04493 GENEFORM Protein DME1304 XEOTICID XEO04493 MOACRIVE Inhibition DME1304 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1304 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04494 XEO_CLAS Peptide DME1304 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO04494 GENEFORM Protein DME1304 XEOTICID XEO04494 MOACRIVE Inhibition DME1304 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1304 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04495 XEO_CLAS Peptide DME1304 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO04495 GENEFORM Protein DME1304 XEOTICID XEO04495 MOACRIVE Inhibition DME1304 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1304 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04496 XEO_CLAS Peptide DME1304 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 67.5 microM) DME1304 XEOTICID XEO04496 GENEFORM Protein DME1304 XEOTICID XEO04496 MOACRIVE Inhibition DME1304 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1304 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04497 XEO_CLAS Peptide DME1304 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO04497 GENEFORM Protein DME1304 XEOTICID XEO04497 MOACRIVE Inhibition DME1304 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1304 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04498 XEO_CLAS Peptide DME1304 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO04498 GENEFORM Protein DME1304 XEOTICID XEO04498 MOACRIVE Inhibition DME1304 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1304 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04499 XEO_CLAS Peptide DME1304 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 43 microM) DME1304 XEOTICID XEO04499 GENEFORM Protein DME1304 XEOTICID XEO04499 MOACRIVE Inhibition DME1304 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1304 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04500 XEO_CLAS Peptide DME1304 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO04500 GENEFORM Protein DME1304 XEOTICID XEO04500 MOACRIVE Inhibition DME1304 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1304 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04504 XEO_CLAS Peptide DME1304 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04504 GENEFORM Protein DME1304 XEOTICID XEO04504 MOACRIVE Inhibition DME1304 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1304 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04505 XEO_CLAS Peptide DME1304 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04505 GENEFORM Protein DME1304 XEOTICID XEO04505 MOACRIVE Inhibition DME1304 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1304 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04506 XEO_CLAS Peptide DME1304 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 40 microM) DME1304 XEOTICID XEO04506 GENEFORM Protein DME1304 XEOTICID XEO04506 MOACRIVE Inhibition DME1304 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1304 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04507 XEO_CLAS Peptide DME1304 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10-20 microM) DME1304 XEOTICID XEO04507 GENEFORM Protein DME1304 XEOTICID XEO04507 MOACRIVE Inhibition DME1304 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1304 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04508 XEO_CLAS Peptide DME1304 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04508 GENEFORM Protein DME1304 XEOTICID XEO04508 MOACRIVE Inhibition DME1304 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1304 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04509 XEO_CLAS Peptide DME1304 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04509 GENEFORM Protein DME1304 XEOTICID XEO04509 MOACRIVE Inhibition DME1304 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1304 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04510 XEO_CLAS Peptide DME1304 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 22-33 microM) DME1304 XEOTICID XEO04510 GENEFORM Protein DME1304 XEOTICID XEO04510 MOACRIVE Inhibition DME1304 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1304 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04525 XEO_CLAS Peptide DME1304 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 32.0 microM) DME1304 XEOTICID XEO04525 GENEFORM Protein DME1304 XEOTICID XEO04525 MOACRIVE Inhibition DME1304 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1304 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04526 XEO_CLAS Peptide DME1304 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.0 microM) DME1304 XEOTICID XEO04526 GENEFORM Protein DME1304 XEOTICID XEO04526 MOACRIVE Inhibition DME1304 XEOTICID XEO04527 XEO_NAME Pepcon DME1304 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04527 XEO_CLAS Peptide DME1304 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO04527 GENEFORM Protein DME1304 XEOTICID XEO04527 MOACRIVE Inhibition DME1304 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1304 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04532 XEO_CLAS Peptide DME1304 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04532 GENEFORM Protein DME1304 XEOTICID XEO04532 MOACRIVE Inhibition DME1304 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1304 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04540 XEO_CLAS Peptide DME1304 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 18.1 ug/ml) DME1304 XEOTICID XEO04540 GENEFORM Protein DME1304 XEOTICID XEO04540 MOACRIVE Inhibition DME1304 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1304 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04541 XEO_CLAS Peptide DME1304 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.5 ug/ml) DME1304 XEOTICID XEO04541 GENEFORM Protein DME1304 XEOTICID XEO04541 MOACRIVE Inhibition DME1304 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1304 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04542 XEO_CLAS Peptide DME1304 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04542 GENEFORM Protein DME1304 XEOTICID XEO04542 MOACRIVE Inhibition DME1304 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1304 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04543 XEO_CLAS Peptide DME1304 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04543 GENEFORM Protein DME1304 XEOTICID XEO04543 MOACRIVE Inhibition DME1304 XEOTICID XEO04546 XEO_NAME Perinerin DME1304 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04546 XEO_CLAS Peptide DME1304 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04546 GENEFORM Protein DME1304 XEOTICID XEO04546 MOACRIVE Inhibition DME1304 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1304 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04548 XEO_CLAS Peptide DME1304 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 72000 ug/ml) DME1304 XEOTICID XEO04548 GENEFORM Protein DME1304 XEOTICID XEO04548 MOACRIVE Inhibition DME1304 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1304 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04549 XEO_CLAS Peptide DME1304 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 62-125 ug/ml) DME1304 XEOTICID XEO04549 GENEFORM Protein DME1304 XEOTICID XEO04549 MOACRIVE Inhibition DME1304 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1304 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04550 XEO_CLAS Peptide DME1304 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO04550 GENEFORM Protein DME1304 XEOTICID XEO04550 MOACRIVE Inhibition DME1304 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1304 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04551 XEO_CLAS Peptide DME1304 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 23.6 ug/ml) DME1304 XEOTICID XEO04551 GENEFORM Protein DME1304 XEOTICID XEO04551 MOACRIVE Inhibition DME1304 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1304 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04552 XEO_CLAS Peptide DME1304 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04552 GENEFORM Protein DME1304 XEOTICID XEO04552 MOACRIVE Inhibition DME1304 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1304 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04553 XEO_CLAS Peptide DME1304 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04553 GENEFORM Protein DME1304 XEOTICID XEO04553 MOACRIVE Inhibition DME1304 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1304 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04554 XEO_CLAS Peptide DME1304 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04554 GENEFORM Protein DME1304 XEOTICID XEO04554 MOACRIVE Inhibition DME1304 XEOTICID XEO04563 XEO_NAME Phosphate DME1304 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1304 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04563 GENEFORM Protein DME1304 XEOTICID XEO04563 MOACRIVE Inhibition DME1304 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1304 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04565 XEO_CLAS Peptide DME1304 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.5 microM) DME1304 XEOTICID XEO04565 GENEFORM Protein DME1304 XEOTICID XEO04565 MOACRIVE Inhibition DME1304 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1304 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04566 XEO_CLAS Peptide DME1304 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.7 microM) DME1304 XEOTICID XEO04566 GENEFORM Protein DME1304 XEOTICID XEO04566 MOACRIVE Inhibition DME1304 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1304 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04569 XEO_CLAS Peptide DME1304 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 7.9 microM) DME1304 XEOTICID XEO04569 GENEFORM Protein DME1304 XEOTICID XEO04569 MOACRIVE Inhibition DME1304 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1304 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04570 XEO_CLAS Peptide DME1304 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04570 GENEFORM Protein DME1304 XEOTICID XEO04570 MOACRIVE Inhibition DME1304 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1304 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04571 XEO_CLAS Peptide DME1304 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04571 GENEFORM Protein DME1304 XEOTICID XEO04571 MOACRIVE Inhibition DME1304 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1304 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04572 XEO_CLAS Peptide DME1304 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04572 GENEFORM Protein DME1304 XEOTICID XEO04572 MOACRIVE Inhibition DME1304 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1304 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04573 XEO_CLAS Peptide DME1304 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 microM) DME1304 XEOTICID XEO04573 GENEFORM Protein DME1304 XEOTICID XEO04573 MOACRIVE Inhibition DME1304 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1304 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04574 XEO_CLAS Peptide DME1304 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 128 ug/ml) DME1304 XEOTICID XEO04574 GENEFORM Protein DME1304 XEOTICID XEO04574 MOACRIVE Inhibition DME1304 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1304 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04575 XEO_CLAS Peptide DME1304 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO04575 GENEFORM Protein DME1304 XEOTICID XEO04575 MOACRIVE Inhibition DME1304 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1304 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04578 GENEFORM Protein DME1304 XEOTICID XEO04578 MOACRIVE Inhibition DME1304 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1304 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04579 GENEFORM Protein DME1304 XEOTICID XEO04579 MOACRIVE Inhibition DME1304 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1304 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04580 GENEFORM Protein DME1304 XEOTICID XEO04580 MOACRIVE Inhibition DME1304 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1304 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04583 GENEFORM Protein DME1304 XEOTICID XEO04583 MOACRIVE Inhibition DME1304 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1304 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04588 GENEFORM Protein DME1304 XEOTICID XEO04588 MOACRIVE Inhibition DME1304 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1304 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04589 GENEFORM Protein DME1304 XEOTICID XEO04589 MOACRIVE Inhibition DME1304 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1304 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04590 GENEFORM Protein DME1304 XEOTICID XEO04590 MOACRIVE Inhibition DME1304 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1304 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04591 GENEFORM Protein DME1304 XEOTICID XEO04591 MOACRIVE Inhibition DME1304 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1304 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04592 GENEFORM Protein DME1304 XEOTICID XEO04592 MOACRIVE Inhibition DME1304 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1304 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04593 GENEFORM Protein DME1304 XEOTICID XEO04593 MOACRIVE Inhibition DME1304 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1304 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04594 GENEFORM Protein DME1304 XEOTICID XEO04594 MOACRIVE Inhibition DME1304 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1304 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04595 GENEFORM Protein DME1304 XEOTICID XEO04595 MOACRIVE Inhibition DME1304 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1304 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04596 GENEFORM Protein DME1304 XEOTICID XEO04596 MOACRIVE Inhibition DME1304 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1304 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04597 GENEFORM Protein DME1304 XEOTICID XEO04597 MOACRIVE Inhibition DME1304 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1304 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04598 GENEFORM Protein DME1304 XEOTICID XEO04598 MOACRIVE Inhibition DME1304 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1304 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04599 GENEFORM Protein DME1304 XEOTICID XEO04599 MOACRIVE Inhibition DME1304 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1304 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04601 XEO_CLAS Peptide DME1304 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 18.75 ug/ml) DME1304 XEOTICID XEO04601 GENEFORM Protein DME1304 XEOTICID XEO04601 MOACRIVE Inhibition DME1304 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1304 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04602 XEO_CLAS Peptide DME1304 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 37.5 ug/ml) DME1304 XEOTICID XEO04602 GENEFORM Protein DME1304 XEOTICID XEO04602 MOACRIVE Inhibition DME1304 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1304 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04604 XEO_CLAS Peptide DME1304 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC < 25 microM) DME1304 XEOTICID XEO04604 GENEFORM Protein DME1304 XEOTICID XEO04604 MOACRIVE Inhibition DME1304 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1304 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04605 XEO_CLAS Peptide DME1304 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC < 6.25 microM) DME1304 XEOTICID XEO04605 GENEFORM Protein DME1304 XEOTICID XEO04605 MOACRIVE Inhibition DME1304 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1304 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04606 XEO_CLAS Peptide DME1304 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO04606 GENEFORM Protein DME1304 XEOTICID XEO04606 MOACRIVE Inhibition DME1304 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1304 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1304 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04607 GENEFORM Protein DME1304 XEOTICID XEO04607 MOACRIVE Inhibition DME1304 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1304 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04612 XEO_CLAS Peptide DME1304 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5-10 microM) DME1304 XEOTICID XEO04612 GENEFORM Protein DME1304 XEOTICID XEO04612 MOACRIVE Inhibition DME1304 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1304 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04613 XEO_CLAS Peptide DME1304 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5-10 microM) DME1304 XEOTICID XEO04613 GENEFORM Protein DME1304 XEOTICID XEO04613 MOACRIVE Inhibition DME1304 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1304 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04625 XEO_CLAS Peptide DME1304 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO04625 GENEFORM Protein DME1304 XEOTICID XEO04625 MOACRIVE Inhibition DME1304 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1304 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04626 XEO_CLAS Peptide DME1304 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO04626 GENEFORM Protein DME1304 XEOTICID XEO04626 MOACRIVE Inhibition DME1304 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1304 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04627 XEO_CLAS Peptide DME1304 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.5 microM) DME1304 XEOTICID XEO04627 GENEFORM Protein DME1304 XEOTICID XEO04627 MOACRIVE Inhibition DME1304 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1304 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04630 XEO_CLAS Peptide DME1304 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 60 ug/ml) DME1304 XEOTICID XEO04630 GENEFORM Protein DME1304 XEOTICID XEO04630 MOACRIVE Inhibition DME1304 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1304 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04631 XEO_CLAS Peptide DME1304 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 60 ug/ml) DME1304 XEOTICID XEO04631 GENEFORM Protein DME1304 XEOTICID XEO04631 MOACRIVE Inhibition DME1304 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1304 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04633 XEO_CLAS Peptide DME1304 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 ug/ml) DME1304 XEOTICID XEO04633 GENEFORM Protein DME1304 XEOTICID XEO04633 MOACRIVE Inhibition DME1304 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1304 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04634 XEO_CLAS Peptide DME1304 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 ug/ml) DME1304 XEOTICID XEO04634 GENEFORM Protein DME1304 XEOTICID XEO04634 MOACRIVE Inhibition DME1304 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1304 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04635 XEO_CLAS Peptide DME1304 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 ug/ml) DME1304 XEOTICID XEO04635 GENEFORM Protein DME1304 XEOTICID XEO04635 MOACRIVE Inhibition DME1304 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1304 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04636 XEO_CLAS Peptide DME1304 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 ug/ml) DME1304 XEOTICID XEO04636 GENEFORM Protein DME1304 XEOTICID XEO04636 MOACRIVE Inhibition DME1304 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1304 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04637 XEO_CLAS Peptide DME1304 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 ug/ml) DME1304 XEOTICID XEO04637 GENEFORM Protein DME1304 XEOTICID XEO04637 MOACRIVE Inhibition DME1304 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1304 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04638 XEO_CLAS Peptide DME1304 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 ug/ml) DME1304 XEOTICID XEO04638 GENEFORM Protein DME1304 XEOTICID XEO04638 MOACRIVE Inhibition DME1304 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1304 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04639 XEO_CLAS Peptide DME1304 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 ug/ml) DME1304 XEOTICID XEO04639 GENEFORM Protein DME1304 XEOTICID XEO04639 MOACRIVE Inhibition DME1304 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1304 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04640 XEO_CLAS Peptide DME1304 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.2-3.3 microM) DME1304 XEOTICID XEO04640 GENEFORM Protein DME1304 XEOTICID XEO04640 MOACRIVE Inhibition DME1304 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1304 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04642 XEO_CLAS Peptide DME1304 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 ug/ml) DME1304 XEOTICID XEO04642 GENEFORM Protein DME1304 XEOTICID XEO04642 MOACRIVE Inhibition DME1304 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1304 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04643 XEO_CLAS Peptide DME1304 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO04643 GENEFORM Protein DME1304 XEOTICID XEO04643 MOACRIVE Inhibition DME1304 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1304 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04644 XEO_CLAS Peptide DME1304 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO04644 GENEFORM Protein DME1304 XEOTICID XEO04644 MOACRIVE Inhibition DME1304 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1304 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04645 XEO_CLAS Peptide DME1304 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 ug/ml) DME1304 XEOTICID XEO04645 GENEFORM Protein DME1304 XEOTICID XEO04645 MOACRIVE Inhibition DME1304 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1304 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04646 XEO_CLAS Peptide DME1304 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1 ug/ml) DME1304 XEOTICID XEO04646 GENEFORM Protein DME1304 XEOTICID XEO04646 MOACRIVE Inhibition DME1304 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1304 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04647 XEO_CLAS Peptide DME1304 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO04647 GENEFORM Protein DME1304 XEOTICID XEO04647 MOACRIVE Inhibition DME1304 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1304 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04648 XEO_CLAS Peptide DME1304 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 ug/ml) DME1304 XEOTICID XEO04648 GENEFORM Protein DME1304 XEOTICID XEO04648 MOACRIVE Inhibition DME1304 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1304 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04649 XEO_CLAS Peptide DME1304 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 64 ug/ml) DME1304 XEOTICID XEO04649 GENEFORM Protein DME1304 XEOTICID XEO04649 MOACRIVE Inhibition DME1304 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1304 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04650 XEO_CLAS Peptide DME1304 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 ug/ml) DME1304 XEOTICID XEO04650 GENEFORM Protein DME1304 XEOTICID XEO04650 MOACRIVE Inhibition DME1304 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1304 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04651 XEO_CLAS Peptide DME1304 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 ug/ml) DME1304 XEOTICID XEO04651 GENEFORM Protein DME1304 XEOTICID XEO04651 MOACRIVE Inhibition DME1304 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1304 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04652 XEO_CLAS Peptide DME1304 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO04652 GENEFORM Protein DME1304 XEOTICID XEO04652 MOACRIVE Inhibition DME1304 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1304 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04653 XEO_CLAS Peptide DME1304 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 64 ug/ml) DME1304 XEOTICID XEO04653 GENEFORM Protein DME1304 XEOTICID XEO04653 MOACRIVE Inhibition DME1304 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1304 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04654 XEO_CLAS Peptide DME1304 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 ug/ml) DME1304 XEOTICID XEO04654 GENEFORM Protein DME1304 XEOTICID XEO04654 MOACRIVE Inhibition DME1304 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1304 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04655 XEO_CLAS Peptide DME1304 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO04655 GENEFORM Protein DME1304 XEOTICID XEO04655 MOACRIVE Inhibition DME1304 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1304 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04657 XEO_CLAS Peptide DME1304 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 300 microM) DME1304 XEOTICID XEO04657 GENEFORM Protein DME1304 XEOTICID XEO04657 MOACRIVE Inhibition DME1304 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1304 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04660 XEO_CLAS Peptide DME1304 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO04660 GENEFORM Protein DME1304 XEOTICID XEO04660 MOACRIVE Inhibition DME1304 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1304 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04661 XEO_CLAS Peptide DME1304 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 microM) DME1304 XEOTICID XEO04661 GENEFORM Protein DME1304 XEOTICID XEO04661 MOACRIVE Inhibition DME1304 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1304 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04662 XEO_CLAS Peptide DME1304 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 microM) DME1304 XEOTICID XEO04662 GENEFORM Protein DME1304 XEOTICID XEO04662 MOACRIVE Inhibition DME1304 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1304 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04663 XEO_CLAS Peptide DME1304 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 microM) DME1304 XEOTICID XEO04663 GENEFORM Protein DME1304 XEOTICID XEO04663 MOACRIVE Inhibition DME1304 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1304 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04664 XEO_CLAS Peptide DME1304 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5.5 microM) DME1304 XEOTICID XEO04664 GENEFORM Protein DME1304 XEOTICID XEO04664 MOACRIVE Inhibition DME1304 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1304 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04665 XEO_CLAS Peptide DME1304 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 microM) DME1304 XEOTICID XEO04665 GENEFORM Protein DME1304 XEOTICID XEO04665 MOACRIVE Inhibition DME1304 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1304 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04666 XEO_CLAS Peptide DME1304 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO04666 GENEFORM Protein DME1304 XEOTICID XEO04666 MOACRIVE Inhibition DME1304 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1304 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04667 XEO_CLAS Peptide DME1304 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6.25 microM) DME1304 XEOTICID XEO04667 GENEFORM Protein DME1304 XEOTICID XEO04667 MOACRIVE Inhibition DME1304 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1304 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04668 XEO_CLAS Peptide DME1304 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 microM) DME1304 XEOTICID XEO04668 GENEFORM Protein DME1304 XEOTICID XEO04668 MOACRIVE Inhibition DME1304 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1304 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04669 XEO_CLAS Peptide DME1304 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO04669 GENEFORM Protein DME1304 XEOTICID XEO04669 MOACRIVE Inhibition DME1304 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1304 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04670 XEO_CLAS Peptide DME1304 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 21 microM) DME1304 XEOTICID XEO04670 GENEFORM Protein DME1304 XEOTICID XEO04670 MOACRIVE Inhibition DME1304 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1304 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04671 XEO_CLAS Peptide DME1304 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 62 microM) DME1304 XEOTICID XEO04671 GENEFORM Protein DME1304 XEOTICID XEO04671 MOACRIVE Inhibition DME1304 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1304 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04672 XEO_CLAS Peptide DME1304 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO04672 GENEFORM Protein DME1304 XEOTICID XEO04672 MOACRIVE Inhibition DME1304 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1304 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04673 XEO_CLAS Peptide DME1304 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO04673 GENEFORM Protein DME1304 XEOTICID XEO04673 MOACRIVE Inhibition DME1304 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1304 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04674 XEO_CLAS Peptide DME1304 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 75 microM) DME1304 XEOTICID XEO04674 GENEFORM Protein DME1304 XEOTICID XEO04674 MOACRIVE Inhibition DME1304 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1304 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04675 XEO_CLAS Peptide DME1304 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 microM) DME1304 XEOTICID XEO04675 GENEFORM Protein DME1304 XEOTICID XEO04675 MOACRIVE Inhibition DME1304 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1304 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04676 XEO_CLAS Peptide DME1304 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 microM) DME1304 XEOTICID XEO04676 GENEFORM Protein DME1304 XEOTICID XEO04676 MOACRIVE Inhibition DME1304 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1304 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04677 XEO_CLAS Peptide DME1304 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO04677 GENEFORM Protein DME1304 XEOTICID XEO04677 MOACRIVE Inhibition DME1304 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1304 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04680 XEO_CLAS Peptide DME1304 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 microM) DME1304 XEOTICID XEO04680 GENEFORM Protein DME1304 XEOTICID XEO04680 MOACRIVE Inhibition DME1304 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1304 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04682 XEO_CLAS Peptide DME1304 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 microM) DME1304 XEOTICID XEO04682 GENEFORM Protein DME1304 XEOTICID XEO04682 MOACRIVE Inhibition DME1304 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1304 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04683 XEO_CLAS Peptide DME1304 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 microM) DME1304 XEOTICID XEO04683 GENEFORM Protein DME1304 XEOTICID XEO04683 MOACRIVE Inhibition DME1304 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1304 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04684 XEO_CLAS Peptide DME1304 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 38 microM) DME1304 XEOTICID XEO04684 GENEFORM Protein DME1304 XEOTICID XEO04684 MOACRIVE Inhibition DME1304 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1304 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04690 XEO_CLAS Peptide DME1304 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.5 ug/ml) DME1304 XEOTICID XEO04690 GENEFORM Protein DME1304 XEOTICID XEO04690 MOACRIVE Inhibition DME1304 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1304 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04695 XEO_CLAS Peptide DME1304 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04695 GENEFORM Protein DME1304 XEOTICID XEO04695 MOACRIVE Inhibition DME1304 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1304 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04696 XEO_CLAS Peptide DME1304 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04696 GENEFORM Protein DME1304 XEOTICID XEO04696 MOACRIVE Inhibition DME1304 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1304 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04712 XEO_CLAS Peptide DME1304 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16.7 microM) DME1304 XEOTICID XEO04712 GENEFORM Protein DME1304 XEOTICID XEO04712 MOACRIVE Inhibition DME1304 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1304 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04713 XEO_CLAS Peptide DME1304 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16.7 microM) DME1304 XEOTICID XEO04713 GENEFORM Protein DME1304 XEOTICID XEO04713 MOACRIVE Inhibition DME1304 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1304 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04714 XEO_CLAS Peptide DME1304 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 23.3 microM) DME1304 XEOTICID XEO04714 GENEFORM Protein DME1304 XEOTICID XEO04714 MOACRIVE Inhibition DME1304 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1304 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04716 XEO_CLAS Peptide DME1304 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 microM) DME1304 XEOTICID XEO04716 GENEFORM Protein DME1304 XEOTICID XEO04716 MOACRIVE Inhibition DME1304 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1304 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04717 XEO_CLAS Peptide DME1304 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 50 microM) DME1304 XEOTICID XEO04717 GENEFORM Protein DME1304 XEOTICID XEO04717 MOACRIVE Inhibition DME1304 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1304 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04725 XEO_CLAS Peptide DME1304 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04725 GENEFORM Protein DME1304 XEOTICID XEO04725 MOACRIVE Inhibition DME1304 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1304 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04726 XEO_CLAS Peptide DME1304 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04726 GENEFORM Protein DME1304 XEOTICID XEO04726 MOACRIVE Inhibition DME1304 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1304 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04731 XEO_CLAS Peptide DME1304 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 ug/ml) DME1304 XEOTICID XEO04731 GENEFORM Protein DME1304 XEOTICID XEO04731 MOACRIVE Inhibition DME1304 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1304 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04732 XEO_CLAS Peptide DME1304 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 25 ug/ml) DME1304 XEOTICID XEO04732 GENEFORM Protein DME1304 XEOTICID XEO04732 MOACRIVE Inhibition DME1304 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1304 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04733 XEO_CLAS Peptide DME1304 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04733 GENEFORM Protein DME1304 XEOTICID XEO04733 MOACRIVE Inhibition DME1304 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1304 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04734 XEO_CLAS Peptide DME1304 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04734 GENEFORM Protein DME1304 XEOTICID XEO04734 MOACRIVE Inhibition DME1304 XEOTICID XEO04737 XEO_NAME Protonectin DME1304 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04737 XEO_CLAS Peptide DME1304 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 ug/ml) DME1304 XEOTICID XEO04737 GENEFORM Protein DME1304 XEOTICID XEO04737 MOACRIVE Inhibition DME1304 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1304 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04739 XEO_CLAS Peptide DME1304 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04739 GENEFORM Protein DME1304 XEOTICID XEO04739 MOACRIVE Inhibition DME1304 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1304 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04740 XEO_CLAS Peptide DME1304 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04740 GENEFORM Protein DME1304 XEOTICID XEO04740 MOACRIVE Inhibition DME1304 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1304 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04741 XEO_CLAS Peptide DME1304 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04741 GENEFORM Protein DME1304 XEOTICID XEO04741 MOACRIVE Inhibition DME1304 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1304 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04742 XEO_CLAS Peptide DME1304 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04742 GENEFORM Protein DME1304 XEOTICID XEO04742 MOACRIVE Inhibition DME1304 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1304 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04762 XEO_CLAS Peptide DME1304 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.8 microM) DME1304 XEOTICID XEO04762 GENEFORM Protein DME1304 XEOTICID XEO04762 MOACRIVE Inhibition DME1304 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1304 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04766 XEO_CLAS Peptide DME1304 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.1 microM) DME1304 XEOTICID XEO04766 GENEFORM Protein DME1304 XEOTICID XEO04766 MOACRIVE Inhibition DME1304 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1304 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04767 XEO_CLAS Peptide DME1304 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.1 ug/ml) DME1304 XEOTICID XEO04767 GENEFORM Protein DME1304 XEOTICID XEO04767 MOACRIVE Inhibition DME1304 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1304 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04779 XEO_CLAS Peptide DME1304 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04779 GENEFORM Protein DME1304 XEOTICID XEO04779 MOACRIVE Inhibition DME1304 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1304 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04780 XEO_CLAS Peptide DME1304 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04780 GENEFORM Protein DME1304 XEOTICID XEO04780 MOACRIVE Inhibition DME1304 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1304 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04781 XEO_CLAS Peptide DME1304 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04781 GENEFORM Protein DME1304 XEOTICID XEO04781 MOACRIVE Inhibition DME1304 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1304 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04782 XEO_CLAS Peptide DME1304 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 ug/ml) DME1304 XEOTICID XEO04782 GENEFORM Protein DME1304 XEOTICID XEO04782 MOACRIVE Inhibition DME1304 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1304 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04783 XEO_CLAS Peptide DME1304 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO04783 GENEFORM Protein DME1304 XEOTICID XEO04783 MOACRIVE Inhibition DME1304 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1304 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04784 XEO_CLAS Peptide DME1304 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO04784 GENEFORM Protein DME1304 XEOTICID XEO04784 MOACRIVE Inhibition DME1304 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1304 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04785 XEO_CLAS Peptide DME1304 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO04785 GENEFORM Protein DME1304 XEOTICID XEO04785 MOACRIVE Inhibition DME1304 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1304 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04786 XEO_CLAS Peptide DME1304 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 ug/ml) DME1304 XEOTICID XEO04786 GENEFORM Protein DME1304 XEOTICID XEO04786 MOACRIVE Inhibition DME1304 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1304 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04787 XEO_CLAS Peptide DME1304 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04787 GENEFORM Protein DME1304 XEOTICID XEO04787 MOACRIVE Inhibition DME1304 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1304 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04793 XEO_CLAS Peptide DME1304 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04793 GENEFORM Protein DME1304 XEOTICID XEO04793 MOACRIVE Inhibition DME1304 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1304 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04798 XEO_CLAS Peptide DME1304 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 microM) DME1304 XEOTICID XEO04798 GENEFORM Protein DME1304 XEOTICID XEO04798 MOACRIVE Inhibition DME1304 XEOTICID XEO04799 XEO_NAME Ranalexin DME1304 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04799 XEO_CLAS Peptide DME1304 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 32 ug/ml) DME1304 XEOTICID XEO04799 GENEFORM Protein DME1304 XEOTICID XEO04799 MOACRIVE Inhibition DME1304 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1304 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04800 XEO_CLAS Peptide DME1304 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 microM) DME1304 XEOTICID XEO04800 GENEFORM Protein DME1304 XEOTICID XEO04800 MOACRIVE Inhibition DME1304 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1304 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04801 XEO_CLAS Peptide DME1304 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 9 microM) DME1304 XEOTICID XEO04801 GENEFORM Protein DME1304 XEOTICID XEO04801 MOACRIVE Inhibition DME1304 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1304 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04802 XEO_CLAS Peptide DME1304 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12 microM) DME1304 XEOTICID XEO04802 GENEFORM Protein DME1304 XEOTICID XEO04802 MOACRIVE Inhibition DME1304 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1304 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04803 XEO_CLAS Peptide DME1304 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO04803 GENEFORM Protein DME1304 XEOTICID XEO04803 MOACRIVE Inhibition DME1304 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1304 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04804 XEO_CLAS Peptide DME1304 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO04804 GENEFORM Protein DME1304 XEOTICID XEO04804 MOACRIVE Inhibition DME1304 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1304 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04805 XEO_CLAS Peptide DME1304 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.5 microM) DME1304 XEOTICID XEO04805 GENEFORM Protein DME1304 XEOTICID XEO04805 MOACRIVE Inhibition DME1304 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1304 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04806 XEO_CLAS Peptide DME1304 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.5 microM) DME1304 XEOTICID XEO04806 GENEFORM Protein DME1304 XEOTICID XEO04806 MOACRIVE Inhibition DME1304 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1304 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04807 XEO_CLAS Peptide DME1304 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04807 GENEFORM Protein DME1304 XEOTICID XEO04807 MOACRIVE Inhibition DME1304 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1304 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04809 XEO_CLAS Peptide DME1304 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 microM) DME1304 XEOTICID XEO04809 GENEFORM Protein DME1304 XEOTICID XEO04809 MOACRIVE Inhibition DME1304 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1304 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04811 XEO_CLAS Peptide DME1304 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO04811 GENEFORM Protein DME1304 XEOTICID XEO04811 MOACRIVE Inhibition DME1304 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1304 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04812 XEO_CLAS Peptide DME1304 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO04812 GENEFORM Protein DME1304 XEOTICID XEO04812 MOACRIVE Inhibition DME1304 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1304 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04813 XEO_CLAS Peptide DME1304 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 microM) DME1304 XEOTICID XEO04813 GENEFORM Protein DME1304 XEOTICID XEO04813 MOACRIVE Inhibition DME1304 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1304 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04814 XEO_CLAS Peptide DME1304 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 19 microM) DME1304 XEOTICID XEO04814 GENEFORM Protein DME1304 XEOTICID XEO04814 MOACRIVE Inhibition DME1304 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1304 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04815 XEO_CLAS Peptide DME1304 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 microM) DME1304 XEOTICID XEO04815 GENEFORM Protein DME1304 XEOTICID XEO04815 MOACRIVE Inhibition DME1304 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1304 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04816 XEO_CLAS Peptide DME1304 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 microM) DME1304 XEOTICID XEO04816 GENEFORM Protein DME1304 XEOTICID XEO04816 MOACRIVE Inhibition DME1304 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1304 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04817 XEO_CLAS Peptide DME1304 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 13 microM) DME1304 XEOTICID XEO04817 GENEFORM Protein DME1304 XEOTICID XEO04817 MOACRIVE Inhibition DME1304 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1304 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04818 XEO_CLAS Peptide DME1304 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO04818 GENEFORM Protein DME1304 XEOTICID XEO04818 MOACRIVE Inhibition DME1304 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1304 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04819 XEO_CLAS Peptide DME1304 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO04819 GENEFORM Protein DME1304 XEOTICID XEO04819 MOACRIVE Inhibition DME1304 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1304 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04820 XEO_CLAS Peptide DME1304 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3 microM) DME1304 XEOTICID XEO04820 GENEFORM Protein DME1304 XEOTICID XEO04820 MOACRIVE Inhibition DME1304 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1304 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04821 XEO_CLAS Peptide DME1304 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 microM) DME1304 XEOTICID XEO04821 GENEFORM Protein DME1304 XEOTICID XEO04821 MOACRIVE Inhibition DME1304 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1304 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04822 XEO_CLAS Peptide DME1304 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO04822 GENEFORM Protein DME1304 XEOTICID XEO04822 MOACRIVE Inhibition DME1304 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1304 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04823 XEO_CLAS Peptide DME1304 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 23 microM) DME1304 XEOTICID XEO04823 GENEFORM Protein DME1304 XEOTICID XEO04823 MOACRIVE Inhibition DME1304 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1304 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04824 XEO_CLAS Peptide DME1304 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04824 GENEFORM Protein DME1304 XEOTICID XEO04824 MOACRIVE Inhibition DME1304 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1304 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04825 XEO_CLAS Peptide DME1304 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04825 GENEFORM Protein DME1304 XEOTICID XEO04825 MOACRIVE Inhibition DME1304 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1304 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04826 XEO_CLAS Peptide DME1304 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO04826 GENEFORM Protein DME1304 XEOTICID XEO04826 MOACRIVE Inhibition DME1304 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1304 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04827 XEO_CLAS Peptide DME1304 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO04827 GENEFORM Protein DME1304 XEOTICID XEO04827 MOACRIVE Inhibition DME1304 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1304 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04835 XEO_CLAS Peptide DME1304 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04835 GENEFORM Protein DME1304 XEOTICID XEO04835 MOACRIVE Inhibition DME1304 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1304 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04836 XEO_CLAS Peptide DME1304 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04836 GENEFORM Protein DME1304 XEOTICID XEO04836 MOACRIVE Inhibition DME1304 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1304 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04837 XEO_CLAS Peptide DME1304 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 microM) DME1304 XEOTICID XEO04837 GENEFORM Protein DME1304 XEOTICID XEO04837 MOACRIVE Inhibition DME1304 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1304 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04839 XEO_CLAS Peptide DME1304 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04839 GENEFORM Protein DME1304 XEOTICID XEO04839 MOACRIVE Inhibition DME1304 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1304 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04840 XEO_CLAS Peptide DME1304 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 35-20 microM) DME1304 XEOTICID XEO04840 GENEFORM Protein DME1304 XEOTICID XEO04840 MOACRIVE Inhibition DME1304 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1304 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04847 XEO_CLAS Peptide DME1304 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04847 GENEFORM Protein DME1304 XEOTICID XEO04847 MOACRIVE Inhibition DME1304 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1304 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04848 XEO_CLAS Peptide DME1304 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04848 GENEFORM Protein DME1304 XEOTICID XEO04848 MOACRIVE Inhibition DME1304 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1304 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04849 XEO_CLAS Peptide DME1304 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04849 GENEFORM Protein DME1304 XEOTICID XEO04849 MOACRIVE Inhibition DME1304 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1304 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04850 XEO_CLAS Peptide DME1304 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04850 GENEFORM Protein DME1304 XEOTICID XEO04850 MOACRIVE Inhibition DME1304 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1304 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04851 XEO_CLAS Peptide DME1304 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1 ug/ml) DME1304 XEOTICID XEO04851 GENEFORM Protein DME1304 XEOTICID XEO04851 MOACRIVE Inhibition DME1304 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1304 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04857 XEO_CLAS Peptide DME1304 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 microM) DME1304 XEOTICID XEO04857 GENEFORM Protein DME1304 XEOTICID XEO04857 MOACRIVE Inhibition DME1304 XEOTICID XEO04863 XEO_NAME RTD peptide DME1304 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04863 XEO_CLAS Peptide DME1304 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.0 microM) DME1304 XEOTICID XEO04863 GENEFORM Protein DME1304 XEOTICID XEO04863 MOACRIVE Inhibition DME1304 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1304 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04865 XEO_CLAS Peptide DME1304 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 ug/ml) DME1304 XEOTICID XEO04865 GENEFORM Protein DME1304 XEOTICID XEO04865 MOACRIVE Inhibition DME1304 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1304 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04866 XEO_CLAS Peptide DME1304 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12.5 ug/ml) DME1304 XEOTICID XEO04866 GENEFORM Protein DME1304 XEOTICID XEO04866 MOACRIVE Inhibition DME1304 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1304 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04868 XEO_CLAS Peptide DME1304 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25.00 ug/ml) DME1304 XEOTICID XEO04868 GENEFORM Protein DME1304 XEOTICID XEO04868 MOACRIVE Inhibition DME1304 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1304 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04869 XEO_CLAS Peptide DME1304 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25.00 ug/ml) DME1304 XEOTICID XEO04869 GENEFORM Protein DME1304 XEOTICID XEO04869 MOACRIVE Inhibition DME1304 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1304 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04870 XEO_CLAS Peptide DME1304 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25.00 ug/ml) DME1304 XEOTICID XEO04870 GENEFORM Protein DME1304 XEOTICID XEO04870 MOACRIVE Inhibition DME1304 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1304 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04877 XEO_CLAS Peptide DME1304 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04877 GENEFORM Protein DME1304 XEOTICID XEO04877 MOACRIVE Inhibition DME1304 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1304 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04880 XEO_CLAS Peptide DME1304 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.5 ug/ml) DME1304 XEOTICID XEO04880 GENEFORM Protein DME1304 XEOTICID XEO04880 MOACRIVE Inhibition DME1304 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1304 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04886 XEO_CLAS Peptide DME1304 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.6 ug/ml) DME1304 XEOTICID XEO04886 GENEFORM Protein DME1304 XEOTICID XEO04886 MOACRIVE Inhibition DME1304 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1304 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04891 XEO_CLAS Peptide DME1304 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04891 GENEFORM Protein DME1304 XEOTICID XEO04891 MOACRIVE Inhibition DME1304 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1304 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04895 XEO_CLAS Peptide DME1304 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04895 GENEFORM Protein DME1304 XEOTICID XEO04895 MOACRIVE Inhibition DME1304 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1304 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04901 XEO_CLAS Peptide DME1304 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 microM) DME1304 XEOTICID XEO04901 GENEFORM Protein DME1304 XEOTICID XEO04901 MOACRIVE Inhibition DME1304 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1304 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04904 XEO_CLAS Peptide DME1304 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 78 ug/ml) DME1304 XEOTICID XEO04904 GENEFORM Protein DME1304 XEOTICID XEO04904 MOACRIVE Inhibition DME1304 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1304 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04905 XEO_CLAS Peptide DME1304 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04905 GENEFORM Protein DME1304 XEOTICID XEO04905 MOACRIVE Inhibition DME1304 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1304 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04906 XEO_CLAS Peptide DME1304 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04906 GENEFORM Protein DME1304 XEOTICID XEO04906 MOACRIVE Inhibition DME1304 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1304 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04907 XEO_CLAS Peptide DME1304 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04907 GENEFORM Protein DME1304 XEOTICID XEO04907 MOACRIVE Inhibition DME1304 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1304 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04908 XEO_CLAS Peptide DME1304 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04908 GENEFORM Protein DME1304 XEOTICID XEO04908 MOACRIVE Inhibition DME1304 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1304 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04909 XEO_CLAS Peptide DME1304 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04909 GENEFORM Protein DME1304 XEOTICID XEO04909 MOACRIVE Inhibition DME1304 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1304 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04915 XEO_CLAS Peptide DME1304 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 100 ug/ml) DME1304 XEOTICID XEO04915 GENEFORM Protein DME1304 XEOTICID XEO04915 MOACRIVE Inhibition DME1304 XEOTICID XEO04916 XEO_NAME Scopoletin DME1304 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1304 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04916 GENEFORM Protein DME1304 XEOTICID XEO04916 MOACRIVE Inhibition DME1304 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1304 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04926 XEO_CLAS Peptide DME1304 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04926 GENEFORM Protein DME1304 XEOTICID XEO04926 MOACRIVE Inhibition DME1304 XEOTICID XEO04931 XEO_NAME Shepherin I DME1304 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04931 XEO_CLAS Peptide DME1304 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04931 GENEFORM Protein DME1304 XEOTICID XEO04931 MOACRIVE Inhibition DME1304 XEOTICID XEO04932 XEO_NAME shepherin II DME1304 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04932 XEO_CLAS Peptide DME1304 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04932 GENEFORM Protein DME1304 XEOTICID XEO04932 MOACRIVE Inhibition DME1304 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1304 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04938 XEO_CLAS Peptide DME1304 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC <= 100 microM) DME1304 XEOTICID XEO04938 GENEFORM Protein DME1304 XEOTICID XEO04938 MOACRIVE Inhibition DME1304 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1304 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04947 XEO_CLAS Natural Product DME1304 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04947 GENEFORM Protein DME1304 XEOTICID XEO04947 MOACRIVE Inhibition DME1304 XEOTICID XEO04948 XEO_NAME Sinensetin DME1304 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1304 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1304 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04948 GENEFORM Protein DME1304 XEOTICID XEO04948 MOACRIVE Inhibition DME1304 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1304 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04950 XEO_CLAS Peptide DME1304 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 ug/ml) DME1304 XEOTICID XEO04950 GENEFORM Protein DME1304 XEOTICID XEO04950 MOACRIVE Inhibition DME1304 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1304 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04955 XEO_CLAS Peptide DME1304 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.07 microM) DME1304 XEOTICID XEO04955 GENEFORM Protein DME1304 XEOTICID XEO04955 MOACRIVE Inhibition DME1304 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1304 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04956 XEO_CLAS Peptide DME1304 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16.0 microM) DME1304 XEOTICID XEO04956 GENEFORM Protein DME1304 XEOTICID XEO04956 MOACRIVE Inhibition DME1304 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1304 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04957 XEO_CLAS Peptide DME1304 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.23 microM) DME1304 XEOTICID XEO04957 GENEFORM Protein DME1304 XEOTICID XEO04957 MOACRIVE Inhibition DME1304 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1304 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04958 XEO_CLAS Peptide DME1304 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 ug/ml) DME1304 XEOTICID XEO04958 GENEFORM Protein DME1304 XEOTICID XEO04958 MOACRIVE Inhibition DME1304 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1304 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04959 XEO_CLAS Peptide DME1304 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04959 GENEFORM Protein DME1304 XEOTICID XEO04959 MOACRIVE Inhibition DME1304 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1304 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04967 XEO_CLAS Peptide DME1304 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 28 microM) DME1304 XEOTICID XEO04967 GENEFORM Protein DME1304 XEOTICID XEO04967 MOACRIVE Inhibition DME1304 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1304 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04969 XEO_CLAS Peptide DME1304 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50-100 ug/ml) DME1304 XEOTICID XEO04969 GENEFORM Protein DME1304 XEOTICID XEO04969 MOACRIVE Inhibition DME1304 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1304 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04970 XEO_CLAS Peptide DME1304 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04970 GENEFORM Protein DME1304 XEOTICID XEO04970 MOACRIVE Inhibition DME1304 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1304 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04971 XEO_CLAS Peptide DME1304 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.8-1.5 microM) DME1304 XEOTICID XEO04971 GENEFORM Protein DME1304 XEOTICID XEO04971 MOACRIVE Inhibition DME1304 XEOTICID XEO04974 XEO_NAME Spinigerin DME1304 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04974 XEO_CLAS Peptide DME1304 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3-6 microM) DME1304 XEOTICID XEO04974 GENEFORM Protein DME1304 XEOTICID XEO04974 MOACRIVE Inhibition DME1304 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1304 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1304 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04975 GENEFORM Protein DME1304 XEOTICID XEO04975 MOACRIVE Inhibition DME1304 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1304 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1304 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04976 GENEFORM Protein DME1304 XEOTICID XEO04976 MOACRIVE Inhibition DME1304 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1304 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1304 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04977 GENEFORM Protein DME1304 XEOTICID XEO04977 MOACRIVE Inhibition DME1304 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1304 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1304 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04978 GENEFORM Protein DME1304 XEOTICID XEO04978 MOACRIVE Inhibition DME1304 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1304 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1304 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04979 GENEFORM Protein DME1304 XEOTICID XEO04979 MOACRIVE Inhibition DME1304 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1304 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04981 XEO_CLAS Peptide DME1304 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10.1 microM) DME1304 XEOTICID XEO04981 GENEFORM Protein DME1304 XEOTICID XEO04981 MOACRIVE Inhibition DME1304 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1304 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04982 XEO_CLAS Peptide DME1304 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40.5 microM) DME1304 XEOTICID XEO04982 GENEFORM Protein DME1304 XEOTICID XEO04982 MOACRIVE Inhibition DME1304 XEOTICID XEO04994 XEO_NAME Stilbene DME1304 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1304 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1304 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO04994 GENEFORM Protein DME1304 XEOTICID XEO04994 MOACRIVE Inhibition DME1304 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1304 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04995 XEO_CLAS Peptide DME1304 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC < 0.19 microM) DME1304 XEOTICID XEO04995 GENEFORM Protein DME1304 XEOTICID XEO04995 MOACRIVE Inhibition DME1304 XEOTICID XEO04998 XEO_NAME Styelin A DME1304 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04998 XEO_CLAS Peptide DME1304 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.7 ug/ml) DME1304 XEOTICID XEO04998 GENEFORM Protein DME1304 XEOTICID XEO04998 MOACRIVE Inhibition DME1304 XEOTICID XEO04999 XEO_NAME Styelin B DME1304 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO04999 XEO_CLAS Peptide DME1304 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.7 ug/ml) DME1304 XEOTICID XEO04999 GENEFORM Protein DME1304 XEOTICID XEO04999 MOACRIVE Inhibition DME1304 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1304 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05000 XEO_CLAS Peptide DME1304 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO05000 GENEFORM Protein DME1304 XEOTICID XEO05000 MOACRIVE Inhibition DME1304 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1304 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05001 XEO_CLAS Peptide DME1304 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.5 ug/ml) DME1304 XEOTICID XEO05001 GENEFORM Protein DME1304 XEOTICID XEO05001 MOACRIVE Inhibition DME1304 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1304 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05002 XEO_CLAS Peptide DME1304 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO05002 GENEFORM Protein DME1304 XEOTICID XEO05002 MOACRIVE Inhibition DME1304 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1304 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05003 XEO_CLAS Peptide DME1304 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO05003 GENEFORM Protein DME1304 XEOTICID XEO05003 MOACRIVE Inhibition DME1304 XEOTICID XEO05006 XEO_NAME Substance P DME1304 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05006 XEO_CLAS Peptide DME1304 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05006 GENEFORM Protein DME1304 XEOTICID XEO05006 MOACRIVE Inhibition DME1304 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1304 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05007 XEO_CLAS Peptide DME1304 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05007 GENEFORM Protein DME1304 XEOTICID XEO05007 MOACRIVE Inhibition DME1304 XEOTICID XEO05008 XEO_NAME Subtilosin DME1304 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05008 XEO_CLAS Peptide DME1304 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05008 GENEFORM Protein DME1304 XEOTICID XEO05008 MOACRIVE Inhibition DME1304 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1304 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05013 XEO_CLAS Peptide DME1304 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO05013 GENEFORM Protein DME1304 XEOTICID XEO05013 MOACRIVE Inhibition DME1304 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1304 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05014 XEO_CLAS Peptide DME1304 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO05014 GENEFORM Protein DME1304 XEOTICID XEO05014 MOACRIVE Inhibition DME1304 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1304 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05015 XEO_CLAS Peptide DME1304 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO05015 GENEFORM Protein DME1304 XEOTICID XEO05015 MOACRIVE Inhibition DME1304 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1304 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05016 XEO_CLAS Peptide DME1304 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO05016 GENEFORM Protein DME1304 XEOTICID XEO05016 MOACRIVE Inhibition DME1304 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1304 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05017 XEO_CLAS Peptide DME1304 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 20 ug/ml) DME1304 XEOTICID XEO05017 GENEFORM Protein DME1304 XEOTICID XEO05017 MOACRIVE Inhibition DME1304 XEOTICID XEO05018 XEO_NAME Syringic acid DME1304 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1304 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05018 GENEFORM Protein DME1304 XEOTICID XEO05018 MOACRIVE Inhibition DME1304 XEOTICID XEO05020 XEO_NAME Tachycitin DME1304 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05020 XEO_CLAS Peptide DME1304 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05020 GENEFORM Protein DME1304 XEOTICID XEO05020 MOACRIVE Inhibition DME1304 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1304 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05023 XEO_CLAS Peptide DME1304 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05023 GENEFORM Protein DME1304 XEOTICID XEO05023 MOACRIVE Inhibition DME1304 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1304 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05024 XEO_CLAS Peptide DME1304 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05024 GENEFORM Protein DME1304 XEOTICID XEO05024 MOACRIVE Inhibition DME1304 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1304 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05027 XEO_CLAS Peptide DME1304 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05027 GENEFORM Protein DME1304 XEOTICID XEO05027 MOACRIVE Inhibition DME1304 XEOTICID XEO05031 XEO_NAME Tannic acid DME1304 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1304 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05031 GENEFORM Protein DME1304 XEOTICID XEO05031 MOACRIVE Inhibition DME1304 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1304 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05033 XEO_CLAS Peptide DME1304 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05033 GENEFORM Protein DME1304 XEOTICID XEO05033 MOACRIVE Inhibition DME1304 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1304 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05042 XEO_CLAS Peptide DME1304 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO05042 GENEFORM Protein DME1304 XEOTICID XEO05042 MOACRIVE Inhibition DME1304 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1304 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05043 XEO_CLAS Peptide DME1304 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO05043 GENEFORM Protein DME1304 XEOTICID XEO05043 MOACRIVE Inhibition DME1304 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1304 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05044 XEO_CLAS Peptide DME1304 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 128 microM) DME1304 XEOTICID XEO05044 GENEFORM Protein DME1304 XEOTICID XEO05044 MOACRIVE Inhibition DME1304 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1304 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05045 XEO_CLAS Peptide DME1304 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 128 microM) DME1304 XEOTICID XEO05045 GENEFORM Protein DME1304 XEOTICID XEO05045 MOACRIVE Inhibition DME1304 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1304 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05046 XEO_CLAS Peptide DME1304 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 microM) DME1304 XEOTICID XEO05046 GENEFORM Protein DME1304 XEOTICID XEO05046 MOACRIVE Inhibition DME1304 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1304 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05047 XEO_CLAS Peptide DME1304 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 60 microM) DME1304 XEOTICID XEO05047 GENEFORM Protein DME1304 XEOTICID XEO05047 MOACRIVE Inhibition DME1304 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1304 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05051 XEO_CLAS Peptide DME1304 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05051 GENEFORM Protein DME1304 XEOTICID XEO05051 MOACRIVE Inhibition DME1304 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1304 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05055 XEO_CLAS Peptide DME1304 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 70 microM) DME1304 XEOTICID XEO05055 GENEFORM Protein DME1304 XEOTICID XEO05055 MOACRIVE Inhibition DME1304 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1304 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05056 XEO_CLAS Peptide DME1304 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05056 GENEFORM Protein DME1304 XEOTICID XEO05056 MOACRIVE Inhibition DME1304 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1304 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05059 XEO_CLAS Peptide DME1304 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05059 GENEFORM Protein DME1304 XEOTICID XEO05059 MOACRIVE Inhibition DME1304 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1304 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05061 XEO_CLAS Peptide DME1304 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO05061 GENEFORM Protein DME1304 XEOTICID XEO05061 MOACRIVE Inhibition DME1304 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1304 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05062 XEO_CLAS Peptide DME1304 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05062 GENEFORM Protein DME1304 XEOTICID XEO05062 MOACRIVE Inhibition DME1304 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1304 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05063 XEO_CLAS Peptide DME1304 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO05063 GENEFORM Protein DME1304 XEOTICID XEO05063 MOACRIVE Inhibition DME1304 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1304 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05064 XEO_CLAS Peptide DME1304 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 231 microM) DME1304 XEOTICID XEO05064 GENEFORM Protein DME1304 XEOTICID XEO05064 MOACRIVE Inhibition DME1304 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1304 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05065 XEO_CLAS Peptide DME1304 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 161 ug/ml) DME1304 XEOTICID XEO05065 GENEFORM Protein DME1304 XEOTICID XEO05065 MOACRIVE Inhibition DME1304 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1304 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05069 XEO_CLAS Peptide DME1304 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO05069 GENEFORM Protein DME1304 XEOTICID XEO05069 MOACRIVE Inhibition DME1304 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1304 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05070 XEO_CLAS Peptide DME1304 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 37.5 microM) DME1304 XEOTICID XEO05070 GENEFORM Protein DME1304 XEOTICID XEO05070 MOACRIVE Inhibition DME1304 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1304 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05071 XEO_CLAS Peptide DME1304 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 150 microM) DME1304 XEOTICID XEO05071 GENEFORM Protein DME1304 XEOTICID XEO05071 MOACRIVE Inhibition DME1304 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1304 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05072 XEO_CLAS Peptide DME1304 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO05072 GENEFORM Protein DME1304 XEOTICID XEO05072 MOACRIVE Inhibition DME1304 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1304 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05073 XEO_CLAS Peptide DME1304 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40 microM) DME1304 XEOTICID XEO05073 GENEFORM Protein DME1304 XEOTICID XEO05073 MOACRIVE Inhibition DME1304 XEOTICID XEO05076 XEO_NAME Temporin-A DME1304 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05076 XEO_CLAS Peptide DME1304 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 11.9 microM) DME1304 XEOTICID XEO05076 GENEFORM Protein DME1304 XEOTICID XEO05076 MOACRIVE Inhibition DME1304 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1304 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05077 XEO_CLAS Peptide DME1304 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.25 ug/ml) DME1304 XEOTICID XEO05077 GENEFORM Protein DME1304 XEOTICID XEO05077 MOACRIVE Inhibition DME1304 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1304 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05078 XEO_CLAS Peptide DME1304 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.25 ug/ml) DME1304 XEOTICID XEO05078 GENEFORM Protein DME1304 XEOTICID XEO05078 MOACRIVE Inhibition DME1304 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1304 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05079 XEO_CLAS Peptide DME1304 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.5 ug/ml) DME1304 XEOTICID XEO05079 GENEFORM Protein DME1304 XEOTICID XEO05079 MOACRIVE Inhibition DME1304 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1304 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05080 XEO_CLAS Peptide DME1304 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 ug/ml) DME1304 XEOTICID XEO05080 GENEFORM Protein DME1304 XEOTICID XEO05080 MOACRIVE Inhibition DME1304 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1304 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05081 XEO_CLAS Peptide DME1304 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 5 ug/ml) DME1304 XEOTICID XEO05081 GENEFORM Protein DME1304 XEOTICID XEO05081 MOACRIVE Inhibition DME1304 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1304 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05082 XEO_CLAS Peptide DME1304 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 7.5 ug/ml) DME1304 XEOTICID XEO05082 GENEFORM Protein DME1304 XEOTICID XEO05082 MOACRIVE Inhibition DME1304 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1304 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05083 XEO_CLAS Peptide DME1304 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 ug/ml) DME1304 XEOTICID XEO05083 GENEFORM Protein DME1304 XEOTICID XEO05083 MOACRIVE Inhibition DME1304 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1304 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05084 XEO_CLAS Peptide DME1304 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 ug/ml) DME1304 XEOTICID XEO05084 GENEFORM Protein DME1304 XEOTICID XEO05084 MOACRIVE Inhibition DME1304 XEOTICID XEO05085 XEO_NAME Temporin-B DME1304 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05085 XEO_CLAS Peptide DME1304 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 21.0 ug/ml) DME1304 XEOTICID XEO05085 GENEFORM Protein DME1304 XEOTICID XEO05085 MOACRIVE Inhibition DME1304 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1304 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05086 XEO_CLAS Peptide DME1304 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC > 100 microM) DME1304 XEOTICID XEO05086 GENEFORM Protein DME1304 XEOTICID XEO05086 MOACRIVE Inhibition DME1304 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1304 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05087 XEO_CLAS Peptide DME1304 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO05087 GENEFORM Protein DME1304 XEOTICID XEO05087 MOACRIVE Inhibition DME1304 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1304 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05097 XEO_CLAS Peptide DME1304 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16.0 microM) DME1304 XEOTICID XEO05097 GENEFORM Protein DME1304 XEOTICID XEO05097 MOACRIVE Inhibition DME1304 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1304 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05099 XEO_CLAS Peptide DME1304 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.0 microM) DME1304 XEOTICID XEO05099 GENEFORM Protein DME1304 XEOTICID XEO05099 MOACRIVE Inhibition DME1304 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1304 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05100 XEO_CLAS Peptide DME1304 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05100 GENEFORM Protein DME1304 XEOTICID XEO05100 MOACRIVE Inhibition DME1304 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1304 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05101 XEO_CLAS Peptide DME1304 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 24.2 ug/ml) DME1304 XEOTICID XEO05101 GENEFORM Protein DME1304 XEOTICID XEO05101 MOACRIVE Inhibition DME1304 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1304 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05102 XEO_CLAS Peptide DME1304 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 34.5 ug/ml) DME1304 XEOTICID XEO05102 GENEFORM Protein DME1304 XEOTICID XEO05102 MOACRIVE Inhibition DME1304 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1304 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05105 XEO_CLAS Peptide DME1304 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO05105 GENEFORM Protein DME1304 XEOTICID XEO05105 MOACRIVE Inhibition DME1304 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1304 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05106 XEO_CLAS Peptide DME1304 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25-200 microM) DME1304 XEOTICID XEO05106 GENEFORM Protein DME1304 XEOTICID XEO05106 MOACRIVE Inhibition DME1304 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1304 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05108 XEO_CLAS Peptide DME1304 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40 microM) DME1304 XEOTICID XEO05108 GENEFORM Protein DME1304 XEOTICID XEO05108 MOACRIVE Inhibition DME1304 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1304 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1304 XEOTICID XEO05111 XEO_CLAS Natural Product DME1304 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05111 GENEFORM Protein DME1304 XEOTICID XEO05111 MOACRIVE Inhibition DME1304 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1304 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05119 XEO_CLAS Peptide DME1304 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05119 GENEFORM Protein DME1304 XEOTICID XEO05119 MOACRIVE Inhibition DME1304 XEOTICID XEO05120 XEO_NAME Thanatin DME1304 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05120 XEO_CLAS Peptide DME1304 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.3-0.6 microM) DME1304 XEOTICID XEO05120 GENEFORM Protein DME1304 XEOTICID XEO05120 MOACRIVE Inhibition DME1304 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1304 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05121 XEO_CLAS Peptide DME1304 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 62.5 ug/ml) DME1304 XEOTICID XEO05121 GENEFORM Protein DME1304 XEOTICID XEO05121 MOACRIVE Inhibition DME1304 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1304 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05125 XEO_CLAS Peptide DME1304 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05125 GENEFORM Protein DME1304 XEOTICID XEO05125 MOACRIVE Inhibition DME1304 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1304 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05130 XEO_CLAS Peptide DME1304 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05130 GENEFORM Protein DME1304 XEOTICID XEO05130 MOACRIVE Inhibition DME1304 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1304 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05144 XEO_CLAS Peptide DME1304 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40 ug/ml) DME1304 XEOTICID XEO05144 GENEFORM Protein DME1304 XEOTICID XEO05144 MOACRIVE Inhibition DME1304 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1304 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05145 XEO_CLAS Peptide DME1304 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 ug/ml) DME1304 XEOTICID XEO05145 GENEFORM Protein DME1304 XEOTICID XEO05145 MOACRIVE Inhibition DME1304 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1304 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05146 XEO_CLAS Peptide DME1304 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 40 ug/ml) DME1304 XEOTICID XEO05146 GENEFORM Protein DME1304 XEOTICID XEO05146 MOACRIVE Inhibition DME1304 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1304 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05147 XEO_CLAS Peptide DME1304 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 60 ug/ml) DME1304 XEOTICID XEO05147 GENEFORM Protein DME1304 XEOTICID XEO05147 MOACRIVE Inhibition DME1304 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1304 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05158 XEO_CLAS Peptide DME1304 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05158 GENEFORM Protein DME1304 XEOTICID XEO05158 MOACRIVE Inhibition DME1304 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1304 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05161 XEO_CLAS Peptide DME1304 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 32 ug/ml) DME1304 XEOTICID XEO05161 GENEFORM Protein DME1304 XEOTICID XEO05161 MOACRIVE Inhibition DME1304 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1304 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05162 XEO_CLAS Peptide DME1304 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 32 ug/ml) DME1304 XEOTICID XEO05162 GENEFORM Protein DME1304 XEOTICID XEO05162 MOACRIVE Inhibition DME1304 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1304 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05163 XEO_CLAS Peptide DME1304 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 12-25 ug/ml) DME1304 XEOTICID XEO05163 GENEFORM Protein DME1304 XEOTICID XEO05163 MOACRIVE Inhibition DME1304 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1304 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05170 XEO_CLAS Peptide DME1304 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 3.0 microM) DME1304 XEOTICID XEO05170 GENEFORM Protein DME1304 XEOTICID XEO05170 MOACRIVE Inhibition DME1304 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1304 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05171 XEO_CLAS Peptide DME1304 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 50 microM) DME1304 XEOTICID XEO05171 GENEFORM Protein DME1304 XEOTICID XEO05171 MOACRIVE Inhibition DME1304 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1304 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05179 XEO_CLAS Peptide DME1304 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05179 GENEFORM Protein DME1304 XEOTICID XEO05179 MOACRIVE Inhibition DME1304 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1304 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05180 XEO_CLAS Peptide DME1304 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 160 microM) DME1304 XEOTICID XEO05180 GENEFORM Protein DME1304 XEOTICID XEO05180 MOACRIVE Inhibition DME1304 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1304 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05182 XEO_CLAS Peptide DME1304 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 microM) DME1304 XEOTICID XEO05182 GENEFORM Protein DME1304 XEOTICID XEO05182 MOACRIVE Inhibition DME1304 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1304 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05183 XEO_CLAS Peptide DME1304 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 microM) DME1304 XEOTICID XEO05183 GENEFORM Protein DME1304 XEOTICID XEO05183 MOACRIVE Inhibition DME1304 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1304 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05184 XEO_CLAS Peptide DME1304 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 microM) DME1304 XEOTICID XEO05184 GENEFORM Protein DME1304 XEOTICID XEO05184 MOACRIVE Inhibition DME1304 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1304 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05185 XEO_CLAS Peptide DME1304 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 microM) DME1304 XEOTICID XEO05185 GENEFORM Protein DME1304 XEOTICID XEO05185 MOACRIVE Inhibition DME1304 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1304 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05186 XEO_CLAS Peptide DME1304 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 microM) DME1304 XEOTICID XEO05186 GENEFORM Protein DME1304 XEOTICID XEO05186 MOACRIVE Inhibition DME1304 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1304 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05187 XEO_CLAS Peptide DME1304 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16 microM) DME1304 XEOTICID XEO05187 GENEFORM Protein DME1304 XEOTICID XEO05187 MOACRIVE Inhibition DME1304 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1304 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05188 XEO_CLAS Peptide DME1304 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 64 microM) DME1304 XEOTICID XEO05188 GENEFORM Protein DME1304 XEOTICID XEO05188 MOACRIVE Inhibition DME1304 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1304 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05190 XEO_CLAS Peptide DME1304 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05190 GENEFORM Protein DME1304 XEOTICID XEO05190 MOACRIVE Inhibition DME1304 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1304 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05193 XEO_CLAS Peptide DME1304 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO05193 GENEFORM Protein DME1304 XEOTICID XEO05193 MOACRIVE Inhibition DME1304 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1304 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05197 XEO_CLAS Peptide DME1304 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05197 GENEFORM Protein DME1304 XEOTICID XEO05197 MOACRIVE Inhibition DME1304 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1304 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05205 XEO_CLAS Peptide DME1304 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05205 GENEFORM Protein DME1304 XEOTICID XEO05205 MOACRIVE Inhibition DME1304 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1304 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05206 XEO_CLAS Peptide DME1304 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 10 microM) DME1304 XEOTICID XEO05206 GENEFORM Protein DME1304 XEOTICID XEO05206 MOACRIVE Inhibition DME1304 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1304 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05207 XEO_CLAS Peptide DME1304 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 25 microM) DME1304 XEOTICID XEO05207 GENEFORM Protein DME1304 XEOTICID XEO05207 MOACRIVE Inhibition DME1304 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1304 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05208 XEO_CLAS Peptide DME1304 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 microM) DME1304 XEOTICID XEO05208 GENEFORM Protein DME1304 XEOTICID XEO05208 MOACRIVE Inhibition DME1304 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1304 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05209 XEO_CLAS Peptide DME1304 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 15 microM) DME1304 XEOTICID XEO05209 GENEFORM Protein DME1304 XEOTICID XEO05209 MOACRIVE Inhibition DME1304 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1304 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05212 XEO_CLAS Peptide DME1304 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.5 ug/ml) DME1304 XEOTICID XEO05212 GENEFORM Protein DME1304 XEOTICID XEO05212 MOACRIVE Inhibition DME1304 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1304 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05220 XEO_CLAS Peptide DME1304 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.6-1.2 microM) DME1304 XEOTICID XEO05220 GENEFORM Protein DME1304 XEOTICID XEO05220 MOACRIVE Inhibition DME1304 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1304 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05230 XEO_CLAS Peptide DME1304 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 7.90 microM) DME1304 XEOTICID XEO05230 GENEFORM Protein DME1304 XEOTICID XEO05230 MOACRIVE Inhibition DME1304 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1304 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05231 XEO_CLAS Peptide DME1304 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2.40 microM) DME1304 XEOTICID XEO05231 GENEFORM Protein DME1304 XEOTICID XEO05231 MOACRIVE Inhibition DME1304 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1304 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05232 XEO_CLAS Peptide DME1304 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05232 GENEFORM Protein DME1304 XEOTICID XEO05232 MOACRIVE Inhibition DME1304 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1304 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05233 XEO_CLAS Peptide DME1304 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 ug/ml) DME1304 XEOTICID XEO05233 GENEFORM Protein DME1304 XEOTICID XEO05233 MOACRIVE Inhibition DME1304 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1304 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05234 XEO_CLAS Peptide DME1304 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 ug/ml) DME1304 XEOTICID XEO05234 GENEFORM Protein DME1304 XEOTICID XEO05234 MOACRIVE Inhibition DME1304 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1304 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05235 XEO_CLAS Peptide DME1304 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 30 ug/ml) DME1304 XEOTICID XEO05235 GENEFORM Protein DME1304 XEOTICID XEO05235 MOACRIVE Inhibition DME1304 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1304 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05237 XEO_CLAS Peptide DME1304 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 microM) DME1304 XEOTICID XEO05237 GENEFORM Protein DME1304 XEOTICID XEO05237 MOACRIVE Inhibition DME1304 XEOTICID XEO05245 XEO_NAME Viresin DME1304 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05245 XEO_CLAS Peptide DME1304 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05245 GENEFORM Protein DME1304 XEOTICID XEO05245 MOACRIVE Inhibition DME1304 XEOTICID XEO05248 XEO_NAME Vitamin C DME1304 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1304 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1304 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05248 GENEFORM Protein DME1304 XEOTICID XEO05248 MOACRIVE Inhibition DME1304 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1304 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05264 XEO_CLAS Peptide DME1304 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 4 ug/ml) DME1304 XEOTICID XEO05264 GENEFORM Protein DME1304 XEOTICID XEO05264 MOACRIVE Inhibition DME1304 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1304 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05267 XEO_CLAS Peptide DME1304 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 2 ug/ml) DME1304 XEOTICID XEO05267 GENEFORM Protein DME1304 XEOTICID XEO05267 MOACRIVE Inhibition DME1304 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1304 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05268 XEO_CLAS Peptide DME1304 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 1.6 ug/ml) DME1304 XEOTICID XEO05268 GENEFORM Protein DME1304 XEOTICID XEO05268 MOACRIVE Inhibition DME1304 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1304 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05269 XEO_CLAS Peptide DME1304 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 6 ug/ml) DME1304 XEOTICID XEO05269 GENEFORM Protein DME1304 XEOTICID XEO05269 MOACRIVE Inhibition DME1304 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1304 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05273 XEO_CLAS Peptide DME1304 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05273 GENEFORM Protein DME1304 XEOTICID XEO05273 MOACRIVE Inhibition DME1304 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1304 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05274 XEO_CLAS Peptide DME1304 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05274 GENEFORM Protein DME1304 XEOTICID XEO05274 MOACRIVE Inhibition DME1304 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1304 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05287 XEO_CLAS Peptide DME1304 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli DME1304 XEOTICID XEO05287 GENEFORM Protein DME1304 XEOTICID XEO05287 MOACRIVE Inhibition DME1304 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1304 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05303 XEO_CLAS Peptide DME1304 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 16-31 ug/ml) DME1304 XEOTICID XEO05303 GENEFORM Protein DME1304 XEOTICID XEO05303 MOACRIVE Inhibition DME1304 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1304 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05306 XEO_CLAS Peptide DME1304 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 8 ug/ml) DME1304 XEOTICID XEO05306 GENEFORM Protein DME1304 XEOTICID XEO05306 MOACRIVE Inhibition DME1304 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1304 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1304 XEOTICID XEO05308 XEO_CLAS Peptide DME1304 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Escherichia coli (MIC = 0.4 ug/ml) DME1304 XEOTICID XEO05308 GENEFORM Protein DME1304 XEOTICID XEO05308 MOACRIVE Inhibition DME1305 DME___ID DME1305 DME1305 DME_NAME Glutamate decarboxylase (gadB) DME1305 SPESNAME Shigella flexneri DME1305 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1305 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1305 XEOTICID XEO02304 XEO_CLAS Peptide DME1305 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Shigella flexneri (MIC = 0.1 ug/ml) DME1305 XEOTICID XEO02304 GENEFORM Protein DME1305 XEOTICID XEO02304 MOACRIVE Inhibition DME1305 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1305 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1305 XEOTICID XEO02305 XEO_CLAS Peptide DME1305 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Shigella flexneri (MIC = 0.1 ug/ml) DME1305 XEOTICID XEO02305 GENEFORM Protein DME1305 XEOTICID XEO02305 MOACRIVE Inhibition DME1305 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1305 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1305 XEOTICID XEO02306 XEO_CLAS Peptide DME1305 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Shigella flexneri (MIC = 0.1 ug/ml) DME1305 XEOTICID XEO02306 GENEFORM Protein DME1305 XEOTICID XEO02306 MOACRIVE Inhibition DME1305 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1305 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1305 XEOTICID XEO02332 XEO_CLAS Peptide DME1305 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Shigella flexneri (MIC = 0.98 ug/ml) DME1305 XEOTICID XEO02332 GENEFORM Protein DME1305 XEOTICID XEO02332 MOACRIVE Inhibition DME1305 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1305 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1305 XEOTICID XEO04111 XEO_CLAS Peptide DME1305 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Shigella flexneri DME1305 XEOTICID XEO04111 GENEFORM Protein DME1305 XEOTICID XEO04111 MOACRIVE Inhibition DME1305 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1305 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1305 XEOTICID XEO04113 XEO_CLAS Peptide DME1305 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Shigella flexneri DME1305 XEOTICID XEO04113 GENEFORM Protein DME1305 XEOTICID XEO04113 MOACRIVE Inhibition DME1305 XEOTICID XEO04114 XEO_NAME Microcin L DME1305 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1305 XEOTICID XEO04114 XEO_CLAS Peptide DME1305 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Shigella flexneri DME1305 XEOTICID XEO04114 GENEFORM Protein DME1305 XEOTICID XEO04114 MOACRIVE Inhibition DME1305 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1305 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1305 XEOTICID XEO04612 XEO_CLAS Peptide DME1305 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Shigella flexneri (MIC = 2.5-5 microM) DME1305 XEOTICID XEO04612 GENEFORM Protein DME1305 XEOTICID XEO04612 MOACRIVE Inhibition DME1305 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1305 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1305 XEOTICID XEO04613 XEO_CLAS Peptide DME1305 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Shigella flexneri (MIC = 2.5-5 microM) DME1305 XEOTICID XEO04613 GENEFORM Protein DME1305 XEOTICID XEO04613 MOACRIVE Inhibition DME1305 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1305 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1305 XEOTICID XEO05005 XEO_CLAS Peptide DME1305 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Shigella flexneri DME1305 XEOTICID XEO05005 GENEFORM Protein DME1305 XEOTICID XEO05005 MOACRIVE Inhibition DME1305 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1305 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1305 XEOTICID XEO05139 XEO_CLAS Peptide DME1305 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Shigella flexneri DME1305 XEOTICID XEO05139 GENEFORM Protein DME1305 XEOTICID XEO05139 MOACRIVE Inhibition DME1305 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1305 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1305 XEOTICID XEO05308 XEO_CLAS Peptide DME1305 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Shigella flexneri (MIC = 2.0 ug/ml) DME1305 XEOTICID XEO05308 GENEFORM Protein DME1305 XEOTICID XEO05308 MOACRIVE Inhibition DME1306 DME___ID DME1306 DME1306 DME_NAME Glutamate decarboxylase (gadB) DME1306 SPESNAME Lactococcus lactis DME1306 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1306 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO02298 XEO_CLAS Peptide DME1306 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis (MIC > 128 ug/ml) DME1306 XEOTICID XEO02298 GENEFORM Protein DME1306 XEOTICID XEO02298 MOACRIVE Inhibition DME1306 XEOTICID XEO02335 XEO_NAME Aurein-1.1 DME1306 XEOTICID XEO02335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO02335 XEO_CLAS Peptide DME1306 XEOTICID XEO02335 DESCRIPT Aurein-1.1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis (MIC = 25 ug/ml) DME1306 XEOTICID XEO02335 GENEFORM Protein DME1306 XEOTICID XEO02335 MOACRIVE Inhibition DME1306 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1306 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO02721 XEO_CLAS Peptide DME1306 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO02721 GENEFORM Protein DME1306 XEOTICID XEO02721 MOACRIVE Inhibition DME1306 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1306 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03111 XEO_CLAS Peptide DME1306 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO03111 GENEFORM Protein DME1306 XEOTICID XEO03111 MOACRIVE Inhibition DME1306 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1306 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03250 XEO_CLAS Peptide DME1306 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO03250 GENEFORM Protein DME1306 XEOTICID XEO03250 MOACRIVE Inhibition DME1306 XEOTICID XEO03255 XEO_NAME Enterocin L50A DME1306 XEOTICID XEO03255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03255 XEO_CLAS Peptide DME1306 XEOTICID XEO03255 DESCRIPT Enterocin L50A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO03255 GENEFORM Protein DME1306 XEOTICID XEO03255 MOACRIVE Inhibition DME1306 XEOTICID XEO03256 XEO_NAME Enterocin L50B DME1306 XEOTICID XEO03256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03256 XEO_CLAS Peptide DME1306 XEOTICID XEO03256 DESCRIPT Enterocin L50B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO03256 GENEFORM Protein DME1306 XEOTICID XEO03256 MOACRIVE Inhibition DME1306 XEOTICID XEO03257 XEO_NAME Enterocin P DME1306 XEOTICID XEO03257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03257 XEO_CLAS Peptide DME1306 XEOTICID XEO03257 DESCRIPT Enterocin P inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis (MIC = 0.022 ug/ml) DME1306 XEOTICID XEO03257 GENEFORM Protein DME1306 XEOTICID XEO03257 MOACRIVE Inhibition DME1306 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1306 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03258 XEO_CLAS Peptide DME1306 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO03258 GENEFORM Protein DME1306 XEOTICID XEO03258 MOACRIVE Inhibition DME1306 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME1306 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03259 XEO_CLAS Peptide DME1306 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis (MIC = 0.813 microM) DME1306 XEOTICID XEO03259 GENEFORM Protein DME1306 XEOTICID XEO03259 MOACRIVE Inhibition DME1306 XEOTICID XEO03381 XEO_NAME Fallaxidin 3.1 DME1306 XEOTICID XEO03381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03381 XEO_CLAS Peptide DME1306 XEOTICID XEO03381 DESCRIPT Fallaxidin 3.1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis (MIC = 100 microM) DME1306 XEOTICID XEO03381 GENEFORM Protein DME1306 XEOTICID XEO03381 MOACRIVE Inhibition DME1306 XEOTICID XEO03382 XEO_NAME Fallaxidin 3.2 DME1306 XEOTICID XEO03382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03382 XEO_CLAS Peptide DME1306 XEOTICID XEO03382 DESCRIPT Fallaxidin 3.2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis (MIC = 500 microM) DME1306 XEOTICID XEO03382 GENEFORM Protein DME1306 XEOTICID XEO03382 MOACRIVE Inhibition DME1306 XEOTICID XEO03383 XEO_NAME Fallaxidin 4.1 DME1306 XEOTICID XEO03383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03383 XEO_CLAS Peptide DME1306 XEOTICID XEO03383 DESCRIPT Fallaxidin 4.1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis (MIC = 12 microM) DME1306 XEOTICID XEO03383 GENEFORM Protein DME1306 XEOTICID XEO03383 MOACRIVE Inhibition DME1306 XEOTICID XEO03473 XEO_NAME Garvicin ML DME1306 XEOTICID XEO03473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03473 XEO_CLAS Peptide DME1306 XEOTICID XEO03473 DESCRIPT Garvicin ML inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO03473 GENEFORM Protein DME1306 XEOTICID XEO03473 MOACRIVE Inhibition DME1306 XEOTICID XEO03478 XEO_NAME Geobacillin I DME1306 XEOTICID XEO03478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03478 XEO_CLAS Peptide DME1306 XEOTICID XEO03478 DESCRIPT Geobacillin I inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO03478 GENEFORM Protein DME1306 XEOTICID XEO03478 MOACRIVE Inhibition DME1306 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1306 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03771 XEO_CLAS Peptide DME1306 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO03771 GENEFORM Protein DME1306 XEOTICID XEO03771 MOACRIVE Inhibition DME1306 XEOTICID XEO03773 XEO_NAME Lactococcin Q alpha DME1306 XEOTICID XEO03773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03773 XEO_CLAS Peptide DME1306 XEOTICID XEO03773 DESCRIPT Lactococcin Q alpha inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis (MIC > 1 microM) DME1306 XEOTICID XEO03773 GENEFORM Protein DME1306 XEOTICID XEO03773 MOACRIVE Inhibition DME1306 XEOTICID XEO03774 XEO_NAME Lactococcin Q beta DME1306 XEOTICID XEO03774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03774 XEO_CLAS Peptide DME1306 XEOTICID XEO03774 DESCRIPT Lactococcin Q beta inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis (MIC > 1 microM) DME1306 XEOTICID XEO03774 GENEFORM Protein DME1306 XEOTICID XEO03774 MOACRIVE Inhibition DME1306 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1306 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03775 XEO_CLAS Peptide DME1306 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis (MIC = 0.141 microM) DME1306 XEOTICID XEO03775 GENEFORM Protein DME1306 XEOTICID XEO03775 MOACRIVE Inhibition DME1306 XEOTICID XEO03806 XEO_NAME Lantibiotic paenibacillin DME1306 XEOTICID XEO03806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03806 XEO_CLAS Peptide DME1306 XEOTICID XEO03806 DESCRIPT Lantibiotic paenibacillin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO03806 GENEFORM Protein DME1306 XEOTICID XEO03806 MOACRIVE Inhibition DME1306 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1306 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO03857 XEO_CLAS Peptide DME1306 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis (MIC = 0.038 microM) DME1306 XEOTICID XEO03857 GENEFORM Protein DME1306 XEOTICID XEO03857 MOACRIVE Inhibition DME1306 XEOTICID XEO04320 XEO_NAME Nisin U DME1306 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04320 XEO_CLAS Peptide DME1306 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04320 GENEFORM Protein DME1306 XEOTICID XEO04320 MOACRIVE Inhibition DME1306 XEOTICID XEO04622 XEO_NAME Plantaricin W alpha DME1306 XEOTICID XEO04622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04622 XEO_CLAS Peptide DME1306 XEOTICID XEO04622 DESCRIPT Plantaricin W alpha inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04622 GENEFORM Protein DME1306 XEOTICID XEO04622 MOACRIVE Inhibition DME1306 XEOTICID XEO04623 XEO_NAME Plantaricin W beta DME1306 XEOTICID XEO04623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04623 XEO_CLAS Peptide DME1306 XEOTICID XEO04623 DESCRIPT Plantaricin W beta inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04623 GENEFORM Protein DME1306 XEOTICID XEO04623 MOACRIVE Inhibition DME1306 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1306 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04695 XEO_CLAS Peptide DME1306 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04695 GENEFORM Protein DME1306 XEOTICID XEO04695 MOACRIVE Inhibition DME1306 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1306 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04696 XEO_CLAS Peptide DME1306 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04696 GENEFORM Protein DME1306 XEOTICID XEO04696 MOACRIVE Inhibition DME1306 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1306 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04697 XEO_CLAS Peptide DME1306 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04697 GENEFORM Protein DME1306 XEOTICID XEO04697 MOACRIVE Inhibition DME1306 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1306 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04698 XEO_CLAS Peptide DME1306 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04698 GENEFORM Protein DME1306 XEOTICID XEO04698 MOACRIVE Inhibition DME1306 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1306 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04699 XEO_CLAS Peptide DME1306 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04699 GENEFORM Protein DME1306 XEOTICID XEO04699 MOACRIVE Inhibition DME1306 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1306 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04700 XEO_CLAS Peptide DME1306 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04700 GENEFORM Protein DME1306 XEOTICID XEO04700 MOACRIVE Inhibition DME1306 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1306 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04701 XEO_CLAS Peptide DME1306 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04701 GENEFORM Protein DME1306 XEOTICID XEO04701 MOACRIVE Inhibition DME1306 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1306 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04702 XEO_CLAS Peptide DME1306 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04702 GENEFORM Protein DME1306 XEOTICID XEO04702 MOACRIVE Inhibition DME1306 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1306 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04703 XEO_CLAS Peptide DME1306 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04703 GENEFORM Protein DME1306 XEOTICID XEO04703 MOACRIVE Inhibition DME1306 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1306 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04704 XEO_CLAS Peptide DME1306 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04704 GENEFORM Protein DME1306 XEOTICID XEO04704 MOACRIVE Inhibition DME1306 XEOTICID XEO04810 XEO_NAME Ranatuerin-2AVa DME1306 XEOTICID XEO04810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04810 XEO_CLAS Peptide DME1306 XEOTICID XEO04810 DESCRIPT Ranatuerin-2AVa inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04810 GENEFORM Protein DME1306 XEOTICID XEO04810 MOACRIVE Inhibition DME1306 XEOTICID XEO04856 XEO_NAME Riparin-2.1 DME1306 XEOTICID XEO04856 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04856 XEO_CLAS Peptide DME1306 XEOTICID XEO04856 DESCRIPT Riparin-2.1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis (MIC = 25 microM) DME1306 XEOTICID XEO04856 GENEFORM Protein DME1306 XEOTICID XEO04856 MOACRIVE Inhibition DME1306 XEOTICID XEO04897 XEO_NAME Sakacin G DME1306 XEOTICID XEO04897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO04897 XEO_CLAS Peptide DME1306 XEOTICID XEO04897 DESCRIPT Sakacin G inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO04897 GENEFORM Protein DME1306 XEOTICID XEO04897 MOACRIVE Inhibition DME1306 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1306 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO05139 XEO_CLAS Peptide DME1306 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO05139 GENEFORM Protein DME1306 XEOTICID XEO05139 MOACRIVE Inhibition DME1306 XEOTICID XEO05196 XEO_NAME Ubericin-A DME1306 XEOTICID XEO05196 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO05196 XEO_CLAS Peptide DME1306 XEOTICID XEO05196 DESCRIPT Ubericin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO05196 GENEFORM Protein DME1306 XEOTICID XEO05196 MOACRIVE Inhibition DME1306 XEOTICID XEO05201 XEO_NAME Uperin-3.5 DME1306 XEOTICID XEO05201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO05201 XEO_CLAS Peptide DME1306 XEOTICID XEO05201 DESCRIPT Uperin-3.5 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis (MIC = 3 ug/ml) DME1306 XEOTICID XEO05201 GENEFORM Protein DME1306 XEOTICID XEO05201 MOACRIVE Inhibition DME1306 XEOTICID XEO05202 XEO_NAME Uperin-3.6 DME1306 XEOTICID XEO05202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO05202 XEO_CLAS Peptide DME1306 XEOTICID XEO05202 DESCRIPT Uperin-3.6 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis (MIC = 3 ug/ml) DME1306 XEOTICID XEO05202 GENEFORM Protein DME1306 XEOTICID XEO05202 MOACRIVE Inhibition DME1306 XEOTICID XEO05228 XEO_NAME Variacin DME1306 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO05228 XEO_CLAS Peptide DME1306 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO05228 GENEFORM Protein DME1306 XEOTICID XEO05228 MOACRIVE Inhibition DME1306 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1306 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1306 XEOTICID XEO05283 XEO_CLAS Peptide DME1306 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactococcus lactis DME1306 XEOTICID XEO05283 GENEFORM Protein DME1306 XEOTICID XEO05283 MOACRIVE Inhibition DME1311 DME___ID DME1311 DME1311 DME_NAME Beta-lactamase (blaB) DME1311 SPESNAME Salmonella enterica DME1311 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1311 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO01810 XEO_CLAS Peptide DME1311 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1.0 microM) DME1311 XEOTICID XEO01810 GENEFORM Protein DME1311 XEOTICID XEO01810 MOACRIVE Inhibition DME1311 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1311 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO01811 XEO_CLAS Peptide DME1311 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC > 64 microM) DME1311 XEOTICID XEO01811 GENEFORM Protein DME1311 XEOTICID XEO01811 MOACRIVE Inhibition DME1311 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1311 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO01817 XEO_CLAS Peptide DME1311 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4.0 microM) DME1311 XEOTICID XEO01817 GENEFORM Protein DME1311 XEOTICID XEO01817 MOACRIVE Inhibition DME1311 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1311 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO01818 XEO_CLAS Peptide DME1311 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1.0 microM) DME1311 XEOTICID XEO01818 GENEFORM Protein DME1311 XEOTICID XEO01818 MOACRIVE Inhibition DME1311 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1311 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO01819 XEO_CLAS Peptide DME1311 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1 microM) DME1311 XEOTICID XEO01819 GENEFORM Protein DME1311 XEOTICID XEO01819 MOACRIVE Inhibition DME1311 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1311 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO01820 XEO_CLAS Peptide DME1311 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1 microM) DME1311 XEOTICID XEO01820 GENEFORM Protein DME1311 XEOTICID XEO01820 MOACRIVE Inhibition DME1311 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1311 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO01821 XEO_CLAS Peptide DME1311 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1 microM) DME1311 XEOTICID XEO01821 GENEFORM Protein DME1311 XEOTICID XEO01821 MOACRIVE Inhibition DME1311 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1311 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO01822 XEO_CLAS Peptide DME1311 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 16 microM) DME1311 XEOTICID XEO01822 GENEFORM Protein DME1311 XEOTICID XEO01822 MOACRIVE Inhibition DME1311 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1311 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02207 XEO_CLAS Peptide DME1311 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.39 ug/ml) DME1311 XEOTICID XEO02207 GENEFORM Protein DME1311 XEOTICID XEO02207 MOACRIVE Inhibition DME1311 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1311 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02208 XEO_CLAS Peptide DME1311 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.78 ug/ml) DME1311 XEOTICID XEO02208 GENEFORM Protein DME1311 XEOTICID XEO02208 MOACRIVE Inhibition DME1311 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1311 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02209 XEO_CLAS Peptide DME1311 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.39 ug/ml) DME1311 XEOTICID XEO02209 GENEFORM Protein DME1311 XEOTICID XEO02209 MOACRIVE Inhibition DME1311 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1311 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02210 XEO_CLAS Peptide DME1311 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 12.5 ug/ml) DME1311 XEOTICID XEO02210 GENEFORM Protein DME1311 XEOTICID XEO02210 MOACRIVE Inhibition DME1311 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1311 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02211 XEO_CLAS Peptide DME1311 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 12.5 ug/ml) DME1311 XEOTICID XEO02211 GENEFORM Protein DME1311 XEOTICID XEO02211 MOACRIVE Inhibition DME1311 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1311 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02212 XEO_CLAS Peptide DME1311 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.39 ug/ml) DME1311 XEOTICID XEO02212 GENEFORM Protein DME1311 XEOTICID XEO02212 MOACRIVE Inhibition DME1311 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1311 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02213 XEO_CLAS Peptide DME1311 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.39 ug/ml) DME1311 XEOTICID XEO02213 GENEFORM Protein DME1311 XEOTICID XEO02213 MOACRIVE Inhibition DME1311 XEOTICID XEO02224 XEO_NAME Androctonin DME1311 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02224 XEO_CLAS Peptide DME1311 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO02224 GENEFORM Protein DME1311 XEOTICID XEO02224 MOACRIVE Inhibition DME1311 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1311 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02230 XEO_CLAS Peptide DME1311 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.1-0.25 microM) DME1311 XEOTICID XEO02230 GENEFORM Protein DME1311 XEOTICID XEO02230 MOACRIVE Inhibition DME1311 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1311 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02242 XEO_CLAS Peptide DME1311 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 microM) DME1311 XEOTICID XEO02242 GENEFORM Protein DME1311 XEOTICID XEO02242 MOACRIVE Inhibition DME1311 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1311 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02243 XEO_CLAS Peptide DME1311 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 48 microM) DME1311 XEOTICID XEO02243 GENEFORM Protein DME1311 XEOTICID XEO02243 MOACRIVE Inhibition DME1311 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1311 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02244 XEO_CLAS Peptide DME1311 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 microM) DME1311 XEOTICID XEO02244 GENEFORM Protein DME1311 XEOTICID XEO02244 MOACRIVE Inhibition DME1311 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1311 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02248 XEO_CLAS Peptide DME1311 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1 microM) DME1311 XEOTICID XEO02248 GENEFORM Protein DME1311 XEOTICID XEO02248 MOACRIVE Inhibition DME1311 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1311 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02283 XEO_CLAS Peptide DME1311 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1.56 ug/ml) DME1311 XEOTICID XEO02283 GENEFORM Protein DME1311 XEOTICID XEO02283 MOACRIVE Inhibition DME1311 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1311 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02304 XEO_CLAS Peptide DME1311 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.1 ug/ml) DME1311 XEOTICID XEO02304 GENEFORM Protein DME1311 XEOTICID XEO02304 MOACRIVE Inhibition DME1311 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1311 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02305 XEO_CLAS Peptide DME1311 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.1 ug/ml) DME1311 XEOTICID XEO02305 GENEFORM Protein DME1311 XEOTICID XEO02305 MOACRIVE Inhibition DME1311 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1311 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02306 XEO_CLAS Peptide DME1311 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.1 ug/ml) DME1311 XEOTICID XEO02306 GENEFORM Protein DME1311 XEOTICID XEO02306 MOACRIVE Inhibition DME1311 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1311 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02333 XEO_CLAS Peptide DME1311 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC > 200 microM) DME1311 XEOTICID XEO02333 GENEFORM Protein DME1311 XEOTICID XEO02333 MOACRIVE Inhibition DME1311 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1311 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02356 XEO_CLAS Peptide DME1311 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 ug/ml) DME1311 XEOTICID XEO02356 GENEFORM Protein DME1311 XEOTICID XEO02356 MOACRIVE Inhibition DME1311 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1311 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02357 XEO_CLAS Peptide DME1311 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 31 ug/ml) DME1311 XEOTICID XEO02357 GENEFORM Protein DME1311 XEOTICID XEO02357 MOACRIVE Inhibition DME1311 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1311 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02358 XEO_CLAS Peptide DME1311 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 16 ug/ml) DME1311 XEOTICID XEO02358 GENEFORM Protein DME1311 XEOTICID XEO02358 MOACRIVE Inhibition DME1311 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1311 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02360 XEO_CLAS Peptide DME1311 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 ug/ml) DME1311 XEOTICID XEO02360 GENEFORM Protein DME1311 XEOTICID XEO02360 MOACRIVE Inhibition DME1311 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1311 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02361 XEO_CLAS Peptide DME1311 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 31 ug/ml) DME1311 XEOTICID XEO02361 GENEFORM Protein DME1311 XEOTICID XEO02361 MOACRIVE Inhibition DME1311 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1311 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02365 XEO_CLAS Peptide DME1311 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC > 64 ug/ml) DME1311 XEOTICID XEO02365 GENEFORM Protein DME1311 XEOTICID XEO02365 MOACRIVE Inhibition DME1311 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1311 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02366 XEO_CLAS Peptide DME1311 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 32 ug/ml) DME1311 XEOTICID XEO02366 GENEFORM Protein DME1311 XEOTICID XEO02366 MOACRIVE Inhibition DME1311 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1311 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02367 XEO_CLAS Peptide DME1311 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 ug/ml) DME1311 XEOTICID XEO02367 GENEFORM Protein DME1311 XEOTICID XEO02367 MOACRIVE Inhibition DME1311 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1311 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02368 XEO_CLAS Peptide DME1311 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 ug/ml) DME1311 XEOTICID XEO02368 GENEFORM Protein DME1311 XEOTICID XEO02368 MOACRIVE Inhibition DME1311 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1311 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02369 XEO_CLAS Peptide DME1311 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 ug/ml) DME1311 XEOTICID XEO02369 GENEFORM Protein DME1311 XEOTICID XEO02369 MOACRIVE Inhibition DME1311 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1311 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02370 XEO_CLAS Peptide DME1311 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2-10 microM) DME1311 XEOTICID XEO02370 GENEFORM Protein DME1311 XEOTICID XEO02370 MOACRIVE Inhibition DME1311 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1311 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02371 XEO_CLAS Peptide DME1311 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 12 ug/ml) DME1311 XEOTICID XEO02371 GENEFORM Protein DME1311 XEOTICID XEO02371 MOACRIVE Inhibition DME1311 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1311 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02378 XEO_CLAS Peptide DME1311 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.19 ug/ml) DME1311 XEOTICID XEO02378 GENEFORM Protein DME1311 XEOTICID XEO02378 MOACRIVE Inhibition DME1311 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1311 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02388 XEO_CLAS Peptide DME1311 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 ug/ml) DME1311 XEOTICID XEO02388 GENEFORM Protein DME1311 XEOTICID XEO02388 MOACRIVE Inhibition DME1311 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1311 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02389 XEO_CLAS Peptide DME1311 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2 ug/ml) DME1311 XEOTICID XEO02389 GENEFORM Protein DME1311 XEOTICID XEO02389 MOACRIVE Inhibition DME1311 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1311 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02451 XEO_CLAS Peptide DME1311 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO02451 GENEFORM Protein DME1311 XEOTICID XEO02451 MOACRIVE Inhibition DME1311 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1311 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02466 XEO_CLAS Peptide DME1311 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 3 microM) DME1311 XEOTICID XEO02466 GENEFORM Protein DME1311 XEOTICID XEO02466 MOACRIVE Inhibition DME1311 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1311 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02649 XEO_CLAS Peptide DME1311 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 ug/ml) DME1311 XEOTICID XEO02649 GENEFORM Protein DME1311 XEOTICID XEO02649 MOACRIVE Inhibition DME1311 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1311 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02650 XEO_CLAS Peptide DME1311 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1 ug/ml) DME1311 XEOTICID XEO02650 GENEFORM Protein DME1311 XEOTICID XEO02650 MOACRIVE Inhibition DME1311 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1311 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02734 XEO_CLAS Peptide DME1311 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.40 microM) DME1311 XEOTICID XEO02734 GENEFORM Protein DME1311 XEOTICID XEO02734 MOACRIVE Inhibition DME1311 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1311 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02735 XEO_CLAS Peptide DME1311 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1 ug/ml) DME1311 XEOTICID XEO02735 GENEFORM Protein DME1311 XEOTICID XEO02735 MOACRIVE Inhibition DME1311 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1311 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02736 XEO_CLAS Peptide DME1311 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.66 microM) DME1311 XEOTICID XEO02736 GENEFORM Protein DME1311 XEOTICID XEO02736 MOACRIVE Inhibition DME1311 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1311 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02738 XEO_CLAS Peptide DME1311 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2 microM) DME1311 XEOTICID XEO02738 GENEFORM Protein DME1311 XEOTICID XEO02738 MOACRIVE Inhibition DME1311 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1311 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02739 XEO_CLAS Peptide DME1311 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1 microM) DME1311 XEOTICID XEO02739 GENEFORM Protein DME1311 XEOTICID XEO02739 MOACRIVE Inhibition DME1311 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1311 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02740 XEO_CLAS Peptide DME1311 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1 ug/ml) DME1311 XEOTICID XEO02740 GENEFORM Protein DME1311 XEOTICID XEO02740 MOACRIVE Inhibition DME1311 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1311 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02768 XEO_CLAS Peptide DME1311 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1-2.5 ug/ml) DME1311 XEOTICID XEO02768 GENEFORM Protein DME1311 XEOTICID XEO02768 MOACRIVE Inhibition DME1311 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1311 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02774 XEO_CLAS Peptide DME1311 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.9 microM) DME1311 XEOTICID XEO02774 GENEFORM Protein DME1311 XEOTICID XEO02774 MOACRIVE Inhibition DME1311 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1311 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02799 XEO_CLAS Peptide DME1311 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 3 ug/ml) DME1311 XEOTICID XEO02799 GENEFORM Protein DME1311 XEOTICID XEO02799 MOACRIVE Inhibition DME1311 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1311 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02800 XEO_CLAS Peptide DME1311 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2 ug/ml) DME1311 XEOTICID XEO02800 GENEFORM Protein DME1311 XEOTICID XEO02800 MOACRIVE Inhibition DME1311 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1311 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02820 XEO_CLAS Peptide DME1311 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 64 ug/ml) DME1311 XEOTICID XEO02820 GENEFORM Protein DME1311 XEOTICID XEO02820 MOACRIVE Inhibition DME1311 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1311 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02885 XEO_CLAS Peptide DME1311 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 5 ug/ml) DME1311 XEOTICID XEO02885 GENEFORM Protein DME1311 XEOTICID XEO02885 MOACRIVE Inhibition DME1311 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1311 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02886 XEO_CLAS Peptide DME1311 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 ug/ml) DME1311 XEOTICID XEO02886 GENEFORM Protein DME1311 XEOTICID XEO02886 MOACRIVE Inhibition DME1311 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1311 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02887 XEO_CLAS Peptide DME1311 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 3 ug/ml) DME1311 XEOTICID XEO02887 GENEFORM Protein DME1311 XEOTICID XEO02887 MOACRIVE Inhibition DME1311 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1311 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02888 XEO_CLAS Peptide DME1311 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 3 ug/ml) DME1311 XEOTICID XEO02888 GENEFORM Protein DME1311 XEOTICID XEO02888 MOACRIVE Inhibition DME1311 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1311 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02889 XEO_CLAS Peptide DME1311 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 29 ug/ml) DME1311 XEOTICID XEO02889 GENEFORM Protein DME1311 XEOTICID XEO02889 MOACRIVE Inhibition DME1311 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1311 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02890 XEO_CLAS Peptide DME1311 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 ug/ml) DME1311 XEOTICID XEO02890 GENEFORM Protein DME1311 XEOTICID XEO02890 MOACRIVE Inhibition DME1311 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1311 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02891 XEO_CLAS Peptide DME1311 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 3 ug/ml) DME1311 XEOTICID XEO02891 GENEFORM Protein DME1311 XEOTICID XEO02891 MOACRIVE Inhibition DME1311 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1311 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02933 XEO_CLAS Peptide DME1311 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 43 ug/ml) DME1311 XEOTICID XEO02933 GENEFORM Protein DME1311 XEOTICID XEO02933 MOACRIVE Inhibition DME1311 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1311 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02934 XEO_CLAS Peptide DME1311 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 16 ug/ml) DME1311 XEOTICID XEO02934 GENEFORM Protein DME1311 XEOTICID XEO02934 MOACRIVE Inhibition DME1311 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1311 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02935 XEO_CLAS Peptide DME1311 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 ug/ml) DME1311 XEOTICID XEO02935 GENEFORM Protein DME1311 XEOTICID XEO02935 MOACRIVE Inhibition DME1311 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1311 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02937 XEO_CLAS Peptide DME1311 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 3 ug/ml) DME1311 XEOTICID XEO02937 GENEFORM Protein DME1311 XEOTICID XEO02937 MOACRIVE Inhibition DME1311 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1311 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02940 XEO_CLAS Peptide DME1311 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 3 ug/ml) DME1311 XEOTICID XEO02940 GENEFORM Protein DME1311 XEOTICID XEO02940 MOACRIVE Inhibition DME1311 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1311 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02941 XEO_CLAS Peptide DME1311 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2 ug/ml) DME1311 XEOTICID XEO02941 GENEFORM Protein DME1311 XEOTICID XEO02941 MOACRIVE Inhibition DME1311 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1311 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02947 XEO_CLAS Peptide DME1311 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 43 ug/ml) DME1311 XEOTICID XEO02947 GENEFORM Protein DME1311 XEOTICID XEO02947 MOACRIVE Inhibition DME1311 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1311 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02948 XEO_CLAS Peptide DME1311 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2 ug/ml) DME1311 XEOTICID XEO02948 GENEFORM Protein DME1311 XEOTICID XEO02948 MOACRIVE Inhibition DME1311 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1311 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02949 XEO_CLAS Peptide DME1311 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 ug/ml) DME1311 XEOTICID XEO02949 GENEFORM Protein DME1311 XEOTICID XEO02949 MOACRIVE Inhibition DME1311 XEOTICID XEO02955 XEO_NAME Cryptdin related sequence CRS4C-3c DME1311 XEOTICID XEO02955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02955 XEO_CLAS Peptide DME1311 XEOTICID XEO02955 DESCRIPT Cryptdin related sequence CRS4C-3c inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO02955 GENEFORM Protein DME1311 XEOTICID XEO02955 MOACRIVE Inhibition DME1311 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1311 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02958 XEO_CLAS Peptide DME1311 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO02958 GENEFORM Protein DME1311 XEOTICID XEO02958 MOACRIVE Inhibition DME1311 XEOTICID XEO02959 XEO_NAME Cryptdin related peptide CRS4C-1d DME1311 XEOTICID XEO02959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02959 XEO_CLAS Peptide DME1311 XEOTICID XEO02959 DESCRIPT Cryptdin related peptide CRS4C-1d inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO02959 GENEFORM Protein DME1311 XEOTICID XEO02959 MOACRIVE Inhibition DME1311 XEOTICID XEO02960 XEO_NAME Cryptdin related peptide CRS4C-2 DME1311 XEOTICID XEO02960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02960 XEO_CLAS Peptide DME1311 XEOTICID XEO02960 DESCRIPT Cryptdin related peptide CRS4C-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO02960 GENEFORM Protein DME1311 XEOTICID XEO02960 MOACRIVE Inhibition DME1311 XEOTICID XEO02961 XEO_NAME Cryptdin related peptide CRS4C-2b DME1311 XEOTICID XEO02961 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO02961 XEO_CLAS Peptide DME1311 XEOTICID XEO02961 DESCRIPT Cryptdin related peptide CRS4C-2b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO02961 GENEFORM Protein DME1311 XEOTICID XEO02961 MOACRIVE Inhibition DME1311 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1311 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03043 XEO_CLAS Peptide DME1311 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2 microM) DME1311 XEOTICID XEO03043 GENEFORM Protein DME1311 XEOTICID XEO03043 MOACRIVE Inhibition DME1311 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1311 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03052 XEO_CLAS Peptide DME1311 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 50 ug/ml) DME1311 XEOTICID XEO03052 GENEFORM Protein DME1311 XEOTICID XEO03052 MOACRIVE Inhibition DME1311 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1311 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03053 XEO_CLAS Peptide DME1311 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 125 ug/ml) DME1311 XEOTICID XEO03053 GENEFORM Protein DME1311 XEOTICID XEO03053 MOACRIVE Inhibition DME1311 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1311 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03060 XEO_CLAS Peptide DME1311 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2 microM) DME1311 XEOTICID XEO03060 GENEFORM Protein DME1311 XEOTICID XEO03060 MOACRIVE Inhibition DME1311 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1311 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03125 XEO_CLAS Peptide DME1311 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO03125 GENEFORM Protein DME1311 XEOTICID XEO03125 MOACRIVE Inhibition DME1311 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1311 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03162 XEO_CLAS Peptide DME1311 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 3.1 microM) DME1311 XEOTICID XEO03162 GENEFORM Protein DME1311 XEOTICID XEO03162 MOACRIVE Inhibition DME1311 XEOTICID XEO03164 XEO_NAME Dermatoxin DME1311 XEOTICID XEO03164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03164 XEO_CLAS Peptide DME1311 XEOTICID XEO03164 DESCRIPT Dermatoxin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO03164 GENEFORM Protein DME1311 XEOTICID XEO03164 MOACRIVE Inhibition DME1311 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1311 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03224 XEO_CLAS Peptide DME1311 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.5-1 microM) DME1311 XEOTICID XEO03224 GENEFORM Protein DME1311 XEOTICID XEO03224 MOACRIVE Inhibition DME1311 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1311 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03251 XEO_CLAS Peptide DME1311 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO03251 GENEFORM Protein DME1311 XEOTICID XEO03251 MOACRIVE Inhibition DME1311 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1311 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03428 XEO_CLAS Peptide DME1311 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 63 ug/ml) DME1311 XEOTICID XEO03428 GENEFORM Protein DME1311 XEOTICID XEO03428 MOACRIVE Inhibition DME1311 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1311 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03430 XEO_CLAS Peptide DME1311 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 63 ug/ml) DME1311 XEOTICID XEO03430 GENEFORM Protein DME1311 XEOTICID XEO03430 MOACRIVE Inhibition DME1311 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1311 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03434 XEO_CLAS Peptide DME1311 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 31 ug/ml) DME1311 XEOTICID XEO03434 GENEFORM Protein DME1311 XEOTICID XEO03434 MOACRIVE Inhibition DME1311 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1311 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03437 XEO_CLAS Peptide DME1311 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 150 ug/ml) DME1311 XEOTICID XEO03437 GENEFORM Protein DME1311 XEOTICID XEO03437 MOACRIVE Inhibition DME1311 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1311 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03438 XEO_CLAS Peptide DME1311 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 150 ug/ml) DME1311 XEOTICID XEO03438 GENEFORM Protein DME1311 XEOTICID XEO03438 MOACRIVE Inhibition DME1311 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1311 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03439 XEO_CLAS Peptide DME1311 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 200 ug/ml) DME1311 XEOTICID XEO03439 GENEFORM Protein DME1311 XEOTICID XEO03439 MOACRIVE Inhibition DME1311 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1311 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03440 XEO_CLAS Peptide DME1311 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 200 ug/ml) DME1311 XEOTICID XEO03440 GENEFORM Protein DME1311 XEOTICID XEO03440 MOACRIVE Inhibition DME1311 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1311 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03441 XEO_CLAS Peptide DME1311 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 200 ug/ml) DME1311 XEOTICID XEO03441 GENEFORM Protein DME1311 XEOTICID XEO03441 MOACRIVE Inhibition DME1311 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1311 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03462 XEO_CLAS Peptide DME1311 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO03462 GENEFORM Protein DME1311 XEOTICID XEO03462 MOACRIVE Inhibition DME1311 XEOTICID XEO03464 XEO_NAME Gallinacin-4 DME1311 XEOTICID XEO03464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03464 XEO_CLAS Peptide DME1311 XEOTICID XEO03464 DESCRIPT Gallinacin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO03464 GENEFORM Protein DME1311 XEOTICID XEO03464 MOACRIVE Inhibition DME1311 XEOTICID XEO03465 XEO_NAME Gallinacin-5 DME1311 XEOTICID XEO03465 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03465 XEO_CLAS Peptide DME1311 XEOTICID XEO03465 DESCRIPT Gallinacin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO03465 GENEFORM Protein DME1311 XEOTICID XEO03465 MOACRIVE Inhibition DME1311 XEOTICID XEO03466 XEO_NAME Gallinacin-6 DME1311 XEOTICID XEO03466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03466 XEO_CLAS Peptide DME1311 XEOTICID XEO03466 DESCRIPT Gallinacin-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO03466 GENEFORM Protein DME1311 XEOTICID XEO03466 MOACRIVE Inhibition DME1311 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1311 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03467 XEO_CLAS Peptide DME1311 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO03467 GENEFORM Protein DME1311 XEOTICID XEO03467 MOACRIVE Inhibition DME1311 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1311 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03498 XEO_CLAS Peptide DME1311 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.8-1.6 microM) DME1311 XEOTICID XEO03498 GENEFORM Protein DME1311 XEOTICID XEO03498 MOACRIVE Inhibition DME1311 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1311 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03504 XEO_CLAS Peptide DME1311 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC > 50 ug/ml) DME1311 XEOTICID XEO03504 GENEFORM Protein DME1311 XEOTICID XEO03504 MOACRIVE Inhibition DME1311 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1311 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03505 XEO_CLAS Peptide DME1311 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 12.5 ug/ml) DME1311 XEOTICID XEO03505 GENEFORM Protein DME1311 XEOTICID XEO03505 MOACRIVE Inhibition DME1311 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1311 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03506 XEO_CLAS Peptide DME1311 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 12.5 ug/ml) DME1311 XEOTICID XEO03506 GENEFORM Protein DME1311 XEOTICID XEO03506 MOACRIVE Inhibition DME1311 XEOTICID XEO03519 XEO_NAME Hadrurin DME1311 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03519 XEO_CLAS Peptide DME1311 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO03519 GENEFORM Protein DME1311 XEOTICID XEO03519 MOACRIVE Inhibition DME1311 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1311 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03609 XEO_CLAS Peptide DME1311 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO03609 GENEFORM Protein DME1311 XEOTICID XEO03609 MOACRIVE Inhibition DME1311 XEOTICID XEO03671 XEO_NAME Plant JCpep7 DME1311 XEOTICID XEO03671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03671 XEO_CLAS Peptide DME1311 XEOTICID XEO03671 DESCRIPT Plant JCpep7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 48 ug/ml) DME1311 XEOTICID XEO03671 GENEFORM Protein DME1311 XEOTICID XEO03671 MOACRIVE Inhibition DME1311 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1311 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03684 XEO_CLAS Peptide DME1311 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 63 ug/ml) DME1311 XEOTICID XEO03684 GENEFORM Protein DME1311 XEOTICID XEO03684 MOACRIVE Inhibition DME1311 XEOTICID XEO03721 XEO_NAME Kunitz-type serine protease inhibitor Xb-KTI DME1311 XEOTICID XEO03721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03721 XEO_CLAS Peptide DME1311 XEOTICID XEO03721 DESCRIPT Kunitz-type serine protease inhibitor Xb-KTI inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 10 microM) DME1311 XEOTICID XEO03721 GENEFORM Protein DME1311 XEOTICID XEO03721 MOACRIVE Inhibition DME1311 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1311 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03746 XEO_CLAS Peptide DME1311 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2 ug/ml) DME1311 XEOTICID XEO03746 GENEFORM Protein DME1311 XEOTICID XEO03746 MOACRIVE Inhibition DME1311 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1311 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03747 XEO_CLAS Peptide DME1311 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1 ug/ml) DME1311 XEOTICID XEO03747 GENEFORM Protein DME1311 XEOTICID XEO03747 MOACRIVE Inhibition DME1311 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1311 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03748 XEO_CLAS Peptide DME1311 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 ug/ml) DME1311 XEOTICID XEO03748 GENEFORM Protein DME1311 XEOTICID XEO03748 MOACRIVE Inhibition DME1311 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1311 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03749 XEO_CLAS Peptide DME1311 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2 ug/ml) DME1311 XEOTICID XEO03749 GENEFORM Protein DME1311 XEOTICID XEO03749 MOACRIVE Inhibition DME1311 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1311 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03750 XEO_CLAS Peptide DME1311 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 ug/ml) DME1311 XEOTICID XEO03750 GENEFORM Protein DME1311 XEOTICID XEO03750 MOACRIVE Inhibition DME1311 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1311 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03751 XEO_CLAS Peptide DME1311 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 ug/ml) DME1311 XEOTICID XEO03751 GENEFORM Protein DME1311 XEOTICID XEO03751 MOACRIVE Inhibition DME1311 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1311 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03752 XEO_CLAS Peptide DME1311 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2 ug/ml) DME1311 XEOTICID XEO03752 GENEFORM Protein DME1311 XEOTICID XEO03752 MOACRIVE Inhibition DME1311 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1311 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03754 XEO_CLAS Peptide DME1311 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 ug/ml) DME1311 XEOTICID XEO03754 GENEFORM Protein DME1311 XEOTICID XEO03754 MOACRIVE Inhibition DME1311 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1311 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03755 XEO_CLAS Peptide DME1311 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 ug/ml) DME1311 XEOTICID XEO03755 GENEFORM Protein DME1311 XEOTICID XEO03755 MOACRIVE Inhibition DME1311 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1311 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03756 XEO_CLAS Peptide DME1311 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2 ug/ml) DME1311 XEOTICID XEO03756 GENEFORM Protein DME1311 XEOTICID XEO03756 MOACRIVE Inhibition DME1311 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1311 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03793 XEO_CLAS Peptide DME1311 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 microM) DME1311 XEOTICID XEO03793 GENEFORM Protein DME1311 XEOTICID XEO03793 MOACRIVE Inhibition DME1311 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1311 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03904 XEO_CLAS Peptide DME1311 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 32 ug/ml) DME1311 XEOTICID XEO03904 GENEFORM Protein DME1311 XEOTICID XEO03904 MOACRIVE Inhibition DME1311 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1311 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03905 XEO_CLAS Peptide DME1311 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC > 64 ug/ml) DME1311 XEOTICID XEO03905 GENEFORM Protein DME1311 XEOTICID XEO03905 MOACRIVE Inhibition DME1311 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1311 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO03928 XEO_CLAS Peptide DME1311 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 16 microM) DME1311 XEOTICID XEO03928 GENEFORM Protein DME1311 XEOTICID XEO03928 MOACRIVE Inhibition DME1311 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1311 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04039 XEO_CLAS Peptide DME1311 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1 microM) DME1311 XEOTICID XEO04039 GENEFORM Protein DME1311 XEOTICID XEO04039 MOACRIVE Inhibition DME1311 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1311 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04111 XEO_CLAS Peptide DME1311 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO04111 GENEFORM Protein DME1311 XEOTICID XEO04111 MOACRIVE Inhibition DME1311 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1311 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04112 XEO_CLAS Peptide DME1311 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1.2 microM) DME1311 XEOTICID XEO04112 GENEFORM Protein DME1311 XEOTICID XEO04112 MOACRIVE Inhibition DME1311 XEOTICID XEO04117 XEO_NAME Misgurin DME1311 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04117 XEO_CLAS Peptide DME1311 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO04117 GENEFORM Protein DME1311 XEOTICID XEO04117 MOACRIVE Inhibition DME1311 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1311 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04142 XEO_CLAS Peptide DME1311 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 32.64 microM) DME1311 XEOTICID XEO04142 GENEFORM Protein DME1311 XEOTICID XEO04142 MOACRIVE Inhibition DME1311 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1311 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04158 XEO_CLAS Peptide DME1311 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 microM) DME1311 XEOTICID XEO04158 GENEFORM Protein DME1311 XEOTICID XEO04158 MOACRIVE Inhibition DME1311 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1311 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04159 XEO_CLAS Peptide DME1311 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2 microM) DME1311 XEOTICID XEO04159 GENEFORM Protein DME1311 XEOTICID XEO04159 MOACRIVE Inhibition DME1311 XEOTICID XEO04252 XEO_NAME Neutrophil antibiotic peptide NP-2 DME1311 XEOTICID XEO04252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04252 XEO_CLAS Peptide DME1311 XEOTICID XEO04252 DESCRIPT Neutrophil antibiotic peptide NP-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO04252 GENEFORM Protein DME1311 XEOTICID XEO04252 MOACRIVE Inhibition DME1311 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1311 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04426 XEO_CLAS Peptide DME1311 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 microM) DME1311 XEOTICID XEO04426 GENEFORM Protein DME1311 XEOTICID XEO04426 MOACRIVE Inhibition DME1311 XEOTICID XEO04481 XEO_NAME Porcine beta-defensin pBD-2 DME1311 XEOTICID XEO04481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04481 XEO_CLAS Peptide DME1311 XEOTICID XEO04481 DESCRIPT Porcine beta-defensin pBD-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO04481 GENEFORM Protein DME1311 XEOTICID XEO04481 MOACRIVE Inhibition DME1311 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1311 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04526 XEO_CLAS Peptide DME1311 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1.0 microM) DME1311 XEOTICID XEO04526 GENEFORM Protein DME1311 XEOTICID XEO04526 MOACRIVE Inhibition DME1311 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1311 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04613 XEO_CLAS Peptide DME1311 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 10-20 microM) DME1311 XEOTICID XEO04613 GENEFORM Protein DME1311 XEOTICID XEO04613 MOACRIVE Inhibition DME1311 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1311 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04627 XEO_CLAS Peptide DME1311 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 25.25 microM) DME1311 XEOTICID XEO04627 GENEFORM Protein DME1311 XEOTICID XEO04627 MOACRIVE Inhibition DME1311 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1311 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04640 XEO_CLAS Peptide DME1311 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8.8-17.7 microM) DME1311 XEOTICID XEO04640 GENEFORM Protein DME1311 XEOTICID XEO04640 MOACRIVE Inhibition DME1311 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1311 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04653 XEO_CLAS Peptide DME1311 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC > 64 ug/ml) DME1311 XEOTICID XEO04653 GENEFORM Protein DME1311 XEOTICID XEO04653 MOACRIVE Inhibition DME1311 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1311 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04654 XEO_CLAS Peptide DME1311 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 64 ug/ml) DME1311 XEOTICID XEO04654 GENEFORM Protein DME1311 XEOTICID XEO04654 MOACRIVE Inhibition DME1311 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1311 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04660 XEO_CLAS Peptide DME1311 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2 ug/ml) DME1311 XEOTICID XEO04660 GENEFORM Protein DME1311 XEOTICID XEO04660 MOACRIVE Inhibition DME1311 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1311 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04690 XEO_CLAS Peptide DME1311 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.25 ug/ml) DME1311 XEOTICID XEO04690 GENEFORM Protein DME1311 XEOTICID XEO04690 MOACRIVE Inhibition DME1311 XEOTICID XEO04770 XEO_NAME Pyrrhocoricin DME1311 XEOTICID XEO04770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04770 XEO_CLAS Peptide DME1311 XEOTICID XEO04770 DESCRIPT Pyrrhocoricin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 5 microM) DME1311 XEOTICID XEO04770 GENEFORM Protein DME1311 XEOTICID XEO04770 MOACRIVE Inhibition DME1311 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1311 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04783 XEO_CLAS Peptide DME1311 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 ug/ml) DME1311 XEOTICID XEO04783 GENEFORM Protein DME1311 XEOTICID XEO04783 MOACRIVE Inhibition DME1311 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1311 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04784 XEO_CLAS Peptide DME1311 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 ug/ml) DME1311 XEOTICID XEO04784 GENEFORM Protein DME1311 XEOTICID XEO04784 MOACRIVE Inhibition DME1311 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1311 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04785 XEO_CLAS Peptide DME1311 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 ug/ml) DME1311 XEOTICID XEO04785 GENEFORM Protein DME1311 XEOTICID XEO04785 MOACRIVE Inhibition DME1311 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1311 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04786 XEO_CLAS Peptide DME1311 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 31 ug/ml) DME1311 XEOTICID XEO04786 GENEFORM Protein DME1311 XEOTICID XEO04786 MOACRIVE Inhibition DME1311 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1311 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04840 XEO_CLAS Peptide DME1311 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC > 20 microM) DME1311 XEOTICID XEO04840 GENEFORM Protein DME1311 XEOTICID XEO04840 MOACRIVE Inhibition DME1311 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1311 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04848 XEO_CLAS Peptide DME1311 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO04848 GENEFORM Protein DME1311 XEOTICID XEO04848 MOACRIVE Inhibition DME1311 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1311 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04849 XEO_CLAS Peptide DME1311 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO04849 GENEFORM Protein DME1311 XEOTICID XEO04849 MOACRIVE Inhibition DME1311 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1311 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04850 XEO_CLAS Peptide DME1311 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO04850 GENEFORM Protein DME1311 XEOTICID XEO04850 MOACRIVE Inhibition DME1311 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1311 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04880 XEO_CLAS Peptide DME1311 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 12.7 ug/ml) DME1311 XEOTICID XEO04880 GENEFORM Protein DME1311 XEOTICID XEO04880 MOACRIVE Inhibition DME1311 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1311 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04886 XEO_CLAS Peptide DME1311 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 1.0 ug/ml) DME1311 XEOTICID XEO04886 GENEFORM Protein DME1311 XEOTICID XEO04886 MOACRIVE Inhibition DME1311 XEOTICID XEO04931 XEO_NAME Shepherin I DME1311 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04931 XEO_CLAS Peptide DME1311 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO04931 GENEFORM Protein DME1311 XEOTICID XEO04931 MOACRIVE Inhibition DME1311 XEOTICID XEO04932 XEO_NAME shepherin II DME1311 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04932 XEO_CLAS Peptide DME1311 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO04932 GENEFORM Protein DME1311 XEOTICID XEO04932 MOACRIVE Inhibition DME1311 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1311 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04956 XEO_CLAS Peptide DME1311 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8.0 microM) DME1311 XEOTICID XEO04956 GENEFORM Protein DME1311 XEOTICID XEO04956 MOACRIVE Inhibition DME1311 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1311 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04971 XEO_CLAS Peptide DME1311 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 6-12 microM) DME1311 XEOTICID XEO04971 GENEFORM Protein DME1311 XEOTICID XEO04971 MOACRIVE Inhibition DME1311 XEOTICID XEO04974 XEO_NAME Spinigerin DME1311 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04974 XEO_CLAS Peptide DME1311 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 3-6 microM) DME1311 XEOTICID XEO04974 GENEFORM Protein DME1311 XEOTICID XEO04974 MOACRIVE Inhibition DME1311 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1311 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04995 XEO_CLAS Peptide DME1311 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.39-0.78 microM) DME1311 XEOTICID XEO04995 GENEFORM Protein DME1311 XEOTICID XEO04995 MOACRIVE Inhibition DME1311 XEOTICID XEO04998 XEO_NAME Styelin A DME1311 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04998 XEO_CLAS Peptide DME1311 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 5 ug/ml) DME1311 XEOTICID XEO04998 GENEFORM Protein DME1311 XEOTICID XEO04998 MOACRIVE Inhibition DME1311 XEOTICID XEO04999 XEO_NAME Styelin B DME1311 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO04999 XEO_CLAS Peptide DME1311 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 5 ug/ml) DME1311 XEOTICID XEO04999 GENEFORM Protein DME1311 XEOTICID XEO04999 MOACRIVE Inhibition DME1311 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1311 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05000 XEO_CLAS Peptide DME1311 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 ug/ml) DME1311 XEOTICID XEO05000 GENEFORM Protein DME1311 XEOTICID XEO05000 MOACRIVE Inhibition DME1311 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1311 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05001 XEO_CLAS Peptide DME1311 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 4 ug/ml) DME1311 XEOTICID XEO05001 GENEFORM Protein DME1311 XEOTICID XEO05001 MOACRIVE Inhibition DME1311 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1311 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05002 XEO_CLAS Peptide DME1311 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 ug/ml) DME1311 XEOTICID XEO05002 GENEFORM Protein DME1311 XEOTICID XEO05002 MOACRIVE Inhibition DME1311 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1311 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05003 XEO_CLAS Peptide DME1311 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 16 ug/ml) DME1311 XEOTICID XEO05003 GENEFORM Protein DME1311 XEOTICID XEO05003 MOACRIVE Inhibition DME1311 XEOTICID XEO05020 XEO_NAME Tachycitin DME1311 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05020 XEO_CLAS Peptide DME1311 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO05020 GENEFORM Protein DME1311 XEOTICID XEO05020 MOACRIVE Inhibition DME1311 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1311 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05119 XEO_CLAS Peptide DME1311 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO05119 GENEFORM Protein DME1311 XEOTICID XEO05119 MOACRIVE Inhibition DME1311 XEOTICID XEO05120 XEO_NAME Thanatin DME1311 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05120 XEO_CLAS Peptide DME1311 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 0.6-1.2 microM) DME1311 XEOTICID XEO05120 GENEFORM Protein DME1311 XEOTICID XEO05120 MOACRIVE Inhibition DME1311 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1311 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05161 XEO_CLAS Peptide DME1311 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 32 ug/ml) DME1311 XEOTICID XEO05161 GENEFORM Protein DME1311 XEOTICID XEO05161 MOACRIVE Inhibition DME1311 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1311 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05162 XEO_CLAS Peptide DME1311 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 32 ug/ml) DME1311 XEOTICID XEO05162 GENEFORM Protein DME1311 XEOTICID XEO05162 MOACRIVE Inhibition DME1311 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1311 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05193 XEO_CLAS Peptide DME1311 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 ug/ml) DME1311 XEOTICID XEO05193 GENEFORM Protein DME1311 XEOTICID XEO05193 MOACRIVE Inhibition DME1311 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1311 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05212 XEO_CLAS Peptide DME1311 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 2.5 ug/ml) DME1311 XEOTICID XEO05212 GENEFORM Protein DME1311 XEOTICID XEO05212 MOACRIVE Inhibition DME1311 XEOTICID XEO05222 XEO_NAME Plant defensin VaD1 DME1311 XEOTICID XEO05222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05222 XEO_CLAS Peptide DME1311 XEOTICID XEO05222 DESCRIPT Plant defensin VaD1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica DME1311 XEOTICID XEO05222 GENEFORM Protein DME1311 XEOTICID XEO05222 MOACRIVE Inhibition DME1311 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1311 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05231 XEO_CLAS Peptide DME1311 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 10.9 microM) DME1311 XEOTICID XEO05231 GENEFORM Protein DME1311 XEOTICID XEO05231 MOACRIVE Inhibition DME1311 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1311 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05264 XEO_CLAS Peptide DME1311 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 ug/ml) DME1311 XEOTICID XEO05264 GENEFORM Protein DME1311 XEOTICID XEO05264 MOACRIVE Inhibition DME1311 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1311 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1311 XEOTICID XEO05267 XEO_CLAS Peptide DME1311 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Salmonella enterica (MIC = 8 ug/ml) DME1311 XEOTICID XEO05267 GENEFORM Protein DME1311 XEOTICID XEO05267 MOACRIVE Inhibition DME1312 DME___ID DME1312 DME1312 DME_NAME Beta-lactamase (blaB) DME1312 SPESNAME Burkholderia cenocepacia DME1312 XEOTICID XEO00164 XEO_NAME Azithromycin DME1312 XEOTICID XEO00164 XEO_TYPE Pharmaceutical Agent(s) DME1312 XEOTICID XEO00164 XEO_CLAS Approved/Marketed Drug DME1312 XEOTICID XEO00164 DESCRIPT Azithromycin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cenocepacia DME1312 XEOTICID XEO00164 GENEFORM Protein DME1312 XEOTICID XEO00164 MOACRIVE Inhibition DME1312 XEOTICID XEO00568 XEO_NAME Resveratrol DME1312 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1312 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1312 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cenocepacia DME1312 XEOTICID XEO00568 GENEFORM Protein DME1312 XEOTICID XEO00568 MOACRIVE Inhibition DME1312 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME1312 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME1312 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME1312 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cenocepacia DME1312 XEOTICID XEO00613 GENEFORM Protein DME1312 XEOTICID XEO00613 MOACRIVE Inhibition DME1312 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME1312 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1312 XEOTICID XEO01253 XEO_CLAS Natural Product DME1312 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cenocepacia DME1312 XEOTICID XEO01253 GENEFORM Protein DME1312 XEOTICID XEO01253 MOACRIVE Inhibition DME1312 XEOTICID XEO01291 XEO_NAME Esculetin DME1312 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1312 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1312 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cenocepacia DME1312 XEOTICID XEO01291 GENEFORM Protein DME1312 XEOTICID XEO01291 MOACRIVE Inhibition DME1312 XEOTICID XEO01298 XEO_NAME Farnesol DME1312 XEOTICID XEO01298 XEO_TYPE Pharmaceutical Agent(s) DME1312 XEOTICID XEO01298 XEO_CLAS Investigative Agent DME1312 XEOTICID XEO01298 DESCRIPT Farnesol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cenocepacia DME1312 XEOTICID XEO01298 GENEFORM Protein DME1312 XEOTICID XEO01298 MOACRIVE Inhibition DME1312 XEOTICID XEO01450 XEO_NAME Quinone DME1312 XEOTICID XEO01450 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1312 XEOTICID XEO01450 XEO_CLAS Natural Product DME1312 XEOTICID XEO01450 DESCRIPT Quinone inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cenocepacia DME1312 XEOTICID XEO01450 GENEFORM Protein DME1312 XEOTICID XEO01450 MOACRIVE Inhibition DME1312 XEOTICID XEO02786 XEO_NAME Ceftazidime hydrate DME1312 XEOTICID XEO02786 XEO_TYPE Pharmaceutical Agent(s) DME1312 XEOTICID XEO02786 XEO_CLAS Approved/Marketed Drug DME1312 XEOTICID XEO02786 DESCRIPT Ceftazidime hydrate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cenocepacia DME1312 XEOTICID XEO02786 GENEFORM Protein DME1312 XEOTICID XEO02786 MOACRIVE Inhibition DME1312 XEOTICID XEO03324 XEO_NAME Esculin hydrate DME1312 XEOTICID XEO03324 XEO_TYPE Pharmaceutical Agent(s) DME1312 XEOTICID XEO03324 XEO_CLAS Investigative Agent DME1312 XEOTICID XEO03324 DESCRIPT Esculin hydrate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cenocepacia DME1312 XEOTICID XEO03324 GENEFORM Protein DME1312 XEOTICID XEO03324 MOACRIVE Inhibition DME1312 XEOTICID XEO03523 XEO_NAME Hamamelitannin DME1312 XEOTICID XEO03523 XEO_TYPE Pharmaceutical Agent(s) DME1312 XEOTICID XEO03523 XEO_CLAS Investigative Agent DME1312 XEOTICID XEO03523 DESCRIPT Hamamelitannin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cenocepacia DME1312 XEOTICID XEO03523 GENEFORM Protein DME1312 XEOTICID XEO03523 MOACRIVE Inhibition DME1312 XEOTICID XEO03644 XEO_NAME Indole DME1312 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1312 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1312 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cenocepacia DME1312 XEOTICID XEO03644 GENEFORM Protein DME1312 XEOTICID XEO03644 MOACRIVE Inhibition DME1312 XEOTICID XEO03812 XEO_NAME L-Canavanine DME1312 XEOTICID XEO03812 XEO_TYPE Pharmaceutical Agent(s) DME1312 XEOTICID XEO03812 XEO_CLAS Investigative Agent DME1312 XEOTICID XEO03812 DESCRIPT L-Canavanine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cenocepacia DME1312 XEOTICID XEO03812 GENEFORM Protein DME1312 XEOTICID XEO03812 MOACRIVE Inhibition DME1312 XEOTICID XEO05156 XEO_NAME Tobramycin DME1312 XEOTICID XEO05156 XEO_TYPE Pharmaceutical Agent(s) DME1312 XEOTICID XEO05156 XEO_CLAS Approved/Marketed Drug DME1312 XEOTICID XEO05156 DESCRIPT Tobramycin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cenocepacia DME1312 XEOTICID XEO05156 GENEFORM Protein DME1312 XEOTICID XEO05156 MOACRIVE Inhibition DME1315 DME___ID DME1315 DME1315 DME_NAME Azoreductase (azoR) DME1315 SPESNAME Enterococcus faecalis DME1315 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1315 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1315 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1315 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO00546 GENEFORM Protein DME1315 XEOTICID XEO00546 MOACRIVE Inhibition DME1315 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1315 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO01812 XEO_CLAS Peptide DME1315 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 1.9 microM) DME1315 XEOTICID XEO01812 GENEFORM Protein DME1315 XEOTICID XEO01812 MOACRIVE Inhibition DME1315 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1315 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO01813 XEO_CLAS Peptide DME1315 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 1.4 microM) DME1315 XEOTICID XEO01813 GENEFORM Protein DME1315 XEOTICID XEO01813 MOACRIVE Inhibition DME1315 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1315 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO01814 XEO_CLAS Peptide DME1315 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 0.7 microM) DME1315 XEOTICID XEO01814 GENEFORM Protein DME1315 XEOTICID XEO01814 MOACRIVE Inhibition DME1315 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1315 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO01815 XEO_CLAS Peptide DME1315 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 1.0 microM) DME1315 XEOTICID XEO01815 GENEFORM Protein DME1315 XEOTICID XEO01815 MOACRIVE Inhibition DME1315 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1315 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1315 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1315 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO01961 GENEFORM Protein DME1315 XEOTICID XEO01961 MOACRIVE Inhibition DME1315 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1315 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1315 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1315 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO01966 GENEFORM Protein DME1315 XEOTICID XEO01966 MOACRIVE Inhibition DME1315 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1315 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02122 XEO_CLAS Peptide DME1315 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 50 ug/ml) DME1315 XEOTICID XEO02122 GENEFORM Protein DME1315 XEOTICID XEO02122 MOACRIVE Inhibition DME1315 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1315 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02247 XEO_CLAS Peptide DME1315 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02247 GENEFORM Protein DME1315 XEOTICID XEO02247 MOACRIVE Inhibition DME1315 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1315 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02319 XEO_CLAS Peptide DME1315 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02319 GENEFORM Protein DME1315 XEOTICID XEO02319 MOACRIVE Inhibition DME1315 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1315 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02325 XEO_CLAS Peptide DME1315 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 100 microM) DME1315 XEOTICID XEO02325 GENEFORM Protein DME1315 XEOTICID XEO02325 MOACRIVE Inhibition DME1315 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1315 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02355 XEO_CLAS Peptide DME1315 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 17 ug/ml) DME1315 XEOTICID XEO02355 GENEFORM Protein DME1315 XEOTICID XEO02355 MOACRIVE Inhibition DME1315 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1315 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02356 XEO_CLAS Peptide DME1315 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 32 ug/ml) DME1315 XEOTICID XEO02356 GENEFORM Protein DME1315 XEOTICID XEO02356 MOACRIVE Inhibition DME1315 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1315 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02357 XEO_CLAS Peptide DME1315 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 16 ug/ml) DME1315 XEOTICID XEO02357 GENEFORM Protein DME1315 XEOTICID XEO02357 MOACRIVE Inhibition DME1315 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1315 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02358 XEO_CLAS Peptide DME1315 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 8 ug/ml) DME1315 XEOTICID XEO02358 GENEFORM Protein DME1315 XEOTICID XEO02358 MOACRIVE Inhibition DME1315 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1315 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02360 XEO_CLAS Peptide DME1315 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 2 ug/ml) DME1315 XEOTICID XEO02360 GENEFORM Protein DME1315 XEOTICID XEO02360 MOACRIVE Inhibition DME1315 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1315 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02361 XEO_CLAS Peptide DME1315 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 32 ug/ml) DME1315 XEOTICID XEO02361 GENEFORM Protein DME1315 XEOTICID XEO02361 MOACRIVE Inhibition DME1315 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1315 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02365 XEO_CLAS Peptide DME1315 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 64 ug/ml) DME1315 XEOTICID XEO02365 GENEFORM Protein DME1315 XEOTICID XEO02365 MOACRIVE Inhibition DME1315 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1315 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02366 XEO_CLAS Peptide DME1315 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 32 ug/ml) DME1315 XEOTICID XEO02366 GENEFORM Protein DME1315 XEOTICID XEO02366 MOACRIVE Inhibition DME1315 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1315 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02367 XEO_CLAS Peptide DME1315 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 32 ug/ml) DME1315 XEOTICID XEO02367 GENEFORM Protein DME1315 XEOTICID XEO02367 MOACRIVE Inhibition DME1315 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1315 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02368 XEO_CLAS Peptide DME1315 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 64 ug/ml) DME1315 XEOTICID XEO02368 GENEFORM Protein DME1315 XEOTICID XEO02368 MOACRIVE Inhibition DME1315 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1315 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02369 XEO_CLAS Peptide DME1315 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 32 ug/ml) DME1315 XEOTICID XEO02369 GENEFORM Protein DME1315 XEOTICID XEO02369 MOACRIVE Inhibition DME1315 XEOTICID XEO02377 XEO_NAME Bacteriocin hiracin-JM79 DME1315 XEOTICID XEO02377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02377 XEO_CLAS Peptide DME1315 XEOTICID XEO02377 DESCRIPT Bacteriocin hiracin-JM79 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02377 GENEFORM Protein DME1315 XEOTICID XEO02377 MOACRIVE Inhibition DME1315 XEOTICID XEO02382 XEO_NAME Bacteriocin plantarican ASM1 DME1315 XEOTICID XEO02382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02382 XEO_CLAS Peptide DME1315 XEOTICID XEO02382 DESCRIPT Bacteriocin plantarican ASM1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02382 GENEFORM Protein DME1315 XEOTICID XEO02382 MOACRIVE Inhibition DME1315 XEOTICID XEO02386 XEO_NAME Bactridin-1 DME1315 XEOTICID XEO02386 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02386 XEO_CLAS Peptide DME1315 XEOTICID XEO02386 DESCRIPT Bactridin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 34 microM) DME1315 XEOTICID XEO02386 GENEFORM Protein DME1315 XEOTICID XEO02386 MOACRIVE Inhibition DME1315 XEOTICID XEO02387 XEO_NAME Bactridin-2 DME1315 XEOTICID XEO02387 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02387 XEO_CLAS Peptide DME1315 XEOTICID XEO02387 DESCRIPT Bactridin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 65 microM) DME1315 XEOTICID XEO02387 GENEFORM Protein DME1315 XEOTICID XEO02387 MOACRIVE Inhibition DME1315 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1315 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02388 XEO_CLAS Peptide DME1315 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 8 ug/ml) DME1315 XEOTICID XEO02388 GENEFORM Protein DME1315 XEOTICID XEO02388 MOACRIVE Inhibition DME1315 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1315 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02389 XEO_CLAS Peptide DME1315 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 2 ug/ml) DME1315 XEOTICID XEO02389 GENEFORM Protein DME1315 XEOTICID XEO02389 MOACRIVE Inhibition DME1315 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1315 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02463 XEO_CLAS Peptide DME1315 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 15 microM) DME1315 XEOTICID XEO02463 GENEFORM Protein DME1315 XEOTICID XEO02463 MOACRIVE Inhibition DME1315 XEOTICID XEO02465 XEO_NAME BMAP-28 DME1315 XEOTICID XEO02465 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02465 XEO_CLAS Peptide DME1315 XEOTICID XEO02465 DESCRIPT BMAP-28 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02465 GENEFORM Protein DME1315 XEOTICID XEO02465 MOACRIVE Inhibition DME1315 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1315 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02491 XEO_CLAS Peptide DME1315 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 57.1 microM) DME1315 XEOTICID XEO02491 GENEFORM Protein DME1315 XEOTICID XEO02491 MOACRIVE Inhibition DME1315 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1315 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02496 XEO_CLAS Peptide DME1315 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 13 microM) DME1315 XEOTICID XEO02496 GENEFORM Protein DME1315 XEOTICID XEO02496 MOACRIVE Inhibition DME1315 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1315 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02497 XEO_CLAS Peptide DME1315 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 6 microM) DME1315 XEOTICID XEO02497 GENEFORM Protein DME1315 XEOTICID XEO02497 MOACRIVE Inhibition DME1315 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1315 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02509 XEO_CLAS Peptide DME1315 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 19 microM) DME1315 XEOTICID XEO02509 GENEFORM Protein DME1315 XEOTICID XEO02509 MOACRIVE Inhibition DME1315 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1315 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02510 XEO_CLAS Peptide DME1315 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 75 microM) DME1315 XEOTICID XEO02510 GENEFORM Protein DME1315 XEOTICID XEO02510 MOACRIVE Inhibition DME1315 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1315 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02511 XEO_CLAS Peptide DME1315 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 9 microM) DME1315 XEOTICID XEO02511 GENEFORM Protein DME1315 XEOTICID XEO02511 MOACRIVE Inhibition DME1315 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1315 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02512 XEO_CLAS Peptide DME1315 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 9 microM) DME1315 XEOTICID XEO02512 GENEFORM Protein DME1315 XEOTICID XEO02512 MOACRIVE Inhibition DME1315 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1315 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02524 XEO_CLAS Peptide DME1315 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 19 microM) DME1315 XEOTICID XEO02524 GENEFORM Protein DME1315 XEOTICID XEO02524 MOACRIVE Inhibition DME1315 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1315 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02566 XEO_CLAS Peptide DME1315 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 50 microM) DME1315 XEOTICID XEO02566 GENEFORM Protein DME1315 XEOTICID XEO02566 MOACRIVE Inhibition DME1315 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1315 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02637 XEO_CLAS Peptide DME1315 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 25 microM) DME1315 XEOTICID XEO02637 GENEFORM Protein DME1315 XEOTICID XEO02637 MOACRIVE Inhibition DME1315 XEOTICID XEO02660 XEO_NAME Butyl gallate DME1315 XEOTICID XEO02660 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1315 XEOTICID XEO02660 XEO_CLAS Chemical Compound DME1315 XEOTICID XEO02660 DESCRIPT Butyl gallate inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02660 GENEFORM Protein DME1315 XEOTICID XEO02660 MOACRIVE Inhibition DME1315 XEOTICID XEO02718 XEO_NAME Carnobacteriocin CbnB2 DME1315 XEOTICID XEO02718 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02718 XEO_CLAS Peptide DME1315 XEOTICID XEO02718 DESCRIPT Carnobacteriocin CbnB2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02718 GENEFORM Protein DME1315 XEOTICID XEO02718 MOACRIVE Inhibition DME1315 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1315 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02721 XEO_CLAS Peptide DME1315 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02721 GENEFORM Protein DME1315 XEOTICID XEO02721 MOACRIVE Inhibition DME1315 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1315 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02820 XEO_CLAS Peptide DME1315 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 64 ug/ml) DME1315 XEOTICID XEO02820 GENEFORM Protein DME1315 XEOTICID XEO02820 MOACRIVE Inhibition DME1315 XEOTICID XEO02864 XEO_NAME Cathelicidin cjaRL-37 DME1315 XEOTICID XEO02864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02864 XEO_CLAS Peptide DME1315 XEOTICID XEO02864 DESCRIPT Cathelicidin cjaRL-37 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 32 microM) DME1315 XEOTICID XEO02864 GENEFORM Protein DME1315 XEOTICID XEO02864 MOACRIVE Inhibition DME1315 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1315 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02872 XEO_CLAS Peptide DME1315 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 300 microM) DME1315 XEOTICID XEO02872 GENEFORM Protein DME1315 XEOTICID XEO02872 MOACRIVE Inhibition DME1315 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1315 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02875 XEO_CLAS Peptide DME1315 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02875 GENEFORM Protein DME1315 XEOTICID XEO02875 MOACRIVE Inhibition DME1315 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1315 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02876 XEO_CLAS Peptide DME1315 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02876 GENEFORM Protein DME1315 XEOTICID XEO02876 MOACRIVE Inhibition DME1315 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1315 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02877 XEO_CLAS Peptide DME1315 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02877 GENEFORM Protein DME1315 XEOTICID XEO02877 MOACRIVE Inhibition DME1315 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1315 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02878 XEO_CLAS Peptide DME1315 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02878 GENEFORM Protein DME1315 XEOTICID XEO02878 MOACRIVE Inhibition DME1315 XEOTICID XEO02930 XEO_NAME Indolicidin derivative CP10A DME1315 XEOTICID XEO02930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02930 XEO_CLAS Peptide DME1315 XEOTICID XEO02930 DESCRIPT Indolicidin derivative CP10A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 8 ug/ml) DME1315 XEOTICID XEO02930 GENEFORM Protein DME1315 XEOTICID XEO02930 MOACRIVE Inhibition DME1315 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1315 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02931 XEO_CLAS Peptide DME1315 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 64 ug/ml) DME1315 XEOTICID XEO02931 GENEFORM Protein DME1315 XEOTICID XEO02931 MOACRIVE Inhibition DME1315 XEOTICID XEO02932 XEO_NAME CP11CN peptide DME1315 XEOTICID XEO02932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02932 XEO_CLAS Peptide DME1315 XEOTICID XEO02932 DESCRIPT CP11CN peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 64 ug/ml) DME1315 XEOTICID XEO02932 GENEFORM Protein DME1315 XEOTICID XEO02932 MOACRIVE Inhibition DME1315 XEOTICID XEO02955 XEO_NAME Cryptdin related sequence CRS4C-3c DME1315 XEOTICID XEO02955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02955 XEO_CLAS Peptide DME1315 XEOTICID XEO02955 DESCRIPT Cryptdin related sequence CRS4C-3c inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02955 GENEFORM Protein DME1315 XEOTICID XEO02955 MOACRIVE Inhibition DME1315 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1315 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02958 XEO_CLAS Peptide DME1315 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02958 GENEFORM Protein DME1315 XEOTICID XEO02958 MOACRIVE Inhibition DME1315 XEOTICID XEO02959 XEO_NAME Cryptdin related peptide CRS4C-1d DME1315 XEOTICID XEO02959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02959 XEO_CLAS Peptide DME1315 XEOTICID XEO02959 DESCRIPT Cryptdin related peptide CRS4C-1d inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02959 GENEFORM Protein DME1315 XEOTICID XEO02959 MOACRIVE Inhibition DME1315 XEOTICID XEO02960 XEO_NAME Cryptdin related peptide CRS4C-2 DME1315 XEOTICID XEO02960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02960 XEO_CLAS Peptide DME1315 XEOTICID XEO02960 DESCRIPT Cryptdin related peptide CRS4C-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02960 GENEFORM Protein DME1315 XEOTICID XEO02960 MOACRIVE Inhibition DME1315 XEOTICID XEO02961 XEO_NAME Cryptdin related peptide CRS4C-2b DME1315 XEOTICID XEO02961 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO02961 XEO_CLAS Peptide DME1315 XEOTICID XEO02961 DESCRIPT Cryptdin related peptide CRS4C-2b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO02961 GENEFORM Protein DME1315 XEOTICID XEO02961 MOACRIVE Inhibition DME1315 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1315 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03021 XEO_CLAS Peptide DME1315 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 1.25-2.50 microM) DME1315 XEOTICID XEO03021 GENEFORM Protein DME1315 XEOTICID XEO03021 MOACRIVE Inhibition DME1315 XEOTICID XEO03025 XEO_NAME Curvacin A DME1315 XEOTICID XEO03025 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03025 XEO_CLAS Peptide DME1315 XEOTICID XEO03025 DESCRIPT Curvacin A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO03025 GENEFORM Protein DME1315 XEOTICID XEO03025 MOACRIVE Inhibition DME1315 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1315 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03073 XEO_CLAS Peptide DME1315 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 16 ug/ml) DME1315 XEOTICID XEO03073 GENEFORM Protein DME1315 XEOTICID XEO03073 MOACRIVE Inhibition DME1315 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1315 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03082 XEO_CLAS Peptide DME1315 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO03082 GENEFORM Protein DME1315 XEOTICID XEO03082 MOACRIVE Inhibition DME1315 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1315 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03137 XEO_CLAS Peptide DME1315 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO03137 GENEFORM Protein DME1315 XEOTICID XEO03137 MOACRIVE Inhibition DME1315 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1315 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03146 XEO_CLAS Peptide DME1315 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 10 microM) DME1315 XEOTICID XEO03146 GENEFORM Protein DME1315 XEOTICID XEO03146 MOACRIVE Inhibition DME1315 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1315 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03147 XEO_CLAS Peptide DME1315 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 38 microM) DME1315 XEOTICID XEO03147 GENEFORM Protein DME1315 XEOTICID XEO03147 MOACRIVE Inhibition DME1315 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1315 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03148 XEO_CLAS Peptide DME1315 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 22 microM) DME1315 XEOTICID XEO03148 GENEFORM Protein DME1315 XEOTICID XEO03148 MOACRIVE Inhibition DME1315 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1315 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03149 XEO_CLAS Peptide DME1315 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 11 microM) DME1315 XEOTICID XEO03149 GENEFORM Protein DME1315 XEOTICID XEO03149 MOACRIVE Inhibition DME1315 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1315 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03197 XEO_CLAS Peptide DME1315 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 14.5 microM) DME1315 XEOTICID XEO03197 GENEFORM Protein DME1315 XEOTICID XEO03197 MOACRIVE Inhibition DME1315 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1315 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03250 XEO_CLAS Peptide DME1315 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO03250 GENEFORM Protein DME1315 XEOTICID XEO03250 MOACRIVE Inhibition DME1315 XEOTICID XEO03252 XEO_NAME Enterocin B DME1315 XEOTICID XEO03252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03252 XEO_CLAS Peptide DME1315 XEOTICID XEO03252 DESCRIPT Enterocin B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 0.0869 microM) DME1315 XEOTICID XEO03252 GENEFORM Protein DME1315 XEOTICID XEO03252 MOACRIVE Inhibition DME1315 XEOTICID XEO03254 XEO_NAME Enterocin EJ97 DME1315 XEOTICID XEO03254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03254 XEO_CLAS Peptide DME1315 XEOTICID XEO03254 DESCRIPT Enterocin EJ97 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 6 ug/ml) DME1315 XEOTICID XEO03254 GENEFORM Protein DME1315 XEOTICID XEO03254 MOACRIVE Inhibition DME1315 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1315 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03258 XEO_CLAS Peptide DME1315 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO03258 GENEFORM Protein DME1315 XEOTICID XEO03258 MOACRIVE Inhibition DME1315 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME1315 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03259 XEO_CLAS Peptide DME1315 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 0.0508 microM) DME1315 XEOTICID XEO03259 GENEFORM Protein DME1315 XEOTICID XEO03259 MOACRIVE Inhibition DME1315 XEOTICID XEO03260 XEO_NAME Enterocin X beta DME1315 XEOTICID XEO03260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03260 XEO_CLAS Peptide DME1315 XEOTICID XEO03260 DESCRIPT Enterocin X beta inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 0.813 microM) DME1315 XEOTICID XEO03260 GENEFORM Protein DME1315 XEOTICID XEO03260 MOACRIVE Inhibition DME1315 XEOTICID XEO03357 XEO_NAME Ethyl gallate DME1315 XEOTICID XEO03357 XEO_TYPE Pharmaceutical Agent(s) DME1315 XEOTICID XEO03357 XEO_CLAS Investigative Agent DME1315 XEOTICID XEO03357 DESCRIPT Ethyl gallate inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO03357 GENEFORM Protein DME1315 XEOTICID XEO03357 MOACRIVE Inhibition DME1315 XEOTICID XEO03381 XEO_NAME Fallaxidin 3.1 DME1315 XEOTICID XEO03381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03381 XEO_CLAS Peptide DME1315 XEOTICID XEO03381 DESCRIPT Fallaxidin 3.1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 100 microM) DME1315 XEOTICID XEO03381 GENEFORM Protein DME1315 XEOTICID XEO03381 MOACRIVE Inhibition DME1315 XEOTICID XEO03382 XEO_NAME Fallaxidin 3.2 DME1315 XEOTICID XEO03382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03382 XEO_CLAS Peptide DME1315 XEOTICID XEO03382 DESCRIPT Fallaxidin 3.2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 100 microM) DME1315 XEOTICID XEO03382 GENEFORM Protein DME1315 XEOTICID XEO03382 MOACRIVE Inhibition DME1315 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1315 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03428 XEO_CLAS Peptide DME1315 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 31 ug/ml) DME1315 XEOTICID XEO03428 GENEFORM Protein DME1315 XEOTICID XEO03428 MOACRIVE Inhibition DME1315 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1315 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03430 XEO_CLAS Peptide DME1315 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 31 ug/ml) DME1315 XEOTICID XEO03430 GENEFORM Protein DME1315 XEOTICID XEO03430 MOACRIVE Inhibition DME1315 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1315 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03434 XEO_CLAS Peptide DME1315 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 31 ug/ml) DME1315 XEOTICID XEO03434 GENEFORM Protein DME1315 XEOTICID XEO03434 MOACRIVE Inhibition DME1315 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1315 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03497 XEO_CLAS Peptide DME1315 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 6.2-12.5 microM) DME1315 XEOTICID XEO03497 GENEFORM Protein DME1315 XEOTICID XEO03497 MOACRIVE Inhibition DME1315 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1315 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03498 XEO_CLAS Peptide DME1315 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 6.2-12.5 microM) DME1315 XEOTICID XEO03498 GENEFORM Protein DME1315 XEOTICID XEO03498 MOACRIVE Inhibition DME1315 XEOTICID XEO03522 XEO_NAME Halocyntin DME1315 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03522 XEO_CLAS Peptide DME1315 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO03522 GENEFORM Protein DME1315 XEOTICID XEO03522 MOACRIVE Inhibition DME1315 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1315 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03540 XEO_CLAS Peptide DME1315 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 32 ug/ml) DME1315 XEOTICID XEO03540 GENEFORM Protein DME1315 XEOTICID XEO03540 MOACRIVE Inhibition DME1315 XEOTICID XEO03555 XEO_NAME Hexyl gallate DME1315 XEOTICID XEO03555 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1315 XEOTICID XEO03555 XEO_CLAS Chemical Compound DME1315 XEOTICID XEO03555 DESCRIPT Hexyl gallate inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO03555 GENEFORM Protein DME1315 XEOTICID XEO03555 MOACRIVE Inhibition DME1315 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1315 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03556 XEO_CLAS Peptide DME1315 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 32 ug/ml) DME1315 XEOTICID XEO03556 GENEFORM Protein DME1315 XEOTICID XEO03556 MOACRIVE Inhibition DME1315 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1315 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03557 XEO_CLAS Peptide DME1315 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 32 ug/ml) DME1315 XEOTICID XEO03557 GENEFORM Protein DME1315 XEOTICID XEO03557 MOACRIVE Inhibition DME1315 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1315 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03569 XEO_CLAS Peptide DME1315 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 300 microM) DME1315 XEOTICID XEO03569 GENEFORM Protein DME1315 XEOTICID XEO03569 MOACRIVE Inhibition DME1315 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1315 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03579 XEO_CLAS Peptide DME1315 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO03579 GENEFORM Protein DME1315 XEOTICID XEO03579 MOACRIVE Inhibition DME1315 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1315 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03588 XEO_CLAS Peptide DME1315 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 15 ug/ml) DME1315 XEOTICID XEO03588 GENEFORM Protein DME1315 XEOTICID XEO03588 MOACRIVE Inhibition DME1315 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1315 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03609 XEO_CLAS Peptide DME1315 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO03609 GENEFORM Protein DME1315 XEOTICID XEO03609 MOACRIVE Inhibition DME1315 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1315 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03616 XEO_CLAS Peptide DME1315 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 16 microM) DME1315 XEOTICID XEO03616 GENEFORM Protein DME1315 XEOTICID XEO03616 MOACRIVE Inhibition DME1315 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1315 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03675 XEO_CLAS Peptide DME1315 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 60 microM) DME1315 XEOTICID XEO03675 GENEFORM Protein DME1315 XEOTICID XEO03675 MOACRIVE Inhibition DME1315 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1315 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03684 XEO_CLAS Peptide DME1315 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 125 ug/ml) DME1315 XEOTICID XEO03684 GENEFORM Protein DME1315 XEOTICID XEO03684 MOACRIVE Inhibition DME1315 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1315 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03697 XEO_CLAS Peptide DME1315 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 12.5 microM) DME1315 XEOTICID XEO03697 GENEFORM Protein DME1315 XEOTICID XEO03697 MOACRIVE Inhibition DME1315 XEOTICID XEO03768 XEO_NAME Lactacin-F subunit LafA DME1315 XEOTICID XEO03768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03768 XEO_CLAS Peptide DME1315 XEOTICID XEO03768 DESCRIPT Lactacin-F subunit LafA inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO03768 GENEFORM Protein DME1315 XEOTICID XEO03768 MOACRIVE Inhibition DME1315 XEOTICID XEO03769 XEO_NAME Lactacin-F subunit LafX DME1315 XEOTICID XEO03769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03769 XEO_CLAS Peptide DME1315 XEOTICID XEO03769 DESCRIPT Lactacin-F subunit LafX inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO03769 GENEFORM Protein DME1315 XEOTICID XEO03769 MOACRIVE Inhibition DME1315 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1315 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03771 XEO_CLAS Peptide DME1315 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO03771 GENEFORM Protein DME1315 XEOTICID XEO03771 MOACRIVE Inhibition DME1315 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1315 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03793 XEO_CLAS Peptide DME1315 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 32 microM) DME1315 XEOTICID XEO03793 GENEFORM Protein DME1315 XEOTICID XEO03793 MOACRIVE Inhibition DME1315 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1315 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03854 XEO_CLAS Peptide DME1315 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 5.20 microM) DME1315 XEOTICID XEO03854 GENEFORM Protein DME1315 XEOTICID XEO03854 MOACRIVE Inhibition DME1315 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1315 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03855 XEO_CLAS Peptide DME1315 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 4.10 microM) DME1315 XEOTICID XEO03855 GENEFORM Protein DME1315 XEOTICID XEO03855 MOACRIVE Inhibition DME1315 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1315 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03873 XEO_CLAS Peptide DME1315 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 30 microM) DME1315 XEOTICID XEO03873 GENEFORM Protein DME1315 XEOTICID XEO03873 MOACRIVE Inhibition DME1315 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1315 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03874 XEO_CLAS Peptide DME1315 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 22.5 microM) DME1315 XEOTICID XEO03874 GENEFORM Protein DME1315 XEOTICID XEO03874 MOACRIVE Inhibition DME1315 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1315 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03875 XEO_CLAS Peptide DME1315 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 22.5 microM) DME1315 XEOTICID XEO03875 GENEFORM Protein DME1315 XEOTICID XEO03875 MOACRIVE Inhibition DME1315 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1315 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03876 XEO_CLAS Peptide DME1315 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 15 microM) DME1315 XEOTICID XEO03876 GENEFORM Protein DME1315 XEOTICID XEO03876 MOACRIVE Inhibition DME1315 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1315 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03877 XEO_CLAS Peptide DME1315 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 11.25 microM) DME1315 XEOTICID XEO03877 GENEFORM Protein DME1315 XEOTICID XEO03877 MOACRIVE Inhibition DME1315 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1315 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03878 XEO_CLAS Peptide DME1315 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 22.5 microM) DME1315 XEOTICID XEO03878 GENEFORM Protein DME1315 XEOTICID XEO03878 MOACRIVE Inhibition DME1315 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1315 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03904 XEO_CLAS Peptide DME1315 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 4 ug/ml) DME1315 XEOTICID XEO03904 GENEFORM Protein DME1315 XEOTICID XEO03904 MOACRIVE Inhibition DME1315 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1315 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03905 XEO_CLAS Peptide DME1315 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 16 ug/ml) DME1315 XEOTICID XEO03905 GENEFORM Protein DME1315 XEOTICID XEO03905 MOACRIVE Inhibition DME1315 XEOTICID XEO03986 XEO_NAME Magainin-I peptide DME1315 XEOTICID XEO03986 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO03986 XEO_CLAS Peptide DME1315 XEOTICID XEO03986 DESCRIPT Magainin-I peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO03986 GENEFORM Protein DME1315 XEOTICID XEO03986 MOACRIVE Inhibition DME1315 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1315 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04001 XEO_CLAS Peptide DME1315 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 25 microM) DME1315 XEOTICID XEO04001 GENEFORM Protein DME1315 XEOTICID XEO04001 MOACRIVE Inhibition DME1315 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1315 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04051 XEO_CLAS Peptide DME1315 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 2.50-5.00 microM) DME1315 XEOTICID XEO04051 GENEFORM Protein DME1315 XEOTICID XEO04051 MOACRIVE Inhibition DME1315 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1315 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04052 XEO_CLAS Peptide DME1315 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04052 GENEFORM Protein DME1315 XEOTICID XEO04052 MOACRIVE Inhibition DME1315 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1315 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04053 XEO_CLAS Peptide DME1315 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 1.25-2.50 microM) DME1315 XEOTICID XEO04053 GENEFORM Protein DME1315 XEOTICID XEO04053 MOACRIVE Inhibition DME1315 XEOTICID XEO04106 XEO_NAME Methyl gallate DME1315 XEOTICID XEO04106 XEO_TYPE Pharmaceutical Agent(s) DME1315 XEOTICID XEO04106 XEO_CLAS Investigative Agent DME1315 XEOTICID XEO04106 DESCRIPT Methyl gallate inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04106 GENEFORM Protein DME1315 XEOTICID XEO04106 MOACRIVE Inhibition DME1315 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1315 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04118 XEO_CLAS Peptide DME1315 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 300 microM) DME1315 XEOTICID XEO04118 GENEFORM Protein DME1315 XEOTICID XEO04118 MOACRIVE Inhibition DME1315 XEOTICID XEO04150 XEO_NAME Mundticin ATO6 DME1315 XEOTICID XEO04150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04150 XEO_CLAS Peptide DME1315 XEOTICID XEO04150 DESCRIPT Mundticin ATO6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04150 GENEFORM Protein DME1315 XEOTICID XEO04150 MOACRIVE Inhibition DME1315 XEOTICID XEO04151 XEO_NAME Mundticin KS DME1315 XEOTICID XEO04151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04151 XEO_CLAS Peptide DME1315 XEOTICID XEO04151 DESCRIPT Mundticin KS inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04151 GENEFORM Protein DME1315 XEOTICID XEO04151 MOACRIVE Inhibition DME1315 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1315 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04169 XEO_CLAS Peptide DME1315 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04169 GENEFORM Protein DME1315 XEOTICID XEO04169 MOACRIVE Inhibition DME1315 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1315 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04249 XEO_CLAS Peptide DME1315 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 500 ug/ml) DME1315 XEOTICID XEO04249 GENEFORM Protein DME1315 XEOTICID XEO04249 MOACRIVE Inhibition DME1315 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1315 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04259 XEO_CLAS Peptide DME1315 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04259 GENEFORM Protein DME1315 XEOTICID XEO04259 MOACRIVE Inhibition DME1315 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1315 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04261 XEO_CLAS Peptide DME1315 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04261 GENEFORM Protein DME1315 XEOTICID XEO04261 MOACRIVE Inhibition DME1315 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1315 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04265 XEO_CLAS Peptide DME1315 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04265 GENEFORM Protein DME1315 XEOTICID XEO04265 MOACRIVE Inhibition DME1315 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1315 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04268 XEO_CLAS Peptide DME1315 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04268 GENEFORM Protein DME1315 XEOTICID XEO04268 MOACRIVE Inhibition DME1315 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1315 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04399 XEO_CLAS Peptide DME1315 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 12.5 microM) DME1315 XEOTICID XEO04399 GENEFORM Protein DME1315 XEOTICID XEO04399 MOACRIVE Inhibition DME1315 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1315 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04444 XEO_CLAS Peptide DME1315 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 20 microM) DME1315 XEOTICID XEO04444 GENEFORM Protein DME1315 XEOTICID XEO04444 MOACRIVE Inhibition DME1315 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1315 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04461 XEO_CLAS Peptide DME1315 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 1.3 microM) DME1315 XEOTICID XEO04461 GENEFORM Protein DME1315 XEOTICID XEO04461 MOACRIVE Inhibition DME1315 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1315 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04462 XEO_CLAS Peptide DME1315 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 2.4 microM) DME1315 XEOTICID XEO04462 GENEFORM Protein DME1315 XEOTICID XEO04462 MOACRIVE Inhibition DME1315 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1315 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04463 XEO_CLAS Peptide DME1315 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04463 GENEFORM Protein DME1315 XEOTICID XEO04463 MOACRIVE Inhibition DME1315 XEOTICID XEO04468 XEO_NAME Papillosin DME1315 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04468 XEO_CLAS Peptide DME1315 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04468 GENEFORM Protein DME1315 XEOTICID XEO04468 MOACRIVE Inhibition DME1315 XEOTICID XEO04521 XEO_NAME Penocin A DME1315 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04521 XEO_CLAS Peptide DME1315 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04521 GENEFORM Protein DME1315 XEOTICID XEO04521 MOACRIVE Inhibition DME1315 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1315 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04569 XEO_CLAS Peptide DME1315 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 4.0 microM) DME1315 XEOTICID XEO04569 GENEFORM Protein DME1315 XEOTICID XEO04569 MOACRIVE Inhibition DME1315 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1315 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04612 XEO_CLAS Peptide DME1315 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 5-10 microM) DME1315 XEOTICID XEO04612 GENEFORM Protein DME1315 XEOTICID XEO04612 MOACRIVE Inhibition DME1315 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1315 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04613 XEO_CLAS Peptide DME1315 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 5-10 microM) DME1315 XEOTICID XEO04613 GENEFORM Protein DME1315 XEOTICID XEO04613 MOACRIVE Inhibition DME1315 XEOTICID XEO04622 XEO_NAME Plantaricin W alpha DME1315 XEOTICID XEO04622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04622 XEO_CLAS Peptide DME1315 XEOTICID XEO04622 DESCRIPT Plantaricin W alpha inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04622 GENEFORM Protein DME1315 XEOTICID XEO04622 MOACRIVE Inhibition DME1315 XEOTICID XEO04623 XEO_NAME Plantaricin W beta DME1315 XEOTICID XEO04623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04623 XEO_CLAS Peptide DME1315 XEOTICID XEO04623 DESCRIPT Plantaricin W beta inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04623 GENEFORM Protein DME1315 XEOTICID XEO04623 MOACRIVE Inhibition DME1315 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1315 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04657 XEO_CLAS Peptide DME1315 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 300 microM) DME1315 XEOTICID XEO04657 GENEFORM Protein DME1315 XEOTICID XEO04657 MOACRIVE Inhibition DME1315 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1315 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04660 XEO_CLAS Peptide DME1315 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 2 ug/ml) DME1315 XEOTICID XEO04660 GENEFORM Protein DME1315 XEOTICID XEO04660 MOACRIVE Inhibition DME1315 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1315 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04680 XEO_CLAS Peptide DME1315 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 1-2 microM) DME1315 XEOTICID XEO04680 GENEFORM Protein DME1315 XEOTICID XEO04680 MOACRIVE Inhibition DME1315 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1315 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04690 XEO_CLAS Peptide DME1315 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 1 ug/ml) DME1315 XEOTICID XEO04690 GENEFORM Protein DME1315 XEOTICID XEO04690 MOACRIVE Inhibition DME1315 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1315 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04695 XEO_CLAS Peptide DME1315 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04695 GENEFORM Protein DME1315 XEOTICID XEO04695 MOACRIVE Inhibition DME1315 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1315 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04696 XEO_CLAS Peptide DME1315 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04696 GENEFORM Protein DME1315 XEOTICID XEO04696 MOACRIVE Inhibition DME1315 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1315 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04699 XEO_CLAS Peptide DME1315 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04699 GENEFORM Protein DME1315 XEOTICID XEO04699 MOACRIVE Inhibition DME1315 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1315 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04700 XEO_CLAS Peptide DME1315 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04700 GENEFORM Protein DME1315 XEOTICID XEO04700 MOACRIVE Inhibition DME1315 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1315 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04701 XEO_CLAS Peptide DME1315 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04701 GENEFORM Protein DME1315 XEOTICID XEO04701 MOACRIVE Inhibition DME1315 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1315 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04702 XEO_CLAS Peptide DME1315 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04702 GENEFORM Protein DME1315 XEOTICID XEO04702 MOACRIVE Inhibition DME1315 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1315 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04703 XEO_CLAS Peptide DME1315 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04703 GENEFORM Protein DME1315 XEOTICID XEO04703 MOACRIVE Inhibition DME1315 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1315 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04704 XEO_CLAS Peptide DME1315 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04704 GENEFORM Protein DME1315 XEOTICID XEO04704 MOACRIVE Inhibition DME1315 XEOTICID XEO04727 XEO_NAME Propyl gallate DME1315 XEOTICID XEO04727 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1315 XEOTICID XEO04727 XEO_CLAS Food Additive DME1315 XEOTICID XEO04727 DESCRIPT Propyl gallate inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04727 GENEFORM Protein DME1315 XEOTICID XEO04727 MOACRIVE Inhibition DME1315 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1315 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04783 XEO_CLAS Peptide DME1315 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 8 ug/ml) DME1315 XEOTICID XEO04783 GENEFORM Protein DME1315 XEOTICID XEO04783 MOACRIVE Inhibition DME1315 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1315 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04784 XEO_CLAS Peptide DME1315 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 16 ug/ml) DME1315 XEOTICID XEO04784 GENEFORM Protein DME1315 XEOTICID XEO04784 MOACRIVE Inhibition DME1315 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1315 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04785 XEO_CLAS Peptide DME1315 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 8 ug/ml) DME1315 XEOTICID XEO04785 GENEFORM Protein DME1315 XEOTICID XEO04785 MOACRIVE Inhibition DME1315 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1315 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04786 XEO_CLAS Peptide DME1315 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 125 ug/ml) DME1315 XEOTICID XEO04786 GENEFORM Protein DME1315 XEOTICID XEO04786 MOACRIVE Inhibition DME1315 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1315 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04809 XEO_CLAS Peptide DME1315 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 40 microM) DME1315 XEOTICID XEO04809 GENEFORM Protein DME1315 XEOTICID XEO04809 MOACRIVE Inhibition DME1315 XEOTICID XEO04863 XEO_NAME RTD peptide DME1315 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04863 XEO_CLAS Peptide DME1315 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 1.2 microM) DME1315 XEOTICID XEO04863 GENEFORM Protein DME1315 XEOTICID XEO04863 MOACRIVE Inhibition DME1315 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1315 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04880 XEO_CLAS Peptide DME1315 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 12.7 ug/ml) DME1315 XEOTICID XEO04880 GENEFORM Protein DME1315 XEOTICID XEO04880 MOACRIVE Inhibition DME1315 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1315 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04886 XEO_CLAS Peptide DME1315 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 12.7 ug/ml) DME1315 XEOTICID XEO04886 GENEFORM Protein DME1315 XEOTICID XEO04886 MOACRIVE Inhibition DME1315 XEOTICID XEO04896 XEO_NAME Sakacin 5X DME1315 XEOTICID XEO04896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04896 XEO_CLAS Peptide DME1315 XEOTICID XEO04896 DESCRIPT Sakacin 5X inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04896 GENEFORM Protein DME1315 XEOTICID XEO04896 MOACRIVE Inhibition DME1315 XEOTICID XEO04898 XEO_NAME Sakacin P DME1315 XEOTICID XEO04898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04898 XEO_CLAS Peptide DME1315 XEOTICID XEO04898 DESCRIPT Sakacin P inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04898 GENEFORM Protein DME1315 XEOTICID XEO04898 MOACRIVE Inhibition DME1315 XEOTICID XEO04936 XEO_NAME Siamycin I DME1315 XEOTICID XEO04936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04936 XEO_CLAS Peptide DME1315 XEOTICID XEO04936 DESCRIPT Siamycin I inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO04936 GENEFORM Protein DME1315 XEOTICID XEO04936 MOACRIVE Inhibition DME1315 XEOTICID XEO04937 XEO_NAME Signiferin-2.1 DME1315 XEOTICID XEO04937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04937 XEO_CLAS Peptide DME1315 XEOTICID XEO04937 DESCRIPT Signiferin-2.1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 100 microM) DME1315 XEOTICID XEO04937 GENEFORM Protein DME1315 XEOTICID XEO04937 MOACRIVE Inhibition DME1315 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1315 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04950 XEO_CLAS Peptide DME1315 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 10 ug/ml) DME1315 XEOTICID XEO04950 GENEFORM Protein DME1315 XEOTICID XEO04950 MOACRIVE Inhibition DME1315 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1315 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04995 XEO_CLAS Peptide DME1315 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 0.78-1.56 microM) DME1315 XEOTICID XEO04995 GENEFORM Protein DME1315 XEOTICID XEO04995 MOACRIVE Inhibition DME1315 XEOTICID XEO04998 XEO_NAME Styelin A DME1315 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04998 XEO_CLAS Peptide DME1315 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 2 ug/ml) DME1315 XEOTICID XEO04998 GENEFORM Protein DME1315 XEOTICID XEO04998 MOACRIVE Inhibition DME1315 XEOTICID XEO04999 XEO_NAME Styelin B DME1315 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO04999 XEO_CLAS Peptide DME1315 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 2 ug/ml) DME1315 XEOTICID XEO04999 GENEFORM Protein DME1315 XEOTICID XEO04999 MOACRIVE Inhibition DME1315 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1315 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05000 XEO_CLAS Peptide DME1315 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 4 ug/ml) DME1315 XEOTICID XEO05000 GENEFORM Protein DME1315 XEOTICID XEO05000 MOACRIVE Inhibition DME1315 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1315 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05001 XEO_CLAS Peptide DME1315 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 4 ug/ml) DME1315 XEOTICID XEO05001 GENEFORM Protein DME1315 XEOTICID XEO05001 MOACRIVE Inhibition DME1315 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1315 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05002 XEO_CLAS Peptide DME1315 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 2 ug/ml) DME1315 XEOTICID XEO05002 GENEFORM Protein DME1315 XEOTICID XEO05002 MOACRIVE Inhibition DME1315 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1315 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05003 XEO_CLAS Peptide DME1315 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 8 ug/ml) DME1315 XEOTICID XEO05003 GENEFORM Protein DME1315 XEOTICID XEO05003 MOACRIVE Inhibition DME1315 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1315 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05005 XEO_CLAS Peptide DME1315 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO05005 GENEFORM Protein DME1315 XEOTICID XEO05005 MOACRIVE Inhibition DME1315 XEOTICID XEO05006 XEO_NAME Substance P DME1315 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05006 XEO_CLAS Peptide DME1315 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO05006 GENEFORM Protein DME1315 XEOTICID XEO05006 MOACRIVE Inhibition DME1315 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1315 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05007 XEO_CLAS Peptide DME1315 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO05007 GENEFORM Protein DME1315 XEOTICID XEO05007 MOACRIVE Inhibition DME1315 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1315 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05063 XEO_CLAS Peptide DME1315 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 10 microM) DME1315 XEOTICID XEO05063 GENEFORM Protein DME1315 XEOTICID XEO05063 MOACRIVE Inhibition DME1315 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1315 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05064 XEO_CLAS Peptide DME1315 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 116 microM) DME1315 XEOTICID XEO05064 GENEFORM Protein DME1315 XEOTICID XEO05064 MOACRIVE Inhibition DME1315 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1315 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05065 XEO_CLAS Peptide DME1315 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC > 80 ug/ml) DME1315 XEOTICID XEO05065 GENEFORM Protein DME1315 XEOTICID XEO05065 MOACRIVE Inhibition DME1315 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1315 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05073 XEO_CLAS Peptide DME1315 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 40 microM) DME1315 XEOTICID XEO05073 GENEFORM Protein DME1315 XEOTICID XEO05073 MOACRIVE Inhibition DME1315 XEOTICID XEO05074 XEO_NAME Temporin-1Vb DME1315 XEOTICID XEO05074 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05074 XEO_CLAS Peptide DME1315 XEOTICID XEO05074 DESCRIPT Temporin-1Vb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 20 microM) DME1315 XEOTICID XEO05074 GENEFORM Protein DME1315 XEOTICID XEO05074 MOACRIVE Inhibition DME1315 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1315 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05075 XEO_CLAS Peptide DME1315 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 40 microM) DME1315 XEOTICID XEO05075 GENEFORM Protein DME1315 XEOTICID XEO05075 MOACRIVE Inhibition DME1315 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1315 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05097 XEO_CLAS Peptide DME1315 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 8.0 microM) DME1315 XEOTICID XEO05097 GENEFORM Protein DME1315 XEOTICID XEO05097 MOACRIVE Inhibition DME1315 XEOTICID XEO05098 XEO_NAME Temporin-PEa DME1315 XEOTICID XEO05098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05098 XEO_CLAS Peptide DME1315 XEOTICID XEO05098 DESCRIPT Temporin-PEa inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 2.0 microM) DME1315 XEOTICID XEO05098 GENEFORM Protein DME1315 XEOTICID XEO05098 MOACRIVE Inhibition DME1315 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1315 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05099 XEO_CLAS Peptide DME1315 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 2.0 microM) DME1315 XEOTICID XEO05099 GENEFORM Protein DME1315 XEOTICID XEO05099 MOACRIVE Inhibition DME1315 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1315 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05170 XEO_CLAS Peptide DME1315 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 1.0 microM) DME1315 XEOTICID XEO05170 GENEFORM Protein DME1315 XEOTICID XEO05170 MOACRIVE Inhibition DME1315 XEOTICID XEO05196 XEO_NAME Ubericin-A DME1315 XEOTICID XEO05196 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05196 XEO_CLAS Peptide DME1315 XEOTICID XEO05196 DESCRIPT Ubericin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO05196 GENEFORM Protein DME1315 XEOTICID XEO05196 MOACRIVE Inhibition DME1315 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1315 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05212 XEO_CLAS Peptide DME1315 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 50.8 ug/ml) DME1315 XEOTICID XEO05212 GENEFORM Protein DME1315 XEOTICID XEO05212 MOACRIVE Inhibition DME1315 XEOTICID XEO05224 XEO_NAME Vancomycin DME1315 XEOTICID XEO05224 XEO_TYPE Pharmaceutical Agent(s) DME1315 XEOTICID XEO05224 XEO_CLAS Approved/Marketed Drug DME1315 XEOTICID XEO05224 DESCRIPT Vancomycin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO05224 GENEFORM Protein DME1315 XEOTICID XEO05224 MOACRIVE Inhibition DME1315 XEOTICID XEO05228 XEO_NAME Variacin DME1315 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05228 XEO_CLAS Peptide DME1315 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO05228 GENEFORM Protein DME1315 XEOTICID XEO05228 MOACRIVE Inhibition DME1315 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1315 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05264 XEO_CLAS Peptide DME1315 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 4 ug/ml) DME1315 XEOTICID XEO05264 GENEFORM Protein DME1315 XEOTICID XEO05264 MOACRIVE Inhibition DME1315 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1315 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05267 XEO_CLAS Peptide DME1315 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis (MIC = 2 ug/ml) DME1315 XEOTICID XEO05267 GENEFORM Protein DME1315 XEOTICID XEO05267 MOACRIVE Inhibition DME1315 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1315 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1315 XEOTICID XEO05283 XEO_CLAS Peptide DME1315 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecalis DME1315 XEOTICID XEO05283 GENEFORM Protein DME1315 XEOTICID XEO05283 MOACRIVE Inhibition DME1316 DME___ID DME1316 DME1316 DME_NAME Azoreductase (azoR) DME1316 SPESNAME Clostridium perfringens DME1316 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1316 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1316 XEOTICID XEO02378 XEO_CLAS Peptide DME1316 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Clostridium perfringens (MIC = 0.7 ug/ml) DME1316 XEOTICID XEO02378 GENEFORM Protein DME1316 XEOTICID XEO02378 MOACRIVE Inhibition DME1316 XEOTICID XEO02720 XEO_NAME Carnobacteriocin-A DME1316 XEOTICID XEO02720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1316 XEOTICID XEO02720 XEO_CLAS Peptide DME1316 XEOTICID XEO02720 DESCRIPT Carnobacteriocin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Clostridium perfringens DME1316 XEOTICID XEO02720 GENEFORM Protein DME1316 XEOTICID XEO02720 MOACRIVE Inhibition DME1316 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1316 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1316 XEOTICID XEO03540 XEO_CLAS Peptide DME1316 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Clostridium perfringens DME1316 XEOTICID XEO03540 GENEFORM Protein DME1316 XEOTICID XEO03540 MOACRIVE Inhibition DME1316 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1316 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1316 XEOTICID XEO03556 XEO_CLAS Peptide DME1316 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Clostridium perfringens (MIC = 4-32 ug/ml) DME1316 XEOTICID XEO03556 GENEFORM Protein DME1316 XEOTICID XEO03556 MOACRIVE Inhibition DME1316 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1316 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1316 XEOTICID XEO03557 XEO_CLAS Peptide DME1316 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Clostridium perfringens (MIC = 4-32 ug/ml) DME1316 XEOTICID XEO03557 GENEFORM Protein DME1316 XEOTICID XEO03557 MOACRIVE Inhibition DME1317 DME___ID DME1317 DME1317 DME_NAME Alcohol dehydrogenase (ADH) DME1317 SPESNAME Lactobacillus reuteri DME1317 XEOTICID XEO03473 XEO_NAME Garvicin ML DME1317 XEOTICID XEO03473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1317 XEOTICID XEO03473 XEO_CLAS Peptide DME1317 XEOTICID XEO03473 DESCRIPT Garvicin ML inhibits the drug-metabolizing activity of Alcohol dehydrogenase (ADH) from Lactobacillus reuteri DME1317 XEOTICID XEO03473 GENEFORM Protein DME1317 XEOTICID XEO03473 MOACRIVE Inhibition DME1317 XEOTICID XEO04319 XEO_NAME Nisin F DME1317 XEOTICID XEO04319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1317 XEOTICID XEO04319 XEO_CLAS Peptide DME1317 XEOTICID XEO04319 DESCRIPT Nisin F inhibits the drug-metabolizing activity of Alcohol dehydrogenase (ADH) from Lactobacillus reuteri DME1317 XEOTICID XEO04319 GENEFORM Protein DME1317 XEOTICID XEO04319 MOACRIVE Inhibition DME1328 DME___ID DME1328 DME1328 DME_NAME Nitroreductase (NTR) DME1328 SPESNAME Enterococcus gallinarum DME1328 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1328 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1328 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1328 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterococcus gallinarum DME1328 XEOTICID XEO01961 GENEFORM Protein DME1328 XEOTICID XEO01961 MOACRIVE Inhibition DME1328 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1328 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1328 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1328 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Enterococcus gallinarum DME1328 XEOTICID XEO01966 GENEFORM Protein DME1328 XEOTICID XEO01966 MOACRIVE Inhibition DME1331 DME___ID DME1331 DME1331 DME_NAME Nitroreductase (NTR) DME1331 SPESNAME Clostridium sporogenes DME1331 XEOTICID XEO02126 XEO_NAME Acidocin A DME1331 XEOTICID XEO02126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1331 XEOTICID XEO02126 XEO_CLAS Peptide DME1331 XEOTICID XEO02126 DESCRIPT Acidocin A inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Clostridium sporogenes DME1331 XEOTICID XEO02126 GENEFORM Protein DME1331 XEOTICID XEO02126 MOACRIVE Inhibition DME1331 XEOTICID XEO02127 XEO_NAME Acidocin B DME1331 XEOTICID XEO02127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1331 XEOTICID XEO02127 XEO_CLAS Peptide DME1331 XEOTICID XEO02127 DESCRIPT Acidocin B inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Clostridium sporogenes DME1331 XEOTICID XEO02127 GENEFORM Protein DME1331 XEOTICID XEO02127 MOACRIVE Inhibition DME1331 XEOTICID XEO03257 XEO_NAME Enterocin P DME1331 XEOTICID XEO03257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1331 XEOTICID XEO03257 XEO_CLAS Peptide DME1331 XEOTICID XEO03257 DESCRIPT Enterocin P inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Clostridium sporogenes (MIC = 0.004 ug/ml) DME1331 XEOTICID XEO03257 GENEFORM Protein DME1331 XEOTICID XEO03257 MOACRIVE Inhibition DME1331 XEOTICID XEO03806 XEO_NAME Lantibiotic paenibacillin DME1331 XEOTICID XEO03806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1331 XEOTICID XEO03806 XEO_CLAS Peptide DME1331 XEOTICID XEO03806 DESCRIPT Lantibiotic paenibacillin inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Clostridium sporogenes DME1331 XEOTICID XEO03806 GENEFORM Protein DME1331 XEOTICID XEO03806 MOACRIVE Inhibition DME1331 XEOTICID XEO04156 XEO_NAME Mutacin II mutacin H-29B DME1331 XEOTICID XEO04156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1331 XEOTICID XEO04156 XEO_CLAS Peptide DME1331 XEOTICID XEO04156 DESCRIPT Mutacin II mutacin H-29B inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Clostridium sporogenes DME1331 XEOTICID XEO04156 GENEFORM Protein DME1331 XEOTICID XEO04156 MOACRIVE Inhibition DME1332 DME___ID DME1332 DME1332 DME_NAME Beta-lactamase (blaB) DME1332 SPESNAME Burkholderia cepacia DME1332 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1332 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1332 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1332 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cepacia DME1332 XEOTICID XEO00117 GENEFORM Protein DME1332 XEOTICID XEO00117 MOACRIVE Inhibition DME1332 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1332 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1332 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1332 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cepacia DME1332 XEOTICID XEO00460 GENEFORM Protein DME1332 XEOTICID XEO00460 MOACRIVE Inhibition DME1332 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1332 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1332 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1332 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cepacia DME1332 XEOTICID XEO00511 GENEFORM Protein DME1332 XEOTICID XEO00511 MOACRIVE Inhibition DME1332 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1332 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1332 XEOTICID XEO02443 XEO_CLAS Peptide DME1332 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cepacia DME1332 XEOTICID XEO02443 GENEFORM Protein DME1332 XEOTICID XEO02443 MOACRIVE Inhibition DME1332 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1332 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1332 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1332 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cepacia DME1332 XEOTICID XEO02714 GENEFORM Protein DME1332 XEOTICID XEO02714 MOACRIVE Inhibition DME1332 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1332 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1332 XEOTICID XEO03127 XEO_CLAS Peptide DME1332 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cepacia DME1332 XEOTICID XEO03127 GENEFORM Protein DME1332 XEOTICID XEO03127 MOACRIVE Inhibition DME1332 XEOTICID XEO03164 XEO_NAME Dermatoxin DME1332 XEOTICID XEO03164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1332 XEOTICID XEO03164 XEO_CLAS Peptide DME1332 XEOTICID XEO03164 DESCRIPT Dermatoxin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cepacia DME1332 XEOTICID XEO03164 GENEFORM Protein DME1332 XEOTICID XEO03164 MOACRIVE Inhibition DME1332 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1332 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1332 XEOTICID XEO03609 XEO_CLAS Peptide DME1332 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cepacia DME1332 XEOTICID XEO03609 GENEFORM Protein DME1332 XEOTICID XEO03609 MOACRIVE Inhibition DME1332 XEOTICID XEO04240 XEO_NAME NCP-0 peptide DME1332 XEOTICID XEO04240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1332 XEOTICID XEO04240 XEO_CLAS Peptide DME1332 XEOTICID XEO04240 DESCRIPT NCP-0 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cepacia DME1332 XEOTICID XEO04240 GENEFORM Protein DME1332 XEOTICID XEO04240 MOACRIVE Inhibition DME1332 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1332 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1332 XEOTICID XEO04241 XEO_CLAS Peptide DME1332 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cepacia DME1332 XEOTICID XEO04241 GENEFORM Protein DME1332 XEOTICID XEO04241 MOACRIVE Inhibition DME1332 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1332 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1332 XEOTICID XEO04242 XEO_CLAS Peptide DME1332 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cepacia DME1332 XEOTICID XEO04242 GENEFORM Protein DME1332 XEOTICID XEO04242 MOACRIVE Inhibition DME1332 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1332 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1332 XEOTICID XEO04612 XEO_CLAS Peptide DME1332 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cepacia (MIC > 20 microM) DME1332 XEOTICID XEO04612 GENEFORM Protein DME1332 XEOTICID XEO04612 MOACRIVE Inhibition DME1332 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1332 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1332 XEOTICID XEO04613 XEO_CLAS Peptide DME1332 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia cepacia (MIC > 20 microM) DME1332 XEOTICID XEO04613 GENEFORM Protein DME1332 XEOTICID XEO04613 MOACRIVE Inhibition DME1338 DME___ID DME1338 DME1338 DME_NAME Linoleate 10-hydratase (10-LAH) DME1338 SPESNAME Lactobacillus plantarum DME1338 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1338 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO02298 XEO_CLAS Peptide DME1338 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum (MIC = 32 ug/ml) DME1338 XEOTICID XEO02298 GENEFORM Protein DME1338 XEOTICID XEO02298 MOACRIVE Inhibition DME1338 XEOTICID XEO02375 XEO_NAME Bacteriocin curvaticin DME1338 XEOTICID XEO02375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO02375 XEO_CLAS Peptide DME1338 XEOTICID XEO02375 DESCRIPT Bacteriocin curvaticin inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO02375 GENEFORM Protein DME1338 XEOTICID XEO02375 MOACRIVE Inhibition DME1338 XEOTICID XEO02382 XEO_NAME Bacteriocin plantarican ASM1 DME1338 XEOTICID XEO02382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO02382 XEO_CLAS Peptide DME1338 XEOTICID XEO02382 DESCRIPT Bacteriocin plantarican ASM1 inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO02382 GENEFORM Protein DME1338 XEOTICID XEO02382 MOACRIVE Inhibition DME1338 XEOTICID XEO02718 XEO_NAME Carnobacteriocin CbnB2 DME1338 XEOTICID XEO02718 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO02718 XEO_CLAS Peptide DME1338 XEOTICID XEO02718 DESCRIPT Carnobacteriocin CbnB2 inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO02718 GENEFORM Protein DME1338 XEOTICID XEO02718 MOACRIVE Inhibition DME1338 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1338 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO03250 XEO_CLAS Peptide DME1338 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO03250 GENEFORM Protein DME1338 XEOTICID XEO03250 MOACRIVE Inhibition DME1338 XEOTICID XEO03252 XEO_NAME Enterocin B DME1338 XEOTICID XEO03252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO03252 XEO_CLAS Peptide DME1338 XEOTICID XEO03252 DESCRIPT Enterocin B inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum (MIC = 0.0869 microM) DME1338 XEOTICID XEO03252 GENEFORM Protein DME1338 XEOTICID XEO03252 MOACRIVE Inhibition DME1338 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME1338 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO03259 XEO_CLAS Peptide DME1338 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum (MIC = 0.102 microM) DME1338 XEOTICID XEO03259 GENEFORM Protein DME1338 XEOTICID XEO03259 MOACRIVE Inhibition DME1338 XEOTICID XEO03260 XEO_NAME Enterocin X beta DME1338 XEOTICID XEO03260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO03260 XEO_CLAS Peptide DME1338 XEOTICID XEO03260 DESCRIPT Enterocin X beta inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum (MIC = 0.813 microM) DME1338 XEOTICID XEO03260 GENEFORM Protein DME1338 XEOTICID XEO03260 MOACRIVE Inhibition DME1338 XEOTICID XEO03474 XEO_NAME Garvieacin Q DME1338 XEOTICID XEO03474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO03474 XEO_CLAS Peptide DME1338 XEOTICID XEO03474 DESCRIPT Garvieacin Q inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO03474 GENEFORM Protein DME1338 XEOTICID XEO03474 MOACRIVE Inhibition DME1338 XEOTICID XEO03493 XEO_NAME Glycocin F DME1338 XEOTICID XEO03493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO03493 XEO_CLAS Peptide DME1338 XEOTICID XEO03493 DESCRIPT Glycocin F inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO03493 GENEFORM Protein DME1338 XEOTICID XEO03493 MOACRIVE Inhibition DME1338 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1338 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO03854 XEO_CLAS Peptide DME1338 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum (MIC = 2.60 microM) DME1338 XEOTICID XEO03854 GENEFORM Protein DME1338 XEOTICID XEO03854 MOACRIVE Inhibition DME1338 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1338 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO03855 XEO_CLAS Peptide DME1338 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum (MIC = 4.10 microM) DME1338 XEOTICID XEO03855 GENEFORM Protein DME1338 XEOTICID XEO03855 MOACRIVE Inhibition DME1338 XEOTICID XEO03967 XEO_NAME Bacteriocin LSEI_2163 DME1338 XEOTICID XEO03967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO03967 XEO_CLAS Peptide DME1338 XEOTICID XEO03967 DESCRIPT Bacteriocin LSEI_2163 inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO03967 GENEFORM Protein DME1338 XEOTICID XEO03967 MOACRIVE Inhibition DME1338 XEOTICID XEO04151 XEO_NAME Mundticin KS DME1338 XEOTICID XEO04151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO04151 XEO_CLAS Peptide DME1338 XEOTICID XEO04151 DESCRIPT Mundticin KS inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO04151 GENEFORM Protein DME1338 XEOTICID XEO04151 MOACRIVE Inhibition DME1338 XEOTICID XEO04319 XEO_NAME Nisin F DME1338 XEOTICID XEO04319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO04319 XEO_CLAS Peptide DME1338 XEOTICID XEO04319 DESCRIPT Nisin F inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO04319 GENEFORM Protein DME1338 XEOTICID XEO04319 MOACRIVE Inhibition DME1338 XEOTICID XEO04501 XEO_NAME Pediocin PA-1 DME1338 XEOTICID XEO04501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO04501 XEO_CLAS Peptide DME1338 XEOTICID XEO04501 DESCRIPT Pediocin PA-1 inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO04501 GENEFORM Protein DME1338 XEOTICID XEO04501 MOACRIVE Inhibition DME1338 XEOTICID XEO04616 XEO_NAME Plantaricin E DME1338 XEOTICID XEO04616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO04616 XEO_CLAS Peptide DME1338 XEOTICID XEO04616 DESCRIPT Plantaricin E inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum (MIC = 0.007 microM) DME1338 XEOTICID XEO04616 GENEFORM Protein DME1338 XEOTICID XEO04616 MOACRIVE Inhibition DME1338 XEOTICID XEO04617 XEO_NAME Plantaricin F DME1338 XEOTICID XEO04617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO04617 XEO_CLAS Peptide DME1338 XEOTICID XEO04617 DESCRIPT Plantaricin F inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum (MIC = 0.007 microM) DME1338 XEOTICID XEO04617 GENEFORM Protein DME1338 XEOTICID XEO04617 MOACRIVE Inhibition DME1338 XEOTICID XEO04618 XEO_NAME Plantaricin J DME1338 XEOTICID XEO04618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO04618 XEO_CLAS Peptide DME1338 XEOTICID XEO04618 DESCRIPT Plantaricin J inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum (MIC = 0.0001 microM) DME1338 XEOTICID XEO04618 GENEFORM Protein DME1338 XEOTICID XEO04618 MOACRIVE Inhibition DME1338 XEOTICID XEO04619 XEO_NAME Plantaricin K DME1338 XEOTICID XEO04619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO04619 XEO_CLAS Peptide DME1338 XEOTICID XEO04619 DESCRIPT Plantaricin K inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum (MIC = 0.0001 microM) DME1338 XEOTICID XEO04619 GENEFORM Protein DME1338 XEOTICID XEO04619 MOACRIVE Inhibition DME1338 XEOTICID XEO04658 XEO_NAME Bacteriocin PlnA-17 DME1338 XEOTICID XEO04658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO04658 XEO_CLAS Peptide DME1338 XEOTICID XEO04658 DESCRIPT Bacteriocin PlnA-17 inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO04658 GENEFORM Protein DME1338 XEOTICID XEO04658 MOACRIVE Inhibition DME1338 XEOTICID XEO04659 XEO_NAME Bacteriocin PlnA-22 DME1338 XEOTICID XEO04659 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO04659 XEO_CLAS Peptide DME1338 XEOTICID XEO04659 DESCRIPT Bacteriocin PlnA-22 inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO04659 GENEFORM Protein DME1338 XEOTICID XEO04659 MOACRIVE Inhibition DME1338 XEOTICID XEO04730 XEO_NAME Protease-activated antimicrobial peptide DME1338 XEOTICID XEO04730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO04730 XEO_CLAS Peptide DME1338 XEOTICID XEO04730 DESCRIPT Protease-activated antimicrobial peptide inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum (MIC = 0.116 microM) DME1338 XEOTICID XEO04730 GENEFORM Protein DME1338 XEOTICID XEO04730 MOACRIVE Inhibition DME1338 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1338 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO05004 XEO_CLAS Peptide DME1338 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO05004 GENEFORM Protein DME1338 XEOTICID XEO05004 MOACRIVE Inhibition DME1338 XEOTICID XEO05228 XEO_NAME Variacin DME1338 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO05228 XEO_CLAS Peptide DME1338 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO05228 GENEFORM Protein DME1338 XEOTICID XEO05228 MOACRIVE Inhibition DME1338 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1338 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1338 XEOTICID XEO05283 XEO_CLAS Peptide DME1338 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Linoleate 10-hydratase (10-LAH) from Lactobacillus plantarum DME1338 XEOTICID XEO05283 GENEFORM Protein DME1338 XEOTICID XEO05283 MOACRIVE Inhibition DME1339 DME___ID DME1339 DME1339 DME_NAME Glutamate decarboxylase (gadB) DME1339 SPESNAME Lactobacillus plantarum DME1339 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1339 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO02298 XEO_CLAS Peptide DME1339 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum (MIC = 32 ug/ml) DME1339 XEOTICID XEO02298 GENEFORM Protein DME1339 XEOTICID XEO02298 MOACRIVE Inhibition DME1339 XEOTICID XEO02375 XEO_NAME Bacteriocin curvaticin DME1339 XEOTICID XEO02375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO02375 XEO_CLAS Peptide DME1339 XEOTICID XEO02375 DESCRIPT Bacteriocin curvaticin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO02375 GENEFORM Protein DME1339 XEOTICID XEO02375 MOACRIVE Inhibition DME1339 XEOTICID XEO02382 XEO_NAME Bacteriocin plantarican ASM1 DME1339 XEOTICID XEO02382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO02382 XEO_CLAS Peptide DME1339 XEOTICID XEO02382 DESCRIPT Bacteriocin plantarican ASM1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO02382 GENEFORM Protein DME1339 XEOTICID XEO02382 MOACRIVE Inhibition DME1339 XEOTICID XEO02718 XEO_NAME Carnobacteriocin CbnB2 DME1339 XEOTICID XEO02718 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO02718 XEO_CLAS Peptide DME1339 XEOTICID XEO02718 DESCRIPT Carnobacteriocin CbnB2 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO02718 GENEFORM Protein DME1339 XEOTICID XEO02718 MOACRIVE Inhibition DME1339 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1339 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO03250 XEO_CLAS Peptide DME1339 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO03250 GENEFORM Protein DME1339 XEOTICID XEO03250 MOACRIVE Inhibition DME1339 XEOTICID XEO03252 XEO_NAME Enterocin B DME1339 XEOTICID XEO03252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO03252 XEO_CLAS Peptide DME1339 XEOTICID XEO03252 DESCRIPT Enterocin B inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum (MIC = 0.0869 microM) DME1339 XEOTICID XEO03252 GENEFORM Protein DME1339 XEOTICID XEO03252 MOACRIVE Inhibition DME1339 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME1339 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO03259 XEO_CLAS Peptide DME1339 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum (MIC = 0.102 microM) DME1339 XEOTICID XEO03259 GENEFORM Protein DME1339 XEOTICID XEO03259 MOACRIVE Inhibition DME1339 XEOTICID XEO03260 XEO_NAME Enterocin X beta DME1339 XEOTICID XEO03260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO03260 XEO_CLAS Peptide DME1339 XEOTICID XEO03260 DESCRIPT Enterocin X beta inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum (MIC = 0.813 microM) DME1339 XEOTICID XEO03260 GENEFORM Protein DME1339 XEOTICID XEO03260 MOACRIVE Inhibition DME1339 XEOTICID XEO03474 XEO_NAME Garvieacin Q DME1339 XEOTICID XEO03474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO03474 XEO_CLAS Peptide DME1339 XEOTICID XEO03474 DESCRIPT Garvieacin Q inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO03474 GENEFORM Protein DME1339 XEOTICID XEO03474 MOACRIVE Inhibition DME1339 XEOTICID XEO03493 XEO_NAME Glycocin F DME1339 XEOTICID XEO03493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO03493 XEO_CLAS Peptide DME1339 XEOTICID XEO03493 DESCRIPT Glycocin F inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO03493 GENEFORM Protein DME1339 XEOTICID XEO03493 MOACRIVE Inhibition DME1339 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1339 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO03854 XEO_CLAS Peptide DME1339 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum (MIC = 2.60 microM) DME1339 XEOTICID XEO03854 GENEFORM Protein DME1339 XEOTICID XEO03854 MOACRIVE Inhibition DME1339 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1339 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO03855 XEO_CLAS Peptide DME1339 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum (MIC = 4.10 microM) DME1339 XEOTICID XEO03855 GENEFORM Protein DME1339 XEOTICID XEO03855 MOACRIVE Inhibition DME1339 XEOTICID XEO03967 XEO_NAME Bacteriocin LSEI_2163 DME1339 XEOTICID XEO03967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO03967 XEO_CLAS Peptide DME1339 XEOTICID XEO03967 DESCRIPT Bacteriocin LSEI_2163 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO03967 GENEFORM Protein DME1339 XEOTICID XEO03967 MOACRIVE Inhibition DME1339 XEOTICID XEO04151 XEO_NAME Mundticin KS DME1339 XEOTICID XEO04151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO04151 XEO_CLAS Peptide DME1339 XEOTICID XEO04151 DESCRIPT Mundticin KS inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO04151 GENEFORM Protein DME1339 XEOTICID XEO04151 MOACRIVE Inhibition DME1339 XEOTICID XEO04319 XEO_NAME Nisin F DME1339 XEOTICID XEO04319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO04319 XEO_CLAS Peptide DME1339 XEOTICID XEO04319 DESCRIPT Nisin F inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO04319 GENEFORM Protein DME1339 XEOTICID XEO04319 MOACRIVE Inhibition DME1339 XEOTICID XEO04501 XEO_NAME Pediocin PA-1 DME1339 XEOTICID XEO04501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO04501 XEO_CLAS Peptide DME1339 XEOTICID XEO04501 DESCRIPT Pediocin PA-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO04501 GENEFORM Protein DME1339 XEOTICID XEO04501 MOACRIVE Inhibition DME1339 XEOTICID XEO04616 XEO_NAME Plantaricin E DME1339 XEOTICID XEO04616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO04616 XEO_CLAS Peptide DME1339 XEOTICID XEO04616 DESCRIPT Plantaricin E inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum (MIC = 0.007 microM) DME1339 XEOTICID XEO04616 GENEFORM Protein DME1339 XEOTICID XEO04616 MOACRIVE Inhibition DME1339 XEOTICID XEO04617 XEO_NAME Plantaricin F DME1339 XEOTICID XEO04617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO04617 XEO_CLAS Peptide DME1339 XEOTICID XEO04617 DESCRIPT Plantaricin F inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum (MIC = 0.007 microM) DME1339 XEOTICID XEO04617 GENEFORM Protein DME1339 XEOTICID XEO04617 MOACRIVE Inhibition DME1339 XEOTICID XEO04618 XEO_NAME Plantaricin J DME1339 XEOTICID XEO04618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO04618 XEO_CLAS Peptide DME1339 XEOTICID XEO04618 DESCRIPT Plantaricin J inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum (MIC = 0.0001 microM) DME1339 XEOTICID XEO04618 GENEFORM Protein DME1339 XEOTICID XEO04618 MOACRIVE Inhibition DME1339 XEOTICID XEO04619 XEO_NAME Plantaricin K DME1339 XEOTICID XEO04619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO04619 XEO_CLAS Peptide DME1339 XEOTICID XEO04619 DESCRIPT Plantaricin K inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum (MIC = 0.0001 microM) DME1339 XEOTICID XEO04619 GENEFORM Protein DME1339 XEOTICID XEO04619 MOACRIVE Inhibition DME1339 XEOTICID XEO04658 XEO_NAME Bacteriocin PlnA-17 DME1339 XEOTICID XEO04658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO04658 XEO_CLAS Peptide DME1339 XEOTICID XEO04658 DESCRIPT Bacteriocin PlnA-17 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO04658 GENEFORM Protein DME1339 XEOTICID XEO04658 MOACRIVE Inhibition DME1339 XEOTICID XEO04659 XEO_NAME Bacteriocin PlnA-22 DME1339 XEOTICID XEO04659 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO04659 XEO_CLAS Peptide DME1339 XEOTICID XEO04659 DESCRIPT Bacteriocin PlnA-22 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO04659 GENEFORM Protein DME1339 XEOTICID XEO04659 MOACRIVE Inhibition DME1339 XEOTICID XEO04730 XEO_NAME Protease-activated antimicrobial peptide DME1339 XEOTICID XEO04730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO04730 XEO_CLAS Peptide DME1339 XEOTICID XEO04730 DESCRIPT Protease-activated antimicrobial peptide inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum (MIC = 0.116 microM) DME1339 XEOTICID XEO04730 GENEFORM Protein DME1339 XEOTICID XEO04730 MOACRIVE Inhibition DME1339 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1339 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO05004 XEO_CLAS Peptide DME1339 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO05004 GENEFORM Protein DME1339 XEOTICID XEO05004 MOACRIVE Inhibition DME1339 XEOTICID XEO05228 XEO_NAME Variacin DME1339 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO05228 XEO_CLAS Peptide DME1339 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO05228 GENEFORM Protein DME1339 XEOTICID XEO05228 MOACRIVE Inhibition DME1339 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1339 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1339 XEOTICID XEO05283 XEO_CLAS Peptide DME1339 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Lactobacillus plantarum DME1339 XEOTICID XEO05283 GENEFORM Protein DME1339 XEOTICID XEO05283 MOACRIVE Inhibition DME1342 DME___ID DME1342 DME1342 DME_NAME Beta-lactamase (blaB) DME1342 SPESNAME Acinetobacter baumannii DME1342 XEOTICID XEO01366 XEO_NAME Linalool DME1342 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1342 XEOTICID XEO01366 XEO_CLAS Natural Product DME1342 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii DME1342 XEOTICID XEO01366 GENEFORM Protein DME1342 XEOTICID XEO01366 MOACRIVE Inhibition DME1342 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1342 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1342 XEOTICID XEO01816 XEO_CLAS Peptide DME1342 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii (MIC = 3 microM) DME1342 XEOTICID XEO01816 GENEFORM Protein DME1342 XEOTICID XEO01816 MOACRIVE Inhibition DME1342 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1342 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1342 XEOTICID XEO01824 XEO_CLAS Peptide DME1342 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii (MIC = 50 microM) DME1342 XEOTICID XEO01824 GENEFORM Protein DME1342 XEOTICID XEO01824 MOACRIVE Inhibition DME1342 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1342 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1342 XEOTICID XEO02731 XEO_CLAS Peptide DME1342 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii DME1342 XEOTICID XEO02731 GENEFORM Protein DME1342 XEOTICID XEO02731 MOACRIVE Inhibition DME1342 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1342 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1342 XEOTICID XEO02900 XEO_CLAS Peptide DME1342 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii DME1342 XEOTICID XEO02900 GENEFORM Protein DME1342 XEOTICID XEO02900 MOACRIVE Inhibition DME1342 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1342 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1342 XEOTICID XEO02942 XEO_CLAS Peptide DME1342 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii DME1342 XEOTICID XEO02942 GENEFORM Protein DME1342 XEOTICID XEO02942 MOACRIVE Inhibition DME1342 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1342 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1342 XEOTICID XEO03540 XEO_CLAS Peptide DME1342 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii (MIC = 8-16 ug/ml) DME1342 XEOTICID XEO03540 GENEFORM Protein DME1342 XEOTICID XEO03540 MOACRIVE Inhibition DME1342 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1342 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1342 XEOTICID XEO03556 XEO_CLAS Peptide DME1342 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii (MIC = 8-16 ug/ml) DME1342 XEOTICID XEO03556 GENEFORM Protein DME1342 XEOTICID XEO03556 MOACRIVE Inhibition DME1342 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1342 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1342 XEOTICID XEO03557 XEO_CLAS Peptide DME1342 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii (MIC = 8-16 ug/ml) DME1342 XEOTICID XEO03557 GENEFORM Protein DME1342 XEOTICID XEO03557 MOACRIVE Inhibition DME1342 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1342 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1342 XEOTICID XEO03609 XEO_CLAS Peptide DME1342 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii DME1342 XEOTICID XEO03609 GENEFORM Protein DME1342 XEOTICID XEO03609 MOACRIVE Inhibition DME1342 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1342 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1342 XEOTICID XEO03678 XEO_CLAS Peptide DME1342 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii (MIC = 0.8 ug/ml) DME1342 XEOTICID XEO03678 GENEFORM Protein DME1342 XEOTICID XEO03678 MOACRIVE Inhibition DME1342 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1342 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1342 XEOTICID XEO04001 XEO_CLAS Peptide DME1342 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii (MIC = 2.7 microM) DME1342 XEOTICID XEO04001 GENEFORM Protein DME1342 XEOTICID XEO04001 MOACRIVE Inhibition DME1342 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1342 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1342 XEOTICID XEO04241 XEO_CLAS Peptide DME1342 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii DME1342 XEOTICID XEO04241 GENEFORM Protein DME1342 XEOTICID XEO04241 MOACRIVE Inhibition DME1342 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1342 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1342 XEOTICID XEO04242 XEO_CLAS Peptide DME1342 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii DME1342 XEOTICID XEO04242 GENEFORM Protein DME1342 XEOTICID XEO04242 MOACRIVE Inhibition DME1342 XEOTICID XEO04331 XEO_NAME Norspermidine DME1342 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1342 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1342 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii DME1342 XEOTICID XEO04331 GENEFORM Protein DME1342 XEOTICID XEO04331 MOACRIVE Inhibition DME1342 XEOTICID XEO04686 XEO_NAME Polyethyleneimine DME1342 XEOTICID XEO04686 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1342 XEOTICID XEO04686 XEO_CLAS Chemical Compound DME1342 XEOTICID XEO04686 DESCRIPT Polyethyleneimine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii DME1342 XEOTICID XEO04686 GENEFORM Protein DME1342 XEOTICID XEO04686 MOACRIVE Inhibition DME1342 XEOTICID XEO04888 XEO_NAME CP-P derivative S16 DME1342 XEOTICID XEO04888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1342 XEOTICID XEO04888 XEO_CLAS Peptide DME1342 XEOTICID XEO04888 DESCRIPT CP-P derivative S16 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Acinetobacter baumannii (MIC = 3.125 ug/ml) DME1342 XEOTICID XEO04888 GENEFORM Protein DME1342 XEOTICID XEO04888 MOACRIVE Inhibition DME1344 DME___ID DME1344 DME1344 DME_NAME Glutamate decarboxylase (gadB) DME1344 SPESNAME Bifidobacterium adolescentis DME1344 XEOTICID XEO03113 XEO_NAME Royalisin defensin-1 DME1344 XEOTICID XEO03113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1344 XEOTICID XEO03113 XEO_CLAS Peptide DME1344 XEOTICID XEO03113 DESCRIPT Royalisin defensin-1 inhibits the drug-metabolizing activity of Glutamate decarboxylase (gadB) from Bifidobacterium adolescentis DME1344 XEOTICID XEO03113 GENEFORM Protein DME1344 XEOTICID XEO03113 MOACRIVE Inhibition DME1345 DME___ID DME1345 DME1345 DME_NAME Azoreductase (azoR) DME1345 SPESNAME Enterococcus faecium DME1345 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1345 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1345 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1345 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO01961 GENEFORM Protein DME1345 XEOTICID XEO01961 MOACRIVE Inhibition DME1345 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1345 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1345 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1345 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO01966 GENEFORM Protein DME1345 XEOTICID XEO01966 MOACRIVE Inhibition DME1345 XEOTICID XEO02373 XEO_NAME Bacteriocin 32 DME1345 XEOTICID XEO02373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO02373 XEO_CLAS Peptide DME1345 XEOTICID XEO02373 DESCRIPT Bacteriocin 32 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO02373 GENEFORM Protein DME1345 XEOTICID XEO02373 MOACRIVE Inhibition DME1345 XEOTICID XEO02377 XEO_NAME Bacteriocin hiracin-JM79 DME1345 XEOTICID XEO02377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO02377 XEO_CLAS Peptide DME1345 XEOTICID XEO02377 DESCRIPT Bacteriocin hiracin-JM79 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO02377 GENEFORM Protein DME1345 XEOTICID XEO02377 MOACRIVE Inhibition DME1345 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1345 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO02440 XEO_CLAS Peptide DME1345 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO02440 GENEFORM Protein DME1345 XEOTICID XEO02440 MOACRIVE Inhibition DME1345 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1345 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO02524 XEO_CLAS Peptide DME1345 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium (MIC = 19 microM) DME1345 XEOTICID XEO02524 GENEFORM Protein DME1345 XEOTICID XEO02524 MOACRIVE Inhibition DME1345 XEOTICID XEO02567 XEO_NAME Brevinin-1V DME1345 XEOTICID XEO02567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO02567 XEO_CLAS Peptide DME1345 XEOTICID XEO02567 DESCRIPT Brevinin-1V inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium (MIC = 19 microM) DME1345 XEOTICID XEO02567 GENEFORM Protein DME1345 XEOTICID XEO02567 MOACRIVE Inhibition DME1345 XEOTICID XEO02718 XEO_NAME Carnobacteriocin CbnB2 DME1345 XEOTICID XEO02718 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO02718 XEO_CLAS Peptide DME1345 XEOTICID XEO02718 DESCRIPT Carnobacteriocin CbnB2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO02718 GENEFORM Protein DME1345 XEOTICID XEO02718 MOACRIVE Inhibition DME1345 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1345 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO02743 XEO_CLAS Peptide DME1345 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium (MIC = 150 ug/ml) DME1345 XEOTICID XEO02743 GENEFORM Protein DME1345 XEOTICID XEO02743 MOACRIVE Inhibition DME1345 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1345 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO03073 XEO_CLAS Peptide DME1345 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium (MIC = 4 ug/ml) DME1345 XEOTICID XEO03073 GENEFORM Protein DME1345 XEOTICID XEO03073 MOACRIVE Inhibition DME1345 XEOTICID XEO03255 XEO_NAME Enterocin L50A DME1345 XEOTICID XEO03255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO03255 XEO_CLAS Peptide DME1345 XEOTICID XEO03255 DESCRIPT Enterocin L50A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO03255 GENEFORM Protein DME1345 XEOTICID XEO03255 MOACRIVE Inhibition DME1345 XEOTICID XEO03256 XEO_NAME Enterocin L50B DME1345 XEOTICID XEO03256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO03256 XEO_CLAS Peptide DME1345 XEOTICID XEO03256 DESCRIPT Enterocin L50B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO03256 GENEFORM Protein DME1345 XEOTICID XEO03256 MOACRIVE Inhibition DME1345 XEOTICID XEO03257 XEO_NAME Enterocin P DME1345 XEOTICID XEO03257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO03257 XEO_CLAS Peptide DME1345 XEOTICID XEO03257 DESCRIPT Enterocin P inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium (MIC = 0.002 ug/ml) DME1345 XEOTICID XEO03257 GENEFORM Protein DME1345 XEOTICID XEO03257 MOACRIVE Inhibition DME1345 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME1345 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO03259 XEO_CLAS Peptide DME1345 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium (MIC = 0.0508 microM) DME1345 XEOTICID XEO03259 GENEFORM Protein DME1345 XEOTICID XEO03259 MOACRIVE Inhibition DME1345 XEOTICID XEO03473 XEO_NAME Garvicin ML DME1345 XEOTICID XEO03473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO03473 XEO_CLAS Peptide DME1345 XEOTICID XEO03473 DESCRIPT Garvicin ML inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO03473 GENEFORM Protein DME1345 XEOTICID XEO03473 MOACRIVE Inhibition DME1345 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1345 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO03540 XEO_CLAS Peptide DME1345 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium (MIC = 4-8 ug/ml) DME1345 XEOTICID XEO03540 GENEFORM Protein DME1345 XEOTICID XEO03540 MOACRIVE Inhibition DME1345 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1345 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO03556 XEO_CLAS Peptide DME1345 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium (MIC = 4-8 ug/ml) DME1345 XEOTICID XEO03556 GENEFORM Protein DME1345 XEOTICID XEO03556 MOACRIVE Inhibition DME1345 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1345 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO03557 XEO_CLAS Peptide DME1345 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium (MIC = 4-8 ug/ml) DME1345 XEOTICID XEO03557 GENEFORM Protein DME1345 XEOTICID XEO03557 MOACRIVE Inhibition DME1345 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1345 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO03771 XEO_CLAS Peptide DME1345 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO03771 GENEFORM Protein DME1345 XEOTICID XEO03771 MOACRIVE Inhibition DME1345 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1345 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO03775 XEO_CLAS Peptide DME1345 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium (MIC = 0.71 microM) DME1345 XEOTICID XEO03775 GENEFORM Protein DME1345 XEOTICID XEO03775 MOACRIVE Inhibition DME1345 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1345 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO03857 XEO_CLAS Peptide DME1345 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium (MIC = 0.038 microM) DME1345 XEOTICID XEO03857 GENEFORM Protein DME1345 XEOTICID XEO03857 MOACRIVE Inhibition DME1345 XEOTICID XEO04151 XEO_NAME Mundticin KS DME1345 XEOTICID XEO04151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO04151 XEO_CLAS Peptide DME1345 XEOTICID XEO04151 DESCRIPT Mundticin KS inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO04151 GENEFORM Protein DME1345 XEOTICID XEO04151 MOACRIVE Inhibition DME1345 XEOTICID XEO04521 XEO_NAME Penocin A DME1345 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO04521 XEO_CLAS Peptide DME1345 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO04521 GENEFORM Protein DME1345 XEOTICID XEO04521 MOACRIVE Inhibition DME1345 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1345 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO04640 XEO_CLAS Peptide DME1345 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO04640 GENEFORM Protein DME1345 XEOTICID XEO04640 MOACRIVE Inhibition DME1345 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1345 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO04877 XEO_CLAS Peptide DME1345 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO04877 GENEFORM Protein DME1345 XEOTICID XEO04877 MOACRIVE Inhibition DME1345 XEOTICID XEO05169 XEO_NAME Tricyclic peptide MS-271 DME1345 XEOTICID XEO05169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO05169 XEO_CLAS Peptide DME1345 XEOTICID XEO05169 DESCRIPT Tricyclic peptide MS-271 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO05169 GENEFORM Protein DME1345 XEOTICID XEO05169 MOACRIVE Inhibition DME1345 XEOTICID XEO05228 XEO_NAME Variacin DME1345 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1345 XEOTICID XEO05228 XEO_CLAS Peptide DME1345 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Enterococcus faecium DME1345 XEOTICID XEO05228 GENEFORM Protein DME1345 XEOTICID XEO05228 MOACRIVE Inhibition DME1350 DME___ID DME1350 DME1350 DME_NAME Beta-glucuronidase (uidA) DME1350 SPESNAME Streptococcus agalactiae DME1350 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1350 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1350 XEOTICID XEO02202 XEO_CLAS Peptide DME1350 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Streptococcus agalactiae (MIC = 20 microM) DME1350 XEOTICID XEO02202 GENEFORM Protein DME1350 XEOTICID XEO02202 MOACRIVE Inhibition DME1350 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1350 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1350 XEOTICID XEO02203 XEO_CLAS Peptide DME1350 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Streptococcus agalactiae (MIC = 20 microM) DME1350 XEOTICID XEO02203 GENEFORM Protein DME1350 XEOTICID XEO02203 MOACRIVE Inhibition DME1350 XEOTICID XEO02347 XEO_NAME Aureocin A53 DME1350 XEOTICID XEO02347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1350 XEOTICID XEO02347 XEO_CLAS Peptide DME1350 XEOTICID XEO02347 DESCRIPT Aureocin A53 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Streptococcus agalactiae DME1350 XEOTICID XEO02347 GENEFORM Protein DME1350 XEOTICID XEO02347 MOACRIVE Inhibition DME1350 XEOTICID XEO03806 XEO_NAME Lantibiotic paenibacillin DME1350 XEOTICID XEO03806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1350 XEOTICID XEO03806 XEO_CLAS Peptide DME1350 XEOTICID XEO03806 DESCRIPT Lantibiotic paenibacillin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Streptococcus agalactiae DME1350 XEOTICID XEO03806 GENEFORM Protein DME1350 XEOTICID XEO03806 MOACRIVE Inhibition DME1350 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1350 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1350 XEOTICID XEO04241 XEO_CLAS Peptide DME1350 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Streptococcus agalactiae DME1350 XEOTICID XEO04241 GENEFORM Protein DME1350 XEOTICID XEO04241 MOACRIVE Inhibition DME1350 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1350 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1350 XEOTICID XEO04242 XEO_CLAS Peptide DME1350 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Streptococcus agalactiae DME1350 XEOTICID XEO04242 GENEFORM Protein DME1350 XEOTICID XEO04242 MOACRIVE Inhibition DME1350 XEOTICID XEO04320 XEO_NAME Nisin U DME1350 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1350 XEOTICID XEO04320 XEO_CLAS Peptide DME1350 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Streptococcus agalactiae DME1350 XEOTICID XEO04320 GENEFORM Protein DME1350 XEOTICID XEO04320 MOACRIVE Inhibition DME1350 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1350 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1350 XEOTICID XEO04613 XEO_CLAS Peptide DME1350 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Streptococcus agalactiae (MIC = 1.25-2.5 microM) DME1350 XEOTICID XEO04613 GENEFORM Protein DME1350 XEOTICID XEO04613 MOACRIVE Inhibition DME1350 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1350 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1350 XEOTICID XEO05101 XEO_CLAS Peptide DME1350 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Streptococcus agalactiae (MIC = 24.7 ug/ml) DME1350 XEOTICID XEO05101 GENEFORM Protein DME1350 XEOTICID XEO05101 MOACRIVE Inhibition DME1350 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1350 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1350 XEOTICID XEO05102 XEO_CLAS Peptide DME1350 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Streptococcus agalactiae (MIC = 30.5 ug/ml) DME1350 XEOTICID XEO05102 GENEFORM Protein DME1350 XEOTICID XEO05102 MOACRIVE Inhibition DME1350 XEOTICID XEO05148 XEO_NAME Tilapia piscidin 3 DME1350 XEOTICID XEO05148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1350 XEOTICID XEO05148 XEO_CLAS Peptide DME1350 XEOTICID XEO05148 DESCRIPT Tilapia piscidin 3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Streptococcus agalactiae (MIC = 9.78 ug/ml) DME1350 XEOTICID XEO05148 GENEFORM Protein DME1350 XEOTICID XEO05148 MOACRIVE Inhibition DME1350 XEOTICID XEO05149 XEO_NAME Tilapia piscidin 4 DME1350 XEOTICID XEO05149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1350 XEOTICID XEO05149 XEO_CLAS Peptide DME1350 XEOTICID XEO05149 DESCRIPT Tilapia piscidin 4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Streptococcus agalactiae (MIC = 2.1 ug/ml) DME1350 XEOTICID XEO05149 GENEFORM Protein DME1350 XEOTICID XEO05149 MOACRIVE Inhibition DME1351 DME___ID DME1351 DME1351 DME_NAME VanG ligase (vanG) DME1351 SPESNAME Streptococcus agalactiae DME1351 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1351 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1351 XEOTICID XEO02202 XEO_CLAS Peptide DME1351 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of VanG ligase (vanG) from Streptococcus agalactiae (MIC = 20 microM) DME1351 XEOTICID XEO02202 GENEFORM Protein DME1351 XEOTICID XEO02202 MOACRIVE Inhibition DME1351 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1351 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1351 XEOTICID XEO02203 XEO_CLAS Peptide DME1351 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of VanG ligase (vanG) from Streptococcus agalactiae (MIC = 20 microM) DME1351 XEOTICID XEO02203 GENEFORM Protein DME1351 XEOTICID XEO02203 MOACRIVE Inhibition DME1351 XEOTICID XEO02347 XEO_NAME Aureocin A53 DME1351 XEOTICID XEO02347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1351 XEOTICID XEO02347 XEO_CLAS Peptide DME1351 XEOTICID XEO02347 DESCRIPT Aureocin A53 inhibits the drug-metabolizing activity of VanG ligase (vanG) from Streptococcus agalactiae DME1351 XEOTICID XEO02347 GENEFORM Protein DME1351 XEOTICID XEO02347 MOACRIVE Inhibition DME1351 XEOTICID XEO03806 XEO_NAME Lantibiotic paenibacillin DME1351 XEOTICID XEO03806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1351 XEOTICID XEO03806 XEO_CLAS Peptide DME1351 XEOTICID XEO03806 DESCRIPT Lantibiotic paenibacillin inhibits the drug-metabolizing activity of VanG ligase (vanG) from Streptococcus agalactiae DME1351 XEOTICID XEO03806 GENEFORM Protein DME1351 XEOTICID XEO03806 MOACRIVE Inhibition DME1351 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1351 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1351 XEOTICID XEO04241 XEO_CLAS Peptide DME1351 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of VanG ligase (vanG) from Streptococcus agalactiae DME1351 XEOTICID XEO04241 GENEFORM Protein DME1351 XEOTICID XEO04241 MOACRIVE Inhibition DME1351 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1351 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1351 XEOTICID XEO04242 XEO_CLAS Peptide DME1351 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of VanG ligase (vanG) from Streptococcus agalactiae DME1351 XEOTICID XEO04242 GENEFORM Protein DME1351 XEOTICID XEO04242 MOACRIVE Inhibition DME1351 XEOTICID XEO04320 XEO_NAME Nisin U DME1351 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1351 XEOTICID XEO04320 XEO_CLAS Peptide DME1351 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of VanG ligase (vanG) from Streptococcus agalactiae DME1351 XEOTICID XEO04320 GENEFORM Protein DME1351 XEOTICID XEO04320 MOACRIVE Inhibition DME1351 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1351 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1351 XEOTICID XEO04613 XEO_CLAS Peptide DME1351 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of VanG ligase (vanG) from Streptococcus agalactiae (MIC = 1.25-2.5 microM) DME1351 XEOTICID XEO04613 GENEFORM Protein DME1351 XEOTICID XEO04613 MOACRIVE Inhibition DME1351 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1351 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1351 XEOTICID XEO05101 XEO_CLAS Peptide DME1351 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of VanG ligase (vanG) from Streptococcus agalactiae (MIC = 24.7 ug/ml) DME1351 XEOTICID XEO05101 GENEFORM Protein DME1351 XEOTICID XEO05101 MOACRIVE Inhibition DME1351 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1351 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1351 XEOTICID XEO05102 XEO_CLAS Peptide DME1351 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of VanG ligase (vanG) from Streptococcus agalactiae (MIC = 30.5 ug/ml) DME1351 XEOTICID XEO05102 GENEFORM Protein DME1351 XEOTICID XEO05102 MOACRIVE Inhibition DME1351 XEOTICID XEO05148 XEO_NAME Tilapia piscidin 3 DME1351 XEOTICID XEO05148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1351 XEOTICID XEO05148 XEO_CLAS Peptide DME1351 XEOTICID XEO05148 DESCRIPT Tilapia piscidin 3 inhibits the drug-metabolizing activity of VanG ligase (vanG) from Streptococcus agalactiae (MIC = 9.78 ug/ml) DME1351 XEOTICID XEO05148 GENEFORM Protein DME1351 XEOTICID XEO05148 MOACRIVE Inhibition DME1351 XEOTICID XEO05149 XEO_NAME Tilapia piscidin 4 DME1351 XEOTICID XEO05149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1351 XEOTICID XEO05149 XEO_CLAS Peptide DME1351 XEOTICID XEO05149 DESCRIPT Tilapia piscidin 4 inhibits the drug-metabolizing activity of VanG ligase (vanG) from Streptococcus agalactiae (MIC = 2.1 ug/ml) DME1351 XEOTICID XEO05149 GENEFORM Protein DME1351 XEOTICID XEO05149 MOACRIVE Inhibition DME1353 DME___ID DME1353 DME1353 DME_NAME Gamma-glutamylcyclotransferase (GGCT) DME1353 SPESNAME Ralstonia solanacearum DME1353 XEOTICID XEO03104 XEO_NAME Defensin So-D1 DME1353 XEOTICID XEO03104 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1353 XEOTICID XEO03104 XEO_CLAS Peptide DME1353 XEOTICID XEO03104 DESCRIPT Defensin So-D1 inhibits the drug-metabolizing activity of Gamma-glutamylcyclotransferase (GGCT) from Ralstonia solanacearum DME1353 XEOTICID XEO03104 GENEFORM Protein DME1353 XEOTICID XEO03104 MOACRIVE Inhibition DME1353 XEOTICID XEO03106 XEO_NAME Defensin So-D2 DME1353 XEOTICID XEO03106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1353 XEOTICID XEO03106 XEO_CLAS Peptide DME1353 XEOTICID XEO03106 DESCRIPT Defensin So-D2 inhibits the drug-metabolizing activity of Gamma-glutamylcyclotransferase (GGCT) from Ralstonia solanacearum DME1353 XEOTICID XEO03106 GENEFORM Protein DME1353 XEOTICID XEO03106 MOACRIVE Inhibition DME1353 XEOTICID XEO03107 XEO_NAME Defensin So-D5 DME1353 XEOTICID XEO03107 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1353 XEOTICID XEO03107 XEO_CLAS Peptide DME1353 XEOTICID XEO03107 DESCRIPT Defensin So-D5 inhibits the drug-metabolizing activity of Gamma-glutamylcyclotransferase (GGCT) from Ralstonia solanacearum DME1353 XEOTICID XEO03107 GENEFORM Protein DME1353 XEOTICID XEO03107 MOACRIVE Inhibition DME1353 XEOTICID XEO03108 XEO_NAME Defensin So-D6 DME1353 XEOTICID XEO03108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1353 XEOTICID XEO03108 XEO_CLAS Peptide DME1353 XEOTICID XEO03108 DESCRIPT Defensin So-D6 inhibits the drug-metabolizing activity of Gamma-glutamylcyclotransferase (GGCT) from Ralstonia solanacearum DME1353 XEOTICID XEO03108 GENEFORM Protein DME1353 XEOTICID XEO03108 MOACRIVE Inhibition DME1353 XEOTICID XEO04960 XEO_NAME Snakin-1 StSN1 DME1353 XEOTICID XEO04960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1353 XEOTICID XEO04960 XEO_CLAS Peptide DME1353 XEOTICID XEO04960 DESCRIPT Snakin-1 StSN1 inhibits the drug-metabolizing activity of Gamma-glutamylcyclotransferase (GGCT) from Ralstonia solanacearum DME1353 XEOTICID XEO04960 GENEFORM Protein DME1353 XEOTICID XEO04960 MOACRIVE Inhibition DME1353 XEOTICID XEO04961 XEO_NAME Snakin-2 StSN2 DME1353 XEOTICID XEO04961 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1353 XEOTICID XEO04961 XEO_CLAS Peptide DME1353 XEOTICID XEO04961 DESCRIPT Snakin-2 StSN2 inhibits the drug-metabolizing activity of Gamma-glutamylcyclotransferase (GGCT) from Ralstonia solanacearum DME1353 XEOTICID XEO04961 GENEFORM Protein DME1353 XEOTICID XEO04961 MOACRIVE Inhibition DME1386 DME___ID DME1386 DME1386 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1386 SPESNAME Bifidobacterium adolescentis DME1386 XEOTICID XEO03113 XEO_NAME Royalisin defensin-1 DME1386 XEOTICID XEO03113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1386 XEOTICID XEO03113 XEO_CLAS Peptide DME1386 XEOTICID XEO03113 DESCRIPT Royalisin defensin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Bifidobacterium adolescentis DME1386 XEOTICID XEO03113 GENEFORM Protein DME1386 XEOTICID XEO03113 MOACRIVE Inhibition DME1396 DME___ID DME1396 DME1396 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1396 SPESNAME Citrobacter freundii DME1396 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME1396 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME1396 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME1396 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Citrobacter freundii DME1396 XEOTICID XEO00613 GENEFORM Protein DME1396 XEOTICID XEO00613 MOACRIVE Inhibition DME1396 XEOTICID XEO00683 XEO_NAME Curcumin DME1396 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1396 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1396 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Citrobacter freundii DME1396 XEOTICID XEO00683 GENEFORM Protein DME1396 XEOTICID XEO00683 MOACRIVE Inhibition DME1396 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1396 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1396 XEOTICID XEO02319 XEO_CLAS Peptide DME1396 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Citrobacter freundii DME1396 XEOTICID XEO02319 GENEFORM Protein DME1396 XEOTICID XEO02319 MOACRIVE Inhibition DME1396 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1396 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1396 XEOTICID XEO02378 XEO_CLAS Peptide DME1396 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Citrobacter freundii (MIC = 0.76 ug/ml) DME1396 XEOTICID XEO02378 GENEFORM Protein DME1396 XEOTICID XEO02378 MOACRIVE Inhibition DME1396 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1396 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1396 XEOTICID XEO03253 XEO_CLAS Peptide DME1396 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Citrobacter freundii (MIC = 1.6 ug/ml) DME1396 XEOTICID XEO03253 GENEFORM Protein DME1396 XEOTICID XEO03253 MOACRIVE Inhibition DME1396 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1396 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1396 XEOTICID XEO03609 XEO_CLAS Peptide DME1396 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Citrobacter freundii DME1396 XEOTICID XEO03609 GENEFORM Protein DME1396 XEOTICID XEO03609 MOACRIVE Inhibition DME1396 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1396 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1396 XEOTICID XEO03853 XEO_CLAS Peptide DME1396 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Citrobacter freundii (MIC = 75 microM) DME1396 XEOTICID XEO03853 GENEFORM Protein DME1396 XEOTICID XEO03853 MOACRIVE Inhibition DME1396 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1396 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1396 XEOTICID XEO03985 XEO_CLAS Peptide DME1396 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Citrobacter freundii (MIC = 30 ug/ml) DME1396 XEOTICID XEO03985 GENEFORM Protein DME1396 XEOTICID XEO03985 MOACRIVE Inhibition DME1396 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1396 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1396 XEOTICID XEO04426 XEO_CLAS Peptide DME1396 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Citrobacter freundii (MIC = 2 microM) DME1396 XEOTICID XEO04426 GENEFORM Protein DME1396 XEOTICID XEO04426 MOACRIVE Inhibition DME1396 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1396 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1396 XEOTICID XEO04606 XEO_CLAS Peptide DME1396 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Citrobacter freundii (MIC = 2 microM) DME1396 XEOTICID XEO04606 GENEFORM Protein DME1396 XEOTICID XEO04606 MOACRIVE Inhibition DME1398 DME___ID DME1398 DME1398 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1398 SPESNAME Clostridioides difficile DME1398 XEOTICID XEO04069 XEO_NAME Mersacidin DME1398 XEOTICID XEO04069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1398 XEOTICID XEO04069 XEO_CLAS Peptide DME1398 XEOTICID XEO04069 DESCRIPT Mersacidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Clostridioides difficile DME1398 XEOTICID XEO04069 GENEFORM Protein DME1398 XEOTICID XEO04069 MOACRIVE Inhibition DME1404 DME___ID DME1404 DME1404 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1404 SPESNAME Clostridium sporogenes DME1404 XEOTICID XEO02126 XEO_NAME Acidocin A DME1404 XEOTICID XEO02126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1404 XEOTICID XEO02126 XEO_CLAS Peptide DME1404 XEOTICID XEO02126 DESCRIPT Acidocin A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Clostridium sporogenes DME1404 XEOTICID XEO02126 GENEFORM Protein DME1404 XEOTICID XEO02126 MOACRIVE Inhibition DME1404 XEOTICID XEO02127 XEO_NAME Acidocin B DME1404 XEOTICID XEO02127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1404 XEOTICID XEO02127 XEO_CLAS Peptide DME1404 XEOTICID XEO02127 DESCRIPT Acidocin B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Clostridium sporogenes DME1404 XEOTICID XEO02127 GENEFORM Protein DME1404 XEOTICID XEO02127 MOACRIVE Inhibition DME1404 XEOTICID XEO03257 XEO_NAME Enterocin P DME1404 XEOTICID XEO03257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1404 XEOTICID XEO03257 XEO_CLAS Peptide DME1404 XEOTICID XEO03257 DESCRIPT Enterocin P inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Clostridium sporogenes (MIC = 0.004 ug/ml) DME1404 XEOTICID XEO03257 GENEFORM Protein DME1404 XEOTICID XEO03257 MOACRIVE Inhibition DME1404 XEOTICID XEO03806 XEO_NAME Lantibiotic paenibacillin DME1404 XEOTICID XEO03806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1404 XEOTICID XEO03806 XEO_CLAS Peptide DME1404 XEOTICID XEO03806 DESCRIPT Lantibiotic paenibacillin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Clostridium sporogenes DME1404 XEOTICID XEO03806 GENEFORM Protein DME1404 XEOTICID XEO03806 MOACRIVE Inhibition DME1404 XEOTICID XEO04156 XEO_NAME Mutacin II mutacin H-29B DME1404 XEOTICID XEO04156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1404 XEOTICID XEO04156 XEO_CLAS Peptide DME1404 XEOTICID XEO04156 DESCRIPT Mutacin II mutacin H-29B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Clostridium sporogenes DME1404 XEOTICID XEO04156 GENEFORM Protein DME1404 XEOTICID XEO04156 MOACRIVE Inhibition DME1413 DME___ID DME1413 DME1413 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1413 SPESNAME Edwardsiella tarda DME1413 XEOTICID XEO00879 XEO_NAME Coumarin DME1413 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1413 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1413 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Edwardsiella tarda DME1413 XEOTICID XEO00879 GENEFORM Protein DME1413 XEOTICID XEO00879 MOACRIVE Inhibition DME1413 XEOTICID XEO04758 XEO_NAME Anti-lipopolysaccharide factor PtALF5 DME1413 XEOTICID XEO04758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1413 XEOTICID XEO04758 XEO_CLAS Peptide DME1413 XEOTICID XEO04758 DESCRIPT Anti-lipopolysaccharide factor PtALF5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Edwardsiella tarda (MIC = 7.78-15.54 microM) DME1413 XEOTICID XEO04758 GENEFORM Protein DME1413 XEOTICID XEO04758 MOACRIVE Inhibition DME1413 XEOTICID XEO04760 XEO_NAME Anti-lipopolysaccharide factor PtALF7 DME1413 XEOTICID XEO04760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1413 XEOTICID XEO04760 XEO_CLAS Peptide DME1413 XEOTICID XEO04760 DESCRIPT Anti-lipopolysaccharide factor PtALF7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Edwardsiella tarda (MIC = 2.04-4.07 microM) DME1413 XEOTICID XEO04760 GENEFORM Protein DME1413 XEOTICID XEO04760 MOACRIVE Inhibition DME1416 DME___ID DME1416 DME1416 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1416 SPESNAME Enterobacter cancerogenus DME1416 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME1416 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME1416 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME1416 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterobacter cancerogenus DME1416 XEOTICID XEO00613 GENEFORM Protein DME1416 XEOTICID XEO00613 MOACRIVE Inhibition DME1416 XEOTICID XEO00683 XEO_NAME Curcumin DME1416 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1416 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1416 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterobacter cancerogenus DME1416 XEOTICID XEO00683 GENEFORM Protein DME1416 XEOTICID XEO00683 MOACRIVE Inhibition DME1418 DME___ID DME1418 DME1418 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1418 SPESNAME Enterococcus faecalis DME1418 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1418 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1418 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1418 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO00546 GENEFORM Protein DME1418 XEOTICID XEO00546 MOACRIVE Inhibition DME1418 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1418 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO01812 XEO_CLAS Peptide DME1418 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 1.9 microM) DME1418 XEOTICID XEO01812 GENEFORM Protein DME1418 XEOTICID XEO01812 MOACRIVE Inhibition DME1418 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1418 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO01813 XEO_CLAS Peptide DME1418 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 1.4 microM) DME1418 XEOTICID XEO01813 GENEFORM Protein DME1418 XEOTICID XEO01813 MOACRIVE Inhibition DME1418 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1418 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO01814 XEO_CLAS Peptide DME1418 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 0.7 microM) DME1418 XEOTICID XEO01814 GENEFORM Protein DME1418 XEOTICID XEO01814 MOACRIVE Inhibition DME1418 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1418 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO01815 XEO_CLAS Peptide DME1418 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 1.0 microM) DME1418 XEOTICID XEO01815 GENEFORM Protein DME1418 XEOTICID XEO01815 MOACRIVE Inhibition DME1418 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1418 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1418 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1418 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO01961 GENEFORM Protein DME1418 XEOTICID XEO01961 MOACRIVE Inhibition DME1418 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1418 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1418 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1418 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO01966 GENEFORM Protein DME1418 XEOTICID XEO01966 MOACRIVE Inhibition DME1418 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1418 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02122 XEO_CLAS Peptide DME1418 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 50 ug/ml) DME1418 XEOTICID XEO02122 GENEFORM Protein DME1418 XEOTICID XEO02122 MOACRIVE Inhibition DME1418 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1418 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02247 XEO_CLAS Peptide DME1418 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02247 GENEFORM Protein DME1418 XEOTICID XEO02247 MOACRIVE Inhibition DME1418 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1418 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02319 XEO_CLAS Peptide DME1418 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02319 GENEFORM Protein DME1418 XEOTICID XEO02319 MOACRIVE Inhibition DME1418 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1418 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02325 XEO_CLAS Peptide DME1418 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 100 microM) DME1418 XEOTICID XEO02325 GENEFORM Protein DME1418 XEOTICID XEO02325 MOACRIVE Inhibition DME1418 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1418 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02355 XEO_CLAS Peptide DME1418 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 17 ug/ml) DME1418 XEOTICID XEO02355 GENEFORM Protein DME1418 XEOTICID XEO02355 MOACRIVE Inhibition DME1418 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1418 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02356 XEO_CLAS Peptide DME1418 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 32 ug/ml) DME1418 XEOTICID XEO02356 GENEFORM Protein DME1418 XEOTICID XEO02356 MOACRIVE Inhibition DME1418 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1418 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02357 XEO_CLAS Peptide DME1418 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 16 ug/ml) DME1418 XEOTICID XEO02357 GENEFORM Protein DME1418 XEOTICID XEO02357 MOACRIVE Inhibition DME1418 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1418 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02358 XEO_CLAS Peptide DME1418 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 8 ug/ml) DME1418 XEOTICID XEO02358 GENEFORM Protein DME1418 XEOTICID XEO02358 MOACRIVE Inhibition DME1418 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1418 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02360 XEO_CLAS Peptide DME1418 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 2 ug/ml) DME1418 XEOTICID XEO02360 GENEFORM Protein DME1418 XEOTICID XEO02360 MOACRIVE Inhibition DME1418 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1418 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02361 XEO_CLAS Peptide DME1418 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 32 ug/ml) DME1418 XEOTICID XEO02361 GENEFORM Protein DME1418 XEOTICID XEO02361 MOACRIVE Inhibition DME1418 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1418 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02365 XEO_CLAS Peptide DME1418 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 64 ug/ml) DME1418 XEOTICID XEO02365 GENEFORM Protein DME1418 XEOTICID XEO02365 MOACRIVE Inhibition DME1418 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1418 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02366 XEO_CLAS Peptide DME1418 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 32 ug/ml) DME1418 XEOTICID XEO02366 GENEFORM Protein DME1418 XEOTICID XEO02366 MOACRIVE Inhibition DME1418 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1418 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02367 XEO_CLAS Peptide DME1418 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 32 ug/ml) DME1418 XEOTICID XEO02367 GENEFORM Protein DME1418 XEOTICID XEO02367 MOACRIVE Inhibition DME1418 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1418 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02368 XEO_CLAS Peptide DME1418 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 64 ug/ml) DME1418 XEOTICID XEO02368 GENEFORM Protein DME1418 XEOTICID XEO02368 MOACRIVE Inhibition DME1418 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1418 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02369 XEO_CLAS Peptide DME1418 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 32 ug/ml) DME1418 XEOTICID XEO02369 GENEFORM Protein DME1418 XEOTICID XEO02369 MOACRIVE Inhibition DME1418 XEOTICID XEO02377 XEO_NAME Bacteriocin hiracin-JM79 DME1418 XEOTICID XEO02377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02377 XEO_CLAS Peptide DME1418 XEOTICID XEO02377 DESCRIPT Bacteriocin hiracin-JM79 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02377 GENEFORM Protein DME1418 XEOTICID XEO02377 MOACRIVE Inhibition DME1418 XEOTICID XEO02382 XEO_NAME Bacteriocin plantarican ASM1 DME1418 XEOTICID XEO02382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02382 XEO_CLAS Peptide DME1418 XEOTICID XEO02382 DESCRIPT Bacteriocin plantarican ASM1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02382 GENEFORM Protein DME1418 XEOTICID XEO02382 MOACRIVE Inhibition DME1418 XEOTICID XEO02386 XEO_NAME Bactridin-1 DME1418 XEOTICID XEO02386 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02386 XEO_CLAS Peptide DME1418 XEOTICID XEO02386 DESCRIPT Bactridin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 34 microM) DME1418 XEOTICID XEO02386 GENEFORM Protein DME1418 XEOTICID XEO02386 MOACRIVE Inhibition DME1418 XEOTICID XEO02387 XEO_NAME Bactridin-2 DME1418 XEOTICID XEO02387 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02387 XEO_CLAS Peptide DME1418 XEOTICID XEO02387 DESCRIPT Bactridin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 65 microM) DME1418 XEOTICID XEO02387 GENEFORM Protein DME1418 XEOTICID XEO02387 MOACRIVE Inhibition DME1418 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1418 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02388 XEO_CLAS Peptide DME1418 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 8 ug/ml) DME1418 XEOTICID XEO02388 GENEFORM Protein DME1418 XEOTICID XEO02388 MOACRIVE Inhibition DME1418 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1418 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02389 XEO_CLAS Peptide DME1418 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 2 ug/ml) DME1418 XEOTICID XEO02389 GENEFORM Protein DME1418 XEOTICID XEO02389 MOACRIVE Inhibition DME1418 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1418 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02463 XEO_CLAS Peptide DME1418 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 15 microM) DME1418 XEOTICID XEO02463 GENEFORM Protein DME1418 XEOTICID XEO02463 MOACRIVE Inhibition DME1418 XEOTICID XEO02465 XEO_NAME BMAP-28 DME1418 XEOTICID XEO02465 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02465 XEO_CLAS Peptide DME1418 XEOTICID XEO02465 DESCRIPT BMAP-28 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02465 GENEFORM Protein DME1418 XEOTICID XEO02465 MOACRIVE Inhibition DME1418 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1418 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02491 XEO_CLAS Peptide DME1418 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 57.1 microM) DME1418 XEOTICID XEO02491 GENEFORM Protein DME1418 XEOTICID XEO02491 MOACRIVE Inhibition DME1418 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1418 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02496 XEO_CLAS Peptide DME1418 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 13 microM) DME1418 XEOTICID XEO02496 GENEFORM Protein DME1418 XEOTICID XEO02496 MOACRIVE Inhibition DME1418 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1418 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02497 XEO_CLAS Peptide DME1418 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 6 microM) DME1418 XEOTICID XEO02497 GENEFORM Protein DME1418 XEOTICID XEO02497 MOACRIVE Inhibition DME1418 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1418 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02509 XEO_CLAS Peptide DME1418 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 19 microM) DME1418 XEOTICID XEO02509 GENEFORM Protein DME1418 XEOTICID XEO02509 MOACRIVE Inhibition DME1418 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1418 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02510 XEO_CLAS Peptide DME1418 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 75 microM) DME1418 XEOTICID XEO02510 GENEFORM Protein DME1418 XEOTICID XEO02510 MOACRIVE Inhibition DME1418 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1418 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02511 XEO_CLAS Peptide DME1418 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 9 microM) DME1418 XEOTICID XEO02511 GENEFORM Protein DME1418 XEOTICID XEO02511 MOACRIVE Inhibition DME1418 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1418 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02512 XEO_CLAS Peptide DME1418 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 9 microM) DME1418 XEOTICID XEO02512 GENEFORM Protein DME1418 XEOTICID XEO02512 MOACRIVE Inhibition DME1418 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1418 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02524 XEO_CLAS Peptide DME1418 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 19 microM) DME1418 XEOTICID XEO02524 GENEFORM Protein DME1418 XEOTICID XEO02524 MOACRIVE Inhibition DME1418 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1418 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02566 XEO_CLAS Peptide DME1418 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 50 microM) DME1418 XEOTICID XEO02566 GENEFORM Protein DME1418 XEOTICID XEO02566 MOACRIVE Inhibition DME1418 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1418 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02637 XEO_CLAS Peptide DME1418 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 25 microM) DME1418 XEOTICID XEO02637 GENEFORM Protein DME1418 XEOTICID XEO02637 MOACRIVE Inhibition DME1418 XEOTICID XEO02660 XEO_NAME Butyl gallate DME1418 XEOTICID XEO02660 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1418 XEOTICID XEO02660 XEO_CLAS Chemical Compound DME1418 XEOTICID XEO02660 DESCRIPT Butyl gallate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02660 GENEFORM Protein DME1418 XEOTICID XEO02660 MOACRIVE Inhibition DME1418 XEOTICID XEO02718 XEO_NAME Carnobacteriocin CbnB2 DME1418 XEOTICID XEO02718 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02718 XEO_CLAS Peptide DME1418 XEOTICID XEO02718 DESCRIPT Carnobacteriocin CbnB2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02718 GENEFORM Protein DME1418 XEOTICID XEO02718 MOACRIVE Inhibition DME1418 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1418 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02721 XEO_CLAS Peptide DME1418 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02721 GENEFORM Protein DME1418 XEOTICID XEO02721 MOACRIVE Inhibition DME1418 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1418 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02820 XEO_CLAS Peptide DME1418 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 64 ug/ml) DME1418 XEOTICID XEO02820 GENEFORM Protein DME1418 XEOTICID XEO02820 MOACRIVE Inhibition DME1418 XEOTICID XEO02864 XEO_NAME Cathelicidin cjaRL-37 DME1418 XEOTICID XEO02864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02864 XEO_CLAS Peptide DME1418 XEOTICID XEO02864 DESCRIPT Cathelicidin cjaRL-37 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 32 microM) DME1418 XEOTICID XEO02864 GENEFORM Protein DME1418 XEOTICID XEO02864 MOACRIVE Inhibition DME1418 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1418 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02872 XEO_CLAS Peptide DME1418 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 300 microM) DME1418 XEOTICID XEO02872 GENEFORM Protein DME1418 XEOTICID XEO02872 MOACRIVE Inhibition DME1418 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1418 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02875 XEO_CLAS Peptide DME1418 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02875 GENEFORM Protein DME1418 XEOTICID XEO02875 MOACRIVE Inhibition DME1418 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1418 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02876 XEO_CLAS Peptide DME1418 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02876 GENEFORM Protein DME1418 XEOTICID XEO02876 MOACRIVE Inhibition DME1418 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1418 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02877 XEO_CLAS Peptide DME1418 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02877 GENEFORM Protein DME1418 XEOTICID XEO02877 MOACRIVE Inhibition DME1418 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1418 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02878 XEO_CLAS Peptide DME1418 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02878 GENEFORM Protein DME1418 XEOTICID XEO02878 MOACRIVE Inhibition DME1418 XEOTICID XEO02930 XEO_NAME Indolicidin derivative CP10A DME1418 XEOTICID XEO02930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02930 XEO_CLAS Peptide DME1418 XEOTICID XEO02930 DESCRIPT Indolicidin derivative CP10A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 8 ug/ml) DME1418 XEOTICID XEO02930 GENEFORM Protein DME1418 XEOTICID XEO02930 MOACRIVE Inhibition DME1418 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1418 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02931 XEO_CLAS Peptide DME1418 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 64 ug/ml) DME1418 XEOTICID XEO02931 GENEFORM Protein DME1418 XEOTICID XEO02931 MOACRIVE Inhibition DME1418 XEOTICID XEO02932 XEO_NAME CP11CN peptide DME1418 XEOTICID XEO02932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02932 XEO_CLAS Peptide DME1418 XEOTICID XEO02932 DESCRIPT CP11CN peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 64 ug/ml) DME1418 XEOTICID XEO02932 GENEFORM Protein DME1418 XEOTICID XEO02932 MOACRIVE Inhibition DME1418 XEOTICID XEO02955 XEO_NAME Cryptdin related sequence CRS4C-3c DME1418 XEOTICID XEO02955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02955 XEO_CLAS Peptide DME1418 XEOTICID XEO02955 DESCRIPT Cryptdin related sequence CRS4C-3c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02955 GENEFORM Protein DME1418 XEOTICID XEO02955 MOACRIVE Inhibition DME1418 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1418 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02958 XEO_CLAS Peptide DME1418 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02958 GENEFORM Protein DME1418 XEOTICID XEO02958 MOACRIVE Inhibition DME1418 XEOTICID XEO02959 XEO_NAME Cryptdin related peptide CRS4C-1d DME1418 XEOTICID XEO02959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02959 XEO_CLAS Peptide DME1418 XEOTICID XEO02959 DESCRIPT Cryptdin related peptide CRS4C-1d inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02959 GENEFORM Protein DME1418 XEOTICID XEO02959 MOACRIVE Inhibition DME1418 XEOTICID XEO02960 XEO_NAME Cryptdin related peptide CRS4C-2 DME1418 XEOTICID XEO02960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02960 XEO_CLAS Peptide DME1418 XEOTICID XEO02960 DESCRIPT Cryptdin related peptide CRS4C-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02960 GENEFORM Protein DME1418 XEOTICID XEO02960 MOACRIVE Inhibition DME1418 XEOTICID XEO02961 XEO_NAME Cryptdin related peptide CRS4C-2b DME1418 XEOTICID XEO02961 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO02961 XEO_CLAS Peptide DME1418 XEOTICID XEO02961 DESCRIPT Cryptdin related peptide CRS4C-2b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO02961 GENEFORM Protein DME1418 XEOTICID XEO02961 MOACRIVE Inhibition DME1418 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1418 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03021 XEO_CLAS Peptide DME1418 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 1.25-2.50 microM) DME1418 XEOTICID XEO03021 GENEFORM Protein DME1418 XEOTICID XEO03021 MOACRIVE Inhibition DME1418 XEOTICID XEO03025 XEO_NAME Curvacin A DME1418 XEOTICID XEO03025 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03025 XEO_CLAS Peptide DME1418 XEOTICID XEO03025 DESCRIPT Curvacin A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO03025 GENEFORM Protein DME1418 XEOTICID XEO03025 MOACRIVE Inhibition DME1418 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1418 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03073 XEO_CLAS Peptide DME1418 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 16 ug/ml) DME1418 XEOTICID XEO03073 GENEFORM Protein DME1418 XEOTICID XEO03073 MOACRIVE Inhibition DME1418 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1418 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03082 XEO_CLAS Peptide DME1418 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO03082 GENEFORM Protein DME1418 XEOTICID XEO03082 MOACRIVE Inhibition DME1418 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1418 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03137 XEO_CLAS Peptide DME1418 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO03137 GENEFORM Protein DME1418 XEOTICID XEO03137 MOACRIVE Inhibition DME1418 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1418 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03146 XEO_CLAS Peptide DME1418 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 10 microM) DME1418 XEOTICID XEO03146 GENEFORM Protein DME1418 XEOTICID XEO03146 MOACRIVE Inhibition DME1418 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1418 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03147 XEO_CLAS Peptide DME1418 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 38 microM) DME1418 XEOTICID XEO03147 GENEFORM Protein DME1418 XEOTICID XEO03147 MOACRIVE Inhibition DME1418 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1418 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03148 XEO_CLAS Peptide DME1418 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 22 microM) DME1418 XEOTICID XEO03148 GENEFORM Protein DME1418 XEOTICID XEO03148 MOACRIVE Inhibition DME1418 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1418 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03149 XEO_CLAS Peptide DME1418 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 11 microM) DME1418 XEOTICID XEO03149 GENEFORM Protein DME1418 XEOTICID XEO03149 MOACRIVE Inhibition DME1418 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1418 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03197 XEO_CLAS Peptide DME1418 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 14.5 microM) DME1418 XEOTICID XEO03197 GENEFORM Protein DME1418 XEOTICID XEO03197 MOACRIVE Inhibition DME1418 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1418 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03250 XEO_CLAS Peptide DME1418 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO03250 GENEFORM Protein DME1418 XEOTICID XEO03250 MOACRIVE Inhibition DME1418 XEOTICID XEO03252 XEO_NAME Enterocin B DME1418 XEOTICID XEO03252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03252 XEO_CLAS Peptide DME1418 XEOTICID XEO03252 DESCRIPT Enterocin B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 0.0869 microM) DME1418 XEOTICID XEO03252 GENEFORM Protein DME1418 XEOTICID XEO03252 MOACRIVE Inhibition DME1418 XEOTICID XEO03254 XEO_NAME Enterocin EJ97 DME1418 XEOTICID XEO03254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03254 XEO_CLAS Peptide DME1418 XEOTICID XEO03254 DESCRIPT Enterocin EJ97 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 6 ug/ml) DME1418 XEOTICID XEO03254 GENEFORM Protein DME1418 XEOTICID XEO03254 MOACRIVE Inhibition DME1418 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1418 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03258 XEO_CLAS Peptide DME1418 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO03258 GENEFORM Protein DME1418 XEOTICID XEO03258 MOACRIVE Inhibition DME1418 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME1418 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03259 XEO_CLAS Peptide DME1418 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 0.0508 microM) DME1418 XEOTICID XEO03259 GENEFORM Protein DME1418 XEOTICID XEO03259 MOACRIVE Inhibition DME1418 XEOTICID XEO03260 XEO_NAME Enterocin X beta DME1418 XEOTICID XEO03260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03260 XEO_CLAS Peptide DME1418 XEOTICID XEO03260 DESCRIPT Enterocin X beta inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 0.813 microM) DME1418 XEOTICID XEO03260 GENEFORM Protein DME1418 XEOTICID XEO03260 MOACRIVE Inhibition DME1418 XEOTICID XEO03357 XEO_NAME Ethyl gallate DME1418 XEOTICID XEO03357 XEO_TYPE Pharmaceutical Agent(s) DME1418 XEOTICID XEO03357 XEO_CLAS Investigative Agent DME1418 XEOTICID XEO03357 DESCRIPT Ethyl gallate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO03357 GENEFORM Protein DME1418 XEOTICID XEO03357 MOACRIVE Inhibition DME1418 XEOTICID XEO03381 XEO_NAME Fallaxidin 3.1 DME1418 XEOTICID XEO03381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03381 XEO_CLAS Peptide DME1418 XEOTICID XEO03381 DESCRIPT Fallaxidin 3.1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 100 microM) DME1418 XEOTICID XEO03381 GENEFORM Protein DME1418 XEOTICID XEO03381 MOACRIVE Inhibition DME1418 XEOTICID XEO03382 XEO_NAME Fallaxidin 3.2 DME1418 XEOTICID XEO03382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03382 XEO_CLAS Peptide DME1418 XEOTICID XEO03382 DESCRIPT Fallaxidin 3.2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 100 microM) DME1418 XEOTICID XEO03382 GENEFORM Protein DME1418 XEOTICID XEO03382 MOACRIVE Inhibition DME1418 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1418 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03428 XEO_CLAS Peptide DME1418 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 31 ug/ml) DME1418 XEOTICID XEO03428 GENEFORM Protein DME1418 XEOTICID XEO03428 MOACRIVE Inhibition DME1418 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1418 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03430 XEO_CLAS Peptide DME1418 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 31 ug/ml) DME1418 XEOTICID XEO03430 GENEFORM Protein DME1418 XEOTICID XEO03430 MOACRIVE Inhibition DME1418 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1418 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03434 XEO_CLAS Peptide DME1418 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 31 ug/ml) DME1418 XEOTICID XEO03434 GENEFORM Protein DME1418 XEOTICID XEO03434 MOACRIVE Inhibition DME1418 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1418 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03497 XEO_CLAS Peptide DME1418 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 6.2-12.5 microM) DME1418 XEOTICID XEO03497 GENEFORM Protein DME1418 XEOTICID XEO03497 MOACRIVE Inhibition DME1418 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1418 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03498 XEO_CLAS Peptide DME1418 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 6.2-12.5 microM) DME1418 XEOTICID XEO03498 GENEFORM Protein DME1418 XEOTICID XEO03498 MOACRIVE Inhibition DME1418 XEOTICID XEO03522 XEO_NAME Halocyntin DME1418 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03522 XEO_CLAS Peptide DME1418 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO03522 GENEFORM Protein DME1418 XEOTICID XEO03522 MOACRIVE Inhibition DME1418 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1418 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03540 XEO_CLAS Peptide DME1418 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 32 ug/ml) DME1418 XEOTICID XEO03540 GENEFORM Protein DME1418 XEOTICID XEO03540 MOACRIVE Inhibition DME1418 XEOTICID XEO03555 XEO_NAME Hexyl gallate DME1418 XEOTICID XEO03555 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1418 XEOTICID XEO03555 XEO_CLAS Chemical Compound DME1418 XEOTICID XEO03555 DESCRIPT Hexyl gallate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO03555 GENEFORM Protein DME1418 XEOTICID XEO03555 MOACRIVE Inhibition DME1418 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1418 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03556 XEO_CLAS Peptide DME1418 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 32 ug/ml) DME1418 XEOTICID XEO03556 GENEFORM Protein DME1418 XEOTICID XEO03556 MOACRIVE Inhibition DME1418 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1418 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03557 XEO_CLAS Peptide DME1418 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 32 ug/ml) DME1418 XEOTICID XEO03557 GENEFORM Protein DME1418 XEOTICID XEO03557 MOACRIVE Inhibition DME1418 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1418 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03569 XEO_CLAS Peptide DME1418 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 300 microM) DME1418 XEOTICID XEO03569 GENEFORM Protein DME1418 XEOTICID XEO03569 MOACRIVE Inhibition DME1418 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1418 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03579 XEO_CLAS Peptide DME1418 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO03579 GENEFORM Protein DME1418 XEOTICID XEO03579 MOACRIVE Inhibition DME1418 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1418 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03588 XEO_CLAS Peptide DME1418 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 15 ug/ml) DME1418 XEOTICID XEO03588 GENEFORM Protein DME1418 XEOTICID XEO03588 MOACRIVE Inhibition DME1418 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1418 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03609 XEO_CLAS Peptide DME1418 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO03609 GENEFORM Protein DME1418 XEOTICID XEO03609 MOACRIVE Inhibition DME1418 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1418 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03616 XEO_CLAS Peptide DME1418 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 16 microM) DME1418 XEOTICID XEO03616 GENEFORM Protein DME1418 XEOTICID XEO03616 MOACRIVE Inhibition DME1418 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1418 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03675 XEO_CLAS Peptide DME1418 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 60 microM) DME1418 XEOTICID XEO03675 GENEFORM Protein DME1418 XEOTICID XEO03675 MOACRIVE Inhibition DME1418 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1418 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03684 XEO_CLAS Peptide DME1418 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 125 ug/ml) DME1418 XEOTICID XEO03684 GENEFORM Protein DME1418 XEOTICID XEO03684 MOACRIVE Inhibition DME1418 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1418 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03697 XEO_CLAS Peptide DME1418 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 12.5 microM) DME1418 XEOTICID XEO03697 GENEFORM Protein DME1418 XEOTICID XEO03697 MOACRIVE Inhibition DME1418 XEOTICID XEO03768 XEO_NAME Lactacin-F subunit LafA DME1418 XEOTICID XEO03768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03768 XEO_CLAS Peptide DME1418 XEOTICID XEO03768 DESCRIPT Lactacin-F subunit LafA inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO03768 GENEFORM Protein DME1418 XEOTICID XEO03768 MOACRIVE Inhibition DME1418 XEOTICID XEO03769 XEO_NAME Lactacin-F subunit LafX DME1418 XEOTICID XEO03769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03769 XEO_CLAS Peptide DME1418 XEOTICID XEO03769 DESCRIPT Lactacin-F subunit LafX inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO03769 GENEFORM Protein DME1418 XEOTICID XEO03769 MOACRIVE Inhibition DME1418 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1418 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03771 XEO_CLAS Peptide DME1418 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO03771 GENEFORM Protein DME1418 XEOTICID XEO03771 MOACRIVE Inhibition DME1418 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1418 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03793 XEO_CLAS Peptide DME1418 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 32 microM) DME1418 XEOTICID XEO03793 GENEFORM Protein DME1418 XEOTICID XEO03793 MOACRIVE Inhibition DME1418 XEOTICID XEO03854 XEO_NAME Bacteriocin leucocin N DME1418 XEOTICID XEO03854 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03854 XEO_CLAS Peptide DME1418 XEOTICID XEO03854 DESCRIPT Bacteriocin leucocin N inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 5.20 microM) DME1418 XEOTICID XEO03854 GENEFORM Protein DME1418 XEOTICID XEO03854 MOACRIVE Inhibition DME1418 XEOTICID XEO03855 XEO_NAME Bacteriocin leucocin Q DME1418 XEOTICID XEO03855 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03855 XEO_CLAS Peptide DME1418 XEOTICID XEO03855 DESCRIPT Bacteriocin leucocin Q inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 4.10 microM) DME1418 XEOTICID XEO03855 GENEFORM Protein DME1418 XEOTICID XEO03855 MOACRIVE Inhibition DME1418 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1418 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03873 XEO_CLAS Peptide DME1418 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 30 microM) DME1418 XEOTICID XEO03873 GENEFORM Protein DME1418 XEOTICID XEO03873 MOACRIVE Inhibition DME1418 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1418 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03874 XEO_CLAS Peptide DME1418 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 22.5 microM) DME1418 XEOTICID XEO03874 GENEFORM Protein DME1418 XEOTICID XEO03874 MOACRIVE Inhibition DME1418 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1418 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03875 XEO_CLAS Peptide DME1418 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 22.5 microM) DME1418 XEOTICID XEO03875 GENEFORM Protein DME1418 XEOTICID XEO03875 MOACRIVE Inhibition DME1418 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1418 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03876 XEO_CLAS Peptide DME1418 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 15 microM) DME1418 XEOTICID XEO03876 GENEFORM Protein DME1418 XEOTICID XEO03876 MOACRIVE Inhibition DME1418 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1418 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03877 XEO_CLAS Peptide DME1418 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 11.25 microM) DME1418 XEOTICID XEO03877 GENEFORM Protein DME1418 XEOTICID XEO03877 MOACRIVE Inhibition DME1418 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1418 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03878 XEO_CLAS Peptide DME1418 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 22.5 microM) DME1418 XEOTICID XEO03878 GENEFORM Protein DME1418 XEOTICID XEO03878 MOACRIVE Inhibition DME1418 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1418 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03904 XEO_CLAS Peptide DME1418 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 4 ug/ml) DME1418 XEOTICID XEO03904 GENEFORM Protein DME1418 XEOTICID XEO03904 MOACRIVE Inhibition DME1418 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1418 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03905 XEO_CLAS Peptide DME1418 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 16 ug/ml) DME1418 XEOTICID XEO03905 GENEFORM Protein DME1418 XEOTICID XEO03905 MOACRIVE Inhibition DME1418 XEOTICID XEO03986 XEO_NAME Magainin-I peptide DME1418 XEOTICID XEO03986 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO03986 XEO_CLAS Peptide DME1418 XEOTICID XEO03986 DESCRIPT Magainin-I peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO03986 GENEFORM Protein DME1418 XEOTICID XEO03986 MOACRIVE Inhibition DME1418 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1418 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04001 XEO_CLAS Peptide DME1418 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 25 microM) DME1418 XEOTICID XEO04001 GENEFORM Protein DME1418 XEOTICID XEO04001 MOACRIVE Inhibition DME1418 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1418 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04051 XEO_CLAS Peptide DME1418 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 2.50-5.00 microM) DME1418 XEOTICID XEO04051 GENEFORM Protein DME1418 XEOTICID XEO04051 MOACRIVE Inhibition DME1418 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1418 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04052 XEO_CLAS Peptide DME1418 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04052 GENEFORM Protein DME1418 XEOTICID XEO04052 MOACRIVE Inhibition DME1418 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1418 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04053 XEO_CLAS Peptide DME1418 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 1.25-2.50 microM) DME1418 XEOTICID XEO04053 GENEFORM Protein DME1418 XEOTICID XEO04053 MOACRIVE Inhibition DME1418 XEOTICID XEO04106 XEO_NAME Methyl gallate DME1418 XEOTICID XEO04106 XEO_TYPE Pharmaceutical Agent(s) DME1418 XEOTICID XEO04106 XEO_CLAS Investigative Agent DME1418 XEOTICID XEO04106 DESCRIPT Methyl gallate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04106 GENEFORM Protein DME1418 XEOTICID XEO04106 MOACRIVE Inhibition DME1418 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1418 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04118 XEO_CLAS Peptide DME1418 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 300 microM) DME1418 XEOTICID XEO04118 GENEFORM Protein DME1418 XEOTICID XEO04118 MOACRIVE Inhibition DME1418 XEOTICID XEO04150 XEO_NAME Mundticin ATO6 DME1418 XEOTICID XEO04150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04150 XEO_CLAS Peptide DME1418 XEOTICID XEO04150 DESCRIPT Mundticin ATO6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04150 GENEFORM Protein DME1418 XEOTICID XEO04150 MOACRIVE Inhibition DME1418 XEOTICID XEO04151 XEO_NAME Mundticin KS DME1418 XEOTICID XEO04151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04151 XEO_CLAS Peptide DME1418 XEOTICID XEO04151 DESCRIPT Mundticin KS inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04151 GENEFORM Protein DME1418 XEOTICID XEO04151 MOACRIVE Inhibition DME1418 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1418 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04169 XEO_CLAS Peptide DME1418 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04169 GENEFORM Protein DME1418 XEOTICID XEO04169 MOACRIVE Inhibition DME1418 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1418 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04249 XEO_CLAS Peptide DME1418 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 500 ug/ml) DME1418 XEOTICID XEO04249 GENEFORM Protein DME1418 XEOTICID XEO04249 MOACRIVE Inhibition DME1418 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1418 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04259 XEO_CLAS Peptide DME1418 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04259 GENEFORM Protein DME1418 XEOTICID XEO04259 MOACRIVE Inhibition DME1418 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1418 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04261 XEO_CLAS Peptide DME1418 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04261 GENEFORM Protein DME1418 XEOTICID XEO04261 MOACRIVE Inhibition DME1418 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1418 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04265 XEO_CLAS Peptide DME1418 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04265 GENEFORM Protein DME1418 XEOTICID XEO04265 MOACRIVE Inhibition DME1418 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1418 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04268 XEO_CLAS Peptide DME1418 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04268 GENEFORM Protein DME1418 XEOTICID XEO04268 MOACRIVE Inhibition DME1418 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1418 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04399 XEO_CLAS Peptide DME1418 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 12.5 microM) DME1418 XEOTICID XEO04399 GENEFORM Protein DME1418 XEOTICID XEO04399 MOACRIVE Inhibition DME1418 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1418 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04444 XEO_CLAS Peptide DME1418 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 20 microM) DME1418 XEOTICID XEO04444 GENEFORM Protein DME1418 XEOTICID XEO04444 MOACRIVE Inhibition DME1418 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1418 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04461 XEO_CLAS Peptide DME1418 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 1.3 microM) DME1418 XEOTICID XEO04461 GENEFORM Protein DME1418 XEOTICID XEO04461 MOACRIVE Inhibition DME1418 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1418 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04462 XEO_CLAS Peptide DME1418 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 2.4 microM) DME1418 XEOTICID XEO04462 GENEFORM Protein DME1418 XEOTICID XEO04462 MOACRIVE Inhibition DME1418 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1418 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04463 XEO_CLAS Peptide DME1418 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04463 GENEFORM Protein DME1418 XEOTICID XEO04463 MOACRIVE Inhibition DME1418 XEOTICID XEO04468 XEO_NAME Papillosin DME1418 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04468 XEO_CLAS Peptide DME1418 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04468 GENEFORM Protein DME1418 XEOTICID XEO04468 MOACRIVE Inhibition DME1418 XEOTICID XEO04521 XEO_NAME Penocin A DME1418 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04521 XEO_CLAS Peptide DME1418 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04521 GENEFORM Protein DME1418 XEOTICID XEO04521 MOACRIVE Inhibition DME1418 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1418 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04569 XEO_CLAS Peptide DME1418 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 4.0 microM) DME1418 XEOTICID XEO04569 GENEFORM Protein DME1418 XEOTICID XEO04569 MOACRIVE Inhibition DME1418 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1418 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04612 XEO_CLAS Peptide DME1418 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 5-10 microM) DME1418 XEOTICID XEO04612 GENEFORM Protein DME1418 XEOTICID XEO04612 MOACRIVE Inhibition DME1418 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1418 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04613 XEO_CLAS Peptide DME1418 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 5-10 microM) DME1418 XEOTICID XEO04613 GENEFORM Protein DME1418 XEOTICID XEO04613 MOACRIVE Inhibition DME1418 XEOTICID XEO04622 XEO_NAME Plantaricin W alpha DME1418 XEOTICID XEO04622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04622 XEO_CLAS Peptide DME1418 XEOTICID XEO04622 DESCRIPT Plantaricin W alpha inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04622 GENEFORM Protein DME1418 XEOTICID XEO04622 MOACRIVE Inhibition DME1418 XEOTICID XEO04623 XEO_NAME Plantaricin W beta DME1418 XEOTICID XEO04623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04623 XEO_CLAS Peptide DME1418 XEOTICID XEO04623 DESCRIPT Plantaricin W beta inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04623 GENEFORM Protein DME1418 XEOTICID XEO04623 MOACRIVE Inhibition DME1418 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1418 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04657 XEO_CLAS Peptide DME1418 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 300 microM) DME1418 XEOTICID XEO04657 GENEFORM Protein DME1418 XEOTICID XEO04657 MOACRIVE Inhibition DME1418 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1418 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04660 XEO_CLAS Peptide DME1418 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 2 ug/ml) DME1418 XEOTICID XEO04660 GENEFORM Protein DME1418 XEOTICID XEO04660 MOACRIVE Inhibition DME1418 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1418 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04680 XEO_CLAS Peptide DME1418 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 1-2 microM) DME1418 XEOTICID XEO04680 GENEFORM Protein DME1418 XEOTICID XEO04680 MOACRIVE Inhibition DME1418 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1418 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04690 XEO_CLAS Peptide DME1418 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 1 ug/ml) DME1418 XEOTICID XEO04690 GENEFORM Protein DME1418 XEOTICID XEO04690 MOACRIVE Inhibition DME1418 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1418 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04695 XEO_CLAS Peptide DME1418 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04695 GENEFORM Protein DME1418 XEOTICID XEO04695 MOACRIVE Inhibition DME1418 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1418 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04696 XEO_CLAS Peptide DME1418 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04696 GENEFORM Protein DME1418 XEOTICID XEO04696 MOACRIVE Inhibition DME1418 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1418 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04699 XEO_CLAS Peptide DME1418 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04699 GENEFORM Protein DME1418 XEOTICID XEO04699 MOACRIVE Inhibition DME1418 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1418 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04700 XEO_CLAS Peptide DME1418 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04700 GENEFORM Protein DME1418 XEOTICID XEO04700 MOACRIVE Inhibition DME1418 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1418 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04701 XEO_CLAS Peptide DME1418 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04701 GENEFORM Protein DME1418 XEOTICID XEO04701 MOACRIVE Inhibition DME1418 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1418 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04702 XEO_CLAS Peptide DME1418 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04702 GENEFORM Protein DME1418 XEOTICID XEO04702 MOACRIVE Inhibition DME1418 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1418 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04703 XEO_CLAS Peptide DME1418 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04703 GENEFORM Protein DME1418 XEOTICID XEO04703 MOACRIVE Inhibition DME1418 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1418 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04704 XEO_CLAS Peptide DME1418 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04704 GENEFORM Protein DME1418 XEOTICID XEO04704 MOACRIVE Inhibition DME1418 XEOTICID XEO04727 XEO_NAME Propyl gallate DME1418 XEOTICID XEO04727 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1418 XEOTICID XEO04727 XEO_CLAS Food Additive DME1418 XEOTICID XEO04727 DESCRIPT Propyl gallate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04727 GENEFORM Protein DME1418 XEOTICID XEO04727 MOACRIVE Inhibition DME1418 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1418 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04783 XEO_CLAS Peptide DME1418 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 8 ug/ml) DME1418 XEOTICID XEO04783 GENEFORM Protein DME1418 XEOTICID XEO04783 MOACRIVE Inhibition DME1418 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1418 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04784 XEO_CLAS Peptide DME1418 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 16 ug/ml) DME1418 XEOTICID XEO04784 GENEFORM Protein DME1418 XEOTICID XEO04784 MOACRIVE Inhibition DME1418 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1418 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04785 XEO_CLAS Peptide DME1418 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 8 ug/ml) DME1418 XEOTICID XEO04785 GENEFORM Protein DME1418 XEOTICID XEO04785 MOACRIVE Inhibition DME1418 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1418 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04786 XEO_CLAS Peptide DME1418 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 125 ug/ml) DME1418 XEOTICID XEO04786 GENEFORM Protein DME1418 XEOTICID XEO04786 MOACRIVE Inhibition DME1418 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1418 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04809 XEO_CLAS Peptide DME1418 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 40 microM) DME1418 XEOTICID XEO04809 GENEFORM Protein DME1418 XEOTICID XEO04809 MOACRIVE Inhibition DME1418 XEOTICID XEO04863 XEO_NAME RTD peptide DME1418 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04863 XEO_CLAS Peptide DME1418 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 1.2 microM) DME1418 XEOTICID XEO04863 GENEFORM Protein DME1418 XEOTICID XEO04863 MOACRIVE Inhibition DME1418 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1418 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04880 XEO_CLAS Peptide DME1418 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 12.7 ug/ml) DME1418 XEOTICID XEO04880 GENEFORM Protein DME1418 XEOTICID XEO04880 MOACRIVE Inhibition DME1418 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1418 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04886 XEO_CLAS Peptide DME1418 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 12.7 ug/ml) DME1418 XEOTICID XEO04886 GENEFORM Protein DME1418 XEOTICID XEO04886 MOACRIVE Inhibition DME1418 XEOTICID XEO04896 XEO_NAME Sakacin 5X DME1418 XEOTICID XEO04896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04896 XEO_CLAS Peptide DME1418 XEOTICID XEO04896 DESCRIPT Sakacin 5X inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04896 GENEFORM Protein DME1418 XEOTICID XEO04896 MOACRIVE Inhibition DME1418 XEOTICID XEO04898 XEO_NAME Sakacin P DME1418 XEOTICID XEO04898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04898 XEO_CLAS Peptide DME1418 XEOTICID XEO04898 DESCRIPT Sakacin P inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04898 GENEFORM Protein DME1418 XEOTICID XEO04898 MOACRIVE Inhibition DME1418 XEOTICID XEO04936 XEO_NAME Siamycin I DME1418 XEOTICID XEO04936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04936 XEO_CLAS Peptide DME1418 XEOTICID XEO04936 DESCRIPT Siamycin I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO04936 GENEFORM Protein DME1418 XEOTICID XEO04936 MOACRIVE Inhibition DME1418 XEOTICID XEO04937 XEO_NAME Signiferin-2.1 DME1418 XEOTICID XEO04937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04937 XEO_CLAS Peptide DME1418 XEOTICID XEO04937 DESCRIPT Signiferin-2.1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 100 microM) DME1418 XEOTICID XEO04937 GENEFORM Protein DME1418 XEOTICID XEO04937 MOACRIVE Inhibition DME1418 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1418 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04950 XEO_CLAS Peptide DME1418 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 10 ug/ml) DME1418 XEOTICID XEO04950 GENEFORM Protein DME1418 XEOTICID XEO04950 MOACRIVE Inhibition DME1418 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1418 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04995 XEO_CLAS Peptide DME1418 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 0.78-1.56 microM) DME1418 XEOTICID XEO04995 GENEFORM Protein DME1418 XEOTICID XEO04995 MOACRIVE Inhibition DME1418 XEOTICID XEO04998 XEO_NAME Styelin A DME1418 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04998 XEO_CLAS Peptide DME1418 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 2 ug/ml) DME1418 XEOTICID XEO04998 GENEFORM Protein DME1418 XEOTICID XEO04998 MOACRIVE Inhibition DME1418 XEOTICID XEO04999 XEO_NAME Styelin B DME1418 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO04999 XEO_CLAS Peptide DME1418 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 2 ug/ml) DME1418 XEOTICID XEO04999 GENEFORM Protein DME1418 XEOTICID XEO04999 MOACRIVE Inhibition DME1418 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1418 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05000 XEO_CLAS Peptide DME1418 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 4 ug/ml) DME1418 XEOTICID XEO05000 GENEFORM Protein DME1418 XEOTICID XEO05000 MOACRIVE Inhibition DME1418 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1418 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05001 XEO_CLAS Peptide DME1418 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 4 ug/ml) DME1418 XEOTICID XEO05001 GENEFORM Protein DME1418 XEOTICID XEO05001 MOACRIVE Inhibition DME1418 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1418 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05002 XEO_CLAS Peptide DME1418 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 2 ug/ml) DME1418 XEOTICID XEO05002 GENEFORM Protein DME1418 XEOTICID XEO05002 MOACRIVE Inhibition DME1418 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1418 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05003 XEO_CLAS Peptide DME1418 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 8 ug/ml) DME1418 XEOTICID XEO05003 GENEFORM Protein DME1418 XEOTICID XEO05003 MOACRIVE Inhibition DME1418 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1418 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05005 XEO_CLAS Peptide DME1418 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO05005 GENEFORM Protein DME1418 XEOTICID XEO05005 MOACRIVE Inhibition DME1418 XEOTICID XEO05006 XEO_NAME Substance P DME1418 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05006 XEO_CLAS Peptide DME1418 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO05006 GENEFORM Protein DME1418 XEOTICID XEO05006 MOACRIVE Inhibition DME1418 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1418 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05007 XEO_CLAS Peptide DME1418 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO05007 GENEFORM Protein DME1418 XEOTICID XEO05007 MOACRIVE Inhibition DME1418 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1418 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05063 XEO_CLAS Peptide DME1418 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 10 microM) DME1418 XEOTICID XEO05063 GENEFORM Protein DME1418 XEOTICID XEO05063 MOACRIVE Inhibition DME1418 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1418 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05064 XEO_CLAS Peptide DME1418 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 116 microM) DME1418 XEOTICID XEO05064 GENEFORM Protein DME1418 XEOTICID XEO05064 MOACRIVE Inhibition DME1418 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1418 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05065 XEO_CLAS Peptide DME1418 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC > 80 ug/ml) DME1418 XEOTICID XEO05065 GENEFORM Protein DME1418 XEOTICID XEO05065 MOACRIVE Inhibition DME1418 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1418 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05073 XEO_CLAS Peptide DME1418 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 40 microM) DME1418 XEOTICID XEO05073 GENEFORM Protein DME1418 XEOTICID XEO05073 MOACRIVE Inhibition DME1418 XEOTICID XEO05074 XEO_NAME Temporin-1Vb DME1418 XEOTICID XEO05074 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05074 XEO_CLAS Peptide DME1418 XEOTICID XEO05074 DESCRIPT Temporin-1Vb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 20 microM) DME1418 XEOTICID XEO05074 GENEFORM Protein DME1418 XEOTICID XEO05074 MOACRIVE Inhibition DME1418 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1418 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05075 XEO_CLAS Peptide DME1418 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 40 microM) DME1418 XEOTICID XEO05075 GENEFORM Protein DME1418 XEOTICID XEO05075 MOACRIVE Inhibition DME1418 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1418 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05097 XEO_CLAS Peptide DME1418 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 8.0 microM) DME1418 XEOTICID XEO05097 GENEFORM Protein DME1418 XEOTICID XEO05097 MOACRIVE Inhibition DME1418 XEOTICID XEO05098 XEO_NAME Temporin-PEa DME1418 XEOTICID XEO05098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05098 XEO_CLAS Peptide DME1418 XEOTICID XEO05098 DESCRIPT Temporin-PEa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 2.0 microM) DME1418 XEOTICID XEO05098 GENEFORM Protein DME1418 XEOTICID XEO05098 MOACRIVE Inhibition DME1418 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1418 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05099 XEO_CLAS Peptide DME1418 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 2.0 microM) DME1418 XEOTICID XEO05099 GENEFORM Protein DME1418 XEOTICID XEO05099 MOACRIVE Inhibition DME1418 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1418 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05170 XEO_CLAS Peptide DME1418 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 1.0 microM) DME1418 XEOTICID XEO05170 GENEFORM Protein DME1418 XEOTICID XEO05170 MOACRIVE Inhibition DME1418 XEOTICID XEO05196 XEO_NAME Ubericin-A DME1418 XEOTICID XEO05196 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05196 XEO_CLAS Peptide DME1418 XEOTICID XEO05196 DESCRIPT Ubericin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO05196 GENEFORM Protein DME1418 XEOTICID XEO05196 MOACRIVE Inhibition DME1418 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1418 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05212 XEO_CLAS Peptide DME1418 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 50.8 ug/ml) DME1418 XEOTICID XEO05212 GENEFORM Protein DME1418 XEOTICID XEO05212 MOACRIVE Inhibition DME1418 XEOTICID XEO05224 XEO_NAME Vancomycin DME1418 XEOTICID XEO05224 XEO_TYPE Pharmaceutical Agent(s) DME1418 XEOTICID XEO05224 XEO_CLAS Approved/Marketed Drug DME1418 XEOTICID XEO05224 DESCRIPT Vancomycin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO05224 GENEFORM Protein DME1418 XEOTICID XEO05224 MOACRIVE Inhibition DME1418 XEOTICID XEO05228 XEO_NAME Variacin DME1418 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05228 XEO_CLAS Peptide DME1418 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO05228 GENEFORM Protein DME1418 XEOTICID XEO05228 MOACRIVE Inhibition DME1418 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1418 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05264 XEO_CLAS Peptide DME1418 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 4 ug/ml) DME1418 XEOTICID XEO05264 GENEFORM Protein DME1418 XEOTICID XEO05264 MOACRIVE Inhibition DME1418 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1418 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05267 XEO_CLAS Peptide DME1418 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis (MIC = 2 ug/ml) DME1418 XEOTICID XEO05267 GENEFORM Protein DME1418 XEOTICID XEO05267 MOACRIVE Inhibition DME1418 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1418 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1418 XEOTICID XEO05283 XEO_CLAS Peptide DME1418 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Enterococcus faecalis DME1418 XEOTICID XEO05283 GENEFORM Protein DME1418 XEOTICID XEO05283 MOACRIVE Inhibition DME1422 DME___ID DME1422 DME1422 DME_NAME Molybdopterin-dependent enzyme (molD) DME1422 SPESNAME Escherichia coli DME1422 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1422 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00117 GENEFORM Protein DME1422 XEOTICID XEO00117 MOACRIVE Inhibition DME1422 XEOTICID XEO00122 XEO_NAME Amikacin DME1422 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00122 GENEFORM Protein DME1422 XEOTICID XEO00122 MOACRIVE Inhibition DME1422 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1422 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00136 GENEFORM Protein DME1422 XEOTICID XEO00136 MOACRIVE Inhibition DME1422 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1422 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00237 GENEFORM Protein DME1422 XEOTICID XEO00237 MOACRIVE Inhibition DME1422 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1422 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00349 GENEFORM Protein DME1422 XEOTICID XEO00349 MOACRIVE Inhibition DME1422 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1422 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00425 GENEFORM Protein DME1422 XEOTICID XEO00425 MOACRIVE Inhibition DME1422 XEOTICID XEO00439 XEO_NAME Daidzein DME1422 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00439 GENEFORM Protein DME1422 XEOTICID XEO00439 MOACRIVE Inhibition DME1422 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1422 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00460 GENEFORM Protein DME1422 XEOTICID XEO00460 MOACRIVE Inhibition DME1422 XEOTICID XEO00487 XEO_NAME Thymol DME1422 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00487 GENEFORM Protein DME1422 XEOTICID XEO00487 MOACRIVE Inhibition DME1422 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1422 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00511 GENEFORM Protein DME1422 XEOTICID XEO00511 MOACRIVE Inhibition DME1422 XEOTICID XEO00537 XEO_NAME Luteolin DME1422 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1422 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00537 GENEFORM Protein DME1422 XEOTICID XEO00537 MOACRIVE Inhibition DME1422 XEOTICID XEO00538 XEO_NAME Quercetin DME1422 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1422 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00538 GENEFORM Protein DME1422 XEOTICID XEO00538 MOACRIVE Inhibition DME1422 XEOTICID XEO00547 XEO_NAME Vitamin E DME1422 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1422 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00547 GENEFORM Protein DME1422 XEOTICID XEO00547 MOACRIVE Inhibition DME1422 XEOTICID XEO00557 XEO_NAME Genistein DME1422 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1422 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00557 GENEFORM Protein DME1422 XEOTICID XEO00557 MOACRIVE Inhibition DME1422 XEOTICID XEO00566 XEO_NAME Guaiacol DME1422 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1422 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00566 GENEFORM Protein DME1422 XEOTICID XEO00566 MOACRIVE Inhibition DME1422 XEOTICID XEO00568 XEO_NAME Resveratrol DME1422 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1422 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00568 GENEFORM Protein DME1422 XEOTICID XEO00568 MOACRIVE Inhibition DME1422 XEOTICID XEO00573 XEO_NAME Naringenin DME1422 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1422 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00573 GENEFORM Protein DME1422 XEOTICID XEO00573 MOACRIVE Inhibition DME1422 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1422 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1422 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00574 GENEFORM Protein DME1422 XEOTICID XEO00574 MOACRIVE Inhibition DME1422 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1422 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1422 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00611 GENEFORM Protein DME1422 XEOTICID XEO00611 MOACRIVE Inhibition DME1422 XEOTICID XEO00621 XEO_NAME Chitosan DME1422 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1422 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00621 GENEFORM Protein DME1422 XEOTICID XEO00621 MOACRIVE Inhibition DME1422 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1422 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1422 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00646 GENEFORM Protein DME1422 XEOTICID XEO00646 MOACRIVE Inhibition DME1422 XEOTICID XEO00683 XEO_NAME Curcumin DME1422 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1422 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00683 GENEFORM Protein DME1422 XEOTICID XEO00683 MOACRIVE Inhibition DME1422 XEOTICID XEO00727 XEO_NAME Vanillin DME1422 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1422 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00727 GENEFORM Protein DME1422 XEOTICID XEO00727 MOACRIVE Inhibition DME1422 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1422 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1422 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00730 GENEFORM Protein DME1422 XEOTICID XEO00730 MOACRIVE Inhibition DME1422 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1422 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO00782 XEO_CLAS Natural Product DME1422 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00782 GENEFORM Protein DME1422 XEOTICID XEO00782 MOACRIVE Inhibition DME1422 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1422 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1422 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00866 GENEFORM Protein DME1422 XEOTICID XEO00866 MOACRIVE Inhibition DME1422 XEOTICID XEO00878 XEO_NAME Chrysin DME1422 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO00878 XEO_CLAS Natural Product DME1422 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00878 GENEFORM Protein DME1422 XEOTICID XEO00878 MOACRIVE Inhibition DME1422 XEOTICID XEO00879 XEO_NAME Coumarin DME1422 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1422 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1422 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00879 GENEFORM Protein DME1422 XEOTICID XEO00879 MOACRIVE Inhibition DME1422 XEOTICID XEO00883 XEO_NAME Phloretin DME1422 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO00883 XEO_CLAS Natural Product DME1422 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00883 GENEFORM Protein DME1422 XEOTICID XEO00883 MOACRIVE Inhibition DME1422 XEOTICID XEO00885 XEO_NAME Eugenol DME1422 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1422 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO00885 GENEFORM Protein DME1422 XEOTICID XEO00885 MOACRIVE Inhibition DME1422 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1422 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1422 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1422 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01032 GENEFORM Protein DME1422 XEOTICID XEO01032 MOACRIVE Inhibition DME1422 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1422 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01174 XEO_CLAS Natural Product DME1422 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01174 GENEFORM Protein DME1422 XEOTICID XEO01174 MOACRIVE Inhibition DME1422 XEOTICID XEO01203 XEO_NAME Apigenin DME1422 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01203 XEO_CLAS Natural Product DME1422 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01203 GENEFORM Protein DME1422 XEOTICID XEO01203 MOACRIVE Inhibition DME1422 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1422 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1422 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1422 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01232 GENEFORM Protein DME1422 XEOTICID XEO01232 MOACRIVE Inhibition DME1422 XEOTICID XEO01237 XEO_NAME Carvacrol DME1422 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1422 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01237 GENEFORM Protein DME1422 XEOTICID XEO01237 MOACRIVE Inhibition DME1422 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1422 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1422 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01287 GENEFORM Protein DME1422 XEOTICID XEO01287 MOACRIVE Inhibition DME1422 XEOTICID XEO01291 XEO_NAME Esculetin DME1422 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1422 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01291 GENEFORM Protein DME1422 XEOTICID XEO01291 MOACRIVE Inhibition DME1422 XEOTICID XEO01304 XEO_NAME Flavone DME1422 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01304 XEO_CLAS Natural Product DME1422 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01304 GENEFORM Protein DME1422 XEOTICID XEO01304 MOACRIVE Inhibition DME1422 XEOTICID XEO01309 XEO_NAME Gallic acid DME1422 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01309 XEO_CLAS Natural Product DME1422 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01309 GENEFORM Protein DME1422 XEOTICID XEO01309 MOACRIVE Inhibition DME1422 XEOTICID XEO01340 XEO_NAME Imperatorin DME1422 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01340 XEO_CLAS Natural Product DME1422 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01340 GENEFORM Protein DME1422 XEOTICID XEO01340 MOACRIVE Inhibition DME1422 XEOTICID XEO01353 XEO_NAME Kaempferol DME1422 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1422 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1422 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01353 GENEFORM Protein DME1422 XEOTICID XEO01353 MOACRIVE Inhibition DME1422 XEOTICID XEO01366 XEO_NAME Linalool DME1422 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01366 XEO_CLAS Natural Product DME1422 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01366 GENEFORM Protein DME1422 XEOTICID XEO01366 MOACRIVE Inhibition DME1422 XEOTICID XEO01391 XEO_NAME Naringin DME1422 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01391 XEO_CLAS Natural Product DME1422 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01391 GENEFORM Protein DME1422 XEOTICID XEO01391 MOACRIVE Inhibition DME1422 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1422 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1422 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01420 GENEFORM Protein DME1422 XEOTICID XEO01420 MOACRIVE Inhibition DME1422 XEOTICID XEO01463 XEO_NAME Rutin DME1422 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01463 XEO_CLAS Natural Product DME1422 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01463 GENEFORM Protein DME1422 XEOTICID XEO01463 MOACRIVE Inhibition DME1422 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1422 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1422 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01496 GENEFORM Protein DME1422 XEOTICID XEO01496 MOACRIVE Inhibition DME1422 XEOTICID XEO01512 XEO_NAME Zinc DME1422 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1422 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1422 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01512 GENEFORM Protein DME1422 XEOTICID XEO01512 MOACRIVE Inhibition DME1422 XEOTICID XEO01527 XEO_NAME Bergamottin DME1422 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01527 XEO_CLAS Natural Product DME1422 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01527 GENEFORM Protein DME1422 XEOTICID XEO01527 MOACRIVE Inhibition DME1422 XEOTICID XEO01531 XEO_NAME Clove oil DME1422 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01531 XEO_CLAS Natural Product DME1422 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01531 GENEFORM Protein DME1422 XEOTICID XEO01531 MOACRIVE Inhibition DME1422 XEOTICID XEO01559 XEO_NAME Limonene DME1422 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01559 XEO_CLAS Natural Product DME1422 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01559 GENEFORM Protein DME1422 XEOTICID XEO01559 MOACRIVE Inhibition DME1422 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1422 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01563 XEO_CLAS Natural Product DME1422 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01563 GENEFORM Protein DME1422 XEOTICID XEO01563 MOACRIVE Inhibition DME1422 XEOTICID XEO01566 XEO_NAME Nobiletin DME1422 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01566 XEO_CLAS Natural Product DME1422 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01566 GENEFORM Protein DME1422 XEOTICID XEO01566 MOACRIVE Inhibition DME1422 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1422 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01778 XEO_CLAS Natural Product DME1422 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01778 GENEFORM Protein DME1422 XEOTICID XEO01778 MOACRIVE Inhibition DME1422 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1422 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01779 XEO_CLAS Peptide DME1422 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 128 microM) DME1422 XEOTICID XEO01779 GENEFORM Protein DME1422 XEOTICID XEO01779 MOACRIVE Inhibition DME1422 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1422 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01810 XEO_CLAS Peptide DME1422 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.0 microM) DME1422 XEOTICID XEO01810 GENEFORM Protein DME1422 XEOTICID XEO01810 MOACRIVE Inhibition DME1422 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1422 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01811 XEO_CLAS Peptide DME1422 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 microM) DME1422 XEOTICID XEO01811 GENEFORM Protein DME1422 XEOTICID XEO01811 MOACRIVE Inhibition DME1422 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1422 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01812 XEO_CLAS Peptide DME1422 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10.4 microM) DME1422 XEOTICID XEO01812 GENEFORM Protein DME1422 XEOTICID XEO01812 MOACRIVE Inhibition DME1422 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1422 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01813 XEO_CLAS Peptide DME1422 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.1 microM) DME1422 XEOTICID XEO01813 GENEFORM Protein DME1422 XEOTICID XEO01813 MOACRIVE Inhibition DME1422 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1422 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01814 XEO_CLAS Peptide DME1422 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.5 microM) DME1422 XEOTICID XEO01814 GENEFORM Protein DME1422 XEOTICID XEO01814 MOACRIVE Inhibition DME1422 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1422 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01815 XEO_CLAS Peptide DME1422 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 9.8 microM) DME1422 XEOTICID XEO01815 GENEFORM Protein DME1422 XEOTICID XEO01815 MOACRIVE Inhibition DME1422 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1422 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01816 XEO_CLAS Peptide DME1422 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO01816 GENEFORM Protein DME1422 XEOTICID XEO01816 MOACRIVE Inhibition DME1422 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1422 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01817 XEO_CLAS Peptide DME1422 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.0 microM) DME1422 XEOTICID XEO01817 GENEFORM Protein DME1422 XEOTICID XEO01817 MOACRIVE Inhibition DME1422 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1422 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01818 XEO_CLAS Peptide DME1422 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4.0 microM) DME1422 XEOTICID XEO01818 GENEFORM Protein DME1422 XEOTICID XEO01818 MOACRIVE Inhibition DME1422 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1422 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01819 XEO_CLAS Peptide DME1422 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO01819 GENEFORM Protein DME1422 XEOTICID XEO01819 MOACRIVE Inhibition DME1422 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1422 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01820 XEO_CLAS Peptide DME1422 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO01820 GENEFORM Protein DME1422 XEOTICID XEO01820 MOACRIVE Inhibition DME1422 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1422 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01821 XEO_CLAS Peptide DME1422 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO01821 GENEFORM Protein DME1422 XEOTICID XEO01821 MOACRIVE Inhibition DME1422 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1422 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01822 XEO_CLAS Peptide DME1422 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 microM) DME1422 XEOTICID XEO01822 GENEFORM Protein DME1422 XEOTICID XEO01822 MOACRIVE Inhibition DME1422 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1422 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01823 XEO_CLAS Peptide DME1422 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO01823 GENEFORM Protein DME1422 XEOTICID XEO01823 MOACRIVE Inhibition DME1422 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1422 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01824 XEO_CLAS Peptide DME1422 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO01824 GENEFORM Protein DME1422 XEOTICID XEO01824 MOACRIVE Inhibition DME1422 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1422 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01825 XEO_CLAS Peptide DME1422 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25.0 microM) DME1422 XEOTICID XEO01825 GENEFORM Protein DME1422 XEOTICID XEO01825 MOACRIVE Inhibition DME1422 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1422 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01827 XEO_CLAS Peptide DME1422 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.12-6.25 microM) DME1422 XEOTICID XEO01827 GENEFORM Protein DME1422 XEOTICID XEO01827 MOACRIVE Inhibition DME1422 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1422 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1422 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1422 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01829 GENEFORM Protein DME1422 XEOTICID XEO01829 MOACRIVE Inhibition DME1422 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1422 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01927 XEO_CLAS Peptide DME1422 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 ug/ml) DME1422 XEOTICID XEO01927 GENEFORM Protein DME1422 XEOTICID XEO01927 MOACRIVE Inhibition DME1422 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1422 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01945 XEO_CLAS Peptide DME1422 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.1 microM) DME1422 XEOTICID XEO01945 GENEFORM Protein DME1422 XEOTICID XEO01945 MOACRIVE Inhibition DME1422 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1422 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01946 XEO_CLAS Peptide DME1422 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.2 microM) DME1422 XEOTICID XEO01946 GENEFORM Protein DME1422 XEOTICID XEO01946 MOACRIVE Inhibition DME1422 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1422 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO01947 XEO_CLAS Natural Product DME1422 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01947 GENEFORM Protein DME1422 XEOTICID XEO01947 MOACRIVE Inhibition DME1422 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1422 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1422 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1422 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01950 GENEFORM Protein DME1422 XEOTICID XEO01950 MOACRIVE Inhibition DME1422 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1422 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1422 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1422 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01961 GENEFORM Protein DME1422 XEOTICID XEO01961 MOACRIVE Inhibition DME1422 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1422 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1422 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1422 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO01966 GENEFORM Protein DME1422 XEOTICID XEO01966 MOACRIVE Inhibition DME1422 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1422 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01996 XEO_CLAS Peptide DME1422 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.7 microM) DME1422 XEOTICID XEO01996 GENEFORM Protein DME1422 XEOTICID XEO01996 MOACRIVE Inhibition DME1422 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1422 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01997 XEO_CLAS Peptide DME1422 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.9 microM) DME1422 XEOTICID XEO01997 GENEFORM Protein DME1422 XEOTICID XEO01997 MOACRIVE Inhibition DME1422 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1422 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01998 XEO_CLAS Peptide DME1422 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO01998 GENEFORM Protein DME1422 XEOTICID XEO01998 MOACRIVE Inhibition DME1422 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1422 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO01999 XEO_CLAS Peptide DME1422 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.5 microM) DME1422 XEOTICID XEO01999 GENEFORM Protein DME1422 XEOTICID XEO01999 MOACRIVE Inhibition DME1422 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1422 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02013 XEO_CLAS Peptide DME1422 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02013 GENEFORM Protein DME1422 XEOTICID XEO02013 MOACRIVE Inhibition DME1422 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1422 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02032 XEO_CLAS Natural Product DME1422 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02032 GENEFORM Protein DME1422 XEOTICID XEO02032 MOACRIVE Inhibition DME1422 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1422 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02033 XEO_CLAS Natural Product DME1422 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02033 GENEFORM Protein DME1422 XEOTICID XEO02033 MOACRIVE Inhibition DME1422 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1422 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02079 XEO_CLAS Natural Product DME1422 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02079 GENEFORM Protein DME1422 XEOTICID XEO02079 MOACRIVE Inhibition DME1422 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1422 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1422 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02085 GENEFORM Protein DME1422 XEOTICID XEO02085 MOACRIVE Inhibition DME1422 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1422 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02111 XEO_CLAS Peptide DME1422 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2-4 ug/ml) DME1422 XEOTICID XEO02111 GENEFORM Protein DME1422 XEOTICID XEO02111 MOACRIVE Inhibition DME1422 XEOTICID XEO02113 XEO_NAME Abaecin DME1422 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02113 XEO_CLAS Peptide DME1422 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02113 GENEFORM Protein DME1422 XEOTICID XEO02113 MOACRIVE Inhibition DME1422 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1422 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02114 XEO_CLAS Peptide DME1422 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-25 ug/ml) DME1422 XEOTICID XEO02114 GENEFORM Protein DME1422 XEOTICID XEO02114 MOACRIVE Inhibition DME1422 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1422 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02115 XEO_CLAS Peptide DME1422 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02115 GENEFORM Protein DME1422 XEOTICID XEO02115 MOACRIVE Inhibition DME1422 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1422 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02117 XEO_CLAS Peptide DME1422 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02117 GENEFORM Protein DME1422 XEOTICID XEO02117 MOACRIVE Inhibition DME1422 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1422 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02118 XEO_CLAS Peptide DME1422 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02118 GENEFORM Protein DME1422 XEOTICID XEO02118 MOACRIVE Inhibition DME1422 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1422 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02119 XEO_CLAS Peptide DME1422 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02119 GENEFORM Protein DME1422 XEOTICID XEO02119 MOACRIVE Inhibition DME1422 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1422 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02120 XEO_CLAS Peptide DME1422 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02120 GENEFORM Protein DME1422 XEOTICID XEO02120 MOACRIVE Inhibition DME1422 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1422 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02121 XEO_CLAS Peptide DME1422 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02121 GENEFORM Protein DME1422 XEOTICID XEO02121 MOACRIVE Inhibition DME1422 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1422 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02122 XEO_CLAS Peptide DME1422 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 ug/ml) DME1422 XEOTICID XEO02122 GENEFORM Protein DME1422 XEOTICID XEO02122 MOACRIVE Inhibition DME1422 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1422 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02130 XEO_CLAS Peptide DME1422 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.7 microM) DME1422 XEOTICID XEO02130 GENEFORM Protein DME1422 XEOTICID XEO02130 MOACRIVE Inhibition DME1422 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1422 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02131 XEO_CLAS Peptide DME1422 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.3 microM) DME1422 XEOTICID XEO02131 GENEFORM Protein DME1422 XEOTICID XEO02131 MOACRIVE Inhibition DME1422 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1422 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02132 XEO_CLAS Peptide DME1422 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.5 microM) DME1422 XEOTICID XEO02132 GENEFORM Protein DME1422 XEOTICID XEO02132 MOACRIVE Inhibition DME1422 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1422 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02136 XEO_CLAS Peptide DME1422 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 ug/ml) DME1422 XEOTICID XEO02136 GENEFORM Protein DME1422 XEOTICID XEO02136 MOACRIVE Inhibition DME1422 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1422 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02147 XEO_CLAS Peptide DME1422 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 382 ug/ml) DME1422 XEOTICID XEO02147 GENEFORM Protein DME1422 XEOTICID XEO02147 MOACRIVE Inhibition DME1422 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1422 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02149 XEO_CLAS Peptide DME1422 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 47.35 microM) DME1422 XEOTICID XEO02149 GENEFORM Protein DME1422 XEOTICID XEO02149 MOACRIVE Inhibition DME1422 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1422 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02164 XEO_CLAS Peptide DME1422 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02164 GENEFORM Protein DME1422 XEOTICID XEO02164 MOACRIVE Inhibition DME1422 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1422 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02165 XEO_CLAS Peptide DME1422 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02165 GENEFORM Protein DME1422 XEOTICID XEO02165 MOACRIVE Inhibition DME1422 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1422 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02166 XEO_CLAS Peptide DME1422 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02166 GENEFORM Protein DME1422 XEOTICID XEO02166 MOACRIVE Inhibition DME1422 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1422 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02167 XEO_CLAS Peptide DME1422 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02167 GENEFORM Protein DME1422 XEOTICID XEO02167 MOACRIVE Inhibition DME1422 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1422 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02168 XEO_CLAS Peptide DME1422 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02168 GENEFORM Protein DME1422 XEOTICID XEO02168 MOACRIVE Inhibition DME1422 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1422 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02169 XEO_CLAS Peptide DME1422 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02169 GENEFORM Protein DME1422 XEOTICID XEO02169 MOACRIVE Inhibition DME1422 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1422 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02170 XEO_CLAS Peptide DME1422 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.4 microM) DME1422 XEOTICID XEO02170 GENEFORM Protein DME1422 XEOTICID XEO02170 MOACRIVE Inhibition DME1422 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1422 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02175 XEO_CLAS Natural Product DME1422 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02175 GENEFORM Protein DME1422 XEOTICID XEO02175 MOACRIVE Inhibition DME1422 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1422 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02177 XEO_CLAS Peptide DME1422 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO02177 GENEFORM Protein DME1422 XEOTICID XEO02177 MOACRIVE Inhibition DME1422 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1422 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02178 XEO_CLAS Peptide DME1422 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO02178 GENEFORM Protein DME1422 XEOTICID XEO02178 MOACRIVE Inhibition DME1422 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1422 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02179 XEO_CLAS Peptide DME1422 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO02179 GENEFORM Protein DME1422 XEOTICID XEO02179 MOACRIVE Inhibition DME1422 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1422 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02180 XEO_CLAS Peptide DME1422 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 214 microM) DME1422 XEOTICID XEO02180 GENEFORM Protein DME1422 XEOTICID XEO02180 MOACRIVE Inhibition DME1422 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1422 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02181 XEO_CLAS Peptide DME1422 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 217 microM) DME1422 XEOTICID XEO02181 GENEFORM Protein DME1422 XEOTICID XEO02181 MOACRIVE Inhibition DME1422 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1422 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02183 XEO_CLAS Peptide DME1422 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 38.4 microM) DME1422 XEOTICID XEO02183 GENEFORM Protein DME1422 XEOTICID XEO02183 MOACRIVE Inhibition DME1422 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1422 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02185 XEO_CLAS Peptide DME1422 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 microM) DME1422 XEOTICID XEO02185 GENEFORM Protein DME1422 XEOTICID XEO02185 MOACRIVE Inhibition DME1422 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1422 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02187 GENEFORM Protein DME1422 XEOTICID XEO02187 MOACRIVE Inhibition DME1422 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1422 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02191 XEO_CLAS Peptide DME1422 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02191 GENEFORM Protein DME1422 XEOTICID XEO02191 MOACRIVE Inhibition DME1422 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1422 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02192 XEO_CLAS Peptide DME1422 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.50 ug/ml) DME1422 XEOTICID XEO02192 GENEFORM Protein DME1422 XEOTICID XEO02192 MOACRIVE Inhibition DME1422 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1422 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02193 XEO_CLAS Peptide DME1422 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02193 GENEFORM Protein DME1422 XEOTICID XEO02193 MOACRIVE Inhibition DME1422 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1422 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02194 XEO_CLAS Peptide DME1422 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02194 GENEFORM Protein DME1422 XEOTICID XEO02194 MOACRIVE Inhibition DME1422 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1422 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02195 XEO_CLAS Peptide DME1422 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.00 ug/ml) DME1422 XEOTICID XEO02195 GENEFORM Protein DME1422 XEOTICID XEO02195 MOACRIVE Inhibition DME1422 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1422 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02197 XEO_CLAS Peptide DME1422 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02197 GENEFORM Protein DME1422 XEOTICID XEO02197 MOACRIVE Inhibition DME1422 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1422 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02200 XEO_CLAS Peptide DME1422 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 ug/ml) DME1422 XEOTICID XEO02200 GENEFORM Protein DME1422 XEOTICID XEO02200 MOACRIVE Inhibition DME1422 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1422 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02201 XEO_CLAS Peptide DME1422 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 ug/ml) DME1422 XEOTICID XEO02201 GENEFORM Protein DME1422 XEOTICID XEO02201 MOACRIVE Inhibition DME1422 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1422 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02202 XEO_CLAS Peptide DME1422 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO02202 GENEFORM Protein DME1422 XEOTICID XEO02202 MOACRIVE Inhibition DME1422 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1422 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02203 XEO_CLAS Peptide DME1422 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 microM) DME1422 XEOTICID XEO02203 GENEFORM Protein DME1422 XEOTICID XEO02203 MOACRIVE Inhibition DME1422 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1422 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02207 XEO_CLAS Peptide DME1422 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.78 ug/ml) DME1422 XEOTICID XEO02207 GENEFORM Protein DME1422 XEOTICID XEO02207 MOACRIVE Inhibition DME1422 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1422 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02208 XEO_CLAS Peptide DME1422 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.13 ug/ml) DME1422 XEOTICID XEO02208 GENEFORM Protein DME1422 XEOTICID XEO02208 MOACRIVE Inhibition DME1422 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1422 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02209 XEO_CLAS Peptide DME1422 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.56 ug/ml) DME1422 XEOTICID XEO02209 GENEFORM Protein DME1422 XEOTICID XEO02209 MOACRIVE Inhibition DME1422 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1422 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02210 XEO_CLAS Peptide DME1422 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 ug/ml) DME1422 XEOTICID XEO02210 GENEFORM Protein DME1422 XEOTICID XEO02210 MOACRIVE Inhibition DME1422 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1422 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02211 XEO_CLAS Peptide DME1422 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25 ug/ml) DME1422 XEOTICID XEO02211 GENEFORM Protein DME1422 XEOTICID XEO02211 MOACRIVE Inhibition DME1422 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1422 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02212 XEO_CLAS Peptide DME1422 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.13 ug/ml) DME1422 XEOTICID XEO02212 GENEFORM Protein DME1422 XEOTICID XEO02212 MOACRIVE Inhibition DME1422 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1422 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02213 XEO_CLAS Peptide DME1422 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.13 ug/ml) DME1422 XEOTICID XEO02213 GENEFORM Protein DME1422 XEOTICID XEO02213 MOACRIVE Inhibition DME1422 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1422 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02214 XEO_CLAS Peptide DME1422 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02214 GENEFORM Protein DME1422 XEOTICID XEO02214 MOACRIVE Inhibition DME1422 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1422 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02215 XEO_CLAS Peptide DME1422 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 ug/ml) DME1422 XEOTICID XEO02215 GENEFORM Protein DME1422 XEOTICID XEO02215 MOACRIVE Inhibition DME1422 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1422 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02216 XEO_CLAS Peptide DME1422 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 126 ug/ml) DME1422 XEOTICID XEO02216 GENEFORM Protein DME1422 XEOTICID XEO02216 MOACRIVE Inhibition DME1422 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1422 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02217 XEO_CLAS Peptide DME1422 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 200 ug/ml) DME1422 XEOTICID XEO02217 GENEFORM Protein DME1422 XEOTICID XEO02217 MOACRIVE Inhibition DME1422 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1422 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02218 XEO_CLAS Peptide DME1422 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 200 ug/ml) DME1422 XEOTICID XEO02218 GENEFORM Protein DME1422 XEOTICID XEO02218 MOACRIVE Inhibition DME1422 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1422 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02219 XEO_CLAS Peptide DME1422 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 200 ug/ml) DME1422 XEOTICID XEO02219 GENEFORM Protein DME1422 XEOTICID XEO02219 MOACRIVE Inhibition DME1422 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1422 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02220 XEO_CLAS Peptide DME1422 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 23.5 ug/ml) DME1422 XEOTICID XEO02220 GENEFORM Protein DME1422 XEOTICID XEO02220 MOACRIVE Inhibition DME1422 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1422 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02221 XEO_CLAS Peptide DME1422 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20.2 ug/ml) DME1422 XEOTICID XEO02221 GENEFORM Protein DME1422 XEOTICID XEO02221 MOACRIVE Inhibition DME1422 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1422 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02222 XEO_CLAS Peptide DME1422 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30.5 ug/ml) DME1422 XEOTICID XEO02222 GENEFORM Protein DME1422 XEOTICID XEO02222 MOACRIVE Inhibition DME1422 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1422 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02223 XEO_CLAS Peptide DME1422 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.2 ug/ml) DME1422 XEOTICID XEO02223 GENEFORM Protein DME1422 XEOTICID XEO02223 MOACRIVE Inhibition DME1422 XEOTICID XEO02224 XEO_NAME Androctonin DME1422 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02224 XEO_CLAS Peptide DME1422 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02224 GENEFORM Protein DME1422 XEOTICID XEO02224 MOACRIVE Inhibition DME1422 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1422 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02225 XEO_CLAS Peptide DME1422 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02225 GENEFORM Protein DME1422 XEOTICID XEO02225 MOACRIVE Inhibition DME1422 XEOTICID XEO02226 XEO_NAME Andropin DME1422 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02226 XEO_CLAS Peptide DME1422 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 140 microM) DME1422 XEOTICID XEO02226 GENEFORM Protein DME1422 XEOTICID XEO02226 MOACRIVE Inhibition DME1422 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1422 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02230 XEO_CLAS Peptide DME1422 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.05-0.1 microM) DME1422 XEOTICID XEO02230 GENEFORM Protein DME1422 XEOTICID XEO02230 MOACRIVE Inhibition DME1422 XEOTICID XEO02232 XEO_NAME Anoplin DME1422 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02232 XEO_CLAS Peptide DME1422 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 13 ug/ml) DME1422 XEOTICID XEO02232 GENEFORM Protein DME1422 XEOTICID XEO02232 MOACRIVE Inhibition DME1422 XEOTICID XEO02233 XEO_NAME Antapin DME1422 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02233 XEO_CLAS Peptide DME1422 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02233 GENEFORM Protein DME1422 XEOTICID XEO02233 MOACRIVE Inhibition DME1422 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1422 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02236 XEO_CLAS Peptide DME1422 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02236 GENEFORM Protein DME1422 XEOTICID XEO02236 MOACRIVE Inhibition DME1422 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1422 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02239 XEO_CLAS Peptide DME1422 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 250 microM) DME1422 XEOTICID XEO02239 GENEFORM Protein DME1422 XEOTICID XEO02239 MOACRIVE Inhibition DME1422 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1422 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02240 XEO_CLAS Peptide DME1422 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 microM) DME1422 XEOTICID XEO02240 GENEFORM Protein DME1422 XEOTICID XEO02240 MOACRIVE Inhibition DME1422 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1422 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02241 XEO_CLAS Peptide DME1422 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02241 GENEFORM Protein DME1422 XEOTICID XEO02241 MOACRIVE Inhibition DME1422 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1422 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02242 XEO_CLAS Peptide DME1422 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO02242 GENEFORM Protein DME1422 XEOTICID XEO02242 MOACRIVE Inhibition DME1422 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1422 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02243 XEO_CLAS Peptide DME1422 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 microM) DME1422 XEOTICID XEO02243 GENEFORM Protein DME1422 XEOTICID XEO02243 MOACRIVE Inhibition DME1422 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1422 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02244 XEO_CLAS Peptide DME1422 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1 microM) DME1422 XEOTICID XEO02244 GENEFORM Protein DME1422 XEOTICID XEO02244 MOACRIVE Inhibition DME1422 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1422 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02245 XEO_CLAS Peptide DME1422 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02245 GENEFORM Protein DME1422 XEOTICID XEO02245 MOACRIVE Inhibition DME1422 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1422 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02246 XEO_CLAS Peptide DME1422 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 microM) DME1422 XEOTICID XEO02246 GENEFORM Protein DME1422 XEOTICID XEO02246 MOACRIVE Inhibition DME1422 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1422 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02247 XEO_CLAS Peptide DME1422 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02247 GENEFORM Protein DME1422 XEOTICID XEO02247 MOACRIVE Inhibition DME1422 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1422 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02248 XEO_CLAS Peptide DME1422 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.3 microM) DME1422 XEOTICID XEO02248 GENEFORM Protein DME1422 XEOTICID XEO02248 MOACRIVE Inhibition DME1422 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1422 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02253 XEO_CLAS Peptide DME1422 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02253 GENEFORM Protein DME1422 XEOTICID XEO02253 MOACRIVE Inhibition DME1422 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1422 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02258 XEO_CLAS Peptide DME1422 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 150 microM) DME1422 XEOTICID XEO02258 GENEFORM Protein DME1422 XEOTICID XEO02258 MOACRIVE Inhibition DME1422 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1422 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02261 XEO_CLAS Peptide DME1422 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 82 ug/ml) DME1422 XEOTICID XEO02261 GENEFORM Protein DME1422 XEOTICID XEO02261 MOACRIVE Inhibition DME1422 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1422 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02263 XEO_CLAS Peptide DME1422 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO02263 GENEFORM Protein DME1422 XEOTICID XEO02263 MOACRIVE Inhibition DME1422 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1422 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02266 XEO_CLAS Peptide DME1422 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 120 microM) DME1422 XEOTICID XEO02266 GENEFORM Protein DME1422 XEOTICID XEO02266 MOACRIVE Inhibition DME1422 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1422 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02268 XEO_CLAS Peptide DME1422 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 170 ug/ml) DME1422 XEOTICID XEO02268 GENEFORM Protein DME1422 XEOTICID XEO02268 MOACRIVE Inhibition DME1422 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1422 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02270 XEO_CLAS Peptide DME1422 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 microM) DME1422 XEOTICID XEO02270 GENEFORM Protein DME1422 XEOTICID XEO02270 MOACRIVE Inhibition DME1422 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1422 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02271 XEO_CLAS Peptide DME1422 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 302 ug/ml) DME1422 XEOTICID XEO02271 GENEFORM Protein DME1422 XEOTICID XEO02271 MOACRIVE Inhibition DME1422 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1422 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02273 XEO_CLAS Peptide DME1422 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 18 microM) DME1422 XEOTICID XEO02273 GENEFORM Protein DME1422 XEOTICID XEO02273 MOACRIVE Inhibition DME1422 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1422 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02274 XEO_CLAS Peptide DME1422 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO02274 GENEFORM Protein DME1422 XEOTICID XEO02274 MOACRIVE Inhibition DME1422 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1422 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02275 XEO_CLAS Peptide DME1422 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 microM) DME1422 XEOTICID XEO02275 GENEFORM Protein DME1422 XEOTICID XEO02275 MOACRIVE Inhibition DME1422 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1422 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02276 XEO_CLAS Peptide DME1422 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 microM) DME1422 XEOTICID XEO02276 GENEFORM Protein DME1422 XEOTICID XEO02276 MOACRIVE Inhibition DME1422 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1422 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02280 XEO_CLAS Peptide DME1422 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02280 GENEFORM Protein DME1422 XEOTICID XEO02280 MOACRIVE Inhibition DME1422 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1422 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02281 XEO_CLAS Peptide DME1422 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02281 GENEFORM Protein DME1422 XEOTICID XEO02281 MOACRIVE Inhibition DME1422 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1422 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02283 XEO_CLAS Peptide DME1422 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 ug/ml) DME1422 XEOTICID XEO02283 GENEFORM Protein DME1422 XEOTICID XEO02283 MOACRIVE Inhibition DME1422 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1422 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02284 XEO_CLAS Peptide DME1422 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50.4 microM) DME1422 XEOTICID XEO02284 GENEFORM Protein DME1422 XEOTICID XEO02284 MOACRIVE Inhibition DME1422 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1422 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02285 XEO_CLAS Peptide DME1422 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50.4 microM) DME1422 XEOTICID XEO02285 GENEFORM Protein DME1422 XEOTICID XEO02285 MOACRIVE Inhibition DME1422 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1422 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02286 XEO_CLAS Peptide DME1422 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50.4 microM) DME1422 XEOTICID XEO02286 GENEFORM Protein DME1422 XEOTICID XEO02286 MOACRIVE Inhibition DME1422 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1422 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02287 XEO_CLAS Peptide DME1422 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50.4 microM) DME1422 XEOTICID XEO02287 GENEFORM Protein DME1422 XEOTICID XEO02287 MOACRIVE Inhibition DME1422 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1422 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02288 XEO_CLAS Peptide DME1422 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.2 ug/ml) DME1422 XEOTICID XEO02288 GENEFORM Protein DME1422 XEOTICID XEO02288 MOACRIVE Inhibition DME1422 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1422 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02289 XEO_CLAS Peptide DME1422 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 ug/ml) DME1422 XEOTICID XEO02289 GENEFORM Protein DME1422 XEOTICID XEO02289 MOACRIVE Inhibition DME1422 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1422 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02290 XEO_CLAS Peptide DME1422 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO02290 GENEFORM Protein DME1422 XEOTICID XEO02290 MOACRIVE Inhibition DME1422 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1422 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02291 XEO_CLAS Peptide DME1422 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02291 GENEFORM Protein DME1422 XEOTICID XEO02291 MOACRIVE Inhibition DME1422 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1422 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02293 XEO_CLAS Peptide DME1422 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 microM) DME1422 XEOTICID XEO02293 GENEFORM Protein DME1422 XEOTICID XEO02293 MOACRIVE Inhibition DME1422 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1422 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02294 XEO_CLAS Peptide DME1422 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 62-250 ug/ml) DME1422 XEOTICID XEO02294 GENEFORM Protein DME1422 XEOTICID XEO02294 MOACRIVE Inhibition DME1422 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1422 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02295 XEO_CLAS Peptide DME1422 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 ug/ml) DME1422 XEOTICID XEO02295 GENEFORM Protein DME1422 XEOTICID XEO02295 MOACRIVE Inhibition DME1422 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1422 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02296 XEO_CLAS Peptide DME1422 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02296 GENEFORM Protein DME1422 XEOTICID XEO02296 MOACRIVE Inhibition DME1422 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1422 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02297 XEO_CLAS Peptide DME1422 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC < 50 ug/ml) DME1422 XEOTICID XEO02297 GENEFORM Protein DME1422 XEOTICID XEO02297 MOACRIVE Inhibition DME1422 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1422 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02298 XEO_CLAS Peptide DME1422 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO02298 GENEFORM Protein DME1422 XEOTICID XEO02298 MOACRIVE Inhibition DME1422 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1422 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02303 XEO_CLAS Peptide DME1422 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02303 GENEFORM Protein DME1422 XEOTICID XEO02303 MOACRIVE Inhibition DME1422 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1422 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02304 XEO_CLAS Peptide DME1422 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.1 ug/ml) DME1422 XEOTICID XEO02304 GENEFORM Protein DME1422 XEOTICID XEO02304 MOACRIVE Inhibition DME1422 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1422 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02305 XEO_CLAS Peptide DME1422 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC <= 1 ug/ml) DME1422 XEOTICID XEO02305 GENEFORM Protein DME1422 XEOTICID XEO02305 MOACRIVE Inhibition DME1422 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1422 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02306 XEO_CLAS Peptide DME1422 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.2 ug/ml) DME1422 XEOTICID XEO02306 GENEFORM Protein DME1422 XEOTICID XEO02306 MOACRIVE Inhibition DME1422 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1422 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02309 XEO_CLAS Peptide DME1422 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02309 GENEFORM Protein DME1422 XEOTICID XEO02309 MOACRIVE Inhibition DME1422 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1422 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02310 XEO_CLAS Peptide DME1422 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02310 GENEFORM Protein DME1422 XEOTICID XEO02310 MOACRIVE Inhibition DME1422 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1422 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02315 XEO_CLAS Peptide DME1422 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO02315 GENEFORM Protein DME1422 XEOTICID XEO02315 MOACRIVE Inhibition DME1422 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1422 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02316 XEO_CLAS Peptide DME1422 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 50 microM) DME1422 XEOTICID XEO02316 GENEFORM Protein DME1422 XEOTICID XEO02316 MOACRIVE Inhibition DME1422 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1422 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02317 XEO_CLAS Peptide DME1422 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 300 microM) DME1422 XEOTICID XEO02317 GENEFORM Protein DME1422 XEOTICID XEO02317 MOACRIVE Inhibition DME1422 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1422 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02318 XEO_CLAS Peptide DME1422 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02318 GENEFORM Protein DME1422 XEOTICID XEO02318 MOACRIVE Inhibition DME1422 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1422 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02319 XEO_CLAS Peptide DME1422 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02319 GENEFORM Protein DME1422 XEOTICID XEO02319 MOACRIVE Inhibition DME1422 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1422 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02320 XEO_CLAS Peptide DME1422 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02320 GENEFORM Protein DME1422 XEOTICID XEO02320 MOACRIVE Inhibition DME1422 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1422 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02321 XEO_CLAS Peptide DME1422 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO02321 GENEFORM Protein DME1422 XEOTICID XEO02321 MOACRIVE Inhibition DME1422 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1422 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02322 XEO_CLAS Peptide DME1422 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02322 GENEFORM Protein DME1422 XEOTICID XEO02322 MOACRIVE Inhibition DME1422 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1422 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02323 XEO_CLAS Peptide DME1422 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO02323 GENEFORM Protein DME1422 XEOTICID XEO02323 MOACRIVE Inhibition DME1422 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1422 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02324 XEO_CLAS Peptide DME1422 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02324 GENEFORM Protein DME1422 XEOTICID XEO02324 MOACRIVE Inhibition DME1422 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1422 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02325 XEO_CLAS Peptide DME1422 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO02325 GENEFORM Protein DME1422 XEOTICID XEO02325 MOACRIVE Inhibition DME1422 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1422 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02326 XEO_CLAS Peptide DME1422 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02326 GENEFORM Protein DME1422 XEOTICID XEO02326 MOACRIVE Inhibition DME1422 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1422 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02327 XEO_CLAS Peptide DME1422 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO02327 GENEFORM Protein DME1422 XEOTICID XEO02327 MOACRIVE Inhibition DME1422 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1422 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02328 XEO_CLAS Peptide DME1422 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO02328 GENEFORM Protein DME1422 XEOTICID XEO02328 MOACRIVE Inhibition DME1422 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1422 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02332 XEO_CLAS Peptide DME1422 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.9 ug/ml) DME1422 XEOTICID XEO02332 GENEFORM Protein DME1422 XEOTICID XEO02332 MOACRIVE Inhibition DME1422 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1422 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02333 XEO_CLAS Peptide DME1422 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 200 microM) DME1422 XEOTICID XEO02333 GENEFORM Protein DME1422 XEOTICID XEO02333 MOACRIVE Inhibition DME1422 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1422 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02336 XEO_CLAS Peptide DME1422 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 microM) DME1422 XEOTICID XEO02336 GENEFORM Protein DME1422 XEOTICID XEO02336 MOACRIVE Inhibition DME1422 XEOTICID XEO02346 XEO_NAME Aurelin DME1422 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02346 XEO_CLAS Peptide DME1422 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 7.66 ug/ml) DME1422 XEOTICID XEO02346 GENEFORM Protein DME1422 XEOTICID XEO02346 MOACRIVE Inhibition DME1422 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1422 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02352 XEO_CLAS Peptide DME1422 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 11 ug/ml) DME1422 XEOTICID XEO02352 GENEFORM Protein DME1422 XEOTICID XEO02352 MOACRIVE Inhibition DME1422 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1422 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02353 XEO_CLAS Peptide DME1422 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 ug/ml) DME1422 XEOTICID XEO02353 GENEFORM Protein DME1422 XEOTICID XEO02353 MOACRIVE Inhibition DME1422 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1422 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02354 XEO_CLAS Peptide DME1422 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 ug/ml) DME1422 XEOTICID XEO02354 GENEFORM Protein DME1422 XEOTICID XEO02354 MOACRIVE Inhibition DME1422 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1422 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02355 XEO_CLAS Peptide DME1422 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 17 ug/ml) DME1422 XEOTICID XEO02355 GENEFORM Protein DME1422 XEOTICID XEO02355 MOACRIVE Inhibition DME1422 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1422 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02356 XEO_CLAS Peptide DME1422 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO02356 GENEFORM Protein DME1422 XEOTICID XEO02356 MOACRIVE Inhibition DME1422 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1422 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02357 XEO_CLAS Peptide DME1422 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO02357 GENEFORM Protein DME1422 XEOTICID XEO02357 MOACRIVE Inhibition DME1422 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1422 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02358 XEO_CLAS Peptide DME1422 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO02358 GENEFORM Protein DME1422 XEOTICID XEO02358 MOACRIVE Inhibition DME1422 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1422 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02360 XEO_CLAS Peptide DME1422 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02360 GENEFORM Protein DME1422 XEOTICID XEO02360 MOACRIVE Inhibition DME1422 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1422 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02361 XEO_CLAS Peptide DME1422 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 ug/ml) DME1422 XEOTICID XEO02361 GENEFORM Protein DME1422 XEOTICID XEO02361 MOACRIVE Inhibition DME1422 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1422 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02365 XEO_CLAS Peptide DME1422 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 32 ug/ml) DME1422 XEOTICID XEO02365 GENEFORM Protein DME1422 XEOTICID XEO02365 MOACRIVE Inhibition DME1422 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1422 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02366 XEO_CLAS Peptide DME1422 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO02366 GENEFORM Protein DME1422 XEOTICID XEO02366 MOACRIVE Inhibition DME1422 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1422 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02367 XEO_CLAS Peptide DME1422 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02367 GENEFORM Protein DME1422 XEOTICID XEO02367 MOACRIVE Inhibition DME1422 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1422 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02368 XEO_CLAS Peptide DME1422 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02368 GENEFORM Protein DME1422 XEOTICID XEO02368 MOACRIVE Inhibition DME1422 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1422 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02369 XEO_CLAS Peptide DME1422 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02369 GENEFORM Protein DME1422 XEOTICID XEO02369 MOACRIVE Inhibition DME1422 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1422 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02370 XEO_CLAS Peptide DME1422 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02370 GENEFORM Protein DME1422 XEOTICID XEO02370 MOACRIVE Inhibition DME1422 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1422 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02371 XEO_CLAS Peptide DME1422 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 ug/ml) DME1422 XEOTICID XEO02371 GENEFORM Protein DME1422 XEOTICID XEO02371 MOACRIVE Inhibition DME1422 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1422 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02374 XEO_CLAS Peptide DME1422 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02374 GENEFORM Protein DME1422 XEOTICID XEO02374 MOACRIVE Inhibition DME1422 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1422 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02376 XEO_CLAS Peptide DME1422 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02376 GENEFORM Protein DME1422 XEOTICID XEO02376 MOACRIVE Inhibition DME1422 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1422 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02378 XEO_CLAS Peptide DME1422 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.19 ug/ml) DME1422 XEOTICID XEO02378 GENEFORM Protein DME1422 XEOTICID XEO02378 MOACRIVE Inhibition DME1422 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1422 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02388 XEO_CLAS Peptide DME1422 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO02388 GENEFORM Protein DME1422 XEOTICID XEO02388 MOACRIVE Inhibition DME1422 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1422 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02389 XEO_CLAS Peptide DME1422 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02389 GENEFORM Protein DME1422 XEOTICID XEO02389 MOACRIVE Inhibition DME1422 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1422 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02415 XEO_CLAS Peptide DME1422 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02415 GENEFORM Protein DME1422 XEOTICID XEO02415 MOACRIVE Inhibition DME1422 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1422 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02416 XEO_CLAS Peptide DME1422 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 11 microM) DME1422 XEOTICID XEO02416 GENEFORM Protein DME1422 XEOTICID XEO02416 MOACRIVE Inhibition DME1422 XEOTICID XEO02419 XEO_NAME Bay oil DME1422 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1422 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02419 GENEFORM Protein DME1422 XEOTICID XEO02419 MOACRIVE Inhibition DME1422 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1422 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02435 XEO_CLAS Peptide DME1422 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02435 GENEFORM Protein DME1422 XEOTICID XEO02435 MOACRIVE Inhibition DME1422 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1422 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02436 XEO_CLAS Peptide DME1422 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02436 GENEFORM Protein DME1422 XEOTICID XEO02436 MOACRIVE Inhibition DME1422 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1422 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02437 XEO_CLAS Peptide DME1422 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02437 GENEFORM Protein DME1422 XEOTICID XEO02437 MOACRIVE Inhibition DME1422 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1422 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02438 XEO_CLAS Peptide DME1422 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02438 GENEFORM Protein DME1422 XEOTICID XEO02438 MOACRIVE Inhibition DME1422 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1422 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02439 XEO_CLAS Peptide DME1422 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02439 GENEFORM Protein DME1422 XEOTICID XEO02439 MOACRIVE Inhibition DME1422 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1422 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02440 XEO_CLAS Peptide DME1422 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02440 GENEFORM Protein DME1422 XEOTICID XEO02440 MOACRIVE Inhibition DME1422 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1422 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02441 XEO_CLAS Peptide DME1422 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02441 GENEFORM Protein DME1422 XEOTICID XEO02441 MOACRIVE Inhibition DME1422 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1422 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02442 XEO_CLAS Peptide DME1422 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO02442 GENEFORM Protein DME1422 XEOTICID XEO02442 MOACRIVE Inhibition DME1422 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1422 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02443 XEO_CLAS Peptide DME1422 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02443 GENEFORM Protein DME1422 XEOTICID XEO02443 MOACRIVE Inhibition DME1422 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1422 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02444 XEO_CLAS Peptide DME1422 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02444 GENEFORM Protein DME1422 XEOTICID XEO02444 MOACRIVE Inhibition DME1422 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1422 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1422 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02447 GENEFORM Protein DME1422 XEOTICID XEO02447 MOACRIVE Inhibition DME1422 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1422 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02452 XEO_CLAS Peptide DME1422 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 76800 ug/ml) DME1422 XEOTICID XEO02452 GENEFORM Protein DME1422 XEOTICID XEO02452 MOACRIVE Inhibition DME1422 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1422 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02453 XEO_CLAS Peptide DME1422 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02453 GENEFORM Protein DME1422 XEOTICID XEO02453 MOACRIVE Inhibition DME1422 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1422 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02463 XEO_CLAS Peptide DME1422 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 11.25 microM) DME1422 XEOTICID XEO02463 GENEFORM Protein DME1422 XEOTICID XEO02463 MOACRIVE Inhibition DME1422 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1422 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02466 XEO_CLAS Peptide DME1422 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.5 microM) DME1422 XEOTICID XEO02466 GENEFORM Protein DME1422 XEOTICID XEO02466 MOACRIVE Inhibition DME1422 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1422 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02467 XEO_CLAS Peptide DME1422 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8.4 microM) DME1422 XEOTICID XEO02467 GENEFORM Protein DME1422 XEOTICID XEO02467 MOACRIVE Inhibition DME1422 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1422 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02468 XEO_CLAS Peptide DME1422 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.7 microM) DME1422 XEOTICID XEO02468 GENEFORM Protein DME1422 XEOTICID XEO02468 MOACRIVE Inhibition DME1422 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1422 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02469 XEO_CLAS Peptide DME1422 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO02469 GENEFORM Protein DME1422 XEOTICID XEO02469 MOACRIVE Inhibition DME1422 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1422 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02470 XEO_CLAS Peptide DME1422 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.8 microM) DME1422 XEOTICID XEO02470 GENEFORM Protein DME1422 XEOTICID XEO02470 MOACRIVE Inhibition DME1422 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1422 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02471 XEO_CLAS Peptide DME1422 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4.8 microM) DME1422 XEOTICID XEO02471 GENEFORM Protein DME1422 XEOTICID XEO02471 MOACRIVE Inhibition DME1422 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1422 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02472 XEO_CLAS Peptide DME1422 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.0 microM) DME1422 XEOTICID XEO02472 GENEFORM Protein DME1422 XEOTICID XEO02472 MOACRIVE Inhibition DME1422 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1422 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02473 XEO_CLAS Peptide DME1422 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02473 GENEFORM Protein DME1422 XEOTICID XEO02473 MOACRIVE Inhibition DME1422 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1422 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02474 XEO_CLAS Peptide DME1422 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.5 microM) DME1422 XEOTICID XEO02474 GENEFORM Protein DME1422 XEOTICID XEO02474 MOACRIVE Inhibition DME1422 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1422 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02475 XEO_CLAS Peptide DME1422 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.5 microM) DME1422 XEOTICID XEO02475 GENEFORM Protein DME1422 XEOTICID XEO02475 MOACRIVE Inhibition DME1422 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1422 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02477 XEO_CLAS Peptide DME1422 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-300 ug/ml) DME1422 XEOTICID XEO02477 GENEFORM Protein DME1422 XEOTICID XEO02477 MOACRIVE Inhibition DME1422 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1422 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02478 XEO_CLAS Peptide DME1422 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-300 ug/ml) DME1422 XEOTICID XEO02478 GENEFORM Protein DME1422 XEOTICID XEO02478 MOACRIVE Inhibition DME1422 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1422 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02479 XEO_CLAS Peptide DME1422 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-300 ug/ml) DME1422 XEOTICID XEO02479 GENEFORM Protein DME1422 XEOTICID XEO02479 MOACRIVE Inhibition DME1422 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1422 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02480 XEO_CLAS Peptide DME1422 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-300 ug/ml) DME1422 XEOTICID XEO02480 GENEFORM Protein DME1422 XEOTICID XEO02480 MOACRIVE Inhibition DME1422 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1422 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02481 XEO_CLAS Peptide DME1422 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-300 ug/ml) DME1422 XEOTICID XEO02481 GENEFORM Protein DME1422 XEOTICID XEO02481 MOACRIVE Inhibition DME1422 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1422 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02482 XEO_CLAS Peptide DME1422 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-300 ug/ml) DME1422 XEOTICID XEO02482 GENEFORM Protein DME1422 XEOTICID XEO02482 MOACRIVE Inhibition DME1422 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1422 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02483 XEO_CLAS Peptide DME1422 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-300 ug/ml) DME1422 XEOTICID XEO02483 GENEFORM Protein DME1422 XEOTICID XEO02483 MOACRIVE Inhibition DME1422 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1422 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02484 XEO_CLAS Peptide DME1422 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-300 ug/ml) DME1422 XEOTICID XEO02484 GENEFORM Protein DME1422 XEOTICID XEO02484 MOACRIVE Inhibition DME1422 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1422 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02485 XEO_CLAS Peptide DME1422 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-300 ug/ml) DME1422 XEOTICID XEO02485 GENEFORM Protein DME1422 XEOTICID XEO02485 MOACRIVE Inhibition DME1422 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1422 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02486 XEO_CLAS Peptide DME1422 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-300 ug/ml) DME1422 XEOTICID XEO02486 GENEFORM Protein DME1422 XEOTICID XEO02486 MOACRIVE Inhibition DME1422 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1422 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02487 XEO_CLAS Peptide DME1422 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02487 GENEFORM Protein DME1422 XEOTICID XEO02487 MOACRIVE Inhibition DME1422 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1422 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02488 XEO_CLAS Peptide DME1422 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-300 ug/ml) DME1422 XEOTICID XEO02488 GENEFORM Protein DME1422 XEOTICID XEO02488 MOACRIVE Inhibition DME1422 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1422 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02489 XEO_CLAS Peptide DME1422 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-301 ug/ml) DME1422 XEOTICID XEO02489 GENEFORM Protein DME1422 XEOTICID XEO02489 MOACRIVE Inhibition DME1422 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1422 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02491 XEO_CLAS Peptide DME1422 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.3 microM) DME1422 XEOTICID XEO02491 GENEFORM Protein DME1422 XEOTICID XEO02491 MOACRIVE Inhibition DME1422 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1422 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02492 XEO_CLAS Peptide DME1422 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 ug/ml) DME1422 XEOTICID XEO02492 GENEFORM Protein DME1422 XEOTICID XEO02492 MOACRIVE Inhibition DME1422 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1422 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02493 XEO_CLAS Peptide DME1422 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 ug/ml) DME1422 XEOTICID XEO02493 GENEFORM Protein DME1422 XEOTICID XEO02493 MOACRIVE Inhibition DME1422 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1422 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02494 XEO_CLAS Peptide DME1422 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 ug/ml) DME1422 XEOTICID XEO02494 GENEFORM Protein DME1422 XEOTICID XEO02494 MOACRIVE Inhibition DME1422 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1422 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02495 XEO_CLAS Peptide DME1422 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 34 ug/ml) DME1422 XEOTICID XEO02495 GENEFORM Protein DME1422 XEOTICID XEO02495 MOACRIVE Inhibition DME1422 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1422 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02496 XEO_CLAS Peptide DME1422 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 13 microM) DME1422 XEOTICID XEO02496 GENEFORM Protein DME1422 XEOTICID XEO02496 MOACRIVE Inhibition DME1422 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1422 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02497 XEO_CLAS Peptide DME1422 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO02497 GENEFORM Protein DME1422 XEOTICID XEO02497 MOACRIVE Inhibition DME1422 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1422 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02499 XEO_CLAS Peptide DME1422 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO02499 GENEFORM Protein DME1422 XEOTICID XEO02499 MOACRIVE Inhibition DME1422 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1422 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02501 XEO_CLAS Peptide DME1422 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 7 microM) DME1422 XEOTICID XEO02501 GENEFORM Protein DME1422 XEOTICID XEO02501 MOACRIVE Inhibition DME1422 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1422 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02502 XEO_CLAS Peptide DME1422 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 microM) DME1422 XEOTICID XEO02502 GENEFORM Protein DME1422 XEOTICID XEO02502 MOACRIVE Inhibition DME1422 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1422 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02503 XEO_CLAS Peptide DME1422 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 19 microM) DME1422 XEOTICID XEO02503 GENEFORM Protein DME1422 XEOTICID XEO02503 MOACRIVE Inhibition DME1422 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1422 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02504 XEO_CLAS Peptide DME1422 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02504 GENEFORM Protein DME1422 XEOTICID XEO02504 MOACRIVE Inhibition DME1422 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1422 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02505 XEO_CLAS Peptide DME1422 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO02505 GENEFORM Protein DME1422 XEOTICID XEO02505 MOACRIVE Inhibition DME1422 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1422 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02507 XEO_CLAS Peptide DME1422 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO02507 GENEFORM Protein DME1422 XEOTICID XEO02507 MOACRIVE Inhibition DME1422 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1422 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02508 XEO_CLAS Peptide DME1422 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 150 microM) DME1422 XEOTICID XEO02508 GENEFORM Protein DME1422 XEOTICID XEO02508 MOACRIVE Inhibition DME1422 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1422 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02509 XEO_CLAS Peptide DME1422 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 150 microM) DME1422 XEOTICID XEO02509 GENEFORM Protein DME1422 XEOTICID XEO02509 MOACRIVE Inhibition DME1422 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1422 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02510 XEO_CLAS Peptide DME1422 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 150 microM) DME1422 XEOTICID XEO02510 GENEFORM Protein DME1422 XEOTICID XEO02510 MOACRIVE Inhibition DME1422 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1422 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02511 XEO_CLAS Peptide DME1422 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 150 microM) DME1422 XEOTICID XEO02511 GENEFORM Protein DME1422 XEOTICID XEO02511 MOACRIVE Inhibition DME1422 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1422 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02512 XEO_CLAS Peptide DME1422 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 75 microM) DME1422 XEOTICID XEO02512 GENEFORM Protein DME1422 XEOTICID XEO02512 MOACRIVE Inhibition DME1422 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1422 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02513 XEO_CLAS Peptide DME1422 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO02513 GENEFORM Protein DME1422 XEOTICID XEO02513 MOACRIVE Inhibition DME1422 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1422 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02514 XEO_CLAS Peptide DME1422 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO02514 GENEFORM Protein DME1422 XEOTICID XEO02514 MOACRIVE Inhibition DME1422 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1422 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02515 XEO_CLAS Peptide DME1422 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 80 microM) DME1422 XEOTICID XEO02515 GENEFORM Protein DME1422 XEOTICID XEO02515 MOACRIVE Inhibition DME1422 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1422 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02516 XEO_CLAS Peptide DME1422 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 32 microM) DME1422 XEOTICID XEO02516 GENEFORM Protein DME1422 XEOTICID XEO02516 MOACRIVE Inhibition DME1422 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1422 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02517 XEO_CLAS Peptide DME1422 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 microM) DME1422 XEOTICID XEO02517 GENEFORM Protein DME1422 XEOTICID XEO02517 MOACRIVE Inhibition DME1422 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1422 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02518 XEO_CLAS Peptide DME1422 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC < 15 microM) DME1422 XEOTICID XEO02518 GENEFORM Protein DME1422 XEOTICID XEO02518 MOACRIVE Inhibition DME1422 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1422 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02519 XEO_CLAS Peptide DME1422 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC < 15 microM) DME1422 XEOTICID XEO02519 GENEFORM Protein DME1422 XEOTICID XEO02519 MOACRIVE Inhibition DME1422 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1422 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02520 XEO_CLAS Peptide DME1422 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC < 15 microM) DME1422 XEOTICID XEO02520 GENEFORM Protein DME1422 XEOTICID XEO02520 MOACRIVE Inhibition DME1422 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1422 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02523 XEO_CLAS Peptide DME1422 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO02523 GENEFORM Protein DME1422 XEOTICID XEO02523 MOACRIVE Inhibition DME1422 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1422 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02524 XEO_CLAS Peptide DME1422 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 150 microM) DME1422 XEOTICID XEO02524 GENEFORM Protein DME1422 XEOTICID XEO02524 MOACRIVE Inhibition DME1422 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1422 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02525 XEO_CLAS Peptide DME1422 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 24 microM) DME1422 XEOTICID XEO02525 GENEFORM Protein DME1422 XEOTICID XEO02525 MOACRIVE Inhibition DME1422 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1422 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02526 XEO_CLAS Peptide DME1422 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 48 microM) DME1422 XEOTICID XEO02526 GENEFORM Protein DME1422 XEOTICID XEO02526 MOACRIVE Inhibition DME1422 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1422 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02527 XEO_CLAS Peptide DME1422 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 119 microM) DME1422 XEOTICID XEO02527 GENEFORM Protein DME1422 XEOTICID XEO02527 MOACRIVE Inhibition DME1422 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1422 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02528 XEO_CLAS Peptide DME1422 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 128 ug/ml) DME1422 XEOTICID XEO02528 GENEFORM Protein DME1422 XEOTICID XEO02528 MOACRIVE Inhibition DME1422 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1422 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02529 XEO_CLAS Peptide DME1422 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 128 ug/ml) DME1422 XEOTICID XEO02529 GENEFORM Protein DME1422 XEOTICID XEO02529 MOACRIVE Inhibition DME1422 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1422 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02530 XEO_CLAS Peptide DME1422 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02530 GENEFORM Protein DME1422 XEOTICID XEO02530 MOACRIVE Inhibition DME1422 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1422 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02531 XEO_CLAS Peptide DME1422 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 microM) DME1422 XEOTICID XEO02531 GENEFORM Protein DME1422 XEOTICID XEO02531 MOACRIVE Inhibition DME1422 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1422 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02533 XEO_CLAS Peptide DME1422 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.2 ug/ml) DME1422 XEOTICID XEO02533 GENEFORM Protein DME1422 XEOTICID XEO02533 MOACRIVE Inhibition DME1422 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1422 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02534 XEO_CLAS Peptide DME1422 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.6 ug/ml) DME1422 XEOTICID XEO02534 GENEFORM Protein DME1422 XEOTICID XEO02534 MOACRIVE Inhibition DME1422 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1422 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02535 XEO_CLAS Peptide DME1422 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.3 ug/ml) DME1422 XEOTICID XEO02535 GENEFORM Protein DME1422 XEOTICID XEO02535 MOACRIVE Inhibition DME1422 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1422 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02536 XEO_CLAS Peptide DME1422 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.4 ug/ml) DME1422 XEOTICID XEO02536 GENEFORM Protein DME1422 XEOTICID XEO02536 MOACRIVE Inhibition DME1422 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1422 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02537 XEO_CLAS Peptide DME1422 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.2 ug/ml) DME1422 XEOTICID XEO02537 GENEFORM Protein DME1422 XEOTICID XEO02537 MOACRIVE Inhibition DME1422 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1422 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02538 XEO_CLAS Peptide DME1422 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 9.1 ug/ml) DME1422 XEOTICID XEO02538 GENEFORM Protein DME1422 XEOTICID XEO02538 MOACRIVE Inhibition DME1422 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1422 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02539 XEO_CLAS Peptide DME1422 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8.6 ug/ml) DME1422 XEOTICID XEO02539 GENEFORM Protein DME1422 XEOTICID XEO02539 MOACRIVE Inhibition DME1422 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1422 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02540 XEO_CLAS Peptide DME1422 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15.2 ug/ml) DME1422 XEOTICID XEO02540 GENEFORM Protein DME1422 XEOTICID XEO02540 MOACRIVE Inhibition DME1422 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1422 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02541 XEO_CLAS Peptide DME1422 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 11.1 ug/ml) DME1422 XEOTICID XEO02541 GENEFORM Protein DME1422 XEOTICID XEO02541 MOACRIVE Inhibition DME1422 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1422 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02542 XEO_CLAS Peptide DME1422 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.7 ug/ml) DME1422 XEOTICID XEO02542 GENEFORM Protein DME1422 XEOTICID XEO02542 MOACRIVE Inhibition DME1422 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1422 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02543 XEO_CLAS Peptide DME1422 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 13.1 ug/ml) DME1422 XEOTICID XEO02543 GENEFORM Protein DME1422 XEOTICID XEO02543 MOACRIVE Inhibition DME1422 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1422 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02544 XEO_CLAS Peptide DME1422 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 9.8 ug/ml) DME1422 XEOTICID XEO02544 GENEFORM Protein DME1422 XEOTICID XEO02544 MOACRIVE Inhibition DME1422 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1422 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02545 XEO_CLAS Peptide DME1422 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 14 microM) DME1422 XEOTICID XEO02545 GENEFORM Protein DME1422 XEOTICID XEO02545 MOACRIVE Inhibition DME1422 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1422 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02546 XEO_CLAS Peptide DME1422 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 14 microM) DME1422 XEOTICID XEO02546 GENEFORM Protein DME1422 XEOTICID XEO02546 MOACRIVE Inhibition DME1422 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1422 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02547 XEO_CLAS Peptide DME1422 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 microM) DME1422 XEOTICID XEO02547 GENEFORM Protein DME1422 XEOTICID XEO02547 MOACRIVE Inhibition DME1422 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1422 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02548 XEO_CLAS Peptide DME1422 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 78 microM) DME1422 XEOTICID XEO02548 GENEFORM Protein DME1422 XEOTICID XEO02548 MOACRIVE Inhibition DME1422 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1422 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02549 XEO_CLAS Peptide DME1422 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02549 GENEFORM Protein DME1422 XEOTICID XEO02549 MOACRIVE Inhibition DME1422 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1422 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02552 XEO_CLAS Peptide DME1422 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 24 microM) DME1422 XEOTICID XEO02552 GENEFORM Protein DME1422 XEOTICID XEO02552 MOACRIVE Inhibition DME1422 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1422 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02553 XEO_CLAS Peptide DME1422 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02553 GENEFORM Protein DME1422 XEOTICID XEO02553 MOACRIVE Inhibition DME1422 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1422 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02556 XEO_CLAS Peptide DME1422 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 55 microM) DME1422 XEOTICID XEO02556 GENEFORM Protein DME1422 XEOTICID XEO02556 MOACRIVE Inhibition DME1422 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1422 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02557 XEO_CLAS Peptide DME1422 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 17 microM) DME1422 XEOTICID XEO02557 GENEFORM Protein DME1422 XEOTICID XEO02557 MOACRIVE Inhibition DME1422 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1422 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02558 XEO_CLAS Peptide DME1422 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 14 microM) DME1422 XEOTICID XEO02558 GENEFORM Protein DME1422 XEOTICID XEO02558 MOACRIVE Inhibition DME1422 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1422 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02559 XEO_CLAS Peptide DME1422 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02559 GENEFORM Protein DME1422 XEOTICID XEO02559 MOACRIVE Inhibition DME1422 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1422 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02560 XEO_CLAS Peptide DME1422 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 13 microM) DME1422 XEOTICID XEO02560 GENEFORM Protein DME1422 XEOTICID XEO02560 MOACRIVE Inhibition DME1422 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1422 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02561 XEO_CLAS Peptide DME1422 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO02561 GENEFORM Protein DME1422 XEOTICID XEO02561 MOACRIVE Inhibition DME1422 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1422 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02562 XEO_CLAS Peptide DME1422 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 13 microM) DME1422 XEOTICID XEO02562 GENEFORM Protein DME1422 XEOTICID XEO02562 MOACRIVE Inhibition DME1422 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1422 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02563 XEO_CLAS Peptide DME1422 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 45 microM) DME1422 XEOTICID XEO02563 GENEFORM Protein DME1422 XEOTICID XEO02563 MOACRIVE Inhibition DME1422 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1422 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02564 XEO_CLAS Peptide DME1422 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 ug/ml) DME1422 XEOTICID XEO02564 GENEFORM Protein DME1422 XEOTICID XEO02564 MOACRIVE Inhibition DME1422 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1422 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02565 XEO_CLAS Peptide DME1422 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 microM) DME1422 XEOTICID XEO02565 GENEFORM Protein DME1422 XEOTICID XEO02565 MOACRIVE Inhibition DME1422 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1422 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02566 XEO_CLAS Peptide DME1422 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO02566 GENEFORM Protein DME1422 XEOTICID XEO02566 MOACRIVE Inhibition DME1422 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1422 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02568 XEO_CLAS Peptide DME1422 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO02568 GENEFORM Protein DME1422 XEOTICID XEO02568 MOACRIVE Inhibition DME1422 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1422 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02569 XEO_CLAS Peptide DME1422 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO02569 GENEFORM Protein DME1422 XEOTICID XEO02569 MOACRIVE Inhibition DME1422 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1422 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02570 XEO_CLAS Peptide DME1422 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO02570 GENEFORM Protein DME1422 XEOTICID XEO02570 MOACRIVE Inhibition DME1422 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1422 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02571 XEO_CLAS Peptide DME1422 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO02571 GENEFORM Protein DME1422 XEOTICID XEO02571 MOACRIVE Inhibition DME1422 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1422 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02572 XEO_CLAS Peptide DME1422 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02572 GENEFORM Protein DME1422 XEOTICID XEO02572 MOACRIVE Inhibition DME1422 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1422 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02573 XEO_CLAS Peptide DME1422 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02573 GENEFORM Protein DME1422 XEOTICID XEO02573 MOACRIVE Inhibition DME1422 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1422 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02574 XEO_CLAS Peptide DME1422 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 microM) DME1422 XEOTICID XEO02574 GENEFORM Protein DME1422 XEOTICID XEO02574 MOACRIVE Inhibition DME1422 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1422 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02575 XEO_CLAS Peptide DME1422 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 microM) DME1422 XEOTICID XEO02575 GENEFORM Protein DME1422 XEOTICID XEO02575 MOACRIVE Inhibition DME1422 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1422 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02576 XEO_CLAS Peptide DME1422 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 33 microM) DME1422 XEOTICID XEO02576 GENEFORM Protein DME1422 XEOTICID XEO02576 MOACRIVE Inhibition DME1422 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1422 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02577 XEO_CLAS Peptide DME1422 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO02577 GENEFORM Protein DME1422 XEOTICID XEO02577 MOACRIVE Inhibition DME1422 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1422 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02578 XEO_CLAS Peptide DME1422 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02578 GENEFORM Protein DME1422 XEOTICID XEO02578 MOACRIVE Inhibition DME1422 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1422 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02579 XEO_CLAS Peptide DME1422 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02579 GENEFORM Protein DME1422 XEOTICID XEO02579 MOACRIVE Inhibition DME1422 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1422 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02580 XEO_CLAS Peptide DME1422 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC < 15 microM) DME1422 XEOTICID XEO02580 GENEFORM Protein DME1422 XEOTICID XEO02580 MOACRIVE Inhibition DME1422 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1422 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02581 XEO_CLAS Peptide DME1422 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 microM) DME1422 XEOTICID XEO02581 GENEFORM Protein DME1422 XEOTICID XEO02581 MOACRIVE Inhibition DME1422 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1422 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02582 XEO_CLAS Peptide DME1422 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 microM) DME1422 XEOTICID XEO02582 GENEFORM Protein DME1422 XEOTICID XEO02582 MOACRIVE Inhibition DME1422 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1422 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02583 XEO_CLAS Peptide DME1422 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 microM) DME1422 XEOTICID XEO02583 GENEFORM Protein DME1422 XEOTICID XEO02583 MOACRIVE Inhibition DME1422 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1422 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02584 XEO_CLAS Peptide DME1422 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 microM) DME1422 XEOTICID XEO02584 GENEFORM Protein DME1422 XEOTICID XEO02584 MOACRIVE Inhibition DME1422 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1422 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02585 XEO_CLAS Peptide DME1422 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO02585 GENEFORM Protein DME1422 XEOTICID XEO02585 MOACRIVE Inhibition DME1422 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1422 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02586 XEO_CLAS Peptide DME1422 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO02586 GENEFORM Protein DME1422 XEOTICID XEO02586 MOACRIVE Inhibition DME1422 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1422 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02587 XEO_CLAS Peptide DME1422 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02587 GENEFORM Protein DME1422 XEOTICID XEO02587 MOACRIVE Inhibition DME1422 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1422 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02589 XEO_CLAS Peptide DME1422 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8.2 ug/ml) DME1422 XEOTICID XEO02589 GENEFORM Protein DME1422 XEOTICID XEO02589 MOACRIVE Inhibition DME1422 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1422 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02590 XEO_CLAS Peptide DME1422 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 19.6 ug/ml) DME1422 XEOTICID XEO02590 GENEFORM Protein DME1422 XEOTICID XEO02590 MOACRIVE Inhibition DME1422 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1422 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02591 XEO_CLAS Peptide DME1422 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO02591 GENEFORM Protein DME1422 XEOTICID XEO02591 MOACRIVE Inhibition DME1422 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1422 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02593 XEO_CLAS Peptide DME1422 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 36 microM) DME1422 XEOTICID XEO02593 GENEFORM Protein DME1422 XEOTICID XEO02593 MOACRIVE Inhibition DME1422 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1422 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02594 XEO_CLAS Peptide DME1422 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02594 GENEFORM Protein DME1422 XEOTICID XEO02594 MOACRIVE Inhibition DME1422 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1422 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02595 XEO_CLAS Peptide DME1422 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO02595 GENEFORM Protein DME1422 XEOTICID XEO02595 MOACRIVE Inhibition DME1422 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1422 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02596 XEO_CLAS Peptide DME1422 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO02596 GENEFORM Protein DME1422 XEOTICID XEO02596 MOACRIVE Inhibition DME1422 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1422 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02597 XEO_CLAS Peptide DME1422 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO02597 GENEFORM Protein DME1422 XEOTICID XEO02597 MOACRIVE Inhibition DME1422 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1422 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02598 XEO_CLAS Peptide DME1422 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 32.5 microM) DME1422 XEOTICID XEO02598 GENEFORM Protein DME1422 XEOTICID XEO02598 MOACRIVE Inhibition DME1422 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1422 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02599 XEO_CLAS Peptide DME1422 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 microM) DME1422 XEOTICID XEO02599 GENEFORM Protein DME1422 XEOTICID XEO02599 MOACRIVE Inhibition DME1422 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1422 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02601 XEO_CLAS Peptide DME1422 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.1 ug/ml) DME1422 XEOTICID XEO02601 GENEFORM Protein DME1422 XEOTICID XEO02601 MOACRIVE Inhibition DME1422 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1422 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02602 XEO_CLAS Peptide DME1422 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 13.2 ug/ml) DME1422 XEOTICID XEO02602 GENEFORM Protein DME1422 XEOTICID XEO02602 MOACRIVE Inhibition DME1422 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1422 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02603 XEO_CLAS Peptide DME1422 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.3 ug/ml) DME1422 XEOTICID XEO02603 GENEFORM Protein DME1422 XEOTICID XEO02603 MOACRIVE Inhibition DME1422 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1422 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02604 XEO_CLAS Peptide DME1422 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO02604 GENEFORM Protein DME1422 XEOTICID XEO02604 MOACRIVE Inhibition DME1422 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1422 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02605 XEO_CLAS Peptide DME1422 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30.6 ug/ml) DME1422 XEOTICID XEO02605 GENEFORM Protein DME1422 XEOTICID XEO02605 MOACRIVE Inhibition DME1422 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1422 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02606 XEO_CLAS Peptide DME1422 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 11.2 ug/ml) DME1422 XEOTICID XEO02606 GENEFORM Protein DME1422 XEOTICID XEO02606 MOACRIVE Inhibition DME1422 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1422 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02607 XEO_CLAS Peptide DME1422 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.8 ug/ml) DME1422 XEOTICID XEO02607 GENEFORM Protein DME1422 XEOTICID XEO02607 MOACRIVE Inhibition DME1422 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1422 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02608 XEO_CLAS Peptide DME1422 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 7.9 ug/ml) DME1422 XEOTICID XEO02608 GENEFORM Protein DME1422 XEOTICID XEO02608 MOACRIVE Inhibition DME1422 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1422 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02609 XEO_CLAS Peptide DME1422 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15.8 ug/ml) DME1422 XEOTICID XEO02609 GENEFORM Protein DME1422 XEOTICID XEO02609 MOACRIVE Inhibition DME1422 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1422 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02610 XEO_CLAS Peptide DME1422 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.1 ug/ml) DME1422 XEOTICID XEO02610 GENEFORM Protein DME1422 XEOTICID XEO02610 MOACRIVE Inhibition DME1422 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1422 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02611 XEO_CLAS Peptide DME1422 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20.6 ug/ml) DME1422 XEOTICID XEO02611 GENEFORM Protein DME1422 XEOTICID XEO02611 MOACRIVE Inhibition DME1422 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1422 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02612 XEO_CLAS Peptide DME1422 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 11.8 ug/ml) DME1422 XEOTICID XEO02612 GENEFORM Protein DME1422 XEOTICID XEO02612 MOACRIVE Inhibition DME1422 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1422 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02613 XEO_CLAS Peptide DME1422 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 13.2 ug/ml) DME1422 XEOTICID XEO02613 GENEFORM Protein DME1422 XEOTICID XEO02613 MOACRIVE Inhibition DME1422 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1422 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02614 XEO_CLAS Peptide DME1422 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.8 ug/ml) DME1422 XEOTICID XEO02614 GENEFORM Protein DME1422 XEOTICID XEO02614 MOACRIVE Inhibition DME1422 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1422 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02615 XEO_CLAS Peptide DME1422 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8.6 ug/ml) DME1422 XEOTICID XEO02615 GENEFORM Protein DME1422 XEOTICID XEO02615 MOACRIVE Inhibition DME1422 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1422 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02616 XEO_CLAS Peptide DME1422 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20.4 ug/ml) DME1422 XEOTICID XEO02616 GENEFORM Protein DME1422 XEOTICID XEO02616 MOACRIVE Inhibition DME1422 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1422 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02617 XEO_CLAS Peptide DME1422 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4.7 ug/ml) DME1422 XEOTICID XEO02617 GENEFORM Protein DME1422 XEOTICID XEO02617 MOACRIVE Inhibition DME1422 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1422 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02618 XEO_CLAS Peptide DME1422 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.6 ug/ml) DME1422 XEOTICID XEO02618 GENEFORM Protein DME1422 XEOTICID XEO02618 MOACRIVE Inhibition DME1422 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1422 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02619 XEO_CLAS Peptide DME1422 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10.5 ug/ml) DME1422 XEOTICID XEO02619 GENEFORM Protein DME1422 XEOTICID XEO02619 MOACRIVE Inhibition DME1422 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1422 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02620 XEO_CLAS Peptide DME1422 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO02620 GENEFORM Protein DME1422 XEOTICID XEO02620 MOACRIVE Inhibition DME1422 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1422 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02621 XEO_CLAS Peptide DME1422 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO02621 GENEFORM Protein DME1422 XEOTICID XEO02621 MOACRIVE Inhibition DME1422 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1422 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02622 XEO_CLAS Peptide DME1422 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO02622 GENEFORM Protein DME1422 XEOTICID XEO02622 MOACRIVE Inhibition DME1422 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1422 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02623 XEO_CLAS Peptide DME1422 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO02623 GENEFORM Protein DME1422 XEOTICID XEO02623 MOACRIVE Inhibition DME1422 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1422 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02624 XEO_CLAS Peptide DME1422 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 18 microM) DME1422 XEOTICID XEO02624 GENEFORM Protein DME1422 XEOTICID XEO02624 MOACRIVE Inhibition DME1422 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1422 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02625 XEO_CLAS Peptide DME1422 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 9 microM) DME1422 XEOTICID XEO02625 GENEFORM Protein DME1422 XEOTICID XEO02625 MOACRIVE Inhibition DME1422 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1422 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02626 XEO_CLAS Peptide DME1422 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 18 microM) DME1422 XEOTICID XEO02626 GENEFORM Protein DME1422 XEOTICID XEO02626 MOACRIVE Inhibition DME1422 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1422 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02627 XEO_CLAS Peptide DME1422 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02627 GENEFORM Protein DME1422 XEOTICID XEO02627 MOACRIVE Inhibition DME1422 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1422 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02628 XEO_CLAS Peptide DME1422 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 18 microM) DME1422 XEOTICID XEO02628 GENEFORM Protein DME1422 XEOTICID XEO02628 MOACRIVE Inhibition DME1422 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1422 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02629 XEO_CLAS Peptide DME1422 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 13 microM) DME1422 XEOTICID XEO02629 GENEFORM Protein DME1422 XEOTICID XEO02629 MOACRIVE Inhibition DME1422 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1422 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02630 XEO_CLAS Peptide DME1422 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 ug/ml) DME1422 XEOTICID XEO02630 GENEFORM Protein DME1422 XEOTICID XEO02630 MOACRIVE Inhibition DME1422 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1422 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02631 XEO_CLAS Peptide DME1422 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 ug/ml) DME1422 XEOTICID XEO02631 GENEFORM Protein DME1422 XEOTICID XEO02631 MOACRIVE Inhibition DME1422 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1422 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02634 XEO_CLAS Peptide DME1422 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO02634 GENEFORM Protein DME1422 XEOTICID XEO02634 MOACRIVE Inhibition DME1422 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1422 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02635 XEO_CLAS Peptide DME1422 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40 ug/ml) DME1422 XEOTICID XEO02635 GENEFORM Protein DME1422 XEOTICID XEO02635 MOACRIVE Inhibition DME1422 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1422 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02636 XEO_CLAS Peptide DME1422 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO02636 GENEFORM Protein DME1422 XEOTICID XEO02636 MOACRIVE Inhibition DME1422 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1422 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02637 XEO_CLAS Peptide DME1422 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO02637 GENEFORM Protein DME1422 XEOTICID XEO02637 MOACRIVE Inhibition DME1422 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1422 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02638 XEO_CLAS Peptide DME1422 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 microM) DME1422 XEOTICID XEO02638 GENEFORM Protein DME1422 XEOTICID XEO02638 MOACRIVE Inhibition DME1422 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1422 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02639 XEO_CLAS Peptide DME1422 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 microM) DME1422 XEOTICID XEO02639 GENEFORM Protein DME1422 XEOTICID XEO02639 MOACRIVE Inhibition DME1422 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1422 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02644 XEO_CLAS Peptide DME1422 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02644 GENEFORM Protein DME1422 XEOTICID XEO02644 MOACRIVE Inhibition DME1422 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1422 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02645 XEO_CLAS Peptide DME1422 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02645 GENEFORM Protein DME1422 XEOTICID XEO02645 MOACRIVE Inhibition DME1422 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1422 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02646 XEO_CLAS Peptide DME1422 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02646 GENEFORM Protein DME1422 XEOTICID XEO02646 MOACRIVE Inhibition DME1422 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1422 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02647 XEO_CLAS Peptide DME1422 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02647 GENEFORM Protein DME1422 XEOTICID XEO02647 MOACRIVE Inhibition DME1422 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1422 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02649 XEO_CLAS Peptide DME1422 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO02649 GENEFORM Protein DME1422 XEOTICID XEO02649 MOACRIVE Inhibition DME1422 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1422 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02650 XEO_CLAS Peptide DME1422 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO02650 GENEFORM Protein DME1422 XEOTICID XEO02650 MOACRIVE Inhibition DME1422 XEOTICID XEO02658 XEO_NAME Buthinin DME1422 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02658 XEO_CLAS Peptide DME1422 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02658 GENEFORM Protein DME1422 XEOTICID XEO02658 MOACRIVE Inhibition DME1422 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1422 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02663 XEO_CLAS Peptide DME1422 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25 microM) DME1422 XEOTICID XEO02663 GENEFORM Protein DME1422 XEOTICID XEO02663 MOACRIVE Inhibition DME1422 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1422 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02664 XEO_CLAS Peptide DME1422 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25 microM) DME1422 XEOTICID XEO02664 GENEFORM Protein DME1422 XEOTICID XEO02664 MOACRIVE Inhibition DME1422 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1422 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02672 XEO_CLAS Peptide DME1422 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25 microM) DME1422 XEOTICID XEO02672 GENEFORM Protein DME1422 XEOTICID XEO02672 MOACRIVE Inhibition DME1422 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1422 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02673 XEO_CLAS Peptide DME1422 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25-12.5 microM) DME1422 XEOTICID XEO02673 GENEFORM Protein DME1422 XEOTICID XEO02673 MOACRIVE Inhibition DME1422 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1422 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02674 XEO_CLAS Peptide DME1422 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.125-6.25 microM) DME1422 XEOTICID XEO02674 GENEFORM Protein DME1422 XEOTICID XEO02674 MOACRIVE Inhibition DME1422 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1422 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02676 XEO_CLAS Peptide DME1422 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO02676 GENEFORM Protein DME1422 XEOTICID XEO02676 MOACRIVE Inhibition DME1422 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1422 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02677 XEO_CLAS Peptide DME1422 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25-12.5 microM) DME1422 XEOTICID XEO02677 GENEFORM Protein DME1422 XEOTICID XEO02677 MOACRIVE Inhibition DME1422 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1422 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02679 XEO_CLAS Peptide DME1422 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25-12.5 microM) DME1422 XEOTICID XEO02679 GENEFORM Protein DME1422 XEOTICID XEO02679 MOACRIVE Inhibition DME1422 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1422 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02680 XEO_CLAS Peptide DME1422 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25 microM) DME1422 XEOTICID XEO02680 GENEFORM Protein DME1422 XEOTICID XEO02680 MOACRIVE Inhibition DME1422 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1422 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02683 XEO_CLAS Peptide DME1422 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO02683 GENEFORM Protein DME1422 XEOTICID XEO02683 MOACRIVE Inhibition DME1422 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1422 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02688 XEO_CLAS Peptide DME1422 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO02688 GENEFORM Protein DME1422 XEOTICID XEO02688 MOACRIVE Inhibition DME1422 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1422 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02693 XEO_CLAS Peptide DME1422 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 ug/ml) DME1422 XEOTICID XEO02693 GENEFORM Protein DME1422 XEOTICID XEO02693 MOACRIVE Inhibition DME1422 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1422 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02699 XEO_CLAS Peptide DME1422 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 ug/ml) DME1422 XEOTICID XEO02699 GENEFORM Protein DME1422 XEOTICID XEO02699 MOACRIVE Inhibition DME1422 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1422 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02700 XEO_CLAS Peptide DME1422 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 ug/ml) DME1422 XEOTICID XEO02700 GENEFORM Protein DME1422 XEOTICID XEO02700 MOACRIVE Inhibition DME1422 XEOTICID XEO02703 XEO_NAME Calcitermin DME1422 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02703 XEO_CLAS Peptide DME1422 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02703 GENEFORM Protein DME1422 XEOTICID XEO02703 MOACRIVE Inhibition DME1422 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1422 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02708 XEO_CLAS Peptide DME1422 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO02708 GENEFORM Protein DME1422 XEOTICID XEO02708 MOACRIVE Inhibition DME1422 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1422 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02709 XEO_CLAS Peptide DME1422 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.05 microM) DME1422 XEOTICID XEO02709 GENEFORM Protein DME1422 XEOTICID XEO02709 MOACRIVE Inhibition DME1422 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1422 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1422 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02713 GENEFORM Protein DME1422 XEOTICID XEO02713 MOACRIVE Inhibition DME1422 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1422 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1422 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02714 GENEFORM Protein DME1422 XEOTICID XEO02714 MOACRIVE Inhibition DME1422 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1422 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02726 XEO_CLAS Peptide DME1422 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02726 GENEFORM Protein DME1422 XEOTICID XEO02726 MOACRIVE Inhibition DME1422 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1422 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02731 XEO_CLAS Peptide DME1422 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1 microM) DME1422 XEOTICID XEO02731 GENEFORM Protein DME1422 XEOTICID XEO02731 MOACRIVE Inhibition DME1422 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1422 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02732 XEO_CLAS Peptide DME1422 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.25 microM) DME1422 XEOTICID XEO02732 GENEFORM Protein DME1422 XEOTICID XEO02732 MOACRIVE Inhibition DME1422 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1422 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02733 XEO_CLAS Peptide DME1422 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8-25 ug/ml) DME1422 XEOTICID XEO02733 GENEFORM Protein DME1422 XEOTICID XEO02733 MOACRIVE Inhibition DME1422 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1422 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02735 XEO_CLAS Peptide DME1422 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1 ug/ml) DME1422 XEOTICID XEO02735 GENEFORM Protein DME1422 XEOTICID XEO02735 MOACRIVE Inhibition DME1422 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1422 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02737 XEO_CLAS Peptide DME1422 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02737 GENEFORM Protein DME1422 XEOTICID XEO02737 MOACRIVE Inhibition DME1422 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1422 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02738 XEO_CLAS Peptide DME1422 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO02738 GENEFORM Protein DME1422 XEOTICID XEO02738 MOACRIVE Inhibition DME1422 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1422 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02739 XEO_CLAS Peptide DME1422 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 microM) DME1422 XEOTICID XEO02739 GENEFORM Protein DME1422 XEOTICID XEO02739 MOACRIVE Inhibition DME1422 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1422 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02740 XEO_CLAS Peptide DME1422 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.25 ug/ml) DME1422 XEOTICID XEO02740 GENEFORM Protein DME1422 XEOTICID XEO02740 MOACRIVE Inhibition DME1422 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1422 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02741 XEO_CLAS Peptide DME1422 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 ug/ml) DME1422 XEOTICID XEO02741 GENEFORM Protein DME1422 XEOTICID XEO02741 MOACRIVE Inhibition DME1422 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1422 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02743 XEO_CLAS Peptide DME1422 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.6 ug/ml) DME1422 XEOTICID XEO02743 GENEFORM Protein DME1422 XEOTICID XEO02743 MOACRIVE Inhibition DME1422 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1422 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02744 XEO_CLAS Peptide DME1422 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 18.7 ug/ml) DME1422 XEOTICID XEO02744 GENEFORM Protein DME1422 XEOTICID XEO02744 MOACRIVE Inhibition DME1422 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1422 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02745 XEO_CLAS Peptide DME1422 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02745 GENEFORM Protein DME1422 XEOTICID XEO02745 MOACRIVE Inhibition DME1422 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1422 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02746 XEO_CLAS Peptide DME1422 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02746 GENEFORM Protein DME1422 XEOTICID XEO02746 MOACRIVE Inhibition DME1422 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1422 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02748 XEO_CLAS Peptide DME1422 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02748 GENEFORM Protein DME1422 XEOTICID XEO02748 MOACRIVE Inhibition DME1422 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1422 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02749 XEO_CLAS Peptide DME1422 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20-25 mug/ml) DME1422 XEOTICID XEO02749 GENEFORM Protein DME1422 XEOTICID XEO02749 MOACRIVE Inhibition DME1422 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1422 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02750 XEO_CLAS Peptide DME1422 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02750 GENEFORM Protein DME1422 XEOTICID XEO02750 MOACRIVE Inhibition DME1422 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1422 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02752 XEO_CLAS Peptide DME1422 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02752 GENEFORM Protein DME1422 XEOTICID XEO02752 MOACRIVE Inhibition DME1422 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1422 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02753 XEO_CLAS Peptide DME1422 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02753 GENEFORM Protein DME1422 XEOTICID XEO02753 MOACRIVE Inhibition DME1422 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1422 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02754 XEO_CLAS Peptide DME1422 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 microM) DME1422 XEOTICID XEO02754 GENEFORM Protein DME1422 XEOTICID XEO02754 MOACRIVE Inhibition DME1422 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1422 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02756 XEO_CLAS Peptide DME1422 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 microM) DME1422 XEOTICID XEO02756 GENEFORM Protein DME1422 XEOTICID XEO02756 MOACRIVE Inhibition DME1422 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1422 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02757 XEO_CLAS Peptide DME1422 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1 microM) DME1422 XEOTICID XEO02757 GENEFORM Protein DME1422 XEOTICID XEO02757 MOACRIVE Inhibition DME1422 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1422 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02758 XEO_CLAS Peptide DME1422 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO02758 GENEFORM Protein DME1422 XEOTICID XEO02758 MOACRIVE Inhibition DME1422 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1422 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02759 XEO_CLAS Peptide DME1422 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.6 microM) DME1422 XEOTICID XEO02759 GENEFORM Protein DME1422 XEOTICID XEO02759 MOACRIVE Inhibition DME1422 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1422 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02760 XEO_CLAS Peptide DME1422 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 microM) DME1422 XEOTICID XEO02760 GENEFORM Protein DME1422 XEOTICID XEO02760 MOACRIVE Inhibition DME1422 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1422 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02761 XEO_CLAS Peptide DME1422 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO02761 GENEFORM Protein DME1422 XEOTICID XEO02761 MOACRIVE Inhibition DME1422 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1422 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02762 XEO_CLAS Peptide DME1422 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 microM) DME1422 XEOTICID XEO02762 GENEFORM Protein DME1422 XEOTICID XEO02762 MOACRIVE Inhibition DME1422 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1422 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02763 XEO_CLAS Peptide DME1422 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.4 microM) DME1422 XEOTICID XEO02763 GENEFORM Protein DME1422 XEOTICID XEO02763 MOACRIVE Inhibition DME1422 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1422 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02764 XEO_CLAS Peptide DME1422 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 microM) DME1422 XEOTICID XEO02764 GENEFORM Protein DME1422 XEOTICID XEO02764 MOACRIVE Inhibition DME1422 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1422 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02765 XEO_CLAS Peptide DME1422 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.3 microM) DME1422 XEOTICID XEO02765 GENEFORM Protein DME1422 XEOTICID XEO02765 MOACRIVE Inhibition DME1422 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1422 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02767 XEO_CLAS Peptide DME1422 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02767 GENEFORM Protein DME1422 XEOTICID XEO02767 MOACRIVE Inhibition DME1422 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1422 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02768 XEO_CLAS Peptide DME1422 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1422 XEOTICID XEO02768 GENEFORM Protein DME1422 XEOTICID XEO02768 MOACRIVE Inhibition DME1422 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1422 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02769 XEO_CLAS Peptide DME1422 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.32 microM) DME1422 XEOTICID XEO02769 GENEFORM Protein DME1422 XEOTICID XEO02769 MOACRIVE Inhibition DME1422 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1422 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02770 XEO_CLAS Peptide DME1422 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.30 microM) DME1422 XEOTICID XEO02770 GENEFORM Protein DME1422 XEOTICID XEO02770 MOACRIVE Inhibition DME1422 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1422 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02771 XEO_CLAS Peptide DME1422 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.21 microM) DME1422 XEOTICID XEO02771 GENEFORM Protein DME1422 XEOTICID XEO02771 MOACRIVE Inhibition DME1422 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1422 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02772 XEO_CLAS Peptide DME1422 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02772 GENEFORM Protein DME1422 XEOTICID XEO02772 MOACRIVE Inhibition DME1422 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1422 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02773 XEO_CLAS Peptide DME1422 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.9-8.6 microM) DME1422 XEOTICID XEO02773 GENEFORM Protein DME1422 XEOTICID XEO02773 MOACRIVE Inhibition DME1422 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1422 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02774 XEO_CLAS Peptide DME1422 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.3 microM) DME1422 XEOTICID XEO02774 GENEFORM Protein DME1422 XEOTICID XEO02774 MOACRIVE Inhibition DME1422 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1422 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02789 GENEFORM Protein DME1422 XEOTICID XEO02789 MOACRIVE Inhibition DME1422 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1422 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02790 GENEFORM Protein DME1422 XEOTICID XEO02790 MOACRIVE Inhibition DME1422 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1422 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02791 GENEFORM Protein DME1422 XEOTICID XEO02791 MOACRIVE Inhibition DME1422 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1422 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02792 GENEFORM Protein DME1422 XEOTICID XEO02792 MOACRIVE Inhibition DME1422 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1422 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02793 GENEFORM Protein DME1422 XEOTICID XEO02793 MOACRIVE Inhibition DME1422 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1422 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02794 GENEFORM Protein DME1422 XEOTICID XEO02794 MOACRIVE Inhibition DME1422 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1422 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02795 GENEFORM Protein DME1422 XEOTICID XEO02795 MOACRIVE Inhibition DME1422 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1422 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02796 GENEFORM Protein DME1422 XEOTICID XEO02796 MOACRIVE Inhibition DME1422 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1422 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02797 GENEFORM Protein DME1422 XEOTICID XEO02797 MOACRIVE Inhibition DME1422 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1422 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02799 XEO_CLAS Peptide DME1422 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02799 GENEFORM Protein DME1422 XEOTICID XEO02799 MOACRIVE Inhibition DME1422 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1422 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02800 XEO_CLAS Peptide DME1422 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02800 GENEFORM Protein DME1422 XEOTICID XEO02800 MOACRIVE Inhibition DME1422 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1422 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02802 XEO_CLAS Peptide DME1422 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 13.6 microM) DME1422 XEOTICID XEO02802 GENEFORM Protein DME1422 XEOTICID XEO02802 MOACRIVE Inhibition DME1422 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1422 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02807 XEO_CLAS Peptide DME1422 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.2 microM) DME1422 XEOTICID XEO02807 GENEFORM Protein DME1422 XEOTICID XEO02807 MOACRIVE Inhibition DME1422 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1422 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02813 XEO_CLAS Peptide DME1422 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 80 microM) DME1422 XEOTICID XEO02813 GENEFORM Protein DME1422 XEOTICID XEO02813 MOACRIVE Inhibition DME1422 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1422 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02814 XEO_CLAS Peptide DME1422 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 80 microM) DME1422 XEOTICID XEO02814 GENEFORM Protein DME1422 XEOTICID XEO02814 MOACRIVE Inhibition DME1422 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1422 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02815 XEO_CLAS Peptide DME1422 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8.5 microM) DME1422 XEOTICID XEO02815 GENEFORM Protein DME1422 XEOTICID XEO02815 MOACRIVE Inhibition DME1422 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1422 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02816 XEO_CLAS Peptide DME1422 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 80 microM) DME1422 XEOTICID XEO02816 GENEFORM Protein DME1422 XEOTICID XEO02816 MOACRIVE Inhibition DME1422 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1422 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02817 XEO_CLAS Peptide DME1422 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 80 microM) DME1422 XEOTICID XEO02817 GENEFORM Protein DME1422 XEOTICID XEO02817 MOACRIVE Inhibition DME1422 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1422 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02818 XEO_CLAS Peptide DME1422 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.4 microM) DME1422 XEOTICID XEO02818 GENEFORM Protein DME1422 XEOTICID XEO02818 MOACRIVE Inhibition DME1422 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1422 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02819 XEO_CLAS Peptide DME1422 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.6 microM) DME1422 XEOTICID XEO02819 GENEFORM Protein DME1422 XEOTICID XEO02819 MOACRIVE Inhibition DME1422 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1422 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02820 XEO_CLAS Peptide DME1422 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO02820 GENEFORM Protein DME1422 XEOTICID XEO02820 MOACRIVE Inhibition DME1422 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1422 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02821 XEO_CLAS Peptide DME1422 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02821 GENEFORM Protein DME1422 XEOTICID XEO02821 MOACRIVE Inhibition DME1422 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1422 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02824 XEO_CLAS Peptide DME1422 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 35 microM) DME1422 XEOTICID XEO02824 GENEFORM Protein DME1422 XEOTICID XEO02824 MOACRIVE Inhibition DME1422 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1422 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02826 XEO_CLAS Peptide DME1422 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.7 ug/ml) DME1422 XEOTICID XEO02826 GENEFORM Protein DME1422 XEOTICID XEO02826 MOACRIVE Inhibition DME1422 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1422 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02834 GENEFORM Protein DME1422 XEOTICID XEO02834 MOACRIVE Inhibition DME1422 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1422 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02839 XEO_CLAS Peptide DME1422 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.25 microM) DME1422 XEOTICID XEO02839 GENEFORM Protein DME1422 XEOTICID XEO02839 MOACRIVE Inhibition DME1422 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1422 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02841 XEO_CLAS Peptide DME1422 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.25 microM) DME1422 XEOTICID XEO02841 GENEFORM Protein DME1422 XEOTICID XEO02841 MOACRIVE Inhibition DME1422 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1422 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02842 XEO_CLAS Peptide DME1422 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.25 microM) DME1422 XEOTICID XEO02842 GENEFORM Protein DME1422 XEOTICID XEO02842 MOACRIVE Inhibition DME1422 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1422 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02843 XEO_CLAS Peptide DME1422 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02843 GENEFORM Protein DME1422 XEOTICID XEO02843 MOACRIVE Inhibition DME1422 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1422 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02849 GENEFORM Protein DME1422 XEOTICID XEO02849 MOACRIVE Inhibition DME1422 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1422 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02857 XEO_CLAS Peptide DME1422 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 53 microM) DME1422 XEOTICID XEO02857 GENEFORM Protein DME1422 XEOTICID XEO02857 MOACRIVE Inhibition DME1422 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1422 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02858 XEO_CLAS Peptide DME1422 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 53 microM) DME1422 XEOTICID XEO02858 GENEFORM Protein DME1422 XEOTICID XEO02858 MOACRIVE Inhibition DME1422 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1422 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02860 XEO_CLAS Peptide DME1422 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 ug/ml) DME1422 XEOTICID XEO02860 GENEFORM Protein DME1422 XEOTICID XEO02860 MOACRIVE Inhibition DME1422 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1422 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02867 XEO_CLAS Peptide DME1422 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02867 GENEFORM Protein DME1422 XEOTICID XEO02867 MOACRIVE Inhibition DME1422 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1422 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02868 XEO_CLAS Peptide DME1422 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02868 GENEFORM Protein DME1422 XEOTICID XEO02868 MOACRIVE Inhibition DME1422 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1422 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02869 XEO_CLAS Peptide DME1422 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02869 GENEFORM Protein DME1422 XEOTICID XEO02869 MOACRIVE Inhibition DME1422 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1422 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02870 XEO_CLAS Peptide DME1422 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02870 GENEFORM Protein DME1422 XEOTICID XEO02870 MOACRIVE Inhibition DME1422 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1422 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02871 XEO_CLAS Peptide DME1422 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02871 GENEFORM Protein DME1422 XEOTICID XEO02871 MOACRIVE Inhibition DME1422 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1422 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02872 XEO_CLAS Peptide DME1422 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 308 microM) DME1422 XEOTICID XEO02872 GENEFORM Protein DME1422 XEOTICID XEO02872 MOACRIVE Inhibition DME1422 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1422 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02875 XEO_CLAS Peptide DME1422 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.1 microM) DME1422 XEOTICID XEO02875 GENEFORM Protein DME1422 XEOTICID XEO02875 MOACRIVE Inhibition DME1422 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1422 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02876 XEO_CLAS Peptide DME1422 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO02876 GENEFORM Protein DME1422 XEOTICID XEO02876 MOACRIVE Inhibition DME1422 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1422 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02877 XEO_CLAS Peptide DME1422 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO02877 GENEFORM Protein DME1422 XEOTICID XEO02877 MOACRIVE Inhibition DME1422 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1422 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02878 XEO_CLAS Peptide DME1422 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.3 microM) DME1422 XEOTICID XEO02878 GENEFORM Protein DME1422 XEOTICID XEO02878 MOACRIVE Inhibition DME1422 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1422 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02885 XEO_CLAS Peptide DME1422 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02885 GENEFORM Protein DME1422 XEOTICID XEO02885 MOACRIVE Inhibition DME1422 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1422 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02886 XEO_CLAS Peptide DME1422 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02886 GENEFORM Protein DME1422 XEOTICID XEO02886 MOACRIVE Inhibition DME1422 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1422 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02887 XEO_CLAS Peptide DME1422 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1 ug/ml) DME1422 XEOTICID XEO02887 GENEFORM Protein DME1422 XEOTICID XEO02887 MOACRIVE Inhibition DME1422 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1422 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02888 XEO_CLAS Peptide DME1422 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 ug/ml) DME1422 XEOTICID XEO02888 GENEFORM Protein DME1422 XEOTICID XEO02888 MOACRIVE Inhibition DME1422 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1422 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02889 XEO_CLAS Peptide DME1422 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 ug/ml) DME1422 XEOTICID XEO02889 GENEFORM Protein DME1422 XEOTICID XEO02889 MOACRIVE Inhibition DME1422 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1422 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02890 XEO_CLAS Peptide DME1422 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02890 GENEFORM Protein DME1422 XEOTICID XEO02890 MOACRIVE Inhibition DME1422 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1422 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02891 XEO_CLAS Peptide DME1422 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02891 GENEFORM Protein DME1422 XEOTICID XEO02891 MOACRIVE Inhibition DME1422 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1422 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02895 XEO_CLAS Peptide DME1422 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO02895 GENEFORM Protein DME1422 XEOTICID XEO02895 MOACRIVE Inhibition DME1422 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1422 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02896 XEO_CLAS Peptide DME1422 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO02896 GENEFORM Protein DME1422 XEOTICID XEO02896 MOACRIVE Inhibition DME1422 XEOTICID XEO02899 XEO_NAME Coladonin DME1422 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1422 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1422 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02899 GENEFORM Protein DME1422 XEOTICID XEO02899 MOACRIVE Inhibition DME1422 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1422 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02900 XEO_CLAS Peptide DME1422 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02900 GENEFORM Protein DME1422 XEOTICID XEO02900 MOACRIVE Inhibition DME1422 XEOTICID XEO02901 XEO_NAME Colicin-V DME1422 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02901 XEO_CLAS Peptide DME1422 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02901 GENEFORM Protein DME1422 XEOTICID XEO02901 MOACRIVE Inhibition DME1422 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1422 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02904 GENEFORM Protein DME1422 XEOTICID XEO02904 MOACRIVE Inhibition DME1422 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1422 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02908 XEO_CLAS Peptide DME1422 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 50 microM) DME1422 XEOTICID XEO02908 GENEFORM Protein DME1422 XEOTICID XEO02908 MOACRIVE Inhibition DME1422 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1422 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02923 XEO_CLAS Peptide DME1422 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02923 GENEFORM Protein DME1422 XEOTICID XEO02923 MOACRIVE Inhibition DME1422 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1422 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02924 XEO_CLAS Peptide DME1422 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 32 microM) DME1422 XEOTICID XEO02924 GENEFORM Protein DME1422 XEOTICID XEO02924 MOACRIVE Inhibition DME1422 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1422 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1422 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02927 GENEFORM Protein DME1422 XEOTICID XEO02927 MOACRIVE Inhibition DME1422 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1422 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02931 XEO_CLAS Peptide DME1422 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 ug/ml) DME1422 XEOTICID XEO02931 GENEFORM Protein DME1422 XEOTICID XEO02931 MOACRIVE Inhibition DME1422 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1422 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02933 XEO_CLAS Peptide DME1422 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO02933 GENEFORM Protein DME1422 XEOTICID XEO02933 MOACRIVE Inhibition DME1422 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1422 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02934 XEO_CLAS Peptide DME1422 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02934 GENEFORM Protein DME1422 XEOTICID XEO02934 MOACRIVE Inhibition DME1422 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1422 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02935 XEO_CLAS Peptide DME1422 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02935 GENEFORM Protein DME1422 XEOTICID XEO02935 MOACRIVE Inhibition DME1422 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1422 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02936 XEO_CLAS Peptide DME1422 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO02936 GENEFORM Protein DME1422 XEOTICID XEO02936 MOACRIVE Inhibition DME1422 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1422 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02937 XEO_CLAS Peptide DME1422 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02937 GENEFORM Protein DME1422 XEOTICID XEO02937 MOACRIVE Inhibition DME1422 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1422 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02938 XEO_CLAS Peptide DME1422 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 32 ug/ml) DME1422 XEOTICID XEO02938 GENEFORM Protein DME1422 XEOTICID XEO02938 MOACRIVE Inhibition DME1422 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1422 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02939 XEO_CLAS Peptide DME1422 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 11 ug/ml) DME1422 XEOTICID XEO02939 GENEFORM Protein DME1422 XEOTICID XEO02939 MOACRIVE Inhibition DME1422 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1422 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02940 XEO_CLAS Peptide DME1422 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1 ug/ml) DME1422 XEOTICID XEO02940 GENEFORM Protein DME1422 XEOTICID XEO02940 MOACRIVE Inhibition DME1422 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1422 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02941 XEO_CLAS Peptide DME1422 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02941 GENEFORM Protein DME1422 XEOTICID XEO02941 MOACRIVE Inhibition DME1422 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1422 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02944 XEO_CLAS Peptide DME1422 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 microM) DME1422 XEOTICID XEO02944 GENEFORM Protein DME1422 XEOTICID XEO02944 MOACRIVE Inhibition DME1422 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1422 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02945 XEO_CLAS Peptide DME1422 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 microM) DME1422 XEOTICID XEO02945 GENEFORM Protein DME1422 XEOTICID XEO02945 MOACRIVE Inhibition DME1422 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1422 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02946 XEO_CLAS Peptide DME1422 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 microM) DME1422 XEOTICID XEO02946 GENEFORM Protein DME1422 XEOTICID XEO02946 MOACRIVE Inhibition DME1422 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1422 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02947 XEO_CLAS Peptide DME1422 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02947 GENEFORM Protein DME1422 XEOTICID XEO02947 MOACRIVE Inhibition DME1422 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1422 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02948 XEO_CLAS Peptide DME1422 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO02948 GENEFORM Protein DME1422 XEOTICID XEO02948 MOACRIVE Inhibition DME1422 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1422 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02949 XEO_CLAS Peptide DME1422 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO02949 GENEFORM Protein DME1422 XEOTICID XEO02949 MOACRIVE Inhibition DME1422 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1422 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02954 XEO_CLAS Peptide DME1422 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02954 GENEFORM Protein DME1422 XEOTICID XEO02954 MOACRIVE Inhibition DME1422 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1422 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02958 XEO_CLAS Peptide DME1422 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02958 GENEFORM Protein DME1422 XEOTICID XEO02958 MOACRIVE Inhibition DME1422 XEOTICID XEO02962 XEO_NAME Cryptonin DME1422 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02962 XEO_CLAS Peptide DME1422 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.12 ug/ml) DME1422 XEOTICID XEO02962 GENEFORM Protein DME1422 XEOTICID XEO02962 MOACRIVE Inhibition DME1422 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1422 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02965 XEO_CLAS Peptide DME1422 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 ug/ml) DME1422 XEOTICID XEO02965 GENEFORM Protein DME1422 XEOTICID XEO02965 MOACRIVE Inhibition DME1422 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1422 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02969 XEO_CLAS Peptide DME1422 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 microM) DME1422 XEOTICID XEO02969 GENEFORM Protein DME1422 XEOTICID XEO02969 MOACRIVE Inhibition DME1422 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1422 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02971 XEO_CLAS Peptide DME1422 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 microM) DME1422 XEOTICID XEO02971 GENEFORM Protein DME1422 XEOTICID XEO02971 MOACRIVE Inhibition DME1422 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1422 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO02972 XEO_CLAS Peptide DME1422 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.4 microM) DME1422 XEOTICID XEO02972 GENEFORM Protein DME1422 XEOTICID XEO02972 MOACRIVE Inhibition DME1422 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1422 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02990 GENEFORM Protein DME1422 XEOTICID XEO02990 MOACRIVE Inhibition DME1422 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1422 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02991 GENEFORM Protein DME1422 XEOTICID XEO02991 MOACRIVE Inhibition DME1422 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1422 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02992 GENEFORM Protein DME1422 XEOTICID XEO02992 MOACRIVE Inhibition DME1422 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1422 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02993 GENEFORM Protein DME1422 XEOTICID XEO02993 MOACRIVE Inhibition DME1422 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1422 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02994 GENEFORM Protein DME1422 XEOTICID XEO02994 MOACRIVE Inhibition DME1422 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1422 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02995 GENEFORM Protein DME1422 XEOTICID XEO02995 MOACRIVE Inhibition DME1422 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1422 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02996 GENEFORM Protein DME1422 XEOTICID XEO02996 MOACRIVE Inhibition DME1422 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1422 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02997 GENEFORM Protein DME1422 XEOTICID XEO02997 MOACRIVE Inhibition DME1422 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1422 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02998 GENEFORM Protein DME1422 XEOTICID XEO02998 MOACRIVE Inhibition DME1422 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1422 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1422 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO02999 GENEFORM Protein DME1422 XEOTICID XEO02999 MOACRIVE Inhibition DME1422 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1422 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03021 XEO_CLAS Peptide DME1422 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.31-0.63 microM) DME1422 XEOTICID XEO03021 GENEFORM Protein DME1422 XEOTICID XEO03021 MOACRIVE Inhibition DME1422 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1422 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03029 XEO_CLAS Peptide DME1422 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.005 microM) DME1422 XEOTICID XEO03029 GENEFORM Protein DME1422 XEOTICID XEO03029 MOACRIVE Inhibition DME1422 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1422 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03030 XEO_CLAS Peptide DME1422 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.005 microM) DME1422 XEOTICID XEO03030 GENEFORM Protein DME1422 XEOTICID XEO03030 MOACRIVE Inhibition DME1422 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1422 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03031 XEO_CLAS Peptide DME1422 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.3 microM) DME1422 XEOTICID XEO03031 GENEFORM Protein DME1422 XEOTICID XEO03031 MOACRIVE Inhibition DME1422 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1422 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03032 XEO_CLAS Peptide DME1422 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.01 microM) DME1422 XEOTICID XEO03032 GENEFORM Protein DME1422 XEOTICID XEO03032 MOACRIVE Inhibition DME1422 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1422 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03033 XEO_CLAS Peptide DME1422 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.173 microM) DME1422 XEOTICID XEO03033 GENEFORM Protein DME1422 XEOTICID XEO03033 MOACRIVE Inhibition DME1422 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1422 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03034 XEO_CLAS Peptide DME1422 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.518 microM) DME1422 XEOTICID XEO03034 GENEFORM Protein DME1422 XEOTICID XEO03034 MOACRIVE Inhibition DME1422 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1422 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03035 XEO_CLAS Peptide DME1422 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.114 microM) DME1422 XEOTICID XEO03035 GENEFORM Protein DME1422 XEOTICID XEO03035 MOACRIVE Inhibition DME1422 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1422 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03039 XEO_CLAS Peptide DME1422 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.55 microM) DME1422 XEOTICID XEO03039 GENEFORM Protein DME1422 XEOTICID XEO03039 MOACRIVE Inhibition DME1422 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1422 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03043 XEO_CLAS Peptide DME1422 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 microM) DME1422 XEOTICID XEO03043 GENEFORM Protein DME1422 XEOTICID XEO03043 MOACRIVE Inhibition DME1422 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1422 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03044 XEO_CLAS Peptide DME1422 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03044 GENEFORM Protein DME1422 XEOTICID XEO03044 MOACRIVE Inhibition DME1422 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1422 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03045 XEO_CLAS Peptide DME1422 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03045 GENEFORM Protein DME1422 XEOTICID XEO03045 MOACRIVE Inhibition DME1422 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1422 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03046 XEO_CLAS Peptide DME1422 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03046 GENEFORM Protein DME1422 XEOTICID XEO03046 MOACRIVE Inhibition DME1422 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1422 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03049 XEO_CLAS Peptide DME1422 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 microM) DME1422 XEOTICID XEO03049 GENEFORM Protein DME1422 XEOTICID XEO03049 MOACRIVE Inhibition DME1422 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1422 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03055 XEO_CLAS Peptide DME1422 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 microM) DME1422 XEOTICID XEO03055 GENEFORM Protein DME1422 XEOTICID XEO03055 MOACRIVE Inhibition DME1422 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1422 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03059 XEO_CLAS Peptide DME1422 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO03059 GENEFORM Protein DME1422 XEOTICID XEO03059 MOACRIVE Inhibition DME1422 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1422 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03060 XEO_CLAS Peptide DME1422 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO03060 GENEFORM Protein DME1422 XEOTICID XEO03060 MOACRIVE Inhibition DME1422 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1422 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03062 XEO_CLAS Peptide DME1422 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO03062 GENEFORM Protein DME1422 XEOTICID XEO03062 MOACRIVE Inhibition DME1422 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1422 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03064 XEO_CLAS Peptide DME1422 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO03064 GENEFORM Protein DME1422 XEOTICID XEO03064 MOACRIVE Inhibition DME1422 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1422 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03066 XEO_CLAS Peptide DME1422 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO03066 GENEFORM Protein DME1422 XEOTICID XEO03066 MOACRIVE Inhibition DME1422 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1422 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03068 XEO_CLAS Peptide DME1422 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO03068 GENEFORM Protein DME1422 XEOTICID XEO03068 MOACRIVE Inhibition DME1422 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1422 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03073 XEO_CLAS Peptide DME1422 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8-16 ug/ml) DME1422 XEOTICID XEO03073 GENEFORM Protein DME1422 XEOTICID XEO03073 MOACRIVE Inhibition DME1422 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1422 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03081 XEO_CLAS Peptide DME1422 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 microM) DME1422 XEOTICID XEO03081 GENEFORM Protein DME1422 XEOTICID XEO03081 MOACRIVE Inhibition DME1422 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1422 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03082 XEO_CLAS Peptide DME1422 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03082 GENEFORM Protein DME1422 XEOTICID XEO03082 MOACRIVE Inhibition DME1422 XEOTICID XEO03089 XEO_NAME Decoralin DME1422 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03089 XEO_CLAS Peptide DME1422 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 160 microM) DME1422 XEOTICID XEO03089 GENEFORM Protein DME1422 XEOTICID XEO03089 MOACRIVE Inhibition DME1422 XEOTICID XEO03098 XEO_NAME Insect defensin DME1422 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03098 XEO_CLAS Peptide DME1422 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 ug/ml) DME1422 XEOTICID XEO03098 GENEFORM Protein DME1422 XEOTICID XEO03098 MOACRIVE Inhibition DME1422 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1422 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03100 XEO_CLAS Peptide DME1422 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03100 GENEFORM Protein DME1422 XEOTICID XEO03100 MOACRIVE Inhibition DME1422 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1422 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03103 XEO_CLAS Peptide DME1422 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03103 GENEFORM Protein DME1422 XEOTICID XEO03103 MOACRIVE Inhibition DME1422 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1422 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03105 XEO_CLAS Peptide DME1422 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03105 GENEFORM Protein DME1422 XEOTICID XEO03105 MOACRIVE Inhibition DME1422 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1422 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03110 XEO_CLAS Peptide DME1422 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.2 microM) DME1422 XEOTICID XEO03110 GENEFORM Protein DME1422 XEOTICID XEO03110 MOACRIVE Inhibition DME1422 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1422 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03111 XEO_CLAS Peptide DME1422 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03111 GENEFORM Protein DME1422 XEOTICID XEO03111 MOACRIVE Inhibition DME1422 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1422 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03112 XEO_CLAS Peptide DME1422 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 50 ug/ml) DME1422 XEOTICID XEO03112 GENEFORM Protein DME1422 XEOTICID XEO03112 MOACRIVE Inhibition DME1422 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1422 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03115 XEO_CLAS Peptide DME1422 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03115 GENEFORM Protein DME1422 XEOTICID XEO03115 MOACRIVE Inhibition DME1422 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1422 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03116 XEO_CLAS Peptide DME1422 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 40 microM) DME1422 XEOTICID XEO03116 GENEFORM Protein DME1422 XEOTICID XEO03116 MOACRIVE Inhibition DME1422 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1422 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03118 XEO_CLAS Peptide DME1422 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03118 GENEFORM Protein DME1422 XEOTICID XEO03118 MOACRIVE Inhibition DME1422 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1422 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03119 XEO_CLAS Peptide DME1422 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03119 GENEFORM Protein DME1422 XEOTICID XEO03119 MOACRIVE Inhibition DME1422 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1422 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03121 XEO_CLAS Peptide DME1422 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03121 GENEFORM Protein DME1422 XEOTICID XEO03121 MOACRIVE Inhibition DME1422 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1422 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03122 XEO_CLAS Peptide DME1422 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64000 ug/ml) DME1422 XEOTICID XEO03122 GENEFORM Protein DME1422 XEOTICID XEO03122 MOACRIVE Inhibition DME1422 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1422 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03124 XEO_CLAS Peptide DME1422 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03124 GENEFORM Protein DME1422 XEOTICID XEO03124 MOACRIVE Inhibition DME1422 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1422 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03125 XEO_CLAS Peptide DME1422 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03125 GENEFORM Protein DME1422 XEOTICID XEO03125 MOACRIVE Inhibition DME1422 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1422 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03126 XEO_CLAS Peptide DME1422 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.86 microM) DME1422 XEOTICID XEO03126 GENEFORM Protein DME1422 XEOTICID XEO03126 MOACRIVE Inhibition DME1422 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1422 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03127 XEO_CLAS Peptide DME1422 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03127 GENEFORM Protein DME1422 XEOTICID XEO03127 MOACRIVE Inhibition DME1422 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1422 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03128 XEO_CLAS Peptide DME1422 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 256 ug/ml) DME1422 XEOTICID XEO03128 GENEFORM Protein DME1422 XEOTICID XEO03128 MOACRIVE Inhibition DME1422 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1422 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03129 XEO_CLAS Peptide DME1422 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 256 ug/ml) DME1422 XEOTICID XEO03129 GENEFORM Protein DME1422 XEOTICID XEO03129 MOACRIVE Inhibition DME1422 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1422 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03130 XEO_CLAS Peptide DME1422 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 256 ug/ml) DME1422 XEOTICID XEO03130 GENEFORM Protein DME1422 XEOTICID XEO03130 MOACRIVE Inhibition DME1422 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1422 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03131 XEO_CLAS Peptide DME1422 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 256 ug/ml) DME1422 XEOTICID XEO03131 GENEFORM Protein DME1422 XEOTICID XEO03131 MOACRIVE Inhibition DME1422 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1422 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03132 XEO_CLAS Peptide DME1422 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 256 ug/ml) DME1422 XEOTICID XEO03132 GENEFORM Protein DME1422 XEOTICID XEO03132 MOACRIVE Inhibition DME1422 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1422 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03137 XEO_CLAS Peptide DME1422 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03137 GENEFORM Protein DME1422 XEOTICID XEO03137 MOACRIVE Inhibition DME1422 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1422 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03143 XEO_CLAS Peptide DME1422 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.6 microM) DME1422 XEOTICID XEO03143 GENEFORM Protein DME1422 XEOTICID XEO03143 MOACRIVE Inhibition DME1422 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1422 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03145 XEO_CLAS Peptide DME1422 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.6 microM) DME1422 XEOTICID XEO03145 GENEFORM Protein DME1422 XEOTICID XEO03145 MOACRIVE Inhibition DME1422 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1422 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03146 XEO_CLAS Peptide DME1422 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.5 microM) DME1422 XEOTICID XEO03146 GENEFORM Protein DME1422 XEOTICID XEO03146 MOACRIVE Inhibition DME1422 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1422 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03147 XEO_CLAS Peptide DME1422 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 9.7 microM) DME1422 XEOTICID XEO03147 GENEFORM Protein DME1422 XEOTICID XEO03147 MOACRIVE Inhibition DME1422 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1422 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03148 XEO_CLAS Peptide DME1422 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.3 microM) DME1422 XEOTICID XEO03148 GENEFORM Protein DME1422 XEOTICID XEO03148 MOACRIVE Inhibition DME1422 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1422 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03149 XEO_CLAS Peptide DME1422 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.6 microM) DME1422 XEOTICID XEO03149 GENEFORM Protein DME1422 XEOTICID XEO03149 MOACRIVE Inhibition DME1422 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1422 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03150 XEO_CLAS Peptide DME1422 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 9-3 microM) DME1422 XEOTICID XEO03150 GENEFORM Protein DME1422 XEOTICID XEO03150 MOACRIVE Inhibition DME1422 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1422 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03151 XEO_CLAS Peptide DME1422 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 ug/ml) DME1422 XEOTICID XEO03151 GENEFORM Protein DME1422 XEOTICID XEO03151 MOACRIVE Inhibition DME1422 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1422 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03152 XEO_CLAS Peptide DME1422 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO03152 GENEFORM Protein DME1422 XEOTICID XEO03152 MOACRIVE Inhibition DME1422 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1422 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03155 XEO_CLAS Peptide DME1422 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.4 microM) DME1422 XEOTICID XEO03155 GENEFORM Protein DME1422 XEOTICID XEO03155 MOACRIVE Inhibition DME1422 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1422 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03156 XEO_CLAS Peptide DME1422 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.3 microM) DME1422 XEOTICID XEO03156 GENEFORM Protein DME1422 XEOTICID XEO03156 MOACRIVE Inhibition DME1422 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1422 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03157 XEO_CLAS Peptide DME1422 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.3 microM) DME1422 XEOTICID XEO03157 GENEFORM Protein DME1422 XEOTICID XEO03157 MOACRIVE Inhibition DME1422 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1422 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03158 XEO_CLAS Peptide DME1422 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 ug/ml) DME1422 XEOTICID XEO03158 GENEFORM Protein DME1422 XEOTICID XEO03158 MOACRIVE Inhibition DME1422 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1422 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03159 XEO_CLAS Peptide DME1422 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03159 GENEFORM Protein DME1422 XEOTICID XEO03159 MOACRIVE Inhibition DME1422 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1422 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03161 XEO_CLAS Peptide DME1422 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 microM) DME1422 XEOTICID XEO03161 GENEFORM Protein DME1422 XEOTICID XEO03161 MOACRIVE Inhibition DME1422 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1422 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03162 XEO_CLAS Peptide DME1422 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.5 microM) DME1422 XEOTICID XEO03162 GENEFORM Protein DME1422 XEOTICID XEO03162 MOACRIVE Inhibition DME1422 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1422 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03169 XEO_CLAS Peptide DME1422 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO03169 GENEFORM Protein DME1422 XEOTICID XEO03169 MOACRIVE Inhibition DME1422 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1422 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03193 XEO_CLAS Peptide DME1422 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25 ug/ml) DME1422 XEOTICID XEO03193 GENEFORM Protein DME1422 XEOTICID XEO03193 MOACRIVE Inhibition DME1422 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1422 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03194 XEO_CLAS Peptide DME1422 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03194 GENEFORM Protein DME1422 XEOTICID XEO03194 MOACRIVE Inhibition DME1422 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1422 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03195 XEO_CLAS Peptide DME1422 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03195 GENEFORM Protein DME1422 XEOTICID XEO03195 MOACRIVE Inhibition DME1422 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1422 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03197 XEO_CLAS Peptide DME1422 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 14.5 microM) DME1422 XEOTICID XEO03197 GENEFORM Protein DME1422 XEOTICID XEO03197 MOACRIVE Inhibition DME1422 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1422 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03202 XEO_CLAS Peptide DME1422 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.51 microM) DME1422 XEOTICID XEO03202 GENEFORM Protein DME1422 XEOTICID XEO03202 MOACRIVE Inhibition DME1422 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1422 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03203 XEO_CLAS Peptide DME1422 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.62 microM) DME1422 XEOTICID XEO03203 GENEFORM Protein DME1422 XEOTICID XEO03203 MOACRIVE Inhibition DME1422 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1422 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03204 XEO_CLAS Peptide DME1422 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.38 microM) DME1422 XEOTICID XEO03204 GENEFORM Protein DME1422 XEOTICID XEO03204 MOACRIVE Inhibition DME1422 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1422 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03205 XEO_CLAS Peptide DME1422 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.29 microM) DME1422 XEOTICID XEO03205 GENEFORM Protein DME1422 XEOTICID XEO03205 MOACRIVE Inhibition DME1422 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1422 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03206 XEO_CLAS Peptide DME1422 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.40 microM) DME1422 XEOTICID XEO03206 GENEFORM Protein DME1422 XEOTICID XEO03206 MOACRIVE Inhibition DME1422 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1422 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03207 XEO_CLAS Peptide DME1422 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.58 microM) DME1422 XEOTICID XEO03207 GENEFORM Protein DME1422 XEOTICID XEO03207 MOACRIVE Inhibition DME1422 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1422 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03208 XEO_CLAS Peptide DME1422 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.76 microM) DME1422 XEOTICID XEO03208 GENEFORM Protein DME1422 XEOTICID XEO03208 MOACRIVE Inhibition DME1422 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1422 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03209 XEO_CLAS Peptide DME1422 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.49 microM) DME1422 XEOTICID XEO03209 GENEFORM Protein DME1422 XEOTICID XEO03209 MOACRIVE Inhibition DME1422 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1422 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03210 XEO_CLAS Peptide DME1422 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 7.07 microM) DME1422 XEOTICID XEO03210 GENEFORM Protein DME1422 XEOTICID XEO03210 MOACRIVE Inhibition DME1422 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1422 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03211 XEO_CLAS Peptide DME1422 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.40 microM) DME1422 XEOTICID XEO03211 GENEFORM Protein DME1422 XEOTICID XEO03211 MOACRIVE Inhibition DME1422 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1422 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03215 XEO_CLAS Peptide DME1422 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20.0 ug/ml) DME1422 XEOTICID XEO03215 GENEFORM Protein DME1422 XEOTICID XEO03215 MOACRIVE Inhibition DME1422 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1422 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03216 XEO_CLAS Peptide DME1422 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO03216 GENEFORM Protein DME1422 XEOTICID XEO03216 MOACRIVE Inhibition DME1422 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1422 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03217 XEO_CLAS Peptide DME1422 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO03217 GENEFORM Protein DME1422 XEOTICID XEO03217 MOACRIVE Inhibition DME1422 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1422 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03223 XEO_CLAS Peptide DME1422 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.8 microM) DME1422 XEOTICID XEO03223 GENEFORM Protein DME1422 XEOTICID XEO03223 MOACRIVE Inhibition DME1422 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1422 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03224 XEO_CLAS Peptide DME1422 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.1-0.25 microM) DME1422 XEOTICID XEO03224 GENEFORM Protein DME1422 XEOTICID XEO03224 MOACRIVE Inhibition DME1422 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1422 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03225 XEO_CLAS Peptide DME1422 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.3 microM) DME1422 XEOTICID XEO03225 GENEFORM Protein DME1422 XEOTICID XEO03225 MOACRIVE Inhibition DME1422 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1422 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03227 XEO_CLAS Peptide DME1422 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.3 microM) DME1422 XEOTICID XEO03227 GENEFORM Protein DME1422 XEOTICID XEO03227 MOACRIVE Inhibition DME1422 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1422 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03231 XEO_CLAS Peptide DME1422 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03231 GENEFORM Protein DME1422 XEOTICID XEO03231 MOACRIVE Inhibition DME1422 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1422 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03232 XEO_CLAS Peptide DME1422 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03232 GENEFORM Protein DME1422 XEOTICID XEO03232 MOACRIVE Inhibition DME1422 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1422 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03234 XEO_CLAS Peptide DME1422 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO03234 GENEFORM Protein DME1422 XEOTICID XEO03234 MOACRIVE Inhibition DME1422 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1422 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03235 XEO_CLAS Peptide DME1422 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 60 ug/ml) DME1422 XEOTICID XEO03235 GENEFORM Protein DME1422 XEOTICID XEO03235 MOACRIVE Inhibition DME1422 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1422 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03236 XEO_CLAS Peptide DME1422 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO03236 GENEFORM Protein DME1422 XEOTICID XEO03236 MOACRIVE Inhibition DME1422 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1422 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03237 XEO_CLAS Peptide DME1422 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 ug/ml) DME1422 XEOTICID XEO03237 GENEFORM Protein DME1422 XEOTICID XEO03237 MOACRIVE Inhibition DME1422 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1422 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03238 XEO_CLAS Peptide DME1422 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 ug/ml) DME1422 XEOTICID XEO03238 GENEFORM Protein DME1422 XEOTICID XEO03238 MOACRIVE Inhibition DME1422 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1422 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03239 XEO_CLAS Peptide DME1422 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 60 ug/ml) DME1422 XEOTICID XEO03239 GENEFORM Protein DME1422 XEOTICID XEO03239 MOACRIVE Inhibition DME1422 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1422 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03241 XEO_CLAS Peptide DME1422 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 128 microM) DME1422 XEOTICID XEO03241 GENEFORM Protein DME1422 XEOTICID XEO03241 MOACRIVE Inhibition DME1422 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1422 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03250 XEO_CLAS Peptide DME1422 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03250 GENEFORM Protein DME1422 XEOTICID XEO03250 MOACRIVE Inhibition DME1422 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1422 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03251 XEO_CLAS Peptide DME1422 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03251 GENEFORM Protein DME1422 XEOTICID XEO03251 MOACRIVE Inhibition DME1422 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1422 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03253 XEO_CLAS Peptide DME1422 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.1 ug/ml) DME1422 XEOTICID XEO03253 GENEFORM Protein DME1422 XEOTICID XEO03253 MOACRIVE Inhibition DME1422 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1422 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03274 XEO_CLAS Peptide DME1422 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.2 microM) DME1422 XEOTICID XEO03274 GENEFORM Protein DME1422 XEOTICID XEO03274 MOACRIVE Inhibition DME1422 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1422 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03275 XEO_CLAS Peptide DME1422 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO03275 GENEFORM Protein DME1422 XEOTICID XEO03275 MOACRIVE Inhibition DME1422 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1422 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03276 XEO_CLAS Peptide DME1422 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO03276 GENEFORM Protein DME1422 XEOTICID XEO03276 MOACRIVE Inhibition DME1422 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1422 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03277 XEO_CLAS Peptide DME1422 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.2 microM) DME1422 XEOTICID XEO03277 GENEFORM Protein DME1422 XEOTICID XEO03277 MOACRIVE Inhibition DME1422 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1422 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03278 XEO_CLAS Peptide DME1422 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO03278 GENEFORM Protein DME1422 XEOTICID XEO03278 MOACRIVE Inhibition DME1422 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1422 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03279 XEO_CLAS Peptide DME1422 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO03279 GENEFORM Protein DME1422 XEOTICID XEO03279 MOACRIVE Inhibition DME1422 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1422 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03280 XEO_CLAS Peptide DME1422 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 microM) DME1422 XEOTICID XEO03280 GENEFORM Protein DME1422 XEOTICID XEO03280 MOACRIVE Inhibition DME1422 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1422 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03281 XEO_CLAS Peptide DME1422 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.3 microM) DME1422 XEOTICID XEO03281 GENEFORM Protein DME1422 XEOTICID XEO03281 MOACRIVE Inhibition DME1422 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1422 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03282 XEO_CLAS Peptide DME1422 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.1 microM) DME1422 XEOTICID XEO03282 GENEFORM Protein DME1422 XEOTICID XEO03282 MOACRIVE Inhibition DME1422 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1422 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03283 XEO_CLAS Peptide DME1422 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 microM) DME1422 XEOTICID XEO03283 GENEFORM Protein DME1422 XEOTICID XEO03283 MOACRIVE Inhibition DME1422 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1422 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03284 XEO_CLAS Peptide DME1422 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.2 ug/ml) DME1422 XEOTICID XEO03284 GENEFORM Protein DME1422 XEOTICID XEO03284 MOACRIVE Inhibition DME1422 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1422 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03285 XEO_CLAS Peptide DME1422 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.5 ug/ml) DME1422 XEOTICID XEO03285 GENEFORM Protein DME1422 XEOTICID XEO03285 MOACRIVE Inhibition DME1422 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1422 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03286 XEO_CLAS Peptide DME1422 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.4 ug/ml) DME1422 XEOTICID XEO03286 GENEFORM Protein DME1422 XEOTICID XEO03286 MOACRIVE Inhibition DME1422 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1422 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03287 XEO_CLAS Peptide DME1422 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.6 ug/ml) DME1422 XEOTICID XEO03287 GENEFORM Protein DME1422 XEOTICID XEO03287 MOACRIVE Inhibition DME1422 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1422 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03288 XEO_CLAS Peptide DME1422 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.4 ug/ml) DME1422 XEOTICID XEO03288 GENEFORM Protein DME1422 XEOTICID XEO03288 MOACRIVE Inhibition DME1422 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1422 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03289 XEO_CLAS Peptide DME1422 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8.8 ug/ml) DME1422 XEOTICID XEO03289 GENEFORM Protein DME1422 XEOTICID XEO03289 MOACRIVE Inhibition DME1422 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1422 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03290 XEO_CLAS Peptide DME1422 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.5 ug/ml) DME1422 XEOTICID XEO03290 GENEFORM Protein DME1422 XEOTICID XEO03290 MOACRIVE Inhibition DME1422 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1422 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03291 XEO_CLAS Peptide DME1422 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8.6 ug/ml) DME1422 XEOTICID XEO03291 GENEFORM Protein DME1422 XEOTICID XEO03291 MOACRIVE Inhibition DME1422 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1422 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03292 XEO_CLAS Peptide DME1422 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4.1 ug/ml) DME1422 XEOTICID XEO03292 GENEFORM Protein DME1422 XEOTICID XEO03292 MOACRIVE Inhibition DME1422 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1422 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03293 XEO_CLAS Peptide DME1422 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1 microM) DME1422 XEOTICID XEO03293 GENEFORM Protein DME1422 XEOTICID XEO03293 MOACRIVE Inhibition DME1422 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1422 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03294 XEO_CLAS Peptide DME1422 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1 microM) DME1422 XEOTICID XEO03294 GENEFORM Protein DME1422 XEOTICID XEO03294 MOACRIVE Inhibition DME1422 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1422 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03295 XEO_CLAS Peptide DME1422 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.7 microM) DME1422 XEOTICID XEO03295 GENEFORM Protein DME1422 XEOTICID XEO03295 MOACRIVE Inhibition DME1422 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1422 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03296 XEO_CLAS Peptide DME1422 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03296 GENEFORM Protein DME1422 XEOTICID XEO03296 MOACRIVE Inhibition DME1422 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1422 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03297 XEO_CLAS Peptide DME1422 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03297 GENEFORM Protein DME1422 XEOTICID XEO03297 MOACRIVE Inhibition DME1422 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1422 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03298 XEO_CLAS Peptide DME1422 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.2 microM) DME1422 XEOTICID XEO03298 GENEFORM Protein DME1422 XEOTICID XEO03298 MOACRIVE Inhibition DME1422 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1422 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03299 XEO_CLAS Peptide DME1422 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.4 microM) DME1422 XEOTICID XEO03299 GENEFORM Protein DME1422 XEOTICID XEO03299 MOACRIVE Inhibition DME1422 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1422 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03300 XEO_CLAS Peptide DME1422 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 ug/ml) DME1422 XEOTICID XEO03300 GENEFORM Protein DME1422 XEOTICID XEO03300 MOACRIVE Inhibition DME1422 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1422 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03301 XEO_CLAS Peptide DME1422 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 ug/ml) DME1422 XEOTICID XEO03301 GENEFORM Protein DME1422 XEOTICID XEO03301 MOACRIVE Inhibition DME1422 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1422 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03302 XEO_CLAS Peptide DME1422 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1 microM) DME1422 XEOTICID XEO03302 GENEFORM Protein DME1422 XEOTICID XEO03302 MOACRIVE Inhibition DME1422 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1422 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03303 XEO_CLAS Peptide DME1422 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 microM) DME1422 XEOTICID XEO03303 GENEFORM Protein DME1422 XEOTICID XEO03303 MOACRIVE Inhibition DME1422 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1422 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03304 XEO_CLAS Peptide DME1422 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO03304 GENEFORM Protein DME1422 XEOTICID XEO03304 MOACRIVE Inhibition DME1422 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1422 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03305 XEO_CLAS Peptide DME1422 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 microM) DME1422 XEOTICID XEO03305 GENEFORM Protein DME1422 XEOTICID XEO03305 MOACRIVE Inhibition DME1422 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1422 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03306 XEO_CLAS Peptide DME1422 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO03306 GENEFORM Protein DME1422 XEOTICID XEO03306 MOACRIVE Inhibition DME1422 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1422 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03307 XEO_CLAS Peptide DME1422 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 34 ug/ml) DME1422 XEOTICID XEO03307 GENEFORM Protein DME1422 XEOTICID XEO03307 MOACRIVE Inhibition DME1422 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1422 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03308 XEO_CLAS Peptide DME1422 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO03308 GENEFORM Protein DME1422 XEOTICID XEO03308 MOACRIVE Inhibition DME1422 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1422 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03310 XEO_CLAS Peptide DME1422 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8.5 ug/ml) DME1422 XEOTICID XEO03310 GENEFORM Protein DME1422 XEOTICID XEO03310 MOACRIVE Inhibition DME1422 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1422 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03311 XEO_CLAS Peptide DME1422 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10.8 ug/ml) DME1422 XEOTICID XEO03311 GENEFORM Protein DME1422 XEOTICID XEO03311 MOACRIVE Inhibition DME1422 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1422 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03312 XEO_CLAS Peptide DME1422 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10.8 ug/ml) DME1422 XEOTICID XEO03312 GENEFORM Protein DME1422 XEOTICID XEO03312 MOACRIVE Inhibition DME1422 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1422 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03313 XEO_CLAS Peptide DME1422 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8.1 ug/ml) DME1422 XEOTICID XEO03313 GENEFORM Protein DME1422 XEOTICID XEO03313 MOACRIVE Inhibition DME1422 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1422 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03314 XEO_CLAS Peptide DME1422 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 7.9 ug/ml) DME1422 XEOTICID XEO03314 GENEFORM Protein DME1422 XEOTICID XEO03314 MOACRIVE Inhibition DME1422 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1422 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03315 XEO_CLAS Peptide DME1422 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.6 ug/ml) DME1422 XEOTICID XEO03315 GENEFORM Protein DME1422 XEOTICID XEO03315 MOACRIVE Inhibition DME1422 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1422 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03316 XEO_CLAS Peptide DME1422 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15.8 ug/ml) DME1422 XEOTICID XEO03316 GENEFORM Protein DME1422 XEOTICID XEO03316 MOACRIVE Inhibition DME1422 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1422 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03317 XEO_CLAS Peptide DME1422 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO03317 GENEFORM Protein DME1422 XEOTICID XEO03317 MOACRIVE Inhibition DME1422 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1422 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03318 XEO_CLAS Peptide DME1422 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1 microM) DME1422 XEOTICID XEO03318 GENEFORM Protein DME1422 XEOTICID XEO03318 MOACRIVE Inhibition DME1422 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1422 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03319 XEO_CLAS Peptide DME1422 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03319 GENEFORM Protein DME1422 XEOTICID XEO03319 MOACRIVE Inhibition DME1422 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1422 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03320 XEO_CLAS Peptide DME1422 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.1 microM) DME1422 XEOTICID XEO03320 GENEFORM Protein DME1422 XEOTICID XEO03320 MOACRIVE Inhibition DME1422 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1422 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03321 XEO_CLAS Peptide DME1422 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.8 microM) DME1422 XEOTICID XEO03321 GENEFORM Protein DME1422 XEOTICID XEO03321 MOACRIVE Inhibition DME1422 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1422 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1422 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03348 GENEFORM Protein DME1422 XEOTICID XEO03348 MOACRIVE Inhibition DME1422 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1422 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03362 XEO_CLAS Peptide DME1422 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO03362 GENEFORM Protein DME1422 XEOTICID XEO03362 MOACRIVE Inhibition DME1422 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1422 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03363 XEO_CLAS Peptide DME1422 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 microM) DME1422 XEOTICID XEO03363 GENEFORM Protein DME1422 XEOTICID XEO03363 MOACRIVE Inhibition DME1422 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1422 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03364 XEO_CLAS Peptide DME1422 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 microM) DME1422 XEOTICID XEO03364 GENEFORM Protein DME1422 XEOTICID XEO03364 MOACRIVE Inhibition DME1422 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1422 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03365 XEO_CLAS Peptide DME1422 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03365 GENEFORM Protein DME1422 XEOTICID XEO03365 MOACRIVE Inhibition DME1422 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1422 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03366 XEO_CLAS Peptide DME1422 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO03366 GENEFORM Protein DME1422 XEOTICID XEO03366 MOACRIVE Inhibition DME1422 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1422 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03367 XEO_CLAS Peptide DME1422 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 microM) DME1422 XEOTICID XEO03367 GENEFORM Protein DME1422 XEOTICID XEO03367 MOACRIVE Inhibition DME1422 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1422 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03368 XEO_CLAS Peptide DME1422 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 microM) DME1422 XEOTICID XEO03368 GENEFORM Protein DME1422 XEOTICID XEO03368 MOACRIVE Inhibition DME1422 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1422 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03379 XEO_CLAS Peptide DME1422 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.6 ug/ml) DME1422 XEOTICID XEO03379 GENEFORM Protein DME1422 XEOTICID XEO03379 MOACRIVE Inhibition DME1422 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1422 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03396 XEO_CLAS Peptide DME1422 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03396 GENEFORM Protein DME1422 XEOTICID XEO03396 MOACRIVE Inhibition DME1422 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1422 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03398 XEO_CLAS Peptide DME1422 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03398 GENEFORM Protein DME1422 XEOTICID XEO03398 MOACRIVE Inhibition DME1422 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1422 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03399 XEO_CLAS Peptide DME1422 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03399 GENEFORM Protein DME1422 XEOTICID XEO03399 MOACRIVE Inhibition DME1422 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1422 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03406 XEO_CLAS Peptide DME1422 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 ug/ml) DME1422 XEOTICID XEO03406 GENEFORM Protein DME1422 XEOTICID XEO03406 MOACRIVE Inhibition DME1422 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1422 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03424 XEO_CLAS Peptide DME1422 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03424 GENEFORM Protein DME1422 XEOTICID XEO03424 MOACRIVE Inhibition DME1422 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1422 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03426 XEO_CLAS Peptide DME1422 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO03426 GENEFORM Protein DME1422 XEOTICID XEO03426 MOACRIVE Inhibition DME1422 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1422 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03427 XEO_CLAS Peptide DME1422 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 microM) DME1422 XEOTICID XEO03427 GENEFORM Protein DME1422 XEOTICID XEO03427 MOACRIVE Inhibition DME1422 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1422 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03428 XEO_CLAS Peptide DME1422 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 ug/ml) DME1422 XEOTICID XEO03428 GENEFORM Protein DME1422 XEOTICID XEO03428 MOACRIVE Inhibition DME1422 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1422 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03430 XEO_CLAS Peptide DME1422 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 ug/ml) DME1422 XEOTICID XEO03430 GENEFORM Protein DME1422 XEOTICID XEO03430 MOACRIVE Inhibition DME1422 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1422 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03434 XEO_CLAS Peptide DME1422 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO03434 GENEFORM Protein DME1422 XEOTICID XEO03434 MOACRIVE Inhibition DME1422 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1422 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03442 XEO_CLAS Peptide DME1422 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 18.75 ug/ml) DME1422 XEOTICID XEO03442 GENEFORM Protein DME1422 XEOTICID XEO03442 MOACRIVE Inhibition DME1422 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1422 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03444 XEO_CLAS Peptide DME1422 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 37.50 ug/ml) DME1422 XEOTICID XEO03444 GENEFORM Protein DME1422 XEOTICID XEO03444 MOACRIVE Inhibition DME1422 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1422 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03459 XEO_CLAS Peptide DME1422 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03459 GENEFORM Protein DME1422 XEOTICID XEO03459 MOACRIVE Inhibition DME1422 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1422 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03460 XEO_CLAS Peptide DME1422 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03460 GENEFORM Protein DME1422 XEOTICID XEO03460 MOACRIVE Inhibition DME1422 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1422 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03461 XEO_CLAS Peptide DME1422 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.05 microM) DME1422 XEOTICID XEO03461 GENEFORM Protein DME1422 XEOTICID XEO03461 MOACRIVE Inhibition DME1422 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1422 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03462 XEO_CLAS Peptide DME1422 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03462 GENEFORM Protein DME1422 XEOTICID XEO03462 MOACRIVE Inhibition DME1422 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1422 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03463 XEO_CLAS Peptide DME1422 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03463 GENEFORM Protein DME1422 XEOTICID XEO03463 MOACRIVE Inhibition DME1422 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1422 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03467 XEO_CLAS Peptide DME1422 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03467 GENEFORM Protein DME1422 XEOTICID XEO03467 MOACRIVE Inhibition DME1422 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1422 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03468 XEO_CLAS Peptide DME1422 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03468 GENEFORM Protein DME1422 XEOTICID XEO03468 MOACRIVE Inhibition DME1422 XEOTICID XEO03471 XEO_NAME Gambicin DME1422 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03471 XEO_CLAS Peptide DME1422 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25-12.5 microM) DME1422 XEOTICID XEO03471 GENEFORM Protein DME1422 XEOTICID XEO03471 MOACRIVE Inhibition DME1422 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1422 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03485 XEO_CLAS Peptide DME1422 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4.07 ug/ml) DME1422 XEOTICID XEO03485 GENEFORM Protein DME1422 XEOTICID XEO03485 MOACRIVE Inhibition DME1422 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1422 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03486 XEO_CLAS Peptide DME1422 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.80 ug/ml) DME1422 XEOTICID XEO03486 GENEFORM Protein DME1422 XEOTICID XEO03486 MOACRIVE Inhibition DME1422 XEOTICID XEO03488 XEO_NAME GLK-19 DME1422 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03488 XEO_CLAS Peptide DME1422 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO03488 GENEFORM Protein DME1422 XEOTICID XEO03488 MOACRIVE Inhibition DME1422 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1422 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03497 XEO_CLAS Peptide DME1422 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.4-0.8 microM) DME1422 XEOTICID XEO03497 GENEFORM Protein DME1422 XEOTICID XEO03497 MOACRIVE Inhibition DME1422 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1422 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03498 XEO_CLAS Peptide DME1422 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.4-0.8 microM) DME1422 XEOTICID XEO03498 GENEFORM Protein DME1422 XEOTICID XEO03498 MOACRIVE Inhibition DME1422 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1422 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03500 XEO_CLAS Peptide DME1422 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-30 ug/ml) DME1422 XEOTICID XEO03500 GENEFORM Protein DME1422 XEOTICID XEO03500 MOACRIVE Inhibition DME1422 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1422 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03504 XEO_CLAS Peptide DME1422 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 ug/ml) DME1422 XEOTICID XEO03504 GENEFORM Protein DME1422 XEOTICID XEO03504 MOACRIVE Inhibition DME1422 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1422 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03505 XEO_CLAS Peptide DME1422 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 ug/ml) DME1422 XEOTICID XEO03505 GENEFORM Protein DME1422 XEOTICID XEO03505 MOACRIVE Inhibition DME1422 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1422 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03506 XEO_CLAS Peptide DME1422 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 ug/ml) DME1422 XEOTICID XEO03506 GENEFORM Protein DME1422 XEOTICID XEO03506 MOACRIVE Inhibition DME1422 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1422 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03513 XEO_CLAS Peptide DME1422 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO03513 GENEFORM Protein DME1422 XEOTICID XEO03513 MOACRIVE Inhibition DME1422 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1422 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03514 XEO_CLAS Peptide DME1422 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03514 GENEFORM Protein DME1422 XEOTICID XEO03514 MOACRIVE Inhibition DME1422 XEOTICID XEO03519 XEO_NAME Hadrurin DME1422 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03519 XEO_CLAS Peptide DME1422 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03519 GENEFORM Protein DME1422 XEOTICID XEO03519 MOACRIVE Inhibition DME1422 XEOTICID XEO03522 XEO_NAME Halocyntin DME1422 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03522 XEO_CLAS Peptide DME1422 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03522 GENEFORM Protein DME1422 XEOTICID XEO03522 MOACRIVE Inhibition DME1422 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1422 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03524 XEO_CLAS Peptide DME1422 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03524 GENEFORM Protein DME1422 XEOTICID XEO03524 MOACRIVE Inhibition DME1422 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1422 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03525 XEO_CLAS Peptide DME1422 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03525 GENEFORM Protein DME1422 XEOTICID XEO03525 MOACRIVE Inhibition DME1422 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1422 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03530 XEO_CLAS Peptide DME1422 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03530 GENEFORM Protein DME1422 XEOTICID XEO03530 MOACRIVE Inhibition DME1422 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1422 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03535 XEO_CLAS Peptide DME1422 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.4 microM) DME1422 XEOTICID XEO03535 GENEFORM Protein DME1422 XEOTICID XEO03535 MOACRIVE Inhibition DME1422 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1422 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03536 XEO_CLAS Peptide DME1422 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 80 microM) DME1422 XEOTICID XEO03536 GENEFORM Protein DME1422 XEOTICID XEO03536 MOACRIVE Inhibition DME1422 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1422 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03537 XEO_CLAS Peptide DME1422 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 ug/ml) DME1422 XEOTICID XEO03537 GENEFORM Protein DME1422 XEOTICID XEO03537 MOACRIVE Inhibition DME1422 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1422 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03538 XEO_CLAS Peptide DME1422 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 ug/ml) DME1422 XEOTICID XEO03538 GENEFORM Protein DME1422 XEOTICID XEO03538 MOACRIVE Inhibition DME1422 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1422 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03540 XEO_CLAS Peptide DME1422 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO03540 GENEFORM Protein DME1422 XEOTICID XEO03540 MOACRIVE Inhibition DME1422 XEOTICID XEO03542 XEO_NAME Hepcidin DME1422 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03542 XEO_CLAS Peptide DME1422 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 24 microM) DME1422 XEOTICID XEO03542 GENEFORM Protein DME1422 XEOTICID XEO03542 MOACRIVE Inhibition DME1422 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1422 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03544 XEO_CLAS Peptide DME1422 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03544 GENEFORM Protein DME1422 XEOTICID XEO03544 MOACRIVE Inhibition DME1422 XEOTICID XEO03548 XEO_NAME Hesperidin DME1422 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03548 GENEFORM Protein DME1422 XEOTICID XEO03548 MOACRIVE Inhibition DME1422 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1422 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1422 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03552 GENEFORM Protein DME1422 XEOTICID XEO03552 MOACRIVE Inhibition DME1422 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1422 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03556 XEO_CLAS Peptide DME1422 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO03556 GENEFORM Protein DME1422 XEOTICID XEO03556 MOACRIVE Inhibition DME1422 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1422 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03557 XEO_CLAS Peptide DME1422 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO03557 GENEFORM Protein DME1422 XEOTICID XEO03557 MOACRIVE Inhibition DME1422 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1422 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03558 XEO_CLAS Peptide DME1422 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 microM) DME1422 XEOTICID XEO03558 GENEFORM Protein DME1422 XEOTICID XEO03558 MOACRIVE Inhibition DME1422 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1422 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03559 XEO_CLAS Peptide DME1422 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 microM) DME1422 XEOTICID XEO03559 GENEFORM Protein DME1422 XEOTICID XEO03559 MOACRIVE Inhibition DME1422 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1422 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03560 XEO_CLAS Peptide DME1422 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 microM) DME1422 XEOTICID XEO03560 GENEFORM Protein DME1422 XEOTICID XEO03560 MOACRIVE Inhibition DME1422 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1422 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03561 XEO_CLAS Peptide DME1422 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03561 GENEFORM Protein DME1422 XEOTICID XEO03561 MOACRIVE Inhibition DME1422 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1422 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03567 XEO_CLAS Peptide DME1422 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03567 GENEFORM Protein DME1422 XEOTICID XEO03567 MOACRIVE Inhibition DME1422 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1422 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03569 XEO_CLAS Peptide DME1422 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 300 microM) DME1422 XEOTICID XEO03569 GENEFORM Protein DME1422 XEOTICID XEO03569 MOACRIVE Inhibition DME1422 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1422 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03570 XEO_CLAS Peptide DME1422 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03570 GENEFORM Protein DME1422 XEOTICID XEO03570 MOACRIVE Inhibition DME1422 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1422 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03572 XEO_CLAS Peptide DME1422 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1422 XEOTICID XEO03572 GENEFORM Protein DME1422 XEOTICID XEO03572 MOACRIVE Inhibition DME1422 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1422 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03573 XEO_CLAS Peptide DME1422 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 28.1 ug/ml) DME1422 XEOTICID XEO03573 GENEFORM Protein DME1422 XEOTICID XEO03573 MOACRIVE Inhibition DME1422 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1422 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03574 XEO_CLAS Peptide DME1422 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 500 microM) DME1422 XEOTICID XEO03574 GENEFORM Protein DME1422 XEOTICID XEO03574 MOACRIVE Inhibition DME1422 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1422 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03575 XEO_CLAS Peptide DME1422 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 18 microM) DME1422 XEOTICID XEO03575 GENEFORM Protein DME1422 XEOTICID XEO03575 MOACRIVE Inhibition DME1422 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1422 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03576 XEO_CLAS Peptide DME1422 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 750 microM) DME1422 XEOTICID XEO03576 GENEFORM Protein DME1422 XEOTICID XEO03576 MOACRIVE Inhibition DME1422 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1422 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03578 XEO_CLAS Peptide DME1422 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1422 XEOTICID XEO03578 GENEFORM Protein DME1422 XEOTICID XEO03578 MOACRIVE Inhibition DME1422 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1422 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03579 XEO_CLAS Peptide DME1422 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03579 GENEFORM Protein DME1422 XEOTICID XEO03579 MOACRIVE Inhibition DME1422 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1422 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03580 XEO_CLAS Peptide DME1422 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03580 GENEFORM Protein DME1422 XEOTICID XEO03580 MOACRIVE Inhibition DME1422 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1422 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03585 XEO_CLAS Peptide DME1422 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 125 ug/ml) DME1422 XEOTICID XEO03585 GENEFORM Protein DME1422 XEOTICID XEO03585 MOACRIVE Inhibition DME1422 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1422 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03588 XEO_CLAS Peptide DME1422 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 62 ug/ml) DME1422 XEOTICID XEO03588 GENEFORM Protein DME1422 XEOTICID XEO03588 MOACRIVE Inhibition DME1422 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1422 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03589 XEO_CLAS Peptide DME1422 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03589 GENEFORM Protein DME1422 XEOTICID XEO03589 MOACRIVE Inhibition DME1422 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1422 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03590 XEO_CLAS Peptide DME1422 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03590 GENEFORM Protein DME1422 XEOTICID XEO03590 MOACRIVE Inhibition DME1422 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1422 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03591 XEO_CLAS Peptide DME1422 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 37.5 ug/ml) DME1422 XEOTICID XEO03591 GENEFORM Protein DME1422 XEOTICID XEO03591 MOACRIVE Inhibition DME1422 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1422 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03593 XEO_CLAS Peptide DME1422 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 9.4 ug/ml) DME1422 XEOTICID XEO03593 GENEFORM Protein DME1422 XEOTICID XEO03593 MOACRIVE Inhibition DME1422 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1422 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03594 XEO_CLAS Peptide DME1422 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 ug/ml) DME1422 XEOTICID XEO03594 GENEFORM Protein DME1422 XEOTICID XEO03594 MOACRIVE Inhibition DME1422 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1422 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03595 XEO_CLAS Peptide DME1422 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03595 GENEFORM Protein DME1422 XEOTICID XEO03595 MOACRIVE Inhibition DME1422 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1422 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03596 XEO_CLAS Peptide DME1422 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03596 GENEFORM Protein DME1422 XEOTICID XEO03596 MOACRIVE Inhibition DME1422 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1422 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03598 XEO_CLAS Peptide DME1422 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03598 GENEFORM Protein DME1422 XEOTICID XEO03598 MOACRIVE Inhibition DME1422 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1422 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03599 XEO_CLAS Peptide DME1422 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03599 GENEFORM Protein DME1422 XEOTICID XEO03599 MOACRIVE Inhibition DME1422 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1422 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03600 XEO_CLAS Peptide DME1422 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03600 GENEFORM Protein DME1422 XEOTICID XEO03600 MOACRIVE Inhibition DME1422 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1422 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03606 XEO_CLAS Peptide DME1422 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03606 GENEFORM Protein DME1422 XEOTICID XEO03606 MOACRIVE Inhibition DME1422 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1422 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03607 XEO_CLAS Peptide DME1422 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03607 GENEFORM Protein DME1422 XEOTICID XEO03607 MOACRIVE Inhibition DME1422 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1422 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03609 XEO_CLAS Peptide DME1422 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03609 GENEFORM Protein DME1422 XEOTICID XEO03609 MOACRIVE Inhibition DME1422 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1422 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03615 XEO_CLAS Peptide DME1422 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1422 XEOTICID XEO03615 GENEFORM Protein DME1422 XEOTICID XEO03615 MOACRIVE Inhibition DME1422 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1422 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03616 XEO_CLAS Peptide DME1422 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 32 microM) DME1422 XEOTICID XEO03616 GENEFORM Protein DME1422 XEOTICID XEO03616 MOACRIVE Inhibition DME1422 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1422 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03617 XEO_CLAS Peptide DME1422 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40 microM) DME1422 XEOTICID XEO03617 GENEFORM Protein DME1422 XEOTICID XEO03617 MOACRIVE Inhibition DME1422 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1422 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03618 XEO_CLAS Peptide DME1422 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5-1 microM) DME1422 XEOTICID XEO03618 GENEFORM Protein DME1422 XEOTICID XEO03618 MOACRIVE Inhibition DME1422 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1422 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03622 XEO_CLAS Peptide DME1422 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20-40 microM) DME1422 XEOTICID XEO03622 GENEFORM Protein DME1422 XEOTICID XEO03622 MOACRIVE Inhibition DME1422 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1422 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03627 XEO_CLAS Peptide DME1422 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.4-0.8 microM) DME1422 XEOTICID XEO03627 GENEFORM Protein DME1422 XEOTICID XEO03627 MOACRIVE Inhibition DME1422 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1422 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03630 XEO_CLAS Peptide DME1422 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03630 GENEFORM Protein DME1422 XEOTICID XEO03630 MOACRIVE Inhibition DME1422 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1422 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03631 XEO_CLAS Peptide DME1422 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03631 GENEFORM Protein DME1422 XEOTICID XEO03631 MOACRIVE Inhibition DME1422 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1422 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03632 XEO_CLAS Peptide DME1422 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03632 GENEFORM Protein DME1422 XEOTICID XEO03632 MOACRIVE Inhibition DME1422 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1422 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03633 XEO_CLAS Peptide DME1422 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03633 GENEFORM Protein DME1422 XEOTICID XEO03633 MOACRIVE Inhibition DME1422 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1422 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03634 XEO_CLAS Peptide DME1422 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03634 GENEFORM Protein DME1422 XEOTICID XEO03634 MOACRIVE Inhibition DME1422 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1422 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03635 XEO_CLAS Peptide DME1422 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03635 GENEFORM Protein DME1422 XEOTICID XEO03635 MOACRIVE Inhibition DME1422 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1422 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03636 XEO_CLAS Peptide DME1422 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03636 GENEFORM Protein DME1422 XEOTICID XEO03636 MOACRIVE Inhibition DME1422 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1422 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03637 XEO_CLAS Peptide DME1422 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03637 GENEFORM Protein DME1422 XEOTICID XEO03637 MOACRIVE Inhibition DME1422 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1422 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03638 XEO_CLAS Peptide DME1422 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03638 GENEFORM Protein DME1422 XEOTICID XEO03638 MOACRIVE Inhibition DME1422 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1422 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03639 XEO_CLAS Peptide DME1422 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03639 GENEFORM Protein DME1422 XEOTICID XEO03639 MOACRIVE Inhibition DME1422 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1422 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03640 XEO_CLAS Peptide DME1422 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03640 GENEFORM Protein DME1422 XEOTICID XEO03640 MOACRIVE Inhibition DME1422 XEOTICID XEO03644 XEO_NAME Indole DME1422 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1422 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1422 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03644 GENEFORM Protein DME1422 XEOTICID XEO03644 MOACRIVE Inhibition DME1422 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1422 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03650 XEO_CLAS Peptide DME1422 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03650 GENEFORM Protein DME1422 XEOTICID XEO03650 MOACRIVE Inhibition DME1422 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1422 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO03655 XEO_CLAS Natural Product DME1422 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03655 GENEFORM Protein DME1422 XEOTICID XEO03655 MOACRIVE Inhibition DME1422 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1422 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03666 XEO_CLAS Peptide DME1422 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 ug/ml) DME1422 XEOTICID XEO03666 GENEFORM Protein DME1422 XEOTICID XEO03666 MOACRIVE Inhibition DME1422 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1422 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03667 XEO_CLAS Peptide DME1422 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 ug/ml) DME1422 XEOTICID XEO03667 GENEFORM Protein DME1422 XEOTICID XEO03667 MOACRIVE Inhibition DME1422 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1422 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03668 XEO_CLAS Peptide DME1422 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 microM) DME1422 XEOTICID XEO03668 GENEFORM Protein DME1422 XEOTICID XEO03668 MOACRIVE Inhibition DME1422 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1422 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03669 XEO_CLAS Peptide DME1422 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO03669 GENEFORM Protein DME1422 XEOTICID XEO03669 MOACRIVE Inhibition DME1422 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1422 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03670 XEO_CLAS Peptide DME1422 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 microM) DME1422 XEOTICID XEO03670 GENEFORM Protein DME1422 XEOTICID XEO03670 MOACRIVE Inhibition DME1422 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1422 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03672 XEO_CLAS Peptide DME1422 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.5 ug/ml) DME1422 XEOTICID XEO03672 GENEFORM Protein DME1422 XEOTICID XEO03672 MOACRIVE Inhibition DME1422 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1422 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03673 XEO_CLAS Peptide DME1422 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 ug/ml) DME1422 XEOTICID XEO03673 GENEFORM Protein DME1422 XEOTICID XEO03673 MOACRIVE Inhibition DME1422 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1422 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03674 XEO_CLAS Peptide DME1422 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 ug/ml) DME1422 XEOTICID XEO03674 GENEFORM Protein DME1422 XEOTICID XEO03674 MOACRIVE Inhibition DME1422 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1422 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03675 XEO_CLAS Peptide DME1422 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO03675 GENEFORM Protein DME1422 XEOTICID XEO03675 MOACRIVE Inhibition DME1422 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1422 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03678 XEO_CLAS Peptide DME1422 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 ug/ml) DME1422 XEOTICID XEO03678 GENEFORM Protein DME1422 XEOTICID XEO03678 MOACRIVE Inhibition DME1422 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1422 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03679 XEO_CLAS Peptide DME1422 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 ug/ml) DME1422 XEOTICID XEO03679 GENEFORM Protein DME1422 XEOTICID XEO03679 MOACRIVE Inhibition DME1422 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1422 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03681 XEO_CLAS Peptide DME1422 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.3-0.6 microM) DME1422 XEOTICID XEO03681 GENEFORM Protein DME1422 XEOTICID XEO03681 MOACRIVE Inhibition DME1422 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1422 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03684 XEO_CLAS Peptide DME1422 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 ug/ml) DME1422 XEOTICID XEO03684 GENEFORM Protein DME1422 XEOTICID XEO03684 MOACRIVE Inhibition DME1422 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1422 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03694 XEO_CLAS Peptide DME1422 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03694 GENEFORM Protein DME1422 XEOTICID XEO03694 MOACRIVE Inhibition DME1422 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1422 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03697 XEO_CLAS Peptide DME1422 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25 microM) DME1422 XEOTICID XEO03697 GENEFORM Protein DME1422 XEOTICID XEO03697 MOACRIVE Inhibition DME1422 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1422 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03698 XEO_CLAS Peptide DME1422 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03698 GENEFORM Protein DME1422 XEOTICID XEO03698 MOACRIVE Inhibition DME1422 XEOTICID XEO03703 XEO_NAME Kasstasin DME1422 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03703 XEO_CLAS Peptide DME1422 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 110 microM) DME1422 XEOTICID XEO03703 GENEFORM Protein DME1422 XEOTICID XEO03703 MOACRIVE Inhibition DME1422 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1422 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03706 XEO_CLAS Peptide DME1422 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03706 GENEFORM Protein DME1422 XEOTICID XEO03706 MOACRIVE Inhibition DME1422 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1422 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03707 XEO_CLAS Peptide DME1422 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03707 GENEFORM Protein DME1422 XEOTICID XEO03707 MOACRIVE Inhibition DME1422 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1422 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03709 XEO_CLAS Peptide DME1422 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 ug/ml) DME1422 XEOTICID XEO03709 GENEFORM Protein DME1422 XEOTICID XEO03709 MOACRIVE Inhibition DME1422 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1422 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03712 XEO_CLAS Peptide DME1422 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03712 GENEFORM Protein DME1422 XEOTICID XEO03712 MOACRIVE Inhibition DME1422 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1422 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03713 XEO_CLAS Peptide DME1422 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 64 microM) DME1422 XEOTICID XEO03713 GENEFORM Protein DME1422 XEOTICID XEO03713 MOACRIVE Inhibition DME1422 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1422 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03714 XEO_CLAS Peptide DME1422 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03714 GENEFORM Protein DME1422 XEOTICID XEO03714 MOACRIVE Inhibition DME1422 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1422 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03715 XEO_CLAS Peptide DME1422 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 microM) DME1422 XEOTICID XEO03715 GENEFORM Protein DME1422 XEOTICID XEO03715 MOACRIVE Inhibition DME1422 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1422 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03719 XEO_CLAS Peptide DME1422 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 microM) DME1422 XEOTICID XEO03719 GENEFORM Protein DME1422 XEOTICID XEO03719 MOACRIVE Inhibition DME1422 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1422 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03720 XEO_CLAS Peptide DME1422 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 microM) DME1422 XEOTICID XEO03720 GENEFORM Protein DME1422 XEOTICID XEO03720 MOACRIVE Inhibition DME1422 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1422 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03723 XEO_CLAS Peptide DME1422 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 62.36 microM) DME1422 XEOTICID XEO03723 GENEFORM Protein DME1422 XEOTICID XEO03723 MOACRIVE Inhibition DME1422 XEOTICID XEO03724 XEO_NAME L10 peptide DME1422 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03724 XEO_CLAS Peptide DME1422 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.8 microM) DME1422 XEOTICID XEO03724 GENEFORM Protein DME1422 XEOTICID XEO03724 MOACRIVE Inhibition DME1422 XEOTICID XEO03726 XEO_NAME L2 peptide DME1422 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03726 XEO_CLAS Peptide DME1422 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 129.66 microM) DME1422 XEOTICID XEO03726 GENEFORM Protein DME1422 XEOTICID XEO03726 MOACRIVE Inhibition DME1422 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1422 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03727 XEO_CLAS Peptide DME1422 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 80 ug/ml) DME1422 XEOTICID XEO03727 GENEFORM Protein DME1422 XEOTICID XEO03727 MOACRIVE Inhibition DME1422 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1422 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03728 XEO_CLAS Peptide DME1422 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40 ug/ml) DME1422 XEOTICID XEO03728 GENEFORM Protein DME1422 XEOTICID XEO03728 MOACRIVE Inhibition DME1422 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1422 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03729 XEO_CLAS Peptide DME1422 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 80 ug/ml) DME1422 XEOTICID XEO03729 GENEFORM Protein DME1422 XEOTICID XEO03729 MOACRIVE Inhibition DME1422 XEOTICID XEO03730 XEO_NAME L3 peptide DME1422 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03730 XEO_CLAS Peptide DME1422 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64.11 microM) DME1422 XEOTICID XEO03730 GENEFORM Protein DME1422 XEOTICID XEO03730 MOACRIVE Inhibition DME1422 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1422 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03731 XEO_CLAS Peptide DME1422 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40 ug/ml) DME1422 XEOTICID XEO03731 GENEFORM Protein DME1422 XEOTICID XEO03731 MOACRIVE Inhibition DME1422 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1422 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03733 XEO_CLAS Peptide DME1422 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40 ug/ml) DME1422 XEOTICID XEO03733 GENEFORM Protein DME1422 XEOTICID XEO03733 MOACRIVE Inhibition DME1422 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1422 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03734 XEO_CLAS Peptide DME1422 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO03734 GENEFORM Protein DME1422 XEOTICID XEO03734 MOACRIVE Inhibition DME1422 XEOTICID XEO03735 XEO_NAME L4 peptide DME1422 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03735 XEO_CLAS Peptide DME1422 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 31.61 microM) DME1422 XEOTICID XEO03735 GENEFORM Protein DME1422 XEOTICID XEO03735 MOACRIVE Inhibition DME1422 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1422 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03738 XEO_CLAS Peptide DME1422 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 ug/ml) DME1422 XEOTICID XEO03738 GENEFORM Protein DME1422 XEOTICID XEO03738 MOACRIVE Inhibition DME1422 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1422 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03741 XEO_CLAS Peptide DME1422 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40 ug/ml) DME1422 XEOTICID XEO03741 GENEFORM Protein DME1422 XEOTICID XEO03741 MOACRIVE Inhibition DME1422 XEOTICID XEO03742 XEO_NAME L5 peptide DME1422 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03742 XEO_CLAS Peptide DME1422 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 7.79 microM) DME1422 XEOTICID XEO03742 GENEFORM Protein DME1422 XEOTICID XEO03742 MOACRIVE Inhibition DME1422 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1422 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03743 XEO_CLAS Peptide DME1422 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 ug/ml) DME1422 XEOTICID XEO03743 GENEFORM Protein DME1422 XEOTICID XEO03743 MOACRIVE Inhibition DME1422 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1422 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03744 XEO_CLAS Peptide DME1422 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 ug/ml) DME1422 XEOTICID XEO03744 GENEFORM Protein DME1422 XEOTICID XEO03744 MOACRIVE Inhibition DME1422 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1422 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03745 XEO_CLAS Peptide DME1422 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 ug/ml) DME1422 XEOTICID XEO03745 GENEFORM Protein DME1422 XEOTICID XEO03745 MOACRIVE Inhibition DME1422 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1422 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03746 XEO_CLAS Peptide DME1422 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO03746 GENEFORM Protein DME1422 XEOTICID XEO03746 MOACRIVE Inhibition DME1422 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1422 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03747 XEO_CLAS Peptide DME1422 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO03747 GENEFORM Protein DME1422 XEOTICID XEO03747 MOACRIVE Inhibition DME1422 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1422 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03748 XEO_CLAS Peptide DME1422 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO03748 GENEFORM Protein DME1422 XEOTICID XEO03748 MOACRIVE Inhibition DME1422 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1422 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03749 XEO_CLAS Peptide DME1422 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO03749 GENEFORM Protein DME1422 XEOTICID XEO03749 MOACRIVE Inhibition DME1422 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1422 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03750 XEO_CLAS Peptide DME1422 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO03750 GENEFORM Protein DME1422 XEOTICID XEO03750 MOACRIVE Inhibition DME1422 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1422 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03751 XEO_CLAS Peptide DME1422 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO03751 GENEFORM Protein DME1422 XEOTICID XEO03751 MOACRIVE Inhibition DME1422 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1422 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03752 XEO_CLAS Peptide DME1422 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO03752 GENEFORM Protein DME1422 XEOTICID XEO03752 MOACRIVE Inhibition DME1422 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1422 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03753 XEO_CLAS Peptide DME1422 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 ug/ml) DME1422 XEOTICID XEO03753 GENEFORM Protein DME1422 XEOTICID XEO03753 MOACRIVE Inhibition DME1422 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1422 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03754 XEO_CLAS Peptide DME1422 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO03754 GENEFORM Protein DME1422 XEOTICID XEO03754 MOACRIVE Inhibition DME1422 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1422 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03755 XEO_CLAS Peptide DME1422 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO03755 GENEFORM Protein DME1422 XEOTICID XEO03755 MOACRIVE Inhibition DME1422 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1422 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03756 XEO_CLAS Peptide DME1422 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO03756 GENEFORM Protein DME1422 XEOTICID XEO03756 MOACRIVE Inhibition DME1422 XEOTICID XEO03757 XEO_NAME L6 peptide DME1422 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03757 XEO_CLAS Peptide DME1422 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15.17 microM) DME1422 XEOTICID XEO03757 GENEFORM Protein DME1422 XEOTICID XEO03757 MOACRIVE Inhibition DME1422 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1422 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03758 XEO_CLAS Peptide DME1422 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 80 ug/ml) DME1422 XEOTICID XEO03758 GENEFORM Protein DME1422 XEOTICID XEO03758 MOACRIVE Inhibition DME1422 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1422 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03759 XEO_CLAS Peptide DME1422 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.3 ug/ml) DME1422 XEOTICID XEO03759 GENEFORM Protein DME1422 XEOTICID XEO03759 MOACRIVE Inhibition DME1422 XEOTICID XEO03760 XEO_NAME L7 peptide DME1422 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03760 XEO_CLAS Peptide DME1422 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16.02 microM) DME1422 XEOTICID XEO03760 GENEFORM Protein DME1422 XEOTICID XEO03760 MOACRIVE Inhibition DME1422 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1422 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03761 XEO_CLAS Peptide DME1422 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 ug/ml) DME1422 XEOTICID XEO03761 GENEFORM Protein DME1422 XEOTICID XEO03761 MOACRIVE Inhibition DME1422 XEOTICID XEO03763 XEO_NAME L8 peptide DME1422 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03763 XEO_CLAS Peptide DME1422 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.71 microM) DME1422 XEOTICID XEO03763 GENEFORM Protein DME1422 XEOTICID XEO03763 MOACRIVE Inhibition DME1422 XEOTICID XEO03765 XEO_NAME L9 peptide DME1422 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03765 XEO_CLAS Peptide DME1422 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.78 microM) DME1422 XEOTICID XEO03765 GENEFORM Protein DME1422 XEOTICID XEO03765 MOACRIVE Inhibition DME1422 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1422 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03775 XEO_CLAS Peptide DME1422 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 17.3 microM) DME1422 XEOTICID XEO03775 GENEFORM Protein DME1422 XEOTICID XEO03775 MOACRIVE Inhibition DME1422 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1422 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03776 XEO_CLAS Peptide DME1422 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03776 GENEFORM Protein DME1422 XEOTICID XEO03776 MOACRIVE Inhibition DME1422 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1422 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03781 XEO_CLAS Peptide DME1422 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.47 microM) DME1422 XEOTICID XEO03781 GENEFORM Protein DME1422 XEOTICID XEO03781 MOACRIVE Inhibition DME1422 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1422 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03782 XEO_CLAS Peptide DME1422 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.47 microM) DME1422 XEOTICID XEO03782 GENEFORM Protein DME1422 XEOTICID XEO03782 MOACRIVE Inhibition DME1422 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1422 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03783 XEO_CLAS Peptide DME1422 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.68 microM) DME1422 XEOTICID XEO03783 GENEFORM Protein DME1422 XEOTICID XEO03783 MOACRIVE Inhibition DME1422 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1422 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03784 XEO_CLAS Peptide DME1422 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.45 microM) DME1422 XEOTICID XEO03784 GENEFORM Protein DME1422 XEOTICID XEO03784 MOACRIVE Inhibition DME1422 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1422 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03785 XEO_CLAS Peptide DME1422 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.73 microM) DME1422 XEOTICID XEO03785 GENEFORM Protein DME1422 XEOTICID XEO03785 MOACRIVE Inhibition DME1422 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1422 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03786 XEO_CLAS Peptide DME1422 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.45 microM) DME1422 XEOTICID XEO03786 GENEFORM Protein DME1422 XEOTICID XEO03786 MOACRIVE Inhibition DME1422 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1422 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03787 XEO_CLAS Peptide DME1422 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.38 microM) DME1422 XEOTICID XEO03787 GENEFORM Protein DME1422 XEOTICID XEO03787 MOACRIVE Inhibition DME1422 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1422 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03788 XEO_CLAS Peptide DME1422 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.46 microM) DME1422 XEOTICID XEO03788 GENEFORM Protein DME1422 XEOTICID XEO03788 MOACRIVE Inhibition DME1422 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1422 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03789 XEO_CLAS Peptide DME1422 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 13.05 microM) DME1422 XEOTICID XEO03789 GENEFORM Protein DME1422 XEOTICID XEO03789 MOACRIVE Inhibition DME1422 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1422 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03790 XEO_CLAS Peptide DME1422 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.82 microM) DME1422 XEOTICID XEO03790 GENEFORM Protein DME1422 XEOTICID XEO03790 MOACRIVE Inhibition DME1422 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1422 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03791 XEO_CLAS Peptide DME1422 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.80 microM) DME1422 XEOTICID XEO03791 GENEFORM Protein DME1422 XEOTICID XEO03791 MOACRIVE Inhibition DME1422 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1422 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03792 XEO_CLAS Peptide DME1422 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.26 microM) DME1422 XEOTICID XEO03792 GENEFORM Protein DME1422 XEOTICID XEO03792 MOACRIVE Inhibition DME1422 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1422 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03793 XEO_CLAS Peptide DME1422 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 microM) DME1422 XEOTICID XEO03793 GENEFORM Protein DME1422 XEOTICID XEO03793 MOACRIVE Inhibition DME1422 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1422 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03797 XEO_CLAS Peptide DME1422 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.4 microM) DME1422 XEOTICID XEO03797 GENEFORM Protein DME1422 XEOTICID XEO03797 MOACRIVE Inhibition DME1422 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1422 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03798 XEO_CLAS Peptide DME1422 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03798 GENEFORM Protein DME1422 XEOTICID XEO03798 MOACRIVE Inhibition DME1422 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1422 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03799 XEO_CLAS Peptide DME1422 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03799 GENEFORM Protein DME1422 XEOTICID XEO03799 MOACRIVE Inhibition DME1422 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1422 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03810 XEO_CLAS Peptide DME1422 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03810 GENEFORM Protein DME1422 XEOTICID XEO03810 MOACRIVE Inhibition DME1422 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1422 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03846 XEO_CLAS Peptide DME1422 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03846 GENEFORM Protein DME1422 XEOTICID XEO03846 MOACRIVE Inhibition DME1422 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1422 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03847 XEO_CLAS Peptide DME1422 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03847 GENEFORM Protein DME1422 XEOTICID XEO03847 MOACRIVE Inhibition DME1422 XEOTICID XEO03850 XEO_NAME Lemon DME1422 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1422 XEOTICID XEO03850 XEO_CLAS Food Additive DME1422 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03850 GENEFORM Protein DME1422 XEOTICID XEO03850 MOACRIVE Inhibition DME1422 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1422 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03853 XEO_CLAS Peptide DME1422 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO03853 GENEFORM Protein DME1422 XEOTICID XEO03853 MOACRIVE Inhibition DME1422 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1422 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03857 XEO_CLAS Peptide DME1422 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 38.49 microM) DME1422 XEOTICID XEO03857 GENEFORM Protein DME1422 XEOTICID XEO03857 MOACRIVE Inhibition DME1422 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1422 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03860 XEO_CLAS Peptide DME1422 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 24 microM) DME1422 XEOTICID XEO03860 GENEFORM Protein DME1422 XEOTICID XEO03860 MOACRIVE Inhibition DME1422 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1422 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03861 XEO_CLAS Peptide DME1422 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 35 microM) DME1422 XEOTICID XEO03861 GENEFORM Protein DME1422 XEOTICID XEO03861 MOACRIVE Inhibition DME1422 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1422 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03862 XEO_CLAS Peptide DME1422 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 70 microM) DME1422 XEOTICID XEO03862 GENEFORM Protein DME1422 XEOTICID XEO03862 MOACRIVE Inhibition DME1422 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1422 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03863 XEO_CLAS Peptide DME1422 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 35 microM) DME1422 XEOTICID XEO03863 GENEFORM Protein DME1422 XEOTICID XEO03863 MOACRIVE Inhibition DME1422 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1422 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03864 XEO_CLAS Peptide DME1422 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO03864 GENEFORM Protein DME1422 XEOTICID XEO03864 MOACRIVE Inhibition DME1422 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1422 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03865 XEO_CLAS Peptide DME1422 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO03865 GENEFORM Protein DME1422 XEOTICID XEO03865 MOACRIVE Inhibition DME1422 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1422 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03866 XEO_CLAS Peptide DME1422 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 microM) DME1422 XEOTICID XEO03866 GENEFORM Protein DME1422 XEOTICID XEO03866 MOACRIVE Inhibition DME1422 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1422 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03867 XEO_CLAS Peptide DME1422 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40 microM) DME1422 XEOTICID XEO03867 GENEFORM Protein DME1422 XEOTICID XEO03867 MOACRIVE Inhibition DME1422 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1422 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03868 XEO_CLAS Peptide DME1422 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 51 microM) DME1422 XEOTICID XEO03868 GENEFORM Protein DME1422 XEOTICID XEO03868 MOACRIVE Inhibition DME1422 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1422 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03869 XEO_CLAS Peptide DME1422 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 35 microM) DME1422 XEOTICID XEO03869 GENEFORM Protein DME1422 XEOTICID XEO03869 MOACRIVE Inhibition DME1422 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1422 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03870 XEO_CLAS Peptide DME1422 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 61 microM) DME1422 XEOTICID XEO03870 GENEFORM Protein DME1422 XEOTICID XEO03870 MOACRIVE Inhibition DME1422 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1422 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03871 XEO_CLAS Peptide DME1422 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 microM) DME1422 XEOTICID XEO03871 GENEFORM Protein DME1422 XEOTICID XEO03871 MOACRIVE Inhibition DME1422 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1422 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03872 XEO_CLAS Peptide DME1422 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 28 microM) DME1422 XEOTICID XEO03872 GENEFORM Protein DME1422 XEOTICID XEO03872 MOACRIVE Inhibition DME1422 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1422 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03873 XEO_CLAS Peptide DME1422 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 22.5 microM) DME1422 XEOTICID XEO03873 GENEFORM Protein DME1422 XEOTICID XEO03873 MOACRIVE Inhibition DME1422 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1422 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03874 XEO_CLAS Peptide DME1422 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 11.25 microM) DME1422 XEOTICID XEO03874 GENEFORM Protein DME1422 XEOTICID XEO03874 MOACRIVE Inhibition DME1422 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1422 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03875 XEO_CLAS Peptide DME1422 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 microM) DME1422 XEOTICID XEO03875 GENEFORM Protein DME1422 XEOTICID XEO03875 MOACRIVE Inhibition DME1422 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1422 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03876 XEO_CLAS Peptide DME1422 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.75 microM) DME1422 XEOTICID XEO03876 GENEFORM Protein DME1422 XEOTICID XEO03876 MOACRIVE Inhibition DME1422 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1422 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03877 XEO_CLAS Peptide DME1422 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 microM) DME1422 XEOTICID XEO03877 GENEFORM Protein DME1422 XEOTICID XEO03877 MOACRIVE Inhibition DME1422 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1422 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03878 XEO_CLAS Peptide DME1422 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 microM) DME1422 XEOTICID XEO03878 GENEFORM Protein DME1422 XEOTICID XEO03878 MOACRIVE Inhibition DME1422 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1422 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03879 XEO_CLAS Peptide DME1422 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 252 microM) DME1422 XEOTICID XEO03879 GENEFORM Protein DME1422 XEOTICID XEO03879 MOACRIVE Inhibition DME1422 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1422 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03880 XEO_CLAS Peptide DME1422 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 174 microM) DME1422 XEOTICID XEO03880 GENEFORM Protein DME1422 XEOTICID XEO03880 MOACRIVE Inhibition DME1422 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1422 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03883 XEO_CLAS Peptide DME1422 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 74 microM) DME1422 XEOTICID XEO03883 GENEFORM Protein DME1422 XEOTICID XEO03883 MOACRIVE Inhibition DME1422 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1422 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03884 XEO_CLAS Peptide DME1422 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 31 microM) DME1422 XEOTICID XEO03884 GENEFORM Protein DME1422 XEOTICID XEO03884 MOACRIVE Inhibition DME1422 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1422 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03885 XEO_CLAS Peptide DME1422 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO03885 GENEFORM Protein DME1422 XEOTICID XEO03885 MOACRIVE Inhibition DME1422 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1422 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03886 XEO_CLAS Peptide DME1422 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 391 microM) DME1422 XEOTICID XEO03886 GENEFORM Protein DME1422 XEOTICID XEO03886 MOACRIVE Inhibition DME1422 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1422 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03887 XEO_CLAS Peptide DME1422 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 151 microM) DME1422 XEOTICID XEO03887 GENEFORM Protein DME1422 XEOTICID XEO03887 MOACRIVE Inhibition DME1422 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1422 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03888 XEO_CLAS Peptide DME1422 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 134 microM) DME1422 XEOTICID XEO03888 GENEFORM Protein DME1422 XEOTICID XEO03888 MOACRIVE Inhibition DME1422 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1422 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03889 XEO_CLAS Peptide DME1422 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 88 microM) DME1422 XEOTICID XEO03889 GENEFORM Protein DME1422 XEOTICID XEO03889 MOACRIVE Inhibition DME1422 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1422 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03890 XEO_CLAS Peptide DME1422 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 31 microM) DME1422 XEOTICID XEO03890 GENEFORM Protein DME1422 XEOTICID XEO03890 MOACRIVE Inhibition DME1422 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1422 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03891 XEO_CLAS Peptide DME1422 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 microM) DME1422 XEOTICID XEO03891 GENEFORM Protein DME1422 XEOTICID XEO03891 MOACRIVE Inhibition DME1422 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1422 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03892 XEO_CLAS Peptide DME1422 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 37 microM) DME1422 XEOTICID XEO03892 GENEFORM Protein DME1422 XEOTICID XEO03892 MOACRIVE Inhibition DME1422 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1422 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03893 XEO_CLAS Peptide DME1422 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 19 microM) DME1422 XEOTICID XEO03893 GENEFORM Protein DME1422 XEOTICID XEO03893 MOACRIVE Inhibition DME1422 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1422 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03894 XEO_CLAS Peptide DME1422 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO03894 GENEFORM Protein DME1422 XEOTICID XEO03894 MOACRIVE Inhibition DME1422 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1422 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03895 XEO_CLAS Peptide DME1422 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO03895 GENEFORM Protein DME1422 XEOTICID XEO03895 MOACRIVE Inhibition DME1422 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1422 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03896 XEO_CLAS Peptide DME1422 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 microM) DME1422 XEOTICID XEO03896 GENEFORM Protein DME1422 XEOTICID XEO03896 MOACRIVE Inhibition DME1422 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1422 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03897 XEO_CLAS Peptide DME1422 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 63 microM) DME1422 XEOTICID XEO03897 GENEFORM Protein DME1422 XEOTICID XEO03897 MOACRIVE Inhibition DME1422 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1422 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03898 XEO_CLAS Peptide DME1422 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 219 microM) DME1422 XEOTICID XEO03898 GENEFORM Protein DME1422 XEOTICID XEO03898 MOACRIVE Inhibition DME1422 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1422 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03901 XEO_CLAS Peptide DME1422 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 35 microM) DME1422 XEOTICID XEO03901 GENEFORM Protein DME1422 XEOTICID XEO03901 MOACRIVE Inhibition DME1422 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1422 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03902 XEO_CLAS Peptide DME1422 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 70 microM) DME1422 XEOTICID XEO03902 GENEFORM Protein DME1422 XEOTICID XEO03902 MOACRIVE Inhibition DME1422 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1422 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03904 XEO_CLAS Peptide DME1422 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO03904 GENEFORM Protein DME1422 XEOTICID XEO03904 MOACRIVE Inhibition DME1422 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1422 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03905 XEO_CLAS Peptide DME1422 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO03905 GENEFORM Protein DME1422 XEOTICID XEO03905 MOACRIVE Inhibition DME1422 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1422 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03908 XEO_CLAS Peptide DME1422 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03908 GENEFORM Protein DME1422 XEOTICID XEO03908 MOACRIVE Inhibition DME1422 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1422 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03915 XEO_CLAS Peptide DME1422 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03915 GENEFORM Protein DME1422 XEOTICID XEO03915 MOACRIVE Inhibition DME1422 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1422 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03916 XEO_CLAS Peptide DME1422 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.8 ug/ml) DME1422 XEOTICID XEO03916 GENEFORM Protein DME1422 XEOTICID XEO03916 MOACRIVE Inhibition DME1422 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1422 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03917 XEO_CLAS Peptide DME1422 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 13.1 ug/ml) DME1422 XEOTICID XEO03917 GENEFORM Protein DME1422 XEOTICID XEO03917 MOACRIVE Inhibition DME1422 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1422 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03918 XEO_CLAS Peptide DME1422 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.5 ug/ml) DME1422 XEOTICID XEO03918 GENEFORM Protein DME1422 XEOTICID XEO03918 MOACRIVE Inhibition DME1422 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1422 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03919 XEO_CLAS Peptide DME1422 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 80 ug/ml) DME1422 XEOTICID XEO03919 GENEFORM Protein DME1422 XEOTICID XEO03919 MOACRIVE Inhibition DME1422 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1422 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03922 XEO_CLAS Peptide DME1422 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 9 microM) DME1422 XEOTICID XEO03922 GENEFORM Protein DME1422 XEOTICID XEO03922 MOACRIVE Inhibition DME1422 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1422 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03923 XEO_CLAS Peptide DME1422 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 80 microM) DME1422 XEOTICID XEO03923 GENEFORM Protein DME1422 XEOTICID XEO03923 MOACRIVE Inhibition DME1422 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1422 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03924 XEO_CLAS Peptide DME1422 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO03924 GENEFORM Protein DME1422 XEOTICID XEO03924 MOACRIVE Inhibition DME1422 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1422 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03927 XEO_CLAS Peptide DME1422 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 80 microM) DME1422 XEOTICID XEO03927 GENEFORM Protein DME1422 XEOTICID XEO03927 MOACRIVE Inhibition DME1422 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1422 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03928 XEO_CLAS Peptide DME1422 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 microM) DME1422 XEOTICID XEO03928 GENEFORM Protein DME1422 XEOTICID XEO03928 MOACRIVE Inhibition DME1422 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1422 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03929 XEO_CLAS Peptide DME1422 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 microM) DME1422 XEOTICID XEO03929 GENEFORM Protein DME1422 XEOTICID XEO03929 MOACRIVE Inhibition DME1422 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1422 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03930 XEO_CLAS Peptide DME1422 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 microM) DME1422 XEOTICID XEO03930 GENEFORM Protein DME1422 XEOTICID XEO03930 MOACRIVE Inhibition DME1422 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1422 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03931 XEO_CLAS Peptide DME1422 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 microM) DME1422 XEOTICID XEO03931 GENEFORM Protein DME1422 XEOTICID XEO03931 MOACRIVE Inhibition DME1422 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1422 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03933 XEO_CLAS Peptide DME1422 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.5 microM) DME1422 XEOTICID XEO03933 GENEFORM Protein DME1422 XEOTICID XEO03933 MOACRIVE Inhibition DME1422 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1422 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03934 XEO_CLAS Peptide DME1422 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.7 microM) DME1422 XEOTICID XEO03934 GENEFORM Protein DME1422 XEOTICID XEO03934 MOACRIVE Inhibition DME1422 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1422 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03935 XEO_CLAS Peptide DME1422 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.7 microM) DME1422 XEOTICID XEO03935 GENEFORM Protein DME1422 XEOTICID XEO03935 MOACRIVE Inhibition DME1422 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1422 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03936 XEO_CLAS Peptide DME1422 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.0 microM) DME1422 XEOTICID XEO03936 GENEFORM Protein DME1422 XEOTICID XEO03936 MOACRIVE Inhibition DME1422 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1422 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03937 XEO_CLAS Peptide DME1422 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.1 microM) DME1422 XEOTICID XEO03937 GENEFORM Protein DME1422 XEOTICID XEO03937 MOACRIVE Inhibition DME1422 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1422 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03938 XEO_CLAS Peptide DME1422 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.7 microM) DME1422 XEOTICID XEO03938 GENEFORM Protein DME1422 XEOTICID XEO03938 MOACRIVE Inhibition DME1422 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1422 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03939 XEO_CLAS Peptide DME1422 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.7 microM) DME1422 XEOTICID XEO03939 GENEFORM Protein DME1422 XEOTICID XEO03939 MOACRIVE Inhibition DME1422 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1422 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03940 XEO_CLAS Peptide DME1422 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.5 microM) DME1422 XEOTICID XEO03940 GENEFORM Protein DME1422 XEOTICID XEO03940 MOACRIVE Inhibition DME1422 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1422 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03941 XEO_CLAS Peptide DME1422 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.4 microM) DME1422 XEOTICID XEO03941 GENEFORM Protein DME1422 XEOTICID XEO03941 MOACRIVE Inhibition DME1422 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1422 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03943 XEO_CLAS Peptide DME1422 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.4 microM) DME1422 XEOTICID XEO03943 GENEFORM Protein DME1422 XEOTICID XEO03943 MOACRIVE Inhibition DME1422 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1422 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03944 XEO_CLAS Peptide DME1422 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.7 microM) DME1422 XEOTICID XEO03944 GENEFORM Protein DME1422 XEOTICID XEO03944 MOACRIVE Inhibition DME1422 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1422 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03945 XEO_CLAS Peptide DME1422 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.2 microM) DME1422 XEOTICID XEO03945 GENEFORM Protein DME1422 XEOTICID XEO03945 MOACRIVE Inhibition DME1422 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1422 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03947 XEO_CLAS Peptide DME1422 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.0 microM) DME1422 XEOTICID XEO03947 GENEFORM Protein DME1422 XEOTICID XEO03947 MOACRIVE Inhibition DME1422 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1422 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03948 XEO_CLAS Peptide DME1422 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 23.3 microM) DME1422 XEOTICID XEO03948 GENEFORM Protein DME1422 XEOTICID XEO03948 MOACRIVE Inhibition DME1422 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1422 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03950 XEO_CLAS Peptide DME1422 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4.4 microM) DME1422 XEOTICID XEO03950 GENEFORM Protein DME1422 XEOTICID XEO03950 MOACRIVE Inhibition DME1422 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1422 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03951 XEO_CLAS Peptide DME1422 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8.8 microM) DME1422 XEOTICID XEO03951 GENEFORM Protein DME1422 XEOTICID XEO03951 MOACRIVE Inhibition DME1422 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1422 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03952 XEO_CLAS Peptide DME1422 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.2 microM) DME1422 XEOTICID XEO03952 GENEFORM Protein DME1422 XEOTICID XEO03952 MOACRIVE Inhibition DME1422 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1422 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03953 XEO_CLAS Peptide DME1422 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 microM) DME1422 XEOTICID XEO03953 GENEFORM Protein DME1422 XEOTICID XEO03953 MOACRIVE Inhibition DME1422 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1422 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03958 XEO_CLAS Peptide DME1422 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03958 GENEFORM Protein DME1422 XEOTICID XEO03958 MOACRIVE Inhibition DME1422 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1422 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03965 XEO_CLAS Peptide DME1422 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 128 microM) DME1422 XEOTICID XEO03965 GENEFORM Protein DME1422 XEOTICID XEO03965 MOACRIVE Inhibition DME1422 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1422 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03966 XEO_CLAS Peptide DME1422 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 microM) DME1422 XEOTICID XEO03966 GENEFORM Protein DME1422 XEOTICID XEO03966 MOACRIVE Inhibition DME1422 XEOTICID XEO03971 XEO_NAME Lumbrican DME1422 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03971 XEO_CLAS Peptide DME1422 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03971 GENEFORM Protein DME1422 XEOTICID XEO03971 MOACRIVE Inhibition DME1422 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1422 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03972 XEO_CLAS Peptide DME1422 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO03972 GENEFORM Protein DME1422 XEOTICID XEO03972 MOACRIVE Inhibition DME1422 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1422 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03980 XEO_CLAS Peptide DME1422 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 32 microM) DME1422 XEOTICID XEO03980 GENEFORM Protein DME1422 XEOTICID XEO03980 MOACRIVE Inhibition DME1422 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1422 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03985 XEO_CLAS Peptide DME1422 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 ug/ml) DME1422 XEOTICID XEO03985 GENEFORM Protein DME1422 XEOTICID XEO03985 MOACRIVE Inhibition DME1422 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1422 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03991 XEO_CLAS Peptide DME1422 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03991 GENEFORM Protein DME1422 XEOTICID XEO03991 MOACRIVE Inhibition DME1422 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1422 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03992 XEO_CLAS Peptide DME1422 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03992 GENEFORM Protein DME1422 XEOTICID XEO03992 MOACRIVE Inhibition DME1422 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1422 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03993 XEO_CLAS Peptide DME1422 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03993 GENEFORM Protein DME1422 XEOTICID XEO03993 MOACRIVE Inhibition DME1422 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1422 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03994 XEO_CLAS Peptide DME1422 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO03994 GENEFORM Protein DME1422 XEOTICID XEO03994 MOACRIVE Inhibition DME1422 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1422 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03996 XEO_CLAS Peptide DME1422 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 65 microM) DME1422 XEOTICID XEO03996 GENEFORM Protein DME1422 XEOTICID XEO03996 MOACRIVE Inhibition DME1422 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1422 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03997 XEO_CLAS Peptide DME1422 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 7.5 microM) DME1422 XEOTICID XEO03997 GENEFORM Protein DME1422 XEOTICID XEO03997 MOACRIVE Inhibition DME1422 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1422 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03998 XEO_CLAS Peptide DME1422 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15.5 microM) DME1422 XEOTICID XEO03998 GENEFORM Protein DME1422 XEOTICID XEO03998 MOACRIVE Inhibition DME1422 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1422 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO03999 XEO_CLAS Peptide DME1422 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25.8 microM) DME1422 XEOTICID XEO03999 GENEFORM Protein DME1422 XEOTICID XEO03999 MOACRIVE Inhibition DME1422 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1422 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04000 XEO_CLAS Peptide DME1422 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO04000 GENEFORM Protein DME1422 XEOTICID XEO04000 MOACRIVE Inhibition DME1422 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1422 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04001 XEO_CLAS Peptide DME1422 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO04001 GENEFORM Protein DME1422 XEOTICID XEO04001 MOACRIVE Inhibition DME1422 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1422 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04002 XEO_CLAS Peptide DME1422 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 7.5 ug/ml) DME1422 XEOTICID XEO04002 GENEFORM Protein DME1422 XEOTICID XEO04002 MOACRIVE Inhibition DME1422 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1422 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04003 XEO_CLAS Peptide DME1422 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 ug/ml) DME1422 XEOTICID XEO04003 GENEFORM Protein DME1422 XEOTICID XEO04003 MOACRIVE Inhibition DME1422 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1422 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04004 XEO_CLAS Peptide DME1422 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.0 ug/ml) DME1422 XEOTICID XEO04004 GENEFORM Protein DME1422 XEOTICID XEO04004 MOACRIVE Inhibition DME1422 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1422 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04005 XEO_CLAS Peptide DME1422 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.0 ug/ml) DME1422 XEOTICID XEO04005 GENEFORM Protein DME1422 XEOTICID XEO04005 MOACRIVE Inhibition DME1422 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1422 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04007 XEO_CLAS Peptide DME1422 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 19.5 ug/ml) DME1422 XEOTICID XEO04007 GENEFORM Protein DME1422 XEOTICID XEO04007 MOACRIVE Inhibition DME1422 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1422 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04011 XEO_CLAS Peptide DME1422 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 19.5 ug/ml) DME1422 XEOTICID XEO04011 GENEFORM Protein DME1422 XEOTICID XEO04011 MOACRIVE Inhibition DME1422 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1422 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04012 XEO_CLAS Peptide DME1422 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.9 ug/ml) DME1422 XEOTICID XEO04012 GENEFORM Protein DME1422 XEOTICID XEO04012 MOACRIVE Inhibition DME1422 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1422 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04013 XEO_CLAS Peptide DME1422 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.7 ug/ml) DME1422 XEOTICID XEO04013 GENEFORM Protein DME1422 XEOTICID XEO04013 MOACRIVE Inhibition DME1422 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1422 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04018 XEO_CLAS Peptide DME1422 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 9 ug/ml) DME1422 XEOTICID XEO04018 GENEFORM Protein DME1422 XEOTICID XEO04018 MOACRIVE Inhibition DME1422 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1422 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04026 XEO_CLAS Peptide DME1422 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO04026 GENEFORM Protein DME1422 XEOTICID XEO04026 MOACRIVE Inhibition DME1422 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1422 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04027 XEO_CLAS Peptide DME1422 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO04027 GENEFORM Protein DME1422 XEOTICID XEO04027 MOACRIVE Inhibition DME1422 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1422 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04028 XEO_CLAS Peptide DME1422 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 ug/ml) DME1422 XEOTICID XEO04028 GENEFORM Protein DME1422 XEOTICID XEO04028 MOACRIVE Inhibition DME1422 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1422 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04038 XEO_CLAS Peptide DME1422 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04038 GENEFORM Protein DME1422 XEOTICID XEO04038 MOACRIVE Inhibition DME1422 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1422 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04039 XEO_CLAS Peptide DME1422 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 microM) DME1422 XEOTICID XEO04039 GENEFORM Protein DME1422 XEOTICID XEO04039 MOACRIVE Inhibition DME1422 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1422 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04051 XEO_CLAS Peptide DME1422 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.31-0.63 microM) DME1422 XEOTICID XEO04051 GENEFORM Protein DME1422 XEOTICID XEO04051 MOACRIVE Inhibition DME1422 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1422 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04052 XEO_CLAS Peptide DME1422 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04052 GENEFORM Protein DME1422 XEOTICID XEO04052 MOACRIVE Inhibition DME1422 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1422 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04053 XEO_CLAS Peptide DME1422 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.08-0.16 microM) DME1422 XEOTICID XEO04053 GENEFORM Protein DME1422 XEOTICID XEO04053 MOACRIVE Inhibition DME1422 XEOTICID XEO04055 XEO_NAME Melectin DME1422 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04055 XEO_CLAS Peptide DME1422 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.0 microM) DME1422 XEOTICID XEO04055 GENEFORM Protein DME1422 XEOTICID XEO04055 MOACRIVE Inhibition DME1422 XEOTICID XEO04057 XEO_NAME Melittin DME1422 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04057 XEO_CLAS Peptide DME1422 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.8 microM) DME1422 XEOTICID XEO04057 GENEFORM Protein DME1422 XEOTICID XEO04057 MOACRIVE Inhibition DME1422 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1422 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04061 XEO_CLAS Peptide DME1422 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.9 microM) DME1422 XEOTICID XEO04061 GENEFORM Protein DME1422 XEOTICID XEO04061 MOACRIVE Inhibition DME1422 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1422 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04062 XEO_CLAS Peptide DME1422 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.5 microM) DME1422 XEOTICID XEO04062 GENEFORM Protein DME1422 XEOTICID XEO04062 MOACRIVE Inhibition DME1422 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1422 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04063 XEO_CLAS Peptide DME1422 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 7.8 microM) DME1422 XEOTICID XEO04063 GENEFORM Protein DME1422 XEOTICID XEO04063 MOACRIVE Inhibition DME1422 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1422 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04064 XEO_CLAS Peptide DME1422 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 46.7 microM) DME1422 XEOTICID XEO04064 GENEFORM Protein DME1422 XEOTICID XEO04064 MOACRIVE Inhibition DME1422 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1422 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04066 XEO_CLAS Peptide DME1422 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16.3 microM) DME1422 XEOTICID XEO04066 GENEFORM Protein DME1422 XEOTICID XEO04066 MOACRIVE Inhibition DME1422 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1422 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04067 XEO_CLAS Peptide DME1422 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.6 microM) DME1422 XEOTICID XEO04067 GENEFORM Protein DME1422 XEOTICID XEO04067 MOACRIVE Inhibition DME1422 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1422 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04068 XEO_CLAS Peptide DME1422 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.6 microM) DME1422 XEOTICID XEO04068 GENEFORM Protein DME1422 XEOTICID XEO04068 MOACRIVE Inhibition DME1422 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1422 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04086 GENEFORM Protein DME1422 XEOTICID XEO04086 MOACRIVE Inhibition DME1422 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1422 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04087 GENEFORM Protein DME1422 XEOTICID XEO04087 MOACRIVE Inhibition DME1422 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1422 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04089 GENEFORM Protein DME1422 XEOTICID XEO04089 MOACRIVE Inhibition DME1422 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1422 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04094 GENEFORM Protein DME1422 XEOTICID XEO04094 MOACRIVE Inhibition DME1422 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1422 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04096 GENEFORM Protein DME1422 XEOTICID XEO04096 MOACRIVE Inhibition DME1422 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1422 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04098 GENEFORM Protein DME1422 XEOTICID XEO04098 MOACRIVE Inhibition DME1422 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1422 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04111 XEO_CLAS Peptide DME1422 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04111 GENEFORM Protein DME1422 XEOTICID XEO04111 MOACRIVE Inhibition DME1422 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1422 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04112 XEO_CLAS Peptide DME1422 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.02 microM) DME1422 XEOTICID XEO04112 GENEFORM Protein DME1422 XEOTICID XEO04112 MOACRIVE Inhibition DME1422 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1422 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04113 XEO_CLAS Peptide DME1422 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.02 ug/ml) DME1422 XEOTICID XEO04113 GENEFORM Protein DME1422 XEOTICID XEO04113 MOACRIVE Inhibition DME1422 XEOTICID XEO04114 XEO_NAME Microcin L DME1422 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04114 XEO_CLAS Peptide DME1422 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04114 GENEFORM Protein DME1422 XEOTICID XEO04114 MOACRIVE Inhibition DME1422 XEOTICID XEO04117 XEO_NAME Misgurin DME1422 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04117 XEO_CLAS Peptide DME1422 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04117 GENEFORM Protein DME1422 XEOTICID XEO04117 MOACRIVE Inhibition DME1422 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1422 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04118 XEO_CLAS Peptide DME1422 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 300 microM) DME1422 XEOTICID XEO04118 GENEFORM Protein DME1422 XEOTICID XEO04118 MOACRIVE Inhibition DME1422 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1422 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04119 XEO_CLAS Peptide DME1422 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-20 microM) DME1422 XEOTICID XEO04119 GENEFORM Protein DME1422 XEOTICID XEO04119 MOACRIVE Inhibition DME1422 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1422 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04120 XEO_CLAS Peptide DME1422 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC < 10 microM) DME1422 XEOTICID XEO04120 GENEFORM Protein DME1422 XEOTICID XEO04120 MOACRIVE Inhibition DME1422 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1422 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04121 XEO_CLAS Peptide DME1422 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.2-6.4 microM) DME1422 XEOTICID XEO04121 GENEFORM Protein DME1422 XEOTICID XEO04121 MOACRIVE Inhibition DME1422 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1422 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04122 XEO_CLAS Peptide DME1422 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.14-6.29 microM) DME1422 XEOTICID XEO04122 GENEFORM Protein DME1422 XEOTICID XEO04122 MOACRIVE Inhibition DME1422 XEOTICID XEO04123 XEO_NAME Modified defensin DME1422 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04123 XEO_CLAS Peptide DME1422 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO04123 GENEFORM Protein DME1422 XEOTICID XEO04123 MOACRIVE Inhibition DME1422 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1422 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04128 XEO_CLAS Peptide DME1422 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.31 microM) DME1422 XEOTICID XEO04128 GENEFORM Protein DME1422 XEOTICID XEO04128 MOACRIVE Inhibition DME1422 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1422 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04129 XEO_CLAS Peptide DME1422 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO04129 GENEFORM Protein DME1422 XEOTICID XEO04129 MOACRIVE Inhibition DME1422 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1422 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04130 XEO_CLAS Peptide DME1422 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO04130 GENEFORM Protein DME1422 XEOTICID XEO04130 MOACRIVE Inhibition DME1422 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1422 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04131 XEO_CLAS Peptide DME1422 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 microM) DME1422 XEOTICID XEO04131 GENEFORM Protein DME1422 XEOTICID XEO04131 MOACRIVE Inhibition DME1422 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1422 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04132 XEO_CLAS Peptide DME1422 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 microM) DME1422 XEOTICID XEO04132 GENEFORM Protein DME1422 XEOTICID XEO04132 MOACRIVE Inhibition DME1422 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1422 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04133 XEO_CLAS Peptide DME1422 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO04133 GENEFORM Protein DME1422 XEOTICID XEO04133 MOACRIVE Inhibition DME1422 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1422 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04134 XEO_CLAS Peptide DME1422 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO04134 GENEFORM Protein DME1422 XEOTICID XEO04134 MOACRIVE Inhibition DME1422 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1422 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04135 XEO_CLAS Peptide DME1422 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 microM) DME1422 XEOTICID XEO04135 GENEFORM Protein DME1422 XEOTICID XEO04135 MOACRIVE Inhibition DME1422 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1422 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04137 XEO_CLAS Peptide DME1422 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.6 microM) DME1422 XEOTICID XEO04137 GENEFORM Protein DME1422 XEOTICID XEO04137 MOACRIVE Inhibition DME1422 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1422 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04138 XEO_CLAS Peptide DME1422 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 microM) DME1422 XEOTICID XEO04138 GENEFORM Protein DME1422 XEOTICID XEO04138 MOACRIVE Inhibition DME1422 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1422 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04139 XEO_CLAS Peptide DME1422 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 microM) DME1422 XEOTICID XEO04139 GENEFORM Protein DME1422 XEOTICID XEO04139 MOACRIVE Inhibition DME1422 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1422 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04140 XEO_CLAS Peptide DME1422 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 70 microM) DME1422 XEOTICID XEO04140 GENEFORM Protein DME1422 XEOTICID XEO04140 MOACRIVE Inhibition DME1422 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1422 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04141 XEO_CLAS Peptide DME1422 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 microM) DME1422 XEOTICID XEO04141 GENEFORM Protein DME1422 XEOTICID XEO04141 MOACRIVE Inhibition DME1422 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1422 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04142 XEO_CLAS Peptide DME1422 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8-16 microM) DME1422 XEOTICID XEO04142 GENEFORM Protein DME1422 XEOTICID XEO04142 MOACRIVE Inhibition DME1422 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1422 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04146 XEO_CLAS Peptide DME1422 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04146 GENEFORM Protein DME1422 XEOTICID XEO04146 MOACRIVE Inhibition DME1422 XEOTICID XEO04149 XEO_NAME Mucroporin DME1422 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04149 XEO_CLAS Peptide DME1422 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 ug/ml) DME1422 XEOTICID XEO04149 GENEFORM Protein DME1422 XEOTICID XEO04149 MOACRIVE Inhibition DME1422 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1422 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04158 XEO_CLAS Peptide DME1422 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO04158 GENEFORM Protein DME1422 XEOTICID XEO04158 MOACRIVE Inhibition DME1422 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1422 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04159 XEO_CLAS Peptide DME1422 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 microM) DME1422 XEOTICID XEO04159 GENEFORM Protein DME1422 XEOTICID XEO04159 MOACRIVE Inhibition DME1422 XEOTICID XEO04167 XEO_NAME Myticin-B DME1422 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04167 XEO_CLAS Peptide DME1422 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04167 GENEFORM Protein DME1422 XEOTICID XEO04167 MOACRIVE Inhibition DME1422 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1422 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04168 XEO_CLAS Peptide DME1422 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.7-12.5 microM) DME1422 XEOTICID XEO04168 GENEFORM Protein DME1422 XEOTICID XEO04168 MOACRIVE Inhibition DME1422 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1422 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04169 XEO_CLAS Peptide DME1422 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04169 GENEFORM Protein DME1422 XEOTICID XEO04169 MOACRIVE Inhibition DME1422 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1422 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04170 XEO_CLAS Peptide DME1422 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04170 GENEFORM Protein DME1422 XEOTICID XEO04170 MOACRIVE Inhibition DME1422 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1422 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04171 XEO_CLAS Peptide DME1422 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04171 GENEFORM Protein DME1422 XEOTICID XEO04171 MOACRIVE Inhibition DME1422 XEOTICID XEO04172 XEO_NAME Myxinidin DME1422 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04172 XEO_CLAS Peptide DME1422 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04172 GENEFORM Protein DME1422 XEOTICID XEO04172 MOACRIVE Inhibition DME1422 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1422 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04177 XEO_CLAS Peptide DME1422 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.7 microM) DME1422 XEOTICID XEO04177 GENEFORM Protein DME1422 XEOTICID XEO04177 MOACRIVE Inhibition DME1422 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1422 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04178 XEO_CLAS Peptide DME1422 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.7 microM) DME1422 XEOTICID XEO04178 GENEFORM Protein DME1422 XEOTICID XEO04178 MOACRIVE Inhibition DME1422 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1422 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04179 XEO_CLAS Peptide DME1422 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.5 microM) DME1422 XEOTICID XEO04179 GENEFORM Protein DME1422 XEOTICID XEO04179 MOACRIVE Inhibition DME1422 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1422 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04180 XEO_CLAS Peptide DME1422 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 23 microM) DME1422 XEOTICID XEO04180 GENEFORM Protein DME1422 XEOTICID XEO04180 MOACRIVE Inhibition DME1422 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1422 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04181 XEO_CLAS Peptide DME1422 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.2 microM) DME1422 XEOTICID XEO04181 GENEFORM Protein DME1422 XEOTICID XEO04181 MOACRIVE Inhibition DME1422 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1422 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04182 XEO_CLAS Peptide DME1422 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4.4 microM) DME1422 XEOTICID XEO04182 GENEFORM Protein DME1422 XEOTICID XEO04182 MOACRIVE Inhibition DME1422 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1422 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04183 XEO_CLAS Peptide DME1422 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.6 microM) DME1422 XEOTICID XEO04183 GENEFORM Protein DME1422 XEOTICID XEO04183 MOACRIVE Inhibition DME1422 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1422 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04184 XEO_CLAS Peptide DME1422 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 microM) DME1422 XEOTICID XEO04184 GENEFORM Protein DME1422 XEOTICID XEO04184 MOACRIVE Inhibition DME1422 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1422 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04185 XEO_CLAS Peptide DME1422 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04185 GENEFORM Protein DME1422 XEOTICID XEO04185 MOACRIVE Inhibition DME1422 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1422 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04186 XEO_CLAS Peptide DME1422 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04186 GENEFORM Protein DME1422 XEOTICID XEO04186 MOACRIVE Inhibition DME1422 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1422 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04187 XEO_CLAS Peptide DME1422 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04187 GENEFORM Protein DME1422 XEOTICID XEO04187 MOACRIVE Inhibition DME1422 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1422 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04188 XEO_CLAS Peptide DME1422 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04188 GENEFORM Protein DME1422 XEOTICID XEO04188 MOACRIVE Inhibition DME1422 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1422 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04206 XEO_CLAS Peptide DME1422 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25 microM) DME1422 XEOTICID XEO04206 GENEFORM Protein DME1422 XEOTICID XEO04206 MOACRIVE Inhibition DME1422 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1422 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04214 XEO_CLAS Peptide DME1422 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25 microM) DME1422 XEOTICID XEO04214 GENEFORM Protein DME1422 XEOTICID XEO04214 MOACRIVE Inhibition DME1422 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1422 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04216 XEO_CLAS Peptide DME1422 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO04216 GENEFORM Protein DME1422 XEOTICID XEO04216 MOACRIVE Inhibition DME1422 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1422 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04218 XEO_CLAS Peptide DME1422 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.125 microM) DME1422 XEOTICID XEO04218 GENEFORM Protein DME1422 XEOTICID XEO04218 MOACRIVE Inhibition DME1422 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1422 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04219 XEO_CLAS Peptide DME1422 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO04219 GENEFORM Protein DME1422 XEOTICID XEO04219 MOACRIVE Inhibition DME1422 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1422 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04220 XEO_CLAS Peptide DME1422 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.125 microM) DME1422 XEOTICID XEO04220 GENEFORM Protein DME1422 XEOTICID XEO04220 MOACRIVE Inhibition DME1422 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1422 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04221 XEO_CLAS Peptide DME1422 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO04221 GENEFORM Protein DME1422 XEOTICID XEO04221 MOACRIVE Inhibition DME1422 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1422 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04222 XEO_CLAS Peptide DME1422 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25 microM) DME1422 XEOTICID XEO04222 GENEFORM Protein DME1422 XEOTICID XEO04222 MOACRIVE Inhibition DME1422 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1422 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04233 XEO_CLAS Peptide DME1422 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04233 GENEFORM Protein DME1422 XEOTICID XEO04233 MOACRIVE Inhibition DME1422 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1422 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04234 XEO_CLAS Peptide DME1422 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04234 GENEFORM Protein DME1422 XEOTICID XEO04234 MOACRIVE Inhibition DME1422 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1422 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04241 XEO_CLAS Peptide DME1422 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04241 GENEFORM Protein DME1422 XEOTICID XEO04241 MOACRIVE Inhibition DME1422 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1422 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04242 XEO_CLAS Peptide DME1422 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04242 GENEFORM Protein DME1422 XEOTICID XEO04242 MOACRIVE Inhibition DME1422 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1422 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04245 XEO_CLAS Natural Product DME1422 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04245 GENEFORM Protein DME1422 XEOTICID XEO04245 MOACRIVE Inhibition DME1422 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1422 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04246 XEO_CLAS Natural Product DME1422 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04246 GENEFORM Protein DME1422 XEOTICID XEO04246 MOACRIVE Inhibition DME1422 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1422 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04249 XEO_CLAS Peptide DME1422 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 500 ug/ml) DME1422 XEOTICID XEO04249 GENEFORM Protein DME1422 XEOTICID XEO04249 MOACRIVE Inhibition DME1422 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1422 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04251 XEO_CLAS Peptide DME1422 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04251 GENEFORM Protein DME1422 XEOTICID XEO04251 MOACRIVE Inhibition DME1422 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1422 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04253 XEO_CLAS Peptide DME1422 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04253 GENEFORM Protein DME1422 XEOTICID XEO04253 MOACRIVE Inhibition DME1422 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1422 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04254 XEO_CLAS Peptide DME1422 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04254 GENEFORM Protein DME1422 XEOTICID XEO04254 MOACRIVE Inhibition DME1422 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1422 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04255 XEO_CLAS Peptide DME1422 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04255 GENEFORM Protein DME1422 XEOTICID XEO04255 MOACRIVE Inhibition DME1422 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1422 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04256 XEO_CLAS Peptide DME1422 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04256 GENEFORM Protein DME1422 XEOTICID XEO04256 MOACRIVE Inhibition DME1422 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1422 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04257 XEO_CLAS Peptide DME1422 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04257 GENEFORM Protein DME1422 XEOTICID XEO04257 MOACRIVE Inhibition DME1422 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1422 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04258 XEO_CLAS Peptide DME1422 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04258 GENEFORM Protein DME1422 XEOTICID XEO04258 MOACRIVE Inhibition DME1422 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1422 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04259 XEO_CLAS Peptide DME1422 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04259 GENEFORM Protein DME1422 XEOTICID XEO04259 MOACRIVE Inhibition DME1422 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1422 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04260 XEO_CLAS Peptide DME1422 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04260 GENEFORM Protein DME1422 XEOTICID XEO04260 MOACRIVE Inhibition DME1422 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1422 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04261 XEO_CLAS Peptide DME1422 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04261 GENEFORM Protein DME1422 XEOTICID XEO04261 MOACRIVE Inhibition DME1422 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1422 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04262 XEO_CLAS Peptide DME1422 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04262 GENEFORM Protein DME1422 XEOTICID XEO04262 MOACRIVE Inhibition DME1422 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1422 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04263 XEO_CLAS Peptide DME1422 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04263 GENEFORM Protein DME1422 XEOTICID XEO04263 MOACRIVE Inhibition DME1422 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1422 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04264 XEO_CLAS Peptide DME1422 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04264 GENEFORM Protein DME1422 XEOTICID XEO04264 MOACRIVE Inhibition DME1422 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1422 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04265 XEO_CLAS Peptide DME1422 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04265 GENEFORM Protein DME1422 XEOTICID XEO04265 MOACRIVE Inhibition DME1422 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1422 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04266 XEO_CLAS Peptide DME1422 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04266 GENEFORM Protein DME1422 XEOTICID XEO04266 MOACRIVE Inhibition DME1422 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1422 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04267 XEO_CLAS Peptide DME1422 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04267 GENEFORM Protein DME1422 XEOTICID XEO04267 MOACRIVE Inhibition DME1422 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1422 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04268 XEO_CLAS Peptide DME1422 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04268 GENEFORM Protein DME1422 XEOTICID XEO04268 MOACRIVE Inhibition DME1422 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1422 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04269 XEO_CLAS Peptide DME1422 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04269 GENEFORM Protein DME1422 XEOTICID XEO04269 MOACRIVE Inhibition DME1422 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1422 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04270 XEO_CLAS Peptide DME1422 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04270 GENEFORM Protein DME1422 XEOTICID XEO04270 MOACRIVE Inhibition DME1422 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1422 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04271 XEO_CLAS Peptide DME1422 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04271 GENEFORM Protein DME1422 XEOTICID XEO04271 MOACRIVE Inhibition DME1422 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1422 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04272 XEO_CLAS Peptide DME1422 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04272 GENEFORM Protein DME1422 XEOTICID XEO04272 MOACRIVE Inhibition DME1422 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1422 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04277 XEO_CLAS Peptide DME1422 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 110.00 ug/ml) DME1422 XEOTICID XEO04277 GENEFORM Protein DME1422 XEOTICID XEO04277 MOACRIVE Inhibition DME1422 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1422 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04280 XEO_CLAS Peptide DME1422 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 37.50 ug/ml) DME1422 XEOTICID XEO04280 GENEFORM Protein DME1422 XEOTICID XEO04280 MOACRIVE Inhibition DME1422 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1422 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04281 XEO_CLAS Peptide DME1422 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25.00 ug/ml) DME1422 XEOTICID XEO04281 GENEFORM Protein DME1422 XEOTICID XEO04281 MOACRIVE Inhibition DME1422 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1422 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04282 XEO_CLAS Peptide DME1422 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.2 ug/ml) DME1422 XEOTICID XEO04282 GENEFORM Protein DME1422 XEOTICID XEO04282 MOACRIVE Inhibition DME1422 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1422 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04283 XEO_CLAS Peptide DME1422 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.3 ug/ml) DME1422 XEOTICID XEO04283 GENEFORM Protein DME1422 XEOTICID XEO04283 MOACRIVE Inhibition DME1422 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1422 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04284 XEO_CLAS Peptide DME1422 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10.8 ug/ml) DME1422 XEOTICID XEO04284 GENEFORM Protein DME1422 XEOTICID XEO04284 MOACRIVE Inhibition DME1422 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1422 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04285 XEO_CLAS Peptide DME1422 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 11.5 ug/ml) DME1422 XEOTICID XEO04285 GENEFORM Protein DME1422 XEOTICID XEO04285 MOACRIVE Inhibition DME1422 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1422 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04286 XEO_CLAS Peptide DME1422 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8.6 ug/ml) DME1422 XEOTICID XEO04286 GENEFORM Protein DME1422 XEOTICID XEO04286 MOACRIVE Inhibition DME1422 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1422 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04287 XEO_CLAS Peptide DME1422 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10.2 ug/ml) DME1422 XEOTICID XEO04287 GENEFORM Protein DME1422 XEOTICID XEO04287 MOACRIVE Inhibition DME1422 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1422 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04288 XEO_CLAS Peptide DME1422 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4.4 ug/ml) DME1422 XEOTICID XEO04288 GENEFORM Protein DME1422 XEOTICID XEO04288 MOACRIVE Inhibition DME1422 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1422 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04289 XEO_CLAS Peptide DME1422 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.2 ug/ml) DME1422 XEOTICID XEO04289 GENEFORM Protein DME1422 XEOTICID XEO04289 MOACRIVE Inhibition DME1422 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1422 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04290 XEO_CLAS Peptide DME1422 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 11.3 ug/ml) DME1422 XEOTICID XEO04290 GENEFORM Protein DME1422 XEOTICID XEO04290 MOACRIVE Inhibition DME1422 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1422 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04291 XEO_CLAS Peptide DME1422 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 7.2 ug/ml) DME1422 XEOTICID XEO04291 GENEFORM Protein DME1422 XEOTICID XEO04291 MOACRIVE Inhibition DME1422 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1422 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04292 XEO_CLAS Peptide DME1422 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.1 ug/ml) DME1422 XEOTICID XEO04292 GENEFORM Protein DME1422 XEOTICID XEO04292 MOACRIVE Inhibition DME1422 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1422 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04293 XEO_CLAS Peptide DME1422 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO04293 GENEFORM Protein DME1422 XEOTICID XEO04293 MOACRIVE Inhibition DME1422 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1422 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04294 XEO_CLAS Peptide DME1422 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO04294 GENEFORM Protein DME1422 XEOTICID XEO04294 MOACRIVE Inhibition DME1422 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1422 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04295 XEO_CLAS Peptide DME1422 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO04295 GENEFORM Protein DME1422 XEOTICID XEO04295 MOACRIVE Inhibition DME1422 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1422 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04296 XEO_CLAS Peptide DME1422 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 28 microM) DME1422 XEOTICID XEO04296 GENEFORM Protein DME1422 XEOTICID XEO04296 MOACRIVE Inhibition DME1422 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1422 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04297 XEO_CLAS Peptide DME1422 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 14 microM) DME1422 XEOTICID XEO04297 GENEFORM Protein DME1422 XEOTICID XEO04297 MOACRIVE Inhibition DME1422 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1422 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04298 XEO_CLAS Peptide DME1422 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO04298 GENEFORM Protein DME1422 XEOTICID XEO04298 MOACRIVE Inhibition DME1422 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1422 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04299 XEO_CLAS Peptide DME1422 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO04299 GENEFORM Protein DME1422 XEOTICID XEO04299 MOACRIVE Inhibition DME1422 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1422 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04300 XEO_CLAS Peptide DME1422 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO04300 GENEFORM Protein DME1422 XEOTICID XEO04300 MOACRIVE Inhibition DME1422 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1422 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04301 XEO_CLAS Peptide DME1422 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 microM) DME1422 XEOTICID XEO04301 GENEFORM Protein DME1422 XEOTICID XEO04301 MOACRIVE Inhibition DME1422 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1422 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04302 XEO_CLAS Peptide DME1422 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 microM) DME1422 XEOTICID XEO04302 GENEFORM Protein DME1422 XEOTICID XEO04302 MOACRIVE Inhibition DME1422 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1422 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04303 XEO_CLAS Peptide DME1422 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 microM) DME1422 XEOTICID XEO04303 GENEFORM Protein DME1422 XEOTICID XEO04303 MOACRIVE Inhibition DME1422 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1422 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04304 XEO_CLAS Peptide DME1422 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO04304 GENEFORM Protein DME1422 XEOTICID XEO04304 MOACRIVE Inhibition DME1422 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1422 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04305 XEO_CLAS Peptide DME1422 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 70 microM) DME1422 XEOTICID XEO04305 GENEFORM Protein DME1422 XEOTICID XEO04305 MOACRIVE Inhibition DME1422 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1422 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04306 XEO_CLAS Peptide DME1422 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO04306 GENEFORM Protein DME1422 XEOTICID XEO04306 MOACRIVE Inhibition DME1422 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1422 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04307 XEO_CLAS Peptide DME1422 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 ug/ml) DME1422 XEOTICID XEO04307 GENEFORM Protein DME1422 XEOTICID XEO04307 MOACRIVE Inhibition DME1422 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1422 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04308 XEO_CLAS Peptide DME1422 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 9.37 ug/ml) DME1422 XEOTICID XEO04308 GENEFORM Protein DME1422 XEOTICID XEO04308 MOACRIVE Inhibition DME1422 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1422 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04309 XEO_CLAS Peptide DME1422 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 microM) DME1422 XEOTICID XEO04309 GENEFORM Protein DME1422 XEOTICID XEO04309 MOACRIVE Inhibition DME1422 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1422 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04310 XEO_CLAS Peptide DME1422 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO04310 GENEFORM Protein DME1422 XEOTICID XEO04310 MOACRIVE Inhibition DME1422 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1422 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04311 XEO_CLAS Peptide DME1422 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO04311 GENEFORM Protein DME1422 XEOTICID XEO04311 MOACRIVE Inhibition DME1422 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1422 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04312 XEO_CLAS Peptide DME1422 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4.68 ug/ml) DME1422 XEOTICID XEO04312 GENEFORM Protein DME1422 XEOTICID XEO04312 MOACRIVE Inhibition DME1422 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1422 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04313 XEO_CLAS Peptide DME1422 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4.68 ug/ml) DME1422 XEOTICID XEO04313 GENEFORM Protein DME1422 XEOTICID XEO04313 MOACRIVE Inhibition DME1422 XEOTICID XEO04331 XEO_NAME Norspermidine DME1422 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1422 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04331 GENEFORM Protein DME1422 XEOTICID XEO04331 MOACRIVE Inhibition DME1422 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1422 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04335 XEO_CLAS Peptide DME1422 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 32 ug/ml) DME1422 XEOTICID XEO04335 GENEFORM Protein DME1422 XEOTICID XEO04335 MOACRIVE Inhibition DME1422 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1422 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04336 XEO_CLAS Peptide DME1422 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 32 ug/ml) DME1422 XEOTICID XEO04336 GENEFORM Protein DME1422 XEOTICID XEO04336 MOACRIVE Inhibition DME1422 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1422 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04338 XEO_CLAS Peptide DME1422 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 ug/ml) DME1422 XEOTICID XEO04338 GENEFORM Protein DME1422 XEOTICID XEO04338 MOACRIVE Inhibition DME1422 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1422 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04339 XEO_CLAS Peptide DME1422 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 ug/ml) DME1422 XEOTICID XEO04339 GENEFORM Protein DME1422 XEOTICID XEO04339 MOACRIVE Inhibition DME1422 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1422 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04340 XEO_CLAS Peptide DME1422 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO04340 GENEFORM Protein DME1422 XEOTICID XEO04340 MOACRIVE Inhibition DME1422 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1422 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04344 XEO_CLAS Peptide DME1422 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04344 GENEFORM Protein DME1422 XEOTICID XEO04344 MOACRIVE Inhibition DME1422 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1422 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04345 XEO_CLAS Peptide DME1422 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04345 GENEFORM Protein DME1422 XEOTICID XEO04345 MOACRIVE Inhibition DME1422 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1422 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04346 XEO_CLAS Peptide DME1422 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04346 GENEFORM Protein DME1422 XEOTICID XEO04346 MOACRIVE Inhibition DME1422 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1422 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04347 XEO_CLAS Peptide DME1422 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 microM) DME1422 XEOTICID XEO04347 GENEFORM Protein DME1422 XEOTICID XEO04347 MOACRIVE Inhibition DME1422 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1422 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04348 XEO_CLAS Peptide DME1422 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40 microM) DME1422 XEOTICID XEO04348 GENEFORM Protein DME1422 XEOTICID XEO04348 MOACRIVE Inhibition DME1422 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1422 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04349 XEO_CLAS Peptide DME1422 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO04349 GENEFORM Protein DME1422 XEOTICID XEO04349 MOACRIVE Inhibition DME1422 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1422 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04354 XEO_CLAS Peptide DME1422 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 35.2 ug/ml) DME1422 XEOTICID XEO04354 GENEFORM Protein DME1422 XEOTICID XEO04354 MOACRIVE Inhibition DME1422 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1422 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04355 XEO_CLAS Peptide DME1422 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.21 ug/ml) DME1422 XEOTICID XEO04355 GENEFORM Protein DME1422 XEOTICID XEO04355 MOACRIVE Inhibition DME1422 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1422 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04356 XEO_CLAS Peptide DME1422 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8.21 ug/ml) DME1422 XEOTICID XEO04356 GENEFORM Protein DME1422 XEOTICID XEO04356 MOACRIVE Inhibition DME1422 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1422 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04357 XEO_CLAS Peptide DME1422 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16.32 ug/ml) DME1422 XEOTICID XEO04357 GENEFORM Protein DME1422 XEOTICID XEO04357 MOACRIVE Inhibition DME1422 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1422 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04358 XEO_CLAS Peptide DME1422 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 9.37 ug/ml) DME1422 XEOTICID XEO04358 GENEFORM Protein DME1422 XEOTICID XEO04358 MOACRIVE Inhibition DME1422 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1422 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04359 XEO_CLAS Peptide DME1422 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4.20 ug/ml) DME1422 XEOTICID XEO04359 GENEFORM Protein DME1422 XEOTICID XEO04359 MOACRIVE Inhibition DME1422 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1422 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04360 XEO_CLAS Peptide DME1422 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 ug/ml) DME1422 XEOTICID XEO04360 GENEFORM Protein DME1422 XEOTICID XEO04360 MOACRIVE Inhibition DME1422 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1422 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04361 XEO_CLAS Peptide DME1422 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 7.5 ug/ml) DME1422 XEOTICID XEO04361 GENEFORM Protein DME1422 XEOTICID XEO04361 MOACRIVE Inhibition DME1422 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1422 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04362 XEO_CLAS Peptide DME1422 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.6 ug/ml) DME1422 XEOTICID XEO04362 GENEFORM Protein DME1422 XEOTICID XEO04362 MOACRIVE Inhibition DME1422 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1422 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04363 XEO_CLAS Peptide DME1422 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8.2 ug/ml) DME1422 XEOTICID XEO04363 GENEFORM Protein DME1422 XEOTICID XEO04363 MOACRIVE Inhibition DME1422 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1422 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04364 XEO_CLAS Peptide DME1422 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO04364 GENEFORM Protein DME1422 XEOTICID XEO04364 MOACRIVE Inhibition DME1422 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1422 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04365 XEO_CLAS Peptide DME1422 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4.68 ug/ml) DME1422 XEOTICID XEO04365 GENEFORM Protein DME1422 XEOTICID XEO04365 MOACRIVE Inhibition DME1422 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1422 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04366 XEO_CLAS Peptide DME1422 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 23.60 ug/ml) DME1422 XEOTICID XEO04366 GENEFORM Protein DME1422 XEOTICID XEO04366 MOACRIVE Inhibition DME1422 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1422 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04367 XEO_CLAS Peptide DME1422 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 35.60 ug/ml) DME1422 XEOTICID XEO04367 GENEFORM Protein DME1422 XEOTICID XEO04367 MOACRIVE Inhibition DME1422 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1422 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04368 XEO_CLAS Peptide DME1422 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40.2 ug/ml) DME1422 XEOTICID XEO04368 GENEFORM Protein DME1422 XEOTICID XEO04368 MOACRIVE Inhibition DME1422 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1422 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04369 XEO_CLAS Peptide DME1422 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40.2 ug/ml) DME1422 XEOTICID XEO04369 GENEFORM Protein DME1422 XEOTICID XEO04369 MOACRIVE Inhibition DME1422 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1422 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04370 XEO_CLAS Peptide DME1422 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4.68 ug/ml) DME1422 XEOTICID XEO04370 GENEFORM Protein DME1422 XEOTICID XEO04370 MOACRIVE Inhibition DME1422 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1422 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04371 XEO_CLAS Peptide DME1422 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 9.37 ug/ml) DME1422 XEOTICID XEO04371 GENEFORM Protein DME1422 XEOTICID XEO04371 MOACRIVE Inhibition DME1422 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1422 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04373 XEO_CLAS Peptide DME1422 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 ug/ml) DME1422 XEOTICID XEO04373 GENEFORM Protein DME1422 XEOTICID XEO04373 MOACRIVE Inhibition DME1422 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1422 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04374 XEO_CLAS Peptide DME1422 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.50 ug/ml) DME1422 XEOTICID XEO04374 GENEFORM Protein DME1422 XEOTICID XEO04374 MOACRIVE Inhibition DME1422 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1422 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04375 XEO_CLAS Peptide DME1422 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25 ug/ml) DME1422 XEOTICID XEO04375 GENEFORM Protein DME1422 XEOTICID XEO04375 MOACRIVE Inhibition DME1422 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1422 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04377 XEO_CLAS Peptide DME1422 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 42.50 ug/ml) DME1422 XEOTICID XEO04377 GENEFORM Protein DME1422 XEOTICID XEO04377 MOACRIVE Inhibition DME1422 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1422 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04378 XEO_CLAS Peptide DME1422 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 17.50 ug/ml) DME1422 XEOTICID XEO04378 GENEFORM Protein DME1422 XEOTICID XEO04378 MOACRIVE Inhibition DME1422 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1422 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04379 XEO_CLAS Peptide DME1422 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 ug/ml) DME1422 XEOTICID XEO04379 GENEFORM Protein DME1422 XEOTICID XEO04379 MOACRIVE Inhibition DME1422 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1422 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04380 XEO_CLAS Peptide DME1422 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 36.00 ug/ml) DME1422 XEOTICID XEO04380 GENEFORM Protein DME1422 XEOTICID XEO04380 MOACRIVE Inhibition DME1422 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1422 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04381 XEO_CLAS Peptide DME1422 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.60 ug/ml) DME1422 XEOTICID XEO04381 GENEFORM Protein DME1422 XEOTICID XEO04381 MOACRIVE Inhibition DME1422 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1422 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04382 XEO_CLAS Peptide DME1422 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 ug/ml) DME1422 XEOTICID XEO04382 GENEFORM Protein DME1422 XEOTICID XEO04382 MOACRIVE Inhibition DME1422 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1422 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04383 XEO_CLAS Peptide DME1422 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO04383 GENEFORM Protein DME1422 XEOTICID XEO04383 MOACRIVE Inhibition DME1422 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1422 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04384 XEO_CLAS Peptide DME1422 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO04384 GENEFORM Protein DME1422 XEOTICID XEO04384 MOACRIVE Inhibition DME1422 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1422 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04385 XEO_CLAS Peptide DME1422 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.25 ug/ml) DME1422 XEOTICID XEO04385 GENEFORM Protein DME1422 XEOTICID XEO04385 MOACRIVE Inhibition DME1422 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1422 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04395 XEO_CLAS Peptide DME1422 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.4-0.8 microM) DME1422 XEOTICID XEO04395 GENEFORM Protein DME1422 XEOTICID XEO04395 MOACRIVE Inhibition DME1422 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1422 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04396 XEO_CLAS Peptide DME1422 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.25-0.5 microM) DME1422 XEOTICID XEO04396 GENEFORM Protein DME1422 XEOTICID XEO04396 MOACRIVE Inhibition DME1422 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1422 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04397 XEO_CLAS Peptide DME1422 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.25-0.5 microM) DME1422 XEOTICID XEO04397 GENEFORM Protein DME1422 XEOTICID XEO04397 MOACRIVE Inhibition DME1422 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1422 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04398 XEO_CLAS Peptide DME1422 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 microM) DME1422 XEOTICID XEO04398 GENEFORM Protein DME1422 XEOTICID XEO04398 MOACRIVE Inhibition DME1422 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1422 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04399 XEO_CLAS Peptide DME1422 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO04399 GENEFORM Protein DME1422 XEOTICID XEO04399 MOACRIVE Inhibition DME1422 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1422 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04400 XEO_CLAS Peptide DME1422 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 ug/ml) DME1422 XEOTICID XEO04400 GENEFORM Protein DME1422 XEOTICID XEO04400 MOACRIVE Inhibition DME1422 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1422 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04401 XEO_CLAS Peptide DME1422 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.6 ug/ml) DME1422 XEOTICID XEO04401 GENEFORM Protein DME1422 XEOTICID XEO04401 MOACRIVE Inhibition DME1422 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1422 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04402 XEO_CLAS Peptide DME1422 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 ug/ml) DME1422 XEOTICID XEO04402 GENEFORM Protein DME1422 XEOTICID XEO04402 MOACRIVE Inhibition DME1422 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1422 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04403 XEO_CLAS Peptide DME1422 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.6 ug/ml) DME1422 XEOTICID XEO04403 GENEFORM Protein DME1422 XEOTICID XEO04403 MOACRIVE Inhibition DME1422 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1422 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04404 XEO_CLAS Peptide DME1422 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.6 ug/ml) DME1422 XEOTICID XEO04404 GENEFORM Protein DME1422 XEOTICID XEO04404 MOACRIVE Inhibition DME1422 XEOTICID XEO04410 XEO_NAME Insect osmin DME1422 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04410 XEO_CLAS Peptide DME1422 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.125-1.56 microM) DME1422 XEOTICID XEO04410 GENEFORM Protein DME1422 XEOTICID XEO04410 MOACRIVE Inhibition DME1422 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1422 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04412 XEO_CLAS Peptide DME1422 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04412 GENEFORM Protein DME1422 XEOTICID XEO04412 MOACRIVE Inhibition DME1422 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1422 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04414 XEO_CLAS Peptide DME1422 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04414 GENEFORM Protein DME1422 XEOTICID XEO04414 MOACRIVE Inhibition DME1422 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1422 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04415 XEO_CLAS Peptide DME1422 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04415 GENEFORM Protein DME1422 XEOTICID XEO04415 MOACRIVE Inhibition DME1422 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1422 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04421 XEO_CLAS Peptide DME1422 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 microM) DME1422 XEOTICID XEO04421 GENEFORM Protein DME1422 XEOTICID XEO04421 MOACRIVE Inhibition DME1422 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1422 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04426 XEO_CLAS Peptide DME1422 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO04426 GENEFORM Protein DME1422 XEOTICID XEO04426 MOACRIVE Inhibition DME1422 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1422 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04428 XEO_CLAS Peptide DME1422 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.3 ug/ml) DME1422 XEOTICID XEO04428 GENEFORM Protein DME1422 XEOTICID XEO04428 MOACRIVE Inhibition DME1422 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1422 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04430 XEO_CLAS Peptide DME1422 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25 microM) DME1422 XEOTICID XEO04430 GENEFORM Protein DME1422 XEOTICID XEO04430 MOACRIVE Inhibition DME1422 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1422 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04433 XEO_CLAS Peptide DME1422 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 160 microM) DME1422 XEOTICID XEO04433 GENEFORM Protein DME1422 XEOTICID XEO04433 MOACRIVE Inhibition DME1422 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1422 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04435 XEO_CLAS Peptide DME1422 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 160 microM) DME1422 XEOTICID XEO04435 GENEFORM Protein DME1422 XEOTICID XEO04435 MOACRIVE Inhibition DME1422 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1422 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1422 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04438 GENEFORM Protein DME1422 XEOTICID XEO04438 MOACRIVE Inhibition DME1422 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1422 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04439 XEO_CLAS Peptide DME1422 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04439 GENEFORM Protein DME1422 XEOTICID XEO04439 MOACRIVE Inhibition DME1422 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1422 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04440 XEO_CLAS Peptide DME1422 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 microM) DME1422 XEOTICID XEO04440 GENEFORM Protein DME1422 XEOTICID XEO04440 MOACRIVE Inhibition DME1422 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1422 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04441 XEO_CLAS Peptide DME1422 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 28 microM) DME1422 XEOTICID XEO04441 GENEFORM Protein DME1422 XEOTICID XEO04441 MOACRIVE Inhibition DME1422 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1422 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04442 XEO_CLAS Peptide DME1422 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 28 microM) DME1422 XEOTICID XEO04442 GENEFORM Protein DME1422 XEOTICID XEO04442 MOACRIVE Inhibition DME1422 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1422 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04443 XEO_CLAS Peptide DME1422 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04443 GENEFORM Protein DME1422 XEOTICID XEO04443 MOACRIVE Inhibition DME1422 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1422 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04444 XEO_CLAS Peptide DME1422 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 13 microM) DME1422 XEOTICID XEO04444 GENEFORM Protein DME1422 XEOTICID XEO04444 MOACRIVE Inhibition DME1422 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1422 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04445 XEO_CLAS Peptide DME1422 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04445 GENEFORM Protein DME1422 XEOTICID XEO04445 MOACRIVE Inhibition DME1422 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1422 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04446 XEO_CLAS Peptide DME1422 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 78 microM) DME1422 XEOTICID XEO04446 GENEFORM Protein DME1422 XEOTICID XEO04446 MOACRIVE Inhibition DME1422 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1422 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04447 XEO_CLAS Peptide DME1422 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 120 microM) DME1422 XEOTICID XEO04447 GENEFORM Protein DME1422 XEOTICID XEO04447 MOACRIVE Inhibition DME1422 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1422 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04448 XEO_CLAS Peptide DME1422 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 microM) DME1422 XEOTICID XEO04448 GENEFORM Protein DME1422 XEOTICID XEO04448 MOACRIVE Inhibition DME1422 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1422 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04449 XEO_CLAS Peptide DME1422 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.3 microM) DME1422 XEOTICID XEO04449 GENEFORM Protein DME1422 XEOTICID XEO04449 MOACRIVE Inhibition DME1422 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1422 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04450 XEO_CLAS Peptide DME1422 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.3 microM) DME1422 XEOTICID XEO04450 GENEFORM Protein DME1422 XEOTICID XEO04450 MOACRIVE Inhibition DME1422 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1422 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04451 XEO_CLAS Peptide DME1422 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO04451 GENEFORM Protein DME1422 XEOTICID XEO04451 MOACRIVE Inhibition DME1422 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1422 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04452 XEO_CLAS Peptide DME1422 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.1 microM) DME1422 XEOTICID XEO04452 GENEFORM Protein DME1422 XEOTICID XEO04452 MOACRIVE Inhibition DME1422 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1422 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04453 XEO_CLAS Peptide DME1422 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO04453 GENEFORM Protein DME1422 XEOTICID XEO04453 MOACRIVE Inhibition DME1422 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1422 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04455 XEO_CLAS Peptide DME1422 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 microM) DME1422 XEOTICID XEO04455 GENEFORM Protein DME1422 XEOTICID XEO04455 MOACRIVE Inhibition DME1422 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1422 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04457 XEO_CLAS Peptide DME1422 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.3 microM) DME1422 XEOTICID XEO04457 GENEFORM Protein DME1422 XEOTICID XEO04457 MOACRIVE Inhibition DME1422 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1422 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04458 XEO_CLAS Peptide DME1422 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1 microM) DME1422 XEOTICID XEO04458 GENEFORM Protein DME1422 XEOTICID XEO04458 MOACRIVE Inhibition DME1422 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1422 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04459 XEO_CLAS Peptide DME1422 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1 microM) DME1422 XEOTICID XEO04459 GENEFORM Protein DME1422 XEOTICID XEO04459 MOACRIVE Inhibition DME1422 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1422 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04461 XEO_CLAS Peptide DME1422 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20.8 microM) DME1422 XEOTICID XEO04461 GENEFORM Protein DME1422 XEOTICID XEO04461 MOACRIVE Inhibition DME1422 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1422 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04462 XEO_CLAS Peptide DME1422 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 19.1 microM) DME1422 XEOTICID XEO04462 GENEFORM Protein DME1422 XEOTICID XEO04462 MOACRIVE Inhibition DME1422 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1422 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04463 XEO_CLAS Peptide DME1422 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04463 GENEFORM Protein DME1422 XEOTICID XEO04463 MOACRIVE Inhibition DME1422 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1422 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04464 XEO_CLAS Peptide DME1422 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.5 microM) DME1422 XEOTICID XEO04464 GENEFORM Protein DME1422 XEOTICID XEO04464 MOACRIVE Inhibition DME1422 XEOTICID XEO04466 XEO_NAME Panusin DME1422 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04466 XEO_CLAS Peptide DME1422 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04466 GENEFORM Protein DME1422 XEOTICID XEO04466 MOACRIVE Inhibition DME1422 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1422 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04467 XEO_CLAS Peptide DME1422 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4.8 microM) DME1422 XEOTICID XEO04467 GENEFORM Protein DME1422 XEOTICID XEO04467 MOACRIVE Inhibition DME1422 XEOTICID XEO04468 XEO_NAME Papillosin DME1422 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04468 XEO_CLAS Peptide DME1422 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04468 GENEFORM Protein DME1422 XEOTICID XEO04468 MOACRIVE Inhibition DME1422 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1422 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04471 XEO_CLAS Peptide DME1422 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.1 microM) DME1422 XEOTICID XEO04471 GENEFORM Protein DME1422 XEOTICID XEO04471 MOACRIVE Inhibition DME1422 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1422 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04480 XEO_CLAS Peptide DME1422 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 ug/ml) DME1422 XEOTICID XEO04480 GENEFORM Protein DME1422 XEOTICID XEO04480 MOACRIVE Inhibition DME1422 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1422 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1422 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04482 GENEFORM Protein DME1422 XEOTICID XEO04482 MOACRIVE Inhibition DME1422 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1422 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04484 XEO_CLAS Peptide DME1422 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 microM) DME1422 XEOTICID XEO04484 GENEFORM Protein DME1422 XEOTICID XEO04484 MOACRIVE Inhibition DME1422 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1422 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04485 XEO_CLAS Peptide DME1422 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO04485 GENEFORM Protein DME1422 XEOTICID XEO04485 MOACRIVE Inhibition DME1422 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1422 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04486 XEO_CLAS Peptide DME1422 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 microM) DME1422 XEOTICID XEO04486 GENEFORM Protein DME1422 XEOTICID XEO04486 MOACRIVE Inhibition DME1422 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1422 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04487 XEO_CLAS Peptide DME1422 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO04487 GENEFORM Protein DME1422 XEOTICID XEO04487 MOACRIVE Inhibition DME1422 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1422 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04488 XEO_CLAS Peptide DME1422 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 9 microM) DME1422 XEOTICID XEO04488 GENEFORM Protein DME1422 XEOTICID XEO04488 MOACRIVE Inhibition DME1422 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1422 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04489 XEO_CLAS Peptide DME1422 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 13 microM) DME1422 XEOTICID XEO04489 GENEFORM Protein DME1422 XEOTICID XEO04489 MOACRIVE Inhibition DME1422 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1422 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04490 XEO_CLAS Peptide DME1422 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 47.5 microM) DME1422 XEOTICID XEO04490 GENEFORM Protein DME1422 XEOTICID XEO04490 MOACRIVE Inhibition DME1422 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1422 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04491 XEO_CLAS Peptide DME1422 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO04491 GENEFORM Protein DME1422 XEOTICID XEO04491 MOACRIVE Inhibition DME1422 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1422 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04492 XEO_CLAS Peptide DME1422 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 35 microM) DME1422 XEOTICID XEO04492 GENEFORM Protein DME1422 XEOTICID XEO04492 MOACRIVE Inhibition DME1422 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1422 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04493 XEO_CLAS Peptide DME1422 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 microM) DME1422 XEOTICID XEO04493 GENEFORM Protein DME1422 XEOTICID XEO04493 MOACRIVE Inhibition DME1422 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1422 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04494 XEO_CLAS Peptide DME1422 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO04494 GENEFORM Protein DME1422 XEOTICID XEO04494 MOACRIVE Inhibition DME1422 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1422 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04495 XEO_CLAS Peptide DME1422 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO04495 GENEFORM Protein DME1422 XEOTICID XEO04495 MOACRIVE Inhibition DME1422 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1422 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04496 XEO_CLAS Peptide DME1422 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 67.5 microM) DME1422 XEOTICID XEO04496 GENEFORM Protein DME1422 XEOTICID XEO04496 MOACRIVE Inhibition DME1422 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1422 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04497 XEO_CLAS Peptide DME1422 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO04497 GENEFORM Protein DME1422 XEOTICID XEO04497 MOACRIVE Inhibition DME1422 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1422 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04498 XEO_CLAS Peptide DME1422 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO04498 GENEFORM Protein DME1422 XEOTICID XEO04498 MOACRIVE Inhibition DME1422 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1422 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04499 XEO_CLAS Peptide DME1422 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 43 microM) DME1422 XEOTICID XEO04499 GENEFORM Protein DME1422 XEOTICID XEO04499 MOACRIVE Inhibition DME1422 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1422 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04500 XEO_CLAS Peptide DME1422 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO04500 GENEFORM Protein DME1422 XEOTICID XEO04500 MOACRIVE Inhibition DME1422 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1422 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04504 XEO_CLAS Peptide DME1422 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04504 GENEFORM Protein DME1422 XEOTICID XEO04504 MOACRIVE Inhibition DME1422 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1422 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04505 XEO_CLAS Peptide DME1422 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04505 GENEFORM Protein DME1422 XEOTICID XEO04505 MOACRIVE Inhibition DME1422 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1422 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04506 XEO_CLAS Peptide DME1422 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 40 microM) DME1422 XEOTICID XEO04506 GENEFORM Protein DME1422 XEOTICID XEO04506 MOACRIVE Inhibition DME1422 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1422 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04507 XEO_CLAS Peptide DME1422 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10-20 microM) DME1422 XEOTICID XEO04507 GENEFORM Protein DME1422 XEOTICID XEO04507 MOACRIVE Inhibition DME1422 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1422 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04508 XEO_CLAS Peptide DME1422 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04508 GENEFORM Protein DME1422 XEOTICID XEO04508 MOACRIVE Inhibition DME1422 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1422 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04509 XEO_CLAS Peptide DME1422 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04509 GENEFORM Protein DME1422 XEOTICID XEO04509 MOACRIVE Inhibition DME1422 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1422 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04510 XEO_CLAS Peptide DME1422 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 22-33 microM) DME1422 XEOTICID XEO04510 GENEFORM Protein DME1422 XEOTICID XEO04510 MOACRIVE Inhibition DME1422 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1422 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04525 XEO_CLAS Peptide DME1422 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 32.0 microM) DME1422 XEOTICID XEO04525 GENEFORM Protein DME1422 XEOTICID XEO04525 MOACRIVE Inhibition DME1422 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1422 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04526 XEO_CLAS Peptide DME1422 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.0 microM) DME1422 XEOTICID XEO04526 GENEFORM Protein DME1422 XEOTICID XEO04526 MOACRIVE Inhibition DME1422 XEOTICID XEO04527 XEO_NAME Pepcon DME1422 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04527 XEO_CLAS Peptide DME1422 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO04527 GENEFORM Protein DME1422 XEOTICID XEO04527 MOACRIVE Inhibition DME1422 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1422 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04532 XEO_CLAS Peptide DME1422 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04532 GENEFORM Protein DME1422 XEOTICID XEO04532 MOACRIVE Inhibition DME1422 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1422 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04540 XEO_CLAS Peptide DME1422 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 18.1 ug/ml) DME1422 XEOTICID XEO04540 GENEFORM Protein DME1422 XEOTICID XEO04540 MOACRIVE Inhibition DME1422 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1422 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04541 XEO_CLAS Peptide DME1422 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.5 ug/ml) DME1422 XEOTICID XEO04541 GENEFORM Protein DME1422 XEOTICID XEO04541 MOACRIVE Inhibition DME1422 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1422 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04542 XEO_CLAS Peptide DME1422 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04542 GENEFORM Protein DME1422 XEOTICID XEO04542 MOACRIVE Inhibition DME1422 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1422 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04543 XEO_CLAS Peptide DME1422 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04543 GENEFORM Protein DME1422 XEOTICID XEO04543 MOACRIVE Inhibition DME1422 XEOTICID XEO04546 XEO_NAME Perinerin DME1422 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04546 XEO_CLAS Peptide DME1422 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04546 GENEFORM Protein DME1422 XEOTICID XEO04546 MOACRIVE Inhibition DME1422 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1422 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04548 XEO_CLAS Peptide DME1422 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 72000 ug/ml) DME1422 XEOTICID XEO04548 GENEFORM Protein DME1422 XEOTICID XEO04548 MOACRIVE Inhibition DME1422 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1422 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04549 XEO_CLAS Peptide DME1422 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 62-125 ug/ml) DME1422 XEOTICID XEO04549 GENEFORM Protein DME1422 XEOTICID XEO04549 MOACRIVE Inhibition DME1422 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1422 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04550 XEO_CLAS Peptide DME1422 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO04550 GENEFORM Protein DME1422 XEOTICID XEO04550 MOACRIVE Inhibition DME1422 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1422 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04551 XEO_CLAS Peptide DME1422 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 23.6 ug/ml) DME1422 XEOTICID XEO04551 GENEFORM Protein DME1422 XEOTICID XEO04551 MOACRIVE Inhibition DME1422 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1422 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04552 XEO_CLAS Peptide DME1422 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04552 GENEFORM Protein DME1422 XEOTICID XEO04552 MOACRIVE Inhibition DME1422 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1422 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04553 XEO_CLAS Peptide DME1422 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04553 GENEFORM Protein DME1422 XEOTICID XEO04553 MOACRIVE Inhibition DME1422 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1422 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04554 XEO_CLAS Peptide DME1422 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04554 GENEFORM Protein DME1422 XEOTICID XEO04554 MOACRIVE Inhibition DME1422 XEOTICID XEO04563 XEO_NAME Phosphate DME1422 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1422 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04563 GENEFORM Protein DME1422 XEOTICID XEO04563 MOACRIVE Inhibition DME1422 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1422 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04565 XEO_CLAS Peptide DME1422 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.5 microM) DME1422 XEOTICID XEO04565 GENEFORM Protein DME1422 XEOTICID XEO04565 MOACRIVE Inhibition DME1422 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1422 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04566 XEO_CLAS Peptide DME1422 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.7 microM) DME1422 XEOTICID XEO04566 GENEFORM Protein DME1422 XEOTICID XEO04566 MOACRIVE Inhibition DME1422 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1422 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04569 XEO_CLAS Peptide DME1422 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 7.9 microM) DME1422 XEOTICID XEO04569 GENEFORM Protein DME1422 XEOTICID XEO04569 MOACRIVE Inhibition DME1422 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1422 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04570 XEO_CLAS Peptide DME1422 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04570 GENEFORM Protein DME1422 XEOTICID XEO04570 MOACRIVE Inhibition DME1422 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1422 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04571 XEO_CLAS Peptide DME1422 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04571 GENEFORM Protein DME1422 XEOTICID XEO04571 MOACRIVE Inhibition DME1422 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1422 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04572 XEO_CLAS Peptide DME1422 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04572 GENEFORM Protein DME1422 XEOTICID XEO04572 MOACRIVE Inhibition DME1422 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1422 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04573 XEO_CLAS Peptide DME1422 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 microM) DME1422 XEOTICID XEO04573 GENEFORM Protein DME1422 XEOTICID XEO04573 MOACRIVE Inhibition DME1422 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1422 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04574 XEO_CLAS Peptide DME1422 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 128 ug/ml) DME1422 XEOTICID XEO04574 GENEFORM Protein DME1422 XEOTICID XEO04574 MOACRIVE Inhibition DME1422 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1422 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04575 XEO_CLAS Peptide DME1422 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO04575 GENEFORM Protein DME1422 XEOTICID XEO04575 MOACRIVE Inhibition DME1422 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1422 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04578 GENEFORM Protein DME1422 XEOTICID XEO04578 MOACRIVE Inhibition DME1422 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1422 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04579 GENEFORM Protein DME1422 XEOTICID XEO04579 MOACRIVE Inhibition DME1422 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1422 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04580 GENEFORM Protein DME1422 XEOTICID XEO04580 MOACRIVE Inhibition DME1422 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1422 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04583 GENEFORM Protein DME1422 XEOTICID XEO04583 MOACRIVE Inhibition DME1422 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1422 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04588 GENEFORM Protein DME1422 XEOTICID XEO04588 MOACRIVE Inhibition DME1422 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1422 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04589 GENEFORM Protein DME1422 XEOTICID XEO04589 MOACRIVE Inhibition DME1422 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1422 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04590 GENEFORM Protein DME1422 XEOTICID XEO04590 MOACRIVE Inhibition DME1422 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1422 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04591 GENEFORM Protein DME1422 XEOTICID XEO04591 MOACRIVE Inhibition DME1422 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1422 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04592 GENEFORM Protein DME1422 XEOTICID XEO04592 MOACRIVE Inhibition DME1422 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1422 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04593 GENEFORM Protein DME1422 XEOTICID XEO04593 MOACRIVE Inhibition DME1422 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1422 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04594 GENEFORM Protein DME1422 XEOTICID XEO04594 MOACRIVE Inhibition DME1422 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1422 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04595 GENEFORM Protein DME1422 XEOTICID XEO04595 MOACRIVE Inhibition DME1422 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1422 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04596 GENEFORM Protein DME1422 XEOTICID XEO04596 MOACRIVE Inhibition DME1422 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1422 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04597 GENEFORM Protein DME1422 XEOTICID XEO04597 MOACRIVE Inhibition DME1422 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1422 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04598 GENEFORM Protein DME1422 XEOTICID XEO04598 MOACRIVE Inhibition DME1422 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1422 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04599 GENEFORM Protein DME1422 XEOTICID XEO04599 MOACRIVE Inhibition DME1422 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1422 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04601 XEO_CLAS Peptide DME1422 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 18.75 ug/ml) DME1422 XEOTICID XEO04601 GENEFORM Protein DME1422 XEOTICID XEO04601 MOACRIVE Inhibition DME1422 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1422 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04602 XEO_CLAS Peptide DME1422 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 37.5 ug/ml) DME1422 XEOTICID XEO04602 GENEFORM Protein DME1422 XEOTICID XEO04602 MOACRIVE Inhibition DME1422 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1422 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04604 XEO_CLAS Peptide DME1422 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC < 25 microM) DME1422 XEOTICID XEO04604 GENEFORM Protein DME1422 XEOTICID XEO04604 MOACRIVE Inhibition DME1422 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1422 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04605 XEO_CLAS Peptide DME1422 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC < 6.25 microM) DME1422 XEOTICID XEO04605 GENEFORM Protein DME1422 XEOTICID XEO04605 MOACRIVE Inhibition DME1422 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1422 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04606 XEO_CLAS Peptide DME1422 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO04606 GENEFORM Protein DME1422 XEOTICID XEO04606 MOACRIVE Inhibition DME1422 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1422 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1422 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04607 GENEFORM Protein DME1422 XEOTICID XEO04607 MOACRIVE Inhibition DME1422 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1422 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04612 XEO_CLAS Peptide DME1422 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5-10 microM) DME1422 XEOTICID XEO04612 GENEFORM Protein DME1422 XEOTICID XEO04612 MOACRIVE Inhibition DME1422 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1422 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04613 XEO_CLAS Peptide DME1422 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5-10 microM) DME1422 XEOTICID XEO04613 GENEFORM Protein DME1422 XEOTICID XEO04613 MOACRIVE Inhibition DME1422 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1422 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04625 XEO_CLAS Peptide DME1422 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO04625 GENEFORM Protein DME1422 XEOTICID XEO04625 MOACRIVE Inhibition DME1422 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1422 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04626 XEO_CLAS Peptide DME1422 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO04626 GENEFORM Protein DME1422 XEOTICID XEO04626 MOACRIVE Inhibition DME1422 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1422 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04627 XEO_CLAS Peptide DME1422 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.5 microM) DME1422 XEOTICID XEO04627 GENEFORM Protein DME1422 XEOTICID XEO04627 MOACRIVE Inhibition DME1422 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1422 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04630 XEO_CLAS Peptide DME1422 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 60 ug/ml) DME1422 XEOTICID XEO04630 GENEFORM Protein DME1422 XEOTICID XEO04630 MOACRIVE Inhibition DME1422 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1422 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04631 XEO_CLAS Peptide DME1422 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 60 ug/ml) DME1422 XEOTICID XEO04631 GENEFORM Protein DME1422 XEOTICID XEO04631 MOACRIVE Inhibition DME1422 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1422 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04633 XEO_CLAS Peptide DME1422 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 ug/ml) DME1422 XEOTICID XEO04633 GENEFORM Protein DME1422 XEOTICID XEO04633 MOACRIVE Inhibition DME1422 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1422 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04634 XEO_CLAS Peptide DME1422 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 ug/ml) DME1422 XEOTICID XEO04634 GENEFORM Protein DME1422 XEOTICID XEO04634 MOACRIVE Inhibition DME1422 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1422 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04635 XEO_CLAS Peptide DME1422 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 ug/ml) DME1422 XEOTICID XEO04635 GENEFORM Protein DME1422 XEOTICID XEO04635 MOACRIVE Inhibition DME1422 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1422 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04636 XEO_CLAS Peptide DME1422 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 ug/ml) DME1422 XEOTICID XEO04636 GENEFORM Protein DME1422 XEOTICID XEO04636 MOACRIVE Inhibition DME1422 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1422 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04637 XEO_CLAS Peptide DME1422 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 ug/ml) DME1422 XEOTICID XEO04637 GENEFORM Protein DME1422 XEOTICID XEO04637 MOACRIVE Inhibition DME1422 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1422 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04638 XEO_CLAS Peptide DME1422 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 ug/ml) DME1422 XEOTICID XEO04638 GENEFORM Protein DME1422 XEOTICID XEO04638 MOACRIVE Inhibition DME1422 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1422 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04639 XEO_CLAS Peptide DME1422 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 ug/ml) DME1422 XEOTICID XEO04639 GENEFORM Protein DME1422 XEOTICID XEO04639 MOACRIVE Inhibition DME1422 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1422 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04640 XEO_CLAS Peptide DME1422 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.2-3.3 microM) DME1422 XEOTICID XEO04640 GENEFORM Protein DME1422 XEOTICID XEO04640 MOACRIVE Inhibition DME1422 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1422 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04642 XEO_CLAS Peptide DME1422 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 ug/ml) DME1422 XEOTICID XEO04642 GENEFORM Protein DME1422 XEOTICID XEO04642 MOACRIVE Inhibition DME1422 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1422 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04643 XEO_CLAS Peptide DME1422 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO04643 GENEFORM Protein DME1422 XEOTICID XEO04643 MOACRIVE Inhibition DME1422 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1422 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04644 XEO_CLAS Peptide DME1422 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO04644 GENEFORM Protein DME1422 XEOTICID XEO04644 MOACRIVE Inhibition DME1422 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1422 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04645 XEO_CLAS Peptide DME1422 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 ug/ml) DME1422 XEOTICID XEO04645 GENEFORM Protein DME1422 XEOTICID XEO04645 MOACRIVE Inhibition DME1422 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1422 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04646 XEO_CLAS Peptide DME1422 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1 ug/ml) DME1422 XEOTICID XEO04646 GENEFORM Protein DME1422 XEOTICID XEO04646 MOACRIVE Inhibition DME1422 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1422 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04647 XEO_CLAS Peptide DME1422 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO04647 GENEFORM Protein DME1422 XEOTICID XEO04647 MOACRIVE Inhibition DME1422 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1422 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04648 XEO_CLAS Peptide DME1422 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 ug/ml) DME1422 XEOTICID XEO04648 GENEFORM Protein DME1422 XEOTICID XEO04648 MOACRIVE Inhibition DME1422 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1422 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04649 XEO_CLAS Peptide DME1422 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 64 ug/ml) DME1422 XEOTICID XEO04649 GENEFORM Protein DME1422 XEOTICID XEO04649 MOACRIVE Inhibition DME1422 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1422 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04650 XEO_CLAS Peptide DME1422 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 ug/ml) DME1422 XEOTICID XEO04650 GENEFORM Protein DME1422 XEOTICID XEO04650 MOACRIVE Inhibition DME1422 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1422 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04651 XEO_CLAS Peptide DME1422 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 ug/ml) DME1422 XEOTICID XEO04651 GENEFORM Protein DME1422 XEOTICID XEO04651 MOACRIVE Inhibition DME1422 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1422 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04652 XEO_CLAS Peptide DME1422 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO04652 GENEFORM Protein DME1422 XEOTICID XEO04652 MOACRIVE Inhibition DME1422 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1422 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04653 XEO_CLAS Peptide DME1422 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 64 ug/ml) DME1422 XEOTICID XEO04653 GENEFORM Protein DME1422 XEOTICID XEO04653 MOACRIVE Inhibition DME1422 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1422 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04654 XEO_CLAS Peptide DME1422 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 ug/ml) DME1422 XEOTICID XEO04654 GENEFORM Protein DME1422 XEOTICID XEO04654 MOACRIVE Inhibition DME1422 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1422 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04655 XEO_CLAS Peptide DME1422 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO04655 GENEFORM Protein DME1422 XEOTICID XEO04655 MOACRIVE Inhibition DME1422 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1422 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04657 XEO_CLAS Peptide DME1422 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 300 microM) DME1422 XEOTICID XEO04657 GENEFORM Protein DME1422 XEOTICID XEO04657 MOACRIVE Inhibition DME1422 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1422 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04660 XEO_CLAS Peptide DME1422 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO04660 GENEFORM Protein DME1422 XEOTICID XEO04660 MOACRIVE Inhibition DME1422 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1422 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04661 XEO_CLAS Peptide DME1422 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 microM) DME1422 XEOTICID XEO04661 GENEFORM Protein DME1422 XEOTICID XEO04661 MOACRIVE Inhibition DME1422 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1422 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04662 XEO_CLAS Peptide DME1422 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 microM) DME1422 XEOTICID XEO04662 GENEFORM Protein DME1422 XEOTICID XEO04662 MOACRIVE Inhibition DME1422 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1422 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04663 XEO_CLAS Peptide DME1422 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 microM) DME1422 XEOTICID XEO04663 GENEFORM Protein DME1422 XEOTICID XEO04663 MOACRIVE Inhibition DME1422 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1422 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04664 XEO_CLAS Peptide DME1422 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5.5 microM) DME1422 XEOTICID XEO04664 GENEFORM Protein DME1422 XEOTICID XEO04664 MOACRIVE Inhibition DME1422 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1422 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04665 XEO_CLAS Peptide DME1422 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 microM) DME1422 XEOTICID XEO04665 GENEFORM Protein DME1422 XEOTICID XEO04665 MOACRIVE Inhibition DME1422 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1422 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04666 XEO_CLAS Peptide DME1422 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO04666 GENEFORM Protein DME1422 XEOTICID XEO04666 MOACRIVE Inhibition DME1422 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1422 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04667 XEO_CLAS Peptide DME1422 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6.25 microM) DME1422 XEOTICID XEO04667 GENEFORM Protein DME1422 XEOTICID XEO04667 MOACRIVE Inhibition DME1422 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1422 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04668 XEO_CLAS Peptide DME1422 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 microM) DME1422 XEOTICID XEO04668 GENEFORM Protein DME1422 XEOTICID XEO04668 MOACRIVE Inhibition DME1422 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1422 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04669 XEO_CLAS Peptide DME1422 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO04669 GENEFORM Protein DME1422 XEOTICID XEO04669 MOACRIVE Inhibition DME1422 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1422 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04670 XEO_CLAS Peptide DME1422 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 21 microM) DME1422 XEOTICID XEO04670 GENEFORM Protein DME1422 XEOTICID XEO04670 MOACRIVE Inhibition DME1422 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1422 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04671 XEO_CLAS Peptide DME1422 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 62 microM) DME1422 XEOTICID XEO04671 GENEFORM Protein DME1422 XEOTICID XEO04671 MOACRIVE Inhibition DME1422 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1422 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04672 XEO_CLAS Peptide DME1422 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO04672 GENEFORM Protein DME1422 XEOTICID XEO04672 MOACRIVE Inhibition DME1422 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1422 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04673 XEO_CLAS Peptide DME1422 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO04673 GENEFORM Protein DME1422 XEOTICID XEO04673 MOACRIVE Inhibition DME1422 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1422 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04674 XEO_CLAS Peptide DME1422 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 75 microM) DME1422 XEOTICID XEO04674 GENEFORM Protein DME1422 XEOTICID XEO04674 MOACRIVE Inhibition DME1422 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1422 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04675 XEO_CLAS Peptide DME1422 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 microM) DME1422 XEOTICID XEO04675 GENEFORM Protein DME1422 XEOTICID XEO04675 MOACRIVE Inhibition DME1422 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1422 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04676 XEO_CLAS Peptide DME1422 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 microM) DME1422 XEOTICID XEO04676 GENEFORM Protein DME1422 XEOTICID XEO04676 MOACRIVE Inhibition DME1422 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1422 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04677 XEO_CLAS Peptide DME1422 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO04677 GENEFORM Protein DME1422 XEOTICID XEO04677 MOACRIVE Inhibition DME1422 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1422 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04680 XEO_CLAS Peptide DME1422 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 microM) DME1422 XEOTICID XEO04680 GENEFORM Protein DME1422 XEOTICID XEO04680 MOACRIVE Inhibition DME1422 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1422 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04682 XEO_CLAS Peptide DME1422 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 microM) DME1422 XEOTICID XEO04682 GENEFORM Protein DME1422 XEOTICID XEO04682 MOACRIVE Inhibition DME1422 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1422 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04683 XEO_CLAS Peptide DME1422 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 microM) DME1422 XEOTICID XEO04683 GENEFORM Protein DME1422 XEOTICID XEO04683 MOACRIVE Inhibition DME1422 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1422 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04684 XEO_CLAS Peptide DME1422 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 38 microM) DME1422 XEOTICID XEO04684 GENEFORM Protein DME1422 XEOTICID XEO04684 MOACRIVE Inhibition DME1422 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1422 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04690 XEO_CLAS Peptide DME1422 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.5 ug/ml) DME1422 XEOTICID XEO04690 GENEFORM Protein DME1422 XEOTICID XEO04690 MOACRIVE Inhibition DME1422 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1422 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04695 XEO_CLAS Peptide DME1422 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04695 GENEFORM Protein DME1422 XEOTICID XEO04695 MOACRIVE Inhibition DME1422 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1422 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04696 XEO_CLAS Peptide DME1422 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04696 GENEFORM Protein DME1422 XEOTICID XEO04696 MOACRIVE Inhibition DME1422 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1422 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04712 XEO_CLAS Peptide DME1422 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16.7 microM) DME1422 XEOTICID XEO04712 GENEFORM Protein DME1422 XEOTICID XEO04712 MOACRIVE Inhibition DME1422 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1422 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04713 XEO_CLAS Peptide DME1422 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16.7 microM) DME1422 XEOTICID XEO04713 GENEFORM Protein DME1422 XEOTICID XEO04713 MOACRIVE Inhibition DME1422 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1422 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04714 XEO_CLAS Peptide DME1422 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 23.3 microM) DME1422 XEOTICID XEO04714 GENEFORM Protein DME1422 XEOTICID XEO04714 MOACRIVE Inhibition DME1422 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1422 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04716 XEO_CLAS Peptide DME1422 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 microM) DME1422 XEOTICID XEO04716 GENEFORM Protein DME1422 XEOTICID XEO04716 MOACRIVE Inhibition DME1422 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1422 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04717 XEO_CLAS Peptide DME1422 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 50 microM) DME1422 XEOTICID XEO04717 GENEFORM Protein DME1422 XEOTICID XEO04717 MOACRIVE Inhibition DME1422 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1422 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04725 XEO_CLAS Peptide DME1422 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04725 GENEFORM Protein DME1422 XEOTICID XEO04725 MOACRIVE Inhibition DME1422 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1422 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04726 XEO_CLAS Peptide DME1422 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04726 GENEFORM Protein DME1422 XEOTICID XEO04726 MOACRIVE Inhibition DME1422 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1422 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04731 XEO_CLAS Peptide DME1422 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 ug/ml) DME1422 XEOTICID XEO04731 GENEFORM Protein DME1422 XEOTICID XEO04731 MOACRIVE Inhibition DME1422 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1422 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04732 XEO_CLAS Peptide DME1422 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 25 ug/ml) DME1422 XEOTICID XEO04732 GENEFORM Protein DME1422 XEOTICID XEO04732 MOACRIVE Inhibition DME1422 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1422 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04733 XEO_CLAS Peptide DME1422 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04733 GENEFORM Protein DME1422 XEOTICID XEO04733 MOACRIVE Inhibition DME1422 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1422 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04734 XEO_CLAS Peptide DME1422 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04734 GENEFORM Protein DME1422 XEOTICID XEO04734 MOACRIVE Inhibition DME1422 XEOTICID XEO04737 XEO_NAME Protonectin DME1422 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04737 XEO_CLAS Peptide DME1422 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 ug/ml) DME1422 XEOTICID XEO04737 GENEFORM Protein DME1422 XEOTICID XEO04737 MOACRIVE Inhibition DME1422 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1422 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04739 XEO_CLAS Peptide DME1422 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04739 GENEFORM Protein DME1422 XEOTICID XEO04739 MOACRIVE Inhibition DME1422 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1422 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04740 XEO_CLAS Peptide DME1422 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04740 GENEFORM Protein DME1422 XEOTICID XEO04740 MOACRIVE Inhibition DME1422 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1422 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04741 XEO_CLAS Peptide DME1422 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04741 GENEFORM Protein DME1422 XEOTICID XEO04741 MOACRIVE Inhibition DME1422 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1422 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04742 XEO_CLAS Peptide DME1422 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04742 GENEFORM Protein DME1422 XEOTICID XEO04742 MOACRIVE Inhibition DME1422 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1422 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04762 XEO_CLAS Peptide DME1422 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.8 microM) DME1422 XEOTICID XEO04762 GENEFORM Protein DME1422 XEOTICID XEO04762 MOACRIVE Inhibition DME1422 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1422 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04766 XEO_CLAS Peptide DME1422 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.1 microM) DME1422 XEOTICID XEO04766 GENEFORM Protein DME1422 XEOTICID XEO04766 MOACRIVE Inhibition DME1422 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1422 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04767 XEO_CLAS Peptide DME1422 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.1 ug/ml) DME1422 XEOTICID XEO04767 GENEFORM Protein DME1422 XEOTICID XEO04767 MOACRIVE Inhibition DME1422 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1422 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04779 XEO_CLAS Peptide DME1422 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04779 GENEFORM Protein DME1422 XEOTICID XEO04779 MOACRIVE Inhibition DME1422 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1422 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04780 XEO_CLAS Peptide DME1422 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04780 GENEFORM Protein DME1422 XEOTICID XEO04780 MOACRIVE Inhibition DME1422 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1422 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04781 XEO_CLAS Peptide DME1422 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04781 GENEFORM Protein DME1422 XEOTICID XEO04781 MOACRIVE Inhibition DME1422 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1422 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04782 XEO_CLAS Peptide DME1422 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 ug/ml) DME1422 XEOTICID XEO04782 GENEFORM Protein DME1422 XEOTICID XEO04782 MOACRIVE Inhibition DME1422 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1422 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04783 XEO_CLAS Peptide DME1422 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO04783 GENEFORM Protein DME1422 XEOTICID XEO04783 MOACRIVE Inhibition DME1422 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1422 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04784 XEO_CLAS Peptide DME1422 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO04784 GENEFORM Protein DME1422 XEOTICID XEO04784 MOACRIVE Inhibition DME1422 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1422 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04785 XEO_CLAS Peptide DME1422 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO04785 GENEFORM Protein DME1422 XEOTICID XEO04785 MOACRIVE Inhibition DME1422 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1422 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04786 XEO_CLAS Peptide DME1422 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 ug/ml) DME1422 XEOTICID XEO04786 GENEFORM Protein DME1422 XEOTICID XEO04786 MOACRIVE Inhibition DME1422 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1422 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04787 XEO_CLAS Peptide DME1422 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04787 GENEFORM Protein DME1422 XEOTICID XEO04787 MOACRIVE Inhibition DME1422 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1422 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04793 XEO_CLAS Peptide DME1422 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04793 GENEFORM Protein DME1422 XEOTICID XEO04793 MOACRIVE Inhibition DME1422 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1422 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04798 XEO_CLAS Peptide DME1422 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 microM) DME1422 XEOTICID XEO04798 GENEFORM Protein DME1422 XEOTICID XEO04798 MOACRIVE Inhibition DME1422 XEOTICID XEO04799 XEO_NAME Ranalexin DME1422 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04799 XEO_CLAS Peptide DME1422 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 32 ug/ml) DME1422 XEOTICID XEO04799 GENEFORM Protein DME1422 XEOTICID XEO04799 MOACRIVE Inhibition DME1422 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1422 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04800 XEO_CLAS Peptide DME1422 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 microM) DME1422 XEOTICID XEO04800 GENEFORM Protein DME1422 XEOTICID XEO04800 MOACRIVE Inhibition DME1422 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1422 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04801 XEO_CLAS Peptide DME1422 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 9 microM) DME1422 XEOTICID XEO04801 GENEFORM Protein DME1422 XEOTICID XEO04801 MOACRIVE Inhibition DME1422 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1422 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04802 XEO_CLAS Peptide DME1422 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12 microM) DME1422 XEOTICID XEO04802 GENEFORM Protein DME1422 XEOTICID XEO04802 MOACRIVE Inhibition DME1422 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1422 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04803 XEO_CLAS Peptide DME1422 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO04803 GENEFORM Protein DME1422 XEOTICID XEO04803 MOACRIVE Inhibition DME1422 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1422 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04804 XEO_CLAS Peptide DME1422 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO04804 GENEFORM Protein DME1422 XEOTICID XEO04804 MOACRIVE Inhibition DME1422 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1422 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04805 XEO_CLAS Peptide DME1422 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.5 microM) DME1422 XEOTICID XEO04805 GENEFORM Protein DME1422 XEOTICID XEO04805 MOACRIVE Inhibition DME1422 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1422 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04806 XEO_CLAS Peptide DME1422 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.5 microM) DME1422 XEOTICID XEO04806 GENEFORM Protein DME1422 XEOTICID XEO04806 MOACRIVE Inhibition DME1422 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1422 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04807 XEO_CLAS Peptide DME1422 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04807 GENEFORM Protein DME1422 XEOTICID XEO04807 MOACRIVE Inhibition DME1422 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1422 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04809 XEO_CLAS Peptide DME1422 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 microM) DME1422 XEOTICID XEO04809 GENEFORM Protein DME1422 XEOTICID XEO04809 MOACRIVE Inhibition DME1422 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1422 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04811 XEO_CLAS Peptide DME1422 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO04811 GENEFORM Protein DME1422 XEOTICID XEO04811 MOACRIVE Inhibition DME1422 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1422 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04812 XEO_CLAS Peptide DME1422 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO04812 GENEFORM Protein DME1422 XEOTICID XEO04812 MOACRIVE Inhibition DME1422 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1422 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04813 XEO_CLAS Peptide DME1422 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 microM) DME1422 XEOTICID XEO04813 GENEFORM Protein DME1422 XEOTICID XEO04813 MOACRIVE Inhibition DME1422 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1422 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04814 XEO_CLAS Peptide DME1422 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 19 microM) DME1422 XEOTICID XEO04814 GENEFORM Protein DME1422 XEOTICID XEO04814 MOACRIVE Inhibition DME1422 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1422 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04815 XEO_CLAS Peptide DME1422 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 microM) DME1422 XEOTICID XEO04815 GENEFORM Protein DME1422 XEOTICID XEO04815 MOACRIVE Inhibition DME1422 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1422 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04816 XEO_CLAS Peptide DME1422 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 microM) DME1422 XEOTICID XEO04816 GENEFORM Protein DME1422 XEOTICID XEO04816 MOACRIVE Inhibition DME1422 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1422 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04817 XEO_CLAS Peptide DME1422 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 13 microM) DME1422 XEOTICID XEO04817 GENEFORM Protein DME1422 XEOTICID XEO04817 MOACRIVE Inhibition DME1422 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1422 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04818 XEO_CLAS Peptide DME1422 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO04818 GENEFORM Protein DME1422 XEOTICID XEO04818 MOACRIVE Inhibition DME1422 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1422 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04819 XEO_CLAS Peptide DME1422 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO04819 GENEFORM Protein DME1422 XEOTICID XEO04819 MOACRIVE Inhibition DME1422 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1422 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04820 XEO_CLAS Peptide DME1422 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3 microM) DME1422 XEOTICID XEO04820 GENEFORM Protein DME1422 XEOTICID XEO04820 MOACRIVE Inhibition DME1422 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1422 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04821 XEO_CLAS Peptide DME1422 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 microM) DME1422 XEOTICID XEO04821 GENEFORM Protein DME1422 XEOTICID XEO04821 MOACRIVE Inhibition DME1422 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1422 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04822 XEO_CLAS Peptide DME1422 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO04822 GENEFORM Protein DME1422 XEOTICID XEO04822 MOACRIVE Inhibition DME1422 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1422 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04823 XEO_CLAS Peptide DME1422 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 23 microM) DME1422 XEOTICID XEO04823 GENEFORM Protein DME1422 XEOTICID XEO04823 MOACRIVE Inhibition DME1422 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1422 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04824 XEO_CLAS Peptide DME1422 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04824 GENEFORM Protein DME1422 XEOTICID XEO04824 MOACRIVE Inhibition DME1422 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1422 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04825 XEO_CLAS Peptide DME1422 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04825 GENEFORM Protein DME1422 XEOTICID XEO04825 MOACRIVE Inhibition DME1422 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1422 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04826 XEO_CLAS Peptide DME1422 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO04826 GENEFORM Protein DME1422 XEOTICID XEO04826 MOACRIVE Inhibition DME1422 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1422 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04827 XEO_CLAS Peptide DME1422 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO04827 GENEFORM Protein DME1422 XEOTICID XEO04827 MOACRIVE Inhibition DME1422 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1422 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04835 XEO_CLAS Peptide DME1422 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04835 GENEFORM Protein DME1422 XEOTICID XEO04835 MOACRIVE Inhibition DME1422 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1422 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04836 XEO_CLAS Peptide DME1422 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04836 GENEFORM Protein DME1422 XEOTICID XEO04836 MOACRIVE Inhibition DME1422 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1422 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04837 XEO_CLAS Peptide DME1422 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 microM) DME1422 XEOTICID XEO04837 GENEFORM Protein DME1422 XEOTICID XEO04837 MOACRIVE Inhibition DME1422 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1422 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04839 XEO_CLAS Peptide DME1422 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04839 GENEFORM Protein DME1422 XEOTICID XEO04839 MOACRIVE Inhibition DME1422 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1422 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04840 XEO_CLAS Peptide DME1422 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 35-20 microM) DME1422 XEOTICID XEO04840 GENEFORM Protein DME1422 XEOTICID XEO04840 MOACRIVE Inhibition DME1422 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1422 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04847 XEO_CLAS Peptide DME1422 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04847 GENEFORM Protein DME1422 XEOTICID XEO04847 MOACRIVE Inhibition DME1422 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1422 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04848 XEO_CLAS Peptide DME1422 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04848 GENEFORM Protein DME1422 XEOTICID XEO04848 MOACRIVE Inhibition DME1422 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1422 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04849 XEO_CLAS Peptide DME1422 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04849 GENEFORM Protein DME1422 XEOTICID XEO04849 MOACRIVE Inhibition DME1422 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1422 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04850 XEO_CLAS Peptide DME1422 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04850 GENEFORM Protein DME1422 XEOTICID XEO04850 MOACRIVE Inhibition DME1422 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1422 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04851 XEO_CLAS Peptide DME1422 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1 ug/ml) DME1422 XEOTICID XEO04851 GENEFORM Protein DME1422 XEOTICID XEO04851 MOACRIVE Inhibition DME1422 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1422 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04857 XEO_CLAS Peptide DME1422 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 microM) DME1422 XEOTICID XEO04857 GENEFORM Protein DME1422 XEOTICID XEO04857 MOACRIVE Inhibition DME1422 XEOTICID XEO04863 XEO_NAME RTD peptide DME1422 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04863 XEO_CLAS Peptide DME1422 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.0 microM) DME1422 XEOTICID XEO04863 GENEFORM Protein DME1422 XEOTICID XEO04863 MOACRIVE Inhibition DME1422 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1422 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04865 XEO_CLAS Peptide DME1422 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 ug/ml) DME1422 XEOTICID XEO04865 GENEFORM Protein DME1422 XEOTICID XEO04865 MOACRIVE Inhibition DME1422 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1422 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04866 XEO_CLAS Peptide DME1422 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12.5 ug/ml) DME1422 XEOTICID XEO04866 GENEFORM Protein DME1422 XEOTICID XEO04866 MOACRIVE Inhibition DME1422 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1422 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04868 XEO_CLAS Peptide DME1422 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25.00 ug/ml) DME1422 XEOTICID XEO04868 GENEFORM Protein DME1422 XEOTICID XEO04868 MOACRIVE Inhibition DME1422 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1422 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04869 XEO_CLAS Peptide DME1422 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25.00 ug/ml) DME1422 XEOTICID XEO04869 GENEFORM Protein DME1422 XEOTICID XEO04869 MOACRIVE Inhibition DME1422 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1422 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04870 XEO_CLAS Peptide DME1422 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25.00 ug/ml) DME1422 XEOTICID XEO04870 GENEFORM Protein DME1422 XEOTICID XEO04870 MOACRIVE Inhibition DME1422 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1422 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04877 XEO_CLAS Peptide DME1422 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04877 GENEFORM Protein DME1422 XEOTICID XEO04877 MOACRIVE Inhibition DME1422 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1422 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04880 XEO_CLAS Peptide DME1422 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.5 ug/ml) DME1422 XEOTICID XEO04880 GENEFORM Protein DME1422 XEOTICID XEO04880 MOACRIVE Inhibition DME1422 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1422 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04886 XEO_CLAS Peptide DME1422 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.6 ug/ml) DME1422 XEOTICID XEO04886 GENEFORM Protein DME1422 XEOTICID XEO04886 MOACRIVE Inhibition DME1422 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1422 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04891 XEO_CLAS Peptide DME1422 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04891 GENEFORM Protein DME1422 XEOTICID XEO04891 MOACRIVE Inhibition DME1422 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1422 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04895 XEO_CLAS Peptide DME1422 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04895 GENEFORM Protein DME1422 XEOTICID XEO04895 MOACRIVE Inhibition DME1422 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1422 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04901 XEO_CLAS Peptide DME1422 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 microM) DME1422 XEOTICID XEO04901 GENEFORM Protein DME1422 XEOTICID XEO04901 MOACRIVE Inhibition DME1422 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1422 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04904 XEO_CLAS Peptide DME1422 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 78 ug/ml) DME1422 XEOTICID XEO04904 GENEFORM Protein DME1422 XEOTICID XEO04904 MOACRIVE Inhibition DME1422 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1422 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04905 XEO_CLAS Peptide DME1422 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04905 GENEFORM Protein DME1422 XEOTICID XEO04905 MOACRIVE Inhibition DME1422 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1422 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04906 XEO_CLAS Peptide DME1422 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04906 GENEFORM Protein DME1422 XEOTICID XEO04906 MOACRIVE Inhibition DME1422 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1422 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04907 XEO_CLAS Peptide DME1422 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04907 GENEFORM Protein DME1422 XEOTICID XEO04907 MOACRIVE Inhibition DME1422 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1422 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04908 XEO_CLAS Peptide DME1422 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04908 GENEFORM Protein DME1422 XEOTICID XEO04908 MOACRIVE Inhibition DME1422 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1422 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04909 XEO_CLAS Peptide DME1422 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04909 GENEFORM Protein DME1422 XEOTICID XEO04909 MOACRIVE Inhibition DME1422 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1422 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04915 XEO_CLAS Peptide DME1422 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 100 ug/ml) DME1422 XEOTICID XEO04915 GENEFORM Protein DME1422 XEOTICID XEO04915 MOACRIVE Inhibition DME1422 XEOTICID XEO04916 XEO_NAME Scopoletin DME1422 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1422 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04916 GENEFORM Protein DME1422 XEOTICID XEO04916 MOACRIVE Inhibition DME1422 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1422 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04926 XEO_CLAS Peptide DME1422 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04926 GENEFORM Protein DME1422 XEOTICID XEO04926 MOACRIVE Inhibition DME1422 XEOTICID XEO04931 XEO_NAME Shepherin I DME1422 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04931 XEO_CLAS Peptide DME1422 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04931 GENEFORM Protein DME1422 XEOTICID XEO04931 MOACRIVE Inhibition DME1422 XEOTICID XEO04932 XEO_NAME shepherin II DME1422 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04932 XEO_CLAS Peptide DME1422 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04932 GENEFORM Protein DME1422 XEOTICID XEO04932 MOACRIVE Inhibition DME1422 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1422 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04938 XEO_CLAS Peptide DME1422 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC <= 100 microM) DME1422 XEOTICID XEO04938 GENEFORM Protein DME1422 XEOTICID XEO04938 MOACRIVE Inhibition DME1422 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1422 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04947 XEO_CLAS Natural Product DME1422 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04947 GENEFORM Protein DME1422 XEOTICID XEO04947 MOACRIVE Inhibition DME1422 XEOTICID XEO04948 XEO_NAME Sinensetin DME1422 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1422 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1422 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04948 GENEFORM Protein DME1422 XEOTICID XEO04948 MOACRIVE Inhibition DME1422 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1422 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04950 XEO_CLAS Peptide DME1422 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 ug/ml) DME1422 XEOTICID XEO04950 GENEFORM Protein DME1422 XEOTICID XEO04950 MOACRIVE Inhibition DME1422 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1422 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04955 XEO_CLAS Peptide DME1422 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.07 microM) DME1422 XEOTICID XEO04955 GENEFORM Protein DME1422 XEOTICID XEO04955 MOACRIVE Inhibition DME1422 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1422 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04956 XEO_CLAS Peptide DME1422 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16.0 microM) DME1422 XEOTICID XEO04956 GENEFORM Protein DME1422 XEOTICID XEO04956 MOACRIVE Inhibition DME1422 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1422 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04957 XEO_CLAS Peptide DME1422 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.23 microM) DME1422 XEOTICID XEO04957 GENEFORM Protein DME1422 XEOTICID XEO04957 MOACRIVE Inhibition DME1422 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1422 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04958 XEO_CLAS Peptide DME1422 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 ug/ml) DME1422 XEOTICID XEO04958 GENEFORM Protein DME1422 XEOTICID XEO04958 MOACRIVE Inhibition DME1422 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1422 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04959 XEO_CLAS Peptide DME1422 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04959 GENEFORM Protein DME1422 XEOTICID XEO04959 MOACRIVE Inhibition DME1422 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1422 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04967 XEO_CLAS Peptide DME1422 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 28 microM) DME1422 XEOTICID XEO04967 GENEFORM Protein DME1422 XEOTICID XEO04967 MOACRIVE Inhibition DME1422 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1422 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04969 XEO_CLAS Peptide DME1422 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50-100 ug/ml) DME1422 XEOTICID XEO04969 GENEFORM Protein DME1422 XEOTICID XEO04969 MOACRIVE Inhibition DME1422 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1422 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04970 XEO_CLAS Peptide DME1422 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04970 GENEFORM Protein DME1422 XEOTICID XEO04970 MOACRIVE Inhibition DME1422 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1422 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04971 XEO_CLAS Peptide DME1422 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.8-1.5 microM) DME1422 XEOTICID XEO04971 GENEFORM Protein DME1422 XEOTICID XEO04971 MOACRIVE Inhibition DME1422 XEOTICID XEO04974 XEO_NAME Spinigerin DME1422 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04974 XEO_CLAS Peptide DME1422 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3-6 microM) DME1422 XEOTICID XEO04974 GENEFORM Protein DME1422 XEOTICID XEO04974 MOACRIVE Inhibition DME1422 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1422 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1422 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04975 GENEFORM Protein DME1422 XEOTICID XEO04975 MOACRIVE Inhibition DME1422 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1422 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1422 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04976 GENEFORM Protein DME1422 XEOTICID XEO04976 MOACRIVE Inhibition DME1422 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1422 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1422 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04977 GENEFORM Protein DME1422 XEOTICID XEO04977 MOACRIVE Inhibition DME1422 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1422 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1422 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04978 GENEFORM Protein DME1422 XEOTICID XEO04978 MOACRIVE Inhibition DME1422 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1422 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1422 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04979 GENEFORM Protein DME1422 XEOTICID XEO04979 MOACRIVE Inhibition DME1422 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1422 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04981 XEO_CLAS Peptide DME1422 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10.1 microM) DME1422 XEOTICID XEO04981 GENEFORM Protein DME1422 XEOTICID XEO04981 MOACRIVE Inhibition DME1422 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1422 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04982 XEO_CLAS Peptide DME1422 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40.5 microM) DME1422 XEOTICID XEO04982 GENEFORM Protein DME1422 XEOTICID XEO04982 MOACRIVE Inhibition DME1422 XEOTICID XEO04994 XEO_NAME Stilbene DME1422 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1422 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1422 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO04994 GENEFORM Protein DME1422 XEOTICID XEO04994 MOACRIVE Inhibition DME1422 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1422 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04995 XEO_CLAS Peptide DME1422 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC < 0.19 microM) DME1422 XEOTICID XEO04995 GENEFORM Protein DME1422 XEOTICID XEO04995 MOACRIVE Inhibition DME1422 XEOTICID XEO04998 XEO_NAME Styelin A DME1422 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04998 XEO_CLAS Peptide DME1422 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.7 ug/ml) DME1422 XEOTICID XEO04998 GENEFORM Protein DME1422 XEOTICID XEO04998 MOACRIVE Inhibition DME1422 XEOTICID XEO04999 XEO_NAME Styelin B DME1422 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO04999 XEO_CLAS Peptide DME1422 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.7 ug/ml) DME1422 XEOTICID XEO04999 GENEFORM Protein DME1422 XEOTICID XEO04999 MOACRIVE Inhibition DME1422 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1422 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05000 XEO_CLAS Peptide DME1422 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO05000 GENEFORM Protein DME1422 XEOTICID XEO05000 MOACRIVE Inhibition DME1422 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1422 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05001 XEO_CLAS Peptide DME1422 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.5 ug/ml) DME1422 XEOTICID XEO05001 GENEFORM Protein DME1422 XEOTICID XEO05001 MOACRIVE Inhibition DME1422 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1422 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05002 XEO_CLAS Peptide DME1422 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO05002 GENEFORM Protein DME1422 XEOTICID XEO05002 MOACRIVE Inhibition DME1422 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1422 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05003 XEO_CLAS Peptide DME1422 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO05003 GENEFORM Protein DME1422 XEOTICID XEO05003 MOACRIVE Inhibition DME1422 XEOTICID XEO05006 XEO_NAME Substance P DME1422 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05006 XEO_CLAS Peptide DME1422 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05006 GENEFORM Protein DME1422 XEOTICID XEO05006 MOACRIVE Inhibition DME1422 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1422 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05007 XEO_CLAS Peptide DME1422 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05007 GENEFORM Protein DME1422 XEOTICID XEO05007 MOACRIVE Inhibition DME1422 XEOTICID XEO05008 XEO_NAME Subtilosin DME1422 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05008 XEO_CLAS Peptide DME1422 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05008 GENEFORM Protein DME1422 XEOTICID XEO05008 MOACRIVE Inhibition DME1422 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1422 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05013 XEO_CLAS Peptide DME1422 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO05013 GENEFORM Protein DME1422 XEOTICID XEO05013 MOACRIVE Inhibition DME1422 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1422 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05014 XEO_CLAS Peptide DME1422 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO05014 GENEFORM Protein DME1422 XEOTICID XEO05014 MOACRIVE Inhibition DME1422 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1422 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05015 XEO_CLAS Peptide DME1422 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO05015 GENEFORM Protein DME1422 XEOTICID XEO05015 MOACRIVE Inhibition DME1422 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1422 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05016 XEO_CLAS Peptide DME1422 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO05016 GENEFORM Protein DME1422 XEOTICID XEO05016 MOACRIVE Inhibition DME1422 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1422 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05017 XEO_CLAS Peptide DME1422 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 20 ug/ml) DME1422 XEOTICID XEO05017 GENEFORM Protein DME1422 XEOTICID XEO05017 MOACRIVE Inhibition DME1422 XEOTICID XEO05018 XEO_NAME Syringic acid DME1422 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1422 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05018 GENEFORM Protein DME1422 XEOTICID XEO05018 MOACRIVE Inhibition DME1422 XEOTICID XEO05020 XEO_NAME Tachycitin DME1422 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05020 XEO_CLAS Peptide DME1422 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05020 GENEFORM Protein DME1422 XEOTICID XEO05020 MOACRIVE Inhibition DME1422 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1422 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05023 XEO_CLAS Peptide DME1422 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05023 GENEFORM Protein DME1422 XEOTICID XEO05023 MOACRIVE Inhibition DME1422 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1422 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05024 XEO_CLAS Peptide DME1422 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05024 GENEFORM Protein DME1422 XEOTICID XEO05024 MOACRIVE Inhibition DME1422 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1422 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05027 XEO_CLAS Peptide DME1422 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05027 GENEFORM Protein DME1422 XEOTICID XEO05027 MOACRIVE Inhibition DME1422 XEOTICID XEO05031 XEO_NAME Tannic acid DME1422 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1422 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05031 GENEFORM Protein DME1422 XEOTICID XEO05031 MOACRIVE Inhibition DME1422 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1422 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05033 XEO_CLAS Peptide DME1422 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05033 GENEFORM Protein DME1422 XEOTICID XEO05033 MOACRIVE Inhibition DME1422 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1422 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05042 XEO_CLAS Peptide DME1422 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO05042 GENEFORM Protein DME1422 XEOTICID XEO05042 MOACRIVE Inhibition DME1422 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1422 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05043 XEO_CLAS Peptide DME1422 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO05043 GENEFORM Protein DME1422 XEOTICID XEO05043 MOACRIVE Inhibition DME1422 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1422 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05044 XEO_CLAS Peptide DME1422 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 128 microM) DME1422 XEOTICID XEO05044 GENEFORM Protein DME1422 XEOTICID XEO05044 MOACRIVE Inhibition DME1422 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1422 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05045 XEO_CLAS Peptide DME1422 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 128 microM) DME1422 XEOTICID XEO05045 GENEFORM Protein DME1422 XEOTICID XEO05045 MOACRIVE Inhibition DME1422 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1422 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05046 XEO_CLAS Peptide DME1422 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 microM) DME1422 XEOTICID XEO05046 GENEFORM Protein DME1422 XEOTICID XEO05046 MOACRIVE Inhibition DME1422 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1422 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05047 XEO_CLAS Peptide DME1422 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 60 microM) DME1422 XEOTICID XEO05047 GENEFORM Protein DME1422 XEOTICID XEO05047 MOACRIVE Inhibition DME1422 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1422 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05051 XEO_CLAS Peptide DME1422 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05051 GENEFORM Protein DME1422 XEOTICID XEO05051 MOACRIVE Inhibition DME1422 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1422 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05055 XEO_CLAS Peptide DME1422 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 70 microM) DME1422 XEOTICID XEO05055 GENEFORM Protein DME1422 XEOTICID XEO05055 MOACRIVE Inhibition DME1422 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1422 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05056 XEO_CLAS Peptide DME1422 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05056 GENEFORM Protein DME1422 XEOTICID XEO05056 MOACRIVE Inhibition DME1422 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1422 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05059 XEO_CLAS Peptide DME1422 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05059 GENEFORM Protein DME1422 XEOTICID XEO05059 MOACRIVE Inhibition DME1422 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1422 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05061 XEO_CLAS Peptide DME1422 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO05061 GENEFORM Protein DME1422 XEOTICID XEO05061 MOACRIVE Inhibition DME1422 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1422 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05062 XEO_CLAS Peptide DME1422 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05062 GENEFORM Protein DME1422 XEOTICID XEO05062 MOACRIVE Inhibition DME1422 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1422 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05063 XEO_CLAS Peptide DME1422 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO05063 GENEFORM Protein DME1422 XEOTICID XEO05063 MOACRIVE Inhibition DME1422 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1422 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05064 XEO_CLAS Peptide DME1422 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 231 microM) DME1422 XEOTICID XEO05064 GENEFORM Protein DME1422 XEOTICID XEO05064 MOACRIVE Inhibition DME1422 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1422 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05065 XEO_CLAS Peptide DME1422 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 161 ug/ml) DME1422 XEOTICID XEO05065 GENEFORM Protein DME1422 XEOTICID XEO05065 MOACRIVE Inhibition DME1422 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1422 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05069 XEO_CLAS Peptide DME1422 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO05069 GENEFORM Protein DME1422 XEOTICID XEO05069 MOACRIVE Inhibition DME1422 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1422 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05070 XEO_CLAS Peptide DME1422 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 37.5 microM) DME1422 XEOTICID XEO05070 GENEFORM Protein DME1422 XEOTICID XEO05070 MOACRIVE Inhibition DME1422 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1422 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05071 XEO_CLAS Peptide DME1422 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 150 microM) DME1422 XEOTICID XEO05071 GENEFORM Protein DME1422 XEOTICID XEO05071 MOACRIVE Inhibition DME1422 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1422 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05072 XEO_CLAS Peptide DME1422 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO05072 GENEFORM Protein DME1422 XEOTICID XEO05072 MOACRIVE Inhibition DME1422 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1422 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05073 XEO_CLAS Peptide DME1422 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40 microM) DME1422 XEOTICID XEO05073 GENEFORM Protein DME1422 XEOTICID XEO05073 MOACRIVE Inhibition DME1422 XEOTICID XEO05076 XEO_NAME Temporin-A DME1422 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05076 XEO_CLAS Peptide DME1422 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 11.9 microM) DME1422 XEOTICID XEO05076 GENEFORM Protein DME1422 XEOTICID XEO05076 MOACRIVE Inhibition DME1422 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1422 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05077 XEO_CLAS Peptide DME1422 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.25 ug/ml) DME1422 XEOTICID XEO05077 GENEFORM Protein DME1422 XEOTICID XEO05077 MOACRIVE Inhibition DME1422 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1422 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05078 XEO_CLAS Peptide DME1422 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.25 ug/ml) DME1422 XEOTICID XEO05078 GENEFORM Protein DME1422 XEOTICID XEO05078 MOACRIVE Inhibition DME1422 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1422 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05079 XEO_CLAS Peptide DME1422 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.5 ug/ml) DME1422 XEOTICID XEO05079 GENEFORM Protein DME1422 XEOTICID XEO05079 MOACRIVE Inhibition DME1422 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1422 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05080 XEO_CLAS Peptide DME1422 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 ug/ml) DME1422 XEOTICID XEO05080 GENEFORM Protein DME1422 XEOTICID XEO05080 MOACRIVE Inhibition DME1422 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1422 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05081 XEO_CLAS Peptide DME1422 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 5 ug/ml) DME1422 XEOTICID XEO05081 GENEFORM Protein DME1422 XEOTICID XEO05081 MOACRIVE Inhibition DME1422 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1422 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05082 XEO_CLAS Peptide DME1422 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 7.5 ug/ml) DME1422 XEOTICID XEO05082 GENEFORM Protein DME1422 XEOTICID XEO05082 MOACRIVE Inhibition DME1422 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1422 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05083 XEO_CLAS Peptide DME1422 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 ug/ml) DME1422 XEOTICID XEO05083 GENEFORM Protein DME1422 XEOTICID XEO05083 MOACRIVE Inhibition DME1422 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1422 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05084 XEO_CLAS Peptide DME1422 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 ug/ml) DME1422 XEOTICID XEO05084 GENEFORM Protein DME1422 XEOTICID XEO05084 MOACRIVE Inhibition DME1422 XEOTICID XEO05085 XEO_NAME Temporin-B DME1422 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05085 XEO_CLAS Peptide DME1422 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 21.0 ug/ml) DME1422 XEOTICID XEO05085 GENEFORM Protein DME1422 XEOTICID XEO05085 MOACRIVE Inhibition DME1422 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1422 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05086 XEO_CLAS Peptide DME1422 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC > 100 microM) DME1422 XEOTICID XEO05086 GENEFORM Protein DME1422 XEOTICID XEO05086 MOACRIVE Inhibition DME1422 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1422 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05087 XEO_CLAS Peptide DME1422 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO05087 GENEFORM Protein DME1422 XEOTICID XEO05087 MOACRIVE Inhibition DME1422 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1422 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05097 XEO_CLAS Peptide DME1422 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16.0 microM) DME1422 XEOTICID XEO05097 GENEFORM Protein DME1422 XEOTICID XEO05097 MOACRIVE Inhibition DME1422 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1422 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05099 XEO_CLAS Peptide DME1422 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.0 microM) DME1422 XEOTICID XEO05099 GENEFORM Protein DME1422 XEOTICID XEO05099 MOACRIVE Inhibition DME1422 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1422 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05100 XEO_CLAS Peptide DME1422 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05100 GENEFORM Protein DME1422 XEOTICID XEO05100 MOACRIVE Inhibition DME1422 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1422 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05101 XEO_CLAS Peptide DME1422 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 24.2 ug/ml) DME1422 XEOTICID XEO05101 GENEFORM Protein DME1422 XEOTICID XEO05101 MOACRIVE Inhibition DME1422 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1422 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05102 XEO_CLAS Peptide DME1422 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 34.5 ug/ml) DME1422 XEOTICID XEO05102 GENEFORM Protein DME1422 XEOTICID XEO05102 MOACRIVE Inhibition DME1422 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1422 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05105 XEO_CLAS Peptide DME1422 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO05105 GENEFORM Protein DME1422 XEOTICID XEO05105 MOACRIVE Inhibition DME1422 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1422 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05106 XEO_CLAS Peptide DME1422 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25-200 microM) DME1422 XEOTICID XEO05106 GENEFORM Protein DME1422 XEOTICID XEO05106 MOACRIVE Inhibition DME1422 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1422 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05108 XEO_CLAS Peptide DME1422 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40 microM) DME1422 XEOTICID XEO05108 GENEFORM Protein DME1422 XEOTICID XEO05108 MOACRIVE Inhibition DME1422 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1422 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1422 XEOTICID XEO05111 XEO_CLAS Natural Product DME1422 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05111 GENEFORM Protein DME1422 XEOTICID XEO05111 MOACRIVE Inhibition DME1422 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1422 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05119 XEO_CLAS Peptide DME1422 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05119 GENEFORM Protein DME1422 XEOTICID XEO05119 MOACRIVE Inhibition DME1422 XEOTICID XEO05120 XEO_NAME Thanatin DME1422 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05120 XEO_CLAS Peptide DME1422 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.3-0.6 microM) DME1422 XEOTICID XEO05120 GENEFORM Protein DME1422 XEOTICID XEO05120 MOACRIVE Inhibition DME1422 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1422 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05121 XEO_CLAS Peptide DME1422 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 62.5 ug/ml) DME1422 XEOTICID XEO05121 GENEFORM Protein DME1422 XEOTICID XEO05121 MOACRIVE Inhibition DME1422 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1422 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05125 XEO_CLAS Peptide DME1422 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05125 GENEFORM Protein DME1422 XEOTICID XEO05125 MOACRIVE Inhibition DME1422 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1422 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05130 XEO_CLAS Peptide DME1422 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05130 GENEFORM Protein DME1422 XEOTICID XEO05130 MOACRIVE Inhibition DME1422 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1422 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05144 XEO_CLAS Peptide DME1422 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40 ug/ml) DME1422 XEOTICID XEO05144 GENEFORM Protein DME1422 XEOTICID XEO05144 MOACRIVE Inhibition DME1422 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1422 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05145 XEO_CLAS Peptide DME1422 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 ug/ml) DME1422 XEOTICID XEO05145 GENEFORM Protein DME1422 XEOTICID XEO05145 MOACRIVE Inhibition DME1422 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1422 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05146 XEO_CLAS Peptide DME1422 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 40 ug/ml) DME1422 XEOTICID XEO05146 GENEFORM Protein DME1422 XEOTICID XEO05146 MOACRIVE Inhibition DME1422 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1422 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05147 XEO_CLAS Peptide DME1422 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 60 ug/ml) DME1422 XEOTICID XEO05147 GENEFORM Protein DME1422 XEOTICID XEO05147 MOACRIVE Inhibition DME1422 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1422 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05158 XEO_CLAS Peptide DME1422 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05158 GENEFORM Protein DME1422 XEOTICID XEO05158 MOACRIVE Inhibition DME1422 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1422 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05161 XEO_CLAS Peptide DME1422 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 32 ug/ml) DME1422 XEOTICID XEO05161 GENEFORM Protein DME1422 XEOTICID XEO05161 MOACRIVE Inhibition DME1422 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1422 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05162 XEO_CLAS Peptide DME1422 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 32 ug/ml) DME1422 XEOTICID XEO05162 GENEFORM Protein DME1422 XEOTICID XEO05162 MOACRIVE Inhibition DME1422 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1422 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05163 XEO_CLAS Peptide DME1422 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 12-25 ug/ml) DME1422 XEOTICID XEO05163 GENEFORM Protein DME1422 XEOTICID XEO05163 MOACRIVE Inhibition DME1422 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1422 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05170 XEO_CLAS Peptide DME1422 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 3.0 microM) DME1422 XEOTICID XEO05170 GENEFORM Protein DME1422 XEOTICID XEO05170 MOACRIVE Inhibition DME1422 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1422 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05171 XEO_CLAS Peptide DME1422 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 50 microM) DME1422 XEOTICID XEO05171 GENEFORM Protein DME1422 XEOTICID XEO05171 MOACRIVE Inhibition DME1422 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1422 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05179 XEO_CLAS Peptide DME1422 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05179 GENEFORM Protein DME1422 XEOTICID XEO05179 MOACRIVE Inhibition DME1422 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1422 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05180 XEO_CLAS Peptide DME1422 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 160 microM) DME1422 XEOTICID XEO05180 GENEFORM Protein DME1422 XEOTICID XEO05180 MOACRIVE Inhibition DME1422 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1422 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05182 XEO_CLAS Peptide DME1422 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 microM) DME1422 XEOTICID XEO05182 GENEFORM Protein DME1422 XEOTICID XEO05182 MOACRIVE Inhibition DME1422 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1422 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05183 XEO_CLAS Peptide DME1422 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 microM) DME1422 XEOTICID XEO05183 GENEFORM Protein DME1422 XEOTICID XEO05183 MOACRIVE Inhibition DME1422 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1422 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05184 XEO_CLAS Peptide DME1422 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 microM) DME1422 XEOTICID XEO05184 GENEFORM Protein DME1422 XEOTICID XEO05184 MOACRIVE Inhibition DME1422 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1422 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05185 XEO_CLAS Peptide DME1422 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 microM) DME1422 XEOTICID XEO05185 GENEFORM Protein DME1422 XEOTICID XEO05185 MOACRIVE Inhibition DME1422 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1422 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05186 XEO_CLAS Peptide DME1422 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 microM) DME1422 XEOTICID XEO05186 GENEFORM Protein DME1422 XEOTICID XEO05186 MOACRIVE Inhibition DME1422 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1422 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05187 XEO_CLAS Peptide DME1422 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16 microM) DME1422 XEOTICID XEO05187 GENEFORM Protein DME1422 XEOTICID XEO05187 MOACRIVE Inhibition DME1422 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1422 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05188 XEO_CLAS Peptide DME1422 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 64 microM) DME1422 XEOTICID XEO05188 GENEFORM Protein DME1422 XEOTICID XEO05188 MOACRIVE Inhibition DME1422 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1422 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05190 XEO_CLAS Peptide DME1422 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05190 GENEFORM Protein DME1422 XEOTICID XEO05190 MOACRIVE Inhibition DME1422 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1422 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05193 XEO_CLAS Peptide DME1422 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO05193 GENEFORM Protein DME1422 XEOTICID XEO05193 MOACRIVE Inhibition DME1422 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1422 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05197 XEO_CLAS Peptide DME1422 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05197 GENEFORM Protein DME1422 XEOTICID XEO05197 MOACRIVE Inhibition DME1422 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1422 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05205 XEO_CLAS Peptide DME1422 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05205 GENEFORM Protein DME1422 XEOTICID XEO05205 MOACRIVE Inhibition DME1422 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1422 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05206 XEO_CLAS Peptide DME1422 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 10 microM) DME1422 XEOTICID XEO05206 GENEFORM Protein DME1422 XEOTICID XEO05206 MOACRIVE Inhibition DME1422 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1422 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05207 XEO_CLAS Peptide DME1422 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 25 microM) DME1422 XEOTICID XEO05207 GENEFORM Protein DME1422 XEOTICID XEO05207 MOACRIVE Inhibition DME1422 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1422 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05208 XEO_CLAS Peptide DME1422 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 microM) DME1422 XEOTICID XEO05208 GENEFORM Protein DME1422 XEOTICID XEO05208 MOACRIVE Inhibition DME1422 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1422 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05209 XEO_CLAS Peptide DME1422 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 15 microM) DME1422 XEOTICID XEO05209 GENEFORM Protein DME1422 XEOTICID XEO05209 MOACRIVE Inhibition DME1422 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1422 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05212 XEO_CLAS Peptide DME1422 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.5 ug/ml) DME1422 XEOTICID XEO05212 GENEFORM Protein DME1422 XEOTICID XEO05212 MOACRIVE Inhibition DME1422 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1422 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05220 XEO_CLAS Peptide DME1422 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.6-1.2 microM) DME1422 XEOTICID XEO05220 GENEFORM Protein DME1422 XEOTICID XEO05220 MOACRIVE Inhibition DME1422 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1422 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05230 XEO_CLAS Peptide DME1422 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 7.90 microM) DME1422 XEOTICID XEO05230 GENEFORM Protein DME1422 XEOTICID XEO05230 MOACRIVE Inhibition DME1422 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1422 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05231 XEO_CLAS Peptide DME1422 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2.40 microM) DME1422 XEOTICID XEO05231 GENEFORM Protein DME1422 XEOTICID XEO05231 MOACRIVE Inhibition DME1422 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1422 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05232 XEO_CLAS Peptide DME1422 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05232 GENEFORM Protein DME1422 XEOTICID XEO05232 MOACRIVE Inhibition DME1422 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1422 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05233 XEO_CLAS Peptide DME1422 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 ug/ml) DME1422 XEOTICID XEO05233 GENEFORM Protein DME1422 XEOTICID XEO05233 MOACRIVE Inhibition DME1422 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1422 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05234 XEO_CLAS Peptide DME1422 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 ug/ml) DME1422 XEOTICID XEO05234 GENEFORM Protein DME1422 XEOTICID XEO05234 MOACRIVE Inhibition DME1422 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1422 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05235 XEO_CLAS Peptide DME1422 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 30 ug/ml) DME1422 XEOTICID XEO05235 GENEFORM Protein DME1422 XEOTICID XEO05235 MOACRIVE Inhibition DME1422 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1422 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05237 XEO_CLAS Peptide DME1422 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 microM) DME1422 XEOTICID XEO05237 GENEFORM Protein DME1422 XEOTICID XEO05237 MOACRIVE Inhibition DME1422 XEOTICID XEO05245 XEO_NAME Viresin DME1422 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05245 XEO_CLAS Peptide DME1422 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05245 GENEFORM Protein DME1422 XEOTICID XEO05245 MOACRIVE Inhibition DME1422 XEOTICID XEO05248 XEO_NAME Vitamin C DME1422 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1422 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1422 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05248 GENEFORM Protein DME1422 XEOTICID XEO05248 MOACRIVE Inhibition DME1422 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1422 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05264 XEO_CLAS Peptide DME1422 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 4 ug/ml) DME1422 XEOTICID XEO05264 GENEFORM Protein DME1422 XEOTICID XEO05264 MOACRIVE Inhibition DME1422 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1422 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05267 XEO_CLAS Peptide DME1422 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 2 ug/ml) DME1422 XEOTICID XEO05267 GENEFORM Protein DME1422 XEOTICID XEO05267 MOACRIVE Inhibition DME1422 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1422 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05268 XEO_CLAS Peptide DME1422 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 1.6 ug/ml) DME1422 XEOTICID XEO05268 GENEFORM Protein DME1422 XEOTICID XEO05268 MOACRIVE Inhibition DME1422 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1422 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05269 XEO_CLAS Peptide DME1422 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 6 ug/ml) DME1422 XEOTICID XEO05269 GENEFORM Protein DME1422 XEOTICID XEO05269 MOACRIVE Inhibition DME1422 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1422 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05273 XEO_CLAS Peptide DME1422 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05273 GENEFORM Protein DME1422 XEOTICID XEO05273 MOACRIVE Inhibition DME1422 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1422 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05274 XEO_CLAS Peptide DME1422 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05274 GENEFORM Protein DME1422 XEOTICID XEO05274 MOACRIVE Inhibition DME1422 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1422 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05287 XEO_CLAS Peptide DME1422 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli DME1422 XEOTICID XEO05287 GENEFORM Protein DME1422 XEOTICID XEO05287 MOACRIVE Inhibition DME1422 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1422 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05303 XEO_CLAS Peptide DME1422 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 16-31 ug/ml) DME1422 XEOTICID XEO05303 GENEFORM Protein DME1422 XEOTICID XEO05303 MOACRIVE Inhibition DME1422 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1422 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05306 XEO_CLAS Peptide DME1422 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 8 ug/ml) DME1422 XEOTICID XEO05306 GENEFORM Protein DME1422 XEOTICID XEO05306 MOACRIVE Inhibition DME1422 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1422 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1422 XEOTICID XEO05308 XEO_CLAS Peptide DME1422 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Molybdopterin-dependent enzyme (molD) from Escherichia coli (MIC = 0.4 ug/ml) DME1422 XEOTICID XEO05308 GENEFORM Protein DME1422 XEOTICID XEO05308 MOACRIVE Inhibition DME1430 DME___ID DME1430 DME1430 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1430 SPESNAME Helicobacter pylori DME1430 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1430 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1430 XEOTICID XEO03958 XEO_CLAS Peptide DME1430 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Helicobacter pylori DME1430 XEOTICID XEO03958 GENEFORM Protein DME1430 XEOTICID XEO03958 MOACRIVE Inhibition DME1430 XEOTICID XEO04156 XEO_NAME Mutacin II mutacin H-29B DME1430 XEOTICID XEO04156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1430 XEOTICID XEO04156 XEO_CLAS Peptide DME1430 XEOTICID XEO04156 DESCRIPT Mutacin II mutacin H-29B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Helicobacter pylori DME1430 XEOTICID XEO04156 GENEFORM Protein DME1430 XEOTICID XEO04156 MOACRIVE Inhibition DME1430 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1430 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1430 XEOTICID XEO04382 XEO_CLAS Peptide DME1430 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Helicobacter pylori (MIC = 20 ug/ml) DME1430 XEOTICID XEO04382 GENEFORM Protein DME1430 XEOTICID XEO04382 MOACRIVE Inhibition DME1430 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1430 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1430 XEOTICID XEO04630 XEO_CLAS Peptide DME1430 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Helicobacter pylori (MIC = 30 ug/ml) DME1430 XEOTICID XEO04630 GENEFORM Protein DME1430 XEOTICID XEO04630 MOACRIVE Inhibition DME1430 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1430 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1430 XEOTICID XEO04631 XEO_CLAS Peptide DME1430 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Helicobacter pylori (MIC = 30 ug/ml) DME1430 XEOTICID XEO04631 GENEFORM Protein DME1430 XEOTICID XEO04631 MOACRIVE Inhibition DME1435 DME___ID DME1435 DME1435 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1435 SPESNAME Lactobacillus reuteri DME1435 XEOTICID XEO03473 XEO_NAME Garvicin ML DME1435 XEOTICID XEO03473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1435 XEOTICID XEO03473 XEO_CLAS Peptide DME1435 XEOTICID XEO03473 DESCRIPT Garvicin ML inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactobacillus reuteri DME1435 XEOTICID XEO03473 GENEFORM Protein DME1435 XEOTICID XEO03473 MOACRIVE Inhibition DME1435 XEOTICID XEO04319 XEO_NAME Nisin F DME1435 XEOTICID XEO04319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1435 XEOTICID XEO04319 XEO_CLAS Peptide DME1435 XEOTICID XEO04319 DESCRIPT Nisin F inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactobacillus reuteri DME1435 XEOTICID XEO04319 GENEFORM Protein DME1435 XEOTICID XEO04319 MOACRIVE Inhibition DME1438 DME___ID DME1438 DME1438 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1438 SPESNAME Lactococcus lactis DME1438 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1438 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO02298 XEO_CLAS Peptide DME1438 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis (MIC > 128 ug/ml) DME1438 XEOTICID XEO02298 GENEFORM Protein DME1438 XEOTICID XEO02298 MOACRIVE Inhibition DME1438 XEOTICID XEO02335 XEO_NAME Aurein-1.1 DME1438 XEOTICID XEO02335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO02335 XEO_CLAS Peptide DME1438 XEOTICID XEO02335 DESCRIPT Aurein-1.1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis (MIC = 25 ug/ml) DME1438 XEOTICID XEO02335 GENEFORM Protein DME1438 XEOTICID XEO02335 MOACRIVE Inhibition DME1438 XEOTICID XEO02721 XEO_NAME Carnocyclin CclA DME1438 XEOTICID XEO02721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO02721 XEO_CLAS Peptide DME1438 XEOTICID XEO02721 DESCRIPT Carnocyclin CclA inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO02721 GENEFORM Protein DME1438 XEOTICID XEO02721 MOACRIVE Inhibition DME1438 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1438 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03111 XEO_CLAS Peptide DME1438 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO03111 GENEFORM Protein DME1438 XEOTICID XEO03111 MOACRIVE Inhibition DME1438 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1438 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03250 XEO_CLAS Peptide DME1438 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO03250 GENEFORM Protein DME1438 XEOTICID XEO03250 MOACRIVE Inhibition DME1438 XEOTICID XEO03255 XEO_NAME Enterocin L50A DME1438 XEOTICID XEO03255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03255 XEO_CLAS Peptide DME1438 XEOTICID XEO03255 DESCRIPT Enterocin L50A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO03255 GENEFORM Protein DME1438 XEOTICID XEO03255 MOACRIVE Inhibition DME1438 XEOTICID XEO03256 XEO_NAME Enterocin L50B DME1438 XEOTICID XEO03256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03256 XEO_CLAS Peptide DME1438 XEOTICID XEO03256 DESCRIPT Enterocin L50B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO03256 GENEFORM Protein DME1438 XEOTICID XEO03256 MOACRIVE Inhibition DME1438 XEOTICID XEO03257 XEO_NAME Enterocin P DME1438 XEOTICID XEO03257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03257 XEO_CLAS Peptide DME1438 XEOTICID XEO03257 DESCRIPT Enterocin P inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis (MIC = 0.022 ug/ml) DME1438 XEOTICID XEO03257 GENEFORM Protein DME1438 XEOTICID XEO03257 MOACRIVE Inhibition DME1438 XEOTICID XEO03258 XEO_NAME Enterocin RJ-11 DME1438 XEOTICID XEO03258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03258 XEO_CLAS Peptide DME1438 XEOTICID XEO03258 DESCRIPT Enterocin RJ-11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO03258 GENEFORM Protein DME1438 XEOTICID XEO03258 MOACRIVE Inhibition DME1438 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME1438 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03259 XEO_CLAS Peptide DME1438 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis (MIC = 0.813 microM) DME1438 XEOTICID XEO03259 GENEFORM Protein DME1438 XEOTICID XEO03259 MOACRIVE Inhibition DME1438 XEOTICID XEO03381 XEO_NAME Fallaxidin 3.1 DME1438 XEOTICID XEO03381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03381 XEO_CLAS Peptide DME1438 XEOTICID XEO03381 DESCRIPT Fallaxidin 3.1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis (MIC = 100 microM) DME1438 XEOTICID XEO03381 GENEFORM Protein DME1438 XEOTICID XEO03381 MOACRIVE Inhibition DME1438 XEOTICID XEO03382 XEO_NAME Fallaxidin 3.2 DME1438 XEOTICID XEO03382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03382 XEO_CLAS Peptide DME1438 XEOTICID XEO03382 DESCRIPT Fallaxidin 3.2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis (MIC = 500 microM) DME1438 XEOTICID XEO03382 GENEFORM Protein DME1438 XEOTICID XEO03382 MOACRIVE Inhibition DME1438 XEOTICID XEO03383 XEO_NAME Fallaxidin 4.1 DME1438 XEOTICID XEO03383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03383 XEO_CLAS Peptide DME1438 XEOTICID XEO03383 DESCRIPT Fallaxidin 4.1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis (MIC = 12 microM) DME1438 XEOTICID XEO03383 GENEFORM Protein DME1438 XEOTICID XEO03383 MOACRIVE Inhibition DME1438 XEOTICID XEO03473 XEO_NAME Garvicin ML DME1438 XEOTICID XEO03473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03473 XEO_CLAS Peptide DME1438 XEOTICID XEO03473 DESCRIPT Garvicin ML inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO03473 GENEFORM Protein DME1438 XEOTICID XEO03473 MOACRIVE Inhibition DME1438 XEOTICID XEO03478 XEO_NAME Geobacillin I DME1438 XEOTICID XEO03478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03478 XEO_CLAS Peptide DME1438 XEOTICID XEO03478 DESCRIPT Geobacillin I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO03478 GENEFORM Protein DME1438 XEOTICID XEO03478 MOACRIVE Inhibition DME1438 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1438 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03771 XEO_CLAS Peptide DME1438 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO03771 GENEFORM Protein DME1438 XEOTICID XEO03771 MOACRIVE Inhibition DME1438 XEOTICID XEO03773 XEO_NAME Lactococcin Q alpha DME1438 XEOTICID XEO03773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03773 XEO_CLAS Peptide DME1438 XEOTICID XEO03773 DESCRIPT Lactococcin Q alpha inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis (MIC > 1 microM) DME1438 XEOTICID XEO03773 GENEFORM Protein DME1438 XEOTICID XEO03773 MOACRIVE Inhibition DME1438 XEOTICID XEO03774 XEO_NAME Lactococcin Q beta DME1438 XEOTICID XEO03774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03774 XEO_CLAS Peptide DME1438 XEOTICID XEO03774 DESCRIPT Lactococcin Q beta inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis (MIC > 1 microM) DME1438 XEOTICID XEO03774 GENEFORM Protein DME1438 XEOTICID XEO03774 MOACRIVE Inhibition DME1438 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1438 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03775 XEO_CLAS Peptide DME1438 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis (MIC = 0.141 microM) DME1438 XEOTICID XEO03775 GENEFORM Protein DME1438 XEOTICID XEO03775 MOACRIVE Inhibition DME1438 XEOTICID XEO03806 XEO_NAME Lantibiotic paenibacillin DME1438 XEOTICID XEO03806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03806 XEO_CLAS Peptide DME1438 XEOTICID XEO03806 DESCRIPT Lantibiotic paenibacillin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO03806 GENEFORM Protein DME1438 XEOTICID XEO03806 MOACRIVE Inhibition DME1438 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1438 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO03857 XEO_CLAS Peptide DME1438 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis (MIC = 0.038 microM) DME1438 XEOTICID XEO03857 GENEFORM Protein DME1438 XEOTICID XEO03857 MOACRIVE Inhibition DME1438 XEOTICID XEO04320 XEO_NAME Nisin U DME1438 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04320 XEO_CLAS Peptide DME1438 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04320 GENEFORM Protein DME1438 XEOTICID XEO04320 MOACRIVE Inhibition DME1438 XEOTICID XEO04622 XEO_NAME Plantaricin W alpha DME1438 XEOTICID XEO04622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04622 XEO_CLAS Peptide DME1438 XEOTICID XEO04622 DESCRIPT Plantaricin W alpha inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04622 GENEFORM Protein DME1438 XEOTICID XEO04622 MOACRIVE Inhibition DME1438 XEOTICID XEO04623 XEO_NAME Plantaricin W beta DME1438 XEOTICID XEO04623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04623 XEO_CLAS Peptide DME1438 XEOTICID XEO04623 DESCRIPT Plantaricin W beta inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04623 GENEFORM Protein DME1438 XEOTICID XEO04623 MOACRIVE Inhibition DME1438 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1438 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04695 XEO_CLAS Peptide DME1438 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04695 GENEFORM Protein DME1438 XEOTICID XEO04695 MOACRIVE Inhibition DME1438 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1438 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04696 XEO_CLAS Peptide DME1438 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04696 GENEFORM Protein DME1438 XEOTICID XEO04696 MOACRIVE Inhibition DME1438 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1438 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04697 XEO_CLAS Peptide DME1438 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04697 GENEFORM Protein DME1438 XEOTICID XEO04697 MOACRIVE Inhibition DME1438 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1438 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04698 XEO_CLAS Peptide DME1438 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04698 GENEFORM Protein DME1438 XEOTICID XEO04698 MOACRIVE Inhibition DME1438 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1438 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04699 XEO_CLAS Peptide DME1438 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04699 GENEFORM Protein DME1438 XEOTICID XEO04699 MOACRIVE Inhibition DME1438 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1438 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04700 XEO_CLAS Peptide DME1438 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04700 GENEFORM Protein DME1438 XEOTICID XEO04700 MOACRIVE Inhibition DME1438 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1438 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04701 XEO_CLAS Peptide DME1438 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04701 GENEFORM Protein DME1438 XEOTICID XEO04701 MOACRIVE Inhibition DME1438 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1438 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04702 XEO_CLAS Peptide DME1438 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04702 GENEFORM Protein DME1438 XEOTICID XEO04702 MOACRIVE Inhibition DME1438 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1438 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04703 XEO_CLAS Peptide DME1438 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04703 GENEFORM Protein DME1438 XEOTICID XEO04703 MOACRIVE Inhibition DME1438 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1438 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04704 XEO_CLAS Peptide DME1438 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04704 GENEFORM Protein DME1438 XEOTICID XEO04704 MOACRIVE Inhibition DME1438 XEOTICID XEO04810 XEO_NAME Ranatuerin-2AVa DME1438 XEOTICID XEO04810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04810 XEO_CLAS Peptide DME1438 XEOTICID XEO04810 DESCRIPT Ranatuerin-2AVa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04810 GENEFORM Protein DME1438 XEOTICID XEO04810 MOACRIVE Inhibition DME1438 XEOTICID XEO04856 XEO_NAME Riparin-2.1 DME1438 XEOTICID XEO04856 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04856 XEO_CLAS Peptide DME1438 XEOTICID XEO04856 DESCRIPT Riparin-2.1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis (MIC = 25 microM) DME1438 XEOTICID XEO04856 GENEFORM Protein DME1438 XEOTICID XEO04856 MOACRIVE Inhibition DME1438 XEOTICID XEO04897 XEO_NAME Sakacin G DME1438 XEOTICID XEO04897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO04897 XEO_CLAS Peptide DME1438 XEOTICID XEO04897 DESCRIPT Sakacin G inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO04897 GENEFORM Protein DME1438 XEOTICID XEO04897 MOACRIVE Inhibition DME1438 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1438 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO05139 XEO_CLAS Peptide DME1438 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO05139 GENEFORM Protein DME1438 XEOTICID XEO05139 MOACRIVE Inhibition DME1438 XEOTICID XEO05196 XEO_NAME Ubericin-A DME1438 XEOTICID XEO05196 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO05196 XEO_CLAS Peptide DME1438 XEOTICID XEO05196 DESCRIPT Ubericin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO05196 GENEFORM Protein DME1438 XEOTICID XEO05196 MOACRIVE Inhibition DME1438 XEOTICID XEO05201 XEO_NAME Uperin-3.5 DME1438 XEOTICID XEO05201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO05201 XEO_CLAS Peptide DME1438 XEOTICID XEO05201 DESCRIPT Uperin-3.5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis (MIC = 3 ug/ml) DME1438 XEOTICID XEO05201 GENEFORM Protein DME1438 XEOTICID XEO05201 MOACRIVE Inhibition DME1438 XEOTICID XEO05202 XEO_NAME Uperin-3.6 DME1438 XEOTICID XEO05202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO05202 XEO_CLAS Peptide DME1438 XEOTICID XEO05202 DESCRIPT Uperin-3.6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis (MIC = 3 ug/ml) DME1438 XEOTICID XEO05202 GENEFORM Protein DME1438 XEOTICID XEO05202 MOACRIVE Inhibition DME1438 XEOTICID XEO05228 XEO_NAME Variacin DME1438 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO05228 XEO_CLAS Peptide DME1438 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO05228 GENEFORM Protein DME1438 XEOTICID XEO05228 MOACRIVE Inhibition DME1438 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1438 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1438 XEOTICID XEO05283 XEO_CLAS Peptide DME1438 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactococcus lactis DME1438 XEOTICID XEO05283 GENEFORM Protein DME1438 XEOTICID XEO05283 MOACRIVE Inhibition DME1442 DME___ID DME1442 DME1442 DME_NAME Cytochrome P450 130A1 (cyp130) DME1442 SPESNAME Mycobacterium tuberculosis DME1442 XEOTICID XEO03807 XEO_NAME Lariatins A DME1442 XEOTICID XEO03807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1442 XEOTICID XEO03807 XEO_CLAS Peptide DME1442 XEOTICID XEO03807 DESCRIPT Lariatins A inhibits the drug-metabolizing activity of Cytochrome P450 130A1 (cyp130) from Mycobacterium tuberculosis DME1442 XEOTICID XEO03807 GENEFORM Protein DME1442 XEOTICID XEO03807 MOACRIVE Inhibition DME1442 XEOTICID XEO03808 XEO_NAME Lariatins B DME1442 XEOTICID XEO03808 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1442 XEOTICID XEO03808 XEO_CLAS Peptide DME1442 XEOTICID XEO03808 DESCRIPT Lariatins B inhibits the drug-metabolizing activity of Cytochrome P450 130A1 (cyp130) from Mycobacterium tuberculosis DME1442 XEOTICID XEO03808 GENEFORM Protein DME1442 XEOTICID XEO03808 MOACRIVE Inhibition DME1448 DME___ID DME1448 DME1448 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1448 SPESNAME Porphyromonas gingivalis DME1448 XEOTICID XEO02101 XEO_NAME 9-hydroxy-2-propyl-4H-pyrido[1,2-a]pyrimidin-4-one DME1448 XEOTICID XEO02101 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1448 XEOTICID XEO02101 XEO_CLAS Chemical Compound DME1448 XEOTICID XEO02101 DESCRIPT 9-hydroxy-2-propyl-4H-pyrido[1,2-a]pyrimidin-4-one inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Porphyromonas gingivalis DME1448 XEOTICID XEO02101 GENEFORM Protein DME1448 XEOTICID XEO02101 MOACRIVE Inhibition DME1448 XEOTICID XEO03778 XEO_NAME Lactoferrin DME1448 XEOTICID XEO03778 XEO_TYPE Pharmaceutical Agent(s) DME1448 XEOTICID XEO03778 XEO_CLAS Approved/Marketed Drug DME1448 XEOTICID XEO03778 DESCRIPT Lactoferrin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Porphyromonas gingivalis DME1448 XEOTICID XEO03778 GENEFORM Protein DME1448 XEOTICID XEO03778 MOACRIVE Inhibition DME1448 XEOTICID XEO04108 XEO_NAME Metronidazole DME1448 XEOTICID XEO04108 XEO_TYPE Pharmaceutical Agent(s) DME1448 XEOTICID XEO04108 XEO_CLAS Approved/Marketed Drug DME1448 XEOTICID XEO04108 DESCRIPT Metronidazole inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Porphyromonas gingivalis DME1448 XEOTICID XEO04108 GENEFORM Protein DME1448 XEOTICID XEO04108 MOACRIVE Inhibition DME1448 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1448 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1448 XEOTICID XEO04146 XEO_CLAS Peptide DME1448 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Porphyromonas gingivalis DME1448 XEOTICID XEO04146 GENEFORM Protein DME1448 XEOTICID XEO04146 MOACRIVE Inhibition DME1448 XEOTICID XEO04419 XEO_NAME Oxantel DME1448 XEOTICID XEO04419 XEO_TYPE Pharmaceutical Agent(s) DME1448 XEOTICID XEO04419 XEO_CLAS Investigative Agent DME1448 XEOTICID XEO04419 DESCRIPT Oxantel inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Porphyromonas gingivalis DME1448 XEOTICID XEO04419 GENEFORM Protein DME1448 XEOTICID XEO04419 MOACRIVE Inhibition DME1453 DME___ID DME1453 DME1453 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1453 SPESNAME Providencia rettgeri DME1453 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1453 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1453 XEOTICID XEO03609 XEO_CLAS Peptide DME1453 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Providencia rettgeri DME1453 XEOTICID XEO03609 GENEFORM Protein DME1453 XEOTICID XEO03609 MOACRIVE Inhibition DME1454 DME___ID DME1454 DME1454 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1454 SPESNAME Providencia stuartii DME1454 XEOTICID XEO00122 XEO_NAME Amikacin DME1454 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1454 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1454 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Providencia stuartii DME1454 XEOTICID XEO00122 GENEFORM Protein DME1454 XEOTICID XEO00122 MOACRIVE Inhibition DME1454 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1454 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1454 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1454 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Providencia stuartii DME1454 XEOTICID XEO00237 GENEFORM Protein DME1454 XEOTICID XEO00237 MOACRIVE Inhibition DME1454 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1454 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1454 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1454 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Providencia stuartii DME1454 XEOTICID XEO00349 GENEFORM Protein DME1454 XEOTICID XEO00349 MOACRIVE Inhibition DME1454 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1454 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1454 XEOTICID XEO03575 XEO_CLAS Peptide DME1454 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Providencia stuartii (MIC = 110 microM) DME1454 XEOTICID XEO03575 GENEFORM Protein DME1454 XEOTICID XEO03575 MOACRIVE Inhibition DME1457 DME___ID DME1457 DME1457 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1457 SPESNAME Ruminococcus albus DME1457 XEOTICID XEO02661 XEO_NAME Butyrivibriocin AR10 DME1457 XEOTICID XEO02661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1457 XEOTICID XEO02661 XEO_CLAS Peptide DME1457 XEOTICID XEO02661 DESCRIPT Butyrivibriocin AR10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Ruminococcus albus DME1457 XEOTICID XEO02661 GENEFORM Protein DME1457 XEOTICID XEO02661 MOACRIVE Inhibition DME1461 DME___ID DME1461 DME1461 DME_NAME Homoserine-O-transsuccinylase (metAA) DME1461 SPESNAME Salmonella enterica DME1461 XEOTICID XEO01237 XEO_NAME Carvacrol DME1461 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1461 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1461 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO01237 GENEFORM Protein DME1461 XEOTICID XEO01237 MOACRIVE Inhibition DME1461 XEOTICID XEO01802 XEO_NAME (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone DME1461 XEOTICID XEO01802 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1461 XEOTICID XEO01802 XEO_CLAS Chemical Compound DME1461 XEOTICID XEO01802 DESCRIPT (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO01802 GENEFORM Protein DME1461 XEOTICID XEO01802 MOACRIVE Inhibition DME1461 XEOTICID XEO01944 XEO_NAME 2-Hexylmaleic anhydride DME1461 XEOTICID XEO01944 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1461 XEOTICID XEO01944 XEO_CLAS Chemical Compound DME1461 XEOTICID XEO01944 DESCRIPT 2-Hexylmaleic anhydride inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO01944 GENEFORM Protein DME1461 XEOTICID XEO01944 MOACRIVE Inhibition DME1461 XEOTICID XEO01990 XEO_NAME 3-hexyl-4-bromo-5-methylene-2(5H)-furanone DME1461 XEOTICID XEO01990 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1461 XEOTICID XEO01990 XEO_CLAS Chemical Compound DME1461 XEOTICID XEO01990 DESCRIPT 3-hexyl-4-bromo-5-methylene-2(5H)-furanone inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO01990 GENEFORM Protein DME1461 XEOTICID XEO01990 MOACRIVE Inhibition DME1461 XEOTICID XEO02235 XEO_NAME Anthranilate DME1461 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1461 XEOTICID XEO02235 XEO_CLAS Natural Product DME1461 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO02235 GENEFORM Protein DME1461 XEOTICID XEO02235 MOACRIVE Inhibition DME1461 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1461 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO02284 XEO_CLAS Peptide DME1461 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 25.0 microM) DME1461 XEOTICID XEO02284 GENEFORM Protein DME1461 XEOTICID XEO02284 MOACRIVE Inhibition DME1461 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1461 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO02285 XEO_CLAS Peptide DME1461 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 25.0 microM) DME1461 XEOTICID XEO02285 GENEFORM Protein DME1461 XEOTICID XEO02285 MOACRIVE Inhibition DME1461 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1461 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO02286 XEO_CLAS Peptide DME1461 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 25.0 microM) DME1461 XEOTICID XEO02286 GENEFORM Protein DME1461 XEOTICID XEO02286 MOACRIVE Inhibition DME1461 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1461 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO02287 XEO_CLAS Peptide DME1461 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 25.0 microM) DME1461 XEOTICID XEO02287 GENEFORM Protein DME1461 XEOTICID XEO02287 MOACRIVE Inhibition DME1461 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1461 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO02317 XEO_CLAS Peptide DME1461 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 300 microM) DME1461 XEOTICID XEO02317 GENEFORM Protein DME1461 XEOTICID XEO02317 MOACRIVE Inhibition DME1461 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1461 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO02491 XEO_CLAS Peptide DME1461 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 2.3 microM) DME1461 XEOTICID XEO02491 GENEFORM Protein DME1461 XEOTICID XEO02491 MOACRIVE Inhibition DME1461 XEOTICID XEO02641 XEO_NAME Bromohexylmaleic anhydride DME1461 XEOTICID XEO02641 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1461 XEOTICID XEO02641 XEO_CLAS Chemical Compound DME1461 XEOTICID XEO02641 DESCRIPT Bromohexylmaleic anhydride inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO02641 GENEFORM Protein DME1461 XEOTICID XEO02641 MOACRIVE Inhibition DME1461 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1461 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1461 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1461 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO02990 GENEFORM Protein DME1461 XEOTICID XEO02990 MOACRIVE Inhibition DME1461 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1461 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO03029 XEO_CLAS Peptide DME1461 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 0.005 microM) DME1461 XEOTICID XEO03029 GENEFORM Protein DME1461 XEOTICID XEO03029 MOACRIVE Inhibition DME1461 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1461 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO03030 XEO_CLAS Peptide DME1461 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 0.005 microM) DME1461 XEOTICID XEO03030 GENEFORM Protein DME1461 XEOTICID XEO03030 MOACRIVE Inhibition DME1461 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1461 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO03031 XEO_CLAS Peptide DME1461 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 0.3 microM) DME1461 XEOTICID XEO03031 GENEFORM Protein DME1461 XEOTICID XEO03031 MOACRIVE Inhibition DME1461 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1461 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO03032 XEO_CLAS Peptide DME1461 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 0.005 microM) DME1461 XEOTICID XEO03032 GENEFORM Protein DME1461 XEOTICID XEO03032 MOACRIVE Inhibition DME1461 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1461 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO03033 XEO_CLAS Peptide DME1461 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 0.005 microM) DME1461 XEOTICID XEO03033 GENEFORM Protein DME1461 XEOTICID XEO03033 MOACRIVE Inhibition DME1461 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1461 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO03034 XEO_CLAS Peptide DME1461 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 0.528 microM) DME1461 XEOTICID XEO03034 GENEFORM Protein DME1461 XEOTICID XEO03034 MOACRIVE Inhibition DME1461 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1461 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO03035 XEO_CLAS Peptide DME1461 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 0.004 microM) DME1461 XEOTICID XEO03035 GENEFORM Protein DME1461 XEOTICID XEO03035 MOACRIVE Inhibition DME1461 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1461 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO03250 XEO_CLAS Peptide DME1461 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO03250 GENEFORM Protein DME1461 XEOTICID XEO03250 MOACRIVE Inhibition DME1461 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1461 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1461 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1461 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO03968 GENEFORM Protein DME1461 XEOTICID XEO03968 MOACRIVE Inhibition DME1461 XEOTICID XEO04114 XEO_NAME Microcin L DME1461 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04114 XEO_CLAS Peptide DME1461 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO04114 GENEFORM Protein DME1461 XEOTICID XEO04114 MOACRIVE Inhibition DME1461 XEOTICID XEO04172 XEO_NAME Myxinidin DME1461 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04172 XEO_CLAS Peptide DME1461 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO04172 GENEFORM Protein DME1461 XEOTICID XEO04172 MOACRIVE Inhibition DME1461 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1461 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04335 XEO_CLAS Peptide DME1461 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 16 ug/ml) DME1461 XEOTICID XEO04335 GENEFORM Protein DME1461 XEOTICID XEO04335 MOACRIVE Inhibition DME1461 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1461 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04336 XEO_CLAS Peptide DME1461 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 16 ug/ml) DME1461 XEOTICID XEO04336 GENEFORM Protein DME1461 XEOTICID XEO04336 MOACRIVE Inhibition DME1461 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1461 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04338 XEO_CLAS Peptide DME1461 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 0.5 ug/ml) DME1461 XEOTICID XEO04338 GENEFORM Protein DME1461 XEOTICID XEO04338 MOACRIVE Inhibition DME1461 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1461 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04339 XEO_CLAS Peptide DME1461 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 64 ug/ml) DME1461 XEOTICID XEO04339 GENEFORM Protein DME1461 XEOTICID XEO04339 MOACRIVE Inhibition DME1461 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1461 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04340 XEO_CLAS Peptide DME1461 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 2 ug/ml) DME1461 XEOTICID XEO04340 GENEFORM Protein DME1461 XEOTICID XEO04340 MOACRIVE Inhibition DME1461 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1461 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04642 XEO_CLAS Peptide DME1461 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 4 ug/ml) DME1461 XEOTICID XEO04642 GENEFORM Protein DME1461 XEOTICID XEO04642 MOACRIVE Inhibition DME1461 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1461 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04643 XEO_CLAS Peptide DME1461 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 2 ug/ml) DME1461 XEOTICID XEO04643 GENEFORM Protein DME1461 XEOTICID XEO04643 MOACRIVE Inhibition DME1461 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1461 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04644 XEO_CLAS Peptide DME1461 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 2 ug/ml) DME1461 XEOTICID XEO04644 GENEFORM Protein DME1461 XEOTICID XEO04644 MOACRIVE Inhibition DME1461 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1461 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04645 XEO_CLAS Peptide DME1461 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 32 ug/ml) DME1461 XEOTICID XEO04645 GENEFORM Protein DME1461 XEOTICID XEO04645 MOACRIVE Inhibition DME1461 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1461 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04646 XEO_CLAS Peptide DME1461 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 1 ug/ml) DME1461 XEOTICID XEO04646 GENEFORM Protein DME1461 XEOTICID XEO04646 MOACRIVE Inhibition DME1461 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1461 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04647 XEO_CLAS Peptide DME1461 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 4 ug/ml) DME1461 XEOTICID XEO04647 GENEFORM Protein DME1461 XEOTICID XEO04647 MOACRIVE Inhibition DME1461 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1461 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04648 XEO_CLAS Peptide DME1461 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 16 ug/ml) DME1461 XEOTICID XEO04648 GENEFORM Protein DME1461 XEOTICID XEO04648 MOACRIVE Inhibition DME1461 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1461 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04649 XEO_CLAS Peptide DME1461 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC > 64 ug/ml) DME1461 XEOTICID XEO04649 GENEFORM Protein DME1461 XEOTICID XEO04649 MOACRIVE Inhibition DME1461 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1461 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04650 XEO_CLAS Peptide DME1461 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 16 ug/ml) DME1461 XEOTICID XEO04650 GENEFORM Protein DME1461 XEOTICID XEO04650 MOACRIVE Inhibition DME1461 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1461 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04651 XEO_CLAS Peptide DME1461 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 64 ug/ml) DME1461 XEOTICID XEO04651 GENEFORM Protein DME1461 XEOTICID XEO04651 MOACRIVE Inhibition DME1461 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1461 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04652 XEO_CLAS Peptide DME1461 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 4 ug/ml) DME1461 XEOTICID XEO04652 GENEFORM Protein DME1461 XEOTICID XEO04652 MOACRIVE Inhibition DME1461 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1461 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04655 XEO_CLAS Peptide DME1461 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 2 ug/ml) DME1461 XEOTICID XEO04655 GENEFORM Protein DME1461 XEOTICID XEO04655 MOACRIVE Inhibition DME1461 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1461 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04695 XEO_CLAS Peptide DME1461 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO04695 GENEFORM Protein DME1461 XEOTICID XEO04695 MOACRIVE Inhibition DME1461 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1461 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04696 XEO_CLAS Peptide DME1461 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO04696 GENEFORM Protein DME1461 XEOTICID XEO04696 MOACRIVE Inhibition DME1461 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1461 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04699 XEO_CLAS Peptide DME1461 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO04699 GENEFORM Protein DME1461 XEOTICID XEO04699 MOACRIVE Inhibition DME1461 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1461 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04700 XEO_CLAS Peptide DME1461 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO04700 GENEFORM Protein DME1461 XEOTICID XEO04700 MOACRIVE Inhibition DME1461 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1461 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04701 XEO_CLAS Peptide DME1461 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO04701 GENEFORM Protein DME1461 XEOTICID XEO04701 MOACRIVE Inhibition DME1461 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1461 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04702 XEO_CLAS Peptide DME1461 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO04702 GENEFORM Protein DME1461 XEOTICID XEO04702 MOACRIVE Inhibition DME1461 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1461 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO04703 XEO_CLAS Peptide DME1461 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO04703 GENEFORM Protein DME1461 XEOTICID XEO04703 MOACRIVE Inhibition DME1461 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1461 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO05171 XEO_CLAS Peptide DME1461 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica DME1461 XEOTICID XEO05171 GENEFORM Protein DME1461 XEOTICID XEO05171 MOACRIVE Inhibition DME1461 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1461 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1461 XEOTICID XEO05308 XEO_CLAS Peptide DME1461 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Homoserine-O-transsuccinylase (metAA) from Salmonella enterica (MIC = 0.9 ug/ml) DME1461 XEOTICID XEO05308 GENEFORM Protein DME1461 XEOTICID XEO05308 MOACRIVE Inhibition DME1462 DME___ID DME1462 DME1462 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1462 SPESNAME Salmonella enterica DME1462 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1462 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO01810 XEO_CLAS Peptide DME1462 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1.0 microM) DME1462 XEOTICID XEO01810 GENEFORM Protein DME1462 XEOTICID XEO01810 MOACRIVE Inhibition DME1462 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1462 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO01811 XEO_CLAS Peptide DME1462 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC > 64 microM) DME1462 XEOTICID XEO01811 GENEFORM Protein DME1462 XEOTICID XEO01811 MOACRIVE Inhibition DME1462 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1462 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO01817 XEO_CLAS Peptide DME1462 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4.0 microM) DME1462 XEOTICID XEO01817 GENEFORM Protein DME1462 XEOTICID XEO01817 MOACRIVE Inhibition DME1462 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1462 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO01818 XEO_CLAS Peptide DME1462 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1.0 microM) DME1462 XEOTICID XEO01818 GENEFORM Protein DME1462 XEOTICID XEO01818 MOACRIVE Inhibition DME1462 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1462 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO01819 XEO_CLAS Peptide DME1462 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1 microM) DME1462 XEOTICID XEO01819 GENEFORM Protein DME1462 XEOTICID XEO01819 MOACRIVE Inhibition DME1462 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1462 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO01820 XEO_CLAS Peptide DME1462 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1 microM) DME1462 XEOTICID XEO01820 GENEFORM Protein DME1462 XEOTICID XEO01820 MOACRIVE Inhibition DME1462 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1462 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO01821 XEO_CLAS Peptide DME1462 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1 microM) DME1462 XEOTICID XEO01821 GENEFORM Protein DME1462 XEOTICID XEO01821 MOACRIVE Inhibition DME1462 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1462 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO01822 XEO_CLAS Peptide DME1462 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 16 microM) DME1462 XEOTICID XEO01822 GENEFORM Protein DME1462 XEOTICID XEO01822 MOACRIVE Inhibition DME1462 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1462 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02207 XEO_CLAS Peptide DME1462 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.39 ug/ml) DME1462 XEOTICID XEO02207 GENEFORM Protein DME1462 XEOTICID XEO02207 MOACRIVE Inhibition DME1462 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1462 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02208 XEO_CLAS Peptide DME1462 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.78 ug/ml) DME1462 XEOTICID XEO02208 GENEFORM Protein DME1462 XEOTICID XEO02208 MOACRIVE Inhibition DME1462 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1462 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02209 XEO_CLAS Peptide DME1462 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.39 ug/ml) DME1462 XEOTICID XEO02209 GENEFORM Protein DME1462 XEOTICID XEO02209 MOACRIVE Inhibition DME1462 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1462 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02210 XEO_CLAS Peptide DME1462 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 12.5 ug/ml) DME1462 XEOTICID XEO02210 GENEFORM Protein DME1462 XEOTICID XEO02210 MOACRIVE Inhibition DME1462 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1462 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02211 XEO_CLAS Peptide DME1462 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 12.5 ug/ml) DME1462 XEOTICID XEO02211 GENEFORM Protein DME1462 XEOTICID XEO02211 MOACRIVE Inhibition DME1462 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1462 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02212 XEO_CLAS Peptide DME1462 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.39 ug/ml) DME1462 XEOTICID XEO02212 GENEFORM Protein DME1462 XEOTICID XEO02212 MOACRIVE Inhibition DME1462 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1462 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02213 XEO_CLAS Peptide DME1462 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.39 ug/ml) DME1462 XEOTICID XEO02213 GENEFORM Protein DME1462 XEOTICID XEO02213 MOACRIVE Inhibition DME1462 XEOTICID XEO02224 XEO_NAME Androctonin DME1462 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02224 XEO_CLAS Peptide DME1462 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO02224 GENEFORM Protein DME1462 XEOTICID XEO02224 MOACRIVE Inhibition DME1462 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1462 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02230 XEO_CLAS Peptide DME1462 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.1-0.25 microM) DME1462 XEOTICID XEO02230 GENEFORM Protein DME1462 XEOTICID XEO02230 MOACRIVE Inhibition DME1462 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1462 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02242 XEO_CLAS Peptide DME1462 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 microM) DME1462 XEOTICID XEO02242 GENEFORM Protein DME1462 XEOTICID XEO02242 MOACRIVE Inhibition DME1462 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1462 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02243 XEO_CLAS Peptide DME1462 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 48 microM) DME1462 XEOTICID XEO02243 GENEFORM Protein DME1462 XEOTICID XEO02243 MOACRIVE Inhibition DME1462 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1462 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02244 XEO_CLAS Peptide DME1462 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 microM) DME1462 XEOTICID XEO02244 GENEFORM Protein DME1462 XEOTICID XEO02244 MOACRIVE Inhibition DME1462 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1462 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02248 XEO_CLAS Peptide DME1462 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1 microM) DME1462 XEOTICID XEO02248 GENEFORM Protein DME1462 XEOTICID XEO02248 MOACRIVE Inhibition DME1462 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1462 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02283 XEO_CLAS Peptide DME1462 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1.56 ug/ml) DME1462 XEOTICID XEO02283 GENEFORM Protein DME1462 XEOTICID XEO02283 MOACRIVE Inhibition DME1462 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1462 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02304 XEO_CLAS Peptide DME1462 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.1 ug/ml) DME1462 XEOTICID XEO02304 GENEFORM Protein DME1462 XEOTICID XEO02304 MOACRIVE Inhibition DME1462 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1462 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02305 XEO_CLAS Peptide DME1462 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.1 ug/ml) DME1462 XEOTICID XEO02305 GENEFORM Protein DME1462 XEOTICID XEO02305 MOACRIVE Inhibition DME1462 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1462 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02306 XEO_CLAS Peptide DME1462 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.1 ug/ml) DME1462 XEOTICID XEO02306 GENEFORM Protein DME1462 XEOTICID XEO02306 MOACRIVE Inhibition DME1462 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1462 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02333 XEO_CLAS Peptide DME1462 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC > 200 microM) DME1462 XEOTICID XEO02333 GENEFORM Protein DME1462 XEOTICID XEO02333 MOACRIVE Inhibition DME1462 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1462 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02356 XEO_CLAS Peptide DME1462 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 ug/ml) DME1462 XEOTICID XEO02356 GENEFORM Protein DME1462 XEOTICID XEO02356 MOACRIVE Inhibition DME1462 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1462 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02357 XEO_CLAS Peptide DME1462 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 31 ug/ml) DME1462 XEOTICID XEO02357 GENEFORM Protein DME1462 XEOTICID XEO02357 MOACRIVE Inhibition DME1462 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1462 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02358 XEO_CLAS Peptide DME1462 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 16 ug/ml) DME1462 XEOTICID XEO02358 GENEFORM Protein DME1462 XEOTICID XEO02358 MOACRIVE Inhibition DME1462 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1462 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02360 XEO_CLAS Peptide DME1462 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 ug/ml) DME1462 XEOTICID XEO02360 GENEFORM Protein DME1462 XEOTICID XEO02360 MOACRIVE Inhibition DME1462 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1462 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02361 XEO_CLAS Peptide DME1462 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 31 ug/ml) DME1462 XEOTICID XEO02361 GENEFORM Protein DME1462 XEOTICID XEO02361 MOACRIVE Inhibition DME1462 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1462 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02365 XEO_CLAS Peptide DME1462 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC > 64 ug/ml) DME1462 XEOTICID XEO02365 GENEFORM Protein DME1462 XEOTICID XEO02365 MOACRIVE Inhibition DME1462 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1462 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02366 XEO_CLAS Peptide DME1462 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 32 ug/ml) DME1462 XEOTICID XEO02366 GENEFORM Protein DME1462 XEOTICID XEO02366 MOACRIVE Inhibition DME1462 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1462 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02367 XEO_CLAS Peptide DME1462 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 ug/ml) DME1462 XEOTICID XEO02367 GENEFORM Protein DME1462 XEOTICID XEO02367 MOACRIVE Inhibition DME1462 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1462 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02368 XEO_CLAS Peptide DME1462 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 ug/ml) DME1462 XEOTICID XEO02368 GENEFORM Protein DME1462 XEOTICID XEO02368 MOACRIVE Inhibition DME1462 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1462 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02369 XEO_CLAS Peptide DME1462 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 ug/ml) DME1462 XEOTICID XEO02369 GENEFORM Protein DME1462 XEOTICID XEO02369 MOACRIVE Inhibition DME1462 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1462 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02370 XEO_CLAS Peptide DME1462 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2-10 microM) DME1462 XEOTICID XEO02370 GENEFORM Protein DME1462 XEOTICID XEO02370 MOACRIVE Inhibition DME1462 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1462 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02371 XEO_CLAS Peptide DME1462 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 12 ug/ml) DME1462 XEOTICID XEO02371 GENEFORM Protein DME1462 XEOTICID XEO02371 MOACRIVE Inhibition DME1462 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1462 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02378 XEO_CLAS Peptide DME1462 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.19 ug/ml) DME1462 XEOTICID XEO02378 GENEFORM Protein DME1462 XEOTICID XEO02378 MOACRIVE Inhibition DME1462 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1462 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02388 XEO_CLAS Peptide DME1462 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 ug/ml) DME1462 XEOTICID XEO02388 GENEFORM Protein DME1462 XEOTICID XEO02388 MOACRIVE Inhibition DME1462 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1462 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02389 XEO_CLAS Peptide DME1462 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2 ug/ml) DME1462 XEOTICID XEO02389 GENEFORM Protein DME1462 XEOTICID XEO02389 MOACRIVE Inhibition DME1462 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1462 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02451 XEO_CLAS Peptide DME1462 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO02451 GENEFORM Protein DME1462 XEOTICID XEO02451 MOACRIVE Inhibition DME1462 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1462 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02466 XEO_CLAS Peptide DME1462 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 3 microM) DME1462 XEOTICID XEO02466 GENEFORM Protein DME1462 XEOTICID XEO02466 MOACRIVE Inhibition DME1462 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1462 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02649 XEO_CLAS Peptide DME1462 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 ug/ml) DME1462 XEOTICID XEO02649 GENEFORM Protein DME1462 XEOTICID XEO02649 MOACRIVE Inhibition DME1462 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1462 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02650 XEO_CLAS Peptide DME1462 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1 ug/ml) DME1462 XEOTICID XEO02650 GENEFORM Protein DME1462 XEOTICID XEO02650 MOACRIVE Inhibition DME1462 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1462 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02734 XEO_CLAS Peptide DME1462 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.40 microM) DME1462 XEOTICID XEO02734 GENEFORM Protein DME1462 XEOTICID XEO02734 MOACRIVE Inhibition DME1462 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1462 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02735 XEO_CLAS Peptide DME1462 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1 ug/ml) DME1462 XEOTICID XEO02735 GENEFORM Protein DME1462 XEOTICID XEO02735 MOACRIVE Inhibition DME1462 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1462 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02736 XEO_CLAS Peptide DME1462 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.66 microM) DME1462 XEOTICID XEO02736 GENEFORM Protein DME1462 XEOTICID XEO02736 MOACRIVE Inhibition DME1462 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1462 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02738 XEO_CLAS Peptide DME1462 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2 microM) DME1462 XEOTICID XEO02738 GENEFORM Protein DME1462 XEOTICID XEO02738 MOACRIVE Inhibition DME1462 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1462 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02739 XEO_CLAS Peptide DME1462 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1 microM) DME1462 XEOTICID XEO02739 GENEFORM Protein DME1462 XEOTICID XEO02739 MOACRIVE Inhibition DME1462 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1462 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02740 XEO_CLAS Peptide DME1462 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1 ug/ml) DME1462 XEOTICID XEO02740 GENEFORM Protein DME1462 XEOTICID XEO02740 MOACRIVE Inhibition DME1462 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1462 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02768 XEO_CLAS Peptide DME1462 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1-2.5 ug/ml) DME1462 XEOTICID XEO02768 GENEFORM Protein DME1462 XEOTICID XEO02768 MOACRIVE Inhibition DME1462 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1462 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02774 XEO_CLAS Peptide DME1462 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.9 microM) DME1462 XEOTICID XEO02774 GENEFORM Protein DME1462 XEOTICID XEO02774 MOACRIVE Inhibition DME1462 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1462 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02799 XEO_CLAS Peptide DME1462 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 3 ug/ml) DME1462 XEOTICID XEO02799 GENEFORM Protein DME1462 XEOTICID XEO02799 MOACRIVE Inhibition DME1462 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1462 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02800 XEO_CLAS Peptide DME1462 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2 ug/ml) DME1462 XEOTICID XEO02800 GENEFORM Protein DME1462 XEOTICID XEO02800 MOACRIVE Inhibition DME1462 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1462 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02820 XEO_CLAS Peptide DME1462 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 64 ug/ml) DME1462 XEOTICID XEO02820 GENEFORM Protein DME1462 XEOTICID XEO02820 MOACRIVE Inhibition DME1462 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1462 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02885 XEO_CLAS Peptide DME1462 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 5 ug/ml) DME1462 XEOTICID XEO02885 GENEFORM Protein DME1462 XEOTICID XEO02885 MOACRIVE Inhibition DME1462 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1462 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02886 XEO_CLAS Peptide DME1462 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 ug/ml) DME1462 XEOTICID XEO02886 GENEFORM Protein DME1462 XEOTICID XEO02886 MOACRIVE Inhibition DME1462 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1462 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02887 XEO_CLAS Peptide DME1462 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 3 ug/ml) DME1462 XEOTICID XEO02887 GENEFORM Protein DME1462 XEOTICID XEO02887 MOACRIVE Inhibition DME1462 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1462 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02888 XEO_CLAS Peptide DME1462 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 3 ug/ml) DME1462 XEOTICID XEO02888 GENEFORM Protein DME1462 XEOTICID XEO02888 MOACRIVE Inhibition DME1462 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1462 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02889 XEO_CLAS Peptide DME1462 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 29 ug/ml) DME1462 XEOTICID XEO02889 GENEFORM Protein DME1462 XEOTICID XEO02889 MOACRIVE Inhibition DME1462 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1462 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02890 XEO_CLAS Peptide DME1462 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 ug/ml) DME1462 XEOTICID XEO02890 GENEFORM Protein DME1462 XEOTICID XEO02890 MOACRIVE Inhibition DME1462 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1462 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02891 XEO_CLAS Peptide DME1462 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 3 ug/ml) DME1462 XEOTICID XEO02891 GENEFORM Protein DME1462 XEOTICID XEO02891 MOACRIVE Inhibition DME1462 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1462 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02933 XEO_CLAS Peptide DME1462 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 43 ug/ml) DME1462 XEOTICID XEO02933 GENEFORM Protein DME1462 XEOTICID XEO02933 MOACRIVE Inhibition DME1462 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1462 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02934 XEO_CLAS Peptide DME1462 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 16 ug/ml) DME1462 XEOTICID XEO02934 GENEFORM Protein DME1462 XEOTICID XEO02934 MOACRIVE Inhibition DME1462 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1462 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02935 XEO_CLAS Peptide DME1462 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 ug/ml) DME1462 XEOTICID XEO02935 GENEFORM Protein DME1462 XEOTICID XEO02935 MOACRIVE Inhibition DME1462 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1462 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02937 XEO_CLAS Peptide DME1462 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 3 ug/ml) DME1462 XEOTICID XEO02937 GENEFORM Protein DME1462 XEOTICID XEO02937 MOACRIVE Inhibition DME1462 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1462 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02940 XEO_CLAS Peptide DME1462 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 3 ug/ml) DME1462 XEOTICID XEO02940 GENEFORM Protein DME1462 XEOTICID XEO02940 MOACRIVE Inhibition DME1462 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1462 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02941 XEO_CLAS Peptide DME1462 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2 ug/ml) DME1462 XEOTICID XEO02941 GENEFORM Protein DME1462 XEOTICID XEO02941 MOACRIVE Inhibition DME1462 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1462 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02947 XEO_CLAS Peptide DME1462 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 43 ug/ml) DME1462 XEOTICID XEO02947 GENEFORM Protein DME1462 XEOTICID XEO02947 MOACRIVE Inhibition DME1462 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1462 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02948 XEO_CLAS Peptide DME1462 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2 ug/ml) DME1462 XEOTICID XEO02948 GENEFORM Protein DME1462 XEOTICID XEO02948 MOACRIVE Inhibition DME1462 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1462 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02949 XEO_CLAS Peptide DME1462 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 ug/ml) DME1462 XEOTICID XEO02949 GENEFORM Protein DME1462 XEOTICID XEO02949 MOACRIVE Inhibition DME1462 XEOTICID XEO02955 XEO_NAME Cryptdin related sequence CRS4C-3c DME1462 XEOTICID XEO02955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02955 XEO_CLAS Peptide DME1462 XEOTICID XEO02955 DESCRIPT Cryptdin related sequence CRS4C-3c inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO02955 GENEFORM Protein DME1462 XEOTICID XEO02955 MOACRIVE Inhibition DME1462 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1462 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02958 XEO_CLAS Peptide DME1462 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO02958 GENEFORM Protein DME1462 XEOTICID XEO02958 MOACRIVE Inhibition DME1462 XEOTICID XEO02959 XEO_NAME Cryptdin related peptide CRS4C-1d DME1462 XEOTICID XEO02959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02959 XEO_CLAS Peptide DME1462 XEOTICID XEO02959 DESCRIPT Cryptdin related peptide CRS4C-1d inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO02959 GENEFORM Protein DME1462 XEOTICID XEO02959 MOACRIVE Inhibition DME1462 XEOTICID XEO02960 XEO_NAME Cryptdin related peptide CRS4C-2 DME1462 XEOTICID XEO02960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02960 XEO_CLAS Peptide DME1462 XEOTICID XEO02960 DESCRIPT Cryptdin related peptide CRS4C-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO02960 GENEFORM Protein DME1462 XEOTICID XEO02960 MOACRIVE Inhibition DME1462 XEOTICID XEO02961 XEO_NAME Cryptdin related peptide CRS4C-2b DME1462 XEOTICID XEO02961 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO02961 XEO_CLAS Peptide DME1462 XEOTICID XEO02961 DESCRIPT Cryptdin related peptide CRS4C-2b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO02961 GENEFORM Protein DME1462 XEOTICID XEO02961 MOACRIVE Inhibition DME1462 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1462 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03043 XEO_CLAS Peptide DME1462 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2 microM) DME1462 XEOTICID XEO03043 GENEFORM Protein DME1462 XEOTICID XEO03043 MOACRIVE Inhibition DME1462 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1462 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03052 XEO_CLAS Peptide DME1462 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 50 ug/ml) DME1462 XEOTICID XEO03052 GENEFORM Protein DME1462 XEOTICID XEO03052 MOACRIVE Inhibition DME1462 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1462 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03053 XEO_CLAS Peptide DME1462 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 125 ug/ml) DME1462 XEOTICID XEO03053 GENEFORM Protein DME1462 XEOTICID XEO03053 MOACRIVE Inhibition DME1462 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1462 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03060 XEO_CLAS Peptide DME1462 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2 microM) DME1462 XEOTICID XEO03060 GENEFORM Protein DME1462 XEOTICID XEO03060 MOACRIVE Inhibition DME1462 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1462 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03125 XEO_CLAS Peptide DME1462 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO03125 GENEFORM Protein DME1462 XEOTICID XEO03125 MOACRIVE Inhibition DME1462 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1462 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03162 XEO_CLAS Peptide DME1462 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 3.1 microM) DME1462 XEOTICID XEO03162 GENEFORM Protein DME1462 XEOTICID XEO03162 MOACRIVE Inhibition DME1462 XEOTICID XEO03164 XEO_NAME Dermatoxin DME1462 XEOTICID XEO03164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03164 XEO_CLAS Peptide DME1462 XEOTICID XEO03164 DESCRIPT Dermatoxin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO03164 GENEFORM Protein DME1462 XEOTICID XEO03164 MOACRIVE Inhibition DME1462 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1462 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03224 XEO_CLAS Peptide DME1462 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.5-1 microM) DME1462 XEOTICID XEO03224 GENEFORM Protein DME1462 XEOTICID XEO03224 MOACRIVE Inhibition DME1462 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1462 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03251 XEO_CLAS Peptide DME1462 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO03251 GENEFORM Protein DME1462 XEOTICID XEO03251 MOACRIVE Inhibition DME1462 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1462 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03428 XEO_CLAS Peptide DME1462 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 63 ug/ml) DME1462 XEOTICID XEO03428 GENEFORM Protein DME1462 XEOTICID XEO03428 MOACRIVE Inhibition DME1462 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1462 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03430 XEO_CLAS Peptide DME1462 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 63 ug/ml) DME1462 XEOTICID XEO03430 GENEFORM Protein DME1462 XEOTICID XEO03430 MOACRIVE Inhibition DME1462 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1462 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03434 XEO_CLAS Peptide DME1462 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 31 ug/ml) DME1462 XEOTICID XEO03434 GENEFORM Protein DME1462 XEOTICID XEO03434 MOACRIVE Inhibition DME1462 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1462 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03437 XEO_CLAS Peptide DME1462 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 150 ug/ml) DME1462 XEOTICID XEO03437 GENEFORM Protein DME1462 XEOTICID XEO03437 MOACRIVE Inhibition DME1462 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1462 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03438 XEO_CLAS Peptide DME1462 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 150 ug/ml) DME1462 XEOTICID XEO03438 GENEFORM Protein DME1462 XEOTICID XEO03438 MOACRIVE Inhibition DME1462 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1462 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03439 XEO_CLAS Peptide DME1462 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 200 ug/ml) DME1462 XEOTICID XEO03439 GENEFORM Protein DME1462 XEOTICID XEO03439 MOACRIVE Inhibition DME1462 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1462 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03440 XEO_CLAS Peptide DME1462 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 200 ug/ml) DME1462 XEOTICID XEO03440 GENEFORM Protein DME1462 XEOTICID XEO03440 MOACRIVE Inhibition DME1462 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1462 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03441 XEO_CLAS Peptide DME1462 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 200 ug/ml) DME1462 XEOTICID XEO03441 GENEFORM Protein DME1462 XEOTICID XEO03441 MOACRIVE Inhibition DME1462 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1462 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03462 XEO_CLAS Peptide DME1462 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO03462 GENEFORM Protein DME1462 XEOTICID XEO03462 MOACRIVE Inhibition DME1462 XEOTICID XEO03464 XEO_NAME Gallinacin-4 DME1462 XEOTICID XEO03464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03464 XEO_CLAS Peptide DME1462 XEOTICID XEO03464 DESCRIPT Gallinacin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO03464 GENEFORM Protein DME1462 XEOTICID XEO03464 MOACRIVE Inhibition DME1462 XEOTICID XEO03465 XEO_NAME Gallinacin-5 DME1462 XEOTICID XEO03465 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03465 XEO_CLAS Peptide DME1462 XEOTICID XEO03465 DESCRIPT Gallinacin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO03465 GENEFORM Protein DME1462 XEOTICID XEO03465 MOACRIVE Inhibition DME1462 XEOTICID XEO03466 XEO_NAME Gallinacin-6 DME1462 XEOTICID XEO03466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03466 XEO_CLAS Peptide DME1462 XEOTICID XEO03466 DESCRIPT Gallinacin-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO03466 GENEFORM Protein DME1462 XEOTICID XEO03466 MOACRIVE Inhibition DME1462 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1462 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03467 XEO_CLAS Peptide DME1462 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO03467 GENEFORM Protein DME1462 XEOTICID XEO03467 MOACRIVE Inhibition DME1462 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1462 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03498 XEO_CLAS Peptide DME1462 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.8-1.6 microM) DME1462 XEOTICID XEO03498 GENEFORM Protein DME1462 XEOTICID XEO03498 MOACRIVE Inhibition DME1462 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1462 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03504 XEO_CLAS Peptide DME1462 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC > 50 ug/ml) DME1462 XEOTICID XEO03504 GENEFORM Protein DME1462 XEOTICID XEO03504 MOACRIVE Inhibition DME1462 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1462 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03505 XEO_CLAS Peptide DME1462 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 12.5 ug/ml) DME1462 XEOTICID XEO03505 GENEFORM Protein DME1462 XEOTICID XEO03505 MOACRIVE Inhibition DME1462 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1462 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03506 XEO_CLAS Peptide DME1462 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 12.5 ug/ml) DME1462 XEOTICID XEO03506 GENEFORM Protein DME1462 XEOTICID XEO03506 MOACRIVE Inhibition DME1462 XEOTICID XEO03519 XEO_NAME Hadrurin DME1462 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03519 XEO_CLAS Peptide DME1462 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO03519 GENEFORM Protein DME1462 XEOTICID XEO03519 MOACRIVE Inhibition DME1462 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1462 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03609 XEO_CLAS Peptide DME1462 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO03609 GENEFORM Protein DME1462 XEOTICID XEO03609 MOACRIVE Inhibition DME1462 XEOTICID XEO03671 XEO_NAME Plant JCpep7 DME1462 XEOTICID XEO03671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03671 XEO_CLAS Peptide DME1462 XEOTICID XEO03671 DESCRIPT Plant JCpep7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 48 ug/ml) DME1462 XEOTICID XEO03671 GENEFORM Protein DME1462 XEOTICID XEO03671 MOACRIVE Inhibition DME1462 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1462 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03684 XEO_CLAS Peptide DME1462 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 63 ug/ml) DME1462 XEOTICID XEO03684 GENEFORM Protein DME1462 XEOTICID XEO03684 MOACRIVE Inhibition DME1462 XEOTICID XEO03721 XEO_NAME Kunitz-type serine protease inhibitor Xb-KTI DME1462 XEOTICID XEO03721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03721 XEO_CLAS Peptide DME1462 XEOTICID XEO03721 DESCRIPT Kunitz-type serine protease inhibitor Xb-KTI inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 10 microM) DME1462 XEOTICID XEO03721 GENEFORM Protein DME1462 XEOTICID XEO03721 MOACRIVE Inhibition DME1462 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1462 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03746 XEO_CLAS Peptide DME1462 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2 ug/ml) DME1462 XEOTICID XEO03746 GENEFORM Protein DME1462 XEOTICID XEO03746 MOACRIVE Inhibition DME1462 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1462 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03747 XEO_CLAS Peptide DME1462 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1 ug/ml) DME1462 XEOTICID XEO03747 GENEFORM Protein DME1462 XEOTICID XEO03747 MOACRIVE Inhibition DME1462 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1462 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03748 XEO_CLAS Peptide DME1462 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 ug/ml) DME1462 XEOTICID XEO03748 GENEFORM Protein DME1462 XEOTICID XEO03748 MOACRIVE Inhibition DME1462 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1462 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03749 XEO_CLAS Peptide DME1462 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2 ug/ml) DME1462 XEOTICID XEO03749 GENEFORM Protein DME1462 XEOTICID XEO03749 MOACRIVE Inhibition DME1462 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1462 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03750 XEO_CLAS Peptide DME1462 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 ug/ml) DME1462 XEOTICID XEO03750 GENEFORM Protein DME1462 XEOTICID XEO03750 MOACRIVE Inhibition DME1462 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1462 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03751 XEO_CLAS Peptide DME1462 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 ug/ml) DME1462 XEOTICID XEO03751 GENEFORM Protein DME1462 XEOTICID XEO03751 MOACRIVE Inhibition DME1462 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1462 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03752 XEO_CLAS Peptide DME1462 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2 ug/ml) DME1462 XEOTICID XEO03752 GENEFORM Protein DME1462 XEOTICID XEO03752 MOACRIVE Inhibition DME1462 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1462 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03754 XEO_CLAS Peptide DME1462 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 ug/ml) DME1462 XEOTICID XEO03754 GENEFORM Protein DME1462 XEOTICID XEO03754 MOACRIVE Inhibition DME1462 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1462 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03755 XEO_CLAS Peptide DME1462 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 ug/ml) DME1462 XEOTICID XEO03755 GENEFORM Protein DME1462 XEOTICID XEO03755 MOACRIVE Inhibition DME1462 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1462 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03756 XEO_CLAS Peptide DME1462 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2 ug/ml) DME1462 XEOTICID XEO03756 GENEFORM Protein DME1462 XEOTICID XEO03756 MOACRIVE Inhibition DME1462 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1462 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03793 XEO_CLAS Peptide DME1462 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 microM) DME1462 XEOTICID XEO03793 GENEFORM Protein DME1462 XEOTICID XEO03793 MOACRIVE Inhibition DME1462 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1462 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03904 XEO_CLAS Peptide DME1462 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 32 ug/ml) DME1462 XEOTICID XEO03904 GENEFORM Protein DME1462 XEOTICID XEO03904 MOACRIVE Inhibition DME1462 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1462 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03905 XEO_CLAS Peptide DME1462 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC > 64 ug/ml) DME1462 XEOTICID XEO03905 GENEFORM Protein DME1462 XEOTICID XEO03905 MOACRIVE Inhibition DME1462 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1462 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO03928 XEO_CLAS Peptide DME1462 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 16 microM) DME1462 XEOTICID XEO03928 GENEFORM Protein DME1462 XEOTICID XEO03928 MOACRIVE Inhibition DME1462 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1462 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04039 XEO_CLAS Peptide DME1462 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1 microM) DME1462 XEOTICID XEO04039 GENEFORM Protein DME1462 XEOTICID XEO04039 MOACRIVE Inhibition DME1462 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1462 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04111 XEO_CLAS Peptide DME1462 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO04111 GENEFORM Protein DME1462 XEOTICID XEO04111 MOACRIVE Inhibition DME1462 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1462 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04112 XEO_CLAS Peptide DME1462 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1.2 microM) DME1462 XEOTICID XEO04112 GENEFORM Protein DME1462 XEOTICID XEO04112 MOACRIVE Inhibition DME1462 XEOTICID XEO04117 XEO_NAME Misgurin DME1462 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04117 XEO_CLAS Peptide DME1462 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO04117 GENEFORM Protein DME1462 XEOTICID XEO04117 MOACRIVE Inhibition DME1462 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1462 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04142 XEO_CLAS Peptide DME1462 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 32.64 microM) DME1462 XEOTICID XEO04142 GENEFORM Protein DME1462 XEOTICID XEO04142 MOACRIVE Inhibition DME1462 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1462 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04158 XEO_CLAS Peptide DME1462 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 microM) DME1462 XEOTICID XEO04158 GENEFORM Protein DME1462 XEOTICID XEO04158 MOACRIVE Inhibition DME1462 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1462 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04159 XEO_CLAS Peptide DME1462 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2 microM) DME1462 XEOTICID XEO04159 GENEFORM Protein DME1462 XEOTICID XEO04159 MOACRIVE Inhibition DME1462 XEOTICID XEO04252 XEO_NAME Neutrophil antibiotic peptide NP-2 DME1462 XEOTICID XEO04252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04252 XEO_CLAS Peptide DME1462 XEOTICID XEO04252 DESCRIPT Neutrophil antibiotic peptide NP-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO04252 GENEFORM Protein DME1462 XEOTICID XEO04252 MOACRIVE Inhibition DME1462 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1462 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04426 XEO_CLAS Peptide DME1462 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 microM) DME1462 XEOTICID XEO04426 GENEFORM Protein DME1462 XEOTICID XEO04426 MOACRIVE Inhibition DME1462 XEOTICID XEO04481 XEO_NAME Porcine beta-defensin pBD-2 DME1462 XEOTICID XEO04481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04481 XEO_CLAS Peptide DME1462 XEOTICID XEO04481 DESCRIPT Porcine beta-defensin pBD-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO04481 GENEFORM Protein DME1462 XEOTICID XEO04481 MOACRIVE Inhibition DME1462 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1462 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04526 XEO_CLAS Peptide DME1462 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1.0 microM) DME1462 XEOTICID XEO04526 GENEFORM Protein DME1462 XEOTICID XEO04526 MOACRIVE Inhibition DME1462 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1462 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04613 XEO_CLAS Peptide DME1462 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 10-20 microM) DME1462 XEOTICID XEO04613 GENEFORM Protein DME1462 XEOTICID XEO04613 MOACRIVE Inhibition DME1462 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1462 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04627 XEO_CLAS Peptide DME1462 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 25.25 microM) DME1462 XEOTICID XEO04627 GENEFORM Protein DME1462 XEOTICID XEO04627 MOACRIVE Inhibition DME1462 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1462 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04640 XEO_CLAS Peptide DME1462 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8.8-17.7 microM) DME1462 XEOTICID XEO04640 GENEFORM Protein DME1462 XEOTICID XEO04640 MOACRIVE Inhibition DME1462 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1462 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04653 XEO_CLAS Peptide DME1462 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC > 64 ug/ml) DME1462 XEOTICID XEO04653 GENEFORM Protein DME1462 XEOTICID XEO04653 MOACRIVE Inhibition DME1462 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1462 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04654 XEO_CLAS Peptide DME1462 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 64 ug/ml) DME1462 XEOTICID XEO04654 GENEFORM Protein DME1462 XEOTICID XEO04654 MOACRIVE Inhibition DME1462 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1462 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04660 XEO_CLAS Peptide DME1462 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2 ug/ml) DME1462 XEOTICID XEO04660 GENEFORM Protein DME1462 XEOTICID XEO04660 MOACRIVE Inhibition DME1462 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1462 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04690 XEO_CLAS Peptide DME1462 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.25 ug/ml) DME1462 XEOTICID XEO04690 GENEFORM Protein DME1462 XEOTICID XEO04690 MOACRIVE Inhibition DME1462 XEOTICID XEO04770 XEO_NAME Pyrrhocoricin DME1462 XEOTICID XEO04770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04770 XEO_CLAS Peptide DME1462 XEOTICID XEO04770 DESCRIPT Pyrrhocoricin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 5 microM) DME1462 XEOTICID XEO04770 GENEFORM Protein DME1462 XEOTICID XEO04770 MOACRIVE Inhibition DME1462 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1462 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04783 XEO_CLAS Peptide DME1462 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 ug/ml) DME1462 XEOTICID XEO04783 GENEFORM Protein DME1462 XEOTICID XEO04783 MOACRIVE Inhibition DME1462 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1462 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04784 XEO_CLAS Peptide DME1462 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 ug/ml) DME1462 XEOTICID XEO04784 GENEFORM Protein DME1462 XEOTICID XEO04784 MOACRIVE Inhibition DME1462 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1462 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04785 XEO_CLAS Peptide DME1462 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 ug/ml) DME1462 XEOTICID XEO04785 GENEFORM Protein DME1462 XEOTICID XEO04785 MOACRIVE Inhibition DME1462 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1462 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04786 XEO_CLAS Peptide DME1462 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 31 ug/ml) DME1462 XEOTICID XEO04786 GENEFORM Protein DME1462 XEOTICID XEO04786 MOACRIVE Inhibition DME1462 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1462 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04840 XEO_CLAS Peptide DME1462 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC > 20 microM) DME1462 XEOTICID XEO04840 GENEFORM Protein DME1462 XEOTICID XEO04840 MOACRIVE Inhibition DME1462 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1462 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04848 XEO_CLAS Peptide DME1462 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO04848 GENEFORM Protein DME1462 XEOTICID XEO04848 MOACRIVE Inhibition DME1462 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1462 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04849 XEO_CLAS Peptide DME1462 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO04849 GENEFORM Protein DME1462 XEOTICID XEO04849 MOACRIVE Inhibition DME1462 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1462 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04850 XEO_CLAS Peptide DME1462 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO04850 GENEFORM Protein DME1462 XEOTICID XEO04850 MOACRIVE Inhibition DME1462 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1462 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04880 XEO_CLAS Peptide DME1462 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 12.7 ug/ml) DME1462 XEOTICID XEO04880 GENEFORM Protein DME1462 XEOTICID XEO04880 MOACRIVE Inhibition DME1462 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1462 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04886 XEO_CLAS Peptide DME1462 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 1.0 ug/ml) DME1462 XEOTICID XEO04886 GENEFORM Protein DME1462 XEOTICID XEO04886 MOACRIVE Inhibition DME1462 XEOTICID XEO04931 XEO_NAME Shepherin I DME1462 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04931 XEO_CLAS Peptide DME1462 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO04931 GENEFORM Protein DME1462 XEOTICID XEO04931 MOACRIVE Inhibition DME1462 XEOTICID XEO04932 XEO_NAME shepherin II DME1462 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04932 XEO_CLAS Peptide DME1462 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO04932 GENEFORM Protein DME1462 XEOTICID XEO04932 MOACRIVE Inhibition DME1462 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1462 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04956 XEO_CLAS Peptide DME1462 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8.0 microM) DME1462 XEOTICID XEO04956 GENEFORM Protein DME1462 XEOTICID XEO04956 MOACRIVE Inhibition DME1462 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1462 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04971 XEO_CLAS Peptide DME1462 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 6-12 microM) DME1462 XEOTICID XEO04971 GENEFORM Protein DME1462 XEOTICID XEO04971 MOACRIVE Inhibition DME1462 XEOTICID XEO04974 XEO_NAME Spinigerin DME1462 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04974 XEO_CLAS Peptide DME1462 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 3-6 microM) DME1462 XEOTICID XEO04974 GENEFORM Protein DME1462 XEOTICID XEO04974 MOACRIVE Inhibition DME1462 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1462 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04995 XEO_CLAS Peptide DME1462 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.39-0.78 microM) DME1462 XEOTICID XEO04995 GENEFORM Protein DME1462 XEOTICID XEO04995 MOACRIVE Inhibition DME1462 XEOTICID XEO04998 XEO_NAME Styelin A DME1462 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04998 XEO_CLAS Peptide DME1462 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 5 ug/ml) DME1462 XEOTICID XEO04998 GENEFORM Protein DME1462 XEOTICID XEO04998 MOACRIVE Inhibition DME1462 XEOTICID XEO04999 XEO_NAME Styelin B DME1462 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO04999 XEO_CLAS Peptide DME1462 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 5 ug/ml) DME1462 XEOTICID XEO04999 GENEFORM Protein DME1462 XEOTICID XEO04999 MOACRIVE Inhibition DME1462 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1462 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05000 XEO_CLAS Peptide DME1462 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 ug/ml) DME1462 XEOTICID XEO05000 GENEFORM Protein DME1462 XEOTICID XEO05000 MOACRIVE Inhibition DME1462 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1462 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05001 XEO_CLAS Peptide DME1462 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 4 ug/ml) DME1462 XEOTICID XEO05001 GENEFORM Protein DME1462 XEOTICID XEO05001 MOACRIVE Inhibition DME1462 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1462 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05002 XEO_CLAS Peptide DME1462 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 ug/ml) DME1462 XEOTICID XEO05002 GENEFORM Protein DME1462 XEOTICID XEO05002 MOACRIVE Inhibition DME1462 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1462 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05003 XEO_CLAS Peptide DME1462 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 16 ug/ml) DME1462 XEOTICID XEO05003 GENEFORM Protein DME1462 XEOTICID XEO05003 MOACRIVE Inhibition DME1462 XEOTICID XEO05020 XEO_NAME Tachycitin DME1462 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05020 XEO_CLAS Peptide DME1462 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO05020 GENEFORM Protein DME1462 XEOTICID XEO05020 MOACRIVE Inhibition DME1462 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1462 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05119 XEO_CLAS Peptide DME1462 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO05119 GENEFORM Protein DME1462 XEOTICID XEO05119 MOACRIVE Inhibition DME1462 XEOTICID XEO05120 XEO_NAME Thanatin DME1462 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05120 XEO_CLAS Peptide DME1462 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 0.6-1.2 microM) DME1462 XEOTICID XEO05120 GENEFORM Protein DME1462 XEOTICID XEO05120 MOACRIVE Inhibition DME1462 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1462 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05161 XEO_CLAS Peptide DME1462 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 32 ug/ml) DME1462 XEOTICID XEO05161 GENEFORM Protein DME1462 XEOTICID XEO05161 MOACRIVE Inhibition DME1462 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1462 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05162 XEO_CLAS Peptide DME1462 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 32 ug/ml) DME1462 XEOTICID XEO05162 GENEFORM Protein DME1462 XEOTICID XEO05162 MOACRIVE Inhibition DME1462 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1462 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05193 XEO_CLAS Peptide DME1462 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 ug/ml) DME1462 XEOTICID XEO05193 GENEFORM Protein DME1462 XEOTICID XEO05193 MOACRIVE Inhibition DME1462 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1462 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05212 XEO_CLAS Peptide DME1462 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 2.5 ug/ml) DME1462 XEOTICID XEO05212 GENEFORM Protein DME1462 XEOTICID XEO05212 MOACRIVE Inhibition DME1462 XEOTICID XEO05222 XEO_NAME Plant defensin VaD1 DME1462 XEOTICID XEO05222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05222 XEO_CLAS Peptide DME1462 XEOTICID XEO05222 DESCRIPT Plant defensin VaD1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica DME1462 XEOTICID XEO05222 GENEFORM Protein DME1462 XEOTICID XEO05222 MOACRIVE Inhibition DME1462 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1462 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05231 XEO_CLAS Peptide DME1462 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 10.9 microM) DME1462 XEOTICID XEO05231 GENEFORM Protein DME1462 XEOTICID XEO05231 MOACRIVE Inhibition DME1462 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1462 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05264 XEO_CLAS Peptide DME1462 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 ug/ml) DME1462 XEOTICID XEO05264 GENEFORM Protein DME1462 XEOTICID XEO05264 MOACRIVE Inhibition DME1462 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1462 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1462 XEOTICID XEO05267 XEO_CLAS Peptide DME1462 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Salmonella enterica (MIC = 8 ug/ml) DME1462 XEOTICID XEO05267 GENEFORM Protein DME1462 XEOTICID XEO05267 MOACRIVE Inhibition DME1472 DME___ID DME1472 DME1472 DME_NAME Cytochrome P450 21A2 (cyp21) DME1472 SPESNAME Bacillus megaterium DME1472 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1472 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO01823 XEO_CLAS Peptide DME1472 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1.56 microM) DME1472 XEOTICID XEO01823 GENEFORM Protein DME1472 XEOTICID XEO01823 MOACRIVE Inhibition DME1472 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1472 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO01824 XEO_CLAS Peptide DME1472 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3.125 microM) DME1472 XEOTICID XEO01824 GENEFORM Protein DME1472 XEOTICID XEO01824 MOACRIVE Inhibition DME1472 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1472 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO01825 XEO_CLAS Peptide DME1472 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3.125 microM) DME1472 XEOTICID XEO01825 GENEFORM Protein DME1472 XEOTICID XEO01825 MOACRIVE Inhibition DME1472 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1472 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO01827 XEO_CLAS Peptide DME1472 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3.12-6.25 microM) DME1472 XEOTICID XEO01827 GENEFORM Protein DME1472 XEOTICID XEO01827 MOACRIVE Inhibition DME1472 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1472 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02230 XEO_CLAS Peptide DME1472 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.5-1 microM) DME1472 XEOTICID XEO02230 GENEFORM Protein DME1472 XEOTICID XEO02230 MOACRIVE Inhibition DME1472 XEOTICID XEO02237 XEO_NAME Antibacterial napin DME1472 XEOTICID XEO02237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02237 XEO_CLAS Peptide DME1472 XEOTICID XEO02237 DESCRIPT Antibacterial napin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 215 microM) DME1472 XEOTICID XEO02237 GENEFORM Protein DME1472 XEOTICID XEO02237 MOACRIVE Inhibition DME1472 XEOTICID XEO02238 XEO_NAME Antibacterial peptide 3910 DME1472 XEOTICID XEO02238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02238 XEO_CLAS Peptide DME1472 XEOTICID XEO02238 DESCRIPT Antibacterial peptide 3910 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO02238 GENEFORM Protein DME1472 XEOTICID XEO02238 MOACRIVE Inhibition DME1472 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1472 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02242 XEO_CLAS Peptide DME1472 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2 microM) DME1472 XEOTICID XEO02242 GENEFORM Protein DME1472 XEOTICID XEO02242 MOACRIVE Inhibition DME1472 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1472 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02243 XEO_CLAS Peptide DME1472 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3 microM) DME1472 XEOTICID XEO02243 GENEFORM Protein DME1472 XEOTICID XEO02243 MOACRIVE Inhibition DME1472 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1472 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02244 XEO_CLAS Peptide DME1472 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 4 microM) DME1472 XEOTICID XEO02244 GENEFORM Protein DME1472 XEOTICID XEO02244 MOACRIVE Inhibition DME1472 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1472 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02248 XEO_CLAS Peptide DME1472 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.3 microM) DME1472 XEOTICID XEO02248 GENEFORM Protein DME1472 XEOTICID XEO02248 MOACRIVE Inhibition DME1472 XEOTICID XEO02259 XEO_NAME Antimicrobial peptide AC-AMP1 DME1472 XEOTICID XEO02259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02259 XEO_CLAS Peptide DME1472 XEOTICID XEO02259 DESCRIPT Antimicrobial peptide AC-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO02259 GENEFORM Protein DME1472 XEOTICID XEO02259 MOACRIVE Inhibition DME1472 XEOTICID XEO02262 XEO_NAME Antimicrobial peptide MJ-AMP1 DME1472 XEOTICID XEO02262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02262 XEO_CLAS Peptide DME1472 XEOTICID XEO02262 DESCRIPT Antimicrobial peptide MJ-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 6 ug/ml) DME1472 XEOTICID XEO02262 GENEFORM Protein DME1472 XEOTICID XEO02262 MOACRIVE Inhibition DME1472 XEOTICID XEO02267 XEO_NAME Antimicrobial peptide AC-AMP2 DME1472 XEOTICID XEO02267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02267 XEO_CLAS Peptide DME1472 XEOTICID XEO02267 DESCRIPT Antimicrobial peptide AC-AMP2 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO02267 GENEFORM Protein DME1472 XEOTICID XEO02267 MOACRIVE Inhibition DME1472 XEOTICID XEO02269 XEO_NAME Antimicrobial peptide MJ-AMP2 DME1472 XEOTICID XEO02269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02269 XEO_CLAS Peptide DME1472 XEOTICID XEO02269 DESCRIPT Antimicrobial peptide MJ-AMP2 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2 ug/ml) DME1472 XEOTICID XEO02269 GENEFORM Protein DME1472 XEOTICID XEO02269 MOACRIVE Inhibition DME1472 XEOTICID XEO02282 XEO_NAME Antimicrobial peptide GP-19 DME1472 XEOTICID XEO02282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02282 XEO_CLAS Peptide DME1472 XEOTICID XEO02282 DESCRIPT Antimicrobial peptide GP-19 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO02282 GENEFORM Protein DME1472 XEOTICID XEO02282 MOACRIVE Inhibition DME1472 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1472 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02293 XEO_CLAS Peptide DME1472 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.8 microM) DME1472 XEOTICID XEO02293 GENEFORM Protein DME1472 XEOTICID XEO02293 MOACRIVE Inhibition DME1472 XEOTICID XEO02299 XEO_NAME Antimicrobial protein Ace-AMP1 DME1472 XEOTICID XEO02299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02299 XEO_CLAS Peptide DME1472 XEOTICID XEO02299 DESCRIPT Antimicrobial protein Ace-AMP1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO02299 GENEFORM Protein DME1472 XEOTICID XEO02299 MOACRIVE Inhibition DME1472 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1472 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02304 XEO_CLAS Peptide DME1472 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 150 ug/ml) DME1472 XEOTICID XEO02304 GENEFORM Protein DME1472 XEOTICID XEO02304 MOACRIVE Inhibition DME1472 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1472 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02305 XEO_CLAS Peptide DME1472 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 100 ug/ml) DME1472 XEOTICID XEO02305 GENEFORM Protein DME1472 XEOTICID XEO02305 MOACRIVE Inhibition DME1472 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1472 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02306 XEO_CLAS Peptide DME1472 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 100 ug/ml) DME1472 XEOTICID XEO02306 GENEFORM Protein DME1472 XEOTICID XEO02306 MOACRIVE Inhibition DME1472 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1472 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02319 XEO_CLAS Peptide DME1472 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.5-1.25 microM) DME1472 XEOTICID XEO02319 GENEFORM Protein DME1472 XEOTICID XEO02319 MOACRIVE Inhibition DME1472 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1472 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02333 XEO_CLAS Peptide DME1472 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC > 200 microM) DME1472 XEOTICID XEO02333 GENEFORM Protein DME1472 XEOTICID XEO02333 MOACRIVE Inhibition DME1472 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1472 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02466 XEO_CLAS Peptide DME1472 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3 microM) DME1472 XEOTICID XEO02466 GENEFORM Protein DME1472 XEOTICID XEO02466 MOACRIVE Inhibition DME1472 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1472 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02468 XEO_CLAS Peptide DME1472 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3.3 microM) DME1472 XEOTICID XEO02468 GENEFORM Protein DME1472 XEOTICID XEO02468 MOACRIVE Inhibition DME1472 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1472 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02474 XEO_CLAS Peptide DME1472 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.3 microM) DME1472 XEOTICID XEO02474 GENEFORM Protein DME1472 XEOTICID XEO02474 MOACRIVE Inhibition DME1472 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1472 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02475 XEO_CLAS Peptide DME1472 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.3 microM) DME1472 XEOTICID XEO02475 GENEFORM Protein DME1472 XEOTICID XEO02475 MOACRIVE Inhibition DME1472 XEOTICID XEO02476 XEO_NAME Bacteriocin HJ50 DME1472 XEOTICID XEO02476 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02476 XEO_CLAS Peptide DME1472 XEOTICID XEO02476 DESCRIPT Bacteriocin HJ50 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO02476 GENEFORM Protein DME1472 XEOTICID XEO02476 MOACRIVE Inhibition DME1472 XEOTICID XEO02521 XEO_NAME Brevinin-1E DME1472 XEOTICID XEO02521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02521 XEO_CLAS Peptide DME1472 XEOTICID XEO02521 DESCRIPT Brevinin-1E inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.4 microM) DME1472 XEOTICID XEO02521 GENEFORM Protein DME1472 XEOTICID XEO02521 MOACRIVE Inhibition DME1472 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1472 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02584 XEO_CLAS Peptide DME1472 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.2 microM) DME1472 XEOTICID XEO02584 GENEFORM Protein DME1472 XEOTICID XEO02584 MOACRIVE Inhibition DME1472 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1472 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02663 XEO_CLAS Peptide DME1472 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1.56 microM) DME1472 XEOTICID XEO02663 GENEFORM Protein DME1472 XEOTICID XEO02663 MOACRIVE Inhibition DME1472 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1472 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02664 XEO_CLAS Peptide DME1472 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3.125 microM) DME1472 XEOTICID XEO02664 GENEFORM Protein DME1472 XEOTICID XEO02664 MOACRIVE Inhibition DME1472 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1472 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02672 XEO_CLAS Peptide DME1472 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1.56 microM) DME1472 XEOTICID XEO02672 GENEFORM Protein DME1472 XEOTICID XEO02672 MOACRIVE Inhibition DME1472 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1472 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02673 XEO_CLAS Peptide DME1472 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3.125 microM) DME1472 XEOTICID XEO02673 GENEFORM Protein DME1472 XEOTICID XEO02673 MOACRIVE Inhibition DME1472 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1472 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02674 XEO_CLAS Peptide DME1472 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3.125 microM) DME1472 XEOTICID XEO02674 GENEFORM Protein DME1472 XEOTICID XEO02674 MOACRIVE Inhibition DME1472 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1472 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02676 XEO_CLAS Peptide DME1472 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1.56 microM) DME1472 XEOTICID XEO02676 GENEFORM Protein DME1472 XEOTICID XEO02676 MOACRIVE Inhibition DME1472 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1472 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02677 XEO_CLAS Peptide DME1472 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3.125 microM) DME1472 XEOTICID XEO02677 GENEFORM Protein DME1472 XEOTICID XEO02677 MOACRIVE Inhibition DME1472 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1472 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02679 XEO_CLAS Peptide DME1472 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3.125 microM) DME1472 XEOTICID XEO02679 GENEFORM Protein DME1472 XEOTICID XEO02679 MOACRIVE Inhibition DME1472 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1472 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02680 XEO_CLAS Peptide DME1472 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3.125 microM) DME1472 XEOTICID XEO02680 GENEFORM Protein DME1472 XEOTICID XEO02680 MOACRIVE Inhibition DME1472 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1472 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02683 XEO_CLAS Peptide DME1472 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3.125 microM) DME1472 XEOTICID XEO02683 GENEFORM Protein DME1472 XEOTICID XEO02683 MOACRIVE Inhibition DME1472 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1472 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02731 XEO_CLAS Peptide DME1472 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 4 microM) DME1472 XEOTICID XEO02731 GENEFORM Protein DME1472 XEOTICID XEO02731 MOACRIVE Inhibition DME1472 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1472 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02739 XEO_CLAS Peptide DME1472 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2 microM) DME1472 XEOTICID XEO02739 GENEFORM Protein DME1472 XEOTICID XEO02739 MOACRIVE Inhibition DME1472 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1472 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02740 XEO_CLAS Peptide DME1472 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2 ug/ml) DME1472 XEOTICID XEO02740 GENEFORM Protein DME1472 XEOTICID XEO02740 MOACRIVE Inhibition DME1472 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1472 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02756 XEO_CLAS Peptide DME1472 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.8 microM) DME1472 XEOTICID XEO02756 GENEFORM Protein DME1472 XEOTICID XEO02756 MOACRIVE Inhibition DME1472 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1472 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02757 XEO_CLAS Peptide DME1472 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.7 microM) DME1472 XEOTICID XEO02757 GENEFORM Protein DME1472 XEOTICID XEO02757 MOACRIVE Inhibition DME1472 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1472 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02758 XEO_CLAS Peptide DME1472 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.9 microM) DME1472 XEOTICID XEO02758 GENEFORM Protein DME1472 XEOTICID XEO02758 MOACRIVE Inhibition DME1472 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1472 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02759 XEO_CLAS Peptide DME1472 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.5 microM) DME1472 XEOTICID XEO02759 GENEFORM Protein DME1472 XEOTICID XEO02759 MOACRIVE Inhibition DME1472 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1472 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02760 XEO_CLAS Peptide DME1472 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.5 microM) DME1472 XEOTICID XEO02760 GENEFORM Protein DME1472 XEOTICID XEO02760 MOACRIVE Inhibition DME1472 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1472 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02761 XEO_CLAS Peptide DME1472 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.5 microM) DME1472 XEOTICID XEO02761 GENEFORM Protein DME1472 XEOTICID XEO02761 MOACRIVE Inhibition DME1472 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1472 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02762 XEO_CLAS Peptide DME1472 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.5 microM) DME1472 XEOTICID XEO02762 GENEFORM Protein DME1472 XEOTICID XEO02762 MOACRIVE Inhibition DME1472 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1472 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02763 XEO_CLAS Peptide DME1472 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.2 microM) DME1472 XEOTICID XEO02763 GENEFORM Protein DME1472 XEOTICID XEO02763 MOACRIVE Inhibition DME1472 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1472 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02765 XEO_CLAS Peptide DME1472 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.4 microM) DME1472 XEOTICID XEO02765 GENEFORM Protein DME1472 XEOTICID XEO02765 MOACRIVE Inhibition DME1472 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1472 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02768 XEO_CLAS Peptide DME1472 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1-2.5 ug/ml) DME1472 XEOTICID XEO02768 GENEFORM Protein DME1472 XEOTICID XEO02768 MOACRIVE Inhibition DME1472 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1472 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02769 XEO_CLAS Peptide DME1472 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.44 microM) DME1472 XEOTICID XEO02769 GENEFORM Protein DME1472 XEOTICID XEO02769 MOACRIVE Inhibition DME1472 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1472 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02770 XEO_CLAS Peptide DME1472 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.64 microM) DME1472 XEOTICID XEO02770 GENEFORM Protein DME1472 XEOTICID XEO02770 MOACRIVE Inhibition DME1472 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1472 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02771 XEO_CLAS Peptide DME1472 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 24 microM) DME1472 XEOTICID XEO02771 GENEFORM Protein DME1472 XEOTICID XEO02771 MOACRIVE Inhibition DME1472 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1472 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02772 XEO_CLAS Peptide DME1472 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO02772 GENEFORM Protein DME1472 XEOTICID XEO02772 MOACRIVE Inhibition DME1472 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1472 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO02774 XEO_CLAS Peptide DME1472 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1.8 microM) DME1472 XEOTICID XEO02774 GENEFORM Protein DME1472 XEOTICID XEO02774 MOACRIVE Inhibition DME1472 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1472 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03081 XEO_CLAS Peptide DME1472 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.69 microM) DME1472 XEOTICID XEO03081 GENEFORM Protein DME1472 XEOTICID XEO03081 MOACRIVE Inhibition DME1472 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1472 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03100 XEO_CLAS Peptide DME1472 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO03100 GENEFORM Protein DME1472 XEOTICID XEO03100 MOACRIVE Inhibition DME1472 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1472 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03110 XEO_CLAS Peptide DME1472 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.8 microM) DME1472 XEOTICID XEO03110 GENEFORM Protein DME1472 XEOTICID XEO03110 MOACRIVE Inhibition DME1472 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1472 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03116 XEO_CLAS Peptide DME1472 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1.2-2.5 microM) DME1472 XEOTICID XEO03116 GENEFORM Protein DME1472 XEOTICID XEO03116 MOACRIVE Inhibition DME1472 XEOTICID XEO03117 XEO_NAME Insect defensin B DME1472 XEOTICID XEO03117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03117 XEO_CLAS Peptide DME1472 XEOTICID XEO03117 DESCRIPT Insect defensin B inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1.2-2.5 microM) DME1472 XEOTICID XEO03117 GENEFORM Protein DME1472 XEOTICID XEO03117 MOACRIVE Inhibition DME1472 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1472 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03119 XEO_CLAS Peptide DME1472 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO03119 GENEFORM Protein DME1472 XEOTICID XEO03119 MOACRIVE Inhibition DME1472 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1472 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03137 XEO_CLAS Peptide DME1472 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO03137 GENEFORM Protein DME1472 XEOTICID XEO03137 MOACRIVE Inhibition DME1472 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1472 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03162 XEO_CLAS Peptide DME1472 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.8 microM) DME1472 XEOTICID XEO03162 GENEFORM Protein DME1472 XEOTICID XEO03162 MOACRIVE Inhibition DME1472 XEOTICID XEO03164 XEO_NAME Dermatoxin DME1472 XEOTICID XEO03164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03164 XEO_CLAS Peptide DME1472 XEOTICID XEO03164 DESCRIPT Dermatoxin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO03164 GENEFORM Protein DME1472 XEOTICID XEO03164 MOACRIVE Inhibition DME1472 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1472 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03224 XEO_CLAS Peptide DME1472 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1-2.5 microM) DME1472 XEOTICID XEO03224 GENEFORM Protein DME1472 XEOTICID XEO03224 MOACRIVE Inhibition DME1472 XEOTICID XEO03243 XEO_NAME Hevein-like antimicrobial peptide Ee-CBPb DME1472 XEOTICID XEO03243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03243 XEO_CLAS Peptide DME1472 XEOTICID XEO03243 DESCRIPT Hevein-like antimicrobial peptide Ee-CBPb inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO03243 GENEFORM Protein DME1472 XEOTICID XEO03243 MOACRIVE Inhibition DME1472 XEOTICID XEO03249 XEO_NAME Enkelytin DME1472 XEOTICID XEO03249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03249 XEO_CLAS Peptide DME1472 XEOTICID XEO03249 DESCRIPT Enkelytin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.2-0.4 microM) DME1472 XEOTICID XEO03249 GENEFORM Protein DME1472 XEOTICID XEO03249 MOACRIVE Inhibition DME1472 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1472 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03251 XEO_CLAS Peptide DME1472 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO03251 GENEFORM Protein DME1472 XEOTICID XEO03251 MOACRIVE Inhibition DME1472 XEOTICID XEO03254 XEO_NAME Enterocin EJ97 DME1472 XEOTICID XEO03254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03254 XEO_CLAS Peptide DME1472 XEOTICID XEO03254 DESCRIPT Enterocin EJ97 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 4 ug/ml) DME1472 XEOTICID XEO03254 GENEFORM Protein DME1472 XEOTICID XEO03254 MOACRIVE Inhibition DME1472 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1472 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03274 XEO_CLAS Peptide DME1472 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.1 microM) DME1472 XEOTICID XEO03274 GENEFORM Protein DME1472 XEOTICID XEO03274 MOACRIVE Inhibition DME1472 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1472 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03277 XEO_CLAS Peptide DME1472 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.1 microM) DME1472 XEOTICID XEO03277 GENEFORM Protein DME1472 XEOTICID XEO03277 MOACRIVE Inhibition DME1472 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1472 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03299 XEO_CLAS Peptide DME1472 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.2 microM) DME1472 XEOTICID XEO03299 GENEFORM Protein DME1472 XEOTICID XEO03299 MOACRIVE Inhibition DME1472 XEOTICID XEO03431 XEO_NAME Thanatin truncated isoform G18C(1-18) DME1472 XEOTICID XEO03431 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03431 XEO_CLAS Peptide DME1472 XEOTICID XEO03431 DESCRIPT Thanatin truncated isoform G18C(1-18) inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 5-10 microM) DME1472 XEOTICID XEO03431 GENEFORM Protein DME1472 XEOTICID XEO03431 MOACRIVE Inhibition DME1472 XEOTICID XEO03432 XEO_NAME Thanatin truncated isoform G19Q(1-19) DME1472 XEOTICID XEO03432 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03432 XEO_CLAS Peptide DME1472 XEOTICID XEO03432 DESCRIPT Thanatin truncated isoform G19Q(1-19) inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 5-10 microM) DME1472 XEOTICID XEO03432 GENEFORM Protein DME1472 XEOTICID XEO03432 MOACRIVE Inhibition DME1472 XEOTICID XEO03435 XEO_NAME Thanatin truncated isoform G20R(1-20) DME1472 XEOTICID XEO03435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03435 XEO_CLAS Peptide DME1472 XEOTICID XEO03435 DESCRIPT Thanatin truncated isoform G20R(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2.5-5 microM) DME1472 XEOTICID XEO03435 GENEFORM Protein DME1472 XEOTICID XEO03435 MOACRIVE Inhibition DME1472 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1472 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03497 XEO_CLAS Peptide DME1472 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.2-0.4 microM) DME1472 XEOTICID XEO03497 GENEFORM Protein DME1472 XEOTICID XEO03497 MOACRIVE Inhibition DME1472 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1472 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03498 XEO_CLAS Peptide DME1472 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.2-0.4 microM) DME1472 XEOTICID XEO03498 GENEFORM Protein DME1472 XEOTICID XEO03498 MOACRIVE Inhibition DME1472 XEOTICID XEO03522 XEO_NAME Halocyntin DME1472 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03522 XEO_CLAS Peptide DME1472 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO03522 GENEFORM Protein DME1472 XEOTICID XEO03522 MOACRIVE Inhibition DME1472 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1472 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03561 XEO_CLAS Peptide DME1472 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO03561 GENEFORM Protein DME1472 XEOTICID XEO03561 MOACRIVE Inhibition DME1472 XEOTICID XEO03605 XEO_NAME Human recombinant Ser-Thr-Ala-CGA1-78 DME1472 XEOTICID XEO03605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03605 XEO_CLAS Peptide DME1472 XEOTICID XEO03605 DESCRIPT Human recombinant Ser-Thr-Ala-CGA1-78 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 30 microM) DME1472 XEOTICID XEO03605 GENEFORM Protein DME1472 XEOTICID XEO03605 MOACRIVE Inhibition DME1472 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1472 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03618 XEO_CLAS Peptide DME1472 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.5-1 microM) DME1472 XEOTICID XEO03618 GENEFORM Protein DME1472 XEOTICID XEO03618 MOACRIVE Inhibition DME1472 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1472 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03622 XEO_CLAS Peptide DME1472 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 10-20 microM) DME1472 XEOTICID XEO03622 GENEFORM Protein DME1472 XEOTICID XEO03622 MOACRIVE Inhibition DME1472 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1472 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03681 XEO_CLAS Peptide DME1472 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2.5-5 microM) DME1472 XEOTICID XEO03681 GENEFORM Protein DME1472 XEOTICID XEO03681 MOACRIVE Inhibition DME1472 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1472 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03712 XEO_CLAS Peptide DME1472 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO03712 GENEFORM Protein DME1472 XEOTICID XEO03712 MOACRIVE Inhibition DME1472 XEOTICID XEO03804 XEO_NAME Lantibiotic lichenicidin VK21 A1 DME1472 XEOTICID XEO03804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03804 XEO_CLAS Peptide DME1472 XEOTICID XEO03804 DESCRIPT Lantibiotic lichenicidin VK21 A1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO03804 GENEFORM Protein DME1472 XEOTICID XEO03804 MOACRIVE Inhibition DME1472 XEOTICID XEO03805 XEO_NAME Lantibiotic lichenicidin VK21 A2 DME1472 XEOTICID XEO03805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03805 XEO_CLAS Peptide DME1472 XEOTICID XEO03805 DESCRIPT Lantibiotic lichenicidin VK21 A2 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO03805 GENEFORM Protein DME1472 XEOTICID XEO03805 MOACRIVE Inhibition DME1472 XEOTICID XEO03973 XEO_NAME Lunatusin DME1472 XEOTICID XEO03973 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO03973 XEO_CLAS Peptide DME1472 XEOTICID XEO03973 DESCRIPT Lunatusin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO03973 GENEFORM Protein DME1472 XEOTICID XEO03973 MOACRIVE Inhibition DME1472 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1472 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04039 XEO_CLAS Peptide DME1472 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2 microM) DME1472 XEOTICID XEO04039 GENEFORM Protein DME1472 XEOTICID XEO04039 MOACRIVE Inhibition DME1472 XEOTICID XEO04057 XEO_NAME Melittin DME1472 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04057 XEO_CLAS Peptide DME1472 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.6 microM) DME1472 XEOTICID XEO04057 GENEFORM Protein DME1472 XEOTICID XEO04057 MOACRIVE Inhibition DME1472 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1472 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04128 XEO_CLAS Peptide DME1472 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.09 microM) DME1472 XEOTICID XEO04128 GENEFORM Protein DME1472 XEOTICID XEO04128 MOACRIVE Inhibition DME1472 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1472 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04158 XEO_CLAS Peptide DME1472 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2 microM) DME1472 XEOTICID XEO04158 GENEFORM Protein DME1472 XEOTICID XEO04158 MOACRIVE Inhibition DME1472 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1472 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04159 XEO_CLAS Peptide DME1472 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2 microM) DME1472 XEOTICID XEO04159 GENEFORM Protein DME1472 XEOTICID XEO04159 MOACRIVE Inhibition DME1472 XEOTICID XEO04166 XEO_NAME Myticin-A DME1472 XEOTICID XEO04166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04166 XEO_CLAS Peptide DME1472 XEOTICID XEO04166 DESCRIPT Myticin-A inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO04166 GENEFORM Protein DME1472 XEOTICID XEO04166 MOACRIVE Inhibition DME1472 XEOTICID XEO04167 XEO_NAME Myticin-B DME1472 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04167 XEO_CLAS Peptide DME1472 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO04167 GENEFORM Protein DME1472 XEOTICID XEO04167 MOACRIVE Inhibition DME1472 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1472 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04168 XEO_CLAS Peptide DME1472 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2.5-5.0 microM) DME1472 XEOTICID XEO04168 GENEFORM Protein DME1472 XEOTICID XEO04168 MOACRIVE Inhibition DME1472 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1472 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04169 XEO_CLAS Peptide DME1472 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO04169 GENEFORM Protein DME1472 XEOTICID XEO04169 MOACRIVE Inhibition DME1472 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1472 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04206 XEO_CLAS Peptide DME1472 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1.56 microM) DME1472 XEOTICID XEO04206 GENEFORM Protein DME1472 XEOTICID XEO04206 MOACRIVE Inhibition DME1472 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1472 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04214 XEO_CLAS Peptide DME1472 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.78 microM) DME1472 XEOTICID XEO04214 GENEFORM Protein DME1472 XEOTICID XEO04214 MOACRIVE Inhibition DME1472 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1472 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04216 XEO_CLAS Peptide DME1472 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1.56 microM) DME1472 XEOTICID XEO04216 GENEFORM Protein DME1472 XEOTICID XEO04216 MOACRIVE Inhibition DME1472 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1472 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04218 XEO_CLAS Peptide DME1472 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.78 microM) DME1472 XEOTICID XEO04218 GENEFORM Protein DME1472 XEOTICID XEO04218 MOACRIVE Inhibition DME1472 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1472 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04219 XEO_CLAS Peptide DME1472 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1.56 microM) DME1472 XEOTICID XEO04219 GENEFORM Protein DME1472 XEOTICID XEO04219 MOACRIVE Inhibition DME1472 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1472 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04220 XEO_CLAS Peptide DME1472 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.78 microM) DME1472 XEOTICID XEO04220 GENEFORM Protein DME1472 XEOTICID XEO04220 MOACRIVE Inhibition DME1472 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1472 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04221 XEO_CLAS Peptide DME1472 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1.56 microM) DME1472 XEOTICID XEO04221 GENEFORM Protein DME1472 XEOTICID XEO04221 MOACRIVE Inhibition DME1472 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1472 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04222 XEO_CLAS Peptide DME1472 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1.56 microM) DME1472 XEOTICID XEO04222 GENEFORM Protein DME1472 XEOTICID XEO04222 MOACRIVE Inhibition DME1472 XEOTICID XEO04235 XEO_NAME Napin-like polypeptide DME1472 XEOTICID XEO04235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04235 XEO_CLAS Peptide DME1472 XEOTICID XEO04235 DESCRIPT Napin-like polypeptide inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO04235 GENEFORM Protein DME1472 XEOTICID XEO04235 MOACRIVE Inhibition DME1472 XEOTICID XEO04394 XEO_NAME Omwaprin-a DME1472 XEOTICID XEO04394 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04394 XEO_CLAS Peptide DME1472 XEOTICID XEO04394 DESCRIPT Omwaprin-a inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO04394 GENEFORM Protein DME1472 XEOTICID XEO04394 MOACRIVE Inhibition DME1472 XEOTICID XEO04424 XEO_NAME P. americana Pa-AMP-1 DME1472 XEOTICID XEO04424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04424 XEO_CLAS Peptide DME1472 XEOTICID XEO04424 DESCRIPT P. americana Pa-AMP-1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO04424 GENEFORM Protein DME1472 XEOTICID XEO04424 MOACRIVE Inhibition DME1472 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1472 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04426 XEO_CLAS Peptide DME1472 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2 microM) DME1472 XEOTICID XEO04426 GENEFORM Protein DME1472 XEOTICID XEO04426 MOACRIVE Inhibition DME1472 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1472 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04430 XEO_CLAS Peptide DME1472 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.78 microM) DME1472 XEOTICID XEO04430 GENEFORM Protein DME1472 XEOTICID XEO04430 MOACRIVE Inhibition DME1472 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1472 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04463 XEO_CLAS Peptide DME1472 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO04463 GENEFORM Protein DME1472 XEOTICID XEO04463 MOACRIVE Inhibition DME1472 XEOTICID XEO04468 XEO_NAME Papillosin DME1472 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04468 XEO_CLAS Peptide DME1472 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO04468 GENEFORM Protein DME1472 XEOTICID XEO04468 MOACRIVE Inhibition DME1472 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1472 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04506 XEO_CLAS Peptide DME1472 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2.5-5 microM) DME1472 XEOTICID XEO04506 GENEFORM Protein DME1472 XEOTICID XEO04506 MOACRIVE Inhibition DME1472 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1472 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04507 XEO_CLAS Peptide DME1472 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2.5-5 microM) DME1472 XEOTICID XEO04507 GENEFORM Protein DME1472 XEOTICID XEO04507 MOACRIVE Inhibition DME1472 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1472 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04510 XEO_CLAS Peptide DME1472 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC > 50 microM) DME1472 XEOTICID XEO04510 GENEFORM Protein DME1472 XEOTICID XEO04510 MOACRIVE Inhibition DME1472 XEOTICID XEO04511 XEO_NAME Penaeidin-4d DME1472 XEOTICID XEO04511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04511 XEO_CLAS Peptide DME1472 XEOTICID XEO04511 DESCRIPT Penaeidin-4d inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC > 50 microM) DME1472 XEOTICID XEO04511 GENEFORM Protein DME1472 XEOTICID XEO04511 MOACRIVE Inhibition DME1472 XEOTICID XEO04545 XEO_NAME Peptide leucine arginine DME1472 XEOTICID XEO04545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04545 XEO_CLAS Peptide DME1472 XEOTICID XEO04545 DESCRIPT Peptide leucine arginine inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 20 microM) DME1472 XEOTICID XEO04545 GENEFORM Protein DME1472 XEOTICID XEO04545 MOACRIVE Inhibition DME1472 XEOTICID XEO04546 XEO_NAME Perinerin DME1472 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04546 XEO_CLAS Peptide DME1472 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO04546 GENEFORM Protein DME1472 XEOTICID XEO04546 MOACRIVE Inhibition DME1472 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1472 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04575 XEO_CLAS Peptide DME1472 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3.12 microM) DME1472 XEOTICID XEO04575 GENEFORM Protein DME1472 XEOTICID XEO04575 MOACRIVE Inhibition DME1472 XEOTICID XEO04624 XEO_NAME Plantazolicin DME1472 XEOTICID XEO04624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04624 XEO_CLAS Peptide DME1472 XEOTICID XEO04624 DESCRIPT Plantazolicin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO04624 GENEFORM Protein DME1472 XEOTICID XEO04624 MOACRIVE Inhibition DME1472 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1472 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04625 XEO_CLAS Peptide DME1472 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 12.5 microM) DME1472 XEOTICID XEO04625 GENEFORM Protein DME1472 XEOTICID XEO04625 MOACRIVE Inhibition DME1472 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1472 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04626 XEO_CLAS Peptide DME1472 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 12.5 microM) DME1472 XEOTICID XEO04626 GENEFORM Protein DME1472 XEOTICID XEO04626 MOACRIVE Inhibition DME1472 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1472 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04627 XEO_CLAS Peptide DME1472 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 50.25 microM) DME1472 XEOTICID XEO04627 GENEFORM Protein DME1472 XEOTICID XEO04627 MOACRIVE Inhibition DME1472 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1472 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04661 XEO_CLAS Peptide DME1472 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3 microM) DME1472 XEOTICID XEO04661 GENEFORM Protein DME1472 XEOTICID XEO04661 MOACRIVE Inhibition DME1472 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1472 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04662 XEO_CLAS Peptide DME1472 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1 microM) DME1472 XEOTICID XEO04662 GENEFORM Protein DME1472 XEOTICID XEO04662 MOACRIVE Inhibition DME1472 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1472 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04663 XEO_CLAS Peptide DME1472 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1 microM) DME1472 XEOTICID XEO04663 GENEFORM Protein DME1472 XEOTICID XEO04663 MOACRIVE Inhibition DME1472 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1472 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04695 XEO_CLAS Peptide DME1472 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO04695 GENEFORM Protein DME1472 XEOTICID XEO04695 MOACRIVE Inhibition DME1472 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1472 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04697 XEO_CLAS Peptide DME1472 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO04697 GENEFORM Protein DME1472 XEOTICID XEO04697 MOACRIVE Inhibition DME1472 XEOTICID XEO04707 XEO_NAME Pore-forming peptide ameobapore A DME1472 XEOTICID XEO04707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04707 XEO_CLAS Peptide DME1472 XEOTICID XEO04707 DESCRIPT Pore-forming peptide ameobapore A inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 13 microM) DME1472 XEOTICID XEO04707 GENEFORM Protein DME1472 XEOTICID XEO04707 MOACRIVE Inhibition DME1472 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1472 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04762 XEO_CLAS Peptide DME1472 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.1 microM) DME1472 XEOTICID XEO04762 GENEFORM Protein DME1472 XEOTICID XEO04762 MOACRIVE Inhibition DME1472 XEOTICID XEO04770 XEO_NAME Pyrrhocoricin DME1472 XEOTICID XEO04770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04770 XEO_CLAS Peptide DME1472 XEOTICID XEO04770 DESCRIPT Pyrrhocoricin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC > 80 microM) DME1472 XEOTICID XEO04770 GENEFORM Protein DME1472 XEOTICID XEO04770 MOACRIVE Inhibition DME1472 XEOTICID XEO04797 XEO_NAME Ranacyclin-E DME1472 XEOTICID XEO04797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04797 XEO_CLAS Peptide DME1472 XEOTICID XEO04797 DESCRIPT Ranacyclin-E inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3 microM) DME1472 XEOTICID XEO04797 GENEFORM Protein DME1472 XEOTICID XEO04797 MOACRIVE Inhibition DME1472 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1472 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04798 XEO_CLAS Peptide DME1472 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 3 microM) DME1472 XEOTICID XEO04798 GENEFORM Protein DME1472 XEOTICID XEO04798 MOACRIVE Inhibition DME1472 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1472 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04840 XEO_CLAS Peptide DME1472 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC > 20 microM) DME1472 XEOTICID XEO04840 GENEFORM Protein DME1472 XEOTICID XEO04840 MOACRIVE Inhibition DME1472 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1472 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04905 XEO_CLAS Peptide DME1472 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO04905 GENEFORM Protein DME1472 XEOTICID XEO04905 MOACRIVE Inhibition DME1472 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1472 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04906 XEO_CLAS Peptide DME1472 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO04906 GENEFORM Protein DME1472 XEOTICID XEO04906 MOACRIVE Inhibition DME1472 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1472 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04971 XEO_CLAS Peptide DME1472 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.4-0.8 microM) DME1472 XEOTICID XEO04971 GENEFORM Protein DME1472 XEOTICID XEO04971 MOACRIVE Inhibition DME1472 XEOTICID XEO04974 XEO_NAME Spinigerin DME1472 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04974 XEO_CLAS Peptide DME1472 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.8-1.5 microM) DME1472 XEOTICID XEO04974 GENEFORM Protein DME1472 XEOTICID XEO04974 MOACRIVE Inhibition DME1472 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1472 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO04995 XEO_CLAS Peptide DME1472 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.78-1.56 microM) DME1472 XEOTICID XEO04995 GENEFORM Protein DME1472 XEOTICID XEO04995 MOACRIVE Inhibition DME1472 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1472 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05004 XEO_CLAS Peptide DME1472 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO05004 GENEFORM Protein DME1472 XEOTICID XEO05004 MOACRIVE Inhibition DME1472 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1472 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05005 XEO_CLAS Peptide DME1472 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO05005 GENEFORM Protein DME1472 XEOTICID XEO05005 MOACRIVE Inhibition DME1472 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1472 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05063 XEO_CLAS Peptide DME1472 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2 microM) DME1472 XEOTICID XEO05063 GENEFORM Protein DME1472 XEOTICID XEO05063 MOACRIVE Inhibition DME1472 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1472 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05064 XEO_CLAS Peptide DME1472 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 46 microM) DME1472 XEOTICID XEO05064 GENEFORM Protein DME1472 XEOTICID XEO05064 MOACRIVE Inhibition DME1472 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1472 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05065 XEO_CLAS Peptide DME1472 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 4 ug/ml) DME1472 XEOTICID XEO05065 GENEFORM Protein DME1472 XEOTICID XEO05065 MOACRIVE Inhibition DME1472 XEOTICID XEO05076 XEO_NAME Temporin-A DME1472 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05076 XEO_CLAS Peptide DME1472 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 1.2 microM) DME1472 XEOTICID XEO05076 GENEFORM Protein DME1472 XEOTICID XEO05076 MOACRIVE Inhibition DME1472 XEOTICID XEO05085 XEO_NAME Temporin-B DME1472 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05085 XEO_CLAS Peptide DME1472 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2.8 ug/ml) DME1472 XEOTICID XEO05085 GENEFORM Protein DME1472 XEOTICID XEO05085 MOACRIVE Inhibition DME1472 XEOTICID XEO05088 XEO_NAME Temporin-D DME1472 XEOTICID XEO05088 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05088 XEO_CLAS Peptide DME1472 XEOTICID XEO05088 DESCRIPT Temporin-D inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO05088 GENEFORM Protein DME1472 XEOTICID XEO05088 MOACRIVE Inhibition DME1472 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1472 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05105 XEO_CLAS Peptide DME1472 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2 microM) DME1472 XEOTICID XEO05105 GENEFORM Protein DME1472 XEOTICID XEO05105 MOACRIVE Inhibition DME1472 XEOTICID XEO05110 XEO_NAME Termicin DME1472 XEOTICID XEO05110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05110 XEO_CLAS Peptide DME1472 XEOTICID XEO05110 DESCRIPT Termicin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO05110 GENEFORM Protein DME1472 XEOTICID XEO05110 MOACRIVE Inhibition DME1472 XEOTICID XEO05120 XEO_NAME Thanatin DME1472 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05120 XEO_CLAS Peptide DME1472 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 2.5-5 microM) DME1472 XEOTICID XEO05120 GENEFORM Protein DME1472 XEOTICID XEO05120 MOACRIVE Inhibition DME1472 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1472 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05125 XEO_CLAS Peptide DME1472 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO05125 GENEFORM Protein DME1472 XEOTICID XEO05125 MOACRIVE Inhibition DME1472 XEOTICID XEO05138 XEO_NAME Thuricin-17 DME1472 XEOTICID XEO05138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05138 XEO_CLAS Peptide DME1472 XEOTICID XEO05138 DESCRIPT Thuricin-17 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium DME1472 XEOTICID XEO05138 GENEFORM Protein DME1472 XEOTICID XEO05138 MOACRIVE Inhibition DME1472 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1472 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05220 XEO_CLAS Peptide DME1472 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 5-10 microM) DME1472 XEOTICID XEO05220 GENEFORM Protein DME1472 XEOTICID XEO05220 MOACRIVE Inhibition DME1472 XEOTICID XEO05229 XEO_NAME Vasostatin-1 DME1472 XEOTICID XEO05229 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05229 XEO_CLAS Peptide DME1472 XEOTICID XEO05229 DESCRIPT Vasostatin-1 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.2 microM) DME1472 XEOTICID XEO05229 GENEFORM Protein DME1472 XEOTICID XEO05229 MOACRIVE Inhibition DME1472 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1472 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05230 XEO_CLAS Peptide DME1472 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.25 microM) DME1472 XEOTICID XEO05230 GENEFORM Protein DME1472 XEOTICID XEO05230 MOACRIVE Inhibition DME1472 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1472 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05231 XEO_CLAS Peptide DME1472 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 0.25 microM) DME1472 XEOTICID XEO05231 GENEFORM Protein DME1472 XEOTICID XEO05231 MOACRIVE Inhibition DME1472 XEOTICID XEO05304 XEO_NAME Thanatin truncated isoform Y12M(10-21) DME1472 XEOTICID XEO05304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1472 XEOTICID XEO05304 XEO_CLAS Peptide DME1472 XEOTICID XEO05304 DESCRIPT Thanatin truncated isoform Y12M(10-21) inhibits the drug-metabolizing activity of Cytochrome P450 21A2 (cyp21) from Bacillus megaterium (MIC = 20-40 microM) DME1472 XEOTICID XEO05304 GENEFORM Protein DME1472 XEOTICID XEO05304 MOACRIVE Inhibition DME1475 DME___ID DME1475 DME1475 DME_NAME Azoreductase (azoR) DME1475 SPESNAME Lactobacillus acidophilus DME1475 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1475 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1475 XEOTICID XEO03771 XEO_CLAS Peptide DME1475 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Azoreductase (azoR) from Lactobacillus acidophilus DME1475 XEOTICID XEO03771 GENEFORM Protein DME1475 XEOTICID XEO03771 MOACRIVE Inhibition DME1475 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1475 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1475 XEOTICID XEO03803 XEO_CLAS Peptide DME1475 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Lactobacillus acidophilus DME1475 XEOTICID XEO03803 GENEFORM Protein DME1475 XEOTICID XEO03803 MOACRIVE Inhibition DME1475 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1475 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1475 XEOTICID XEO04249 XEO_CLAS Peptide DME1475 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Lactobacillus acidophilus (MIC > 500 ug/ml) DME1475 XEOTICID XEO04249 GENEFORM Protein DME1475 XEOTICID XEO04249 MOACRIVE Inhibition DME1475 XEOTICID XEO04320 XEO_NAME Nisin U DME1475 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1475 XEOTICID XEO04320 XEO_CLAS Peptide DME1475 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of Azoreductase (azoR) from Lactobacillus acidophilus DME1475 XEOTICID XEO04320 GENEFORM Protein DME1475 XEOTICID XEO04320 MOACRIVE Inhibition DME1475 XEOTICID XEO05228 XEO_NAME Variacin DME1475 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1475 XEOTICID XEO05228 XEO_CLAS Peptide DME1475 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Lactobacillus acidophilus DME1475 XEOTICID XEO05228 GENEFORM Protein DME1475 XEOTICID XEO05228 MOACRIVE Inhibition DME1476 DME___ID DME1476 DME1476 DME_NAME Azoreductase (azoR) DME1476 SPESNAME Streptococcus pyogenes DME1476 XEOTICID XEO00110 XEO_NAME Acetylcysteine DME1476 XEOTICID XEO00110 XEO_TYPE Pharmaceutical Agent(s) DME1476 XEOTICID XEO00110 XEO_CLAS Approved/Marketed Drug DME1476 XEOTICID XEO00110 DESCRIPT Acetylcysteine inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO00110 GENEFORM Protein DME1476 XEOTICID XEO00110 MOACRIVE Inhibition DME1476 XEOTICID XEO01559 XEO_NAME Limonene DME1476 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO01559 XEO_CLAS Natural Product DME1476 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO01559 GENEFORM Protein DME1476 XEOTICID XEO01559 MOACRIVE Inhibition DME1476 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1476 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO01816 XEO_CLAS Peptide DME1476 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 6.25 microM) DME1476 XEOTICID XEO01816 GENEFORM Protein DME1476 XEOTICID XEO01816 MOACRIVE Inhibition DME1476 XEOTICID XEO02133 XEO_NAME Actagardine DME1476 XEOTICID XEO02133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02133 XEO_CLAS Peptide DME1476 XEOTICID XEO02133 DESCRIPT Actagardine inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02133 GENEFORM Protein DME1476 XEOTICID XEO02133 MOACRIVE Inhibition DME1476 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1476 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02230 XEO_CLAS Peptide DME1476 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 0.1-0.25 microM) DME1476 XEOTICID XEO02230 GENEFORM Protein DME1476 XEOTICID XEO02230 MOACRIVE Inhibition DME1476 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1476 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02248 XEO_CLAS Peptide DME1476 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 2 microM) DME1476 XEOTICID XEO02248 GENEFORM Protein DME1476 XEOTICID XEO02248 MOACRIVE Inhibition DME1476 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1476 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02293 XEO_CLAS Peptide DME1476 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 34 microM) DME1476 XEOTICID XEO02293 GENEFORM Protein DME1476 XEOTICID XEO02293 MOACRIVE Inhibition DME1476 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1476 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02297 XEO_CLAS Peptide DME1476 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC < 50 ug/ml) DME1476 XEOTICID XEO02297 GENEFORM Protein DME1476 XEOTICID XEO02297 MOACRIVE Inhibition DME1476 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1476 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02333 XEO_CLAS Peptide DME1476 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC > 200 microM) DME1476 XEOTICID XEO02333 GENEFORM Protein DME1476 XEOTICID XEO02333 MOACRIVE Inhibition DME1476 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1476 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02365 XEO_CLAS Peptide DME1476 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 64 ug/ml) DME1476 XEOTICID XEO02365 GENEFORM Protein DME1476 XEOTICID XEO02365 MOACRIVE Inhibition DME1476 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1476 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02367 XEO_CLAS Peptide DME1476 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 8 ug/ml) DME1476 XEOTICID XEO02367 GENEFORM Protein DME1476 XEOTICID XEO02367 MOACRIVE Inhibition DME1476 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1476 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02368 XEO_CLAS Peptide DME1476 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 4 ug/ml) DME1476 XEOTICID XEO02368 GENEFORM Protein DME1476 XEOTICID XEO02368 MOACRIVE Inhibition DME1476 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1476 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02369 XEO_CLAS Peptide DME1476 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 8 ug/ml) DME1476 XEOTICID XEO02369 GENEFORM Protein DME1476 XEOTICID XEO02369 MOACRIVE Inhibition DME1476 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1476 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02388 XEO_CLAS Peptide DME1476 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 2 ug/ml) DME1476 XEOTICID XEO02388 GENEFORM Protein DME1476 XEOTICID XEO02388 MOACRIVE Inhibition DME1476 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1476 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02389 XEO_CLAS Peptide DME1476 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 1 ug/ml) DME1476 XEOTICID XEO02389 GENEFORM Protein DME1476 XEOTICID XEO02389 MOACRIVE Inhibition DME1476 XEOTICID XEO02652 XEO_NAME Eleutherine americana bulb extract DME1476 XEOTICID XEO02652 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO02652 XEO_CLAS Plant Extract DME1476 XEOTICID XEO02652 DESCRIPT Eleutherine americana bulb extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02652 GENEFORM Protein DME1476 XEOTICID XEO02652 MOACRIVE Inhibition DME1476 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1476 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02756 XEO_CLAS Peptide DME1476 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 0.7 microM) DME1476 XEOTICID XEO02756 GENEFORM Protein DME1476 XEOTICID XEO02756 MOACRIVE Inhibition DME1476 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1476 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02757 XEO_CLAS Peptide DME1476 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 0.5 microM) DME1476 XEOTICID XEO02757 GENEFORM Protein DME1476 XEOTICID XEO02757 MOACRIVE Inhibition DME1476 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1476 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02758 XEO_CLAS Peptide DME1476 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 1 microM) DME1476 XEOTICID XEO02758 GENEFORM Protein DME1476 XEOTICID XEO02758 MOACRIVE Inhibition DME1476 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1476 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02759 XEO_CLAS Peptide DME1476 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 0.7 microM) DME1476 XEOTICID XEO02759 GENEFORM Protein DME1476 XEOTICID XEO02759 MOACRIVE Inhibition DME1476 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1476 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02760 XEO_CLAS Peptide DME1476 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 0.4 microM) DME1476 XEOTICID XEO02760 GENEFORM Protein DME1476 XEOTICID XEO02760 MOACRIVE Inhibition DME1476 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1476 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02761 XEO_CLAS Peptide DME1476 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 0.4 microM) DME1476 XEOTICID XEO02761 GENEFORM Protein DME1476 XEOTICID XEO02761 MOACRIVE Inhibition DME1476 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1476 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02762 XEO_CLAS Peptide DME1476 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 0.8 microM) DME1476 XEOTICID XEO02762 GENEFORM Protein DME1476 XEOTICID XEO02762 MOACRIVE Inhibition DME1476 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1476 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02763 XEO_CLAS Peptide DME1476 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 0.1 microM) DME1476 XEOTICID XEO02763 GENEFORM Protein DME1476 XEOTICID XEO02763 MOACRIVE Inhibition DME1476 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1476 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02764 XEO_CLAS Peptide DME1476 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 1 microM) DME1476 XEOTICID XEO02764 GENEFORM Protein DME1476 XEOTICID XEO02764 MOACRIVE Inhibition DME1476 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1476 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02765 XEO_CLAS Peptide DME1476 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 2 microM) DME1476 XEOTICID XEO02765 GENEFORM Protein DME1476 XEOTICID XEO02765 MOACRIVE Inhibition DME1476 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1476 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02768 XEO_CLAS Peptide DME1476 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 10-25 ug/ml) DME1476 XEOTICID XEO02768 GENEFORM Protein DME1476 XEOTICID XEO02768 MOACRIVE Inhibition DME1476 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1476 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02774 XEO_CLAS Peptide DME1476 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 19 microM) DME1476 XEOTICID XEO02774 GENEFORM Protein DME1476 XEOTICID XEO02774 MOACRIVE Inhibition DME1476 XEOTICID XEO02915 XEO_NAME Bacillus firmus coral bacterial extract DME1476 XEOTICID XEO02915 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO02915 XEO_CLAS Bacterial Extract DME1476 XEOTICID XEO02915 DESCRIPT Bacillus firmus coral bacterial extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02915 GENEFORM Protein DME1476 XEOTICID XEO02915 MOACRIVE Inhibition DME1476 XEOTICID XEO02916 XEO_NAME Bacillus horikoshii coral bacterial extract DME1476 XEOTICID XEO02916 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO02916 XEO_CLAS Bacterial Extract DME1476 XEOTICID XEO02916 DESCRIPT Bacillus horikoshii coral bacterial extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02916 GENEFORM Protein DME1476 XEOTICID XEO02916 MOACRIVE Inhibition DME1476 XEOTICID XEO02917 XEO_NAME Bacillus pumilus coral bacterial extract DME1476 XEOTICID XEO02917 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO02917 XEO_CLAS Bacterial Extract DME1476 XEOTICID XEO02917 DESCRIPT Bacillus pumilus coral bacterial extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02917 GENEFORM Protein DME1476 XEOTICID XEO02917 MOACRIVE Inhibition DME1476 XEOTICID XEO02918 XEO_NAME Bacillus subtilis coral bacterial extract DME1476 XEOTICID XEO02918 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO02918 XEO_CLAS Bacterial Extract DME1476 XEOTICID XEO02918 DESCRIPT Bacillus subtilis coral bacterial extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02918 GENEFORM Protein DME1476 XEOTICID XEO02918 MOACRIVE Inhibition DME1476 XEOTICID XEO02919 XEO_NAME Halomonas salaria coral bacterial extract DME1476 XEOTICID XEO02919 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO02919 XEO_CLAS Bacterial Extract DME1476 XEOTICID XEO02919 DESCRIPT Halomonas salaria coral bacterial extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02919 GENEFORM Protein DME1476 XEOTICID XEO02919 MOACRIVE Inhibition DME1476 XEOTICID XEO02920 XEO_NAME Vibrio natriegens coral bacterial extract DME1476 XEOTICID XEO02920 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO02920 XEO_CLAS Bacterial Extract DME1476 XEOTICID XEO02920 DESCRIPT Vibrio natriegens coral bacterial extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02920 GENEFORM Protein DME1476 XEOTICID XEO02920 MOACRIVE Inhibition DME1476 XEOTICID XEO02921 XEO_NAME Vibrio parahaemolyticus coral bacterial extract DME1476 XEOTICID XEO02921 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO02921 XEO_CLAS Bacterial Extract DME1476 XEOTICID XEO02921 DESCRIPT Vibrio parahaemolyticus coral bacterial extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02921 GENEFORM Protein DME1476 XEOTICID XEO02921 MOACRIVE Inhibition DME1476 XEOTICID XEO02930 XEO_NAME Indolicidin derivative CP10A DME1476 XEOTICID XEO02930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02930 XEO_CLAS Peptide DME1476 XEOTICID XEO02930 DESCRIPT Indolicidin derivative CP10A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 1 ug/ml) DME1476 XEOTICID XEO02930 GENEFORM Protein DME1476 XEOTICID XEO02930 MOACRIVE Inhibition DME1476 XEOTICID XEO02932 XEO_NAME CP11CN peptide DME1476 XEOTICID XEO02932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02932 XEO_CLAS Peptide DME1476 XEOTICID XEO02932 DESCRIPT CP11CN peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 8 ug/ml) DME1476 XEOTICID XEO02932 GENEFORM Protein DME1476 XEOTICID XEO02932 MOACRIVE Inhibition DME1476 XEOTICID XEO02955 XEO_NAME Cryptdin related sequence CRS4C-3c DME1476 XEOTICID XEO02955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02955 XEO_CLAS Peptide DME1476 XEOTICID XEO02955 DESCRIPT Cryptdin related sequence CRS4C-3c inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02955 GENEFORM Protein DME1476 XEOTICID XEO02955 MOACRIVE Inhibition DME1476 XEOTICID XEO02959 XEO_NAME Cryptdin related peptide CRS4C-1d DME1476 XEOTICID XEO02959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02959 XEO_CLAS Peptide DME1476 XEOTICID XEO02959 DESCRIPT Cryptdin related peptide CRS4C-1d inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02959 GENEFORM Protein DME1476 XEOTICID XEO02959 MOACRIVE Inhibition DME1476 XEOTICID XEO02960 XEO_NAME Cryptdin related peptide CRS4C-2 DME1476 XEOTICID XEO02960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02960 XEO_CLAS Peptide DME1476 XEOTICID XEO02960 DESCRIPT Cryptdin related peptide CRS4C-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02960 GENEFORM Protein DME1476 XEOTICID XEO02960 MOACRIVE Inhibition DME1476 XEOTICID XEO02961 XEO_NAME Cryptdin related peptide CRS4C-2b DME1476 XEOTICID XEO02961 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO02961 XEO_CLAS Peptide DME1476 XEOTICID XEO02961 DESCRIPT Cryptdin related peptide CRS4C-2b inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02961 GENEFORM Protein DME1476 XEOTICID XEO02961 MOACRIVE Inhibition DME1476 XEOTICID XEO02973 XEO_NAME Actinobacterium sp culture extract DME1476 XEOTICID XEO02973 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO02973 XEO_CLAS Bacterial Extract DME1476 XEOTICID XEO02973 DESCRIPT Actinobacterium sp culture extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02973 GENEFORM Protein DME1476 XEOTICID XEO02973 MOACRIVE Inhibition DME1476 XEOTICID XEO02975 XEO_NAME Micrococcus luteus culture extract DME1476 XEOTICID XEO02975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO02975 XEO_CLAS Bacterial Extract DME1476 XEOTICID XEO02975 DESCRIPT Micrococcus luteus culture extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02975 GENEFORM Protein DME1476 XEOTICID XEO02975 MOACRIVE Inhibition DME1476 XEOTICID XEO02977 XEO_NAME Propionibacterium sp culture extract DME1476 XEOTICID XEO02977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO02977 XEO_CLAS Bacterial Extract DME1476 XEOTICID XEO02977 DESCRIPT Propionibacterium sp culture extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02977 GENEFORM Protein DME1476 XEOTICID XEO02977 MOACRIVE Inhibition DME1476 XEOTICID XEO02978 XEO_NAME Streptomyces akiyoshinensis culture extract DME1476 XEOTICID XEO02978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO02978 XEO_CLAS Bacterial Extract DME1476 XEOTICID XEO02978 DESCRIPT Streptomyces akiyoshinensis culture extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02978 GENEFORM Protein DME1476 XEOTICID XEO02978 MOACRIVE Inhibition DME1476 XEOTICID XEO02979 XEO_NAME Streptomyces rochei culture extract DME1476 XEOTICID XEO02979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO02979 XEO_CLAS Bacterial Extract DME1476 XEOTICID XEO02979 DESCRIPT Streptomyces rochei culture extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO02979 GENEFORM Protein DME1476 XEOTICID XEO02979 MOACRIVE Inhibition DME1476 XEOTICID XEO03099 XEO_NAME Invertebrate defensin DME1476 XEOTICID XEO03099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03099 XEO_CLAS Peptide DME1476 XEOTICID XEO03099 DESCRIPT Invertebrate defensin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO03099 GENEFORM Protein DME1476 XEOTICID XEO03099 MOACRIVE Inhibition DME1476 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1476 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03363 XEO_CLAS Peptide DME1476 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC > 30 microM) DME1476 XEOTICID XEO03363 GENEFORM Protein DME1476 XEOTICID XEO03363 MOACRIVE Inhibition DME1476 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1476 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03364 XEO_CLAS Peptide DME1476 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC > 30 microM) DME1476 XEOTICID XEO03364 GENEFORM Protein DME1476 XEOTICID XEO03364 MOACRIVE Inhibition DME1476 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1476 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03367 XEO_CLAS Peptide DME1476 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 30 microM) DME1476 XEOTICID XEO03367 GENEFORM Protein DME1476 XEOTICID XEO03367 MOACRIVE Inhibition DME1476 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1476 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03368 XEO_CLAS Peptide DME1476 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 15 microM) DME1476 XEOTICID XEO03368 GENEFORM Protein DME1476 XEOTICID XEO03368 MOACRIVE Inhibition DME1476 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1476 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03462 XEO_CLAS Peptide DME1476 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO03462 GENEFORM Protein DME1476 XEOTICID XEO03462 MOACRIVE Inhibition DME1476 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1476 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03467 XEO_CLAS Peptide DME1476 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO03467 GENEFORM Protein DME1476 XEOTICID XEO03467 MOACRIVE Inhibition DME1476 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1476 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03497 XEO_CLAS Peptide DME1476 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 1.6-3.15 microM) DME1476 XEOTICID XEO03497 GENEFORM Protein DME1476 XEOTICID XEO03497 MOACRIVE Inhibition DME1476 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1476 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03498 XEO_CLAS Peptide DME1476 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 1.6-3.15 microM) DME1476 XEOTICID XEO03498 GENEFORM Protein DME1476 XEOTICID XEO03498 MOACRIVE Inhibition DME1476 XEOTICID XEO03501 XEO_NAME Gramicidin [Scr2]-GS analogue DME1476 XEOTICID XEO03501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03501 XEO_CLAS Peptide DME1476 XEOTICID XEO03501 DESCRIPT Gramicidin [Scr2]-GS analogue inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 25 ug/ml) DME1476 XEOTICID XEO03501 GENEFORM Protein DME1476 XEOTICID XEO03501 MOACRIVE Inhibition DME1476 XEOTICID XEO03502 XEO_NAME Gramicidin [Ser2,2']-GS analogue DME1476 XEOTICID XEO03502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03502 XEO_CLAS Peptide DME1476 XEOTICID XEO03502 DESCRIPT Gramicidin [Ser2,2']-GS analogue inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 25 ug/ml) DME1476 XEOTICID XEO03502 GENEFORM Protein DME1476 XEOTICID XEO03502 MOACRIVE Inhibition DME1476 XEOTICID XEO03503 XEO_NAME Gramicidin S DME1476 XEOTICID XEO03503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03503 XEO_CLAS Peptide DME1476 XEOTICID XEO03503 DESCRIPT Gramicidin S inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 1.6 ug/ml) DME1476 XEOTICID XEO03503 GENEFORM Protein DME1476 XEOTICID XEO03503 MOACRIVE Inhibition DME1476 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1476 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03540 XEO_CLAS Peptide DME1476 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 4 ug/ml) DME1476 XEOTICID XEO03540 GENEFORM Protein DME1476 XEOTICID XEO03540 MOACRIVE Inhibition DME1476 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1476 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03556 XEO_CLAS Peptide DME1476 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 4 ug/ml) DME1476 XEOTICID XEO03556 GENEFORM Protein DME1476 XEOTICID XEO03556 MOACRIVE Inhibition DME1476 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1476 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03557 XEO_CLAS Peptide DME1476 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 4 ug/ml) DME1476 XEOTICID XEO03557 GENEFORM Protein DME1476 XEOTICID XEO03557 MOACRIVE Inhibition DME1476 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1476 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03609 XEO_CLAS Peptide DME1476 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO03609 GENEFORM Protein DME1476 XEOTICID XEO03609 MOACRIVE Inhibition DME1476 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1476 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03793 XEO_CLAS Peptide DME1476 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 8 microM) DME1476 XEOTICID XEO03793 GENEFORM Protein DME1476 XEOTICID XEO03793 MOACRIVE Inhibition DME1476 XEOTICID XEO03837 XEO_NAME Rhodomyrtus tomentosa leaf extract DME1476 XEOTICID XEO03837 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1476 XEOTICID XEO03837 XEO_CLAS Plant Extract DME1476 XEOTICID XEO03837 DESCRIPT Rhodomyrtus tomentosa leaf extract inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO03837 GENEFORM Protein DME1476 XEOTICID XEO03837 MOACRIVE Inhibition DME1476 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1476 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03904 XEO_CLAS Peptide DME1476 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 2 ug/ml) DME1476 XEOTICID XEO03904 GENEFORM Protein DME1476 XEOTICID XEO03904 MOACRIVE Inhibition DME1476 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1476 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03905 XEO_CLAS Peptide DME1476 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 8 ug/ml) DME1476 XEOTICID XEO03905 GENEFORM Protein DME1476 XEOTICID XEO03905 MOACRIVE Inhibition DME1476 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1476 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO03908 XEO_CLAS Peptide DME1476 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO03908 GENEFORM Protein DME1476 XEOTICID XEO03908 MOACRIVE Inhibition DME1476 XEOTICID XEO04057 XEO_NAME Melittin DME1476 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04057 XEO_CLAS Peptide DME1476 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 0.5 microM) DME1476 XEOTICID XEO04057 GENEFORM Protein DME1476 XEOTICID XEO04057 MOACRIVE Inhibition DME1476 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1476 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04128 XEO_CLAS Peptide DME1476 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 0.25 microM) DME1476 XEOTICID XEO04128 GENEFORM Protein DME1476 XEOTICID XEO04128 MOACRIVE Inhibition DME1476 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1476 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04259 XEO_CLAS Peptide DME1476 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04259 GENEFORM Protein DME1476 XEOTICID XEO04259 MOACRIVE Inhibition DME1476 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1476 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04261 XEO_CLAS Peptide DME1476 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04261 GENEFORM Protein DME1476 XEOTICID XEO04261 MOACRIVE Inhibition DME1476 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1476 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04265 XEO_CLAS Peptide DME1476 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04265 GENEFORM Protein DME1476 XEOTICID XEO04265 MOACRIVE Inhibition DME1476 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1476 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04268 XEO_CLAS Peptide DME1476 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04268 GENEFORM Protein DME1476 XEOTICID XEO04268 MOACRIVE Inhibition DME1476 XEOTICID XEO04320 XEO_NAME Nisin U DME1476 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04320 XEO_CLAS Peptide DME1476 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04320 GENEFORM Protein DME1476 XEOTICID XEO04320 MOACRIVE Inhibition DME1476 XEOTICID XEO04332 XEO_NAME Nosiheptide DME1476 XEOTICID XEO04332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04332 XEO_CLAS Peptide DME1476 XEOTICID XEO04332 DESCRIPT Nosiheptide inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 0.00028 ug/ml) DME1476 XEOTICID XEO04332 GENEFORM Protein DME1476 XEOTICID XEO04332 MOACRIVE Inhibition DME1476 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1476 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04463 XEO_CLAS Peptide DME1476 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04463 GENEFORM Protein DME1476 XEOTICID XEO04463 MOACRIVE Inhibition DME1476 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1476 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04542 XEO_CLAS Peptide DME1476 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04542 GENEFORM Protein DME1476 XEOTICID XEO04542 MOACRIVE Inhibition DME1476 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1476 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04613 XEO_CLAS Peptide DME1476 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 1.25-2.5 microM) DME1476 XEOTICID XEO04613 GENEFORM Protein DME1476 XEOTICID XEO04613 MOACRIVE Inhibition DME1476 XEOTICID XEO04624 XEO_NAME Plantazolicin DME1476 XEOTICID XEO04624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04624 XEO_CLAS Peptide DME1476 XEOTICID XEO04624 DESCRIPT Plantazolicin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 128 ug/ml) DME1476 XEOTICID XEO04624 GENEFORM Protein DME1476 XEOTICID XEO04624 MOACRIVE Inhibition DME1476 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1476 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04695 XEO_CLAS Peptide DME1476 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04695 GENEFORM Protein DME1476 XEOTICID XEO04695 MOACRIVE Inhibition DME1476 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1476 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04696 XEO_CLAS Peptide DME1476 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04696 GENEFORM Protein DME1476 XEOTICID XEO04696 MOACRIVE Inhibition DME1476 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1476 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04697 XEO_CLAS Peptide DME1476 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04697 GENEFORM Protein DME1476 XEOTICID XEO04697 MOACRIVE Inhibition DME1476 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1476 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04698 XEO_CLAS Peptide DME1476 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04698 GENEFORM Protein DME1476 XEOTICID XEO04698 MOACRIVE Inhibition DME1476 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1476 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04699 XEO_CLAS Peptide DME1476 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04699 GENEFORM Protein DME1476 XEOTICID XEO04699 MOACRIVE Inhibition DME1476 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1476 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04700 XEO_CLAS Peptide DME1476 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04700 GENEFORM Protein DME1476 XEOTICID XEO04700 MOACRIVE Inhibition DME1476 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1476 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04701 XEO_CLAS Peptide DME1476 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04701 GENEFORM Protein DME1476 XEOTICID XEO04701 MOACRIVE Inhibition DME1476 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1476 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04702 XEO_CLAS Peptide DME1476 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04702 GENEFORM Protein DME1476 XEOTICID XEO04702 MOACRIVE Inhibition DME1476 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1476 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04703 XEO_CLAS Peptide DME1476 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04703 GENEFORM Protein DME1476 XEOTICID XEO04703 MOACRIVE Inhibition DME1476 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1476 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04704 XEO_CLAS Peptide DME1476 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04704 GENEFORM Protein DME1476 XEOTICID XEO04704 MOACRIVE Inhibition DME1476 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1476 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04851 XEO_CLAS Peptide DME1476 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 1 ug/ml) DME1476 XEOTICID XEO04851 GENEFORM Protein DME1476 XEOTICID XEO04851 MOACRIVE Inhibition DME1476 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1476 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04865 XEO_CLAS Peptide DME1476 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 50 ug/ml) DME1476 XEOTICID XEO04865 GENEFORM Protein DME1476 XEOTICID XEO04865 MOACRIVE Inhibition DME1476 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1476 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04866 XEO_CLAS Peptide DME1476 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 12.5 ug/ml) DME1476 XEOTICID XEO04866 GENEFORM Protein DME1476 XEOTICID XEO04866 MOACRIVE Inhibition DME1476 XEOTICID XEO04900 XEO_NAME Salivaricin 9 DME1476 XEOTICID XEO04900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04900 XEO_CLAS Peptide DME1476 XEOTICID XEO04900 DESCRIPT Salivaricin 9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes DME1476 XEOTICID XEO04900 GENEFORM Protein DME1476 XEOTICID XEO04900 MOACRIVE Inhibition DME1476 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1476 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO04995 XEO_CLAS Peptide DME1476 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 1.56-3.12 microM) DME1476 XEOTICID XEO04995 GENEFORM Protein DME1476 XEOTICID XEO04995 MOACRIVE Inhibition DME1476 XEOTICID XEO05009 XEO_NAME Subtilosin A1 DME1476 XEOTICID XEO05009 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO05009 XEO_CLAS Peptide DME1476 XEOTICID XEO05009 DESCRIPT Subtilosin A1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 100 microM) DME1476 XEOTICID XEO05009 GENEFORM Protein DME1476 XEOTICID XEO05009 MOACRIVE Inhibition DME1476 XEOTICID XEO05076 XEO_NAME Temporin-A DME1476 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO05076 XEO_CLAS Peptide DME1476 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 2.0 microM) DME1476 XEOTICID XEO05076 GENEFORM Protein DME1476 XEOTICID XEO05076 MOACRIVE Inhibition DME1476 XEOTICID XEO05085 XEO_NAME Temporin-B DME1476 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1476 XEOTICID XEO05085 XEO_CLAS Peptide DME1476 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Azoreductase (azoR) from Streptococcus pyogenes (MIC = 7.0 ug/ml) DME1476 XEOTICID XEO05085 GENEFORM Protein DME1476 XEOTICID XEO05085 MOACRIVE Inhibition DME1480 DME___ID DME1480 DME1480 DME_NAME Alpha-L-rhamnosidase (lrA) DME1480 SPESNAME Bacillus subtilis DME1480 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1480 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1480 XEOTICID XEO05230 XEO_CLAS Peptide DME1480 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Alpha-L-rhamnosidase (lrA) from Bacillus subtilis (MIC = 2 microM) DME1480 XEOTICID XEO05230 GENEFORM Protein DME1480 XEOTICID XEO05230 MOACRIVE Inhibition DME1480 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1480 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1480 XEOTICID XEO05231 XEO_CLAS Peptide DME1480 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Alpha-L-rhamnosidase (lrA) from Bacillus subtilis (MIC = 0.60 microM) DME1480 XEOTICID XEO05231 GENEFORM Protein DME1480 XEOTICID XEO05231 MOACRIVE Inhibition DME1480 XEOTICID XEO05260 XEO_NAME V. philippinarum beta defensin VpBD DME1480 XEOTICID XEO05260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1480 XEOTICID XEO05260 XEO_CLAS Peptide DME1480 XEOTICID XEO05260 DESCRIPT V. philippinarum beta defensin VpBD inhibits the drug-metabolizing activity of Alpha-L-rhamnosidase (lrA) from Bacillus subtilis (MIC = 13.13-26.26 microM) DME1480 XEOTICID XEO05260 GENEFORM Protein DME1480 XEOTICID XEO05260 MOACRIVE Inhibition DME1484 DME___ID DME1484 DME1484 DME_NAME Beta-lactamase (blaB) DME1484 SPESNAME Enterobacter cancerogenus DME1484 XEOTICID XEO05260 XEO_NAME V. philippinarum beta defensin VpBD DME1484 XEOTICID XEO05260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1484 XEOTICID XEO05260 XEO_CLAS Peptide DME1484 XEOTICID XEO05260 DESCRIPT V. philippinarum beta defensin VpBD inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Enterobacter cancerogenus (MIC = 13.13-26.26 microM) DME1484 XEOTICID XEO05260 GENEFORM Protein DME1484 XEOTICID XEO05260 MOACRIVE Inhibition DME1495 DME___ID DME1495 DME1495 DME_NAME Glucansucrase (gtf106B) DME1495 SPESNAME Lactobacillus reuteri DME1495 XEOTICID XEO03473 XEO_NAME Garvicin ML DME1495 XEOTICID XEO03473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1495 XEOTICID XEO03473 XEO_CLAS Peptide DME1495 XEOTICID XEO03473 DESCRIPT Garvicin ML inhibits the drug-metabolizing activity of Glucansucrase (gtf106B) from Lactobacillus reuteri DME1495 XEOTICID XEO03473 GENEFORM Protein DME1495 XEOTICID XEO03473 MOACRIVE Inhibition DME1495 XEOTICID XEO04319 XEO_NAME Nisin F DME1495 XEOTICID XEO04319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1495 XEOTICID XEO04319 XEO_CLAS Peptide DME1495 XEOTICID XEO04319 DESCRIPT Nisin F inhibits the drug-metabolizing activity of Glucansucrase (gtf106B) from Lactobacillus reuteri DME1495 XEOTICID XEO04319 GENEFORM Protein DME1495 XEOTICID XEO04319 MOACRIVE Inhibition DME1512 DME___ID DME1512 DME1512 DME_NAME L-Lactate dehydrogenase (ldh) DME1512 SPESNAME Lactobacillus casei DME1512 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1512 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1512 XEOTICID XEO03771 XEO_CLAS Peptide DME1512 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of L-Lactate dehydrogenase (ldh) from Lactobacillus casei DME1512 XEOTICID XEO03771 GENEFORM Protein DME1512 XEOTICID XEO03771 MOACRIVE Inhibition DME1512 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1512 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1512 XEOTICID XEO03775 XEO_CLAS Peptide DME1512 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of L-Lactate dehydrogenase (ldh) from Lactobacillus casei (MIC = 2.27 microM) DME1512 XEOTICID XEO03775 GENEFORM Protein DME1512 XEOTICID XEO03775 MOACRIVE Inhibition DME1512 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1512 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1512 XEOTICID XEO03803 XEO_CLAS Peptide DME1512 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of L-Lactate dehydrogenase (ldh) from Lactobacillus casei DME1512 XEOTICID XEO03803 GENEFORM Protein DME1512 XEOTICID XEO03803 MOACRIVE Inhibition DME1512 XEOTICID XEO03967 XEO_NAME Bacteriocin LSEI_2163 DME1512 XEOTICID XEO03967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1512 XEOTICID XEO03967 XEO_CLAS Peptide DME1512 XEOTICID XEO03967 DESCRIPT Bacteriocin LSEI_2163 inhibits the drug-metabolizing activity of L-Lactate dehydrogenase (ldh) from Lactobacillus casei DME1512 XEOTICID XEO03967 GENEFORM Protein DME1512 XEOTICID XEO03967 MOACRIVE Inhibition DME1512 XEOTICID XEO04332 XEO_NAME Nosiheptide DME1512 XEOTICID XEO04332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1512 XEOTICID XEO04332 XEO_CLAS Peptide DME1512 XEOTICID XEO04332 DESCRIPT Nosiheptide inhibits the drug-metabolizing activity of L-Lactate dehydrogenase (ldh) from Lactobacillus casei (MIC = 0.003 ug/ml) DME1512 XEOTICID XEO04332 GENEFORM Protein DME1512 XEOTICID XEO04332 MOACRIVE Inhibition DME1512 XEOTICID XEO04521 XEO_NAME Penocin A DME1512 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1512 XEOTICID XEO04521 XEO_CLAS Peptide DME1512 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of L-Lactate dehydrogenase (ldh) from Lactobacillus casei DME1512 XEOTICID XEO04521 GENEFORM Protein DME1512 XEOTICID XEO04521 MOACRIVE Inhibition DME1512 XEOTICID XEO04616 XEO_NAME Plantaricin E DME1512 XEOTICID XEO04616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1512 XEOTICID XEO04616 XEO_CLAS Peptide DME1512 XEOTICID XEO04616 DESCRIPT Plantaricin E inhibits the drug-metabolizing activity of L-Lactate dehydrogenase (ldh) from Lactobacillus casei (MIC = 0.02 microM) DME1512 XEOTICID XEO04616 GENEFORM Protein DME1512 XEOTICID XEO04616 MOACRIVE Inhibition DME1512 XEOTICID XEO04617 XEO_NAME Plantaricin F DME1512 XEOTICID XEO04617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1512 XEOTICID XEO04617 XEO_CLAS Peptide DME1512 XEOTICID XEO04617 DESCRIPT Plantaricin F inhibits the drug-metabolizing activity of L-Lactate dehydrogenase (ldh) from Lactobacillus casei (MIC = 0.02 microM) DME1512 XEOTICID XEO04617 GENEFORM Protein DME1512 XEOTICID XEO04617 MOACRIVE Inhibition DME1512 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1512 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1512 XEOTICID XEO05004 XEO_CLAS Peptide DME1512 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of L-Lactate dehydrogenase (ldh) from Lactobacillus casei DME1512 XEOTICID XEO05004 GENEFORM Protein DME1512 XEOTICID XEO05004 MOACRIVE Inhibition DME1512 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1512 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1512 XEOTICID XEO05005 XEO_CLAS Peptide DME1512 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of L-Lactate dehydrogenase (ldh) from Lactobacillus casei DME1512 XEOTICID XEO05005 GENEFORM Protein DME1512 XEOTICID XEO05005 MOACRIVE Inhibition DME1512 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1512 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1512 XEOTICID XEO05283 XEO_CLAS Peptide DME1512 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of L-Lactate dehydrogenase (ldh) from Lactobacillus casei DME1512 XEOTICID XEO05283 GENEFORM Protein DME1512 XEOTICID XEO05283 MOACRIVE Inhibition DME1513 DME___ID DME1513 DME1513 DME_NAME Maltose phosphorylase (malP) DME1513 SPESNAME Lactobacillus brevis DME1513 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1513 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1513 XEOTICID XEO03771 XEO_CLAS Peptide DME1513 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Maltose phosphorylase (malP) from Lactobacillus brevis DME1513 XEOTICID XEO03771 GENEFORM Protein DME1513 XEOTICID XEO03771 MOACRIVE Inhibition DME1545 DME___ID DME1545 DME1545 DME_NAME Sucrose phosphorylase (Spase) DME1545 SPESNAME Bifidobacterium longum DME1545 XEOTICID XEO03113 XEO_NAME Royalisin defensin-1 DME1545 XEOTICID XEO03113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1545 XEOTICID XEO03113 XEO_CLAS Peptide DME1545 XEOTICID XEO03113 DESCRIPT Royalisin defensin-1 inhibits the drug-metabolizing activity of Sucrose phosphorylase (Spase) from Bifidobacterium longum DME1545 XEOTICID XEO03113 GENEFORM Protein DME1545 XEOTICID XEO03113 MOACRIVE Inhibition DME1549 DME___ID DME1549 DME1549 DME_NAME Cytochrome P450 125A3 (cyp125) DME1549 SPESNAME Mycolicibacterium smegmatis DME1549 XEOTICID XEO00110 XEO_NAME Acetylcysteine DME1549 XEOTICID XEO00110 XEO_TYPE Pharmaceutical Agent(s) DME1549 XEOTICID XEO00110 XEO_CLAS Approved/Marketed Drug DME1549 XEOTICID XEO00110 DESCRIPT Acetylcysteine inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis DME1549 XEOTICID XEO00110 GENEFORM Protein DME1549 XEOTICID XEO00110 MOACRIVE Inhibition DME1549 XEOTICID XEO03084 XEO_NAME Parinari curatellifolia DCM extract DME1549 XEOTICID XEO03084 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1549 XEOTICID XEO03084 XEO_CLAS Plant Extract DME1549 XEOTICID XEO03084 DESCRIPT Parinari curatellifolia DCM extract inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis DME1549 XEOTICID XEO03084 GENEFORM Protein DME1549 XEOTICID XEO03084 MOACRIVE Inhibition DME1549 XEOTICID XEO03353 XEO_NAME Parinari curatellifolia ethyl acetate extract DME1549 XEOTICID XEO03353 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1549 XEOTICID XEO03353 XEO_CLAS Plant Extract DME1549 XEOTICID XEO03353 DESCRIPT Parinari curatellifolia ethyl acetate extract inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis DME1549 XEOTICID XEO03353 GENEFORM Protein DME1549 XEOTICID XEO03353 MOACRIVE Inhibition DME1549 XEOTICID XEO03553 XEO_NAME Parinari curatellifolia hexane extract DME1549 XEOTICID XEO03553 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1549 XEOTICID XEO03553 XEO_CLAS Plant Extract DME1549 XEOTICID XEO03553 DESCRIPT Parinari curatellifolia hexane extract inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis DME1549 XEOTICID XEO03553 GENEFORM Protein DME1549 XEOTICID XEO03553 MOACRIVE Inhibition DME1549 XEOTICID XEO03807 XEO_NAME Lariatins A DME1549 XEOTICID XEO03807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1549 XEOTICID XEO03807 XEO_CLAS Peptide DME1549 XEOTICID XEO03807 DESCRIPT Lariatins A inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis DME1549 XEOTICID XEO03807 GENEFORM Protein DME1549 XEOTICID XEO03807 MOACRIVE Inhibition DME1549 XEOTICID XEO03808 XEO_NAME Lariatins B DME1549 XEOTICID XEO03808 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1549 XEOTICID XEO03808 XEO_CLAS Peptide DME1549 XEOTICID XEO03808 DESCRIPT Lariatins B inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis DME1549 XEOTICID XEO03808 GENEFORM Protein DME1549 XEOTICID XEO03808 MOACRIVE Inhibition DME1549 XEOTICID XEO04085 XEO_NAME Parinari curatellifolia methanol extract DME1549 XEOTICID XEO04085 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1549 XEOTICID XEO04085 XEO_CLAS Plant Extract DME1549 XEOTICID XEO04085 DESCRIPT Parinari curatellifolia methanol extract inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis DME1549 XEOTICID XEO04085 GENEFORM Protein DME1549 XEOTICID XEO04085 MOACRIVE Inhibition DME1549 XEOTICID XEO04156 XEO_NAME Mutacin II mutacin H-29B DME1549 XEOTICID XEO04156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1549 XEOTICID XEO04156 XEO_CLAS Peptide DME1549 XEOTICID XEO04156 DESCRIPT Mutacin II mutacin H-29B inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis DME1549 XEOTICID XEO04156 GENEFORM Protein DME1549 XEOTICID XEO04156 MOACRIVE Inhibition DME1549 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1549 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1549 XEOTICID XEO04904 XEO_CLAS Peptide DME1549 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis (MIC = 78 ug/ml) DME1549 XEOTICID XEO04904 GENEFORM Protein DME1549 XEOTICID XEO04904 MOACRIVE Inhibition DME1549 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1549 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1549 XEOTICID XEO04909 XEO_CLAS Peptide DME1549 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis DME1549 XEOTICID XEO04909 GENEFORM Protein DME1549 XEOTICID XEO04909 MOACRIVE Inhibition DME1550 DME___ID DME1550 DME1550 DME_NAME Cytochrome P450 142A2 (cyp142) DME1550 SPESNAME Mycolicibacterium smegmatis DME1550 XEOTICID XEO00110 XEO_NAME Acetylcysteine DME1550 XEOTICID XEO00110 XEO_TYPE Pharmaceutical Agent(s) DME1550 XEOTICID XEO00110 XEO_CLAS Approved/Marketed Drug DME1550 XEOTICID XEO00110 DESCRIPT Acetylcysteine inhibits the drug-metabolizing activity of Cytochrome P450 142A2 (cyp142) from Mycolicibacterium smegmatis DME1550 XEOTICID XEO00110 GENEFORM Protein DME1550 XEOTICID XEO00110 MOACRIVE Inhibition DME1550 XEOTICID XEO03084 XEO_NAME Parinari curatellifolia DCM extract DME1550 XEOTICID XEO03084 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1550 XEOTICID XEO03084 XEO_CLAS Plant Extract DME1550 XEOTICID XEO03084 DESCRIPT Parinari curatellifolia DCM extract inhibits the drug-metabolizing activity of Cytochrome P450 142A2 (cyp142) from Mycolicibacterium smegmatis DME1550 XEOTICID XEO03084 GENEFORM Protein DME1550 XEOTICID XEO03084 MOACRIVE Inhibition DME1550 XEOTICID XEO03353 XEO_NAME Parinari curatellifolia ethyl acetate extract DME1550 XEOTICID XEO03353 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1550 XEOTICID XEO03353 XEO_CLAS Plant Extract DME1550 XEOTICID XEO03353 DESCRIPT Parinari curatellifolia ethyl acetate extract inhibits the drug-metabolizing activity of Cytochrome P450 142A2 (cyp142) from Mycolicibacterium smegmatis DME1550 XEOTICID XEO03353 GENEFORM Protein DME1550 XEOTICID XEO03353 MOACRIVE Inhibition DME1550 XEOTICID XEO03553 XEO_NAME Parinari curatellifolia hexane extract DME1550 XEOTICID XEO03553 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1550 XEOTICID XEO03553 XEO_CLAS Plant Extract DME1550 XEOTICID XEO03553 DESCRIPT Parinari curatellifolia hexane extract inhibits the drug-metabolizing activity of Cytochrome P450 142A2 (cyp142) from Mycolicibacterium smegmatis DME1550 XEOTICID XEO03553 GENEFORM Protein DME1550 XEOTICID XEO03553 MOACRIVE Inhibition DME1550 XEOTICID XEO03807 XEO_NAME Lariatins A DME1550 XEOTICID XEO03807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1550 XEOTICID XEO03807 XEO_CLAS Peptide DME1550 XEOTICID XEO03807 DESCRIPT Lariatins A inhibits the drug-metabolizing activity of Cytochrome P450 142A2 (cyp142) from Mycolicibacterium smegmatis DME1550 XEOTICID XEO03807 GENEFORM Protein DME1550 XEOTICID XEO03807 MOACRIVE Inhibition DME1550 XEOTICID XEO03808 XEO_NAME Lariatins B DME1550 XEOTICID XEO03808 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1550 XEOTICID XEO03808 XEO_CLAS Peptide DME1550 XEOTICID XEO03808 DESCRIPT Lariatins B inhibits the drug-metabolizing activity of Cytochrome P450 142A2 (cyp142) from Mycolicibacterium smegmatis DME1550 XEOTICID XEO03808 GENEFORM Protein DME1550 XEOTICID XEO03808 MOACRIVE Inhibition DME1550 XEOTICID XEO04085 XEO_NAME Parinari curatellifolia methanol extract DME1550 XEOTICID XEO04085 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1550 XEOTICID XEO04085 XEO_CLAS Plant Extract DME1550 XEOTICID XEO04085 DESCRIPT Parinari curatellifolia methanol extract inhibits the drug-metabolizing activity of Cytochrome P450 142A2 (cyp142) from Mycolicibacterium smegmatis DME1550 XEOTICID XEO04085 GENEFORM Protein DME1550 XEOTICID XEO04085 MOACRIVE Inhibition DME1550 XEOTICID XEO04156 XEO_NAME Mutacin II mutacin H-29B DME1550 XEOTICID XEO04156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1550 XEOTICID XEO04156 XEO_CLAS Peptide DME1550 XEOTICID XEO04156 DESCRIPT Mutacin II mutacin H-29B inhibits the drug-metabolizing activity of Cytochrome P450 142A2 (cyp142) from Mycolicibacterium smegmatis DME1550 XEOTICID XEO04156 GENEFORM Protein DME1550 XEOTICID XEO04156 MOACRIVE Inhibition DME1550 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1550 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1550 XEOTICID XEO04904 XEO_CLAS Peptide DME1550 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Cytochrome P450 142A2 (cyp142) from Mycolicibacterium smegmatis (MIC = 78 ug/ml) DME1550 XEOTICID XEO04904 GENEFORM Protein DME1550 XEOTICID XEO04904 MOACRIVE Inhibition DME1550 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1550 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1550 XEOTICID XEO04909 XEO_CLAS Peptide DME1550 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Cytochrome P450 142A2 (cyp142) from Mycolicibacterium smegmatis DME1550 XEOTICID XEO04909 GENEFORM Protein DME1550 XEOTICID XEO04909 MOACRIVE Inhibition DME1551 DME___ID DME1551 DME1551 DME_NAME Cytochrome P450 125A1 (cyp125) DME1551 SPESNAME Mycobacterium tuberculosis DME1551 XEOTICID XEO03807 XEO_NAME Lariatins A DME1551 XEOTICID XEO03807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1551 XEOTICID XEO03807 XEO_CLAS Peptide DME1551 XEOTICID XEO03807 DESCRIPT Lariatins A inhibits the drug-metabolizing activity of Cytochrome P450 125A1 (cyp125) from Mycobacterium tuberculosis DME1551 XEOTICID XEO03807 GENEFORM Protein DME1551 XEOTICID XEO03807 MOACRIVE Inhibition DME1551 XEOTICID XEO03808 XEO_NAME Lariatins B DME1551 XEOTICID XEO03808 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1551 XEOTICID XEO03808 XEO_CLAS Peptide DME1551 XEOTICID XEO03808 DESCRIPT Lariatins B inhibits the drug-metabolizing activity of Cytochrome P450 125A1 (cyp125) from Mycobacterium tuberculosis DME1551 XEOTICID XEO03808 GENEFORM Protein DME1551 XEOTICID XEO03808 MOACRIVE Inhibition DME1552 DME___ID DME1552 DME1552 DME_NAME Cytochrome P450 142A1 (cyp142) DME1552 SPESNAME Mycobacterium tuberculosis DME1552 XEOTICID XEO03807 XEO_NAME Lariatins A DME1552 XEOTICID XEO03807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1552 XEOTICID XEO03807 XEO_CLAS Peptide DME1552 XEOTICID XEO03807 DESCRIPT Lariatins A inhibits the drug-metabolizing activity of Cytochrome P450 142A1 (cyp142) from Mycobacterium tuberculosis DME1552 XEOTICID XEO03807 GENEFORM Protein DME1552 XEOTICID XEO03807 MOACRIVE Inhibition DME1552 XEOTICID XEO03808 XEO_NAME Lariatins B DME1552 XEOTICID XEO03808 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1552 XEOTICID XEO03808 XEO_CLAS Peptide DME1552 XEOTICID XEO03808 DESCRIPT Lariatins B inhibits the drug-metabolizing activity of Cytochrome P450 142A1 (cyp142) from Mycobacterium tuberculosis DME1552 XEOTICID XEO03808 GENEFORM Protein DME1552 XEOTICID XEO03808 MOACRIVE Inhibition DME1553 DME___ID DME1553 DME1553 DME_NAME Tyrosine decarboxylase (tdc) DME1553 SPESNAME Lactobacillus brevis DME1553 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1553 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1553 XEOTICID XEO03771 XEO_CLAS Peptide DME1553 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Tyrosine decarboxylase (tdc) from Lactobacillus brevis DME1553 XEOTICID XEO03771 GENEFORM Protein DME1553 XEOTICID XEO03771 MOACRIVE Inhibition DME1559 DME___ID DME1559 DME1559 DME_NAME PenA beta-lactamase (penA1) DME1559 SPESNAME Burkholderia cepacia DME1559 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1559 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1559 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1559 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia DME1559 XEOTICID XEO00117 GENEFORM Protein DME1559 XEOTICID XEO00117 MOACRIVE Inhibition DME1559 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1559 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1559 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1559 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia DME1559 XEOTICID XEO00460 GENEFORM Protein DME1559 XEOTICID XEO00460 MOACRIVE Inhibition DME1559 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1559 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1559 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1559 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia DME1559 XEOTICID XEO00511 GENEFORM Protein DME1559 XEOTICID XEO00511 MOACRIVE Inhibition DME1559 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1559 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1559 XEOTICID XEO02443 XEO_CLAS Peptide DME1559 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia DME1559 XEOTICID XEO02443 GENEFORM Protein DME1559 XEOTICID XEO02443 MOACRIVE Inhibition DME1559 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1559 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1559 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1559 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia DME1559 XEOTICID XEO02714 GENEFORM Protein DME1559 XEOTICID XEO02714 MOACRIVE Inhibition DME1559 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1559 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1559 XEOTICID XEO03127 XEO_CLAS Peptide DME1559 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia DME1559 XEOTICID XEO03127 GENEFORM Protein DME1559 XEOTICID XEO03127 MOACRIVE Inhibition DME1559 XEOTICID XEO03164 XEO_NAME Dermatoxin DME1559 XEOTICID XEO03164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1559 XEOTICID XEO03164 XEO_CLAS Peptide DME1559 XEOTICID XEO03164 DESCRIPT Dermatoxin inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia DME1559 XEOTICID XEO03164 GENEFORM Protein DME1559 XEOTICID XEO03164 MOACRIVE Inhibition DME1559 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1559 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1559 XEOTICID XEO03609 XEO_CLAS Peptide DME1559 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia DME1559 XEOTICID XEO03609 GENEFORM Protein DME1559 XEOTICID XEO03609 MOACRIVE Inhibition DME1559 XEOTICID XEO04240 XEO_NAME NCP-0 peptide DME1559 XEOTICID XEO04240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1559 XEOTICID XEO04240 XEO_CLAS Peptide DME1559 XEOTICID XEO04240 DESCRIPT NCP-0 peptide inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia DME1559 XEOTICID XEO04240 GENEFORM Protein DME1559 XEOTICID XEO04240 MOACRIVE Inhibition DME1559 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1559 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1559 XEOTICID XEO04241 XEO_CLAS Peptide DME1559 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia DME1559 XEOTICID XEO04241 GENEFORM Protein DME1559 XEOTICID XEO04241 MOACRIVE Inhibition DME1559 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1559 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1559 XEOTICID XEO04242 XEO_CLAS Peptide DME1559 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia DME1559 XEOTICID XEO04242 GENEFORM Protein DME1559 XEOTICID XEO04242 MOACRIVE Inhibition DME1559 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1559 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1559 XEOTICID XEO04612 XEO_CLAS Peptide DME1559 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia (MIC > 20 microM) DME1559 XEOTICID XEO04612 GENEFORM Protein DME1559 XEOTICID XEO04612 MOACRIVE Inhibition DME1559 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1559 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1559 XEOTICID XEO04613 XEO_CLAS Peptide DME1559 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia (MIC > 20 microM) DME1559 XEOTICID XEO04613 GENEFORM Protein DME1559 XEOTICID XEO04613 MOACRIVE Inhibition DME1562 DME___ID DME1562 DME1562 DME_NAME Beta-lactamase (blaB) DME1562 SPESNAME Corynebacterium acnes DME1562 XEOTICID XEO00110 XEO_NAME Acetylcysteine DME1562 XEOTICID XEO00110 XEO_TYPE Pharmaceutical Agent(s) DME1562 XEOTICID XEO00110 XEO_CLAS Approved/Marketed Drug DME1562 XEOTICID XEO00110 DESCRIPT Acetylcysteine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes DME1562 XEOTICID XEO00110 GENEFORM Protein DME1562 XEOTICID XEO00110 MOACRIVE Inhibition DME1562 XEOTICID XEO00111 XEO_NAME Erythromycin DME1562 XEOTICID XEO00111 XEO_TYPE Pharmaceutical Agent(s) DME1562 XEOTICID XEO00111 XEO_CLAS Approved/Marketed Drug DME1562 XEOTICID XEO00111 DESCRIPT Erythromycin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes DME1562 XEOTICID XEO00111 GENEFORM Protein DME1562 XEOTICID XEO00111 MOACRIVE Inhibition DME1562 XEOTICID XEO00202 XEO_NAME Oxytetracycline DME1562 XEOTICID XEO00202 XEO_TYPE Pharmaceutical Agent(s) DME1562 XEOTICID XEO00202 XEO_CLAS Approved/Marketed Drug DME1562 XEOTICID XEO00202 DESCRIPT Oxytetracycline inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes DME1562 XEOTICID XEO00202 GENEFORM Protein DME1562 XEOTICID XEO00202 MOACRIVE Inhibition DME1562 XEOTICID XEO00240 XEO_NAME Clindamycin DME1562 XEOTICID XEO00240 XEO_TYPE Pharmaceutical Agent(s) DME1562 XEOTICID XEO00240 XEO_CLAS Approved/Marketed Drug DME1562 XEOTICID XEO00240 DESCRIPT Clindamycin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes DME1562 XEOTICID XEO00240 GENEFORM Protein DME1562 XEOTICID XEO00240 MOACRIVE Inhibition DME1562 XEOTICID XEO00389 XEO_NAME Benzoyl peroxide DME1562 XEOTICID XEO00389 XEO_TYPE Pharmaceutical Agent(s) DME1562 XEOTICID XEO00389 XEO_CLAS Approved/Marketed Drug DME1562 XEOTICID XEO00389 DESCRIPT Benzoyl peroxide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes DME1562 XEOTICID XEO00389 GENEFORM Protein DME1562 XEOTICID XEO00389 MOACRIVE Inhibition DME1562 XEOTICID XEO01807 XEO_NAME (Z)-5-decylidenethiazolidine-2,4-dione DME1562 XEOTICID XEO01807 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1562 XEOTICID XEO01807 XEO_CLAS Chemical Compound DME1562 XEOTICID XEO01807 DESCRIPT (Z)-5-decylidenethiazolidine-2,4-dione inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes DME1562 XEOTICID XEO01807 GENEFORM Protein DME1562 XEOTICID XEO01807 MOACRIVE Inhibition DME1562 XEOTICID XEO01808 XEO_NAME (Z)-5-octylidenethiazolidine-2,4-dione DME1562 XEOTICID XEO01808 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1562 XEOTICID XEO01808 XEO_CLAS Chemical Compound DME1562 XEOTICID XEO01808 DESCRIPT (Z)-5-octylidenethiazolidine-2,4-dione inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes DME1562 XEOTICID XEO01808 GENEFORM Protein DME1562 XEOTICID XEO01808 MOACRIVE Inhibition DME1562 XEOTICID XEO01826 XEO_NAME Temporin-Dra T5k DME1562 XEOTICID XEO01826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1562 XEOTICID XEO01826 XEO_CLAS Peptide DME1562 XEOTICID XEO01826 DESCRIPT Temporin-Dra T5k inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes (MIC = 6 microM) DME1562 XEOTICID XEO01826 GENEFORM Protein DME1562 XEOTICID XEO01826 MOACRIVE Inhibition DME1562 XEOTICID XEO03088 XEO_NAME Decanediol DME1562 XEOTICID XEO03088 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1562 XEOTICID XEO03088 XEO_CLAS Chemical Compound DME1562 XEOTICID XEO03088 DESCRIPT Decanediol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes DME1562 XEOTICID XEO03088 GENEFORM Protein DME1562 XEOTICID XEO03088 MOACRIVE Inhibition DME1562 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1562 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1562 XEOTICID XEO03540 XEO_CLAS Peptide DME1562 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes DME1562 XEOTICID XEO03540 GENEFORM Protein DME1562 XEOTICID XEO03540 MOACRIVE Inhibition DME1562 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1562 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1562 XEOTICID XEO03556 XEO_CLAS Peptide DME1562 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes (MIC = 2 ug/ml) DME1562 XEOTICID XEO03556 GENEFORM Protein DME1562 XEOTICID XEO03556 MOACRIVE Inhibition DME1562 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1562 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1562 XEOTICID XEO03557 XEO_CLAS Peptide DME1562 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes (MIC = 2 ug/ml) DME1562 XEOTICID XEO03557 GENEFORM Protein DME1562 XEOTICID XEO03557 MOACRIVE Inhibition DME1562 XEOTICID XEO04116 XEO_NAME Minocycline DME1562 XEOTICID XEO04116 XEO_TYPE Pharmaceutical Agent(s) DME1562 XEOTICID XEO04116 XEO_CLAS Approved/Marketed Drug DME1562 XEOTICID XEO04116 DESCRIPT Minocycline inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes DME1562 XEOTICID XEO04116 GENEFORM Protein DME1562 XEOTICID XEO04116 MOACRIVE Inhibition DME1562 XEOTICID XEO04156 XEO_NAME Mutacin II mutacin H-29B DME1562 XEOTICID XEO04156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1562 XEOTICID XEO04156 XEO_CLAS Peptide DME1562 XEOTICID XEO04156 DESCRIPT Mutacin II mutacin H-29B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes DME1562 XEOTICID XEO04156 GENEFORM Protein DME1562 XEOTICID XEO04156 MOACRIVE Inhibition DME1562 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1562 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1562 XEOTICID XEO04640 XEO_CLAS Peptide DME1562 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes DME1562 XEOTICID XEO04640 GENEFORM Protein DME1562 XEOTICID XEO04640 MOACRIVE Inhibition DME1562 XEOTICID XEO04854 XEO_NAME Rhodomyrtone DME1562 XEOTICID XEO04854 XEO_TYPE Pharmaceutical Agent(s) DME1562 XEOTICID XEO04854 XEO_CLAS Investigative Agent DME1562 XEOTICID XEO04854 DESCRIPT Rhodomyrtone inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Corynebacterium acnes DME1562 XEOTICID XEO04854 GENEFORM Protein DME1562 XEOTICID XEO04854 MOACRIVE Inhibition DME1564 DME___ID DME1564 DME1564 DME_NAME Beta-lactamase (blaB) DME1564 SPESNAME Staphylococcus aureus DME1564 XEOTICID XEO05275 XEO_NAME Warnerin DME1564 XEOTICID XEO05275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1564 XEOTICID XEO05275 XEO_CLAS Peptide DME1564 XEOTICID XEO05275 DESCRIPT Warnerin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Staphylococcus aureus (MIC = 32 ug/ml) DME1564 XEOTICID XEO05275 GENEFORM Protein DME1564 XEOTICID XEO05275 MOACRIVE Inhibition DME1584 DME___ID DME1584 DME1584 DME_NAME Retro-nitroreductase (rNR) DME1584 SPESNAME Enterobacter cloacae DME1584 XEOTICID XEO02226 XEO_NAME Andropin DME1584 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02226 XEO_CLAS Peptide DME1584 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC > 300 microM) DME1584 XEOTICID XEO02226 GENEFORM Protein DME1584 XEOTICID XEO02226 MOACRIVE Inhibition DME1584 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1584 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02230 XEO_CLAS Peptide DME1584 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 0.5-1 microM) DME1584 XEOTICID XEO02230 GENEFORM Protein DME1584 XEOTICID XEO02230 MOACRIVE Inhibition DME1584 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1584 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02275 XEO_CLAS Peptide DME1584 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 35 microM) DME1584 XEOTICID XEO02275 GENEFORM Protein DME1584 XEOTICID XEO02275 MOACRIVE Inhibition DME1584 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1584 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02284 XEO_CLAS Peptide DME1584 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 47.9 microM) DME1584 XEOTICID XEO02284 GENEFORM Protein DME1584 XEOTICID XEO02284 MOACRIVE Inhibition DME1584 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1584 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02285 XEO_CLAS Peptide DME1584 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 47.9 microM) DME1584 XEOTICID XEO02285 GENEFORM Protein DME1584 XEOTICID XEO02285 MOACRIVE Inhibition DME1584 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1584 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02286 XEO_CLAS Peptide DME1584 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 47.9 microM) DME1584 XEOTICID XEO02286 GENEFORM Protein DME1584 XEOTICID XEO02286 MOACRIVE Inhibition DME1584 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1584 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02287 XEO_CLAS Peptide DME1584 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 47.9 microM) DME1584 XEOTICID XEO02287 GENEFORM Protein DME1584 XEOTICID XEO02287 MOACRIVE Inhibition DME1584 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1584 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02319 XEO_CLAS Peptide DME1584 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO02319 GENEFORM Protein DME1584 XEOTICID XEO02319 MOACRIVE Inhibition DME1584 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1584 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02325 XEO_CLAS Peptide DME1584 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 6 microM) DME1584 XEOTICID XEO02325 GENEFORM Protein DME1584 XEOTICID XEO02325 MOACRIVE Inhibition DME1584 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1584 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02333 XEO_CLAS Peptide DME1584 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC > 200 microM) DME1584 XEOTICID XEO02333 GENEFORM Protein DME1584 XEOTICID XEO02333 MOACRIVE Inhibition DME1584 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1584 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02371 XEO_CLAS Peptide DME1584 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 25 ug/ml) DME1584 XEOTICID XEO02371 GENEFORM Protein DME1584 XEOTICID XEO02371 MOACRIVE Inhibition DME1584 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1584 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02473 XEO_CLAS Peptide DME1584 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO02473 GENEFORM Protein DME1584 XEOTICID XEO02473 MOACRIVE Inhibition DME1584 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1584 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02496 XEO_CLAS Peptide DME1584 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 13 microM) DME1584 XEOTICID XEO02496 GENEFORM Protein DME1584 XEOTICID XEO02496 MOACRIVE Inhibition DME1584 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1584 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02497 XEO_CLAS Peptide DME1584 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 25 microM) DME1584 XEOTICID XEO02497 GENEFORM Protein DME1584 XEOTICID XEO02497 MOACRIVE Inhibition DME1584 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1584 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02566 XEO_CLAS Peptide DME1584 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 50 microM) DME1584 XEOTICID XEO02566 GENEFORM Protein DME1584 XEOTICID XEO02566 MOACRIVE Inhibition DME1584 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1584 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02637 XEO_CLAS Peptide DME1584 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 6 microM) DME1584 XEOTICID XEO02637 GENEFORM Protein DME1584 XEOTICID XEO02637 MOACRIVE Inhibition DME1584 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1584 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02688 XEO_CLAS Peptide DME1584 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 50 microM) DME1584 XEOTICID XEO02688 GENEFORM Protein DME1584 XEOTICID XEO02688 MOACRIVE Inhibition DME1584 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1584 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02745 XEO_CLAS Peptide DME1584 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO02745 GENEFORM Protein DME1584 XEOTICID XEO02745 MOACRIVE Inhibition DME1584 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1584 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02746 XEO_CLAS Peptide DME1584 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO02746 GENEFORM Protein DME1584 XEOTICID XEO02746 MOACRIVE Inhibition DME1584 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1584 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO02768 XEO_CLAS Peptide DME1584 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 50-100 ug/ml) DME1584 XEOTICID XEO02768 GENEFORM Protein DME1584 XEOTICID XEO02768 MOACRIVE Inhibition DME1584 XEOTICID XEO03114 XEO_NAME Defensin AaeDefA DME1584 XEOTICID XEO03114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03114 XEO_CLAS Peptide DME1584 XEOTICID XEO03114 DESCRIPT Defensin AaeDefA inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 1.2-2.4 microM) DME1584 XEOTICID XEO03114 GENEFORM Protein DME1584 XEOTICID XEO03114 MOACRIVE Inhibition DME1584 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1584 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03137 XEO_CLAS Peptide DME1584 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO03137 GENEFORM Protein DME1584 XEOTICID XEO03137 MOACRIVE Inhibition DME1584 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1584 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03162 XEO_CLAS Peptide DME1584 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 12.5 microM) DME1584 XEOTICID XEO03162 GENEFORM Protein DME1584 XEOTICID XEO03162 MOACRIVE Inhibition DME1584 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1584 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03223 XEO_CLAS Peptide DME1584 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 1.0 microM) DME1584 XEOTICID XEO03223 GENEFORM Protein DME1584 XEOTICID XEO03223 MOACRIVE Inhibition DME1584 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1584 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03224 XEO_CLAS Peptide DME1584 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 0.5-1 microM) DME1584 XEOTICID XEO03224 GENEFORM Protein DME1584 XEOTICID XEO03224 MOACRIVE Inhibition DME1584 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1584 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03225 XEO_CLAS Peptide DME1584 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 0.4 microM) DME1584 XEOTICID XEO03225 GENEFORM Protein DME1584 XEOTICID XEO03225 MOACRIVE Inhibition DME1584 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1584 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03250 XEO_CLAS Peptide DME1584 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO03250 GENEFORM Protein DME1584 XEOTICID XEO03250 MOACRIVE Inhibition DME1584 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1584 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03251 XEO_CLAS Peptide DME1584 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO03251 GENEFORM Protein DME1584 XEOTICID XEO03251 MOACRIVE Inhibition DME1584 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1584 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03497 XEO_CLAS Peptide DME1584 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 3.15-6.25 microM) DME1584 XEOTICID XEO03497 GENEFORM Protein DME1584 XEOTICID XEO03497 MOACRIVE Inhibition DME1584 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1584 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03498 XEO_CLAS Peptide DME1584 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 3.15-6.25 microM) DME1584 XEOTICID XEO03498 GENEFORM Protein DME1584 XEOTICID XEO03498 MOACRIVE Inhibition DME1584 XEOTICID XEO03519 XEO_NAME Hadrurin DME1584 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03519 XEO_CLAS Peptide DME1584 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO03519 GENEFORM Protein DME1584 XEOTICID XEO03519 MOACRIVE Inhibition DME1584 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1584 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03540 XEO_CLAS Peptide DME1584 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 8-16 ug/ml) DME1584 XEOTICID XEO03540 GENEFORM Protein DME1584 XEOTICID XEO03540 MOACRIVE Inhibition DME1584 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1584 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03556 XEO_CLAS Peptide DME1584 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 8-16 ug/ml) DME1584 XEOTICID XEO03556 GENEFORM Protein DME1584 XEOTICID XEO03556 MOACRIVE Inhibition DME1584 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1584 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03557 XEO_CLAS Peptide DME1584 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 8-16 ug/ml) DME1584 XEOTICID XEO03557 GENEFORM Protein DME1584 XEOTICID XEO03557 MOACRIVE Inhibition DME1584 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1584 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03561 XEO_CLAS Peptide DME1584 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO03561 GENEFORM Protein DME1584 XEOTICID XEO03561 MOACRIVE Inhibition DME1584 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1584 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03585 XEO_CLAS Peptide DME1584 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 62.5 ug/ml) DME1584 XEOTICID XEO03585 GENEFORM Protein DME1584 XEOTICID XEO03585 MOACRIVE Inhibition DME1584 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1584 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03609 XEO_CLAS Peptide DME1584 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO03609 GENEFORM Protein DME1584 XEOTICID XEO03609 MOACRIVE Inhibition DME1584 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1584 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03672 XEO_CLAS Peptide DME1584 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 10 ug/ml) DME1584 XEOTICID XEO03672 GENEFORM Protein DME1584 XEOTICID XEO03672 MOACRIVE Inhibition DME1584 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1584 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03673 XEO_CLAS Peptide DME1584 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 15 ug/ml) DME1584 XEOTICID XEO03673 GENEFORM Protein DME1584 XEOTICID XEO03673 MOACRIVE Inhibition DME1584 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1584 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03674 XEO_CLAS Peptide DME1584 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO03674 GENEFORM Protein DME1584 XEOTICID XEO03674 MOACRIVE Inhibition DME1584 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1584 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03675 XEO_CLAS Peptide DME1584 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 40 microM) DME1584 XEOTICID XEO03675 GENEFORM Protein DME1584 XEOTICID XEO03675 MOACRIVE Inhibition DME1584 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1584 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03681 XEO_CLAS Peptide DME1584 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 1.2-2.5 microM) DME1584 XEOTICID XEO03681 GENEFORM Protein DME1584 XEOTICID XEO03681 MOACRIVE Inhibition DME1584 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1584 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03697 XEO_CLAS Peptide DME1584 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 6.25 microM) DME1584 XEOTICID XEO03697 GENEFORM Protein DME1584 XEOTICID XEO03697 MOACRIVE Inhibition DME1584 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1584 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO03985 XEO_CLAS Peptide DME1584 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 50 ug/ml) DME1584 XEOTICID XEO03985 GENEFORM Protein DME1584 XEOTICID XEO03985 MOACRIVE Inhibition DME1584 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1584 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04348 XEO_CLAS Peptide DME1584 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 20 microM) DME1584 XEOTICID XEO04348 GENEFORM Protein DME1584 XEOTICID XEO04348 MOACRIVE Inhibition DME1584 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1584 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04349 XEO_CLAS Peptide DME1584 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 50 microM) DME1584 XEOTICID XEO04349 GENEFORM Protein DME1584 XEOTICID XEO04349 MOACRIVE Inhibition DME1584 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1584 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04612 XEO_CLAS Peptide DME1584 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 10-20 microM) DME1584 XEOTICID XEO04612 GENEFORM Protein DME1584 XEOTICID XEO04612 MOACRIVE Inhibition DME1584 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1584 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04613 XEO_CLAS Peptide DME1584 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 10-20 microM) DME1584 XEOTICID XEO04613 GENEFORM Protein DME1584 XEOTICID XEO04613 MOACRIVE Inhibition DME1584 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1584 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04627 XEO_CLAS Peptide DME1584 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 12.5 microM) DME1584 XEOTICID XEO04627 GENEFORM Protein DME1584 XEOTICID XEO04627 MOACRIVE Inhibition DME1584 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1584 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04695 XEO_CLAS Peptide DME1584 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO04695 GENEFORM Protein DME1584 XEOTICID XEO04695 MOACRIVE Inhibition DME1584 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1584 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04696 XEO_CLAS Peptide DME1584 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO04696 GENEFORM Protein DME1584 XEOTICID XEO04696 MOACRIVE Inhibition DME1584 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1584 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04699 XEO_CLAS Peptide DME1584 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO04699 GENEFORM Protein DME1584 XEOTICID XEO04699 MOACRIVE Inhibition DME1584 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1584 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04700 XEO_CLAS Peptide DME1584 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO04700 GENEFORM Protein DME1584 XEOTICID XEO04700 MOACRIVE Inhibition DME1584 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1584 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04701 XEO_CLAS Peptide DME1584 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO04701 GENEFORM Protein DME1584 XEOTICID XEO04701 MOACRIVE Inhibition DME1584 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1584 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04702 XEO_CLAS Peptide DME1584 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO04702 GENEFORM Protein DME1584 XEOTICID XEO04702 MOACRIVE Inhibition DME1584 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1584 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04703 XEO_CLAS Peptide DME1584 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO04703 GENEFORM Protein DME1584 XEOTICID XEO04703 MOACRIVE Inhibition DME1584 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1584 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04809 XEO_CLAS Peptide DME1584 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 5 microM) DME1584 XEOTICID XEO04809 GENEFORM Protein DME1584 XEOTICID XEO04809 MOACRIVE Inhibition DME1584 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1584 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04938 XEO_CLAS Peptide DME1584 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC <= 100 microM) DME1584 XEOTICID XEO04938 GENEFORM Protein DME1584 XEOTICID XEO04938 MOACRIVE Inhibition DME1584 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1584 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO04995 XEO_CLAS Peptide DME1584 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 3.12-6.25 microM) DME1584 XEOTICID XEO04995 GENEFORM Protein DME1584 XEOTICID XEO04995 MOACRIVE Inhibition DME1584 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1584 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO05073 XEO_CLAS Peptide DME1584 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 40 microM) DME1584 XEOTICID XEO05073 GENEFORM Protein DME1584 XEOTICID XEO05073 MOACRIVE Inhibition DME1584 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1584 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO05075 XEO_CLAS Peptide DME1584 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 40 microM) DME1584 XEOTICID XEO05075 GENEFORM Protein DME1584 XEOTICID XEO05075 MOACRIVE Inhibition DME1584 XEOTICID XEO05120 XEO_NAME Thanatin DME1584 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO05120 XEO_CLAS Peptide DME1584 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 1.2-2.5 microM) DME1584 XEOTICID XEO05120 GENEFORM Protein DME1584 XEOTICID XEO05120 MOACRIVE Inhibition DME1584 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1584 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO05139 XEO_CLAS Peptide DME1584 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae DME1584 XEOTICID XEO05139 GENEFORM Protein DME1584 XEOTICID XEO05139 MOACRIVE Inhibition DME1584 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1584 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO05220 XEO_CLAS Peptide DME1584 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 5-10 microM) DME1584 XEOTICID XEO05220 GENEFORM Protein DME1584 XEOTICID XEO05220 MOACRIVE Inhibition DME1584 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1584 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1584 XEOTICID XEO05308 XEO_CLAS Peptide DME1584 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Retro-nitroreductase (rNR) from Enterobacter cloacae (MIC = 12.0 ug/ml) DME1584 XEOTICID XEO05308 GENEFORM Protein DME1584 XEOTICID XEO05308 MOACRIVE Inhibition DME1586 DME___ID DME1586 DME1586 DME_NAME Oxygen-insensitive NADPH nitroreductase A (nfsA) DME1586 SPESNAME Pseudomonas putida DME1586 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1586 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO02649 XEO_CLAS Peptide DME1586 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 4 ug/ml) DME1586 XEOTICID XEO02649 GENEFORM Protein DME1586 XEOTICID XEO02649 MOACRIVE Inhibition DME1586 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1586 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO02650 XEO_CLAS Peptide DME1586 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 2 ug/ml) DME1586 XEOTICID XEO02650 GENEFORM Protein DME1586 XEOTICID XEO02650 MOACRIVE Inhibition DME1586 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1586 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO02839 XEO_CLAS Peptide DME1586 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 40 microM) DME1586 XEOTICID XEO02839 GENEFORM Protein DME1586 XEOTICID XEO02839 MOACRIVE Inhibition DME1586 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1586 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO02842 XEO_CLAS Peptide DME1586 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 40 microM) DME1586 XEOTICID XEO02842 GENEFORM Protein DME1586 XEOTICID XEO02842 MOACRIVE Inhibition DME1586 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1586 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO03052 XEO_CLAS Peptide DME1586 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 100 ug/ml) DME1586 XEOTICID XEO03052 GENEFORM Protein DME1586 XEOTICID XEO03052 MOACRIVE Inhibition DME1586 XEOTICID XEO03349 XEO_NAME Burdock leaf ethanolic extract DME1586 XEOTICID XEO03349 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1586 XEOTICID XEO03349 XEO_CLAS Plant Extract DME1586 XEOTICID XEO03349 DESCRIPT Burdock leaf ethanolic extract inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida DME1586 XEOTICID XEO03349 GENEFORM Protein DME1586 XEOTICID XEO03349 MOACRIVE Inhibition DME1586 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1586 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO03436 XEO_CLAS Peptide DME1586 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 50 ug/ml) DME1586 XEOTICID XEO03436 GENEFORM Protein DME1586 XEOTICID XEO03436 MOACRIVE Inhibition DME1586 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1586 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO03437 XEO_CLAS Peptide DME1586 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 50 ug/ml) DME1586 XEOTICID XEO03437 GENEFORM Protein DME1586 XEOTICID XEO03437 MOACRIVE Inhibition DME1586 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1586 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO03438 XEO_CLAS Peptide DME1586 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 50 ug/ml) DME1586 XEOTICID XEO03438 GENEFORM Protein DME1586 XEOTICID XEO03438 MOACRIVE Inhibition DME1586 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1586 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO03439 XEO_CLAS Peptide DME1586 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 100 ug/ml) DME1586 XEOTICID XEO03439 GENEFORM Protein DME1586 XEOTICID XEO03439 MOACRIVE Inhibition DME1586 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1586 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO03440 XEO_CLAS Peptide DME1586 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 50 ug/ml) DME1586 XEOTICID XEO03440 GENEFORM Protein DME1586 XEOTICID XEO03440 MOACRIVE Inhibition DME1586 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1586 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO03441 XEO_CLAS Peptide DME1586 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 50 ug/ml) DME1586 XEOTICID XEO03441 GENEFORM Protein DME1586 XEOTICID XEO03441 MOACRIVE Inhibition DME1586 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1586 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO03706 XEO_CLAS Peptide DME1586 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida DME1586 XEOTICID XEO03706 GENEFORM Protein DME1586 XEOTICID XEO03706 MOACRIVE Inhibition DME1586 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1586 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO03707 XEO_CLAS Peptide DME1586 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida DME1586 XEOTICID XEO03707 GENEFORM Protein DME1586 XEOTICID XEO03707 MOACRIVE Inhibition DME1586 XEOTICID XEO03971 XEO_NAME Lumbrican DME1586 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO03971 XEO_CLAS Peptide DME1586 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida DME1586 XEOTICID XEO03971 GENEFORM Protein DME1586 XEOTICID XEO03971 MOACRIVE Inhibition DME1586 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1586 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO03985 XEO_CLAS Peptide DME1586 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 10 ug/ml) DME1586 XEOTICID XEO03985 GENEFORM Protein DME1586 XEOTICID XEO03985 MOACRIVE Inhibition DME1586 XEOTICID XEO04117 XEO_NAME Misgurin DME1586 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO04117 XEO_CLAS Peptide DME1586 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida DME1586 XEOTICID XEO04117 GENEFORM Protein DME1586 XEOTICID XEO04117 MOACRIVE Inhibition DME1586 XEOTICID XEO04931 XEO_NAME Shepherin I DME1586 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO04931 XEO_CLAS Peptide DME1586 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida DME1586 XEOTICID XEO04931 GENEFORM Protein DME1586 XEOTICID XEO04931 MOACRIVE Inhibition DME1586 XEOTICID XEO04932 XEO_NAME shepherin II DME1586 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO04932 XEO_CLAS Peptide DME1586 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida DME1586 XEOTICID XEO04932 GENEFORM Protein DME1586 XEOTICID XEO04932 MOACRIVE Inhibition DME1586 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1586 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1586 XEOTICID XEO05111 XEO_CLAS Natural Product DME1586 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida DME1586 XEOTICID XEO05111 GENEFORM Protein DME1586 XEOTICID XEO05111 MOACRIVE Inhibition DME1586 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1586 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO05144 XEO_CLAS Peptide DME1586 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 40 ug/ml) DME1586 XEOTICID XEO05144 GENEFORM Protein DME1586 XEOTICID XEO05144 MOACRIVE Inhibition DME1586 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1586 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO05145 XEO_CLAS Peptide DME1586 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 50 ug/ml) DME1586 XEOTICID XEO05145 GENEFORM Protein DME1586 XEOTICID XEO05145 MOACRIVE Inhibition DME1586 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1586 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO05146 XEO_CLAS Peptide DME1586 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 40 ug/ml) DME1586 XEOTICID XEO05146 GENEFORM Protein DME1586 XEOTICID XEO05146 MOACRIVE Inhibition DME1586 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1586 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO05147 XEO_CLAS Peptide DME1586 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 60 ug/ml) DME1586 XEOTICID XEO05147 GENEFORM Protein DME1586 XEOTICID XEO05147 MOACRIVE Inhibition DME1586 XEOTICID XEO05260 XEO_NAME V. philippinarum beta defensin VpBD DME1586 XEOTICID XEO05260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1586 XEOTICID XEO05260 XEO_CLAS Peptide DME1586 XEOTICID XEO05260 DESCRIPT V. philippinarum beta defensin VpBD inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Pseudomonas putida (MIC = 1.64-3.28 microM) DME1586 XEOTICID XEO05260 GENEFORM Protein DME1586 XEOTICID XEO05260 MOACRIVE Inhibition DME1617 DME___ID DME1617 DME1617 DME_NAME Oxygen-insensitive NADPH nitroreductase B (nfsB) DME1617 SPESNAME Salmonella enterica DME1617 XEOTICID XEO01237 XEO_NAME Carvacrol DME1617 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1617 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1617 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO01237 GENEFORM Protein DME1617 XEOTICID XEO01237 MOACRIVE Inhibition DME1617 XEOTICID XEO01802 XEO_NAME (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone DME1617 XEOTICID XEO01802 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1617 XEOTICID XEO01802 XEO_CLAS Chemical Compound DME1617 XEOTICID XEO01802 DESCRIPT (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO01802 GENEFORM Protein DME1617 XEOTICID XEO01802 MOACRIVE Inhibition DME1617 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1617 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO01810 XEO_CLAS Peptide DME1617 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1.0 microM) DME1617 XEOTICID XEO01810 GENEFORM Protein DME1617 XEOTICID XEO01810 MOACRIVE Inhibition DME1617 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1617 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO01811 XEO_CLAS Peptide DME1617 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC > 64 microM) DME1617 XEOTICID XEO01811 GENEFORM Protein DME1617 XEOTICID XEO01811 MOACRIVE Inhibition DME1617 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1617 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO01817 XEO_CLAS Peptide DME1617 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4.0 microM) DME1617 XEOTICID XEO01817 GENEFORM Protein DME1617 XEOTICID XEO01817 MOACRIVE Inhibition DME1617 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1617 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO01818 XEO_CLAS Peptide DME1617 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1.0 microM) DME1617 XEOTICID XEO01818 GENEFORM Protein DME1617 XEOTICID XEO01818 MOACRIVE Inhibition DME1617 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1617 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO01819 XEO_CLAS Peptide DME1617 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1 microM) DME1617 XEOTICID XEO01819 GENEFORM Protein DME1617 XEOTICID XEO01819 MOACRIVE Inhibition DME1617 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1617 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO01820 XEO_CLAS Peptide DME1617 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1 microM) DME1617 XEOTICID XEO01820 GENEFORM Protein DME1617 XEOTICID XEO01820 MOACRIVE Inhibition DME1617 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1617 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO01821 XEO_CLAS Peptide DME1617 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1 microM) DME1617 XEOTICID XEO01821 GENEFORM Protein DME1617 XEOTICID XEO01821 MOACRIVE Inhibition DME1617 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1617 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO01822 XEO_CLAS Peptide DME1617 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 16 microM) DME1617 XEOTICID XEO01822 GENEFORM Protein DME1617 XEOTICID XEO01822 MOACRIVE Inhibition DME1617 XEOTICID XEO01944 XEO_NAME 2-Hexylmaleic anhydride DME1617 XEOTICID XEO01944 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1617 XEOTICID XEO01944 XEO_CLAS Chemical Compound DME1617 XEOTICID XEO01944 DESCRIPT 2-Hexylmaleic anhydride inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO01944 GENEFORM Protein DME1617 XEOTICID XEO01944 MOACRIVE Inhibition DME1617 XEOTICID XEO01990 XEO_NAME 3-hexyl-4-bromo-5-methylene-2(5H)-furanone DME1617 XEOTICID XEO01990 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1617 XEOTICID XEO01990 XEO_CLAS Chemical Compound DME1617 XEOTICID XEO01990 DESCRIPT 3-hexyl-4-bromo-5-methylene-2(5H)-furanone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO01990 GENEFORM Protein DME1617 XEOTICID XEO01990 MOACRIVE Inhibition DME1617 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1617 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02207 XEO_CLAS Peptide DME1617 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.39 ug/ml) DME1617 XEOTICID XEO02207 GENEFORM Protein DME1617 XEOTICID XEO02207 MOACRIVE Inhibition DME1617 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1617 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02208 XEO_CLAS Peptide DME1617 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.78 ug/ml) DME1617 XEOTICID XEO02208 GENEFORM Protein DME1617 XEOTICID XEO02208 MOACRIVE Inhibition DME1617 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1617 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02209 XEO_CLAS Peptide DME1617 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.39 ug/ml) DME1617 XEOTICID XEO02209 GENEFORM Protein DME1617 XEOTICID XEO02209 MOACRIVE Inhibition DME1617 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1617 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02210 XEO_CLAS Peptide DME1617 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 12.5 ug/ml) DME1617 XEOTICID XEO02210 GENEFORM Protein DME1617 XEOTICID XEO02210 MOACRIVE Inhibition DME1617 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1617 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02211 XEO_CLAS Peptide DME1617 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 12.5 ug/ml) DME1617 XEOTICID XEO02211 GENEFORM Protein DME1617 XEOTICID XEO02211 MOACRIVE Inhibition DME1617 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1617 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02212 XEO_CLAS Peptide DME1617 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.39 ug/ml) DME1617 XEOTICID XEO02212 GENEFORM Protein DME1617 XEOTICID XEO02212 MOACRIVE Inhibition DME1617 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1617 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02213 XEO_CLAS Peptide DME1617 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.39 ug/ml) DME1617 XEOTICID XEO02213 GENEFORM Protein DME1617 XEOTICID XEO02213 MOACRIVE Inhibition DME1617 XEOTICID XEO02224 XEO_NAME Androctonin DME1617 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02224 XEO_CLAS Peptide DME1617 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO02224 GENEFORM Protein DME1617 XEOTICID XEO02224 MOACRIVE Inhibition DME1617 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1617 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02230 XEO_CLAS Peptide DME1617 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.1-0.25 microM) DME1617 XEOTICID XEO02230 GENEFORM Protein DME1617 XEOTICID XEO02230 MOACRIVE Inhibition DME1617 XEOTICID XEO02235 XEO_NAME Anthranilate DME1617 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1617 XEOTICID XEO02235 XEO_CLAS Natural Product DME1617 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO02235 GENEFORM Protein DME1617 XEOTICID XEO02235 MOACRIVE Inhibition DME1617 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1617 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02242 XEO_CLAS Peptide DME1617 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 microM) DME1617 XEOTICID XEO02242 GENEFORM Protein DME1617 XEOTICID XEO02242 MOACRIVE Inhibition DME1617 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1617 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02243 XEO_CLAS Peptide DME1617 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 48 microM) DME1617 XEOTICID XEO02243 GENEFORM Protein DME1617 XEOTICID XEO02243 MOACRIVE Inhibition DME1617 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1617 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02244 XEO_CLAS Peptide DME1617 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 microM) DME1617 XEOTICID XEO02244 GENEFORM Protein DME1617 XEOTICID XEO02244 MOACRIVE Inhibition DME1617 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1617 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02248 XEO_CLAS Peptide DME1617 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1 microM) DME1617 XEOTICID XEO02248 GENEFORM Protein DME1617 XEOTICID XEO02248 MOACRIVE Inhibition DME1617 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1617 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02283 XEO_CLAS Peptide DME1617 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1.56 ug/ml) DME1617 XEOTICID XEO02283 GENEFORM Protein DME1617 XEOTICID XEO02283 MOACRIVE Inhibition DME1617 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1617 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02284 XEO_CLAS Peptide DME1617 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 25.0 microM) DME1617 XEOTICID XEO02284 GENEFORM Protein DME1617 XEOTICID XEO02284 MOACRIVE Inhibition DME1617 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1617 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02285 XEO_CLAS Peptide DME1617 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 25.0 microM) DME1617 XEOTICID XEO02285 GENEFORM Protein DME1617 XEOTICID XEO02285 MOACRIVE Inhibition DME1617 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1617 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02286 XEO_CLAS Peptide DME1617 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 25.0 microM) DME1617 XEOTICID XEO02286 GENEFORM Protein DME1617 XEOTICID XEO02286 MOACRIVE Inhibition DME1617 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1617 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02287 XEO_CLAS Peptide DME1617 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 25.0 microM) DME1617 XEOTICID XEO02287 GENEFORM Protein DME1617 XEOTICID XEO02287 MOACRIVE Inhibition DME1617 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1617 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02304 XEO_CLAS Peptide DME1617 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.1 ug/ml) DME1617 XEOTICID XEO02304 GENEFORM Protein DME1617 XEOTICID XEO02304 MOACRIVE Inhibition DME1617 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1617 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02305 XEO_CLAS Peptide DME1617 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.1 ug/ml) DME1617 XEOTICID XEO02305 GENEFORM Protein DME1617 XEOTICID XEO02305 MOACRIVE Inhibition DME1617 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1617 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02306 XEO_CLAS Peptide DME1617 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.1 ug/ml) DME1617 XEOTICID XEO02306 GENEFORM Protein DME1617 XEOTICID XEO02306 MOACRIVE Inhibition DME1617 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1617 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02317 XEO_CLAS Peptide DME1617 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 300 microM) DME1617 XEOTICID XEO02317 GENEFORM Protein DME1617 XEOTICID XEO02317 MOACRIVE Inhibition DME1617 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1617 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02333 XEO_CLAS Peptide DME1617 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC > 200 microM) DME1617 XEOTICID XEO02333 GENEFORM Protein DME1617 XEOTICID XEO02333 MOACRIVE Inhibition DME1617 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1617 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02356 XEO_CLAS Peptide DME1617 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 ug/ml) DME1617 XEOTICID XEO02356 GENEFORM Protein DME1617 XEOTICID XEO02356 MOACRIVE Inhibition DME1617 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1617 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02357 XEO_CLAS Peptide DME1617 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 31 ug/ml) DME1617 XEOTICID XEO02357 GENEFORM Protein DME1617 XEOTICID XEO02357 MOACRIVE Inhibition DME1617 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1617 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02358 XEO_CLAS Peptide DME1617 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 16 ug/ml) DME1617 XEOTICID XEO02358 GENEFORM Protein DME1617 XEOTICID XEO02358 MOACRIVE Inhibition DME1617 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1617 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02360 XEO_CLAS Peptide DME1617 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 ug/ml) DME1617 XEOTICID XEO02360 GENEFORM Protein DME1617 XEOTICID XEO02360 MOACRIVE Inhibition DME1617 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1617 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02361 XEO_CLAS Peptide DME1617 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 31 ug/ml) DME1617 XEOTICID XEO02361 GENEFORM Protein DME1617 XEOTICID XEO02361 MOACRIVE Inhibition DME1617 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1617 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02365 XEO_CLAS Peptide DME1617 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC > 64 ug/ml) DME1617 XEOTICID XEO02365 GENEFORM Protein DME1617 XEOTICID XEO02365 MOACRIVE Inhibition DME1617 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1617 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02366 XEO_CLAS Peptide DME1617 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 32 ug/ml) DME1617 XEOTICID XEO02366 GENEFORM Protein DME1617 XEOTICID XEO02366 MOACRIVE Inhibition DME1617 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1617 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02367 XEO_CLAS Peptide DME1617 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 ug/ml) DME1617 XEOTICID XEO02367 GENEFORM Protein DME1617 XEOTICID XEO02367 MOACRIVE Inhibition DME1617 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1617 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02368 XEO_CLAS Peptide DME1617 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 ug/ml) DME1617 XEOTICID XEO02368 GENEFORM Protein DME1617 XEOTICID XEO02368 MOACRIVE Inhibition DME1617 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1617 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02369 XEO_CLAS Peptide DME1617 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO02369 GENEFORM Protein DME1617 XEOTICID XEO02369 MOACRIVE Inhibition DME1617 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1617 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02370 XEO_CLAS Peptide DME1617 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2-10 microM) DME1617 XEOTICID XEO02370 GENEFORM Protein DME1617 XEOTICID XEO02370 MOACRIVE Inhibition DME1617 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1617 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02371 XEO_CLAS Peptide DME1617 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 12 ug/ml) DME1617 XEOTICID XEO02371 GENEFORM Protein DME1617 XEOTICID XEO02371 MOACRIVE Inhibition DME1617 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1617 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02378 XEO_CLAS Peptide DME1617 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.19 ug/ml) DME1617 XEOTICID XEO02378 GENEFORM Protein DME1617 XEOTICID XEO02378 MOACRIVE Inhibition DME1617 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1617 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02388 XEO_CLAS Peptide DME1617 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO02388 GENEFORM Protein DME1617 XEOTICID XEO02388 MOACRIVE Inhibition DME1617 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1617 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02389 XEO_CLAS Peptide DME1617 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 ug/ml) DME1617 XEOTICID XEO02389 GENEFORM Protein DME1617 XEOTICID XEO02389 MOACRIVE Inhibition DME1617 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1617 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02451 XEO_CLAS Peptide DME1617 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO02451 GENEFORM Protein DME1617 XEOTICID XEO02451 MOACRIVE Inhibition DME1617 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1617 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02466 XEO_CLAS Peptide DME1617 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 3 microM) DME1617 XEOTICID XEO02466 GENEFORM Protein DME1617 XEOTICID XEO02466 MOACRIVE Inhibition DME1617 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1617 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02491 XEO_CLAS Peptide DME1617 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2.3 microM) DME1617 XEOTICID XEO02491 GENEFORM Protein DME1617 XEOTICID XEO02491 MOACRIVE Inhibition DME1617 XEOTICID XEO02641 XEO_NAME Bromohexylmaleic anhydride DME1617 XEOTICID XEO02641 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1617 XEOTICID XEO02641 XEO_CLAS Chemical Compound DME1617 XEOTICID XEO02641 DESCRIPT Bromohexylmaleic anhydride inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO02641 GENEFORM Protein DME1617 XEOTICID XEO02641 MOACRIVE Inhibition DME1617 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1617 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02649 XEO_CLAS Peptide DME1617 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO02649 GENEFORM Protein DME1617 XEOTICID XEO02649 MOACRIVE Inhibition DME1617 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1617 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02650 XEO_CLAS Peptide DME1617 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1 ug/ml) DME1617 XEOTICID XEO02650 GENEFORM Protein DME1617 XEOTICID XEO02650 MOACRIVE Inhibition DME1617 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1617 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02734 XEO_CLAS Peptide DME1617 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.40 microM) DME1617 XEOTICID XEO02734 GENEFORM Protein DME1617 XEOTICID XEO02734 MOACRIVE Inhibition DME1617 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1617 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02735 XEO_CLAS Peptide DME1617 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1 ug/ml) DME1617 XEOTICID XEO02735 GENEFORM Protein DME1617 XEOTICID XEO02735 MOACRIVE Inhibition DME1617 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1617 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02736 XEO_CLAS Peptide DME1617 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.66 microM) DME1617 XEOTICID XEO02736 GENEFORM Protein DME1617 XEOTICID XEO02736 MOACRIVE Inhibition DME1617 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1617 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02738 XEO_CLAS Peptide DME1617 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 microM) DME1617 XEOTICID XEO02738 GENEFORM Protein DME1617 XEOTICID XEO02738 MOACRIVE Inhibition DME1617 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1617 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02739 XEO_CLAS Peptide DME1617 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1 microM) DME1617 XEOTICID XEO02739 GENEFORM Protein DME1617 XEOTICID XEO02739 MOACRIVE Inhibition DME1617 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1617 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02740 XEO_CLAS Peptide DME1617 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1 ug/ml) DME1617 XEOTICID XEO02740 GENEFORM Protein DME1617 XEOTICID XEO02740 MOACRIVE Inhibition DME1617 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1617 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02768 XEO_CLAS Peptide DME1617 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1-2.5 ug/ml) DME1617 XEOTICID XEO02768 GENEFORM Protein DME1617 XEOTICID XEO02768 MOACRIVE Inhibition DME1617 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1617 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02774 XEO_CLAS Peptide DME1617 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.9 microM) DME1617 XEOTICID XEO02774 GENEFORM Protein DME1617 XEOTICID XEO02774 MOACRIVE Inhibition DME1617 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1617 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02799 XEO_CLAS Peptide DME1617 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 3 ug/ml) DME1617 XEOTICID XEO02799 GENEFORM Protein DME1617 XEOTICID XEO02799 MOACRIVE Inhibition DME1617 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1617 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02800 XEO_CLAS Peptide DME1617 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 ug/ml) DME1617 XEOTICID XEO02800 GENEFORM Protein DME1617 XEOTICID XEO02800 MOACRIVE Inhibition DME1617 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1617 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02820 XEO_CLAS Peptide DME1617 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 64 ug/ml) DME1617 XEOTICID XEO02820 GENEFORM Protein DME1617 XEOTICID XEO02820 MOACRIVE Inhibition DME1617 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1617 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02885 XEO_CLAS Peptide DME1617 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 5 ug/ml) DME1617 XEOTICID XEO02885 GENEFORM Protein DME1617 XEOTICID XEO02885 MOACRIVE Inhibition DME1617 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1617 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02886 XEO_CLAS Peptide DME1617 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO02886 GENEFORM Protein DME1617 XEOTICID XEO02886 MOACRIVE Inhibition DME1617 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1617 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02887 XEO_CLAS Peptide DME1617 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 3 ug/ml) DME1617 XEOTICID XEO02887 GENEFORM Protein DME1617 XEOTICID XEO02887 MOACRIVE Inhibition DME1617 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1617 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02888 XEO_CLAS Peptide DME1617 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 3 ug/ml) DME1617 XEOTICID XEO02888 GENEFORM Protein DME1617 XEOTICID XEO02888 MOACRIVE Inhibition DME1617 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1617 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02889 XEO_CLAS Peptide DME1617 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 29 ug/ml) DME1617 XEOTICID XEO02889 GENEFORM Protein DME1617 XEOTICID XEO02889 MOACRIVE Inhibition DME1617 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1617 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02890 XEO_CLAS Peptide DME1617 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO02890 GENEFORM Protein DME1617 XEOTICID XEO02890 MOACRIVE Inhibition DME1617 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1617 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02891 XEO_CLAS Peptide DME1617 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 3 ug/ml) DME1617 XEOTICID XEO02891 GENEFORM Protein DME1617 XEOTICID XEO02891 MOACRIVE Inhibition DME1617 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1617 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02933 XEO_CLAS Peptide DME1617 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 43 ug/ml) DME1617 XEOTICID XEO02933 GENEFORM Protein DME1617 XEOTICID XEO02933 MOACRIVE Inhibition DME1617 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1617 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02934 XEO_CLAS Peptide DME1617 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 16 ug/ml) DME1617 XEOTICID XEO02934 GENEFORM Protein DME1617 XEOTICID XEO02934 MOACRIVE Inhibition DME1617 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1617 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02935 XEO_CLAS Peptide DME1617 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO02935 GENEFORM Protein DME1617 XEOTICID XEO02935 MOACRIVE Inhibition DME1617 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1617 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02937 XEO_CLAS Peptide DME1617 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 3 ug/ml) DME1617 XEOTICID XEO02937 GENEFORM Protein DME1617 XEOTICID XEO02937 MOACRIVE Inhibition DME1617 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1617 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02940 XEO_CLAS Peptide DME1617 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 3 ug/ml) DME1617 XEOTICID XEO02940 GENEFORM Protein DME1617 XEOTICID XEO02940 MOACRIVE Inhibition DME1617 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1617 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02941 XEO_CLAS Peptide DME1617 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 ug/ml) DME1617 XEOTICID XEO02941 GENEFORM Protein DME1617 XEOTICID XEO02941 MOACRIVE Inhibition DME1617 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1617 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02947 XEO_CLAS Peptide DME1617 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 43 ug/ml) DME1617 XEOTICID XEO02947 GENEFORM Protein DME1617 XEOTICID XEO02947 MOACRIVE Inhibition DME1617 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1617 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02948 XEO_CLAS Peptide DME1617 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 ug/ml) DME1617 XEOTICID XEO02948 GENEFORM Protein DME1617 XEOTICID XEO02948 MOACRIVE Inhibition DME1617 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1617 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02949 XEO_CLAS Peptide DME1617 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO02949 GENEFORM Protein DME1617 XEOTICID XEO02949 MOACRIVE Inhibition DME1617 XEOTICID XEO02955 XEO_NAME Cryptdin related sequence CRS4C-3c DME1617 XEOTICID XEO02955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02955 XEO_CLAS Peptide DME1617 XEOTICID XEO02955 DESCRIPT Cryptdin related sequence CRS4C-3c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO02955 GENEFORM Protein DME1617 XEOTICID XEO02955 MOACRIVE Inhibition DME1617 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1617 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02958 XEO_CLAS Peptide DME1617 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO02958 GENEFORM Protein DME1617 XEOTICID XEO02958 MOACRIVE Inhibition DME1617 XEOTICID XEO02959 XEO_NAME Cryptdin related peptide CRS4C-1d DME1617 XEOTICID XEO02959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02959 XEO_CLAS Peptide DME1617 XEOTICID XEO02959 DESCRIPT Cryptdin related peptide CRS4C-1d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO02959 GENEFORM Protein DME1617 XEOTICID XEO02959 MOACRIVE Inhibition DME1617 XEOTICID XEO02960 XEO_NAME Cryptdin related peptide CRS4C-2 DME1617 XEOTICID XEO02960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02960 XEO_CLAS Peptide DME1617 XEOTICID XEO02960 DESCRIPT Cryptdin related peptide CRS4C-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO02960 GENEFORM Protein DME1617 XEOTICID XEO02960 MOACRIVE Inhibition DME1617 XEOTICID XEO02961 XEO_NAME Cryptdin related peptide CRS4C-2b DME1617 XEOTICID XEO02961 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO02961 XEO_CLAS Peptide DME1617 XEOTICID XEO02961 DESCRIPT Cryptdin related peptide CRS4C-2b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO02961 GENEFORM Protein DME1617 XEOTICID XEO02961 MOACRIVE Inhibition DME1617 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1617 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1617 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1617 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO02990 GENEFORM Protein DME1617 XEOTICID XEO02990 MOACRIVE Inhibition DME1617 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1617 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03029 XEO_CLAS Peptide DME1617 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.005 microM) DME1617 XEOTICID XEO03029 GENEFORM Protein DME1617 XEOTICID XEO03029 MOACRIVE Inhibition DME1617 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1617 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03030 XEO_CLAS Peptide DME1617 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.005 microM) DME1617 XEOTICID XEO03030 GENEFORM Protein DME1617 XEOTICID XEO03030 MOACRIVE Inhibition DME1617 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1617 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03031 XEO_CLAS Peptide DME1617 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.3 microM) DME1617 XEOTICID XEO03031 GENEFORM Protein DME1617 XEOTICID XEO03031 MOACRIVE Inhibition DME1617 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1617 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03032 XEO_CLAS Peptide DME1617 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.005 microM) DME1617 XEOTICID XEO03032 GENEFORM Protein DME1617 XEOTICID XEO03032 MOACRIVE Inhibition DME1617 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1617 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03033 XEO_CLAS Peptide DME1617 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.005 microM) DME1617 XEOTICID XEO03033 GENEFORM Protein DME1617 XEOTICID XEO03033 MOACRIVE Inhibition DME1617 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1617 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03034 XEO_CLAS Peptide DME1617 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.528 microM) DME1617 XEOTICID XEO03034 GENEFORM Protein DME1617 XEOTICID XEO03034 MOACRIVE Inhibition DME1617 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1617 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03035 XEO_CLAS Peptide DME1617 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.004 microM) DME1617 XEOTICID XEO03035 GENEFORM Protein DME1617 XEOTICID XEO03035 MOACRIVE Inhibition DME1617 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1617 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03043 XEO_CLAS Peptide DME1617 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 microM) DME1617 XEOTICID XEO03043 GENEFORM Protein DME1617 XEOTICID XEO03043 MOACRIVE Inhibition DME1617 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1617 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03052 XEO_CLAS Peptide DME1617 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 50 ug/ml) DME1617 XEOTICID XEO03052 GENEFORM Protein DME1617 XEOTICID XEO03052 MOACRIVE Inhibition DME1617 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1617 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03053 XEO_CLAS Peptide DME1617 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 125 ug/ml) DME1617 XEOTICID XEO03053 GENEFORM Protein DME1617 XEOTICID XEO03053 MOACRIVE Inhibition DME1617 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1617 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03060 XEO_CLAS Peptide DME1617 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 microM) DME1617 XEOTICID XEO03060 GENEFORM Protein DME1617 XEOTICID XEO03060 MOACRIVE Inhibition DME1617 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1617 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03125 XEO_CLAS Peptide DME1617 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO03125 GENEFORM Protein DME1617 XEOTICID XEO03125 MOACRIVE Inhibition DME1617 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1617 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03162 XEO_CLAS Peptide DME1617 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 3.1 microM) DME1617 XEOTICID XEO03162 GENEFORM Protein DME1617 XEOTICID XEO03162 MOACRIVE Inhibition DME1617 XEOTICID XEO03164 XEO_NAME Dermatoxin DME1617 XEOTICID XEO03164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03164 XEO_CLAS Peptide DME1617 XEOTICID XEO03164 DESCRIPT Dermatoxin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO03164 GENEFORM Protein DME1617 XEOTICID XEO03164 MOACRIVE Inhibition DME1617 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1617 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03224 XEO_CLAS Peptide DME1617 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.5-1 microM) DME1617 XEOTICID XEO03224 GENEFORM Protein DME1617 XEOTICID XEO03224 MOACRIVE Inhibition DME1617 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1617 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03250 XEO_CLAS Peptide DME1617 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO03250 GENEFORM Protein DME1617 XEOTICID XEO03250 MOACRIVE Inhibition DME1617 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1617 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03251 XEO_CLAS Peptide DME1617 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO03251 GENEFORM Protein DME1617 XEOTICID XEO03251 MOACRIVE Inhibition DME1617 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1617 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03428 XEO_CLAS Peptide DME1617 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 63 ug/ml) DME1617 XEOTICID XEO03428 GENEFORM Protein DME1617 XEOTICID XEO03428 MOACRIVE Inhibition DME1617 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1617 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03430 XEO_CLAS Peptide DME1617 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 63 ug/ml) DME1617 XEOTICID XEO03430 GENEFORM Protein DME1617 XEOTICID XEO03430 MOACRIVE Inhibition DME1617 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1617 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03434 XEO_CLAS Peptide DME1617 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 31 ug/ml) DME1617 XEOTICID XEO03434 GENEFORM Protein DME1617 XEOTICID XEO03434 MOACRIVE Inhibition DME1617 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1617 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03437 XEO_CLAS Peptide DME1617 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 150 ug/ml) DME1617 XEOTICID XEO03437 GENEFORM Protein DME1617 XEOTICID XEO03437 MOACRIVE Inhibition DME1617 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1617 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03438 XEO_CLAS Peptide DME1617 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 150 ug/ml) DME1617 XEOTICID XEO03438 GENEFORM Protein DME1617 XEOTICID XEO03438 MOACRIVE Inhibition DME1617 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1617 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03439 XEO_CLAS Peptide DME1617 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 200 ug/ml) DME1617 XEOTICID XEO03439 GENEFORM Protein DME1617 XEOTICID XEO03439 MOACRIVE Inhibition DME1617 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1617 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03440 XEO_CLAS Peptide DME1617 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 200 ug/ml) DME1617 XEOTICID XEO03440 GENEFORM Protein DME1617 XEOTICID XEO03440 MOACRIVE Inhibition DME1617 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1617 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03441 XEO_CLAS Peptide DME1617 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 200 ug/ml) DME1617 XEOTICID XEO03441 GENEFORM Protein DME1617 XEOTICID XEO03441 MOACRIVE Inhibition DME1617 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1617 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03462 XEO_CLAS Peptide DME1617 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO03462 GENEFORM Protein DME1617 XEOTICID XEO03462 MOACRIVE Inhibition DME1617 XEOTICID XEO03464 XEO_NAME Gallinacin-4 DME1617 XEOTICID XEO03464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03464 XEO_CLAS Peptide DME1617 XEOTICID XEO03464 DESCRIPT Gallinacin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO03464 GENEFORM Protein DME1617 XEOTICID XEO03464 MOACRIVE Inhibition DME1617 XEOTICID XEO03465 XEO_NAME Gallinacin-5 DME1617 XEOTICID XEO03465 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03465 XEO_CLAS Peptide DME1617 XEOTICID XEO03465 DESCRIPT Gallinacin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO03465 GENEFORM Protein DME1617 XEOTICID XEO03465 MOACRIVE Inhibition DME1617 XEOTICID XEO03466 XEO_NAME Gallinacin-6 DME1617 XEOTICID XEO03466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03466 XEO_CLAS Peptide DME1617 XEOTICID XEO03466 DESCRIPT Gallinacin-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO03466 GENEFORM Protein DME1617 XEOTICID XEO03466 MOACRIVE Inhibition DME1617 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1617 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03467 XEO_CLAS Peptide DME1617 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO03467 GENEFORM Protein DME1617 XEOTICID XEO03467 MOACRIVE Inhibition DME1617 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1617 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03498 XEO_CLAS Peptide DME1617 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.8-1.6 microM) DME1617 XEOTICID XEO03498 GENEFORM Protein DME1617 XEOTICID XEO03498 MOACRIVE Inhibition DME1617 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1617 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03504 XEO_CLAS Peptide DME1617 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC > 50 ug/ml) DME1617 XEOTICID XEO03504 GENEFORM Protein DME1617 XEOTICID XEO03504 MOACRIVE Inhibition DME1617 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1617 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03505 XEO_CLAS Peptide DME1617 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 12.5 ug/ml) DME1617 XEOTICID XEO03505 GENEFORM Protein DME1617 XEOTICID XEO03505 MOACRIVE Inhibition DME1617 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1617 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03506 XEO_CLAS Peptide DME1617 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 12.5 ug/ml) DME1617 XEOTICID XEO03506 GENEFORM Protein DME1617 XEOTICID XEO03506 MOACRIVE Inhibition DME1617 XEOTICID XEO03519 XEO_NAME Hadrurin DME1617 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03519 XEO_CLAS Peptide DME1617 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO03519 GENEFORM Protein DME1617 XEOTICID XEO03519 MOACRIVE Inhibition DME1617 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1617 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03609 XEO_CLAS Peptide DME1617 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO03609 GENEFORM Protein DME1617 XEOTICID XEO03609 MOACRIVE Inhibition DME1617 XEOTICID XEO03671 XEO_NAME Plant JCpep7 DME1617 XEOTICID XEO03671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03671 XEO_CLAS Peptide DME1617 XEOTICID XEO03671 DESCRIPT Plant JCpep7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 48 ug/ml) DME1617 XEOTICID XEO03671 GENEFORM Protein DME1617 XEOTICID XEO03671 MOACRIVE Inhibition DME1617 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1617 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03684 XEO_CLAS Peptide DME1617 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 63 ug/ml) DME1617 XEOTICID XEO03684 GENEFORM Protein DME1617 XEOTICID XEO03684 MOACRIVE Inhibition DME1617 XEOTICID XEO03721 XEO_NAME Kunitz-type serine protease inhibitor Xb-KTI DME1617 XEOTICID XEO03721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03721 XEO_CLAS Peptide DME1617 XEOTICID XEO03721 DESCRIPT Kunitz-type serine protease inhibitor Xb-KTI inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 10 microM) DME1617 XEOTICID XEO03721 GENEFORM Protein DME1617 XEOTICID XEO03721 MOACRIVE Inhibition DME1617 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1617 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03746 XEO_CLAS Peptide DME1617 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 ug/ml) DME1617 XEOTICID XEO03746 GENEFORM Protein DME1617 XEOTICID XEO03746 MOACRIVE Inhibition DME1617 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1617 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03747 XEO_CLAS Peptide DME1617 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1 ug/ml) DME1617 XEOTICID XEO03747 GENEFORM Protein DME1617 XEOTICID XEO03747 MOACRIVE Inhibition DME1617 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1617 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03748 XEO_CLAS Peptide DME1617 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO03748 GENEFORM Protein DME1617 XEOTICID XEO03748 MOACRIVE Inhibition DME1617 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1617 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03749 XEO_CLAS Peptide DME1617 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 ug/ml) DME1617 XEOTICID XEO03749 GENEFORM Protein DME1617 XEOTICID XEO03749 MOACRIVE Inhibition DME1617 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1617 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03750 XEO_CLAS Peptide DME1617 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO03750 GENEFORM Protein DME1617 XEOTICID XEO03750 MOACRIVE Inhibition DME1617 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1617 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03751 XEO_CLAS Peptide DME1617 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO03751 GENEFORM Protein DME1617 XEOTICID XEO03751 MOACRIVE Inhibition DME1617 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1617 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03752 XEO_CLAS Peptide DME1617 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 ug/ml) DME1617 XEOTICID XEO03752 GENEFORM Protein DME1617 XEOTICID XEO03752 MOACRIVE Inhibition DME1617 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1617 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03754 XEO_CLAS Peptide DME1617 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO03754 GENEFORM Protein DME1617 XEOTICID XEO03754 MOACRIVE Inhibition DME1617 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1617 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03755 XEO_CLAS Peptide DME1617 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO03755 GENEFORM Protein DME1617 XEOTICID XEO03755 MOACRIVE Inhibition DME1617 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1617 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03756 XEO_CLAS Peptide DME1617 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 ug/ml) DME1617 XEOTICID XEO03756 GENEFORM Protein DME1617 XEOTICID XEO03756 MOACRIVE Inhibition DME1617 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1617 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03793 XEO_CLAS Peptide DME1617 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 microM) DME1617 XEOTICID XEO03793 GENEFORM Protein DME1617 XEOTICID XEO03793 MOACRIVE Inhibition DME1617 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1617 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03904 XEO_CLAS Peptide DME1617 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 32 ug/ml) DME1617 XEOTICID XEO03904 GENEFORM Protein DME1617 XEOTICID XEO03904 MOACRIVE Inhibition DME1617 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1617 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03905 XEO_CLAS Peptide DME1617 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC > 64 ug/ml) DME1617 XEOTICID XEO03905 GENEFORM Protein DME1617 XEOTICID XEO03905 MOACRIVE Inhibition DME1617 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1617 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO03928 XEO_CLAS Peptide DME1617 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 16 microM) DME1617 XEOTICID XEO03928 GENEFORM Protein DME1617 XEOTICID XEO03928 MOACRIVE Inhibition DME1617 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1617 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1617 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1617 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO03968 GENEFORM Protein DME1617 XEOTICID XEO03968 MOACRIVE Inhibition DME1617 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1617 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04039 XEO_CLAS Peptide DME1617 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1 microM) DME1617 XEOTICID XEO04039 GENEFORM Protein DME1617 XEOTICID XEO04039 MOACRIVE Inhibition DME1617 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1617 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04111 XEO_CLAS Peptide DME1617 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04111 GENEFORM Protein DME1617 XEOTICID XEO04111 MOACRIVE Inhibition DME1617 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1617 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04112 XEO_CLAS Peptide DME1617 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1.2 microM) DME1617 XEOTICID XEO04112 GENEFORM Protein DME1617 XEOTICID XEO04112 MOACRIVE Inhibition DME1617 XEOTICID XEO04114 XEO_NAME Microcin L DME1617 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04114 XEO_CLAS Peptide DME1617 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04114 GENEFORM Protein DME1617 XEOTICID XEO04114 MOACRIVE Inhibition DME1617 XEOTICID XEO04117 XEO_NAME Misgurin DME1617 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04117 XEO_CLAS Peptide DME1617 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04117 GENEFORM Protein DME1617 XEOTICID XEO04117 MOACRIVE Inhibition DME1617 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1617 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04142 XEO_CLAS Peptide DME1617 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 32.64 microM) DME1617 XEOTICID XEO04142 GENEFORM Protein DME1617 XEOTICID XEO04142 MOACRIVE Inhibition DME1617 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1617 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04158 XEO_CLAS Peptide DME1617 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 microM) DME1617 XEOTICID XEO04158 GENEFORM Protein DME1617 XEOTICID XEO04158 MOACRIVE Inhibition DME1617 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1617 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04159 XEO_CLAS Peptide DME1617 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 microM) DME1617 XEOTICID XEO04159 GENEFORM Protein DME1617 XEOTICID XEO04159 MOACRIVE Inhibition DME1617 XEOTICID XEO04172 XEO_NAME Myxinidin DME1617 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04172 XEO_CLAS Peptide DME1617 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04172 GENEFORM Protein DME1617 XEOTICID XEO04172 MOACRIVE Inhibition DME1617 XEOTICID XEO04252 XEO_NAME Neutrophil antibiotic peptide NP-2 DME1617 XEOTICID XEO04252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04252 XEO_CLAS Peptide DME1617 XEOTICID XEO04252 DESCRIPT Neutrophil antibiotic peptide NP-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04252 GENEFORM Protein DME1617 XEOTICID XEO04252 MOACRIVE Inhibition DME1617 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1617 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04335 XEO_CLAS Peptide DME1617 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 16 ug/ml) DME1617 XEOTICID XEO04335 GENEFORM Protein DME1617 XEOTICID XEO04335 MOACRIVE Inhibition DME1617 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1617 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04336 XEO_CLAS Peptide DME1617 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 16 ug/ml) DME1617 XEOTICID XEO04336 GENEFORM Protein DME1617 XEOTICID XEO04336 MOACRIVE Inhibition DME1617 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1617 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04338 XEO_CLAS Peptide DME1617 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.5 ug/ml) DME1617 XEOTICID XEO04338 GENEFORM Protein DME1617 XEOTICID XEO04338 MOACRIVE Inhibition DME1617 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1617 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04339 XEO_CLAS Peptide DME1617 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 64 ug/ml) DME1617 XEOTICID XEO04339 GENEFORM Protein DME1617 XEOTICID XEO04339 MOACRIVE Inhibition DME1617 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1617 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04340 XEO_CLAS Peptide DME1617 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 ug/ml) DME1617 XEOTICID XEO04340 GENEFORM Protein DME1617 XEOTICID XEO04340 MOACRIVE Inhibition DME1617 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1617 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04426 XEO_CLAS Peptide DME1617 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 microM) DME1617 XEOTICID XEO04426 GENEFORM Protein DME1617 XEOTICID XEO04426 MOACRIVE Inhibition DME1617 XEOTICID XEO04481 XEO_NAME Porcine beta-defensin pBD-2 DME1617 XEOTICID XEO04481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04481 XEO_CLAS Peptide DME1617 XEOTICID XEO04481 DESCRIPT Porcine beta-defensin pBD-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04481 GENEFORM Protein DME1617 XEOTICID XEO04481 MOACRIVE Inhibition DME1617 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1617 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04526 XEO_CLAS Peptide DME1617 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1.0 microM) DME1617 XEOTICID XEO04526 GENEFORM Protein DME1617 XEOTICID XEO04526 MOACRIVE Inhibition DME1617 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1617 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04613 XEO_CLAS Peptide DME1617 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 10-20 microM) DME1617 XEOTICID XEO04613 GENEFORM Protein DME1617 XEOTICID XEO04613 MOACRIVE Inhibition DME1617 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1617 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04627 XEO_CLAS Peptide DME1617 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 25.25 microM) DME1617 XEOTICID XEO04627 GENEFORM Protein DME1617 XEOTICID XEO04627 MOACRIVE Inhibition DME1617 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1617 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04640 XEO_CLAS Peptide DME1617 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8.8-17.7 microM) DME1617 XEOTICID XEO04640 GENEFORM Protein DME1617 XEOTICID XEO04640 MOACRIVE Inhibition DME1617 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1617 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04642 XEO_CLAS Peptide DME1617 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO04642 GENEFORM Protein DME1617 XEOTICID XEO04642 MOACRIVE Inhibition DME1617 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1617 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04643 XEO_CLAS Peptide DME1617 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 ug/ml) DME1617 XEOTICID XEO04643 GENEFORM Protein DME1617 XEOTICID XEO04643 MOACRIVE Inhibition DME1617 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1617 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04644 XEO_CLAS Peptide DME1617 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 ug/ml) DME1617 XEOTICID XEO04644 GENEFORM Protein DME1617 XEOTICID XEO04644 MOACRIVE Inhibition DME1617 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1617 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04645 XEO_CLAS Peptide DME1617 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 32 ug/ml) DME1617 XEOTICID XEO04645 GENEFORM Protein DME1617 XEOTICID XEO04645 MOACRIVE Inhibition DME1617 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1617 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04646 XEO_CLAS Peptide DME1617 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1 ug/ml) DME1617 XEOTICID XEO04646 GENEFORM Protein DME1617 XEOTICID XEO04646 MOACRIVE Inhibition DME1617 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1617 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04647 XEO_CLAS Peptide DME1617 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO04647 GENEFORM Protein DME1617 XEOTICID XEO04647 MOACRIVE Inhibition DME1617 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1617 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04648 XEO_CLAS Peptide DME1617 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 16 ug/ml) DME1617 XEOTICID XEO04648 GENEFORM Protein DME1617 XEOTICID XEO04648 MOACRIVE Inhibition DME1617 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1617 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04649 XEO_CLAS Peptide DME1617 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC > 64 ug/ml) DME1617 XEOTICID XEO04649 GENEFORM Protein DME1617 XEOTICID XEO04649 MOACRIVE Inhibition DME1617 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1617 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04650 XEO_CLAS Peptide DME1617 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 16 ug/ml) DME1617 XEOTICID XEO04650 GENEFORM Protein DME1617 XEOTICID XEO04650 MOACRIVE Inhibition DME1617 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1617 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04651 XEO_CLAS Peptide DME1617 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 64 ug/ml) DME1617 XEOTICID XEO04651 GENEFORM Protein DME1617 XEOTICID XEO04651 MOACRIVE Inhibition DME1617 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1617 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04652 XEO_CLAS Peptide DME1617 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO04652 GENEFORM Protein DME1617 XEOTICID XEO04652 MOACRIVE Inhibition DME1617 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1617 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04653 XEO_CLAS Peptide DME1617 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC > 64 ug/ml) DME1617 XEOTICID XEO04653 GENEFORM Protein DME1617 XEOTICID XEO04653 MOACRIVE Inhibition DME1617 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1617 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04654 XEO_CLAS Peptide DME1617 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 64 ug/ml) DME1617 XEOTICID XEO04654 GENEFORM Protein DME1617 XEOTICID XEO04654 MOACRIVE Inhibition DME1617 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1617 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04655 XEO_CLAS Peptide DME1617 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 ug/ml) DME1617 XEOTICID XEO04655 GENEFORM Protein DME1617 XEOTICID XEO04655 MOACRIVE Inhibition DME1617 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1617 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04660 XEO_CLAS Peptide DME1617 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2 ug/ml) DME1617 XEOTICID XEO04660 GENEFORM Protein DME1617 XEOTICID XEO04660 MOACRIVE Inhibition DME1617 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1617 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04690 XEO_CLAS Peptide DME1617 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.25 ug/ml) DME1617 XEOTICID XEO04690 GENEFORM Protein DME1617 XEOTICID XEO04690 MOACRIVE Inhibition DME1617 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1617 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04695 XEO_CLAS Peptide DME1617 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04695 GENEFORM Protein DME1617 XEOTICID XEO04695 MOACRIVE Inhibition DME1617 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1617 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04696 XEO_CLAS Peptide DME1617 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04696 GENEFORM Protein DME1617 XEOTICID XEO04696 MOACRIVE Inhibition DME1617 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1617 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04699 XEO_CLAS Peptide DME1617 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04699 GENEFORM Protein DME1617 XEOTICID XEO04699 MOACRIVE Inhibition DME1617 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1617 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04700 XEO_CLAS Peptide DME1617 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04700 GENEFORM Protein DME1617 XEOTICID XEO04700 MOACRIVE Inhibition DME1617 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1617 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04701 XEO_CLAS Peptide DME1617 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04701 GENEFORM Protein DME1617 XEOTICID XEO04701 MOACRIVE Inhibition DME1617 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1617 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04702 XEO_CLAS Peptide DME1617 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04702 GENEFORM Protein DME1617 XEOTICID XEO04702 MOACRIVE Inhibition DME1617 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1617 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04703 XEO_CLAS Peptide DME1617 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04703 GENEFORM Protein DME1617 XEOTICID XEO04703 MOACRIVE Inhibition DME1617 XEOTICID XEO04770 XEO_NAME Pyrrhocoricin DME1617 XEOTICID XEO04770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04770 XEO_CLAS Peptide DME1617 XEOTICID XEO04770 DESCRIPT Pyrrhocoricin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 5 microM) DME1617 XEOTICID XEO04770 GENEFORM Protein DME1617 XEOTICID XEO04770 MOACRIVE Inhibition DME1617 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1617 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04783 XEO_CLAS Peptide DME1617 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 ug/ml) DME1617 XEOTICID XEO04783 GENEFORM Protein DME1617 XEOTICID XEO04783 MOACRIVE Inhibition DME1617 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1617 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04784 XEO_CLAS Peptide DME1617 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 ug/ml) DME1617 XEOTICID XEO04784 GENEFORM Protein DME1617 XEOTICID XEO04784 MOACRIVE Inhibition DME1617 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1617 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04785 XEO_CLAS Peptide DME1617 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 ug/ml) DME1617 XEOTICID XEO04785 GENEFORM Protein DME1617 XEOTICID XEO04785 MOACRIVE Inhibition DME1617 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1617 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04786 XEO_CLAS Peptide DME1617 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 31 ug/ml) DME1617 XEOTICID XEO04786 GENEFORM Protein DME1617 XEOTICID XEO04786 MOACRIVE Inhibition DME1617 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1617 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04840 XEO_CLAS Peptide DME1617 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC > 20 microM) DME1617 XEOTICID XEO04840 GENEFORM Protein DME1617 XEOTICID XEO04840 MOACRIVE Inhibition DME1617 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1617 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04848 XEO_CLAS Peptide DME1617 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04848 GENEFORM Protein DME1617 XEOTICID XEO04848 MOACRIVE Inhibition DME1617 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1617 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04849 XEO_CLAS Peptide DME1617 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04849 GENEFORM Protein DME1617 XEOTICID XEO04849 MOACRIVE Inhibition DME1617 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1617 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04850 XEO_CLAS Peptide DME1617 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04850 GENEFORM Protein DME1617 XEOTICID XEO04850 MOACRIVE Inhibition DME1617 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1617 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04880 XEO_CLAS Peptide DME1617 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 12.7 ug/ml) DME1617 XEOTICID XEO04880 GENEFORM Protein DME1617 XEOTICID XEO04880 MOACRIVE Inhibition DME1617 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1617 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04886 XEO_CLAS Peptide DME1617 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 1.0 ug/ml) DME1617 XEOTICID XEO04886 GENEFORM Protein DME1617 XEOTICID XEO04886 MOACRIVE Inhibition DME1617 XEOTICID XEO04931 XEO_NAME Shepherin I DME1617 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04931 XEO_CLAS Peptide DME1617 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04931 GENEFORM Protein DME1617 XEOTICID XEO04931 MOACRIVE Inhibition DME1617 XEOTICID XEO04932 XEO_NAME shepherin II DME1617 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04932 XEO_CLAS Peptide DME1617 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO04932 GENEFORM Protein DME1617 XEOTICID XEO04932 MOACRIVE Inhibition DME1617 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1617 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04956 XEO_CLAS Peptide DME1617 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8.0 microM) DME1617 XEOTICID XEO04956 GENEFORM Protein DME1617 XEOTICID XEO04956 MOACRIVE Inhibition DME1617 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1617 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04971 XEO_CLAS Peptide DME1617 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 6-12 microM) DME1617 XEOTICID XEO04971 GENEFORM Protein DME1617 XEOTICID XEO04971 MOACRIVE Inhibition DME1617 XEOTICID XEO04974 XEO_NAME Spinigerin DME1617 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04974 XEO_CLAS Peptide DME1617 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 3-6 microM) DME1617 XEOTICID XEO04974 GENEFORM Protein DME1617 XEOTICID XEO04974 MOACRIVE Inhibition DME1617 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1617 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04995 XEO_CLAS Peptide DME1617 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.39-0.78 microM) DME1617 XEOTICID XEO04995 GENEFORM Protein DME1617 XEOTICID XEO04995 MOACRIVE Inhibition DME1617 XEOTICID XEO04998 XEO_NAME Styelin A DME1617 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04998 XEO_CLAS Peptide DME1617 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 5 ug/ml) DME1617 XEOTICID XEO04998 GENEFORM Protein DME1617 XEOTICID XEO04998 MOACRIVE Inhibition DME1617 XEOTICID XEO04999 XEO_NAME Styelin B DME1617 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO04999 XEO_CLAS Peptide DME1617 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 5 ug/ml) DME1617 XEOTICID XEO04999 GENEFORM Protein DME1617 XEOTICID XEO04999 MOACRIVE Inhibition DME1617 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1617 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05000 XEO_CLAS Peptide DME1617 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 ug/ml) DME1617 XEOTICID XEO05000 GENEFORM Protein DME1617 XEOTICID XEO05000 MOACRIVE Inhibition DME1617 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1617 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05001 XEO_CLAS Peptide DME1617 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 4 ug/ml) DME1617 XEOTICID XEO05001 GENEFORM Protein DME1617 XEOTICID XEO05001 MOACRIVE Inhibition DME1617 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1617 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05002 XEO_CLAS Peptide DME1617 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 ug/ml) DME1617 XEOTICID XEO05002 GENEFORM Protein DME1617 XEOTICID XEO05002 MOACRIVE Inhibition DME1617 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1617 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05003 XEO_CLAS Peptide DME1617 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 16 ug/ml) DME1617 XEOTICID XEO05003 GENEFORM Protein DME1617 XEOTICID XEO05003 MOACRIVE Inhibition DME1617 XEOTICID XEO05020 XEO_NAME Tachycitin DME1617 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05020 XEO_CLAS Peptide DME1617 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO05020 GENEFORM Protein DME1617 XEOTICID XEO05020 MOACRIVE Inhibition DME1617 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1617 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05119 XEO_CLAS Peptide DME1617 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO05119 GENEFORM Protein DME1617 XEOTICID XEO05119 MOACRIVE Inhibition DME1617 XEOTICID XEO05120 XEO_NAME Thanatin DME1617 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05120 XEO_CLAS Peptide DME1617 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.6-1.2 microM) DME1617 XEOTICID XEO05120 GENEFORM Protein DME1617 XEOTICID XEO05120 MOACRIVE Inhibition DME1617 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1617 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05161 XEO_CLAS Peptide DME1617 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 32 ug/ml) DME1617 XEOTICID XEO05161 GENEFORM Protein DME1617 XEOTICID XEO05161 MOACRIVE Inhibition DME1617 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1617 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05162 XEO_CLAS Peptide DME1617 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 32 ug/ml) DME1617 XEOTICID XEO05162 GENEFORM Protein DME1617 XEOTICID XEO05162 MOACRIVE Inhibition DME1617 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1617 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05171 XEO_CLAS Peptide DME1617 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO05171 GENEFORM Protein DME1617 XEOTICID XEO05171 MOACRIVE Inhibition DME1617 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1617 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05193 XEO_CLAS Peptide DME1617 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 ug/ml) DME1617 XEOTICID XEO05193 GENEFORM Protein DME1617 XEOTICID XEO05193 MOACRIVE Inhibition DME1617 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1617 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05212 XEO_CLAS Peptide DME1617 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 2.5 ug/ml) DME1617 XEOTICID XEO05212 GENEFORM Protein DME1617 XEOTICID XEO05212 MOACRIVE Inhibition DME1617 XEOTICID XEO05222 XEO_NAME Plant defensin VaD1 DME1617 XEOTICID XEO05222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05222 XEO_CLAS Peptide DME1617 XEOTICID XEO05222 DESCRIPT Plant defensin VaD1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica DME1617 XEOTICID XEO05222 GENEFORM Protein DME1617 XEOTICID XEO05222 MOACRIVE Inhibition DME1617 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1617 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05231 XEO_CLAS Peptide DME1617 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 10.9 microM) DME1617 XEOTICID XEO05231 GENEFORM Protein DME1617 XEOTICID XEO05231 MOACRIVE Inhibition DME1617 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1617 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05264 XEO_CLAS Peptide DME1617 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 ug/ml) DME1617 XEOTICID XEO05264 GENEFORM Protein DME1617 XEOTICID XEO05264 MOACRIVE Inhibition DME1617 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1617 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05267 XEO_CLAS Peptide DME1617 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 8 ug/ml) DME1617 XEOTICID XEO05267 GENEFORM Protein DME1617 XEOTICID XEO05267 MOACRIVE Inhibition DME1617 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1617 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1617 XEOTICID XEO05308 XEO_CLAS Peptide DME1617 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase B (nfsB) from Salmonella enterica (MIC = 0.9 ug/ml) DME1617 XEOTICID XEO05308 GENEFORM Protein DME1617 XEOTICID XEO05308 MOACRIVE Inhibition DME1630 DME___ID DME1630 DME1630 DME_NAME VanA ligase (vanA) DME1630 SPESNAME Enterococcus gallinarum DME1630 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1630 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1630 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1630 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus gallinarum DME1630 XEOTICID XEO01961 GENEFORM Protein DME1630 XEOTICID XEO01961 MOACRIVE Inhibition DME1630 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1630 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1630 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1630 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of VanA ligase (vanA) from Enterococcus gallinarum DME1630 XEOTICID XEO01966 GENEFORM Protein DME1630 XEOTICID XEO01966 MOACRIVE Inhibition DME1632 DME___ID DME1632 DME1632 DME_NAME Aminoglycoside adenylyltransferase (aadA1a) DME1632 SPESNAME Salmonella enterica DME1632 XEOTICID XEO01237 XEO_NAME Carvacrol DME1632 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1632 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1632 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO01237 GENEFORM Protein DME1632 XEOTICID XEO01237 MOACRIVE Inhibition DME1632 XEOTICID XEO01802 XEO_NAME (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone DME1632 XEOTICID XEO01802 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1632 XEOTICID XEO01802 XEO_CLAS Chemical Compound DME1632 XEOTICID XEO01802 DESCRIPT (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO01802 GENEFORM Protein DME1632 XEOTICID XEO01802 MOACRIVE Inhibition DME1632 XEOTICID XEO01944 XEO_NAME 2-Hexylmaleic anhydride DME1632 XEOTICID XEO01944 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1632 XEOTICID XEO01944 XEO_CLAS Chemical Compound DME1632 XEOTICID XEO01944 DESCRIPT 2-Hexylmaleic anhydride inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO01944 GENEFORM Protein DME1632 XEOTICID XEO01944 MOACRIVE Inhibition DME1632 XEOTICID XEO01990 XEO_NAME 3-hexyl-4-bromo-5-methylene-2(5H)-furanone DME1632 XEOTICID XEO01990 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1632 XEOTICID XEO01990 XEO_CLAS Chemical Compound DME1632 XEOTICID XEO01990 DESCRIPT 3-hexyl-4-bromo-5-methylene-2(5H)-furanone inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO01990 GENEFORM Protein DME1632 XEOTICID XEO01990 MOACRIVE Inhibition DME1632 XEOTICID XEO02235 XEO_NAME Anthranilate DME1632 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1632 XEOTICID XEO02235 XEO_CLAS Natural Product DME1632 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO02235 GENEFORM Protein DME1632 XEOTICID XEO02235 MOACRIVE Inhibition DME1632 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1632 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO02284 XEO_CLAS Peptide DME1632 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 25.0 microM) DME1632 XEOTICID XEO02284 GENEFORM Protein DME1632 XEOTICID XEO02284 MOACRIVE Inhibition DME1632 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1632 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO02285 XEO_CLAS Peptide DME1632 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 25.0 microM) DME1632 XEOTICID XEO02285 GENEFORM Protein DME1632 XEOTICID XEO02285 MOACRIVE Inhibition DME1632 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1632 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO02286 XEO_CLAS Peptide DME1632 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 25.0 microM) DME1632 XEOTICID XEO02286 GENEFORM Protein DME1632 XEOTICID XEO02286 MOACRIVE Inhibition DME1632 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1632 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO02287 XEO_CLAS Peptide DME1632 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 25.0 microM) DME1632 XEOTICID XEO02287 GENEFORM Protein DME1632 XEOTICID XEO02287 MOACRIVE Inhibition DME1632 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1632 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO02317 XEO_CLAS Peptide DME1632 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 300 microM) DME1632 XEOTICID XEO02317 GENEFORM Protein DME1632 XEOTICID XEO02317 MOACRIVE Inhibition DME1632 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1632 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO02491 XEO_CLAS Peptide DME1632 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 2.3 microM) DME1632 XEOTICID XEO02491 GENEFORM Protein DME1632 XEOTICID XEO02491 MOACRIVE Inhibition DME1632 XEOTICID XEO02641 XEO_NAME Bromohexylmaleic anhydride DME1632 XEOTICID XEO02641 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1632 XEOTICID XEO02641 XEO_CLAS Chemical Compound DME1632 XEOTICID XEO02641 DESCRIPT Bromohexylmaleic anhydride inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO02641 GENEFORM Protein DME1632 XEOTICID XEO02641 MOACRIVE Inhibition DME1632 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1632 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1632 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1632 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO02990 GENEFORM Protein DME1632 XEOTICID XEO02990 MOACRIVE Inhibition DME1632 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1632 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO03029 XEO_CLAS Peptide DME1632 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 0.005 microM) DME1632 XEOTICID XEO03029 GENEFORM Protein DME1632 XEOTICID XEO03029 MOACRIVE Inhibition DME1632 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1632 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO03030 XEO_CLAS Peptide DME1632 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 0.005 microM) DME1632 XEOTICID XEO03030 GENEFORM Protein DME1632 XEOTICID XEO03030 MOACRIVE Inhibition DME1632 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1632 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO03031 XEO_CLAS Peptide DME1632 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 0.3 microM) DME1632 XEOTICID XEO03031 GENEFORM Protein DME1632 XEOTICID XEO03031 MOACRIVE Inhibition DME1632 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1632 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO03032 XEO_CLAS Peptide DME1632 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 0.005 microM) DME1632 XEOTICID XEO03032 GENEFORM Protein DME1632 XEOTICID XEO03032 MOACRIVE Inhibition DME1632 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1632 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO03033 XEO_CLAS Peptide DME1632 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 0.005 microM) DME1632 XEOTICID XEO03033 GENEFORM Protein DME1632 XEOTICID XEO03033 MOACRIVE Inhibition DME1632 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1632 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO03034 XEO_CLAS Peptide DME1632 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 0.528 microM) DME1632 XEOTICID XEO03034 GENEFORM Protein DME1632 XEOTICID XEO03034 MOACRIVE Inhibition DME1632 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1632 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO03035 XEO_CLAS Peptide DME1632 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 0.004 microM) DME1632 XEOTICID XEO03035 GENEFORM Protein DME1632 XEOTICID XEO03035 MOACRIVE Inhibition DME1632 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1632 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO03250 XEO_CLAS Peptide DME1632 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO03250 GENEFORM Protein DME1632 XEOTICID XEO03250 MOACRIVE Inhibition DME1632 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1632 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1632 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1632 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO03968 GENEFORM Protein DME1632 XEOTICID XEO03968 MOACRIVE Inhibition DME1632 XEOTICID XEO04114 XEO_NAME Microcin L DME1632 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04114 XEO_CLAS Peptide DME1632 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO04114 GENEFORM Protein DME1632 XEOTICID XEO04114 MOACRIVE Inhibition DME1632 XEOTICID XEO04172 XEO_NAME Myxinidin DME1632 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04172 XEO_CLAS Peptide DME1632 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO04172 GENEFORM Protein DME1632 XEOTICID XEO04172 MOACRIVE Inhibition DME1632 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1632 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04335 XEO_CLAS Peptide DME1632 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 16 ug/ml) DME1632 XEOTICID XEO04335 GENEFORM Protein DME1632 XEOTICID XEO04335 MOACRIVE Inhibition DME1632 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1632 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04336 XEO_CLAS Peptide DME1632 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 16 ug/ml) DME1632 XEOTICID XEO04336 GENEFORM Protein DME1632 XEOTICID XEO04336 MOACRIVE Inhibition DME1632 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1632 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04338 XEO_CLAS Peptide DME1632 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 0.5 ug/ml) DME1632 XEOTICID XEO04338 GENEFORM Protein DME1632 XEOTICID XEO04338 MOACRIVE Inhibition DME1632 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1632 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04339 XEO_CLAS Peptide DME1632 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 64 ug/ml) DME1632 XEOTICID XEO04339 GENEFORM Protein DME1632 XEOTICID XEO04339 MOACRIVE Inhibition DME1632 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1632 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04340 XEO_CLAS Peptide DME1632 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 2 ug/ml) DME1632 XEOTICID XEO04340 GENEFORM Protein DME1632 XEOTICID XEO04340 MOACRIVE Inhibition DME1632 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1632 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04642 XEO_CLAS Peptide DME1632 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 4 ug/ml) DME1632 XEOTICID XEO04642 GENEFORM Protein DME1632 XEOTICID XEO04642 MOACRIVE Inhibition DME1632 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1632 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04643 XEO_CLAS Peptide DME1632 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 2 ug/ml) DME1632 XEOTICID XEO04643 GENEFORM Protein DME1632 XEOTICID XEO04643 MOACRIVE Inhibition DME1632 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1632 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04644 XEO_CLAS Peptide DME1632 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 2 ug/ml) DME1632 XEOTICID XEO04644 GENEFORM Protein DME1632 XEOTICID XEO04644 MOACRIVE Inhibition DME1632 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1632 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04645 XEO_CLAS Peptide DME1632 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 32 ug/ml) DME1632 XEOTICID XEO04645 GENEFORM Protein DME1632 XEOTICID XEO04645 MOACRIVE Inhibition DME1632 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1632 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04646 XEO_CLAS Peptide DME1632 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 1 ug/ml) DME1632 XEOTICID XEO04646 GENEFORM Protein DME1632 XEOTICID XEO04646 MOACRIVE Inhibition DME1632 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1632 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04647 XEO_CLAS Peptide DME1632 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 4 ug/ml) DME1632 XEOTICID XEO04647 GENEFORM Protein DME1632 XEOTICID XEO04647 MOACRIVE Inhibition DME1632 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1632 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04648 XEO_CLAS Peptide DME1632 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 16 ug/ml) DME1632 XEOTICID XEO04648 GENEFORM Protein DME1632 XEOTICID XEO04648 MOACRIVE Inhibition DME1632 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1632 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04649 XEO_CLAS Peptide DME1632 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC > 64 ug/ml) DME1632 XEOTICID XEO04649 GENEFORM Protein DME1632 XEOTICID XEO04649 MOACRIVE Inhibition DME1632 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1632 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04650 XEO_CLAS Peptide DME1632 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 16 ug/ml) DME1632 XEOTICID XEO04650 GENEFORM Protein DME1632 XEOTICID XEO04650 MOACRIVE Inhibition DME1632 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1632 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04651 XEO_CLAS Peptide DME1632 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 64 ug/ml) DME1632 XEOTICID XEO04651 GENEFORM Protein DME1632 XEOTICID XEO04651 MOACRIVE Inhibition DME1632 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1632 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04652 XEO_CLAS Peptide DME1632 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 4 ug/ml) DME1632 XEOTICID XEO04652 GENEFORM Protein DME1632 XEOTICID XEO04652 MOACRIVE Inhibition DME1632 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1632 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04655 XEO_CLAS Peptide DME1632 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 2 ug/ml) DME1632 XEOTICID XEO04655 GENEFORM Protein DME1632 XEOTICID XEO04655 MOACRIVE Inhibition DME1632 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1632 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04695 XEO_CLAS Peptide DME1632 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO04695 GENEFORM Protein DME1632 XEOTICID XEO04695 MOACRIVE Inhibition DME1632 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1632 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04696 XEO_CLAS Peptide DME1632 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO04696 GENEFORM Protein DME1632 XEOTICID XEO04696 MOACRIVE Inhibition DME1632 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1632 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04699 XEO_CLAS Peptide DME1632 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO04699 GENEFORM Protein DME1632 XEOTICID XEO04699 MOACRIVE Inhibition DME1632 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1632 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04700 XEO_CLAS Peptide DME1632 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO04700 GENEFORM Protein DME1632 XEOTICID XEO04700 MOACRIVE Inhibition DME1632 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1632 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04701 XEO_CLAS Peptide DME1632 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO04701 GENEFORM Protein DME1632 XEOTICID XEO04701 MOACRIVE Inhibition DME1632 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1632 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04702 XEO_CLAS Peptide DME1632 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO04702 GENEFORM Protein DME1632 XEOTICID XEO04702 MOACRIVE Inhibition DME1632 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1632 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO04703 XEO_CLAS Peptide DME1632 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO04703 GENEFORM Protein DME1632 XEOTICID XEO04703 MOACRIVE Inhibition DME1632 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1632 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO05171 XEO_CLAS Peptide DME1632 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica DME1632 XEOTICID XEO05171 GENEFORM Protein DME1632 XEOTICID XEO05171 MOACRIVE Inhibition DME1632 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1632 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1632 XEOTICID XEO05308 XEO_CLAS Peptide DME1632 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Aminoglycoside adenylyltransferase (aadA1a) from Salmonella enterica (MIC = 0.9 ug/ml) DME1632 XEOTICID XEO05308 GENEFORM Protein DME1632 XEOTICID XEO05308 MOACRIVE Inhibition DME1643 DME___ID DME1643 DME1643 DME_NAME Beta-lactamase (blaB) DME1643 SPESNAME Chromobacterium violaceum DME1643 XEOTICID XEO01237 XEO_NAME Carvacrol DME1643 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1643 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1643 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Chromobacterium violaceum DME1643 XEOTICID XEO01237 GENEFORM Protein DME1643 XEOTICID XEO01237 MOACRIVE Inhibition DME1662 DME___ID DME1662 DME1662 DME_NAME Cytochrome P450 121A1 (cyp121) DME1662 SPESNAME Mycobacterium tuberculosis DME1662 XEOTICID XEO03807 XEO_NAME Lariatins A DME1662 XEOTICID XEO03807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1662 XEOTICID XEO03807 XEO_CLAS Peptide DME1662 XEOTICID XEO03807 DESCRIPT Lariatins A inhibits the drug-metabolizing activity of Cytochrome P450 121A1 (cyp121) from Mycobacterium tuberculosis DME1662 XEOTICID XEO03807 GENEFORM Protein DME1662 XEOTICID XEO03807 MOACRIVE Inhibition DME1662 XEOTICID XEO03808 XEO_NAME Lariatins B DME1662 XEOTICID XEO03808 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1662 XEOTICID XEO03808 XEO_CLAS Peptide DME1662 XEOTICID XEO03808 DESCRIPT Lariatins B inhibits the drug-metabolizing activity of Cytochrome P450 121A1 (cyp121) from Mycobacterium tuberculosis DME1662 XEOTICID XEO03808 GENEFORM Protein DME1662 XEOTICID XEO03808 MOACRIVE Inhibition DME1664 DME___ID DME1664 DME1664 DME_NAME Cytochrome P450 monooxygenase 51A (cyp51A) DME1664 SPESNAME Aspergillus fumigatus DME1664 XEOTICID XEO00621 XEO_NAME Chitosan DME1664 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1664 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1664 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO00621 GENEFORM Protein DME1664 XEOTICID XEO00621 MOACRIVE Inhibition DME1664 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1664 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02136 XEO_CLAS Peptide DME1664 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 125 ug/ml) DME1664 XEOTICID XEO02136 GENEFORM Protein DME1664 XEOTICID XEO02136 MOACRIVE Inhibition DME1664 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1664 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02207 XEO_CLAS Peptide DME1664 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 50 ug/ml) DME1664 XEOTICID XEO02207 GENEFORM Protein DME1664 XEOTICID XEO02207 MOACRIVE Inhibition DME1664 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1664 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02208 XEO_CLAS Peptide DME1664 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 50 ug/ml) DME1664 XEOTICID XEO02208 GENEFORM Protein DME1664 XEOTICID XEO02208 MOACRIVE Inhibition DME1664 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1664 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02209 XEO_CLAS Peptide DME1664 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 25 ug/ml) DME1664 XEOTICID XEO02209 GENEFORM Protein DME1664 XEOTICID XEO02209 MOACRIVE Inhibition DME1664 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1664 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02210 XEO_CLAS Peptide DME1664 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 50 ug/ml) DME1664 XEOTICID XEO02210 GENEFORM Protein DME1664 XEOTICID XEO02210 MOACRIVE Inhibition DME1664 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1664 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02211 XEO_CLAS Peptide DME1664 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 50 ug/ml) DME1664 XEOTICID XEO02211 GENEFORM Protein DME1664 XEOTICID XEO02211 MOACRIVE Inhibition DME1664 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1664 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02212 XEO_CLAS Peptide DME1664 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 50-25 ug/ml) DME1664 XEOTICID XEO02212 GENEFORM Protein DME1664 XEOTICID XEO02212 MOACRIVE Inhibition DME1664 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1664 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02213 XEO_CLAS Peptide DME1664 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 50-25 ug/ml) DME1664 XEOTICID XEO02213 GENEFORM Protein DME1664 XEOTICID XEO02213 MOACRIVE Inhibition DME1664 XEOTICID XEO02224 XEO_NAME Androctonin DME1664 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02224 XEO_CLAS Peptide DME1664 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO02224 GENEFORM Protein DME1664 XEOTICID XEO02224 MOACRIVE Inhibition DME1664 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1664 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02230 XEO_CLAS Peptide DME1664 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 5-10 microM) DME1664 XEOTICID XEO02230 GENEFORM Protein DME1664 XEOTICID XEO02230 MOACRIVE Inhibition DME1664 XEOTICID XEO02252 XEO_NAME Antifungal protein Pf-AFP1 DME1664 XEOTICID XEO02252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02252 XEO_CLAS Peptide DME1664 XEOTICID XEO02252 DESCRIPT Antifungal protein Pf-AFP1 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO02252 GENEFORM Protein DME1664 XEOTICID XEO02252 MOACRIVE Inhibition DME1664 XEOTICID XEO02255 XEO_NAME Antifungal protein Pr-2 DME1664 XEOTICID XEO02255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02255 XEO_CLAS Peptide DME1664 XEOTICID XEO02255 DESCRIPT Antifungal protein Pr-2 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO02255 GENEFORM Protein DME1664 XEOTICID XEO02255 MOACRIVE Inhibition DME1664 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1664 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02283 XEO_CLAS Peptide DME1664 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 50 ug/ml) DME1664 XEOTICID XEO02283 GENEFORM Protein DME1664 XEOTICID XEO02283 MOACRIVE Inhibition DME1664 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1664 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02333 XEO_CLAS Peptide DME1664 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 200 microM) DME1664 XEOTICID XEO02333 GENEFORM Protein DME1664 XEOTICID XEO02333 MOACRIVE Inhibition DME1664 XEOTICID XEO02803 XEO_NAME hrVS-1-derived peptide CGA47-60 DME1664 XEOTICID XEO02803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02803 XEO_CLAS Peptide DME1664 XEOTICID XEO02803 DESCRIPT hrVS-1-derived peptide CGA47-60 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 50 microM) DME1664 XEOTICID XEO02803 GENEFORM Protein DME1664 XEOTICID XEO02803 MOACRIVE Inhibition DME1664 XEOTICID XEO02804 XEO_NAME hrVS-1-derived peptide CGA47-70 DME1664 XEOTICID XEO02804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02804 XEO_CLAS Peptide DME1664 XEOTICID XEO02804 DESCRIPT hrVS-1-derived peptide CGA47-70 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 30 microM) DME1664 XEOTICID XEO02804 GENEFORM Protein DME1664 XEOTICID XEO02804 MOACRIVE Inhibition DME1664 XEOTICID XEO02906 XEO_NAME Colutellin-A DME1664 XEOTICID XEO02906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO02906 XEO_CLAS Peptide DME1664 XEOTICID XEO02906 DESCRIPT Colutellin-A inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO02906 GENEFORM Protein DME1664 XEOTICID XEO02906 MOACRIVE Inhibition DME1664 XEOTICID XEO03102 XEO_NAME Defensin ARD1 DME1664 XEOTICID XEO03102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03102 XEO_CLAS Peptide DME1664 XEOTICID XEO03102 DESCRIPT Defensin ARD1 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 12.5 ug/ml) DME1664 XEOTICID XEO03102 GENEFORM Protein DME1664 XEOTICID XEO03102 MOACRIVE Inhibition DME1664 XEOTICID XEO03109 XEO_NAME Defensin heliomicin DME1664 XEOTICID XEO03109 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03109 XEO_CLAS Peptide DME1664 XEOTICID XEO03109 DESCRIPT Defensin heliomicin inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 6-12 microM) DME1664 XEOTICID XEO03109 GENEFORM Protein DME1664 XEOTICID XEO03109 MOACRIVE Inhibition DME1664 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1664 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03151 XEO_CLAS Peptide DME1664 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 100 ug/ml) DME1664 XEOTICID XEO03151 GENEFORM Protein DME1664 XEOTICID XEO03151 MOACRIVE Inhibition DME1664 XEOTICID XEO03153 XEO_NAME Dermaseptin DS2 DME1664 XEOTICID XEO03153 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03153 XEO_CLAS Peptide DME1664 XEOTICID XEO03153 DESCRIPT Dermaseptin DS2 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03153 GENEFORM Protein DME1664 XEOTICID XEO03153 MOACRIVE Inhibition DME1664 XEOTICID XEO03154 XEO_NAME Dermaseptin DS3 DME1664 XEOTICID XEO03154 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03154 XEO_CLAS Peptide DME1664 XEOTICID XEO03154 DESCRIPT Dermaseptin DS3 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03154 GENEFORM Protein DME1664 XEOTICID XEO03154 MOACRIVE Inhibition DME1664 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1664 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03158 XEO_CLAS Peptide DME1664 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 125 ug/ml) DME1664 XEOTICID XEO03158 GENEFORM Protein DME1664 XEOTICID XEO03158 MOACRIVE Inhibition DME1664 XEOTICID XEO03327 XEO_NAME ARD1 Mutant ETD130 DME1664 XEOTICID XEO03327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03327 XEO_CLAS Peptide DME1664 XEOTICID XEO03327 DESCRIPT ARD1 Mutant ETD130 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03327 GENEFORM Protein DME1664 XEOTICID XEO03327 MOACRIVE Inhibition DME1664 XEOTICID XEO03328 XEO_NAME ARD1 Mutant ETD131 DME1664 XEOTICID XEO03328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03328 XEO_CLAS Peptide DME1664 XEOTICID XEO03328 DESCRIPT ARD1 Mutant ETD131 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03328 GENEFORM Protein DME1664 XEOTICID XEO03328 MOACRIVE Inhibition DME1664 XEOTICID XEO03329 XEO_NAME ARD1 Mutant ETD132 DME1664 XEOTICID XEO03329 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03329 XEO_CLAS Peptide DME1664 XEOTICID XEO03329 DESCRIPT ARD1 Mutant ETD132 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03329 GENEFORM Protein DME1664 XEOTICID XEO03329 MOACRIVE Inhibition DME1664 XEOTICID XEO03330 XEO_NAME ARD1 Mutant ETD133 DME1664 XEOTICID XEO03330 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03330 XEO_CLAS Peptide DME1664 XEOTICID XEO03330 DESCRIPT ARD1 Mutant ETD133 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03330 GENEFORM Protein DME1664 XEOTICID XEO03330 MOACRIVE Inhibition DME1664 XEOTICID XEO03331 XEO_NAME ARD1 Mutant ETD134 DME1664 XEOTICID XEO03331 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03331 XEO_CLAS Peptide DME1664 XEOTICID XEO03331 DESCRIPT ARD1 Mutant ETD134 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03331 GENEFORM Protein DME1664 XEOTICID XEO03331 MOACRIVE Inhibition DME1664 XEOTICID XEO03332 XEO_NAME ARD1 Mutant ETD135 DME1664 XEOTICID XEO03332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03332 XEO_CLAS Peptide DME1664 XEOTICID XEO03332 DESCRIPT ARD1 Mutant ETD135 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03332 GENEFORM Protein DME1664 XEOTICID XEO03332 MOACRIVE Inhibition DME1664 XEOTICID XEO03333 XEO_NAME ARD1 Mutant ETD140 DME1664 XEOTICID XEO03333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03333 XEO_CLAS Peptide DME1664 XEOTICID XEO03333 DESCRIPT ARD1 Mutant ETD140 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03333 GENEFORM Protein DME1664 XEOTICID XEO03333 MOACRIVE Inhibition DME1664 XEOTICID XEO03334 XEO_NAME ARD1 Mutant ETD150 DME1664 XEOTICID XEO03334 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03334 XEO_CLAS Peptide DME1664 XEOTICID XEO03334 DESCRIPT ARD1 Mutant ETD150 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03334 GENEFORM Protein DME1664 XEOTICID XEO03334 MOACRIVE Inhibition DME1664 XEOTICID XEO03335 XEO_NAME ARD1 Mutant ETD151 DME1664 XEOTICID XEO03335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03335 XEO_CLAS Peptide DME1664 XEOTICID XEO03335 DESCRIPT ARD1 Mutant ETD151 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03335 GENEFORM Protein DME1664 XEOTICID XEO03335 MOACRIVE Inhibition DME1664 XEOTICID XEO03336 XEO_NAME ARD1 Mutant ETD152 DME1664 XEOTICID XEO03336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03336 XEO_CLAS Peptide DME1664 XEOTICID XEO03336 DESCRIPT ARD1 Mutant ETD152 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03336 GENEFORM Protein DME1664 XEOTICID XEO03336 MOACRIVE Inhibition DME1664 XEOTICID XEO03337 XEO_NAME ARD1 Mutant ETD154 DME1664 XEOTICID XEO03337 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03337 XEO_CLAS Peptide DME1664 XEOTICID XEO03337 DESCRIPT ARD1 Mutant ETD154 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03337 GENEFORM Protein DME1664 XEOTICID XEO03337 MOACRIVE Inhibition DME1664 XEOTICID XEO03338 XEO_NAME ARD1 Mutant ETD156 DME1664 XEOTICID XEO03338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03338 XEO_CLAS Peptide DME1664 XEOTICID XEO03338 DESCRIPT ARD1 Mutant ETD156 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03338 GENEFORM Protein DME1664 XEOTICID XEO03338 MOACRIVE Inhibition DME1664 XEOTICID XEO03339 XEO_NAME ARD1 Mutant ETD179 DME1664 XEOTICID XEO03339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03339 XEO_CLAS Peptide DME1664 XEOTICID XEO03339 DESCRIPT ARD1 Mutant ETD179 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03339 GENEFORM Protein DME1664 XEOTICID XEO03339 MOACRIVE Inhibition DME1664 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1664 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03497 XEO_CLAS Peptide DME1664 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 1.6-3.15 microM) DME1664 XEOTICID XEO03497 GENEFORM Protein DME1664 XEOTICID XEO03497 MOACRIVE Inhibition DME1664 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1664 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03498 XEO_CLAS Peptide DME1664 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 1.6-3.15 microM) DME1664 XEOTICID XEO03498 GENEFORM Protein DME1664 XEOTICID XEO03498 MOACRIVE Inhibition DME1664 XEOTICID XEO03597 XEO_NAME Human drosomycin-like defensin DLD DME1664 XEOTICID XEO03597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03597 XEO_CLAS Peptide DME1664 XEOTICID XEO03597 DESCRIPT Human drosomycin-like defensin DLD inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 6.25 microM) DME1664 XEOTICID XEO03597 GENEFORM Protein DME1664 XEOTICID XEO03597 MOACRIVE Inhibition DME1664 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1664 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03598 XEO_CLAS Peptide DME1664 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03598 GENEFORM Protein DME1664 XEOTICID XEO03598 MOACRIVE Inhibition DME1664 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1664 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03599 XEO_CLAS Peptide DME1664 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03599 GENEFORM Protein DME1664 XEOTICID XEO03599 MOACRIVE Inhibition DME1664 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1664 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO03776 XEO_CLAS Peptide DME1664 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO03776 GENEFORM Protein DME1664 XEOTICID XEO03776 MOACRIVE Inhibition DME1664 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1664 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO04506 XEO_CLAS Peptide DME1664 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 20 microM) DME1664 XEOTICID XEO04506 GENEFORM Protein DME1664 XEOTICID XEO04506 MOACRIVE Inhibition DME1664 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1664 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO04507 XEO_CLAS Peptide DME1664 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 20 microM) DME1664 XEOTICID XEO04507 GENEFORM Protein DME1664 XEOTICID XEO04507 MOACRIVE Inhibition DME1664 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1664 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO04532 XEO_CLAS Peptide DME1664 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus DME1664 XEOTICID XEO04532 GENEFORM Protein DME1664 XEOTICID XEO04532 MOACRIVE Inhibition DME1664 XEOTICID XEO04560 XEO_NAME Phlebotomus duboscqi defensin DME1664 XEOTICID XEO04560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO04560 XEO_CLAS Peptide DME1664 XEOTICID XEO04560 DESCRIPT Phlebotomus duboscqi defensin inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 12.5-25 microM) DME1664 XEOTICID XEO04560 GENEFORM Protein DME1664 XEOTICID XEO04560 MOACRIVE Inhibition DME1664 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1664 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO04613 XEO_CLAS Peptide DME1664 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 50-100 microM) DME1664 XEOTICID XEO04613 GENEFORM Protein DME1664 XEOTICID XEO04613 MOACRIVE Inhibition DME1664 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1664 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO04766 XEO_CLAS Peptide DME1664 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 16.0 microM) DME1664 XEOTICID XEO04766 GENEFORM Protein DME1664 XEOTICID XEO04766 MOACRIVE Inhibition DME1664 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1664 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO04767 XEO_CLAS Peptide DME1664 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 16.0 ug/ml) DME1664 XEOTICID XEO04767 GENEFORM Protein DME1664 XEOTICID XEO04767 MOACRIVE Inhibition DME1664 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1664 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO04950 XEO_CLAS Peptide DME1664 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 80 ug/ml) DME1664 XEOTICID XEO04950 GENEFORM Protein DME1664 XEOTICID XEO04950 MOACRIVE Inhibition DME1664 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1664 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO04971 XEO_CLAS Peptide DME1664 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 3-6 microM) DME1664 XEOTICID XEO04971 GENEFORM Protein DME1664 XEOTICID XEO04971 MOACRIVE Inhibition DME1664 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1664 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO04995 XEO_CLAS Peptide DME1664 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 50-100 microM) DME1664 XEOTICID XEO04995 GENEFORM Protein DME1664 XEOTICID XEO04995 MOACRIVE Inhibition DME1664 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1664 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO05179 XEO_CLAS Peptide DME1664 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 250 ug/ml) DME1664 XEOTICID XEO05179 GENEFORM Protein DME1664 XEOTICID XEO05179 MOACRIVE Inhibition DME1664 XEOTICID XEO05229 XEO_NAME Vasostatin-1 DME1664 XEOTICID XEO05229 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO05229 XEO_CLAS Peptide DME1664 XEOTICID XEO05229 DESCRIPT Vasostatin-1 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 5 microM) DME1664 XEOTICID XEO05229 GENEFORM Protein DME1664 XEOTICID XEO05229 MOACRIVE Inhibition DME1664 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1664 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1664 XEOTICID XEO05231 XEO_CLAS Peptide DME1664 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 8.3 microM) DME1664 XEOTICID XEO05231 GENEFORM Protein DME1664 XEOTICID XEO05231 MOACRIVE Inhibition DME1670 DME___ID DME1670 DME1670 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1670 SPESNAME Lactobacillus salivarius DME1670 XEOTICID XEO04150 XEO_NAME Mundticin ATO6 DME1670 XEOTICID XEO04150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1670 XEOTICID XEO04150 XEO_CLAS Peptide DME1670 XEOTICID XEO04150 DESCRIPT Mundticin ATO6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactobacillus salivarius DME1670 XEOTICID XEO04150 GENEFORM Protein DME1670 XEOTICID XEO04150 MOACRIVE Inhibition DME1678 DME___ID DME1678 DME1678 DME_NAME GH3 beta-glucosidase (BAD1610) DME1678 SPESNAME Bifidobacterium adolescentis DME1678 XEOTICID XEO03113 XEO_NAME Royalisin defensin-1 DME1678 XEOTICID XEO03113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1678 XEOTICID XEO03113 XEO_CLAS Peptide DME1678 XEOTICID XEO03113 DESCRIPT Royalisin defensin-1 inhibits the drug-metabolizing activity of GH3 beta-glucosidase (BAD1610) from Bifidobacterium adolescentis DME1678 XEOTICID XEO03113 GENEFORM Protein DME1678 XEOTICID XEO03113 MOACRIVE Inhibition DME1687 DME___ID DME1687 DME1687 DME_NAME D-Lactate dehydrogenase (ldhA) DME1687 SPESNAME Lactobacillus delbrueckii DME1687 XEOTICID XEO02377 XEO_NAME Bacteriocin hiracin-JM79 DME1687 XEOTICID XEO02377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1687 XEOTICID XEO02377 XEO_CLAS Peptide DME1687 XEOTICID XEO02377 DESCRIPT Bacteriocin hiracin-JM79 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Lactobacillus delbrueckii DME1687 XEOTICID XEO02377 GENEFORM Protein DME1687 XEOTICID XEO02377 MOACRIVE Inhibition DME1688 DME___ID DME1688 DME1688 DME_NAME L-Lactate dehydrogenase (ldh) DME1688 SPESNAME Lactobacillus delbrueckii DME1688 XEOTICID XEO02377 XEO_NAME Bacteriocin hiracin-JM79 DME1688 XEOTICID XEO02377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1688 XEOTICID XEO02377 XEO_CLAS Peptide DME1688 XEOTICID XEO02377 DESCRIPT Bacteriocin hiracin-JM79 inhibits the drug-metabolizing activity of L-Lactate dehydrogenase (ldh) from Lactobacillus delbrueckii DME1688 XEOTICID XEO02377 GENEFORM Protein DME1688 XEOTICID XEO02377 MOACRIVE Inhibition DME1690 DME___ID DME1690 DME1690 DME_NAME D-Lactate dehydrogenase (ldhA) DME1690 SPESNAME Escherichia coli DME1690 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1690 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00117 GENEFORM Protein DME1690 XEOTICID XEO00117 MOACRIVE Inhibition DME1690 XEOTICID XEO00122 XEO_NAME Amikacin DME1690 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00122 GENEFORM Protein DME1690 XEOTICID XEO00122 MOACRIVE Inhibition DME1690 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1690 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00136 GENEFORM Protein DME1690 XEOTICID XEO00136 MOACRIVE Inhibition DME1690 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1690 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00237 GENEFORM Protein DME1690 XEOTICID XEO00237 MOACRIVE Inhibition DME1690 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1690 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00349 GENEFORM Protein DME1690 XEOTICID XEO00349 MOACRIVE Inhibition DME1690 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1690 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00425 GENEFORM Protein DME1690 XEOTICID XEO00425 MOACRIVE Inhibition DME1690 XEOTICID XEO00439 XEO_NAME Daidzein DME1690 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00439 GENEFORM Protein DME1690 XEOTICID XEO00439 MOACRIVE Inhibition DME1690 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1690 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00460 GENEFORM Protein DME1690 XEOTICID XEO00460 MOACRIVE Inhibition DME1690 XEOTICID XEO00487 XEO_NAME Thymol DME1690 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00487 GENEFORM Protein DME1690 XEOTICID XEO00487 MOACRIVE Inhibition DME1690 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1690 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00511 GENEFORM Protein DME1690 XEOTICID XEO00511 MOACRIVE Inhibition DME1690 XEOTICID XEO00537 XEO_NAME Luteolin DME1690 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1690 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00537 GENEFORM Protein DME1690 XEOTICID XEO00537 MOACRIVE Inhibition DME1690 XEOTICID XEO00538 XEO_NAME Quercetin DME1690 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1690 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00538 GENEFORM Protein DME1690 XEOTICID XEO00538 MOACRIVE Inhibition DME1690 XEOTICID XEO00547 XEO_NAME Vitamin E DME1690 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1690 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00547 GENEFORM Protein DME1690 XEOTICID XEO00547 MOACRIVE Inhibition DME1690 XEOTICID XEO00557 XEO_NAME Genistein DME1690 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1690 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00557 GENEFORM Protein DME1690 XEOTICID XEO00557 MOACRIVE Inhibition DME1690 XEOTICID XEO00566 XEO_NAME Guaiacol DME1690 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1690 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00566 GENEFORM Protein DME1690 XEOTICID XEO00566 MOACRIVE Inhibition DME1690 XEOTICID XEO00568 XEO_NAME Resveratrol DME1690 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1690 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00568 GENEFORM Protein DME1690 XEOTICID XEO00568 MOACRIVE Inhibition DME1690 XEOTICID XEO00573 XEO_NAME Naringenin DME1690 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1690 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00573 GENEFORM Protein DME1690 XEOTICID XEO00573 MOACRIVE Inhibition DME1690 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1690 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1690 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00574 GENEFORM Protein DME1690 XEOTICID XEO00574 MOACRIVE Inhibition DME1690 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1690 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1690 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00611 GENEFORM Protein DME1690 XEOTICID XEO00611 MOACRIVE Inhibition DME1690 XEOTICID XEO00621 XEO_NAME Chitosan DME1690 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1690 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00621 GENEFORM Protein DME1690 XEOTICID XEO00621 MOACRIVE Inhibition DME1690 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1690 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1690 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00646 GENEFORM Protein DME1690 XEOTICID XEO00646 MOACRIVE Inhibition DME1690 XEOTICID XEO00683 XEO_NAME Curcumin DME1690 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1690 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00683 GENEFORM Protein DME1690 XEOTICID XEO00683 MOACRIVE Inhibition DME1690 XEOTICID XEO00727 XEO_NAME Vanillin DME1690 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1690 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00727 GENEFORM Protein DME1690 XEOTICID XEO00727 MOACRIVE Inhibition DME1690 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1690 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1690 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00730 GENEFORM Protein DME1690 XEOTICID XEO00730 MOACRIVE Inhibition DME1690 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1690 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO00782 XEO_CLAS Natural Product DME1690 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00782 GENEFORM Protein DME1690 XEOTICID XEO00782 MOACRIVE Inhibition DME1690 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1690 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1690 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00866 GENEFORM Protein DME1690 XEOTICID XEO00866 MOACRIVE Inhibition DME1690 XEOTICID XEO00878 XEO_NAME Chrysin DME1690 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO00878 XEO_CLAS Natural Product DME1690 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00878 GENEFORM Protein DME1690 XEOTICID XEO00878 MOACRIVE Inhibition DME1690 XEOTICID XEO00879 XEO_NAME Coumarin DME1690 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1690 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1690 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00879 GENEFORM Protein DME1690 XEOTICID XEO00879 MOACRIVE Inhibition DME1690 XEOTICID XEO00883 XEO_NAME Phloretin DME1690 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO00883 XEO_CLAS Natural Product DME1690 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00883 GENEFORM Protein DME1690 XEOTICID XEO00883 MOACRIVE Inhibition DME1690 XEOTICID XEO00885 XEO_NAME Eugenol DME1690 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1690 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO00885 GENEFORM Protein DME1690 XEOTICID XEO00885 MOACRIVE Inhibition DME1690 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1690 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1690 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1690 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01032 GENEFORM Protein DME1690 XEOTICID XEO01032 MOACRIVE Inhibition DME1690 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1690 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01174 XEO_CLAS Natural Product DME1690 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01174 GENEFORM Protein DME1690 XEOTICID XEO01174 MOACRIVE Inhibition DME1690 XEOTICID XEO01203 XEO_NAME Apigenin DME1690 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01203 XEO_CLAS Natural Product DME1690 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01203 GENEFORM Protein DME1690 XEOTICID XEO01203 MOACRIVE Inhibition DME1690 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1690 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1690 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1690 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01232 GENEFORM Protein DME1690 XEOTICID XEO01232 MOACRIVE Inhibition DME1690 XEOTICID XEO01237 XEO_NAME Carvacrol DME1690 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1690 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01237 GENEFORM Protein DME1690 XEOTICID XEO01237 MOACRIVE Inhibition DME1690 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1690 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1690 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01287 GENEFORM Protein DME1690 XEOTICID XEO01287 MOACRIVE Inhibition DME1690 XEOTICID XEO01291 XEO_NAME Esculetin DME1690 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1690 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01291 GENEFORM Protein DME1690 XEOTICID XEO01291 MOACRIVE Inhibition DME1690 XEOTICID XEO01304 XEO_NAME Flavone DME1690 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01304 XEO_CLAS Natural Product DME1690 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01304 GENEFORM Protein DME1690 XEOTICID XEO01304 MOACRIVE Inhibition DME1690 XEOTICID XEO01309 XEO_NAME Gallic acid DME1690 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01309 XEO_CLAS Natural Product DME1690 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01309 GENEFORM Protein DME1690 XEOTICID XEO01309 MOACRIVE Inhibition DME1690 XEOTICID XEO01340 XEO_NAME Imperatorin DME1690 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01340 XEO_CLAS Natural Product DME1690 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01340 GENEFORM Protein DME1690 XEOTICID XEO01340 MOACRIVE Inhibition DME1690 XEOTICID XEO01353 XEO_NAME Kaempferol DME1690 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1690 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1690 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01353 GENEFORM Protein DME1690 XEOTICID XEO01353 MOACRIVE Inhibition DME1690 XEOTICID XEO01366 XEO_NAME Linalool DME1690 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01366 XEO_CLAS Natural Product DME1690 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01366 GENEFORM Protein DME1690 XEOTICID XEO01366 MOACRIVE Inhibition DME1690 XEOTICID XEO01391 XEO_NAME Naringin DME1690 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01391 XEO_CLAS Natural Product DME1690 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01391 GENEFORM Protein DME1690 XEOTICID XEO01391 MOACRIVE Inhibition DME1690 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1690 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1690 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01420 GENEFORM Protein DME1690 XEOTICID XEO01420 MOACRIVE Inhibition DME1690 XEOTICID XEO01463 XEO_NAME Rutin DME1690 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01463 XEO_CLAS Natural Product DME1690 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01463 GENEFORM Protein DME1690 XEOTICID XEO01463 MOACRIVE Inhibition DME1690 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1690 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1690 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01496 GENEFORM Protein DME1690 XEOTICID XEO01496 MOACRIVE Inhibition DME1690 XEOTICID XEO01512 XEO_NAME Zinc DME1690 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1690 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1690 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01512 GENEFORM Protein DME1690 XEOTICID XEO01512 MOACRIVE Inhibition DME1690 XEOTICID XEO01527 XEO_NAME Bergamottin DME1690 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01527 XEO_CLAS Natural Product DME1690 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01527 GENEFORM Protein DME1690 XEOTICID XEO01527 MOACRIVE Inhibition DME1690 XEOTICID XEO01531 XEO_NAME Clove oil DME1690 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01531 XEO_CLAS Natural Product DME1690 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01531 GENEFORM Protein DME1690 XEOTICID XEO01531 MOACRIVE Inhibition DME1690 XEOTICID XEO01559 XEO_NAME Limonene DME1690 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01559 XEO_CLAS Natural Product DME1690 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01559 GENEFORM Protein DME1690 XEOTICID XEO01559 MOACRIVE Inhibition DME1690 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1690 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01563 XEO_CLAS Natural Product DME1690 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01563 GENEFORM Protein DME1690 XEOTICID XEO01563 MOACRIVE Inhibition DME1690 XEOTICID XEO01566 XEO_NAME Nobiletin DME1690 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01566 XEO_CLAS Natural Product DME1690 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01566 GENEFORM Protein DME1690 XEOTICID XEO01566 MOACRIVE Inhibition DME1690 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1690 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01778 XEO_CLAS Natural Product DME1690 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01778 GENEFORM Protein DME1690 XEOTICID XEO01778 MOACRIVE Inhibition DME1690 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1690 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01779 XEO_CLAS Peptide DME1690 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 128 microM) DME1690 XEOTICID XEO01779 GENEFORM Protein DME1690 XEOTICID XEO01779 MOACRIVE Inhibition DME1690 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1690 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01810 XEO_CLAS Peptide DME1690 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.0 microM) DME1690 XEOTICID XEO01810 GENEFORM Protein DME1690 XEOTICID XEO01810 MOACRIVE Inhibition DME1690 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1690 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01811 XEO_CLAS Peptide DME1690 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 microM) DME1690 XEOTICID XEO01811 GENEFORM Protein DME1690 XEOTICID XEO01811 MOACRIVE Inhibition DME1690 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1690 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01812 XEO_CLAS Peptide DME1690 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10.4 microM) DME1690 XEOTICID XEO01812 GENEFORM Protein DME1690 XEOTICID XEO01812 MOACRIVE Inhibition DME1690 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1690 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01813 XEO_CLAS Peptide DME1690 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.1 microM) DME1690 XEOTICID XEO01813 GENEFORM Protein DME1690 XEOTICID XEO01813 MOACRIVE Inhibition DME1690 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1690 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01814 XEO_CLAS Peptide DME1690 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.5 microM) DME1690 XEOTICID XEO01814 GENEFORM Protein DME1690 XEOTICID XEO01814 MOACRIVE Inhibition DME1690 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1690 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01815 XEO_CLAS Peptide DME1690 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 9.8 microM) DME1690 XEOTICID XEO01815 GENEFORM Protein DME1690 XEOTICID XEO01815 MOACRIVE Inhibition DME1690 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1690 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01816 XEO_CLAS Peptide DME1690 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO01816 GENEFORM Protein DME1690 XEOTICID XEO01816 MOACRIVE Inhibition DME1690 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1690 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01817 XEO_CLAS Peptide DME1690 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.0 microM) DME1690 XEOTICID XEO01817 GENEFORM Protein DME1690 XEOTICID XEO01817 MOACRIVE Inhibition DME1690 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1690 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01818 XEO_CLAS Peptide DME1690 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4.0 microM) DME1690 XEOTICID XEO01818 GENEFORM Protein DME1690 XEOTICID XEO01818 MOACRIVE Inhibition DME1690 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1690 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01819 XEO_CLAS Peptide DME1690 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO01819 GENEFORM Protein DME1690 XEOTICID XEO01819 MOACRIVE Inhibition DME1690 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1690 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01820 XEO_CLAS Peptide DME1690 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO01820 GENEFORM Protein DME1690 XEOTICID XEO01820 MOACRIVE Inhibition DME1690 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1690 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01821 XEO_CLAS Peptide DME1690 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO01821 GENEFORM Protein DME1690 XEOTICID XEO01821 MOACRIVE Inhibition DME1690 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1690 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01822 XEO_CLAS Peptide DME1690 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 microM) DME1690 XEOTICID XEO01822 GENEFORM Protein DME1690 XEOTICID XEO01822 MOACRIVE Inhibition DME1690 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1690 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01823 XEO_CLAS Peptide DME1690 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO01823 GENEFORM Protein DME1690 XEOTICID XEO01823 MOACRIVE Inhibition DME1690 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1690 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01824 XEO_CLAS Peptide DME1690 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO01824 GENEFORM Protein DME1690 XEOTICID XEO01824 MOACRIVE Inhibition DME1690 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1690 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01825 XEO_CLAS Peptide DME1690 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25.0 microM) DME1690 XEOTICID XEO01825 GENEFORM Protein DME1690 XEOTICID XEO01825 MOACRIVE Inhibition DME1690 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1690 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01827 XEO_CLAS Peptide DME1690 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.12-6.25 microM) DME1690 XEOTICID XEO01827 GENEFORM Protein DME1690 XEOTICID XEO01827 MOACRIVE Inhibition DME1690 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1690 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1690 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1690 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01829 GENEFORM Protein DME1690 XEOTICID XEO01829 MOACRIVE Inhibition DME1690 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1690 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01927 XEO_CLAS Peptide DME1690 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 ug/ml) DME1690 XEOTICID XEO01927 GENEFORM Protein DME1690 XEOTICID XEO01927 MOACRIVE Inhibition DME1690 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1690 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01945 XEO_CLAS Peptide DME1690 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.1 microM) DME1690 XEOTICID XEO01945 GENEFORM Protein DME1690 XEOTICID XEO01945 MOACRIVE Inhibition DME1690 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1690 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01946 XEO_CLAS Peptide DME1690 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.2 microM) DME1690 XEOTICID XEO01946 GENEFORM Protein DME1690 XEOTICID XEO01946 MOACRIVE Inhibition DME1690 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1690 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO01947 XEO_CLAS Natural Product DME1690 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01947 GENEFORM Protein DME1690 XEOTICID XEO01947 MOACRIVE Inhibition DME1690 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1690 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1690 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1690 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01950 GENEFORM Protein DME1690 XEOTICID XEO01950 MOACRIVE Inhibition DME1690 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1690 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1690 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1690 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01961 GENEFORM Protein DME1690 XEOTICID XEO01961 MOACRIVE Inhibition DME1690 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1690 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1690 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1690 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO01966 GENEFORM Protein DME1690 XEOTICID XEO01966 MOACRIVE Inhibition DME1690 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1690 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01996 XEO_CLAS Peptide DME1690 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.7 microM) DME1690 XEOTICID XEO01996 GENEFORM Protein DME1690 XEOTICID XEO01996 MOACRIVE Inhibition DME1690 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1690 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01997 XEO_CLAS Peptide DME1690 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.9 microM) DME1690 XEOTICID XEO01997 GENEFORM Protein DME1690 XEOTICID XEO01997 MOACRIVE Inhibition DME1690 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1690 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01998 XEO_CLAS Peptide DME1690 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO01998 GENEFORM Protein DME1690 XEOTICID XEO01998 MOACRIVE Inhibition DME1690 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1690 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO01999 XEO_CLAS Peptide DME1690 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.5 microM) DME1690 XEOTICID XEO01999 GENEFORM Protein DME1690 XEOTICID XEO01999 MOACRIVE Inhibition DME1690 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1690 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02013 XEO_CLAS Peptide DME1690 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02013 GENEFORM Protein DME1690 XEOTICID XEO02013 MOACRIVE Inhibition DME1690 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1690 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02032 XEO_CLAS Natural Product DME1690 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02032 GENEFORM Protein DME1690 XEOTICID XEO02032 MOACRIVE Inhibition DME1690 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1690 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02033 XEO_CLAS Natural Product DME1690 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02033 GENEFORM Protein DME1690 XEOTICID XEO02033 MOACRIVE Inhibition DME1690 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1690 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02079 XEO_CLAS Natural Product DME1690 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02079 GENEFORM Protein DME1690 XEOTICID XEO02079 MOACRIVE Inhibition DME1690 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1690 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1690 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02085 GENEFORM Protein DME1690 XEOTICID XEO02085 MOACRIVE Inhibition DME1690 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1690 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02111 XEO_CLAS Peptide DME1690 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2-4 ug/ml) DME1690 XEOTICID XEO02111 GENEFORM Protein DME1690 XEOTICID XEO02111 MOACRIVE Inhibition DME1690 XEOTICID XEO02113 XEO_NAME Abaecin DME1690 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02113 XEO_CLAS Peptide DME1690 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02113 GENEFORM Protein DME1690 XEOTICID XEO02113 MOACRIVE Inhibition DME1690 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1690 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02114 XEO_CLAS Peptide DME1690 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-25 ug/ml) DME1690 XEOTICID XEO02114 GENEFORM Protein DME1690 XEOTICID XEO02114 MOACRIVE Inhibition DME1690 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1690 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02115 XEO_CLAS Peptide DME1690 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02115 GENEFORM Protein DME1690 XEOTICID XEO02115 MOACRIVE Inhibition DME1690 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1690 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02117 XEO_CLAS Peptide DME1690 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02117 GENEFORM Protein DME1690 XEOTICID XEO02117 MOACRIVE Inhibition DME1690 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1690 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02118 XEO_CLAS Peptide DME1690 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02118 GENEFORM Protein DME1690 XEOTICID XEO02118 MOACRIVE Inhibition DME1690 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1690 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02119 XEO_CLAS Peptide DME1690 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02119 GENEFORM Protein DME1690 XEOTICID XEO02119 MOACRIVE Inhibition DME1690 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1690 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02120 XEO_CLAS Peptide DME1690 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02120 GENEFORM Protein DME1690 XEOTICID XEO02120 MOACRIVE Inhibition DME1690 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1690 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02121 XEO_CLAS Peptide DME1690 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02121 GENEFORM Protein DME1690 XEOTICID XEO02121 MOACRIVE Inhibition DME1690 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1690 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02122 XEO_CLAS Peptide DME1690 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 ug/ml) DME1690 XEOTICID XEO02122 GENEFORM Protein DME1690 XEOTICID XEO02122 MOACRIVE Inhibition DME1690 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1690 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02130 XEO_CLAS Peptide DME1690 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.7 microM) DME1690 XEOTICID XEO02130 GENEFORM Protein DME1690 XEOTICID XEO02130 MOACRIVE Inhibition DME1690 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1690 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02131 XEO_CLAS Peptide DME1690 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.3 microM) DME1690 XEOTICID XEO02131 GENEFORM Protein DME1690 XEOTICID XEO02131 MOACRIVE Inhibition DME1690 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1690 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02132 XEO_CLAS Peptide DME1690 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.5 microM) DME1690 XEOTICID XEO02132 GENEFORM Protein DME1690 XEOTICID XEO02132 MOACRIVE Inhibition DME1690 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1690 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02136 XEO_CLAS Peptide DME1690 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 ug/ml) DME1690 XEOTICID XEO02136 GENEFORM Protein DME1690 XEOTICID XEO02136 MOACRIVE Inhibition DME1690 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1690 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02147 XEO_CLAS Peptide DME1690 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 382 ug/ml) DME1690 XEOTICID XEO02147 GENEFORM Protein DME1690 XEOTICID XEO02147 MOACRIVE Inhibition DME1690 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1690 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02149 XEO_CLAS Peptide DME1690 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 47.35 microM) DME1690 XEOTICID XEO02149 GENEFORM Protein DME1690 XEOTICID XEO02149 MOACRIVE Inhibition DME1690 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1690 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02164 XEO_CLAS Peptide DME1690 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02164 GENEFORM Protein DME1690 XEOTICID XEO02164 MOACRIVE Inhibition DME1690 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1690 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02165 XEO_CLAS Peptide DME1690 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02165 GENEFORM Protein DME1690 XEOTICID XEO02165 MOACRIVE Inhibition DME1690 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1690 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02166 XEO_CLAS Peptide DME1690 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02166 GENEFORM Protein DME1690 XEOTICID XEO02166 MOACRIVE Inhibition DME1690 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1690 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02167 XEO_CLAS Peptide DME1690 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02167 GENEFORM Protein DME1690 XEOTICID XEO02167 MOACRIVE Inhibition DME1690 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1690 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02168 XEO_CLAS Peptide DME1690 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02168 GENEFORM Protein DME1690 XEOTICID XEO02168 MOACRIVE Inhibition DME1690 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1690 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02169 XEO_CLAS Peptide DME1690 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02169 GENEFORM Protein DME1690 XEOTICID XEO02169 MOACRIVE Inhibition DME1690 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1690 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02170 XEO_CLAS Peptide DME1690 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.4 microM) DME1690 XEOTICID XEO02170 GENEFORM Protein DME1690 XEOTICID XEO02170 MOACRIVE Inhibition DME1690 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1690 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02175 XEO_CLAS Natural Product DME1690 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02175 GENEFORM Protein DME1690 XEOTICID XEO02175 MOACRIVE Inhibition DME1690 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1690 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02177 XEO_CLAS Peptide DME1690 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO02177 GENEFORM Protein DME1690 XEOTICID XEO02177 MOACRIVE Inhibition DME1690 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1690 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02178 XEO_CLAS Peptide DME1690 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO02178 GENEFORM Protein DME1690 XEOTICID XEO02178 MOACRIVE Inhibition DME1690 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1690 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02179 XEO_CLAS Peptide DME1690 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO02179 GENEFORM Protein DME1690 XEOTICID XEO02179 MOACRIVE Inhibition DME1690 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1690 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02180 XEO_CLAS Peptide DME1690 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 214 microM) DME1690 XEOTICID XEO02180 GENEFORM Protein DME1690 XEOTICID XEO02180 MOACRIVE Inhibition DME1690 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1690 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02181 XEO_CLAS Peptide DME1690 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 217 microM) DME1690 XEOTICID XEO02181 GENEFORM Protein DME1690 XEOTICID XEO02181 MOACRIVE Inhibition DME1690 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1690 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02183 XEO_CLAS Peptide DME1690 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 38.4 microM) DME1690 XEOTICID XEO02183 GENEFORM Protein DME1690 XEOTICID XEO02183 MOACRIVE Inhibition DME1690 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1690 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02185 XEO_CLAS Peptide DME1690 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 microM) DME1690 XEOTICID XEO02185 GENEFORM Protein DME1690 XEOTICID XEO02185 MOACRIVE Inhibition DME1690 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1690 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02187 GENEFORM Protein DME1690 XEOTICID XEO02187 MOACRIVE Inhibition DME1690 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1690 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02191 XEO_CLAS Peptide DME1690 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02191 GENEFORM Protein DME1690 XEOTICID XEO02191 MOACRIVE Inhibition DME1690 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1690 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02192 XEO_CLAS Peptide DME1690 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.50 ug/ml) DME1690 XEOTICID XEO02192 GENEFORM Protein DME1690 XEOTICID XEO02192 MOACRIVE Inhibition DME1690 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1690 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02193 XEO_CLAS Peptide DME1690 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02193 GENEFORM Protein DME1690 XEOTICID XEO02193 MOACRIVE Inhibition DME1690 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1690 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02194 XEO_CLAS Peptide DME1690 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02194 GENEFORM Protein DME1690 XEOTICID XEO02194 MOACRIVE Inhibition DME1690 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1690 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02195 XEO_CLAS Peptide DME1690 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.00 ug/ml) DME1690 XEOTICID XEO02195 GENEFORM Protein DME1690 XEOTICID XEO02195 MOACRIVE Inhibition DME1690 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1690 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02197 XEO_CLAS Peptide DME1690 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02197 GENEFORM Protein DME1690 XEOTICID XEO02197 MOACRIVE Inhibition DME1690 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1690 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02200 XEO_CLAS Peptide DME1690 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 ug/ml) DME1690 XEOTICID XEO02200 GENEFORM Protein DME1690 XEOTICID XEO02200 MOACRIVE Inhibition DME1690 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1690 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02201 XEO_CLAS Peptide DME1690 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 ug/ml) DME1690 XEOTICID XEO02201 GENEFORM Protein DME1690 XEOTICID XEO02201 MOACRIVE Inhibition DME1690 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1690 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02202 XEO_CLAS Peptide DME1690 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO02202 GENEFORM Protein DME1690 XEOTICID XEO02202 MOACRIVE Inhibition DME1690 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1690 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02203 XEO_CLAS Peptide DME1690 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 microM) DME1690 XEOTICID XEO02203 GENEFORM Protein DME1690 XEOTICID XEO02203 MOACRIVE Inhibition DME1690 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1690 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02207 XEO_CLAS Peptide DME1690 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.78 ug/ml) DME1690 XEOTICID XEO02207 GENEFORM Protein DME1690 XEOTICID XEO02207 MOACRIVE Inhibition DME1690 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1690 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02208 XEO_CLAS Peptide DME1690 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.13 ug/ml) DME1690 XEOTICID XEO02208 GENEFORM Protein DME1690 XEOTICID XEO02208 MOACRIVE Inhibition DME1690 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1690 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02209 XEO_CLAS Peptide DME1690 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.56 ug/ml) DME1690 XEOTICID XEO02209 GENEFORM Protein DME1690 XEOTICID XEO02209 MOACRIVE Inhibition DME1690 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1690 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02210 XEO_CLAS Peptide DME1690 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 ug/ml) DME1690 XEOTICID XEO02210 GENEFORM Protein DME1690 XEOTICID XEO02210 MOACRIVE Inhibition DME1690 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1690 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02211 XEO_CLAS Peptide DME1690 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25 ug/ml) DME1690 XEOTICID XEO02211 GENEFORM Protein DME1690 XEOTICID XEO02211 MOACRIVE Inhibition DME1690 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1690 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02212 XEO_CLAS Peptide DME1690 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.13 ug/ml) DME1690 XEOTICID XEO02212 GENEFORM Protein DME1690 XEOTICID XEO02212 MOACRIVE Inhibition DME1690 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1690 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02213 XEO_CLAS Peptide DME1690 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.13 ug/ml) DME1690 XEOTICID XEO02213 GENEFORM Protein DME1690 XEOTICID XEO02213 MOACRIVE Inhibition DME1690 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1690 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02214 XEO_CLAS Peptide DME1690 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02214 GENEFORM Protein DME1690 XEOTICID XEO02214 MOACRIVE Inhibition DME1690 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1690 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02215 XEO_CLAS Peptide DME1690 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 ug/ml) DME1690 XEOTICID XEO02215 GENEFORM Protein DME1690 XEOTICID XEO02215 MOACRIVE Inhibition DME1690 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1690 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02216 XEO_CLAS Peptide DME1690 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 126 ug/ml) DME1690 XEOTICID XEO02216 GENEFORM Protein DME1690 XEOTICID XEO02216 MOACRIVE Inhibition DME1690 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1690 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02217 XEO_CLAS Peptide DME1690 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 200 ug/ml) DME1690 XEOTICID XEO02217 GENEFORM Protein DME1690 XEOTICID XEO02217 MOACRIVE Inhibition DME1690 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1690 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02218 XEO_CLAS Peptide DME1690 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 200 ug/ml) DME1690 XEOTICID XEO02218 GENEFORM Protein DME1690 XEOTICID XEO02218 MOACRIVE Inhibition DME1690 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1690 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02219 XEO_CLAS Peptide DME1690 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 200 ug/ml) DME1690 XEOTICID XEO02219 GENEFORM Protein DME1690 XEOTICID XEO02219 MOACRIVE Inhibition DME1690 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1690 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02220 XEO_CLAS Peptide DME1690 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 23.5 ug/ml) DME1690 XEOTICID XEO02220 GENEFORM Protein DME1690 XEOTICID XEO02220 MOACRIVE Inhibition DME1690 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1690 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02221 XEO_CLAS Peptide DME1690 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20.2 ug/ml) DME1690 XEOTICID XEO02221 GENEFORM Protein DME1690 XEOTICID XEO02221 MOACRIVE Inhibition DME1690 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1690 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02222 XEO_CLAS Peptide DME1690 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30.5 ug/ml) DME1690 XEOTICID XEO02222 GENEFORM Protein DME1690 XEOTICID XEO02222 MOACRIVE Inhibition DME1690 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1690 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02223 XEO_CLAS Peptide DME1690 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.2 ug/ml) DME1690 XEOTICID XEO02223 GENEFORM Protein DME1690 XEOTICID XEO02223 MOACRIVE Inhibition DME1690 XEOTICID XEO02224 XEO_NAME Androctonin DME1690 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02224 XEO_CLAS Peptide DME1690 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02224 GENEFORM Protein DME1690 XEOTICID XEO02224 MOACRIVE Inhibition DME1690 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1690 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02225 XEO_CLAS Peptide DME1690 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02225 GENEFORM Protein DME1690 XEOTICID XEO02225 MOACRIVE Inhibition DME1690 XEOTICID XEO02226 XEO_NAME Andropin DME1690 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02226 XEO_CLAS Peptide DME1690 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 140 microM) DME1690 XEOTICID XEO02226 GENEFORM Protein DME1690 XEOTICID XEO02226 MOACRIVE Inhibition DME1690 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1690 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02230 XEO_CLAS Peptide DME1690 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.05-0.1 microM) DME1690 XEOTICID XEO02230 GENEFORM Protein DME1690 XEOTICID XEO02230 MOACRIVE Inhibition DME1690 XEOTICID XEO02232 XEO_NAME Anoplin DME1690 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02232 XEO_CLAS Peptide DME1690 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 13 ug/ml) DME1690 XEOTICID XEO02232 GENEFORM Protein DME1690 XEOTICID XEO02232 MOACRIVE Inhibition DME1690 XEOTICID XEO02233 XEO_NAME Antapin DME1690 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02233 XEO_CLAS Peptide DME1690 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02233 GENEFORM Protein DME1690 XEOTICID XEO02233 MOACRIVE Inhibition DME1690 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1690 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02236 XEO_CLAS Peptide DME1690 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02236 GENEFORM Protein DME1690 XEOTICID XEO02236 MOACRIVE Inhibition DME1690 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1690 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02239 XEO_CLAS Peptide DME1690 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 250 microM) DME1690 XEOTICID XEO02239 GENEFORM Protein DME1690 XEOTICID XEO02239 MOACRIVE Inhibition DME1690 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1690 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02240 XEO_CLAS Peptide DME1690 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 microM) DME1690 XEOTICID XEO02240 GENEFORM Protein DME1690 XEOTICID XEO02240 MOACRIVE Inhibition DME1690 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1690 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02241 XEO_CLAS Peptide DME1690 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02241 GENEFORM Protein DME1690 XEOTICID XEO02241 MOACRIVE Inhibition DME1690 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1690 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02242 XEO_CLAS Peptide DME1690 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO02242 GENEFORM Protein DME1690 XEOTICID XEO02242 MOACRIVE Inhibition DME1690 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1690 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02243 XEO_CLAS Peptide DME1690 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 microM) DME1690 XEOTICID XEO02243 GENEFORM Protein DME1690 XEOTICID XEO02243 MOACRIVE Inhibition DME1690 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1690 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02244 XEO_CLAS Peptide DME1690 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1 microM) DME1690 XEOTICID XEO02244 GENEFORM Protein DME1690 XEOTICID XEO02244 MOACRIVE Inhibition DME1690 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1690 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02245 XEO_CLAS Peptide DME1690 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02245 GENEFORM Protein DME1690 XEOTICID XEO02245 MOACRIVE Inhibition DME1690 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1690 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02246 XEO_CLAS Peptide DME1690 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 microM) DME1690 XEOTICID XEO02246 GENEFORM Protein DME1690 XEOTICID XEO02246 MOACRIVE Inhibition DME1690 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1690 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02247 XEO_CLAS Peptide DME1690 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02247 GENEFORM Protein DME1690 XEOTICID XEO02247 MOACRIVE Inhibition DME1690 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1690 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02248 XEO_CLAS Peptide DME1690 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.3 microM) DME1690 XEOTICID XEO02248 GENEFORM Protein DME1690 XEOTICID XEO02248 MOACRIVE Inhibition DME1690 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1690 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02253 XEO_CLAS Peptide DME1690 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02253 GENEFORM Protein DME1690 XEOTICID XEO02253 MOACRIVE Inhibition DME1690 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1690 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02258 XEO_CLAS Peptide DME1690 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 150 microM) DME1690 XEOTICID XEO02258 GENEFORM Protein DME1690 XEOTICID XEO02258 MOACRIVE Inhibition DME1690 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1690 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02261 XEO_CLAS Peptide DME1690 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 82 ug/ml) DME1690 XEOTICID XEO02261 GENEFORM Protein DME1690 XEOTICID XEO02261 MOACRIVE Inhibition DME1690 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1690 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02263 XEO_CLAS Peptide DME1690 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO02263 GENEFORM Protein DME1690 XEOTICID XEO02263 MOACRIVE Inhibition DME1690 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1690 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02266 XEO_CLAS Peptide DME1690 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 120 microM) DME1690 XEOTICID XEO02266 GENEFORM Protein DME1690 XEOTICID XEO02266 MOACRIVE Inhibition DME1690 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1690 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02268 XEO_CLAS Peptide DME1690 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 170 ug/ml) DME1690 XEOTICID XEO02268 GENEFORM Protein DME1690 XEOTICID XEO02268 MOACRIVE Inhibition DME1690 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1690 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02270 XEO_CLAS Peptide DME1690 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 microM) DME1690 XEOTICID XEO02270 GENEFORM Protein DME1690 XEOTICID XEO02270 MOACRIVE Inhibition DME1690 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1690 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02271 XEO_CLAS Peptide DME1690 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 302 ug/ml) DME1690 XEOTICID XEO02271 GENEFORM Protein DME1690 XEOTICID XEO02271 MOACRIVE Inhibition DME1690 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1690 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02273 XEO_CLAS Peptide DME1690 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 18 microM) DME1690 XEOTICID XEO02273 GENEFORM Protein DME1690 XEOTICID XEO02273 MOACRIVE Inhibition DME1690 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1690 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02274 XEO_CLAS Peptide DME1690 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO02274 GENEFORM Protein DME1690 XEOTICID XEO02274 MOACRIVE Inhibition DME1690 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1690 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02275 XEO_CLAS Peptide DME1690 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 microM) DME1690 XEOTICID XEO02275 GENEFORM Protein DME1690 XEOTICID XEO02275 MOACRIVE Inhibition DME1690 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1690 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02276 XEO_CLAS Peptide DME1690 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 microM) DME1690 XEOTICID XEO02276 GENEFORM Protein DME1690 XEOTICID XEO02276 MOACRIVE Inhibition DME1690 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1690 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02280 XEO_CLAS Peptide DME1690 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02280 GENEFORM Protein DME1690 XEOTICID XEO02280 MOACRIVE Inhibition DME1690 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1690 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02281 XEO_CLAS Peptide DME1690 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02281 GENEFORM Protein DME1690 XEOTICID XEO02281 MOACRIVE Inhibition DME1690 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1690 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02283 XEO_CLAS Peptide DME1690 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 ug/ml) DME1690 XEOTICID XEO02283 GENEFORM Protein DME1690 XEOTICID XEO02283 MOACRIVE Inhibition DME1690 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1690 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02284 XEO_CLAS Peptide DME1690 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50.4 microM) DME1690 XEOTICID XEO02284 GENEFORM Protein DME1690 XEOTICID XEO02284 MOACRIVE Inhibition DME1690 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1690 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02285 XEO_CLAS Peptide DME1690 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50.4 microM) DME1690 XEOTICID XEO02285 GENEFORM Protein DME1690 XEOTICID XEO02285 MOACRIVE Inhibition DME1690 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1690 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02286 XEO_CLAS Peptide DME1690 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50.4 microM) DME1690 XEOTICID XEO02286 GENEFORM Protein DME1690 XEOTICID XEO02286 MOACRIVE Inhibition DME1690 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1690 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02287 XEO_CLAS Peptide DME1690 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50.4 microM) DME1690 XEOTICID XEO02287 GENEFORM Protein DME1690 XEOTICID XEO02287 MOACRIVE Inhibition DME1690 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1690 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02288 XEO_CLAS Peptide DME1690 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.2 ug/ml) DME1690 XEOTICID XEO02288 GENEFORM Protein DME1690 XEOTICID XEO02288 MOACRIVE Inhibition DME1690 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1690 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02289 XEO_CLAS Peptide DME1690 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 ug/ml) DME1690 XEOTICID XEO02289 GENEFORM Protein DME1690 XEOTICID XEO02289 MOACRIVE Inhibition DME1690 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1690 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02290 XEO_CLAS Peptide DME1690 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO02290 GENEFORM Protein DME1690 XEOTICID XEO02290 MOACRIVE Inhibition DME1690 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1690 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02291 XEO_CLAS Peptide DME1690 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02291 GENEFORM Protein DME1690 XEOTICID XEO02291 MOACRIVE Inhibition DME1690 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1690 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02293 XEO_CLAS Peptide DME1690 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 microM) DME1690 XEOTICID XEO02293 GENEFORM Protein DME1690 XEOTICID XEO02293 MOACRIVE Inhibition DME1690 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1690 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02294 XEO_CLAS Peptide DME1690 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 62-250 ug/ml) DME1690 XEOTICID XEO02294 GENEFORM Protein DME1690 XEOTICID XEO02294 MOACRIVE Inhibition DME1690 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1690 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02295 XEO_CLAS Peptide DME1690 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 ug/ml) DME1690 XEOTICID XEO02295 GENEFORM Protein DME1690 XEOTICID XEO02295 MOACRIVE Inhibition DME1690 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1690 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02296 XEO_CLAS Peptide DME1690 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02296 GENEFORM Protein DME1690 XEOTICID XEO02296 MOACRIVE Inhibition DME1690 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1690 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02297 XEO_CLAS Peptide DME1690 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC < 50 ug/ml) DME1690 XEOTICID XEO02297 GENEFORM Protein DME1690 XEOTICID XEO02297 MOACRIVE Inhibition DME1690 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1690 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02298 XEO_CLAS Peptide DME1690 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO02298 GENEFORM Protein DME1690 XEOTICID XEO02298 MOACRIVE Inhibition DME1690 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1690 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02303 XEO_CLAS Peptide DME1690 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02303 GENEFORM Protein DME1690 XEOTICID XEO02303 MOACRIVE Inhibition DME1690 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1690 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02304 XEO_CLAS Peptide DME1690 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.1 ug/ml) DME1690 XEOTICID XEO02304 GENEFORM Protein DME1690 XEOTICID XEO02304 MOACRIVE Inhibition DME1690 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1690 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02305 XEO_CLAS Peptide DME1690 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC <= 1 ug/ml) DME1690 XEOTICID XEO02305 GENEFORM Protein DME1690 XEOTICID XEO02305 MOACRIVE Inhibition DME1690 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1690 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02306 XEO_CLAS Peptide DME1690 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.2 ug/ml) DME1690 XEOTICID XEO02306 GENEFORM Protein DME1690 XEOTICID XEO02306 MOACRIVE Inhibition DME1690 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1690 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02309 XEO_CLAS Peptide DME1690 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02309 GENEFORM Protein DME1690 XEOTICID XEO02309 MOACRIVE Inhibition DME1690 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1690 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02310 XEO_CLAS Peptide DME1690 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02310 GENEFORM Protein DME1690 XEOTICID XEO02310 MOACRIVE Inhibition DME1690 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1690 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02315 XEO_CLAS Peptide DME1690 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO02315 GENEFORM Protein DME1690 XEOTICID XEO02315 MOACRIVE Inhibition DME1690 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1690 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02316 XEO_CLAS Peptide DME1690 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 50 microM) DME1690 XEOTICID XEO02316 GENEFORM Protein DME1690 XEOTICID XEO02316 MOACRIVE Inhibition DME1690 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1690 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02317 XEO_CLAS Peptide DME1690 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 300 microM) DME1690 XEOTICID XEO02317 GENEFORM Protein DME1690 XEOTICID XEO02317 MOACRIVE Inhibition DME1690 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1690 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02318 XEO_CLAS Peptide DME1690 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02318 GENEFORM Protein DME1690 XEOTICID XEO02318 MOACRIVE Inhibition DME1690 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1690 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02319 XEO_CLAS Peptide DME1690 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02319 GENEFORM Protein DME1690 XEOTICID XEO02319 MOACRIVE Inhibition DME1690 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1690 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02320 XEO_CLAS Peptide DME1690 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02320 GENEFORM Protein DME1690 XEOTICID XEO02320 MOACRIVE Inhibition DME1690 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1690 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02321 XEO_CLAS Peptide DME1690 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO02321 GENEFORM Protein DME1690 XEOTICID XEO02321 MOACRIVE Inhibition DME1690 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1690 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02322 XEO_CLAS Peptide DME1690 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02322 GENEFORM Protein DME1690 XEOTICID XEO02322 MOACRIVE Inhibition DME1690 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1690 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02323 XEO_CLAS Peptide DME1690 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO02323 GENEFORM Protein DME1690 XEOTICID XEO02323 MOACRIVE Inhibition DME1690 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1690 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02324 XEO_CLAS Peptide DME1690 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02324 GENEFORM Protein DME1690 XEOTICID XEO02324 MOACRIVE Inhibition DME1690 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1690 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02325 XEO_CLAS Peptide DME1690 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO02325 GENEFORM Protein DME1690 XEOTICID XEO02325 MOACRIVE Inhibition DME1690 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1690 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02326 XEO_CLAS Peptide DME1690 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02326 GENEFORM Protein DME1690 XEOTICID XEO02326 MOACRIVE Inhibition DME1690 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1690 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02327 XEO_CLAS Peptide DME1690 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO02327 GENEFORM Protein DME1690 XEOTICID XEO02327 MOACRIVE Inhibition DME1690 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1690 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02328 XEO_CLAS Peptide DME1690 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO02328 GENEFORM Protein DME1690 XEOTICID XEO02328 MOACRIVE Inhibition DME1690 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1690 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02332 XEO_CLAS Peptide DME1690 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.9 ug/ml) DME1690 XEOTICID XEO02332 GENEFORM Protein DME1690 XEOTICID XEO02332 MOACRIVE Inhibition DME1690 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1690 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02333 XEO_CLAS Peptide DME1690 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 200 microM) DME1690 XEOTICID XEO02333 GENEFORM Protein DME1690 XEOTICID XEO02333 MOACRIVE Inhibition DME1690 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1690 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02336 XEO_CLAS Peptide DME1690 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 microM) DME1690 XEOTICID XEO02336 GENEFORM Protein DME1690 XEOTICID XEO02336 MOACRIVE Inhibition DME1690 XEOTICID XEO02346 XEO_NAME Aurelin DME1690 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02346 XEO_CLAS Peptide DME1690 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 7.66 ug/ml) DME1690 XEOTICID XEO02346 GENEFORM Protein DME1690 XEOTICID XEO02346 MOACRIVE Inhibition DME1690 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1690 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02352 XEO_CLAS Peptide DME1690 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 11 ug/ml) DME1690 XEOTICID XEO02352 GENEFORM Protein DME1690 XEOTICID XEO02352 MOACRIVE Inhibition DME1690 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1690 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02353 XEO_CLAS Peptide DME1690 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 ug/ml) DME1690 XEOTICID XEO02353 GENEFORM Protein DME1690 XEOTICID XEO02353 MOACRIVE Inhibition DME1690 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1690 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02354 XEO_CLAS Peptide DME1690 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 ug/ml) DME1690 XEOTICID XEO02354 GENEFORM Protein DME1690 XEOTICID XEO02354 MOACRIVE Inhibition DME1690 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1690 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02355 XEO_CLAS Peptide DME1690 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 17 ug/ml) DME1690 XEOTICID XEO02355 GENEFORM Protein DME1690 XEOTICID XEO02355 MOACRIVE Inhibition DME1690 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1690 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02356 XEO_CLAS Peptide DME1690 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO02356 GENEFORM Protein DME1690 XEOTICID XEO02356 MOACRIVE Inhibition DME1690 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1690 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02357 XEO_CLAS Peptide DME1690 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO02357 GENEFORM Protein DME1690 XEOTICID XEO02357 MOACRIVE Inhibition DME1690 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1690 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02358 XEO_CLAS Peptide DME1690 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO02358 GENEFORM Protein DME1690 XEOTICID XEO02358 MOACRIVE Inhibition DME1690 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1690 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02360 XEO_CLAS Peptide DME1690 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02360 GENEFORM Protein DME1690 XEOTICID XEO02360 MOACRIVE Inhibition DME1690 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1690 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02361 XEO_CLAS Peptide DME1690 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 ug/ml) DME1690 XEOTICID XEO02361 GENEFORM Protein DME1690 XEOTICID XEO02361 MOACRIVE Inhibition DME1690 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1690 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02365 XEO_CLAS Peptide DME1690 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 32 ug/ml) DME1690 XEOTICID XEO02365 GENEFORM Protein DME1690 XEOTICID XEO02365 MOACRIVE Inhibition DME1690 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1690 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02366 XEO_CLAS Peptide DME1690 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO02366 GENEFORM Protein DME1690 XEOTICID XEO02366 MOACRIVE Inhibition DME1690 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1690 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02367 XEO_CLAS Peptide DME1690 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02367 GENEFORM Protein DME1690 XEOTICID XEO02367 MOACRIVE Inhibition DME1690 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1690 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02368 XEO_CLAS Peptide DME1690 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02368 GENEFORM Protein DME1690 XEOTICID XEO02368 MOACRIVE Inhibition DME1690 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1690 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02369 XEO_CLAS Peptide DME1690 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02369 GENEFORM Protein DME1690 XEOTICID XEO02369 MOACRIVE Inhibition DME1690 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1690 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02370 XEO_CLAS Peptide DME1690 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02370 GENEFORM Protein DME1690 XEOTICID XEO02370 MOACRIVE Inhibition DME1690 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1690 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02371 XEO_CLAS Peptide DME1690 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 ug/ml) DME1690 XEOTICID XEO02371 GENEFORM Protein DME1690 XEOTICID XEO02371 MOACRIVE Inhibition DME1690 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1690 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02374 XEO_CLAS Peptide DME1690 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02374 GENEFORM Protein DME1690 XEOTICID XEO02374 MOACRIVE Inhibition DME1690 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1690 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02376 XEO_CLAS Peptide DME1690 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02376 GENEFORM Protein DME1690 XEOTICID XEO02376 MOACRIVE Inhibition DME1690 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1690 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02378 XEO_CLAS Peptide DME1690 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.19 ug/ml) DME1690 XEOTICID XEO02378 GENEFORM Protein DME1690 XEOTICID XEO02378 MOACRIVE Inhibition DME1690 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1690 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02388 XEO_CLAS Peptide DME1690 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO02388 GENEFORM Protein DME1690 XEOTICID XEO02388 MOACRIVE Inhibition DME1690 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1690 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02389 XEO_CLAS Peptide DME1690 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02389 GENEFORM Protein DME1690 XEOTICID XEO02389 MOACRIVE Inhibition DME1690 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1690 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02415 XEO_CLAS Peptide DME1690 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02415 GENEFORM Protein DME1690 XEOTICID XEO02415 MOACRIVE Inhibition DME1690 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1690 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02416 XEO_CLAS Peptide DME1690 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 11 microM) DME1690 XEOTICID XEO02416 GENEFORM Protein DME1690 XEOTICID XEO02416 MOACRIVE Inhibition DME1690 XEOTICID XEO02419 XEO_NAME Bay oil DME1690 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1690 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02419 GENEFORM Protein DME1690 XEOTICID XEO02419 MOACRIVE Inhibition DME1690 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1690 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02435 XEO_CLAS Peptide DME1690 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02435 GENEFORM Protein DME1690 XEOTICID XEO02435 MOACRIVE Inhibition DME1690 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1690 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02436 XEO_CLAS Peptide DME1690 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02436 GENEFORM Protein DME1690 XEOTICID XEO02436 MOACRIVE Inhibition DME1690 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1690 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02437 XEO_CLAS Peptide DME1690 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02437 GENEFORM Protein DME1690 XEOTICID XEO02437 MOACRIVE Inhibition DME1690 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1690 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02438 XEO_CLAS Peptide DME1690 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02438 GENEFORM Protein DME1690 XEOTICID XEO02438 MOACRIVE Inhibition DME1690 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1690 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02439 XEO_CLAS Peptide DME1690 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02439 GENEFORM Protein DME1690 XEOTICID XEO02439 MOACRIVE Inhibition DME1690 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1690 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02440 XEO_CLAS Peptide DME1690 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02440 GENEFORM Protein DME1690 XEOTICID XEO02440 MOACRIVE Inhibition DME1690 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1690 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02441 XEO_CLAS Peptide DME1690 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02441 GENEFORM Protein DME1690 XEOTICID XEO02441 MOACRIVE Inhibition DME1690 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1690 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02442 XEO_CLAS Peptide DME1690 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO02442 GENEFORM Protein DME1690 XEOTICID XEO02442 MOACRIVE Inhibition DME1690 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1690 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02443 XEO_CLAS Peptide DME1690 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02443 GENEFORM Protein DME1690 XEOTICID XEO02443 MOACRIVE Inhibition DME1690 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1690 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02444 XEO_CLAS Peptide DME1690 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02444 GENEFORM Protein DME1690 XEOTICID XEO02444 MOACRIVE Inhibition DME1690 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1690 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1690 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02447 GENEFORM Protein DME1690 XEOTICID XEO02447 MOACRIVE Inhibition DME1690 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1690 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02452 XEO_CLAS Peptide DME1690 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 76800 ug/ml) DME1690 XEOTICID XEO02452 GENEFORM Protein DME1690 XEOTICID XEO02452 MOACRIVE Inhibition DME1690 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1690 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02453 XEO_CLAS Peptide DME1690 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02453 GENEFORM Protein DME1690 XEOTICID XEO02453 MOACRIVE Inhibition DME1690 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1690 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02463 XEO_CLAS Peptide DME1690 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 11.25 microM) DME1690 XEOTICID XEO02463 GENEFORM Protein DME1690 XEOTICID XEO02463 MOACRIVE Inhibition DME1690 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1690 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02466 XEO_CLAS Peptide DME1690 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.5 microM) DME1690 XEOTICID XEO02466 GENEFORM Protein DME1690 XEOTICID XEO02466 MOACRIVE Inhibition DME1690 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1690 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02467 XEO_CLAS Peptide DME1690 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8.4 microM) DME1690 XEOTICID XEO02467 GENEFORM Protein DME1690 XEOTICID XEO02467 MOACRIVE Inhibition DME1690 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1690 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02468 XEO_CLAS Peptide DME1690 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.7 microM) DME1690 XEOTICID XEO02468 GENEFORM Protein DME1690 XEOTICID XEO02468 MOACRIVE Inhibition DME1690 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1690 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02469 XEO_CLAS Peptide DME1690 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO02469 GENEFORM Protein DME1690 XEOTICID XEO02469 MOACRIVE Inhibition DME1690 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1690 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02470 XEO_CLAS Peptide DME1690 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.8 microM) DME1690 XEOTICID XEO02470 GENEFORM Protein DME1690 XEOTICID XEO02470 MOACRIVE Inhibition DME1690 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1690 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02471 XEO_CLAS Peptide DME1690 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4.8 microM) DME1690 XEOTICID XEO02471 GENEFORM Protein DME1690 XEOTICID XEO02471 MOACRIVE Inhibition DME1690 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1690 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02472 XEO_CLAS Peptide DME1690 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.0 microM) DME1690 XEOTICID XEO02472 GENEFORM Protein DME1690 XEOTICID XEO02472 MOACRIVE Inhibition DME1690 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1690 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02473 XEO_CLAS Peptide DME1690 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02473 GENEFORM Protein DME1690 XEOTICID XEO02473 MOACRIVE Inhibition DME1690 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1690 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02474 XEO_CLAS Peptide DME1690 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.5 microM) DME1690 XEOTICID XEO02474 GENEFORM Protein DME1690 XEOTICID XEO02474 MOACRIVE Inhibition DME1690 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1690 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02475 XEO_CLAS Peptide DME1690 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.5 microM) DME1690 XEOTICID XEO02475 GENEFORM Protein DME1690 XEOTICID XEO02475 MOACRIVE Inhibition DME1690 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1690 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02477 XEO_CLAS Peptide DME1690 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-300 ug/ml) DME1690 XEOTICID XEO02477 GENEFORM Protein DME1690 XEOTICID XEO02477 MOACRIVE Inhibition DME1690 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1690 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02478 XEO_CLAS Peptide DME1690 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-300 ug/ml) DME1690 XEOTICID XEO02478 GENEFORM Protein DME1690 XEOTICID XEO02478 MOACRIVE Inhibition DME1690 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1690 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02479 XEO_CLAS Peptide DME1690 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-300 ug/ml) DME1690 XEOTICID XEO02479 GENEFORM Protein DME1690 XEOTICID XEO02479 MOACRIVE Inhibition DME1690 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1690 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02480 XEO_CLAS Peptide DME1690 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-300 ug/ml) DME1690 XEOTICID XEO02480 GENEFORM Protein DME1690 XEOTICID XEO02480 MOACRIVE Inhibition DME1690 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1690 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02481 XEO_CLAS Peptide DME1690 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-300 ug/ml) DME1690 XEOTICID XEO02481 GENEFORM Protein DME1690 XEOTICID XEO02481 MOACRIVE Inhibition DME1690 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1690 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02482 XEO_CLAS Peptide DME1690 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-300 ug/ml) DME1690 XEOTICID XEO02482 GENEFORM Protein DME1690 XEOTICID XEO02482 MOACRIVE Inhibition DME1690 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1690 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02483 XEO_CLAS Peptide DME1690 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-300 ug/ml) DME1690 XEOTICID XEO02483 GENEFORM Protein DME1690 XEOTICID XEO02483 MOACRIVE Inhibition DME1690 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1690 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02484 XEO_CLAS Peptide DME1690 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-300 ug/ml) DME1690 XEOTICID XEO02484 GENEFORM Protein DME1690 XEOTICID XEO02484 MOACRIVE Inhibition DME1690 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1690 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02485 XEO_CLAS Peptide DME1690 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-300 ug/ml) DME1690 XEOTICID XEO02485 GENEFORM Protein DME1690 XEOTICID XEO02485 MOACRIVE Inhibition DME1690 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1690 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02486 XEO_CLAS Peptide DME1690 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-300 ug/ml) DME1690 XEOTICID XEO02486 GENEFORM Protein DME1690 XEOTICID XEO02486 MOACRIVE Inhibition DME1690 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1690 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02487 XEO_CLAS Peptide DME1690 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02487 GENEFORM Protein DME1690 XEOTICID XEO02487 MOACRIVE Inhibition DME1690 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1690 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02488 XEO_CLAS Peptide DME1690 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-300 ug/ml) DME1690 XEOTICID XEO02488 GENEFORM Protein DME1690 XEOTICID XEO02488 MOACRIVE Inhibition DME1690 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1690 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02489 XEO_CLAS Peptide DME1690 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-301 ug/ml) DME1690 XEOTICID XEO02489 GENEFORM Protein DME1690 XEOTICID XEO02489 MOACRIVE Inhibition DME1690 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1690 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02491 XEO_CLAS Peptide DME1690 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.3 microM) DME1690 XEOTICID XEO02491 GENEFORM Protein DME1690 XEOTICID XEO02491 MOACRIVE Inhibition DME1690 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1690 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02492 XEO_CLAS Peptide DME1690 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 ug/ml) DME1690 XEOTICID XEO02492 GENEFORM Protein DME1690 XEOTICID XEO02492 MOACRIVE Inhibition DME1690 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1690 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02493 XEO_CLAS Peptide DME1690 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 ug/ml) DME1690 XEOTICID XEO02493 GENEFORM Protein DME1690 XEOTICID XEO02493 MOACRIVE Inhibition DME1690 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1690 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02494 XEO_CLAS Peptide DME1690 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 ug/ml) DME1690 XEOTICID XEO02494 GENEFORM Protein DME1690 XEOTICID XEO02494 MOACRIVE Inhibition DME1690 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1690 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02495 XEO_CLAS Peptide DME1690 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 34 ug/ml) DME1690 XEOTICID XEO02495 GENEFORM Protein DME1690 XEOTICID XEO02495 MOACRIVE Inhibition DME1690 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1690 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02496 XEO_CLAS Peptide DME1690 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 13 microM) DME1690 XEOTICID XEO02496 GENEFORM Protein DME1690 XEOTICID XEO02496 MOACRIVE Inhibition DME1690 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1690 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02497 XEO_CLAS Peptide DME1690 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO02497 GENEFORM Protein DME1690 XEOTICID XEO02497 MOACRIVE Inhibition DME1690 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1690 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02499 XEO_CLAS Peptide DME1690 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO02499 GENEFORM Protein DME1690 XEOTICID XEO02499 MOACRIVE Inhibition DME1690 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1690 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02501 XEO_CLAS Peptide DME1690 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 7 microM) DME1690 XEOTICID XEO02501 GENEFORM Protein DME1690 XEOTICID XEO02501 MOACRIVE Inhibition DME1690 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1690 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02502 XEO_CLAS Peptide DME1690 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 microM) DME1690 XEOTICID XEO02502 GENEFORM Protein DME1690 XEOTICID XEO02502 MOACRIVE Inhibition DME1690 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1690 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02503 XEO_CLAS Peptide DME1690 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 19 microM) DME1690 XEOTICID XEO02503 GENEFORM Protein DME1690 XEOTICID XEO02503 MOACRIVE Inhibition DME1690 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1690 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02504 XEO_CLAS Peptide DME1690 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02504 GENEFORM Protein DME1690 XEOTICID XEO02504 MOACRIVE Inhibition DME1690 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1690 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02505 XEO_CLAS Peptide DME1690 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO02505 GENEFORM Protein DME1690 XEOTICID XEO02505 MOACRIVE Inhibition DME1690 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1690 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02507 XEO_CLAS Peptide DME1690 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO02507 GENEFORM Protein DME1690 XEOTICID XEO02507 MOACRIVE Inhibition DME1690 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1690 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02508 XEO_CLAS Peptide DME1690 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 150 microM) DME1690 XEOTICID XEO02508 GENEFORM Protein DME1690 XEOTICID XEO02508 MOACRIVE Inhibition DME1690 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1690 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02509 XEO_CLAS Peptide DME1690 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 150 microM) DME1690 XEOTICID XEO02509 GENEFORM Protein DME1690 XEOTICID XEO02509 MOACRIVE Inhibition DME1690 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1690 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02510 XEO_CLAS Peptide DME1690 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 150 microM) DME1690 XEOTICID XEO02510 GENEFORM Protein DME1690 XEOTICID XEO02510 MOACRIVE Inhibition DME1690 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1690 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02511 XEO_CLAS Peptide DME1690 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 150 microM) DME1690 XEOTICID XEO02511 GENEFORM Protein DME1690 XEOTICID XEO02511 MOACRIVE Inhibition DME1690 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1690 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02512 XEO_CLAS Peptide DME1690 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 75 microM) DME1690 XEOTICID XEO02512 GENEFORM Protein DME1690 XEOTICID XEO02512 MOACRIVE Inhibition DME1690 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1690 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02513 XEO_CLAS Peptide DME1690 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO02513 GENEFORM Protein DME1690 XEOTICID XEO02513 MOACRIVE Inhibition DME1690 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1690 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02514 XEO_CLAS Peptide DME1690 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO02514 GENEFORM Protein DME1690 XEOTICID XEO02514 MOACRIVE Inhibition DME1690 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1690 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02515 XEO_CLAS Peptide DME1690 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 80 microM) DME1690 XEOTICID XEO02515 GENEFORM Protein DME1690 XEOTICID XEO02515 MOACRIVE Inhibition DME1690 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1690 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02516 XEO_CLAS Peptide DME1690 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 32 microM) DME1690 XEOTICID XEO02516 GENEFORM Protein DME1690 XEOTICID XEO02516 MOACRIVE Inhibition DME1690 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1690 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02517 XEO_CLAS Peptide DME1690 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 microM) DME1690 XEOTICID XEO02517 GENEFORM Protein DME1690 XEOTICID XEO02517 MOACRIVE Inhibition DME1690 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1690 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02518 XEO_CLAS Peptide DME1690 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC < 15 microM) DME1690 XEOTICID XEO02518 GENEFORM Protein DME1690 XEOTICID XEO02518 MOACRIVE Inhibition DME1690 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1690 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02519 XEO_CLAS Peptide DME1690 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC < 15 microM) DME1690 XEOTICID XEO02519 GENEFORM Protein DME1690 XEOTICID XEO02519 MOACRIVE Inhibition DME1690 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1690 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02520 XEO_CLAS Peptide DME1690 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC < 15 microM) DME1690 XEOTICID XEO02520 GENEFORM Protein DME1690 XEOTICID XEO02520 MOACRIVE Inhibition DME1690 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1690 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02523 XEO_CLAS Peptide DME1690 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO02523 GENEFORM Protein DME1690 XEOTICID XEO02523 MOACRIVE Inhibition DME1690 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1690 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02524 XEO_CLAS Peptide DME1690 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 150 microM) DME1690 XEOTICID XEO02524 GENEFORM Protein DME1690 XEOTICID XEO02524 MOACRIVE Inhibition DME1690 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1690 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02525 XEO_CLAS Peptide DME1690 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 24 microM) DME1690 XEOTICID XEO02525 GENEFORM Protein DME1690 XEOTICID XEO02525 MOACRIVE Inhibition DME1690 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1690 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02526 XEO_CLAS Peptide DME1690 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 48 microM) DME1690 XEOTICID XEO02526 GENEFORM Protein DME1690 XEOTICID XEO02526 MOACRIVE Inhibition DME1690 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1690 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02527 XEO_CLAS Peptide DME1690 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 119 microM) DME1690 XEOTICID XEO02527 GENEFORM Protein DME1690 XEOTICID XEO02527 MOACRIVE Inhibition DME1690 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1690 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02528 XEO_CLAS Peptide DME1690 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 128 ug/ml) DME1690 XEOTICID XEO02528 GENEFORM Protein DME1690 XEOTICID XEO02528 MOACRIVE Inhibition DME1690 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1690 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02529 XEO_CLAS Peptide DME1690 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 128 ug/ml) DME1690 XEOTICID XEO02529 GENEFORM Protein DME1690 XEOTICID XEO02529 MOACRIVE Inhibition DME1690 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1690 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02530 XEO_CLAS Peptide DME1690 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02530 GENEFORM Protein DME1690 XEOTICID XEO02530 MOACRIVE Inhibition DME1690 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1690 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02531 XEO_CLAS Peptide DME1690 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 microM) DME1690 XEOTICID XEO02531 GENEFORM Protein DME1690 XEOTICID XEO02531 MOACRIVE Inhibition DME1690 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1690 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02533 XEO_CLAS Peptide DME1690 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.2 ug/ml) DME1690 XEOTICID XEO02533 GENEFORM Protein DME1690 XEOTICID XEO02533 MOACRIVE Inhibition DME1690 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1690 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02534 XEO_CLAS Peptide DME1690 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.6 ug/ml) DME1690 XEOTICID XEO02534 GENEFORM Protein DME1690 XEOTICID XEO02534 MOACRIVE Inhibition DME1690 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1690 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02535 XEO_CLAS Peptide DME1690 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.3 ug/ml) DME1690 XEOTICID XEO02535 GENEFORM Protein DME1690 XEOTICID XEO02535 MOACRIVE Inhibition DME1690 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1690 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02536 XEO_CLAS Peptide DME1690 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.4 ug/ml) DME1690 XEOTICID XEO02536 GENEFORM Protein DME1690 XEOTICID XEO02536 MOACRIVE Inhibition DME1690 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1690 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02537 XEO_CLAS Peptide DME1690 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.2 ug/ml) DME1690 XEOTICID XEO02537 GENEFORM Protein DME1690 XEOTICID XEO02537 MOACRIVE Inhibition DME1690 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1690 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02538 XEO_CLAS Peptide DME1690 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 9.1 ug/ml) DME1690 XEOTICID XEO02538 GENEFORM Protein DME1690 XEOTICID XEO02538 MOACRIVE Inhibition DME1690 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1690 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02539 XEO_CLAS Peptide DME1690 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8.6 ug/ml) DME1690 XEOTICID XEO02539 GENEFORM Protein DME1690 XEOTICID XEO02539 MOACRIVE Inhibition DME1690 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1690 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02540 XEO_CLAS Peptide DME1690 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15.2 ug/ml) DME1690 XEOTICID XEO02540 GENEFORM Protein DME1690 XEOTICID XEO02540 MOACRIVE Inhibition DME1690 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1690 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02541 XEO_CLAS Peptide DME1690 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 11.1 ug/ml) DME1690 XEOTICID XEO02541 GENEFORM Protein DME1690 XEOTICID XEO02541 MOACRIVE Inhibition DME1690 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1690 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02542 XEO_CLAS Peptide DME1690 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.7 ug/ml) DME1690 XEOTICID XEO02542 GENEFORM Protein DME1690 XEOTICID XEO02542 MOACRIVE Inhibition DME1690 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1690 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02543 XEO_CLAS Peptide DME1690 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 13.1 ug/ml) DME1690 XEOTICID XEO02543 GENEFORM Protein DME1690 XEOTICID XEO02543 MOACRIVE Inhibition DME1690 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1690 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02544 XEO_CLAS Peptide DME1690 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 9.8 ug/ml) DME1690 XEOTICID XEO02544 GENEFORM Protein DME1690 XEOTICID XEO02544 MOACRIVE Inhibition DME1690 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1690 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02545 XEO_CLAS Peptide DME1690 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 14 microM) DME1690 XEOTICID XEO02545 GENEFORM Protein DME1690 XEOTICID XEO02545 MOACRIVE Inhibition DME1690 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1690 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02546 XEO_CLAS Peptide DME1690 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 14 microM) DME1690 XEOTICID XEO02546 GENEFORM Protein DME1690 XEOTICID XEO02546 MOACRIVE Inhibition DME1690 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1690 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02547 XEO_CLAS Peptide DME1690 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 microM) DME1690 XEOTICID XEO02547 GENEFORM Protein DME1690 XEOTICID XEO02547 MOACRIVE Inhibition DME1690 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1690 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02548 XEO_CLAS Peptide DME1690 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 78 microM) DME1690 XEOTICID XEO02548 GENEFORM Protein DME1690 XEOTICID XEO02548 MOACRIVE Inhibition DME1690 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1690 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02549 XEO_CLAS Peptide DME1690 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02549 GENEFORM Protein DME1690 XEOTICID XEO02549 MOACRIVE Inhibition DME1690 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1690 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02552 XEO_CLAS Peptide DME1690 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 24 microM) DME1690 XEOTICID XEO02552 GENEFORM Protein DME1690 XEOTICID XEO02552 MOACRIVE Inhibition DME1690 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1690 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02553 XEO_CLAS Peptide DME1690 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02553 GENEFORM Protein DME1690 XEOTICID XEO02553 MOACRIVE Inhibition DME1690 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1690 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02556 XEO_CLAS Peptide DME1690 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 55 microM) DME1690 XEOTICID XEO02556 GENEFORM Protein DME1690 XEOTICID XEO02556 MOACRIVE Inhibition DME1690 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1690 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02557 XEO_CLAS Peptide DME1690 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 17 microM) DME1690 XEOTICID XEO02557 GENEFORM Protein DME1690 XEOTICID XEO02557 MOACRIVE Inhibition DME1690 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1690 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02558 XEO_CLAS Peptide DME1690 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 14 microM) DME1690 XEOTICID XEO02558 GENEFORM Protein DME1690 XEOTICID XEO02558 MOACRIVE Inhibition DME1690 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1690 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02559 XEO_CLAS Peptide DME1690 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02559 GENEFORM Protein DME1690 XEOTICID XEO02559 MOACRIVE Inhibition DME1690 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1690 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02560 XEO_CLAS Peptide DME1690 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 13 microM) DME1690 XEOTICID XEO02560 GENEFORM Protein DME1690 XEOTICID XEO02560 MOACRIVE Inhibition DME1690 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1690 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02561 XEO_CLAS Peptide DME1690 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO02561 GENEFORM Protein DME1690 XEOTICID XEO02561 MOACRIVE Inhibition DME1690 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1690 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02562 XEO_CLAS Peptide DME1690 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 13 microM) DME1690 XEOTICID XEO02562 GENEFORM Protein DME1690 XEOTICID XEO02562 MOACRIVE Inhibition DME1690 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1690 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02563 XEO_CLAS Peptide DME1690 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 45 microM) DME1690 XEOTICID XEO02563 GENEFORM Protein DME1690 XEOTICID XEO02563 MOACRIVE Inhibition DME1690 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1690 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02564 XEO_CLAS Peptide DME1690 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 ug/ml) DME1690 XEOTICID XEO02564 GENEFORM Protein DME1690 XEOTICID XEO02564 MOACRIVE Inhibition DME1690 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1690 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02565 XEO_CLAS Peptide DME1690 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 microM) DME1690 XEOTICID XEO02565 GENEFORM Protein DME1690 XEOTICID XEO02565 MOACRIVE Inhibition DME1690 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1690 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02566 XEO_CLAS Peptide DME1690 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO02566 GENEFORM Protein DME1690 XEOTICID XEO02566 MOACRIVE Inhibition DME1690 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1690 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02568 XEO_CLAS Peptide DME1690 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO02568 GENEFORM Protein DME1690 XEOTICID XEO02568 MOACRIVE Inhibition DME1690 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1690 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02569 XEO_CLAS Peptide DME1690 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO02569 GENEFORM Protein DME1690 XEOTICID XEO02569 MOACRIVE Inhibition DME1690 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1690 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02570 XEO_CLAS Peptide DME1690 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO02570 GENEFORM Protein DME1690 XEOTICID XEO02570 MOACRIVE Inhibition DME1690 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1690 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02571 XEO_CLAS Peptide DME1690 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO02571 GENEFORM Protein DME1690 XEOTICID XEO02571 MOACRIVE Inhibition DME1690 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1690 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02572 XEO_CLAS Peptide DME1690 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02572 GENEFORM Protein DME1690 XEOTICID XEO02572 MOACRIVE Inhibition DME1690 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1690 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02573 XEO_CLAS Peptide DME1690 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02573 GENEFORM Protein DME1690 XEOTICID XEO02573 MOACRIVE Inhibition DME1690 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1690 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02574 XEO_CLAS Peptide DME1690 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 microM) DME1690 XEOTICID XEO02574 GENEFORM Protein DME1690 XEOTICID XEO02574 MOACRIVE Inhibition DME1690 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1690 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02575 XEO_CLAS Peptide DME1690 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 microM) DME1690 XEOTICID XEO02575 GENEFORM Protein DME1690 XEOTICID XEO02575 MOACRIVE Inhibition DME1690 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1690 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02576 XEO_CLAS Peptide DME1690 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 33 microM) DME1690 XEOTICID XEO02576 GENEFORM Protein DME1690 XEOTICID XEO02576 MOACRIVE Inhibition DME1690 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1690 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02577 XEO_CLAS Peptide DME1690 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO02577 GENEFORM Protein DME1690 XEOTICID XEO02577 MOACRIVE Inhibition DME1690 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1690 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02578 XEO_CLAS Peptide DME1690 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02578 GENEFORM Protein DME1690 XEOTICID XEO02578 MOACRIVE Inhibition DME1690 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1690 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02579 XEO_CLAS Peptide DME1690 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02579 GENEFORM Protein DME1690 XEOTICID XEO02579 MOACRIVE Inhibition DME1690 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1690 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02580 XEO_CLAS Peptide DME1690 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC < 15 microM) DME1690 XEOTICID XEO02580 GENEFORM Protein DME1690 XEOTICID XEO02580 MOACRIVE Inhibition DME1690 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1690 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02581 XEO_CLAS Peptide DME1690 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 microM) DME1690 XEOTICID XEO02581 GENEFORM Protein DME1690 XEOTICID XEO02581 MOACRIVE Inhibition DME1690 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1690 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02582 XEO_CLAS Peptide DME1690 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 microM) DME1690 XEOTICID XEO02582 GENEFORM Protein DME1690 XEOTICID XEO02582 MOACRIVE Inhibition DME1690 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1690 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02583 XEO_CLAS Peptide DME1690 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 microM) DME1690 XEOTICID XEO02583 GENEFORM Protein DME1690 XEOTICID XEO02583 MOACRIVE Inhibition DME1690 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1690 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02584 XEO_CLAS Peptide DME1690 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 microM) DME1690 XEOTICID XEO02584 GENEFORM Protein DME1690 XEOTICID XEO02584 MOACRIVE Inhibition DME1690 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1690 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02585 XEO_CLAS Peptide DME1690 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO02585 GENEFORM Protein DME1690 XEOTICID XEO02585 MOACRIVE Inhibition DME1690 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1690 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02586 XEO_CLAS Peptide DME1690 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO02586 GENEFORM Protein DME1690 XEOTICID XEO02586 MOACRIVE Inhibition DME1690 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1690 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02587 XEO_CLAS Peptide DME1690 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02587 GENEFORM Protein DME1690 XEOTICID XEO02587 MOACRIVE Inhibition DME1690 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1690 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02589 XEO_CLAS Peptide DME1690 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8.2 ug/ml) DME1690 XEOTICID XEO02589 GENEFORM Protein DME1690 XEOTICID XEO02589 MOACRIVE Inhibition DME1690 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1690 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02590 XEO_CLAS Peptide DME1690 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 19.6 ug/ml) DME1690 XEOTICID XEO02590 GENEFORM Protein DME1690 XEOTICID XEO02590 MOACRIVE Inhibition DME1690 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1690 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02591 XEO_CLAS Peptide DME1690 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO02591 GENEFORM Protein DME1690 XEOTICID XEO02591 MOACRIVE Inhibition DME1690 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1690 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02593 XEO_CLAS Peptide DME1690 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 36 microM) DME1690 XEOTICID XEO02593 GENEFORM Protein DME1690 XEOTICID XEO02593 MOACRIVE Inhibition DME1690 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1690 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02594 XEO_CLAS Peptide DME1690 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02594 GENEFORM Protein DME1690 XEOTICID XEO02594 MOACRIVE Inhibition DME1690 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1690 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02595 XEO_CLAS Peptide DME1690 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO02595 GENEFORM Protein DME1690 XEOTICID XEO02595 MOACRIVE Inhibition DME1690 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1690 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02596 XEO_CLAS Peptide DME1690 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO02596 GENEFORM Protein DME1690 XEOTICID XEO02596 MOACRIVE Inhibition DME1690 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1690 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02597 XEO_CLAS Peptide DME1690 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO02597 GENEFORM Protein DME1690 XEOTICID XEO02597 MOACRIVE Inhibition DME1690 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1690 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02598 XEO_CLAS Peptide DME1690 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 32.5 microM) DME1690 XEOTICID XEO02598 GENEFORM Protein DME1690 XEOTICID XEO02598 MOACRIVE Inhibition DME1690 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1690 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02599 XEO_CLAS Peptide DME1690 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 microM) DME1690 XEOTICID XEO02599 GENEFORM Protein DME1690 XEOTICID XEO02599 MOACRIVE Inhibition DME1690 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1690 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02601 XEO_CLAS Peptide DME1690 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.1 ug/ml) DME1690 XEOTICID XEO02601 GENEFORM Protein DME1690 XEOTICID XEO02601 MOACRIVE Inhibition DME1690 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1690 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02602 XEO_CLAS Peptide DME1690 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 13.2 ug/ml) DME1690 XEOTICID XEO02602 GENEFORM Protein DME1690 XEOTICID XEO02602 MOACRIVE Inhibition DME1690 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1690 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02603 XEO_CLAS Peptide DME1690 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.3 ug/ml) DME1690 XEOTICID XEO02603 GENEFORM Protein DME1690 XEOTICID XEO02603 MOACRIVE Inhibition DME1690 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1690 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02604 XEO_CLAS Peptide DME1690 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO02604 GENEFORM Protein DME1690 XEOTICID XEO02604 MOACRIVE Inhibition DME1690 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1690 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02605 XEO_CLAS Peptide DME1690 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30.6 ug/ml) DME1690 XEOTICID XEO02605 GENEFORM Protein DME1690 XEOTICID XEO02605 MOACRIVE Inhibition DME1690 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1690 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02606 XEO_CLAS Peptide DME1690 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 11.2 ug/ml) DME1690 XEOTICID XEO02606 GENEFORM Protein DME1690 XEOTICID XEO02606 MOACRIVE Inhibition DME1690 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1690 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02607 XEO_CLAS Peptide DME1690 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.8 ug/ml) DME1690 XEOTICID XEO02607 GENEFORM Protein DME1690 XEOTICID XEO02607 MOACRIVE Inhibition DME1690 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1690 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02608 XEO_CLAS Peptide DME1690 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 7.9 ug/ml) DME1690 XEOTICID XEO02608 GENEFORM Protein DME1690 XEOTICID XEO02608 MOACRIVE Inhibition DME1690 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1690 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02609 XEO_CLAS Peptide DME1690 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15.8 ug/ml) DME1690 XEOTICID XEO02609 GENEFORM Protein DME1690 XEOTICID XEO02609 MOACRIVE Inhibition DME1690 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1690 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02610 XEO_CLAS Peptide DME1690 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.1 ug/ml) DME1690 XEOTICID XEO02610 GENEFORM Protein DME1690 XEOTICID XEO02610 MOACRIVE Inhibition DME1690 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1690 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02611 XEO_CLAS Peptide DME1690 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20.6 ug/ml) DME1690 XEOTICID XEO02611 GENEFORM Protein DME1690 XEOTICID XEO02611 MOACRIVE Inhibition DME1690 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1690 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02612 XEO_CLAS Peptide DME1690 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 11.8 ug/ml) DME1690 XEOTICID XEO02612 GENEFORM Protein DME1690 XEOTICID XEO02612 MOACRIVE Inhibition DME1690 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1690 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02613 XEO_CLAS Peptide DME1690 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 13.2 ug/ml) DME1690 XEOTICID XEO02613 GENEFORM Protein DME1690 XEOTICID XEO02613 MOACRIVE Inhibition DME1690 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1690 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02614 XEO_CLAS Peptide DME1690 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.8 ug/ml) DME1690 XEOTICID XEO02614 GENEFORM Protein DME1690 XEOTICID XEO02614 MOACRIVE Inhibition DME1690 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1690 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02615 XEO_CLAS Peptide DME1690 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8.6 ug/ml) DME1690 XEOTICID XEO02615 GENEFORM Protein DME1690 XEOTICID XEO02615 MOACRIVE Inhibition DME1690 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1690 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02616 XEO_CLAS Peptide DME1690 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20.4 ug/ml) DME1690 XEOTICID XEO02616 GENEFORM Protein DME1690 XEOTICID XEO02616 MOACRIVE Inhibition DME1690 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1690 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02617 XEO_CLAS Peptide DME1690 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4.7 ug/ml) DME1690 XEOTICID XEO02617 GENEFORM Protein DME1690 XEOTICID XEO02617 MOACRIVE Inhibition DME1690 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1690 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02618 XEO_CLAS Peptide DME1690 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.6 ug/ml) DME1690 XEOTICID XEO02618 GENEFORM Protein DME1690 XEOTICID XEO02618 MOACRIVE Inhibition DME1690 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1690 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02619 XEO_CLAS Peptide DME1690 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10.5 ug/ml) DME1690 XEOTICID XEO02619 GENEFORM Protein DME1690 XEOTICID XEO02619 MOACRIVE Inhibition DME1690 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1690 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02620 XEO_CLAS Peptide DME1690 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO02620 GENEFORM Protein DME1690 XEOTICID XEO02620 MOACRIVE Inhibition DME1690 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1690 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02621 XEO_CLAS Peptide DME1690 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO02621 GENEFORM Protein DME1690 XEOTICID XEO02621 MOACRIVE Inhibition DME1690 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1690 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02622 XEO_CLAS Peptide DME1690 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO02622 GENEFORM Protein DME1690 XEOTICID XEO02622 MOACRIVE Inhibition DME1690 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1690 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02623 XEO_CLAS Peptide DME1690 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO02623 GENEFORM Protein DME1690 XEOTICID XEO02623 MOACRIVE Inhibition DME1690 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1690 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02624 XEO_CLAS Peptide DME1690 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 18 microM) DME1690 XEOTICID XEO02624 GENEFORM Protein DME1690 XEOTICID XEO02624 MOACRIVE Inhibition DME1690 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1690 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02625 XEO_CLAS Peptide DME1690 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 9 microM) DME1690 XEOTICID XEO02625 GENEFORM Protein DME1690 XEOTICID XEO02625 MOACRIVE Inhibition DME1690 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1690 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02626 XEO_CLAS Peptide DME1690 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 18 microM) DME1690 XEOTICID XEO02626 GENEFORM Protein DME1690 XEOTICID XEO02626 MOACRIVE Inhibition DME1690 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1690 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02627 XEO_CLAS Peptide DME1690 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02627 GENEFORM Protein DME1690 XEOTICID XEO02627 MOACRIVE Inhibition DME1690 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1690 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02628 XEO_CLAS Peptide DME1690 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 18 microM) DME1690 XEOTICID XEO02628 GENEFORM Protein DME1690 XEOTICID XEO02628 MOACRIVE Inhibition DME1690 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1690 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02629 XEO_CLAS Peptide DME1690 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 13 microM) DME1690 XEOTICID XEO02629 GENEFORM Protein DME1690 XEOTICID XEO02629 MOACRIVE Inhibition DME1690 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1690 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02630 XEO_CLAS Peptide DME1690 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 ug/ml) DME1690 XEOTICID XEO02630 GENEFORM Protein DME1690 XEOTICID XEO02630 MOACRIVE Inhibition DME1690 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1690 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02631 XEO_CLAS Peptide DME1690 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 ug/ml) DME1690 XEOTICID XEO02631 GENEFORM Protein DME1690 XEOTICID XEO02631 MOACRIVE Inhibition DME1690 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1690 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02634 XEO_CLAS Peptide DME1690 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO02634 GENEFORM Protein DME1690 XEOTICID XEO02634 MOACRIVE Inhibition DME1690 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1690 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02635 XEO_CLAS Peptide DME1690 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40 ug/ml) DME1690 XEOTICID XEO02635 GENEFORM Protein DME1690 XEOTICID XEO02635 MOACRIVE Inhibition DME1690 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1690 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02636 XEO_CLAS Peptide DME1690 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO02636 GENEFORM Protein DME1690 XEOTICID XEO02636 MOACRIVE Inhibition DME1690 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1690 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02637 XEO_CLAS Peptide DME1690 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO02637 GENEFORM Protein DME1690 XEOTICID XEO02637 MOACRIVE Inhibition DME1690 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1690 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02638 XEO_CLAS Peptide DME1690 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 microM) DME1690 XEOTICID XEO02638 GENEFORM Protein DME1690 XEOTICID XEO02638 MOACRIVE Inhibition DME1690 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1690 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02639 XEO_CLAS Peptide DME1690 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 microM) DME1690 XEOTICID XEO02639 GENEFORM Protein DME1690 XEOTICID XEO02639 MOACRIVE Inhibition DME1690 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1690 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02644 XEO_CLAS Peptide DME1690 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02644 GENEFORM Protein DME1690 XEOTICID XEO02644 MOACRIVE Inhibition DME1690 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1690 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02645 XEO_CLAS Peptide DME1690 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02645 GENEFORM Protein DME1690 XEOTICID XEO02645 MOACRIVE Inhibition DME1690 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1690 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02646 XEO_CLAS Peptide DME1690 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02646 GENEFORM Protein DME1690 XEOTICID XEO02646 MOACRIVE Inhibition DME1690 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1690 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02647 XEO_CLAS Peptide DME1690 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02647 GENEFORM Protein DME1690 XEOTICID XEO02647 MOACRIVE Inhibition DME1690 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1690 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02649 XEO_CLAS Peptide DME1690 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO02649 GENEFORM Protein DME1690 XEOTICID XEO02649 MOACRIVE Inhibition DME1690 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1690 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02650 XEO_CLAS Peptide DME1690 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO02650 GENEFORM Protein DME1690 XEOTICID XEO02650 MOACRIVE Inhibition DME1690 XEOTICID XEO02658 XEO_NAME Buthinin DME1690 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02658 XEO_CLAS Peptide DME1690 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02658 GENEFORM Protein DME1690 XEOTICID XEO02658 MOACRIVE Inhibition DME1690 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1690 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02663 XEO_CLAS Peptide DME1690 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25 microM) DME1690 XEOTICID XEO02663 GENEFORM Protein DME1690 XEOTICID XEO02663 MOACRIVE Inhibition DME1690 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1690 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02664 XEO_CLAS Peptide DME1690 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25 microM) DME1690 XEOTICID XEO02664 GENEFORM Protein DME1690 XEOTICID XEO02664 MOACRIVE Inhibition DME1690 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1690 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02672 XEO_CLAS Peptide DME1690 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25 microM) DME1690 XEOTICID XEO02672 GENEFORM Protein DME1690 XEOTICID XEO02672 MOACRIVE Inhibition DME1690 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1690 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02673 XEO_CLAS Peptide DME1690 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1690 XEOTICID XEO02673 GENEFORM Protein DME1690 XEOTICID XEO02673 MOACRIVE Inhibition DME1690 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1690 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02674 XEO_CLAS Peptide DME1690 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.125-6.25 microM) DME1690 XEOTICID XEO02674 GENEFORM Protein DME1690 XEOTICID XEO02674 MOACRIVE Inhibition DME1690 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1690 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02676 XEO_CLAS Peptide DME1690 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO02676 GENEFORM Protein DME1690 XEOTICID XEO02676 MOACRIVE Inhibition DME1690 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1690 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02677 XEO_CLAS Peptide DME1690 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1690 XEOTICID XEO02677 GENEFORM Protein DME1690 XEOTICID XEO02677 MOACRIVE Inhibition DME1690 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1690 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02679 XEO_CLAS Peptide DME1690 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1690 XEOTICID XEO02679 GENEFORM Protein DME1690 XEOTICID XEO02679 MOACRIVE Inhibition DME1690 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1690 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02680 XEO_CLAS Peptide DME1690 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25 microM) DME1690 XEOTICID XEO02680 GENEFORM Protein DME1690 XEOTICID XEO02680 MOACRIVE Inhibition DME1690 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1690 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02683 XEO_CLAS Peptide DME1690 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO02683 GENEFORM Protein DME1690 XEOTICID XEO02683 MOACRIVE Inhibition DME1690 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1690 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02688 XEO_CLAS Peptide DME1690 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO02688 GENEFORM Protein DME1690 XEOTICID XEO02688 MOACRIVE Inhibition DME1690 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1690 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02693 XEO_CLAS Peptide DME1690 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 ug/ml) DME1690 XEOTICID XEO02693 GENEFORM Protein DME1690 XEOTICID XEO02693 MOACRIVE Inhibition DME1690 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1690 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02699 XEO_CLAS Peptide DME1690 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 ug/ml) DME1690 XEOTICID XEO02699 GENEFORM Protein DME1690 XEOTICID XEO02699 MOACRIVE Inhibition DME1690 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1690 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02700 XEO_CLAS Peptide DME1690 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 ug/ml) DME1690 XEOTICID XEO02700 GENEFORM Protein DME1690 XEOTICID XEO02700 MOACRIVE Inhibition DME1690 XEOTICID XEO02703 XEO_NAME Calcitermin DME1690 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02703 XEO_CLAS Peptide DME1690 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02703 GENEFORM Protein DME1690 XEOTICID XEO02703 MOACRIVE Inhibition DME1690 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1690 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02708 XEO_CLAS Peptide DME1690 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO02708 GENEFORM Protein DME1690 XEOTICID XEO02708 MOACRIVE Inhibition DME1690 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1690 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02709 XEO_CLAS Peptide DME1690 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.05 microM) DME1690 XEOTICID XEO02709 GENEFORM Protein DME1690 XEOTICID XEO02709 MOACRIVE Inhibition DME1690 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1690 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1690 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02713 GENEFORM Protein DME1690 XEOTICID XEO02713 MOACRIVE Inhibition DME1690 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1690 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1690 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02714 GENEFORM Protein DME1690 XEOTICID XEO02714 MOACRIVE Inhibition DME1690 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1690 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02726 XEO_CLAS Peptide DME1690 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02726 GENEFORM Protein DME1690 XEOTICID XEO02726 MOACRIVE Inhibition DME1690 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1690 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02731 XEO_CLAS Peptide DME1690 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1 microM) DME1690 XEOTICID XEO02731 GENEFORM Protein DME1690 XEOTICID XEO02731 MOACRIVE Inhibition DME1690 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1690 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02732 XEO_CLAS Peptide DME1690 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.25 microM) DME1690 XEOTICID XEO02732 GENEFORM Protein DME1690 XEOTICID XEO02732 MOACRIVE Inhibition DME1690 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1690 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02733 XEO_CLAS Peptide DME1690 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8-25 ug/ml) DME1690 XEOTICID XEO02733 GENEFORM Protein DME1690 XEOTICID XEO02733 MOACRIVE Inhibition DME1690 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1690 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02735 XEO_CLAS Peptide DME1690 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1 ug/ml) DME1690 XEOTICID XEO02735 GENEFORM Protein DME1690 XEOTICID XEO02735 MOACRIVE Inhibition DME1690 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1690 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02737 XEO_CLAS Peptide DME1690 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02737 GENEFORM Protein DME1690 XEOTICID XEO02737 MOACRIVE Inhibition DME1690 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1690 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02738 XEO_CLAS Peptide DME1690 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO02738 GENEFORM Protein DME1690 XEOTICID XEO02738 MOACRIVE Inhibition DME1690 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1690 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02739 XEO_CLAS Peptide DME1690 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 microM) DME1690 XEOTICID XEO02739 GENEFORM Protein DME1690 XEOTICID XEO02739 MOACRIVE Inhibition DME1690 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1690 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02740 XEO_CLAS Peptide DME1690 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.25 ug/ml) DME1690 XEOTICID XEO02740 GENEFORM Protein DME1690 XEOTICID XEO02740 MOACRIVE Inhibition DME1690 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1690 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02741 XEO_CLAS Peptide DME1690 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 ug/ml) DME1690 XEOTICID XEO02741 GENEFORM Protein DME1690 XEOTICID XEO02741 MOACRIVE Inhibition DME1690 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1690 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02743 XEO_CLAS Peptide DME1690 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.6 ug/ml) DME1690 XEOTICID XEO02743 GENEFORM Protein DME1690 XEOTICID XEO02743 MOACRIVE Inhibition DME1690 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1690 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02744 XEO_CLAS Peptide DME1690 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 18.7 ug/ml) DME1690 XEOTICID XEO02744 GENEFORM Protein DME1690 XEOTICID XEO02744 MOACRIVE Inhibition DME1690 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1690 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02745 XEO_CLAS Peptide DME1690 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02745 GENEFORM Protein DME1690 XEOTICID XEO02745 MOACRIVE Inhibition DME1690 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1690 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02746 XEO_CLAS Peptide DME1690 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02746 GENEFORM Protein DME1690 XEOTICID XEO02746 MOACRIVE Inhibition DME1690 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1690 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02748 XEO_CLAS Peptide DME1690 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02748 GENEFORM Protein DME1690 XEOTICID XEO02748 MOACRIVE Inhibition DME1690 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1690 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02749 XEO_CLAS Peptide DME1690 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20-25 mug/ml) DME1690 XEOTICID XEO02749 GENEFORM Protein DME1690 XEOTICID XEO02749 MOACRIVE Inhibition DME1690 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1690 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02750 XEO_CLAS Peptide DME1690 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02750 GENEFORM Protein DME1690 XEOTICID XEO02750 MOACRIVE Inhibition DME1690 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1690 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02752 XEO_CLAS Peptide DME1690 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02752 GENEFORM Protein DME1690 XEOTICID XEO02752 MOACRIVE Inhibition DME1690 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1690 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02753 XEO_CLAS Peptide DME1690 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02753 GENEFORM Protein DME1690 XEOTICID XEO02753 MOACRIVE Inhibition DME1690 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1690 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02754 XEO_CLAS Peptide DME1690 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 microM) DME1690 XEOTICID XEO02754 GENEFORM Protein DME1690 XEOTICID XEO02754 MOACRIVE Inhibition DME1690 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1690 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02756 XEO_CLAS Peptide DME1690 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 microM) DME1690 XEOTICID XEO02756 GENEFORM Protein DME1690 XEOTICID XEO02756 MOACRIVE Inhibition DME1690 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1690 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02757 XEO_CLAS Peptide DME1690 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1 microM) DME1690 XEOTICID XEO02757 GENEFORM Protein DME1690 XEOTICID XEO02757 MOACRIVE Inhibition DME1690 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1690 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02758 XEO_CLAS Peptide DME1690 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO02758 GENEFORM Protein DME1690 XEOTICID XEO02758 MOACRIVE Inhibition DME1690 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1690 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02759 XEO_CLAS Peptide DME1690 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.6 microM) DME1690 XEOTICID XEO02759 GENEFORM Protein DME1690 XEOTICID XEO02759 MOACRIVE Inhibition DME1690 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1690 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02760 XEO_CLAS Peptide DME1690 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 microM) DME1690 XEOTICID XEO02760 GENEFORM Protein DME1690 XEOTICID XEO02760 MOACRIVE Inhibition DME1690 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1690 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02761 XEO_CLAS Peptide DME1690 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO02761 GENEFORM Protein DME1690 XEOTICID XEO02761 MOACRIVE Inhibition DME1690 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1690 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02762 XEO_CLAS Peptide DME1690 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 microM) DME1690 XEOTICID XEO02762 GENEFORM Protein DME1690 XEOTICID XEO02762 MOACRIVE Inhibition DME1690 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1690 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02763 XEO_CLAS Peptide DME1690 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.4 microM) DME1690 XEOTICID XEO02763 GENEFORM Protein DME1690 XEOTICID XEO02763 MOACRIVE Inhibition DME1690 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1690 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02764 XEO_CLAS Peptide DME1690 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 microM) DME1690 XEOTICID XEO02764 GENEFORM Protein DME1690 XEOTICID XEO02764 MOACRIVE Inhibition DME1690 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1690 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02765 XEO_CLAS Peptide DME1690 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.3 microM) DME1690 XEOTICID XEO02765 GENEFORM Protein DME1690 XEOTICID XEO02765 MOACRIVE Inhibition DME1690 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1690 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02767 XEO_CLAS Peptide DME1690 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02767 GENEFORM Protein DME1690 XEOTICID XEO02767 MOACRIVE Inhibition DME1690 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1690 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02768 XEO_CLAS Peptide DME1690 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1690 XEOTICID XEO02768 GENEFORM Protein DME1690 XEOTICID XEO02768 MOACRIVE Inhibition DME1690 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1690 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02769 XEO_CLAS Peptide DME1690 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.32 microM) DME1690 XEOTICID XEO02769 GENEFORM Protein DME1690 XEOTICID XEO02769 MOACRIVE Inhibition DME1690 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1690 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02770 XEO_CLAS Peptide DME1690 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.30 microM) DME1690 XEOTICID XEO02770 GENEFORM Protein DME1690 XEOTICID XEO02770 MOACRIVE Inhibition DME1690 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1690 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02771 XEO_CLAS Peptide DME1690 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.21 microM) DME1690 XEOTICID XEO02771 GENEFORM Protein DME1690 XEOTICID XEO02771 MOACRIVE Inhibition DME1690 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1690 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02772 XEO_CLAS Peptide DME1690 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02772 GENEFORM Protein DME1690 XEOTICID XEO02772 MOACRIVE Inhibition DME1690 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1690 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02773 XEO_CLAS Peptide DME1690 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.9-8.6 microM) DME1690 XEOTICID XEO02773 GENEFORM Protein DME1690 XEOTICID XEO02773 MOACRIVE Inhibition DME1690 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1690 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02774 XEO_CLAS Peptide DME1690 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.3 microM) DME1690 XEOTICID XEO02774 GENEFORM Protein DME1690 XEOTICID XEO02774 MOACRIVE Inhibition DME1690 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1690 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02789 GENEFORM Protein DME1690 XEOTICID XEO02789 MOACRIVE Inhibition DME1690 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1690 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02790 GENEFORM Protein DME1690 XEOTICID XEO02790 MOACRIVE Inhibition DME1690 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1690 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02791 GENEFORM Protein DME1690 XEOTICID XEO02791 MOACRIVE Inhibition DME1690 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1690 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02792 GENEFORM Protein DME1690 XEOTICID XEO02792 MOACRIVE Inhibition DME1690 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1690 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02793 GENEFORM Protein DME1690 XEOTICID XEO02793 MOACRIVE Inhibition DME1690 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1690 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02794 GENEFORM Protein DME1690 XEOTICID XEO02794 MOACRIVE Inhibition DME1690 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1690 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02795 GENEFORM Protein DME1690 XEOTICID XEO02795 MOACRIVE Inhibition DME1690 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1690 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02796 GENEFORM Protein DME1690 XEOTICID XEO02796 MOACRIVE Inhibition DME1690 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1690 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02797 GENEFORM Protein DME1690 XEOTICID XEO02797 MOACRIVE Inhibition DME1690 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1690 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02799 XEO_CLAS Peptide DME1690 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02799 GENEFORM Protein DME1690 XEOTICID XEO02799 MOACRIVE Inhibition DME1690 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1690 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02800 XEO_CLAS Peptide DME1690 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02800 GENEFORM Protein DME1690 XEOTICID XEO02800 MOACRIVE Inhibition DME1690 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1690 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02802 XEO_CLAS Peptide DME1690 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 13.6 microM) DME1690 XEOTICID XEO02802 GENEFORM Protein DME1690 XEOTICID XEO02802 MOACRIVE Inhibition DME1690 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1690 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02807 XEO_CLAS Peptide DME1690 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.2 microM) DME1690 XEOTICID XEO02807 GENEFORM Protein DME1690 XEOTICID XEO02807 MOACRIVE Inhibition DME1690 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1690 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02813 XEO_CLAS Peptide DME1690 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 80 microM) DME1690 XEOTICID XEO02813 GENEFORM Protein DME1690 XEOTICID XEO02813 MOACRIVE Inhibition DME1690 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1690 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02814 XEO_CLAS Peptide DME1690 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 80 microM) DME1690 XEOTICID XEO02814 GENEFORM Protein DME1690 XEOTICID XEO02814 MOACRIVE Inhibition DME1690 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1690 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02815 XEO_CLAS Peptide DME1690 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8.5 microM) DME1690 XEOTICID XEO02815 GENEFORM Protein DME1690 XEOTICID XEO02815 MOACRIVE Inhibition DME1690 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1690 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02816 XEO_CLAS Peptide DME1690 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 80 microM) DME1690 XEOTICID XEO02816 GENEFORM Protein DME1690 XEOTICID XEO02816 MOACRIVE Inhibition DME1690 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1690 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02817 XEO_CLAS Peptide DME1690 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 80 microM) DME1690 XEOTICID XEO02817 GENEFORM Protein DME1690 XEOTICID XEO02817 MOACRIVE Inhibition DME1690 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1690 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02818 XEO_CLAS Peptide DME1690 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.4 microM) DME1690 XEOTICID XEO02818 GENEFORM Protein DME1690 XEOTICID XEO02818 MOACRIVE Inhibition DME1690 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1690 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02819 XEO_CLAS Peptide DME1690 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.6 microM) DME1690 XEOTICID XEO02819 GENEFORM Protein DME1690 XEOTICID XEO02819 MOACRIVE Inhibition DME1690 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1690 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02820 XEO_CLAS Peptide DME1690 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO02820 GENEFORM Protein DME1690 XEOTICID XEO02820 MOACRIVE Inhibition DME1690 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1690 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02821 XEO_CLAS Peptide DME1690 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02821 GENEFORM Protein DME1690 XEOTICID XEO02821 MOACRIVE Inhibition DME1690 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1690 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02824 XEO_CLAS Peptide DME1690 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 35 microM) DME1690 XEOTICID XEO02824 GENEFORM Protein DME1690 XEOTICID XEO02824 MOACRIVE Inhibition DME1690 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1690 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02826 XEO_CLAS Peptide DME1690 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.7 ug/ml) DME1690 XEOTICID XEO02826 GENEFORM Protein DME1690 XEOTICID XEO02826 MOACRIVE Inhibition DME1690 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1690 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02834 GENEFORM Protein DME1690 XEOTICID XEO02834 MOACRIVE Inhibition DME1690 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1690 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02839 XEO_CLAS Peptide DME1690 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.25 microM) DME1690 XEOTICID XEO02839 GENEFORM Protein DME1690 XEOTICID XEO02839 MOACRIVE Inhibition DME1690 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1690 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02841 XEO_CLAS Peptide DME1690 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.25 microM) DME1690 XEOTICID XEO02841 GENEFORM Protein DME1690 XEOTICID XEO02841 MOACRIVE Inhibition DME1690 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1690 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02842 XEO_CLAS Peptide DME1690 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.25 microM) DME1690 XEOTICID XEO02842 GENEFORM Protein DME1690 XEOTICID XEO02842 MOACRIVE Inhibition DME1690 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1690 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02843 XEO_CLAS Peptide DME1690 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02843 GENEFORM Protein DME1690 XEOTICID XEO02843 MOACRIVE Inhibition DME1690 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1690 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02849 GENEFORM Protein DME1690 XEOTICID XEO02849 MOACRIVE Inhibition DME1690 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1690 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02857 XEO_CLAS Peptide DME1690 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 53 microM) DME1690 XEOTICID XEO02857 GENEFORM Protein DME1690 XEOTICID XEO02857 MOACRIVE Inhibition DME1690 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1690 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02858 XEO_CLAS Peptide DME1690 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 53 microM) DME1690 XEOTICID XEO02858 GENEFORM Protein DME1690 XEOTICID XEO02858 MOACRIVE Inhibition DME1690 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1690 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02860 XEO_CLAS Peptide DME1690 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 ug/ml) DME1690 XEOTICID XEO02860 GENEFORM Protein DME1690 XEOTICID XEO02860 MOACRIVE Inhibition DME1690 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1690 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02867 XEO_CLAS Peptide DME1690 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02867 GENEFORM Protein DME1690 XEOTICID XEO02867 MOACRIVE Inhibition DME1690 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1690 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02868 XEO_CLAS Peptide DME1690 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02868 GENEFORM Protein DME1690 XEOTICID XEO02868 MOACRIVE Inhibition DME1690 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1690 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02869 XEO_CLAS Peptide DME1690 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02869 GENEFORM Protein DME1690 XEOTICID XEO02869 MOACRIVE Inhibition DME1690 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1690 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02870 XEO_CLAS Peptide DME1690 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02870 GENEFORM Protein DME1690 XEOTICID XEO02870 MOACRIVE Inhibition DME1690 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1690 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02871 XEO_CLAS Peptide DME1690 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02871 GENEFORM Protein DME1690 XEOTICID XEO02871 MOACRIVE Inhibition DME1690 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1690 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02872 XEO_CLAS Peptide DME1690 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 308 microM) DME1690 XEOTICID XEO02872 GENEFORM Protein DME1690 XEOTICID XEO02872 MOACRIVE Inhibition DME1690 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1690 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02875 XEO_CLAS Peptide DME1690 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.1 microM) DME1690 XEOTICID XEO02875 GENEFORM Protein DME1690 XEOTICID XEO02875 MOACRIVE Inhibition DME1690 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1690 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02876 XEO_CLAS Peptide DME1690 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO02876 GENEFORM Protein DME1690 XEOTICID XEO02876 MOACRIVE Inhibition DME1690 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1690 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02877 XEO_CLAS Peptide DME1690 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO02877 GENEFORM Protein DME1690 XEOTICID XEO02877 MOACRIVE Inhibition DME1690 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1690 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02878 XEO_CLAS Peptide DME1690 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.3 microM) DME1690 XEOTICID XEO02878 GENEFORM Protein DME1690 XEOTICID XEO02878 MOACRIVE Inhibition DME1690 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1690 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02885 XEO_CLAS Peptide DME1690 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02885 GENEFORM Protein DME1690 XEOTICID XEO02885 MOACRIVE Inhibition DME1690 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1690 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02886 XEO_CLAS Peptide DME1690 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02886 GENEFORM Protein DME1690 XEOTICID XEO02886 MOACRIVE Inhibition DME1690 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1690 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02887 XEO_CLAS Peptide DME1690 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1 ug/ml) DME1690 XEOTICID XEO02887 GENEFORM Protein DME1690 XEOTICID XEO02887 MOACRIVE Inhibition DME1690 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1690 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02888 XEO_CLAS Peptide DME1690 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 ug/ml) DME1690 XEOTICID XEO02888 GENEFORM Protein DME1690 XEOTICID XEO02888 MOACRIVE Inhibition DME1690 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1690 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02889 XEO_CLAS Peptide DME1690 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 ug/ml) DME1690 XEOTICID XEO02889 GENEFORM Protein DME1690 XEOTICID XEO02889 MOACRIVE Inhibition DME1690 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1690 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02890 XEO_CLAS Peptide DME1690 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02890 GENEFORM Protein DME1690 XEOTICID XEO02890 MOACRIVE Inhibition DME1690 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1690 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02891 XEO_CLAS Peptide DME1690 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02891 GENEFORM Protein DME1690 XEOTICID XEO02891 MOACRIVE Inhibition DME1690 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1690 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02895 XEO_CLAS Peptide DME1690 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO02895 GENEFORM Protein DME1690 XEOTICID XEO02895 MOACRIVE Inhibition DME1690 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1690 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02896 XEO_CLAS Peptide DME1690 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO02896 GENEFORM Protein DME1690 XEOTICID XEO02896 MOACRIVE Inhibition DME1690 XEOTICID XEO02899 XEO_NAME Coladonin DME1690 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1690 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1690 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02899 GENEFORM Protein DME1690 XEOTICID XEO02899 MOACRIVE Inhibition DME1690 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1690 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02900 XEO_CLAS Peptide DME1690 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02900 GENEFORM Protein DME1690 XEOTICID XEO02900 MOACRIVE Inhibition DME1690 XEOTICID XEO02901 XEO_NAME Colicin-V DME1690 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02901 XEO_CLAS Peptide DME1690 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02901 GENEFORM Protein DME1690 XEOTICID XEO02901 MOACRIVE Inhibition DME1690 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1690 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02904 GENEFORM Protein DME1690 XEOTICID XEO02904 MOACRIVE Inhibition DME1690 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1690 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02908 XEO_CLAS Peptide DME1690 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 50 microM) DME1690 XEOTICID XEO02908 GENEFORM Protein DME1690 XEOTICID XEO02908 MOACRIVE Inhibition DME1690 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1690 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02923 XEO_CLAS Peptide DME1690 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02923 GENEFORM Protein DME1690 XEOTICID XEO02923 MOACRIVE Inhibition DME1690 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1690 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02924 XEO_CLAS Peptide DME1690 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 32 microM) DME1690 XEOTICID XEO02924 GENEFORM Protein DME1690 XEOTICID XEO02924 MOACRIVE Inhibition DME1690 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1690 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1690 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02927 GENEFORM Protein DME1690 XEOTICID XEO02927 MOACRIVE Inhibition DME1690 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1690 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02931 XEO_CLAS Peptide DME1690 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 ug/ml) DME1690 XEOTICID XEO02931 GENEFORM Protein DME1690 XEOTICID XEO02931 MOACRIVE Inhibition DME1690 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1690 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02933 XEO_CLAS Peptide DME1690 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO02933 GENEFORM Protein DME1690 XEOTICID XEO02933 MOACRIVE Inhibition DME1690 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1690 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02934 XEO_CLAS Peptide DME1690 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02934 GENEFORM Protein DME1690 XEOTICID XEO02934 MOACRIVE Inhibition DME1690 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1690 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02935 XEO_CLAS Peptide DME1690 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02935 GENEFORM Protein DME1690 XEOTICID XEO02935 MOACRIVE Inhibition DME1690 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1690 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02936 XEO_CLAS Peptide DME1690 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO02936 GENEFORM Protein DME1690 XEOTICID XEO02936 MOACRIVE Inhibition DME1690 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1690 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02937 XEO_CLAS Peptide DME1690 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02937 GENEFORM Protein DME1690 XEOTICID XEO02937 MOACRIVE Inhibition DME1690 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1690 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02938 XEO_CLAS Peptide DME1690 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 32 ug/ml) DME1690 XEOTICID XEO02938 GENEFORM Protein DME1690 XEOTICID XEO02938 MOACRIVE Inhibition DME1690 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1690 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02939 XEO_CLAS Peptide DME1690 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 11 ug/ml) DME1690 XEOTICID XEO02939 GENEFORM Protein DME1690 XEOTICID XEO02939 MOACRIVE Inhibition DME1690 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1690 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02940 XEO_CLAS Peptide DME1690 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1 ug/ml) DME1690 XEOTICID XEO02940 GENEFORM Protein DME1690 XEOTICID XEO02940 MOACRIVE Inhibition DME1690 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1690 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02941 XEO_CLAS Peptide DME1690 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02941 GENEFORM Protein DME1690 XEOTICID XEO02941 MOACRIVE Inhibition DME1690 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1690 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02944 XEO_CLAS Peptide DME1690 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 microM) DME1690 XEOTICID XEO02944 GENEFORM Protein DME1690 XEOTICID XEO02944 MOACRIVE Inhibition DME1690 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1690 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02945 XEO_CLAS Peptide DME1690 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 microM) DME1690 XEOTICID XEO02945 GENEFORM Protein DME1690 XEOTICID XEO02945 MOACRIVE Inhibition DME1690 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1690 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02946 XEO_CLAS Peptide DME1690 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 microM) DME1690 XEOTICID XEO02946 GENEFORM Protein DME1690 XEOTICID XEO02946 MOACRIVE Inhibition DME1690 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1690 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02947 XEO_CLAS Peptide DME1690 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02947 GENEFORM Protein DME1690 XEOTICID XEO02947 MOACRIVE Inhibition DME1690 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1690 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02948 XEO_CLAS Peptide DME1690 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO02948 GENEFORM Protein DME1690 XEOTICID XEO02948 MOACRIVE Inhibition DME1690 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1690 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02949 XEO_CLAS Peptide DME1690 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO02949 GENEFORM Protein DME1690 XEOTICID XEO02949 MOACRIVE Inhibition DME1690 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1690 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02954 XEO_CLAS Peptide DME1690 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02954 GENEFORM Protein DME1690 XEOTICID XEO02954 MOACRIVE Inhibition DME1690 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1690 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02958 XEO_CLAS Peptide DME1690 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02958 GENEFORM Protein DME1690 XEOTICID XEO02958 MOACRIVE Inhibition DME1690 XEOTICID XEO02962 XEO_NAME Cryptonin DME1690 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02962 XEO_CLAS Peptide DME1690 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.12 ug/ml) DME1690 XEOTICID XEO02962 GENEFORM Protein DME1690 XEOTICID XEO02962 MOACRIVE Inhibition DME1690 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1690 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02965 XEO_CLAS Peptide DME1690 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 ug/ml) DME1690 XEOTICID XEO02965 GENEFORM Protein DME1690 XEOTICID XEO02965 MOACRIVE Inhibition DME1690 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1690 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02969 XEO_CLAS Peptide DME1690 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 microM) DME1690 XEOTICID XEO02969 GENEFORM Protein DME1690 XEOTICID XEO02969 MOACRIVE Inhibition DME1690 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1690 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02971 XEO_CLAS Peptide DME1690 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 microM) DME1690 XEOTICID XEO02971 GENEFORM Protein DME1690 XEOTICID XEO02971 MOACRIVE Inhibition DME1690 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1690 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO02972 XEO_CLAS Peptide DME1690 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.4 microM) DME1690 XEOTICID XEO02972 GENEFORM Protein DME1690 XEOTICID XEO02972 MOACRIVE Inhibition DME1690 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1690 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02990 GENEFORM Protein DME1690 XEOTICID XEO02990 MOACRIVE Inhibition DME1690 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1690 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02991 GENEFORM Protein DME1690 XEOTICID XEO02991 MOACRIVE Inhibition DME1690 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1690 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02992 GENEFORM Protein DME1690 XEOTICID XEO02992 MOACRIVE Inhibition DME1690 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1690 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02993 GENEFORM Protein DME1690 XEOTICID XEO02993 MOACRIVE Inhibition DME1690 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1690 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02994 GENEFORM Protein DME1690 XEOTICID XEO02994 MOACRIVE Inhibition DME1690 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1690 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02995 GENEFORM Protein DME1690 XEOTICID XEO02995 MOACRIVE Inhibition DME1690 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1690 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02996 GENEFORM Protein DME1690 XEOTICID XEO02996 MOACRIVE Inhibition DME1690 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1690 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02997 GENEFORM Protein DME1690 XEOTICID XEO02997 MOACRIVE Inhibition DME1690 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1690 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02998 GENEFORM Protein DME1690 XEOTICID XEO02998 MOACRIVE Inhibition DME1690 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1690 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1690 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO02999 GENEFORM Protein DME1690 XEOTICID XEO02999 MOACRIVE Inhibition DME1690 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1690 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03021 XEO_CLAS Peptide DME1690 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1690 XEOTICID XEO03021 GENEFORM Protein DME1690 XEOTICID XEO03021 MOACRIVE Inhibition DME1690 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1690 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03029 XEO_CLAS Peptide DME1690 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.005 microM) DME1690 XEOTICID XEO03029 GENEFORM Protein DME1690 XEOTICID XEO03029 MOACRIVE Inhibition DME1690 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1690 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03030 XEO_CLAS Peptide DME1690 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.005 microM) DME1690 XEOTICID XEO03030 GENEFORM Protein DME1690 XEOTICID XEO03030 MOACRIVE Inhibition DME1690 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1690 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03031 XEO_CLAS Peptide DME1690 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.3 microM) DME1690 XEOTICID XEO03031 GENEFORM Protein DME1690 XEOTICID XEO03031 MOACRIVE Inhibition DME1690 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1690 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03032 XEO_CLAS Peptide DME1690 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.01 microM) DME1690 XEOTICID XEO03032 GENEFORM Protein DME1690 XEOTICID XEO03032 MOACRIVE Inhibition DME1690 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1690 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03033 XEO_CLAS Peptide DME1690 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.173 microM) DME1690 XEOTICID XEO03033 GENEFORM Protein DME1690 XEOTICID XEO03033 MOACRIVE Inhibition DME1690 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1690 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03034 XEO_CLAS Peptide DME1690 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.518 microM) DME1690 XEOTICID XEO03034 GENEFORM Protein DME1690 XEOTICID XEO03034 MOACRIVE Inhibition DME1690 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1690 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03035 XEO_CLAS Peptide DME1690 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.114 microM) DME1690 XEOTICID XEO03035 GENEFORM Protein DME1690 XEOTICID XEO03035 MOACRIVE Inhibition DME1690 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1690 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03039 XEO_CLAS Peptide DME1690 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.55 microM) DME1690 XEOTICID XEO03039 GENEFORM Protein DME1690 XEOTICID XEO03039 MOACRIVE Inhibition DME1690 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1690 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03043 XEO_CLAS Peptide DME1690 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 microM) DME1690 XEOTICID XEO03043 GENEFORM Protein DME1690 XEOTICID XEO03043 MOACRIVE Inhibition DME1690 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1690 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03044 XEO_CLAS Peptide DME1690 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03044 GENEFORM Protein DME1690 XEOTICID XEO03044 MOACRIVE Inhibition DME1690 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1690 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03045 XEO_CLAS Peptide DME1690 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03045 GENEFORM Protein DME1690 XEOTICID XEO03045 MOACRIVE Inhibition DME1690 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1690 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03046 XEO_CLAS Peptide DME1690 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03046 GENEFORM Protein DME1690 XEOTICID XEO03046 MOACRIVE Inhibition DME1690 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1690 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03049 XEO_CLAS Peptide DME1690 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 microM) DME1690 XEOTICID XEO03049 GENEFORM Protein DME1690 XEOTICID XEO03049 MOACRIVE Inhibition DME1690 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1690 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03055 XEO_CLAS Peptide DME1690 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 microM) DME1690 XEOTICID XEO03055 GENEFORM Protein DME1690 XEOTICID XEO03055 MOACRIVE Inhibition DME1690 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1690 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03059 XEO_CLAS Peptide DME1690 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO03059 GENEFORM Protein DME1690 XEOTICID XEO03059 MOACRIVE Inhibition DME1690 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1690 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03060 XEO_CLAS Peptide DME1690 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO03060 GENEFORM Protein DME1690 XEOTICID XEO03060 MOACRIVE Inhibition DME1690 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1690 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03062 XEO_CLAS Peptide DME1690 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO03062 GENEFORM Protein DME1690 XEOTICID XEO03062 MOACRIVE Inhibition DME1690 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1690 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03064 XEO_CLAS Peptide DME1690 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO03064 GENEFORM Protein DME1690 XEOTICID XEO03064 MOACRIVE Inhibition DME1690 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1690 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03066 XEO_CLAS Peptide DME1690 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO03066 GENEFORM Protein DME1690 XEOTICID XEO03066 MOACRIVE Inhibition DME1690 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1690 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03068 XEO_CLAS Peptide DME1690 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO03068 GENEFORM Protein DME1690 XEOTICID XEO03068 MOACRIVE Inhibition DME1690 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1690 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03073 XEO_CLAS Peptide DME1690 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8-16 ug/ml) DME1690 XEOTICID XEO03073 GENEFORM Protein DME1690 XEOTICID XEO03073 MOACRIVE Inhibition DME1690 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1690 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03081 XEO_CLAS Peptide DME1690 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 microM) DME1690 XEOTICID XEO03081 GENEFORM Protein DME1690 XEOTICID XEO03081 MOACRIVE Inhibition DME1690 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1690 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03082 XEO_CLAS Peptide DME1690 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03082 GENEFORM Protein DME1690 XEOTICID XEO03082 MOACRIVE Inhibition DME1690 XEOTICID XEO03089 XEO_NAME Decoralin DME1690 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03089 XEO_CLAS Peptide DME1690 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 160 microM) DME1690 XEOTICID XEO03089 GENEFORM Protein DME1690 XEOTICID XEO03089 MOACRIVE Inhibition DME1690 XEOTICID XEO03098 XEO_NAME Insect defensin DME1690 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03098 XEO_CLAS Peptide DME1690 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 ug/ml) DME1690 XEOTICID XEO03098 GENEFORM Protein DME1690 XEOTICID XEO03098 MOACRIVE Inhibition DME1690 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1690 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03100 XEO_CLAS Peptide DME1690 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03100 GENEFORM Protein DME1690 XEOTICID XEO03100 MOACRIVE Inhibition DME1690 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1690 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03103 XEO_CLAS Peptide DME1690 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03103 GENEFORM Protein DME1690 XEOTICID XEO03103 MOACRIVE Inhibition DME1690 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1690 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03105 XEO_CLAS Peptide DME1690 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03105 GENEFORM Protein DME1690 XEOTICID XEO03105 MOACRIVE Inhibition DME1690 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1690 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03110 XEO_CLAS Peptide DME1690 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.2 microM) DME1690 XEOTICID XEO03110 GENEFORM Protein DME1690 XEOTICID XEO03110 MOACRIVE Inhibition DME1690 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1690 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03111 XEO_CLAS Peptide DME1690 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03111 GENEFORM Protein DME1690 XEOTICID XEO03111 MOACRIVE Inhibition DME1690 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1690 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03112 XEO_CLAS Peptide DME1690 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 50 ug/ml) DME1690 XEOTICID XEO03112 GENEFORM Protein DME1690 XEOTICID XEO03112 MOACRIVE Inhibition DME1690 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1690 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03115 XEO_CLAS Peptide DME1690 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03115 GENEFORM Protein DME1690 XEOTICID XEO03115 MOACRIVE Inhibition DME1690 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1690 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03116 XEO_CLAS Peptide DME1690 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 40 microM) DME1690 XEOTICID XEO03116 GENEFORM Protein DME1690 XEOTICID XEO03116 MOACRIVE Inhibition DME1690 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1690 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03118 XEO_CLAS Peptide DME1690 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03118 GENEFORM Protein DME1690 XEOTICID XEO03118 MOACRIVE Inhibition DME1690 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1690 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03119 XEO_CLAS Peptide DME1690 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03119 GENEFORM Protein DME1690 XEOTICID XEO03119 MOACRIVE Inhibition DME1690 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1690 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03121 XEO_CLAS Peptide DME1690 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03121 GENEFORM Protein DME1690 XEOTICID XEO03121 MOACRIVE Inhibition DME1690 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1690 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03122 XEO_CLAS Peptide DME1690 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64000 ug/ml) DME1690 XEOTICID XEO03122 GENEFORM Protein DME1690 XEOTICID XEO03122 MOACRIVE Inhibition DME1690 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1690 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03124 XEO_CLAS Peptide DME1690 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03124 GENEFORM Protein DME1690 XEOTICID XEO03124 MOACRIVE Inhibition DME1690 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1690 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03125 XEO_CLAS Peptide DME1690 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03125 GENEFORM Protein DME1690 XEOTICID XEO03125 MOACRIVE Inhibition DME1690 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1690 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03126 XEO_CLAS Peptide DME1690 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.86 microM) DME1690 XEOTICID XEO03126 GENEFORM Protein DME1690 XEOTICID XEO03126 MOACRIVE Inhibition DME1690 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1690 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03127 XEO_CLAS Peptide DME1690 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03127 GENEFORM Protein DME1690 XEOTICID XEO03127 MOACRIVE Inhibition DME1690 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1690 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03128 XEO_CLAS Peptide DME1690 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 256 ug/ml) DME1690 XEOTICID XEO03128 GENEFORM Protein DME1690 XEOTICID XEO03128 MOACRIVE Inhibition DME1690 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1690 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03129 XEO_CLAS Peptide DME1690 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 256 ug/ml) DME1690 XEOTICID XEO03129 GENEFORM Protein DME1690 XEOTICID XEO03129 MOACRIVE Inhibition DME1690 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1690 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03130 XEO_CLAS Peptide DME1690 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 256 ug/ml) DME1690 XEOTICID XEO03130 GENEFORM Protein DME1690 XEOTICID XEO03130 MOACRIVE Inhibition DME1690 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1690 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03131 XEO_CLAS Peptide DME1690 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 256 ug/ml) DME1690 XEOTICID XEO03131 GENEFORM Protein DME1690 XEOTICID XEO03131 MOACRIVE Inhibition DME1690 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1690 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03132 XEO_CLAS Peptide DME1690 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 256 ug/ml) DME1690 XEOTICID XEO03132 GENEFORM Protein DME1690 XEOTICID XEO03132 MOACRIVE Inhibition DME1690 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1690 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03137 XEO_CLAS Peptide DME1690 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03137 GENEFORM Protein DME1690 XEOTICID XEO03137 MOACRIVE Inhibition DME1690 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1690 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03143 XEO_CLAS Peptide DME1690 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.6 microM) DME1690 XEOTICID XEO03143 GENEFORM Protein DME1690 XEOTICID XEO03143 MOACRIVE Inhibition DME1690 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1690 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03145 XEO_CLAS Peptide DME1690 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.6 microM) DME1690 XEOTICID XEO03145 GENEFORM Protein DME1690 XEOTICID XEO03145 MOACRIVE Inhibition DME1690 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1690 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03146 XEO_CLAS Peptide DME1690 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.5 microM) DME1690 XEOTICID XEO03146 GENEFORM Protein DME1690 XEOTICID XEO03146 MOACRIVE Inhibition DME1690 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1690 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03147 XEO_CLAS Peptide DME1690 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 9.7 microM) DME1690 XEOTICID XEO03147 GENEFORM Protein DME1690 XEOTICID XEO03147 MOACRIVE Inhibition DME1690 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1690 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03148 XEO_CLAS Peptide DME1690 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.3 microM) DME1690 XEOTICID XEO03148 GENEFORM Protein DME1690 XEOTICID XEO03148 MOACRIVE Inhibition DME1690 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1690 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03149 XEO_CLAS Peptide DME1690 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.6 microM) DME1690 XEOTICID XEO03149 GENEFORM Protein DME1690 XEOTICID XEO03149 MOACRIVE Inhibition DME1690 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1690 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03150 XEO_CLAS Peptide DME1690 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 9-3 microM) DME1690 XEOTICID XEO03150 GENEFORM Protein DME1690 XEOTICID XEO03150 MOACRIVE Inhibition DME1690 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1690 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03151 XEO_CLAS Peptide DME1690 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 ug/ml) DME1690 XEOTICID XEO03151 GENEFORM Protein DME1690 XEOTICID XEO03151 MOACRIVE Inhibition DME1690 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1690 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03152 XEO_CLAS Peptide DME1690 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO03152 GENEFORM Protein DME1690 XEOTICID XEO03152 MOACRIVE Inhibition DME1690 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1690 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03155 XEO_CLAS Peptide DME1690 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.4 microM) DME1690 XEOTICID XEO03155 GENEFORM Protein DME1690 XEOTICID XEO03155 MOACRIVE Inhibition DME1690 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1690 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03156 XEO_CLAS Peptide DME1690 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.3 microM) DME1690 XEOTICID XEO03156 GENEFORM Protein DME1690 XEOTICID XEO03156 MOACRIVE Inhibition DME1690 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1690 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03157 XEO_CLAS Peptide DME1690 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.3 microM) DME1690 XEOTICID XEO03157 GENEFORM Protein DME1690 XEOTICID XEO03157 MOACRIVE Inhibition DME1690 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1690 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03158 XEO_CLAS Peptide DME1690 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 ug/ml) DME1690 XEOTICID XEO03158 GENEFORM Protein DME1690 XEOTICID XEO03158 MOACRIVE Inhibition DME1690 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1690 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03159 XEO_CLAS Peptide DME1690 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03159 GENEFORM Protein DME1690 XEOTICID XEO03159 MOACRIVE Inhibition DME1690 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1690 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03161 XEO_CLAS Peptide DME1690 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 microM) DME1690 XEOTICID XEO03161 GENEFORM Protein DME1690 XEOTICID XEO03161 MOACRIVE Inhibition DME1690 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1690 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03162 XEO_CLAS Peptide DME1690 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.5 microM) DME1690 XEOTICID XEO03162 GENEFORM Protein DME1690 XEOTICID XEO03162 MOACRIVE Inhibition DME1690 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1690 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03169 XEO_CLAS Peptide DME1690 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO03169 GENEFORM Protein DME1690 XEOTICID XEO03169 MOACRIVE Inhibition DME1690 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1690 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03193 XEO_CLAS Peptide DME1690 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25 ug/ml) DME1690 XEOTICID XEO03193 GENEFORM Protein DME1690 XEOTICID XEO03193 MOACRIVE Inhibition DME1690 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1690 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03194 XEO_CLAS Peptide DME1690 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03194 GENEFORM Protein DME1690 XEOTICID XEO03194 MOACRIVE Inhibition DME1690 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1690 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03195 XEO_CLAS Peptide DME1690 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03195 GENEFORM Protein DME1690 XEOTICID XEO03195 MOACRIVE Inhibition DME1690 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1690 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03197 XEO_CLAS Peptide DME1690 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 14.5 microM) DME1690 XEOTICID XEO03197 GENEFORM Protein DME1690 XEOTICID XEO03197 MOACRIVE Inhibition DME1690 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1690 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03202 XEO_CLAS Peptide DME1690 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.51 microM) DME1690 XEOTICID XEO03202 GENEFORM Protein DME1690 XEOTICID XEO03202 MOACRIVE Inhibition DME1690 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1690 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03203 XEO_CLAS Peptide DME1690 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.62 microM) DME1690 XEOTICID XEO03203 GENEFORM Protein DME1690 XEOTICID XEO03203 MOACRIVE Inhibition DME1690 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1690 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03204 XEO_CLAS Peptide DME1690 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.38 microM) DME1690 XEOTICID XEO03204 GENEFORM Protein DME1690 XEOTICID XEO03204 MOACRIVE Inhibition DME1690 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1690 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03205 XEO_CLAS Peptide DME1690 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.29 microM) DME1690 XEOTICID XEO03205 GENEFORM Protein DME1690 XEOTICID XEO03205 MOACRIVE Inhibition DME1690 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1690 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03206 XEO_CLAS Peptide DME1690 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.40 microM) DME1690 XEOTICID XEO03206 GENEFORM Protein DME1690 XEOTICID XEO03206 MOACRIVE Inhibition DME1690 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1690 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03207 XEO_CLAS Peptide DME1690 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.58 microM) DME1690 XEOTICID XEO03207 GENEFORM Protein DME1690 XEOTICID XEO03207 MOACRIVE Inhibition DME1690 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1690 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03208 XEO_CLAS Peptide DME1690 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.76 microM) DME1690 XEOTICID XEO03208 GENEFORM Protein DME1690 XEOTICID XEO03208 MOACRIVE Inhibition DME1690 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1690 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03209 XEO_CLAS Peptide DME1690 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.49 microM) DME1690 XEOTICID XEO03209 GENEFORM Protein DME1690 XEOTICID XEO03209 MOACRIVE Inhibition DME1690 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1690 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03210 XEO_CLAS Peptide DME1690 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 7.07 microM) DME1690 XEOTICID XEO03210 GENEFORM Protein DME1690 XEOTICID XEO03210 MOACRIVE Inhibition DME1690 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1690 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03211 XEO_CLAS Peptide DME1690 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.40 microM) DME1690 XEOTICID XEO03211 GENEFORM Protein DME1690 XEOTICID XEO03211 MOACRIVE Inhibition DME1690 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1690 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03215 XEO_CLAS Peptide DME1690 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20.0 ug/ml) DME1690 XEOTICID XEO03215 GENEFORM Protein DME1690 XEOTICID XEO03215 MOACRIVE Inhibition DME1690 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1690 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03216 XEO_CLAS Peptide DME1690 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO03216 GENEFORM Protein DME1690 XEOTICID XEO03216 MOACRIVE Inhibition DME1690 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1690 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03217 XEO_CLAS Peptide DME1690 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO03217 GENEFORM Protein DME1690 XEOTICID XEO03217 MOACRIVE Inhibition DME1690 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1690 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03223 XEO_CLAS Peptide DME1690 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.8 microM) DME1690 XEOTICID XEO03223 GENEFORM Protein DME1690 XEOTICID XEO03223 MOACRIVE Inhibition DME1690 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1690 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03224 XEO_CLAS Peptide DME1690 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.1-0.25 microM) DME1690 XEOTICID XEO03224 GENEFORM Protein DME1690 XEOTICID XEO03224 MOACRIVE Inhibition DME1690 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1690 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03225 XEO_CLAS Peptide DME1690 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.3 microM) DME1690 XEOTICID XEO03225 GENEFORM Protein DME1690 XEOTICID XEO03225 MOACRIVE Inhibition DME1690 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1690 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03227 XEO_CLAS Peptide DME1690 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.3 microM) DME1690 XEOTICID XEO03227 GENEFORM Protein DME1690 XEOTICID XEO03227 MOACRIVE Inhibition DME1690 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1690 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03231 XEO_CLAS Peptide DME1690 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03231 GENEFORM Protein DME1690 XEOTICID XEO03231 MOACRIVE Inhibition DME1690 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1690 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03232 XEO_CLAS Peptide DME1690 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03232 GENEFORM Protein DME1690 XEOTICID XEO03232 MOACRIVE Inhibition DME1690 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1690 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03234 XEO_CLAS Peptide DME1690 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO03234 GENEFORM Protein DME1690 XEOTICID XEO03234 MOACRIVE Inhibition DME1690 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1690 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03235 XEO_CLAS Peptide DME1690 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 60 ug/ml) DME1690 XEOTICID XEO03235 GENEFORM Protein DME1690 XEOTICID XEO03235 MOACRIVE Inhibition DME1690 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1690 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03236 XEO_CLAS Peptide DME1690 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO03236 GENEFORM Protein DME1690 XEOTICID XEO03236 MOACRIVE Inhibition DME1690 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1690 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03237 XEO_CLAS Peptide DME1690 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 ug/ml) DME1690 XEOTICID XEO03237 GENEFORM Protein DME1690 XEOTICID XEO03237 MOACRIVE Inhibition DME1690 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1690 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03238 XEO_CLAS Peptide DME1690 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 ug/ml) DME1690 XEOTICID XEO03238 GENEFORM Protein DME1690 XEOTICID XEO03238 MOACRIVE Inhibition DME1690 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1690 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03239 XEO_CLAS Peptide DME1690 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 60 ug/ml) DME1690 XEOTICID XEO03239 GENEFORM Protein DME1690 XEOTICID XEO03239 MOACRIVE Inhibition DME1690 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1690 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03241 XEO_CLAS Peptide DME1690 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 128 microM) DME1690 XEOTICID XEO03241 GENEFORM Protein DME1690 XEOTICID XEO03241 MOACRIVE Inhibition DME1690 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1690 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03250 XEO_CLAS Peptide DME1690 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03250 GENEFORM Protein DME1690 XEOTICID XEO03250 MOACRIVE Inhibition DME1690 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1690 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03251 XEO_CLAS Peptide DME1690 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03251 GENEFORM Protein DME1690 XEOTICID XEO03251 MOACRIVE Inhibition DME1690 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1690 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03253 XEO_CLAS Peptide DME1690 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.1 ug/ml) DME1690 XEOTICID XEO03253 GENEFORM Protein DME1690 XEOTICID XEO03253 MOACRIVE Inhibition DME1690 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1690 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03274 XEO_CLAS Peptide DME1690 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.2 microM) DME1690 XEOTICID XEO03274 GENEFORM Protein DME1690 XEOTICID XEO03274 MOACRIVE Inhibition DME1690 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1690 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03275 XEO_CLAS Peptide DME1690 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO03275 GENEFORM Protein DME1690 XEOTICID XEO03275 MOACRIVE Inhibition DME1690 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1690 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03276 XEO_CLAS Peptide DME1690 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO03276 GENEFORM Protein DME1690 XEOTICID XEO03276 MOACRIVE Inhibition DME1690 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1690 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03277 XEO_CLAS Peptide DME1690 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.2 microM) DME1690 XEOTICID XEO03277 GENEFORM Protein DME1690 XEOTICID XEO03277 MOACRIVE Inhibition DME1690 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1690 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03278 XEO_CLAS Peptide DME1690 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO03278 GENEFORM Protein DME1690 XEOTICID XEO03278 MOACRIVE Inhibition DME1690 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1690 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03279 XEO_CLAS Peptide DME1690 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO03279 GENEFORM Protein DME1690 XEOTICID XEO03279 MOACRIVE Inhibition DME1690 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1690 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03280 XEO_CLAS Peptide DME1690 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 microM) DME1690 XEOTICID XEO03280 GENEFORM Protein DME1690 XEOTICID XEO03280 MOACRIVE Inhibition DME1690 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1690 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03281 XEO_CLAS Peptide DME1690 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.3 microM) DME1690 XEOTICID XEO03281 GENEFORM Protein DME1690 XEOTICID XEO03281 MOACRIVE Inhibition DME1690 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1690 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03282 XEO_CLAS Peptide DME1690 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.1 microM) DME1690 XEOTICID XEO03282 GENEFORM Protein DME1690 XEOTICID XEO03282 MOACRIVE Inhibition DME1690 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1690 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03283 XEO_CLAS Peptide DME1690 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 microM) DME1690 XEOTICID XEO03283 GENEFORM Protein DME1690 XEOTICID XEO03283 MOACRIVE Inhibition DME1690 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1690 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03284 XEO_CLAS Peptide DME1690 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.2 ug/ml) DME1690 XEOTICID XEO03284 GENEFORM Protein DME1690 XEOTICID XEO03284 MOACRIVE Inhibition DME1690 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1690 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03285 XEO_CLAS Peptide DME1690 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.5 ug/ml) DME1690 XEOTICID XEO03285 GENEFORM Protein DME1690 XEOTICID XEO03285 MOACRIVE Inhibition DME1690 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1690 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03286 XEO_CLAS Peptide DME1690 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.4 ug/ml) DME1690 XEOTICID XEO03286 GENEFORM Protein DME1690 XEOTICID XEO03286 MOACRIVE Inhibition DME1690 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1690 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03287 XEO_CLAS Peptide DME1690 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.6 ug/ml) DME1690 XEOTICID XEO03287 GENEFORM Protein DME1690 XEOTICID XEO03287 MOACRIVE Inhibition DME1690 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1690 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03288 XEO_CLAS Peptide DME1690 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.4 ug/ml) DME1690 XEOTICID XEO03288 GENEFORM Protein DME1690 XEOTICID XEO03288 MOACRIVE Inhibition DME1690 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1690 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03289 XEO_CLAS Peptide DME1690 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8.8 ug/ml) DME1690 XEOTICID XEO03289 GENEFORM Protein DME1690 XEOTICID XEO03289 MOACRIVE Inhibition DME1690 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1690 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03290 XEO_CLAS Peptide DME1690 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.5 ug/ml) DME1690 XEOTICID XEO03290 GENEFORM Protein DME1690 XEOTICID XEO03290 MOACRIVE Inhibition DME1690 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1690 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03291 XEO_CLAS Peptide DME1690 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8.6 ug/ml) DME1690 XEOTICID XEO03291 GENEFORM Protein DME1690 XEOTICID XEO03291 MOACRIVE Inhibition DME1690 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1690 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03292 XEO_CLAS Peptide DME1690 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4.1 ug/ml) DME1690 XEOTICID XEO03292 GENEFORM Protein DME1690 XEOTICID XEO03292 MOACRIVE Inhibition DME1690 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1690 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03293 XEO_CLAS Peptide DME1690 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1 microM) DME1690 XEOTICID XEO03293 GENEFORM Protein DME1690 XEOTICID XEO03293 MOACRIVE Inhibition DME1690 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1690 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03294 XEO_CLAS Peptide DME1690 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1 microM) DME1690 XEOTICID XEO03294 GENEFORM Protein DME1690 XEOTICID XEO03294 MOACRIVE Inhibition DME1690 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1690 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03295 XEO_CLAS Peptide DME1690 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.7 microM) DME1690 XEOTICID XEO03295 GENEFORM Protein DME1690 XEOTICID XEO03295 MOACRIVE Inhibition DME1690 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1690 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03296 XEO_CLAS Peptide DME1690 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03296 GENEFORM Protein DME1690 XEOTICID XEO03296 MOACRIVE Inhibition DME1690 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1690 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03297 XEO_CLAS Peptide DME1690 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03297 GENEFORM Protein DME1690 XEOTICID XEO03297 MOACRIVE Inhibition DME1690 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1690 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03298 XEO_CLAS Peptide DME1690 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.2 microM) DME1690 XEOTICID XEO03298 GENEFORM Protein DME1690 XEOTICID XEO03298 MOACRIVE Inhibition DME1690 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1690 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03299 XEO_CLAS Peptide DME1690 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.4 microM) DME1690 XEOTICID XEO03299 GENEFORM Protein DME1690 XEOTICID XEO03299 MOACRIVE Inhibition DME1690 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1690 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03300 XEO_CLAS Peptide DME1690 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 ug/ml) DME1690 XEOTICID XEO03300 GENEFORM Protein DME1690 XEOTICID XEO03300 MOACRIVE Inhibition DME1690 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1690 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03301 XEO_CLAS Peptide DME1690 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 ug/ml) DME1690 XEOTICID XEO03301 GENEFORM Protein DME1690 XEOTICID XEO03301 MOACRIVE Inhibition DME1690 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1690 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03302 XEO_CLAS Peptide DME1690 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1 microM) DME1690 XEOTICID XEO03302 GENEFORM Protein DME1690 XEOTICID XEO03302 MOACRIVE Inhibition DME1690 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1690 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03303 XEO_CLAS Peptide DME1690 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 microM) DME1690 XEOTICID XEO03303 GENEFORM Protein DME1690 XEOTICID XEO03303 MOACRIVE Inhibition DME1690 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1690 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03304 XEO_CLAS Peptide DME1690 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO03304 GENEFORM Protein DME1690 XEOTICID XEO03304 MOACRIVE Inhibition DME1690 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1690 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03305 XEO_CLAS Peptide DME1690 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 microM) DME1690 XEOTICID XEO03305 GENEFORM Protein DME1690 XEOTICID XEO03305 MOACRIVE Inhibition DME1690 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1690 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03306 XEO_CLAS Peptide DME1690 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO03306 GENEFORM Protein DME1690 XEOTICID XEO03306 MOACRIVE Inhibition DME1690 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1690 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03307 XEO_CLAS Peptide DME1690 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 34 ug/ml) DME1690 XEOTICID XEO03307 GENEFORM Protein DME1690 XEOTICID XEO03307 MOACRIVE Inhibition DME1690 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1690 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03308 XEO_CLAS Peptide DME1690 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO03308 GENEFORM Protein DME1690 XEOTICID XEO03308 MOACRIVE Inhibition DME1690 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1690 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03310 XEO_CLAS Peptide DME1690 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8.5 ug/ml) DME1690 XEOTICID XEO03310 GENEFORM Protein DME1690 XEOTICID XEO03310 MOACRIVE Inhibition DME1690 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1690 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03311 XEO_CLAS Peptide DME1690 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10.8 ug/ml) DME1690 XEOTICID XEO03311 GENEFORM Protein DME1690 XEOTICID XEO03311 MOACRIVE Inhibition DME1690 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1690 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03312 XEO_CLAS Peptide DME1690 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10.8 ug/ml) DME1690 XEOTICID XEO03312 GENEFORM Protein DME1690 XEOTICID XEO03312 MOACRIVE Inhibition DME1690 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1690 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03313 XEO_CLAS Peptide DME1690 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8.1 ug/ml) DME1690 XEOTICID XEO03313 GENEFORM Protein DME1690 XEOTICID XEO03313 MOACRIVE Inhibition DME1690 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1690 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03314 XEO_CLAS Peptide DME1690 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 7.9 ug/ml) DME1690 XEOTICID XEO03314 GENEFORM Protein DME1690 XEOTICID XEO03314 MOACRIVE Inhibition DME1690 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1690 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03315 XEO_CLAS Peptide DME1690 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.6 ug/ml) DME1690 XEOTICID XEO03315 GENEFORM Protein DME1690 XEOTICID XEO03315 MOACRIVE Inhibition DME1690 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1690 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03316 XEO_CLAS Peptide DME1690 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15.8 ug/ml) DME1690 XEOTICID XEO03316 GENEFORM Protein DME1690 XEOTICID XEO03316 MOACRIVE Inhibition DME1690 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1690 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03317 XEO_CLAS Peptide DME1690 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO03317 GENEFORM Protein DME1690 XEOTICID XEO03317 MOACRIVE Inhibition DME1690 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1690 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03318 XEO_CLAS Peptide DME1690 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1 microM) DME1690 XEOTICID XEO03318 GENEFORM Protein DME1690 XEOTICID XEO03318 MOACRIVE Inhibition DME1690 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1690 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03319 XEO_CLAS Peptide DME1690 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03319 GENEFORM Protein DME1690 XEOTICID XEO03319 MOACRIVE Inhibition DME1690 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1690 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03320 XEO_CLAS Peptide DME1690 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.1 microM) DME1690 XEOTICID XEO03320 GENEFORM Protein DME1690 XEOTICID XEO03320 MOACRIVE Inhibition DME1690 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1690 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03321 XEO_CLAS Peptide DME1690 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.8 microM) DME1690 XEOTICID XEO03321 GENEFORM Protein DME1690 XEOTICID XEO03321 MOACRIVE Inhibition DME1690 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1690 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1690 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03348 GENEFORM Protein DME1690 XEOTICID XEO03348 MOACRIVE Inhibition DME1690 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1690 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03362 XEO_CLAS Peptide DME1690 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO03362 GENEFORM Protein DME1690 XEOTICID XEO03362 MOACRIVE Inhibition DME1690 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1690 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03363 XEO_CLAS Peptide DME1690 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 microM) DME1690 XEOTICID XEO03363 GENEFORM Protein DME1690 XEOTICID XEO03363 MOACRIVE Inhibition DME1690 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1690 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03364 XEO_CLAS Peptide DME1690 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 microM) DME1690 XEOTICID XEO03364 GENEFORM Protein DME1690 XEOTICID XEO03364 MOACRIVE Inhibition DME1690 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1690 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03365 XEO_CLAS Peptide DME1690 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03365 GENEFORM Protein DME1690 XEOTICID XEO03365 MOACRIVE Inhibition DME1690 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1690 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03366 XEO_CLAS Peptide DME1690 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO03366 GENEFORM Protein DME1690 XEOTICID XEO03366 MOACRIVE Inhibition DME1690 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1690 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03367 XEO_CLAS Peptide DME1690 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 microM) DME1690 XEOTICID XEO03367 GENEFORM Protein DME1690 XEOTICID XEO03367 MOACRIVE Inhibition DME1690 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1690 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03368 XEO_CLAS Peptide DME1690 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 microM) DME1690 XEOTICID XEO03368 GENEFORM Protein DME1690 XEOTICID XEO03368 MOACRIVE Inhibition DME1690 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1690 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03379 XEO_CLAS Peptide DME1690 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.6 ug/ml) DME1690 XEOTICID XEO03379 GENEFORM Protein DME1690 XEOTICID XEO03379 MOACRIVE Inhibition DME1690 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1690 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03396 XEO_CLAS Peptide DME1690 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03396 GENEFORM Protein DME1690 XEOTICID XEO03396 MOACRIVE Inhibition DME1690 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1690 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03398 XEO_CLAS Peptide DME1690 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03398 GENEFORM Protein DME1690 XEOTICID XEO03398 MOACRIVE Inhibition DME1690 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1690 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03399 XEO_CLAS Peptide DME1690 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03399 GENEFORM Protein DME1690 XEOTICID XEO03399 MOACRIVE Inhibition DME1690 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1690 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03406 XEO_CLAS Peptide DME1690 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 ug/ml) DME1690 XEOTICID XEO03406 GENEFORM Protein DME1690 XEOTICID XEO03406 MOACRIVE Inhibition DME1690 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1690 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03424 XEO_CLAS Peptide DME1690 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03424 GENEFORM Protein DME1690 XEOTICID XEO03424 MOACRIVE Inhibition DME1690 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1690 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03426 XEO_CLAS Peptide DME1690 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO03426 GENEFORM Protein DME1690 XEOTICID XEO03426 MOACRIVE Inhibition DME1690 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1690 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03427 XEO_CLAS Peptide DME1690 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 microM) DME1690 XEOTICID XEO03427 GENEFORM Protein DME1690 XEOTICID XEO03427 MOACRIVE Inhibition DME1690 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1690 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03428 XEO_CLAS Peptide DME1690 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 ug/ml) DME1690 XEOTICID XEO03428 GENEFORM Protein DME1690 XEOTICID XEO03428 MOACRIVE Inhibition DME1690 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1690 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03430 XEO_CLAS Peptide DME1690 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 ug/ml) DME1690 XEOTICID XEO03430 GENEFORM Protein DME1690 XEOTICID XEO03430 MOACRIVE Inhibition DME1690 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1690 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03434 XEO_CLAS Peptide DME1690 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO03434 GENEFORM Protein DME1690 XEOTICID XEO03434 MOACRIVE Inhibition DME1690 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1690 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03442 XEO_CLAS Peptide DME1690 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 18.75 ug/ml) DME1690 XEOTICID XEO03442 GENEFORM Protein DME1690 XEOTICID XEO03442 MOACRIVE Inhibition DME1690 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1690 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03444 XEO_CLAS Peptide DME1690 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 37.50 ug/ml) DME1690 XEOTICID XEO03444 GENEFORM Protein DME1690 XEOTICID XEO03444 MOACRIVE Inhibition DME1690 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1690 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03459 XEO_CLAS Peptide DME1690 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03459 GENEFORM Protein DME1690 XEOTICID XEO03459 MOACRIVE Inhibition DME1690 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1690 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03460 XEO_CLAS Peptide DME1690 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03460 GENEFORM Protein DME1690 XEOTICID XEO03460 MOACRIVE Inhibition DME1690 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1690 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03461 XEO_CLAS Peptide DME1690 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.05 microM) DME1690 XEOTICID XEO03461 GENEFORM Protein DME1690 XEOTICID XEO03461 MOACRIVE Inhibition DME1690 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1690 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03462 XEO_CLAS Peptide DME1690 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03462 GENEFORM Protein DME1690 XEOTICID XEO03462 MOACRIVE Inhibition DME1690 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1690 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03463 XEO_CLAS Peptide DME1690 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03463 GENEFORM Protein DME1690 XEOTICID XEO03463 MOACRIVE Inhibition DME1690 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1690 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03467 XEO_CLAS Peptide DME1690 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03467 GENEFORM Protein DME1690 XEOTICID XEO03467 MOACRIVE Inhibition DME1690 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1690 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03468 XEO_CLAS Peptide DME1690 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03468 GENEFORM Protein DME1690 XEOTICID XEO03468 MOACRIVE Inhibition DME1690 XEOTICID XEO03471 XEO_NAME Gambicin DME1690 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03471 XEO_CLAS Peptide DME1690 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1690 XEOTICID XEO03471 GENEFORM Protein DME1690 XEOTICID XEO03471 MOACRIVE Inhibition DME1690 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1690 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03485 XEO_CLAS Peptide DME1690 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4.07 ug/ml) DME1690 XEOTICID XEO03485 GENEFORM Protein DME1690 XEOTICID XEO03485 MOACRIVE Inhibition DME1690 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1690 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03486 XEO_CLAS Peptide DME1690 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.80 ug/ml) DME1690 XEOTICID XEO03486 GENEFORM Protein DME1690 XEOTICID XEO03486 MOACRIVE Inhibition DME1690 XEOTICID XEO03488 XEO_NAME GLK-19 DME1690 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03488 XEO_CLAS Peptide DME1690 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO03488 GENEFORM Protein DME1690 XEOTICID XEO03488 MOACRIVE Inhibition DME1690 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1690 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03497 XEO_CLAS Peptide DME1690 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1690 XEOTICID XEO03497 GENEFORM Protein DME1690 XEOTICID XEO03497 MOACRIVE Inhibition DME1690 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1690 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03498 XEO_CLAS Peptide DME1690 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1690 XEOTICID XEO03498 GENEFORM Protein DME1690 XEOTICID XEO03498 MOACRIVE Inhibition DME1690 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1690 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03500 XEO_CLAS Peptide DME1690 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-30 ug/ml) DME1690 XEOTICID XEO03500 GENEFORM Protein DME1690 XEOTICID XEO03500 MOACRIVE Inhibition DME1690 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1690 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03504 XEO_CLAS Peptide DME1690 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 ug/ml) DME1690 XEOTICID XEO03504 GENEFORM Protein DME1690 XEOTICID XEO03504 MOACRIVE Inhibition DME1690 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1690 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03505 XEO_CLAS Peptide DME1690 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 ug/ml) DME1690 XEOTICID XEO03505 GENEFORM Protein DME1690 XEOTICID XEO03505 MOACRIVE Inhibition DME1690 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1690 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03506 XEO_CLAS Peptide DME1690 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 ug/ml) DME1690 XEOTICID XEO03506 GENEFORM Protein DME1690 XEOTICID XEO03506 MOACRIVE Inhibition DME1690 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1690 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03513 XEO_CLAS Peptide DME1690 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO03513 GENEFORM Protein DME1690 XEOTICID XEO03513 MOACRIVE Inhibition DME1690 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1690 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03514 XEO_CLAS Peptide DME1690 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03514 GENEFORM Protein DME1690 XEOTICID XEO03514 MOACRIVE Inhibition DME1690 XEOTICID XEO03519 XEO_NAME Hadrurin DME1690 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03519 XEO_CLAS Peptide DME1690 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03519 GENEFORM Protein DME1690 XEOTICID XEO03519 MOACRIVE Inhibition DME1690 XEOTICID XEO03522 XEO_NAME Halocyntin DME1690 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03522 XEO_CLAS Peptide DME1690 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03522 GENEFORM Protein DME1690 XEOTICID XEO03522 MOACRIVE Inhibition DME1690 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1690 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03524 XEO_CLAS Peptide DME1690 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03524 GENEFORM Protein DME1690 XEOTICID XEO03524 MOACRIVE Inhibition DME1690 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1690 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03525 XEO_CLAS Peptide DME1690 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03525 GENEFORM Protein DME1690 XEOTICID XEO03525 MOACRIVE Inhibition DME1690 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1690 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03530 XEO_CLAS Peptide DME1690 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03530 GENEFORM Protein DME1690 XEOTICID XEO03530 MOACRIVE Inhibition DME1690 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1690 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03535 XEO_CLAS Peptide DME1690 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.4 microM) DME1690 XEOTICID XEO03535 GENEFORM Protein DME1690 XEOTICID XEO03535 MOACRIVE Inhibition DME1690 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1690 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03536 XEO_CLAS Peptide DME1690 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 80 microM) DME1690 XEOTICID XEO03536 GENEFORM Protein DME1690 XEOTICID XEO03536 MOACRIVE Inhibition DME1690 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1690 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03537 XEO_CLAS Peptide DME1690 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 ug/ml) DME1690 XEOTICID XEO03537 GENEFORM Protein DME1690 XEOTICID XEO03537 MOACRIVE Inhibition DME1690 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1690 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03538 XEO_CLAS Peptide DME1690 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 ug/ml) DME1690 XEOTICID XEO03538 GENEFORM Protein DME1690 XEOTICID XEO03538 MOACRIVE Inhibition DME1690 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1690 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03540 XEO_CLAS Peptide DME1690 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO03540 GENEFORM Protein DME1690 XEOTICID XEO03540 MOACRIVE Inhibition DME1690 XEOTICID XEO03542 XEO_NAME Hepcidin DME1690 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03542 XEO_CLAS Peptide DME1690 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 24 microM) DME1690 XEOTICID XEO03542 GENEFORM Protein DME1690 XEOTICID XEO03542 MOACRIVE Inhibition DME1690 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1690 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03544 XEO_CLAS Peptide DME1690 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03544 GENEFORM Protein DME1690 XEOTICID XEO03544 MOACRIVE Inhibition DME1690 XEOTICID XEO03548 XEO_NAME Hesperidin DME1690 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03548 GENEFORM Protein DME1690 XEOTICID XEO03548 MOACRIVE Inhibition DME1690 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1690 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1690 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03552 GENEFORM Protein DME1690 XEOTICID XEO03552 MOACRIVE Inhibition DME1690 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1690 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03556 XEO_CLAS Peptide DME1690 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO03556 GENEFORM Protein DME1690 XEOTICID XEO03556 MOACRIVE Inhibition DME1690 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1690 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03557 XEO_CLAS Peptide DME1690 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO03557 GENEFORM Protein DME1690 XEOTICID XEO03557 MOACRIVE Inhibition DME1690 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1690 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03558 XEO_CLAS Peptide DME1690 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 microM) DME1690 XEOTICID XEO03558 GENEFORM Protein DME1690 XEOTICID XEO03558 MOACRIVE Inhibition DME1690 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1690 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03559 XEO_CLAS Peptide DME1690 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 microM) DME1690 XEOTICID XEO03559 GENEFORM Protein DME1690 XEOTICID XEO03559 MOACRIVE Inhibition DME1690 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1690 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03560 XEO_CLAS Peptide DME1690 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 microM) DME1690 XEOTICID XEO03560 GENEFORM Protein DME1690 XEOTICID XEO03560 MOACRIVE Inhibition DME1690 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1690 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03561 XEO_CLAS Peptide DME1690 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03561 GENEFORM Protein DME1690 XEOTICID XEO03561 MOACRIVE Inhibition DME1690 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1690 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03567 XEO_CLAS Peptide DME1690 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03567 GENEFORM Protein DME1690 XEOTICID XEO03567 MOACRIVE Inhibition DME1690 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1690 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03569 XEO_CLAS Peptide DME1690 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 300 microM) DME1690 XEOTICID XEO03569 GENEFORM Protein DME1690 XEOTICID XEO03569 MOACRIVE Inhibition DME1690 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1690 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03570 XEO_CLAS Peptide DME1690 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03570 GENEFORM Protein DME1690 XEOTICID XEO03570 MOACRIVE Inhibition DME1690 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1690 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03572 XEO_CLAS Peptide DME1690 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1690 XEOTICID XEO03572 GENEFORM Protein DME1690 XEOTICID XEO03572 MOACRIVE Inhibition DME1690 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1690 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03573 XEO_CLAS Peptide DME1690 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 28.1 ug/ml) DME1690 XEOTICID XEO03573 GENEFORM Protein DME1690 XEOTICID XEO03573 MOACRIVE Inhibition DME1690 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1690 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03574 XEO_CLAS Peptide DME1690 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 500 microM) DME1690 XEOTICID XEO03574 GENEFORM Protein DME1690 XEOTICID XEO03574 MOACRIVE Inhibition DME1690 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1690 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03575 XEO_CLAS Peptide DME1690 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 18 microM) DME1690 XEOTICID XEO03575 GENEFORM Protein DME1690 XEOTICID XEO03575 MOACRIVE Inhibition DME1690 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1690 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03576 XEO_CLAS Peptide DME1690 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 750 microM) DME1690 XEOTICID XEO03576 GENEFORM Protein DME1690 XEOTICID XEO03576 MOACRIVE Inhibition DME1690 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1690 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03578 XEO_CLAS Peptide DME1690 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1690 XEOTICID XEO03578 GENEFORM Protein DME1690 XEOTICID XEO03578 MOACRIVE Inhibition DME1690 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1690 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03579 XEO_CLAS Peptide DME1690 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03579 GENEFORM Protein DME1690 XEOTICID XEO03579 MOACRIVE Inhibition DME1690 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1690 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03580 XEO_CLAS Peptide DME1690 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03580 GENEFORM Protein DME1690 XEOTICID XEO03580 MOACRIVE Inhibition DME1690 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1690 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03585 XEO_CLAS Peptide DME1690 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 125 ug/ml) DME1690 XEOTICID XEO03585 GENEFORM Protein DME1690 XEOTICID XEO03585 MOACRIVE Inhibition DME1690 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1690 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03588 XEO_CLAS Peptide DME1690 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 62 ug/ml) DME1690 XEOTICID XEO03588 GENEFORM Protein DME1690 XEOTICID XEO03588 MOACRIVE Inhibition DME1690 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1690 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03589 XEO_CLAS Peptide DME1690 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03589 GENEFORM Protein DME1690 XEOTICID XEO03589 MOACRIVE Inhibition DME1690 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1690 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03590 XEO_CLAS Peptide DME1690 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03590 GENEFORM Protein DME1690 XEOTICID XEO03590 MOACRIVE Inhibition DME1690 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1690 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03591 XEO_CLAS Peptide DME1690 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 37.5 ug/ml) DME1690 XEOTICID XEO03591 GENEFORM Protein DME1690 XEOTICID XEO03591 MOACRIVE Inhibition DME1690 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1690 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03593 XEO_CLAS Peptide DME1690 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 9.4 ug/ml) DME1690 XEOTICID XEO03593 GENEFORM Protein DME1690 XEOTICID XEO03593 MOACRIVE Inhibition DME1690 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1690 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03594 XEO_CLAS Peptide DME1690 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 ug/ml) DME1690 XEOTICID XEO03594 GENEFORM Protein DME1690 XEOTICID XEO03594 MOACRIVE Inhibition DME1690 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1690 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03595 XEO_CLAS Peptide DME1690 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03595 GENEFORM Protein DME1690 XEOTICID XEO03595 MOACRIVE Inhibition DME1690 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1690 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03596 XEO_CLAS Peptide DME1690 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03596 GENEFORM Protein DME1690 XEOTICID XEO03596 MOACRIVE Inhibition DME1690 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1690 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03598 XEO_CLAS Peptide DME1690 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03598 GENEFORM Protein DME1690 XEOTICID XEO03598 MOACRIVE Inhibition DME1690 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1690 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03599 XEO_CLAS Peptide DME1690 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03599 GENEFORM Protein DME1690 XEOTICID XEO03599 MOACRIVE Inhibition DME1690 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1690 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03600 XEO_CLAS Peptide DME1690 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03600 GENEFORM Protein DME1690 XEOTICID XEO03600 MOACRIVE Inhibition DME1690 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1690 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03606 XEO_CLAS Peptide DME1690 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03606 GENEFORM Protein DME1690 XEOTICID XEO03606 MOACRIVE Inhibition DME1690 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1690 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03607 XEO_CLAS Peptide DME1690 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03607 GENEFORM Protein DME1690 XEOTICID XEO03607 MOACRIVE Inhibition DME1690 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1690 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03609 XEO_CLAS Peptide DME1690 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03609 GENEFORM Protein DME1690 XEOTICID XEO03609 MOACRIVE Inhibition DME1690 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1690 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03615 XEO_CLAS Peptide DME1690 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1690 XEOTICID XEO03615 GENEFORM Protein DME1690 XEOTICID XEO03615 MOACRIVE Inhibition DME1690 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1690 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03616 XEO_CLAS Peptide DME1690 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 32 microM) DME1690 XEOTICID XEO03616 GENEFORM Protein DME1690 XEOTICID XEO03616 MOACRIVE Inhibition DME1690 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1690 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03617 XEO_CLAS Peptide DME1690 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40 microM) DME1690 XEOTICID XEO03617 GENEFORM Protein DME1690 XEOTICID XEO03617 MOACRIVE Inhibition DME1690 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1690 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03618 XEO_CLAS Peptide DME1690 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5-1 microM) DME1690 XEOTICID XEO03618 GENEFORM Protein DME1690 XEOTICID XEO03618 MOACRIVE Inhibition DME1690 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1690 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03622 XEO_CLAS Peptide DME1690 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20-40 microM) DME1690 XEOTICID XEO03622 GENEFORM Protein DME1690 XEOTICID XEO03622 MOACRIVE Inhibition DME1690 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1690 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03627 XEO_CLAS Peptide DME1690 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1690 XEOTICID XEO03627 GENEFORM Protein DME1690 XEOTICID XEO03627 MOACRIVE Inhibition DME1690 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1690 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03630 XEO_CLAS Peptide DME1690 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03630 GENEFORM Protein DME1690 XEOTICID XEO03630 MOACRIVE Inhibition DME1690 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1690 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03631 XEO_CLAS Peptide DME1690 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03631 GENEFORM Protein DME1690 XEOTICID XEO03631 MOACRIVE Inhibition DME1690 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1690 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03632 XEO_CLAS Peptide DME1690 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03632 GENEFORM Protein DME1690 XEOTICID XEO03632 MOACRIVE Inhibition DME1690 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1690 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03633 XEO_CLAS Peptide DME1690 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03633 GENEFORM Protein DME1690 XEOTICID XEO03633 MOACRIVE Inhibition DME1690 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1690 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03634 XEO_CLAS Peptide DME1690 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03634 GENEFORM Protein DME1690 XEOTICID XEO03634 MOACRIVE Inhibition DME1690 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1690 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03635 XEO_CLAS Peptide DME1690 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03635 GENEFORM Protein DME1690 XEOTICID XEO03635 MOACRIVE Inhibition DME1690 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1690 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03636 XEO_CLAS Peptide DME1690 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03636 GENEFORM Protein DME1690 XEOTICID XEO03636 MOACRIVE Inhibition DME1690 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1690 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03637 XEO_CLAS Peptide DME1690 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03637 GENEFORM Protein DME1690 XEOTICID XEO03637 MOACRIVE Inhibition DME1690 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1690 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03638 XEO_CLAS Peptide DME1690 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03638 GENEFORM Protein DME1690 XEOTICID XEO03638 MOACRIVE Inhibition DME1690 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1690 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03639 XEO_CLAS Peptide DME1690 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03639 GENEFORM Protein DME1690 XEOTICID XEO03639 MOACRIVE Inhibition DME1690 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1690 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03640 XEO_CLAS Peptide DME1690 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03640 GENEFORM Protein DME1690 XEOTICID XEO03640 MOACRIVE Inhibition DME1690 XEOTICID XEO03644 XEO_NAME Indole DME1690 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1690 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1690 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03644 GENEFORM Protein DME1690 XEOTICID XEO03644 MOACRIVE Inhibition DME1690 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1690 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03650 XEO_CLAS Peptide DME1690 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03650 GENEFORM Protein DME1690 XEOTICID XEO03650 MOACRIVE Inhibition DME1690 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1690 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO03655 XEO_CLAS Natural Product DME1690 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03655 GENEFORM Protein DME1690 XEOTICID XEO03655 MOACRIVE Inhibition DME1690 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1690 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03666 XEO_CLAS Peptide DME1690 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 ug/ml) DME1690 XEOTICID XEO03666 GENEFORM Protein DME1690 XEOTICID XEO03666 MOACRIVE Inhibition DME1690 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1690 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03667 XEO_CLAS Peptide DME1690 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 ug/ml) DME1690 XEOTICID XEO03667 GENEFORM Protein DME1690 XEOTICID XEO03667 MOACRIVE Inhibition DME1690 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1690 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03668 XEO_CLAS Peptide DME1690 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 microM) DME1690 XEOTICID XEO03668 GENEFORM Protein DME1690 XEOTICID XEO03668 MOACRIVE Inhibition DME1690 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1690 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03669 XEO_CLAS Peptide DME1690 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO03669 GENEFORM Protein DME1690 XEOTICID XEO03669 MOACRIVE Inhibition DME1690 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1690 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03670 XEO_CLAS Peptide DME1690 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 microM) DME1690 XEOTICID XEO03670 GENEFORM Protein DME1690 XEOTICID XEO03670 MOACRIVE Inhibition DME1690 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1690 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03672 XEO_CLAS Peptide DME1690 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.5 ug/ml) DME1690 XEOTICID XEO03672 GENEFORM Protein DME1690 XEOTICID XEO03672 MOACRIVE Inhibition DME1690 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1690 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03673 XEO_CLAS Peptide DME1690 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 ug/ml) DME1690 XEOTICID XEO03673 GENEFORM Protein DME1690 XEOTICID XEO03673 MOACRIVE Inhibition DME1690 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1690 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03674 XEO_CLAS Peptide DME1690 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 ug/ml) DME1690 XEOTICID XEO03674 GENEFORM Protein DME1690 XEOTICID XEO03674 MOACRIVE Inhibition DME1690 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1690 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03675 XEO_CLAS Peptide DME1690 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO03675 GENEFORM Protein DME1690 XEOTICID XEO03675 MOACRIVE Inhibition DME1690 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1690 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03678 XEO_CLAS Peptide DME1690 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 ug/ml) DME1690 XEOTICID XEO03678 GENEFORM Protein DME1690 XEOTICID XEO03678 MOACRIVE Inhibition DME1690 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1690 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03679 XEO_CLAS Peptide DME1690 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 ug/ml) DME1690 XEOTICID XEO03679 GENEFORM Protein DME1690 XEOTICID XEO03679 MOACRIVE Inhibition DME1690 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1690 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03681 XEO_CLAS Peptide DME1690 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1690 XEOTICID XEO03681 GENEFORM Protein DME1690 XEOTICID XEO03681 MOACRIVE Inhibition DME1690 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1690 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03684 XEO_CLAS Peptide DME1690 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 ug/ml) DME1690 XEOTICID XEO03684 GENEFORM Protein DME1690 XEOTICID XEO03684 MOACRIVE Inhibition DME1690 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1690 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03694 XEO_CLAS Peptide DME1690 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03694 GENEFORM Protein DME1690 XEOTICID XEO03694 MOACRIVE Inhibition DME1690 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1690 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03697 XEO_CLAS Peptide DME1690 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25 microM) DME1690 XEOTICID XEO03697 GENEFORM Protein DME1690 XEOTICID XEO03697 MOACRIVE Inhibition DME1690 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1690 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03698 XEO_CLAS Peptide DME1690 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03698 GENEFORM Protein DME1690 XEOTICID XEO03698 MOACRIVE Inhibition DME1690 XEOTICID XEO03703 XEO_NAME Kasstasin DME1690 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03703 XEO_CLAS Peptide DME1690 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 110 microM) DME1690 XEOTICID XEO03703 GENEFORM Protein DME1690 XEOTICID XEO03703 MOACRIVE Inhibition DME1690 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1690 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03706 XEO_CLAS Peptide DME1690 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03706 GENEFORM Protein DME1690 XEOTICID XEO03706 MOACRIVE Inhibition DME1690 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1690 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03707 XEO_CLAS Peptide DME1690 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03707 GENEFORM Protein DME1690 XEOTICID XEO03707 MOACRIVE Inhibition DME1690 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1690 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03709 XEO_CLAS Peptide DME1690 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 ug/ml) DME1690 XEOTICID XEO03709 GENEFORM Protein DME1690 XEOTICID XEO03709 MOACRIVE Inhibition DME1690 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1690 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03712 XEO_CLAS Peptide DME1690 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03712 GENEFORM Protein DME1690 XEOTICID XEO03712 MOACRIVE Inhibition DME1690 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1690 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03713 XEO_CLAS Peptide DME1690 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 64 microM) DME1690 XEOTICID XEO03713 GENEFORM Protein DME1690 XEOTICID XEO03713 MOACRIVE Inhibition DME1690 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1690 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03714 XEO_CLAS Peptide DME1690 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03714 GENEFORM Protein DME1690 XEOTICID XEO03714 MOACRIVE Inhibition DME1690 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1690 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03715 XEO_CLAS Peptide DME1690 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 microM) DME1690 XEOTICID XEO03715 GENEFORM Protein DME1690 XEOTICID XEO03715 MOACRIVE Inhibition DME1690 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1690 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03719 XEO_CLAS Peptide DME1690 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 microM) DME1690 XEOTICID XEO03719 GENEFORM Protein DME1690 XEOTICID XEO03719 MOACRIVE Inhibition DME1690 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1690 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03720 XEO_CLAS Peptide DME1690 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 microM) DME1690 XEOTICID XEO03720 GENEFORM Protein DME1690 XEOTICID XEO03720 MOACRIVE Inhibition DME1690 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1690 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03723 XEO_CLAS Peptide DME1690 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 62.36 microM) DME1690 XEOTICID XEO03723 GENEFORM Protein DME1690 XEOTICID XEO03723 MOACRIVE Inhibition DME1690 XEOTICID XEO03724 XEO_NAME L10 peptide DME1690 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03724 XEO_CLAS Peptide DME1690 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.8 microM) DME1690 XEOTICID XEO03724 GENEFORM Protein DME1690 XEOTICID XEO03724 MOACRIVE Inhibition DME1690 XEOTICID XEO03726 XEO_NAME L2 peptide DME1690 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03726 XEO_CLAS Peptide DME1690 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 129.66 microM) DME1690 XEOTICID XEO03726 GENEFORM Protein DME1690 XEOTICID XEO03726 MOACRIVE Inhibition DME1690 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1690 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03727 XEO_CLAS Peptide DME1690 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 80 ug/ml) DME1690 XEOTICID XEO03727 GENEFORM Protein DME1690 XEOTICID XEO03727 MOACRIVE Inhibition DME1690 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1690 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03728 XEO_CLAS Peptide DME1690 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40 ug/ml) DME1690 XEOTICID XEO03728 GENEFORM Protein DME1690 XEOTICID XEO03728 MOACRIVE Inhibition DME1690 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1690 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03729 XEO_CLAS Peptide DME1690 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 80 ug/ml) DME1690 XEOTICID XEO03729 GENEFORM Protein DME1690 XEOTICID XEO03729 MOACRIVE Inhibition DME1690 XEOTICID XEO03730 XEO_NAME L3 peptide DME1690 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03730 XEO_CLAS Peptide DME1690 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64.11 microM) DME1690 XEOTICID XEO03730 GENEFORM Protein DME1690 XEOTICID XEO03730 MOACRIVE Inhibition DME1690 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1690 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03731 XEO_CLAS Peptide DME1690 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40 ug/ml) DME1690 XEOTICID XEO03731 GENEFORM Protein DME1690 XEOTICID XEO03731 MOACRIVE Inhibition DME1690 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1690 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03733 XEO_CLAS Peptide DME1690 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40 ug/ml) DME1690 XEOTICID XEO03733 GENEFORM Protein DME1690 XEOTICID XEO03733 MOACRIVE Inhibition DME1690 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1690 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03734 XEO_CLAS Peptide DME1690 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO03734 GENEFORM Protein DME1690 XEOTICID XEO03734 MOACRIVE Inhibition DME1690 XEOTICID XEO03735 XEO_NAME L4 peptide DME1690 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03735 XEO_CLAS Peptide DME1690 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 31.61 microM) DME1690 XEOTICID XEO03735 GENEFORM Protein DME1690 XEOTICID XEO03735 MOACRIVE Inhibition DME1690 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1690 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03738 XEO_CLAS Peptide DME1690 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 ug/ml) DME1690 XEOTICID XEO03738 GENEFORM Protein DME1690 XEOTICID XEO03738 MOACRIVE Inhibition DME1690 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1690 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03741 XEO_CLAS Peptide DME1690 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40 ug/ml) DME1690 XEOTICID XEO03741 GENEFORM Protein DME1690 XEOTICID XEO03741 MOACRIVE Inhibition DME1690 XEOTICID XEO03742 XEO_NAME L5 peptide DME1690 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03742 XEO_CLAS Peptide DME1690 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 7.79 microM) DME1690 XEOTICID XEO03742 GENEFORM Protein DME1690 XEOTICID XEO03742 MOACRIVE Inhibition DME1690 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1690 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03743 XEO_CLAS Peptide DME1690 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 ug/ml) DME1690 XEOTICID XEO03743 GENEFORM Protein DME1690 XEOTICID XEO03743 MOACRIVE Inhibition DME1690 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1690 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03744 XEO_CLAS Peptide DME1690 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 ug/ml) DME1690 XEOTICID XEO03744 GENEFORM Protein DME1690 XEOTICID XEO03744 MOACRIVE Inhibition DME1690 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1690 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03745 XEO_CLAS Peptide DME1690 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 ug/ml) DME1690 XEOTICID XEO03745 GENEFORM Protein DME1690 XEOTICID XEO03745 MOACRIVE Inhibition DME1690 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1690 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03746 XEO_CLAS Peptide DME1690 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO03746 GENEFORM Protein DME1690 XEOTICID XEO03746 MOACRIVE Inhibition DME1690 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1690 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03747 XEO_CLAS Peptide DME1690 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO03747 GENEFORM Protein DME1690 XEOTICID XEO03747 MOACRIVE Inhibition DME1690 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1690 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03748 XEO_CLAS Peptide DME1690 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO03748 GENEFORM Protein DME1690 XEOTICID XEO03748 MOACRIVE Inhibition DME1690 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1690 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03749 XEO_CLAS Peptide DME1690 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO03749 GENEFORM Protein DME1690 XEOTICID XEO03749 MOACRIVE Inhibition DME1690 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1690 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03750 XEO_CLAS Peptide DME1690 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO03750 GENEFORM Protein DME1690 XEOTICID XEO03750 MOACRIVE Inhibition DME1690 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1690 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03751 XEO_CLAS Peptide DME1690 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO03751 GENEFORM Protein DME1690 XEOTICID XEO03751 MOACRIVE Inhibition DME1690 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1690 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03752 XEO_CLAS Peptide DME1690 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO03752 GENEFORM Protein DME1690 XEOTICID XEO03752 MOACRIVE Inhibition DME1690 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1690 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03753 XEO_CLAS Peptide DME1690 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 ug/ml) DME1690 XEOTICID XEO03753 GENEFORM Protein DME1690 XEOTICID XEO03753 MOACRIVE Inhibition DME1690 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1690 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03754 XEO_CLAS Peptide DME1690 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO03754 GENEFORM Protein DME1690 XEOTICID XEO03754 MOACRIVE Inhibition DME1690 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1690 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03755 XEO_CLAS Peptide DME1690 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO03755 GENEFORM Protein DME1690 XEOTICID XEO03755 MOACRIVE Inhibition DME1690 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1690 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03756 XEO_CLAS Peptide DME1690 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO03756 GENEFORM Protein DME1690 XEOTICID XEO03756 MOACRIVE Inhibition DME1690 XEOTICID XEO03757 XEO_NAME L6 peptide DME1690 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03757 XEO_CLAS Peptide DME1690 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15.17 microM) DME1690 XEOTICID XEO03757 GENEFORM Protein DME1690 XEOTICID XEO03757 MOACRIVE Inhibition DME1690 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1690 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03758 XEO_CLAS Peptide DME1690 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 80 ug/ml) DME1690 XEOTICID XEO03758 GENEFORM Protein DME1690 XEOTICID XEO03758 MOACRIVE Inhibition DME1690 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1690 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03759 XEO_CLAS Peptide DME1690 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.3 ug/ml) DME1690 XEOTICID XEO03759 GENEFORM Protein DME1690 XEOTICID XEO03759 MOACRIVE Inhibition DME1690 XEOTICID XEO03760 XEO_NAME L7 peptide DME1690 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03760 XEO_CLAS Peptide DME1690 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16.02 microM) DME1690 XEOTICID XEO03760 GENEFORM Protein DME1690 XEOTICID XEO03760 MOACRIVE Inhibition DME1690 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1690 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03761 XEO_CLAS Peptide DME1690 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 ug/ml) DME1690 XEOTICID XEO03761 GENEFORM Protein DME1690 XEOTICID XEO03761 MOACRIVE Inhibition DME1690 XEOTICID XEO03763 XEO_NAME L8 peptide DME1690 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03763 XEO_CLAS Peptide DME1690 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.71 microM) DME1690 XEOTICID XEO03763 GENEFORM Protein DME1690 XEOTICID XEO03763 MOACRIVE Inhibition DME1690 XEOTICID XEO03765 XEO_NAME L9 peptide DME1690 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03765 XEO_CLAS Peptide DME1690 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.78 microM) DME1690 XEOTICID XEO03765 GENEFORM Protein DME1690 XEOTICID XEO03765 MOACRIVE Inhibition DME1690 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1690 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03775 XEO_CLAS Peptide DME1690 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 17.3 microM) DME1690 XEOTICID XEO03775 GENEFORM Protein DME1690 XEOTICID XEO03775 MOACRIVE Inhibition DME1690 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1690 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03776 XEO_CLAS Peptide DME1690 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03776 GENEFORM Protein DME1690 XEOTICID XEO03776 MOACRIVE Inhibition DME1690 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1690 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03781 XEO_CLAS Peptide DME1690 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.47 microM) DME1690 XEOTICID XEO03781 GENEFORM Protein DME1690 XEOTICID XEO03781 MOACRIVE Inhibition DME1690 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1690 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03782 XEO_CLAS Peptide DME1690 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.47 microM) DME1690 XEOTICID XEO03782 GENEFORM Protein DME1690 XEOTICID XEO03782 MOACRIVE Inhibition DME1690 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1690 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03783 XEO_CLAS Peptide DME1690 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.68 microM) DME1690 XEOTICID XEO03783 GENEFORM Protein DME1690 XEOTICID XEO03783 MOACRIVE Inhibition DME1690 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1690 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03784 XEO_CLAS Peptide DME1690 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.45 microM) DME1690 XEOTICID XEO03784 GENEFORM Protein DME1690 XEOTICID XEO03784 MOACRIVE Inhibition DME1690 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1690 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03785 XEO_CLAS Peptide DME1690 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.73 microM) DME1690 XEOTICID XEO03785 GENEFORM Protein DME1690 XEOTICID XEO03785 MOACRIVE Inhibition DME1690 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1690 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03786 XEO_CLAS Peptide DME1690 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.45 microM) DME1690 XEOTICID XEO03786 GENEFORM Protein DME1690 XEOTICID XEO03786 MOACRIVE Inhibition DME1690 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1690 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03787 XEO_CLAS Peptide DME1690 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.38 microM) DME1690 XEOTICID XEO03787 GENEFORM Protein DME1690 XEOTICID XEO03787 MOACRIVE Inhibition DME1690 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1690 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03788 XEO_CLAS Peptide DME1690 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.46 microM) DME1690 XEOTICID XEO03788 GENEFORM Protein DME1690 XEOTICID XEO03788 MOACRIVE Inhibition DME1690 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1690 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03789 XEO_CLAS Peptide DME1690 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 13.05 microM) DME1690 XEOTICID XEO03789 GENEFORM Protein DME1690 XEOTICID XEO03789 MOACRIVE Inhibition DME1690 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1690 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03790 XEO_CLAS Peptide DME1690 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.82 microM) DME1690 XEOTICID XEO03790 GENEFORM Protein DME1690 XEOTICID XEO03790 MOACRIVE Inhibition DME1690 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1690 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03791 XEO_CLAS Peptide DME1690 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.80 microM) DME1690 XEOTICID XEO03791 GENEFORM Protein DME1690 XEOTICID XEO03791 MOACRIVE Inhibition DME1690 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1690 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03792 XEO_CLAS Peptide DME1690 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.26 microM) DME1690 XEOTICID XEO03792 GENEFORM Protein DME1690 XEOTICID XEO03792 MOACRIVE Inhibition DME1690 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1690 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03793 XEO_CLAS Peptide DME1690 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 microM) DME1690 XEOTICID XEO03793 GENEFORM Protein DME1690 XEOTICID XEO03793 MOACRIVE Inhibition DME1690 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1690 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03797 XEO_CLAS Peptide DME1690 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.4 microM) DME1690 XEOTICID XEO03797 GENEFORM Protein DME1690 XEOTICID XEO03797 MOACRIVE Inhibition DME1690 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1690 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03798 XEO_CLAS Peptide DME1690 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03798 GENEFORM Protein DME1690 XEOTICID XEO03798 MOACRIVE Inhibition DME1690 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1690 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03799 XEO_CLAS Peptide DME1690 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03799 GENEFORM Protein DME1690 XEOTICID XEO03799 MOACRIVE Inhibition DME1690 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1690 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03810 XEO_CLAS Peptide DME1690 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03810 GENEFORM Protein DME1690 XEOTICID XEO03810 MOACRIVE Inhibition DME1690 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1690 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03846 XEO_CLAS Peptide DME1690 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03846 GENEFORM Protein DME1690 XEOTICID XEO03846 MOACRIVE Inhibition DME1690 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1690 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03847 XEO_CLAS Peptide DME1690 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03847 GENEFORM Protein DME1690 XEOTICID XEO03847 MOACRIVE Inhibition DME1690 XEOTICID XEO03850 XEO_NAME Lemon DME1690 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1690 XEOTICID XEO03850 XEO_CLAS Food Additive DME1690 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03850 GENEFORM Protein DME1690 XEOTICID XEO03850 MOACRIVE Inhibition DME1690 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1690 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03853 XEO_CLAS Peptide DME1690 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO03853 GENEFORM Protein DME1690 XEOTICID XEO03853 MOACRIVE Inhibition DME1690 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1690 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03857 XEO_CLAS Peptide DME1690 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 38.49 microM) DME1690 XEOTICID XEO03857 GENEFORM Protein DME1690 XEOTICID XEO03857 MOACRIVE Inhibition DME1690 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1690 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03860 XEO_CLAS Peptide DME1690 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 24 microM) DME1690 XEOTICID XEO03860 GENEFORM Protein DME1690 XEOTICID XEO03860 MOACRIVE Inhibition DME1690 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1690 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03861 XEO_CLAS Peptide DME1690 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 35 microM) DME1690 XEOTICID XEO03861 GENEFORM Protein DME1690 XEOTICID XEO03861 MOACRIVE Inhibition DME1690 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1690 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03862 XEO_CLAS Peptide DME1690 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 70 microM) DME1690 XEOTICID XEO03862 GENEFORM Protein DME1690 XEOTICID XEO03862 MOACRIVE Inhibition DME1690 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1690 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03863 XEO_CLAS Peptide DME1690 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 35 microM) DME1690 XEOTICID XEO03863 GENEFORM Protein DME1690 XEOTICID XEO03863 MOACRIVE Inhibition DME1690 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1690 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03864 XEO_CLAS Peptide DME1690 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO03864 GENEFORM Protein DME1690 XEOTICID XEO03864 MOACRIVE Inhibition DME1690 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1690 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03865 XEO_CLAS Peptide DME1690 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO03865 GENEFORM Protein DME1690 XEOTICID XEO03865 MOACRIVE Inhibition DME1690 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1690 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03866 XEO_CLAS Peptide DME1690 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 microM) DME1690 XEOTICID XEO03866 GENEFORM Protein DME1690 XEOTICID XEO03866 MOACRIVE Inhibition DME1690 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1690 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03867 XEO_CLAS Peptide DME1690 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40 microM) DME1690 XEOTICID XEO03867 GENEFORM Protein DME1690 XEOTICID XEO03867 MOACRIVE Inhibition DME1690 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1690 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03868 XEO_CLAS Peptide DME1690 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 51 microM) DME1690 XEOTICID XEO03868 GENEFORM Protein DME1690 XEOTICID XEO03868 MOACRIVE Inhibition DME1690 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1690 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03869 XEO_CLAS Peptide DME1690 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 35 microM) DME1690 XEOTICID XEO03869 GENEFORM Protein DME1690 XEOTICID XEO03869 MOACRIVE Inhibition DME1690 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1690 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03870 XEO_CLAS Peptide DME1690 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 61 microM) DME1690 XEOTICID XEO03870 GENEFORM Protein DME1690 XEOTICID XEO03870 MOACRIVE Inhibition DME1690 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1690 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03871 XEO_CLAS Peptide DME1690 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 microM) DME1690 XEOTICID XEO03871 GENEFORM Protein DME1690 XEOTICID XEO03871 MOACRIVE Inhibition DME1690 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1690 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03872 XEO_CLAS Peptide DME1690 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 28 microM) DME1690 XEOTICID XEO03872 GENEFORM Protein DME1690 XEOTICID XEO03872 MOACRIVE Inhibition DME1690 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1690 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03873 XEO_CLAS Peptide DME1690 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 22.5 microM) DME1690 XEOTICID XEO03873 GENEFORM Protein DME1690 XEOTICID XEO03873 MOACRIVE Inhibition DME1690 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1690 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03874 XEO_CLAS Peptide DME1690 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 11.25 microM) DME1690 XEOTICID XEO03874 GENEFORM Protein DME1690 XEOTICID XEO03874 MOACRIVE Inhibition DME1690 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1690 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03875 XEO_CLAS Peptide DME1690 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 microM) DME1690 XEOTICID XEO03875 GENEFORM Protein DME1690 XEOTICID XEO03875 MOACRIVE Inhibition DME1690 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1690 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03876 XEO_CLAS Peptide DME1690 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.75 microM) DME1690 XEOTICID XEO03876 GENEFORM Protein DME1690 XEOTICID XEO03876 MOACRIVE Inhibition DME1690 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1690 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03877 XEO_CLAS Peptide DME1690 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 microM) DME1690 XEOTICID XEO03877 GENEFORM Protein DME1690 XEOTICID XEO03877 MOACRIVE Inhibition DME1690 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1690 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03878 XEO_CLAS Peptide DME1690 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 microM) DME1690 XEOTICID XEO03878 GENEFORM Protein DME1690 XEOTICID XEO03878 MOACRIVE Inhibition DME1690 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1690 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03879 XEO_CLAS Peptide DME1690 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 252 microM) DME1690 XEOTICID XEO03879 GENEFORM Protein DME1690 XEOTICID XEO03879 MOACRIVE Inhibition DME1690 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1690 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03880 XEO_CLAS Peptide DME1690 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 174 microM) DME1690 XEOTICID XEO03880 GENEFORM Protein DME1690 XEOTICID XEO03880 MOACRIVE Inhibition DME1690 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1690 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03883 XEO_CLAS Peptide DME1690 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 74 microM) DME1690 XEOTICID XEO03883 GENEFORM Protein DME1690 XEOTICID XEO03883 MOACRIVE Inhibition DME1690 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1690 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03884 XEO_CLAS Peptide DME1690 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 31 microM) DME1690 XEOTICID XEO03884 GENEFORM Protein DME1690 XEOTICID XEO03884 MOACRIVE Inhibition DME1690 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1690 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03885 XEO_CLAS Peptide DME1690 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO03885 GENEFORM Protein DME1690 XEOTICID XEO03885 MOACRIVE Inhibition DME1690 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1690 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03886 XEO_CLAS Peptide DME1690 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 391 microM) DME1690 XEOTICID XEO03886 GENEFORM Protein DME1690 XEOTICID XEO03886 MOACRIVE Inhibition DME1690 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1690 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03887 XEO_CLAS Peptide DME1690 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 151 microM) DME1690 XEOTICID XEO03887 GENEFORM Protein DME1690 XEOTICID XEO03887 MOACRIVE Inhibition DME1690 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1690 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03888 XEO_CLAS Peptide DME1690 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 134 microM) DME1690 XEOTICID XEO03888 GENEFORM Protein DME1690 XEOTICID XEO03888 MOACRIVE Inhibition DME1690 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1690 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03889 XEO_CLAS Peptide DME1690 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 88 microM) DME1690 XEOTICID XEO03889 GENEFORM Protein DME1690 XEOTICID XEO03889 MOACRIVE Inhibition DME1690 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1690 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03890 XEO_CLAS Peptide DME1690 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 31 microM) DME1690 XEOTICID XEO03890 GENEFORM Protein DME1690 XEOTICID XEO03890 MOACRIVE Inhibition DME1690 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1690 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03891 XEO_CLAS Peptide DME1690 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 microM) DME1690 XEOTICID XEO03891 GENEFORM Protein DME1690 XEOTICID XEO03891 MOACRIVE Inhibition DME1690 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1690 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03892 XEO_CLAS Peptide DME1690 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 37 microM) DME1690 XEOTICID XEO03892 GENEFORM Protein DME1690 XEOTICID XEO03892 MOACRIVE Inhibition DME1690 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1690 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03893 XEO_CLAS Peptide DME1690 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 19 microM) DME1690 XEOTICID XEO03893 GENEFORM Protein DME1690 XEOTICID XEO03893 MOACRIVE Inhibition DME1690 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1690 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03894 XEO_CLAS Peptide DME1690 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO03894 GENEFORM Protein DME1690 XEOTICID XEO03894 MOACRIVE Inhibition DME1690 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1690 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03895 XEO_CLAS Peptide DME1690 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO03895 GENEFORM Protein DME1690 XEOTICID XEO03895 MOACRIVE Inhibition DME1690 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1690 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03896 XEO_CLAS Peptide DME1690 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 microM) DME1690 XEOTICID XEO03896 GENEFORM Protein DME1690 XEOTICID XEO03896 MOACRIVE Inhibition DME1690 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1690 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03897 XEO_CLAS Peptide DME1690 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 63 microM) DME1690 XEOTICID XEO03897 GENEFORM Protein DME1690 XEOTICID XEO03897 MOACRIVE Inhibition DME1690 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1690 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03898 XEO_CLAS Peptide DME1690 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 219 microM) DME1690 XEOTICID XEO03898 GENEFORM Protein DME1690 XEOTICID XEO03898 MOACRIVE Inhibition DME1690 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1690 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03901 XEO_CLAS Peptide DME1690 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 35 microM) DME1690 XEOTICID XEO03901 GENEFORM Protein DME1690 XEOTICID XEO03901 MOACRIVE Inhibition DME1690 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1690 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03902 XEO_CLAS Peptide DME1690 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 70 microM) DME1690 XEOTICID XEO03902 GENEFORM Protein DME1690 XEOTICID XEO03902 MOACRIVE Inhibition DME1690 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1690 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03904 XEO_CLAS Peptide DME1690 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO03904 GENEFORM Protein DME1690 XEOTICID XEO03904 MOACRIVE Inhibition DME1690 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1690 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03905 XEO_CLAS Peptide DME1690 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO03905 GENEFORM Protein DME1690 XEOTICID XEO03905 MOACRIVE Inhibition DME1690 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1690 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03908 XEO_CLAS Peptide DME1690 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03908 GENEFORM Protein DME1690 XEOTICID XEO03908 MOACRIVE Inhibition DME1690 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1690 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03915 XEO_CLAS Peptide DME1690 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03915 GENEFORM Protein DME1690 XEOTICID XEO03915 MOACRIVE Inhibition DME1690 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1690 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03916 XEO_CLAS Peptide DME1690 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.8 ug/ml) DME1690 XEOTICID XEO03916 GENEFORM Protein DME1690 XEOTICID XEO03916 MOACRIVE Inhibition DME1690 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1690 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03917 XEO_CLAS Peptide DME1690 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 13.1 ug/ml) DME1690 XEOTICID XEO03917 GENEFORM Protein DME1690 XEOTICID XEO03917 MOACRIVE Inhibition DME1690 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1690 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03918 XEO_CLAS Peptide DME1690 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.5 ug/ml) DME1690 XEOTICID XEO03918 GENEFORM Protein DME1690 XEOTICID XEO03918 MOACRIVE Inhibition DME1690 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1690 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03919 XEO_CLAS Peptide DME1690 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 80 ug/ml) DME1690 XEOTICID XEO03919 GENEFORM Protein DME1690 XEOTICID XEO03919 MOACRIVE Inhibition DME1690 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1690 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03922 XEO_CLAS Peptide DME1690 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 9 microM) DME1690 XEOTICID XEO03922 GENEFORM Protein DME1690 XEOTICID XEO03922 MOACRIVE Inhibition DME1690 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1690 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03923 XEO_CLAS Peptide DME1690 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 80 microM) DME1690 XEOTICID XEO03923 GENEFORM Protein DME1690 XEOTICID XEO03923 MOACRIVE Inhibition DME1690 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1690 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03924 XEO_CLAS Peptide DME1690 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO03924 GENEFORM Protein DME1690 XEOTICID XEO03924 MOACRIVE Inhibition DME1690 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1690 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03927 XEO_CLAS Peptide DME1690 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 80 microM) DME1690 XEOTICID XEO03927 GENEFORM Protein DME1690 XEOTICID XEO03927 MOACRIVE Inhibition DME1690 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1690 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03928 XEO_CLAS Peptide DME1690 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 microM) DME1690 XEOTICID XEO03928 GENEFORM Protein DME1690 XEOTICID XEO03928 MOACRIVE Inhibition DME1690 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1690 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03929 XEO_CLAS Peptide DME1690 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 microM) DME1690 XEOTICID XEO03929 GENEFORM Protein DME1690 XEOTICID XEO03929 MOACRIVE Inhibition DME1690 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1690 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03930 XEO_CLAS Peptide DME1690 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 microM) DME1690 XEOTICID XEO03930 GENEFORM Protein DME1690 XEOTICID XEO03930 MOACRIVE Inhibition DME1690 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1690 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03931 XEO_CLAS Peptide DME1690 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 microM) DME1690 XEOTICID XEO03931 GENEFORM Protein DME1690 XEOTICID XEO03931 MOACRIVE Inhibition DME1690 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1690 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03933 XEO_CLAS Peptide DME1690 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.5 microM) DME1690 XEOTICID XEO03933 GENEFORM Protein DME1690 XEOTICID XEO03933 MOACRIVE Inhibition DME1690 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1690 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03934 XEO_CLAS Peptide DME1690 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.7 microM) DME1690 XEOTICID XEO03934 GENEFORM Protein DME1690 XEOTICID XEO03934 MOACRIVE Inhibition DME1690 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1690 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03935 XEO_CLAS Peptide DME1690 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.7 microM) DME1690 XEOTICID XEO03935 GENEFORM Protein DME1690 XEOTICID XEO03935 MOACRIVE Inhibition DME1690 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1690 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03936 XEO_CLAS Peptide DME1690 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.0 microM) DME1690 XEOTICID XEO03936 GENEFORM Protein DME1690 XEOTICID XEO03936 MOACRIVE Inhibition DME1690 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1690 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03937 XEO_CLAS Peptide DME1690 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.1 microM) DME1690 XEOTICID XEO03937 GENEFORM Protein DME1690 XEOTICID XEO03937 MOACRIVE Inhibition DME1690 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1690 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03938 XEO_CLAS Peptide DME1690 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.7 microM) DME1690 XEOTICID XEO03938 GENEFORM Protein DME1690 XEOTICID XEO03938 MOACRIVE Inhibition DME1690 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1690 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03939 XEO_CLAS Peptide DME1690 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.7 microM) DME1690 XEOTICID XEO03939 GENEFORM Protein DME1690 XEOTICID XEO03939 MOACRIVE Inhibition DME1690 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1690 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03940 XEO_CLAS Peptide DME1690 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.5 microM) DME1690 XEOTICID XEO03940 GENEFORM Protein DME1690 XEOTICID XEO03940 MOACRIVE Inhibition DME1690 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1690 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03941 XEO_CLAS Peptide DME1690 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.4 microM) DME1690 XEOTICID XEO03941 GENEFORM Protein DME1690 XEOTICID XEO03941 MOACRIVE Inhibition DME1690 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1690 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03943 XEO_CLAS Peptide DME1690 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.4 microM) DME1690 XEOTICID XEO03943 GENEFORM Protein DME1690 XEOTICID XEO03943 MOACRIVE Inhibition DME1690 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1690 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03944 XEO_CLAS Peptide DME1690 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.7 microM) DME1690 XEOTICID XEO03944 GENEFORM Protein DME1690 XEOTICID XEO03944 MOACRIVE Inhibition DME1690 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1690 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03945 XEO_CLAS Peptide DME1690 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.2 microM) DME1690 XEOTICID XEO03945 GENEFORM Protein DME1690 XEOTICID XEO03945 MOACRIVE Inhibition DME1690 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1690 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03947 XEO_CLAS Peptide DME1690 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.0 microM) DME1690 XEOTICID XEO03947 GENEFORM Protein DME1690 XEOTICID XEO03947 MOACRIVE Inhibition DME1690 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1690 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03948 XEO_CLAS Peptide DME1690 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 23.3 microM) DME1690 XEOTICID XEO03948 GENEFORM Protein DME1690 XEOTICID XEO03948 MOACRIVE Inhibition DME1690 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1690 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03950 XEO_CLAS Peptide DME1690 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4.4 microM) DME1690 XEOTICID XEO03950 GENEFORM Protein DME1690 XEOTICID XEO03950 MOACRIVE Inhibition DME1690 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1690 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03951 XEO_CLAS Peptide DME1690 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8.8 microM) DME1690 XEOTICID XEO03951 GENEFORM Protein DME1690 XEOTICID XEO03951 MOACRIVE Inhibition DME1690 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1690 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03952 XEO_CLAS Peptide DME1690 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.2 microM) DME1690 XEOTICID XEO03952 GENEFORM Protein DME1690 XEOTICID XEO03952 MOACRIVE Inhibition DME1690 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1690 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03953 XEO_CLAS Peptide DME1690 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 microM) DME1690 XEOTICID XEO03953 GENEFORM Protein DME1690 XEOTICID XEO03953 MOACRIVE Inhibition DME1690 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1690 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03958 XEO_CLAS Peptide DME1690 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03958 GENEFORM Protein DME1690 XEOTICID XEO03958 MOACRIVE Inhibition DME1690 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1690 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03965 XEO_CLAS Peptide DME1690 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 128 microM) DME1690 XEOTICID XEO03965 GENEFORM Protein DME1690 XEOTICID XEO03965 MOACRIVE Inhibition DME1690 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1690 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03966 XEO_CLAS Peptide DME1690 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 microM) DME1690 XEOTICID XEO03966 GENEFORM Protein DME1690 XEOTICID XEO03966 MOACRIVE Inhibition DME1690 XEOTICID XEO03971 XEO_NAME Lumbrican DME1690 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03971 XEO_CLAS Peptide DME1690 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03971 GENEFORM Protein DME1690 XEOTICID XEO03971 MOACRIVE Inhibition DME1690 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1690 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03972 XEO_CLAS Peptide DME1690 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO03972 GENEFORM Protein DME1690 XEOTICID XEO03972 MOACRIVE Inhibition DME1690 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1690 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03980 XEO_CLAS Peptide DME1690 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 32 microM) DME1690 XEOTICID XEO03980 GENEFORM Protein DME1690 XEOTICID XEO03980 MOACRIVE Inhibition DME1690 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1690 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03985 XEO_CLAS Peptide DME1690 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 ug/ml) DME1690 XEOTICID XEO03985 GENEFORM Protein DME1690 XEOTICID XEO03985 MOACRIVE Inhibition DME1690 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1690 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03991 XEO_CLAS Peptide DME1690 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03991 GENEFORM Protein DME1690 XEOTICID XEO03991 MOACRIVE Inhibition DME1690 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1690 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03992 XEO_CLAS Peptide DME1690 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03992 GENEFORM Protein DME1690 XEOTICID XEO03992 MOACRIVE Inhibition DME1690 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1690 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03993 XEO_CLAS Peptide DME1690 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03993 GENEFORM Protein DME1690 XEOTICID XEO03993 MOACRIVE Inhibition DME1690 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1690 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03994 XEO_CLAS Peptide DME1690 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO03994 GENEFORM Protein DME1690 XEOTICID XEO03994 MOACRIVE Inhibition DME1690 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1690 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03996 XEO_CLAS Peptide DME1690 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 65 microM) DME1690 XEOTICID XEO03996 GENEFORM Protein DME1690 XEOTICID XEO03996 MOACRIVE Inhibition DME1690 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1690 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03997 XEO_CLAS Peptide DME1690 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 7.5 microM) DME1690 XEOTICID XEO03997 GENEFORM Protein DME1690 XEOTICID XEO03997 MOACRIVE Inhibition DME1690 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1690 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03998 XEO_CLAS Peptide DME1690 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15.5 microM) DME1690 XEOTICID XEO03998 GENEFORM Protein DME1690 XEOTICID XEO03998 MOACRIVE Inhibition DME1690 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1690 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO03999 XEO_CLAS Peptide DME1690 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25.8 microM) DME1690 XEOTICID XEO03999 GENEFORM Protein DME1690 XEOTICID XEO03999 MOACRIVE Inhibition DME1690 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1690 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04000 XEO_CLAS Peptide DME1690 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO04000 GENEFORM Protein DME1690 XEOTICID XEO04000 MOACRIVE Inhibition DME1690 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1690 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04001 XEO_CLAS Peptide DME1690 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO04001 GENEFORM Protein DME1690 XEOTICID XEO04001 MOACRIVE Inhibition DME1690 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1690 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04002 XEO_CLAS Peptide DME1690 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 7.5 ug/ml) DME1690 XEOTICID XEO04002 GENEFORM Protein DME1690 XEOTICID XEO04002 MOACRIVE Inhibition DME1690 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1690 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04003 XEO_CLAS Peptide DME1690 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 ug/ml) DME1690 XEOTICID XEO04003 GENEFORM Protein DME1690 XEOTICID XEO04003 MOACRIVE Inhibition DME1690 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1690 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04004 XEO_CLAS Peptide DME1690 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.0 ug/ml) DME1690 XEOTICID XEO04004 GENEFORM Protein DME1690 XEOTICID XEO04004 MOACRIVE Inhibition DME1690 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1690 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04005 XEO_CLAS Peptide DME1690 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.0 ug/ml) DME1690 XEOTICID XEO04005 GENEFORM Protein DME1690 XEOTICID XEO04005 MOACRIVE Inhibition DME1690 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1690 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04007 XEO_CLAS Peptide DME1690 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 19.5 ug/ml) DME1690 XEOTICID XEO04007 GENEFORM Protein DME1690 XEOTICID XEO04007 MOACRIVE Inhibition DME1690 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1690 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04011 XEO_CLAS Peptide DME1690 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 19.5 ug/ml) DME1690 XEOTICID XEO04011 GENEFORM Protein DME1690 XEOTICID XEO04011 MOACRIVE Inhibition DME1690 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1690 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04012 XEO_CLAS Peptide DME1690 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.9 ug/ml) DME1690 XEOTICID XEO04012 GENEFORM Protein DME1690 XEOTICID XEO04012 MOACRIVE Inhibition DME1690 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1690 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04013 XEO_CLAS Peptide DME1690 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.7 ug/ml) DME1690 XEOTICID XEO04013 GENEFORM Protein DME1690 XEOTICID XEO04013 MOACRIVE Inhibition DME1690 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1690 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04018 XEO_CLAS Peptide DME1690 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 9 ug/ml) DME1690 XEOTICID XEO04018 GENEFORM Protein DME1690 XEOTICID XEO04018 MOACRIVE Inhibition DME1690 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1690 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04026 XEO_CLAS Peptide DME1690 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO04026 GENEFORM Protein DME1690 XEOTICID XEO04026 MOACRIVE Inhibition DME1690 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1690 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04027 XEO_CLAS Peptide DME1690 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO04027 GENEFORM Protein DME1690 XEOTICID XEO04027 MOACRIVE Inhibition DME1690 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1690 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04028 XEO_CLAS Peptide DME1690 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 ug/ml) DME1690 XEOTICID XEO04028 GENEFORM Protein DME1690 XEOTICID XEO04028 MOACRIVE Inhibition DME1690 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1690 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04038 XEO_CLAS Peptide DME1690 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04038 GENEFORM Protein DME1690 XEOTICID XEO04038 MOACRIVE Inhibition DME1690 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1690 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04039 XEO_CLAS Peptide DME1690 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 microM) DME1690 XEOTICID XEO04039 GENEFORM Protein DME1690 XEOTICID XEO04039 MOACRIVE Inhibition DME1690 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1690 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04051 XEO_CLAS Peptide DME1690 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1690 XEOTICID XEO04051 GENEFORM Protein DME1690 XEOTICID XEO04051 MOACRIVE Inhibition DME1690 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1690 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04052 XEO_CLAS Peptide DME1690 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04052 GENEFORM Protein DME1690 XEOTICID XEO04052 MOACRIVE Inhibition DME1690 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1690 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04053 XEO_CLAS Peptide DME1690 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.08-0.16 microM) DME1690 XEOTICID XEO04053 GENEFORM Protein DME1690 XEOTICID XEO04053 MOACRIVE Inhibition DME1690 XEOTICID XEO04055 XEO_NAME Melectin DME1690 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04055 XEO_CLAS Peptide DME1690 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.0 microM) DME1690 XEOTICID XEO04055 GENEFORM Protein DME1690 XEOTICID XEO04055 MOACRIVE Inhibition DME1690 XEOTICID XEO04057 XEO_NAME Melittin DME1690 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04057 XEO_CLAS Peptide DME1690 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.8 microM) DME1690 XEOTICID XEO04057 GENEFORM Protein DME1690 XEOTICID XEO04057 MOACRIVE Inhibition DME1690 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1690 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04061 XEO_CLAS Peptide DME1690 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.9 microM) DME1690 XEOTICID XEO04061 GENEFORM Protein DME1690 XEOTICID XEO04061 MOACRIVE Inhibition DME1690 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1690 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04062 XEO_CLAS Peptide DME1690 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.5 microM) DME1690 XEOTICID XEO04062 GENEFORM Protein DME1690 XEOTICID XEO04062 MOACRIVE Inhibition DME1690 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1690 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04063 XEO_CLAS Peptide DME1690 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 7.8 microM) DME1690 XEOTICID XEO04063 GENEFORM Protein DME1690 XEOTICID XEO04063 MOACRIVE Inhibition DME1690 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1690 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04064 XEO_CLAS Peptide DME1690 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 46.7 microM) DME1690 XEOTICID XEO04064 GENEFORM Protein DME1690 XEOTICID XEO04064 MOACRIVE Inhibition DME1690 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1690 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04066 XEO_CLAS Peptide DME1690 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16.3 microM) DME1690 XEOTICID XEO04066 GENEFORM Protein DME1690 XEOTICID XEO04066 MOACRIVE Inhibition DME1690 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1690 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04067 XEO_CLAS Peptide DME1690 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.6 microM) DME1690 XEOTICID XEO04067 GENEFORM Protein DME1690 XEOTICID XEO04067 MOACRIVE Inhibition DME1690 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1690 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04068 XEO_CLAS Peptide DME1690 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.6 microM) DME1690 XEOTICID XEO04068 GENEFORM Protein DME1690 XEOTICID XEO04068 MOACRIVE Inhibition DME1690 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1690 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04086 GENEFORM Protein DME1690 XEOTICID XEO04086 MOACRIVE Inhibition DME1690 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1690 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04087 GENEFORM Protein DME1690 XEOTICID XEO04087 MOACRIVE Inhibition DME1690 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1690 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04089 GENEFORM Protein DME1690 XEOTICID XEO04089 MOACRIVE Inhibition DME1690 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1690 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04094 GENEFORM Protein DME1690 XEOTICID XEO04094 MOACRIVE Inhibition DME1690 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1690 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04096 GENEFORM Protein DME1690 XEOTICID XEO04096 MOACRIVE Inhibition DME1690 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1690 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04098 GENEFORM Protein DME1690 XEOTICID XEO04098 MOACRIVE Inhibition DME1690 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1690 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04111 XEO_CLAS Peptide DME1690 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04111 GENEFORM Protein DME1690 XEOTICID XEO04111 MOACRIVE Inhibition DME1690 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1690 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04112 XEO_CLAS Peptide DME1690 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.02 microM) DME1690 XEOTICID XEO04112 GENEFORM Protein DME1690 XEOTICID XEO04112 MOACRIVE Inhibition DME1690 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1690 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04113 XEO_CLAS Peptide DME1690 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.02 ug/ml) DME1690 XEOTICID XEO04113 GENEFORM Protein DME1690 XEOTICID XEO04113 MOACRIVE Inhibition DME1690 XEOTICID XEO04114 XEO_NAME Microcin L DME1690 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04114 XEO_CLAS Peptide DME1690 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04114 GENEFORM Protein DME1690 XEOTICID XEO04114 MOACRIVE Inhibition DME1690 XEOTICID XEO04117 XEO_NAME Misgurin DME1690 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04117 XEO_CLAS Peptide DME1690 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04117 GENEFORM Protein DME1690 XEOTICID XEO04117 MOACRIVE Inhibition DME1690 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1690 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04118 XEO_CLAS Peptide DME1690 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 300 microM) DME1690 XEOTICID XEO04118 GENEFORM Protein DME1690 XEOTICID XEO04118 MOACRIVE Inhibition DME1690 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1690 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04119 XEO_CLAS Peptide DME1690 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-20 microM) DME1690 XEOTICID XEO04119 GENEFORM Protein DME1690 XEOTICID XEO04119 MOACRIVE Inhibition DME1690 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1690 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04120 XEO_CLAS Peptide DME1690 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC < 10 microM) DME1690 XEOTICID XEO04120 GENEFORM Protein DME1690 XEOTICID XEO04120 MOACRIVE Inhibition DME1690 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1690 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04121 XEO_CLAS Peptide DME1690 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.2-6.4 microM) DME1690 XEOTICID XEO04121 GENEFORM Protein DME1690 XEOTICID XEO04121 MOACRIVE Inhibition DME1690 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1690 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04122 XEO_CLAS Peptide DME1690 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.14-6.29 microM) DME1690 XEOTICID XEO04122 GENEFORM Protein DME1690 XEOTICID XEO04122 MOACRIVE Inhibition DME1690 XEOTICID XEO04123 XEO_NAME Modified defensin DME1690 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04123 XEO_CLAS Peptide DME1690 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO04123 GENEFORM Protein DME1690 XEOTICID XEO04123 MOACRIVE Inhibition DME1690 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1690 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04128 XEO_CLAS Peptide DME1690 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.31 microM) DME1690 XEOTICID XEO04128 GENEFORM Protein DME1690 XEOTICID XEO04128 MOACRIVE Inhibition DME1690 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1690 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04129 XEO_CLAS Peptide DME1690 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO04129 GENEFORM Protein DME1690 XEOTICID XEO04129 MOACRIVE Inhibition DME1690 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1690 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04130 XEO_CLAS Peptide DME1690 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO04130 GENEFORM Protein DME1690 XEOTICID XEO04130 MOACRIVE Inhibition DME1690 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1690 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04131 XEO_CLAS Peptide DME1690 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 microM) DME1690 XEOTICID XEO04131 GENEFORM Protein DME1690 XEOTICID XEO04131 MOACRIVE Inhibition DME1690 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1690 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04132 XEO_CLAS Peptide DME1690 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 microM) DME1690 XEOTICID XEO04132 GENEFORM Protein DME1690 XEOTICID XEO04132 MOACRIVE Inhibition DME1690 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1690 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04133 XEO_CLAS Peptide DME1690 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO04133 GENEFORM Protein DME1690 XEOTICID XEO04133 MOACRIVE Inhibition DME1690 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1690 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04134 XEO_CLAS Peptide DME1690 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO04134 GENEFORM Protein DME1690 XEOTICID XEO04134 MOACRIVE Inhibition DME1690 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1690 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04135 XEO_CLAS Peptide DME1690 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 microM) DME1690 XEOTICID XEO04135 GENEFORM Protein DME1690 XEOTICID XEO04135 MOACRIVE Inhibition DME1690 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1690 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04137 XEO_CLAS Peptide DME1690 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.6 microM) DME1690 XEOTICID XEO04137 GENEFORM Protein DME1690 XEOTICID XEO04137 MOACRIVE Inhibition DME1690 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1690 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04138 XEO_CLAS Peptide DME1690 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 microM) DME1690 XEOTICID XEO04138 GENEFORM Protein DME1690 XEOTICID XEO04138 MOACRIVE Inhibition DME1690 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1690 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04139 XEO_CLAS Peptide DME1690 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 microM) DME1690 XEOTICID XEO04139 GENEFORM Protein DME1690 XEOTICID XEO04139 MOACRIVE Inhibition DME1690 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1690 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04140 XEO_CLAS Peptide DME1690 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 70 microM) DME1690 XEOTICID XEO04140 GENEFORM Protein DME1690 XEOTICID XEO04140 MOACRIVE Inhibition DME1690 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1690 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04141 XEO_CLAS Peptide DME1690 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 microM) DME1690 XEOTICID XEO04141 GENEFORM Protein DME1690 XEOTICID XEO04141 MOACRIVE Inhibition DME1690 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1690 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04142 XEO_CLAS Peptide DME1690 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8-16 microM) DME1690 XEOTICID XEO04142 GENEFORM Protein DME1690 XEOTICID XEO04142 MOACRIVE Inhibition DME1690 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1690 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04146 XEO_CLAS Peptide DME1690 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04146 GENEFORM Protein DME1690 XEOTICID XEO04146 MOACRIVE Inhibition DME1690 XEOTICID XEO04149 XEO_NAME Mucroporin DME1690 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04149 XEO_CLAS Peptide DME1690 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 ug/ml) DME1690 XEOTICID XEO04149 GENEFORM Protein DME1690 XEOTICID XEO04149 MOACRIVE Inhibition DME1690 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1690 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04158 XEO_CLAS Peptide DME1690 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO04158 GENEFORM Protein DME1690 XEOTICID XEO04158 MOACRIVE Inhibition DME1690 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1690 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04159 XEO_CLAS Peptide DME1690 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 microM) DME1690 XEOTICID XEO04159 GENEFORM Protein DME1690 XEOTICID XEO04159 MOACRIVE Inhibition DME1690 XEOTICID XEO04167 XEO_NAME Myticin-B DME1690 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04167 XEO_CLAS Peptide DME1690 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04167 GENEFORM Protein DME1690 XEOTICID XEO04167 MOACRIVE Inhibition DME1690 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1690 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04168 XEO_CLAS Peptide DME1690 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.7-12.5 microM) DME1690 XEOTICID XEO04168 GENEFORM Protein DME1690 XEOTICID XEO04168 MOACRIVE Inhibition DME1690 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1690 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04169 XEO_CLAS Peptide DME1690 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04169 GENEFORM Protein DME1690 XEOTICID XEO04169 MOACRIVE Inhibition DME1690 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1690 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04170 XEO_CLAS Peptide DME1690 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04170 GENEFORM Protein DME1690 XEOTICID XEO04170 MOACRIVE Inhibition DME1690 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1690 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04171 XEO_CLAS Peptide DME1690 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04171 GENEFORM Protein DME1690 XEOTICID XEO04171 MOACRIVE Inhibition DME1690 XEOTICID XEO04172 XEO_NAME Myxinidin DME1690 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04172 XEO_CLAS Peptide DME1690 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04172 GENEFORM Protein DME1690 XEOTICID XEO04172 MOACRIVE Inhibition DME1690 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1690 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04177 XEO_CLAS Peptide DME1690 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.7 microM) DME1690 XEOTICID XEO04177 GENEFORM Protein DME1690 XEOTICID XEO04177 MOACRIVE Inhibition DME1690 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1690 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04178 XEO_CLAS Peptide DME1690 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.7 microM) DME1690 XEOTICID XEO04178 GENEFORM Protein DME1690 XEOTICID XEO04178 MOACRIVE Inhibition DME1690 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1690 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04179 XEO_CLAS Peptide DME1690 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.5 microM) DME1690 XEOTICID XEO04179 GENEFORM Protein DME1690 XEOTICID XEO04179 MOACRIVE Inhibition DME1690 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1690 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04180 XEO_CLAS Peptide DME1690 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 23 microM) DME1690 XEOTICID XEO04180 GENEFORM Protein DME1690 XEOTICID XEO04180 MOACRIVE Inhibition DME1690 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1690 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04181 XEO_CLAS Peptide DME1690 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.2 microM) DME1690 XEOTICID XEO04181 GENEFORM Protein DME1690 XEOTICID XEO04181 MOACRIVE Inhibition DME1690 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1690 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04182 XEO_CLAS Peptide DME1690 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4.4 microM) DME1690 XEOTICID XEO04182 GENEFORM Protein DME1690 XEOTICID XEO04182 MOACRIVE Inhibition DME1690 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1690 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04183 XEO_CLAS Peptide DME1690 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.6 microM) DME1690 XEOTICID XEO04183 GENEFORM Protein DME1690 XEOTICID XEO04183 MOACRIVE Inhibition DME1690 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1690 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04184 XEO_CLAS Peptide DME1690 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 microM) DME1690 XEOTICID XEO04184 GENEFORM Protein DME1690 XEOTICID XEO04184 MOACRIVE Inhibition DME1690 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1690 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04185 XEO_CLAS Peptide DME1690 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04185 GENEFORM Protein DME1690 XEOTICID XEO04185 MOACRIVE Inhibition DME1690 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1690 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04186 XEO_CLAS Peptide DME1690 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04186 GENEFORM Protein DME1690 XEOTICID XEO04186 MOACRIVE Inhibition DME1690 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1690 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04187 XEO_CLAS Peptide DME1690 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04187 GENEFORM Protein DME1690 XEOTICID XEO04187 MOACRIVE Inhibition DME1690 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1690 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04188 XEO_CLAS Peptide DME1690 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04188 GENEFORM Protein DME1690 XEOTICID XEO04188 MOACRIVE Inhibition DME1690 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1690 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04206 XEO_CLAS Peptide DME1690 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25 microM) DME1690 XEOTICID XEO04206 GENEFORM Protein DME1690 XEOTICID XEO04206 MOACRIVE Inhibition DME1690 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1690 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04214 XEO_CLAS Peptide DME1690 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25 microM) DME1690 XEOTICID XEO04214 GENEFORM Protein DME1690 XEOTICID XEO04214 MOACRIVE Inhibition DME1690 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1690 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04216 XEO_CLAS Peptide DME1690 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO04216 GENEFORM Protein DME1690 XEOTICID XEO04216 MOACRIVE Inhibition DME1690 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1690 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04218 XEO_CLAS Peptide DME1690 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.125 microM) DME1690 XEOTICID XEO04218 GENEFORM Protein DME1690 XEOTICID XEO04218 MOACRIVE Inhibition DME1690 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1690 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04219 XEO_CLAS Peptide DME1690 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO04219 GENEFORM Protein DME1690 XEOTICID XEO04219 MOACRIVE Inhibition DME1690 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1690 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04220 XEO_CLAS Peptide DME1690 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.125 microM) DME1690 XEOTICID XEO04220 GENEFORM Protein DME1690 XEOTICID XEO04220 MOACRIVE Inhibition DME1690 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1690 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04221 XEO_CLAS Peptide DME1690 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO04221 GENEFORM Protein DME1690 XEOTICID XEO04221 MOACRIVE Inhibition DME1690 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1690 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04222 XEO_CLAS Peptide DME1690 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25 microM) DME1690 XEOTICID XEO04222 GENEFORM Protein DME1690 XEOTICID XEO04222 MOACRIVE Inhibition DME1690 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1690 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04233 XEO_CLAS Peptide DME1690 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04233 GENEFORM Protein DME1690 XEOTICID XEO04233 MOACRIVE Inhibition DME1690 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1690 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04234 XEO_CLAS Peptide DME1690 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04234 GENEFORM Protein DME1690 XEOTICID XEO04234 MOACRIVE Inhibition DME1690 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1690 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04241 XEO_CLAS Peptide DME1690 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04241 GENEFORM Protein DME1690 XEOTICID XEO04241 MOACRIVE Inhibition DME1690 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1690 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04242 XEO_CLAS Peptide DME1690 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04242 GENEFORM Protein DME1690 XEOTICID XEO04242 MOACRIVE Inhibition DME1690 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1690 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04245 XEO_CLAS Natural Product DME1690 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04245 GENEFORM Protein DME1690 XEOTICID XEO04245 MOACRIVE Inhibition DME1690 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1690 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04246 XEO_CLAS Natural Product DME1690 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04246 GENEFORM Protein DME1690 XEOTICID XEO04246 MOACRIVE Inhibition DME1690 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1690 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04249 XEO_CLAS Peptide DME1690 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 500 ug/ml) DME1690 XEOTICID XEO04249 GENEFORM Protein DME1690 XEOTICID XEO04249 MOACRIVE Inhibition DME1690 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1690 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04251 XEO_CLAS Peptide DME1690 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04251 GENEFORM Protein DME1690 XEOTICID XEO04251 MOACRIVE Inhibition DME1690 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1690 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04253 XEO_CLAS Peptide DME1690 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04253 GENEFORM Protein DME1690 XEOTICID XEO04253 MOACRIVE Inhibition DME1690 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1690 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04254 XEO_CLAS Peptide DME1690 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04254 GENEFORM Protein DME1690 XEOTICID XEO04254 MOACRIVE Inhibition DME1690 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1690 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04255 XEO_CLAS Peptide DME1690 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04255 GENEFORM Protein DME1690 XEOTICID XEO04255 MOACRIVE Inhibition DME1690 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1690 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04256 XEO_CLAS Peptide DME1690 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04256 GENEFORM Protein DME1690 XEOTICID XEO04256 MOACRIVE Inhibition DME1690 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1690 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04257 XEO_CLAS Peptide DME1690 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04257 GENEFORM Protein DME1690 XEOTICID XEO04257 MOACRIVE Inhibition DME1690 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1690 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04258 XEO_CLAS Peptide DME1690 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04258 GENEFORM Protein DME1690 XEOTICID XEO04258 MOACRIVE Inhibition DME1690 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1690 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04259 XEO_CLAS Peptide DME1690 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04259 GENEFORM Protein DME1690 XEOTICID XEO04259 MOACRIVE Inhibition DME1690 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1690 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04260 XEO_CLAS Peptide DME1690 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04260 GENEFORM Protein DME1690 XEOTICID XEO04260 MOACRIVE Inhibition DME1690 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1690 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04261 XEO_CLAS Peptide DME1690 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04261 GENEFORM Protein DME1690 XEOTICID XEO04261 MOACRIVE Inhibition DME1690 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1690 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04262 XEO_CLAS Peptide DME1690 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04262 GENEFORM Protein DME1690 XEOTICID XEO04262 MOACRIVE Inhibition DME1690 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1690 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04263 XEO_CLAS Peptide DME1690 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04263 GENEFORM Protein DME1690 XEOTICID XEO04263 MOACRIVE Inhibition DME1690 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1690 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04264 XEO_CLAS Peptide DME1690 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04264 GENEFORM Protein DME1690 XEOTICID XEO04264 MOACRIVE Inhibition DME1690 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1690 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04265 XEO_CLAS Peptide DME1690 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04265 GENEFORM Protein DME1690 XEOTICID XEO04265 MOACRIVE Inhibition DME1690 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1690 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04266 XEO_CLAS Peptide DME1690 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04266 GENEFORM Protein DME1690 XEOTICID XEO04266 MOACRIVE Inhibition DME1690 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1690 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04267 XEO_CLAS Peptide DME1690 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04267 GENEFORM Protein DME1690 XEOTICID XEO04267 MOACRIVE Inhibition DME1690 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1690 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04268 XEO_CLAS Peptide DME1690 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04268 GENEFORM Protein DME1690 XEOTICID XEO04268 MOACRIVE Inhibition DME1690 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1690 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04269 XEO_CLAS Peptide DME1690 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04269 GENEFORM Protein DME1690 XEOTICID XEO04269 MOACRIVE Inhibition DME1690 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1690 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04270 XEO_CLAS Peptide DME1690 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04270 GENEFORM Protein DME1690 XEOTICID XEO04270 MOACRIVE Inhibition DME1690 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1690 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04271 XEO_CLAS Peptide DME1690 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04271 GENEFORM Protein DME1690 XEOTICID XEO04271 MOACRIVE Inhibition DME1690 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1690 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04272 XEO_CLAS Peptide DME1690 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04272 GENEFORM Protein DME1690 XEOTICID XEO04272 MOACRIVE Inhibition DME1690 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1690 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04277 XEO_CLAS Peptide DME1690 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 110.00 ug/ml) DME1690 XEOTICID XEO04277 GENEFORM Protein DME1690 XEOTICID XEO04277 MOACRIVE Inhibition DME1690 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1690 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04280 XEO_CLAS Peptide DME1690 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 37.50 ug/ml) DME1690 XEOTICID XEO04280 GENEFORM Protein DME1690 XEOTICID XEO04280 MOACRIVE Inhibition DME1690 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1690 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04281 XEO_CLAS Peptide DME1690 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25.00 ug/ml) DME1690 XEOTICID XEO04281 GENEFORM Protein DME1690 XEOTICID XEO04281 MOACRIVE Inhibition DME1690 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1690 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04282 XEO_CLAS Peptide DME1690 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.2 ug/ml) DME1690 XEOTICID XEO04282 GENEFORM Protein DME1690 XEOTICID XEO04282 MOACRIVE Inhibition DME1690 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1690 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04283 XEO_CLAS Peptide DME1690 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.3 ug/ml) DME1690 XEOTICID XEO04283 GENEFORM Protein DME1690 XEOTICID XEO04283 MOACRIVE Inhibition DME1690 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1690 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04284 XEO_CLAS Peptide DME1690 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10.8 ug/ml) DME1690 XEOTICID XEO04284 GENEFORM Protein DME1690 XEOTICID XEO04284 MOACRIVE Inhibition DME1690 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1690 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04285 XEO_CLAS Peptide DME1690 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 11.5 ug/ml) DME1690 XEOTICID XEO04285 GENEFORM Protein DME1690 XEOTICID XEO04285 MOACRIVE Inhibition DME1690 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1690 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04286 XEO_CLAS Peptide DME1690 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8.6 ug/ml) DME1690 XEOTICID XEO04286 GENEFORM Protein DME1690 XEOTICID XEO04286 MOACRIVE Inhibition DME1690 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1690 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04287 XEO_CLAS Peptide DME1690 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10.2 ug/ml) DME1690 XEOTICID XEO04287 GENEFORM Protein DME1690 XEOTICID XEO04287 MOACRIVE Inhibition DME1690 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1690 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04288 XEO_CLAS Peptide DME1690 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4.4 ug/ml) DME1690 XEOTICID XEO04288 GENEFORM Protein DME1690 XEOTICID XEO04288 MOACRIVE Inhibition DME1690 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1690 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04289 XEO_CLAS Peptide DME1690 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.2 ug/ml) DME1690 XEOTICID XEO04289 GENEFORM Protein DME1690 XEOTICID XEO04289 MOACRIVE Inhibition DME1690 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1690 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04290 XEO_CLAS Peptide DME1690 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 11.3 ug/ml) DME1690 XEOTICID XEO04290 GENEFORM Protein DME1690 XEOTICID XEO04290 MOACRIVE Inhibition DME1690 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1690 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04291 XEO_CLAS Peptide DME1690 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 7.2 ug/ml) DME1690 XEOTICID XEO04291 GENEFORM Protein DME1690 XEOTICID XEO04291 MOACRIVE Inhibition DME1690 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1690 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04292 XEO_CLAS Peptide DME1690 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.1 ug/ml) DME1690 XEOTICID XEO04292 GENEFORM Protein DME1690 XEOTICID XEO04292 MOACRIVE Inhibition DME1690 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1690 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04293 XEO_CLAS Peptide DME1690 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO04293 GENEFORM Protein DME1690 XEOTICID XEO04293 MOACRIVE Inhibition DME1690 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1690 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04294 XEO_CLAS Peptide DME1690 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO04294 GENEFORM Protein DME1690 XEOTICID XEO04294 MOACRIVE Inhibition DME1690 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1690 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04295 XEO_CLAS Peptide DME1690 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO04295 GENEFORM Protein DME1690 XEOTICID XEO04295 MOACRIVE Inhibition DME1690 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1690 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04296 XEO_CLAS Peptide DME1690 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 28 microM) DME1690 XEOTICID XEO04296 GENEFORM Protein DME1690 XEOTICID XEO04296 MOACRIVE Inhibition DME1690 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1690 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04297 XEO_CLAS Peptide DME1690 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 14 microM) DME1690 XEOTICID XEO04297 GENEFORM Protein DME1690 XEOTICID XEO04297 MOACRIVE Inhibition DME1690 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1690 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04298 XEO_CLAS Peptide DME1690 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO04298 GENEFORM Protein DME1690 XEOTICID XEO04298 MOACRIVE Inhibition DME1690 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1690 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04299 XEO_CLAS Peptide DME1690 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO04299 GENEFORM Protein DME1690 XEOTICID XEO04299 MOACRIVE Inhibition DME1690 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1690 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04300 XEO_CLAS Peptide DME1690 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO04300 GENEFORM Protein DME1690 XEOTICID XEO04300 MOACRIVE Inhibition DME1690 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1690 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04301 XEO_CLAS Peptide DME1690 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 microM) DME1690 XEOTICID XEO04301 GENEFORM Protein DME1690 XEOTICID XEO04301 MOACRIVE Inhibition DME1690 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1690 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04302 XEO_CLAS Peptide DME1690 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 microM) DME1690 XEOTICID XEO04302 GENEFORM Protein DME1690 XEOTICID XEO04302 MOACRIVE Inhibition DME1690 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1690 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04303 XEO_CLAS Peptide DME1690 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 microM) DME1690 XEOTICID XEO04303 GENEFORM Protein DME1690 XEOTICID XEO04303 MOACRIVE Inhibition DME1690 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1690 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04304 XEO_CLAS Peptide DME1690 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO04304 GENEFORM Protein DME1690 XEOTICID XEO04304 MOACRIVE Inhibition DME1690 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1690 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04305 XEO_CLAS Peptide DME1690 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 70 microM) DME1690 XEOTICID XEO04305 GENEFORM Protein DME1690 XEOTICID XEO04305 MOACRIVE Inhibition DME1690 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1690 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04306 XEO_CLAS Peptide DME1690 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO04306 GENEFORM Protein DME1690 XEOTICID XEO04306 MOACRIVE Inhibition DME1690 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1690 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04307 XEO_CLAS Peptide DME1690 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 ug/ml) DME1690 XEOTICID XEO04307 GENEFORM Protein DME1690 XEOTICID XEO04307 MOACRIVE Inhibition DME1690 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1690 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04308 XEO_CLAS Peptide DME1690 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 9.37 ug/ml) DME1690 XEOTICID XEO04308 GENEFORM Protein DME1690 XEOTICID XEO04308 MOACRIVE Inhibition DME1690 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1690 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04309 XEO_CLAS Peptide DME1690 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 microM) DME1690 XEOTICID XEO04309 GENEFORM Protein DME1690 XEOTICID XEO04309 MOACRIVE Inhibition DME1690 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1690 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04310 XEO_CLAS Peptide DME1690 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO04310 GENEFORM Protein DME1690 XEOTICID XEO04310 MOACRIVE Inhibition DME1690 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1690 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04311 XEO_CLAS Peptide DME1690 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO04311 GENEFORM Protein DME1690 XEOTICID XEO04311 MOACRIVE Inhibition DME1690 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1690 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04312 XEO_CLAS Peptide DME1690 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4.68 ug/ml) DME1690 XEOTICID XEO04312 GENEFORM Protein DME1690 XEOTICID XEO04312 MOACRIVE Inhibition DME1690 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1690 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04313 XEO_CLAS Peptide DME1690 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4.68 ug/ml) DME1690 XEOTICID XEO04313 GENEFORM Protein DME1690 XEOTICID XEO04313 MOACRIVE Inhibition DME1690 XEOTICID XEO04331 XEO_NAME Norspermidine DME1690 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1690 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04331 GENEFORM Protein DME1690 XEOTICID XEO04331 MOACRIVE Inhibition DME1690 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1690 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04335 XEO_CLAS Peptide DME1690 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 32 ug/ml) DME1690 XEOTICID XEO04335 GENEFORM Protein DME1690 XEOTICID XEO04335 MOACRIVE Inhibition DME1690 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1690 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04336 XEO_CLAS Peptide DME1690 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 32 ug/ml) DME1690 XEOTICID XEO04336 GENEFORM Protein DME1690 XEOTICID XEO04336 MOACRIVE Inhibition DME1690 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1690 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04338 XEO_CLAS Peptide DME1690 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 ug/ml) DME1690 XEOTICID XEO04338 GENEFORM Protein DME1690 XEOTICID XEO04338 MOACRIVE Inhibition DME1690 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1690 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04339 XEO_CLAS Peptide DME1690 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 ug/ml) DME1690 XEOTICID XEO04339 GENEFORM Protein DME1690 XEOTICID XEO04339 MOACRIVE Inhibition DME1690 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1690 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04340 XEO_CLAS Peptide DME1690 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO04340 GENEFORM Protein DME1690 XEOTICID XEO04340 MOACRIVE Inhibition DME1690 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1690 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04344 XEO_CLAS Peptide DME1690 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04344 GENEFORM Protein DME1690 XEOTICID XEO04344 MOACRIVE Inhibition DME1690 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1690 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04345 XEO_CLAS Peptide DME1690 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04345 GENEFORM Protein DME1690 XEOTICID XEO04345 MOACRIVE Inhibition DME1690 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1690 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04346 XEO_CLAS Peptide DME1690 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04346 GENEFORM Protein DME1690 XEOTICID XEO04346 MOACRIVE Inhibition DME1690 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1690 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04347 XEO_CLAS Peptide DME1690 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 microM) DME1690 XEOTICID XEO04347 GENEFORM Protein DME1690 XEOTICID XEO04347 MOACRIVE Inhibition DME1690 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1690 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04348 XEO_CLAS Peptide DME1690 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40 microM) DME1690 XEOTICID XEO04348 GENEFORM Protein DME1690 XEOTICID XEO04348 MOACRIVE Inhibition DME1690 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1690 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04349 XEO_CLAS Peptide DME1690 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO04349 GENEFORM Protein DME1690 XEOTICID XEO04349 MOACRIVE Inhibition DME1690 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1690 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04354 XEO_CLAS Peptide DME1690 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 35.2 ug/ml) DME1690 XEOTICID XEO04354 GENEFORM Protein DME1690 XEOTICID XEO04354 MOACRIVE Inhibition DME1690 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1690 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04355 XEO_CLAS Peptide DME1690 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.21 ug/ml) DME1690 XEOTICID XEO04355 GENEFORM Protein DME1690 XEOTICID XEO04355 MOACRIVE Inhibition DME1690 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1690 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04356 XEO_CLAS Peptide DME1690 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8.21 ug/ml) DME1690 XEOTICID XEO04356 GENEFORM Protein DME1690 XEOTICID XEO04356 MOACRIVE Inhibition DME1690 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1690 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04357 XEO_CLAS Peptide DME1690 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16.32 ug/ml) DME1690 XEOTICID XEO04357 GENEFORM Protein DME1690 XEOTICID XEO04357 MOACRIVE Inhibition DME1690 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1690 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04358 XEO_CLAS Peptide DME1690 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 9.37 ug/ml) DME1690 XEOTICID XEO04358 GENEFORM Protein DME1690 XEOTICID XEO04358 MOACRIVE Inhibition DME1690 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1690 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04359 XEO_CLAS Peptide DME1690 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4.20 ug/ml) DME1690 XEOTICID XEO04359 GENEFORM Protein DME1690 XEOTICID XEO04359 MOACRIVE Inhibition DME1690 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1690 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04360 XEO_CLAS Peptide DME1690 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 ug/ml) DME1690 XEOTICID XEO04360 GENEFORM Protein DME1690 XEOTICID XEO04360 MOACRIVE Inhibition DME1690 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1690 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04361 XEO_CLAS Peptide DME1690 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 7.5 ug/ml) DME1690 XEOTICID XEO04361 GENEFORM Protein DME1690 XEOTICID XEO04361 MOACRIVE Inhibition DME1690 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1690 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04362 XEO_CLAS Peptide DME1690 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.6 ug/ml) DME1690 XEOTICID XEO04362 GENEFORM Protein DME1690 XEOTICID XEO04362 MOACRIVE Inhibition DME1690 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1690 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04363 XEO_CLAS Peptide DME1690 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8.2 ug/ml) DME1690 XEOTICID XEO04363 GENEFORM Protein DME1690 XEOTICID XEO04363 MOACRIVE Inhibition DME1690 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1690 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04364 XEO_CLAS Peptide DME1690 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO04364 GENEFORM Protein DME1690 XEOTICID XEO04364 MOACRIVE Inhibition DME1690 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1690 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04365 XEO_CLAS Peptide DME1690 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4.68 ug/ml) DME1690 XEOTICID XEO04365 GENEFORM Protein DME1690 XEOTICID XEO04365 MOACRIVE Inhibition DME1690 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1690 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04366 XEO_CLAS Peptide DME1690 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 23.60 ug/ml) DME1690 XEOTICID XEO04366 GENEFORM Protein DME1690 XEOTICID XEO04366 MOACRIVE Inhibition DME1690 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1690 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04367 XEO_CLAS Peptide DME1690 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 35.60 ug/ml) DME1690 XEOTICID XEO04367 GENEFORM Protein DME1690 XEOTICID XEO04367 MOACRIVE Inhibition DME1690 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1690 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04368 XEO_CLAS Peptide DME1690 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40.2 ug/ml) DME1690 XEOTICID XEO04368 GENEFORM Protein DME1690 XEOTICID XEO04368 MOACRIVE Inhibition DME1690 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1690 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04369 XEO_CLAS Peptide DME1690 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40.2 ug/ml) DME1690 XEOTICID XEO04369 GENEFORM Protein DME1690 XEOTICID XEO04369 MOACRIVE Inhibition DME1690 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1690 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04370 XEO_CLAS Peptide DME1690 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4.68 ug/ml) DME1690 XEOTICID XEO04370 GENEFORM Protein DME1690 XEOTICID XEO04370 MOACRIVE Inhibition DME1690 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1690 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04371 XEO_CLAS Peptide DME1690 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 9.37 ug/ml) DME1690 XEOTICID XEO04371 GENEFORM Protein DME1690 XEOTICID XEO04371 MOACRIVE Inhibition DME1690 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1690 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04373 XEO_CLAS Peptide DME1690 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 ug/ml) DME1690 XEOTICID XEO04373 GENEFORM Protein DME1690 XEOTICID XEO04373 MOACRIVE Inhibition DME1690 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1690 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04374 XEO_CLAS Peptide DME1690 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.50 ug/ml) DME1690 XEOTICID XEO04374 GENEFORM Protein DME1690 XEOTICID XEO04374 MOACRIVE Inhibition DME1690 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1690 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04375 XEO_CLAS Peptide DME1690 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25 ug/ml) DME1690 XEOTICID XEO04375 GENEFORM Protein DME1690 XEOTICID XEO04375 MOACRIVE Inhibition DME1690 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1690 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04377 XEO_CLAS Peptide DME1690 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 42.50 ug/ml) DME1690 XEOTICID XEO04377 GENEFORM Protein DME1690 XEOTICID XEO04377 MOACRIVE Inhibition DME1690 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1690 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04378 XEO_CLAS Peptide DME1690 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 17.50 ug/ml) DME1690 XEOTICID XEO04378 GENEFORM Protein DME1690 XEOTICID XEO04378 MOACRIVE Inhibition DME1690 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1690 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04379 XEO_CLAS Peptide DME1690 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 ug/ml) DME1690 XEOTICID XEO04379 GENEFORM Protein DME1690 XEOTICID XEO04379 MOACRIVE Inhibition DME1690 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1690 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04380 XEO_CLAS Peptide DME1690 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 36.00 ug/ml) DME1690 XEOTICID XEO04380 GENEFORM Protein DME1690 XEOTICID XEO04380 MOACRIVE Inhibition DME1690 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1690 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04381 XEO_CLAS Peptide DME1690 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.60 ug/ml) DME1690 XEOTICID XEO04381 GENEFORM Protein DME1690 XEOTICID XEO04381 MOACRIVE Inhibition DME1690 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1690 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04382 XEO_CLAS Peptide DME1690 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 ug/ml) DME1690 XEOTICID XEO04382 GENEFORM Protein DME1690 XEOTICID XEO04382 MOACRIVE Inhibition DME1690 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1690 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04383 XEO_CLAS Peptide DME1690 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO04383 GENEFORM Protein DME1690 XEOTICID XEO04383 MOACRIVE Inhibition DME1690 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1690 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04384 XEO_CLAS Peptide DME1690 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO04384 GENEFORM Protein DME1690 XEOTICID XEO04384 MOACRIVE Inhibition DME1690 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1690 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04385 XEO_CLAS Peptide DME1690 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.25 ug/ml) DME1690 XEOTICID XEO04385 GENEFORM Protein DME1690 XEOTICID XEO04385 MOACRIVE Inhibition DME1690 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1690 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04395 XEO_CLAS Peptide DME1690 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1690 XEOTICID XEO04395 GENEFORM Protein DME1690 XEOTICID XEO04395 MOACRIVE Inhibition DME1690 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1690 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04396 XEO_CLAS Peptide DME1690 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1690 XEOTICID XEO04396 GENEFORM Protein DME1690 XEOTICID XEO04396 MOACRIVE Inhibition DME1690 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1690 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04397 XEO_CLAS Peptide DME1690 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1690 XEOTICID XEO04397 GENEFORM Protein DME1690 XEOTICID XEO04397 MOACRIVE Inhibition DME1690 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1690 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04398 XEO_CLAS Peptide DME1690 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 microM) DME1690 XEOTICID XEO04398 GENEFORM Protein DME1690 XEOTICID XEO04398 MOACRIVE Inhibition DME1690 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1690 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04399 XEO_CLAS Peptide DME1690 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO04399 GENEFORM Protein DME1690 XEOTICID XEO04399 MOACRIVE Inhibition DME1690 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1690 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04400 XEO_CLAS Peptide DME1690 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 ug/ml) DME1690 XEOTICID XEO04400 GENEFORM Protein DME1690 XEOTICID XEO04400 MOACRIVE Inhibition DME1690 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1690 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04401 XEO_CLAS Peptide DME1690 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.6 ug/ml) DME1690 XEOTICID XEO04401 GENEFORM Protein DME1690 XEOTICID XEO04401 MOACRIVE Inhibition DME1690 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1690 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04402 XEO_CLAS Peptide DME1690 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 ug/ml) DME1690 XEOTICID XEO04402 GENEFORM Protein DME1690 XEOTICID XEO04402 MOACRIVE Inhibition DME1690 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1690 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04403 XEO_CLAS Peptide DME1690 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.6 ug/ml) DME1690 XEOTICID XEO04403 GENEFORM Protein DME1690 XEOTICID XEO04403 MOACRIVE Inhibition DME1690 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1690 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04404 XEO_CLAS Peptide DME1690 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.6 ug/ml) DME1690 XEOTICID XEO04404 GENEFORM Protein DME1690 XEOTICID XEO04404 MOACRIVE Inhibition DME1690 XEOTICID XEO04410 XEO_NAME Insect osmin DME1690 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04410 XEO_CLAS Peptide DME1690 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.125-1.56 microM) DME1690 XEOTICID XEO04410 GENEFORM Protein DME1690 XEOTICID XEO04410 MOACRIVE Inhibition DME1690 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1690 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04412 XEO_CLAS Peptide DME1690 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04412 GENEFORM Protein DME1690 XEOTICID XEO04412 MOACRIVE Inhibition DME1690 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1690 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04414 XEO_CLAS Peptide DME1690 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04414 GENEFORM Protein DME1690 XEOTICID XEO04414 MOACRIVE Inhibition DME1690 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1690 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04415 XEO_CLAS Peptide DME1690 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04415 GENEFORM Protein DME1690 XEOTICID XEO04415 MOACRIVE Inhibition DME1690 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1690 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04421 XEO_CLAS Peptide DME1690 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 microM) DME1690 XEOTICID XEO04421 GENEFORM Protein DME1690 XEOTICID XEO04421 MOACRIVE Inhibition DME1690 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1690 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04426 XEO_CLAS Peptide DME1690 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO04426 GENEFORM Protein DME1690 XEOTICID XEO04426 MOACRIVE Inhibition DME1690 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1690 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04428 XEO_CLAS Peptide DME1690 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.3 ug/ml) DME1690 XEOTICID XEO04428 GENEFORM Protein DME1690 XEOTICID XEO04428 MOACRIVE Inhibition DME1690 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1690 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04430 XEO_CLAS Peptide DME1690 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25 microM) DME1690 XEOTICID XEO04430 GENEFORM Protein DME1690 XEOTICID XEO04430 MOACRIVE Inhibition DME1690 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1690 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04433 XEO_CLAS Peptide DME1690 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 160 microM) DME1690 XEOTICID XEO04433 GENEFORM Protein DME1690 XEOTICID XEO04433 MOACRIVE Inhibition DME1690 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1690 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04435 XEO_CLAS Peptide DME1690 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 160 microM) DME1690 XEOTICID XEO04435 GENEFORM Protein DME1690 XEOTICID XEO04435 MOACRIVE Inhibition DME1690 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1690 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1690 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04438 GENEFORM Protein DME1690 XEOTICID XEO04438 MOACRIVE Inhibition DME1690 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1690 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04439 XEO_CLAS Peptide DME1690 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04439 GENEFORM Protein DME1690 XEOTICID XEO04439 MOACRIVE Inhibition DME1690 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1690 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04440 XEO_CLAS Peptide DME1690 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 microM) DME1690 XEOTICID XEO04440 GENEFORM Protein DME1690 XEOTICID XEO04440 MOACRIVE Inhibition DME1690 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1690 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04441 XEO_CLAS Peptide DME1690 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 28 microM) DME1690 XEOTICID XEO04441 GENEFORM Protein DME1690 XEOTICID XEO04441 MOACRIVE Inhibition DME1690 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1690 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04442 XEO_CLAS Peptide DME1690 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 28 microM) DME1690 XEOTICID XEO04442 GENEFORM Protein DME1690 XEOTICID XEO04442 MOACRIVE Inhibition DME1690 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1690 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04443 XEO_CLAS Peptide DME1690 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04443 GENEFORM Protein DME1690 XEOTICID XEO04443 MOACRIVE Inhibition DME1690 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1690 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04444 XEO_CLAS Peptide DME1690 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 13 microM) DME1690 XEOTICID XEO04444 GENEFORM Protein DME1690 XEOTICID XEO04444 MOACRIVE Inhibition DME1690 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1690 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04445 XEO_CLAS Peptide DME1690 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04445 GENEFORM Protein DME1690 XEOTICID XEO04445 MOACRIVE Inhibition DME1690 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1690 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04446 XEO_CLAS Peptide DME1690 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 78 microM) DME1690 XEOTICID XEO04446 GENEFORM Protein DME1690 XEOTICID XEO04446 MOACRIVE Inhibition DME1690 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1690 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04447 XEO_CLAS Peptide DME1690 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 120 microM) DME1690 XEOTICID XEO04447 GENEFORM Protein DME1690 XEOTICID XEO04447 MOACRIVE Inhibition DME1690 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1690 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04448 XEO_CLAS Peptide DME1690 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 microM) DME1690 XEOTICID XEO04448 GENEFORM Protein DME1690 XEOTICID XEO04448 MOACRIVE Inhibition DME1690 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1690 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04449 XEO_CLAS Peptide DME1690 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.3 microM) DME1690 XEOTICID XEO04449 GENEFORM Protein DME1690 XEOTICID XEO04449 MOACRIVE Inhibition DME1690 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1690 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04450 XEO_CLAS Peptide DME1690 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.3 microM) DME1690 XEOTICID XEO04450 GENEFORM Protein DME1690 XEOTICID XEO04450 MOACRIVE Inhibition DME1690 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1690 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04451 XEO_CLAS Peptide DME1690 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO04451 GENEFORM Protein DME1690 XEOTICID XEO04451 MOACRIVE Inhibition DME1690 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1690 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04452 XEO_CLAS Peptide DME1690 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.1 microM) DME1690 XEOTICID XEO04452 GENEFORM Protein DME1690 XEOTICID XEO04452 MOACRIVE Inhibition DME1690 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1690 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04453 XEO_CLAS Peptide DME1690 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO04453 GENEFORM Protein DME1690 XEOTICID XEO04453 MOACRIVE Inhibition DME1690 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1690 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04455 XEO_CLAS Peptide DME1690 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 microM) DME1690 XEOTICID XEO04455 GENEFORM Protein DME1690 XEOTICID XEO04455 MOACRIVE Inhibition DME1690 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1690 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04457 XEO_CLAS Peptide DME1690 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.3 microM) DME1690 XEOTICID XEO04457 GENEFORM Protein DME1690 XEOTICID XEO04457 MOACRIVE Inhibition DME1690 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1690 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04458 XEO_CLAS Peptide DME1690 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1 microM) DME1690 XEOTICID XEO04458 GENEFORM Protein DME1690 XEOTICID XEO04458 MOACRIVE Inhibition DME1690 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1690 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04459 XEO_CLAS Peptide DME1690 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1 microM) DME1690 XEOTICID XEO04459 GENEFORM Protein DME1690 XEOTICID XEO04459 MOACRIVE Inhibition DME1690 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1690 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04461 XEO_CLAS Peptide DME1690 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20.8 microM) DME1690 XEOTICID XEO04461 GENEFORM Protein DME1690 XEOTICID XEO04461 MOACRIVE Inhibition DME1690 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1690 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04462 XEO_CLAS Peptide DME1690 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 19.1 microM) DME1690 XEOTICID XEO04462 GENEFORM Protein DME1690 XEOTICID XEO04462 MOACRIVE Inhibition DME1690 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1690 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04463 XEO_CLAS Peptide DME1690 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04463 GENEFORM Protein DME1690 XEOTICID XEO04463 MOACRIVE Inhibition DME1690 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1690 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04464 XEO_CLAS Peptide DME1690 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.5 microM) DME1690 XEOTICID XEO04464 GENEFORM Protein DME1690 XEOTICID XEO04464 MOACRIVE Inhibition DME1690 XEOTICID XEO04466 XEO_NAME Panusin DME1690 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04466 XEO_CLAS Peptide DME1690 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04466 GENEFORM Protein DME1690 XEOTICID XEO04466 MOACRIVE Inhibition DME1690 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1690 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04467 XEO_CLAS Peptide DME1690 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4.8 microM) DME1690 XEOTICID XEO04467 GENEFORM Protein DME1690 XEOTICID XEO04467 MOACRIVE Inhibition DME1690 XEOTICID XEO04468 XEO_NAME Papillosin DME1690 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04468 XEO_CLAS Peptide DME1690 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04468 GENEFORM Protein DME1690 XEOTICID XEO04468 MOACRIVE Inhibition DME1690 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1690 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04471 XEO_CLAS Peptide DME1690 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.1 microM) DME1690 XEOTICID XEO04471 GENEFORM Protein DME1690 XEOTICID XEO04471 MOACRIVE Inhibition DME1690 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1690 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04480 XEO_CLAS Peptide DME1690 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 ug/ml) DME1690 XEOTICID XEO04480 GENEFORM Protein DME1690 XEOTICID XEO04480 MOACRIVE Inhibition DME1690 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1690 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1690 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04482 GENEFORM Protein DME1690 XEOTICID XEO04482 MOACRIVE Inhibition DME1690 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1690 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04484 XEO_CLAS Peptide DME1690 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 microM) DME1690 XEOTICID XEO04484 GENEFORM Protein DME1690 XEOTICID XEO04484 MOACRIVE Inhibition DME1690 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1690 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04485 XEO_CLAS Peptide DME1690 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO04485 GENEFORM Protein DME1690 XEOTICID XEO04485 MOACRIVE Inhibition DME1690 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1690 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04486 XEO_CLAS Peptide DME1690 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 microM) DME1690 XEOTICID XEO04486 GENEFORM Protein DME1690 XEOTICID XEO04486 MOACRIVE Inhibition DME1690 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1690 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04487 XEO_CLAS Peptide DME1690 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO04487 GENEFORM Protein DME1690 XEOTICID XEO04487 MOACRIVE Inhibition DME1690 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1690 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04488 XEO_CLAS Peptide DME1690 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 9 microM) DME1690 XEOTICID XEO04488 GENEFORM Protein DME1690 XEOTICID XEO04488 MOACRIVE Inhibition DME1690 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1690 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04489 XEO_CLAS Peptide DME1690 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 13 microM) DME1690 XEOTICID XEO04489 GENEFORM Protein DME1690 XEOTICID XEO04489 MOACRIVE Inhibition DME1690 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1690 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04490 XEO_CLAS Peptide DME1690 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 47.5 microM) DME1690 XEOTICID XEO04490 GENEFORM Protein DME1690 XEOTICID XEO04490 MOACRIVE Inhibition DME1690 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1690 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04491 XEO_CLAS Peptide DME1690 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO04491 GENEFORM Protein DME1690 XEOTICID XEO04491 MOACRIVE Inhibition DME1690 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1690 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04492 XEO_CLAS Peptide DME1690 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 35 microM) DME1690 XEOTICID XEO04492 GENEFORM Protein DME1690 XEOTICID XEO04492 MOACRIVE Inhibition DME1690 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1690 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04493 XEO_CLAS Peptide DME1690 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 microM) DME1690 XEOTICID XEO04493 GENEFORM Protein DME1690 XEOTICID XEO04493 MOACRIVE Inhibition DME1690 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1690 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04494 XEO_CLAS Peptide DME1690 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO04494 GENEFORM Protein DME1690 XEOTICID XEO04494 MOACRIVE Inhibition DME1690 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1690 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04495 XEO_CLAS Peptide DME1690 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO04495 GENEFORM Protein DME1690 XEOTICID XEO04495 MOACRIVE Inhibition DME1690 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1690 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04496 XEO_CLAS Peptide DME1690 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 67.5 microM) DME1690 XEOTICID XEO04496 GENEFORM Protein DME1690 XEOTICID XEO04496 MOACRIVE Inhibition DME1690 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1690 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04497 XEO_CLAS Peptide DME1690 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO04497 GENEFORM Protein DME1690 XEOTICID XEO04497 MOACRIVE Inhibition DME1690 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1690 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04498 XEO_CLAS Peptide DME1690 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO04498 GENEFORM Protein DME1690 XEOTICID XEO04498 MOACRIVE Inhibition DME1690 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1690 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04499 XEO_CLAS Peptide DME1690 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 43 microM) DME1690 XEOTICID XEO04499 GENEFORM Protein DME1690 XEOTICID XEO04499 MOACRIVE Inhibition DME1690 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1690 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04500 XEO_CLAS Peptide DME1690 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO04500 GENEFORM Protein DME1690 XEOTICID XEO04500 MOACRIVE Inhibition DME1690 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1690 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04504 XEO_CLAS Peptide DME1690 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04504 GENEFORM Protein DME1690 XEOTICID XEO04504 MOACRIVE Inhibition DME1690 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1690 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04505 XEO_CLAS Peptide DME1690 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04505 GENEFORM Protein DME1690 XEOTICID XEO04505 MOACRIVE Inhibition DME1690 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1690 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04506 XEO_CLAS Peptide DME1690 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 40 microM) DME1690 XEOTICID XEO04506 GENEFORM Protein DME1690 XEOTICID XEO04506 MOACRIVE Inhibition DME1690 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1690 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04507 XEO_CLAS Peptide DME1690 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10-20 microM) DME1690 XEOTICID XEO04507 GENEFORM Protein DME1690 XEOTICID XEO04507 MOACRIVE Inhibition DME1690 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1690 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04508 XEO_CLAS Peptide DME1690 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04508 GENEFORM Protein DME1690 XEOTICID XEO04508 MOACRIVE Inhibition DME1690 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1690 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04509 XEO_CLAS Peptide DME1690 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04509 GENEFORM Protein DME1690 XEOTICID XEO04509 MOACRIVE Inhibition DME1690 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1690 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04510 XEO_CLAS Peptide DME1690 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 22-33 microM) DME1690 XEOTICID XEO04510 GENEFORM Protein DME1690 XEOTICID XEO04510 MOACRIVE Inhibition DME1690 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1690 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04525 XEO_CLAS Peptide DME1690 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 32.0 microM) DME1690 XEOTICID XEO04525 GENEFORM Protein DME1690 XEOTICID XEO04525 MOACRIVE Inhibition DME1690 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1690 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04526 XEO_CLAS Peptide DME1690 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.0 microM) DME1690 XEOTICID XEO04526 GENEFORM Protein DME1690 XEOTICID XEO04526 MOACRIVE Inhibition DME1690 XEOTICID XEO04527 XEO_NAME Pepcon DME1690 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04527 XEO_CLAS Peptide DME1690 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO04527 GENEFORM Protein DME1690 XEOTICID XEO04527 MOACRIVE Inhibition DME1690 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1690 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04532 XEO_CLAS Peptide DME1690 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04532 GENEFORM Protein DME1690 XEOTICID XEO04532 MOACRIVE Inhibition DME1690 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1690 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04540 XEO_CLAS Peptide DME1690 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 18.1 ug/ml) DME1690 XEOTICID XEO04540 GENEFORM Protein DME1690 XEOTICID XEO04540 MOACRIVE Inhibition DME1690 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1690 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04541 XEO_CLAS Peptide DME1690 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.5 ug/ml) DME1690 XEOTICID XEO04541 GENEFORM Protein DME1690 XEOTICID XEO04541 MOACRIVE Inhibition DME1690 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1690 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04542 XEO_CLAS Peptide DME1690 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04542 GENEFORM Protein DME1690 XEOTICID XEO04542 MOACRIVE Inhibition DME1690 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1690 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04543 XEO_CLAS Peptide DME1690 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04543 GENEFORM Protein DME1690 XEOTICID XEO04543 MOACRIVE Inhibition DME1690 XEOTICID XEO04546 XEO_NAME Perinerin DME1690 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04546 XEO_CLAS Peptide DME1690 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04546 GENEFORM Protein DME1690 XEOTICID XEO04546 MOACRIVE Inhibition DME1690 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1690 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04548 XEO_CLAS Peptide DME1690 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 72000 ug/ml) DME1690 XEOTICID XEO04548 GENEFORM Protein DME1690 XEOTICID XEO04548 MOACRIVE Inhibition DME1690 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1690 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04549 XEO_CLAS Peptide DME1690 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 62-125 ug/ml) DME1690 XEOTICID XEO04549 GENEFORM Protein DME1690 XEOTICID XEO04549 MOACRIVE Inhibition DME1690 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1690 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04550 XEO_CLAS Peptide DME1690 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO04550 GENEFORM Protein DME1690 XEOTICID XEO04550 MOACRIVE Inhibition DME1690 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1690 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04551 XEO_CLAS Peptide DME1690 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 23.6 ug/ml) DME1690 XEOTICID XEO04551 GENEFORM Protein DME1690 XEOTICID XEO04551 MOACRIVE Inhibition DME1690 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1690 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04552 XEO_CLAS Peptide DME1690 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04552 GENEFORM Protein DME1690 XEOTICID XEO04552 MOACRIVE Inhibition DME1690 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1690 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04553 XEO_CLAS Peptide DME1690 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04553 GENEFORM Protein DME1690 XEOTICID XEO04553 MOACRIVE Inhibition DME1690 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1690 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04554 XEO_CLAS Peptide DME1690 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04554 GENEFORM Protein DME1690 XEOTICID XEO04554 MOACRIVE Inhibition DME1690 XEOTICID XEO04563 XEO_NAME Phosphate DME1690 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1690 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04563 GENEFORM Protein DME1690 XEOTICID XEO04563 MOACRIVE Inhibition DME1690 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1690 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04565 XEO_CLAS Peptide DME1690 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.5 microM) DME1690 XEOTICID XEO04565 GENEFORM Protein DME1690 XEOTICID XEO04565 MOACRIVE Inhibition DME1690 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1690 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04566 XEO_CLAS Peptide DME1690 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.7 microM) DME1690 XEOTICID XEO04566 GENEFORM Protein DME1690 XEOTICID XEO04566 MOACRIVE Inhibition DME1690 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1690 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04569 XEO_CLAS Peptide DME1690 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 7.9 microM) DME1690 XEOTICID XEO04569 GENEFORM Protein DME1690 XEOTICID XEO04569 MOACRIVE Inhibition DME1690 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1690 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04570 XEO_CLAS Peptide DME1690 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04570 GENEFORM Protein DME1690 XEOTICID XEO04570 MOACRIVE Inhibition DME1690 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1690 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04571 XEO_CLAS Peptide DME1690 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04571 GENEFORM Protein DME1690 XEOTICID XEO04571 MOACRIVE Inhibition DME1690 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1690 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04572 XEO_CLAS Peptide DME1690 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04572 GENEFORM Protein DME1690 XEOTICID XEO04572 MOACRIVE Inhibition DME1690 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1690 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04573 XEO_CLAS Peptide DME1690 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 microM) DME1690 XEOTICID XEO04573 GENEFORM Protein DME1690 XEOTICID XEO04573 MOACRIVE Inhibition DME1690 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1690 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04574 XEO_CLAS Peptide DME1690 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 128 ug/ml) DME1690 XEOTICID XEO04574 GENEFORM Protein DME1690 XEOTICID XEO04574 MOACRIVE Inhibition DME1690 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1690 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04575 XEO_CLAS Peptide DME1690 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO04575 GENEFORM Protein DME1690 XEOTICID XEO04575 MOACRIVE Inhibition DME1690 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1690 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04578 GENEFORM Protein DME1690 XEOTICID XEO04578 MOACRIVE Inhibition DME1690 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1690 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04579 GENEFORM Protein DME1690 XEOTICID XEO04579 MOACRIVE Inhibition DME1690 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1690 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04580 GENEFORM Protein DME1690 XEOTICID XEO04580 MOACRIVE Inhibition DME1690 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1690 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04583 GENEFORM Protein DME1690 XEOTICID XEO04583 MOACRIVE Inhibition DME1690 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1690 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04588 GENEFORM Protein DME1690 XEOTICID XEO04588 MOACRIVE Inhibition DME1690 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1690 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04589 GENEFORM Protein DME1690 XEOTICID XEO04589 MOACRIVE Inhibition DME1690 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1690 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04590 GENEFORM Protein DME1690 XEOTICID XEO04590 MOACRIVE Inhibition DME1690 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1690 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04591 GENEFORM Protein DME1690 XEOTICID XEO04591 MOACRIVE Inhibition DME1690 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1690 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04592 GENEFORM Protein DME1690 XEOTICID XEO04592 MOACRIVE Inhibition DME1690 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1690 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04593 GENEFORM Protein DME1690 XEOTICID XEO04593 MOACRIVE Inhibition DME1690 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1690 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04594 GENEFORM Protein DME1690 XEOTICID XEO04594 MOACRIVE Inhibition DME1690 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1690 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04595 GENEFORM Protein DME1690 XEOTICID XEO04595 MOACRIVE Inhibition DME1690 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1690 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04596 GENEFORM Protein DME1690 XEOTICID XEO04596 MOACRIVE Inhibition DME1690 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1690 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04597 GENEFORM Protein DME1690 XEOTICID XEO04597 MOACRIVE Inhibition DME1690 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1690 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04598 GENEFORM Protein DME1690 XEOTICID XEO04598 MOACRIVE Inhibition DME1690 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1690 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04599 GENEFORM Protein DME1690 XEOTICID XEO04599 MOACRIVE Inhibition DME1690 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1690 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04601 XEO_CLAS Peptide DME1690 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 18.75 ug/ml) DME1690 XEOTICID XEO04601 GENEFORM Protein DME1690 XEOTICID XEO04601 MOACRIVE Inhibition DME1690 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1690 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04602 XEO_CLAS Peptide DME1690 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 37.5 ug/ml) DME1690 XEOTICID XEO04602 GENEFORM Protein DME1690 XEOTICID XEO04602 MOACRIVE Inhibition DME1690 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1690 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04604 XEO_CLAS Peptide DME1690 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC < 25 microM) DME1690 XEOTICID XEO04604 GENEFORM Protein DME1690 XEOTICID XEO04604 MOACRIVE Inhibition DME1690 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1690 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04605 XEO_CLAS Peptide DME1690 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC < 6.25 microM) DME1690 XEOTICID XEO04605 GENEFORM Protein DME1690 XEOTICID XEO04605 MOACRIVE Inhibition DME1690 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1690 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04606 XEO_CLAS Peptide DME1690 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO04606 GENEFORM Protein DME1690 XEOTICID XEO04606 MOACRIVE Inhibition DME1690 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1690 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1690 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04607 GENEFORM Protein DME1690 XEOTICID XEO04607 MOACRIVE Inhibition DME1690 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1690 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04612 XEO_CLAS Peptide DME1690 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5-10 microM) DME1690 XEOTICID XEO04612 GENEFORM Protein DME1690 XEOTICID XEO04612 MOACRIVE Inhibition DME1690 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1690 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04613 XEO_CLAS Peptide DME1690 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5-10 microM) DME1690 XEOTICID XEO04613 GENEFORM Protein DME1690 XEOTICID XEO04613 MOACRIVE Inhibition DME1690 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1690 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04625 XEO_CLAS Peptide DME1690 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO04625 GENEFORM Protein DME1690 XEOTICID XEO04625 MOACRIVE Inhibition DME1690 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1690 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04626 XEO_CLAS Peptide DME1690 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO04626 GENEFORM Protein DME1690 XEOTICID XEO04626 MOACRIVE Inhibition DME1690 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1690 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04627 XEO_CLAS Peptide DME1690 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.5 microM) DME1690 XEOTICID XEO04627 GENEFORM Protein DME1690 XEOTICID XEO04627 MOACRIVE Inhibition DME1690 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1690 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04630 XEO_CLAS Peptide DME1690 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 60 ug/ml) DME1690 XEOTICID XEO04630 GENEFORM Protein DME1690 XEOTICID XEO04630 MOACRIVE Inhibition DME1690 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1690 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04631 XEO_CLAS Peptide DME1690 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 60 ug/ml) DME1690 XEOTICID XEO04631 GENEFORM Protein DME1690 XEOTICID XEO04631 MOACRIVE Inhibition DME1690 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1690 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04633 XEO_CLAS Peptide DME1690 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 ug/ml) DME1690 XEOTICID XEO04633 GENEFORM Protein DME1690 XEOTICID XEO04633 MOACRIVE Inhibition DME1690 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1690 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04634 XEO_CLAS Peptide DME1690 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 ug/ml) DME1690 XEOTICID XEO04634 GENEFORM Protein DME1690 XEOTICID XEO04634 MOACRIVE Inhibition DME1690 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1690 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04635 XEO_CLAS Peptide DME1690 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 ug/ml) DME1690 XEOTICID XEO04635 GENEFORM Protein DME1690 XEOTICID XEO04635 MOACRIVE Inhibition DME1690 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1690 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04636 XEO_CLAS Peptide DME1690 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 ug/ml) DME1690 XEOTICID XEO04636 GENEFORM Protein DME1690 XEOTICID XEO04636 MOACRIVE Inhibition DME1690 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1690 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04637 XEO_CLAS Peptide DME1690 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 ug/ml) DME1690 XEOTICID XEO04637 GENEFORM Protein DME1690 XEOTICID XEO04637 MOACRIVE Inhibition DME1690 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1690 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04638 XEO_CLAS Peptide DME1690 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 ug/ml) DME1690 XEOTICID XEO04638 GENEFORM Protein DME1690 XEOTICID XEO04638 MOACRIVE Inhibition DME1690 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1690 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04639 XEO_CLAS Peptide DME1690 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 ug/ml) DME1690 XEOTICID XEO04639 GENEFORM Protein DME1690 XEOTICID XEO04639 MOACRIVE Inhibition DME1690 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1690 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04640 XEO_CLAS Peptide DME1690 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.2-3.3 microM) DME1690 XEOTICID XEO04640 GENEFORM Protein DME1690 XEOTICID XEO04640 MOACRIVE Inhibition DME1690 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1690 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04642 XEO_CLAS Peptide DME1690 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 ug/ml) DME1690 XEOTICID XEO04642 GENEFORM Protein DME1690 XEOTICID XEO04642 MOACRIVE Inhibition DME1690 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1690 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04643 XEO_CLAS Peptide DME1690 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO04643 GENEFORM Protein DME1690 XEOTICID XEO04643 MOACRIVE Inhibition DME1690 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1690 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04644 XEO_CLAS Peptide DME1690 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO04644 GENEFORM Protein DME1690 XEOTICID XEO04644 MOACRIVE Inhibition DME1690 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1690 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04645 XEO_CLAS Peptide DME1690 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 ug/ml) DME1690 XEOTICID XEO04645 GENEFORM Protein DME1690 XEOTICID XEO04645 MOACRIVE Inhibition DME1690 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1690 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04646 XEO_CLAS Peptide DME1690 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1 ug/ml) DME1690 XEOTICID XEO04646 GENEFORM Protein DME1690 XEOTICID XEO04646 MOACRIVE Inhibition DME1690 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1690 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04647 XEO_CLAS Peptide DME1690 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO04647 GENEFORM Protein DME1690 XEOTICID XEO04647 MOACRIVE Inhibition DME1690 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1690 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04648 XEO_CLAS Peptide DME1690 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 ug/ml) DME1690 XEOTICID XEO04648 GENEFORM Protein DME1690 XEOTICID XEO04648 MOACRIVE Inhibition DME1690 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1690 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04649 XEO_CLAS Peptide DME1690 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 64 ug/ml) DME1690 XEOTICID XEO04649 GENEFORM Protein DME1690 XEOTICID XEO04649 MOACRIVE Inhibition DME1690 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1690 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04650 XEO_CLAS Peptide DME1690 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 ug/ml) DME1690 XEOTICID XEO04650 GENEFORM Protein DME1690 XEOTICID XEO04650 MOACRIVE Inhibition DME1690 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1690 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04651 XEO_CLAS Peptide DME1690 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 ug/ml) DME1690 XEOTICID XEO04651 GENEFORM Protein DME1690 XEOTICID XEO04651 MOACRIVE Inhibition DME1690 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1690 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04652 XEO_CLAS Peptide DME1690 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO04652 GENEFORM Protein DME1690 XEOTICID XEO04652 MOACRIVE Inhibition DME1690 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1690 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04653 XEO_CLAS Peptide DME1690 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 64 ug/ml) DME1690 XEOTICID XEO04653 GENEFORM Protein DME1690 XEOTICID XEO04653 MOACRIVE Inhibition DME1690 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1690 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04654 XEO_CLAS Peptide DME1690 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 ug/ml) DME1690 XEOTICID XEO04654 GENEFORM Protein DME1690 XEOTICID XEO04654 MOACRIVE Inhibition DME1690 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1690 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04655 XEO_CLAS Peptide DME1690 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO04655 GENEFORM Protein DME1690 XEOTICID XEO04655 MOACRIVE Inhibition DME1690 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1690 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04657 XEO_CLAS Peptide DME1690 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 300 microM) DME1690 XEOTICID XEO04657 GENEFORM Protein DME1690 XEOTICID XEO04657 MOACRIVE Inhibition DME1690 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1690 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04660 XEO_CLAS Peptide DME1690 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO04660 GENEFORM Protein DME1690 XEOTICID XEO04660 MOACRIVE Inhibition DME1690 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1690 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04661 XEO_CLAS Peptide DME1690 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 microM) DME1690 XEOTICID XEO04661 GENEFORM Protein DME1690 XEOTICID XEO04661 MOACRIVE Inhibition DME1690 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1690 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04662 XEO_CLAS Peptide DME1690 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 microM) DME1690 XEOTICID XEO04662 GENEFORM Protein DME1690 XEOTICID XEO04662 MOACRIVE Inhibition DME1690 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1690 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04663 XEO_CLAS Peptide DME1690 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 microM) DME1690 XEOTICID XEO04663 GENEFORM Protein DME1690 XEOTICID XEO04663 MOACRIVE Inhibition DME1690 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1690 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04664 XEO_CLAS Peptide DME1690 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5.5 microM) DME1690 XEOTICID XEO04664 GENEFORM Protein DME1690 XEOTICID XEO04664 MOACRIVE Inhibition DME1690 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1690 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04665 XEO_CLAS Peptide DME1690 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 microM) DME1690 XEOTICID XEO04665 GENEFORM Protein DME1690 XEOTICID XEO04665 MOACRIVE Inhibition DME1690 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1690 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04666 XEO_CLAS Peptide DME1690 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO04666 GENEFORM Protein DME1690 XEOTICID XEO04666 MOACRIVE Inhibition DME1690 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1690 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04667 XEO_CLAS Peptide DME1690 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6.25 microM) DME1690 XEOTICID XEO04667 GENEFORM Protein DME1690 XEOTICID XEO04667 MOACRIVE Inhibition DME1690 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1690 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04668 XEO_CLAS Peptide DME1690 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 microM) DME1690 XEOTICID XEO04668 GENEFORM Protein DME1690 XEOTICID XEO04668 MOACRIVE Inhibition DME1690 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1690 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04669 XEO_CLAS Peptide DME1690 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO04669 GENEFORM Protein DME1690 XEOTICID XEO04669 MOACRIVE Inhibition DME1690 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1690 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04670 XEO_CLAS Peptide DME1690 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 21 microM) DME1690 XEOTICID XEO04670 GENEFORM Protein DME1690 XEOTICID XEO04670 MOACRIVE Inhibition DME1690 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1690 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04671 XEO_CLAS Peptide DME1690 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 62 microM) DME1690 XEOTICID XEO04671 GENEFORM Protein DME1690 XEOTICID XEO04671 MOACRIVE Inhibition DME1690 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1690 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04672 XEO_CLAS Peptide DME1690 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO04672 GENEFORM Protein DME1690 XEOTICID XEO04672 MOACRIVE Inhibition DME1690 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1690 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04673 XEO_CLAS Peptide DME1690 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO04673 GENEFORM Protein DME1690 XEOTICID XEO04673 MOACRIVE Inhibition DME1690 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1690 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04674 XEO_CLAS Peptide DME1690 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 75 microM) DME1690 XEOTICID XEO04674 GENEFORM Protein DME1690 XEOTICID XEO04674 MOACRIVE Inhibition DME1690 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1690 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04675 XEO_CLAS Peptide DME1690 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 microM) DME1690 XEOTICID XEO04675 GENEFORM Protein DME1690 XEOTICID XEO04675 MOACRIVE Inhibition DME1690 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1690 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04676 XEO_CLAS Peptide DME1690 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 microM) DME1690 XEOTICID XEO04676 GENEFORM Protein DME1690 XEOTICID XEO04676 MOACRIVE Inhibition DME1690 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1690 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04677 XEO_CLAS Peptide DME1690 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO04677 GENEFORM Protein DME1690 XEOTICID XEO04677 MOACRIVE Inhibition DME1690 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1690 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04680 XEO_CLAS Peptide DME1690 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 microM) DME1690 XEOTICID XEO04680 GENEFORM Protein DME1690 XEOTICID XEO04680 MOACRIVE Inhibition DME1690 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1690 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04682 XEO_CLAS Peptide DME1690 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 microM) DME1690 XEOTICID XEO04682 GENEFORM Protein DME1690 XEOTICID XEO04682 MOACRIVE Inhibition DME1690 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1690 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04683 XEO_CLAS Peptide DME1690 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 microM) DME1690 XEOTICID XEO04683 GENEFORM Protein DME1690 XEOTICID XEO04683 MOACRIVE Inhibition DME1690 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1690 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04684 XEO_CLAS Peptide DME1690 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 38 microM) DME1690 XEOTICID XEO04684 GENEFORM Protein DME1690 XEOTICID XEO04684 MOACRIVE Inhibition DME1690 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1690 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04690 XEO_CLAS Peptide DME1690 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.5 ug/ml) DME1690 XEOTICID XEO04690 GENEFORM Protein DME1690 XEOTICID XEO04690 MOACRIVE Inhibition DME1690 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1690 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04695 XEO_CLAS Peptide DME1690 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04695 GENEFORM Protein DME1690 XEOTICID XEO04695 MOACRIVE Inhibition DME1690 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1690 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04696 XEO_CLAS Peptide DME1690 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04696 GENEFORM Protein DME1690 XEOTICID XEO04696 MOACRIVE Inhibition DME1690 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1690 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04712 XEO_CLAS Peptide DME1690 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16.7 microM) DME1690 XEOTICID XEO04712 GENEFORM Protein DME1690 XEOTICID XEO04712 MOACRIVE Inhibition DME1690 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1690 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04713 XEO_CLAS Peptide DME1690 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16.7 microM) DME1690 XEOTICID XEO04713 GENEFORM Protein DME1690 XEOTICID XEO04713 MOACRIVE Inhibition DME1690 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1690 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04714 XEO_CLAS Peptide DME1690 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 23.3 microM) DME1690 XEOTICID XEO04714 GENEFORM Protein DME1690 XEOTICID XEO04714 MOACRIVE Inhibition DME1690 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1690 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04716 XEO_CLAS Peptide DME1690 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 microM) DME1690 XEOTICID XEO04716 GENEFORM Protein DME1690 XEOTICID XEO04716 MOACRIVE Inhibition DME1690 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1690 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04717 XEO_CLAS Peptide DME1690 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 50 microM) DME1690 XEOTICID XEO04717 GENEFORM Protein DME1690 XEOTICID XEO04717 MOACRIVE Inhibition DME1690 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1690 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04725 XEO_CLAS Peptide DME1690 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04725 GENEFORM Protein DME1690 XEOTICID XEO04725 MOACRIVE Inhibition DME1690 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1690 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04726 XEO_CLAS Peptide DME1690 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04726 GENEFORM Protein DME1690 XEOTICID XEO04726 MOACRIVE Inhibition DME1690 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1690 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04731 XEO_CLAS Peptide DME1690 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 ug/ml) DME1690 XEOTICID XEO04731 GENEFORM Protein DME1690 XEOTICID XEO04731 MOACRIVE Inhibition DME1690 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1690 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04732 XEO_CLAS Peptide DME1690 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 25 ug/ml) DME1690 XEOTICID XEO04732 GENEFORM Protein DME1690 XEOTICID XEO04732 MOACRIVE Inhibition DME1690 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1690 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04733 XEO_CLAS Peptide DME1690 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04733 GENEFORM Protein DME1690 XEOTICID XEO04733 MOACRIVE Inhibition DME1690 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1690 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04734 XEO_CLAS Peptide DME1690 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04734 GENEFORM Protein DME1690 XEOTICID XEO04734 MOACRIVE Inhibition DME1690 XEOTICID XEO04737 XEO_NAME Protonectin DME1690 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04737 XEO_CLAS Peptide DME1690 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 ug/ml) DME1690 XEOTICID XEO04737 GENEFORM Protein DME1690 XEOTICID XEO04737 MOACRIVE Inhibition DME1690 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1690 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04739 XEO_CLAS Peptide DME1690 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04739 GENEFORM Protein DME1690 XEOTICID XEO04739 MOACRIVE Inhibition DME1690 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1690 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04740 XEO_CLAS Peptide DME1690 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04740 GENEFORM Protein DME1690 XEOTICID XEO04740 MOACRIVE Inhibition DME1690 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1690 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04741 XEO_CLAS Peptide DME1690 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04741 GENEFORM Protein DME1690 XEOTICID XEO04741 MOACRIVE Inhibition DME1690 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1690 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04742 XEO_CLAS Peptide DME1690 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04742 GENEFORM Protein DME1690 XEOTICID XEO04742 MOACRIVE Inhibition DME1690 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1690 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04762 XEO_CLAS Peptide DME1690 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.8 microM) DME1690 XEOTICID XEO04762 GENEFORM Protein DME1690 XEOTICID XEO04762 MOACRIVE Inhibition DME1690 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1690 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04766 XEO_CLAS Peptide DME1690 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.1 microM) DME1690 XEOTICID XEO04766 GENEFORM Protein DME1690 XEOTICID XEO04766 MOACRIVE Inhibition DME1690 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1690 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04767 XEO_CLAS Peptide DME1690 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.1 ug/ml) DME1690 XEOTICID XEO04767 GENEFORM Protein DME1690 XEOTICID XEO04767 MOACRIVE Inhibition DME1690 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1690 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04779 XEO_CLAS Peptide DME1690 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04779 GENEFORM Protein DME1690 XEOTICID XEO04779 MOACRIVE Inhibition DME1690 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1690 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04780 XEO_CLAS Peptide DME1690 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04780 GENEFORM Protein DME1690 XEOTICID XEO04780 MOACRIVE Inhibition DME1690 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1690 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04781 XEO_CLAS Peptide DME1690 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04781 GENEFORM Protein DME1690 XEOTICID XEO04781 MOACRIVE Inhibition DME1690 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1690 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04782 XEO_CLAS Peptide DME1690 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 ug/ml) DME1690 XEOTICID XEO04782 GENEFORM Protein DME1690 XEOTICID XEO04782 MOACRIVE Inhibition DME1690 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1690 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04783 XEO_CLAS Peptide DME1690 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO04783 GENEFORM Protein DME1690 XEOTICID XEO04783 MOACRIVE Inhibition DME1690 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1690 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04784 XEO_CLAS Peptide DME1690 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO04784 GENEFORM Protein DME1690 XEOTICID XEO04784 MOACRIVE Inhibition DME1690 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1690 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04785 XEO_CLAS Peptide DME1690 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO04785 GENEFORM Protein DME1690 XEOTICID XEO04785 MOACRIVE Inhibition DME1690 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1690 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04786 XEO_CLAS Peptide DME1690 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 ug/ml) DME1690 XEOTICID XEO04786 GENEFORM Protein DME1690 XEOTICID XEO04786 MOACRIVE Inhibition DME1690 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1690 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04787 XEO_CLAS Peptide DME1690 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04787 GENEFORM Protein DME1690 XEOTICID XEO04787 MOACRIVE Inhibition DME1690 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1690 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04793 XEO_CLAS Peptide DME1690 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04793 GENEFORM Protein DME1690 XEOTICID XEO04793 MOACRIVE Inhibition DME1690 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1690 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04798 XEO_CLAS Peptide DME1690 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 microM) DME1690 XEOTICID XEO04798 GENEFORM Protein DME1690 XEOTICID XEO04798 MOACRIVE Inhibition DME1690 XEOTICID XEO04799 XEO_NAME Ranalexin DME1690 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04799 XEO_CLAS Peptide DME1690 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 32 ug/ml) DME1690 XEOTICID XEO04799 GENEFORM Protein DME1690 XEOTICID XEO04799 MOACRIVE Inhibition DME1690 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1690 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04800 XEO_CLAS Peptide DME1690 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 microM) DME1690 XEOTICID XEO04800 GENEFORM Protein DME1690 XEOTICID XEO04800 MOACRIVE Inhibition DME1690 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1690 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04801 XEO_CLAS Peptide DME1690 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 9 microM) DME1690 XEOTICID XEO04801 GENEFORM Protein DME1690 XEOTICID XEO04801 MOACRIVE Inhibition DME1690 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1690 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04802 XEO_CLAS Peptide DME1690 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12 microM) DME1690 XEOTICID XEO04802 GENEFORM Protein DME1690 XEOTICID XEO04802 MOACRIVE Inhibition DME1690 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1690 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04803 XEO_CLAS Peptide DME1690 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO04803 GENEFORM Protein DME1690 XEOTICID XEO04803 MOACRIVE Inhibition DME1690 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1690 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04804 XEO_CLAS Peptide DME1690 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO04804 GENEFORM Protein DME1690 XEOTICID XEO04804 MOACRIVE Inhibition DME1690 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1690 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04805 XEO_CLAS Peptide DME1690 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.5 microM) DME1690 XEOTICID XEO04805 GENEFORM Protein DME1690 XEOTICID XEO04805 MOACRIVE Inhibition DME1690 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1690 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04806 XEO_CLAS Peptide DME1690 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.5 microM) DME1690 XEOTICID XEO04806 GENEFORM Protein DME1690 XEOTICID XEO04806 MOACRIVE Inhibition DME1690 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1690 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04807 XEO_CLAS Peptide DME1690 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04807 GENEFORM Protein DME1690 XEOTICID XEO04807 MOACRIVE Inhibition DME1690 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1690 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04809 XEO_CLAS Peptide DME1690 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 microM) DME1690 XEOTICID XEO04809 GENEFORM Protein DME1690 XEOTICID XEO04809 MOACRIVE Inhibition DME1690 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1690 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04811 XEO_CLAS Peptide DME1690 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO04811 GENEFORM Protein DME1690 XEOTICID XEO04811 MOACRIVE Inhibition DME1690 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1690 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04812 XEO_CLAS Peptide DME1690 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO04812 GENEFORM Protein DME1690 XEOTICID XEO04812 MOACRIVE Inhibition DME1690 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1690 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04813 XEO_CLAS Peptide DME1690 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 microM) DME1690 XEOTICID XEO04813 GENEFORM Protein DME1690 XEOTICID XEO04813 MOACRIVE Inhibition DME1690 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1690 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04814 XEO_CLAS Peptide DME1690 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 19 microM) DME1690 XEOTICID XEO04814 GENEFORM Protein DME1690 XEOTICID XEO04814 MOACRIVE Inhibition DME1690 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1690 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04815 XEO_CLAS Peptide DME1690 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 microM) DME1690 XEOTICID XEO04815 GENEFORM Protein DME1690 XEOTICID XEO04815 MOACRIVE Inhibition DME1690 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1690 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04816 XEO_CLAS Peptide DME1690 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 microM) DME1690 XEOTICID XEO04816 GENEFORM Protein DME1690 XEOTICID XEO04816 MOACRIVE Inhibition DME1690 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1690 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04817 XEO_CLAS Peptide DME1690 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 13 microM) DME1690 XEOTICID XEO04817 GENEFORM Protein DME1690 XEOTICID XEO04817 MOACRIVE Inhibition DME1690 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1690 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04818 XEO_CLAS Peptide DME1690 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO04818 GENEFORM Protein DME1690 XEOTICID XEO04818 MOACRIVE Inhibition DME1690 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1690 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04819 XEO_CLAS Peptide DME1690 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO04819 GENEFORM Protein DME1690 XEOTICID XEO04819 MOACRIVE Inhibition DME1690 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1690 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04820 XEO_CLAS Peptide DME1690 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3 microM) DME1690 XEOTICID XEO04820 GENEFORM Protein DME1690 XEOTICID XEO04820 MOACRIVE Inhibition DME1690 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1690 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04821 XEO_CLAS Peptide DME1690 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 microM) DME1690 XEOTICID XEO04821 GENEFORM Protein DME1690 XEOTICID XEO04821 MOACRIVE Inhibition DME1690 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1690 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04822 XEO_CLAS Peptide DME1690 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO04822 GENEFORM Protein DME1690 XEOTICID XEO04822 MOACRIVE Inhibition DME1690 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1690 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04823 XEO_CLAS Peptide DME1690 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 23 microM) DME1690 XEOTICID XEO04823 GENEFORM Protein DME1690 XEOTICID XEO04823 MOACRIVE Inhibition DME1690 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1690 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04824 XEO_CLAS Peptide DME1690 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04824 GENEFORM Protein DME1690 XEOTICID XEO04824 MOACRIVE Inhibition DME1690 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1690 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04825 XEO_CLAS Peptide DME1690 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04825 GENEFORM Protein DME1690 XEOTICID XEO04825 MOACRIVE Inhibition DME1690 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1690 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04826 XEO_CLAS Peptide DME1690 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO04826 GENEFORM Protein DME1690 XEOTICID XEO04826 MOACRIVE Inhibition DME1690 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1690 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04827 XEO_CLAS Peptide DME1690 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO04827 GENEFORM Protein DME1690 XEOTICID XEO04827 MOACRIVE Inhibition DME1690 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1690 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04835 XEO_CLAS Peptide DME1690 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04835 GENEFORM Protein DME1690 XEOTICID XEO04835 MOACRIVE Inhibition DME1690 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1690 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04836 XEO_CLAS Peptide DME1690 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04836 GENEFORM Protein DME1690 XEOTICID XEO04836 MOACRIVE Inhibition DME1690 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1690 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04837 XEO_CLAS Peptide DME1690 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 microM) DME1690 XEOTICID XEO04837 GENEFORM Protein DME1690 XEOTICID XEO04837 MOACRIVE Inhibition DME1690 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1690 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04839 XEO_CLAS Peptide DME1690 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04839 GENEFORM Protein DME1690 XEOTICID XEO04839 MOACRIVE Inhibition DME1690 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1690 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04840 XEO_CLAS Peptide DME1690 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 35-20 microM) DME1690 XEOTICID XEO04840 GENEFORM Protein DME1690 XEOTICID XEO04840 MOACRIVE Inhibition DME1690 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1690 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04847 XEO_CLAS Peptide DME1690 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04847 GENEFORM Protein DME1690 XEOTICID XEO04847 MOACRIVE Inhibition DME1690 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1690 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04848 XEO_CLAS Peptide DME1690 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04848 GENEFORM Protein DME1690 XEOTICID XEO04848 MOACRIVE Inhibition DME1690 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1690 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04849 XEO_CLAS Peptide DME1690 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04849 GENEFORM Protein DME1690 XEOTICID XEO04849 MOACRIVE Inhibition DME1690 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1690 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04850 XEO_CLAS Peptide DME1690 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04850 GENEFORM Protein DME1690 XEOTICID XEO04850 MOACRIVE Inhibition DME1690 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1690 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04851 XEO_CLAS Peptide DME1690 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1 ug/ml) DME1690 XEOTICID XEO04851 GENEFORM Protein DME1690 XEOTICID XEO04851 MOACRIVE Inhibition DME1690 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1690 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04857 XEO_CLAS Peptide DME1690 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 microM) DME1690 XEOTICID XEO04857 GENEFORM Protein DME1690 XEOTICID XEO04857 MOACRIVE Inhibition DME1690 XEOTICID XEO04863 XEO_NAME RTD peptide DME1690 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04863 XEO_CLAS Peptide DME1690 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.0 microM) DME1690 XEOTICID XEO04863 GENEFORM Protein DME1690 XEOTICID XEO04863 MOACRIVE Inhibition DME1690 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1690 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04865 XEO_CLAS Peptide DME1690 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 ug/ml) DME1690 XEOTICID XEO04865 GENEFORM Protein DME1690 XEOTICID XEO04865 MOACRIVE Inhibition DME1690 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1690 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04866 XEO_CLAS Peptide DME1690 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12.5 ug/ml) DME1690 XEOTICID XEO04866 GENEFORM Protein DME1690 XEOTICID XEO04866 MOACRIVE Inhibition DME1690 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1690 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04868 XEO_CLAS Peptide DME1690 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25.00 ug/ml) DME1690 XEOTICID XEO04868 GENEFORM Protein DME1690 XEOTICID XEO04868 MOACRIVE Inhibition DME1690 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1690 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04869 XEO_CLAS Peptide DME1690 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25.00 ug/ml) DME1690 XEOTICID XEO04869 GENEFORM Protein DME1690 XEOTICID XEO04869 MOACRIVE Inhibition DME1690 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1690 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04870 XEO_CLAS Peptide DME1690 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25.00 ug/ml) DME1690 XEOTICID XEO04870 GENEFORM Protein DME1690 XEOTICID XEO04870 MOACRIVE Inhibition DME1690 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1690 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04877 XEO_CLAS Peptide DME1690 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04877 GENEFORM Protein DME1690 XEOTICID XEO04877 MOACRIVE Inhibition DME1690 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1690 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04880 XEO_CLAS Peptide DME1690 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.5 ug/ml) DME1690 XEOTICID XEO04880 GENEFORM Protein DME1690 XEOTICID XEO04880 MOACRIVE Inhibition DME1690 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1690 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04886 XEO_CLAS Peptide DME1690 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.6 ug/ml) DME1690 XEOTICID XEO04886 GENEFORM Protein DME1690 XEOTICID XEO04886 MOACRIVE Inhibition DME1690 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1690 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04891 XEO_CLAS Peptide DME1690 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04891 GENEFORM Protein DME1690 XEOTICID XEO04891 MOACRIVE Inhibition DME1690 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1690 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04895 XEO_CLAS Peptide DME1690 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04895 GENEFORM Protein DME1690 XEOTICID XEO04895 MOACRIVE Inhibition DME1690 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1690 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04901 XEO_CLAS Peptide DME1690 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 microM) DME1690 XEOTICID XEO04901 GENEFORM Protein DME1690 XEOTICID XEO04901 MOACRIVE Inhibition DME1690 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1690 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04904 XEO_CLAS Peptide DME1690 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 78 ug/ml) DME1690 XEOTICID XEO04904 GENEFORM Protein DME1690 XEOTICID XEO04904 MOACRIVE Inhibition DME1690 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1690 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04905 XEO_CLAS Peptide DME1690 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04905 GENEFORM Protein DME1690 XEOTICID XEO04905 MOACRIVE Inhibition DME1690 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1690 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04906 XEO_CLAS Peptide DME1690 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04906 GENEFORM Protein DME1690 XEOTICID XEO04906 MOACRIVE Inhibition DME1690 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1690 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04907 XEO_CLAS Peptide DME1690 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04907 GENEFORM Protein DME1690 XEOTICID XEO04907 MOACRIVE Inhibition DME1690 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1690 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04908 XEO_CLAS Peptide DME1690 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04908 GENEFORM Protein DME1690 XEOTICID XEO04908 MOACRIVE Inhibition DME1690 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1690 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04909 XEO_CLAS Peptide DME1690 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04909 GENEFORM Protein DME1690 XEOTICID XEO04909 MOACRIVE Inhibition DME1690 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1690 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04915 XEO_CLAS Peptide DME1690 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 100 ug/ml) DME1690 XEOTICID XEO04915 GENEFORM Protein DME1690 XEOTICID XEO04915 MOACRIVE Inhibition DME1690 XEOTICID XEO04916 XEO_NAME Scopoletin DME1690 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1690 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04916 GENEFORM Protein DME1690 XEOTICID XEO04916 MOACRIVE Inhibition DME1690 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1690 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04926 XEO_CLAS Peptide DME1690 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04926 GENEFORM Protein DME1690 XEOTICID XEO04926 MOACRIVE Inhibition DME1690 XEOTICID XEO04931 XEO_NAME Shepherin I DME1690 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04931 XEO_CLAS Peptide DME1690 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04931 GENEFORM Protein DME1690 XEOTICID XEO04931 MOACRIVE Inhibition DME1690 XEOTICID XEO04932 XEO_NAME shepherin II DME1690 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04932 XEO_CLAS Peptide DME1690 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04932 GENEFORM Protein DME1690 XEOTICID XEO04932 MOACRIVE Inhibition DME1690 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1690 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04938 XEO_CLAS Peptide DME1690 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC <= 100 microM) DME1690 XEOTICID XEO04938 GENEFORM Protein DME1690 XEOTICID XEO04938 MOACRIVE Inhibition DME1690 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1690 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04947 XEO_CLAS Natural Product DME1690 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04947 GENEFORM Protein DME1690 XEOTICID XEO04947 MOACRIVE Inhibition DME1690 XEOTICID XEO04948 XEO_NAME Sinensetin DME1690 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1690 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1690 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04948 GENEFORM Protein DME1690 XEOTICID XEO04948 MOACRIVE Inhibition DME1690 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1690 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04950 XEO_CLAS Peptide DME1690 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 ug/ml) DME1690 XEOTICID XEO04950 GENEFORM Protein DME1690 XEOTICID XEO04950 MOACRIVE Inhibition DME1690 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1690 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04955 XEO_CLAS Peptide DME1690 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.07 microM) DME1690 XEOTICID XEO04955 GENEFORM Protein DME1690 XEOTICID XEO04955 MOACRIVE Inhibition DME1690 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1690 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04956 XEO_CLAS Peptide DME1690 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16.0 microM) DME1690 XEOTICID XEO04956 GENEFORM Protein DME1690 XEOTICID XEO04956 MOACRIVE Inhibition DME1690 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1690 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04957 XEO_CLAS Peptide DME1690 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.23 microM) DME1690 XEOTICID XEO04957 GENEFORM Protein DME1690 XEOTICID XEO04957 MOACRIVE Inhibition DME1690 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1690 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04958 XEO_CLAS Peptide DME1690 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 ug/ml) DME1690 XEOTICID XEO04958 GENEFORM Protein DME1690 XEOTICID XEO04958 MOACRIVE Inhibition DME1690 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1690 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04959 XEO_CLAS Peptide DME1690 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04959 GENEFORM Protein DME1690 XEOTICID XEO04959 MOACRIVE Inhibition DME1690 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1690 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04967 XEO_CLAS Peptide DME1690 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 28 microM) DME1690 XEOTICID XEO04967 GENEFORM Protein DME1690 XEOTICID XEO04967 MOACRIVE Inhibition DME1690 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1690 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04969 XEO_CLAS Peptide DME1690 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50-100 ug/ml) DME1690 XEOTICID XEO04969 GENEFORM Protein DME1690 XEOTICID XEO04969 MOACRIVE Inhibition DME1690 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1690 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04970 XEO_CLAS Peptide DME1690 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04970 GENEFORM Protein DME1690 XEOTICID XEO04970 MOACRIVE Inhibition DME1690 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1690 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04971 XEO_CLAS Peptide DME1690 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.8-1.5 microM) DME1690 XEOTICID XEO04971 GENEFORM Protein DME1690 XEOTICID XEO04971 MOACRIVE Inhibition DME1690 XEOTICID XEO04974 XEO_NAME Spinigerin DME1690 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04974 XEO_CLAS Peptide DME1690 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3-6 microM) DME1690 XEOTICID XEO04974 GENEFORM Protein DME1690 XEOTICID XEO04974 MOACRIVE Inhibition DME1690 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1690 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1690 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04975 GENEFORM Protein DME1690 XEOTICID XEO04975 MOACRIVE Inhibition DME1690 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1690 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1690 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04976 GENEFORM Protein DME1690 XEOTICID XEO04976 MOACRIVE Inhibition DME1690 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1690 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1690 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04977 GENEFORM Protein DME1690 XEOTICID XEO04977 MOACRIVE Inhibition DME1690 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1690 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1690 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04978 GENEFORM Protein DME1690 XEOTICID XEO04978 MOACRIVE Inhibition DME1690 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1690 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1690 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04979 GENEFORM Protein DME1690 XEOTICID XEO04979 MOACRIVE Inhibition DME1690 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1690 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04981 XEO_CLAS Peptide DME1690 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10.1 microM) DME1690 XEOTICID XEO04981 GENEFORM Protein DME1690 XEOTICID XEO04981 MOACRIVE Inhibition DME1690 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1690 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04982 XEO_CLAS Peptide DME1690 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40.5 microM) DME1690 XEOTICID XEO04982 GENEFORM Protein DME1690 XEOTICID XEO04982 MOACRIVE Inhibition DME1690 XEOTICID XEO04994 XEO_NAME Stilbene DME1690 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1690 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1690 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO04994 GENEFORM Protein DME1690 XEOTICID XEO04994 MOACRIVE Inhibition DME1690 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1690 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04995 XEO_CLAS Peptide DME1690 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC < 0.19 microM) DME1690 XEOTICID XEO04995 GENEFORM Protein DME1690 XEOTICID XEO04995 MOACRIVE Inhibition DME1690 XEOTICID XEO04998 XEO_NAME Styelin A DME1690 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04998 XEO_CLAS Peptide DME1690 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.7 ug/ml) DME1690 XEOTICID XEO04998 GENEFORM Protein DME1690 XEOTICID XEO04998 MOACRIVE Inhibition DME1690 XEOTICID XEO04999 XEO_NAME Styelin B DME1690 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO04999 XEO_CLAS Peptide DME1690 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.7 ug/ml) DME1690 XEOTICID XEO04999 GENEFORM Protein DME1690 XEOTICID XEO04999 MOACRIVE Inhibition DME1690 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1690 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05000 XEO_CLAS Peptide DME1690 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO05000 GENEFORM Protein DME1690 XEOTICID XEO05000 MOACRIVE Inhibition DME1690 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1690 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05001 XEO_CLAS Peptide DME1690 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.5 ug/ml) DME1690 XEOTICID XEO05001 GENEFORM Protein DME1690 XEOTICID XEO05001 MOACRIVE Inhibition DME1690 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1690 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05002 XEO_CLAS Peptide DME1690 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO05002 GENEFORM Protein DME1690 XEOTICID XEO05002 MOACRIVE Inhibition DME1690 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1690 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05003 XEO_CLAS Peptide DME1690 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO05003 GENEFORM Protein DME1690 XEOTICID XEO05003 MOACRIVE Inhibition DME1690 XEOTICID XEO05006 XEO_NAME Substance P DME1690 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05006 XEO_CLAS Peptide DME1690 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05006 GENEFORM Protein DME1690 XEOTICID XEO05006 MOACRIVE Inhibition DME1690 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1690 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05007 XEO_CLAS Peptide DME1690 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05007 GENEFORM Protein DME1690 XEOTICID XEO05007 MOACRIVE Inhibition DME1690 XEOTICID XEO05008 XEO_NAME Subtilosin DME1690 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05008 XEO_CLAS Peptide DME1690 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05008 GENEFORM Protein DME1690 XEOTICID XEO05008 MOACRIVE Inhibition DME1690 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1690 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05013 XEO_CLAS Peptide DME1690 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO05013 GENEFORM Protein DME1690 XEOTICID XEO05013 MOACRIVE Inhibition DME1690 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1690 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05014 XEO_CLAS Peptide DME1690 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO05014 GENEFORM Protein DME1690 XEOTICID XEO05014 MOACRIVE Inhibition DME1690 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1690 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05015 XEO_CLAS Peptide DME1690 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO05015 GENEFORM Protein DME1690 XEOTICID XEO05015 MOACRIVE Inhibition DME1690 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1690 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05016 XEO_CLAS Peptide DME1690 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO05016 GENEFORM Protein DME1690 XEOTICID XEO05016 MOACRIVE Inhibition DME1690 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1690 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05017 XEO_CLAS Peptide DME1690 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 20 ug/ml) DME1690 XEOTICID XEO05017 GENEFORM Protein DME1690 XEOTICID XEO05017 MOACRIVE Inhibition DME1690 XEOTICID XEO05018 XEO_NAME Syringic acid DME1690 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1690 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05018 GENEFORM Protein DME1690 XEOTICID XEO05018 MOACRIVE Inhibition DME1690 XEOTICID XEO05020 XEO_NAME Tachycitin DME1690 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05020 XEO_CLAS Peptide DME1690 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05020 GENEFORM Protein DME1690 XEOTICID XEO05020 MOACRIVE Inhibition DME1690 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1690 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05023 XEO_CLAS Peptide DME1690 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05023 GENEFORM Protein DME1690 XEOTICID XEO05023 MOACRIVE Inhibition DME1690 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1690 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05024 XEO_CLAS Peptide DME1690 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05024 GENEFORM Protein DME1690 XEOTICID XEO05024 MOACRIVE Inhibition DME1690 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1690 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05027 XEO_CLAS Peptide DME1690 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05027 GENEFORM Protein DME1690 XEOTICID XEO05027 MOACRIVE Inhibition DME1690 XEOTICID XEO05031 XEO_NAME Tannic acid DME1690 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1690 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05031 GENEFORM Protein DME1690 XEOTICID XEO05031 MOACRIVE Inhibition DME1690 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1690 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05033 XEO_CLAS Peptide DME1690 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05033 GENEFORM Protein DME1690 XEOTICID XEO05033 MOACRIVE Inhibition DME1690 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1690 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05042 XEO_CLAS Peptide DME1690 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO05042 GENEFORM Protein DME1690 XEOTICID XEO05042 MOACRIVE Inhibition DME1690 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1690 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05043 XEO_CLAS Peptide DME1690 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO05043 GENEFORM Protein DME1690 XEOTICID XEO05043 MOACRIVE Inhibition DME1690 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1690 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05044 XEO_CLAS Peptide DME1690 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 128 microM) DME1690 XEOTICID XEO05044 GENEFORM Protein DME1690 XEOTICID XEO05044 MOACRIVE Inhibition DME1690 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1690 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05045 XEO_CLAS Peptide DME1690 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 128 microM) DME1690 XEOTICID XEO05045 GENEFORM Protein DME1690 XEOTICID XEO05045 MOACRIVE Inhibition DME1690 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1690 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05046 XEO_CLAS Peptide DME1690 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 microM) DME1690 XEOTICID XEO05046 GENEFORM Protein DME1690 XEOTICID XEO05046 MOACRIVE Inhibition DME1690 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1690 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05047 XEO_CLAS Peptide DME1690 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 60 microM) DME1690 XEOTICID XEO05047 GENEFORM Protein DME1690 XEOTICID XEO05047 MOACRIVE Inhibition DME1690 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1690 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05051 XEO_CLAS Peptide DME1690 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05051 GENEFORM Protein DME1690 XEOTICID XEO05051 MOACRIVE Inhibition DME1690 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1690 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05055 XEO_CLAS Peptide DME1690 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 70 microM) DME1690 XEOTICID XEO05055 GENEFORM Protein DME1690 XEOTICID XEO05055 MOACRIVE Inhibition DME1690 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1690 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05056 XEO_CLAS Peptide DME1690 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05056 GENEFORM Protein DME1690 XEOTICID XEO05056 MOACRIVE Inhibition DME1690 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1690 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05059 XEO_CLAS Peptide DME1690 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05059 GENEFORM Protein DME1690 XEOTICID XEO05059 MOACRIVE Inhibition DME1690 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1690 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05061 XEO_CLAS Peptide DME1690 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO05061 GENEFORM Protein DME1690 XEOTICID XEO05061 MOACRIVE Inhibition DME1690 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1690 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05062 XEO_CLAS Peptide DME1690 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05062 GENEFORM Protein DME1690 XEOTICID XEO05062 MOACRIVE Inhibition DME1690 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1690 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05063 XEO_CLAS Peptide DME1690 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO05063 GENEFORM Protein DME1690 XEOTICID XEO05063 MOACRIVE Inhibition DME1690 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1690 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05064 XEO_CLAS Peptide DME1690 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 231 microM) DME1690 XEOTICID XEO05064 GENEFORM Protein DME1690 XEOTICID XEO05064 MOACRIVE Inhibition DME1690 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1690 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05065 XEO_CLAS Peptide DME1690 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 161 ug/ml) DME1690 XEOTICID XEO05065 GENEFORM Protein DME1690 XEOTICID XEO05065 MOACRIVE Inhibition DME1690 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1690 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05069 XEO_CLAS Peptide DME1690 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO05069 GENEFORM Protein DME1690 XEOTICID XEO05069 MOACRIVE Inhibition DME1690 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1690 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05070 XEO_CLAS Peptide DME1690 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 37.5 microM) DME1690 XEOTICID XEO05070 GENEFORM Protein DME1690 XEOTICID XEO05070 MOACRIVE Inhibition DME1690 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1690 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05071 XEO_CLAS Peptide DME1690 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 150 microM) DME1690 XEOTICID XEO05071 GENEFORM Protein DME1690 XEOTICID XEO05071 MOACRIVE Inhibition DME1690 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1690 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05072 XEO_CLAS Peptide DME1690 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO05072 GENEFORM Protein DME1690 XEOTICID XEO05072 MOACRIVE Inhibition DME1690 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1690 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05073 XEO_CLAS Peptide DME1690 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40 microM) DME1690 XEOTICID XEO05073 GENEFORM Protein DME1690 XEOTICID XEO05073 MOACRIVE Inhibition DME1690 XEOTICID XEO05076 XEO_NAME Temporin-A DME1690 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05076 XEO_CLAS Peptide DME1690 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 11.9 microM) DME1690 XEOTICID XEO05076 GENEFORM Protein DME1690 XEOTICID XEO05076 MOACRIVE Inhibition DME1690 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1690 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05077 XEO_CLAS Peptide DME1690 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.25 ug/ml) DME1690 XEOTICID XEO05077 GENEFORM Protein DME1690 XEOTICID XEO05077 MOACRIVE Inhibition DME1690 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1690 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05078 XEO_CLAS Peptide DME1690 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.25 ug/ml) DME1690 XEOTICID XEO05078 GENEFORM Protein DME1690 XEOTICID XEO05078 MOACRIVE Inhibition DME1690 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1690 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05079 XEO_CLAS Peptide DME1690 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.5 ug/ml) DME1690 XEOTICID XEO05079 GENEFORM Protein DME1690 XEOTICID XEO05079 MOACRIVE Inhibition DME1690 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1690 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05080 XEO_CLAS Peptide DME1690 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 ug/ml) DME1690 XEOTICID XEO05080 GENEFORM Protein DME1690 XEOTICID XEO05080 MOACRIVE Inhibition DME1690 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1690 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05081 XEO_CLAS Peptide DME1690 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 5 ug/ml) DME1690 XEOTICID XEO05081 GENEFORM Protein DME1690 XEOTICID XEO05081 MOACRIVE Inhibition DME1690 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1690 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05082 XEO_CLAS Peptide DME1690 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 7.5 ug/ml) DME1690 XEOTICID XEO05082 GENEFORM Protein DME1690 XEOTICID XEO05082 MOACRIVE Inhibition DME1690 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1690 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05083 XEO_CLAS Peptide DME1690 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 ug/ml) DME1690 XEOTICID XEO05083 GENEFORM Protein DME1690 XEOTICID XEO05083 MOACRIVE Inhibition DME1690 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1690 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05084 XEO_CLAS Peptide DME1690 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 ug/ml) DME1690 XEOTICID XEO05084 GENEFORM Protein DME1690 XEOTICID XEO05084 MOACRIVE Inhibition DME1690 XEOTICID XEO05085 XEO_NAME Temporin-B DME1690 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05085 XEO_CLAS Peptide DME1690 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 21.0 ug/ml) DME1690 XEOTICID XEO05085 GENEFORM Protein DME1690 XEOTICID XEO05085 MOACRIVE Inhibition DME1690 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1690 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05086 XEO_CLAS Peptide DME1690 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC > 100 microM) DME1690 XEOTICID XEO05086 GENEFORM Protein DME1690 XEOTICID XEO05086 MOACRIVE Inhibition DME1690 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1690 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05087 XEO_CLAS Peptide DME1690 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO05087 GENEFORM Protein DME1690 XEOTICID XEO05087 MOACRIVE Inhibition DME1690 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1690 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05097 XEO_CLAS Peptide DME1690 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16.0 microM) DME1690 XEOTICID XEO05097 GENEFORM Protein DME1690 XEOTICID XEO05097 MOACRIVE Inhibition DME1690 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1690 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05099 XEO_CLAS Peptide DME1690 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.0 microM) DME1690 XEOTICID XEO05099 GENEFORM Protein DME1690 XEOTICID XEO05099 MOACRIVE Inhibition DME1690 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1690 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05100 XEO_CLAS Peptide DME1690 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05100 GENEFORM Protein DME1690 XEOTICID XEO05100 MOACRIVE Inhibition DME1690 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1690 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05101 XEO_CLAS Peptide DME1690 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 24.2 ug/ml) DME1690 XEOTICID XEO05101 GENEFORM Protein DME1690 XEOTICID XEO05101 MOACRIVE Inhibition DME1690 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1690 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05102 XEO_CLAS Peptide DME1690 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 34.5 ug/ml) DME1690 XEOTICID XEO05102 GENEFORM Protein DME1690 XEOTICID XEO05102 MOACRIVE Inhibition DME1690 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1690 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05105 XEO_CLAS Peptide DME1690 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO05105 GENEFORM Protein DME1690 XEOTICID XEO05105 MOACRIVE Inhibition DME1690 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1690 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05106 XEO_CLAS Peptide DME1690 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25-200 microM) DME1690 XEOTICID XEO05106 GENEFORM Protein DME1690 XEOTICID XEO05106 MOACRIVE Inhibition DME1690 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1690 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05108 XEO_CLAS Peptide DME1690 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40 microM) DME1690 XEOTICID XEO05108 GENEFORM Protein DME1690 XEOTICID XEO05108 MOACRIVE Inhibition DME1690 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1690 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1690 XEOTICID XEO05111 XEO_CLAS Natural Product DME1690 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05111 GENEFORM Protein DME1690 XEOTICID XEO05111 MOACRIVE Inhibition DME1690 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1690 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05119 XEO_CLAS Peptide DME1690 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05119 GENEFORM Protein DME1690 XEOTICID XEO05119 MOACRIVE Inhibition DME1690 XEOTICID XEO05120 XEO_NAME Thanatin DME1690 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05120 XEO_CLAS Peptide DME1690 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1690 XEOTICID XEO05120 GENEFORM Protein DME1690 XEOTICID XEO05120 MOACRIVE Inhibition DME1690 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1690 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05121 XEO_CLAS Peptide DME1690 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 62.5 ug/ml) DME1690 XEOTICID XEO05121 GENEFORM Protein DME1690 XEOTICID XEO05121 MOACRIVE Inhibition DME1690 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1690 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05125 XEO_CLAS Peptide DME1690 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05125 GENEFORM Protein DME1690 XEOTICID XEO05125 MOACRIVE Inhibition DME1690 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1690 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05130 XEO_CLAS Peptide DME1690 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05130 GENEFORM Protein DME1690 XEOTICID XEO05130 MOACRIVE Inhibition DME1690 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1690 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05144 XEO_CLAS Peptide DME1690 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40 ug/ml) DME1690 XEOTICID XEO05144 GENEFORM Protein DME1690 XEOTICID XEO05144 MOACRIVE Inhibition DME1690 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1690 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05145 XEO_CLAS Peptide DME1690 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 ug/ml) DME1690 XEOTICID XEO05145 GENEFORM Protein DME1690 XEOTICID XEO05145 MOACRIVE Inhibition DME1690 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1690 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05146 XEO_CLAS Peptide DME1690 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 40 ug/ml) DME1690 XEOTICID XEO05146 GENEFORM Protein DME1690 XEOTICID XEO05146 MOACRIVE Inhibition DME1690 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1690 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05147 XEO_CLAS Peptide DME1690 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 60 ug/ml) DME1690 XEOTICID XEO05147 GENEFORM Protein DME1690 XEOTICID XEO05147 MOACRIVE Inhibition DME1690 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1690 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05158 XEO_CLAS Peptide DME1690 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05158 GENEFORM Protein DME1690 XEOTICID XEO05158 MOACRIVE Inhibition DME1690 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1690 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05161 XEO_CLAS Peptide DME1690 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 32 ug/ml) DME1690 XEOTICID XEO05161 GENEFORM Protein DME1690 XEOTICID XEO05161 MOACRIVE Inhibition DME1690 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1690 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05162 XEO_CLAS Peptide DME1690 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 32 ug/ml) DME1690 XEOTICID XEO05162 GENEFORM Protein DME1690 XEOTICID XEO05162 MOACRIVE Inhibition DME1690 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1690 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05163 XEO_CLAS Peptide DME1690 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 12-25 ug/ml) DME1690 XEOTICID XEO05163 GENEFORM Protein DME1690 XEOTICID XEO05163 MOACRIVE Inhibition DME1690 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1690 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05170 XEO_CLAS Peptide DME1690 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 3.0 microM) DME1690 XEOTICID XEO05170 GENEFORM Protein DME1690 XEOTICID XEO05170 MOACRIVE Inhibition DME1690 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1690 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05171 XEO_CLAS Peptide DME1690 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 50 microM) DME1690 XEOTICID XEO05171 GENEFORM Protein DME1690 XEOTICID XEO05171 MOACRIVE Inhibition DME1690 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1690 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05179 XEO_CLAS Peptide DME1690 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05179 GENEFORM Protein DME1690 XEOTICID XEO05179 MOACRIVE Inhibition DME1690 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1690 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05180 XEO_CLAS Peptide DME1690 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 160 microM) DME1690 XEOTICID XEO05180 GENEFORM Protein DME1690 XEOTICID XEO05180 MOACRIVE Inhibition DME1690 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1690 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05182 XEO_CLAS Peptide DME1690 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 microM) DME1690 XEOTICID XEO05182 GENEFORM Protein DME1690 XEOTICID XEO05182 MOACRIVE Inhibition DME1690 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1690 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05183 XEO_CLAS Peptide DME1690 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 microM) DME1690 XEOTICID XEO05183 GENEFORM Protein DME1690 XEOTICID XEO05183 MOACRIVE Inhibition DME1690 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1690 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05184 XEO_CLAS Peptide DME1690 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 microM) DME1690 XEOTICID XEO05184 GENEFORM Protein DME1690 XEOTICID XEO05184 MOACRIVE Inhibition DME1690 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1690 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05185 XEO_CLAS Peptide DME1690 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 microM) DME1690 XEOTICID XEO05185 GENEFORM Protein DME1690 XEOTICID XEO05185 MOACRIVE Inhibition DME1690 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1690 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05186 XEO_CLAS Peptide DME1690 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 microM) DME1690 XEOTICID XEO05186 GENEFORM Protein DME1690 XEOTICID XEO05186 MOACRIVE Inhibition DME1690 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1690 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05187 XEO_CLAS Peptide DME1690 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16 microM) DME1690 XEOTICID XEO05187 GENEFORM Protein DME1690 XEOTICID XEO05187 MOACRIVE Inhibition DME1690 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1690 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05188 XEO_CLAS Peptide DME1690 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 64 microM) DME1690 XEOTICID XEO05188 GENEFORM Protein DME1690 XEOTICID XEO05188 MOACRIVE Inhibition DME1690 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1690 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05190 XEO_CLAS Peptide DME1690 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05190 GENEFORM Protein DME1690 XEOTICID XEO05190 MOACRIVE Inhibition DME1690 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1690 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05193 XEO_CLAS Peptide DME1690 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO05193 GENEFORM Protein DME1690 XEOTICID XEO05193 MOACRIVE Inhibition DME1690 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1690 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05197 XEO_CLAS Peptide DME1690 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05197 GENEFORM Protein DME1690 XEOTICID XEO05197 MOACRIVE Inhibition DME1690 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1690 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05205 XEO_CLAS Peptide DME1690 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05205 GENEFORM Protein DME1690 XEOTICID XEO05205 MOACRIVE Inhibition DME1690 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1690 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05206 XEO_CLAS Peptide DME1690 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 10 microM) DME1690 XEOTICID XEO05206 GENEFORM Protein DME1690 XEOTICID XEO05206 MOACRIVE Inhibition DME1690 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1690 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05207 XEO_CLAS Peptide DME1690 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 25 microM) DME1690 XEOTICID XEO05207 GENEFORM Protein DME1690 XEOTICID XEO05207 MOACRIVE Inhibition DME1690 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1690 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05208 XEO_CLAS Peptide DME1690 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 microM) DME1690 XEOTICID XEO05208 GENEFORM Protein DME1690 XEOTICID XEO05208 MOACRIVE Inhibition DME1690 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1690 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05209 XEO_CLAS Peptide DME1690 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 15 microM) DME1690 XEOTICID XEO05209 GENEFORM Protein DME1690 XEOTICID XEO05209 MOACRIVE Inhibition DME1690 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1690 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05212 XEO_CLAS Peptide DME1690 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.5 ug/ml) DME1690 XEOTICID XEO05212 GENEFORM Protein DME1690 XEOTICID XEO05212 MOACRIVE Inhibition DME1690 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1690 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05220 XEO_CLAS Peptide DME1690 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.6-1.2 microM) DME1690 XEOTICID XEO05220 GENEFORM Protein DME1690 XEOTICID XEO05220 MOACRIVE Inhibition DME1690 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1690 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05230 XEO_CLAS Peptide DME1690 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 7.90 microM) DME1690 XEOTICID XEO05230 GENEFORM Protein DME1690 XEOTICID XEO05230 MOACRIVE Inhibition DME1690 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1690 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05231 XEO_CLAS Peptide DME1690 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2.40 microM) DME1690 XEOTICID XEO05231 GENEFORM Protein DME1690 XEOTICID XEO05231 MOACRIVE Inhibition DME1690 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1690 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05232 XEO_CLAS Peptide DME1690 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05232 GENEFORM Protein DME1690 XEOTICID XEO05232 MOACRIVE Inhibition DME1690 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1690 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05233 XEO_CLAS Peptide DME1690 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 ug/ml) DME1690 XEOTICID XEO05233 GENEFORM Protein DME1690 XEOTICID XEO05233 MOACRIVE Inhibition DME1690 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1690 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05234 XEO_CLAS Peptide DME1690 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 ug/ml) DME1690 XEOTICID XEO05234 GENEFORM Protein DME1690 XEOTICID XEO05234 MOACRIVE Inhibition DME1690 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1690 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05235 XEO_CLAS Peptide DME1690 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 30 ug/ml) DME1690 XEOTICID XEO05235 GENEFORM Protein DME1690 XEOTICID XEO05235 MOACRIVE Inhibition DME1690 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1690 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05237 XEO_CLAS Peptide DME1690 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 microM) DME1690 XEOTICID XEO05237 GENEFORM Protein DME1690 XEOTICID XEO05237 MOACRIVE Inhibition DME1690 XEOTICID XEO05245 XEO_NAME Viresin DME1690 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05245 XEO_CLAS Peptide DME1690 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05245 GENEFORM Protein DME1690 XEOTICID XEO05245 MOACRIVE Inhibition DME1690 XEOTICID XEO05248 XEO_NAME Vitamin C DME1690 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1690 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1690 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05248 GENEFORM Protein DME1690 XEOTICID XEO05248 MOACRIVE Inhibition DME1690 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1690 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05264 XEO_CLAS Peptide DME1690 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 4 ug/ml) DME1690 XEOTICID XEO05264 GENEFORM Protein DME1690 XEOTICID XEO05264 MOACRIVE Inhibition DME1690 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1690 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05267 XEO_CLAS Peptide DME1690 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 2 ug/ml) DME1690 XEOTICID XEO05267 GENEFORM Protein DME1690 XEOTICID XEO05267 MOACRIVE Inhibition DME1690 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1690 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05268 XEO_CLAS Peptide DME1690 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 1.6 ug/ml) DME1690 XEOTICID XEO05268 GENEFORM Protein DME1690 XEOTICID XEO05268 MOACRIVE Inhibition DME1690 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1690 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05269 XEO_CLAS Peptide DME1690 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 6 ug/ml) DME1690 XEOTICID XEO05269 GENEFORM Protein DME1690 XEOTICID XEO05269 MOACRIVE Inhibition DME1690 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1690 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05273 XEO_CLAS Peptide DME1690 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05273 GENEFORM Protein DME1690 XEOTICID XEO05273 MOACRIVE Inhibition DME1690 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1690 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05274 XEO_CLAS Peptide DME1690 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05274 GENEFORM Protein DME1690 XEOTICID XEO05274 MOACRIVE Inhibition DME1690 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1690 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05287 XEO_CLAS Peptide DME1690 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli DME1690 XEOTICID XEO05287 GENEFORM Protein DME1690 XEOTICID XEO05287 MOACRIVE Inhibition DME1690 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1690 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05303 XEO_CLAS Peptide DME1690 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 16-31 ug/ml) DME1690 XEOTICID XEO05303 GENEFORM Protein DME1690 XEOTICID XEO05303 MOACRIVE Inhibition DME1690 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1690 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05306 XEO_CLAS Peptide DME1690 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 8 ug/ml) DME1690 XEOTICID XEO05306 GENEFORM Protein DME1690 XEOTICID XEO05306 MOACRIVE Inhibition DME1690 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1690 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1690 XEOTICID XEO05308 XEO_CLAS Peptide DME1690 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Escherichia coli (MIC = 0.4 ug/ml) DME1690 XEOTICID XEO05308 GENEFORM Protein DME1690 XEOTICID XEO05308 MOACRIVE Inhibition DME1691 DME___ID DME1691 DME1691 DME_NAME Pyruvate oxidase (pyrO) DME1691 SPESNAME Lactobacillus casei DME1691 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1691 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1691 XEOTICID XEO03771 XEO_CLAS Peptide DME1691 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Pyruvate oxidase (pyrO) from Lactobacillus casei DME1691 XEOTICID XEO03771 GENEFORM Protein DME1691 XEOTICID XEO03771 MOACRIVE Inhibition DME1691 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1691 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1691 XEOTICID XEO03775 XEO_CLAS Peptide DME1691 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Pyruvate oxidase (pyrO) from Lactobacillus casei (MIC = 2.27 microM) DME1691 XEOTICID XEO03775 GENEFORM Protein DME1691 XEOTICID XEO03775 MOACRIVE Inhibition DME1691 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1691 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1691 XEOTICID XEO03803 XEO_CLAS Peptide DME1691 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Pyruvate oxidase (pyrO) from Lactobacillus casei DME1691 XEOTICID XEO03803 GENEFORM Protein DME1691 XEOTICID XEO03803 MOACRIVE Inhibition DME1691 XEOTICID XEO03967 XEO_NAME Bacteriocin LSEI_2163 DME1691 XEOTICID XEO03967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1691 XEOTICID XEO03967 XEO_CLAS Peptide DME1691 XEOTICID XEO03967 DESCRIPT Bacteriocin LSEI_2163 inhibits the drug-metabolizing activity of Pyruvate oxidase (pyrO) from Lactobacillus casei DME1691 XEOTICID XEO03967 GENEFORM Protein DME1691 XEOTICID XEO03967 MOACRIVE Inhibition DME1691 XEOTICID XEO04332 XEO_NAME Nosiheptide DME1691 XEOTICID XEO04332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1691 XEOTICID XEO04332 XEO_CLAS Peptide DME1691 XEOTICID XEO04332 DESCRIPT Nosiheptide inhibits the drug-metabolizing activity of Pyruvate oxidase (pyrO) from Lactobacillus casei (MIC = 0.003 ug/ml) DME1691 XEOTICID XEO04332 GENEFORM Protein DME1691 XEOTICID XEO04332 MOACRIVE Inhibition DME1691 XEOTICID XEO04521 XEO_NAME Penocin A DME1691 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1691 XEOTICID XEO04521 XEO_CLAS Peptide DME1691 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Pyruvate oxidase (pyrO) from Lactobacillus casei DME1691 XEOTICID XEO04521 GENEFORM Protein DME1691 XEOTICID XEO04521 MOACRIVE Inhibition DME1691 XEOTICID XEO04616 XEO_NAME Plantaricin E DME1691 XEOTICID XEO04616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1691 XEOTICID XEO04616 XEO_CLAS Peptide DME1691 XEOTICID XEO04616 DESCRIPT Plantaricin E inhibits the drug-metabolizing activity of Pyruvate oxidase (pyrO) from Lactobacillus casei (MIC = 0.02 microM) DME1691 XEOTICID XEO04616 GENEFORM Protein DME1691 XEOTICID XEO04616 MOACRIVE Inhibition DME1691 XEOTICID XEO04617 XEO_NAME Plantaricin F DME1691 XEOTICID XEO04617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1691 XEOTICID XEO04617 XEO_CLAS Peptide DME1691 XEOTICID XEO04617 DESCRIPT Plantaricin F inhibits the drug-metabolizing activity of Pyruvate oxidase (pyrO) from Lactobacillus casei (MIC = 0.02 microM) DME1691 XEOTICID XEO04617 GENEFORM Protein DME1691 XEOTICID XEO04617 MOACRIVE Inhibition DME1691 XEOTICID XEO05004 XEO_NAME Subpeptin JM4-A DME1691 XEOTICID XEO05004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1691 XEOTICID XEO05004 XEO_CLAS Peptide DME1691 XEOTICID XEO05004 DESCRIPT Subpeptin JM4-A inhibits the drug-metabolizing activity of Pyruvate oxidase (pyrO) from Lactobacillus casei DME1691 XEOTICID XEO05004 GENEFORM Protein DME1691 XEOTICID XEO05004 MOACRIVE Inhibition DME1691 XEOTICID XEO05005 XEO_NAME Subpeptin JM4-B DME1691 XEOTICID XEO05005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1691 XEOTICID XEO05005 XEO_CLAS Peptide DME1691 XEOTICID XEO05005 DESCRIPT Subpeptin JM4-B inhibits the drug-metabolizing activity of Pyruvate oxidase (pyrO) from Lactobacillus casei DME1691 XEOTICID XEO05005 GENEFORM Protein DME1691 XEOTICID XEO05005 MOACRIVE Inhibition DME1691 XEOTICID XEO05283 XEO_NAME Weissellin-A DME1691 XEOTICID XEO05283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1691 XEOTICID XEO05283 XEO_CLAS Peptide DME1691 XEOTICID XEO05283 DESCRIPT Weissellin-A inhibits the drug-metabolizing activity of Pyruvate oxidase (pyrO) from Lactobacillus casei DME1691 XEOTICID XEO05283 GENEFORM Protein DME1691 XEOTICID XEO05283 MOACRIVE Inhibition DME1692 DME___ID DME1692 DME1692 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1692 SPESNAME Streptococcus mutans DME1692 XEOTICID XEO00222 XEO_NAME Reserpine DME1692 XEOTICID XEO00222 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO00222 XEO_CLAS Approved/Marketed Drug DME1692 XEOTICID XEO00222 DESCRIPT Reserpine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO00222 GENEFORM Protein DME1692 XEOTICID XEO00222 MOACRIVE Inhibition DME1692 XEOTICID XEO00487 XEO_NAME Thymol DME1692 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1692 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO00487 GENEFORM Protein DME1692 XEOTICID XEO00487 MOACRIVE Inhibition DME1692 XEOTICID XEO00516 XEO_NAME Danthron DME1692 XEOTICID XEO00516 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO00516 XEO_CLAS Drug Marketed but Withdrawn from Market DME1692 XEOTICID XEO00516 DESCRIPT Danthron inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO00516 GENEFORM Protein DME1692 XEOTICID XEO00516 MOACRIVE Inhibition DME1692 XEOTICID XEO00560 XEO_NAME Triclosan DME1692 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME1692 XEOTICID XEO00560 DESCRIPT Triclosan inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO00560 GENEFORM Protein DME1692 XEOTICID XEO00560 MOACRIVE Inhibition DME1692 XEOTICID XEO00579 XEO_NAME SGX301 DME1692 XEOTICID XEO00579 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO00579 XEO_CLAS Drug in Phase 3 Clinical Trial DME1692 XEOTICID XEO00579 DESCRIPT SGX301 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO00579 GENEFORM Protein DME1692 XEOTICID XEO00579 MOACRIVE Inhibition DME1692 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME1692 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME1692 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO00613 GENEFORM Protein DME1692 XEOTICID XEO00613 MOACRIVE Inhibition DME1692 XEOTICID XEO00683 XEO_NAME Curcumin DME1692 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1692 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO00683 GENEFORM Protein DME1692 XEOTICID XEO00683 MOACRIVE Inhibition DME1692 XEOTICID XEO00692 XEO_NAME Emodin DME1692 XEOTICID XEO00692 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO00692 XEO_CLAS Preclinical/Patented Drug DME1692 XEOTICID XEO00692 DESCRIPT Emodin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO00692 GENEFORM Protein DME1692 XEOTICID XEO00692 MOACRIVE Inhibition DME1692 XEOTICID XEO01191 XEO_NAME Aloe-emodin DME1692 XEOTICID XEO01191 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO01191 XEO_CLAS Natural Product DME1692 XEOTICID XEO01191 DESCRIPT Aloe-emodin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO01191 GENEFORM Protein DME1692 XEOTICID XEO01191 MOACRIVE Inhibition DME1692 XEOTICID XEO01237 XEO_NAME Carvacrol DME1692 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1692 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO01237 GENEFORM Protein DME1692 XEOTICID XEO01237 MOACRIVE Inhibition DME1692 XEOTICID XEO01309 XEO_NAME Gallic acid DME1692 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO01309 XEO_CLAS Natural Product DME1692 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO01309 GENEFORM Protein DME1692 XEOTICID XEO01309 MOACRIVE Inhibition DME1692 XEOTICID XEO01408 XEO_NAME Octyl gallate DME1692 XEOTICID XEO01408 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO01408 XEO_CLAS Natural Product DME1692 XEOTICID XEO01408 DESCRIPT Octyl gallate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO01408 GENEFORM Protein DME1692 XEOTICID XEO01408 MOACRIVE Inhibition DME1692 XEOTICID XEO01455 XEO_NAME Rhein DME1692 XEOTICID XEO01455 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO01455 XEO_CLAS Investigative Agent DME1692 XEOTICID XEO01455 DESCRIPT Rhein inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO01455 GENEFORM Protein DME1692 XEOTICID XEO01455 MOACRIVE Inhibition DME1692 XEOTICID XEO01528 XEO_NAME Chrysophanic acid DME1692 XEOTICID XEO01528 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO01528 XEO_CLAS Natural Product DME1692 XEOTICID XEO01528 DESCRIPT Chrysophanic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO01528 GENEFORM Protein DME1692 XEOTICID XEO01528 MOACRIVE Inhibition DME1692 XEOTICID XEO01531 XEO_NAME Clove oil DME1692 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO01531 XEO_CLAS Natural Product DME1692 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO01531 GENEFORM Protein DME1692 XEOTICID XEO01531 MOACRIVE Inhibition DME1692 XEOTICID XEO01559 XEO_NAME Limonene DME1692 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO01559 XEO_CLAS Natural Product DME1692 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO01559 GENEFORM Protein DME1692 XEOTICID XEO01559 MOACRIVE Inhibition DME1692 XEOTICID XEO01931 XEO_NAME Alliin DME1692 XEOTICID XEO01931 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO01931 XEO_CLAS Investigative Agent DME1692 XEOTICID XEO01931 DESCRIPT Alliin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO01931 GENEFORM Protein DME1692 XEOTICID XEO01931 MOACRIVE Inhibition DME1692 XEOTICID XEO01940 XEO_NAME 2C-4 peptide DME1692 XEOTICID XEO01940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO01940 XEO_CLAS Peptide DME1692 XEOTICID XEO01940 DESCRIPT 2C-4 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO01940 GENEFORM Protein DME1692 XEOTICID XEO01940 MOACRIVE Inhibition DME1692 XEOTICID XEO01976 XEO_NAME Allicin DME1692 XEOTICID XEO01976 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO01976 XEO_CLAS Drug in Phase 1 Clinical Trial DME1692 XEOTICID XEO01976 DESCRIPT Allicin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO01976 GENEFORM Protein DME1692 XEOTICID XEO01976 MOACRIVE Inhibition DME1692 XEOTICID XEO02124 XEO_NAME Salvadora persica acetone extract DME1692 XEOTICID XEO02124 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO02124 XEO_CLAS Plant Extract DME1692 XEOTICID XEO02124 DESCRIPT Salvadora persica acetone extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO02124 GENEFORM Protein DME1692 XEOTICID XEO02124 MOACRIVE Inhibition DME1692 XEOTICID XEO02234 XEO_NAME Anthraflavic acid DME1692 XEOTICID XEO02234 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO02234 XEO_CLAS Investigative Agent DME1692 XEOTICID XEO02234 DESCRIPT Anthraflavic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO02234 GENEFORM Protein DME1692 XEOTICID XEO02234 MOACRIVE Inhibition DME1692 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1692 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO02289 XEO_CLAS Peptide DME1692 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans (MIC = 30 ug/ml) DME1692 XEOTICID XEO02289 GENEFORM Protein DME1692 XEOTICID XEO02289 MOACRIVE Inhibition DME1692 XEOTICID XEO02313 XEO_NAME Salvadora persica aqueous extract DME1692 XEOTICID XEO02313 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO02313 XEO_CLAS Plant Extract DME1692 XEOTICID XEO02313 DESCRIPT Salvadora persica aqueous extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO02313 GENEFORM Protein DME1692 XEOTICID XEO02313 MOACRIVE Inhibition DME1692 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1692 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO02649 XEO_CLAS Peptide DME1692 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans (MIC = 8 ug/ml) DME1692 XEOTICID XEO02649 GENEFORM Protein DME1692 XEOTICID XEO02649 MOACRIVE Inhibition DME1692 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1692 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO02650 XEO_CLAS Peptide DME1692 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans (MIC = 2 ug/ml) DME1692 XEOTICID XEO02650 GENEFORM Protein DME1692 XEOTICID XEO02650 MOACRIVE Inhibition DME1692 XEOTICID XEO02660 XEO_NAME Butyl gallate DME1692 XEOTICID XEO02660 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO02660 XEO_CLAS Chemical Compound DME1692 XEOTICID XEO02660 DESCRIPT Butyl gallate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO02660 GENEFORM Protein DME1692 XEOTICID XEO02660 MOACRIVE Inhibition DME1692 XEOTICID XEO02670 XEO_NAME C16-33 peptide DME1692 XEOTICID XEO02670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO02670 XEO_CLAS Peptide DME1692 XEOTICID XEO02670 DESCRIPT C16-33 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO02670 GENEFORM Protein DME1692 XEOTICID XEO02670 MOACRIVE Inhibition DME1692 XEOTICID XEO02716 XEO_NAME Carminic acid DME1692 XEOTICID XEO02716 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO02716 XEO_CLAS Natural Product DME1692 XEOTICID XEO02716 DESCRIPT Carminic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO02716 GENEFORM Protein DME1692 XEOTICID XEO02716 MOACRIVE Inhibition DME1692 XEOTICID XEO02717 XEO_NAME Carnitine hydrochloride DME1692 XEOTICID XEO02717 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO02717 XEO_CLAS Investigative Agent DME1692 XEOTICID XEO02717 DESCRIPT Carnitine hydrochloride inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO02717 GENEFORM Protein DME1692 XEOTICID XEO02717 MOACRIVE Inhibition DME1692 XEOTICID XEO02722 XEO_NAME Carolacton DME1692 XEOTICID XEO02722 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO02722 XEO_CLAS Natural Product DME1692 XEOTICID XEO02722 DESCRIPT Carolacton inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO02722 GENEFORM Protein DME1692 XEOTICID XEO02722 MOACRIVE Inhibition DME1692 XEOTICID XEO02780 XEO_NAME Cefixime DME1692 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1692 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO02780 GENEFORM Protein DME1692 XEOTICID XEO02780 MOACRIVE Inhibition DME1692 XEOTICID XEO02830 XEO_NAME Chlorhexidine DME1692 XEOTICID XEO02830 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO02830 XEO_CLAS Approved/Marketed Drug DME1692 XEOTICID XEO02830 DESCRIPT Chlorhexidine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO02830 GENEFORM Protein DME1692 XEOTICID XEO02830 MOACRIVE Inhibition DME1692 XEOTICID XEO02831 XEO_NAME Chlorhexidine acetate DME1692 XEOTICID XEO02831 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO02831 XEO_CLAS Drug in Phase 1 Clinical Trial DME1692 XEOTICID XEO02831 DESCRIPT Chlorhexidine acetate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO02831 GENEFORM Protein DME1692 XEOTICID XEO02831 MOACRIVE Inhibition DME1692 XEOTICID XEO02832 XEO_NAME Salvadora persica chloroform extract DME1692 XEOTICID XEO02832 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO02832 XEO_CLAS Plant Extract DME1692 XEOTICID XEO02832 DESCRIPT Salvadora persica chloroform extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO02832 GENEFORM Protein DME1692 XEOTICID XEO02832 MOACRIVE Inhibition DME1692 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1692 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO02839 XEO_CLAS Peptide DME1692 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO02839 GENEFORM Protein DME1692 XEOTICID XEO02839 MOACRIVE Inhibition DME1692 XEOTICID XEO03009 XEO_NAME Streptococcus salivarius culture supernatant DME1692 XEOTICID XEO03009 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO03009 XEO_CLAS Bacterial Extract DME1692 XEOTICID XEO03009 DESCRIPT Streptococcus salivarius culture supernatant inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03009 GENEFORM Protein DME1692 XEOTICID XEO03009 MOACRIVE Inhibition DME1692 XEOTICID XEO03179 XEO_NAME Dibenzyl disulphide DME1692 XEOTICID XEO03179 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO03179 XEO_CLAS Chemical Compound DME1692 XEOTICID XEO03179 DESCRIPT Dibenzyl disulphide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03179 GENEFORM Protein DME1692 XEOTICID XEO03179 MOACRIVE Inhibition DME1692 XEOTICID XEO03180 XEO_NAME Dibenzyl sulphide DME1692 XEOTICID XEO03180 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO03180 XEO_CLAS Chemical Compound DME1692 XEOTICID XEO03180 DESCRIPT Dibenzyl sulphide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03180 GENEFORM Protein DME1692 XEOTICID XEO03180 MOACRIVE Inhibition DME1692 XEOTICID XEO03191 XEO_NAME Diphenyl disulphide DME1692 XEOTICID XEO03191 XEO_TYPE Health or Environmental Toxicant(s) DME1692 XEOTICID XEO03191 XEO_CLAS Environmental Pollutant DME1692 XEOTICID XEO03191 DESCRIPT Diphenyl disulphide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03191 GENEFORM Protein DME1692 XEOTICID XEO03191 MOACRIVE Inhibition DME1692 XEOTICID XEO03199 XEO_NAME Djenkolic acid DME1692 XEOTICID XEO03199 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO03199 XEO_CLAS Chemical Compound DME1692 XEOTICID XEO03199 DESCRIPT Djenkolic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03199 GENEFORM Protein DME1692 XEOTICID XEO03199 MOACRIVE Inhibition DME1692 XEOTICID XEO03271 XEO_NAME Erythritol DME1692 XEOTICID XEO03271 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO03271 XEO_CLAS Natural Product DME1692 XEOTICID XEO03271 DESCRIPT Erythritol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03271 GENEFORM Protein DME1692 XEOTICID XEO03271 MOACRIVE Inhibition DME1692 XEOTICID XEO03350 XEO_NAME Salvadora persica ethanolic extract DME1692 XEOTICID XEO03350 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO03350 XEO_CLAS Plant Extract DME1692 XEOTICID XEO03350 DESCRIPT Salvadora persica ethanolic extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03350 GENEFORM Protein DME1692 XEOTICID XEO03350 MOACRIVE Inhibition DME1692 XEOTICID XEO03372 XEO_NAME Hypsizygus marmoreus extract DME1692 XEOTICID XEO03372 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO03372 XEO_CLAS Fungal Extract DME1692 XEOTICID XEO03372 DESCRIPT Hypsizygus marmoreus extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03372 GENEFORM Protein DME1692 XEOTICID XEO03372 MOACRIVE Inhibition DME1692 XEOTICID XEO03373 XEO_NAME Lentinula edodes extract DME1692 XEOTICID XEO03373 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO03373 XEO_CLAS Fungal Extract DME1692 XEOTICID XEO03373 DESCRIPT Lentinula edodes extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03373 GENEFORM Protein DME1692 XEOTICID XEO03373 MOACRIVE Inhibition DME1692 XEOTICID XEO03374 XEO_NAME Pholiota nameko extract DME1692 XEOTICID XEO03374 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO03374 XEO_CLAS Fungal Extract DME1692 XEOTICID XEO03374 DESCRIPT Pholiota nameko extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03374 GENEFORM Protein DME1692 XEOTICID XEO03374 MOACRIVE Inhibition DME1692 XEOTICID XEO03375 XEO_NAME Pleurotus eryngii extract DME1692 XEOTICID XEO03375 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO03375 XEO_CLAS Fungal Extract DME1692 XEOTICID XEO03375 DESCRIPT Pleurotus eryngii extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03375 GENEFORM Protein DME1692 XEOTICID XEO03375 MOACRIVE Inhibition DME1692 XEOTICID XEO03415 XEO_NAME Furanone C-30 DME1692 XEOTICID XEO03415 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO03415 XEO_CLAS Investigative Agent DME1692 XEOTICID XEO03415 DESCRIPT Furanone C-30 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03415 GENEFORM Protein DME1692 XEOTICID XEO03415 MOACRIVE Inhibition DME1692 XEOTICID XEO03433 XEO_NAME G2 peptide DME1692 XEOTICID XEO03433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO03433 XEO_CLAS Peptide DME1692 XEOTICID XEO03433 DESCRIPT G2 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03433 GENEFORM Protein DME1692 XEOTICID XEO03433 MOACRIVE Inhibition DME1692 XEOTICID XEO03492 XEO_NAME Glycinamide hydrochloride DME1692 XEOTICID XEO03492 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO03492 XEO_CLAS Chemical Compound DME1692 XEOTICID XEO03492 DESCRIPT Glycinamide hydrochloride inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03492 GENEFORM Protein DME1692 XEOTICID XEO03492 MOACRIVE Inhibition DME1692 XEOTICID XEO03555 XEO_NAME Hexyl gallate DME1692 XEOTICID XEO03555 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO03555 XEO_CLAS Chemical Compound DME1692 XEOTICID XEO03555 DESCRIPT Hexyl gallate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03555 GENEFORM Protein DME1692 XEOTICID XEO03555 MOACRIVE Inhibition DME1692 XEOTICID XEO03704 XEO_NAME Kaurenoic acid DME1692 XEOTICID XEO03704 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO03704 XEO_CLAS Natural Product DME1692 XEOTICID XEO03704 DESCRIPT Kaurenoic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03704 GENEFORM Protein DME1692 XEOTICID XEO03704 MOACRIVE Inhibition DME1692 XEOTICID XEO03796 XEO_NAME L-amino-acid oxidase Casca LAO DME1692 XEOTICID XEO03796 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO03796 XEO_CLAS Peptide DME1692 XEOTICID XEO03796 DESCRIPT L-amino-acid oxidase Casca LAO inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03796 GENEFORM Protein DME1692 XEOTICID XEO03796 MOACRIVE Inhibition DME1692 XEOTICID XEO03813 XEO_NAME L-cysteic acid DME1692 XEOTICID XEO03813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO03813 XEO_CLAS Amino Acid DME1692 XEOTICID XEO03813 DESCRIPT L-cysteic acid inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03813 GENEFORM Protein DME1692 XEOTICID XEO03813 MOACRIVE Inhibition DME1692 XEOTICID XEO03912 XEO_NAME Listerine DME1692 XEOTICID XEO03912 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO03912 XEO_CLAS Investigative Agent DME1692 XEOTICID XEO03912 DESCRIPT Listerine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03912 GENEFORM Protein DME1692 XEOTICID XEO03912 MOACRIVE Inhibition DME1692 XEOTICID XEO03971 XEO_NAME Lumbrican DME1692 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO03971 XEO_CLAS Peptide DME1692 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03971 GENEFORM Protein DME1692 XEOTICID XEO03971 MOACRIVE Inhibition DME1692 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1692 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO03972 XEO_CLAS Peptide DME1692 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans (MIC = 20 ug/ml) DME1692 XEOTICID XEO03972 GENEFORM Protein DME1692 XEOTICID XEO03972 MOACRIVE Inhibition DME1692 XEOTICID XEO03978 XEO_NAME M8-33 peptide DME1692 XEOTICID XEO03978 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO03978 XEO_CLAS Peptide DME1692 XEOTICID XEO03978 DESCRIPT M8-33 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO03978 GENEFORM Protein DME1692 XEOTICID XEO03978 MOACRIVE Inhibition DME1692 XEOTICID XEO04099 XEO_NAME Salvadora persica methanolic extract DME1692 XEOTICID XEO04099 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO04099 XEO_CLAS Plant Extract DME1692 XEOTICID XEO04099 DESCRIPT Salvadora persica methanolic extract inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04099 GENEFORM Protein DME1692 XEOTICID XEO04099 MOACRIVE Inhibition DME1692 XEOTICID XEO04106 XEO_NAME Methyl gallate DME1692 XEOTICID XEO04106 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO04106 XEO_CLAS Investigative Agent DME1692 XEOTICID XEO04106 DESCRIPT Methyl gallate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04106 GENEFORM Protein DME1692 XEOTICID XEO04106 MOACRIVE Inhibition DME1692 XEOTICID XEO04117 XEO_NAME Misgurin DME1692 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO04117 XEO_CLAS Peptide DME1692 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04117 GENEFORM Protein DME1692 XEOTICID XEO04117 MOACRIVE Inhibition DME1692 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1692 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO04146 XEO_CLAS Peptide DME1692 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04146 GENEFORM Protein DME1692 XEOTICID XEO04146 MOACRIVE Inhibition DME1692 XEOTICID XEO04155 XEO_NAME Mutacin-1140 DME1692 XEOTICID XEO04155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO04155 XEO_CLAS Peptide DME1692 XEOTICID XEO04155 DESCRIPT Mutacin-1140 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04155 GENEFORM Protein DME1692 XEOTICID XEO04155 MOACRIVE Inhibition DME1692 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1692 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO04249 XEO_CLAS Peptide DME1692 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans (MIC > 500 ug/ml) DME1692 XEOTICID XEO04249 GENEFORM Protein DME1692 XEOTICID XEO04249 MOACRIVE Inhibition DME1692 XEOTICID XEO04331 XEO_NAME Norspermidine DME1692 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1692 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04331 GENEFORM Protein DME1692 XEOTICID XEO04331 MOACRIVE Inhibition DME1692 XEOTICID XEO04350 XEO_NAME Octadecyl gallate DME1692 XEOTICID XEO04350 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO04350 XEO_CLAS Chemical Compound DME1692 XEOTICID XEO04350 DESCRIPT Octadecyl gallate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04350 GENEFORM Protein DME1692 XEOTICID XEO04350 MOACRIVE Inhibition DME1692 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1692 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1692 XEOTICID XEO04640 XEO_CLAS Peptide DME1692 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04640 GENEFORM Protein DME1692 XEOTICID XEO04640 MOACRIVE Inhibition DME1692 XEOTICID XEO04723 XEO_NAME Allylsulfenate DME1692 XEOTICID XEO04723 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO04723 XEO_CLAS Chemical Compound DME1692 XEOTICID XEO04723 DESCRIPT Allylsulfenate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04723 GENEFORM Protein DME1692 XEOTICID XEO04723 MOACRIVE Inhibition DME1692 XEOTICID XEO04727 XEO_NAME Propyl gallate DME1692 XEOTICID XEO04727 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO04727 XEO_CLAS Food Additive DME1692 XEOTICID XEO04727 DESCRIPT Propyl gallate inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04727 GENEFORM Protein DME1692 XEOTICID XEO04727 MOACRIVE Inhibition DME1692 XEOTICID XEO04753 XEO_NAME Pseudomonas quinolone signal DME1692 XEOTICID XEO04753 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO04753 XEO_CLAS Natural Product DME1692 XEOTICID XEO04753 DESCRIPT Pseudomonas quinolone signal inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04753 GENEFORM Protein DME1692 XEOTICID XEO04753 MOACRIVE Inhibition DME1692 XEOTICID XEO04775 XEO_NAME Quinizarin DME1692 XEOTICID XEO04775 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO04775 XEO_CLAS Investigative Agent DME1692 XEOTICID XEO04775 DESCRIPT Quinizarin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04775 GENEFORM Protein DME1692 XEOTICID XEO04775 MOACRIVE Inhibition DME1692 XEOTICID XEO04873 XEO_NAME S-(2-Aminoethyl)-L-cysteine hydrochloride DME1692 XEOTICID XEO04873 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO04873 XEO_CLAS Chemical Compound DME1692 XEOTICID XEO04873 DESCRIPT S-(2-Aminoethyl)-L-cysteine hydrochloride inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04873 GENEFORM Protein DME1692 XEOTICID XEO04873 MOACRIVE Inhibition DME1692 XEOTICID XEO04875 XEO_NAME S-(2-thienyl)-L-cysteine DME1692 XEOTICID XEO04875 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO04875 XEO_CLAS Chemical Compound DME1692 XEOTICID XEO04875 DESCRIPT S-(2-thienyl)-L-cysteine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04875 GENEFORM Protein DME1692 XEOTICID XEO04875 MOACRIVE Inhibition DME1692 XEOTICID XEO04876 XEO_NAME S-(4-tolyl)-L-cysteine DME1692 XEOTICID XEO04876 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO04876 XEO_CLAS Chemical Compound DME1692 XEOTICID XEO04876 DESCRIPT S-(4-tolyl)-L-cysteine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04876 GENEFORM Protein DME1692 XEOTICID XEO04876 MOACRIVE Inhibition DME1692 XEOTICID XEO04914 XEO_NAME S-carboxylmethyl-L-cysteine DME1692 XEOTICID XEO04914 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO04914 XEO_CLAS Investigative Agent DME1692 XEOTICID XEO04914 DESCRIPT S-carboxylmethyl-L-cysteine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04914 GENEFORM Protein DME1692 XEOTICID XEO04914 MOACRIVE Inhibition DME1692 XEOTICID XEO04928 XEO_NAME Sennidin A DME1692 XEOTICID XEO04928 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO04928 XEO_CLAS Natural Product DME1692 XEOTICID XEO04928 DESCRIPT Sennidin A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04928 GENEFORM Protein DME1692 XEOTICID XEO04928 MOACRIVE Inhibition DME1692 XEOTICID XEO04930 XEO_NAME S-ethyl-L-cysteine DME1692 XEOTICID XEO04930 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO04930 XEO_CLAS Chemical Compound DME1692 XEOTICID XEO04930 DESCRIPT S-ethyl-L-cysteine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04930 GENEFORM Protein DME1692 XEOTICID XEO04930 MOACRIVE Inhibition DME1692 XEOTICID XEO04972 XEO_NAME S-phenyl-L-cysteine DME1692 XEOTICID XEO04972 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO04972 XEO_CLAS Chemical Compound DME1692 XEOTICID XEO04972 DESCRIPT S-phenyl-L-cysteine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04972 GENEFORM Protein DME1692 XEOTICID XEO04972 MOACRIVE Inhibition DME1692 XEOTICID XEO04980 XEO_NAME S-propyl-L-cysteine DME1692 XEOTICID XEO04980 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1692 XEOTICID XEO04980 XEO_CLAS Chemical Compound DME1692 XEOTICID XEO04980 DESCRIPT S-propyl-L-cysteine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO04980 GENEFORM Protein DME1692 XEOTICID XEO04980 MOACRIVE Inhibition DME1692 XEOTICID XEO05032 XEO_NAME Taurine DME1692 XEOTICID XEO05032 XEO_TYPE Pharmaceutical Agent(s) DME1692 XEOTICID XEO05032 XEO_CLAS Approved/Marketed Drug DME1692 XEOTICID XEO05032 DESCRIPT Taurine inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO05032 GENEFORM Protein DME1692 XEOTICID XEO05032 MOACRIVE Inhibition DME1692 XEOTICID XEO05194 XEO_NAME Tyrosol DME1692 XEOTICID XEO05194 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1692 XEOTICID XEO05194 XEO_CLAS Natural Product DME1692 XEOTICID XEO05194 DESCRIPT Tyrosol inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Streptococcus mutans DME1692 XEOTICID XEO05194 GENEFORM Protein DME1692 XEOTICID XEO05194 MOACRIVE Inhibition DME1693 DME___ID DME1693 DME1693 DME_NAME D-Lactate dehydrogenase (ldhA) DME1693 SPESNAME Pseudomonas aeruginosa DME1693 XEOTICID XEO00001 XEO_NAME Dimethyl sulfoxide DME1693 XEOTICID XEO00001 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00001 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00001 DESCRIPT Dimethyl sulfoxide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00001 GENEFORM Protein DME1693 XEOTICID XEO00001 MOACRIVE Inhibition DME1693 XEOTICID XEO00037 XEO_NAME Fluorouracil DME1693 XEOTICID XEO00037 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00037 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00037 DESCRIPT Fluorouracil inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00037 GENEFORM Protein DME1693 XEOTICID XEO00037 MOACRIVE Inhibition DME1693 XEOTICID XEO00096 XEO_NAME Ampicillin DME1693 XEOTICID XEO00096 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00096 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00096 DESCRIPT Ampicillin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00096 GENEFORM Protein DME1693 XEOTICID XEO00096 MOACRIVE Inhibition DME1693 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1693 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00117 GENEFORM Protein DME1693 XEOTICID XEO00117 MOACRIVE Inhibition DME1693 XEOTICID XEO00164 XEO_NAME Azithromycin DME1693 XEOTICID XEO00164 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00164 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00164 DESCRIPT Azithromycin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00164 GENEFORM Protein DME1693 XEOTICID XEO00164 MOACRIVE Inhibition DME1693 XEOTICID XEO00199 XEO_NAME Doxycycline DME1693 XEOTICID XEO00199 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00199 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00199 DESCRIPT Doxycycline inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00199 GENEFORM Protein DME1693 XEOTICID XEO00199 MOACRIVE Inhibition DME1693 XEOTICID XEO00218 XEO_NAME Caffeine DME1693 XEOTICID XEO00218 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00218 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00218 DESCRIPT Caffeine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00218 GENEFORM Protein DME1693 XEOTICID XEO00218 MOACRIVE Inhibition DME1693 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1693 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00237 GENEFORM Protein DME1693 XEOTICID XEO00237 MOACRIVE Inhibition DME1693 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1693 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00349 GENEFORM Protein DME1693 XEOTICID XEO00349 MOACRIVE Inhibition DME1693 XEOTICID XEO00375 XEO_NAME Piperacillin DME1693 XEOTICID XEO00375 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00375 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00375 DESCRIPT Piperacillin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00375 GENEFORM Protein DME1693 XEOTICID XEO00375 MOACRIVE Inhibition DME1693 XEOTICID XEO00388 XEO_NAME Hydrogen peroxide DME1693 XEOTICID XEO00388 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00388 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00388 DESCRIPT Hydrogen peroxide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00388 GENEFORM Protein DME1693 XEOTICID XEO00388 MOACRIVE Inhibition DME1693 XEOTICID XEO00396 XEO_NAME Gentamicin DME1693 XEOTICID XEO00396 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00396 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00396 DESCRIPT Gentamicin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00396 GENEFORM Protein DME1693 XEOTICID XEO00396 MOACRIVE Inhibition DME1693 XEOTICID XEO00405 XEO_NAME Niclosamide DME1693 XEOTICID XEO00405 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00405 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00405 DESCRIPT Niclosamide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00405 GENEFORM Protein DME1693 XEOTICID XEO00405 MOACRIVE Inhibition DME1693 XEOTICID XEO00416 XEO_NAME Menthol DME1693 XEOTICID XEO00416 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00416 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00416 DESCRIPT Menthol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00416 GENEFORM Protein DME1693 XEOTICID XEO00416 MOACRIVE Inhibition DME1693 XEOTICID XEO00444 XEO_NAME Zinc chloride DME1693 XEOTICID XEO00444 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00444 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00444 DESCRIPT Zinc chloride inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00444 GENEFORM Protein DME1693 XEOTICID XEO00444 MOACRIVE Inhibition DME1693 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1693 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00460 GENEFORM Protein DME1693 XEOTICID XEO00460 MOACRIVE Inhibition DME1693 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1693 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00511 GENEFORM Protein DME1693 XEOTICID XEO00511 MOACRIVE Inhibition DME1693 XEOTICID XEO00538 XEO_NAME Quercetin DME1693 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1693 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00538 GENEFORM Protein DME1693 XEOTICID XEO00538 MOACRIVE Inhibition DME1693 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1693 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1693 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00546 GENEFORM Protein DME1693 XEOTICID XEO00546 MOACRIVE Inhibition DME1693 XEOTICID XEO00568 XEO_NAME Resveratrol DME1693 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1693 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00568 GENEFORM Protein DME1693 XEOTICID XEO00568 MOACRIVE Inhibition DME1693 XEOTICID XEO00573 XEO_NAME Naringenin DME1693 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1693 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00573 GENEFORM Protein DME1693 XEOTICID XEO00573 MOACRIVE Inhibition DME1693 XEOTICID XEO00619 XEO_NAME Delphinidin DME1693 XEOTICID XEO00619 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00619 XEO_CLAS Drug in Phase 2 Clinical Trial DME1693 XEOTICID XEO00619 DESCRIPT Delphinidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00619 GENEFORM Protein DME1693 XEOTICID XEO00619 MOACRIVE Inhibition DME1693 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1693 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1693 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00646 GENEFORM Protein DME1693 XEOTICID XEO00646 MOACRIVE Inhibition DME1693 XEOTICID XEO00683 XEO_NAME Curcumin DME1693 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1693 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00683 GENEFORM Protein DME1693 XEOTICID XEO00683 MOACRIVE Inhibition DME1693 XEOTICID XEO00692 XEO_NAME Emodin DME1693 XEOTICID XEO00692 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00692 XEO_CLAS Preclinical/Patented Drug DME1693 XEOTICID XEO00692 DESCRIPT Emodin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00692 GENEFORM Protein DME1693 XEOTICID XEO00692 MOACRIVE Inhibition DME1693 XEOTICID XEO00702 XEO_NAME Baicalin DME1693 XEOTICID XEO00702 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00702 XEO_CLAS Preclinical/Patented Drug DME1693 XEOTICID XEO00702 DESCRIPT Baicalin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00702 GENEFORM Protein DME1693 XEOTICID XEO00702 MOACRIVE Inhibition DME1693 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1693 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1693 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00730 GENEFORM Protein DME1693 XEOTICID XEO00730 MOACRIVE Inhibition DME1693 XEOTICID XEO00858 XEO_NAME Flavonoids DME1693 XEOTICID XEO00858 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO00858 XEO_CLAS Natural Mixture DME1693 XEOTICID XEO00858 DESCRIPT Flavonoids inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00858 GENEFORM Protein DME1693 XEOTICID XEO00858 MOACRIVE Inhibition DME1693 XEOTICID XEO00879 XEO_NAME Coumarin DME1693 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1693 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1693 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00879 GENEFORM Protein DME1693 XEOTICID XEO00879 MOACRIVE Inhibition DME1693 XEOTICID XEO00880 XEO_NAME Isatin DME1693 XEOTICID XEO00880 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO00880 XEO_CLAS Natural Product DME1693 XEOTICID XEO00880 DESCRIPT Isatin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00880 GENEFORM Protein DME1693 XEOTICID XEO00880 MOACRIVE Inhibition DME1693 XEOTICID XEO00885 XEO_NAME Eugenol DME1693 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1693 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO00885 GENEFORM Protein DME1693 XEOTICID XEO00885 MOACRIVE Inhibition DME1693 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1693 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1693 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1693 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01032 GENEFORM Protein DME1693 XEOTICID XEO01032 MOACRIVE Inhibition DME1693 XEOTICID XEO01212 XEO_NAME Baicalein DME1693 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO01212 XEO_CLAS Natural Product DME1693 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01212 GENEFORM Protein DME1693 XEOTICID XEO01212 MOACRIVE Inhibition DME1693 XEOTICID XEO01221 XEO_NAME Betulin DME1693 XEOTICID XEO01221 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO01221 XEO_CLAS Natural Product DME1693 XEOTICID XEO01221 DESCRIPT Betulin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01221 GENEFORM Protein DME1693 XEOTICID XEO01221 MOACRIVE Inhibition DME1693 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1693 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1693 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1693 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01232 GENEFORM Protein DME1693 XEOTICID XEO01232 MOACRIVE Inhibition DME1693 XEOTICID XEO01237 XEO_NAME Carvacrol DME1693 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1693 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01237 GENEFORM Protein DME1693 XEOTICID XEO01237 MOACRIVE Inhibition DME1693 XEOTICID XEO01239 XEO_NAME Catechin DME1693 XEOTICID XEO01239 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO01239 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO01239 DESCRIPT Catechin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01239 GENEFORM Protein DME1693 XEOTICID XEO01239 MOACRIVE Inhibition DME1693 XEOTICID XEO01252 XEO_NAME Cinnamic acid DME1693 XEOTICID XEO01252 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO01252 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO01252 DESCRIPT Cinnamic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01252 GENEFORM Protein DME1693 XEOTICID XEO01252 MOACRIVE Inhibition DME1693 XEOTICID XEO01266 XEO_NAME Cyanidin DME1693 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME1693 XEOTICID XEO01266 DESCRIPT Cyanidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01266 GENEFORM Protein DME1693 XEOTICID XEO01266 MOACRIVE Inhibition DME1693 XEOTICID XEO01291 XEO_NAME Esculetin DME1693 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1693 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01291 GENEFORM Protein DME1693 XEOTICID XEO01291 MOACRIVE Inhibition DME1693 XEOTICID XEO01357 XEO_NAME Kojic acid DME1693 XEOTICID XEO01357 XEO_TYPE Health or Environmental Toxicant(s) DME1693 XEOTICID XEO01357 XEO_CLAS Health Hazard/Toxicant DME1693 XEOTICID XEO01357 DESCRIPT Kojic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01357 GENEFORM Protein DME1693 XEOTICID XEO01357 MOACRIVE Inhibition DME1693 XEOTICID XEO01412 XEO_NAME Oleic acid DME1693 XEOTICID XEO01412 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO01412 XEO_CLAS Preclinical/Patented Drug DME1693 XEOTICID XEO01412 DESCRIPT Oleic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01412 GENEFORM Protein DME1693 XEOTICID XEO01412 MOACRIVE Inhibition DME1693 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1693 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1693 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01420 GENEFORM Protein DME1693 XEOTICID XEO01420 MOACRIVE Inhibition DME1693 XEOTICID XEO01424 XEO_NAME Pelargonidin DME1693 XEOTICID XEO01424 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO01424 XEO_CLAS Natural Product DME1693 XEOTICID XEO01424 DESCRIPT Pelargonidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01424 GENEFORM Protein DME1693 XEOTICID XEO01424 MOACRIVE Inhibition DME1693 XEOTICID XEO01442 XEO_NAME Puag-haad DME1693 XEOTICID XEO01442 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO01442 XEO_CLAS Natural Product DME1693 XEOTICID XEO01442 DESCRIPT Puag-haad inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01442 GENEFORM Protein DME1693 XEOTICID XEO01442 MOACRIVE Inhibition DME1693 XEOTICID XEO01455 XEO_NAME Rhein DME1693 XEOTICID XEO01455 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO01455 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO01455 DESCRIPT Rhein inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01455 GENEFORM Protein DME1693 XEOTICID XEO01455 MOACRIVE Inhibition DME1693 XEOTICID XEO01460 XEO_NAME Rosmarinic acid DME1693 XEOTICID XEO01460 XEO_TYPE Health or Environmental Toxicant(s) DME1693 XEOTICID XEO01460 XEO_CLAS Acute Toxic Substance DME1693 XEOTICID XEO01460 DESCRIPT Rosmarinic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01460 GENEFORM Protein DME1693 XEOTICID XEO01460 MOACRIVE Inhibition DME1693 XEOTICID XEO01463 XEO_NAME Rutin DME1693 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO01463 XEO_CLAS Natural Product DME1693 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01463 GENEFORM Protein DME1693 XEOTICID XEO01463 MOACRIVE Inhibition DME1693 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1693 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1693 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01496 GENEFORM Protein DME1693 XEOTICID XEO01496 MOACRIVE Inhibition DME1693 XEOTICID XEO01528 XEO_NAME Chrysophanic acid DME1693 XEOTICID XEO01528 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO01528 XEO_CLAS Natural Product DME1693 XEOTICID XEO01528 DESCRIPT Chrysophanic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01528 GENEFORM Protein DME1693 XEOTICID XEO01528 MOACRIVE Inhibition DME1693 XEOTICID XEO01531 XEO_NAME Clove oil DME1693 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO01531 XEO_CLAS Natural Product DME1693 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01531 GENEFORM Protein DME1693 XEOTICID XEO01531 MOACRIVE Inhibition DME1693 XEOTICID XEO01571 XEO_NAME Peppermint oil DME1693 XEOTICID XEO01571 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO01571 XEO_CLAS Natural Product DME1693 XEOTICID XEO01571 DESCRIPT Peppermint oil inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01571 GENEFORM Protein DME1693 XEOTICID XEO01571 MOACRIVE Inhibition DME1693 XEOTICID XEO01587 XEO_NAME Shikonin DME1693 XEOTICID XEO01587 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO01587 XEO_CLAS Natural Product DME1693 XEOTICID XEO01587 DESCRIPT Shikonin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01587 GENEFORM Protein DME1693 XEOTICID XEO01587 MOACRIVE Inhibition DME1693 XEOTICID XEO01804 XEO_NAME (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one DME1693 XEOTICID XEO01804 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01804 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01804 DESCRIPT (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01804 GENEFORM Protein DME1693 XEOTICID XEO01804 MOACRIVE Inhibition DME1693 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1693 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01810 XEO_CLAS Peptide DME1693 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4.0 microM) DME1693 XEOTICID XEO01810 GENEFORM Protein DME1693 XEOTICID XEO01810 MOACRIVE Inhibition DME1693 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1693 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01811 XEO_CLAS Peptide DME1693 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 32 microM) DME1693 XEOTICID XEO01811 GENEFORM Protein DME1693 XEOTICID XEO01811 MOACRIVE Inhibition DME1693 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1693 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01812 XEO_CLAS Peptide DME1693 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.2 microM) DME1693 XEOTICID XEO01812 GENEFORM Protein DME1693 XEOTICID XEO01812 MOACRIVE Inhibition DME1693 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1693 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01813 XEO_CLAS Peptide DME1693 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.0 microM) DME1693 XEOTICID XEO01813 GENEFORM Protein DME1693 XEOTICID XEO01813 MOACRIVE Inhibition DME1693 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1693 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01814 XEO_CLAS Peptide DME1693 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3.9 microM) DME1693 XEOTICID XEO01814 GENEFORM Protein DME1693 XEOTICID XEO01814 MOACRIVE Inhibition DME1693 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1693 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01815 XEO_CLAS Peptide DME1693 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8.0 microM) DME1693 XEOTICID XEO01815 GENEFORM Protein DME1693 XEOTICID XEO01815 MOACRIVE Inhibition DME1693 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1693 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01816 XEO_CLAS Peptide DME1693 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1693 XEOTICID XEO01816 GENEFORM Protein DME1693 XEOTICID XEO01816 MOACRIVE Inhibition DME1693 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1693 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01817 XEO_CLAS Peptide DME1693 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3.0 microM) DME1693 XEOTICID XEO01817 GENEFORM Protein DME1693 XEOTICID XEO01817 MOACRIVE Inhibition DME1693 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1693 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01818 XEO_CLAS Peptide DME1693 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4.0 microM) DME1693 XEOTICID XEO01818 GENEFORM Protein DME1693 XEOTICID XEO01818 MOACRIVE Inhibition DME1693 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1693 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01819 XEO_CLAS Peptide DME1693 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1693 XEOTICID XEO01819 GENEFORM Protein DME1693 XEOTICID XEO01819 MOACRIVE Inhibition DME1693 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1693 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01820 XEO_CLAS Peptide DME1693 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1693 XEOTICID XEO01820 GENEFORM Protein DME1693 XEOTICID XEO01820 MOACRIVE Inhibition DME1693 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1693 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01821 XEO_CLAS Peptide DME1693 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1693 XEOTICID XEO01821 GENEFORM Protein DME1693 XEOTICID XEO01821 MOACRIVE Inhibition DME1693 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1693 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01822 XEO_CLAS Peptide DME1693 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 microM) DME1693 XEOTICID XEO01822 GENEFORM Protein DME1693 XEOTICID XEO01822 MOACRIVE Inhibition DME1693 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1693 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01823 XEO_CLAS Peptide DME1693 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3.125 microM) DME1693 XEOTICID XEO01823 GENEFORM Protein DME1693 XEOTICID XEO01823 MOACRIVE Inhibition DME1693 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1693 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO01825 XEO_CLAS Peptide DME1693 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1693 XEOTICID XEO01825 GENEFORM Protein DME1693 XEOTICID XEO01825 MOACRIVE Inhibition DME1693 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1693 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01829 GENEFORM Protein DME1693 XEOTICID XEO01829 MOACRIVE Inhibition DME1693 XEOTICID XEO01831 XEO_NAME 3',5'-Dinitroacetophenone DME1693 XEOTICID XEO01831 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01831 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01831 DESCRIPT 3',5'-Dinitroacetophenone inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01831 GENEFORM Protein DME1693 XEOTICID XEO01831 MOACRIVE Inhibition DME1693 XEOTICID XEO01832 XEO_NAME 1-(4-amino-2-hydroxyphenyl)ethan-1-one DME1693 XEOTICID XEO01832 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01832 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01832 DESCRIPT 1-(4-amino-2-hydroxyphenyl)ethan-1-one inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01832 GENEFORM Protein DME1693 XEOTICID XEO01832 MOACRIVE Inhibition DME1693 XEOTICID XEO01837 XEO_NAME 2-Amino-5-acetylpyridine DME1693 XEOTICID XEO01837 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01837 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01837 DESCRIPT 2-Amino-5-acetylpyridine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01837 GENEFORM Protein DME1693 XEOTICID XEO01837 MOACRIVE Inhibition DME1693 XEOTICID XEO01838 XEO_NAME 1-(pyrazin-2-yl)ethan-1-one DME1693 XEOTICID XEO01838 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01838 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01838 DESCRIPT 1-(pyrazin-2-yl)ethan-1-one inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01838 GENEFORM Protein DME1693 XEOTICID XEO01838 MOACRIVE Inhibition DME1693 XEOTICID XEO01839 XEO_NAME 4-Acetylpyridine DME1693 XEOTICID XEO01839 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01839 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01839 DESCRIPT 4-Acetylpyridine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01839 GENEFORM Protein DME1693 XEOTICID XEO01839 MOACRIVE Inhibition DME1693 XEOTICID XEO01860 XEO_NAME Aseanostatin P5 DME1693 XEOTICID XEO01860 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO01860 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO01860 DESCRIPT Aseanostatin P5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01860 GENEFORM Protein DME1693 XEOTICID XEO01860 MOACRIVE Inhibition DME1693 XEOTICID XEO01869 XEO_NAME Isopentadecylic acid DME1693 XEOTICID XEO01869 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO01869 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO01869 DESCRIPT Isopentadecylic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01869 GENEFORM Protein DME1693 XEOTICID XEO01869 MOACRIVE Inhibition DME1693 XEOTICID XEO01872 XEO_NAME AL-1 DME1693 XEOTICID XEO01872 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO01872 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO01872 DESCRIPT AL-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01872 GENEFORM Protein DME1693 XEOTICID XEO01872 MOACRIVE Inhibition DME1693 XEOTICID XEO01879 XEO_NAME 1-methanesulfonyl-4-methylbenzene DME1693 XEOTICID XEO01879 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01879 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01879 DESCRIPT 1-methanesulfonyl-4-methylbenzene inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01879 GENEFORM Protein DME1693 XEOTICID XEO01879 MOACRIVE Inhibition DME1693 XEOTICID XEO01937 XEO_NAME 2-bromodecanoic acid DME1693 XEOTICID XEO01937 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01937 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01937 DESCRIPT 2-bromodecanoic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01937 GENEFORM Protein DME1693 XEOTICID XEO01937 MOACRIVE Inhibition DME1693 XEOTICID XEO01938 XEO_NAME 2-bromohexanoic acid DME1693 XEOTICID XEO01938 XEO_TYPE Health or Environmental Toxicant(s) DME1693 XEOTICID XEO01938 XEO_CLAS Health Hazard/Toxicant DME1693 XEOTICID XEO01938 DESCRIPT 2-bromohexanoic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01938 GENEFORM Protein DME1693 XEOTICID XEO01938 MOACRIVE Inhibition DME1693 XEOTICID XEO01939 XEO_NAME 2-bromooctanoic acid DME1693 XEOTICID XEO01939 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01939 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01939 DESCRIPT 2-bromooctanoic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01939 GENEFORM Protein DME1693 XEOTICID XEO01939 MOACRIVE Inhibition DME1693 XEOTICID XEO01952 XEO_NAME 2-oxindole DME1693 XEOTICID XEO01952 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01952 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01952 DESCRIPT 2-oxindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01952 GENEFORM Protein DME1693 XEOTICID XEO01952 MOACRIVE Inhibition DME1693 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1693 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01961 GENEFORM Protein DME1693 XEOTICID XEO01961 MOACRIVE Inhibition DME1693 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1693 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01966 GENEFORM Protein DME1693 XEOTICID XEO01966 MOACRIVE Inhibition DME1693 XEOTICID XEO01975 XEO_NAME 3,5-dimethylaniline DME1693 XEOTICID XEO01975 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01975 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01975 DESCRIPT 3,5-dimethylaniline inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01975 GENEFORM Protein DME1693 XEOTICID XEO01975 MOACRIVE Inhibition DME1693 XEOTICID XEO01976 XEO_NAME Allicin DME1693 XEOTICID XEO01976 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO01976 XEO_CLAS Drug in Phase 1 Clinical Trial DME1693 XEOTICID XEO01976 DESCRIPT Allicin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01976 GENEFORM Protein DME1693 XEOTICID XEO01976 MOACRIVE Inhibition DME1693 XEOTICID XEO01987 XEO_NAME 3-fluoroaniline DME1693 XEOTICID XEO01987 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01987 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01987 DESCRIPT 3-fluoroaniline inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01987 GENEFORM Protein DME1693 XEOTICID XEO01987 MOACRIVE Inhibition DME1693 XEOTICID XEO01994 XEO_NAME 3-Indoleacetonitrile DME1693 XEOTICID XEO01994 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO01994 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO01994 DESCRIPT 3-Indoleacetonitrile inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO01994 GENEFORM Protein DME1693 XEOTICID XEO01994 MOACRIVE Inhibition DME1693 XEOTICID XEO02026 XEO_NAME 4-bromoaniline DME1693 XEOTICID XEO02026 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02026 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02026 DESCRIPT 4-bromoaniline inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02026 GENEFORM Protein DME1693 XEOTICID XEO02026 MOACRIVE Inhibition DME1693 XEOTICID XEO02029 XEO_NAME 4-chloro-7-(trifluoromethyl)quinoline DME1693 XEOTICID XEO02029 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02029 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02029 DESCRIPT 4-chloro-7-(trifluoromethyl)quinoline inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02029 GENEFORM Protein DME1693 XEOTICID XEO02029 MOACRIVE Inhibition DME1693 XEOTICID XEO02030 XEO_NAME 4-chloroaniline DME1693 XEOTICID XEO02030 XEO_TYPE Health or Environmental Toxicant(s) DME1693 XEOTICID XEO02030 XEO_CLAS Health Hazard/Toxicant DME1693 XEOTICID XEO02030 DESCRIPT 4-chloroaniline inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02030 GENEFORM Protein DME1693 XEOTICID XEO02030 MOACRIVE Inhibition DME1693 XEOTICID XEO02036 XEO_NAME 4-fluoroindole DME1693 XEOTICID XEO02036 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02036 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02036 DESCRIPT 4-fluoroindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02036 GENEFORM Protein DME1693 XEOTICID XEO02036 MOACRIVE Inhibition DME1693 XEOTICID XEO02040 XEO_NAME Furaneol DME1693 XEOTICID XEO02040 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02040 XEO_CLAS Food Additive DME1693 XEOTICID XEO02040 DESCRIPT Furaneol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02040 GENEFORM Protein DME1693 XEOTICID XEO02040 MOACRIVE Inhibition DME1693 XEOTICID XEO02042 XEO_NAME 4-methanesulfonylaniline DME1693 XEOTICID XEO02042 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02042 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02042 DESCRIPT 4-methanesulfonylaniline inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02042 GENEFORM Protein DME1693 XEOTICID XEO02042 MOACRIVE Inhibition DME1693 XEOTICID XEO02065 XEO_NAME 5-Bromoindole DME1693 XEOTICID XEO02065 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02065 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02065 DESCRIPT 5-Bromoindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02065 GENEFORM Protein DME1693 XEOTICID XEO02065 MOACRIVE Inhibition DME1693 XEOTICID XEO02068 XEO_NAME 5-Chloro-1-(2-chloroacetyl)indoline-2,3-dione DME1693 XEOTICID XEO02068 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02068 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02068 DESCRIPT 5-Chloro-1-(2-chloroacetyl)indoline-2,3-dione inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02068 GENEFORM Protein DME1693 XEOTICID XEO02068 MOACRIVE Inhibition DME1693 XEOTICID XEO02069 XEO_NAME 5-Chloroindole DME1693 XEOTICID XEO02069 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO02069 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO02069 DESCRIPT 5-Chloroindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02069 GENEFORM Protein DME1693 XEOTICID XEO02069 MOACRIVE Inhibition DME1693 XEOTICID XEO02072 XEO_NAME 5-fluoroindole DME1693 XEOTICID XEO02072 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO02072 XEO_CLAS Preclinical/Patented Drug DME1693 XEOTICID XEO02072 DESCRIPT 5-fluoroindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02072 GENEFORM Protein DME1693 XEOTICID XEO02072 MOACRIVE Inhibition DME1693 XEOTICID XEO02081 XEO_NAME 6-Chloroindole DME1693 XEOTICID XEO02081 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02081 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02081 DESCRIPT 6-Chloroindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02081 GENEFORM Protein DME1693 XEOTICID XEO02081 MOACRIVE Inhibition DME1693 XEOTICID XEO02082 XEO_NAME 6-Chlorooxindole DME1693 XEOTICID XEO02082 XEO_TYPE Health or Environmental Toxicant(s) DME1693 XEOTICID XEO02082 XEO_CLAS Environmental Pollutant DME1693 XEOTICID XEO02082 DESCRIPT 6-Chlorooxindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02082 GENEFORM Protein DME1693 XEOTICID XEO02082 MOACRIVE Inhibition DME1693 XEOTICID XEO02083 XEO_NAME 6-fluoroindole DME1693 XEOTICID XEO02083 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02083 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02083 DESCRIPT 6-fluoroindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02083 GENEFORM Protein DME1693 XEOTICID XEO02083 MOACRIVE Inhibition DME1693 XEOTICID XEO02084 XEO_NAME 6-Gingerol DME1693 XEOTICID XEO02084 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO02084 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO02084 DESCRIPT 6-Gingerol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02084 GENEFORM Protein DME1693 XEOTICID XEO02084 MOACRIVE Inhibition DME1693 XEOTICID XEO02089 XEO_NAME 7-bromoindole DME1693 XEOTICID XEO02089 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02089 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02089 DESCRIPT 7-bromoindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02089 GENEFORM Protein DME1693 XEOTICID XEO02089 MOACRIVE Inhibition DME1693 XEOTICID XEO02090 XEO_NAME 7-chloroindole DME1693 XEOTICID XEO02090 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02090 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02090 DESCRIPT 7-chloroindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02090 GENEFORM Protein DME1693 XEOTICID XEO02090 MOACRIVE Inhibition DME1693 XEOTICID XEO02092 XEO_NAME 7-fluoroindole DME1693 XEOTICID XEO02092 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02092 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02092 DESCRIPT 7-fluoroindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02092 GENEFORM Protein DME1693 XEOTICID XEO02092 MOACRIVE Inhibition DME1693 XEOTICID XEO02093 XEO_NAME 7-Fluoroisatin DME1693 XEOTICID XEO02093 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02093 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02093 DESCRIPT 7-Fluoroisatin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02093 GENEFORM Protein DME1693 XEOTICID XEO02093 MOACRIVE Inhibition DME1693 XEOTICID XEO02094 XEO_NAME 7-formylindole DME1693 XEOTICID XEO02094 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02094 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02094 DESCRIPT 7-formylindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02094 GENEFORM Protein DME1693 XEOTICID XEO02094 MOACRIVE Inhibition DME1693 XEOTICID XEO02095 XEO_NAME 7-hydroxyindole DME1693 XEOTICID XEO02095 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02095 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02095 DESCRIPT 7-hydroxyindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02095 GENEFORM Protein DME1693 XEOTICID XEO02095 MOACRIVE Inhibition DME1693 XEOTICID XEO02096 XEO_NAME 7-methoxyindole DME1693 XEOTICID XEO02096 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02096 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02096 DESCRIPT 7-methoxyindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02096 GENEFORM Protein DME1693 XEOTICID XEO02096 MOACRIVE Inhibition DME1693 XEOTICID XEO02097 XEO_NAME 7-methylindole DME1693 XEOTICID XEO02097 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02097 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02097 DESCRIPT 7-methylindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02097 GENEFORM Protein DME1693 XEOTICID XEO02097 MOACRIVE Inhibition DME1693 XEOTICID XEO02098 XEO_NAME 7-nitroindole DME1693 XEOTICID XEO02098 XEO_TYPE Health or Environmental Toxicant(s) DME1693 XEOTICID XEO02098 XEO_CLAS Health Hazard/Toxicant DME1693 XEOTICID XEO02098 DESCRIPT 7-nitroindole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02098 GENEFORM Protein DME1693 XEOTICID XEO02098 MOACRIVE Inhibition DME1693 XEOTICID XEO02100 XEO_NAME 8-fluoroquinoline DME1693 XEOTICID XEO02100 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO02100 XEO_CLAS Preclinical/Patented Drug DME1693 XEOTICID XEO02100 DESCRIPT 8-fluoroquinoline inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02100 GENEFORM Protein DME1693 XEOTICID XEO02100 MOACRIVE Inhibition DME1693 XEOTICID XEO02103 XEO_NAME CP-P derivative A10 DME1693 XEOTICID XEO02103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02103 XEO_CLAS Peptide DME1693 XEOTICID XEO02103 DESCRIPT CP-P derivative A10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1693 XEOTICID XEO02103 GENEFORM Protein DME1693 XEOTICID XEO02103 MOACRIVE Inhibition DME1693 XEOTICID XEO02104 XEO_NAME V13KL peptide derivative A12L DME1693 XEOTICID XEO02104 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02104 XEO_CLAS Peptide DME1693 XEOTICID XEO02104 DESCRIPT V13KL peptide derivative A12L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 24.8 ug/ml) DME1693 XEOTICID XEO02104 GENEFORM Protein DME1693 XEOTICID XEO02104 MOACRIVE Inhibition DME1693 XEOTICID XEO02105 XEO_NAME V13KL peptide derivative A12L/A20L DME1693 XEOTICID XEO02105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02105 XEO_CLAS Peptide DME1693 XEOTICID XEO02105 DESCRIPT V13KL peptide derivative A12L/A20L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 125 ug/ml) DME1693 XEOTICID XEO02105 GENEFORM Protein DME1693 XEOTICID XEO02105 MOACRIVE Inhibition DME1693 XEOTICID XEO02106 XEO_NAME V13KL peptide derivative A12L/A23L DME1693 XEOTICID XEO02106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02106 XEO_CLAS Peptide DME1693 XEOTICID XEO02106 DESCRIPT V13KL peptide derivative A12L/A23L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 31.2 ug/ml) DME1693 XEOTICID XEO02106 GENEFORM Protein DME1693 XEOTICID XEO02106 MOACRIVE Inhibition DME1693 XEOTICID XEO02107 XEO_NAME CP-P derivative A13 DME1693 XEOTICID XEO02107 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02107 XEO_CLAS Peptide DME1693 XEOTICID XEO02107 DESCRIPT CP-P derivative A13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1693 XEOTICID XEO02107 GENEFORM Protein DME1693 XEOTICID XEO02107 MOACRIVE Inhibition DME1693 XEOTICID XEO02108 XEO_NAME V13KL peptide derivative A20L DME1693 XEOTICID XEO02108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02108 XEO_CLAS Peptide DME1693 XEOTICID XEO02108 DESCRIPT V13KL peptide derivative A20L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 15.6 ug/ml) DME1693 XEOTICID XEO02108 GENEFORM Protein DME1693 XEOTICID XEO02108 MOACRIVE Inhibition DME1693 XEOTICID XEO02109 XEO_NAME V13KL peptide derivative A23L DME1693 XEOTICID XEO02109 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02109 XEO_CLAS Peptide DME1693 XEOTICID XEO02109 DESCRIPT V13KL peptide derivative A23L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 35.1 ug/ml) DME1693 XEOTICID XEO02109 GENEFORM Protein DME1693 XEOTICID XEO02109 MOACRIVE Inhibition DME1693 XEOTICID XEO02110 XEO_NAME CP-P derivative A9 DME1693 XEOTICID XEO02110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02110 XEO_CLAS Peptide DME1693 XEOTICID XEO02110 DESCRIPT CP-P derivative A9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1693 XEOTICID XEO02110 GENEFORM Protein DME1693 XEOTICID XEO02110 MOACRIVE Inhibition DME1693 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1693 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02122 XEO_CLAS Peptide DME1693 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1693 XEOTICID XEO02122 GENEFORM Protein DME1693 XEOTICID XEO02122 MOACRIVE Inhibition DME1693 XEOTICID XEO02123 XEO_NAME Aceroside VIII DME1693 XEOTICID XEO02123 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02123 XEO_CLAS Natural Product DME1693 XEOTICID XEO02123 DESCRIPT Aceroside VIII inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02123 GENEFORM Protein DME1693 XEOTICID XEO02123 MOACRIVE Inhibition DME1693 XEOTICID XEO02134 XEO_NAME Acylase DME1693 XEOTICID XEO02134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02134 XEO_CLAS Peptide DME1693 XEOTICID XEO02134 DESCRIPT Acylase inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02134 GENEFORM Protein DME1693 XEOTICID XEO02134 MOACRIVE Inhibition DME1693 XEOTICID XEO02139 XEO_NAME Clidemia dentata aerial part extract DME1693 XEOTICID XEO02139 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02139 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02139 DESCRIPT Clidemia dentata aerial part extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02139 GENEFORM Protein DME1693 XEOTICID XEO02139 MOACRIVE Inhibition DME1693 XEOTICID XEO02143 XEO_NAME Ossaea brenesii aerial part extract DME1693 XEOTICID XEO02143 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02143 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02143 DESCRIPT Ossaea brenesii aerial part extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02143 GENEFORM Protein DME1693 XEOTICID XEO02143 MOACRIVE Inhibition DME1693 XEOTICID XEO02144 XEO_NAME Piper bisasperatum aerial part extract DME1693 XEOTICID XEO02144 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02144 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02144 DESCRIPT Piper bisasperatum aerial part extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02144 GENEFORM Protein DME1693 XEOTICID XEO02144 MOACRIVE Inhibition DME1693 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1693 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02147 XEO_CLAS Peptide DME1693 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 257 ug/ml) DME1693 XEOTICID XEO02147 GENEFORM Protein DME1693 XEOTICID XEO02147 MOACRIVE Inhibition DME1693 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1693 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02149 XEO_CLAS Peptide DME1693 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 47.35 microM) DME1693 XEOTICID XEO02149 GENEFORM Protein DME1693 XEOTICID XEO02149 MOACRIVE Inhibition DME1693 XEOTICID XEO02150 XEO_NAME AI-hemocidins 3 DME1693 XEOTICID XEO02150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02150 XEO_CLAS Peptide DME1693 XEOTICID XEO02150 DESCRIPT AI-hemocidins 3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 95.37 microM) DME1693 XEOTICID XEO02150 GENEFORM Protein DME1693 XEOTICID XEO02150 MOACRIVE Inhibition DME1693 XEOTICID XEO02152 XEO_NAME Ajoene DME1693 XEOTICID XEO02152 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02152 XEO_CLAS Natural Product DME1693 XEOTICID XEO02152 DESCRIPT Ajoene inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02152 GENEFORM Protein DME1693 XEOTICID XEO02152 MOACRIVE Inhibition DME1693 XEOTICID XEO02188 XEO_NAME Aminocyclopropane DME1693 XEOTICID XEO02188 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02188 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02188 DESCRIPT Aminocyclopropane inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02188 GENEFORM Protein DME1693 XEOTICID XEO02188 MOACRIVE Inhibition DME1693 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1693 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02200 XEO_CLAS Peptide DME1693 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1693 XEOTICID XEO02200 GENEFORM Protein DME1693 XEOTICID XEO02200 MOACRIVE Inhibition DME1693 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1693 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02201 XEO_CLAS Peptide DME1693 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 100 ug/ml) DME1693 XEOTICID XEO02201 GENEFORM Protein DME1693 XEOTICID XEO02201 MOACRIVE Inhibition DME1693 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1693 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02202 XEO_CLAS Peptide DME1693 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 10 microM) DME1693 XEOTICID XEO02202 GENEFORM Protein DME1693 XEOTICID XEO02202 MOACRIVE Inhibition DME1693 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1693 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02203 XEO_CLAS Peptide DME1693 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 10 microM) DME1693 XEOTICID XEO02203 GENEFORM Protein DME1693 XEOTICID XEO02203 MOACRIVE Inhibition DME1693 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1693 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02207 XEO_CLAS Peptide DME1693 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3.13 ug/ml) DME1693 XEOTICID XEO02207 GENEFORM Protein DME1693 XEOTICID XEO02207 MOACRIVE Inhibition DME1693 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1693 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02208 XEO_CLAS Peptide DME1693 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1693 XEOTICID XEO02208 GENEFORM Protein DME1693 XEOTICID XEO02208 MOACRIVE Inhibition DME1693 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1693 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02209 XEO_CLAS Peptide DME1693 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3.13 ug/ml) DME1693 XEOTICID XEO02209 GENEFORM Protein DME1693 XEOTICID XEO02209 MOACRIVE Inhibition DME1693 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1693 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02210 XEO_CLAS Peptide DME1693 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1693 XEOTICID XEO02210 GENEFORM Protein DME1693 XEOTICID XEO02210 MOACRIVE Inhibition DME1693 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1693 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02211 XEO_CLAS Peptide DME1693 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1693 XEOTICID XEO02211 GENEFORM Protein DME1693 XEOTICID XEO02211 MOACRIVE Inhibition DME1693 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1693 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02212 XEO_CLAS Peptide DME1693 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1693 XEOTICID XEO02212 GENEFORM Protein DME1693 XEOTICID XEO02212 MOACRIVE Inhibition DME1693 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1693 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02213 XEO_CLAS Peptide DME1693 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3.13 ug/ml) DME1693 XEOTICID XEO02213 GENEFORM Protein DME1693 XEOTICID XEO02213 MOACRIVE Inhibition DME1693 XEOTICID XEO02226 XEO_NAME Andropin DME1693 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02226 XEO_CLAS Peptide DME1693 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 300 microM) DME1693 XEOTICID XEO02226 GENEFORM Protein DME1693 XEOTICID XEO02226 MOACRIVE Inhibition DME1693 XEOTICID XEO02228 XEO_NAME Aniline DME1693 XEOTICID XEO02228 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02228 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02228 DESCRIPT Aniline inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02228 GENEFORM Protein DME1693 XEOTICID XEO02228 MOACRIVE Inhibition DME1693 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1693 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02230 XEO_CLAS Peptide DME1693 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1-2.5 microM) DME1693 XEOTICID XEO02230 GENEFORM Protein DME1693 XEOTICID XEO02230 MOACRIVE Inhibition DME1693 XEOTICID XEO02235 XEO_NAME Anthranilate DME1693 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02235 XEO_CLAS Natural Product DME1693 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02235 GENEFORM Protein DME1693 XEOTICID XEO02235 MOACRIVE Inhibition DME1693 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1693 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02242 XEO_CLAS Peptide DME1693 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 microM) DME1693 XEOTICID XEO02242 GENEFORM Protein DME1693 XEOTICID XEO02242 MOACRIVE Inhibition DME1693 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1693 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02243 XEO_CLAS Peptide DME1693 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3 microM) DME1693 XEOTICID XEO02243 GENEFORM Protein DME1693 XEOTICID XEO02243 MOACRIVE Inhibition DME1693 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1693 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02244 XEO_CLAS Peptide DME1693 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1693 XEOTICID XEO02244 GENEFORM Protein DME1693 XEOTICID XEO02244 MOACRIVE Inhibition DME1693 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1693 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02247 XEO_CLAS Peptide DME1693 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02247 GENEFORM Protein DME1693 XEOTICID XEO02247 MOACRIVE Inhibition DME1693 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1693 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02248 XEO_CLAS Peptide DME1693 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 200 microM) DME1693 XEOTICID XEO02248 GENEFORM Protein DME1693 XEOTICID XEO02248 MOACRIVE Inhibition DME1693 XEOTICID XEO02249 XEO_NAME Anticancerous peptide Cr-ACP1 DME1693 XEOTICID XEO02249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02249 XEO_CLAS Peptide DME1693 XEOTICID XEO02249 DESCRIPT Anticancerous peptide Cr-ACP1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 30 microM) DME1693 XEOTICID XEO02249 GENEFORM Protein DME1693 XEOTICID XEO02249 MOACRIVE Inhibition DME1693 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1693 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02253 XEO_CLAS Peptide DME1693 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02253 GENEFORM Protein DME1693 XEOTICID XEO02253 MOACRIVE Inhibition DME1693 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1693 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02261 XEO_CLAS Peptide DME1693 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 79 ug/ml) DME1693 XEOTICID XEO02261 GENEFORM Protein DME1693 XEOTICID XEO02261 MOACRIVE Inhibition DME1693 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1693 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02268 XEO_CLAS Peptide DME1693 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 169 ug/ml) DME1693 XEOTICID XEO02268 GENEFORM Protein DME1693 XEOTICID XEO02268 MOACRIVE Inhibition DME1693 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1693 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02271 XEO_CLAS Peptide DME1693 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 259 ug/ml) DME1693 XEOTICID XEO02271 GENEFORM Protein DME1693 XEOTICID XEO02271 MOACRIVE Inhibition DME1693 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1693 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02275 XEO_CLAS Peptide DME1693 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 60 microM) DME1693 XEOTICID XEO02275 GENEFORM Protein DME1693 XEOTICID XEO02275 MOACRIVE Inhibition DME1693 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1693 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02280 XEO_CLAS Peptide DME1693 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02280 GENEFORM Protein DME1693 XEOTICID XEO02280 MOACRIVE Inhibition DME1693 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1693 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02281 XEO_CLAS Peptide DME1693 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02281 GENEFORM Protein DME1693 XEOTICID XEO02281 MOACRIVE Inhibition DME1693 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1693 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02283 XEO_CLAS Peptide DME1693 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1693 XEOTICID XEO02283 GENEFORM Protein DME1693 XEOTICID XEO02283 MOACRIVE Inhibition DME1693 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1693 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02290 XEO_CLAS Peptide DME1693 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.5 ug/ml) DME1693 XEOTICID XEO02290 GENEFORM Protein DME1693 XEOTICID XEO02290 MOACRIVE Inhibition DME1693 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1693 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02294 XEO_CLAS Peptide DME1693 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 250-500 ug/ml) DME1693 XEOTICID XEO02294 GENEFORM Protein DME1693 XEOTICID XEO02294 MOACRIVE Inhibition DME1693 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1693 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02297 XEO_CLAS Peptide DME1693 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC < 25 ug/ml) DME1693 XEOTICID XEO02297 GENEFORM Protein DME1693 XEOTICID XEO02297 MOACRIVE Inhibition DME1693 XEOTICID XEO02301 XEO_NAME Fungus ribonuclease DME1693 XEOTICID XEO02301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02301 XEO_CLAS Peptide DME1693 XEOTICID XEO02301 DESCRIPT Fungus ribonuclease inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02301 GENEFORM Protein DME1693 XEOTICID XEO02301 MOACRIVE Inhibition DME1693 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1693 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02325 XEO_CLAS Peptide DME1693 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 13 microM) DME1693 XEOTICID XEO02325 GENEFORM Protein DME1693 XEOTICID XEO02325 MOACRIVE Inhibition DME1693 XEOTICID XEO02329 XEO_NAME Asperdiol DME1693 XEOTICID XEO02329 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02329 XEO_CLAS Natural Product DME1693 XEOTICID XEO02329 DESCRIPT Asperdiol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02329 GENEFORM Protein DME1693 XEOTICID XEO02329 MOACRIVE Inhibition DME1693 XEOTICID XEO02330 XEO_NAME Asperdiol acetate DME1693 XEOTICID XEO02330 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02330 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO02330 DESCRIPT Asperdiol acetate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02330 GENEFORM Protein DME1693 XEOTICID XEO02330 MOACRIVE Inhibition DME1693 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1693 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02333 XEO_CLAS Peptide DME1693 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 200 microM) DME1693 XEOTICID XEO02333 GENEFORM Protein DME1693 XEOTICID XEO02333 MOACRIVE Inhibition DME1693 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1693 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02352 XEO_CLAS Peptide DME1693 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 23 ug/ml) DME1693 XEOTICID XEO02352 GENEFORM Protein DME1693 XEOTICID XEO02352 MOACRIVE Inhibition DME1693 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1693 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02353 XEO_CLAS Peptide DME1693 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 11 ug/ml) DME1693 XEOTICID XEO02353 GENEFORM Protein DME1693 XEOTICID XEO02353 MOACRIVE Inhibition DME1693 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1693 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02354 XEO_CLAS Peptide DME1693 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1693 XEOTICID XEO02354 GENEFORM Protein DME1693 XEOTICID XEO02354 MOACRIVE Inhibition DME1693 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1693 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02355 XEO_CLAS Peptide DME1693 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1693 XEOTICID XEO02355 GENEFORM Protein DME1693 XEOTICID XEO02355 MOACRIVE Inhibition DME1693 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1693 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02356 XEO_CLAS Peptide DME1693 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO02356 GENEFORM Protein DME1693 XEOTICID XEO02356 MOACRIVE Inhibition DME1693 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1693 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02357 XEO_CLAS Peptide DME1693 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO02357 GENEFORM Protein DME1693 XEOTICID XEO02357 MOACRIVE Inhibition DME1693 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1693 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02358 XEO_CLAS Peptide DME1693 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO02358 GENEFORM Protein DME1693 XEOTICID XEO02358 MOACRIVE Inhibition DME1693 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1693 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02360 XEO_CLAS Peptide DME1693 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO02360 GENEFORM Protein DME1693 XEOTICID XEO02360 MOACRIVE Inhibition DME1693 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1693 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02361 XEO_CLAS Peptide DME1693 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 250 ug/ml) DME1693 XEOTICID XEO02361 GENEFORM Protein DME1693 XEOTICID XEO02361 MOACRIVE Inhibition DME1693 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1693 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02365 XEO_CLAS Peptide DME1693 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 64 ug/ml) DME1693 XEOTICID XEO02365 GENEFORM Protein DME1693 XEOTICID XEO02365 MOACRIVE Inhibition DME1693 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1693 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02366 XEO_CLAS Peptide DME1693 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO02366 GENEFORM Protein DME1693 XEOTICID XEO02366 MOACRIVE Inhibition DME1693 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1693 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02367 XEO_CLAS Peptide DME1693 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO02367 GENEFORM Protein DME1693 XEOTICID XEO02367 MOACRIVE Inhibition DME1693 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1693 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02368 XEO_CLAS Peptide DME1693 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO02368 GENEFORM Protein DME1693 XEOTICID XEO02368 MOACRIVE Inhibition DME1693 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1693 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02369 XEO_CLAS Peptide DME1693 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1693 XEOTICID XEO02369 GENEFORM Protein DME1693 XEOTICID XEO02369 MOACRIVE Inhibition DME1693 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1693 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02371 XEO_CLAS Peptide DME1693 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1693 XEOTICID XEO02371 GENEFORM Protein DME1693 XEOTICID XEO02371 MOACRIVE Inhibition DME1693 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1693 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02378 XEO_CLAS Peptide DME1693 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.38 ug/ml) DME1693 XEOTICID XEO02378 GENEFORM Protein DME1693 XEOTICID XEO02378 MOACRIVE Inhibition DME1693 XEOTICID XEO02386 XEO_NAME Bactridin-1 DME1693 XEOTICID XEO02386 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02386 XEO_CLAS Peptide DME1693 XEOTICID XEO02386 DESCRIPT Bactridin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 77 microM) DME1693 XEOTICID XEO02386 GENEFORM Protein DME1693 XEOTICID XEO02386 MOACRIVE Inhibition DME1693 XEOTICID XEO02387 XEO_NAME Bactridin-2 DME1693 XEOTICID XEO02387 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02387 XEO_CLAS Peptide DME1693 XEOTICID XEO02387 DESCRIPT Bactridin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 54 microM) DME1693 XEOTICID XEO02387 GENEFORM Protein DME1693 XEOTICID XEO02387 MOACRIVE Inhibition DME1693 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1693 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02388 XEO_CLAS Peptide DME1693 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1693 XEOTICID XEO02388 GENEFORM Protein DME1693 XEOTICID XEO02388 MOACRIVE Inhibition DME1693 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1693 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02389 XEO_CLAS Peptide DME1693 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1693 XEOTICID XEO02389 GENEFORM Protein DME1693 XEOTICID XEO02389 MOACRIVE Inhibition DME1693 XEOTICID XEO02393 XEO_NAME Azadirachta indica bark extract DME1693 XEOTICID XEO02393 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02393 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02393 DESCRIPT Azadirachta indica bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02393 GENEFORM Protein DME1693 XEOTICID XEO02393 MOACRIVE Inhibition DME1693 XEOTICID XEO02394 XEO_NAME Cabralea canjerana bark extract DME1693 XEOTICID XEO02394 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02394 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02394 DESCRIPT Cabralea canjerana bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02394 GENEFORM Protein DME1693 XEOTICID XEO02394 MOACRIVE Inhibition DME1693 XEOTICID XEO02395 XEO_NAME Carapa guianensis bark extract DME1693 XEOTICID XEO02395 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02395 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02395 DESCRIPT Carapa guianensis bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02395 GENEFORM Protein DME1693 XEOTICID XEO02395 MOACRIVE Inhibition DME1693 XEOTICID XEO02396 XEO_NAME Cedrela fissilis bark extract DME1693 XEOTICID XEO02396 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02396 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02396 DESCRIPT Cedrela fissilis bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02396 GENEFORM Protein DME1693 XEOTICID XEO02396 MOACRIVE Inhibition DME1693 XEOTICID XEO02397 XEO_NAME Cedrela odorata bark extract DME1693 XEOTICID XEO02397 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02397 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02397 DESCRIPT Cedrela odorata bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02397 GENEFORM Protein DME1693 XEOTICID XEO02397 MOACRIVE Inhibition DME1693 XEOTICID XEO02398 XEO_NAME Cedrela salvadorensis bark extract DME1693 XEOTICID XEO02398 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02398 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02398 DESCRIPT Cedrela salvadorensis bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02398 GENEFORM Protein DME1693 XEOTICID XEO02398 MOACRIVE Inhibition DME1693 XEOTICID XEO02399 XEO_NAME Cedrela tonduzii bark extract DME1693 XEOTICID XEO02399 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02399 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02399 DESCRIPT Cedrela tonduzii bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02399 GENEFORM Protein DME1693 XEOTICID XEO02399 MOACRIVE Inhibition DME1693 XEOTICID XEO02400 XEO_NAME Chukrasia tabularis bark extract DME1693 XEOTICID XEO02400 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02400 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02400 DESCRIPT Chukrasia tabularis bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02400 GENEFORM Protein DME1693 XEOTICID XEO02400 MOACRIVE Inhibition DME1693 XEOTICID XEO02401 XEO_NAME Cupania glabra bark extract DME1693 XEOTICID XEO02401 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02401 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02401 DESCRIPT Cupania glabra bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02401 GENEFORM Protein DME1693 XEOTICID XEO02401 MOACRIVE Inhibition DME1693 XEOTICID XEO02402 XEO_NAME Dalbergia trichocarpa bark extract DME1693 XEOTICID XEO02402 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02402 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02402 DESCRIPT Dalbergia trichocarpa bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02402 GENEFORM Protein DME1693 XEOTICID XEO02402 MOACRIVE Inhibition DME1693 XEOTICID XEO02403 XEO_NAME Guarea glabra bark extract DME1693 XEOTICID XEO02403 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02403 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02403 DESCRIPT Guarea glabra bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02403 GENEFORM Protein DME1693 XEOTICID XEO02403 MOACRIVE Inhibition DME1693 XEOTICID XEO02404 XEO_NAME Guarea grandifolia bark extract DME1693 XEOTICID XEO02404 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02404 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02404 DESCRIPT Guarea grandifolia bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02404 GENEFORM Protein DME1693 XEOTICID XEO02404 MOACRIVE Inhibition DME1693 XEOTICID XEO02405 XEO_NAME Guarea guidonia bark extract DME1693 XEOTICID XEO02405 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02405 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02405 DESCRIPT Guarea guidonia bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02405 GENEFORM Protein DME1693 XEOTICID XEO02405 MOACRIVE Inhibition DME1693 XEOTICID XEO02406 XEO_NAME Guarea pterorhachis bark extract DME1693 XEOTICID XEO02406 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02406 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02406 DESCRIPT Guarea pterorhachis bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02406 GENEFORM Protein DME1693 XEOTICID XEO02406 MOACRIVE Inhibition DME1693 XEOTICID XEO02407 XEO_NAME Guarea pyriformis bark extract DME1693 XEOTICID XEO02407 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02407 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02407 DESCRIPT Guarea pyriformis bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02407 GENEFORM Protein DME1693 XEOTICID XEO02407 MOACRIVE Inhibition DME1693 XEOTICID XEO02408 XEO_NAME Ruptiliocarpon caracolito bark extract DME1693 XEOTICID XEO02408 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02408 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02408 DESCRIPT Ruptiliocarpon caracolito bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02408 GENEFORM Protein DME1693 XEOTICID XEO02408 MOACRIVE Inhibition DME1693 XEOTICID XEO02409 XEO_NAME Simarouba glauca bark extract DME1693 XEOTICID XEO02409 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02409 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02409 DESCRIPT Simarouba glauca bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02409 GENEFORM Protein DME1693 XEOTICID XEO02409 MOACRIVE Inhibition DME1693 XEOTICID XEO02410 XEO_NAME Swietenia macrophylla bark extract DME1693 XEOTICID XEO02410 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02410 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02410 DESCRIPT Swietenia macrophylla bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02410 GENEFORM Protein DME1693 XEOTICID XEO02410 MOACRIVE Inhibition DME1693 XEOTICID XEO02411 XEO_NAME Swietenia mahogani bark extract DME1693 XEOTICID XEO02411 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02411 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02411 DESCRIPT Swietenia mahogani bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02411 GENEFORM Protein DME1693 XEOTICID XEO02411 MOACRIVE Inhibition DME1693 XEOTICID XEO02413 XEO_NAME Trichilia martiana bark extract DME1693 XEOTICID XEO02413 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02413 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02413 DESCRIPT Trichilia martiana bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02413 GENEFORM Protein DME1693 XEOTICID XEO02413 MOACRIVE Inhibition DME1693 XEOTICID XEO02414 XEO_NAME Trichilia pleeana bark extract DME1693 XEOTICID XEO02414 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02414 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02414 DESCRIPT Trichilia pleeana bark extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02414 GENEFORM Protein DME1693 XEOTICID XEO02414 MOACRIVE Inhibition DME1693 XEOTICID XEO02425 XEO_NAME Benzocaine DME1693 XEOTICID XEO02425 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO02425 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO02425 DESCRIPT Benzocaine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02425 GENEFORM Protein DME1693 XEOTICID XEO02425 MOACRIVE Inhibition DME1693 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1693 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02437 XEO_CLAS Peptide DME1693 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02437 GENEFORM Protein DME1693 XEOTICID XEO02437 MOACRIVE Inhibition DME1693 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1693 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02438 XEO_CLAS Peptide DME1693 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02438 GENEFORM Protein DME1693 XEOTICID XEO02438 MOACRIVE Inhibition DME1693 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1693 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02440 XEO_CLAS Peptide DME1693 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02440 GENEFORM Protein DME1693 XEOTICID XEO02440 MOACRIVE Inhibition DME1693 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1693 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02443 XEO_CLAS Peptide DME1693 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02443 GENEFORM Protein DME1693 XEOTICID XEO02443 MOACRIVE Inhibition DME1693 XEOTICID XEO02462 XEO_NAME bLF peptide DME1693 XEOTICID XEO02462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02462 XEO_CLAS Peptide DME1693 XEOTICID XEO02462 DESCRIPT bLF peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02462 GENEFORM Protein DME1693 XEOTICID XEO02462 MOACRIVE Inhibition DME1693 XEOTICID XEO02464 XEO_NAME BMAP-27 DME1693 XEOTICID XEO02464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02464 XEO_CLAS Peptide DME1693 XEOTICID XEO02464 DESCRIPT BMAP-27 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02464 GENEFORM Protein DME1693 XEOTICID XEO02464 MOACRIVE Inhibition DME1693 XEOTICID XEO02465 XEO_NAME BMAP-28 DME1693 XEOTICID XEO02465 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02465 XEO_CLAS Peptide DME1693 XEOTICID XEO02465 DESCRIPT BMAP-28 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02465 GENEFORM Protein DME1693 XEOTICID XEO02465 MOACRIVE Inhibition DME1693 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1693 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02466 XEO_CLAS Peptide DME1693 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC <= 18 microM) DME1693 XEOTICID XEO02466 GENEFORM Protein DME1693 XEOTICID XEO02466 MOACRIVE Inhibition DME1693 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1693 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02473 XEO_CLAS Peptide DME1693 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02473 GENEFORM Protein DME1693 XEOTICID XEO02473 MOACRIVE Inhibition DME1693 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1693 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02474 XEO_CLAS Peptide DME1693 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.3 microM) DME1693 XEOTICID XEO02474 GENEFORM Protein DME1693 XEOTICID XEO02474 MOACRIVE Inhibition DME1693 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1693 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02475 XEO_CLAS Peptide DME1693 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 9.2 microM) DME1693 XEOTICID XEO02475 GENEFORM Protein DME1693 XEOTICID XEO02475 MOACRIVE Inhibition DME1693 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1693 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02491 XEO_CLAS Peptide DME1693 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4.7 microM) DME1693 XEOTICID XEO02491 GENEFORM Protein DME1693 XEOTICID XEO02491 MOACRIVE Inhibition DME1693 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1693 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02492 XEO_CLAS Peptide DME1693 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1693 XEOTICID XEO02492 GENEFORM Protein DME1693 XEOTICID XEO02492 MOACRIVE Inhibition DME1693 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1693 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02493 XEO_CLAS Peptide DME1693 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1693 XEOTICID XEO02493 GENEFORM Protein DME1693 XEOTICID XEO02493 MOACRIVE Inhibition DME1693 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1693 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02494 XEO_CLAS Peptide DME1693 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1693 XEOTICID XEO02494 GENEFORM Protein DME1693 XEOTICID XEO02494 MOACRIVE Inhibition DME1693 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1693 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02496 XEO_CLAS Peptide DME1693 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 25 microM) DME1693 XEOTICID XEO02496 GENEFORM Protein DME1693 XEOTICID XEO02496 MOACRIVE Inhibition DME1693 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1693 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02497 XEO_CLAS Peptide DME1693 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 25 microM) DME1693 XEOTICID XEO02497 GENEFORM Protein DME1693 XEOTICID XEO02497 MOACRIVE Inhibition DME1693 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1693 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02511 XEO_CLAS Peptide DME1693 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 75 microM) DME1693 XEOTICID XEO02511 GENEFORM Protein DME1693 XEOTICID XEO02511 MOACRIVE Inhibition DME1693 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1693 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02512 XEO_CLAS Peptide DME1693 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 75 microM) DME1693 XEOTICID XEO02512 GENEFORM Protein DME1693 XEOTICID XEO02512 MOACRIVE Inhibition DME1693 XEOTICID XEO02521 XEO_NAME Brevinin-1E DME1693 XEOTICID XEO02521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02521 XEO_CLAS Peptide DME1693 XEOTICID XEO02521 DESCRIPT Brevinin-1E inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 30.6 microM) DME1693 XEOTICID XEO02521 GENEFORM Protein DME1693 XEOTICID XEO02521 MOACRIVE Inhibition DME1693 XEOTICID XEO02554 XEO_NAME Brevinin-1RTa DME1693 XEOTICID XEO02554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02554 XEO_CLAS Peptide DME1693 XEOTICID XEO02554 DESCRIPT Brevinin-1RTa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02554 GENEFORM Protein DME1693 XEOTICID XEO02554 MOACRIVE Inhibition DME1693 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1693 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02566 XEO_CLAS Peptide DME1693 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50 microM) DME1693 XEOTICID XEO02566 GENEFORM Protein DME1693 XEOTICID XEO02566 MOACRIVE Inhibition DME1693 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1693 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02575 XEO_CLAS Peptide DME1693 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 32 microM) DME1693 XEOTICID XEO02575 GENEFORM Protein DME1693 XEOTICID XEO02575 MOACRIVE Inhibition DME1693 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1693 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02576 XEO_CLAS Peptide DME1693 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 44 microM) DME1693 XEOTICID XEO02576 GENEFORM Protein DME1693 XEOTICID XEO02576 MOACRIVE Inhibition DME1693 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1693 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02584 XEO_CLAS Peptide DME1693 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 30 microM) DME1693 XEOTICID XEO02584 GENEFORM Protein DME1693 XEOTICID XEO02584 MOACRIVE Inhibition DME1693 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1693 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02598 XEO_CLAS Peptide DME1693 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 65 microM) DME1693 XEOTICID XEO02598 GENEFORM Protein DME1693 XEOTICID XEO02598 MOACRIVE Inhibition DME1693 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1693 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02599 XEO_CLAS Peptide DME1693 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 30 microM) DME1693 XEOTICID XEO02599 GENEFORM Protein DME1693 XEOTICID XEO02599 MOACRIVE Inhibition DME1693 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1693 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02630 XEO_CLAS Peptide DME1693 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1693 XEOTICID XEO02630 GENEFORM Protein DME1693 XEOTICID XEO02630 MOACRIVE Inhibition DME1693 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1693 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02631 XEO_CLAS Peptide DME1693 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1693 XEOTICID XEO02631 GENEFORM Protein DME1693 XEOTICID XEO02631 MOACRIVE Inhibition DME1693 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1693 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02637 XEO_CLAS Peptide DME1693 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6 microM) DME1693 XEOTICID XEO02637 GENEFORM Protein DME1693 XEOTICID XEO02637 MOACRIVE Inhibition DME1693 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1693 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02639 XEO_CLAS Peptide DME1693 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 5 microM) DME1693 XEOTICID XEO02639 GENEFORM Protein DME1693 XEOTICID XEO02639 MOACRIVE Inhibition DME1693 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1693 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02663 XEO_CLAS Peptide DME1693 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1693 XEOTICID XEO02663 GENEFORM Protein DME1693 XEOTICID XEO02663 MOACRIVE Inhibition DME1693 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1693 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02664 XEO_CLAS Peptide DME1693 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25-12.5 microM) DME1693 XEOTICID XEO02664 GENEFORM Protein DME1693 XEOTICID XEO02664 MOACRIVE Inhibition DME1693 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1693 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02672 XEO_CLAS Peptide DME1693 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1693 XEOTICID XEO02672 GENEFORM Protein DME1693 XEOTICID XEO02672 MOACRIVE Inhibition DME1693 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1693 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02673 XEO_CLAS Peptide DME1693 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1693 XEOTICID XEO02673 GENEFORM Protein DME1693 XEOTICID XEO02673 MOACRIVE Inhibition DME1693 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1693 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02674 XEO_CLAS Peptide DME1693 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1693 XEOTICID XEO02674 GENEFORM Protein DME1693 XEOTICID XEO02674 MOACRIVE Inhibition DME1693 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1693 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02676 XEO_CLAS Peptide DME1693 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1693 XEOTICID XEO02676 GENEFORM Protein DME1693 XEOTICID XEO02676 MOACRIVE Inhibition DME1693 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1693 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02677 XEO_CLAS Peptide DME1693 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1693 XEOTICID XEO02677 GENEFORM Protein DME1693 XEOTICID XEO02677 MOACRIVE Inhibition DME1693 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1693 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02679 XEO_CLAS Peptide DME1693 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1693 XEOTICID XEO02679 GENEFORM Protein DME1693 XEOTICID XEO02679 MOACRIVE Inhibition DME1693 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1693 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02680 XEO_CLAS Peptide DME1693 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25 microM) DME1693 XEOTICID XEO02680 GENEFORM Protein DME1693 XEOTICID XEO02680 MOACRIVE Inhibition DME1693 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1693 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02683 XEO_CLAS Peptide DME1693 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1693 XEOTICID XEO02683 GENEFORM Protein DME1693 XEOTICID XEO02683 MOACRIVE Inhibition DME1693 XEOTICID XEO02685 XEO_NAME Cadmium Ion DME1693 XEOTICID XEO02685 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02685 XEO_CLAS Nanoparticle DME1693 XEOTICID XEO02685 DESCRIPT Cadmium Ion inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02685 GENEFORM Protein DME1693 XEOTICID XEO02685 MOACRIVE Inhibition DME1693 XEOTICID XEO02703 XEO_NAME Calcitermin DME1693 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02703 XEO_CLAS Peptide DME1693 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02703 GENEFORM Protein DME1693 XEOTICID XEO02703 MOACRIVE Inhibition DME1693 XEOTICID XEO02705 XEO_NAME CAMA peptide DME1693 XEOTICID XEO02705 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02705 XEO_CLAS Peptide DME1693 XEOTICID XEO02705 DESCRIPT CAMA peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02705 GENEFORM Protein DME1693 XEOTICID XEO02705 MOACRIVE Inhibition DME1693 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1693 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02709 XEO_CLAS Peptide DME1693 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.05 microM) DME1693 XEOTICID XEO02709 GENEFORM Protein DME1693 XEOTICID XEO02709 MOACRIVE Inhibition DME1693 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1693 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1693 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02713 GENEFORM Protein DME1693 XEOTICID XEO02713 MOACRIVE Inhibition DME1693 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1693 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02714 GENEFORM Protein DME1693 XEOTICID XEO02714 MOACRIVE Inhibition DME1693 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1693 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02731 XEO_CLAS Peptide DME1693 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.63 microM) DME1693 XEOTICID XEO02731 GENEFORM Protein DME1693 XEOTICID XEO02731 MOACRIVE Inhibition DME1693 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1693 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02732 XEO_CLAS Peptide DME1693 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.25 microM) DME1693 XEOTICID XEO02732 GENEFORM Protein DME1693 XEOTICID XEO02732 MOACRIVE Inhibition DME1693 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1693 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02734 XEO_CLAS Peptide DME1693 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3.18 microM) DME1693 XEOTICID XEO02734 GENEFORM Protein DME1693 XEOTICID XEO02734 MOACRIVE Inhibition DME1693 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1693 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02735 XEO_CLAS Peptide DME1693 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1693 XEOTICID XEO02735 GENEFORM Protein DME1693 XEOTICID XEO02735 MOACRIVE Inhibition DME1693 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1693 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02736 XEO_CLAS Peptide DME1693 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.66 microM) DME1693 XEOTICID XEO02736 GENEFORM Protein DME1693 XEOTICID XEO02736 MOACRIVE Inhibition DME1693 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1693 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02739 XEO_CLAS Peptide DME1693 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1 microM) DME1693 XEOTICID XEO02739 GENEFORM Protein DME1693 XEOTICID XEO02739 MOACRIVE Inhibition DME1693 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1693 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02740 XEO_CLAS Peptide DME1693 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1693 XEOTICID XEO02740 GENEFORM Protein DME1693 XEOTICID XEO02740 MOACRIVE Inhibition DME1693 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1693 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02743 XEO_CLAS Peptide DME1693 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.2 ug/ml) DME1693 XEOTICID XEO02743 GENEFORM Protein DME1693 XEOTICID XEO02743 MOACRIVE Inhibition DME1693 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1693 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02744 XEO_CLAS Peptide DME1693 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4.7 ug/ml) DME1693 XEOTICID XEO02744 GENEFORM Protein DME1693 XEOTICID XEO02744 MOACRIVE Inhibition DME1693 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1693 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02745 XEO_CLAS Peptide DME1693 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02745 GENEFORM Protein DME1693 XEOTICID XEO02745 MOACRIVE Inhibition DME1693 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1693 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02746 XEO_CLAS Peptide DME1693 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02746 GENEFORM Protein DME1693 XEOTICID XEO02746 MOACRIVE Inhibition DME1693 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1693 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02756 XEO_CLAS Peptide DME1693 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 15 microM) DME1693 XEOTICID XEO02756 GENEFORM Protein DME1693 XEOTICID XEO02756 MOACRIVE Inhibition DME1693 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1693 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02757 XEO_CLAS Peptide DME1693 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 microM) DME1693 XEOTICID XEO02757 GENEFORM Protein DME1693 XEOTICID XEO02757 MOACRIVE Inhibition DME1693 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1693 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02758 XEO_CLAS Peptide DME1693 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 15 microM) DME1693 XEOTICID XEO02758 GENEFORM Protein DME1693 XEOTICID XEO02758 MOACRIVE Inhibition DME1693 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1693 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02759 XEO_CLAS Peptide DME1693 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 microM) DME1693 XEOTICID XEO02759 GENEFORM Protein DME1693 XEOTICID XEO02759 MOACRIVE Inhibition DME1693 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1693 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02760 XEO_CLAS Peptide DME1693 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1693 XEOTICID XEO02760 GENEFORM Protein DME1693 XEOTICID XEO02760 MOACRIVE Inhibition DME1693 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1693 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02761 XEO_CLAS Peptide DME1693 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 microM) DME1693 XEOTICID XEO02761 GENEFORM Protein DME1693 XEOTICID XEO02761 MOACRIVE Inhibition DME1693 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1693 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02762 XEO_CLAS Peptide DME1693 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3 microM) DME1693 XEOTICID XEO02762 GENEFORM Protein DME1693 XEOTICID XEO02762 MOACRIVE Inhibition DME1693 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1693 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02763 XEO_CLAS Peptide DME1693 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.9 microM) DME1693 XEOTICID XEO02763 GENEFORM Protein DME1693 XEOTICID XEO02763 MOACRIVE Inhibition DME1693 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1693 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02764 XEO_CLAS Peptide DME1693 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1 microM) DME1693 XEOTICID XEO02764 GENEFORM Protein DME1693 XEOTICID XEO02764 MOACRIVE Inhibition DME1693 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1693 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02765 XEO_CLAS Peptide DME1693 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.7 microM) DME1693 XEOTICID XEO02765 GENEFORM Protein DME1693 XEOTICID XEO02765 MOACRIVE Inhibition DME1693 XEOTICID XEO02766 XEO_NAME Cecropin-B DME1693 XEOTICID XEO02766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02766 XEO_CLAS Peptide DME1693 XEOTICID XEO02766 DESCRIPT Cecropin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02766 GENEFORM Protein DME1693 XEOTICID XEO02766 MOACRIVE Inhibition DME1693 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1693 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02767 XEO_CLAS Peptide DME1693 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02767 GENEFORM Protein DME1693 XEOTICID XEO02767 MOACRIVE Inhibition DME1693 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1693 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02768 XEO_CLAS Peptide DME1693 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 10-25 ug/ml) DME1693 XEOTICID XEO02768 GENEFORM Protein DME1693 XEOTICID XEO02768 MOACRIVE Inhibition DME1693 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1693 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02769 XEO_CLAS Peptide DME1693 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.9 microM) DME1693 XEOTICID XEO02769 GENEFORM Protein DME1693 XEOTICID XEO02769 MOACRIVE Inhibition DME1693 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1693 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02770 XEO_CLAS Peptide DME1693 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.9 microM) DME1693 XEOTICID XEO02770 GENEFORM Protein DME1693 XEOTICID XEO02770 MOACRIVE Inhibition DME1693 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1693 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02771 XEO_CLAS Peptide DME1693 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 81 microM) DME1693 XEOTICID XEO02771 GENEFORM Protein DME1693 XEOTICID XEO02771 MOACRIVE Inhibition DME1693 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1693 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02772 XEO_CLAS Peptide DME1693 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02772 GENEFORM Protein DME1693 XEOTICID XEO02772 MOACRIVE Inhibition DME1693 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1693 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02774 XEO_CLAS Peptide DME1693 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 5.9 microM) DME1693 XEOTICID XEO02774 GENEFORM Protein DME1693 XEOTICID XEO02774 MOACRIVE Inhibition DME1693 XEOTICID XEO02798 XEO_NAME Enterobacter asburiae cell-free lysate DME1693 XEOTICID XEO02798 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02798 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO02798 DESCRIPT Enterobacter asburiae cell-free lysate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02798 GENEFORM Protein DME1693 XEOTICID XEO02798 MOACRIVE Inhibition DME1693 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1693 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02799 XEO_CLAS Peptide DME1693 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1693 XEOTICID XEO02799 GENEFORM Protein DME1693 XEOTICID XEO02799 MOACRIVE Inhibition DME1693 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1693 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02800 XEO_CLAS Peptide DME1693 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1693 XEOTICID XEO02800 GENEFORM Protein DME1693 XEOTICID XEO02800 MOACRIVE Inhibition DME1693 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1693 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02802 XEO_CLAS Peptide DME1693 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 50 microM) DME1693 XEOTICID XEO02802 GENEFORM Protein DME1693 XEOTICID XEO02802 MOACRIVE Inhibition DME1693 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1693 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02820 XEO_CLAS Peptide DME1693 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO02820 GENEFORM Protein DME1693 XEOTICID XEO02820 MOACRIVE Inhibition DME1693 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1693 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02824 XEO_CLAS Peptide DME1693 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 9 microM) DME1693 XEOTICID XEO02824 GENEFORM Protein DME1693 XEOTICID XEO02824 MOACRIVE Inhibition DME1693 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1693 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02834 GENEFORM Protein DME1693 XEOTICID XEO02834 MOACRIVE Inhibition DME1693 XEOTICID XEO02836 XEO_NAME Chromate DME1693 XEOTICID XEO02836 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02836 XEO_CLAS Nanoparticle DME1693 XEOTICID XEO02836 DESCRIPT Chromate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02836 GENEFORM Protein DME1693 XEOTICID XEO02836 MOACRIVE Inhibition DME1693 XEOTICID XEO02847 XEO_NAME Cinnamon oil DME1693 XEOTICID XEO02847 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02847 XEO_CLAS Natural Product DME1693 XEOTICID XEO02847 DESCRIPT Cinnamon oil inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02847 GENEFORM Protein DME1693 XEOTICID XEO02847 MOACRIVE Inhibition DME1693 XEOTICID XEO02852 XEO_NAME Cis-2-dodecenoic acid DME1693 XEOTICID XEO02852 XEO_TYPE Health or Environmental Toxicant(s) DME1693 XEOTICID XEO02852 XEO_CLAS Environmental Pollutant DME1693 XEOTICID XEO02852 DESCRIPT Cis-2-dodecenoic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02852 GENEFORM Protein DME1693 XEOTICID XEO02852 MOACRIVE Inhibition DME1693 XEOTICID XEO02864 XEO_NAME Cathelicidin cjaRL-37 DME1693 XEOTICID XEO02864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02864 XEO_CLAS Peptide DME1693 XEOTICID XEO02864 DESCRIPT Cathelicidin cjaRL-37 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1693 XEOTICID XEO02864 GENEFORM Protein DME1693 XEOTICID XEO02864 MOACRIVE Inhibition DME1693 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1693 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02875 XEO_CLAS Peptide DME1693 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.7 microM) DME1693 XEOTICID XEO02875 GENEFORM Protein DME1693 XEOTICID XEO02875 MOACRIVE Inhibition DME1693 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1693 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02876 XEO_CLAS Peptide DME1693 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1693 XEOTICID XEO02876 GENEFORM Protein DME1693 XEOTICID XEO02876 MOACRIVE Inhibition DME1693 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1693 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02877 XEO_CLAS Peptide DME1693 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1693 XEOTICID XEO02877 GENEFORM Protein DME1693 XEOTICID XEO02877 MOACRIVE Inhibition DME1693 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1693 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02878 XEO_CLAS Peptide DME1693 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.9 microM) DME1693 XEOTICID XEO02878 GENEFORM Protein DME1693 XEOTICID XEO02878 MOACRIVE Inhibition DME1693 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1693 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02885 XEO_CLAS Peptide DME1693 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO02885 GENEFORM Protein DME1693 XEOTICID XEO02885 MOACRIVE Inhibition DME1693 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1693 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02886 XEO_CLAS Peptide DME1693 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1693 XEOTICID XEO02886 GENEFORM Protein DME1693 XEOTICID XEO02886 MOACRIVE Inhibition DME1693 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1693 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02887 XEO_CLAS Peptide DME1693 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1693 XEOTICID XEO02887 GENEFORM Protein DME1693 XEOTICID XEO02887 MOACRIVE Inhibition DME1693 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1693 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02888 XEO_CLAS Peptide DME1693 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1693 XEOTICID XEO02888 GENEFORM Protein DME1693 XEOTICID XEO02888 MOACRIVE Inhibition DME1693 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1693 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02889 XEO_CLAS Peptide DME1693 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 19 ug/ml) DME1693 XEOTICID XEO02889 GENEFORM Protein DME1693 XEOTICID XEO02889 MOACRIVE Inhibition DME1693 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1693 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02890 XEO_CLAS Peptide DME1693 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1693 XEOTICID XEO02890 GENEFORM Protein DME1693 XEOTICID XEO02890 MOACRIVE Inhibition DME1693 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1693 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02891 XEO_CLAS Peptide DME1693 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO02891 GENEFORM Protein DME1693 XEOTICID XEO02891 MOACRIVE Inhibition DME1693 XEOTICID XEO02898 XEO_NAME Cobalt Ion DME1693 XEOTICID XEO02898 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO02898 XEO_CLAS Nanoparticle DME1693 XEOTICID XEO02898 DESCRIPT Cobalt Ion inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02898 GENEFORM Protein DME1693 XEOTICID XEO02898 MOACRIVE Inhibition DME1693 XEOTICID XEO02903 XEO_NAME Colistin DME1693 XEOTICID XEO02903 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO02903 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO02903 DESCRIPT Colistin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02903 GENEFORM Protein DME1693 XEOTICID XEO02903 MOACRIVE Inhibition DME1693 XEOTICID XEO02914 XEO_NAME Coral associated bacteria extract DME1693 XEOTICID XEO02914 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02914 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO02914 DESCRIPT Coral associated bacteria extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02914 GENEFORM Protein DME1693 XEOTICID XEO02914 MOACRIVE Inhibition DME1693 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1693 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02931 XEO_CLAS Peptide DME1693 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1693 XEOTICID XEO02931 GENEFORM Protein DME1693 XEOTICID XEO02931 MOACRIVE Inhibition DME1693 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1693 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02933 XEO_CLAS Peptide DME1693 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO02933 GENEFORM Protein DME1693 XEOTICID XEO02933 MOACRIVE Inhibition DME1693 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1693 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02934 XEO_CLAS Peptide DME1693 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO02934 GENEFORM Protein DME1693 XEOTICID XEO02934 MOACRIVE Inhibition DME1693 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1693 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02935 XEO_CLAS Peptide DME1693 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1693 XEOTICID XEO02935 GENEFORM Protein DME1693 XEOTICID XEO02935 MOACRIVE Inhibition DME1693 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1693 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02936 XEO_CLAS Peptide DME1693 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO02936 GENEFORM Protein DME1693 XEOTICID XEO02936 MOACRIVE Inhibition DME1693 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1693 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02937 XEO_CLAS Peptide DME1693 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1693 XEOTICID XEO02937 GENEFORM Protein DME1693 XEOTICID XEO02937 MOACRIVE Inhibition DME1693 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1693 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02938 XEO_CLAS Peptide DME1693 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1693 XEOTICID XEO02938 GENEFORM Protein DME1693 XEOTICID XEO02938 MOACRIVE Inhibition DME1693 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1693 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02939 XEO_CLAS Peptide DME1693 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1693 XEOTICID XEO02939 GENEFORM Protein DME1693 XEOTICID XEO02939 MOACRIVE Inhibition DME1693 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1693 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02940 XEO_CLAS Peptide DME1693 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1693 XEOTICID XEO02940 GENEFORM Protein DME1693 XEOTICID XEO02940 MOACRIVE Inhibition DME1693 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1693 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02941 XEO_CLAS Peptide DME1693 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1693 XEOTICID XEO02941 GENEFORM Protein DME1693 XEOTICID XEO02941 MOACRIVE Inhibition DME1693 XEOTICID XEO02943 XEO_NAME CP-P peptide DME1693 XEOTICID XEO02943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02943 XEO_CLAS Peptide DME1693 XEOTICID XEO02943 DESCRIPT CP-P peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1693 XEOTICID XEO02943 GENEFORM Protein DME1693 XEOTICID XEO02943 MOACRIVE Inhibition DME1693 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1693 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02947 XEO_CLAS Peptide DME1693 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO02947 GENEFORM Protein DME1693 XEOTICID XEO02947 MOACRIVE Inhibition DME1693 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1693 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02948 XEO_CLAS Peptide DME1693 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1693 XEOTICID XEO02948 GENEFORM Protein DME1693 XEOTICID XEO02948 MOACRIVE Inhibition DME1693 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1693 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02949 XEO_CLAS Peptide DME1693 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO02949 GENEFORM Protein DME1693 XEOTICID XEO02949 MOACRIVE Inhibition DME1693 XEOTICID XEO02953 XEO_NAME Crocin DME1693 XEOTICID XEO02953 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02953 XEO_CLAS Natural Product DME1693 XEOTICID XEO02953 DESCRIPT Crocin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02953 GENEFORM Protein DME1693 XEOTICID XEO02953 MOACRIVE Inhibition DME1693 XEOTICID XEO02957 XEO_NAME Equisetum hyemale crude extract DME1693 XEOTICID XEO02957 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02957 XEO_CLAS Plant Extract DME1693 XEOTICID XEO02957 DESCRIPT Equisetum hyemale crude extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02957 GENEFORM Protein DME1693 XEOTICID XEO02957 MOACRIVE Inhibition DME1693 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1693 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02969 XEO_CLAS Peptide DME1693 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 32 microM) DME1693 XEOTICID XEO02969 GENEFORM Protein DME1693 XEOTICID XEO02969 MOACRIVE Inhibition DME1693 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1693 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO02971 XEO_CLAS Peptide DME1693 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 128 microM) DME1693 XEOTICID XEO02971 GENEFORM Protein DME1693 XEOTICID XEO02971 MOACRIVE Inhibition DME1693 XEOTICID XEO02974 XEO_NAME Bacillus sp. culture extract DME1693 XEOTICID XEO02974 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02974 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO02974 DESCRIPT Bacillus sp. culture extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02974 GENEFORM Protein DME1693 XEOTICID XEO02974 MOACRIVE Inhibition DME1693 XEOTICID XEO02976 XEO_NAME Paenibacillus strain culture extract DME1693 XEOTICID XEO02976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02976 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO02976 DESCRIPT Paenibacillus strain culture extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02976 GENEFORM Protein DME1693 XEOTICID XEO02976 MOACRIVE Inhibition DME1693 XEOTICID XEO02986 XEO_NAME Bacillus aquimaris culture supernatant DME1693 XEOTICID XEO02986 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02986 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO02986 DESCRIPT Bacillus aquimaris culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02986 GENEFORM Protein DME1693 XEOTICID XEO02986 MOACRIVE Inhibition DME1693 XEOTICID XEO02987 XEO_NAME Bacillus arsenicus culture supernatant DME1693 XEOTICID XEO02987 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02987 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO02987 DESCRIPT Bacillus arsenicus culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02987 GENEFORM Protein DME1693 XEOTICID XEO02987 MOACRIVE Inhibition DME1693 XEOTICID XEO02988 XEO_NAME Bacillus cereus culture supernatant DME1693 XEOTICID XEO02988 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02988 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO02988 DESCRIPT Bacillus cereus culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02988 GENEFORM Protein DME1693 XEOTICID XEO02988 MOACRIVE Inhibition DME1693 XEOTICID XEO02989 XEO_NAME Bacillus indicus culture supernatant DME1693 XEOTICID XEO02989 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO02989 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO02989 DESCRIPT Bacillus indicus culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO02989 GENEFORM Protein DME1693 XEOTICID XEO02989 MOACRIVE Inhibition DME1693 XEOTICID XEO03000 XEO_NAME Bacillus niabensis culture supernatant DME1693 XEOTICID XEO03000 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03000 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO03000 DESCRIPT Bacillus niabensis culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03000 GENEFORM Protein DME1693 XEOTICID XEO03000 MOACRIVE Inhibition DME1693 XEOTICID XEO03001 XEO_NAME Bacillus pumilus culture supernatant DME1693 XEOTICID XEO03001 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03001 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO03001 DESCRIPT Bacillus pumilus culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03001 GENEFORM Protein DME1693 XEOTICID XEO03001 MOACRIVE Inhibition DME1693 XEOTICID XEO03002 XEO_NAME Ferrimonas balearica culture supernatant DME1693 XEOTICID XEO03002 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03002 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO03002 DESCRIPT Ferrimonas balearica culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03002 GENEFORM Protein DME1693 XEOTICID XEO03002 MOACRIVE Inhibition DME1693 XEOTICID XEO03003 XEO_NAME Halobacillus trueperi S6-09 culture supernatant DME1693 XEOTICID XEO03003 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03003 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO03003 DESCRIPT Halobacillus trueperi S6-09 culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03003 GENEFORM Protein DME1693 XEOTICID XEO03003 MOACRIVE Inhibition DME1693 XEOTICID XEO03004 XEO_NAME Halobacillus trueperi S6-16 culture supernatant DME1693 XEOTICID XEO03004 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03004 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO03004 DESCRIPT Halobacillus trueperi S6-16 culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03004 GENEFORM Protein DME1693 XEOTICID XEO03004 MOACRIVE Inhibition DME1693 XEOTICID XEO03007 XEO_NAME Marinobacter hydrocarbonoclasticus culture supernatant DME1693 XEOTICID XEO03007 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03007 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO03007 DESCRIPT Marinobacter hydrocarbonoclasticus culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03007 GENEFORM Protein DME1693 XEOTICID XEO03007 MOACRIVE Inhibition DME1693 XEOTICID XEO03008 XEO_NAME Staphylococcus pasteuri culture supernatant DME1693 XEOTICID XEO03008 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03008 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO03008 DESCRIPT Staphylococcus pasteuri culture supernatant inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03008 GENEFORM Protein DME1693 XEOTICID XEO03008 MOACRIVE Inhibition DME1693 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1693 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03021 XEO_CLAS Peptide DME1693 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.31-0.63 microM) DME1693 XEOTICID XEO03021 GENEFORM Protein DME1693 XEOTICID XEO03021 MOACRIVE Inhibition DME1693 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1693 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03029 XEO_CLAS Peptide DME1693 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 0.619 microM) DME1693 XEOTICID XEO03029 GENEFORM Protein DME1693 XEOTICID XEO03029 MOACRIVE Inhibition DME1693 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1693 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03030 XEO_CLAS Peptide DME1693 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 0.643 microM) DME1693 XEOTICID XEO03030 GENEFORM Protein DME1693 XEOTICID XEO03030 MOACRIVE Inhibition DME1693 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1693 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03031 XEO_CLAS Peptide DME1693 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.005 microM) DME1693 XEOTICID XEO03031 GENEFORM Protein DME1693 XEOTICID XEO03031 MOACRIVE Inhibition DME1693 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1693 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03032 XEO_CLAS Peptide DME1693 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.005 microM) DME1693 XEOTICID XEO03032 GENEFORM Protein DME1693 XEOTICID XEO03032 MOACRIVE Inhibition DME1693 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1693 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03033 XEO_CLAS Peptide DME1693 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.005 microM) DME1693 XEOTICID XEO03033 GENEFORM Protein DME1693 XEOTICID XEO03033 MOACRIVE Inhibition DME1693 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1693 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03034 XEO_CLAS Peptide DME1693 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.004 microM) DME1693 XEOTICID XEO03034 GENEFORM Protein DME1693 XEOTICID XEO03034 MOACRIVE Inhibition DME1693 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1693 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03035 XEO_CLAS Peptide DME1693 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.004 microM) DME1693 XEOTICID XEO03035 GENEFORM Protein DME1693 XEOTICID XEO03035 MOACRIVE Inhibition DME1693 XEOTICID XEO03036 XEO_NAME Cyclic protegrin-1-mimetic L27-11 DME1693 XEOTICID XEO03036 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03036 XEO_CLAS Peptide DME1693 XEOTICID XEO03036 DESCRIPT Cyclic protegrin-1-mimetic L27-11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03036 GENEFORM Protein DME1693 XEOTICID XEO03036 MOACRIVE Inhibition DME1693 XEOTICID XEO03037 XEO_NAME Cyclo(Trp-Ser) DME1693 XEOTICID XEO03037 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03037 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO03037 DESCRIPT Cyclo(Trp-Ser) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03037 GENEFORM Protein DME1693 XEOTICID XEO03037 MOACRIVE Inhibition DME1693 XEOTICID XEO03038 XEO_NAME Cyclobutanamine DME1693 XEOTICID XEO03038 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO03038 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO03038 DESCRIPT Cyclobutanamine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03038 GENEFORM Protein DME1693 XEOTICID XEO03038 MOACRIVE Inhibition DME1693 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1693 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03039 XEO_CLAS Peptide DME1693 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 13.5 microM) DME1693 XEOTICID XEO03039 GENEFORM Protein DME1693 XEOTICID XEO03039 MOACRIVE Inhibition DME1693 XEOTICID XEO03040 XEO_NAME Cynarin DME1693 XEOTICID XEO03040 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO03040 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO03040 DESCRIPT Cynarin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03040 GENEFORM Protein DME1693 XEOTICID XEO03040 MOACRIVE Inhibition DME1693 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1693 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03043 XEO_CLAS Peptide DME1693 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1693 XEOTICID XEO03043 GENEFORM Protein DME1693 XEOTICID XEO03043 MOACRIVE Inhibition DME1693 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1693 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03049 XEO_CLAS Peptide DME1693 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1693 XEOTICID XEO03049 GENEFORM Protein DME1693 XEOTICID XEO03049 MOACRIVE Inhibition DME1693 XEOTICID XEO03050 XEO_NAME CP-P derivative D11 DME1693 XEOTICID XEO03050 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03050 XEO_CLAS Peptide DME1693 XEOTICID XEO03050 DESCRIPT CP-P derivative D11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1693 XEOTICID XEO03050 GENEFORM Protein DME1693 XEOTICID XEO03050 MOACRIVE Inhibition DME1693 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1693 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03051 XEO_CLAS Peptide DME1693 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 200 ug/ml) DME1693 XEOTICID XEO03051 GENEFORM Protein DME1693 XEOTICID XEO03051 MOACRIVE Inhibition DME1693 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1693 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03052 XEO_CLAS Peptide DME1693 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1693 XEOTICID XEO03052 GENEFORM Protein DME1693 XEOTICID XEO03052 MOACRIVE Inhibition DME1693 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1693 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03053 XEO_CLAS Peptide DME1693 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 125 ug/ml) DME1693 XEOTICID XEO03053 GENEFORM Protein DME1693 XEOTICID XEO03053 MOACRIVE Inhibition DME1693 XEOTICID XEO03054 XEO_NAME CP-P derivative D18 DME1693 XEOTICID XEO03054 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03054 XEO_CLAS Peptide DME1693 XEOTICID XEO03054 DESCRIPT CP-P derivative D18 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1693 XEOTICID XEO03054 GENEFORM Protein DME1693 XEOTICID XEO03054 MOACRIVE Inhibition DME1693 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1693 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03055 XEO_CLAS Peptide DME1693 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1693 XEOTICID XEO03055 GENEFORM Protein DME1693 XEOTICID XEO03055 MOACRIVE Inhibition DME1693 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1693 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03059 XEO_CLAS Peptide DME1693 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12 microM) DME1693 XEOTICID XEO03059 GENEFORM Protein DME1693 XEOTICID XEO03059 MOACRIVE Inhibition DME1693 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1693 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03060 XEO_CLAS Peptide DME1693 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1693 XEOTICID XEO03060 GENEFORM Protein DME1693 XEOTICID XEO03060 MOACRIVE Inhibition DME1693 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1693 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03062 XEO_CLAS Peptide DME1693 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6 microM) DME1693 XEOTICID XEO03062 GENEFORM Protein DME1693 XEOTICID XEO03062 MOACRIVE Inhibition DME1693 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1693 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03064 XEO_CLAS Peptide DME1693 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6 microM) DME1693 XEOTICID XEO03064 GENEFORM Protein DME1693 XEOTICID XEO03064 MOACRIVE Inhibition DME1693 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1693 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03066 XEO_CLAS Peptide DME1693 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3 microM) DME1693 XEOTICID XEO03066 GENEFORM Protein DME1693 XEOTICID XEO03066 MOACRIVE Inhibition DME1693 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1693 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03068 XEO_CLAS Peptide DME1693 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3 microM) DME1693 XEOTICID XEO03068 GENEFORM Protein DME1693 XEOTICID XEO03068 MOACRIVE Inhibition DME1693 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1693 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03073 XEO_CLAS Peptide DME1693 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16-32 ug/ml) DME1693 XEOTICID XEO03073 GENEFORM Protein DME1693 XEOTICID XEO03073 MOACRIVE Inhibition DME1693 XEOTICID XEO03096 XEO_NAME Frog defensin DME1693 XEOTICID XEO03096 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03096 XEO_CLAS Peptide DME1693 XEOTICID XEO03096 DESCRIPT Frog defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03096 GENEFORM Protein DME1693 XEOTICID XEO03096 MOACRIVE Inhibition DME1693 XEOTICID XEO03098 XEO_NAME Insect defensin DME1693 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03098 XEO_CLAS Peptide DME1693 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 50 ug/ml) DME1693 XEOTICID XEO03098 GENEFORM Protein DME1693 XEOTICID XEO03098 MOACRIVE Inhibition DME1693 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1693 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03116 XEO_CLAS Peptide DME1693 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 40 microM) DME1693 XEOTICID XEO03116 GENEFORM Protein DME1693 XEOTICID XEO03116 MOACRIVE Inhibition DME1693 XEOTICID XEO03123 XEO_NAME Defensin-like protein fabatin-2 DME1693 XEOTICID XEO03123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03123 XEO_CLAS Peptide DME1693 XEOTICID XEO03123 DESCRIPT Defensin-like protein fabatin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03123 GENEFORM Protein DME1693 XEOTICID XEO03123 MOACRIVE Inhibition DME1693 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1693 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03126 XEO_CLAS Peptide DME1693 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 9.3 microM) DME1693 XEOTICID XEO03126 GENEFORM Protein DME1693 XEOTICID XEO03126 MOACRIVE Inhibition DME1693 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1693 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03127 XEO_CLAS Peptide DME1693 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03127 GENEFORM Protein DME1693 XEOTICID XEO03127 MOACRIVE Inhibition DME1693 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1693 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03128 XEO_CLAS Peptide DME1693 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 256 ug/ml) DME1693 XEOTICID XEO03128 GENEFORM Protein DME1693 XEOTICID XEO03128 MOACRIVE Inhibition DME1693 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1693 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03129 XEO_CLAS Peptide DME1693 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 256 ug/ml) DME1693 XEOTICID XEO03129 GENEFORM Protein DME1693 XEOTICID XEO03129 MOACRIVE Inhibition DME1693 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1693 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03130 XEO_CLAS Peptide DME1693 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 256 ug/ml) DME1693 XEOTICID XEO03130 GENEFORM Protein DME1693 XEOTICID XEO03130 MOACRIVE Inhibition DME1693 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1693 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03131 XEO_CLAS Peptide DME1693 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 256 ug/ml) DME1693 XEOTICID XEO03131 GENEFORM Protein DME1693 XEOTICID XEO03131 MOACRIVE Inhibition DME1693 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1693 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03132 XEO_CLAS Peptide DME1693 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 128 ug/ml) DME1693 XEOTICID XEO03132 GENEFORM Protein DME1693 XEOTICID XEO03132 MOACRIVE Inhibition DME1693 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1693 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03137 XEO_CLAS Peptide DME1693 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03137 GENEFORM Protein DME1693 XEOTICID XEO03137 MOACRIVE Inhibition DME1693 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1693 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03145 XEO_CLAS Peptide DME1693 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.4 microM) DME1693 XEOTICID XEO03145 GENEFORM Protein DME1693 XEOTICID XEO03145 MOACRIVE Inhibition DME1693 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1693 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03146 XEO_CLAS Peptide DME1693 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 40 microM) DME1693 XEOTICID XEO03146 GENEFORM Protein DME1693 XEOTICID XEO03146 MOACRIVE Inhibition DME1693 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1693 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03147 XEO_CLAS Peptide DME1693 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 38 microM) DME1693 XEOTICID XEO03147 GENEFORM Protein DME1693 XEOTICID XEO03147 MOACRIVE Inhibition DME1693 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1693 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03148 XEO_CLAS Peptide DME1693 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 5.4 microM) DME1693 XEOTICID XEO03148 GENEFORM Protein DME1693 XEOTICID XEO03148 MOACRIVE Inhibition DME1693 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1693 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03149 XEO_CLAS Peptide DME1693 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 22 microM) DME1693 XEOTICID XEO03149 GENEFORM Protein DME1693 XEOTICID XEO03149 MOACRIVE Inhibition DME1693 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1693 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03152 XEO_CLAS Peptide DME1693 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.6 microM) DME1693 XEOTICID XEO03152 GENEFORM Protein DME1693 XEOTICID XEO03152 MOACRIVE Inhibition DME1693 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1693 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03156 XEO_CLAS Peptide DME1693 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.3 microM) DME1693 XEOTICID XEO03156 GENEFORM Protein DME1693 XEOTICID XEO03156 MOACRIVE Inhibition DME1693 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1693 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03157 XEO_CLAS Peptide DME1693 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 11.6 microM) DME1693 XEOTICID XEO03157 GENEFORM Protein DME1693 XEOTICID XEO03157 MOACRIVE Inhibition DME1693 XEOTICID XEO03164 XEO_NAME Dermatoxin DME1693 XEOTICID XEO03164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03164 XEO_CLAS Peptide DME1693 XEOTICID XEO03164 DESCRIPT Dermatoxin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03164 GENEFORM Protein DME1693 XEOTICID XEO03164 MOACRIVE Inhibition DME1693 XEOTICID XEO03179 XEO_NAME Dibenzyl disulphide DME1693 XEOTICID XEO03179 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO03179 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO03179 DESCRIPT Dibenzyl disulphide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03179 GENEFORM Protein DME1693 XEOTICID XEO03179 MOACRIVE Inhibition DME1693 XEOTICID XEO03184 XEO_NAME Diclofenac sodium DME1693 XEOTICID XEO03184 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO03184 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO03184 DESCRIPT Diclofenac sodium inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03184 GENEFORM Protein DME1693 XEOTICID XEO03184 MOACRIVE Inhibition DME1693 XEOTICID XEO03191 XEO_NAME Diphenyl disulphide DME1693 XEOTICID XEO03191 XEO_TYPE Health or Environmental Toxicant(s) DME1693 XEOTICID XEO03191 XEO_CLAS Environmental Pollutant DME1693 XEOTICID XEO03191 DESCRIPT Diphenyl disulphide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03191 GENEFORM Protein DME1693 XEOTICID XEO03191 MOACRIVE Inhibition DME1693 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1693 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03197 XEO_CLAS Peptide DME1693 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 28.0 microM) DME1693 XEOTICID XEO03197 GENEFORM Protein DME1693 XEOTICID XEO03197 MOACRIVE Inhibition DME1693 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1693 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03202 XEO_CLAS Peptide DME1693 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 7.92 microM) DME1693 XEOTICID XEO03202 GENEFORM Protein DME1693 XEOTICID XEO03202 MOACRIVE Inhibition DME1693 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1693 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03203 XEO_CLAS Peptide DME1693 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.71 microM) DME1693 XEOTICID XEO03203 GENEFORM Protein DME1693 XEOTICID XEO03203 MOACRIVE Inhibition DME1693 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1693 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03204 XEO_CLAS Peptide DME1693 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.83 microM) DME1693 XEOTICID XEO03204 GENEFORM Protein DME1693 XEOTICID XEO03204 MOACRIVE Inhibition DME1693 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1693 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03205 XEO_CLAS Peptide DME1693 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.22 microM) DME1693 XEOTICID XEO03205 GENEFORM Protein DME1693 XEOTICID XEO03205 MOACRIVE Inhibition DME1693 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1693 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03206 XEO_CLAS Peptide DME1693 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.35 microM) DME1693 XEOTICID XEO03206 GENEFORM Protein DME1693 XEOTICID XEO03206 MOACRIVE Inhibition DME1693 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1693 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03207 XEO_CLAS Peptide DME1693 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.42 microM) DME1693 XEOTICID XEO03207 GENEFORM Protein DME1693 XEOTICID XEO03207 MOACRIVE Inhibition DME1693 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1693 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03208 XEO_CLAS Peptide DME1693 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4.69 microM) DME1693 XEOTICID XEO03208 GENEFORM Protein DME1693 XEOTICID XEO03208 MOACRIVE Inhibition DME1693 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1693 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03209 XEO_CLAS Peptide DME1693 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.23 microM) DME1693 XEOTICID XEO03209 GENEFORM Protein DME1693 XEOTICID XEO03209 MOACRIVE Inhibition DME1693 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1693 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03210 XEO_CLAS Peptide DME1693 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 22.62 microM) DME1693 XEOTICID XEO03210 GENEFORM Protein DME1693 XEOTICID XEO03210 MOACRIVE Inhibition DME1693 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1693 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03211 XEO_CLAS Peptide DME1693 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 22.62 microM) DME1693 XEOTICID XEO03211 GENEFORM Protein DME1693 XEOTICID XEO03211 MOACRIVE Inhibition DME1693 XEOTICID XEO03218 XEO_NAME Dorema oil DME1693 XEOTICID XEO03218 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03218 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03218 DESCRIPT Dorema oil inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03218 GENEFORM Protein DME1693 XEOTICID XEO03218 MOACRIVE Inhibition DME1693 XEOTICID XEO03219 XEO_NAME Doripenem DME1693 XEOTICID XEO03219 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO03219 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO03219 DESCRIPT Doripenem inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03219 GENEFORM Protein DME1693 XEOTICID XEO03219 MOACRIVE Inhibition DME1693 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1693 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03223 XEO_CLAS Peptide DME1693 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4.2 microM) DME1693 XEOTICID XEO03223 GENEFORM Protein DME1693 XEOTICID XEO03223 MOACRIVE Inhibition DME1693 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1693 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03224 XEO_CLAS Peptide DME1693 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1-2.5 microM) DME1693 XEOTICID XEO03224 GENEFORM Protein DME1693 XEOTICID XEO03224 MOACRIVE Inhibition DME1693 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1693 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03225 XEO_CLAS Peptide DME1693 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.2 microM) DME1693 XEOTICID XEO03225 GENEFORM Protein DME1693 XEOTICID XEO03225 MOACRIVE Inhibition DME1693 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1693 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03251 XEO_CLAS Peptide DME1693 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03251 GENEFORM Protein DME1693 XEOTICID XEO03251 MOACRIVE Inhibition DME1693 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1693 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03253 XEO_CLAS Peptide DME1693 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03253 GENEFORM Protein DME1693 XEOTICID XEO03253 MOACRIVE Inhibition DME1693 XEOTICID XEO03263 XEO_NAME Ephedrine DME1693 XEOTICID XEO03263 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03263 XEO_CLAS Natural Product DME1693 XEOTICID XEO03263 DESCRIPT Ephedrine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03263 GENEFORM Protein DME1693 XEOTICID XEO03263 MOACRIVE Inhibition DME1693 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1693 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03277 XEO_CLAS Peptide DME1693 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.7 microM) DME1693 XEOTICID XEO03277 GENEFORM Protein DME1693 XEOTICID XEO03277 MOACRIVE Inhibition DME1693 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1693 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03299 XEO_CLAS Peptide DME1693 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3.5 microM) DME1693 XEOTICID XEO03299 GENEFORM Protein DME1693 XEOTICID XEO03299 MOACRIVE Inhibition DME1693 XEOTICID XEO03323 XEO_NAME Esculin DME1693 XEOTICID XEO03323 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO03323 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO03323 DESCRIPT Esculin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03323 GENEFORM Protein DME1693 XEOTICID XEO03323 MOACRIVE Inhibition DME1693 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1693 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03348 GENEFORM Protein DME1693 XEOTICID XEO03348 MOACRIVE Inhibition DME1693 XEOTICID XEO03349 XEO_NAME Burdock leaf ethanolic extract DME1693 XEOTICID XEO03349 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03349 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03349 DESCRIPT Burdock leaf ethanolic extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03349 GENEFORM Protein DME1693 XEOTICID XEO03349 MOACRIVE Inhibition DME1693 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1693 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03362 XEO_CLAS Peptide DME1693 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 20 ug/ml) DME1693 XEOTICID XEO03362 GENEFORM Protein DME1693 XEOTICID XEO03362 MOACRIVE Inhibition DME1693 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1693 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03363 XEO_CLAS Peptide DME1693 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 30 microM) DME1693 XEOTICID XEO03363 GENEFORM Protein DME1693 XEOTICID XEO03363 MOACRIVE Inhibition DME1693 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1693 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03364 XEO_CLAS Peptide DME1693 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 30 microM) DME1693 XEOTICID XEO03364 GENEFORM Protein DME1693 XEOTICID XEO03364 MOACRIVE Inhibition DME1693 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1693 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03366 XEO_CLAS Peptide DME1693 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 30 microM) DME1693 XEOTICID XEO03366 GENEFORM Protein DME1693 XEOTICID XEO03366 MOACRIVE Inhibition DME1693 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1693 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03367 XEO_CLAS Peptide DME1693 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 30 microM) DME1693 XEOTICID XEO03367 GENEFORM Protein DME1693 XEOTICID XEO03367 MOACRIVE Inhibition DME1693 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1693 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03368 XEO_CLAS Peptide DME1693 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 30 microM) DME1693 XEOTICID XEO03368 GENEFORM Protein DME1693 XEOTICID XEO03368 MOACRIVE Inhibition DME1693 XEOTICID XEO03371 XEO_NAME Herba patriniae extract DME1693 XEOTICID XEO03371 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03371 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03371 DESCRIPT Herba patriniae extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03371 GENEFORM Protein DME1693 XEOTICID XEO03371 MOACRIVE Inhibition DME1693 XEOTICID XEO03377 XEO_NAME CP-P derivative F2 DME1693 XEOTICID XEO03377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03377 XEO_CLAS Peptide DME1693 XEOTICID XEO03377 DESCRIPT CP-P derivative F2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1693 XEOTICID XEO03377 GENEFORM Protein DME1693 XEOTICID XEO03377 MOACRIVE Inhibition DME1693 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1693 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03379 XEO_CLAS Peptide DME1693 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1693 XEOTICID XEO03379 GENEFORM Protein DME1693 XEOTICID XEO03379 MOACRIVE Inhibition DME1693 XEOTICID XEO03388 XEO_NAME Ferrous DME1693 XEOTICID XEO03388 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO03388 XEO_CLAS Nanoparticle DME1693 XEOTICID XEO03388 DESCRIPT Ferrous inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03388 GENEFORM Protein DME1693 XEOTICID XEO03388 MOACRIVE Inhibition DME1693 XEOTICID XEO03389 XEO_NAME Ferula oil DME1693 XEOTICID XEO03389 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03389 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03389 DESCRIPT Ferula oil inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03389 GENEFORM Protein DME1693 XEOTICID XEO03389 MOACRIVE Inhibition DME1693 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1693 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03396 XEO_CLAS Peptide DME1693 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03396 GENEFORM Protein DME1693 XEOTICID XEO03396 MOACRIVE Inhibition DME1693 XEOTICID XEO03403 XEO_NAME Fraxin DME1693 XEOTICID XEO03403 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03403 XEO_CLAS Natural Product DME1693 XEOTICID XEO03403 DESCRIPT Fraxin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03403 GENEFORM Protein DME1693 XEOTICID XEO03403 MOACRIVE Inhibition DME1693 XEOTICID XEO03408 XEO_NAME Lagerstroemia speciosa fruit extract DME1693 XEOTICID XEO03408 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03408 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03408 DESCRIPT Lagerstroemia speciosa fruit extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03408 GENEFORM Protein DME1693 XEOTICID XEO03408 MOACRIVE Inhibition DME1693 XEOTICID XEO03409 XEO_NAME Ruptiliocarpon caracolito fruit extract DME1693 XEOTICID XEO03409 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03409 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03409 DESCRIPT Ruptiliocarpon caracolito fruit extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03409 GENEFORM Protein DME1693 XEOTICID XEO03409 MOACRIVE Inhibition DME1693 XEOTICID XEO03410 XEO_NAME Terminalia chebula fruit extract DME1693 XEOTICID XEO03410 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03410 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03410 DESCRIPT Terminalia chebula fruit extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03410 GENEFORM Protein DME1693 XEOTICID XEO03410 MOACRIVE Inhibition DME1693 XEOTICID XEO03411 XEO_NAME Trichilia martiana fruit extract DME1693 XEOTICID XEO03411 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03411 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03411 DESCRIPT Trichilia martiana fruit extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03411 GENEFORM Protein DME1693 XEOTICID XEO03411 MOACRIVE Inhibition DME1693 XEOTICID XEO03413 XEO_NAME Furanone DME1693 XEOTICID XEO03413 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO03413 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO03413 DESCRIPT Furanone inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03413 GENEFORM Protein DME1693 XEOTICID XEO03413 MOACRIVE Inhibition DME1693 XEOTICID XEO03415 XEO_NAME Furanone C-30 DME1693 XEOTICID XEO03415 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO03415 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO03415 DESCRIPT Furanone C-30 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03415 GENEFORM Protein DME1693 XEOTICID XEO03415 MOACRIVE Inhibition DME1693 XEOTICID XEO03422 XEO_NAME Furvina DME1693 XEOTICID XEO03422 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO03422 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO03422 DESCRIPT Furvina inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03422 GENEFORM Protein DME1693 XEOTICID XEO03422 MOACRIVE Inhibition DME1693 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1693 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03424 XEO_CLAS Peptide DME1693 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03424 GENEFORM Protein DME1693 XEOTICID XEO03424 MOACRIVE Inhibition DME1693 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1693 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03428 XEO_CLAS Peptide DME1693 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 125 ug/ml) DME1693 XEOTICID XEO03428 GENEFORM Protein DME1693 XEOTICID XEO03428 MOACRIVE Inhibition DME1693 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1693 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03430 XEO_CLAS Peptide DME1693 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 63 ug/ml) DME1693 XEOTICID XEO03430 GENEFORM Protein DME1693 XEOTICID XEO03430 MOACRIVE Inhibition DME1693 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1693 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03434 XEO_CLAS Peptide DME1693 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 31 ug/ml) DME1693 XEOTICID XEO03434 GENEFORM Protein DME1693 XEOTICID XEO03434 MOACRIVE Inhibition DME1693 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1693 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03436 XEO_CLAS Peptide DME1693 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1693 XEOTICID XEO03436 GENEFORM Protein DME1693 XEOTICID XEO03436 MOACRIVE Inhibition DME1693 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1693 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03437 XEO_CLAS Peptide DME1693 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1693 XEOTICID XEO03437 GENEFORM Protein DME1693 XEOTICID XEO03437 MOACRIVE Inhibition DME1693 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1693 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03438 XEO_CLAS Peptide DME1693 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1693 XEOTICID XEO03438 GENEFORM Protein DME1693 XEOTICID XEO03438 MOACRIVE Inhibition DME1693 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1693 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03439 XEO_CLAS Peptide DME1693 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1693 XEOTICID XEO03439 GENEFORM Protein DME1693 XEOTICID XEO03439 MOACRIVE Inhibition DME1693 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1693 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03440 XEO_CLAS Peptide DME1693 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1693 XEOTICID XEO03440 GENEFORM Protein DME1693 XEOTICID XEO03440 MOACRIVE Inhibition DME1693 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1693 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03441 XEO_CLAS Peptide DME1693 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1693 XEOTICID XEO03441 GENEFORM Protein DME1693 XEOTICID XEO03441 MOACRIVE Inhibition DME1693 XEOTICID XEO03469 XEO_NAME Gallium cation DME1693 XEOTICID XEO03469 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO03469 XEO_CLAS Nanoparticle DME1693 XEOTICID XEO03469 DESCRIPT Gallium cation inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03469 GENEFORM Protein DME1693 XEOTICID XEO03469 MOACRIVE Inhibition DME1693 XEOTICID XEO03472 XEO_NAME Garlic extract DME1693 XEOTICID XEO03472 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03472 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03472 DESCRIPT Garlic extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03472 GENEFORM Protein DME1693 XEOTICID XEO03472 MOACRIVE Inhibition DME1693 XEOTICID XEO03482 XEO_NAME Ginger extract DME1693 XEOTICID XEO03482 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03482 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03482 DESCRIPT Ginger extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03482 GENEFORM Protein DME1693 XEOTICID XEO03482 MOACRIVE Inhibition DME1693 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1693 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03497 XEO_CLAS Peptide DME1693 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.6-3.15 microM) DME1693 XEOTICID XEO03497 GENEFORM Protein DME1693 XEOTICID XEO03497 MOACRIVE Inhibition DME1693 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1693 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03498 XEO_CLAS Peptide DME1693 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.6-3.15 microM) DME1693 XEOTICID XEO03498 GENEFORM Protein DME1693 XEOTICID XEO03498 MOACRIVE Inhibition DME1693 XEOTICID XEO03508 XEO_NAME Gratisin analogue DME1693 XEOTICID XEO03508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03508 XEO_CLAS Peptide DME1693 XEOTICID XEO03508 DESCRIPT Gratisin analogue inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03508 GENEFORM Protein DME1693 XEOTICID XEO03508 MOACRIVE Inhibition DME1693 XEOTICID XEO03517 XEO_NAME Histone H5 peptide derivative H5(61-90) DME1693 XEOTICID XEO03517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03517 XEO_CLAS Peptide DME1693 XEOTICID XEO03517 DESCRIPT Histone H5 peptide derivative H5(61-90) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO03517 GENEFORM Protein DME1693 XEOTICID XEO03517 MOACRIVE Inhibition DME1693 XEOTICID XEO03519 XEO_NAME Hadrurin DME1693 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03519 XEO_CLAS Peptide DME1693 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03519 GENEFORM Protein DME1693 XEOTICID XEO03519 MOACRIVE Inhibition DME1693 XEOTICID XEO03520 XEO_NAME Halocidin subunit A DME1693 XEOTICID XEO03520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03520 XEO_CLAS Peptide DME1693 XEOTICID XEO03520 DESCRIPT Halocidin subunit A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03520 GENEFORM Protein DME1693 XEOTICID XEO03520 MOACRIVE Inhibition DME1693 XEOTICID XEO03521 XEO_NAME Halocidin subunit B DME1693 XEOTICID XEO03521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03521 XEO_CLAS Peptide DME1693 XEOTICID XEO03521 DESCRIPT Halocidin subunit B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03521 GENEFORM Protein DME1693 XEOTICID XEO03521 MOACRIVE Inhibition DME1693 XEOTICID XEO03522 XEO_NAME Halocyntin DME1693 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03522 XEO_CLAS Peptide DME1693 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03522 GENEFORM Protein DME1693 XEOTICID XEO03522 MOACRIVE Inhibition DME1693 XEOTICID XEO03523 XEO_NAME Hamamelitannin DME1693 XEOTICID XEO03523 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO03523 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO03523 DESCRIPT Hamamelitannin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03523 GENEFORM Protein DME1693 XEOTICID XEO03523 MOACRIVE Inhibition DME1693 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1693 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03540 XEO_CLAS Peptide DME1693 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO03540 GENEFORM Protein DME1693 XEOTICID XEO03540 MOACRIVE Inhibition DME1693 XEOTICID XEO03545 XEO_NAME Heptadecanoic acid DME1693 XEOTICID XEO03545 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO03545 XEO_CLAS Food Additive DME1693 XEOTICID XEO03545 DESCRIPT Heptadecanoic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03545 GENEFORM Protein DME1693 XEOTICID XEO03545 MOACRIVE Inhibition DME1693 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1693 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03549 XEO_CLAS Peptide DME1693 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03549 GENEFORM Protein DME1693 XEOTICID XEO03549 MOACRIVE Inhibition DME1693 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1693 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03556 XEO_CLAS Peptide DME1693 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO03556 GENEFORM Protein DME1693 XEOTICID XEO03556 MOACRIVE Inhibition DME1693 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1693 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03557 XEO_CLAS Peptide DME1693 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO03557 GENEFORM Protein DME1693 XEOTICID XEO03557 MOACRIVE Inhibition DME1693 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1693 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03558 XEO_CLAS Peptide DME1693 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 microM) DME1693 XEOTICID XEO03558 GENEFORM Protein DME1693 XEOTICID XEO03558 MOACRIVE Inhibition DME1693 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1693 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03559 XEO_CLAS Peptide DME1693 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 microM) DME1693 XEOTICID XEO03559 GENEFORM Protein DME1693 XEOTICID XEO03559 MOACRIVE Inhibition DME1693 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1693 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03560 XEO_CLAS Peptide DME1693 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 microM) DME1693 XEOTICID XEO03560 GENEFORM Protein DME1693 XEOTICID XEO03560 MOACRIVE Inhibition DME1693 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1693 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03573 XEO_CLAS Peptide DME1693 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 37.5 ug/ml) DME1693 XEOTICID XEO03573 GENEFORM Protein DME1693 XEOTICID XEO03573 MOACRIVE Inhibition DME1693 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1693 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03579 XEO_CLAS Peptide DME1693 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03579 GENEFORM Protein DME1693 XEOTICID XEO03579 MOACRIVE Inhibition DME1693 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1693 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03585 XEO_CLAS Peptide DME1693 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 125 ug/ml) DME1693 XEOTICID XEO03585 GENEFORM Protein DME1693 XEOTICID XEO03585 MOACRIVE Inhibition DME1693 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1693 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03588 XEO_CLAS Peptide DME1693 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 62 ug/ml) DME1693 XEOTICID XEO03588 GENEFORM Protein DME1693 XEOTICID XEO03588 MOACRIVE Inhibition DME1693 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1693 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03591 XEO_CLAS Peptide DME1693 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 37.5 ug/ml) DME1693 XEOTICID XEO03591 GENEFORM Protein DME1693 XEOTICID XEO03591 MOACRIVE Inhibition DME1693 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1693 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03593 XEO_CLAS Peptide DME1693 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 18.75 ug/ml) DME1693 XEOTICID XEO03593 GENEFORM Protein DME1693 XEOTICID XEO03593 MOACRIVE Inhibition DME1693 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1693 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03594 XEO_CLAS Peptide DME1693 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4.1 ug/ml) DME1693 XEOTICID XEO03594 GENEFORM Protein DME1693 XEOTICID XEO03594 MOACRIVE Inhibition DME1693 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1693 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03609 XEO_CLAS Peptide DME1693 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03609 GENEFORM Protein DME1693 XEOTICID XEO03609 MOACRIVE Inhibition DME1693 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1693 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03615 XEO_CLAS Peptide DME1693 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 48.8-64.0 ug/ml) DME1693 XEOTICID XEO03615 GENEFORM Protein DME1693 XEOTICID XEO03615 MOACRIVE Inhibition DME1693 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1693 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03616 XEO_CLAS Peptide DME1693 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 64 microM) DME1693 XEOTICID XEO03616 GENEFORM Protein DME1693 XEOTICID XEO03616 MOACRIVE Inhibition DME1693 XEOTICID XEO03620 XEO_NAME Hyperoside DME1693 XEOTICID XEO03620 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03620 XEO_CLAS Natural Product DME1693 XEOTICID XEO03620 DESCRIPT Hyperoside inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03620 GENEFORM Protein DME1693 XEOTICID XEO03620 MOACRIVE Inhibition DME1693 XEOTICID XEO03642 XEO_NAME Indirubin DME1693 XEOTICID XEO03642 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03642 XEO_CLAS Natural Product DME1693 XEOTICID XEO03642 DESCRIPT Indirubin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03642 GENEFORM Protein DME1693 XEOTICID XEO03642 MOACRIVE Inhibition DME1693 XEOTICID XEO03644 XEO_NAME Indole DME1693 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1693 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1693 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03644 GENEFORM Protein DME1693 XEOTICID XEO03644 MOACRIVE Inhibition DME1693 XEOTICID XEO03645 XEO_NAME Indole-3-acetaldehyde DME1693 XEOTICID XEO03645 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO03645 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO03645 DESCRIPT Indole-3-acetaldehyde inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03645 GENEFORM Protein DME1693 XEOTICID XEO03645 MOACRIVE Inhibition DME1693 XEOTICID XEO03647 XEO_NAME Indole-3-carboxyaldehyde DME1693 XEOTICID XEO03647 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO03647 XEO_CLAS Food Additive DME1693 XEOTICID XEO03647 DESCRIPT Indole-3-carboxyaldehyde inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03647 GENEFORM Protein DME1693 XEOTICID XEO03647 MOACRIVE Inhibition DME1693 XEOTICID XEO03648 XEO_NAME Indole-7-carboxylic acid DME1693 XEOTICID XEO03648 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO03648 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO03648 DESCRIPT Indole-7-carboxylic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03648 GENEFORM Protein DME1693 XEOTICID XEO03648 MOACRIVE Inhibition DME1693 XEOTICID XEO03649 XEO_NAME Indolicidin DME1693 XEOTICID XEO03649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03649 XEO_CLAS Peptide DME1693 XEOTICID XEO03649 DESCRIPT Indolicidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03649 GENEFORM Protein DME1693 XEOTICID XEO03649 MOACRIVE Inhibition DME1693 XEOTICID XEO03671 XEO_NAME Plant JCpep7 DME1693 XEOTICID XEO03671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03671 XEO_CLAS Peptide DME1693 XEOTICID XEO03671 DESCRIPT Plant JCpep7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1693 XEOTICID XEO03671 GENEFORM Protein DME1693 XEOTICID XEO03671 MOACRIVE Inhibition DME1693 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1693 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03672 XEO_CLAS Peptide DME1693 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 10 ug/ml) DME1693 XEOTICID XEO03672 GENEFORM Protein DME1693 XEOTICID XEO03672 MOACRIVE Inhibition DME1693 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1693 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03673 XEO_CLAS Peptide DME1693 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 15 ug/ml) DME1693 XEOTICID XEO03673 GENEFORM Protein DME1693 XEOTICID XEO03673 MOACRIVE Inhibition DME1693 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1693 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03674 XEO_CLAS Peptide DME1693 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 30 ug/ml) DME1693 XEOTICID XEO03674 GENEFORM Protein DME1693 XEOTICID XEO03674 MOACRIVE Inhibition DME1693 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1693 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03675 XEO_CLAS Peptide DME1693 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 23 microM) DME1693 XEOTICID XEO03675 GENEFORM Protein DME1693 XEOTICID XEO03675 MOACRIVE Inhibition DME1693 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1693 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03678 XEO_CLAS Peptide DME1693 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1693 XEOTICID XEO03678 GENEFORM Protein DME1693 XEOTICID XEO03678 MOACRIVE Inhibition DME1693 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1693 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03679 XEO_CLAS Peptide DME1693 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1693 XEOTICID XEO03679 GENEFORM Protein DME1693 XEOTICID XEO03679 MOACRIVE Inhibition DME1693 XEOTICID XEO03680 XEO_NAME CP-P derivative K17 DME1693 XEOTICID XEO03680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03680 XEO_CLAS Peptide DME1693 XEOTICID XEO03680 DESCRIPT CP-P derivative K17 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1693 XEOTICID XEO03680 GENEFORM Protein DME1693 XEOTICID XEO03680 MOACRIVE Inhibition DME1693 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1693 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03681 XEO_CLAS Peptide DME1693 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 20-40 microM) DME1693 XEOTICID XEO03681 GENEFORM Protein DME1693 XEOTICID XEO03681 MOACRIVE Inhibition DME1693 XEOTICID XEO03683 XEO_NAME CP-P derivative K6 DME1693 XEOTICID XEO03683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03683 XEO_CLAS Peptide DME1693 XEOTICID XEO03683 DESCRIPT CP-P derivative K6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1693 XEOTICID XEO03683 GENEFORM Protein DME1693 XEOTICID XEO03683 MOACRIVE Inhibition DME1693 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1693 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03684 XEO_CLAS Peptide DME1693 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 31 ug/ml) DME1693 XEOTICID XEO03684 GENEFORM Protein DME1693 XEOTICID XEO03684 MOACRIVE Inhibition DME1693 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1693 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03697 XEO_CLAS Peptide DME1693 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 25 microM) DME1693 XEOTICID XEO03697 GENEFORM Protein DME1693 XEOTICID XEO03697 MOACRIVE Inhibition DME1693 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1693 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03709 XEO_CLAS Peptide DME1693 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1693 XEOTICID XEO03709 GENEFORM Protein DME1693 XEOTICID XEO03709 MOACRIVE Inhibition DME1693 XEOTICID XEO03710 XEO_NAME knightine DME1693 XEOTICID XEO03710 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03710 XEO_CLAS Natural Product DME1693 XEOTICID XEO03710 DESCRIPT knightine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03710 GENEFORM Protein DME1693 XEOTICID XEO03710 MOACRIVE Inhibition DME1693 XEOTICID XEO03725 XEO_NAME CP-P derivative L10 DME1693 XEOTICID XEO03725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03725 XEO_CLAS Peptide DME1693 XEOTICID XEO03725 DESCRIPT CP-P derivative L10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1693 XEOTICID XEO03725 GENEFORM Protein DME1693 XEOTICID XEO03725 MOACRIVE Inhibition DME1693 XEOTICID XEO03739 XEO_NAME LlKmWn model peptide L4K3W4 DME1693 XEOTICID XEO03739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03739 XEO_CLAS Peptide DME1693 XEOTICID XEO03739 DESCRIPT LlKmWn model peptide L4K3W4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1693 XEOTICID XEO03739 GENEFORM Protein DME1693 XEOTICID XEO03739 MOACRIVE Inhibition DME1693 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1693 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03744 XEO_CLAS Peptide DME1693 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1693 XEOTICID XEO03744 GENEFORM Protein DME1693 XEOTICID XEO03744 MOACRIVE Inhibition DME1693 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1693 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03746 XEO_CLAS Peptide DME1693 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO03746 GENEFORM Protein DME1693 XEOTICID XEO03746 MOACRIVE Inhibition DME1693 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1693 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03747 XEO_CLAS Peptide DME1693 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1693 XEOTICID XEO03747 GENEFORM Protein DME1693 XEOTICID XEO03747 MOACRIVE Inhibition DME1693 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1693 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03748 XEO_CLAS Peptide DME1693 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO03748 GENEFORM Protein DME1693 XEOTICID XEO03748 MOACRIVE Inhibition DME1693 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1693 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03749 XEO_CLAS Peptide DME1693 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO03749 GENEFORM Protein DME1693 XEOTICID XEO03749 MOACRIVE Inhibition DME1693 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1693 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03750 XEO_CLAS Peptide DME1693 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO03750 GENEFORM Protein DME1693 XEOTICID XEO03750 MOACRIVE Inhibition DME1693 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1693 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03751 XEO_CLAS Peptide DME1693 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1693 XEOTICID XEO03751 GENEFORM Protein DME1693 XEOTICID XEO03751 MOACRIVE Inhibition DME1693 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1693 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03752 XEO_CLAS Peptide DME1693 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO03752 GENEFORM Protein DME1693 XEOTICID XEO03752 MOACRIVE Inhibition DME1693 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1693 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03753 XEO_CLAS Peptide DME1693 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 25 ug/ml) DME1693 XEOTICID XEO03753 GENEFORM Protein DME1693 XEOTICID XEO03753 MOACRIVE Inhibition DME1693 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1693 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03754 XEO_CLAS Peptide DME1693 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO03754 GENEFORM Protein DME1693 XEOTICID XEO03754 MOACRIVE Inhibition DME1693 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1693 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03755 XEO_CLAS Peptide DME1693 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO03755 GENEFORM Protein DME1693 XEOTICID XEO03755 MOACRIVE Inhibition DME1693 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1693 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03756 XEO_CLAS Peptide DME1693 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1693 XEOTICID XEO03756 GENEFORM Protein DME1693 XEOTICID XEO03756 MOACRIVE Inhibition DME1693 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1693 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03759 XEO_CLAS Peptide DME1693 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1693 XEOTICID XEO03759 GENEFORM Protein DME1693 XEOTICID XEO03759 MOACRIVE Inhibition DME1693 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1693 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03781 XEO_CLAS Peptide DME1693 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4.20 microM) DME1693 XEOTICID XEO03781 GENEFORM Protein DME1693 XEOTICID XEO03781 MOACRIVE Inhibition DME1693 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1693 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03782 XEO_CLAS Peptide DME1693 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 9.16 microM) DME1693 XEOTICID XEO03782 GENEFORM Protein DME1693 XEOTICID XEO03782 MOACRIVE Inhibition DME1693 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1693 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03783 XEO_CLAS Peptide DME1693 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.14 microM) DME1693 XEOTICID XEO03783 GENEFORM Protein DME1693 XEOTICID XEO03783 MOACRIVE Inhibition DME1693 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1693 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03784 XEO_CLAS Peptide DME1693 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4.45 microM) DME1693 XEOTICID XEO03784 GENEFORM Protein DME1693 XEOTICID XEO03784 MOACRIVE Inhibition DME1693 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1693 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03785 XEO_CLAS Peptide DME1693 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.23 microM) DME1693 XEOTICID XEO03785 GENEFORM Protein DME1693 XEOTICID XEO03785 MOACRIVE Inhibition DME1693 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1693 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03786 XEO_CLAS Peptide DME1693 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4.14 microM) DME1693 XEOTICID XEO03786 GENEFORM Protein DME1693 XEOTICID XEO03786 MOACRIVE Inhibition DME1693 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1693 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03787 XEO_CLAS Peptide DME1693 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.69 microM) DME1693 XEOTICID XEO03787 GENEFORM Protein DME1693 XEOTICID XEO03787 MOACRIVE Inhibition DME1693 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1693 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03788 XEO_CLAS Peptide DME1693 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.98 microM) DME1693 XEOTICID XEO03788 GENEFORM Protein DME1693 XEOTICID XEO03788 MOACRIVE Inhibition DME1693 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1693 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03790 XEO_CLAS Peptide DME1693 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.18 microM) DME1693 XEOTICID XEO03790 GENEFORM Protein DME1693 XEOTICID XEO03790 MOACRIVE Inhibition DME1693 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1693 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03791 XEO_CLAS Peptide DME1693 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.86 microM) DME1693 XEOTICID XEO03791 GENEFORM Protein DME1693 XEOTICID XEO03791 MOACRIVE Inhibition DME1693 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1693 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03792 XEO_CLAS Peptide DME1693 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.13 microM) DME1693 XEOTICID XEO03792 GENEFORM Protein DME1693 XEOTICID XEO03792 MOACRIVE Inhibition DME1693 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1693 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03793 XEO_CLAS Peptide DME1693 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 microM) DME1693 XEOTICID XEO03793 GENEFORM Protein DME1693 XEOTICID XEO03793 MOACRIVE Inhibition DME1693 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1693 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03797 XEO_CLAS Peptide DME1693 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.2 microM) DME1693 XEOTICID XEO03797 GENEFORM Protein DME1693 XEOTICID XEO03797 MOACRIVE Inhibition DME1693 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1693 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03810 XEO_CLAS Peptide DME1693 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03810 GENEFORM Protein DME1693 XEOTICID XEO03810 MOACRIVE Inhibition DME1693 XEOTICID XEO03815 XEO_NAME Blakea gracilis leaf extract DME1693 XEOTICID XEO03815 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03815 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03815 DESCRIPT Blakea gracilis leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03815 GENEFORM Protein DME1693 XEOTICID XEO03815 MOACRIVE Inhibition DME1693 XEOTICID XEO03816 XEO_NAME Carapa guianensis leaf extract DME1693 XEOTICID XEO03816 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03816 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03816 DESCRIPT Carapa guianensis leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03816 GENEFORM Protein DME1693 XEOTICID XEO03816 MOACRIVE Inhibition DME1693 XEOTICID XEO03817 XEO_NAME Cedrela fissilis leaf extract DME1693 XEOTICID XEO03817 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03817 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03817 DESCRIPT Cedrela fissilis leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03817 GENEFORM Protein DME1693 XEOTICID XEO03817 MOACRIVE Inhibition DME1693 XEOTICID XEO03818 XEO_NAME Cedrela tonduzii leaf extract DME1693 XEOTICID XEO03818 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03818 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03818 DESCRIPT Cedrela tonduzii leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03818 GENEFORM Protein DME1693 XEOTICID XEO03818 MOACRIVE Inhibition DME1693 XEOTICID XEO03819 XEO_NAME Chukrasia tabularis leaf extract DME1693 XEOTICID XEO03819 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03819 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03819 DESCRIPT Chukrasia tabularis leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03819 GENEFORM Protein DME1693 XEOTICID XEO03819 MOACRIVE Inhibition DME1693 XEOTICID XEO03822 XEO_NAME Conostegia rhodopetala leaf extract DME1693 XEOTICID XEO03822 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03822 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03822 DESCRIPT Conostegia rhodopetala leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03822 GENEFORM Protein DME1693 XEOTICID XEO03822 MOACRIVE Inhibition DME1693 XEOTICID XEO03823 XEO_NAME Cupania glabra leaf extract DME1693 XEOTICID XEO03823 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03823 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03823 DESCRIPT Cupania glabra leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03823 GENEFORM Protein DME1693 XEOTICID XEO03823 MOACRIVE Inhibition DME1693 XEOTICID XEO03824 XEO_NAME Guarea bullata leaf extract DME1693 XEOTICID XEO03824 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03824 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03824 DESCRIPT Guarea bullata leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03824 GENEFORM Protein DME1693 XEOTICID XEO03824 MOACRIVE Inhibition DME1693 XEOTICID XEO03825 XEO_NAME Guarea glabra leaf extract DME1693 XEOTICID XEO03825 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03825 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03825 DESCRIPT Guarea glabra leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03825 GENEFORM Protein DME1693 XEOTICID XEO03825 MOACRIVE Inhibition DME1693 XEOTICID XEO03826 XEO_NAME Guarea grandifolia leaf extract DME1693 XEOTICID XEO03826 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03826 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03826 DESCRIPT Guarea grandifolia leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03826 GENEFORM Protein DME1693 XEOTICID XEO03826 MOACRIVE Inhibition DME1693 XEOTICID XEO03827 XEO_NAME Guarea guidonia leaf extract DME1693 XEOTICID XEO03827 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03827 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03827 DESCRIPT Guarea guidonia leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03827 GENEFORM Protein DME1693 XEOTICID XEO03827 MOACRIVE Inhibition DME1693 XEOTICID XEO03828 XEO_NAME Guarea pterorhachis leaf extract DME1693 XEOTICID XEO03828 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03828 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03828 DESCRIPT Guarea pterorhachis leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03828 GENEFORM Protein DME1693 XEOTICID XEO03828 MOACRIVE Inhibition DME1693 XEOTICID XEO03829 XEO_NAME Leandra melanodesma leaf extract DME1693 XEOTICID XEO03829 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03829 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03829 DESCRIPT Leandra melanodesma leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03829 GENEFORM Protein DME1693 XEOTICID XEO03829 MOACRIVE Inhibition DME1693 XEOTICID XEO03830 XEO_NAME Mangifera indica leaf extract DME1693 XEOTICID XEO03830 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03830 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03830 DESCRIPT Mangifera indica leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03830 GENEFORM Protein DME1693 XEOTICID XEO03830 MOACRIVE Inhibition DME1693 XEOTICID XEO03831 XEO_NAME Miconia longifolia leaf extract DME1693 XEOTICID XEO03831 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03831 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03831 DESCRIPT Miconia longifolia leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03831 GENEFORM Protein DME1693 XEOTICID XEO03831 MOACRIVE Inhibition DME1693 XEOTICID XEO03832 XEO_NAME Miconia pittieri leaf extract DME1693 XEOTICID XEO03832 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03832 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03832 DESCRIPT Miconia pittieri leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03832 GENEFORM Protein DME1693 XEOTICID XEO03832 MOACRIVE Inhibition DME1693 XEOTICID XEO03833 XEO_NAME Piper decurrens leaf extract DME1693 XEOTICID XEO03833 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03833 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03833 DESCRIPT Piper decurrens leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03833 GENEFORM Protein DME1693 XEOTICID XEO03833 MOACRIVE Inhibition DME1693 XEOTICID XEO03834 XEO_NAME Piper pseudolindenii leaf extract DME1693 XEOTICID XEO03834 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03834 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03834 DESCRIPT Piper pseudolindenii leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03834 GENEFORM Protein DME1693 XEOTICID XEO03834 MOACRIVE Inhibition DME1693 XEOTICID XEO03835 XEO_NAME Piper reticulatum leaf extract DME1693 XEOTICID XEO03835 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03835 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03835 DESCRIPT Piper reticulatum leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03835 GENEFORM Protein DME1693 XEOTICID XEO03835 MOACRIVE Inhibition DME1693 XEOTICID XEO03836 XEO_NAME Piper urostachyum leaf extract DME1693 XEOTICID XEO03836 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03836 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03836 DESCRIPT Piper urostachyum leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03836 GENEFORM Protein DME1693 XEOTICID XEO03836 MOACRIVE Inhibition DME1693 XEOTICID XEO03838 XEO_NAME Ruptiliocarpon caracolito leaf extract DME1693 XEOTICID XEO03838 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03838 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03838 DESCRIPT Ruptiliocarpon caracolito leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03838 GENEFORM Protein DME1693 XEOTICID XEO03838 MOACRIVE Inhibition DME1693 XEOTICID XEO03839 XEO_NAME Simarouba amara leaf extract DME1693 XEOTICID XEO03839 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03839 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03839 DESCRIPT Simarouba amara leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03839 GENEFORM Protein DME1693 XEOTICID XEO03839 MOACRIVE Inhibition DME1693 XEOTICID XEO03840 XEO_NAME Simarouba glauca leaf extract DME1693 XEOTICID XEO03840 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03840 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03840 DESCRIPT Simarouba glauca leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03840 GENEFORM Protein DME1693 XEOTICID XEO03840 MOACRIVE Inhibition DME1693 XEOTICID XEO03841 XEO_NAME Swietenia macrophylla leaf extract DME1693 XEOTICID XEO03841 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03841 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03841 DESCRIPT Swietenia macrophylla leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03841 GENEFORM Protein DME1693 XEOTICID XEO03841 MOACRIVE Inhibition DME1693 XEOTICID XEO03842 XEO_NAME Swietenia mahogani leaf extract DME1693 XEOTICID XEO03842 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03842 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03842 DESCRIPT Swietenia mahogani leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03842 GENEFORM Protein DME1693 XEOTICID XEO03842 MOACRIVE Inhibition DME1693 XEOTICID XEO03843 XEO_NAME Trichilia martiana leaf extract DME1693 XEOTICID XEO03843 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03843 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03843 DESCRIPT Trichilia martiana leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03843 GENEFORM Protein DME1693 XEOTICID XEO03843 MOACRIVE Inhibition DME1693 XEOTICID XEO03844 XEO_NAME Trichilia pleeana leaf extract DME1693 XEOTICID XEO03844 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03844 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03844 DESCRIPT Trichilia pleeana leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03844 GENEFORM Protein DME1693 XEOTICID XEO03844 MOACRIVE Inhibition DME1693 XEOTICID XEO03845 XEO_NAME Trichilia septentrionalis leaf extract DME1693 XEOTICID XEO03845 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03845 XEO_CLAS Plant Extract DME1693 XEOTICID XEO03845 DESCRIPT Trichilia septentrionalis leaf extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03845 GENEFORM Protein DME1693 XEOTICID XEO03845 MOACRIVE Inhibition DME1693 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1693 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03853 XEO_CLAS Peptide DME1693 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 microM) DME1693 XEOTICID XEO03853 GENEFORM Protein DME1693 XEOTICID XEO03853 MOACRIVE Inhibition DME1693 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1693 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03904 XEO_CLAS Peptide DME1693 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO03904 GENEFORM Protein DME1693 XEOTICID XEO03904 MOACRIVE Inhibition DME1693 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1693 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03905 XEO_CLAS Peptide DME1693 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO03905 GENEFORM Protein DME1693 XEOTICID XEO03905 MOACRIVE Inhibition DME1693 XEOTICID XEO03911 XEO_NAME Lipoic acid DME1693 XEOTICID XEO03911 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO03911 XEO_CLAS Drug in Phase 2 Clinical Trial DME1693 XEOTICID XEO03911 DESCRIPT Lipoic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03911 GENEFORM Protein DME1693 XEOTICID XEO03911 MOACRIVE Inhibition DME1693 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1693 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03928 XEO_CLAS Peptide DME1693 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 microM) DME1693 XEOTICID XEO03928 GENEFORM Protein DME1693 XEOTICID XEO03928 MOACRIVE Inhibition DME1693 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1693 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03933 XEO_CLAS Peptide DME1693 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 22.7 microM) DME1693 XEOTICID XEO03933 GENEFORM Protein DME1693 XEOTICID XEO03933 MOACRIVE Inhibition DME1693 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1693 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03934 XEO_CLAS Peptide DME1693 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 26.9 microM) DME1693 XEOTICID XEO03934 GENEFORM Protein DME1693 XEOTICID XEO03934 MOACRIVE Inhibition DME1693 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1693 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03935 XEO_CLAS Peptide DME1693 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 19.0 microM) DME1693 XEOTICID XEO03935 GENEFORM Protein DME1693 XEOTICID XEO03935 MOACRIVE Inhibition DME1693 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1693 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03936 XEO_CLAS Peptide DME1693 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 100 microM) DME1693 XEOTICID XEO03936 GENEFORM Protein DME1693 XEOTICID XEO03936 MOACRIVE Inhibition DME1693 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1693 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03937 XEO_CLAS Peptide DME1693 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 23.3 microM) DME1693 XEOTICID XEO03937 GENEFORM Protein DME1693 XEOTICID XEO03937 MOACRIVE Inhibition DME1693 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1693 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03938 XEO_CLAS Peptide DME1693 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 22.5 microM) DME1693 XEOTICID XEO03938 GENEFORM Protein DME1693 XEOTICID XEO03938 MOACRIVE Inhibition DME1693 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1693 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03939 XEO_CLAS Peptide DME1693 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 26.1 microM) DME1693 XEOTICID XEO03939 GENEFORM Protein DME1693 XEOTICID XEO03939 MOACRIVE Inhibition DME1693 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1693 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03940 XEO_CLAS Peptide DME1693 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 100 microM) DME1693 XEOTICID XEO03940 GENEFORM Protein DME1693 XEOTICID XEO03940 MOACRIVE Inhibition DME1693 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1693 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03941 XEO_CLAS Peptide DME1693 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 23.1 microM) DME1693 XEOTICID XEO03941 GENEFORM Protein DME1693 XEOTICID XEO03941 MOACRIVE Inhibition DME1693 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1693 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03943 XEO_CLAS Peptide DME1693 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 27.1 microM) DME1693 XEOTICID XEO03943 GENEFORM Protein DME1693 XEOTICID XEO03943 MOACRIVE Inhibition DME1693 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1693 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03944 XEO_CLAS Peptide DME1693 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 26.1 microM) DME1693 XEOTICID XEO03944 GENEFORM Protein DME1693 XEOTICID XEO03944 MOACRIVE Inhibition DME1693 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1693 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03945 XEO_CLAS Peptide DME1693 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 100 microM) DME1693 XEOTICID XEO03945 GENEFORM Protein DME1693 XEOTICID XEO03945 MOACRIVE Inhibition DME1693 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1693 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03947 XEO_CLAS Peptide DME1693 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 22.5 microM) DME1693 XEOTICID XEO03947 GENEFORM Protein DME1693 XEOTICID XEO03947 MOACRIVE Inhibition DME1693 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1693 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03948 XEO_CLAS Peptide DME1693 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 75 microM) DME1693 XEOTICID XEO03948 GENEFORM Protein DME1693 XEOTICID XEO03948 MOACRIVE Inhibition DME1693 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1693 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03950 XEO_CLAS Peptide DME1693 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 78.7 microM) DME1693 XEOTICID XEO03950 GENEFORM Protein DME1693 XEOTICID XEO03950 MOACRIVE Inhibition DME1693 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1693 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03951 XEO_CLAS Peptide DME1693 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 86.7 microM) DME1693 XEOTICID XEO03951 GENEFORM Protein DME1693 XEOTICID XEO03951 MOACRIVE Inhibition DME1693 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1693 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03952 XEO_CLAS Peptide DME1693 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 76.3 microM) DME1693 XEOTICID XEO03952 GENEFORM Protein DME1693 XEOTICID XEO03952 MOACRIVE Inhibition DME1693 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1693 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03958 XEO_CLAS Peptide DME1693 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03958 GENEFORM Protein DME1693 XEOTICID XEO03958 MOACRIVE Inhibition DME1693 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1693 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1693 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03968 GENEFORM Protein DME1693 XEOTICID XEO03968 MOACRIVE Inhibition DME1693 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1693 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO03985 XEO_CLAS Peptide DME1693 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1693 XEOTICID XEO03985 GENEFORM Protein DME1693 XEOTICID XEO03985 MOACRIVE Inhibition DME1693 XEOTICID XEO03988 XEO_NAME Malabaricone C DME1693 XEOTICID XEO03988 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO03988 XEO_CLAS Natural Product DME1693 XEOTICID XEO03988 DESCRIPT Malabaricone C inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO03988 GENEFORM Protein DME1693 XEOTICID XEO03988 MOACRIVE Inhibition DME1693 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1693 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04000 XEO_CLAS Peptide DME1693 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO04000 GENEFORM Protein DME1693 XEOTICID XEO04000 MOACRIVE Inhibition DME1693 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1693 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04001 XEO_CLAS Peptide DME1693 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50 microM) DME1693 XEOTICID XEO04001 GENEFORM Protein DME1693 XEOTICID XEO04001 MOACRIVE Inhibition DME1693 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1693 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04039 XEO_CLAS Peptide DME1693 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.5 microM) DME1693 XEOTICID XEO04039 GENEFORM Protein DME1693 XEOTICID XEO04039 MOACRIVE Inhibition DME1693 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1693 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04051 XEO_CLAS Peptide DME1693 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.31-0.63 microM) DME1693 XEOTICID XEO04051 GENEFORM Protein DME1693 XEOTICID XEO04051 MOACRIVE Inhibition DME1693 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1693 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04052 XEO_CLAS Peptide DME1693 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04052 GENEFORM Protein DME1693 XEOTICID XEO04052 MOACRIVE Inhibition DME1693 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1693 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04053 XEO_CLAS Peptide DME1693 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.16-0.31 microM) DME1693 XEOTICID XEO04053 GENEFORM Protein DME1693 XEOTICID XEO04053 MOACRIVE Inhibition DME1693 XEOTICID XEO04055 XEO_NAME Melectin DME1693 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04055 XEO_CLAS Peptide DME1693 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 18.5 microM) DME1693 XEOTICID XEO04055 GENEFORM Protein DME1693 XEOTICID XEO04055 MOACRIVE Inhibition DME1693 XEOTICID XEO04057 XEO_NAME Melittin DME1693 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04057 XEO_CLAS Peptide DME1693 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3 microM) DME1693 XEOTICID XEO04057 GENEFORM Protein DME1693 XEOTICID XEO04057 MOACRIVE Inhibition DME1693 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1693 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04061 XEO_CLAS Peptide DME1693 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 17.3 microM) DME1693 XEOTICID XEO04061 GENEFORM Protein DME1693 XEOTICID XEO04061 MOACRIVE Inhibition DME1693 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1693 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04062 XEO_CLAS Peptide DME1693 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 77 microM) DME1693 XEOTICID XEO04062 GENEFORM Protein DME1693 XEOTICID XEO04062 MOACRIVE Inhibition DME1693 XEOTICID XEO04073 XEO_NAME meta-toluidine DME1693 XEOTICID XEO04073 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO04073 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO04073 DESCRIPT meta-toluidine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04073 GENEFORM Protein DME1693 XEOTICID XEO04073 MOACRIVE Inhibition DME1693 XEOTICID XEO04076 XEO_NAME methanesulfonylbenzene DME1693 XEOTICID XEO04076 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO04076 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO04076 DESCRIPT methanesulfonylbenzene inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04076 GENEFORM Protein DME1693 XEOTICID XEO04076 MOACRIVE Inhibition DME1693 XEOTICID XEO04078 XEO_NAME Actinomycetes NIO 10058 methanol extract DME1693 XEOTICID XEO04078 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04078 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO04078 DESCRIPT Actinomycetes NIO 10058 methanol extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04078 GENEFORM Protein DME1693 XEOTICID XEO04078 MOACRIVE Inhibition DME1693 XEOTICID XEO04079 XEO_NAME Actinomycetes NIO 10068 methanol extract DME1693 XEOTICID XEO04079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04079 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO04079 DESCRIPT Actinomycetes NIO 10068 methanol extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04079 GENEFORM Protein DME1693 XEOTICID XEO04079 MOACRIVE Inhibition DME1693 XEOTICID XEO04080 XEO_NAME Actinomycetes NIO 10090 methanol extract DME1693 XEOTICID XEO04080 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04080 XEO_CLAS Bacterial Extract DME1693 XEOTICID XEO04080 DESCRIPT Actinomycetes NIO 10090 methanol extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04080 GENEFORM Protein DME1693 XEOTICID XEO04080 MOACRIVE Inhibition DME1693 XEOTICID XEO04084 XEO_NAME Kalanchoe blossfeldiana leaf methanol extract DME1693 XEOTICID XEO04084 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04084 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04084 DESCRIPT Kalanchoe blossfeldiana leaf methanol extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04084 GENEFORM Protein DME1693 XEOTICID XEO04084 MOACRIVE Inhibition DME1693 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1693 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04087 GENEFORM Protein DME1693 XEOTICID XEO04087 MOACRIVE Inhibition DME1693 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1693 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04089 GENEFORM Protein DME1693 XEOTICID XEO04089 MOACRIVE Inhibition DME1693 XEOTICID XEO04106 XEO_NAME Methyl gallate DME1693 XEOTICID XEO04106 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO04106 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO04106 DESCRIPT Methyl gallate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04106 GENEFORM Protein DME1693 XEOTICID XEO04106 MOACRIVE Inhibition DME1693 XEOTICID XEO04107 XEO_NAME Methyl indole-7-carboxylate DME1693 XEOTICID XEO04107 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO04107 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO04107 DESCRIPT Methyl indole-7-carboxylate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04107 GENEFORM Protein DME1693 XEOTICID XEO04107 MOACRIVE Inhibition DME1693 XEOTICID XEO04109 XEO_NAME Micafungin DME1693 XEOTICID XEO04109 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO04109 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO04109 DESCRIPT Micafungin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04109 GENEFORM Protein DME1693 XEOTICID XEO04109 MOACRIVE Inhibition DME1693 XEOTICID XEO04114 XEO_NAME Microcin L DME1693 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04114 XEO_CLAS Peptide DME1693 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04114 GENEFORM Protein DME1693 XEOTICID XEO04114 MOACRIVE Inhibition DME1693 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1693 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04121 XEO_CLAS Peptide DME1693 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04121 GENEFORM Protein DME1693 XEOTICID XEO04121 MOACRIVE Inhibition DME1693 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1693 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04122 XEO_CLAS Peptide DME1693 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 5.02-10.05 microM) DME1693 XEOTICID XEO04122 GENEFORM Protein DME1693 XEOTICID XEO04122 MOACRIVE Inhibition DME1693 XEOTICID XEO04123 XEO_NAME Modified defensin DME1693 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04123 XEO_CLAS Peptide DME1693 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1693 XEOTICID XEO04123 GENEFORM Protein DME1693 XEOTICID XEO04123 MOACRIVE Inhibition DME1693 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1693 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04128 XEO_CLAS Peptide DME1693 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.81 microM) DME1693 XEOTICID XEO04128 GENEFORM Protein DME1693 XEOTICID XEO04128 MOACRIVE Inhibition DME1693 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1693 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04142 XEO_CLAS Peptide DME1693 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8-16 microM) DME1693 XEOTICID XEO04142 GENEFORM Protein DME1693 XEOTICID XEO04142 MOACRIVE Inhibition DME1693 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1693 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04146 XEO_CLAS Peptide DME1693 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04146 GENEFORM Protein DME1693 XEOTICID XEO04146 MOACRIVE Inhibition DME1693 XEOTICID XEO04149 XEO_NAME Mucroporin DME1693 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04149 XEO_CLAS Peptide DME1693 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 100 ug/ml) DME1693 XEOTICID XEO04149 GENEFORM Protein DME1693 XEOTICID XEO04149 MOACRIVE Inhibition DME1693 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1693 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04158 XEO_CLAS Peptide DME1693 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1 microM) DME1693 XEOTICID XEO04158 GENEFORM Protein DME1693 XEOTICID XEO04158 MOACRIVE Inhibition DME1693 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1693 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04159 XEO_CLAS Peptide DME1693 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1 microM) DME1693 XEOTICID XEO04159 GENEFORM Protein DME1693 XEOTICID XEO04159 MOACRIVE Inhibition DME1693 XEOTICID XEO04162 XEO_NAME Myristic acid DME1693 XEOTICID XEO04162 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO04162 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO04162 DESCRIPT Myristic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04162 GENEFORM Protein DME1693 XEOTICID XEO04162 MOACRIVE Inhibition DME1693 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1693 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04168 XEO_CLAS Peptide DME1693 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 25.0 microM) DME1693 XEOTICID XEO04168 GENEFORM Protein DME1693 XEOTICID XEO04168 MOACRIVE Inhibition DME1693 XEOTICID XEO04172 XEO_NAME Myxinidin DME1693 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04172 XEO_CLAS Peptide DME1693 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04172 GENEFORM Protein DME1693 XEOTICID XEO04172 MOACRIVE Inhibition DME1693 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1693 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04177 XEO_CLAS Peptide DME1693 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4.1 microM) DME1693 XEOTICID XEO04177 GENEFORM Protein DME1693 XEOTICID XEO04177 MOACRIVE Inhibition DME1693 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1693 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04178 XEO_CLAS Peptide DME1693 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.7 microM) DME1693 XEOTICID XEO04178 GENEFORM Protein DME1693 XEOTICID XEO04178 MOACRIVE Inhibition DME1693 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1693 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04179 XEO_CLAS Peptide DME1693 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 40 microM) DME1693 XEOTICID XEO04179 GENEFORM Protein DME1693 XEOTICID XEO04179 MOACRIVE Inhibition DME1693 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1693 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04180 XEO_CLAS Peptide DME1693 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 45 microM) DME1693 XEOTICID XEO04180 GENEFORM Protein DME1693 XEOTICID XEO04180 MOACRIVE Inhibition DME1693 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1693 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04181 XEO_CLAS Peptide DME1693 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 35 microM) DME1693 XEOTICID XEO04181 GENEFORM Protein DME1693 XEOTICID XEO04181 MOACRIVE Inhibition DME1693 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1693 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04182 XEO_CLAS Peptide DME1693 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 35 microM) DME1693 XEOTICID XEO04182 GENEFORM Protein DME1693 XEOTICID XEO04182 MOACRIVE Inhibition DME1693 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1693 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04183 XEO_CLAS Peptide DME1693 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 18 microM) DME1693 XEOTICID XEO04183 GENEFORM Protein DME1693 XEOTICID XEO04183 MOACRIVE Inhibition DME1693 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1693 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04184 XEO_CLAS Peptide DME1693 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.9 microM) DME1693 XEOTICID XEO04184 GENEFORM Protein DME1693 XEOTICID XEO04184 MOACRIVE Inhibition DME1693 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1693 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04185 XEO_CLAS Peptide DME1693 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04185 GENEFORM Protein DME1693 XEOTICID XEO04185 MOACRIVE Inhibition DME1693 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1693 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04206 XEO_CLAS Peptide DME1693 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1693 XEOTICID XEO04206 GENEFORM Protein DME1693 XEOTICID XEO04206 MOACRIVE Inhibition DME1693 XEOTICID XEO04213 XEO_NAME CP-P derivative N18 DME1693 XEOTICID XEO04213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04213 XEO_CLAS Peptide DME1693 XEOTICID XEO04213 DESCRIPT CP-P derivative N18 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1693 XEOTICID XEO04213 GENEFORM Protein DME1693 XEOTICID XEO04213 MOACRIVE Inhibition DME1693 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1693 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04214 XEO_CLAS Peptide DME1693 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1693 XEOTICID XEO04214 GENEFORM Protein DME1693 XEOTICID XEO04214 MOACRIVE Inhibition DME1693 XEOTICID XEO04215 XEO_NAME CP-P derivative N20 DME1693 XEOTICID XEO04215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04215 XEO_CLAS Peptide DME1693 XEOTICID XEO04215 DESCRIPT CP-P derivative N20 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.25 ug/ml) DME1693 XEOTICID XEO04215 GENEFORM Protein DME1693 XEOTICID XEO04215 MOACRIVE Inhibition DME1693 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1693 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04216 XEO_CLAS Peptide DME1693 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1693 XEOTICID XEO04216 GENEFORM Protein DME1693 XEOTICID XEO04216 MOACRIVE Inhibition DME1693 XEOTICID XEO04217 XEO_NAME CP-P derivative N3 DME1693 XEOTICID XEO04217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04217 XEO_CLAS Peptide DME1693 XEOTICID XEO04217 DESCRIPT CP-P derivative N3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1693 XEOTICID XEO04217 GENEFORM Protein DME1693 XEOTICID XEO04217 MOACRIVE Inhibition DME1693 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1693 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04218 XEO_CLAS Peptide DME1693 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3.125 microM) DME1693 XEOTICID XEO04218 GENEFORM Protein DME1693 XEOTICID XEO04218 MOACRIVE Inhibition DME1693 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1693 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04219 XEO_CLAS Peptide DME1693 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1693 XEOTICID XEO04219 GENEFORM Protein DME1693 XEOTICID XEO04219 MOACRIVE Inhibition DME1693 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1693 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04220 XEO_CLAS Peptide DME1693 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1693 XEOTICID XEO04220 GENEFORM Protein DME1693 XEOTICID XEO04220 MOACRIVE Inhibition DME1693 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1693 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04221 XEO_CLAS Peptide DME1693 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3.125 microM) DME1693 XEOTICID XEO04221 GENEFORM Protein DME1693 XEOTICID XEO04221 MOACRIVE Inhibition DME1693 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1693 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04222 XEO_CLAS Peptide DME1693 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3.125 microM) DME1693 XEOTICID XEO04222 GENEFORM Protein DME1693 XEOTICID XEO04222 MOACRIVE Inhibition DME1693 XEOTICID XEO04223 XEO_NAME CP-P derivative N7 DME1693 XEOTICID XEO04223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04223 XEO_CLAS Peptide DME1693 XEOTICID XEO04223 DESCRIPT CP-P derivative N7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 ug/ml) DME1693 XEOTICID XEO04223 GENEFORM Protein DME1693 XEOTICID XEO04223 MOACRIVE Inhibition DME1693 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1693 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04241 XEO_CLAS Peptide DME1693 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04241 GENEFORM Protein DME1693 XEOTICID XEO04241 MOACRIVE Inhibition DME1693 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1693 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04242 XEO_CLAS Peptide DME1693 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04242 GENEFORM Protein DME1693 XEOTICID XEO04242 MOACRIVE Inhibition DME1693 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1693 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04249 XEO_CLAS Peptide DME1693 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 500 ug/ml) DME1693 XEOTICID XEO04249 GENEFORM Protein DME1693 XEOTICID XEO04249 MOACRIVE Inhibition DME1693 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1693 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04256 XEO_CLAS Peptide DME1693 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04256 GENEFORM Protein DME1693 XEOTICID XEO04256 MOACRIVE Inhibition DME1693 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1693 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04259 XEO_CLAS Peptide DME1693 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04259 GENEFORM Protein DME1693 XEOTICID XEO04259 MOACRIVE Inhibition DME1693 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1693 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04261 XEO_CLAS Peptide DME1693 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04261 GENEFORM Protein DME1693 XEOTICID XEO04261 MOACRIVE Inhibition DME1693 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1693 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04265 XEO_CLAS Peptide DME1693 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04265 GENEFORM Protein DME1693 XEOTICID XEO04265 MOACRIVE Inhibition DME1693 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1693 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04268 XEO_CLAS Peptide DME1693 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04268 GENEFORM Protein DME1693 XEOTICID XEO04268 MOACRIVE Inhibition DME1693 XEOTICID XEO04276 XEO_NAME Nigroain-B1 DME1693 XEOTICID XEO04276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04276 XEO_CLAS Peptide DME1693 XEOTICID XEO04276 DESCRIPT Nigroain-B1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 25.00 ug/ml) DME1693 XEOTICID XEO04276 GENEFORM Protein DME1693 XEOTICID XEO04276 MOACRIVE Inhibition DME1693 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1693 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04277 XEO_CLAS Peptide DME1693 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 55.00 ug/ml) DME1693 XEOTICID XEO04277 GENEFORM Protein DME1693 XEOTICID XEO04277 MOACRIVE Inhibition DME1693 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1693 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04281 XEO_CLAS Peptide DME1693 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 25.00 ug/ml) DME1693 XEOTICID XEO04281 GENEFORM Protein DME1693 XEOTICID XEO04281 MOACRIVE Inhibition DME1693 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1693 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04309 XEO_CLAS Peptide DME1693 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 7 microM) DME1693 XEOTICID XEO04309 GENEFORM Protein DME1693 XEOTICID XEO04309 MOACRIVE Inhibition DME1693 XEOTICID XEO04325 XEO_NAME Nodakenetin DME1693 XEOTICID XEO04325 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04325 XEO_CLAS Natural Product DME1693 XEOTICID XEO04325 DESCRIPT Nodakenetin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04325 GENEFORM Protein DME1693 XEOTICID XEO04325 MOACRIVE Inhibition DME1693 XEOTICID XEO04331 XEO_NAME Norspermidine DME1693 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04331 GENEFORM Protein DME1693 XEOTICID XEO04331 MOACRIVE Inhibition DME1693 XEOTICID XEO04333 XEO_NAME Novispirin G-10 DME1693 XEOTICID XEO04333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04333 XEO_CLAS Peptide DME1693 XEOTICID XEO04333 DESCRIPT Novispirin G-10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.11-12.7 ug/ml) DME1693 XEOTICID XEO04333 GENEFORM Protein DME1693 XEOTICID XEO04333 MOACRIVE Inhibition DME1693 XEOTICID XEO04334 XEO_NAME Novispirin T-7 DME1693 XEOTICID XEO04334 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04334 XEO_CLAS Peptide DME1693 XEOTICID XEO04334 DESCRIPT Novispirin T-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.26-27.8 ug/ml) DME1693 XEOTICID XEO04334 GENEFORM Protein DME1693 XEOTICID XEO04334 MOACRIVE Inhibition DME1693 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1693 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04335 XEO_CLAS Peptide DME1693 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1693 XEOTICID XEO04335 GENEFORM Protein DME1693 XEOTICID XEO04335 MOACRIVE Inhibition DME1693 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1693 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04336 XEO_CLAS Peptide DME1693 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1693 XEOTICID XEO04336 GENEFORM Protein DME1693 XEOTICID XEO04336 MOACRIVE Inhibition DME1693 XEOTICID XEO04337 XEO_NAME NRC-16 peptide DME1693 XEOTICID XEO04337 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04337 XEO_CLAS Peptide DME1693 XEOTICID XEO04337 DESCRIPT NRC-16 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04337 GENEFORM Protein DME1693 XEOTICID XEO04337 MOACRIVE Inhibition DME1693 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1693 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04338 XEO_CLAS Peptide DME1693 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1693 XEOTICID XEO04338 GENEFORM Protein DME1693 XEOTICID XEO04338 MOACRIVE Inhibition DME1693 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1693 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04339 XEO_CLAS Peptide DME1693 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1693 XEOTICID XEO04339 GENEFORM Protein DME1693 XEOTICID XEO04339 MOACRIVE Inhibition DME1693 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1693 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04340 XEO_CLAS Peptide DME1693 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1693 XEOTICID XEO04340 GENEFORM Protein DME1693 XEOTICID XEO04340 MOACRIVE Inhibition DME1693 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1693 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04348 XEO_CLAS Peptide DME1693 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 80 microM) DME1693 XEOTICID XEO04348 GENEFORM Protein DME1693 XEOTICID XEO04348 MOACRIVE Inhibition DME1693 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1693 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04349 XEO_CLAS Peptide DME1693 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 100 microM) DME1693 XEOTICID XEO04349 GENEFORM Protein DME1693 XEOTICID XEO04349 MOACRIVE Inhibition DME1693 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1693 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04364 XEO_CLAS Peptide DME1693 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 microM) DME1693 XEOTICID XEO04364 GENEFORM Protein DME1693 XEOTICID XEO04364 MOACRIVE Inhibition DME1693 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1693 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04384 XEO_CLAS Peptide DME1693 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1693 XEOTICID XEO04384 GENEFORM Protein DME1693 XEOTICID XEO04384 MOACRIVE Inhibition DME1693 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1693 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04385 XEO_CLAS Peptide DME1693 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 5 ug/ml) DME1693 XEOTICID XEO04385 GENEFORM Protein DME1693 XEOTICID XEO04385 MOACRIVE Inhibition DME1693 XEOTICID XEO04386 XEO_NAME Syzygium aromaticum oil DME1693 XEOTICID XEO04386 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04386 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04386 DESCRIPT Syzygium aromaticum oil inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04386 GENEFORM Protein DME1693 XEOTICID XEO04386 MOACRIVE Inhibition DME1693 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1693 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04399 XEO_CLAS Peptide DME1693 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1693 XEOTICID XEO04399 GENEFORM Protein DME1693 XEOTICID XEO04399 MOACRIVE Inhibition DME1693 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1693 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04400 XEO_CLAS Peptide DME1693 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1693 XEOTICID XEO04400 GENEFORM Protein DME1693 XEOTICID XEO04400 MOACRIVE Inhibition DME1693 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1693 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04401 XEO_CLAS Peptide DME1693 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1693 XEOTICID XEO04401 GENEFORM Protein DME1693 XEOTICID XEO04401 MOACRIVE Inhibition DME1693 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1693 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04402 XEO_CLAS Peptide DME1693 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1693 XEOTICID XEO04402 GENEFORM Protein DME1693 XEOTICID XEO04402 MOACRIVE Inhibition DME1693 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1693 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04403 XEO_CLAS Peptide DME1693 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1693 XEOTICID XEO04403 GENEFORM Protein DME1693 XEOTICID XEO04403 MOACRIVE Inhibition DME1693 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1693 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04404 XEO_CLAS Peptide DME1693 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3 ug/ml) DME1693 XEOTICID XEO04404 GENEFORM Protein DME1693 XEOTICID XEO04404 MOACRIVE Inhibition DME1693 XEOTICID XEO04416 XEO_NAME Ovispirin-1 DME1693 XEOTICID XEO04416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04416 XEO_CLAS Peptide DME1693 XEOTICID XEO04416 DESCRIPT Ovispirin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.7-5.6 ug/ml) DME1693 XEOTICID XEO04416 GENEFORM Protein DME1693 XEOTICID XEO04416 MOACRIVE Inhibition DME1693 XEOTICID XEO04417 XEO_NAME Ovispirin-2 DME1693 XEOTICID XEO04417 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04417 XEO_CLAS Peptide DME1693 XEOTICID XEO04417 DESCRIPT Ovispirin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.03-16 ug/ml) DME1693 XEOTICID XEO04417 GENEFORM Protein DME1693 XEOTICID XEO04417 MOACRIVE Inhibition DME1693 XEOTICID XEO04418 XEO_NAME Ovispirin-3 DME1693 XEOTICID XEO04418 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04418 XEO_CLAS Peptide DME1693 XEOTICID XEO04418 DESCRIPT Ovispirin-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1-8 ug/ml) DME1693 XEOTICID XEO04418 GENEFORM Protein DME1693 XEOTICID XEO04418 MOACRIVE Inhibition DME1693 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1693 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04426 XEO_CLAS Peptide DME1693 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 microM) DME1693 XEOTICID XEO04426 GENEFORM Protein DME1693 XEOTICID XEO04426 MOACRIVE Inhibition DME1693 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1693 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04430 XEO_CLAS Peptide DME1693 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.56 microM) DME1693 XEOTICID XEO04430 GENEFORM Protein DME1693 XEOTICID XEO04430 MOACRIVE Inhibition DME1693 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1693 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04438 GENEFORM Protein DME1693 XEOTICID XEO04438 MOACRIVE Inhibition DME1693 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1693 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04444 XEO_CLAS Peptide DME1693 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 33 microM) DME1693 XEOTICID XEO04444 GENEFORM Protein DME1693 XEOTICID XEO04444 MOACRIVE Inhibition DME1693 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1693 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04461 XEO_CLAS Peptide DME1693 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 20.8 microM) DME1693 XEOTICID XEO04461 GENEFORM Protein DME1693 XEOTICID XEO04461 MOACRIVE Inhibition DME1693 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1693 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04462 XEO_CLAS Peptide DME1693 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 38.2 microM) DME1693 XEOTICID XEO04462 GENEFORM Protein DME1693 XEOTICID XEO04462 MOACRIVE Inhibition DME1693 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1693 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04463 XEO_CLAS Peptide DME1693 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04463 GENEFORM Protein DME1693 XEOTICID XEO04463 MOACRIVE Inhibition DME1693 XEOTICID XEO04468 XEO_NAME Papillosin DME1693 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04468 XEO_CLAS Peptide DME1693 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04468 GENEFORM Protein DME1693 XEOTICID XEO04468 MOACRIVE Inhibition DME1693 XEOTICID XEO04469 XEO_NAME para-anisidine DME1693 XEOTICID XEO04469 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO04469 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO04469 DESCRIPT para-anisidine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04469 GENEFORM Protein DME1693 XEOTICID XEO04469 MOACRIVE Inhibition DME1693 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1693 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04471 XEO_CLAS Peptide DME1693 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6.3 microM) DME1693 XEOTICID XEO04471 GENEFORM Protein DME1693 XEOTICID XEO04471 MOACRIVE Inhibition DME1693 XEOTICID XEO04473 XEO_NAME para-ethylaniline DME1693 XEOTICID XEO04473 XEO_TYPE Health or Environmental Toxicant(s) DME1693 XEOTICID XEO04473 XEO_CLAS Acute Toxic Substance DME1693 XEOTICID XEO04473 DESCRIPT para-ethylaniline inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04473 GENEFORM Protein DME1693 XEOTICID XEO04473 MOACRIVE Inhibition DME1693 XEOTICID XEO04475 XEO_NAME para-toluidine DME1693 XEOTICID XEO04475 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO04475 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO04475 DESCRIPT para-toluidine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04475 GENEFORM Protein DME1693 XEOTICID XEO04475 MOACRIVE Inhibition DME1693 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1693 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04482 GENEFORM Protein DME1693 XEOTICID XEO04482 MOACRIVE Inhibition DME1693 XEOTICID XEO04503 XEO_NAME Defensin-like AMP pelovaterin DME1693 XEOTICID XEO04503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04503 XEO_CLAS Peptide DME1693 XEOTICID XEO04503 DESCRIPT Defensin-like AMP pelovaterin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04503 GENEFORM Protein DME1693 XEOTICID XEO04503 MOACRIVE Inhibition DME1693 XEOTICID XEO04512 XEO_NAME Penicillenol A1 DME1693 XEOTICID XEO04512 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04512 XEO_CLAS Natural Product DME1693 XEOTICID XEO04512 DESCRIPT Penicillenol A1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04512 GENEFORM Protein DME1693 XEOTICID XEO04512 MOACRIVE Inhibition DME1693 XEOTICID XEO04513 XEO_NAME Penicillenol A2 DME1693 XEOTICID XEO04513 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04513 XEO_CLAS Natural Product DME1693 XEOTICID XEO04513 DESCRIPT Penicillenol A2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04513 GENEFORM Protein DME1693 XEOTICID XEO04513 MOACRIVE Inhibition DME1693 XEOTICID XEO04514 XEO_NAME Penicillenol B1 DME1693 XEOTICID XEO04514 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04514 XEO_CLAS Natural Product DME1693 XEOTICID XEO04514 DESCRIPT Penicillenol B1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04514 GENEFORM Protein DME1693 XEOTICID XEO04514 MOACRIVE Inhibition DME1693 XEOTICID XEO04515 XEO_NAME Penicillenol B2 DME1693 XEOTICID XEO04515 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04515 XEO_CLAS Natural Product DME1693 XEOTICID XEO04515 DESCRIPT Penicillenol B2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04515 GENEFORM Protein DME1693 XEOTICID XEO04515 MOACRIVE Inhibition DME1693 XEOTICID XEO04516 XEO_NAME Penicillenol C1 DME1693 XEOTICID XEO04516 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04516 XEO_CLAS Natural Product DME1693 XEOTICID XEO04516 DESCRIPT Penicillenol C1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04516 GENEFORM Protein DME1693 XEOTICID XEO04516 MOACRIVE Inhibition DME1693 XEOTICID XEO04517 XEO_NAME Penicillenol C2 DME1693 XEOTICID XEO04517 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04517 XEO_CLAS Natural Product DME1693 XEOTICID XEO04517 DESCRIPT Penicillenol C2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04517 GENEFORM Protein DME1693 XEOTICID XEO04517 MOACRIVE Inhibition DME1693 XEOTICID XEO04518 XEO_NAME Penicillic acid DME1693 XEOTICID XEO04518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04518 XEO_CLAS Natural Product DME1693 XEOTICID XEO04518 DESCRIPT Penicillic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04518 GENEFORM Protein DME1693 XEOTICID XEO04518 MOACRIVE Inhibition DME1693 XEOTICID XEO04522 XEO_NAME Pentagalloylglucose DME1693 XEOTICID XEO04522 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO04522 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO04522 DESCRIPT Pentagalloylglucose inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04522 GENEFORM Protein DME1693 XEOTICID XEO04522 MOACRIVE Inhibition DME1693 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1693 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04526 XEO_CLAS Peptide DME1693 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.0 microM) DME1693 XEOTICID XEO04526 GENEFORM Protein DME1693 XEOTICID XEO04526 MOACRIVE Inhibition DME1693 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1693 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04532 XEO_CLAS Peptide DME1693 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04532 GENEFORM Protein DME1693 XEOTICID XEO04532 MOACRIVE Inhibition DME1693 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1693 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04540 XEO_CLAS Peptide DME1693 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 90.8 ug/ml) DME1693 XEOTICID XEO04540 GENEFORM Protein DME1693 XEOTICID XEO04540 MOACRIVE Inhibition DME1693 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1693 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04541 XEO_CLAS Peptide DME1693 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 21.3 ug/ml) DME1693 XEOTICID XEO04541 GENEFORM Protein DME1693 XEOTICID XEO04541 MOACRIVE Inhibition DME1693 XEOTICID XEO04544 XEO_NAME Histone H5 derivative(71-90) DME1693 XEOTICID XEO04544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04544 XEO_CLAS Peptide DME1693 XEOTICID XEO04544 DESCRIPT Histone H5 derivative(71-90) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 26.7 ug/ml) DME1693 XEOTICID XEO04544 GENEFORM Protein DME1693 XEOTICID XEO04544 MOACRIVE Inhibition DME1693 XEOTICID XEO04546 XEO_NAME Perinerin DME1693 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04546 XEO_CLAS Peptide DME1693 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04546 GENEFORM Protein DME1693 XEOTICID XEO04546 MOACRIVE Inhibition DME1693 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1693 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04549 XEO_CLAS Peptide DME1693 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 250-500 ug/ml) DME1693 XEOTICID XEO04549 GENEFORM Protein DME1693 XEOTICID XEO04549 MOACRIVE Inhibition DME1693 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1693 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04571 XEO_CLAS Peptide DME1693 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04571 GENEFORM Protein DME1693 XEOTICID XEO04571 MOACRIVE Inhibition DME1693 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1693 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04572 XEO_CLAS Peptide DME1693 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04572 GENEFORM Protein DME1693 XEOTICID XEO04572 MOACRIVE Inhibition DME1693 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1693 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04573 XEO_CLAS Peptide DME1693 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6 microM) DME1693 XEOTICID XEO04573 GENEFORM Protein DME1693 XEOTICID XEO04573 MOACRIVE Inhibition DME1693 XEOTICID XEO04581 XEO_NAME Carex arenicola extract DME1693 XEOTICID XEO04581 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04581 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04581 DESCRIPT Carex arenicola extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04581 GENEFORM Protein DME1693 XEOTICID XEO04581 MOACRIVE Inhibition DME1693 XEOTICID XEO04582 XEO_NAME Carex boottiana extract DME1693 XEOTICID XEO04582 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04582 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04582 DESCRIPT Carex boottiana extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04582 GENEFORM Protein DME1693 XEOTICID XEO04582 MOACRIVE Inhibition DME1693 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1693 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04583 GENEFORM Protein DME1693 XEOTICID XEO04583 MOACRIVE Inhibition DME1693 XEOTICID XEO04584 XEO_NAME Carex humilis extract DME1693 XEOTICID XEO04584 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04584 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04584 DESCRIPT Carex humilis extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04584 GENEFORM Protein DME1693 XEOTICID XEO04584 MOACRIVE Inhibition DME1693 XEOTICID XEO04585 XEO_NAME Carex lanceolata extract DME1693 XEOTICID XEO04585 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04585 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04585 DESCRIPT Carex lanceolata extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04585 GENEFORM Protein DME1693 XEOTICID XEO04585 MOACRIVE Inhibition DME1693 XEOTICID XEO04586 XEO_NAME Carex pumila extract DME1693 XEOTICID XEO04586 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04586 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04586 DESCRIPT Carex pumila extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04586 GENEFORM Protein DME1693 XEOTICID XEO04586 MOACRIVE Inhibition DME1693 XEOTICID XEO04587 XEO_NAME Carex scabrifolia extract DME1693 XEOTICID XEO04587 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04587 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04587 DESCRIPT Carex scabrifolia extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04587 GENEFORM Protein DME1693 XEOTICID XEO04587 MOACRIVE Inhibition DME1693 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1693 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04588 GENEFORM Protein DME1693 XEOTICID XEO04588 MOACRIVE Inhibition DME1693 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1693 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04601 XEO_CLAS Peptide DME1693 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 37.5 ug/ml) DME1693 XEOTICID XEO04601 GENEFORM Protein DME1693 XEOTICID XEO04601 MOACRIVE Inhibition DME1693 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1693 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04602 XEO_CLAS Peptide DME1693 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 18.75 ug/ml) DME1693 XEOTICID XEO04602 GENEFORM Protein DME1693 XEOTICID XEO04602 MOACRIVE Inhibition DME1693 XEOTICID XEO04603 XEO_NAME Picolinic acid DME1693 XEOTICID XEO04603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04603 XEO_CLAS Amino Acid DME1693 XEOTICID XEO04603 DESCRIPT Picolinic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04603 GENEFORM Protein DME1693 XEOTICID XEO04603 MOACRIVE Inhibition DME1693 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1693 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04605 XEO_CLAS Peptide DME1693 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC < 25 microM) DME1693 XEOTICID XEO04605 GENEFORM Protein DME1693 XEOTICID XEO04605 MOACRIVE Inhibition DME1693 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1693 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04606 XEO_CLAS Peptide DME1693 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 microM) DME1693 XEOTICID XEO04606 GENEFORM Protein DME1693 XEOTICID XEO04606 MOACRIVE Inhibition DME1693 XEOTICID XEO04609 XEO_NAME Pinguisenol DME1693 XEOTICID XEO04609 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO04609 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO04609 DESCRIPT Pinguisenol inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04609 GENEFORM Protein DME1693 XEOTICID XEO04609 MOACRIVE Inhibition DME1693 XEOTICID XEO04611 XEO_NAME Piperacillin-Tazobactam DME1693 XEOTICID XEO04611 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO04611 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO04611 DESCRIPT Piperacillin-Tazobactam inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04611 GENEFORM Protein DME1693 XEOTICID XEO04611 MOACRIVE Inhibition DME1693 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1693 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04613 XEO_CLAS Peptide DME1693 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 5-10 microM) DME1693 XEOTICID XEO04613 GENEFORM Protein DME1693 XEOTICID XEO04613 MOACRIVE Inhibition DME1693 XEOTICID XEO04628 XEO_NAME Platinum (IV) ion DME1693 XEOTICID XEO04628 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO04628 XEO_CLAS Nanoparticle DME1693 XEOTICID XEO04628 DESCRIPT Platinum (IV) ion inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04628 GENEFORM Protein DME1693 XEOTICID XEO04628 MOACRIVE Inhibition DME1693 XEOTICID XEO04629 XEO_NAME Platyphylloside DME1693 XEOTICID XEO04629 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04629 XEO_CLAS Natural Product DME1693 XEOTICID XEO04629 DESCRIPT Platyphylloside inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04629 GENEFORM Protein DME1693 XEOTICID XEO04629 MOACRIVE Inhibition DME1693 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1693 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04640 XEO_CLAS Peptide DME1693 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 35.0 microM) DME1693 XEOTICID XEO04640 GENEFORM Protein DME1693 XEOTICID XEO04640 MOACRIVE Inhibition DME1693 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1693 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04642 XEO_CLAS Peptide DME1693 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1693 XEOTICID XEO04642 GENEFORM Protein DME1693 XEOTICID XEO04642 MOACRIVE Inhibition DME1693 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1693 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04643 XEO_CLAS Peptide DME1693 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1693 XEOTICID XEO04643 GENEFORM Protein DME1693 XEOTICID XEO04643 MOACRIVE Inhibition DME1693 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1693 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04644 XEO_CLAS Peptide DME1693 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1 ug/ml) DME1693 XEOTICID XEO04644 GENEFORM Protein DME1693 XEOTICID XEO04644 MOACRIVE Inhibition DME1693 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1693 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04645 XEO_CLAS Peptide DME1693 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1693 XEOTICID XEO04645 GENEFORM Protein DME1693 XEOTICID XEO04645 MOACRIVE Inhibition DME1693 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1693 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04646 XEO_CLAS Peptide DME1693 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1693 XEOTICID XEO04646 GENEFORM Protein DME1693 XEOTICID XEO04646 MOACRIVE Inhibition DME1693 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1693 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04647 XEO_CLAS Peptide DME1693 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1693 XEOTICID XEO04647 GENEFORM Protein DME1693 XEOTICID XEO04647 MOACRIVE Inhibition DME1693 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1693 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04648 XEO_CLAS Peptide DME1693 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1693 XEOTICID XEO04648 GENEFORM Protein DME1693 XEOTICID XEO04648 MOACRIVE Inhibition DME1693 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1693 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04649 XEO_CLAS Peptide DME1693 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1693 XEOTICID XEO04649 GENEFORM Protein DME1693 XEOTICID XEO04649 MOACRIVE Inhibition DME1693 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1693 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04650 XEO_CLAS Peptide DME1693 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1693 XEOTICID XEO04650 GENEFORM Protein DME1693 XEOTICID XEO04650 MOACRIVE Inhibition DME1693 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1693 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04651 XEO_CLAS Peptide DME1693 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1693 XEOTICID XEO04651 GENEFORM Protein DME1693 XEOTICID XEO04651 MOACRIVE Inhibition DME1693 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1693 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04652 XEO_CLAS Peptide DME1693 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO04652 GENEFORM Protein DME1693 XEOTICID XEO04652 MOACRIVE Inhibition DME1693 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1693 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04653 XEO_CLAS Peptide DME1693 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 64 ug/ml) DME1693 XEOTICID XEO04653 GENEFORM Protein DME1693 XEOTICID XEO04653 MOACRIVE Inhibition DME1693 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1693 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04654 XEO_CLAS Peptide DME1693 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1693 XEOTICID XEO04654 GENEFORM Protein DME1693 XEOTICID XEO04654 MOACRIVE Inhibition DME1693 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1693 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04655 XEO_CLAS Peptide DME1693 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1693 XEOTICID XEO04655 GENEFORM Protein DME1693 XEOTICID XEO04655 MOACRIVE Inhibition DME1693 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1693 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04660 XEO_CLAS Peptide DME1693 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 32 ug/ml) DME1693 XEOTICID XEO04660 GENEFORM Protein DME1693 XEOTICID XEO04660 MOACRIVE Inhibition DME1693 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1693 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04661 XEO_CLAS Peptide DME1693 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3 microM) DME1693 XEOTICID XEO04661 GENEFORM Protein DME1693 XEOTICID XEO04661 MOACRIVE Inhibition DME1693 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1693 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04680 XEO_CLAS Peptide DME1693 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.5-1 microM) DME1693 XEOTICID XEO04680 GENEFORM Protein DME1693 XEOTICID XEO04680 MOACRIVE Inhibition DME1693 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1693 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04682 XEO_CLAS Peptide DME1693 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 5 microM) DME1693 XEOTICID XEO04682 GENEFORM Protein DME1693 XEOTICID XEO04682 MOACRIVE Inhibition DME1693 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1693 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04683 XEO_CLAS Peptide DME1693 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 38 microM) DME1693 XEOTICID XEO04683 GENEFORM Protein DME1693 XEOTICID XEO04683 MOACRIVE Inhibition DME1693 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1693 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04684 XEO_CLAS Peptide DME1693 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 310 microM) DME1693 XEOTICID XEO04684 GENEFORM Protein DME1693 XEOTICID XEO04684 MOACRIVE Inhibition DME1693 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1693 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04690 XEO_CLAS Peptide DME1693 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1693 XEOTICID XEO04690 GENEFORM Protein DME1693 XEOTICID XEO04690 MOACRIVE Inhibition DME1693 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1693 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04695 XEO_CLAS Peptide DME1693 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04695 GENEFORM Protein DME1693 XEOTICID XEO04695 MOACRIVE Inhibition DME1693 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1693 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04696 XEO_CLAS Peptide DME1693 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04696 GENEFORM Protein DME1693 XEOTICID XEO04696 MOACRIVE Inhibition DME1693 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1693 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04697 XEO_CLAS Peptide DME1693 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04697 GENEFORM Protein DME1693 XEOTICID XEO04697 MOACRIVE Inhibition DME1693 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1693 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04698 XEO_CLAS Peptide DME1693 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04698 GENEFORM Protein DME1693 XEOTICID XEO04698 MOACRIVE Inhibition DME1693 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1693 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04699 XEO_CLAS Peptide DME1693 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04699 GENEFORM Protein DME1693 XEOTICID XEO04699 MOACRIVE Inhibition DME1693 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1693 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04700 XEO_CLAS Peptide DME1693 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04700 GENEFORM Protein DME1693 XEOTICID XEO04700 MOACRIVE Inhibition DME1693 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1693 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04701 XEO_CLAS Peptide DME1693 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04701 GENEFORM Protein DME1693 XEOTICID XEO04701 MOACRIVE Inhibition DME1693 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1693 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04702 XEO_CLAS Peptide DME1693 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04702 GENEFORM Protein DME1693 XEOTICID XEO04702 MOACRIVE Inhibition DME1693 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1693 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04703 XEO_CLAS Peptide DME1693 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04703 GENEFORM Protein DME1693 XEOTICID XEO04703 MOACRIVE Inhibition DME1693 XEOTICID XEO04704 XEO_NAME Ponericin-W6 DME1693 XEOTICID XEO04704 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04704 XEO_CLAS Peptide DME1693 XEOTICID XEO04704 DESCRIPT Ponericin-W6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04704 GENEFORM Protein DME1693 XEOTICID XEO04704 MOACRIVE Inhibition DME1693 XEOTICID XEO04719 XEO_NAME Pro-Gly DME1693 XEOTICID XEO04719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04719 XEO_CLAS Peptide DME1693 XEOTICID XEO04719 DESCRIPT Pro-Gly inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04719 GENEFORM Protein DME1693 XEOTICID XEO04719 MOACRIVE Inhibition DME1693 XEOTICID XEO04736 XEO_NAME Protocatechuic acid DME1693 XEOTICID XEO04736 XEO_TYPE Health or Environmental Toxicant(s) DME1693 XEOTICID XEO04736 XEO_CLAS Environmental Pollutant DME1693 XEOTICID XEO04736 DESCRIPT Protocatechuic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04736 GENEFORM Protein DME1693 XEOTICID XEO04736 MOACRIVE Inhibition DME1693 XEOTICID XEO04737 XEO_NAME Protonectin DME1693 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04737 XEO_CLAS Peptide DME1693 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.7 ug/ml) DME1693 XEOTICID XEO04737 GENEFORM Protein DME1693 XEOTICID XEO04737 MOACRIVE Inhibition DME1693 XEOTICID XEO04757 XEO_NAME Psoralen DME1693 XEOTICID XEO04757 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04757 XEO_CLAS Natural Product DME1693 XEOTICID XEO04757 DESCRIPT Psoralen inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04757 GENEFORM Protein DME1693 XEOTICID XEO04757 MOACRIVE Inhibition DME1693 XEOTICID XEO04758 XEO_NAME Anti-lipopolysaccharide factor PtALF5 DME1693 XEOTICID XEO04758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04758 XEO_CLAS Peptide DME1693 XEOTICID XEO04758 DESCRIPT Anti-lipopolysaccharide factor PtALF5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 15.54-31.08 microM) DME1693 XEOTICID XEO04758 GENEFORM Protein DME1693 XEOTICID XEO04758 MOACRIVE Inhibition DME1693 XEOTICID XEO04759 XEO_NAME Anti-lipopolysaccharide factor PtALF6 DME1693 XEOTICID XEO04759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04759 XEO_CLAS Peptide DME1693 XEOTICID XEO04759 DESCRIPT Anti-lipopolysaccharide factor PtALF6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 9.32-18.64 microM) DME1693 XEOTICID XEO04759 GENEFORM Protein DME1693 XEOTICID XEO04759 MOACRIVE Inhibition DME1693 XEOTICID XEO04760 XEO_NAME Anti-lipopolysaccharide factor PtALF7 DME1693 XEOTICID XEO04760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04760 XEO_CLAS Peptide DME1693 XEOTICID XEO04760 DESCRIPT Anti-lipopolysaccharide factor PtALF7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 1.02-2.04 microM) DME1693 XEOTICID XEO04760 GENEFORM Protein DME1693 XEOTICID XEO04760 MOACRIVE Inhibition DME1693 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1693 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04762 XEO_CLAS Peptide DME1693 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12.5 microM) DME1693 XEOTICID XEO04762 GENEFORM Protein DME1693 XEOTICID XEO04762 MOACRIVE Inhibition DME1693 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1693 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04782 XEO_CLAS Peptide DME1693 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 12 ug/ml) DME1693 XEOTICID XEO04782 GENEFORM Protein DME1693 XEOTICID XEO04782 MOACRIVE Inhibition DME1693 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1693 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04783 XEO_CLAS Peptide DME1693 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO04783 GENEFORM Protein DME1693 XEOTICID XEO04783 MOACRIVE Inhibition DME1693 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1693 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04784 XEO_CLAS Peptide DME1693 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO04784 GENEFORM Protein DME1693 XEOTICID XEO04784 MOACRIVE Inhibition DME1693 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1693 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04785 XEO_CLAS Peptide DME1693 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO04785 GENEFORM Protein DME1693 XEOTICID XEO04785 MOACRIVE Inhibition DME1693 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1693 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04786 XEO_CLAS Peptide DME1693 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 63 ug/ml) DME1693 XEOTICID XEO04786 GENEFORM Protein DME1693 XEOTICID XEO04786 MOACRIVE Inhibition DME1693 XEOTICID XEO04799 XEO_NAME Ranalexin DME1693 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04799 XEO_CLAS Peptide DME1693 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 128 ug/ml) DME1693 XEOTICID XEO04799 GENEFORM Protein DME1693 XEOTICID XEO04799 MOACRIVE Inhibition DME1693 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1693 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04809 XEO_CLAS Peptide DME1693 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 5 microM) DME1693 XEOTICID XEO04809 GENEFORM Protein DME1693 XEOTICID XEO04809 MOACRIVE Inhibition DME1693 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1693 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04827 XEO_CLAS Peptide DME1693 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6 microM) DME1693 XEOTICID XEO04827 GENEFORM Protein DME1693 XEOTICID XEO04827 MOACRIVE Inhibition DME1693 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1693 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04837 XEO_CLAS Peptide DME1693 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 10 microM) DME1693 XEOTICID XEO04837 GENEFORM Protein DME1693 XEOTICID XEO04837 MOACRIVE Inhibition DME1693 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1693 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04839 XEO_CLAS Peptide DME1693 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04839 GENEFORM Protein DME1693 XEOTICID XEO04839 MOACRIVE Inhibition DME1693 XEOTICID XEO04852 XEO_NAME Rhipicephalus microplus egg-wax DME1693 XEOTICID XEO04852 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04852 XEO_CLAS Parasite Extract DME1693 XEOTICID XEO04852 DESCRIPT Rhipicephalus microplus egg-wax inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04852 GENEFORM Protein DME1693 XEOTICID XEO04852 MOACRIVE Inhibition DME1693 XEOTICID XEO04863 XEO_NAME RTD peptide DME1693 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04863 XEO_CLAS Peptide DME1693 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2.0 microM) DME1693 XEOTICID XEO04863 GENEFORM Protein DME1693 XEOTICID XEO04863 MOACRIVE Inhibition DME1693 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1693 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04865 XEO_CLAS Peptide DME1693 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 100 ug/ml) DME1693 XEOTICID XEO04865 GENEFORM Protein DME1693 XEOTICID XEO04865 MOACRIVE Inhibition DME1693 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1693 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04866 XEO_CLAS Peptide DME1693 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 100 ug/ml) DME1693 XEOTICID XEO04866 GENEFORM Protein DME1693 XEOTICID XEO04866 MOACRIVE Inhibition DME1693 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1693 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04877 XEO_CLAS Peptide DME1693 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04877 GENEFORM Protein DME1693 XEOTICID XEO04877 MOACRIVE Inhibition DME1693 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1693 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04880 XEO_CLAS Peptide DME1693 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 10.1 ug/ml) DME1693 XEOTICID XEO04880 GENEFORM Protein DME1693 XEOTICID XEO04880 MOACRIVE Inhibition DME1693 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1693 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04886 XEO_CLAS Peptide DME1693 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 10.1 ug/ml) DME1693 XEOTICID XEO04886 GENEFORM Protein DME1693 XEOTICID XEO04886 MOACRIVE Inhibition DME1693 XEOTICID XEO04888 XEO_NAME CP-P derivative S16 DME1693 XEOTICID XEO04888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04888 XEO_CLAS Peptide DME1693 XEOTICID XEO04888 DESCRIPT CP-P derivative S16 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3.125 ug/ml) DME1693 XEOTICID XEO04888 GENEFORM Protein DME1693 XEOTICID XEO04888 MOACRIVE Inhibition DME1693 XEOTICID XEO04890 XEO_NAME CP-P derivative S9 DME1693 XEOTICID XEO04890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04890 XEO_CLAS Peptide DME1693 XEOTICID XEO04890 DESCRIPT CP-P derivative S9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50 ug/ml) DME1693 XEOTICID XEO04890 GENEFORM Protein DME1693 XEOTICID XEO04890 MOACRIVE Inhibition DME1693 XEOTICID XEO04912 XEO_NAME Scandium carbonate DME1693 XEOTICID XEO04912 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO04912 XEO_CLAS Nanoparticle DME1693 XEOTICID XEO04912 DESCRIPT Scandium carbonate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04912 GENEFORM Protein DME1693 XEOTICID XEO04912 MOACRIVE Inhibition DME1693 XEOTICID XEO04925 XEO_NAME Selenium nanoparticles DME1693 XEOTICID XEO04925 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04925 XEO_CLAS Natural Product DME1693 XEOTICID XEO04925 DESCRIPT Selenium nanoparticles inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04925 GENEFORM Protein DME1693 XEOTICID XEO04925 MOACRIVE Inhibition DME1693 XEOTICID XEO04940 XEO_NAME Silver Ion DME1693 XEOTICID XEO04940 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO04940 XEO_CLAS Nanoparticle DME1693 XEOTICID XEO04940 DESCRIPT Silver Ion inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04940 GENEFORM Protein DME1693 XEOTICID XEO04940 MOACRIVE Inhibition DME1693 XEOTICID XEO04941 XEO_NAME Silver nanoparticle DME1693 XEOTICID XEO04941 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO04941 XEO_CLAS Nanoparticle DME1693 XEOTICID XEO04941 DESCRIPT Silver nanoparticle inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04941 GENEFORM Protein DME1693 XEOTICID XEO04941 MOACRIVE Inhibition DME1693 XEOTICID XEO04954 XEO_NAME SMAP-29 DME1693 XEOTICID XEO04954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04954 XEO_CLAS Peptide DME1693 XEOTICID XEO04954 DESCRIPT SMAP-29 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04954 GENEFORM Protein DME1693 XEOTICID XEO04954 MOACRIVE Inhibition DME1693 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1693 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04955 XEO_CLAS Peptide DME1693 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.08 microM) DME1693 XEOTICID XEO04955 GENEFORM Protein DME1693 XEOTICID XEO04955 MOACRIVE Inhibition DME1693 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1693 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04956 XEO_CLAS Peptide DME1693 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16.0 microM) DME1693 XEOTICID XEO04956 GENEFORM Protein DME1693 XEOTICID XEO04956 MOACRIVE Inhibition DME1693 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1693 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04957 XEO_CLAS Peptide DME1693 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.77 microM) DME1693 XEOTICID XEO04957 GENEFORM Protein DME1693 XEOTICID XEO04957 MOACRIVE Inhibition DME1693 XEOTICID XEO04962 XEO_NAME Sodium ascorbate DME1693 XEOTICID XEO04962 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO04962 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO04962 DESCRIPT Sodium ascorbate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04962 GENEFORM Protein DME1693 XEOTICID XEO04962 MOACRIVE Inhibition DME1693 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1693 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04971 XEO_CLAS Peptide DME1693 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6-12 microM) DME1693 XEOTICID XEO04971 GENEFORM Protein DME1693 XEOTICID XEO04971 MOACRIVE Inhibition DME1693 XEOTICID XEO04973 XEO_NAME 3-(Phenylsulfinyl)-L-alanine DME1693 XEOTICID XEO04973 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO04973 XEO_CLAS Chemical Compound DME1693 XEOTICID XEO04973 DESCRIPT 3-(Phenylsulfinyl)-L-alanine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04973 GENEFORM Protein DME1693 XEOTICID XEO04973 MOACRIVE Inhibition DME1693 XEOTICID XEO04974 XEO_NAME Spinigerin DME1693 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04974 XEO_CLAS Peptide DME1693 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 50-100 microM) DME1693 XEOTICID XEO04974 GENEFORM Protein DME1693 XEOTICID XEO04974 MOACRIVE Inhibition DME1693 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1693 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1693 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04975 GENEFORM Protein DME1693 XEOTICID XEO04975 MOACRIVE Inhibition DME1693 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1693 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1693 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04976 GENEFORM Protein DME1693 XEOTICID XEO04976 MOACRIVE Inhibition DME1693 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1693 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1693 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04977 GENEFORM Protein DME1693 XEOTICID XEO04977 MOACRIVE Inhibition DME1693 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1693 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1693 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04978 GENEFORM Protein DME1693 XEOTICID XEO04978 MOACRIVE Inhibition DME1693 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1693 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1693 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04979 GENEFORM Protein DME1693 XEOTICID XEO04979 MOACRIVE Inhibition DME1693 XEOTICID XEO04988 XEO_NAME Guarea bullata stem extract DME1693 XEOTICID XEO04988 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04988 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04988 DESCRIPT Guarea bullata stem extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04988 GENEFORM Protein DME1693 XEOTICID XEO04988 MOACRIVE Inhibition DME1693 XEOTICID XEO04989 XEO_NAME Guarea grandifolia stem extract DME1693 XEOTICID XEO04989 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04989 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04989 DESCRIPT Guarea grandifolia stem extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04989 GENEFORM Protein DME1693 XEOTICID XEO04989 MOACRIVE Inhibition DME1693 XEOTICID XEO04990 XEO_NAME Leandra melanodesma stem extract DME1693 XEOTICID XEO04990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04990 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04990 DESCRIPT Leandra melanodesma stem extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04990 GENEFORM Protein DME1693 XEOTICID XEO04990 MOACRIVE Inhibition DME1693 XEOTICID XEO04991 XEO_NAME Miconia pittieri stem extract DME1693 XEOTICID XEO04991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04991 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04991 DESCRIPT Miconia pittieri stem extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04991 GENEFORM Protein DME1693 XEOTICID XEO04991 MOACRIVE Inhibition DME1693 XEOTICID XEO04992 XEO_NAME Piper urostachyum stem extract DME1693 XEOTICID XEO04992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04992 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04992 DESCRIPT Piper urostachyum stem extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04992 GENEFORM Protein DME1693 XEOTICID XEO04992 MOACRIVE Inhibition DME1693 XEOTICID XEO04993 XEO_NAME Trichilia pittieri stem extract DME1693 XEOTICID XEO04993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO04993 XEO_CLAS Plant Extract DME1693 XEOTICID XEO04993 DESCRIPT Trichilia pittieri stem extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04993 GENEFORM Protein DME1693 XEOTICID XEO04993 MOACRIVE Inhibition DME1693 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1693 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04995 XEO_CLAS Peptide DME1693 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 0.39-0.78 microM) DME1693 XEOTICID XEO04995 GENEFORM Protein DME1693 XEOTICID XEO04995 MOACRIVE Inhibition DME1693 XEOTICID XEO04996 XEO_NAME Streptomycin DME1693 XEOTICID XEO04996 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO04996 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO04996 DESCRIPT Streptomycin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO04996 GENEFORM Protein DME1693 XEOTICID XEO04996 MOACRIVE Inhibition DME1693 XEOTICID XEO04998 XEO_NAME Styelin A DME1693 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04998 XEO_CLAS Peptide DME1693 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4 ug/ml) DME1693 XEOTICID XEO04998 GENEFORM Protein DME1693 XEOTICID XEO04998 MOACRIVE Inhibition DME1693 XEOTICID XEO04999 XEO_NAME Styelin B DME1693 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO04999 XEO_CLAS Peptide DME1693 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4.5 ug/ml) DME1693 XEOTICID XEO04999 GENEFORM Protein DME1693 XEOTICID XEO04999 MOACRIVE Inhibition DME1693 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1693 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05000 XEO_CLAS Peptide DME1693 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO05000 GENEFORM Protein DME1693 XEOTICID XEO05000 MOACRIVE Inhibition DME1693 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1693 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05001 XEO_CLAS Peptide DME1693 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1693 XEOTICID XEO05001 GENEFORM Protein DME1693 XEOTICID XEO05001 MOACRIVE Inhibition DME1693 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1693 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05002 XEO_CLAS Peptide DME1693 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 ug/ml) DME1693 XEOTICID XEO05002 GENEFORM Protein DME1693 XEOTICID XEO05002 MOACRIVE Inhibition DME1693 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1693 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05003 XEO_CLAS Peptide DME1693 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 31 ug/ml) DME1693 XEOTICID XEO05003 GENEFORM Protein DME1693 XEOTICID XEO05003 MOACRIVE Inhibition DME1693 XEOTICID XEO05006 XEO_NAME Substance P DME1693 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05006 XEO_CLAS Peptide DME1693 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05006 GENEFORM Protein DME1693 XEOTICID XEO05006 MOACRIVE Inhibition DME1693 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1693 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05007 XEO_CLAS Peptide DME1693 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05007 GENEFORM Protein DME1693 XEOTICID XEO05007 MOACRIVE Inhibition DME1693 XEOTICID XEO05021 XEO_NAME Tachyplesin III DME1693 XEOTICID XEO05021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05021 XEO_CLAS Peptide DME1693 XEOTICID XEO05021 DESCRIPT Tachyplesin III inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05021 GENEFORM Protein DME1693 XEOTICID XEO05021 MOACRIVE Inhibition DME1693 XEOTICID XEO05031 XEO_NAME Tannic acid DME1693 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05031 GENEFORM Protein DME1693 XEOTICID XEO05031 MOACRIVE Inhibition DME1693 XEOTICID XEO05037 XEO_NAME Tellurite DME1693 XEOTICID XEO05037 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO05037 XEO_CLAS Nanoparticle DME1693 XEOTICID XEO05037 DESCRIPT Tellurite inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05037 GENEFORM Protein DME1693 XEOTICID XEO05037 MOACRIVE Inhibition DME1693 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1693 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05063 XEO_CLAS Peptide DME1693 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 31 microM) DME1693 XEOTICID XEO05063 GENEFORM Protein DME1693 XEOTICID XEO05063 MOACRIVE Inhibition DME1693 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1693 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05065 XEO_CLAS Peptide DME1693 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 161 ug/ml) DME1693 XEOTICID XEO05065 GENEFORM Protein DME1693 XEOTICID XEO05065 MOACRIVE Inhibition DME1693 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1693 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05073 XEO_CLAS Peptide DME1693 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 160 microM) DME1693 XEOTICID XEO05073 GENEFORM Protein DME1693 XEOTICID XEO05073 MOACRIVE Inhibition DME1693 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1693 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05075 XEO_CLAS Peptide DME1693 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 160 microM) DME1693 XEOTICID XEO05075 GENEFORM Protein DME1693 XEOTICID XEO05075 MOACRIVE Inhibition DME1693 XEOTICID XEO05076 XEO_NAME Temporin-A DME1693 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05076 XEO_CLAS Peptide DME1693 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 360 microM) DME1693 XEOTICID XEO05076 GENEFORM Protein DME1693 XEOTICID XEO05076 MOACRIVE Inhibition DME1693 XEOTICID XEO05085 XEO_NAME Temporin-B DME1693 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05085 XEO_CLAS Peptide DME1693 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 360 microM) DME1693 XEOTICID XEO05085 GENEFORM Protein DME1693 XEOTICID XEO05085 MOACRIVE Inhibition DME1693 XEOTICID XEO05103 XEO_NAME Temporin-RN1 DME1693 XEOTICID XEO05103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05103 XEO_CLAS Peptide DME1693 XEOTICID XEO05103 DESCRIPT Temporin-RN1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 4.7 ug/ml) DME1693 XEOTICID XEO05103 GENEFORM Protein DME1693 XEOTICID XEO05103 MOACRIVE Inhibition DME1693 XEOTICID XEO05104 XEO_NAME Temporin-RN3 DME1693 XEOTICID XEO05104 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05104 XEO_CLAS Peptide DME1693 XEOTICID XEO05104 DESCRIPT Temporin-RN3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 3.75 ug/ml) DME1693 XEOTICID XEO05104 GENEFORM Protein DME1693 XEOTICID XEO05104 MOACRIVE Inhibition DME1693 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1693 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05139 XEO_CLAS Peptide DME1693 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05139 GENEFORM Protein DME1693 XEOTICID XEO05139 MOACRIVE Inhibition DME1693 XEOTICID XEO05156 XEO_NAME Tobramycin DME1693 XEOTICID XEO05156 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO05156 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO05156 DESCRIPT Tobramycin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05156 GENEFORM Protein DME1693 XEOTICID XEO05156 MOACRIVE Inhibition DME1693 XEOTICID XEO05160 XEO_NAME Toremifene DME1693 XEOTICID XEO05160 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO05160 XEO_CLAS Approved/Marketed Drug DME1693 XEOTICID XEO05160 DESCRIPT Toremifene inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05160 GENEFORM Protein DME1693 XEOTICID XEO05160 MOACRIVE Inhibition DME1693 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1693 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05161 XEO_CLAS Peptide DME1693 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1693 XEOTICID XEO05161 GENEFORM Protein DME1693 XEOTICID XEO05161 MOACRIVE Inhibition DME1693 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1693 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05162 XEO_CLAS Peptide DME1693 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 64 ug/ml) DME1693 XEOTICID XEO05162 GENEFORM Protein DME1693 XEOTICID XEO05162 MOACRIVE Inhibition DME1693 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1693 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05163 XEO_CLAS Peptide DME1693 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 25-50 ug/ml) DME1693 XEOTICID XEO05163 GENEFORM Protein DME1693 XEOTICID XEO05163 MOACRIVE Inhibition DME1693 XEOTICID XEO05167 XEO_NAME Tricaine DME1693 XEOTICID XEO05167 XEO_TYPE Pharmaceutical Agent(s) DME1693 XEOTICID XEO05167 XEO_CLAS Investigative Agent DME1693 XEOTICID XEO05167 DESCRIPT Tricaine inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05167 GENEFORM Protein DME1693 XEOTICID XEO05167 MOACRIVE Inhibition DME1693 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1693 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05170 XEO_CLAS Peptide DME1693 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 5.0 microM) DME1693 XEOTICID XEO05170 GENEFORM Protein DME1693 XEOTICID XEO05170 MOACRIVE Inhibition DME1693 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1693 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05179 XEO_CLAS Peptide DME1693 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05179 GENEFORM Protein DME1693 XEOTICID XEO05179 MOACRIVE Inhibition DME1693 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1693 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05182 XEO_CLAS Peptide DME1693 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1693 XEOTICID XEO05182 GENEFORM Protein DME1693 XEOTICID XEO05182 MOACRIVE Inhibition DME1693 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1693 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05183 XEO_CLAS Peptide DME1693 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1693 XEOTICID XEO05183 GENEFORM Protein DME1693 XEOTICID XEO05183 MOACRIVE Inhibition DME1693 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1693 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05184 XEO_CLAS Peptide DME1693 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1693 XEOTICID XEO05184 GENEFORM Protein DME1693 XEOTICID XEO05184 MOACRIVE Inhibition DME1693 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1693 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05185 XEO_CLAS Peptide DME1693 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 100 microM) DME1693 XEOTICID XEO05185 GENEFORM Protein DME1693 XEOTICID XEO05185 MOACRIVE Inhibition DME1693 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1693 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05186 XEO_CLAS Peptide DME1693 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1693 XEOTICID XEO05186 GENEFORM Protein DME1693 XEOTICID XEO05186 MOACRIVE Inhibition DME1693 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1693 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05187 XEO_CLAS Peptide DME1693 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1693 XEOTICID XEO05187 GENEFORM Protein DME1693 XEOTICID XEO05187 MOACRIVE Inhibition DME1693 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1693 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05188 XEO_CLAS Peptide DME1693 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 100 microM) DME1693 XEOTICID XEO05188 GENEFORM Protein DME1693 XEOTICID XEO05188 MOACRIVE Inhibition DME1693 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1693 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05193 XEO_CLAS Peptide DME1693 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO05193 GENEFORM Protein DME1693 XEOTICID XEO05193 MOACRIVE Inhibition DME1693 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1693 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05206 XEO_CLAS Peptide DME1693 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 10 microM) DME1693 XEOTICID XEO05206 GENEFORM Protein DME1693 XEOTICID XEO05206 MOACRIVE Inhibition DME1693 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1693 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05207 XEO_CLAS Peptide DME1693 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 40 microM) DME1693 XEOTICID XEO05207 GENEFORM Protein DME1693 XEOTICID XEO05207 MOACRIVE Inhibition DME1693 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1693 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05208 XEO_CLAS Peptide DME1693 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6 microM) DME1693 XEOTICID XEO05208 GENEFORM Protein DME1693 XEOTICID XEO05208 MOACRIVE Inhibition DME1693 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1693 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05209 XEO_CLAS Peptide DME1693 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 2 microM) DME1693 XEOTICID XEO05209 GENEFORM Protein DME1693 XEOTICID XEO05209 MOACRIVE Inhibition DME1693 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1693 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05212 XEO_CLAS Peptide DME1693 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 10.1 ug/ml) DME1693 XEOTICID XEO05212 GENEFORM Protein DME1693 XEOTICID XEO05212 MOACRIVE Inhibition DME1693 XEOTICID XEO05227 XEO_NAME Vanillylacetone DME1693 XEOTICID XEO05227 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05227 XEO_CLAS Natural Product DME1693 XEOTICID XEO05227 DESCRIPT Vanillylacetone inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05227 GENEFORM Protein DME1693 XEOTICID XEO05227 MOACRIVE Inhibition DME1693 XEOTICID XEO05250 XEO_NAME Vitexin DME1693 XEOTICID XEO05250 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05250 XEO_CLAS Natural Product DME1693 XEOTICID XEO05250 DESCRIPT Vitexin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05250 GENEFORM Protein DME1693 XEOTICID XEO05250 MOACRIVE Inhibition DME1693 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1693 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05264 XEO_CLAS Peptide DME1693 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 16 ug/ml) DME1693 XEOTICID XEO05264 GENEFORM Protein DME1693 XEOTICID XEO05264 MOACRIVE Inhibition DME1693 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1693 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05267 XEO_CLAS Peptide DME1693 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 8 ug/ml) DME1693 XEOTICID XEO05267 GENEFORM Protein DME1693 XEOTICID XEO05267 MOACRIVE Inhibition DME1693 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1693 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05268 XEO_CLAS Peptide DME1693 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 6 ug/ml) DME1693 XEOTICID XEO05268 GENEFORM Protein DME1693 XEOTICID XEO05268 MOACRIVE Inhibition DME1693 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1693 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05269 XEO_CLAS Peptide DME1693 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC > 50 ug/ml) DME1693 XEOTICID XEO05269 GENEFORM Protein DME1693 XEOTICID XEO05269 MOACRIVE Inhibition DME1693 XEOTICID XEO05276 XEO_NAME Agaricus blazei water extract DME1693 XEOTICID XEO05276 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05276 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05276 DESCRIPT Agaricus blazei water extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05276 GENEFORM Protein DME1693 XEOTICID XEO05276 MOACRIVE Inhibition DME1693 XEOTICID XEO05286 XEO_NAME Peperomia vinasiana extract DME1693 XEOTICID XEO05286 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05286 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05286 DESCRIPT Peperomia vinasiana extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05286 GENEFORM Protein DME1693 XEOTICID XEO05286 MOACRIVE Inhibition DME1693 XEOTICID XEO05288 XEO_NAME Azadirachta indica wood extract DME1693 XEOTICID XEO05288 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05288 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05288 DESCRIPT Azadirachta indica wood extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05288 GENEFORM Protein DME1693 XEOTICID XEO05288 MOACRIVE Inhibition DME1693 XEOTICID XEO05289 XEO_NAME Carapa guianensis wood extract DME1693 XEOTICID XEO05289 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05289 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05289 DESCRIPT Carapa guianensis wood extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05289 GENEFORM Protein DME1693 XEOTICID XEO05289 MOACRIVE Inhibition DME1693 XEOTICID XEO05290 XEO_NAME Cedrela odorata wood extract DME1693 XEOTICID XEO05290 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05290 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05290 DESCRIPT Cedrela odorata wood extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05290 GENEFORM Protein DME1693 XEOTICID XEO05290 MOACRIVE Inhibition DME1693 XEOTICID XEO05291 XEO_NAME Cedrela tonduzii wood extract DME1693 XEOTICID XEO05291 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05291 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05291 DESCRIPT Cedrela tonduzii wood extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05291 GENEFORM Protein DME1693 XEOTICID XEO05291 MOACRIVE Inhibition DME1693 XEOTICID XEO05292 XEO_NAME Chukrasia tabularis wood extract DME1693 XEOTICID XEO05292 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05292 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05292 DESCRIPT Chukrasia tabularis wood extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05292 GENEFORM Protein DME1693 XEOTICID XEO05292 MOACRIVE Inhibition DME1693 XEOTICID XEO05293 XEO_NAME Cupania glabra wood extract DME1693 XEOTICID XEO05293 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05293 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05293 DESCRIPT Cupania glabra wood extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05293 GENEFORM Protein DME1693 XEOTICID XEO05293 MOACRIVE Inhibition DME1693 XEOTICID XEO05294 XEO_NAME Ruptiliocarpon caracolito wood extract DME1693 XEOTICID XEO05294 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05294 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05294 DESCRIPT Ruptiliocarpon caracolito wood extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05294 GENEFORM Protein DME1693 XEOTICID XEO05294 MOACRIVE Inhibition DME1693 XEOTICID XEO05295 XEO_NAME Swietenia macrophylla wood extract DME1693 XEOTICID XEO05295 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05295 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05295 DESCRIPT Swietenia macrophylla wood extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05295 GENEFORM Protein DME1693 XEOTICID XEO05295 MOACRIVE Inhibition DME1693 XEOTICID XEO05296 XEO_NAME Swietenia mahogani wood extract DME1693 XEOTICID XEO05296 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05296 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05296 DESCRIPT Swietenia mahogani wood extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05296 GENEFORM Protein DME1693 XEOTICID XEO05296 MOACRIVE Inhibition DME1693 XEOTICID XEO05297 XEO_NAME Toona ciliata wood extract DME1693 XEOTICID XEO05297 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05297 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05297 DESCRIPT Toona ciliata wood extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05297 GENEFORM Protein DME1693 XEOTICID XEO05297 MOACRIVE Inhibition DME1693 XEOTICID XEO05298 XEO_NAME Trichilia glabra wood extract DME1693 XEOTICID XEO05298 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05298 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05298 DESCRIPT Trichilia glabra wood extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05298 GENEFORM Protein DME1693 XEOTICID XEO05298 MOACRIVE Inhibition DME1693 XEOTICID XEO05299 XEO_NAME Trichilia pleeana wood extract DME1693 XEOTICID XEO05299 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05299 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05299 DESCRIPT Trichilia pleeana wood extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05299 GENEFORM Protein DME1693 XEOTICID XEO05299 MOACRIVE Inhibition DME1693 XEOTICID XEO05300 XEO_NAME Trichilia septentrionalis wood extract DME1693 XEOTICID XEO05300 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05300 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05300 DESCRIPT Trichilia septentrionalis wood extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05300 GENEFORM Protein DME1693 XEOTICID XEO05300 MOACRIVE Inhibition DME1693 XEOTICID XEO05301 XEO_NAME Trichilia trifolia wood extract DME1693 XEOTICID XEO05301 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1693 XEOTICID XEO05301 XEO_CLAS Plant Extract DME1693 XEOTICID XEO05301 DESCRIPT Trichilia trifolia wood extract inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05301 GENEFORM Protein DME1693 XEOTICID XEO05301 MOACRIVE Inhibition DME1693 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1693 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1693 XEOTICID XEO05303 XEO_CLAS Peptide DME1693 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa (MIC = 125-250 ug/ml) DME1693 XEOTICID XEO05303 GENEFORM Protein DME1693 XEOTICID XEO05303 MOACRIVE Inhibition DME1693 XEOTICID XEO05311 XEO_NAME Zeaxanthin DME1693 XEOTICID XEO05311 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO05311 XEO_CLAS Food Additive DME1693 XEOTICID XEO05311 DESCRIPT Zeaxanthin inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05311 GENEFORM Protein DME1693 XEOTICID XEO05311 MOACRIVE Inhibition DME1693 XEOTICID XEO05315 XEO_NAME Zinc Nitrate DME1693 XEOTICID XEO05315 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1693 XEOTICID XEO05315 XEO_CLAS Nanoparticle DME1693 XEOTICID XEO05315 DESCRIPT Zinc Nitrate inhibits the drug-metabolizing activity of D-Lactate dehydrogenase (ldhA) from Pseudomonas aeruginosa DME1693 XEOTICID XEO05315 GENEFORM Protein DME1693 XEOTICID XEO05315 MOACRIVE Inhibition DME1699 DME___ID DME1699 DME1699 DME_NAME Beta-lactamase (blaB) DME1699 SPESNAME Morganella morganii DME1699 XEOTICID XEO00122 XEO_NAME Amikacin DME1699 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1699 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1699 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Morganella morganii DME1699 XEOTICID XEO00122 GENEFORM Protein DME1699 XEOTICID XEO00122 MOACRIVE Inhibition DME1699 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1699 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1699 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1699 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Morganella morganii DME1699 XEOTICID XEO00237 GENEFORM Protein DME1699 XEOTICID XEO00237 MOACRIVE Inhibition DME1699 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1699 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1699 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1699 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Morganella morganii DME1699 XEOTICID XEO00349 GENEFORM Protein DME1699 XEOTICID XEO00349 MOACRIVE Inhibition DME1699 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1699 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1699 XEOTICID XEO02376 XEO_CLAS Peptide DME1699 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Morganella morganii DME1699 XEOTICID XEO02376 GENEFORM Protein DME1699 XEOTICID XEO02376 MOACRIVE Inhibition DME1699 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1699 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1699 XEOTICID XEO02378 XEO_CLAS Peptide DME1699 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Morganella morganii (MIC = 0.38 ug/ml) DME1699 XEOTICID XEO02378 GENEFORM Protein DME1699 XEOTICID XEO02378 MOACRIVE Inhibition DME1699 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1699 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1699 XEOTICID XEO03253 XEO_CLAS Peptide DME1699 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Morganella morganii DME1699 XEOTICID XEO03253 GENEFORM Protein DME1699 XEOTICID XEO03253 MOACRIVE Inhibition DME1713 DME___ID DME1713 DME1713 DME_NAME Beta-fructofuranosidase (BFRU) DME1713 SPESNAME Lactobacillus salivarius DME1713 XEOTICID XEO04150 XEO_NAME Mundticin ATO6 DME1713 XEOTICID XEO04150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1713 XEOTICID XEO04150 XEO_CLAS Peptide DME1713 XEOTICID XEO04150 DESCRIPT Mundticin ATO6 inhibits the drug-metabolizing activity of Beta-fructofuranosidase (BFRU) from Lactobacillus salivarius DME1713 XEOTICID XEO04150 GENEFORM Protein DME1713 XEOTICID XEO04150 MOACRIVE Inhibition DME1714 DME___ID DME1714 DME1714 DME_NAME Alpha-galactosidase (melA) DME1714 SPESNAME Lactobacillus acidophilus DME1714 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1714 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1714 XEOTICID XEO03771 XEO_CLAS Peptide DME1714 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Alpha-galactosidase (melA) from Lactobacillus acidophilus DME1714 XEOTICID XEO03771 GENEFORM Protein DME1714 XEOTICID XEO03771 MOACRIVE Inhibition DME1714 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1714 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1714 XEOTICID XEO03803 XEO_CLAS Peptide DME1714 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Alpha-galactosidase (melA) from Lactobacillus acidophilus DME1714 XEOTICID XEO03803 GENEFORM Protein DME1714 XEOTICID XEO03803 MOACRIVE Inhibition DME1714 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1714 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1714 XEOTICID XEO04249 XEO_CLAS Peptide DME1714 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Alpha-galactosidase (melA) from Lactobacillus acidophilus (MIC > 500 ug/ml) DME1714 XEOTICID XEO04249 GENEFORM Protein DME1714 XEOTICID XEO04249 MOACRIVE Inhibition DME1714 XEOTICID XEO04320 XEO_NAME Nisin U DME1714 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1714 XEOTICID XEO04320 XEO_CLAS Peptide DME1714 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of Alpha-galactosidase (melA) from Lactobacillus acidophilus DME1714 XEOTICID XEO04320 GENEFORM Protein DME1714 XEOTICID XEO04320 MOACRIVE Inhibition DME1714 XEOTICID XEO05228 XEO_NAME Variacin DME1714 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1714 XEOTICID XEO05228 XEO_CLAS Peptide DME1714 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Alpha-galactosidase (melA) from Lactobacillus acidophilus DME1714 XEOTICID XEO05228 GENEFORM Protein DME1714 XEOTICID XEO05228 MOACRIVE Inhibition DME1715 DME___ID DME1715 DME1715 DME_NAME Beta-galactosidase (bgaB) DME1715 SPESNAME Lactobacillus acidophilus DME1715 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1715 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1715 XEOTICID XEO03771 XEO_CLAS Peptide DME1715 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Lactobacillus acidophilus DME1715 XEOTICID XEO03771 GENEFORM Protein DME1715 XEOTICID XEO03771 MOACRIVE Inhibition DME1715 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1715 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1715 XEOTICID XEO03803 XEO_CLAS Peptide DME1715 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Lactobacillus acidophilus DME1715 XEOTICID XEO03803 GENEFORM Protein DME1715 XEOTICID XEO03803 MOACRIVE Inhibition DME1715 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1715 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1715 XEOTICID XEO04249 XEO_CLAS Peptide DME1715 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Lactobacillus acidophilus (MIC > 500 ug/ml) DME1715 XEOTICID XEO04249 GENEFORM Protein DME1715 XEOTICID XEO04249 MOACRIVE Inhibition DME1715 XEOTICID XEO04320 XEO_NAME Nisin U DME1715 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1715 XEOTICID XEO04320 XEO_CLAS Peptide DME1715 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Lactobacillus acidophilus DME1715 XEOTICID XEO04320 GENEFORM Protein DME1715 XEOTICID XEO04320 MOACRIVE Inhibition DME1715 XEOTICID XEO05228 XEO_NAME Variacin DME1715 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1715 XEOTICID XEO05228 XEO_CLAS Peptide DME1715 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Lactobacillus acidophilus DME1715 XEOTICID XEO05228 GENEFORM Protein DME1715 XEOTICID XEO05228 MOACRIVE Inhibition DME1718 DME___ID DME1718 DME1718 DME_NAME Sucrose phosphorylase (Spase) DME1718 SPESNAME Lactobacillus acidophilus DME1718 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1718 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1718 XEOTICID XEO03771 XEO_CLAS Peptide DME1718 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Sucrose phosphorylase (Spase) from Lactobacillus acidophilus DME1718 XEOTICID XEO03771 GENEFORM Protein DME1718 XEOTICID XEO03771 MOACRIVE Inhibition DME1718 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1718 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1718 XEOTICID XEO03803 XEO_CLAS Peptide DME1718 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Sucrose phosphorylase (Spase) from Lactobacillus acidophilus DME1718 XEOTICID XEO03803 GENEFORM Protein DME1718 XEOTICID XEO03803 MOACRIVE Inhibition DME1718 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1718 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1718 XEOTICID XEO04249 XEO_CLAS Peptide DME1718 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Sucrose phosphorylase (Spase) from Lactobacillus acidophilus (MIC > 500 ug/ml) DME1718 XEOTICID XEO04249 GENEFORM Protein DME1718 XEOTICID XEO04249 MOACRIVE Inhibition DME1718 XEOTICID XEO04320 XEO_NAME Nisin U DME1718 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1718 XEOTICID XEO04320 XEO_CLAS Peptide DME1718 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of Sucrose phosphorylase (Spase) from Lactobacillus acidophilus DME1718 XEOTICID XEO04320 GENEFORM Protein DME1718 XEOTICID XEO04320 MOACRIVE Inhibition DME1718 XEOTICID XEO05228 XEO_NAME Variacin DME1718 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1718 XEOTICID XEO05228 XEO_CLAS Peptide DME1718 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Sucrose phosphorylase (Spase) from Lactobacillus acidophilus DME1718 XEOTICID XEO05228 GENEFORM Protein DME1718 XEOTICID XEO05228 MOACRIVE Inhibition DME1719 DME___ID DME1719 DME1719 DME_NAME Alpha-galactosidase (melA) DME1719 SPESNAME Streptococcus thermophilus DME1719 XEOTICID XEO05132 XEO_NAME Thermophilin 13 chain ThmA DME1719 XEOTICID XEO05132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1719 XEOTICID XEO05132 XEO_CLAS Peptide DME1719 XEOTICID XEO05132 DESCRIPT Thermophilin 13 chain ThmA inhibits the drug-metabolizing activity of Alpha-galactosidase (melA) from Streptococcus thermophilus DME1719 XEOTICID XEO05132 GENEFORM Protein DME1719 XEOTICID XEO05132 MOACRIVE Inhibition DME1719 XEOTICID XEO05133 XEO_NAME Thermophilin 13 chain ThmB DME1719 XEOTICID XEO05133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1719 XEOTICID XEO05133 XEO_CLAS Peptide DME1719 XEOTICID XEO05133 DESCRIPT Thermophilin 13 chain ThmB inhibits the drug-metabolizing activity of Alpha-galactosidase (melA) from Streptococcus thermophilus DME1719 XEOTICID XEO05133 GENEFORM Protein DME1719 XEOTICID XEO05133 MOACRIVE Inhibition DME1719 XEOTICID XEO05228 XEO_NAME Variacin DME1719 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1719 XEOTICID XEO05228 XEO_CLAS Peptide DME1719 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Alpha-galactosidase (melA) from Streptococcus thermophilus DME1719 XEOTICID XEO05228 GENEFORM Protein DME1719 XEOTICID XEO05228 MOACRIVE Inhibition DME1720 DME___ID DME1720 DME1720 DME_NAME Phospho-beta-glucosidase (LBA1706) DME1720 SPESNAME Lactobacillus acidophilus DME1720 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1720 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1720 XEOTICID XEO03771 XEO_CLAS Peptide DME1720 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Phospho-beta-glucosidase (LBA1706) from Lactobacillus acidophilus DME1720 XEOTICID XEO03771 GENEFORM Protein DME1720 XEOTICID XEO03771 MOACRIVE Inhibition DME1720 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1720 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1720 XEOTICID XEO03803 XEO_CLAS Peptide DME1720 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Phospho-beta-glucosidase (LBA1706) from Lactobacillus acidophilus DME1720 XEOTICID XEO03803 GENEFORM Protein DME1720 XEOTICID XEO03803 MOACRIVE Inhibition DME1720 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1720 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1720 XEOTICID XEO04249 XEO_CLAS Peptide DME1720 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Phospho-beta-glucosidase (LBA1706) from Lactobacillus acidophilus (MIC > 500 ug/ml) DME1720 XEOTICID XEO04249 GENEFORM Protein DME1720 XEOTICID XEO04249 MOACRIVE Inhibition DME1720 XEOTICID XEO04320 XEO_NAME Nisin U DME1720 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1720 XEOTICID XEO04320 XEO_CLAS Peptide DME1720 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of Phospho-beta-glucosidase (LBA1706) from Lactobacillus acidophilus DME1720 XEOTICID XEO04320 GENEFORM Protein DME1720 XEOTICID XEO04320 MOACRIVE Inhibition DME1720 XEOTICID XEO05228 XEO_NAME Variacin DME1720 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1720 XEOTICID XEO05228 XEO_CLAS Peptide DME1720 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Phospho-beta-glucosidase (LBA1706) from Lactobacillus acidophilus DME1720 XEOTICID XEO05228 GENEFORM Protein DME1720 XEOTICID XEO05228 MOACRIVE Inhibition DME1724 DME___ID DME1724 DME1724 DME_NAME Glycoside hydrolase (cscA) DME1724 SPESNAME Escherichia coli DME1724 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1724 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00117 GENEFORM Protein DME1724 XEOTICID XEO00117 MOACRIVE Inhibition DME1724 XEOTICID XEO00122 XEO_NAME Amikacin DME1724 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00122 GENEFORM Protein DME1724 XEOTICID XEO00122 MOACRIVE Inhibition DME1724 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1724 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00136 GENEFORM Protein DME1724 XEOTICID XEO00136 MOACRIVE Inhibition DME1724 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1724 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00237 GENEFORM Protein DME1724 XEOTICID XEO00237 MOACRIVE Inhibition DME1724 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1724 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00349 GENEFORM Protein DME1724 XEOTICID XEO00349 MOACRIVE Inhibition DME1724 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1724 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00425 GENEFORM Protein DME1724 XEOTICID XEO00425 MOACRIVE Inhibition DME1724 XEOTICID XEO00439 XEO_NAME Daidzein DME1724 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00439 GENEFORM Protein DME1724 XEOTICID XEO00439 MOACRIVE Inhibition DME1724 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1724 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00460 GENEFORM Protein DME1724 XEOTICID XEO00460 MOACRIVE Inhibition DME1724 XEOTICID XEO00487 XEO_NAME Thymol DME1724 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00487 GENEFORM Protein DME1724 XEOTICID XEO00487 MOACRIVE Inhibition DME1724 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1724 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00511 GENEFORM Protein DME1724 XEOTICID XEO00511 MOACRIVE Inhibition DME1724 XEOTICID XEO00537 XEO_NAME Luteolin DME1724 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1724 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00537 GENEFORM Protein DME1724 XEOTICID XEO00537 MOACRIVE Inhibition DME1724 XEOTICID XEO00538 XEO_NAME Quercetin DME1724 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1724 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00538 GENEFORM Protein DME1724 XEOTICID XEO00538 MOACRIVE Inhibition DME1724 XEOTICID XEO00547 XEO_NAME Vitamin E DME1724 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1724 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00547 GENEFORM Protein DME1724 XEOTICID XEO00547 MOACRIVE Inhibition DME1724 XEOTICID XEO00557 XEO_NAME Genistein DME1724 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1724 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00557 GENEFORM Protein DME1724 XEOTICID XEO00557 MOACRIVE Inhibition DME1724 XEOTICID XEO00566 XEO_NAME Guaiacol DME1724 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1724 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00566 GENEFORM Protein DME1724 XEOTICID XEO00566 MOACRIVE Inhibition DME1724 XEOTICID XEO00568 XEO_NAME Resveratrol DME1724 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1724 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00568 GENEFORM Protein DME1724 XEOTICID XEO00568 MOACRIVE Inhibition DME1724 XEOTICID XEO00573 XEO_NAME Naringenin DME1724 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1724 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00573 GENEFORM Protein DME1724 XEOTICID XEO00573 MOACRIVE Inhibition DME1724 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1724 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1724 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00574 GENEFORM Protein DME1724 XEOTICID XEO00574 MOACRIVE Inhibition DME1724 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1724 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1724 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00611 GENEFORM Protein DME1724 XEOTICID XEO00611 MOACRIVE Inhibition DME1724 XEOTICID XEO00621 XEO_NAME Chitosan DME1724 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1724 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00621 GENEFORM Protein DME1724 XEOTICID XEO00621 MOACRIVE Inhibition DME1724 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1724 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1724 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00646 GENEFORM Protein DME1724 XEOTICID XEO00646 MOACRIVE Inhibition DME1724 XEOTICID XEO00683 XEO_NAME Curcumin DME1724 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1724 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00683 GENEFORM Protein DME1724 XEOTICID XEO00683 MOACRIVE Inhibition DME1724 XEOTICID XEO00727 XEO_NAME Vanillin DME1724 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1724 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00727 GENEFORM Protein DME1724 XEOTICID XEO00727 MOACRIVE Inhibition DME1724 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1724 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1724 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00730 GENEFORM Protein DME1724 XEOTICID XEO00730 MOACRIVE Inhibition DME1724 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1724 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO00782 XEO_CLAS Natural Product DME1724 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00782 GENEFORM Protein DME1724 XEOTICID XEO00782 MOACRIVE Inhibition DME1724 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1724 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1724 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00866 GENEFORM Protein DME1724 XEOTICID XEO00866 MOACRIVE Inhibition DME1724 XEOTICID XEO00878 XEO_NAME Chrysin DME1724 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO00878 XEO_CLAS Natural Product DME1724 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00878 GENEFORM Protein DME1724 XEOTICID XEO00878 MOACRIVE Inhibition DME1724 XEOTICID XEO00879 XEO_NAME Coumarin DME1724 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1724 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1724 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00879 GENEFORM Protein DME1724 XEOTICID XEO00879 MOACRIVE Inhibition DME1724 XEOTICID XEO00883 XEO_NAME Phloretin DME1724 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO00883 XEO_CLAS Natural Product DME1724 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00883 GENEFORM Protein DME1724 XEOTICID XEO00883 MOACRIVE Inhibition DME1724 XEOTICID XEO00885 XEO_NAME Eugenol DME1724 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1724 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO00885 GENEFORM Protein DME1724 XEOTICID XEO00885 MOACRIVE Inhibition DME1724 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1724 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1724 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1724 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01032 GENEFORM Protein DME1724 XEOTICID XEO01032 MOACRIVE Inhibition DME1724 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1724 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01174 XEO_CLAS Natural Product DME1724 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01174 GENEFORM Protein DME1724 XEOTICID XEO01174 MOACRIVE Inhibition DME1724 XEOTICID XEO01203 XEO_NAME Apigenin DME1724 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01203 XEO_CLAS Natural Product DME1724 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01203 GENEFORM Protein DME1724 XEOTICID XEO01203 MOACRIVE Inhibition DME1724 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1724 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1724 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1724 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01232 GENEFORM Protein DME1724 XEOTICID XEO01232 MOACRIVE Inhibition DME1724 XEOTICID XEO01237 XEO_NAME Carvacrol DME1724 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1724 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01237 GENEFORM Protein DME1724 XEOTICID XEO01237 MOACRIVE Inhibition DME1724 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1724 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1724 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01287 GENEFORM Protein DME1724 XEOTICID XEO01287 MOACRIVE Inhibition DME1724 XEOTICID XEO01291 XEO_NAME Esculetin DME1724 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1724 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01291 GENEFORM Protein DME1724 XEOTICID XEO01291 MOACRIVE Inhibition DME1724 XEOTICID XEO01304 XEO_NAME Flavone DME1724 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01304 XEO_CLAS Natural Product DME1724 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01304 GENEFORM Protein DME1724 XEOTICID XEO01304 MOACRIVE Inhibition DME1724 XEOTICID XEO01309 XEO_NAME Gallic acid DME1724 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01309 XEO_CLAS Natural Product DME1724 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01309 GENEFORM Protein DME1724 XEOTICID XEO01309 MOACRIVE Inhibition DME1724 XEOTICID XEO01340 XEO_NAME Imperatorin DME1724 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01340 XEO_CLAS Natural Product DME1724 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01340 GENEFORM Protein DME1724 XEOTICID XEO01340 MOACRIVE Inhibition DME1724 XEOTICID XEO01353 XEO_NAME Kaempferol DME1724 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1724 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1724 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01353 GENEFORM Protein DME1724 XEOTICID XEO01353 MOACRIVE Inhibition DME1724 XEOTICID XEO01366 XEO_NAME Linalool DME1724 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01366 XEO_CLAS Natural Product DME1724 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01366 GENEFORM Protein DME1724 XEOTICID XEO01366 MOACRIVE Inhibition DME1724 XEOTICID XEO01391 XEO_NAME Naringin DME1724 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01391 XEO_CLAS Natural Product DME1724 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01391 GENEFORM Protein DME1724 XEOTICID XEO01391 MOACRIVE Inhibition DME1724 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1724 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1724 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01420 GENEFORM Protein DME1724 XEOTICID XEO01420 MOACRIVE Inhibition DME1724 XEOTICID XEO01463 XEO_NAME Rutin DME1724 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01463 XEO_CLAS Natural Product DME1724 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01463 GENEFORM Protein DME1724 XEOTICID XEO01463 MOACRIVE Inhibition DME1724 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1724 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1724 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01496 GENEFORM Protein DME1724 XEOTICID XEO01496 MOACRIVE Inhibition DME1724 XEOTICID XEO01512 XEO_NAME Zinc DME1724 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1724 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1724 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01512 GENEFORM Protein DME1724 XEOTICID XEO01512 MOACRIVE Inhibition DME1724 XEOTICID XEO01527 XEO_NAME Bergamottin DME1724 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01527 XEO_CLAS Natural Product DME1724 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01527 GENEFORM Protein DME1724 XEOTICID XEO01527 MOACRIVE Inhibition DME1724 XEOTICID XEO01531 XEO_NAME Clove oil DME1724 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01531 XEO_CLAS Natural Product DME1724 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01531 GENEFORM Protein DME1724 XEOTICID XEO01531 MOACRIVE Inhibition DME1724 XEOTICID XEO01559 XEO_NAME Limonene DME1724 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01559 XEO_CLAS Natural Product DME1724 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01559 GENEFORM Protein DME1724 XEOTICID XEO01559 MOACRIVE Inhibition DME1724 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1724 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01563 XEO_CLAS Natural Product DME1724 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01563 GENEFORM Protein DME1724 XEOTICID XEO01563 MOACRIVE Inhibition DME1724 XEOTICID XEO01566 XEO_NAME Nobiletin DME1724 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01566 XEO_CLAS Natural Product DME1724 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01566 GENEFORM Protein DME1724 XEOTICID XEO01566 MOACRIVE Inhibition DME1724 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1724 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01778 XEO_CLAS Natural Product DME1724 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01778 GENEFORM Protein DME1724 XEOTICID XEO01778 MOACRIVE Inhibition DME1724 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1724 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01779 XEO_CLAS Peptide DME1724 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 128 microM) DME1724 XEOTICID XEO01779 GENEFORM Protein DME1724 XEOTICID XEO01779 MOACRIVE Inhibition DME1724 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1724 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01810 XEO_CLAS Peptide DME1724 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.0 microM) DME1724 XEOTICID XEO01810 GENEFORM Protein DME1724 XEOTICID XEO01810 MOACRIVE Inhibition DME1724 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1724 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01811 XEO_CLAS Peptide DME1724 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 microM) DME1724 XEOTICID XEO01811 GENEFORM Protein DME1724 XEOTICID XEO01811 MOACRIVE Inhibition DME1724 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1724 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01812 XEO_CLAS Peptide DME1724 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10.4 microM) DME1724 XEOTICID XEO01812 GENEFORM Protein DME1724 XEOTICID XEO01812 MOACRIVE Inhibition DME1724 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1724 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01813 XEO_CLAS Peptide DME1724 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.1 microM) DME1724 XEOTICID XEO01813 GENEFORM Protein DME1724 XEOTICID XEO01813 MOACRIVE Inhibition DME1724 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1724 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01814 XEO_CLAS Peptide DME1724 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.5 microM) DME1724 XEOTICID XEO01814 GENEFORM Protein DME1724 XEOTICID XEO01814 MOACRIVE Inhibition DME1724 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1724 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01815 XEO_CLAS Peptide DME1724 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 9.8 microM) DME1724 XEOTICID XEO01815 GENEFORM Protein DME1724 XEOTICID XEO01815 MOACRIVE Inhibition DME1724 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1724 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01816 XEO_CLAS Peptide DME1724 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO01816 GENEFORM Protein DME1724 XEOTICID XEO01816 MOACRIVE Inhibition DME1724 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1724 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01817 XEO_CLAS Peptide DME1724 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.0 microM) DME1724 XEOTICID XEO01817 GENEFORM Protein DME1724 XEOTICID XEO01817 MOACRIVE Inhibition DME1724 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1724 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01818 XEO_CLAS Peptide DME1724 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4.0 microM) DME1724 XEOTICID XEO01818 GENEFORM Protein DME1724 XEOTICID XEO01818 MOACRIVE Inhibition DME1724 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1724 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01819 XEO_CLAS Peptide DME1724 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO01819 GENEFORM Protein DME1724 XEOTICID XEO01819 MOACRIVE Inhibition DME1724 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1724 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01820 XEO_CLAS Peptide DME1724 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO01820 GENEFORM Protein DME1724 XEOTICID XEO01820 MOACRIVE Inhibition DME1724 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1724 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01821 XEO_CLAS Peptide DME1724 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO01821 GENEFORM Protein DME1724 XEOTICID XEO01821 MOACRIVE Inhibition DME1724 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1724 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01822 XEO_CLAS Peptide DME1724 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 microM) DME1724 XEOTICID XEO01822 GENEFORM Protein DME1724 XEOTICID XEO01822 MOACRIVE Inhibition DME1724 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1724 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01823 XEO_CLAS Peptide DME1724 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO01823 GENEFORM Protein DME1724 XEOTICID XEO01823 MOACRIVE Inhibition DME1724 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1724 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01824 XEO_CLAS Peptide DME1724 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO01824 GENEFORM Protein DME1724 XEOTICID XEO01824 MOACRIVE Inhibition DME1724 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1724 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01825 XEO_CLAS Peptide DME1724 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25.0 microM) DME1724 XEOTICID XEO01825 GENEFORM Protein DME1724 XEOTICID XEO01825 MOACRIVE Inhibition DME1724 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1724 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01827 XEO_CLAS Peptide DME1724 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.12-6.25 microM) DME1724 XEOTICID XEO01827 GENEFORM Protein DME1724 XEOTICID XEO01827 MOACRIVE Inhibition DME1724 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1724 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1724 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1724 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01829 GENEFORM Protein DME1724 XEOTICID XEO01829 MOACRIVE Inhibition DME1724 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1724 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01927 XEO_CLAS Peptide DME1724 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 ug/ml) DME1724 XEOTICID XEO01927 GENEFORM Protein DME1724 XEOTICID XEO01927 MOACRIVE Inhibition DME1724 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1724 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01945 XEO_CLAS Peptide DME1724 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.1 microM) DME1724 XEOTICID XEO01945 GENEFORM Protein DME1724 XEOTICID XEO01945 MOACRIVE Inhibition DME1724 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1724 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01946 XEO_CLAS Peptide DME1724 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.2 microM) DME1724 XEOTICID XEO01946 GENEFORM Protein DME1724 XEOTICID XEO01946 MOACRIVE Inhibition DME1724 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1724 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO01947 XEO_CLAS Natural Product DME1724 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01947 GENEFORM Protein DME1724 XEOTICID XEO01947 MOACRIVE Inhibition DME1724 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1724 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1724 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1724 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01950 GENEFORM Protein DME1724 XEOTICID XEO01950 MOACRIVE Inhibition DME1724 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1724 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1724 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1724 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01961 GENEFORM Protein DME1724 XEOTICID XEO01961 MOACRIVE Inhibition DME1724 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1724 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1724 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1724 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO01966 GENEFORM Protein DME1724 XEOTICID XEO01966 MOACRIVE Inhibition DME1724 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1724 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01996 XEO_CLAS Peptide DME1724 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.7 microM) DME1724 XEOTICID XEO01996 GENEFORM Protein DME1724 XEOTICID XEO01996 MOACRIVE Inhibition DME1724 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1724 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01997 XEO_CLAS Peptide DME1724 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.9 microM) DME1724 XEOTICID XEO01997 GENEFORM Protein DME1724 XEOTICID XEO01997 MOACRIVE Inhibition DME1724 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1724 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01998 XEO_CLAS Peptide DME1724 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO01998 GENEFORM Protein DME1724 XEOTICID XEO01998 MOACRIVE Inhibition DME1724 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1724 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO01999 XEO_CLAS Peptide DME1724 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.5 microM) DME1724 XEOTICID XEO01999 GENEFORM Protein DME1724 XEOTICID XEO01999 MOACRIVE Inhibition DME1724 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1724 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02013 XEO_CLAS Peptide DME1724 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02013 GENEFORM Protein DME1724 XEOTICID XEO02013 MOACRIVE Inhibition DME1724 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1724 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02032 XEO_CLAS Natural Product DME1724 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02032 GENEFORM Protein DME1724 XEOTICID XEO02032 MOACRIVE Inhibition DME1724 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1724 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02033 XEO_CLAS Natural Product DME1724 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02033 GENEFORM Protein DME1724 XEOTICID XEO02033 MOACRIVE Inhibition DME1724 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1724 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02079 XEO_CLAS Natural Product DME1724 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02079 GENEFORM Protein DME1724 XEOTICID XEO02079 MOACRIVE Inhibition DME1724 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1724 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1724 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02085 GENEFORM Protein DME1724 XEOTICID XEO02085 MOACRIVE Inhibition DME1724 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1724 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02111 XEO_CLAS Peptide DME1724 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2-4 ug/ml) DME1724 XEOTICID XEO02111 GENEFORM Protein DME1724 XEOTICID XEO02111 MOACRIVE Inhibition DME1724 XEOTICID XEO02113 XEO_NAME Abaecin DME1724 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02113 XEO_CLAS Peptide DME1724 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02113 GENEFORM Protein DME1724 XEOTICID XEO02113 MOACRIVE Inhibition DME1724 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1724 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02114 XEO_CLAS Peptide DME1724 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-25 ug/ml) DME1724 XEOTICID XEO02114 GENEFORM Protein DME1724 XEOTICID XEO02114 MOACRIVE Inhibition DME1724 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1724 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02115 XEO_CLAS Peptide DME1724 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02115 GENEFORM Protein DME1724 XEOTICID XEO02115 MOACRIVE Inhibition DME1724 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1724 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02117 XEO_CLAS Peptide DME1724 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02117 GENEFORM Protein DME1724 XEOTICID XEO02117 MOACRIVE Inhibition DME1724 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1724 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02118 XEO_CLAS Peptide DME1724 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02118 GENEFORM Protein DME1724 XEOTICID XEO02118 MOACRIVE Inhibition DME1724 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1724 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02119 XEO_CLAS Peptide DME1724 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02119 GENEFORM Protein DME1724 XEOTICID XEO02119 MOACRIVE Inhibition DME1724 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1724 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02120 XEO_CLAS Peptide DME1724 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02120 GENEFORM Protein DME1724 XEOTICID XEO02120 MOACRIVE Inhibition DME1724 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1724 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02121 XEO_CLAS Peptide DME1724 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02121 GENEFORM Protein DME1724 XEOTICID XEO02121 MOACRIVE Inhibition DME1724 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1724 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02122 XEO_CLAS Peptide DME1724 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 ug/ml) DME1724 XEOTICID XEO02122 GENEFORM Protein DME1724 XEOTICID XEO02122 MOACRIVE Inhibition DME1724 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1724 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02130 XEO_CLAS Peptide DME1724 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.7 microM) DME1724 XEOTICID XEO02130 GENEFORM Protein DME1724 XEOTICID XEO02130 MOACRIVE Inhibition DME1724 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1724 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02131 XEO_CLAS Peptide DME1724 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.3 microM) DME1724 XEOTICID XEO02131 GENEFORM Protein DME1724 XEOTICID XEO02131 MOACRIVE Inhibition DME1724 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1724 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02132 XEO_CLAS Peptide DME1724 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.5 microM) DME1724 XEOTICID XEO02132 GENEFORM Protein DME1724 XEOTICID XEO02132 MOACRIVE Inhibition DME1724 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1724 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02136 XEO_CLAS Peptide DME1724 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 ug/ml) DME1724 XEOTICID XEO02136 GENEFORM Protein DME1724 XEOTICID XEO02136 MOACRIVE Inhibition DME1724 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1724 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02147 XEO_CLAS Peptide DME1724 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 382 ug/ml) DME1724 XEOTICID XEO02147 GENEFORM Protein DME1724 XEOTICID XEO02147 MOACRIVE Inhibition DME1724 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1724 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02149 XEO_CLAS Peptide DME1724 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 47.35 microM) DME1724 XEOTICID XEO02149 GENEFORM Protein DME1724 XEOTICID XEO02149 MOACRIVE Inhibition DME1724 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1724 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02164 XEO_CLAS Peptide DME1724 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02164 GENEFORM Protein DME1724 XEOTICID XEO02164 MOACRIVE Inhibition DME1724 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1724 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02165 XEO_CLAS Peptide DME1724 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02165 GENEFORM Protein DME1724 XEOTICID XEO02165 MOACRIVE Inhibition DME1724 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1724 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02166 XEO_CLAS Peptide DME1724 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02166 GENEFORM Protein DME1724 XEOTICID XEO02166 MOACRIVE Inhibition DME1724 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1724 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02167 XEO_CLAS Peptide DME1724 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02167 GENEFORM Protein DME1724 XEOTICID XEO02167 MOACRIVE Inhibition DME1724 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1724 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02168 XEO_CLAS Peptide DME1724 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02168 GENEFORM Protein DME1724 XEOTICID XEO02168 MOACRIVE Inhibition DME1724 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1724 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02169 XEO_CLAS Peptide DME1724 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02169 GENEFORM Protein DME1724 XEOTICID XEO02169 MOACRIVE Inhibition DME1724 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1724 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02170 XEO_CLAS Peptide DME1724 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.4 microM) DME1724 XEOTICID XEO02170 GENEFORM Protein DME1724 XEOTICID XEO02170 MOACRIVE Inhibition DME1724 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1724 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02175 XEO_CLAS Natural Product DME1724 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02175 GENEFORM Protein DME1724 XEOTICID XEO02175 MOACRIVE Inhibition DME1724 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1724 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02177 XEO_CLAS Peptide DME1724 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO02177 GENEFORM Protein DME1724 XEOTICID XEO02177 MOACRIVE Inhibition DME1724 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1724 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02178 XEO_CLAS Peptide DME1724 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO02178 GENEFORM Protein DME1724 XEOTICID XEO02178 MOACRIVE Inhibition DME1724 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1724 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02179 XEO_CLAS Peptide DME1724 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO02179 GENEFORM Protein DME1724 XEOTICID XEO02179 MOACRIVE Inhibition DME1724 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1724 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02180 XEO_CLAS Peptide DME1724 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 214 microM) DME1724 XEOTICID XEO02180 GENEFORM Protein DME1724 XEOTICID XEO02180 MOACRIVE Inhibition DME1724 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1724 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02181 XEO_CLAS Peptide DME1724 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 217 microM) DME1724 XEOTICID XEO02181 GENEFORM Protein DME1724 XEOTICID XEO02181 MOACRIVE Inhibition DME1724 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1724 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02183 XEO_CLAS Peptide DME1724 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 38.4 microM) DME1724 XEOTICID XEO02183 GENEFORM Protein DME1724 XEOTICID XEO02183 MOACRIVE Inhibition DME1724 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1724 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02185 XEO_CLAS Peptide DME1724 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 microM) DME1724 XEOTICID XEO02185 GENEFORM Protein DME1724 XEOTICID XEO02185 MOACRIVE Inhibition DME1724 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1724 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02187 GENEFORM Protein DME1724 XEOTICID XEO02187 MOACRIVE Inhibition DME1724 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1724 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02191 XEO_CLAS Peptide DME1724 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02191 GENEFORM Protein DME1724 XEOTICID XEO02191 MOACRIVE Inhibition DME1724 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1724 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02192 XEO_CLAS Peptide DME1724 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.50 ug/ml) DME1724 XEOTICID XEO02192 GENEFORM Protein DME1724 XEOTICID XEO02192 MOACRIVE Inhibition DME1724 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1724 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02193 XEO_CLAS Peptide DME1724 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02193 GENEFORM Protein DME1724 XEOTICID XEO02193 MOACRIVE Inhibition DME1724 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1724 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02194 XEO_CLAS Peptide DME1724 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02194 GENEFORM Protein DME1724 XEOTICID XEO02194 MOACRIVE Inhibition DME1724 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1724 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02195 XEO_CLAS Peptide DME1724 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.00 ug/ml) DME1724 XEOTICID XEO02195 GENEFORM Protein DME1724 XEOTICID XEO02195 MOACRIVE Inhibition DME1724 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1724 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02197 XEO_CLAS Peptide DME1724 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02197 GENEFORM Protein DME1724 XEOTICID XEO02197 MOACRIVE Inhibition DME1724 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1724 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02200 XEO_CLAS Peptide DME1724 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 ug/ml) DME1724 XEOTICID XEO02200 GENEFORM Protein DME1724 XEOTICID XEO02200 MOACRIVE Inhibition DME1724 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1724 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02201 XEO_CLAS Peptide DME1724 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 ug/ml) DME1724 XEOTICID XEO02201 GENEFORM Protein DME1724 XEOTICID XEO02201 MOACRIVE Inhibition DME1724 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1724 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02202 XEO_CLAS Peptide DME1724 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO02202 GENEFORM Protein DME1724 XEOTICID XEO02202 MOACRIVE Inhibition DME1724 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1724 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02203 XEO_CLAS Peptide DME1724 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 microM) DME1724 XEOTICID XEO02203 GENEFORM Protein DME1724 XEOTICID XEO02203 MOACRIVE Inhibition DME1724 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1724 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02207 XEO_CLAS Peptide DME1724 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.78 ug/ml) DME1724 XEOTICID XEO02207 GENEFORM Protein DME1724 XEOTICID XEO02207 MOACRIVE Inhibition DME1724 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1724 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02208 XEO_CLAS Peptide DME1724 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.13 ug/ml) DME1724 XEOTICID XEO02208 GENEFORM Protein DME1724 XEOTICID XEO02208 MOACRIVE Inhibition DME1724 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1724 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02209 XEO_CLAS Peptide DME1724 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.56 ug/ml) DME1724 XEOTICID XEO02209 GENEFORM Protein DME1724 XEOTICID XEO02209 MOACRIVE Inhibition DME1724 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1724 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02210 XEO_CLAS Peptide DME1724 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 ug/ml) DME1724 XEOTICID XEO02210 GENEFORM Protein DME1724 XEOTICID XEO02210 MOACRIVE Inhibition DME1724 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1724 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02211 XEO_CLAS Peptide DME1724 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25 ug/ml) DME1724 XEOTICID XEO02211 GENEFORM Protein DME1724 XEOTICID XEO02211 MOACRIVE Inhibition DME1724 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1724 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02212 XEO_CLAS Peptide DME1724 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.13 ug/ml) DME1724 XEOTICID XEO02212 GENEFORM Protein DME1724 XEOTICID XEO02212 MOACRIVE Inhibition DME1724 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1724 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02213 XEO_CLAS Peptide DME1724 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.13 ug/ml) DME1724 XEOTICID XEO02213 GENEFORM Protein DME1724 XEOTICID XEO02213 MOACRIVE Inhibition DME1724 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1724 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02214 XEO_CLAS Peptide DME1724 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02214 GENEFORM Protein DME1724 XEOTICID XEO02214 MOACRIVE Inhibition DME1724 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1724 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02215 XEO_CLAS Peptide DME1724 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 ug/ml) DME1724 XEOTICID XEO02215 GENEFORM Protein DME1724 XEOTICID XEO02215 MOACRIVE Inhibition DME1724 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1724 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02216 XEO_CLAS Peptide DME1724 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 126 ug/ml) DME1724 XEOTICID XEO02216 GENEFORM Protein DME1724 XEOTICID XEO02216 MOACRIVE Inhibition DME1724 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1724 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02217 XEO_CLAS Peptide DME1724 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 200 ug/ml) DME1724 XEOTICID XEO02217 GENEFORM Protein DME1724 XEOTICID XEO02217 MOACRIVE Inhibition DME1724 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1724 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02218 XEO_CLAS Peptide DME1724 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 200 ug/ml) DME1724 XEOTICID XEO02218 GENEFORM Protein DME1724 XEOTICID XEO02218 MOACRIVE Inhibition DME1724 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1724 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02219 XEO_CLAS Peptide DME1724 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 200 ug/ml) DME1724 XEOTICID XEO02219 GENEFORM Protein DME1724 XEOTICID XEO02219 MOACRIVE Inhibition DME1724 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1724 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02220 XEO_CLAS Peptide DME1724 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 23.5 ug/ml) DME1724 XEOTICID XEO02220 GENEFORM Protein DME1724 XEOTICID XEO02220 MOACRIVE Inhibition DME1724 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1724 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02221 XEO_CLAS Peptide DME1724 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20.2 ug/ml) DME1724 XEOTICID XEO02221 GENEFORM Protein DME1724 XEOTICID XEO02221 MOACRIVE Inhibition DME1724 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1724 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02222 XEO_CLAS Peptide DME1724 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30.5 ug/ml) DME1724 XEOTICID XEO02222 GENEFORM Protein DME1724 XEOTICID XEO02222 MOACRIVE Inhibition DME1724 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1724 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02223 XEO_CLAS Peptide DME1724 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.2 ug/ml) DME1724 XEOTICID XEO02223 GENEFORM Protein DME1724 XEOTICID XEO02223 MOACRIVE Inhibition DME1724 XEOTICID XEO02224 XEO_NAME Androctonin DME1724 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02224 XEO_CLAS Peptide DME1724 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02224 GENEFORM Protein DME1724 XEOTICID XEO02224 MOACRIVE Inhibition DME1724 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1724 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02225 XEO_CLAS Peptide DME1724 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02225 GENEFORM Protein DME1724 XEOTICID XEO02225 MOACRIVE Inhibition DME1724 XEOTICID XEO02226 XEO_NAME Andropin DME1724 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02226 XEO_CLAS Peptide DME1724 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 140 microM) DME1724 XEOTICID XEO02226 GENEFORM Protein DME1724 XEOTICID XEO02226 MOACRIVE Inhibition DME1724 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1724 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02230 XEO_CLAS Peptide DME1724 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.05-0.1 microM) DME1724 XEOTICID XEO02230 GENEFORM Protein DME1724 XEOTICID XEO02230 MOACRIVE Inhibition DME1724 XEOTICID XEO02232 XEO_NAME Anoplin DME1724 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02232 XEO_CLAS Peptide DME1724 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 13 ug/ml) DME1724 XEOTICID XEO02232 GENEFORM Protein DME1724 XEOTICID XEO02232 MOACRIVE Inhibition DME1724 XEOTICID XEO02233 XEO_NAME Antapin DME1724 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02233 XEO_CLAS Peptide DME1724 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02233 GENEFORM Protein DME1724 XEOTICID XEO02233 MOACRIVE Inhibition DME1724 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1724 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02236 XEO_CLAS Peptide DME1724 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02236 GENEFORM Protein DME1724 XEOTICID XEO02236 MOACRIVE Inhibition DME1724 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1724 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02239 XEO_CLAS Peptide DME1724 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 250 microM) DME1724 XEOTICID XEO02239 GENEFORM Protein DME1724 XEOTICID XEO02239 MOACRIVE Inhibition DME1724 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1724 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02240 XEO_CLAS Peptide DME1724 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 microM) DME1724 XEOTICID XEO02240 GENEFORM Protein DME1724 XEOTICID XEO02240 MOACRIVE Inhibition DME1724 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1724 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02241 XEO_CLAS Peptide DME1724 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02241 GENEFORM Protein DME1724 XEOTICID XEO02241 MOACRIVE Inhibition DME1724 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1724 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02242 XEO_CLAS Peptide DME1724 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO02242 GENEFORM Protein DME1724 XEOTICID XEO02242 MOACRIVE Inhibition DME1724 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1724 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02243 XEO_CLAS Peptide DME1724 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 microM) DME1724 XEOTICID XEO02243 GENEFORM Protein DME1724 XEOTICID XEO02243 MOACRIVE Inhibition DME1724 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1724 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02244 XEO_CLAS Peptide DME1724 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1 microM) DME1724 XEOTICID XEO02244 GENEFORM Protein DME1724 XEOTICID XEO02244 MOACRIVE Inhibition DME1724 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1724 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02245 XEO_CLAS Peptide DME1724 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02245 GENEFORM Protein DME1724 XEOTICID XEO02245 MOACRIVE Inhibition DME1724 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1724 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02246 XEO_CLAS Peptide DME1724 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 microM) DME1724 XEOTICID XEO02246 GENEFORM Protein DME1724 XEOTICID XEO02246 MOACRIVE Inhibition DME1724 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1724 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02247 XEO_CLAS Peptide DME1724 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02247 GENEFORM Protein DME1724 XEOTICID XEO02247 MOACRIVE Inhibition DME1724 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1724 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02248 XEO_CLAS Peptide DME1724 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.3 microM) DME1724 XEOTICID XEO02248 GENEFORM Protein DME1724 XEOTICID XEO02248 MOACRIVE Inhibition DME1724 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1724 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02253 XEO_CLAS Peptide DME1724 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02253 GENEFORM Protein DME1724 XEOTICID XEO02253 MOACRIVE Inhibition DME1724 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1724 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02258 XEO_CLAS Peptide DME1724 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 150 microM) DME1724 XEOTICID XEO02258 GENEFORM Protein DME1724 XEOTICID XEO02258 MOACRIVE Inhibition DME1724 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1724 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02261 XEO_CLAS Peptide DME1724 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 82 ug/ml) DME1724 XEOTICID XEO02261 GENEFORM Protein DME1724 XEOTICID XEO02261 MOACRIVE Inhibition DME1724 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1724 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02263 XEO_CLAS Peptide DME1724 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO02263 GENEFORM Protein DME1724 XEOTICID XEO02263 MOACRIVE Inhibition DME1724 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1724 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02266 XEO_CLAS Peptide DME1724 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 120 microM) DME1724 XEOTICID XEO02266 GENEFORM Protein DME1724 XEOTICID XEO02266 MOACRIVE Inhibition DME1724 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1724 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02268 XEO_CLAS Peptide DME1724 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 170 ug/ml) DME1724 XEOTICID XEO02268 GENEFORM Protein DME1724 XEOTICID XEO02268 MOACRIVE Inhibition DME1724 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1724 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02270 XEO_CLAS Peptide DME1724 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 microM) DME1724 XEOTICID XEO02270 GENEFORM Protein DME1724 XEOTICID XEO02270 MOACRIVE Inhibition DME1724 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1724 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02271 XEO_CLAS Peptide DME1724 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 302 ug/ml) DME1724 XEOTICID XEO02271 GENEFORM Protein DME1724 XEOTICID XEO02271 MOACRIVE Inhibition DME1724 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1724 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02273 XEO_CLAS Peptide DME1724 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 18 microM) DME1724 XEOTICID XEO02273 GENEFORM Protein DME1724 XEOTICID XEO02273 MOACRIVE Inhibition DME1724 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1724 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02274 XEO_CLAS Peptide DME1724 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO02274 GENEFORM Protein DME1724 XEOTICID XEO02274 MOACRIVE Inhibition DME1724 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1724 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02275 XEO_CLAS Peptide DME1724 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 microM) DME1724 XEOTICID XEO02275 GENEFORM Protein DME1724 XEOTICID XEO02275 MOACRIVE Inhibition DME1724 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1724 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02276 XEO_CLAS Peptide DME1724 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 microM) DME1724 XEOTICID XEO02276 GENEFORM Protein DME1724 XEOTICID XEO02276 MOACRIVE Inhibition DME1724 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1724 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02280 XEO_CLAS Peptide DME1724 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02280 GENEFORM Protein DME1724 XEOTICID XEO02280 MOACRIVE Inhibition DME1724 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1724 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02281 XEO_CLAS Peptide DME1724 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02281 GENEFORM Protein DME1724 XEOTICID XEO02281 MOACRIVE Inhibition DME1724 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1724 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02283 XEO_CLAS Peptide DME1724 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 ug/ml) DME1724 XEOTICID XEO02283 GENEFORM Protein DME1724 XEOTICID XEO02283 MOACRIVE Inhibition DME1724 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1724 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02284 XEO_CLAS Peptide DME1724 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50.4 microM) DME1724 XEOTICID XEO02284 GENEFORM Protein DME1724 XEOTICID XEO02284 MOACRIVE Inhibition DME1724 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1724 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02285 XEO_CLAS Peptide DME1724 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50.4 microM) DME1724 XEOTICID XEO02285 GENEFORM Protein DME1724 XEOTICID XEO02285 MOACRIVE Inhibition DME1724 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1724 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02286 XEO_CLAS Peptide DME1724 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50.4 microM) DME1724 XEOTICID XEO02286 GENEFORM Protein DME1724 XEOTICID XEO02286 MOACRIVE Inhibition DME1724 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1724 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02287 XEO_CLAS Peptide DME1724 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50.4 microM) DME1724 XEOTICID XEO02287 GENEFORM Protein DME1724 XEOTICID XEO02287 MOACRIVE Inhibition DME1724 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1724 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02288 XEO_CLAS Peptide DME1724 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.2 ug/ml) DME1724 XEOTICID XEO02288 GENEFORM Protein DME1724 XEOTICID XEO02288 MOACRIVE Inhibition DME1724 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1724 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02289 XEO_CLAS Peptide DME1724 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 ug/ml) DME1724 XEOTICID XEO02289 GENEFORM Protein DME1724 XEOTICID XEO02289 MOACRIVE Inhibition DME1724 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1724 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02290 XEO_CLAS Peptide DME1724 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO02290 GENEFORM Protein DME1724 XEOTICID XEO02290 MOACRIVE Inhibition DME1724 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1724 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02291 XEO_CLAS Peptide DME1724 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02291 GENEFORM Protein DME1724 XEOTICID XEO02291 MOACRIVE Inhibition DME1724 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1724 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02293 XEO_CLAS Peptide DME1724 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 microM) DME1724 XEOTICID XEO02293 GENEFORM Protein DME1724 XEOTICID XEO02293 MOACRIVE Inhibition DME1724 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1724 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02294 XEO_CLAS Peptide DME1724 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 62-250 ug/ml) DME1724 XEOTICID XEO02294 GENEFORM Protein DME1724 XEOTICID XEO02294 MOACRIVE Inhibition DME1724 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1724 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02295 XEO_CLAS Peptide DME1724 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 ug/ml) DME1724 XEOTICID XEO02295 GENEFORM Protein DME1724 XEOTICID XEO02295 MOACRIVE Inhibition DME1724 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1724 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02296 XEO_CLAS Peptide DME1724 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02296 GENEFORM Protein DME1724 XEOTICID XEO02296 MOACRIVE Inhibition DME1724 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1724 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02297 XEO_CLAS Peptide DME1724 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC < 50 ug/ml) DME1724 XEOTICID XEO02297 GENEFORM Protein DME1724 XEOTICID XEO02297 MOACRIVE Inhibition DME1724 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1724 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02298 XEO_CLAS Peptide DME1724 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO02298 GENEFORM Protein DME1724 XEOTICID XEO02298 MOACRIVE Inhibition DME1724 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1724 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02303 XEO_CLAS Peptide DME1724 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02303 GENEFORM Protein DME1724 XEOTICID XEO02303 MOACRIVE Inhibition DME1724 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1724 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02304 XEO_CLAS Peptide DME1724 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.1 ug/ml) DME1724 XEOTICID XEO02304 GENEFORM Protein DME1724 XEOTICID XEO02304 MOACRIVE Inhibition DME1724 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1724 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02305 XEO_CLAS Peptide DME1724 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC <= 1 ug/ml) DME1724 XEOTICID XEO02305 GENEFORM Protein DME1724 XEOTICID XEO02305 MOACRIVE Inhibition DME1724 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1724 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02306 XEO_CLAS Peptide DME1724 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.2 ug/ml) DME1724 XEOTICID XEO02306 GENEFORM Protein DME1724 XEOTICID XEO02306 MOACRIVE Inhibition DME1724 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1724 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02309 XEO_CLAS Peptide DME1724 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02309 GENEFORM Protein DME1724 XEOTICID XEO02309 MOACRIVE Inhibition DME1724 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1724 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02310 XEO_CLAS Peptide DME1724 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02310 GENEFORM Protein DME1724 XEOTICID XEO02310 MOACRIVE Inhibition DME1724 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1724 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02315 XEO_CLAS Peptide DME1724 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO02315 GENEFORM Protein DME1724 XEOTICID XEO02315 MOACRIVE Inhibition DME1724 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1724 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02316 XEO_CLAS Peptide DME1724 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 50 microM) DME1724 XEOTICID XEO02316 GENEFORM Protein DME1724 XEOTICID XEO02316 MOACRIVE Inhibition DME1724 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1724 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02317 XEO_CLAS Peptide DME1724 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 300 microM) DME1724 XEOTICID XEO02317 GENEFORM Protein DME1724 XEOTICID XEO02317 MOACRIVE Inhibition DME1724 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1724 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02318 XEO_CLAS Peptide DME1724 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02318 GENEFORM Protein DME1724 XEOTICID XEO02318 MOACRIVE Inhibition DME1724 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1724 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02319 XEO_CLAS Peptide DME1724 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02319 GENEFORM Protein DME1724 XEOTICID XEO02319 MOACRIVE Inhibition DME1724 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1724 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02320 XEO_CLAS Peptide DME1724 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02320 GENEFORM Protein DME1724 XEOTICID XEO02320 MOACRIVE Inhibition DME1724 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1724 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02321 XEO_CLAS Peptide DME1724 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO02321 GENEFORM Protein DME1724 XEOTICID XEO02321 MOACRIVE Inhibition DME1724 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1724 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02322 XEO_CLAS Peptide DME1724 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02322 GENEFORM Protein DME1724 XEOTICID XEO02322 MOACRIVE Inhibition DME1724 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1724 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02323 XEO_CLAS Peptide DME1724 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO02323 GENEFORM Protein DME1724 XEOTICID XEO02323 MOACRIVE Inhibition DME1724 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1724 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02324 XEO_CLAS Peptide DME1724 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02324 GENEFORM Protein DME1724 XEOTICID XEO02324 MOACRIVE Inhibition DME1724 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1724 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02325 XEO_CLAS Peptide DME1724 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO02325 GENEFORM Protein DME1724 XEOTICID XEO02325 MOACRIVE Inhibition DME1724 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1724 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02326 XEO_CLAS Peptide DME1724 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02326 GENEFORM Protein DME1724 XEOTICID XEO02326 MOACRIVE Inhibition DME1724 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1724 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02327 XEO_CLAS Peptide DME1724 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO02327 GENEFORM Protein DME1724 XEOTICID XEO02327 MOACRIVE Inhibition DME1724 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1724 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02328 XEO_CLAS Peptide DME1724 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO02328 GENEFORM Protein DME1724 XEOTICID XEO02328 MOACRIVE Inhibition DME1724 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1724 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02332 XEO_CLAS Peptide DME1724 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.9 ug/ml) DME1724 XEOTICID XEO02332 GENEFORM Protein DME1724 XEOTICID XEO02332 MOACRIVE Inhibition DME1724 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1724 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02333 XEO_CLAS Peptide DME1724 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 200 microM) DME1724 XEOTICID XEO02333 GENEFORM Protein DME1724 XEOTICID XEO02333 MOACRIVE Inhibition DME1724 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1724 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02336 XEO_CLAS Peptide DME1724 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 microM) DME1724 XEOTICID XEO02336 GENEFORM Protein DME1724 XEOTICID XEO02336 MOACRIVE Inhibition DME1724 XEOTICID XEO02346 XEO_NAME Aurelin DME1724 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02346 XEO_CLAS Peptide DME1724 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 7.66 ug/ml) DME1724 XEOTICID XEO02346 GENEFORM Protein DME1724 XEOTICID XEO02346 MOACRIVE Inhibition DME1724 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1724 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02352 XEO_CLAS Peptide DME1724 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 11 ug/ml) DME1724 XEOTICID XEO02352 GENEFORM Protein DME1724 XEOTICID XEO02352 MOACRIVE Inhibition DME1724 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1724 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02353 XEO_CLAS Peptide DME1724 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 ug/ml) DME1724 XEOTICID XEO02353 GENEFORM Protein DME1724 XEOTICID XEO02353 MOACRIVE Inhibition DME1724 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1724 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02354 XEO_CLAS Peptide DME1724 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 ug/ml) DME1724 XEOTICID XEO02354 GENEFORM Protein DME1724 XEOTICID XEO02354 MOACRIVE Inhibition DME1724 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1724 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02355 XEO_CLAS Peptide DME1724 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 17 ug/ml) DME1724 XEOTICID XEO02355 GENEFORM Protein DME1724 XEOTICID XEO02355 MOACRIVE Inhibition DME1724 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1724 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02356 XEO_CLAS Peptide DME1724 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO02356 GENEFORM Protein DME1724 XEOTICID XEO02356 MOACRIVE Inhibition DME1724 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1724 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02357 XEO_CLAS Peptide DME1724 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO02357 GENEFORM Protein DME1724 XEOTICID XEO02357 MOACRIVE Inhibition DME1724 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1724 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02358 XEO_CLAS Peptide DME1724 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO02358 GENEFORM Protein DME1724 XEOTICID XEO02358 MOACRIVE Inhibition DME1724 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1724 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02360 XEO_CLAS Peptide DME1724 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02360 GENEFORM Protein DME1724 XEOTICID XEO02360 MOACRIVE Inhibition DME1724 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1724 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02361 XEO_CLAS Peptide DME1724 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 ug/ml) DME1724 XEOTICID XEO02361 GENEFORM Protein DME1724 XEOTICID XEO02361 MOACRIVE Inhibition DME1724 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1724 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02365 XEO_CLAS Peptide DME1724 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 32 ug/ml) DME1724 XEOTICID XEO02365 GENEFORM Protein DME1724 XEOTICID XEO02365 MOACRIVE Inhibition DME1724 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1724 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02366 XEO_CLAS Peptide DME1724 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO02366 GENEFORM Protein DME1724 XEOTICID XEO02366 MOACRIVE Inhibition DME1724 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1724 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02367 XEO_CLAS Peptide DME1724 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02367 GENEFORM Protein DME1724 XEOTICID XEO02367 MOACRIVE Inhibition DME1724 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1724 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02368 XEO_CLAS Peptide DME1724 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02368 GENEFORM Protein DME1724 XEOTICID XEO02368 MOACRIVE Inhibition DME1724 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1724 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02369 XEO_CLAS Peptide DME1724 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02369 GENEFORM Protein DME1724 XEOTICID XEO02369 MOACRIVE Inhibition DME1724 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1724 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02370 XEO_CLAS Peptide DME1724 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02370 GENEFORM Protein DME1724 XEOTICID XEO02370 MOACRIVE Inhibition DME1724 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1724 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02371 XEO_CLAS Peptide DME1724 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 ug/ml) DME1724 XEOTICID XEO02371 GENEFORM Protein DME1724 XEOTICID XEO02371 MOACRIVE Inhibition DME1724 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1724 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02374 XEO_CLAS Peptide DME1724 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02374 GENEFORM Protein DME1724 XEOTICID XEO02374 MOACRIVE Inhibition DME1724 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1724 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02376 XEO_CLAS Peptide DME1724 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02376 GENEFORM Protein DME1724 XEOTICID XEO02376 MOACRIVE Inhibition DME1724 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1724 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02378 XEO_CLAS Peptide DME1724 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.19 ug/ml) DME1724 XEOTICID XEO02378 GENEFORM Protein DME1724 XEOTICID XEO02378 MOACRIVE Inhibition DME1724 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1724 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02388 XEO_CLAS Peptide DME1724 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO02388 GENEFORM Protein DME1724 XEOTICID XEO02388 MOACRIVE Inhibition DME1724 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1724 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02389 XEO_CLAS Peptide DME1724 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02389 GENEFORM Protein DME1724 XEOTICID XEO02389 MOACRIVE Inhibition DME1724 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1724 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02415 XEO_CLAS Peptide DME1724 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02415 GENEFORM Protein DME1724 XEOTICID XEO02415 MOACRIVE Inhibition DME1724 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1724 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02416 XEO_CLAS Peptide DME1724 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 11 microM) DME1724 XEOTICID XEO02416 GENEFORM Protein DME1724 XEOTICID XEO02416 MOACRIVE Inhibition DME1724 XEOTICID XEO02419 XEO_NAME Bay oil DME1724 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1724 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02419 GENEFORM Protein DME1724 XEOTICID XEO02419 MOACRIVE Inhibition DME1724 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1724 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02435 XEO_CLAS Peptide DME1724 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02435 GENEFORM Protein DME1724 XEOTICID XEO02435 MOACRIVE Inhibition DME1724 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1724 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02436 XEO_CLAS Peptide DME1724 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02436 GENEFORM Protein DME1724 XEOTICID XEO02436 MOACRIVE Inhibition DME1724 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1724 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02437 XEO_CLAS Peptide DME1724 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02437 GENEFORM Protein DME1724 XEOTICID XEO02437 MOACRIVE Inhibition DME1724 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1724 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02438 XEO_CLAS Peptide DME1724 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02438 GENEFORM Protein DME1724 XEOTICID XEO02438 MOACRIVE Inhibition DME1724 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1724 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02439 XEO_CLAS Peptide DME1724 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02439 GENEFORM Protein DME1724 XEOTICID XEO02439 MOACRIVE Inhibition DME1724 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1724 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02440 XEO_CLAS Peptide DME1724 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02440 GENEFORM Protein DME1724 XEOTICID XEO02440 MOACRIVE Inhibition DME1724 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1724 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02441 XEO_CLAS Peptide DME1724 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02441 GENEFORM Protein DME1724 XEOTICID XEO02441 MOACRIVE Inhibition DME1724 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1724 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02442 XEO_CLAS Peptide DME1724 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO02442 GENEFORM Protein DME1724 XEOTICID XEO02442 MOACRIVE Inhibition DME1724 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1724 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02443 XEO_CLAS Peptide DME1724 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02443 GENEFORM Protein DME1724 XEOTICID XEO02443 MOACRIVE Inhibition DME1724 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1724 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02444 XEO_CLAS Peptide DME1724 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02444 GENEFORM Protein DME1724 XEOTICID XEO02444 MOACRIVE Inhibition DME1724 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1724 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1724 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02447 GENEFORM Protein DME1724 XEOTICID XEO02447 MOACRIVE Inhibition DME1724 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1724 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02452 XEO_CLAS Peptide DME1724 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 76800 ug/ml) DME1724 XEOTICID XEO02452 GENEFORM Protein DME1724 XEOTICID XEO02452 MOACRIVE Inhibition DME1724 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1724 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02453 XEO_CLAS Peptide DME1724 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02453 GENEFORM Protein DME1724 XEOTICID XEO02453 MOACRIVE Inhibition DME1724 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1724 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02463 XEO_CLAS Peptide DME1724 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 11.25 microM) DME1724 XEOTICID XEO02463 GENEFORM Protein DME1724 XEOTICID XEO02463 MOACRIVE Inhibition DME1724 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1724 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02466 XEO_CLAS Peptide DME1724 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.5 microM) DME1724 XEOTICID XEO02466 GENEFORM Protein DME1724 XEOTICID XEO02466 MOACRIVE Inhibition DME1724 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1724 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02467 XEO_CLAS Peptide DME1724 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8.4 microM) DME1724 XEOTICID XEO02467 GENEFORM Protein DME1724 XEOTICID XEO02467 MOACRIVE Inhibition DME1724 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1724 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02468 XEO_CLAS Peptide DME1724 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.7 microM) DME1724 XEOTICID XEO02468 GENEFORM Protein DME1724 XEOTICID XEO02468 MOACRIVE Inhibition DME1724 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1724 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02469 XEO_CLAS Peptide DME1724 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO02469 GENEFORM Protein DME1724 XEOTICID XEO02469 MOACRIVE Inhibition DME1724 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1724 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02470 XEO_CLAS Peptide DME1724 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.8 microM) DME1724 XEOTICID XEO02470 GENEFORM Protein DME1724 XEOTICID XEO02470 MOACRIVE Inhibition DME1724 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1724 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02471 XEO_CLAS Peptide DME1724 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4.8 microM) DME1724 XEOTICID XEO02471 GENEFORM Protein DME1724 XEOTICID XEO02471 MOACRIVE Inhibition DME1724 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1724 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02472 XEO_CLAS Peptide DME1724 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.0 microM) DME1724 XEOTICID XEO02472 GENEFORM Protein DME1724 XEOTICID XEO02472 MOACRIVE Inhibition DME1724 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1724 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02473 XEO_CLAS Peptide DME1724 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02473 GENEFORM Protein DME1724 XEOTICID XEO02473 MOACRIVE Inhibition DME1724 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1724 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02474 XEO_CLAS Peptide DME1724 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.5 microM) DME1724 XEOTICID XEO02474 GENEFORM Protein DME1724 XEOTICID XEO02474 MOACRIVE Inhibition DME1724 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1724 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02475 XEO_CLAS Peptide DME1724 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.5 microM) DME1724 XEOTICID XEO02475 GENEFORM Protein DME1724 XEOTICID XEO02475 MOACRIVE Inhibition DME1724 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1724 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02477 XEO_CLAS Peptide DME1724 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-300 ug/ml) DME1724 XEOTICID XEO02477 GENEFORM Protein DME1724 XEOTICID XEO02477 MOACRIVE Inhibition DME1724 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1724 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02478 XEO_CLAS Peptide DME1724 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-300 ug/ml) DME1724 XEOTICID XEO02478 GENEFORM Protein DME1724 XEOTICID XEO02478 MOACRIVE Inhibition DME1724 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1724 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02479 XEO_CLAS Peptide DME1724 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-300 ug/ml) DME1724 XEOTICID XEO02479 GENEFORM Protein DME1724 XEOTICID XEO02479 MOACRIVE Inhibition DME1724 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1724 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02480 XEO_CLAS Peptide DME1724 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-300 ug/ml) DME1724 XEOTICID XEO02480 GENEFORM Protein DME1724 XEOTICID XEO02480 MOACRIVE Inhibition DME1724 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1724 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02481 XEO_CLAS Peptide DME1724 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-300 ug/ml) DME1724 XEOTICID XEO02481 GENEFORM Protein DME1724 XEOTICID XEO02481 MOACRIVE Inhibition DME1724 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1724 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02482 XEO_CLAS Peptide DME1724 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-300 ug/ml) DME1724 XEOTICID XEO02482 GENEFORM Protein DME1724 XEOTICID XEO02482 MOACRIVE Inhibition DME1724 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1724 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02483 XEO_CLAS Peptide DME1724 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-300 ug/ml) DME1724 XEOTICID XEO02483 GENEFORM Protein DME1724 XEOTICID XEO02483 MOACRIVE Inhibition DME1724 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1724 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02484 XEO_CLAS Peptide DME1724 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-300 ug/ml) DME1724 XEOTICID XEO02484 GENEFORM Protein DME1724 XEOTICID XEO02484 MOACRIVE Inhibition DME1724 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1724 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02485 XEO_CLAS Peptide DME1724 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-300 ug/ml) DME1724 XEOTICID XEO02485 GENEFORM Protein DME1724 XEOTICID XEO02485 MOACRIVE Inhibition DME1724 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1724 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02486 XEO_CLAS Peptide DME1724 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-300 ug/ml) DME1724 XEOTICID XEO02486 GENEFORM Protein DME1724 XEOTICID XEO02486 MOACRIVE Inhibition DME1724 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1724 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02487 XEO_CLAS Peptide DME1724 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02487 GENEFORM Protein DME1724 XEOTICID XEO02487 MOACRIVE Inhibition DME1724 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1724 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02488 XEO_CLAS Peptide DME1724 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-300 ug/ml) DME1724 XEOTICID XEO02488 GENEFORM Protein DME1724 XEOTICID XEO02488 MOACRIVE Inhibition DME1724 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1724 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02489 XEO_CLAS Peptide DME1724 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-301 ug/ml) DME1724 XEOTICID XEO02489 GENEFORM Protein DME1724 XEOTICID XEO02489 MOACRIVE Inhibition DME1724 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1724 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02491 XEO_CLAS Peptide DME1724 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.3 microM) DME1724 XEOTICID XEO02491 GENEFORM Protein DME1724 XEOTICID XEO02491 MOACRIVE Inhibition DME1724 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1724 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02492 XEO_CLAS Peptide DME1724 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 ug/ml) DME1724 XEOTICID XEO02492 GENEFORM Protein DME1724 XEOTICID XEO02492 MOACRIVE Inhibition DME1724 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1724 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02493 XEO_CLAS Peptide DME1724 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 ug/ml) DME1724 XEOTICID XEO02493 GENEFORM Protein DME1724 XEOTICID XEO02493 MOACRIVE Inhibition DME1724 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1724 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02494 XEO_CLAS Peptide DME1724 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 ug/ml) DME1724 XEOTICID XEO02494 GENEFORM Protein DME1724 XEOTICID XEO02494 MOACRIVE Inhibition DME1724 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1724 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02495 XEO_CLAS Peptide DME1724 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 34 ug/ml) DME1724 XEOTICID XEO02495 GENEFORM Protein DME1724 XEOTICID XEO02495 MOACRIVE Inhibition DME1724 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1724 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02496 XEO_CLAS Peptide DME1724 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 13 microM) DME1724 XEOTICID XEO02496 GENEFORM Protein DME1724 XEOTICID XEO02496 MOACRIVE Inhibition DME1724 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1724 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02497 XEO_CLAS Peptide DME1724 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO02497 GENEFORM Protein DME1724 XEOTICID XEO02497 MOACRIVE Inhibition DME1724 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1724 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02499 XEO_CLAS Peptide DME1724 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO02499 GENEFORM Protein DME1724 XEOTICID XEO02499 MOACRIVE Inhibition DME1724 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1724 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02501 XEO_CLAS Peptide DME1724 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 7 microM) DME1724 XEOTICID XEO02501 GENEFORM Protein DME1724 XEOTICID XEO02501 MOACRIVE Inhibition DME1724 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1724 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02502 XEO_CLAS Peptide DME1724 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 microM) DME1724 XEOTICID XEO02502 GENEFORM Protein DME1724 XEOTICID XEO02502 MOACRIVE Inhibition DME1724 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1724 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02503 XEO_CLAS Peptide DME1724 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 19 microM) DME1724 XEOTICID XEO02503 GENEFORM Protein DME1724 XEOTICID XEO02503 MOACRIVE Inhibition DME1724 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1724 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02504 XEO_CLAS Peptide DME1724 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02504 GENEFORM Protein DME1724 XEOTICID XEO02504 MOACRIVE Inhibition DME1724 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1724 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02505 XEO_CLAS Peptide DME1724 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO02505 GENEFORM Protein DME1724 XEOTICID XEO02505 MOACRIVE Inhibition DME1724 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1724 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02507 XEO_CLAS Peptide DME1724 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO02507 GENEFORM Protein DME1724 XEOTICID XEO02507 MOACRIVE Inhibition DME1724 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1724 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02508 XEO_CLAS Peptide DME1724 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 150 microM) DME1724 XEOTICID XEO02508 GENEFORM Protein DME1724 XEOTICID XEO02508 MOACRIVE Inhibition DME1724 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1724 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02509 XEO_CLAS Peptide DME1724 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 150 microM) DME1724 XEOTICID XEO02509 GENEFORM Protein DME1724 XEOTICID XEO02509 MOACRIVE Inhibition DME1724 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1724 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02510 XEO_CLAS Peptide DME1724 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 150 microM) DME1724 XEOTICID XEO02510 GENEFORM Protein DME1724 XEOTICID XEO02510 MOACRIVE Inhibition DME1724 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1724 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02511 XEO_CLAS Peptide DME1724 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 150 microM) DME1724 XEOTICID XEO02511 GENEFORM Protein DME1724 XEOTICID XEO02511 MOACRIVE Inhibition DME1724 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1724 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02512 XEO_CLAS Peptide DME1724 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 75 microM) DME1724 XEOTICID XEO02512 GENEFORM Protein DME1724 XEOTICID XEO02512 MOACRIVE Inhibition DME1724 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1724 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02513 XEO_CLAS Peptide DME1724 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO02513 GENEFORM Protein DME1724 XEOTICID XEO02513 MOACRIVE Inhibition DME1724 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1724 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02514 XEO_CLAS Peptide DME1724 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO02514 GENEFORM Protein DME1724 XEOTICID XEO02514 MOACRIVE Inhibition DME1724 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1724 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02515 XEO_CLAS Peptide DME1724 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 80 microM) DME1724 XEOTICID XEO02515 GENEFORM Protein DME1724 XEOTICID XEO02515 MOACRIVE Inhibition DME1724 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1724 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02516 XEO_CLAS Peptide DME1724 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 32 microM) DME1724 XEOTICID XEO02516 GENEFORM Protein DME1724 XEOTICID XEO02516 MOACRIVE Inhibition DME1724 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1724 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02517 XEO_CLAS Peptide DME1724 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 microM) DME1724 XEOTICID XEO02517 GENEFORM Protein DME1724 XEOTICID XEO02517 MOACRIVE Inhibition DME1724 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1724 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02518 XEO_CLAS Peptide DME1724 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC < 15 microM) DME1724 XEOTICID XEO02518 GENEFORM Protein DME1724 XEOTICID XEO02518 MOACRIVE Inhibition DME1724 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1724 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02519 XEO_CLAS Peptide DME1724 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC < 15 microM) DME1724 XEOTICID XEO02519 GENEFORM Protein DME1724 XEOTICID XEO02519 MOACRIVE Inhibition DME1724 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1724 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02520 XEO_CLAS Peptide DME1724 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC < 15 microM) DME1724 XEOTICID XEO02520 GENEFORM Protein DME1724 XEOTICID XEO02520 MOACRIVE Inhibition DME1724 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1724 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02523 XEO_CLAS Peptide DME1724 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO02523 GENEFORM Protein DME1724 XEOTICID XEO02523 MOACRIVE Inhibition DME1724 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1724 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02524 XEO_CLAS Peptide DME1724 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 150 microM) DME1724 XEOTICID XEO02524 GENEFORM Protein DME1724 XEOTICID XEO02524 MOACRIVE Inhibition DME1724 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1724 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02525 XEO_CLAS Peptide DME1724 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 24 microM) DME1724 XEOTICID XEO02525 GENEFORM Protein DME1724 XEOTICID XEO02525 MOACRIVE Inhibition DME1724 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1724 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02526 XEO_CLAS Peptide DME1724 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 48 microM) DME1724 XEOTICID XEO02526 GENEFORM Protein DME1724 XEOTICID XEO02526 MOACRIVE Inhibition DME1724 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1724 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02527 XEO_CLAS Peptide DME1724 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 119 microM) DME1724 XEOTICID XEO02527 GENEFORM Protein DME1724 XEOTICID XEO02527 MOACRIVE Inhibition DME1724 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1724 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02528 XEO_CLAS Peptide DME1724 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 128 ug/ml) DME1724 XEOTICID XEO02528 GENEFORM Protein DME1724 XEOTICID XEO02528 MOACRIVE Inhibition DME1724 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1724 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02529 XEO_CLAS Peptide DME1724 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 128 ug/ml) DME1724 XEOTICID XEO02529 GENEFORM Protein DME1724 XEOTICID XEO02529 MOACRIVE Inhibition DME1724 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1724 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02530 XEO_CLAS Peptide DME1724 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02530 GENEFORM Protein DME1724 XEOTICID XEO02530 MOACRIVE Inhibition DME1724 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1724 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02531 XEO_CLAS Peptide DME1724 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 microM) DME1724 XEOTICID XEO02531 GENEFORM Protein DME1724 XEOTICID XEO02531 MOACRIVE Inhibition DME1724 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1724 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02533 XEO_CLAS Peptide DME1724 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.2 ug/ml) DME1724 XEOTICID XEO02533 GENEFORM Protein DME1724 XEOTICID XEO02533 MOACRIVE Inhibition DME1724 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1724 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02534 XEO_CLAS Peptide DME1724 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.6 ug/ml) DME1724 XEOTICID XEO02534 GENEFORM Protein DME1724 XEOTICID XEO02534 MOACRIVE Inhibition DME1724 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1724 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02535 XEO_CLAS Peptide DME1724 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.3 ug/ml) DME1724 XEOTICID XEO02535 GENEFORM Protein DME1724 XEOTICID XEO02535 MOACRIVE Inhibition DME1724 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1724 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02536 XEO_CLAS Peptide DME1724 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.4 ug/ml) DME1724 XEOTICID XEO02536 GENEFORM Protein DME1724 XEOTICID XEO02536 MOACRIVE Inhibition DME1724 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1724 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02537 XEO_CLAS Peptide DME1724 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.2 ug/ml) DME1724 XEOTICID XEO02537 GENEFORM Protein DME1724 XEOTICID XEO02537 MOACRIVE Inhibition DME1724 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1724 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02538 XEO_CLAS Peptide DME1724 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 9.1 ug/ml) DME1724 XEOTICID XEO02538 GENEFORM Protein DME1724 XEOTICID XEO02538 MOACRIVE Inhibition DME1724 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1724 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02539 XEO_CLAS Peptide DME1724 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8.6 ug/ml) DME1724 XEOTICID XEO02539 GENEFORM Protein DME1724 XEOTICID XEO02539 MOACRIVE Inhibition DME1724 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1724 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02540 XEO_CLAS Peptide DME1724 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15.2 ug/ml) DME1724 XEOTICID XEO02540 GENEFORM Protein DME1724 XEOTICID XEO02540 MOACRIVE Inhibition DME1724 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1724 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02541 XEO_CLAS Peptide DME1724 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 11.1 ug/ml) DME1724 XEOTICID XEO02541 GENEFORM Protein DME1724 XEOTICID XEO02541 MOACRIVE Inhibition DME1724 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1724 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02542 XEO_CLAS Peptide DME1724 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.7 ug/ml) DME1724 XEOTICID XEO02542 GENEFORM Protein DME1724 XEOTICID XEO02542 MOACRIVE Inhibition DME1724 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1724 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02543 XEO_CLAS Peptide DME1724 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 13.1 ug/ml) DME1724 XEOTICID XEO02543 GENEFORM Protein DME1724 XEOTICID XEO02543 MOACRIVE Inhibition DME1724 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1724 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02544 XEO_CLAS Peptide DME1724 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 9.8 ug/ml) DME1724 XEOTICID XEO02544 GENEFORM Protein DME1724 XEOTICID XEO02544 MOACRIVE Inhibition DME1724 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1724 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02545 XEO_CLAS Peptide DME1724 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 14 microM) DME1724 XEOTICID XEO02545 GENEFORM Protein DME1724 XEOTICID XEO02545 MOACRIVE Inhibition DME1724 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1724 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02546 XEO_CLAS Peptide DME1724 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 14 microM) DME1724 XEOTICID XEO02546 GENEFORM Protein DME1724 XEOTICID XEO02546 MOACRIVE Inhibition DME1724 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1724 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02547 XEO_CLAS Peptide DME1724 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 microM) DME1724 XEOTICID XEO02547 GENEFORM Protein DME1724 XEOTICID XEO02547 MOACRIVE Inhibition DME1724 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1724 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02548 XEO_CLAS Peptide DME1724 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 78 microM) DME1724 XEOTICID XEO02548 GENEFORM Protein DME1724 XEOTICID XEO02548 MOACRIVE Inhibition DME1724 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1724 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02549 XEO_CLAS Peptide DME1724 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02549 GENEFORM Protein DME1724 XEOTICID XEO02549 MOACRIVE Inhibition DME1724 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1724 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02552 XEO_CLAS Peptide DME1724 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 24 microM) DME1724 XEOTICID XEO02552 GENEFORM Protein DME1724 XEOTICID XEO02552 MOACRIVE Inhibition DME1724 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1724 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02553 XEO_CLAS Peptide DME1724 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02553 GENEFORM Protein DME1724 XEOTICID XEO02553 MOACRIVE Inhibition DME1724 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1724 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02556 XEO_CLAS Peptide DME1724 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 55 microM) DME1724 XEOTICID XEO02556 GENEFORM Protein DME1724 XEOTICID XEO02556 MOACRIVE Inhibition DME1724 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1724 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02557 XEO_CLAS Peptide DME1724 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 17 microM) DME1724 XEOTICID XEO02557 GENEFORM Protein DME1724 XEOTICID XEO02557 MOACRIVE Inhibition DME1724 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1724 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02558 XEO_CLAS Peptide DME1724 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 14 microM) DME1724 XEOTICID XEO02558 GENEFORM Protein DME1724 XEOTICID XEO02558 MOACRIVE Inhibition DME1724 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1724 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02559 XEO_CLAS Peptide DME1724 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02559 GENEFORM Protein DME1724 XEOTICID XEO02559 MOACRIVE Inhibition DME1724 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1724 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02560 XEO_CLAS Peptide DME1724 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 13 microM) DME1724 XEOTICID XEO02560 GENEFORM Protein DME1724 XEOTICID XEO02560 MOACRIVE Inhibition DME1724 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1724 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02561 XEO_CLAS Peptide DME1724 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO02561 GENEFORM Protein DME1724 XEOTICID XEO02561 MOACRIVE Inhibition DME1724 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1724 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02562 XEO_CLAS Peptide DME1724 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 13 microM) DME1724 XEOTICID XEO02562 GENEFORM Protein DME1724 XEOTICID XEO02562 MOACRIVE Inhibition DME1724 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1724 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02563 XEO_CLAS Peptide DME1724 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 45 microM) DME1724 XEOTICID XEO02563 GENEFORM Protein DME1724 XEOTICID XEO02563 MOACRIVE Inhibition DME1724 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1724 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02564 XEO_CLAS Peptide DME1724 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 ug/ml) DME1724 XEOTICID XEO02564 GENEFORM Protein DME1724 XEOTICID XEO02564 MOACRIVE Inhibition DME1724 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1724 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02565 XEO_CLAS Peptide DME1724 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 microM) DME1724 XEOTICID XEO02565 GENEFORM Protein DME1724 XEOTICID XEO02565 MOACRIVE Inhibition DME1724 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1724 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02566 XEO_CLAS Peptide DME1724 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO02566 GENEFORM Protein DME1724 XEOTICID XEO02566 MOACRIVE Inhibition DME1724 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1724 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02568 XEO_CLAS Peptide DME1724 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO02568 GENEFORM Protein DME1724 XEOTICID XEO02568 MOACRIVE Inhibition DME1724 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1724 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02569 XEO_CLAS Peptide DME1724 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO02569 GENEFORM Protein DME1724 XEOTICID XEO02569 MOACRIVE Inhibition DME1724 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1724 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02570 XEO_CLAS Peptide DME1724 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO02570 GENEFORM Protein DME1724 XEOTICID XEO02570 MOACRIVE Inhibition DME1724 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1724 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02571 XEO_CLAS Peptide DME1724 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO02571 GENEFORM Protein DME1724 XEOTICID XEO02571 MOACRIVE Inhibition DME1724 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1724 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02572 XEO_CLAS Peptide DME1724 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02572 GENEFORM Protein DME1724 XEOTICID XEO02572 MOACRIVE Inhibition DME1724 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1724 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02573 XEO_CLAS Peptide DME1724 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02573 GENEFORM Protein DME1724 XEOTICID XEO02573 MOACRIVE Inhibition DME1724 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1724 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02574 XEO_CLAS Peptide DME1724 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 microM) DME1724 XEOTICID XEO02574 GENEFORM Protein DME1724 XEOTICID XEO02574 MOACRIVE Inhibition DME1724 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1724 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02575 XEO_CLAS Peptide DME1724 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 microM) DME1724 XEOTICID XEO02575 GENEFORM Protein DME1724 XEOTICID XEO02575 MOACRIVE Inhibition DME1724 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1724 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02576 XEO_CLAS Peptide DME1724 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 33 microM) DME1724 XEOTICID XEO02576 GENEFORM Protein DME1724 XEOTICID XEO02576 MOACRIVE Inhibition DME1724 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1724 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02577 XEO_CLAS Peptide DME1724 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO02577 GENEFORM Protein DME1724 XEOTICID XEO02577 MOACRIVE Inhibition DME1724 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1724 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02578 XEO_CLAS Peptide DME1724 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02578 GENEFORM Protein DME1724 XEOTICID XEO02578 MOACRIVE Inhibition DME1724 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1724 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02579 XEO_CLAS Peptide DME1724 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02579 GENEFORM Protein DME1724 XEOTICID XEO02579 MOACRIVE Inhibition DME1724 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1724 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02580 XEO_CLAS Peptide DME1724 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC < 15 microM) DME1724 XEOTICID XEO02580 GENEFORM Protein DME1724 XEOTICID XEO02580 MOACRIVE Inhibition DME1724 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1724 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02581 XEO_CLAS Peptide DME1724 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 microM) DME1724 XEOTICID XEO02581 GENEFORM Protein DME1724 XEOTICID XEO02581 MOACRIVE Inhibition DME1724 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1724 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02582 XEO_CLAS Peptide DME1724 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 microM) DME1724 XEOTICID XEO02582 GENEFORM Protein DME1724 XEOTICID XEO02582 MOACRIVE Inhibition DME1724 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1724 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02583 XEO_CLAS Peptide DME1724 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 microM) DME1724 XEOTICID XEO02583 GENEFORM Protein DME1724 XEOTICID XEO02583 MOACRIVE Inhibition DME1724 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1724 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02584 XEO_CLAS Peptide DME1724 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 microM) DME1724 XEOTICID XEO02584 GENEFORM Protein DME1724 XEOTICID XEO02584 MOACRIVE Inhibition DME1724 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1724 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02585 XEO_CLAS Peptide DME1724 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO02585 GENEFORM Protein DME1724 XEOTICID XEO02585 MOACRIVE Inhibition DME1724 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1724 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02586 XEO_CLAS Peptide DME1724 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO02586 GENEFORM Protein DME1724 XEOTICID XEO02586 MOACRIVE Inhibition DME1724 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1724 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02587 XEO_CLAS Peptide DME1724 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02587 GENEFORM Protein DME1724 XEOTICID XEO02587 MOACRIVE Inhibition DME1724 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1724 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02589 XEO_CLAS Peptide DME1724 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8.2 ug/ml) DME1724 XEOTICID XEO02589 GENEFORM Protein DME1724 XEOTICID XEO02589 MOACRIVE Inhibition DME1724 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1724 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02590 XEO_CLAS Peptide DME1724 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 19.6 ug/ml) DME1724 XEOTICID XEO02590 GENEFORM Protein DME1724 XEOTICID XEO02590 MOACRIVE Inhibition DME1724 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1724 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02591 XEO_CLAS Peptide DME1724 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO02591 GENEFORM Protein DME1724 XEOTICID XEO02591 MOACRIVE Inhibition DME1724 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1724 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02593 XEO_CLAS Peptide DME1724 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 36 microM) DME1724 XEOTICID XEO02593 GENEFORM Protein DME1724 XEOTICID XEO02593 MOACRIVE Inhibition DME1724 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1724 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02594 XEO_CLAS Peptide DME1724 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02594 GENEFORM Protein DME1724 XEOTICID XEO02594 MOACRIVE Inhibition DME1724 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1724 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02595 XEO_CLAS Peptide DME1724 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO02595 GENEFORM Protein DME1724 XEOTICID XEO02595 MOACRIVE Inhibition DME1724 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1724 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02596 XEO_CLAS Peptide DME1724 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO02596 GENEFORM Protein DME1724 XEOTICID XEO02596 MOACRIVE Inhibition DME1724 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1724 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02597 XEO_CLAS Peptide DME1724 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO02597 GENEFORM Protein DME1724 XEOTICID XEO02597 MOACRIVE Inhibition DME1724 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1724 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02598 XEO_CLAS Peptide DME1724 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 32.5 microM) DME1724 XEOTICID XEO02598 GENEFORM Protein DME1724 XEOTICID XEO02598 MOACRIVE Inhibition DME1724 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1724 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02599 XEO_CLAS Peptide DME1724 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 microM) DME1724 XEOTICID XEO02599 GENEFORM Protein DME1724 XEOTICID XEO02599 MOACRIVE Inhibition DME1724 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1724 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02601 XEO_CLAS Peptide DME1724 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.1 ug/ml) DME1724 XEOTICID XEO02601 GENEFORM Protein DME1724 XEOTICID XEO02601 MOACRIVE Inhibition DME1724 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1724 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02602 XEO_CLAS Peptide DME1724 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 13.2 ug/ml) DME1724 XEOTICID XEO02602 GENEFORM Protein DME1724 XEOTICID XEO02602 MOACRIVE Inhibition DME1724 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1724 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02603 XEO_CLAS Peptide DME1724 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.3 ug/ml) DME1724 XEOTICID XEO02603 GENEFORM Protein DME1724 XEOTICID XEO02603 MOACRIVE Inhibition DME1724 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1724 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02604 XEO_CLAS Peptide DME1724 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO02604 GENEFORM Protein DME1724 XEOTICID XEO02604 MOACRIVE Inhibition DME1724 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1724 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02605 XEO_CLAS Peptide DME1724 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30.6 ug/ml) DME1724 XEOTICID XEO02605 GENEFORM Protein DME1724 XEOTICID XEO02605 MOACRIVE Inhibition DME1724 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1724 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02606 XEO_CLAS Peptide DME1724 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 11.2 ug/ml) DME1724 XEOTICID XEO02606 GENEFORM Protein DME1724 XEOTICID XEO02606 MOACRIVE Inhibition DME1724 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1724 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02607 XEO_CLAS Peptide DME1724 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.8 ug/ml) DME1724 XEOTICID XEO02607 GENEFORM Protein DME1724 XEOTICID XEO02607 MOACRIVE Inhibition DME1724 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1724 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02608 XEO_CLAS Peptide DME1724 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 7.9 ug/ml) DME1724 XEOTICID XEO02608 GENEFORM Protein DME1724 XEOTICID XEO02608 MOACRIVE Inhibition DME1724 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1724 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02609 XEO_CLAS Peptide DME1724 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15.8 ug/ml) DME1724 XEOTICID XEO02609 GENEFORM Protein DME1724 XEOTICID XEO02609 MOACRIVE Inhibition DME1724 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1724 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02610 XEO_CLAS Peptide DME1724 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.1 ug/ml) DME1724 XEOTICID XEO02610 GENEFORM Protein DME1724 XEOTICID XEO02610 MOACRIVE Inhibition DME1724 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1724 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02611 XEO_CLAS Peptide DME1724 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20.6 ug/ml) DME1724 XEOTICID XEO02611 GENEFORM Protein DME1724 XEOTICID XEO02611 MOACRIVE Inhibition DME1724 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1724 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02612 XEO_CLAS Peptide DME1724 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 11.8 ug/ml) DME1724 XEOTICID XEO02612 GENEFORM Protein DME1724 XEOTICID XEO02612 MOACRIVE Inhibition DME1724 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1724 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02613 XEO_CLAS Peptide DME1724 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 13.2 ug/ml) DME1724 XEOTICID XEO02613 GENEFORM Protein DME1724 XEOTICID XEO02613 MOACRIVE Inhibition DME1724 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1724 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02614 XEO_CLAS Peptide DME1724 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.8 ug/ml) DME1724 XEOTICID XEO02614 GENEFORM Protein DME1724 XEOTICID XEO02614 MOACRIVE Inhibition DME1724 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1724 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02615 XEO_CLAS Peptide DME1724 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8.6 ug/ml) DME1724 XEOTICID XEO02615 GENEFORM Protein DME1724 XEOTICID XEO02615 MOACRIVE Inhibition DME1724 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1724 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02616 XEO_CLAS Peptide DME1724 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20.4 ug/ml) DME1724 XEOTICID XEO02616 GENEFORM Protein DME1724 XEOTICID XEO02616 MOACRIVE Inhibition DME1724 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1724 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02617 XEO_CLAS Peptide DME1724 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4.7 ug/ml) DME1724 XEOTICID XEO02617 GENEFORM Protein DME1724 XEOTICID XEO02617 MOACRIVE Inhibition DME1724 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1724 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02618 XEO_CLAS Peptide DME1724 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.6 ug/ml) DME1724 XEOTICID XEO02618 GENEFORM Protein DME1724 XEOTICID XEO02618 MOACRIVE Inhibition DME1724 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1724 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02619 XEO_CLAS Peptide DME1724 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10.5 ug/ml) DME1724 XEOTICID XEO02619 GENEFORM Protein DME1724 XEOTICID XEO02619 MOACRIVE Inhibition DME1724 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1724 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02620 XEO_CLAS Peptide DME1724 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO02620 GENEFORM Protein DME1724 XEOTICID XEO02620 MOACRIVE Inhibition DME1724 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1724 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02621 XEO_CLAS Peptide DME1724 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO02621 GENEFORM Protein DME1724 XEOTICID XEO02621 MOACRIVE Inhibition DME1724 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1724 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02622 XEO_CLAS Peptide DME1724 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO02622 GENEFORM Protein DME1724 XEOTICID XEO02622 MOACRIVE Inhibition DME1724 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1724 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02623 XEO_CLAS Peptide DME1724 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO02623 GENEFORM Protein DME1724 XEOTICID XEO02623 MOACRIVE Inhibition DME1724 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1724 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02624 XEO_CLAS Peptide DME1724 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 18 microM) DME1724 XEOTICID XEO02624 GENEFORM Protein DME1724 XEOTICID XEO02624 MOACRIVE Inhibition DME1724 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1724 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02625 XEO_CLAS Peptide DME1724 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 9 microM) DME1724 XEOTICID XEO02625 GENEFORM Protein DME1724 XEOTICID XEO02625 MOACRIVE Inhibition DME1724 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1724 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02626 XEO_CLAS Peptide DME1724 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 18 microM) DME1724 XEOTICID XEO02626 GENEFORM Protein DME1724 XEOTICID XEO02626 MOACRIVE Inhibition DME1724 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1724 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02627 XEO_CLAS Peptide DME1724 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02627 GENEFORM Protein DME1724 XEOTICID XEO02627 MOACRIVE Inhibition DME1724 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1724 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02628 XEO_CLAS Peptide DME1724 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 18 microM) DME1724 XEOTICID XEO02628 GENEFORM Protein DME1724 XEOTICID XEO02628 MOACRIVE Inhibition DME1724 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1724 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02629 XEO_CLAS Peptide DME1724 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 13 microM) DME1724 XEOTICID XEO02629 GENEFORM Protein DME1724 XEOTICID XEO02629 MOACRIVE Inhibition DME1724 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1724 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02630 XEO_CLAS Peptide DME1724 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 ug/ml) DME1724 XEOTICID XEO02630 GENEFORM Protein DME1724 XEOTICID XEO02630 MOACRIVE Inhibition DME1724 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1724 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02631 XEO_CLAS Peptide DME1724 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 ug/ml) DME1724 XEOTICID XEO02631 GENEFORM Protein DME1724 XEOTICID XEO02631 MOACRIVE Inhibition DME1724 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1724 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02634 XEO_CLAS Peptide DME1724 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO02634 GENEFORM Protein DME1724 XEOTICID XEO02634 MOACRIVE Inhibition DME1724 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1724 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02635 XEO_CLAS Peptide DME1724 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40 ug/ml) DME1724 XEOTICID XEO02635 GENEFORM Protein DME1724 XEOTICID XEO02635 MOACRIVE Inhibition DME1724 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1724 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02636 XEO_CLAS Peptide DME1724 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO02636 GENEFORM Protein DME1724 XEOTICID XEO02636 MOACRIVE Inhibition DME1724 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1724 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02637 XEO_CLAS Peptide DME1724 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO02637 GENEFORM Protein DME1724 XEOTICID XEO02637 MOACRIVE Inhibition DME1724 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1724 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02638 XEO_CLAS Peptide DME1724 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 microM) DME1724 XEOTICID XEO02638 GENEFORM Protein DME1724 XEOTICID XEO02638 MOACRIVE Inhibition DME1724 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1724 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02639 XEO_CLAS Peptide DME1724 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 microM) DME1724 XEOTICID XEO02639 GENEFORM Protein DME1724 XEOTICID XEO02639 MOACRIVE Inhibition DME1724 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1724 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02644 XEO_CLAS Peptide DME1724 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02644 GENEFORM Protein DME1724 XEOTICID XEO02644 MOACRIVE Inhibition DME1724 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1724 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02645 XEO_CLAS Peptide DME1724 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02645 GENEFORM Protein DME1724 XEOTICID XEO02645 MOACRIVE Inhibition DME1724 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1724 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02646 XEO_CLAS Peptide DME1724 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02646 GENEFORM Protein DME1724 XEOTICID XEO02646 MOACRIVE Inhibition DME1724 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1724 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02647 XEO_CLAS Peptide DME1724 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02647 GENEFORM Protein DME1724 XEOTICID XEO02647 MOACRIVE Inhibition DME1724 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1724 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02649 XEO_CLAS Peptide DME1724 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO02649 GENEFORM Protein DME1724 XEOTICID XEO02649 MOACRIVE Inhibition DME1724 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1724 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02650 XEO_CLAS Peptide DME1724 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO02650 GENEFORM Protein DME1724 XEOTICID XEO02650 MOACRIVE Inhibition DME1724 XEOTICID XEO02658 XEO_NAME Buthinin DME1724 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02658 XEO_CLAS Peptide DME1724 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02658 GENEFORM Protein DME1724 XEOTICID XEO02658 MOACRIVE Inhibition DME1724 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1724 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02663 XEO_CLAS Peptide DME1724 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25 microM) DME1724 XEOTICID XEO02663 GENEFORM Protein DME1724 XEOTICID XEO02663 MOACRIVE Inhibition DME1724 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1724 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02664 XEO_CLAS Peptide DME1724 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25 microM) DME1724 XEOTICID XEO02664 GENEFORM Protein DME1724 XEOTICID XEO02664 MOACRIVE Inhibition DME1724 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1724 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02672 XEO_CLAS Peptide DME1724 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25 microM) DME1724 XEOTICID XEO02672 GENEFORM Protein DME1724 XEOTICID XEO02672 MOACRIVE Inhibition DME1724 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1724 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02673 XEO_CLAS Peptide DME1724 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1724 XEOTICID XEO02673 GENEFORM Protein DME1724 XEOTICID XEO02673 MOACRIVE Inhibition DME1724 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1724 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02674 XEO_CLAS Peptide DME1724 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.125-6.25 microM) DME1724 XEOTICID XEO02674 GENEFORM Protein DME1724 XEOTICID XEO02674 MOACRIVE Inhibition DME1724 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1724 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02676 XEO_CLAS Peptide DME1724 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO02676 GENEFORM Protein DME1724 XEOTICID XEO02676 MOACRIVE Inhibition DME1724 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1724 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02677 XEO_CLAS Peptide DME1724 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1724 XEOTICID XEO02677 GENEFORM Protein DME1724 XEOTICID XEO02677 MOACRIVE Inhibition DME1724 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1724 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02679 XEO_CLAS Peptide DME1724 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1724 XEOTICID XEO02679 GENEFORM Protein DME1724 XEOTICID XEO02679 MOACRIVE Inhibition DME1724 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1724 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02680 XEO_CLAS Peptide DME1724 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25 microM) DME1724 XEOTICID XEO02680 GENEFORM Protein DME1724 XEOTICID XEO02680 MOACRIVE Inhibition DME1724 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1724 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02683 XEO_CLAS Peptide DME1724 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO02683 GENEFORM Protein DME1724 XEOTICID XEO02683 MOACRIVE Inhibition DME1724 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1724 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02688 XEO_CLAS Peptide DME1724 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO02688 GENEFORM Protein DME1724 XEOTICID XEO02688 MOACRIVE Inhibition DME1724 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1724 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02693 XEO_CLAS Peptide DME1724 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 ug/ml) DME1724 XEOTICID XEO02693 GENEFORM Protein DME1724 XEOTICID XEO02693 MOACRIVE Inhibition DME1724 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1724 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02699 XEO_CLAS Peptide DME1724 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 ug/ml) DME1724 XEOTICID XEO02699 GENEFORM Protein DME1724 XEOTICID XEO02699 MOACRIVE Inhibition DME1724 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1724 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02700 XEO_CLAS Peptide DME1724 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 ug/ml) DME1724 XEOTICID XEO02700 GENEFORM Protein DME1724 XEOTICID XEO02700 MOACRIVE Inhibition DME1724 XEOTICID XEO02703 XEO_NAME Calcitermin DME1724 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02703 XEO_CLAS Peptide DME1724 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02703 GENEFORM Protein DME1724 XEOTICID XEO02703 MOACRIVE Inhibition DME1724 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1724 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02708 XEO_CLAS Peptide DME1724 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO02708 GENEFORM Protein DME1724 XEOTICID XEO02708 MOACRIVE Inhibition DME1724 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1724 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02709 XEO_CLAS Peptide DME1724 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.05 microM) DME1724 XEOTICID XEO02709 GENEFORM Protein DME1724 XEOTICID XEO02709 MOACRIVE Inhibition DME1724 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1724 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1724 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02713 GENEFORM Protein DME1724 XEOTICID XEO02713 MOACRIVE Inhibition DME1724 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1724 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1724 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02714 GENEFORM Protein DME1724 XEOTICID XEO02714 MOACRIVE Inhibition DME1724 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1724 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02726 XEO_CLAS Peptide DME1724 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02726 GENEFORM Protein DME1724 XEOTICID XEO02726 MOACRIVE Inhibition DME1724 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1724 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02731 XEO_CLAS Peptide DME1724 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1 microM) DME1724 XEOTICID XEO02731 GENEFORM Protein DME1724 XEOTICID XEO02731 MOACRIVE Inhibition DME1724 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1724 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02732 XEO_CLAS Peptide DME1724 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.25 microM) DME1724 XEOTICID XEO02732 GENEFORM Protein DME1724 XEOTICID XEO02732 MOACRIVE Inhibition DME1724 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1724 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02733 XEO_CLAS Peptide DME1724 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8-25 ug/ml) DME1724 XEOTICID XEO02733 GENEFORM Protein DME1724 XEOTICID XEO02733 MOACRIVE Inhibition DME1724 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1724 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02735 XEO_CLAS Peptide DME1724 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1 ug/ml) DME1724 XEOTICID XEO02735 GENEFORM Protein DME1724 XEOTICID XEO02735 MOACRIVE Inhibition DME1724 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1724 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02737 XEO_CLAS Peptide DME1724 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02737 GENEFORM Protein DME1724 XEOTICID XEO02737 MOACRIVE Inhibition DME1724 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1724 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02738 XEO_CLAS Peptide DME1724 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO02738 GENEFORM Protein DME1724 XEOTICID XEO02738 MOACRIVE Inhibition DME1724 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1724 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02739 XEO_CLAS Peptide DME1724 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 microM) DME1724 XEOTICID XEO02739 GENEFORM Protein DME1724 XEOTICID XEO02739 MOACRIVE Inhibition DME1724 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1724 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02740 XEO_CLAS Peptide DME1724 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.25 ug/ml) DME1724 XEOTICID XEO02740 GENEFORM Protein DME1724 XEOTICID XEO02740 MOACRIVE Inhibition DME1724 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1724 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02741 XEO_CLAS Peptide DME1724 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 ug/ml) DME1724 XEOTICID XEO02741 GENEFORM Protein DME1724 XEOTICID XEO02741 MOACRIVE Inhibition DME1724 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1724 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02743 XEO_CLAS Peptide DME1724 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.6 ug/ml) DME1724 XEOTICID XEO02743 GENEFORM Protein DME1724 XEOTICID XEO02743 MOACRIVE Inhibition DME1724 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1724 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02744 XEO_CLAS Peptide DME1724 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 18.7 ug/ml) DME1724 XEOTICID XEO02744 GENEFORM Protein DME1724 XEOTICID XEO02744 MOACRIVE Inhibition DME1724 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1724 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02745 XEO_CLAS Peptide DME1724 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02745 GENEFORM Protein DME1724 XEOTICID XEO02745 MOACRIVE Inhibition DME1724 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1724 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02746 XEO_CLAS Peptide DME1724 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02746 GENEFORM Protein DME1724 XEOTICID XEO02746 MOACRIVE Inhibition DME1724 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1724 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02748 XEO_CLAS Peptide DME1724 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02748 GENEFORM Protein DME1724 XEOTICID XEO02748 MOACRIVE Inhibition DME1724 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1724 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02749 XEO_CLAS Peptide DME1724 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20-25 mug/ml) DME1724 XEOTICID XEO02749 GENEFORM Protein DME1724 XEOTICID XEO02749 MOACRIVE Inhibition DME1724 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1724 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02750 XEO_CLAS Peptide DME1724 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02750 GENEFORM Protein DME1724 XEOTICID XEO02750 MOACRIVE Inhibition DME1724 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1724 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02752 XEO_CLAS Peptide DME1724 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02752 GENEFORM Protein DME1724 XEOTICID XEO02752 MOACRIVE Inhibition DME1724 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1724 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02753 XEO_CLAS Peptide DME1724 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02753 GENEFORM Protein DME1724 XEOTICID XEO02753 MOACRIVE Inhibition DME1724 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1724 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02754 XEO_CLAS Peptide DME1724 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 microM) DME1724 XEOTICID XEO02754 GENEFORM Protein DME1724 XEOTICID XEO02754 MOACRIVE Inhibition DME1724 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1724 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02756 XEO_CLAS Peptide DME1724 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 microM) DME1724 XEOTICID XEO02756 GENEFORM Protein DME1724 XEOTICID XEO02756 MOACRIVE Inhibition DME1724 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1724 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02757 XEO_CLAS Peptide DME1724 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1 microM) DME1724 XEOTICID XEO02757 GENEFORM Protein DME1724 XEOTICID XEO02757 MOACRIVE Inhibition DME1724 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1724 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02758 XEO_CLAS Peptide DME1724 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO02758 GENEFORM Protein DME1724 XEOTICID XEO02758 MOACRIVE Inhibition DME1724 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1724 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02759 XEO_CLAS Peptide DME1724 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.6 microM) DME1724 XEOTICID XEO02759 GENEFORM Protein DME1724 XEOTICID XEO02759 MOACRIVE Inhibition DME1724 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1724 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02760 XEO_CLAS Peptide DME1724 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 microM) DME1724 XEOTICID XEO02760 GENEFORM Protein DME1724 XEOTICID XEO02760 MOACRIVE Inhibition DME1724 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1724 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02761 XEO_CLAS Peptide DME1724 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO02761 GENEFORM Protein DME1724 XEOTICID XEO02761 MOACRIVE Inhibition DME1724 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1724 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02762 XEO_CLAS Peptide DME1724 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 microM) DME1724 XEOTICID XEO02762 GENEFORM Protein DME1724 XEOTICID XEO02762 MOACRIVE Inhibition DME1724 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1724 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02763 XEO_CLAS Peptide DME1724 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.4 microM) DME1724 XEOTICID XEO02763 GENEFORM Protein DME1724 XEOTICID XEO02763 MOACRIVE Inhibition DME1724 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1724 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02764 XEO_CLAS Peptide DME1724 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 microM) DME1724 XEOTICID XEO02764 GENEFORM Protein DME1724 XEOTICID XEO02764 MOACRIVE Inhibition DME1724 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1724 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02765 XEO_CLAS Peptide DME1724 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.3 microM) DME1724 XEOTICID XEO02765 GENEFORM Protein DME1724 XEOTICID XEO02765 MOACRIVE Inhibition DME1724 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1724 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02767 XEO_CLAS Peptide DME1724 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02767 GENEFORM Protein DME1724 XEOTICID XEO02767 MOACRIVE Inhibition DME1724 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1724 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02768 XEO_CLAS Peptide DME1724 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1724 XEOTICID XEO02768 GENEFORM Protein DME1724 XEOTICID XEO02768 MOACRIVE Inhibition DME1724 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1724 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02769 XEO_CLAS Peptide DME1724 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.32 microM) DME1724 XEOTICID XEO02769 GENEFORM Protein DME1724 XEOTICID XEO02769 MOACRIVE Inhibition DME1724 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1724 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02770 XEO_CLAS Peptide DME1724 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.30 microM) DME1724 XEOTICID XEO02770 GENEFORM Protein DME1724 XEOTICID XEO02770 MOACRIVE Inhibition DME1724 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1724 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02771 XEO_CLAS Peptide DME1724 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.21 microM) DME1724 XEOTICID XEO02771 GENEFORM Protein DME1724 XEOTICID XEO02771 MOACRIVE Inhibition DME1724 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1724 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02772 XEO_CLAS Peptide DME1724 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02772 GENEFORM Protein DME1724 XEOTICID XEO02772 MOACRIVE Inhibition DME1724 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1724 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02773 XEO_CLAS Peptide DME1724 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.9-8.6 microM) DME1724 XEOTICID XEO02773 GENEFORM Protein DME1724 XEOTICID XEO02773 MOACRIVE Inhibition DME1724 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1724 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02774 XEO_CLAS Peptide DME1724 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.3 microM) DME1724 XEOTICID XEO02774 GENEFORM Protein DME1724 XEOTICID XEO02774 MOACRIVE Inhibition DME1724 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1724 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02789 GENEFORM Protein DME1724 XEOTICID XEO02789 MOACRIVE Inhibition DME1724 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1724 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02790 GENEFORM Protein DME1724 XEOTICID XEO02790 MOACRIVE Inhibition DME1724 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1724 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02791 GENEFORM Protein DME1724 XEOTICID XEO02791 MOACRIVE Inhibition DME1724 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1724 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02792 GENEFORM Protein DME1724 XEOTICID XEO02792 MOACRIVE Inhibition DME1724 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1724 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02793 GENEFORM Protein DME1724 XEOTICID XEO02793 MOACRIVE Inhibition DME1724 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1724 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02794 GENEFORM Protein DME1724 XEOTICID XEO02794 MOACRIVE Inhibition DME1724 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1724 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02795 GENEFORM Protein DME1724 XEOTICID XEO02795 MOACRIVE Inhibition DME1724 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1724 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02796 GENEFORM Protein DME1724 XEOTICID XEO02796 MOACRIVE Inhibition DME1724 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1724 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02797 GENEFORM Protein DME1724 XEOTICID XEO02797 MOACRIVE Inhibition DME1724 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1724 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02799 XEO_CLAS Peptide DME1724 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02799 GENEFORM Protein DME1724 XEOTICID XEO02799 MOACRIVE Inhibition DME1724 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1724 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02800 XEO_CLAS Peptide DME1724 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02800 GENEFORM Protein DME1724 XEOTICID XEO02800 MOACRIVE Inhibition DME1724 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1724 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02802 XEO_CLAS Peptide DME1724 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 13.6 microM) DME1724 XEOTICID XEO02802 GENEFORM Protein DME1724 XEOTICID XEO02802 MOACRIVE Inhibition DME1724 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1724 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02807 XEO_CLAS Peptide DME1724 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.2 microM) DME1724 XEOTICID XEO02807 GENEFORM Protein DME1724 XEOTICID XEO02807 MOACRIVE Inhibition DME1724 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1724 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02813 XEO_CLAS Peptide DME1724 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 80 microM) DME1724 XEOTICID XEO02813 GENEFORM Protein DME1724 XEOTICID XEO02813 MOACRIVE Inhibition DME1724 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1724 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02814 XEO_CLAS Peptide DME1724 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 80 microM) DME1724 XEOTICID XEO02814 GENEFORM Protein DME1724 XEOTICID XEO02814 MOACRIVE Inhibition DME1724 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1724 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02815 XEO_CLAS Peptide DME1724 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8.5 microM) DME1724 XEOTICID XEO02815 GENEFORM Protein DME1724 XEOTICID XEO02815 MOACRIVE Inhibition DME1724 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1724 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02816 XEO_CLAS Peptide DME1724 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 80 microM) DME1724 XEOTICID XEO02816 GENEFORM Protein DME1724 XEOTICID XEO02816 MOACRIVE Inhibition DME1724 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1724 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02817 XEO_CLAS Peptide DME1724 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 80 microM) DME1724 XEOTICID XEO02817 GENEFORM Protein DME1724 XEOTICID XEO02817 MOACRIVE Inhibition DME1724 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1724 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02818 XEO_CLAS Peptide DME1724 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.4 microM) DME1724 XEOTICID XEO02818 GENEFORM Protein DME1724 XEOTICID XEO02818 MOACRIVE Inhibition DME1724 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1724 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02819 XEO_CLAS Peptide DME1724 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.6 microM) DME1724 XEOTICID XEO02819 GENEFORM Protein DME1724 XEOTICID XEO02819 MOACRIVE Inhibition DME1724 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1724 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02820 XEO_CLAS Peptide DME1724 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO02820 GENEFORM Protein DME1724 XEOTICID XEO02820 MOACRIVE Inhibition DME1724 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1724 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02821 XEO_CLAS Peptide DME1724 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02821 GENEFORM Protein DME1724 XEOTICID XEO02821 MOACRIVE Inhibition DME1724 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1724 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02824 XEO_CLAS Peptide DME1724 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 35 microM) DME1724 XEOTICID XEO02824 GENEFORM Protein DME1724 XEOTICID XEO02824 MOACRIVE Inhibition DME1724 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1724 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02826 XEO_CLAS Peptide DME1724 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.7 ug/ml) DME1724 XEOTICID XEO02826 GENEFORM Protein DME1724 XEOTICID XEO02826 MOACRIVE Inhibition DME1724 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1724 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02834 GENEFORM Protein DME1724 XEOTICID XEO02834 MOACRIVE Inhibition DME1724 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1724 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02839 XEO_CLAS Peptide DME1724 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.25 microM) DME1724 XEOTICID XEO02839 GENEFORM Protein DME1724 XEOTICID XEO02839 MOACRIVE Inhibition DME1724 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1724 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02841 XEO_CLAS Peptide DME1724 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.25 microM) DME1724 XEOTICID XEO02841 GENEFORM Protein DME1724 XEOTICID XEO02841 MOACRIVE Inhibition DME1724 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1724 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02842 XEO_CLAS Peptide DME1724 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.25 microM) DME1724 XEOTICID XEO02842 GENEFORM Protein DME1724 XEOTICID XEO02842 MOACRIVE Inhibition DME1724 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1724 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02843 XEO_CLAS Peptide DME1724 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02843 GENEFORM Protein DME1724 XEOTICID XEO02843 MOACRIVE Inhibition DME1724 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1724 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02849 GENEFORM Protein DME1724 XEOTICID XEO02849 MOACRIVE Inhibition DME1724 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1724 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02857 XEO_CLAS Peptide DME1724 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 53 microM) DME1724 XEOTICID XEO02857 GENEFORM Protein DME1724 XEOTICID XEO02857 MOACRIVE Inhibition DME1724 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1724 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02858 XEO_CLAS Peptide DME1724 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 53 microM) DME1724 XEOTICID XEO02858 GENEFORM Protein DME1724 XEOTICID XEO02858 MOACRIVE Inhibition DME1724 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1724 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02860 XEO_CLAS Peptide DME1724 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 ug/ml) DME1724 XEOTICID XEO02860 GENEFORM Protein DME1724 XEOTICID XEO02860 MOACRIVE Inhibition DME1724 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1724 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02867 XEO_CLAS Peptide DME1724 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02867 GENEFORM Protein DME1724 XEOTICID XEO02867 MOACRIVE Inhibition DME1724 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1724 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02868 XEO_CLAS Peptide DME1724 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02868 GENEFORM Protein DME1724 XEOTICID XEO02868 MOACRIVE Inhibition DME1724 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1724 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02869 XEO_CLAS Peptide DME1724 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02869 GENEFORM Protein DME1724 XEOTICID XEO02869 MOACRIVE Inhibition DME1724 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1724 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02870 XEO_CLAS Peptide DME1724 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02870 GENEFORM Protein DME1724 XEOTICID XEO02870 MOACRIVE Inhibition DME1724 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1724 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02871 XEO_CLAS Peptide DME1724 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02871 GENEFORM Protein DME1724 XEOTICID XEO02871 MOACRIVE Inhibition DME1724 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1724 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02872 XEO_CLAS Peptide DME1724 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 308 microM) DME1724 XEOTICID XEO02872 GENEFORM Protein DME1724 XEOTICID XEO02872 MOACRIVE Inhibition DME1724 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1724 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02875 XEO_CLAS Peptide DME1724 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.1 microM) DME1724 XEOTICID XEO02875 GENEFORM Protein DME1724 XEOTICID XEO02875 MOACRIVE Inhibition DME1724 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1724 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02876 XEO_CLAS Peptide DME1724 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO02876 GENEFORM Protein DME1724 XEOTICID XEO02876 MOACRIVE Inhibition DME1724 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1724 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02877 XEO_CLAS Peptide DME1724 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO02877 GENEFORM Protein DME1724 XEOTICID XEO02877 MOACRIVE Inhibition DME1724 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1724 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02878 XEO_CLAS Peptide DME1724 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.3 microM) DME1724 XEOTICID XEO02878 GENEFORM Protein DME1724 XEOTICID XEO02878 MOACRIVE Inhibition DME1724 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1724 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02885 XEO_CLAS Peptide DME1724 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02885 GENEFORM Protein DME1724 XEOTICID XEO02885 MOACRIVE Inhibition DME1724 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1724 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02886 XEO_CLAS Peptide DME1724 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02886 GENEFORM Protein DME1724 XEOTICID XEO02886 MOACRIVE Inhibition DME1724 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1724 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02887 XEO_CLAS Peptide DME1724 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1 ug/ml) DME1724 XEOTICID XEO02887 GENEFORM Protein DME1724 XEOTICID XEO02887 MOACRIVE Inhibition DME1724 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1724 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02888 XEO_CLAS Peptide DME1724 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 ug/ml) DME1724 XEOTICID XEO02888 GENEFORM Protein DME1724 XEOTICID XEO02888 MOACRIVE Inhibition DME1724 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1724 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02889 XEO_CLAS Peptide DME1724 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 ug/ml) DME1724 XEOTICID XEO02889 GENEFORM Protein DME1724 XEOTICID XEO02889 MOACRIVE Inhibition DME1724 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1724 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02890 XEO_CLAS Peptide DME1724 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02890 GENEFORM Protein DME1724 XEOTICID XEO02890 MOACRIVE Inhibition DME1724 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1724 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02891 XEO_CLAS Peptide DME1724 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02891 GENEFORM Protein DME1724 XEOTICID XEO02891 MOACRIVE Inhibition DME1724 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1724 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02895 XEO_CLAS Peptide DME1724 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO02895 GENEFORM Protein DME1724 XEOTICID XEO02895 MOACRIVE Inhibition DME1724 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1724 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02896 XEO_CLAS Peptide DME1724 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO02896 GENEFORM Protein DME1724 XEOTICID XEO02896 MOACRIVE Inhibition DME1724 XEOTICID XEO02899 XEO_NAME Coladonin DME1724 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1724 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1724 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02899 GENEFORM Protein DME1724 XEOTICID XEO02899 MOACRIVE Inhibition DME1724 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1724 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02900 XEO_CLAS Peptide DME1724 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02900 GENEFORM Protein DME1724 XEOTICID XEO02900 MOACRIVE Inhibition DME1724 XEOTICID XEO02901 XEO_NAME Colicin-V DME1724 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02901 XEO_CLAS Peptide DME1724 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02901 GENEFORM Protein DME1724 XEOTICID XEO02901 MOACRIVE Inhibition DME1724 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1724 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02904 GENEFORM Protein DME1724 XEOTICID XEO02904 MOACRIVE Inhibition DME1724 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1724 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02908 XEO_CLAS Peptide DME1724 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 50 microM) DME1724 XEOTICID XEO02908 GENEFORM Protein DME1724 XEOTICID XEO02908 MOACRIVE Inhibition DME1724 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1724 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02923 XEO_CLAS Peptide DME1724 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02923 GENEFORM Protein DME1724 XEOTICID XEO02923 MOACRIVE Inhibition DME1724 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1724 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02924 XEO_CLAS Peptide DME1724 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 32 microM) DME1724 XEOTICID XEO02924 GENEFORM Protein DME1724 XEOTICID XEO02924 MOACRIVE Inhibition DME1724 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1724 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1724 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02927 GENEFORM Protein DME1724 XEOTICID XEO02927 MOACRIVE Inhibition DME1724 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1724 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02931 XEO_CLAS Peptide DME1724 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 ug/ml) DME1724 XEOTICID XEO02931 GENEFORM Protein DME1724 XEOTICID XEO02931 MOACRIVE Inhibition DME1724 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1724 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02933 XEO_CLAS Peptide DME1724 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO02933 GENEFORM Protein DME1724 XEOTICID XEO02933 MOACRIVE Inhibition DME1724 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1724 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02934 XEO_CLAS Peptide DME1724 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02934 GENEFORM Protein DME1724 XEOTICID XEO02934 MOACRIVE Inhibition DME1724 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1724 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02935 XEO_CLAS Peptide DME1724 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02935 GENEFORM Protein DME1724 XEOTICID XEO02935 MOACRIVE Inhibition DME1724 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1724 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02936 XEO_CLAS Peptide DME1724 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO02936 GENEFORM Protein DME1724 XEOTICID XEO02936 MOACRIVE Inhibition DME1724 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1724 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02937 XEO_CLAS Peptide DME1724 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02937 GENEFORM Protein DME1724 XEOTICID XEO02937 MOACRIVE Inhibition DME1724 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1724 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02938 XEO_CLAS Peptide DME1724 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 32 ug/ml) DME1724 XEOTICID XEO02938 GENEFORM Protein DME1724 XEOTICID XEO02938 MOACRIVE Inhibition DME1724 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1724 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02939 XEO_CLAS Peptide DME1724 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 11 ug/ml) DME1724 XEOTICID XEO02939 GENEFORM Protein DME1724 XEOTICID XEO02939 MOACRIVE Inhibition DME1724 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1724 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02940 XEO_CLAS Peptide DME1724 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1 ug/ml) DME1724 XEOTICID XEO02940 GENEFORM Protein DME1724 XEOTICID XEO02940 MOACRIVE Inhibition DME1724 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1724 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02941 XEO_CLAS Peptide DME1724 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02941 GENEFORM Protein DME1724 XEOTICID XEO02941 MOACRIVE Inhibition DME1724 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1724 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02944 XEO_CLAS Peptide DME1724 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 microM) DME1724 XEOTICID XEO02944 GENEFORM Protein DME1724 XEOTICID XEO02944 MOACRIVE Inhibition DME1724 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1724 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02945 XEO_CLAS Peptide DME1724 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 microM) DME1724 XEOTICID XEO02945 GENEFORM Protein DME1724 XEOTICID XEO02945 MOACRIVE Inhibition DME1724 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1724 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02946 XEO_CLAS Peptide DME1724 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 microM) DME1724 XEOTICID XEO02946 GENEFORM Protein DME1724 XEOTICID XEO02946 MOACRIVE Inhibition DME1724 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1724 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02947 XEO_CLAS Peptide DME1724 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02947 GENEFORM Protein DME1724 XEOTICID XEO02947 MOACRIVE Inhibition DME1724 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1724 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02948 XEO_CLAS Peptide DME1724 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO02948 GENEFORM Protein DME1724 XEOTICID XEO02948 MOACRIVE Inhibition DME1724 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1724 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02949 XEO_CLAS Peptide DME1724 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO02949 GENEFORM Protein DME1724 XEOTICID XEO02949 MOACRIVE Inhibition DME1724 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1724 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02954 XEO_CLAS Peptide DME1724 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02954 GENEFORM Protein DME1724 XEOTICID XEO02954 MOACRIVE Inhibition DME1724 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1724 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02958 XEO_CLAS Peptide DME1724 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02958 GENEFORM Protein DME1724 XEOTICID XEO02958 MOACRIVE Inhibition DME1724 XEOTICID XEO02962 XEO_NAME Cryptonin DME1724 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02962 XEO_CLAS Peptide DME1724 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.12 ug/ml) DME1724 XEOTICID XEO02962 GENEFORM Protein DME1724 XEOTICID XEO02962 MOACRIVE Inhibition DME1724 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1724 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02965 XEO_CLAS Peptide DME1724 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 ug/ml) DME1724 XEOTICID XEO02965 GENEFORM Protein DME1724 XEOTICID XEO02965 MOACRIVE Inhibition DME1724 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1724 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02969 XEO_CLAS Peptide DME1724 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 microM) DME1724 XEOTICID XEO02969 GENEFORM Protein DME1724 XEOTICID XEO02969 MOACRIVE Inhibition DME1724 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1724 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02971 XEO_CLAS Peptide DME1724 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 microM) DME1724 XEOTICID XEO02971 GENEFORM Protein DME1724 XEOTICID XEO02971 MOACRIVE Inhibition DME1724 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1724 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO02972 XEO_CLAS Peptide DME1724 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.4 microM) DME1724 XEOTICID XEO02972 GENEFORM Protein DME1724 XEOTICID XEO02972 MOACRIVE Inhibition DME1724 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1724 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02990 GENEFORM Protein DME1724 XEOTICID XEO02990 MOACRIVE Inhibition DME1724 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1724 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02991 GENEFORM Protein DME1724 XEOTICID XEO02991 MOACRIVE Inhibition DME1724 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1724 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02992 GENEFORM Protein DME1724 XEOTICID XEO02992 MOACRIVE Inhibition DME1724 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1724 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02993 GENEFORM Protein DME1724 XEOTICID XEO02993 MOACRIVE Inhibition DME1724 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1724 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02994 GENEFORM Protein DME1724 XEOTICID XEO02994 MOACRIVE Inhibition DME1724 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1724 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02995 GENEFORM Protein DME1724 XEOTICID XEO02995 MOACRIVE Inhibition DME1724 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1724 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02996 GENEFORM Protein DME1724 XEOTICID XEO02996 MOACRIVE Inhibition DME1724 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1724 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02997 GENEFORM Protein DME1724 XEOTICID XEO02997 MOACRIVE Inhibition DME1724 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1724 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02998 GENEFORM Protein DME1724 XEOTICID XEO02998 MOACRIVE Inhibition DME1724 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1724 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1724 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO02999 GENEFORM Protein DME1724 XEOTICID XEO02999 MOACRIVE Inhibition DME1724 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1724 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03021 XEO_CLAS Peptide DME1724 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1724 XEOTICID XEO03021 GENEFORM Protein DME1724 XEOTICID XEO03021 MOACRIVE Inhibition DME1724 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1724 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03029 XEO_CLAS Peptide DME1724 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.005 microM) DME1724 XEOTICID XEO03029 GENEFORM Protein DME1724 XEOTICID XEO03029 MOACRIVE Inhibition DME1724 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1724 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03030 XEO_CLAS Peptide DME1724 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.005 microM) DME1724 XEOTICID XEO03030 GENEFORM Protein DME1724 XEOTICID XEO03030 MOACRIVE Inhibition DME1724 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1724 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03031 XEO_CLAS Peptide DME1724 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.3 microM) DME1724 XEOTICID XEO03031 GENEFORM Protein DME1724 XEOTICID XEO03031 MOACRIVE Inhibition DME1724 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1724 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03032 XEO_CLAS Peptide DME1724 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.01 microM) DME1724 XEOTICID XEO03032 GENEFORM Protein DME1724 XEOTICID XEO03032 MOACRIVE Inhibition DME1724 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1724 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03033 XEO_CLAS Peptide DME1724 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.173 microM) DME1724 XEOTICID XEO03033 GENEFORM Protein DME1724 XEOTICID XEO03033 MOACRIVE Inhibition DME1724 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1724 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03034 XEO_CLAS Peptide DME1724 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.518 microM) DME1724 XEOTICID XEO03034 GENEFORM Protein DME1724 XEOTICID XEO03034 MOACRIVE Inhibition DME1724 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1724 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03035 XEO_CLAS Peptide DME1724 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.114 microM) DME1724 XEOTICID XEO03035 GENEFORM Protein DME1724 XEOTICID XEO03035 MOACRIVE Inhibition DME1724 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1724 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03039 XEO_CLAS Peptide DME1724 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.55 microM) DME1724 XEOTICID XEO03039 GENEFORM Protein DME1724 XEOTICID XEO03039 MOACRIVE Inhibition DME1724 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1724 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03043 XEO_CLAS Peptide DME1724 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 microM) DME1724 XEOTICID XEO03043 GENEFORM Protein DME1724 XEOTICID XEO03043 MOACRIVE Inhibition DME1724 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1724 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03044 XEO_CLAS Peptide DME1724 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03044 GENEFORM Protein DME1724 XEOTICID XEO03044 MOACRIVE Inhibition DME1724 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1724 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03045 XEO_CLAS Peptide DME1724 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03045 GENEFORM Protein DME1724 XEOTICID XEO03045 MOACRIVE Inhibition DME1724 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1724 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03046 XEO_CLAS Peptide DME1724 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03046 GENEFORM Protein DME1724 XEOTICID XEO03046 MOACRIVE Inhibition DME1724 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1724 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03049 XEO_CLAS Peptide DME1724 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 microM) DME1724 XEOTICID XEO03049 GENEFORM Protein DME1724 XEOTICID XEO03049 MOACRIVE Inhibition DME1724 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1724 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03055 XEO_CLAS Peptide DME1724 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 microM) DME1724 XEOTICID XEO03055 GENEFORM Protein DME1724 XEOTICID XEO03055 MOACRIVE Inhibition DME1724 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1724 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03059 XEO_CLAS Peptide DME1724 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO03059 GENEFORM Protein DME1724 XEOTICID XEO03059 MOACRIVE Inhibition DME1724 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1724 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03060 XEO_CLAS Peptide DME1724 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO03060 GENEFORM Protein DME1724 XEOTICID XEO03060 MOACRIVE Inhibition DME1724 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1724 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03062 XEO_CLAS Peptide DME1724 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO03062 GENEFORM Protein DME1724 XEOTICID XEO03062 MOACRIVE Inhibition DME1724 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1724 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03064 XEO_CLAS Peptide DME1724 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO03064 GENEFORM Protein DME1724 XEOTICID XEO03064 MOACRIVE Inhibition DME1724 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1724 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03066 XEO_CLAS Peptide DME1724 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO03066 GENEFORM Protein DME1724 XEOTICID XEO03066 MOACRIVE Inhibition DME1724 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1724 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03068 XEO_CLAS Peptide DME1724 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO03068 GENEFORM Protein DME1724 XEOTICID XEO03068 MOACRIVE Inhibition DME1724 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1724 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03073 XEO_CLAS Peptide DME1724 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8-16 ug/ml) DME1724 XEOTICID XEO03073 GENEFORM Protein DME1724 XEOTICID XEO03073 MOACRIVE Inhibition DME1724 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1724 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03081 XEO_CLAS Peptide DME1724 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 microM) DME1724 XEOTICID XEO03081 GENEFORM Protein DME1724 XEOTICID XEO03081 MOACRIVE Inhibition DME1724 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1724 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03082 XEO_CLAS Peptide DME1724 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03082 GENEFORM Protein DME1724 XEOTICID XEO03082 MOACRIVE Inhibition DME1724 XEOTICID XEO03089 XEO_NAME Decoralin DME1724 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03089 XEO_CLAS Peptide DME1724 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 160 microM) DME1724 XEOTICID XEO03089 GENEFORM Protein DME1724 XEOTICID XEO03089 MOACRIVE Inhibition DME1724 XEOTICID XEO03098 XEO_NAME Insect defensin DME1724 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03098 XEO_CLAS Peptide DME1724 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 ug/ml) DME1724 XEOTICID XEO03098 GENEFORM Protein DME1724 XEOTICID XEO03098 MOACRIVE Inhibition DME1724 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1724 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03100 XEO_CLAS Peptide DME1724 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03100 GENEFORM Protein DME1724 XEOTICID XEO03100 MOACRIVE Inhibition DME1724 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1724 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03103 XEO_CLAS Peptide DME1724 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03103 GENEFORM Protein DME1724 XEOTICID XEO03103 MOACRIVE Inhibition DME1724 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1724 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03105 XEO_CLAS Peptide DME1724 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03105 GENEFORM Protein DME1724 XEOTICID XEO03105 MOACRIVE Inhibition DME1724 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1724 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03110 XEO_CLAS Peptide DME1724 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.2 microM) DME1724 XEOTICID XEO03110 GENEFORM Protein DME1724 XEOTICID XEO03110 MOACRIVE Inhibition DME1724 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1724 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03111 XEO_CLAS Peptide DME1724 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03111 GENEFORM Protein DME1724 XEOTICID XEO03111 MOACRIVE Inhibition DME1724 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1724 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03112 XEO_CLAS Peptide DME1724 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 50 ug/ml) DME1724 XEOTICID XEO03112 GENEFORM Protein DME1724 XEOTICID XEO03112 MOACRIVE Inhibition DME1724 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1724 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03115 XEO_CLAS Peptide DME1724 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03115 GENEFORM Protein DME1724 XEOTICID XEO03115 MOACRIVE Inhibition DME1724 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1724 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03116 XEO_CLAS Peptide DME1724 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 40 microM) DME1724 XEOTICID XEO03116 GENEFORM Protein DME1724 XEOTICID XEO03116 MOACRIVE Inhibition DME1724 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1724 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03118 XEO_CLAS Peptide DME1724 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03118 GENEFORM Protein DME1724 XEOTICID XEO03118 MOACRIVE Inhibition DME1724 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1724 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03119 XEO_CLAS Peptide DME1724 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03119 GENEFORM Protein DME1724 XEOTICID XEO03119 MOACRIVE Inhibition DME1724 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1724 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03121 XEO_CLAS Peptide DME1724 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03121 GENEFORM Protein DME1724 XEOTICID XEO03121 MOACRIVE Inhibition DME1724 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1724 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03122 XEO_CLAS Peptide DME1724 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64000 ug/ml) DME1724 XEOTICID XEO03122 GENEFORM Protein DME1724 XEOTICID XEO03122 MOACRIVE Inhibition DME1724 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1724 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03124 XEO_CLAS Peptide DME1724 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03124 GENEFORM Protein DME1724 XEOTICID XEO03124 MOACRIVE Inhibition DME1724 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1724 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03125 XEO_CLAS Peptide DME1724 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03125 GENEFORM Protein DME1724 XEOTICID XEO03125 MOACRIVE Inhibition DME1724 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1724 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03126 XEO_CLAS Peptide DME1724 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.86 microM) DME1724 XEOTICID XEO03126 GENEFORM Protein DME1724 XEOTICID XEO03126 MOACRIVE Inhibition DME1724 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1724 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03127 XEO_CLAS Peptide DME1724 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03127 GENEFORM Protein DME1724 XEOTICID XEO03127 MOACRIVE Inhibition DME1724 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1724 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03128 XEO_CLAS Peptide DME1724 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 256 ug/ml) DME1724 XEOTICID XEO03128 GENEFORM Protein DME1724 XEOTICID XEO03128 MOACRIVE Inhibition DME1724 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1724 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03129 XEO_CLAS Peptide DME1724 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 256 ug/ml) DME1724 XEOTICID XEO03129 GENEFORM Protein DME1724 XEOTICID XEO03129 MOACRIVE Inhibition DME1724 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1724 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03130 XEO_CLAS Peptide DME1724 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 256 ug/ml) DME1724 XEOTICID XEO03130 GENEFORM Protein DME1724 XEOTICID XEO03130 MOACRIVE Inhibition DME1724 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1724 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03131 XEO_CLAS Peptide DME1724 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 256 ug/ml) DME1724 XEOTICID XEO03131 GENEFORM Protein DME1724 XEOTICID XEO03131 MOACRIVE Inhibition DME1724 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1724 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03132 XEO_CLAS Peptide DME1724 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 256 ug/ml) DME1724 XEOTICID XEO03132 GENEFORM Protein DME1724 XEOTICID XEO03132 MOACRIVE Inhibition DME1724 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1724 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03137 XEO_CLAS Peptide DME1724 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03137 GENEFORM Protein DME1724 XEOTICID XEO03137 MOACRIVE Inhibition DME1724 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1724 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03143 XEO_CLAS Peptide DME1724 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.6 microM) DME1724 XEOTICID XEO03143 GENEFORM Protein DME1724 XEOTICID XEO03143 MOACRIVE Inhibition DME1724 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1724 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03145 XEO_CLAS Peptide DME1724 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.6 microM) DME1724 XEOTICID XEO03145 GENEFORM Protein DME1724 XEOTICID XEO03145 MOACRIVE Inhibition DME1724 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1724 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03146 XEO_CLAS Peptide DME1724 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.5 microM) DME1724 XEOTICID XEO03146 GENEFORM Protein DME1724 XEOTICID XEO03146 MOACRIVE Inhibition DME1724 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1724 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03147 XEO_CLAS Peptide DME1724 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 9.7 microM) DME1724 XEOTICID XEO03147 GENEFORM Protein DME1724 XEOTICID XEO03147 MOACRIVE Inhibition DME1724 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1724 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03148 XEO_CLAS Peptide DME1724 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.3 microM) DME1724 XEOTICID XEO03148 GENEFORM Protein DME1724 XEOTICID XEO03148 MOACRIVE Inhibition DME1724 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1724 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03149 XEO_CLAS Peptide DME1724 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.6 microM) DME1724 XEOTICID XEO03149 GENEFORM Protein DME1724 XEOTICID XEO03149 MOACRIVE Inhibition DME1724 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1724 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03150 XEO_CLAS Peptide DME1724 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 9-3 microM) DME1724 XEOTICID XEO03150 GENEFORM Protein DME1724 XEOTICID XEO03150 MOACRIVE Inhibition DME1724 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1724 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03151 XEO_CLAS Peptide DME1724 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 ug/ml) DME1724 XEOTICID XEO03151 GENEFORM Protein DME1724 XEOTICID XEO03151 MOACRIVE Inhibition DME1724 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1724 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03152 XEO_CLAS Peptide DME1724 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO03152 GENEFORM Protein DME1724 XEOTICID XEO03152 MOACRIVE Inhibition DME1724 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1724 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03155 XEO_CLAS Peptide DME1724 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.4 microM) DME1724 XEOTICID XEO03155 GENEFORM Protein DME1724 XEOTICID XEO03155 MOACRIVE Inhibition DME1724 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1724 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03156 XEO_CLAS Peptide DME1724 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.3 microM) DME1724 XEOTICID XEO03156 GENEFORM Protein DME1724 XEOTICID XEO03156 MOACRIVE Inhibition DME1724 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1724 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03157 XEO_CLAS Peptide DME1724 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.3 microM) DME1724 XEOTICID XEO03157 GENEFORM Protein DME1724 XEOTICID XEO03157 MOACRIVE Inhibition DME1724 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1724 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03158 XEO_CLAS Peptide DME1724 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 ug/ml) DME1724 XEOTICID XEO03158 GENEFORM Protein DME1724 XEOTICID XEO03158 MOACRIVE Inhibition DME1724 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1724 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03159 XEO_CLAS Peptide DME1724 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03159 GENEFORM Protein DME1724 XEOTICID XEO03159 MOACRIVE Inhibition DME1724 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1724 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03161 XEO_CLAS Peptide DME1724 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 microM) DME1724 XEOTICID XEO03161 GENEFORM Protein DME1724 XEOTICID XEO03161 MOACRIVE Inhibition DME1724 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1724 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03162 XEO_CLAS Peptide DME1724 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.5 microM) DME1724 XEOTICID XEO03162 GENEFORM Protein DME1724 XEOTICID XEO03162 MOACRIVE Inhibition DME1724 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1724 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03169 XEO_CLAS Peptide DME1724 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO03169 GENEFORM Protein DME1724 XEOTICID XEO03169 MOACRIVE Inhibition DME1724 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1724 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03193 XEO_CLAS Peptide DME1724 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25 ug/ml) DME1724 XEOTICID XEO03193 GENEFORM Protein DME1724 XEOTICID XEO03193 MOACRIVE Inhibition DME1724 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1724 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03194 XEO_CLAS Peptide DME1724 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03194 GENEFORM Protein DME1724 XEOTICID XEO03194 MOACRIVE Inhibition DME1724 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1724 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03195 XEO_CLAS Peptide DME1724 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03195 GENEFORM Protein DME1724 XEOTICID XEO03195 MOACRIVE Inhibition DME1724 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1724 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03197 XEO_CLAS Peptide DME1724 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 14.5 microM) DME1724 XEOTICID XEO03197 GENEFORM Protein DME1724 XEOTICID XEO03197 MOACRIVE Inhibition DME1724 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1724 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03202 XEO_CLAS Peptide DME1724 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.51 microM) DME1724 XEOTICID XEO03202 GENEFORM Protein DME1724 XEOTICID XEO03202 MOACRIVE Inhibition DME1724 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1724 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03203 XEO_CLAS Peptide DME1724 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.62 microM) DME1724 XEOTICID XEO03203 GENEFORM Protein DME1724 XEOTICID XEO03203 MOACRIVE Inhibition DME1724 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1724 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03204 XEO_CLAS Peptide DME1724 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.38 microM) DME1724 XEOTICID XEO03204 GENEFORM Protein DME1724 XEOTICID XEO03204 MOACRIVE Inhibition DME1724 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1724 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03205 XEO_CLAS Peptide DME1724 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.29 microM) DME1724 XEOTICID XEO03205 GENEFORM Protein DME1724 XEOTICID XEO03205 MOACRIVE Inhibition DME1724 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1724 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03206 XEO_CLAS Peptide DME1724 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.40 microM) DME1724 XEOTICID XEO03206 GENEFORM Protein DME1724 XEOTICID XEO03206 MOACRIVE Inhibition DME1724 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1724 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03207 XEO_CLAS Peptide DME1724 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.58 microM) DME1724 XEOTICID XEO03207 GENEFORM Protein DME1724 XEOTICID XEO03207 MOACRIVE Inhibition DME1724 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1724 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03208 XEO_CLAS Peptide DME1724 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.76 microM) DME1724 XEOTICID XEO03208 GENEFORM Protein DME1724 XEOTICID XEO03208 MOACRIVE Inhibition DME1724 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1724 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03209 XEO_CLAS Peptide DME1724 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.49 microM) DME1724 XEOTICID XEO03209 GENEFORM Protein DME1724 XEOTICID XEO03209 MOACRIVE Inhibition DME1724 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1724 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03210 XEO_CLAS Peptide DME1724 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 7.07 microM) DME1724 XEOTICID XEO03210 GENEFORM Protein DME1724 XEOTICID XEO03210 MOACRIVE Inhibition DME1724 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1724 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03211 XEO_CLAS Peptide DME1724 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.40 microM) DME1724 XEOTICID XEO03211 GENEFORM Protein DME1724 XEOTICID XEO03211 MOACRIVE Inhibition DME1724 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1724 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03215 XEO_CLAS Peptide DME1724 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20.0 ug/ml) DME1724 XEOTICID XEO03215 GENEFORM Protein DME1724 XEOTICID XEO03215 MOACRIVE Inhibition DME1724 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1724 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03216 XEO_CLAS Peptide DME1724 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO03216 GENEFORM Protein DME1724 XEOTICID XEO03216 MOACRIVE Inhibition DME1724 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1724 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03217 XEO_CLAS Peptide DME1724 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO03217 GENEFORM Protein DME1724 XEOTICID XEO03217 MOACRIVE Inhibition DME1724 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1724 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03223 XEO_CLAS Peptide DME1724 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.8 microM) DME1724 XEOTICID XEO03223 GENEFORM Protein DME1724 XEOTICID XEO03223 MOACRIVE Inhibition DME1724 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1724 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03224 XEO_CLAS Peptide DME1724 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.1-0.25 microM) DME1724 XEOTICID XEO03224 GENEFORM Protein DME1724 XEOTICID XEO03224 MOACRIVE Inhibition DME1724 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1724 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03225 XEO_CLAS Peptide DME1724 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.3 microM) DME1724 XEOTICID XEO03225 GENEFORM Protein DME1724 XEOTICID XEO03225 MOACRIVE Inhibition DME1724 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1724 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03227 XEO_CLAS Peptide DME1724 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.3 microM) DME1724 XEOTICID XEO03227 GENEFORM Protein DME1724 XEOTICID XEO03227 MOACRIVE Inhibition DME1724 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1724 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03231 XEO_CLAS Peptide DME1724 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03231 GENEFORM Protein DME1724 XEOTICID XEO03231 MOACRIVE Inhibition DME1724 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1724 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03232 XEO_CLAS Peptide DME1724 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03232 GENEFORM Protein DME1724 XEOTICID XEO03232 MOACRIVE Inhibition DME1724 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1724 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03234 XEO_CLAS Peptide DME1724 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO03234 GENEFORM Protein DME1724 XEOTICID XEO03234 MOACRIVE Inhibition DME1724 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1724 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03235 XEO_CLAS Peptide DME1724 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 60 ug/ml) DME1724 XEOTICID XEO03235 GENEFORM Protein DME1724 XEOTICID XEO03235 MOACRIVE Inhibition DME1724 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1724 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03236 XEO_CLAS Peptide DME1724 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO03236 GENEFORM Protein DME1724 XEOTICID XEO03236 MOACRIVE Inhibition DME1724 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1724 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03237 XEO_CLAS Peptide DME1724 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 ug/ml) DME1724 XEOTICID XEO03237 GENEFORM Protein DME1724 XEOTICID XEO03237 MOACRIVE Inhibition DME1724 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1724 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03238 XEO_CLAS Peptide DME1724 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 ug/ml) DME1724 XEOTICID XEO03238 GENEFORM Protein DME1724 XEOTICID XEO03238 MOACRIVE Inhibition DME1724 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1724 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03239 XEO_CLAS Peptide DME1724 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 60 ug/ml) DME1724 XEOTICID XEO03239 GENEFORM Protein DME1724 XEOTICID XEO03239 MOACRIVE Inhibition DME1724 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1724 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03241 XEO_CLAS Peptide DME1724 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 128 microM) DME1724 XEOTICID XEO03241 GENEFORM Protein DME1724 XEOTICID XEO03241 MOACRIVE Inhibition DME1724 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1724 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03250 XEO_CLAS Peptide DME1724 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03250 GENEFORM Protein DME1724 XEOTICID XEO03250 MOACRIVE Inhibition DME1724 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1724 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03251 XEO_CLAS Peptide DME1724 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03251 GENEFORM Protein DME1724 XEOTICID XEO03251 MOACRIVE Inhibition DME1724 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1724 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03253 XEO_CLAS Peptide DME1724 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.1 ug/ml) DME1724 XEOTICID XEO03253 GENEFORM Protein DME1724 XEOTICID XEO03253 MOACRIVE Inhibition DME1724 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1724 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03274 XEO_CLAS Peptide DME1724 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.2 microM) DME1724 XEOTICID XEO03274 GENEFORM Protein DME1724 XEOTICID XEO03274 MOACRIVE Inhibition DME1724 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1724 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03275 XEO_CLAS Peptide DME1724 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO03275 GENEFORM Protein DME1724 XEOTICID XEO03275 MOACRIVE Inhibition DME1724 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1724 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03276 XEO_CLAS Peptide DME1724 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO03276 GENEFORM Protein DME1724 XEOTICID XEO03276 MOACRIVE Inhibition DME1724 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1724 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03277 XEO_CLAS Peptide DME1724 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.2 microM) DME1724 XEOTICID XEO03277 GENEFORM Protein DME1724 XEOTICID XEO03277 MOACRIVE Inhibition DME1724 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1724 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03278 XEO_CLAS Peptide DME1724 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO03278 GENEFORM Protein DME1724 XEOTICID XEO03278 MOACRIVE Inhibition DME1724 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1724 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03279 XEO_CLAS Peptide DME1724 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO03279 GENEFORM Protein DME1724 XEOTICID XEO03279 MOACRIVE Inhibition DME1724 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1724 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03280 XEO_CLAS Peptide DME1724 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 microM) DME1724 XEOTICID XEO03280 GENEFORM Protein DME1724 XEOTICID XEO03280 MOACRIVE Inhibition DME1724 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1724 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03281 XEO_CLAS Peptide DME1724 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.3 microM) DME1724 XEOTICID XEO03281 GENEFORM Protein DME1724 XEOTICID XEO03281 MOACRIVE Inhibition DME1724 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1724 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03282 XEO_CLAS Peptide DME1724 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.1 microM) DME1724 XEOTICID XEO03282 GENEFORM Protein DME1724 XEOTICID XEO03282 MOACRIVE Inhibition DME1724 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1724 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03283 XEO_CLAS Peptide DME1724 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 microM) DME1724 XEOTICID XEO03283 GENEFORM Protein DME1724 XEOTICID XEO03283 MOACRIVE Inhibition DME1724 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1724 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03284 XEO_CLAS Peptide DME1724 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.2 ug/ml) DME1724 XEOTICID XEO03284 GENEFORM Protein DME1724 XEOTICID XEO03284 MOACRIVE Inhibition DME1724 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1724 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03285 XEO_CLAS Peptide DME1724 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.5 ug/ml) DME1724 XEOTICID XEO03285 GENEFORM Protein DME1724 XEOTICID XEO03285 MOACRIVE Inhibition DME1724 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1724 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03286 XEO_CLAS Peptide DME1724 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.4 ug/ml) DME1724 XEOTICID XEO03286 GENEFORM Protein DME1724 XEOTICID XEO03286 MOACRIVE Inhibition DME1724 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1724 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03287 XEO_CLAS Peptide DME1724 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.6 ug/ml) DME1724 XEOTICID XEO03287 GENEFORM Protein DME1724 XEOTICID XEO03287 MOACRIVE Inhibition DME1724 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1724 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03288 XEO_CLAS Peptide DME1724 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.4 ug/ml) DME1724 XEOTICID XEO03288 GENEFORM Protein DME1724 XEOTICID XEO03288 MOACRIVE Inhibition DME1724 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1724 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03289 XEO_CLAS Peptide DME1724 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8.8 ug/ml) DME1724 XEOTICID XEO03289 GENEFORM Protein DME1724 XEOTICID XEO03289 MOACRIVE Inhibition DME1724 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1724 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03290 XEO_CLAS Peptide DME1724 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.5 ug/ml) DME1724 XEOTICID XEO03290 GENEFORM Protein DME1724 XEOTICID XEO03290 MOACRIVE Inhibition DME1724 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1724 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03291 XEO_CLAS Peptide DME1724 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8.6 ug/ml) DME1724 XEOTICID XEO03291 GENEFORM Protein DME1724 XEOTICID XEO03291 MOACRIVE Inhibition DME1724 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1724 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03292 XEO_CLAS Peptide DME1724 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4.1 ug/ml) DME1724 XEOTICID XEO03292 GENEFORM Protein DME1724 XEOTICID XEO03292 MOACRIVE Inhibition DME1724 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1724 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03293 XEO_CLAS Peptide DME1724 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1 microM) DME1724 XEOTICID XEO03293 GENEFORM Protein DME1724 XEOTICID XEO03293 MOACRIVE Inhibition DME1724 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1724 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03294 XEO_CLAS Peptide DME1724 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1 microM) DME1724 XEOTICID XEO03294 GENEFORM Protein DME1724 XEOTICID XEO03294 MOACRIVE Inhibition DME1724 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1724 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03295 XEO_CLAS Peptide DME1724 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.7 microM) DME1724 XEOTICID XEO03295 GENEFORM Protein DME1724 XEOTICID XEO03295 MOACRIVE Inhibition DME1724 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1724 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03296 XEO_CLAS Peptide DME1724 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03296 GENEFORM Protein DME1724 XEOTICID XEO03296 MOACRIVE Inhibition DME1724 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1724 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03297 XEO_CLAS Peptide DME1724 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03297 GENEFORM Protein DME1724 XEOTICID XEO03297 MOACRIVE Inhibition DME1724 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1724 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03298 XEO_CLAS Peptide DME1724 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.2 microM) DME1724 XEOTICID XEO03298 GENEFORM Protein DME1724 XEOTICID XEO03298 MOACRIVE Inhibition DME1724 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1724 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03299 XEO_CLAS Peptide DME1724 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.4 microM) DME1724 XEOTICID XEO03299 GENEFORM Protein DME1724 XEOTICID XEO03299 MOACRIVE Inhibition DME1724 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1724 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03300 XEO_CLAS Peptide DME1724 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 ug/ml) DME1724 XEOTICID XEO03300 GENEFORM Protein DME1724 XEOTICID XEO03300 MOACRIVE Inhibition DME1724 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1724 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03301 XEO_CLAS Peptide DME1724 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 ug/ml) DME1724 XEOTICID XEO03301 GENEFORM Protein DME1724 XEOTICID XEO03301 MOACRIVE Inhibition DME1724 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1724 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03302 XEO_CLAS Peptide DME1724 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1 microM) DME1724 XEOTICID XEO03302 GENEFORM Protein DME1724 XEOTICID XEO03302 MOACRIVE Inhibition DME1724 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1724 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03303 XEO_CLAS Peptide DME1724 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 microM) DME1724 XEOTICID XEO03303 GENEFORM Protein DME1724 XEOTICID XEO03303 MOACRIVE Inhibition DME1724 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1724 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03304 XEO_CLAS Peptide DME1724 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO03304 GENEFORM Protein DME1724 XEOTICID XEO03304 MOACRIVE Inhibition DME1724 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1724 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03305 XEO_CLAS Peptide DME1724 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 microM) DME1724 XEOTICID XEO03305 GENEFORM Protein DME1724 XEOTICID XEO03305 MOACRIVE Inhibition DME1724 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1724 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03306 XEO_CLAS Peptide DME1724 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO03306 GENEFORM Protein DME1724 XEOTICID XEO03306 MOACRIVE Inhibition DME1724 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1724 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03307 XEO_CLAS Peptide DME1724 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 34 ug/ml) DME1724 XEOTICID XEO03307 GENEFORM Protein DME1724 XEOTICID XEO03307 MOACRIVE Inhibition DME1724 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1724 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03308 XEO_CLAS Peptide DME1724 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO03308 GENEFORM Protein DME1724 XEOTICID XEO03308 MOACRIVE Inhibition DME1724 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1724 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03310 XEO_CLAS Peptide DME1724 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8.5 ug/ml) DME1724 XEOTICID XEO03310 GENEFORM Protein DME1724 XEOTICID XEO03310 MOACRIVE Inhibition DME1724 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1724 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03311 XEO_CLAS Peptide DME1724 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10.8 ug/ml) DME1724 XEOTICID XEO03311 GENEFORM Protein DME1724 XEOTICID XEO03311 MOACRIVE Inhibition DME1724 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1724 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03312 XEO_CLAS Peptide DME1724 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10.8 ug/ml) DME1724 XEOTICID XEO03312 GENEFORM Protein DME1724 XEOTICID XEO03312 MOACRIVE Inhibition DME1724 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1724 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03313 XEO_CLAS Peptide DME1724 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8.1 ug/ml) DME1724 XEOTICID XEO03313 GENEFORM Protein DME1724 XEOTICID XEO03313 MOACRIVE Inhibition DME1724 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1724 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03314 XEO_CLAS Peptide DME1724 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 7.9 ug/ml) DME1724 XEOTICID XEO03314 GENEFORM Protein DME1724 XEOTICID XEO03314 MOACRIVE Inhibition DME1724 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1724 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03315 XEO_CLAS Peptide DME1724 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.6 ug/ml) DME1724 XEOTICID XEO03315 GENEFORM Protein DME1724 XEOTICID XEO03315 MOACRIVE Inhibition DME1724 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1724 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03316 XEO_CLAS Peptide DME1724 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15.8 ug/ml) DME1724 XEOTICID XEO03316 GENEFORM Protein DME1724 XEOTICID XEO03316 MOACRIVE Inhibition DME1724 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1724 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03317 XEO_CLAS Peptide DME1724 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO03317 GENEFORM Protein DME1724 XEOTICID XEO03317 MOACRIVE Inhibition DME1724 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1724 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03318 XEO_CLAS Peptide DME1724 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1 microM) DME1724 XEOTICID XEO03318 GENEFORM Protein DME1724 XEOTICID XEO03318 MOACRIVE Inhibition DME1724 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1724 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03319 XEO_CLAS Peptide DME1724 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03319 GENEFORM Protein DME1724 XEOTICID XEO03319 MOACRIVE Inhibition DME1724 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1724 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03320 XEO_CLAS Peptide DME1724 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.1 microM) DME1724 XEOTICID XEO03320 GENEFORM Protein DME1724 XEOTICID XEO03320 MOACRIVE Inhibition DME1724 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1724 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03321 XEO_CLAS Peptide DME1724 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.8 microM) DME1724 XEOTICID XEO03321 GENEFORM Protein DME1724 XEOTICID XEO03321 MOACRIVE Inhibition DME1724 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1724 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1724 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03348 GENEFORM Protein DME1724 XEOTICID XEO03348 MOACRIVE Inhibition DME1724 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1724 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03362 XEO_CLAS Peptide DME1724 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO03362 GENEFORM Protein DME1724 XEOTICID XEO03362 MOACRIVE Inhibition DME1724 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1724 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03363 XEO_CLAS Peptide DME1724 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 microM) DME1724 XEOTICID XEO03363 GENEFORM Protein DME1724 XEOTICID XEO03363 MOACRIVE Inhibition DME1724 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1724 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03364 XEO_CLAS Peptide DME1724 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 microM) DME1724 XEOTICID XEO03364 GENEFORM Protein DME1724 XEOTICID XEO03364 MOACRIVE Inhibition DME1724 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1724 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03365 XEO_CLAS Peptide DME1724 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03365 GENEFORM Protein DME1724 XEOTICID XEO03365 MOACRIVE Inhibition DME1724 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1724 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03366 XEO_CLAS Peptide DME1724 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO03366 GENEFORM Protein DME1724 XEOTICID XEO03366 MOACRIVE Inhibition DME1724 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1724 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03367 XEO_CLAS Peptide DME1724 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 microM) DME1724 XEOTICID XEO03367 GENEFORM Protein DME1724 XEOTICID XEO03367 MOACRIVE Inhibition DME1724 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1724 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03368 XEO_CLAS Peptide DME1724 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 microM) DME1724 XEOTICID XEO03368 GENEFORM Protein DME1724 XEOTICID XEO03368 MOACRIVE Inhibition DME1724 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1724 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03379 XEO_CLAS Peptide DME1724 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.6 ug/ml) DME1724 XEOTICID XEO03379 GENEFORM Protein DME1724 XEOTICID XEO03379 MOACRIVE Inhibition DME1724 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1724 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03396 XEO_CLAS Peptide DME1724 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03396 GENEFORM Protein DME1724 XEOTICID XEO03396 MOACRIVE Inhibition DME1724 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1724 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03398 XEO_CLAS Peptide DME1724 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03398 GENEFORM Protein DME1724 XEOTICID XEO03398 MOACRIVE Inhibition DME1724 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1724 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03399 XEO_CLAS Peptide DME1724 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03399 GENEFORM Protein DME1724 XEOTICID XEO03399 MOACRIVE Inhibition DME1724 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1724 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03406 XEO_CLAS Peptide DME1724 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 ug/ml) DME1724 XEOTICID XEO03406 GENEFORM Protein DME1724 XEOTICID XEO03406 MOACRIVE Inhibition DME1724 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1724 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03424 XEO_CLAS Peptide DME1724 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03424 GENEFORM Protein DME1724 XEOTICID XEO03424 MOACRIVE Inhibition DME1724 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1724 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03426 XEO_CLAS Peptide DME1724 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO03426 GENEFORM Protein DME1724 XEOTICID XEO03426 MOACRIVE Inhibition DME1724 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1724 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03427 XEO_CLAS Peptide DME1724 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 microM) DME1724 XEOTICID XEO03427 GENEFORM Protein DME1724 XEOTICID XEO03427 MOACRIVE Inhibition DME1724 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1724 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03428 XEO_CLAS Peptide DME1724 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 ug/ml) DME1724 XEOTICID XEO03428 GENEFORM Protein DME1724 XEOTICID XEO03428 MOACRIVE Inhibition DME1724 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1724 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03430 XEO_CLAS Peptide DME1724 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 ug/ml) DME1724 XEOTICID XEO03430 GENEFORM Protein DME1724 XEOTICID XEO03430 MOACRIVE Inhibition DME1724 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1724 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03434 XEO_CLAS Peptide DME1724 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO03434 GENEFORM Protein DME1724 XEOTICID XEO03434 MOACRIVE Inhibition DME1724 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1724 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03442 XEO_CLAS Peptide DME1724 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 18.75 ug/ml) DME1724 XEOTICID XEO03442 GENEFORM Protein DME1724 XEOTICID XEO03442 MOACRIVE Inhibition DME1724 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1724 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03444 XEO_CLAS Peptide DME1724 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 37.50 ug/ml) DME1724 XEOTICID XEO03444 GENEFORM Protein DME1724 XEOTICID XEO03444 MOACRIVE Inhibition DME1724 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1724 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03459 XEO_CLAS Peptide DME1724 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03459 GENEFORM Protein DME1724 XEOTICID XEO03459 MOACRIVE Inhibition DME1724 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1724 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03460 XEO_CLAS Peptide DME1724 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03460 GENEFORM Protein DME1724 XEOTICID XEO03460 MOACRIVE Inhibition DME1724 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1724 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03461 XEO_CLAS Peptide DME1724 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.05 microM) DME1724 XEOTICID XEO03461 GENEFORM Protein DME1724 XEOTICID XEO03461 MOACRIVE Inhibition DME1724 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1724 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03462 XEO_CLAS Peptide DME1724 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03462 GENEFORM Protein DME1724 XEOTICID XEO03462 MOACRIVE Inhibition DME1724 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1724 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03463 XEO_CLAS Peptide DME1724 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03463 GENEFORM Protein DME1724 XEOTICID XEO03463 MOACRIVE Inhibition DME1724 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1724 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03467 XEO_CLAS Peptide DME1724 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03467 GENEFORM Protein DME1724 XEOTICID XEO03467 MOACRIVE Inhibition DME1724 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1724 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03468 XEO_CLAS Peptide DME1724 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03468 GENEFORM Protein DME1724 XEOTICID XEO03468 MOACRIVE Inhibition DME1724 XEOTICID XEO03471 XEO_NAME Gambicin DME1724 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03471 XEO_CLAS Peptide DME1724 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1724 XEOTICID XEO03471 GENEFORM Protein DME1724 XEOTICID XEO03471 MOACRIVE Inhibition DME1724 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1724 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03485 XEO_CLAS Peptide DME1724 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4.07 ug/ml) DME1724 XEOTICID XEO03485 GENEFORM Protein DME1724 XEOTICID XEO03485 MOACRIVE Inhibition DME1724 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1724 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03486 XEO_CLAS Peptide DME1724 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.80 ug/ml) DME1724 XEOTICID XEO03486 GENEFORM Protein DME1724 XEOTICID XEO03486 MOACRIVE Inhibition DME1724 XEOTICID XEO03488 XEO_NAME GLK-19 DME1724 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03488 XEO_CLAS Peptide DME1724 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO03488 GENEFORM Protein DME1724 XEOTICID XEO03488 MOACRIVE Inhibition DME1724 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1724 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03497 XEO_CLAS Peptide DME1724 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1724 XEOTICID XEO03497 GENEFORM Protein DME1724 XEOTICID XEO03497 MOACRIVE Inhibition DME1724 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1724 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03498 XEO_CLAS Peptide DME1724 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1724 XEOTICID XEO03498 GENEFORM Protein DME1724 XEOTICID XEO03498 MOACRIVE Inhibition DME1724 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1724 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03500 XEO_CLAS Peptide DME1724 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-30 ug/ml) DME1724 XEOTICID XEO03500 GENEFORM Protein DME1724 XEOTICID XEO03500 MOACRIVE Inhibition DME1724 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1724 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03504 XEO_CLAS Peptide DME1724 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 ug/ml) DME1724 XEOTICID XEO03504 GENEFORM Protein DME1724 XEOTICID XEO03504 MOACRIVE Inhibition DME1724 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1724 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03505 XEO_CLAS Peptide DME1724 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 ug/ml) DME1724 XEOTICID XEO03505 GENEFORM Protein DME1724 XEOTICID XEO03505 MOACRIVE Inhibition DME1724 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1724 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03506 XEO_CLAS Peptide DME1724 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 ug/ml) DME1724 XEOTICID XEO03506 GENEFORM Protein DME1724 XEOTICID XEO03506 MOACRIVE Inhibition DME1724 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1724 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03513 XEO_CLAS Peptide DME1724 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO03513 GENEFORM Protein DME1724 XEOTICID XEO03513 MOACRIVE Inhibition DME1724 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1724 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03514 XEO_CLAS Peptide DME1724 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03514 GENEFORM Protein DME1724 XEOTICID XEO03514 MOACRIVE Inhibition DME1724 XEOTICID XEO03519 XEO_NAME Hadrurin DME1724 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03519 XEO_CLAS Peptide DME1724 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03519 GENEFORM Protein DME1724 XEOTICID XEO03519 MOACRIVE Inhibition DME1724 XEOTICID XEO03522 XEO_NAME Halocyntin DME1724 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03522 XEO_CLAS Peptide DME1724 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03522 GENEFORM Protein DME1724 XEOTICID XEO03522 MOACRIVE Inhibition DME1724 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1724 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03524 XEO_CLAS Peptide DME1724 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03524 GENEFORM Protein DME1724 XEOTICID XEO03524 MOACRIVE Inhibition DME1724 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1724 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03525 XEO_CLAS Peptide DME1724 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03525 GENEFORM Protein DME1724 XEOTICID XEO03525 MOACRIVE Inhibition DME1724 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1724 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03530 XEO_CLAS Peptide DME1724 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03530 GENEFORM Protein DME1724 XEOTICID XEO03530 MOACRIVE Inhibition DME1724 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1724 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03535 XEO_CLAS Peptide DME1724 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.4 microM) DME1724 XEOTICID XEO03535 GENEFORM Protein DME1724 XEOTICID XEO03535 MOACRIVE Inhibition DME1724 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1724 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03536 XEO_CLAS Peptide DME1724 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 80 microM) DME1724 XEOTICID XEO03536 GENEFORM Protein DME1724 XEOTICID XEO03536 MOACRIVE Inhibition DME1724 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1724 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03537 XEO_CLAS Peptide DME1724 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 ug/ml) DME1724 XEOTICID XEO03537 GENEFORM Protein DME1724 XEOTICID XEO03537 MOACRIVE Inhibition DME1724 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1724 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03538 XEO_CLAS Peptide DME1724 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 ug/ml) DME1724 XEOTICID XEO03538 GENEFORM Protein DME1724 XEOTICID XEO03538 MOACRIVE Inhibition DME1724 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1724 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03540 XEO_CLAS Peptide DME1724 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO03540 GENEFORM Protein DME1724 XEOTICID XEO03540 MOACRIVE Inhibition DME1724 XEOTICID XEO03542 XEO_NAME Hepcidin DME1724 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03542 XEO_CLAS Peptide DME1724 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 24 microM) DME1724 XEOTICID XEO03542 GENEFORM Protein DME1724 XEOTICID XEO03542 MOACRIVE Inhibition DME1724 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1724 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03544 XEO_CLAS Peptide DME1724 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03544 GENEFORM Protein DME1724 XEOTICID XEO03544 MOACRIVE Inhibition DME1724 XEOTICID XEO03548 XEO_NAME Hesperidin DME1724 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03548 GENEFORM Protein DME1724 XEOTICID XEO03548 MOACRIVE Inhibition DME1724 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1724 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1724 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03552 GENEFORM Protein DME1724 XEOTICID XEO03552 MOACRIVE Inhibition DME1724 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1724 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03556 XEO_CLAS Peptide DME1724 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO03556 GENEFORM Protein DME1724 XEOTICID XEO03556 MOACRIVE Inhibition DME1724 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1724 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03557 XEO_CLAS Peptide DME1724 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO03557 GENEFORM Protein DME1724 XEOTICID XEO03557 MOACRIVE Inhibition DME1724 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1724 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03558 XEO_CLAS Peptide DME1724 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 microM) DME1724 XEOTICID XEO03558 GENEFORM Protein DME1724 XEOTICID XEO03558 MOACRIVE Inhibition DME1724 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1724 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03559 XEO_CLAS Peptide DME1724 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 microM) DME1724 XEOTICID XEO03559 GENEFORM Protein DME1724 XEOTICID XEO03559 MOACRIVE Inhibition DME1724 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1724 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03560 XEO_CLAS Peptide DME1724 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 microM) DME1724 XEOTICID XEO03560 GENEFORM Protein DME1724 XEOTICID XEO03560 MOACRIVE Inhibition DME1724 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1724 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03561 XEO_CLAS Peptide DME1724 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03561 GENEFORM Protein DME1724 XEOTICID XEO03561 MOACRIVE Inhibition DME1724 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1724 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03567 XEO_CLAS Peptide DME1724 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03567 GENEFORM Protein DME1724 XEOTICID XEO03567 MOACRIVE Inhibition DME1724 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1724 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03569 XEO_CLAS Peptide DME1724 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 300 microM) DME1724 XEOTICID XEO03569 GENEFORM Protein DME1724 XEOTICID XEO03569 MOACRIVE Inhibition DME1724 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1724 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03570 XEO_CLAS Peptide DME1724 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03570 GENEFORM Protein DME1724 XEOTICID XEO03570 MOACRIVE Inhibition DME1724 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1724 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03572 XEO_CLAS Peptide DME1724 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1724 XEOTICID XEO03572 GENEFORM Protein DME1724 XEOTICID XEO03572 MOACRIVE Inhibition DME1724 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1724 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03573 XEO_CLAS Peptide DME1724 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 28.1 ug/ml) DME1724 XEOTICID XEO03573 GENEFORM Protein DME1724 XEOTICID XEO03573 MOACRIVE Inhibition DME1724 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1724 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03574 XEO_CLAS Peptide DME1724 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 500 microM) DME1724 XEOTICID XEO03574 GENEFORM Protein DME1724 XEOTICID XEO03574 MOACRIVE Inhibition DME1724 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1724 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03575 XEO_CLAS Peptide DME1724 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 18 microM) DME1724 XEOTICID XEO03575 GENEFORM Protein DME1724 XEOTICID XEO03575 MOACRIVE Inhibition DME1724 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1724 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03576 XEO_CLAS Peptide DME1724 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 750 microM) DME1724 XEOTICID XEO03576 GENEFORM Protein DME1724 XEOTICID XEO03576 MOACRIVE Inhibition DME1724 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1724 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03578 XEO_CLAS Peptide DME1724 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1724 XEOTICID XEO03578 GENEFORM Protein DME1724 XEOTICID XEO03578 MOACRIVE Inhibition DME1724 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1724 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03579 XEO_CLAS Peptide DME1724 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03579 GENEFORM Protein DME1724 XEOTICID XEO03579 MOACRIVE Inhibition DME1724 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1724 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03580 XEO_CLAS Peptide DME1724 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03580 GENEFORM Protein DME1724 XEOTICID XEO03580 MOACRIVE Inhibition DME1724 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1724 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03585 XEO_CLAS Peptide DME1724 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 125 ug/ml) DME1724 XEOTICID XEO03585 GENEFORM Protein DME1724 XEOTICID XEO03585 MOACRIVE Inhibition DME1724 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1724 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03588 XEO_CLAS Peptide DME1724 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 62 ug/ml) DME1724 XEOTICID XEO03588 GENEFORM Protein DME1724 XEOTICID XEO03588 MOACRIVE Inhibition DME1724 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1724 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03589 XEO_CLAS Peptide DME1724 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03589 GENEFORM Protein DME1724 XEOTICID XEO03589 MOACRIVE Inhibition DME1724 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1724 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03590 XEO_CLAS Peptide DME1724 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03590 GENEFORM Protein DME1724 XEOTICID XEO03590 MOACRIVE Inhibition DME1724 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1724 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03591 XEO_CLAS Peptide DME1724 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 37.5 ug/ml) DME1724 XEOTICID XEO03591 GENEFORM Protein DME1724 XEOTICID XEO03591 MOACRIVE Inhibition DME1724 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1724 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03593 XEO_CLAS Peptide DME1724 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 9.4 ug/ml) DME1724 XEOTICID XEO03593 GENEFORM Protein DME1724 XEOTICID XEO03593 MOACRIVE Inhibition DME1724 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1724 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03594 XEO_CLAS Peptide DME1724 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 ug/ml) DME1724 XEOTICID XEO03594 GENEFORM Protein DME1724 XEOTICID XEO03594 MOACRIVE Inhibition DME1724 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1724 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03595 XEO_CLAS Peptide DME1724 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03595 GENEFORM Protein DME1724 XEOTICID XEO03595 MOACRIVE Inhibition DME1724 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1724 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03596 XEO_CLAS Peptide DME1724 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03596 GENEFORM Protein DME1724 XEOTICID XEO03596 MOACRIVE Inhibition DME1724 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1724 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03598 XEO_CLAS Peptide DME1724 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03598 GENEFORM Protein DME1724 XEOTICID XEO03598 MOACRIVE Inhibition DME1724 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1724 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03599 XEO_CLAS Peptide DME1724 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03599 GENEFORM Protein DME1724 XEOTICID XEO03599 MOACRIVE Inhibition DME1724 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1724 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03600 XEO_CLAS Peptide DME1724 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03600 GENEFORM Protein DME1724 XEOTICID XEO03600 MOACRIVE Inhibition DME1724 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1724 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03606 XEO_CLAS Peptide DME1724 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03606 GENEFORM Protein DME1724 XEOTICID XEO03606 MOACRIVE Inhibition DME1724 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1724 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03607 XEO_CLAS Peptide DME1724 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03607 GENEFORM Protein DME1724 XEOTICID XEO03607 MOACRIVE Inhibition DME1724 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1724 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03609 XEO_CLAS Peptide DME1724 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03609 GENEFORM Protein DME1724 XEOTICID XEO03609 MOACRIVE Inhibition DME1724 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1724 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03615 XEO_CLAS Peptide DME1724 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1724 XEOTICID XEO03615 GENEFORM Protein DME1724 XEOTICID XEO03615 MOACRIVE Inhibition DME1724 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1724 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03616 XEO_CLAS Peptide DME1724 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 32 microM) DME1724 XEOTICID XEO03616 GENEFORM Protein DME1724 XEOTICID XEO03616 MOACRIVE Inhibition DME1724 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1724 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03617 XEO_CLAS Peptide DME1724 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40 microM) DME1724 XEOTICID XEO03617 GENEFORM Protein DME1724 XEOTICID XEO03617 MOACRIVE Inhibition DME1724 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1724 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03618 XEO_CLAS Peptide DME1724 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5-1 microM) DME1724 XEOTICID XEO03618 GENEFORM Protein DME1724 XEOTICID XEO03618 MOACRIVE Inhibition DME1724 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1724 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03622 XEO_CLAS Peptide DME1724 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20-40 microM) DME1724 XEOTICID XEO03622 GENEFORM Protein DME1724 XEOTICID XEO03622 MOACRIVE Inhibition DME1724 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1724 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03627 XEO_CLAS Peptide DME1724 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1724 XEOTICID XEO03627 GENEFORM Protein DME1724 XEOTICID XEO03627 MOACRIVE Inhibition DME1724 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1724 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03630 XEO_CLAS Peptide DME1724 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03630 GENEFORM Protein DME1724 XEOTICID XEO03630 MOACRIVE Inhibition DME1724 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1724 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03631 XEO_CLAS Peptide DME1724 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03631 GENEFORM Protein DME1724 XEOTICID XEO03631 MOACRIVE Inhibition DME1724 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1724 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03632 XEO_CLAS Peptide DME1724 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03632 GENEFORM Protein DME1724 XEOTICID XEO03632 MOACRIVE Inhibition DME1724 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1724 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03633 XEO_CLAS Peptide DME1724 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03633 GENEFORM Protein DME1724 XEOTICID XEO03633 MOACRIVE Inhibition DME1724 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1724 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03634 XEO_CLAS Peptide DME1724 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03634 GENEFORM Protein DME1724 XEOTICID XEO03634 MOACRIVE Inhibition DME1724 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1724 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03635 XEO_CLAS Peptide DME1724 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03635 GENEFORM Protein DME1724 XEOTICID XEO03635 MOACRIVE Inhibition DME1724 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1724 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03636 XEO_CLAS Peptide DME1724 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03636 GENEFORM Protein DME1724 XEOTICID XEO03636 MOACRIVE Inhibition DME1724 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1724 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03637 XEO_CLAS Peptide DME1724 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03637 GENEFORM Protein DME1724 XEOTICID XEO03637 MOACRIVE Inhibition DME1724 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1724 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03638 XEO_CLAS Peptide DME1724 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03638 GENEFORM Protein DME1724 XEOTICID XEO03638 MOACRIVE Inhibition DME1724 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1724 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03639 XEO_CLAS Peptide DME1724 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03639 GENEFORM Protein DME1724 XEOTICID XEO03639 MOACRIVE Inhibition DME1724 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1724 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03640 XEO_CLAS Peptide DME1724 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03640 GENEFORM Protein DME1724 XEOTICID XEO03640 MOACRIVE Inhibition DME1724 XEOTICID XEO03644 XEO_NAME Indole DME1724 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1724 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1724 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03644 GENEFORM Protein DME1724 XEOTICID XEO03644 MOACRIVE Inhibition DME1724 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1724 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03650 XEO_CLAS Peptide DME1724 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03650 GENEFORM Protein DME1724 XEOTICID XEO03650 MOACRIVE Inhibition DME1724 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1724 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO03655 XEO_CLAS Natural Product DME1724 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03655 GENEFORM Protein DME1724 XEOTICID XEO03655 MOACRIVE Inhibition DME1724 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1724 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03666 XEO_CLAS Peptide DME1724 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 ug/ml) DME1724 XEOTICID XEO03666 GENEFORM Protein DME1724 XEOTICID XEO03666 MOACRIVE Inhibition DME1724 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1724 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03667 XEO_CLAS Peptide DME1724 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 ug/ml) DME1724 XEOTICID XEO03667 GENEFORM Protein DME1724 XEOTICID XEO03667 MOACRIVE Inhibition DME1724 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1724 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03668 XEO_CLAS Peptide DME1724 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 microM) DME1724 XEOTICID XEO03668 GENEFORM Protein DME1724 XEOTICID XEO03668 MOACRIVE Inhibition DME1724 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1724 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03669 XEO_CLAS Peptide DME1724 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO03669 GENEFORM Protein DME1724 XEOTICID XEO03669 MOACRIVE Inhibition DME1724 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1724 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03670 XEO_CLAS Peptide DME1724 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 microM) DME1724 XEOTICID XEO03670 GENEFORM Protein DME1724 XEOTICID XEO03670 MOACRIVE Inhibition DME1724 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1724 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03672 XEO_CLAS Peptide DME1724 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.5 ug/ml) DME1724 XEOTICID XEO03672 GENEFORM Protein DME1724 XEOTICID XEO03672 MOACRIVE Inhibition DME1724 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1724 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03673 XEO_CLAS Peptide DME1724 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 ug/ml) DME1724 XEOTICID XEO03673 GENEFORM Protein DME1724 XEOTICID XEO03673 MOACRIVE Inhibition DME1724 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1724 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03674 XEO_CLAS Peptide DME1724 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 ug/ml) DME1724 XEOTICID XEO03674 GENEFORM Protein DME1724 XEOTICID XEO03674 MOACRIVE Inhibition DME1724 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1724 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03675 XEO_CLAS Peptide DME1724 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO03675 GENEFORM Protein DME1724 XEOTICID XEO03675 MOACRIVE Inhibition DME1724 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1724 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03678 XEO_CLAS Peptide DME1724 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 ug/ml) DME1724 XEOTICID XEO03678 GENEFORM Protein DME1724 XEOTICID XEO03678 MOACRIVE Inhibition DME1724 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1724 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03679 XEO_CLAS Peptide DME1724 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 ug/ml) DME1724 XEOTICID XEO03679 GENEFORM Protein DME1724 XEOTICID XEO03679 MOACRIVE Inhibition DME1724 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1724 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03681 XEO_CLAS Peptide DME1724 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1724 XEOTICID XEO03681 GENEFORM Protein DME1724 XEOTICID XEO03681 MOACRIVE Inhibition DME1724 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1724 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03684 XEO_CLAS Peptide DME1724 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 ug/ml) DME1724 XEOTICID XEO03684 GENEFORM Protein DME1724 XEOTICID XEO03684 MOACRIVE Inhibition DME1724 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1724 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03694 XEO_CLAS Peptide DME1724 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03694 GENEFORM Protein DME1724 XEOTICID XEO03694 MOACRIVE Inhibition DME1724 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1724 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03697 XEO_CLAS Peptide DME1724 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25 microM) DME1724 XEOTICID XEO03697 GENEFORM Protein DME1724 XEOTICID XEO03697 MOACRIVE Inhibition DME1724 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1724 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03698 XEO_CLAS Peptide DME1724 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03698 GENEFORM Protein DME1724 XEOTICID XEO03698 MOACRIVE Inhibition DME1724 XEOTICID XEO03703 XEO_NAME Kasstasin DME1724 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03703 XEO_CLAS Peptide DME1724 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 110 microM) DME1724 XEOTICID XEO03703 GENEFORM Protein DME1724 XEOTICID XEO03703 MOACRIVE Inhibition DME1724 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1724 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03706 XEO_CLAS Peptide DME1724 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03706 GENEFORM Protein DME1724 XEOTICID XEO03706 MOACRIVE Inhibition DME1724 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1724 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03707 XEO_CLAS Peptide DME1724 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03707 GENEFORM Protein DME1724 XEOTICID XEO03707 MOACRIVE Inhibition DME1724 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1724 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03709 XEO_CLAS Peptide DME1724 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 ug/ml) DME1724 XEOTICID XEO03709 GENEFORM Protein DME1724 XEOTICID XEO03709 MOACRIVE Inhibition DME1724 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1724 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03712 XEO_CLAS Peptide DME1724 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03712 GENEFORM Protein DME1724 XEOTICID XEO03712 MOACRIVE Inhibition DME1724 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1724 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03713 XEO_CLAS Peptide DME1724 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 64 microM) DME1724 XEOTICID XEO03713 GENEFORM Protein DME1724 XEOTICID XEO03713 MOACRIVE Inhibition DME1724 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1724 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03714 XEO_CLAS Peptide DME1724 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03714 GENEFORM Protein DME1724 XEOTICID XEO03714 MOACRIVE Inhibition DME1724 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1724 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03715 XEO_CLAS Peptide DME1724 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 microM) DME1724 XEOTICID XEO03715 GENEFORM Protein DME1724 XEOTICID XEO03715 MOACRIVE Inhibition DME1724 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1724 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03719 XEO_CLAS Peptide DME1724 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 microM) DME1724 XEOTICID XEO03719 GENEFORM Protein DME1724 XEOTICID XEO03719 MOACRIVE Inhibition DME1724 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1724 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03720 XEO_CLAS Peptide DME1724 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 microM) DME1724 XEOTICID XEO03720 GENEFORM Protein DME1724 XEOTICID XEO03720 MOACRIVE Inhibition DME1724 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1724 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03723 XEO_CLAS Peptide DME1724 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 62.36 microM) DME1724 XEOTICID XEO03723 GENEFORM Protein DME1724 XEOTICID XEO03723 MOACRIVE Inhibition DME1724 XEOTICID XEO03724 XEO_NAME L10 peptide DME1724 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03724 XEO_CLAS Peptide DME1724 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.8 microM) DME1724 XEOTICID XEO03724 GENEFORM Protein DME1724 XEOTICID XEO03724 MOACRIVE Inhibition DME1724 XEOTICID XEO03726 XEO_NAME L2 peptide DME1724 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03726 XEO_CLAS Peptide DME1724 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 129.66 microM) DME1724 XEOTICID XEO03726 GENEFORM Protein DME1724 XEOTICID XEO03726 MOACRIVE Inhibition DME1724 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1724 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03727 XEO_CLAS Peptide DME1724 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 80 ug/ml) DME1724 XEOTICID XEO03727 GENEFORM Protein DME1724 XEOTICID XEO03727 MOACRIVE Inhibition DME1724 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1724 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03728 XEO_CLAS Peptide DME1724 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40 ug/ml) DME1724 XEOTICID XEO03728 GENEFORM Protein DME1724 XEOTICID XEO03728 MOACRIVE Inhibition DME1724 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1724 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03729 XEO_CLAS Peptide DME1724 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 80 ug/ml) DME1724 XEOTICID XEO03729 GENEFORM Protein DME1724 XEOTICID XEO03729 MOACRIVE Inhibition DME1724 XEOTICID XEO03730 XEO_NAME L3 peptide DME1724 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03730 XEO_CLAS Peptide DME1724 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64.11 microM) DME1724 XEOTICID XEO03730 GENEFORM Protein DME1724 XEOTICID XEO03730 MOACRIVE Inhibition DME1724 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1724 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03731 XEO_CLAS Peptide DME1724 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40 ug/ml) DME1724 XEOTICID XEO03731 GENEFORM Protein DME1724 XEOTICID XEO03731 MOACRIVE Inhibition DME1724 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1724 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03733 XEO_CLAS Peptide DME1724 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40 ug/ml) DME1724 XEOTICID XEO03733 GENEFORM Protein DME1724 XEOTICID XEO03733 MOACRIVE Inhibition DME1724 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1724 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03734 XEO_CLAS Peptide DME1724 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO03734 GENEFORM Protein DME1724 XEOTICID XEO03734 MOACRIVE Inhibition DME1724 XEOTICID XEO03735 XEO_NAME L4 peptide DME1724 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03735 XEO_CLAS Peptide DME1724 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 31.61 microM) DME1724 XEOTICID XEO03735 GENEFORM Protein DME1724 XEOTICID XEO03735 MOACRIVE Inhibition DME1724 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1724 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03738 XEO_CLAS Peptide DME1724 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 ug/ml) DME1724 XEOTICID XEO03738 GENEFORM Protein DME1724 XEOTICID XEO03738 MOACRIVE Inhibition DME1724 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1724 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03741 XEO_CLAS Peptide DME1724 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40 ug/ml) DME1724 XEOTICID XEO03741 GENEFORM Protein DME1724 XEOTICID XEO03741 MOACRIVE Inhibition DME1724 XEOTICID XEO03742 XEO_NAME L5 peptide DME1724 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03742 XEO_CLAS Peptide DME1724 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 7.79 microM) DME1724 XEOTICID XEO03742 GENEFORM Protein DME1724 XEOTICID XEO03742 MOACRIVE Inhibition DME1724 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1724 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03743 XEO_CLAS Peptide DME1724 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 ug/ml) DME1724 XEOTICID XEO03743 GENEFORM Protein DME1724 XEOTICID XEO03743 MOACRIVE Inhibition DME1724 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1724 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03744 XEO_CLAS Peptide DME1724 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 ug/ml) DME1724 XEOTICID XEO03744 GENEFORM Protein DME1724 XEOTICID XEO03744 MOACRIVE Inhibition DME1724 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1724 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03745 XEO_CLAS Peptide DME1724 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 ug/ml) DME1724 XEOTICID XEO03745 GENEFORM Protein DME1724 XEOTICID XEO03745 MOACRIVE Inhibition DME1724 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1724 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03746 XEO_CLAS Peptide DME1724 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO03746 GENEFORM Protein DME1724 XEOTICID XEO03746 MOACRIVE Inhibition DME1724 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1724 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03747 XEO_CLAS Peptide DME1724 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO03747 GENEFORM Protein DME1724 XEOTICID XEO03747 MOACRIVE Inhibition DME1724 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1724 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03748 XEO_CLAS Peptide DME1724 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO03748 GENEFORM Protein DME1724 XEOTICID XEO03748 MOACRIVE Inhibition DME1724 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1724 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03749 XEO_CLAS Peptide DME1724 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO03749 GENEFORM Protein DME1724 XEOTICID XEO03749 MOACRIVE Inhibition DME1724 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1724 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03750 XEO_CLAS Peptide DME1724 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO03750 GENEFORM Protein DME1724 XEOTICID XEO03750 MOACRIVE Inhibition DME1724 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1724 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03751 XEO_CLAS Peptide DME1724 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO03751 GENEFORM Protein DME1724 XEOTICID XEO03751 MOACRIVE Inhibition DME1724 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1724 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03752 XEO_CLAS Peptide DME1724 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO03752 GENEFORM Protein DME1724 XEOTICID XEO03752 MOACRIVE Inhibition DME1724 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1724 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03753 XEO_CLAS Peptide DME1724 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 ug/ml) DME1724 XEOTICID XEO03753 GENEFORM Protein DME1724 XEOTICID XEO03753 MOACRIVE Inhibition DME1724 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1724 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03754 XEO_CLAS Peptide DME1724 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO03754 GENEFORM Protein DME1724 XEOTICID XEO03754 MOACRIVE Inhibition DME1724 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1724 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03755 XEO_CLAS Peptide DME1724 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO03755 GENEFORM Protein DME1724 XEOTICID XEO03755 MOACRIVE Inhibition DME1724 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1724 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03756 XEO_CLAS Peptide DME1724 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO03756 GENEFORM Protein DME1724 XEOTICID XEO03756 MOACRIVE Inhibition DME1724 XEOTICID XEO03757 XEO_NAME L6 peptide DME1724 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03757 XEO_CLAS Peptide DME1724 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15.17 microM) DME1724 XEOTICID XEO03757 GENEFORM Protein DME1724 XEOTICID XEO03757 MOACRIVE Inhibition DME1724 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1724 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03758 XEO_CLAS Peptide DME1724 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 80 ug/ml) DME1724 XEOTICID XEO03758 GENEFORM Protein DME1724 XEOTICID XEO03758 MOACRIVE Inhibition DME1724 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1724 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03759 XEO_CLAS Peptide DME1724 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.3 ug/ml) DME1724 XEOTICID XEO03759 GENEFORM Protein DME1724 XEOTICID XEO03759 MOACRIVE Inhibition DME1724 XEOTICID XEO03760 XEO_NAME L7 peptide DME1724 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03760 XEO_CLAS Peptide DME1724 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16.02 microM) DME1724 XEOTICID XEO03760 GENEFORM Protein DME1724 XEOTICID XEO03760 MOACRIVE Inhibition DME1724 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1724 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03761 XEO_CLAS Peptide DME1724 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 ug/ml) DME1724 XEOTICID XEO03761 GENEFORM Protein DME1724 XEOTICID XEO03761 MOACRIVE Inhibition DME1724 XEOTICID XEO03763 XEO_NAME L8 peptide DME1724 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03763 XEO_CLAS Peptide DME1724 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.71 microM) DME1724 XEOTICID XEO03763 GENEFORM Protein DME1724 XEOTICID XEO03763 MOACRIVE Inhibition DME1724 XEOTICID XEO03765 XEO_NAME L9 peptide DME1724 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03765 XEO_CLAS Peptide DME1724 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.78 microM) DME1724 XEOTICID XEO03765 GENEFORM Protein DME1724 XEOTICID XEO03765 MOACRIVE Inhibition DME1724 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1724 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03775 XEO_CLAS Peptide DME1724 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 17.3 microM) DME1724 XEOTICID XEO03775 GENEFORM Protein DME1724 XEOTICID XEO03775 MOACRIVE Inhibition DME1724 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1724 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03776 XEO_CLAS Peptide DME1724 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03776 GENEFORM Protein DME1724 XEOTICID XEO03776 MOACRIVE Inhibition DME1724 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1724 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03781 XEO_CLAS Peptide DME1724 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.47 microM) DME1724 XEOTICID XEO03781 GENEFORM Protein DME1724 XEOTICID XEO03781 MOACRIVE Inhibition DME1724 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1724 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03782 XEO_CLAS Peptide DME1724 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.47 microM) DME1724 XEOTICID XEO03782 GENEFORM Protein DME1724 XEOTICID XEO03782 MOACRIVE Inhibition DME1724 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1724 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03783 XEO_CLAS Peptide DME1724 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.68 microM) DME1724 XEOTICID XEO03783 GENEFORM Protein DME1724 XEOTICID XEO03783 MOACRIVE Inhibition DME1724 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1724 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03784 XEO_CLAS Peptide DME1724 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.45 microM) DME1724 XEOTICID XEO03784 GENEFORM Protein DME1724 XEOTICID XEO03784 MOACRIVE Inhibition DME1724 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1724 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03785 XEO_CLAS Peptide DME1724 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.73 microM) DME1724 XEOTICID XEO03785 GENEFORM Protein DME1724 XEOTICID XEO03785 MOACRIVE Inhibition DME1724 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1724 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03786 XEO_CLAS Peptide DME1724 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.45 microM) DME1724 XEOTICID XEO03786 GENEFORM Protein DME1724 XEOTICID XEO03786 MOACRIVE Inhibition DME1724 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1724 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03787 XEO_CLAS Peptide DME1724 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.38 microM) DME1724 XEOTICID XEO03787 GENEFORM Protein DME1724 XEOTICID XEO03787 MOACRIVE Inhibition DME1724 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1724 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03788 XEO_CLAS Peptide DME1724 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.46 microM) DME1724 XEOTICID XEO03788 GENEFORM Protein DME1724 XEOTICID XEO03788 MOACRIVE Inhibition DME1724 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1724 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03789 XEO_CLAS Peptide DME1724 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 13.05 microM) DME1724 XEOTICID XEO03789 GENEFORM Protein DME1724 XEOTICID XEO03789 MOACRIVE Inhibition DME1724 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1724 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03790 XEO_CLAS Peptide DME1724 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.82 microM) DME1724 XEOTICID XEO03790 GENEFORM Protein DME1724 XEOTICID XEO03790 MOACRIVE Inhibition DME1724 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1724 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03791 XEO_CLAS Peptide DME1724 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.80 microM) DME1724 XEOTICID XEO03791 GENEFORM Protein DME1724 XEOTICID XEO03791 MOACRIVE Inhibition DME1724 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1724 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03792 XEO_CLAS Peptide DME1724 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.26 microM) DME1724 XEOTICID XEO03792 GENEFORM Protein DME1724 XEOTICID XEO03792 MOACRIVE Inhibition DME1724 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1724 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03793 XEO_CLAS Peptide DME1724 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 microM) DME1724 XEOTICID XEO03793 GENEFORM Protein DME1724 XEOTICID XEO03793 MOACRIVE Inhibition DME1724 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1724 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03797 XEO_CLAS Peptide DME1724 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.4 microM) DME1724 XEOTICID XEO03797 GENEFORM Protein DME1724 XEOTICID XEO03797 MOACRIVE Inhibition DME1724 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1724 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03798 XEO_CLAS Peptide DME1724 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03798 GENEFORM Protein DME1724 XEOTICID XEO03798 MOACRIVE Inhibition DME1724 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1724 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03799 XEO_CLAS Peptide DME1724 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03799 GENEFORM Protein DME1724 XEOTICID XEO03799 MOACRIVE Inhibition DME1724 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1724 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03810 XEO_CLAS Peptide DME1724 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03810 GENEFORM Protein DME1724 XEOTICID XEO03810 MOACRIVE Inhibition DME1724 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1724 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03846 XEO_CLAS Peptide DME1724 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03846 GENEFORM Protein DME1724 XEOTICID XEO03846 MOACRIVE Inhibition DME1724 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1724 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03847 XEO_CLAS Peptide DME1724 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03847 GENEFORM Protein DME1724 XEOTICID XEO03847 MOACRIVE Inhibition DME1724 XEOTICID XEO03850 XEO_NAME Lemon DME1724 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1724 XEOTICID XEO03850 XEO_CLAS Food Additive DME1724 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03850 GENEFORM Protein DME1724 XEOTICID XEO03850 MOACRIVE Inhibition DME1724 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1724 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03853 XEO_CLAS Peptide DME1724 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO03853 GENEFORM Protein DME1724 XEOTICID XEO03853 MOACRIVE Inhibition DME1724 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1724 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03857 XEO_CLAS Peptide DME1724 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 38.49 microM) DME1724 XEOTICID XEO03857 GENEFORM Protein DME1724 XEOTICID XEO03857 MOACRIVE Inhibition DME1724 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1724 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03860 XEO_CLAS Peptide DME1724 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 24 microM) DME1724 XEOTICID XEO03860 GENEFORM Protein DME1724 XEOTICID XEO03860 MOACRIVE Inhibition DME1724 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1724 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03861 XEO_CLAS Peptide DME1724 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 35 microM) DME1724 XEOTICID XEO03861 GENEFORM Protein DME1724 XEOTICID XEO03861 MOACRIVE Inhibition DME1724 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1724 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03862 XEO_CLAS Peptide DME1724 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 70 microM) DME1724 XEOTICID XEO03862 GENEFORM Protein DME1724 XEOTICID XEO03862 MOACRIVE Inhibition DME1724 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1724 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03863 XEO_CLAS Peptide DME1724 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 35 microM) DME1724 XEOTICID XEO03863 GENEFORM Protein DME1724 XEOTICID XEO03863 MOACRIVE Inhibition DME1724 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1724 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03864 XEO_CLAS Peptide DME1724 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO03864 GENEFORM Protein DME1724 XEOTICID XEO03864 MOACRIVE Inhibition DME1724 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1724 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03865 XEO_CLAS Peptide DME1724 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO03865 GENEFORM Protein DME1724 XEOTICID XEO03865 MOACRIVE Inhibition DME1724 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1724 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03866 XEO_CLAS Peptide DME1724 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 microM) DME1724 XEOTICID XEO03866 GENEFORM Protein DME1724 XEOTICID XEO03866 MOACRIVE Inhibition DME1724 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1724 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03867 XEO_CLAS Peptide DME1724 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40 microM) DME1724 XEOTICID XEO03867 GENEFORM Protein DME1724 XEOTICID XEO03867 MOACRIVE Inhibition DME1724 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1724 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03868 XEO_CLAS Peptide DME1724 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 51 microM) DME1724 XEOTICID XEO03868 GENEFORM Protein DME1724 XEOTICID XEO03868 MOACRIVE Inhibition DME1724 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1724 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03869 XEO_CLAS Peptide DME1724 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 35 microM) DME1724 XEOTICID XEO03869 GENEFORM Protein DME1724 XEOTICID XEO03869 MOACRIVE Inhibition DME1724 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1724 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03870 XEO_CLAS Peptide DME1724 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 61 microM) DME1724 XEOTICID XEO03870 GENEFORM Protein DME1724 XEOTICID XEO03870 MOACRIVE Inhibition DME1724 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1724 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03871 XEO_CLAS Peptide DME1724 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 microM) DME1724 XEOTICID XEO03871 GENEFORM Protein DME1724 XEOTICID XEO03871 MOACRIVE Inhibition DME1724 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1724 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03872 XEO_CLAS Peptide DME1724 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 28 microM) DME1724 XEOTICID XEO03872 GENEFORM Protein DME1724 XEOTICID XEO03872 MOACRIVE Inhibition DME1724 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1724 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03873 XEO_CLAS Peptide DME1724 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 22.5 microM) DME1724 XEOTICID XEO03873 GENEFORM Protein DME1724 XEOTICID XEO03873 MOACRIVE Inhibition DME1724 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1724 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03874 XEO_CLAS Peptide DME1724 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 11.25 microM) DME1724 XEOTICID XEO03874 GENEFORM Protein DME1724 XEOTICID XEO03874 MOACRIVE Inhibition DME1724 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1724 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03875 XEO_CLAS Peptide DME1724 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 microM) DME1724 XEOTICID XEO03875 GENEFORM Protein DME1724 XEOTICID XEO03875 MOACRIVE Inhibition DME1724 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1724 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03876 XEO_CLAS Peptide DME1724 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.75 microM) DME1724 XEOTICID XEO03876 GENEFORM Protein DME1724 XEOTICID XEO03876 MOACRIVE Inhibition DME1724 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1724 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03877 XEO_CLAS Peptide DME1724 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 microM) DME1724 XEOTICID XEO03877 GENEFORM Protein DME1724 XEOTICID XEO03877 MOACRIVE Inhibition DME1724 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1724 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03878 XEO_CLAS Peptide DME1724 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 microM) DME1724 XEOTICID XEO03878 GENEFORM Protein DME1724 XEOTICID XEO03878 MOACRIVE Inhibition DME1724 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1724 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03879 XEO_CLAS Peptide DME1724 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 252 microM) DME1724 XEOTICID XEO03879 GENEFORM Protein DME1724 XEOTICID XEO03879 MOACRIVE Inhibition DME1724 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1724 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03880 XEO_CLAS Peptide DME1724 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 174 microM) DME1724 XEOTICID XEO03880 GENEFORM Protein DME1724 XEOTICID XEO03880 MOACRIVE Inhibition DME1724 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1724 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03883 XEO_CLAS Peptide DME1724 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 74 microM) DME1724 XEOTICID XEO03883 GENEFORM Protein DME1724 XEOTICID XEO03883 MOACRIVE Inhibition DME1724 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1724 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03884 XEO_CLAS Peptide DME1724 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 31 microM) DME1724 XEOTICID XEO03884 GENEFORM Protein DME1724 XEOTICID XEO03884 MOACRIVE Inhibition DME1724 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1724 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03885 XEO_CLAS Peptide DME1724 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO03885 GENEFORM Protein DME1724 XEOTICID XEO03885 MOACRIVE Inhibition DME1724 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1724 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03886 XEO_CLAS Peptide DME1724 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 391 microM) DME1724 XEOTICID XEO03886 GENEFORM Protein DME1724 XEOTICID XEO03886 MOACRIVE Inhibition DME1724 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1724 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03887 XEO_CLAS Peptide DME1724 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 151 microM) DME1724 XEOTICID XEO03887 GENEFORM Protein DME1724 XEOTICID XEO03887 MOACRIVE Inhibition DME1724 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1724 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03888 XEO_CLAS Peptide DME1724 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 134 microM) DME1724 XEOTICID XEO03888 GENEFORM Protein DME1724 XEOTICID XEO03888 MOACRIVE Inhibition DME1724 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1724 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03889 XEO_CLAS Peptide DME1724 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 88 microM) DME1724 XEOTICID XEO03889 GENEFORM Protein DME1724 XEOTICID XEO03889 MOACRIVE Inhibition DME1724 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1724 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03890 XEO_CLAS Peptide DME1724 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 31 microM) DME1724 XEOTICID XEO03890 GENEFORM Protein DME1724 XEOTICID XEO03890 MOACRIVE Inhibition DME1724 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1724 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03891 XEO_CLAS Peptide DME1724 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 microM) DME1724 XEOTICID XEO03891 GENEFORM Protein DME1724 XEOTICID XEO03891 MOACRIVE Inhibition DME1724 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1724 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03892 XEO_CLAS Peptide DME1724 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 37 microM) DME1724 XEOTICID XEO03892 GENEFORM Protein DME1724 XEOTICID XEO03892 MOACRIVE Inhibition DME1724 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1724 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03893 XEO_CLAS Peptide DME1724 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 19 microM) DME1724 XEOTICID XEO03893 GENEFORM Protein DME1724 XEOTICID XEO03893 MOACRIVE Inhibition DME1724 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1724 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03894 XEO_CLAS Peptide DME1724 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO03894 GENEFORM Protein DME1724 XEOTICID XEO03894 MOACRIVE Inhibition DME1724 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1724 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03895 XEO_CLAS Peptide DME1724 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO03895 GENEFORM Protein DME1724 XEOTICID XEO03895 MOACRIVE Inhibition DME1724 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1724 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03896 XEO_CLAS Peptide DME1724 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 microM) DME1724 XEOTICID XEO03896 GENEFORM Protein DME1724 XEOTICID XEO03896 MOACRIVE Inhibition DME1724 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1724 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03897 XEO_CLAS Peptide DME1724 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 63 microM) DME1724 XEOTICID XEO03897 GENEFORM Protein DME1724 XEOTICID XEO03897 MOACRIVE Inhibition DME1724 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1724 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03898 XEO_CLAS Peptide DME1724 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 219 microM) DME1724 XEOTICID XEO03898 GENEFORM Protein DME1724 XEOTICID XEO03898 MOACRIVE Inhibition DME1724 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1724 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03901 XEO_CLAS Peptide DME1724 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 35 microM) DME1724 XEOTICID XEO03901 GENEFORM Protein DME1724 XEOTICID XEO03901 MOACRIVE Inhibition DME1724 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1724 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03902 XEO_CLAS Peptide DME1724 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 70 microM) DME1724 XEOTICID XEO03902 GENEFORM Protein DME1724 XEOTICID XEO03902 MOACRIVE Inhibition DME1724 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1724 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03904 XEO_CLAS Peptide DME1724 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO03904 GENEFORM Protein DME1724 XEOTICID XEO03904 MOACRIVE Inhibition DME1724 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1724 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03905 XEO_CLAS Peptide DME1724 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO03905 GENEFORM Protein DME1724 XEOTICID XEO03905 MOACRIVE Inhibition DME1724 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1724 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03908 XEO_CLAS Peptide DME1724 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03908 GENEFORM Protein DME1724 XEOTICID XEO03908 MOACRIVE Inhibition DME1724 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1724 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03915 XEO_CLAS Peptide DME1724 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03915 GENEFORM Protein DME1724 XEOTICID XEO03915 MOACRIVE Inhibition DME1724 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1724 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03916 XEO_CLAS Peptide DME1724 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.8 ug/ml) DME1724 XEOTICID XEO03916 GENEFORM Protein DME1724 XEOTICID XEO03916 MOACRIVE Inhibition DME1724 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1724 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03917 XEO_CLAS Peptide DME1724 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 13.1 ug/ml) DME1724 XEOTICID XEO03917 GENEFORM Protein DME1724 XEOTICID XEO03917 MOACRIVE Inhibition DME1724 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1724 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03918 XEO_CLAS Peptide DME1724 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.5 ug/ml) DME1724 XEOTICID XEO03918 GENEFORM Protein DME1724 XEOTICID XEO03918 MOACRIVE Inhibition DME1724 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1724 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03919 XEO_CLAS Peptide DME1724 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 80 ug/ml) DME1724 XEOTICID XEO03919 GENEFORM Protein DME1724 XEOTICID XEO03919 MOACRIVE Inhibition DME1724 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1724 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03922 XEO_CLAS Peptide DME1724 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 9 microM) DME1724 XEOTICID XEO03922 GENEFORM Protein DME1724 XEOTICID XEO03922 MOACRIVE Inhibition DME1724 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1724 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03923 XEO_CLAS Peptide DME1724 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 80 microM) DME1724 XEOTICID XEO03923 GENEFORM Protein DME1724 XEOTICID XEO03923 MOACRIVE Inhibition DME1724 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1724 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03924 XEO_CLAS Peptide DME1724 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO03924 GENEFORM Protein DME1724 XEOTICID XEO03924 MOACRIVE Inhibition DME1724 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1724 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03927 XEO_CLAS Peptide DME1724 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 80 microM) DME1724 XEOTICID XEO03927 GENEFORM Protein DME1724 XEOTICID XEO03927 MOACRIVE Inhibition DME1724 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1724 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03928 XEO_CLAS Peptide DME1724 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 microM) DME1724 XEOTICID XEO03928 GENEFORM Protein DME1724 XEOTICID XEO03928 MOACRIVE Inhibition DME1724 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1724 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03929 XEO_CLAS Peptide DME1724 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 microM) DME1724 XEOTICID XEO03929 GENEFORM Protein DME1724 XEOTICID XEO03929 MOACRIVE Inhibition DME1724 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1724 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03930 XEO_CLAS Peptide DME1724 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 microM) DME1724 XEOTICID XEO03930 GENEFORM Protein DME1724 XEOTICID XEO03930 MOACRIVE Inhibition DME1724 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1724 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03931 XEO_CLAS Peptide DME1724 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 microM) DME1724 XEOTICID XEO03931 GENEFORM Protein DME1724 XEOTICID XEO03931 MOACRIVE Inhibition DME1724 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1724 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03933 XEO_CLAS Peptide DME1724 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.5 microM) DME1724 XEOTICID XEO03933 GENEFORM Protein DME1724 XEOTICID XEO03933 MOACRIVE Inhibition DME1724 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1724 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03934 XEO_CLAS Peptide DME1724 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.7 microM) DME1724 XEOTICID XEO03934 GENEFORM Protein DME1724 XEOTICID XEO03934 MOACRIVE Inhibition DME1724 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1724 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03935 XEO_CLAS Peptide DME1724 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.7 microM) DME1724 XEOTICID XEO03935 GENEFORM Protein DME1724 XEOTICID XEO03935 MOACRIVE Inhibition DME1724 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1724 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03936 XEO_CLAS Peptide DME1724 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.0 microM) DME1724 XEOTICID XEO03936 GENEFORM Protein DME1724 XEOTICID XEO03936 MOACRIVE Inhibition DME1724 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1724 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03937 XEO_CLAS Peptide DME1724 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.1 microM) DME1724 XEOTICID XEO03937 GENEFORM Protein DME1724 XEOTICID XEO03937 MOACRIVE Inhibition DME1724 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1724 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03938 XEO_CLAS Peptide DME1724 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.7 microM) DME1724 XEOTICID XEO03938 GENEFORM Protein DME1724 XEOTICID XEO03938 MOACRIVE Inhibition DME1724 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1724 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03939 XEO_CLAS Peptide DME1724 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.7 microM) DME1724 XEOTICID XEO03939 GENEFORM Protein DME1724 XEOTICID XEO03939 MOACRIVE Inhibition DME1724 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1724 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03940 XEO_CLAS Peptide DME1724 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.5 microM) DME1724 XEOTICID XEO03940 GENEFORM Protein DME1724 XEOTICID XEO03940 MOACRIVE Inhibition DME1724 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1724 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03941 XEO_CLAS Peptide DME1724 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.4 microM) DME1724 XEOTICID XEO03941 GENEFORM Protein DME1724 XEOTICID XEO03941 MOACRIVE Inhibition DME1724 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1724 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03943 XEO_CLAS Peptide DME1724 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.4 microM) DME1724 XEOTICID XEO03943 GENEFORM Protein DME1724 XEOTICID XEO03943 MOACRIVE Inhibition DME1724 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1724 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03944 XEO_CLAS Peptide DME1724 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.7 microM) DME1724 XEOTICID XEO03944 GENEFORM Protein DME1724 XEOTICID XEO03944 MOACRIVE Inhibition DME1724 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1724 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03945 XEO_CLAS Peptide DME1724 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.2 microM) DME1724 XEOTICID XEO03945 GENEFORM Protein DME1724 XEOTICID XEO03945 MOACRIVE Inhibition DME1724 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1724 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03947 XEO_CLAS Peptide DME1724 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.0 microM) DME1724 XEOTICID XEO03947 GENEFORM Protein DME1724 XEOTICID XEO03947 MOACRIVE Inhibition DME1724 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1724 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03948 XEO_CLAS Peptide DME1724 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 23.3 microM) DME1724 XEOTICID XEO03948 GENEFORM Protein DME1724 XEOTICID XEO03948 MOACRIVE Inhibition DME1724 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1724 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03950 XEO_CLAS Peptide DME1724 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4.4 microM) DME1724 XEOTICID XEO03950 GENEFORM Protein DME1724 XEOTICID XEO03950 MOACRIVE Inhibition DME1724 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1724 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03951 XEO_CLAS Peptide DME1724 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8.8 microM) DME1724 XEOTICID XEO03951 GENEFORM Protein DME1724 XEOTICID XEO03951 MOACRIVE Inhibition DME1724 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1724 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03952 XEO_CLAS Peptide DME1724 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.2 microM) DME1724 XEOTICID XEO03952 GENEFORM Protein DME1724 XEOTICID XEO03952 MOACRIVE Inhibition DME1724 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1724 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03953 XEO_CLAS Peptide DME1724 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 microM) DME1724 XEOTICID XEO03953 GENEFORM Protein DME1724 XEOTICID XEO03953 MOACRIVE Inhibition DME1724 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1724 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03958 XEO_CLAS Peptide DME1724 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03958 GENEFORM Protein DME1724 XEOTICID XEO03958 MOACRIVE Inhibition DME1724 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1724 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03965 XEO_CLAS Peptide DME1724 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 128 microM) DME1724 XEOTICID XEO03965 GENEFORM Protein DME1724 XEOTICID XEO03965 MOACRIVE Inhibition DME1724 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1724 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03966 XEO_CLAS Peptide DME1724 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 microM) DME1724 XEOTICID XEO03966 GENEFORM Protein DME1724 XEOTICID XEO03966 MOACRIVE Inhibition DME1724 XEOTICID XEO03971 XEO_NAME Lumbrican DME1724 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03971 XEO_CLAS Peptide DME1724 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03971 GENEFORM Protein DME1724 XEOTICID XEO03971 MOACRIVE Inhibition DME1724 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1724 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03972 XEO_CLAS Peptide DME1724 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO03972 GENEFORM Protein DME1724 XEOTICID XEO03972 MOACRIVE Inhibition DME1724 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1724 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03980 XEO_CLAS Peptide DME1724 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 32 microM) DME1724 XEOTICID XEO03980 GENEFORM Protein DME1724 XEOTICID XEO03980 MOACRIVE Inhibition DME1724 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1724 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03985 XEO_CLAS Peptide DME1724 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 ug/ml) DME1724 XEOTICID XEO03985 GENEFORM Protein DME1724 XEOTICID XEO03985 MOACRIVE Inhibition DME1724 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1724 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03991 XEO_CLAS Peptide DME1724 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03991 GENEFORM Protein DME1724 XEOTICID XEO03991 MOACRIVE Inhibition DME1724 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1724 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03992 XEO_CLAS Peptide DME1724 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03992 GENEFORM Protein DME1724 XEOTICID XEO03992 MOACRIVE Inhibition DME1724 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1724 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03993 XEO_CLAS Peptide DME1724 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03993 GENEFORM Protein DME1724 XEOTICID XEO03993 MOACRIVE Inhibition DME1724 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1724 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03994 XEO_CLAS Peptide DME1724 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO03994 GENEFORM Protein DME1724 XEOTICID XEO03994 MOACRIVE Inhibition DME1724 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1724 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03996 XEO_CLAS Peptide DME1724 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 65 microM) DME1724 XEOTICID XEO03996 GENEFORM Protein DME1724 XEOTICID XEO03996 MOACRIVE Inhibition DME1724 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1724 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03997 XEO_CLAS Peptide DME1724 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 7.5 microM) DME1724 XEOTICID XEO03997 GENEFORM Protein DME1724 XEOTICID XEO03997 MOACRIVE Inhibition DME1724 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1724 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03998 XEO_CLAS Peptide DME1724 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15.5 microM) DME1724 XEOTICID XEO03998 GENEFORM Protein DME1724 XEOTICID XEO03998 MOACRIVE Inhibition DME1724 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1724 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO03999 XEO_CLAS Peptide DME1724 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25.8 microM) DME1724 XEOTICID XEO03999 GENEFORM Protein DME1724 XEOTICID XEO03999 MOACRIVE Inhibition DME1724 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1724 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04000 XEO_CLAS Peptide DME1724 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO04000 GENEFORM Protein DME1724 XEOTICID XEO04000 MOACRIVE Inhibition DME1724 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1724 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04001 XEO_CLAS Peptide DME1724 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO04001 GENEFORM Protein DME1724 XEOTICID XEO04001 MOACRIVE Inhibition DME1724 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1724 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04002 XEO_CLAS Peptide DME1724 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 7.5 ug/ml) DME1724 XEOTICID XEO04002 GENEFORM Protein DME1724 XEOTICID XEO04002 MOACRIVE Inhibition DME1724 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1724 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04003 XEO_CLAS Peptide DME1724 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 ug/ml) DME1724 XEOTICID XEO04003 GENEFORM Protein DME1724 XEOTICID XEO04003 MOACRIVE Inhibition DME1724 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1724 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04004 XEO_CLAS Peptide DME1724 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.0 ug/ml) DME1724 XEOTICID XEO04004 GENEFORM Protein DME1724 XEOTICID XEO04004 MOACRIVE Inhibition DME1724 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1724 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04005 XEO_CLAS Peptide DME1724 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.0 ug/ml) DME1724 XEOTICID XEO04005 GENEFORM Protein DME1724 XEOTICID XEO04005 MOACRIVE Inhibition DME1724 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1724 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04007 XEO_CLAS Peptide DME1724 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 19.5 ug/ml) DME1724 XEOTICID XEO04007 GENEFORM Protein DME1724 XEOTICID XEO04007 MOACRIVE Inhibition DME1724 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1724 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04011 XEO_CLAS Peptide DME1724 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 19.5 ug/ml) DME1724 XEOTICID XEO04011 GENEFORM Protein DME1724 XEOTICID XEO04011 MOACRIVE Inhibition DME1724 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1724 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04012 XEO_CLAS Peptide DME1724 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.9 ug/ml) DME1724 XEOTICID XEO04012 GENEFORM Protein DME1724 XEOTICID XEO04012 MOACRIVE Inhibition DME1724 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1724 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04013 XEO_CLAS Peptide DME1724 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.7 ug/ml) DME1724 XEOTICID XEO04013 GENEFORM Protein DME1724 XEOTICID XEO04013 MOACRIVE Inhibition DME1724 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1724 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04018 XEO_CLAS Peptide DME1724 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 9 ug/ml) DME1724 XEOTICID XEO04018 GENEFORM Protein DME1724 XEOTICID XEO04018 MOACRIVE Inhibition DME1724 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1724 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04026 XEO_CLAS Peptide DME1724 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO04026 GENEFORM Protein DME1724 XEOTICID XEO04026 MOACRIVE Inhibition DME1724 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1724 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04027 XEO_CLAS Peptide DME1724 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO04027 GENEFORM Protein DME1724 XEOTICID XEO04027 MOACRIVE Inhibition DME1724 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1724 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04028 XEO_CLAS Peptide DME1724 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 ug/ml) DME1724 XEOTICID XEO04028 GENEFORM Protein DME1724 XEOTICID XEO04028 MOACRIVE Inhibition DME1724 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1724 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04038 XEO_CLAS Peptide DME1724 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04038 GENEFORM Protein DME1724 XEOTICID XEO04038 MOACRIVE Inhibition DME1724 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1724 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04039 XEO_CLAS Peptide DME1724 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 microM) DME1724 XEOTICID XEO04039 GENEFORM Protein DME1724 XEOTICID XEO04039 MOACRIVE Inhibition DME1724 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1724 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04051 XEO_CLAS Peptide DME1724 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1724 XEOTICID XEO04051 GENEFORM Protein DME1724 XEOTICID XEO04051 MOACRIVE Inhibition DME1724 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1724 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04052 XEO_CLAS Peptide DME1724 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04052 GENEFORM Protein DME1724 XEOTICID XEO04052 MOACRIVE Inhibition DME1724 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1724 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04053 XEO_CLAS Peptide DME1724 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.08-0.16 microM) DME1724 XEOTICID XEO04053 GENEFORM Protein DME1724 XEOTICID XEO04053 MOACRIVE Inhibition DME1724 XEOTICID XEO04055 XEO_NAME Melectin DME1724 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04055 XEO_CLAS Peptide DME1724 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.0 microM) DME1724 XEOTICID XEO04055 GENEFORM Protein DME1724 XEOTICID XEO04055 MOACRIVE Inhibition DME1724 XEOTICID XEO04057 XEO_NAME Melittin DME1724 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04057 XEO_CLAS Peptide DME1724 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.8 microM) DME1724 XEOTICID XEO04057 GENEFORM Protein DME1724 XEOTICID XEO04057 MOACRIVE Inhibition DME1724 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1724 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04061 XEO_CLAS Peptide DME1724 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.9 microM) DME1724 XEOTICID XEO04061 GENEFORM Protein DME1724 XEOTICID XEO04061 MOACRIVE Inhibition DME1724 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1724 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04062 XEO_CLAS Peptide DME1724 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.5 microM) DME1724 XEOTICID XEO04062 GENEFORM Protein DME1724 XEOTICID XEO04062 MOACRIVE Inhibition DME1724 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1724 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04063 XEO_CLAS Peptide DME1724 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 7.8 microM) DME1724 XEOTICID XEO04063 GENEFORM Protein DME1724 XEOTICID XEO04063 MOACRIVE Inhibition DME1724 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1724 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04064 XEO_CLAS Peptide DME1724 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 46.7 microM) DME1724 XEOTICID XEO04064 GENEFORM Protein DME1724 XEOTICID XEO04064 MOACRIVE Inhibition DME1724 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1724 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04066 XEO_CLAS Peptide DME1724 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16.3 microM) DME1724 XEOTICID XEO04066 GENEFORM Protein DME1724 XEOTICID XEO04066 MOACRIVE Inhibition DME1724 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1724 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04067 XEO_CLAS Peptide DME1724 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.6 microM) DME1724 XEOTICID XEO04067 GENEFORM Protein DME1724 XEOTICID XEO04067 MOACRIVE Inhibition DME1724 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1724 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04068 XEO_CLAS Peptide DME1724 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.6 microM) DME1724 XEOTICID XEO04068 GENEFORM Protein DME1724 XEOTICID XEO04068 MOACRIVE Inhibition DME1724 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1724 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04086 GENEFORM Protein DME1724 XEOTICID XEO04086 MOACRIVE Inhibition DME1724 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1724 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04087 GENEFORM Protein DME1724 XEOTICID XEO04087 MOACRIVE Inhibition DME1724 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1724 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04089 GENEFORM Protein DME1724 XEOTICID XEO04089 MOACRIVE Inhibition DME1724 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1724 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04094 GENEFORM Protein DME1724 XEOTICID XEO04094 MOACRIVE Inhibition DME1724 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1724 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04096 GENEFORM Protein DME1724 XEOTICID XEO04096 MOACRIVE Inhibition DME1724 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1724 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04098 GENEFORM Protein DME1724 XEOTICID XEO04098 MOACRIVE Inhibition DME1724 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1724 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04111 XEO_CLAS Peptide DME1724 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04111 GENEFORM Protein DME1724 XEOTICID XEO04111 MOACRIVE Inhibition DME1724 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1724 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04112 XEO_CLAS Peptide DME1724 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.02 microM) DME1724 XEOTICID XEO04112 GENEFORM Protein DME1724 XEOTICID XEO04112 MOACRIVE Inhibition DME1724 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1724 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04113 XEO_CLAS Peptide DME1724 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.02 ug/ml) DME1724 XEOTICID XEO04113 GENEFORM Protein DME1724 XEOTICID XEO04113 MOACRIVE Inhibition DME1724 XEOTICID XEO04114 XEO_NAME Microcin L DME1724 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04114 XEO_CLAS Peptide DME1724 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04114 GENEFORM Protein DME1724 XEOTICID XEO04114 MOACRIVE Inhibition DME1724 XEOTICID XEO04117 XEO_NAME Misgurin DME1724 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04117 XEO_CLAS Peptide DME1724 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04117 GENEFORM Protein DME1724 XEOTICID XEO04117 MOACRIVE Inhibition DME1724 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1724 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04118 XEO_CLAS Peptide DME1724 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 300 microM) DME1724 XEOTICID XEO04118 GENEFORM Protein DME1724 XEOTICID XEO04118 MOACRIVE Inhibition DME1724 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1724 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04119 XEO_CLAS Peptide DME1724 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-20 microM) DME1724 XEOTICID XEO04119 GENEFORM Protein DME1724 XEOTICID XEO04119 MOACRIVE Inhibition DME1724 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1724 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04120 XEO_CLAS Peptide DME1724 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC < 10 microM) DME1724 XEOTICID XEO04120 GENEFORM Protein DME1724 XEOTICID XEO04120 MOACRIVE Inhibition DME1724 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1724 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04121 XEO_CLAS Peptide DME1724 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.2-6.4 microM) DME1724 XEOTICID XEO04121 GENEFORM Protein DME1724 XEOTICID XEO04121 MOACRIVE Inhibition DME1724 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1724 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04122 XEO_CLAS Peptide DME1724 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.14-6.29 microM) DME1724 XEOTICID XEO04122 GENEFORM Protein DME1724 XEOTICID XEO04122 MOACRIVE Inhibition DME1724 XEOTICID XEO04123 XEO_NAME Modified defensin DME1724 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04123 XEO_CLAS Peptide DME1724 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO04123 GENEFORM Protein DME1724 XEOTICID XEO04123 MOACRIVE Inhibition DME1724 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1724 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04128 XEO_CLAS Peptide DME1724 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.31 microM) DME1724 XEOTICID XEO04128 GENEFORM Protein DME1724 XEOTICID XEO04128 MOACRIVE Inhibition DME1724 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1724 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04129 XEO_CLAS Peptide DME1724 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO04129 GENEFORM Protein DME1724 XEOTICID XEO04129 MOACRIVE Inhibition DME1724 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1724 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04130 XEO_CLAS Peptide DME1724 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO04130 GENEFORM Protein DME1724 XEOTICID XEO04130 MOACRIVE Inhibition DME1724 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1724 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04131 XEO_CLAS Peptide DME1724 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 microM) DME1724 XEOTICID XEO04131 GENEFORM Protein DME1724 XEOTICID XEO04131 MOACRIVE Inhibition DME1724 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1724 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04132 XEO_CLAS Peptide DME1724 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 microM) DME1724 XEOTICID XEO04132 GENEFORM Protein DME1724 XEOTICID XEO04132 MOACRIVE Inhibition DME1724 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1724 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04133 XEO_CLAS Peptide DME1724 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO04133 GENEFORM Protein DME1724 XEOTICID XEO04133 MOACRIVE Inhibition DME1724 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1724 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04134 XEO_CLAS Peptide DME1724 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO04134 GENEFORM Protein DME1724 XEOTICID XEO04134 MOACRIVE Inhibition DME1724 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1724 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04135 XEO_CLAS Peptide DME1724 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 microM) DME1724 XEOTICID XEO04135 GENEFORM Protein DME1724 XEOTICID XEO04135 MOACRIVE Inhibition DME1724 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1724 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04137 XEO_CLAS Peptide DME1724 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.6 microM) DME1724 XEOTICID XEO04137 GENEFORM Protein DME1724 XEOTICID XEO04137 MOACRIVE Inhibition DME1724 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1724 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04138 XEO_CLAS Peptide DME1724 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 microM) DME1724 XEOTICID XEO04138 GENEFORM Protein DME1724 XEOTICID XEO04138 MOACRIVE Inhibition DME1724 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1724 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04139 XEO_CLAS Peptide DME1724 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 microM) DME1724 XEOTICID XEO04139 GENEFORM Protein DME1724 XEOTICID XEO04139 MOACRIVE Inhibition DME1724 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1724 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04140 XEO_CLAS Peptide DME1724 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 70 microM) DME1724 XEOTICID XEO04140 GENEFORM Protein DME1724 XEOTICID XEO04140 MOACRIVE Inhibition DME1724 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1724 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04141 XEO_CLAS Peptide DME1724 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 microM) DME1724 XEOTICID XEO04141 GENEFORM Protein DME1724 XEOTICID XEO04141 MOACRIVE Inhibition DME1724 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1724 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04142 XEO_CLAS Peptide DME1724 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8-16 microM) DME1724 XEOTICID XEO04142 GENEFORM Protein DME1724 XEOTICID XEO04142 MOACRIVE Inhibition DME1724 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1724 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04146 XEO_CLAS Peptide DME1724 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04146 GENEFORM Protein DME1724 XEOTICID XEO04146 MOACRIVE Inhibition DME1724 XEOTICID XEO04149 XEO_NAME Mucroporin DME1724 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04149 XEO_CLAS Peptide DME1724 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 ug/ml) DME1724 XEOTICID XEO04149 GENEFORM Protein DME1724 XEOTICID XEO04149 MOACRIVE Inhibition DME1724 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1724 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04158 XEO_CLAS Peptide DME1724 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO04158 GENEFORM Protein DME1724 XEOTICID XEO04158 MOACRIVE Inhibition DME1724 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1724 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04159 XEO_CLAS Peptide DME1724 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 microM) DME1724 XEOTICID XEO04159 GENEFORM Protein DME1724 XEOTICID XEO04159 MOACRIVE Inhibition DME1724 XEOTICID XEO04167 XEO_NAME Myticin-B DME1724 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04167 XEO_CLAS Peptide DME1724 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04167 GENEFORM Protein DME1724 XEOTICID XEO04167 MOACRIVE Inhibition DME1724 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1724 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04168 XEO_CLAS Peptide DME1724 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.7-12.5 microM) DME1724 XEOTICID XEO04168 GENEFORM Protein DME1724 XEOTICID XEO04168 MOACRIVE Inhibition DME1724 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1724 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04169 XEO_CLAS Peptide DME1724 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04169 GENEFORM Protein DME1724 XEOTICID XEO04169 MOACRIVE Inhibition DME1724 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1724 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04170 XEO_CLAS Peptide DME1724 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04170 GENEFORM Protein DME1724 XEOTICID XEO04170 MOACRIVE Inhibition DME1724 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1724 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04171 XEO_CLAS Peptide DME1724 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04171 GENEFORM Protein DME1724 XEOTICID XEO04171 MOACRIVE Inhibition DME1724 XEOTICID XEO04172 XEO_NAME Myxinidin DME1724 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04172 XEO_CLAS Peptide DME1724 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04172 GENEFORM Protein DME1724 XEOTICID XEO04172 MOACRIVE Inhibition DME1724 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1724 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04177 XEO_CLAS Peptide DME1724 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.7 microM) DME1724 XEOTICID XEO04177 GENEFORM Protein DME1724 XEOTICID XEO04177 MOACRIVE Inhibition DME1724 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1724 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04178 XEO_CLAS Peptide DME1724 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.7 microM) DME1724 XEOTICID XEO04178 GENEFORM Protein DME1724 XEOTICID XEO04178 MOACRIVE Inhibition DME1724 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1724 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04179 XEO_CLAS Peptide DME1724 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.5 microM) DME1724 XEOTICID XEO04179 GENEFORM Protein DME1724 XEOTICID XEO04179 MOACRIVE Inhibition DME1724 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1724 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04180 XEO_CLAS Peptide DME1724 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 23 microM) DME1724 XEOTICID XEO04180 GENEFORM Protein DME1724 XEOTICID XEO04180 MOACRIVE Inhibition DME1724 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1724 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04181 XEO_CLAS Peptide DME1724 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.2 microM) DME1724 XEOTICID XEO04181 GENEFORM Protein DME1724 XEOTICID XEO04181 MOACRIVE Inhibition DME1724 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1724 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04182 XEO_CLAS Peptide DME1724 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4.4 microM) DME1724 XEOTICID XEO04182 GENEFORM Protein DME1724 XEOTICID XEO04182 MOACRIVE Inhibition DME1724 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1724 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04183 XEO_CLAS Peptide DME1724 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.6 microM) DME1724 XEOTICID XEO04183 GENEFORM Protein DME1724 XEOTICID XEO04183 MOACRIVE Inhibition DME1724 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1724 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04184 XEO_CLAS Peptide DME1724 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 microM) DME1724 XEOTICID XEO04184 GENEFORM Protein DME1724 XEOTICID XEO04184 MOACRIVE Inhibition DME1724 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1724 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04185 XEO_CLAS Peptide DME1724 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04185 GENEFORM Protein DME1724 XEOTICID XEO04185 MOACRIVE Inhibition DME1724 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1724 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04186 XEO_CLAS Peptide DME1724 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04186 GENEFORM Protein DME1724 XEOTICID XEO04186 MOACRIVE Inhibition DME1724 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1724 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04187 XEO_CLAS Peptide DME1724 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04187 GENEFORM Protein DME1724 XEOTICID XEO04187 MOACRIVE Inhibition DME1724 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1724 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04188 XEO_CLAS Peptide DME1724 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04188 GENEFORM Protein DME1724 XEOTICID XEO04188 MOACRIVE Inhibition DME1724 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1724 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04206 XEO_CLAS Peptide DME1724 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25 microM) DME1724 XEOTICID XEO04206 GENEFORM Protein DME1724 XEOTICID XEO04206 MOACRIVE Inhibition DME1724 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1724 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04214 XEO_CLAS Peptide DME1724 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25 microM) DME1724 XEOTICID XEO04214 GENEFORM Protein DME1724 XEOTICID XEO04214 MOACRIVE Inhibition DME1724 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1724 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04216 XEO_CLAS Peptide DME1724 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO04216 GENEFORM Protein DME1724 XEOTICID XEO04216 MOACRIVE Inhibition DME1724 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1724 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04218 XEO_CLAS Peptide DME1724 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.125 microM) DME1724 XEOTICID XEO04218 GENEFORM Protein DME1724 XEOTICID XEO04218 MOACRIVE Inhibition DME1724 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1724 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04219 XEO_CLAS Peptide DME1724 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO04219 GENEFORM Protein DME1724 XEOTICID XEO04219 MOACRIVE Inhibition DME1724 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1724 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04220 XEO_CLAS Peptide DME1724 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.125 microM) DME1724 XEOTICID XEO04220 GENEFORM Protein DME1724 XEOTICID XEO04220 MOACRIVE Inhibition DME1724 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1724 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04221 XEO_CLAS Peptide DME1724 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO04221 GENEFORM Protein DME1724 XEOTICID XEO04221 MOACRIVE Inhibition DME1724 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1724 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04222 XEO_CLAS Peptide DME1724 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25 microM) DME1724 XEOTICID XEO04222 GENEFORM Protein DME1724 XEOTICID XEO04222 MOACRIVE Inhibition DME1724 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1724 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04233 XEO_CLAS Peptide DME1724 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04233 GENEFORM Protein DME1724 XEOTICID XEO04233 MOACRIVE Inhibition DME1724 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1724 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04234 XEO_CLAS Peptide DME1724 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04234 GENEFORM Protein DME1724 XEOTICID XEO04234 MOACRIVE Inhibition DME1724 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1724 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04241 XEO_CLAS Peptide DME1724 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04241 GENEFORM Protein DME1724 XEOTICID XEO04241 MOACRIVE Inhibition DME1724 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1724 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04242 XEO_CLAS Peptide DME1724 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04242 GENEFORM Protein DME1724 XEOTICID XEO04242 MOACRIVE Inhibition DME1724 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1724 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04245 XEO_CLAS Natural Product DME1724 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04245 GENEFORM Protein DME1724 XEOTICID XEO04245 MOACRIVE Inhibition DME1724 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1724 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04246 XEO_CLAS Natural Product DME1724 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04246 GENEFORM Protein DME1724 XEOTICID XEO04246 MOACRIVE Inhibition DME1724 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1724 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04249 XEO_CLAS Peptide DME1724 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 500 ug/ml) DME1724 XEOTICID XEO04249 GENEFORM Protein DME1724 XEOTICID XEO04249 MOACRIVE Inhibition DME1724 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1724 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04251 XEO_CLAS Peptide DME1724 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04251 GENEFORM Protein DME1724 XEOTICID XEO04251 MOACRIVE Inhibition DME1724 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1724 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04253 XEO_CLAS Peptide DME1724 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04253 GENEFORM Protein DME1724 XEOTICID XEO04253 MOACRIVE Inhibition DME1724 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1724 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04254 XEO_CLAS Peptide DME1724 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04254 GENEFORM Protein DME1724 XEOTICID XEO04254 MOACRIVE Inhibition DME1724 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1724 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04255 XEO_CLAS Peptide DME1724 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04255 GENEFORM Protein DME1724 XEOTICID XEO04255 MOACRIVE Inhibition DME1724 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1724 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04256 XEO_CLAS Peptide DME1724 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04256 GENEFORM Protein DME1724 XEOTICID XEO04256 MOACRIVE Inhibition DME1724 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1724 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04257 XEO_CLAS Peptide DME1724 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04257 GENEFORM Protein DME1724 XEOTICID XEO04257 MOACRIVE Inhibition DME1724 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1724 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04258 XEO_CLAS Peptide DME1724 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04258 GENEFORM Protein DME1724 XEOTICID XEO04258 MOACRIVE Inhibition DME1724 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1724 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04259 XEO_CLAS Peptide DME1724 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04259 GENEFORM Protein DME1724 XEOTICID XEO04259 MOACRIVE Inhibition DME1724 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1724 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04260 XEO_CLAS Peptide DME1724 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04260 GENEFORM Protein DME1724 XEOTICID XEO04260 MOACRIVE Inhibition DME1724 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1724 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04261 XEO_CLAS Peptide DME1724 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04261 GENEFORM Protein DME1724 XEOTICID XEO04261 MOACRIVE Inhibition DME1724 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1724 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04262 XEO_CLAS Peptide DME1724 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04262 GENEFORM Protein DME1724 XEOTICID XEO04262 MOACRIVE Inhibition DME1724 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1724 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04263 XEO_CLAS Peptide DME1724 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04263 GENEFORM Protein DME1724 XEOTICID XEO04263 MOACRIVE Inhibition DME1724 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1724 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04264 XEO_CLAS Peptide DME1724 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04264 GENEFORM Protein DME1724 XEOTICID XEO04264 MOACRIVE Inhibition DME1724 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1724 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04265 XEO_CLAS Peptide DME1724 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04265 GENEFORM Protein DME1724 XEOTICID XEO04265 MOACRIVE Inhibition DME1724 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1724 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04266 XEO_CLAS Peptide DME1724 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04266 GENEFORM Protein DME1724 XEOTICID XEO04266 MOACRIVE Inhibition DME1724 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1724 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04267 XEO_CLAS Peptide DME1724 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04267 GENEFORM Protein DME1724 XEOTICID XEO04267 MOACRIVE Inhibition DME1724 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1724 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04268 XEO_CLAS Peptide DME1724 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04268 GENEFORM Protein DME1724 XEOTICID XEO04268 MOACRIVE Inhibition DME1724 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1724 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04269 XEO_CLAS Peptide DME1724 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04269 GENEFORM Protein DME1724 XEOTICID XEO04269 MOACRIVE Inhibition DME1724 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1724 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04270 XEO_CLAS Peptide DME1724 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04270 GENEFORM Protein DME1724 XEOTICID XEO04270 MOACRIVE Inhibition DME1724 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1724 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04271 XEO_CLAS Peptide DME1724 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04271 GENEFORM Protein DME1724 XEOTICID XEO04271 MOACRIVE Inhibition DME1724 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1724 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04272 XEO_CLAS Peptide DME1724 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04272 GENEFORM Protein DME1724 XEOTICID XEO04272 MOACRIVE Inhibition DME1724 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1724 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04277 XEO_CLAS Peptide DME1724 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 110.00 ug/ml) DME1724 XEOTICID XEO04277 GENEFORM Protein DME1724 XEOTICID XEO04277 MOACRIVE Inhibition DME1724 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1724 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04280 XEO_CLAS Peptide DME1724 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 37.50 ug/ml) DME1724 XEOTICID XEO04280 GENEFORM Protein DME1724 XEOTICID XEO04280 MOACRIVE Inhibition DME1724 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1724 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04281 XEO_CLAS Peptide DME1724 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25.00 ug/ml) DME1724 XEOTICID XEO04281 GENEFORM Protein DME1724 XEOTICID XEO04281 MOACRIVE Inhibition DME1724 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1724 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04282 XEO_CLAS Peptide DME1724 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.2 ug/ml) DME1724 XEOTICID XEO04282 GENEFORM Protein DME1724 XEOTICID XEO04282 MOACRIVE Inhibition DME1724 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1724 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04283 XEO_CLAS Peptide DME1724 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.3 ug/ml) DME1724 XEOTICID XEO04283 GENEFORM Protein DME1724 XEOTICID XEO04283 MOACRIVE Inhibition DME1724 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1724 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04284 XEO_CLAS Peptide DME1724 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10.8 ug/ml) DME1724 XEOTICID XEO04284 GENEFORM Protein DME1724 XEOTICID XEO04284 MOACRIVE Inhibition DME1724 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1724 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04285 XEO_CLAS Peptide DME1724 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 11.5 ug/ml) DME1724 XEOTICID XEO04285 GENEFORM Protein DME1724 XEOTICID XEO04285 MOACRIVE Inhibition DME1724 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1724 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04286 XEO_CLAS Peptide DME1724 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8.6 ug/ml) DME1724 XEOTICID XEO04286 GENEFORM Protein DME1724 XEOTICID XEO04286 MOACRIVE Inhibition DME1724 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1724 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04287 XEO_CLAS Peptide DME1724 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10.2 ug/ml) DME1724 XEOTICID XEO04287 GENEFORM Protein DME1724 XEOTICID XEO04287 MOACRIVE Inhibition DME1724 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1724 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04288 XEO_CLAS Peptide DME1724 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4.4 ug/ml) DME1724 XEOTICID XEO04288 GENEFORM Protein DME1724 XEOTICID XEO04288 MOACRIVE Inhibition DME1724 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1724 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04289 XEO_CLAS Peptide DME1724 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.2 ug/ml) DME1724 XEOTICID XEO04289 GENEFORM Protein DME1724 XEOTICID XEO04289 MOACRIVE Inhibition DME1724 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1724 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04290 XEO_CLAS Peptide DME1724 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 11.3 ug/ml) DME1724 XEOTICID XEO04290 GENEFORM Protein DME1724 XEOTICID XEO04290 MOACRIVE Inhibition DME1724 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1724 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04291 XEO_CLAS Peptide DME1724 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 7.2 ug/ml) DME1724 XEOTICID XEO04291 GENEFORM Protein DME1724 XEOTICID XEO04291 MOACRIVE Inhibition DME1724 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1724 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04292 XEO_CLAS Peptide DME1724 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.1 ug/ml) DME1724 XEOTICID XEO04292 GENEFORM Protein DME1724 XEOTICID XEO04292 MOACRIVE Inhibition DME1724 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1724 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04293 XEO_CLAS Peptide DME1724 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO04293 GENEFORM Protein DME1724 XEOTICID XEO04293 MOACRIVE Inhibition DME1724 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1724 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04294 XEO_CLAS Peptide DME1724 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO04294 GENEFORM Protein DME1724 XEOTICID XEO04294 MOACRIVE Inhibition DME1724 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1724 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04295 XEO_CLAS Peptide DME1724 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO04295 GENEFORM Protein DME1724 XEOTICID XEO04295 MOACRIVE Inhibition DME1724 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1724 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04296 XEO_CLAS Peptide DME1724 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 28 microM) DME1724 XEOTICID XEO04296 GENEFORM Protein DME1724 XEOTICID XEO04296 MOACRIVE Inhibition DME1724 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1724 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04297 XEO_CLAS Peptide DME1724 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 14 microM) DME1724 XEOTICID XEO04297 GENEFORM Protein DME1724 XEOTICID XEO04297 MOACRIVE Inhibition DME1724 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1724 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04298 XEO_CLAS Peptide DME1724 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO04298 GENEFORM Protein DME1724 XEOTICID XEO04298 MOACRIVE Inhibition DME1724 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1724 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04299 XEO_CLAS Peptide DME1724 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO04299 GENEFORM Protein DME1724 XEOTICID XEO04299 MOACRIVE Inhibition DME1724 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1724 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04300 XEO_CLAS Peptide DME1724 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO04300 GENEFORM Protein DME1724 XEOTICID XEO04300 MOACRIVE Inhibition DME1724 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1724 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04301 XEO_CLAS Peptide DME1724 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 microM) DME1724 XEOTICID XEO04301 GENEFORM Protein DME1724 XEOTICID XEO04301 MOACRIVE Inhibition DME1724 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1724 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04302 XEO_CLAS Peptide DME1724 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 microM) DME1724 XEOTICID XEO04302 GENEFORM Protein DME1724 XEOTICID XEO04302 MOACRIVE Inhibition DME1724 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1724 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04303 XEO_CLAS Peptide DME1724 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 microM) DME1724 XEOTICID XEO04303 GENEFORM Protein DME1724 XEOTICID XEO04303 MOACRIVE Inhibition DME1724 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1724 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04304 XEO_CLAS Peptide DME1724 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO04304 GENEFORM Protein DME1724 XEOTICID XEO04304 MOACRIVE Inhibition DME1724 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1724 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04305 XEO_CLAS Peptide DME1724 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 70 microM) DME1724 XEOTICID XEO04305 GENEFORM Protein DME1724 XEOTICID XEO04305 MOACRIVE Inhibition DME1724 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1724 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04306 XEO_CLAS Peptide DME1724 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO04306 GENEFORM Protein DME1724 XEOTICID XEO04306 MOACRIVE Inhibition DME1724 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1724 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04307 XEO_CLAS Peptide DME1724 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 ug/ml) DME1724 XEOTICID XEO04307 GENEFORM Protein DME1724 XEOTICID XEO04307 MOACRIVE Inhibition DME1724 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1724 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04308 XEO_CLAS Peptide DME1724 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 9.37 ug/ml) DME1724 XEOTICID XEO04308 GENEFORM Protein DME1724 XEOTICID XEO04308 MOACRIVE Inhibition DME1724 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1724 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04309 XEO_CLAS Peptide DME1724 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 microM) DME1724 XEOTICID XEO04309 GENEFORM Protein DME1724 XEOTICID XEO04309 MOACRIVE Inhibition DME1724 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1724 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04310 XEO_CLAS Peptide DME1724 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO04310 GENEFORM Protein DME1724 XEOTICID XEO04310 MOACRIVE Inhibition DME1724 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1724 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04311 XEO_CLAS Peptide DME1724 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO04311 GENEFORM Protein DME1724 XEOTICID XEO04311 MOACRIVE Inhibition DME1724 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1724 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04312 XEO_CLAS Peptide DME1724 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4.68 ug/ml) DME1724 XEOTICID XEO04312 GENEFORM Protein DME1724 XEOTICID XEO04312 MOACRIVE Inhibition DME1724 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1724 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04313 XEO_CLAS Peptide DME1724 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4.68 ug/ml) DME1724 XEOTICID XEO04313 GENEFORM Protein DME1724 XEOTICID XEO04313 MOACRIVE Inhibition DME1724 XEOTICID XEO04331 XEO_NAME Norspermidine DME1724 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1724 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04331 GENEFORM Protein DME1724 XEOTICID XEO04331 MOACRIVE Inhibition DME1724 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1724 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04335 XEO_CLAS Peptide DME1724 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 32 ug/ml) DME1724 XEOTICID XEO04335 GENEFORM Protein DME1724 XEOTICID XEO04335 MOACRIVE Inhibition DME1724 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1724 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04336 XEO_CLAS Peptide DME1724 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 32 ug/ml) DME1724 XEOTICID XEO04336 GENEFORM Protein DME1724 XEOTICID XEO04336 MOACRIVE Inhibition DME1724 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1724 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04338 XEO_CLAS Peptide DME1724 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 ug/ml) DME1724 XEOTICID XEO04338 GENEFORM Protein DME1724 XEOTICID XEO04338 MOACRIVE Inhibition DME1724 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1724 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04339 XEO_CLAS Peptide DME1724 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 ug/ml) DME1724 XEOTICID XEO04339 GENEFORM Protein DME1724 XEOTICID XEO04339 MOACRIVE Inhibition DME1724 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1724 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04340 XEO_CLAS Peptide DME1724 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO04340 GENEFORM Protein DME1724 XEOTICID XEO04340 MOACRIVE Inhibition DME1724 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1724 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04344 XEO_CLAS Peptide DME1724 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04344 GENEFORM Protein DME1724 XEOTICID XEO04344 MOACRIVE Inhibition DME1724 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1724 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04345 XEO_CLAS Peptide DME1724 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04345 GENEFORM Protein DME1724 XEOTICID XEO04345 MOACRIVE Inhibition DME1724 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1724 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04346 XEO_CLAS Peptide DME1724 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04346 GENEFORM Protein DME1724 XEOTICID XEO04346 MOACRIVE Inhibition DME1724 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1724 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04347 XEO_CLAS Peptide DME1724 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 microM) DME1724 XEOTICID XEO04347 GENEFORM Protein DME1724 XEOTICID XEO04347 MOACRIVE Inhibition DME1724 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1724 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04348 XEO_CLAS Peptide DME1724 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40 microM) DME1724 XEOTICID XEO04348 GENEFORM Protein DME1724 XEOTICID XEO04348 MOACRIVE Inhibition DME1724 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1724 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04349 XEO_CLAS Peptide DME1724 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO04349 GENEFORM Protein DME1724 XEOTICID XEO04349 MOACRIVE Inhibition DME1724 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1724 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04354 XEO_CLAS Peptide DME1724 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 35.2 ug/ml) DME1724 XEOTICID XEO04354 GENEFORM Protein DME1724 XEOTICID XEO04354 MOACRIVE Inhibition DME1724 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1724 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04355 XEO_CLAS Peptide DME1724 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.21 ug/ml) DME1724 XEOTICID XEO04355 GENEFORM Protein DME1724 XEOTICID XEO04355 MOACRIVE Inhibition DME1724 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1724 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04356 XEO_CLAS Peptide DME1724 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8.21 ug/ml) DME1724 XEOTICID XEO04356 GENEFORM Protein DME1724 XEOTICID XEO04356 MOACRIVE Inhibition DME1724 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1724 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04357 XEO_CLAS Peptide DME1724 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16.32 ug/ml) DME1724 XEOTICID XEO04357 GENEFORM Protein DME1724 XEOTICID XEO04357 MOACRIVE Inhibition DME1724 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1724 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04358 XEO_CLAS Peptide DME1724 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 9.37 ug/ml) DME1724 XEOTICID XEO04358 GENEFORM Protein DME1724 XEOTICID XEO04358 MOACRIVE Inhibition DME1724 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1724 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04359 XEO_CLAS Peptide DME1724 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4.20 ug/ml) DME1724 XEOTICID XEO04359 GENEFORM Protein DME1724 XEOTICID XEO04359 MOACRIVE Inhibition DME1724 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1724 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04360 XEO_CLAS Peptide DME1724 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 ug/ml) DME1724 XEOTICID XEO04360 GENEFORM Protein DME1724 XEOTICID XEO04360 MOACRIVE Inhibition DME1724 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1724 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04361 XEO_CLAS Peptide DME1724 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 7.5 ug/ml) DME1724 XEOTICID XEO04361 GENEFORM Protein DME1724 XEOTICID XEO04361 MOACRIVE Inhibition DME1724 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1724 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04362 XEO_CLAS Peptide DME1724 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.6 ug/ml) DME1724 XEOTICID XEO04362 GENEFORM Protein DME1724 XEOTICID XEO04362 MOACRIVE Inhibition DME1724 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1724 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04363 XEO_CLAS Peptide DME1724 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8.2 ug/ml) DME1724 XEOTICID XEO04363 GENEFORM Protein DME1724 XEOTICID XEO04363 MOACRIVE Inhibition DME1724 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1724 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04364 XEO_CLAS Peptide DME1724 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO04364 GENEFORM Protein DME1724 XEOTICID XEO04364 MOACRIVE Inhibition DME1724 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1724 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04365 XEO_CLAS Peptide DME1724 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4.68 ug/ml) DME1724 XEOTICID XEO04365 GENEFORM Protein DME1724 XEOTICID XEO04365 MOACRIVE Inhibition DME1724 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1724 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04366 XEO_CLAS Peptide DME1724 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 23.60 ug/ml) DME1724 XEOTICID XEO04366 GENEFORM Protein DME1724 XEOTICID XEO04366 MOACRIVE Inhibition DME1724 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1724 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04367 XEO_CLAS Peptide DME1724 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 35.60 ug/ml) DME1724 XEOTICID XEO04367 GENEFORM Protein DME1724 XEOTICID XEO04367 MOACRIVE Inhibition DME1724 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1724 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04368 XEO_CLAS Peptide DME1724 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40.2 ug/ml) DME1724 XEOTICID XEO04368 GENEFORM Protein DME1724 XEOTICID XEO04368 MOACRIVE Inhibition DME1724 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1724 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04369 XEO_CLAS Peptide DME1724 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40.2 ug/ml) DME1724 XEOTICID XEO04369 GENEFORM Protein DME1724 XEOTICID XEO04369 MOACRIVE Inhibition DME1724 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1724 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04370 XEO_CLAS Peptide DME1724 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4.68 ug/ml) DME1724 XEOTICID XEO04370 GENEFORM Protein DME1724 XEOTICID XEO04370 MOACRIVE Inhibition DME1724 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1724 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04371 XEO_CLAS Peptide DME1724 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 9.37 ug/ml) DME1724 XEOTICID XEO04371 GENEFORM Protein DME1724 XEOTICID XEO04371 MOACRIVE Inhibition DME1724 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1724 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04373 XEO_CLAS Peptide DME1724 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 ug/ml) DME1724 XEOTICID XEO04373 GENEFORM Protein DME1724 XEOTICID XEO04373 MOACRIVE Inhibition DME1724 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1724 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04374 XEO_CLAS Peptide DME1724 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.50 ug/ml) DME1724 XEOTICID XEO04374 GENEFORM Protein DME1724 XEOTICID XEO04374 MOACRIVE Inhibition DME1724 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1724 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04375 XEO_CLAS Peptide DME1724 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25 ug/ml) DME1724 XEOTICID XEO04375 GENEFORM Protein DME1724 XEOTICID XEO04375 MOACRIVE Inhibition DME1724 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1724 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04377 XEO_CLAS Peptide DME1724 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 42.50 ug/ml) DME1724 XEOTICID XEO04377 GENEFORM Protein DME1724 XEOTICID XEO04377 MOACRIVE Inhibition DME1724 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1724 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04378 XEO_CLAS Peptide DME1724 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 17.50 ug/ml) DME1724 XEOTICID XEO04378 GENEFORM Protein DME1724 XEOTICID XEO04378 MOACRIVE Inhibition DME1724 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1724 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04379 XEO_CLAS Peptide DME1724 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 ug/ml) DME1724 XEOTICID XEO04379 GENEFORM Protein DME1724 XEOTICID XEO04379 MOACRIVE Inhibition DME1724 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1724 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04380 XEO_CLAS Peptide DME1724 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 36.00 ug/ml) DME1724 XEOTICID XEO04380 GENEFORM Protein DME1724 XEOTICID XEO04380 MOACRIVE Inhibition DME1724 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1724 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04381 XEO_CLAS Peptide DME1724 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.60 ug/ml) DME1724 XEOTICID XEO04381 GENEFORM Protein DME1724 XEOTICID XEO04381 MOACRIVE Inhibition DME1724 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1724 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04382 XEO_CLAS Peptide DME1724 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 ug/ml) DME1724 XEOTICID XEO04382 GENEFORM Protein DME1724 XEOTICID XEO04382 MOACRIVE Inhibition DME1724 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1724 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04383 XEO_CLAS Peptide DME1724 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO04383 GENEFORM Protein DME1724 XEOTICID XEO04383 MOACRIVE Inhibition DME1724 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1724 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04384 XEO_CLAS Peptide DME1724 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO04384 GENEFORM Protein DME1724 XEOTICID XEO04384 MOACRIVE Inhibition DME1724 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1724 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04385 XEO_CLAS Peptide DME1724 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.25 ug/ml) DME1724 XEOTICID XEO04385 GENEFORM Protein DME1724 XEOTICID XEO04385 MOACRIVE Inhibition DME1724 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1724 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04395 XEO_CLAS Peptide DME1724 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1724 XEOTICID XEO04395 GENEFORM Protein DME1724 XEOTICID XEO04395 MOACRIVE Inhibition DME1724 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1724 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04396 XEO_CLAS Peptide DME1724 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1724 XEOTICID XEO04396 GENEFORM Protein DME1724 XEOTICID XEO04396 MOACRIVE Inhibition DME1724 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1724 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04397 XEO_CLAS Peptide DME1724 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1724 XEOTICID XEO04397 GENEFORM Protein DME1724 XEOTICID XEO04397 MOACRIVE Inhibition DME1724 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1724 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04398 XEO_CLAS Peptide DME1724 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 microM) DME1724 XEOTICID XEO04398 GENEFORM Protein DME1724 XEOTICID XEO04398 MOACRIVE Inhibition DME1724 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1724 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04399 XEO_CLAS Peptide DME1724 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO04399 GENEFORM Protein DME1724 XEOTICID XEO04399 MOACRIVE Inhibition DME1724 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1724 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04400 XEO_CLAS Peptide DME1724 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 ug/ml) DME1724 XEOTICID XEO04400 GENEFORM Protein DME1724 XEOTICID XEO04400 MOACRIVE Inhibition DME1724 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1724 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04401 XEO_CLAS Peptide DME1724 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.6 ug/ml) DME1724 XEOTICID XEO04401 GENEFORM Protein DME1724 XEOTICID XEO04401 MOACRIVE Inhibition DME1724 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1724 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04402 XEO_CLAS Peptide DME1724 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 ug/ml) DME1724 XEOTICID XEO04402 GENEFORM Protein DME1724 XEOTICID XEO04402 MOACRIVE Inhibition DME1724 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1724 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04403 XEO_CLAS Peptide DME1724 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.6 ug/ml) DME1724 XEOTICID XEO04403 GENEFORM Protein DME1724 XEOTICID XEO04403 MOACRIVE Inhibition DME1724 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1724 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04404 XEO_CLAS Peptide DME1724 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.6 ug/ml) DME1724 XEOTICID XEO04404 GENEFORM Protein DME1724 XEOTICID XEO04404 MOACRIVE Inhibition DME1724 XEOTICID XEO04410 XEO_NAME Insect osmin DME1724 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04410 XEO_CLAS Peptide DME1724 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.125-1.56 microM) DME1724 XEOTICID XEO04410 GENEFORM Protein DME1724 XEOTICID XEO04410 MOACRIVE Inhibition DME1724 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1724 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04412 XEO_CLAS Peptide DME1724 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04412 GENEFORM Protein DME1724 XEOTICID XEO04412 MOACRIVE Inhibition DME1724 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1724 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04414 XEO_CLAS Peptide DME1724 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04414 GENEFORM Protein DME1724 XEOTICID XEO04414 MOACRIVE Inhibition DME1724 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1724 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04415 XEO_CLAS Peptide DME1724 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04415 GENEFORM Protein DME1724 XEOTICID XEO04415 MOACRIVE Inhibition DME1724 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1724 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04421 XEO_CLAS Peptide DME1724 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 microM) DME1724 XEOTICID XEO04421 GENEFORM Protein DME1724 XEOTICID XEO04421 MOACRIVE Inhibition DME1724 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1724 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04426 XEO_CLAS Peptide DME1724 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO04426 GENEFORM Protein DME1724 XEOTICID XEO04426 MOACRIVE Inhibition DME1724 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1724 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04428 XEO_CLAS Peptide DME1724 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.3 ug/ml) DME1724 XEOTICID XEO04428 GENEFORM Protein DME1724 XEOTICID XEO04428 MOACRIVE Inhibition DME1724 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1724 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04430 XEO_CLAS Peptide DME1724 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25 microM) DME1724 XEOTICID XEO04430 GENEFORM Protein DME1724 XEOTICID XEO04430 MOACRIVE Inhibition DME1724 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1724 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04433 XEO_CLAS Peptide DME1724 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 160 microM) DME1724 XEOTICID XEO04433 GENEFORM Protein DME1724 XEOTICID XEO04433 MOACRIVE Inhibition DME1724 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1724 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04435 XEO_CLAS Peptide DME1724 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 160 microM) DME1724 XEOTICID XEO04435 GENEFORM Protein DME1724 XEOTICID XEO04435 MOACRIVE Inhibition DME1724 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1724 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1724 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04438 GENEFORM Protein DME1724 XEOTICID XEO04438 MOACRIVE Inhibition DME1724 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1724 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04439 XEO_CLAS Peptide DME1724 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04439 GENEFORM Protein DME1724 XEOTICID XEO04439 MOACRIVE Inhibition DME1724 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1724 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04440 XEO_CLAS Peptide DME1724 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 microM) DME1724 XEOTICID XEO04440 GENEFORM Protein DME1724 XEOTICID XEO04440 MOACRIVE Inhibition DME1724 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1724 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04441 XEO_CLAS Peptide DME1724 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 28 microM) DME1724 XEOTICID XEO04441 GENEFORM Protein DME1724 XEOTICID XEO04441 MOACRIVE Inhibition DME1724 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1724 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04442 XEO_CLAS Peptide DME1724 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 28 microM) DME1724 XEOTICID XEO04442 GENEFORM Protein DME1724 XEOTICID XEO04442 MOACRIVE Inhibition DME1724 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1724 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04443 XEO_CLAS Peptide DME1724 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04443 GENEFORM Protein DME1724 XEOTICID XEO04443 MOACRIVE Inhibition DME1724 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1724 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04444 XEO_CLAS Peptide DME1724 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 13 microM) DME1724 XEOTICID XEO04444 GENEFORM Protein DME1724 XEOTICID XEO04444 MOACRIVE Inhibition DME1724 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1724 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04445 XEO_CLAS Peptide DME1724 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04445 GENEFORM Protein DME1724 XEOTICID XEO04445 MOACRIVE Inhibition DME1724 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1724 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04446 XEO_CLAS Peptide DME1724 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 78 microM) DME1724 XEOTICID XEO04446 GENEFORM Protein DME1724 XEOTICID XEO04446 MOACRIVE Inhibition DME1724 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1724 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04447 XEO_CLAS Peptide DME1724 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 120 microM) DME1724 XEOTICID XEO04447 GENEFORM Protein DME1724 XEOTICID XEO04447 MOACRIVE Inhibition DME1724 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1724 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04448 XEO_CLAS Peptide DME1724 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 microM) DME1724 XEOTICID XEO04448 GENEFORM Protein DME1724 XEOTICID XEO04448 MOACRIVE Inhibition DME1724 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1724 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04449 XEO_CLAS Peptide DME1724 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.3 microM) DME1724 XEOTICID XEO04449 GENEFORM Protein DME1724 XEOTICID XEO04449 MOACRIVE Inhibition DME1724 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1724 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04450 XEO_CLAS Peptide DME1724 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.3 microM) DME1724 XEOTICID XEO04450 GENEFORM Protein DME1724 XEOTICID XEO04450 MOACRIVE Inhibition DME1724 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1724 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04451 XEO_CLAS Peptide DME1724 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO04451 GENEFORM Protein DME1724 XEOTICID XEO04451 MOACRIVE Inhibition DME1724 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1724 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04452 XEO_CLAS Peptide DME1724 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.1 microM) DME1724 XEOTICID XEO04452 GENEFORM Protein DME1724 XEOTICID XEO04452 MOACRIVE Inhibition DME1724 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1724 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04453 XEO_CLAS Peptide DME1724 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO04453 GENEFORM Protein DME1724 XEOTICID XEO04453 MOACRIVE Inhibition DME1724 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1724 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04455 XEO_CLAS Peptide DME1724 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 microM) DME1724 XEOTICID XEO04455 GENEFORM Protein DME1724 XEOTICID XEO04455 MOACRIVE Inhibition DME1724 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1724 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04457 XEO_CLAS Peptide DME1724 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.3 microM) DME1724 XEOTICID XEO04457 GENEFORM Protein DME1724 XEOTICID XEO04457 MOACRIVE Inhibition DME1724 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1724 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04458 XEO_CLAS Peptide DME1724 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1 microM) DME1724 XEOTICID XEO04458 GENEFORM Protein DME1724 XEOTICID XEO04458 MOACRIVE Inhibition DME1724 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1724 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04459 XEO_CLAS Peptide DME1724 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1 microM) DME1724 XEOTICID XEO04459 GENEFORM Protein DME1724 XEOTICID XEO04459 MOACRIVE Inhibition DME1724 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1724 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04461 XEO_CLAS Peptide DME1724 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20.8 microM) DME1724 XEOTICID XEO04461 GENEFORM Protein DME1724 XEOTICID XEO04461 MOACRIVE Inhibition DME1724 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1724 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04462 XEO_CLAS Peptide DME1724 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 19.1 microM) DME1724 XEOTICID XEO04462 GENEFORM Protein DME1724 XEOTICID XEO04462 MOACRIVE Inhibition DME1724 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1724 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04463 XEO_CLAS Peptide DME1724 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04463 GENEFORM Protein DME1724 XEOTICID XEO04463 MOACRIVE Inhibition DME1724 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1724 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04464 XEO_CLAS Peptide DME1724 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.5 microM) DME1724 XEOTICID XEO04464 GENEFORM Protein DME1724 XEOTICID XEO04464 MOACRIVE Inhibition DME1724 XEOTICID XEO04466 XEO_NAME Panusin DME1724 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04466 XEO_CLAS Peptide DME1724 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04466 GENEFORM Protein DME1724 XEOTICID XEO04466 MOACRIVE Inhibition DME1724 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1724 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04467 XEO_CLAS Peptide DME1724 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4.8 microM) DME1724 XEOTICID XEO04467 GENEFORM Protein DME1724 XEOTICID XEO04467 MOACRIVE Inhibition DME1724 XEOTICID XEO04468 XEO_NAME Papillosin DME1724 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04468 XEO_CLAS Peptide DME1724 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04468 GENEFORM Protein DME1724 XEOTICID XEO04468 MOACRIVE Inhibition DME1724 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1724 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04471 XEO_CLAS Peptide DME1724 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.1 microM) DME1724 XEOTICID XEO04471 GENEFORM Protein DME1724 XEOTICID XEO04471 MOACRIVE Inhibition DME1724 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1724 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04480 XEO_CLAS Peptide DME1724 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 ug/ml) DME1724 XEOTICID XEO04480 GENEFORM Protein DME1724 XEOTICID XEO04480 MOACRIVE Inhibition DME1724 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1724 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1724 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04482 GENEFORM Protein DME1724 XEOTICID XEO04482 MOACRIVE Inhibition DME1724 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1724 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04484 XEO_CLAS Peptide DME1724 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 microM) DME1724 XEOTICID XEO04484 GENEFORM Protein DME1724 XEOTICID XEO04484 MOACRIVE Inhibition DME1724 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1724 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04485 XEO_CLAS Peptide DME1724 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO04485 GENEFORM Protein DME1724 XEOTICID XEO04485 MOACRIVE Inhibition DME1724 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1724 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04486 XEO_CLAS Peptide DME1724 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 microM) DME1724 XEOTICID XEO04486 GENEFORM Protein DME1724 XEOTICID XEO04486 MOACRIVE Inhibition DME1724 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1724 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04487 XEO_CLAS Peptide DME1724 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO04487 GENEFORM Protein DME1724 XEOTICID XEO04487 MOACRIVE Inhibition DME1724 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1724 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04488 XEO_CLAS Peptide DME1724 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 9 microM) DME1724 XEOTICID XEO04488 GENEFORM Protein DME1724 XEOTICID XEO04488 MOACRIVE Inhibition DME1724 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1724 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04489 XEO_CLAS Peptide DME1724 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 13 microM) DME1724 XEOTICID XEO04489 GENEFORM Protein DME1724 XEOTICID XEO04489 MOACRIVE Inhibition DME1724 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1724 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04490 XEO_CLAS Peptide DME1724 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 47.5 microM) DME1724 XEOTICID XEO04490 GENEFORM Protein DME1724 XEOTICID XEO04490 MOACRIVE Inhibition DME1724 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1724 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04491 XEO_CLAS Peptide DME1724 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO04491 GENEFORM Protein DME1724 XEOTICID XEO04491 MOACRIVE Inhibition DME1724 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1724 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04492 XEO_CLAS Peptide DME1724 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 35 microM) DME1724 XEOTICID XEO04492 GENEFORM Protein DME1724 XEOTICID XEO04492 MOACRIVE Inhibition DME1724 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1724 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04493 XEO_CLAS Peptide DME1724 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 microM) DME1724 XEOTICID XEO04493 GENEFORM Protein DME1724 XEOTICID XEO04493 MOACRIVE Inhibition DME1724 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1724 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04494 XEO_CLAS Peptide DME1724 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO04494 GENEFORM Protein DME1724 XEOTICID XEO04494 MOACRIVE Inhibition DME1724 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1724 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04495 XEO_CLAS Peptide DME1724 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO04495 GENEFORM Protein DME1724 XEOTICID XEO04495 MOACRIVE Inhibition DME1724 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1724 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04496 XEO_CLAS Peptide DME1724 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 67.5 microM) DME1724 XEOTICID XEO04496 GENEFORM Protein DME1724 XEOTICID XEO04496 MOACRIVE Inhibition DME1724 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1724 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04497 XEO_CLAS Peptide DME1724 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO04497 GENEFORM Protein DME1724 XEOTICID XEO04497 MOACRIVE Inhibition DME1724 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1724 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04498 XEO_CLAS Peptide DME1724 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO04498 GENEFORM Protein DME1724 XEOTICID XEO04498 MOACRIVE Inhibition DME1724 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1724 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04499 XEO_CLAS Peptide DME1724 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 43 microM) DME1724 XEOTICID XEO04499 GENEFORM Protein DME1724 XEOTICID XEO04499 MOACRIVE Inhibition DME1724 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1724 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04500 XEO_CLAS Peptide DME1724 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO04500 GENEFORM Protein DME1724 XEOTICID XEO04500 MOACRIVE Inhibition DME1724 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1724 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04504 XEO_CLAS Peptide DME1724 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04504 GENEFORM Protein DME1724 XEOTICID XEO04504 MOACRIVE Inhibition DME1724 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1724 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04505 XEO_CLAS Peptide DME1724 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04505 GENEFORM Protein DME1724 XEOTICID XEO04505 MOACRIVE Inhibition DME1724 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1724 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04506 XEO_CLAS Peptide DME1724 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 40 microM) DME1724 XEOTICID XEO04506 GENEFORM Protein DME1724 XEOTICID XEO04506 MOACRIVE Inhibition DME1724 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1724 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04507 XEO_CLAS Peptide DME1724 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10-20 microM) DME1724 XEOTICID XEO04507 GENEFORM Protein DME1724 XEOTICID XEO04507 MOACRIVE Inhibition DME1724 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1724 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04508 XEO_CLAS Peptide DME1724 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04508 GENEFORM Protein DME1724 XEOTICID XEO04508 MOACRIVE Inhibition DME1724 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1724 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04509 XEO_CLAS Peptide DME1724 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04509 GENEFORM Protein DME1724 XEOTICID XEO04509 MOACRIVE Inhibition DME1724 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1724 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04510 XEO_CLAS Peptide DME1724 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 22-33 microM) DME1724 XEOTICID XEO04510 GENEFORM Protein DME1724 XEOTICID XEO04510 MOACRIVE Inhibition DME1724 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1724 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04525 XEO_CLAS Peptide DME1724 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 32.0 microM) DME1724 XEOTICID XEO04525 GENEFORM Protein DME1724 XEOTICID XEO04525 MOACRIVE Inhibition DME1724 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1724 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04526 XEO_CLAS Peptide DME1724 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.0 microM) DME1724 XEOTICID XEO04526 GENEFORM Protein DME1724 XEOTICID XEO04526 MOACRIVE Inhibition DME1724 XEOTICID XEO04527 XEO_NAME Pepcon DME1724 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04527 XEO_CLAS Peptide DME1724 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO04527 GENEFORM Protein DME1724 XEOTICID XEO04527 MOACRIVE Inhibition DME1724 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1724 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04532 XEO_CLAS Peptide DME1724 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04532 GENEFORM Protein DME1724 XEOTICID XEO04532 MOACRIVE Inhibition DME1724 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1724 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04540 XEO_CLAS Peptide DME1724 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 18.1 ug/ml) DME1724 XEOTICID XEO04540 GENEFORM Protein DME1724 XEOTICID XEO04540 MOACRIVE Inhibition DME1724 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1724 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04541 XEO_CLAS Peptide DME1724 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.5 ug/ml) DME1724 XEOTICID XEO04541 GENEFORM Protein DME1724 XEOTICID XEO04541 MOACRIVE Inhibition DME1724 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1724 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04542 XEO_CLAS Peptide DME1724 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04542 GENEFORM Protein DME1724 XEOTICID XEO04542 MOACRIVE Inhibition DME1724 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1724 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04543 XEO_CLAS Peptide DME1724 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04543 GENEFORM Protein DME1724 XEOTICID XEO04543 MOACRIVE Inhibition DME1724 XEOTICID XEO04546 XEO_NAME Perinerin DME1724 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04546 XEO_CLAS Peptide DME1724 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04546 GENEFORM Protein DME1724 XEOTICID XEO04546 MOACRIVE Inhibition DME1724 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1724 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04548 XEO_CLAS Peptide DME1724 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 72000 ug/ml) DME1724 XEOTICID XEO04548 GENEFORM Protein DME1724 XEOTICID XEO04548 MOACRIVE Inhibition DME1724 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1724 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04549 XEO_CLAS Peptide DME1724 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 62-125 ug/ml) DME1724 XEOTICID XEO04549 GENEFORM Protein DME1724 XEOTICID XEO04549 MOACRIVE Inhibition DME1724 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1724 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04550 XEO_CLAS Peptide DME1724 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO04550 GENEFORM Protein DME1724 XEOTICID XEO04550 MOACRIVE Inhibition DME1724 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1724 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04551 XEO_CLAS Peptide DME1724 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 23.6 ug/ml) DME1724 XEOTICID XEO04551 GENEFORM Protein DME1724 XEOTICID XEO04551 MOACRIVE Inhibition DME1724 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1724 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04552 XEO_CLAS Peptide DME1724 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04552 GENEFORM Protein DME1724 XEOTICID XEO04552 MOACRIVE Inhibition DME1724 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1724 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04553 XEO_CLAS Peptide DME1724 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04553 GENEFORM Protein DME1724 XEOTICID XEO04553 MOACRIVE Inhibition DME1724 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1724 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04554 XEO_CLAS Peptide DME1724 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04554 GENEFORM Protein DME1724 XEOTICID XEO04554 MOACRIVE Inhibition DME1724 XEOTICID XEO04563 XEO_NAME Phosphate DME1724 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1724 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04563 GENEFORM Protein DME1724 XEOTICID XEO04563 MOACRIVE Inhibition DME1724 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1724 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04565 XEO_CLAS Peptide DME1724 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.5 microM) DME1724 XEOTICID XEO04565 GENEFORM Protein DME1724 XEOTICID XEO04565 MOACRIVE Inhibition DME1724 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1724 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04566 XEO_CLAS Peptide DME1724 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.7 microM) DME1724 XEOTICID XEO04566 GENEFORM Protein DME1724 XEOTICID XEO04566 MOACRIVE Inhibition DME1724 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1724 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04569 XEO_CLAS Peptide DME1724 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 7.9 microM) DME1724 XEOTICID XEO04569 GENEFORM Protein DME1724 XEOTICID XEO04569 MOACRIVE Inhibition DME1724 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1724 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04570 XEO_CLAS Peptide DME1724 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04570 GENEFORM Protein DME1724 XEOTICID XEO04570 MOACRIVE Inhibition DME1724 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1724 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04571 XEO_CLAS Peptide DME1724 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04571 GENEFORM Protein DME1724 XEOTICID XEO04571 MOACRIVE Inhibition DME1724 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1724 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04572 XEO_CLAS Peptide DME1724 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04572 GENEFORM Protein DME1724 XEOTICID XEO04572 MOACRIVE Inhibition DME1724 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1724 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04573 XEO_CLAS Peptide DME1724 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 microM) DME1724 XEOTICID XEO04573 GENEFORM Protein DME1724 XEOTICID XEO04573 MOACRIVE Inhibition DME1724 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1724 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04574 XEO_CLAS Peptide DME1724 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 128 ug/ml) DME1724 XEOTICID XEO04574 GENEFORM Protein DME1724 XEOTICID XEO04574 MOACRIVE Inhibition DME1724 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1724 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04575 XEO_CLAS Peptide DME1724 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO04575 GENEFORM Protein DME1724 XEOTICID XEO04575 MOACRIVE Inhibition DME1724 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1724 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04578 GENEFORM Protein DME1724 XEOTICID XEO04578 MOACRIVE Inhibition DME1724 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1724 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04579 GENEFORM Protein DME1724 XEOTICID XEO04579 MOACRIVE Inhibition DME1724 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1724 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04580 GENEFORM Protein DME1724 XEOTICID XEO04580 MOACRIVE Inhibition DME1724 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1724 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04583 GENEFORM Protein DME1724 XEOTICID XEO04583 MOACRIVE Inhibition DME1724 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1724 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04588 GENEFORM Protein DME1724 XEOTICID XEO04588 MOACRIVE Inhibition DME1724 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1724 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04589 GENEFORM Protein DME1724 XEOTICID XEO04589 MOACRIVE Inhibition DME1724 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1724 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04590 GENEFORM Protein DME1724 XEOTICID XEO04590 MOACRIVE Inhibition DME1724 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1724 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04591 GENEFORM Protein DME1724 XEOTICID XEO04591 MOACRIVE Inhibition DME1724 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1724 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04592 GENEFORM Protein DME1724 XEOTICID XEO04592 MOACRIVE Inhibition DME1724 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1724 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04593 GENEFORM Protein DME1724 XEOTICID XEO04593 MOACRIVE Inhibition DME1724 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1724 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04594 GENEFORM Protein DME1724 XEOTICID XEO04594 MOACRIVE Inhibition DME1724 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1724 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04595 GENEFORM Protein DME1724 XEOTICID XEO04595 MOACRIVE Inhibition DME1724 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1724 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04596 GENEFORM Protein DME1724 XEOTICID XEO04596 MOACRIVE Inhibition DME1724 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1724 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04597 GENEFORM Protein DME1724 XEOTICID XEO04597 MOACRIVE Inhibition DME1724 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1724 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04598 GENEFORM Protein DME1724 XEOTICID XEO04598 MOACRIVE Inhibition DME1724 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1724 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04599 GENEFORM Protein DME1724 XEOTICID XEO04599 MOACRIVE Inhibition DME1724 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1724 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04601 XEO_CLAS Peptide DME1724 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 18.75 ug/ml) DME1724 XEOTICID XEO04601 GENEFORM Protein DME1724 XEOTICID XEO04601 MOACRIVE Inhibition DME1724 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1724 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04602 XEO_CLAS Peptide DME1724 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 37.5 ug/ml) DME1724 XEOTICID XEO04602 GENEFORM Protein DME1724 XEOTICID XEO04602 MOACRIVE Inhibition DME1724 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1724 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04604 XEO_CLAS Peptide DME1724 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC < 25 microM) DME1724 XEOTICID XEO04604 GENEFORM Protein DME1724 XEOTICID XEO04604 MOACRIVE Inhibition DME1724 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1724 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04605 XEO_CLAS Peptide DME1724 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC < 6.25 microM) DME1724 XEOTICID XEO04605 GENEFORM Protein DME1724 XEOTICID XEO04605 MOACRIVE Inhibition DME1724 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1724 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04606 XEO_CLAS Peptide DME1724 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO04606 GENEFORM Protein DME1724 XEOTICID XEO04606 MOACRIVE Inhibition DME1724 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1724 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1724 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04607 GENEFORM Protein DME1724 XEOTICID XEO04607 MOACRIVE Inhibition DME1724 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1724 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04612 XEO_CLAS Peptide DME1724 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5-10 microM) DME1724 XEOTICID XEO04612 GENEFORM Protein DME1724 XEOTICID XEO04612 MOACRIVE Inhibition DME1724 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1724 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04613 XEO_CLAS Peptide DME1724 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5-10 microM) DME1724 XEOTICID XEO04613 GENEFORM Protein DME1724 XEOTICID XEO04613 MOACRIVE Inhibition DME1724 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1724 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04625 XEO_CLAS Peptide DME1724 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO04625 GENEFORM Protein DME1724 XEOTICID XEO04625 MOACRIVE Inhibition DME1724 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1724 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04626 XEO_CLAS Peptide DME1724 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO04626 GENEFORM Protein DME1724 XEOTICID XEO04626 MOACRIVE Inhibition DME1724 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1724 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04627 XEO_CLAS Peptide DME1724 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.5 microM) DME1724 XEOTICID XEO04627 GENEFORM Protein DME1724 XEOTICID XEO04627 MOACRIVE Inhibition DME1724 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1724 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04630 XEO_CLAS Peptide DME1724 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 60 ug/ml) DME1724 XEOTICID XEO04630 GENEFORM Protein DME1724 XEOTICID XEO04630 MOACRIVE Inhibition DME1724 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1724 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04631 XEO_CLAS Peptide DME1724 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 60 ug/ml) DME1724 XEOTICID XEO04631 GENEFORM Protein DME1724 XEOTICID XEO04631 MOACRIVE Inhibition DME1724 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1724 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04633 XEO_CLAS Peptide DME1724 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 ug/ml) DME1724 XEOTICID XEO04633 GENEFORM Protein DME1724 XEOTICID XEO04633 MOACRIVE Inhibition DME1724 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1724 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04634 XEO_CLAS Peptide DME1724 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 ug/ml) DME1724 XEOTICID XEO04634 GENEFORM Protein DME1724 XEOTICID XEO04634 MOACRIVE Inhibition DME1724 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1724 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04635 XEO_CLAS Peptide DME1724 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 ug/ml) DME1724 XEOTICID XEO04635 GENEFORM Protein DME1724 XEOTICID XEO04635 MOACRIVE Inhibition DME1724 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1724 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04636 XEO_CLAS Peptide DME1724 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 ug/ml) DME1724 XEOTICID XEO04636 GENEFORM Protein DME1724 XEOTICID XEO04636 MOACRIVE Inhibition DME1724 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1724 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04637 XEO_CLAS Peptide DME1724 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 ug/ml) DME1724 XEOTICID XEO04637 GENEFORM Protein DME1724 XEOTICID XEO04637 MOACRIVE Inhibition DME1724 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1724 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04638 XEO_CLAS Peptide DME1724 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 ug/ml) DME1724 XEOTICID XEO04638 GENEFORM Protein DME1724 XEOTICID XEO04638 MOACRIVE Inhibition DME1724 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1724 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04639 XEO_CLAS Peptide DME1724 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 ug/ml) DME1724 XEOTICID XEO04639 GENEFORM Protein DME1724 XEOTICID XEO04639 MOACRIVE Inhibition DME1724 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1724 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04640 XEO_CLAS Peptide DME1724 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.2-3.3 microM) DME1724 XEOTICID XEO04640 GENEFORM Protein DME1724 XEOTICID XEO04640 MOACRIVE Inhibition DME1724 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1724 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04642 XEO_CLAS Peptide DME1724 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 ug/ml) DME1724 XEOTICID XEO04642 GENEFORM Protein DME1724 XEOTICID XEO04642 MOACRIVE Inhibition DME1724 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1724 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04643 XEO_CLAS Peptide DME1724 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO04643 GENEFORM Protein DME1724 XEOTICID XEO04643 MOACRIVE Inhibition DME1724 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1724 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04644 XEO_CLAS Peptide DME1724 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO04644 GENEFORM Protein DME1724 XEOTICID XEO04644 MOACRIVE Inhibition DME1724 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1724 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04645 XEO_CLAS Peptide DME1724 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 ug/ml) DME1724 XEOTICID XEO04645 GENEFORM Protein DME1724 XEOTICID XEO04645 MOACRIVE Inhibition DME1724 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1724 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04646 XEO_CLAS Peptide DME1724 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1 ug/ml) DME1724 XEOTICID XEO04646 GENEFORM Protein DME1724 XEOTICID XEO04646 MOACRIVE Inhibition DME1724 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1724 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04647 XEO_CLAS Peptide DME1724 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO04647 GENEFORM Protein DME1724 XEOTICID XEO04647 MOACRIVE Inhibition DME1724 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1724 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04648 XEO_CLAS Peptide DME1724 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 ug/ml) DME1724 XEOTICID XEO04648 GENEFORM Protein DME1724 XEOTICID XEO04648 MOACRIVE Inhibition DME1724 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1724 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04649 XEO_CLAS Peptide DME1724 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 64 ug/ml) DME1724 XEOTICID XEO04649 GENEFORM Protein DME1724 XEOTICID XEO04649 MOACRIVE Inhibition DME1724 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1724 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04650 XEO_CLAS Peptide DME1724 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 ug/ml) DME1724 XEOTICID XEO04650 GENEFORM Protein DME1724 XEOTICID XEO04650 MOACRIVE Inhibition DME1724 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1724 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04651 XEO_CLAS Peptide DME1724 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 ug/ml) DME1724 XEOTICID XEO04651 GENEFORM Protein DME1724 XEOTICID XEO04651 MOACRIVE Inhibition DME1724 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1724 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04652 XEO_CLAS Peptide DME1724 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO04652 GENEFORM Protein DME1724 XEOTICID XEO04652 MOACRIVE Inhibition DME1724 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1724 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04653 XEO_CLAS Peptide DME1724 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 64 ug/ml) DME1724 XEOTICID XEO04653 GENEFORM Protein DME1724 XEOTICID XEO04653 MOACRIVE Inhibition DME1724 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1724 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04654 XEO_CLAS Peptide DME1724 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 ug/ml) DME1724 XEOTICID XEO04654 GENEFORM Protein DME1724 XEOTICID XEO04654 MOACRIVE Inhibition DME1724 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1724 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04655 XEO_CLAS Peptide DME1724 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO04655 GENEFORM Protein DME1724 XEOTICID XEO04655 MOACRIVE Inhibition DME1724 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1724 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04657 XEO_CLAS Peptide DME1724 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 300 microM) DME1724 XEOTICID XEO04657 GENEFORM Protein DME1724 XEOTICID XEO04657 MOACRIVE Inhibition DME1724 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1724 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04660 XEO_CLAS Peptide DME1724 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO04660 GENEFORM Protein DME1724 XEOTICID XEO04660 MOACRIVE Inhibition DME1724 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1724 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04661 XEO_CLAS Peptide DME1724 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 microM) DME1724 XEOTICID XEO04661 GENEFORM Protein DME1724 XEOTICID XEO04661 MOACRIVE Inhibition DME1724 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1724 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04662 XEO_CLAS Peptide DME1724 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 microM) DME1724 XEOTICID XEO04662 GENEFORM Protein DME1724 XEOTICID XEO04662 MOACRIVE Inhibition DME1724 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1724 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04663 XEO_CLAS Peptide DME1724 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 microM) DME1724 XEOTICID XEO04663 GENEFORM Protein DME1724 XEOTICID XEO04663 MOACRIVE Inhibition DME1724 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1724 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04664 XEO_CLAS Peptide DME1724 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5.5 microM) DME1724 XEOTICID XEO04664 GENEFORM Protein DME1724 XEOTICID XEO04664 MOACRIVE Inhibition DME1724 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1724 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04665 XEO_CLAS Peptide DME1724 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 microM) DME1724 XEOTICID XEO04665 GENEFORM Protein DME1724 XEOTICID XEO04665 MOACRIVE Inhibition DME1724 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1724 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04666 XEO_CLAS Peptide DME1724 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO04666 GENEFORM Protein DME1724 XEOTICID XEO04666 MOACRIVE Inhibition DME1724 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1724 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04667 XEO_CLAS Peptide DME1724 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6.25 microM) DME1724 XEOTICID XEO04667 GENEFORM Protein DME1724 XEOTICID XEO04667 MOACRIVE Inhibition DME1724 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1724 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04668 XEO_CLAS Peptide DME1724 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 microM) DME1724 XEOTICID XEO04668 GENEFORM Protein DME1724 XEOTICID XEO04668 MOACRIVE Inhibition DME1724 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1724 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04669 XEO_CLAS Peptide DME1724 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO04669 GENEFORM Protein DME1724 XEOTICID XEO04669 MOACRIVE Inhibition DME1724 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1724 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04670 XEO_CLAS Peptide DME1724 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 21 microM) DME1724 XEOTICID XEO04670 GENEFORM Protein DME1724 XEOTICID XEO04670 MOACRIVE Inhibition DME1724 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1724 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04671 XEO_CLAS Peptide DME1724 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 62 microM) DME1724 XEOTICID XEO04671 GENEFORM Protein DME1724 XEOTICID XEO04671 MOACRIVE Inhibition DME1724 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1724 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04672 XEO_CLAS Peptide DME1724 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO04672 GENEFORM Protein DME1724 XEOTICID XEO04672 MOACRIVE Inhibition DME1724 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1724 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04673 XEO_CLAS Peptide DME1724 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO04673 GENEFORM Protein DME1724 XEOTICID XEO04673 MOACRIVE Inhibition DME1724 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1724 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04674 XEO_CLAS Peptide DME1724 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 75 microM) DME1724 XEOTICID XEO04674 GENEFORM Protein DME1724 XEOTICID XEO04674 MOACRIVE Inhibition DME1724 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1724 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04675 XEO_CLAS Peptide DME1724 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 microM) DME1724 XEOTICID XEO04675 GENEFORM Protein DME1724 XEOTICID XEO04675 MOACRIVE Inhibition DME1724 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1724 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04676 XEO_CLAS Peptide DME1724 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 microM) DME1724 XEOTICID XEO04676 GENEFORM Protein DME1724 XEOTICID XEO04676 MOACRIVE Inhibition DME1724 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1724 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04677 XEO_CLAS Peptide DME1724 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO04677 GENEFORM Protein DME1724 XEOTICID XEO04677 MOACRIVE Inhibition DME1724 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1724 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04680 XEO_CLAS Peptide DME1724 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 microM) DME1724 XEOTICID XEO04680 GENEFORM Protein DME1724 XEOTICID XEO04680 MOACRIVE Inhibition DME1724 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1724 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04682 XEO_CLAS Peptide DME1724 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 microM) DME1724 XEOTICID XEO04682 GENEFORM Protein DME1724 XEOTICID XEO04682 MOACRIVE Inhibition DME1724 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1724 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04683 XEO_CLAS Peptide DME1724 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 microM) DME1724 XEOTICID XEO04683 GENEFORM Protein DME1724 XEOTICID XEO04683 MOACRIVE Inhibition DME1724 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1724 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04684 XEO_CLAS Peptide DME1724 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 38 microM) DME1724 XEOTICID XEO04684 GENEFORM Protein DME1724 XEOTICID XEO04684 MOACRIVE Inhibition DME1724 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1724 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04690 XEO_CLAS Peptide DME1724 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.5 ug/ml) DME1724 XEOTICID XEO04690 GENEFORM Protein DME1724 XEOTICID XEO04690 MOACRIVE Inhibition DME1724 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1724 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04695 XEO_CLAS Peptide DME1724 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04695 GENEFORM Protein DME1724 XEOTICID XEO04695 MOACRIVE Inhibition DME1724 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1724 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04696 XEO_CLAS Peptide DME1724 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04696 GENEFORM Protein DME1724 XEOTICID XEO04696 MOACRIVE Inhibition DME1724 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1724 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04712 XEO_CLAS Peptide DME1724 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16.7 microM) DME1724 XEOTICID XEO04712 GENEFORM Protein DME1724 XEOTICID XEO04712 MOACRIVE Inhibition DME1724 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1724 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04713 XEO_CLAS Peptide DME1724 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16.7 microM) DME1724 XEOTICID XEO04713 GENEFORM Protein DME1724 XEOTICID XEO04713 MOACRIVE Inhibition DME1724 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1724 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04714 XEO_CLAS Peptide DME1724 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 23.3 microM) DME1724 XEOTICID XEO04714 GENEFORM Protein DME1724 XEOTICID XEO04714 MOACRIVE Inhibition DME1724 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1724 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04716 XEO_CLAS Peptide DME1724 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 microM) DME1724 XEOTICID XEO04716 GENEFORM Protein DME1724 XEOTICID XEO04716 MOACRIVE Inhibition DME1724 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1724 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04717 XEO_CLAS Peptide DME1724 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 50 microM) DME1724 XEOTICID XEO04717 GENEFORM Protein DME1724 XEOTICID XEO04717 MOACRIVE Inhibition DME1724 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1724 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04725 XEO_CLAS Peptide DME1724 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04725 GENEFORM Protein DME1724 XEOTICID XEO04725 MOACRIVE Inhibition DME1724 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1724 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04726 XEO_CLAS Peptide DME1724 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04726 GENEFORM Protein DME1724 XEOTICID XEO04726 MOACRIVE Inhibition DME1724 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1724 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04731 XEO_CLAS Peptide DME1724 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 ug/ml) DME1724 XEOTICID XEO04731 GENEFORM Protein DME1724 XEOTICID XEO04731 MOACRIVE Inhibition DME1724 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1724 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04732 XEO_CLAS Peptide DME1724 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 25 ug/ml) DME1724 XEOTICID XEO04732 GENEFORM Protein DME1724 XEOTICID XEO04732 MOACRIVE Inhibition DME1724 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1724 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04733 XEO_CLAS Peptide DME1724 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04733 GENEFORM Protein DME1724 XEOTICID XEO04733 MOACRIVE Inhibition DME1724 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1724 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04734 XEO_CLAS Peptide DME1724 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04734 GENEFORM Protein DME1724 XEOTICID XEO04734 MOACRIVE Inhibition DME1724 XEOTICID XEO04737 XEO_NAME Protonectin DME1724 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04737 XEO_CLAS Peptide DME1724 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 ug/ml) DME1724 XEOTICID XEO04737 GENEFORM Protein DME1724 XEOTICID XEO04737 MOACRIVE Inhibition DME1724 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1724 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04739 XEO_CLAS Peptide DME1724 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04739 GENEFORM Protein DME1724 XEOTICID XEO04739 MOACRIVE Inhibition DME1724 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1724 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04740 XEO_CLAS Peptide DME1724 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04740 GENEFORM Protein DME1724 XEOTICID XEO04740 MOACRIVE Inhibition DME1724 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1724 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04741 XEO_CLAS Peptide DME1724 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04741 GENEFORM Protein DME1724 XEOTICID XEO04741 MOACRIVE Inhibition DME1724 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1724 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04742 XEO_CLAS Peptide DME1724 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04742 GENEFORM Protein DME1724 XEOTICID XEO04742 MOACRIVE Inhibition DME1724 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1724 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04762 XEO_CLAS Peptide DME1724 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.8 microM) DME1724 XEOTICID XEO04762 GENEFORM Protein DME1724 XEOTICID XEO04762 MOACRIVE Inhibition DME1724 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1724 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04766 XEO_CLAS Peptide DME1724 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.1 microM) DME1724 XEOTICID XEO04766 GENEFORM Protein DME1724 XEOTICID XEO04766 MOACRIVE Inhibition DME1724 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1724 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04767 XEO_CLAS Peptide DME1724 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.1 ug/ml) DME1724 XEOTICID XEO04767 GENEFORM Protein DME1724 XEOTICID XEO04767 MOACRIVE Inhibition DME1724 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1724 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04779 XEO_CLAS Peptide DME1724 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04779 GENEFORM Protein DME1724 XEOTICID XEO04779 MOACRIVE Inhibition DME1724 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1724 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04780 XEO_CLAS Peptide DME1724 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04780 GENEFORM Protein DME1724 XEOTICID XEO04780 MOACRIVE Inhibition DME1724 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1724 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04781 XEO_CLAS Peptide DME1724 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04781 GENEFORM Protein DME1724 XEOTICID XEO04781 MOACRIVE Inhibition DME1724 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1724 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04782 XEO_CLAS Peptide DME1724 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 ug/ml) DME1724 XEOTICID XEO04782 GENEFORM Protein DME1724 XEOTICID XEO04782 MOACRIVE Inhibition DME1724 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1724 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04783 XEO_CLAS Peptide DME1724 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO04783 GENEFORM Protein DME1724 XEOTICID XEO04783 MOACRIVE Inhibition DME1724 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1724 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04784 XEO_CLAS Peptide DME1724 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO04784 GENEFORM Protein DME1724 XEOTICID XEO04784 MOACRIVE Inhibition DME1724 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1724 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04785 XEO_CLAS Peptide DME1724 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO04785 GENEFORM Protein DME1724 XEOTICID XEO04785 MOACRIVE Inhibition DME1724 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1724 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04786 XEO_CLAS Peptide DME1724 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 ug/ml) DME1724 XEOTICID XEO04786 GENEFORM Protein DME1724 XEOTICID XEO04786 MOACRIVE Inhibition DME1724 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1724 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04787 XEO_CLAS Peptide DME1724 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04787 GENEFORM Protein DME1724 XEOTICID XEO04787 MOACRIVE Inhibition DME1724 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1724 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04793 XEO_CLAS Peptide DME1724 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04793 GENEFORM Protein DME1724 XEOTICID XEO04793 MOACRIVE Inhibition DME1724 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1724 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04798 XEO_CLAS Peptide DME1724 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 microM) DME1724 XEOTICID XEO04798 GENEFORM Protein DME1724 XEOTICID XEO04798 MOACRIVE Inhibition DME1724 XEOTICID XEO04799 XEO_NAME Ranalexin DME1724 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04799 XEO_CLAS Peptide DME1724 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 32 ug/ml) DME1724 XEOTICID XEO04799 GENEFORM Protein DME1724 XEOTICID XEO04799 MOACRIVE Inhibition DME1724 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1724 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04800 XEO_CLAS Peptide DME1724 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 microM) DME1724 XEOTICID XEO04800 GENEFORM Protein DME1724 XEOTICID XEO04800 MOACRIVE Inhibition DME1724 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1724 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04801 XEO_CLAS Peptide DME1724 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 9 microM) DME1724 XEOTICID XEO04801 GENEFORM Protein DME1724 XEOTICID XEO04801 MOACRIVE Inhibition DME1724 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1724 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04802 XEO_CLAS Peptide DME1724 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12 microM) DME1724 XEOTICID XEO04802 GENEFORM Protein DME1724 XEOTICID XEO04802 MOACRIVE Inhibition DME1724 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1724 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04803 XEO_CLAS Peptide DME1724 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO04803 GENEFORM Protein DME1724 XEOTICID XEO04803 MOACRIVE Inhibition DME1724 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1724 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04804 XEO_CLAS Peptide DME1724 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO04804 GENEFORM Protein DME1724 XEOTICID XEO04804 MOACRIVE Inhibition DME1724 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1724 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04805 XEO_CLAS Peptide DME1724 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.5 microM) DME1724 XEOTICID XEO04805 GENEFORM Protein DME1724 XEOTICID XEO04805 MOACRIVE Inhibition DME1724 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1724 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04806 XEO_CLAS Peptide DME1724 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.5 microM) DME1724 XEOTICID XEO04806 GENEFORM Protein DME1724 XEOTICID XEO04806 MOACRIVE Inhibition DME1724 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1724 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04807 XEO_CLAS Peptide DME1724 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04807 GENEFORM Protein DME1724 XEOTICID XEO04807 MOACRIVE Inhibition DME1724 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1724 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04809 XEO_CLAS Peptide DME1724 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 microM) DME1724 XEOTICID XEO04809 GENEFORM Protein DME1724 XEOTICID XEO04809 MOACRIVE Inhibition DME1724 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1724 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04811 XEO_CLAS Peptide DME1724 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO04811 GENEFORM Protein DME1724 XEOTICID XEO04811 MOACRIVE Inhibition DME1724 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1724 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04812 XEO_CLAS Peptide DME1724 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO04812 GENEFORM Protein DME1724 XEOTICID XEO04812 MOACRIVE Inhibition DME1724 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1724 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04813 XEO_CLAS Peptide DME1724 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 microM) DME1724 XEOTICID XEO04813 GENEFORM Protein DME1724 XEOTICID XEO04813 MOACRIVE Inhibition DME1724 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1724 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04814 XEO_CLAS Peptide DME1724 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 19 microM) DME1724 XEOTICID XEO04814 GENEFORM Protein DME1724 XEOTICID XEO04814 MOACRIVE Inhibition DME1724 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1724 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04815 XEO_CLAS Peptide DME1724 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 microM) DME1724 XEOTICID XEO04815 GENEFORM Protein DME1724 XEOTICID XEO04815 MOACRIVE Inhibition DME1724 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1724 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04816 XEO_CLAS Peptide DME1724 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 microM) DME1724 XEOTICID XEO04816 GENEFORM Protein DME1724 XEOTICID XEO04816 MOACRIVE Inhibition DME1724 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1724 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04817 XEO_CLAS Peptide DME1724 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 13 microM) DME1724 XEOTICID XEO04817 GENEFORM Protein DME1724 XEOTICID XEO04817 MOACRIVE Inhibition DME1724 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1724 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04818 XEO_CLAS Peptide DME1724 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO04818 GENEFORM Protein DME1724 XEOTICID XEO04818 MOACRIVE Inhibition DME1724 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1724 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04819 XEO_CLAS Peptide DME1724 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO04819 GENEFORM Protein DME1724 XEOTICID XEO04819 MOACRIVE Inhibition DME1724 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1724 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04820 XEO_CLAS Peptide DME1724 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3 microM) DME1724 XEOTICID XEO04820 GENEFORM Protein DME1724 XEOTICID XEO04820 MOACRIVE Inhibition DME1724 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1724 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04821 XEO_CLAS Peptide DME1724 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 microM) DME1724 XEOTICID XEO04821 GENEFORM Protein DME1724 XEOTICID XEO04821 MOACRIVE Inhibition DME1724 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1724 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04822 XEO_CLAS Peptide DME1724 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO04822 GENEFORM Protein DME1724 XEOTICID XEO04822 MOACRIVE Inhibition DME1724 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1724 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04823 XEO_CLAS Peptide DME1724 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 23 microM) DME1724 XEOTICID XEO04823 GENEFORM Protein DME1724 XEOTICID XEO04823 MOACRIVE Inhibition DME1724 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1724 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04824 XEO_CLAS Peptide DME1724 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04824 GENEFORM Protein DME1724 XEOTICID XEO04824 MOACRIVE Inhibition DME1724 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1724 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04825 XEO_CLAS Peptide DME1724 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04825 GENEFORM Protein DME1724 XEOTICID XEO04825 MOACRIVE Inhibition DME1724 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1724 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04826 XEO_CLAS Peptide DME1724 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO04826 GENEFORM Protein DME1724 XEOTICID XEO04826 MOACRIVE Inhibition DME1724 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1724 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04827 XEO_CLAS Peptide DME1724 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO04827 GENEFORM Protein DME1724 XEOTICID XEO04827 MOACRIVE Inhibition DME1724 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1724 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04835 XEO_CLAS Peptide DME1724 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04835 GENEFORM Protein DME1724 XEOTICID XEO04835 MOACRIVE Inhibition DME1724 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1724 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04836 XEO_CLAS Peptide DME1724 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04836 GENEFORM Protein DME1724 XEOTICID XEO04836 MOACRIVE Inhibition DME1724 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1724 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04837 XEO_CLAS Peptide DME1724 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 microM) DME1724 XEOTICID XEO04837 GENEFORM Protein DME1724 XEOTICID XEO04837 MOACRIVE Inhibition DME1724 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1724 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04839 XEO_CLAS Peptide DME1724 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04839 GENEFORM Protein DME1724 XEOTICID XEO04839 MOACRIVE Inhibition DME1724 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1724 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04840 XEO_CLAS Peptide DME1724 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 35-20 microM) DME1724 XEOTICID XEO04840 GENEFORM Protein DME1724 XEOTICID XEO04840 MOACRIVE Inhibition DME1724 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1724 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04847 XEO_CLAS Peptide DME1724 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04847 GENEFORM Protein DME1724 XEOTICID XEO04847 MOACRIVE Inhibition DME1724 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1724 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04848 XEO_CLAS Peptide DME1724 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04848 GENEFORM Protein DME1724 XEOTICID XEO04848 MOACRIVE Inhibition DME1724 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1724 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04849 XEO_CLAS Peptide DME1724 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04849 GENEFORM Protein DME1724 XEOTICID XEO04849 MOACRIVE Inhibition DME1724 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1724 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04850 XEO_CLAS Peptide DME1724 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04850 GENEFORM Protein DME1724 XEOTICID XEO04850 MOACRIVE Inhibition DME1724 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1724 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04851 XEO_CLAS Peptide DME1724 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1 ug/ml) DME1724 XEOTICID XEO04851 GENEFORM Protein DME1724 XEOTICID XEO04851 MOACRIVE Inhibition DME1724 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1724 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04857 XEO_CLAS Peptide DME1724 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 microM) DME1724 XEOTICID XEO04857 GENEFORM Protein DME1724 XEOTICID XEO04857 MOACRIVE Inhibition DME1724 XEOTICID XEO04863 XEO_NAME RTD peptide DME1724 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04863 XEO_CLAS Peptide DME1724 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.0 microM) DME1724 XEOTICID XEO04863 GENEFORM Protein DME1724 XEOTICID XEO04863 MOACRIVE Inhibition DME1724 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1724 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04865 XEO_CLAS Peptide DME1724 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 ug/ml) DME1724 XEOTICID XEO04865 GENEFORM Protein DME1724 XEOTICID XEO04865 MOACRIVE Inhibition DME1724 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1724 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04866 XEO_CLAS Peptide DME1724 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12.5 ug/ml) DME1724 XEOTICID XEO04866 GENEFORM Protein DME1724 XEOTICID XEO04866 MOACRIVE Inhibition DME1724 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1724 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04868 XEO_CLAS Peptide DME1724 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25.00 ug/ml) DME1724 XEOTICID XEO04868 GENEFORM Protein DME1724 XEOTICID XEO04868 MOACRIVE Inhibition DME1724 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1724 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04869 XEO_CLAS Peptide DME1724 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25.00 ug/ml) DME1724 XEOTICID XEO04869 GENEFORM Protein DME1724 XEOTICID XEO04869 MOACRIVE Inhibition DME1724 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1724 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04870 XEO_CLAS Peptide DME1724 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25.00 ug/ml) DME1724 XEOTICID XEO04870 GENEFORM Protein DME1724 XEOTICID XEO04870 MOACRIVE Inhibition DME1724 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1724 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04877 XEO_CLAS Peptide DME1724 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04877 GENEFORM Protein DME1724 XEOTICID XEO04877 MOACRIVE Inhibition DME1724 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1724 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04880 XEO_CLAS Peptide DME1724 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.5 ug/ml) DME1724 XEOTICID XEO04880 GENEFORM Protein DME1724 XEOTICID XEO04880 MOACRIVE Inhibition DME1724 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1724 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04886 XEO_CLAS Peptide DME1724 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.6 ug/ml) DME1724 XEOTICID XEO04886 GENEFORM Protein DME1724 XEOTICID XEO04886 MOACRIVE Inhibition DME1724 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1724 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04891 XEO_CLAS Peptide DME1724 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04891 GENEFORM Protein DME1724 XEOTICID XEO04891 MOACRIVE Inhibition DME1724 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1724 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04895 XEO_CLAS Peptide DME1724 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04895 GENEFORM Protein DME1724 XEOTICID XEO04895 MOACRIVE Inhibition DME1724 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1724 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04901 XEO_CLAS Peptide DME1724 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 microM) DME1724 XEOTICID XEO04901 GENEFORM Protein DME1724 XEOTICID XEO04901 MOACRIVE Inhibition DME1724 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1724 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04904 XEO_CLAS Peptide DME1724 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 78 ug/ml) DME1724 XEOTICID XEO04904 GENEFORM Protein DME1724 XEOTICID XEO04904 MOACRIVE Inhibition DME1724 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1724 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04905 XEO_CLAS Peptide DME1724 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04905 GENEFORM Protein DME1724 XEOTICID XEO04905 MOACRIVE Inhibition DME1724 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1724 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04906 XEO_CLAS Peptide DME1724 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04906 GENEFORM Protein DME1724 XEOTICID XEO04906 MOACRIVE Inhibition DME1724 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1724 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04907 XEO_CLAS Peptide DME1724 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04907 GENEFORM Protein DME1724 XEOTICID XEO04907 MOACRIVE Inhibition DME1724 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1724 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04908 XEO_CLAS Peptide DME1724 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04908 GENEFORM Protein DME1724 XEOTICID XEO04908 MOACRIVE Inhibition DME1724 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1724 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04909 XEO_CLAS Peptide DME1724 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04909 GENEFORM Protein DME1724 XEOTICID XEO04909 MOACRIVE Inhibition DME1724 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1724 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04915 XEO_CLAS Peptide DME1724 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 100 ug/ml) DME1724 XEOTICID XEO04915 GENEFORM Protein DME1724 XEOTICID XEO04915 MOACRIVE Inhibition DME1724 XEOTICID XEO04916 XEO_NAME Scopoletin DME1724 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1724 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04916 GENEFORM Protein DME1724 XEOTICID XEO04916 MOACRIVE Inhibition DME1724 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1724 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04926 XEO_CLAS Peptide DME1724 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04926 GENEFORM Protein DME1724 XEOTICID XEO04926 MOACRIVE Inhibition DME1724 XEOTICID XEO04931 XEO_NAME Shepherin I DME1724 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04931 XEO_CLAS Peptide DME1724 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04931 GENEFORM Protein DME1724 XEOTICID XEO04931 MOACRIVE Inhibition DME1724 XEOTICID XEO04932 XEO_NAME shepherin II DME1724 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04932 XEO_CLAS Peptide DME1724 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04932 GENEFORM Protein DME1724 XEOTICID XEO04932 MOACRIVE Inhibition DME1724 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1724 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04938 XEO_CLAS Peptide DME1724 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC <= 100 microM) DME1724 XEOTICID XEO04938 GENEFORM Protein DME1724 XEOTICID XEO04938 MOACRIVE Inhibition DME1724 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1724 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04947 XEO_CLAS Natural Product DME1724 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04947 GENEFORM Protein DME1724 XEOTICID XEO04947 MOACRIVE Inhibition DME1724 XEOTICID XEO04948 XEO_NAME Sinensetin DME1724 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1724 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1724 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04948 GENEFORM Protein DME1724 XEOTICID XEO04948 MOACRIVE Inhibition DME1724 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1724 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04950 XEO_CLAS Peptide DME1724 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 ug/ml) DME1724 XEOTICID XEO04950 GENEFORM Protein DME1724 XEOTICID XEO04950 MOACRIVE Inhibition DME1724 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1724 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04955 XEO_CLAS Peptide DME1724 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.07 microM) DME1724 XEOTICID XEO04955 GENEFORM Protein DME1724 XEOTICID XEO04955 MOACRIVE Inhibition DME1724 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1724 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04956 XEO_CLAS Peptide DME1724 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16.0 microM) DME1724 XEOTICID XEO04956 GENEFORM Protein DME1724 XEOTICID XEO04956 MOACRIVE Inhibition DME1724 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1724 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04957 XEO_CLAS Peptide DME1724 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.23 microM) DME1724 XEOTICID XEO04957 GENEFORM Protein DME1724 XEOTICID XEO04957 MOACRIVE Inhibition DME1724 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1724 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04958 XEO_CLAS Peptide DME1724 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 ug/ml) DME1724 XEOTICID XEO04958 GENEFORM Protein DME1724 XEOTICID XEO04958 MOACRIVE Inhibition DME1724 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1724 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04959 XEO_CLAS Peptide DME1724 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04959 GENEFORM Protein DME1724 XEOTICID XEO04959 MOACRIVE Inhibition DME1724 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1724 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04967 XEO_CLAS Peptide DME1724 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 28 microM) DME1724 XEOTICID XEO04967 GENEFORM Protein DME1724 XEOTICID XEO04967 MOACRIVE Inhibition DME1724 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1724 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04969 XEO_CLAS Peptide DME1724 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50-100 ug/ml) DME1724 XEOTICID XEO04969 GENEFORM Protein DME1724 XEOTICID XEO04969 MOACRIVE Inhibition DME1724 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1724 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04970 XEO_CLAS Peptide DME1724 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04970 GENEFORM Protein DME1724 XEOTICID XEO04970 MOACRIVE Inhibition DME1724 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1724 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04971 XEO_CLAS Peptide DME1724 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.8-1.5 microM) DME1724 XEOTICID XEO04971 GENEFORM Protein DME1724 XEOTICID XEO04971 MOACRIVE Inhibition DME1724 XEOTICID XEO04974 XEO_NAME Spinigerin DME1724 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04974 XEO_CLAS Peptide DME1724 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3-6 microM) DME1724 XEOTICID XEO04974 GENEFORM Protein DME1724 XEOTICID XEO04974 MOACRIVE Inhibition DME1724 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1724 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1724 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04975 GENEFORM Protein DME1724 XEOTICID XEO04975 MOACRIVE Inhibition DME1724 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1724 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1724 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04976 GENEFORM Protein DME1724 XEOTICID XEO04976 MOACRIVE Inhibition DME1724 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1724 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1724 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04977 GENEFORM Protein DME1724 XEOTICID XEO04977 MOACRIVE Inhibition DME1724 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1724 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1724 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04978 GENEFORM Protein DME1724 XEOTICID XEO04978 MOACRIVE Inhibition DME1724 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1724 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1724 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04979 GENEFORM Protein DME1724 XEOTICID XEO04979 MOACRIVE Inhibition DME1724 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1724 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04981 XEO_CLAS Peptide DME1724 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10.1 microM) DME1724 XEOTICID XEO04981 GENEFORM Protein DME1724 XEOTICID XEO04981 MOACRIVE Inhibition DME1724 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1724 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04982 XEO_CLAS Peptide DME1724 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40.5 microM) DME1724 XEOTICID XEO04982 GENEFORM Protein DME1724 XEOTICID XEO04982 MOACRIVE Inhibition DME1724 XEOTICID XEO04994 XEO_NAME Stilbene DME1724 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1724 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1724 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO04994 GENEFORM Protein DME1724 XEOTICID XEO04994 MOACRIVE Inhibition DME1724 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1724 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04995 XEO_CLAS Peptide DME1724 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC < 0.19 microM) DME1724 XEOTICID XEO04995 GENEFORM Protein DME1724 XEOTICID XEO04995 MOACRIVE Inhibition DME1724 XEOTICID XEO04998 XEO_NAME Styelin A DME1724 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04998 XEO_CLAS Peptide DME1724 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.7 ug/ml) DME1724 XEOTICID XEO04998 GENEFORM Protein DME1724 XEOTICID XEO04998 MOACRIVE Inhibition DME1724 XEOTICID XEO04999 XEO_NAME Styelin B DME1724 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO04999 XEO_CLAS Peptide DME1724 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.7 ug/ml) DME1724 XEOTICID XEO04999 GENEFORM Protein DME1724 XEOTICID XEO04999 MOACRIVE Inhibition DME1724 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1724 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05000 XEO_CLAS Peptide DME1724 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO05000 GENEFORM Protein DME1724 XEOTICID XEO05000 MOACRIVE Inhibition DME1724 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1724 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05001 XEO_CLAS Peptide DME1724 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.5 ug/ml) DME1724 XEOTICID XEO05001 GENEFORM Protein DME1724 XEOTICID XEO05001 MOACRIVE Inhibition DME1724 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1724 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05002 XEO_CLAS Peptide DME1724 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO05002 GENEFORM Protein DME1724 XEOTICID XEO05002 MOACRIVE Inhibition DME1724 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1724 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05003 XEO_CLAS Peptide DME1724 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO05003 GENEFORM Protein DME1724 XEOTICID XEO05003 MOACRIVE Inhibition DME1724 XEOTICID XEO05006 XEO_NAME Substance P DME1724 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05006 XEO_CLAS Peptide DME1724 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05006 GENEFORM Protein DME1724 XEOTICID XEO05006 MOACRIVE Inhibition DME1724 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1724 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05007 XEO_CLAS Peptide DME1724 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05007 GENEFORM Protein DME1724 XEOTICID XEO05007 MOACRIVE Inhibition DME1724 XEOTICID XEO05008 XEO_NAME Subtilosin DME1724 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05008 XEO_CLAS Peptide DME1724 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05008 GENEFORM Protein DME1724 XEOTICID XEO05008 MOACRIVE Inhibition DME1724 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1724 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05013 XEO_CLAS Peptide DME1724 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO05013 GENEFORM Protein DME1724 XEOTICID XEO05013 MOACRIVE Inhibition DME1724 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1724 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05014 XEO_CLAS Peptide DME1724 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO05014 GENEFORM Protein DME1724 XEOTICID XEO05014 MOACRIVE Inhibition DME1724 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1724 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05015 XEO_CLAS Peptide DME1724 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO05015 GENEFORM Protein DME1724 XEOTICID XEO05015 MOACRIVE Inhibition DME1724 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1724 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05016 XEO_CLAS Peptide DME1724 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO05016 GENEFORM Protein DME1724 XEOTICID XEO05016 MOACRIVE Inhibition DME1724 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1724 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05017 XEO_CLAS Peptide DME1724 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 20 ug/ml) DME1724 XEOTICID XEO05017 GENEFORM Protein DME1724 XEOTICID XEO05017 MOACRIVE Inhibition DME1724 XEOTICID XEO05018 XEO_NAME Syringic acid DME1724 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1724 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05018 GENEFORM Protein DME1724 XEOTICID XEO05018 MOACRIVE Inhibition DME1724 XEOTICID XEO05020 XEO_NAME Tachycitin DME1724 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05020 XEO_CLAS Peptide DME1724 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05020 GENEFORM Protein DME1724 XEOTICID XEO05020 MOACRIVE Inhibition DME1724 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1724 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05023 XEO_CLAS Peptide DME1724 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05023 GENEFORM Protein DME1724 XEOTICID XEO05023 MOACRIVE Inhibition DME1724 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1724 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05024 XEO_CLAS Peptide DME1724 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05024 GENEFORM Protein DME1724 XEOTICID XEO05024 MOACRIVE Inhibition DME1724 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1724 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05027 XEO_CLAS Peptide DME1724 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05027 GENEFORM Protein DME1724 XEOTICID XEO05027 MOACRIVE Inhibition DME1724 XEOTICID XEO05031 XEO_NAME Tannic acid DME1724 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1724 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05031 GENEFORM Protein DME1724 XEOTICID XEO05031 MOACRIVE Inhibition DME1724 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1724 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05033 XEO_CLAS Peptide DME1724 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05033 GENEFORM Protein DME1724 XEOTICID XEO05033 MOACRIVE Inhibition DME1724 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1724 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05042 XEO_CLAS Peptide DME1724 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO05042 GENEFORM Protein DME1724 XEOTICID XEO05042 MOACRIVE Inhibition DME1724 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1724 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05043 XEO_CLAS Peptide DME1724 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO05043 GENEFORM Protein DME1724 XEOTICID XEO05043 MOACRIVE Inhibition DME1724 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1724 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05044 XEO_CLAS Peptide DME1724 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 128 microM) DME1724 XEOTICID XEO05044 GENEFORM Protein DME1724 XEOTICID XEO05044 MOACRIVE Inhibition DME1724 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1724 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05045 XEO_CLAS Peptide DME1724 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 128 microM) DME1724 XEOTICID XEO05045 GENEFORM Protein DME1724 XEOTICID XEO05045 MOACRIVE Inhibition DME1724 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1724 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05046 XEO_CLAS Peptide DME1724 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 microM) DME1724 XEOTICID XEO05046 GENEFORM Protein DME1724 XEOTICID XEO05046 MOACRIVE Inhibition DME1724 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1724 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05047 XEO_CLAS Peptide DME1724 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 60 microM) DME1724 XEOTICID XEO05047 GENEFORM Protein DME1724 XEOTICID XEO05047 MOACRIVE Inhibition DME1724 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1724 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05051 XEO_CLAS Peptide DME1724 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05051 GENEFORM Protein DME1724 XEOTICID XEO05051 MOACRIVE Inhibition DME1724 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1724 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05055 XEO_CLAS Peptide DME1724 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 70 microM) DME1724 XEOTICID XEO05055 GENEFORM Protein DME1724 XEOTICID XEO05055 MOACRIVE Inhibition DME1724 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1724 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05056 XEO_CLAS Peptide DME1724 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05056 GENEFORM Protein DME1724 XEOTICID XEO05056 MOACRIVE Inhibition DME1724 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1724 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05059 XEO_CLAS Peptide DME1724 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05059 GENEFORM Protein DME1724 XEOTICID XEO05059 MOACRIVE Inhibition DME1724 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1724 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05061 XEO_CLAS Peptide DME1724 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO05061 GENEFORM Protein DME1724 XEOTICID XEO05061 MOACRIVE Inhibition DME1724 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1724 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05062 XEO_CLAS Peptide DME1724 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05062 GENEFORM Protein DME1724 XEOTICID XEO05062 MOACRIVE Inhibition DME1724 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1724 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05063 XEO_CLAS Peptide DME1724 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO05063 GENEFORM Protein DME1724 XEOTICID XEO05063 MOACRIVE Inhibition DME1724 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1724 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05064 XEO_CLAS Peptide DME1724 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 231 microM) DME1724 XEOTICID XEO05064 GENEFORM Protein DME1724 XEOTICID XEO05064 MOACRIVE Inhibition DME1724 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1724 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05065 XEO_CLAS Peptide DME1724 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 161 ug/ml) DME1724 XEOTICID XEO05065 GENEFORM Protein DME1724 XEOTICID XEO05065 MOACRIVE Inhibition DME1724 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1724 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05069 XEO_CLAS Peptide DME1724 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO05069 GENEFORM Protein DME1724 XEOTICID XEO05069 MOACRIVE Inhibition DME1724 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1724 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05070 XEO_CLAS Peptide DME1724 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 37.5 microM) DME1724 XEOTICID XEO05070 GENEFORM Protein DME1724 XEOTICID XEO05070 MOACRIVE Inhibition DME1724 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1724 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05071 XEO_CLAS Peptide DME1724 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 150 microM) DME1724 XEOTICID XEO05071 GENEFORM Protein DME1724 XEOTICID XEO05071 MOACRIVE Inhibition DME1724 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1724 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05072 XEO_CLAS Peptide DME1724 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO05072 GENEFORM Protein DME1724 XEOTICID XEO05072 MOACRIVE Inhibition DME1724 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1724 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05073 XEO_CLAS Peptide DME1724 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40 microM) DME1724 XEOTICID XEO05073 GENEFORM Protein DME1724 XEOTICID XEO05073 MOACRIVE Inhibition DME1724 XEOTICID XEO05076 XEO_NAME Temporin-A DME1724 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05076 XEO_CLAS Peptide DME1724 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 11.9 microM) DME1724 XEOTICID XEO05076 GENEFORM Protein DME1724 XEOTICID XEO05076 MOACRIVE Inhibition DME1724 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1724 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05077 XEO_CLAS Peptide DME1724 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.25 ug/ml) DME1724 XEOTICID XEO05077 GENEFORM Protein DME1724 XEOTICID XEO05077 MOACRIVE Inhibition DME1724 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1724 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05078 XEO_CLAS Peptide DME1724 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.25 ug/ml) DME1724 XEOTICID XEO05078 GENEFORM Protein DME1724 XEOTICID XEO05078 MOACRIVE Inhibition DME1724 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1724 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05079 XEO_CLAS Peptide DME1724 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.5 ug/ml) DME1724 XEOTICID XEO05079 GENEFORM Protein DME1724 XEOTICID XEO05079 MOACRIVE Inhibition DME1724 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1724 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05080 XEO_CLAS Peptide DME1724 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 ug/ml) DME1724 XEOTICID XEO05080 GENEFORM Protein DME1724 XEOTICID XEO05080 MOACRIVE Inhibition DME1724 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1724 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05081 XEO_CLAS Peptide DME1724 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 5 ug/ml) DME1724 XEOTICID XEO05081 GENEFORM Protein DME1724 XEOTICID XEO05081 MOACRIVE Inhibition DME1724 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1724 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05082 XEO_CLAS Peptide DME1724 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 7.5 ug/ml) DME1724 XEOTICID XEO05082 GENEFORM Protein DME1724 XEOTICID XEO05082 MOACRIVE Inhibition DME1724 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1724 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05083 XEO_CLAS Peptide DME1724 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 ug/ml) DME1724 XEOTICID XEO05083 GENEFORM Protein DME1724 XEOTICID XEO05083 MOACRIVE Inhibition DME1724 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1724 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05084 XEO_CLAS Peptide DME1724 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 ug/ml) DME1724 XEOTICID XEO05084 GENEFORM Protein DME1724 XEOTICID XEO05084 MOACRIVE Inhibition DME1724 XEOTICID XEO05085 XEO_NAME Temporin-B DME1724 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05085 XEO_CLAS Peptide DME1724 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 21.0 ug/ml) DME1724 XEOTICID XEO05085 GENEFORM Protein DME1724 XEOTICID XEO05085 MOACRIVE Inhibition DME1724 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1724 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05086 XEO_CLAS Peptide DME1724 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC > 100 microM) DME1724 XEOTICID XEO05086 GENEFORM Protein DME1724 XEOTICID XEO05086 MOACRIVE Inhibition DME1724 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1724 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05087 XEO_CLAS Peptide DME1724 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO05087 GENEFORM Protein DME1724 XEOTICID XEO05087 MOACRIVE Inhibition DME1724 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1724 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05097 XEO_CLAS Peptide DME1724 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16.0 microM) DME1724 XEOTICID XEO05097 GENEFORM Protein DME1724 XEOTICID XEO05097 MOACRIVE Inhibition DME1724 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1724 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05099 XEO_CLAS Peptide DME1724 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.0 microM) DME1724 XEOTICID XEO05099 GENEFORM Protein DME1724 XEOTICID XEO05099 MOACRIVE Inhibition DME1724 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1724 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05100 XEO_CLAS Peptide DME1724 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05100 GENEFORM Protein DME1724 XEOTICID XEO05100 MOACRIVE Inhibition DME1724 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1724 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05101 XEO_CLAS Peptide DME1724 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 24.2 ug/ml) DME1724 XEOTICID XEO05101 GENEFORM Protein DME1724 XEOTICID XEO05101 MOACRIVE Inhibition DME1724 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1724 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05102 XEO_CLAS Peptide DME1724 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 34.5 ug/ml) DME1724 XEOTICID XEO05102 GENEFORM Protein DME1724 XEOTICID XEO05102 MOACRIVE Inhibition DME1724 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1724 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05105 XEO_CLAS Peptide DME1724 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO05105 GENEFORM Protein DME1724 XEOTICID XEO05105 MOACRIVE Inhibition DME1724 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1724 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05106 XEO_CLAS Peptide DME1724 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25-200 microM) DME1724 XEOTICID XEO05106 GENEFORM Protein DME1724 XEOTICID XEO05106 MOACRIVE Inhibition DME1724 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1724 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05108 XEO_CLAS Peptide DME1724 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40 microM) DME1724 XEOTICID XEO05108 GENEFORM Protein DME1724 XEOTICID XEO05108 MOACRIVE Inhibition DME1724 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1724 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1724 XEOTICID XEO05111 XEO_CLAS Natural Product DME1724 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05111 GENEFORM Protein DME1724 XEOTICID XEO05111 MOACRIVE Inhibition DME1724 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1724 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05119 XEO_CLAS Peptide DME1724 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05119 GENEFORM Protein DME1724 XEOTICID XEO05119 MOACRIVE Inhibition DME1724 XEOTICID XEO05120 XEO_NAME Thanatin DME1724 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05120 XEO_CLAS Peptide DME1724 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1724 XEOTICID XEO05120 GENEFORM Protein DME1724 XEOTICID XEO05120 MOACRIVE Inhibition DME1724 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1724 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05121 XEO_CLAS Peptide DME1724 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 62.5 ug/ml) DME1724 XEOTICID XEO05121 GENEFORM Protein DME1724 XEOTICID XEO05121 MOACRIVE Inhibition DME1724 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1724 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05125 XEO_CLAS Peptide DME1724 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05125 GENEFORM Protein DME1724 XEOTICID XEO05125 MOACRIVE Inhibition DME1724 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1724 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05130 XEO_CLAS Peptide DME1724 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05130 GENEFORM Protein DME1724 XEOTICID XEO05130 MOACRIVE Inhibition DME1724 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1724 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05144 XEO_CLAS Peptide DME1724 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40 ug/ml) DME1724 XEOTICID XEO05144 GENEFORM Protein DME1724 XEOTICID XEO05144 MOACRIVE Inhibition DME1724 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1724 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05145 XEO_CLAS Peptide DME1724 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 ug/ml) DME1724 XEOTICID XEO05145 GENEFORM Protein DME1724 XEOTICID XEO05145 MOACRIVE Inhibition DME1724 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1724 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05146 XEO_CLAS Peptide DME1724 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 40 ug/ml) DME1724 XEOTICID XEO05146 GENEFORM Protein DME1724 XEOTICID XEO05146 MOACRIVE Inhibition DME1724 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1724 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05147 XEO_CLAS Peptide DME1724 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 60 ug/ml) DME1724 XEOTICID XEO05147 GENEFORM Protein DME1724 XEOTICID XEO05147 MOACRIVE Inhibition DME1724 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1724 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05158 XEO_CLAS Peptide DME1724 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05158 GENEFORM Protein DME1724 XEOTICID XEO05158 MOACRIVE Inhibition DME1724 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1724 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05161 XEO_CLAS Peptide DME1724 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 32 ug/ml) DME1724 XEOTICID XEO05161 GENEFORM Protein DME1724 XEOTICID XEO05161 MOACRIVE Inhibition DME1724 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1724 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05162 XEO_CLAS Peptide DME1724 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 32 ug/ml) DME1724 XEOTICID XEO05162 GENEFORM Protein DME1724 XEOTICID XEO05162 MOACRIVE Inhibition DME1724 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1724 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05163 XEO_CLAS Peptide DME1724 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 12-25 ug/ml) DME1724 XEOTICID XEO05163 GENEFORM Protein DME1724 XEOTICID XEO05163 MOACRIVE Inhibition DME1724 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1724 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05170 XEO_CLAS Peptide DME1724 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 3.0 microM) DME1724 XEOTICID XEO05170 GENEFORM Protein DME1724 XEOTICID XEO05170 MOACRIVE Inhibition DME1724 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1724 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05171 XEO_CLAS Peptide DME1724 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 50 microM) DME1724 XEOTICID XEO05171 GENEFORM Protein DME1724 XEOTICID XEO05171 MOACRIVE Inhibition DME1724 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1724 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05179 XEO_CLAS Peptide DME1724 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05179 GENEFORM Protein DME1724 XEOTICID XEO05179 MOACRIVE Inhibition DME1724 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1724 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05180 XEO_CLAS Peptide DME1724 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 160 microM) DME1724 XEOTICID XEO05180 GENEFORM Protein DME1724 XEOTICID XEO05180 MOACRIVE Inhibition DME1724 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1724 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05182 XEO_CLAS Peptide DME1724 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 microM) DME1724 XEOTICID XEO05182 GENEFORM Protein DME1724 XEOTICID XEO05182 MOACRIVE Inhibition DME1724 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1724 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05183 XEO_CLAS Peptide DME1724 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 microM) DME1724 XEOTICID XEO05183 GENEFORM Protein DME1724 XEOTICID XEO05183 MOACRIVE Inhibition DME1724 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1724 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05184 XEO_CLAS Peptide DME1724 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 microM) DME1724 XEOTICID XEO05184 GENEFORM Protein DME1724 XEOTICID XEO05184 MOACRIVE Inhibition DME1724 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1724 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05185 XEO_CLAS Peptide DME1724 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 microM) DME1724 XEOTICID XEO05185 GENEFORM Protein DME1724 XEOTICID XEO05185 MOACRIVE Inhibition DME1724 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1724 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05186 XEO_CLAS Peptide DME1724 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 microM) DME1724 XEOTICID XEO05186 GENEFORM Protein DME1724 XEOTICID XEO05186 MOACRIVE Inhibition DME1724 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1724 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05187 XEO_CLAS Peptide DME1724 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16 microM) DME1724 XEOTICID XEO05187 GENEFORM Protein DME1724 XEOTICID XEO05187 MOACRIVE Inhibition DME1724 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1724 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05188 XEO_CLAS Peptide DME1724 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 64 microM) DME1724 XEOTICID XEO05188 GENEFORM Protein DME1724 XEOTICID XEO05188 MOACRIVE Inhibition DME1724 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1724 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05190 XEO_CLAS Peptide DME1724 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05190 GENEFORM Protein DME1724 XEOTICID XEO05190 MOACRIVE Inhibition DME1724 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1724 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05193 XEO_CLAS Peptide DME1724 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO05193 GENEFORM Protein DME1724 XEOTICID XEO05193 MOACRIVE Inhibition DME1724 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1724 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05197 XEO_CLAS Peptide DME1724 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05197 GENEFORM Protein DME1724 XEOTICID XEO05197 MOACRIVE Inhibition DME1724 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1724 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05205 XEO_CLAS Peptide DME1724 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05205 GENEFORM Protein DME1724 XEOTICID XEO05205 MOACRIVE Inhibition DME1724 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1724 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05206 XEO_CLAS Peptide DME1724 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 10 microM) DME1724 XEOTICID XEO05206 GENEFORM Protein DME1724 XEOTICID XEO05206 MOACRIVE Inhibition DME1724 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1724 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05207 XEO_CLAS Peptide DME1724 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 25 microM) DME1724 XEOTICID XEO05207 GENEFORM Protein DME1724 XEOTICID XEO05207 MOACRIVE Inhibition DME1724 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1724 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05208 XEO_CLAS Peptide DME1724 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 microM) DME1724 XEOTICID XEO05208 GENEFORM Protein DME1724 XEOTICID XEO05208 MOACRIVE Inhibition DME1724 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1724 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05209 XEO_CLAS Peptide DME1724 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 15 microM) DME1724 XEOTICID XEO05209 GENEFORM Protein DME1724 XEOTICID XEO05209 MOACRIVE Inhibition DME1724 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1724 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05212 XEO_CLAS Peptide DME1724 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.5 ug/ml) DME1724 XEOTICID XEO05212 GENEFORM Protein DME1724 XEOTICID XEO05212 MOACRIVE Inhibition DME1724 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1724 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05220 XEO_CLAS Peptide DME1724 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.6-1.2 microM) DME1724 XEOTICID XEO05220 GENEFORM Protein DME1724 XEOTICID XEO05220 MOACRIVE Inhibition DME1724 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1724 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05230 XEO_CLAS Peptide DME1724 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 7.90 microM) DME1724 XEOTICID XEO05230 GENEFORM Protein DME1724 XEOTICID XEO05230 MOACRIVE Inhibition DME1724 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1724 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05231 XEO_CLAS Peptide DME1724 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2.40 microM) DME1724 XEOTICID XEO05231 GENEFORM Protein DME1724 XEOTICID XEO05231 MOACRIVE Inhibition DME1724 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1724 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05232 XEO_CLAS Peptide DME1724 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05232 GENEFORM Protein DME1724 XEOTICID XEO05232 MOACRIVE Inhibition DME1724 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1724 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05233 XEO_CLAS Peptide DME1724 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 ug/ml) DME1724 XEOTICID XEO05233 GENEFORM Protein DME1724 XEOTICID XEO05233 MOACRIVE Inhibition DME1724 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1724 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05234 XEO_CLAS Peptide DME1724 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 ug/ml) DME1724 XEOTICID XEO05234 GENEFORM Protein DME1724 XEOTICID XEO05234 MOACRIVE Inhibition DME1724 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1724 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05235 XEO_CLAS Peptide DME1724 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 30 ug/ml) DME1724 XEOTICID XEO05235 GENEFORM Protein DME1724 XEOTICID XEO05235 MOACRIVE Inhibition DME1724 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1724 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05237 XEO_CLAS Peptide DME1724 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 microM) DME1724 XEOTICID XEO05237 GENEFORM Protein DME1724 XEOTICID XEO05237 MOACRIVE Inhibition DME1724 XEOTICID XEO05245 XEO_NAME Viresin DME1724 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05245 XEO_CLAS Peptide DME1724 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05245 GENEFORM Protein DME1724 XEOTICID XEO05245 MOACRIVE Inhibition DME1724 XEOTICID XEO05248 XEO_NAME Vitamin C DME1724 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1724 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1724 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05248 GENEFORM Protein DME1724 XEOTICID XEO05248 MOACRIVE Inhibition DME1724 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1724 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05264 XEO_CLAS Peptide DME1724 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 4 ug/ml) DME1724 XEOTICID XEO05264 GENEFORM Protein DME1724 XEOTICID XEO05264 MOACRIVE Inhibition DME1724 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1724 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05267 XEO_CLAS Peptide DME1724 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 2 ug/ml) DME1724 XEOTICID XEO05267 GENEFORM Protein DME1724 XEOTICID XEO05267 MOACRIVE Inhibition DME1724 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1724 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05268 XEO_CLAS Peptide DME1724 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 1.6 ug/ml) DME1724 XEOTICID XEO05268 GENEFORM Protein DME1724 XEOTICID XEO05268 MOACRIVE Inhibition DME1724 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1724 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05269 XEO_CLAS Peptide DME1724 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 6 ug/ml) DME1724 XEOTICID XEO05269 GENEFORM Protein DME1724 XEOTICID XEO05269 MOACRIVE Inhibition DME1724 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1724 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05273 XEO_CLAS Peptide DME1724 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05273 GENEFORM Protein DME1724 XEOTICID XEO05273 MOACRIVE Inhibition DME1724 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1724 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05274 XEO_CLAS Peptide DME1724 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05274 GENEFORM Protein DME1724 XEOTICID XEO05274 MOACRIVE Inhibition DME1724 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1724 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05287 XEO_CLAS Peptide DME1724 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli DME1724 XEOTICID XEO05287 GENEFORM Protein DME1724 XEOTICID XEO05287 MOACRIVE Inhibition DME1724 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1724 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05303 XEO_CLAS Peptide DME1724 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 16-31 ug/ml) DME1724 XEOTICID XEO05303 GENEFORM Protein DME1724 XEOTICID XEO05303 MOACRIVE Inhibition DME1724 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1724 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05306 XEO_CLAS Peptide DME1724 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 8 ug/ml) DME1724 XEOTICID XEO05306 GENEFORM Protein DME1724 XEOTICID XEO05306 MOACRIVE Inhibition DME1724 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1724 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1724 XEOTICID XEO05308 XEO_CLAS Peptide DME1724 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Glycoside hydrolase (cscA) from Escherichia coli (MIC = 0.4 ug/ml) DME1724 XEOTICID XEO05308 GENEFORM Protein DME1724 XEOTICID XEO05308 MOACRIVE Inhibition DME1725 DME___ID DME1725 DME1725 DME_NAME Beta-galactosidase (bgaB) DME1725 SPESNAME Enterobacter cloacae DME1725 XEOTICID XEO02226 XEO_NAME Andropin DME1725 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02226 XEO_CLAS Peptide DME1725 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC > 300 microM) DME1725 XEOTICID XEO02226 GENEFORM Protein DME1725 XEOTICID XEO02226 MOACRIVE Inhibition DME1725 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1725 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02230 XEO_CLAS Peptide DME1725 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 0.5-1 microM) DME1725 XEOTICID XEO02230 GENEFORM Protein DME1725 XEOTICID XEO02230 MOACRIVE Inhibition DME1725 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1725 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02275 XEO_CLAS Peptide DME1725 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 35 microM) DME1725 XEOTICID XEO02275 GENEFORM Protein DME1725 XEOTICID XEO02275 MOACRIVE Inhibition DME1725 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1725 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02284 XEO_CLAS Peptide DME1725 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 47.9 microM) DME1725 XEOTICID XEO02284 GENEFORM Protein DME1725 XEOTICID XEO02284 MOACRIVE Inhibition DME1725 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1725 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02285 XEO_CLAS Peptide DME1725 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 47.9 microM) DME1725 XEOTICID XEO02285 GENEFORM Protein DME1725 XEOTICID XEO02285 MOACRIVE Inhibition DME1725 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1725 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02286 XEO_CLAS Peptide DME1725 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 47.9 microM) DME1725 XEOTICID XEO02286 GENEFORM Protein DME1725 XEOTICID XEO02286 MOACRIVE Inhibition DME1725 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1725 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02287 XEO_CLAS Peptide DME1725 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 47.9 microM) DME1725 XEOTICID XEO02287 GENEFORM Protein DME1725 XEOTICID XEO02287 MOACRIVE Inhibition DME1725 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1725 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02319 XEO_CLAS Peptide DME1725 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO02319 GENEFORM Protein DME1725 XEOTICID XEO02319 MOACRIVE Inhibition DME1725 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1725 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02325 XEO_CLAS Peptide DME1725 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 6 microM) DME1725 XEOTICID XEO02325 GENEFORM Protein DME1725 XEOTICID XEO02325 MOACRIVE Inhibition DME1725 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1725 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02333 XEO_CLAS Peptide DME1725 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC > 200 microM) DME1725 XEOTICID XEO02333 GENEFORM Protein DME1725 XEOTICID XEO02333 MOACRIVE Inhibition DME1725 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1725 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02371 XEO_CLAS Peptide DME1725 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 25 ug/ml) DME1725 XEOTICID XEO02371 GENEFORM Protein DME1725 XEOTICID XEO02371 MOACRIVE Inhibition DME1725 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1725 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02473 XEO_CLAS Peptide DME1725 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO02473 GENEFORM Protein DME1725 XEOTICID XEO02473 MOACRIVE Inhibition DME1725 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1725 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02496 XEO_CLAS Peptide DME1725 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 13 microM) DME1725 XEOTICID XEO02496 GENEFORM Protein DME1725 XEOTICID XEO02496 MOACRIVE Inhibition DME1725 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1725 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02497 XEO_CLAS Peptide DME1725 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 25 microM) DME1725 XEOTICID XEO02497 GENEFORM Protein DME1725 XEOTICID XEO02497 MOACRIVE Inhibition DME1725 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1725 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02566 XEO_CLAS Peptide DME1725 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 50 microM) DME1725 XEOTICID XEO02566 GENEFORM Protein DME1725 XEOTICID XEO02566 MOACRIVE Inhibition DME1725 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1725 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02637 XEO_CLAS Peptide DME1725 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 6 microM) DME1725 XEOTICID XEO02637 GENEFORM Protein DME1725 XEOTICID XEO02637 MOACRIVE Inhibition DME1725 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1725 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02688 XEO_CLAS Peptide DME1725 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 50 microM) DME1725 XEOTICID XEO02688 GENEFORM Protein DME1725 XEOTICID XEO02688 MOACRIVE Inhibition DME1725 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1725 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02745 XEO_CLAS Peptide DME1725 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO02745 GENEFORM Protein DME1725 XEOTICID XEO02745 MOACRIVE Inhibition DME1725 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1725 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02746 XEO_CLAS Peptide DME1725 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO02746 GENEFORM Protein DME1725 XEOTICID XEO02746 MOACRIVE Inhibition DME1725 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1725 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO02768 XEO_CLAS Peptide DME1725 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 50-100 ug/ml) DME1725 XEOTICID XEO02768 GENEFORM Protein DME1725 XEOTICID XEO02768 MOACRIVE Inhibition DME1725 XEOTICID XEO03114 XEO_NAME Defensin AaeDefA DME1725 XEOTICID XEO03114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03114 XEO_CLAS Peptide DME1725 XEOTICID XEO03114 DESCRIPT Defensin AaeDefA inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 1.2-2.4 microM) DME1725 XEOTICID XEO03114 GENEFORM Protein DME1725 XEOTICID XEO03114 MOACRIVE Inhibition DME1725 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1725 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03137 XEO_CLAS Peptide DME1725 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO03137 GENEFORM Protein DME1725 XEOTICID XEO03137 MOACRIVE Inhibition DME1725 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1725 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03162 XEO_CLAS Peptide DME1725 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 12.5 microM) DME1725 XEOTICID XEO03162 GENEFORM Protein DME1725 XEOTICID XEO03162 MOACRIVE Inhibition DME1725 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1725 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03223 XEO_CLAS Peptide DME1725 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 1.0 microM) DME1725 XEOTICID XEO03223 GENEFORM Protein DME1725 XEOTICID XEO03223 MOACRIVE Inhibition DME1725 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1725 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03224 XEO_CLAS Peptide DME1725 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 0.5-1 microM) DME1725 XEOTICID XEO03224 GENEFORM Protein DME1725 XEOTICID XEO03224 MOACRIVE Inhibition DME1725 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1725 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03225 XEO_CLAS Peptide DME1725 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 0.4 microM) DME1725 XEOTICID XEO03225 GENEFORM Protein DME1725 XEOTICID XEO03225 MOACRIVE Inhibition DME1725 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1725 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03250 XEO_CLAS Peptide DME1725 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO03250 GENEFORM Protein DME1725 XEOTICID XEO03250 MOACRIVE Inhibition DME1725 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1725 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03251 XEO_CLAS Peptide DME1725 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO03251 GENEFORM Protein DME1725 XEOTICID XEO03251 MOACRIVE Inhibition DME1725 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1725 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03497 XEO_CLAS Peptide DME1725 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 3.15-6.25 microM) DME1725 XEOTICID XEO03497 GENEFORM Protein DME1725 XEOTICID XEO03497 MOACRIVE Inhibition DME1725 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1725 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03498 XEO_CLAS Peptide DME1725 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 3.15-6.25 microM) DME1725 XEOTICID XEO03498 GENEFORM Protein DME1725 XEOTICID XEO03498 MOACRIVE Inhibition DME1725 XEOTICID XEO03519 XEO_NAME Hadrurin DME1725 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03519 XEO_CLAS Peptide DME1725 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO03519 GENEFORM Protein DME1725 XEOTICID XEO03519 MOACRIVE Inhibition DME1725 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1725 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03540 XEO_CLAS Peptide DME1725 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 8-16 ug/ml) DME1725 XEOTICID XEO03540 GENEFORM Protein DME1725 XEOTICID XEO03540 MOACRIVE Inhibition DME1725 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1725 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03556 XEO_CLAS Peptide DME1725 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 8-16 ug/ml) DME1725 XEOTICID XEO03556 GENEFORM Protein DME1725 XEOTICID XEO03556 MOACRIVE Inhibition DME1725 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1725 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03557 XEO_CLAS Peptide DME1725 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 8-16 ug/ml) DME1725 XEOTICID XEO03557 GENEFORM Protein DME1725 XEOTICID XEO03557 MOACRIVE Inhibition DME1725 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1725 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03561 XEO_CLAS Peptide DME1725 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO03561 GENEFORM Protein DME1725 XEOTICID XEO03561 MOACRIVE Inhibition DME1725 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1725 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03585 XEO_CLAS Peptide DME1725 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 62.5 ug/ml) DME1725 XEOTICID XEO03585 GENEFORM Protein DME1725 XEOTICID XEO03585 MOACRIVE Inhibition DME1725 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1725 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03609 XEO_CLAS Peptide DME1725 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO03609 GENEFORM Protein DME1725 XEOTICID XEO03609 MOACRIVE Inhibition DME1725 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1725 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03672 XEO_CLAS Peptide DME1725 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 10 ug/ml) DME1725 XEOTICID XEO03672 GENEFORM Protein DME1725 XEOTICID XEO03672 MOACRIVE Inhibition DME1725 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1725 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03673 XEO_CLAS Peptide DME1725 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 15 ug/ml) DME1725 XEOTICID XEO03673 GENEFORM Protein DME1725 XEOTICID XEO03673 MOACRIVE Inhibition DME1725 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1725 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03674 XEO_CLAS Peptide DME1725 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO03674 GENEFORM Protein DME1725 XEOTICID XEO03674 MOACRIVE Inhibition DME1725 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1725 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03675 XEO_CLAS Peptide DME1725 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 40 microM) DME1725 XEOTICID XEO03675 GENEFORM Protein DME1725 XEOTICID XEO03675 MOACRIVE Inhibition DME1725 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1725 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03681 XEO_CLAS Peptide DME1725 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 1.2-2.5 microM) DME1725 XEOTICID XEO03681 GENEFORM Protein DME1725 XEOTICID XEO03681 MOACRIVE Inhibition DME1725 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1725 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03697 XEO_CLAS Peptide DME1725 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 6.25 microM) DME1725 XEOTICID XEO03697 GENEFORM Protein DME1725 XEOTICID XEO03697 MOACRIVE Inhibition DME1725 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1725 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO03985 XEO_CLAS Peptide DME1725 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 50 ug/ml) DME1725 XEOTICID XEO03985 GENEFORM Protein DME1725 XEOTICID XEO03985 MOACRIVE Inhibition DME1725 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1725 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04348 XEO_CLAS Peptide DME1725 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 20 microM) DME1725 XEOTICID XEO04348 GENEFORM Protein DME1725 XEOTICID XEO04348 MOACRIVE Inhibition DME1725 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1725 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04349 XEO_CLAS Peptide DME1725 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 50 microM) DME1725 XEOTICID XEO04349 GENEFORM Protein DME1725 XEOTICID XEO04349 MOACRIVE Inhibition DME1725 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1725 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04612 XEO_CLAS Peptide DME1725 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 10-20 microM) DME1725 XEOTICID XEO04612 GENEFORM Protein DME1725 XEOTICID XEO04612 MOACRIVE Inhibition DME1725 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1725 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04613 XEO_CLAS Peptide DME1725 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 10-20 microM) DME1725 XEOTICID XEO04613 GENEFORM Protein DME1725 XEOTICID XEO04613 MOACRIVE Inhibition DME1725 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1725 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04627 XEO_CLAS Peptide DME1725 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 12.5 microM) DME1725 XEOTICID XEO04627 GENEFORM Protein DME1725 XEOTICID XEO04627 MOACRIVE Inhibition DME1725 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1725 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04695 XEO_CLAS Peptide DME1725 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO04695 GENEFORM Protein DME1725 XEOTICID XEO04695 MOACRIVE Inhibition DME1725 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1725 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04696 XEO_CLAS Peptide DME1725 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO04696 GENEFORM Protein DME1725 XEOTICID XEO04696 MOACRIVE Inhibition DME1725 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1725 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04699 XEO_CLAS Peptide DME1725 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO04699 GENEFORM Protein DME1725 XEOTICID XEO04699 MOACRIVE Inhibition DME1725 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1725 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04700 XEO_CLAS Peptide DME1725 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO04700 GENEFORM Protein DME1725 XEOTICID XEO04700 MOACRIVE Inhibition DME1725 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1725 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04701 XEO_CLAS Peptide DME1725 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO04701 GENEFORM Protein DME1725 XEOTICID XEO04701 MOACRIVE Inhibition DME1725 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1725 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04702 XEO_CLAS Peptide DME1725 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO04702 GENEFORM Protein DME1725 XEOTICID XEO04702 MOACRIVE Inhibition DME1725 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1725 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04703 XEO_CLAS Peptide DME1725 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO04703 GENEFORM Protein DME1725 XEOTICID XEO04703 MOACRIVE Inhibition DME1725 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1725 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04809 XEO_CLAS Peptide DME1725 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 5 microM) DME1725 XEOTICID XEO04809 GENEFORM Protein DME1725 XEOTICID XEO04809 MOACRIVE Inhibition DME1725 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1725 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04938 XEO_CLAS Peptide DME1725 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC <= 100 microM) DME1725 XEOTICID XEO04938 GENEFORM Protein DME1725 XEOTICID XEO04938 MOACRIVE Inhibition DME1725 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1725 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO04995 XEO_CLAS Peptide DME1725 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 3.12-6.25 microM) DME1725 XEOTICID XEO04995 GENEFORM Protein DME1725 XEOTICID XEO04995 MOACRIVE Inhibition DME1725 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1725 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO05073 XEO_CLAS Peptide DME1725 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 40 microM) DME1725 XEOTICID XEO05073 GENEFORM Protein DME1725 XEOTICID XEO05073 MOACRIVE Inhibition DME1725 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1725 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO05075 XEO_CLAS Peptide DME1725 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 40 microM) DME1725 XEOTICID XEO05075 GENEFORM Protein DME1725 XEOTICID XEO05075 MOACRIVE Inhibition DME1725 XEOTICID XEO05120 XEO_NAME Thanatin DME1725 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO05120 XEO_CLAS Peptide DME1725 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 1.2-2.5 microM) DME1725 XEOTICID XEO05120 GENEFORM Protein DME1725 XEOTICID XEO05120 MOACRIVE Inhibition DME1725 XEOTICID XEO05139 XEO_NAME Thuricin-S DME1725 XEOTICID XEO05139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO05139 XEO_CLAS Peptide DME1725 XEOTICID XEO05139 DESCRIPT Thuricin-S inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae DME1725 XEOTICID XEO05139 GENEFORM Protein DME1725 XEOTICID XEO05139 MOACRIVE Inhibition DME1725 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1725 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO05220 XEO_CLAS Peptide DME1725 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 5-10 microM) DME1725 XEOTICID XEO05220 GENEFORM Protein DME1725 XEOTICID XEO05220 MOACRIVE Inhibition DME1725 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1725 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1725 XEOTICID XEO05308 XEO_CLAS Peptide DME1725 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Enterobacter cloacae (MIC = 12.0 ug/ml) DME1725 XEOTICID XEO05308 GENEFORM Protein DME1725 XEOTICID XEO05308 MOACRIVE Inhibition DME1731 DME___ID DME1731 DME1731 DME_NAME Carbapenemase (cphA) DME1731 SPESNAME Aeromonas hydrophila DME1731 XEOTICID XEO00416 XEO_NAME Menthol DME1731 XEOTICID XEO00416 XEO_TYPE Pharmaceutical Agent(s) DME1731 XEOTICID XEO00416 XEO_CLAS Approved/Marketed Drug DME1731 XEOTICID XEO00416 DESCRIPT Menthol inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO00416 GENEFORM Protein DME1731 XEOTICID XEO00416 MOACRIVE Inhibition DME1731 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME1731 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME1731 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME1731 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO00613 GENEFORM Protein DME1731 XEOTICID XEO00613 MOACRIVE Inhibition DME1731 XEOTICID XEO00683 XEO_NAME Curcumin DME1731 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1731 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1731 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO00683 GENEFORM Protein DME1731 XEOTICID XEO00683 MOACRIVE Inhibition DME1731 XEOTICID XEO00727 XEO_NAME Vanillin DME1731 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1731 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1731 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO00727 GENEFORM Protein DME1731 XEOTICID XEO00727 MOACRIVE Inhibition DME1731 XEOTICID XEO01460 XEO_NAME Rosmarinic acid DME1731 XEOTICID XEO01460 XEO_TYPE Health or Environmental Toxicant(s) DME1731 XEOTICID XEO01460 XEO_CLAS Acute Toxic Substance DME1731 XEOTICID XEO01460 DESCRIPT Rosmarinic acid inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO01460 GENEFORM Protein DME1731 XEOTICID XEO01460 MOACRIVE Inhibition DME1731 XEOTICID XEO01571 XEO_NAME Peppermint oil DME1731 XEOTICID XEO01571 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1731 XEOTICID XEO01571 XEO_CLAS Natural Product DME1731 XEOTICID XEO01571 DESCRIPT Peppermint oil inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO01571 GENEFORM Protein DME1731 XEOTICID XEO01571 MOACRIVE Inhibition DME1731 XEOTICID XEO01914 XEO_NAME 2(5H)-furanone DME1731 XEOTICID XEO01914 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1731 XEOTICID XEO01914 XEO_CLAS Chemical Compound DME1731 XEOTICID XEO01914 DESCRIPT 2(5H)-furanone inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO01914 GENEFORM Protein DME1731 XEOTICID XEO01914 MOACRIVE Inhibition DME1731 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1731 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO01927 XEO_CLAS Peptide DME1731 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila (MIC = 5 ug/ml) DME1731 XEOTICID XEO01927 GENEFORM Protein DME1731 XEOTICID XEO01927 MOACRIVE Inhibition DME1731 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1731 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO02117 XEO_CLAS Peptide DME1731 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO02117 GENEFORM Protein DME1731 XEOTICID XEO02117 MOACRIVE Inhibition DME1731 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1731 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO02118 XEO_CLAS Peptide DME1731 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO02118 GENEFORM Protein DME1731 XEOTICID XEO02118 MOACRIVE Inhibition DME1731 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1731 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO02119 XEO_CLAS Peptide DME1731 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO02119 GENEFORM Protein DME1731 XEOTICID XEO02119 MOACRIVE Inhibition DME1731 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1731 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO02120 XEO_CLAS Peptide DME1731 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO02120 GENEFORM Protein DME1731 XEOTICID XEO02120 MOACRIVE Inhibition DME1731 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1731 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO02121 XEO_CLAS Peptide DME1731 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO02121 GENEFORM Protein DME1731 XEOTICID XEO02121 MOACRIVE Inhibition DME1731 XEOTICID XEO02277 XEO_NAME Antimicrobial peptide AJN-10 DME1731 XEOTICID XEO02277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO02277 XEO_CLAS Peptide DME1731 XEOTICID XEO02277 DESCRIPT Antimicrobial peptide AJN-10 inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO02277 GENEFORM Protein DME1731 XEOTICID XEO02277 MOACRIVE Inhibition DME1731 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1731 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO02316 XEO_CLAS Peptide DME1731 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila (MIC > 50 microM) DME1731 XEOTICID XEO02316 GENEFORM Protein DME1731 XEOTICID XEO02316 MOACRIVE Inhibition DME1731 XEOTICID XEO02363 XEO_NAME Bacillus sp. QSI-1 DME1731 XEOTICID XEO02363 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1731 XEOTICID XEO02363 XEO_CLAS Bacterial Extract DME1731 XEOTICID XEO02363 DESCRIPT Bacillus sp. QSI-1 inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO02363 GENEFORM Protein DME1731 XEOTICID XEO02363 MOACRIVE Inhibition DME1731 XEOTICID XEO03542 XEO_NAME Hepcidin DME1731 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO03542 XEO_CLAS Peptide DME1731 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila (MIC = 6 microM) DME1731 XEOTICID XEO03542 GENEFORM Protein DME1731 XEOTICID XEO03542 MOACRIVE Inhibition DME1731 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1731 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO03567 XEO_CLAS Peptide DME1731 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO03567 GENEFORM Protein DME1731 XEOTICID XEO03567 MOACRIVE Inhibition DME1731 XEOTICID XEO03568 XEO_NAME Histone HIIb-3 DME1731 XEOTICID XEO03568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO03568 XEO_CLAS Peptide DME1731 XEOTICID XEO03568 DESCRIPT Histone HIIb-3 inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO03568 GENEFORM Protein DME1731 XEOTICID XEO03568 MOACRIVE Inhibition DME1731 XEOTICID XEO03830 XEO_NAME Mangifera indica leaf extract DME1731 XEOTICID XEO03830 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1731 XEOTICID XEO03830 XEO_CLAS Plant Extract DME1731 XEOTICID XEO03830 DESCRIPT Mangifera indica leaf extract inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO03830 GENEFORM Protein DME1731 XEOTICID XEO03830 MOACRIVE Inhibition DME1731 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1731 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO03915 XEO_CLAS Peptide DME1731 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO03915 GENEFORM Protein DME1731 XEOTICID XEO03915 MOACRIVE Inhibition DME1731 XEOTICID XEO04386 XEO_NAME Syzygium aromaticum oil DME1731 XEOTICID XEO04386 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1731 XEOTICID XEO04386 XEO_CLAS Plant Extract DME1731 XEOTICID XEO04386 DESCRIPT Syzygium aromaticum oil inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila DME1731 XEOTICID XEO04386 GENEFORM Protein DME1731 XEOTICID XEO04386 MOACRIVE Inhibition DME1731 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1731 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO04396 XEO_CLAS Peptide DME1731 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila (MIC > 0.5 microM) DME1731 XEOTICID XEO04396 GENEFORM Protein DME1731 XEOTICID XEO04396 MOACRIVE Inhibition DME1731 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1731 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO04397 XEO_CLAS Peptide DME1731 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila (MIC > 0.5 microM) DME1731 XEOTICID XEO04397 GENEFORM Protein DME1731 XEOTICID XEO04397 MOACRIVE Inhibition DME1731 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1731 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO04612 XEO_CLAS Peptide DME1731 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila (MIC > 20 microM) DME1731 XEOTICID XEO04612 GENEFORM Protein DME1731 XEOTICID XEO04612 MOACRIVE Inhibition DME1731 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1731 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO04613 XEO_CLAS Peptide DME1731 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila (MIC > 20 microM) DME1731 XEOTICID XEO04613 GENEFORM Protein DME1731 XEOTICID XEO04613 MOACRIVE Inhibition DME1731 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1731 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1731 XEOTICID XEO05308 XEO_CLAS Peptide DME1731 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Aeromonas hydrophila (MIC = 3.6 ug/ml) DME1731 XEOTICID XEO05308 GENEFORM Protein DME1731 XEOTICID XEO05308 MOACRIVE Inhibition DME1732 DME___ID DME1732 DME1732 DME_NAME New delhi metallo-beta-lactamase NDM-1 (blaNDM) DME1732 SPESNAME Salmonella enterica DME1732 XEOTICID XEO01237 XEO_NAME Carvacrol DME1732 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1732 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1732 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO01237 GENEFORM Protein DME1732 XEOTICID XEO01237 MOACRIVE Inhibition DME1732 XEOTICID XEO01802 XEO_NAME (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone DME1732 XEOTICID XEO01802 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1732 XEOTICID XEO01802 XEO_CLAS Chemical Compound DME1732 XEOTICID XEO01802 DESCRIPT (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO01802 GENEFORM Protein DME1732 XEOTICID XEO01802 MOACRIVE Inhibition DME1732 XEOTICID XEO01944 XEO_NAME 2-Hexylmaleic anhydride DME1732 XEOTICID XEO01944 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1732 XEOTICID XEO01944 XEO_CLAS Chemical Compound DME1732 XEOTICID XEO01944 DESCRIPT 2-Hexylmaleic anhydride inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO01944 GENEFORM Protein DME1732 XEOTICID XEO01944 MOACRIVE Inhibition DME1732 XEOTICID XEO01990 XEO_NAME 3-hexyl-4-bromo-5-methylene-2(5H)-furanone DME1732 XEOTICID XEO01990 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1732 XEOTICID XEO01990 XEO_CLAS Chemical Compound DME1732 XEOTICID XEO01990 DESCRIPT 3-hexyl-4-bromo-5-methylene-2(5H)-furanone inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO01990 GENEFORM Protein DME1732 XEOTICID XEO01990 MOACRIVE Inhibition DME1732 XEOTICID XEO02235 XEO_NAME Anthranilate DME1732 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1732 XEOTICID XEO02235 XEO_CLAS Natural Product DME1732 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO02235 GENEFORM Protein DME1732 XEOTICID XEO02235 MOACRIVE Inhibition DME1732 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1732 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO02284 XEO_CLAS Peptide DME1732 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 25.0 microM) DME1732 XEOTICID XEO02284 GENEFORM Protein DME1732 XEOTICID XEO02284 MOACRIVE Inhibition DME1732 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1732 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO02285 XEO_CLAS Peptide DME1732 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 25.0 microM) DME1732 XEOTICID XEO02285 GENEFORM Protein DME1732 XEOTICID XEO02285 MOACRIVE Inhibition DME1732 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1732 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO02286 XEO_CLAS Peptide DME1732 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 25.0 microM) DME1732 XEOTICID XEO02286 GENEFORM Protein DME1732 XEOTICID XEO02286 MOACRIVE Inhibition DME1732 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1732 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO02287 XEO_CLAS Peptide DME1732 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 25.0 microM) DME1732 XEOTICID XEO02287 GENEFORM Protein DME1732 XEOTICID XEO02287 MOACRIVE Inhibition DME1732 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1732 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO02317 XEO_CLAS Peptide DME1732 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 300 microM) DME1732 XEOTICID XEO02317 GENEFORM Protein DME1732 XEOTICID XEO02317 MOACRIVE Inhibition DME1732 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1732 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO02491 XEO_CLAS Peptide DME1732 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 2.3 microM) DME1732 XEOTICID XEO02491 GENEFORM Protein DME1732 XEOTICID XEO02491 MOACRIVE Inhibition DME1732 XEOTICID XEO02641 XEO_NAME Bromohexylmaleic anhydride DME1732 XEOTICID XEO02641 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1732 XEOTICID XEO02641 XEO_CLAS Chemical Compound DME1732 XEOTICID XEO02641 DESCRIPT Bromohexylmaleic anhydride inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO02641 GENEFORM Protein DME1732 XEOTICID XEO02641 MOACRIVE Inhibition DME1732 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1732 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1732 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1732 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO02990 GENEFORM Protein DME1732 XEOTICID XEO02990 MOACRIVE Inhibition DME1732 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1732 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO03029 XEO_CLAS Peptide DME1732 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 0.005 microM) DME1732 XEOTICID XEO03029 GENEFORM Protein DME1732 XEOTICID XEO03029 MOACRIVE Inhibition DME1732 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1732 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO03030 XEO_CLAS Peptide DME1732 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 0.005 microM) DME1732 XEOTICID XEO03030 GENEFORM Protein DME1732 XEOTICID XEO03030 MOACRIVE Inhibition DME1732 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1732 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO03031 XEO_CLAS Peptide DME1732 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 0.3 microM) DME1732 XEOTICID XEO03031 GENEFORM Protein DME1732 XEOTICID XEO03031 MOACRIVE Inhibition DME1732 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1732 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO03032 XEO_CLAS Peptide DME1732 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 0.005 microM) DME1732 XEOTICID XEO03032 GENEFORM Protein DME1732 XEOTICID XEO03032 MOACRIVE Inhibition DME1732 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1732 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO03033 XEO_CLAS Peptide DME1732 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 0.005 microM) DME1732 XEOTICID XEO03033 GENEFORM Protein DME1732 XEOTICID XEO03033 MOACRIVE Inhibition DME1732 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1732 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO03034 XEO_CLAS Peptide DME1732 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 0.528 microM) DME1732 XEOTICID XEO03034 GENEFORM Protein DME1732 XEOTICID XEO03034 MOACRIVE Inhibition DME1732 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1732 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO03035 XEO_CLAS Peptide DME1732 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 0.004 microM) DME1732 XEOTICID XEO03035 GENEFORM Protein DME1732 XEOTICID XEO03035 MOACRIVE Inhibition DME1732 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1732 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO03250 XEO_CLAS Peptide DME1732 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO03250 GENEFORM Protein DME1732 XEOTICID XEO03250 MOACRIVE Inhibition DME1732 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1732 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1732 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1732 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO03968 GENEFORM Protein DME1732 XEOTICID XEO03968 MOACRIVE Inhibition DME1732 XEOTICID XEO04114 XEO_NAME Microcin L DME1732 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04114 XEO_CLAS Peptide DME1732 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO04114 GENEFORM Protein DME1732 XEOTICID XEO04114 MOACRIVE Inhibition DME1732 XEOTICID XEO04172 XEO_NAME Myxinidin DME1732 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04172 XEO_CLAS Peptide DME1732 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO04172 GENEFORM Protein DME1732 XEOTICID XEO04172 MOACRIVE Inhibition DME1732 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1732 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04335 XEO_CLAS Peptide DME1732 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 16 ug/ml) DME1732 XEOTICID XEO04335 GENEFORM Protein DME1732 XEOTICID XEO04335 MOACRIVE Inhibition DME1732 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1732 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04336 XEO_CLAS Peptide DME1732 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 16 ug/ml) DME1732 XEOTICID XEO04336 GENEFORM Protein DME1732 XEOTICID XEO04336 MOACRIVE Inhibition DME1732 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1732 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04338 XEO_CLAS Peptide DME1732 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 0.5 ug/ml) DME1732 XEOTICID XEO04338 GENEFORM Protein DME1732 XEOTICID XEO04338 MOACRIVE Inhibition DME1732 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1732 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04339 XEO_CLAS Peptide DME1732 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 64 ug/ml) DME1732 XEOTICID XEO04339 GENEFORM Protein DME1732 XEOTICID XEO04339 MOACRIVE Inhibition DME1732 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1732 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04340 XEO_CLAS Peptide DME1732 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 2 ug/ml) DME1732 XEOTICID XEO04340 GENEFORM Protein DME1732 XEOTICID XEO04340 MOACRIVE Inhibition DME1732 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1732 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04642 XEO_CLAS Peptide DME1732 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 4 ug/ml) DME1732 XEOTICID XEO04642 GENEFORM Protein DME1732 XEOTICID XEO04642 MOACRIVE Inhibition DME1732 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1732 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04643 XEO_CLAS Peptide DME1732 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 2 ug/ml) DME1732 XEOTICID XEO04643 GENEFORM Protein DME1732 XEOTICID XEO04643 MOACRIVE Inhibition DME1732 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1732 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04644 XEO_CLAS Peptide DME1732 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 2 ug/ml) DME1732 XEOTICID XEO04644 GENEFORM Protein DME1732 XEOTICID XEO04644 MOACRIVE Inhibition DME1732 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1732 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04645 XEO_CLAS Peptide DME1732 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 32 ug/ml) DME1732 XEOTICID XEO04645 GENEFORM Protein DME1732 XEOTICID XEO04645 MOACRIVE Inhibition DME1732 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1732 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04646 XEO_CLAS Peptide DME1732 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 1 ug/ml) DME1732 XEOTICID XEO04646 GENEFORM Protein DME1732 XEOTICID XEO04646 MOACRIVE Inhibition DME1732 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1732 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04647 XEO_CLAS Peptide DME1732 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 4 ug/ml) DME1732 XEOTICID XEO04647 GENEFORM Protein DME1732 XEOTICID XEO04647 MOACRIVE Inhibition DME1732 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1732 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04648 XEO_CLAS Peptide DME1732 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 16 ug/ml) DME1732 XEOTICID XEO04648 GENEFORM Protein DME1732 XEOTICID XEO04648 MOACRIVE Inhibition DME1732 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1732 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04649 XEO_CLAS Peptide DME1732 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC > 64 ug/ml) DME1732 XEOTICID XEO04649 GENEFORM Protein DME1732 XEOTICID XEO04649 MOACRIVE Inhibition DME1732 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1732 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04650 XEO_CLAS Peptide DME1732 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 16 ug/ml) DME1732 XEOTICID XEO04650 GENEFORM Protein DME1732 XEOTICID XEO04650 MOACRIVE Inhibition DME1732 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1732 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04651 XEO_CLAS Peptide DME1732 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 64 ug/ml) DME1732 XEOTICID XEO04651 GENEFORM Protein DME1732 XEOTICID XEO04651 MOACRIVE Inhibition DME1732 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1732 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04652 XEO_CLAS Peptide DME1732 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 4 ug/ml) DME1732 XEOTICID XEO04652 GENEFORM Protein DME1732 XEOTICID XEO04652 MOACRIVE Inhibition DME1732 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1732 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04655 XEO_CLAS Peptide DME1732 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 2 ug/ml) DME1732 XEOTICID XEO04655 GENEFORM Protein DME1732 XEOTICID XEO04655 MOACRIVE Inhibition DME1732 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1732 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04695 XEO_CLAS Peptide DME1732 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO04695 GENEFORM Protein DME1732 XEOTICID XEO04695 MOACRIVE Inhibition DME1732 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1732 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04696 XEO_CLAS Peptide DME1732 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO04696 GENEFORM Protein DME1732 XEOTICID XEO04696 MOACRIVE Inhibition DME1732 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1732 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04699 XEO_CLAS Peptide DME1732 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO04699 GENEFORM Protein DME1732 XEOTICID XEO04699 MOACRIVE Inhibition DME1732 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1732 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04700 XEO_CLAS Peptide DME1732 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO04700 GENEFORM Protein DME1732 XEOTICID XEO04700 MOACRIVE Inhibition DME1732 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1732 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04701 XEO_CLAS Peptide DME1732 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO04701 GENEFORM Protein DME1732 XEOTICID XEO04701 MOACRIVE Inhibition DME1732 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1732 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04702 XEO_CLAS Peptide DME1732 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO04702 GENEFORM Protein DME1732 XEOTICID XEO04702 MOACRIVE Inhibition DME1732 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1732 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO04703 XEO_CLAS Peptide DME1732 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO04703 GENEFORM Protein DME1732 XEOTICID XEO04703 MOACRIVE Inhibition DME1732 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1732 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO05171 XEO_CLAS Peptide DME1732 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica DME1732 XEOTICID XEO05171 GENEFORM Protein DME1732 XEOTICID XEO05171 MOACRIVE Inhibition DME1732 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1732 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1732 XEOTICID XEO05308 XEO_CLAS Peptide DME1732 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of New delhi metallo-beta-lactamase NDM-1 (blaNDM) from Salmonella enterica (MIC = 0.9 ug/ml) DME1732 XEOTICID XEO05308 GENEFORM Protein DME1732 XEOTICID XEO05308 MOACRIVE Inhibition DME1739 DME___ID DME1739 DME1739 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1739 SPESNAME Bacillus subtilis DME1739 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1739 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1739 XEOTICID XEO05230 XEO_CLAS Peptide DME1739 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Bacillus subtilis (MIC = 2 microM) DME1739 XEOTICID XEO05230 GENEFORM Protein DME1739 XEOTICID XEO05230 MOACRIVE Inhibition DME1739 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1739 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1739 XEOTICID XEO05231 XEO_CLAS Peptide DME1739 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Bacillus subtilis (MIC = 0.60 microM) DME1739 XEOTICID XEO05231 GENEFORM Protein DME1739 XEOTICID XEO05231 MOACRIVE Inhibition DME1739 XEOTICID XEO05260 XEO_NAME V. philippinarum beta defensin VpBD DME1739 XEOTICID XEO05260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1739 XEOTICID XEO05260 XEO_CLAS Peptide DME1739 XEOTICID XEO05260 DESCRIPT V. philippinarum beta defensin VpBD inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Bacillus subtilis (MIC = 13.13-26.26 microM) DME1739 XEOTICID XEO05260 GENEFORM Protein DME1739 XEOTICID XEO05260 MOACRIVE Inhibition DME1745 DME___ID DME1745 DME1745 DME_NAME Cytochrome P450 109B1 (cyp109) DME1745 SPESNAME Bacillus anthracis DME1745 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1745 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1745 XEOTICID XEO05230 XEO_CLAS Peptide DME1745 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Cytochrome P450 109B1 (cyp109) from Bacillus anthracis (MIC = 2 microM) DME1745 XEOTICID XEO05230 GENEFORM Protein DME1745 XEOTICID XEO05230 MOACRIVE Inhibition DME1745 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1745 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1745 XEOTICID XEO05231 XEO_CLAS Peptide DME1745 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Cytochrome P450 109B1 (cyp109) from Bacillus anthracis (MIC = 0.60 microM) DME1745 XEOTICID XEO05231 GENEFORM Protein DME1745 XEOTICID XEO05231 MOACRIVE Inhibition DME1745 XEOTICID XEO05260 XEO_NAME V. philippinarum beta defensin VpBD DME1745 XEOTICID XEO05260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1745 XEOTICID XEO05260 XEO_CLAS Peptide DME1745 XEOTICID XEO05260 DESCRIPT V. philippinarum beta defensin VpBD inhibits the drug-metabolizing activity of Cytochrome P450 109B1 (cyp109) from Bacillus anthracis (MIC = 13.13-26.26 microM) DME1745 XEOTICID XEO05260 GENEFORM Protein DME1745 XEOTICID XEO05260 MOACRIVE Inhibition DME1755 DME___ID DME1755 DME1755 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1755 SPESNAME Lactobacillus acidophilus DME1755 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1755 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1755 XEOTICID XEO03771 XEO_CLAS Peptide DME1755 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactobacillus acidophilus DME1755 XEOTICID XEO03771 GENEFORM Protein DME1755 XEOTICID XEO03771 MOACRIVE Inhibition DME1755 XEOTICID XEO03803 XEO_NAME Lantibiotic carnocin-UI49 DME1755 XEOTICID XEO03803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1755 XEOTICID XEO03803 XEO_CLAS Peptide DME1755 XEOTICID XEO03803 DESCRIPT Lantibiotic carnocin-UI49 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactobacillus acidophilus DME1755 XEOTICID XEO03803 GENEFORM Protein DME1755 XEOTICID XEO03803 MOACRIVE Inhibition DME1755 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1755 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1755 XEOTICID XEO04249 XEO_CLAS Peptide DME1755 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactobacillus acidophilus (MIC > 500 ug/ml) DME1755 XEOTICID XEO04249 GENEFORM Protein DME1755 XEOTICID XEO04249 MOACRIVE Inhibition DME1755 XEOTICID XEO04320 XEO_NAME Nisin U DME1755 XEOTICID XEO04320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1755 XEOTICID XEO04320 XEO_CLAS Peptide DME1755 XEOTICID XEO04320 DESCRIPT Nisin U inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactobacillus acidophilus DME1755 XEOTICID XEO04320 GENEFORM Protein DME1755 XEOTICID XEO04320 MOACRIVE Inhibition DME1755 XEOTICID XEO05228 XEO_NAME Variacin DME1755 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1755 XEOTICID XEO05228 XEO_CLAS Peptide DME1755 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Lactobacillus acidophilus DME1755 XEOTICID XEO05228 GENEFORM Protein DME1755 XEOTICID XEO05228 MOACRIVE Inhibition DME1779 DME___ID DME1779 DME1779 DME_NAME Dipeptidylpeptidase IV (DPP4) DME1779 SPESNAME Streptococcus suis DME1779 XEOTICID XEO02314 XEO_NAME Syringa oblata aqueous extract DME1779 XEOTICID XEO02314 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1779 XEOTICID XEO02314 XEO_CLAS Plant Extract DME1779 XEOTICID XEO02314 DESCRIPT Syringa oblata aqueous extract inhibits the drug-metabolizing activity of Dipeptidylpeptidase IV (DPP4) from Streptococcus suis DME1779 XEOTICID XEO02314 GENEFORM Protein DME1779 XEOTICID XEO02314 MOACRIVE Inhibition DME1779 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1779 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1779 XEOTICID XEO02436 XEO_CLAS Peptide DME1779 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of Dipeptidylpeptidase IV (DPP4) from Streptococcus suis DME1779 XEOTICID XEO02436 GENEFORM Protein DME1779 XEOTICID XEO02436 MOACRIVE Inhibition DME1780 DME___ID DME1780 DME1780 DME_NAME Phosphoenolpyruvate carboxykinase (pckG) DME1780 SPESNAME Ruminococcus flavefaciens DME1780 XEOTICID XEO02662 XEO_NAME Butyrivibriocin OR79 DME1780 XEOTICID XEO02662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1780 XEOTICID XEO02662 XEO_CLAS Peptide DME1780 XEOTICID XEO02662 DESCRIPT Butyrivibriocin OR79 inhibits the drug-metabolizing activity of Phosphoenolpyruvate carboxykinase (pckG) from Ruminococcus flavefaciens DME1780 XEOTICID XEO02662 GENEFORM Protein DME1780 XEOTICID XEO02662 MOACRIVE Inhibition DME1788 DME___ID DME1788 DME1788 DME_NAME Beta-glucuronidase (uidA) DME1788 SPESNAME Escherichia coli DME1788 XEOTICID XEO00117 XEO_NAME Copper sulfate DME1788 XEOTICID XEO00117 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00117 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO00117 DESCRIPT Copper sulfate inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00117 GENEFORM Protein DME1788 XEOTICID XEO00117 MOACRIVE Inhibition DME1788 XEOTICID XEO00122 XEO_NAME Amikacin DME1788 XEOTICID XEO00122 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00122 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO00122 DESCRIPT Amikacin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00122 GENEFORM Protein DME1788 XEOTICID XEO00122 MOACRIVE Inhibition DME1788 XEOTICID XEO00136 XEO_NAME Gallium nitrate DME1788 XEOTICID XEO00136 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00136 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO00136 DESCRIPT Gallium nitrate inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00136 GENEFORM Protein DME1788 XEOTICID XEO00136 MOACRIVE Inhibition DME1788 XEOTICID XEO00237 XEO_NAME Ceftazidime DME1788 XEOTICID XEO00237 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00237 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO00237 DESCRIPT Ceftazidime inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00237 GENEFORM Protein DME1788 XEOTICID XEO00237 MOACRIVE Inhibition DME1788 XEOTICID XEO00349 XEO_NAME Ciprofloxacin DME1788 XEOTICID XEO00349 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00349 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO00349 DESCRIPT Ciprofloxacin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00349 GENEFORM Protein DME1788 XEOTICID XEO00349 MOACRIVE Inhibition DME1788 XEOTICID XEO00425 XEO_NAME Titanium dioxide DME1788 XEOTICID XEO00425 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00425 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO00425 DESCRIPT Titanium dioxide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00425 GENEFORM Protein DME1788 XEOTICID XEO00425 MOACRIVE Inhibition DME1788 XEOTICID XEO00439 XEO_NAME Daidzein DME1788 XEOTICID XEO00439 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00439 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO00439 DESCRIPT Daidzein inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00439 GENEFORM Protein DME1788 XEOTICID XEO00439 MOACRIVE Inhibition DME1788 XEOTICID XEO00460 XEO_NAME Zinc sulfate DME1788 XEOTICID XEO00460 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00460 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO00460 DESCRIPT Zinc sulfate inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00460 GENEFORM Protein DME1788 XEOTICID XEO00460 MOACRIVE Inhibition DME1788 XEOTICID XEO00487 XEO_NAME Thymol DME1788 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00487 GENEFORM Protein DME1788 XEOTICID XEO00487 MOACRIVE Inhibition DME1788 XEOTICID XEO00511 XEO_NAME Silver nitrate DME1788 XEOTICID XEO00511 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00511 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO00511 DESCRIPT Silver nitrate inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00511 GENEFORM Protein DME1788 XEOTICID XEO00511 MOACRIVE Inhibition DME1788 XEOTICID XEO00537 XEO_NAME Luteolin DME1788 XEOTICID XEO00537 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00537 XEO_CLAS Drug in Phase 1 Clinical Trial DME1788 XEOTICID XEO00537 DESCRIPT Luteolin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00537 GENEFORM Protein DME1788 XEOTICID XEO00537 MOACRIVE Inhibition DME1788 XEOTICID XEO00538 XEO_NAME Quercetin DME1788 XEOTICID XEO00538 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00538 XEO_CLAS Drug in Phase 1 Clinical Trial DME1788 XEOTICID XEO00538 DESCRIPT Quercetin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00538 GENEFORM Protein DME1788 XEOTICID XEO00538 MOACRIVE Inhibition DME1788 XEOTICID XEO00547 XEO_NAME Vitamin E DME1788 XEOTICID XEO00547 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00547 XEO_CLAS Drug in Phase 3 Clinical Trial DME1788 XEOTICID XEO00547 DESCRIPT Vitamin E inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00547 GENEFORM Protein DME1788 XEOTICID XEO00547 MOACRIVE Inhibition DME1788 XEOTICID XEO00557 XEO_NAME Genistein DME1788 XEOTICID XEO00557 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00557 XEO_CLAS Drug in Phase 2 Clinical Trial DME1788 XEOTICID XEO00557 DESCRIPT Genistein inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00557 GENEFORM Protein DME1788 XEOTICID XEO00557 MOACRIVE Inhibition DME1788 XEOTICID XEO00566 XEO_NAME Guaiacol DME1788 XEOTICID XEO00566 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00566 XEO_CLAS Drug in Phase 3 Clinical Trial DME1788 XEOTICID XEO00566 DESCRIPT Guaiacol inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00566 GENEFORM Protein DME1788 XEOTICID XEO00566 MOACRIVE Inhibition DME1788 XEOTICID XEO00568 XEO_NAME Resveratrol DME1788 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME1788 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00568 GENEFORM Protein DME1788 XEOTICID XEO00568 MOACRIVE Inhibition DME1788 XEOTICID XEO00573 XEO_NAME Naringenin DME1788 XEOTICID XEO00573 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00573 XEO_CLAS Drug in Phase 1 Clinical Trial DME1788 XEOTICID XEO00573 DESCRIPT Naringenin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00573 GENEFORM Protein DME1788 XEOTICID XEO00573 MOACRIVE Inhibition DME1788 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1788 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1788 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00574 GENEFORM Protein DME1788 XEOTICID XEO00574 MOACRIVE Inhibition DME1788 XEOTICID XEO00611 XEO_NAME Betulinic acid DME1788 XEOTICID XEO00611 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00611 XEO_CLAS Drug in Phase 1 Clinical Trial DME1788 XEOTICID XEO00611 DESCRIPT Betulinic acid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00611 GENEFORM Protein DME1788 XEOTICID XEO00611 MOACRIVE Inhibition DME1788 XEOTICID XEO00621 XEO_NAME Chitosan DME1788 XEOTICID XEO00621 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00621 XEO_CLAS Drug in Phase 1 Clinical Trial DME1788 XEOTICID XEO00621 DESCRIPT Chitosan inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00621 GENEFORM Protein DME1788 XEOTICID XEO00621 MOACRIVE Inhibition DME1788 XEOTICID XEO00646 XEO_NAME Epsilon-viniferin DME1788 XEOTICID XEO00646 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00646 XEO_CLAS Drug in Phase 1 Clinical Trial DME1788 XEOTICID XEO00646 DESCRIPT Epsilon-viniferin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00646 GENEFORM Protein DME1788 XEOTICID XEO00646 MOACRIVE Inhibition DME1788 XEOTICID XEO00683 XEO_NAME Curcumin DME1788 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1788 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00683 GENEFORM Protein DME1788 XEOTICID XEO00683 MOACRIVE Inhibition DME1788 XEOTICID XEO00727 XEO_NAME Vanillin DME1788 XEOTICID XEO00727 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00727 XEO_CLAS Preclinical/Patented Drug DME1788 XEOTICID XEO00727 DESCRIPT Vanillin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00727 GENEFORM Protein DME1788 XEOTICID XEO00727 MOACRIVE Inhibition DME1788 XEOTICID XEO00730 XEO_NAME Ferulic acid DME1788 XEOTICID XEO00730 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00730 XEO_CLAS Preclinical/Patented Drug DME1788 XEOTICID XEO00730 DESCRIPT Ferulic acid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00730 GENEFORM Protein DME1788 XEOTICID XEO00730 MOACRIVE Inhibition DME1788 XEOTICID XEO00782 XEO_NAME Vanillic acid DME1788 XEOTICID XEO00782 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO00782 XEO_CLAS Natural Product DME1788 XEOTICID XEO00782 DESCRIPT Vanillic acid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00782 GENEFORM Protein DME1788 XEOTICID XEO00782 MOACRIVE Inhibition DME1788 XEOTICID XEO00866 XEO_NAME 4-hydroxycoumarin DME1788 XEOTICID XEO00866 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00866 XEO_CLAS Investigative Agent DME1788 XEOTICID XEO00866 DESCRIPT 4-hydroxycoumarin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00866 GENEFORM Protein DME1788 XEOTICID XEO00866 MOACRIVE Inhibition DME1788 XEOTICID XEO00878 XEO_NAME Chrysin DME1788 XEOTICID XEO00878 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO00878 XEO_CLAS Natural Product DME1788 XEOTICID XEO00878 DESCRIPT Chrysin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00878 GENEFORM Protein DME1788 XEOTICID XEO00878 MOACRIVE Inhibition DME1788 XEOTICID XEO00879 XEO_NAME Coumarin DME1788 XEOTICID XEO00879 XEO_TYPE Health or Environmental Toxicant(s) DME1788 XEOTICID XEO00879 XEO_CLAS Health Hazard/Toxicant DME1788 XEOTICID XEO00879 DESCRIPT Coumarin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00879 GENEFORM Protein DME1788 XEOTICID XEO00879 MOACRIVE Inhibition DME1788 XEOTICID XEO00883 XEO_NAME Phloretin DME1788 XEOTICID XEO00883 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO00883 XEO_CLAS Natural Product DME1788 XEOTICID XEO00883 DESCRIPT Phloretin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00883 GENEFORM Protein DME1788 XEOTICID XEO00883 MOACRIVE Inhibition DME1788 XEOTICID XEO00885 XEO_NAME Eugenol DME1788 XEOTICID XEO00885 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO00885 XEO_CLAS Preclinical/Patented Drug DME1788 XEOTICID XEO00885 DESCRIPT Eugenol inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO00885 GENEFORM Protein DME1788 XEOTICID XEO00885 MOACRIVE Inhibition DME1788 XEOTICID XEO01032 XEO_NAME Zinc oxide DME1788 XEOTICID XEO01032 XEO_TYPE Health or Environmental Toxicant(s) DME1788 XEOTICID XEO01032 XEO_CLAS Environmental Pollutant DME1788 XEOTICID XEO01032 DESCRIPT Zinc oxide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01032 GENEFORM Protein DME1788 XEOTICID XEO01032 MOACRIVE Inhibition DME1788 XEOTICID XEO01174 XEO_NAME 7-hydroxycoumarin DME1788 XEOTICID XEO01174 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01174 XEO_CLAS Natural Product DME1788 XEOTICID XEO01174 DESCRIPT 7-hydroxycoumarin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01174 GENEFORM Protein DME1788 XEOTICID XEO01174 MOACRIVE Inhibition DME1788 XEOTICID XEO01203 XEO_NAME Apigenin DME1788 XEOTICID XEO01203 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01203 XEO_CLAS Natural Product DME1788 XEOTICID XEO01203 DESCRIPT Apigenin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01203 GENEFORM Protein DME1788 XEOTICID XEO01203 MOACRIVE Inhibition DME1788 XEOTICID XEO01232 XEO_NAME Caffeic acid DME1788 XEOTICID XEO01232 XEO_TYPE Health or Environmental Toxicant(s) DME1788 XEOTICID XEO01232 XEO_CLAS Health Hazard/Toxicant DME1788 XEOTICID XEO01232 DESCRIPT Caffeic acid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01232 GENEFORM Protein DME1788 XEOTICID XEO01232 MOACRIVE Inhibition DME1788 XEOTICID XEO01237 XEO_NAME Carvacrol DME1788 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1788 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01237 GENEFORM Protein DME1788 XEOTICID XEO01237 MOACRIVE Inhibition DME1788 XEOTICID XEO01287 XEO_NAME Ellagic acid DME1788 XEOTICID XEO01287 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO01287 XEO_CLAS Drug in Phase 1 Clinical Trial DME1788 XEOTICID XEO01287 DESCRIPT Ellagic acid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01287 GENEFORM Protein DME1788 XEOTICID XEO01287 MOACRIVE Inhibition DME1788 XEOTICID XEO01291 XEO_NAME Esculetin DME1788 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME1788 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01291 GENEFORM Protein DME1788 XEOTICID XEO01291 MOACRIVE Inhibition DME1788 XEOTICID XEO01304 XEO_NAME Flavone DME1788 XEOTICID XEO01304 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01304 XEO_CLAS Natural Product DME1788 XEOTICID XEO01304 DESCRIPT Flavone inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01304 GENEFORM Protein DME1788 XEOTICID XEO01304 MOACRIVE Inhibition DME1788 XEOTICID XEO01309 XEO_NAME Gallic acid DME1788 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01309 XEO_CLAS Natural Product DME1788 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01309 GENEFORM Protein DME1788 XEOTICID XEO01309 MOACRIVE Inhibition DME1788 XEOTICID XEO01340 XEO_NAME Imperatorin DME1788 XEOTICID XEO01340 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01340 XEO_CLAS Natural Product DME1788 XEOTICID XEO01340 DESCRIPT Imperatorin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01340 GENEFORM Protein DME1788 XEOTICID XEO01340 MOACRIVE Inhibition DME1788 XEOTICID XEO01353 XEO_NAME Kaempferol DME1788 XEOTICID XEO01353 XEO_TYPE Health or Environmental Toxicant(s) DME1788 XEOTICID XEO01353 XEO_CLAS Acute Toxic Substance DME1788 XEOTICID XEO01353 DESCRIPT Kaempferol inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01353 GENEFORM Protein DME1788 XEOTICID XEO01353 MOACRIVE Inhibition DME1788 XEOTICID XEO01366 XEO_NAME Linalool DME1788 XEOTICID XEO01366 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01366 XEO_CLAS Natural Product DME1788 XEOTICID XEO01366 DESCRIPT Linalool inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01366 GENEFORM Protein DME1788 XEOTICID XEO01366 MOACRIVE Inhibition DME1788 XEOTICID XEO01391 XEO_NAME Naringin DME1788 XEOTICID XEO01391 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01391 XEO_CLAS Natural Product DME1788 XEOTICID XEO01391 DESCRIPT Naringin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01391 GENEFORM Protein DME1788 XEOTICID XEO01391 MOACRIVE Inhibition DME1788 XEOTICID XEO01420 XEO_NAME Palmitic acid DME1788 XEOTICID XEO01420 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO01420 XEO_CLAS Drug in Phase 1 Clinical Trial DME1788 XEOTICID XEO01420 DESCRIPT Palmitic acid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01420 GENEFORM Protein DME1788 XEOTICID XEO01420 MOACRIVE Inhibition DME1788 XEOTICID XEO01463 XEO_NAME Rutin DME1788 XEOTICID XEO01463 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01463 XEO_CLAS Natural Product DME1788 XEOTICID XEO01463 DESCRIPT Rutin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01463 GENEFORM Protein DME1788 XEOTICID XEO01463 MOACRIVE Inhibition DME1788 XEOTICID XEO01496 XEO_NAME Ursolic acid DME1788 XEOTICID XEO01496 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO01496 XEO_CLAS Drug in Phase 2 Clinical Trial DME1788 XEOTICID XEO01496 DESCRIPT Ursolic acid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01496 GENEFORM Protein DME1788 XEOTICID XEO01496 MOACRIVE Inhibition DME1788 XEOTICID XEO01512 XEO_NAME Zinc DME1788 XEOTICID XEO01512 XEO_TYPE Health or Environmental Toxicant(s) DME1788 XEOTICID XEO01512 XEO_CLAS Environmental Pollutant DME1788 XEOTICID XEO01512 DESCRIPT Zinc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01512 GENEFORM Protein DME1788 XEOTICID XEO01512 MOACRIVE Inhibition DME1788 XEOTICID XEO01527 XEO_NAME Bergamottin DME1788 XEOTICID XEO01527 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01527 XEO_CLAS Natural Product DME1788 XEOTICID XEO01527 DESCRIPT Bergamottin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01527 GENEFORM Protein DME1788 XEOTICID XEO01527 MOACRIVE Inhibition DME1788 XEOTICID XEO01531 XEO_NAME Clove oil DME1788 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01531 XEO_CLAS Natural Product DME1788 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01531 GENEFORM Protein DME1788 XEOTICID XEO01531 MOACRIVE Inhibition DME1788 XEOTICID XEO01559 XEO_NAME Limonene DME1788 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01559 XEO_CLAS Natural Product DME1788 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01559 GENEFORM Protein DME1788 XEOTICID XEO01559 MOACRIVE Inhibition DME1788 XEOTICID XEO01563 XEO_NAME Methyleugenol DME1788 XEOTICID XEO01563 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01563 XEO_CLAS Natural Product DME1788 XEOTICID XEO01563 DESCRIPT Methyleugenol inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01563 GENEFORM Protein DME1788 XEOTICID XEO01563 MOACRIVE Inhibition DME1788 XEOTICID XEO01566 XEO_NAME Nobiletin DME1788 XEOTICID XEO01566 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01566 XEO_CLAS Natural Product DME1788 XEOTICID XEO01566 DESCRIPT Nobiletin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01566 GENEFORM Protein DME1788 XEOTICID XEO01566 MOACRIVE Inhibition DME1788 XEOTICID XEO01778 XEO_NAME (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone DME1788 XEOTICID XEO01778 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01778 XEO_CLAS Natural Product DME1788 XEOTICID XEO01778 DESCRIPT (5Z)-4-Bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01778 GENEFORM Protein DME1788 XEOTICID XEO01778 MOACRIVE Inhibition DME1788 XEOTICID XEO01779 XEO_NAME Aurein 1.2 derivative (AU)2K DME1788 XEOTICID XEO01779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01779 XEO_CLAS Peptide DME1788 XEOTICID XEO01779 DESCRIPT Aurein 1.2 derivative (AU)2K inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 128 microM) DME1788 XEOTICID XEO01779 GENEFORM Protein DME1788 XEOTICID XEO01779 MOACRIVE Inhibition DME1788 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1788 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01810 XEO_CLAS Peptide DME1788 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.0 microM) DME1788 XEOTICID XEO01810 GENEFORM Protein DME1788 XEOTICID XEO01810 MOACRIVE Inhibition DME1788 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1788 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01811 XEO_CLAS Peptide DME1788 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 microM) DME1788 XEOTICID XEO01811 GENEFORM Protein DME1788 XEOTICID XEO01811 MOACRIVE Inhibition DME1788 XEOTICID XEO01812 XEO_NAME ccTP derivative Arg13 DME1788 XEOTICID XEO01812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01812 XEO_CLAS Peptide DME1788 XEOTICID XEO01812 DESCRIPT ccTP derivative Arg13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10.4 microM) DME1788 XEOTICID XEO01812 GENEFORM Protein DME1788 XEOTICID XEO01812 MOACRIVE Inhibition DME1788 XEOTICID XEO01813 XEO_NAME ccTP derivative Arg4,8,13 Lys18 DME1788 XEOTICID XEO01813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01813 XEO_CLAS Peptide DME1788 XEOTICID XEO01813 DESCRIPT ccTP derivative Arg4,8,13 Lys18 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.1 microM) DME1788 XEOTICID XEO01813 GENEFORM Protein DME1788 XEOTICID XEO01813 MOACRIVE Inhibition DME1788 XEOTICID XEO01814 XEO_NAME ccTP derivative Arg4,8,13 DME1788 XEOTICID XEO01814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01814 XEO_CLAS Peptide DME1788 XEOTICID XEO01814 DESCRIPT ccTP derivative Arg4,8,13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.5 microM) DME1788 XEOTICID XEO01814 GENEFORM Protein DME1788 XEOTICID XEO01814 MOACRIVE Inhibition DME1788 XEOTICID XEO01815 XEO_NAME ccTP derivative Arg4,8 DME1788 XEOTICID XEO01815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01815 XEO_CLAS Peptide DME1788 XEOTICID XEO01815 DESCRIPT ccTP derivative Arg4,8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 9.8 microM) DME1788 XEOTICID XEO01815 GENEFORM Protein DME1788 XEOTICID XEO01815 MOACRIVE Inhibition DME1788 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1788 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01816 XEO_CLAS Peptide DME1788 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO01816 GENEFORM Protein DME1788 XEOTICID XEO01816 MOACRIVE Inhibition DME1788 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1788 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01817 XEO_CLAS Peptide DME1788 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.0 microM) DME1788 XEOTICID XEO01817 GENEFORM Protein DME1788 XEOTICID XEO01817 MOACRIVE Inhibition DME1788 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1788 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01818 XEO_CLAS Peptide DME1788 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4.0 microM) DME1788 XEOTICID XEO01818 GENEFORM Protein DME1788 XEOTICID XEO01818 MOACRIVE Inhibition DME1788 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1788 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01819 XEO_CLAS Peptide DME1788 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO01819 GENEFORM Protein DME1788 XEOTICID XEO01819 MOACRIVE Inhibition DME1788 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1788 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01820 XEO_CLAS Peptide DME1788 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO01820 GENEFORM Protein DME1788 XEOTICID XEO01820 MOACRIVE Inhibition DME1788 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1788 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01821 XEO_CLAS Peptide DME1788 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO01821 GENEFORM Protein DME1788 XEOTICID XEO01821 MOACRIVE Inhibition DME1788 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1788 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01822 XEO_CLAS Peptide DME1788 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 microM) DME1788 XEOTICID XEO01822 GENEFORM Protein DME1788 XEOTICID XEO01822 MOACRIVE Inhibition DME1788 XEOTICID XEO01823 XEO_NAME P18 analogue L9 DME1788 XEOTICID XEO01823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01823 XEO_CLAS Peptide DME1788 XEOTICID XEO01823 DESCRIPT P18 analogue L9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO01823 GENEFORM Protein DME1788 XEOTICID XEO01823 MOACRIVE Inhibition DME1788 XEOTICID XEO01824 XEO_NAME TL(3)[Pro3,DLeu9] DME1788 XEOTICID XEO01824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01824 XEO_CLAS Peptide DME1788 XEOTICID XEO01824 DESCRIPT TL(3)[Pro3,DLeu9] inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO01824 GENEFORM Protein DME1788 XEOTICID XEO01824 MOACRIVE Inhibition DME1788 XEOTICID XEO01825 XEO_NAME P18 analogue S9 DME1788 XEOTICID XEO01825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01825 XEO_CLAS Peptide DME1788 XEOTICID XEO01825 DESCRIPT P18 analogue S9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25.0 microM) DME1788 XEOTICID XEO01825 GENEFORM Protein DME1788 XEOTICID XEO01825 MOACRIVE Inhibition DME1788 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1788 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01827 XEO_CLAS Peptide DME1788 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.12-6.25 microM) DME1788 XEOTICID XEO01827 GENEFORM Protein DME1788 XEOTICID XEO01827 MOACRIVE Inhibition DME1788 XEOTICID XEO01829 XEO_NAME 5-Methylisatin DME1788 XEOTICID XEO01829 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1788 XEOTICID XEO01829 XEO_CLAS Chemical Compound DME1788 XEOTICID XEO01829 DESCRIPT 5-Methylisatin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01829 GENEFORM Protein DME1788 XEOTICID XEO01829 MOACRIVE Inhibition DME1788 XEOTICID XEO01927 XEO_NAME Antibacterial protein 27kDa DME1788 XEOTICID XEO01927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01927 XEO_CLAS Peptide DME1788 XEOTICID XEO01927 DESCRIPT Antibacterial protein 27kDa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 ug/ml) DME1788 XEOTICID XEO01927 GENEFORM Protein DME1788 XEOTICID XEO01927 MOACRIVE Inhibition DME1788 XEOTICID XEO01945 XEO_NAME Peptide 2IQ2 DME1788 XEOTICID XEO01945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01945 XEO_CLAS Peptide DME1788 XEOTICID XEO01945 DESCRIPT Peptide 2IQ2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.1 microM) DME1788 XEOTICID XEO01945 GENEFORM Protein DME1788 XEOTICID XEO01945 MOACRIVE Inhibition DME1788 XEOTICID XEO01946 XEO_NAME Peptide 2IQ3 DME1788 XEOTICID XEO01946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01946 XEO_CLAS Peptide DME1788 XEOTICID XEO01946 DESCRIPT Peptide 2IQ3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.2 microM) DME1788 XEOTICID XEO01946 GENEFORM Protein DME1788 XEOTICID XEO01946 MOACRIVE Inhibition DME1788 XEOTICID XEO01947 XEO_NAME Dihydroeugenol DME1788 XEOTICID XEO01947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO01947 XEO_CLAS Natural Product DME1788 XEOTICID XEO01947 DESCRIPT Dihydroeugenol inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01947 GENEFORM Protein DME1788 XEOTICID XEO01947 MOACRIVE Inhibition DME1788 XEOTICID XEO01950 XEO_NAME 2-Methoxyhydroquinone DME1788 XEOTICID XEO01950 XEO_TYPE Health or Environmental Toxicant(s) DME1788 XEOTICID XEO01950 XEO_CLAS Environmental Pollutant DME1788 XEOTICID XEO01950 DESCRIPT 2-Methoxyhydroquinone inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01950 GENEFORM Protein DME1788 XEOTICID XEO01950 MOACRIVE Inhibition DME1788 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1788 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1788 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME1788 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01961 GENEFORM Protein DME1788 XEOTICID XEO01961 MOACRIVE Inhibition DME1788 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME1788 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1788 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME1788 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO01966 GENEFORM Protein DME1788 XEOTICID XEO01966 MOACRIVE Inhibition DME1788 XEOTICID XEO01996 XEO_NAME Peptide 3IQ1 DME1788 XEOTICID XEO01996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01996 XEO_CLAS Peptide DME1788 XEOTICID XEO01996 DESCRIPT Peptide 3IQ1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.7 microM) DME1788 XEOTICID XEO01996 GENEFORM Protein DME1788 XEOTICID XEO01996 MOACRIVE Inhibition DME1788 XEOTICID XEO01997 XEO_NAME Peptide 3IQ2 DME1788 XEOTICID XEO01997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01997 XEO_CLAS Peptide DME1788 XEOTICID XEO01997 DESCRIPT Peptide 3IQ2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.9 microM) DME1788 XEOTICID XEO01997 GENEFORM Protein DME1788 XEOTICID XEO01997 MOACRIVE Inhibition DME1788 XEOTICID XEO01998 XEO_NAME Peptide 3IQ3 DME1788 XEOTICID XEO01998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01998 XEO_CLAS Peptide DME1788 XEOTICID XEO01998 DESCRIPT Peptide 3IQ3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO01998 GENEFORM Protein DME1788 XEOTICID XEO01998 MOACRIVE Inhibition DME1788 XEOTICID XEO01999 XEO_NAME Peptide 3IQ4 DME1788 XEOTICID XEO01999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO01999 XEO_CLAS Peptide DME1788 XEOTICID XEO01999 DESCRIPT Peptide 3IQ4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.5 microM) DME1788 XEOTICID XEO01999 GENEFORM Protein DME1788 XEOTICID XEO01999 MOACRIVE Inhibition DME1788 XEOTICID XEO02013 XEO_NAME 40S ribosomal protein S30 DME1788 XEOTICID XEO02013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02013 XEO_CLAS Peptide DME1788 XEOTICID XEO02013 DESCRIPT 40S ribosomal protein S30 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02013 GENEFORM Protein DME1788 XEOTICID XEO02013 MOACRIVE Inhibition DME1788 XEOTICID XEO02032 XEO_NAME 4-Ethylcatechol DME1788 XEOTICID XEO02032 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02032 XEO_CLAS Natural Product DME1788 XEOTICID XEO02032 DESCRIPT 4-Ethylcatechol inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02032 GENEFORM Protein DME1788 XEOTICID XEO02032 MOACRIVE Inhibition DME1788 XEOTICID XEO02033 XEO_NAME 4-Ethylguaiacol DME1788 XEOTICID XEO02033 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02033 XEO_CLAS Natural Product DME1788 XEOTICID XEO02033 DESCRIPT 4-Ethylguaiacol inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02033 GENEFORM Protein DME1788 XEOTICID XEO02033 MOACRIVE Inhibition DME1788 XEOTICID XEO02079 XEO_NAME 6-Aminoflavone DME1788 XEOTICID XEO02079 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02079 XEO_CLAS Natural Product DME1788 XEOTICID XEO02079 DESCRIPT 6-Aminoflavone inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02079 GENEFORM Protein DME1788 XEOTICID XEO02079 MOACRIVE Inhibition DME1788 XEOTICID XEO02085 XEO_NAME 6-hydroxyflavone DME1788 XEOTICID XEO02085 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO02085 XEO_CLAS Investigative Agent DME1788 XEOTICID XEO02085 DESCRIPT 6-hydroxyflavone inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02085 GENEFORM Protein DME1788 XEOTICID XEO02085 MOACRIVE Inhibition DME1788 XEOTICID XEO02111 XEO_NAME AAEL000598-PA DME1788 XEOTICID XEO02111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02111 XEO_CLAS Peptide DME1788 XEOTICID XEO02111 DESCRIPT AAEL000598-PA inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2-4 ug/ml) DME1788 XEOTICID XEO02111 GENEFORM Protein DME1788 XEOTICID XEO02111 MOACRIVE Inhibition DME1788 XEOTICID XEO02113 XEO_NAME Abaecin DME1788 XEOTICID XEO02113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02113 XEO_CLAS Peptide DME1788 XEOTICID XEO02113 DESCRIPT Abaecin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02113 GENEFORM Protein DME1788 XEOTICID XEO02113 MOACRIVE Inhibition DME1788 XEOTICID XEO02114 XEO_NAME Pro-rich abaecin DME1788 XEOTICID XEO02114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02114 XEO_CLAS Peptide DME1788 XEOTICID XEO02114 DESCRIPT Pro-rich abaecin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-25 ug/ml) DME1788 XEOTICID XEO02114 GENEFORM Protein DME1788 XEOTICID XEO02114 MOACRIVE Inhibition DME1788 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1788 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02115 XEO_CLAS Peptide DME1788 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02115 GENEFORM Protein DME1788 XEOTICID XEO02115 MOACRIVE Inhibition DME1788 XEOTICID XEO02117 XEO_NAME Acaloleptin-A1 DME1788 XEOTICID XEO02117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02117 XEO_CLAS Peptide DME1788 XEOTICID XEO02117 DESCRIPT Acaloleptin-A1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02117 GENEFORM Protein DME1788 XEOTICID XEO02117 MOACRIVE Inhibition DME1788 XEOTICID XEO02118 XEO_NAME Acaloleptin-A2 DME1788 XEOTICID XEO02118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02118 XEO_CLAS Peptide DME1788 XEOTICID XEO02118 DESCRIPT Acaloleptin-A2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02118 GENEFORM Protein DME1788 XEOTICID XEO02118 MOACRIVE Inhibition DME1788 XEOTICID XEO02119 XEO_NAME Acaloleptin-A3 DME1788 XEOTICID XEO02119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02119 XEO_CLAS Peptide DME1788 XEOTICID XEO02119 DESCRIPT Acaloleptin-A3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02119 GENEFORM Protein DME1788 XEOTICID XEO02119 MOACRIVE Inhibition DME1788 XEOTICID XEO02120 XEO_NAME Acaloleptin-A4 DME1788 XEOTICID XEO02120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02120 XEO_CLAS Peptide DME1788 XEOTICID XEO02120 DESCRIPT Acaloleptin-A4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02120 GENEFORM Protein DME1788 XEOTICID XEO02120 MOACRIVE Inhibition DME1788 XEOTICID XEO02121 XEO_NAME Acaloleptin-A5 DME1788 XEOTICID XEO02121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02121 XEO_CLAS Peptide DME1788 XEOTICID XEO02121 DESCRIPT Acaloleptin-A5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02121 GENEFORM Protein DME1788 XEOTICID XEO02121 MOACRIVE Inhibition DME1788 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1788 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02122 XEO_CLAS Peptide DME1788 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 ug/ml) DME1788 XEOTICID XEO02122 GENEFORM Protein DME1788 XEOTICID XEO02122 MOACRIVE Inhibition DME1788 XEOTICID XEO02130 XEO_NAME Acipensin Ac1 DME1788 XEOTICID XEO02130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02130 XEO_CLAS Peptide DME1788 XEOTICID XEO02130 DESCRIPT Acipensin Ac1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.7 microM) DME1788 XEOTICID XEO02130 GENEFORM Protein DME1788 XEOTICID XEO02130 MOACRIVE Inhibition DME1788 XEOTICID XEO02131 XEO_NAME Acipensin Ac2 DME1788 XEOTICID XEO02131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02131 XEO_CLAS Peptide DME1788 XEOTICID XEO02131 DESCRIPT Acipensin Ac2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.3 microM) DME1788 XEOTICID XEO02131 GENEFORM Protein DME1788 XEOTICID XEO02131 MOACRIVE Inhibition DME1788 XEOTICID XEO02132 XEO_NAME Acipensin Ac6 DME1788 XEOTICID XEO02132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02132 XEO_CLAS Peptide DME1788 XEOTICID XEO02132 DESCRIPT Acipensin Ac6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.5 microM) DME1788 XEOTICID XEO02132 GENEFORM Protein DME1788 XEOTICID XEO02132 MOACRIVE Inhibition DME1788 XEOTICID XEO02136 XEO_NAME Adenoregulin DME1788 XEOTICID XEO02136 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02136 XEO_CLAS Peptide DME1788 XEOTICID XEO02136 DESCRIPT Adenoregulin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 ug/ml) DME1788 XEOTICID XEO02136 GENEFORM Protein DME1788 XEOTICID XEO02136 MOACRIVE Inhibition DME1788 XEOTICID XEO02147 XEO_NAME Agelaia-mastoparan DME1788 XEOTICID XEO02147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02147 XEO_CLAS Peptide DME1788 XEOTICID XEO02147 DESCRIPT Agelaia-mastoparan inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 382 ug/ml) DME1788 XEOTICID XEO02147 GENEFORM Protein DME1788 XEOTICID XEO02147 MOACRIVE Inhibition DME1788 XEOTICID XEO02149 XEO_NAME AI-hemocidins 1 DME1788 XEOTICID XEO02149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02149 XEO_CLAS Peptide DME1788 XEOTICID XEO02149 DESCRIPT AI-hemocidins 1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 47.35 microM) DME1788 XEOTICID XEO02149 GENEFORM Protein DME1788 XEOTICID XEO02149 MOACRIVE Inhibition DME1788 XEOTICID XEO02164 XEO_NAME Alpha-defensin cryptdin-1 DME1788 XEOTICID XEO02164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02164 XEO_CLAS Peptide DME1788 XEOTICID XEO02164 DESCRIPT Alpha-defensin cryptdin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02164 GENEFORM Protein DME1788 XEOTICID XEO02164 MOACRIVE Inhibition DME1788 XEOTICID XEO02165 XEO_NAME Alpha-defensin cryptdin-2 DME1788 XEOTICID XEO02165 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02165 XEO_CLAS Peptide DME1788 XEOTICID XEO02165 DESCRIPT Alpha-defensin cryptdin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02165 GENEFORM Protein DME1788 XEOTICID XEO02165 MOACRIVE Inhibition DME1788 XEOTICID XEO02166 XEO_NAME Alpha-defensin cryptdin-3 DME1788 XEOTICID XEO02166 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02166 XEO_CLAS Peptide DME1788 XEOTICID XEO02166 DESCRIPT Alpha-defensin cryptdin-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02166 GENEFORM Protein DME1788 XEOTICID XEO02166 MOACRIVE Inhibition DME1788 XEOTICID XEO02167 XEO_NAME Alpha-defensin cryptdin-4 DME1788 XEOTICID XEO02167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02167 XEO_CLAS Peptide DME1788 XEOTICID XEO02167 DESCRIPT Alpha-defensin cryptdin-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02167 GENEFORM Protein DME1788 XEOTICID XEO02167 MOACRIVE Inhibition DME1788 XEOTICID XEO02168 XEO_NAME Alpha-defensin cryptdin-5 DME1788 XEOTICID XEO02168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02168 XEO_CLAS Peptide DME1788 XEOTICID XEO02168 DESCRIPT Alpha-defensin cryptdin-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02168 GENEFORM Protein DME1788 XEOTICID XEO02168 MOACRIVE Inhibition DME1788 XEOTICID XEO02169 XEO_NAME Alpha-defensin cryptdin-6/12 DME1788 XEOTICID XEO02169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02169 XEO_CLAS Peptide DME1788 XEOTICID XEO02169 DESCRIPT Alpha-defensin cryptdin-6/12 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02169 GENEFORM Protein DME1788 XEOTICID XEO02169 MOACRIVE Inhibition DME1788 XEOTICID XEO02170 XEO_NAME Alpha-defensin PhD-4 DME1788 XEOTICID XEO02170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02170 XEO_CLAS Peptide DME1788 XEOTICID XEO02170 DESCRIPT Alpha-defensin PhD-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.4 microM) DME1788 XEOTICID XEO02170 GENEFORM Protein DME1788 XEOTICID XEO02170 MOACRIVE Inhibition DME1788 XEOTICID XEO02175 XEO_NAME alpha-Pinene DME1788 XEOTICID XEO02175 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02175 XEO_CLAS Natural Product DME1788 XEOTICID XEO02175 DESCRIPT alpha-Pinene inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02175 GENEFORM Protein DME1788 XEOTICID XEO02175 MOACRIVE Inhibition DME1788 XEOTICID XEO02177 XEO_NAME Alyteserin-1a DME1788 XEOTICID XEO02177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02177 XEO_CLAS Peptide DME1788 XEOTICID XEO02177 DESCRIPT Alyteserin-1a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO02177 GENEFORM Protein DME1788 XEOTICID XEO02177 MOACRIVE Inhibition DME1788 XEOTICID XEO02178 XEO_NAME Alyteserin-1b DME1788 XEOTICID XEO02178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02178 XEO_CLAS Peptide DME1788 XEOTICID XEO02178 DESCRIPT Alyteserin-1b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO02178 GENEFORM Protein DME1788 XEOTICID XEO02178 MOACRIVE Inhibition DME1788 XEOTICID XEO02179 XEO_NAME Alyteserin-1c DME1788 XEOTICID XEO02179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02179 XEO_CLAS Peptide DME1788 XEOTICID XEO02179 DESCRIPT Alyteserin-1c inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO02179 GENEFORM Protein DME1788 XEOTICID XEO02179 MOACRIVE Inhibition DME1788 XEOTICID XEO02180 XEO_NAME Alyteserin-1Ma DME1788 XEOTICID XEO02180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02180 XEO_CLAS Peptide DME1788 XEOTICID XEO02180 DESCRIPT Alyteserin-1Ma inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 214 microM) DME1788 XEOTICID XEO02180 GENEFORM Protein DME1788 XEOTICID XEO02180 MOACRIVE Inhibition DME1788 XEOTICID XEO02181 XEO_NAME Alyteserin-1Mb DME1788 XEOTICID XEO02181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02181 XEO_CLAS Peptide DME1788 XEOTICID XEO02181 DESCRIPT Alyteserin-1Mb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 217 microM) DME1788 XEOTICID XEO02181 GENEFORM Protein DME1788 XEOTICID XEO02181 MOACRIVE Inhibition DME1788 XEOTICID XEO02183 XEO_NAME Alyteserin-2Ma DME1788 XEOTICID XEO02183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02183 XEO_CLAS Peptide DME1788 XEOTICID XEO02183 DESCRIPT Alyteserin-2Ma inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 38.4 microM) DME1788 XEOTICID XEO02183 GENEFORM Protein DME1788 XEOTICID XEO02183 MOACRIVE Inhibition DME1788 XEOTICID XEO02185 XEO_NAME Amblyomma defensin ADP-2 DME1788 XEOTICID XEO02185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02185 XEO_CLAS Peptide DME1788 XEOTICID XEO02185 DESCRIPT Amblyomma defensin ADP-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 microM) DME1788 XEOTICID XEO02185 GENEFORM Protein DME1788 XEOTICID XEO02185 MOACRIVE Inhibition DME1788 XEOTICID XEO02187 XEO_NAME Amikacin sulfate DME1788 XEOTICID XEO02187 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO02187 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO02187 DESCRIPT Amikacin sulfate inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02187 GENEFORM Protein DME1788 XEOTICID XEO02187 MOACRIVE Inhibition DME1788 XEOTICID XEO02191 XEO_NAME Amolopin-1a DME1788 XEOTICID XEO02191 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02191 XEO_CLAS Peptide DME1788 XEOTICID XEO02191 DESCRIPT Amolopin-1a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02191 GENEFORM Protein DME1788 XEOTICID XEO02191 MOACRIVE Inhibition DME1788 XEOTICID XEO02192 XEO_NAME Amolopin-1b DME1788 XEOTICID XEO02192 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02192 XEO_CLAS Peptide DME1788 XEOTICID XEO02192 DESCRIPT Amolopin-1b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.50 ug/ml) DME1788 XEOTICID XEO02192 GENEFORM Protein DME1788 XEOTICID XEO02192 MOACRIVE Inhibition DME1788 XEOTICID XEO02193 XEO_NAME Amolopin-1c DME1788 XEOTICID XEO02193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02193 XEO_CLAS Peptide DME1788 XEOTICID XEO02193 DESCRIPT Amolopin-1c inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02193 GENEFORM Protein DME1788 XEOTICID XEO02193 MOACRIVE Inhibition DME1788 XEOTICID XEO02194 XEO_NAME Amolopin-1d DME1788 XEOTICID XEO02194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02194 XEO_CLAS Peptide DME1788 XEOTICID XEO02194 DESCRIPT Amolopin-1d inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02194 GENEFORM Protein DME1788 XEOTICID XEO02194 MOACRIVE Inhibition DME1788 XEOTICID XEO02195 XEO_NAME Amolopin-2a DME1788 XEOTICID XEO02195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02195 XEO_CLAS Peptide DME1788 XEOTICID XEO02195 DESCRIPT Amolopin-2a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.00 ug/ml) DME1788 XEOTICID XEO02195 GENEFORM Protein DME1788 XEOTICID XEO02195 MOACRIVE Inhibition DME1788 XEOTICID XEO02197 XEO_NAME Amolopin-2c DME1788 XEOTICID XEO02197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02197 XEO_CLAS Peptide DME1788 XEOTICID XEO02197 DESCRIPT Amolopin-2c inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02197 GENEFORM Protein DME1788 XEOTICID XEO02197 MOACRIVE Inhibition DME1788 XEOTICID XEO02200 XEO_NAME Amphipathic peptide StCT1 DME1788 XEOTICID XEO02200 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02200 XEO_CLAS Peptide DME1788 XEOTICID XEO02200 DESCRIPT Amphipathic peptide StCT1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 ug/ml) DME1788 XEOTICID XEO02200 GENEFORM Protein DME1788 XEOTICID XEO02200 MOACRIVE Inhibition DME1788 XEOTICID XEO02201 XEO_NAME Amphipathic peptide StCT2 DME1788 XEOTICID XEO02201 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02201 XEO_CLAS Peptide DME1788 XEOTICID XEO02201 DESCRIPT Amphipathic peptide StCT2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 ug/ml) DME1788 XEOTICID XEO02201 GENEFORM Protein DME1788 XEOTICID XEO02201 MOACRIVE Inhibition DME1788 XEOTICID XEO02202 XEO_NAME Amphiphatic peptide VmCT1 DME1788 XEOTICID XEO02202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02202 XEO_CLAS Peptide DME1788 XEOTICID XEO02202 DESCRIPT Amphiphatic peptide VmCT1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO02202 GENEFORM Protein DME1788 XEOTICID XEO02202 MOACRIVE Inhibition DME1788 XEOTICID XEO02203 XEO_NAME Amphiphatic peptide VmCT2 DME1788 XEOTICID XEO02203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02203 XEO_CLAS Peptide DME1788 XEOTICID XEO02203 DESCRIPT Amphiphatic peptide VmCT2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 microM) DME1788 XEOTICID XEO02203 GENEFORM Protein DME1788 XEOTICID XEO02203 MOACRIVE Inhibition DME1788 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1788 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02207 XEO_CLAS Peptide DME1788 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.78 ug/ml) DME1788 XEOTICID XEO02207 GENEFORM Protein DME1788 XEOTICID XEO02207 MOACRIVE Inhibition DME1788 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1788 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02208 XEO_CLAS Peptide DME1788 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.13 ug/ml) DME1788 XEOTICID XEO02208 GENEFORM Protein DME1788 XEOTICID XEO02208 MOACRIVE Inhibition DME1788 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1788 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02209 XEO_CLAS Peptide DME1788 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.56 ug/ml) DME1788 XEOTICID XEO02209 GENEFORM Protein DME1788 XEOTICID XEO02209 MOACRIVE Inhibition DME1788 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1788 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02210 XEO_CLAS Peptide DME1788 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 ug/ml) DME1788 XEOTICID XEO02210 GENEFORM Protein DME1788 XEOTICID XEO02210 MOACRIVE Inhibition DME1788 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1788 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02211 XEO_CLAS Peptide DME1788 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25 ug/ml) DME1788 XEOTICID XEO02211 GENEFORM Protein DME1788 XEOTICID XEO02211 MOACRIVE Inhibition DME1788 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1788 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02212 XEO_CLAS Peptide DME1788 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.13 ug/ml) DME1788 XEOTICID XEO02212 GENEFORM Protein DME1788 XEOTICID XEO02212 MOACRIVE Inhibition DME1788 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1788 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02213 XEO_CLAS Peptide DME1788 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.13 ug/ml) DME1788 XEOTICID XEO02213 GENEFORM Protein DME1788 XEOTICID XEO02213 MOACRIVE Inhibition DME1788 XEOTICID XEO02214 XEO_NAME Beta-defensin AplAvBD2 DME1788 XEOTICID XEO02214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02214 XEO_CLAS Peptide DME1788 XEOTICID XEO02214 DESCRIPT Beta-defensin AplAvBD2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02214 GENEFORM Protein DME1788 XEOTICID XEO02214 MOACRIVE Inhibition DME1788 XEOTICID XEO02215 XEO_NAME Andersonin-C1 DME1788 XEOTICID XEO02215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02215 XEO_CLAS Peptide DME1788 XEOTICID XEO02215 DESCRIPT Andersonin-C1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 ug/ml) DME1788 XEOTICID XEO02215 GENEFORM Protein DME1788 XEOTICID XEO02215 MOACRIVE Inhibition DME1788 XEOTICID XEO02216 XEO_NAME Andersonin-D1 DME1788 XEOTICID XEO02216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02216 XEO_CLAS Peptide DME1788 XEOTICID XEO02216 DESCRIPT Andersonin-D1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 126 ug/ml) DME1788 XEOTICID XEO02216 GENEFORM Protein DME1788 XEOTICID XEO02216 MOACRIVE Inhibition DME1788 XEOTICID XEO02217 XEO_NAME Andersonin-G1 DME1788 XEOTICID XEO02217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02217 XEO_CLAS Peptide DME1788 XEOTICID XEO02217 DESCRIPT Andersonin-G1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 200 ug/ml) DME1788 XEOTICID XEO02217 GENEFORM Protein DME1788 XEOTICID XEO02217 MOACRIVE Inhibition DME1788 XEOTICID XEO02218 XEO_NAME Andersonin-N1 DME1788 XEOTICID XEO02218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02218 XEO_CLAS Peptide DME1788 XEOTICID XEO02218 DESCRIPT Andersonin-N1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 200 ug/ml) DME1788 XEOTICID XEO02218 GENEFORM Protein DME1788 XEOTICID XEO02218 MOACRIVE Inhibition DME1788 XEOTICID XEO02219 XEO_NAME Andersonin-Q1 DME1788 XEOTICID XEO02219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02219 XEO_CLAS Peptide DME1788 XEOTICID XEO02219 DESCRIPT Andersonin-Q1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 200 ug/ml) DME1788 XEOTICID XEO02219 GENEFORM Protein DME1788 XEOTICID XEO02219 MOACRIVE Inhibition DME1788 XEOTICID XEO02220 XEO_NAME Andersonin-W1 DME1788 XEOTICID XEO02220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02220 XEO_CLAS Peptide DME1788 XEOTICID XEO02220 DESCRIPT Andersonin-W1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 23.5 ug/ml) DME1788 XEOTICID XEO02220 GENEFORM Protein DME1788 XEOTICID XEO02220 MOACRIVE Inhibition DME1788 XEOTICID XEO02221 XEO_NAME Andersonin-W2 DME1788 XEOTICID XEO02221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02221 XEO_CLAS Peptide DME1788 XEOTICID XEO02221 DESCRIPT Andersonin-W2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20.2 ug/ml) DME1788 XEOTICID XEO02221 GENEFORM Protein DME1788 XEOTICID XEO02221 MOACRIVE Inhibition DME1788 XEOTICID XEO02222 XEO_NAME Andersonin-X1 DME1788 XEOTICID XEO02222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02222 XEO_CLAS Peptide DME1788 XEOTICID XEO02222 DESCRIPT Andersonin-X1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30.5 ug/ml) DME1788 XEOTICID XEO02222 GENEFORM Protein DME1788 XEOTICID XEO02222 MOACRIVE Inhibition DME1788 XEOTICID XEO02223 XEO_NAME Andersonin-Y1 DME1788 XEOTICID XEO02223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02223 XEO_CLAS Peptide DME1788 XEOTICID XEO02223 DESCRIPT Andersonin-Y1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.2 ug/ml) DME1788 XEOTICID XEO02223 GENEFORM Protein DME1788 XEOTICID XEO02223 MOACRIVE Inhibition DME1788 XEOTICID XEO02224 XEO_NAME Androctonin DME1788 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02224 XEO_CLAS Peptide DME1788 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02224 GENEFORM Protein DME1788 XEOTICID XEO02224 MOACRIVE Inhibition DME1788 XEOTICID XEO02225 XEO_NAME Androctonus defensin DME1788 XEOTICID XEO02225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02225 XEO_CLAS Peptide DME1788 XEOTICID XEO02225 DESCRIPT Androctonus defensin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02225 GENEFORM Protein DME1788 XEOTICID XEO02225 MOACRIVE Inhibition DME1788 XEOTICID XEO02226 XEO_NAME Andropin DME1788 XEOTICID XEO02226 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02226 XEO_CLAS Peptide DME1788 XEOTICID XEO02226 DESCRIPT Andropin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 140 microM) DME1788 XEOTICID XEO02226 GENEFORM Protein DME1788 XEOTICID XEO02226 MOACRIVE Inhibition DME1788 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1788 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02230 XEO_CLAS Peptide DME1788 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.05-0.1 microM) DME1788 XEOTICID XEO02230 GENEFORM Protein DME1788 XEOTICID XEO02230 MOACRIVE Inhibition DME1788 XEOTICID XEO02232 XEO_NAME Anoplin DME1788 XEOTICID XEO02232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02232 XEO_CLAS Peptide DME1788 XEOTICID XEO02232 DESCRIPT Anoplin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 13 ug/ml) DME1788 XEOTICID XEO02232 GENEFORM Protein DME1788 XEOTICID XEO02232 MOACRIVE Inhibition DME1788 XEOTICID XEO02233 XEO_NAME Antapin DME1788 XEOTICID XEO02233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02233 XEO_CLAS Peptide DME1788 XEOTICID XEO02233 DESCRIPT Antapin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02233 GENEFORM Protein DME1788 XEOTICID XEO02233 MOACRIVE Inhibition DME1788 XEOTICID XEO02236 XEO_NAME Antibacterial 6.5 kDa protein DME1788 XEOTICID XEO02236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02236 XEO_CLAS Peptide DME1788 XEOTICID XEO02236 DESCRIPT Antibacterial 6.5 kDa protein inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02236 GENEFORM Protein DME1788 XEOTICID XEO02236 MOACRIVE Inhibition DME1788 XEOTICID XEO02239 XEO_NAME Antibacterial peptide A2 DME1788 XEOTICID XEO02239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02239 XEO_CLAS Peptide DME1788 XEOTICID XEO02239 DESCRIPT Antibacterial peptide A2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 250 microM) DME1788 XEOTICID XEO02239 GENEFORM Protein DME1788 XEOTICID XEO02239 MOACRIVE Inhibition DME1788 XEOTICID XEO02240 XEO_NAME Antibacterial peptide A4 DME1788 XEOTICID XEO02240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02240 XEO_CLAS Peptide DME1788 XEOTICID XEO02240 DESCRIPT Antibacterial peptide A4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 microM) DME1788 XEOTICID XEO02240 GENEFORM Protein DME1788 XEOTICID XEO02240 MOACRIVE Inhibition DME1788 XEOTICID XEO02241 XEO_NAME Antibacterial peptide enbocin DME1788 XEOTICID XEO02241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02241 XEO_CLAS Peptide DME1788 XEOTICID XEO02241 DESCRIPT Antibacterial peptide enbocin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02241 GENEFORM Protein DME1788 XEOTICID XEO02241 MOACRIVE Inhibition DME1788 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1788 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02242 XEO_CLAS Peptide DME1788 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO02242 GENEFORM Protein DME1788 XEOTICID XEO02242 MOACRIVE Inhibition DME1788 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1788 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02243 XEO_CLAS Peptide DME1788 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 microM) DME1788 XEOTICID XEO02243 GENEFORM Protein DME1788 XEOTICID XEO02243 MOACRIVE Inhibition DME1788 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1788 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02244 XEO_CLAS Peptide DME1788 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1 microM) DME1788 XEOTICID XEO02244 GENEFORM Protein DME1788 XEOTICID XEO02244 MOACRIVE Inhibition DME1788 XEOTICID XEO02245 XEO_NAME Antibacterial peptide/melittin homolog DME1788 XEOTICID XEO02245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02245 XEO_CLAS Peptide DME1788 XEOTICID XEO02245 DESCRIPT Antibacterial peptide/melittin homolog inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02245 GENEFORM Protein DME1788 XEOTICID XEO02245 MOACRIVE Inhibition DME1788 XEOTICID XEO02246 XEO_NAME Antibacterial protein LL-37 hCAP-18 DME1788 XEOTICID XEO02246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02246 XEO_CLAS Peptide DME1788 XEOTICID XEO02246 DESCRIPT Antibacterial protein LL-37 hCAP-18 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 microM) DME1788 XEOTICID XEO02246 GENEFORM Protein DME1788 XEOTICID XEO02246 MOACRIVE Inhibition DME1788 XEOTICID XEO02247 XEO_NAME Antibacterial protein LL-37 DME1788 XEOTICID XEO02247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02247 XEO_CLAS Peptide DME1788 XEOTICID XEO02247 DESCRIPT Antibacterial protein LL-37 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02247 GENEFORM Protein DME1788 XEOTICID XEO02247 MOACRIVE Inhibition DME1788 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1788 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02248 XEO_CLAS Peptide DME1788 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.3 microM) DME1788 XEOTICID XEO02248 GENEFORM Protein DME1788 XEOTICID XEO02248 MOACRIVE Inhibition DME1788 XEOTICID XEO02253 XEO_NAME Antifungal protein ginkbilobin-1 DME1788 XEOTICID XEO02253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02253 XEO_CLAS Peptide DME1788 XEOTICID XEO02253 DESCRIPT Antifungal protein ginkbilobin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02253 GENEFORM Protein DME1788 XEOTICID XEO02253 MOACRIVE Inhibition DME1788 XEOTICID XEO02258 XEO_NAME Antimicrobial peptide AamAP1 DME1788 XEOTICID XEO02258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02258 XEO_CLAS Peptide DME1788 XEOTICID XEO02258 DESCRIPT Antimicrobial peptide AamAP1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 150 microM) DME1788 XEOTICID XEO02258 GENEFORM Protein DME1788 XEOTICID XEO02258 MOACRIVE Inhibition DME1788 XEOTICID XEO02261 XEO_NAME Antimicrobial peptide Cn-AMP1 DME1788 XEOTICID XEO02261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02261 XEO_CLAS Peptide DME1788 XEOTICID XEO02261 DESCRIPT Antimicrobial peptide Cn-AMP1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 82 ug/ml) DME1788 XEOTICID XEO02261 GENEFORM Protein DME1788 XEOTICID XEO02261 MOACRIVE Inhibition DME1788 XEOTICID XEO02263 XEO_NAME Antimicrobial peptide XT-1 DME1788 XEOTICID XEO02263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02263 XEO_CLAS Peptide DME1788 XEOTICID XEO02263 DESCRIPT Antimicrobial peptide XT-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO02263 GENEFORM Protein DME1788 XEOTICID XEO02263 MOACRIVE Inhibition DME1788 XEOTICID XEO02266 XEO_NAME Antimicrobial peptide AamAP2 DME1788 XEOTICID XEO02266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02266 XEO_CLAS Peptide DME1788 XEOTICID XEO02266 DESCRIPT Antimicrobial peptide AamAP2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 120 microM) DME1788 XEOTICID XEO02266 GENEFORM Protein DME1788 XEOTICID XEO02266 MOACRIVE Inhibition DME1788 XEOTICID XEO02268 XEO_NAME Antimicrobial peptide Cn-AMP2 DME1788 XEOTICID XEO02268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02268 XEO_CLAS Peptide DME1788 XEOTICID XEO02268 DESCRIPT Antimicrobial peptide Cn-AMP2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 170 ug/ml) DME1788 XEOTICID XEO02268 GENEFORM Protein DME1788 XEOTICID XEO02268 MOACRIVE Inhibition DME1788 XEOTICID XEO02270 XEO_NAME Antimicrobial peptide XT-2 DME1788 XEOTICID XEO02270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02270 XEO_CLAS Peptide DME1788 XEOTICID XEO02270 DESCRIPT Antimicrobial peptide XT-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 microM) DME1788 XEOTICID XEO02270 GENEFORM Protein DME1788 XEOTICID XEO02270 MOACRIVE Inhibition DME1788 XEOTICID XEO02271 XEO_NAME Antimicrobial peptide Cn-AMP3 DME1788 XEOTICID XEO02271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02271 XEO_CLAS Peptide DME1788 XEOTICID XEO02271 DESCRIPT Antimicrobial peptide Cn-AMP3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 302 ug/ml) DME1788 XEOTICID XEO02271 GENEFORM Protein DME1788 XEOTICID XEO02271 MOACRIVE Inhibition DME1788 XEOTICID XEO02273 XEO_NAME Antimicrobial peptide XT-4 DME1788 XEOTICID XEO02273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02273 XEO_CLAS Peptide DME1788 XEOTICID XEO02273 DESCRIPT Antimicrobial peptide XT-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 18 microM) DME1788 XEOTICID XEO02273 GENEFORM Protein DME1788 XEOTICID XEO02273 MOACRIVE Inhibition DME1788 XEOTICID XEO02274 XEO_NAME Antimicrobial peptide XT-5 DME1788 XEOTICID XEO02274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02274 XEO_CLAS Peptide DME1788 XEOTICID XEO02274 DESCRIPT Antimicrobial peptide XT-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO02274 GENEFORM Protein DME1788 XEOTICID XEO02274 MOACRIVE Inhibition DME1788 XEOTICID XEO02275 XEO_NAME Antimicrobial peptide XT-6 DME1788 XEOTICID XEO02275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02275 XEO_CLAS Peptide DME1788 XEOTICID XEO02275 DESCRIPT Antimicrobial peptide XT-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 microM) DME1788 XEOTICID XEO02275 GENEFORM Protein DME1788 XEOTICID XEO02275 MOACRIVE Inhibition DME1788 XEOTICID XEO02276 XEO_NAME Antimicrobial peptide XT-7 DME1788 XEOTICID XEO02276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02276 XEO_CLAS Peptide DME1788 XEOTICID XEO02276 DESCRIPT Antimicrobial peptide XT-7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 microM) DME1788 XEOTICID XEO02276 GENEFORM Protein DME1788 XEOTICID XEO02276 MOACRIVE Inhibition DME1788 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1788 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02280 XEO_CLAS Peptide DME1788 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02280 GENEFORM Protein DME1788 XEOTICID XEO02280 MOACRIVE Inhibition DME1788 XEOTICID XEO02281 XEO_NAME Antimicrobial peptide eNAP-2 DME1788 XEOTICID XEO02281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02281 XEO_CLAS Peptide DME1788 XEOTICID XEO02281 DESCRIPT Antimicrobial peptide eNAP-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02281 GENEFORM Protein DME1788 XEOTICID XEO02281 MOACRIVE Inhibition DME1788 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1788 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02283 XEO_CLAS Peptide DME1788 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 ug/ml) DME1788 XEOTICID XEO02283 GENEFORM Protein DME1788 XEOTICID XEO02283 MOACRIVE Inhibition DME1788 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1788 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02284 XEO_CLAS Peptide DME1788 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50.4 microM) DME1788 XEOTICID XEO02284 GENEFORM Protein DME1788 XEOTICID XEO02284 MOACRIVE Inhibition DME1788 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1788 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02285 XEO_CLAS Peptide DME1788 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50.4 microM) DME1788 XEOTICID XEO02285 GENEFORM Protein DME1788 XEOTICID XEO02285 MOACRIVE Inhibition DME1788 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1788 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02286 XEO_CLAS Peptide DME1788 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50.4 microM) DME1788 XEOTICID XEO02286 GENEFORM Protein DME1788 XEOTICID XEO02286 MOACRIVE Inhibition DME1788 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1788 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02287 XEO_CLAS Peptide DME1788 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50.4 microM) DME1788 XEOTICID XEO02287 GENEFORM Protein DME1788 XEOTICID XEO02287 MOACRIVE Inhibition DME1788 XEOTICID XEO02288 XEO_NAME Antimicrobial peptide ISAMP DME1788 XEOTICID XEO02288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02288 XEO_CLAS Peptide DME1788 XEOTICID XEO02288 DESCRIPT Antimicrobial peptide ISAMP inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.2 ug/ml) DME1788 XEOTICID XEO02288 GENEFORM Protein DME1788 XEOTICID XEO02288 MOACRIVE Inhibition DME1788 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1788 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02289 XEO_CLAS Peptide DME1788 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 ug/ml) DME1788 XEOTICID XEO02289 GENEFORM Protein DME1788 XEOTICID XEO02289 MOACRIVE Inhibition DME1788 XEOTICID XEO02290 XEO_NAME Lumbricin-PG DME1788 XEOTICID XEO02290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02290 XEO_CLAS Peptide DME1788 XEOTICID XEO02290 DESCRIPT Lumbricin-PG inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO02290 GENEFORM Protein DME1788 XEOTICID XEO02290 MOACRIVE Inhibition DME1788 XEOTICID XEO02291 XEO_NAME Antimicrobial peptide MBP-1 DME1788 XEOTICID XEO02291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02291 XEO_CLAS Peptide DME1788 XEOTICID XEO02291 DESCRIPT Antimicrobial peptide MBP-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02291 GENEFORM Protein DME1788 XEOTICID XEO02291 MOACRIVE Inhibition DME1788 XEOTICID XEO02293 XEO_NAME Antimicrobial peptide NK-lysin DME1788 XEOTICID XEO02293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02293 XEO_CLAS Peptide DME1788 XEOTICID XEO02293 DESCRIPT Antimicrobial peptide NK-lysin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 microM) DME1788 XEOTICID XEO02293 GENEFORM Protein DME1788 XEOTICID XEO02293 MOACRIVE Inhibition DME1788 XEOTICID XEO02294 XEO_NAME Antimicrobial peptide PGQ DME1788 XEOTICID XEO02294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02294 XEO_CLAS Peptide DME1788 XEOTICID XEO02294 DESCRIPT Antimicrobial peptide PGQ inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 62-250 ug/ml) DME1788 XEOTICID XEO02294 GENEFORM Protein DME1788 XEOTICID XEO02294 MOACRIVE Inhibition DME1788 XEOTICID XEO02295 XEO_NAME Antimicrobial peptide scolopin-1 DME1788 XEOTICID XEO02295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02295 XEO_CLAS Peptide DME1788 XEOTICID XEO02295 DESCRIPT Antimicrobial peptide scolopin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 ug/ml) DME1788 XEOTICID XEO02295 GENEFORM Protein DME1788 XEOTICID XEO02295 MOACRIVE Inhibition DME1788 XEOTICID XEO02296 XEO_NAME Antimicrobial peptide scolopin-2 DME1788 XEOTICID XEO02296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02296 XEO_CLAS Peptide DME1788 XEOTICID XEO02296 DESCRIPT Antimicrobial peptide scolopin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02296 GENEFORM Protein DME1788 XEOTICID XEO02296 MOACRIVE Inhibition DME1788 XEOTICID XEO02297 XEO_NAME Antimicrobial protein AMP1 DME1788 XEOTICID XEO02297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02297 XEO_CLAS Peptide DME1788 XEOTICID XEO02297 DESCRIPT Antimicrobial protein AMP1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC < 50 ug/ml) DME1788 XEOTICID XEO02297 GENEFORM Protein DME1788 XEOTICID XEO02297 MOACRIVE Inhibition DME1788 XEOTICID XEO02298 XEO_NAME Antimicrobial protein AN5-1 DME1788 XEOTICID XEO02298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02298 XEO_CLAS Peptide DME1788 XEOTICID XEO02298 DESCRIPT Antimicrobial protein AN5-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO02298 GENEFORM Protein DME1788 XEOTICID XEO02298 MOACRIVE Inhibition DME1788 XEOTICID XEO02303 XEO_NAME Insect apidaecin DME1788 XEOTICID XEO02303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02303 XEO_CLAS Peptide DME1788 XEOTICID XEO02303 DESCRIPT Insect apidaecin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02303 GENEFORM Protein DME1788 XEOTICID XEO02303 MOACRIVE Inhibition DME1788 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1788 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02304 XEO_CLAS Peptide DME1788 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.1 ug/ml) DME1788 XEOTICID XEO02304 GENEFORM Protein DME1788 XEOTICID XEO02304 MOACRIVE Inhibition DME1788 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1788 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02305 XEO_CLAS Peptide DME1788 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC <= 1 ug/ml) DME1788 XEOTICID XEO02305 GENEFORM Protein DME1788 XEOTICID XEO02305 MOACRIVE Inhibition DME1788 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1788 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02306 XEO_CLAS Peptide DME1788 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.2 ug/ml) DME1788 XEOTICID XEO02306 GENEFORM Protein DME1788 XEOTICID XEO02306 MOACRIVE Inhibition DME1788 XEOTICID XEO02309 XEO_NAME Apolipoprotein BAMP-1 DME1788 XEOTICID XEO02309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02309 XEO_CLAS Peptide DME1788 XEOTICID XEO02309 DESCRIPT Apolipoprotein BAMP-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02309 GENEFORM Protein DME1788 XEOTICID XEO02309 MOACRIVE Inhibition DME1788 XEOTICID XEO02310 XEO_NAME Apolipoprotein A-II(1-76) DME1788 XEOTICID XEO02310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02310 XEO_CLAS Peptide DME1788 XEOTICID XEO02310 DESCRIPT Apolipoprotein A-II(1-76) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02310 GENEFORM Protein DME1788 XEOTICID XEO02310 MOACRIVE Inhibition DME1788 XEOTICID XEO02315 XEO_NAME Pro-rich arasin-1 DME1788 XEOTICID XEO02315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02315 XEO_CLAS Peptide DME1788 XEOTICID XEO02315 DESCRIPT Pro-rich arasin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO02315 GENEFORM Protein DME1788 XEOTICID XEO02315 MOACRIVE Inhibition DME1788 XEOTICID XEO02316 XEO_NAME Arasin-likeSp DME1788 XEOTICID XEO02316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02316 XEO_CLAS Peptide DME1788 XEOTICID XEO02316 DESCRIPT Arasin-likeSp inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 50 microM) DME1788 XEOTICID XEO02316 GENEFORM Protein DME1788 XEOTICID XEO02316 MOACRIVE Inhibition DME1788 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1788 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02317 XEO_CLAS Peptide DME1788 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 300 microM) DME1788 XEOTICID XEO02317 GENEFORM Protein DME1788 XEOTICID XEO02317 MOACRIVE Inhibition DME1788 XEOTICID XEO02318 XEO_NAME Arenicin-2 DME1788 XEOTICID XEO02318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02318 XEO_CLAS Peptide DME1788 XEOTICID XEO02318 DESCRIPT Arenicin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02318 GENEFORM Protein DME1788 XEOTICID XEO02318 MOACRIVE Inhibition DME1788 XEOTICID XEO02319 XEO_NAME Armadillidin glyc-rich DME1788 XEOTICID XEO02319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02319 XEO_CLAS Peptide DME1788 XEOTICID XEO02319 DESCRIPT Armadillidin glyc-rich inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02319 GENEFORM Protein DME1788 XEOTICID XEO02319 MOACRIVE Inhibition DME1788 XEOTICID XEO02320 XEO_NAME ASABF-alpha DME1788 XEOTICID XEO02320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02320 XEO_CLAS Peptide DME1788 XEOTICID XEO02320 DESCRIPT ASABF-alpha inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02320 GENEFORM Protein DME1788 XEOTICID XEO02320 MOACRIVE Inhibition DME1788 XEOTICID XEO02321 XEO_NAME Ascaphin-1 DME1788 XEOTICID XEO02321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02321 XEO_CLAS Peptide DME1788 XEOTICID XEO02321 DESCRIPT Ascaphin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO02321 GENEFORM Protein DME1788 XEOTICID XEO02321 MOACRIVE Inhibition DME1788 XEOTICID XEO02322 XEO_NAME Ascaphin-2 DME1788 XEOTICID XEO02322 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02322 XEO_CLAS Peptide DME1788 XEOTICID XEO02322 DESCRIPT Ascaphin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02322 GENEFORM Protein DME1788 XEOTICID XEO02322 MOACRIVE Inhibition DME1788 XEOTICID XEO02323 XEO_NAME Ascaphin-3 DME1788 XEOTICID XEO02323 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02323 XEO_CLAS Peptide DME1788 XEOTICID XEO02323 DESCRIPT Ascaphin-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO02323 GENEFORM Protein DME1788 XEOTICID XEO02323 MOACRIVE Inhibition DME1788 XEOTICID XEO02324 XEO_NAME Ascaphin-4 DME1788 XEOTICID XEO02324 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02324 XEO_CLAS Peptide DME1788 XEOTICID XEO02324 DESCRIPT Ascaphin-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02324 GENEFORM Protein DME1788 XEOTICID XEO02324 MOACRIVE Inhibition DME1788 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1788 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02325 XEO_CLAS Peptide DME1788 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO02325 GENEFORM Protein DME1788 XEOTICID XEO02325 MOACRIVE Inhibition DME1788 XEOTICID XEO02326 XEO_NAME Ascaphin-6 DME1788 XEOTICID XEO02326 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02326 XEO_CLAS Peptide DME1788 XEOTICID XEO02326 DESCRIPT Ascaphin-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02326 GENEFORM Protein DME1788 XEOTICID XEO02326 MOACRIVE Inhibition DME1788 XEOTICID XEO02327 XEO_NAME Ascaphin-7 DME1788 XEOTICID XEO02327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02327 XEO_CLAS Peptide DME1788 XEOTICID XEO02327 DESCRIPT Ascaphin-7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO02327 GENEFORM Protein DME1788 XEOTICID XEO02327 MOACRIVE Inhibition DME1788 XEOTICID XEO02328 XEO_NAME Ascaphin-8 DME1788 XEOTICID XEO02328 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02328 XEO_CLAS Peptide DME1788 XEOTICID XEO02328 DESCRIPT Ascaphin-8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO02328 GENEFORM Protein DME1788 XEOTICID XEO02328 MOACRIVE Inhibition DME1788 XEOTICID XEO02332 XEO_NAME Astacidin 2 DME1788 XEOTICID XEO02332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02332 XEO_CLAS Peptide DME1788 XEOTICID XEO02332 DESCRIPT Astacidin 2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.9 ug/ml) DME1788 XEOTICID XEO02332 GENEFORM Protein DME1788 XEOTICID XEO02332 MOACRIVE Inhibition DME1788 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1788 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02333 XEO_CLAS Peptide DME1788 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 200 microM) DME1788 XEOTICID XEO02333 GENEFORM Protein DME1788 XEOTICID XEO02333 MOACRIVE Inhibition DME1788 XEOTICID XEO02336 XEO_NAME Aurein-1.2 DME1788 XEOTICID XEO02336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02336 XEO_CLAS Peptide DME1788 XEOTICID XEO02336 DESCRIPT Aurein-1.2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 microM) DME1788 XEOTICID XEO02336 GENEFORM Protein DME1788 XEOTICID XEO02336 MOACRIVE Inhibition DME1788 XEOTICID XEO02346 XEO_NAME Aurelin DME1788 XEOTICID XEO02346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02346 XEO_CLAS Peptide DME1788 XEOTICID XEO02346 DESCRIPT Aurelin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 7.66 ug/ml) DME1788 XEOTICID XEO02346 GENEFORM Protein DME1788 XEOTICID XEO02346 MOACRIVE Inhibition DME1788 XEOTICID XEO02352 XEO_NAME Bac2A scrambled variant Bac014 DME1788 XEOTICID XEO02352 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02352 XEO_CLAS Peptide DME1788 XEOTICID XEO02352 DESCRIPT Bac2A scrambled variant Bac014 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 11 ug/ml) DME1788 XEOTICID XEO02352 GENEFORM Protein DME1788 XEOTICID XEO02352 MOACRIVE Inhibition DME1788 XEOTICID XEO02353 XEO_NAME Bac2A scrambled variant Bac020 DME1788 XEOTICID XEO02353 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02353 XEO_CLAS Peptide DME1788 XEOTICID XEO02353 DESCRIPT Bac2A scrambled variant Bac020 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 ug/ml) DME1788 XEOTICID XEO02353 GENEFORM Protein DME1788 XEOTICID XEO02353 MOACRIVE Inhibition DME1788 XEOTICID XEO02354 XEO_NAME Bac2A scrambled variant Bac034 DME1788 XEOTICID XEO02354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02354 XEO_CLAS Peptide DME1788 XEOTICID XEO02354 DESCRIPT Bac2A scrambled variant Bac034 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 ug/ml) DME1788 XEOTICID XEO02354 GENEFORM Protein DME1788 XEOTICID XEO02354 MOACRIVE Inhibition DME1788 XEOTICID XEO02355 XEO_NAME Bovine dodecapeptide linear variant Bac2A DME1788 XEOTICID XEO02355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02355 XEO_CLAS Peptide DME1788 XEOTICID XEO02355 DESCRIPT Bovine dodecapeptide linear variant Bac2A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 17 ug/ml) DME1788 XEOTICID XEO02355 GENEFORM Protein DME1788 XEOTICID XEO02355 MOACRIVE Inhibition DME1788 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1788 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02356 XEO_CLAS Peptide DME1788 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO02356 GENEFORM Protein DME1788 XEOTICID XEO02356 MOACRIVE Inhibition DME1788 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1788 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02357 XEO_CLAS Peptide DME1788 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO02357 GENEFORM Protein DME1788 XEOTICID XEO02357 MOACRIVE Inhibition DME1788 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1788 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02358 XEO_CLAS Peptide DME1788 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO02358 GENEFORM Protein DME1788 XEOTICID XEO02358 MOACRIVE Inhibition DME1788 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1788 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02360 XEO_CLAS Peptide DME1788 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02360 GENEFORM Protein DME1788 XEOTICID XEO02360 MOACRIVE Inhibition DME1788 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1788 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02361 XEO_CLAS Peptide DME1788 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 ug/ml) DME1788 XEOTICID XEO02361 GENEFORM Protein DME1788 XEOTICID XEO02361 MOACRIVE Inhibition DME1788 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1788 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02365 XEO_CLAS Peptide DME1788 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 32 ug/ml) DME1788 XEOTICID XEO02365 GENEFORM Protein DME1788 XEOTICID XEO02365 MOACRIVE Inhibition DME1788 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1788 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02366 XEO_CLAS Peptide DME1788 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO02366 GENEFORM Protein DME1788 XEOTICID XEO02366 MOACRIVE Inhibition DME1788 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1788 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02367 XEO_CLAS Peptide DME1788 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02367 GENEFORM Protein DME1788 XEOTICID XEO02367 MOACRIVE Inhibition DME1788 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1788 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02368 XEO_CLAS Peptide DME1788 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02368 GENEFORM Protein DME1788 XEOTICID XEO02368 MOACRIVE Inhibition DME1788 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1788 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02369 XEO_CLAS Peptide DME1788 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02369 GENEFORM Protein DME1788 XEOTICID XEO02369 MOACRIVE Inhibition DME1788 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1788 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02370 XEO_CLAS Peptide DME1788 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02370 GENEFORM Protein DME1788 XEOTICID XEO02370 MOACRIVE Inhibition DME1788 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1788 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02371 XEO_CLAS Peptide DME1788 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 ug/ml) DME1788 XEOTICID XEO02371 GENEFORM Protein DME1788 XEOTICID XEO02371 MOACRIVE Inhibition DME1788 XEOTICID XEO02374 XEO_NAME Bacteriocin 97518 DME1788 XEOTICID XEO02374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02374 XEO_CLAS Peptide DME1788 XEOTICID XEO02374 DESCRIPT Bacteriocin 97518 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02374 GENEFORM Protein DME1788 XEOTICID XEO02374 MOACRIVE Inhibition DME1788 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1788 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02376 XEO_CLAS Peptide DME1788 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02376 GENEFORM Protein DME1788 XEOTICID XEO02376 MOACRIVE Inhibition DME1788 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1788 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02378 XEO_CLAS Peptide DME1788 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.19 ug/ml) DME1788 XEOTICID XEO02378 GENEFORM Protein DME1788 XEOTICID XEO02378 MOACRIVE Inhibition DME1788 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1788 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02388 XEO_CLAS Peptide DME1788 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO02388 GENEFORM Protein DME1788 XEOTICID XEO02388 MOACRIVE Inhibition DME1788 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1788 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02389 XEO_CLAS Peptide DME1788 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02389 GENEFORM Protein DME1788 XEOTICID XEO02389 MOACRIVE Inhibition DME1788 XEOTICID XEO02415 XEO_NAME Basic phospholipase A2 BnpTX-1 DME1788 XEOTICID XEO02415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02415 XEO_CLAS Peptide DME1788 XEOTICID XEO02415 DESCRIPT Basic phospholipase A2 BnpTX-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02415 GENEFORM Protein DME1788 XEOTICID XEO02415 MOACRIVE Inhibition DME1788 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1788 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02416 XEO_CLAS Peptide DME1788 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 11 microM) DME1788 XEOTICID XEO02416 GENEFORM Protein DME1788 XEOTICID XEO02416 MOACRIVE Inhibition DME1788 XEOTICID XEO02419 XEO_NAME Bay oil DME1788 XEOTICID XEO02419 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02419 XEO_CLAS Plant Extract DME1788 XEOTICID XEO02419 DESCRIPT Bay oil inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02419 GENEFORM Protein DME1788 XEOTICID XEO02419 MOACRIVE Inhibition DME1788 XEOTICID XEO02435 XEO_NAME Rodent beta-defensin BD-1 DME1788 XEOTICID XEO02435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02435 XEO_CLAS Peptide DME1788 XEOTICID XEO02435 DESCRIPT Rodent beta-defensin BD-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02435 GENEFORM Protein DME1788 XEOTICID XEO02435 MOACRIVE Inhibition DME1788 XEOTICID XEO02436 XEO_NAME Pig beta-defensin BD-1 DME1788 XEOTICID XEO02436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02436 XEO_CLAS Peptide DME1788 XEOTICID XEO02436 DESCRIPT Pig beta-defensin BD-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02436 GENEFORM Protein DME1788 XEOTICID XEO02436 MOACRIVE Inhibition DME1788 XEOTICID XEO02437 XEO_NAME Beta-defensin BD-1 DME1788 XEOTICID XEO02437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02437 XEO_CLAS Peptide DME1788 XEOTICID XEO02437 DESCRIPT Beta-defensin BD-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02437 GENEFORM Protein DME1788 XEOTICID XEO02437 MOACRIVE Inhibition DME1788 XEOTICID XEO02438 XEO_NAME Beta-defensin BD-3 DME1788 XEOTICID XEO02438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02438 XEO_CLAS Peptide DME1788 XEOTICID XEO02438 DESCRIPT Beta-defensin BD-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02438 GENEFORM Protein DME1788 XEOTICID XEO02438 MOACRIVE Inhibition DME1788 XEOTICID XEO02439 XEO_NAME Beta-defensin BD-30 DME1788 XEOTICID XEO02439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02439 XEO_CLAS Peptide DME1788 XEOTICID XEO02439 DESCRIPT Beta-defensin BD-30 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02439 GENEFORM Protein DME1788 XEOTICID XEO02439 MOACRIVE Inhibition DME1788 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME1788 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02440 XEO_CLAS Peptide DME1788 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02440 GENEFORM Protein DME1788 XEOTICID XEO02440 MOACRIVE Inhibition DME1788 XEOTICID XEO02441 XEO_NAME Beta-defensin BD-4 DME1788 XEOTICID XEO02441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02441 XEO_CLAS Peptide DME1788 XEOTICID XEO02441 DESCRIPT Beta-defensin BD-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02441 GENEFORM Protein DME1788 XEOTICID XEO02441 MOACRIVE Inhibition DME1788 XEOTICID XEO02442 XEO_NAME Beta-defensin BD-6 DME1788 XEOTICID XEO02442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02442 XEO_CLAS Peptide DME1788 XEOTICID XEO02442 DESCRIPT Beta-defensin BD-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO02442 GENEFORM Protein DME1788 XEOTICID XEO02442 MOACRIVE Inhibition DME1788 XEOTICID XEO02443 XEO_NAME Beta-defensin BD-8 DME1788 XEOTICID XEO02443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02443 XEO_CLAS Peptide DME1788 XEOTICID XEO02443 DESCRIPT Beta-defensin BD-8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02443 GENEFORM Protein DME1788 XEOTICID XEO02443 MOACRIVE Inhibition DME1788 XEOTICID XEO02444 XEO_NAME Beta-defensin BBD(C7) DME1788 XEOTICID XEO02444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02444 XEO_CLAS Peptide DME1788 XEOTICID XEO02444 DESCRIPT Beta-defensin BBD(C7) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02444 GENEFORM Protein DME1788 XEOTICID XEO02444 MOACRIVE Inhibition DME1788 XEOTICID XEO02447 XEO_NAME beta-sitosterol glucoside DME1788 XEOTICID XEO02447 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO02447 XEO_CLAS Investigative Agent DME1788 XEOTICID XEO02447 DESCRIPT beta-sitosterol glucoside inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02447 GENEFORM Protein DME1788 XEOTICID XEO02447 MOACRIVE Inhibition DME1788 XEOTICID XEO02452 XEO_NAME Big defensin RPD-1 DME1788 XEOTICID XEO02452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02452 XEO_CLAS Peptide DME1788 XEOTICID XEO02452 DESCRIPT Big defensin RPD-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 76800 ug/ml) DME1788 XEOTICID XEO02452 GENEFORM Protein DME1788 XEOTICID XEO02452 MOACRIVE Inhibition DME1788 XEOTICID XEO02453 XEO_NAME Sperm-associated antigen BIN1b DME1788 XEOTICID XEO02453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02453 XEO_CLAS Peptide DME1788 XEOTICID XEO02453 DESCRIPT Sperm-associated antigen BIN1b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02453 GENEFORM Protein DME1788 XEOTICID XEO02453 MOACRIVE Inhibition DME1788 XEOTICID XEO02463 XEO_NAME Bovine lactoferricin bLf 20-29 DME1788 XEOTICID XEO02463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02463 XEO_CLAS Peptide DME1788 XEOTICID XEO02463 DESCRIPT Bovine lactoferricin bLf 20-29 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 11.25 microM) DME1788 XEOTICID XEO02463 GENEFORM Protein DME1788 XEOTICID XEO02463 MOACRIVE Inhibition DME1788 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1788 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02466 XEO_CLAS Peptide DME1788 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.5 microM) DME1788 XEOTICID XEO02466 GENEFORM Protein DME1788 XEOTICID XEO02466 MOACRIVE Inhibition DME1788 XEOTICID XEO02467 XEO_NAME Defensin BnPRP1 DME1788 XEOTICID XEO02467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02467 XEO_CLAS Peptide DME1788 XEOTICID XEO02467 DESCRIPT Defensin BnPRP1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8.4 microM) DME1788 XEOTICID XEO02467 GENEFORM Protein DME1788 XEOTICID XEO02467 MOACRIVE Inhibition DME1788 XEOTICID XEO02468 XEO_NAME Bombin H7 DME1788 XEOTICID XEO02468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02468 XEO_CLAS Peptide DME1788 XEOTICID XEO02468 DESCRIPT Bombin H7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.7 microM) DME1788 XEOTICID XEO02468 GENEFORM Protein DME1788 XEOTICID XEO02468 MOACRIVE Inhibition DME1788 XEOTICID XEO02469 XEO_NAME Toad bombinin-H1 DME1788 XEOTICID XEO02469 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02469 XEO_CLAS Peptide DME1788 XEOTICID XEO02469 DESCRIPT Toad bombinin-H1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO02469 GENEFORM Protein DME1788 XEOTICID XEO02469 MOACRIVE Inhibition DME1788 XEOTICID XEO02470 XEO_NAME Frog bombinin-H1 DME1788 XEOTICID XEO02470 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02470 XEO_CLAS Peptide DME1788 XEOTICID XEO02470 DESCRIPT Frog bombinin-H1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.8 microM) DME1788 XEOTICID XEO02470 GENEFORM Protein DME1788 XEOTICID XEO02470 MOACRIVE Inhibition DME1788 XEOTICID XEO02471 XEO_NAME Bombinin-H4 DME1788 XEOTICID XEO02471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02471 XEO_CLAS Peptide DME1788 XEOTICID XEO02471 DESCRIPT Bombinin-H4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4.8 microM) DME1788 XEOTICID XEO02471 GENEFORM Protein DME1788 XEOTICID XEO02471 MOACRIVE Inhibition DME1788 XEOTICID XEO02472 XEO_NAME Bombinin-H5 DME1788 XEOTICID XEO02472 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02472 XEO_CLAS Peptide DME1788 XEOTICID XEO02472 DESCRIPT Bombinin-H5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.0 microM) DME1788 XEOTICID XEO02472 GENEFORM Protein DME1788 XEOTICID XEO02472 MOACRIVE Inhibition DME1788 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1788 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02473 XEO_CLAS Peptide DME1788 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02473 GENEFORM Protein DME1788 XEOTICID XEO02473 MOACRIVE Inhibition DME1788 XEOTICID XEO02474 XEO_NAME Frog bombinin-like peptide BLP-1 DME1788 XEOTICID XEO02474 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02474 XEO_CLAS Peptide DME1788 XEOTICID XEO02474 DESCRIPT Frog bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.5 microM) DME1788 XEOTICID XEO02474 GENEFORM Protein DME1788 XEOTICID XEO02474 MOACRIVE Inhibition DME1788 XEOTICID XEO02475 XEO_NAME Bombinin-like peptide BLP-3 DME1788 XEOTICID XEO02475 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02475 XEO_CLAS Peptide DME1788 XEOTICID XEO02475 DESCRIPT Bombinin-like peptide BLP-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.5 microM) DME1788 XEOTICID XEO02475 GENEFORM Protein DME1788 XEOTICID XEO02475 MOACRIVE Inhibition DME1788 XEOTICID XEO02477 XEO_NAME Bovine beta-defensin bBD-1 DME1788 XEOTICID XEO02477 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02477 XEO_CLAS Peptide DME1788 XEOTICID XEO02477 DESCRIPT Bovine beta-defensin bBD-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-300 ug/ml) DME1788 XEOTICID XEO02477 GENEFORM Protein DME1788 XEOTICID XEO02477 MOACRIVE Inhibition DME1788 XEOTICID XEO02478 XEO_NAME Bovine beta-defensin bBD-10 DME1788 XEOTICID XEO02478 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02478 XEO_CLAS Peptide DME1788 XEOTICID XEO02478 DESCRIPT Bovine beta-defensin bBD-10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-300 ug/ml) DME1788 XEOTICID XEO02478 GENEFORM Protein DME1788 XEOTICID XEO02478 MOACRIVE Inhibition DME1788 XEOTICID XEO02479 XEO_NAME Bovine beta-defensin bBD-11 DME1788 XEOTICID XEO02479 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02479 XEO_CLAS Peptide DME1788 XEOTICID XEO02479 DESCRIPT Bovine beta-defensin bBD-11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-300 ug/ml) DME1788 XEOTICID XEO02479 GENEFORM Protein DME1788 XEOTICID XEO02479 MOACRIVE Inhibition DME1788 XEOTICID XEO02480 XEO_NAME Bovine beta-defensin bBD-12 DME1788 XEOTICID XEO02480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02480 XEO_CLAS Peptide DME1788 XEOTICID XEO02480 DESCRIPT Bovine beta-defensin bBD-12 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-300 ug/ml) DME1788 XEOTICID XEO02480 GENEFORM Protein DME1788 XEOTICID XEO02480 MOACRIVE Inhibition DME1788 XEOTICID XEO02481 XEO_NAME Bovine beta-defensin bBD-13 DME1788 XEOTICID XEO02481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02481 XEO_CLAS Peptide DME1788 XEOTICID XEO02481 DESCRIPT Bovine beta-defensin bBD-13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-300 ug/ml) DME1788 XEOTICID XEO02481 GENEFORM Protein DME1788 XEOTICID XEO02481 MOACRIVE Inhibition DME1788 XEOTICID XEO02482 XEO_NAME Bovine beta-defensin bBD-2 DME1788 XEOTICID XEO02482 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02482 XEO_CLAS Peptide DME1788 XEOTICID XEO02482 DESCRIPT Bovine beta-defensin bBD-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-300 ug/ml) DME1788 XEOTICID XEO02482 GENEFORM Protein DME1788 XEOTICID XEO02482 MOACRIVE Inhibition DME1788 XEOTICID XEO02483 XEO_NAME Bovine beta-defensin bBD-3 DME1788 XEOTICID XEO02483 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02483 XEO_CLAS Peptide DME1788 XEOTICID XEO02483 DESCRIPT Bovine beta-defensin bBD-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-300 ug/ml) DME1788 XEOTICID XEO02483 GENEFORM Protein DME1788 XEOTICID XEO02483 MOACRIVE Inhibition DME1788 XEOTICID XEO02484 XEO_NAME Bovine beta-defensin bBD-4 DME1788 XEOTICID XEO02484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02484 XEO_CLAS Peptide DME1788 XEOTICID XEO02484 DESCRIPT Bovine beta-defensin bBD-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-300 ug/ml) DME1788 XEOTICID XEO02484 GENEFORM Protein DME1788 XEOTICID XEO02484 MOACRIVE Inhibition DME1788 XEOTICID XEO02485 XEO_NAME Bovine beta-defensin bBD-5 DME1788 XEOTICID XEO02485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02485 XEO_CLAS Peptide DME1788 XEOTICID XEO02485 DESCRIPT Bovine beta-defensin bBD-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-300 ug/ml) DME1788 XEOTICID XEO02485 GENEFORM Protein DME1788 XEOTICID XEO02485 MOACRIVE Inhibition DME1788 XEOTICID XEO02486 XEO_NAME Bovine beta-defensin bBD-6 DME1788 XEOTICID XEO02486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02486 XEO_CLAS Peptide DME1788 XEOTICID XEO02486 DESCRIPT Bovine beta-defensin bBD-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-300 ug/ml) DME1788 XEOTICID XEO02486 GENEFORM Protein DME1788 XEOTICID XEO02486 MOACRIVE Inhibition DME1788 XEOTICID XEO02487 XEO_NAME Bovine beta-defensin bBD-7 DME1788 XEOTICID XEO02487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02487 XEO_CLAS Peptide DME1788 XEOTICID XEO02487 DESCRIPT Bovine beta-defensin bBD-7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02487 GENEFORM Protein DME1788 XEOTICID XEO02487 MOACRIVE Inhibition DME1788 XEOTICID XEO02488 XEO_NAME Bovine beta-defensin bBD-8 DME1788 XEOTICID XEO02488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02488 XEO_CLAS Peptide DME1788 XEOTICID XEO02488 DESCRIPT Bovine beta-defensin bBD-8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-300 ug/ml) DME1788 XEOTICID XEO02488 GENEFORM Protein DME1788 XEOTICID XEO02488 MOACRIVE Inhibition DME1788 XEOTICID XEO02489 XEO_NAME Bovine beta-defensin bBD-9 DME1788 XEOTICID XEO02489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02489 XEO_CLAS Peptide DME1788 XEOTICID XEO02489 DESCRIPT Bovine beta-defensin bBD-9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-301 ug/ml) DME1788 XEOTICID XEO02489 GENEFORM Protein DME1788 XEOTICID XEO02489 MOACRIVE Inhibition DME1788 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1788 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02491 XEO_CLAS Peptide DME1788 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.3 microM) DME1788 XEOTICID XEO02491 GENEFORM Protein DME1788 XEOTICID XEO02491 MOACRIVE Inhibition DME1788 XEOTICID XEO02492 XEO_NAME Brevinin-1E15 DME1788 XEOTICID XEO02492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02492 XEO_CLAS Peptide DME1788 XEOTICID XEO02492 DESCRIPT Brevinin-1E15 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 ug/ml) DME1788 XEOTICID XEO02492 GENEFORM Protein DME1788 XEOTICID XEO02492 MOACRIVE Inhibition DME1788 XEOTICID XEO02493 XEO_NAME Brevinin-1E18 DME1788 XEOTICID XEO02493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02493 XEO_CLAS Peptide DME1788 XEOTICID XEO02493 DESCRIPT Brevinin-1E18 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 ug/ml) DME1788 XEOTICID XEO02493 GENEFORM Protein DME1788 XEOTICID XEO02493 MOACRIVE Inhibition DME1788 XEOTICID XEO02494 XEO_NAME Brevinin-1E21 DME1788 XEOTICID XEO02494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02494 XEO_CLAS Peptide DME1788 XEOTICID XEO02494 DESCRIPT Brevinin-1E21 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 ug/ml) DME1788 XEOTICID XEO02494 GENEFORM Protein DME1788 XEOTICID XEO02494 MOACRIVE Inhibition DME1788 XEOTICID XEO02495 XEO_NAME Frog brevinin-1 DME1788 XEOTICID XEO02495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02495 XEO_CLAS Peptide DME1788 XEOTICID XEO02495 DESCRIPT Frog brevinin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 34 ug/ml) DME1788 XEOTICID XEO02495 GENEFORM Protein DME1788 XEOTICID XEO02495 MOACRIVE Inhibition DME1788 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1788 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02496 XEO_CLAS Peptide DME1788 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 13 microM) DME1788 XEOTICID XEO02496 GENEFORM Protein DME1788 XEOTICID XEO02496 MOACRIVE Inhibition DME1788 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1788 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02497 XEO_CLAS Peptide DME1788 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO02497 GENEFORM Protein DME1788 XEOTICID XEO02497 MOACRIVE Inhibition DME1788 XEOTICID XEO02499 XEO_NAME Brevinin-1Bb DME1788 XEOTICID XEO02499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02499 XEO_CLAS Peptide DME1788 XEOTICID XEO02499 DESCRIPT Brevinin-1Bb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO02499 GENEFORM Protein DME1788 XEOTICID XEO02499 MOACRIVE Inhibition DME1788 XEOTICID XEO02501 XEO_NAME Brevinin-1Bd DME1788 XEOTICID XEO02501 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02501 XEO_CLAS Peptide DME1788 XEOTICID XEO02501 DESCRIPT Brevinin-1Bd inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 7 microM) DME1788 XEOTICID XEO02501 GENEFORM Protein DME1788 XEOTICID XEO02501 MOACRIVE Inhibition DME1788 XEOTICID XEO02502 XEO_NAME Brevinin-1Be DME1788 XEOTICID XEO02502 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02502 XEO_CLAS Peptide DME1788 XEOTICID XEO02502 DESCRIPT Brevinin-1Be inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 microM) DME1788 XEOTICID XEO02502 GENEFORM Protein DME1788 XEOTICID XEO02502 MOACRIVE Inhibition DME1788 XEOTICID XEO02503 XEO_NAME Brevinin-1Bf DME1788 XEOTICID XEO02503 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02503 XEO_CLAS Peptide DME1788 XEOTICID XEO02503 DESCRIPT Brevinin-1Bf inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 19 microM) DME1788 XEOTICID XEO02503 GENEFORM Protein DME1788 XEOTICID XEO02503 MOACRIVE Inhibition DME1788 XEOTICID XEO02504 XEO_NAME Brevinin-1BLa DME1788 XEOTICID XEO02504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02504 XEO_CLAS Peptide DME1788 XEOTICID XEO02504 DESCRIPT Brevinin-1BLa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02504 GENEFORM Protein DME1788 XEOTICID XEO02504 MOACRIVE Inhibition DME1788 XEOTICID XEO02505 XEO_NAME Brevinin-1BLc DME1788 XEOTICID XEO02505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02505 XEO_CLAS Peptide DME1788 XEOTICID XEO02505 DESCRIPT Brevinin-1BLc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO02505 GENEFORM Protein DME1788 XEOTICID XEO02505 MOACRIVE Inhibition DME1788 XEOTICID XEO02507 XEO_NAME Brevinin-1CDYa DME1788 XEOTICID XEO02507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02507 XEO_CLAS Peptide DME1788 XEOTICID XEO02507 DESCRIPT Brevinin-1CDYa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO02507 GENEFORM Protein DME1788 XEOTICID XEO02507 MOACRIVE Inhibition DME1788 XEOTICID XEO02508 XEO_NAME Brevinin-1CG1 DME1788 XEOTICID XEO02508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02508 XEO_CLAS Peptide DME1788 XEOTICID XEO02508 DESCRIPT Brevinin-1CG1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 150 microM) DME1788 XEOTICID XEO02508 GENEFORM Protein DME1788 XEOTICID XEO02508 MOACRIVE Inhibition DME1788 XEOTICID XEO02509 XEO_NAME Brevinin-1CG2 DME1788 XEOTICID XEO02509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02509 XEO_CLAS Peptide DME1788 XEOTICID XEO02509 DESCRIPT Brevinin-1CG2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 150 microM) DME1788 XEOTICID XEO02509 GENEFORM Protein DME1788 XEOTICID XEO02509 MOACRIVE Inhibition DME1788 XEOTICID XEO02510 XEO_NAME Brevinin-1CG3 DME1788 XEOTICID XEO02510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02510 XEO_CLAS Peptide DME1788 XEOTICID XEO02510 DESCRIPT Brevinin-1CG3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 150 microM) DME1788 XEOTICID XEO02510 GENEFORM Protein DME1788 XEOTICID XEO02510 MOACRIVE Inhibition DME1788 XEOTICID XEO02511 XEO_NAME Brevinin-1CG4 DME1788 XEOTICID XEO02511 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02511 XEO_CLAS Peptide DME1788 XEOTICID XEO02511 DESCRIPT Brevinin-1CG4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 150 microM) DME1788 XEOTICID XEO02511 GENEFORM Protein DME1788 XEOTICID XEO02511 MOACRIVE Inhibition DME1788 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1788 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02512 XEO_CLAS Peptide DME1788 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 75 microM) DME1788 XEOTICID XEO02512 GENEFORM Protein DME1788 XEOTICID XEO02512 MOACRIVE Inhibition DME1788 XEOTICID XEO02513 XEO_NAME Brevinin-1CHa DME1788 XEOTICID XEO02513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02513 XEO_CLAS Peptide DME1788 XEOTICID XEO02513 DESCRIPT Brevinin-1CHa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO02513 GENEFORM Protein DME1788 XEOTICID XEO02513 MOACRIVE Inhibition DME1788 XEOTICID XEO02514 XEO_NAME Brevinin-1CHb DME1788 XEOTICID XEO02514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02514 XEO_CLAS Peptide DME1788 XEOTICID XEO02514 DESCRIPT Brevinin-1CHb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO02514 GENEFORM Protein DME1788 XEOTICID XEO02514 MOACRIVE Inhibition DME1788 XEOTICID XEO02515 XEO_NAME Brevinin-1CHc DME1788 XEOTICID XEO02515 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02515 XEO_CLAS Peptide DME1788 XEOTICID XEO02515 DESCRIPT Brevinin-1CHc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 80 microM) DME1788 XEOTICID XEO02515 GENEFORM Protein DME1788 XEOTICID XEO02515 MOACRIVE Inhibition DME1788 XEOTICID XEO02516 XEO_NAME Brevinin-1CSa DME1788 XEOTICID XEO02516 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02516 XEO_CLAS Peptide DME1788 XEOTICID XEO02516 DESCRIPT Brevinin-1CSa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 32 microM) DME1788 XEOTICID XEO02516 GENEFORM Protein DME1788 XEOTICID XEO02516 MOACRIVE Inhibition DME1788 XEOTICID XEO02517 XEO_NAME Brevinin-1Da DME1788 XEOTICID XEO02517 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02517 XEO_CLAS Peptide DME1788 XEOTICID XEO02517 DESCRIPT Brevinin-1Da inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 microM) DME1788 XEOTICID XEO02517 GENEFORM Protein DME1788 XEOTICID XEO02517 MOACRIVE Inhibition DME1788 XEOTICID XEO02518 XEO_NAME Brevinin-1DYa DME1788 XEOTICID XEO02518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02518 XEO_CLAS Peptide DME1788 XEOTICID XEO02518 DESCRIPT Brevinin-1DYa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC < 15 microM) DME1788 XEOTICID XEO02518 GENEFORM Protein DME1788 XEOTICID XEO02518 MOACRIVE Inhibition DME1788 XEOTICID XEO02519 XEO_NAME Brevinin-1DYb DME1788 XEOTICID XEO02519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02519 XEO_CLAS Peptide DME1788 XEOTICID XEO02519 DESCRIPT Brevinin-1DYb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC < 15 microM) DME1788 XEOTICID XEO02519 GENEFORM Protein DME1788 XEOTICID XEO02519 MOACRIVE Inhibition DME1788 XEOTICID XEO02520 XEO_NAME Brevinin-1DYc DME1788 XEOTICID XEO02520 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02520 XEO_CLAS Peptide DME1788 XEOTICID XEO02520 DESCRIPT Brevinin-1DYc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC < 15 microM) DME1788 XEOTICID XEO02520 GENEFORM Protein DME1788 XEOTICID XEO02520 MOACRIVE Inhibition DME1788 XEOTICID XEO02523 XEO_NAME Brevinin-1GRa DME1788 XEOTICID XEO02523 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02523 XEO_CLAS Peptide DME1788 XEOTICID XEO02523 DESCRIPT Brevinin-1GRa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO02523 GENEFORM Protein DME1788 XEOTICID XEO02523 MOACRIVE Inhibition DME1788 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME1788 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02524 XEO_CLAS Peptide DME1788 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 150 microM) DME1788 XEOTICID XEO02524 GENEFORM Protein DME1788 XEOTICID XEO02524 MOACRIVE Inhibition DME1788 XEOTICID XEO02525 XEO_NAME Brevinin-1HSa DME1788 XEOTICID XEO02525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02525 XEO_CLAS Peptide DME1788 XEOTICID XEO02525 DESCRIPT Brevinin-1HSa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 24 microM) DME1788 XEOTICID XEO02525 GENEFORM Protein DME1788 XEOTICID XEO02525 MOACRIVE Inhibition DME1788 XEOTICID XEO02526 XEO_NAME Brevinin-1HSb DME1788 XEOTICID XEO02526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02526 XEO_CLAS Peptide DME1788 XEOTICID XEO02526 DESCRIPT Brevinin-1HSb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 48 microM) DME1788 XEOTICID XEO02526 GENEFORM Protein DME1788 XEOTICID XEO02526 MOACRIVE Inhibition DME1788 XEOTICID XEO02527 XEO_NAME Brevinin-1Ja DME1788 XEOTICID XEO02527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02527 XEO_CLAS Peptide DME1788 XEOTICID XEO02527 DESCRIPT Brevinin-1Ja inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 119 microM) DME1788 XEOTICID XEO02527 GENEFORM Protein DME1788 XEOTICID XEO02527 MOACRIVE Inhibition DME1788 XEOTICID XEO02528 XEO_NAME Brevinin-1JDa DME1788 XEOTICID XEO02528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02528 XEO_CLAS Peptide DME1788 XEOTICID XEO02528 DESCRIPT Brevinin-1JDa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 128 ug/ml) DME1788 XEOTICID XEO02528 GENEFORM Protein DME1788 XEOTICID XEO02528 MOACRIVE Inhibition DME1788 XEOTICID XEO02529 XEO_NAME Brevinin-1JDc DME1788 XEOTICID XEO02529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02529 XEO_CLAS Peptide DME1788 XEOTICID XEO02529 DESCRIPT Brevinin-1JDc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 128 ug/ml) DME1788 XEOTICID XEO02529 GENEFORM Protein DME1788 XEOTICID XEO02529 MOACRIVE Inhibition DME1788 XEOTICID XEO02530 XEO_NAME Brevinin-1La DME1788 XEOTICID XEO02530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02530 XEO_CLAS Peptide DME1788 XEOTICID XEO02530 DESCRIPT Brevinin-1La inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02530 GENEFORM Protein DME1788 XEOTICID XEO02530 MOACRIVE Inhibition DME1788 XEOTICID XEO02531 XEO_NAME Brevinin-1Lb DME1788 XEOTICID XEO02531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02531 XEO_CLAS Peptide DME1788 XEOTICID XEO02531 DESCRIPT Brevinin-1Lb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 microM) DME1788 XEOTICID XEO02531 GENEFORM Protein DME1788 XEOTICID XEO02531 MOACRIVE Inhibition DME1788 XEOTICID XEO02533 XEO_NAME Brevinin-1-OA1 DME1788 XEOTICID XEO02533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02533 XEO_CLAS Peptide DME1788 XEOTICID XEO02533 DESCRIPT Brevinin-1-OA1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.2 ug/ml) DME1788 XEOTICID XEO02533 GENEFORM Protein DME1788 XEOTICID XEO02533 MOACRIVE Inhibition DME1788 XEOTICID XEO02534 XEO_NAME Brevinin-1-OA12 DME1788 XEOTICID XEO02534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02534 XEO_CLAS Peptide DME1788 XEOTICID XEO02534 DESCRIPT Brevinin-1-OA12 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.6 ug/ml) DME1788 XEOTICID XEO02534 GENEFORM Protein DME1788 XEOTICID XEO02534 MOACRIVE Inhibition DME1788 XEOTICID XEO02535 XEO_NAME Brevinin-1-OR1 DME1788 XEOTICID XEO02535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02535 XEO_CLAS Peptide DME1788 XEOTICID XEO02535 DESCRIPT Brevinin-1-OR1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.3 ug/ml) DME1788 XEOTICID XEO02535 GENEFORM Protein DME1788 XEOTICID XEO02535 MOACRIVE Inhibition DME1788 XEOTICID XEO02536 XEO_NAME Brevinin-1-OR10 DME1788 XEOTICID XEO02536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02536 XEO_CLAS Peptide DME1788 XEOTICID XEO02536 DESCRIPT Brevinin-1-OR10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.4 ug/ml) DME1788 XEOTICID XEO02536 GENEFORM Protein DME1788 XEOTICID XEO02536 MOACRIVE Inhibition DME1788 XEOTICID XEO02537 XEO_NAME Brevinin-1-OR11 DME1788 XEOTICID XEO02537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02537 XEO_CLAS Peptide DME1788 XEOTICID XEO02537 DESCRIPT Brevinin-1-OR11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.2 ug/ml) DME1788 XEOTICID XEO02537 GENEFORM Protein DME1788 XEOTICID XEO02537 MOACRIVE Inhibition DME1788 XEOTICID XEO02538 XEO_NAME Brevinin-1-OR3 DME1788 XEOTICID XEO02538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02538 XEO_CLAS Peptide DME1788 XEOTICID XEO02538 DESCRIPT Brevinin-1-OR3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 9.1 ug/ml) DME1788 XEOTICID XEO02538 GENEFORM Protein DME1788 XEOTICID XEO02538 MOACRIVE Inhibition DME1788 XEOTICID XEO02539 XEO_NAME Brevinin-1-OR4 DME1788 XEOTICID XEO02539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02539 XEO_CLAS Peptide DME1788 XEOTICID XEO02539 DESCRIPT Brevinin-1-OR4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8.6 ug/ml) DME1788 XEOTICID XEO02539 GENEFORM Protein DME1788 XEOTICID XEO02539 MOACRIVE Inhibition DME1788 XEOTICID XEO02540 XEO_NAME Brevinin-1-OR5 DME1788 XEOTICID XEO02540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02540 XEO_CLAS Peptide DME1788 XEOTICID XEO02540 DESCRIPT Brevinin-1-OR5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15.2 ug/ml) DME1788 XEOTICID XEO02540 GENEFORM Protein DME1788 XEOTICID XEO02540 MOACRIVE Inhibition DME1788 XEOTICID XEO02541 XEO_NAME Brevinin-1-OR6 DME1788 XEOTICID XEO02541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02541 XEO_CLAS Peptide DME1788 XEOTICID XEO02541 DESCRIPT Brevinin-1-OR6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 11.1 ug/ml) DME1788 XEOTICID XEO02541 GENEFORM Protein DME1788 XEOTICID XEO02541 MOACRIVE Inhibition DME1788 XEOTICID XEO02542 XEO_NAME Brevinin-1-OR7 DME1788 XEOTICID XEO02542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02542 XEO_CLAS Peptide DME1788 XEOTICID XEO02542 DESCRIPT Brevinin-1-OR7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.7 ug/ml) DME1788 XEOTICID XEO02542 GENEFORM Protein DME1788 XEOTICID XEO02542 MOACRIVE Inhibition DME1788 XEOTICID XEO02543 XEO_NAME Brevinin-1-OR8 DME1788 XEOTICID XEO02543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02543 XEO_CLAS Peptide DME1788 XEOTICID XEO02543 DESCRIPT Brevinin-1-OR8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 13.1 ug/ml) DME1788 XEOTICID XEO02543 GENEFORM Protein DME1788 XEOTICID XEO02543 MOACRIVE Inhibition DME1788 XEOTICID XEO02544 XEO_NAME Brevinin-1-OR9 DME1788 XEOTICID XEO02544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02544 XEO_CLAS Peptide DME1788 XEOTICID XEO02544 DESCRIPT Brevinin-1-OR9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 9.8 ug/ml) DME1788 XEOTICID XEO02544 GENEFORM Protein DME1788 XEOTICID XEO02544 MOACRIVE Inhibition DME1788 XEOTICID XEO02545 XEO_NAME Brevinin-1Pa DME1788 XEOTICID XEO02545 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02545 XEO_CLAS Peptide DME1788 XEOTICID XEO02545 DESCRIPT Brevinin-1Pa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 14 microM) DME1788 XEOTICID XEO02545 GENEFORM Protein DME1788 XEOTICID XEO02545 MOACRIVE Inhibition DME1788 XEOTICID XEO02546 XEO_NAME Brevinin-1Pb DME1788 XEOTICID XEO02546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02546 XEO_CLAS Peptide DME1788 XEOTICID XEO02546 DESCRIPT Brevinin-1Pb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 14 microM) DME1788 XEOTICID XEO02546 GENEFORM Protein DME1788 XEOTICID XEO02546 MOACRIVE Inhibition DME1788 XEOTICID XEO02547 XEO_NAME Brevinin-1Pc DME1788 XEOTICID XEO02547 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02547 XEO_CLAS Peptide DME1788 XEOTICID XEO02547 DESCRIPT Brevinin-1Pc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 microM) DME1788 XEOTICID XEO02547 GENEFORM Protein DME1788 XEOTICID XEO02547 MOACRIVE Inhibition DME1788 XEOTICID XEO02548 XEO_NAME Brevinin-1Pd DME1788 XEOTICID XEO02548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02548 XEO_CLAS Peptide DME1788 XEOTICID XEO02548 DESCRIPT Brevinin-1Pd inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 78 microM) DME1788 XEOTICID XEO02548 GENEFORM Protein DME1788 XEOTICID XEO02548 MOACRIVE Inhibition DME1788 XEOTICID XEO02549 XEO_NAME Brevinin-1Pe DME1788 XEOTICID XEO02549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02549 XEO_CLAS Peptide DME1788 XEOTICID XEO02549 DESCRIPT Brevinin-1Pe inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02549 GENEFORM Protein DME1788 XEOTICID XEO02549 MOACRIVE Inhibition DME1788 XEOTICID XEO02552 XEO_NAME Brevinin-1PTa DME1788 XEOTICID XEO02552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02552 XEO_CLAS Peptide DME1788 XEOTICID XEO02552 DESCRIPT Brevinin-1PTa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 24 microM) DME1788 XEOTICID XEO02552 GENEFORM Protein DME1788 XEOTICID XEO02552 MOACRIVE Inhibition DME1788 XEOTICID XEO02553 XEO_NAME Brevinin-1PTb DME1788 XEOTICID XEO02553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02553 XEO_CLAS Peptide DME1788 XEOTICID XEO02553 DESCRIPT Brevinin-1PTb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02553 GENEFORM Protein DME1788 XEOTICID XEO02553 MOACRIVE Inhibition DME1788 XEOTICID XEO02556 XEO_NAME Brevinin-1Sa DME1788 XEOTICID XEO02556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02556 XEO_CLAS Peptide DME1788 XEOTICID XEO02556 DESCRIPT Brevinin-1Sa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 55 microM) DME1788 XEOTICID XEO02556 GENEFORM Protein DME1788 XEOTICID XEO02556 MOACRIVE Inhibition DME1788 XEOTICID XEO02557 XEO_NAME Brevinin-1Sb DME1788 XEOTICID XEO02557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02557 XEO_CLAS Peptide DME1788 XEOTICID XEO02557 DESCRIPT Brevinin-1Sb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 17 microM) DME1788 XEOTICID XEO02557 GENEFORM Protein DME1788 XEOTICID XEO02557 MOACRIVE Inhibition DME1788 XEOTICID XEO02558 XEO_NAME Brevinin-1Sc DME1788 XEOTICID XEO02558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02558 XEO_CLAS Peptide DME1788 XEOTICID XEO02558 DESCRIPT Brevinin-1Sc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 14 microM) DME1788 XEOTICID XEO02558 GENEFORM Protein DME1788 XEOTICID XEO02558 MOACRIVE Inhibition DME1788 XEOTICID XEO02559 XEO_NAME Brevinin-1SE DME1788 XEOTICID XEO02559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02559 XEO_CLAS Peptide DME1788 XEOTICID XEO02559 DESCRIPT Brevinin-1SE inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02559 GENEFORM Protein DME1788 XEOTICID XEO02559 MOACRIVE Inhibition DME1788 XEOTICID XEO02560 XEO_NAME Brevinin-1SPa DME1788 XEOTICID XEO02560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02560 XEO_CLAS Peptide DME1788 XEOTICID XEO02560 DESCRIPT Brevinin-1SPa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 13 microM) DME1788 XEOTICID XEO02560 GENEFORM Protein DME1788 XEOTICID XEO02560 MOACRIVE Inhibition DME1788 XEOTICID XEO02561 XEO_NAME Brevinin-1SPb DME1788 XEOTICID XEO02561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02561 XEO_CLAS Peptide DME1788 XEOTICID XEO02561 DESCRIPT Brevinin-1SPb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO02561 GENEFORM Protein DME1788 XEOTICID XEO02561 MOACRIVE Inhibition DME1788 XEOTICID XEO02562 XEO_NAME Brevinin-1SPd DME1788 XEOTICID XEO02562 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02562 XEO_CLAS Peptide DME1788 XEOTICID XEO02562 DESCRIPT Brevinin-1SPd inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 13 microM) DME1788 XEOTICID XEO02562 GENEFORM Protein DME1788 XEOTICID XEO02562 MOACRIVE Inhibition DME1788 XEOTICID XEO02563 XEO_NAME Brevinin-1SY DME1788 XEOTICID XEO02563 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02563 XEO_CLAS Peptide DME1788 XEOTICID XEO02563 DESCRIPT Brevinin-1SY inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 45 microM) DME1788 XEOTICID XEO02563 GENEFORM Protein DME1788 XEOTICID XEO02563 MOACRIVE Inhibition DME1788 XEOTICID XEO02564 XEO_NAME Brevinin-1TEa DME1788 XEOTICID XEO02564 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02564 XEO_CLAS Peptide DME1788 XEOTICID XEO02564 DESCRIPT Brevinin-1TEa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 ug/ml) DME1788 XEOTICID XEO02564 GENEFORM Protein DME1788 XEOTICID XEO02564 MOACRIVE Inhibition DME1788 XEOTICID XEO02565 XEO_NAME Brevinin-1TOa DME1788 XEOTICID XEO02565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02565 XEO_CLAS Peptide DME1788 XEOTICID XEO02565 DESCRIPT Brevinin-1TOa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 microM) DME1788 XEOTICID XEO02565 GENEFORM Protein DME1788 XEOTICID XEO02565 MOACRIVE Inhibition DME1788 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1788 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02566 XEO_CLAS Peptide DME1788 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO02566 GENEFORM Protein DME1788 XEOTICID XEO02566 MOACRIVE Inhibition DME1788 XEOTICID XEO02568 XEO_NAME Brevinin-1VLa DME1788 XEOTICID XEO02568 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02568 XEO_CLAS Peptide DME1788 XEOTICID XEO02568 DESCRIPT Brevinin-1VLa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO02568 GENEFORM Protein DME1788 XEOTICID XEO02568 MOACRIVE Inhibition DME1788 XEOTICID XEO02569 XEO_NAME Brevinin-1VLc DME1788 XEOTICID XEO02569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02569 XEO_CLAS Peptide DME1788 XEOTICID XEO02569 DESCRIPT Brevinin-1VLc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO02569 GENEFORM Protein DME1788 XEOTICID XEO02569 MOACRIVE Inhibition DME1788 XEOTICID XEO02570 XEO_NAME Brevinin-1VLd DME1788 XEOTICID XEO02570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02570 XEO_CLAS Peptide DME1788 XEOTICID XEO02570 DESCRIPT Brevinin-1VLd inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO02570 GENEFORM Protein DME1788 XEOTICID XEO02570 MOACRIVE Inhibition DME1788 XEOTICID XEO02571 XEO_NAME Brevinin-1VLe DME1788 XEOTICID XEO02571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02571 XEO_CLAS Peptide DME1788 XEOTICID XEO02571 DESCRIPT Brevinin-1VLe inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO02571 GENEFORM Protein DME1788 XEOTICID XEO02571 MOACRIVE Inhibition DME1788 XEOTICID XEO02572 XEO_NAME Brevinin-1Ya DME1788 XEOTICID XEO02572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02572 XEO_CLAS Peptide DME1788 XEOTICID XEO02572 DESCRIPT Brevinin-1Ya inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02572 GENEFORM Protein DME1788 XEOTICID XEO02572 MOACRIVE Inhibition DME1788 XEOTICID XEO02573 XEO_NAME Brevinin-1Yb DME1788 XEOTICID XEO02573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02573 XEO_CLAS Peptide DME1788 XEOTICID XEO02573 DESCRIPT Brevinin-1Yb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02573 GENEFORM Protein DME1788 XEOTICID XEO02573 MOACRIVE Inhibition DME1788 XEOTICID XEO02574 XEO_NAME Brevinin-1Yc DME1788 XEOTICID XEO02574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02574 XEO_CLAS Peptide DME1788 XEOTICID XEO02574 DESCRIPT Brevinin-1Yc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 microM) DME1788 XEOTICID XEO02574 GENEFORM Protein DME1788 XEOTICID XEO02574 MOACRIVE Inhibition DME1788 XEOTICID XEO02575 XEO_NAME Brevinin-1ZHa DME1788 XEOTICID XEO02575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02575 XEO_CLAS Peptide DME1788 XEOTICID XEO02575 DESCRIPT Brevinin-1ZHa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 microM) DME1788 XEOTICID XEO02575 GENEFORM Protein DME1788 XEOTICID XEO02575 MOACRIVE Inhibition DME1788 XEOTICID XEO02576 XEO_NAME Brevinin-1ZHb DME1788 XEOTICID XEO02576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02576 XEO_CLAS Peptide DME1788 XEOTICID XEO02576 DESCRIPT Brevinin-1ZHb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 33 microM) DME1788 XEOTICID XEO02576 GENEFORM Protein DME1788 XEOTICID XEO02576 MOACRIVE Inhibition DME1788 XEOTICID XEO02577 XEO_NAME Brevinin-2 DME1788 XEOTICID XEO02577 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02577 XEO_CLAS Peptide DME1788 XEOTICID XEO02577 DESCRIPT Brevinin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO02577 GENEFORM Protein DME1788 XEOTICID XEO02577 MOACRIVE Inhibition DME1788 XEOTICID XEO02578 XEO_NAME Brevinin-20a DME1788 XEOTICID XEO02578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02578 XEO_CLAS Peptide DME1788 XEOTICID XEO02578 DESCRIPT Brevinin-20a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02578 GENEFORM Protein DME1788 XEOTICID XEO02578 MOACRIVE Inhibition DME1788 XEOTICID XEO02579 XEO_NAME Brevinin-20b DME1788 XEOTICID XEO02579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02579 XEO_CLAS Peptide DME1788 XEOTICID XEO02579 DESCRIPT Brevinin-20b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02579 GENEFORM Protein DME1788 XEOTICID XEO02579 MOACRIVE Inhibition DME1788 XEOTICID XEO02580 XEO_NAME Brevinin-2DYa DME1788 XEOTICID XEO02580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02580 XEO_CLAS Peptide DME1788 XEOTICID XEO02580 DESCRIPT Brevinin-2DYa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC < 15 microM) DME1788 XEOTICID XEO02580 GENEFORM Protein DME1788 XEOTICID XEO02580 MOACRIVE Inhibition DME1788 XEOTICID XEO02581 XEO_NAME Brevinin-2DYb DME1788 XEOTICID XEO02581 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02581 XEO_CLAS Peptide DME1788 XEOTICID XEO02581 DESCRIPT Brevinin-2DYb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 microM) DME1788 XEOTICID XEO02581 GENEFORM Protein DME1788 XEOTICID XEO02581 MOACRIVE Inhibition DME1788 XEOTICID XEO02582 XEO_NAME Brevinin-2DYd DME1788 XEOTICID XEO02582 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02582 XEO_CLAS Peptide DME1788 XEOTICID XEO02582 DESCRIPT Brevinin-2DYd inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 microM) DME1788 XEOTICID XEO02582 GENEFORM Protein DME1788 XEOTICID XEO02582 MOACRIVE Inhibition DME1788 XEOTICID XEO02583 XEO_NAME Brevinin-2DYe DME1788 XEOTICID XEO02583 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02583 XEO_CLAS Peptide DME1788 XEOTICID XEO02583 DESCRIPT Brevinin-2DYe inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 microM) DME1788 XEOTICID XEO02583 GENEFORM Protein DME1788 XEOTICID XEO02583 MOACRIVE Inhibition DME1788 XEOTICID XEO02584 XEO_NAME Brevinin-2E DME1788 XEOTICID XEO02584 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02584 XEO_CLAS Peptide DME1788 XEOTICID XEO02584 DESCRIPT Brevinin-2E inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 microM) DME1788 XEOTICID XEO02584 GENEFORM Protein DME1788 XEOTICID XEO02584 MOACRIVE Inhibition DME1788 XEOTICID XEO02585 XEO_NAME Brevinin-2Ei DME1788 XEOTICID XEO02585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02585 XEO_CLAS Peptide DME1788 XEOTICID XEO02585 DESCRIPT Brevinin-2Ei inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO02585 GENEFORM Protein DME1788 XEOTICID XEO02585 MOACRIVE Inhibition DME1788 XEOTICID XEO02586 XEO_NAME Brevinin-2Ej DME1788 XEOTICID XEO02586 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02586 XEO_CLAS Peptide DME1788 XEOTICID XEO02586 DESCRIPT Brevinin-2Ej inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO02586 GENEFORM Protein DME1788 XEOTICID XEO02586 MOACRIVE Inhibition DME1788 XEOTICID XEO02587 XEO_NAME Brevinin-2Ek DME1788 XEOTICID XEO02587 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02587 XEO_CLAS Peptide DME1788 XEOTICID XEO02587 DESCRIPT Brevinin-2Ek inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02587 GENEFORM Protein DME1788 XEOTICID XEO02587 MOACRIVE Inhibition DME1788 XEOTICID XEO02589 XEO_NAME Brevinin-2GHb DME1788 XEOTICID XEO02589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02589 XEO_CLAS Peptide DME1788 XEOTICID XEO02589 DESCRIPT Brevinin-2GHb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8.2 ug/ml) DME1788 XEOTICID XEO02589 GENEFORM Protein DME1788 XEOTICID XEO02589 MOACRIVE Inhibition DME1788 XEOTICID XEO02590 XEO_NAME Brevinin-2GHc DME1788 XEOTICID XEO02590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02590 XEO_CLAS Peptide DME1788 XEOTICID XEO02590 DESCRIPT Brevinin-2GHc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 19.6 ug/ml) DME1788 XEOTICID XEO02590 GENEFORM Protein DME1788 XEOTICID XEO02590 MOACRIVE Inhibition DME1788 XEOTICID XEO02591 XEO_NAME Brevinin-2GRa DME1788 XEOTICID XEO02591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02591 XEO_CLAS Peptide DME1788 XEOTICID XEO02591 DESCRIPT Brevinin-2GRa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO02591 GENEFORM Protein DME1788 XEOTICID XEO02591 MOACRIVE Inhibition DME1788 XEOTICID XEO02593 XEO_NAME Brevinin-2HSa DME1788 XEOTICID XEO02593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02593 XEO_CLAS Peptide DME1788 XEOTICID XEO02593 DESCRIPT Brevinin-2HSa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 36 microM) DME1788 XEOTICID XEO02593 GENEFORM Protein DME1788 XEOTICID XEO02593 MOACRIVE Inhibition DME1788 XEOTICID XEO02594 XEO_NAME Brevinin-2HSb DME1788 XEOTICID XEO02594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02594 XEO_CLAS Peptide DME1788 XEOTICID XEO02594 DESCRIPT Brevinin-2HSb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02594 GENEFORM Protein DME1788 XEOTICID XEO02594 MOACRIVE Inhibition DME1788 XEOTICID XEO02595 XEO_NAME Brevinin-2ISa DME1788 XEOTICID XEO02595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02595 XEO_CLAS Peptide DME1788 XEOTICID XEO02595 DESCRIPT Brevinin-2ISa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO02595 GENEFORM Protein DME1788 XEOTICID XEO02595 MOACRIVE Inhibition DME1788 XEOTICID XEO02596 XEO_NAME Brevinin-2ISb DME1788 XEOTICID XEO02596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02596 XEO_CLAS Peptide DME1788 XEOTICID XEO02596 DESCRIPT Brevinin-2ISb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO02596 GENEFORM Protein DME1788 XEOTICID XEO02596 MOACRIVE Inhibition DME1788 XEOTICID XEO02597 XEO_NAME Brevinin-2ISc DME1788 XEOTICID XEO02597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02597 XEO_CLAS Peptide DME1788 XEOTICID XEO02597 DESCRIPT Brevinin-2ISc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO02597 GENEFORM Protein DME1788 XEOTICID XEO02597 MOACRIVE Inhibition DME1788 XEOTICID XEO02598 XEO_NAME Brevinin-2LTa DME1788 XEOTICID XEO02598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02598 XEO_CLAS Peptide DME1788 XEOTICID XEO02598 DESCRIPT Brevinin-2LTa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 32.5 microM) DME1788 XEOTICID XEO02598 GENEFORM Protein DME1788 XEOTICID XEO02598 MOACRIVE Inhibition DME1788 XEOTICID XEO02599 XEO_NAME Brevinin-2LTb DME1788 XEOTICID XEO02599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02599 XEO_CLAS Peptide DME1788 XEOTICID XEO02599 DESCRIPT Brevinin-2LTb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 microM) DME1788 XEOTICID XEO02599 GENEFORM Protein DME1788 XEOTICID XEO02599 MOACRIVE Inhibition DME1788 XEOTICID XEO02601 XEO_NAME Brevinin-2-OA1 DME1788 XEOTICID XEO02601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02601 XEO_CLAS Peptide DME1788 XEOTICID XEO02601 DESCRIPT Brevinin-2-OA1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.1 ug/ml) DME1788 XEOTICID XEO02601 GENEFORM Protein DME1788 XEOTICID XEO02601 MOACRIVE Inhibition DME1788 XEOTICID XEO02602 XEO_NAME Brevinin-2-OA2 DME1788 XEOTICID XEO02602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02602 XEO_CLAS Peptide DME1788 XEOTICID XEO02602 DESCRIPT Brevinin-2-OA2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 13.2 ug/ml) DME1788 XEOTICID XEO02602 GENEFORM Protein DME1788 XEOTICID XEO02602 MOACRIVE Inhibition DME1788 XEOTICID XEO02603 XEO_NAME Brevinin-2-OA3 DME1788 XEOTICID XEO02603 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02603 XEO_CLAS Peptide DME1788 XEOTICID XEO02603 DESCRIPT Brevinin-2-OA3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.3 ug/ml) DME1788 XEOTICID XEO02603 GENEFORM Protein DME1788 XEOTICID XEO02603 MOACRIVE Inhibition DME1788 XEOTICID XEO02604 XEO_NAME Brevinin-2-OA4 DME1788 XEOTICID XEO02604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02604 XEO_CLAS Peptide DME1788 XEOTICID XEO02604 DESCRIPT Brevinin-2-OA4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO02604 GENEFORM Protein DME1788 XEOTICID XEO02604 MOACRIVE Inhibition DME1788 XEOTICID XEO02605 XEO_NAME Brevinin-2-OA5 DME1788 XEOTICID XEO02605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02605 XEO_CLAS Peptide DME1788 XEOTICID XEO02605 DESCRIPT Brevinin-2-OA5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30.6 ug/ml) DME1788 XEOTICID XEO02605 GENEFORM Protein DME1788 XEOTICID XEO02605 MOACRIVE Inhibition DME1788 XEOTICID XEO02606 XEO_NAME Brevinin-2-OA6 DME1788 XEOTICID XEO02606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02606 XEO_CLAS Peptide DME1788 XEOTICID XEO02606 DESCRIPT Brevinin-2-OA6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 11.2 ug/ml) DME1788 XEOTICID XEO02606 GENEFORM Protein DME1788 XEOTICID XEO02606 MOACRIVE Inhibition DME1788 XEOTICID XEO02607 XEO_NAME Brevinin-2-OA7 DME1788 XEOTICID XEO02607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02607 XEO_CLAS Peptide DME1788 XEOTICID XEO02607 DESCRIPT Brevinin-2-OA7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.8 ug/ml) DME1788 XEOTICID XEO02607 GENEFORM Protein DME1788 XEOTICID XEO02607 MOACRIVE Inhibition DME1788 XEOTICID XEO02608 XEO_NAME Brevinin-2-OA8 DME1788 XEOTICID XEO02608 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02608 XEO_CLAS Peptide DME1788 XEOTICID XEO02608 DESCRIPT Brevinin-2-OA8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 7.9 ug/ml) DME1788 XEOTICID XEO02608 GENEFORM Protein DME1788 XEOTICID XEO02608 MOACRIVE Inhibition DME1788 XEOTICID XEO02609 XEO_NAME Brevinin-2-OR10 DME1788 XEOTICID XEO02609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02609 XEO_CLAS Peptide DME1788 XEOTICID XEO02609 DESCRIPT Brevinin-2-OR10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15.8 ug/ml) DME1788 XEOTICID XEO02609 GENEFORM Protein DME1788 XEOTICID XEO02609 MOACRIVE Inhibition DME1788 XEOTICID XEO02610 XEO_NAME Brevinin-2-OR2 DME1788 XEOTICID XEO02610 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02610 XEO_CLAS Peptide DME1788 XEOTICID XEO02610 DESCRIPT Brevinin-2-OR2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.1 ug/ml) DME1788 XEOTICID XEO02610 GENEFORM Protein DME1788 XEOTICID XEO02610 MOACRIVE Inhibition DME1788 XEOTICID XEO02611 XEO_NAME Brevinin-2-OR3 DME1788 XEOTICID XEO02611 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02611 XEO_CLAS Peptide DME1788 XEOTICID XEO02611 DESCRIPT Brevinin-2-OR3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20.6 ug/ml) DME1788 XEOTICID XEO02611 GENEFORM Protein DME1788 XEOTICID XEO02611 MOACRIVE Inhibition DME1788 XEOTICID XEO02612 XEO_NAME Brevinin-2-OR4 DME1788 XEOTICID XEO02612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02612 XEO_CLAS Peptide DME1788 XEOTICID XEO02612 DESCRIPT Brevinin-2-OR4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 11.8 ug/ml) DME1788 XEOTICID XEO02612 GENEFORM Protein DME1788 XEOTICID XEO02612 MOACRIVE Inhibition DME1788 XEOTICID XEO02613 XEO_NAME Brevinin-2-OR5 DME1788 XEOTICID XEO02613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02613 XEO_CLAS Peptide DME1788 XEOTICID XEO02613 DESCRIPT Brevinin-2-OR5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 13.2 ug/ml) DME1788 XEOTICID XEO02613 GENEFORM Protein DME1788 XEOTICID XEO02613 MOACRIVE Inhibition DME1788 XEOTICID XEO02614 XEO_NAME Brevinin-2-OR6 DME1788 XEOTICID XEO02614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02614 XEO_CLAS Peptide DME1788 XEOTICID XEO02614 DESCRIPT Brevinin-2-OR6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.8 ug/ml) DME1788 XEOTICID XEO02614 GENEFORM Protein DME1788 XEOTICID XEO02614 MOACRIVE Inhibition DME1788 XEOTICID XEO02615 XEO_NAME Brevinin-2-OR7 DME1788 XEOTICID XEO02615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02615 XEO_CLAS Peptide DME1788 XEOTICID XEO02615 DESCRIPT Brevinin-2-OR7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8.6 ug/ml) DME1788 XEOTICID XEO02615 GENEFORM Protein DME1788 XEOTICID XEO02615 MOACRIVE Inhibition DME1788 XEOTICID XEO02616 XEO_NAME Brevinin-2-OR9 DME1788 XEOTICID XEO02616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02616 XEO_CLAS Peptide DME1788 XEOTICID XEO02616 DESCRIPT Brevinin-2-OR9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20.4 ug/ml) DME1788 XEOTICID XEO02616 GENEFORM Protein DME1788 XEOTICID XEO02616 MOACRIVE Inhibition DME1788 XEOTICID XEO02617 XEO_NAME Brevinin-2-OW1 DME1788 XEOTICID XEO02617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02617 XEO_CLAS Peptide DME1788 XEOTICID XEO02617 DESCRIPT Brevinin-2-OW1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4.7 ug/ml) DME1788 XEOTICID XEO02617 GENEFORM Protein DME1788 XEOTICID XEO02617 MOACRIVE Inhibition DME1788 XEOTICID XEO02618 XEO_NAME Brevinin-2-OW2 DME1788 XEOTICID XEO02618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02618 XEO_CLAS Peptide DME1788 XEOTICID XEO02618 DESCRIPT Brevinin-2-OW2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.6 ug/ml) DME1788 XEOTICID XEO02618 GENEFORM Protein DME1788 XEOTICID XEO02618 MOACRIVE Inhibition DME1788 XEOTICID XEO02619 XEO_NAME Brevinin-2-OW3 DME1788 XEOTICID XEO02619 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02619 XEO_CLAS Peptide DME1788 XEOTICID XEO02619 DESCRIPT Brevinin-2-OW3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10.5 ug/ml) DME1788 XEOTICID XEO02619 GENEFORM Protein DME1788 XEOTICID XEO02619 MOACRIVE Inhibition DME1788 XEOTICID XEO02620 XEO_NAME Brevinin-2PRa DME1788 XEOTICID XEO02620 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02620 XEO_CLAS Peptide DME1788 XEOTICID XEO02620 DESCRIPT Brevinin-2PRa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO02620 GENEFORM Protein DME1788 XEOTICID XEO02620 MOACRIVE Inhibition DME1788 XEOTICID XEO02621 XEO_NAME Brevinin-2PRb DME1788 XEOTICID XEO02621 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02621 XEO_CLAS Peptide DME1788 XEOTICID XEO02621 DESCRIPT Brevinin-2PRb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO02621 GENEFORM Protein DME1788 XEOTICID XEO02621 MOACRIVE Inhibition DME1788 XEOTICID XEO02622 XEO_NAME Brevinin-2PRd DME1788 XEOTICID XEO02622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02622 XEO_CLAS Peptide DME1788 XEOTICID XEO02622 DESCRIPT Brevinin-2PRd inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO02622 GENEFORM Protein DME1788 XEOTICID XEO02622 MOACRIVE Inhibition DME1788 XEOTICID XEO02623 XEO_NAME Brevinin-2PRe DME1788 XEOTICID XEO02623 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02623 XEO_CLAS Peptide DME1788 XEOTICID XEO02623 DESCRIPT Brevinin-2PRe inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO02623 GENEFORM Protein DME1788 XEOTICID XEO02623 MOACRIVE Inhibition DME1788 XEOTICID XEO02624 XEO_NAME Brevinin-2PTa DME1788 XEOTICID XEO02624 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02624 XEO_CLAS Peptide DME1788 XEOTICID XEO02624 DESCRIPT Brevinin-2PTa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 18 microM) DME1788 XEOTICID XEO02624 GENEFORM Protein DME1788 XEOTICID XEO02624 MOACRIVE Inhibition DME1788 XEOTICID XEO02625 XEO_NAME Brevinin-2PTb DME1788 XEOTICID XEO02625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02625 XEO_CLAS Peptide DME1788 XEOTICID XEO02625 DESCRIPT Brevinin-2PTb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 9 microM) DME1788 XEOTICID XEO02625 GENEFORM Protein DME1788 XEOTICID XEO02625 MOACRIVE Inhibition DME1788 XEOTICID XEO02626 XEO_NAME Brevinin-2PTc DME1788 XEOTICID XEO02626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02626 XEO_CLAS Peptide DME1788 XEOTICID XEO02626 DESCRIPT Brevinin-2PTc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 18 microM) DME1788 XEOTICID XEO02626 GENEFORM Protein DME1788 XEOTICID XEO02626 MOACRIVE Inhibition DME1788 XEOTICID XEO02627 XEO_NAME Brevinin-2PTd DME1788 XEOTICID XEO02627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02627 XEO_CLAS Peptide DME1788 XEOTICID XEO02627 DESCRIPT Brevinin-2PTd inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02627 GENEFORM Protein DME1788 XEOTICID XEO02627 MOACRIVE Inhibition DME1788 XEOTICID XEO02628 XEO_NAME Brevinin-2PTe DME1788 XEOTICID XEO02628 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02628 XEO_CLAS Peptide DME1788 XEOTICID XEO02628 DESCRIPT Brevinin-2PTe inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 18 microM) DME1788 XEOTICID XEO02628 GENEFORM Protein DME1788 XEOTICID XEO02628 MOACRIVE Inhibition DME1788 XEOTICID XEO02629 XEO_NAME Brevinin-2-related peptide DME1788 XEOTICID XEO02629 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02629 XEO_CLAS Peptide DME1788 XEOTICID XEO02629 DESCRIPT Brevinin-2-related peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 13 microM) DME1788 XEOTICID XEO02629 GENEFORM Protein DME1788 XEOTICID XEO02629 MOACRIVE Inhibition DME1788 XEOTICID XEO02630 XEO_NAME Brevinin-2-RN1 DME1788 XEOTICID XEO02630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02630 XEO_CLAS Peptide DME1788 XEOTICID XEO02630 DESCRIPT Brevinin-2-RN1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 ug/ml) DME1788 XEOTICID XEO02630 GENEFORM Protein DME1788 XEOTICID XEO02630 MOACRIVE Inhibition DME1788 XEOTICID XEO02631 XEO_NAME Brevinin-2-RN2 DME1788 XEOTICID XEO02631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02631 XEO_CLAS Peptide DME1788 XEOTICID XEO02631 DESCRIPT Brevinin-2-RN2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 ug/ml) DME1788 XEOTICID XEO02631 GENEFORM Protein DME1788 XEOTICID XEO02631 MOACRIVE Inhibition DME1788 XEOTICID XEO02634 XEO_NAME Brevinin-2SKb DME1788 XEOTICID XEO02634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02634 XEO_CLAS Peptide DME1788 XEOTICID XEO02634 DESCRIPT Brevinin-2SKb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO02634 GENEFORM Protein DME1788 XEOTICID XEO02634 MOACRIVE Inhibition DME1788 XEOTICID XEO02635 XEO_NAME Brevinin-2TEa DME1788 XEOTICID XEO02635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02635 XEO_CLAS Peptide DME1788 XEOTICID XEO02635 DESCRIPT Brevinin-2TEa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40 ug/ml) DME1788 XEOTICID XEO02635 GENEFORM Protein DME1788 XEOTICID XEO02635 MOACRIVE Inhibition DME1788 XEOTICID XEO02636 XEO_NAME Brevinin-2TEb DME1788 XEOTICID XEO02636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02636 XEO_CLAS Peptide DME1788 XEOTICID XEO02636 DESCRIPT Brevinin-2TEb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO02636 GENEFORM Protein DME1788 XEOTICID XEO02636 MOACRIVE Inhibition DME1788 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1788 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02637 XEO_CLAS Peptide DME1788 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO02637 GENEFORM Protein DME1788 XEOTICID XEO02637 MOACRIVE Inhibition DME1788 XEOTICID XEO02638 XEO_NAME Brevinin-2Va DME1788 XEOTICID XEO02638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02638 XEO_CLAS Peptide DME1788 XEOTICID XEO02638 DESCRIPT Brevinin-2Va inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 microM) DME1788 XEOTICID XEO02638 GENEFORM Protein DME1788 XEOTICID XEO02638 MOACRIVE Inhibition DME1788 XEOTICID XEO02639 XEO_NAME Brevinin-2ZHa DME1788 XEOTICID XEO02639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02639 XEO_CLAS Peptide DME1788 XEOTICID XEO02639 DESCRIPT Brevinin-2ZHa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 microM) DME1788 XEOTICID XEO02639 GENEFORM Protein DME1788 XEOTICID XEO02639 MOACRIVE Inhibition DME1788 XEOTICID XEO02644 XEO_NAME Theta-defensin BTD-1 DME1788 XEOTICID XEO02644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02644 XEO_CLAS Peptide DME1788 XEOTICID XEO02644 DESCRIPT Theta-defensin BTD-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02644 GENEFORM Protein DME1788 XEOTICID XEO02644 MOACRIVE Inhibition DME1788 XEOTICID XEO02645 XEO_NAME Theta-defensin BTD-2 DME1788 XEOTICID XEO02645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02645 XEO_CLAS Peptide DME1788 XEOTICID XEO02645 DESCRIPT Theta-defensin BTD-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02645 GENEFORM Protein DME1788 XEOTICID XEO02645 MOACRIVE Inhibition DME1788 XEOTICID XEO02646 XEO_NAME Theta-defensin BTD-4 DME1788 XEOTICID XEO02646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02646 XEO_CLAS Peptide DME1788 XEOTICID XEO02646 DESCRIPT Theta-defensin BTD-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02646 GENEFORM Protein DME1788 XEOTICID XEO02646 MOACRIVE Inhibition DME1788 XEOTICID XEO02647 XEO_NAME Theta-defensin BTD-7 DME1788 XEOTICID XEO02647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02647 XEO_CLAS Peptide DME1788 XEOTICID XEO02647 DESCRIPT Theta-defensin BTD-7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02647 GENEFORM Protein DME1788 XEOTICID XEO02647 MOACRIVE Inhibition DME1788 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1788 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02649 XEO_CLAS Peptide DME1788 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO02649 GENEFORM Protein DME1788 XEOTICID XEO02649 MOACRIVE Inhibition DME1788 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1788 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02650 XEO_CLAS Peptide DME1788 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO02650 GENEFORM Protein DME1788 XEOTICID XEO02650 MOACRIVE Inhibition DME1788 XEOTICID XEO02658 XEO_NAME Buthinin DME1788 XEOTICID XEO02658 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02658 XEO_CLAS Peptide DME1788 XEOTICID XEO02658 DESCRIPT Buthinin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02658 GENEFORM Protein DME1788 XEOTICID XEO02658 MOACRIVE Inhibition DME1788 XEOTICID XEO02663 XEO_NAME P18 analogue C-1 DME1788 XEOTICID XEO02663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02663 XEO_CLAS Peptide DME1788 XEOTICID XEO02663 DESCRIPT P18 analogue C-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25 microM) DME1788 XEOTICID XEO02663 GENEFORM Protein DME1788 XEOTICID XEO02663 MOACRIVE Inhibition DME1788 XEOTICID XEO02664 XEO_NAME P18 analogue C-10 DME1788 XEOTICID XEO02664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02664 XEO_CLAS Peptide DME1788 XEOTICID XEO02664 DESCRIPT P18 analogue C-10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25 microM) DME1788 XEOTICID XEO02664 GENEFORM Protein DME1788 XEOTICID XEO02664 MOACRIVE Inhibition DME1788 XEOTICID XEO02672 XEO_NAME P18 analogue C-2 DME1788 XEOTICID XEO02672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02672 XEO_CLAS Peptide DME1788 XEOTICID XEO02672 DESCRIPT P18 analogue C-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25 microM) DME1788 XEOTICID XEO02672 GENEFORM Protein DME1788 XEOTICID XEO02672 MOACRIVE Inhibition DME1788 XEOTICID XEO02673 XEO_NAME P18 analogue C-3 DME1788 XEOTICID XEO02673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02673 XEO_CLAS Peptide DME1788 XEOTICID XEO02673 DESCRIPT P18 analogue C-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1788 XEOTICID XEO02673 GENEFORM Protein DME1788 XEOTICID XEO02673 MOACRIVE Inhibition DME1788 XEOTICID XEO02674 XEO_NAME P18 analogue C-4 DME1788 XEOTICID XEO02674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02674 XEO_CLAS Peptide DME1788 XEOTICID XEO02674 DESCRIPT P18 analogue C-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.125-6.25 microM) DME1788 XEOTICID XEO02674 GENEFORM Protein DME1788 XEOTICID XEO02674 MOACRIVE Inhibition DME1788 XEOTICID XEO02676 XEO_NAME P18 analogue C-5 DME1788 XEOTICID XEO02676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02676 XEO_CLAS Peptide DME1788 XEOTICID XEO02676 DESCRIPT P18 analogue C-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO02676 GENEFORM Protein DME1788 XEOTICID XEO02676 MOACRIVE Inhibition DME1788 XEOTICID XEO02677 XEO_NAME P18 analogue C-6 DME1788 XEOTICID XEO02677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02677 XEO_CLAS Peptide DME1788 XEOTICID XEO02677 DESCRIPT P18 analogue C-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1788 XEOTICID XEO02677 GENEFORM Protein DME1788 XEOTICID XEO02677 MOACRIVE Inhibition DME1788 XEOTICID XEO02679 XEO_NAME P18 analogue C-7 DME1788 XEOTICID XEO02679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02679 XEO_CLAS Peptide DME1788 XEOTICID XEO02679 DESCRIPT P18 analogue C-7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1788 XEOTICID XEO02679 GENEFORM Protein DME1788 XEOTICID XEO02679 MOACRIVE Inhibition DME1788 XEOTICID XEO02680 XEO_NAME P18 analogue C-8 DME1788 XEOTICID XEO02680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02680 XEO_CLAS Peptide DME1788 XEOTICID XEO02680 DESCRIPT P18 analogue C-8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25 microM) DME1788 XEOTICID XEO02680 GENEFORM Protein DME1788 XEOTICID XEO02680 MOACRIVE Inhibition DME1788 XEOTICID XEO02683 XEO_NAME P18 analogue C-9 DME1788 XEOTICID XEO02683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02683 XEO_CLAS Peptide DME1788 XEOTICID XEO02683 DESCRIPT P18 analogue C-9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO02683 GENEFORM Protein DME1788 XEOTICID XEO02683 MOACRIVE Inhibition DME1788 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1788 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02688 XEO_CLAS Peptide DME1788 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO02688 GENEFORM Protein DME1788 XEOTICID XEO02688 MOACRIVE Inhibition DME1788 XEOTICID XEO02693 XEO_NAME Caerin-1.4 DME1788 XEOTICID XEO02693 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02693 XEO_CLAS Peptide DME1788 XEOTICID XEO02693 DESCRIPT Caerin-1.4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 ug/ml) DME1788 XEOTICID XEO02693 GENEFORM Protein DME1788 XEOTICID XEO02693 MOACRIVE Inhibition DME1788 XEOTICID XEO02699 XEO_NAME Caerin-4.1 DME1788 XEOTICID XEO02699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02699 XEO_CLAS Peptide DME1788 XEOTICID XEO02699 DESCRIPT Caerin-4.1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 ug/ml) DME1788 XEOTICID XEO02699 GENEFORM Protein DME1788 XEOTICID XEO02699 MOACRIVE Inhibition DME1788 XEOTICID XEO02700 XEO_NAME Caerin-4.3 DME1788 XEOTICID XEO02700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02700 XEO_CLAS Peptide DME1788 XEOTICID XEO02700 DESCRIPT Caerin-4.3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 ug/ml) DME1788 XEOTICID XEO02700 GENEFORM Protein DME1788 XEOTICID XEO02700 MOACRIVE Inhibition DME1788 XEOTICID XEO02703 XEO_NAME Calcitermin DME1788 XEOTICID XEO02703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02703 XEO_CLAS Peptide DME1788 XEOTICID XEO02703 DESCRIPT Calcitermin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02703 GENEFORM Protein DME1788 XEOTICID XEO02703 MOACRIVE Inhibition DME1788 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1788 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02708 XEO_CLAS Peptide DME1788 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO02708 GENEFORM Protein DME1788 XEOTICID XEO02708 MOACRIVE Inhibition DME1788 XEOTICID XEO02709 XEO_NAME CAP18 fragment CAP7 DME1788 XEOTICID XEO02709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02709 XEO_CLAS Peptide DME1788 XEOTICID XEO02709 DESCRIPT CAP18 fragment CAP7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.05 microM) DME1788 XEOTICID XEO02709 GENEFORM Protein DME1788 XEOTICID XEO02709 MOACRIVE Inhibition DME1788 XEOTICID XEO02713 XEO_NAME Carbonyl cyanide m-chlorophenylhydrazone DME1788 XEOTICID XEO02713 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO02713 XEO_CLAS Preclinical/Patented Drug DME1788 XEOTICID XEO02713 DESCRIPT Carbonyl cyanide m-chlorophenylhydrazone inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02713 GENEFORM Protein DME1788 XEOTICID XEO02713 MOACRIVE Inhibition DME1788 XEOTICID XEO02714 XEO_NAME Carboxymethyl chitosan DME1788 XEOTICID XEO02714 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO02714 XEO_CLAS Investigative Agent DME1788 XEOTICID XEO02714 DESCRIPT Carboxymethyl chitosan inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02714 GENEFORM Protein DME1788 XEOTICID XEO02714 MOACRIVE Inhibition DME1788 XEOTICID XEO02726 XEO_NAME Casocidin-1 DME1788 XEOTICID XEO02726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02726 XEO_CLAS Peptide DME1788 XEOTICID XEO02726 DESCRIPT Casocidin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02726 GENEFORM Protein DME1788 XEOTICID XEO02726 MOACRIVE Inhibition DME1788 XEOTICID XEO02731 XEO_NAME Cathelicidin DME1788 XEOTICID XEO02731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02731 XEO_CLAS Peptide DME1788 XEOTICID XEO02731 DESCRIPT Cathelicidin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1 microM) DME1788 XEOTICID XEO02731 GENEFORM Protein DME1788 XEOTICID XEO02731 MOACRIVE Inhibition DME1788 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1788 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02732 XEO_CLAS Peptide DME1788 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.25 microM) DME1788 XEOTICID XEO02732 GENEFORM Protein DME1788 XEOTICID XEO02732 MOACRIVE Inhibition DME1788 XEOTICID XEO02733 XEO_NAME Bactenecin-1 DME1788 XEOTICID XEO02733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02733 XEO_CLAS Peptide DME1788 XEOTICID XEO02733 DESCRIPT Bactenecin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8-25 ug/ml) DME1788 XEOTICID XEO02733 GENEFORM Protein DME1788 XEOTICID XEO02733 MOACRIVE Inhibition DME1788 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1788 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02735 XEO_CLAS Peptide DME1788 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1 ug/ml) DME1788 XEOTICID XEO02735 GENEFORM Protein DME1788 XEOTICID XEO02735 MOACRIVE Inhibition DME1788 XEOTICID XEO02737 XEO_NAME Bactenecin-7 DME1788 XEOTICID XEO02737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02737 XEO_CLAS Peptide DME1788 XEOTICID XEO02737 DESCRIPT Bactenecin-7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02737 GENEFORM Protein DME1788 XEOTICID XEO02737 MOACRIVE Inhibition DME1788 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1788 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02738 XEO_CLAS Peptide DME1788 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO02738 GENEFORM Protein DME1788 XEOTICID XEO02738 MOACRIVE Inhibition DME1788 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1788 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02739 XEO_CLAS Peptide DME1788 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 microM) DME1788 XEOTICID XEO02739 GENEFORM Protein DME1788 XEOTICID XEO02739 MOACRIVE Inhibition DME1788 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1788 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02740 XEO_CLAS Peptide DME1788 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.25 ug/ml) DME1788 XEOTICID XEO02740 GENEFORM Protein DME1788 XEOTICID XEO02740 MOACRIVE Inhibition DME1788 XEOTICID XEO02741 XEO_NAME Cathelicidin-AL DME1788 XEOTICID XEO02741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02741 XEO_CLAS Peptide DME1788 XEOTICID XEO02741 DESCRIPT Cathelicidin-AL inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 ug/ml) DME1788 XEOTICID XEO02741 GENEFORM Protein DME1788 XEOTICID XEO02741 MOACRIVE Inhibition DME1788 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1788 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02743 XEO_CLAS Peptide DME1788 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.6 ug/ml) DME1788 XEOTICID XEO02743 GENEFORM Protein DME1788 XEOTICID XEO02743 MOACRIVE Inhibition DME1788 XEOTICID XEO02744 XEO_NAME cathelicidin-BF15 DME1788 XEOTICID XEO02744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02744 XEO_CLAS Peptide DME1788 XEOTICID XEO02744 DESCRIPT cathelicidin-BF15 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 18.7 ug/ml) DME1788 XEOTICID XEO02744 GENEFORM Protein DME1788 XEOTICID XEO02744 MOACRIVE Inhibition DME1788 XEOTICID XEO02745 XEO_NAME Cathelicidin-NA DME1788 XEOTICID XEO02745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02745 XEO_CLAS Peptide DME1788 XEOTICID XEO02745 DESCRIPT Cathelicidin-NA inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02745 GENEFORM Protein DME1788 XEOTICID XEO02745 MOACRIVE Inhibition DME1788 XEOTICID XEO02746 XEO_NAME Cathelicidin-OH DME1788 XEOTICID XEO02746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02746 XEO_CLAS Peptide DME1788 XEOTICID XEO02746 DESCRIPT Cathelicidin-OH inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02746 GENEFORM Protein DME1788 XEOTICID XEO02746 MOACRIVE Inhibition DME1788 XEOTICID XEO02748 XEO_NAME Cathelicidin-related antimicrobial peptide DME1788 XEOTICID XEO02748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02748 XEO_CLAS Peptide DME1788 XEOTICID XEO02748 DESCRIPT Cathelicidin-related antimicrobial peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02748 GENEFORM Protein DME1788 XEOTICID XEO02748 MOACRIVE Inhibition DME1788 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1788 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02749 XEO_CLAS Peptide DME1788 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20-25 mug/ml) DME1788 XEOTICID XEO02749 GENEFORM Protein DME1788 XEOTICID XEO02749 MOACRIVE Inhibition DME1788 XEOTICID XEO02750 XEO_NAME C-C motif chemokine ligand 20 DME1788 XEOTICID XEO02750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02750 XEO_CLAS Peptide DME1788 XEOTICID XEO02750 DESCRIPT C-C motif chemokine ligand 20 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02750 GENEFORM Protein DME1788 XEOTICID XEO02750 MOACRIVE Inhibition DME1788 XEOTICID XEO02752 XEO_NAME C-C motif chemokine 20(1-67) DME1788 XEOTICID XEO02752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02752 XEO_CLAS Peptide DME1788 XEOTICID XEO02752 DESCRIPT C-C motif chemokine 20(1-67) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02752 GENEFORM Protein DME1788 XEOTICID XEO02752 MOACRIVE Inhibition DME1788 XEOTICID XEO02753 XEO_NAME C-C motif chemokine 20(2-70) DME1788 XEOTICID XEO02753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02753 XEO_CLAS Peptide DME1788 XEOTICID XEO02753 DESCRIPT C-C motif chemokine 20(2-70) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02753 GENEFORM Protein DME1788 XEOTICID XEO02753 MOACRIVE Inhibition DME1788 XEOTICID XEO02754 XEO_NAME Cecropin-A CE DME1788 XEOTICID XEO02754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02754 XEO_CLAS Peptide DME1788 XEOTICID XEO02754 DESCRIPT Cecropin-A CE inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 microM) DME1788 XEOTICID XEO02754 GENEFORM Protein DME1788 XEOTICID XEO02754 MOACRIVE Inhibition DME1788 XEOTICID XEO02756 XEO_NAME Cecropin-A(1-7)-melittin(1-8) hybrid DME1788 XEOTICID XEO02756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02756 XEO_CLAS Peptide DME1788 XEOTICID XEO02756 DESCRIPT Cecropin-A(1-7)-melittin(1-8) hybrid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 microM) DME1788 XEOTICID XEO02756 GENEFORM Protein DME1788 XEOTICID XEO02756 MOACRIVE Inhibition DME1788 XEOTICID XEO02757 XEO_NAME Cecropin-A(1-7)-melittin(2-9) hybrid DME1788 XEOTICID XEO02757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02757 XEO_CLAS Peptide DME1788 XEOTICID XEO02757 DESCRIPT Cecropin-A(1-7)-melittin(2-9) hybrid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1 microM) DME1788 XEOTICID XEO02757 GENEFORM Protein DME1788 XEOTICID XEO02757 MOACRIVE Inhibition DME1788 XEOTICID XEO02758 XEO_NAME Cecropin-A(1-7)-melittin(3-10) hybrid DME1788 XEOTICID XEO02758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02758 XEO_CLAS Peptide DME1788 XEOTICID XEO02758 DESCRIPT Cecropin-A(1-7)-melittin(3-10) hybrid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO02758 GENEFORM Protein DME1788 XEOTICID XEO02758 MOACRIVE Inhibition DME1788 XEOTICID XEO02759 XEO_NAME Cecropin-A(1-7)-melittin(4-11) hybrid DME1788 XEOTICID XEO02759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02759 XEO_CLAS Peptide DME1788 XEOTICID XEO02759 DESCRIPT Cecropin-A(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.6 microM) DME1788 XEOTICID XEO02759 GENEFORM Protein DME1788 XEOTICID XEO02759 MOACRIVE Inhibition DME1788 XEOTICID XEO02760 XEO_NAME Cecropin-A(1-7)-melittin(5-12) hybrid DME1788 XEOTICID XEO02760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02760 XEO_CLAS Peptide DME1788 XEOTICID XEO02760 DESCRIPT Cecropin-A(1-7)-melittin(5-12) hybrid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 microM) DME1788 XEOTICID XEO02760 GENEFORM Protein DME1788 XEOTICID XEO02760 MOACRIVE Inhibition DME1788 XEOTICID XEO02761 XEO_NAME Cecropin-A(1-7)-melittin(6-13) hybrid DME1788 XEOTICID XEO02761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02761 XEO_CLAS Peptide DME1788 XEOTICID XEO02761 DESCRIPT Cecropin-A(1-7)-melittin(6-13) hybrid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO02761 GENEFORM Protein DME1788 XEOTICID XEO02761 MOACRIVE Inhibition DME1788 XEOTICID XEO02762 XEO_NAME Cecropin-A(1-8)-melittin(1-10) hybrid DME1788 XEOTICID XEO02762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02762 XEO_CLAS Peptide DME1788 XEOTICID XEO02762 DESCRIPT Cecropin-A(1-8)-melittin(1-10) hybrid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 microM) DME1788 XEOTICID XEO02762 GENEFORM Protein DME1788 XEOTICID XEO02762 MOACRIVE Inhibition DME1788 XEOTICID XEO02763 XEO_NAME Cecropin-A(1-8)-melittin(1-12) hybrid DME1788 XEOTICID XEO02763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02763 XEO_CLAS Peptide DME1788 XEOTICID XEO02763 DESCRIPT Cecropin-A(1-8)-melittin(1-12) hybrid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.4 microM) DME1788 XEOTICID XEO02763 GENEFORM Protein DME1788 XEOTICID XEO02763 MOACRIVE Inhibition DME1788 XEOTICID XEO02764 XEO_NAME Cecropin-A(1-8)-melittin(1-13) hybrid DME1788 XEOTICID XEO02764 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02764 XEO_CLAS Peptide DME1788 XEOTICID XEO02764 DESCRIPT Cecropin-A(1-8)-melittin(1-13) hybrid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 microM) DME1788 XEOTICID XEO02764 GENEFORM Protein DME1788 XEOTICID XEO02764 MOACRIVE Inhibition DME1788 XEOTICID XEO02765 XEO_NAME Cecropin-A(1-8)-melittin(1-18) hybrid DME1788 XEOTICID XEO02765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02765 XEO_CLAS Peptide DME1788 XEOTICID XEO02765 DESCRIPT Cecropin-A(1-8)-melittin(1-18) hybrid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.3 microM) DME1788 XEOTICID XEO02765 GENEFORM Protein DME1788 XEOTICID XEO02765 MOACRIVE Inhibition DME1788 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1788 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02767 XEO_CLAS Peptide DME1788 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02767 GENEFORM Protein DME1788 XEOTICID XEO02767 MOACRIVE Inhibition DME1788 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1788 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02768 XEO_CLAS Peptide DME1788 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.1-0.25 ug/ml) DME1788 XEOTICID XEO02768 GENEFORM Protein DME1788 XEOTICID XEO02768 MOACRIVE Inhibition DME1788 XEOTICID XEO02769 XEO_NAME Immune protein P9 DME1788 XEOTICID XEO02769 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02769 XEO_CLAS Peptide DME1788 XEOTICID XEO02769 DESCRIPT Immune protein P9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.32 microM) DME1788 XEOTICID XEO02769 GENEFORM Protein DME1788 XEOTICID XEO02769 MOACRIVE Inhibition DME1788 XEOTICID XEO02770 XEO_NAME Insect cecropin-B DME1788 XEOTICID XEO02770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02770 XEO_CLAS Peptide DME1788 XEOTICID XEO02770 DESCRIPT Insect cecropin-B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.30 microM) DME1788 XEOTICID XEO02770 GENEFORM Protein DME1788 XEOTICID XEO02770 MOACRIVE Inhibition DME1788 XEOTICID XEO02771 XEO_NAME Cecropin-D DME1788 XEOTICID XEO02771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02771 XEO_CLAS Peptide DME1788 XEOTICID XEO02771 DESCRIPT Cecropin-D inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.21 microM) DME1788 XEOTICID XEO02771 GENEFORM Protein DME1788 XEOTICID XEO02771 MOACRIVE Inhibition DME1788 XEOTICID XEO02772 XEO_NAME Insect cecropin-D DME1788 XEOTICID XEO02772 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02772 XEO_CLAS Peptide DME1788 XEOTICID XEO02772 DESCRIPT Insect cecropin-D inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02772 GENEFORM Protein DME1788 XEOTICID XEO02772 MOACRIVE Inhibition DME1788 XEOTICID XEO02773 XEO_NAME Cecropin-D-like peptide DME1788 XEOTICID XEO02773 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02773 XEO_CLAS Peptide DME1788 XEOTICID XEO02773 DESCRIPT Cecropin-D-like peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.9-8.6 microM) DME1788 XEOTICID XEO02773 GENEFORM Protein DME1788 XEOTICID XEO02773 MOACRIVE Inhibition DME1788 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1788 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02774 XEO_CLAS Peptide DME1788 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.3 microM) DME1788 XEOTICID XEO02774 GENEFORM Protein DME1788 XEOTICID XEO02774 MOACRIVE Inhibition DME1788 XEOTICID XEO02789 XEO_NAME Bifidobacterium adolescentis cell extract DME1788 XEOTICID XEO02789 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02789 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02789 DESCRIPT Bifidobacterium adolescentis cell extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02789 GENEFORM Protein DME1788 XEOTICID XEO02789 MOACRIVE Inhibition DME1788 XEOTICID XEO02790 XEO_NAME Bifidobacterium bifidum cell extract DME1788 XEOTICID XEO02790 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02790 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02790 DESCRIPT Bifidobacterium bifidum cell extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02790 GENEFORM Protein DME1788 XEOTICID XEO02790 MOACRIVE Inhibition DME1788 XEOTICID XEO02791 XEO_NAME Bifidobacterium breve cell extract DME1788 XEOTICID XEO02791 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02791 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02791 DESCRIPT Bifidobacterium breve cell extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02791 GENEFORM Protein DME1788 XEOTICID XEO02791 MOACRIVE Inhibition DME1788 XEOTICID XEO02792 XEO_NAME Bifidobacterium catenulatum cell extract DME1788 XEOTICID XEO02792 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02792 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02792 DESCRIPT Bifidobacterium catenulatum cell extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02792 GENEFORM Protein DME1788 XEOTICID XEO02792 MOACRIVE Inhibition DME1788 XEOTICID XEO02793 XEO_NAME Bifidobacterium infantis ATCC 15697 cell extract DME1788 XEOTICID XEO02793 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02793 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02793 DESCRIPT Bifidobacterium infantis ATCC 15697 cell extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02793 GENEFORM Protein DME1788 XEOTICID XEO02793 MOACRIVE Inhibition DME1788 XEOTICID XEO02794 XEO_NAME Bifidobacterium infantis KCTC 3368 cell extract DME1788 XEOTICID XEO02794 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02794 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02794 DESCRIPT Bifidobacterium infantis KCTC 3368 cell extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02794 GENEFORM Protein DME1788 XEOTICID XEO02794 MOACRIVE Inhibition DME1788 XEOTICID XEO02795 XEO_NAME Bifidobacterium longum ATCC 15707 cell extract DME1788 XEOTICID XEO02795 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02795 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02795 DESCRIPT Bifidobacterium longum ATCC 15707 cell extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02795 GENEFORM Protein DME1788 XEOTICID XEO02795 MOACRIVE Inhibition DME1788 XEOTICID XEO02796 XEO_NAME Bifidobacterium longum DSM 20097 cell extract DME1788 XEOTICID XEO02796 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02796 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02796 DESCRIPT Bifidobacterium longum DSM 20097 cell extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02796 GENEFORM Protein DME1788 XEOTICID XEO02796 MOACRIVE Inhibition DME1788 XEOTICID XEO02797 XEO_NAME Bifidobacterium pseudolongum cell extract DME1788 XEOTICID XEO02797 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02797 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02797 DESCRIPT Bifidobacterium pseudolongum cell extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02797 GENEFORM Protein DME1788 XEOTICID XEO02797 MOACRIVE Inhibition DME1788 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1788 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02799 XEO_CLAS Peptide DME1788 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02799 GENEFORM Protein DME1788 XEOTICID XEO02799 MOACRIVE Inhibition DME1788 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1788 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02800 XEO_CLAS Peptide DME1788 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02800 GENEFORM Protein DME1788 XEOTICID XEO02800 MOACRIVE Inhibition DME1788 XEOTICID XEO02802 XEO_NAME Ceratotoxin-C DME1788 XEOTICID XEO02802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02802 XEO_CLAS Peptide DME1788 XEOTICID XEO02802 DESCRIPT Ceratotoxin-C inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 13.6 microM) DME1788 XEOTICID XEO02802 GENEFORM Protein DME1788 XEOTICID XEO02802 MOACRIVE Inhibition DME1788 XEOTICID XEO02807 XEO_NAME Oyster cgUbiquitin DME1788 XEOTICID XEO02807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02807 XEO_CLAS Peptide DME1788 XEOTICID XEO02807 DESCRIPT Oyster cgUbiquitin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.2 microM) DME1788 XEOTICID XEO02807 GENEFORM Protein DME1788 XEOTICID XEO02807 MOACRIVE Inhibition DME1788 XEOTICID XEO02813 XEO_NAME Chassatide ChaC1 DME1788 XEOTICID XEO02813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02813 XEO_CLAS Peptide DME1788 XEOTICID XEO02813 DESCRIPT Chassatide ChaC1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 80 microM) DME1788 XEOTICID XEO02813 GENEFORM Protein DME1788 XEOTICID XEO02813 MOACRIVE Inhibition DME1788 XEOTICID XEO02814 XEO_NAME Chassatide ChaC10 DME1788 XEOTICID XEO02814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02814 XEO_CLAS Peptide DME1788 XEOTICID XEO02814 DESCRIPT Chassatide ChaC10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 80 microM) DME1788 XEOTICID XEO02814 GENEFORM Protein DME1788 XEOTICID XEO02814 MOACRIVE Inhibition DME1788 XEOTICID XEO02815 XEO_NAME Chassatide ChaC11 DME1788 XEOTICID XEO02815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02815 XEO_CLAS Peptide DME1788 XEOTICID XEO02815 DESCRIPT Chassatide ChaC11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8.5 microM) DME1788 XEOTICID XEO02815 GENEFORM Protein DME1788 XEOTICID XEO02815 MOACRIVE Inhibition DME1788 XEOTICID XEO02816 XEO_NAME Chassatide ChaC2 DME1788 XEOTICID XEO02816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02816 XEO_CLAS Peptide DME1788 XEOTICID XEO02816 DESCRIPT Chassatide ChaC2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 80 microM) DME1788 XEOTICID XEO02816 GENEFORM Protein DME1788 XEOTICID XEO02816 MOACRIVE Inhibition DME1788 XEOTICID XEO02817 XEO_NAME Chassatide ChaC4 DME1788 XEOTICID XEO02817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02817 XEO_CLAS Peptide DME1788 XEOTICID XEO02817 DESCRIPT Chassatide ChaC4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 80 microM) DME1788 XEOTICID XEO02817 GENEFORM Protein DME1788 XEOTICID XEO02817 MOACRIVE Inhibition DME1788 XEOTICID XEO02818 XEO_NAME Chassatide ChaC7 DME1788 XEOTICID XEO02818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02818 XEO_CLAS Peptide DME1788 XEOTICID XEO02818 DESCRIPT Chassatide ChaC7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.4 microM) DME1788 XEOTICID XEO02818 GENEFORM Protein DME1788 XEOTICID XEO02818 MOACRIVE Inhibition DME1788 XEOTICID XEO02819 XEO_NAME Chassatide ChaC8 DME1788 XEOTICID XEO02819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02819 XEO_CLAS Peptide DME1788 XEOTICID XEO02819 DESCRIPT Chassatide ChaC8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.6 microM) DME1788 XEOTICID XEO02819 GENEFORM Protein DME1788 XEOTICID XEO02819 MOACRIVE Inhibition DME1788 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1788 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02820 XEO_CLAS Peptide DME1788 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO02820 GENEFORM Protein DME1788 XEOTICID XEO02820 MOACRIVE Inhibition DME1788 XEOTICID XEO02821 XEO_NAME Charybdotoxin DME1788 XEOTICID XEO02821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02821 XEO_CLAS Peptide DME1788 XEOTICID XEO02821 DESCRIPT Charybdotoxin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02821 GENEFORM Protein DME1788 XEOTICID XEO02821 MOACRIVE Inhibition DME1788 XEOTICID XEO02824 XEO_NAME Chensinin-1ZHa DME1788 XEOTICID XEO02824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02824 XEO_CLAS Peptide DME1788 XEOTICID XEO02824 DESCRIPT Chensinin-1ZHa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 35 microM) DME1788 XEOTICID XEO02824 GENEFORM Protein DME1788 XEOTICID XEO02824 MOACRIVE Inhibition DME1788 XEOTICID XEO02826 XEO_NAME Chicken heterophil peptides CHP1 DME1788 XEOTICID XEO02826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02826 XEO_CLAS Peptide DME1788 XEOTICID XEO02826 DESCRIPT Chicken heterophil peptides CHP1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.7 ug/ml) DME1788 XEOTICID XEO02826 GENEFORM Protein DME1788 XEOTICID XEO02826 MOACRIVE Inhibition DME1788 XEOTICID XEO02834 XEO_NAME Chlorpromazine DME1788 XEOTICID XEO02834 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO02834 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO02834 DESCRIPT Chlorpromazine inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02834 GENEFORM Protein DME1788 XEOTICID XEO02834 MOACRIVE Inhibition DME1788 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1788 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02839 XEO_CLAS Peptide DME1788 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.25 microM) DME1788 XEOTICID XEO02839 GENEFORM Protein DME1788 XEOTICID XEO02839 MOACRIVE Inhibition DME1788 XEOTICID XEO02841 XEO_NAME Chrysophsin-2 DME1788 XEOTICID XEO02841 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02841 XEO_CLAS Peptide DME1788 XEOTICID XEO02841 DESCRIPT Chrysophsin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.25 microM) DME1788 XEOTICID XEO02841 GENEFORM Protein DME1788 XEOTICID XEO02841 MOACRIVE Inhibition DME1788 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME1788 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02842 XEO_CLAS Peptide DME1788 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.25 microM) DME1788 XEOTICID XEO02842 GENEFORM Protein DME1788 XEOTICID XEO02842 MOACRIVE Inhibition DME1788 XEOTICID XEO02843 XEO_NAME Chymotrypsin-elastase inhibitor ixodidin DME1788 XEOTICID XEO02843 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02843 XEO_CLAS Peptide DME1788 XEOTICID XEO02843 DESCRIPT Chymotrypsin-elastase inhibitor ixodidin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02843 GENEFORM Protein DME1788 XEOTICID XEO02843 MOACRIVE Inhibition DME1788 XEOTICID XEO02849 XEO_NAME Ciprofloxacin lactate DME1788 XEOTICID XEO02849 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO02849 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO02849 DESCRIPT Ciprofloxacin lactate inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02849 GENEFORM Protein DME1788 XEOTICID XEO02849 MOACRIVE Inhibition DME1788 XEOTICID XEO02857 XEO_NAME Citropin-1.1 M14 DME1788 XEOTICID XEO02857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02857 XEO_CLAS Peptide DME1788 XEOTICID XEO02857 DESCRIPT Citropin-1.1 M14 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 53 microM) DME1788 XEOTICID XEO02857 GENEFORM Protein DME1788 XEOTICID XEO02857 MOACRIVE Inhibition DME1788 XEOTICID XEO02858 XEO_NAME Citropin-1.1 M15 DME1788 XEOTICID XEO02858 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02858 XEO_CLAS Peptide DME1788 XEOTICID XEO02858 DESCRIPT Citropin-1.1 M15 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 53 microM) DME1788 XEOTICID XEO02858 GENEFORM Protein DME1788 XEOTICID XEO02858 MOACRIVE Inhibition DME1788 XEOTICID XEO02860 XEO_NAME Citropin-1.1 sm1 DME1788 XEOTICID XEO02860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02860 XEO_CLAS Peptide DME1788 XEOTICID XEO02860 DESCRIPT Citropin-1.1 sm1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 ug/ml) DME1788 XEOTICID XEO02860 GENEFORM Protein DME1788 XEOTICID XEO02860 MOACRIVE Inhibition DME1788 XEOTICID XEO02867 XEO_NAME Clavanin-E DME1788 XEOTICID XEO02867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02867 XEO_CLAS Peptide DME1788 XEOTICID XEO02867 DESCRIPT Clavanin-E inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02867 GENEFORM Protein DME1788 XEOTICID XEO02867 MOACRIVE Inhibition DME1788 XEOTICID XEO02868 XEO_NAME Clavanin-A DME1788 XEOTICID XEO02868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02868 XEO_CLAS Peptide DME1788 XEOTICID XEO02868 DESCRIPT Clavanin-A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02868 GENEFORM Protein DME1788 XEOTICID XEO02868 MOACRIVE Inhibition DME1788 XEOTICID XEO02869 XEO_NAME Clavanin-B DME1788 XEOTICID XEO02869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02869 XEO_CLAS Peptide DME1788 XEOTICID XEO02869 DESCRIPT Clavanin-B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02869 GENEFORM Protein DME1788 XEOTICID XEO02869 MOACRIVE Inhibition DME1788 XEOTICID XEO02870 XEO_NAME Clavanin-C DME1788 XEOTICID XEO02870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02870 XEO_CLAS Peptide DME1788 XEOTICID XEO02870 DESCRIPT Clavanin-C inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02870 GENEFORM Protein DME1788 XEOTICID XEO02870 MOACRIVE Inhibition DME1788 XEOTICID XEO02871 XEO_NAME Clavanin-D DME1788 XEOTICID XEO02871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02871 XEO_CLAS Peptide DME1788 XEOTICID XEO02871 DESCRIPT Clavanin-D inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02871 GENEFORM Protein DME1788 XEOTICID XEO02871 MOACRIVE Inhibition DME1788 XEOTICID XEO02872 XEO_NAME Caprine lalctoferricin fragment cLf 20-29 DME1788 XEOTICID XEO02872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02872 XEO_CLAS Peptide DME1788 XEOTICID XEO02872 DESCRIPT Caprine lalctoferricin fragment cLf 20-29 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 308 microM) DME1788 XEOTICID XEO02872 GENEFORM Protein DME1788 XEOTICID XEO02872 MOACRIVE Inhibition DME1788 XEOTICID XEO02875 XEO_NAME Cliotide cT1 DME1788 XEOTICID XEO02875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02875 XEO_CLAS Peptide DME1788 XEOTICID XEO02875 DESCRIPT Cliotide cT1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.1 microM) DME1788 XEOTICID XEO02875 GENEFORM Protein DME1788 XEOTICID XEO02875 MOACRIVE Inhibition DME1788 XEOTICID XEO02876 XEO_NAME Cliotide cT2 DME1788 XEOTICID XEO02876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02876 XEO_CLAS Peptide DME1788 XEOTICID XEO02876 DESCRIPT Cliotide cT2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO02876 GENEFORM Protein DME1788 XEOTICID XEO02876 MOACRIVE Inhibition DME1788 XEOTICID XEO02877 XEO_NAME Cliotide cT3 DME1788 XEOTICID XEO02877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02877 XEO_CLAS Peptide DME1788 XEOTICID XEO02877 DESCRIPT Cliotide cT3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO02877 GENEFORM Protein DME1788 XEOTICID XEO02877 MOACRIVE Inhibition DME1788 XEOTICID XEO02878 XEO_NAME Cliotide cT4 DME1788 XEOTICID XEO02878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02878 XEO_CLAS Peptide DME1788 XEOTICID XEO02878 DESCRIPT Cliotide cT4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.3 microM) DME1788 XEOTICID XEO02878 GENEFORM Protein DME1788 XEOTICID XEO02878 MOACRIVE Inhibition DME1788 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1788 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02885 XEO_CLAS Peptide DME1788 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02885 GENEFORM Protein DME1788 XEOTICID XEO02885 MOACRIVE Inhibition DME1788 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1788 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02886 XEO_CLAS Peptide DME1788 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02886 GENEFORM Protein DME1788 XEOTICID XEO02886 MOACRIVE Inhibition DME1788 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1788 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02887 XEO_CLAS Peptide DME1788 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1 ug/ml) DME1788 XEOTICID XEO02887 GENEFORM Protein DME1788 XEOTICID XEO02887 MOACRIVE Inhibition DME1788 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1788 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02888 XEO_CLAS Peptide DME1788 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 ug/ml) DME1788 XEOTICID XEO02888 GENEFORM Protein DME1788 XEOTICID XEO02888 MOACRIVE Inhibition DME1788 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1788 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02889 XEO_CLAS Peptide DME1788 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 ug/ml) DME1788 XEOTICID XEO02889 GENEFORM Protein DME1788 XEOTICID XEO02889 MOACRIVE Inhibition DME1788 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1788 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02890 XEO_CLAS Peptide DME1788 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02890 GENEFORM Protein DME1788 XEOTICID XEO02890 MOACRIVE Inhibition DME1788 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1788 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02891 XEO_CLAS Peptide DME1788 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02891 GENEFORM Protein DME1788 XEOTICID XEO02891 MOACRIVE Inhibition DME1788 XEOTICID XEO02895 XEO_NAME CNBr-cleaved lactoferricin 1 DME1788 XEOTICID XEO02895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02895 XEO_CLAS Peptide DME1788 XEOTICID XEO02895 DESCRIPT CNBr-cleaved lactoferricin 1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO02895 GENEFORM Protein DME1788 XEOTICID XEO02895 MOACRIVE Inhibition DME1788 XEOTICID XEO02896 XEO_NAME CNBr-cleaved lactoferricin 2 DME1788 XEOTICID XEO02896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02896 XEO_CLAS Peptide DME1788 XEOTICID XEO02896 DESCRIPT CNBr-cleaved lactoferricin 2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO02896 GENEFORM Protein DME1788 XEOTICID XEO02896 MOACRIVE Inhibition DME1788 XEOTICID XEO02899 XEO_NAME Coladonin DME1788 XEOTICID XEO02899 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1788 XEOTICID XEO02899 XEO_CLAS Chemical Compound DME1788 XEOTICID XEO02899 DESCRIPT Coladonin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02899 GENEFORM Protein DME1788 XEOTICID XEO02899 MOACRIVE Inhibition DME1788 XEOTICID XEO02900 XEO_NAME Coleoptericin DME1788 XEOTICID XEO02900 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02900 XEO_CLAS Peptide DME1788 XEOTICID XEO02900 DESCRIPT Coleoptericin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02900 GENEFORM Protein DME1788 XEOTICID XEO02900 MOACRIVE Inhibition DME1788 XEOTICID XEO02901 XEO_NAME Colicin-V DME1788 XEOTICID XEO02901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02901 XEO_CLAS Peptide DME1788 XEOTICID XEO02901 DESCRIPT Colicin-V inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02901 GENEFORM Protein DME1788 XEOTICID XEO02901 MOACRIVE Inhibition DME1788 XEOTICID XEO02904 XEO_NAME Colistin sodium methanesulfonate DME1788 XEOTICID XEO02904 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO02904 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO02904 DESCRIPT Colistin sodium methanesulfonate inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02904 GENEFORM Protein DME1788 XEOTICID XEO02904 MOACRIVE Inhibition DME1788 XEOTICID XEO02908 XEO_NAME Conolysin-Mt1 DME1788 XEOTICID XEO02908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02908 XEO_CLAS Peptide DME1788 XEOTICID XEO02908 DESCRIPT Conolysin-Mt1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 50 microM) DME1788 XEOTICID XEO02908 GENEFORM Protein DME1788 XEOTICID XEO02908 MOACRIVE Inhibition DME1788 XEOTICID XEO02923 XEO_NAME Corticostatin-related RK-1 DME1788 XEOTICID XEO02923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02923 XEO_CLAS Peptide DME1788 XEOTICID XEO02923 DESCRIPT Corticostatin-related RK-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02923 GENEFORM Protein DME1788 XEOTICID XEO02923 MOACRIVE Inhibition DME1788 XEOTICID XEO02924 XEO_NAME Reptile cOT2 DME1788 XEOTICID XEO02924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02924 XEO_CLAS Peptide DME1788 XEOTICID XEO02924 DESCRIPT Reptile cOT2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 32 microM) DME1788 XEOTICID XEO02924 GENEFORM Protein DME1788 XEOTICID XEO02924 MOACRIVE Inhibition DME1788 XEOTICID XEO02927 XEO_NAME Coumarin-3-carboxylic acid DME1788 XEOTICID XEO02927 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO02927 XEO_CLAS Investigative Agent DME1788 XEOTICID XEO02927 DESCRIPT Coumarin-3-carboxylic acid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02927 GENEFORM Protein DME1788 XEOTICID XEO02927 MOACRIVE Inhibition DME1788 XEOTICID XEO02931 XEO_NAME Cathelicidin CP-11 DME1788 XEOTICID XEO02931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02931 XEO_CLAS Peptide DME1788 XEOTICID XEO02931 DESCRIPT Cathelicidin CP-11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 ug/ml) DME1788 XEOTICID XEO02931 GENEFORM Protein DME1788 XEOTICID XEO02931 MOACRIVE Inhibition DME1788 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1788 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02933 XEO_CLAS Peptide DME1788 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO02933 GENEFORM Protein DME1788 XEOTICID XEO02933 MOACRIVE Inhibition DME1788 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1788 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02934 XEO_CLAS Peptide DME1788 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02934 GENEFORM Protein DME1788 XEOTICID XEO02934 MOACRIVE Inhibition DME1788 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1788 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02935 XEO_CLAS Peptide DME1788 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02935 GENEFORM Protein DME1788 XEOTICID XEO02935 MOACRIVE Inhibition DME1788 XEOTICID XEO02936 XEO_NAME CP206 peptide DME1788 XEOTICID XEO02936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02936 XEO_CLAS Peptide DME1788 XEOTICID XEO02936 DESCRIPT CP206 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO02936 GENEFORM Protein DME1788 XEOTICID XEO02936 MOACRIVE Inhibition DME1788 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1788 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02937 XEO_CLAS Peptide DME1788 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02937 GENEFORM Protein DME1788 XEOTICID XEO02937 MOACRIVE Inhibition DME1788 XEOTICID XEO02938 XEO_NAME CP208 peptide DME1788 XEOTICID XEO02938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02938 XEO_CLAS Peptide DME1788 XEOTICID XEO02938 DESCRIPT CP208 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 32 ug/ml) DME1788 XEOTICID XEO02938 GENEFORM Protein DME1788 XEOTICID XEO02938 MOACRIVE Inhibition DME1788 XEOTICID XEO02939 XEO_NAME CP209 peptide DME1788 XEOTICID XEO02939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02939 XEO_CLAS Peptide DME1788 XEOTICID XEO02939 DESCRIPT CP209 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 11 ug/ml) DME1788 XEOTICID XEO02939 GENEFORM Protein DME1788 XEOTICID XEO02939 MOACRIVE Inhibition DME1788 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1788 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02940 XEO_CLAS Peptide DME1788 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1 ug/ml) DME1788 XEOTICID XEO02940 GENEFORM Protein DME1788 XEOTICID XEO02940 MOACRIVE Inhibition DME1788 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1788 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02941 XEO_CLAS Peptide DME1788 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02941 GENEFORM Protein DME1788 XEOTICID XEO02941 MOACRIVE Inhibition DME1788 XEOTICID XEO02944 XEO_NAME Caerulein precursor-related fragment-Ea DME1788 XEOTICID XEO02944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02944 XEO_CLAS Peptide DME1788 XEOTICID XEO02944 DESCRIPT Caerulein precursor-related fragment-Ea inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 microM) DME1788 XEOTICID XEO02944 GENEFORM Protein DME1788 XEOTICID XEO02944 MOACRIVE Inhibition DME1788 XEOTICID XEO02945 XEO_NAME Caerulein precursor-related fragment-Eb DME1788 XEOTICID XEO02945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02945 XEO_CLAS Peptide DME1788 XEOTICID XEO02945 DESCRIPT Caerulein precursor-related fragment-Eb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 microM) DME1788 XEOTICID XEO02945 GENEFORM Protein DME1788 XEOTICID XEO02945 MOACRIVE Inhibition DME1788 XEOTICID XEO02946 XEO_NAME Caerulein precursor-related fragment-Ec DME1788 XEOTICID XEO02946 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02946 XEO_CLAS Peptide DME1788 XEOTICID XEO02946 DESCRIPT Caerulein precursor-related fragment-Ec inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 microM) DME1788 XEOTICID XEO02946 GENEFORM Protein DME1788 XEOTICID XEO02946 MOACRIVE Inhibition DME1788 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1788 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02947 XEO_CLAS Peptide DME1788 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02947 GENEFORM Protein DME1788 XEOTICID XEO02947 MOACRIVE Inhibition DME1788 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1788 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02948 XEO_CLAS Peptide DME1788 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO02948 GENEFORM Protein DME1788 XEOTICID XEO02948 MOACRIVE Inhibition DME1788 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1788 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02949 XEO_CLAS Peptide DME1788 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO02949 GENEFORM Protein DME1788 XEOTICID XEO02949 MOACRIVE Inhibition DME1788 XEOTICID XEO02954 XEO_NAME Crotamine defensin-like toxin DME1788 XEOTICID XEO02954 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02954 XEO_CLAS Peptide DME1788 XEOTICID XEO02954 DESCRIPT Crotamine defensin-like toxin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02954 GENEFORM Protein DME1788 XEOTICID XEO02954 MOACRIVE Inhibition DME1788 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1788 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02958 XEO_CLAS Peptide DME1788 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02958 GENEFORM Protein DME1788 XEOTICID XEO02958 MOACRIVE Inhibition DME1788 XEOTICID XEO02962 XEO_NAME Cryptonin DME1788 XEOTICID XEO02962 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02962 XEO_CLAS Peptide DME1788 XEOTICID XEO02962 DESCRIPT Cryptonin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.12 ug/ml) DME1788 XEOTICID XEO02962 GENEFORM Protein DME1788 XEOTICID XEO02962 MOACRIVE Inhibition DME1788 XEOTICID XEO02965 XEO_NAME Scorpion Css54 DME1788 XEOTICID XEO02965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02965 XEO_CLAS Peptide DME1788 XEOTICID XEO02965 DESCRIPT Scorpion Css54 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 ug/ml) DME1788 XEOTICID XEO02965 GENEFORM Protein DME1788 XEOTICID XEO02965 MOACRIVE Inhibition DME1788 XEOTICID XEO02969 XEO_NAME Ctx(Ile21)-Ha-I9K peptide DME1788 XEOTICID XEO02969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02969 XEO_CLAS Peptide DME1788 XEOTICID XEO02969 DESCRIPT Ctx(Ile21)-Ha-I9K peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 microM) DME1788 XEOTICID XEO02969 GENEFORM Protein DME1788 XEOTICID XEO02969 MOACRIVE Inhibition DME1788 XEOTICID XEO02971 XEO_NAME Ctx-Ha peptide derivative Ctx(Ile21)-Ha DME1788 XEOTICID XEO02971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02971 XEO_CLAS Peptide DME1788 XEOTICID XEO02971 DESCRIPT Ctx-Ha peptide derivative Ctx(Ile21)-Ha inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 microM) DME1788 XEOTICID XEO02971 GENEFORM Protein DME1788 XEOTICID XEO02971 MOACRIVE Inhibition DME1788 XEOTICID XEO02972 XEO_NAME Frog ctx-Ha DME1788 XEOTICID XEO02972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO02972 XEO_CLAS Peptide DME1788 XEOTICID XEO02972 DESCRIPT Frog ctx-Ha inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.4 microM) DME1788 XEOTICID XEO02972 GENEFORM Protein DME1788 XEOTICID XEO02972 MOACRIVE Inhibition DME1788 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1788 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02990 GENEFORM Protein DME1788 XEOTICID XEO02990 MOACRIVE Inhibition DME1788 XEOTICID XEO02991 XEO_NAME Bacillus licheniformis SP10 culture supernatant DME1788 XEOTICID XEO02991 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02991 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02991 DESCRIPT Bacillus licheniformis SP10 culture supernatant inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02991 GENEFORM Protein DME1788 XEOTICID XEO02991 MOACRIVE Inhibition DME1788 XEOTICID XEO02992 XEO_NAME Bacillus licheniformis SP2 culture supernatant DME1788 XEOTICID XEO02992 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02992 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02992 DESCRIPT Bacillus licheniformis SP2 culture supernatant inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02992 GENEFORM Protein DME1788 XEOTICID XEO02992 MOACRIVE Inhibition DME1788 XEOTICID XEO02993 XEO_NAME Bacillus licheniformis SP3 culture supernatant DME1788 XEOTICID XEO02993 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02993 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02993 DESCRIPT Bacillus licheniformis SP3 culture supernatant inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02993 GENEFORM Protein DME1788 XEOTICID XEO02993 MOACRIVE Inhibition DME1788 XEOTICID XEO02994 XEO_NAME Bacillus licheniformis SP4 culture supernatant DME1788 XEOTICID XEO02994 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02994 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02994 DESCRIPT Bacillus licheniformis SP4 culture supernatant inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02994 GENEFORM Protein DME1788 XEOTICID XEO02994 MOACRIVE Inhibition DME1788 XEOTICID XEO02995 XEO_NAME Bacillus licheniformis SP5 culture supernatant DME1788 XEOTICID XEO02995 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02995 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02995 DESCRIPT Bacillus licheniformis SP5 culture supernatant inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02995 GENEFORM Protein DME1788 XEOTICID XEO02995 MOACRIVE Inhibition DME1788 XEOTICID XEO02996 XEO_NAME Bacillus licheniformis SP6 culture supernatant DME1788 XEOTICID XEO02996 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02996 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02996 DESCRIPT Bacillus licheniformis SP6 culture supernatant inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02996 GENEFORM Protein DME1788 XEOTICID XEO02996 MOACRIVE Inhibition DME1788 XEOTICID XEO02997 XEO_NAME Bacillus licheniformis SP7 culture supernatant DME1788 XEOTICID XEO02997 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02997 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02997 DESCRIPT Bacillus licheniformis SP7 culture supernatant inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02997 GENEFORM Protein DME1788 XEOTICID XEO02997 MOACRIVE Inhibition DME1788 XEOTICID XEO02998 XEO_NAME Bacillus licheniformis SP8 culture supernatant DME1788 XEOTICID XEO02998 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02998 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02998 DESCRIPT Bacillus licheniformis SP8 culture supernatant inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02998 GENEFORM Protein DME1788 XEOTICID XEO02998 MOACRIVE Inhibition DME1788 XEOTICID XEO02999 XEO_NAME Bacillus licheniformis SP9 culture supernatant DME1788 XEOTICID XEO02999 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO02999 XEO_CLAS Bacterial Extract DME1788 XEOTICID XEO02999 DESCRIPT Bacillus licheniformis SP9 culture supernatant inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO02999 GENEFORM Protein DME1788 XEOTICID XEO02999 MOACRIVE Inhibition DME1788 XEOTICID XEO03021 XEO_NAME Cupiennin-1D DME1788 XEOTICID XEO03021 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03021 XEO_CLAS Peptide DME1788 XEOTICID XEO03021 DESCRIPT Cupiennin-1D inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1788 XEOTICID XEO03021 GENEFORM Protein DME1788 XEOTICID XEO03021 MOACRIVE Inhibition DME1788 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1788 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03029 XEO_CLAS Peptide DME1788 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.005 microM) DME1788 XEOTICID XEO03029 GENEFORM Protein DME1788 XEOTICID XEO03029 MOACRIVE Inhibition DME1788 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1788 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03030 XEO_CLAS Peptide DME1788 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.005 microM) DME1788 XEOTICID XEO03030 GENEFORM Protein DME1788 XEOTICID XEO03030 MOACRIVE Inhibition DME1788 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1788 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03031 XEO_CLAS Peptide DME1788 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.3 microM) DME1788 XEOTICID XEO03031 GENEFORM Protein DME1788 XEOTICID XEO03031 MOACRIVE Inhibition DME1788 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1788 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03032 XEO_CLAS Peptide DME1788 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.01 microM) DME1788 XEOTICID XEO03032 GENEFORM Protein DME1788 XEOTICID XEO03032 MOACRIVE Inhibition DME1788 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1788 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03033 XEO_CLAS Peptide DME1788 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.173 microM) DME1788 XEOTICID XEO03033 GENEFORM Protein DME1788 XEOTICID XEO03033 MOACRIVE Inhibition DME1788 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1788 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03034 XEO_CLAS Peptide DME1788 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.518 microM) DME1788 XEOTICID XEO03034 GENEFORM Protein DME1788 XEOTICID XEO03034 MOACRIVE Inhibition DME1788 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1788 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03035 XEO_CLAS Peptide DME1788 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.114 microM) DME1788 XEOTICID XEO03035 GENEFORM Protein DME1788 XEOTICID XEO03035 MOACRIVE Inhibition DME1788 XEOTICID XEO03039 XEO_NAME Cyclopsychotride-A DME1788 XEOTICID XEO03039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03039 XEO_CLAS Peptide DME1788 XEOTICID XEO03039 DESCRIPT Cyclopsychotride-A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.55 microM) DME1788 XEOTICID XEO03039 GENEFORM Protein DME1788 XEOTICID XEO03039 MOACRIVE Inhibition DME1788 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1788 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03043 XEO_CLAS Peptide DME1788 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 microM) DME1788 XEOTICID XEO03043 GENEFORM Protein DME1788 XEOTICID XEO03043 MOACRIVE Inhibition DME1788 XEOTICID XEO03044 XEO_NAME Cruzioseptin CZS-1 DME1788 XEOTICID XEO03044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03044 XEO_CLAS Peptide DME1788 XEOTICID XEO03044 DESCRIPT Cruzioseptin CZS-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03044 GENEFORM Protein DME1788 XEOTICID XEO03044 MOACRIVE Inhibition DME1788 XEOTICID XEO03045 XEO_NAME Cruzioseptin CZS-2 DME1788 XEOTICID XEO03045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03045 XEO_CLAS Peptide DME1788 XEOTICID XEO03045 DESCRIPT Cruzioseptin CZS-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03045 GENEFORM Protein DME1788 XEOTICID XEO03045 MOACRIVE Inhibition DME1788 XEOTICID XEO03046 XEO_NAME Cruzioseptin CZS-3 DME1788 XEOTICID XEO03046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03046 XEO_CLAS Peptide DME1788 XEOTICID XEO03046 DESCRIPT Cruzioseptin CZS-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03046 GENEFORM Protein DME1788 XEOTICID XEO03046 MOACRIVE Inhibition DME1788 XEOTICID XEO03049 XEO_NAME D0-NH2 peptide DME1788 XEOTICID XEO03049 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03049 XEO_CLAS Peptide DME1788 XEOTICID XEO03049 DESCRIPT D0-NH2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 microM) DME1788 XEOTICID XEO03049 GENEFORM Protein DME1788 XEOTICID XEO03049 MOACRIVE Inhibition DME1788 XEOTICID XEO03055 XEO_NAME D1-NH2 peptide DME1788 XEOTICID XEO03055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03055 XEO_CLAS Peptide DME1788 XEOTICID XEO03055 DESCRIPT D1-NH2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 microM) DME1788 XEOTICID XEO03055 GENEFORM Protein DME1788 XEOTICID XEO03055 MOACRIVE Inhibition DME1788 XEOTICID XEO03059 XEO_NAME D2-NH2 peptide DME1788 XEOTICID XEO03059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03059 XEO_CLAS Peptide DME1788 XEOTICID XEO03059 DESCRIPT D2-NH2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO03059 GENEFORM Protein DME1788 XEOTICID XEO03059 MOACRIVE Inhibition DME1788 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1788 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03060 XEO_CLAS Peptide DME1788 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO03060 GENEFORM Protein DME1788 XEOTICID XEO03060 MOACRIVE Inhibition DME1788 XEOTICID XEO03062 XEO_NAME D3-NH2 peptide DME1788 XEOTICID XEO03062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03062 XEO_CLAS Peptide DME1788 XEOTICID XEO03062 DESCRIPT D3-NH2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO03062 GENEFORM Protein DME1788 XEOTICID XEO03062 MOACRIVE Inhibition DME1788 XEOTICID XEO03064 XEO_NAME D4-NH2 peptide DME1788 XEOTICID XEO03064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03064 XEO_CLAS Peptide DME1788 XEOTICID XEO03064 DESCRIPT D4-NH2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO03064 GENEFORM Protein DME1788 XEOTICID XEO03064 MOACRIVE Inhibition DME1788 XEOTICID XEO03066 XEO_NAME D5-NH2 peptide DME1788 XEOTICID XEO03066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03066 XEO_CLAS Peptide DME1788 XEOTICID XEO03066 DESCRIPT D5-NH2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO03066 GENEFORM Protein DME1788 XEOTICID XEO03066 MOACRIVE Inhibition DME1788 XEOTICID XEO03068 XEO_NAME D6-NH2 peptide DME1788 XEOTICID XEO03068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03068 XEO_CLAS Peptide DME1788 XEOTICID XEO03068 DESCRIPT D6-NH2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO03068 GENEFORM Protein DME1788 XEOTICID XEO03068 MOACRIVE Inhibition DME1788 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME1788 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03073 XEO_CLAS Peptide DME1788 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8-16 ug/ml) DME1788 XEOTICID XEO03073 GENEFORM Protein DME1788 XEOTICID XEO03073 MOACRIVE Inhibition DME1788 XEOTICID XEO03081 XEO_NAME Pig DBI(32-86) DME1788 XEOTICID XEO03081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03081 XEO_CLAS Peptide DME1788 XEOTICID XEO03081 DESCRIPT Pig DBI(32-86) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 microM) DME1788 XEOTICID XEO03081 GENEFORM Protein DME1788 XEOTICID XEO03081 MOACRIVE Inhibition DME1788 XEOTICID XEO03082 XEO_NAME Dermcidin chain DCD-1 DME1788 XEOTICID XEO03082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03082 XEO_CLAS Peptide DME1788 XEOTICID XEO03082 DESCRIPT Dermcidin chain DCD-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03082 GENEFORM Protein DME1788 XEOTICID XEO03082 MOACRIVE Inhibition DME1788 XEOTICID XEO03089 XEO_NAME Decoralin DME1788 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03089 XEO_CLAS Peptide DME1788 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 160 microM) DME1788 XEOTICID XEO03089 GENEFORM Protein DME1788 XEOTICID XEO03089 MOACRIVE Inhibition DME1788 XEOTICID XEO03098 XEO_NAME Insect defensin DME1788 XEOTICID XEO03098 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03098 XEO_CLAS Peptide DME1788 XEOTICID XEO03098 DESCRIPT Insect defensin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 ug/ml) DME1788 XEOTICID XEO03098 GENEFORM Protein DME1788 XEOTICID XEO03098 MOACRIVE Inhibition DME1788 XEOTICID XEO03100 XEO_NAME Type 1 invertebrate defensin DME1788 XEOTICID XEO03100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03100 XEO_CLAS Peptide DME1788 XEOTICID XEO03100 DESCRIPT Type 1 invertebrate defensin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03100 GENEFORM Protein DME1788 XEOTICID XEO03100 MOACRIVE Inhibition DME1788 XEOTICID XEO03103 XEO_NAME Defensin Ns-D1 DME1788 XEOTICID XEO03103 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03103 XEO_CLAS Peptide DME1788 XEOTICID XEO03103 DESCRIPT Defensin Ns-D1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03103 GENEFORM Protein DME1788 XEOTICID XEO03103 MOACRIVE Inhibition DME1788 XEOTICID XEO03105 XEO_NAME Defensin Ns-D2 DME1788 XEOTICID XEO03105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03105 XEO_CLAS Peptide DME1788 XEOTICID XEO03105 DESCRIPT Defensin Ns-D2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03105 GENEFORM Protein DME1788 XEOTICID XEO03105 MOACRIVE Inhibition DME1788 XEOTICID XEO03110 XEO_NAME Defensin MGD-1 DME1788 XEOTICID XEO03110 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03110 XEO_CLAS Peptide DME1788 XEOTICID XEO03110 DESCRIPT Defensin MGD-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.2 microM) DME1788 XEOTICID XEO03110 GENEFORM Protein DME1788 XEOTICID XEO03110 MOACRIVE Inhibition DME1788 XEOTICID XEO03111 XEO_NAME American oyster defensin-1 DME1788 XEOTICID XEO03111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03111 XEO_CLAS Peptide DME1788 XEOTICID XEO03111 DESCRIPT American oyster defensin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03111 GENEFORM Protein DME1788 XEOTICID XEO03111 MOACRIVE Inhibition DME1788 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1788 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03112 XEO_CLAS Peptide DME1788 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 50 ug/ml) DME1788 XEOTICID XEO03112 GENEFORM Protein DME1788 XEOTICID XEO03112 MOACRIVE Inhibition DME1788 XEOTICID XEO03115 XEO_NAME Defensin DefA DME1788 XEOTICID XEO03115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03115 XEO_CLAS Peptide DME1788 XEOTICID XEO03115 DESCRIPT Defensin DefA inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03115 GENEFORM Protein DME1788 XEOTICID XEO03115 MOACRIVE Inhibition DME1788 XEOTICID XEO03116 XEO_NAME Insect defensin A DME1788 XEOTICID XEO03116 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03116 XEO_CLAS Peptide DME1788 XEOTICID XEO03116 DESCRIPT Insect defensin A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 40 microM) DME1788 XEOTICID XEO03116 GENEFORM Protein DME1788 XEOTICID XEO03116 MOACRIVE Inhibition DME1788 XEOTICID XEO03118 XEO_NAME Defensin AaeDefD DME1788 XEOTICID XEO03118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03118 XEO_CLAS Peptide DME1788 XEOTICID XEO03118 DESCRIPT Defensin AaeDefD inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03118 GENEFORM Protein DME1788 XEOTICID XEO03118 MOACRIVE Inhibition DME1788 XEOTICID XEO03119 XEO_NAME Defensin-like protein sesquin DME1788 XEOTICID XEO03119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03119 XEO_CLAS Peptide DME1788 XEOTICID XEO03119 DESCRIPT Defensin-like protein sesquin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03119 GENEFORM Protein DME1788 XEOTICID XEO03119 MOACRIVE Inhibition DME1788 XEOTICID XEO03121 XEO_NAME Defensin-like protein fabatin-1 DME1788 XEOTICID XEO03121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03121 XEO_CLAS Peptide DME1788 XEOTICID XEO03121 DESCRIPT Defensin-like protein fabatin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03121 GENEFORM Protein DME1788 XEOTICID XEO03121 MOACRIVE Inhibition DME1788 XEOTICID XEO03122 XEO_NAME Defensin-like protein Cp-thionin II DME1788 XEOTICID XEO03122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03122 XEO_CLAS Peptide DME1788 XEOTICID XEO03122 DESCRIPT Defensin-like protein Cp-thionin II inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64000 ug/ml) DME1788 XEOTICID XEO03122 GENEFORM Protein DME1788 XEOTICID XEO03122 MOACRIVE Inhibition DME1788 XEOTICID XEO03124 XEO_NAME Defensin-like protein brazzein DME1788 XEOTICID XEO03124 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03124 XEO_CLAS Peptide DME1788 XEOTICID XEO03124 DESCRIPT Defensin-like protein brazzein inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03124 GENEFORM Protein DME1788 XEOTICID XEO03124 MOACRIVE Inhibition DME1788 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1788 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03125 XEO_CLAS Peptide DME1788 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03125 GENEFORM Protein DME1788 XEOTICID XEO03125 MOACRIVE Inhibition DME1788 XEOTICID XEO03126 XEO_NAME Defensin-NV DME1788 XEOTICID XEO03126 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03126 XEO_CLAS Peptide DME1788 XEOTICID XEO03126 DESCRIPT Defensin-NV inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.86 microM) DME1788 XEOTICID XEO03126 GENEFORM Protein DME1788 XEOTICID XEO03126 MOACRIVE Inhibition DME1788 XEOTICID XEO03127 XEO_NAME Murine beta-defensin related peptide Defr1 DME1788 XEOTICID XEO03127 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03127 XEO_CLAS Peptide DME1788 XEOTICID XEO03127 DESCRIPT Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03127 GENEFORM Protein DME1788 XEOTICID XEO03127 MOACRIVE Inhibition DME1788 XEOTICID XEO03128 XEO_NAME Ranalexin analog Del 1 DME1788 XEOTICID XEO03128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03128 XEO_CLAS Peptide DME1788 XEOTICID XEO03128 DESCRIPT Ranalexin analog Del 1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 256 ug/ml) DME1788 XEOTICID XEO03128 GENEFORM Protein DME1788 XEOTICID XEO03128 MOACRIVE Inhibition DME1788 XEOTICID XEO03129 XEO_NAME Ranalexin analog Del 1-2 DME1788 XEOTICID XEO03129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03129 XEO_CLAS Peptide DME1788 XEOTICID XEO03129 DESCRIPT Ranalexin analog Del 1-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 256 ug/ml) DME1788 XEOTICID XEO03129 GENEFORM Protein DME1788 XEOTICID XEO03129 MOACRIVE Inhibition DME1788 XEOTICID XEO03130 XEO_NAME Ranalexin analog Del 1-3 DME1788 XEOTICID XEO03130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03130 XEO_CLAS Peptide DME1788 XEOTICID XEO03130 DESCRIPT Ranalexin analog Del 1-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 256 ug/ml) DME1788 XEOTICID XEO03130 GENEFORM Protein DME1788 XEOTICID XEO03130 MOACRIVE Inhibition DME1788 XEOTICID XEO03131 XEO_NAME Ranalexin analog Del 1-4 DME1788 XEOTICID XEO03131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03131 XEO_CLAS Peptide DME1788 XEOTICID XEO03131 DESCRIPT Ranalexin analog Del 1-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 256 ug/ml) DME1788 XEOTICID XEO03131 GENEFORM Protein DME1788 XEOTICID XEO03131 MOACRIVE Inhibition DME1788 XEOTICID XEO03132 XEO_NAME Ranalexin analog Del 20 DME1788 XEOTICID XEO03132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03132 XEO_CLAS Peptide DME1788 XEOTICID XEO03132 DESCRIPT Ranalexin analog Del 20 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 256 ug/ml) DME1788 XEOTICID XEO03132 GENEFORM Protein DME1788 XEOTICID XEO03132 MOACRIVE Inhibition DME1788 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1788 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03137 XEO_CLAS Peptide DME1788 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03137 GENEFORM Protein DME1788 XEOTICID XEO03137 MOACRIVE Inhibition DME1788 XEOTICID XEO03143 XEO_NAME Ctx-Ha peptide derivative DEP DME1788 XEOTICID XEO03143 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03143 XEO_CLAS Peptide DME1788 XEOTICID XEO03143 DESCRIPT Ctx-Ha peptide derivative DEP inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.6 microM) DME1788 XEOTICID XEO03143 GENEFORM Protein DME1788 XEOTICID XEO03143 MOACRIVE Inhibition DME1788 XEOTICID XEO03145 XEO_NAME Dermadistinctin DD K DME1788 XEOTICID XEO03145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03145 XEO_CLAS Peptide DME1788 XEOTICID XEO03145 DESCRIPT Dermadistinctin DD K inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.6 microM) DME1788 XEOTICID XEO03145 GENEFORM Protein DME1788 XEOTICID XEO03145 MOACRIVE Inhibition DME1788 XEOTICID XEO03146 XEO_NAME Dermadistinctin DD L DME1788 XEOTICID XEO03146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03146 XEO_CLAS Peptide DME1788 XEOTICID XEO03146 DESCRIPT Dermadistinctin DD L inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.5 microM) DME1788 XEOTICID XEO03146 GENEFORM Protein DME1788 XEOTICID XEO03146 MOACRIVE Inhibition DME1788 XEOTICID XEO03147 XEO_NAME Dermadistinctin DD M DME1788 XEOTICID XEO03147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03147 XEO_CLAS Peptide DME1788 XEOTICID XEO03147 DESCRIPT Dermadistinctin DD M inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 9.7 microM) DME1788 XEOTICID XEO03147 GENEFORM Protein DME1788 XEOTICID XEO03147 MOACRIVE Inhibition DME1788 XEOTICID XEO03148 XEO_NAME Dermadistinctin DD Q1 DME1788 XEOTICID XEO03148 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03148 XEO_CLAS Peptide DME1788 XEOTICID XEO03148 DESCRIPT Dermadistinctin DD Q1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.3 microM) DME1788 XEOTICID XEO03148 GENEFORM Protein DME1788 XEOTICID XEO03148 MOACRIVE Inhibition DME1788 XEOTICID XEO03149 XEO_NAME Dermadistinctin DD Q2 DME1788 XEOTICID XEO03149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03149 XEO_CLAS Peptide DME1788 XEOTICID XEO03149 DESCRIPT Dermadistinctin DD Q2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.6 microM) DME1788 XEOTICID XEO03149 GENEFORM Protein DME1788 XEOTICID XEO03149 MOACRIVE Inhibition DME1788 XEOTICID XEO03150 XEO_NAME Dermaseptin K4-S4(1-13) DME1788 XEOTICID XEO03150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03150 XEO_CLAS Peptide DME1788 XEOTICID XEO03150 DESCRIPT Dermaseptin K4-S4(1-13) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 9-3 microM) DME1788 XEOTICID XEO03150 GENEFORM Protein DME1788 XEOTICID XEO03150 MOACRIVE Inhibition DME1788 XEOTICID XEO03151 XEO_NAME Dermaseptin DS1 DME1788 XEOTICID XEO03151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03151 XEO_CLAS Peptide DME1788 XEOTICID XEO03151 DESCRIPT Dermaseptin DS1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 ug/ml) DME1788 XEOTICID XEO03151 GENEFORM Protein DME1788 XEOTICID XEO03151 MOACRIVE Inhibition DME1788 XEOTICID XEO03152 XEO_NAME Dermaseptin DPh-1 DME1788 XEOTICID XEO03152 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03152 XEO_CLAS Peptide DME1788 XEOTICID XEO03152 DESCRIPT Dermaseptin DPh-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO03152 GENEFORM Protein DME1788 XEOTICID XEO03152 MOACRIVE Inhibition DME1788 XEOTICID XEO03155 XEO_NAME Dermaseptin DS5 DME1788 XEOTICID XEO03155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03155 XEO_CLAS Peptide DME1788 XEOTICID XEO03155 DESCRIPT Dermaseptin DS5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.4 microM) DME1788 XEOTICID XEO03155 GENEFORM Protein DME1788 XEOTICID XEO03155 MOACRIVE Inhibition DME1788 XEOTICID XEO03156 XEO_NAME Dermaseptin BIII DME1788 XEOTICID XEO03156 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03156 XEO_CLAS Peptide DME1788 XEOTICID XEO03156 DESCRIPT Dermaseptin BIII inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.3 microM) DME1788 XEOTICID XEO03156 GENEFORM Protein DME1788 XEOTICID XEO03156 MOACRIVE Inhibition DME1788 XEOTICID XEO03157 XEO_NAME Dermaseptin BIV DME1788 XEOTICID XEO03157 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03157 XEO_CLAS Peptide DME1788 XEOTICID XEO03157 DESCRIPT Dermaseptin BIV inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.3 microM) DME1788 XEOTICID XEO03157 GENEFORM Protein DME1788 XEOTICID XEO03157 MOACRIVE Inhibition DME1788 XEOTICID XEO03158 XEO_NAME Dermaseptin B1 DME1788 XEOTICID XEO03158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03158 XEO_CLAS Peptide DME1788 XEOTICID XEO03158 DESCRIPT Dermaseptin B1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 ug/ml) DME1788 XEOTICID XEO03158 GENEFORM Protein DME1788 XEOTICID XEO03158 MOACRIVE Inhibition DME1788 XEOTICID XEO03159 XEO_NAME Dermaseptin DMS3 DME1788 XEOTICID XEO03159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03159 XEO_CLAS Peptide DME1788 XEOTICID XEO03159 DESCRIPT Dermaseptin DMS3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03159 GENEFORM Protein DME1788 XEOTICID XEO03159 MOACRIVE Inhibition DME1788 XEOTICID XEO03161 XEO_NAME Dermaseptin L1 DME1788 XEOTICID XEO03161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03161 XEO_CLAS Peptide DME1788 XEOTICID XEO03161 DESCRIPT Dermaseptin L1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 microM) DME1788 XEOTICID XEO03161 GENEFORM Protein DME1788 XEOTICID XEO03161 MOACRIVE Inhibition DME1788 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1788 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03162 XEO_CLAS Peptide DME1788 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.5 microM) DME1788 XEOTICID XEO03162 GENEFORM Protein DME1788 XEOTICID XEO03162 MOACRIVE Inhibition DME1788 XEOTICID XEO03169 XEO_NAME DFTamP1-p peptide DME1788 XEOTICID XEO03169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03169 XEO_CLAS Peptide DME1788 XEOTICID XEO03169 DESCRIPT DFTamP1-p peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO03169 GENEFORM Protein DME1788 XEOTICID XEO03169 MOACRIVE Inhibition DME1788 XEOTICID XEO03193 XEO_NAME Insect diptericin DME1788 XEOTICID XEO03193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03193 XEO_CLAS Peptide DME1788 XEOTICID XEO03193 DESCRIPT Insect diptericin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25 ug/ml) DME1788 XEOTICID XEO03193 GENEFORM Protein DME1788 XEOTICID XEO03193 MOACRIVE Inhibition DME1788 XEOTICID XEO03194 XEO_NAME Diptericin-A DME1788 XEOTICID XEO03194 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03194 XEO_CLAS Peptide DME1788 XEOTICID XEO03194 DESCRIPT Diptericin-A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03194 GENEFORM Protein DME1788 XEOTICID XEO03194 MOACRIVE Inhibition DME1788 XEOTICID XEO03195 XEO_NAME Diptericin-D DME1788 XEOTICID XEO03195 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03195 XEO_CLAS Peptide DME1788 XEOTICID XEO03195 DESCRIPT Diptericin-D inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03195 GENEFORM Protein DME1788 XEOTICID XEO03195 MOACRIVE Inhibition DME1788 XEOTICID XEO03197 XEO_NAME Distinctin-2 DME1788 XEOTICID XEO03197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03197 XEO_CLAS Peptide DME1788 XEOTICID XEO03197 DESCRIPT Distinctin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 14.5 microM) DME1788 XEOTICID XEO03197 GENEFORM Protein DME1788 XEOTICID XEO03197 MOACRIVE Inhibition DME1788 XEOTICID XEO03202 XEO_NAME Peptide D-LAK100 DME1788 XEOTICID XEO03202 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03202 XEO_CLAS Peptide DME1788 XEOTICID XEO03202 DESCRIPT Peptide D-LAK100 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.51 microM) DME1788 XEOTICID XEO03202 GENEFORM Protein DME1788 XEOTICID XEO03202 MOACRIVE Inhibition DME1788 XEOTICID XEO03203 XEO_NAME Peptide D-LAK120 DME1788 XEOTICID XEO03203 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03203 XEO_CLAS Peptide DME1788 XEOTICID XEO03203 DESCRIPT Peptide D-LAK120 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.62 microM) DME1788 XEOTICID XEO03203 GENEFORM Protein DME1788 XEOTICID XEO03203 MOACRIVE Inhibition DME1788 XEOTICID XEO03204 XEO_NAME Peptide D-LAK120-A DME1788 XEOTICID XEO03204 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03204 XEO_CLAS Peptide DME1788 XEOTICID XEO03204 DESCRIPT Peptide D-LAK120-A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.38 microM) DME1788 XEOTICID XEO03204 GENEFORM Protein DME1788 XEOTICID XEO03204 MOACRIVE Inhibition DME1788 XEOTICID XEO03205 XEO_NAME Peptide D-LAK120-AP13 DME1788 XEOTICID XEO03205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03205 XEO_CLAS Peptide DME1788 XEOTICID XEO03205 DESCRIPT Peptide D-LAK120-AP13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.29 microM) DME1788 XEOTICID XEO03205 GENEFORM Protein DME1788 XEOTICID XEO03205 MOACRIVE Inhibition DME1788 XEOTICID XEO03206 XEO_NAME Peptide D-LAK120-H DME1788 XEOTICID XEO03206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03206 XEO_CLAS Peptide DME1788 XEOTICID XEO03206 DESCRIPT Peptide D-LAK120-H inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.40 microM) DME1788 XEOTICID XEO03206 GENEFORM Protein DME1788 XEOTICID XEO03206 MOACRIVE Inhibition DME1788 XEOTICID XEO03207 XEO_NAME Peptide D-LAK120-P13 DME1788 XEOTICID XEO03207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03207 XEO_CLAS Peptide DME1788 XEOTICID XEO03207 DESCRIPT Peptide D-LAK120-P13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.58 microM) DME1788 XEOTICID XEO03207 GENEFORM Protein DME1788 XEOTICID XEO03207 MOACRIVE Inhibition DME1788 XEOTICID XEO03208 XEO_NAME Peptide D-LAK140 DME1788 XEOTICID XEO03208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03208 XEO_CLAS Peptide DME1788 XEOTICID XEO03208 DESCRIPT Peptide D-LAK140 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.76 microM) DME1788 XEOTICID XEO03208 GENEFORM Protein DME1788 XEOTICID XEO03208 MOACRIVE Inhibition DME1788 XEOTICID XEO03209 XEO_NAME Peptide D-LAK160 DME1788 XEOTICID XEO03209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03209 XEO_CLAS Peptide DME1788 XEOTICID XEO03209 DESCRIPT Peptide D-LAK160 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.49 microM) DME1788 XEOTICID XEO03209 GENEFORM Protein DME1788 XEOTICID XEO03209 MOACRIVE Inhibition DME1788 XEOTICID XEO03210 XEO_NAME D-LAK60 peptide DME1788 XEOTICID XEO03210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03210 XEO_CLAS Peptide DME1788 XEOTICID XEO03210 DESCRIPT D-LAK60 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 7.07 microM) DME1788 XEOTICID XEO03210 GENEFORM Protein DME1788 XEOTICID XEO03210 MOACRIVE Inhibition DME1788 XEOTICID XEO03211 XEO_NAME D-LAK80 peptide DME1788 XEOTICID XEO03211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03211 XEO_CLAS Peptide DME1788 XEOTICID XEO03211 DESCRIPT D-LAK80 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.40 microM) DME1788 XEOTICID XEO03211 GENEFORM Protein DME1788 XEOTICID XEO03211 MOACRIVE Inhibition DME1788 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1788 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03215 XEO_CLAS Peptide DME1788 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20.0 ug/ml) DME1788 XEOTICID XEO03215 GENEFORM Protein DME1788 XEOTICID XEO03215 MOACRIVE Inhibition DME1788 XEOTICID XEO03216 XEO_NAME Dominulin-A DME1788 XEOTICID XEO03216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03216 XEO_CLAS Peptide DME1788 XEOTICID XEO03216 DESCRIPT Dominulin-A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO03216 GENEFORM Protein DME1788 XEOTICID XEO03216 MOACRIVE Inhibition DME1788 XEOTICID XEO03217 XEO_NAME Dominulin-B DME1788 XEOTICID XEO03217 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03217 XEO_CLAS Peptide DME1788 XEOTICID XEO03217 DESCRIPT Dominulin-B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO03217 GENEFORM Protein DME1788 XEOTICID XEO03217 MOACRIVE Inhibition DME1788 XEOTICID XEO03223 XEO_NAME Drosophila cecropin-B DME1788 XEOTICID XEO03223 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03223 XEO_CLAS Peptide DME1788 XEOTICID XEO03223 DESCRIPT Drosophila cecropin-B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.8 microM) DME1788 XEOTICID XEO03223 GENEFORM Protein DME1788 XEOTICID XEO03223 MOACRIVE Inhibition DME1788 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1788 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03224 XEO_CLAS Peptide DME1788 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.1-0.25 microM) DME1788 XEOTICID XEO03224 GENEFORM Protein DME1788 XEOTICID XEO03224 MOACRIVE Inhibition DME1788 XEOTICID XEO03225 XEO_NAME Drosophila cecropin-A1/A2 DME1788 XEOTICID XEO03225 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03225 XEO_CLAS Peptide DME1788 XEOTICID XEO03225 DESCRIPT Drosophila cecropin-A1/A2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.3 microM) DME1788 XEOTICID XEO03225 GENEFORM Protein DME1788 XEOTICID XEO03225 MOACRIVE Inhibition DME1788 XEOTICID XEO03227 XEO_NAME Ctx-Ha peptide derivative DSE DME1788 XEOTICID XEO03227 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03227 XEO_CLAS Peptide DME1788 XEOTICID XEO03227 DESCRIPT Ctx-Ha peptide derivative DSE inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.3 microM) DME1788 XEOTICID XEO03227 GENEFORM Protein DME1788 XEOTICID XEO03227 MOACRIVE Inhibition DME1788 XEOTICID XEO03231 XEO_NAME Duck AvBD10 DME1788 XEOTICID XEO03231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03231 XEO_CLAS Peptide DME1788 XEOTICID XEO03231 DESCRIPT Duck AvBD10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03231 GENEFORM Protein DME1788 XEOTICID XEO03231 MOACRIVE Inhibition DME1788 XEOTICID XEO03232 XEO_NAME Duck AvBD9 DME1788 XEOTICID XEO03232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03232 XEO_CLAS Peptide DME1788 XEOTICID XEO03232 DESCRIPT Duck AvBD9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03232 GENEFORM Protein DME1788 XEOTICID XEO03232 MOACRIVE Inhibition DME1788 XEOTICID XEO03234 XEO_NAME Dybowskin-1CDYa DME1788 XEOTICID XEO03234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03234 XEO_CLAS Peptide DME1788 XEOTICID XEO03234 DESCRIPT Dybowskin-1CDYa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO03234 GENEFORM Protein DME1788 XEOTICID XEO03234 MOACRIVE Inhibition DME1788 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1788 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03235 XEO_CLAS Peptide DME1788 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 60 ug/ml) DME1788 XEOTICID XEO03235 GENEFORM Protein DME1788 XEOTICID XEO03235 MOACRIVE Inhibition DME1788 XEOTICID XEO03236 XEO_NAME Dybowskin-2CDYa DME1788 XEOTICID XEO03236 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03236 XEO_CLAS Peptide DME1788 XEOTICID XEO03236 DESCRIPT Dybowskin-2CDYa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO03236 GENEFORM Protein DME1788 XEOTICID XEO03236 MOACRIVE Inhibition DME1788 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1788 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03237 XEO_CLAS Peptide DME1788 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 ug/ml) DME1788 XEOTICID XEO03237 GENEFORM Protein DME1788 XEOTICID XEO03237 MOACRIVE Inhibition DME1788 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1788 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03238 XEO_CLAS Peptide DME1788 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 ug/ml) DME1788 XEOTICID XEO03238 GENEFORM Protein DME1788 XEOTICID XEO03238 MOACRIVE Inhibition DME1788 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1788 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03239 XEO_CLAS Peptide DME1788 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 60 ug/ml) DME1788 XEOTICID XEO03239 GENEFORM Protein DME1788 XEOTICID XEO03239 MOACRIVE Inhibition DME1788 XEOTICID XEO03241 XEO_NAME Aurein 1.2 peptide derivative E(AU)2 DME1788 XEOTICID XEO03241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03241 XEO_CLAS Peptide DME1788 XEOTICID XEO03241 DESCRIPT Aurein 1.2 peptide derivative E(AU)2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 128 microM) DME1788 XEOTICID XEO03241 GENEFORM Protein DME1788 XEOTICID XEO03241 MOACRIVE Inhibition DME1788 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1788 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03250 XEO_CLAS Peptide DME1788 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03250 GENEFORM Protein DME1788 XEOTICID XEO03250 MOACRIVE Inhibition DME1788 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1788 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03251 XEO_CLAS Peptide DME1788 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03251 GENEFORM Protein DME1788 XEOTICID XEO03251 MOACRIVE Inhibition DME1788 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1788 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03253 XEO_CLAS Peptide DME1788 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.1 ug/ml) DME1788 XEOTICID XEO03253 GENEFORM Protein DME1788 XEOTICID XEO03253 MOACRIVE Inhibition DME1788 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1788 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03274 XEO_CLAS Peptide DME1788 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.2 microM) DME1788 XEOTICID XEO03274 GENEFORM Protein DME1788 XEOTICID XEO03274 MOACRIVE Inhibition DME1788 XEOTICID XEO03275 XEO_NAME Esculentin-1ARa DME1788 XEOTICID XEO03275 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03275 XEO_CLAS Peptide DME1788 XEOTICID XEO03275 DESCRIPT Esculentin-1ARa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO03275 GENEFORM Protein DME1788 XEOTICID XEO03275 MOACRIVE Inhibition DME1788 XEOTICID XEO03276 XEO_NAME Esculentin-1ARb DME1788 XEOTICID XEO03276 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03276 XEO_CLAS Peptide DME1788 XEOTICID XEO03276 DESCRIPT Esculentin-1ARb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO03276 GENEFORM Protein DME1788 XEOTICID XEO03276 MOACRIVE Inhibition DME1788 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1788 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03277 XEO_CLAS Peptide DME1788 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.2 microM) DME1788 XEOTICID XEO03277 GENEFORM Protein DME1788 XEOTICID XEO03277 MOACRIVE Inhibition DME1788 XEOTICID XEO03278 XEO_NAME Esculentin-1CPa DME1788 XEOTICID XEO03278 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03278 XEO_CLAS Peptide DME1788 XEOTICID XEO03278 DESCRIPT Esculentin-1CPa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO03278 GENEFORM Protein DME1788 XEOTICID XEO03278 MOACRIVE Inhibition DME1788 XEOTICID XEO03279 XEO_NAME Esculentin-1GRa DME1788 XEOTICID XEO03279 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03279 XEO_CLAS Peptide DME1788 XEOTICID XEO03279 DESCRIPT Esculentin-1GRa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO03279 GENEFORM Protein DME1788 XEOTICID XEO03279 MOACRIVE Inhibition DME1788 XEOTICID XEO03280 XEO_NAME Esculentin-1HSa DME1788 XEOTICID XEO03280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03280 XEO_CLAS Peptide DME1788 XEOTICID XEO03280 DESCRIPT Esculentin-1HSa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 microM) DME1788 XEOTICID XEO03280 GENEFORM Protein DME1788 XEOTICID XEO03280 MOACRIVE Inhibition DME1788 XEOTICID XEO03281 XEO_NAME Esculentin-1ISa DME1788 XEOTICID XEO03281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03281 XEO_CLAS Peptide DME1788 XEOTICID XEO03281 DESCRIPT Esculentin-1ISa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.3 microM) DME1788 XEOTICID XEO03281 GENEFORM Protein DME1788 XEOTICID XEO03281 MOACRIVE Inhibition DME1788 XEOTICID XEO03282 XEO_NAME Esculentin-1ISb DME1788 XEOTICID XEO03282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03282 XEO_CLAS Peptide DME1788 XEOTICID XEO03282 DESCRIPT Esculentin-1ISb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.1 microM) DME1788 XEOTICID XEO03282 GENEFORM Protein DME1788 XEOTICID XEO03282 MOACRIVE Inhibition DME1788 XEOTICID XEO03283 XEO_NAME Esculentin-1LTa DME1788 XEOTICID XEO03283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03283 XEO_CLAS Peptide DME1788 XEOTICID XEO03283 DESCRIPT Esculentin-1LTa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 microM) DME1788 XEOTICID XEO03283 GENEFORM Protein DME1788 XEOTICID XEO03283 MOACRIVE Inhibition DME1788 XEOTICID XEO03284 XEO_NAME Esculentin-1-OA1 DME1788 XEOTICID XEO03284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03284 XEO_CLAS Peptide DME1788 XEOTICID XEO03284 DESCRIPT Esculentin-1-OA1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.2 ug/ml) DME1788 XEOTICID XEO03284 GENEFORM Protein DME1788 XEOTICID XEO03284 MOACRIVE Inhibition DME1788 XEOTICID XEO03285 XEO_NAME Esculentin-1-OA2 DME1788 XEOTICID XEO03285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03285 XEO_CLAS Peptide DME1788 XEOTICID XEO03285 DESCRIPT Esculentin-1-OA2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.5 ug/ml) DME1788 XEOTICID XEO03285 GENEFORM Protein DME1788 XEOTICID XEO03285 MOACRIVE Inhibition DME1788 XEOTICID XEO03286 XEO_NAME Esculentin-1-OA3 DME1788 XEOTICID XEO03286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03286 XEO_CLAS Peptide DME1788 XEOTICID XEO03286 DESCRIPT Esculentin-1-OA3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.4 ug/ml) DME1788 XEOTICID XEO03286 GENEFORM Protein DME1788 XEOTICID XEO03286 MOACRIVE Inhibition DME1788 XEOTICID XEO03287 XEO_NAME Esculentin-1-OA4 DME1788 XEOTICID XEO03287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03287 XEO_CLAS Peptide DME1788 XEOTICID XEO03287 DESCRIPT Esculentin-1-OA4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.6 ug/ml) DME1788 XEOTICID XEO03287 GENEFORM Protein DME1788 XEOTICID XEO03287 MOACRIVE Inhibition DME1788 XEOTICID XEO03288 XEO_NAME Esculentin-1-OA5 DME1788 XEOTICID XEO03288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03288 XEO_CLAS Peptide DME1788 XEOTICID XEO03288 DESCRIPT Esculentin-1-OA5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.4 ug/ml) DME1788 XEOTICID XEO03288 GENEFORM Protein DME1788 XEOTICID XEO03288 MOACRIVE Inhibition DME1788 XEOTICID XEO03289 XEO_NAME Esculentin-1-OR1 DME1788 XEOTICID XEO03289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03289 XEO_CLAS Peptide DME1788 XEOTICID XEO03289 DESCRIPT Esculentin-1-OR1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8.8 ug/ml) DME1788 XEOTICID XEO03289 GENEFORM Protein DME1788 XEOTICID XEO03289 MOACRIVE Inhibition DME1788 XEOTICID XEO03290 XEO_NAME Esculentin-1-OR3 DME1788 XEOTICID XEO03290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03290 XEO_CLAS Peptide DME1788 XEOTICID XEO03290 DESCRIPT Esculentin-1-OR3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.5 ug/ml) DME1788 XEOTICID XEO03290 GENEFORM Protein DME1788 XEOTICID XEO03290 MOACRIVE Inhibition DME1788 XEOTICID XEO03291 XEO_NAME Esculentin-1-OR4 DME1788 XEOTICID XEO03291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03291 XEO_CLAS Peptide DME1788 XEOTICID XEO03291 DESCRIPT Esculentin-1-OR4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8.6 ug/ml) DME1788 XEOTICID XEO03291 GENEFORM Protein DME1788 XEOTICID XEO03291 MOACRIVE Inhibition DME1788 XEOTICID XEO03292 XEO_NAME Esculentin-1-OR5 DME1788 XEOTICID XEO03292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03292 XEO_CLAS Peptide DME1788 XEOTICID XEO03292 DESCRIPT Esculentin-1-OR5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4.1 ug/ml) DME1788 XEOTICID XEO03292 GENEFORM Protein DME1788 XEOTICID XEO03292 MOACRIVE Inhibition DME1788 XEOTICID XEO03293 XEO_NAME Esculentin-1PLa DME1788 XEOTICID XEO03293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03293 XEO_CLAS Peptide DME1788 XEOTICID XEO03293 DESCRIPT Esculentin-1PLa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1 microM) DME1788 XEOTICID XEO03293 GENEFORM Protein DME1788 XEOTICID XEO03293 MOACRIVE Inhibition DME1788 XEOTICID XEO03294 XEO_NAME Esculentin-1PLb DME1788 XEOTICID XEO03294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03294 XEO_CLAS Peptide DME1788 XEOTICID XEO03294 DESCRIPT Esculentin-1PLb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1 microM) DME1788 XEOTICID XEO03294 GENEFORM Protein DME1788 XEOTICID XEO03294 MOACRIVE Inhibition DME1788 XEOTICID XEO03295 XEO_NAME Esculentin-1S DME1788 XEOTICID XEO03295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03295 XEO_CLAS Peptide DME1788 XEOTICID XEO03295 DESCRIPT Esculentin-1S inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.7 microM) DME1788 XEOTICID XEO03295 GENEFORM Protein DME1788 XEOTICID XEO03295 MOACRIVE Inhibition DME1788 XEOTICID XEO03296 XEO_NAME Esculentin-1SEa DME1788 XEOTICID XEO03296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03296 XEO_CLAS Peptide DME1788 XEOTICID XEO03296 DESCRIPT Esculentin-1SEa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03296 GENEFORM Protein DME1788 XEOTICID XEO03296 MOACRIVE Inhibition DME1788 XEOTICID XEO03297 XEO_NAME Esculentin-1SEb DME1788 XEOTICID XEO03297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03297 XEO_CLAS Peptide DME1788 XEOTICID XEO03297 DESCRIPT Esculentin-1SEb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03297 GENEFORM Protein DME1788 XEOTICID XEO03297 MOACRIVE Inhibition DME1788 XEOTICID XEO03298 XEO_NAME Esculentin-1V DME1788 XEOTICID XEO03298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03298 XEO_CLAS Peptide DME1788 XEOTICID XEO03298 DESCRIPT Esculentin-1V inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.2 microM) DME1788 XEOTICID XEO03298 GENEFORM Protein DME1788 XEOTICID XEO03298 MOACRIVE Inhibition DME1788 XEOTICID XEO03299 XEO_NAME Esculentin-2A DME1788 XEOTICID XEO03299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03299 XEO_CLAS Peptide DME1788 XEOTICID XEO03299 DESCRIPT Esculentin-2A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.4 microM) DME1788 XEOTICID XEO03299 GENEFORM Protein DME1788 XEOTICID XEO03299 MOACRIVE Inhibition DME1788 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME1788 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03300 XEO_CLAS Peptide DME1788 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 ug/ml) DME1788 XEOTICID XEO03300 GENEFORM Protein DME1788 XEOTICID XEO03300 MOACRIVE Inhibition DME1788 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME1788 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03301 XEO_CLAS Peptide DME1788 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 ug/ml) DME1788 XEOTICID XEO03301 GENEFORM Protein DME1788 XEOTICID XEO03301 MOACRIVE Inhibition DME1788 XEOTICID XEO03302 XEO_NAME Esculentin-2B DME1788 XEOTICID XEO03302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03302 XEO_CLAS Peptide DME1788 XEOTICID XEO03302 DESCRIPT Esculentin-2B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1 microM) DME1788 XEOTICID XEO03302 GENEFORM Protein DME1788 XEOTICID XEO03302 MOACRIVE Inhibition DME1788 XEOTICID XEO03303 XEO_NAME Esculentin-2CHa DME1788 XEOTICID XEO03303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03303 XEO_CLAS Peptide DME1788 XEOTICID XEO03303 DESCRIPT Esculentin-2CHa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 microM) DME1788 XEOTICID XEO03303 GENEFORM Protein DME1788 XEOTICID XEO03303 MOACRIVE Inhibition DME1788 XEOTICID XEO03304 XEO_NAME Esculentin-2CPa DME1788 XEOTICID XEO03304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03304 XEO_CLAS Peptide DME1788 XEOTICID XEO03304 DESCRIPT Esculentin-2CPa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO03304 GENEFORM Protein DME1788 XEOTICID XEO03304 MOACRIVE Inhibition DME1788 XEOTICID XEO03305 XEO_NAME Esculentin-2HSa DME1788 XEOTICID XEO03305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03305 XEO_CLAS Peptide DME1788 XEOTICID XEO03305 DESCRIPT Esculentin-2HSa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 microM) DME1788 XEOTICID XEO03305 GENEFORM Protein DME1788 XEOTICID XEO03305 MOACRIVE Inhibition DME1788 XEOTICID XEO03306 XEO_NAME Esculentin-2ISa DME1788 XEOTICID XEO03306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03306 XEO_CLAS Peptide DME1788 XEOTICID XEO03306 DESCRIPT Esculentin-2ISa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO03306 GENEFORM Protein DME1788 XEOTICID XEO03306 MOACRIVE Inhibition DME1788 XEOTICID XEO03307 XEO_NAME Esculentin-2JDa DME1788 XEOTICID XEO03307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03307 XEO_CLAS Peptide DME1788 XEOTICID XEO03307 DESCRIPT Esculentin-2JDa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 34 ug/ml) DME1788 XEOTICID XEO03307 GENEFORM Protein DME1788 XEOTICID XEO03307 MOACRIVE Inhibition DME1788 XEOTICID XEO03308 XEO_NAME Esculentin-2L DME1788 XEOTICID XEO03308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03308 XEO_CLAS Peptide DME1788 XEOTICID XEO03308 DESCRIPT Esculentin-2L inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO03308 GENEFORM Protein DME1788 XEOTICID XEO03308 MOACRIVE Inhibition DME1788 XEOTICID XEO03310 XEO_NAME Esculentin-2-OA1 DME1788 XEOTICID XEO03310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03310 XEO_CLAS Peptide DME1788 XEOTICID XEO03310 DESCRIPT Esculentin-2-OA1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8.5 ug/ml) DME1788 XEOTICID XEO03310 GENEFORM Protein DME1788 XEOTICID XEO03310 MOACRIVE Inhibition DME1788 XEOTICID XEO03311 XEO_NAME Esculentin-2-OA2 DME1788 XEOTICID XEO03311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03311 XEO_CLAS Peptide DME1788 XEOTICID XEO03311 DESCRIPT Esculentin-2-OA2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10.8 ug/ml) DME1788 XEOTICID XEO03311 GENEFORM Protein DME1788 XEOTICID XEO03311 MOACRIVE Inhibition DME1788 XEOTICID XEO03312 XEO_NAME Esculentin-2-OR1 DME1788 XEOTICID XEO03312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03312 XEO_CLAS Peptide DME1788 XEOTICID XEO03312 DESCRIPT Esculentin-2-OR1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10.8 ug/ml) DME1788 XEOTICID XEO03312 GENEFORM Protein DME1788 XEOTICID XEO03312 MOACRIVE Inhibition DME1788 XEOTICID XEO03313 XEO_NAME Esculentin-2-OR2 DME1788 XEOTICID XEO03313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03313 XEO_CLAS Peptide DME1788 XEOTICID XEO03313 DESCRIPT Esculentin-2-OR2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8.1 ug/ml) DME1788 XEOTICID XEO03313 GENEFORM Protein DME1788 XEOTICID XEO03313 MOACRIVE Inhibition DME1788 XEOTICID XEO03314 XEO_NAME Esculentin-2-OR3 DME1788 XEOTICID XEO03314 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03314 XEO_CLAS Peptide DME1788 XEOTICID XEO03314 DESCRIPT Esculentin-2-OR3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 7.9 ug/ml) DME1788 XEOTICID XEO03314 GENEFORM Protein DME1788 XEOTICID XEO03314 MOACRIVE Inhibition DME1788 XEOTICID XEO03315 XEO_NAME Esculentin-2-OR4 DME1788 XEOTICID XEO03315 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03315 XEO_CLAS Peptide DME1788 XEOTICID XEO03315 DESCRIPT Esculentin-2-OR4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.6 ug/ml) DME1788 XEOTICID XEO03315 GENEFORM Protein DME1788 XEOTICID XEO03315 MOACRIVE Inhibition DME1788 XEOTICID XEO03316 XEO_NAME Esculentin-2-OR5 DME1788 XEOTICID XEO03316 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03316 XEO_CLAS Peptide DME1788 XEOTICID XEO03316 DESCRIPT Esculentin-2-OR5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15.8 ug/ml) DME1788 XEOTICID XEO03316 GENEFORM Protein DME1788 XEOTICID XEO03316 MOACRIVE Inhibition DME1788 XEOTICID XEO03317 XEO_NAME Esculentin-2P DME1788 XEOTICID XEO03317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03317 XEO_CLAS Peptide DME1788 XEOTICID XEO03317 DESCRIPT Esculentin-2P inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO03317 GENEFORM Protein DME1788 XEOTICID XEO03317 MOACRIVE Inhibition DME1788 XEOTICID XEO03318 XEO_NAME Esculentin-2PLa DME1788 XEOTICID XEO03318 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03318 XEO_CLAS Peptide DME1788 XEOTICID XEO03318 DESCRIPT Esculentin-2PLa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1 microM) DME1788 XEOTICID XEO03318 GENEFORM Protein DME1788 XEOTICID XEO03318 MOACRIVE Inhibition DME1788 XEOTICID XEO03319 XEO_NAME Esculentin-2PRa DME1788 XEOTICID XEO03319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03319 XEO_CLAS Peptide DME1788 XEOTICID XEO03319 DESCRIPT Esculentin-2PRa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03319 GENEFORM Protein DME1788 XEOTICID XEO03319 MOACRIVE Inhibition DME1788 XEOTICID XEO03320 XEO_NAME Esculentin-2S DME1788 XEOTICID XEO03320 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03320 XEO_CLAS Peptide DME1788 XEOTICID XEO03320 DESCRIPT Esculentin-2S inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.1 microM) DME1788 XEOTICID XEO03320 GENEFORM Protein DME1788 XEOTICID XEO03320 MOACRIVE Inhibition DME1788 XEOTICID XEO03321 XEO_NAME Esculentin-2V DME1788 XEOTICID XEO03321 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03321 XEO_CLAS Peptide DME1788 XEOTICID XEO03321 DESCRIPT Esculentin-2V inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.8 microM) DME1788 XEOTICID XEO03321 GENEFORM Protein DME1788 XEOTICID XEO03321 MOACRIVE Inhibition DME1788 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1788 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1788 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03348 GENEFORM Protein DME1788 XEOTICID XEO03348 MOACRIVE Inhibition DME1788 XEOTICID XEO03362 XEO_NAME Eumenine mastoparan-AF DME1788 XEOTICID XEO03362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03362 XEO_CLAS Peptide DME1788 XEOTICID XEO03362 DESCRIPT Eumenine mastoparan-AF inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO03362 GENEFORM Protein DME1788 XEOTICID XEO03362 MOACRIVE Inhibition DME1788 XEOTICID XEO03363 XEO_NAME Eumenine mastoparan-EF DME1788 XEOTICID XEO03363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03363 XEO_CLAS Peptide DME1788 XEOTICID XEO03363 DESCRIPT Eumenine mastoparan-EF inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 microM) DME1788 XEOTICID XEO03363 GENEFORM Protein DME1788 XEOTICID XEO03363 MOACRIVE Inhibition DME1788 XEOTICID XEO03364 XEO_NAME Eumenine mastoparan-ER DME1788 XEOTICID XEO03364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03364 XEO_CLAS Peptide DME1788 XEOTICID XEO03364 DESCRIPT Eumenine mastoparan-ER inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 microM) DME1788 XEOTICID XEO03364 GENEFORM Protein DME1788 XEOTICID XEO03364 MOACRIVE Inhibition DME1788 XEOTICID XEO03365 XEO_NAME Eumenine mastoparan-OD DME1788 XEOTICID XEO03365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03365 XEO_CLAS Peptide DME1788 XEOTICID XEO03365 DESCRIPT Eumenine mastoparan-OD inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03365 GENEFORM Protein DME1788 XEOTICID XEO03365 MOACRIVE Inhibition DME1788 XEOTICID XEO03366 XEO_NAME Eumenitin Er-12 DME1788 XEOTICID XEO03366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03366 XEO_CLAS Peptide DME1788 XEOTICID XEO03366 DESCRIPT Eumenitin Er-12 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO03366 GENEFORM Protein DME1788 XEOTICID XEO03366 MOACRIVE Inhibition DME1788 XEOTICID XEO03367 XEO_NAME Eumenitin F DME1788 XEOTICID XEO03367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03367 XEO_CLAS Peptide DME1788 XEOTICID XEO03367 DESCRIPT Eumenitin F inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 microM) DME1788 XEOTICID XEO03367 GENEFORM Protein DME1788 XEOTICID XEO03367 MOACRIVE Inhibition DME1788 XEOTICID XEO03368 XEO_NAME Eumenitin R DME1788 XEOTICID XEO03368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03368 XEO_CLAS Peptide DME1788 XEOTICID XEO03368 DESCRIPT Eumenitin R inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 microM) DME1788 XEOTICID XEO03368 GENEFORM Protein DME1788 XEOTICID XEO03368 MOACRIVE Inhibition DME1788 XEOTICID XEO03379 XEO_NAME Bac2A scrambled variant F3 DME1788 XEOTICID XEO03379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03379 XEO_CLAS Peptide DME1788 XEOTICID XEO03379 DESCRIPT Bac2A scrambled variant F3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.6 ug/ml) DME1788 XEOTICID XEO03379 GENEFORM Protein DME1788 XEOTICID XEO03379 MOACRIVE Inhibition DME1788 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1788 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03396 XEO_CLAS Peptide DME1788 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03396 GENEFORM Protein DME1788 XEOTICID XEO03396 MOACRIVE Inhibition DME1788 XEOTICID XEO03398 XEO_NAME Formaecin-1 DME1788 XEOTICID XEO03398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03398 XEO_CLAS Peptide DME1788 XEOTICID XEO03398 DESCRIPT Formaecin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03398 GENEFORM Protein DME1788 XEOTICID XEO03398 MOACRIVE Inhibition DME1788 XEOTICID XEO03399 XEO_NAME Formaecin-2 DME1788 XEOTICID XEO03399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03399 XEO_CLAS Peptide DME1788 XEOTICID XEO03399 DESCRIPT Formaecin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03399 GENEFORM Protein DME1788 XEOTICID XEO03399 MOACRIVE Inhibition DME1788 XEOTICID XEO03406 XEO_NAME Frenatin-3 DME1788 XEOTICID XEO03406 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03406 XEO_CLAS Peptide DME1788 XEOTICID XEO03406 DESCRIPT Frenatin-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 ug/ml) DME1788 XEOTICID XEO03406 GENEFORM Protein DME1788 XEOTICID XEO03406 MOACRIVE Inhibition DME1788 XEOTICID XEO03424 XEO_NAME FV7 peptide DME1788 XEOTICID XEO03424 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03424 XEO_CLAS Peptide DME1788 XEOTICID XEO03424 DESCRIPT FV7 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03424 GENEFORM Protein DME1788 XEOTICID XEO03424 MOACRIVE Inhibition DME1788 XEOTICID XEO03426 XEO_NAME Moricin-like peptide Gm-mlpA DME1788 XEOTICID XEO03426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03426 XEO_CLAS Peptide DME1788 XEOTICID XEO03426 DESCRIPT Moricin-like peptide Gm-mlpA inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO03426 GENEFORM Protein DME1788 XEOTICID XEO03426 MOACRIVE Inhibition DME1788 XEOTICID XEO03427 XEO_NAME Moricin-like peptide Gm-mlpB DME1788 XEOTICID XEO03427 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03427 XEO_CLAS Peptide DME1788 XEOTICID XEO03427 DESCRIPT Moricin-like peptide Gm-mlpB inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 microM) DME1788 XEOTICID XEO03427 GENEFORM Protein DME1788 XEOTICID XEO03427 MOACRIVE Inhibition DME1788 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1788 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03428 XEO_CLAS Peptide DME1788 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 ug/ml) DME1788 XEOTICID XEO03428 GENEFORM Protein DME1788 XEOTICID XEO03428 MOACRIVE Inhibition DME1788 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1788 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03430 XEO_CLAS Peptide DME1788 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 ug/ml) DME1788 XEOTICID XEO03430 GENEFORM Protein DME1788 XEOTICID XEO03430 MOACRIVE Inhibition DME1788 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1788 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03434 XEO_CLAS Peptide DME1788 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO03434 GENEFORM Protein DME1788 XEOTICID XEO03434 MOACRIVE Inhibition DME1788 XEOTICID XEO03442 XEO_NAME Gaegurin-RN1 DME1788 XEOTICID XEO03442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03442 XEO_CLAS Peptide DME1788 XEOTICID XEO03442 DESCRIPT Gaegurin-RN1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 18.75 ug/ml) DME1788 XEOTICID XEO03442 GENEFORM Protein DME1788 XEOTICID XEO03442 MOACRIVE Inhibition DME1788 XEOTICID XEO03444 XEO_NAME Gaegurin-RN5 DME1788 XEOTICID XEO03444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03444 XEO_CLAS Peptide DME1788 XEOTICID XEO03444 DESCRIPT Gaegurin-RN5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 37.50 ug/ml) DME1788 XEOTICID XEO03444 GENEFORM Protein DME1788 XEOTICID XEO03444 MOACRIVE Inhibition DME1788 XEOTICID XEO03459 XEO_NAME Gallinacin gal-1 DME1788 XEOTICID XEO03459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03459 XEO_CLAS Peptide DME1788 XEOTICID XEO03459 DESCRIPT Gallinacin gal-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03459 GENEFORM Protein DME1788 XEOTICID XEO03459 MOACRIVE Inhibition DME1788 XEOTICID XEO03460 XEO_NAME Gallinacin-1 alpha DME1788 XEOTICID XEO03460 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03460 XEO_CLAS Peptide DME1788 XEOTICID XEO03460 DESCRIPT Gallinacin-1 alpha inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03460 GENEFORM Protein DME1788 XEOTICID XEO03460 MOACRIVE Inhibition DME1788 XEOTICID XEO03461 XEO_NAME Gallinacin-11 DME1788 XEOTICID XEO03461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03461 XEO_CLAS Peptide DME1788 XEOTICID XEO03461 DESCRIPT Gallinacin-11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.05 microM) DME1788 XEOTICID XEO03461 GENEFORM Protein DME1788 XEOTICID XEO03461 MOACRIVE Inhibition DME1788 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1788 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03462 XEO_CLAS Peptide DME1788 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03462 GENEFORM Protein DME1788 XEOTICID XEO03462 MOACRIVE Inhibition DME1788 XEOTICID XEO03463 XEO_NAME Gallinacin-2 DME1788 XEOTICID XEO03463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03463 XEO_CLAS Peptide DME1788 XEOTICID XEO03463 DESCRIPT Gallinacin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03463 GENEFORM Protein DME1788 XEOTICID XEO03463 MOACRIVE Inhibition DME1788 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1788 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03467 XEO_CLAS Peptide DME1788 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03467 GENEFORM Protein DME1788 XEOTICID XEO03467 MOACRIVE Inhibition DME1788 XEOTICID XEO03468 XEO_NAME Gallinacin-9 DME1788 XEOTICID XEO03468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03468 XEO_CLAS Peptide DME1788 XEOTICID XEO03468 DESCRIPT Gallinacin-9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03468 GENEFORM Protein DME1788 XEOTICID XEO03468 MOACRIVE Inhibition DME1788 XEOTICID XEO03471 XEO_NAME Gambicin DME1788 XEOTICID XEO03471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03471 XEO_CLAS Peptide DME1788 XEOTICID XEO03471 DESCRIPT Gambicin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25-12.5 microM) DME1788 XEOTICID XEO03471 GENEFORM Protein DME1788 XEOTICID XEO03471 MOACRIVE Inhibition DME1788 XEOTICID XEO03485 XEO_NAME Lactoferrin fragment GLFcin DME1788 XEOTICID XEO03485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03485 XEO_CLAS Peptide DME1788 XEOTICID XEO03485 DESCRIPT Lactoferrin fragment GLFcin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4.07 ug/ml) DME1788 XEOTICID XEO03485 GENEFORM Protein DME1788 XEOTICID XEO03485 MOACRIVE Inhibition DME1788 XEOTICID XEO03486 XEO_NAME Lactoferrin fragment GLFcin II DME1788 XEOTICID XEO03486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03486 XEO_CLAS Peptide DME1788 XEOTICID XEO03486 DESCRIPT Lactoferrin fragment GLFcin II inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.80 ug/ml) DME1788 XEOTICID XEO03486 GENEFORM Protein DME1788 XEOTICID XEO03486 MOACRIVE Inhibition DME1788 XEOTICID XEO03488 XEO_NAME GLK-19 DME1788 XEOTICID XEO03488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03488 XEO_CLAS Peptide DME1788 XEOTICID XEO03488 DESCRIPT GLK-19 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO03488 GENEFORM Protein DME1788 XEOTICID XEO03488 MOACRIVE Inhibition DME1788 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1788 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03497 XEO_CLAS Peptide DME1788 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1788 XEOTICID XEO03497 GENEFORM Protein DME1788 XEOTICID XEO03497 MOACRIVE Inhibition DME1788 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1788 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03498 XEO_CLAS Peptide DME1788 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1788 XEOTICID XEO03498 GENEFORM Protein DME1788 XEOTICID XEO03498 MOACRIVE Inhibition DME1788 XEOTICID XEO03500 XEO_NAME Gp41 peptide derivative gp41w-FKA DME1788 XEOTICID XEO03500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03500 XEO_CLAS Peptide DME1788 XEOTICID XEO03500 DESCRIPT Gp41 peptide derivative gp41w-FKA inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-30 ug/ml) DME1788 XEOTICID XEO03500 GENEFORM Protein DME1788 XEOTICID XEO03500 MOACRIVE Inhibition DME1788 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1788 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03504 XEO_CLAS Peptide DME1788 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 ug/ml) DME1788 XEOTICID XEO03504 GENEFORM Protein DME1788 XEOTICID XEO03504 MOACRIVE Inhibition DME1788 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1788 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03505 XEO_CLAS Peptide DME1788 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 ug/ml) DME1788 XEOTICID XEO03505 GENEFORM Protein DME1788 XEOTICID XEO03505 MOACRIVE Inhibition DME1788 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1788 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03506 XEO_CLAS Peptide DME1788 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 ug/ml) DME1788 XEOTICID XEO03506 GENEFORM Protein DME1788 XEOTICID XEO03506 MOACRIVE Inhibition DME1788 XEOTICID XEO03513 XEO_NAME H. erythraea B2RP DME1788 XEOTICID XEO03513 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03513 XEO_CLAS Peptide DME1788 XEOTICID XEO03513 DESCRIPT H. erythraea B2RP inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO03513 GENEFORM Protein DME1788 XEOTICID XEO03513 MOACRIVE Inhibition DME1788 XEOTICID XEO03514 XEO_NAME Histone-derived H4-(86-100) DME1788 XEOTICID XEO03514 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03514 XEO_CLAS Peptide DME1788 XEOTICID XEO03514 DESCRIPT Histone-derived H4-(86-100) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03514 GENEFORM Protein DME1788 XEOTICID XEO03514 MOACRIVE Inhibition DME1788 XEOTICID XEO03519 XEO_NAME Hadrurin DME1788 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03519 XEO_CLAS Peptide DME1788 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03519 GENEFORM Protein DME1788 XEOTICID XEO03519 MOACRIVE Inhibition DME1788 XEOTICID XEO03522 XEO_NAME Halocyntin DME1788 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03522 XEO_CLAS Peptide DME1788 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03522 GENEFORM Protein DME1788 XEOTICID XEO03522 MOACRIVE Inhibition DME1788 XEOTICID XEO03524 XEO_NAME Human beta-defensin hBD-5 DME1788 XEOTICID XEO03524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03524 XEO_CLAS Peptide DME1788 XEOTICID XEO03524 DESCRIPT Human beta-defensin hBD-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03524 GENEFORM Protein DME1788 XEOTICID XEO03524 MOACRIVE Inhibition DME1788 XEOTICID XEO03525 XEO_NAME Human beta-defensin hBD-6 DME1788 XEOTICID XEO03525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03525 XEO_CLAS Peptide DME1788 XEOTICID XEO03525 DESCRIPT Human beta-defensin hBD-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03525 GENEFORM Protein DME1788 XEOTICID XEO03525 MOACRIVE Inhibition DME1788 XEOTICID XEO03530 XEO_NAME Lys-rich hdMolluscidin DME1788 XEOTICID XEO03530 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03530 XEO_CLAS Peptide DME1788 XEOTICID XEO03530 DESCRIPT Lys-rich hdMolluscidin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03530 GENEFORM Protein DME1788 XEOTICID XEO03530 MOACRIVE Inhibition DME1788 XEOTICID XEO03535 XEO_NAME Hedyotide hB1 DME1788 XEOTICID XEO03535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03535 XEO_CLAS Peptide DME1788 XEOTICID XEO03535 DESCRIPT Hedyotide hB1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.4 microM) DME1788 XEOTICID XEO03535 GENEFORM Protein DME1788 XEOTICID XEO03535 MOACRIVE Inhibition DME1788 XEOTICID XEO03536 XEO_NAME Hedyotide hB2 DME1788 XEOTICID XEO03536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03536 XEO_CLAS Peptide DME1788 XEOTICID XEO03536 DESCRIPT Hedyotide hB2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 80 microM) DME1788 XEOTICID XEO03536 GENEFORM Protein DME1788 XEOTICID XEO03536 MOACRIVE Inhibition DME1788 XEOTICID XEO03537 XEO_NAME Hejiangin-A1 DME1788 XEOTICID XEO03537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03537 XEO_CLAS Peptide DME1788 XEOTICID XEO03537 DESCRIPT Hejiangin-A1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 ug/ml) DME1788 XEOTICID XEO03537 GENEFORM Protein DME1788 XEOTICID XEO03537 MOACRIVE Inhibition DME1788 XEOTICID XEO03538 XEO_NAME Hejiangin-F1 DME1788 XEOTICID XEO03538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03538 XEO_CLAS Peptide DME1788 XEOTICID XEO03538 DESCRIPT Hejiangin-F1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 ug/ml) DME1788 XEOTICID XEO03538 GENEFORM Protein DME1788 XEOTICID XEO03538 MOACRIVE Inhibition DME1788 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1788 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03540 XEO_CLAS Peptide DME1788 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO03540 GENEFORM Protein DME1788 XEOTICID XEO03540 MOACRIVE Inhibition DME1788 XEOTICID XEO03542 XEO_NAME Hepcidin DME1788 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03542 XEO_CLAS Peptide DME1788 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 24 microM) DME1788 XEOTICID XEO03542 GENEFORM Protein DME1788 XEOTICID XEO03542 MOACRIVE Inhibition DME1788 XEOTICID XEO03544 XEO_NAME Hepcidin AS-hepc6 DME1788 XEOTICID XEO03544 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03544 XEO_CLAS Peptide DME1788 XEOTICID XEO03544 DESCRIPT Hepcidin AS-hepc6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03544 GENEFORM Protein DME1788 XEOTICID XEO03544 MOACRIVE Inhibition DME1788 XEOTICID XEO03548 XEO_NAME Hesperidin DME1788 XEOTICID XEO03548 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO03548 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO03548 DESCRIPT Hesperidin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03548 GENEFORM Protein DME1788 XEOTICID XEO03548 MOACRIVE Inhibition DME1788 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1788 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1788 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03552 GENEFORM Protein DME1788 XEOTICID XEO03552 MOACRIVE Inhibition DME1788 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1788 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03556 XEO_CLAS Peptide DME1788 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO03556 GENEFORM Protein DME1788 XEOTICID XEO03556 MOACRIVE Inhibition DME1788 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1788 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03557 XEO_CLAS Peptide DME1788 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO03557 GENEFORM Protein DME1788 XEOTICID XEO03557 MOACRIVE Inhibition DME1788 XEOTICID XEO03558 XEO_NAME HFU3 peptide DME1788 XEOTICID XEO03558 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03558 XEO_CLAS Peptide DME1788 XEOTICID XEO03558 DESCRIPT HFU3 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 microM) DME1788 XEOTICID XEO03558 GENEFORM Protein DME1788 XEOTICID XEO03558 MOACRIVE Inhibition DME1788 XEOTICID XEO03559 XEO_NAME HFU4 peptide DME1788 XEOTICID XEO03559 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03559 XEO_CLAS Peptide DME1788 XEOTICID XEO03559 DESCRIPT HFU4 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 microM) DME1788 XEOTICID XEO03559 GENEFORM Protein DME1788 XEOTICID XEO03559 MOACRIVE Inhibition DME1788 XEOTICID XEO03560 XEO_NAME HFU5 peptide DME1788 XEOTICID XEO03560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03560 XEO_CLAS Peptide DME1788 XEOTICID XEO03560 DESCRIPT HFU5 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 microM) DME1788 XEOTICID XEO03560 GENEFORM Protein DME1788 XEOTICID XEO03560 MOACRIVE Inhibition DME1788 XEOTICID XEO03561 XEO_NAME Hinnavin I DME1788 XEOTICID XEO03561 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03561 XEO_CLAS Peptide DME1788 XEOTICID XEO03561 DESCRIPT Hinnavin I inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03561 GENEFORM Protein DME1788 XEOTICID XEO03561 MOACRIVE Inhibition DME1788 XEOTICID XEO03567 XEO_NAME Histone HIIb-1 DME1788 XEOTICID XEO03567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03567 XEO_CLAS Peptide DME1788 XEOTICID XEO03567 DESCRIPT Histone HIIb-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03567 GENEFORM Protein DME1788 XEOTICID XEO03567 MOACRIVE Inhibition DME1788 XEOTICID XEO03569 XEO_NAME Human lalctoferricin hLf(21-30) DME1788 XEOTICID XEO03569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03569 XEO_CLAS Peptide DME1788 XEOTICID XEO03569 DESCRIPT Human lalctoferricin hLf(21-30) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 300 microM) DME1788 XEOTICID XEO03569 GENEFORM Protein DME1788 XEOTICID XEO03569 MOACRIVE Inhibition DME1788 XEOTICID XEO03570 XEO_NAME Human lactoferrin hLF(1-11) DME1788 XEOTICID XEO03570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03570 XEO_CLAS Peptide DME1788 XEOTICID XEO03570 DESCRIPT Human lactoferrin hLF(1-11) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03570 GENEFORM Protein DME1788 XEOTICID XEO03570 MOACRIVE Inhibition DME1788 XEOTICID XEO03572 XEO_NAME Hlgut-defensin DME1788 XEOTICID XEO03572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03572 XEO_CLAS Peptide DME1788 XEOTICID XEO03572 DESCRIPT Hlgut-defensin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1788 XEOTICID XEO03572 GENEFORM Protein DME1788 XEOTICID XEO03572 MOACRIVE Inhibition DME1788 XEOTICID XEO03573 XEO_NAME HlMS-defensin DME1788 XEOTICID XEO03573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03573 XEO_CLAS Peptide DME1788 XEOTICID XEO03573 DESCRIPT HlMS-defensin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 28.1 ug/ml) DME1788 XEOTICID XEO03573 GENEFORM Protein DME1788 XEOTICID XEO03573 MOACRIVE Inhibition DME1788 XEOTICID XEO03574 XEO_NAME Lactotransferrin truncated peptide HLP1 DME1788 XEOTICID XEO03574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03574 XEO_CLAS Peptide DME1788 XEOTICID XEO03574 DESCRIPT Lactotransferrin truncated peptide HLP1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 500 microM) DME1788 XEOTICID XEO03574 GENEFORM Protein DME1788 XEOTICID XEO03574 MOACRIVE Inhibition DME1788 XEOTICID XEO03575 XEO_NAME Lactotransferrin truncated peptide HLP2 DME1788 XEOTICID XEO03575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03575 XEO_CLAS Peptide DME1788 XEOTICID XEO03575 DESCRIPT Lactotransferrin truncated peptide HLP2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 18 microM) DME1788 XEOTICID XEO03575 GENEFORM Protein DME1788 XEOTICID XEO03575 MOACRIVE Inhibition DME1788 XEOTICID XEO03576 XEO_NAME HLP2 peptide derivative HLP6 DME1788 XEOTICID XEO03576 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03576 XEO_CLAS Peptide DME1788 XEOTICID XEO03576 DESCRIPT HLP2 peptide derivative HLP6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 750 microM) DME1788 XEOTICID XEO03576 GENEFORM Protein DME1788 XEOTICID XEO03576 MOACRIVE Inhibition DME1788 XEOTICID XEO03578 XEO_NAME Hlsal-defensin DME1788 XEOTICID XEO03578 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03578 XEO_CLAS Peptide DME1788 XEOTICID XEO03578 DESCRIPT Hlsal-defensin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10000-25000 ug/ml) DME1788 XEOTICID XEO03578 GENEFORM Protein DME1788 XEOTICID XEO03578 MOACRIVE Inhibition DME1788 XEOTICID XEO03579 XEO_NAME Cathelicidin HmdSL-37 DME1788 XEOTICID XEO03579 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03579 XEO_CLAS Peptide DME1788 XEOTICID XEO03579 DESCRIPT Cathelicidin HmdSL-37 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03579 GENEFORM Protein DME1788 XEOTICID XEO03579 MOACRIVE Inhibition DME1788 XEOTICID XEO03580 XEO_NAME Histone-derived HNr DME1788 XEOTICID XEO03580 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03580 XEO_CLAS Peptide DME1788 XEOTICID XEO03580 DESCRIPT Histone-derived HNr inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03580 GENEFORM Protein DME1788 XEOTICID XEO03580 MOACRIVE Inhibition DME1788 XEOTICID XEO03585 XEO_NAME hBD-2 variant hPAB-beta DME1788 XEOTICID XEO03585 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03585 XEO_CLAS Peptide DME1788 XEOTICID XEO03585 DESCRIPT hBD-2 variant hPAB-beta inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 125 ug/ml) DME1788 XEOTICID XEO03585 GENEFORM Protein DME1788 XEOTICID XEO03585 MOACRIVE Inhibition DME1788 XEOTICID XEO03588 XEO_NAME Human beta-defensin hBD-2 DME1788 XEOTICID XEO03588 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03588 XEO_CLAS Peptide DME1788 XEOTICID XEO03588 DESCRIPT Human beta-defensin hBD-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 62 ug/ml) DME1788 XEOTICID XEO03588 GENEFORM Protein DME1788 XEOTICID XEO03588 MOACRIVE Inhibition DME1788 XEOTICID XEO03589 XEO_NAME Human beta-defensin hBD-26 DME1788 XEOTICID XEO03589 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03589 XEO_CLAS Peptide DME1788 XEOTICID XEO03589 DESCRIPT Human beta-defensin hBD-26 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03589 GENEFORM Protein DME1788 XEOTICID XEO03589 MOACRIVE Inhibition DME1788 XEOTICID XEO03590 XEO_NAME Human beta-defensin hBD-27 DME1788 XEOTICID XEO03590 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03590 XEO_CLAS Peptide DME1788 XEOTICID XEO03590 DESCRIPT Human beta-defensin hBD-27 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03590 GENEFORM Protein DME1788 XEOTICID XEO03590 MOACRIVE Inhibition DME1788 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1788 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03591 XEO_CLAS Peptide DME1788 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 37.5 ug/ml) DME1788 XEOTICID XEO03591 GENEFORM Protein DME1788 XEOTICID XEO03591 MOACRIVE Inhibition DME1788 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1788 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03593 XEO_CLAS Peptide DME1788 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 9.4 ug/ml) DME1788 XEOTICID XEO03593 GENEFORM Protein DME1788 XEOTICID XEO03593 MOACRIVE Inhibition DME1788 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1788 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03594 XEO_CLAS Peptide DME1788 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 ug/ml) DME1788 XEOTICID XEO03594 GENEFORM Protein DME1788 XEOTICID XEO03594 MOACRIVE Inhibition DME1788 XEOTICID XEO03595 XEO_NAME Human defensin HD-5 DME1788 XEOTICID XEO03595 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03595 XEO_CLAS Peptide DME1788 XEOTICID XEO03595 DESCRIPT Human defensin HD-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03595 GENEFORM Protein DME1788 XEOTICID XEO03595 MOACRIVE Inhibition DME1788 XEOTICID XEO03596 XEO_NAME Human defensin HD-6 DME1788 XEOTICID XEO03596 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03596 XEO_CLAS Peptide DME1788 XEOTICID XEO03596 DESCRIPT Human defensin HD-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03596 GENEFORM Protein DME1788 XEOTICID XEO03596 MOACRIVE Inhibition DME1788 XEOTICID XEO03598 XEO_NAME Human hepcidin Hepc20 DME1788 XEOTICID XEO03598 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03598 XEO_CLAS Peptide DME1788 XEOTICID XEO03598 DESCRIPT Human hepcidin Hepc20 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03598 GENEFORM Protein DME1788 XEOTICID XEO03598 MOACRIVE Inhibition DME1788 XEOTICID XEO03599 XEO_NAME Human hepcidin Hepc25 DME1788 XEOTICID XEO03599 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03599 XEO_CLAS Peptide DME1788 XEOTICID XEO03599 DESCRIPT Human hepcidin Hepc25 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03599 GENEFORM Protein DME1788 XEOTICID XEO03599 MOACRIVE Inhibition DME1788 XEOTICID XEO03600 XEO_NAME Human lactoferricin LfcinH DME1788 XEOTICID XEO03600 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03600 XEO_CLAS Peptide DME1788 XEOTICID XEO03600 DESCRIPT Human lactoferricin LfcinH inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03600 GENEFORM Protein DME1788 XEOTICID XEO03600 MOACRIVE Inhibition DME1788 XEOTICID XEO03606 XEO_NAME Chain of Platelet basic TC-1 DME1788 XEOTICID XEO03606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03606 XEO_CLAS Peptide DME1788 XEOTICID XEO03606 DESCRIPT Chain of Platelet basic TC-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03606 GENEFORM Protein DME1788 XEOTICID XEO03606 MOACRIVE Inhibition DME1788 XEOTICID XEO03607 XEO_NAME Chain of Platelet basic TC-2 DME1788 XEOTICID XEO03607 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03607 XEO_CLAS Peptide DME1788 XEOTICID XEO03607 DESCRIPT Chain of Platelet basic TC-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03607 GENEFORM Protein DME1788 XEOTICID XEO03607 MOACRIVE Inhibition DME1788 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1788 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03609 XEO_CLAS Peptide DME1788 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03609 GENEFORM Protein DME1788 XEOTICID XEO03609 MOACRIVE Inhibition DME1788 XEOTICID XEO03615 XEO_NAME Hylaseptin-P1 DME1788 XEOTICID XEO03615 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03615 XEO_CLAS Peptide DME1788 XEOTICID XEO03615 DESCRIPT Hylaseptin-P1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 24.4-32.0 ug/ml) DME1788 XEOTICID XEO03615 GENEFORM Protein DME1788 XEOTICID XEO03615 MOACRIVE Inhibition DME1788 XEOTICID XEO03616 XEO_NAME Hylin-a1 Hy-a1 DME1788 XEOTICID XEO03616 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03616 XEO_CLAS Peptide DME1788 XEOTICID XEO03616 DESCRIPT Hylin-a1 Hy-a1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 32 microM) DME1788 XEOTICID XEO03616 GENEFORM Protein DME1788 XEOTICID XEO03616 MOACRIVE Inhibition DME1788 XEOTICID XEO03617 XEO_NAME Hymenochirin-5B DME1788 XEOTICID XEO03617 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03617 XEO_CLAS Peptide DME1788 XEOTICID XEO03617 DESCRIPT Hymenochirin-5B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40 microM) DME1788 XEOTICID XEO03617 GENEFORM Protein DME1788 XEOTICID XEO03617 MOACRIVE Inhibition DME1788 XEOTICID XEO03618 XEO_NAME Hymenoptaecin DME1788 XEOTICID XEO03618 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03618 XEO_CLAS Peptide DME1788 XEOTICID XEO03618 DESCRIPT Hymenoptaecin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5-1 microM) DME1788 XEOTICID XEO03618 GENEFORM Protein DME1788 XEOTICID XEO03618 MOACRIVE Inhibition DME1788 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1788 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03622 XEO_CLAS Peptide DME1788 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20-40 microM) DME1788 XEOTICID XEO03622 GENEFORM Protein DME1788 XEOTICID XEO03622 MOACRIVE Inhibition DME1788 XEOTICID XEO03627 XEO_NAME Arthropod Im-1 DME1788 XEOTICID XEO03627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03627 XEO_CLAS Peptide DME1788 XEOTICID XEO03627 DESCRIPT Arthropod Im-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1788 XEOTICID XEO03627 GENEFORM Protein DME1788 XEOTICID XEO03627 MOACRIVE Inhibition DME1788 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1788 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03630 XEO_CLAS Peptide DME1788 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03630 GENEFORM Protein DME1788 XEOTICID XEO03630 MOACRIVE Inhibition DME1788 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1788 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03631 XEO_CLAS Peptide DME1788 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03631 GENEFORM Protein DME1788 XEOTICID XEO03631 MOACRIVE Inhibition DME1788 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1788 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03632 XEO_CLAS Peptide DME1788 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03632 GENEFORM Protein DME1788 XEOTICID XEO03632 MOACRIVE Inhibition DME1788 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1788 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03633 XEO_CLAS Peptide DME1788 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03633 GENEFORM Protein DME1788 XEOTICID XEO03633 MOACRIVE Inhibition DME1788 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1788 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03634 XEO_CLAS Peptide DME1788 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03634 GENEFORM Protein DME1788 XEOTICID XEO03634 MOACRIVE Inhibition DME1788 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1788 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03635 XEO_CLAS Peptide DME1788 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03635 GENEFORM Protein DME1788 XEOTICID XEO03635 MOACRIVE Inhibition DME1788 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1788 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03636 XEO_CLAS Peptide DME1788 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03636 GENEFORM Protein DME1788 XEOTICID XEO03636 MOACRIVE Inhibition DME1788 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1788 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03637 XEO_CLAS Peptide DME1788 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03637 GENEFORM Protein DME1788 XEOTICID XEO03637 MOACRIVE Inhibition DME1788 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1788 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03638 XEO_CLAS Peptide DME1788 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03638 GENEFORM Protein DME1788 XEOTICID XEO03638 MOACRIVE Inhibition DME1788 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1788 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03639 XEO_CLAS Peptide DME1788 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03639 GENEFORM Protein DME1788 XEOTICID XEO03639 MOACRIVE Inhibition DME1788 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1788 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03640 XEO_CLAS Peptide DME1788 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03640 GENEFORM Protein DME1788 XEOTICID XEO03640 MOACRIVE Inhibition DME1788 XEOTICID XEO03644 XEO_NAME Indole DME1788 XEOTICID XEO03644 XEO_TYPE Health or Environmental Toxicant(s) DME1788 XEOTICID XEO03644 XEO_CLAS Acute Toxic Substance DME1788 XEOTICID XEO03644 DESCRIPT Indole inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03644 GENEFORM Protein DME1788 XEOTICID XEO03644 MOACRIVE Inhibition DME1788 XEOTICID XEO03650 XEO_NAME Indolicidin cathelicidin-4 DME1788 XEOTICID XEO03650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03650 XEO_CLAS Peptide DME1788 XEOTICID XEO03650 DESCRIPT Indolicidin cathelicidin-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03650 GENEFORM Protein DME1788 XEOTICID XEO03650 MOACRIVE Inhibition DME1788 XEOTICID XEO03655 XEO_NAME Isoeugenol DME1788 XEOTICID XEO03655 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO03655 XEO_CLAS Natural Product DME1788 XEOTICID XEO03655 DESCRIPT Isoeugenol inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03655 GENEFORM Protein DME1788 XEOTICID XEO03655 MOACRIVE Inhibition DME1788 XEOTICID XEO03666 XEO_NAME Ixosin-A DME1788 XEOTICID XEO03666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03666 XEO_CLAS Peptide DME1788 XEOTICID XEO03666 DESCRIPT Ixosin-A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 ug/ml) DME1788 XEOTICID XEO03666 GENEFORM Protein DME1788 XEOTICID XEO03666 MOACRIVE Inhibition DME1788 XEOTICID XEO03667 XEO_NAME Ixosin-B DME1788 XEOTICID XEO03667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03667 XEO_CLAS Peptide DME1788 XEOTICID XEO03667 DESCRIPT Ixosin-B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 ug/ml) DME1788 XEOTICID XEO03667 GENEFORM Protein DME1788 XEOTICID XEO03667 MOACRIVE Inhibition DME1788 XEOTICID XEO03668 XEO_NAME Frog japonicin-1 DME1788 XEOTICID XEO03668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03668 XEO_CLAS Peptide DME1788 XEOTICID XEO03668 DESCRIPT Frog japonicin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 microM) DME1788 XEOTICID XEO03668 GENEFORM Protein DME1788 XEOTICID XEO03668 MOACRIVE Inhibition DME1788 XEOTICID XEO03669 XEO_NAME Japonicin-1CDYa DME1788 XEOTICID XEO03669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03669 XEO_CLAS Peptide DME1788 XEOTICID XEO03669 DESCRIPT Japonicin-1CDYa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO03669 GENEFORM Protein DME1788 XEOTICID XEO03669 MOACRIVE Inhibition DME1788 XEOTICID XEO03670 XEO_NAME Japonicin-2 DME1788 XEOTICID XEO03670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03670 XEO_CLAS Peptide DME1788 XEOTICID XEO03670 DESCRIPT Japonicin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 microM) DME1788 XEOTICID XEO03670 GENEFORM Protein DME1788 XEOTICID XEO03670 MOACRIVE Inhibition DME1788 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1788 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03672 XEO_CLAS Peptide DME1788 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.5 ug/ml) DME1788 XEOTICID XEO03672 GENEFORM Protein DME1788 XEOTICID XEO03672 MOACRIVE Inhibition DME1788 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1788 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03673 XEO_CLAS Peptide DME1788 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 ug/ml) DME1788 XEOTICID XEO03673 GENEFORM Protein DME1788 XEOTICID XEO03673 MOACRIVE Inhibition DME1788 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1788 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03674 XEO_CLAS Peptide DME1788 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 ug/ml) DME1788 XEOTICID XEO03674 GENEFORM Protein DME1788 XEOTICID XEO03674 MOACRIVE Inhibition DME1788 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1788 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03675 XEO_CLAS Peptide DME1788 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO03675 GENEFORM Protein DME1788 XEOTICID XEO03675 MOACRIVE Inhibition DME1788 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1788 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03678 XEO_CLAS Peptide DME1788 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 ug/ml) DME1788 XEOTICID XEO03678 GENEFORM Protein DME1788 XEOTICID XEO03678 MOACRIVE Inhibition DME1788 XEOTICID XEO03679 XEO_NAME Bac2A scrambled variant K12 DME1788 XEOTICID XEO03679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03679 XEO_CLAS Peptide DME1788 XEOTICID XEO03679 DESCRIPT Bac2A scrambled variant K12 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 ug/ml) DME1788 XEOTICID XEO03679 GENEFORM Protein DME1788 XEOTICID XEO03679 MOACRIVE Inhibition DME1788 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1788 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03681 XEO_CLAS Peptide DME1788 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1788 XEOTICID XEO03681 GENEFORM Protein DME1788 XEOTICID XEO03681 MOACRIVE Inhibition DME1788 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1788 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03684 XEO_CLAS Peptide DME1788 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 ug/ml) DME1788 XEOTICID XEO03684 GENEFORM Protein DME1788 XEOTICID XEO03684 MOACRIVE Inhibition DME1788 XEOTICID XEO03694 XEO_NAME Kaliocin-1 DME1788 XEOTICID XEO03694 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03694 XEO_CLAS Peptide DME1788 XEOTICID XEO03694 DESCRIPT Kaliocin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03694 GENEFORM Protein DME1788 XEOTICID XEO03694 MOACRIVE Inhibition DME1788 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1788 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03697 XEO_CLAS Peptide DME1788 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25 microM) DME1788 XEOTICID XEO03697 GENEFORM Protein DME1788 XEOTICID XEO03697 MOACRIVE Inhibition DME1788 XEOTICID XEO03698 XEO_NAME Kassinatuerin-2Ma DME1788 XEOTICID XEO03698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03698 XEO_CLAS Peptide DME1788 XEOTICID XEO03698 DESCRIPT Kassinatuerin-2Ma inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03698 GENEFORM Protein DME1788 XEOTICID XEO03698 MOACRIVE Inhibition DME1788 XEOTICID XEO03703 XEO_NAME Kasstasin DME1788 XEOTICID XEO03703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03703 XEO_CLAS Peptide DME1788 XEOTICID XEO03703 DESCRIPT Kasstasin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 110 microM) DME1788 XEOTICID XEO03703 GENEFORM Protein DME1788 XEOTICID XEO03703 MOACRIVE Inhibition DME1788 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME1788 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03706 XEO_CLAS Peptide DME1788 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03706 GENEFORM Protein DME1788 XEOTICID XEO03706 MOACRIVE Inhibition DME1788 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME1788 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03707 XEO_CLAS Peptide DME1788 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03707 GENEFORM Protein DME1788 XEOTICID XEO03707 MOACRIVE Inhibition DME1788 XEOTICID XEO03709 XEO_NAME BmKn2 derivative Kn2-7 DME1788 XEOTICID XEO03709 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03709 XEO_CLAS Peptide DME1788 XEOTICID XEO03709 DESCRIPT BmKn2 derivative Kn2-7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 ug/ml) DME1788 XEOTICID XEO03709 GENEFORM Protein DME1788 XEOTICID XEO03709 MOACRIVE Inhibition DME1788 XEOTICID XEO03712 XEO_NAME KR-12 peptide DME1788 XEOTICID XEO03712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03712 XEO_CLAS Peptide DME1788 XEOTICID XEO03712 DESCRIPT KR-12 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03712 GENEFORM Protein DME1788 XEOTICID XEO03712 MOACRIVE Inhibition DME1788 XEOTICID XEO03713 XEO_NAME LL-37 derivative KR-20 DME1788 XEOTICID XEO03713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03713 XEO_CLAS Peptide DME1788 XEOTICID XEO03713 DESCRIPT LL-37 derivative KR-20 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 64 microM) DME1788 XEOTICID XEO03713 GENEFORM Protein DME1788 XEOTICID XEO03713 MOACRIVE Inhibition DME1788 XEOTICID XEO03714 XEO_NAME KRS22 peptide DME1788 XEOTICID XEO03714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03714 XEO_CLAS Peptide DME1788 XEOTICID XEO03714 DESCRIPT KRS22 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03714 GENEFORM Protein DME1788 XEOTICID XEO03714 MOACRIVE Inhibition DME1788 XEOTICID XEO03715 XEO_NAME LL-37 derivative KS-30 DME1788 XEOTICID XEO03715 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03715 XEO_CLAS Peptide DME1788 XEOTICID XEO03715 DESCRIPT LL-37 derivative KS-30 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 microM) DME1788 XEOTICID XEO03715 GENEFORM Protein DME1788 XEOTICID XEO03715 MOACRIVE Inhibition DME1788 XEOTICID XEO03719 XEO_NAME Kunitzin-OS DME1788 XEOTICID XEO03719 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03719 XEO_CLAS Peptide DME1788 XEOTICID XEO03719 DESCRIPT Kunitzin-OS inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 microM) DME1788 XEOTICID XEO03719 GENEFORM Protein DME1788 XEOTICID XEO03719 MOACRIVE Inhibition DME1788 XEOTICID XEO03720 XEO_NAME Kunitzin-RE DME1788 XEOTICID XEO03720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03720 XEO_CLAS Peptide DME1788 XEOTICID XEO03720 DESCRIPT Kunitzin-RE inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 microM) DME1788 XEOTICID XEO03720 GENEFORM Protein DME1788 XEOTICID XEO03720 MOACRIVE Inhibition DME1788 XEOTICID XEO03723 XEO_NAME Bovine LF L1 DME1788 XEOTICID XEO03723 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03723 XEO_CLAS Peptide DME1788 XEOTICID XEO03723 DESCRIPT Bovine LF L1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 62.36 microM) DME1788 XEOTICID XEO03723 GENEFORM Protein DME1788 XEOTICID XEO03723 MOACRIVE Inhibition DME1788 XEOTICID XEO03724 XEO_NAME L10 peptide DME1788 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03724 XEO_CLAS Peptide DME1788 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.8 microM) DME1788 XEOTICID XEO03724 GENEFORM Protein DME1788 XEOTICID XEO03724 MOACRIVE Inhibition DME1788 XEOTICID XEO03726 XEO_NAME L2 peptide DME1788 XEOTICID XEO03726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03726 XEO_CLAS Peptide DME1788 XEOTICID XEO03726 DESCRIPT L2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 129.66 microM) DME1788 XEOTICID XEO03726 GENEFORM Protein DME1788 XEOTICID XEO03726 MOACRIVE Inhibition DME1788 XEOTICID XEO03727 XEO_NAME LlKmW2 model peptide L2K3W2 DME1788 XEOTICID XEO03727 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03727 XEO_CLAS Peptide DME1788 XEOTICID XEO03727 DESCRIPT LlKmW2 model peptide L2K3W2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 80 ug/ml) DME1788 XEOTICID XEO03727 GENEFORM Protein DME1788 XEOTICID XEO03727 MOACRIVE Inhibition DME1788 XEOTICID XEO03728 XEO_NAME LlKmW2 model peptide L2K5W2 DME1788 XEOTICID XEO03728 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03728 XEO_CLAS Peptide DME1788 XEOTICID XEO03728 DESCRIPT LlKmW2 model peptide L2K5W2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40 ug/ml) DME1788 XEOTICID XEO03728 GENEFORM Protein DME1788 XEOTICID XEO03728 MOACRIVE Inhibition DME1788 XEOTICID XEO03729 XEO_NAME LlKmW2 model peptide L2KW2 DME1788 XEOTICID XEO03729 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03729 XEO_CLAS Peptide DME1788 XEOTICID XEO03729 DESCRIPT LlKmW2 model peptide L2KW2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 80 ug/ml) DME1788 XEOTICID XEO03729 GENEFORM Protein DME1788 XEOTICID XEO03729 MOACRIVE Inhibition DME1788 XEOTICID XEO03730 XEO_NAME L3 peptide DME1788 XEOTICID XEO03730 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03730 XEO_CLAS Peptide DME1788 XEOTICID XEO03730 DESCRIPT L3 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64.11 microM) DME1788 XEOTICID XEO03730 GENEFORM Protein DME1788 XEOTICID XEO03730 MOACRIVE Inhibition DME1788 XEOTICID XEO03731 XEO_NAME LlKmW2 model peptide L3K2W2 DME1788 XEOTICID XEO03731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03731 XEO_CLAS Peptide DME1788 XEOTICID XEO03731 DESCRIPT LlKmW2 model peptide L3K2W2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40 ug/ml) DME1788 XEOTICID XEO03731 GENEFORM Protein DME1788 XEOTICID XEO03731 MOACRIVE Inhibition DME1788 XEOTICID XEO03733 XEO_NAME LlKmW2 model peptide L3K4W2 DME1788 XEOTICID XEO03733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03733 XEO_CLAS Peptide DME1788 XEOTICID XEO03733 DESCRIPT LlKmW2 model peptide L3K4W2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40 ug/ml) DME1788 XEOTICID XEO03733 GENEFORM Protein DME1788 XEOTICID XEO03733 MOACRIVE Inhibition DME1788 XEOTICID XEO03734 XEO_NAME LlKmW2 model peptide L3K6W2 DME1788 XEOTICID XEO03734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03734 XEO_CLAS Peptide DME1788 XEOTICID XEO03734 DESCRIPT LlKmW2 model peptide L3K6W2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO03734 GENEFORM Protein DME1788 XEOTICID XEO03734 MOACRIVE Inhibition DME1788 XEOTICID XEO03735 XEO_NAME L4 peptide DME1788 XEOTICID XEO03735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03735 XEO_CLAS Peptide DME1788 XEOTICID XEO03735 DESCRIPT L4 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 31.61 microM) DME1788 XEOTICID XEO03735 GENEFORM Protein DME1788 XEOTICID XEO03735 MOACRIVE Inhibition DME1788 XEOTICID XEO03738 XEO_NAME LlKmW2 model peptide L4K3W2 DME1788 XEOTICID XEO03738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03738 XEO_CLAS Peptide DME1788 XEOTICID XEO03738 DESCRIPT LlKmW2 model peptide L4K3W2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 ug/ml) DME1788 XEOTICID XEO03738 GENEFORM Protein DME1788 XEOTICID XEO03738 MOACRIVE Inhibition DME1788 XEOTICID XEO03741 XEO_NAME LlKmW2 model peptide L4K5W2 DME1788 XEOTICID XEO03741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03741 XEO_CLAS Peptide DME1788 XEOTICID XEO03741 DESCRIPT LlKmW2 model peptide L4K5W2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40 ug/ml) DME1788 XEOTICID XEO03741 GENEFORM Protein DME1788 XEOTICID XEO03741 MOACRIVE Inhibition DME1788 XEOTICID XEO03742 XEO_NAME L5 peptide DME1788 XEOTICID XEO03742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03742 XEO_CLAS Peptide DME1788 XEOTICID XEO03742 DESCRIPT L5 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 7.79 microM) DME1788 XEOTICID XEO03742 GENEFORM Protein DME1788 XEOTICID XEO03742 MOACRIVE Inhibition DME1788 XEOTICID XEO03743 XEO_NAME LlKmW2 model peptide L5K2W2 DME1788 XEOTICID XEO03743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03743 XEO_CLAS Peptide DME1788 XEOTICID XEO03743 DESCRIPT LlKmW2 model peptide L5K2W2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 ug/ml) DME1788 XEOTICID XEO03743 GENEFORM Protein DME1788 XEOTICID XEO03743 MOACRIVE Inhibition DME1788 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1788 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03744 XEO_CLAS Peptide DME1788 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 ug/ml) DME1788 XEOTICID XEO03744 GENEFORM Protein DME1788 XEOTICID XEO03744 MOACRIVE Inhibition DME1788 XEOTICID XEO03745 XEO_NAME LlKmW2 model peptide L5K4W2 DME1788 XEOTICID XEO03745 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03745 XEO_CLAS Peptide DME1788 XEOTICID XEO03745 DESCRIPT LlKmW2 model peptide L5K4W2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 ug/ml) DME1788 XEOTICID XEO03745 GENEFORM Protein DME1788 XEOTICID XEO03745 MOACRIVE Inhibition DME1788 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1788 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03746 XEO_CLAS Peptide DME1788 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO03746 GENEFORM Protein DME1788 XEOTICID XEO03746 MOACRIVE Inhibition DME1788 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1788 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03747 XEO_CLAS Peptide DME1788 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO03747 GENEFORM Protein DME1788 XEOTICID XEO03747 MOACRIVE Inhibition DME1788 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1788 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03748 XEO_CLAS Peptide DME1788 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO03748 GENEFORM Protein DME1788 XEOTICID XEO03748 MOACRIVE Inhibition DME1788 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1788 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03749 XEO_CLAS Peptide DME1788 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO03749 GENEFORM Protein DME1788 XEOTICID XEO03749 MOACRIVE Inhibition DME1788 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1788 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03750 XEO_CLAS Peptide DME1788 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO03750 GENEFORM Protein DME1788 XEOTICID XEO03750 MOACRIVE Inhibition DME1788 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1788 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03751 XEO_CLAS Peptide DME1788 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO03751 GENEFORM Protein DME1788 XEOTICID XEO03751 MOACRIVE Inhibition DME1788 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1788 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03752 XEO_CLAS Peptide DME1788 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO03752 GENEFORM Protein DME1788 XEOTICID XEO03752 MOACRIVE Inhibition DME1788 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1788 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03753 XEO_CLAS Peptide DME1788 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 ug/ml) DME1788 XEOTICID XEO03753 GENEFORM Protein DME1788 XEOTICID XEO03753 MOACRIVE Inhibition DME1788 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1788 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03754 XEO_CLAS Peptide DME1788 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO03754 GENEFORM Protein DME1788 XEOTICID XEO03754 MOACRIVE Inhibition DME1788 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1788 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03755 XEO_CLAS Peptide DME1788 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO03755 GENEFORM Protein DME1788 XEOTICID XEO03755 MOACRIVE Inhibition DME1788 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1788 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03756 XEO_CLAS Peptide DME1788 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO03756 GENEFORM Protein DME1788 XEOTICID XEO03756 MOACRIVE Inhibition DME1788 XEOTICID XEO03757 XEO_NAME L6 peptide DME1788 XEOTICID XEO03757 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03757 XEO_CLAS Peptide DME1788 XEOTICID XEO03757 DESCRIPT L6 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15.17 microM) DME1788 XEOTICID XEO03757 GENEFORM Protein DME1788 XEOTICID XEO03757 MOACRIVE Inhibition DME1788 XEOTICID XEO03758 XEO_NAME LlKmW2 model peptide L6K3W2 DME1788 XEOTICID XEO03758 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03758 XEO_CLAS Peptide DME1788 XEOTICID XEO03758 DESCRIPT LlKmW2 model peptide L6K3W2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 80 ug/ml) DME1788 XEOTICID XEO03758 GENEFORM Protein DME1788 XEOTICID XEO03758 MOACRIVE Inhibition DME1788 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1788 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03759 XEO_CLAS Peptide DME1788 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.3 ug/ml) DME1788 XEOTICID XEO03759 GENEFORM Protein DME1788 XEOTICID XEO03759 MOACRIVE Inhibition DME1788 XEOTICID XEO03760 XEO_NAME L7 peptide DME1788 XEOTICID XEO03760 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03760 XEO_CLAS Peptide DME1788 XEOTICID XEO03760 DESCRIPT L7 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16.02 microM) DME1788 XEOTICID XEO03760 GENEFORM Protein DME1788 XEOTICID XEO03760 MOACRIVE Inhibition DME1788 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1788 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03761 XEO_CLAS Peptide DME1788 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 ug/ml) DME1788 XEOTICID XEO03761 GENEFORM Protein DME1788 XEOTICID XEO03761 MOACRIVE Inhibition DME1788 XEOTICID XEO03763 XEO_NAME L8 peptide DME1788 XEOTICID XEO03763 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03763 XEO_CLAS Peptide DME1788 XEOTICID XEO03763 DESCRIPT L8 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.71 microM) DME1788 XEOTICID XEO03763 GENEFORM Protein DME1788 XEOTICID XEO03763 MOACRIVE Inhibition DME1788 XEOTICID XEO03765 XEO_NAME L9 peptide DME1788 XEOTICID XEO03765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03765 XEO_CLAS Peptide DME1788 XEOTICID XEO03765 DESCRIPT L9 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.78 microM) DME1788 XEOTICID XEO03765 GENEFORM Protein DME1788 XEOTICID XEO03765 MOACRIVE Inhibition DME1788 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME1788 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03775 XEO_CLAS Peptide DME1788 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 17.3 microM) DME1788 XEOTICID XEO03775 GENEFORM Protein DME1788 XEOTICID XEO03775 MOACRIVE Inhibition DME1788 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1788 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03776 XEO_CLAS Peptide DME1788 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03776 GENEFORM Protein DME1788 XEOTICID XEO03776 MOACRIVE Inhibition DME1788 XEOTICID XEO03781 XEO_NAME Peptide LAK120 DME1788 XEOTICID XEO03781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03781 XEO_CLAS Peptide DME1788 XEOTICID XEO03781 DESCRIPT Peptide LAK120 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.47 microM) DME1788 XEOTICID XEO03781 GENEFORM Protein DME1788 XEOTICID XEO03781 MOACRIVE Inhibition DME1788 XEOTICID XEO03782 XEO_NAME Peptide LAK120-P10 DME1788 XEOTICID XEO03782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03782 XEO_CLAS Peptide DME1788 XEOTICID XEO03782 DESCRIPT Peptide LAK120-P10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.47 microM) DME1788 XEOTICID XEO03782 GENEFORM Protein DME1788 XEOTICID XEO03782 MOACRIVE Inhibition DME1788 XEOTICID XEO03783 XEO_NAME Peptide LAK120-P12 DME1788 XEOTICID XEO03783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03783 XEO_CLAS Peptide DME1788 XEOTICID XEO03783 DESCRIPT Peptide LAK120-P12 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.68 microM) DME1788 XEOTICID XEO03783 GENEFORM Protein DME1788 XEOTICID XEO03783 MOACRIVE Inhibition DME1788 XEOTICID XEO03784 XEO_NAME Peptide LAK120-P7 DME1788 XEOTICID XEO03784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03784 XEO_CLAS Peptide DME1788 XEOTICID XEO03784 DESCRIPT Peptide LAK120-P7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.45 microM) DME1788 XEOTICID XEO03784 GENEFORM Protein DME1788 XEOTICID XEO03784 MOACRIVE Inhibition DME1788 XEOTICID XEO03785 XEO_NAME Peptide LAK160 DME1788 XEOTICID XEO03785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03785 XEO_CLAS Peptide DME1788 XEOTICID XEO03785 DESCRIPT Peptide LAK160 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.73 microM) DME1788 XEOTICID XEO03785 GENEFORM Protein DME1788 XEOTICID XEO03785 MOACRIVE Inhibition DME1788 XEOTICID XEO03786 XEO_NAME Peptide LAK160-P10 DME1788 XEOTICID XEO03786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03786 XEO_CLAS Peptide DME1788 XEOTICID XEO03786 DESCRIPT Peptide LAK160-P10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.45 microM) DME1788 XEOTICID XEO03786 GENEFORM Protein DME1788 XEOTICID XEO03786 MOACRIVE Inhibition DME1788 XEOTICID XEO03787 XEO_NAME Peptide LAK160-P12 DME1788 XEOTICID XEO03787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03787 XEO_CLAS Peptide DME1788 XEOTICID XEO03787 DESCRIPT Peptide LAK160-P12 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.38 microM) DME1788 XEOTICID XEO03787 GENEFORM Protein DME1788 XEOTICID XEO03787 MOACRIVE Inhibition DME1788 XEOTICID XEO03788 XEO_NAME Peptide LAK160-P7 DME1788 XEOTICID XEO03788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03788 XEO_CLAS Peptide DME1788 XEOTICID XEO03788 DESCRIPT Peptide LAK160-P7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.46 microM) DME1788 XEOTICID XEO03788 GENEFORM Protein DME1788 XEOTICID XEO03788 MOACRIVE Inhibition DME1788 XEOTICID XEO03789 XEO_NAME LAK80 peptide DME1788 XEOTICID XEO03789 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03789 XEO_CLAS Peptide DME1788 XEOTICID XEO03789 DESCRIPT LAK80 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 13.05 microM) DME1788 XEOTICID XEO03789 GENEFORM Protein DME1788 XEOTICID XEO03789 MOACRIVE Inhibition DME1788 XEOTICID XEO03790 XEO_NAME Peptide LAK80-P10 DME1788 XEOTICID XEO03790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03790 XEO_CLAS Peptide DME1788 XEOTICID XEO03790 DESCRIPT Peptide LAK80-P10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.82 microM) DME1788 XEOTICID XEO03790 GENEFORM Protein DME1788 XEOTICID XEO03790 MOACRIVE Inhibition DME1788 XEOTICID XEO03791 XEO_NAME Peptide LAK80-P12 DME1788 XEOTICID XEO03791 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03791 XEO_CLAS Peptide DME1788 XEOTICID XEO03791 DESCRIPT Peptide LAK80-P12 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.80 microM) DME1788 XEOTICID XEO03791 GENEFORM Protein DME1788 XEOTICID XEO03791 MOACRIVE Inhibition DME1788 XEOTICID XEO03792 XEO_NAME Peptide LAK80-P7 DME1788 XEOTICID XEO03792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03792 XEO_CLAS Peptide DME1788 XEOTICID XEO03792 DESCRIPT Peptide LAK80-P7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.26 microM) DME1788 XEOTICID XEO03792 GENEFORM Protein DME1788 XEOTICID XEO03792 MOACRIVE Inhibition DME1788 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1788 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03793 XEO_CLAS Peptide DME1788 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 microM) DME1788 XEOTICID XEO03793 GENEFORM Protein DME1788 XEOTICID XEO03793 MOACRIVE Inhibition DME1788 XEOTICID XEO03797 XEO_NAME L-amino-acid oxidase Oh-LAAO DME1788 XEOTICID XEO03797 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03797 XEO_CLAS Peptide DME1788 XEOTICID XEO03797 DESCRIPT L-amino-acid oxidase Oh-LAAO inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.4 microM) DME1788 XEOTICID XEO03797 GENEFORM Protein DME1788 XEOTICID XEO03797 MOACRIVE Inhibition DME1788 XEOTICID XEO03798 XEO_NAME L-amino-acid oxidase TM-LAO DME1788 XEOTICID XEO03798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03798 XEO_CLAS Peptide DME1788 XEOTICID XEO03798 DESCRIPT L-amino-acid oxidase TM-LAO inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03798 GENEFORM Protein DME1788 XEOTICID XEO03798 MOACRIVE Inhibition DME1788 XEOTICID XEO03799 XEO_NAME L-amino-acid oxidase BpirLAAO-I DME1788 XEOTICID XEO03799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03799 XEO_CLAS Peptide DME1788 XEOTICID XEO03799 DESCRIPT L-amino-acid oxidase BpirLAAO-I inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03799 GENEFORM Protein DME1788 XEOTICID XEO03799 MOACRIVE Inhibition DME1788 XEOTICID XEO03810 XEO_NAME Laterosporulin DME1788 XEOTICID XEO03810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03810 XEO_CLAS Peptide DME1788 XEOTICID XEO03810 DESCRIPT Laterosporulin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03810 GENEFORM Protein DME1788 XEOTICID XEO03810 MOACRIVE Inhibition DME1788 XEOTICID XEO03846 XEO_NAME Lebocin-1/2 DME1788 XEOTICID XEO03846 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03846 XEO_CLAS Peptide DME1788 XEOTICID XEO03846 DESCRIPT Lebocin-1/2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03846 GENEFORM Protein DME1788 XEOTICID XEO03846 MOACRIVE Inhibition DME1788 XEOTICID XEO03847 XEO_NAME Lebocin-3 DME1788 XEOTICID XEO03847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03847 XEO_CLAS Peptide DME1788 XEOTICID XEO03847 DESCRIPT Lebocin-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03847 GENEFORM Protein DME1788 XEOTICID XEO03847 MOACRIVE Inhibition DME1788 XEOTICID XEO03850 XEO_NAME Lemon DME1788 XEOTICID XEO03850 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1788 XEOTICID XEO03850 XEO_CLAS Food Additive DME1788 XEOTICID XEO03850 DESCRIPT Lemon inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03850 GENEFORM Protein DME1788 XEOTICID XEO03850 MOACRIVE Inhibition DME1788 XEOTICID XEO03853 XEO_NAME Leptoglycin DME1788 XEOTICID XEO03853 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03853 XEO_CLAS Peptide DME1788 XEOTICID XEO03853 DESCRIPT Leptoglycin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO03853 GENEFORM Protein DME1788 XEOTICID XEO03853 MOACRIVE Inhibition DME1788 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME1788 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03857 XEO_CLAS Peptide DME1788 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 38.49 microM) DME1788 XEOTICID XEO03857 GENEFORM Protein DME1788 XEOTICID XEO03857 MOACRIVE Inhibition DME1788 XEOTICID XEO03860 XEO_NAME Bovine lalctoferricin fragment LFB(17-31) DME1788 XEOTICID XEO03860 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03860 XEO_CLAS Peptide DME1788 XEOTICID XEO03860 DESCRIPT Bovine lalctoferricin fragment LFB(17-31) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 24 microM) DME1788 XEOTICID XEO03860 GENEFORM Protein DME1788 XEOTICID XEO03860 MOACRIVE Inhibition DME1788 XEOTICID XEO03861 XEO_NAME LFB derivative A1 DME1788 XEOTICID XEO03861 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03861 XEO_CLAS Peptide DME1788 XEOTICID XEO03861 DESCRIPT LFB derivative A1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 35 microM) DME1788 XEOTICID XEO03861 GENEFORM Protein DME1788 XEOTICID XEO03861 MOACRIVE Inhibition DME1788 XEOTICID XEO03862 XEO_NAME LFB derivative A10 DME1788 XEOTICID XEO03862 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03862 XEO_CLAS Peptide DME1788 XEOTICID XEO03862 DESCRIPT LFB derivative A10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 70 microM) DME1788 XEOTICID XEO03862 GENEFORM Protein DME1788 XEOTICID XEO03862 MOACRIVE Inhibition DME1788 XEOTICID XEO03863 XEO_NAME LFB derivative A11 DME1788 XEOTICID XEO03863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03863 XEO_CLAS Peptide DME1788 XEOTICID XEO03863 DESCRIPT LFB derivative A11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 35 microM) DME1788 XEOTICID XEO03863 GENEFORM Protein DME1788 XEOTICID XEO03863 MOACRIVE Inhibition DME1788 XEOTICID XEO03864 XEO_NAME LFB derivative A12 DME1788 XEOTICID XEO03864 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03864 XEO_CLAS Peptide DME1788 XEOTICID XEO03864 DESCRIPT LFB derivative A12 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO03864 GENEFORM Protein DME1788 XEOTICID XEO03864 MOACRIVE Inhibition DME1788 XEOTICID XEO03865 XEO_NAME LFB derivative A13 DME1788 XEOTICID XEO03865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03865 XEO_CLAS Peptide DME1788 XEOTICID XEO03865 DESCRIPT LFB derivative A13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO03865 GENEFORM Protein DME1788 XEOTICID XEO03865 MOACRIVE Inhibition DME1788 XEOTICID XEO03866 XEO_NAME LFB derivative A14 DME1788 XEOTICID XEO03866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03866 XEO_CLAS Peptide DME1788 XEOTICID XEO03866 DESCRIPT LFB derivative A14 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 microM) DME1788 XEOTICID XEO03866 GENEFORM Protein DME1788 XEOTICID XEO03866 MOACRIVE Inhibition DME1788 XEOTICID XEO03867 XEO_NAME LFB derivative A2 DME1788 XEOTICID XEO03867 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03867 XEO_CLAS Peptide DME1788 XEOTICID XEO03867 DESCRIPT LFB derivative A2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40 microM) DME1788 XEOTICID XEO03867 GENEFORM Protein DME1788 XEOTICID XEO03867 MOACRIVE Inhibition DME1788 XEOTICID XEO03868 XEO_NAME LFB derivative A3 DME1788 XEOTICID XEO03868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03868 XEO_CLAS Peptide DME1788 XEOTICID XEO03868 DESCRIPT LFB derivative A3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 51 microM) DME1788 XEOTICID XEO03868 GENEFORM Protein DME1788 XEOTICID XEO03868 MOACRIVE Inhibition DME1788 XEOTICID XEO03869 XEO_NAME LFB derivative A4 DME1788 XEOTICID XEO03869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03869 XEO_CLAS Peptide DME1788 XEOTICID XEO03869 DESCRIPT LFB derivative A4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 35 microM) DME1788 XEOTICID XEO03869 GENEFORM Protein DME1788 XEOTICID XEO03869 MOACRIVE Inhibition DME1788 XEOTICID XEO03870 XEO_NAME LFB derivative A5 DME1788 XEOTICID XEO03870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03870 XEO_CLAS Peptide DME1788 XEOTICID XEO03870 DESCRIPT LFB derivative A5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 61 microM) DME1788 XEOTICID XEO03870 GENEFORM Protein DME1788 XEOTICID XEO03870 MOACRIVE Inhibition DME1788 XEOTICID XEO03871 XEO_NAME LFB derivative A7 DME1788 XEOTICID XEO03871 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03871 XEO_CLAS Peptide DME1788 XEOTICID XEO03871 DESCRIPT LFB derivative A7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 microM) DME1788 XEOTICID XEO03871 GENEFORM Protein DME1788 XEOTICID XEO03871 MOACRIVE Inhibition DME1788 XEOTICID XEO03872 XEO_NAME LFB derivative A9 DME1788 XEOTICID XEO03872 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03872 XEO_CLAS Peptide DME1788 XEOTICID XEO03872 DESCRIPT LFB derivative A9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 28 microM) DME1788 XEOTICID XEO03872 GENEFORM Protein DME1788 XEOTICID XEO03872 MOACRIVE Inhibition DME1788 XEOTICID XEO03873 XEO_NAME Bovine lactoferrin LFB-6RW DME1788 XEOTICID XEO03873 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03873 XEO_CLAS Peptide DME1788 XEOTICID XEO03873 DESCRIPT Bovine lactoferrin LFB-6RW inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 22.5 microM) DME1788 XEOTICID XEO03873 GENEFORM Protein DME1788 XEOTICID XEO03873 MOACRIVE Inhibition DME1788 XEOTICID XEO03874 XEO_NAME Bovine lactoferrin LFB-KW DME1788 XEOTICID XEO03874 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03874 XEO_CLAS Peptide DME1788 XEOTICID XEO03874 DESCRIPT Bovine lactoferrin LFB-KW inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 11.25 microM) DME1788 XEOTICID XEO03874 GENEFORM Protein DME1788 XEOTICID XEO03874 MOACRIVE Inhibition DME1788 XEOTICID XEO03875 XEO_NAME Bovine lactoferrin LFB-RF DME1788 XEOTICID XEO03875 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03875 XEO_CLAS Peptide DME1788 XEOTICID XEO03875 DESCRIPT Bovine lactoferrin LFB-RF inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 microM) DME1788 XEOTICID XEO03875 GENEFORM Protein DME1788 XEOTICID XEO03875 MOACRIVE Inhibition DME1788 XEOTICID XEO03876 XEO_NAME Bovine lactoferrin LFB-RI DME1788 XEOTICID XEO03876 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03876 XEO_CLAS Peptide DME1788 XEOTICID XEO03876 DESCRIPT Bovine lactoferrin LFB-RI inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.75 microM) DME1788 XEOTICID XEO03876 GENEFORM Protein DME1788 XEOTICID XEO03876 MOACRIVE Inhibition DME1788 XEOTICID XEO03877 XEO_NAME Bovine lactoferrin LFB-RW DME1788 XEOTICID XEO03877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03877 XEO_CLAS Peptide DME1788 XEOTICID XEO03877 DESCRIPT Bovine lactoferrin LFB-RW inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 microM) DME1788 XEOTICID XEO03877 GENEFORM Protein DME1788 XEOTICID XEO03877 MOACRIVE Inhibition DME1788 XEOTICID XEO03878 XEO_NAME Bovine lactoferrin LFB-Rwa DME1788 XEOTICID XEO03878 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03878 XEO_CLAS Peptide DME1788 XEOTICID XEO03878 DESCRIPT Bovine lactoferrin LFB-Rwa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 microM) DME1788 XEOTICID XEO03878 GENEFORM Protein DME1788 XEOTICID XEO03878 MOACRIVE Inhibition DME1788 XEOTICID XEO03879 XEO_NAME Caprine lactoferrin fragment LFC(17-31) DME1788 XEOTICID XEO03879 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03879 XEO_CLAS Peptide DME1788 XEOTICID XEO03879 DESCRIPT Caprine lactoferrin fragment LFC(17-31) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 252 microM) DME1788 XEOTICID XEO03879 GENEFORM Protein DME1788 XEOTICID XEO03879 MOACRIVE Inhibition DME1788 XEOTICID XEO03880 XEO_NAME Caprine lactoferricin derivative LFC W8 DME1788 XEOTICID XEO03880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03880 XEO_CLAS Peptide DME1788 XEOTICID XEO03880 DESCRIPT Caprine lactoferricin derivative LFC W8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 174 microM) DME1788 XEOTICID XEO03880 GENEFORM Protein DME1788 XEOTICID XEO03880 MOACRIVE Inhibition DME1788 XEOTICID XEO03883 XEO_NAME Human lactoferricin derivative LFH W8 DME1788 XEOTICID XEO03883 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03883 XEO_CLAS Peptide DME1788 XEOTICID XEO03883 DESCRIPT Human lactoferricin derivative LFH W8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 74 microM) DME1788 XEOTICID XEO03883 GENEFORM Protein DME1788 XEOTICID XEO03883 MOACRIVE Inhibition DME1788 XEOTICID XEO03884 XEO_NAME LFM peptide A1 R9 W8 DME1788 XEOTICID XEO03884 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03884 XEO_CLAS Peptide DME1788 XEOTICID XEO03884 DESCRIPT LFM peptide A1 R9 W8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 31 microM) DME1788 XEOTICID XEO03884 GENEFORM Protein DME1788 XEOTICID XEO03884 MOACRIVE Inhibition DME1788 XEOTICID XEO03885 XEO_NAME LFM peptide A1 R9 W8 Y13 DME1788 XEOTICID XEO03885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03885 XEO_CLAS Peptide DME1788 XEOTICID XEO03885 DESCRIPT LFM peptide A1 R9 W8 Y13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO03885 GENEFORM Protein DME1788 XEOTICID XEO03885 MOACRIVE Inhibition DME1788 XEOTICID XEO03886 XEO_NAME LFM peptide A1 W8 DME1788 XEOTICID XEO03886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03886 XEO_CLAS Peptide DME1788 XEOTICID XEO03886 DESCRIPT LFM peptide A1 W8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 391 microM) DME1788 XEOTICID XEO03886 GENEFORM Protein DME1788 XEOTICID XEO03886 MOACRIVE Inhibition DME1788 XEOTICID XEO03887 XEO_NAME LFM peptide A1 W8 Y13 DME1788 XEOTICID XEO03887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03887 XEO_CLAS Peptide DME1788 XEOTICID XEO03887 DESCRIPT LFM peptide A1 W8 Y13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 151 microM) DME1788 XEOTICID XEO03887 GENEFORM Protein DME1788 XEOTICID XEO03887 MOACRIVE Inhibition DME1788 XEOTICID XEO03888 XEO_NAME LFM peptide A1,9 W8 DME1788 XEOTICID XEO03888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03888 XEO_CLAS Peptide DME1788 XEOTICID XEO03888 DESCRIPT LFM peptide A1,9 W8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 134 microM) DME1788 XEOTICID XEO03888 GENEFORM Protein DME1788 XEOTICID XEO03888 MOACRIVE Inhibition DME1788 XEOTICID XEO03889 XEO_NAME LFM peptide A1,9 W8 Y13 DME1788 XEOTICID XEO03889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03889 XEO_CLAS Peptide DME1788 XEOTICID XEO03889 DESCRIPT LFM peptide A1,9 W8 Y13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 88 microM) DME1788 XEOTICID XEO03889 GENEFORM Protein DME1788 XEOTICID XEO03889 MOACRIVE Inhibition DME1788 XEOTICID XEO03890 XEO_NAME LFM peptide A9 R1 W8 DME1788 XEOTICID XEO03890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03890 XEO_CLAS Peptide DME1788 XEOTICID XEO03890 DESCRIPT LFM peptide A9 R1 W8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 31 microM) DME1788 XEOTICID XEO03890 GENEFORM Protein DME1788 XEOTICID XEO03890 MOACRIVE Inhibition DME1788 XEOTICID XEO03891 XEO_NAME LFM peptide A9 R1 W8 Y13 DME1788 XEOTICID XEO03891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03891 XEO_CLAS Peptide DME1788 XEOTICID XEO03891 DESCRIPT LFM peptide A9 R1 W8 Y13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 microM) DME1788 XEOTICID XEO03891 GENEFORM Protein DME1788 XEOTICID XEO03891 MOACRIVE Inhibition DME1788 XEOTICID XEO03892 XEO_NAME LFM peptide R1 W8 DME1788 XEOTICID XEO03892 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03892 XEO_CLAS Peptide DME1788 XEOTICID XEO03892 DESCRIPT LFM peptide R1 W8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 37 microM) DME1788 XEOTICID XEO03892 GENEFORM Protein DME1788 XEOTICID XEO03892 MOACRIVE Inhibition DME1788 XEOTICID XEO03893 XEO_NAME LFM peptide R1 W8 Y13 DME1788 XEOTICID XEO03893 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03893 XEO_CLAS Peptide DME1788 XEOTICID XEO03893 DESCRIPT LFM peptide R1 W8 Y13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 19 microM) DME1788 XEOTICID XEO03893 GENEFORM Protein DME1788 XEOTICID XEO03893 MOACRIVE Inhibition DME1788 XEOTICID XEO03894 XEO_NAME LFM peptide R1,9 W8 DME1788 XEOTICID XEO03894 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03894 XEO_CLAS Peptide DME1788 XEOTICID XEO03894 DESCRIPT LFM peptide R1,9 W8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO03894 GENEFORM Protein DME1788 XEOTICID XEO03894 MOACRIVE Inhibition DME1788 XEOTICID XEO03895 XEO_NAME LFM peptide R1,9 W8 Y13 DME1788 XEOTICID XEO03895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03895 XEO_CLAS Peptide DME1788 XEOTICID XEO03895 DESCRIPT LFM peptide R1,9 W8 Y13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO03895 GENEFORM Protein DME1788 XEOTICID XEO03895 MOACRIVE Inhibition DME1788 XEOTICID XEO03896 XEO_NAME LFM peptide R9 W8 DME1788 XEOTICID XEO03896 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03896 XEO_CLAS Peptide DME1788 XEOTICID XEO03896 DESCRIPT LFM peptide R9 W8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 microM) DME1788 XEOTICID XEO03896 GENEFORM Protein DME1788 XEOTICID XEO03896 MOACRIVE Inhibition DME1788 XEOTICID XEO03897 XEO_NAME LFM peptide R9 W8 Y13 DME1788 XEOTICID XEO03897 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03897 XEO_CLAS Peptide DME1788 XEOTICID XEO03897 DESCRIPT LFM peptide R9 W8 Y13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 63 microM) DME1788 XEOTICID XEO03897 GENEFORM Protein DME1788 XEOTICID XEO03897 MOACRIVE Inhibition DME1788 XEOTICID XEO03898 XEO_NAME Porcine lactoferricin derivative LFP W8 DME1788 XEOTICID XEO03898 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03898 XEO_CLAS Peptide DME1788 XEOTICID XEO03898 DESCRIPT Porcine lactoferricin derivative LFP W8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 219 microM) DME1788 XEOTICID XEO03898 GENEFORM Protein DME1788 XEOTICID XEO03898 MOACRIVE Inhibition DME1788 XEOTICID XEO03901 XEO_NAME Limnonectin-1Fa DME1788 XEOTICID XEO03901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03901 XEO_CLAS Peptide DME1788 XEOTICID XEO03901 DESCRIPT Limnonectin-1Fa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 35 microM) DME1788 XEOTICID XEO03901 GENEFORM Protein DME1788 XEOTICID XEO03901 MOACRIVE Inhibition DME1788 XEOTICID XEO03902 XEO_NAME Limnonectin-1Fb DME1788 XEOTICID XEO03902 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03902 XEO_CLAS Peptide DME1788 XEOTICID XEO03902 DESCRIPT Limnonectin-1Fb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 70 microM) DME1788 XEOTICID XEO03902 GENEFORM Protein DME1788 XEOTICID XEO03902 MOACRIVE Inhibition DME1788 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1788 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03904 XEO_CLAS Peptide DME1788 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO03904 GENEFORM Protein DME1788 XEOTICID XEO03904 MOACRIVE Inhibition DME1788 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1788 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03905 XEO_CLAS Peptide DME1788 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO03905 GENEFORM Protein DME1788 XEOTICID XEO03905 MOACRIVE Inhibition DME1788 XEOTICID XEO03908 XEO_NAME Lingual antimicrobial peptide DME1788 XEOTICID XEO03908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03908 XEO_CLAS Peptide DME1788 XEOTICID XEO03908 DESCRIPT Lingual antimicrobial peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03908 GENEFORM Protein DME1788 XEOTICID XEO03908 MOACRIVE Inhibition DME1788 XEOTICID XEO03915 XEO_NAME Liver-expressed antimicrobial peptide 2 DME1788 XEOTICID XEO03915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03915 XEO_CLAS Peptide DME1788 XEOTICID XEO03915 DESCRIPT Liver-expressed antimicrobial peptide 2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03915 GENEFORM Protein DME1788 XEOTICID XEO03915 MOACRIVE Inhibition DME1788 XEOTICID XEO03916 XEO_NAME Lividin-1 DME1788 XEOTICID XEO03916 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03916 XEO_CLAS Peptide DME1788 XEOTICID XEO03916 DESCRIPT Lividin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.8 ug/ml) DME1788 XEOTICID XEO03916 GENEFORM Protein DME1788 XEOTICID XEO03916 MOACRIVE Inhibition DME1788 XEOTICID XEO03917 XEO_NAME Lividin-2 DME1788 XEOTICID XEO03917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03917 XEO_CLAS Peptide DME1788 XEOTICID XEO03917 DESCRIPT Lividin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 13.1 ug/ml) DME1788 XEOTICID XEO03917 GENEFORM Protein DME1788 XEOTICID XEO03917 MOACRIVE Inhibition DME1788 XEOTICID XEO03918 XEO_NAME Lividin-3 DME1788 XEOTICID XEO03918 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03918 XEO_CLAS Peptide DME1788 XEOTICID XEO03918 DESCRIPT Lividin-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.5 ug/ml) DME1788 XEOTICID XEO03918 GENEFORM Protein DME1788 XEOTICID XEO03918 MOACRIVE Inhibition DME1788 XEOTICID XEO03919 XEO_NAME LlKmW2 model peptide LK2W2 DME1788 XEOTICID XEO03919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03919 XEO_CLAS Peptide DME1788 XEOTICID XEO03919 DESCRIPT LlKmW2 model peptide LK2W2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 80 ug/ml) DME1788 XEOTICID XEO03919 GENEFORM Protein DME1788 XEOTICID XEO03919 MOACRIVE Inhibition DME1788 XEOTICID XEO03922 XEO_NAME LL-37 derivative LL-23 DME1788 XEOTICID XEO03922 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03922 XEO_CLAS Peptide DME1788 XEOTICID XEO03922 DESCRIPT LL-37 derivative LL-23 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 9 microM) DME1788 XEOTICID XEO03922 GENEFORM Protein DME1788 XEOTICID XEO03922 MOACRIVE Inhibition DME1788 XEOTICID XEO03923 XEO_NAME LL-23 variant LL-23A9 DME1788 XEOTICID XEO03923 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03923 XEO_CLAS Peptide DME1788 XEOTICID XEO03923 DESCRIPT LL-23 variant LL-23A9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 80 microM) DME1788 XEOTICID XEO03923 GENEFORM Protein DME1788 XEOTICID XEO03923 MOACRIVE Inhibition DME1788 XEOTICID XEO03924 XEO_NAME LL-23 variant LL-23V9 DME1788 XEOTICID XEO03924 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03924 XEO_CLAS Peptide DME1788 XEOTICID XEO03924 DESCRIPT LL-23 variant LL-23V9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO03924 GENEFORM Protein DME1788 XEOTICID XEO03924 MOACRIVE Inhibition DME1788 XEOTICID XEO03927 XEO_NAME LL-37(13-37) peptide DME1788 XEOTICID XEO03927 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03927 XEO_CLAS Peptide DME1788 XEOTICID XEO03927 DESCRIPT LL-37(13-37) peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 80 microM) DME1788 XEOTICID XEO03927 GENEFORM Protein DME1788 XEOTICID XEO03927 MOACRIVE Inhibition DME1788 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1788 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03928 XEO_CLAS Peptide DME1788 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 microM) DME1788 XEOTICID XEO03928 GENEFORM Protein DME1788 XEOTICID XEO03928 MOACRIVE Inhibition DME1788 XEOTICID XEO03929 XEO_NAME LL-37(17-32) peptide DME1788 XEOTICID XEO03929 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03929 XEO_CLAS Peptide DME1788 XEOTICID XEO03929 DESCRIPT LL-37(17-32) peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 microM) DME1788 XEOTICID XEO03929 GENEFORM Protein DME1788 XEOTICID XEO03929 MOACRIVE Inhibition DME1788 XEOTICID XEO03930 XEO_NAME LL-37 variant LL-37A9 DME1788 XEOTICID XEO03930 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03930 XEO_CLAS Peptide DME1788 XEOTICID XEO03930 DESCRIPT LL-37 variant LL-37A9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 microM) DME1788 XEOTICID XEO03930 GENEFORM Protein DME1788 XEOTICID XEO03930 MOACRIVE Inhibition DME1788 XEOTICID XEO03931 XEO_NAME LL-37 variant LL-37V9 DME1788 XEOTICID XEO03931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03931 XEO_CLAS Peptide DME1788 XEOTICID XEO03931 DESCRIPT LL-37 variant LL-37V9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 microM) DME1788 XEOTICID XEO03931 GENEFORM Protein DME1788 XEOTICID XEO03931 MOACRIVE Inhibition DME1788 XEOTICID XEO03933 XEO_NAME Lasioglossin LL-I derivative 1 DME1788 XEOTICID XEO03933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03933 XEO_CLAS Peptide DME1788 XEOTICID XEO03933 DESCRIPT Lasioglossin LL-I derivative 1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.5 microM) DME1788 XEOTICID XEO03933 GENEFORM Protein DME1788 XEOTICID XEO03933 MOACRIVE Inhibition DME1788 XEOTICID XEO03934 XEO_NAME Lasioglossin LL-I derivative 2 DME1788 XEOTICID XEO03934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03934 XEO_CLAS Peptide DME1788 XEOTICID XEO03934 DESCRIPT Lasioglossin LL-I derivative 2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.7 microM) DME1788 XEOTICID XEO03934 GENEFORM Protein DME1788 XEOTICID XEO03934 MOACRIVE Inhibition DME1788 XEOTICID XEO03935 XEO_NAME Lasioglossin LL-I derivative 3 DME1788 XEOTICID XEO03935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03935 XEO_CLAS Peptide DME1788 XEOTICID XEO03935 DESCRIPT Lasioglossin LL-I derivative 3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.7 microM) DME1788 XEOTICID XEO03935 GENEFORM Protein DME1788 XEOTICID XEO03935 MOACRIVE Inhibition DME1788 XEOTICID XEO03936 XEO_NAME Lasioglossin LL-I derivative 4 DME1788 XEOTICID XEO03936 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03936 XEO_CLAS Peptide DME1788 XEOTICID XEO03936 DESCRIPT Lasioglossin LL-I derivative 4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.0 microM) DME1788 XEOTICID XEO03936 GENEFORM Protein DME1788 XEOTICID XEO03936 MOACRIVE Inhibition DME1788 XEOTICID XEO03937 XEO_NAME Lasioglossin LL-II derivative 1 DME1788 XEOTICID XEO03937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03937 XEO_CLAS Peptide DME1788 XEOTICID XEO03937 DESCRIPT Lasioglossin LL-II derivative 1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.1 microM) DME1788 XEOTICID XEO03937 GENEFORM Protein DME1788 XEOTICID XEO03937 MOACRIVE Inhibition DME1788 XEOTICID XEO03938 XEO_NAME Lasioglossin LL-II derivative 2 DME1788 XEOTICID XEO03938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03938 XEO_CLAS Peptide DME1788 XEOTICID XEO03938 DESCRIPT Lasioglossin LL-II derivative 2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.7 microM) DME1788 XEOTICID XEO03938 GENEFORM Protein DME1788 XEOTICID XEO03938 MOACRIVE Inhibition DME1788 XEOTICID XEO03939 XEO_NAME Lasioglossin LL-II derivative 3 DME1788 XEOTICID XEO03939 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03939 XEO_CLAS Peptide DME1788 XEOTICID XEO03939 DESCRIPT Lasioglossin LL-II derivative 3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.7 microM) DME1788 XEOTICID XEO03939 GENEFORM Protein DME1788 XEOTICID XEO03939 MOACRIVE Inhibition DME1788 XEOTICID XEO03940 XEO_NAME Lasioglossin LL-II derivative 4 DME1788 XEOTICID XEO03940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03940 XEO_CLAS Peptide DME1788 XEOTICID XEO03940 DESCRIPT Lasioglossin LL-II derivative 4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.5 microM) DME1788 XEOTICID XEO03940 GENEFORM Protein DME1788 XEOTICID XEO03940 MOACRIVE Inhibition DME1788 XEOTICID XEO03941 XEO_NAME Lasioglossin LL-III derivative 1 DME1788 XEOTICID XEO03941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03941 XEO_CLAS Peptide DME1788 XEOTICID XEO03941 DESCRIPT Lasioglossin LL-III derivative 1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.4 microM) DME1788 XEOTICID XEO03941 GENEFORM Protein DME1788 XEOTICID XEO03941 MOACRIVE Inhibition DME1788 XEOTICID XEO03943 XEO_NAME Lasioglossin LL-III derivative 2 DME1788 XEOTICID XEO03943 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03943 XEO_CLAS Peptide DME1788 XEOTICID XEO03943 DESCRIPT Lasioglossin LL-III derivative 2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.4 microM) DME1788 XEOTICID XEO03943 GENEFORM Protein DME1788 XEOTICID XEO03943 MOACRIVE Inhibition DME1788 XEOTICID XEO03944 XEO_NAME Lasioglossin LL-III derivative 3 DME1788 XEOTICID XEO03944 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03944 XEO_CLAS Peptide DME1788 XEOTICID XEO03944 DESCRIPT Lasioglossin LL-III derivative 3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.7 microM) DME1788 XEOTICID XEO03944 GENEFORM Protein DME1788 XEOTICID XEO03944 MOACRIVE Inhibition DME1788 XEOTICID XEO03945 XEO_NAME Lasioglossin LL-III derivative 4 DME1788 XEOTICID XEO03945 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03945 XEO_CLAS Peptide DME1788 XEOTICID XEO03945 DESCRIPT Lasioglossin LL-III derivative 4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.2 microM) DME1788 XEOTICID XEO03945 GENEFORM Protein DME1788 XEOTICID XEO03945 MOACRIVE Inhibition DME1788 XEOTICID XEO03947 XEO_NAME Lasioglossin III derivative LL-III DME1788 XEOTICID XEO03947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03947 XEO_CLAS Peptide DME1788 XEOTICID XEO03947 DESCRIPT Lasioglossin III derivative LL-III inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.0 microM) DME1788 XEOTICID XEO03947 GENEFORM Protein DME1788 XEOTICID XEO03947 MOACRIVE Inhibition DME1788 XEOTICID XEO03948 XEO_NAME Lasioglossin LL-III derivative 7 DME1788 XEOTICID XEO03948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03948 XEO_CLAS Peptide DME1788 XEOTICID XEO03948 DESCRIPT Lasioglossin LL-III derivative 7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 23.3 microM) DME1788 XEOTICID XEO03948 GENEFORM Protein DME1788 XEOTICID XEO03948 MOACRIVE Inhibition DME1788 XEOTICID XEO03950 XEO_NAME Lasioglossin LL-III derivative s-1 DME1788 XEOTICID XEO03950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03950 XEO_CLAS Peptide DME1788 XEOTICID XEO03950 DESCRIPT Lasioglossin LL-III derivative s-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4.4 microM) DME1788 XEOTICID XEO03950 GENEFORM Protein DME1788 XEOTICID XEO03950 MOACRIVE Inhibition DME1788 XEOTICID XEO03951 XEO_NAME Lasioglossin LL-III derivative s-2 DME1788 XEOTICID XEO03951 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03951 XEO_CLAS Peptide DME1788 XEOTICID XEO03951 DESCRIPT Lasioglossin LL-III derivative s-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8.8 microM) DME1788 XEOTICID XEO03951 GENEFORM Protein DME1788 XEOTICID XEO03951 MOACRIVE Inhibition DME1788 XEOTICID XEO03952 XEO_NAME Lasioglossin LL-III derivative s-3 DME1788 XEOTICID XEO03952 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03952 XEO_CLAS Peptide DME1788 XEOTICID XEO03952 DESCRIPT Lasioglossin LL-III derivative s-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.2 microM) DME1788 XEOTICID XEO03952 GENEFORM Protein DME1788 XEOTICID XEO03952 MOACRIVE Inhibition DME1788 XEOTICID XEO03953 XEO_NAME Lasioglossin LL-III derivative s-4 DME1788 XEOTICID XEO03953 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03953 XEO_CLAS Peptide DME1788 XEOTICID XEO03953 DESCRIPT Lasioglossin LL-III derivative s-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 microM) DME1788 XEOTICID XEO03953 GENEFORM Protein DME1788 XEOTICID XEO03953 MOACRIVE Inhibition DME1788 XEOTICID XEO03958 XEO_NAME Defensin-like longicornsin DME1788 XEOTICID XEO03958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03958 XEO_CLAS Peptide DME1788 XEOTICID XEO03958 DESCRIPT Defensin-like longicornsin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03958 GENEFORM Protein DME1788 XEOTICID XEO03958 MOACRIVE Inhibition DME1788 XEOTICID XEO03965 XEO_NAME LRR-1 peptide DME1788 XEOTICID XEO03965 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03965 XEO_CLAS Peptide DME1788 XEOTICID XEO03965 DESCRIPT LRR-1 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 128 microM) DME1788 XEOTICID XEO03965 GENEFORM Protein DME1788 XEOTICID XEO03965 MOACRIVE Inhibition DME1788 XEOTICID XEO03966 XEO_NAME LRR-2 peptide DME1788 XEOTICID XEO03966 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03966 XEO_CLAS Peptide DME1788 XEOTICID XEO03966 DESCRIPT LRR-2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 microM) DME1788 XEOTICID XEO03966 GENEFORM Protein DME1788 XEOTICID XEO03966 MOACRIVE Inhibition DME1788 XEOTICID XEO03971 XEO_NAME Lumbrican DME1788 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03971 XEO_CLAS Peptide DME1788 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03971 GENEFORM Protein DME1788 XEOTICID XEO03971 MOACRIVE Inhibition DME1788 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1788 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03972 XEO_CLAS Peptide DME1788 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO03972 GENEFORM Protein DME1788 XEOTICID XEO03972 MOACRIVE Inhibition DME1788 XEOTICID XEO03980 XEO_NAME Magainin 2 truncated peptide MA(9-21) DME1788 XEOTICID XEO03980 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03980 XEO_CLAS Peptide DME1788 XEOTICID XEO03980 DESCRIPT Magainin 2 truncated peptide MA(9-21) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 32 microM) DME1788 XEOTICID XEO03980 GENEFORM Protein DME1788 XEOTICID XEO03980 MOACRIVE Inhibition DME1788 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1788 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03985 XEO_CLAS Peptide DME1788 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 ug/ml) DME1788 XEOTICID XEO03985 GENEFORM Protein DME1788 XEOTICID XEO03985 MOACRIVE Inhibition DME1788 XEOTICID XEO03991 XEO_NAME Ixosin-B peptide MAP-04-01 DME1788 XEOTICID XEO03991 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03991 XEO_CLAS Peptide DME1788 XEOTICID XEO03991 DESCRIPT Ixosin-B peptide MAP-04-01 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03991 GENEFORM Protein DME1788 XEOTICID XEO03991 MOACRIVE Inhibition DME1788 XEOTICID XEO03992 XEO_NAME Ixosin-B peptide MAP-04-02 DME1788 XEOTICID XEO03992 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03992 XEO_CLAS Peptide DME1788 XEOTICID XEO03992 DESCRIPT Ixosin-B peptide MAP-04-02 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03992 GENEFORM Protein DME1788 XEOTICID XEO03992 MOACRIVE Inhibition DME1788 XEOTICID XEO03993 XEO_NAME Ixosin-B peptide MAP-04-03 DME1788 XEOTICID XEO03993 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03993 XEO_CLAS Peptide DME1788 XEOTICID XEO03993 DESCRIPT Ixosin-B peptide MAP-04-03 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03993 GENEFORM Protein DME1788 XEOTICID XEO03993 MOACRIVE Inhibition DME1788 XEOTICID XEO03994 XEO_NAME Ixosin-B peptide MAP-04-04 DME1788 XEOTICID XEO03994 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03994 XEO_CLAS Peptide DME1788 XEOTICID XEO03994 DESCRIPT Ixosin-B peptide MAP-04-04 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO03994 GENEFORM Protein DME1788 XEOTICID XEO03994 MOACRIVE Inhibition DME1788 XEOTICID XEO03996 XEO_NAME Mastoparan MP DME1788 XEOTICID XEO03996 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03996 XEO_CLAS Peptide DME1788 XEOTICID XEO03996 DESCRIPT Mastoparan MP inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 65 microM) DME1788 XEOTICID XEO03996 GENEFORM Protein DME1788 XEOTICID XEO03996 MOACRIVE Inhibition DME1788 XEOTICID XEO03997 XEO_NAME Mastoparan PDD-A DME1788 XEOTICID XEO03997 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03997 XEO_CLAS Peptide DME1788 XEOTICID XEO03997 DESCRIPT Mastoparan PDD-A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 7.5 microM) DME1788 XEOTICID XEO03997 GENEFORM Protein DME1788 XEOTICID XEO03997 MOACRIVE Inhibition DME1788 XEOTICID XEO03998 XEO_NAME Mastoparan PDD-B DME1788 XEOTICID XEO03998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03998 XEO_CLAS Peptide DME1788 XEOTICID XEO03998 DESCRIPT Mastoparan PDD-B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15.5 microM) DME1788 XEOTICID XEO03998 GENEFORM Protein DME1788 XEOTICID XEO03998 MOACRIVE Inhibition DME1788 XEOTICID XEO03999 XEO_NAME Mastoparan PMM DME1788 XEOTICID XEO03999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO03999 XEO_CLAS Peptide DME1788 XEOTICID XEO03999 DESCRIPT Mastoparan PMM inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25.8 microM) DME1788 XEOTICID XEO03999 GENEFORM Protein DME1788 XEOTICID XEO03999 MOACRIVE Inhibition DME1788 XEOTICID XEO04000 XEO_NAME Mastoparan MP-1 DME1788 XEOTICID XEO04000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04000 XEO_CLAS Peptide DME1788 XEOTICID XEO04000 DESCRIPT Mastoparan MP-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO04000 GENEFORM Protein DME1788 XEOTICID XEO04000 MOACRIVE Inhibition DME1788 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1788 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04001 XEO_CLAS Peptide DME1788 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO04001 GENEFORM Protein DME1788 XEOTICID XEO04001 MOACRIVE Inhibition DME1788 XEOTICID XEO04002 XEO_NAME Mastoparan-like peptide 12a DME1788 XEOTICID XEO04002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04002 XEO_CLAS Peptide DME1788 XEOTICID XEO04002 DESCRIPT Mastoparan-like peptide 12a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 7.5 ug/ml) DME1788 XEOTICID XEO04002 GENEFORM Protein DME1788 XEOTICID XEO04002 MOACRIVE Inhibition DME1788 XEOTICID XEO04003 XEO_NAME Mastoparan-like peptide 12b DME1788 XEOTICID XEO04003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04003 XEO_CLAS Peptide DME1788 XEOTICID XEO04003 DESCRIPT Mastoparan-like peptide 12b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 ug/ml) DME1788 XEOTICID XEO04003 GENEFORM Protein DME1788 XEOTICID XEO04003 MOACRIVE Inhibition DME1788 XEOTICID XEO04004 XEO_NAME Mastoparan-like peptide 12c DME1788 XEOTICID XEO04004 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04004 XEO_CLAS Peptide DME1788 XEOTICID XEO04004 DESCRIPT Mastoparan-like peptide 12c inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.0 ug/ml) DME1788 XEOTICID XEO04004 GENEFORM Protein DME1788 XEOTICID XEO04004 MOACRIVE Inhibition DME1788 XEOTICID XEO04005 XEO_NAME Mastoparan-like peptide 12d DME1788 XEOTICID XEO04005 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04005 XEO_CLAS Peptide DME1788 XEOTICID XEO04005 DESCRIPT Mastoparan-like peptide 12d inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.0 ug/ml) DME1788 XEOTICID XEO04005 GENEFORM Protein DME1788 XEOTICID XEO04005 MOACRIVE Inhibition DME1788 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1788 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04007 XEO_CLAS Peptide DME1788 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 19.5 ug/ml) DME1788 XEOTICID XEO04007 GENEFORM Protein DME1788 XEOTICID XEO04007 MOACRIVE Inhibition DME1788 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1788 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04011 XEO_CLAS Peptide DME1788 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 19.5 ug/ml) DME1788 XEOTICID XEO04011 GENEFORM Protein DME1788 XEOTICID XEO04011 MOACRIVE Inhibition DME1788 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1788 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04012 XEO_CLAS Peptide DME1788 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.9 ug/ml) DME1788 XEOTICID XEO04012 GENEFORM Protein DME1788 XEOTICID XEO04012 MOACRIVE Inhibition DME1788 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1788 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04013 XEO_CLAS Peptide DME1788 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.7 ug/ml) DME1788 XEOTICID XEO04013 GENEFORM Protein DME1788 XEOTICID XEO04013 MOACRIVE Inhibition DME1788 XEOTICID XEO04018 XEO_NAME Maximin-H1 DME1788 XEOTICID XEO04018 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04018 XEO_CLAS Peptide DME1788 XEOTICID XEO04018 DESCRIPT Maximin-H1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 9 ug/ml) DME1788 XEOTICID XEO04018 GENEFORM Protein DME1788 XEOTICID XEO04018 MOACRIVE Inhibition DME1788 XEOTICID XEO04026 XEO_NAME Maximin-H2 DME1788 XEOTICID XEO04026 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04026 XEO_CLAS Peptide DME1788 XEOTICID XEO04026 DESCRIPT Maximin-H2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO04026 GENEFORM Protein DME1788 XEOTICID XEO04026 MOACRIVE Inhibition DME1788 XEOTICID XEO04027 XEO_NAME Maximin-H3 DME1788 XEOTICID XEO04027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04027 XEO_CLAS Peptide DME1788 XEOTICID XEO04027 DESCRIPT Maximin-H3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO04027 GENEFORM Protein DME1788 XEOTICID XEO04027 MOACRIVE Inhibition DME1788 XEOTICID XEO04028 XEO_NAME Maximin-H4 DME1788 XEOTICID XEO04028 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04028 XEO_CLAS Peptide DME1788 XEOTICID XEO04028 DESCRIPT Maximin-H4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 ug/ml) DME1788 XEOTICID XEO04028 GENEFORM Protein DME1788 XEOTICID XEO04028 MOACRIVE Inhibition DME1788 XEOTICID XEO04038 XEO_NAME Murine beta-defensin mBD-6 DME1788 XEOTICID XEO04038 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04038 XEO_CLAS Peptide DME1788 XEOTICID XEO04038 DESCRIPT Murine beta-defensin mBD-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04038 GENEFORM Protein DME1788 XEOTICID XEO04038 MOACRIVE Inhibition DME1788 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1788 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04039 XEO_CLAS Peptide DME1788 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 microM) DME1788 XEOTICID XEO04039 GENEFORM Protein DME1788 XEOTICID XEO04039 MOACRIVE Inhibition DME1788 XEOTICID XEO04051 XEO_NAME M-ctenitoxin-Cs1a DME1788 XEOTICID XEO04051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04051 XEO_CLAS Peptide DME1788 XEOTICID XEO04051 DESCRIPT M-ctenitoxin-Cs1a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.31-0.63 microM) DME1788 XEOTICID XEO04051 GENEFORM Protein DME1788 XEOTICID XEO04051 MOACRIVE Inhibition DME1788 XEOTICID XEO04052 XEO_NAME M-ctenitoxin-Cs1c DME1788 XEOTICID XEO04052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04052 XEO_CLAS Peptide DME1788 XEOTICID XEO04052 DESCRIPT M-ctenitoxin-Cs1c inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04052 GENEFORM Protein DME1788 XEOTICID XEO04052 MOACRIVE Inhibition DME1788 XEOTICID XEO04053 XEO_NAME M-ctenitoxin-Cs1d DME1788 XEOTICID XEO04053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04053 XEO_CLAS Peptide DME1788 XEOTICID XEO04053 DESCRIPT M-ctenitoxin-Cs1d inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.08-0.16 microM) DME1788 XEOTICID XEO04053 GENEFORM Protein DME1788 XEOTICID XEO04053 MOACRIVE Inhibition DME1788 XEOTICID XEO04055 XEO_NAME Melectin DME1788 XEOTICID XEO04055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04055 XEO_CLAS Peptide DME1788 XEOTICID XEO04055 DESCRIPT Melectin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.0 microM) DME1788 XEOTICID XEO04055 GENEFORM Protein DME1788 XEOTICID XEO04055 MOACRIVE Inhibition DME1788 XEOTICID XEO04057 XEO_NAME Melittin DME1788 XEOTICID XEO04057 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04057 XEO_CLAS Peptide DME1788 XEOTICID XEO04057 DESCRIPT Melittin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.8 microM) DME1788 XEOTICID XEO04057 GENEFORM Protein DME1788 XEOTICID XEO04057 MOACRIVE Inhibition DME1788 XEOTICID XEO04061 XEO_NAME Melectin peptide MEP-N DME1788 XEOTICID XEO04061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04061 XEO_CLAS Peptide DME1788 XEOTICID XEO04061 DESCRIPT Melectin peptide MEP-N inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.9 microM) DME1788 XEOTICID XEO04061 GENEFORM Protein DME1788 XEOTICID XEO04061 MOACRIVE Inhibition DME1788 XEOTICID XEO04062 XEO_NAME Melectin peptide MEP-Ns-1 DME1788 XEOTICID XEO04062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04062 XEO_CLAS Peptide DME1788 XEOTICID XEO04062 DESCRIPT Melectin peptide MEP-Ns-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.5 microM) DME1788 XEOTICID XEO04062 GENEFORM Protein DME1788 XEOTICID XEO04062 MOACRIVE Inhibition DME1788 XEOTICID XEO04063 XEO_NAME Melectin peptide MEP-Ns-2 DME1788 XEOTICID XEO04063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04063 XEO_CLAS Peptide DME1788 XEOTICID XEO04063 DESCRIPT Melectin peptide MEP-Ns-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 7.8 microM) DME1788 XEOTICID XEO04063 GENEFORM Protein DME1788 XEOTICID XEO04063 MOACRIVE Inhibition DME1788 XEOTICID XEO04064 XEO_NAME Melectin peptide MEP-Ns-3 DME1788 XEOTICID XEO04064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04064 XEO_CLAS Peptide DME1788 XEOTICID XEO04064 DESCRIPT Melectin peptide MEP-Ns-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 46.7 microM) DME1788 XEOTICID XEO04064 GENEFORM Protein DME1788 XEOTICID XEO04064 MOACRIVE Inhibition DME1788 XEOTICID XEO04066 XEO_NAME Melectin peptide derivative MEP-Ns-4 DME1788 XEOTICID XEO04066 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04066 XEO_CLAS Peptide DME1788 XEOTICID XEO04066 DESCRIPT Melectin peptide derivative MEP-Ns-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16.3 microM) DME1788 XEOTICID XEO04066 GENEFORM Protein DME1788 XEOTICID XEO04066 MOACRIVE Inhibition DME1788 XEOTICID XEO04067 XEO_NAME Melectin peptide MEP-Ns-5 DME1788 XEOTICID XEO04067 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04067 XEO_CLAS Peptide DME1788 XEOTICID XEO04067 DESCRIPT Melectin peptide MEP-Ns-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.6 microM) DME1788 XEOTICID XEO04067 GENEFORM Protein DME1788 XEOTICID XEO04067 MOACRIVE Inhibition DME1788 XEOTICID XEO04068 XEO_NAME Melectin peptide MEP-Ns-6 DME1788 XEOTICID XEO04068 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04068 XEO_CLAS Peptide DME1788 XEOTICID XEO04068 DESCRIPT Melectin peptide MEP-Ns-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.6 microM) DME1788 XEOTICID XEO04068 GENEFORM Protein DME1788 XEOTICID XEO04068 MOACRIVE Inhibition DME1788 XEOTICID XEO04086 XEO_NAME Burdock roots methanol extract DME1788 XEOTICID XEO04086 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04086 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04086 DESCRIPT Burdock roots methanol extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04086 GENEFORM Protein DME1788 XEOTICID XEO04086 MOACRIVE Inhibition DME1788 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1788 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04087 GENEFORM Protein DME1788 XEOTICID XEO04087 MOACRIVE Inhibition DME1788 XEOTICID XEO04089 XEO_NAME Capparis spinosa methanolic extract DME1788 XEOTICID XEO04089 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04089 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04089 DESCRIPT Capparis spinosa methanolic extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04089 GENEFORM Protein DME1788 XEOTICID XEO04089 MOACRIVE Inhibition DME1788 XEOTICID XEO04094 XEO_NAME Gutierrezia microcephala methanolic extract DME1788 XEOTICID XEO04094 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04094 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04094 DESCRIPT Gutierrezia microcephala methanolic extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04094 GENEFORM Protein DME1788 XEOTICID XEO04094 MOACRIVE Inhibition DME1788 XEOTICID XEO04096 XEO_NAME Opuntia fucus methanolic extract DME1788 XEOTICID XEO04096 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04096 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04096 DESCRIPT Opuntia fucus methanolic extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04096 GENEFORM Protein DME1788 XEOTICID XEO04096 MOACRIVE Inhibition DME1788 XEOTICID XEO04098 XEO_NAME Prosopis laevigata methanolic extract DME1788 XEOTICID XEO04098 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04098 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04098 DESCRIPT Prosopis laevigata methanolic extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04098 GENEFORM Protein DME1788 XEOTICID XEO04098 MOACRIVE Inhibition DME1788 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1788 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04111 XEO_CLAS Peptide DME1788 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04111 GENEFORM Protein DME1788 XEOTICID XEO04111 MOACRIVE Inhibition DME1788 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1788 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04112 XEO_CLAS Peptide DME1788 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.02 microM) DME1788 XEOTICID XEO04112 GENEFORM Protein DME1788 XEOTICID XEO04112 MOACRIVE Inhibition DME1788 XEOTICID XEO04113 XEO_NAME Microcin J25 DME1788 XEOTICID XEO04113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04113 XEO_CLAS Peptide DME1788 XEOTICID XEO04113 DESCRIPT Microcin J25 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.02 ug/ml) DME1788 XEOTICID XEO04113 GENEFORM Protein DME1788 XEOTICID XEO04113 MOACRIVE Inhibition DME1788 XEOTICID XEO04114 XEO_NAME Microcin L DME1788 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04114 XEO_CLAS Peptide DME1788 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04114 GENEFORM Protein DME1788 XEOTICID XEO04114 MOACRIVE Inhibition DME1788 XEOTICID XEO04117 XEO_NAME Misgurin DME1788 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04117 XEO_CLAS Peptide DME1788 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04117 GENEFORM Protein DME1788 XEOTICID XEO04117 MOACRIVE Inhibition DME1788 XEOTICID XEO04118 XEO_NAME Murine lalctoferricin fragment mLf(20-29) DME1788 XEOTICID XEO04118 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04118 XEO_CLAS Peptide DME1788 XEOTICID XEO04118 DESCRIPT Murine lalctoferricin fragment mLf(20-29) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 300 microM) DME1788 XEOTICID XEO04118 GENEFORM Protein DME1788 XEOTICID XEO04118 MOACRIVE Inhibition DME1788 XEOTICID XEO04119 XEO_NAME Lycotoxin I DME1788 XEOTICID XEO04119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04119 XEO_CLAS Peptide DME1788 XEOTICID XEO04119 DESCRIPT Lycotoxin I inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-20 microM) DME1788 XEOTICID XEO04119 GENEFORM Protein DME1788 XEOTICID XEO04119 MOACRIVE Inhibition DME1788 XEOTICID XEO04120 XEO_NAME M-lycotoxin-Hc2a DME1788 XEOTICID XEO04120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04120 XEO_CLAS Peptide DME1788 XEOTICID XEO04120 DESCRIPT M-lycotoxin-Hc2a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC < 10 microM) DME1788 XEOTICID XEO04120 GENEFORM Protein DME1788 XEOTICID XEO04120 MOACRIVE Inhibition DME1788 XEOTICID XEO04121 XEO_NAME M-lycotoxin-Ls3a DME1788 XEOTICID XEO04121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04121 XEO_CLAS Peptide DME1788 XEOTICID XEO04121 DESCRIPT M-lycotoxin-Ls3a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.2-6.4 microM) DME1788 XEOTICID XEO04121 GENEFORM Protein DME1788 XEOTICID XEO04121 MOACRIVE Inhibition DME1788 XEOTICID XEO04122 XEO_NAME M-lycotoxin-Ls3b DME1788 XEOTICID XEO04122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04122 XEO_CLAS Peptide DME1788 XEOTICID XEO04122 DESCRIPT M-lycotoxin-Ls3b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.14-6.29 microM) DME1788 XEOTICID XEO04122 GENEFORM Protein DME1788 XEOTICID XEO04122 MOACRIVE Inhibition DME1788 XEOTICID XEO04123 XEO_NAME Modified defensin DME1788 XEOTICID XEO04123 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04123 XEO_CLAS Peptide DME1788 XEOTICID XEO04123 DESCRIPT Modified defensin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO04123 GENEFORM Protein DME1788 XEOTICID XEO04123 MOACRIVE Inhibition DME1788 XEOTICID XEO04128 XEO_NAME Moricin-1 DME1788 XEOTICID XEO04128 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04128 XEO_CLAS Peptide DME1788 XEOTICID XEO04128 DESCRIPT Moricin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.31 microM) DME1788 XEOTICID XEO04128 GENEFORM Protein DME1788 XEOTICID XEO04128 MOACRIVE Inhibition DME1788 XEOTICID XEO04129 XEO_NAME Moricin-like peptide C1 DME1788 XEOTICID XEO04129 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04129 XEO_CLAS Peptide DME1788 XEOTICID XEO04129 DESCRIPT Moricin-like peptide C1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO04129 GENEFORM Protein DME1788 XEOTICID XEO04129 MOACRIVE Inhibition DME1788 XEOTICID XEO04130 XEO_NAME Moricin-like peptide C2 DME1788 XEOTICID XEO04130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04130 XEO_CLAS Peptide DME1788 XEOTICID XEO04130 DESCRIPT Moricin-like peptide C2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO04130 GENEFORM Protein DME1788 XEOTICID XEO04130 MOACRIVE Inhibition DME1788 XEOTICID XEO04131 XEO_NAME Moricin-like peptide C3 DME1788 XEOTICID XEO04131 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04131 XEO_CLAS Peptide DME1788 XEOTICID XEO04131 DESCRIPT Moricin-like peptide C3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 microM) DME1788 XEOTICID XEO04131 GENEFORM Protein DME1788 XEOTICID XEO04131 MOACRIVE Inhibition DME1788 XEOTICID XEO04132 XEO_NAME Moricin-like peptide C4/C5 DME1788 XEOTICID XEO04132 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04132 XEO_CLAS Peptide DME1788 XEOTICID XEO04132 DESCRIPT Moricin-like peptide C4/C5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 microM) DME1788 XEOTICID XEO04132 GENEFORM Protein DME1788 XEOTICID XEO04132 MOACRIVE Inhibition DME1788 XEOTICID XEO04133 XEO_NAME Moricin-like peptide D DME1788 XEOTICID XEO04133 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04133 XEO_CLAS Peptide DME1788 XEOTICID XEO04133 DESCRIPT Moricin-like peptide D inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO04133 GENEFORM Protein DME1788 XEOTICID XEO04133 MOACRIVE Inhibition DME1788 XEOTICID XEO04134 XEO_NAME Moronecidin-like peptide moroNC-NH2 DME1788 XEOTICID XEO04134 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04134 XEO_CLAS Peptide DME1788 XEOTICID XEO04134 DESCRIPT Moronecidin-like peptide moroNC-NH2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO04134 GENEFORM Protein DME1788 XEOTICID XEO04134 MOACRIVE Inhibition DME1788 XEOTICID XEO04135 XEO_NAME Moronecidin-like peptide moroPC-NH2 DME1788 XEOTICID XEO04135 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04135 XEO_CLAS Peptide DME1788 XEOTICID XEO04135 DESCRIPT Moronecidin-like peptide moroPC-NH2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 microM) DME1788 XEOTICID XEO04135 GENEFORM Protein DME1788 XEOTICID XEO04135 MOACRIVE Inhibition DME1788 XEOTICID XEO04137 XEO_NAME Oxyopinin-1 M-oxotoxin-Ot1a DME1788 XEOTICID XEO04137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04137 XEO_CLAS Peptide DME1788 XEOTICID XEO04137 DESCRIPT Oxyopinin-1 M-oxotoxin-Ot1a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.6 microM) DME1788 XEOTICID XEO04137 GENEFORM Protein DME1788 XEOTICID XEO04137 MOACRIVE Inhibition DME1788 XEOTICID XEO04138 XEO_NAME MP analog MP-1 DME1788 XEOTICID XEO04138 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04138 XEO_CLAS Peptide DME1788 XEOTICID XEO04138 DESCRIPT MP analog MP-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 microM) DME1788 XEOTICID XEO04138 GENEFORM Protein DME1788 XEOTICID XEO04138 MOACRIVE Inhibition DME1788 XEOTICID XEO04139 XEO_NAME MP analog MP-2 DME1788 XEOTICID XEO04139 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04139 XEO_CLAS Peptide DME1788 XEOTICID XEO04139 DESCRIPT MP analog MP-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 microM) DME1788 XEOTICID XEO04139 GENEFORM Protein DME1788 XEOTICID XEO04139 MOACRIVE Inhibition DME1788 XEOTICID XEO04140 XEO_NAME MP analog MP-5 DME1788 XEOTICID XEO04140 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04140 XEO_CLAS Peptide DME1788 XEOTICID XEO04140 DESCRIPT MP analog MP-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 70 microM) DME1788 XEOTICID XEO04140 GENEFORM Protein DME1788 XEOTICID XEO04140 MOACRIVE Inhibition DME1788 XEOTICID XEO04141 XEO_NAME MP analog MP-6 DME1788 XEOTICID XEO04141 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04141 XEO_CLAS Peptide DME1788 XEOTICID XEO04141 DESCRIPT MP analog MP-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 microM) DME1788 XEOTICID XEO04141 GENEFORM Protein DME1788 XEOTICID XEO04141 MOACRIVE Inhibition DME1788 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1788 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04142 XEO_CLAS Peptide DME1788 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8-16 microM) DME1788 XEOTICID XEO04142 GENEFORM Protein DME1788 XEOTICID XEO04142 MOACRIVE Inhibition DME1788 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1788 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04146 XEO_CLAS Peptide DME1788 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04146 GENEFORM Protein DME1788 XEOTICID XEO04146 MOACRIVE Inhibition DME1788 XEOTICID XEO04149 XEO_NAME Mucroporin DME1788 XEOTICID XEO04149 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04149 XEO_CLAS Peptide DME1788 XEOTICID XEO04149 DESCRIPT Mucroporin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 ug/ml) DME1788 XEOTICID XEO04149 GENEFORM Protein DME1788 XEOTICID XEO04149 MOACRIVE Inhibition DME1788 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1788 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04158 XEO_CLAS Peptide DME1788 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO04158 GENEFORM Protein DME1788 XEOTICID XEO04158 MOACRIVE Inhibition DME1788 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1788 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04159 XEO_CLAS Peptide DME1788 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 microM) DME1788 XEOTICID XEO04159 GENEFORM Protein DME1788 XEOTICID XEO04159 MOACRIVE Inhibition DME1788 XEOTICID XEO04167 XEO_NAME Myticin-B DME1788 XEOTICID XEO04167 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04167 XEO_CLAS Peptide DME1788 XEOTICID XEO04167 DESCRIPT Myticin-B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04167 GENEFORM Protein DME1788 XEOTICID XEO04167 MOACRIVE Inhibition DME1788 XEOTICID XEO04168 XEO_NAME Myticusin-1 DME1788 XEOTICID XEO04168 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04168 XEO_CLAS Peptide DME1788 XEOTICID XEO04168 DESCRIPT Myticusin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.7-12.5 microM) DME1788 XEOTICID XEO04168 GENEFORM Protein DME1788 XEOTICID XEO04168 MOACRIVE Inhibition DME1788 XEOTICID XEO04169 XEO_NAME Mytilin-A DME1788 XEOTICID XEO04169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04169 XEO_CLAS Peptide DME1788 XEOTICID XEO04169 DESCRIPT Mytilin-A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04169 GENEFORM Protein DME1788 XEOTICID XEO04169 MOACRIVE Inhibition DME1788 XEOTICID XEO04170 XEO_NAME Mytilus defensin-A DME1788 XEOTICID XEO04170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04170 XEO_CLAS Peptide DME1788 XEOTICID XEO04170 DESCRIPT Mytilus defensin-A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04170 GENEFORM Protein DME1788 XEOTICID XEO04170 MOACRIVE Inhibition DME1788 XEOTICID XEO04171 XEO_NAME Mytilus defensin-B DME1788 XEOTICID XEO04171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04171 XEO_CLAS Peptide DME1788 XEOTICID XEO04171 DESCRIPT Mytilus defensin-B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04171 GENEFORM Protein DME1788 XEOTICID XEO04171 MOACRIVE Inhibition DME1788 XEOTICID XEO04172 XEO_NAME Myxinidin DME1788 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04172 XEO_CLAS Peptide DME1788 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04172 GENEFORM Protein DME1788 XEOTICID XEO04172 MOACRIVE Inhibition DME1788 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1788 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04177 XEO_CLAS Peptide DME1788 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.7 microM) DME1788 XEOTICID XEO04177 GENEFORM Protein DME1788 XEOTICID XEO04177 MOACRIVE Inhibition DME1788 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1788 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04178 XEO_CLAS Peptide DME1788 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.7 microM) DME1788 XEOTICID XEO04178 GENEFORM Protein DME1788 XEOTICID XEO04178 MOACRIVE Inhibition DME1788 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1788 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04179 XEO_CLAS Peptide DME1788 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.5 microM) DME1788 XEOTICID XEO04179 GENEFORM Protein DME1788 XEOTICID XEO04179 MOACRIVE Inhibition DME1788 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1788 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04180 XEO_CLAS Peptide DME1788 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 23 microM) DME1788 XEOTICID XEO04180 GENEFORM Protein DME1788 XEOTICID XEO04180 MOACRIVE Inhibition DME1788 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1788 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04181 XEO_CLAS Peptide DME1788 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.2 microM) DME1788 XEOTICID XEO04181 GENEFORM Protein DME1788 XEOTICID XEO04181 MOACRIVE Inhibition DME1788 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1788 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04182 XEO_CLAS Peptide DME1788 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4.4 microM) DME1788 XEOTICID XEO04182 GENEFORM Protein DME1788 XEOTICID XEO04182 MOACRIVE Inhibition DME1788 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1788 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04183 XEO_CLAS Peptide DME1788 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.6 microM) DME1788 XEOTICID XEO04183 GENEFORM Protein DME1788 XEOTICID XEO04183 MOACRIVE Inhibition DME1788 XEOTICID XEO04184 XEO_NAME M-zodatoxin-Lt8a DME1788 XEOTICID XEO04184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04184 XEO_CLAS Peptide DME1788 XEOTICID XEO04184 DESCRIPT M-zodatoxin-Lt8a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 microM) DME1788 XEOTICID XEO04184 GENEFORM Protein DME1788 XEOTICID XEO04184 MOACRIVE Inhibition DME1788 XEOTICID XEO04185 XEO_NAME M-zodatoxin-Lt8c DME1788 XEOTICID XEO04185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04185 XEO_CLAS Peptide DME1788 XEOTICID XEO04185 DESCRIPT M-zodatoxin-Lt8c inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04185 GENEFORM Protein DME1788 XEOTICID XEO04185 MOACRIVE Inhibition DME1788 XEOTICID XEO04186 XEO_NAME M-zodatoxin-Lt8f DME1788 XEOTICID XEO04186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04186 XEO_CLAS Peptide DME1788 XEOTICID XEO04186 DESCRIPT M-zodatoxin-Lt8f inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04186 GENEFORM Protein DME1788 XEOTICID XEO04186 MOACRIVE Inhibition DME1788 XEOTICID XEO04187 XEO_NAME M-zodatoxin-Lt8g DME1788 XEOTICID XEO04187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04187 XEO_CLAS Peptide DME1788 XEOTICID XEO04187 DESCRIPT M-zodatoxin-Lt8g inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04187 GENEFORM Protein DME1788 XEOTICID XEO04187 MOACRIVE Inhibition DME1788 XEOTICID XEO04188 XEO_NAME M-zodatoxin-Lt8h DME1788 XEOTICID XEO04188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04188 XEO_CLAS Peptide DME1788 XEOTICID XEO04188 DESCRIPT M-zodatoxin-Lt8h inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04188 GENEFORM Protein DME1788 XEOTICID XEO04188 MOACRIVE Inhibition DME1788 XEOTICID XEO04206 XEO_NAME P18 analog N-1 DME1788 XEOTICID XEO04206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04206 XEO_CLAS Peptide DME1788 XEOTICID XEO04206 DESCRIPT P18 analog N-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25 microM) DME1788 XEOTICID XEO04206 GENEFORM Protein DME1788 XEOTICID XEO04206 MOACRIVE Inhibition DME1788 XEOTICID XEO04214 XEO_NAME P18 analog N-2 DME1788 XEOTICID XEO04214 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04214 XEO_CLAS Peptide DME1788 XEOTICID XEO04214 DESCRIPT P18 analog N-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25 microM) DME1788 XEOTICID XEO04214 GENEFORM Protein DME1788 XEOTICID XEO04214 MOACRIVE Inhibition DME1788 XEOTICID XEO04216 XEO_NAME P18 analog N-3 DME1788 XEOTICID XEO04216 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04216 XEO_CLAS Peptide DME1788 XEOTICID XEO04216 DESCRIPT P18 analog N-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO04216 GENEFORM Protein DME1788 XEOTICID XEO04216 MOACRIVE Inhibition DME1788 XEOTICID XEO04218 XEO_NAME P18 analog N-3L DME1788 XEOTICID XEO04218 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04218 XEO_CLAS Peptide DME1788 XEOTICID XEO04218 DESCRIPT P18 analog N-3L inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.125 microM) DME1788 XEOTICID XEO04218 GENEFORM Protein DME1788 XEOTICID XEO04218 MOACRIVE Inhibition DME1788 XEOTICID XEO04219 XEO_NAME P18 analog N-4 DME1788 XEOTICID XEO04219 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04219 XEO_CLAS Peptide DME1788 XEOTICID XEO04219 DESCRIPT P18 analog N-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO04219 GENEFORM Protein DME1788 XEOTICID XEO04219 MOACRIVE Inhibition DME1788 XEOTICID XEO04220 XEO_NAME P18 analog N-4L DME1788 XEOTICID XEO04220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04220 XEO_CLAS Peptide DME1788 XEOTICID XEO04220 DESCRIPT P18 analog N-4L inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.125 microM) DME1788 XEOTICID XEO04220 GENEFORM Protein DME1788 XEOTICID XEO04220 MOACRIVE Inhibition DME1788 XEOTICID XEO04221 XEO_NAME P18 analog N-5 DME1788 XEOTICID XEO04221 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04221 XEO_CLAS Peptide DME1788 XEOTICID XEO04221 DESCRIPT P18 analog N-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO04221 GENEFORM Protein DME1788 XEOTICID XEO04221 MOACRIVE Inhibition DME1788 XEOTICID XEO04222 XEO_NAME P18 analog N-5L DME1788 XEOTICID XEO04222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04222 XEO_CLAS Peptide DME1788 XEOTICID XEO04222 DESCRIPT P18 analog N-5L inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25 microM) DME1788 XEOTICID XEO04222 GENEFORM Protein DME1788 XEOTICID XEO04222 MOACRIVE Inhibition DME1788 XEOTICID XEO04233 XEO_NAME Naegleriapore A DME1788 XEOTICID XEO04233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04233 XEO_CLAS Peptide DME1788 XEOTICID XEO04233 DESCRIPT Naegleriapore A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04233 GENEFORM Protein DME1788 XEOTICID XEO04233 MOACRIVE Inhibition DME1788 XEOTICID XEO04234 XEO_NAME Naegleriapore B DME1788 XEOTICID XEO04234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04234 XEO_CLAS Peptide DME1788 XEOTICID XEO04234 DESCRIPT Naegleriapore B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04234 GENEFORM Protein DME1788 XEOTICID XEO04234 MOACRIVE Inhibition DME1788 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1788 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04241 XEO_CLAS Peptide DME1788 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04241 GENEFORM Protein DME1788 XEOTICID XEO04241 MOACRIVE Inhibition DME1788 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1788 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04242 XEO_CLAS Peptide DME1788 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04242 GENEFORM Protein DME1788 XEOTICID XEO04242 MOACRIVE Inhibition DME1788 XEOTICID XEO04245 XEO_NAME Neoeriocitrin DME1788 XEOTICID XEO04245 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04245 XEO_CLAS Natural Product DME1788 XEOTICID XEO04245 DESCRIPT Neoeriocitrin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04245 GENEFORM Protein DME1788 XEOTICID XEO04245 MOACRIVE Inhibition DME1788 XEOTICID XEO04246 XEO_NAME Neohesperidin DME1788 XEOTICID XEO04246 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04246 XEO_CLAS Natural Product DME1788 XEOTICID XEO04246 DESCRIPT Neohesperidin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04246 GENEFORM Protein DME1788 XEOTICID XEO04246 MOACRIVE Inhibition DME1788 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1788 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04249 XEO_CLAS Peptide DME1788 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 500 ug/ml) DME1788 XEOTICID XEO04249 GENEFORM Protein DME1788 XEOTICID XEO04249 MOACRIVE Inhibition DME1788 XEOTICID XEO04251 XEO_NAME Neutrophil antibiotic peptide NP-1 DME1788 XEOTICID XEO04251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04251 XEO_CLAS Peptide DME1788 XEOTICID XEO04251 DESCRIPT Neutrophil antibiotic peptide NP-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04251 GENEFORM Protein DME1788 XEOTICID XEO04251 MOACRIVE Inhibition DME1788 XEOTICID XEO04253 XEO_NAME Neutrophil antibiotic peptide NP-3 DME1788 XEOTICID XEO04253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04253 XEO_CLAS Peptide DME1788 XEOTICID XEO04253 DESCRIPT Neutrophil antibiotic peptide NP-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04253 GENEFORM Protein DME1788 XEOTICID XEO04253 MOACRIVE Inhibition DME1788 XEOTICID XEO04254 XEO_NAME Neutrophil antibiotic peptide NP-4 DME1788 XEOTICID XEO04254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04254 XEO_CLAS Peptide DME1788 XEOTICID XEO04254 DESCRIPT Neutrophil antibiotic peptide NP-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04254 GENEFORM Protein DME1788 XEOTICID XEO04254 MOACRIVE Inhibition DME1788 XEOTICID XEO04255 XEO_NAME Neutrophil cationic polypeptide CAP11 DME1788 XEOTICID XEO04255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04255 XEO_CLAS Peptide DME1788 XEOTICID XEO04255 DESCRIPT Neutrophil cationic polypeptide CAP11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04255 GENEFORM Protein DME1788 XEOTICID XEO04255 MOACRIVE Inhibition DME1788 XEOTICID XEO04256 XEO_NAME Neutrophil cationic peptide 1 DME1788 XEOTICID XEO04256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04256 XEO_CLAS Peptide DME1788 XEOTICID XEO04256 DESCRIPT Neutrophil cationic peptide 1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04256 GENEFORM Protein DME1788 XEOTICID XEO04256 MOACRIVE Inhibition DME1788 XEOTICID XEO04257 XEO_NAME Neutrophil cationic peptide 2 DME1788 XEOTICID XEO04257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04257 XEO_CLAS Peptide DME1788 XEOTICID XEO04257 DESCRIPT Neutrophil cationic peptide 2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04257 GENEFORM Protein DME1788 XEOTICID XEO04257 MOACRIVE Inhibition DME1788 XEOTICID XEO04258 XEO_NAME Neutrophil defensin HNP-1 DME1788 XEOTICID XEO04258 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04258 XEO_CLAS Peptide DME1788 XEOTICID XEO04258 DESCRIPT Neutrophil defensin HNP-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04258 GENEFORM Protein DME1788 XEOTICID XEO04258 MOACRIVE Inhibition DME1788 XEOTICID XEO04259 XEO_NAME Neutrophil defensin HANP-1 DME1788 XEOTICID XEO04259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04259 XEO_CLAS Peptide DME1788 XEOTICID XEO04259 DESCRIPT Neutrophil defensin HANP-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04259 GENEFORM Protein DME1788 XEOTICID XEO04259 MOACRIVE Inhibition DME1788 XEOTICID XEO04260 XEO_NAME Neutrophil defensin RMAD-1 DME1788 XEOTICID XEO04260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04260 XEO_CLAS Peptide DME1788 XEOTICID XEO04260 DESCRIPT Neutrophil defensin RMAD-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04260 GENEFORM Protein DME1788 XEOTICID XEO04260 MOACRIVE Inhibition DME1788 XEOTICID XEO04261 XEO_NAME Neutrophil defensin HANP-2 DME1788 XEOTICID XEO04261 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04261 XEO_CLAS Peptide DME1788 XEOTICID XEO04261 DESCRIPT Neutrophil defensin HANP-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04261 GENEFORM Protein DME1788 XEOTICID XEO04261 MOACRIVE Inhibition DME1788 XEOTICID XEO04262 XEO_NAME Neutrophil defensin HNP-2 DME1788 XEOTICID XEO04262 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04262 XEO_CLAS Peptide DME1788 XEOTICID XEO04262 DESCRIPT Neutrophil defensin HNP-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04262 GENEFORM Protein DME1788 XEOTICID XEO04262 MOACRIVE Inhibition DME1788 XEOTICID XEO04263 XEO_NAME Neutrophil defensin RMAD-2 DME1788 XEOTICID XEO04263 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04263 XEO_CLAS Peptide DME1788 XEOTICID XEO04263 DESCRIPT Neutrophil defensin RMAD-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04263 GENEFORM Protein DME1788 XEOTICID XEO04263 MOACRIVE Inhibition DME1788 XEOTICID XEO04264 XEO_NAME Neutrophil defensin HNP-3 DME1788 XEOTICID XEO04264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04264 XEO_CLAS Peptide DME1788 XEOTICID XEO04264 DESCRIPT Neutrophil defensin HNP-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04264 GENEFORM Protein DME1788 XEOTICID XEO04264 MOACRIVE Inhibition DME1788 XEOTICID XEO04265 XEO_NAME Neutrophil defensin HANP-3 DME1788 XEOTICID XEO04265 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04265 XEO_CLAS Peptide DME1788 XEOTICID XEO04265 DESCRIPT Neutrophil defensin HANP-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04265 GENEFORM Protein DME1788 XEOTICID XEO04265 MOACRIVE Inhibition DME1788 XEOTICID XEO04266 XEO_NAME Neutrophil defensin RMAD-3 DME1788 XEOTICID XEO04266 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04266 XEO_CLAS Peptide DME1788 XEOTICID XEO04266 DESCRIPT Neutrophil defensin RMAD-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04266 GENEFORM Protein DME1788 XEOTICID XEO04266 MOACRIVE Inhibition DME1788 XEOTICID XEO04267 XEO_NAME Neutrophil defensin HNP-4 DME1788 XEOTICID XEO04267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04267 XEO_CLAS Peptide DME1788 XEOTICID XEO04267 DESCRIPT Neutrophil defensin HNP-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04267 GENEFORM Protein DME1788 XEOTICID XEO04267 MOACRIVE Inhibition DME1788 XEOTICID XEO04268 XEO_NAME Neutrophil defensin HANP-4 DME1788 XEOTICID XEO04268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04268 XEO_CLAS Peptide DME1788 XEOTICID XEO04268 DESCRIPT Neutrophil defensin HANP-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04268 GENEFORM Protein DME1788 XEOTICID XEO04268 MOACRIVE Inhibition DME1788 XEOTICID XEO04269 XEO_NAME Neutrophil defensin RMAD-4 DME1788 XEOTICID XEO04269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04269 XEO_CLAS Peptide DME1788 XEOTICID XEO04269 DESCRIPT Neutrophil defensin RMAD-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04269 GENEFORM Protein DME1788 XEOTICID XEO04269 MOACRIVE Inhibition DME1788 XEOTICID XEO04270 XEO_NAME Neutrophil defensin RMAD-5 DME1788 XEOTICID XEO04270 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04270 XEO_CLAS Peptide DME1788 XEOTICID XEO04270 DESCRIPT Neutrophil defensin RMAD-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04270 GENEFORM Protein DME1788 XEOTICID XEO04270 MOACRIVE Inhibition DME1788 XEOTICID XEO04271 XEO_NAME Neutrophil defensin RMAD-6 DME1788 XEOTICID XEO04271 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04271 XEO_CLAS Peptide DME1788 XEOTICID XEO04271 DESCRIPT Neutrophil defensin RMAD-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04271 GENEFORM Protein DME1788 XEOTICID XEO04271 MOACRIVE Inhibition DME1788 XEOTICID XEO04272 XEO_NAME Neutrophil defensin RMAD-7 DME1788 XEOTICID XEO04272 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04272 XEO_CLAS Peptide DME1788 XEOTICID XEO04272 DESCRIPT Neutrophil defensin RMAD-7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04272 GENEFORM Protein DME1788 XEOTICID XEO04272 MOACRIVE Inhibition DME1788 XEOTICID XEO04277 XEO_NAME Nigroain-C2 DME1788 XEOTICID XEO04277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04277 XEO_CLAS Peptide DME1788 XEOTICID XEO04277 DESCRIPT Nigroain-C2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 110.00 ug/ml) DME1788 XEOTICID XEO04277 GENEFORM Protein DME1788 XEOTICID XEO04277 MOACRIVE Inhibition DME1788 XEOTICID XEO04280 XEO_NAME Nigroain-K1 DME1788 XEOTICID XEO04280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04280 XEO_CLAS Peptide DME1788 XEOTICID XEO04280 DESCRIPT Nigroain-K1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 37.50 ug/ml) DME1788 XEOTICID XEO04280 GENEFORM Protein DME1788 XEOTICID XEO04280 MOACRIVE Inhibition DME1788 XEOTICID XEO04281 XEO_NAME Nigroain-K2 DME1788 XEOTICID XEO04281 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04281 XEO_CLAS Peptide DME1788 XEOTICID XEO04281 DESCRIPT Nigroain-K2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25.00 ug/ml) DME1788 XEOTICID XEO04281 GENEFORM Protein DME1788 XEOTICID XEO04281 MOACRIVE Inhibition DME1788 XEOTICID XEO04282 XEO_NAME Nigrocin-1-OA1 DME1788 XEOTICID XEO04282 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04282 XEO_CLAS Peptide DME1788 XEOTICID XEO04282 DESCRIPT Nigrocin-1-OA1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.2 ug/ml) DME1788 XEOTICID XEO04282 GENEFORM Protein DME1788 XEOTICID XEO04282 MOACRIVE Inhibition DME1788 XEOTICID XEO04283 XEO_NAME Nigrocin-1-OA2 DME1788 XEOTICID XEO04283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04283 XEO_CLAS Peptide DME1788 XEOTICID XEO04283 DESCRIPT Nigrocin-1-OA2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.3 ug/ml) DME1788 XEOTICID XEO04283 GENEFORM Protein DME1788 XEOTICID XEO04283 MOACRIVE Inhibition DME1788 XEOTICID XEO04284 XEO_NAME Nigrocin-1-OA3 DME1788 XEOTICID XEO04284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04284 XEO_CLAS Peptide DME1788 XEOTICID XEO04284 DESCRIPT Nigrocin-1-OA3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10.8 ug/ml) DME1788 XEOTICID XEO04284 GENEFORM Protein DME1788 XEOTICID XEO04284 MOACRIVE Inhibition DME1788 XEOTICID XEO04285 XEO_NAME Nigrocin-1-OR1 DME1788 XEOTICID XEO04285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04285 XEO_CLAS Peptide DME1788 XEOTICID XEO04285 DESCRIPT Nigrocin-1-OR1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 11.5 ug/ml) DME1788 XEOTICID XEO04285 GENEFORM Protein DME1788 XEOTICID XEO04285 MOACRIVE Inhibition DME1788 XEOTICID XEO04286 XEO_NAME Nigrocin-1-OR2 DME1788 XEOTICID XEO04286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04286 XEO_CLAS Peptide DME1788 XEOTICID XEO04286 DESCRIPT Nigrocin-1-OR2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8.6 ug/ml) DME1788 XEOTICID XEO04286 GENEFORM Protein DME1788 XEOTICID XEO04286 MOACRIVE Inhibition DME1788 XEOTICID XEO04287 XEO_NAME Nigrocin-1-OR3 DME1788 XEOTICID XEO04287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04287 XEO_CLAS Peptide DME1788 XEOTICID XEO04287 DESCRIPT Nigrocin-1-OR3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10.2 ug/ml) DME1788 XEOTICID XEO04287 GENEFORM Protein DME1788 XEOTICID XEO04287 MOACRIVE Inhibition DME1788 XEOTICID XEO04288 XEO_NAME Nigrocin-1-OW1 DME1788 XEOTICID XEO04288 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04288 XEO_CLAS Peptide DME1788 XEOTICID XEO04288 DESCRIPT Nigrocin-1-OW1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4.4 ug/ml) DME1788 XEOTICID XEO04288 GENEFORM Protein DME1788 XEOTICID XEO04288 MOACRIVE Inhibition DME1788 XEOTICID XEO04289 XEO_NAME Nigrocin-1-OW2 DME1788 XEOTICID XEO04289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04289 XEO_CLAS Peptide DME1788 XEOTICID XEO04289 DESCRIPT Nigrocin-1-OW2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.2 ug/ml) DME1788 XEOTICID XEO04289 GENEFORM Protein DME1788 XEOTICID XEO04289 MOACRIVE Inhibition DME1788 XEOTICID XEO04290 XEO_NAME Nigrocin-1-OW3 DME1788 XEOTICID XEO04290 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04290 XEO_CLAS Peptide DME1788 XEOTICID XEO04290 DESCRIPT Nigrocin-1-OW3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 11.3 ug/ml) DME1788 XEOTICID XEO04290 GENEFORM Protein DME1788 XEOTICID XEO04290 MOACRIVE Inhibition DME1788 XEOTICID XEO04291 XEO_NAME Nigrocin-1-OW4 DME1788 XEOTICID XEO04291 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04291 XEO_CLAS Peptide DME1788 XEOTICID XEO04291 DESCRIPT Nigrocin-1-OW4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 7.2 ug/ml) DME1788 XEOTICID XEO04291 GENEFORM Protein DME1788 XEOTICID XEO04291 MOACRIVE Inhibition DME1788 XEOTICID XEO04292 XEO_NAME Nigrocin-1-OW5 DME1788 XEOTICID XEO04292 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04292 XEO_CLAS Peptide DME1788 XEOTICID XEO04292 DESCRIPT Nigrocin-1-OW5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.1 ug/ml) DME1788 XEOTICID XEO04292 GENEFORM Protein DME1788 XEOTICID XEO04292 MOACRIVE Inhibition DME1788 XEOTICID XEO04293 XEO_NAME Nigrocin-2GRa DME1788 XEOTICID XEO04293 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04293 XEO_CLAS Peptide DME1788 XEOTICID XEO04293 DESCRIPT Nigrocin-2GRa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO04293 GENEFORM Protein DME1788 XEOTICID XEO04293 MOACRIVE Inhibition DME1788 XEOTICID XEO04294 XEO_NAME Nigrocin-2GRb DME1788 XEOTICID XEO04294 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04294 XEO_CLAS Peptide DME1788 XEOTICID XEO04294 DESCRIPT Nigrocin-2GRb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO04294 GENEFORM Protein DME1788 XEOTICID XEO04294 MOACRIVE Inhibition DME1788 XEOTICID XEO04295 XEO_NAME Nigrocin-2GRc DME1788 XEOTICID XEO04295 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04295 XEO_CLAS Peptide DME1788 XEOTICID XEO04295 DESCRIPT Nigrocin-2GRc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO04295 GENEFORM Protein DME1788 XEOTICID XEO04295 MOACRIVE Inhibition DME1788 XEOTICID XEO04296 XEO_NAME Nigrocin-2HSa DME1788 XEOTICID XEO04296 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04296 XEO_CLAS Peptide DME1788 XEOTICID XEO04296 DESCRIPT Nigrocin-2HSa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 28 microM) DME1788 XEOTICID XEO04296 GENEFORM Protein DME1788 XEOTICID XEO04296 MOACRIVE Inhibition DME1788 XEOTICID XEO04297 XEO_NAME Nigrocin-2HSb DME1788 XEOTICID XEO04297 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04297 XEO_CLAS Peptide DME1788 XEOTICID XEO04297 DESCRIPT Nigrocin-2HSb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 14 microM) DME1788 XEOTICID XEO04297 GENEFORM Protein DME1788 XEOTICID XEO04297 MOACRIVE Inhibition DME1788 XEOTICID XEO04298 XEO_NAME Nigrocin-2ISa DME1788 XEOTICID XEO04298 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04298 XEO_CLAS Peptide DME1788 XEOTICID XEO04298 DESCRIPT Nigrocin-2ISa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO04298 GENEFORM Protein DME1788 XEOTICID XEO04298 MOACRIVE Inhibition DME1788 XEOTICID XEO04299 XEO_NAME Nigrocin-2ISb DME1788 XEOTICID XEO04299 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04299 XEO_CLAS Peptide DME1788 XEOTICID XEO04299 DESCRIPT Nigrocin-2ISb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO04299 GENEFORM Protein DME1788 XEOTICID XEO04299 MOACRIVE Inhibition DME1788 XEOTICID XEO04300 XEO_NAME Nigrocin-2ISc DME1788 XEOTICID XEO04300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04300 XEO_CLAS Peptide DME1788 XEOTICID XEO04300 DESCRIPT Nigrocin-2ISc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO04300 GENEFORM Protein DME1788 XEOTICID XEO04300 MOACRIVE Inhibition DME1788 XEOTICID XEO04301 XEO_NAME Nigrocin-2JDa DME1788 XEOTICID XEO04301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04301 XEO_CLAS Peptide DME1788 XEOTICID XEO04301 DESCRIPT Nigrocin-2JDa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 microM) DME1788 XEOTICID XEO04301 GENEFORM Protein DME1788 XEOTICID XEO04301 MOACRIVE Inhibition DME1788 XEOTICID XEO04302 XEO_NAME Nigrocin-2JDb DME1788 XEOTICID XEO04302 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04302 XEO_CLAS Peptide DME1788 XEOTICID XEO04302 DESCRIPT Nigrocin-2JDb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 microM) DME1788 XEOTICID XEO04302 GENEFORM Protein DME1788 XEOTICID XEO04302 MOACRIVE Inhibition DME1788 XEOTICID XEO04303 XEO_NAME Nigrocin-2LVb DME1788 XEOTICID XEO04303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04303 XEO_CLAS Peptide DME1788 XEOTICID XEO04303 DESCRIPT Nigrocin-2LVb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 microM) DME1788 XEOTICID XEO04303 GENEFORM Protein DME1788 XEOTICID XEO04303 MOACRIVE Inhibition DME1788 XEOTICID XEO04304 XEO_NAME Nigrocin-2SCa DME1788 XEOTICID XEO04304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04304 XEO_CLAS Peptide DME1788 XEOTICID XEO04304 DESCRIPT Nigrocin-2SCa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO04304 GENEFORM Protein DME1788 XEOTICID XEO04304 MOACRIVE Inhibition DME1788 XEOTICID XEO04305 XEO_NAME Nigrocin-2SCc DME1788 XEOTICID XEO04305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04305 XEO_CLAS Peptide DME1788 XEOTICID XEO04305 DESCRIPT Nigrocin-2SCc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 70 microM) DME1788 XEOTICID XEO04305 GENEFORM Protein DME1788 XEOTICID XEO04305 MOACRIVE Inhibition DME1788 XEOTICID XEO04306 XEO_NAME Nigrocin-2VB DME1788 XEOTICID XEO04306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04306 XEO_CLAS Peptide DME1788 XEOTICID XEO04306 DESCRIPT Nigrocin-2VB inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO04306 GENEFORM Protein DME1788 XEOTICID XEO04306 MOACRIVE Inhibition DME1788 XEOTICID XEO04307 XEO_NAME Nigrocin-OG4 DME1788 XEOTICID XEO04307 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04307 XEO_CLAS Peptide DME1788 XEOTICID XEO04307 DESCRIPT Nigrocin-OG4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 ug/ml) DME1788 XEOTICID XEO04307 GENEFORM Protein DME1788 XEOTICID XEO04307 MOACRIVE Inhibition DME1788 XEOTICID XEO04308 XEO_NAME Nigrocin-OG5 DME1788 XEOTICID XEO04308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04308 XEO_CLAS Peptide DME1788 XEOTICID XEO04308 DESCRIPT Nigrocin-OG5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 9.37 ug/ml) DME1788 XEOTICID XEO04308 GENEFORM Protein DME1788 XEOTICID XEO04308 MOACRIVE Inhibition DME1788 XEOTICID XEO04309 XEO_NAME Nigrocin-OR1 DME1788 XEOTICID XEO04309 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04309 XEO_CLAS Peptide DME1788 XEOTICID XEO04309 DESCRIPT Nigrocin-OR1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 microM) DME1788 XEOTICID XEO04309 GENEFORM Protein DME1788 XEOTICID XEO04309 MOACRIVE Inhibition DME1788 XEOTICID XEO04310 XEO_NAME Nigrocin-OR2 DME1788 XEOTICID XEO04310 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04310 XEO_CLAS Peptide DME1788 XEOTICID XEO04310 DESCRIPT Nigrocin-OR2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO04310 GENEFORM Protein DME1788 XEOTICID XEO04310 MOACRIVE Inhibition DME1788 XEOTICID XEO04311 XEO_NAME Nigrocin-OR3 DME1788 XEOTICID XEO04311 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04311 XEO_CLAS Peptide DME1788 XEOTICID XEO04311 DESCRIPT Nigrocin-OR3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO04311 GENEFORM Protein DME1788 XEOTICID XEO04311 MOACRIVE Inhibition DME1788 XEOTICID XEO04312 XEO_NAME Nigrosin-OG13 DME1788 XEOTICID XEO04312 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04312 XEO_CLAS Peptide DME1788 XEOTICID XEO04312 DESCRIPT Nigrosin-OG13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4.68 ug/ml) DME1788 XEOTICID XEO04312 GENEFORM Protein DME1788 XEOTICID XEO04312 MOACRIVE Inhibition DME1788 XEOTICID XEO04313 XEO_NAME Nigrosin-OG21 DME1788 XEOTICID XEO04313 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04313 XEO_CLAS Peptide DME1788 XEOTICID XEO04313 DESCRIPT Nigrosin-OG21 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4.68 ug/ml) DME1788 XEOTICID XEO04313 GENEFORM Protein DME1788 XEOTICID XEO04313 MOACRIVE Inhibition DME1788 XEOTICID XEO04331 XEO_NAME Norspermidine DME1788 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1788 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04331 GENEFORM Protein DME1788 XEOTICID XEO04331 MOACRIVE Inhibition DME1788 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1788 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04335 XEO_CLAS Peptide DME1788 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 32 ug/ml) DME1788 XEOTICID XEO04335 GENEFORM Protein DME1788 XEOTICID XEO04335 MOACRIVE Inhibition DME1788 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1788 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04336 XEO_CLAS Peptide DME1788 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 32 ug/ml) DME1788 XEOTICID XEO04336 GENEFORM Protein DME1788 XEOTICID XEO04336 MOACRIVE Inhibition DME1788 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1788 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04338 XEO_CLAS Peptide DME1788 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 ug/ml) DME1788 XEOTICID XEO04338 GENEFORM Protein DME1788 XEOTICID XEO04338 MOACRIVE Inhibition DME1788 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1788 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04339 XEO_CLAS Peptide DME1788 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 ug/ml) DME1788 XEOTICID XEO04339 GENEFORM Protein DME1788 XEOTICID XEO04339 MOACRIVE Inhibition DME1788 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1788 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04340 XEO_CLAS Peptide DME1788 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO04340 GENEFORM Protein DME1788 XEOTICID XEO04340 MOACRIVE Inhibition DME1788 XEOTICID XEO04344 XEO_NAME Ocellatin-1 DME1788 XEOTICID XEO04344 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04344 XEO_CLAS Peptide DME1788 XEOTICID XEO04344 DESCRIPT Ocellatin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04344 GENEFORM Protein DME1788 XEOTICID XEO04344 MOACRIVE Inhibition DME1788 XEOTICID XEO04345 XEO_NAME Ocellatin-2 DME1788 XEOTICID XEO04345 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04345 XEO_CLAS Peptide DME1788 XEOTICID XEO04345 DESCRIPT Ocellatin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04345 GENEFORM Protein DME1788 XEOTICID XEO04345 MOACRIVE Inhibition DME1788 XEOTICID XEO04346 XEO_NAME Ocellatin-3 DME1788 XEOTICID XEO04346 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04346 XEO_CLAS Peptide DME1788 XEOTICID XEO04346 DESCRIPT Ocellatin-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04346 GENEFORM Protein DME1788 XEOTICID XEO04346 MOACRIVE Inhibition DME1788 XEOTICID XEO04347 XEO_NAME Ocellatin-4 DME1788 XEOTICID XEO04347 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04347 XEO_CLAS Peptide DME1788 XEOTICID XEO04347 DESCRIPT Ocellatin-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 microM) DME1788 XEOTICID XEO04347 GENEFORM Protein DME1788 XEOTICID XEO04347 MOACRIVE Inhibition DME1788 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1788 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04348 XEO_CLAS Peptide DME1788 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40 microM) DME1788 XEOTICID XEO04348 GENEFORM Protein DME1788 XEOTICID XEO04348 MOACRIVE Inhibition DME1788 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1788 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04349 XEO_CLAS Peptide DME1788 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO04349 GENEFORM Protein DME1788 XEOTICID XEO04349 MOACRIVE Inhibition DME1788 XEOTICID XEO04354 XEO_NAME Odorranain-A-OA1 DME1788 XEOTICID XEO04354 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04354 XEO_CLAS Peptide DME1788 XEOTICID XEO04354 DESCRIPT Odorranain-A-OA1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 35.2 ug/ml) DME1788 XEOTICID XEO04354 GENEFORM Protein DME1788 XEOTICID XEO04354 MOACRIVE Inhibition DME1788 XEOTICID XEO04355 XEO_NAME Odorranain-B1 DME1788 XEOTICID XEO04355 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04355 XEO_CLAS Peptide DME1788 XEOTICID XEO04355 DESCRIPT Odorranain-B1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.21 ug/ml) DME1788 XEOTICID XEO04355 GENEFORM Protein DME1788 XEOTICID XEO04355 MOACRIVE Inhibition DME1788 XEOTICID XEO04356 XEO_NAME Odorranain-C1 DME1788 XEOTICID XEO04356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04356 XEO_CLAS Peptide DME1788 XEOTICID XEO04356 DESCRIPT Odorranain-C1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8.21 ug/ml) DME1788 XEOTICID XEO04356 GENEFORM Protein DME1788 XEOTICID XEO04356 MOACRIVE Inhibition DME1788 XEOTICID XEO04357 XEO_NAME Odorranain-D1 DME1788 XEOTICID XEO04357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04357 XEO_CLAS Peptide DME1788 XEOTICID XEO04357 DESCRIPT Odorranain-D1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16.32 ug/ml) DME1788 XEOTICID XEO04357 GENEFORM Protein DME1788 XEOTICID XEO04357 MOACRIVE Inhibition DME1788 XEOTICID XEO04358 XEO_NAME Odorranain-E1 DME1788 XEOTICID XEO04358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04358 XEO_CLAS Peptide DME1788 XEOTICID XEO04358 DESCRIPT Odorranain-E1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 9.37 ug/ml) DME1788 XEOTICID XEO04358 GENEFORM Protein DME1788 XEOTICID XEO04358 MOACRIVE Inhibition DME1788 XEOTICID XEO04359 XEO_NAME Odorranain-F1 DME1788 XEOTICID XEO04359 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04359 XEO_CLAS Peptide DME1788 XEOTICID XEO04359 DESCRIPT Odorranain-F1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4.20 ug/ml) DME1788 XEOTICID XEO04359 GENEFORM Protein DME1788 XEOTICID XEO04359 MOACRIVE Inhibition DME1788 XEOTICID XEO04360 XEO_NAME Odorranain-F-OA1 DME1788 XEOTICID XEO04360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04360 XEO_CLAS Peptide DME1788 XEOTICID XEO04360 DESCRIPT Odorranain-F-OA1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 ug/ml) DME1788 XEOTICID XEO04360 GENEFORM Protein DME1788 XEOTICID XEO04360 MOACRIVE Inhibition DME1788 XEOTICID XEO04361 XEO_NAME Odorranain-F-OA2 DME1788 XEOTICID XEO04361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04361 XEO_CLAS Peptide DME1788 XEOTICID XEO04361 DESCRIPT Odorranain-F-OA2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 7.5 ug/ml) DME1788 XEOTICID XEO04361 GENEFORM Protein DME1788 XEOTICID XEO04361 MOACRIVE Inhibition DME1788 XEOTICID XEO04362 XEO_NAME Odorranain-F-OA3 DME1788 XEOTICID XEO04362 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04362 XEO_CLAS Peptide DME1788 XEOTICID XEO04362 DESCRIPT Odorranain-F-OA3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.6 ug/ml) DME1788 XEOTICID XEO04362 GENEFORM Protein DME1788 XEOTICID XEO04362 MOACRIVE Inhibition DME1788 XEOTICID XEO04363 XEO_NAME Odorranain-F-OA4 DME1788 XEOTICID XEO04363 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04363 XEO_CLAS Peptide DME1788 XEOTICID XEO04363 DESCRIPT Odorranain-F-OA4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8.2 ug/ml) DME1788 XEOTICID XEO04363 GENEFORM Protein DME1788 XEOTICID XEO04363 MOACRIVE Inhibition DME1788 XEOTICID XEO04364 XEO_NAME Odorranain-F-OW1 DME1788 XEOTICID XEO04364 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04364 XEO_CLAS Peptide DME1788 XEOTICID XEO04364 DESCRIPT Odorranain-F-OW1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO04364 GENEFORM Protein DME1788 XEOTICID XEO04364 MOACRIVE Inhibition DME1788 XEOTICID XEO04365 XEO_NAME Odorranain-G1 DME1788 XEOTICID XEO04365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04365 XEO_CLAS Peptide DME1788 XEOTICID XEO04365 DESCRIPT Odorranain-G1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4.68 ug/ml) DME1788 XEOTICID XEO04365 GENEFORM Protein DME1788 XEOTICID XEO04365 MOACRIVE Inhibition DME1788 XEOTICID XEO04366 XEO_NAME Odorranain-H1 DME1788 XEOTICID XEO04366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04366 XEO_CLAS Peptide DME1788 XEOTICID XEO04366 DESCRIPT Odorranain-H1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 23.60 ug/ml) DME1788 XEOTICID XEO04366 GENEFORM Protein DME1788 XEOTICID XEO04366 MOACRIVE Inhibition DME1788 XEOTICID XEO04367 XEO_NAME Odorranain-J1 DME1788 XEOTICID XEO04367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04367 XEO_CLAS Peptide DME1788 XEOTICID XEO04367 DESCRIPT Odorranain-J1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 35.60 ug/ml) DME1788 XEOTICID XEO04367 GENEFORM Protein DME1788 XEOTICID XEO04367 MOACRIVE Inhibition DME1788 XEOTICID XEO04368 XEO_NAME Odorranain-J-OA1 DME1788 XEOTICID XEO04368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04368 XEO_CLAS Peptide DME1788 XEOTICID XEO04368 DESCRIPT Odorranain-J-OA1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40.2 ug/ml) DME1788 XEOTICID XEO04368 GENEFORM Protein DME1788 XEOTICID XEO04368 MOACRIVE Inhibition DME1788 XEOTICID XEO04369 XEO_NAME Odorranain-J-OA2 DME1788 XEOTICID XEO04369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04369 XEO_CLAS Peptide DME1788 XEOTICID XEO04369 DESCRIPT Odorranain-J-OA2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40.2 ug/ml) DME1788 XEOTICID XEO04369 GENEFORM Protein DME1788 XEOTICID XEO04369 MOACRIVE Inhibition DME1788 XEOTICID XEO04370 XEO_NAME Odorranain-K1 DME1788 XEOTICID XEO04370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04370 XEO_CLAS Peptide DME1788 XEOTICID XEO04370 DESCRIPT Odorranain-K1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4.68 ug/ml) DME1788 XEOTICID XEO04370 GENEFORM Protein DME1788 XEOTICID XEO04370 MOACRIVE Inhibition DME1788 XEOTICID XEO04371 XEO_NAME Odorranain-M1 DME1788 XEOTICID XEO04371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04371 XEO_CLAS Peptide DME1788 XEOTICID XEO04371 DESCRIPT Odorranain-M1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 9.37 ug/ml) DME1788 XEOTICID XEO04371 GENEFORM Protein DME1788 XEOTICID XEO04371 MOACRIVE Inhibition DME1788 XEOTICID XEO04373 XEO_NAME Odorranain-NR DME1788 XEOTICID XEO04373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04373 XEO_CLAS Peptide DME1788 XEOTICID XEO04373 DESCRIPT Odorranain-NR inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 ug/ml) DME1788 XEOTICID XEO04373 GENEFORM Protein DME1788 XEOTICID XEO04373 MOACRIVE Inhibition DME1788 XEOTICID XEO04374 XEO_NAME Odorranain-P1a DME1788 XEOTICID XEO04374 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04374 XEO_CLAS Peptide DME1788 XEOTICID XEO04374 DESCRIPT Odorranain-P1a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.50 ug/ml) DME1788 XEOTICID XEO04374 GENEFORM Protein DME1788 XEOTICID XEO04374 MOACRIVE Inhibition DME1788 XEOTICID XEO04375 XEO_NAME Odorranain-P2a DME1788 XEOTICID XEO04375 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04375 XEO_CLAS Peptide DME1788 XEOTICID XEO04375 DESCRIPT Odorranain-P2a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25 ug/ml) DME1788 XEOTICID XEO04375 GENEFORM Protein DME1788 XEOTICID XEO04375 MOACRIVE Inhibition DME1788 XEOTICID XEO04377 XEO_NAME Odorranain-S1 DME1788 XEOTICID XEO04377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04377 XEO_CLAS Peptide DME1788 XEOTICID XEO04377 DESCRIPT Odorranain-S1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 42.50 ug/ml) DME1788 XEOTICID XEO04377 GENEFORM Protein DME1788 XEOTICID XEO04377 MOACRIVE Inhibition DME1788 XEOTICID XEO04378 XEO_NAME Odorranain-T1 DME1788 XEOTICID XEO04378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04378 XEO_CLAS Peptide DME1788 XEOTICID XEO04378 DESCRIPT Odorranain-T1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 17.50 ug/ml) DME1788 XEOTICID XEO04378 GENEFORM Protein DME1788 XEOTICID XEO04378 MOACRIVE Inhibition DME1788 XEOTICID XEO04379 XEO_NAME Odorranain-U1 DME1788 XEOTICID XEO04379 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04379 XEO_CLAS Peptide DME1788 XEOTICID XEO04379 DESCRIPT Odorranain-U1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 ug/ml) DME1788 XEOTICID XEO04379 GENEFORM Protein DME1788 XEOTICID XEO04379 MOACRIVE Inhibition DME1788 XEOTICID XEO04380 XEO_NAME Odorranain-V1 DME1788 XEOTICID XEO04380 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04380 XEO_CLAS Peptide DME1788 XEOTICID XEO04380 DESCRIPT Odorranain-V1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 36.00 ug/ml) DME1788 XEOTICID XEO04380 GENEFORM Protein DME1788 XEOTICID XEO04380 MOACRIVE Inhibition DME1788 XEOTICID XEO04381 XEO_NAME Odorranain-W1 DME1788 XEOTICID XEO04381 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04381 XEO_CLAS Peptide DME1788 XEOTICID XEO04381 DESCRIPT Odorranain-W1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.60 ug/ml) DME1788 XEOTICID XEO04381 GENEFORM Protein DME1788 XEOTICID XEO04381 MOACRIVE Inhibition DME1788 XEOTICID XEO04382 XEO_NAME Odorranain-W2 DME1788 XEOTICID XEO04382 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04382 XEO_CLAS Peptide DME1788 XEOTICID XEO04382 DESCRIPT Odorranain-W2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 ug/ml) DME1788 XEOTICID XEO04382 GENEFORM Protein DME1788 XEOTICID XEO04382 MOACRIVE Inhibition DME1788 XEOTICID XEO04383 XEO_NAME Palustrin-OG1 derivative OG2 DME1788 XEOTICID XEO04383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04383 XEO_CLAS Peptide DME1788 XEOTICID XEO04383 DESCRIPT Palustrin-OG1 derivative OG2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO04383 GENEFORM Protein DME1788 XEOTICID XEO04383 MOACRIVE Inhibition DME1788 XEOTICID XEO04384 XEO_NAME Snake OH-CATH peptide DME1788 XEOTICID XEO04384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04384 XEO_CLAS Peptide DME1788 XEOTICID XEO04384 DESCRIPT Snake OH-CATH peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO04384 GENEFORM Protein DME1788 XEOTICID XEO04384 MOACRIVE Inhibition DME1788 XEOTICID XEO04385 XEO_NAME Oh-defensin DME1788 XEOTICID XEO04385 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04385 XEO_CLAS Peptide DME1788 XEOTICID XEO04385 DESCRIPT Oh-defensin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.25 ug/ml) DME1788 XEOTICID XEO04385 GENEFORM Protein DME1788 XEOTICID XEO04385 MOACRIVE Inhibition DME1788 XEOTICID XEO04395 XEO_NAME Oncorhyncin II DME1788 XEOTICID XEO04395 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04395 XEO_CLAS Peptide DME1788 XEOTICID XEO04395 DESCRIPT Oncorhyncin II inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.4-0.8 microM) DME1788 XEOTICID XEO04395 GENEFORM Protein DME1788 XEOTICID XEO04395 MOACRIVE Inhibition DME1788 XEOTICID XEO04396 XEO_NAME Oncorhyncin III DME1788 XEOTICID XEO04396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04396 XEO_CLAS Peptide DME1788 XEOTICID XEO04396 DESCRIPT Oncorhyncin III inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1788 XEOTICID XEO04396 GENEFORM Protein DME1788 XEOTICID XEO04396 MOACRIVE Inhibition DME1788 XEOTICID XEO04397 XEO_NAME Histone-derived oncorhyncin III DME1788 XEOTICID XEO04397 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04397 XEO_CLAS Peptide DME1788 XEOTICID XEO04397 DESCRIPT Histone-derived oncorhyncin III inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.25-0.5 microM) DME1788 XEOTICID XEO04397 GENEFORM Protein DME1788 XEOTICID XEO04397 MOACRIVE Inhibition DME1788 XEOTICID XEO04398 XEO_NAME Opiscorpine-1 DME1788 XEOTICID XEO04398 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04398 XEO_CLAS Peptide DME1788 XEOTICID XEO04398 DESCRIPT Opiscorpine-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 microM) DME1788 XEOTICID XEO04398 GENEFORM Protein DME1788 XEOTICID XEO04398 MOACRIVE Inhibition DME1788 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1788 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04399 XEO_CLAS Peptide DME1788 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO04399 GENEFORM Protein DME1788 XEOTICID XEO04399 MOACRIVE Inhibition DME1788 XEOTICID XEO04400 XEO_NAME Bac2A scrambled variant opt1 DME1788 XEOTICID XEO04400 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04400 XEO_CLAS Peptide DME1788 XEOTICID XEO04400 DESCRIPT Bac2A scrambled variant opt1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 ug/ml) DME1788 XEOTICID XEO04400 GENEFORM Protein DME1788 XEOTICID XEO04400 MOACRIVE Inhibition DME1788 XEOTICID XEO04401 XEO_NAME Bac2A scrambled variant opt2 DME1788 XEOTICID XEO04401 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04401 XEO_CLAS Peptide DME1788 XEOTICID XEO04401 DESCRIPT Bac2A scrambled variant opt2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.6 ug/ml) DME1788 XEOTICID XEO04401 GENEFORM Protein DME1788 XEOTICID XEO04401 MOACRIVE Inhibition DME1788 XEOTICID XEO04402 XEO_NAME Bac2A scrambled variant opt3 DME1788 XEOTICID XEO04402 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04402 XEO_CLAS Peptide DME1788 XEOTICID XEO04402 DESCRIPT Bac2A scrambled variant opt3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 ug/ml) DME1788 XEOTICID XEO04402 GENEFORM Protein DME1788 XEOTICID XEO04402 MOACRIVE Inhibition DME1788 XEOTICID XEO04403 XEO_NAME Bac2A scrambled variant opt4 DME1788 XEOTICID XEO04403 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04403 XEO_CLAS Peptide DME1788 XEOTICID XEO04403 DESCRIPT Bac2A scrambled variant opt4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.6 ug/ml) DME1788 XEOTICID XEO04403 GENEFORM Protein DME1788 XEOTICID XEO04403 MOACRIVE Inhibition DME1788 XEOTICID XEO04404 XEO_NAME Bac2A scrambled variant opt5 DME1788 XEOTICID XEO04404 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04404 XEO_CLAS Peptide DME1788 XEOTICID XEO04404 DESCRIPT Bac2A scrambled variant opt5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.6 ug/ml) DME1788 XEOTICID XEO04404 GENEFORM Protein DME1788 XEOTICID XEO04404 MOACRIVE Inhibition DME1788 XEOTICID XEO04410 XEO_NAME Insect osmin DME1788 XEOTICID XEO04410 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04410 XEO_CLAS Peptide DME1788 XEOTICID XEO04410 DESCRIPT Insect osmin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.125-1.56 microM) DME1788 XEOTICID XEO04410 GENEFORM Protein DME1788 XEOTICID XEO04410 MOACRIVE Inhibition DME1788 XEOTICID XEO04412 XEO_NAME Ostricacin-1 DME1788 XEOTICID XEO04412 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04412 XEO_CLAS Peptide DME1788 XEOTICID XEO04412 DESCRIPT Ostricacin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04412 GENEFORM Protein DME1788 XEOTICID XEO04412 MOACRIVE Inhibition DME1788 XEOTICID XEO04414 XEO_NAME Ostricacin-3 DME1788 XEOTICID XEO04414 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04414 XEO_CLAS Peptide DME1788 XEOTICID XEO04414 DESCRIPT Ostricacin-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04414 GENEFORM Protein DME1788 XEOTICID XEO04414 MOACRIVE Inhibition DME1788 XEOTICID XEO04415 XEO_NAME Ostricacin-4 DME1788 XEOTICID XEO04415 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04415 XEO_CLAS Peptide DME1788 XEOTICID XEO04415 DESCRIPT Ostricacin-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04415 GENEFORM Protein DME1788 XEOTICID XEO04415 MOACRIVE Inhibition DME1788 XEOTICID XEO04421 XEO_NAME Oxyopinin-4a DME1788 XEOTICID XEO04421 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04421 XEO_CLAS Peptide DME1788 XEOTICID XEO04421 DESCRIPT Oxyopinin-4a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 microM) DME1788 XEOTICID XEO04421 GENEFORM Protein DME1788 XEOTICID XEO04421 MOACRIVE Inhibition DME1788 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1788 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04426 XEO_CLAS Peptide DME1788 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO04426 GENEFORM Protein DME1788 XEOTICID XEO04426 MOACRIVE Inhibition DME1788 XEOTICID XEO04428 XEO_NAME Deer beta-defensin P15 DME1788 XEOTICID XEO04428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04428 XEO_CLAS Peptide DME1788 XEOTICID XEO04428 DESCRIPT Deer beta-defensin P15 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.3 ug/ml) DME1788 XEOTICID XEO04428 GENEFORM Protein DME1788 XEOTICID XEO04428 MOACRIVE Inhibition DME1788 XEOTICID XEO04430 XEO_NAME Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 DME1788 XEOTICID XEO04430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04430 XEO_CLAS Peptide DME1788 XEOTICID XEO04430 DESCRIPT Cecropin-A(1-8)-Magainin-2(1-12) hybrid P18 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25 microM) DME1788 XEOTICID XEO04430 GENEFORM Protein DME1788 XEOTICID XEO04430 MOACRIVE Inhibition DME1788 XEOTICID XEO04433 XEO_NAME Trp-rich PAF26 peptide DME1788 XEOTICID XEO04433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04433 XEO_CLAS Peptide DME1788 XEOTICID XEO04433 DESCRIPT Trp-rich PAF26 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 160 microM) DME1788 XEOTICID XEO04433 GENEFORM Protein DME1788 XEOTICID XEO04433 MOACRIVE Inhibition DME1788 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1788 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04435 XEO_CLAS Peptide DME1788 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 160 microM) DME1788 XEOTICID XEO04435 GENEFORM Protein DME1788 XEOTICID XEO04435 MOACRIVE Inhibition DME1788 XEOTICID XEO04438 XEO_NAME Palmitoyl-DL-carnitine DME1788 XEOTICID XEO04438 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO04438 XEO_CLAS Investigative Agent DME1788 XEOTICID XEO04438 DESCRIPT Palmitoyl-DL-carnitine inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04438 GENEFORM Protein DME1788 XEOTICID XEO04438 MOACRIVE Inhibition DME1788 XEOTICID XEO04439 XEO_NAME Palustrin-1a DME1788 XEOTICID XEO04439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04439 XEO_CLAS Peptide DME1788 XEOTICID XEO04439 DESCRIPT Palustrin-1a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04439 GENEFORM Protein DME1788 XEOTICID XEO04439 MOACRIVE Inhibition DME1788 XEOTICID XEO04440 XEO_NAME Palustrin-1b DME1788 XEOTICID XEO04440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04440 XEO_CLAS Peptide DME1788 XEOTICID XEO04440 DESCRIPT Palustrin-1b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 microM) DME1788 XEOTICID XEO04440 GENEFORM Protein DME1788 XEOTICID XEO04440 MOACRIVE Inhibition DME1788 XEOTICID XEO04441 XEO_NAME Palustrin-1c DME1788 XEOTICID XEO04441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04441 XEO_CLAS Peptide DME1788 XEOTICID XEO04441 DESCRIPT Palustrin-1c inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 28 microM) DME1788 XEOTICID XEO04441 GENEFORM Protein DME1788 XEOTICID XEO04441 MOACRIVE Inhibition DME1788 XEOTICID XEO04442 XEO_NAME Palustrin-1d DME1788 XEOTICID XEO04442 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04442 XEO_CLAS Peptide DME1788 XEOTICID XEO04442 DESCRIPT Palustrin-1d inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 28 microM) DME1788 XEOTICID XEO04442 GENEFORM Protein DME1788 XEOTICID XEO04442 MOACRIVE Inhibition DME1788 XEOTICID XEO04443 XEO_NAME Palustrin-2a DME1788 XEOTICID XEO04443 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04443 XEO_CLAS Peptide DME1788 XEOTICID XEO04443 DESCRIPT Palustrin-2a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04443 GENEFORM Protein DME1788 XEOTICID XEO04443 MOACRIVE Inhibition DME1788 XEOTICID XEO04444 XEO_NAME Palustrin-2AJ1 DME1788 XEOTICID XEO04444 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04444 XEO_CLAS Peptide DME1788 XEOTICID XEO04444 DESCRIPT Palustrin-2AJ1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 13 microM) DME1788 XEOTICID XEO04444 GENEFORM Protein DME1788 XEOTICID XEO04444 MOACRIVE Inhibition DME1788 XEOTICID XEO04445 XEO_NAME Palustrin-2AR DME1788 XEOTICID XEO04445 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04445 XEO_CLAS Peptide DME1788 XEOTICID XEO04445 DESCRIPT Palustrin-2AR inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04445 GENEFORM Protein DME1788 XEOTICID XEO04445 MOACRIVE Inhibition DME1788 XEOTICID XEO04446 XEO_NAME Palustrin-2b DME1788 XEOTICID XEO04446 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04446 XEO_CLAS Peptide DME1788 XEOTICID XEO04446 DESCRIPT Palustrin-2b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 78 microM) DME1788 XEOTICID XEO04446 GENEFORM Protein DME1788 XEOTICID XEO04446 MOACRIVE Inhibition DME1788 XEOTICID XEO04447 XEO_NAME Palustrin-2c DME1788 XEOTICID XEO04447 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04447 XEO_CLAS Peptide DME1788 XEOTICID XEO04447 DESCRIPT Palustrin-2c inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 120 microM) DME1788 XEOTICID XEO04447 GENEFORM Protein DME1788 XEOTICID XEO04447 MOACRIVE Inhibition DME1788 XEOTICID XEO04448 XEO_NAME Palustrin-2ISa DME1788 XEOTICID XEO04448 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04448 XEO_CLAS Peptide DME1788 XEOTICID XEO04448 DESCRIPT Palustrin-2ISa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 microM) DME1788 XEOTICID XEO04448 GENEFORM Protein DME1788 XEOTICID XEO04448 MOACRIVE Inhibition DME1788 XEOTICID XEO04449 XEO_NAME Palustrin-2ISb+3aa DME1788 XEOTICID XEO04449 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04449 XEO_CLAS Peptide DME1788 XEOTICID XEO04449 DESCRIPT Palustrin-2ISb+3aa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.3 microM) DME1788 XEOTICID XEO04449 GENEFORM Protein DME1788 XEOTICID XEO04449 MOACRIVE Inhibition DME1788 XEOTICID XEO04450 XEO_NAME Palustrin-2ISb-des-C7 DME1788 XEOTICID XEO04450 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04450 XEO_CLAS Peptide DME1788 XEOTICID XEO04450 DESCRIPT Palustrin-2ISb-des-C7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.3 microM) DME1788 XEOTICID XEO04450 GENEFORM Protein DME1788 XEOTICID XEO04450 MOACRIVE Inhibition DME1788 XEOTICID XEO04451 XEO_NAME Palustrin-2ISb-des-C7-12N DME1788 XEOTICID XEO04451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04451 XEO_CLAS Peptide DME1788 XEOTICID XEO04451 DESCRIPT Palustrin-2ISb-des-C7-12N inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO04451 GENEFORM Protein DME1788 XEOTICID XEO04451 MOACRIVE Inhibition DME1788 XEOTICID XEO04452 XEO_NAME Palustrin-2ISb-des-C7-23,29S DME1788 XEOTICID XEO04452 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04452 XEO_CLAS Peptide DME1788 XEOTICID XEO04452 DESCRIPT Palustrin-2ISb-des-C7-23,29S inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.1 microM) DME1788 XEOTICID XEO04452 GENEFORM Protein DME1788 XEOTICID XEO04452 MOACRIVE Inhibition DME1788 XEOTICID XEO04453 XEO_NAME Palustrin-2ISb-des-C7-4D DME1788 XEOTICID XEO04453 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04453 XEO_CLAS Peptide DME1788 XEOTICID XEO04453 DESCRIPT Palustrin-2ISb-des-C7-4D inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO04453 GENEFORM Protein DME1788 XEOTICID XEO04453 MOACRIVE Inhibition DME1788 XEOTICID XEO04455 XEO_NAME Palustrin-2ISc DME1788 XEOTICID XEO04455 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04455 XEO_CLAS Peptide DME1788 XEOTICID XEO04455 DESCRIPT Palustrin-2ISc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 microM) DME1788 XEOTICID XEO04455 GENEFORM Protein DME1788 XEOTICID XEO04455 MOACRIVE Inhibition DME1788 XEOTICID XEO04457 XEO_NAME Palustrin-2SIb DME1788 XEOTICID XEO04457 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04457 XEO_CLAS Peptide DME1788 XEOTICID XEO04457 DESCRIPT Palustrin-2SIb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.3 microM) DME1788 XEOTICID XEO04457 GENEFORM Protein DME1788 XEOTICID XEO04457 MOACRIVE Inhibition DME1788 XEOTICID XEO04458 XEO_NAME Palustrin-3a DME1788 XEOTICID XEO04458 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04458 XEO_CLAS Peptide DME1788 XEOTICID XEO04458 DESCRIPT Palustrin-3a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1 microM) DME1788 XEOTICID XEO04458 GENEFORM Protein DME1788 XEOTICID XEO04458 MOACRIVE Inhibition DME1788 XEOTICID XEO04459 XEO_NAME Palustrin-3b DME1788 XEOTICID XEO04459 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04459 XEO_CLAS Peptide DME1788 XEOTICID XEO04459 DESCRIPT Palustrin-3b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1 microM) DME1788 XEOTICID XEO04459 GENEFORM Protein DME1788 XEOTICID XEO04459 MOACRIVE Inhibition DME1788 XEOTICID XEO04461 XEO_NAME Pandinin-1 DME1788 XEOTICID XEO04461 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04461 XEO_CLAS Peptide DME1788 XEOTICID XEO04461 DESCRIPT Pandinin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20.8 microM) DME1788 XEOTICID XEO04461 GENEFORM Protein DME1788 XEOTICID XEO04461 MOACRIVE Inhibition DME1788 XEOTICID XEO04462 XEO_NAME Pandinin-2 DME1788 XEOTICID XEO04462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04462 XEO_CLAS Peptide DME1788 XEOTICID XEO04462 DESCRIPT Pandinin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 19.1 microM) DME1788 XEOTICID XEO04462 GENEFORM Protein DME1788 XEOTICID XEO04462 MOACRIVE Inhibition DME1788 XEOTICID XEO04463 XEO_NAME Paneth cell-specific alpha-defensin 1 DME1788 XEOTICID XEO04463 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04463 XEO_CLAS Peptide DME1788 XEOTICID XEO04463 DESCRIPT Paneth cell-specific alpha-defensin 1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04463 GENEFORM Protein DME1788 XEOTICID XEO04463 MOACRIVE Inhibition DME1788 XEOTICID XEO04464 XEO_NAME Panitide L2 DME1788 XEOTICID XEO04464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04464 XEO_CLAS Peptide DME1788 XEOTICID XEO04464 DESCRIPT Panitide L2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.5 microM) DME1788 XEOTICID XEO04464 GENEFORM Protein DME1788 XEOTICID XEO04464 MOACRIVE Inhibition DME1788 XEOTICID XEO04466 XEO_NAME Panusin DME1788 XEOTICID XEO04466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04466 XEO_CLAS Peptide DME1788 XEOTICID XEO04466 DESCRIPT Panusin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04466 GENEFORM Protein DME1788 XEOTICID XEO04466 MOACRIVE Inhibition DME1788 XEOTICID XEO04467 XEO_NAME Panusin PaD7 DME1788 XEOTICID XEO04467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04467 XEO_CLAS Peptide DME1788 XEOTICID XEO04467 DESCRIPT Panusin PaD7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4.8 microM) DME1788 XEOTICID XEO04467 GENEFORM Protein DME1788 XEOTICID XEO04467 MOACRIVE Inhibition DME1788 XEOTICID XEO04468 XEO_NAME Papillosin DME1788 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04468 XEO_CLAS Peptide DME1788 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04468 GENEFORM Protein DME1788 XEOTICID XEO04468 MOACRIVE Inhibition DME1788 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1788 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04471 XEO_CLAS Peptide DME1788 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.1 microM) DME1788 XEOTICID XEO04471 GENEFORM Protein DME1788 XEOTICID XEO04471 MOACRIVE Inhibition DME1788 XEOTICID XEO04480 XEO_NAME PBD1-42 peptide DME1788 XEOTICID XEO04480 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04480 XEO_CLAS Peptide DME1788 XEOTICID XEO04480 DESCRIPT PBD1-42 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 ug/ml) DME1788 XEOTICID XEO04480 GENEFORM Protein DME1788 XEOTICID XEO04480 MOACRIVE Inhibition DME1788 XEOTICID XEO04482 XEO_NAME p-Coumaric acid DME1788 XEOTICID XEO04482 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO04482 XEO_CLAS Investigative Agent DME1788 XEOTICID XEO04482 DESCRIPT p-Coumaric acid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04482 GENEFORM Protein DME1788 XEOTICID XEO04482 MOACRIVE Inhibition DME1788 XEOTICID XEO04484 XEO_NAME PDD-A analog PDD-A-1 DME1788 XEOTICID XEO04484 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04484 XEO_CLAS Peptide DME1788 XEOTICID XEO04484 DESCRIPT PDD-A analog PDD-A-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 microM) DME1788 XEOTICID XEO04484 GENEFORM Protein DME1788 XEOTICID XEO04484 MOACRIVE Inhibition DME1788 XEOTICID XEO04485 XEO_NAME PDD-A analog PDD-A-10 DME1788 XEOTICID XEO04485 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04485 XEO_CLAS Peptide DME1788 XEOTICID XEO04485 DESCRIPT PDD-A analog PDD-A-10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO04485 GENEFORM Protein DME1788 XEOTICID XEO04485 MOACRIVE Inhibition DME1788 XEOTICID XEO04486 XEO_NAME PDD-A analog PDD-A-11 DME1788 XEOTICID XEO04486 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04486 XEO_CLAS Peptide DME1788 XEOTICID XEO04486 DESCRIPT PDD-A analog PDD-A-11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 microM) DME1788 XEOTICID XEO04486 GENEFORM Protein DME1788 XEOTICID XEO04486 MOACRIVE Inhibition DME1788 XEOTICID XEO04487 XEO_NAME PDD-A analog PDD-A-12 DME1788 XEOTICID XEO04487 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04487 XEO_CLAS Peptide DME1788 XEOTICID XEO04487 DESCRIPT PDD-A analog PDD-A-12 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO04487 GENEFORM Protein DME1788 XEOTICID XEO04487 MOACRIVE Inhibition DME1788 XEOTICID XEO04488 XEO_NAME PDD-A analog PDD-A-2 DME1788 XEOTICID XEO04488 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04488 XEO_CLAS Peptide DME1788 XEOTICID XEO04488 DESCRIPT PDD-A analog PDD-A-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 9 microM) DME1788 XEOTICID XEO04488 GENEFORM Protein DME1788 XEOTICID XEO04488 MOACRIVE Inhibition DME1788 XEOTICID XEO04489 XEO_NAME PDD-A analog PDD-A-3 DME1788 XEOTICID XEO04489 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04489 XEO_CLAS Peptide DME1788 XEOTICID XEO04489 DESCRIPT PDD-A analog PDD-A-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 13 microM) DME1788 XEOTICID XEO04489 GENEFORM Protein DME1788 XEOTICID XEO04489 MOACRIVE Inhibition DME1788 XEOTICID XEO04490 XEO_NAME PDD-A analog PDD-A-4 DME1788 XEOTICID XEO04490 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04490 XEO_CLAS Peptide DME1788 XEOTICID XEO04490 DESCRIPT PDD-A analog PDD-A-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 47.5 microM) DME1788 XEOTICID XEO04490 GENEFORM Protein DME1788 XEOTICID XEO04490 MOACRIVE Inhibition DME1788 XEOTICID XEO04491 XEO_NAME PDD-A analog PDD-A-5 DME1788 XEOTICID XEO04491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04491 XEO_CLAS Peptide DME1788 XEOTICID XEO04491 DESCRIPT PDD-A analog PDD-A-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO04491 GENEFORM Protein DME1788 XEOTICID XEO04491 MOACRIVE Inhibition DME1788 XEOTICID XEO04492 XEO_NAME PDD-A analog PDD-A-6 DME1788 XEOTICID XEO04492 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04492 XEO_CLAS Peptide DME1788 XEOTICID XEO04492 DESCRIPT PDD-A analog PDD-A-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 35 microM) DME1788 XEOTICID XEO04492 GENEFORM Protein DME1788 XEOTICID XEO04492 MOACRIVE Inhibition DME1788 XEOTICID XEO04493 XEO_NAME PDD-A analog PDD-A-7 DME1788 XEOTICID XEO04493 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04493 XEO_CLAS Peptide DME1788 XEOTICID XEO04493 DESCRIPT PDD-A analog PDD-A-7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 microM) DME1788 XEOTICID XEO04493 GENEFORM Protein DME1788 XEOTICID XEO04493 MOACRIVE Inhibition DME1788 XEOTICID XEO04494 XEO_NAME PDD-A analog PDD-A-8 DME1788 XEOTICID XEO04494 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04494 XEO_CLAS Peptide DME1788 XEOTICID XEO04494 DESCRIPT PDD-A analog PDD-A-8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO04494 GENEFORM Protein DME1788 XEOTICID XEO04494 MOACRIVE Inhibition DME1788 XEOTICID XEO04495 XEO_NAME PDD-A analog PDD-A-9 DME1788 XEOTICID XEO04495 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04495 XEO_CLAS Peptide DME1788 XEOTICID XEO04495 DESCRIPT PDD-A analog PDD-A-9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO04495 GENEFORM Protein DME1788 XEOTICID XEO04495 MOACRIVE Inhibition DME1788 XEOTICID XEO04496 XEO_NAME PDD-A analog PDD-B-1 DME1788 XEOTICID XEO04496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04496 XEO_CLAS Peptide DME1788 XEOTICID XEO04496 DESCRIPT PDD-A analog PDD-B-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 67.5 microM) DME1788 XEOTICID XEO04496 GENEFORM Protein DME1788 XEOTICID XEO04496 MOACRIVE Inhibition DME1788 XEOTICID XEO04497 XEO_NAME PDD-A analog PDD-B-2 DME1788 XEOTICID XEO04497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04497 XEO_CLAS Peptide DME1788 XEOTICID XEO04497 DESCRIPT PDD-A analog PDD-B-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO04497 GENEFORM Protein DME1788 XEOTICID XEO04497 MOACRIVE Inhibition DME1788 XEOTICID XEO04498 XEO_NAME PDD-A analog PDD-B-3 DME1788 XEOTICID XEO04498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04498 XEO_CLAS Peptide DME1788 XEOTICID XEO04498 DESCRIPT PDD-A analog PDD-B-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO04498 GENEFORM Protein DME1788 XEOTICID XEO04498 MOACRIVE Inhibition DME1788 XEOTICID XEO04499 XEO_NAME PDD-A analog PDD-B-4 DME1788 XEOTICID XEO04499 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04499 XEO_CLAS Peptide DME1788 XEOTICID XEO04499 DESCRIPT PDD-A analog PDD-B-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 43 microM) DME1788 XEOTICID XEO04499 GENEFORM Protein DME1788 XEOTICID XEO04499 MOACRIVE Inhibition DME1788 XEOTICID XEO04500 XEO_NAME PDD-A analog PDD-B-5 DME1788 XEOTICID XEO04500 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04500 XEO_CLAS Peptide DME1788 XEOTICID XEO04500 DESCRIPT PDD-A analog PDD-B-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO04500 GENEFORM Protein DME1788 XEOTICID XEO04500 MOACRIVE Inhibition DME1788 XEOTICID XEO04504 XEO_NAME Penaeidin-1 DME1788 XEOTICID XEO04504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04504 XEO_CLAS Peptide DME1788 XEOTICID XEO04504 DESCRIPT Penaeidin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04504 GENEFORM Protein DME1788 XEOTICID XEO04504 MOACRIVE Inhibition DME1788 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1788 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04505 XEO_CLAS Peptide DME1788 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04505 GENEFORM Protein DME1788 XEOTICID XEO04505 MOACRIVE Inhibition DME1788 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1788 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04506 XEO_CLAS Peptide DME1788 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 40 microM) DME1788 XEOTICID XEO04506 GENEFORM Protein DME1788 XEOTICID XEO04506 MOACRIVE Inhibition DME1788 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1788 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04507 XEO_CLAS Peptide DME1788 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10-20 microM) DME1788 XEOTICID XEO04507 GENEFORM Protein DME1788 XEOTICID XEO04507 MOACRIVE Inhibition DME1788 XEOTICID XEO04508 XEO_NAME Penaeidin-3b DME1788 XEOTICID XEO04508 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04508 XEO_CLAS Peptide DME1788 XEOTICID XEO04508 DESCRIPT Penaeidin-3b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04508 GENEFORM Protein DME1788 XEOTICID XEO04508 MOACRIVE Inhibition DME1788 XEOTICID XEO04509 XEO_NAME Penaeidin-3c DME1788 XEOTICID XEO04509 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04509 XEO_CLAS Peptide DME1788 XEOTICID XEO04509 DESCRIPT Penaeidin-3c inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04509 GENEFORM Protein DME1788 XEOTICID XEO04509 MOACRIVE Inhibition DME1788 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1788 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04510 XEO_CLAS Peptide DME1788 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 22-33 microM) DME1788 XEOTICID XEO04510 GENEFORM Protein DME1788 XEOTICID XEO04510 MOACRIVE Inhibition DME1788 XEOTICID XEO04525 XEO_NAME Pep-1 peptide DME1788 XEOTICID XEO04525 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04525 XEO_CLAS Peptide DME1788 XEOTICID XEO04525 DESCRIPT Pep-1 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 32.0 microM) DME1788 XEOTICID XEO04525 GENEFORM Protein DME1788 XEOTICID XEO04525 MOACRIVE Inhibition DME1788 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1788 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04526 XEO_CLAS Peptide DME1788 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.0 microM) DME1788 XEOTICID XEO04526 GENEFORM Protein DME1788 XEOTICID XEO04526 MOACRIVE Inhibition DME1788 XEOTICID XEO04527 XEO_NAME Pepcon DME1788 XEOTICID XEO04527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04527 XEO_CLAS Peptide DME1788 XEOTICID XEO04527 DESCRIPT Pepcon inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO04527 GENEFORM Protein DME1788 XEOTICID XEO04527 MOACRIVE Inhibition DME1788 XEOTICID XEO04532 XEO_NAME Trp- and Arg-rich peptide 2 DME1788 XEOTICID XEO04532 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04532 XEO_CLAS Peptide DME1788 XEOTICID XEO04532 DESCRIPT Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04532 GENEFORM Protein DME1788 XEOTICID XEO04532 MOACRIVE Inhibition DME1788 XEOTICID XEO04540 XEO_NAME Non-disulfide-bridged peptide BmKb1 DME1788 XEOTICID XEO04540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04540 XEO_CLAS Peptide DME1788 XEOTICID XEO04540 DESCRIPT Non-disulfide-bridged peptide BmKb1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 18.1 ug/ml) DME1788 XEOTICID XEO04540 GENEFORM Protein DME1788 XEOTICID XEO04540 MOACRIVE Inhibition DME1788 XEOTICID XEO04541 XEO_NAME Biologically active peptide BmKn2 DME1788 XEOTICID XEO04541 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04541 XEO_CLAS Peptide DME1788 XEOTICID XEO04541 DESCRIPT Biologically active peptide BmKn2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.5 ug/ml) DME1788 XEOTICID XEO04541 GENEFORM Protein DME1788 XEOTICID XEO04541 MOACRIVE Inhibition DME1788 XEOTICID XEO04542 XEO_NAME Insect peptide C DME1788 XEOTICID XEO04542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04542 XEO_CLAS Peptide DME1788 XEOTICID XEO04542 DESCRIPT Insect peptide C inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04542 GENEFORM Protein DME1788 XEOTICID XEO04542 MOACRIVE Inhibition DME1788 XEOTICID XEO04543 XEO_NAME Gly-rich peptide fraction II DME1788 XEOTICID XEO04543 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04543 XEO_CLAS Peptide DME1788 XEOTICID XEO04543 DESCRIPT Gly-rich peptide fraction II inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04543 GENEFORM Protein DME1788 XEOTICID XEO04543 MOACRIVE Inhibition DME1788 XEOTICID XEO04546 XEO_NAME Perinerin DME1788 XEOTICID XEO04546 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04546 XEO_CLAS Peptide DME1788 XEOTICID XEO04546 DESCRIPT Perinerin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04546 GENEFORM Protein DME1788 XEOTICID XEO04546 MOACRIVE Inhibition DME1788 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1788 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04548 XEO_CLAS Peptide DME1788 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 72000 ug/ml) DME1788 XEOTICID XEO04548 GENEFORM Protein DME1788 XEOTICID XEO04548 MOACRIVE Inhibition DME1788 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1788 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04549 XEO_CLAS Peptide DME1788 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 62-125 ug/ml) DME1788 XEOTICID XEO04549 GENEFORM Protein DME1788 XEOTICID XEO04549 MOACRIVE Inhibition DME1788 XEOTICID XEO04550 XEO_NAME PGLa-AN2 peptide DME1788 XEOTICID XEO04550 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04550 XEO_CLAS Peptide DME1788 XEOTICID XEO04550 DESCRIPT PGLa-AN2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO04550 GENEFORM Protein DME1788 XEOTICID XEO04550 MOACRIVE Inhibition DME1788 XEOTICID XEO04551 XEO_NAME PYLa/PGLa A chain PGLa-H DME1788 XEOTICID XEO04551 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04551 XEO_CLAS Peptide DME1788 XEOTICID XEO04551 DESCRIPT PYLa/PGLa A chain PGLa-H inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 23.6 ug/ml) DME1788 XEOTICID XEO04551 GENEFORM Protein DME1788 XEOTICID XEO04551 MOACRIVE Inhibition DME1788 XEOTICID XEO04552 XEO_NAME Defensin-1 PhD1 DME1788 XEOTICID XEO04552 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04552 XEO_CLAS Peptide DME1788 XEOTICID XEO04552 DESCRIPT Defensin-1 PhD1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04552 GENEFORM Protein DME1788 XEOTICID XEO04552 MOACRIVE Inhibition DME1788 XEOTICID XEO04553 XEO_NAME Defensin-2 PhD2 DME1788 XEOTICID XEO04553 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04553 XEO_CLAS Peptide DME1788 XEOTICID XEO04553 DESCRIPT Defensin-2 PhD2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04553 GENEFORM Protein DME1788 XEOTICID XEO04553 MOACRIVE Inhibition DME1788 XEOTICID XEO04554 XEO_NAME Defensin-3 PhD3 DME1788 XEOTICID XEO04554 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04554 XEO_CLAS Peptide DME1788 XEOTICID XEO04554 DESCRIPT Defensin-3 PhD3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04554 GENEFORM Protein DME1788 XEOTICID XEO04554 MOACRIVE Inhibition DME1788 XEOTICID XEO04563 XEO_NAME Phosphate DME1788 XEOTICID XEO04563 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO04563 XEO_CLAS Investigative Agent DME1788 XEOTICID XEO04563 DESCRIPT Phosphate inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04563 GENEFORM Protein DME1788 XEOTICID XEO04563 MOACRIVE Inhibition DME1788 XEOTICID XEO04565 XEO_NAME Primate peptide PhTD-1 DME1788 XEOTICID XEO04565 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04565 XEO_CLAS Peptide DME1788 XEOTICID XEO04565 DESCRIPT Primate peptide PhTD-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.5 microM) DME1788 XEOTICID XEO04565 GENEFORM Protein DME1788 XEOTICID XEO04565 MOACRIVE Inhibition DME1788 XEOTICID XEO04566 XEO_NAME Primate peptide PhTD-3 DME1788 XEOTICID XEO04566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04566 XEO_CLAS Peptide DME1788 XEOTICID XEO04566 DESCRIPT Primate peptide PhTD-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.7 microM) DME1788 XEOTICID XEO04566 GENEFORM Protein DME1788 XEOTICID XEO04566 MOACRIVE Inhibition DME1788 XEOTICID XEO04569 XEO_NAME Phylloseptin PS-1 DME1788 XEOTICID XEO04569 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04569 XEO_CLAS Peptide DME1788 XEOTICID XEO04569 DESCRIPT Phylloseptin PS-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 7.9 microM) DME1788 XEOTICID XEO04569 GENEFORM Protein DME1788 XEOTICID XEO04569 MOACRIVE Inhibition DME1788 XEOTICID XEO04570 XEO_NAME Phylloseptin PSN-1 DME1788 XEOTICID XEO04570 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04570 XEO_CLAS Peptide DME1788 XEOTICID XEO04570 DESCRIPT Phylloseptin PSN-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04570 GENEFORM Protein DME1788 XEOTICID XEO04570 MOACRIVE Inhibition DME1788 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1788 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04571 XEO_CLAS Peptide DME1788 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04571 GENEFORM Protein DME1788 XEOTICID XEO04571 MOACRIVE Inhibition DME1788 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1788 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04572 XEO_CLAS Peptide DME1788 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04572 GENEFORM Protein DME1788 XEOTICID XEO04572 MOACRIVE Inhibition DME1788 XEOTICID XEO04573 XEO_NAME Phylloseptin PS-7 DME1788 XEOTICID XEO04573 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04573 XEO_CLAS Peptide DME1788 XEOTICID XEO04573 DESCRIPT Phylloseptin PS-7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 microM) DME1788 XEOTICID XEO04573 GENEFORM Protein DME1788 XEOTICID XEO04573 MOACRIVE Inhibition DME1788 XEOTICID XEO04574 XEO_NAME Phylloseptin PBa DME1788 XEOTICID XEO04574 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04574 XEO_CLAS Peptide DME1788 XEOTICID XEO04574 DESCRIPT Phylloseptin PBa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 128 ug/ml) DME1788 XEOTICID XEO04574 GENEFORM Protein DME1788 XEOTICID XEO04574 MOACRIVE Inhibition DME1788 XEOTICID XEO04575 XEO_NAME Frog phylloxin DME1788 XEOTICID XEO04575 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04575 XEO_CLAS Peptide DME1788 XEOTICID XEO04575 DESCRIPT Frog phylloxin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO04575 GENEFORM Protein DME1788 XEOTICID XEO04575 MOACRIVE Inhibition DME1788 XEOTICID XEO04578 XEO_NAME Acer ukurunduense extract DME1788 XEOTICID XEO04578 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04578 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04578 DESCRIPT Acer ukurunduense extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04578 GENEFORM Protein DME1788 XEOTICID XEO04578 MOACRIVE Inhibition DME1788 XEOTICID XEO04579 XEO_NAME Bletilla striata extract DME1788 XEOTICID XEO04579 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04579 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04579 DESCRIPT Bletilla striata extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04579 GENEFORM Protein DME1788 XEOTICID XEO04579 MOACRIVE Inhibition DME1788 XEOTICID XEO04580 XEO_NAME Caragana sinica extract DME1788 XEOTICID XEO04580 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04580 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04580 DESCRIPT Caragana sinica extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04580 GENEFORM Protein DME1788 XEOTICID XEO04580 MOACRIVE Inhibition DME1788 XEOTICID XEO04583 XEO_NAME Carex dimorpholepis extract DME1788 XEOTICID XEO04583 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04583 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04583 DESCRIPT Carex dimorpholepis extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04583 GENEFORM Protein DME1788 XEOTICID XEO04583 MOACRIVE Inhibition DME1788 XEOTICID XEO04588 XEO_NAME Carex siderosticta extract DME1788 XEOTICID XEO04588 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04588 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04588 DESCRIPT Carex siderosticta extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04588 GENEFORM Protein DME1788 XEOTICID XEO04588 MOACRIVE Inhibition DME1788 XEOTICID XEO04589 XEO_NAME Euphorbia jolkini extract DME1788 XEOTICID XEO04589 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04589 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04589 DESCRIPT Euphorbia jolkini extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04589 GENEFORM Protein DME1788 XEOTICID XEO04589 MOACRIVE Inhibition DME1788 XEOTICID XEO04590 XEO_NAME Juglans mandshurica extract DME1788 XEOTICID XEO04590 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04590 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04590 DESCRIPT Juglans mandshurica extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04590 GENEFORM Protein DME1788 XEOTICID XEO04590 MOACRIVE Inhibition DME1788 XEOTICID XEO04591 XEO_NAME Largerstroemia indica extract DME1788 XEOTICID XEO04591 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04591 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04591 DESCRIPT Largerstroemia indica extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04591 GENEFORM Protein DME1788 XEOTICID XEO04591 MOACRIVE Inhibition DME1788 XEOTICID XEO04592 XEO_NAME Lythrum salicaria extract DME1788 XEOTICID XEO04592 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04592 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04592 DESCRIPT Lythrum salicaria extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04592 GENEFORM Protein DME1788 XEOTICID XEO04592 MOACRIVE Inhibition DME1788 XEOTICID XEO04593 XEO_NAME Mallotus japonica extract DME1788 XEOTICID XEO04593 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04593 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04593 DESCRIPT Mallotus japonica extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04593 GENEFORM Protein DME1788 XEOTICID XEO04593 MOACRIVE Inhibition DME1788 XEOTICID XEO04594 XEO_NAME Morus bombycis extract DME1788 XEOTICID XEO04594 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04594 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04594 DESCRIPT Morus bombycis extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04594 GENEFORM Protein DME1788 XEOTICID XEO04594 MOACRIVE Inhibition DME1788 XEOTICID XEO04595 XEO_NAME Oenothera laciniata extract DME1788 XEOTICID XEO04595 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04595 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04595 DESCRIPT Oenothera laciniata extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04595 GENEFORM Protein DME1788 XEOTICID XEO04595 MOACRIVE Inhibition DME1788 XEOTICID XEO04596 XEO_NAME Platycarya strobilacea extract DME1788 XEOTICID XEO04596 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04596 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04596 DESCRIPT Platycarya strobilacea extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04596 GENEFORM Protein DME1788 XEOTICID XEO04596 MOACRIVE Inhibition DME1788 XEOTICID XEO04597 XEO_NAME Punica granatum extract DME1788 XEOTICID XEO04597 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04597 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04597 DESCRIPT Punica granatum extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04597 GENEFORM Protein DME1788 XEOTICID XEO04597 MOACRIVE Inhibition DME1788 XEOTICID XEO04598 XEO_NAME Rhus succedanea extract DME1788 XEOTICID XEO04598 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04598 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04598 DESCRIPT Rhus succedanea extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04598 GENEFORM Protein DME1788 XEOTICID XEO04598 MOACRIVE Inhibition DME1788 XEOTICID XEO04599 XEO_NAME Zephyranthes candida extract DME1788 XEOTICID XEO04599 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04599 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04599 DESCRIPT Zephyranthes candida extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04599 GENEFORM Protein DME1788 XEOTICID XEO04599 MOACRIVE Inhibition DME1788 XEOTICID XEO04601 XEO_NAME Plant piceain 1 DME1788 XEOTICID XEO04601 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04601 XEO_CLAS Peptide DME1788 XEOTICID XEO04601 DESCRIPT Plant piceain 1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 18.75 ug/ml) DME1788 XEOTICID XEO04601 GENEFORM Protein DME1788 XEOTICID XEO04601 MOACRIVE Inhibition DME1788 XEOTICID XEO04602 XEO_NAME Plant piceain 2 DME1788 XEOTICID XEO04602 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04602 XEO_CLAS Peptide DME1788 XEOTICID XEO04602 DESCRIPT Plant piceain 2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 37.5 ug/ml) DME1788 XEOTICID XEO04602 GENEFORM Protein DME1788 XEOTICID XEO04602 MOACRIVE Inhibition DME1788 XEOTICID XEO04604 XEO_NAME Pilosulin 3 DME1788 XEOTICID XEO04604 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04604 XEO_CLAS Peptide DME1788 XEOTICID XEO04604 DESCRIPT Pilosulin 3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC < 25 microM) DME1788 XEOTICID XEO04604 GENEFORM Protein DME1788 XEOTICID XEO04604 MOACRIVE Inhibition DME1788 XEOTICID XEO04605 XEO_NAME Pilosulin 4 DME1788 XEOTICID XEO04605 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04605 XEO_CLAS Peptide DME1788 XEOTICID XEO04605 DESCRIPT Pilosulin 4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC < 6.25 microM) DME1788 XEOTICID XEO04605 GENEFORM Protein DME1788 XEOTICID XEO04605 MOACRIVE Inhibition DME1788 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1788 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04606 XEO_CLAS Peptide DME1788 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO04606 GENEFORM Protein DME1788 XEOTICID XEO04606 MOACRIVE Inhibition DME1788 XEOTICID XEO04607 XEO_NAME Pimento berry oil DME1788 XEOTICID XEO04607 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04607 XEO_CLAS Plant Extract DME1788 XEOTICID XEO04607 DESCRIPT Pimento berry oil inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04607 GENEFORM Protein DME1788 XEOTICID XEO04607 MOACRIVE Inhibition DME1788 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1788 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04612 XEO_CLAS Peptide DME1788 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5-10 microM) DME1788 XEOTICID XEO04612 GENEFORM Protein DME1788 XEOTICID XEO04612 MOACRIVE Inhibition DME1788 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1788 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04613 XEO_CLAS Peptide DME1788 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5-10 microM) DME1788 XEOTICID XEO04613 GENEFORM Protein DME1788 XEOTICID XEO04613 MOACRIVE Inhibition DME1788 XEOTICID XEO04625 XEO_NAME Plasticin ANC KF DME1788 XEOTICID XEO04625 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04625 XEO_CLAS Peptide DME1788 XEOTICID XEO04625 DESCRIPT Plasticin ANC KF inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO04625 GENEFORM Protein DME1788 XEOTICID XEO04625 MOACRIVE Inhibition DME1788 XEOTICID XEO04626 XEO_NAME Plasticin PD36 K DME1788 XEOTICID XEO04626 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04626 XEO_CLAS Peptide DME1788 XEOTICID XEO04626 DESCRIPT Plasticin PD36 K inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO04626 GENEFORM Protein DME1788 XEOTICID XEO04626 MOACRIVE Inhibition DME1788 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1788 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04627 XEO_CLAS Peptide DME1788 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.5 microM) DME1788 XEOTICID XEO04627 GENEFORM Protein DME1788 XEOTICID XEO04627 MOACRIVE Inhibition DME1788 XEOTICID XEO04630 XEO_NAME Pleurain-A1 DME1788 XEOTICID XEO04630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04630 XEO_CLAS Peptide DME1788 XEOTICID XEO04630 DESCRIPT Pleurain-A1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 60 ug/ml) DME1788 XEOTICID XEO04630 GENEFORM Protein DME1788 XEOTICID XEO04630 MOACRIVE Inhibition DME1788 XEOTICID XEO04631 XEO_NAME Pleurain-A2 DME1788 XEOTICID XEO04631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04631 XEO_CLAS Peptide DME1788 XEOTICID XEO04631 DESCRIPT Pleurain-A2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 60 ug/ml) DME1788 XEOTICID XEO04631 GENEFORM Protein DME1788 XEOTICID XEO04631 MOACRIVE Inhibition DME1788 XEOTICID XEO04633 XEO_NAME Pleurain-C1 DME1788 XEOTICID XEO04633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04633 XEO_CLAS Peptide DME1788 XEOTICID XEO04633 DESCRIPT Pleurain-C1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 ug/ml) DME1788 XEOTICID XEO04633 GENEFORM Protein DME1788 XEOTICID XEO04633 MOACRIVE Inhibition DME1788 XEOTICID XEO04634 XEO_NAME Pleurain-D4 DME1788 XEOTICID XEO04634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04634 XEO_CLAS Peptide DME1788 XEOTICID XEO04634 DESCRIPT Pleurain-D4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 ug/ml) DME1788 XEOTICID XEO04634 GENEFORM Protein DME1788 XEOTICID XEO04634 MOACRIVE Inhibition DME1788 XEOTICID XEO04635 XEO_NAME Pleurain-E1 DME1788 XEOTICID XEO04635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04635 XEO_CLAS Peptide DME1788 XEOTICID XEO04635 DESCRIPT Pleurain-E1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 ug/ml) DME1788 XEOTICID XEO04635 GENEFORM Protein DME1788 XEOTICID XEO04635 MOACRIVE Inhibition DME1788 XEOTICID XEO04636 XEO_NAME Pleurain-G1 DME1788 XEOTICID XEO04636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04636 XEO_CLAS Peptide DME1788 XEOTICID XEO04636 DESCRIPT Pleurain-G1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 ug/ml) DME1788 XEOTICID XEO04636 GENEFORM Protein DME1788 XEOTICID XEO04636 MOACRIVE Inhibition DME1788 XEOTICID XEO04637 XEO_NAME Pleurain-J1 DME1788 XEOTICID XEO04637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04637 XEO_CLAS Peptide DME1788 XEOTICID XEO04637 DESCRIPT Pleurain-J1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 ug/ml) DME1788 XEOTICID XEO04637 GENEFORM Protein DME1788 XEOTICID XEO04637 MOACRIVE Inhibition DME1788 XEOTICID XEO04638 XEO_NAME Pleurain-N1 DME1788 XEOTICID XEO04638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04638 XEO_CLAS Peptide DME1788 XEOTICID XEO04638 DESCRIPT Pleurain-N1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 ug/ml) DME1788 XEOTICID XEO04638 GENEFORM Protein DME1788 XEOTICID XEO04638 MOACRIVE Inhibition DME1788 XEOTICID XEO04639 XEO_NAME Pleurain-R1 DME1788 XEOTICID XEO04639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04639 XEO_CLAS Peptide DME1788 XEOTICID XEO04639 DESCRIPT Pleurain-R1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 ug/ml) DME1788 XEOTICID XEO04639 GENEFORM Protein DME1788 XEOTICID XEO04639 MOACRIVE Inhibition DME1788 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1788 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04640 XEO_CLAS Peptide DME1788 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.2-3.3 microM) DME1788 XEOTICID XEO04640 GENEFORM Protein DME1788 XEOTICID XEO04640 MOACRIVE Inhibition DME1788 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1788 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04642 XEO_CLAS Peptide DME1788 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 ug/ml) DME1788 XEOTICID XEO04642 GENEFORM Protein DME1788 XEOTICID XEO04642 MOACRIVE Inhibition DME1788 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1788 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04643 XEO_CLAS Peptide DME1788 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO04643 GENEFORM Protein DME1788 XEOTICID XEO04643 MOACRIVE Inhibition DME1788 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1788 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04644 XEO_CLAS Peptide DME1788 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO04644 GENEFORM Protein DME1788 XEOTICID XEO04644 MOACRIVE Inhibition DME1788 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1788 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04645 XEO_CLAS Peptide DME1788 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 ug/ml) DME1788 XEOTICID XEO04645 GENEFORM Protein DME1788 XEOTICID XEO04645 MOACRIVE Inhibition DME1788 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1788 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04646 XEO_CLAS Peptide DME1788 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1 ug/ml) DME1788 XEOTICID XEO04646 GENEFORM Protein DME1788 XEOTICID XEO04646 MOACRIVE Inhibition DME1788 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1788 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04647 XEO_CLAS Peptide DME1788 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO04647 GENEFORM Protein DME1788 XEOTICID XEO04647 MOACRIVE Inhibition DME1788 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1788 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04648 XEO_CLAS Peptide DME1788 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 ug/ml) DME1788 XEOTICID XEO04648 GENEFORM Protein DME1788 XEOTICID XEO04648 MOACRIVE Inhibition DME1788 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1788 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04649 XEO_CLAS Peptide DME1788 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 64 ug/ml) DME1788 XEOTICID XEO04649 GENEFORM Protein DME1788 XEOTICID XEO04649 MOACRIVE Inhibition DME1788 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1788 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04650 XEO_CLAS Peptide DME1788 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 ug/ml) DME1788 XEOTICID XEO04650 GENEFORM Protein DME1788 XEOTICID XEO04650 MOACRIVE Inhibition DME1788 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1788 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04651 XEO_CLAS Peptide DME1788 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 ug/ml) DME1788 XEOTICID XEO04651 GENEFORM Protein DME1788 XEOTICID XEO04651 MOACRIVE Inhibition DME1788 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1788 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04652 XEO_CLAS Peptide DME1788 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO04652 GENEFORM Protein DME1788 XEOTICID XEO04652 MOACRIVE Inhibition DME1788 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1788 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04653 XEO_CLAS Peptide DME1788 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 64 ug/ml) DME1788 XEOTICID XEO04653 GENEFORM Protein DME1788 XEOTICID XEO04653 MOACRIVE Inhibition DME1788 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1788 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04654 XEO_CLAS Peptide DME1788 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 ug/ml) DME1788 XEOTICID XEO04654 GENEFORM Protein DME1788 XEOTICID XEO04654 MOACRIVE Inhibition DME1788 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1788 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04655 XEO_CLAS Peptide DME1788 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO04655 GENEFORM Protein DME1788 XEOTICID XEO04655 MOACRIVE Inhibition DME1788 XEOTICID XEO04657 XEO_NAME Porcine lactoferricin fragment pLf(20-29) DME1788 XEOTICID XEO04657 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04657 XEO_CLAS Peptide DME1788 XEOTICID XEO04657 DESCRIPT Porcine lactoferricin fragment pLf(20-29) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 300 microM) DME1788 XEOTICID XEO04657 GENEFORM Protein DME1788 XEOTICID XEO04657 MOACRIVE Inhibition DME1788 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1788 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04660 XEO_CLAS Peptide DME1788 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO04660 GENEFORM Protein DME1788 XEOTICID XEO04660 MOACRIVE Inhibition DME1788 XEOTICID XEO04661 XEO_NAME Peptide PMAP-36(1-20) DME1788 XEOTICID XEO04661 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04661 XEO_CLAS Peptide DME1788 XEOTICID XEO04661 DESCRIPT Peptide PMAP-36(1-20) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 microM) DME1788 XEOTICID XEO04661 GENEFORM Protein DME1788 XEOTICID XEO04661 MOACRIVE Inhibition DME1788 XEOTICID XEO04662 XEO_NAME Peptide PMAP-36(1-34) DME1788 XEOTICID XEO04662 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04662 XEO_CLAS Peptide DME1788 XEOTICID XEO04662 DESCRIPT Peptide PMAP-36(1-34) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 microM) DME1788 XEOTICID XEO04662 GENEFORM Protein DME1788 XEOTICID XEO04662 MOACRIVE Inhibition DME1788 XEOTICID XEO04663 XEO_NAME Peptide PMAP-36(1-35)2 DME1788 XEOTICID XEO04663 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04663 XEO_CLAS Peptide DME1788 XEOTICID XEO04663 DESCRIPT Peptide PMAP-36(1-35)2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 microM) DME1788 XEOTICID XEO04663 GENEFORM Protein DME1788 XEOTICID XEO04663 MOACRIVE Inhibition DME1788 XEOTICID XEO04664 XEO_NAME PMM analog PMM-1 DME1788 XEOTICID XEO04664 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04664 XEO_CLAS Peptide DME1788 XEOTICID XEO04664 DESCRIPT PMM analog PMM-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5.5 microM) DME1788 XEOTICID XEO04664 GENEFORM Protein DME1788 XEOTICID XEO04664 MOACRIVE Inhibition DME1788 XEOTICID XEO04665 XEO_NAME PMM analog PMM-10 DME1788 XEOTICID XEO04665 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04665 XEO_CLAS Peptide DME1788 XEOTICID XEO04665 DESCRIPT PMM analog PMM-10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 microM) DME1788 XEOTICID XEO04665 GENEFORM Protein DME1788 XEOTICID XEO04665 MOACRIVE Inhibition DME1788 XEOTICID XEO04666 XEO_NAME PMM analog PMM-11 DME1788 XEOTICID XEO04666 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04666 XEO_CLAS Peptide DME1788 XEOTICID XEO04666 DESCRIPT PMM analog PMM-11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO04666 GENEFORM Protein DME1788 XEOTICID XEO04666 MOACRIVE Inhibition DME1788 XEOTICID XEO04667 XEO_NAME PMM analog PMM-12 DME1788 XEOTICID XEO04667 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04667 XEO_CLAS Peptide DME1788 XEOTICID XEO04667 DESCRIPT PMM analog PMM-12 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6.25 microM) DME1788 XEOTICID XEO04667 GENEFORM Protein DME1788 XEOTICID XEO04667 MOACRIVE Inhibition DME1788 XEOTICID XEO04668 XEO_NAME PMM analog PMM-13 DME1788 XEOTICID XEO04668 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04668 XEO_CLAS Peptide DME1788 XEOTICID XEO04668 DESCRIPT PMM analog PMM-13 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 microM) DME1788 XEOTICID XEO04668 GENEFORM Protein DME1788 XEOTICID XEO04668 MOACRIVE Inhibition DME1788 XEOTICID XEO04669 XEO_NAME PMM analog PMM-14 DME1788 XEOTICID XEO04669 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04669 XEO_CLAS Peptide DME1788 XEOTICID XEO04669 DESCRIPT PMM analog PMM-14 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO04669 GENEFORM Protein DME1788 XEOTICID XEO04669 MOACRIVE Inhibition DME1788 XEOTICID XEO04670 XEO_NAME PMM analog PMM-2 DME1788 XEOTICID XEO04670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04670 XEO_CLAS Peptide DME1788 XEOTICID XEO04670 DESCRIPT PMM analog PMM-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 21 microM) DME1788 XEOTICID XEO04670 GENEFORM Protein DME1788 XEOTICID XEO04670 MOACRIVE Inhibition DME1788 XEOTICID XEO04671 XEO_NAME PMM analog PMM-3 DME1788 XEOTICID XEO04671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04671 XEO_CLAS Peptide DME1788 XEOTICID XEO04671 DESCRIPT PMM analog PMM-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 62 microM) DME1788 XEOTICID XEO04671 GENEFORM Protein DME1788 XEOTICID XEO04671 MOACRIVE Inhibition DME1788 XEOTICID XEO04672 XEO_NAME PMM analog PMM-4 DME1788 XEOTICID XEO04672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04672 XEO_CLAS Peptide DME1788 XEOTICID XEO04672 DESCRIPT PMM analog PMM-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO04672 GENEFORM Protein DME1788 XEOTICID XEO04672 MOACRIVE Inhibition DME1788 XEOTICID XEO04673 XEO_NAME PMM analog PMM-5 DME1788 XEOTICID XEO04673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04673 XEO_CLAS Peptide DME1788 XEOTICID XEO04673 DESCRIPT PMM analog PMM-5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO04673 GENEFORM Protein DME1788 XEOTICID XEO04673 MOACRIVE Inhibition DME1788 XEOTICID XEO04674 XEO_NAME PMM analog PMM-6 DME1788 XEOTICID XEO04674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04674 XEO_CLAS Peptide DME1788 XEOTICID XEO04674 DESCRIPT PMM analog PMM-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 75 microM) DME1788 XEOTICID XEO04674 GENEFORM Protein DME1788 XEOTICID XEO04674 MOACRIVE Inhibition DME1788 XEOTICID XEO04675 XEO_NAME PMM analog PMM-7 DME1788 XEOTICID XEO04675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04675 XEO_CLAS Peptide DME1788 XEOTICID XEO04675 DESCRIPT PMM analog PMM-7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 microM) DME1788 XEOTICID XEO04675 GENEFORM Protein DME1788 XEOTICID XEO04675 MOACRIVE Inhibition DME1788 XEOTICID XEO04676 XEO_NAME PMM analog PMM-8 DME1788 XEOTICID XEO04676 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04676 XEO_CLAS Peptide DME1788 XEOTICID XEO04676 DESCRIPT PMM analog PMM-8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 microM) DME1788 XEOTICID XEO04676 GENEFORM Protein DME1788 XEOTICID XEO04676 MOACRIVE Inhibition DME1788 XEOTICID XEO04677 XEO_NAME PMM analog PMM-9 DME1788 XEOTICID XEO04677 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04677 XEO_CLAS Peptide DME1788 XEOTICID XEO04677 DESCRIPT PMM analog PMM-9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO04677 GENEFORM Protein DME1788 XEOTICID XEO04677 MOACRIVE Inhibition DME1788 XEOTICID XEO04680 XEO_NAME Cathelicidin PobRL-37 DME1788 XEOTICID XEO04680 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04680 XEO_CLAS Peptide DME1788 XEOTICID XEO04680 DESCRIPT Cathelicidin PobRL-37 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 microM) DME1788 XEOTICID XEO04680 GENEFORM Protein DME1788 XEOTICID XEO04680 MOACRIVE Inhibition DME1788 XEOTICID XEO04682 XEO_NAME Insect polybia-MP-I DME1788 XEOTICID XEO04682 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04682 XEO_CLAS Peptide DME1788 XEOTICID XEO04682 DESCRIPT Insect polybia-MP-I inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 microM) DME1788 XEOTICID XEO04682 GENEFORM Protein DME1788 XEOTICID XEO04682 MOACRIVE Inhibition DME1788 XEOTICID XEO04683 XEO_NAME Insect polybia-MP-II DME1788 XEOTICID XEO04683 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04683 XEO_CLAS Peptide DME1788 XEOTICID XEO04683 DESCRIPT Insect polybia-MP-II inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 microM) DME1788 XEOTICID XEO04683 GENEFORM Protein DME1788 XEOTICID XEO04683 MOACRIVE Inhibition DME1788 XEOTICID XEO04684 XEO_NAME Insect polybia-MP-III DME1788 XEOTICID XEO04684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04684 XEO_CLAS Peptide DME1788 XEOTICID XEO04684 DESCRIPT Insect polybia-MP-III inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 38 microM) DME1788 XEOTICID XEO04684 GENEFORM Protein DME1788 XEOTICID XEO04684 MOACRIVE Inhibition DME1788 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1788 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04690 XEO_CLAS Peptide DME1788 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.5 ug/ml) DME1788 XEOTICID XEO04690 GENEFORM Protein DME1788 XEOTICID XEO04690 MOACRIVE Inhibition DME1788 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1788 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04695 XEO_CLAS Peptide DME1788 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04695 GENEFORM Protein DME1788 XEOTICID XEO04695 MOACRIVE Inhibition DME1788 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1788 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04696 XEO_CLAS Peptide DME1788 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04696 GENEFORM Protein DME1788 XEOTICID XEO04696 MOACRIVE Inhibition DME1788 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME1788 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04712 XEO_CLAS Peptide DME1788 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16.7 microM) DME1788 XEOTICID XEO04712 GENEFORM Protein DME1788 XEOTICID XEO04712 MOACRIVE Inhibition DME1788 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME1788 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04713 XEO_CLAS Peptide DME1788 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16.7 microM) DME1788 XEOTICID XEO04713 GENEFORM Protein DME1788 XEOTICID XEO04713 MOACRIVE Inhibition DME1788 XEOTICID XEO04714 XEO_NAME Pro-rich PP30 peptide DME1788 XEOTICID XEO04714 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04714 XEO_CLAS Peptide DME1788 XEOTICID XEO04714 DESCRIPT Pro-rich PP30 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 23.3 microM) DME1788 XEOTICID XEO04714 GENEFORM Protein DME1788 XEOTICID XEO04714 MOACRIVE Inhibition DME1788 XEOTICID XEO04716 XEO_NAME Prepromelittin-related peptide DME1788 XEOTICID XEO04716 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04716 XEO_CLAS Peptide DME1788 XEOTICID XEO04716 DESCRIPT Prepromelittin-related peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 microM) DME1788 XEOTICID XEO04716 GENEFORM Protein DME1788 XEOTICID XEO04716 MOACRIVE Inhibition DME1788 XEOTICID XEO04717 XEO_NAME Preprotemporin-1SKa DME1788 XEOTICID XEO04717 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04717 XEO_CLAS Peptide DME1788 XEOTICID XEO04717 DESCRIPT Preprotemporin-1SKa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 50 microM) DME1788 XEOTICID XEO04717 GENEFORM Protein DME1788 XEOTICID XEO04717 MOACRIVE Inhibition DME1788 XEOTICID XEO04725 XEO_NAME Prophenin-1 DME1788 XEOTICID XEO04725 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04725 XEO_CLAS Peptide DME1788 XEOTICID XEO04725 DESCRIPT Prophenin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04725 GENEFORM Protein DME1788 XEOTICID XEO04725 MOACRIVE Inhibition DME1788 XEOTICID XEO04726 XEO_NAME Prophenin-2 DME1788 XEOTICID XEO04726 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04726 XEO_CLAS Peptide DME1788 XEOTICID XEO04726 DESCRIPT Prophenin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04726 GENEFORM Protein DME1788 XEOTICID XEO04726 MOACRIVE Inhibition DME1788 XEOTICID XEO04731 XEO_NAME Protegrin-1 DME1788 XEOTICID XEO04731 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04731 XEO_CLAS Peptide DME1788 XEOTICID XEO04731 DESCRIPT Protegrin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 ug/ml) DME1788 XEOTICID XEO04731 GENEFORM Protein DME1788 XEOTICID XEO04731 MOACRIVE Inhibition DME1788 XEOTICID XEO04732 XEO_NAME Prostaglandin D2 DME1788 XEOTICID XEO04732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04732 XEO_CLAS Peptide DME1788 XEOTICID XEO04732 DESCRIPT Prostaglandin D2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 25 ug/ml) DME1788 XEOTICID XEO04732 GENEFORM Protein DME1788 XEOTICID XEO04732 MOACRIVE Inhibition DME1788 XEOTICID XEO04733 XEO_NAME Guanidine-3-propanol DME1788 XEOTICID XEO04733 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04733 XEO_CLAS Peptide DME1788 XEOTICID XEO04733 DESCRIPT Guanidine-3-propanol inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04733 GENEFORM Protein DME1788 XEOTICID XEO04733 MOACRIVE Inhibition DME1788 XEOTICID XEO04734 XEO_NAME Proteinase inhibitor PSKP-1 DME1788 XEOTICID XEO04734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04734 XEO_CLAS Peptide DME1788 XEOTICID XEO04734 DESCRIPT Proteinase inhibitor PSKP-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04734 GENEFORM Protein DME1788 XEOTICID XEO04734 MOACRIVE Inhibition DME1788 XEOTICID XEO04737 XEO_NAME Protonectin DME1788 XEOTICID XEO04737 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04737 XEO_CLAS Peptide DME1788 XEOTICID XEO04737 DESCRIPT Protonectin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 ug/ml) DME1788 XEOTICID XEO04737 GENEFORM Protein DME1788 XEOTICID XEO04737 MOACRIVE Inhibition DME1788 XEOTICID XEO04739 XEO_NAME Pseudin-1 DME1788 XEOTICID XEO04739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04739 XEO_CLAS Peptide DME1788 XEOTICID XEO04739 DESCRIPT Pseudin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04739 GENEFORM Protein DME1788 XEOTICID XEO04739 MOACRIVE Inhibition DME1788 XEOTICID XEO04740 XEO_NAME Pseudin-2 DME1788 XEOTICID XEO04740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04740 XEO_CLAS Peptide DME1788 XEOTICID XEO04740 DESCRIPT Pseudin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04740 GENEFORM Protein DME1788 XEOTICID XEO04740 MOACRIVE Inhibition DME1788 XEOTICID XEO04741 XEO_NAME Pseudin-3 DME1788 XEOTICID XEO04741 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04741 XEO_CLAS Peptide DME1788 XEOTICID XEO04741 DESCRIPT Pseudin-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04741 GENEFORM Protein DME1788 XEOTICID XEO04741 MOACRIVE Inhibition DME1788 XEOTICID XEO04742 XEO_NAME Pseudin-4 DME1788 XEOTICID XEO04742 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04742 XEO_CLAS Peptide DME1788 XEOTICID XEO04742 DESCRIPT Pseudin-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04742 GENEFORM Protein DME1788 XEOTICID XEO04742 MOACRIVE Inhibition DME1788 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1788 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04762 XEO_CLAS Peptide DME1788 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.8 microM) DME1788 XEOTICID XEO04762 GENEFORM Protein DME1788 XEOTICID XEO04762 MOACRIVE Inhibition DME1788 XEOTICID XEO04766 XEO_NAME Px-cec1 peptide DME1788 XEOTICID XEO04766 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04766 XEO_CLAS Peptide DME1788 XEOTICID XEO04766 DESCRIPT Px-cec1 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.1 microM) DME1788 XEOTICID XEO04766 GENEFORM Protein DME1788 XEOTICID XEO04766 MOACRIVE Inhibition DME1788 XEOTICID XEO04767 XEO_NAME Cecropin1 peptide derivative Px-cec1 DME1788 XEOTICID XEO04767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04767 XEO_CLAS Peptide DME1788 XEOTICID XEO04767 DESCRIPT Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.1 ug/ml) DME1788 XEOTICID XEO04767 GENEFORM Protein DME1788 XEOTICID XEO04767 MOACRIVE Inhibition DME1788 XEOTICID XEO04779 XEO_NAME R. prolixus defensin A DME1788 XEOTICID XEO04779 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04779 XEO_CLAS Peptide DME1788 XEOTICID XEO04779 DESCRIPT R. prolixus defensin A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04779 GENEFORM Protein DME1788 XEOTICID XEO04779 MOACRIVE Inhibition DME1788 XEOTICID XEO04780 XEO_NAME R. prolixus defensin B DME1788 XEOTICID XEO04780 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04780 XEO_CLAS Peptide DME1788 XEOTICID XEO04780 DESCRIPT R. prolixus defensin B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04780 GENEFORM Protein DME1788 XEOTICID XEO04780 MOACRIVE Inhibition DME1788 XEOTICID XEO04781 XEO_NAME R. prolixus defensin C DME1788 XEOTICID XEO04781 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04781 XEO_CLAS Peptide DME1788 XEOTICID XEO04781 DESCRIPT R. prolixus defensin C inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04781 GENEFORM Protein DME1788 XEOTICID XEO04781 MOACRIVE Inhibition DME1788 XEOTICID XEO04782 XEO_NAME Bac2A scrambled variant R10 DME1788 XEOTICID XEO04782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04782 XEO_CLAS Peptide DME1788 XEOTICID XEO04782 DESCRIPT Bac2A scrambled variant R10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 ug/ml) DME1788 XEOTICID XEO04782 GENEFORM Protein DME1788 XEOTICID XEO04782 MOACRIVE Inhibition DME1788 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1788 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04783 XEO_CLAS Peptide DME1788 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO04783 GENEFORM Protein DME1788 XEOTICID XEO04783 MOACRIVE Inhibition DME1788 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1788 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04784 XEO_CLAS Peptide DME1788 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO04784 GENEFORM Protein DME1788 XEOTICID XEO04784 MOACRIVE Inhibition DME1788 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1788 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04785 XEO_CLAS Peptide DME1788 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO04785 GENEFORM Protein DME1788 XEOTICID XEO04785 MOACRIVE Inhibition DME1788 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1788 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04786 XEO_CLAS Peptide DME1788 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 ug/ml) DME1788 XEOTICID XEO04786 GENEFORM Protein DME1788 XEOTICID XEO04786 MOACRIVE Inhibition DME1788 XEOTICID XEO04787 XEO_NAME Rabbit kidney defensin RK-2 DME1788 XEOTICID XEO04787 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04787 XEO_CLAS Peptide DME1788 XEOTICID XEO04787 DESCRIPT Rabbit kidney defensin RK-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04787 GENEFORM Protein DME1788 XEOTICID XEO04787 MOACRIVE Inhibition DME1788 XEOTICID XEO04793 XEO_NAME Ranacyclin-B-RL1 DME1788 XEOTICID XEO04793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04793 XEO_CLAS Peptide DME1788 XEOTICID XEO04793 DESCRIPT Ranacyclin-B-RL1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04793 GENEFORM Protein DME1788 XEOTICID XEO04793 MOACRIVE Inhibition DME1788 XEOTICID XEO04798 XEO_NAME Ranacyclin-T DME1788 XEOTICID XEO04798 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04798 XEO_CLAS Peptide DME1788 XEOTICID XEO04798 DESCRIPT Ranacyclin-T inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 microM) DME1788 XEOTICID XEO04798 GENEFORM Protein DME1788 XEOTICID XEO04798 MOACRIVE Inhibition DME1788 XEOTICID XEO04799 XEO_NAME Ranalexin DME1788 XEOTICID XEO04799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04799 XEO_CLAS Peptide DME1788 XEOTICID XEO04799 DESCRIPT Ranalexin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 32 ug/ml) DME1788 XEOTICID XEO04799 GENEFORM Protein DME1788 XEOTICID XEO04799 MOACRIVE Inhibition DME1788 XEOTICID XEO04800 XEO_NAME Ranalexin-1Ca DME1788 XEOTICID XEO04800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04800 XEO_CLAS Peptide DME1788 XEOTICID XEO04800 DESCRIPT Ranalexin-1Ca inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 microM) DME1788 XEOTICID XEO04800 GENEFORM Protein DME1788 XEOTICID XEO04800 MOACRIVE Inhibition DME1788 XEOTICID XEO04801 XEO_NAME Ranalexin-1G DME1788 XEOTICID XEO04801 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04801 XEO_CLAS Peptide DME1788 XEOTICID XEO04801 DESCRIPT Ranalexin-1G inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 9 microM) DME1788 XEOTICID XEO04801 GENEFORM Protein DME1788 XEOTICID XEO04801 MOACRIVE Inhibition DME1788 XEOTICID XEO04802 XEO_NAME Ranalexin-Vb DME1788 XEOTICID XEO04802 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04802 XEO_CLAS Peptide DME1788 XEOTICID XEO04802 DESCRIPT Ranalexin-Vb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12 microM) DME1788 XEOTICID XEO04802 GENEFORM Protein DME1788 XEOTICID XEO04802 MOACRIVE Inhibition DME1788 XEOTICID XEO04803 XEO_NAME Ranatuerin 2SKa DME1788 XEOTICID XEO04803 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04803 XEO_CLAS Peptide DME1788 XEOTICID XEO04803 DESCRIPT Ranatuerin 2SKa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO04803 GENEFORM Protein DME1788 XEOTICID XEO04803 MOACRIVE Inhibition DME1788 XEOTICID XEO04804 XEO_NAME Ranatuerin-1 DME1788 XEOTICID XEO04804 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04804 XEO_CLAS Peptide DME1788 XEOTICID XEO04804 DESCRIPT Ranatuerin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO04804 GENEFORM Protein DME1788 XEOTICID XEO04804 MOACRIVE Inhibition DME1788 XEOTICID XEO04805 XEO_NAME Ranatuerin-1C DME1788 XEOTICID XEO04805 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04805 XEO_CLAS Peptide DME1788 XEOTICID XEO04805 DESCRIPT Ranatuerin-1C inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.5 microM) DME1788 XEOTICID XEO04805 GENEFORM Protein DME1788 XEOTICID XEO04805 MOACRIVE Inhibition DME1788 XEOTICID XEO04806 XEO_NAME Ranatuerin-1Ga DME1788 XEOTICID XEO04806 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04806 XEO_CLAS Peptide DME1788 XEOTICID XEO04806 DESCRIPT Ranatuerin-1Ga inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.5 microM) DME1788 XEOTICID XEO04806 GENEFORM Protein DME1788 XEOTICID XEO04806 MOACRIVE Inhibition DME1788 XEOTICID XEO04807 XEO_NAME Ranatuerin-1T DME1788 XEOTICID XEO04807 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04807 XEO_CLAS Peptide DME1788 XEOTICID XEO04807 DESCRIPT Ranatuerin-1T inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04807 GENEFORM Protein DME1788 XEOTICID XEO04807 MOACRIVE Inhibition DME1788 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1788 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04809 XEO_CLAS Peptide DME1788 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 microM) DME1788 XEOTICID XEO04809 GENEFORM Protein DME1788 XEOTICID XEO04809 MOACRIVE Inhibition DME1788 XEOTICID XEO04811 XEO_NAME Ranatuerin-2B DME1788 XEOTICID XEO04811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04811 XEO_CLAS Peptide DME1788 XEOTICID XEO04811 DESCRIPT Ranatuerin-2B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO04811 GENEFORM Protein DME1788 XEOTICID XEO04811 MOACRIVE Inhibition DME1788 XEOTICID XEO04812 XEO_NAME Ranatuerin-2Cb DME1788 XEOTICID XEO04812 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04812 XEO_CLAS Peptide DME1788 XEOTICID XEO04812 DESCRIPT Ranatuerin-2Cb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO04812 GENEFORM Protein DME1788 XEOTICID XEO04812 MOACRIVE Inhibition DME1788 XEOTICID XEO04813 XEO_NAME Ranatuerin-2CSa DME1788 XEOTICID XEO04813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04813 XEO_CLAS Peptide DME1788 XEOTICID XEO04813 DESCRIPT Ranatuerin-2CSa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 microM) DME1788 XEOTICID XEO04813 GENEFORM Protein DME1788 XEOTICID XEO04813 MOACRIVE Inhibition DME1788 XEOTICID XEO04814 XEO_NAME Ranatuerin-2G DME1788 XEOTICID XEO04814 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04814 XEO_CLAS Peptide DME1788 XEOTICID XEO04814 DESCRIPT Ranatuerin-2G inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 19 microM) DME1788 XEOTICID XEO04814 GENEFORM Protein DME1788 XEOTICID XEO04814 MOACRIVE Inhibition DME1788 XEOTICID XEO04815 XEO_NAME Ranatuerin-2La DME1788 XEOTICID XEO04815 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04815 XEO_CLAS Peptide DME1788 XEOTICID XEO04815 DESCRIPT Ranatuerin-2La inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 microM) DME1788 XEOTICID XEO04815 GENEFORM Protein DME1788 XEOTICID XEO04815 MOACRIVE Inhibition DME1788 XEOTICID XEO04816 XEO_NAME Ranatuerin-2Lb DME1788 XEOTICID XEO04816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04816 XEO_CLAS Peptide DME1788 XEOTICID XEO04816 DESCRIPT Ranatuerin-2Lb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 microM) DME1788 XEOTICID XEO04816 GENEFORM Protein DME1788 XEOTICID XEO04816 MOACRIVE Inhibition DME1788 XEOTICID XEO04817 XEO_NAME Ranatuerin-2P DME1788 XEOTICID XEO04817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04817 XEO_CLAS Peptide DME1788 XEOTICID XEO04817 DESCRIPT Ranatuerin-2P inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 13 microM) DME1788 XEOTICID XEO04817 GENEFORM Protein DME1788 XEOTICID XEO04817 MOACRIVE Inhibition DME1788 XEOTICID XEO04818 XEO_NAME Ranatuerin-2PLa DME1788 XEOTICID XEO04818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04818 XEO_CLAS Peptide DME1788 XEOTICID XEO04818 DESCRIPT Ranatuerin-2PLa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO04818 GENEFORM Protein DME1788 XEOTICID XEO04818 MOACRIVE Inhibition DME1788 XEOTICID XEO04819 XEO_NAME Ranatuerin-2PLb DME1788 XEOTICID XEO04819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04819 XEO_CLAS Peptide DME1788 XEOTICID XEO04819 DESCRIPT Ranatuerin-2PLb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO04819 GENEFORM Protein DME1788 XEOTICID XEO04819 MOACRIVE Inhibition DME1788 XEOTICID XEO04820 XEO_NAME Ranatuerin-2PLc DME1788 XEOTICID XEO04820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04820 XEO_CLAS Peptide DME1788 XEOTICID XEO04820 DESCRIPT Ranatuerin-2PLc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3 microM) DME1788 XEOTICID XEO04820 GENEFORM Protein DME1788 XEOTICID XEO04820 MOACRIVE Inhibition DME1788 XEOTICID XEO04821 XEO_NAME Ranatuerin-2PLd DME1788 XEOTICID XEO04821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04821 XEO_CLAS Peptide DME1788 XEOTICID XEO04821 DESCRIPT Ranatuerin-2PLd inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 microM) DME1788 XEOTICID XEO04821 GENEFORM Protein DME1788 XEOTICID XEO04821 MOACRIVE Inhibition DME1788 XEOTICID XEO04822 XEO_NAME Ranatuerin-2PLe DME1788 XEOTICID XEO04822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04822 XEO_CLAS Peptide DME1788 XEOTICID XEO04822 DESCRIPT Ranatuerin-2PLe inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO04822 GENEFORM Protein DME1788 XEOTICID XEO04822 MOACRIVE Inhibition DME1788 XEOTICID XEO04823 XEO_NAME Ranatuerin-2PLf DME1788 XEOTICID XEO04823 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04823 XEO_CLAS Peptide DME1788 XEOTICID XEO04823 DESCRIPT Ranatuerin-2PLf inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 23 microM) DME1788 XEOTICID XEO04823 GENEFORM Protein DME1788 XEOTICID XEO04823 MOACRIVE Inhibition DME1788 XEOTICID XEO04824 XEO_NAME Ranatuerin-2SEB DME1788 XEOTICID XEO04824 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04824 XEO_CLAS Peptide DME1788 XEOTICID XEO04824 DESCRIPT Ranatuerin-2SEB inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04824 GENEFORM Protein DME1788 XEOTICID XEO04824 MOACRIVE Inhibition DME1788 XEOTICID XEO04825 XEO_NAME Ranatuerin-2SEC DME1788 XEOTICID XEO04825 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04825 XEO_CLAS Peptide DME1788 XEOTICID XEO04825 DESCRIPT Ranatuerin-2SEC inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04825 GENEFORM Protein DME1788 XEOTICID XEO04825 MOACRIVE Inhibition DME1788 XEOTICID XEO04826 XEO_NAME Ranatuerin-2Ya DME1788 XEOTICID XEO04826 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04826 XEO_CLAS Peptide DME1788 XEOTICID XEO04826 DESCRIPT Ranatuerin-2Ya inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO04826 GENEFORM Protein DME1788 XEOTICID XEO04826 MOACRIVE Inhibition DME1788 XEOTICID XEO04827 XEO_NAME Ranatuerin-2ZHa DME1788 XEOTICID XEO04827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04827 XEO_CLAS Peptide DME1788 XEOTICID XEO04827 DESCRIPT Ranatuerin-2ZHa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO04827 GENEFORM Protein DME1788 XEOTICID XEO04827 MOACRIVE Inhibition DME1788 XEOTICID XEO04835 XEO_NAME Ranatuerin-IIbYa DME1788 XEOTICID XEO04835 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04835 XEO_CLAS Peptide DME1788 XEOTICID XEO04835 DESCRIPT Ranatuerin-IIbYa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04835 GENEFORM Protein DME1788 XEOTICID XEO04835 MOACRIVE Inhibition DME1788 XEOTICID XEO04836 XEO_NAME Ranatuerin-IIbYb DME1788 XEOTICID XEO04836 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04836 XEO_CLAS Peptide DME1788 XEOTICID XEO04836 DESCRIPT Ranatuerin-IIbYb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04836 GENEFORM Protein DME1788 XEOTICID XEO04836 MOACRIVE Inhibition DME1788 XEOTICID XEO04837 XEO_NAME Raniseptin-1 DME1788 XEOTICID XEO04837 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04837 XEO_CLAS Peptide DME1788 XEOTICID XEO04837 DESCRIPT Raniseptin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 microM) DME1788 XEOTICID XEO04837 GENEFORM Protein DME1788 XEOTICID XEO04837 MOACRIVE Inhibition DME1788 XEOTICID XEO04839 XEO_NAME Cathelin-related antimicrobial peptide rCRAMP DME1788 XEOTICID XEO04839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04839 XEO_CLAS Peptide DME1788 XEOTICID XEO04839 DESCRIPT Cathelin-related antimicrobial peptide rCRAMP inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04839 GENEFORM Protein DME1788 XEOTICID XEO04839 MOACRIVE Inhibition DME1788 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1788 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04840 XEO_CLAS Peptide DME1788 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 35-20 microM) DME1788 XEOTICID XEO04840 GENEFORM Protein DME1788 XEOTICID XEO04840 MOACRIVE Inhibition DME1788 XEOTICID XEO04847 XEO_NAME Rhesus macaque oral alpha-defensins DME1788 XEOTICID XEO04847 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04847 XEO_CLAS Peptide DME1788 XEOTICID XEO04847 DESCRIPT Rhesus macaque oral alpha-defensins inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04847 GENEFORM Protein DME1788 XEOTICID XEO04847 MOACRIVE Inhibition DME1788 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1788 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04848 XEO_CLAS Peptide DME1788 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04848 GENEFORM Protein DME1788 XEOTICID XEO04848 MOACRIVE Inhibition DME1788 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1788 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04849 XEO_CLAS Peptide DME1788 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04849 GENEFORM Protein DME1788 XEOTICID XEO04849 MOACRIVE Inhibition DME1788 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1788 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04850 XEO_CLAS Peptide DME1788 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04850 GENEFORM Protein DME1788 XEOTICID XEO04850 MOACRIVE Inhibition DME1788 XEOTICID XEO04851 XEO_NAME Rhinocerosin DME1788 XEOTICID XEO04851 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04851 XEO_CLAS Peptide DME1788 XEOTICID XEO04851 DESCRIPT Rhinocerosin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1 ug/ml) DME1788 XEOTICID XEO04851 GENEFORM Protein DME1788 XEOTICID XEO04851 MOACRIVE Inhibition DME1788 XEOTICID XEO04857 XEO_NAME LL-37 derivative RK-31 DME1788 XEOTICID XEO04857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04857 XEO_CLAS Peptide DME1788 XEOTICID XEO04857 DESCRIPT LL-37 derivative RK-31 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 microM) DME1788 XEOTICID XEO04857 GENEFORM Protein DME1788 XEOTICID XEO04857 MOACRIVE Inhibition DME1788 XEOTICID XEO04863 XEO_NAME RTD peptide DME1788 XEOTICID XEO04863 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04863 XEO_CLAS Peptide DME1788 XEOTICID XEO04863 DESCRIPT RTD peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.0 microM) DME1788 XEOTICID XEO04863 GENEFORM Protein DME1788 XEOTICID XEO04863 MOACRIVE Inhibition DME1788 XEOTICID XEO04865 XEO_NAME Rugosin-A DME1788 XEOTICID XEO04865 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04865 XEO_CLAS Peptide DME1788 XEOTICID XEO04865 DESCRIPT Rugosin-A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 ug/ml) DME1788 XEOTICID XEO04865 GENEFORM Protein DME1788 XEOTICID XEO04865 MOACRIVE Inhibition DME1788 XEOTICID XEO04866 XEO_NAME Rugosin-B DME1788 XEOTICID XEO04866 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04866 XEO_CLAS Peptide DME1788 XEOTICID XEO04866 DESCRIPT Rugosin-B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12.5 ug/ml) DME1788 XEOTICID XEO04866 GENEFORM Protein DME1788 XEOTICID XEO04866 MOACRIVE Inhibition DME1788 XEOTICID XEO04868 XEO_NAME Rugosin-RN1 DME1788 XEOTICID XEO04868 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04868 XEO_CLAS Peptide DME1788 XEOTICID XEO04868 DESCRIPT Rugosin-RN1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25.00 ug/ml) DME1788 XEOTICID XEO04868 GENEFORM Protein DME1788 XEOTICID XEO04868 MOACRIVE Inhibition DME1788 XEOTICID XEO04869 XEO_NAME Rugosin-RN3 DME1788 XEOTICID XEO04869 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04869 XEO_CLAS Peptide DME1788 XEOTICID XEO04869 DESCRIPT Rugosin-RN3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25.00 ug/ml) DME1788 XEOTICID XEO04869 GENEFORM Protein DME1788 XEOTICID XEO04869 MOACRIVE Inhibition DME1788 XEOTICID XEO04870 XEO_NAME Rugosin-RN5 DME1788 XEOTICID XEO04870 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04870 XEO_CLAS Peptide DME1788 XEOTICID XEO04870 DESCRIPT Rugosin-RN5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25.00 ug/ml) DME1788 XEOTICID XEO04870 GENEFORM Protein DME1788 XEOTICID XEO04870 MOACRIVE Inhibition DME1788 XEOTICID XEO04877 XEO_NAME S. litura moricin DME1788 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04877 XEO_CLAS Peptide DME1788 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04877 GENEFORM Protein DME1788 XEOTICID XEO04877 MOACRIVE Inhibition DME1788 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1788 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04880 XEO_CLAS Peptide DME1788 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.5 ug/ml) DME1788 XEOTICID XEO04880 GENEFORM Protein DME1788 XEOTICID XEO04880 MOACRIVE Inhibition DME1788 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1788 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04886 XEO_CLAS Peptide DME1788 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.6 ug/ml) DME1788 XEOTICID XEO04886 GENEFORM Protein DME1788 XEOTICID XEO04886 MOACRIVE Inhibition DME1788 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1788 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04891 XEO_CLAS Peptide DME1788 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04891 GENEFORM Protein DME1788 XEOTICID XEO04891 MOACRIVE Inhibition DME1788 XEOTICID XEO04895 XEO_NAME Saha-CATH5 DME1788 XEOTICID XEO04895 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04895 XEO_CLAS Peptide DME1788 XEOTICID XEO04895 DESCRIPT Saha-CATH5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04895 GENEFORM Protein DME1788 XEOTICID XEO04895 MOACRIVE Inhibition DME1788 XEOTICID XEO04901 XEO_NAME SAMP H1 DME1788 XEOTICID XEO04901 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04901 XEO_CLAS Peptide DME1788 XEOTICID XEO04901 DESCRIPT SAMP H1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 microM) DME1788 XEOTICID XEO04901 GENEFORM Protein DME1788 XEOTICID XEO04901 MOACRIVE Inhibition DME1788 XEOTICID XEO04904 XEO_NAME Sapecin defensin DME1788 XEOTICID XEO04904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04904 XEO_CLAS Peptide DME1788 XEOTICID XEO04904 DESCRIPT Sapecin defensin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 78 ug/ml) DME1788 XEOTICID XEO04904 GENEFORM Protein DME1788 XEOTICID XEO04904 MOACRIVE Inhibition DME1788 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1788 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04905 XEO_CLAS Peptide DME1788 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04905 GENEFORM Protein DME1788 XEOTICID XEO04905 MOACRIVE Inhibition DME1788 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1788 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04906 XEO_CLAS Peptide DME1788 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04906 GENEFORM Protein DME1788 XEOTICID XEO04906 MOACRIVE Inhibition DME1788 XEOTICID XEO04907 XEO_NAME Sarcotoxin-1B DME1788 XEOTICID XEO04907 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04907 XEO_CLAS Peptide DME1788 XEOTICID XEO04907 DESCRIPT Sarcotoxin-1B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04907 GENEFORM Protein DME1788 XEOTICID XEO04907 MOACRIVE Inhibition DME1788 XEOTICID XEO04908 XEO_NAME Sarcotoxin-1C DME1788 XEOTICID XEO04908 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04908 XEO_CLAS Peptide DME1788 XEOTICID XEO04908 DESCRIPT Sarcotoxin-1C inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04908 GENEFORM Protein DME1788 XEOTICID XEO04908 MOACRIVE Inhibition DME1788 XEOTICID XEO04909 XEO_NAME Sarcotoxin-1D DME1788 XEOTICID XEO04909 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04909 XEO_CLAS Peptide DME1788 XEOTICID XEO04909 DESCRIPT Sarcotoxin-1D inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04909 GENEFORM Protein DME1788 XEOTICID XEO04909 MOACRIVE Inhibition DME1788 XEOTICID XEO04915 XEO_NAME Schmackerin-C1 DME1788 XEOTICID XEO04915 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04915 XEO_CLAS Peptide DME1788 XEOTICID XEO04915 DESCRIPT Schmackerin-C1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 100 ug/ml) DME1788 XEOTICID XEO04915 GENEFORM Protein DME1788 XEOTICID XEO04915 MOACRIVE Inhibition DME1788 XEOTICID XEO04916 XEO_NAME Scopoletin DME1788 XEOTICID XEO04916 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO04916 XEO_CLAS Investigative Agent DME1788 XEOTICID XEO04916 DESCRIPT Scopoletin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04916 GENEFORM Protein DME1788 XEOTICID XEO04916 MOACRIVE Inhibition DME1788 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1788 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04926 XEO_CLAS Peptide DME1788 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04926 GENEFORM Protein DME1788 XEOTICID XEO04926 MOACRIVE Inhibition DME1788 XEOTICID XEO04931 XEO_NAME Shepherin I DME1788 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04931 XEO_CLAS Peptide DME1788 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04931 GENEFORM Protein DME1788 XEOTICID XEO04931 MOACRIVE Inhibition DME1788 XEOTICID XEO04932 XEO_NAME shepherin II DME1788 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04932 XEO_CLAS Peptide DME1788 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04932 GENEFORM Protein DME1788 XEOTICID XEO04932 MOACRIVE Inhibition DME1788 XEOTICID XEO04938 XEO_NAME Signiferin-2.2 DME1788 XEOTICID XEO04938 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04938 XEO_CLAS Peptide DME1788 XEOTICID XEO04938 DESCRIPT Signiferin-2.2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC <= 100 microM) DME1788 XEOTICID XEO04938 GENEFORM Protein DME1788 XEOTICID XEO04938 MOACRIVE Inhibition DME1788 XEOTICID XEO04947 XEO_NAME Sinapic acid DME1788 XEOTICID XEO04947 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04947 XEO_CLAS Natural Product DME1788 XEOTICID XEO04947 DESCRIPT Sinapic acid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04947 GENEFORM Protein DME1788 XEOTICID XEO04947 MOACRIVE Inhibition DME1788 XEOTICID XEO04948 XEO_NAME Sinensetin DME1788 XEOTICID XEO04948 XEO_TYPE Health or Environmental Toxicant(s) DME1788 XEOTICID XEO04948 XEO_CLAS Acute Toxic Substance DME1788 XEOTICID XEO04948 DESCRIPT Sinensetin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04948 GENEFORM Protein DME1788 XEOTICID XEO04948 MOACRIVE Inhibition DME1788 XEOTICID XEO04950 XEO_NAME Skin peptide tyrosine-tyrosine DME1788 XEOTICID XEO04950 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04950 XEO_CLAS Peptide DME1788 XEOTICID XEO04950 DESCRIPT Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 ug/ml) DME1788 XEOTICID XEO04950 GENEFORM Protein DME1788 XEOTICID XEO04950 MOACRIVE Inhibition DME1788 XEOTICID XEO04955 XEO_NAME Cathelin-related peptide SC5 SMAP-29 DME1788 XEOTICID XEO04955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04955 XEO_CLAS Peptide DME1788 XEOTICID XEO04955 DESCRIPT Cathelin-related peptide SC5 SMAP-29 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.07 microM) DME1788 XEOTICID XEO04955 GENEFORM Protein DME1788 XEOTICID XEO04955 MOACRIVE Inhibition DME1788 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1788 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04956 XEO_CLAS Peptide DME1788 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16.0 microM) DME1788 XEOTICID XEO04956 GENEFORM Protein DME1788 XEOTICID XEO04956 MOACRIVE Inhibition DME1788 XEOTICID XEO04957 XEO_NAME Cathelicidin SMAP-34 DME1788 XEOTICID XEO04957 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04957 XEO_CLAS Peptide DME1788 XEOTICID XEO04957 DESCRIPT Cathelicidin SMAP-34 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.23 microM) DME1788 XEOTICID XEO04957 GENEFORM Protein DME1788 XEOTICID XEO04957 MOACRIVE Inhibition DME1788 XEOTICID XEO04958 XEO_NAME Scorpion Smp24 peptide DME1788 XEOTICID XEO04958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04958 XEO_CLAS Peptide DME1788 XEOTICID XEO04958 DESCRIPT Scorpion Smp24 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 ug/ml) DME1788 XEOTICID XEO04958 GENEFORM Protein DME1788 XEOTICID XEO04958 MOACRIVE Inhibition DME1788 XEOTICID XEO04959 XEO_NAME Scorpion Smp43 peptide DME1788 XEOTICID XEO04959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04959 XEO_CLAS Peptide DME1788 XEOTICID XEO04959 DESCRIPT Scorpion Smp43 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04959 GENEFORM Protein DME1788 XEOTICID XEO04959 MOACRIVE Inhibition DME1788 XEOTICID XEO04967 XEO_NAME Reptile sOT2 peptide DME1788 XEOTICID XEO04967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04967 XEO_CLAS Peptide DME1788 XEOTICID XEO04967 DESCRIPT Reptile sOT2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 28 microM) DME1788 XEOTICID XEO04967 GENEFORM Protein DME1788 XEOTICID XEO04967 MOACRIVE Inhibition DME1788 XEOTICID XEO04969 XEO_NAME Sperm associated antigen 11 isoform C DME1788 XEOTICID XEO04969 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04969 XEO_CLAS Peptide DME1788 XEOTICID XEO04969 DESCRIPT Sperm associated antigen 11 isoform C inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50-100 ug/ml) DME1788 XEOTICID XEO04969 GENEFORM Protein DME1788 XEOTICID XEO04969 MOACRIVE Inhibition DME1788 XEOTICID XEO04970 XEO_NAME Rodent sperm-associated antigen 11 DME1788 XEOTICID XEO04970 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04970 XEO_CLAS Peptide DME1788 XEOTICID XEO04970 DESCRIPT Rodent sperm-associated antigen 11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04970 GENEFORM Protein DME1788 XEOTICID XEO04970 MOACRIVE Inhibition DME1788 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1788 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04971 XEO_CLAS Peptide DME1788 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.8-1.5 microM) DME1788 XEOTICID XEO04971 GENEFORM Protein DME1788 XEOTICID XEO04971 MOACRIVE Inhibition DME1788 XEOTICID XEO04974 XEO_NAME Spinigerin DME1788 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04974 XEO_CLAS Peptide DME1788 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3-6 microM) DME1788 XEOTICID XEO04974 GENEFORM Protein DME1788 XEOTICID XEO04974 MOACRIVE Inhibition DME1788 XEOTICID XEO04975 XEO_NAME Amphimedon chloros sponge extract DME1788 XEOTICID XEO04975 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04975 XEO_CLAS Sponge Extract DME1788 XEOTICID XEO04975 DESCRIPT Amphimedon chloros sponge extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04975 GENEFORM Protein DME1788 XEOTICID XEO04975 MOACRIVE Inhibition DME1788 XEOTICID XEO04976 XEO_NAME Crella cyathophora sponge extract DME1788 XEOTICID XEO04976 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04976 XEO_CLAS Sponge Extract DME1788 XEOTICID XEO04976 DESCRIPT Crella cyathophora sponge extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04976 GENEFORM Protein DME1788 XEOTICID XEO04976 MOACRIVE Inhibition DME1788 XEOTICID XEO04977 XEO_NAME Diacarnus erythraenus sponge extract DME1788 XEOTICID XEO04977 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04977 XEO_CLAS Sponge Extract DME1788 XEOTICID XEO04977 DESCRIPT Diacarnus erythraenus sponge extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04977 GENEFORM Protein DME1788 XEOTICID XEO04977 MOACRIVE Inhibition DME1788 XEOTICID XEO04978 XEO_NAME Pione vastifica sponge extract DME1788 XEOTICID XEO04978 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04978 XEO_CLAS Sponge Extract DME1788 XEOTICID XEO04978 DESCRIPT Pione vastifica sponge extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04978 GENEFORM Protein DME1788 XEOTICID XEO04978 MOACRIVE Inhibition DME1788 XEOTICID XEO04979 XEO_NAME Sarcotragus sp sponge extract DME1788 XEOTICID XEO04979 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO04979 XEO_CLAS Sponge Extract DME1788 XEOTICID XEO04979 DESCRIPT Sarcotragus sp sponge extract inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04979 GENEFORM Protein DME1788 XEOTICID XEO04979 MOACRIVE Inhibition DME1788 XEOTICID XEO04981 XEO_NAME Syphaxin(1-16) DME1788 XEOTICID XEO04981 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04981 XEO_CLAS Peptide DME1788 XEOTICID XEO04981 DESCRIPT Syphaxin(1-16) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10.1 microM) DME1788 XEOTICID XEO04981 GENEFORM Protein DME1788 XEOTICID XEO04981 MOACRIVE Inhibition DME1788 XEOTICID XEO04982 XEO_NAME Syphaxin truncated peptide SPX(1-22) DME1788 XEOTICID XEO04982 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04982 XEO_CLAS Peptide DME1788 XEOTICID XEO04982 DESCRIPT Syphaxin truncated peptide SPX(1-22) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40.5 microM) DME1788 XEOTICID XEO04982 GENEFORM Protein DME1788 XEOTICID XEO04982 MOACRIVE Inhibition DME1788 XEOTICID XEO04994 XEO_NAME Stilbene DME1788 XEOTICID XEO04994 XEO_TYPE Health or Environmental Toxicant(s) DME1788 XEOTICID XEO04994 XEO_CLAS Environmental Pollutant DME1788 XEOTICID XEO04994 DESCRIPT Stilbene inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO04994 GENEFORM Protein DME1788 XEOTICID XEO04994 MOACRIVE Inhibition DME1788 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1788 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04995 XEO_CLAS Peptide DME1788 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC < 0.19 microM) DME1788 XEOTICID XEO04995 GENEFORM Protein DME1788 XEOTICID XEO04995 MOACRIVE Inhibition DME1788 XEOTICID XEO04998 XEO_NAME Styelin A DME1788 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04998 XEO_CLAS Peptide DME1788 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.7 ug/ml) DME1788 XEOTICID XEO04998 GENEFORM Protein DME1788 XEOTICID XEO04998 MOACRIVE Inhibition DME1788 XEOTICID XEO04999 XEO_NAME Styelin B DME1788 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO04999 XEO_CLAS Peptide DME1788 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.7 ug/ml) DME1788 XEOTICID XEO04999 GENEFORM Protein DME1788 XEOTICID XEO04999 MOACRIVE Inhibition DME1788 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1788 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05000 XEO_CLAS Peptide DME1788 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO05000 GENEFORM Protein DME1788 XEOTICID XEO05000 MOACRIVE Inhibition DME1788 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1788 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05001 XEO_CLAS Peptide DME1788 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.5 ug/ml) DME1788 XEOTICID XEO05001 GENEFORM Protein DME1788 XEOTICID XEO05001 MOACRIVE Inhibition DME1788 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1788 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05002 XEO_CLAS Peptide DME1788 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO05002 GENEFORM Protein DME1788 XEOTICID XEO05002 MOACRIVE Inhibition DME1788 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1788 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05003 XEO_CLAS Peptide DME1788 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO05003 GENEFORM Protein DME1788 XEOTICID XEO05003 MOACRIVE Inhibition DME1788 XEOTICID XEO05006 XEO_NAME Substance P DME1788 XEOTICID XEO05006 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05006 XEO_CLAS Peptide DME1788 XEOTICID XEO05006 DESCRIPT Substance P inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05006 GENEFORM Protein DME1788 XEOTICID XEO05006 MOACRIVE Inhibition DME1788 XEOTICID XEO05007 XEO_NAME substance P antagonist DME1788 XEOTICID XEO05007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05007 XEO_CLAS Peptide DME1788 XEOTICID XEO05007 DESCRIPT substance P antagonist inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05007 GENEFORM Protein DME1788 XEOTICID XEO05007 MOACRIVE Inhibition DME1788 XEOTICID XEO05008 XEO_NAME Subtilosin DME1788 XEOTICID XEO05008 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05008 XEO_CLAS Peptide DME1788 XEOTICID XEO05008 DESCRIPT Subtilosin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05008 GENEFORM Protein DME1788 XEOTICID XEO05008 MOACRIVE Inhibition DME1788 XEOTICID XEO05013 XEO_NAME Synthetic 1 DME1788 XEOTICID XEO05013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05013 XEO_CLAS Peptide DME1788 XEOTICID XEO05013 DESCRIPT Synthetic 1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO05013 GENEFORM Protein DME1788 XEOTICID XEO05013 MOACRIVE Inhibition DME1788 XEOTICID XEO05014 XEO_NAME Synthetic 2 DME1788 XEOTICID XEO05014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05014 XEO_CLAS Peptide DME1788 XEOTICID XEO05014 DESCRIPT Synthetic 2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO05014 GENEFORM Protein DME1788 XEOTICID XEO05014 MOACRIVE Inhibition DME1788 XEOTICID XEO05015 XEO_NAME Synthetic 3 DME1788 XEOTICID XEO05015 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05015 XEO_CLAS Peptide DME1788 XEOTICID XEO05015 DESCRIPT Synthetic 3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO05015 GENEFORM Protein DME1788 XEOTICID XEO05015 MOACRIVE Inhibition DME1788 XEOTICID XEO05016 XEO_NAME Synthetic 4 DME1788 XEOTICID XEO05016 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05016 XEO_CLAS Peptide DME1788 XEOTICID XEO05016 DESCRIPT Synthetic 4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO05016 GENEFORM Protein DME1788 XEOTICID XEO05016 MOACRIVE Inhibition DME1788 XEOTICID XEO05017 XEO_NAME Synthetic 5 DME1788 XEOTICID XEO05017 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05017 XEO_CLAS Peptide DME1788 XEOTICID XEO05017 DESCRIPT Synthetic 5 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 20 ug/ml) DME1788 XEOTICID XEO05017 GENEFORM Protein DME1788 XEOTICID XEO05017 MOACRIVE Inhibition DME1788 XEOTICID XEO05018 XEO_NAME Syringic acid DME1788 XEOTICID XEO05018 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO05018 XEO_CLAS Investigative Agent DME1788 XEOTICID XEO05018 DESCRIPT Syringic acid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05018 GENEFORM Protein DME1788 XEOTICID XEO05018 MOACRIVE Inhibition DME1788 XEOTICID XEO05020 XEO_NAME Tachycitin DME1788 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05020 XEO_CLAS Peptide DME1788 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05020 GENEFORM Protein DME1788 XEOTICID XEO05020 MOACRIVE Inhibition DME1788 XEOTICID XEO05023 XEO_NAME Tachystatin-A1 DME1788 XEOTICID XEO05023 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05023 XEO_CLAS Peptide DME1788 XEOTICID XEO05023 DESCRIPT Tachystatin-A1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05023 GENEFORM Protein DME1788 XEOTICID XEO05023 MOACRIVE Inhibition DME1788 XEOTICID XEO05024 XEO_NAME Tachystatin-A2 DME1788 XEOTICID XEO05024 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05024 XEO_CLAS Peptide DME1788 XEOTICID XEO05024 DESCRIPT Tachystatin-A2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05024 GENEFORM Protein DME1788 XEOTICID XEO05024 MOACRIVE Inhibition DME1788 XEOTICID XEO05027 XEO_NAME Tachystatin-C DME1788 XEOTICID XEO05027 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05027 XEO_CLAS Peptide DME1788 XEOTICID XEO05027 DESCRIPT Tachystatin-C inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05027 GENEFORM Protein DME1788 XEOTICID XEO05027 MOACRIVE Inhibition DME1788 XEOTICID XEO05031 XEO_NAME Tannic acid DME1788 XEOTICID XEO05031 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO05031 XEO_CLAS Investigative Agent DME1788 XEOTICID XEO05031 DESCRIPT Tannic acid inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05031 GENEFORM Protein DME1788 XEOTICID XEO05031 MOACRIVE Inhibition DME1788 XEOTICID XEO05033 XEO_NAME Turtle beta-defensin TBD-1 DME1788 XEOTICID XEO05033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05033 XEO_CLAS Peptide DME1788 XEOTICID XEO05033 DESCRIPT Turtle beta-defensin TBD-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05033 GENEFORM Protein DME1788 XEOTICID XEO05033 MOACRIVE Inhibition DME1788 XEOTICID XEO05042 XEO_NAME Temporin-1CEa DME1788 XEOTICID XEO05042 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05042 XEO_CLAS Peptide DME1788 XEOTICID XEO05042 DESCRIPT Temporin-1CEa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO05042 GENEFORM Protein DME1788 XEOTICID XEO05042 MOACRIVE Inhibition DME1788 XEOTICID XEO05043 XEO_NAME Temporin-1CEb DME1788 XEOTICID XEO05043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05043 XEO_CLAS Peptide DME1788 XEOTICID XEO05043 DESCRIPT Temporin-1CEb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO05043 GENEFORM Protein DME1788 XEOTICID XEO05043 MOACRIVE Inhibition DME1788 XEOTICID XEO05044 XEO_NAME Temporin-1CSb DME1788 XEOTICID XEO05044 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05044 XEO_CLAS Peptide DME1788 XEOTICID XEO05044 DESCRIPT Temporin-1CSb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 128 microM) DME1788 XEOTICID XEO05044 GENEFORM Protein DME1788 XEOTICID XEO05044 MOACRIVE Inhibition DME1788 XEOTICID XEO05045 XEO_NAME Temporin-1CSc DME1788 XEOTICID XEO05045 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05045 XEO_CLAS Peptide DME1788 XEOTICID XEO05045 DESCRIPT Temporin-1CSc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 128 microM) DME1788 XEOTICID XEO05045 GENEFORM Protein DME1788 XEOTICID XEO05045 MOACRIVE Inhibition DME1788 XEOTICID XEO05046 XEO_NAME Temporin-1CSd DME1788 XEOTICID XEO05046 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05046 XEO_CLAS Peptide DME1788 XEOTICID XEO05046 DESCRIPT Temporin-1CSd inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 microM) DME1788 XEOTICID XEO05046 GENEFORM Protein DME1788 XEOTICID XEO05046 MOACRIVE Inhibition DME1788 XEOTICID XEO05047 XEO_NAME Temporin-1DYa DME1788 XEOTICID XEO05047 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05047 XEO_CLAS Peptide DME1788 XEOTICID XEO05047 DESCRIPT Temporin-1DYa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 60 microM) DME1788 XEOTICID XEO05047 GENEFORM Protein DME1788 XEOTICID XEO05047 MOACRIVE Inhibition DME1788 XEOTICID XEO05051 XEO_NAME Temporin-1Ja DME1788 XEOTICID XEO05051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05051 XEO_CLAS Peptide DME1788 XEOTICID XEO05051 DESCRIPT Temporin-1Ja inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05051 GENEFORM Protein DME1788 XEOTICID XEO05051 MOACRIVE Inhibition DME1788 XEOTICID XEO05055 XEO_NAME Temporin-1Oa DME1788 XEOTICID XEO05055 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05055 XEO_CLAS Peptide DME1788 XEOTICID XEO05055 DESCRIPT Temporin-1Oa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 70 microM) DME1788 XEOTICID XEO05055 GENEFORM Protein DME1788 XEOTICID XEO05055 MOACRIVE Inhibition DME1788 XEOTICID XEO05056 XEO_NAME Temporin-1Ob DME1788 XEOTICID XEO05056 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05056 XEO_CLAS Peptide DME1788 XEOTICID XEO05056 DESCRIPT Temporin-1Ob inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05056 GENEFORM Protein DME1788 XEOTICID XEO05056 MOACRIVE Inhibition DME1788 XEOTICID XEO05059 XEO_NAME Amolopin-2b DME1788 XEOTICID XEO05059 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05059 XEO_CLAS Peptide DME1788 XEOTICID XEO05059 DESCRIPT Amolopin-2b inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05059 GENEFORM Protein DME1788 XEOTICID XEO05059 MOACRIVE Inhibition DME1788 XEOTICID XEO05061 XEO_NAME Temporin-1PRa DME1788 XEOTICID XEO05061 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05061 XEO_CLAS Peptide DME1788 XEOTICID XEO05061 DESCRIPT Temporin-1PRa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO05061 GENEFORM Protein DME1788 XEOTICID XEO05061 MOACRIVE Inhibition DME1788 XEOTICID XEO05062 XEO_NAME Temporin-1PRb DME1788 XEOTICID XEO05062 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05062 XEO_CLAS Peptide DME1788 XEOTICID XEO05062 DESCRIPT Temporin-1PRb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05062 GENEFORM Protein DME1788 XEOTICID XEO05062 MOACRIVE Inhibition DME1788 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1788 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05063 XEO_CLAS Peptide DME1788 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO05063 GENEFORM Protein DME1788 XEOTICID XEO05063 MOACRIVE Inhibition DME1788 XEOTICID XEO05064 XEO_NAME Temporin-1Sb DME1788 XEOTICID XEO05064 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05064 XEO_CLAS Peptide DME1788 XEOTICID XEO05064 DESCRIPT Temporin-1Sb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 231 microM) DME1788 XEOTICID XEO05064 GENEFORM Protein DME1788 XEOTICID XEO05064 MOACRIVE Inhibition DME1788 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1788 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05065 XEO_CLAS Peptide DME1788 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 161 ug/ml) DME1788 XEOTICID XEO05065 GENEFORM Protein DME1788 XEOTICID XEO05065 MOACRIVE Inhibition DME1788 XEOTICID XEO05069 XEO_NAME Temporin-1TGa DME1788 XEOTICID XEO05069 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05069 XEO_CLAS Peptide DME1788 XEOTICID XEO05069 DESCRIPT Temporin-1TGa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO05069 GENEFORM Protein DME1788 XEOTICID XEO05069 MOACRIVE Inhibition DME1788 XEOTICID XEO05070 XEO_NAME Temporin-1TGb DME1788 XEOTICID XEO05070 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05070 XEO_CLAS Peptide DME1788 XEOTICID XEO05070 DESCRIPT Temporin-1TGb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 37.5 microM) DME1788 XEOTICID XEO05070 GENEFORM Protein DME1788 XEOTICID XEO05070 MOACRIVE Inhibition DME1788 XEOTICID XEO05071 XEO_NAME Temporin-1TGc DME1788 XEOTICID XEO05071 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05071 XEO_CLAS Peptide DME1788 XEOTICID XEO05071 DESCRIPT Temporin-1TGc inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 150 microM) DME1788 XEOTICID XEO05071 GENEFORM Protein DME1788 XEOTICID XEO05071 MOACRIVE Inhibition DME1788 XEOTICID XEO05072 XEO_NAME Temporin-1TSa DME1788 XEOTICID XEO05072 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05072 XEO_CLAS Peptide DME1788 XEOTICID XEO05072 DESCRIPT Temporin-1TSa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO05072 GENEFORM Protein DME1788 XEOTICID XEO05072 MOACRIVE Inhibition DME1788 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1788 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05073 XEO_CLAS Peptide DME1788 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40 microM) DME1788 XEOTICID XEO05073 GENEFORM Protein DME1788 XEOTICID XEO05073 MOACRIVE Inhibition DME1788 XEOTICID XEO05076 XEO_NAME Temporin-A DME1788 XEOTICID XEO05076 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05076 XEO_CLAS Peptide DME1788 XEOTICID XEO05076 DESCRIPT Temporin-A inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 11.9 microM) DME1788 XEOTICID XEO05076 GENEFORM Protein DME1788 XEOTICID XEO05076 MOACRIVE Inhibition DME1788 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME1788 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05077 XEO_CLAS Peptide DME1788 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.25 ug/ml) DME1788 XEOTICID XEO05077 GENEFORM Protein DME1788 XEOTICID XEO05077 MOACRIVE Inhibition DME1788 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME1788 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05078 XEO_CLAS Peptide DME1788 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.25 ug/ml) DME1788 XEOTICID XEO05078 GENEFORM Protein DME1788 XEOTICID XEO05078 MOACRIVE Inhibition DME1788 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME1788 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05079 XEO_CLAS Peptide DME1788 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.5 ug/ml) DME1788 XEOTICID XEO05079 GENEFORM Protein DME1788 XEOTICID XEO05079 MOACRIVE Inhibition DME1788 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME1788 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05080 XEO_CLAS Peptide DME1788 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 ug/ml) DME1788 XEOTICID XEO05080 GENEFORM Protein DME1788 XEOTICID XEO05080 MOACRIVE Inhibition DME1788 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME1788 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05081 XEO_CLAS Peptide DME1788 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 5 ug/ml) DME1788 XEOTICID XEO05081 GENEFORM Protein DME1788 XEOTICID XEO05081 MOACRIVE Inhibition DME1788 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME1788 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05082 XEO_CLAS Peptide DME1788 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 7.5 ug/ml) DME1788 XEOTICID XEO05082 GENEFORM Protein DME1788 XEOTICID XEO05082 MOACRIVE Inhibition DME1788 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME1788 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05083 XEO_CLAS Peptide DME1788 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 ug/ml) DME1788 XEOTICID XEO05083 GENEFORM Protein DME1788 XEOTICID XEO05083 MOACRIVE Inhibition DME1788 XEOTICID XEO05084 XEO_NAME Temporin-ALk DME1788 XEOTICID XEO05084 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05084 XEO_CLAS Peptide DME1788 XEOTICID XEO05084 DESCRIPT Temporin-ALk inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 ug/ml) DME1788 XEOTICID XEO05084 GENEFORM Protein DME1788 XEOTICID XEO05084 MOACRIVE Inhibition DME1788 XEOTICID XEO05085 XEO_NAME Temporin-B DME1788 XEOTICID XEO05085 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05085 XEO_CLAS Peptide DME1788 XEOTICID XEO05085 DESCRIPT Temporin-B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 21.0 ug/ml) DME1788 XEOTICID XEO05085 GENEFORM Protein DME1788 XEOTICID XEO05085 MOACRIVE Inhibition DME1788 XEOTICID XEO05086 XEO_NAME Temporin-CDYb DME1788 XEOTICID XEO05086 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05086 XEO_CLAS Peptide DME1788 XEOTICID XEO05086 DESCRIPT Temporin-CDYb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC > 100 microM) DME1788 XEOTICID XEO05086 GENEFORM Protein DME1788 XEOTICID XEO05086 MOACRIVE Inhibition DME1788 XEOTICID XEO05087 XEO_NAME Temporin-CPa DME1788 XEOTICID XEO05087 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05087 XEO_CLAS Peptide DME1788 XEOTICID XEO05087 DESCRIPT Temporin-CPa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO05087 GENEFORM Protein DME1788 XEOTICID XEO05087 MOACRIVE Inhibition DME1788 XEOTICID XEO05097 XEO_NAME Temporin-PE DME1788 XEOTICID XEO05097 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05097 XEO_CLAS Peptide DME1788 XEOTICID XEO05097 DESCRIPT Temporin-PE inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16.0 microM) DME1788 XEOTICID XEO05097 GENEFORM Protein DME1788 XEOTICID XEO05097 MOACRIVE Inhibition DME1788 XEOTICID XEO05099 XEO_NAME Temporin-PEb DME1788 XEOTICID XEO05099 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05099 XEO_CLAS Peptide DME1788 XEOTICID XEO05099 DESCRIPT Temporin-PEb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.0 microM) DME1788 XEOTICID XEO05099 GENEFORM Protein DME1788 XEOTICID XEO05099 MOACRIVE Inhibition DME1788 XEOTICID XEO05100 XEO_NAME Temporin-PTa DME1788 XEOTICID XEO05100 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05100 XEO_CLAS Peptide DME1788 XEOTICID XEO05100 DESCRIPT Temporin-PTa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05100 GENEFORM Protein DME1788 XEOTICID XEO05100 MOACRIVE Inhibition DME1788 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1788 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05101 XEO_CLAS Peptide DME1788 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 24.2 ug/ml) DME1788 XEOTICID XEO05101 GENEFORM Protein DME1788 XEOTICID XEO05101 MOACRIVE Inhibition DME1788 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1788 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05102 XEO_CLAS Peptide DME1788 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 34.5 ug/ml) DME1788 XEOTICID XEO05102 GENEFORM Protein DME1788 XEOTICID XEO05102 MOACRIVE Inhibition DME1788 XEOTICID XEO05105 XEO_NAME Temporin-SHa DME1788 XEOTICID XEO05105 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05105 XEO_CLAS Peptide DME1788 XEOTICID XEO05105 DESCRIPT Temporin-SHa inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO05105 GENEFORM Protein DME1788 XEOTICID XEO05105 MOACRIVE Inhibition DME1788 XEOTICID XEO05106 XEO_NAME Temporin-SHf DME1788 XEOTICID XEO05106 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05106 XEO_CLAS Peptide DME1788 XEOTICID XEO05106 DESCRIPT Temporin-SHf inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25-200 microM) DME1788 XEOTICID XEO05106 GENEFORM Protein DME1788 XEOTICID XEO05106 MOACRIVE Inhibition DME1788 XEOTICID XEO05108 XEO_NAME Tepmporin-1Ee DME1788 XEOTICID XEO05108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05108 XEO_CLAS Peptide DME1788 XEOTICID XEO05108 DESCRIPT Tepmporin-1Ee inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40 microM) DME1788 XEOTICID XEO05108 GENEFORM Protein DME1788 XEOTICID XEO05108 MOACRIVE Inhibition DME1788 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME1788 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1788 XEOTICID XEO05111 XEO_CLAS Natural Product DME1788 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05111 GENEFORM Protein DME1788 XEOTICID XEO05111 MOACRIVE Inhibition DME1788 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1788 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05119 XEO_CLAS Peptide DME1788 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05119 GENEFORM Protein DME1788 XEOTICID XEO05119 MOACRIVE Inhibition DME1788 XEOTICID XEO05120 XEO_NAME Thanatin DME1788 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05120 XEO_CLAS Peptide DME1788 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.3-0.6 microM) DME1788 XEOTICID XEO05120 GENEFORM Protein DME1788 XEOTICID XEO05120 MOACRIVE Inhibition DME1788 XEOTICID XEO05121 XEO_NAME Thaulin-1 DME1788 XEOTICID XEO05121 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05121 XEO_CLAS Peptide DME1788 XEOTICID XEO05121 DESCRIPT Thaulin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 62.5 ug/ml) DME1788 XEOTICID XEO05121 GENEFORM Protein DME1788 XEOTICID XEO05121 MOACRIVE Inhibition DME1788 XEOTICID XEO05125 XEO_NAME Arthropods theromacin DME1788 XEOTICID XEO05125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05125 XEO_CLAS Peptide DME1788 XEOTICID XEO05125 DESCRIPT Arthropods theromacin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05125 GENEFORM Protein DME1788 XEOTICID XEO05125 MOACRIVE Inhibition DME1788 XEOTICID XEO05130 XEO_NAME Thionin-like peptide 1 DME1788 XEOTICID XEO05130 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05130 XEO_CLAS Peptide DME1788 XEOTICID XEO05130 DESCRIPT Thionin-like peptide 1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05130 GENEFORM Protein DME1788 XEOTICID XEO05130 MOACRIVE Inhibition DME1788 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1788 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05144 XEO_CLAS Peptide DME1788 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40 ug/ml) DME1788 XEOTICID XEO05144 GENEFORM Protein DME1788 XEOTICID XEO05144 MOACRIVE Inhibition DME1788 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1788 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05145 XEO_CLAS Peptide DME1788 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 ug/ml) DME1788 XEOTICID XEO05145 GENEFORM Protein DME1788 XEOTICID XEO05145 MOACRIVE Inhibition DME1788 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1788 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05146 XEO_CLAS Peptide DME1788 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 40 ug/ml) DME1788 XEOTICID XEO05146 GENEFORM Protein DME1788 XEOTICID XEO05146 MOACRIVE Inhibition DME1788 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1788 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05147 XEO_CLAS Peptide DME1788 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 60 ug/ml) DME1788 XEOTICID XEO05147 GENEFORM Protein DME1788 XEOTICID XEO05147 MOACRIVE Inhibition DME1788 XEOTICID XEO05158 XEO_NAME Tomato Snakin-2 DME1788 XEOTICID XEO05158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05158 XEO_CLAS Peptide DME1788 XEOTICID XEO05158 DESCRIPT Tomato Snakin-2 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05158 GENEFORM Protein DME1788 XEOTICID XEO05158 MOACRIVE Inhibition DME1788 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1788 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05161 XEO_CLAS Peptide DME1788 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 32 ug/ml) DME1788 XEOTICID XEO05161 GENEFORM Protein DME1788 XEOTICID XEO05161 MOACRIVE Inhibition DME1788 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1788 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05162 XEO_CLAS Peptide DME1788 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 32 ug/ml) DME1788 XEOTICID XEO05162 GENEFORM Protein DME1788 XEOTICID XEO05162 MOACRIVE Inhibition DME1788 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1788 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05163 XEO_CLAS Peptide DME1788 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 12-25 ug/ml) DME1788 XEOTICID XEO05163 GENEFORM Protein DME1788 XEOTICID XEO05163 MOACRIVE Inhibition DME1788 XEOTICID XEO05170 XEO_NAME Tricystine cyclic cystine TP DME1788 XEOTICID XEO05170 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05170 XEO_CLAS Peptide DME1788 XEOTICID XEO05170 DESCRIPT Tricystine cyclic cystine TP inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 3.0 microM) DME1788 XEOTICID XEO05170 GENEFORM Protein DME1788 XEOTICID XEO05170 MOACRIVE Inhibition DME1788 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1788 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05171 XEO_CLAS Peptide DME1788 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 50 microM) DME1788 XEOTICID XEO05171 GENEFORM Protein DME1788 XEOTICID XEO05171 MOACRIVE Inhibition DME1788 XEOTICID XEO05179 XEO_NAME Tritrpticin DME1788 XEOTICID XEO05179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05179 XEO_CLAS Peptide DME1788 XEOTICID XEO05179 DESCRIPT Tritrpticin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05179 GENEFORM Protein DME1788 XEOTICID XEO05179 MOACRIVE Inhibition DME1788 XEOTICID XEO05180 XEO_NAME T. serrulatus antimicrobial peptide TsAP-1 DME1788 XEOTICID XEO05180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05180 XEO_CLAS Peptide DME1788 XEOTICID XEO05180 DESCRIPT T. serrulatus antimicrobial peptide TsAP-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 160 microM) DME1788 XEOTICID XEO05180 GENEFORM Protein DME1788 XEOTICID XEO05180 MOACRIVE Inhibition DME1788 XEOTICID XEO05182 XEO_NAME Ixosin-B peptide derivative TSG-10 DME1788 XEOTICID XEO05182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05182 XEO_CLAS Peptide DME1788 XEOTICID XEO05182 DESCRIPT Ixosin-B peptide derivative TSG-10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 microM) DME1788 XEOTICID XEO05182 GENEFORM Protein DME1788 XEOTICID XEO05182 MOACRIVE Inhibition DME1788 XEOTICID XEO05183 XEO_NAME Ixosin-B peptide derivative TSG-11 DME1788 XEOTICID XEO05183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05183 XEO_CLAS Peptide DME1788 XEOTICID XEO05183 DESCRIPT Ixosin-B peptide derivative TSG-11 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 microM) DME1788 XEOTICID XEO05183 GENEFORM Protein DME1788 XEOTICID XEO05183 MOACRIVE Inhibition DME1788 XEOTICID XEO05184 XEO_NAME Ixosin-B peptide derivative TSG-6 DME1788 XEOTICID XEO05184 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05184 XEO_CLAS Peptide DME1788 XEOTICID XEO05184 DESCRIPT Ixosin-B peptide derivative TSG-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 microM) DME1788 XEOTICID XEO05184 GENEFORM Protein DME1788 XEOTICID XEO05184 MOACRIVE Inhibition DME1788 XEOTICID XEO05185 XEO_NAME Ixosin-B peptide derivative TSG-7 DME1788 XEOTICID XEO05185 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05185 XEO_CLAS Peptide DME1788 XEOTICID XEO05185 DESCRIPT Ixosin-B peptide derivative TSG-7 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 microM) DME1788 XEOTICID XEO05185 GENEFORM Protein DME1788 XEOTICID XEO05185 MOACRIVE Inhibition DME1788 XEOTICID XEO05186 XEO_NAME Ixosin-B peptide derivative TSG-8 DME1788 XEOTICID XEO05186 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05186 XEO_CLAS Peptide DME1788 XEOTICID XEO05186 DESCRIPT Ixosin-B peptide derivative TSG-8 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 microM) DME1788 XEOTICID XEO05186 GENEFORM Protein DME1788 XEOTICID XEO05186 MOACRIVE Inhibition DME1788 XEOTICID XEO05187 XEO_NAME Ixosin-B peptide derivative TSG-8-1 DME1788 XEOTICID XEO05187 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05187 XEO_CLAS Peptide DME1788 XEOTICID XEO05187 DESCRIPT Ixosin-B peptide derivative TSG-8-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16 microM) DME1788 XEOTICID XEO05187 GENEFORM Protein DME1788 XEOTICID XEO05187 MOACRIVE Inhibition DME1788 XEOTICID XEO05188 XEO_NAME Ixosin-B peptide derivative TSG-9 DME1788 XEOTICID XEO05188 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05188 XEO_CLAS Peptide DME1788 XEOTICID XEO05188 DESCRIPT Ixosin-B peptide derivative TSG-9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 64 microM) DME1788 XEOTICID XEO05188 GENEFORM Protein DME1788 XEOTICID XEO05188 MOACRIVE Inhibition DME1788 XEOTICID XEO05190 XEO_NAME Turkey Heterophil Peptide 1 DME1788 XEOTICID XEO05190 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05190 XEO_CLAS Peptide DME1788 XEOTICID XEO05190 DESCRIPT Turkey Heterophil Peptide 1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05190 GENEFORM Protein DME1788 XEOTICID XEO05190 MOACRIVE Inhibition DME1788 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1788 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05193 XEO_CLAS Peptide DME1788 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO05193 GENEFORM Protein DME1788 XEOTICID XEO05193 MOACRIVE Inhibition DME1788 XEOTICID XEO05197 XEO_NAME Scorpion Um4 peptide DME1788 XEOTICID XEO05197 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05197 XEO_CLAS Peptide DME1788 XEOTICID XEO05197 DESCRIPT Scorpion Um4 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05197 GENEFORM Protein DME1788 XEOTICID XEO05197 MOACRIVE Inhibition DME1788 XEOTICID XEO05205 XEO_NAME Scorpion Uy192 peptide DME1788 XEOTICID XEO05205 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05205 XEO_CLAS Peptide DME1788 XEOTICID XEO05205 DESCRIPT Scorpion Uy192 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05205 GENEFORM Protein DME1788 XEOTICID XEO05205 MOACRIVE Inhibition DME1788 XEOTICID XEO05206 XEO_NAME Arthropod UyCT1 peptide DME1788 XEOTICID XEO05206 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05206 XEO_CLAS Peptide DME1788 XEOTICID XEO05206 DESCRIPT Arthropod UyCT1 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 10 microM) DME1788 XEOTICID XEO05206 GENEFORM Protein DME1788 XEOTICID XEO05206 MOACRIVE Inhibition DME1788 XEOTICID XEO05207 XEO_NAME Arthropod UyCT2 peptide DME1788 XEOTICID XEO05207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05207 XEO_CLAS Peptide DME1788 XEOTICID XEO05207 DESCRIPT Arthropod UyCT2 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 25 microM) DME1788 XEOTICID XEO05207 GENEFORM Protein DME1788 XEOTICID XEO05207 MOACRIVE Inhibition DME1788 XEOTICID XEO05208 XEO_NAME Arthropod UyCT3 peptide DME1788 XEOTICID XEO05208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05208 XEO_CLAS Peptide DME1788 XEOTICID XEO05208 DESCRIPT Arthropod UyCT3 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 microM) DME1788 XEOTICID XEO05208 GENEFORM Protein DME1788 XEOTICID XEO05208 MOACRIVE Inhibition DME1788 XEOTICID XEO05209 XEO_NAME Arthropod UyCT5 peptide DME1788 XEOTICID XEO05209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05209 XEO_CLAS Peptide DME1788 XEOTICID XEO05209 DESCRIPT Arthropod UyCT5 peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 15 microM) DME1788 XEOTICID XEO05209 GENEFORM Protein DME1788 XEOTICID XEO05209 MOACRIVE Inhibition DME1788 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1788 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05212 XEO_CLAS Peptide DME1788 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.5 ug/ml) DME1788 XEOTICID XEO05212 GENEFORM Protein DME1788 XEOTICID XEO05212 MOACRIVE Inhibition DME1788 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1788 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05220 XEO_CLAS Peptide DME1788 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.6-1.2 microM) DME1788 XEOTICID XEO05220 GENEFORM Protein DME1788 XEOTICID XEO05220 MOACRIVE Inhibition DME1788 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1788 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05230 XEO_CLAS Peptide DME1788 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 7.90 microM) DME1788 XEOTICID XEO05230 GENEFORM Protein DME1788 XEOTICID XEO05230 MOACRIVE Inhibition DME1788 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1788 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05231 XEO_CLAS Peptide DME1788 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2.40 microM) DME1788 XEOTICID XEO05231 GENEFORM Protein DME1788 XEOTICID XEO05231 MOACRIVE Inhibition DME1788 XEOTICID XEO05232 XEO_NAME Venom peptide 2-long DME1788 XEOTICID XEO05232 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05232 XEO_CLAS Peptide DME1788 XEOTICID XEO05232 DESCRIPT Venom peptide 2-long inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05232 GENEFORM Protein DME1788 XEOTICID XEO05232 MOACRIVE Inhibition DME1788 XEOTICID XEO05233 XEO_NAME Vespid chemotactic peptide 5e DME1788 XEOTICID XEO05233 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05233 XEO_CLAS Peptide DME1788 XEOTICID XEO05233 DESCRIPT Vespid chemotactic peptide 5e inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 ug/ml) DME1788 XEOTICID XEO05233 GENEFORM Protein DME1788 XEOTICID XEO05233 MOACRIVE Inhibition DME1788 XEOTICID XEO05234 XEO_NAME Vespid chemotactic peptide 5f DME1788 XEOTICID XEO05234 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05234 XEO_CLAS Peptide DME1788 XEOTICID XEO05234 DESCRIPT Vespid chemotactic peptide 5f inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 ug/ml) DME1788 XEOTICID XEO05234 GENEFORM Protein DME1788 XEOTICID XEO05234 MOACRIVE Inhibition DME1788 XEOTICID XEO05235 XEO_NAME Vespid chemotactic peptide 5g DME1788 XEOTICID XEO05235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05235 XEO_CLAS Peptide DME1788 XEOTICID XEO05235 DESCRIPT Vespid chemotactic peptide 5g inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 30 ug/ml) DME1788 XEOTICID XEO05235 GENEFORM Protein DME1788 XEOTICID XEO05235 MOACRIVE Inhibition DME1788 XEOTICID XEO05237 XEO_NAME VG16KRKP peptide DME1788 XEOTICID XEO05237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05237 XEO_CLAS Peptide DME1788 XEOTICID XEO05237 DESCRIPT VG16KRKP peptide inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 microM) DME1788 XEOTICID XEO05237 GENEFORM Protein DME1788 XEOTICID XEO05237 MOACRIVE Inhibition DME1788 XEOTICID XEO05245 XEO_NAME Viresin DME1788 XEOTICID XEO05245 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05245 XEO_CLAS Peptide DME1788 XEOTICID XEO05245 DESCRIPT Viresin inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05245 GENEFORM Protein DME1788 XEOTICID XEO05245 MOACRIVE Inhibition DME1788 XEOTICID XEO05248 XEO_NAME Vitamin C DME1788 XEOTICID XEO05248 XEO_TYPE Pharmaceutical Agent(s) DME1788 XEOTICID XEO05248 XEO_CLAS Approved/Marketed Drug DME1788 XEOTICID XEO05248 DESCRIPT Vitamin C inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05248 GENEFORM Protein DME1788 XEOTICID XEO05248 MOACRIVE Inhibition DME1788 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1788 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05264 XEO_CLAS Peptide DME1788 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 4 ug/ml) DME1788 XEOTICID XEO05264 GENEFORM Protein DME1788 XEOTICID XEO05264 MOACRIVE Inhibition DME1788 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1788 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05267 XEO_CLAS Peptide DME1788 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 2 ug/ml) DME1788 XEOTICID XEO05267 GENEFORM Protein DME1788 XEOTICID XEO05267 MOACRIVE Inhibition DME1788 XEOTICID XEO05268 XEO_NAME Bac2A scrambled variant W3 DME1788 XEOTICID XEO05268 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05268 XEO_CLAS Peptide DME1788 XEOTICID XEO05268 DESCRIPT Bac2A scrambled variant W3 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 1.6 ug/ml) DME1788 XEOTICID XEO05268 GENEFORM Protein DME1788 XEOTICID XEO05268 MOACRIVE Inhibition DME1788 XEOTICID XEO05269 XEO_NAME Bac2A scrambled variant W4 DME1788 XEOTICID XEO05269 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05269 XEO_CLAS Peptide DME1788 XEOTICID XEO05269 DESCRIPT Bac2A scrambled variant W4 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 6 ug/ml) DME1788 XEOTICID XEO05269 GENEFORM Protein DME1788 XEOTICID XEO05269 MOACRIVE Inhibition DME1788 XEOTICID XEO05273 XEO_NAME WAP four-disulfide core domain protein 12 DME1788 XEOTICID XEO05273 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05273 XEO_CLAS Peptide DME1788 XEOTICID XEO05273 DESCRIPT WAP four-disulfide core domain protein 12 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05273 GENEFORM Protein DME1788 XEOTICID XEO05273 MOACRIVE Inhibition DME1788 XEOTICID XEO05274 XEO_NAME WAP four-disulfide core domain protein 15B DME1788 XEOTICID XEO05274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05274 XEO_CLAS Peptide DME1788 XEOTICID XEO05274 DESCRIPT WAP four-disulfide core domain protein 15B inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05274 GENEFORM Protein DME1788 XEOTICID XEO05274 MOACRIVE Inhibition DME1788 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1788 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05287 XEO_CLAS Peptide DME1788 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli DME1788 XEOTICID XEO05287 GENEFORM Protein DME1788 XEOTICID XEO05287 MOACRIVE Inhibition DME1788 XEOTICID XEO05303 XEO_NAME Xenopsin precursor fragment DME1788 XEOTICID XEO05303 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05303 XEO_CLAS Peptide DME1788 XEOTICID XEO05303 DESCRIPT Xenopsin precursor fragment inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 16-31 ug/ml) DME1788 XEOTICID XEO05303 GENEFORM Protein DME1788 XEOTICID XEO05303 MOACRIVE Inhibition DME1788 XEOTICID XEO05306 XEO_NAME Bacteriocin YD1 DME1788 XEOTICID XEO05306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05306 XEO_CLAS Peptide DME1788 XEOTICID XEO05306 DESCRIPT Bacteriocin YD1 inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 8 ug/ml) DME1788 XEOTICID XEO05306 GENEFORM Protein DME1788 XEOTICID XEO05306 MOACRIVE Inhibition DME1788 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1788 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1788 XEOTICID XEO05308 XEO_CLAS Peptide DME1788 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Beta-glucuronidase (uidA) from Escherichia coli (MIC = 0.4 ug/ml) DME1788 XEOTICID XEO05308 GENEFORM Protein DME1788 XEOTICID XEO05308 MOACRIVE Inhibition DME1847 DME___ID DME1847 DME1847 DME_NAME Beta-glucosidase (bglA) DME1847 SPESNAME Bifidobacterium adolescentis DME1847 XEOTICID XEO03113 XEO_NAME Royalisin defensin-1 DME1847 XEOTICID XEO03113 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1847 XEOTICID XEO03113 XEO_CLAS Peptide DME1847 XEOTICID XEO03113 DESCRIPT Royalisin defensin-1 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Bifidobacterium adolescentis DME1847 XEOTICID XEO03113 GENEFORM Protein DME1847 XEOTICID XEO03113 MOACRIVE Inhibition DME1865 DME___ID DME1865 DME1865 DME_NAME Flavin adenine dinucleotide dehydrogenase (fadd) DME1865 SPESNAME Clostridium perfringens DME1865 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1865 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1865 XEOTICID XEO02378 XEO_CLAS Peptide DME1865 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Flavin adenine dinucleotide dehydrogenase (fadd) from Clostridium perfringens (MIC = 0.7 ug/ml) DME1865 XEOTICID XEO02378 GENEFORM Protein DME1865 XEOTICID XEO02378 MOACRIVE Inhibition DME1865 XEOTICID XEO02720 XEO_NAME Carnobacteriocin-A DME1865 XEOTICID XEO02720 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1865 XEOTICID XEO02720 XEO_CLAS Peptide DME1865 XEOTICID XEO02720 DESCRIPT Carnobacteriocin-A inhibits the drug-metabolizing activity of Flavin adenine dinucleotide dehydrogenase (fadd) from Clostridium perfringens DME1865 XEOTICID XEO02720 GENEFORM Protein DME1865 XEOTICID XEO02720 MOACRIVE Inhibition DME1865 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1865 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1865 XEOTICID XEO03540 XEO_CLAS Peptide DME1865 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Flavin adenine dinucleotide dehydrogenase (fadd) from Clostridium perfringens DME1865 XEOTICID XEO03540 GENEFORM Protein DME1865 XEOTICID XEO03540 MOACRIVE Inhibition DME1865 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1865 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1865 XEOTICID XEO03556 XEO_CLAS Peptide DME1865 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Flavin adenine dinucleotide dehydrogenase (fadd) from Clostridium perfringens (MIC = 4-32 ug/ml) DME1865 XEOTICID XEO03556 GENEFORM Protein DME1865 XEOTICID XEO03556 MOACRIVE Inhibition DME1865 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1865 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1865 XEOTICID XEO03557 XEO_CLAS Peptide DME1865 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Flavin adenine dinucleotide dehydrogenase (fadd) from Clostridium perfringens (MIC = 4-32 ug/ml) DME1865 XEOTICID XEO03557 GENEFORM Protein DME1865 XEOTICID XEO03557 MOACRIVE Inhibition DME1870 DME___ID DME1870 DME1870 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1870 SPESNAME Fusarium oxysporum DME1870 XEOTICID XEO02751 XEO_NAME Gly-rich Cc-GRP DME1870 XEOTICID XEO02751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1870 XEOTICID XEO02751 XEO_CLAS Peptide DME1870 XEOTICID XEO02751 DESCRIPT Gly-rich Cc-GRP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium oxysporum (MIC = 90 ug/ml) DME1870 XEOTICID XEO02751 GENEFORM Protein DME1870 XEOTICID XEO02751 MOACRIVE Inhibition DME1872 DME___ID DME1872 DME1872 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1872 SPESNAME Fusarium solani DME1872 XEOTICID XEO01782 XEO_NAME Peptide (KW)3 DME1872 XEOTICID XEO01782 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO01782 XEO_CLAS Peptide DME1872 XEOTICID XEO01782 DESCRIPT Peptide (KW)3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO01782 GENEFORM Protein DME1872 XEOTICID XEO01782 MOACRIVE Inhibition DME1872 XEOTICID XEO01783 XEO_NAME Peptide (KW)4 DME1872 XEOTICID XEO01783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO01783 XEO_CLAS Peptide DME1872 XEOTICID XEO01783 DESCRIPT Peptide (KW)4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO01783 GENEFORM Protein DME1872 XEOTICID XEO01783 MOACRIVE Inhibition DME1872 XEOTICID XEO01784 XEO_NAME KW5 peptide DME1872 XEOTICID XEO01784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO01784 XEO_CLAS Peptide DME1872 XEOTICID XEO01784 DESCRIPT KW5 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO01784 GENEFORM Protein DME1872 XEOTICID XEO01784 MOACRIVE Inhibition DME1872 XEOTICID XEO01788 XEO_NAME Peptide (RW)2 DME1872 XEOTICID XEO01788 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO01788 XEO_CLAS Peptide DME1872 XEOTICID XEO01788 DESCRIPT Peptide (RW)2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO01788 GENEFORM Protein DME1872 XEOTICID XEO01788 MOACRIVE Inhibition DME1872 XEOTICID XEO01790 XEO_NAME RW3 peptide DME1872 XEOTICID XEO01790 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO01790 XEO_CLAS Peptide DME1872 XEOTICID XEO01790 DESCRIPT RW3 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO01790 GENEFORM Protein DME1872 XEOTICID XEO01790 MOACRIVE Inhibition DME1872 XEOTICID XEO01792 XEO_NAME RW4 peptide DME1872 XEOTICID XEO01792 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO01792 XEO_CLAS Peptide DME1872 XEOTICID XEO01792 DESCRIPT RW4 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO01792 GENEFORM Protein DME1872 XEOTICID XEO01792 MOACRIVE Inhibition DME1872 XEOTICID XEO01795 XEO_NAME Peptide (RW)5 DME1872 XEOTICID XEO01795 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO01795 XEO_CLAS Peptide DME1872 XEOTICID XEO01795 DESCRIPT Peptide (RW)5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO01795 GENEFORM Protein DME1872 XEOTICID XEO01795 MOACRIVE Inhibition DME1872 XEOTICID XEO02122 XEO_NAME A. clavatus peptide AcAMP DME1872 XEOTICID XEO02122 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO02122 XEO_CLAS Peptide DME1872 XEOTICID XEO02122 DESCRIPT A. clavatus peptide AcAMP inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO02122 GENEFORM Protein DME1872 XEOTICID XEO02122 MOACRIVE Inhibition DME1872 XEOTICID XEO02255 XEO_NAME Antifungal protein Pr-2 DME1872 XEOTICID XEO02255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO02255 XEO_CLAS Peptide DME1872 XEOTICID XEO02255 DESCRIPT Antifungal protein Pr-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO02255 GENEFORM Protein DME1872 XEOTICID XEO02255 MOACRIVE Inhibition DME1872 XEOTICID XEO02264 XEO_NAME Antimicrobial peptide WAMP-1a DME1872 XEOTICID XEO02264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO02264 XEO_CLAS Peptide DME1872 XEOTICID XEO02264 DESCRIPT Antimicrobial peptide WAMP-1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO02264 GENEFORM Protein DME1872 XEOTICID XEO02264 MOACRIVE Inhibition DME1872 XEOTICID XEO02906 XEO_NAME Colutellin-A DME1872 XEOTICID XEO02906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO02906 XEO_CLAS Peptide DME1872 XEOTICID XEO02906 DESCRIPT Colutellin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO02906 GENEFORM Protein DME1872 XEOTICID XEO02906 MOACRIVE Inhibition DME1872 XEOTICID XEO03107 XEO_NAME Defensin So-D5 DME1872 XEOTICID XEO03107 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO03107 XEO_CLAS Peptide DME1872 XEOTICID XEO03107 DESCRIPT Defensin So-D5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO03107 GENEFORM Protein DME1872 XEOTICID XEO03107 MOACRIVE Inhibition DME1872 XEOTICID XEO03108 XEO_NAME Defensin So-D6 DME1872 XEOTICID XEO03108 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO03108 XEO_CLAS Peptide DME1872 XEOTICID XEO03108 DESCRIPT Defensin So-D6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO03108 GENEFORM Protein DME1872 XEOTICID XEO03108 MOACRIVE Inhibition DME1872 XEOTICID XEO03332 XEO_NAME ARD1 Mutant ETD135 DME1872 XEOTICID XEO03332 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO03332 XEO_CLAS Peptide DME1872 XEOTICID XEO03332 DESCRIPT ARD1 Mutant ETD135 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO03332 GENEFORM Protein DME1872 XEOTICID XEO03332 MOACRIVE Inhibition DME1872 XEOTICID XEO03335 XEO_NAME ARD1 Mutant ETD151 DME1872 XEOTICID XEO03335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO03335 XEO_CLAS Peptide DME1872 XEOTICID XEO03335 DESCRIPT ARD1 Mutant ETD151 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO03335 GENEFORM Protein DME1872 XEOTICID XEO03335 MOACRIVE Inhibition DME1872 XEOTICID XEO03526 XEO_NAME Plant defensin Hc-AFP1 DME1872 XEOTICID XEO03526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO03526 XEO_CLAS Peptide DME1872 XEOTICID XEO03526 DESCRIPT Plant defensin Hc-AFP1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO03526 GENEFORM Protein DME1872 XEOTICID XEO03526 MOACRIVE Inhibition DME1872 XEOTICID XEO03527 XEO_NAME Plant defensin Hc-AFP2 DME1872 XEOTICID XEO03527 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO03527 XEO_CLAS Peptide DME1872 XEOTICID XEO03527 DESCRIPT Plant defensin Hc-AFP2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO03527 GENEFORM Protein DME1872 XEOTICID XEO03527 MOACRIVE Inhibition DME1872 XEOTICID XEO03528 XEO_NAME Plant defensin Hc-AFP3 DME1872 XEOTICID XEO03528 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO03528 XEO_CLAS Peptide DME1872 XEOTICID XEO03528 DESCRIPT Plant defensin Hc-AFP3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO03528 GENEFORM Protein DME1872 XEOTICID XEO03528 MOACRIVE Inhibition DME1872 XEOTICID XEO03529 XEO_NAME Plant defensin Hc-AFP4 DME1872 XEOTICID XEO03529 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO03529 XEO_CLAS Peptide DME1872 XEOTICID XEO03529 DESCRIPT Plant defensin Hc-AFP4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO03529 GENEFORM Protein DME1872 XEOTICID XEO03529 MOACRIVE Inhibition DME1872 XEOTICID XEO03542 XEO_NAME Hepcidin DME1872 XEOTICID XEO03542 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO03542 XEO_CLAS Peptide DME1872 XEOTICID XEO03542 DESCRIPT Hepcidin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani (MIC = 24 microM) DME1872 XEOTICID XEO03542 GENEFORM Protein DME1872 XEOTICID XEO03542 MOACRIVE Inhibition DME1872 XEOTICID XEO03597 XEO_NAME Human drosomycin-like defensin DLD DME1872 XEOTICID XEO03597 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO03597 XEO_CLAS Peptide DME1872 XEOTICID XEO03597 DESCRIPT Human drosomycin-like defensin DLD inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani (MIC = 25 microM) DME1872 XEOTICID XEO03597 GENEFORM Protein DME1872 XEOTICID XEO03597 MOACRIVE Inhibition DME1872 XEOTICID XEO03776 XEO_NAME Lactoferricin B DME1872 XEOTICID XEO03776 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO03776 XEO_CLAS Peptide DME1872 XEOTICID XEO03776 DESCRIPT Lactoferricin B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO03776 GENEFORM Protein DME1872 XEOTICID XEO03776 MOACRIVE Inhibition DME1872 XEOTICID XEO04327 XEO_NAME Non-specific lipid transfer peptide DME1872 XEOTICID XEO04327 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO04327 XEO_CLAS Peptide DME1872 XEOTICID XEO04327 DESCRIPT Non-specific lipid transfer peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO04327 GENEFORM Protein DME1872 XEOTICID XEO04327 MOACRIVE Inhibition DME1872 XEOTICID XEO04411 XEO_NAME Osmotin DME1872 XEOTICID XEO04411 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO04411 XEO_CLAS Peptide DME1872 XEOTICID XEO04411 DESCRIPT Osmotin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO04411 GENEFORM Protein DME1872 XEOTICID XEO04411 MOACRIVE Inhibition DME1872 XEOTICID XEO04614 XEO_NAME Pisum sativum defensin Psd2 DME1872 XEOTICID XEO04614 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO04614 XEO_CLAS Peptide DME1872 XEOTICID XEO04614 DESCRIPT Pisum sativum defensin Psd2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani (MIC = 5.0 ug/ml) DME1872 XEOTICID XEO04614 GENEFORM Protein DME1872 XEOTICID XEO04614 MOACRIVE Inhibition DME1872 XEOTICID XEO04738 XEO_NAME P. sylvestris defensin PsDef1 DME1872 XEOTICID XEO04738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO04738 XEO_CLAS Peptide DME1872 XEOTICID XEO04738 DESCRIPT P. sylvestris defensin PsDef1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO04738 GENEFORM Protein DME1872 XEOTICID XEO04738 MOACRIVE Inhibition DME1872 XEOTICID XEO04756 XEO_NAME Pseudothionin solanum tuberosum 1 DME1872 XEOTICID XEO04756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO04756 XEO_CLAS Peptide DME1872 XEOTICID XEO04756 DESCRIPT Pseudothionin solanum tuberosum 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO04756 GENEFORM Protein DME1872 XEOTICID XEO04756 MOACRIVE Inhibition DME1872 XEOTICID XEO04919 XEO_NAME Sugarcane defensin Sd1 DME1872 XEOTICID XEO04919 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO04919 XEO_CLAS Peptide DME1872 XEOTICID XEO04919 DESCRIPT Sugarcane defensin Sd1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO04919 GENEFORM Protein DME1872 XEOTICID XEO04919 MOACRIVE Inhibition DME1872 XEOTICID XEO04920 XEO_NAME Sugarcane defensin Sd5 DME1872 XEOTICID XEO04920 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO04920 XEO_CLAS Peptide DME1872 XEOTICID XEO04920 DESCRIPT Sugarcane defensin Sd5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO04920 GENEFORM Protein DME1872 XEOTICID XEO04920 MOACRIVE Inhibition DME1872 XEOTICID XEO04960 XEO_NAME Snakin-1 StSN1 DME1872 XEOTICID XEO04960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO04960 XEO_CLAS Peptide DME1872 XEOTICID XEO04960 DESCRIPT Snakin-1 StSN1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO04960 GENEFORM Protein DME1872 XEOTICID XEO04960 MOACRIVE Inhibition DME1872 XEOTICID XEO04961 XEO_NAME Snakin-2 StSN2 DME1872 XEOTICID XEO04961 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO04961 XEO_CLAS Peptide DME1872 XEOTICID XEO04961 DESCRIPT Snakin-2 StSN2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO04961 GENEFORM Protein DME1872 XEOTICID XEO04961 MOACRIVE Inhibition DME1872 XEOTICID XEO05246 XEO_NAME Viscotoxin-A3 DME1872 XEOTICID XEO05246 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO05246 XEO_CLAS Peptide DME1872 XEOTICID XEO05246 DESCRIPT Viscotoxin-A3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO05246 GENEFORM Protein DME1872 XEOTICID XEO05246 MOACRIVE Inhibition DME1872 XEOTICID XEO05247 XEO_NAME Viscotoxin-B DME1872 XEOTICID XEO05247 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO05247 XEO_CLAS Peptide DME1872 XEOTICID XEO05247 DESCRIPT Viscotoxin-B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO05247 GENEFORM Protein DME1872 XEOTICID XEO05247 MOACRIVE Inhibition DME1872 XEOTICID XEO05287 XEO_NAME Hevein C-terminal domain WjAMP-1 DME1872 XEOTICID XEO05287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1872 XEOTICID XEO05287 XEO_CLAS Peptide DME1872 XEOTICID XEO05287 DESCRIPT Hevein C-terminal domain WjAMP-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Fusarium solani DME1872 XEOTICID XEO05287 GENEFORM Protein DME1872 XEOTICID XEO05287 MOACRIVE Inhibition DME1880 DME___ID DME1880 DME1880 DME_NAME Beta-lactamase (blaB) DME1880 SPESNAME Klebsiella aerogenes DME1880 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1880 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1880 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1880 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO00546 GENEFORM Protein DME1880 XEOTICID XEO00546 MOACRIVE Inhibition DME1880 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1880 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1880 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1880 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO00574 GENEFORM Protein DME1880 XEOTICID XEO00574 MOACRIVE Inhibition DME1880 XEOTICID XEO01266 XEO_NAME Cyanidin DME1880 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME1880 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME1880 XEOTICID XEO01266 DESCRIPT Cyanidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO01266 GENEFORM Protein DME1880 XEOTICID XEO01266 MOACRIVE Inhibition DME1880 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1880 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO01816 XEO_CLAS Peptide DME1880 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 6.25 microM) DME1880 XEOTICID XEO01816 GENEFORM Protein DME1880 XEOTICID XEO01816 MOACRIVE Inhibition DME1880 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1880 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO01827 XEO_CLAS Peptide DME1880 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC > 50 microM) DME1880 XEOTICID XEO01827 GENEFORM Protein DME1880 XEOTICID XEO01827 MOACRIVE Inhibition DME1880 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1880 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02115 XEO_CLAS Peptide DME1880 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO02115 GENEFORM Protein DME1880 XEOTICID XEO02115 MOACRIVE Inhibition DME1880 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1880 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02230 XEO_CLAS Peptide DME1880 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 1-2.5 microM) DME1880 XEOTICID XEO02230 GENEFORM Protein DME1880 XEOTICID XEO02230 MOACRIVE Inhibition DME1880 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1880 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02280 XEO_CLAS Peptide DME1880 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO02280 GENEFORM Protein DME1880 XEOTICID XEO02280 MOACRIVE Inhibition DME1880 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1880 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02325 XEO_CLAS Peptide DME1880 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 13 microM) DME1880 XEOTICID XEO02325 GENEFORM Protein DME1880 XEOTICID XEO02325 MOACRIVE Inhibition DME1880 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1880 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02370 XEO_CLAS Peptide DME1880 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO02370 GENEFORM Protein DME1880 XEOTICID XEO02370 MOACRIVE Inhibition DME1880 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1880 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02371 XEO_CLAS Peptide DME1880 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 12 ug/ml) DME1880 XEOTICID XEO02371 GENEFORM Protein DME1880 XEOTICID XEO02371 MOACRIVE Inhibition DME1880 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1880 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02378 XEO_CLAS Peptide DME1880 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 0.76 ug/ml) DME1880 XEOTICID XEO02378 GENEFORM Protein DME1880 XEOTICID XEO02378 MOACRIVE Inhibition DME1880 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1880 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02416 XEO_CLAS Peptide DME1880 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO02416 GENEFORM Protein DME1880 XEOTICID XEO02416 MOACRIVE Inhibition DME1880 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1880 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02451 XEO_CLAS Peptide DME1880 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO02451 GENEFORM Protein DME1880 XEOTICID XEO02451 MOACRIVE Inhibition DME1880 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1880 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02473 XEO_CLAS Peptide DME1880 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO02473 GENEFORM Protein DME1880 XEOTICID XEO02473 MOACRIVE Inhibition DME1880 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1880 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02491 XEO_CLAS Peptide DME1880 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 2.8 microM) DME1880 XEOTICID XEO02491 GENEFORM Protein DME1880 XEOTICID XEO02491 MOACRIVE Inhibition DME1880 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1880 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02496 XEO_CLAS Peptide DME1880 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 50 microM) DME1880 XEOTICID XEO02496 GENEFORM Protein DME1880 XEOTICID XEO02496 MOACRIVE Inhibition DME1880 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1880 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02497 XEO_CLAS Peptide DME1880 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC > 50 microM) DME1880 XEOTICID XEO02497 GENEFORM Protein DME1880 XEOTICID XEO02497 MOACRIVE Inhibition DME1880 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1880 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02512 XEO_CLAS Peptide DME1880 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 150 microM) DME1880 XEOTICID XEO02512 GENEFORM Protein DME1880 XEOTICID XEO02512 MOACRIVE Inhibition DME1880 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1880 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02566 XEO_CLAS Peptide DME1880 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC > 100 microM) DME1880 XEOTICID XEO02566 GENEFORM Protein DME1880 XEOTICID XEO02566 MOACRIVE Inhibition DME1880 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1880 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02637 XEO_CLAS Peptide DME1880 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 6 microM) DME1880 XEOTICID XEO02637 GENEFORM Protein DME1880 XEOTICID XEO02637 MOACRIVE Inhibition DME1880 XEOTICID XEO02656 XEO_NAME Himatanthus drasticus butanolic extract DME1880 XEOTICID XEO02656 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1880 XEOTICID XEO02656 XEO_CLAS Plant Extract DME1880 XEOTICID XEO02656 DESCRIPT Himatanthus drasticus butanolic extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO02656 GENEFORM Protein DME1880 XEOTICID XEO02656 MOACRIVE Inhibition DME1880 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1880 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02688 XEO_CLAS Peptide DME1880 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 25 microM) DME1880 XEOTICID XEO02688 GENEFORM Protein DME1880 XEOTICID XEO02688 MOACRIVE Inhibition DME1880 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1880 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02708 XEO_CLAS Peptide DME1880 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 20 ug/ml) DME1880 XEOTICID XEO02708 GENEFORM Protein DME1880 XEOTICID XEO02708 MOACRIVE Inhibition DME1880 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1880 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02732 XEO_CLAS Peptide DME1880 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 1.25 microM) DME1880 XEOTICID XEO02732 GENEFORM Protein DME1880 XEOTICID XEO02732 MOACRIVE Inhibition DME1880 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1880 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02734 XEO_CLAS Peptide DME1880 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 0.40 microM) DME1880 XEOTICID XEO02734 GENEFORM Protein DME1880 XEOTICID XEO02734 MOACRIVE Inhibition DME1880 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1880 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02736 XEO_CLAS Peptide DME1880 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 0.66 microM) DME1880 XEOTICID XEO02736 GENEFORM Protein DME1880 XEOTICID XEO02736 MOACRIVE Inhibition DME1880 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1880 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02738 XEO_CLAS Peptide DME1880 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 1 microM) DME1880 XEOTICID XEO02738 GENEFORM Protein DME1880 XEOTICID XEO02738 MOACRIVE Inhibition DME1880 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1880 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02743 XEO_CLAS Peptide DME1880 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 4.7 ug/ml) DME1880 XEOTICID XEO02743 GENEFORM Protein DME1880 XEOTICID XEO02743 MOACRIVE Inhibition DME1880 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1880 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02749 XEO_CLAS Peptide DME1880 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 20 mug/ml) DME1880 XEOTICID XEO02749 GENEFORM Protein DME1880 XEOTICID XEO02749 MOACRIVE Inhibition DME1880 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1880 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02767 XEO_CLAS Peptide DME1880 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO02767 GENEFORM Protein DME1880 XEOTICID XEO02767 MOACRIVE Inhibition DME1880 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1880 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02768 XEO_CLAS Peptide DME1880 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 1-2.5 ug/ml) DME1880 XEOTICID XEO02768 GENEFORM Protein DME1880 XEOTICID XEO02768 MOACRIVE Inhibition DME1880 XEOTICID XEO02780 XEO_NAME Cefixime DME1880 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1880 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1880 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO02780 GENEFORM Protein DME1880 XEOTICID XEO02780 MOACRIVE Inhibition DME1880 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1880 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO02942 XEO_CLAS Peptide DME1880 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO02942 GENEFORM Protein DME1880 XEOTICID XEO02942 MOACRIVE Inhibition DME1880 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1880 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03029 XEO_CLAS Peptide DME1880 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 0.145 microM) DME1880 XEOTICID XEO03029 GENEFORM Protein DME1880 XEOTICID XEO03029 MOACRIVE Inhibition DME1880 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1880 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03030 XEO_CLAS Peptide DME1880 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 0.643 microM) DME1880 XEOTICID XEO03030 GENEFORM Protein DME1880 XEOTICID XEO03030 MOACRIVE Inhibition DME1880 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1880 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03031 XEO_CLAS Peptide DME1880 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 0.01 microM) DME1880 XEOTICID XEO03031 GENEFORM Protein DME1880 XEOTICID XEO03031 MOACRIVE Inhibition DME1880 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1880 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03032 XEO_CLAS Peptide DME1880 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC < 0.005 microM) DME1880 XEOTICID XEO03032 GENEFORM Protein DME1880 XEOTICID XEO03032 MOACRIVE Inhibition DME1880 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1880 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03033 XEO_CLAS Peptide DME1880 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC > 0.692 microM) DME1880 XEOTICID XEO03033 GENEFORM Protein DME1880 XEOTICID XEO03033 MOACRIVE Inhibition DME1880 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1880 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03034 XEO_CLAS Peptide DME1880 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 0.004 microM) DME1880 XEOTICID XEO03034 GENEFORM Protein DME1880 XEOTICID XEO03034 MOACRIVE Inhibition DME1880 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1880 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03035 XEO_CLAS Peptide DME1880 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 0.458 microM) DME1880 XEOTICID XEO03035 GENEFORM Protein DME1880 XEOTICID XEO03035 MOACRIVE Inhibition DME1880 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1880 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03051 XEO_CLAS Peptide DME1880 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 100 ug/ml) DME1880 XEOTICID XEO03051 GENEFORM Protein DME1880 XEOTICID XEO03051 MOACRIVE Inhibition DME1880 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1880 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03052 XEO_CLAS Peptide DME1880 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 10 ug/ml) DME1880 XEOTICID XEO03052 GENEFORM Protein DME1880 XEOTICID XEO03052 MOACRIVE Inhibition DME1880 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1880 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03053 XEO_CLAS Peptide DME1880 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 25 ug/ml) DME1880 XEOTICID XEO03053 GENEFORM Protein DME1880 XEOTICID XEO03053 MOACRIVE Inhibition DME1880 XEOTICID XEO03089 XEO_NAME Decoralin DME1880 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03089 XEO_CLAS Peptide DME1880 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 80 microM) DME1880 XEOTICID XEO03089 GENEFORM Protein DME1880 XEOTICID XEO03089 MOACRIVE Inhibition DME1880 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1880 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03112 XEO_CLAS Peptide DME1880 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC > 50 ug/ml) DME1880 XEOTICID XEO03112 GENEFORM Protein DME1880 XEOTICID XEO03112 MOACRIVE Inhibition DME1880 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1880 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03137 XEO_CLAS Peptide DME1880 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03137 GENEFORM Protein DME1880 XEOTICID XEO03137 MOACRIVE Inhibition DME1880 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1880 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03162 XEO_CLAS Peptide DME1880 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 0.8 microM) DME1880 XEOTICID XEO03162 GENEFORM Protein DME1880 XEOTICID XEO03162 MOACRIVE Inhibition DME1880 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1880 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03224 XEO_CLAS Peptide DME1880 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 1-2.5 microM) DME1880 XEOTICID XEO03224 GENEFORM Protein DME1880 XEOTICID XEO03224 MOACRIVE Inhibition DME1880 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1880 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03235 XEO_CLAS Peptide DME1880 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 60 ug/ml) DME1880 XEOTICID XEO03235 GENEFORM Protein DME1880 XEOTICID XEO03235 MOACRIVE Inhibition DME1880 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1880 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03237 XEO_CLAS Peptide DME1880 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC > 100 ug/ml) DME1880 XEOTICID XEO03237 GENEFORM Protein DME1880 XEOTICID XEO03237 MOACRIVE Inhibition DME1880 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1880 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03238 XEO_CLAS Peptide DME1880 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 15 ug/ml) DME1880 XEOTICID XEO03238 GENEFORM Protein DME1880 XEOTICID XEO03238 MOACRIVE Inhibition DME1880 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1880 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03239 XEO_CLAS Peptide DME1880 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 50 ug/ml) DME1880 XEOTICID XEO03239 GENEFORM Protein DME1880 XEOTICID XEO03239 MOACRIVE Inhibition DME1880 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1880 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03250 XEO_CLAS Peptide DME1880 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03250 GENEFORM Protein DME1880 XEOTICID XEO03250 MOACRIVE Inhibition DME1880 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1880 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03251 XEO_CLAS Peptide DME1880 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03251 GENEFORM Protein DME1880 XEOTICID XEO03251 MOACRIVE Inhibition DME1880 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1880 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03253 XEO_CLAS Peptide DME1880 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 3.2 ug/ml) DME1880 XEOTICID XEO03253 GENEFORM Protein DME1880 XEOTICID XEO03253 MOACRIVE Inhibition DME1880 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1880 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1880 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1880 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03348 GENEFORM Protein DME1880 XEOTICID XEO03348 MOACRIVE Inhibition DME1880 XEOTICID XEO03387 XEO_NAME Ferric chloride DME1880 XEOTICID XEO03387 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1880 XEOTICID XEO03387 XEO_CLAS Chemical Compound DME1880 XEOTICID XEO03387 DESCRIPT Ferric chloride inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03387 GENEFORM Protein DME1880 XEOTICID XEO03387 MOACRIVE Inhibition DME1880 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1880 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03436 XEO_CLAS Peptide DME1880 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 100 ug/ml) DME1880 XEOTICID XEO03436 GENEFORM Protein DME1880 XEOTICID XEO03436 MOACRIVE Inhibition DME1880 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1880 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03437 XEO_CLAS Peptide DME1880 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 25 ug/ml) DME1880 XEOTICID XEO03437 GENEFORM Protein DME1880 XEOTICID XEO03437 MOACRIVE Inhibition DME1880 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1880 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03438 XEO_CLAS Peptide DME1880 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 25 ug/ml) DME1880 XEOTICID XEO03438 GENEFORM Protein DME1880 XEOTICID XEO03438 MOACRIVE Inhibition DME1880 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1880 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03439 XEO_CLAS Peptide DME1880 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 25 ug/ml) DME1880 XEOTICID XEO03439 GENEFORM Protein DME1880 XEOTICID XEO03439 MOACRIVE Inhibition DME1880 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1880 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03440 XEO_CLAS Peptide DME1880 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 50 ug/ml) DME1880 XEOTICID XEO03440 GENEFORM Protein DME1880 XEOTICID XEO03440 MOACRIVE Inhibition DME1880 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1880 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03441 XEO_CLAS Peptide DME1880 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 50 ug/ml) DME1880 XEOTICID XEO03441 GENEFORM Protein DME1880 XEOTICID XEO03441 MOACRIVE Inhibition DME1880 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1880 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03497 XEO_CLAS Peptide DME1880 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 3.15-6.25 microM) DME1880 XEOTICID XEO03497 GENEFORM Protein DME1880 XEOTICID XEO03497 MOACRIVE Inhibition DME1880 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1880 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03498 XEO_CLAS Peptide DME1880 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 3.15-6.25 microM) DME1880 XEOTICID XEO03498 GENEFORM Protein DME1880 XEOTICID XEO03498 MOACRIVE Inhibition DME1880 XEOTICID XEO03519 XEO_NAME Hadrurin DME1880 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03519 XEO_CLAS Peptide DME1880 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03519 GENEFORM Protein DME1880 XEOTICID XEO03519 MOACRIVE Inhibition DME1880 XEOTICID XEO03522 XEO_NAME Halocyntin DME1880 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03522 XEO_CLAS Peptide DME1880 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03522 GENEFORM Protein DME1880 XEOTICID XEO03522 MOACRIVE Inhibition DME1880 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1880 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03540 XEO_CLAS Peptide DME1880 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 8-16 ug/ml) DME1880 XEOTICID XEO03540 GENEFORM Protein DME1880 XEOTICID XEO03540 MOACRIVE Inhibition DME1880 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1880 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03549 XEO_CLAS Peptide DME1880 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03549 GENEFORM Protein DME1880 XEOTICID XEO03549 MOACRIVE Inhibition DME1880 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1880 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1880 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1880 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03552 GENEFORM Protein DME1880 XEOTICID XEO03552 MOACRIVE Inhibition DME1880 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1880 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03556 XEO_CLAS Peptide DME1880 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 8-16 ug/ml) DME1880 XEOTICID XEO03556 GENEFORM Protein DME1880 XEOTICID XEO03556 MOACRIVE Inhibition DME1880 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1880 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03557 XEO_CLAS Peptide DME1880 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 8-16 ug/ml) DME1880 XEOTICID XEO03557 GENEFORM Protein DME1880 XEOTICID XEO03557 MOACRIVE Inhibition DME1880 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1880 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03591 XEO_CLAS Peptide DME1880 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 50 ug/ml) DME1880 XEOTICID XEO03591 GENEFORM Protein DME1880 XEOTICID XEO03591 MOACRIVE Inhibition DME1880 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1880 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03593 XEO_CLAS Peptide DME1880 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 25 ug/ml) DME1880 XEOTICID XEO03593 GENEFORM Protein DME1880 XEOTICID XEO03593 MOACRIVE Inhibition DME1880 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1880 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03609 XEO_CLAS Peptide DME1880 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03609 GENEFORM Protein DME1880 XEOTICID XEO03609 MOACRIVE Inhibition DME1880 XEOTICID XEO03611 XEO_NAME Himatanthus drasticus hydroalcoholic extract DME1880 XEOTICID XEO03611 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1880 XEOTICID XEO03611 XEO_CLAS Plant Extract DME1880 XEOTICID XEO03611 DESCRIPT Himatanthus drasticus hydroalcoholic extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03611 GENEFORM Protein DME1880 XEOTICID XEO03611 MOACRIVE Inhibition DME1880 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1880 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03622 XEO_CLAS Peptide DME1880 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 20-40 microM) DME1880 XEOTICID XEO03622 GENEFORM Protein DME1880 XEOTICID XEO03622 MOACRIVE Inhibition DME1880 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1880 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03630 XEO_CLAS Peptide DME1880 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03630 GENEFORM Protein DME1880 XEOTICID XEO03630 MOACRIVE Inhibition DME1880 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1880 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03631 XEO_CLAS Peptide DME1880 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03631 GENEFORM Protein DME1880 XEOTICID XEO03631 MOACRIVE Inhibition DME1880 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1880 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03632 XEO_CLAS Peptide DME1880 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03632 GENEFORM Protein DME1880 XEOTICID XEO03632 MOACRIVE Inhibition DME1880 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1880 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03633 XEO_CLAS Peptide DME1880 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03633 GENEFORM Protein DME1880 XEOTICID XEO03633 MOACRIVE Inhibition DME1880 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1880 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03634 XEO_CLAS Peptide DME1880 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03634 GENEFORM Protein DME1880 XEOTICID XEO03634 MOACRIVE Inhibition DME1880 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1880 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03635 XEO_CLAS Peptide DME1880 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03635 GENEFORM Protein DME1880 XEOTICID XEO03635 MOACRIVE Inhibition DME1880 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1880 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03636 XEO_CLAS Peptide DME1880 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03636 GENEFORM Protein DME1880 XEOTICID XEO03636 MOACRIVE Inhibition DME1880 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1880 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03637 XEO_CLAS Peptide DME1880 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03637 GENEFORM Protein DME1880 XEOTICID XEO03637 MOACRIVE Inhibition DME1880 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1880 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03638 XEO_CLAS Peptide DME1880 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03638 GENEFORM Protein DME1880 XEOTICID XEO03638 MOACRIVE Inhibition DME1880 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1880 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03639 XEO_CLAS Peptide DME1880 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03639 GENEFORM Protein DME1880 XEOTICID XEO03639 MOACRIVE Inhibition DME1880 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1880 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03640 XEO_CLAS Peptide DME1880 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03640 GENEFORM Protein DME1880 XEOTICID XEO03640 MOACRIVE Inhibition DME1880 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1880 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03672 XEO_CLAS Peptide DME1880 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 10 ug/ml) DME1880 XEOTICID XEO03672 GENEFORM Protein DME1880 XEOTICID XEO03672 MOACRIVE Inhibition DME1880 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1880 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03673 XEO_CLAS Peptide DME1880 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 15 ug/ml) DME1880 XEOTICID XEO03673 GENEFORM Protein DME1880 XEOTICID XEO03673 MOACRIVE Inhibition DME1880 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1880 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03674 XEO_CLAS Peptide DME1880 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO03674 GENEFORM Protein DME1880 XEOTICID XEO03674 MOACRIVE Inhibition DME1880 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1880 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03675 XEO_CLAS Peptide DME1880 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 15 microM) DME1880 XEOTICID XEO03675 GENEFORM Protein DME1880 XEOTICID XEO03675 MOACRIVE Inhibition DME1880 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1880 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03678 XEO_CLAS Peptide DME1880 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 2 ug/ml) DME1880 XEOTICID XEO03678 GENEFORM Protein DME1880 XEOTICID XEO03678 MOACRIVE Inhibition DME1880 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1880 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03681 XEO_CLAS Peptide DME1880 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 1.2-2.5 microM) DME1880 XEOTICID XEO03681 GENEFORM Protein DME1880 XEOTICID XEO03681 MOACRIVE Inhibition DME1880 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1880 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03697 XEO_CLAS Peptide DME1880 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 25 microM) DME1880 XEOTICID XEO03697 GENEFORM Protein DME1880 XEOTICID XEO03697 MOACRIVE Inhibition DME1880 XEOTICID XEO03724 XEO_NAME L10 peptide DME1880 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03724 XEO_CLAS Peptide DME1880 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 3.35 microM) DME1880 XEOTICID XEO03724 GENEFORM Protein DME1880 XEOTICID XEO03724 MOACRIVE Inhibition DME1880 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1880 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03744 XEO_CLAS Peptide DME1880 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 6.3 ug/ml) DME1880 XEOTICID XEO03744 GENEFORM Protein DME1880 XEOTICID XEO03744 MOACRIVE Inhibition DME1880 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1880 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03746 XEO_CLAS Peptide DME1880 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 2 ug/ml) DME1880 XEOTICID XEO03746 GENEFORM Protein DME1880 XEOTICID XEO03746 MOACRIVE Inhibition DME1880 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1880 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03747 XEO_CLAS Peptide DME1880 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 2 ug/ml) DME1880 XEOTICID XEO03747 GENEFORM Protein DME1880 XEOTICID XEO03747 MOACRIVE Inhibition DME1880 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1880 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03748 XEO_CLAS Peptide DME1880 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 4 ug/ml) DME1880 XEOTICID XEO03748 GENEFORM Protein DME1880 XEOTICID XEO03748 MOACRIVE Inhibition DME1880 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1880 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03749 XEO_CLAS Peptide DME1880 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 2 ug/ml) DME1880 XEOTICID XEO03749 GENEFORM Protein DME1880 XEOTICID XEO03749 MOACRIVE Inhibition DME1880 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1880 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03750 XEO_CLAS Peptide DME1880 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 2 ug/ml) DME1880 XEOTICID XEO03750 GENEFORM Protein DME1880 XEOTICID XEO03750 MOACRIVE Inhibition DME1880 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1880 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03751 XEO_CLAS Peptide DME1880 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 4 ug/ml) DME1880 XEOTICID XEO03751 GENEFORM Protein DME1880 XEOTICID XEO03751 MOACRIVE Inhibition DME1880 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1880 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03752 XEO_CLAS Peptide DME1880 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 2 ug/ml) DME1880 XEOTICID XEO03752 GENEFORM Protein DME1880 XEOTICID XEO03752 MOACRIVE Inhibition DME1880 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1880 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03753 XEO_CLAS Peptide DME1880 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 6.3 ug/ml) DME1880 XEOTICID XEO03753 GENEFORM Protein DME1880 XEOTICID XEO03753 MOACRIVE Inhibition DME1880 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1880 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03754 XEO_CLAS Peptide DME1880 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 2 ug/ml) DME1880 XEOTICID XEO03754 GENEFORM Protein DME1880 XEOTICID XEO03754 MOACRIVE Inhibition DME1880 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1880 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03755 XEO_CLAS Peptide DME1880 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 4 ug/ml) DME1880 XEOTICID XEO03755 GENEFORM Protein DME1880 XEOTICID XEO03755 MOACRIVE Inhibition DME1880 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1880 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03756 XEO_CLAS Peptide DME1880 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 2 ug/ml) DME1880 XEOTICID XEO03756 GENEFORM Protein DME1880 XEOTICID XEO03756 MOACRIVE Inhibition DME1880 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1880 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03759 XEO_CLAS Peptide DME1880 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 3.1 ug/ml) DME1880 XEOTICID XEO03759 GENEFORM Protein DME1880 XEOTICID XEO03759 MOACRIVE Inhibition DME1880 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1880 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03761 XEO_CLAS Peptide DME1880 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 50 ug/ml) DME1880 XEOTICID XEO03761 GENEFORM Protein DME1880 XEOTICID XEO03761 MOACRIVE Inhibition DME1880 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1880 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO03985 XEO_CLAS Peptide DME1880 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 10 ug/ml) DME1880 XEOTICID XEO03985 GENEFORM Protein DME1880 XEOTICID XEO03985 MOACRIVE Inhibition DME1880 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1880 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04001 XEO_CLAS Peptide DME1880 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 12.5 microM) DME1880 XEOTICID XEO04001 GENEFORM Protein DME1880 XEOTICID XEO04001 MOACRIVE Inhibition DME1880 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1880 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04007 XEO_CLAS Peptide DME1880 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 9 ug/ml) DME1880 XEOTICID XEO04007 GENEFORM Protein DME1880 XEOTICID XEO04007 MOACRIVE Inhibition DME1880 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1880 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04011 XEO_CLAS Peptide DME1880 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 9 ug/ml) DME1880 XEOTICID XEO04011 GENEFORM Protein DME1880 XEOTICID XEO04011 MOACRIVE Inhibition DME1880 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1880 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04012 XEO_CLAS Peptide DME1880 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 3.1 ug/ml) DME1880 XEOTICID XEO04012 GENEFORM Protein DME1880 XEOTICID XEO04012 MOACRIVE Inhibition DME1880 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1880 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04013 XEO_CLAS Peptide DME1880 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 15 ug/ml) DME1880 XEOTICID XEO04013 GENEFORM Protein DME1880 XEOTICID XEO04013 MOACRIVE Inhibition DME1880 XEOTICID XEO04014 XEO_NAME Maximin-5 DME1880 XEOTICID XEO04014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04014 XEO_CLAS Peptide DME1880 XEOTICID XEO04014 DESCRIPT Maximin-5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 3.6 ug/ml) DME1880 XEOTICID XEO04014 GENEFORM Protein DME1880 XEOTICID XEO04014 MOACRIVE Inhibition DME1880 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1880 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1880 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1880 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04087 GENEFORM Protein DME1880 XEOTICID XEO04087 MOACRIVE Inhibition DME1880 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1880 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04111 XEO_CLAS Peptide DME1880 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04111 GENEFORM Protein DME1880 XEOTICID XEO04111 MOACRIVE Inhibition DME1880 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1880 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04241 XEO_CLAS Peptide DME1880 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04241 GENEFORM Protein DME1880 XEOTICID XEO04241 MOACRIVE Inhibition DME1880 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1880 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04242 XEO_CLAS Peptide DME1880 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04242 GENEFORM Protein DME1880 XEOTICID XEO04242 MOACRIVE Inhibition DME1880 XEOTICID XEO04331 XEO_NAME Norspermidine DME1880 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1880 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1880 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04331 GENEFORM Protein DME1880 XEOTICID XEO04331 MOACRIVE Inhibition DME1880 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1880 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04348 XEO_CLAS Peptide DME1880 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 80 microM) DME1880 XEOTICID XEO04348 GENEFORM Protein DME1880 XEOTICID XEO04348 MOACRIVE Inhibition DME1880 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1880 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04349 XEO_CLAS Peptide DME1880 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 100 microM) DME1880 XEOTICID XEO04349 GENEFORM Protein DME1880 XEOTICID XEO04349 MOACRIVE Inhibition DME1880 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1880 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04399 XEO_CLAS Peptide DME1880 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 6.3 microM) DME1880 XEOTICID XEO04399 GENEFORM Protein DME1880 XEOTICID XEO04399 MOACRIVE Inhibition DME1880 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1880 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04426 XEO_CLAS Peptide DME1880 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 2 microM) DME1880 XEOTICID XEO04426 GENEFORM Protein DME1880 XEOTICID XEO04426 MOACRIVE Inhibition DME1880 XEOTICID XEO04468 XEO_NAME Papillosin DME1880 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04468 XEO_CLAS Peptide DME1880 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04468 GENEFORM Protein DME1880 XEOTICID XEO04468 MOACRIVE Inhibition DME1880 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1880 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04471 XEO_CLAS Peptide DME1880 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 1.6 microM) DME1880 XEOTICID XEO04471 GENEFORM Protein DME1880 XEOTICID XEO04471 MOACRIVE Inhibition DME1880 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1880 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04506 XEO_CLAS Peptide DME1880 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC > 20 microM) DME1880 XEOTICID XEO04506 GENEFORM Protein DME1880 XEOTICID XEO04506 MOACRIVE Inhibition DME1880 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1880 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04507 XEO_CLAS Peptide DME1880 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC > 40 microM) DME1880 XEOTICID XEO04507 GENEFORM Protein DME1880 XEOTICID XEO04507 MOACRIVE Inhibition DME1880 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1880 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04510 XEO_CLAS Peptide DME1880 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC > 50 microM) DME1880 XEOTICID XEO04510 GENEFORM Protein DME1880 XEOTICID XEO04510 MOACRIVE Inhibition DME1880 XEOTICID XEO04531 XEO_NAME Mollusca/molluscs/mollusks peptide 2 DME1880 XEOTICID XEO04531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04531 XEO_CLAS Peptide DME1880 XEOTICID XEO04531 DESCRIPT Mollusca/molluscs/mollusks peptide 2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04531 GENEFORM Protein DME1880 XEOTICID XEO04531 MOACRIVE Inhibition DME1880 XEOTICID XEO04533 XEO_NAME Mollusca/molluscs/mollusks peptide 3 DME1880 XEOTICID XEO04533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04533 XEO_CLAS Peptide DME1880 XEOTICID XEO04533 DESCRIPT Mollusca/molluscs/mollusks peptide 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04533 GENEFORM Protein DME1880 XEOTICID XEO04533 MOACRIVE Inhibition DME1880 XEOTICID XEO04534 XEO_NAME Mollusca/molluscs/mollusks peptide 4 DME1880 XEOTICID XEO04534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04534 XEO_CLAS Peptide DME1880 XEOTICID XEO04534 DESCRIPT Mollusca/molluscs/mollusks peptide 4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04534 GENEFORM Protein DME1880 XEOTICID XEO04534 MOACRIVE Inhibition DME1880 XEOTICID XEO04535 XEO_NAME Mollusca/molluscs/mollusks peptide 5 DME1880 XEOTICID XEO04535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04535 XEO_CLAS Peptide DME1880 XEOTICID XEO04535 DESCRIPT Mollusca/molluscs/mollusks peptide 5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04535 GENEFORM Protein DME1880 XEOTICID XEO04535 MOACRIVE Inhibition DME1880 XEOTICID XEO04536 XEO_NAME Mollusca/molluscs/mollusks peptide 6 DME1880 XEOTICID XEO04536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04536 XEO_CLAS Peptide DME1880 XEOTICID XEO04536 DESCRIPT Mollusca/molluscs/mollusks peptide 6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04536 GENEFORM Protein DME1880 XEOTICID XEO04536 MOACRIVE Inhibition DME1880 XEOTICID XEO04537 XEO_NAME Mollusca/molluscs/mollusks peptide 7 DME1880 XEOTICID XEO04537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04537 XEO_CLAS Peptide DME1880 XEOTICID XEO04537 DESCRIPT Mollusca/molluscs/mollusks peptide 7 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04537 GENEFORM Protein DME1880 XEOTICID XEO04537 MOACRIVE Inhibition DME1880 XEOTICID XEO04538 XEO_NAME Mollusca/molluscs/mollusks peptide 8 DME1880 XEOTICID XEO04538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04538 XEO_CLAS Peptide DME1880 XEOTICID XEO04538 DESCRIPT Mollusca/molluscs/mollusks peptide 8 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04538 GENEFORM Protein DME1880 XEOTICID XEO04538 MOACRIVE Inhibition DME1880 XEOTICID XEO04539 XEO_NAME Mollusca/molluscs/mollusks peptide 9 DME1880 XEOTICID XEO04539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04539 XEO_CLAS Peptide DME1880 XEOTICID XEO04539 DESCRIPT Mollusca/molluscs/mollusks peptide 9 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04539 GENEFORM Protein DME1880 XEOTICID XEO04539 MOACRIVE Inhibition DME1880 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1880 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04548 XEO_CLAS Peptide DME1880 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 32000 ug/ml) DME1880 XEOTICID XEO04548 GENEFORM Protein DME1880 XEOTICID XEO04548 MOACRIVE Inhibition DME1880 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1880 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04549 XEO_CLAS Peptide DME1880 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 250-500 ug/ml) DME1880 XEOTICID XEO04549 GENEFORM Protein DME1880 XEOTICID XEO04549 MOACRIVE Inhibition DME1880 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1880 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04571 XEO_CLAS Peptide DME1880 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04571 GENEFORM Protein DME1880 XEOTICID XEO04571 MOACRIVE Inhibition DME1880 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1880 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04572 XEO_CLAS Peptide DME1880 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04572 GENEFORM Protein DME1880 XEOTICID XEO04572 MOACRIVE Inhibition DME1880 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1880 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04606 XEO_CLAS Peptide DME1880 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 2 microM) DME1880 XEOTICID XEO04606 GENEFORM Protein DME1880 XEOTICID XEO04606 MOACRIVE Inhibition DME1880 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1880 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04612 XEO_CLAS Peptide DME1880 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 2.5-5 microM) DME1880 XEOTICID XEO04612 GENEFORM Protein DME1880 XEOTICID XEO04612 MOACRIVE Inhibition DME1880 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1880 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04613 XEO_CLAS Peptide DME1880 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 2.5-5 microM) DME1880 XEOTICID XEO04613 GENEFORM Protein DME1880 XEOTICID XEO04613 MOACRIVE Inhibition DME1880 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1880 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04695 XEO_CLAS Peptide DME1880 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04695 GENEFORM Protein DME1880 XEOTICID XEO04695 MOACRIVE Inhibition DME1880 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1880 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04696 XEO_CLAS Peptide DME1880 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04696 GENEFORM Protein DME1880 XEOTICID XEO04696 MOACRIVE Inhibition DME1880 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1880 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04697 XEO_CLAS Peptide DME1880 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04697 GENEFORM Protein DME1880 XEOTICID XEO04697 MOACRIVE Inhibition DME1880 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1880 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04698 XEO_CLAS Peptide DME1880 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04698 GENEFORM Protein DME1880 XEOTICID XEO04698 MOACRIVE Inhibition DME1880 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1880 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04699 XEO_CLAS Peptide DME1880 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04699 GENEFORM Protein DME1880 XEOTICID XEO04699 MOACRIVE Inhibition DME1880 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1880 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04700 XEO_CLAS Peptide DME1880 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04700 GENEFORM Protein DME1880 XEOTICID XEO04700 MOACRIVE Inhibition DME1880 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1880 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04701 XEO_CLAS Peptide DME1880 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04701 GENEFORM Protein DME1880 XEOTICID XEO04701 MOACRIVE Inhibition DME1880 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1880 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04702 XEO_CLAS Peptide DME1880 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04702 GENEFORM Protein DME1880 XEOTICID XEO04702 MOACRIVE Inhibition DME1880 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1880 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04703 XEO_CLAS Peptide DME1880 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04703 GENEFORM Protein DME1880 XEOTICID XEO04703 MOACRIVE Inhibition DME1880 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1880 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04762 XEO_CLAS Peptide DME1880 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC > 25 microM) DME1880 XEOTICID XEO04762 GENEFORM Protein DME1880 XEOTICID XEO04762 MOACRIVE Inhibition DME1880 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1880 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04809 XEO_CLAS Peptide DME1880 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 10 microM) DME1880 XEOTICID XEO04809 GENEFORM Protein DME1880 XEOTICID XEO04809 MOACRIVE Inhibition DME1880 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1880 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04891 XEO_CLAS Peptide DME1880 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04891 GENEFORM Protein DME1880 XEOTICID XEO04891 MOACRIVE Inhibition DME1880 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1880 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04905 XEO_CLAS Peptide DME1880 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04905 GENEFORM Protein DME1880 XEOTICID XEO04905 MOACRIVE Inhibition DME1880 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1880 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04906 XEO_CLAS Peptide DME1880 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO04906 GENEFORM Protein DME1880 XEOTICID XEO04906 MOACRIVE Inhibition DME1880 XEOTICID XEO04917 XEO_NAME Scorpine DME1880 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04917 XEO_CLAS Peptide DME1880 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 10 microM) DME1880 XEOTICID XEO04917 GENEFORM Protein DME1880 XEOTICID XEO04917 MOACRIVE Inhibition DME1880 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1880 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04971 XEO_CLAS Peptide DME1880 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 50-100 microM) DME1880 XEOTICID XEO04971 GENEFORM Protein DME1880 XEOTICID XEO04971 MOACRIVE Inhibition DME1880 XEOTICID XEO04974 XEO_NAME Spinigerin DME1880 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04974 XEO_CLAS Peptide DME1880 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 50-100 microM) DME1880 XEOTICID XEO04974 GENEFORM Protein DME1880 XEOTICID XEO04974 MOACRIVE Inhibition DME1880 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1880 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO04995 XEO_CLAS Peptide DME1880 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 0.78-1.56 microM) DME1880 XEOTICID XEO04995 GENEFORM Protein DME1880 XEOTICID XEO04995 MOACRIVE Inhibition DME1880 XEOTICID XEO05020 XEO_NAME Tachycitin DME1880 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO05020 XEO_CLAS Peptide DME1880 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes DME1880 XEOTICID XEO05020 GENEFORM Protein DME1880 XEOTICID XEO05020 MOACRIVE Inhibition DME1880 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1880 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO05073 XEO_CLAS Peptide DME1880 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 80 microM) DME1880 XEOTICID XEO05073 GENEFORM Protein DME1880 XEOTICID XEO05073 MOACRIVE Inhibition DME1880 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1880 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO05075 XEO_CLAS Peptide DME1880 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 80 microM) DME1880 XEOTICID XEO05075 GENEFORM Protein DME1880 XEOTICID XEO05075 MOACRIVE Inhibition DME1880 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1880 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO05101 XEO_CLAS Peptide DME1880 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 31.2 ug/ml) DME1880 XEOTICID XEO05101 GENEFORM Protein DME1880 XEOTICID XEO05101 MOACRIVE Inhibition DME1880 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1880 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO05102 XEO_CLAS Peptide DME1880 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 35.1 ug/ml) DME1880 XEOTICID XEO05102 GENEFORM Protein DME1880 XEOTICID XEO05102 MOACRIVE Inhibition DME1880 XEOTICID XEO05120 XEO_NAME Thanatin DME1880 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO05120 XEO_CLAS Peptide DME1880 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 0.6-1.2 microM) DME1880 XEOTICID XEO05120 GENEFORM Protein DME1880 XEOTICID XEO05120 MOACRIVE Inhibition DME1880 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1880 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO05163 XEO_CLAS Peptide DME1880 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 12-25 ug/ml) DME1880 XEOTICID XEO05163 GENEFORM Protein DME1880 XEOTICID XEO05163 MOACRIVE Inhibition DME1880 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1880 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1880 XEOTICID XEO05220 XEO_CLAS Peptide DME1880 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Klebsiella aerogenes (MIC = 2.5-5 microM) DME1880 XEOTICID XEO05220 GENEFORM Protein DME1880 XEOTICID XEO05220 MOACRIVE Inhibition DME1881 DME___ID DME1881 DME1881 DME_NAME Metallo-beta-lactamase (blaM) DME1881 SPESNAME Klebsiella pneumoniae DME1881 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1881 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1881 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1881 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO00546 GENEFORM Protein DME1881 XEOTICID XEO00546 MOACRIVE Inhibition DME1881 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1881 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1881 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1881 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO00574 GENEFORM Protein DME1881 XEOTICID XEO00574 MOACRIVE Inhibition DME1881 XEOTICID XEO01266 XEO_NAME Cyanidin DME1881 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME1881 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME1881 XEOTICID XEO01266 DESCRIPT Cyanidin inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO01266 GENEFORM Protein DME1881 XEOTICID XEO01266 MOACRIVE Inhibition DME1881 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1881 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO01816 XEO_CLAS Peptide DME1881 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 6.25 microM) DME1881 XEOTICID XEO01816 GENEFORM Protein DME1881 XEOTICID XEO01816 MOACRIVE Inhibition DME1881 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1881 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO01827 XEO_CLAS Peptide DME1881 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC > 50 microM) DME1881 XEOTICID XEO01827 GENEFORM Protein DME1881 XEOTICID XEO01827 MOACRIVE Inhibition DME1881 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1881 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02115 XEO_CLAS Peptide DME1881 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO02115 GENEFORM Protein DME1881 XEOTICID XEO02115 MOACRIVE Inhibition DME1881 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1881 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02230 XEO_CLAS Peptide DME1881 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1881 XEOTICID XEO02230 GENEFORM Protein DME1881 XEOTICID XEO02230 MOACRIVE Inhibition DME1881 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1881 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02280 XEO_CLAS Peptide DME1881 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO02280 GENEFORM Protein DME1881 XEOTICID XEO02280 MOACRIVE Inhibition DME1881 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1881 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02325 XEO_CLAS Peptide DME1881 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 13 microM) DME1881 XEOTICID XEO02325 GENEFORM Protein DME1881 XEOTICID XEO02325 MOACRIVE Inhibition DME1881 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1881 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02370 XEO_CLAS Peptide DME1881 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO02370 GENEFORM Protein DME1881 XEOTICID XEO02370 MOACRIVE Inhibition DME1881 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1881 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02371 XEO_CLAS Peptide DME1881 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 12 ug/ml) DME1881 XEOTICID XEO02371 GENEFORM Protein DME1881 XEOTICID XEO02371 MOACRIVE Inhibition DME1881 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1881 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02378 XEO_CLAS Peptide DME1881 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 0.76 ug/ml) DME1881 XEOTICID XEO02378 GENEFORM Protein DME1881 XEOTICID XEO02378 MOACRIVE Inhibition DME1881 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1881 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02416 XEO_CLAS Peptide DME1881 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO02416 GENEFORM Protein DME1881 XEOTICID XEO02416 MOACRIVE Inhibition DME1881 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1881 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02451 XEO_CLAS Peptide DME1881 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO02451 GENEFORM Protein DME1881 XEOTICID XEO02451 MOACRIVE Inhibition DME1881 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1881 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02473 XEO_CLAS Peptide DME1881 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO02473 GENEFORM Protein DME1881 XEOTICID XEO02473 MOACRIVE Inhibition DME1881 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1881 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02491 XEO_CLAS Peptide DME1881 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 2.8 microM) DME1881 XEOTICID XEO02491 GENEFORM Protein DME1881 XEOTICID XEO02491 MOACRIVE Inhibition DME1881 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1881 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02496 XEO_CLAS Peptide DME1881 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 50 microM) DME1881 XEOTICID XEO02496 GENEFORM Protein DME1881 XEOTICID XEO02496 MOACRIVE Inhibition DME1881 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1881 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02497 XEO_CLAS Peptide DME1881 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC > 50 microM) DME1881 XEOTICID XEO02497 GENEFORM Protein DME1881 XEOTICID XEO02497 MOACRIVE Inhibition DME1881 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1881 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02512 XEO_CLAS Peptide DME1881 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 150 microM) DME1881 XEOTICID XEO02512 GENEFORM Protein DME1881 XEOTICID XEO02512 MOACRIVE Inhibition DME1881 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1881 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02566 XEO_CLAS Peptide DME1881 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC > 100 microM) DME1881 XEOTICID XEO02566 GENEFORM Protein DME1881 XEOTICID XEO02566 MOACRIVE Inhibition DME1881 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1881 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02637 XEO_CLAS Peptide DME1881 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 6 microM) DME1881 XEOTICID XEO02637 GENEFORM Protein DME1881 XEOTICID XEO02637 MOACRIVE Inhibition DME1881 XEOTICID XEO02656 XEO_NAME Himatanthus drasticus butanolic extract DME1881 XEOTICID XEO02656 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1881 XEOTICID XEO02656 XEO_CLAS Plant Extract DME1881 XEOTICID XEO02656 DESCRIPT Himatanthus drasticus butanolic extract inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO02656 GENEFORM Protein DME1881 XEOTICID XEO02656 MOACRIVE Inhibition DME1881 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1881 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02688 XEO_CLAS Peptide DME1881 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 25 microM) DME1881 XEOTICID XEO02688 GENEFORM Protein DME1881 XEOTICID XEO02688 MOACRIVE Inhibition DME1881 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1881 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02708 XEO_CLAS Peptide DME1881 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 20 ug/ml) DME1881 XEOTICID XEO02708 GENEFORM Protein DME1881 XEOTICID XEO02708 MOACRIVE Inhibition DME1881 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1881 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02732 XEO_CLAS Peptide DME1881 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 1.25 microM) DME1881 XEOTICID XEO02732 GENEFORM Protein DME1881 XEOTICID XEO02732 MOACRIVE Inhibition DME1881 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1881 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02734 XEO_CLAS Peptide DME1881 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 0.40 microM) DME1881 XEOTICID XEO02734 GENEFORM Protein DME1881 XEOTICID XEO02734 MOACRIVE Inhibition DME1881 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1881 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02736 XEO_CLAS Peptide DME1881 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 0.66 microM) DME1881 XEOTICID XEO02736 GENEFORM Protein DME1881 XEOTICID XEO02736 MOACRIVE Inhibition DME1881 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1881 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02738 XEO_CLAS Peptide DME1881 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 1 microM) DME1881 XEOTICID XEO02738 GENEFORM Protein DME1881 XEOTICID XEO02738 MOACRIVE Inhibition DME1881 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1881 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02743 XEO_CLAS Peptide DME1881 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 4.7 ug/ml) DME1881 XEOTICID XEO02743 GENEFORM Protein DME1881 XEOTICID XEO02743 MOACRIVE Inhibition DME1881 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1881 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02749 XEO_CLAS Peptide DME1881 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 20 mug/ml) DME1881 XEOTICID XEO02749 GENEFORM Protein DME1881 XEOTICID XEO02749 MOACRIVE Inhibition DME1881 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1881 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02767 XEO_CLAS Peptide DME1881 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO02767 GENEFORM Protein DME1881 XEOTICID XEO02767 MOACRIVE Inhibition DME1881 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1881 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02768 XEO_CLAS Peptide DME1881 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 1-2.5 ug/ml) DME1881 XEOTICID XEO02768 GENEFORM Protein DME1881 XEOTICID XEO02768 MOACRIVE Inhibition DME1881 XEOTICID XEO02780 XEO_NAME Cefixime DME1881 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1881 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1881 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO02780 GENEFORM Protein DME1881 XEOTICID XEO02780 MOACRIVE Inhibition DME1881 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1881 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO02942 XEO_CLAS Peptide DME1881 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO02942 GENEFORM Protein DME1881 XEOTICID XEO02942 MOACRIVE Inhibition DME1881 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1881 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03029 XEO_CLAS Peptide DME1881 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 0.145 microM) DME1881 XEOTICID XEO03029 GENEFORM Protein DME1881 XEOTICID XEO03029 MOACRIVE Inhibition DME1881 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1881 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03030 XEO_CLAS Peptide DME1881 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 0.643 microM) DME1881 XEOTICID XEO03030 GENEFORM Protein DME1881 XEOTICID XEO03030 MOACRIVE Inhibition DME1881 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1881 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03031 XEO_CLAS Peptide DME1881 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 0.01 microM) DME1881 XEOTICID XEO03031 GENEFORM Protein DME1881 XEOTICID XEO03031 MOACRIVE Inhibition DME1881 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1881 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03032 XEO_CLAS Peptide DME1881 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC < 0.005 microM) DME1881 XEOTICID XEO03032 GENEFORM Protein DME1881 XEOTICID XEO03032 MOACRIVE Inhibition DME1881 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1881 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03033 XEO_CLAS Peptide DME1881 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC > 0.692 microM) DME1881 XEOTICID XEO03033 GENEFORM Protein DME1881 XEOTICID XEO03033 MOACRIVE Inhibition DME1881 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1881 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03034 XEO_CLAS Peptide DME1881 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 0.004 microM) DME1881 XEOTICID XEO03034 GENEFORM Protein DME1881 XEOTICID XEO03034 MOACRIVE Inhibition DME1881 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1881 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03035 XEO_CLAS Peptide DME1881 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 0.458 microM) DME1881 XEOTICID XEO03035 GENEFORM Protein DME1881 XEOTICID XEO03035 MOACRIVE Inhibition DME1881 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1881 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03051 XEO_CLAS Peptide DME1881 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1881 XEOTICID XEO03051 GENEFORM Protein DME1881 XEOTICID XEO03051 MOACRIVE Inhibition DME1881 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1881 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03052 XEO_CLAS Peptide DME1881 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1881 XEOTICID XEO03052 GENEFORM Protein DME1881 XEOTICID XEO03052 MOACRIVE Inhibition DME1881 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1881 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03053 XEO_CLAS Peptide DME1881 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1881 XEOTICID XEO03053 GENEFORM Protein DME1881 XEOTICID XEO03053 MOACRIVE Inhibition DME1881 XEOTICID XEO03089 XEO_NAME Decoralin DME1881 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03089 XEO_CLAS Peptide DME1881 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 80 microM) DME1881 XEOTICID XEO03089 GENEFORM Protein DME1881 XEOTICID XEO03089 MOACRIVE Inhibition DME1881 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1881 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03112 XEO_CLAS Peptide DME1881 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC > 50 ug/ml) DME1881 XEOTICID XEO03112 GENEFORM Protein DME1881 XEOTICID XEO03112 MOACRIVE Inhibition DME1881 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1881 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03137 XEO_CLAS Peptide DME1881 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03137 GENEFORM Protein DME1881 XEOTICID XEO03137 MOACRIVE Inhibition DME1881 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1881 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03162 XEO_CLAS Peptide DME1881 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 0.8 microM) DME1881 XEOTICID XEO03162 GENEFORM Protein DME1881 XEOTICID XEO03162 MOACRIVE Inhibition DME1881 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1881 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03224 XEO_CLAS Peptide DME1881 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1881 XEOTICID XEO03224 GENEFORM Protein DME1881 XEOTICID XEO03224 MOACRIVE Inhibition DME1881 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1881 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03235 XEO_CLAS Peptide DME1881 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 60 ug/ml) DME1881 XEOTICID XEO03235 GENEFORM Protein DME1881 XEOTICID XEO03235 MOACRIVE Inhibition DME1881 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1881 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03237 XEO_CLAS Peptide DME1881 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC > 100 ug/ml) DME1881 XEOTICID XEO03237 GENEFORM Protein DME1881 XEOTICID XEO03237 MOACRIVE Inhibition DME1881 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1881 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03238 XEO_CLAS Peptide DME1881 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1881 XEOTICID XEO03238 GENEFORM Protein DME1881 XEOTICID XEO03238 MOACRIVE Inhibition DME1881 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1881 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03239 XEO_CLAS Peptide DME1881 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1881 XEOTICID XEO03239 GENEFORM Protein DME1881 XEOTICID XEO03239 MOACRIVE Inhibition DME1881 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1881 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03250 XEO_CLAS Peptide DME1881 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03250 GENEFORM Protein DME1881 XEOTICID XEO03250 MOACRIVE Inhibition DME1881 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1881 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03251 XEO_CLAS Peptide DME1881 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03251 GENEFORM Protein DME1881 XEOTICID XEO03251 MOACRIVE Inhibition DME1881 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1881 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03253 XEO_CLAS Peptide DME1881 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 3.2 ug/ml) DME1881 XEOTICID XEO03253 GENEFORM Protein DME1881 XEOTICID XEO03253 MOACRIVE Inhibition DME1881 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1881 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1881 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1881 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03348 GENEFORM Protein DME1881 XEOTICID XEO03348 MOACRIVE Inhibition DME1881 XEOTICID XEO03387 XEO_NAME Ferric chloride DME1881 XEOTICID XEO03387 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1881 XEOTICID XEO03387 XEO_CLAS Chemical Compound DME1881 XEOTICID XEO03387 DESCRIPT Ferric chloride inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03387 GENEFORM Protein DME1881 XEOTICID XEO03387 MOACRIVE Inhibition DME1881 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1881 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03436 XEO_CLAS Peptide DME1881 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1881 XEOTICID XEO03436 GENEFORM Protein DME1881 XEOTICID XEO03436 MOACRIVE Inhibition DME1881 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1881 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03437 XEO_CLAS Peptide DME1881 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1881 XEOTICID XEO03437 GENEFORM Protein DME1881 XEOTICID XEO03437 MOACRIVE Inhibition DME1881 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1881 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03438 XEO_CLAS Peptide DME1881 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1881 XEOTICID XEO03438 GENEFORM Protein DME1881 XEOTICID XEO03438 MOACRIVE Inhibition DME1881 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1881 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03439 XEO_CLAS Peptide DME1881 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1881 XEOTICID XEO03439 GENEFORM Protein DME1881 XEOTICID XEO03439 MOACRIVE Inhibition DME1881 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1881 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03440 XEO_CLAS Peptide DME1881 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1881 XEOTICID XEO03440 GENEFORM Protein DME1881 XEOTICID XEO03440 MOACRIVE Inhibition DME1881 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1881 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03441 XEO_CLAS Peptide DME1881 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1881 XEOTICID XEO03441 GENEFORM Protein DME1881 XEOTICID XEO03441 MOACRIVE Inhibition DME1881 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1881 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03497 XEO_CLAS Peptide DME1881 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1881 XEOTICID XEO03497 GENEFORM Protein DME1881 XEOTICID XEO03497 MOACRIVE Inhibition DME1881 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1881 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03498 XEO_CLAS Peptide DME1881 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1881 XEOTICID XEO03498 GENEFORM Protein DME1881 XEOTICID XEO03498 MOACRIVE Inhibition DME1881 XEOTICID XEO03519 XEO_NAME Hadrurin DME1881 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03519 XEO_CLAS Peptide DME1881 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03519 GENEFORM Protein DME1881 XEOTICID XEO03519 MOACRIVE Inhibition DME1881 XEOTICID XEO03522 XEO_NAME Halocyntin DME1881 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03522 XEO_CLAS Peptide DME1881 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03522 GENEFORM Protein DME1881 XEOTICID XEO03522 MOACRIVE Inhibition DME1881 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1881 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03540 XEO_CLAS Peptide DME1881 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1881 XEOTICID XEO03540 GENEFORM Protein DME1881 XEOTICID XEO03540 MOACRIVE Inhibition DME1881 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1881 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03549 XEO_CLAS Peptide DME1881 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03549 GENEFORM Protein DME1881 XEOTICID XEO03549 MOACRIVE Inhibition DME1881 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1881 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1881 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1881 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03552 GENEFORM Protein DME1881 XEOTICID XEO03552 MOACRIVE Inhibition DME1881 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1881 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03556 XEO_CLAS Peptide DME1881 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1881 XEOTICID XEO03556 GENEFORM Protein DME1881 XEOTICID XEO03556 MOACRIVE Inhibition DME1881 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1881 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03557 XEO_CLAS Peptide DME1881 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1881 XEOTICID XEO03557 GENEFORM Protein DME1881 XEOTICID XEO03557 MOACRIVE Inhibition DME1881 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1881 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03591 XEO_CLAS Peptide DME1881 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1881 XEOTICID XEO03591 GENEFORM Protein DME1881 XEOTICID XEO03591 MOACRIVE Inhibition DME1881 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1881 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03593 XEO_CLAS Peptide DME1881 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1881 XEOTICID XEO03593 GENEFORM Protein DME1881 XEOTICID XEO03593 MOACRIVE Inhibition DME1881 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1881 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03609 XEO_CLAS Peptide DME1881 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03609 GENEFORM Protein DME1881 XEOTICID XEO03609 MOACRIVE Inhibition DME1881 XEOTICID XEO03611 XEO_NAME Himatanthus drasticus hydroalcoholic extract DME1881 XEOTICID XEO03611 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1881 XEOTICID XEO03611 XEO_CLAS Plant Extract DME1881 XEOTICID XEO03611 DESCRIPT Himatanthus drasticus hydroalcoholic extract inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03611 GENEFORM Protein DME1881 XEOTICID XEO03611 MOACRIVE Inhibition DME1881 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1881 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03622 XEO_CLAS Peptide DME1881 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 20-40 microM) DME1881 XEOTICID XEO03622 GENEFORM Protein DME1881 XEOTICID XEO03622 MOACRIVE Inhibition DME1881 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1881 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03630 XEO_CLAS Peptide DME1881 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03630 GENEFORM Protein DME1881 XEOTICID XEO03630 MOACRIVE Inhibition DME1881 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1881 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03631 XEO_CLAS Peptide DME1881 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03631 GENEFORM Protein DME1881 XEOTICID XEO03631 MOACRIVE Inhibition DME1881 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1881 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03632 XEO_CLAS Peptide DME1881 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03632 GENEFORM Protein DME1881 XEOTICID XEO03632 MOACRIVE Inhibition DME1881 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1881 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03633 XEO_CLAS Peptide DME1881 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03633 GENEFORM Protein DME1881 XEOTICID XEO03633 MOACRIVE Inhibition DME1881 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1881 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03634 XEO_CLAS Peptide DME1881 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03634 GENEFORM Protein DME1881 XEOTICID XEO03634 MOACRIVE Inhibition DME1881 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1881 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03635 XEO_CLAS Peptide DME1881 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03635 GENEFORM Protein DME1881 XEOTICID XEO03635 MOACRIVE Inhibition DME1881 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1881 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03636 XEO_CLAS Peptide DME1881 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03636 GENEFORM Protein DME1881 XEOTICID XEO03636 MOACRIVE Inhibition DME1881 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1881 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03637 XEO_CLAS Peptide DME1881 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03637 GENEFORM Protein DME1881 XEOTICID XEO03637 MOACRIVE Inhibition DME1881 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1881 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03638 XEO_CLAS Peptide DME1881 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03638 GENEFORM Protein DME1881 XEOTICID XEO03638 MOACRIVE Inhibition DME1881 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1881 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03639 XEO_CLAS Peptide DME1881 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03639 GENEFORM Protein DME1881 XEOTICID XEO03639 MOACRIVE Inhibition DME1881 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1881 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03640 XEO_CLAS Peptide DME1881 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03640 GENEFORM Protein DME1881 XEOTICID XEO03640 MOACRIVE Inhibition DME1881 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1881 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03672 XEO_CLAS Peptide DME1881 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1881 XEOTICID XEO03672 GENEFORM Protein DME1881 XEOTICID XEO03672 MOACRIVE Inhibition DME1881 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1881 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03673 XEO_CLAS Peptide DME1881 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1881 XEOTICID XEO03673 GENEFORM Protein DME1881 XEOTICID XEO03673 MOACRIVE Inhibition DME1881 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1881 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03674 XEO_CLAS Peptide DME1881 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO03674 GENEFORM Protein DME1881 XEOTICID XEO03674 MOACRIVE Inhibition DME1881 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1881 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03675 XEO_CLAS Peptide DME1881 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 15 microM) DME1881 XEOTICID XEO03675 GENEFORM Protein DME1881 XEOTICID XEO03675 MOACRIVE Inhibition DME1881 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1881 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03678 XEO_CLAS Peptide DME1881 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1881 XEOTICID XEO03678 GENEFORM Protein DME1881 XEOTICID XEO03678 MOACRIVE Inhibition DME1881 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1881 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03681 XEO_CLAS Peptide DME1881 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 1.2-2.5 microM) DME1881 XEOTICID XEO03681 GENEFORM Protein DME1881 XEOTICID XEO03681 MOACRIVE Inhibition DME1881 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1881 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03697 XEO_CLAS Peptide DME1881 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 25 microM) DME1881 XEOTICID XEO03697 GENEFORM Protein DME1881 XEOTICID XEO03697 MOACRIVE Inhibition DME1881 XEOTICID XEO03724 XEO_NAME L10 peptide DME1881 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03724 XEO_CLAS Peptide DME1881 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 3.35 microM) DME1881 XEOTICID XEO03724 GENEFORM Protein DME1881 XEOTICID XEO03724 MOACRIVE Inhibition DME1881 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1881 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03744 XEO_CLAS Peptide DME1881 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1881 XEOTICID XEO03744 GENEFORM Protein DME1881 XEOTICID XEO03744 MOACRIVE Inhibition DME1881 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1881 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03746 XEO_CLAS Peptide DME1881 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1881 XEOTICID XEO03746 GENEFORM Protein DME1881 XEOTICID XEO03746 MOACRIVE Inhibition DME1881 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1881 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03747 XEO_CLAS Peptide DME1881 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1881 XEOTICID XEO03747 GENEFORM Protein DME1881 XEOTICID XEO03747 MOACRIVE Inhibition DME1881 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1881 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03748 XEO_CLAS Peptide DME1881 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1881 XEOTICID XEO03748 GENEFORM Protein DME1881 XEOTICID XEO03748 MOACRIVE Inhibition DME1881 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1881 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03749 XEO_CLAS Peptide DME1881 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1881 XEOTICID XEO03749 GENEFORM Protein DME1881 XEOTICID XEO03749 MOACRIVE Inhibition DME1881 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1881 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03750 XEO_CLAS Peptide DME1881 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1881 XEOTICID XEO03750 GENEFORM Protein DME1881 XEOTICID XEO03750 MOACRIVE Inhibition DME1881 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1881 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03751 XEO_CLAS Peptide DME1881 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1881 XEOTICID XEO03751 GENEFORM Protein DME1881 XEOTICID XEO03751 MOACRIVE Inhibition DME1881 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1881 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03752 XEO_CLAS Peptide DME1881 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1881 XEOTICID XEO03752 GENEFORM Protein DME1881 XEOTICID XEO03752 MOACRIVE Inhibition DME1881 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1881 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03753 XEO_CLAS Peptide DME1881 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1881 XEOTICID XEO03753 GENEFORM Protein DME1881 XEOTICID XEO03753 MOACRIVE Inhibition DME1881 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1881 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03754 XEO_CLAS Peptide DME1881 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1881 XEOTICID XEO03754 GENEFORM Protein DME1881 XEOTICID XEO03754 MOACRIVE Inhibition DME1881 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1881 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03755 XEO_CLAS Peptide DME1881 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1881 XEOTICID XEO03755 GENEFORM Protein DME1881 XEOTICID XEO03755 MOACRIVE Inhibition DME1881 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1881 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03756 XEO_CLAS Peptide DME1881 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1881 XEOTICID XEO03756 GENEFORM Protein DME1881 XEOTICID XEO03756 MOACRIVE Inhibition DME1881 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1881 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03759 XEO_CLAS Peptide DME1881 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1881 XEOTICID XEO03759 GENEFORM Protein DME1881 XEOTICID XEO03759 MOACRIVE Inhibition DME1881 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1881 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03761 XEO_CLAS Peptide DME1881 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1881 XEOTICID XEO03761 GENEFORM Protein DME1881 XEOTICID XEO03761 MOACRIVE Inhibition DME1881 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1881 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO03985 XEO_CLAS Peptide DME1881 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1881 XEOTICID XEO03985 GENEFORM Protein DME1881 XEOTICID XEO03985 MOACRIVE Inhibition DME1881 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1881 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04001 XEO_CLAS Peptide DME1881 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 12.5 microM) DME1881 XEOTICID XEO04001 GENEFORM Protein DME1881 XEOTICID XEO04001 MOACRIVE Inhibition DME1881 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1881 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04007 XEO_CLAS Peptide DME1881 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1881 XEOTICID XEO04007 GENEFORM Protein DME1881 XEOTICID XEO04007 MOACRIVE Inhibition DME1881 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1881 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04011 XEO_CLAS Peptide DME1881 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1881 XEOTICID XEO04011 GENEFORM Protein DME1881 XEOTICID XEO04011 MOACRIVE Inhibition DME1881 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1881 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04012 XEO_CLAS Peptide DME1881 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1881 XEOTICID XEO04012 GENEFORM Protein DME1881 XEOTICID XEO04012 MOACRIVE Inhibition DME1881 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1881 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04013 XEO_CLAS Peptide DME1881 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1881 XEOTICID XEO04013 GENEFORM Protein DME1881 XEOTICID XEO04013 MOACRIVE Inhibition DME1881 XEOTICID XEO04014 XEO_NAME Maximin-5 DME1881 XEOTICID XEO04014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04014 XEO_CLAS Peptide DME1881 XEOTICID XEO04014 DESCRIPT Maximin-5 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 3.6 ug/ml) DME1881 XEOTICID XEO04014 GENEFORM Protein DME1881 XEOTICID XEO04014 MOACRIVE Inhibition DME1881 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1881 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1881 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1881 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04087 GENEFORM Protein DME1881 XEOTICID XEO04087 MOACRIVE Inhibition DME1881 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1881 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04111 XEO_CLAS Peptide DME1881 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04111 GENEFORM Protein DME1881 XEOTICID XEO04111 MOACRIVE Inhibition DME1881 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1881 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04241 XEO_CLAS Peptide DME1881 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04241 GENEFORM Protein DME1881 XEOTICID XEO04241 MOACRIVE Inhibition DME1881 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1881 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04242 XEO_CLAS Peptide DME1881 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04242 GENEFORM Protein DME1881 XEOTICID XEO04242 MOACRIVE Inhibition DME1881 XEOTICID XEO04331 XEO_NAME Norspermidine DME1881 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1881 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1881 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04331 GENEFORM Protein DME1881 XEOTICID XEO04331 MOACRIVE Inhibition DME1881 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1881 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04348 XEO_CLAS Peptide DME1881 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 80 microM) DME1881 XEOTICID XEO04348 GENEFORM Protein DME1881 XEOTICID XEO04348 MOACRIVE Inhibition DME1881 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1881 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04349 XEO_CLAS Peptide DME1881 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 100 microM) DME1881 XEOTICID XEO04349 GENEFORM Protein DME1881 XEOTICID XEO04349 MOACRIVE Inhibition DME1881 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1881 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04399 XEO_CLAS Peptide DME1881 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 6.3 microM) DME1881 XEOTICID XEO04399 GENEFORM Protein DME1881 XEOTICID XEO04399 MOACRIVE Inhibition DME1881 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1881 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04426 XEO_CLAS Peptide DME1881 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 2 microM) DME1881 XEOTICID XEO04426 GENEFORM Protein DME1881 XEOTICID XEO04426 MOACRIVE Inhibition DME1881 XEOTICID XEO04468 XEO_NAME Papillosin DME1881 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04468 XEO_CLAS Peptide DME1881 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04468 GENEFORM Protein DME1881 XEOTICID XEO04468 MOACRIVE Inhibition DME1881 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1881 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04471 XEO_CLAS Peptide DME1881 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 1.6 microM) DME1881 XEOTICID XEO04471 GENEFORM Protein DME1881 XEOTICID XEO04471 MOACRIVE Inhibition DME1881 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1881 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04506 XEO_CLAS Peptide DME1881 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC > 20 microM) DME1881 XEOTICID XEO04506 GENEFORM Protein DME1881 XEOTICID XEO04506 MOACRIVE Inhibition DME1881 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1881 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04507 XEO_CLAS Peptide DME1881 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC > 40 microM) DME1881 XEOTICID XEO04507 GENEFORM Protein DME1881 XEOTICID XEO04507 MOACRIVE Inhibition DME1881 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1881 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04510 XEO_CLAS Peptide DME1881 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC > 50 microM) DME1881 XEOTICID XEO04510 GENEFORM Protein DME1881 XEOTICID XEO04510 MOACRIVE Inhibition DME1881 XEOTICID XEO04531 XEO_NAME Mollusca/molluscs/mollusks peptide 2 DME1881 XEOTICID XEO04531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04531 XEO_CLAS Peptide DME1881 XEOTICID XEO04531 DESCRIPT Mollusca/molluscs/mollusks peptide 2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04531 GENEFORM Protein DME1881 XEOTICID XEO04531 MOACRIVE Inhibition DME1881 XEOTICID XEO04533 XEO_NAME Mollusca/molluscs/mollusks peptide 3 DME1881 XEOTICID XEO04533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04533 XEO_CLAS Peptide DME1881 XEOTICID XEO04533 DESCRIPT Mollusca/molluscs/mollusks peptide 3 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04533 GENEFORM Protein DME1881 XEOTICID XEO04533 MOACRIVE Inhibition DME1881 XEOTICID XEO04534 XEO_NAME Mollusca/molluscs/mollusks peptide 4 DME1881 XEOTICID XEO04534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04534 XEO_CLAS Peptide DME1881 XEOTICID XEO04534 DESCRIPT Mollusca/molluscs/mollusks peptide 4 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04534 GENEFORM Protein DME1881 XEOTICID XEO04534 MOACRIVE Inhibition DME1881 XEOTICID XEO04535 XEO_NAME Mollusca/molluscs/mollusks peptide 5 DME1881 XEOTICID XEO04535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04535 XEO_CLAS Peptide DME1881 XEOTICID XEO04535 DESCRIPT Mollusca/molluscs/mollusks peptide 5 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04535 GENEFORM Protein DME1881 XEOTICID XEO04535 MOACRIVE Inhibition DME1881 XEOTICID XEO04536 XEO_NAME Mollusca/molluscs/mollusks peptide 6 DME1881 XEOTICID XEO04536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04536 XEO_CLAS Peptide DME1881 XEOTICID XEO04536 DESCRIPT Mollusca/molluscs/mollusks peptide 6 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04536 GENEFORM Protein DME1881 XEOTICID XEO04536 MOACRIVE Inhibition DME1881 XEOTICID XEO04537 XEO_NAME Mollusca/molluscs/mollusks peptide 7 DME1881 XEOTICID XEO04537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04537 XEO_CLAS Peptide DME1881 XEOTICID XEO04537 DESCRIPT Mollusca/molluscs/mollusks peptide 7 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04537 GENEFORM Protein DME1881 XEOTICID XEO04537 MOACRIVE Inhibition DME1881 XEOTICID XEO04538 XEO_NAME Mollusca/molluscs/mollusks peptide 8 DME1881 XEOTICID XEO04538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04538 XEO_CLAS Peptide DME1881 XEOTICID XEO04538 DESCRIPT Mollusca/molluscs/mollusks peptide 8 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04538 GENEFORM Protein DME1881 XEOTICID XEO04538 MOACRIVE Inhibition DME1881 XEOTICID XEO04539 XEO_NAME Mollusca/molluscs/mollusks peptide 9 DME1881 XEOTICID XEO04539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04539 XEO_CLAS Peptide DME1881 XEOTICID XEO04539 DESCRIPT Mollusca/molluscs/mollusks peptide 9 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04539 GENEFORM Protein DME1881 XEOTICID XEO04539 MOACRIVE Inhibition DME1881 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1881 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04548 XEO_CLAS Peptide DME1881 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 32000 ug/ml) DME1881 XEOTICID XEO04548 GENEFORM Protein DME1881 XEOTICID XEO04548 MOACRIVE Inhibition DME1881 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1881 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04549 XEO_CLAS Peptide DME1881 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 250-500 ug/ml) DME1881 XEOTICID XEO04549 GENEFORM Protein DME1881 XEOTICID XEO04549 MOACRIVE Inhibition DME1881 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1881 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04571 XEO_CLAS Peptide DME1881 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04571 GENEFORM Protein DME1881 XEOTICID XEO04571 MOACRIVE Inhibition DME1881 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1881 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04572 XEO_CLAS Peptide DME1881 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04572 GENEFORM Protein DME1881 XEOTICID XEO04572 MOACRIVE Inhibition DME1881 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1881 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04606 XEO_CLAS Peptide DME1881 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 2 microM) DME1881 XEOTICID XEO04606 GENEFORM Protein DME1881 XEOTICID XEO04606 MOACRIVE Inhibition DME1881 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1881 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04612 XEO_CLAS Peptide DME1881 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1881 XEOTICID XEO04612 GENEFORM Protein DME1881 XEOTICID XEO04612 MOACRIVE Inhibition DME1881 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1881 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04613 XEO_CLAS Peptide DME1881 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1881 XEOTICID XEO04613 GENEFORM Protein DME1881 XEOTICID XEO04613 MOACRIVE Inhibition DME1881 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1881 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04695 XEO_CLAS Peptide DME1881 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04695 GENEFORM Protein DME1881 XEOTICID XEO04695 MOACRIVE Inhibition DME1881 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1881 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04696 XEO_CLAS Peptide DME1881 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04696 GENEFORM Protein DME1881 XEOTICID XEO04696 MOACRIVE Inhibition DME1881 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1881 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04697 XEO_CLAS Peptide DME1881 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04697 GENEFORM Protein DME1881 XEOTICID XEO04697 MOACRIVE Inhibition DME1881 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1881 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04698 XEO_CLAS Peptide DME1881 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04698 GENEFORM Protein DME1881 XEOTICID XEO04698 MOACRIVE Inhibition DME1881 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1881 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04699 XEO_CLAS Peptide DME1881 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04699 GENEFORM Protein DME1881 XEOTICID XEO04699 MOACRIVE Inhibition DME1881 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1881 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04700 XEO_CLAS Peptide DME1881 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04700 GENEFORM Protein DME1881 XEOTICID XEO04700 MOACRIVE Inhibition DME1881 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1881 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04701 XEO_CLAS Peptide DME1881 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04701 GENEFORM Protein DME1881 XEOTICID XEO04701 MOACRIVE Inhibition DME1881 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1881 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04702 XEO_CLAS Peptide DME1881 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04702 GENEFORM Protein DME1881 XEOTICID XEO04702 MOACRIVE Inhibition DME1881 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1881 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04703 XEO_CLAS Peptide DME1881 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04703 GENEFORM Protein DME1881 XEOTICID XEO04703 MOACRIVE Inhibition DME1881 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1881 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04762 XEO_CLAS Peptide DME1881 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC > 25 microM) DME1881 XEOTICID XEO04762 GENEFORM Protein DME1881 XEOTICID XEO04762 MOACRIVE Inhibition DME1881 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1881 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04809 XEO_CLAS Peptide DME1881 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 10 microM) DME1881 XEOTICID XEO04809 GENEFORM Protein DME1881 XEOTICID XEO04809 MOACRIVE Inhibition DME1881 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1881 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04891 XEO_CLAS Peptide DME1881 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04891 GENEFORM Protein DME1881 XEOTICID XEO04891 MOACRIVE Inhibition DME1881 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1881 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04905 XEO_CLAS Peptide DME1881 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04905 GENEFORM Protein DME1881 XEOTICID XEO04905 MOACRIVE Inhibition DME1881 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1881 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04906 XEO_CLAS Peptide DME1881 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO04906 GENEFORM Protein DME1881 XEOTICID XEO04906 MOACRIVE Inhibition DME1881 XEOTICID XEO04917 XEO_NAME Scorpine DME1881 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04917 XEO_CLAS Peptide DME1881 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 10 microM) DME1881 XEOTICID XEO04917 GENEFORM Protein DME1881 XEOTICID XEO04917 MOACRIVE Inhibition DME1881 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1881 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04971 XEO_CLAS Peptide DME1881 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1881 XEOTICID XEO04971 GENEFORM Protein DME1881 XEOTICID XEO04971 MOACRIVE Inhibition DME1881 XEOTICID XEO04974 XEO_NAME Spinigerin DME1881 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04974 XEO_CLAS Peptide DME1881 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1881 XEOTICID XEO04974 GENEFORM Protein DME1881 XEOTICID XEO04974 MOACRIVE Inhibition DME1881 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1881 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO04995 XEO_CLAS Peptide DME1881 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 0.78-1.56 microM) DME1881 XEOTICID XEO04995 GENEFORM Protein DME1881 XEOTICID XEO04995 MOACRIVE Inhibition DME1881 XEOTICID XEO05020 XEO_NAME Tachycitin DME1881 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO05020 XEO_CLAS Peptide DME1881 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae DME1881 XEOTICID XEO05020 GENEFORM Protein DME1881 XEOTICID XEO05020 MOACRIVE Inhibition DME1881 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1881 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO05073 XEO_CLAS Peptide DME1881 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 80 microM) DME1881 XEOTICID XEO05073 GENEFORM Protein DME1881 XEOTICID XEO05073 MOACRIVE Inhibition DME1881 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1881 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO05075 XEO_CLAS Peptide DME1881 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 80 microM) DME1881 XEOTICID XEO05075 GENEFORM Protein DME1881 XEOTICID XEO05075 MOACRIVE Inhibition DME1881 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1881 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO05101 XEO_CLAS Peptide DME1881 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 31.2 ug/ml) DME1881 XEOTICID XEO05101 GENEFORM Protein DME1881 XEOTICID XEO05101 MOACRIVE Inhibition DME1881 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1881 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO05102 XEO_CLAS Peptide DME1881 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 35.1 ug/ml) DME1881 XEOTICID XEO05102 GENEFORM Protein DME1881 XEOTICID XEO05102 MOACRIVE Inhibition DME1881 XEOTICID XEO05120 XEO_NAME Thanatin DME1881 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO05120 XEO_CLAS Peptide DME1881 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 0.6-1.2 microM) DME1881 XEOTICID XEO05120 GENEFORM Protein DME1881 XEOTICID XEO05120 MOACRIVE Inhibition DME1881 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1881 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO05163 XEO_CLAS Peptide DME1881 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 12-25 ug/ml) DME1881 XEOTICID XEO05163 GENEFORM Protein DME1881 XEOTICID XEO05163 MOACRIVE Inhibition DME1881 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1881 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1881 XEOTICID XEO05220 XEO_CLAS Peptide DME1881 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Metallo-beta-lactamase (blaM) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1881 XEOTICID XEO05220 GENEFORM Protein DME1881 XEOTICID XEO05220 MOACRIVE Inhibition DME1916 DME___ID DME1916 DME1916 DME_NAME Methylthioribose kinase (mtnK) DME1916 SPESNAME Klebsiella pneumoniae DME1916 XEOTICID XEO00546 XEO_NAME Salicylic acid DME1916 XEOTICID XEO00546 XEO_TYPE Pharmaceutical Agent(s) DME1916 XEOTICID XEO00546 XEO_CLAS Drug in Phase 2 Clinical Trial DME1916 XEOTICID XEO00546 DESCRIPT Salicylic acid inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO00546 GENEFORM Protein DME1916 XEOTICID XEO00546 MOACRIVE Inhibition DME1916 XEOTICID XEO00574 XEO_NAME Phenanthrene DME1916 XEOTICID XEO00574 XEO_TYPE Pharmaceutical Agent(s) DME1916 XEOTICID XEO00574 XEO_CLAS Drug in Phase 1 Clinical Trial DME1916 XEOTICID XEO00574 DESCRIPT Phenanthrene inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO00574 GENEFORM Protein DME1916 XEOTICID XEO00574 MOACRIVE Inhibition DME1916 XEOTICID XEO01266 XEO_NAME Cyanidin DME1916 XEOTICID XEO01266 XEO_TYPE Pharmaceutical Agent(s) DME1916 XEOTICID XEO01266 XEO_CLAS Drug in Phase 1 Clinical Trial DME1916 XEOTICID XEO01266 DESCRIPT Cyanidin inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO01266 GENEFORM Protein DME1916 XEOTICID XEO01266 MOACRIVE Inhibition DME1916 XEOTICID XEO01816 XEO_NAME Mastoparan-L [I5,R8] derivative DME1916 XEOTICID XEO01816 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO01816 XEO_CLAS Peptide DME1916 XEOTICID XEO01816 DESCRIPT Mastoparan-L [I5,R8] derivative inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 6.25 microM) DME1916 XEOTICID XEO01816 GENEFORM Protein DME1916 XEOTICID XEO01816 MOACRIVE Inhibition DME1916 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME1916 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO01827 XEO_CLAS Peptide DME1916 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC > 50 microM) DME1916 XEOTICID XEO01827 GENEFORM Protein DME1916 XEOTICID XEO01827 MOACRIVE Inhibition DME1916 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1916 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02115 XEO_CLAS Peptide DME1916 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO02115 GENEFORM Protein DME1916 XEOTICID XEO02115 MOACRIVE Inhibition DME1916 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1916 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02230 XEO_CLAS Peptide DME1916 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1916 XEOTICID XEO02230 GENEFORM Protein DME1916 XEOTICID XEO02230 MOACRIVE Inhibition DME1916 XEOTICID XEO02280 XEO_NAME Antimicrobial peptide eNAP-1 DME1916 XEOTICID XEO02280 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02280 XEO_CLAS Peptide DME1916 XEOTICID XEO02280 DESCRIPT Antimicrobial peptide eNAP-1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO02280 GENEFORM Protein DME1916 XEOTICID XEO02280 MOACRIVE Inhibition DME1916 XEOTICID XEO02325 XEO_NAME Ascaphin-5 DME1916 XEOTICID XEO02325 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02325 XEO_CLAS Peptide DME1916 XEOTICID XEO02325 DESCRIPT Ascaphin-5 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 13 microM) DME1916 XEOTICID XEO02325 GENEFORM Protein DME1916 XEOTICID XEO02325 MOACRIVE Inhibition DME1916 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1916 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02370 XEO_CLAS Peptide DME1916 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO02370 GENEFORM Protein DME1916 XEOTICID XEO02370 MOACRIVE Inhibition DME1916 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1916 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02371 XEO_CLAS Peptide DME1916 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 12 ug/ml) DME1916 XEOTICID XEO02371 GENEFORM Protein DME1916 XEOTICID XEO02371 MOACRIVE Inhibition DME1916 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1916 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02378 XEO_CLAS Peptide DME1916 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 0.76 ug/ml) DME1916 XEOTICID XEO02378 GENEFORM Protein DME1916 XEOTICID XEO02378 MOACRIVE Inhibition DME1916 XEOTICID XEO02416 XEO_NAME Bass hepcidin DME1916 XEOTICID XEO02416 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02416 XEO_CLAS Peptide DME1916 XEOTICID XEO02416 DESCRIPT Bass hepcidin inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO02416 GENEFORM Protein DME1916 XEOTICID XEO02416 MOACRIVE Inhibition DME1916 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1916 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02451 XEO_CLAS Peptide DME1916 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO02451 GENEFORM Protein DME1916 XEOTICID XEO02451 MOACRIVE Inhibition DME1916 XEOTICID XEO02473 XEO_NAME Toad bombinin-like peptide BLP-1 DME1916 XEOTICID XEO02473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02473 XEO_CLAS Peptide DME1916 XEOTICID XEO02473 DESCRIPT Toad bombinin-like peptide BLP-1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO02473 GENEFORM Protein DME1916 XEOTICID XEO02473 MOACRIVE Inhibition DME1916 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1916 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02491 XEO_CLAS Peptide DME1916 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 2.8 microM) DME1916 XEOTICID XEO02491 GENEFORM Protein DME1916 XEOTICID XEO02491 MOACRIVE Inhibition DME1916 XEOTICID XEO02496 XEO_NAME Brevinin-1AUa DME1916 XEOTICID XEO02496 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02496 XEO_CLAS Peptide DME1916 XEOTICID XEO02496 DESCRIPT Brevinin-1AUa inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 50 microM) DME1916 XEOTICID XEO02496 GENEFORM Protein DME1916 XEOTICID XEO02496 MOACRIVE Inhibition DME1916 XEOTICID XEO02497 XEO_NAME Brevinin-1AUb DME1916 XEOTICID XEO02497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02497 XEO_CLAS Peptide DME1916 XEOTICID XEO02497 DESCRIPT Brevinin-1AUb inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC > 50 microM) DME1916 XEOTICID XEO02497 GENEFORM Protein DME1916 XEOTICID XEO02497 MOACRIVE Inhibition DME1916 XEOTICID XEO02512 XEO_NAME Brevinin-1CG5 DME1916 XEOTICID XEO02512 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02512 XEO_CLAS Peptide DME1916 XEOTICID XEO02512 DESCRIPT Brevinin-1CG5 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 150 microM) DME1916 XEOTICID XEO02512 GENEFORM Protein DME1916 XEOTICID XEO02512 MOACRIVE Inhibition DME1916 XEOTICID XEO02566 XEO_NAME Brevinin-1TSa DME1916 XEOTICID XEO02566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02566 XEO_CLAS Peptide DME1916 XEOTICID XEO02566 DESCRIPT Brevinin-1TSa inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC > 100 microM) DME1916 XEOTICID XEO02566 GENEFORM Protein DME1916 XEOTICID XEO02566 MOACRIVE Inhibition DME1916 XEOTICID XEO02637 XEO_NAME Brevinin-2TSa DME1916 XEOTICID XEO02637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02637 XEO_CLAS Peptide DME1916 XEOTICID XEO02637 DESCRIPT Brevinin-2TSa inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 6 microM) DME1916 XEOTICID XEO02637 GENEFORM Protein DME1916 XEOTICID XEO02637 MOACRIVE Inhibition DME1916 XEOTICID XEO02656 XEO_NAME Himatanthus drasticus butanolic extract DME1916 XEOTICID XEO02656 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1916 XEOTICID XEO02656 XEO_CLAS Plant Extract DME1916 XEOTICID XEO02656 DESCRIPT Himatanthus drasticus butanolic extract inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO02656 GENEFORM Protein DME1916 XEOTICID XEO02656 MOACRIVE Inhibition DME1916 XEOTICID XEO02688 XEO_NAME Caerin-1.11 DME1916 XEOTICID XEO02688 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02688 XEO_CLAS Peptide DME1916 XEOTICID XEO02688 DESCRIPT Caerin-1.11 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 25 microM) DME1916 XEOTICID XEO02688 GENEFORM Protein DME1916 XEOTICID XEO02688 MOACRIVE Inhibition DME1916 XEOTICID XEO02708 XEO_NAME Canine beta-defensin DME1916 XEOTICID XEO02708 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02708 XEO_CLAS Peptide DME1916 XEOTICID XEO02708 DESCRIPT Canine beta-defensin inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 20 ug/ml) DME1916 XEOTICID XEO02708 GENEFORM Protein DME1916 XEOTICID XEO02708 MOACRIVE Inhibition DME1916 XEOTICID XEO02732 XEO_NAME Cathelicidin-1 DME1916 XEOTICID XEO02732 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02732 XEO_CLAS Peptide DME1916 XEOTICID XEO02732 DESCRIPT Cathelicidin-1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 1.25 microM) DME1916 XEOTICID XEO02732 GENEFORM Protein DME1916 XEOTICID XEO02732 MOACRIVE Inhibition DME1916 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1916 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02734 XEO_CLAS Peptide DME1916 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 0.40 microM) DME1916 XEOTICID XEO02734 GENEFORM Protein DME1916 XEOTICID XEO02734 MOACRIVE Inhibition DME1916 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1916 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02736 XEO_CLAS Peptide DME1916 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 0.66 microM) DME1916 XEOTICID XEO02736 GENEFORM Protein DME1916 XEOTICID XEO02736 MOACRIVE Inhibition DME1916 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1916 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02738 XEO_CLAS Peptide DME1916 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 1 microM) DME1916 XEOTICID XEO02738 GENEFORM Protein DME1916 XEOTICID XEO02738 MOACRIVE Inhibition DME1916 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME1916 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02743 XEO_CLAS Peptide DME1916 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 4.7 ug/ml) DME1916 XEOTICID XEO02743 GENEFORM Protein DME1916 XEOTICID XEO02743 MOACRIVE Inhibition DME1916 XEOTICID XEO02749 XEO_NAME Canine beta-defensin cBD-1 DME1916 XEOTICID XEO02749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02749 XEO_CLAS Peptide DME1916 XEOTICID XEO02749 DESCRIPT Canine beta-defensin cBD-1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 20 mug/ml) DME1916 XEOTICID XEO02749 GENEFORM Protein DME1916 XEOTICID XEO02749 MOACRIVE Inhibition DME1916 XEOTICID XEO02767 XEO_NAME Cecropin-B(1-7)-melittin(4-11) hybrid DME1916 XEOTICID XEO02767 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02767 XEO_CLAS Peptide DME1916 XEOTICID XEO02767 DESCRIPT Cecropin-B(1-7)-melittin(4-11) hybrid inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO02767 GENEFORM Protein DME1916 XEOTICID XEO02767 MOACRIVE Inhibition DME1916 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1916 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02768 XEO_CLAS Peptide DME1916 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 1-2.5 ug/ml) DME1916 XEOTICID XEO02768 GENEFORM Protein DME1916 XEOTICID XEO02768 MOACRIVE Inhibition DME1916 XEOTICID XEO02780 XEO_NAME Cefixime DME1916 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1916 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1916 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO02780 GENEFORM Protein DME1916 XEOTICID XEO02780 MOACRIVE Inhibition DME1916 XEOTICID XEO02942 XEO_NAME Caerulein precursor fragment-SP1 DME1916 XEOTICID XEO02942 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO02942 XEO_CLAS Peptide DME1916 XEOTICID XEO02942 DESCRIPT Caerulein precursor fragment-SP1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO02942 GENEFORM Protein DME1916 XEOTICID XEO02942 MOACRIVE Inhibition DME1916 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1916 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03029 XEO_CLAS Peptide DME1916 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 0.145 microM) DME1916 XEOTICID XEO03029 GENEFORM Protein DME1916 XEOTICID XEO03029 MOACRIVE Inhibition DME1916 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1916 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03030 XEO_CLAS Peptide DME1916 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 0.643 microM) DME1916 XEOTICID XEO03030 GENEFORM Protein DME1916 XEOTICID XEO03030 MOACRIVE Inhibition DME1916 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1916 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03031 XEO_CLAS Peptide DME1916 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 0.01 microM) DME1916 XEOTICID XEO03031 GENEFORM Protein DME1916 XEOTICID XEO03031 MOACRIVE Inhibition DME1916 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1916 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03032 XEO_CLAS Peptide DME1916 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC < 0.005 microM) DME1916 XEOTICID XEO03032 GENEFORM Protein DME1916 XEOTICID XEO03032 MOACRIVE Inhibition DME1916 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1916 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03033 XEO_CLAS Peptide DME1916 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC > 0.692 microM) DME1916 XEOTICID XEO03033 GENEFORM Protein DME1916 XEOTICID XEO03033 MOACRIVE Inhibition DME1916 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1916 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03034 XEO_CLAS Peptide DME1916 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 0.004 microM) DME1916 XEOTICID XEO03034 GENEFORM Protein DME1916 XEOTICID XEO03034 MOACRIVE Inhibition DME1916 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1916 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03035 XEO_CLAS Peptide DME1916 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 0.458 microM) DME1916 XEOTICID XEO03035 GENEFORM Protein DME1916 XEOTICID XEO03035 MOACRIVE Inhibition DME1916 XEOTICID XEO03051 XEO_NAME Single AA substitution D16F-N23 DME1916 XEOTICID XEO03051 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03051 XEO_CLAS Peptide DME1916 XEOTICID XEO03051 DESCRIPT Single AA substitution D16F-N23 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1916 XEOTICID XEO03051 GENEFORM Protein DME1916 XEOTICID XEO03051 MOACRIVE Inhibition DME1916 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1916 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03052 XEO_CLAS Peptide DME1916 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1916 XEOTICID XEO03052 GENEFORM Protein DME1916 XEOTICID XEO03052 MOACRIVE Inhibition DME1916 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1916 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03053 XEO_CLAS Peptide DME1916 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1916 XEOTICID XEO03053 GENEFORM Protein DME1916 XEOTICID XEO03053 MOACRIVE Inhibition DME1916 XEOTICID XEO03089 XEO_NAME Decoralin DME1916 XEOTICID XEO03089 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03089 XEO_CLAS Peptide DME1916 XEOTICID XEO03089 DESCRIPT Decoralin inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 80 microM) DME1916 XEOTICID XEO03089 GENEFORM Protein DME1916 XEOTICID XEO03089 MOACRIVE Inhibition DME1916 XEOTICID XEO03112 XEO_NAME Defensin Cll-dlp DME1916 XEOTICID XEO03112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03112 XEO_CLAS Peptide DME1916 XEOTICID XEO03112 DESCRIPT Defensin Cll-dlp inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC > 50 ug/ml) DME1916 XEOTICID XEO03112 GENEFORM Protein DME1916 XEOTICID XEO03112 MOACRIVE Inhibition DME1916 XEOTICID XEO03137 XEO_NAME Bacteriocin delta-lysin I DME1916 XEOTICID XEO03137 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03137 XEO_CLAS Peptide DME1916 XEOTICID XEO03137 DESCRIPT Bacteriocin delta-lysin I inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03137 GENEFORM Protein DME1916 XEOTICID XEO03137 MOACRIVE Inhibition DME1916 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1916 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03162 XEO_CLAS Peptide DME1916 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 0.8 microM) DME1916 XEOTICID XEO03162 GENEFORM Protein DME1916 XEOTICID XEO03162 MOACRIVE Inhibition DME1916 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1916 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03224 XEO_CLAS Peptide DME1916 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 1-2.5 microM) DME1916 XEOTICID XEO03224 GENEFORM Protein DME1916 XEOTICID XEO03224 MOACRIVE Inhibition DME1916 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1916 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03235 XEO_CLAS Peptide DME1916 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 60 ug/ml) DME1916 XEOTICID XEO03235 GENEFORM Protein DME1916 XEOTICID XEO03235 MOACRIVE Inhibition DME1916 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1916 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03237 XEO_CLAS Peptide DME1916 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC > 100 ug/ml) DME1916 XEOTICID XEO03237 GENEFORM Protein DME1916 XEOTICID XEO03237 MOACRIVE Inhibition DME1916 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1916 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03238 XEO_CLAS Peptide DME1916 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1916 XEOTICID XEO03238 GENEFORM Protein DME1916 XEOTICID XEO03238 MOACRIVE Inhibition DME1916 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1916 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03239 XEO_CLAS Peptide DME1916 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1916 XEOTICID XEO03239 GENEFORM Protein DME1916 XEOTICID XEO03239 MOACRIVE Inhibition DME1916 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1916 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03250 XEO_CLAS Peptide DME1916 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03250 GENEFORM Protein DME1916 XEOTICID XEO03250 MOACRIVE Inhibition DME1916 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1916 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03251 XEO_CLAS Peptide DME1916 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03251 GENEFORM Protein DME1916 XEOTICID XEO03251 MOACRIVE Inhibition DME1916 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1916 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03253 XEO_CLAS Peptide DME1916 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 3.2 ug/ml) DME1916 XEOTICID XEO03253 GENEFORM Protein DME1916 XEOTICID XEO03253 MOACRIVE Inhibition DME1916 XEOTICID XEO03348 XEO_NAME Thymus vulgaris ethanol extract DME1916 XEOTICID XEO03348 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1916 XEOTICID XEO03348 XEO_CLAS Plant Extract DME1916 XEOTICID XEO03348 DESCRIPT Thymus vulgaris ethanol extract inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03348 GENEFORM Protein DME1916 XEOTICID XEO03348 MOACRIVE Inhibition DME1916 XEOTICID XEO03387 XEO_NAME Ferric chloride DME1916 XEOTICID XEO03387 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1916 XEOTICID XEO03387 XEO_CLAS Chemical Compound DME1916 XEOTICID XEO03387 DESCRIPT Ferric chloride inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03387 GENEFORM Protein DME1916 XEOTICID XEO03387 MOACRIVE Inhibition DME1916 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME1916 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03436 XEO_CLAS Peptide DME1916 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 100 ug/ml) DME1916 XEOTICID XEO03436 GENEFORM Protein DME1916 XEOTICID XEO03436 MOACRIVE Inhibition DME1916 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1916 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03437 XEO_CLAS Peptide DME1916 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1916 XEOTICID XEO03437 GENEFORM Protein DME1916 XEOTICID XEO03437 MOACRIVE Inhibition DME1916 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1916 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03438 XEO_CLAS Peptide DME1916 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1916 XEOTICID XEO03438 GENEFORM Protein DME1916 XEOTICID XEO03438 MOACRIVE Inhibition DME1916 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1916 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03439 XEO_CLAS Peptide DME1916 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1916 XEOTICID XEO03439 GENEFORM Protein DME1916 XEOTICID XEO03439 MOACRIVE Inhibition DME1916 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1916 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03440 XEO_CLAS Peptide DME1916 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1916 XEOTICID XEO03440 GENEFORM Protein DME1916 XEOTICID XEO03440 MOACRIVE Inhibition DME1916 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1916 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03441 XEO_CLAS Peptide DME1916 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1916 XEOTICID XEO03441 GENEFORM Protein DME1916 XEOTICID XEO03441 MOACRIVE Inhibition DME1916 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1916 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03497 XEO_CLAS Peptide DME1916 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1916 XEOTICID XEO03497 GENEFORM Protein DME1916 XEOTICID XEO03497 MOACRIVE Inhibition DME1916 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1916 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03498 XEO_CLAS Peptide DME1916 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 3.15-6.25 microM) DME1916 XEOTICID XEO03498 GENEFORM Protein DME1916 XEOTICID XEO03498 MOACRIVE Inhibition DME1916 XEOTICID XEO03519 XEO_NAME Hadrurin DME1916 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03519 XEO_CLAS Peptide DME1916 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03519 GENEFORM Protein DME1916 XEOTICID XEO03519 MOACRIVE Inhibition DME1916 XEOTICID XEO03522 XEO_NAME Halocyntin DME1916 XEOTICID XEO03522 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03522 XEO_CLAS Peptide DME1916 XEOTICID XEO03522 DESCRIPT Halocyntin inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03522 GENEFORM Protein DME1916 XEOTICID XEO03522 MOACRIVE Inhibition DME1916 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME1916 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03540 XEO_CLAS Peptide DME1916 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1916 XEOTICID XEO03540 GENEFORM Protein DME1916 XEOTICID XEO03540 MOACRIVE Inhibition DME1916 XEOTICID XEO03549 XEO_NAME Heteroscorpine-1 DME1916 XEOTICID XEO03549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03549 XEO_CLAS Peptide DME1916 XEOTICID XEO03549 DESCRIPT Heteroscorpine-1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03549 GENEFORM Protein DME1916 XEOTICID XEO03549 MOACRIVE Inhibition DME1916 XEOTICID XEO03552 XEO_NAME Hyptis suaveolens hexane extract DME1916 XEOTICID XEO03552 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1916 XEOTICID XEO03552 XEO_CLAS Plant Extract DME1916 XEOTICID XEO03552 DESCRIPT Hyptis suaveolens hexane extract inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03552 GENEFORM Protein DME1916 XEOTICID XEO03552 MOACRIVE Inhibition DME1916 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME1916 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03556 XEO_CLAS Peptide DME1916 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1916 XEOTICID XEO03556 GENEFORM Protein DME1916 XEOTICID XEO03556 MOACRIVE Inhibition DME1916 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME1916 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03557 XEO_CLAS Peptide DME1916 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 8-16 ug/ml) DME1916 XEOTICID XEO03557 GENEFORM Protein DME1916 XEOTICID XEO03557 MOACRIVE Inhibition DME1916 XEOTICID XEO03591 XEO_NAME Human beta-defensin hBD-28 DME1916 XEOTICID XEO03591 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03591 XEO_CLAS Peptide DME1916 XEOTICID XEO03591 DESCRIPT Human beta-defensin hBD-28 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1916 XEOTICID XEO03591 GENEFORM Protein DME1916 XEOTICID XEO03591 MOACRIVE Inhibition DME1916 XEOTICID XEO03593 XEO_NAME Human beta-defensin hBD-3 DME1916 XEOTICID XEO03593 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03593 XEO_CLAS Peptide DME1916 XEOTICID XEO03593 DESCRIPT Human beta-defensin hBD-3 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 25 ug/ml) DME1916 XEOTICID XEO03593 GENEFORM Protein DME1916 XEOTICID XEO03593 MOACRIVE Inhibition DME1916 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1916 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03609 XEO_CLAS Peptide DME1916 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03609 GENEFORM Protein DME1916 XEOTICID XEO03609 MOACRIVE Inhibition DME1916 XEOTICID XEO03611 XEO_NAME Himatanthus drasticus hydroalcoholic extract DME1916 XEOTICID XEO03611 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1916 XEOTICID XEO03611 XEO_CLAS Plant Extract DME1916 XEOTICID XEO03611 DESCRIPT Himatanthus drasticus hydroalcoholic extract inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03611 GENEFORM Protein DME1916 XEOTICID XEO03611 MOACRIVE Inhibition DME1916 XEOTICID XEO03622 XEO_NAME Thanatin truncated isoform I14M(8-21) DME1916 XEOTICID XEO03622 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03622 XEO_CLAS Peptide DME1916 XEOTICID XEO03622 DESCRIPT Thanatin truncated isoform I14M(8-21) inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 20-40 microM) DME1916 XEOTICID XEO03622 GENEFORM Protein DME1916 XEOTICID XEO03622 MOACRIVE Inhibition DME1916 XEOTICID XEO03630 XEO_NAME Immobilized peptide E10KKL DME1916 XEOTICID XEO03630 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03630 XEO_CLAS Peptide DME1916 XEOTICID XEO03630 DESCRIPT Immobilized peptide E10KKL inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03630 GENEFORM Protein DME1916 XEOTICID XEO03630 MOACRIVE Inhibition DME1916 XEOTICID XEO03631 XEO_NAME Immobilized peptide E12LLK DME1916 XEOTICID XEO03631 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03631 XEO_CLAS Peptide DME1916 XEOTICID XEO03631 DESCRIPT Immobilized peptide E12LLK inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03631 GENEFORM Protein DME1916 XEOTICID XEO03631 MOACRIVE Inhibition DME1916 XEOTICID XEO03632 XEO_NAME Immobilized peptide E14KKL DME1916 XEOTICID XEO03632 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03632 XEO_CLAS Peptide DME1916 XEOTICID XEO03632 DESCRIPT Immobilized peptide E14KKL inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03632 GENEFORM Protein DME1916 XEOTICID XEO03632 MOACRIVE Inhibition DME1916 XEOTICID XEO03633 XEO_NAME Immobilized peptide E07LKK DME1916 XEOTICID XEO03633 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03633 XEO_CLAS Peptide DME1916 XEOTICID XEO03633 DESCRIPT Immobilized peptide E07LKK inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03633 GENEFORM Protein DME1916 XEOTICID XEO03633 MOACRIVE Inhibition DME1916 XEOTICID XEO03634 XEO_NAME Immobilized peptide E14LKK/H14LKK DME1916 XEOTICID XEO03634 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03634 XEO_CLAS Peptide DME1916 XEOTICID XEO03634 DESCRIPT Immobilized peptide E14LKK/H14LKK inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03634 GENEFORM Protein DME1916 XEOTICID XEO03634 MOACRIVE Inhibition DME1916 XEOTICID XEO03635 XEO_NAME Immobilized peptide E16LKL DME1916 XEOTICID XEO03635 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03635 XEO_CLAS Peptide DME1916 XEOTICID XEO03635 DESCRIPT Immobilized peptide E16LKL inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03635 GENEFORM Protein DME1916 XEOTICID XEO03635 MOACRIVE Inhibition DME1916 XEOTICID XEO03636 XEO_NAME Immobilized peptide E17HSA magainin 2 deletion DME1916 XEOTICID XEO03636 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03636 XEO_CLAS Peptide DME1916 XEOTICID XEO03636 DESCRIPT Immobilized peptide E17HSA magainin 2 deletion inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03636 GENEFORM Protein DME1916 XEOTICID XEO03636 MOACRIVE Inhibition DME1916 XEOTICID XEO03637 XEO_NAME Immobilized peptide E17KGG DME1916 XEOTICID XEO03637 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03637 XEO_CLAS Peptide DME1916 XEOTICID XEO03637 DESCRIPT Immobilized peptide E17KGG inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03637 GENEFORM Protein DME1916 XEOTICID XEO03637 MOACRIVE Inhibition DME1916 XEOTICID XEO03638 XEO_NAME Immobilized peptide E18KGG DME1916 XEOTICID XEO03638 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03638 XEO_CLAS Peptide DME1916 XEOTICID XEO03638 DESCRIPT Immobilized peptide E18KGG inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03638 GENEFORM Protein DME1916 XEOTICID XEO03638 MOACRIVE Inhibition DME1916 XEOTICID XEO03639 XEO_NAME Immobilized peptide E23GIG magainin 2 DME1916 XEOTICID XEO03639 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03639 XEO_CLAS Peptide DME1916 XEOTICID XEO03639 DESCRIPT Immobilized peptide E23GIG magainin 2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03639 GENEFORM Protein DME1916 XEOTICID XEO03639 MOACRIVE Inhibition DME1916 XEOTICID XEO03640 XEO_NAME Immobilized peptige E16KGL/H16KGL DME1916 XEOTICID XEO03640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03640 XEO_CLAS Peptide DME1916 XEOTICID XEO03640 DESCRIPT Immobilized peptige E16KGL/H16KGL inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03640 GENEFORM Protein DME1916 XEOTICID XEO03640 MOACRIVE Inhibition DME1916 XEOTICID XEO03672 XEO_NAME Jellein-1 DME1916 XEOTICID XEO03672 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03672 XEO_CLAS Peptide DME1916 XEOTICID XEO03672 DESCRIPT Jellein-1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1916 XEOTICID XEO03672 GENEFORM Protein DME1916 XEOTICID XEO03672 MOACRIVE Inhibition DME1916 XEOTICID XEO03673 XEO_NAME Jellein-2 DME1916 XEOTICID XEO03673 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03673 XEO_CLAS Peptide DME1916 XEOTICID XEO03673 DESCRIPT Jellein-2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1916 XEOTICID XEO03673 GENEFORM Protein DME1916 XEOTICID XEO03673 MOACRIVE Inhibition DME1916 XEOTICID XEO03674 XEO_NAME Jellein-3 DME1916 XEOTICID XEO03674 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03674 XEO_CLAS Peptide DME1916 XEOTICID XEO03674 DESCRIPT Jellein-3 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO03674 GENEFORM Protein DME1916 XEOTICID XEO03674 MOACRIVE Inhibition DME1916 XEOTICID XEO03675 XEO_NAME Jindongenin-1a DME1916 XEOTICID XEO03675 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03675 XEO_CLAS Peptide DME1916 XEOTICID XEO03675 DESCRIPT Jindongenin-1a inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 15 microM) DME1916 XEOTICID XEO03675 GENEFORM Protein DME1916 XEOTICID XEO03675 MOACRIVE Inhibition DME1916 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME1916 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03678 XEO_CLAS Peptide DME1916 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1916 XEOTICID XEO03678 GENEFORM Protein DME1916 XEOTICID XEO03678 MOACRIVE Inhibition DME1916 XEOTICID XEO03681 XEO_NAME Thanatin truncated isoform K18M(4-21) DME1916 XEOTICID XEO03681 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03681 XEO_CLAS Peptide DME1916 XEOTICID XEO03681 DESCRIPT Thanatin truncated isoform K18M(4-21) inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 1.2-2.5 microM) DME1916 XEOTICID XEO03681 GENEFORM Protein DME1916 XEOTICID XEO03681 MOACRIVE Inhibition DME1916 XEOTICID XEO03697 XEO_NAME Kassinatuerin-1 DME1916 XEOTICID XEO03697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03697 XEO_CLAS Peptide DME1916 XEOTICID XEO03697 DESCRIPT Kassinatuerin-1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 25 microM) DME1916 XEOTICID XEO03697 GENEFORM Protein DME1916 XEOTICID XEO03697 MOACRIVE Inhibition DME1916 XEOTICID XEO03724 XEO_NAME L10 peptide DME1916 XEOTICID XEO03724 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03724 XEO_CLAS Peptide DME1916 XEOTICID XEO03724 DESCRIPT L10 peptide inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 3.35 microM) DME1916 XEOTICID XEO03724 GENEFORM Protein DME1916 XEOTICID XEO03724 MOACRIVE Inhibition DME1916 XEOTICID XEO03744 XEO_NAME LlKmWn model peptide L5K3W5 DME1916 XEOTICID XEO03744 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03744 XEO_CLAS Peptide DME1916 XEOTICID XEO03744 DESCRIPT LlKmWn model peptide L5K3W5 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1916 XEOTICID XEO03744 GENEFORM Protein DME1916 XEOTICID XEO03744 MOACRIVE Inhibition DME1916 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1916 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03746 XEO_CLAS Peptide DME1916 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1916 XEOTICID XEO03746 GENEFORM Protein DME1916 XEOTICID XEO03746 MOACRIVE Inhibition DME1916 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1916 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03747 XEO_CLAS Peptide DME1916 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1916 XEOTICID XEO03747 GENEFORM Protein DME1916 XEOTICID XEO03747 MOACRIVE Inhibition DME1916 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1916 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03748 XEO_CLAS Peptide DME1916 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1916 XEOTICID XEO03748 GENEFORM Protein DME1916 XEOTICID XEO03748 MOACRIVE Inhibition DME1916 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1916 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03749 XEO_CLAS Peptide DME1916 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1916 XEOTICID XEO03749 GENEFORM Protein DME1916 XEOTICID XEO03749 MOACRIVE Inhibition DME1916 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1916 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03750 XEO_CLAS Peptide DME1916 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1916 XEOTICID XEO03750 GENEFORM Protein DME1916 XEOTICID XEO03750 MOACRIVE Inhibition DME1916 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1916 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03751 XEO_CLAS Peptide DME1916 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1916 XEOTICID XEO03751 GENEFORM Protein DME1916 XEOTICID XEO03751 MOACRIVE Inhibition DME1916 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1916 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03752 XEO_CLAS Peptide DME1916 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1916 XEOTICID XEO03752 GENEFORM Protein DME1916 XEOTICID XEO03752 MOACRIVE Inhibition DME1916 XEOTICID XEO03753 XEO_NAME LlKmWn model peptide L5K5W6 DME1916 XEOTICID XEO03753 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03753 XEO_CLAS Peptide DME1916 XEOTICID XEO03753 DESCRIPT LlKmWn model peptide L5K5W6 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 6.3 ug/ml) DME1916 XEOTICID XEO03753 GENEFORM Protein DME1916 XEOTICID XEO03753 MOACRIVE Inhibition DME1916 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1916 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03754 XEO_CLAS Peptide DME1916 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1916 XEOTICID XEO03754 GENEFORM Protein DME1916 XEOTICID XEO03754 MOACRIVE Inhibition DME1916 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1916 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03755 XEO_CLAS Peptide DME1916 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 4 ug/ml) DME1916 XEOTICID XEO03755 GENEFORM Protein DME1916 XEOTICID XEO03755 MOACRIVE Inhibition DME1916 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1916 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03756 XEO_CLAS Peptide DME1916 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 2 ug/ml) DME1916 XEOTICID XEO03756 GENEFORM Protein DME1916 XEOTICID XEO03756 MOACRIVE Inhibition DME1916 XEOTICID XEO03759 XEO_NAME LlKmWn model peptide L6K4W6 DME1916 XEOTICID XEO03759 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03759 XEO_CLAS Peptide DME1916 XEOTICID XEO03759 DESCRIPT LlKmWn model peptide L6K4W6 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1916 XEOTICID XEO03759 GENEFORM Protein DME1916 XEOTICID XEO03759 MOACRIVE Inhibition DME1916 XEOTICID XEO03761 XEO_NAME LlKmWn model peptide L7K3W6 DME1916 XEOTICID XEO03761 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03761 XEO_CLAS Peptide DME1916 XEOTICID XEO03761 DESCRIPT LlKmWn model peptide L7K3W6 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 50 ug/ml) DME1916 XEOTICID XEO03761 GENEFORM Protein DME1916 XEOTICID XEO03761 MOACRIVE Inhibition DME1916 XEOTICID XEO03985 XEO_NAME Magainin-2 DME1916 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO03985 XEO_CLAS Peptide DME1916 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 10 ug/ml) DME1916 XEOTICID XEO03985 GENEFORM Protein DME1916 XEOTICID XEO03985 MOACRIVE Inhibition DME1916 XEOTICID XEO04001 XEO_NAME Mastoparan MP-L DME1916 XEOTICID XEO04001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04001 XEO_CLAS Peptide DME1916 XEOTICID XEO04001 DESCRIPT Mastoparan MP-L inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 12.5 microM) DME1916 XEOTICID XEO04001 GENEFORM Protein DME1916 XEOTICID XEO04001 MOACRIVE Inhibition DME1916 XEOTICID XEO04007 XEO_NAME Maximin-1 DME1916 XEOTICID XEO04007 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04007 XEO_CLAS Peptide DME1916 XEOTICID XEO04007 DESCRIPT Maximin-1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1916 XEOTICID XEO04007 GENEFORM Protein DME1916 XEOTICID XEO04007 MOACRIVE Inhibition DME1916 XEOTICID XEO04011 XEO_NAME Maximin-2 DME1916 XEOTICID XEO04011 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04011 XEO_CLAS Peptide DME1916 XEOTICID XEO04011 DESCRIPT Maximin-2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 9 ug/ml) DME1916 XEOTICID XEO04011 GENEFORM Protein DME1916 XEOTICID XEO04011 MOACRIVE Inhibition DME1916 XEOTICID XEO04012 XEO_NAME Maximin-3 DME1916 XEOTICID XEO04012 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04012 XEO_CLAS Peptide DME1916 XEOTICID XEO04012 DESCRIPT Maximin-3 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 3.1 ug/ml) DME1916 XEOTICID XEO04012 GENEFORM Protein DME1916 XEOTICID XEO04012 MOACRIVE Inhibition DME1916 XEOTICID XEO04013 XEO_NAME Maximin-4 DME1916 XEOTICID XEO04013 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04013 XEO_CLAS Peptide DME1916 XEOTICID XEO04013 DESCRIPT Maximin-4 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 15 ug/ml) DME1916 XEOTICID XEO04013 GENEFORM Protein DME1916 XEOTICID XEO04013 MOACRIVE Inhibition DME1916 XEOTICID XEO04014 XEO_NAME Maximin-5 DME1916 XEOTICID XEO04014 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04014 XEO_CLAS Peptide DME1916 XEOTICID XEO04014 DESCRIPT Maximin-5 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 3.6 ug/ml) DME1916 XEOTICID XEO04014 GENEFORM Protein DME1916 XEOTICID XEO04014 MOACRIVE Inhibition DME1916 XEOTICID XEO04087 XEO_NAME Thymus vulgaris methanol extract DME1916 XEOTICID XEO04087 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1916 XEOTICID XEO04087 XEO_CLAS Plant Extract DME1916 XEOTICID XEO04087 DESCRIPT Thymus vulgaris methanol extract inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04087 GENEFORM Protein DME1916 XEOTICID XEO04087 MOACRIVE Inhibition DME1916 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1916 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04111 XEO_CLAS Peptide DME1916 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04111 GENEFORM Protein DME1916 XEOTICID XEO04111 MOACRIVE Inhibition DME1916 XEOTICID XEO04241 XEO_NAME CTX-1 peptide NCP-3a DME1916 XEOTICID XEO04241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04241 XEO_CLAS Peptide DME1916 XEOTICID XEO04241 DESCRIPT CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04241 GENEFORM Protein DME1916 XEOTICID XEO04241 MOACRIVE Inhibition DME1916 XEOTICID XEO04242 XEO_NAME CTX-1 peptide NCP-3b DME1916 XEOTICID XEO04242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04242 XEO_CLAS Peptide DME1916 XEOTICID XEO04242 DESCRIPT CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04242 GENEFORM Protein DME1916 XEOTICID XEO04242 MOACRIVE Inhibition DME1916 XEOTICID XEO04331 XEO_NAME Norspermidine DME1916 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1916 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1916 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04331 GENEFORM Protein DME1916 XEOTICID XEO04331 MOACRIVE Inhibition DME1916 XEOTICID XEO04348 XEO_NAME Ocellatin-F1 DME1916 XEOTICID XEO04348 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04348 XEO_CLAS Peptide DME1916 XEOTICID XEO04348 DESCRIPT Ocellatin-F1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 80 microM) DME1916 XEOTICID XEO04348 GENEFORM Protein DME1916 XEOTICID XEO04348 MOACRIVE Inhibition DME1916 XEOTICID XEO04349 XEO_NAME Ocellatin-P1 DME1916 XEOTICID XEO04349 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04349 XEO_CLAS Peptide DME1916 XEOTICID XEO04349 DESCRIPT Ocellatin-P1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 100 microM) DME1916 XEOTICID XEO04349 GENEFORM Protein DME1916 XEOTICID XEO04349 MOACRIVE Inhibition DME1916 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1916 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04399 XEO_CLAS Peptide DME1916 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 6.3 microM) DME1916 XEOTICID XEO04399 GENEFORM Protein DME1916 XEOTICID XEO04399 MOACRIVE Inhibition DME1916 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1916 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04426 XEO_CLAS Peptide DME1916 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 2 microM) DME1916 XEOTICID XEO04426 GENEFORM Protein DME1916 XEOTICID XEO04426 MOACRIVE Inhibition DME1916 XEOTICID XEO04468 XEO_NAME Papillosin DME1916 XEOTICID XEO04468 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04468 XEO_CLAS Peptide DME1916 XEOTICID XEO04468 DESCRIPT Papillosin inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04468 GENEFORM Protein DME1916 XEOTICID XEO04468 MOACRIVE Inhibition DME1916 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1916 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04471 XEO_CLAS Peptide DME1916 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 1.6 microM) DME1916 XEOTICID XEO04471 GENEFORM Protein DME1916 XEOTICID XEO04471 MOACRIVE Inhibition DME1916 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME1916 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04506 XEO_CLAS Peptide DME1916 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC > 20 microM) DME1916 XEOTICID XEO04506 GENEFORM Protein DME1916 XEOTICID XEO04506 MOACRIVE Inhibition DME1916 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME1916 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04507 XEO_CLAS Peptide DME1916 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC > 40 microM) DME1916 XEOTICID XEO04507 GENEFORM Protein DME1916 XEOTICID XEO04507 MOACRIVE Inhibition DME1916 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME1916 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04510 XEO_CLAS Peptide DME1916 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC > 50 microM) DME1916 XEOTICID XEO04510 GENEFORM Protein DME1916 XEOTICID XEO04510 MOACRIVE Inhibition DME1916 XEOTICID XEO04531 XEO_NAME Mollusca/molluscs/mollusks peptide 2 DME1916 XEOTICID XEO04531 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04531 XEO_CLAS Peptide DME1916 XEOTICID XEO04531 DESCRIPT Mollusca/molluscs/mollusks peptide 2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04531 GENEFORM Protein DME1916 XEOTICID XEO04531 MOACRIVE Inhibition DME1916 XEOTICID XEO04533 XEO_NAME Mollusca/molluscs/mollusks peptide 3 DME1916 XEOTICID XEO04533 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04533 XEO_CLAS Peptide DME1916 XEOTICID XEO04533 DESCRIPT Mollusca/molluscs/mollusks peptide 3 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04533 GENEFORM Protein DME1916 XEOTICID XEO04533 MOACRIVE Inhibition DME1916 XEOTICID XEO04534 XEO_NAME Mollusca/molluscs/mollusks peptide 4 DME1916 XEOTICID XEO04534 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04534 XEO_CLAS Peptide DME1916 XEOTICID XEO04534 DESCRIPT Mollusca/molluscs/mollusks peptide 4 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04534 GENEFORM Protein DME1916 XEOTICID XEO04534 MOACRIVE Inhibition DME1916 XEOTICID XEO04535 XEO_NAME Mollusca/molluscs/mollusks peptide 5 DME1916 XEOTICID XEO04535 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04535 XEO_CLAS Peptide DME1916 XEOTICID XEO04535 DESCRIPT Mollusca/molluscs/mollusks peptide 5 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04535 GENEFORM Protein DME1916 XEOTICID XEO04535 MOACRIVE Inhibition DME1916 XEOTICID XEO04536 XEO_NAME Mollusca/molluscs/mollusks peptide 6 DME1916 XEOTICID XEO04536 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04536 XEO_CLAS Peptide DME1916 XEOTICID XEO04536 DESCRIPT Mollusca/molluscs/mollusks peptide 6 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04536 GENEFORM Protein DME1916 XEOTICID XEO04536 MOACRIVE Inhibition DME1916 XEOTICID XEO04537 XEO_NAME Mollusca/molluscs/mollusks peptide 7 DME1916 XEOTICID XEO04537 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04537 XEO_CLAS Peptide DME1916 XEOTICID XEO04537 DESCRIPT Mollusca/molluscs/mollusks peptide 7 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04537 GENEFORM Protein DME1916 XEOTICID XEO04537 MOACRIVE Inhibition DME1916 XEOTICID XEO04538 XEO_NAME Mollusca/molluscs/mollusks peptide 8 DME1916 XEOTICID XEO04538 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04538 XEO_CLAS Peptide DME1916 XEOTICID XEO04538 DESCRIPT Mollusca/molluscs/mollusks peptide 8 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04538 GENEFORM Protein DME1916 XEOTICID XEO04538 MOACRIVE Inhibition DME1916 XEOTICID XEO04539 XEO_NAME Mollusca/molluscs/mollusks peptide 9 DME1916 XEOTICID XEO04539 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04539 XEO_CLAS Peptide DME1916 XEOTICID XEO04539 DESCRIPT Mollusca/molluscs/mollusks peptide 9 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04539 GENEFORM Protein DME1916 XEOTICID XEO04539 MOACRIVE Inhibition DME1916 XEOTICID XEO04548 XEO_NAME Gly-rich Pg-AMP DME1916 XEOTICID XEO04548 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04548 XEO_CLAS Peptide DME1916 XEOTICID XEO04548 DESCRIPT Gly-rich Pg-AMP inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 32000 ug/ml) DME1916 XEOTICID XEO04548 GENEFORM Protein DME1916 XEOTICID XEO04548 MOACRIVE Inhibition DME1916 XEOTICID XEO04549 XEO_NAME PYLa/PGLa A chain PGLa DME1916 XEOTICID XEO04549 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04549 XEO_CLAS Peptide DME1916 XEOTICID XEO04549 DESCRIPT PYLa/PGLa A chain PGLa inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 250-500 ug/ml) DME1916 XEOTICID XEO04549 GENEFORM Protein DME1916 XEOTICID XEO04549 MOACRIVE Inhibition DME1916 XEOTICID XEO04571 XEO_NAME Phylloseptin PS-2 DME1916 XEOTICID XEO04571 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04571 XEO_CLAS Peptide DME1916 XEOTICID XEO04571 DESCRIPT Phylloseptin PS-2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04571 GENEFORM Protein DME1916 XEOTICID XEO04571 MOACRIVE Inhibition DME1916 XEOTICID XEO04572 XEO_NAME Phylloseptin PS-3 DME1916 XEOTICID XEO04572 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04572 XEO_CLAS Peptide DME1916 XEOTICID XEO04572 DESCRIPT Phylloseptin PS-3 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04572 GENEFORM Protein DME1916 XEOTICID XEO04572 MOACRIVE Inhibition DME1916 XEOTICID XEO04606 XEO_NAME Pilosulin Myr b I DME1916 XEOTICID XEO04606 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04606 XEO_CLAS Peptide DME1916 XEOTICID XEO04606 DESCRIPT Pilosulin Myr b I inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 2 microM) DME1916 XEOTICID XEO04606 GENEFORM Protein DME1916 XEOTICID XEO04606 MOACRIVE Inhibition DME1916 XEOTICID XEO04612 XEO_NAME Piscidin Pis-1 DME1916 XEOTICID XEO04612 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04612 XEO_CLAS Peptide DME1916 XEOTICID XEO04612 DESCRIPT Piscidin Pis-1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1916 XEOTICID XEO04612 GENEFORM Protein DME1916 XEOTICID XEO04612 MOACRIVE Inhibition DME1916 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1916 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04613 XEO_CLAS Peptide DME1916 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1916 XEOTICID XEO04613 GENEFORM Protein DME1916 XEOTICID XEO04613 MOACRIVE Inhibition DME1916 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1916 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04695 XEO_CLAS Peptide DME1916 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04695 GENEFORM Protein DME1916 XEOTICID XEO04695 MOACRIVE Inhibition DME1916 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1916 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04696 XEO_CLAS Peptide DME1916 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04696 GENEFORM Protein DME1916 XEOTICID XEO04696 MOACRIVE Inhibition DME1916 XEOTICID XEO04697 XEO_NAME Ponericin G4 DME1916 XEOTICID XEO04697 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04697 XEO_CLAS Peptide DME1916 XEOTICID XEO04697 DESCRIPT Ponericin G4 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04697 GENEFORM Protein DME1916 XEOTICID XEO04697 MOACRIVE Inhibition DME1916 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1916 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04698 XEO_CLAS Peptide DME1916 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04698 GENEFORM Protein DME1916 XEOTICID XEO04698 MOACRIVE Inhibition DME1916 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1916 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04699 XEO_CLAS Peptide DME1916 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04699 GENEFORM Protein DME1916 XEOTICID XEO04699 MOACRIVE Inhibition DME1916 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1916 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04700 XEO_CLAS Peptide DME1916 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04700 GENEFORM Protein DME1916 XEOTICID XEO04700 MOACRIVE Inhibition DME1916 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1916 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04701 XEO_CLAS Peptide DME1916 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04701 GENEFORM Protein DME1916 XEOTICID XEO04701 MOACRIVE Inhibition DME1916 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1916 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04702 XEO_CLAS Peptide DME1916 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04702 GENEFORM Protein DME1916 XEOTICID XEO04702 MOACRIVE Inhibition DME1916 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1916 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04703 XEO_CLAS Peptide DME1916 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04703 GENEFORM Protein DME1916 XEOTICID XEO04703 MOACRIVE Inhibition DME1916 XEOTICID XEO04762 XEO_NAME Heligoland antimicrobial peptide A DME1916 XEOTICID XEO04762 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04762 XEO_CLAS Peptide DME1916 XEOTICID XEO04762 DESCRIPT Heligoland antimicrobial peptide A inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC > 25 microM) DME1916 XEOTICID XEO04762 GENEFORM Protein DME1916 XEOTICID XEO04762 MOACRIVE Inhibition DME1916 XEOTICID XEO04809 XEO_NAME Ranatuerin-2AUa DME1916 XEOTICID XEO04809 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04809 XEO_CLAS Peptide DME1916 XEOTICID XEO04809 DESCRIPT Ranatuerin-2AUa inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 10 microM) DME1916 XEOTICID XEO04809 GENEFORM Protein DME1916 XEOTICID XEO04809 MOACRIVE Inhibition DME1916 XEOTICID XEO04891 XEO_NAME SAAP fraction 3 DME1916 XEOTICID XEO04891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04891 XEO_CLAS Peptide DME1916 XEOTICID XEO04891 DESCRIPT SAAP fraction 3 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04891 GENEFORM Protein DME1916 XEOTICID XEO04891 MOACRIVE Inhibition DME1916 XEOTICID XEO04905 XEO_NAME Defensin sapecin-B DME1916 XEOTICID XEO04905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04905 XEO_CLAS Peptide DME1916 XEOTICID XEO04905 DESCRIPT Defensin sapecin-B inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04905 GENEFORM Protein DME1916 XEOTICID XEO04905 MOACRIVE Inhibition DME1916 XEOTICID XEO04906 XEO_NAME Sapecin-C DME1916 XEOTICID XEO04906 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04906 XEO_CLAS Peptide DME1916 XEOTICID XEO04906 DESCRIPT Sapecin-C inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO04906 GENEFORM Protein DME1916 XEOTICID XEO04906 MOACRIVE Inhibition DME1916 XEOTICID XEO04917 XEO_NAME Scorpine DME1916 XEOTICID XEO04917 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04917 XEO_CLAS Peptide DME1916 XEOTICID XEO04917 DESCRIPT Scorpine inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 10 microM) DME1916 XEOTICID XEO04917 GENEFORM Protein DME1916 XEOTICID XEO04917 MOACRIVE Inhibition DME1916 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1916 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04971 XEO_CLAS Peptide DME1916 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1916 XEOTICID XEO04971 GENEFORM Protein DME1916 XEOTICID XEO04971 MOACRIVE Inhibition DME1916 XEOTICID XEO04974 XEO_NAME Spinigerin DME1916 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04974 XEO_CLAS Peptide DME1916 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 50-100 microM) DME1916 XEOTICID XEO04974 GENEFORM Protein DME1916 XEOTICID XEO04974 MOACRIVE Inhibition DME1916 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1916 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO04995 XEO_CLAS Peptide DME1916 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 0.78-1.56 microM) DME1916 XEOTICID XEO04995 GENEFORM Protein DME1916 XEOTICID XEO04995 MOACRIVE Inhibition DME1916 XEOTICID XEO05020 XEO_NAME Tachycitin DME1916 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO05020 XEO_CLAS Peptide DME1916 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae DME1916 XEOTICID XEO05020 GENEFORM Protein DME1916 XEOTICID XEO05020 MOACRIVE Inhibition DME1916 XEOTICID XEO05073 XEO_NAME Temporin-1Va DME1916 XEOTICID XEO05073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO05073 XEO_CLAS Peptide DME1916 XEOTICID XEO05073 DESCRIPT Temporin-1Va inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 80 microM) DME1916 XEOTICID XEO05073 GENEFORM Protein DME1916 XEOTICID XEO05073 MOACRIVE Inhibition DME1916 XEOTICID XEO05075 XEO_NAME Temporin-1Vc DME1916 XEOTICID XEO05075 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO05075 XEO_CLAS Peptide DME1916 XEOTICID XEO05075 DESCRIPT Temporin-1Vc inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 80 microM) DME1916 XEOTICID XEO05075 GENEFORM Protein DME1916 XEOTICID XEO05075 MOACRIVE Inhibition DME1916 XEOTICID XEO05101 XEO_NAME Temporin-Ra DME1916 XEOTICID XEO05101 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO05101 XEO_CLAS Peptide DME1916 XEOTICID XEO05101 DESCRIPT Temporin-Ra inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 31.2 ug/ml) DME1916 XEOTICID XEO05101 GENEFORM Protein DME1916 XEOTICID XEO05101 MOACRIVE Inhibition DME1916 XEOTICID XEO05102 XEO_NAME Temporin-Rb DME1916 XEOTICID XEO05102 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO05102 XEO_CLAS Peptide DME1916 XEOTICID XEO05102 DESCRIPT Temporin-Rb inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 35.1 ug/ml) DME1916 XEOTICID XEO05102 GENEFORM Protein DME1916 XEOTICID XEO05102 MOACRIVE Inhibition DME1916 XEOTICID XEO05120 XEO_NAME Thanatin DME1916 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO05120 XEO_CLAS Peptide DME1916 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 0.6-1.2 microM) DME1916 XEOTICID XEO05120 GENEFORM Protein DME1916 XEOTICID XEO05120 MOACRIVE Inhibition DME1916 XEOTICID XEO05163 XEO_NAME Tracheal antimicrobial peptide DME1916 XEOTICID XEO05163 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO05163 XEO_CLAS Peptide DME1916 XEOTICID XEO05163 DESCRIPT Tracheal antimicrobial peptide inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 12-25 ug/ml) DME1916 XEOTICID XEO05163 GENEFORM Protein DME1916 XEOTICID XEO05163 MOACRIVE Inhibition DME1916 XEOTICID XEO05220 XEO_NAME Thanatin truncated isoform V16M(6-21) DME1916 XEOTICID XEO05220 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1916 XEOTICID XEO05220 XEO_CLAS Peptide DME1916 XEOTICID XEO05220 DESCRIPT Thanatin truncated isoform V16M(6-21) inhibits the drug-metabolizing activity of Methylthioribose kinase (mtnK) from Klebsiella pneumoniae (MIC = 2.5-5 microM) DME1916 XEOTICID XEO05220 GENEFORM Protein DME1916 XEOTICID XEO05220 MOACRIVE Inhibition DME1918 DME___ID DME1918 DME1918 DME_NAME Alcohol dehydrogenase (ADH) DME1918 SPESNAME Lactobacillus brevis DME1918 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME1918 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1918 XEOTICID XEO03771 XEO_CLAS Peptide DME1918 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Alcohol dehydrogenase (ADH) from Lactobacillus brevis DME1918 XEOTICID XEO03771 GENEFORM Protein DME1918 XEOTICID XEO03771 MOACRIVE Inhibition DME1923 DME___ID DME1923 DME1923 DME_NAME Glycerol/diol dehydratase (dhaB) DME1923 SPESNAME Lactobacillus reuteri DME1923 XEOTICID XEO03473 XEO_NAME Garvicin ML DME1923 XEOTICID XEO03473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1923 XEOTICID XEO03473 XEO_CLAS Peptide DME1923 XEOTICID XEO03473 DESCRIPT Garvicin ML inhibits the drug-metabolizing activity of Glycerol/diol dehydratase (dhaB) from Lactobacillus reuteri DME1923 XEOTICID XEO03473 GENEFORM Protein DME1923 XEOTICID XEO03473 MOACRIVE Inhibition DME1923 XEOTICID XEO04319 XEO_NAME Nisin F DME1923 XEOTICID XEO04319 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1923 XEOTICID XEO04319 XEO_CLAS Peptide DME1923 XEOTICID XEO04319 DESCRIPT Nisin F inhibits the drug-metabolizing activity of Glycerol/diol dehydratase (dhaB) from Lactobacillus reuteri DME1923 XEOTICID XEO04319 GENEFORM Protein DME1923 XEOTICID XEO04319 MOACRIVE Inhibition DME1929 DME___ID DME1929 DME1929 DME_NAME Alpha-L-rhamnosidase (lrA) DME1929 SPESNAME Lactobacillus rhamnosus DME1929 XEOTICID XEO03967 XEO_NAME Bacteriocin LSEI_2163 DME1929 XEOTICID XEO03967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1929 XEOTICID XEO03967 XEO_CLAS Peptide DME1929 XEOTICID XEO03967 DESCRIPT Bacteriocin LSEI_2163 inhibits the drug-metabolizing activity of Alpha-L-rhamnosidase (lrA) from Lactobacillus rhamnosus DME1929 XEOTICID XEO03967 GENEFORM Protein DME1929 XEOTICID XEO03967 MOACRIVE Inhibition DME1943 DME___ID DME1943 DME1943 DME_NAME Unclear metabolic mechanism (DME-unclear) DME1943 SPESNAME Saccharomyces cerevisiae DME1943 XEOTICID XEO02115 XEO_NAME Nematode ABF-2 DME1943 XEOTICID XEO02115 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02115 XEO_CLAS Peptide DME1943 XEOTICID XEO02115 DESCRIPT Nematode ABF-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO02115 GENEFORM Protein DME1943 XEOTICID XEO02115 MOACRIVE Inhibition DME1943 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1943 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02207 XEO_CLAS Peptide DME1943 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 25 ug/ml) DME1943 XEOTICID XEO02207 GENEFORM Protein DME1943 XEOTICID XEO02207 MOACRIVE Inhibition DME1943 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1943 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02208 XEO_CLAS Peptide DME1943 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 25 ug/ml) DME1943 XEOTICID XEO02208 GENEFORM Protein DME1943 XEOTICID XEO02208 MOACRIVE Inhibition DME1943 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1943 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02209 XEO_CLAS Peptide DME1943 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 25 ug/ml) DME1943 XEOTICID XEO02209 GENEFORM Protein DME1943 XEOTICID XEO02209 MOACRIVE Inhibition DME1943 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1943 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02210 XEO_CLAS Peptide DME1943 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC > 25 ug/ml) DME1943 XEOTICID XEO02210 GENEFORM Protein DME1943 XEOTICID XEO02210 MOACRIVE Inhibition DME1943 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1943 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02211 XEO_CLAS Peptide DME1943 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC > 25 ug/ml) DME1943 XEOTICID XEO02211 GENEFORM Protein DME1943 XEOTICID XEO02211 MOACRIVE Inhibition DME1943 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1943 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02212 XEO_CLAS Peptide DME1943 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 25 ug/ml) DME1943 XEOTICID XEO02212 GENEFORM Protein DME1943 XEOTICID XEO02212 MOACRIVE Inhibition DME1943 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1943 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02213 XEO_CLAS Peptide DME1943 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 25 ug/ml) DME1943 XEOTICID XEO02213 GENEFORM Protein DME1943 XEOTICID XEO02213 MOACRIVE Inhibition DME1943 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1943 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02230 XEO_CLAS Peptide DME1943 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 25-50 microM) DME1943 XEOTICID XEO02230 GENEFORM Protein DME1943 XEOTICID XEO02230 MOACRIVE Inhibition DME1943 XEOTICID XEO02254 XEO_NAME Antifungal protein J DME1943 XEOTICID XEO02254 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02254 XEO_CLAS Peptide DME1943 XEOTICID XEO02254 DESCRIPT Antifungal protein J inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 6.25ug/ml) DME1943 XEOTICID XEO02254 GENEFORM Protein DME1943 XEOTICID XEO02254 MOACRIVE Inhibition DME1943 XEOTICID XEO02260 XEO_NAME Antimicrobial peptide MiAMP1 DME1943 XEOTICID XEO02260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02260 XEO_CLAS Peptide DME1943 XEOTICID XEO02260 DESCRIPT Antimicrobial peptide MiAMP1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 2-5 ug/ml) DME1943 XEOTICID XEO02260 GENEFORM Protein DME1943 XEOTICID XEO02260 MOACRIVE Inhibition DME1943 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1943 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02283 XEO_CLAS Peptide DME1943 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC > 25 ug/ml) DME1943 XEOTICID XEO02283 GENEFORM Protein DME1943 XEOTICID XEO02283 MOACRIVE Inhibition DME1943 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1943 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02289 XEO_CLAS Peptide DME1943 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 12 ug/ml) DME1943 XEOTICID XEO02289 GENEFORM Protein DME1943 XEOTICID XEO02289 MOACRIVE Inhibition DME1943 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1943 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02333 XEO_CLAS Peptide DME1943 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC > 200 microM) DME1943 XEOTICID XEO02333 GENEFORM Protein DME1943 XEOTICID XEO02333 MOACRIVE Inhibition DME1943 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1943 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02649 XEO_CLAS Peptide DME1943 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 4 ug/ml) DME1943 XEOTICID XEO02649 GENEFORM Protein DME1943 XEOTICID XEO02649 MOACRIVE Inhibition DME1943 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1943 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02650 XEO_CLAS Peptide DME1943 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 1 ug/ml) DME1943 XEOTICID XEO02650 GENEFORM Protein DME1943 XEOTICID XEO02650 MOACRIVE Inhibition DME1943 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1943 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO02768 XEO_CLAS Peptide DME1943 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 50-100 ug/ml) DME1943 XEOTICID XEO02768 GENEFORM Protein DME1943 XEOTICID XEO02768 MOACRIVE Inhibition DME1943 XEOTICID XEO03215 XEO_NAME Dolabellanin B2 DME1943 XEOTICID XEO03215 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03215 XEO_CLAS Peptide DME1943 XEOTICID XEO03215 DESCRIPT Dolabellanin B2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO03215 GENEFORM Protein DME1943 XEOTICID XEO03215 MOACRIVE Inhibition DME1943 XEOTICID XEO03274 XEO_NAME Esculentin-1 DME1943 XEOTICID XEO03274 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03274 XEO_CLAS Peptide DME1943 XEOTICID XEO03274 DESCRIPT Esculentin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 0.9 microM) DME1943 XEOTICID XEO03274 GENEFORM Protein DME1943 XEOTICID XEO03274 MOACRIVE Inhibition DME1943 XEOTICID XEO03277 XEO_NAME Esculentin-1B DME1943 XEOTICID XEO03277 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03277 XEO_CLAS Peptide DME1943 XEOTICID XEO03277 DESCRIPT Esculentin-1B inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 0.9 microM) DME1943 XEOTICID XEO03277 GENEFORM Protein DME1943 XEOTICID XEO03277 MOACRIVE Inhibition DME1943 XEOTICID XEO03396 XEO_NAME Flower-specific defensin NaD1 DME1943 XEOTICID XEO03396 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03396 XEO_CLAS Peptide DME1943 XEOTICID XEO03396 DESCRIPT Flower-specific defensin NaD1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO03396 GENEFORM Protein DME1943 XEOTICID XEO03396 MOACRIVE Inhibition DME1943 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1943 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03437 XEO_CLAS Peptide DME1943 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 150 ug/ml) DME1943 XEOTICID XEO03437 GENEFORM Protein DME1943 XEOTICID XEO03437 MOACRIVE Inhibition DME1943 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1943 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03438 XEO_CLAS Peptide DME1943 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC > 200 ug/ml) DME1943 XEOTICID XEO03438 GENEFORM Protein DME1943 XEOTICID XEO03438 MOACRIVE Inhibition DME1943 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1943 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03439 XEO_CLAS Peptide DME1943 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 200 ug/ml) DME1943 XEOTICID XEO03439 GENEFORM Protein DME1943 XEOTICID XEO03439 MOACRIVE Inhibition DME1943 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1943 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03440 XEO_CLAS Peptide DME1943 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 50 ug/ml) DME1943 XEOTICID XEO03440 GENEFORM Protein DME1943 XEOTICID XEO03440 MOACRIVE Inhibition DME1943 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1943 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03441 XEO_CLAS Peptide DME1943 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 50 ug/ml) DME1943 XEOTICID XEO03441 GENEFORM Protein DME1943 XEOTICID XEO03441 MOACRIVE Inhibition DME1943 XEOTICID XEO03497 XEO_NAME Arachnid gomesin DME1943 XEOTICID XEO03497 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03497 XEO_CLAS Peptide DME1943 XEOTICID XEO03497 DESCRIPT Arachnid gomesin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 1.6-3.15 microM) DME1943 XEOTICID XEO03497 GENEFORM Protein DME1943 XEOTICID XEO03497 MOACRIVE Inhibition DME1943 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1943 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03498 XEO_CLAS Peptide DME1943 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 1.6-3.15 microM) DME1943 XEOTICID XEO03498 GENEFORM Protein DME1943 XEOTICID XEO03498 MOACRIVE Inhibition DME1943 XEOTICID XEO03518 XEO_NAME H. annuus defensin Ha-DEF1 DME1943 XEOTICID XEO03518 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03518 XEO_CLAS Peptide DME1943 XEOTICID XEO03518 DESCRIPT H. annuus defensin Ha-DEF1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO03518 GENEFORM Protein DME1943 XEOTICID XEO03518 MOACRIVE Inhibition DME1943 XEOTICID XEO03566 XEO_NAME Histone H2A DME1943 XEOTICID XEO03566 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03566 XEO_CLAS Peptide DME1943 XEOTICID XEO03566 DESCRIPT Histone H2A inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 0.3-0.6 microM) DME1943 XEOTICID XEO03566 GENEFORM Protein DME1943 XEOTICID XEO03566 MOACRIVE Inhibition DME1943 XEOTICID XEO03594 XEO_NAME Human beta-defensin hBD-4 DME1943 XEOTICID XEO03594 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03594 XEO_CLAS Peptide DME1943 XEOTICID XEO03594 DESCRIPT Human beta-defensin hBD-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC > 100 ug/ml) DME1943 XEOTICID XEO03594 GENEFORM Protein DME1943 XEOTICID XEO03594 MOACRIVE Inhibition DME1943 XEOTICID XEO03971 XEO_NAME Lumbrican DME1943 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03971 XEO_CLAS Peptide DME1943 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO03971 GENEFORM Protein DME1943 XEOTICID XEO03971 MOACRIVE Inhibition DME1943 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1943 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO03972 XEO_CLAS Peptide DME1943 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 8 ug/ml) DME1943 XEOTICID XEO03972 GENEFORM Protein DME1943 XEOTICID XEO03972 MOACRIVE Inhibition DME1943 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1943 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04146 XEO_CLAS Peptide DME1943 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO04146 GENEFORM Protein DME1943 XEOTICID XEO04146 MOACRIVE Inhibition DME1943 XEOTICID XEO04177 XEO_NAME M-zodatoxin-Lt1a DME1943 XEOTICID XEO04177 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04177 XEO_CLAS Peptide DME1943 XEOTICID XEO04177 DESCRIPT M-zodatoxin-Lt1a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC > 33 microM) DME1943 XEOTICID XEO04177 GENEFORM Protein DME1943 XEOTICID XEO04177 MOACRIVE Inhibition DME1943 XEOTICID XEO04178 XEO_NAME M-zodatoxin-Lt2a DME1943 XEOTICID XEO04178 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04178 XEO_CLAS Peptide DME1943 XEOTICID XEO04178 DESCRIPT M-zodatoxin-Lt2a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 54 microM) DME1943 XEOTICID XEO04178 GENEFORM Protein DME1943 XEOTICID XEO04178 MOACRIVE Inhibition DME1943 XEOTICID XEO04179 XEO_NAME M-zodatoxin-Lt3a DME1943 XEOTICID XEO04179 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04179 XEO_CLAS Peptide DME1943 XEOTICID XEO04179 DESCRIPT M-zodatoxin-Lt3a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 20 microM) DME1943 XEOTICID XEO04179 GENEFORM Protein DME1943 XEOTICID XEO04179 MOACRIVE Inhibition DME1943 XEOTICID XEO04180 XEO_NAME M-zodatoxin-Lt3b DME1943 XEOTICID XEO04180 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04180 XEO_CLAS Peptide DME1943 XEOTICID XEO04180 DESCRIPT M-zodatoxin-Lt3b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 23 microM) DME1943 XEOTICID XEO04180 GENEFORM Protein DME1943 XEOTICID XEO04180 MOACRIVE Inhibition DME1943 XEOTICID XEO04181 XEO_NAME M-zodatoxin-Lt4a DME1943 XEOTICID XEO04181 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04181 XEO_CLAS Peptide DME1943 XEOTICID XEO04181 DESCRIPT M-zodatoxin-Lt4a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 18 microM) DME1943 XEOTICID XEO04181 GENEFORM Protein DME1943 XEOTICID XEO04181 MOACRIVE Inhibition DME1943 XEOTICID XEO04182 XEO_NAME M-zodatoxin-Lt4b DME1943 XEOTICID XEO04182 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04182 XEO_CLAS Peptide DME1943 XEOTICID XEO04182 DESCRIPT M-zodatoxin-Lt4b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 35 microM) DME1943 XEOTICID XEO04182 GENEFORM Protein DME1943 XEOTICID XEO04182 MOACRIVE Inhibition DME1943 XEOTICID XEO04183 XEO_NAME M-zodatoxin-Lt5a DME1943 XEOTICID XEO04183 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04183 XEO_CLAS Peptide DME1943 XEOTICID XEO04183 DESCRIPT M-zodatoxin-Lt5a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC > 37 microM) DME1943 XEOTICID XEO04183 GENEFORM Protein DME1943 XEOTICID XEO04183 MOACRIVE Inhibition DME1943 XEOTICID XEO04399 XEO_NAME Opistoporin-1 DME1943 XEOTICID XEO04399 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04399 XEO_CLAS Peptide DME1943 XEOTICID XEO04399 DESCRIPT Opistoporin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO04399 GENEFORM Protein DME1943 XEOTICID XEO04399 MOACRIVE Inhibition DME1943 XEOTICID XEO04434 XEO_NAME PAF32 peptide DME1943 XEOTICID XEO04434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04434 XEO_CLAS Peptide DME1943 XEOTICID XEO04434 DESCRIPT PAF32 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC > 160 microM) DME1943 XEOTICID XEO04434 GENEFORM Protein DME1943 XEOTICID XEO04434 MOACRIVE Inhibition DME1943 XEOTICID XEO04435 XEO_NAME PAF34 peptide DME1943 XEOTICID XEO04435 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04435 XEO_CLAS Peptide DME1943 XEOTICID XEO04435 DESCRIPT PAF34 peptide inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC > 160 microM) DME1943 XEOTICID XEO04435 GENEFORM Protein DME1943 XEOTICID XEO04435 MOACRIVE Inhibition DME1943 XEOTICID XEO04471 XEO_NAME Parabutoporin DME1943 XEOTICID XEO04471 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04471 XEO_CLAS Peptide DME1943 XEOTICID XEO04471 DESCRIPT Parabutoporin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 2 microM) DME1943 XEOTICID XEO04471 GENEFORM Protein DME1943 XEOTICID XEO04471 MOACRIVE Inhibition DME1943 XEOTICID XEO04505 XEO_NAME Penaeidin-2a DME1943 XEOTICID XEO04505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04505 XEO_CLAS Peptide DME1943 XEOTICID XEO04505 DESCRIPT Penaeidin-2a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO04505 GENEFORM Protein DME1943 XEOTICID XEO04505 MOACRIVE Inhibition DME1943 XEOTICID XEO04560 XEO_NAME Phlebotomus duboscqi defensin DME1943 XEOTICID XEO04560 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04560 XEO_CLAS Peptide DME1943 XEOTICID XEO04560 DESCRIPT Phlebotomus duboscqi defensin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 25-50 microM) DME1943 XEOTICID XEO04560 GENEFORM Protein DME1943 XEOTICID XEO04560 MOACRIVE Inhibition DME1943 XEOTICID XEO04678 XEO_NAME Plant defensin Pn-AMP1 DME1943 XEOTICID XEO04678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04678 XEO_CLAS Peptide DME1943 XEOTICID XEO04678 DESCRIPT Plant defensin Pn-AMP1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO04678 GENEFORM Protein DME1943 XEOTICID XEO04678 MOACRIVE Inhibition DME1943 XEOTICID XEO04679 XEO_NAME Plant defensin Pn-AMP2 DME1943 XEOTICID XEO04679 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04679 XEO_CLAS Peptide DME1943 XEOTICID XEO04679 DESCRIPT Plant defensin Pn-AMP2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO04679 GENEFORM Protein DME1943 XEOTICID XEO04679 MOACRIVE Inhibition DME1943 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1943 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04695 XEO_CLAS Peptide DME1943 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO04695 GENEFORM Protein DME1943 XEOTICID XEO04695 MOACRIVE Inhibition DME1943 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1943 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04696 XEO_CLAS Peptide DME1943 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO04696 GENEFORM Protein DME1943 XEOTICID XEO04696 MOACRIVE Inhibition DME1943 XEOTICID XEO04698 XEO_NAME Ponericin G6 DME1943 XEOTICID XEO04698 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04698 XEO_CLAS Peptide DME1943 XEOTICID XEO04698 DESCRIPT Ponericin G6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO04698 GENEFORM Protein DME1943 XEOTICID XEO04698 MOACRIVE Inhibition DME1943 XEOTICID XEO04765 XEO_NAME P. vulgaris defensin PvD1 DME1943 XEOTICID XEO04765 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04765 XEO_CLAS Peptide DME1943 XEOTICID XEO04765 DESCRIPT P. vulgaris defensin PvD1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO04765 GENEFORM Protein DME1943 XEOTICID XEO04765 MOACRIVE Inhibition DME1943 XEOTICID XEO04926 XEO_NAME Seminalplasmin DME1943 XEOTICID XEO04926 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04926 XEO_CLAS Peptide DME1943 XEOTICID XEO04926 DESCRIPT Seminalplasmin inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO04926 GENEFORM Protein DME1943 XEOTICID XEO04926 MOACRIVE Inhibition DME1943 XEOTICID XEO04931 XEO_NAME Shepherin I DME1943 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04931 XEO_CLAS Peptide DME1943 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO04931 GENEFORM Protein DME1943 XEOTICID XEO04931 MOACRIVE Inhibition DME1943 XEOTICID XEO04932 XEO_NAME shepherin II DME1943 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO04932 XEO_CLAS Peptide DME1943 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO04932 GENEFORM Protein DME1943 XEOTICID XEO04932 MOACRIVE Inhibition DME1943 XEOTICID XEO05063 XEO_NAME Temporin-1Sa DME1943 XEOTICID XEO05063 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05063 XEO_CLAS Peptide DME1943 XEOTICID XEO05063 DESCRIPT Temporin-1Sa inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 8 microM) DME1943 XEOTICID XEO05063 GENEFORM Protein DME1943 XEOTICID XEO05063 MOACRIVE Inhibition DME1943 XEOTICID XEO05065 XEO_NAME Temporin-1Sc DME1943 XEOTICID XEO05065 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05065 XEO_CLAS Peptide DME1943 XEOTICID XEO05065 DESCRIPT Temporin-1Sc inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 10 ug/ml) DME1943 XEOTICID XEO05065 GENEFORM Protein DME1943 XEOTICID XEO05065 MOACRIVE Inhibition DME1943 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME1943 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05144 XEO_CLAS Peptide DME1943 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 80 ug/ml) DME1943 XEOTICID XEO05144 GENEFORM Protein DME1943 XEOTICID XEO05144 MOACRIVE Inhibition DME1943 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME1943 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05145 XEO_CLAS Peptide DME1943 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 100 ug/ml) DME1943 XEOTICID XEO05145 GENEFORM Protein DME1943 XEOTICID XEO05145 MOACRIVE Inhibition DME1943 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME1943 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05146 XEO_CLAS Peptide DME1943 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 80 ug/ml) DME1943 XEOTICID XEO05146 GENEFORM Protein DME1943 XEOTICID XEO05146 MOACRIVE Inhibition DME1943 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME1943 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05147 XEO_CLAS Peptide DME1943 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 100 ug/ml) DME1943 XEOTICID XEO05147 GENEFORM Protein DME1943 XEOTICID XEO05147 MOACRIVE Inhibition DME1943 XEOTICID XEO05229 XEO_NAME Vasostatin-1 DME1943 XEOTICID XEO05229 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05229 XEO_CLAS Peptide DME1943 XEOTICID XEO05229 DESCRIPT Vasostatin-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 10 microM) DME1943 XEOTICID XEO05229 GENEFORM Protein DME1943 XEOTICID XEO05229 MOACRIVE Inhibition DME1943 XEOTICID XEO05230 XEO_NAME Venom antimicrobial peptide-6 DME1943 XEOTICID XEO05230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05230 XEO_CLAS Peptide DME1943 XEOTICID XEO05230 DESCRIPT Venom antimicrobial peptide-6 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 18.3 microM) DME1943 XEOTICID XEO05230 GENEFORM Protein DME1943 XEOTICID XEO05230 MOACRIVE Inhibition DME1943 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1943 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05231 XEO_CLAS Peptide DME1943 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae (MIC = 25.1 microM) DME1943 XEOTICID XEO05231 GENEFORM Protein DME1943 XEOTICID XEO05231 MOACRIVE Inhibition DME1943 XEOTICID XEO05238 XEO_NAME Vicilin-like Antimicrobial peptide MiAMP2a DME1943 XEOTICID XEO05238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05238 XEO_CLAS Peptide DME1943 XEOTICID XEO05238 DESCRIPT Vicilin-like Antimicrobial peptide MiAMP2a inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO05238 GENEFORM Protein DME1943 XEOTICID XEO05238 MOACRIVE Inhibition DME1943 XEOTICID XEO05239 XEO_NAME Vicilin-like Antimicrobial peptide MiAMP2b DME1943 XEOTICID XEO05239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05239 XEO_CLAS Peptide DME1943 XEOTICID XEO05239 DESCRIPT Vicilin-like Antimicrobial peptide MiAMP2b inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO05239 GENEFORM Protein DME1943 XEOTICID XEO05239 MOACRIVE Inhibition DME1943 XEOTICID XEO05240 XEO_NAME Vicilin-like Antimicrobial peptide MiAMP2c-1 DME1943 XEOTICID XEO05240 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05240 XEO_CLAS Peptide DME1943 XEOTICID XEO05240 DESCRIPT Vicilin-like Antimicrobial peptide MiAMP2c-1 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO05240 GENEFORM Protein DME1943 XEOTICID XEO05240 MOACRIVE Inhibition DME1943 XEOTICID XEO05241 XEO_NAME Vicilin-like Antimicrobial peptide MiAMP2c-2 DME1943 XEOTICID XEO05241 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05241 XEO_CLAS Peptide DME1943 XEOTICID XEO05241 DESCRIPT Vicilin-like Antimicrobial peptide MiAMP2c-2 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO05241 GENEFORM Protein DME1943 XEOTICID XEO05241 MOACRIVE Inhibition DME1943 XEOTICID XEO05242 XEO_NAME Vicilin-like Antimicrobial peptide MiAMP2c-3 DME1943 XEOTICID XEO05242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05242 XEO_CLAS Peptide DME1943 XEOTICID XEO05242 DESCRIPT Vicilin-like Antimicrobial peptide MiAMP2c-3 inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO05242 GENEFORM Protein DME1943 XEOTICID XEO05242 MOACRIVE Inhibition DME1943 XEOTICID XEO05243 XEO_NAME Vicilin-like Antimicrobial peptide MiAMP2d DME1943 XEOTICID XEO05243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05243 XEO_CLAS Peptide DME1943 XEOTICID XEO05243 DESCRIPT Vicilin-like Antimicrobial peptide MiAMP2d inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO05243 GENEFORM Protein DME1943 XEOTICID XEO05243 MOACRIVE Inhibition DME1943 XEOTICID XEO05244 XEO_NAME Vicilin-like Antimicrobial peptide MiAMP2dfens DME1943 XEOTICID XEO05244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1943 XEOTICID XEO05244 XEO_CLAS Peptide DME1943 XEOTICID XEO05244 DESCRIPT Vicilin-like Antimicrobial peptide MiAMP2dfens inhibits the drug-metabolizing activity of Unclear enzyme (DME-unclear) from Saccharomyces cerevisiae DME1943 XEOTICID XEO05244 GENEFORM Protein DME1943 XEOTICID XEO05244 MOACRIVE Inhibition DME1946 DME___ID DME1946 DME1946 DME_NAME Azoreductase (azoR) DME1946 SPESNAME Shigella dysenteriae DME1946 XEOTICID XEO02376 XEO_NAME Bacteriocin E50-52 DME1946 XEOTICID XEO02376 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO02376 XEO_CLAS Peptide DME1946 XEOTICID XEO02376 DESCRIPT Bacteriocin E50-52 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae DME1946 XEOTICID XEO02376 GENEFORM Protein DME1946 XEOTICID XEO02376 MOACRIVE Inhibition DME1946 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1946 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO02378 XEO_CLAS Peptide DME1946 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 0.76 ug/ml) DME1946 XEOTICID XEO02378 GENEFORM Protein DME1946 XEOTICID XEO02378 MOACRIVE Inhibition DME1946 XEOTICID XEO03235 XEO_NAME Dybowskin-2 DME1946 XEOTICID XEO03235 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03235 XEO_CLAS Peptide DME1946 XEOTICID XEO03235 DESCRIPT Dybowskin-2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 50 ug/ml) DME1946 XEOTICID XEO03235 GENEFORM Protein DME1946 XEOTICID XEO03235 MOACRIVE Inhibition DME1946 XEOTICID XEO03237 XEO_NAME Dybowskin-3 DME1946 XEOTICID XEO03237 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03237 XEO_CLAS Peptide DME1946 XEOTICID XEO03237 DESCRIPT Dybowskin-3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 15 ug/ml) DME1946 XEOTICID XEO03237 GENEFORM Protein DME1946 XEOTICID XEO03237 MOACRIVE Inhibition DME1946 XEOTICID XEO03238 XEO_NAME Dybowskin-4 DME1946 XEOTICID XEO03238 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03238 XEO_CLAS Peptide DME1946 XEOTICID XEO03238 DESCRIPT Dybowskin-4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 30 ug/ml) DME1946 XEOTICID XEO03238 GENEFORM Protein DME1946 XEOTICID XEO03238 MOACRIVE Inhibition DME1946 XEOTICID XEO03239 XEO_NAME Dybowskin-5 DME1946 XEOTICID XEO03239 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03239 XEO_CLAS Peptide DME1946 XEOTICID XEO03239 DESCRIPT Dybowskin-5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 50 ug/ml) DME1946 XEOTICID XEO03239 GENEFORM Protein DME1946 XEOTICID XEO03239 MOACRIVE Inhibition DME1946 XEOTICID XEO03253 XEO_NAME Enterocin E-760 DME1946 XEOTICID XEO03253 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03253 XEO_CLAS Peptide DME1946 XEOTICID XEO03253 DESCRIPT Enterocin E-760 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 0.1 ug/ml) DME1946 XEOTICID XEO03253 GENEFORM Protein DME1946 XEOTICID XEO03253 MOACRIVE Inhibition DME1946 XEOTICID XEO03671 XEO_NAME Plant JCpep7 DME1946 XEOTICID XEO03671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03671 XEO_CLAS Peptide DME1946 XEOTICID XEO03671 DESCRIPT Plant JCpep7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 48 ug/ml) DME1946 XEOTICID XEO03671 GENEFORM Protein DME1946 XEOTICID XEO03671 MOACRIVE Inhibition DME1946 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1946 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03746 XEO_CLAS Peptide DME1946 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 2 ug/ml) DME1946 XEOTICID XEO03746 GENEFORM Protein DME1946 XEOTICID XEO03746 MOACRIVE Inhibition DME1946 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1946 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03747 XEO_CLAS Peptide DME1946 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 1 ug/ml) DME1946 XEOTICID XEO03747 GENEFORM Protein DME1946 XEOTICID XEO03747 MOACRIVE Inhibition DME1946 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1946 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03748 XEO_CLAS Peptide DME1946 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 2 ug/ml) DME1946 XEOTICID XEO03748 GENEFORM Protein DME1946 XEOTICID XEO03748 MOACRIVE Inhibition DME1946 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1946 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03749 XEO_CLAS Peptide DME1946 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 1 ug/ml) DME1946 XEOTICID XEO03749 GENEFORM Protein DME1946 XEOTICID XEO03749 MOACRIVE Inhibition DME1946 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1946 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03750 XEO_CLAS Peptide DME1946 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 2 ug/ml) DME1946 XEOTICID XEO03750 GENEFORM Protein DME1946 XEOTICID XEO03750 MOACRIVE Inhibition DME1946 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1946 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03751 XEO_CLAS Peptide DME1946 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 2 ug/ml) DME1946 XEOTICID XEO03751 GENEFORM Protein DME1946 XEOTICID XEO03751 MOACRIVE Inhibition DME1946 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1946 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03752 XEO_CLAS Peptide DME1946 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 2 ug/ml) DME1946 XEOTICID XEO03752 GENEFORM Protein DME1946 XEOTICID XEO03752 MOACRIVE Inhibition DME1946 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1946 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03754 XEO_CLAS Peptide DME1946 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 2 ug/ml) DME1946 XEOTICID XEO03754 GENEFORM Protein DME1946 XEOTICID XEO03754 MOACRIVE Inhibition DME1946 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1946 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03755 XEO_CLAS Peptide DME1946 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 4 ug/ml) DME1946 XEOTICID XEO03755 GENEFORM Protein DME1946 XEOTICID XEO03755 MOACRIVE Inhibition DME1946 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1946 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1946 XEOTICID XEO03756 XEO_CLAS Peptide DME1946 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Azoreductase (azoR) from Shigella dysenteriae (MIC = 2 ug/ml) DME1946 XEOTICID XEO03756 GENEFORM Protein DME1946 XEOTICID XEO03756 MOACRIVE Inhibition DME1953 DME___ID DME1953 DME1953 DME_NAME Glutamate racemase (MurI) DME1953 SPESNAME Streptococcus mutans DME1953 XEOTICID XEO00222 XEO_NAME Reserpine DME1953 XEOTICID XEO00222 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO00222 XEO_CLAS Approved/Marketed Drug DME1953 XEOTICID XEO00222 DESCRIPT Reserpine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO00222 GENEFORM Protein DME1953 XEOTICID XEO00222 MOACRIVE Inhibition DME1953 XEOTICID XEO00487 XEO_NAME Thymol DME1953 XEOTICID XEO00487 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO00487 XEO_CLAS Approved/Marketed Drug DME1953 XEOTICID XEO00487 DESCRIPT Thymol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO00487 GENEFORM Protein DME1953 XEOTICID XEO00487 MOACRIVE Inhibition DME1953 XEOTICID XEO00516 XEO_NAME Danthron DME1953 XEOTICID XEO00516 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO00516 XEO_CLAS Drug Marketed but Withdrawn from Market DME1953 XEOTICID XEO00516 DESCRIPT Danthron inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO00516 GENEFORM Protein DME1953 XEOTICID XEO00516 MOACRIVE Inhibition DME1953 XEOTICID XEO00560 XEO_NAME Triclosan DME1953 XEOTICID XEO00560 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO00560 XEO_CLAS Drug in Phase 3 Clinical Trial DME1953 XEOTICID XEO00560 DESCRIPT Triclosan inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO00560 GENEFORM Protein DME1953 XEOTICID XEO00560 MOACRIVE Inhibition DME1953 XEOTICID XEO00579 XEO_NAME SGX301 DME1953 XEOTICID XEO00579 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO00579 XEO_CLAS Drug in Phase 3 Clinical Trial DME1953 XEOTICID XEO00579 DESCRIPT SGX301 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO00579 GENEFORM Protein DME1953 XEOTICID XEO00579 MOACRIVE Inhibition DME1953 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME1953 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME1953 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO00613 GENEFORM Protein DME1953 XEOTICID XEO00613 MOACRIVE Inhibition DME1953 XEOTICID XEO00683 XEO_NAME Curcumin DME1953 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME1953 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO00683 GENEFORM Protein DME1953 XEOTICID XEO00683 MOACRIVE Inhibition DME1953 XEOTICID XEO00692 XEO_NAME Emodin DME1953 XEOTICID XEO00692 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO00692 XEO_CLAS Preclinical/Patented Drug DME1953 XEOTICID XEO00692 DESCRIPT Emodin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO00692 GENEFORM Protein DME1953 XEOTICID XEO00692 MOACRIVE Inhibition DME1953 XEOTICID XEO01191 XEO_NAME Aloe-emodin DME1953 XEOTICID XEO01191 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO01191 XEO_CLAS Natural Product DME1953 XEOTICID XEO01191 DESCRIPT Aloe-emodin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO01191 GENEFORM Protein DME1953 XEOTICID XEO01191 MOACRIVE Inhibition DME1953 XEOTICID XEO01237 XEO_NAME Carvacrol DME1953 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1953 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO01237 GENEFORM Protein DME1953 XEOTICID XEO01237 MOACRIVE Inhibition DME1953 XEOTICID XEO01309 XEO_NAME Gallic acid DME1953 XEOTICID XEO01309 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO01309 XEO_CLAS Natural Product DME1953 XEOTICID XEO01309 DESCRIPT Gallic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO01309 GENEFORM Protein DME1953 XEOTICID XEO01309 MOACRIVE Inhibition DME1953 XEOTICID XEO01408 XEO_NAME Octyl gallate DME1953 XEOTICID XEO01408 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO01408 XEO_CLAS Natural Product DME1953 XEOTICID XEO01408 DESCRIPT Octyl gallate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO01408 GENEFORM Protein DME1953 XEOTICID XEO01408 MOACRIVE Inhibition DME1953 XEOTICID XEO01455 XEO_NAME Rhein DME1953 XEOTICID XEO01455 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO01455 XEO_CLAS Investigative Agent DME1953 XEOTICID XEO01455 DESCRIPT Rhein inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO01455 GENEFORM Protein DME1953 XEOTICID XEO01455 MOACRIVE Inhibition DME1953 XEOTICID XEO01528 XEO_NAME Chrysophanic acid DME1953 XEOTICID XEO01528 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO01528 XEO_CLAS Natural Product DME1953 XEOTICID XEO01528 DESCRIPT Chrysophanic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO01528 GENEFORM Protein DME1953 XEOTICID XEO01528 MOACRIVE Inhibition DME1953 XEOTICID XEO01531 XEO_NAME Clove oil DME1953 XEOTICID XEO01531 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO01531 XEO_CLAS Natural Product DME1953 XEOTICID XEO01531 DESCRIPT Clove oil inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO01531 GENEFORM Protein DME1953 XEOTICID XEO01531 MOACRIVE Inhibition DME1953 XEOTICID XEO01559 XEO_NAME Limonene DME1953 XEOTICID XEO01559 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO01559 XEO_CLAS Natural Product DME1953 XEOTICID XEO01559 DESCRIPT Limonene inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO01559 GENEFORM Protein DME1953 XEOTICID XEO01559 MOACRIVE Inhibition DME1953 XEOTICID XEO01931 XEO_NAME Alliin DME1953 XEOTICID XEO01931 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO01931 XEO_CLAS Investigative Agent DME1953 XEOTICID XEO01931 DESCRIPT Alliin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO01931 GENEFORM Protein DME1953 XEOTICID XEO01931 MOACRIVE Inhibition DME1953 XEOTICID XEO01940 XEO_NAME 2C-4 peptide DME1953 XEOTICID XEO01940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO01940 XEO_CLAS Peptide DME1953 XEOTICID XEO01940 DESCRIPT 2C-4 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO01940 GENEFORM Protein DME1953 XEOTICID XEO01940 MOACRIVE Inhibition DME1953 XEOTICID XEO01976 XEO_NAME Allicin DME1953 XEOTICID XEO01976 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO01976 XEO_CLAS Drug in Phase 1 Clinical Trial DME1953 XEOTICID XEO01976 DESCRIPT Allicin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO01976 GENEFORM Protein DME1953 XEOTICID XEO01976 MOACRIVE Inhibition DME1953 XEOTICID XEO02124 XEO_NAME Salvadora persica acetone extract DME1953 XEOTICID XEO02124 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO02124 XEO_CLAS Plant Extract DME1953 XEOTICID XEO02124 DESCRIPT Salvadora persica acetone extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO02124 GENEFORM Protein DME1953 XEOTICID XEO02124 MOACRIVE Inhibition DME1953 XEOTICID XEO02234 XEO_NAME Anthraflavic acid DME1953 XEOTICID XEO02234 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO02234 XEO_CLAS Investigative Agent DME1953 XEOTICID XEO02234 DESCRIPT Anthraflavic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO02234 GENEFORM Protein DME1953 XEOTICID XEO02234 MOACRIVE Inhibition DME1953 XEOTICID XEO02289 XEO_NAME Antimicrobial peptide lumbricin-1 DME1953 XEOTICID XEO02289 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO02289 XEO_CLAS Peptide DME1953 XEOTICID XEO02289 DESCRIPT Antimicrobial peptide lumbricin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans (MIC = 30 ug/ml) DME1953 XEOTICID XEO02289 GENEFORM Protein DME1953 XEOTICID XEO02289 MOACRIVE Inhibition DME1953 XEOTICID XEO02313 XEO_NAME Salvadora persica aqueous extract DME1953 XEOTICID XEO02313 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO02313 XEO_CLAS Plant Extract DME1953 XEOTICID XEO02313 DESCRIPT Salvadora persica aqueous extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO02313 GENEFORM Protein DME1953 XEOTICID XEO02313 MOACRIVE Inhibition DME1953 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1953 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO02649 XEO_CLAS Peptide DME1953 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans (MIC = 8 ug/ml) DME1953 XEOTICID XEO02649 GENEFORM Protein DME1953 XEOTICID XEO02649 MOACRIVE Inhibition DME1953 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1953 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO02650 XEO_CLAS Peptide DME1953 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans (MIC = 2 ug/ml) DME1953 XEOTICID XEO02650 GENEFORM Protein DME1953 XEOTICID XEO02650 MOACRIVE Inhibition DME1953 XEOTICID XEO02660 XEO_NAME Butyl gallate DME1953 XEOTICID XEO02660 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO02660 XEO_CLAS Chemical Compound DME1953 XEOTICID XEO02660 DESCRIPT Butyl gallate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO02660 GENEFORM Protein DME1953 XEOTICID XEO02660 MOACRIVE Inhibition DME1953 XEOTICID XEO02670 XEO_NAME C16-33 peptide DME1953 XEOTICID XEO02670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO02670 XEO_CLAS Peptide DME1953 XEOTICID XEO02670 DESCRIPT C16-33 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO02670 GENEFORM Protein DME1953 XEOTICID XEO02670 MOACRIVE Inhibition DME1953 XEOTICID XEO02716 XEO_NAME Carminic acid DME1953 XEOTICID XEO02716 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO02716 XEO_CLAS Natural Product DME1953 XEOTICID XEO02716 DESCRIPT Carminic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO02716 GENEFORM Protein DME1953 XEOTICID XEO02716 MOACRIVE Inhibition DME1953 XEOTICID XEO02717 XEO_NAME Carnitine hydrochloride DME1953 XEOTICID XEO02717 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO02717 XEO_CLAS Investigative Agent DME1953 XEOTICID XEO02717 DESCRIPT Carnitine hydrochloride inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO02717 GENEFORM Protein DME1953 XEOTICID XEO02717 MOACRIVE Inhibition DME1953 XEOTICID XEO02722 XEO_NAME Carolacton DME1953 XEOTICID XEO02722 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO02722 XEO_CLAS Natural Product DME1953 XEOTICID XEO02722 DESCRIPT Carolacton inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO02722 GENEFORM Protein DME1953 XEOTICID XEO02722 MOACRIVE Inhibition DME1953 XEOTICID XEO02780 XEO_NAME Cefixime DME1953 XEOTICID XEO02780 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO02780 XEO_CLAS Approved/Marketed Drug DME1953 XEOTICID XEO02780 DESCRIPT Cefixime inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO02780 GENEFORM Protein DME1953 XEOTICID XEO02780 MOACRIVE Inhibition DME1953 XEOTICID XEO02830 XEO_NAME Chlorhexidine DME1953 XEOTICID XEO02830 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO02830 XEO_CLAS Approved/Marketed Drug DME1953 XEOTICID XEO02830 DESCRIPT Chlorhexidine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO02830 GENEFORM Protein DME1953 XEOTICID XEO02830 MOACRIVE Inhibition DME1953 XEOTICID XEO02831 XEO_NAME Chlorhexidine acetate DME1953 XEOTICID XEO02831 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO02831 XEO_CLAS Drug in Phase 1 Clinical Trial DME1953 XEOTICID XEO02831 DESCRIPT Chlorhexidine acetate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO02831 GENEFORM Protein DME1953 XEOTICID XEO02831 MOACRIVE Inhibition DME1953 XEOTICID XEO02832 XEO_NAME Salvadora persica chloroform extract DME1953 XEOTICID XEO02832 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO02832 XEO_CLAS Plant Extract DME1953 XEOTICID XEO02832 DESCRIPT Salvadora persica chloroform extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO02832 GENEFORM Protein DME1953 XEOTICID XEO02832 MOACRIVE Inhibition DME1953 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME1953 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO02839 XEO_CLAS Peptide DME1953 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO02839 GENEFORM Protein DME1953 XEOTICID XEO02839 MOACRIVE Inhibition DME1953 XEOTICID XEO03009 XEO_NAME Streptococcus salivarius culture supernatant DME1953 XEOTICID XEO03009 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO03009 XEO_CLAS Bacterial Extract DME1953 XEOTICID XEO03009 DESCRIPT Streptococcus salivarius culture supernatant inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03009 GENEFORM Protein DME1953 XEOTICID XEO03009 MOACRIVE Inhibition DME1953 XEOTICID XEO03179 XEO_NAME Dibenzyl disulphide DME1953 XEOTICID XEO03179 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO03179 XEO_CLAS Chemical Compound DME1953 XEOTICID XEO03179 DESCRIPT Dibenzyl disulphide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03179 GENEFORM Protein DME1953 XEOTICID XEO03179 MOACRIVE Inhibition DME1953 XEOTICID XEO03180 XEO_NAME Dibenzyl sulphide DME1953 XEOTICID XEO03180 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO03180 XEO_CLAS Chemical Compound DME1953 XEOTICID XEO03180 DESCRIPT Dibenzyl sulphide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03180 GENEFORM Protein DME1953 XEOTICID XEO03180 MOACRIVE Inhibition DME1953 XEOTICID XEO03191 XEO_NAME Diphenyl disulphide DME1953 XEOTICID XEO03191 XEO_TYPE Health or Environmental Toxicant(s) DME1953 XEOTICID XEO03191 XEO_CLAS Environmental Pollutant DME1953 XEOTICID XEO03191 DESCRIPT Diphenyl disulphide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03191 GENEFORM Protein DME1953 XEOTICID XEO03191 MOACRIVE Inhibition DME1953 XEOTICID XEO03199 XEO_NAME Djenkolic acid DME1953 XEOTICID XEO03199 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO03199 XEO_CLAS Chemical Compound DME1953 XEOTICID XEO03199 DESCRIPT Djenkolic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03199 GENEFORM Protein DME1953 XEOTICID XEO03199 MOACRIVE Inhibition DME1953 XEOTICID XEO03271 XEO_NAME Erythritol DME1953 XEOTICID XEO03271 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO03271 XEO_CLAS Natural Product DME1953 XEOTICID XEO03271 DESCRIPT Erythritol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03271 GENEFORM Protein DME1953 XEOTICID XEO03271 MOACRIVE Inhibition DME1953 XEOTICID XEO03350 XEO_NAME Salvadora persica ethanolic extract DME1953 XEOTICID XEO03350 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO03350 XEO_CLAS Plant Extract DME1953 XEOTICID XEO03350 DESCRIPT Salvadora persica ethanolic extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03350 GENEFORM Protein DME1953 XEOTICID XEO03350 MOACRIVE Inhibition DME1953 XEOTICID XEO03372 XEO_NAME Hypsizygus marmoreus extract DME1953 XEOTICID XEO03372 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO03372 XEO_CLAS Fungal Extract DME1953 XEOTICID XEO03372 DESCRIPT Hypsizygus marmoreus extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03372 GENEFORM Protein DME1953 XEOTICID XEO03372 MOACRIVE Inhibition DME1953 XEOTICID XEO03373 XEO_NAME Lentinula edodes extract DME1953 XEOTICID XEO03373 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO03373 XEO_CLAS Fungal Extract DME1953 XEOTICID XEO03373 DESCRIPT Lentinula edodes extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03373 GENEFORM Protein DME1953 XEOTICID XEO03373 MOACRIVE Inhibition DME1953 XEOTICID XEO03374 XEO_NAME Pholiota nameko extract DME1953 XEOTICID XEO03374 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO03374 XEO_CLAS Fungal Extract DME1953 XEOTICID XEO03374 DESCRIPT Pholiota nameko extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03374 GENEFORM Protein DME1953 XEOTICID XEO03374 MOACRIVE Inhibition DME1953 XEOTICID XEO03375 XEO_NAME Pleurotus eryngii extract DME1953 XEOTICID XEO03375 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO03375 XEO_CLAS Fungal Extract DME1953 XEOTICID XEO03375 DESCRIPT Pleurotus eryngii extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03375 GENEFORM Protein DME1953 XEOTICID XEO03375 MOACRIVE Inhibition DME1953 XEOTICID XEO03415 XEO_NAME Furanone C-30 DME1953 XEOTICID XEO03415 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO03415 XEO_CLAS Investigative Agent DME1953 XEOTICID XEO03415 DESCRIPT Furanone C-30 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03415 GENEFORM Protein DME1953 XEOTICID XEO03415 MOACRIVE Inhibition DME1953 XEOTICID XEO03433 XEO_NAME G2 peptide DME1953 XEOTICID XEO03433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO03433 XEO_CLAS Peptide DME1953 XEOTICID XEO03433 DESCRIPT G2 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03433 GENEFORM Protein DME1953 XEOTICID XEO03433 MOACRIVE Inhibition DME1953 XEOTICID XEO03492 XEO_NAME Glycinamide hydrochloride DME1953 XEOTICID XEO03492 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO03492 XEO_CLAS Chemical Compound DME1953 XEOTICID XEO03492 DESCRIPT Glycinamide hydrochloride inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03492 GENEFORM Protein DME1953 XEOTICID XEO03492 MOACRIVE Inhibition DME1953 XEOTICID XEO03555 XEO_NAME Hexyl gallate DME1953 XEOTICID XEO03555 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO03555 XEO_CLAS Chemical Compound DME1953 XEOTICID XEO03555 DESCRIPT Hexyl gallate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03555 GENEFORM Protein DME1953 XEOTICID XEO03555 MOACRIVE Inhibition DME1953 XEOTICID XEO03704 XEO_NAME Kaurenoic acid DME1953 XEOTICID XEO03704 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO03704 XEO_CLAS Natural Product DME1953 XEOTICID XEO03704 DESCRIPT Kaurenoic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03704 GENEFORM Protein DME1953 XEOTICID XEO03704 MOACRIVE Inhibition DME1953 XEOTICID XEO03796 XEO_NAME L-amino-acid oxidase Casca LAO DME1953 XEOTICID XEO03796 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO03796 XEO_CLAS Peptide DME1953 XEOTICID XEO03796 DESCRIPT L-amino-acid oxidase Casca LAO inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03796 GENEFORM Protein DME1953 XEOTICID XEO03796 MOACRIVE Inhibition DME1953 XEOTICID XEO03813 XEO_NAME L-cysteic acid DME1953 XEOTICID XEO03813 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO03813 XEO_CLAS Amino Acid DME1953 XEOTICID XEO03813 DESCRIPT L-cysteic acid inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03813 GENEFORM Protein DME1953 XEOTICID XEO03813 MOACRIVE Inhibition DME1953 XEOTICID XEO03912 XEO_NAME Listerine DME1953 XEOTICID XEO03912 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO03912 XEO_CLAS Investigative Agent DME1953 XEOTICID XEO03912 DESCRIPT Listerine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03912 GENEFORM Protein DME1953 XEOTICID XEO03912 MOACRIVE Inhibition DME1953 XEOTICID XEO03971 XEO_NAME Lumbrican DME1953 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO03971 XEO_CLAS Peptide DME1953 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03971 GENEFORM Protein DME1953 XEOTICID XEO03971 MOACRIVE Inhibition DME1953 XEOTICID XEO03972 XEO_NAME Lumbricin I(6-34) DME1953 XEOTICID XEO03972 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO03972 XEO_CLAS Peptide DME1953 XEOTICID XEO03972 DESCRIPT Lumbricin I(6-34) inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans (MIC = 20 ug/ml) DME1953 XEOTICID XEO03972 GENEFORM Protein DME1953 XEOTICID XEO03972 MOACRIVE Inhibition DME1953 XEOTICID XEO03978 XEO_NAME M8-33 peptide DME1953 XEOTICID XEO03978 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO03978 XEO_CLAS Peptide DME1953 XEOTICID XEO03978 DESCRIPT M8-33 peptide inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO03978 GENEFORM Protein DME1953 XEOTICID XEO03978 MOACRIVE Inhibition DME1953 XEOTICID XEO04099 XEO_NAME Salvadora persica methanolic extract DME1953 XEOTICID XEO04099 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO04099 XEO_CLAS Plant Extract DME1953 XEOTICID XEO04099 DESCRIPT Salvadora persica methanolic extract inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04099 GENEFORM Protein DME1953 XEOTICID XEO04099 MOACRIVE Inhibition DME1953 XEOTICID XEO04106 XEO_NAME Methyl gallate DME1953 XEOTICID XEO04106 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO04106 XEO_CLAS Investigative Agent DME1953 XEOTICID XEO04106 DESCRIPT Methyl gallate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04106 GENEFORM Protein DME1953 XEOTICID XEO04106 MOACRIVE Inhibition DME1953 XEOTICID XEO04117 XEO_NAME Misgurin DME1953 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO04117 XEO_CLAS Peptide DME1953 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04117 GENEFORM Protein DME1953 XEOTICID XEO04117 MOACRIVE Inhibition DME1953 XEOTICID XEO04146 XEO_NAME Human MUC7 20-Mer DME1953 XEOTICID XEO04146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO04146 XEO_CLAS Peptide DME1953 XEOTICID XEO04146 DESCRIPT Human MUC7 20-Mer inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04146 GENEFORM Protein DME1953 XEOTICID XEO04146 MOACRIVE Inhibition DME1953 XEOTICID XEO04155 XEO_NAME Mutacin-1140 DME1953 XEOTICID XEO04155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO04155 XEO_CLAS Peptide DME1953 XEOTICID XEO04155 DESCRIPT Mutacin-1140 inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04155 GENEFORM Protein DME1953 XEOTICID XEO04155 MOACRIVE Inhibition DME1953 XEOTICID XEO04249 XEO_NAME Neurokinin A DME1953 XEOTICID XEO04249 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO04249 XEO_CLAS Peptide DME1953 XEOTICID XEO04249 DESCRIPT Neurokinin A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans (MIC > 500 ug/ml) DME1953 XEOTICID XEO04249 GENEFORM Protein DME1953 XEOTICID XEO04249 MOACRIVE Inhibition DME1953 XEOTICID XEO04331 XEO_NAME Norspermidine DME1953 XEOTICID XEO04331 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO04331 XEO_CLAS Investigative Agent DME1953 XEOTICID XEO04331 DESCRIPT Norspermidine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04331 GENEFORM Protein DME1953 XEOTICID XEO04331 MOACRIVE Inhibition DME1953 XEOTICID XEO04350 XEO_NAME Octadecyl gallate DME1953 XEOTICID XEO04350 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO04350 XEO_CLAS Chemical Compound DME1953 XEOTICID XEO04350 DESCRIPT Octadecyl gallate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04350 GENEFORM Protein DME1953 XEOTICID XEO04350 MOACRIVE Inhibition DME1953 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1953 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1953 XEOTICID XEO04640 XEO_CLAS Peptide DME1953 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04640 GENEFORM Protein DME1953 XEOTICID XEO04640 MOACRIVE Inhibition DME1953 XEOTICID XEO04723 XEO_NAME Allylsulfenate DME1953 XEOTICID XEO04723 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO04723 XEO_CLAS Chemical Compound DME1953 XEOTICID XEO04723 DESCRIPT Allylsulfenate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04723 GENEFORM Protein DME1953 XEOTICID XEO04723 MOACRIVE Inhibition DME1953 XEOTICID XEO04727 XEO_NAME Propyl gallate DME1953 XEOTICID XEO04727 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO04727 XEO_CLAS Food Additive DME1953 XEOTICID XEO04727 DESCRIPT Propyl gallate inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04727 GENEFORM Protein DME1953 XEOTICID XEO04727 MOACRIVE Inhibition DME1953 XEOTICID XEO04753 XEO_NAME Pseudomonas quinolone signal DME1953 XEOTICID XEO04753 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO04753 XEO_CLAS Natural Product DME1953 XEOTICID XEO04753 DESCRIPT Pseudomonas quinolone signal inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04753 GENEFORM Protein DME1953 XEOTICID XEO04753 MOACRIVE Inhibition DME1953 XEOTICID XEO04775 XEO_NAME Quinizarin DME1953 XEOTICID XEO04775 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO04775 XEO_CLAS Investigative Agent DME1953 XEOTICID XEO04775 DESCRIPT Quinizarin inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04775 GENEFORM Protein DME1953 XEOTICID XEO04775 MOACRIVE Inhibition DME1953 XEOTICID XEO04873 XEO_NAME S-(2-Aminoethyl)-L-cysteine hydrochloride DME1953 XEOTICID XEO04873 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO04873 XEO_CLAS Chemical Compound DME1953 XEOTICID XEO04873 DESCRIPT S-(2-Aminoethyl)-L-cysteine hydrochloride inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04873 GENEFORM Protein DME1953 XEOTICID XEO04873 MOACRIVE Inhibition DME1953 XEOTICID XEO04875 XEO_NAME S-(2-thienyl)-L-cysteine DME1953 XEOTICID XEO04875 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO04875 XEO_CLAS Chemical Compound DME1953 XEOTICID XEO04875 DESCRIPT S-(2-thienyl)-L-cysteine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04875 GENEFORM Protein DME1953 XEOTICID XEO04875 MOACRIVE Inhibition DME1953 XEOTICID XEO04876 XEO_NAME S-(4-tolyl)-L-cysteine DME1953 XEOTICID XEO04876 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO04876 XEO_CLAS Chemical Compound DME1953 XEOTICID XEO04876 DESCRIPT S-(4-tolyl)-L-cysteine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04876 GENEFORM Protein DME1953 XEOTICID XEO04876 MOACRIVE Inhibition DME1953 XEOTICID XEO04914 XEO_NAME S-carboxylmethyl-L-cysteine DME1953 XEOTICID XEO04914 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO04914 XEO_CLAS Investigative Agent DME1953 XEOTICID XEO04914 DESCRIPT S-carboxylmethyl-L-cysteine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04914 GENEFORM Protein DME1953 XEOTICID XEO04914 MOACRIVE Inhibition DME1953 XEOTICID XEO04928 XEO_NAME Sennidin A DME1953 XEOTICID XEO04928 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO04928 XEO_CLAS Natural Product DME1953 XEOTICID XEO04928 DESCRIPT Sennidin A inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04928 GENEFORM Protein DME1953 XEOTICID XEO04928 MOACRIVE Inhibition DME1953 XEOTICID XEO04930 XEO_NAME S-ethyl-L-cysteine DME1953 XEOTICID XEO04930 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO04930 XEO_CLAS Chemical Compound DME1953 XEOTICID XEO04930 DESCRIPT S-ethyl-L-cysteine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04930 GENEFORM Protein DME1953 XEOTICID XEO04930 MOACRIVE Inhibition DME1953 XEOTICID XEO04972 XEO_NAME S-phenyl-L-cysteine DME1953 XEOTICID XEO04972 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO04972 XEO_CLAS Chemical Compound DME1953 XEOTICID XEO04972 DESCRIPT S-phenyl-L-cysteine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04972 GENEFORM Protein DME1953 XEOTICID XEO04972 MOACRIVE Inhibition DME1953 XEOTICID XEO04980 XEO_NAME S-propyl-L-cysteine DME1953 XEOTICID XEO04980 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1953 XEOTICID XEO04980 XEO_CLAS Chemical Compound DME1953 XEOTICID XEO04980 DESCRIPT S-propyl-L-cysteine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO04980 GENEFORM Protein DME1953 XEOTICID XEO04980 MOACRIVE Inhibition DME1953 XEOTICID XEO05032 XEO_NAME Taurine DME1953 XEOTICID XEO05032 XEO_TYPE Pharmaceutical Agent(s) DME1953 XEOTICID XEO05032 XEO_CLAS Approved/Marketed Drug DME1953 XEOTICID XEO05032 DESCRIPT Taurine inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO05032 GENEFORM Protein DME1953 XEOTICID XEO05032 MOACRIVE Inhibition DME1953 XEOTICID XEO05194 XEO_NAME Tyrosol DME1953 XEOTICID XEO05194 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1953 XEOTICID XEO05194 XEO_CLAS Natural Product DME1953 XEOTICID XEO05194 DESCRIPT Tyrosol inhibits the drug-metabolizing activity of Glutamate racemase (MurI) from Streptococcus mutans DME1953 XEOTICID XEO05194 GENEFORM Protein DME1953 XEOTICID XEO05194 MOACRIVE Inhibition DME1957 DME___ID DME1957 DME1957 DME_NAME Methylenetetrahydrofolate reductase (metF) DME1957 SPESNAME Streptococcus sanguinis DME1957 XEOTICID XEO02670 XEO_NAME C16-33 peptide DME1957 XEOTICID XEO02670 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1957 XEOTICID XEO02670 XEO_CLAS Peptide DME1957 XEOTICID XEO02670 DESCRIPT C16-33 peptide inhibits the drug-metabolizing activity of Methylenetetrahydrofolate reductase (metF) from Streptococcus sanguinis DME1957 XEOTICID XEO02670 GENEFORM Protein DME1957 XEOTICID XEO02670 MOACRIVE Inhibition DME1957 XEOTICID XEO03433 XEO_NAME G2 peptide DME1957 XEOTICID XEO03433 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1957 XEOTICID XEO03433 XEO_CLAS Peptide DME1957 XEOTICID XEO03433 DESCRIPT G2 peptide inhibits the drug-metabolizing activity of Methylenetetrahydrofolate reductase (metF) from Streptococcus sanguinis DME1957 XEOTICID XEO03433 GENEFORM Protein DME1957 XEOTICID XEO03433 MOACRIVE Inhibition DME1957 XEOTICID XEO03978 XEO_NAME M8-33 peptide DME1957 XEOTICID XEO03978 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1957 XEOTICID XEO03978 XEO_CLAS Peptide DME1957 XEOTICID XEO03978 DESCRIPT M8-33 peptide inhibits the drug-metabolizing activity of Methylenetetrahydrofolate reductase (metF) from Streptococcus sanguinis DME1957 XEOTICID XEO03978 GENEFORM Protein DME1957 XEOTICID XEO03978 MOACRIVE Inhibition DME1957 XEOTICID XEO04155 XEO_NAME Mutacin-1140 DME1957 XEOTICID XEO04155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1957 XEOTICID XEO04155 XEO_CLAS Peptide DME1957 XEOTICID XEO04155 DESCRIPT Mutacin-1140 inhibits the drug-metabolizing activity of Methylenetetrahydrofolate reductase (metF) from Streptococcus sanguinis DME1957 XEOTICID XEO04155 GENEFORM Protein DME1957 XEOTICID XEO04155 MOACRIVE Inhibition DME1968 DME___ID DME1968 DME1968 DME_NAME Nitroreductase (NTR) DME1968 SPESNAME Salmonella typhimurium DME1968 XEOTICID XEO01237 XEO_NAME Carvacrol DME1968 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1968 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1968 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO01237 GENEFORM Protein DME1968 XEOTICID XEO01237 MOACRIVE Inhibition DME1968 XEOTICID XEO01802 XEO_NAME (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone DME1968 XEOTICID XEO01802 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1968 XEOTICID XEO01802 XEO_CLAS Chemical Compound DME1968 XEOTICID XEO01802 DESCRIPT (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO01802 GENEFORM Protein DME1968 XEOTICID XEO01802 MOACRIVE Inhibition DME1968 XEOTICID XEO01944 XEO_NAME 2-Hexylmaleic anhydride DME1968 XEOTICID XEO01944 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1968 XEOTICID XEO01944 XEO_CLAS Chemical Compound DME1968 XEOTICID XEO01944 DESCRIPT 2-Hexylmaleic anhydride inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO01944 GENEFORM Protein DME1968 XEOTICID XEO01944 MOACRIVE Inhibition DME1968 XEOTICID XEO01990 XEO_NAME 3-hexyl-4-bromo-5-methylene-2(5H)-furanone DME1968 XEOTICID XEO01990 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1968 XEOTICID XEO01990 XEO_CLAS Chemical Compound DME1968 XEOTICID XEO01990 DESCRIPT 3-hexyl-4-bromo-5-methylene-2(5H)-furanone inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO01990 GENEFORM Protein DME1968 XEOTICID XEO01990 MOACRIVE Inhibition DME1968 XEOTICID XEO02235 XEO_NAME Anthranilate DME1968 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1968 XEOTICID XEO02235 XEO_CLAS Natural Product DME1968 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO02235 GENEFORM Protein DME1968 XEOTICID XEO02235 MOACRIVE Inhibition DME1968 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1968 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO02284 XEO_CLAS Peptide DME1968 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 25.0 microM) DME1968 XEOTICID XEO02284 GENEFORM Protein DME1968 XEOTICID XEO02284 MOACRIVE Inhibition DME1968 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1968 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO02285 XEO_CLAS Peptide DME1968 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 25.0 microM) DME1968 XEOTICID XEO02285 GENEFORM Protein DME1968 XEOTICID XEO02285 MOACRIVE Inhibition DME1968 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1968 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO02286 XEO_CLAS Peptide DME1968 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 25.0 microM) DME1968 XEOTICID XEO02286 GENEFORM Protein DME1968 XEOTICID XEO02286 MOACRIVE Inhibition DME1968 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1968 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO02287 XEO_CLAS Peptide DME1968 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 25.0 microM) DME1968 XEOTICID XEO02287 GENEFORM Protein DME1968 XEOTICID XEO02287 MOACRIVE Inhibition DME1968 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1968 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO02317 XEO_CLAS Peptide DME1968 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 300 microM) DME1968 XEOTICID XEO02317 GENEFORM Protein DME1968 XEOTICID XEO02317 MOACRIVE Inhibition DME1968 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1968 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO02491 XEO_CLAS Peptide DME1968 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 2.3 microM) DME1968 XEOTICID XEO02491 GENEFORM Protein DME1968 XEOTICID XEO02491 MOACRIVE Inhibition DME1968 XEOTICID XEO02641 XEO_NAME Bromohexylmaleic anhydride DME1968 XEOTICID XEO02641 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1968 XEOTICID XEO02641 XEO_CLAS Chemical Compound DME1968 XEOTICID XEO02641 DESCRIPT Bromohexylmaleic anhydride inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO02641 GENEFORM Protein DME1968 XEOTICID XEO02641 MOACRIVE Inhibition DME1968 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1968 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1968 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1968 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO02990 GENEFORM Protein DME1968 XEOTICID XEO02990 MOACRIVE Inhibition DME1968 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1968 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO03029 XEO_CLAS Peptide DME1968 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 0.005 microM) DME1968 XEOTICID XEO03029 GENEFORM Protein DME1968 XEOTICID XEO03029 MOACRIVE Inhibition DME1968 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1968 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO03030 XEO_CLAS Peptide DME1968 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 0.005 microM) DME1968 XEOTICID XEO03030 GENEFORM Protein DME1968 XEOTICID XEO03030 MOACRIVE Inhibition DME1968 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1968 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO03031 XEO_CLAS Peptide DME1968 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 0.3 microM) DME1968 XEOTICID XEO03031 GENEFORM Protein DME1968 XEOTICID XEO03031 MOACRIVE Inhibition DME1968 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1968 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO03032 XEO_CLAS Peptide DME1968 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 0.005 microM) DME1968 XEOTICID XEO03032 GENEFORM Protein DME1968 XEOTICID XEO03032 MOACRIVE Inhibition DME1968 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1968 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO03033 XEO_CLAS Peptide DME1968 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 0.005 microM) DME1968 XEOTICID XEO03033 GENEFORM Protein DME1968 XEOTICID XEO03033 MOACRIVE Inhibition DME1968 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1968 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO03034 XEO_CLAS Peptide DME1968 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 0.528 microM) DME1968 XEOTICID XEO03034 GENEFORM Protein DME1968 XEOTICID XEO03034 MOACRIVE Inhibition DME1968 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1968 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO03035 XEO_CLAS Peptide DME1968 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 0.004 microM) DME1968 XEOTICID XEO03035 GENEFORM Protein DME1968 XEOTICID XEO03035 MOACRIVE Inhibition DME1968 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1968 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO03250 XEO_CLAS Peptide DME1968 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO03250 GENEFORM Protein DME1968 XEOTICID XEO03250 MOACRIVE Inhibition DME1968 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1968 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1968 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1968 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO03968 GENEFORM Protein DME1968 XEOTICID XEO03968 MOACRIVE Inhibition DME1968 XEOTICID XEO04114 XEO_NAME Microcin L DME1968 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04114 XEO_CLAS Peptide DME1968 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO04114 GENEFORM Protein DME1968 XEOTICID XEO04114 MOACRIVE Inhibition DME1968 XEOTICID XEO04172 XEO_NAME Myxinidin DME1968 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04172 XEO_CLAS Peptide DME1968 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO04172 GENEFORM Protein DME1968 XEOTICID XEO04172 MOACRIVE Inhibition DME1968 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1968 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04335 XEO_CLAS Peptide DME1968 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 16 ug/ml) DME1968 XEOTICID XEO04335 GENEFORM Protein DME1968 XEOTICID XEO04335 MOACRIVE Inhibition DME1968 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1968 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04336 XEO_CLAS Peptide DME1968 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 16 ug/ml) DME1968 XEOTICID XEO04336 GENEFORM Protein DME1968 XEOTICID XEO04336 MOACRIVE Inhibition DME1968 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1968 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04338 XEO_CLAS Peptide DME1968 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 0.5 ug/ml) DME1968 XEOTICID XEO04338 GENEFORM Protein DME1968 XEOTICID XEO04338 MOACRIVE Inhibition DME1968 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1968 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04339 XEO_CLAS Peptide DME1968 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 64 ug/ml) DME1968 XEOTICID XEO04339 GENEFORM Protein DME1968 XEOTICID XEO04339 MOACRIVE Inhibition DME1968 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1968 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04340 XEO_CLAS Peptide DME1968 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 2 ug/ml) DME1968 XEOTICID XEO04340 GENEFORM Protein DME1968 XEOTICID XEO04340 MOACRIVE Inhibition DME1968 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1968 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04642 XEO_CLAS Peptide DME1968 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 4 ug/ml) DME1968 XEOTICID XEO04642 GENEFORM Protein DME1968 XEOTICID XEO04642 MOACRIVE Inhibition DME1968 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1968 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04643 XEO_CLAS Peptide DME1968 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 2 ug/ml) DME1968 XEOTICID XEO04643 GENEFORM Protein DME1968 XEOTICID XEO04643 MOACRIVE Inhibition DME1968 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1968 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04644 XEO_CLAS Peptide DME1968 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 2 ug/ml) DME1968 XEOTICID XEO04644 GENEFORM Protein DME1968 XEOTICID XEO04644 MOACRIVE Inhibition DME1968 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1968 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04645 XEO_CLAS Peptide DME1968 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 32 ug/ml) DME1968 XEOTICID XEO04645 GENEFORM Protein DME1968 XEOTICID XEO04645 MOACRIVE Inhibition DME1968 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1968 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04646 XEO_CLAS Peptide DME1968 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 1 ug/ml) DME1968 XEOTICID XEO04646 GENEFORM Protein DME1968 XEOTICID XEO04646 MOACRIVE Inhibition DME1968 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1968 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04647 XEO_CLAS Peptide DME1968 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 4 ug/ml) DME1968 XEOTICID XEO04647 GENEFORM Protein DME1968 XEOTICID XEO04647 MOACRIVE Inhibition DME1968 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1968 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04648 XEO_CLAS Peptide DME1968 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 16 ug/ml) DME1968 XEOTICID XEO04648 GENEFORM Protein DME1968 XEOTICID XEO04648 MOACRIVE Inhibition DME1968 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1968 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04649 XEO_CLAS Peptide DME1968 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC > 64 ug/ml) DME1968 XEOTICID XEO04649 GENEFORM Protein DME1968 XEOTICID XEO04649 MOACRIVE Inhibition DME1968 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1968 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04650 XEO_CLAS Peptide DME1968 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 16 ug/ml) DME1968 XEOTICID XEO04650 GENEFORM Protein DME1968 XEOTICID XEO04650 MOACRIVE Inhibition DME1968 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1968 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04651 XEO_CLAS Peptide DME1968 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 64 ug/ml) DME1968 XEOTICID XEO04651 GENEFORM Protein DME1968 XEOTICID XEO04651 MOACRIVE Inhibition DME1968 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1968 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04652 XEO_CLAS Peptide DME1968 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 4 ug/ml) DME1968 XEOTICID XEO04652 GENEFORM Protein DME1968 XEOTICID XEO04652 MOACRIVE Inhibition DME1968 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1968 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04655 XEO_CLAS Peptide DME1968 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 2 ug/ml) DME1968 XEOTICID XEO04655 GENEFORM Protein DME1968 XEOTICID XEO04655 MOACRIVE Inhibition DME1968 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1968 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04695 XEO_CLAS Peptide DME1968 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO04695 GENEFORM Protein DME1968 XEOTICID XEO04695 MOACRIVE Inhibition DME1968 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1968 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04696 XEO_CLAS Peptide DME1968 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO04696 GENEFORM Protein DME1968 XEOTICID XEO04696 MOACRIVE Inhibition DME1968 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1968 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04699 XEO_CLAS Peptide DME1968 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO04699 GENEFORM Protein DME1968 XEOTICID XEO04699 MOACRIVE Inhibition DME1968 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1968 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04700 XEO_CLAS Peptide DME1968 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO04700 GENEFORM Protein DME1968 XEOTICID XEO04700 MOACRIVE Inhibition DME1968 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1968 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04701 XEO_CLAS Peptide DME1968 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO04701 GENEFORM Protein DME1968 XEOTICID XEO04701 MOACRIVE Inhibition DME1968 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1968 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04702 XEO_CLAS Peptide DME1968 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO04702 GENEFORM Protein DME1968 XEOTICID XEO04702 MOACRIVE Inhibition DME1968 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1968 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO04703 XEO_CLAS Peptide DME1968 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO04703 GENEFORM Protein DME1968 XEOTICID XEO04703 MOACRIVE Inhibition DME1968 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1968 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO05171 XEO_CLAS Peptide DME1968 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium DME1968 XEOTICID XEO05171 GENEFORM Protein DME1968 XEOTICID XEO05171 MOACRIVE Inhibition DME1968 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1968 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1968 XEOTICID XEO05308 XEO_CLAS Peptide DME1968 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Nitroreductase (NTR) from Salmonella typhimurium (MIC = 0.9 ug/ml) DME1968 XEOTICID XEO05308 GENEFORM Protein DME1968 XEOTICID XEO05308 MOACRIVE Inhibition DME1971 DME___ID DME1971 DME1971 DME_NAME Oxygen-insensitive NADPH nitroreductase A (nfsA) DME1971 SPESNAME Salmonella enterica DME1971 XEOTICID XEO01237 XEO_NAME Carvacrol DME1971 XEOTICID XEO01237 XEO_TYPE Pharmaceutical Agent(s) DME1971 XEOTICID XEO01237 XEO_CLAS Drug in Phase 1 Clinical Trial DME1971 XEOTICID XEO01237 DESCRIPT Carvacrol inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO01237 GENEFORM Protein DME1971 XEOTICID XEO01237 MOACRIVE Inhibition DME1971 XEOTICID XEO01802 XEO_NAME (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone DME1971 XEOTICID XEO01802 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1971 XEOTICID XEO01802 XEO_CLAS Chemical Compound DME1971 XEOTICID XEO01802 DESCRIPT (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO01802 GENEFORM Protein DME1971 XEOTICID XEO01802 MOACRIVE Inhibition DME1971 XEOTICID XEO01810 XEO_NAME SMAP-29 derivative A19 DME1971 XEOTICID XEO01810 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO01810 XEO_CLAS Peptide DME1971 XEOTICID XEO01810 DESCRIPT SMAP-29 derivative A19 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1.0 microM) DME1971 XEOTICID XEO01810 GENEFORM Protein DME1971 XEOTICID XEO01810 MOACRIVE Inhibition DME1971 XEOTICID XEO01811 XEO_NAME IsCT analog W6A [A6] DME1971 XEOTICID XEO01811 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO01811 XEO_CLAS Peptide DME1971 XEOTICID XEO01811 DESCRIPT IsCT analog W6A [A6] inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC > 64 microM) DME1971 XEOTICID XEO01811 GENEFORM Protein DME1971 XEOTICID XEO01811 MOACRIVE Inhibition DME1971 XEOTICID XEO01817 XEO_NAME SMAP-29 derivative K2,7,13 DME1971 XEOTICID XEO01817 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO01817 XEO_CLAS Peptide DME1971 XEOTICID XEO01817 DESCRIPT SMAP-29 derivative K2,7,13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4.0 microM) DME1971 XEOTICID XEO01817 GENEFORM Protein DME1971 XEOTICID XEO01817 MOACRIVE Inhibition DME1971 XEOTICID XEO01818 XEO_NAME SMAP-29 derivative K22,25,27 DME1971 XEOTICID XEO01818 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO01818 XEO_CLAS Peptide DME1971 XEOTICID XEO01818 DESCRIPT SMAP-29 derivative K22,25,27 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1.0 microM) DME1971 XEOTICID XEO01818 GENEFORM Protein DME1971 XEOTICID XEO01818 MOACRIVE Inhibition DME1971 XEOTICID XEO01819 XEO_NAME IsCT analog K7,P8,K11 DME1971 XEOTICID XEO01819 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO01819 XEO_CLAS Peptide DME1971 XEOTICID XEO01819 DESCRIPT IsCT analog K7,P8,K11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1 microM) DME1971 XEOTICID XEO01819 GENEFORM Protein DME1971 XEOTICID XEO01819 MOACRIVE Inhibition DME1971 XEOTICID XEO01820 XEO_NAME IsCT analog E7K [K7] DME1971 XEOTICID XEO01820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO01820 XEO_CLAS Peptide DME1971 XEOTICID XEO01820 DESCRIPT IsCT analog E7K [K7] inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1 microM) DME1971 XEOTICID XEO01820 GENEFORM Protein DME1971 XEOTICID XEO01820 MOACRIVE Inhibition DME1971 XEOTICID XEO01821 XEO_NAME IsCT analog L6,K11 DME1971 XEOTICID XEO01821 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO01821 XEO_CLAS Peptide DME1971 XEOTICID XEO01821 DESCRIPT IsCT analog L6,K11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1 microM) DME1971 XEOTICID XEO01821 GENEFORM Protein DME1971 XEOTICID XEO01821 MOACRIVE Inhibition DME1971 XEOTICID XEO01822 XEO_NAME IsCT analog W6L [L6] DME1971 XEOTICID XEO01822 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO01822 XEO_CLAS Peptide DME1971 XEOTICID XEO01822 DESCRIPT IsCT analog W6L [L6] inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 16 microM) DME1971 XEOTICID XEO01822 GENEFORM Protein DME1971 XEOTICID XEO01822 MOACRIVE Inhibition DME1971 XEOTICID XEO01944 XEO_NAME 2-Hexylmaleic anhydride DME1971 XEOTICID XEO01944 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1971 XEOTICID XEO01944 XEO_CLAS Chemical Compound DME1971 XEOTICID XEO01944 DESCRIPT 2-Hexylmaleic anhydride inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO01944 GENEFORM Protein DME1971 XEOTICID XEO01944 MOACRIVE Inhibition DME1971 XEOTICID XEO01990 XEO_NAME 3-hexyl-4-bromo-5-methylene-2(5H)-furanone DME1971 XEOTICID XEO01990 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1971 XEOTICID XEO01990 XEO_CLAS Chemical Compound DME1971 XEOTICID XEO01990 DESCRIPT 3-hexyl-4-bromo-5-methylene-2(5H)-furanone inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO01990 GENEFORM Protein DME1971 XEOTICID XEO01990 MOACRIVE Inhibition DME1971 XEOTICID XEO02207 XEO_NAME HP(2-20) analogue Anal 1 DME1971 XEOTICID XEO02207 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02207 XEO_CLAS Peptide DME1971 XEOTICID XEO02207 DESCRIPT HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.39 ug/ml) DME1971 XEOTICID XEO02207 GENEFORM Protein DME1971 XEOTICID XEO02207 MOACRIVE Inhibition DME1971 XEOTICID XEO02208 XEO_NAME HP(2-20) analogue Anal 2 DME1971 XEOTICID XEO02208 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02208 XEO_CLAS Peptide DME1971 XEOTICID XEO02208 DESCRIPT HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.78 ug/ml) DME1971 XEOTICID XEO02208 GENEFORM Protein DME1971 XEOTICID XEO02208 MOACRIVE Inhibition DME1971 XEOTICID XEO02209 XEO_NAME HP(2-20) analogue Anal 3 DME1971 XEOTICID XEO02209 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02209 XEO_CLAS Peptide DME1971 XEOTICID XEO02209 DESCRIPT HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.39 ug/ml) DME1971 XEOTICID XEO02209 GENEFORM Protein DME1971 XEOTICID XEO02209 MOACRIVE Inhibition DME1971 XEOTICID XEO02210 XEO_NAME HP(2-20) analogue Anal 4 DME1971 XEOTICID XEO02210 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02210 XEO_CLAS Peptide DME1971 XEOTICID XEO02210 DESCRIPT HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 12.5 ug/ml) DME1971 XEOTICID XEO02210 GENEFORM Protein DME1971 XEOTICID XEO02210 MOACRIVE Inhibition DME1971 XEOTICID XEO02211 XEO_NAME HP(2-20) analogue Anal 5 DME1971 XEOTICID XEO02211 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02211 XEO_CLAS Peptide DME1971 XEOTICID XEO02211 DESCRIPT HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 12.5 ug/ml) DME1971 XEOTICID XEO02211 GENEFORM Protein DME1971 XEOTICID XEO02211 MOACRIVE Inhibition DME1971 XEOTICID XEO02212 XEO_NAME HP(2-20) analogue Anal 6 DME1971 XEOTICID XEO02212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02212 XEO_CLAS Peptide DME1971 XEOTICID XEO02212 DESCRIPT HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.39 ug/ml) DME1971 XEOTICID XEO02212 GENEFORM Protein DME1971 XEOTICID XEO02212 MOACRIVE Inhibition DME1971 XEOTICID XEO02213 XEO_NAME HP(2-20) analogue Anal 7 DME1971 XEOTICID XEO02213 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02213 XEO_CLAS Peptide DME1971 XEOTICID XEO02213 DESCRIPT HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.39 ug/ml) DME1971 XEOTICID XEO02213 GENEFORM Protein DME1971 XEOTICID XEO02213 MOACRIVE Inhibition DME1971 XEOTICID XEO02224 XEO_NAME Androctonin DME1971 XEOTICID XEO02224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02224 XEO_CLAS Peptide DME1971 XEOTICID XEO02224 DESCRIPT Androctonin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO02224 GENEFORM Protein DME1971 XEOTICID XEO02224 MOACRIVE Inhibition DME1971 XEOTICID XEO02230 XEO_NAME Anopheles cecropin-A amidated isoform DME1971 XEOTICID XEO02230 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02230 XEO_CLAS Peptide DME1971 XEOTICID XEO02230 DESCRIPT Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.1-0.25 microM) DME1971 XEOTICID XEO02230 GENEFORM Protein DME1971 XEOTICID XEO02230 MOACRIVE Inhibition DME1971 XEOTICID XEO02235 XEO_NAME Anthranilate DME1971 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1971 XEOTICID XEO02235 XEO_CLAS Natural Product DME1971 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO02235 GENEFORM Protein DME1971 XEOTICID XEO02235 MOACRIVE Inhibition DME1971 XEOTICID XEO02242 XEO_NAME Antibacterial peptide PMAP-23 DME1971 XEOTICID XEO02242 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02242 XEO_CLAS Peptide DME1971 XEOTICID XEO02242 DESCRIPT Antibacterial peptide PMAP-23 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 microM) DME1971 XEOTICID XEO02242 GENEFORM Protein DME1971 XEOTICID XEO02242 MOACRIVE Inhibition DME1971 XEOTICID XEO02243 XEO_NAME Antibacterial peptide PMAP-36 DME1971 XEOTICID XEO02243 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02243 XEO_CLAS Peptide DME1971 XEOTICID XEO02243 DESCRIPT Antibacterial peptide PMAP-36 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 48 microM) DME1971 XEOTICID XEO02243 GENEFORM Protein DME1971 XEOTICID XEO02243 MOACRIVE Inhibition DME1971 XEOTICID XEO02244 XEO_NAME Antibacterial peptide PMAP-37 DME1971 XEOTICID XEO02244 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02244 XEO_CLAS Peptide DME1971 XEOTICID XEO02244 DESCRIPT Antibacterial peptide PMAP-37 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 microM) DME1971 XEOTICID XEO02244 GENEFORM Protein DME1971 XEOTICID XEO02244 MOACRIVE Inhibition DME1971 XEOTICID XEO02248 XEO_NAME Antibacterial protein PR-39 DME1971 XEOTICID XEO02248 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02248 XEO_CLAS Peptide DME1971 XEOTICID XEO02248 DESCRIPT Antibacterial protein PR-39 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1 microM) DME1971 XEOTICID XEO02248 GENEFORM Protein DME1971 XEOTICID XEO02248 MOACRIVE Inhibition DME1971 XEOTICID XEO02283 XEO_NAME Antimicrobial peptide HP(2-20) DME1971 XEOTICID XEO02283 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02283 XEO_CLAS Peptide DME1971 XEOTICID XEO02283 DESCRIPT Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1.56 ug/ml) DME1971 XEOTICID XEO02283 GENEFORM Protein DME1971 XEOTICID XEO02283 MOACRIVE Inhibition DME1971 XEOTICID XEO02284 XEO_NAME Antimicrobial peptide HsAp1 DME1971 XEOTICID XEO02284 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02284 XEO_CLAS Peptide DME1971 XEOTICID XEO02284 DESCRIPT Antimicrobial peptide HsAp1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 25.0 microM) DME1971 XEOTICID XEO02284 GENEFORM Protein DME1971 XEOTICID XEO02284 MOACRIVE Inhibition DME1971 XEOTICID XEO02285 XEO_NAME Antimicrobial peptide HsAp2 DME1971 XEOTICID XEO02285 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02285 XEO_CLAS Peptide DME1971 XEOTICID XEO02285 DESCRIPT Antimicrobial peptide HsAp2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 25.0 microM) DME1971 XEOTICID XEO02285 GENEFORM Protein DME1971 XEOTICID XEO02285 MOACRIVE Inhibition DME1971 XEOTICID XEO02286 XEO_NAME Antimicrobial peptide HsAp3 DME1971 XEOTICID XEO02286 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02286 XEO_CLAS Peptide DME1971 XEOTICID XEO02286 DESCRIPT Antimicrobial peptide HsAp3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 25.0 microM) DME1971 XEOTICID XEO02286 GENEFORM Protein DME1971 XEOTICID XEO02286 MOACRIVE Inhibition DME1971 XEOTICID XEO02287 XEO_NAME Antimicrobial peptide HsAp4 DME1971 XEOTICID XEO02287 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02287 XEO_CLAS Peptide DME1971 XEOTICID XEO02287 DESCRIPT Antimicrobial peptide HsAp4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 25.0 microM) DME1971 XEOTICID XEO02287 GENEFORM Protein DME1971 XEOTICID XEO02287 MOACRIVE Inhibition DME1971 XEOTICID XEO02304 XEO_NAME Apidaecin-1A DME1971 XEOTICID XEO02304 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02304 XEO_CLAS Peptide DME1971 XEOTICID XEO02304 DESCRIPT Apidaecin-1A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.1 ug/ml) DME1971 XEOTICID XEO02304 GENEFORM Protein DME1971 XEOTICID XEO02304 MOACRIVE Inhibition DME1971 XEOTICID XEO02305 XEO_NAME Apidaecin-1B DME1971 XEOTICID XEO02305 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02305 XEO_CLAS Peptide DME1971 XEOTICID XEO02305 DESCRIPT Apidaecin-1B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.1 ug/ml) DME1971 XEOTICID XEO02305 GENEFORM Protein DME1971 XEOTICID XEO02305 MOACRIVE Inhibition DME1971 XEOTICID XEO02306 XEO_NAME Apidaecin-2 DME1971 XEOTICID XEO02306 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02306 XEO_CLAS Peptide DME1971 XEOTICID XEO02306 DESCRIPT Apidaecin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.1 ug/ml) DME1971 XEOTICID XEO02306 GENEFORM Protein DME1971 XEOTICID XEO02306 MOACRIVE Inhibition DME1971 XEOTICID XEO02317 XEO_NAME Arenicin-1 DME1971 XEOTICID XEO02317 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02317 XEO_CLAS Peptide DME1971 XEOTICID XEO02317 DESCRIPT Arenicin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 300 microM) DME1971 XEOTICID XEO02317 GENEFORM Protein DME1971 XEOTICID XEO02317 MOACRIVE Inhibition DME1971 XEOTICID XEO02333 XEO_NAME Insect attacin-C DME1971 XEOTICID XEO02333 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02333 XEO_CLAS Peptide DME1971 XEOTICID XEO02333 DESCRIPT Insect attacin-C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC > 200 microM) DME1971 XEOTICID XEO02333 GENEFORM Protein DME1971 XEOTICID XEO02333 MOACRIVE Inhibition DME1971 XEOTICID XEO02356 XEO_NAME Bactenecin bac2I-NH2 DME1971 XEOTICID XEO02356 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02356 XEO_CLAS Peptide DME1971 XEOTICID XEO02356 DESCRIPT Bactenecin bac2I-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 ug/ml) DME1971 XEOTICID XEO02356 GENEFORM Protein DME1971 XEOTICID XEO02356 MOACRIVE Inhibition DME1971 XEOTICID XEO02357 XEO_NAME Bac2A variant Bac8a DME1971 XEOTICID XEO02357 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02357 XEO_CLAS Peptide DME1971 XEOTICID XEO02357 DESCRIPT Bac2A variant Bac8a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 31 ug/ml) DME1971 XEOTICID XEO02357 GENEFORM Protein DME1971 XEOTICID XEO02357 MOACRIVE Inhibition DME1971 XEOTICID XEO02358 XEO_NAME Bac2A variant Bac8b DME1971 XEOTICID XEO02358 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02358 XEO_CLAS Peptide DME1971 XEOTICID XEO02358 DESCRIPT Bac2A variant Bac8b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 16 ug/ml) DME1971 XEOTICID XEO02358 GENEFORM Protein DME1971 XEOTICID XEO02358 MOACRIVE Inhibition DME1971 XEOTICID XEO02360 XEO_NAME Bac2A variant Bac8c DME1971 XEOTICID XEO02360 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02360 XEO_CLAS Peptide DME1971 XEOTICID XEO02360 DESCRIPT Bac2A variant Bac8c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 ug/ml) DME1971 XEOTICID XEO02360 GENEFORM Protein DME1971 XEOTICID XEO02360 MOACRIVE Inhibition DME1971 XEOTICID XEO02361 XEO_NAME Bac2A variant Bac8d DME1971 XEOTICID XEO02361 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02361 XEO_CLAS Peptide DME1971 XEOTICID XEO02361 DESCRIPT Bac2A variant Bac8d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 31 ug/ml) DME1971 XEOTICID XEO02361 GENEFORM Protein DME1971 XEOTICID XEO02361 MOACRIVE Inhibition DME1971 XEOTICID XEO02365 XEO_NAME Bactenecin cyclic derivative BacP1 DME1971 XEOTICID XEO02365 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02365 XEO_CLAS Peptide DME1971 XEOTICID XEO02365 DESCRIPT Bactenecin cyclic derivative BacP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC > 64 ug/ml) DME1971 XEOTICID XEO02365 GENEFORM Protein DME1971 XEOTICID XEO02365 MOACRIVE Inhibition DME1971 XEOTICID XEO02366 XEO_NAME Bactenecin bacP2R-NH2 DME1971 XEOTICID XEO02366 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02366 XEO_CLAS Peptide DME1971 XEOTICID XEO02366 DESCRIPT Bactenecin bacP2R-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 32 ug/ml) DME1971 XEOTICID XEO02366 GENEFORM Protein DME1971 XEOTICID XEO02366 MOACRIVE Inhibition DME1971 XEOTICID XEO02367 XEO_NAME Bactenecin cyclic derivative BacP3R DME1971 XEOTICID XEO02367 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02367 XEO_CLAS Peptide DME1971 XEOTICID XEO02367 DESCRIPT Bactenecin cyclic derivative BacP3R inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 ug/ml) DME1971 XEOTICID XEO02367 GENEFORM Protein DME1971 XEOTICID XEO02367 MOACRIVE Inhibition DME1971 XEOTICID XEO02368 XEO_NAME Bactenecin bacP3R-V DME1971 XEOTICID XEO02368 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02368 XEO_CLAS Peptide DME1971 XEOTICID XEO02368 DESCRIPT Bactenecin bacP3R-V inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 ug/ml) DME1971 XEOTICID XEO02368 GENEFORM Protein DME1971 XEOTICID XEO02368 MOACRIVE Inhibition DME1971 XEOTICID XEO02369 XEO_NAME Bactenecin cyclic derivative BacR DME1971 XEOTICID XEO02369 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02369 XEO_CLAS Peptide DME1971 XEOTICID XEO02369 DESCRIPT Bactenecin cyclic derivative BacR inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO02369 GENEFORM Protein DME1971 XEOTICID XEO02369 MOACRIVE Inhibition DME1971 XEOTICID XEO02370 XEO_NAME Bactenecin 5 DME1971 XEOTICID XEO02370 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02370 XEO_CLAS Peptide DME1971 XEOTICID XEO02370 DESCRIPT Bactenecin 5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2-10 microM) DME1971 XEOTICID XEO02370 GENEFORM Protein DME1971 XEOTICID XEO02370 MOACRIVE Inhibition DME1971 XEOTICID XEO02371 XEO_NAME Bactenecin 7 DME1971 XEOTICID XEO02371 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02371 XEO_CLAS Peptide DME1971 XEOTICID XEO02371 DESCRIPT Bactenecin 7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 12 ug/ml) DME1971 XEOTICID XEO02371 GENEFORM Protein DME1971 XEOTICID XEO02371 MOACRIVE Inhibition DME1971 XEOTICID XEO02378 XEO_NAME Bacteriocin L-1077 DME1971 XEOTICID XEO02378 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02378 XEO_CLAS Peptide DME1971 XEOTICID XEO02378 DESCRIPT Bacteriocin L-1077 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.19 ug/ml) DME1971 XEOTICID XEO02378 GENEFORM Protein DME1971 XEOTICID XEO02378 MOACRIVE Inhibition DME1971 XEOTICID XEO02388 XEO_NAME Bactenecin cyclic derivative BacW DME1971 XEOTICID XEO02388 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02388 XEO_CLAS Peptide DME1971 XEOTICID XEO02388 DESCRIPT Bactenecin cyclic derivative BacW inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO02388 GENEFORM Protein DME1971 XEOTICID XEO02388 MOACRIVE Inhibition DME1971 XEOTICID XEO02389 XEO_NAME Bactenecin cyclic derivative BacW2R DME1971 XEOTICID XEO02389 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02389 XEO_CLAS Peptide DME1971 XEOTICID XEO02389 DESCRIPT Bactenecin cyclic derivative BacW2R inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 ug/ml) DME1971 XEOTICID XEO02389 GENEFORM Protein DME1971 XEOTICID XEO02389 MOACRIVE Inhibition DME1971 XEOTICID XEO02451 XEO_NAME Big defensin crabs DME1971 XEOTICID XEO02451 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02451 XEO_CLAS Peptide DME1971 XEOTICID XEO02451 DESCRIPT Big defensin crabs inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO02451 GENEFORM Protein DME1971 XEOTICID XEO02451 MOACRIVE Inhibition DME1971 XEOTICID XEO02466 XEO_NAME Bovine cathelicidin BMAP-34 DME1971 XEOTICID XEO02466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02466 XEO_CLAS Peptide DME1971 XEOTICID XEO02466 DESCRIPT Bovine cathelicidin BMAP-34 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 3 microM) DME1971 XEOTICID XEO02466 GENEFORM Protein DME1971 XEOTICID XEO02466 MOACRIVE Inhibition DME1971 XEOTICID XEO02491 XEO_NAME Bradykinin-potentiating BmK3 DME1971 XEOTICID XEO02491 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02491 XEO_CLAS Peptide DME1971 XEOTICID XEO02491 DESCRIPT Bradykinin-potentiating BmK3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2.3 microM) DME1971 XEOTICID XEO02491 GENEFORM Protein DME1971 XEOTICID XEO02491 MOACRIVE Inhibition DME1971 XEOTICID XEO02641 XEO_NAME Bromohexylmaleic anhydride DME1971 XEOTICID XEO02641 XEO_TYPE Other Chemical Compound(s) or Element(s) DME1971 XEOTICID XEO02641 XEO_CLAS Chemical Compound DME1971 XEOTICID XEO02641 DESCRIPT Bromohexylmaleic anhydride inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO02641 GENEFORM Protein DME1971 XEOTICID XEO02641 MOACRIVE Inhibition DME1971 XEOTICID XEO02649 XEO_NAME Buforin-1 DME1971 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02649 XEO_CLAS Peptide DME1971 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO02649 GENEFORM Protein DME1971 XEOTICID XEO02649 MOACRIVE Inhibition DME1971 XEOTICID XEO02650 XEO_NAME Buforin-2 DME1971 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02650 XEO_CLAS Peptide DME1971 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1 ug/ml) DME1971 XEOTICID XEO02650 GENEFORM Protein DME1971 XEOTICID XEO02650 MOACRIVE Inhibition DME1971 XEOTICID XEO02734 XEO_NAME Fowlicidin-1 DME1971 XEOTICID XEO02734 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02734 XEO_CLAS Peptide DME1971 XEOTICID XEO02734 DESCRIPT Fowlicidin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.40 microM) DME1971 XEOTICID XEO02734 GENEFORM Protein DME1971 XEOTICID XEO02734 MOACRIVE Inhibition DME1971 XEOTICID XEO02735 XEO_NAME Bactenecin-5 DME1971 XEOTICID XEO02735 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02735 XEO_CLAS Peptide DME1971 XEOTICID XEO02735 DESCRIPT Bactenecin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1 ug/ml) DME1971 XEOTICID XEO02735 GENEFORM Protein DME1971 XEOTICID XEO02735 MOACRIVE Inhibition DME1971 XEOTICID XEO02736 XEO_NAME Fowlicidin-2 DME1971 XEOTICID XEO02736 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02736 XEO_CLAS Peptide DME1971 XEOTICID XEO02736 DESCRIPT Fowlicidin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.66 microM) DME1971 XEOTICID XEO02736 GENEFORM Protein DME1971 XEOTICID XEO02736 MOACRIVE Inhibition DME1971 XEOTICID XEO02738 XEO_NAME Fowlicidin-3 DME1971 XEOTICID XEO02738 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02738 XEO_CLAS Peptide DME1971 XEOTICID XEO02738 DESCRIPT Fowlicidin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 microM) DME1971 XEOTICID XEO02738 GENEFORM Protein DME1971 XEOTICID XEO02738 MOACRIVE Inhibition DME1971 XEOTICID XEO02739 XEO_NAME Cathelicidin-5 DME1971 XEOTICID XEO02739 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02739 XEO_CLAS Peptide DME1971 XEOTICID XEO02739 DESCRIPT Cathelicidin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1 microM) DME1971 XEOTICID XEO02739 GENEFORM Protein DME1971 XEOTICID XEO02739 MOACRIVE Inhibition DME1971 XEOTICID XEO02740 XEO_NAME Cathelicidin-6 DME1971 XEOTICID XEO02740 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02740 XEO_CLAS Peptide DME1971 XEOTICID XEO02740 DESCRIPT Cathelicidin-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1 ug/ml) DME1971 XEOTICID XEO02740 GENEFORM Protein DME1971 XEOTICID XEO02740 MOACRIVE Inhibition DME1971 XEOTICID XEO02768 XEO_NAME Insect cecropin-A DME1971 XEOTICID XEO02768 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02768 XEO_CLAS Peptide DME1971 XEOTICID XEO02768 DESCRIPT Insect cecropin-A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1-2.5 ug/ml) DME1971 XEOTICID XEO02768 GENEFORM Protein DME1971 XEOTICID XEO02768 MOACRIVE Inhibition DME1971 XEOTICID XEO02774 XEO_NAME Cecropin-P1 DME1971 XEOTICID XEO02774 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02774 XEO_CLAS Peptide DME1971 XEOTICID XEO02774 DESCRIPT Cecropin-P1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.9 microM) DME1971 XEOTICID XEO02774 GENEFORM Protein DME1971 XEOTICID XEO02774 MOACRIVE Inhibition DME1971 XEOTICID XEO02799 XEO_NAME CEMA protein MBI-28 DME1971 XEOTICID XEO02799 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02799 XEO_CLAS Peptide DME1971 XEOTICID XEO02799 DESCRIPT CEMA protein MBI-28 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 3 ug/ml) DME1971 XEOTICID XEO02799 GENEFORM Protein DME1971 XEOTICID XEO02799 MOACRIVE Inhibition DME1971 XEOTICID XEO02800 XEO_NAME CEME protein MBI-27 DME1971 XEOTICID XEO02800 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02800 XEO_CLAS Peptide DME1971 XEOTICID XEO02800 DESCRIPT CEME protein MBI-27 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 ug/ml) DME1971 XEOTICID XEO02800 GENEFORM Protein DME1971 XEOTICID XEO02800 MOACRIVE Inhibition DME1971 XEOTICID XEO02820 XEO_NAME Indolicidin derivative chain a DME1971 XEOTICID XEO02820 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02820 XEO_CLAS Peptide DME1971 XEOTICID XEO02820 DESCRIPT Indolicidin derivative chain a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 64 ug/ml) DME1971 XEOTICID XEO02820 GENEFORM Protein DME1971 XEOTICID XEO02820 MOACRIVE Inhibition DME1971 XEOTICID XEO02885 XEO_NAME CM1 peptide DME1971 XEOTICID XEO02885 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02885 XEO_CLAS Peptide DME1971 XEOTICID XEO02885 DESCRIPT CM1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 5 ug/ml) DME1971 XEOTICID XEO02885 GENEFORM Protein DME1971 XEOTICID XEO02885 MOACRIVE Inhibition DME1971 XEOTICID XEO02886 XEO_NAME CM2 peptide DME1971 XEOTICID XEO02886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02886 XEO_CLAS Peptide DME1971 XEOTICID XEO02886 DESCRIPT CM2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO02886 GENEFORM Protein DME1971 XEOTICID XEO02886 MOACRIVE Inhibition DME1971 XEOTICID XEO02887 XEO_NAME CM3 peptide DME1971 XEOTICID XEO02887 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02887 XEO_CLAS Peptide DME1971 XEOTICID XEO02887 DESCRIPT CM3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 3 ug/ml) DME1971 XEOTICID XEO02887 GENEFORM Protein DME1971 XEOTICID XEO02887 MOACRIVE Inhibition DME1971 XEOTICID XEO02888 XEO_NAME CM4 peptide DME1971 XEOTICID XEO02888 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02888 XEO_CLAS Peptide DME1971 XEOTICID XEO02888 DESCRIPT CM4 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 3 ug/ml) DME1971 XEOTICID XEO02888 GENEFORM Protein DME1971 XEOTICID XEO02888 MOACRIVE Inhibition DME1971 XEOTICID XEO02889 XEO_NAME CM5 peptide DME1971 XEOTICID XEO02889 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02889 XEO_CLAS Peptide DME1971 XEOTICID XEO02889 DESCRIPT CM5 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 29 ug/ml) DME1971 XEOTICID XEO02889 GENEFORM Protein DME1971 XEOTICID XEO02889 MOACRIVE Inhibition DME1971 XEOTICID XEO02890 XEO_NAME CM6 peptide DME1971 XEOTICID XEO02890 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02890 XEO_CLAS Peptide DME1971 XEOTICID XEO02890 DESCRIPT CM6 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO02890 GENEFORM Protein DME1971 XEOTICID XEO02890 MOACRIVE Inhibition DME1971 XEOTICID XEO02891 XEO_NAME CM7 peptide DME1971 XEOTICID XEO02891 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02891 XEO_CLAS Peptide DME1971 XEOTICID XEO02891 DESCRIPT CM7 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 3 ug/ml) DME1971 XEOTICID XEO02891 GENEFORM Protein DME1971 XEOTICID XEO02891 MOACRIVE Inhibition DME1971 XEOTICID XEO02933 XEO_NAME CP201 peptide DME1971 XEOTICID XEO02933 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02933 XEO_CLAS Peptide DME1971 XEOTICID XEO02933 DESCRIPT CP201 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 43 ug/ml) DME1971 XEOTICID XEO02933 GENEFORM Protein DME1971 XEOTICID XEO02933 MOACRIVE Inhibition DME1971 XEOTICID XEO02934 XEO_NAME CP202 peptide DME1971 XEOTICID XEO02934 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02934 XEO_CLAS Peptide DME1971 XEOTICID XEO02934 DESCRIPT CP202 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 16 ug/ml) DME1971 XEOTICID XEO02934 GENEFORM Protein DME1971 XEOTICID XEO02934 MOACRIVE Inhibition DME1971 XEOTICID XEO02935 XEO_NAME CP203 peptide DME1971 XEOTICID XEO02935 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02935 XEO_CLAS Peptide DME1971 XEOTICID XEO02935 DESCRIPT CP203 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO02935 GENEFORM Protein DME1971 XEOTICID XEO02935 MOACRIVE Inhibition DME1971 XEOTICID XEO02937 XEO_NAME CP207 peptide DME1971 XEOTICID XEO02937 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02937 XEO_CLAS Peptide DME1971 XEOTICID XEO02937 DESCRIPT CP207 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 3 ug/ml) DME1971 XEOTICID XEO02937 GENEFORM Protein DME1971 XEOTICID XEO02937 MOACRIVE Inhibition DME1971 XEOTICID XEO02940 XEO_NAME CP26 peptide DME1971 XEOTICID XEO02940 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02940 XEO_CLAS Peptide DME1971 XEOTICID XEO02940 DESCRIPT CP26 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 3 ug/ml) DME1971 XEOTICID XEO02940 GENEFORM Protein DME1971 XEOTICID XEO02940 MOACRIVE Inhibition DME1971 XEOTICID XEO02941 XEO_NAME CP29 peptide DME1971 XEOTICID XEO02941 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02941 XEO_CLAS Peptide DME1971 XEOTICID XEO02941 DESCRIPT CP29 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 ug/ml) DME1971 XEOTICID XEO02941 GENEFORM Protein DME1971 XEOTICID XEO02941 MOACRIVE Inhibition DME1971 XEOTICID XEO02947 XEO_NAME CP alpha 1 peptide DME1971 XEOTICID XEO02947 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02947 XEO_CLAS Peptide DME1971 XEOTICID XEO02947 DESCRIPT CP alpha 1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 43 ug/ml) DME1971 XEOTICID XEO02947 GENEFORM Protein DME1971 XEOTICID XEO02947 MOACRIVE Inhibition DME1971 XEOTICID XEO02948 XEO_NAME CP alpha 2 peptide DME1971 XEOTICID XEO02948 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02948 XEO_CLAS Peptide DME1971 XEOTICID XEO02948 DESCRIPT CP alpha 2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 ug/ml) DME1971 XEOTICID XEO02948 GENEFORM Protein DME1971 XEOTICID XEO02948 MOACRIVE Inhibition DME1971 XEOTICID XEO02949 XEO_NAME CP alpha 3 peptide DME1971 XEOTICID XEO02949 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02949 XEO_CLAS Peptide DME1971 XEOTICID XEO02949 DESCRIPT CP alpha 3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO02949 GENEFORM Protein DME1971 XEOTICID XEO02949 MOACRIVE Inhibition DME1971 XEOTICID XEO02955 XEO_NAME Cryptdin related sequence CRS4C-3c DME1971 XEOTICID XEO02955 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02955 XEO_CLAS Peptide DME1971 XEOTICID XEO02955 DESCRIPT Cryptdin related sequence CRS4C-3c inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO02955 GENEFORM Protein DME1971 XEOTICID XEO02955 MOACRIVE Inhibition DME1971 XEOTICID XEO02958 XEO_NAME Cryptdin related peptide CRS4C-1a DME1971 XEOTICID XEO02958 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02958 XEO_CLAS Peptide DME1971 XEOTICID XEO02958 DESCRIPT Cryptdin related peptide CRS4C-1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO02958 GENEFORM Protein DME1971 XEOTICID XEO02958 MOACRIVE Inhibition DME1971 XEOTICID XEO02959 XEO_NAME Cryptdin related peptide CRS4C-1d DME1971 XEOTICID XEO02959 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02959 XEO_CLAS Peptide DME1971 XEOTICID XEO02959 DESCRIPT Cryptdin related peptide CRS4C-1d inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO02959 GENEFORM Protein DME1971 XEOTICID XEO02959 MOACRIVE Inhibition DME1971 XEOTICID XEO02960 XEO_NAME Cryptdin related peptide CRS4C-2 DME1971 XEOTICID XEO02960 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02960 XEO_CLAS Peptide DME1971 XEOTICID XEO02960 DESCRIPT Cryptdin related peptide CRS4C-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO02960 GENEFORM Protein DME1971 XEOTICID XEO02960 MOACRIVE Inhibition DME1971 XEOTICID XEO02961 XEO_NAME Cryptdin related peptide CRS4C-2b DME1971 XEOTICID XEO02961 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO02961 XEO_CLAS Peptide DME1971 XEOTICID XEO02961 DESCRIPT Cryptdin related peptide CRS4C-2b inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO02961 GENEFORM Protein DME1971 XEOTICID XEO02961 MOACRIVE Inhibition DME1971 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME1971 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME1971 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME1971 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO02990 GENEFORM Protein DME1971 XEOTICID XEO02990 MOACRIVE Inhibition DME1971 XEOTICID XEO03029 XEO_NAME Cyclic cationic V1 peptide DME1971 XEOTICID XEO03029 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03029 XEO_CLAS Peptide DME1971 XEOTICID XEO03029 DESCRIPT Cyclic cationic V1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.005 microM) DME1971 XEOTICID XEO03029 GENEFORM Protein DME1971 XEOTICID XEO03029 MOACRIVE Inhibition DME1971 XEOTICID XEO03030 XEO_NAME Cyclic cationic V2 peptide DME1971 XEOTICID XEO03030 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03030 XEO_CLAS Peptide DME1971 XEOTICID XEO03030 DESCRIPT Cyclic cationic V2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.005 microM) DME1971 XEOTICID XEO03030 GENEFORM Protein DME1971 XEOTICID XEO03030 MOACRIVE Inhibition DME1971 XEOTICID XEO03031 XEO_NAME Cyclic cationic V3 peptide DME1971 XEOTICID XEO03031 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03031 XEO_CLAS Peptide DME1971 XEOTICID XEO03031 DESCRIPT Cyclic cationic V3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.3 microM) DME1971 XEOTICID XEO03031 GENEFORM Protein DME1971 XEOTICID XEO03031 MOACRIVE Inhibition DME1971 XEOTICID XEO03032 XEO_NAME Cyclic cationic V4 peptide DME1971 XEOTICID XEO03032 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03032 XEO_CLAS Peptide DME1971 XEOTICID XEO03032 DESCRIPT Cyclic cationic V4 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.005 microM) DME1971 XEOTICID XEO03032 GENEFORM Protein DME1971 XEOTICID XEO03032 MOACRIVE Inhibition DME1971 XEOTICID XEO03033 XEO_NAME Cyclic cationic V5 peptide DME1971 XEOTICID XEO03033 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03033 XEO_CLAS Peptide DME1971 XEOTICID XEO03033 DESCRIPT Cyclic cationic V5 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.005 microM) DME1971 XEOTICID XEO03033 GENEFORM Protein DME1971 XEOTICID XEO03033 MOACRIVE Inhibition DME1971 XEOTICID XEO03034 XEO_NAME Cyclic cationic V6 peptide DME1971 XEOTICID XEO03034 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03034 XEO_CLAS Peptide DME1971 XEOTICID XEO03034 DESCRIPT Cyclic cationic V6 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.528 microM) DME1971 XEOTICID XEO03034 GENEFORM Protein DME1971 XEOTICID XEO03034 MOACRIVE Inhibition DME1971 XEOTICID XEO03035 XEO_NAME Cyclic cationic V7 peptide DME1971 XEOTICID XEO03035 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03035 XEO_CLAS Peptide DME1971 XEOTICID XEO03035 DESCRIPT Cyclic cationic V7 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.004 microM) DME1971 XEOTICID XEO03035 GENEFORM Protein DME1971 XEOTICID XEO03035 MOACRIVE Inhibition DME1971 XEOTICID XEO03043 XEO_NAME Cytotoxic linear peptide IsCT DME1971 XEOTICID XEO03043 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03043 XEO_CLAS Peptide DME1971 XEOTICID XEO03043 DESCRIPT Cytotoxic linear peptide IsCT inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 microM) DME1971 XEOTICID XEO03043 GENEFORM Protein DME1971 XEOTICID XEO03043 MOACRIVE Inhibition DME1971 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME1971 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03052 XEO_CLAS Peptide DME1971 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 50 ug/ml) DME1971 XEOTICID XEO03052 GENEFORM Protein DME1971 XEOTICID XEO03052 MOACRIVE Inhibition DME1971 XEOTICID XEO03053 XEO_NAME Single AA substitution D16W-N23 DME1971 XEOTICID XEO03053 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03053 XEO_CLAS Peptide DME1971 XEOTICID XEO03053 DESCRIPT Single AA substitution D16W-N23 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 125 ug/ml) DME1971 XEOTICID XEO03053 GENEFORM Protein DME1971 XEOTICID XEO03053 MOACRIVE Inhibition DME1971 XEOTICID XEO03060 XEO_NAME D-amino acid substitution of K9L8W DME1971 XEOTICID XEO03060 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03060 XEO_CLAS Peptide DME1971 XEOTICID XEO03060 DESCRIPT D-amino acid substitution of K9L8W inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 microM) DME1971 XEOTICID XEO03060 GENEFORM Protein DME1971 XEOTICID XEO03060 MOACRIVE Inhibition DME1971 XEOTICID XEO03125 XEO_NAME Defensin-like turtle protein TEWP DME1971 XEOTICID XEO03125 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03125 XEO_CLAS Peptide DME1971 XEOTICID XEO03125 DESCRIPT Defensin-like turtle protein TEWP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO03125 GENEFORM Protein DME1971 XEOTICID XEO03125 MOACRIVE Inhibition DME1971 XEOTICID XEO03162 XEO_NAME Dermaseptin-like PBN2 DME1971 XEOTICID XEO03162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03162 XEO_CLAS Peptide DME1971 XEOTICID XEO03162 DESCRIPT Dermaseptin-like PBN2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 3.1 microM) DME1971 XEOTICID XEO03162 GENEFORM Protein DME1971 XEOTICID XEO03162 MOACRIVE Inhibition DME1971 XEOTICID XEO03164 XEO_NAME Dermatoxin DME1971 XEOTICID XEO03164 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03164 XEO_CLAS Peptide DME1971 XEOTICID XEO03164 DESCRIPT Dermatoxin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO03164 GENEFORM Protein DME1971 XEOTICID XEO03164 MOACRIVE Inhibition DME1971 XEOTICID XEO03224 XEO_NAME Drosophila cecropin-A1 DME1971 XEOTICID XEO03224 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03224 XEO_CLAS Peptide DME1971 XEOTICID XEO03224 DESCRIPT Drosophila cecropin-A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.5-1 microM) DME1971 XEOTICID XEO03224 GENEFORM Protein DME1971 XEOTICID XEO03224 MOACRIVE Inhibition DME1971 XEOTICID XEO03250 XEO_NAME Enterocin 96 DME1971 XEOTICID XEO03250 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03250 XEO_CLAS Peptide DME1971 XEOTICID XEO03250 DESCRIPT Enterocin 96 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO03250 GENEFORM Protein DME1971 XEOTICID XEO03250 MOACRIVE Inhibition DME1971 XEOTICID XEO03251 XEO_NAME Enterocin AS-48 DME1971 XEOTICID XEO03251 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03251 XEO_CLAS Peptide DME1971 XEOTICID XEO03251 DESCRIPT Enterocin AS-48 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO03251 GENEFORM Protein DME1971 XEOTICID XEO03251 MOACRIVE Inhibition DME1971 XEOTICID XEO03428 XEO_NAME Bac2A variant G1 DME1971 XEOTICID XEO03428 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03428 XEO_CLAS Peptide DME1971 XEOTICID XEO03428 DESCRIPT Bac2A variant G1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 63 ug/ml) DME1971 XEOTICID XEO03428 GENEFORM Protein DME1971 XEOTICID XEO03428 MOACRIVE Inhibition DME1971 XEOTICID XEO03430 XEO_NAME Bac2A variant G12 DME1971 XEOTICID XEO03430 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03430 XEO_CLAS Peptide DME1971 XEOTICID XEO03430 DESCRIPT Bac2A variant G12 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 63 ug/ml) DME1971 XEOTICID XEO03430 GENEFORM Protein DME1971 XEOTICID XEO03430 MOACRIVE Inhibition DME1971 XEOTICID XEO03434 XEO_NAME Bac2A variant G2 DME1971 XEOTICID XEO03434 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03434 XEO_CLAS Peptide DME1971 XEOTICID XEO03434 DESCRIPT Bac2A variant G2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 31 ug/ml) DME1971 XEOTICID XEO03434 GENEFORM Protein DME1971 XEOTICID XEO03434 MOACRIVE Inhibition DME1971 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME1971 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03437 XEO_CLAS Peptide DME1971 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 150 ug/ml) DME1971 XEOTICID XEO03437 GENEFORM Protein DME1971 XEOTICID XEO03437 MOACRIVE Inhibition DME1971 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME1971 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03438 XEO_CLAS Peptide DME1971 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 150 ug/ml) DME1971 XEOTICID XEO03438 GENEFORM Protein DME1971 XEOTICID XEO03438 MOACRIVE Inhibition DME1971 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME1971 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03439 XEO_CLAS Peptide DME1971 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 200 ug/ml) DME1971 XEOTICID XEO03439 GENEFORM Protein DME1971 XEOTICID XEO03439 MOACRIVE Inhibition DME1971 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME1971 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03440 XEO_CLAS Peptide DME1971 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 200 ug/ml) DME1971 XEOTICID XEO03440 GENEFORM Protein DME1971 XEOTICID XEO03440 MOACRIVE Inhibition DME1971 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME1971 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03441 XEO_CLAS Peptide DME1971 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 200 ug/ml) DME1971 XEOTICID XEO03441 GENEFORM Protein DME1971 XEOTICID XEO03441 MOACRIVE Inhibition DME1971 XEOTICID XEO03462 XEO_NAME Gallinacin-13 DME1971 XEOTICID XEO03462 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03462 XEO_CLAS Peptide DME1971 XEOTICID XEO03462 DESCRIPT Gallinacin-13 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO03462 GENEFORM Protein DME1971 XEOTICID XEO03462 MOACRIVE Inhibition DME1971 XEOTICID XEO03464 XEO_NAME Gallinacin-4 DME1971 XEOTICID XEO03464 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03464 XEO_CLAS Peptide DME1971 XEOTICID XEO03464 DESCRIPT Gallinacin-4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO03464 GENEFORM Protein DME1971 XEOTICID XEO03464 MOACRIVE Inhibition DME1971 XEOTICID XEO03465 XEO_NAME Gallinacin-5 DME1971 XEOTICID XEO03465 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03465 XEO_CLAS Peptide DME1971 XEOTICID XEO03465 DESCRIPT Gallinacin-5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO03465 GENEFORM Protein DME1971 XEOTICID XEO03465 MOACRIVE Inhibition DME1971 XEOTICID XEO03466 XEO_NAME Gallinacin-6 DME1971 XEOTICID XEO03466 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03466 XEO_CLAS Peptide DME1971 XEOTICID XEO03466 DESCRIPT Gallinacin-6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO03466 GENEFORM Protein DME1971 XEOTICID XEO03466 MOACRIVE Inhibition DME1971 XEOTICID XEO03467 XEO_NAME Gallinacin-8 DME1971 XEOTICID XEO03467 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03467 XEO_CLAS Peptide DME1971 XEOTICID XEO03467 DESCRIPT Gallinacin-8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO03467 GENEFORM Protein DME1971 XEOTICID XEO03467 MOACRIVE Inhibition DME1971 XEOTICID XEO03498 XEO_NAME Spider gomesin DME1971 XEOTICID XEO03498 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03498 XEO_CLAS Peptide DME1971 XEOTICID XEO03498 DESCRIPT Spider gomesin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.8-1.6 microM) DME1971 XEOTICID XEO03498 GENEFORM Protein DME1971 XEOTICID XEO03498 MOACRIVE Inhibition DME1971 XEOTICID XEO03504 XEO_NAME Grammistin Gs A DME1971 XEOTICID XEO03504 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03504 XEO_CLAS Peptide DME1971 XEOTICID XEO03504 DESCRIPT Grammistin Gs A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC > 50 ug/ml) DME1971 XEOTICID XEO03504 GENEFORM Protein DME1971 XEOTICID XEO03504 MOACRIVE Inhibition DME1971 XEOTICID XEO03505 XEO_NAME Grammistin Gs B DME1971 XEOTICID XEO03505 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03505 XEO_CLAS Peptide DME1971 XEOTICID XEO03505 DESCRIPT Grammistin Gs B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 12.5 ug/ml) DME1971 XEOTICID XEO03505 GENEFORM Protein DME1971 XEOTICID XEO03505 MOACRIVE Inhibition DME1971 XEOTICID XEO03506 XEO_NAME Grammistin Gs C DME1971 XEOTICID XEO03506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03506 XEO_CLAS Peptide DME1971 XEOTICID XEO03506 DESCRIPT Grammistin Gs C inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 12.5 ug/ml) DME1971 XEOTICID XEO03506 GENEFORM Protein DME1971 XEOTICID XEO03506 MOACRIVE Inhibition DME1971 XEOTICID XEO03519 XEO_NAME Hadrurin DME1971 XEOTICID XEO03519 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03519 XEO_CLAS Peptide DME1971 XEOTICID XEO03519 DESCRIPT Hadrurin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO03519 GENEFORM Protein DME1971 XEOTICID XEO03519 MOACRIVE Inhibition DME1971 XEOTICID XEO03609 XEO_NAME Hydramacin Hm-1 DME1971 XEOTICID XEO03609 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03609 XEO_CLAS Peptide DME1971 XEOTICID XEO03609 DESCRIPT Hydramacin Hm-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO03609 GENEFORM Protein DME1971 XEOTICID XEO03609 MOACRIVE Inhibition DME1971 XEOTICID XEO03671 XEO_NAME Plant JCpep7 DME1971 XEOTICID XEO03671 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03671 XEO_CLAS Peptide DME1971 XEOTICID XEO03671 DESCRIPT Plant JCpep7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 48 ug/ml) DME1971 XEOTICID XEO03671 GENEFORM Protein DME1971 XEOTICID XEO03671 MOACRIVE Inhibition DME1971 XEOTICID XEO03684 XEO_NAME Bac2A variant K7 DME1971 XEOTICID XEO03684 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03684 XEO_CLAS Peptide DME1971 XEOTICID XEO03684 DESCRIPT Bac2A variant K7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 63 ug/ml) DME1971 XEOTICID XEO03684 GENEFORM Protein DME1971 XEOTICID XEO03684 MOACRIVE Inhibition DME1971 XEOTICID XEO03721 XEO_NAME Kunitz-type serine protease inhibitor Xb-KTI DME1971 XEOTICID XEO03721 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03721 XEO_CLAS Peptide DME1971 XEOTICID XEO03721 DESCRIPT Kunitz-type serine protease inhibitor Xb-KTI inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 10 microM) DME1971 XEOTICID XEO03721 GENEFORM Protein DME1971 XEOTICID XEO03721 MOACRIVE Inhibition DME1971 XEOTICID XEO03746 XEO_NAME L5K5Wn model peptide L5K5W1 DME1971 XEOTICID XEO03746 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03746 XEO_CLAS Peptide DME1971 XEOTICID XEO03746 DESCRIPT L5K5Wn model peptide L5K5W1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 ug/ml) DME1971 XEOTICID XEO03746 GENEFORM Protein DME1971 XEOTICID XEO03746 MOACRIVE Inhibition DME1971 XEOTICID XEO03747 XEO_NAME L5K5Wn model peptide L5K5W10 DME1971 XEOTICID XEO03747 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03747 XEO_CLAS Peptide DME1971 XEOTICID XEO03747 DESCRIPT L5K5Wn model peptide L5K5W10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1 ug/ml) DME1971 XEOTICID XEO03747 GENEFORM Protein DME1971 XEOTICID XEO03747 MOACRIVE Inhibition DME1971 XEOTICID XEO03748 XEO_NAME L5K5Wn model peptide L5K5W11 DME1971 XEOTICID XEO03748 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03748 XEO_CLAS Peptide DME1971 XEOTICID XEO03748 DESCRIPT L5K5Wn model peptide L5K5W11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO03748 GENEFORM Protein DME1971 XEOTICID XEO03748 MOACRIVE Inhibition DME1971 XEOTICID XEO03749 XEO_NAME L5K5Wn model peptide L5K5W2 DME1971 XEOTICID XEO03749 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03749 XEO_CLAS Peptide DME1971 XEOTICID XEO03749 DESCRIPT L5K5Wn model peptide L5K5W2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 ug/ml) DME1971 XEOTICID XEO03749 GENEFORM Protein DME1971 XEOTICID XEO03749 MOACRIVE Inhibition DME1971 XEOTICID XEO03750 XEO_NAME L5K5Wn model peptide L5K5W3 DME1971 XEOTICID XEO03750 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03750 XEO_CLAS Peptide DME1971 XEOTICID XEO03750 DESCRIPT L5K5Wn model peptide L5K5W3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO03750 GENEFORM Protein DME1971 XEOTICID XEO03750 MOACRIVE Inhibition DME1971 XEOTICID XEO03751 XEO_NAME L5K5Wn model peptide L5K5W4 DME1971 XEOTICID XEO03751 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03751 XEO_CLAS Peptide DME1971 XEOTICID XEO03751 DESCRIPT L5K5Wn model peptide L5K5W4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO03751 GENEFORM Protein DME1971 XEOTICID XEO03751 MOACRIVE Inhibition DME1971 XEOTICID XEO03752 XEO_NAME L5K5Wn model peptide L5K5W5 DME1971 XEOTICID XEO03752 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03752 XEO_CLAS Peptide DME1971 XEOTICID XEO03752 DESCRIPT L5K5Wn model peptide L5K5W5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 ug/ml) DME1971 XEOTICID XEO03752 GENEFORM Protein DME1971 XEOTICID XEO03752 MOACRIVE Inhibition DME1971 XEOTICID XEO03754 XEO_NAME L5K5Wn model peptide L5K5W7 DME1971 XEOTICID XEO03754 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03754 XEO_CLAS Peptide DME1971 XEOTICID XEO03754 DESCRIPT L5K5Wn model peptide L5K5W7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO03754 GENEFORM Protein DME1971 XEOTICID XEO03754 MOACRIVE Inhibition DME1971 XEOTICID XEO03755 XEO_NAME L5K5Wn model peptide L5K5W8 DME1971 XEOTICID XEO03755 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03755 XEO_CLAS Peptide DME1971 XEOTICID XEO03755 DESCRIPT L5K5Wn model peptide L5K5W8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO03755 GENEFORM Protein DME1971 XEOTICID XEO03755 MOACRIVE Inhibition DME1971 XEOTICID XEO03756 XEO_NAME L5K5Wn model peptide L5K5W9 DME1971 XEOTICID XEO03756 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03756 XEO_CLAS Peptide DME1971 XEOTICID XEO03756 DESCRIPT L5K5Wn model peptide L5K5W9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 ug/ml) DME1971 XEOTICID XEO03756 GENEFORM Protein DME1971 XEOTICID XEO03756 MOACRIVE Inhibition DME1971 XEOTICID XEO03793 XEO_NAME L-amino-acid oxidase DME1971 XEOTICID XEO03793 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03793 XEO_CLAS Peptide DME1971 XEOTICID XEO03793 DESCRIPT L-amino-acid oxidase inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 microM) DME1971 XEOTICID XEO03793 GENEFORM Protein DME1971 XEOTICID XEO03793 MOACRIVE Inhibition DME1971 XEOTICID XEO03904 XEO_NAME Linear bactenecin bac2S-NH2 DME1971 XEOTICID XEO03904 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03904 XEO_CLAS Peptide DME1971 XEOTICID XEO03904 DESCRIPT Linear bactenecin bac2S-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 32 ug/ml) DME1971 XEOTICID XEO03904 GENEFORM Protein DME1971 XEOTICID XEO03904 MOACRIVE Inhibition DME1971 XEOTICID XEO03905 XEO_NAME Linear bactenecin bacS-NH2 DME1971 XEOTICID XEO03905 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03905 XEO_CLAS Peptide DME1971 XEOTICID XEO03905 DESCRIPT Linear bactenecin bacS-NH2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC > 64 ug/ml) DME1971 XEOTICID XEO03905 GENEFORM Protein DME1971 XEOTICID XEO03905 MOACRIVE Inhibition DME1971 XEOTICID XEO03928 XEO_NAME LL-37(17-29) peptide DME1971 XEOTICID XEO03928 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO03928 XEO_CLAS Peptide DME1971 XEOTICID XEO03928 DESCRIPT LL-37(17-29) peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 16 microM) DME1971 XEOTICID XEO03928 GENEFORM Protein DME1971 XEOTICID XEO03928 MOACRIVE Inhibition DME1971 XEOTICID XEO03968 XEO_NAME L-tryptophan DME1971 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME1971 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME1971 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO03968 GENEFORM Protein DME1971 XEOTICID XEO03968 MOACRIVE Inhibition DME1971 XEOTICID XEO04039 XEO_NAME Mammal mBMAP28 DME1971 XEOTICID XEO04039 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04039 XEO_CLAS Peptide DME1971 XEOTICID XEO04039 DESCRIPT Mammal mBMAP28 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1 microM) DME1971 XEOTICID XEO04039 GENEFORM Protein DME1971 XEOTICID XEO04039 MOACRIVE Inhibition DME1971 XEOTICID XEO04111 XEO_NAME Microcin 7 DME1971 XEOTICID XEO04111 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04111 XEO_CLAS Peptide DME1971 XEOTICID XEO04111 DESCRIPT Microcin 7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04111 GENEFORM Protein DME1971 XEOTICID XEO04111 MOACRIVE Inhibition DME1971 XEOTICID XEO04112 XEO_NAME Microcin E492 DME1971 XEOTICID XEO04112 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04112 XEO_CLAS Peptide DME1971 XEOTICID XEO04112 DESCRIPT Microcin E492 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1.2 microM) DME1971 XEOTICID XEO04112 GENEFORM Protein DME1971 XEOTICID XEO04112 MOACRIVE Inhibition DME1971 XEOTICID XEO04114 XEO_NAME Microcin L DME1971 XEOTICID XEO04114 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04114 XEO_CLAS Peptide DME1971 XEOTICID XEO04114 DESCRIPT Microcin L inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04114 GENEFORM Protein DME1971 XEOTICID XEO04114 MOACRIVE Inhibition DME1971 XEOTICID XEO04117 XEO_NAME Misgurin DME1971 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04117 XEO_CLAS Peptide DME1971 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04117 GENEFORM Protein DME1971 XEOTICID XEO04117 MOACRIVE Inhibition DME1971 XEOTICID XEO04142 XEO_NAME M-theraphotoxin-Gr1a DME1971 XEOTICID XEO04142 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04142 XEO_CLAS Peptide DME1971 XEOTICID XEO04142 DESCRIPT M-theraphotoxin-Gr1a inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 32.64 microM) DME1971 XEOTICID XEO04142 GENEFORM Protein DME1971 XEOTICID XEO04142 MOACRIVE Inhibition DME1971 XEOTICID XEO04158 XEO_NAME Myeloid antimicrobial peptide BMAP-27 DME1971 XEOTICID XEO04158 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04158 XEO_CLAS Peptide DME1971 XEOTICID XEO04158 DESCRIPT Myeloid antimicrobial peptide BMAP-27 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 microM) DME1971 XEOTICID XEO04158 GENEFORM Protein DME1971 XEOTICID XEO04158 MOACRIVE Inhibition DME1971 XEOTICID XEO04159 XEO_NAME Myeloid antimicrobial peptide BMAP-28 DME1971 XEOTICID XEO04159 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04159 XEO_CLAS Peptide DME1971 XEOTICID XEO04159 DESCRIPT Myeloid antimicrobial peptide BMAP-28 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 microM) DME1971 XEOTICID XEO04159 GENEFORM Protein DME1971 XEOTICID XEO04159 MOACRIVE Inhibition DME1971 XEOTICID XEO04172 XEO_NAME Myxinidin DME1971 XEOTICID XEO04172 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04172 XEO_CLAS Peptide DME1971 XEOTICID XEO04172 DESCRIPT Myxinidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04172 GENEFORM Protein DME1971 XEOTICID XEO04172 MOACRIVE Inhibition DME1971 XEOTICID XEO04252 XEO_NAME Neutrophil antibiotic peptide NP-2 DME1971 XEOTICID XEO04252 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04252 XEO_CLAS Peptide DME1971 XEOTICID XEO04252 DESCRIPT Neutrophil antibiotic peptide NP-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04252 GENEFORM Protein DME1971 XEOTICID XEO04252 MOACRIVE Inhibition DME1971 XEOTICID XEO04335 XEO_NAME Fish NRC-1 peptide DME1971 XEOTICID XEO04335 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04335 XEO_CLAS Peptide DME1971 XEOTICID XEO04335 DESCRIPT Fish NRC-1 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 16 ug/ml) DME1971 XEOTICID XEO04335 GENEFORM Protein DME1971 XEOTICID XEO04335 MOACRIVE Inhibition DME1971 XEOTICID XEO04336 XEO_NAME Fish NRC-10 peptide DME1971 XEOTICID XEO04336 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04336 XEO_CLAS Peptide DME1971 XEOTICID XEO04336 DESCRIPT Fish NRC-10 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 16 ug/ml) DME1971 XEOTICID XEO04336 GENEFORM Protein DME1971 XEOTICID XEO04336 MOACRIVE Inhibition DME1971 XEOTICID XEO04338 XEO_NAME Fish NRC-16 peptide DME1971 XEOTICID XEO04338 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04338 XEO_CLAS Peptide DME1971 XEOTICID XEO04338 DESCRIPT Fish NRC-16 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.5 ug/ml) DME1971 XEOTICID XEO04338 GENEFORM Protein DME1971 XEOTICID XEO04338 MOACRIVE Inhibition DME1971 XEOTICID XEO04339 XEO_NAME Fish NRC-2 peptide DME1971 XEOTICID XEO04339 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04339 XEO_CLAS Peptide DME1971 XEOTICID XEO04339 DESCRIPT Fish NRC-2 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 64 ug/ml) DME1971 XEOTICID XEO04339 GENEFORM Protein DME1971 XEOTICID XEO04339 MOACRIVE Inhibition DME1971 XEOTICID XEO04340 XEO_NAME Fish NRC-3 peptide DME1971 XEOTICID XEO04340 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04340 XEO_CLAS Peptide DME1971 XEOTICID XEO04340 DESCRIPT Fish NRC-3 peptide inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 ug/ml) DME1971 XEOTICID XEO04340 GENEFORM Protein DME1971 XEOTICID XEO04340 MOACRIVE Inhibition DME1971 XEOTICID XEO04426 XEO_NAME Pilosulin P1(1-20) DME1971 XEOTICID XEO04426 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04426 XEO_CLAS Peptide DME1971 XEOTICID XEO04426 DESCRIPT Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 microM) DME1971 XEOTICID XEO04426 GENEFORM Protein DME1971 XEOTICID XEO04426 MOACRIVE Inhibition DME1971 XEOTICID XEO04481 XEO_NAME Porcine beta-defensin pBD-2 DME1971 XEOTICID XEO04481 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04481 XEO_CLAS Peptide DME1971 XEOTICID XEO04481 DESCRIPT Porcine beta-defensin pBD-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04481 GENEFORM Protein DME1971 XEOTICID XEO04481 MOACRIVE Inhibition DME1971 XEOTICID XEO04526 XEO_NAME Pep-1 peptide derivative Pep-1-K DME1971 XEOTICID XEO04526 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04526 XEO_CLAS Peptide DME1971 XEOTICID XEO04526 DESCRIPT Pep-1 peptide derivative Pep-1-K inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1.0 microM) DME1971 XEOTICID XEO04526 GENEFORM Protein DME1971 XEOTICID XEO04526 MOACRIVE Inhibition DME1971 XEOTICID XEO04613 XEO_NAME Piscidin Pis-2 DME1971 XEOTICID XEO04613 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04613 XEO_CLAS Peptide DME1971 XEOTICID XEO04613 DESCRIPT Piscidin Pis-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 10-20 microM) DME1971 XEOTICID XEO04613 GENEFORM Protein DME1971 XEOTICID XEO04613 MOACRIVE Inhibition DME1971 XEOTICID XEO04627 XEO_NAME Plasticin PD36 KF DME1971 XEOTICID XEO04627 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04627 XEO_CLAS Peptide DME1971 XEOTICID XEO04627 DESCRIPT Plasticin PD36 KF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 25.25 microM) DME1971 XEOTICID XEO04627 GENEFORM Protein DME1971 XEOTICID XEO04627 MOACRIVE Inhibition DME1971 XEOTICID XEO04640 XEO_NAME Pleurocidin DME1971 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04640 XEO_CLAS Peptide DME1971 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8.8-17.7 microM) DME1971 XEOTICID XEO04640 GENEFORM Protein DME1971 XEOTICID XEO04640 MOACRIVE Inhibition DME1971 XEOTICID XEO04642 XEO_NAME Pleurocidin-like peptide AP1 DME1971 XEOTICID XEO04642 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04642 XEO_CLAS Peptide DME1971 XEOTICID XEO04642 DESCRIPT Pleurocidin-like peptide AP1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO04642 GENEFORM Protein DME1971 XEOTICID XEO04642 MOACRIVE Inhibition DME1971 XEOTICID XEO04643 XEO_NAME Pleurocidin-like peptide AP2 DME1971 XEOTICID XEO04643 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04643 XEO_CLAS Peptide DME1971 XEOTICID XEO04643 DESCRIPT Pleurocidin-like peptide AP2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 ug/ml) DME1971 XEOTICID XEO04643 GENEFORM Protein DME1971 XEOTICID XEO04643 MOACRIVE Inhibition DME1971 XEOTICID XEO04644 XEO_NAME Pleurocidin-like peptide AP3 DME1971 XEOTICID XEO04644 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04644 XEO_CLAS Peptide DME1971 XEOTICID XEO04644 DESCRIPT Pleurocidin-like peptide AP3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 ug/ml) DME1971 XEOTICID XEO04644 GENEFORM Protein DME1971 XEOTICID XEO04644 MOACRIVE Inhibition DME1971 XEOTICID XEO04645 XEO_NAME Pleurocidin-like peptide GC3.2 DME1971 XEOTICID XEO04645 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04645 XEO_CLAS Peptide DME1971 XEOTICID XEO04645 DESCRIPT Pleurocidin-like peptide GC3.2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 32 ug/ml) DME1971 XEOTICID XEO04645 GENEFORM Protein DME1971 XEOTICID XEO04645 MOACRIVE Inhibition DME1971 XEOTICID XEO04646 XEO_NAME Pleurocidin-like peptide GC3.8 DME1971 XEOTICID XEO04646 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04646 XEO_CLAS Peptide DME1971 XEOTICID XEO04646 DESCRIPT Pleurocidin-like peptide GC3.8 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1 ug/ml) DME1971 XEOTICID XEO04646 GENEFORM Protein DME1971 XEOTICID XEO04646 MOACRIVE Inhibition DME1971 XEOTICID XEO04647 XEO_NAME Pleurocidin-like peptide GcSc4B7 DME1971 XEOTICID XEO04647 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04647 XEO_CLAS Peptide DME1971 XEOTICID XEO04647 DESCRIPT Pleurocidin-like peptide GcSc4B7 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO04647 GENEFORM Protein DME1971 XEOTICID XEO04647 MOACRIVE Inhibition DME1971 XEOTICID XEO04648 XEO_NAME Pleurocidin-like peptide GcSc4C5 DME1971 XEOTICID XEO04648 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04648 XEO_CLAS Peptide DME1971 XEOTICID XEO04648 DESCRIPT Pleurocidin-like peptide GcSc4C5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 16 ug/ml) DME1971 XEOTICID XEO04648 GENEFORM Protein DME1971 XEOTICID XEO04648 MOACRIVE Inhibition DME1971 XEOTICID XEO04649 XEO_NAME Pleurocidin-like peptide Hb18 DME1971 XEOTICID XEO04649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04649 XEO_CLAS Peptide DME1971 XEOTICID XEO04649 DESCRIPT Pleurocidin-like peptide Hb18 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC > 64 ug/ml) DME1971 XEOTICID XEO04649 GENEFORM Protein DME1971 XEOTICID XEO04649 MOACRIVE Inhibition DME1971 XEOTICID XEO04650 XEO_NAME Pleurocidin-like peptide Hb26 DME1971 XEOTICID XEO04650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04650 XEO_CLAS Peptide DME1971 XEOTICID XEO04650 DESCRIPT Pleurocidin-like peptide Hb26 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 16 ug/ml) DME1971 XEOTICID XEO04650 GENEFORM Protein DME1971 XEOTICID XEO04650 MOACRIVE Inhibition DME1971 XEOTICID XEO04651 XEO_NAME Pleurocidin-like peptide WF3 DME1971 XEOTICID XEO04651 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04651 XEO_CLAS Peptide DME1971 XEOTICID XEO04651 DESCRIPT Pleurocidin-like peptide WF3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 64 ug/ml) DME1971 XEOTICID XEO04651 GENEFORM Protein DME1971 XEOTICID XEO04651 MOACRIVE Inhibition DME1971 XEOTICID XEO04652 XEO_NAME Pleurocidin-like peptide WF4 DME1971 XEOTICID XEO04652 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04652 XEO_CLAS Peptide DME1971 XEOTICID XEO04652 DESCRIPT Pleurocidin-like peptide WF4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO04652 GENEFORM Protein DME1971 XEOTICID XEO04652 MOACRIVE Inhibition DME1971 XEOTICID XEO04653 XEO_NAME Pleurocidin-like peptide WFX DME1971 XEOTICID XEO04653 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04653 XEO_CLAS Peptide DME1971 XEOTICID XEO04653 DESCRIPT Pleurocidin-like peptide WFX inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC > 64 ug/ml) DME1971 XEOTICID XEO04653 GENEFORM Protein DME1971 XEOTICID XEO04653 MOACRIVE Inhibition DME1971 XEOTICID XEO04654 XEO_NAME Pleurocidin-like peptide WFY DME1971 XEOTICID XEO04654 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04654 XEO_CLAS Peptide DME1971 XEOTICID XEO04654 DESCRIPT Pleurocidin-like peptide WFY inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 64 ug/ml) DME1971 XEOTICID XEO04654 GENEFORM Protein DME1971 XEOTICID XEO04654 MOACRIVE Inhibition DME1971 XEOTICID XEO04655 XEO_NAME Pleurocidin-like peptide YT2 DME1971 XEOTICID XEO04655 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04655 XEO_CLAS Peptide DME1971 XEOTICID XEO04655 DESCRIPT Pleurocidin-like peptide YT2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 ug/ml) DME1971 XEOTICID XEO04655 GENEFORM Protein DME1971 XEOTICID XEO04655 MOACRIVE Inhibition DME1971 XEOTICID XEO04660 XEO_NAME PM1 linear derivative PM1-S DME1971 XEOTICID XEO04660 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04660 XEO_CLAS Peptide DME1971 XEOTICID XEO04660 DESCRIPT PM1 linear derivative PM1-S inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2 ug/ml) DME1971 XEOTICID XEO04660 GENEFORM Protein DME1971 XEOTICID XEO04660 MOACRIVE Inhibition DME1971 XEOTICID XEO04690 XEO_NAME Polyphemusin-1 DME1971 XEOTICID XEO04690 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04690 XEO_CLAS Peptide DME1971 XEOTICID XEO04690 DESCRIPT Polyphemusin-1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.25 ug/ml) DME1971 XEOTICID XEO04690 GENEFORM Protein DME1971 XEOTICID XEO04690 MOACRIVE Inhibition DME1971 XEOTICID XEO04695 XEO_NAME Ponericin G1 DME1971 XEOTICID XEO04695 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04695 XEO_CLAS Peptide DME1971 XEOTICID XEO04695 DESCRIPT Ponericin G1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04695 GENEFORM Protein DME1971 XEOTICID XEO04695 MOACRIVE Inhibition DME1971 XEOTICID XEO04696 XEO_NAME Ponericin G3 DME1971 XEOTICID XEO04696 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04696 XEO_CLAS Peptide DME1971 XEOTICID XEO04696 DESCRIPT Ponericin G3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04696 GENEFORM Protein DME1971 XEOTICID XEO04696 MOACRIVE Inhibition DME1971 XEOTICID XEO04699 XEO_NAME Ponericin-L2 DME1971 XEOTICID XEO04699 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04699 XEO_CLAS Peptide DME1971 XEOTICID XEO04699 DESCRIPT Ponericin-L2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04699 GENEFORM Protein DME1971 XEOTICID XEO04699 MOACRIVE Inhibition DME1971 XEOTICID XEO04700 XEO_NAME Ponericin-W1 DME1971 XEOTICID XEO04700 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04700 XEO_CLAS Peptide DME1971 XEOTICID XEO04700 DESCRIPT Ponericin-W1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04700 GENEFORM Protein DME1971 XEOTICID XEO04700 MOACRIVE Inhibition DME1971 XEOTICID XEO04701 XEO_NAME Ponericin-W3 DME1971 XEOTICID XEO04701 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04701 XEO_CLAS Peptide DME1971 XEOTICID XEO04701 DESCRIPT Ponericin-W3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04701 GENEFORM Protein DME1971 XEOTICID XEO04701 MOACRIVE Inhibition DME1971 XEOTICID XEO04702 XEO_NAME Ponericin-W4 DME1971 XEOTICID XEO04702 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04702 XEO_CLAS Peptide DME1971 XEOTICID XEO04702 DESCRIPT Ponericin-W4 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04702 GENEFORM Protein DME1971 XEOTICID XEO04702 MOACRIVE Inhibition DME1971 XEOTICID XEO04703 XEO_NAME Ponericin-W5 DME1971 XEOTICID XEO04703 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04703 XEO_CLAS Peptide DME1971 XEOTICID XEO04703 DESCRIPT Ponericin-W5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04703 GENEFORM Protein DME1971 XEOTICID XEO04703 MOACRIVE Inhibition DME1971 XEOTICID XEO04770 XEO_NAME Pyrrhocoricin DME1971 XEOTICID XEO04770 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04770 XEO_CLAS Peptide DME1971 XEOTICID XEO04770 DESCRIPT Pyrrhocoricin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 5 microM) DME1971 XEOTICID XEO04770 GENEFORM Protein DME1971 XEOTICID XEO04770 MOACRIVE Inhibition DME1971 XEOTICID XEO04783 XEO_NAME Bac2A variant R11 DME1971 XEOTICID XEO04783 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04783 XEO_CLAS Peptide DME1971 XEOTICID XEO04783 DESCRIPT Bac2A variant R11 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 ug/ml) DME1971 XEOTICID XEO04783 GENEFORM Protein DME1971 XEOTICID XEO04783 MOACRIVE Inhibition DME1971 XEOTICID XEO04784 XEO_NAME Bac2A variant R2 DME1971 XEOTICID XEO04784 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04784 XEO_CLAS Peptide DME1971 XEOTICID XEO04784 DESCRIPT Bac2A variant R2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 ug/ml) DME1971 XEOTICID XEO04784 GENEFORM Protein DME1971 XEOTICID XEO04784 MOACRIVE Inhibition DME1971 XEOTICID XEO04785 XEO_NAME Bac2A variant R3 DME1971 XEOTICID XEO04785 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04785 XEO_CLAS Peptide DME1971 XEOTICID XEO04785 DESCRIPT Bac2A variant R3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 ug/ml) DME1971 XEOTICID XEO04785 GENEFORM Protein DME1971 XEOTICID XEO04785 MOACRIVE Inhibition DME1971 XEOTICID XEO04786 XEO_NAME Bac2A variant R5 DME1971 XEOTICID XEO04786 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04786 XEO_CLAS Peptide DME1971 XEOTICID XEO04786 DESCRIPT Bac2A variant R5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 31 ug/ml) DME1971 XEOTICID XEO04786 GENEFORM Protein DME1971 XEOTICID XEO04786 MOACRIVE Inhibition DME1971 XEOTICID XEO04840 XEO_NAME Recombinant Crassostrea Gigas Defensin DME1971 XEOTICID XEO04840 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04840 XEO_CLAS Peptide DME1971 XEOTICID XEO04840 DESCRIPT Recombinant Crassostrea Gigas Defensin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC > 20 microM) DME1971 XEOTICID XEO04840 GENEFORM Protein DME1971 XEOTICID XEO04840 MOACRIVE Inhibition DME1971 XEOTICID XEO04848 XEO_NAME Rhesus theta-defensin 1 DME1971 XEOTICID XEO04848 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04848 XEO_CLAS Peptide DME1971 XEOTICID XEO04848 DESCRIPT Rhesus theta-defensin 1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04848 GENEFORM Protein DME1971 XEOTICID XEO04848 MOACRIVE Inhibition DME1971 XEOTICID XEO04849 XEO_NAME Rhesus theta-defensin 2 DME1971 XEOTICID XEO04849 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04849 XEO_CLAS Peptide DME1971 XEOTICID XEO04849 DESCRIPT Rhesus theta-defensin 2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04849 GENEFORM Protein DME1971 XEOTICID XEO04849 MOACRIVE Inhibition DME1971 XEOTICID XEO04850 XEO_NAME Rhesus theta-defensin 3 DME1971 XEOTICID XEO04850 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04850 XEO_CLAS Peptide DME1971 XEOTICID XEO04850 DESCRIPT Rhesus theta-defensin 3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04850 GENEFORM Protein DME1971 XEOTICID XEO04850 MOACRIVE Inhibition DME1971 XEOTICID XEO04880 XEO_NAME V681 peptide derivative S11G DME1971 XEOTICID XEO04880 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04880 XEO_CLAS Peptide DME1971 XEOTICID XEO04880 DESCRIPT V681 peptide derivative S11G inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 12.7 ug/ml) DME1971 XEOTICID XEO04880 GENEFORM Protein DME1971 XEOTICID XEO04880 MOACRIVE Inhibition DME1971 XEOTICID XEO04886 XEO_NAME V681 peptide derivative S11AD DME1971 XEOTICID XEO04886 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04886 XEO_CLAS Peptide DME1971 XEOTICID XEO04886 DESCRIPT V681 peptide derivative S11AD inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 1.0 ug/ml) DME1971 XEOTICID XEO04886 GENEFORM Protein DME1971 XEOTICID XEO04886 MOACRIVE Inhibition DME1971 XEOTICID XEO04931 XEO_NAME Shepherin I DME1971 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04931 XEO_CLAS Peptide DME1971 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04931 GENEFORM Protein DME1971 XEOTICID XEO04931 MOACRIVE Inhibition DME1971 XEOTICID XEO04932 XEO_NAME shepherin II DME1971 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04932 XEO_CLAS Peptide DME1971 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO04932 GENEFORM Protein DME1971 XEOTICID XEO04932 MOACRIVE Inhibition DME1971 XEOTICID XEO04956 XEO_NAME SMAP-29 peptide derivative(1-17) DME1971 XEOTICID XEO04956 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04956 XEO_CLAS Peptide DME1971 XEOTICID XEO04956 DESCRIPT SMAP-29 peptide derivative(1-17) inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8.0 microM) DME1971 XEOTICID XEO04956 GENEFORM Protein DME1971 XEOTICID XEO04956 MOACRIVE Inhibition DME1971 XEOTICID XEO04971 XEO_NAME Spheniscin-2 DME1971 XEOTICID XEO04971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04971 XEO_CLAS Peptide DME1971 XEOTICID XEO04971 DESCRIPT Spheniscin-2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 6-12 microM) DME1971 XEOTICID XEO04971 GENEFORM Protein DME1971 XEOTICID XEO04971 MOACRIVE Inhibition DME1971 XEOTICID XEO04974 XEO_NAME Spinigerin DME1971 XEOTICID XEO04974 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04974 XEO_CLAS Peptide DME1971 XEOTICID XEO04974 DESCRIPT Spinigerin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 3-6 microM) DME1971 XEOTICID XEO04974 GENEFORM Protein DME1971 XEOTICID XEO04974 MOACRIVE Inhibition DME1971 XEOTICID XEO04995 XEO_NAME Stomoxyn DME1971 XEOTICID XEO04995 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04995 XEO_CLAS Peptide DME1971 XEOTICID XEO04995 DESCRIPT Stomoxyn inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.39-0.78 microM) DME1971 XEOTICID XEO04995 GENEFORM Protein DME1971 XEOTICID XEO04995 MOACRIVE Inhibition DME1971 XEOTICID XEO04998 XEO_NAME Styelin A DME1971 XEOTICID XEO04998 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04998 XEO_CLAS Peptide DME1971 XEOTICID XEO04998 DESCRIPT Styelin A inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 5 ug/ml) DME1971 XEOTICID XEO04998 GENEFORM Protein DME1971 XEOTICID XEO04998 MOACRIVE Inhibition DME1971 XEOTICID XEO04999 XEO_NAME Styelin B DME1971 XEOTICID XEO04999 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO04999 XEO_CLAS Peptide DME1971 XEOTICID XEO04999 DESCRIPT Styelin B inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 5 ug/ml) DME1971 XEOTICID XEO04999 GENEFORM Protein DME1971 XEOTICID XEO04999 MOACRIVE Inhibition DME1971 XEOTICID XEO05000 XEO_NAME Bac2A variant Sub2 DME1971 XEOTICID XEO05000 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05000 XEO_CLAS Peptide DME1971 XEOTICID XEO05000 DESCRIPT Bac2A variant Sub2 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 ug/ml) DME1971 XEOTICID XEO05000 GENEFORM Protein DME1971 XEOTICID XEO05000 MOACRIVE Inhibition DME1971 XEOTICID XEO05001 XEO_NAME Bac2A variant Sub3 DME1971 XEOTICID XEO05001 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05001 XEO_CLAS Peptide DME1971 XEOTICID XEO05001 DESCRIPT Bac2A variant Sub3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 4 ug/ml) DME1971 XEOTICID XEO05001 GENEFORM Protein DME1971 XEOTICID XEO05001 MOACRIVE Inhibition DME1971 XEOTICID XEO05002 XEO_NAME Bac2A variant Sub5 DME1971 XEOTICID XEO05002 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05002 XEO_CLAS Peptide DME1971 XEOTICID XEO05002 DESCRIPT Bac2A variant Sub5 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 ug/ml) DME1971 XEOTICID XEO05002 GENEFORM Protein DME1971 XEOTICID XEO05002 MOACRIVE Inhibition DME1971 XEOTICID XEO05003 XEO_NAME Bac2A variant Sub6 DME1971 XEOTICID XEO05003 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05003 XEO_CLAS Peptide DME1971 XEOTICID XEO05003 DESCRIPT Bac2A variant Sub6 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 16 ug/ml) DME1971 XEOTICID XEO05003 GENEFORM Protein DME1971 XEOTICID XEO05003 MOACRIVE Inhibition DME1971 XEOTICID XEO05020 XEO_NAME Tachycitin DME1971 XEOTICID XEO05020 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05020 XEO_CLAS Peptide DME1971 XEOTICID XEO05020 DESCRIPT Tachycitin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO05020 GENEFORM Protein DME1971 XEOTICID XEO05020 MOACRIVE Inhibition DME1971 XEOTICID XEO05119 XEO_NAME Turtle egg-white protein TEWP DME1971 XEOTICID XEO05119 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05119 XEO_CLAS Peptide DME1971 XEOTICID XEO05119 DESCRIPT Turtle egg-white protein TEWP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO05119 GENEFORM Protein DME1971 XEOTICID XEO05119 MOACRIVE Inhibition DME1971 XEOTICID XEO05120 XEO_NAME Thanatin DME1971 XEOTICID XEO05120 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05120 XEO_CLAS Peptide DME1971 XEOTICID XEO05120 DESCRIPT Thanatin inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.6-1.2 microM) DME1971 XEOTICID XEO05120 GENEFORM Protein DME1971 XEOTICID XEO05120 MOACRIVE Inhibition DME1971 XEOTICID XEO05161 XEO_NAME Tritrpticin derivative TPA DME1971 XEOTICID XEO05161 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05161 XEO_CLAS Peptide DME1971 XEOTICID XEO05161 DESCRIPT Tritrpticin derivative TPA inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 32 ug/ml) DME1971 XEOTICID XEO05161 GENEFORM Protein DME1971 XEOTICID XEO05161 MOACRIVE Inhibition DME1971 XEOTICID XEO05162 XEO_NAME Tritrpticin derivative TPG DME1971 XEOTICID XEO05162 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05162 XEO_CLAS Peptide DME1971 XEOTICID XEO05162 DESCRIPT Tritrpticin derivative TPG inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 32 ug/ml) DME1971 XEOTICID XEO05162 GENEFORM Protein DME1971 XEOTICID XEO05162 MOACRIVE Inhibition DME1971 XEOTICID XEO05171 XEO_NAME Tridecaptin A1 DME1971 XEOTICID XEO05171 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05171 XEO_CLAS Peptide DME1971 XEOTICID XEO05171 DESCRIPT Tridecaptin A1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO05171 GENEFORM Protein DME1971 XEOTICID XEO05171 MOACRIVE Inhibition DME1971 XEOTICID XEO05193 XEO_NAME Tritrpticin peptide derivative TWF DME1971 XEOTICID XEO05193 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05193 XEO_CLAS Peptide DME1971 XEOTICID XEO05193 DESCRIPT Tritrpticin peptide derivative TWF inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 ug/ml) DME1971 XEOTICID XEO05193 GENEFORM Protein DME1971 XEOTICID XEO05193 MOACRIVE Inhibition DME1971 XEOTICID XEO05212 XEO_NAME V681 peptide derivative V13G DME1971 XEOTICID XEO05212 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05212 XEO_CLAS Peptide DME1971 XEOTICID XEO05212 DESCRIPT V681 peptide derivative V13G inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 2.5 ug/ml) DME1971 XEOTICID XEO05212 GENEFORM Protein DME1971 XEOTICID XEO05212 MOACRIVE Inhibition DME1971 XEOTICID XEO05222 XEO_NAME Plant defensin VaD1 DME1971 XEOTICID XEO05222 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05222 XEO_CLAS Peptide DME1971 XEOTICID XEO05222 DESCRIPT Plant defensin VaD1 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica DME1971 XEOTICID XEO05222 GENEFORM Protein DME1971 XEOTICID XEO05222 MOACRIVE Inhibition DME1971 XEOTICID XEO05231 XEO_NAME Venom antimicrobial peptide-9 DME1971 XEOTICID XEO05231 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05231 XEO_CLAS Peptide DME1971 XEOTICID XEO05231 DESCRIPT Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 10.9 microM) DME1971 XEOTICID XEO05231 GENEFORM Protein DME1971 XEOTICID XEO05231 MOACRIVE Inhibition DME1971 XEOTICID XEO05264 XEO_NAME Bac2A variant W10 DME1971 XEOTICID XEO05264 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05264 XEO_CLAS Peptide DME1971 XEOTICID XEO05264 DESCRIPT Bac2A variant W10 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 ug/ml) DME1971 XEOTICID XEO05264 GENEFORM Protein DME1971 XEOTICID XEO05264 MOACRIVE Inhibition DME1971 XEOTICID XEO05267 XEO_NAME Bac2A variant W3 DME1971 XEOTICID XEO05267 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05267 XEO_CLAS Peptide DME1971 XEOTICID XEO05267 DESCRIPT Bac2A variant W3 inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 8 ug/ml) DME1971 XEOTICID XEO05267 GENEFORM Protein DME1971 XEOTICID XEO05267 MOACRIVE Inhibition DME1971 XEOTICID XEO05308 XEO_NAME GAPDH-related antimicrobial YFGAP DME1971 XEOTICID XEO05308 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME1971 XEOTICID XEO05308 XEO_CLAS Peptide DME1971 XEOTICID XEO05308 DESCRIPT GAPDH-related antimicrobial YFGAP inhibits the drug-metabolizing activity of Oxygen-insensitive NADPH nitroreductase A (nfsA) from Salmonella enterica (MIC = 0.9 ug/ml) DME1971 XEOTICID XEO05308 GENEFORM Protein DME1971 XEOTICID XEO05308 MOACRIVE Inhibition DME2014 DME___ID DME2014 DME2014 DME_NAME Insulin-degrading enzyme (ide) DME2014 SPESNAME Vibrio vulnificus DME2014 XEOTICID XEO00683 XEO_NAME Curcumin DME2014 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME2014 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME2014 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus DME2014 XEOTICID XEO00683 GENEFORM Protein DME2014 XEOTICID XEO00683 MOACRIVE Inhibition DME2014 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME2014 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2014 XEOTICID XEO01253 XEO_CLAS Natural Product DME2014 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus DME2014 XEOTICID XEO01253 GENEFORM Protein DME2014 XEOTICID XEO01253 MOACRIVE Inhibition DME2014 XEOTICID XEO01446 XEO_NAME Pyrogallol DME2014 XEOTICID XEO01446 XEO_TYPE Health or Environmental Toxicant(s) DME2014 XEOTICID XEO01446 XEO_CLAS Health Hazard/Toxicant DME2014 XEOTICID XEO01446 DESCRIPT Pyrogallol inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus DME2014 XEOTICID XEO01446 GENEFORM Protein DME2014 XEOTICID XEO01446 MOACRIVE Inhibition DME2014 XEOTICID XEO01827 XEO_NAME Penaeidin-3a T8A DME2014 XEOTICID XEO01827 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2014 XEOTICID XEO01827 XEO_CLAS Peptide DME2014 XEOTICID XEO01827 DESCRIPT Penaeidin-3a T8A inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus (MIC > 50 microM) DME2014 XEOTICID XEO01827 GENEFORM Protein DME2014 XEOTICID XEO01827 MOACRIVE Inhibition DME2014 XEOTICID XEO01894 XEO_NAME 2-(2-Thienylsulfonyl)ethanethioamide DME2014 XEOTICID XEO01894 XEO_TYPE Other Chemical Compound(s) or Element(s) DME2014 XEOTICID XEO01894 XEO_CLAS Chemical Compound DME2014 XEOTICID XEO01894 DESCRIPT 2-(2-Thienylsulfonyl)ethanethioamide inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus DME2014 XEOTICID XEO01894 GENEFORM Protein DME2014 XEOTICID XEO01894 MOACRIVE Inhibition DME2014 XEOTICID XEO02043 XEO_NAME Methyl 4-boronobenzoate DME2014 XEOTICID XEO02043 XEO_TYPE Other Chemical Compound(s) or Element(s) DME2014 XEOTICID XEO02043 XEO_CLAS Chemical Compound DME2014 XEOTICID XEO02043 DESCRIPT Methyl 4-boronobenzoate inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus DME2014 XEOTICID XEO02043 GENEFORM Protein DME2014 XEOTICID XEO02043 MOACRIVE Inhibition DME2014 XEOTICID XEO02235 XEO_NAME Anthranilate DME2014 XEOTICID XEO02235 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2014 XEOTICID XEO02235 XEO_CLAS Natural Product DME2014 XEOTICID XEO02235 DESCRIPT Anthranilate inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus DME2014 XEOTICID XEO02235 GENEFORM Protein DME2014 XEOTICID XEO02235 MOACRIVE Inhibition DME2014 XEOTICID XEO02967 XEO_NAME TO17 peptide derivative CTO17 DME2014 XEOTICID XEO02967 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2014 XEOTICID XEO02967 XEO_CLAS Peptide DME2014 XEOTICID XEO02967 DESCRIPT TO17 peptide derivative CTO17 inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus (MIC = 20 microM) DME2014 XEOTICID XEO02967 GENEFORM Protein DME2014 XEOTICID XEO02967 MOACRIVE Inhibition DME2014 XEOTICID XEO02983 XEO_NAME Actinomycetes A66 culture supernatant DME2014 XEOTICID XEO02983 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2014 XEOTICID XEO02983 XEO_CLAS Bacterial Extract DME2014 XEOTICID XEO02983 DESCRIPT Actinomycetes A66 culture supernatant inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus DME2014 XEOTICID XEO02983 GENEFORM Protein DME2014 XEOTICID XEO02983 MOACRIVE Inhibition DME2014 XEOTICID XEO02984 XEO_NAME Actinomycetes A67 culture supernatant DME2014 XEOTICID XEO02984 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2014 XEOTICID XEO02984 XEO_CLAS Bacterial Extract DME2014 XEOTICID XEO02984 DESCRIPT Actinomycetes A67 culture supernatant inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus DME2014 XEOTICID XEO02984 GENEFORM Protein DME2014 XEOTICID XEO02984 MOACRIVE Inhibition DME2014 XEOTICID XEO02985 XEO_NAME Actinomycetes B15 culture supernatant DME2014 XEOTICID XEO02985 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2014 XEOTICID XEO02985 XEO_CLAS Bacterial Extract DME2014 XEOTICID XEO02985 DESCRIPT Actinomycetes B15 culture supernatant inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus DME2014 XEOTICID XEO02985 GENEFORM Protein DME2014 XEOTICID XEO02985 MOACRIVE Inhibition DME2014 XEOTICID XEO03968 XEO_NAME L-tryptophan DME2014 XEOTICID XEO03968 XEO_TYPE Pharmaceutical Agent(s) DME2014 XEOTICID XEO03968 XEO_CLAS Drug in Phase 1 Clinical Trial DME2014 XEOTICID XEO03968 DESCRIPT L-tryptophan inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus DME2014 XEOTICID XEO03968 GENEFORM Protein DME2014 XEOTICID XEO03968 MOACRIVE Inhibition DME2014 XEOTICID XEO04506 XEO_NAME Penaeidin-2d DME2014 XEOTICID XEO04506 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2014 XEOTICID XEO04506 XEO_CLAS Peptide DME2014 XEOTICID XEO04506 DESCRIPT Penaeidin-2d inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus (MIC > 20 microM) DME2014 XEOTICID XEO04506 GENEFORM Protein DME2014 XEOTICID XEO04506 MOACRIVE Inhibition DME2014 XEOTICID XEO04507 XEO_NAME Penaeidin-3a DME2014 XEOTICID XEO04507 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2014 XEOTICID XEO04507 XEO_CLAS Peptide DME2014 XEOTICID XEO04507 DESCRIPT Penaeidin-3a inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus (MIC > 20 microM) DME2014 XEOTICID XEO04507 GENEFORM Protein DME2014 XEOTICID XEO04507 MOACRIVE Inhibition DME2014 XEOTICID XEO04510 XEO_NAME Penaeidin-4a DME2014 XEOTICID XEO04510 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2014 XEOTICID XEO04510 XEO_CLAS Peptide DME2014 XEOTICID XEO04510 DESCRIPT Penaeidin-4a inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus (MIC > 50 microM) DME2014 XEOTICID XEO04510 GENEFORM Protein DME2014 XEOTICID XEO04510 MOACRIVE Inhibition DME2014 XEOTICID XEO05154 XEO_NAME TFPI-1 C-terminal peptide TO17 DME2014 XEOTICID XEO05154 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2014 XEOTICID XEO05154 XEO_CLAS Peptide DME2014 XEOTICID XEO05154 DESCRIPT TFPI-1 C-terminal peptide TO17 inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus (MIC = 80 microM) DME2014 XEOTICID XEO05154 GENEFORM Protein DME2014 XEOTICID XEO05154 MOACRIVE Inhibition DME2014 XEOTICID XEO05155 XEO_NAME TO17 peptide derivative TO19 DME2014 XEOTICID XEO05155 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2014 XEOTICID XEO05155 XEO_CLAS Peptide DME2014 XEOTICID XEO05155 DESCRIPT TO17 peptide derivative TO19 inhibits the drug-metabolizing activity of Insulin-degrading enzyme (ide) from Vibrio vulnificus (MIC = 20 microM) DME2014 XEOTICID XEO05155 GENEFORM Protein DME2014 XEOTICID XEO05155 MOACRIVE Inhibition DME2021 DME___ID DME2021 DME2021 DME_NAME Carbapenemase (cphA) DME2021 SPESNAME Achromobacter xylosoxidans DME2021 XEOTICID XEO04478 XEO_NAME Patulin DME2021 XEOTICID XEO04478 XEO_TYPE Pharmaceutical Agent(s) DME2021 XEOTICID XEO04478 XEO_CLAS Investigative Agent DME2021 XEOTICID XEO04478 DESCRIPT Patulin inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Achromobacter xylosoxidans DME2021 XEOTICID XEO04478 GENEFORM Protein DME2021 XEOTICID XEO04478 MOACRIVE Inhibition DME2021 XEOTICID XEO04518 XEO_NAME Penicillic acid DME2021 XEOTICID XEO04518 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2021 XEOTICID XEO04518 XEO_CLAS Natural Product DME2021 XEOTICID XEO04518 DESCRIPT Penicillic acid inhibits the drug-metabolizing activity of Carbapenemase (cphA) from Achromobacter xylosoxidans DME2021 XEOTICID XEO04518 GENEFORM Protein DME2021 XEOTICID XEO04518 MOACRIVE Inhibition DME2059 DME___ID DME2059 DME2059 DME_NAME Beta-galactosidase (bgaB) DME2059 SPESNAME Cronobacter sakazakii DME2059 XEOTICID XEO01254 XEO_NAME Citral DME2059 XEOTICID XEO01254 XEO_TYPE Pharmaceutical Agent(s) DME2059 XEOTICID XEO01254 XEO_CLAS Drug in Phase 1 Clinical Trial DME2059 XEOTICID XEO01254 DESCRIPT Citral inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Cronobacter sakazakii DME2059 XEOTICID XEO01254 GENEFORM Protein DME2059 XEOTICID XEO01254 MOACRIVE Inhibition DME2059 XEOTICID XEO04088 XEO_NAME Allium sativum methanolic extract DME2059 XEOTICID XEO04088 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2059 XEOTICID XEO04088 XEO_CLAS Plant Extract DME2059 XEOTICID XEO04088 DESCRIPT Allium sativum methanolic extract inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Cronobacter sakazakii DME2059 XEOTICID XEO04088 GENEFORM Protein DME2059 XEOTICID XEO04088 MOACRIVE Inhibition DME2059 XEOTICID XEO04091 XEO_NAME Cinnamomum verum methanolic extract DME2059 XEOTICID XEO04091 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2059 XEOTICID XEO04091 XEO_CLAS Plant Extract DME2059 XEOTICID XEO04091 DESCRIPT Cinnamomum verum methanolic extract inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Cronobacter sakazakii DME2059 XEOTICID XEO04091 GENEFORM Protein DME2059 XEOTICID XEO04091 MOACRIVE Inhibition DME2059 XEOTICID XEO04092 XEO_NAME Coriandrum sativum methanolic extract DME2059 XEOTICID XEO04092 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2059 XEOTICID XEO04092 XEO_CLAS Plant Extract DME2059 XEOTICID XEO04092 DESCRIPT Coriandrum sativum methanolic extract inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Cronobacter sakazakii DME2059 XEOTICID XEO04092 GENEFORM Protein DME2059 XEOTICID XEO04092 MOACRIVE Inhibition DME2059 XEOTICID XEO04093 XEO_NAME Cuminum cyminum methanolic extract DME2059 XEOTICID XEO04093 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2059 XEOTICID XEO04093 XEO_CLAS Plant Extract DME2059 XEOTICID XEO04093 DESCRIPT Cuminum cyminum methanolic extract inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Cronobacter sakazakii DME2059 XEOTICID XEO04093 GENEFORM Protein DME2059 XEOTICID XEO04093 MOACRIVE Inhibition DME2059 XEOTICID XEO04095 XEO_NAME Myristica fragrans methanolic extract DME2059 XEOTICID XEO04095 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2059 XEOTICID XEO04095 XEO_CLAS Plant Extract DME2059 XEOTICID XEO04095 DESCRIPT Myristica fragrans methanolic extract inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Cronobacter sakazakii DME2059 XEOTICID XEO04095 GENEFORM Protein DME2059 XEOTICID XEO04095 MOACRIVE Inhibition DME2059 XEOTICID XEO04097 XEO_NAME Piper nigrum methanolic extract DME2059 XEOTICID XEO04097 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2059 XEOTICID XEO04097 XEO_CLAS Plant Extract DME2059 XEOTICID XEO04097 DESCRIPT Piper nigrum methanolic extract inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Cronobacter sakazakii DME2059 XEOTICID XEO04097 GENEFORM Protein DME2059 XEOTICID XEO04097 MOACRIVE Inhibition DME2059 XEOTICID XEO04100 XEO_NAME Syzygium aromaticum methanolic extract DME2059 XEOTICID XEO04100 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2059 XEOTICID XEO04100 XEO_CLAS Plant Extract DME2059 XEOTICID XEO04100 DESCRIPT Syzygium aromaticum methanolic extract inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Cronobacter sakazakii DME2059 XEOTICID XEO04100 GENEFORM Protein DME2059 XEOTICID XEO04100 MOACRIVE Inhibition DME2059 XEOTICID XEO04101 XEO_NAME Fenugreek methanolic extract DME2059 XEOTICID XEO04101 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2059 XEOTICID XEO04101 XEO_CLAS Plant Extract DME2059 XEOTICID XEO04101 DESCRIPT Fenugreek methanolic extract inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Cronobacter sakazakii DME2059 XEOTICID XEO04101 GENEFORM Protein DME2059 XEOTICID XEO04101 MOACRIVE Inhibition DME2059 XEOTICID XEO04103 XEO_NAME Zingiber officinale methanolic extract DME2059 XEOTICID XEO04103 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2059 XEOTICID XEO04103 XEO_CLAS Plant Extract DME2059 XEOTICID XEO04103 DESCRIPT Zingiber officinale methanolic extract inhibits the drug-metabolizing activity of Beta-galactosidase (bgaB) from Cronobacter sakazakii DME2059 XEOTICID XEO04103 GENEFORM Protein DME2059 XEOTICID XEO04103 MOACRIVE Inhibition DME2060 DME___ID DME2060 DME2060 DME_NAME Beta-glucosidase (bglA) DME2060 SPESNAME Enterococcus faecium DME2060 XEOTICID XEO01961 XEO_NAME 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME2060 XEOTICID XEO01961 XEO_TYPE Other Chemical Compound(s) or Element(s) DME2060 XEOTICID XEO01961 XEO_CLAS Chemical Compound DME2060 XEOTICID XEO01961 DESCRIPT 3-(3-fluorophenyl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO01961 GENEFORM Protein DME2060 XEOTICID XEO01961 MOACRIVE Inhibition DME2060 XEOTICID XEO01966 XEO_NAME 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one DME2060 XEOTICID XEO01966 XEO_TYPE Other Chemical Compound(s) or Element(s) DME2060 XEOTICID XEO01966 XEO_CLAS Chemical Compound DME2060 XEOTICID XEO01966 DESCRIPT 3-(pyridin-3-yl)-5-(3-ethoxy-4-hydroxybenzylidene)-2-thioxothiazolidin-4-one inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO01966 GENEFORM Protein DME2060 XEOTICID XEO01966 MOACRIVE Inhibition DME2060 XEOTICID XEO02373 XEO_NAME Bacteriocin 32 DME2060 XEOTICID XEO02373 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO02373 XEO_CLAS Peptide DME2060 XEOTICID XEO02373 DESCRIPT Bacteriocin 32 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO02373 GENEFORM Protein DME2060 XEOTICID XEO02373 MOACRIVE Inhibition DME2060 XEOTICID XEO02377 XEO_NAME Bacteriocin hiracin-JM79 DME2060 XEOTICID XEO02377 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO02377 XEO_CLAS Peptide DME2060 XEOTICID XEO02377 DESCRIPT Bacteriocin hiracin-JM79 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO02377 GENEFORM Protein DME2060 XEOTICID XEO02377 MOACRIVE Inhibition DME2060 XEOTICID XEO02440 XEO_NAME Beta-defensin BD-38 DME2060 XEOTICID XEO02440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO02440 XEO_CLAS Peptide DME2060 XEOTICID XEO02440 DESCRIPT Beta-defensin BD-38 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO02440 GENEFORM Protein DME2060 XEOTICID XEO02440 MOACRIVE Inhibition DME2060 XEOTICID XEO02524 XEO_NAME Brevinin-1HN1 DME2060 XEOTICID XEO02524 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO02524 XEO_CLAS Peptide DME2060 XEOTICID XEO02524 DESCRIPT Brevinin-1HN1 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium (MIC = 19 microM) DME2060 XEOTICID XEO02524 GENEFORM Protein DME2060 XEOTICID XEO02524 MOACRIVE Inhibition DME2060 XEOTICID XEO02567 XEO_NAME Brevinin-1V DME2060 XEOTICID XEO02567 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO02567 XEO_CLAS Peptide DME2060 XEOTICID XEO02567 DESCRIPT Brevinin-1V inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium (MIC = 19 microM) DME2060 XEOTICID XEO02567 GENEFORM Protein DME2060 XEOTICID XEO02567 MOACRIVE Inhibition DME2060 XEOTICID XEO02718 XEO_NAME Carnobacteriocin CbnB2 DME2060 XEOTICID XEO02718 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO02718 XEO_CLAS Peptide DME2060 XEOTICID XEO02718 DESCRIPT Carnobacteriocin CbnB2 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO02718 GENEFORM Protein DME2060 XEOTICID XEO02718 MOACRIVE Inhibition DME2060 XEOTICID XEO02743 XEO_NAME Cathelicidin-BF DME2060 XEOTICID XEO02743 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO02743 XEO_CLAS Peptide DME2060 XEOTICID XEO02743 DESCRIPT Cathelicidin-BF inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium (MIC = 150 ug/ml) DME2060 XEOTICID XEO02743 GENEFORM Protein DME2060 XEOTICID XEO02743 MOACRIVE Inhibition DME2060 XEOTICID XEO03073 XEO_NAME D-amino-acid pexiganan MSI-214 DME2060 XEOTICID XEO03073 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO03073 XEO_CLAS Peptide DME2060 XEOTICID XEO03073 DESCRIPT D-amino-acid pexiganan MSI-214 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium (MIC = 4 ug/ml) DME2060 XEOTICID XEO03073 GENEFORM Protein DME2060 XEOTICID XEO03073 MOACRIVE Inhibition DME2060 XEOTICID XEO03255 XEO_NAME Enterocin L50A DME2060 XEOTICID XEO03255 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO03255 XEO_CLAS Peptide DME2060 XEOTICID XEO03255 DESCRIPT Enterocin L50A inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO03255 GENEFORM Protein DME2060 XEOTICID XEO03255 MOACRIVE Inhibition DME2060 XEOTICID XEO03256 XEO_NAME Enterocin L50B DME2060 XEOTICID XEO03256 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO03256 XEO_CLAS Peptide DME2060 XEOTICID XEO03256 DESCRIPT Enterocin L50B inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO03256 GENEFORM Protein DME2060 XEOTICID XEO03256 MOACRIVE Inhibition DME2060 XEOTICID XEO03257 XEO_NAME Enterocin P DME2060 XEOTICID XEO03257 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO03257 XEO_CLAS Peptide DME2060 XEOTICID XEO03257 DESCRIPT Enterocin P inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium (MIC = 0.002 ug/ml) DME2060 XEOTICID XEO03257 GENEFORM Protein DME2060 XEOTICID XEO03257 MOACRIVE Inhibition DME2060 XEOTICID XEO03259 XEO_NAME Enterocin X alpha DME2060 XEOTICID XEO03259 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO03259 XEO_CLAS Peptide DME2060 XEOTICID XEO03259 DESCRIPT Enterocin X alpha inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium (MIC = 0.0508 microM) DME2060 XEOTICID XEO03259 GENEFORM Protein DME2060 XEOTICID XEO03259 MOACRIVE Inhibition DME2060 XEOTICID XEO03473 XEO_NAME Garvicin ML DME2060 XEOTICID XEO03473 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO03473 XEO_CLAS Peptide DME2060 XEOTICID XEO03473 DESCRIPT Garvicin ML inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO03473 GENEFORM Protein DME2060 XEOTICID XEO03473 MOACRIVE Inhibition DME2060 XEOTICID XEO03540 XEO_NAME Hematopoietic antimicrobial MgCath37 DME2060 XEOTICID XEO03540 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO03540 XEO_CLAS Peptide DME2060 XEOTICID XEO03540 DESCRIPT Hematopoietic antimicrobial MgCath37 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium (MIC = 4-8 ug/ml) DME2060 XEOTICID XEO03540 GENEFORM Protein DME2060 XEOTICID XEO03540 MOACRIVE Inhibition DME2060 XEOTICID XEO03556 XEO_NAME Hagfish HFIAP-1/2 DME2060 XEOTICID XEO03556 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO03556 XEO_CLAS Peptide DME2060 XEOTICID XEO03556 DESCRIPT Hagfish HFIAP-1/2 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium (MIC = 4-8 ug/ml) DME2060 XEOTICID XEO03556 GENEFORM Protein DME2060 XEOTICID XEO03556 MOACRIVE Inhibition DME2060 XEOTICID XEO03557 XEO_NAME Hagfish HFIAP-3 DME2060 XEOTICID XEO03557 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO03557 XEO_CLAS Peptide DME2060 XEOTICID XEO03557 DESCRIPT Hagfish HFIAP-3 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium (MIC = 4-8 ug/ml) DME2060 XEOTICID XEO03557 GENEFORM Protein DME2060 XEOTICID XEO03557 MOACRIVE Inhibition DME2060 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME2060 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO03771 XEO_CLAS Peptide DME2060 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO03771 GENEFORM Protein DME2060 XEOTICID XEO03771 MOACRIVE Inhibition DME2060 XEOTICID XEO03775 XEO_NAME Bacteriocin lactocyclicin Q DME2060 XEOTICID XEO03775 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO03775 XEO_CLAS Peptide DME2060 XEOTICID XEO03775 DESCRIPT Bacteriocin lactocyclicin Q inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium (MIC = 0.71 microM) DME2060 XEOTICID XEO03775 GENEFORM Protein DME2060 XEOTICID XEO03775 MOACRIVE Inhibition DME2060 XEOTICID XEO03857 XEO_NAME Leucocyclicin Q DME2060 XEOTICID XEO03857 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO03857 XEO_CLAS Peptide DME2060 XEOTICID XEO03857 DESCRIPT Leucocyclicin Q inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium (MIC = 0.038 microM) DME2060 XEOTICID XEO03857 GENEFORM Protein DME2060 XEOTICID XEO03857 MOACRIVE Inhibition DME2060 XEOTICID XEO04151 XEO_NAME Mundticin KS DME2060 XEOTICID XEO04151 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO04151 XEO_CLAS Peptide DME2060 XEOTICID XEO04151 DESCRIPT Mundticin KS inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO04151 GENEFORM Protein DME2060 XEOTICID XEO04151 MOACRIVE Inhibition DME2060 XEOTICID XEO04521 XEO_NAME Penocin A DME2060 XEOTICID XEO04521 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO04521 XEO_CLAS Peptide DME2060 XEOTICID XEO04521 DESCRIPT Penocin A inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO04521 GENEFORM Protein DME2060 XEOTICID XEO04521 MOACRIVE Inhibition DME2060 XEOTICID XEO04640 XEO_NAME Pleurocidin DME2060 XEOTICID XEO04640 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO04640 XEO_CLAS Peptide DME2060 XEOTICID XEO04640 DESCRIPT Pleurocidin inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO04640 GENEFORM Protein DME2060 XEOTICID XEO04640 MOACRIVE Inhibition DME2060 XEOTICID XEO04877 XEO_NAME S. litura moricin DME2060 XEOTICID XEO04877 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO04877 XEO_CLAS Peptide DME2060 XEOTICID XEO04877 DESCRIPT S. litura moricin inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO04877 GENEFORM Protein DME2060 XEOTICID XEO04877 MOACRIVE Inhibition DME2060 XEOTICID XEO05169 XEO_NAME Tricyclic peptide MS-271 DME2060 XEOTICID XEO05169 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO05169 XEO_CLAS Peptide DME2060 XEOTICID XEO05169 DESCRIPT Tricyclic peptide MS-271 inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO05169 GENEFORM Protein DME2060 XEOTICID XEO05169 MOACRIVE Inhibition DME2060 XEOTICID XEO05228 XEO_NAME Variacin DME2060 XEOTICID XEO05228 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2060 XEOTICID XEO05228 XEO_CLAS Peptide DME2060 XEOTICID XEO05228 DESCRIPT Variacin inhibits the drug-metabolizing activity of Beta-glucosidase (bglA) from Enterococcus faecium DME2060 XEOTICID XEO05228 GENEFORM Protein DME2060 XEOTICID XEO05228 MOACRIVE Inhibition DME2062 DME___ID DME2062 DME2062 DME_NAME Glycosyl hydrolase (glyH) DME2062 SPESNAME Pseudomonas putida DME2062 XEOTICID XEO02649 XEO_NAME Buforin-1 DME2062 XEOTICID XEO02649 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO02649 XEO_CLAS Peptide DME2062 XEOTICID XEO02649 DESCRIPT Buforin-1 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 4 ug/ml) DME2062 XEOTICID XEO02649 GENEFORM Protein DME2062 XEOTICID XEO02649 MOACRIVE Inhibition DME2062 XEOTICID XEO02650 XEO_NAME Buforin-2 DME2062 XEOTICID XEO02650 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO02650 XEO_CLAS Peptide DME2062 XEOTICID XEO02650 DESCRIPT Buforin-2 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 2 ug/ml) DME2062 XEOTICID XEO02650 GENEFORM Protein DME2062 XEOTICID XEO02650 MOACRIVE Inhibition DME2062 XEOTICID XEO02839 XEO_NAME Chrysophsin-1 DME2062 XEOTICID XEO02839 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO02839 XEO_CLAS Peptide DME2062 XEOTICID XEO02839 DESCRIPT Chrysophsin-1 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 40 microM) DME2062 XEOTICID XEO02839 GENEFORM Protein DME2062 XEOTICID XEO02839 MOACRIVE Inhibition DME2062 XEOTICID XEO02842 XEO_NAME Chrysophsin-3 DME2062 XEOTICID XEO02842 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO02842 XEO_CLAS Peptide DME2062 XEOTICID XEO02842 DESCRIPT Chrysophsin-3 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 40 microM) DME2062 XEOTICID XEO02842 GENEFORM Protein DME2062 XEOTICID XEO02842 MOACRIVE Inhibition DME2062 XEOTICID XEO03052 XEO_NAME GGN4 analogue peptide D16W DME2062 XEOTICID XEO03052 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO03052 XEO_CLAS Peptide DME2062 XEOTICID XEO03052 DESCRIPT GGN4 analogue peptide D16W inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 100 ug/ml) DME2062 XEOTICID XEO03052 GENEFORM Protein DME2062 XEOTICID XEO03052 MOACRIVE Inhibition DME2062 XEOTICID XEO03349 XEO_NAME Burdock leaf ethanolic extract DME2062 XEOTICID XEO03349 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2062 XEOTICID XEO03349 XEO_CLAS Plant Extract DME2062 XEOTICID XEO03349 DESCRIPT Burdock leaf ethanolic extract inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida DME2062 XEOTICID XEO03349 GENEFORM Protein DME2062 XEOTICID XEO03349 MOACRIVE Inhibition DME2062 XEOTICID XEO03436 XEO_NAME Gaegurin-1 DME2062 XEOTICID XEO03436 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO03436 XEO_CLAS Peptide DME2062 XEOTICID XEO03436 DESCRIPT Gaegurin-1 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 50 ug/ml) DME2062 XEOTICID XEO03436 GENEFORM Protein DME2062 XEOTICID XEO03436 MOACRIVE Inhibition DME2062 XEOTICID XEO03437 XEO_NAME Gaegurin-2 DME2062 XEOTICID XEO03437 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO03437 XEO_CLAS Peptide DME2062 XEOTICID XEO03437 DESCRIPT Gaegurin-2 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 50 ug/ml) DME2062 XEOTICID XEO03437 GENEFORM Protein DME2062 XEOTICID XEO03437 MOACRIVE Inhibition DME2062 XEOTICID XEO03438 XEO_NAME Gaegurin-3 DME2062 XEOTICID XEO03438 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO03438 XEO_CLAS Peptide DME2062 XEOTICID XEO03438 DESCRIPT Gaegurin-3 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 50 ug/ml) DME2062 XEOTICID XEO03438 GENEFORM Protein DME2062 XEOTICID XEO03438 MOACRIVE Inhibition DME2062 XEOTICID XEO03439 XEO_NAME Gaegurin-4 DME2062 XEOTICID XEO03439 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO03439 XEO_CLAS Peptide DME2062 XEOTICID XEO03439 DESCRIPT Gaegurin-4 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 100 ug/ml) DME2062 XEOTICID XEO03439 GENEFORM Protein DME2062 XEOTICID XEO03439 MOACRIVE Inhibition DME2062 XEOTICID XEO03440 XEO_NAME Gaegurin-5 DME2062 XEOTICID XEO03440 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO03440 XEO_CLAS Peptide DME2062 XEOTICID XEO03440 DESCRIPT Gaegurin-5 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 50 ug/ml) DME2062 XEOTICID XEO03440 GENEFORM Protein DME2062 XEOTICID XEO03440 MOACRIVE Inhibition DME2062 XEOTICID XEO03441 XEO_NAME Gaegurin-6 DME2062 XEOTICID XEO03441 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO03441 XEO_CLAS Peptide DME2062 XEOTICID XEO03441 DESCRIPT Gaegurin-6 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 50 ug/ml) DME2062 XEOTICID XEO03441 GENEFORM Protein DME2062 XEOTICID XEO03441 MOACRIVE Inhibition DME2062 XEOTICID XEO03706 XEO_NAME KCM12 peptide DME2062 XEOTICID XEO03706 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO03706 XEO_CLAS Peptide DME2062 XEOTICID XEO03706 DESCRIPT KCM12 peptide inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida DME2062 XEOTICID XEO03706 GENEFORM Protein DME2062 XEOTICID XEO03706 MOACRIVE Inhibition DME2062 XEOTICID XEO03707 XEO_NAME KCM21 peptide DME2062 XEOTICID XEO03707 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO03707 XEO_CLAS Peptide DME2062 XEOTICID XEO03707 DESCRIPT KCM21 peptide inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida DME2062 XEOTICID XEO03707 GENEFORM Protein DME2062 XEOTICID XEO03707 MOACRIVE Inhibition DME2062 XEOTICID XEO03971 XEO_NAME Lumbrican DME2062 XEOTICID XEO03971 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO03971 XEO_CLAS Peptide DME2062 XEOTICID XEO03971 DESCRIPT Lumbrican inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida DME2062 XEOTICID XEO03971 GENEFORM Protein DME2062 XEOTICID XEO03971 MOACRIVE Inhibition DME2062 XEOTICID XEO03985 XEO_NAME Magainin-2 DME2062 XEOTICID XEO03985 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO03985 XEO_CLAS Peptide DME2062 XEOTICID XEO03985 DESCRIPT Magainin-2 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 10 ug/ml) DME2062 XEOTICID XEO03985 GENEFORM Protein DME2062 XEOTICID XEO03985 MOACRIVE Inhibition DME2062 XEOTICID XEO04117 XEO_NAME Misgurin DME2062 XEOTICID XEO04117 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO04117 XEO_CLAS Peptide DME2062 XEOTICID XEO04117 DESCRIPT Misgurin inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida DME2062 XEOTICID XEO04117 GENEFORM Protein DME2062 XEOTICID XEO04117 MOACRIVE Inhibition DME2062 XEOTICID XEO04931 XEO_NAME Shepherin I DME2062 XEOTICID XEO04931 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO04931 XEO_CLAS Peptide DME2062 XEOTICID XEO04931 DESCRIPT Shepherin I inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida DME2062 XEOTICID XEO04931 GENEFORM Protein DME2062 XEOTICID XEO04931 MOACRIVE Inhibition DME2062 XEOTICID XEO04932 XEO_NAME shepherin II DME2062 XEOTICID XEO04932 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO04932 XEO_CLAS Peptide DME2062 XEOTICID XEO04932 DESCRIPT shepherin II inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida DME2062 XEOTICID XEO04932 GENEFORM Protein DME2062 XEOTICID XEO04932 MOACRIVE Inhibition DME2062 XEOTICID XEO05111 XEO_NAME Terpinene-4-ol DME2062 XEOTICID XEO05111 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2062 XEOTICID XEO05111 XEO_CLAS Natural Product DME2062 XEOTICID XEO05111 DESCRIPT Terpinene-4-ol inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida DME2062 XEOTICID XEO05111 GENEFORM Protein DME2062 XEOTICID XEO05111 MOACRIVE Inhibition DME2062 XEOTICID XEO05144 XEO_NAME Tigerinin-1 DME2062 XEOTICID XEO05144 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO05144 XEO_CLAS Peptide DME2062 XEOTICID XEO05144 DESCRIPT Tigerinin-1 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 40 ug/ml) DME2062 XEOTICID XEO05144 GENEFORM Protein DME2062 XEOTICID XEO05144 MOACRIVE Inhibition DME2062 XEOTICID XEO05145 XEO_NAME Tigerinin-2 DME2062 XEOTICID XEO05145 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO05145 XEO_CLAS Peptide DME2062 XEOTICID XEO05145 DESCRIPT Tigerinin-2 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 50 ug/ml) DME2062 XEOTICID XEO05145 GENEFORM Protein DME2062 XEOTICID XEO05145 MOACRIVE Inhibition DME2062 XEOTICID XEO05146 XEO_NAME Tigerinin-3 DME2062 XEOTICID XEO05146 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO05146 XEO_CLAS Peptide DME2062 XEOTICID XEO05146 DESCRIPT Tigerinin-3 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 40 ug/ml) DME2062 XEOTICID XEO05146 GENEFORM Protein DME2062 XEOTICID XEO05146 MOACRIVE Inhibition DME2062 XEOTICID XEO05147 XEO_NAME Tigerinin-4 DME2062 XEOTICID XEO05147 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO05147 XEO_CLAS Peptide DME2062 XEOTICID XEO05147 DESCRIPT Tigerinin-4 inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 60 ug/ml) DME2062 XEOTICID XEO05147 GENEFORM Protein DME2062 XEOTICID XEO05147 MOACRIVE Inhibition DME2062 XEOTICID XEO05260 XEO_NAME V. philippinarum beta defensin VpBD DME2062 XEOTICID XEO05260 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2062 XEOTICID XEO05260 XEO_CLAS Peptide DME2062 XEOTICID XEO05260 DESCRIPT V. philippinarum beta defensin VpBD inhibits the drug-metabolizing activity of Glycosyl hydrolase (glyH) from Pseudomonas putida (MIC = 1.64-3.28 microM) DME2062 XEOTICID XEO05260 GENEFORM Protein DME2062 XEOTICID XEO05260 MOACRIVE Inhibition DME2071 DME___ID DME2071 DME2071 DME_NAME Beta-lactamase (blaB) DME2071 SPESNAME Bacillus pumilus DME2071 XEOTICID XEO02412 XEO_NAME Tamarix aphylla bark extract DME2071 XEOTICID XEO02412 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2071 XEOTICID XEO02412 XEO_CLAS Plant Extract DME2071 XEOTICID XEO02412 DESCRIPT Tamarix aphylla bark extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus DME2071 XEOTICID XEO02412 GENEFORM Protein DME2071 XEOTICID XEO02412 MOACRIVE Inhibition DME2071 XEOTICID XEO02990 XEO_NAME Bacillus licheniformis SP1 culture supernatant DME2071 XEOTICID XEO02990 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2071 XEOTICID XEO02990 XEO_CLAS Bacterial Extract DME2071 XEOTICID XEO02990 DESCRIPT Bacillus licheniformis SP1 culture supernatant inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus DME2071 XEOTICID XEO02990 GENEFORM Protein DME2071 XEOTICID XEO02990 MOACRIVE Inhibition DME2071 XEOTICID XEO03300 XEO_NAME Esculentin-2-Ala DME2071 XEOTICID XEO03300 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2071 XEOTICID XEO03300 XEO_CLAS Peptide DME2071 XEOTICID XEO03300 DESCRIPT Esculentin-2-Ala inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus (MIC = 2.5 ug/ml) DME2071 XEOTICID XEO03300 GENEFORM Protein DME2071 XEOTICID XEO03300 MOACRIVE Inhibition DME2071 XEOTICID XEO03301 XEO_NAME Esculentin-2-ALb DME2071 XEOTICID XEO03301 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2071 XEOTICID XEO03301 XEO_CLAS Peptide DME2071 XEOTICID XEO03301 DESCRIPT Esculentin-2-ALb inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus (MIC = 2.5 ug/ml) DME2071 XEOTICID XEO03301 GENEFORM Protein DME2071 XEOTICID XEO03301 MOACRIVE Inhibition DME2071 XEOTICID XEO03678 XEO_NAME CP-P derivative K11 DME2071 XEOTICID XEO03678 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2071 XEOTICID XEO03678 XEO_CLAS Peptide DME2071 XEOTICID XEO03678 DESCRIPT CP-P derivative K11 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus (MIC = 0.5 ug/ml) DME2071 XEOTICID XEO03678 GENEFORM Protein DME2071 XEOTICID XEO03678 MOACRIVE Inhibition DME2071 XEOTICID XEO04711 XEO_NAME Insect PP102 peptide DME2071 XEOTICID XEO04711 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2071 XEOTICID XEO04711 XEO_CLAS Peptide DME2071 XEOTICID XEO04711 DESCRIPT Insect PP102 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus (MIC = 23.3 microM) DME2071 XEOTICID XEO04711 GENEFORM Protein DME2071 XEOTICID XEO04711 MOACRIVE Inhibition DME2071 XEOTICID XEO04712 XEO_NAME Insect PP113 peptide DME2071 XEOTICID XEO04712 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2071 XEOTICID XEO04712 XEO_CLAS Peptide DME2071 XEOTICID XEO04712 DESCRIPT Insect PP113 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus (MIC = 23.3 microM) DME2071 XEOTICID XEO04712 GENEFORM Protein DME2071 XEOTICID XEO04712 MOACRIVE Inhibition DME2071 XEOTICID XEO04713 XEO_NAME Insect PP13 peptide DME2071 XEOTICID XEO04713 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2071 XEOTICID XEO04713 XEO_CLAS Peptide DME2071 XEOTICID XEO04713 DESCRIPT Insect PP13 peptide inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus (MIC = 9 microM) DME2071 XEOTICID XEO04713 GENEFORM Protein DME2071 XEOTICID XEO04713 MOACRIVE Inhibition DME2071 XEOTICID XEO04987 XEO_NAME Acacia arabica stem extract DME2071 XEOTICID XEO04987 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2071 XEOTICID XEO04987 XEO_CLAS Plant Extract DME2071 XEOTICID XEO04987 DESCRIPT Acacia arabica stem extract inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus DME2071 XEOTICID XEO04987 GENEFORM Protein DME2071 XEOTICID XEO04987 MOACRIVE Inhibition DME2071 XEOTICID XEO05077 XEO_NAME Temporin-ALd DME2071 XEOTICID XEO05077 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2071 XEOTICID XEO05077 XEO_CLAS Peptide DME2071 XEOTICID XEO05077 DESCRIPT Temporin-ALd inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus (MIC = 2.5 ug/ml) DME2071 XEOTICID XEO05077 GENEFORM Protein DME2071 XEOTICID XEO05077 MOACRIVE Inhibition DME2071 XEOTICID XEO05078 XEO_NAME Temporin-ALe DME2071 XEOTICID XEO05078 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2071 XEOTICID XEO05078 XEO_CLAS Peptide DME2071 XEOTICID XEO05078 DESCRIPT Temporin-ALe inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus (MIC = 5 ug/ml) DME2071 XEOTICID XEO05078 GENEFORM Protein DME2071 XEOTICID XEO05078 MOACRIVE Inhibition DME2071 XEOTICID XEO05079 XEO_NAME Temporin-ALf DME2071 XEOTICID XEO05079 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2071 XEOTICID XEO05079 XEO_CLAS Peptide DME2071 XEOTICID XEO05079 DESCRIPT Temporin-ALf inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus (MIC = 5 ug/ml) DME2071 XEOTICID XEO05079 GENEFORM Protein DME2071 XEOTICID XEO05079 MOACRIVE Inhibition DME2071 XEOTICID XEO05080 XEO_NAME Temporin-ALg DME2071 XEOTICID XEO05080 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2071 XEOTICID XEO05080 XEO_CLAS Peptide DME2071 XEOTICID XEO05080 DESCRIPT Temporin-ALg inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus (MIC = 2.5 ug/ml) DME2071 XEOTICID XEO05080 GENEFORM Protein DME2071 XEOTICID XEO05080 MOACRIVE Inhibition DME2071 XEOTICID XEO05081 XEO_NAME Temporin-ALh DME2071 XEOTICID XEO05081 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2071 XEOTICID XEO05081 XEO_CLAS Peptide DME2071 XEOTICID XEO05081 DESCRIPT Temporin-ALh inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus (MIC = 7.5 ug/ml) DME2071 XEOTICID XEO05081 GENEFORM Protein DME2071 XEOTICID XEO05081 MOACRIVE Inhibition DME2071 XEOTICID XEO05082 XEO_NAME Temporin-ALi DME2071 XEOTICID XEO05082 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2071 XEOTICID XEO05082 XEO_CLAS Peptide DME2071 XEOTICID XEO05082 DESCRIPT Temporin-ALi inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus (MIC = 7.5 ug/ml) DME2071 XEOTICID XEO05082 GENEFORM Protein DME2071 XEOTICID XEO05082 MOACRIVE Inhibition DME2071 XEOTICID XEO05083 XEO_NAME Temporin-ALj DME2071 XEOTICID XEO05083 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2071 XEOTICID XEO05083 XEO_CLAS Peptide DME2071 XEOTICID XEO05083 DESCRIPT Temporin-ALj inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Bacillus pumilus (MIC = 15 ug/ml) DME2071 XEOTICID XEO05083 GENEFORM Protein DME2071 XEOTICID XEO05083 MOACRIVE Inhibition DME2081 DME___ID DME2081 DME2081 DME_NAME Alpha-galactosidase (melA) DME2081 SPESNAME Lactobacillus salivarius DME2081 XEOTICID XEO04150 XEO_NAME Mundticin ATO6 DME2081 XEOTICID XEO04150 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2081 XEOTICID XEO04150 XEO_CLAS Peptide DME2081 XEOTICID XEO04150 DESCRIPT Mundticin ATO6 inhibits the drug-metabolizing activity of Alpha-galactosidase (melA) from Lactobacillus salivarius DME2081 XEOTICID XEO04150 GENEFORM Protein DME2081 XEOTICID XEO04150 MOACRIVE Inhibition DME2082 DME___ID DME2082 DME2082 DME_NAME Alpha-galactosidase (melA) DME2082 SPESNAME Lactobacillus brevis DME2082 XEOTICID XEO03771 XEO_NAME Bacteriocin lacticin Q DME2082 XEOTICID XEO03771 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2082 XEOTICID XEO03771 XEO_CLAS Peptide DME2082 XEOTICID XEO03771 DESCRIPT Bacteriocin lacticin Q inhibits the drug-metabolizing activity of Alpha-galactosidase (melA) from Lactobacillus brevis DME2082 XEOTICID XEO03771 GENEFORM Protein DME2082 XEOTICID XEO03771 MOACRIVE Inhibition DME2100 DME___ID DME2100 DME2100 DME_NAME Beta-lactamase (blaB) DME2100 SPESNAME Burkholderia multivorans DME2100 XEOTICID XEO00568 XEO_NAME Resveratrol DME2100 XEOTICID XEO00568 XEO_TYPE Pharmaceutical Agent(s) DME2100 XEOTICID XEO00568 XEO_CLAS Drug in Phase 3 Clinical Trial DME2100 XEOTICID XEO00568 DESCRIPT Resveratrol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia multivorans DME2100 XEOTICID XEO00568 GENEFORM Protein DME2100 XEOTICID XEO00568 MOACRIVE Inhibition DME2100 XEOTICID XEO00613 XEO_NAME Epigallocatechin gallate DME2100 XEOTICID XEO00613 XEO_TYPE Pharmaceutical Agent(s) DME2100 XEOTICID XEO00613 XEO_CLAS Drug in Phase 3 Clinical Trial DME2100 XEOTICID XEO00613 DESCRIPT Epigallocatechin gallate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia multivorans DME2100 XEOTICID XEO00613 GENEFORM Protein DME2100 XEOTICID XEO00613 MOACRIVE Inhibition DME2100 XEOTICID XEO00683 XEO_NAME Curcumin DME2100 XEOTICID XEO00683 XEO_TYPE Pharmaceutical Agent(s) DME2100 XEOTICID XEO00683 XEO_CLAS Drug in Phase 3 Clinical Trial DME2100 XEOTICID XEO00683 DESCRIPT Curcumin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia multivorans DME2100 XEOTICID XEO00683 GENEFORM Protein DME2100 XEOTICID XEO00683 MOACRIVE Inhibition DME2100 XEOTICID XEO01212 XEO_NAME Baicalein DME2100 XEOTICID XEO01212 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2100 XEOTICID XEO01212 XEO_CLAS Natural Product DME2100 XEOTICID XEO01212 DESCRIPT Baicalein inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia multivorans DME2100 XEOTICID XEO01212 GENEFORM Protein DME2100 XEOTICID XEO01212 MOACRIVE Inhibition DME2100 XEOTICID XEO01253 XEO_NAME Cinnamic aldehyde DME2100 XEOTICID XEO01253 XEO_TYPE Natural Product(s), Extract(s) or Medicine(s) DME2100 XEOTICID XEO01253 XEO_CLAS Natural Product DME2100 XEOTICID XEO01253 DESCRIPT Cinnamic aldehyde inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia multivorans DME2100 XEOTICID XEO01253 GENEFORM Protein DME2100 XEOTICID XEO01253 MOACRIVE Inhibition DME2100 XEOTICID XEO01291 XEO_NAME Esculetin DME2100 XEOTICID XEO01291 XEO_TYPE Pharmaceutical Agent(s) DME2100 XEOTICID XEO01291 XEO_CLAS Preclinical/Patented Drug DME2100 XEOTICID XEO01291 DESCRIPT Esculetin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia multivorans DME2100 XEOTICID XEO01291 GENEFORM Protein DME2100 XEOTICID XEO01291 MOACRIVE Inhibition DME2100 XEOTICID XEO01298 XEO_NAME Farnesol DME2100 XEOTICID XEO01298 XEO_TYPE Pharmaceutical Agent(s) DME2100 XEOTICID XEO01298 XEO_CLAS Investigative Agent DME2100 XEOTICID XEO01298 DESCRIPT Farnesol inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia multivorans DME2100 XEOTICID XEO01298 GENEFORM Protein DME2100 XEOTICID XEO01298 MOACRIVE Inhibition DME2100 XEOTICID XEO01933 XEO_NAME 6-Fluoroanthranilic acid DME2100 XEOTICID XEO01933 XEO_TYPE Other Chemical Compound(s) or Element(s) DME2100 XEOTICID XEO01933 XEO_CLAS Chemical Compound DME2100 XEOTICID XEO01933 DESCRIPT 6-Fluoroanthranilic acid inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia multivorans DME2100 XEOTICID XEO01933 GENEFORM Protein DME2100 XEOTICID XEO01933 MOACRIVE Inhibition DME2100 XEOTICID XEO02786 XEO_NAME Ceftazidime hydrate DME2100 XEOTICID XEO02786 XEO_TYPE Pharmaceutical Agent(s) DME2100 XEOTICID XEO02786 XEO_CLAS Approved/Marketed Drug DME2100 XEOTICID XEO02786 DESCRIPT Ceftazidime hydrate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia multivorans DME2100 XEOTICID XEO02786 GENEFORM Protein DME2100 XEOTICID XEO02786 MOACRIVE Inhibition DME2100 XEOTICID XEO03324 XEO_NAME Esculin hydrate DME2100 XEOTICID XEO03324 XEO_TYPE Pharmaceutical Agent(s) DME2100 XEOTICID XEO03324 XEO_CLAS Investigative Agent DME2100 XEOTICID XEO03324 DESCRIPT Esculin hydrate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia multivorans DME2100 XEOTICID XEO03324 GENEFORM Protein DME2100 XEOTICID XEO03324 MOACRIVE Inhibition DME2100 XEOTICID XEO03812 XEO_NAME L-Canavanine DME2100 XEOTICID XEO03812 XEO_TYPE Pharmaceutical Agent(s) DME2100 XEOTICID XEO03812 XEO_CLAS Investigative Agent DME2100 XEOTICID XEO03812 DESCRIPT L-Canavanine inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Burkholderia multivorans DME2100 XEOTICID XEO03812 GENEFORM Protein DME2100 XEOTICID XEO03812 MOACRIVE Inhibition DME2103 DME___ID DME2103 DME2103 DME_NAME Phosphotransferase enzyme strB (strB) DME2103 SPESNAME Erwinia amylovora DME2103 XEOTICID XEO02383 XEO_NAME Bacteriocin serracin-P 23 kDa DME2103 XEOTICID XEO02383 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2103 XEOTICID XEO02383 XEO_CLAS Peptide DME2103 XEOTICID XEO02383 DESCRIPT Bacteriocin serracin-P 23 kDa inhibits the drug-metabolizing activity of Phosphotransferase enzyme strB (strB) from Erwinia amylovora DME2103 XEOTICID XEO02383 GENEFORM Protein DME2103 XEOTICID XEO02383 MOACRIVE Inhibition DME2103 XEOTICID XEO02384 XEO_NAME Bacteriocin serracin-P 43 kDa DME2103 XEOTICID XEO02384 XEO_TYPE Amino Acid(s), Peptide(s) or Protein(s) DME2103 XEOTICID XEO02384 XEO_CLAS Peptide DME2103 XEOTICID XEO02384 DESCRIPT Bacteriocin serracin-P 43 kDa inhibits the drug-metabolizing activity of Phosphotransferase enzyme strB (strB) from Erwinia amylovora DME2103 XEOTICID XEO02384 GENEFORM Protein DME2103 XEOTICID XEO02384 MOACRIVE Inhibition >END